PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Kim, JW; Myung, SJ; Yoon, HB; Moon, SH; Ryu, H; Yim, JJ				Kim, Ju Whi; Myung, Sun Jung; Yoon, Hyun Bae; Moon, Sang Hui; Ryu, Hyunjin; Yim, Jae-Joon			How medical education survives and evolves during COVID-19: Our experience and future direction	PLOS ONE			English	Article								Background Due to the outbreak of coronavirus disease 2019 (COVID-19), school openings were postponed worldwide as a way to stop its spread. Most classes are moving online, and this includes medical school classes. The authors present their experience of running such online classes with offline clinical clerkship under pandemic conditions, and also present data on student satisfaction, academic performance, and preference. Methods The medical school changed every first-year to fourth-year course to an online format except the clinical clerkship, clinical skills training, and basic laboratory classes such as anatomy lab sessions. Online courses were pre-recorded video lectures or live-streamed using video communication software. At the end of each course, students and professors were asked to report their satisfaction with the online course and comment on it. The authors also compared students' academic performance before and after the introduction of online courses. Results A total of 69.7% (318/456) of students and 35.2% (44/125) of professors answered the questionnaire. Students were generally satisfied with the online course and 62.2% of them preferred the online course to the offline course. The majority (84.3%) of the students wanted to maintain the online course after the end of COVID-19. In contrast, just 13.6% of professors preferred online lectures and half (52.3%) wanted to go back to the offline course. With the introduction of online classes, students' academic achievement did not change significantly in four subjects, but decreased in two subjects. Conclusions The inevitable transformation of medical education caused by COVID-19 is still ongoing. As the safety of students and the training of competent physicians are the responsibilities of medical schools, further research into how future physicians will be educated is needed.	[Kim, Ju Whi; Myung, Sun Jung; Yoon, Hyun Bae; Moon, Sang Hui; Ryu, Hyunjin; Yim, Jae-Joon] Seoul Natl Univ, Coll Med, Off Med Educ, Seoul, South Korea; [Yim, Jae-Joon] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Myung, SJ (corresponding author), Seoul Natl Univ, Coll Med, Off Med Educ, Seoul, South Korea.	issac73@snu.ac.kr		Yim, Jae-Joon/0000-0002-9605-0074; Kim, Ju Whi/0000-0001-8011-3547; Myung, Sun Jung/0000-0001-7332-0126				[Anonymous], 2020, J SW U NATL SCIED, V42, P1, DOI 10.13718/j.cnki.xdzk.2020.07.001; Ashokka B, 2020, MED TEACH, V42, P762, DOI 10.1080/0142159X.2020.1757634; Brockfeld Thomas, 2018, Med Educ Online, V23, P1555434, DOI 10.1080/10872981.2018.1555434; Cheng B, 2014, EDUC RES REV-NETH, V11, P56, DOI 10.1016/j.edurev.2014.01.001; George PP, 2014, J GLOB HEALTH, V4, DOI 10.7189/jogh.04.010406; Huynh R, 2017, ACAD MED, V92, P430, DOI 10.1097/ACM.0000000000001596; Korean Soc Infect Dis, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e112; Lakhani M, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2220; Lee H, 2006, 7 INT C ED RES SEOUL, P392; Liu Q, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.4807; Ramlogan S, 2014, EUR J DENT EDUC, V18, P31, DOI 10.1111/eje.12053; Ranasinghe L, 2019, MED EDUC ONLINE, V24, DOI 10.1080/10872981.2019.1583970; Ruiz JG, 2006, ACAD MED, V81, P207, DOI 10.1097/00001888-200603000-00002; Shepherd SSG, 2004, RELATIONSHIPS COMPUT; Tolsgaard MG, 2020, MED TEACH, V42, P741, DOI 10.1080/0142159X.2020.1767769; WHO Thailand, 2020, JOINT INTR REV PUBL; Wolcott LL, 2003, HANDBOOK OF DISTANCE EDUCATION, P549; Woolliscroft JO, 2020, ACAD MED, V95, P1140, DOI 10.1097/ACM.0000000000003402	18	34	34	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0243958	10.1371/journal.pone.0243958	http://dx.doi.org/10.1371/journal.pone.0243958			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8CZ	33338045	Green Published, gold			2022-12-27	WOS:000601313500042
J	Arnadottir, SS; Mattesen, TB; Vang, S; Madsen, MR; Madsen, AH; Birkbak, NJ; Bramsen, JB; Andersen, CL				arnadottir, Sigrid Salling; Mattesen, Trine Block; Vang, Soren; Madsen, Mogens Rorbaek; Madsen, Anders Husted; Birkbak, Nicolai Juul; Bramsen, Jesper Bertram; Andersen, Claus Lindbjerg			Transcriptomic and proteomic intra-tumor heterogeneity of colorectal cancer varies depending on tumor location within the colorectum	PLOS ONE			English	Article							CONSENSUS MOLECULAR SUBTYPES; INTRATUMORAL HETEROGENEITY; COLON-CANCER; PACKAGE; DISTAL	Background Intra-tumor heterogeneity (ITH) of colorectal cancer (CRC) complicates molecular tumor classification, such as transcriptional subtyping. Differences in cellular states, biopsy cell composition, and tumor microenvironment may all lead to ITH. Here we analyze ITH at the transcriptomic and proteomic levels to ascertain whether subtype discordance between multiregional biopsies reflects relevant biological ITH or lack of classifier robustness. Further, we study the impact of tumor location on ITH. Methods Multiregional biopsies from stage II and III CRC tumors were analyzed by RNA sequencing (41 biopsies, 14 tumors) and multiplex immune protein analysis (89 biopsies, 29 tumors). CRC subtyping was performed using consensus molecular subtypes (CMS), CRC intrinsic subtypes (CRIS), and TUMOR types. ITH-scores and network maps were defined to determine the origin of heterogeneity. A validation cohort was used with one biopsy per tumor (162 tumors). Results Overall, inter-tumor transcriptional variation exceeded ITH, and subtyping calls were frequently concordant between multiregional biopsies. Still, some tumors had high transcriptional ITH and were classified discordantly. Subtyping of proximal MSS tumors were discordant for 50% of the tumors, this ITH was related to differences in the microenvironment. Subtyping of distal MSS tumors were less discordant, here the ITH was more cancer-cell related. The subtype discordancy reflected actual molecular ITH within the tumors. The relevance of the subtypes was reflected at protein level where several inflammation markers were significantly increased in immune related transcriptional subtypes, which was verified in an independent cohort (Wilcoxon rank sum test; p<0.05). Unsupervised hierarchical clustering of the protein data identified large ITH at protein level; as the multiregional biopsies clustered together for only 9 out of 29 tumors. Conclusion Our transcriptomic and proteomic analyses show that the tumor location along the colorectum influence the ITH of CRC, which again influence the concordance of subtyping.	[arnadottir, Sigrid Salling; Mattesen, Trine Block; Vang, Soren; Birkbak, Nicolai Juul; Bramsen, Jesper Bertram; Andersen, Claus Lindbjerg] Aarhus Univ Hosp, Dept Mol Med, Aarhus, Denmark; [arnadottir, Sigrid Salling; Mattesen, Trine Block; Vang, Soren; Madsen, Anders Husted; Birkbak, Nicolai Juul; Bramsen, Jesper Bertram; Andersen, Claus Lindbjerg] Aarhus Univ, Dept Clin Med, Aarhus, Denmark; [Madsen, Mogens Rorbaek; Madsen, Anders Husted] Herning Reg Hosp, Dept Surg, Surg Res Unit, Herning, Denmark	Aarhus University; Aarhus University; Aarhus University	Andersen, CL (corresponding author), Aarhus Univ Hosp, Dept Mol Med, Aarhus, Denmark.; Andersen, CL (corresponding author), Aarhus Univ, Dept Clin Med, Aarhus, Denmark.	cla@clin.au.dk	; Andersen, Claus Lindbjerg/A-9217-2012	Block Mattesen, Trine/0000-0002-8608-8589; Vang, Soren/0000-0002-1899-4205; Andersen, Claus Lindbjerg/0000-0002-7406-2103; Birkbak, Nicolai/0000-0003-1613-9587	Aarhus University; Dagmar Marshalls Foundation; Aage and Johanne LouisHansen's Foundation; Novo Nordisk Foundation [NNF16OC0023182]; Danish Cancer Society [R40-A1965_11_S2, R56-A311012-S2, R107-A7035, R133-A8520]; Danish Council for Independent Research (Medical Sciences) [DFF-0602-02128B, DFF-4183-00619]; National Cancer Institute [R01 CA207467]	Aarhus University; Dagmar Marshalls Foundation; Aage and Johanne LouisHansen's Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Cancer Society(Danish Cancer Society); Danish Council for Independent Research (Medical Sciences)(Det Frie Forskningsrad (DFF)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by Aarhus University (SSA), The Dagmar Marshalls Foundation (SSA), Aage and Johanne LouisHansen's Foundation (SSA), the Novo Nordisk Foundation (NNF16OC0023182) (JBB), the Danish Cancer Society (R40-A1965_11_S2, R56-A311012-S2, R107-A7035, R133-A8520), the Danish Council for Independent Research (Medical Sciences) (DFF-0602-02128B, DFF-4183-00619) (CLA), and the National Cancer Institute (R01 CA207467) (CLA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Arnadottir SS, 2018, MOL ONCOL, V12, P132, DOI 10.1002/1878-0261.12156; Berntsson J, 2017, INT J CANCER, V141, P1654, DOI 10.1002/ijc.30869; Bramsen JB, 2017, CELL REP, V19, P1268, DOI 10.1016/j.celrep.2017.04.045; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cremonesi E, 2018, GUT, V67, P1984, DOI 10.1136/gutjnl-2016-313498; Donaldson GP, 2016, NAT REV MICROBIOL, V14, P20, DOI 10.1038/nrmicro3552; Dunne PD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15657; Dunne PD, 2016, CLIN CANCER RES, V22, P4095, DOI 10.1158/1078-0432.CCR-16-0032; Eisenberg E, 2013, TRENDS GENET, V29, P569, DOI 10.1016/j.tig.2013.05.010; Gallois C, 2018, DRUGS, V78, P789, DOI 10.1007/s40265-018-0921-7; Gaujoux R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-367; Guinney J, 2015, NAT MED, V21, P1350, DOI 10.1038/nm.3967; Hedegaard J, 2016, CANCER CELL, V30, P27, DOI 10.1016/j.ccell.2016.05.004; Isella C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15107; Isella C, 2015, NAT GENET, V47, P312, DOI 10.1038/ng.3224; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Lee GH, 2015, EJSO-EUR J SURG ONC, V41, P300, DOI 10.1016/j.ejso.2014.11.001; Lee WC, 2018, MODERN PATHOL, V31, P947, DOI 10.1038/s41379-018-0029-3; Lex A, 2012, COMPUT GRAPH FORUM, V31, P1175, DOI 10.1111/j.1467-8659.2012.03110.x; Mary Goldman B. C., 2019, BIORXIV, DOI [DOI 10.1101/326470, 10.1101/326470]; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Missiaglia E, 2014, ANN ONCOL, V25, P1995, DOI 10.1093/annonc/mdu275; Molinari C, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123733; Mowat AM, 2014, NAT REV IMMUNOL, V14, P667, DOI 10.1038/nri3738; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; NIH_GDC-Data-Portal, 2019, TCGA GEN LIST DOWNL; Paski SC, 2007, AM J GASTROENTEROL, V102, P2294, DOI 10.1111/j.1572-0241.2007.01389.x; Puppa G, 2010, ARCH PATHOL LAB MED, V134, P837, DOI 10.1043/1543-2165-134.6.837; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Ribatti D, 2007, LEUKEMIA, V21, P2085, DOI 10.1038/sj.leu.2404900; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suraweera N, 2002, GASTROENTEROLOGY, V123, P1804, DOI 10.1053/gast.2002.37070; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Suzuki Y, 2017, MOL ONCOL, V11, P124, DOI 10.1002/1878-0261.12012; Szmulowicz UM, 2011, J GASTROINTEST SURG, V15, P803, DOI 10.1007/s11605-011-1460-7; Tamas K, 2015, CANCER TREAT REV, V41, P671, DOI 10.1016/j.ctrv.2015.06.007; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Uchi R, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005778; Yamauchi M, 2012, GUT, V61, P847, DOI 10.1136/gutjnl-2011-300865; Yang SY, 2018, EXPERT REV ANTICANC, V18, P351, DOI 10.1080/14737140.2018.1442217	43	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0241148	10.1371/journal.pone.0241148	http://dx.doi.org/10.1371/journal.pone.0241148			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332369	Green Published, gold			2022-12-27	WOS:000601310900095
J	Grima, N; Corcoran, W; Hill-James, C; Langton, B; Sommer, H; Fisher, B				Grima, Nelson; Corcoran, Will; Hill-James, Corinne; Langton, Benjamin; Sommer, Haley; Fisher, Brendan			The importance of urban natural areas and urban ecosystem services during the COVID-19 pandemic	PLOS ONE			English	Article							INNER-CITY; ENVIRONMENTS; VEGETATION; OUTCOMES; HEALTH	Urban, peri-urban forests and other natural areas provide a wide range of material and non-material benefits to people known as ecosystem services. Access to these areas has been linked to benefits for physical and mental health of local populations. In the spring of 2020, the COVID-19 global pandemic forced many governments to impose a set of restrictions including the closure of businesses, cancelation of public events and schooling, social distancing, limitations on the size of social gatherings, and travel restrictions. During this period of restrictions, we conducted a study assessing the importance of urban and peri-urban forests and other natural areas to people living in and around the city of Burlington, Vermont, USA. We evaluated the self-reported use and changes in personal importance related to these natural areas before and during the period of restrictions. We received over 400 responses to our field survey. The results show that 69.0% of the respondents had increased or greatly increased their visitation rate to our natural areas and urban forests, and 80.6% of respondents considered that the importance of these areas, and access to them, either increased or greatly increased. Moreover 25.8% of the sample had either never, or very rarely accessed their local natural areas before the pandemic, but 69.2% of the first time or infrequent visitors reported that having access to these areas during COVID-19 as 'very important'. People reported that these areas were important for a wide range of activities from exercise to birding, but also reported values related to reducing stress in a time of global chaos. Our results indicate the increasing demand and value of such areas in times of crisis such as COVID-19. Experts in zoonotic disease predict the potential for more frequent pandemic events, thus predicating the importance for continued funding for, maintenance of, and improved access to, natural areas to our largely urban civilization.	[Grima, Nelson; Corcoran, Will; Hill-James, Corinne; Langton, Benjamin; Sommer, Haley; Fisher, Brendan] Univ Vermont, Environm Program, Rubenstein Sch Environm & Nat Resources, Burlington, VT 05405 USA; [Fisher, Brendan] Univ Vermont, Gund Inst Environm, Burlington, VT USA	University of Vermont; University of Vermont	Grima, N (corresponding author), Univ Vermont, Environm Program, Rubenstein Sch Environm & Nat Resources, Burlington, VT 05405 USA.	nelson.grima@uvm.edu		Grima, Nelson/0000-0001-5563-691X	Ian Worley Award at the University of Vermont	Ian Worley Award at the University of Vermont	The Environmental Program and Ian Worley Award at the University of Vermont supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annerstedt M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-337; [Anonymous], 2005, MILLENNIUM ECOSYSTEM; Bateman IJ, 2013, SCIENCE, V341, P45, DOI 10.1126/science.1234379; Branas CC, 2011, AM J EPIDEMIOL, V174, P1296, DOI 10.1093/aje/kwr273; Bratman GN, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax0903; Bratman GN, 2012, ANN NY ACAD SCI, V1249, P118, DOI 10.1111/j.1749-6632.2011.06400.x; CDC-Centers for Disease Control and Prevention, 2020, COVID 19 FOR; Chan KMA, 2011, NATURAL CAPITAL: THEORY & PRACTICE OF MAPPING ECOSYSTEM SERVICES, P206; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Chiesura A, 2004, LANDSCAPE URBAN PLAN, V68, P129, DOI 10.1016/j.landurbplan.2003.08.003; de Bell S, 2020, LANDSCAPE URBAN PLAN, V200, DOI 10.1016/j.landurbplan.2020.103836; Eigenschenk B, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16060937; Fan Y, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11030210; Gladkikh TM, 2019, ECOSYST SERV, V40, DOI 10.1016/j.ecoser.2019.101036; Golding SE, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15020300; Gomez-Baggethun Erik, 2013, P175; Gomez-Baggethun E, 2013, ECOL ECON, V86, P235, DOI 10.1016/j.ecolecon.2012.08.019; Goodier M, 2020, CITYMETRIC; Hartig T, 2014, ANNU REV PUBL HEALTH, V35, P207, DOI 10.1146/annurev-publhealth-032013-182443; Hitchings R, 2016, T I BRIT GEOGR, V41, P503, DOI 10.1111/tran.12138; Honey-Roses J., 2020, CITIES HLTH, V5, pS263, DOI [10., DOI 10.1080/23748834.2020.1780074, 10.1080/23748834.2020.1780074]; iek Slavoj., 2020, COVID 19 CORONAVIRUS; Jager J, 2017, MONOGR SOC RES CHILD, V82, P13, DOI 10.1111/mono.12296; Kaplan R, 2001, ENVIRON BEHAV, V33, P507, DOI 10.1177/00139160121973115; Keeler BL, 2019, NAT SUSTAIN, V2, P29, DOI 10.1038/s41893-018-0202-1; Kuo FE, 2001, ENVIRON BEHAV, V33, P343, DOI 10.1177/00139160121973025; Kuo FE, 2001, ENVIRON BEHAV, V33, P543, DOI 10.1177/00139160121973124; Lamdin C., 2020, SEVENDAYS VT    0320; Larson LR, 2016, ECOSYST SERV, V22, P111, DOI 10.1016/j.ecoser.2016.10.004; Lawson S. R., 2006, Journal of Sustainable Tourism, V14, P600, DOI 10.2167/jost625.0; Lu HZ, 2020, J MED VIROL, V92, P401, DOI [10.1002/jmv.25678, 10.1002/jmv.2567]; Mabon L, 2019, LANDSCAPE URBAN PLAN, V187, P105, DOI 10.1016/j.landurbplan.2019.03.013; Mackenzie SH, 2021, LEISURE SCI, V43, P62, DOI 10.1080/01490400.2020.1773984; Marrone J, 1999, PSYCHIATR REHABIL J, V23, P187, DOI 10.1037/h0095171; Natural Areas Lab, 2019, DAT SPEC LIV U UNPUB; Nesbitt L, 2019, LANDSCAPE URBAN PLAN, V181, P51, DOI 10.1016/j.landurbplan.2018.08.007; Nguyen MN, 2010, PLOS ONE, V5, pe9907; OIA, 2017, VERM OUTD RECR EC RE; Ottosson J, 2008, LANDSCAPE RES, V33, P51, DOI 10.1080/01426390701773813; Poole W, 2006, SEVENTEENTH CENT, V21, P45, DOI 10.1080/0268117X.2006.10555567; Poulsen DV, 2018, HEALTHCARE-BASEL, V6, DOI 10.3390/healthcare6020064; Poulsen DV, 2017, J PUBLIC MENT HEALTH, V16, P15, DOI 10.1108/JPMH-08-2016-0039; Pretty J, 2005, INT J ENVIRON HEAL R, V15, P319, DOI 10.1080/09603120500155963; Sachdeva S, 2018, SOC NATUR RESOUR, V31, P977, DOI 10.1080/08941920.2018.1450914; Schwartz AJ, 2019, PEOPLE NAT, V1, P476, DOI 10.1002/pan3.10045; Servedio D., 2020, STAR LEDGER; Sinha CC, 2004, CAUTHE 2004 CREATING, V702; Slater SJ, 2020, PREV CHRONIC DIS, V17, DOI 10.5888/pcd17.200204; Takano T, 2002, J EPIDEMIOL COMMUN H, V56, P913, DOI 10.1136/jech.56.12.913; Tamosiunas A, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-20; U.S. Census Bureau, 2019, POP EST VERM US; UN-WTO, 2002, SUST TOUR PROT AR GU, DOI DOI 10.18111/9789284405435; UVM, 2019, UVM NAT AR; Venter ZS, 2020, ENVIRON RES LETT, V15, DOI 10.1088/1748-9326/abb396; Verkehrsclub Osterreich VCO - Mobilitat mit Zukunft, 2014, VOC MAGAZIN, V6, P5; Wang J, 2020, ENVIRON RES LETT, V15, DOI 10.1088/1748-9326/ab719f; Weed M., 2020, J SPORT TOUR, V24, P79, DOI [10.1080/14775085.2020.1794351, DOI 10.1080/14775085.2020.1794351, DOI 10.1080/14775085.2020.1794351,0]	57	82	82	21	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243344	10.1371/journal.pone.0243344	http://dx.doi.org/10.1371/journal.pone.0243344			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PI8BZ	33332364	Green Published, gold, Green Submitted			2022-12-27	WOS:000601310900065
J	Hamedani, Y; Chakraborty, S; Sabarwal, A; Pal, S; Bhowmick, S; Balan, M				Hamedani, Yasaman; Chakraborty, Samik; Sabarwal, Akash; Pal, Soumitro; Bhowmick, Sankha; Balan, Murugabaskar			Novel Honokiol-eluting PLGA-based scaffold effectively restricts the growth of renal cancer cells	PLOS ONE			English	Article							CONTROLLED DRUG-DELIVERY; ELECTROSPUN NANOFIBERS; RELEASE	Renal Cell Carcinoma (RCC) often becomes resistant to targeted therapies, and in addition, dose-dependent toxicities limit the effectiveness of therapeutic agents. Therefore, identifying novel drug delivery approaches to achieve optimal dosing of therapeutic agents can be beneficial in managing toxicities and to attain optimal therapeutic effects. Previously, we have demonstrated that Honokiol, a natural compound with potent anti-tumorigenic and anti-inflammatory effects, can induce cancer cell apoptosis and inhibit the growth of renal tumors in vivo. In cancer treatment, implant-based drug delivery systems can be used for gradual and sustained delivery of therapeutic agents like Honokiol to minimize systemic toxicity. Electrospun polymeric fibrous scaffolds are ideal candidates to be used as drug implants due to their favorable morphological properties such as high surface to volume ratio, flexibility and ease of fabrication. In this study, we fabricated Honokiol-loaded Poly(lactide-co-glycolide) (PLGA) electrospun scaffolds; and evaluated their structural characterization and biological activity. Proton nuclear magnetic resonance data proved the existence of Honokiol in the drug loaded polymeric scaffolds. The release kinetics showed that only 24% of the loaded Honokiol were released in 24hr, suggesting that sustained delivery of Honokiol is feasible. We calculated the cumulative concentration of the Honokiol released from the scaffold in 24hr; and the extent of renal cancer cell apoptosis induced with the released Honokiol is similar to an equivalent concentration of direct application of Honokiol. Also, Honokiol-loaded scaffolds placed directly in renal cell culture inhibited renal cancer cell proliferation and migration. Together, we demonstrate that Honokiol delivered through electrospun PLGA-based scaffolds is effective in inhibiting the growth of renal cancer cells; and our data necessitates further in vivo studies to explore the potential of sustained release of therapeutic agents-loaded electrospun scaffolds in the treatment of RCC and other cancer types.	[Hamedani, Yasaman; Bhowmick, Sankha] Univ Massachusetts, Biomed Engn & Biotechnol Program, Dept Mech Engn, Dartmouth, MA 02747 USA; [Chakraborty, Samik; Sabarwal, Akash; Pal, Soumitro; Balan, Murugabaskar] Boston Childrens Hosp, Div Nephrol, Boston, MA USA; [Chakraborty, Samik; Sabarwal, Akash; Pal, Soumitro; Balan, Murugabaskar] Harvard Med Sch, Boston, MA 02115 USA	University of Massachusetts System; University Massachusetts Dartmouth; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Bhowmick, S (corresponding author), Univ Massachusetts, Biomed Engn & Biotechnol Program, Dept Mech Engn, Dartmouth, MA 02747 USA.; Balan, M (corresponding author), Boston Childrens Hosp, Div Nephrol, Boston, MA USA.; Balan, M (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	murugabaskar.balan@childrens.harvard.edu; sbhowmick@umassd.edu	Sabarwal, Akash/AAD-3605-2021; Sabarwal, Akash/AAG-9554-2021; Chakraborty, Samik/Q-1779-2018	Sabarwal, Akash/0000-0003-1760-4903; Chakraborty, Samik/0000-0002-5232-0474	National Institute of Health [R01 CA193675, R01 CA222355, R03 CA219731, R03 CA230944]; Office of the Provost at University of Massachusetts Dartmouth; National Science Foundation [1726239]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of the Provost at University of Massachusetts Dartmouth; National Science Foundation(National Science Foundation (NSF))	The work has been funded by the National Institute of Health Grants R01 CA193675 and R01 CA222355 (to S.P.), R03 CA219731 and R03 CA230944 (to M.B.), as well as "Multiinstitutional Collaborative Seed Funding Program" (2019-2020) provided by the Office of the Provost at University of Massachusetts Dartmouth (to S. B.). The electron microscopy images in this work were obtained using a scanning electron microscope supported by the National Science Foundation under Grant No. 1726239.	Akhgari A, 2013, ADV PHARM BULL, V3, P85, DOI 10.5681/apb.2013.014; [Anonymous], 2017, ECONOMICS-KIEL, V6, P1, DOI 10.1057/s11369-017-0051-3; Balan M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05455-1; Banerjee P, 2013, CANCER LETT, V338, P292, DOI 10.1016/j.canlet.2013.05.036; Bruneau M, 2019, J CONTROL RELEASE, V294, P355, DOI 10.1016/j.jconrel.2018.12.038; Chen SX, 2018, ADV DRUG DELIVER REV, V132, P188, DOI 10.1016/j.addr.2018.05.001; Chien YW, 1992, NOVEL DRUG DELIVERY, V1992; Chomachayi MD, 2018, J BIOMED MATER RES A, V106, P1092, DOI 10.1002/jbm.a.36303; Choueiri TK, 2017, NEW ENGL J MED, V376, P354, DOI 10.1056/NEJMra1601333; Crane C, 2009, J IMMUNOTHER, V32, P585, DOI 10.1097/CJI.0b013e3181a8efe6; Dag A, 2019, BIOMACROMOLECULES, V20, P2962, DOI 10.1021/acs.biomac.9b00528; Dana P, 2020, COLLOID SURFACE B, V196, DOI 10.1016/j.colsurfb.2020.111270; Davoodi P, 2018, ADV DRUG DELIVER REV, V132, P104, DOI 10.1016/j.addr.2018.07.002; Freitas LBD, 2017, MICROPOR MESOPOR MAT, V242, P271, DOI 10.1016/j.micromeso.2017.01.036; Fried LE, 2009, ANTIOXID REDOX SIGN, V11, P1139, DOI 10.1089/ARS.2009.2440; Graham J, 2019, EUR UROL ONCOL; Guo Y, 2018, ACTA BIOMATER, V80, P308, DOI 10.1016/j.actbio.2018.09.024; Hahn AW, 2019, EUR UROL ONCOL, V2, P708, DOI 10.1016/j.euo.2019.09.002; Hamedani Y, 2017, IRANIAN J CHEM ENG, V14, P3; Hamedani Y, 2020, J BIOMED MATER RES A, V108, P829, DOI 10.1002/jbm.a.36861; Hillery AM, 2017, DRUG DELIVERY: FUNDAMENTALS AND APPLICATIONS, 2ND EDITION, P1; Hu J, 2016, J PHARM SCI-US, V105, P1104, DOI 10.1016/S0022-3549(15)00191-4; Hu XL, 2014, J CONTROL RELEASE, V185, P12, DOI 10.1016/j.jconrel.2014.04.018; Jassal M, 2015, J BIOMAT SCI-POLYM E, V26, P1425, DOI 10.1080/09205063.2015.1100495; Ji W, 2010, ACTA BIOMATER, V6, P4199, DOI 10.1016/j.actbio.2010.05.025; Kajdic S, 2019, J DRUG DELIV SCI TEC, V51, P672, DOI 10.1016/j.jddst.2019.03.038; Kaljevic O, 2017, INT J PHARMACEUT, V533, P445, DOI 10.1016/j.ijpharm.2017.05.017; Karimian SAM, 2016, INT J BIOL MACROMOL, V88, P288, DOI 10.1016/j.ijbiomac.2016.03.061; Khampieng T, 2014, J BIOMAT SCI-POLYM E, V25, P1292, DOI 10.1080/09205063.2014.929431; Kim YJ, 2013, ADV FUNCT MATER, V23, P5753, DOI 10.1002/adfm.201300746; Kwa YC, 2020, J DRUG DELIV SCI TEC, V59, DOI 10.1016/j.jddst.2020.101905; Kydonieus AF, 1992, TREATISE CONTROLLED, V1992; LANGER RS, 1981, BIOMATERIALS, V2, P201, DOI 10.1016/0142-9612(81)90059-4; Li B, 2020, MATER TODAY CHEM, V17, DOI 10.1016/j.mtchem.2020.100308; Li XQ, 2013, COLLOID SURFACE B, V103, P182, DOI 10.1016/j.colsurfb.2012.10.016; Lu YJ, 2020, COLLOID SURFACE B, V189, DOI 10.1016/j.colsurfb.2020.110830; Nam S, 2017, INT J PHARMACEUT, P526, DOI 10.1016/j.ijpharm.2017.03.076; Paaver U, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/789765; Perez RA, 2015, ACTA BIOMATER, V21, P2, DOI 10.1016/j.actbio.2015.03.013; Poller B, 2017, EUR J PHARM BIOPHARM, V114, P213, DOI 10.1016/j.ejpb.2017.01.022; Rajendran P, 2012, J CELL PHYSIOL, V227, P2184, DOI 10.1002/jcp.22954; Sabarwal A, CANCERS BASEL; Sang QQ, 2017, MAT SCI ENG C-MATER, V81, P359, DOI 10.1016/j.msec.2017.08.007; Sirc J, 2017, PHARM RES-DORDR, V34, P1391, DOI 10.1007/s11095-017-2155-x; Stratton S, 2016, BIOACT MATER, V1, P93, DOI 10.1016/j.bioactmat.2016.11.001; Vachhani P, 2016, CLIN ADV HEMATOL ONC, V14, P1016; Virlan MJR, 2015, J CHEM-NY, V2015, DOI 10.1155/2015/525832; Wang S, 2014, MAT SCI ENG B, P190; Wang X, 2015, INT J PHARMACEUT, V490, P384, DOI 10.1016/j.ijpharm.2015.05.077; Wang YQ, 2020, CANCER BIOL MED, V17, P237, DOI 10.20892/j.issn.2095-3941.2019.0169; Wang YH, 2020, MATER DESIGN, V186, DOI 10.1016/j.matdes.2019.108336; Wright ME, 2017, J CONTROL RELEASE, V250, P107, DOI 10.1016/j.jconrel.2017.02.008; Yang YK, 2020, BIOMATERIALS, V230, DOI 10.1016/j.biomaterials.2019.119618; Yohe ST, 2012, J AM CHEM SOC, V134, P2016, DOI 10.1021/ja211148a; Yu SS, 2016, ONCOTARGETS THER, V9, P5825, DOI 10.2147/OTT.S97397; Yun J, 2011, EUR POLYM J, V47, P1893, DOI 10.1016/j.eurpolymj.2011.07.024; Zhang HY, 2020, ASIAN J PHARM SCI, V15, P397, DOI 10.1016/j.ajps.2019.11.004	57	4	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243837	10.1371/journal.pone.0243837	http://dx.doi.org/10.1371/journal.pone.0243837			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332399	Green Published, gold			2022-12-27	WOS:000601310900100
J	Mansell, DS; Frank, EG; Kelly, NS; Agostinho-Hernandez, B; Fletcher, J; Bruno, VD; Sammut, E; Chiribiri, A; Johnson, T; Ascione, R; Bartlett, JW; Gill, HS; Fraser, KH; Cookson, AN				Mansell, Doyin S.; Frank, Evelyn G.; Kelly, Nathaniel S.; Agostinho-Hernandez, Bruno; Fletcher, James; Bruno, Vito D.; Sammut, Eva; Chiribiri, Amedeo; Johnson, Thomas; Ascione, Raimondo; Bartlett, Jonathan W.; Gill, Harinderjit S.; Fraser, Katharine H.; Cookson, Andrew N.			Comparison of the within-reader and inter-vendor agreement of left ventricular circumferential strains and volume indices derived from cardiovascular magnetic resonance imaging	PLOS ONE			English	Article							INFARCT TRANSMURALITY; MYOCARDIAL-INFARCTION; VARIABILITY; QUANTIFICATION; HEART	Purpose Volume indices and left ventricular ejection fraction (LVEF) are routinely used to assess cardiac function. Ventricular strain values may provide additional diagnostic information, but their reproducibility is unclear. This study therefore compares the repeatability and reproducibility of volumes, volume fraction, and regional ventricular strains, derived from cardiovascular magnetic resonance (CMR) imaging, across three software packages and between readers. Methods Seven readers analysed 16 short-axis CMR stacks of a porcine heart. Endocardial contours were manually drawn using OsiriX and Simpleware ScanIP and repeated in both softwares. The images were also contoured automatically in Circle CVI42. Endocardial global, apical, mid-ventricular, and basal circumferential strains, as well as end-diastolic and end-systolic volume and LVEF were compared. Results Bland-Altman analysis found systematic biases in contour length between software packages. Compared to OsiriX, contour lengths were shorter in both ScanIP (-1.9 cm) and CVI42 (-0.6 cm), causing statistically significant differences in end-diastolic and end-systolic volumes, and apical circumferential strain (all p<0.006). No differences were found for mid-ventricular, basal or global strains, or left ventricular ejection fraction (all p<0.007). All CVI42 results lay within the ranges of the OsiriX results. Intra-software differences were found to be lower than inter-software differences. Conclusion OsiriX and CVI42 gave consistent results for all strain and volume metrics, with no statistical differences found between OsiriX and ScanIP for mid-ventricular, global or basal strains, or left ventricular ejection fraction. However, volumes were influenced by the choice of contouring software, suggesting care should be taken when comparing volumes across different software.	[Mansell, Doyin S.; Frank, Evelyn G.; Kelly, Nathaniel S.; Agostinho-Hernandez, Bruno; Gill, Harinderjit S.; Fraser, Katharine H.; Cookson, Andrew N.] Univ Bath, Dept Mech Engn, Bath, Avon, England; [Fletcher, James] Univ Bath, Dept Hlth, Bath, Avon, England; [Bruno, Vito D.; Sammut, Eva; Johnson, Thomas; Ascione, Raimondo] Univ Bristol, Fac Hlth Sci, Bristol Heart Inst & Translat Biomed Res Ctr, Bristol, Avon, England; [Chiribiri, Amedeo] Kings Coll London, Sch Biomed Engn & Imaging Sci, London, England; [Bartlett, Jonathan W.] Univ Bath, Dept Math Sci, Bath, Avon, England	University of Bath; University of Bath; University of Bristol; University of London; King's College London; University of Bath	Cookson, AN (corresponding author), Univ Bath, Dept Mech Engn, Bath, Avon, England.	a.n.cookson@bath.ac.uk	Gill, Richie H. S./A-9808-2011; Hernandez, Bruno Agostinho/AAB-3616-2019; Bruno, Vito Domenico/V-6421-2018	Gill, Richie H. S./0000-0002-7740-2062; Hernandez, Bruno Agostinho/0000-0002-2716-4262; Fraser, Katharine/0000-0002-7828-1354; Chiribiri, Amedeo/0000-0003-3394-4289; Bartlett, Jonathan/0000-0001-7117-0195; Johnson, Thomas/0000-0003-4638-601X; Kelly, Nathaniel/0000-0002-5939-9728; Bruno, Vito Domenico/0000-0002-8193-9559	EPSRC [1792324]; Great West 4 Initiator grant [GW4-AF4-011]; University of Bath	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Great West 4 Initiator grant; University of Bath	D.S.M. was supported by an EPSRC (https://epsrc.ukri.org) DTP (1792324) scholarship. This work was also supported by a Great West 4 (https://gw4.ac.uk) Initiator grant to R. A. (GW4-AF4-011) and partially by the University of Bath. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altiok E, 2013, EUR HEART J-CARD IMG, V14, P570, DOI 10.1093/ehjci/jes229; Altman D.G., 1991, PRACTICAL STAT MED R; [Anonymous], 2013, J AM SOC ECHOCARDIOG, V26, pA21; Bai WJ, 2018, J CARDIOVASC MAGN R, V20, DOI 10.1186/s12968-018-0471-x; Bartlett JW, 2008, ULTRASOUND OBST GYN, V31, P466, DOI 10.1002/uog.5256; Crick SJ, 1998, J ANAT, V193, P105, DOI 10.1046/j.1469-7580.1998.19310105.x; Dobrovie M, 2019, EUR RADIOL, V29, P6846, DOI 10.1007/s00330-019-06315-4; Ersboll M, 2013, J AM COLL CARDIOL, V61, P2365, DOI 10.1016/j.jacc.2013.02.061; GAUDRON P, 1993, CIRCULATION, V87, P83; Gavara J, 2018, JACC-CARDIOVASC IMAG, V11, P1448, DOI 10.1016/j.jcmg.2017.09.017; Gertz RJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193746; Hill A. J., 2005, HDB CARDIAC ANATOMY; JENNINGS RB, 1974, CIRC RES, V35, P156; Karamiltsos TD, 2007, J CARDIOVASC MAGN R, V9, P777, DOI 10.1080/10976640701545073; Koos R, 2013, INT J CARDIOL, V166, P85, DOI 10.1016/j.ijcard.2011.10.004; Mansell D. S., 2020, NATURE SCI REPORTS; Miller CA, 2013, J MAGN RESON IMAGING, V37, P1213, DOI 10.1002/jmri.23892; O'Dell WG, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.009124; Pedrana G, 2016, J DEV ORIG HLTH DIS, V7, P342, DOI 10.1017/S2040174416000118; Rademakers F., 2017, JACC-CARDIOVASC IMAG, P2469; Schulz-Menger J, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-35; Schuster A, 2015, CLIN RADIOL, V70, P989, DOI 10.1016/j.crad.2015.05.006; Smiseth OA, 2016, EUR HEART J, V37, P1196, DOI 10.1093/eurheartj/ehv529; Suinesiaputra A, 2015, J CARDIOVASC MAGN R, V17, DOI 10.1186/s12968-015-0170-9; Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981; Voigt JU, 2003, CIRCULATION, V107, P2120, DOI 10.1161/01.CIR.0000065249.69988.AA; Zheng Q, 2018, IEEE T MED IMAGING, V37, P2137, DOI 10.1109/TMI.2018.2820742	27	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0242908	10.1371/journal.pone.0242908	http://dx.doi.org/10.1371/journal.pone.0242908			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320865	Green Published, gold			2022-12-27	WOS:000600339800017
J	Markos, JR; Schaepe, KS; Teaford, HR; Rule, AD; Kashani, KB; Lieske, JC; Barreto, EF				Markos, James Roland; Schaepe, Karen S.; Teaford, Hilary R.; Rule, Andrew D.; Kashani, Kianoush B.; Lieske, John C.; Barreto, Erin F.			Clinician perspectives on inpatient cystatin C utilization: A qualitative case study at Mayo Clinic	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; SERUM CREATININE; MARKER; LIMITATIONS; BIOMARKERS; RELEVANCE; GFR	Introduction Serum creatinine (SCr) testing has been the mainstay of kidney function assessment for decades despite known limitations. Cystatin C (CysC) is an alternative biomarker that is generally less affected than SCr by pertinent non-renal factors in hospitalized patients, such as muscle mass. Despite its potential advantages, the adoption of CysC for inpatient care is not widespread. At one hospital with CysC testing, we demonstrated a significant rise in non-protocolized use over the last decade. This study uses qualitative methods to provide the first report of how clinicians understand, approach, and apply CysC testing in inpatient care. Methods Fifteen clinicians from various disciplines were interviewed about their experience with inpatient CysC testing. The semi-structured interviews were audio-recorded, transcribed verbatim, and analyzed thematically using a phenomenological approach. Results Knowledge and confidence with CysC varied greatly. Clinicians reported first learning about the test from colleagues on consulting services or multidisciplinary teams. The majority believed CysC to provide a more accurate measure of kidney function than SCr. Common scenarios for CysC ordering included medication dosing, evaluation of acute kidney injury, and a thorough evaluation of kidney function in patients with risk factors for an altered SCr. Facilitators for ordering CysC included the availability of rapid results turnaround and the automated calculation of glomerular filtration rate based on the biomarker. Barriers to use included a lack of education about CysC, and the absence of an institutional protocol for use. Discussion Clinicians at our site decided independent of institutional guidance whether and when CysC added value to patient care. While the majority of study participants indicated advantages to rapid turnaround CysC testing, its use depended not just on the features of the specific case but on clinician familiarity and personal preference. Findings from this research can guide the implementation and expansion of CysC testing.	[Markos, James Roland] Mayo Clin, Alix Sch Med, Rochester, MN USA; [Schaepe, Karen S.; Barreto, Erin F.] Mayo Clin, Robert D & Patricia E Kern Ctr Sci Hlth Care Deli, Rochester, MN 55905 USA; [Teaford, Hilary R.] Cedars Sinai Med Ctr, Dept Pharm, Los Angeles, CA 90048 USA; [Rule, Andrew D.; Kashani, Kianoush B.; Lieske, John C.] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN USA; [Rule, Andrew D.] Mayo Clin, Div Epidemiol, Rochester, MN USA; [Kashani, Kianoush B.] Mayo Clin, Div Pulm & Crit Care Med, Rochester, MN USA; [Lieske, John C.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Barreto, Erin F.] Mayo Clin, Dept Pharm, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Cedars Sinai Medical Center; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Barreto, EF (corresponding author), Mayo Clin, Robert D & Patricia E Kern Ctr Sci Hlth Care Deli, Rochester, MN 55905 USA.; Barreto, EF (corresponding author), Mayo Clin, Dept Pharm, Rochester, MN 55905 USA.	Barreto.Erin@mayo.edu		Markos, James/0000-0001-7042-0674; Lieske, John/0000-0002-0202-5944; Kashani, Kianoush/0000-0003-2184-3683	Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery; National Institute of Allergy and Infectious Diseases of the National Institutes of Health [K23AI143882]	Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery; National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was supported in part by the Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery and the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number K23AI143882 (PI; Dr. Erin Barreto). The funding sources had no role in study design; data collection, analysis, or interpretation; writing the report; or the decision to submit the report for publication. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funder provided support in the form of salaries for authors [KSS, EFB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section. https://www.mayo.edu/research/centersprograms/robert-d-patricia-e-kern-center-science-health-care-delivery/about https://www.niaid.nih.gov/	Al Musaimi O, 2019, MED FAM-SEMERGEN, V45, P44, DOI 10.1016/j.semerg.2018.07.005; Alge JL, 2015, CLIN J AM SOC NEPHRO, V10, P147, DOI 10.2215/CJN.12191213; Anderson TS, 2020, JAMA INTERN MED, V180, P984, DOI 10.1001/jamainternmed.2020.1588; Barreto EF, 2019, MAYO CLIN PROC, V94, P500, DOI 10.1016/j.mayocp.2018.08.002; Barreto EF, 2018, PHARMACOTHERAPY, V38, P794, DOI 10.1002/phar.2149; Chau Katrina, 2014, Can J Kidney Health Dis, V1, P19, DOI 10.1186/s40697-014-0019-4; Colaizzi P. F., 1978, EXISTENTIAL PHENOMEN; Coll E, 2000, AM J KIDNEY DIS, V36, P29, DOI 10.1053/ajkd.2000.8237; Delanaye P, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-9; Digvijay K, 2019, BLOOD PURIFICAT, V47, P113, DOI 10.1159/000493724; Ebert N, 2020, CURR OPIN NEPHROL HY, V29, P591, DOI 10.1097/MNH.0000000000000638; Ferguson TW, 2015, CURR OPIN NEPHROL HY, V24, P295, DOI 10.1097/MNH.0000000000000115; Filler G, 2005, CLIN BIOCHEM, V38, P1, DOI 10.1016/j.clinbiochem.2004.09.025; Filler G, 2016, CURR OPIN PEDIATR, V28, P173, DOI 10.1097/MOP.0000000000000318; Frazee E, 2017, AM J KIDNEY DIS, V69, P658, DOI 10.1053/j.ajkd.2016.11.016; Frazee Erin N, 2016, J Pharm Pract, V29, P125, DOI 10.1177/0897190014549841; Frazee EN, 2014, CRIT CARE, V18, DOI 10.1186/cc13899; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Gharaibeh KA, 2018, KIDNEY INT REP, V3, P337, DOI 10.1016/j.ekir.2017.10.012; Giorgi A., 2006, HUMANIST PSYCHOL, V34, P305, DOI [10.1207/s15473333thp3404_2, DOI 10.1207/S15473333THP3404_2]; Horio M, 2011, CLIN EXP NEPHROL, V15, P868, DOI 10.1007/s10157-011-0525-y; Hudson JQ, 2018, ADV CHRONIC KIDNEY D, V25, P14, DOI 10.1053/j.ackd.2017.10.003; Inker LA, 2016, AM J KIDNEY DIS, V67, P40, DOI 10.1053/j.ajkd.2015.07.025; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Kane-Gill SL, 2017, DRUG SAFETY, V40, P1049, DOI 10.1007/s40264-017-0565-7; Kashani K, 2020, EUR J INTERN MED, V72, P9, DOI 10.1016/j.ejim.2019.10.025; Levey AS, 2014, CLIN CHEM, V60, P916, DOI 10.1373/clinchem.2014.225383; Liu KD, 2011, CRIT CARE MED, V39, P2665, DOI 10.1097/CCM.0b013e318228234b; Meersch M, 2017, INTENS CARE MED, V43, P1551, DOI 10.1007/s00134-016-4670-3; Mussap M, 2002, KIDNEY INT, V61, P1453, DOI 10.1046/j.1523-1755.2002.00253.x; Rule AD, 2006, MAYO CLIN PROC, V81, P1427, DOI 10.4065/81.11.1427; SHEMESH O, 1985, KIDNEY INT, V28, P830, DOI 10.1038/ki.1985.205; Stabuc B, 2000, CLIN CHEM, V46, P193; Teaford HR, 2020, MAYO CLIN PROC, V95, P1649, DOI 10.1016/j.mayocp.2020.03.030; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Wasen E, 2004, J INTERN MED, V256, P70, DOI 10.1111/j.1365-2796.2004.01340.x; Woo KS, 2014, DIABETES METAB J, V38, P278, DOI 10.4093/dmj.2014.38.4.278	37	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243618	10.1371/journal.pone.0243618	http://dx.doi.org/10.1371/journal.pone.0243618			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306741	Green Published, gold			2022-12-27	WOS:000600144200012
J	Rao, S; Linke, L; Doster, E; Hyatt, D; Burgess, BA; Magnuson, R; Pabilonia, KL; Morley, PS				Rao, Sangeeta; Linke, Lyndsey; Doster, Enrique; Hyatt, Doreene; Burgess, Brandy A.; Magnuson, Roberta; Pabilonia, Kristy L.; Morley, Paul S.			Genomic diversity of class I integrons from antimicrobial resistant strains of Salmonella Typhimurium isolated from livestock, poultry and humans	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; GENE CASSETTES; ESCHERICHIA-COLI; IDENTIFICATION; ORGANIZATION; INTEGRASES; INFECTIONS; ACCURACY; SEROVARS; SITE	Introduction Multidrug resistance (MDR) is a serious issue prevalent in various agriculture-related foodborne pathogens including Salmonella enterica (S. enterica) Typhimurium. Class I integrons have been detected in Salmonella spp. strains isolated from food producing animals and humans and likely play a critical role in transmitting antimicrobial resistance within and between livestock and human populations. Objective The main objective of our study was to characterize class I integron presence to identify possible integron diversity among and between antimicrobial resistant Salmonella Typhimurium isolates from various host species, including humans, cattle, swine, and poultry. Methods An association between integron presence with multidrug resistance was evaluated. One hundred and eighty-three S. Typhimurium isolates were tested for antimicrobial resistance (AMR). Class I integrons were detected and sequenced. Similarity of AMR patterns between host species was also studied within each integron type. Results One hundred seventy-four (95.1%) of 183 S.Typhimurium isolates were resistant to at least one antimicrobial and 82 (44.8%) were resistant to 5 or more antimicrobials. The majority of isolates resistant to at least one antimicrobial was from humans (45.9%), followed by swine (19.1%) and then bovine (16.9%) isolates; poultry showed the lowest number (13.1%) of resistant isolates. Our study has demonstrated high occurrence of class I integrons in S. Typhimurium across different host species. Only one integron size was detected in poultry isolates. There was a significant association between integron presence of any size and specific multidrug resistance pattern among the isolates from human, bovine and swine. Conclusions Our study has demonstrated a high occurrence of class I integrons of different sizes in Salmonella Typhimurium across various host species and their association with multidrug resistance. This demonstration indicates that multidrug resistant Salmonella Typhimurium is of significant public health occurrence and reflects on the importance of judicious use of antimicrobials among livestock and poultry.	[Rao, Sangeeta; Linke, Lyndsey; Magnuson, Roberta; Pabilonia, Kristy L.] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Clin Sci, Ft Collins, CO 80523 USA; [Doster, Enrique] Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, Minneapolis, MN USA; [Doster, Enrique; Morley, Paul S.] Texas A&M Univ, Vet Educ Res & Outreach Program, College Stn, TX USA; [Doster, Enrique; Morley, Paul S.] West Texas A&M Univ, Vet Educ Res & Outreach Program, College Stn, TX USA; [Hyatt, Doreene] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Ft Collins, CO USA; [Burgess, Brandy A.] Univ Georgia, Coll Vet Med, Athens, GA USA	Colorado State University; University of Minnesota System; University of Minnesota Twin Cities; Texas A&M University System; Texas A&M University College Station; Colorado State University; University System of Georgia; University of Georgia	Rao, S (corresponding author), Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Clin Sci, Ft Collins, CO 80523 USA.	Sangeeta.Rao@Colostate.edu	; Morley, Paul/C-9960-2009	Rao, Sangeeta/0000-0002-9234-0082; Linke, Lyndsey/0000-0002-9423-2456; Morley, Paul/0000-0001-8138-2714	Gates Grand Challenges One Health and United States Department of Agriculture - Animal Health and Disease	Gates Grand Challenges One Health and United States Department of Agriculture - Animal Health and Disease	The funding support was provided by Gates Grand Challenges One Health and United States Department of Agriculture - Animal Health and Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AM, 2014, INT J FOOD MICROBIOL, V189, P39, DOI 10.1016/j.ijfoodmicro.2014.07.031; [Anonymous], 1995, CHINESE J EXP SURG, V12, P131; Barlow RS, 2009, J APPL MICROBIOL, V107, P540, DOI 10.1111/j.1365-2672.2009.04240.x; Bennett PM, 1999, J ANTIMICROB CHEMOTH, V43, P1, DOI 10.1093/jac/43.1.1; Cambray G, 2010, ANNU REV GENET, V44, P141, DOI 10.1146/annurev-genet-102209-163504; Centers for Disease Control and Prevention, 2016, SURVEILLANCE; Clinical and Laboratory Standards Institute, 2014, M100S24 CLSI WAYN PA; Collis CM, 2002, MOL MICROBIOL, V46, P1415, DOI 10.1046/j.1365-2958.2002.03260.x; Deng XL, 2012, FOODBORNE PATHOG DIS, V9, P305, DOI 10.1089/fpd.2011.1008; Diaz-Mejia JJ, 2008, MICROBIOL-SGM, V154, P94, DOI 10.1099/mic.0.2007/008649-0; Doyle ME, 2015, FOODBORNE PATHOG DIS, V12, P261, DOI 10.1089/fpd.2014.1865; Ebner P, 2004, J ANTIMICROB CHEMOTH, V53, P1004, DOI 10.1093/jac/dkh192; El-Najjar NG, 2010, LETT APPL MICROBIOL, V51, P456, DOI 10.1111/j.1472-765X.2010.02926.x; European Food Safety Authority, 2017, EFSA J, V15, DOI 10.2903/j.efsa.2017.5077; Falagas ME, 2006, J MED MICROBIOL, V55, P1619, DOI 10.1099/jmm.0.46747-0; Gebreyes WA, 2004, J ANTIMICROB CHEMOTH, V53, P997, DOI 10.1093/jac/dkh247; Gruenberg W., 2019, OVERVIEW SALMONELLOS; HALL RM, 1995, MOL MICROBIOL, V15, P593, DOI 10.1111/j.1365-2958.1995.tb02368.x; Hall RM, 2012, ANN NY ACAD SCI, V1267, P71, DOI 10.1111/j.1749-6632.2012.06588.x; Hendriksen RS, 2011, FOODBORNE PATHOG DIS, V8, P887, DOI 10.1089/fpd.2010.0787; Hsu YM, 2013, COMP IMMUNOL MICROB, V36, P9, DOI 10.1016/j.cimid.2012.08.004; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Khemtong S, 2008, MICROB DRUG RESIST, V14, P65, DOI 10.1089/mdr.2008.0807; Krauland MG, 2009, EMERG INFECT DIS, V15, P388, DOI 10.3201/eid1503.081131; Lakin SM, 2017, NUCLEIC ACIDS RES, V45, pD574, DOI 10.1093/nar/gkw1009; Lee KM, 2015, FOOD CONTROL, V47, P264, DOI 10.1016/j.foodcont.2014.07.011; Lopes GV, 2016, VET MICROBIOL, V194, P84, DOI 10.1016/j.vetmic.2016.04.020; Lucey B, 2000, EMERG INFECT DIS, V6, P50; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Makela P, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3129; Malorny B, 2003, APPL ENVIRON MICROB, V69, P290, DOI 10.1128/AEM.69.1.290-296.2003; Martinez JL, 2008, SCIENCE, V321, P365, DOI 10.1126/science.1159483; Mazel D, 2006, NAT REV MICROBIOL, V4, P608, DOI 10.1038/nrmicro1462; NDRC: Natural Resources Defense Council, 2018, ANT CONS US PORK BEE; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Rao S, 2008, J CLIN MICROBIOL, V46, P916, DOI 10.1128/JCM.01597-07; Roe MT, 2003, POULTRY SCI, V82, P622, DOI 10.1093/ps/82.4.622; Sneath PHA., 1973, NUMERICAL TAXONOMY, P230, DOI DOI 10.1111/J.1523-1739.2007.00775.X; Threlfall EJ, 2002, FEMS MICROBIOL REV, V26, P141, DOI 10.1016/S0168-6445(02)00092-X; Wannaprasat W, 2011, INT J ANTIMICROB AG, V37, P457, DOI 10.1016/j.ijantimicag.2010.12.001; Zhao S, 2005, FOODBORNE PATHOG DIS, V2, P169, DOI 10.1089/fpd.2005.2.169	41	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243477	10.1371/journal.pone.0243477	http://dx.doi.org/10.1371/journal.pone.0243477			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306723	Green Published, gold			2022-12-27	WOS:000600144200018
J	Miller, DJ; Capodilupo, JV; Lastella, M; Sargent, C; Roach, GD; Lee, VH; Capodilupo, ER				Miller, Dean J.; Capodilupo, John, V; Lastella, Michele; Sargent, Charli; Roach, Gregory D.; Lee, Victoria H.; Capodilupo, Emily R.			Analyzing changes in respiratory rate to predict the risk of COVID-19 infection	PLOS ONE			English	Article								COVID-19, the disease caused by the SARS-CoV-2 virus, can cause shortness of breath, lung damage, and impaired respiratory function. Containing the virus has proven difficult, in large part due to its high transmissibility during the pre-symptomatic incubation. The study's aim was to determine if changes in respiratory rate could serve as a leading indicator of SARS-CoV-2 infections. A total of 271 individuals (age = 37.3 +/- 9.5, 190 male, 81 female) who experienced symptoms consistent with COVID-19 were included- 81 tested positive for SARS-CoV-2 and 190 tested negative; these 271 individuals collectively contributed 2672 samples (days) of data (1856 healthy days, 231 while infected with COVID-19 and 585 while negative for COVID-19 but experiencing symptoms). To train a novel algorithm, individuals were segmented as follows; (1) a training dataset of individuals who tested positive for COVID-19 (n = 57 people, 537 samples); (2) a validation dataset of individuals who tested positive for COVID-19 (n = 24 people, 320 samples); (3) a validation dataset of individuals who tested negative for COVID-19 (n = 190 people, 1815 samples). All data was extracted from the WHOOP system, which uses data from a wrist-worn strap to produce validated estimates of respiratory rate and other physiological measures. Using the training dataset, a model was developed to estimate the probability of SARS-CoV-2 infection based on changes in respiratory rate during night-time sleep. The model's ability to identify COVID-positive individuals not used in training and robustness against COVID-negative individuals with similar symptoms were examined for a critical six-day period spanning the onset of symptoms. The model identified 20% of COVID-19 positive individuals in the validation dataset in the two days prior to symptom onset, and 80% of COVID-19 positive cases by the third day of symptoms.	[Miller, Dean J.; Lastella, Michele; Sargent, Charli; Roach, Gregory D.] Cent Queensland Univ, Appleton Inst Behav Sci, Adelaide, SA, Australia; [Capodilupo, John, V; Lee, Victoria H.; Capodilupo, Emily R.] Whoop Inc, Data Sci & Res, Boston, MA USA	Central Queensland University	Miller, DJ (corresponding author), Cent Queensland Univ, Appleton Inst Behav Sci, Adelaide, SA, Australia.	d.j.miller@cqu.edu.au		Capodilupo, Emily/0000-0003-4203-5693; Lastella, Michele/0000-0003-1793-3811; Miller, Dr Dean J./0000-0003-3869-4346	ERC	ERC(European Research Council (ERC)European Commission)	There was no specific funding provided for this project. However, ERC, JVC and VHL are employees of Whoop Inc. In addition, Whoop Inc is sponsoring the employment of DJM's position at CQUniversity. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berryhill S, 2020, J CLIN SLEEP MED, V16, P775, DOI 10.5664/jcsm.8356; Ebell MH, 2007, AM FAM PHYSICIAN, V76, P560; Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z; He X, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0869-5; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105924; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Liu Y, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa021; Pedregosa F., 2011, J MACH LEARN RES, V12, P2825; Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468; World-Health-Organization, 2021, WORLD HLTH ORG	11	57	57	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243693	10.1371/journal.pone.0243693	http://dx.doi.org/10.1371/journal.pone.0243693			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301493	gold, Green Published, Green Submitted			2022-12-27	WOS:000600143100081
J	Cao, HY; Zhang, XY; Ruan, YY; Zhang, LJ; Cui, ZH; Li, XX; Jia, B				Cao, Huiying; Zhang, Xinyue; Ruan, Yanye; Zhang, Lijun; Cui, Zhenhai; Li, Xuxiao; Jia, Bing			miRNA expression profiling and zeatin dynamic changes in a new model system of in vivo indirect regeneration of tomato	PLOS ONE			English	Article							SHOOT APICAL MERISTEM; SBP-BOX GENE; SMALL RNAS; TRANSCRIPTION FACTORS; ARABIDOPSIS-THALIANA; REGULATORY ROLES; MICRORNAS; AUXIN; CYTOKININ; DIFFERENTIATION	Callus formation and adventitious shoot differentiation could be observed on the cut surface of completely decapitated tomato plants. We propose that this process can be used as a model system to investigate the mechanisms that regulate indirect regeneration of higher plants without the addition of exogenous hormones. This study analyzed the patterns of trans-zeatin and miRNA expression during in vivo regeneration of tomato. Analysis of trans-zeatin revealed that the hormone cytokinin played an important role in in vivo regeneration of tomato. Among 183 miRNAs and 1168 predicted target genes sequences identified, 93 miRNAs and 505 potential targets were selected based on differential expression levels for further characterization. Expression patterns of six miRNAs, including sly-miR166, sly-miR167, sly-miR396, sly-miR397, novel 156, and novel 128, were further validated by qRT-PCR. We speculate that sly-miR156, sly-miR160, sly-miR166, and sly-miR397 play major roles in callus formation of tomato during in vivo regeneration by regulating cytokinin, IAA, and laccase levels. Overall, our microRNA sequence and target analyses of callus formation during in vivo regeneration of tomato provide novel insights into the regulation of regeneration in higher plants.	[Cao, Huiying; Zhang, Xinyue; Ruan, Yanye; Zhang, Lijun; Cui, Zhenhai; Li, Xuxiao; Jia, Bing] Shenyang Agr Univ, Coll Biol Sci & Technol, Liaoning Prov Res Ctr Plant Genet Engn Technol, Shenyang Key Lab Maize Genom Select Breeding, Shenyang, Peoples R China	Shenyang Agricultural University	Ruan, YY; Zhang, LJ (corresponding author), Shenyang Agr Univ, Coll Biol Sci & Technol, Liaoning Prov Res Ctr Plant Genet Engn Technol, Shenyang Key Lab Maize Genom Select Breeding, Shenyang, Peoples R China.	yanyeruan@syau.edu.cn; ljzhang@syau.edu.cn			National Natural Science Foundation of China [31300164]; Scientific and Technological Project of Shenyang [18-013-0-92]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific and Technological Project of Shenyang	This work was supported by the National Natural Science Foundation of China (grant numbers 31300164) and the Scientific and Technological Project of Shenyang (grant number 18-013-0-92) received from HC.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Alejandri-Ramirez ND, 2018, PLANT PHYSIOL BIOCH, V122, P78, DOI 10.1016/j.plaphy.2017.11.013; Altpeter F, 2016, PLANT CELL, V28, P1510, DOI 10.1105/tpc.16.00196; Amutha S, 2009, IN VITRO CELL DEV-PL, V45, P758, DOI 10.1007/s11627-009-9232-8; [Anonymous], 2014, REG ANESTH PAIN MED; [Anonymous], 2011, P 2011 NAT S PLANT B; Barton MK, 2010, DEV BIOL, V341, P95, DOI 10.1016/j.ydbio.2009.11.029; Boualem A, 2008, PLANT J, V54, P876, DOI 10.1111/j.1365-313X.2008.03448.x; Brandt R, 2012, PLANT J, V72, P31, DOI 10.1111/j.1365-313X.2012.05049.x; Buechel S, 2010, EUR J CELL BIOL, V89, P279, DOI 10.1016/j.ejcb.2009.11.016; C. on O. Practice, 2016, AM COLL OBSTET GYNEC, V127, P1; Cardon GH, 1997, PLANT J, V12, P367, DOI 10.1046/j.1365-313X.1997.12020367.x; Chavez-Hernandez EC, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00555; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen CJ, 2011, RNA BIOL, V8, P538, DOI 10.4161/rna.8.3.15199; Chu ZL, 2016, FRONT PLANT SCI, V7, DOI [10.3359/fpls.2016.01302, 10.3389/fpls.2016.01302]; Chuck G, 2010, DEVELOPMENT, V137, P1243, DOI 10.1242/dev.048348; Constabel CP, 2000, PLANT PHYSIOL, V124, P285, DOI 10.1104/pp.124.1.285; CROWELL DN, 1992, PLANT PHYSIOL, V100, P2090, DOI 10.1104/pp.100.4.2090; Dauwe R, 2007, PLANT J, V52, P263, DOI 10.1111/j.1365-313X.2007.03233.x; de Lima JC, 2012, GENET MOL BIOL, V35, P1069, DOI 10.1590/S1415-47572012000600023; Ehlert B, 2008, J EXP BOT, V59, P3635, DOI 10.1093/jxb/ern213; Ferreira FJ, 2005, CURR OPIN PLANT BIOL, V8, P518, DOI 10.1016/j.pbi.2005.07.013; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Gandikota M, 2007, PLANT J, V49, P683, DOI 10.1111/j.1365-313X.2006.02983.x; Gao C, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3587-8; Gao Y, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56686-3; Ge F, 2016, PHYSIOL PLANTARUM, V158, P452, DOI 10.1111/ppl.12470; Gordon SP, 2007, DEVELOPMENT, V134, P3539, DOI 10.1242/dev.010298; Hartig K, 2005, PHYSIOL PLANTARUM, V125, P260, DOI 10.1111/j.1399-3054.2005.00556.x; Howell SH, 2003, TRENDS PLANT SCI, V8, P453, DOI 10.1016/S1360-1385(03)00191-2; Huang TB, 2014, PLANT CELL, V26, P246, DOI 10.1105/tpc.113.111526; Hwang I, 2012, ANNU REV PLANT BIOL, V63, P353, DOI 10.1146/annurev-arplant-042811-105503; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Jung J, 2007, PLANTA, V225, P575, DOI 10.1007/s00425-006-0373-2; Li C, 2016, J CELL PHYSIOL, V231, P303, DOI 10.1002/jcp.25125; Li TT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043451; Li ZX, 2018, MOL GENET GENOMICS, V293, P1355, DOI 10.1007/s00438-018-1465-y; Li ZX, 2017, J PLANT GROWTH REGUL, V36, P889, DOI 10.1007/s00344-017-9693-7; Linares-Vasquez M, 2017, J SYST SOFTWARE, V130, P1, DOI 10.1016/j.jss.2017.04.018; Liu ZH, 2016, PLANT J, V87, P391, DOI 10.1111/tpj.13211; Long JM, 2018, J EXP BOT, V69, P2979, DOI 10.1093/jxb/ery132; Lowe K, 2016, PLANT CELL, V28, P1998, DOI 10.1105/tpc.16.00124; Lu SF, 2013, P NATL ACAD SCI USA, V110, P10848, DOI 10.1073/pnas.1308936110; Luo YC, 2006, FEBS LETT, V580, P5111, DOI 10.1016/j.febslet.2006.08.046; Ma JY, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21061971; Maher MF, 2020, NAT BIOTECHNOL, V38, P84, DOI 10.1038/s41587-019-0337-2; Masafumi J, 2008, VIVO SHOOT REGENERAT, V43, P220, DOI 10.21273/HORTSCI.43.1.220; Motose H, 2001, PLANTA, V213, P121, DOI 10.1007/s004250000482; Nagasaki H, 2007, P NATL ACAD SCI USA, V104, P14867, DOI 10.1073/pnas.0704339104; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Nielsen MD, 2003, EUR J HORTIC SCI, V68, P161; Oda Y, 2005, PLANT PHYSIOL, V137, P1027, DOI 10.1104/pp.104.052613; Park J, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0443-x; Plastira VA, 1997, ACTA HORTIC, P231, DOI 10.17660/ActaHortic.1997.447.47; Prakash AP, 2002, PLANT J, V29, P141, DOI 10.1046/j.0960-7412.2001.01206.x; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Rodrigues AS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47789-y; Sabana AA, 2020, PLANTA, V251, DOI 10.1007/s00425-020-03368-4; Sakai H, 2001, SCIENCE, V294, P1519, DOI 10.1126/science.1065201; Si-Ammour A, 2011, PLANT PHYSIOL, V157, P683, DOI 10.1104/pp.111.180083; Siddiqui ZH, 2019, GENOMICS, V111, P1026, DOI 10.1016/j.ygeno.2018.11.022; Singh A, 2018, PLANTA, V248, P545, DOI 10.1007/s00425-018-2927-5; Smoczynska A, 2016, ACTA BIOCHIM POL, V63, P687, DOI 10.18388/abp.2016_1358; Su YH, 2016, PLANT CELL TISS ORG, V124, P405, DOI 10.1007/s11240-015-0903-3; Sun HJ, 2006, PLANT CELL PHYSIOL, V47, P426, DOI 10.1093/pcp/pci251; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Tanaka N, 2011, PLANT CELL, V23, P2143, DOI 10.1105/tpc.111.083436; Tezuka T, 2011, HORTSCIENCE, V46, P1661, DOI 10.21273/HORTSCI.46.12.1661; The Lancet Public H, 2018, LANCET PUBLIC HLTH, V3, pe153, DOI 10.1016/S2468-2667(18)30053-7; Turchi L, 2015, J EXP BOT, V66, P5043, DOI 10.1093/jxb/erv174; Unte US, 2003, PLANT CELL, V15, P1009, DOI 10.1105/tpc.010678; Vanneste S, 2009, CELL, V136, P1005, DOI 10.1016/j.cell.2009.03.001; Wang JW, 2008, PLANT CELL, V20, P1231, DOI 10.1105/tpc.108.058180; Wang M, 2018, INT J BIOL SCI, V14, P565, DOI 10.7150/ijbs.24562; Wen M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-140; Williams L, 2005, DEVELOPMENT, V132, P3657, DOI 10.1242/dev.01942; Wojcik AM, 2016, PLANTA, V244, P231, DOI 10.1007/s00425-016-2505-7; Wong CE, 2011, J EXP BOT, V62, P2495, DOI 10.1093/jxb/erq437; Wu G, 2006, DEVELOPMENT, V133, P3539, DOI 10.1242/dev.02521; Wu MF, 2006, DEVELOPMENT, V133, P4211, DOI 10.1242/dev.02602; Wu XM, 2015, PLANT BIOTECHNOL J, V13, P383, DOI 10.1111/pbi.12317; Xu XY, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66025-6; Yakovlev IA, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00674; Yang Q, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-6250-8; Yang XY, 2013, J EXP BOT, V64, P1521, DOI 10.1093/jxb/ert013; Yin L, 2008, PLANT MOL BIOL, V68, P597, DOI 10.1007/s11103-008-9395-4; Zhai LL, 2014, PLANT MOL BIOL REP, V32, P900, DOI 10.1007/s11105-014-0700-x; Zhang J, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00566; Zhang JH, 2012, PLANTA, V236, P647, DOI 10.1007/s00425-012-1643-9; Zhang TQ, 2015, PLANT CELL, V27, P349, DOI 10.1105/tpc.114.135186; Zhang Y, 2007, PLANT MOL BIOL, V63, P429, DOI 10.1007/s11103-006-9099-6; Zhong RQ, 2001, PLANT PHYSIOL, V126, P549, DOI 10.1104/pp.126.2.549; Zhou LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015224; Zuo JR, 2002, PLANT J, V30, P349, DOI 10.1046/j.1365-313X.2002.01289.x	96	1	2	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0237690	10.1371/journal.pone.0237690	http://dx.doi.org/10.1371/journal.pone.0237690			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332392	Green Published, Green Submitted, gold			2022-12-27	WOS:000601310900106
J	Palomares, A; Rebollo, M; Carrascosa, C				Palomares, A.; Rebollo, M.; Carrascosa, C.			Supportive consensus	PLOS ONE			English	Article							MULTIAGENT SYSTEMS	The paper is concerned with the consensus problem in a multi-agent system such that each agent has boundary constraints. Classical Olfati-Saber's consensus algorithm converges to the same value of the consensus variable, and all the agents reach the same value. These algorithms find an equality solution. However, what happens when this equality solution is out of the range of some of the agents? In this case, this solution is not adequate for the proposed problem. In this paper, we propose a new kind of algorithms called supportive consensus where some agents of the network can compensate for the lack of capacity of other agents to reach the average value, and so obtain an acceptable solution for the proposed problem. Supportive consensus finds an equity solution. In the rest of the paper, we define the supportive consensus, analyze and demonstrate the network's capacity to compensate out of boundaries agents, propose different supportive consensus algorithms, and finally, provide some simulations to show the performance of the proposed algorithms.	[Palomares, A.; Rebollo, M.; Carrascosa, C.] Univ Politecn Valencia, VRAIn Valencian Res Inst Artificial Intelligence, Valencia, Spain	Universitat Politecnica de Valencia	Palomares, A (corresponding author), Univ Politecn Valencia, VRAIn Valencian Res Inst Artificial Intelligence, Valencia, Spain.	apaloma@vrain.upv.es		Palomares Chust, Alberto/0000-0002-4583-467X	Valencian Research Institute for Artificial Intelligence (VRAIN); Spanish Government [RTI2018-095390-B-C31]; GVA-CEICE project [PROMETEO/2018/002]; TAILOR - EU Horizon 2020 research and innovation programme [952215]	Valencian Research Institute for Artificial Intelligence (VRAIN); Spanish Government(Spanish GovernmentEuropean Commission); GVA-CEICE project; TAILOR - EU Horizon 2020 research and innovation programme	The author(s) received specific funding for this work from the Valencian Research Institute for Artificial Intelligence (VRAIN) where the authors are currently working. This work is partially supported by the Spanish Government project RTI2018-095390-B-C31, GVA-CEICE project PROMETEO/2018/002, and TAILOR, a project funded by EU Horizon 2020 research and innovation programme under GA No 952215. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfonso B, 2014, INFORM SYST FRONT, V16, P183, DOI 10.1007/s10796-013-9443-8; [Anonymous], 2012, MMWR-MORBID MORTAL W, V61, P918; Cavalcante R., 2011, P AAMAS 2011, P165; Du SF, 2016, J CLEAN PROD, V112, P1600, DOI 10.1016/j.jclepro.2014.08.086; Elhage N., 2010, 9 INT C AUT AG MULT, P907; Fischbacher U, 2010, AM ECON REV, V100, P541, DOI 10.1257/aer.100.1.541; Fontan A., 2017, P 56 IEEE C DEC CONT, P4155; Hou WY, 2018, INT J SYST SCI, V49, P947, DOI 10.1080/00207721.2018.1433899; Hu HX, 2013, J FRANKLIN I, V350, P575, DOI 10.1016/j.jfranklin.2012.12.020; Jianting L, 2015, INT J ROBUST NONLIN, V26, P2977; Knorn F, 2011, IEEE DECIS CONTR P, P1299, DOI 10.1109/CDC.2011.6160599; Li YJ, 2019, SYST SCI CONTROL ENG, V7, P468, DOI 10.1080/21642583.2019.1695689; Liu S., 2016, INT J ROBUST NONLIN, V27, P3043; Mo LP, 2018, INT J ROBUST NONLIN, V28, P3657, DOI 10.1002/rnc.4076; Olfati-Saber R, 2004, IEEE T AUTOMAT CONTR, V49, P1520, DOI 10.1109/TAC.2004.834113; Olfati-Saber R, 2007, P IEEE, V95, P215, DOI 10.1109/JPROC.2006.887293; Pedroche F, 2013, ABS13077562 CORR; Perez IJ, 2018, INFORM SCIENCES, V459, P20, DOI 10.1016/j.ins.2018.05.017; Qiu ZR, 2018, INT J ROBUST NONLIN, V28, P2619, DOI 10.1002/rnc.4040; Rebollo M, 2014, COMM COM INF SC, V430, P250; Ren W, 2005, IEEE T AUTOMAT CONTR, V50, P655, DOI 10.1109/TAC.2005.846556; Ren W, 2008, COMMUN CONTROL ENG, P3; Roy S, 2015, AUTOMATICA, V51, P259, DOI 10.1016/j.automatica.2014.10.073; Salazar N, 2010, AI COMMUN, V23, P357, DOI 10.3233/AIC-2010-0479; Wang QL, 2014, SYST SCI CONTROL ENG, V2, P275, DOI 10.1080/21642583.2014.897658; Xi JX, 2018, INFORM SCIENCES, V467, P1, DOI 10.1016/j.ins.2018.07.069; Zhao TQ, 2018, IEEE T SUSTAIN ENERG, V9, P443, DOI 10.1109/TSTE.2017.2740833	27	0	0	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243215	10.1371/journal.pone.0243215	http://dx.doi.org/10.1371/journal.pone.0243215			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332368	gold, Green Published			2022-12-27	WOS:000601310900108
J	Perisse, ARS; Souza-Santos, R; Duarte, R; Santos, F; de Andrade, CR; Rodrigues, NCP; Schramm, JMD; da Silva, ED; Jacobson, LDV; Lemos, MCF; Sobral, A				Perisse, Andre Reynaldo Santos; Souza-Santos, Reinaldo; Duarte, Rosemere; Santos, Fernanda; de Andrade, Celia Regina; Rodrigues, Nadia Cristina Pinheiro; Schramm, Joyce Mendes de Andrade; da Silva, Edimilson Domingues; Jacobson, Ludmilla da Silva Viana; Lemos, Maria Cristina Ferreira; Sobral, Andrea			Zika, dengue and chikungunya population prevalence in Rio de Janeiro city, Brazil, and the importance of seroprevalence studies to estimate the real number of infected individuals	PLOS ONE			English	Article							VIRUS-INFECTION; BURDEN; LIFE	In the last 40 years, Latin America countries, including Brazil, have suffered from the emergence and reemergence of arboviruses, first Dengue (DENV) and recently Zika (ZIKV) and Chikungunya (CHIKV). All three arboviruses are currently endemic in Brazil and have caused major outbreaks in recent years. Rio de Janeiro city, host of the last Summer Olympic Games and the Football World Cup, has been specially affected by them. A surveillance system based on symptomatic reports is in place in Rio, but the true number of affected individuals is unknown due to the great number of Zika, Dengue and Chikungunya asymptomatic cases. Seroprevalence studies are more suitable to evaluate the real number of cases in a given population. We performed a populational seroprevalence survey in Rio, with recruitment of a sample of volunteers of all ages and gender from July to October 2018, within randomly selected census tracts and household. A total of 2,120 volunteers were interviewed and tested with rapid immunochromatographic test for ZIKV, DENV and CHIKV. Individuals with positive results for IgG and/or IgM from only one virus were classified accordingly, while those with test results positive for both ZIKV and DENV were classified as flaviviruses. We corrected for sample design and non-response in data analysis, and calculated point estimate prevalence and 95% confidence intervals for each virus. Arbovirus prevalence in the Rio's population (n = 6,688,927) was estimated at 48.6% [95% CI 44.8-52.4] (n = 3,254,121) for flaviviruses and at 18.0% [95% CI 14.8-21.2] (n = 1,204,765) for CHIKV. Approximately 17.0% [95% CI 14.1-20.1] (n = 1,145,674) of Rio ' s population had no contact with any of the three arboviruses. The reported cases of Zika, Dengue and Chikungunya by the current surveillance system in place is insufficient to estimate their real numbers, and our data indicate that Zika seroprevalence could be at least five times and Chikungunya 45 times bigger. The high number of individuals having never been infected by any of the three arboviruses, may indicate a proper scenario for future outbreaks.	[Perisse, Andre Reynaldo Santos; Duarte, Rosemere; Santos, Fernanda] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Dept Ciencias Biol, Rio De Janeiro, Brazil; [Perisse, Andre Reynaldo Santos; Souza-Santos, Reinaldo; Sobral, Andrea] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Dept Endemias Samuel Pessoa, Rio De Janeiro, Brazil; [de Andrade, Celia Regina; Schramm, Joyce Mendes de Andrade] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Dept Epidemiol & Metodos Quantitat, Rio De Janeiro, Brazil; [Rodrigues, Nadia Cristina Pinheiro] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Ctr Saude Escola Germano Sinval Faria, Rio De Janeiro, Brazil; [da Silva, Edimilson Domingues] Fundacao Oswaldo Cruz, Inst Tecnol Imunobiol, Rio De Janeiro, Brazil; [Jacobson, Ludmilla da Silva Viana] Univ Fed Fluminense, Inst Matemat & Estat, Dept Estat, Niteroi, RJ, Brazil; [Lemos, Maria Cristina Ferreira] Secretaria Municipal Saude Rio de Janeiro, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal Fluminense	Perisse, ARS (corresponding author), Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Dept Ciencias Biol, Rio De Janeiro, Brazil.; Perisse, ARS (corresponding author), Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Dept Endemias Samuel Pessoa, Rio De Janeiro, Brazil.	aperisse@ensp.fiocruz.br			"Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil" (CAPES) [001]; Science and Technology Department of the Brazilian Ministry of Health (DECIT/Ministerio da Saude, Brasil) [33/2016]; Graduate Program in Public Health and the Environment at Sergio Arouca National School of Public Health/Fiocruz	"Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil" (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Science and Technology Department of the Brazilian Ministry of Health (DECIT/Ministerio da Saude, Brasil); Graduate Program in Public Health and the Environment at Sergio Arouca National School of Public Health/Fiocruz	This study was funded in part by the "Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil" (CAPES) - Finance Code 001 granted to ARSP and AS. This study was also funded by a grant from the Science and Technology Department of the Brazilian Ministry of Health (DECIT/Ministerio da Saude, Brasil) (Grant number 33/2016) awarded to ARSP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all field investigators, supervisors, drivers and laboratory and administrative personnel involved in the study for their efforts to make the project possible. We also thank the volunteers for welcoming us to their homes and participating in the research. This work was supported by the Graduate Program in Public Health and the Environment at Sergio Arouca National School of Public Health/Fiocruz.	Esposito DLA, 2016, REV SOC BRAS MED TRO, V49, P535, DOI 10.1590/0037-8682-0428-2016; Cardona-Ospina JA, 2015, INT J INFECT DIS, V38, P60, DOI 10.1016/j.ijid.2015.07.015; [Anonymous], 2017, J PROSTHET DENT, V11, pe1; Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Brady OJ, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002755; Braga IA, 2007, EPIDEMIOL SERV SAUDE, V16, P113; Chiaravalloti-Neto F, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4074-4; Couturier E, 2012, RHEUMATOLOGY, V51, P1315, DOI 10.1093/rheumatology/kes015; da Silva-Nunes M, 2008, AM J TROP MED HYG, V79, P485, DOI 10.4269/ajtmh.2008.79.485; Fritzell Camille, 2018, PLoS Negl Trop Dis, V12, pe0006533, DOI 10.1371/journal.pntd.0006533; Haby MM, 2018, B WORLD HEALTH ORGAN, V96, P402, DOI 10.2471/BLT.17.201541; Kerkhove MV, 2017, STANDARDIZED PROTOCO; Kuan G, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004773; de Vasconcellos MTL, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00176013; Levy P, 1999, SAMPLING POPULATIONS; LITTLE RJA, 1986, INT STAT REV, V54, P139, DOI 10.2307/1403140; Lowe R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010096; Luiz RR, 2000, CIENC SAUDE COLETIVA, V8, P9; LUMLEY T., 2010, COMPLEX SURVEYS GUID; Murhekar MV, 2019, LANCET GLOB HEALTH, V7, pE1065, DOI 10.1016/S2214-109X(19)30250-5; Ochieng C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132645; RATHGEBER EM, 1993, SOC SCI MED, V37, P513, DOI 10.1016/0277-9536(93)90286-D; Rodriguez-Barraquer I, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003906; Sarndal CE, 2005, WILEY SER SURV METH, P1; Sergon K, 2008, AM J TROP MED HYG, V78, P333, DOI 10.4269/ajtmh.2008.78.333; Sissoko D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003066; Soghaier MA, 2014, J INFECT PUBLIC HEAL, V7, P54, DOI 10.1016/j.jiph.2013.07.008; Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; Vasconcellos Mauricio Teixeira Leite de, 2005, Cad. Saúde Pública, V21, pS89, DOI 10.1590/S0102-311X2005000700010; Zambrana JV, 2018, P NATL ACAD SCI USA, V115, P9294, DOI 10.1073/pnas.1804672115; Waldman Eliseu Alves, 2008, Rev. bras. epidemiol., V11, P168, DOI 10.1590/S1415-790X2008000500018; 2019, J CROHNS COLITIS S1, V13	34	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243239	10.1371/journal.pone.0243239	http://dx.doi.org/10.1371/journal.pone.0243239			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332373	Green Published, gold			2022-12-27	WOS:000601310900082
J	Abe, T; Okuyama, K; Kamada, M; Yano, S; Toyama, Y; Isomura, M; Nabika, T; Sakane, N; Ando, H; Miyazaki, R				Abe, Takafumi; Okuyama, Kenta; Kamada, Masamitsu; Yano, Shozo; Toyama, Yuta; Isomura, Minoru; Nabika, Toru; Sakane, Naoki; Ando, Hitoshi; Miyazaki, Ryo			Social participation and physical prefrailty in older Japanese adults: The Shimane CoHRE study	PLOS ONE			English	Article							ASIAN WORKING GROUP; LIFE-STYLE; FRAILTY; PREVALENCE; HEALTH; PEOPLE; ASSOCIATION; SARCOPENIA; CRITERIA	As older adults in an early stage (prefrailty) of frailty may return to a healthy state, it is necessary to examine the prevention of prefrailty. In this context, the number and types of social participation activities associated with physical prefrailty in community-dwelling older adults have remained relatively unexplored. This cross-sectional study investigates this issue by analyzing 616 participants living in Okinoshima, Shimane, a rural area of Japan, in 2019. Frailty was assessed using the 5-item frailty phenotype (unintentional weight loss, self-reported exhaustion, weakness, slow walking speed, and low physical activity). Data on social participation were obtained using a questionnaire based on participants' level of involvement with volunteer groups, sports clubs/groups, neighborhood associations, religious organizations/groups, and community elderly salons; their answers were categorized as "yes" if they answered "several times per year or more" and "no" if they answered "never." Binominal logistic regression was used to estimate odds ratios (OR) and 95% confidence intervals (CI) of prefrailty by the number or types of social participation activities, adjusted for gender, age, body mass index, smoking, medication-taking, educational attainment, working status, and living arrangement. Of the 616 participants, 273 (44.3%) and 28 (4.5%) had prefrailty and frailty, respectively. The analysis showed that the number of social participation activities was significantly associated with lower odds of prefrailty (OR = 0.83; 95% CI, 0.74-0.94). Regarding the types of social participation, sports clubs/groups were associated with lower odds of prefrailty (OR = 0.47; 95% CI, 0.31-0.73). Participation in neighborhood associations was associated with prefrailty/frailty (OR = 0.57; 95% CI, 0.37-0.86). These results suggest that increasing the number of social participation activities or involvement in sports clubs/groups and neighborhood associations may be important to prevent physical prefrailty in the older population.	[Abe, Takafumi; Okuyama, Kenta; Yano, Shozo; Toyama, Yuta; Isomura, Minoru; Nabika, Toru; Miyazaki, Ryo] Shimane Univ, Ctr Community Based Healthcare Res & Educ CoHRE, Org Res & Acad Informat, Izumo, Shimane, Japan; [Okuyama, Kenta] Lund Univ, Ctr Primary Hlth Care Res, Malmo, Sweden; [Kamada, Masamitsu] Univ Tokyo, Sch Publ Hlth, Grad Sch Med, Dept Hlth & Social Behav,Bunkyo Ku, Tokyo, Japan; [Yano, Shozo] Shimane Univ, Fac Med, Dept Lab Med, Izumo, Shimane, Japan; [Isomura, Minoru; Miyazaki, Ryo] Shimane Univ, Fac Human Sci, Matsue, Shimane, Japan; [Nabika, Toru] Shimane Univ, Fac Med, Dept Funct Pathol, Izumo, Shimane, Japan; [Sakane, Naoki] Kyoto Med Ctr, Natl Hosp Org, Clin Res Inst Endocrine & Metab Dis, Div Prevent Med,Fushimi Ku, Kyoto, Japan; [Ando, Hitoshi] Kanazawa Univ, Grad Sch Med Sci, Dept Cellular & Mol Funct Anal, Kanazawa, Ishikawa, Japan	Shimane University; Lund University; University of Tokyo; Shimane University; Shimane University; Shimane University; Kanazawa University	Abe, T (corresponding author), Shimane Univ, Ctr Community Based Healthcare Res & Educ CoHRE, Org Res & Acad Informat, Izumo, Shimane, Japan.	t-abe@med.shimane-u.ac.jp	Miyazaki, Ryo/GPW-7412-2022; Kamada, Masamitsu/H-4411-2011	Miyazaki, Ryo/0000-0002-1996-709X; Kamada, Masamitsu/0000-0003-1703-076X	JSPS KAKENHI [19H03996, 19K11667]; Kieikai Research Foundation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Kieikai Research Foundation(Kieikai Research Foundation)	This study was supported by JSPS KAKENHI Grant Number 19H03996(MK) and 19K11667 (RM)and the Kieikai Research Foundation (RM). JSPS KAKENHI: https://kaken.nii.ac.jp/ja/index/Kiekai Research Foundation: https://www.nakashima-foundation.org/kieikai/research/index19.html The funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2020, MATURITAS, V136, P54, DOI 10.1016/j.maturitas.2020.04.007; Allison PD, 2005, SUGI 30 P, P113; Barnard J, 1999, STAT METHODS MED RES, V8, P17, DOI 10.1191/096228099666230705; Bunt S, 2017, EUR J AGEING, V14, P323, DOI 10.1007/s10433-017-0414-7; Chen LJ, 2014, INT J GERONTOL, V8, P114, DOI 10.1016/j.ijge.2013.12.002; Chen LK, 2020, J AM MED DIR ASSOC, V21, P300, DOI 10.1016/j.jamda.2019.12.012; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Choi J, 2015, J AM MED DIR ASSOC, V16, P548, DOI 10.1016/j.jamda.2015.02.004; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; Collard RM, 2012, J AM GERIATR SOC, V60, P1487, DOI 10.1111/j.1532-5415.2012.04054.x; de Labra Carmen, 2015, BMC Geriatr, V15, P154, DOI 10.1186/s12877-015-0155-4; Duppen D, 2019, J APPL GERONTOL, V38, P3, DOI 10.1177/0733464816688310; Etman A, 2015, EUR J PUBLIC HEALTH, V25, P345, DOI 10.1093/eurpub/cku093; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Hajek A, 2016, J NUTR HEALTH AGING, V20, P952, DOI 10.1007/s12603-015-0634-5; Hamano T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013214; Hoogendijk EO, 2019, LANCET, V394, P1365, DOI 10.1016/S0140-6736(19)31786-6; Ide K, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17020617; Ito T, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16122142; James BD, 2011, J GERONTOL A-BIOL, V66, P467, DOI 10.1093/gerona/gly231; Kanamori S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099638; Kawachi I, 2001, J URBAN HEALTH, V78, P458, DOI 10.1093/jurban/78.3.458; Kikuchi H, 2017, GERIATR GERONTOL INT, V17, P1921, DOI 10.1111/ggi.12995; Kojima G, 2018, AGE AGEING, V47, P193, DOI 10.1093/ageing/afx162; Kojima G, 2017, DISABIL REHABIL, V39, P1897, DOI 10.1080/09638288.2016.1212282; Kojima G, 2017, J EPIDEMIOL, V27, P347, DOI 10.1016/j.je.2016.09.008; Kojima G, 2016, J EPIDEMIOL COMMUN H, V70, P716, DOI 10.1136/jech-2015-206717; Ministry of Health Labor and Welfare Japan, 2017, EST COMM BAS INT CAR; Nakagawa K, 2019, SOC SCI MED, V238, DOI 10.1016/j.socscimed.2019.112484; Paw MJMCA, 2008, SPORTS MED, V38, P781, DOI 10.2165/00007256-200838090-00006; Perruccio AV, 2021, ARTHRIT CARE RES, V73, P1638, DOI 10.1002/acr.24366; Satake S, 2017, GERIATR GERONTOL INT, V17, P2629, DOI 10.1111/ggi.13129; Satake S, 2016, GERIATR GERONTOL INT, V16, P709, DOI 10.1111/ggi.12543; Serrat R, 2020, GERONTOLOGIST, V60, pE38, DOI 10.1093/geront/gnz021; Takayanagi Naoto, 2018, J Phys Ther Sci, V30, P461, DOI 10.1589/jpts.30.461; Theou O, 2015, AGEING RES REV, V21, P78, DOI 10.1016/j.arr.2015.04.001; Tomioka K, 2017, J AM GERIATR SOC, V65, P107, DOI 10.1111/jgs.14447; Castell MV, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0807-8; Vogelsang EM, 2016, HEALTH PLACE, V42, P111, DOI 10.1016/j.healthplace.2016.09.010; Woo J, 2005, GERONTOLOGY, V51, P402, DOI 10.1159/000088705; Ye B, 2018, BMC GERIATR, V18, DOI 10.1186/s12877-018-0982-1	41	11	12	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243548	10.1371/journal.pone.0243548	http://dx.doi.org/10.1371/journal.pone.0243548			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH1IW	33326452	Green Published, gold			2022-12-27	WOS:000600176400003
J	Borie, R; Savale, L; Dossier, A; Ghosn, J; Taille, C; Visseaux, B; Jebreen, K; Diallo, A; Tesmoingt, C; Morer, L; Goletto, T; Faucher, N; Hajouji, L; Neukirch, C; Phillips, M; Stelianides, S; Bouadma, L; Brosseau, S; Ottaviani, S; Pluvy, J; Le Pluart, D; Debray, MP; Raynaud-Simon, A; Descamps, D; Khalil, A; Timsit, JF; Lescure, FX; Descamps, V; Papo, T; Humbert, M; Crestani, B; Dieude, P; Vicaut, E; Zalcman, G				Borie, Raphael; Savale, Laurent; Dossier, Antoine; Ghosn, Jade; Taille, Camille; Visseaux, Benoit; Jebreen, Kamel; Diallo, Abourahmane; Tesmoingt, Chloe; Morer, Lise; Goletto, Tiphaine; Faucher, Nathalie; Hajouji, Linda; Neukirch, Catherine; Phillips, Mathilde; Stelianides, Sandrine; Bouadma, Lila; Brosseau, Solenn; Ottaviani, Sebastien; Pluvy, Johan; Le Pluart, Diane; Debray, Marie-Pierre; Raynaud-Simon, Agathe; Descamps, Diane; Khalil, Antoine; Timsit, Jean Francois; Lescure, Francois-Xavier; Descamps, Vincent; Papo, Thomas; Humbert, Marc; Crestani, Bruno; Dieude, Philippe; Vicaut, Eric; Zalcman, Gerard		Bichat Kremlin-Bicetre AP-HP COVID	Glucocorticoids with low-dose anti-IL1 anakinra rescue in severe non-ICU COVID-19 infection: A cohort study	PLOS ONE			English	Article							INTERLEUKIN-1; PNEUMONIA; MORTALITY; BLOCKADE; WUHAN; ARDS	Background The optimal treatment for patients with severe coronavirus-19 disease (COVID-19) and hyper-inflammation remains debated. Material and methods A cohort study was designed to evaluate whether a therapeutic algorithm using steroids with or without interleukin-1 antagonist (anakinra) could prevent death/invasive ventilation. Patients with a >= 5-day evolution since symptoms onset, with hyper-inflammation (CRP >= 50mg/L), requiring 3-5 L/min oxygen, received methylprednisolone alone. Patients needing >= 6 L/min received methylprednisolone + subcutaneous anakinra daily either frontline or in case clinical deterioration upon corticosteroids alone. Death rate and death or intensive care unit (ICU) invasive ventilation rate at Day 15, with Odds Ratio (OR) and 95% CIs, were determined according to logistic regression and propensity scores. A Bayesian analysis estimated the treatment effects. Results Of 108 consecutive patients, 70 patients received glucocorticoids alone. The control group comprised 63 patients receiving standard of care. In the corticosteroidstanakinra group (n = 108), death rate was 20.4%, versus 30.2% in the controls, indicating a 30% relative decrease in death risk and a number of 10 patients to treat to avoid a death (p = 0.15). Using propensity scores a per-protocol analysis showed an OR for COVID-19-related death of 0.9 (95%CI [0.80-1.01], p = 0.067). On Bayesian analysis, the posterior probability of any mortality benefit with corticosteroids+/-anakinra was 87.5%, with a 7.8% probability of treatment-related harm. Pre-existing diabetes exacerbation occurred in 29 of 108 patients (26.9%). Conclusion In COVID-19 non-ICU inpatients at the cytokine release phase, corticosteroids with or without anakinra were associated with a 30% decrease of death risk on Day 15.	[Borie, Raphael; Taille, Camille; Morer, Lise; Goletto, Tiphaine; Hajouji, Linda; Neukirch, Catherine; Phillips, Mathilde; Stelianides, Sandrine; Brosseau, Solenn; Pluvy, Johan; Crestani, Bruno; Zalcman, Gerard] Univ Paris, Univ Hosp Bichat Claude Bernard, Pulmonol & Thorac Oncol Dept, AP HP, Paris, France; [Savale, Laurent; Humbert, Marc] Paris Saclay Univ, Kremlin Bicetre Univ Hosp, Pulmonol Dept, AP HP, Le Kremlin Bicetre, France; [Dossier, Antoine; Papo, Thomas] Univ Paris, Univ Hosp Bichat Claude Bernard, Internal Med Dept, AP HP, Paris, France; [Ghosn, Jade; Le Pluart, Diane; Lescure, Francois-Xavier] Univ Paris, Univ Hosp Bichat Claude Bernard, Infect Dis Dept, AP HP, Paris, France; [Visseaux, Benoit; Descamps, Diane] Univ Paris, Univ Hosp Bichat Claude Bernard, Virol Dept, AP HP, Paris, France; [Jebreen, Kamel; Diallo, Abourahmane; Vicaut, Eric] Univ Paris, Univ Hosp Lariboisiere, Biostat & Clin Res Dept, AP HP, Paris, France; [Tesmoingt, Chloe; Raynaud-Simon, Agathe] Univ Paris, Univ Hosp Bichat Claude Bernard, Pharm Dept, AP HP, Paris, France; [Faucher, Nathalie] Univ Paris, Univ Hosp Bichat Claude Bernard, Geriatr Dept, AP HP, Paris, France; [Bouadma, Lila; Timsit, Jean Francois] Univ Paris, Univ Hosp Bichat Claude Bernard, Intens Care Dept, AP HP,Med & Infect Dis ICU, Paris, France; [Ottaviani, Sebastien; Dieude, Philippe] Univ Paris, Univ Hosp Bichat Claude Bernard, Rheumatol Dept, AP HP, Paris, France; [Debray, Marie-Pierre; Khalil, Antoine] Univ Paris, Univ Hosp Bichat Claude Bernard, Radiol Dept, AP HP, Paris, France; [Descamps, Vincent] Univ Paris, Univ Hosp Bichat Claude Bernard, Dermatol Dept, AP HP, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Zalcman, G (corresponding author), Univ Paris, Univ Hosp Bichat Claude Bernard, Pulmonol & Thorac Oncol Dept, AP HP, Paris, France.	gerard.zalcman@aphp.fr	Dossier, Antoine/AGG-9850-2022; Humbert, Marc/ABD-5112-2021	Taille, Camille/0000-0001-9768-5728; Borie, Raphael/0000-0002-9906-0024				Alfaraj SH, 2019, TRAVEL MED INFECT DI, V29, P48, DOI 10.1016/j.tmaid.2019.03.004; Aouba A, 2020, ANN RHEUM DIS, V79, P1381, DOI 10.1136/annrheumdis-2020-217706; Bai HX, 2020, RADIOLOGY, V296, pE46, DOI 10.1148/radiol.2020200823; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1001/jama.2020.2565, 10.1056/NEJMoa2001316]; Banerjee A, 2020, LANCET, V395, P1715, DOI 10.1016/S0140-6736(20)30854-0; Beigel JH, 2020, N ENGL J MED, V383, P1813; Borba MGS, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.8857; Caly Leon, 2020, Antiviral Res, V178, P104787, DOI 10.1016/j.antiviral.2020.104787; Cao B, 2020, NEW ENGL J MED, V382, P1787, DOI 10.1056/NEJMoa2001282; Cavalli G, 2020, LANCET RHEUMATOL, V2, pE325, DOI 10.1016/S2665-9913(20)30127-2; Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244; Chen J, 2020, J INFECTION, V80, pE1, DOI 10.1016/j.jinf.2020.03.004; COVID19 APHP Grp, 2020, LANCET, V395, P1760, DOI 10.1016/S0140-6736(20)31210-1; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Dowd JB, 2020, P NATL ACAD SCI USA, V117, P9696, DOI 10.1073/pnas.2004911117; Fadel R, 2020, CLIN INFECT DIS, V71, P2114, DOI 10.1093/cid/ciaa601; Farag NS, 2020, INT J BIOCHEM CELL B, V122, DOI 10.1016/j.biocel.2020.105738; Giavridis T, 2018, NAT MED, V24, P731, DOI 10.1038/s41591-018-0041-7; Horby P, 2020, NEW ENGL J MED, DOI [10.1101/2020.06.22.20137273:24, DOI 10.1056/NEJMOA2021436, 10.1101/2020.06.22.20137273, 10.1101/2020.06.22.20137273v1, DOI 10.1101/2020.07.15.20151852]; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Huet T, 2020, LANCET RHEUMATOL, V2, pE393, DOI 10.1016/S2665-9913(20)30164-8; Kernan KF, 2019, GENES IMMUN, V20, P520, DOI 10.1038/s41435-018-0030-3; Kucharski AJ, 2020, LANCET INFECT DIS, V20, P553, DOI 10.1016/S1473-3099(20)30144-4; Lee N, 2004, J CLIN VIROL, V31, P304, DOI 10.1016/j.jcv.2004.07.006; McCandless LC, 2009, STAT MED, V28, P94, DOI 10.1002/sim.3460; Meduri GU, 2007, CHEST, V131, P954, DOI 10.1378/chest.06-2100; Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0; Navarro-Millan I, 2020, ARTHRITIS RHEUMATOL, V72, P1990, DOI 10.1002/art.41422; Ni YN, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2395-8; Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5; ROBINS JM, 1994, J AM STAT ASSOC, V89, P846, DOI 10.2307/2290910; Rotz SJ, 2017, PEDIATR BLOOD CANCER, V64, DOI 10.1002/pbc.26642; Seam N, 2016, INTENS CARE MED, V42, P924, DOI 10.1007/s00134-015-4160-z; Shakoory B, 2016, CRIT CARE MED, V44, P275, DOI 10.1097/CCM.0000000000001402; Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; Wang Y, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0158-2; Who Mers-Cov Research Group, 2013, PLoS Curr, V5, DOI 10.1371/currents.outbreaks.0bf719e352e7478f8ad85fa30127ddb8; Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994; Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	41	8	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243961	10.1371/journal.pone.0243961	http://dx.doi.org/10.1371/journal.pone.0243961			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326457	Green Published, gold			2022-12-27	WOS:000600176400066
J	Chireh, B; D'Arcy, C				Chireh, Batholomew; D'Arcy, Carl			A comparison of the prevalence of and modifiable risk factors for cognitive impairment among community-dwelling Canadian seniors over two decades, 1991-2009	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; DEMENTIA INCIDENCE; HEALTH; POPULATION; PREVENTION; SCIENCE; DECLINE; COHORT	Background The prevalence of cognitive impairment or dementia is of public health concern globally. Accurate estimates of this debilitating condition are needed for future public health policy planning. In this study, we estimate prevalence and modifiable risk factors for cognitive impairment by sex over approximately 16 years. Methods Canadian Study of Health and Aging (CSHA) baseline data conducted between 1991-1992 were used to measure the prevalence of cognitive impairment and dementia among adults aged 65+ years. The standard Modified Mini-Mental State Examination (3MS) was used for the screening test for cognitive impairment. We compared the CSHA data with Canadian Community Health Survey-Healthy Aging (CCHS-HA) conducted between 2008-2009. The CCHS-HA used a four-dimension cognitive module to screen for cognitive impairment. Only survey community-dwelling respondents were included in the final sample. After applying exclusion criteria, final samples of (N = 8504) respondents in the CSHA sample and (N = 7764) respondents for CCHS-HA sample were analyzed. To account for changes in the age structure of the Canadian population, prevalence estimates were calculated using age-sex standardization to the 2001 population census of Canada. Logistic regression analyses were used to examine predictors of cognitive impairment. A sex stratified analysis was used to examine risk factors for cognitive impairment in the survey samples. Results We found that prevalence of cognitive impairment among respondents in CSHA sample was 15.5% in 1991 while a prevalence of 10.8% was reported in the CCHS-HA sample in 2009, a 4.7% reduction [15.5% (CI = 14.8-16.3), CSHA vs 10.8% (CI = 10.1-11.5), CCHS-HA]. Men reported higher prevalence of cognitive impairment in CSHA study (16.0%) while women reported higher prevalence of cognitive impairment in CCHS-HA (11.6%). In the multivariable analyses, risk factors such as age, poor self-rated health, stroke, Parkinson's disease, and hearing problems were common to both cohorts. Sex differences in risk factors were also noted. Conclusions This study provides suggestive evidence of a potential reduction in the occurrence of cognitive impairment among community-dwelling Canadian seniors despite the aging of the Canadian population. The moderating roles of improved prevention and treatment of vascular morbidity and improvements in the levels of education of the Canadian population are possible explanations for this decrease in the cognitive impairment.	[Chireh, Batholomew] Saskatchewan Hlth Qual Council, Saskatoon, SK, Canada; [D'Arcy, Carl] Univ Saskatchewan, Dept Psychiat, Saskatoon, SK, Canada; [D'Arcy, Carl] Univ Saskatchewan, Sch Publ Hlth, Saskatoon, SK, Canada	University of Saskatchewan; University of Saskatchewan	Chireh, B (corresponding author), Saskatchewan Hlth Qual Council, Saskatoon, SK, Canada.	bac563@mail.usask.ca		Chireh, Batholomew/0000-0002-1803-2890	University of Saskatchewan School of Public Health	University of Saskatchewan School of Public Health	The University of Saskatchewan School of Public Health provided support for this study in the form of a scholarship awarded to BC.	Albert M, 2013, NCHS DATA BRIEF; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Alzheimer Society of Canada, 2010, RIS TID IMP DEM CAN; [Anonymous], 2020, CANADIAN CHRONIC DIS; [Anonymous], 2008, PRIM HLTH CAR NOW MO; [Anonymous], 2010, CLIN INFECT DIS S3, V50, pS173, DOI 10.1086/651488; Beydoun MA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-643; Daviglus ML, 2010, ANN INTERN MED, V153, P176, DOI 10.7326/0003-4819-153-3-201008030-00260; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Fischer BL, 2014, PHYS THER, V94, P355, DOI 10.2522/ptj.20130195; Freedman VA, 2018, J GERONTOL B-PSYCHOL, V73, pS48, DOI 10.1093/geronb/gbx144; Institut canadien d'information sur la sante, 2011, HLTH CAR CAN FOC SEN; Jacklin KM, 2013, CAN J PUBLIC HEALTH, V104, pE39, DOI 10.1007/BF03405652; Katz MJ, 2012, ALZ DIS ASSOC DIS, V26, P335, DOI 10.1097/WAD.0b013e31823dbcfc; Kosteniuk JG, 2016, INT PSYCHOGERIATR, V28, P1643, DOI 10.1017/S1041610216000818; Koyanagi A, 2018, J AM GERIATR SOC, V66, P721, DOI 10.1111/jgs.15288; Launay C, 2014, GERIATR PSYCHOL NEUR, V12, P43, DOI 10.1684/pnv.2014.0455; Lipnicki DM, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002261; Lipnicki DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065841; Livingston G, 2020, LANCET, V396, P413, DOI 10.1016/S0140-6736(20)30367-6; Loef M, 2012, J NUTR HEALTH AGING, V16, P626, DOI 10.1007/s12603-012-0097-x; Lu WH, 2016, J CLIN GERONTOL GERI, V7, P44, DOI 10.1016/j.jcgg.2015.08.002; Matthews FE, 2013, LANCET, V382, P1405, DOI 10.1016/S0140-6736(13)61570-6; MCDOWELL I, 1994, CAN MED ASSOC J, V150, P899; Meng XF, 2013, INT J GERIATR PSYCH, V28, P1005, DOI 10.1002/gps.3918; Meng XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038268; Nakamura K, 2016, ENVIRON HEALTH PREV, V21, P422, DOI 10.1007/s12199-016-0542-2; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Prince MJ, 2015, LANCET, V385, P549, DOI 10.1016/S0140-6736(14)61347-7; Ramage-Morin Pamela L, 2010, Health Rep, V21, P45; Rodriguez-Sanchez E, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-147; Roehr S, 2018, CLIN EPIDEMIOL, V10, P1233, DOI 10.2147/CLEP.S163649; ROWE JW, 1987, SCIENCE, V237, P143, DOI 10.1126/science.3299702; Sampson EL, 2009, BRIT J PSYCHIAT, V195, P61, DOI 10.1192/bjp.bp.108.055335; Satizabal CL, 2016, NEW ENGL J MED, V374, P523, DOI 10.1056/NEJMoa1504327; Statistics Canada, 2016, CANC CENS POP STAT C; Statistics Canada, 2017, ABORIGINAL PEOPLES C; Stryhn H., 2012, METHODS EPIDEMIOLOGI; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; Tierney MC, 2004, J AM GERIATR SOC, V52, P1435, DOI 10.1111/j.0002-8614.2004.52404.x; Tschanz JT, 2006, NEUROLOGY, V67, P229, DOI 10.1212/01.wnl.0000224748.48011.84; van den Kommer TN, 2018, J GERONTOL B-PSYCHOL, V73, pS57, DOI 10.1093/geronb/gbx151; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31678-6, 10.1016/S0140-6736(16)31012-1]; Winblad B, 2016, LANCET NEUROL, V15, P455, DOI 10.1016/S1474-4422(16)00062-4; World Health Organization, 2019, INT CLASS DIS ICD 10; Wu YT, 2016, LANCET NEUROL, V15, P116, DOI 10.1016/S1474-4422(15)00092-7	46	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0242911	10.1371/journal.pone.0242911	http://dx.doi.org/10.1371/journal.pone.0242911			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH1IW	33326422	gold, Green Published			2022-12-27	WOS:000600176400032
J	Doshi, S; Moorthi, RN; Fried, LF; Sarnak, MJ; Satterfield, S; Shlipak, M; Lange-Maia, BS; Newman, AB; Strotmeyer, ES				Doshi, Simit; Moorthi, Ranjani N.; Fried, Linda F.; Sarnak, Mark J.; Satterfield, Suzanne; Shlipak, Michael; Lange-Maia, Brittney S.; Newman, Anne B.; Strotmeyer, Elsa S.			Chronic kidney disease as a risk factor for peripheral nerve impairment in older adults: A longitudinal analysis of Health, Aging and Body Composition (Health ABC) study	PLOS ONE			English	Article							CONDUCTION-VELOCITY; AXONAL DYSFUNCTION; BLACK ADULTS; NEUROPATHY; ERYTHROPOIETIN; POLYNEUROPATHY; ASSOCIATION; PERFORMANCE; CREATININE; WALKING	Introduction Sensory and motor nerve deficits are prevalent in older adults and are associated with loss of functional independence. We hypothesize that chronic kidney disease predisposes to worsening sensorimotor nerve function over time. Materials and methods Participants were from the Health, Aging and Body Composition Study (N = 1121) with longitudinal data between 2000-01 (initial visit) and 2007-08 (follow-up visit). Only participants with non-impaired nerve function at the initial visit were included. The predictor was presence of CKD (estimated GFR <= 60 ml/min/1.73m(2)) from the 1999-2000 visit. Peripheral nerve function outcomes at 7-year follow-up were 1) Motor: "new" impairments in motor parameters (nerve conduction velocity NCV < 40 m/s or peroneal compound motor action potential < 1 mv) at follow-up, and 2) Sensory: "new" impairment defined as insensitivity to standard 10-g monofilament or light 1.4-g monofilament at the great toe and "worsening" as a change from light to standard touch insensitivity over time. The association between CKD and "new" or "worsening" peripheral nerve impairment was studied using logistic regression. Results The study population was 45.9% male, 34.3% Black and median age 75 y. CKD participants (15.6%) were older, more hypertensive, higher in BMI and had 2.37 (95% CI 1.30-4.34) fold higher adjusted odds of developing new motor nerve impairments in NCV. CKD was associated with a 2.02 (95% CI 1.01-4.03) fold higher odds of worsening monofilament insensitivity. CKD was not associated with development of new monofilament insensitivity. Conclusions Pre-existing CKD leads to new and worsening sensorimotor nerve impairments over a 7-year time period in community-dwelling older adults.	[Doshi, Simit; Moorthi, Ranjani N.] Indiana Univ, Div Nephrol, Indianapolis, IN 46204 USA; [Fried, Linda F.; Newman, Anne B.; Strotmeyer, Elsa S.] Univ Pittsburgh, Pittsburgh, PA USA; [Sarnak, Mark J.] Tufts Med Ctr, Boston, MA 02111 USA; [Satterfield, Suzanne] Univ Tennessee, Memphis, TN USA; [Shlipak, Michael] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Lange-Maia, Brittney S.] Rush Univ, Med Ctr, Chicago, IL 60612 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Tufts Medical Center; University of Tennessee System; University of Tennessee Health Science Center; University of California System; University of California San Francisco; Rush University	Moorthi, RN (corresponding author), Indiana Univ, Div Nephrol, Indianapolis, IN 46204 USA.	rmoorthi@iu.edu		Strotmeyer, Elsa/0000-0002-4093-6036	National Institute on Aging (NIA) [N01-AG-6-2101, N01-AG-6-2103, N01-AG-6-2106]; NINR [R01-NR012459]; Intramural Research Program of the NIH, National Institute on Aging; NIH NIDDK [K23 DK102824]; NIA [R01AG028050]	National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); Intramural Research Program of the NIH, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by National Institute on Aging (NIA) Contracts N01-AG-6-2101; N01-AG-6-2103; N01-AG-6-2106; NIA grant R01AG028050, and NINR grant R01-NR012459. This research was funded in part by the Intramural Research Program of the NIH, National Institute on Aging. This work was also supported by NIH NIDDK K23 DK102824 (RNM).	Aggarwal HK, 2013, RENAL FAILURE, V35, P1105, DOI 10.3109/0886022X.2013.815102; Alam U, 2017, DIABETES THER, V8, P1253, DOI 10.1007/s13300-017-0295-y; Arnold R, 2017, CLIN J AM SOC NEPHRO, V12, P1569, DOI 10.2215/CJN.00670117; Arnold R, 2016, JRSM CARDIOVASC DIS, V5, DOI 10.1177/2048004016677687; Arnold R, 2014, CLIN NEUROPHYSIOL, V125, P179, DOI 10.1016/j.clinph.2013.06.022; Arnold R, 2013, DIABETES-METAB RES, V29, P53, DOI 10.1002/dmrr.2360; AVRAM MM, 1978, NEW ENGL J MED, V298, P1000, DOI 10.1056/NEJM197805042981805; Bowling CB, 2018, J GERONTOL A-BIOL, V73, P1216, DOI 10.1093/gerona/glx260; Bowling CB, 2016, CLIN J AM SOC NEPHRO, V11, P1236, DOI 10.2215/CJN.11111015; Brown SA, 2017, CLIN KIDNEY J, V10, P788, DOI 10.1093/ckj/sfx057; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Denislic M, 2015, INT UROL NEPHROL, V47, P1879, DOI 10.1007/s11255-015-1117-7; Deshpande N, 2016, AGE, V38, DOI 10.1007/s11357-016-9918-x; Fried LF, 2007, J AM SOC NEPHROL, V18, P282, DOI 10.1681/ASN.2006050546; Fried LF, 2006, J AM GERIATR SOC, V54, P750, DOI 10.1111/j.1532-5415.2006.00727.x; Hanewinckel R, 2016, NEUROLOGY, V87, P1892, DOI 10.1212/WNL.0000000000003293; Hassan K, 2003, J NEPHROL, V16, P121; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Jasti DB, 2017, J NEUROSCI RURAL PRA, V8, P516, DOI 10.4103/jnrp.jnrp_186_17; Kistler BM, 2018, PREV CHRONIC DIS, V15, DOI 10.5888/pcd15.170518; Kooman JP, 2014, NAT REV NEPHROL, V10, P732, DOI 10.1038/nrneph.2014.185; Kurella M, 2005, J AM SOC NEPHROL, V16, P2127, DOI 10.1681/ASN.2005010005; Lange-Maia BS, 2017, EXP GERONTOL, V96, P38, DOI 10.1016/j.exger.2017.04.007; Lange-Maia BS, 2016, ARCH PHYS MED REHAB, V97, P45, DOI 10.1016/j.apmr.2015.08.423; Lange-Maia BS, 2015, J AM GERIATR SOC, V63, P1348, DOI 10.1111/jgs.13487; MASER R E, 1991, Journal of Diabetic Complications, V5, P6, DOI 10.1016/0891-6632(91)90003-8; Moorthi RN, 2017, CURR OPIN NEPHROL HY, V26, P219, DOI 10.1097/MNH.0000000000000318; Moorthi RN, 2018, NEPHROL DIAL TRANSPL; Roshanravan B, 2015, AM J KIDNEY DIS, V65, P737, DOI 10.1053/j.ajkd.2014.10.016; Said G, 2013, HAND CLINIC, V115, P607, DOI 10.1016/B978-0-444-52902-2.00035-7; Smyth A, 2013, AGE AGEING, V42, P488, DOI 10.1093/ageing/aft007; SOBH MA, 1992, SCAND J UROL NEPHROL, V26, P65, DOI 10.3109/00365599209180398; Strotmeyer ES, 2008, DIABETES CARE, V31, P1767, DOI 10.2337/dc08-0433; Strotmeyer ES, 2006, J BONE MINER RES, V21, P1803, DOI 10.1359/JBMR.060725; Strotmeyer ES, 2009, J AM GERIATR SOC, V57, P2004, DOI 10.1111/j.1532-5415.2009.02487.x; Walker Simon R, 2015, Can J Kidney Health Dis, V2, P32, DOI 10.1186/s40697-015-0067-4; Ward RE, 2016, AGING DIS, V7, P466, DOI 10.14336/AD.2015.1127; Ward RE, 2015, J GERONTOL A-BIOL, V70, P464, DOI 10.1093/gerona/glu183; Ward RE, 2014, J AM GERIATR SOC, V62, P2273, DOI 10.1111/jgs.13152; Ward RE, 2013, CLIN NEUROPHYSIOL, V124, P603, DOI 10.1016/j.clinph.2012.07.027; Wilson JR, 1998, MUSCLE NERVE, V21, P1228, DOI 10.1002/(SICI)1097-4598(199809)21:9<1228::AID-MUS20>3.0.CO;2-M	41	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0242406	10.1371/journal.pone.0242406	http://dx.doi.org/10.1371/journal.pone.0242406			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH3TP	33320861	Green Published, gold			2022-12-27	WOS:000600339800041
J	Kaufmann, M; Solderer, A; Gubler, A; Wegehaupt, FJ; Attin, T; Schmidlin, PR				Kaufmann, Manuela; Solderer, Alex; Gubler, Andrea; Wegehaupt, Florian J.; Attin, Thomas; Schmidlin, Patrick R.			Quantitative measurements of aerosols from air-polishing and ultrasonic devices: (How) can we protect ourselves?	PLOS ONE			English	Article							SPATTER-REDUCTION; INFECTION-CONTROL; CONTAMINATION; SPLATTER; EFFICACY; RISK	Aim To assess the distribution and deposition of aerosols during simulated periodontal therapy. Methods A manikin with simulated fluorescein salivation was treated by four experienced dentists applying two different periodontal treatment options, i.e. air-polishing with an airflow device or ultrasonic scaling in the upper and lower anterior front for 5 minutes, respectively. Aerosol deposition was quantitatively measured on 21 pre-defined locations with varying distances to the manikins mouth in triplicates using absorbent filter papers. Results The selected periodontal interventions resulted in different contamination levels around the patient's mouth. The highest contamination could be measured on probes on the patient's chest and forehead but also on the practitioner's glove. With increasing distance to the working site contamination of the probes decreased with both devices. Air-polishing led to greater contamination than ultrasonic. Conclusion Both devices showed contamination of the nearby structures, less contamination was detected when using the ultrasonic. Affirming the value of wearing protective equipment we support the need for universal barrier precautions and effective routine infection control in dental practice.	[Kaufmann, Manuela; Solderer, Alex; Gubler, Andrea; Wegehaupt, Florian J.; Attin, Thomas; Schmidlin, Patrick R.] Univ Zurich, Ctr Dent Med, Clin Conservat & Prevent Dent, Zurich, Switzerland	University of Zurich	Schmidlin, PR (corresponding author), Univ Zurich, Ctr Dent Med, Clin Conservat & Prevent Dent, Zurich, Switzerland.	patrick.schmidlin@zzm.uzh.ch	Attin, Thomas/ABF-9246-2020	Wegehaupt, Florian/0000-0002-3972-0561; Schmidlin, Patrick/0000-0002-1377-0325; Attin, Thomas/0000-0002-6141-1263				Bennett AM, 2000, BRIT DENT J, V189, P664, DOI 10.1038/sj.bdj.4800859a; BENTLEY CD, 1994, J AM DENT ASSOC, V125, P579, DOI 10.14219/jada.archive.1994.0093; Booth TF, 2005, J INFECT DIS, V191, P1472, DOI 10.1086/429634; COCHRAN MA, 1989, J AM DENT ASSOC, V119, P141, DOI 10.14219/jada.archive.1989.0131; Cottone J A, 1987, Tex Dent J, V104, P7; Dahlke WO, 2012, J AM DENT ASSOC, V143, P1199, DOI 10.14219/jada.archive.2012.0064; DEGRAAFF J, 1988, J DENT CHILD, V55, P56; Devker Nihal R, 2012, J Contemp Dent Pract, V13, P681; Gupta G, 2014, J PERIODONTOL, V85, P562, DOI 10.1902/jop.2013.120616; Harrel SK, 1999, QUINTESSENCE INT, V30, P623; Harrel SK, 2004, J AM DENT ASSOC, V135, P429, DOI 10.14219/jada.archive.2004.0207; Harrel SK, 1998, J AM DENT ASSOC, V129, P1241, DOI 10.14219/jada.archive.1998.0421; Holloman JL, 2015, J AM DENT ASSOC, V146, P27, DOI 10.1016/j.adaj.2014.10.001; Hunter A, 2014, IMAGNG SCI DENT, V44, P149, DOI 10.5624/isd.2014.44.2.149; Jacks Mary E, 2002, J Dent Hyg, V76, P202; Joshi Amruta Arun, 2017, J Int Acad Periodontol, V19, P138; Klyn Steven L., 2001, General Dentistry, V49, P648; Kohn WG, 2004, J AM DENT ASSOC, V135, P33, DOI 10.14219/jada.archive.2004.0019; Lewis D, 2020, NATURE, V580, P175, DOI 10.1038/d41586-020-00974-w; Meng L, 2020, J DENT RES, V99, P481, DOI 10.1177/0022034520914246; MICIK RE, 1969, J DENT RES, V48, P49, DOI 10.1177/00220345690480012401; Oshitani H., 2020, CLOSED ENV FACILITAT; Peng PWH, 2020, BRIT J ANAESTH, V124, P497, DOI 10.1016/j.bja.2020.02.008; Pereira RJ, 2020, PUBLIC HEALTH, V183, P42, DOI 10.1016/j.puhe.2020.04.042; Radcliffe RA, 2013, J AM DENT ASSOC, V144, P1110, DOI 10.14219/jada.archive.2013.0029; Tellier R, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3707-y; To KKW, 2020, LANCET INFECT DIS, V20, P565, DOI 10.1016/S1473-3099(20)30196-1; Veena HR, 2015, J INFECT PUBLIC HEAL, V8, P260, DOI 10.1016/j.jiph.2014.11.004; Yoon JG, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e195; Zemouri C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178007	30	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0244020	10.1371/journal.pone.0244020	http://dx.doi.org/10.1371/journal.pone.0244020			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320905	gold, Green Published			2022-12-27	WOS:000600339800059
J	Ali, AS; Langer, SW; Federspiel, B; Hjortland, GO; Gronbaek, H; Ladekarl, M; Welin, S; Vestermark, LW; Arola, J; Osterlund, P; Knigge, U; Sorbye, H; Micke, P; Grimelius, L; Gronberg, M; Janson, ET				Ali, Abir Salwa; Langer, Seppo W.; Federspiel, Birgitte; Hjortland, Geir Olav; Gronbaek, Henning; Ladekarl, Morten; Welin, Staffan; Vestermark, Lene Weber; Arola, Johanna; Osterlund, Pia; Knigge, Ulrich; Sorbye, Halfdan; Micke, Patrick; Grimelius, Lars; Gronberg, Malin; Janson, Eva Tiensuu			PD-L1 expression in gastroenteropancreatic neuroendocrine neoplasms grade 3	PLOS ONE			English	Article							CONSENSUS GUIDELINES; CELL CARCINOMA; CANCER; TUMORS; STIMULATION; DIAGNOSIS; SYSTEM; NSCLC	Gastroenteropancreatic neuroendocrine neoplasms grade 3 (GEP-NENs G3) are rare tumors. These highly aggressive neoplasms are traditionally treated with platinum-based chemotherapy in combination with etoposide. Immune checkpoint proteins such as programmed cell death ligand (PD-L1) may have a role in different cancers allowing them escape the immune system and hence, progress. We aimed to investigate the immunohistochemical expression of PD-L1 in GEP-NEN G3 and evaluate its correlation to clinical parameters. In a cohort of 136 patients, 14 (10%) expressed PD-L1 immunoreactivity; four (3%) patients in the tumor cells and 10 (7%) had immunoreactive immune cells. PD-L1 expression did not correlate to clinical parameters, progression-free survival or overall survival. We conclude that PD-L1 expression is present only in a subset of GEP-NEN G3 patients. Further studies are needed to fully understand the role of PD-L1 in patients with GEP-NEN G3, including the future possibility for treatment with immune checkpoint inhibitors.	[Ali, Abir Salwa; Welin, Staffan; Gronberg, Malin; Janson, Eva Tiensuu] Uppsala Univ, Sect Endocrine Oncol, Dept Med Sci, Uppsala, Sweden; [Langer, Seppo W.] Copenhagen Univ Hosp, Dept Oncol, Rigshosp, Copenhagen, Denmark; [Federspiel, Birgitte] Copenhagen Univ Hosp, Dept Pathol, Rigshosp, Copenhagen, Denmark; [Hjortland, Geir Olav] Univ Oslo, Dept Oncol, Oslo, Norway; [Gronbaek, Henning] Aarhus Univ Hosp, Dept Hepatol & Gastroenterol, Aarhus, Denmark; [Ladekarl, Morten] Aarhus Univ Hosp, Dept Oncol, Aarhus, Denmark; [Ladekarl, Morten] Aalborg Univ Hosp, Dept Oncol, Clin Canc Res Ctr, Aalborg, Denmark; [Vestermark, Lene Weber] Odense Univ Hosp, Dept Oncol, Odense, Denmark; [Arola, Johanna] Univ Helsinki, Pathol, HUSLAB, Helsinki, Finland; [Arola, Johanna] Helsinki Univ Hosp, Helsinki, Finland; [Osterlund, Pia] Helsinki Univ Hosp, Dept Oncol, Helsinki, Finland; [Osterlund, Pia] Univ Helsinki, Helsinki, Finland; [Osterlund, Pia] Tampere Univ Hosp, Dept Oncol, Tampere, Finland; [Osterlund, Pia] Tampere Univ, Tampere, Finland; [Knigge, Ulrich] Copenhagen Univ Hosp, Dept Surg & Endocrinol PE C, Rigshosp, Copenhagen, Denmark; [Sorbye, Halfdan] Univ Bergen, Haukeland Univ Hosp, Dept Oncol, Bergen, Norway; [Sorbye, Halfdan] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Micke, Patrick; Grimelius, Lars] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden	Uppsala University; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Oslo; Aarhus University; Aarhus University; Aalborg University; Aalborg University Hospital; University of Southern Denmark; Odense University Hospital; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Tampere University; Tampere University Hospital; Tampere University; Rigshospitalet; University of Copenhagen; University of Bergen; Haukeland University Hospital; University of Bergen; Uppsala University	Gronberg, M (corresponding author), Uppsala Univ, Sect Endocrine Oncol, Dept Med Sci, Uppsala, Sweden.	malin.gronberg@medsci.uu.se	Gronbaek, Henning/AAJ-3202-2020; Grönberg, Malin/A-9331-2010	Gronbaek, Henning/0000-0001-8998-7910; Osterlund, Pia/0000-0002-7124-3515; Ladekarl, Morten/0000-0002-0182-1228; /0000-0001-9732-9192	Swedish Cancer Society [ETJ CAN 18 0576]; Lions Foundation for Cancer Research at the Uppsala University Hospital; Selander foundation; foundation for International Studies at the Faculty of Health Science, University of Copenhagen	Swedish Cancer Society(Swedish Cancer Society); Lions Foundation for Cancer Research at the Uppsala University Hospital; Selander foundation; foundation for International Studies at the Faculty of Health Science, University of Copenhagen	This work was supported by the Swedish Cancer Society (ETJ CAN 18 0576, www.cancerfonden.se), the Lions Foundation for Cancer Research at the Uppsala University Hospital (ETJ), the Selander foundation (ETJ) and the foundation for International Studies at the Faculty of Health Science, University of Copenhagen (UK).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsaab HO, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00561; [Anonymous], 2010, J AM COLL CARDIOL, V56, pe50; [Anonymous], 2019, CIRCULATION, V2019; Bosch F, 2019, ENDOCR-RELAT CANCER, V26, P293, DOI 10.1530/ERC-18-0494; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Brennan SM, 2010, CANCER-AM CANCER SOC, V116, P888, DOI 10.1002/cncr.24858; Brenner B, 2004, BRIT J CANCER, V90, P1720, DOI 10.1038/sj.bjc.6601758; Cavalcanti E, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.401; Chemnitz JM, 2004, J IMMUNOL, V173, P945, DOI 10.4049/jimmunol.173.2.945; Cortez MA, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv303; Ferrata M, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00343; Garcia-Carbonero R, 2016, NEUROENDOCRINOLOGY, V103, P186, DOI 10.1159/000443172; Haugvik SP, 2016, ANN SURG ONCOL, V23, P1721, DOI 10.1245/s10434-015-5013-2; Hutarew G, 2016, MEMO-MAG EUR MED ONC, V9, P201, DOI 10.1007/s12254-016-0292-2; Ilett EE, 2015, DIAGNOSTICS, V5, P119, DOI 10.3390/diagnostics5020119; Janson ET, 2014, ACTA ONCOL, V53, P1284, DOI 10.3109/0284186X.2014.941999; Jernman J, 2012, NEUROENDOCRINOLOGY, V95, P317, DOI 10.1159/000333035; Karwacz K, 2011, EMBO MOL MED, V3, P581, DOI 10.1002/emmm.201100165; Kim ST, 2016, J CANCER, V7, P484, DOI 10.7150/jca.13711; Kloppel G, 2004, ANN NY ACAD SCI, V1014, P13, DOI 10.1196/annals.1294.002; Kulangara K, 2019, ARCH PATHOL LAB MED, V143, P330, DOI 10.5858/arpa.2018-0043-OA; Lesterhuis WJ, 2011, J CLIN INVEST, V121, P3100, DOI 10.1172/JCI43656; Li AFY, 2010, J SURG ONCOL, V102, P497, DOI 10.1002/jso.21629; Luo M, 2016, ONCOTARGET, V7, P29794, DOI 10.18632/oncotarget.7631; Niederle MB, 2010, ENDOCR-RELAT CANCER, V17, P909, DOI 10.1677/ERC-10-0152; Oberg KE, 2010, ANN ONCOL, V21, P72, DOI 10.1093/annonc/mdq290; Passiglia F, 2016, ONCOTARGET, V7, P19738, DOI 10.18632/oncotarget.7582; Sahu A, 2019, J ONCOL, V2019, DOI 10.1155/2019/9032753; Sampedro-Nunez M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-36129-1; Sorbye H, 2013, ANN ONCOL, V24, P152, DOI 10.1093/annonc/mds276; Sorbye H, 2018, ENDOCRIN METAB CLIN, V47, P683, DOI 10.1016/j.ecl.2018.05.001; Sorbye H, 2014, CANCER-AM CANCER SOC, V120, P2814, DOI 10.1002/cncr.28721; Strosberg JR, 2010, PANCREAS, V39, P799, DOI 10.1097/MPA.0b013e3181ebb56f; Thompson RH, 2004, P NATL ACAD SCI USA, V101, P17174, DOI 10.1073/pnas.0406351101; Webb ES, 2018, J BIOMED RES, V32, P317, DOI 10.7555/JBR.31.20160168; Zhang J, 2015, THORAC CANCER, V6, P534, DOI 10.1111/1759-7714.12247	36	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243900	10.1371/journal.pone.0243900	http://dx.doi.org/10.1371/journal.pone.0243900			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315908	Green Published, gold			2022-12-27	WOS:000600186100029
J	Oruko, K; Maixenchs, M; Phillips-Howard, P; Ondire, M; Akelo, C; Sanz, A; Ordi, J; Menendez, C; Bassat, Q; Odhiambo, FO; Munguambe, K				Oruko, Kelvin; Maixenchs, Maria; Phillips-Howard, Penelope; Ondire, Maureen; Akelo, Clarah; Sanz, Ariadna; Ordi, Jaume; Menendez, Clara; Bassat, Quique; Odhiambo, Frank O.; Munguambe, Khatia			Conceptual frameworks for understanding the acceptability and feasibility of the minimally invasive autopsy to determine cause of death: Findings from the CADMIA Study in western Kenya	PLOS ONE			English	Article							POSTMORTEM EXAMINATION; CLINICAL-DIAGNOSIS; VERBAL AUTOPSY; DISCREPANCIES; RELATIVES; BIOPSIES	Establishing the cause of death (CoD) is critical to better understanding health and prioritizing health investments, however the use of full post-mortem examination is rare in most low and middle-income counties for multiple reasons. The use of minimally invasive autopsy (MIA) approaches, such as needle biopsies, presents an alternate means to assess CoD. In order to understand the feasibility and acceptability of MIA among communities in western Kenya, we conducted focus groups and in-depth interviews with next-of-kin of recently deceased persons, community leaders and health care workers in Siaya and Kisumu counties. Results suggest two conceptual framework can be drawn, one with facilitating factors for acceptance of MIA due to the ability to satisfy immediate needs related to interest in learning CoD or protecting social status and honoring the deceased), and one framework covering barriers to acceptance of MIA, for reasons relating to the failure to serve an existing need, and/or the exacerbation of an already difficult time.	[Oruko, Kelvin; Ondire, Maureen; Akelo, Clarah; Odhiambo, Frank O.] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya; [Oruko, Kelvin] Kenya Med Training Coll, Nairobi, Kenya; [Maixenchs, Maria; Sanz, Ariadna; Ordi, Jaume; Menendez, Clara; Bassat, Quique] Univ Barcelona, ISGlobal, Hosp Clin, Barcelona, Spain; [Maixenchs, Maria; Menendez, Clara; Bassat, Quique; Munguambe, Khatia] CISM, Maputo, Mozambique; [Phillips-Howard, Penelope] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England; [Ordi, Jaume] Hosp Clin Univ Barcelona, Dept Pathol, Barcelona, Spain; [Menendez, Clara] Consorcio Invest Biomed Red Epidemiol & Salud Pub, Madrid, Spain; [Bassat, Quique] Catalan Inst Res & Adv Studies ICREA, Barcelona, Spain; [Bassat, Quique] Univ Barcelona, Pediat Infect Dis Unit, Dept Pediat, Hosp St Joan, Barcelona, Spain; [Munguambe, Khatia] Univ Eduardo Mondlane UEM, Fac Med, Maputo, Mozambique	Kenya Medical Research Institute; ISGlobal; University of Barcelona; Hospital Clinic de Barcelona; Centro de Investigacao em Saude de Manhica; Liverpool School of Tropical Medicine; University of Barcelona; Hospital Clinic de Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; ICREA; University of Barcelona; Eduardo Mondlane University	Oruko, K (corresponding author), Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya.; Oruko, K (corresponding author), Kenya Med Training Coll, Nairobi, Kenya.	kelvinoov@gmail.com	Bassat, Quique/P-2341-2016	Bassat, Quique/0000-0003-0875-7596; Maixenchs, Maria/0000-0002-5782-8197; Phillips-Howard, Penelope A/0000-0003-1018-116X	Bill & Melinda Gates Foundation [OPP1067522, OPP1128001]; Spanish Instituto de Salud Carlos III (FIS) [PI12/00757]; Government of Mozambique; Spanish Agency for International Development (AECID); program Miguel Servet of the ISCIII (Plan Nacional de I+D+I 2008-2011) [CP11/00269]	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Spanish Instituto de Salud Carlos III (FIS); Government of Mozambique; Spanish Agency for International Development (AECID); program Miguel Servet of the ISCIII (Plan Nacional de I+D+I 2008-2011)	The CaDMIA research project (Validation of the minimally invasive autopsy tool for cause of death investigation in developing countries) is funded by the Bill & Melinda Gates Foundation (Global Health grant numbers OPP1067522 and OPP1128001) and by the Spanish Instituto de Salud Carlos III (FIS, PI12/00757; CM, Acciones CIBER). ISGlobal is included in the CERCA Programme/Generalitat de Catalunya CISM is supported by the Government of Mozambique and the Spanish Agency for International Development (AECID). QB has a fellowship from the program Miguel Servet of the ISCIII (Plan Nacional de I+D+I 2008-2011, grant number: CP11/00269). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amornkul PN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006470; Bassat Q, 2013, LANCET GLOB HEALTH, V1, pE125, DOI 10.1016/S2214-109X(13)70037-8; Breeze ACG, 2008, VIRCHOWS ARCH, V452, P201, DOI 10.1007/s00428-007-0548-7; Breeze ACG, 2011, ULTRASOUND OBST GYN, V37, P317, DOI 10.1002/uog.8844; Byass P, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.19281; Chintu C, 2002, LANCET, V360, P985, DOI 10.1016/S0140-6736(02)11082-8; Cohen D.W., 1989, SIAYA HISTORICAL ANT; Costache Mariana, 2014, Maedica (Bucur), V9, P261; Cox JA, 2011, TROP MED INT HEALTH, V16, P1015, DOI 10.1111/j.1365-3156.2011.02798.x; Desai M, 2014, PLOS ONE; Desai M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068733; El-Reshaid W, 2005, MED PRIN PRACT, V14, P173, DOI 10.1159/000084635; Fligner CL, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-25; Gargano JW, 2012, AIDS, V26, P1545, DOI 10.1097/QAD.0b013e328353b7b9; Geissler Wenzel., 2010, LAND IS DYING CONTIN; Gurley ES, 2011, BMC MED ETHICS, V12, DOI 10.1186/1472-6939-12-10; Hamel MJ, 2011, AM J TROP MED HYG, V85, P597, DOI 10.4269/ajtmh.2011.10-0678; Inai K, 2016, VIRCHOWS ARCH, V469, P101, DOI 10.1007/s00428-016-1937-6; Ioan B, 2012, ROM J LEG MED, V20, P307, DOI 10.4323/rjlm.2012.307; KAIS, 2013, KEN AIDS IND SURV 20; Maixenchs M, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002172; Murray CJL, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-18; Nyamthimba P, 2016, EXPERIENCES IMPLEMEN; Odhiambo FO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079840; Odhiambo FO, 2012, INT J EPIDEMIOL, V41, P977, DOI 10.1093/ije/dys108; Oluwasola OA, 2009, ARCH PATHOL LAB MED, V133, P78, DOI 10.1043/1543-2165-133.1.78; Ordi J, 2009, PLOS MED, V6, P174, DOI 10.1371/journal.pmed.1000036; Phillips-Howard PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114010; Phillips-Howard PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047017; Sebire NJ, 2012, J MATERN-FETAL NEO M, V25, P513, DOI 10.3109/14767058.2011.601368; SHINO W, 1997, DEATH RITUALS LUO S; Tavora F, 2008, AM J CLIN PATHOL, V129, P102, DOI 10.1309/9M7DFE62RTDKHH4D; Taylor TE, 2004, NAT MED, V10, P143, DOI 10.1038/nm986; Thayyil S, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-120; Tsitsikas DA, 2011, J CLIN PATHOL, V64, P412, DOI 10.1136/jcp.2010.086645; Ugiagbe EE, 2012, PEDIATR DEVEL PATHOL, V15, P1, DOI 10.2350/10-12-0952-OA.1; van Eijk AM, 2008, TROP MED INT HEALTH, V13, P1314, DOI 10.1111/j.1365-3156.2008.02136.x; WALDRON G, 1995, BRIT MED J, V310, P870, DOI 10.1136/bmj.310.6983.870	38	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0242574	10.1371/journal.pone.0242574	http://dx.doi.org/10.1371/journal.pone.0242574			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315918	Green Published, gold, Green Accepted			2022-12-27	WOS:000600186100007
J	Yen, FS; Lai, JN; Wei, JCC; Chiu, LT; Hwu, CM; Hou, MC; Hsu, CC				Yen, Fu-Shun; Lai, Jung-Nien; Wei, James Cheng-Chung; Chiu, Lu-Ting; Hwu, Chii-Min; Hou, Ming-Chih; Hsu, Chih-Cheng			Sulfonylureas may be useful for glycemic management in patients with diabetes and liver cirrhosis	PLOS ONE			English	Article							CARDIOVASCULAR EVENTS; CLAIMS DATA; MORTALITY; COMPLICATIONS; METAANALYSIS; RISK; ASSOCIATION; MELLITUS; THERAPY; DRUGS	This study aimed to investigate the long-term outcomes of sulfonylurea (SU) use in patients with T2DM and compensated liver cirrhosis. From January 1, 2000, to December 31, 2012, we selected the data of 3781 propensity-score-matched SU users and nonusers from Taiwan's National Health Insurance Research Database. The mean follow-up time for this study was 5.74 years. Cox proportional hazards models with robust sandwich standard error estimates were used to compare the risks of main outcomes between SU users and nonusers. The incidence of mortality during follow-up was 3.24 and 4.09 per 100 person-years for SU users and nonusers, respectively. The adjusted hazard ratios and 95% confidence intervals for all-cause mortality, major cardiovascular events, and decompensated cirrhosis in SU users relative to SU nonusers were 0.79 (0.71-0.88), 0.69 (0.61-0.80), and 0.82 (0.66-1.03), respectively. The SU-associated lower risks of death and cardiovascular events seemed to have a dose-response trend. This population-based cohort study demonstrated that SU use was associated with lower risks of death and major cardiovascular events compared with SU non-use in patients with T2DM and compensated liver cirrhosis. SUs may be useful for glycemic management for patients with liver cirrhosis.	[Yen, Fu-Shun] Dr Yens Clin, Taoyuan, Taiwan; [Lai, Jung-Nien] China Med Univ, Coll Chinese Med, Sch Chinese Med, Taichung, Taiwan; [Lai, Jung-Nien] China Med Univ Hosp, Dept Chinese Med, Taichung, Taiwan; [Wei, James Cheng-Chung] Chung Shan Med Univ Hosp, Dept Allergy Immunol & Rheumatol, Taichung, Taiwan; [Wei, James Cheng-Chung] Chung Shan Med Univ, Inst Med, Coll Med, Taichung, Taiwan; [Wei, James Cheng-Chung] China Med Univ, Grad Inst Integrated Med, Taichung, Taiwan; [Chiu, Lu-Ting] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Chiu, Lu-Ting] China Med Univ, Coll Med, Taichung, Taiwan; [Hwu, Chii-Min] Natl Yang Ming Univ, Fac Med, Sch Med, Taipei, Taiwan; [Hwu, Chii-Min] Taipei Vet Gen Hosp, Sect Endocrinol & Metab, Dept Med, Taipei, Taiwan; [Hou, Ming-Chih] Taipei Vet Gen Hosp, Div Gastroenterol & Hepatol, Dept Med, Taipei, Taiwan; [Hsu, Chih-Cheng] Natl Hlth Res Inst, Inst Populat Hlth Sci, Miaoli, Taiwan; [Hsu, Chih-Cheng] China Med Univ, Dept Hlth Serv Adm, Taichung, Taiwan; [Hsu, Chih-Cheng] Min Sheng Gen Hosp, Dept Family Med, Taoyuan, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Health Research Institutes - Taiwan; China Medical University Taiwan	Hou, MC (corresponding author), Taipei Vet Gen Hosp, Div Gastroenterol & Hepatol, Dept Med, Taipei, Taiwan.; Hsu, CC (corresponding author), Natl Hlth Res Inst, Inst Populat Hlth Sci, Miaoli, Taiwan.; Hsu, CC (corresponding author), China Med Univ, Dept Hlth Serv Adm, Taichung, Taiwan.; Hsu, CC (corresponding author), Min Sheng Gen Hosp, Dept Family Med, Taoyuan, Taiwan.	mchou@vghtpe.gov.tw; cch@nhri.edu.tw	Hwu, Chii-Min/AAZ-7384-2021	Hsu, Chih-Cheng/0000-0003-4563-4341	Taiwan's Ministry of Health and Welfare Clinical Trial Center [MOHW109-TDU-B-212-114004]; Ministry of Science and Technology Clinical Trial Consortium for Stroke [MOST 108-2321-B-039003]; Tseng-Lien Lin Foundation, Taichung, Taiwan	Taiwan's Ministry of Health and Welfare Clinical Trial Center; Ministry of Science and Technology Clinical Trial Consortium for Stroke; Tseng-Lien Lin Foundation, Taichung, Taiwan	This study is supported in part by Taiwan's Ministry of Health and Welfare Clinical Trial Center (MOHW109-TDU-B-212-114004), Ministry of Science and Technology Clinical Trial Consortium for Stroke (MOST 108-2321-B-039003), Tseng-Lien Lin Foundation, Taichung, Taiwan (URL of each funder website: https://www.taiwanclinicaltrials.tw/ctc; http://www.ltl-charity.org.tw/about.php?id=4).These funding agencies did not influence the study design, data collection and analysis, decision to publish, or manuscript preparation. The writing and preparation of this paper was not funded by any organization, and employees of funders or any author who received the funding did not undertake data analysis. The funders did not offer support for writing. The corresponding authors had complete access to all data in the study and final responsibility for the publication decision. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, PREV CHRONIC DIS, V13, pE40; [Anonymous], 2020, INT DIABETES FEDERAT; Bain S, 2017, DIABETES OBES METAB, V19, P329, DOI 10.1111/dom.12821; Cheng TM, 2003, HEALTH AFFAIR, V22, P61, DOI 10.1377/hlthaff.22.3.61; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; DeFronzo RA, 1999, ANN INTERN MED, V131, P281, DOI 10.7326/0003-4819-131-4-199908170-00008; Elkrief L, 2016, LIVER INT, V36, P936, DOI 10.1111/liv.13115; Gundling F, 2013, DIGESTION, V87, P75, DOI 10.1159/000343458; Inzucchi SE, 2002, JAMA-J AM MED ASSOC, V287, P360, DOI 10.1001/jama.287.3.360; Johnson PJ, 2015, J CLIN ONCOL, V33, P550, DOI 10.1200/JCO.2014.57.9151; Kawaguchi T, 2010, LIVER INT, V30, P479, DOI 10.1111/j.1478-3231.2009.02191.x; Khunti K, 2018, LANCET DIABETES ENDO, V6, P821, DOI 10.1016/S2213-8587(18)30025-1; Klepzig H, 1999, EUR HEART J, V20, P439, DOI 10.1053/euhj.1998.1242; Koshiba K, 2006, J MED INVESTIG, V53, P87, DOI 10.2152/jmi.53.87; Lin CC, 2005, J FORMOS MED ASSOC, V104, P157; Meduru P, 2007, J GEN INTERN MED, V22, P408, DOI 10.1007/s11606-007-0310-5; MEINERT CL, 1970, DIABETES, V19, P789; Monami M, 2013, DIABETES OBES METAB, V15, P938, DOI 10.1111/dom.12116; MOREAU R, 1994, GASTROENTEROLOGY, V106, P1016, DOI 10.1016/0016-5085(94)90762-5; Mukerji AN, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/318627; Nehra MS, 2013, J CLIN GASTROENTEROL, V47, pE50, DOI 10.1097/MCG.0b013e3182688d2f; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; PETRIDES AS, 1994, HEPATOLOGY, V19, P616, DOI 10.1002/hep.1840190312; Rendell M, 2004, DRUGS, V64, P1339, DOI 10.2165/00003495-200464120-00006; Rosenstock J, 2019, JAMA-J AM MED ASSOC, V322, P1155, DOI 10.1001/jama.2019.13772; Scheen AJ, 2014, EXPERT OPIN DRUG MET, V10, P839, DOI 10.1517/17425255.2014.902444; Simpson SH, 2015, LANCET DIABETES ENDO, V3, P43, DOI 10.1016/S2213-8587(14)70213-X; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Tolman KG, 2007, DIABETES CARE, V30, P734, DOI 10.2337/dc06-1539; Udell JA, 2015, LANCET DIABETES ENDO, V3, P356, DOI 10.1016/S2213-8587(15)00044-3; Vaccaro O, 2017, LANCET DIABETES ENDO, V5, P887, DOI 10.1016/S2213-8587(17)30317-0; Young BA, 2008, AM J MANAG CARE, V14, P15	32	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243783	10.1371/journal.pone.0243783	http://dx.doi.org/10.1371/journal.pone.0243783			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315940	gold, Green Published			2022-12-27	WOS:000600186100008
J	Galiero, R; Pafundi, PC; Simeon, V; Rinaldi, L; Perrella, A; Vetrano, E; Caturano, A; Alfano, M; Beccia, D; Nevola, R; Marfella, R; Sardu, C; Coppola, C; Scarano, F; Maggi, P; Sposito, PD; Vocciante, L; Rescigno, C; Sbreglia, C; Fraganza, F; Parrella, R; Romano, A; Calabria, G; Polverino, B; Pagano, A; Bologna, C; Amitrano, M; Esposito, V; Coppola, N; Maturo, N; Adinolfi, LE; Chiodini, P; Sasso, FC				Galiero, Raffaele; Pafundi, Pia Clara; Simeon, Vittorio; Rinaldi, Luca; Perrella, Alessandro; Vetrano, Erica; Caturano, Alfredo; Alfano, Maria; Beccia, Domenico; Nevola, Riccardo; Marfella, Raffaele; Sardu, Celestino; Coppola, Carmine; Scarano, Ferdinando; Maggi, Paolo; Sposito, Pellegrino De Lucia; Vocciante, Laura; Rescigno, Carolina; Sbreglia, Costanza; Fraganza, Fiorentino; Parrella, Roberto; Romano, Annamaria; Calabria, Giosuele; Polverino, Benedetto; Pagano, Antonio; Bologna, Carolina; Amitrano, Maria; Esposito, Vincenzo; Coppola, Nicola; Maturo, Nicola; Adinolfi, Luigi Elio; Chiodini, Paolo; Sasso, Ferdinando Carlo		COVOCA Study Grp	Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study	PLOS ONE			English	Article								Background Italy has been the first Western country to be heavily affected by the spread of SARS-COV-2 infection and among the pioneers of the clinical management of pandemic. To improve the outcome, identification of patients at the highest risk seems mandatory. Objectives Aim of this study is to identify comorbidities and clinical conditions upon admission associated with in-hospital mortality in several COVID Centers in Campania Region (Italy). Methods COVOCA is a multicentre retrospective observational cohort study, which involved 18 COVID Centers throughout Campania Region, Italy. Data were collected from patients who completed their hospitalization between March-June 2020. The endpoint was in-hospital mortality, assessed either from data at discharge or death certificate, whilst all exposure variables were collected at hospital admission. Results Among 618 COVID-19 hospitalized patients included in the study, 143 in-hospital mortality events were recorded, with a cumulative incidence of about 23%. At multivariable logistic analysis, male sex (OR 2.63, 95%CI 1.42-4.90; p = 0.001), Chronic Liver Disease (OR 5.88, 95%CI 2.39-14.46; p<0.001) and malignancies (OR 2.62, 95%CI 1.21-5.68; p = 0.015) disclosed an independent association with a poor prognosis, Glasgow Coma Scale (GCS) and Respiratory Severity Scale allowed to identify at higher mortality risk. Sensitivity analysis further enhanced these findings. Conclusion Mortality of patients hospitalized for COVID-19 appears strongly affected by both clinical conditions on admission and comorbidities. Originally, we observed a very poor outcome in subjects with a chronic liver disease, alongside with an increase of hepatic damage.	[Galiero, Raffaele; Pafundi, Pia Clara; Rinaldi, Luca; Vetrano, Erica; Caturano, Alfredo; Alfano, Maria; Beccia, Domenico; Nevola, Riccardo; Marfella, Raffaele; Sardu, Celestino; Adinolfi, Luigi Elio; Sasso, Ferdinando Carlo] Univ Campania Luigi Vanvitelli, Dept Adv Med & Surg Sci, Naples, Italy; [Simeon, Vittorio; Chiodini, Paolo] Univ Campania Luigi Vanvitelli, Dept Phys & Mental Hlth & Prevent Med, Med Stat Unit, Naples, Italy; [Perrella, Alessandro] Task Force Covid 19 Regione Campania, Naples, Italy; [Nevola, Riccardo] St Ottone Frangipane Hosp, Internal Med, Ariano Irpino, Italy; [Coppola, Carmine; Scarano, Ferdinando] COVID Ctr S Anna & SS Madonna Neve Hosp, Boscotrecase, Italy; [Maggi, Paolo] S Anna & S Sebastiano Hosp, UOC Infect & Trop Dis, Caserta, Italy; [Sposito, Pellegrino De Lucia] Maddaloni Hosp, Covid Ctr, Maddaloni, Italy; [Vocciante, Laura] Loreto Mare Hosp, Gen Med Unit, Naples, Italy; [Rescigno, Carolina] Cotugno Hosp, UOC Infect Dis & Neurol, Naples, Italy; [Sbreglia, Costanza] Cotugno Hosp, UOC Infect Dis Elderly, Naples, Italy; [Fraganza, Fiorentino] Cotugno Hosp, UOC Anestesia & Intens Care Unit, Naples, Italy; [Parrella, Roberto] Cotugno Hosp, UOC Resp Infect Dis, Naples, Italy; [Romano, Annamaria] Moscati Hosp, UOC Pneumol, Avellino, Italy; [Calabria, Giosuele] Cotugno Hosp, Div Infect Dis & Intervent Ultrasound 9, Naples, Italy; [Polverino, Benedetto] Giovanni Procida Hosp, Salerno, Italy; [Pagano, Antonio] Santa Maria Grazie Hosp, Emergency & Acceptance Unit, Pozzuoli, Italy; [Bologna, Carolina] Osped Mare, Internal Med Unit, Naples, Italy; [Amitrano, Maria] Moscati Hosp, UOC Internal Med, Avellino, Italy; [Esposito, Vincenzo] Cotugno Hosp, Div Immunodeficiency & Gender Infect Dis 4, Naples, Italy; [Coppola, Nicola] Ctr COVID AOU Vanvitelli, Dept Mental Hlth & Publ Med, Naples, Italy; [Maturo, Nicola] Cotugno Hosp, UOSD Infect Dis Emergency & Acceptance, Naples, Italy	Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; San Giuseppe Moscati Hospital; San Giuseppe Moscati Hospital	Sasso, FC (corresponding author), Univ Campania Luigi Vanvitelli, Dept Adv Med & Surg Sci, Naples, Italy.; Chiodini, P (corresponding author), Univ Campania Luigi Vanvitelli, Dept Phys & Mental Hlth & Prevent Med, Med Stat Unit, Naples, Italy.	paolo.chiodini@unicampania.it; ferdinandocarlo.sasso@unicampania.it	Simeon, Vittorio/K-6373-2016; Sasso, Ferdinando Carlo/AAE-5665-2019; Caturano, Alfredo/ACM-4169-2022; Caturano, Alfredo/AAA-4014-2022; Pafundi, Pia Clara/AAC-3991-2021	Simeon, Vittorio/0000-0003-2387-4125; Sasso, Ferdinando Carlo/0000-0002-9142-7848; Caturano, Alfredo/0000-0001-7761-7533; Caturano, Alfredo/0000-0001-7761-7533; Pafundi, Pia Clara/0000-0002-0310-3529; Codella, Alessio Vinicio/0000-0003-1657-6613; marfella, raffaele/0000-0003-3960-9270; Esposito, Vincenzo/0000-0003-4696-2363				Adams DH, 2006, AM J PATHOL, V168, P1057, DOI 10.2353/ajpath.2006.051296; Ali N, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00458; American Diabetes Association, 2020, Diabetes Care, V43, pS14, DOI 10.2337/dc20-S002; [Anonymous], 1992, GRIFFITH LAW REV, V1, pviii; Boettler T, 2020, JHEP REP, V2, DOI 10.1016/j.jhepr.2020.100169; Ciccone G, 2020, EPIDEMIOL PREV S2, V44; Du RH, 2020, EUR RESPIR J, V56; Du RH, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00524-2020; Espinosa OA, 2020, REV INST MED TROP SP, V62, DOI [10.1590/S1678-9946202062043, 10.1590/s1678-9946202062043]; Fang HL, 2021, J INVEST MED, V69, P75, DOI 10.1136/jim-2020-001555; Fraternale A, 2009, MOL ASPECTS MED, V30, P99, DOI 10.1016/j.mam.2008.09.001; Guan WJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00597-2020; Guo T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122124; Harrell FE, 2015, SPRINGER SER STAT, DOI 10.1007/978-3-319-19425-7; Huang R, 2020, HEPATOL COMMUN, V4, P1758, DOI 10.1002/hep4.1592; Iaccarino G, 2020, HYPERTENSION, V76, P366, DOI 10.1161/HYPERTENSIONAHA.120.15324; Iavarone M, 2020, J HEPATOL, V73, P1063, DOI 10.1016/j.jhep.2020.06.001; Ji D, 2020, HEPATOL INT, V14, P701, DOI 10.1007/s12072-020-10058-6; Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group, 2013, KIDNEY INT S, V3, P1, DOI [DOI 10.1038/KISUP.2012.73, 10.1038/kisup.2012.48]; Kuswardhani RAT, 2020, DIABETES METAB SYND, V14, P2103, DOI 10.1016/j.dsx.2020.10.022; Labenz C, 2021, EUR J GASTROEN HEPAT, V33, P1194, DOI 10.1097/MEG.0000000000001827; Lei F, 2020, HEPATOLOGY, V72, P389, DOI 10.1002/hep.31301; Luo LM, 2020, CLIN CARDIOL, V43, P1478, DOI 10.1002/clc.23465; Medetalibeyoglu A, 2020, ANN HEPATOL, V19, P614, DOI 10.1016/j.aohep.2020.08.068; Mi J, 2020, AM J TRANSL RES, V12, P6537; Palmieri L, 2020, J GERONTOL A-BIOL, V75, P1796, DOI 10.1093/gerona/glaa146; Polverino F, 2020, FRONT CARDIOVASC MED, V7, DOI 10.3389/fcvm.2020.585866; Portincasa P, 2020, EUR J CLIN INVEST, V50, DOI 10.1111/eci.13338; Pranata R, 2020, J STROKE CEREBROVASC, V29, DOI 10.1016/j.jstrokecerebrovasdis.2020.104949; Raoof S, 2020, CHEST, V158, P1992, DOI 10.1016/j.chest.2020.07.013; Ribeiro RT, 2013, IEEE T BIO-MED ENG, V60, P1336, DOI 10.1109/TBME.2012.2235438; RODRIGUEZMOLINERO, 2020, PLOS ONE, V15, DOI DOI 10.1371/JOURNAL.PONE.0239571; Schulkin J, 2004, ALLOSTASIS HOMEOSTAS, DOI [10.1017/CBO9781316257081, DOI 10.1017/CBO9781316257081]; Schunemann HJ, 2020, ANN INTERN MED, V173, P204, DOI 10.7326/M20-2306; Shalimar, 2020, INDIAN J GASTROENTER, V39, P285, DOI 10.1007/s12664-020-01074-3; Silvagno F, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9070624; Singh S, 2020, GASTROENTEROLOGY, V159, P768, DOI 10.1053/j.gastro.2020.04.064; Ssentongo P, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238215; Suleyman G, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.12270; Sun J, 2020, LIVER INT, V40, P1278, DOI 10.1111/liv.14470; Targher G, 2020, GUT, V69, P1545, DOI 10.1136/gutjnl-2020-321611; The WHO Alliance for Maternal and Newborn Health Improvement late pregnancy dating study group, 2020, LANCET GLOB HEALTH, V8, pe545; van Smeden M, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0267-3; Williams B, 2018, EUR HEART J, V39, P3021, DOI 10.1093/eurheartj/ehy339; World Health Organization (WHO), WHO2019NCOVCLINICAL2; Yang RX, 2020, WORLD J GASTROENTERO, V26, P4753, DOI 10.3748/wjg.v26.i32.4753; Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5; Zhang C, 2020, LANCET GASTROENTEROL, V5, P428, DOI 10.1016/S2468-1253(20)30057-1; Zhang LJ, 2020, STROKE, V51, P2674, DOI 10.1161/STROKEAHA.120.030642	50	31	31	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243700	10.1371/journal.pone.0243700	http://dx.doi.org/10.1371/journal.pone.0243700			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301529	gold, Green Published			2022-12-27	WOS:000600143100005
J	Hyde, MK; Masser, BM				Hyde, Melissa K.; Masser, Barbara M.			Determinants of community members' willingness to donate stool for faecal microbiota transplantation	PLOS ONE			English	Article							PATTERNS; SCALE	Universal stool banks rely on, but face difficulties recruiting, community volunteers to donate stool for faecal microbiota transplantation (FMT) to effectively treat recurrent Clostridioides difficile. This study sought to identify determinants of community members' willingness to donate stool to guide donor recruitment. 397 Australian residents (52% male, 47% 21-30 years, 63% university educated) completed a survey to gauge willingness to donate stool, bowel habits, information needs, attitudes, barriers, and motives for donation. Most reported regular bowel movements (BMs; 90%), morning BMs (63%), BMs <= 5 minutes duration (67%), and some discomfort doing BMs in public restrooms (69%). Less than half were willing to donate stool in-centre (45% willing) or at home (48%). Important information needs identified by >80% were convenience and travel requirements associated with donation. Main barriers were logistics, capabilities to donate, disgust (e.g., donation process), and discomfort (e.g., privacy). The main motivator was altruism, with compensation secondary. Linear regression models identified less discomfort doing BMs in public restrooms (beta = -0.15), understanding benefits to patients (beta = 0.15), placing less importance on understanding the donation process (beta = -0.13), and positive attitudes (beta = 0.56) as determinants of willingness to donate in-centre. Understanding benefits to self (beta = 0.11) and patients (beta = 0.24), placing less importance on understanding the donation purpose (beta = -0.19), and positive attitudes (beta = 0.50) determined willingness to donate at home. Stool banks should consider donor's bowel habits, comfort donating in-centre, and information needs early in recruitment; and implement flexible logistics for potential donors who face time constraints and limited access to stool banks.	[Hyde, Melissa K.; Masser, Barbara M.] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia; [Masser, Barbara M.] Australian Red Cross Lifeblood, Clin Serv & Res, Sydney, NSW, Australia	University of Queensland	Hyde, MK (corresponding author), Univ Queensland, Sch Psychol, Brisbane, Qld, Australia.	m.hyde@uq.edu.au	Hyde, Melissa/H-6785-2012	Hyde, Melissa/0000-0001-9616-2028	University of Queensland Vice-Chancellor's Strategic Funds; University of Queensland School of Psychology	University of Queensland Vice-Chancellor's Strategic Funds; University of Queensland School of Psychology	The authors received funding from The University of Queensland Vice-Chancellor's Strategic Funds (BM) and internal funds granted by The University of Queensland School of Psychology (MH) to collect data using a paid participant panel and to employ a research assistant to assist with data collection and coding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional internal or external funding received for this study.	Allegretti JR, 2019, LANCET, V394, P420, DOI 10.1016/S0140-6736(19)31266-8; American College of Physicians, 2019, CLOSTR DIFF INF; American Gut Health Check Survey, 2018, AM GUT HLTH CHECK SU; [Anonymous], 2019, BRAIN STIMUL MAR; Arnetz J, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4724-z; Australian Government Department of Health. Therapeutic Goods Administration, 2019, DRAFT STAND FAEC MIC; Australian Government Department of Health. Therapeutic Goods Administration, 2020, THER GOODS STAND FAE; Australian Red Cross Lifeblood, 2019, WA HOST LIF CHANG CL; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, https://doi.org/10.1191/1478088706qp063oa, 10.1191/1478088706qp063oa]; Burns LJ, 2015, GASTROENTEROLOGY, V148, pS96, DOI 10.1016/S0016-5085(15)30331-0; Cammarota G, 2019, GUT, V68, P2111, DOI 10.1136/gutjnl-2019-319548; Centre for Digestive Diseases, 2016, FAEC MICR TRANSPL; Costello SP, 2017, ALIMENT PHARM THER, V46, P213, DOI 10.1111/apt.14173; Costello SP, 2019, INTERN MED J, V49, P148, DOI 10.1111/imj.14212; Edelstein C, 2016, CAN MED ASSOC J, V188, pE431, DOI 10.1503/cmaj.150672; EVERHART JE, 1989, DIGEST DIS SCI, V34, P1153, DOI 10.1007/BF01537261; Harari D, 1996, ARCH INTERN MED, V156, P315, DOI 10.1001/archinte.156.3.315; Hota Susy S, 2019, J Assoc Med Microbiol Infect Dis Can, V4, P218, DOI 10.3138/jammi.2019-0003; HYDE MK, 2020, TRANSFUSION 1001, DOI DOI 10.1111/TRF.16109; Jones CW, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-013649; Jorgensen SMD, 2018, GUT MICROBES, V9, P540, DOI 10.1080/19490976.2018.1458179; Kassam Z, 2019, GASTROENTEROLOGY, V156, pS100; Knowles SR, 2016, COGN BEHAV THERAPY, V45, P324, DOI 10.1080/16506073.2016.1178800; Konig J, 2017, ALIMENT PHARM THER, V45, P222, DOI 10.1111/apt.13868; Krishnan S, 2020, ABC NEWS; Lewis SJ, 1997, SCAND J GASTROENTERO, V32, P920, DOI 10.3109/00365529709011203; Ling K, 2018, AM J GASTROENTEROL, V113, pS1590; McSweeney B, 2020, GUT MICROBES, V11, P51, DOI 10.1080/19490976.2019.1611153; Merlo G, 2016, J GASTROEN HEPATOL, V31, P1927, DOI 10.1111/jgh.13402; NHS University of Southampton, 2017, PAT INF FACTSH CLOST; Open Biome, 2019, FMT; Paramsothy S, 2015, INFLAMM BOWEL DIS, V21, P1600, DOI 10.1097/MIB.0000000000000405; RAYBARDHAN S, 2017, JAMMI OFFICIAL J ASS, V2, P9, DOI DOI 10.3138/JAMMI.2.1.002; RENDTORFF RC, 1967, DIS COLON RECTUM, V10, P222, DOI 10.1007/BF02617184; Rode AA, 2019, EUR J CLIN MICROBIOL, V38, P1837, DOI 10.1007/s10096-019-03615-x; Sanjoaquin MA, 2004, PUBLIC HEALTH NUTR, V7, P77, DOI 10.1079/PHN2003522; Shi Q, 2020, CHINESE MED J-PEKING, V133, P2330, DOI 10.1097/CM9.0000000000000954; Tariq R, 2018, J CLIN GASTROENTEROL, V52, P146, DOI 10.1097/MCG.0000000000000768; Terveer EM, 2020, UNITED EUR GASTROENT, V8, P1236, DOI 10.1177/2050640620957765; The Lancet HIV, 2015, LANCET HIV, V2, pe115; Turse EP, 2019, CURR OPIN PHARMACOL, V49, P24, DOI 10.1016/j.coph.2019.04.009; US Department of Health and Human Services Centers for Disease Control and Prevention, 2019, CLOSTR DIFF C DIFF; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Wu X, 2019, THER ADV GASTROENTER, V12, DOI 10.1177/1756284819869144; ZUCKERMAN MJ, 1995, DIGEST DIS SCI, V40, P1763, DOI 10.1007/BF02212699	45	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243751	10.1371/journal.pone.0243751	http://dx.doi.org/10.1371/journal.pone.0243751			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301497	gold, Green Published			2022-12-27	WOS:000600143100020
J	Bermudez-Guzman, L; Jimenez-Huezo, G; Arguedas, A; Leal, A				Bermudez-Guzman, Luis; Jimenez-Huezo, Gabriel; Arguedas, Andres; Leal, Alejandro			Mutational survivorship bias: The case of PNKP	PLOS ONE			English	Article							POLYNUCLEOTIDE KINASE-PHOSPHATASE; PROTEIN-STRUCTURE; SINGLE-STRAND; DEVELOPMENTAL DELAY; REPAIR; SEQUENCE; DISEASE; PREDICTION; SEIZURES; GENE	The molecular function of a protein relies on its structure. Understanding how variants alter structure and function in multidomain proteins is key to elucidate the generation of a pathological phenotype. However, one may fall into the logical bias of assessing protein damage only based on the variants that are visible (survivorship bias), which can lead to partial conclusions. This is the case of PNKP, an important nuclear and mitochondrial DNA repair enzyme with both kinase and phosphatase function. Most variants in PNKP are confined to the kinase domain, leading to a pathological spectrum of three apparently distinct clinical entities. Since proteins and domains may have a different tolerability to variation, we evaluated whether variants in PNKP are under survivorship bias. Here, we provide the evidence that supports a higher tolerance in the kinase domain even when all variants reported are deleterious. Instead, the phosphatase domain is less tolerant due to its lower variant rates, a higher degree of sequence conservation, lower dN/dS ratios, and the presence of more disease-propensity hotspots. Together, our results support previous experimental evidence that demonstrated that the phosphatase domain is functionally more necessary and relevant for DNA repair, especially in the context of the development of the central nervous system. Finally, we propose the term "Wald's domain" for future studies analyzing the possible survivorship bias in multidomain proteins.	[Bermudez-Guzman, Luis; Jimenez-Huezo, Gabriel; Leal, Alejandro] Univ Costa Rica, Sch Biol, Sect Genet & Biotechnol, San Jose, Costa Rica; [Arguedas, Andres] Univ Costa Rica, Sch Stat, San Jose, Costa Rica	Universidad Costa Rica; Universidad Costa Rica	Leal, A (corresponding author), Univ Costa Rica, Sch Biol, Sect Genet & Biotechnol, San Jose, Costa Rica.	alejandro.leal@ucr.ac.cr		Leal, Alejandro/0000-0002-5384-8166; Bermudez-Guzman, Luis/0000-0002-0749-4010	University of Costa Rica [111-B8-372]	University of Costa Rica	Our project was founded by the University of Costa Rica, Vice-rectory of Research (Project 111-B8-372). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Alejandro Leal and Andres Arguedas received a salary from University of Costa Rica.	Aceytuno RD, 2017, NUCLEIC ACIDS RES, V45, P6238, DOI 10.1093/nar/gkx275; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Andressoo JO, 2006, PLOS BIOL, V4, P1821, DOI 10.1371/journal.pbio.0040322; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Bermudez-Guzman L, 2019, TRANSL NEURODEGENER, V8, DOI 10.1186/s40035-019-0156-x; Bernstein NK, 2005, MOL CELL, V17, P657, DOI 10.1016/j.molcel.2005.02.012; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bornberg-Bauer E, 2005, CELL MOL LIFE SCI, V62, P435, DOI 10.1007/s00018-004-4416-1; Bras J, 2015, AM J HUM GENET, V96, P474, DOI 10.1016/j.ajhg.2015.01.005; Breslin C, 2009, MOL CELL BIOL, V29, P4653, DOI 10.1128/MCB.00677-09; Campopiano R, 2020, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01331; Chalasani SL, 2018, DNA REPAIR, V68, P12, DOI 10.1016/j.dnarep.2018.05.002; Chen MJ, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aag1796; David A, 2015, J MOL BIOL, V427, P2886, DOI 10.1016/j.jmb.2015.07.004; David A, 2012, HUM MUTAT, V33, P359, DOI 10.1002/humu.21656; Della-Maria J, 2012, J BIOL CHEM, V287, P39233, DOI 10.1074/jbc.M112.369975; Dinkel H, 2011, NUCLEIC ACIDS RES, V39, pD261, DOI 10.1093/nar/gkq1104; Dobson CJ, 2006, NUCLEIC ACIDS RES, V34, P2230, DOI 10.1093/nar/gkl275; Gao M, 2015, STRUCTURE, V23, P1362, DOI 10.1016/j.str.2015.03.028; Garces F, 2011, MOL CELL, V44, P385, DOI 10.1016/j.molcel.2011.08.036; Gatti M, 2019, AM J MED GENET A, V179, P2277, DOI 10.1002/ajmg.a.61339; Gussow AB, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0869-4; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Huber CD, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05281-7; Ittisoponpisan S, 2019, J MOL BIOL, V431, P2197, DOI 10.1016/j.jmb.2019.04.009; Jilani A, 1999, J BIOL CHEM, V274, P24176, DOI 10.1074/jbc.274.34.24176; Kalasova I, 2020, NUCLEIC ACIDS RES, V48, P6672, DOI 10.1093/nar/gkaa489; Kalasova I, 2019, NEUROL-GENET, V5, DOI 10.1212/NXG.0000000000000320; Karczewski K.J., 2019, GENOMICS, DOI [10.1101/531210, DOI 10.1101/531210]; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kucukkal TG, 2015, CURR OPIN STRUC BIOL, V32, P18, DOI 10.1016/j.sbi.2015.01.003; Leal A, 2018, NEUROGENETICS, V19, P215, DOI 10.1007/s10048-018-0555-7; Letunic I, 2019, NUCLEIC ACIDS RES, V47, pW256, DOI 10.1093/nar/gkz239; Liu JF, 2004, PROTEINS, V55, P678, DOI 10.1002/prot.20095; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; MANGEL M, 1984, J AM STAT ASSOC, V79, P259, DOI 10.2307/2288257; Nakashima M, 2014, J HUM GENET, V59, P471, DOI 10.1038/jhg.2014.51; Op 't Eyndee J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228802; Pais FSM, 2014, ALGORITHM MOL BIOL, V9, DOI 10.1186/1748-7188-9-4; Pedroso JL, 2015, NEUROL-GENET, V1, DOI 10.1212/NXG.0000000000000030; Petukh M, 2015, HUM MUTAT, V36, P524, DOI 10.1002/humu.22770; Reynolds JJ, 2013, BRAIN, V136, P14, DOI 10.1093/brain/aws310; Reynolds JJ, 2012, NUCLEIC ACIDS RES, V40, P6608, DOI 10.1093/nar/gks318; Rodrigues CHM, 2018, NUCLEIC ACIDS RES, V46, pW350, DOI 10.1093/nar/gky300; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Shen J, 2010, NAT GENET, V42, P245, DOI 10.1038/ng.526; Shimada M, 2019, J RADIAT RES, V60, P719, DOI 10.1093/jrr/rrz057; Shimada M, 2015, EMBO J, V34, P2465, DOI 10.15252/embj.201591363; Stoltzfus A, 2016, MOL BIOL EVOL, V33, P595, DOI 10.1093/molbev/msv274; Tebbs RS, 1999, DEV BIOL, V208, P513, DOI 10.1006/dbio.1999.9232; Veitia RA, 2018, CLIN GENET, V93, P419, DOI 10.1111/cge.13107; Veitia RA, 2010, J PATHOL, V220, P174, DOI 10.1002/path.2623; Ward JF, 1998, CONT CANC RES, P65; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Weinfeld M, 2011, TRENDS BIOCHEM SCI, V36, P262, DOI 10.1016/j.tibs.2011.01.006; Wiel L, 2019, HUM MUTAT, V40, P1030, DOI 10.1002/humu.23798; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Yang JY, 2013, BIOINFORMATICS, V29, P2588, DOI 10.1093/bioinformatics/btt447; Yates CM, 2014, J MOL BIOL, V426, P2692, DOI 10.1016/j.jmb.2014.04.026; Yates CM, 2013, J MOL BIOL, V425, P1274, DOI 10.1016/j.jmb.2013.01.026; Zhang CX, 2017, NUCLEIC ACIDS RES, V45, pW291, DOI 10.1093/nar/gkx366	64	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0237682	10.1371/journal.pone.0237682	http://dx.doi.org/10.1371/journal.pone.0237682			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332469	Green Published, Green Submitted, gold			2022-12-27	WOS:000601310900102
J	Fan, XM; Gao, YY; Zhang, XL; Lughmani, HY; Kennedy, DJ; Haller, ST; Pierre, SV; Shapiro, JI; Tian, J				Fan, Xiaoming; Gao, Yingnyu; Zhang, Xiaolu; Lughmani, Haroon Y.; Kennedy, David J.; Haller, Steven T.; Pierre, Sandrine V.; Shapiro, Joseph I.; Tian, Jiang			A strategic expression method of miR-29b and its anti-fibrotic effect based on RNA-sequencing analysis	PLOS ONE			English	Article							SUDDEN CARDIAC DEATH; GENE-THERAPY; MYOCARDIAL FIBROSIS; TGF-BETA; COLLAGEN; MYOFIBROBLASTS; FIBROBLASTS	Tissue fibrosis is a significant health issue associated with organ dysfunction and failure. Increased deposition of collagen and other extracellular matrix (ECM) proteins in the interstitial area is a major process in tissue fibrosis. The microRNA-29 (miR-29) family has been demonstrated as anti-fibrotic microRNAs. Our recent work showed that dysregulation of miR-29 contributes to the formation of cardiac fibrosis in animal models of uremic cardiomyopathy, whereas replenishing miR-29 attenuated cardiac fibrosis in these animals. However, excessive overexpression of miR-29 is a concern because microRNAs usually have multiple targets, which could result in unknown and unexpected side effect. In the current study, we constructed a novel Col1a1-miR-29b vector using collagen 1a1 (Col1a1) promoter, which can strategically express miR-29b-3p (miR-29b) in response to increased collagen synthesis and reach a dynamic balance between collagen and miR-29b. Our experimental results showed that in mouse embryonic fibroblasts (MEF cells) transfected with Col1a1-miR-29b vector, the miR-29b expression is about 1000 times less than that in cells transfected with CMV-miR-29b vector, which uses cytomegalovirus (CMV) as a promoter for miR-29b expression. Moreover, TGF-beta treatment increased the miR-29b expression by about 20 times in cells transfected with Col1a1-miR-29b, suggesting a dynamic response to fibrotic stimulation. Western blot using cell lysates and culture media demonstrated that transfection of Col1a1-miR-29b vector significantly reduced TGF-beta induced collagen synthesis and secretion, and the effect was as effective as the CMV-miR-29b vector. Using RNA-sequencing analysis, we found that 249 genes were significantly altered (180 upregulated and 69 downregulated, at least 2-fold change and adjusted p-value <0.05) after TGF-beta treatment in MEF cells transfected with empty vector. The Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis using GAGE R-package showed that the top 5 upregulated pathways after TGF-beta treatment were mostly fibrosis-related, including focal adhesion, ECM reaction, and TGF-beta signaling pathways. As expected, transfection of Col1a1-miR-29b or CMV-miR-29b vector partially reversed the activation of these pathways. We also analyzed the expression pattern of the top 100 miR-29b targeting genes in these cells using the RNA-sequencing data. We identified that miR-29b targeted a broad spectrum of ECM genes, but the inhibition effect is mostly moderate. In summary, our work demonstrated that the Col1a1-miR-29b vector can be used as a dynamic regulator of collagen and other ECM protein expression in response to fibrotic stimulation, which could potentially reduce unnecessary side effect due to excessive miR-29b levels while remaining an effective potential therapeutic approach for fibrosis.	[Fan, Xiaoming; Zhang, Xiaolu; Lughmani, Haroon Y.; Kennedy, David J.; Haller, Steven T.] Univ Toledo, Dept Med, 2801 W Bancroft St, Toledo, OH 43606 USA; [Gao, Yingnyu; Pierre, Sandrine V.] Marshall Univ, Marshall Inst Interdisciplinary Res, Huntington, WV USA; [Shapiro, Joseph I.; Tian, Jiang] Marshall Univ, Dept Biomed Sci, Joan C Edwards Sch Med, Huntington, WV 25755 USA	University System of Ohio; University of Toledo; Marshall University; Marshall University	Tian, J (corresponding author), Marshall Univ, Dept Biomed Sci, Joan C Edwards Sch Med, Huntington, WV 25755 USA.	tianj@marshall.edu	Gao, Yingnyu/W-4311-2019; Fan, Xiaoming/AAU-7713-2021	Lughmani, Haroon/0000-0001-6483-0247; Tian, Jiang/0000-0002-0812-8135	National Institutes of Health [HL-105649, HL-137004, HL145666]; Marshall University; University of Toledo Biomedical Research Innovation Program; National Affiliate of the American Heart Association [12SDG12050473]; David and Helen Boone Foundation Research Fund; Central Society for Clinical and Translational Research; WV-INBRE grant from NIH [P20GM103434]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marshall University; University of Toledo Biomedical Research Innovation Program; National Affiliate of the American Heart Association; David and Helen Boone Foundation Research Fund; Central Society for Clinical and Translational Research; WV-INBRE grant from NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health (HL-105649 to JT and JIS, HL-137004 to DJK, and HL145666 to SP). Additional support was from the Marshall University Startup Funding to JT, University of Toledo Biomedical Research Innovation Program to JT, the National Affiliate of the American Heart Association (12SDG12050473 to DJK), the David and Helen Boone Foundation Research Fund (DJK), an Early Career Development Award from the Central Society for Clinical and Translational Research (DJK). This work was also supported by the WV-INBRE grant from NIH (P20GM103434). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghajanian H, 2019, NATURE, V573, P430, DOI 10.1038/s41586-019-1546-z; Anderton MJ, 2011, TOXICOL PATHOL, V39, P916, DOI 10.1177/0192623311416259; [Anonymous], 2000, DATABASE MED PLANT U, V2, P112; [Anonymous], 2017, ONCOGENESIS, V6, pe345; Athanasopoulos T, 2017, HEMATOL ONCOL CLIN N, V31, P753, DOI 10.1016/j.hoc.2017.06.007; Baudino TA, 2006, AM J PHYSIOL-HEART C, V291, pH1015, DOI 10.1152/ajpheart.00023.2006; Boon RA, 2011, CIRC RES, V109, P1115, DOI 10.1161/CIRCRESAHA.111.255737; Brilla CG, 2000, CIRCULATION, V102, P1388, DOI 10.1161/01.CIR.102.12.1388; Calderone A, 2006, J CELL PHYSIOL, V207, P165, DOI 10.1002/jcp.20548; Cheng J, 2013, AM J MED SCI, V346, P98, DOI 10.1097/MAJ.0b013e318267680d; Derangeon M, 2017, CARDIOVASC RES, V113, P464, DOI 10.1093/cvr/cvx026; Drummond CA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197688; Drummond CA, 2016, PHYSIOL GENOMICS, V48, P220, DOI 10.1152/physiolgenomics.00116.2015; Finocchiaro G, 2016, J AM COLL CARDIOL, V67, P2108, DOI 10.1016/j.jacc.2016.02.062; Gonzalez A, 2018, J AM COLL CARDIOL, V71, P1696, DOI 10.1016/j.jacc.2018.02.021; Gulati A, 2013, JAMA-J AM MED ASSOC, V309, P896, DOI 10.1001/jama.2013.1363; Hookana E, 2011, HEART RHYTHM, V8, P1570, DOI 10.1016/j.hrthm.2011.06.031; Ikawa Y, 2019, HUM MOL GENET, V28, pR24, DOI 10.1093/hmg/ddz172; JALIL JE, 1989, CIRC RES, V64, P1041, DOI 10.1161/01.RES.64.6.1041; Kaufmann KB, 2013, EMBO MOL MED, V5, P1642, DOI 10.1002/emmm.201202287; Kotterman MA, 2015, ANNU REV BIOMED ENG, V17, P63, DOI 10.1146/annurev-bioeng-071813-104938; Kuwahara F, 2002, CIRCULATION, V106, P130, DOI 10.1161/01.CIR.0000020689.12472.E0; Kwiecinski M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024568; Liu J, 2016, SCI REP-UK, V6, DOI 10.1038/srep34592; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luo WJ, 2013, BIOINFORMATICS, V29, P1830, DOI 10.1093/bioinformatics/btt285; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Mitra MS, 2020, TOXICOL SCI, V175, P24, DOI 10.1093/toxsci/kfaa024; Montgomery RL, 2014, EMBO MOL MED, V6, P1347, DOI 10.15252/emmm.201303604; Morine KJ, 2018, CIRCULATION, V138, P513, DOI 10.1161/CIRCULATIONAHA.117.031635; Ramdas V, 2013, AM J PATHOL, V183, P1885, DOI 10.1016/j.ajpath.2013.08.027; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sweeney M, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.201910865; Talman V, 2016, CELL TISSUE RES, V365, P563, DOI 10.1007/s00441-016-2431-9; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Travers JG, 2016, CIRC RES, V118, P1021, DOI 10.1161/CIRCRESAHA.115.306565; Valiente-Alandi I, 2018, CIRCULATION, V138, P1236, DOI 10.1161/CIRCULATIONAHA.118.034609; van den Borne SWM, 2010, NAT REV CARDIOL, V7, P30, DOI 10.1038/nrcardio.2009.199; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; van Rooij E, 2012, NAT REV DRUG DISCOV, V11, P860, DOI 10.1038/nrd3864; van Rooij E, 2012, CIRC RES, V110, P496, DOI 10.1161/CIRCRESAHA.111.247916; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006	43	4	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0244065	10.1371/journal.pone.0244065	http://dx.doi.org/10.1371/journal.pone.0244065			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332475	gold, Green Published			2022-12-27	WOS:000601310900053
J	Herzog, AL; Busch, J; Wanner, C; von Jouanne-Diedrich, HK				Herzog, Anna Laura; Busch, Jonas; Wanner, Christoph; von Jouanne-Diedrich, Holger K.			Survey about do-it-yourself closed loop systems in the treatment of diabetes in Germany	PLOS ONE			English	Article							ARTIFICIAL PANCREAS SYSTEMS; INSULIN PUMP THERAPY; COMPLICATIONS-TRIAL/EPIDEMIOLOGY; GLYCEMIC CONTROL; INTERVENTIONS; MELLITUS	Continuous glucose monitoring (CGM) improves treatment with lower blood glucose levels and less patient effort. In combination with continuous insulin application, glycemic control improves and hypoglycemic episodes should decrease. Direct feedback of CGM to continuous subcutaneous insulin application, using an algorithm is called a closed-loop (CL) artificial pancreas system. Commercial devices stop insulin application by predicting hypoglycemic blood glucose levels through direct interaction between the sensor and pump. The prediction is usually made for about 30 minutes and insulin delivery is restarted at the previous level if a rise in blood glucose is predicted within the next 30 minutes (hybrid closed loop system, HCL this is known as a predictive low glucose suspend system (PLGS)). In a fully CL system, sensor and pump communicate permanently with each other. Hybrid closed-loop (HCL) systems, which require the user to estimate the meal size and provide a meal insulin basis, are commercially available in Germany at the moment. These systems result in fewer hyperglycemic and hypoglycemic episodes with improved glucose control. Open source initiatives have provided support by building do-it-yourself CL (DIYCL) devices for automated insulin application since 2014, and are used by a tech-savvy subgroup of patients. The first commercial hybrid CL system has been available in Germany since September 2019. We surveyed 1054 patients to determine which devices are currently used, which features would be in demand by potential users, and the benefits of DIYCL systems. 9.7% of these used a DIYCL system, while 50% would most likely trust these systems but more than 85% of the patients would use a commercial closed loop system, if available. The DIYCL users had a better glucose control regarding their time in range (TIR) and glycated hemoglobin (HbA1c).	[Herzog, Anna Laura] Univ Wurzburg, Univ Klinikum, Div Nephrol, Transplantat Zentrum, Wurzburg, Germany; [Busch, Jonas] TH Aschaffenburg Univ Appl Sci, Aschaffenburg, Germany; [Wanner, Christoph] Univ Wurzburg, Univ Klinikum, Div Nephrol, Med Klin 1, Wurzburg, Germany; [von Jouanne-Diedrich, Holger K.] TH Aschaffenburg Univ Appl Sci, Competence Ctr Artificial Intelligence, Fac Engn, Aschaffenburg, Germany	University of Wurzburg; University of Wurzburg	Herzog, AL (corresponding author), Univ Wurzburg, Univ Klinikum, Div Nephrol, Transplantat Zentrum, Wurzburg, Germany.	Herzog_A1@ukw.de		von Jouanne-Diedrich, Holger K./0000-0002-5787-7351				Ang KH, 2015, EXPERT OPIN DRUG DEL, V12, P1579, DOI 10.1517/17425247.2015.1074174; [Anonymous], AM DIAB ASS SCI SESS; [Anonymous], 2016, GES; [Anonymous], FDA WARNS USE UN DIA; Barnard Katharine D, 2018, J Diabetes Sci Technol, V12, P1223, DOI 10.1177/1932296818792577; Beck Roy W, 2019, J Diabetes Sci Technol, V13, P614, DOI 10.1177/1932296818822496; Bekiari E, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k1310; Blauw H, 2016, DIABETES OBES METAB, V18, P671, DOI 10.1111/dom.12663; Cleary PA, 2006, DIABETES, V55, P3556, DOI 10.2337/db06-0653; de Boer IH, 2011, ARCH INTERN MED, V171, P412, DOI 10.1001/archinternmed.2011.16; Deshpande S, 2020, INT J THER REHABIL, V27, DOI 10.12968/ijtr.2019.0072; Doyle FJ, 2014, DIABETES CARE, V37, P1191, DOI 10.2337/dc13-2108; Farrington C, 2017, LANCET DIABETES ENDO, V5, P332, DOI 10.1016/S2213-8587(16)30397-7; Haidar A, 2015, LANCET DIABETES ENDO, V3, P17, DOI 10.1016/S2213-8587(14)70226-8; Jacob R., 2014, UMFRAGE EINFUHRUNG M, V3; Jacobson AM, 2013, DIABETES CARE, V36, P3131, DOI 10.2337/dc12-2109; Koster I, 2014, EXP CLIN ENDOCR DIAB, V122, P510, DOI 10.1055/s-0034-1375675; Lewis Dana, 2019, J Diabetes Sci Technol, V13, P790, DOI 10.1177/1932296818808307; Lewis Dana, 2016, J Diabetes Sci Technol, V10, P1411; Ly TT, 2015, DIABETES CARE, V38, P1205, DOI 10.2337/dc14-3073; Medtronic, REIMB KOST; Musolino G, 2019, PEDIATR DIABETES, V20, P794, DOI 10.1111/pedi.12872; Nathan DM, 2014, DIABETES CARE, V37, P9, DOI 10.2337/dc13-2112; Oubre AY, 1997, DIABETOLOGIA, V40, P614, DOI 10.1007/s001250050724; Oukes Tamara, 2019, J Diabetes Sci Technol, V13, P899, DOI 10.1177/1932296818823728; Porst R., 2014, FRAGEBOGEN ARBEITSBU, V4th ed.; Quianzon CC, 2012, J COMMUNITY HOSP INT, V2, DOI 10.3402/jchimp.v2i2.18701; Ruedy KJ, 2012, J CARDIOVASC TRANSL, V5, P380, DOI 10.1007/s12265-012-9364-9; Russell SJ, 2016, LANCET DIABETES ENDO, V4, P233, DOI 10.1016/S2213-8587(15)00489-1; Thomas A, 2017, DIABETES C REPORT, V2017, P34; Trevitt Sara, 2016, J Diabetes Sci Technol, V10, P714, DOI 10.1177/1932296815617968; Turksoy K, 2014, J HEALTHC ENG, V5, P1, DOI 10.1260/2040-2295.5.1.1; Vasiloglou MF, 2018, NUTRIENTS, V10, DOI 10.3390/nu10060741; Vigersky RA, 2019, DIABETES TECHNOL THE, V21, P81, DOI 10.1089/dia.2018.0310; Waugh N, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k1613; Weaver KW, 2018, DIABETES TECHNOL THE, V20, P16, DOI 10.1089/dia.2018.0091; Weisman A, 2017, LANCET DIABETES ENDO, V5, P501, DOI 10.1016/S2213-8587(17)30167-5; Weiss R, 2015, DIABETES TECHNOL THE, V17, P542, DOI 10.1089/dia.2014.0306	38	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243465	10.1371/journal.pone.0243465	http://dx.doi.org/10.1371/journal.pone.0243465			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332410	Green Published, gold			2022-12-27	WOS:000601310900066
J	Sacks, G; Riesenberg, D; Mialon, M; Dean, S; Cameron, AJ				Sacks, Gary; Riesenberg, Devorah; Mialon, Melissa; Dean, Sarah; Cameron, Adrian J.			The characteristics and extent of food industry involvement in peer-reviewed research articles from 10 leading nutrition-related journals in 2018	PLOS ONE			English	Article							CONFLICTS-OF-INTEREST; HEALTH; SPONSORSHIP; QUALITY; SCIENCE; SAFETY	Introduction There is emerging evidence that food industry involvement in nutrition research may bias research findings and/or research agendas. However, the extent of food industry involvement in nutrition research has not been systematically explored. This study aimed to identify the extent of food industry involvement in peer-reviewed articles from a sample of leading nutrition-related journals, and to examine the extent to which findings from research involving the food industry support industry interests. Methods All original research articles published in 2018 in the top 10 most-cited nutrition- and dietetics-related journals were analysed. We evaluated the proportion of articles that disclosed involvement from the food industry, including through author affiliations, funding sources, declarations of interest or other acknowledgments. Principal research findings from articles with food industry involvement, and a random sample of articles without food industry involvement, were categorised according to the extent to which they supported relevant food industry interests. Results 196/1,461 (13.4%) articles reported food industry involvement. The extent of food industry involvement varied by journal, with The Journal of Nutrition (28.3%) having the highest and Paediatric Obesity (3.8%) having the lowest proportion of industry involvement. Processed food manufacturers were involved in the most articles (77/196, 39.3%). Of articles with food industry involvement, 55.6% reported findings favourable to relevant food industry interests, compared to 9.7% of articles without food industry involvement. Conclusion Food industry involvement in peer-reviewed research in leading nutrition-related journals is commonplace. In line with previous literature, this study has shown that a greater proportion of peer-reviewed studies involving the food industry have results that favour relevant food industry interests than peer-reviewed studies without food industry involvement. Given the potential competing interests of the food industry, it is important to explore mechanisms that can safeguard the integrity and public relevance of nutrition research.	[Sacks, Gary; Riesenberg, Devorah; Dean, Sarah; Cameron, Adrian J.] Deakin Univ, Inst Hlth Transformat, Sch Hlth & Social Dev, Fac Hlth,Global Obes Ctr GLOBE, Geelong, Vic, Australia; [Mialon, Melissa] Univ Sao Paulo, Sch Publ Hlth, Sao Paulo, Brazil	Deakin University; Universidade de Sao Paulo	Sacks, G (corresponding author), Deakin Univ, Inst Hlth Transformat, Sch Hlth & Social Dev, Fac Hlth,Global Obes Ctr GLOBE, Geelong, Vic, Australia.	gary.sacks@deakin.edu.au	; Sacks, Gary/I-5731-2014	Riesenberg, Devorah/0000-0003-2797-2574; Sacks, Gary/0000-0001-9736-1539	Heart Foundation Future Leader Fellowships from the National Heart Foundation of Australia [102035, 36357]	Heart Foundation Future Leader Fellowships from the National Heart Foundation of Australia	GS and AJC were supported by Heart Foundation Future Leader Fellowships (102035 and 36357, respectively) from the National Heart Foundation of Australia (https://www.heartfoundation.org.au/).GS and AJC are researchers within a National Health and Medical Research Council (NHMRC) (https://www.nhmrc.gov.au/) Centre of Research Excellence in Food Retail Environments for Health (RE-FRESH) (APP1152968) (Australia). GS is also a researcher within a NHMRC Centre for Research Excellence entitled Reducing Salt Intake Using Food Policy Interventions (APP1117300). The authors are solely responsible for the opinions, hypotheses and conclusions or recommendations expressed in this publication, and they do not necessarily reflect their funders' vision. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshin A, 2019, LANCET, V393, P1958, DOI 10.1016/S0140-6736(19)30041-8; Albala K, 2007, BUSINESS FOOD ENCY F; American Scoiety for Nutrition, SUS PARTN; American Society for Nutrition, ED BOARD CONFL INT S; AVEYARD P, 2016, BMJ-BRIT MED J, V353, DOI DOI 10.1136/BMJ.I2161; Baker P, 2020, OBES REV, V21, DOI 10.1111/obr.13126; Bes-Rastrollo M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001578; Charles Perkins Centre Engagement With Industry- Committee Members, 2016, ENGAGEMENT IND GUIDE; Chartres N, 2016, JAMA INTERN MED, V176, P1769, DOI 10.1001/jamainternmed.2016.6721; Cohen JE, 2009, TOB CONTROL, V18, P228, DOI 10.1136/tc.2008.027623; DariushMozaffarian, 2017, JAMA-J AM MED ASSOC, V317, P1755, DOI 10.1001/jama.2017.3456; Euromonitor International, 2018, PASSPORT; Fabbri A, 2018, AM J PUBLIC HEALTH, V108, pE9, DOI 10.2105/AJPH.2018.304677; Fabbri A, 2018, PUBLIC HEALTH NUTR, V21, P3422, DOI 10.1017/S1368980018002100; Fooks GJ, 2019, GLOBALIZATION HEALTH, V15, DOI 10.1186/s12992-019-0495-5; Gornall J, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h231; Kroeger CM, 2018, AM J CLIN NUTR, V107, P484, DOI 10.1093/ajcn/nqx067; Kypri K, 2009, ADDICTION, V104, P1765, DOI 10.1111/j.1360-0443.2009.02651.x; Layman DK, 2014, PHYSIOL BEHAV, V134, P126, DOI 10.1016/j.physbeh.2013.12.005; Lesser LI, 2007, PLOS MED, V4, P41, DOI 10.1371/journal.pmed.0040005; Lesser LI, 2009, AM J CLIN NUTR, V90, P699, DOI 10.3945/ajcn.2009.28093; Liberati A, 2010, EUR J CLIN INVEST, V40, P69, DOI 10.1111/j.1365-2362.2009.02226.x; Ludwig DS, 2008, JAMA-J AM MED ASSOC, V300, P1808, DOI 10.1001/jama.300.15.1808; Massougbodji J, 2014, AM J CLIN NUTR, V99, P1096, DOI 10.3945/ajcn.113.063776; McCambridge J, 2018, DRUG ALCOHOL REV, V37, P565, DOI 10.1111/dar.12826; Mialon M, 2015, OBES REV, V16, P519, DOI 10.1111/obr.12289; Nestle M, 2001, PUBLIC HEALTH NUTR, V4, P1015, DOI 10.1079/PHN2001253; Nestle M, 2013, FOOD POLITICS FOOD I; Nestle M, 2016, JAMA INTERN MED, V176, P1685, DOI 10.1001/jamainternmed.2016.5400; Nestle M, 2016, JAMA INTERN MED, V176, P13, DOI 10.1001/jamainternmed.2015.6667; Nestle M, 2013, JAMA INTERN MED, V173, P2036, DOI 10.1001/jamainternmed.2013.9158; Oxfam, 2013, BRANDS FOOD JUSTICE; Rowe S, 2013, NUTR REV, V71, P682, DOI 10.1111/nure.12072; Rowe S, 2009, NUTR REV, V67, P264, DOI 10.1111/j.1753-4887.2009.00188.x; Ruff K, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/s12940-015-0035-6; Sacks G, GLOBAL OBESITY CTR G; Savell E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087389; SCImago, SCIMAGO J COUNTRY RA; Simon M., 2013, BEST PUBLIC RELATION; Smith KE, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000202; Smith KE, 2015, J HEALTH POLIT POLIC, V40, P325, DOI 10.1215/03616878-2882231; Steele S, 2020, PUBLIC HEALTH NUTR, P1; Steele S, 2019, GLOBALIZATION HEALTH, V15, DOI 10.1186/s12992-019-0478-6; Steele S, 2019, J PUBLIC HEALTH POL, V40, P273, DOI 10.1057/s41271-019-00170-9; Stuckler D, 2012, PLOS MED, V9, DOI [10.1371/journal.pmed.1001242, 10.1371/journal.pmed.1001235]; Ulucanlar S, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002125; Vandevijvere S, 2019, OBES REV, V20, P10, DOI 10.1111/obr.12860; Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782; White J, 2010, STANFORD LAW POL REV, V21, P105; White M, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m545; Woteki CE, 2006, J AM DIET ASSOC, V106, P27, DOI 10.1016/j.jada.2005.11.011; Yanamadala S, 2012, PUBLIC HEALTH NUTR, V15, P1331, DOI 10.1017/S1368980012003187	52	8	8	6	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243144	10.1371/journal.pone.0243144	http://dx.doi.org/10.1371/journal.pone.0243144			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH1IW	33326431	Green Published, gold			2022-12-27	WOS:000600176400040
J	Aimagambetova, G; Issanov, A; Terzic, S; Bapayeva, G; Ukybassova, T; Baikoshkarova, S; Aldiyarova, A; Shauyen, F; Terzic, M				Aimagambetova, Gulzhanat; Issanov, Alpamys; Terzic, Sanja; Bapayeva, Gauri; Ukybassova, Talshyn; Baikoshkarova, Saltanat; Aldiyarova, Aidana; Shauyen, Fariza; Terzic, Milan			The effect of psychological distress on IVF outcomes: Reality or speculations?	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; ASSISTED REPRODUCTIVE TECHNOLOGY; CENTRAL-ASIA; STRESS; WOMEN; FERTILITY; INFERTILITY; DEPRESSION; KAZAKSTAN; OBESITY	Introduction Infertility is a problem that affects millions of people worldwide. The aim of this study was to assess the effect of stress, depression and anxiety on the IVF outcomes in Kazakhstan. Methods The prospective cohort study was performed using questionnaires to assess psychological distress in 304 infertile female in three different cities in Kazakhstan. Results The average age of participants was 33.7 years with infertility duration of 5.9 years. Regarding stress, depression and anxiety we found that more than 80% of all respondents had CES-D score higher than 16, indicating that they are at risk of developing clinical depression. On average, FPI subscales' scores, global stress score and anxiety scale (STAI-S and STAI-T) scores were statistically significantly higher among not pregnant women than pregnant women. Similarly, in simple logistic regression analysis all FPI subscales scores, global stress scale score and anxiety scales' scores were negatively associated with clinical pregnancy. Conclusion Rates of stress, anxiety and depression among IVF patients are higher than in general population. If the level of infertility-related stress is higher, IVF success rate is lower. Findings of our study indicate the need for the specific psychological interventions for all infertility women, to improve IVF success rate.	[Aimagambetova, Gulzhanat] Nazarbayev Univ, Sch Med, Dept Biomed Sci, Nur Sultan, Kazakhstan; [Issanov, Alpamys; Terzic, Sanja; Terzic, Milan] Nazarbayev Univ, Sch Med, Dept Med, Nur Sultan, Kazakhstan; [Bapayeva, Gauri; Ukybassova, Talshyn; Aldiyarova, Aidana; Shauyen, Fariza; Terzic, Milan] Univ Med Ctr, Natl Res Ctr Mother & Child Hlth, Clin Acad Dept Womens Hlth, Nur Sultan, Kazakhstan; [Baikoshkarova, Saltanat] IVF Clin Ecomed, Alma Ata, Kazakhstan; [Terzic, Milan] Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA USA	Nazarbayev University; Nazarbayev University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Aimagambetova, G (corresponding author), Nazarbayev Univ, Sch Med, Dept Biomed Sci, Nur Sultan, Kazakhstan.	gulzhanat.aimagambetova@nu.edu.kz	Terzic, Sanja/ABH-4367-2020; Issanov, Alpamys/AAD-2792-2020; Aimagambetova, Gulzhanat/M-2731-2019; Terzic, Milan/P-7243-2017	Terzic, Sanja/0000-0002-0034-2559; Issanov, Alpamys/0000-0002-8968-2655; Aimagambetova, Gulzhanat/0000-0002-2868-4497; Otarbaev, Marat/0000-0002-4323-9252; Terzic, Milan/0000-0003-3914-5154; Shauyen, Fariza/0000-0001-7241-2811; Baikoshkarova, Saltanat/0000-0001-9428-489X	Nazarbayev University Social policy grant	Nazarbayev University Social policy grant	The research was supported by the Nazarbayev University Social policy grant awarded for author MT. Ecomed provided support for this study in the form of salary for author SB. The specific roles of these authors are articulated in the `author contributions' section. The funders had no other role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agadjanian V, 2013, J POPUL RES, V30, P197, DOI 10.1007/s12546-013-9112-2; Aketayeva A, 2018, IRAN J PUBLIC HEALTH, V47, P135; Alchinbaev M. K., 2016, Urologiya (Moscow), P75; Amer Soc Reprod Med, 2020, FERTIL STERIL, V113, P533, DOI 10.1016/j.fertnstert.2019.11.025; An Y, 2013, J ASSIST REPROD GEN, V30, P35, DOI 10.1007/s10815-012-9904-x; An Y, 2011, FERTIL STERIL, V96, P404, DOI 10.1016/j.fertnstert.2011.05.092; Anderheim L, 2005, HUM REPROD, V20, P2969, DOI 10.1093/humrep/dei219; [Anonymous], 2019, Obstet Gynecol, V133, pe377, DOI 10.1097/AOG.0000000000003271; Barut MU, 2016, MED SCI MONITOR, V22, P4386, DOI 10.12659/MSM.897620; Bellver J, 2010, FERTIL STERIL, V93, P447, DOI 10.1016/j.fertnstert.2008.12.032; Cox SJ, 2006, FERTIL STERIL, V85, P84, DOI 10.1016/j.fertnstert.2005.07.1287; De Pergola G, 2006, OBESITY, V14, P1954, DOI 10.1038/oby.2006.228; Ebbesen SMS, 2009, HUM REPROD, V24, P2173, DOI 10.1093/humrep/dep185; Gabnai-Nagy E, 2020, GEBURTSH FRAUENHEILK, V80, P200, DOI 10.1055/a-0854-5987; Garcia-Blanco A, 2018, HUM REPROD, V33, P1237, DOI 10.1093/humrep/dey109; Henry SK, 2018, J AFFECT DISORDERS, V234, P270, DOI 10.1016/j.jad.2018.02.071; Klonoff-Cohen H, 2001, FERTIL STERIL, V76, P675, DOI 10.1016/S0015-0282(01)02008-8; Lakatos E, 2017, BMC WOMENS HEALTH, V17, DOI 10.1186/s12905-017-0410-2; Lewinsohn PM, 1997, PSYCHOL AGING, V12, P277, DOI 10.1037/0882-7974.12.2.277; Lokshin V.N., 2018, REP, V1, P37; Mahalingaiah S, 2011, FERTIL STERIL, V95, P2618, DOI 10.1016/j.fertnstert.2011.05.015; Maheshwari A, 2007, HUM REPROD UPDATE, V13, P433, DOI 10.1093/humupd/dmm017; Mandrik O, 2015, CLINICOECONOMIC OUTC, V7, P347, DOI 10.2147/CEOR.S79513; Maroufizadeh S, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4294-0; Matthiesen SMS, 2011, HUM REPROD, V26, P2763, DOI 10.1093/humrep/der246; Michael Anthony E, 2003, Reprod Biomed Online, V7, P683; Newton CR, 1999, FERTIL STERIL, V72, P54, DOI 10.1016/S0015-0282(99)00164-8; Nouri K, 2014, ASIAN J ANDROL, V16, P597, DOI 10.4103/1008-682X.125404; Ombelet W, 2008, HUM REPROD UPDATE, V14, P605, DOI 10.1093/humupd/dmn042; Pasch LA, 2018, FERTIL STERIL, V110, P1194, DOI 10.1016/j.fertnstert.2018.08.055; Pasch LA, 2017, CURR OPIN PSYCHOL, V13, P131, DOI 10.1016/j.copsyc.2016.07.004; Pasch LA, 2012, FERTIL STERIL, V98, P459, DOI 10.1016/j.fertnstert.2012.05.023; Pike JL, 1997, PSYCHOSOM MED, V59, P447, DOI 10.1097/00006842-199707000-00015; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rooney KL, 2018, DIALOGUES CLIN NEURO, V20, P41; Rossi Brooke V, 2016, Fertil Res Pract, V2, P11, DOI 10.1186/s40738-016-0026-5; Sapolsky RM, 2015, NAT NEUROSCI, V18, P1344, DOI 10.1038/nn.4109; Spielberger CD, 1970, MANUAL STATETRAIT IN; Spoorenberg T, 2017, J BIOSOC SCI, V49, pS62, DOI 10.1017/S0021932017000335; Tabyshalieva A, 1997, ANTHR ARCHEOL EURAS, V36, P45, DOI 10.2753/AAE1061-1959360245; Utepova G, 2019, CLIN EXP OBSTET GYN, V46, P461, DOI 10.12891/ceog4685.2019; Vander Borght M, 2018, CLIN BIOCHEM, V62, P2, DOI 10.1016/j.clinbiochem.2018.03.012	42	19	19	6	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0242024	10.1371/journal.pone.0242024	http://dx.doi.org/10.1371/journal.pone.0242024			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH1MP	33315878	gold, Green Published			2022-12-27	WOS:000600186100035
J	Macedo, MCF; Pinheiro, IM; Carvalho, CJL; Fraga, HCJR; Araujo, IPC; Montes, SS; Araujo, OAC; Alves, LA; Saba, H; Araujo, MLV; Queiroz, ITL; Sampaio, RL; Souza, MSPL; da Silva, ACFN; Souza, ACS				Macedo, Marcio C. F.; Pinheiro, Isabelle M.; Carvalho, Caio J. L.; Fraga, Hilda C. J. R.; Araujo, Isaac P. C.; Montes, Simone S.; Araujo, Otavio A. C.; Alves, Lucas A.; Saba, Hugo; Araujo, Marcio L. V.; Queiroz, Ivonete T. L.; Sampaio, Romilson L.; Souza, Marcia S. P. L.; da Silva, Ana Claudia F. N.; Souza, Antonio C. S.			Correlation between hospitalized patients' demographics, symptoms, comorbidities, and COVID-19 pandemic in Bahia, Brazil	PLOS ONE			English	Article								In this paper, we provide a retrospective cohort study with patients that have been hospitalized for general or intensive care unit admission due to COVID-19, between March 3 and July 29, 2020, in the state of Bahia, Brazil. We aim to correlate those patients' demographics, symptoms and comorbidities, with the risk of mortality from COVID-19, length of hospital stay, and time from diagnosis to definitive outcome. On the basis of a dataset provided by the Health Secretary of the State of Bahia, we selected 3,896 hospitalized patients from a total of 154,868 COVID-19 patients that included non-hospitalized patients and patients with invalid registration in the dataset. Then, we statistically analyzed whether there was a significant correlation between the patient record data and the COVID-19 pandemic, and our main findings reinforced by the use of a multivariable logistic regression were that older age (Odds Ratio [OR] = 1.03, 95% Confidence Interval [CI] = 1.03-1.04, p-value (p) <0.001), an initial symptom of shortness of breath (OR = 1.88, 95% CI = 1.60-2.20, p < 0.001), and the presence of comorbidities, mainly chronic kidney disease (OR = 2.41, 95% CI = 1.67-3.48, p < 0.001) are related to an increased risk of mortality from COVID-19. On the other hand, sore throat (OR = 0.74, 95% CI = 0.58-0.95, p = 0.02) and length of hospital stay (OR = 0.96, 95% CI = 0.58-0.95, p < 0.001) are more related to a reduced risk of mortality from COVID-19. Moreover, a multivariable linear regression conducted with statistically significant variables (p < 0.05) showed that age (OR = 0.97, 95% CI = 0.95-0.98, p < 0.001) and time from diagnosis to definitive outcome (OR = 1.67, 95% CI = 1.64-1.71, p < 0.001) are associated with the length of hospital stay.	[Macedo, Marcio C. F.; Carvalho, Caio J. L.; Araujo, Otavio A. C.] Univ Fed Bahia, Dept Comp Sci, Salvador, BA, Brazil; [Pinheiro, Isabelle M.] Univ Fed Bahia, Dept Radiol, Salvador, BA, Brazil; [Pinheiro, Isabelle M.; Fraga, Hilda C. J. R.; Montes, Simone S.; Saba, Hugo; Araujo, Marcio L. V.; Sampaio, Romilson L.; Souza, Antonio C. S.] Univ Fed Bahia, Grad Program Knowledge Diffus, Salvador, BA, Brazil; [Carvalho, Caio J. L.] SENAI CIMATEC, Supercomp Ctr Ind Innovat, Salvador, BA, Brazil; [Fraga, Hilda C. J. R.] Fundacao Oswaldo Cruz, Salvador, BA, Brazil; [Araujo, Isaac P. C.; Alves, Lucas A.] Univ Fed Bahia, Dept Elect Engn, Salvador, BA, Brazil; [Saba, Hugo] Univ Estado Bahia, Dept Exact & Earth Sci, Salvador, BA, Brazil; [Araujo, Marcio L. V.] Fed Inst Bahia, Dept Tech Educ, Santo Amaro, BA, Brazil; [Araujo, Marcio L. V.; Souza, Marcia S. P. L.; da Silva, Ana Claudia F. N.] Hlth Secretary State Bahia, Salvador, BA, Brazil; [Queiroz, Ivonete T. L.] Fed Inst Bahia, Dept Tech Educ, Barreiras, BA, Brazil; [Sampaio, Romilson L.; Souza, Antonio C. S.] Fed Inst Bahia, Dept Comp Sci, Salvador, BA, Brazil	Universidade Federal da Bahia; Universidade Federal da Bahia; Universidade Federal da Bahia; Faculdade de Tecnologia Senai Cimatec; Fundacao Oswaldo Cruz; Universidade Federal da Bahia; Universidade do Estado Bahia; Instituto Federal da Bahia (IFBA); Instituto Federal da Bahia (IFBA); Instituto Federal da Bahia (IFBA)	Macedo, MCF (corresponding author), Univ Fed Bahia, Dept Comp Sci, Salvador, BA, Brazil.	marcio.cerqueira@ufba.br	Luis Valença Araújo, Marcio/C-4916-2016; Araújo, Marcio Luis Valença/ABC-7718-2021; Saba, Hugo/H-5594-2012	Luis Valença Araújo, Marcio/0000-0003-2376-0160; Araújo, Marcio Luis Valença/0000-0003-2376-0160; Saba, Hugo/0000-0001-8402-6416; Macedo, Marcio/0000-0003-2729-7193; de Lima Carvalho, Caio Jordao/0000-0002-1112-7600; Araujo, Isaac/0000-0001-8275-0101; Fraga, Hilda/0000-0002-1191-5789	National Council for Scientific and Technological Development - CNPq [431990/2018-2, 313423/2019-9]; Postdoctoral National Program of the Coordination for the Improvement of Higher Education Personnel - CAPES [88882.306277/2018-01]; National Council of Institutions of the Federal Network of Vocational, Scientific and Technological Education - CONIF; Secretariat of Professional and Technological Education - SETEC	National Council for Scientific and Technological Development - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Postdoctoral National Program of the Coordination for the Improvement of Higher Education Personnel - CAPES; National Council of Institutions of the Federal Network of Vocational, Scientific and Technological Education - CONIF; Secretariat of Professional and Technological Education - SETEC	Hugo Saba received financial support from the National Council for Scientific and Technological Development - CNPq (http://cnpq.br/), grant numbers 431990/2018-2 and 313423/2019-9 Marcio C. F. Macedo received financial support from the Postdoctoral National Program of the Coordination for the Improvement of Higher Education Personnel - CAPES (https://www.capes.gov.br/), grant number 88882.306277/2018-01. This work was supported by the National Council of Institutions of the Federal Network of Vocational, Scientific and Technological Education - CONIF (http://portal.conif.org.br/br/).This work was also supported by the Secretariat of Professional and Technological Education - SETEC (http://portal.mec.gov.br/setec-secretaria-de-educacaoprofissional-e-tecnologica).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Najjar H, 2020, EUR REV MED PHARMACO, V24, P3400, DOI 10.26355/eurrev_202003_20709; Barda N, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18297-9; Cheng YC, 2020, KIDNEY INT, V97, P829, DOI 10.1016/j.kint.2020.03.005; Colombi D, 2020, RADIOLOGY, V296, pE86, DOI 10.1148/radiol.2020201433; Hu H, 2020, ACAD EMERG MED, V27, P461, DOI 10.1111/acem.13992; Imam Z, 2020, J INTERN MED, V288, P469, DOI 10.1111/joim.13119; KIM L, 2020, CLIN INFECT DIS, DOI DOI 10.1093/CID/CIAA1012; Liu XK, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235459; Soares RDM, 2020, AM J TROP MED HYG, V103, P1184, DOI 10.4269/ajtmh.20-0483; Pinheiro ALS, 2016, TEXTO CONTEXTO ENFER, V25; Rivera-Izquierdo M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235107; Shi Y, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-2833-7; Smith V, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234187; Souza FSH, 2020, ANAL MORTALITY RISK, DOI [10.1101/2020.09.24.20200768, DOI 10.1101/2020.09.24.20200768]; Wang S, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.00775-2020; WHO (World Health Organization), 2020, CONS QUAR IND CONT C; Wynants L, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1328; Yan L, 2020, NAT MACH INTELL, V2, P283, DOI 10.1038/s42256-020-0180-7; Bello-Chavolla OY, 2020, J CLIN ENDOCR METAB, V105, P2752, DOI 10.1210/clinem/dgaa346; Yuan ML, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230548; Yue HM, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm-20-3026; Zhang BiCheng, 2020, PLoS ONE, V15, DOI 10.1371/journal.pone.0235458; Zhao ZR, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236618	23	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243966	10.1371/journal.pone.0243966	http://dx.doi.org/10.1371/journal.pone.0243966			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33318711	gold, Green Published			2022-12-27	WOS:000600186100072
J	Wakuma, B; Mosisa, G; Etafa, W; Mulisa, D; Tolossa, T; Fetensa, G; Besho, M; Gebre, M; Tsegaye, R				Wakuma, Bizuneh; Mosisa, Getu; Etafa, Werku; Mulisa, Diriba; Tolossa, Tadesse; Fetensa, Getahun; Besho, Merga; Gebre, Mohammed; Tsegaye, Reta			Postpartum modern contraception utilization and its determinants in Ethiopia: A systematic review and meta-analysis	PLOS ONE			English	Review							WOMEN; PERIOD; PREGNANCY; INTERVAL; TOWN	Background Contraceptive use is the best and most cost-effective strategy to reduce feto-maternal adverse effects of short birth intervals. More than two-thirds of women in developing countries who do not want to conceive are not using contraception methods. Although there were various primary studies in different parts of the country, there is no nationally representative evidence on postpartum modern contraception utilization and its determinants in Ethiopia. Objective This review was aimed to determine the best available pieces of evidence to pool the magnitude of postpartum modern contraception utilization and find out its determinants. Methods Published studies were extensively searched by using electronic databases and unpublished studies were identified from the digital library. All observational studies conducted on the magnitude of postpartum modern contraception utilization and its determinants in Ethiopia were included. Data were extracted on the Microsoft Excel spreadsheet and analyzed using STATA 14.1 version. A random-effects model was used to estimate the pooled magnitude of postpartum modern contraception utilization with a 95% confidence interval (CI). Inverse variance (I2) was used to identify the presence of heterogeneity and forest plot was used to estimate the pooled magnitude of postpartum contraception utilization. The presence of publication bias was assessed by funnel plots and Egger's statistical tests. Sub-group analysis was computed to minimize underlying heterogeneity. Findings In this review, 19 primary studies were included. The pooled magnitude of postpartum modern contraception utilization in Ethiopia was 45.79% (95%CI 36.45%, 55.13%). The review found that having more than four Antenatal care visits(ANC), having postnatal care visit (PNC), having a formal education, history of family planning use, history of counseling on family planning, and having greater than four alive children as significant determinants of postpartum modern contraception utilization. Conclusion The magnitude of postpartum modern contraception utilization in Ethiopia was low. ANC visit, PNC visit, maternal educational status, history of previous family planning use, counseling on family planning, and number of alive children were found to be significant determinants of postpartum modern contraception utilization. Therefore, strengthening focused ANC and PNC services to encourage women in utilizing modern contraception during the postnatal period is needed.	[Wakuma, Bizuneh; Mosisa, Getu; Etafa, Werku; Mulisa, Diriba; Fetensa, Getahun; Besho, Merga; Tsegaye, Reta] Wollega Univ, Inst Hlth Sci, Sch Nursing & Midwifery, Nekemte, Ethiopia; [Tolossa, Tadesse] Wollega Univ, Inst Hlth Sci, Dept Publ Hlth, Nekemte, Ethiopia; [Gebre, Mohammed] Wollega Univ, Inst Hlth Sci, Dept Pharm, Nekemte, Ethiopia; [Gebre, Mohammed] Addis Ababa Univ, Sch Pharm, Dept Pharmacol & Clin Pharm, Coll Hlth Sci, Addis Ababa, Ethiopia	Addis Ababa University	Wakuma, B (corresponding author), Wollega Univ, Inst Hlth Sci, Sch Nursing & Midwifery, Nekemte, Ethiopia.	buzuna2014@gmail.com	Hirko, Getahun Fetensa/ABY-0109-2022; Ebi, Werku Etafa/Q-2742-2019; Kebebew, Getu Mosisa/ABI-5268-2020	Ebi, Werku Etafa/0000-0001-9576-8888; Dedefo, Mohammed Gebre/0000-0003-2262-0158				Abera Y, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0178-1; Abraha Teklehaymanot Huluf, 2018, BMC Res Notes, V11, P641, DOI 10.1186/s13104-018-3754-2; Abraha TH, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5941-4; Abraha TH, 2017, EPIDEMIOL HEALTH, V39, DOI 10.4178/epih.e2017012; Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Alkema L, 2019, TRENDS MATERNAL MORT; Anguzu R, 2018, CONTRACEP REPROD MED, V3, DOI 10.1186/s40834-018-0059-8; [Anonymous], 2015, ENERGY STORAGE IND O, V3, P22; [Anonymous], 2014, PROGR STRAT POSTP FA; Apanga PA, 2015, PAN AFR MED J, V20, DOI 10.11604/pamj.2015.20.10.5301; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Belete GA, 2019, UTILIZATION ASS FACT; Berta M, 2018, ETHIOP J HEALTH SCI, V28, P207, DOI 10.4314/ejhs.v28i2.12; BRiz GOMEz Antonio, 2003, ORALIA ANALISIS DISC, V6, P7; Brown W, 2014, STUD FAMILY PLANN, V45, P73, DOI 10.1111/j.1728-4465.2014.00377.x; Bwazi C., 2014, Health, V6, P1724, DOI 10.4236/health.2014.614205; Cleland J, 2012, LANCET, V380, P149, DOI 10.1016/S0140-6736(12)60609-6; CSA Ethiopia and ICF, 2016, ETH DEM HLTH SURV 20; DaVanzo J, 2007, BJOG-INT J OBSTET GY, V114, P1079, DOI 10.1111/j.1471-0528.2007.01338.x; Demie T., 2018, J WOMENS HLTH CARE, V7, P2167, DOI DOI 10.4172/2167-0420.100042618; Derso T, PREVALENCE DETERMINA; Dona A, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5981-9; Ethiopian Public Health Institute (EPHI) [Ethiopia] and ICF, 2019, ETH MIN DEM HLTH SUR; Gaffield ME, 2014, GLOB HEALTH-SCI PRAC, V2, P4, DOI 10.9745/GHSP-D-13-00156; Gebremariam A, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1613-0; Gebremedhin AY, 2018, CONTRACEP REPROD MED, V3, DOI 10.1186/s40834-017-0054-5; Gejo NG, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217167; Gizaw W, 2017, INSIGHTS REPROD MED, V1, P8; Gonie A, 2018, BMC WOMENS HEALTH, V18, DOI 10.1186/s12905-018-0539-7; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hounkponou F, 2019, OPEN ACCESS J CONTR, V10, P19, DOI 10.2147/OAJC.S219709; Institute JB, 2006, MET STAT ASS REV INS, P20032007; Jalang'o R, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4510-6; Mahmood SE, 2011, INDAN J COMMUNITY HE, V23, P56; MALAHLELA MK, 2013, J SOCIAL SCI, V37, P137, DOI DOI 10.1080/09718923.2013.11893212; Mody SK, 2014, CONTRACEPTION, V89, P516, DOI 10.1016/j.contraception.2014.01.001; Moher D, 2009, PHYS THER, V89, P873, DOI 10.1093/ptj/89.9.873; Rutaremwa G, 2018, PAN AFR MED J, V30, DOI 10.11604/pamj.2018.30.303.15105; Rutaremwa G, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1611-y; Rutstein S., 2008, DHS WORKING PAPERS; SS V et al. on behalf of the American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee, 2020, CIRCULATION, V2020, pe1; Tafere Tadese Ejigu, 2018, Contracept Reprod Med, V3, P28, DOI 10.1186/s40834-018-0081-x; Taye EB, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4464-0; Tedla Z., 2017, POSTPARTUM CONTRACEP; Teka Takele Teshome, 2018, BMC Res Notes, V11, P581, DOI 10.1186/s13104-018-3698-6; Tirah H, THESIS; Tura G, 2016, J WOMENS HLTH CARE, V5, DOI DOI 10.4172/2167-0420.1000340; Wendt A, 2012, PAEDIATR PERINAT EP, V26, P239, DOI 10.1111/j.1365-3016.2012.01285.x; Wudineh KG, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-2138-x	49	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243776	10.1371/journal.pone.0243776	http://dx.doi.org/10.1371/journal.pone.0243776			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315904	Green Published, gold			2022-12-27	WOS:000600186100023
J	Ahmed, I; Hasan, M; Akter, R; Sarkar, BK; Rahman, M; Sarker, MS; Samad, MA				Ahmed, Iftekhar; Hasan, Maruf; Akter, Rahima; Sarkar, Bidduth Kumar; Rahman, Marufa; Sarker, Md Samun; Samad, Mohammed A.			Behavioral preventive measures and the use of medicines and herbal products among the public in response to Covid-19 in Bangladesh: A cross-sectional study	PLOS ONE			English	Article							HOMEOPATHY	The present study was conducted to assess the behavioral preventive measures and the use of medicines and herbal foods/products among the public in response to Covid-19. A cross-sectional survey comprised of 1222 participants was conducted from 27 June to 20 July 2020. Kruskal-Wallis test was used to identify the differences in behavioral preventive practices across different demographic categories. To identify the factors associated with the use of preventive medicines and herbal foods/products, multivariable logistic regression was performed. Most participants adopted the recommended preventive practices such as washing hands more frequently (87.5%), staying home more often (85.5%), avoiding crowds (86%), and wearing masks (91.6%). About half of the smokers reported a decreased rate of smoking during the pandemic. Also, 14.8% took medicines, 57.6% took herbal foods/products, and 11.2% took both medicines and herbal foods/products as preventive measure against Covid-19. Arsenicum album, vitamin supplements, and zinc supplements were the most commonly used preventive medicines. Gender, age, and fear of Covid-19 were significantly associated with the use of both preventive medicines and herbal foods/products. For the management of Covid-19 related symptoms, paracetamol, antihistamines, antibiotics, and mineral (zinc and calcium) supplements were used most often. Most participants sought information from non-medical sources while using medicines and herbal products. Moreover, potentially inappropriate and unnecessary use of certain drugs was identified.	[Ahmed, Iftekhar; Hasan, Maruf; Rahman, Marufa] Jahangirnagar Univ, Dept Pharm, Dhaka, Bangladesh; [Akter, Rahima] World Univ Bangladesh, Dept Pharm, Dhaka, Bangladesh; [Sarkar, Bidduth Kumar] Ranada Prasad Shaha Univ, Dept Pharm, Narayanganj, Bangladesh; [Sarker, Md Samun; Samad, Mohammed A.] Bangladesh Livestock Res Inst BLRI, Antimicrobial Resistance Act Ctr ARAC, Dhaka, Bangladesh	Jahangirnagar University; Bangladesh Livestock Research Institute (BLRI)	Ahmed, I (corresponding author), Jahangirnagar Univ, Dept Pharm, Dhaka, Bangladesh.	iftekhar2727@gmail.com	Ahmed, Iftekhar/GPW-8881-2022	Sarker, Md Samun/0000-0001-5445-1040; SAMAD, MOHAMMED/0000-0001-7329-7325; Ahmed, Iftekhar/0000-0001-8480-5225; Rahima, Akter/0000-0001-9039-6157				Ali I, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138861; [Anonymous], 2020, BANGL SHOULD LIST IT; [Anonymous], 2020, DHAKA TRIBUNE   0614; [Anonymous], 2020, ACAD EMERG MED, V27, pS7, DOI 10.1111/acem.13961; [Anonymous], 2020, DHAKA TRIBUNE   0621; [Anonymous], 2020, DAILY NEWNATION 0616; [Anonymous], [No title captured]; Anwar S, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00154; Apisarnthanarak A, 2020, INFECT CONT HOSP EP, V41, P1093, DOI 10.1017/ice.2020.280; Banik R, 2020, PUBLIC HEALTH, V183, P50, DOI 10.1016/j.puhe.2020.04.037; Ernst E, 2005, TRENDS PHARMACOL SCI, V26, P547, DOI 10.1016/j.tips.2005.09.003; Ferdous MZ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239254; Gupta L, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e256; Haque T, 2020, KNOWLEDGE ATTITUDE P; Jayawardena R, 2020, DIABETES METAB SYND, V14, P367, DOI 10.1016/j.dsx.2020.04.015; Mhatre S, 2021, PHYTOMEDICINE, V85, DOI 10.1016/j.phymed.2020.153286; Molento MB, 2020, ONE HEALTH-AMSTERDAM, V10, DOI 10.1016/j.onehlt.2020.100148; Nilashi M, 2020, J INFECT PUBLIC HEAL, V13, P893, DOI 10.1016/j.jiph.2020.05.009; Panyod S, 2020, J TRADIT COMPL MED, V10, P420, DOI 10.1016/j.jtcme.2020.05.004; Patanavanich R, 2020, NICOTINE TOB RES, V22, P1653, DOI 10.1093/ntr/ntaa082; Paul A, 2020, KNOWLEDGE ATTITUDE P; Rahman MT, 2020, J HERB MED, V23, DOI 10.1016/j.hermed.2020.100382; Services DGoH, NAT GUID CLIN MAN CO; Shang AJ, 2005, LANCET, V366, P726, DOI 10.1016/S0140-6736(05)67177-2; van Zyl-Smit RN, 2020, LANCET RESP MED, V8, P664, DOI 10.1016/S2213-2600(20)30239-3; Vellingiri B, 2020, SCI TOTAL ENVIRON, V725, DOI 10.1016/j.scitotenv.2020.138277; WHO-World Health Organization, COR DIS COVID 19 ADV; World Health Organization, 2022, TIM WHOS COVID 19 RE; Yildirim M, 2021, PSYCHOL HEALTH MED, V26, P35, DOI 10.1080/13548506.2020.1776891; Zarocostas J, 2020, LANCET, V395, P676, DOI 10.1016/S0140-6736(20)30461-X	30	24	24	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243706	10.1371/journal.pone.0243706	http://dx.doi.org/10.1371/journal.pone.0243706			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306725	Green Submitted, gold, Green Published			2022-12-27	WOS:000600144200034
J	Bayoumi, A; Jalil, I; Metwally, M; Adams, LA; Aller, R; Garcia-Monzon, C; Arias-Loste, MT; Miele, L; Petta, S; Craxi, A; Gallego-Duran, R; Fischer, J; Berg, T; Qiao, L; Liddle, C; Bugianesi, E; Romero-Gomez, M; George, J; Eslam, M				Bayoumi, Ali; Jalil, Ismail; Metwally, Mayada; Adams, Leon A.; Aller, Rocio; Garcia-Monzon, Carmelo; Teresa Arias-Loste, Maria; Miele, Luca; Petta, Salvatore; Craxi, Antonio; Gallego-Duran, Rocio; Fischer, Janett; Berg, Thomas; Qiao, Liang; Liddle, Christopher; Bugianesi, Elisabetta; Romero-Gomez, Manuel; George, Jacob; Eslam, Mohammed			Genetic variation in the TLL1 gene is not associated with fibrosis in patients with metabolic associated fatty liver disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; VARIANT; NAFLD; RISK; PROGRESSION; STEATOSIS; INCREASES; TM6SF2; PNPLA3	Metabolic associated fatty liver disease (MAFLD) is the most prevalent liver disease in Western nations, with high heritability. A recent study of Japanese patients with the disease suggested that TLL1 rs17047200 is associated with fibrosis; whether a similar association is observed in Caucasian patients with MAFLD is unknown. We investigated the association of the TLL1 rs17047200 polymorphism with liver fibrosis in a cohort of Caucasian patients with MAFLD (n = 728). We also investigated whether TLL1 expression is altered during liver injury in humans, in murine models of fibrosis, and in in-vitro. While TLL1 expression is upregulated in the liver of humans with MAFLD and in mice, the rs17047200 variant was not associated with fibrosis or any other histological features, or with hepatic TLL1 expression. In conclusion, the TLL1 rs17047200 variant is not a risk variant for fibrosis in Caucasian patients with MAFLD. However, TLL1 could be involved in the pathogenesis of liver fibrosis.	[Bayoumi, Ali; Jalil, Ismail; Metwally, Mayada; Qiao, Liang; Liddle, Christopher; George, Jacob; Eslam, Mohammed] Westmead Hosp, Storr Liver Ctr, Westmead Inst Med Res, Sydney, NSW, Australia; [Bayoumi, Ali; Jalil, Ismail; Metwally, Mayada; Qiao, Liang; Liddle, Christopher; George, Jacob; Eslam, Mohammed] Univ Sydney, Sydney, NSW, Australia; [Adams, Leon A.] Univ Western Australia, Sir Charles Gairdner Hosp Unit, Med Sch, Nedlands, WA, Australia; [Aller, Rocio] Valladolid Univ, Hosp Clin Univ Valladolid, Sch Med, Gastroenterol Svo, Valladolid, Spain; [Garcia-Monzon, Carmelo] Univ Hosp Santa Cristina, CIBERehd, Inst Invest Sanitaria Princesa, Liver Res Unit, Madrid, Spain; [Teresa Arias-Loste, Maria] Marques de Valdecilla Univ Hosp, Gastroenterol & Hepatol Dept, Santander, Spain; [Miele, Luca] Univ Cattolica Sacro Cuore, Dept Internal Med, Rome, Italy; [Petta, Salvatore; Craxi, Antonio] Univ Palermo, Sect Gastroenterol & Hepatol, PROMISE, Palermo, Italy; [Gallego-Duran, Rocio; Romero-Gomez, Manuel] Virgen del Rocio Univ Hosp, Inst Biomed Seville, Seville, Spain; [Fischer, Janett; Berg, Thomas] Univ Leipzig, Dept Med 2, Div Hepatol, Med Ctr, Leipzig, Germany; [Bugianesi, Elisabetta] Univ Turin, Dept Med Sci, Div Gastroenterol, Turin, Italy	University of Sydney; Westmead Institute for Medical Research; University of Sydney; University of Western Australia; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Hospital Universitario Marques de Valdecilla (HUMV); Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Palermo; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Leipzig University; University of Turin	George, J; Eslam, M (corresponding author), Westmead Hosp, Storr Liver Ctr, Westmead Inst Med Res, Sydney, NSW, Australia.; George, J; Eslam, M (corresponding author), Univ Sydney, Sydney, NSW, Australia.	jacob.george@sydney.edu.au; mohammed.eslam@sydney.edu.au	Romero-Gomez, Manuel/L-8030-2014; Miele, Luca/C-2255-2015	Romero-Gomez, Manuel/0000-0001-8494-8947; Miele, Luca/0000-0003-3464-0068; Bayoumi, Ali/0000-0002-4939-1351; Arias-Loste, Maria Teresa/0000-0001-8864-3833; George, Jacob/0000-0002-8421-5476	Robert W. Storr Bequest to the Sydney Medical Foundation, University of Sydney; National Health and Medical Research Council of Australia (NHMRC) [1053206, 1149976, 1107178, 1108422]; Australian Government Research Training Program (RTP) scholarship; Horizon 2020 [634413]	Robert W. Storr Bequest to the Sydney Medical Foundation, University of Sydney; National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Government Research Training Program (RTP) scholarship(Australian GovernmentDepartment of Industry, Innovation and Science); Horizon 2020	ME and JG are supported by the Robert W. Storr Bequest to the Sydney Medical Foundation, University of Sydney; National Health and Medical Research Council of Australia (NHMRC) Program Grants (1053206 and 1149976) and Project grants (1107178 and 1108422). EB is supported by Horizon 2020 under grant 634413 for the project EPoS. AB is supported by an Australian Government Research Training Program (RTP) scholarship.	Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; Buch S, 2015, NAT GENET, V47, P1443, DOI 10.1038/ng.3417; Chitturi S, 2002, HEPATOLOGY, V36, P403, DOI 10.1053/jhep.2002.34738; El Sharkawy R, 2018, ALIMENT PHARM THER, V48, P564, DOI 10.1111/apt.14866; Eslam M, 2020, HEPATOL INT, V14, P889, DOI 10.1007/s12072-020-10094-2; Eslam M, 2020, J HEPATOL, V73, P202, DOI 10.1016/j.jhep.2020.03.039; Eslam M, 2020, GASTROENTEROLOGY, V158, P1999, DOI 10.1053/j.gastro.2019.11.312; Eslam M, 2020, NAT REV GASTRO HEPAT, V17, P40, DOI 10.1038/s41575-019-0212-0; Eslam M, 2019, GASTROENTEROLOGY, V157, P590, DOI 10.1053/j.gastro.2019.05.064; Eslam M, 2018, J HEPATOL, V68, P268, DOI 10.1016/j.jhep.2017.09.003; Eslam M, 2016, HEPATOLOGY, V64, P34, DOI 10.1002/hep.28475; Eslam M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7422; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fouad Y, 2020, LIVER INT, V40, P1254, DOI 10.1111/liv.14478; John M, 2017, GASTROENTEROLOGY, V153, P1448, DOI 10.1053/j.gastro.2017.04.056; Karlsen TH, 2015, J HEPATOL, V62, pS6, DOI 10.1016/j.jhep.2015.02.025; Kazankov K, 2016, LIVER INT, V36, P1549, DOI 10.1111/liv.13150; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Loomba R, 2015, GASTROENTEROLOGY, V149, P1784, DOI 10.1053/j.gastro.2015.08.011; Mancina RM, 2016, GASTROENTEROLOGY, V150, P1219, DOI 10.1053/j.gastro.2016.01.032; Matsuura K, 2017, GASTROENTEROLOGY, V152, P1383, DOI 10.1053/j.gastro.2017.01.041; Mendez-Sanchez N, 2020, LANCET GASTROENTEROL; Scott IC, 1999, DEV BIOL, V213, P283, DOI 10.1006/dbio.1999.9383; Seko Y, 2018, J GASTROENTEROL, V53, P438, DOI 10.1007/s00535-017-1372-8; Shiha G, 2021, LANCET GASTROENTEROL, V6, P73, DOI 10.1016/S2468-1253(20)30294-6; Shiha G, 2021, LANCET GASTROENTEROL, V6, P57, DOI 10.1016/S2468-1253(20)30213-2; Thabet K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12757; Vilar-Gomez E, 2018, GASTROENTEROLOGY, V155, P443, DOI 10.1053/j.gastro.2018.04.034; Yang J, 2019, INT J CANCER, V144, P533, DOI 10.1002/ijc.31910; Younossi Z, 2018, NAT REV GASTRO HEPAT, V15, P11, DOI 10.1038/nrgastro.2017.109; Zheng Kenneth I, 2020, Chin Med J (Engl), V133, P2271, DOI 10.1097/CM9.0000000000000981	31	1	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243590	10.1371/journal.pone.0243590	http://dx.doi.org/10.1371/journal.pone.0243590			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306709	Green Published, gold			2022-12-27	WOS:000600144200028
J	Morakinyo, OM; Adebowale, AS; Obembe, TA; Oloruntoba, EO				Morakinyo, Oyewale Mayowa; Adebowale, Ayo Stephen; Obembe, Taiwo Akinyode; Oloruntoba, Elizabeth Omoladun			Association between household environmental conditions and nutritional status of women of childbearing age in Nigeria	PLOS ONE			English	Article							UNDER-5 CHILDREN; UNDERNUTRITION; HEALTH	Maternal undernutrition remains a leading cause of morbidity and mortality in Nigeria. Yet, most interventional programmes are focused on infant and child nutrition outcomes and not on maternal nutrition-related outcomes. Evidence suggests that the integration of household environmental interventions into nutrition actions can make a difference in reducing the burden of maternal undernutrition. This study examined the influence of household environmental conditions (HHEC) on the nutritional status of women of childbearing age in Nigeria using secondary data from the 2013 Nigeria Demographic and Health Survey. The original sample of 38,948 women age 15-49 years was selected using multi-stage probability sampling. The sample for the current analysis was 23,344 after exclusion of women due to health status or provision of incomplete information. The dependent and main independent variables were undernutrition (defined as Body Mass Index below 18.5) and HHEC (generated from cooking fuel, toilet type, source of drinking water, and housing materials) respectively. Data were analysed using descriptive statistics, Chi-square, and logistic regression model at 5% level of significance. The prevalence of undernutrition among women living in houses with unimproved and improved HHEC was 17.2% and 7.2% respectively. The adjusted odds of undernutrition was significantly higher among women who lived in houses with unimproved HHEC (aOR = 2.02, C.I = 1.37-2.97, p <0.001). The odds of undernutrition are greater in young women (aOR = 2.38, C.I. = 1.88-3.00, p <0.001) compared to older, and those of lower wealth status (aOR = 2.14, CI = 1.69-2.71, p <0.001) compared to higher. Other predictors of undernutrition in women of reproductive age in Nigeria include the level of education, marital status, and working status. Living in a house with unimproved environmental conditions is a predictor of undernutrition in women. The integration of environmental and nutrition programmes could assist in addressing this burden in Nigeria.	[Morakinyo, Oyewale Mayowa; Oloruntoba, Elizabeth Omoladun] Univ Ibadan, Coll Med, Fac Publ Hlth, Dept Environm Hlth Sci, Ibadan, Nigeria; [Adebowale, Ayo Stephen] Univ Ibadan, Coll Med, Fac Publ Hlth, Dept Epidemiol & Med Stat, Ibadan, Nigeria; [Obembe, Taiwo Akinyode] Univ Ibadan, Coll Med, Fac Publ Hlth, Dept Hlth Policy & Management, Ibadan, Nigeria	University of Ibadan; University of Ibadan; University of Ibadan	Morakinyo, OM (corresponding author), Univ Ibadan, Coll Med, Fac Publ Hlth, Dept Environm Hlth Sci, Ibadan, Nigeria.	omorakinyo@cartafrica.org	Obembe, Taiwo/GMW-8754-2022	Obembe, Taiwo/0000-0001-9610-1137; Morakinyo, Oyewale/0000-0001-5289-9378	Consortium for Advanced Research Training in Africa (CARTA); Carnegie Corporation of New York [B 8606.R02]; Sida [54100029]; DELTAS Africa Initiative [107768/Z/15/Z]; African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust (UK) [107768/Z/15/Z]; UK government	Consortium for Advanced Research Training in Africa (CARTA); Carnegie Corporation of New York; Sida; DELTAS Africa Initiative; African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust (UK)(Wellcome Trust); UK government	The research is supported by Consortium for Advanced Research Training in Africa (CARTA). CARTA is jointly led by the African Population and Health Research Center and the University of the Witwatersrand and funded by the Carnegie Corporation of New York (Grant No- -B 8606.R02), Sida (Grant No: 54100029), the DELTAS Africa Initiative (Grant No: 107768/Z/15/Z). The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA) and supported by the New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust (UK) (Grant No: 107768/Z/15/Z) and the UK government. The statements made and views expressed are solely the responsibility of the authors and do not represent opinions of any of the funders.	Action contre la Faim (ACF), 2011, WAT SAN HYG POL; Adebowale SA, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-016-0742-3; Aileen Croft TN, 2013, GUIDE DHS STAT; Akinyemi JO, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3207-5; Akombi BJ, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-016-0770-z; Alnsour J, 2011, JORDAN JOURNAL OF SO, V4, P339; [Anonymous], 2011, MOL CELLULAR PROTEOM, V10, pR110; [Anonymous], 2017, J MOL BIOMARKERS DIA, V8, P1, DOI [10.4172/2155-9929.S2-026, DOI 10.4172/2155-9929.S2-026, DOI 10.5334/LABPHON.19]; Bhutta ZA, 2019, AM J CLIN NUTR, V109, P249, DOI 10.1093/ajcn/nqy336; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Cairncross S, 2010, INT J EPIDEMIOL, V39, P193, DOI 10.1093/ije/dyq035; Central Statistical Agency of Ethiopia Measure DHS, 2011, ETH DEM HLTH SURV 20; Croft TN, 2018, GUIDE DHS STAT; Dangour AD, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009382.pub2; Dupree JL, 2018, SCI COMPUT PROGRAM, V152, P1, DOI 10.1016/j.scico.2017.08.010; Fagbamigbe AF, 2017, ANN MED HEALTH SCI R, V7, P119; Food and Agricultural Organization (FAO), 2006, DOUBL BURD MALN CAR; Girma W., 2002, DETERMINANTS NUTR ST; Katona P, 2008, CLIN INFECT DIS, V46, P1582, DOI 10.1086/587658; Kimbi HK, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-193; Lin A, 2013, AM J TROP MED HYG, V89, P130, DOI 10.4269/ajtmh.12-0629; Maziya-Dixon B., 2004, NIGERIA FOOD CONSUMP; Mishra V, 2007, INT J EPIDEMIOL, V36, P117, DOI 10.1093/ije/dyl234; Morakinyo OM, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2463-6; Mostafa Kamal S M Jr, 2010, Malays J Nutr, V16, P349; Mtumwa AH, 2016, S AFR J CLIN NUTR, V29, P75, DOI 10.1080/16070658.2016.1216509; Muller O, 2005, CAN MED ASSOC J, V173, P279, DOI 10.1503/cmaj.050342; Nasr NA, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-27; National Bureau of Statistics (NBS), 2014, REP NUTR HLTH SIT NI; National Bureau of Statistics Nigeria, 2018, NAT NUTR HLTH SURV N; National Population Commission Nigeria, 2001, NAT POL FOOD NUTR NI; National Population Commission of Nigeria, 2014, NIG DEM HLTH SURV 20; Pruss-Ustun A., 2006, Preventing disease through healthy environments: towards an estimate of the environmental burden of disease; Reinhardt Kristina, 2014, Front Nutr, V1, P13, DOI 10.3389/fnut.2014.00013; Rutstein S.O., 2004, DHS COMP REPORTS; Rutstein S.O., 2008, DHS WEALTH INDEX APP; Rutstein SO, 2006, GUID DHS STAT DEM HL; Scaling Up Nutritiion (SUN), 2020, INT WASH NUTR ACT; Tebekaw Y, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1126; The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team, 2020, CHINA CDC WEEKLY, V2, P1, DOI DOI 10.5194/GCHRON-2-1-2020; UNICEF, 2013, ACH IMP GLOB PROGR; UNICEF, 1998, STAT WORLDS CHILDR 1; United Nations, 2015, 17 GOALS; Welsh T, 2019, SUN MOVEMENT CONFRON; WHO UNICEF, 2010, PROGR SAN DRINK WAT; WHO/UNICEF, 2014, PROGR DRINK WAT SAN; World Health Organization, 1995, PHYS STAT US INT ANT; World Health Organization, 2015, IMPR NUTR OUTC BETT; World Health Organization (WHO), 2019, MALN IS WORLD HLTH C; Ziegelbauer K, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001162	50	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243356	10.1371/journal.pone.0243356	http://dx.doi.org/10.1371/journal.pone.0243356			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306726	Green Published, gold			2022-12-27	WOS:000600144200017
J	Grillo, M; Palmer, C; Holmes, N; Sang, F; Larner, AC; Bhosale, R; Shaw, PE				Grillo, Michela; Palmer, Carolyn; Holmes, Nadine; Sang, Fei; Larner, Andrew C.; Bhosale, Rahul; Shaw, Peter E.			Stat3 oxidation-dependent regulation of gene expression impacts on developmental processes and involves cooperation with Hif-1 alpha	PLOS ONE			English	Article							MAMMARY EPITHELIAL-CELLS; SIGNAL TRANSDUCER; BINDING-SITES; UNPHOSPHORYLATED STAT3; VEGF EXPRESSION; TARGET GENES; TRANSCRIPTION; ACTIVATION; GROWTH; TRANSFORMATION	Reactive oxygen species are bona fide intracellular second messengers that influence cell metabolism and aging by mechanisms that are incompletely resolved. Mitochondria generate superoxide that is dis-mutated to hydrogen peroxide, which in turn oxidises cysteine-based enzymes such as phosphatases, peroxiredoxins and redox-sensitive transcription factors to modulate their activity. Signal Transducer and Activator of Transcription 3 (Stat3) has been shown to participate in an oxidative relay with peroxiredoxin II but the impact of Stat3 oxidation on target gene expression and its biological consequences remain to be established. Thus, we created murine embryonic fibroblasts (MEFs) that express either WT-Stat3 or a redox-insensitive mutant of Stat3 (Stat3-C3S). The Stat3-C3S cells differed from WT-Stat3 cells in morphology, proliferation and resistance to oxidative stress; in response to cytokine stimulation, they displayed elevated Stat3 tyrosine phosphorylation and Socs3 expression, implying that Stat3-C3S is insensitive to oxidative inhibition. Comparative analysis of global gene expression in WT-Stat3 and Stat3-C3S cells revealed differential expression (DE) of genes both under basal conditions and during oxidative stress. Using differential gene regulation pattern analysis, we identified 199 genes clustered into 10 distinct patterns that were selectively responsive to Stat3 oxidation. GO term analysis identified down-regulated genes to be enriched for tissue/organ development and morphogenesis and up-regulated genes to be enriched for cell-cell adhesion, immune responses and transport related processes. Although most DE gene promoters contain consensus Stat3 inducible elements (SIEs), our chromatin immunoprecipitation (ChIP) and ChIP-seq analyses did not detect Stat3 binding at these sites in control or oxidant-stimulated cells, suggesting that oxidised Stat3 regulates these genes indirectly. Our further computational analysis revealed enrichment of hypoxia response elements (HREs) within DE gene promoters, implying a role for Hif-1. Experimental validation revealed that efficient stabilisation of Hif-1 alpha in response to oxidative stress or hypoxia required an oxidation-competent Stat3 and that depletion of Hif-1 alpha suppressed the inducible expression of Kcnb1, a representative DE gene. Our data suggest that Stat3 and Hif-1 alpha cooperate to regulate genes involved in immune functions and developmental processes in response to oxidative stress.	[Grillo, Michela; Palmer, Carolyn; Shaw, Peter E.] Univ Nottingham, Sch Life Sci, Queens Med Ctr, Nottingham, England; [Holmes, Nadine; Sang, Fei] Univ Nottingham, Queens Med Ctr, Sch Life Sci, Deep Seq Unit, Nottingham, England; [Larner, Andrew C.] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Massey Canc Ctr, Richmond, VA USA; [Bhosale, Rahul] Univ Nottingham, Sch Biosci, Loughborough, England	University of Nottingham; University of Nottingham; Virginia Commonwealth University; University of Nottingham	Shaw, PE (corresponding author), Univ Nottingham, Sch Life Sci, Queens Med Ctr, Nottingham, England.	peter.shaw1@nottingham.ac.uk		Sang, Fei/0000-0002-8746-5868; Bhosale, Rahul/0000-0001-6515-4922	British Heart Foundation [FS/11/58/28937, FS/15/43/3156]; BBSRC Discovery Fellowship [BB/S011102/1]; University of Nottingham Future Food Beacon of Excellence Nottingham Research; Massey Cancer Center; NIH [R01GM129260]	British Heart Foundation(British Heart Foundation); BBSRC Discovery Fellowship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Nottingham Future Food Beacon of Excellence Nottingham Research; Massey Cancer Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded with British Heart Foundation PhD Fellowships to CP (FS/11/58/28937) and MG (FS/15/43/3156); RB is supported by a BBSRC Discovery Fellowship (BB/S011102/1) and University of Nottingham Future Food Beacon of Excellence Nottingham Research. Work from ACL's lab was funded by the Massey Cancer Center and a grant from NIH (R01GM129260). https://www.bhf.org.uk/https://bbsrc.ukri.org/https://www.nih.gov/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acker T, 2006, CARDIOVASC RES, V71, P195, DOI 10.1016/j.cardiores.2006.04.008; Alvarez JV, 2005, CANCER RES, V65, P5054, DOI 10.1158/0008-5472.CAN-04-4281; ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; [Anonymous], 2011, AM J PHYSIOL-HEART C, V301, pH287; Azare J, 2007, MOL CELL BIOL, V27, P4444, DOI 10.1128/MCB.02404-06; Barry SP, 2013, INT J CARDIOL, V163, P326, DOI 10.1016/j.ijcard.2011.08.849; Bhakat KK, 2009, ANTIOXID REDOX SIGN, V11, P621, DOI [10.1089/ars.2008.2198, 10.1089/ARS.2008.2198]; Boengler K, 2010, BASIC RES CARDIOL, V105, P771, DOI 10.1007/s00395-010-0124-1; Boyden LM, 2020, AM J HUM GENET, V107, P158, DOI 10.1016/j.ajhg.2020.05.013; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Cadenas S, 2018, FREE RADICAL BIO MED, V117, P76, DOI 10.1016/j.freeradbiomed.2018.01.024; Cai Z, 2008, CARDIOVASC RES, V77, P463, DOI 10.1093/cvr/cvm035; Calautti E, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010171; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Clarkson RWE, 2006, MOL ENDOCRINOL, V20, P675, DOI 10.1210/me.2005-0392; Cui Y, 2016, ONCOL REP, V36, P108, DOI 10.3892/or.2016.4822; Dechow TN, 2004, P NATL ACAD SCI USA, V101, P10602, DOI 10.1073/pnas.0404100101; Demaria M, 2010, AGING-US, V2, P823, DOI 10.18632/aging.100232; Dodd KM, 2015, ONCOGENE, V34, P2239, DOI 10.1038/onc.2014.164; Dong Q, 2012, BOSNIAN J BASIC MED, V12, P158, DOI 10.17305/bjbms.2012.2463; Fishel ML, 2015, J BIOL CHEM, V290, P3057, DOI 10.1074/jbc.M114.621995; Foxler DE, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708304; Galbraith MD, 2013, NUCLEIC ACIDS RES, V41, P10241, DOI 10.1093/nar/gkt837; Gray MJ, 2005, ONCOGENE, V24, P3110, DOI 10.1038/sj.onc.1208513; Hilfiker-Kleiner D, 2004, CIRC RES, V95, P187, DOI 10.1161/01.RES.0000134921.50377.61; Hirahara K, 2010, CYTOKINE GROWTH F R, V21, P425, DOI 10.1016/j.cytogfr.2010.10.006; Hoang LT, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0102-6; Hu HX, 2017, P NATL ACAD SCI USA, V114, P11908, DOI 10.1073/pnas.1704723114; Jacoby JJ, 2003, P NATL ACAD SCI USA, V100, P12929, DOI 10.1073/pnas.2134694100; Jung JE, 2005, FASEB J, V19, P1296, DOI 10.1096/fj.04-3099fje; Jung JE, 2008, EXP MOL MED, V40, P479, DOI 10.3858/emm.2008.40.5.479; Kang K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-4; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Li L, 2006, J BIOL CHEM, V281, P33172, DOI 10.1074/jbc.M606940200; Li L, 2010, CANCER RES, V70, P8222, DOI 10.1158/0008-5472.CAN-10-0894; Lin L, 2004, SCIENCE, V303, P1017, DOI 10.1126/science.1093889; Lufei CC, 2003, EMBO J, V22, P1325, DOI 10.1093/emboj/cdg135; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Malhotra D, 2010, NUCLEIC ACIDS RES, V38, P5718, DOI 10.1093/nar/gkq212; Mehta NU, 2016, ARTERIOSCL THROM VAS, V36, P1152, DOI 10.1161/ATVBAHA.115.306991; Meier JA, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aag2588; Minegishi Y, 2007, NATURE, V448, P1058, DOI 10.1038/nature06096; Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016; Na HK, 2006, MOL CARCINOGEN, V45, P368, DOI 10.1002/mc.20225; Nakai S, 2003, DEVELOPMENT, V130, P4751, DOI 10.1242/dev.00666; Nathan C, 2013, NAT REV IMMUNOL, V13, P349, DOI 10.1038/nri3423; Nechemia-Arbely Y, 2013, CLIN EXP PHARMACOL P, V40, P262, DOI 10.1111/1440-1681.12064; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Pawlus MR, 2014, ONCOGENE, V33, P1670, DOI 10.1038/onc.2013.115; Paz K, 2004, ONCOGENE, V23, P8455, DOI 10.1038/sj.onc.1207803; Poli V, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00121; Pott S, 2015, NAT GENET, V47, P8, DOI 10.1038/ng.3167; Roder K, 2006, BIOL CHEM, V387, P1237, DOI 10.1515/BC.2006.153; Sakamoto T, 2020, CIRC RES, V126, P1685, DOI 10.1161/CIRCRESAHA.119.316100; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Sekkai D, 2005, STEM CELLS, V23, P1634, DOI 10.1634/stemcells.2005-0182; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Sesti F, 2016, AGING DIS, V7, P130, DOI 10.14336/AD.2015.0901; Shah NH, 2014, TRANSL STROKE RES, V5, P38, DOI 10.1007/s12975-013-0297-7; Smith RM, 2004, CARDIOVASC RES, V63, P611, DOI 10.1016/j.cardiores.2004.06.019; Snyder M, 2008, J BIOL CHEM, V283, P3791, DOI 10.1074/jbc.M706976200; Sobotta MC, 2015, NAT CHEM BIOL, V11, P64, DOI 10.1038/nchembio.1695; Speca DJ, 2014, GENES BRAIN BEHAV, V13, P394, DOI 10.1111/gbb.12120; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Suply T, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aal0180; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Tammineni P, 2013, J BIOL CHEM, V288, P4723, DOI 10.1074/jbc.M112.378984; Tempel D, 2012, CIRC RES, V111, P585, DOI 10.1161/CIRCRESAHA.111.262097; Torbica T, 2019, J INVEST DERMATOL, V139, P1583, DOI 10.1016/j.jid.2018.12.030; Vallania F, 2009, P NATL ACAD SCI USA, V106, P5117, DOI 10.1073/pnas.0900473106; Vougier S, 2007, BIOCHEM BIOPH RES CO, V364, P627, DOI 10.1016/j.bbrc.2007.10.044; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Xu L, 2015, NUCLEIC ACIDS RES, V43, P8898, DOI 10.1093/nar/gkv911; Xu Q, 2005, ONCOGENE, V24, P5552, DOI 10.1038/sj.onc.1208719; Yang JB, 2007, GENE DEV, V21, P1396, DOI 10.1101/gad.1553707; Yue H, 2010, CARDIOVASC RES, V85, P90, DOI 10.1093/cvr/cvp285; Zhang J, 2003, P NATL ACAD SCI USA, V100, P9342, DOI 10.1073/pnas.1633516100	78	2	2	5	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0244255	10.1371/journal.pone.0244255	http://dx.doi.org/10.1371/journal.pone.0244255			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332446	Green Published, gold			2022-12-27	WOS:000601310900098
J	Hajarian, N; Sobhani, FM; Sadjadi, SJ				Hajarian, Nastaran; Movahedi Sobhani, Farzad; Sadjadi, Seyed Jafar			An improved approach for fault detection by simultaneous overcoming of high-dimensionality, autocorrelation, and time-variability	PLOS ONE			English	Article							PCA	The control charts with the Principal Component Analysis (PCA) approach and its extension are among the data-driven methods for process monitoring and the detection of faults. Industrial processing data involves complexities such as high dimensionality, auto-correlation, and non-stationary which may occur simultaneously. An efficient fault detection technique is an approach that is robust against data training, sensitive to all the feasible faults of the process, and agile to the detection of the faults. To date, approaches such as the recursive PCA (RPCA) model and the moving-window PCA (MWPCA) model have been proposed when data is high-dimensional and non-stationary or dynamic PCA (DPCA) model and its extension have been suggested for autocorrelation data. But, using the techniques listed without considering all aspects of the process data increases fault detection indicators such as false alarm rate (FAR), delay time detection (DTD), and confuses the operator or causes adverse consequences. A new PCA monitoring method is proposed in this study, which can simultaneously reduce the impact of high-dimensionality, non-stationary, and autocorrelation properties. This technique utilizes DPCA property to decrease the effect of autocorrelation and adaptive behavior of MWPCA to control non-stationary characteristics. The proposed approach has been tested on the Tennessee Eastman Process (TEP). The findings suggest that the proposed approach is capable of detecting various forms of faults and comparing attempts to improve the detection of fault indicators with other approaches. The empirical application of the proposed approach has been implemented on a turbine exit temperature (TET). The results demonstrate that the proposed approach has detected a real fault successfully.	[Hajarian, Nastaran; Movahedi Sobhani, Farzad] Islamic Azad Univ, Sci & Res Branch, Dept Ind Engn, Tehran, Iran; [Sadjadi, Seyed Jafar] Iran Univ Sci & Technol, Dept Ind Engn, Tehran, Iran	Islamic Azad University; Iran University Science & Technology	Sobhani, FM (corresponding author), Islamic Azad Univ, Sci & Res Branch, Dept Ind Engn, Tehran, Iran.	fmovahedi@iau.ac.ir	Sadjadi, Seyed Jafar/S-8969-2018; Hajarian, Nastaran/AAN-7891-2021	Sadjadi, Seyed Jafar/0000-0002-9069-5453; Movahedi sobhani, Farzad/0000-0002-4602-2710				Alzghoul A, 2014, COMPUT IND, V65, P1126, DOI 10.1016/j.compind.2014.06.003; Ammiche M, 2018, ONLINE THRESHOLDING; Ammiche M, 2018, CHEM ENG SCI, V187, P269, DOI 10.1016/j.ces.2018.05.001; [Anonymous], 1997, ILM, V37, P1; Bin He X, 2008, IND ENG CHEM RES, V47, P419, DOI 10.1021/ie070712z; Chiang L.H., 2000, DATA DRIVEN METHODS; De Ketelaere B, 2016, QUAL ENG, V28, P127, DOI 10.1080/08982112.2015.1100474; de Ketelaere B, 2015, J QUAL TECHNOL, V47, P318, DOI 10.1080/00224065.2015.11918137; Ding SX, 2014, ADV IND CONTROL, P1, DOI 10.1007/978-1-4471-6410-4; DOWNS JJ, 1993, COMPUT CHEM ENG, V17, P245, DOI 10.1016/0098-1354(93)80018-I; Fan CM, 2008, 2008 WINTER SIMULATION CONFERENCE, VOLS 1-5, P2323, DOI 10.1109/WSC.2008.4736337; Gao Y, 2016, CHEMOMETR INTELL LAB, V158, P102, DOI 10.1016/j.chemolab.2016.07.005; Huang J, 2015, CHEMOMETR INTELL LAB, V148, P115, DOI 10.1016/j.chemolab.2015.09.010; Ie A, 2006, EN TECHN PERSP SCEN; Jackson J.E, 2005, USERS GUIDE PRINCIPA, V587; Jaffel I, 2016, ISA T, V64, P184, DOI 10.1016/j.isatra.2016.06.002; Jaffel I, 2015, INT J ADV MANUF TECH, V80, P947, DOI 10.1007/s00170-015-7094-2; Jeng JC, 2010, J TAIWAN INST CHEM E, V41, P475, DOI 10.1016/j.jtice.2010.03.015; Jolliffe IT, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0202; Klyuzhin IS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206607; Kruger U., 2012, STAT MONITORING COMP, DOI [10.1002/9780470517253, DOI 10.1002/9780470517253]; Ku WF, 1995, CHEMOMETR INTELL LAB, V30, P179, DOI 10.1016/0169-7439(95)00076-3; Li W, 2018, ANN NUCL ENERGY, V118, P131, DOI 10.1016/j.anucene.2018.04.012; Li WH, 2000, J PROCESS CONTR, V10, P471, DOI 10.1016/S0959-1524(00)00022-6; Ma JZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040115; Rato T, 2016, AICHE J, V62, P1478, DOI 10.1002/aic.15062; Rato TJ, 2013, CHEMOMETR INTELL LAB, V125, P74, DOI 10.1016/j.chemolab.2013.03.009; Russell E.L., 2012, DATA DRIVEN METHODS; Russell EL, 2000, CHEMOMETR INTELL LAB, V51, P81, DOI 10.1016/S0169-7439(00)00058-7; Sankavaram C, 2009, IEEE INT CON AUTO SC, P96, DOI 10.1109/COASE.2009.5234108; Sumana C, 2012, INT J ADV ENG SCI AP, V4, P52, DOI 10.1007/s12572-012-0060-4; Valle S, 1999, IND ENG CHEM RES, V38, P4389, DOI 10.1021/ie990110i; Vanhatalo E, 2017, CHEMOMETR INTELL LAB, V167, P1, DOI 10.1016/j.chemolab.2017.05.016; Wang X, 2005, IND ENG CHEM RES, V44, P5691, DOI 10.1021/ie048873f; Woodall WH, 2014, J QUAL TECHNOL, V46, P78, DOI 10.1080/00224065.2014.11917955; Yin S, 2012, DATA DRIVEN DESIGN F; Zhang YM, 2008, ANNU REV CONTROL, V32, P229, DOI 10.1016/j.arcontrol.2008.03.008	37	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243146	10.1371/journal.pone.0243146	http://dx.doi.org/10.1371/journal.pone.0243146			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332390	Green Published, gold			2022-12-27	WOS:000601310900002
J	Hasan, NI; Taib, AM; Muhammad, NS; Yazid, MRM; Mutalib, AA; Hasbollah, DZA				Hasan, Noor Ibrahim; Mohd Taib, Aizat; Muhammad, Nur Shazwani; Mat Yazid, Muhamad Razuhanafi; Mutalib, Azrul A.; Abang Hasbollah, Dayang Zulaika			Effectiveness of strip footing with geogrid reinforcement for different types of soils in Mosul, Iraq	PLOS ONE			English	Article							ULTIMATE BEARING CAPACITY; SAND; BEHAVIOR; MODEL; FOUNDATIONS; SETTLEMENT; DESIGN	The main cause of problematic soil failure under a certain load is due to low bearing capacity and excessive settlement. With a growing interest in employing shallow foundation to support heavy structures, it is important to study the soil improvement techniques. The technique of using geosynthetic reinforcement is commonly applied over the last few decades. This paper aims to determine the effect of using geogrid Tensar BX1500 on the bearing capacity and settlement of strip footing for different types of soils, namely Al-Hamedat, Ba'shiqah, and Al-Rashidia in Mosul, Iraq. The analysis of reinforced and unreinforced soil foundations was conducted numerically and analytically. A series of conditions were tested by varying the number (N) and the width (b) of the geogrid layers. The results showed that the geogrid could improve the footing's bearing capacity and reduce settlement. The soil of the Al-Rashidia site was sandy and indicated better improvement than the other two sites' soils (clayey soils). The optimum geogrid width (b) was five times the footing width (B), while no optimum geogrid number (N) was obtained. Finally, the numerical results of the ultimate bearing capacity were compared with the analytical results, and the comparison showed good agreement between both the analyses and the optimum range published in the literature. The significant findings reveal that the geogrid reinforcement may induce improvement to the soil foundation, however, not directly subject to the width and number of the geogrid alone. The varying soil properties and footing size also contribute to both BCR and SRR values supported by the improvement factor calculations. Hence, the output complemented the benefit of applying reinforced soil foundations effectively.	[Hasan, Noor Ibrahim; Mohd Taib, Aizat; Muhammad, Nur Shazwani; Mat Yazid, Muhamad Razuhanafi; Mutalib, Azrul A.] Univ Kebangsaan Malaysia, Fac Engn & Built Environm, Bangi Ukm, Selangor, Malaysia; [Abang Hasbollah, Dayang Zulaika] Univ Teknol Malaysia, Sch Civil Engn, Fac Engn, Skudai, Johor, Malaysia	Universiti Kebangsaan Malaysia; Universiti Teknologi Malaysia	Taib, AM (corresponding author), Univ Kebangsaan Malaysia, Fac Engn & Built Environm, Bangi Ukm, Selangor, Malaysia.	amohdtaib@ukm.edu.my	Hasbollah, Dayang Zulaika Abang/AAL-7628-2021; Mohd Taib, Aizat/GLN-4759-2022	Mohd Taib, Aizat/0000-0002-0307-3016	Universiti Kebangsaan Malaysia [GGPM-2018-039]	Universiti Kebangsaan Malaysia	Initials of author: AMT Grant number: GGPM-2018-039 Funder: Universiti Kebangsaan Malaysia URL: https://www.ukm.my/portal/Sponsors role: Pay publication fees and provide project equipment.	Adams M. T., 1997, J GEOTECHNICAL GEOEN, V123; Ahmed A, 2008, GEOTECHNICAL ENGINEERING FOR DISASTER MITIGATION AND REHABILITATION, P1003, DOI 10.1007/978-3-540-79846-0_133; Akinmusuru J. O., 1981, J GEOTECHNICAL GEOEN, V107; Alawaji H. A., 1998, J KING SAUD U ENG SC, V10; [Anonymous], 2012, Kidney Int Suppl (2011), V2, P156; [Anonymous], 2008, ELECTRON J GEOTECH E; [Anonymous], 1883, APPL POTENTIALS ETUD; [Anonymous], 2009, DIABETES CARE S1, V27, ps5; [Anonymous], 2003, FRONT BIOSCI J VIS L, V8, pd1128; [Anonymous], 1997, J ENERGY NATURAL RES, V15, P313; [Anonymous], 2017, CIRC RES, V120, pe6; Azrief M., 2019, EAGE GSM 2 AS PAC M; Azzam WR, 2015, J ADV RES, V6, P727, DOI 10.1016/j.jare.2014.04.003; Binquet J., 1975, J GEOTECHNICAL GEOEN, V101; Boushehrian AH, 2011, GEOTEXT GEOMEMBRANES, V29, P242, DOI 10.1016/j.geotexmem.2010.11.008; Brinkgreve R., 2014, PLAXIS 2014; Brinkgreve R. B. J., 1998, FINITE ELEMENT CODE; Chen Q., 2011, ASCE P GEOFR 2011 C; Chen QM, 2007, TRANSPORT RES REC, P28, DOI 10.3141/2004-04; Chen QM, 2015, SOILS FOUND, V55, P74, DOI 10.1016/j.sandf.2014.12.006; Chik Z, 2014, ARAB J GEOSCI, V7, P4877, DOI 10.1007/s12517-013-1128-6; Das B. M., 1996, INT SOC OFFSH POL EN; El Sawwaf MA, 2007, GEOTEXT GEOMEMBRANES, V25, P50, DOI 10.1016/j.geotexmem.2006.06.001; Gabr M. A., 1998, GEOSYNTHETICS FDN RE; Goldscheider M, 1982, WORKSH CONST REL SOI, P11; GUIDO VA, 1986, CAN GEOTECH J, V23, P435, DOI 10.1139/t86-073; Han J, 2011, J MATER CIVIL ENG, V23, P1525, DOI 10.1061/(ASCE)MT.1943-5533.0000286; HUANG CC, 1990, GEOTEXT GEOMEMBRANES, V9, P51, DOI 10.1016/0266-1144(90)90005-W; Huang ZF, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229532; Hussein MG, 2016, GEOTEXT GEOMEMBRANES, V44, P295, DOI 10.1016/j.geotexmem.2015.12.004; JohSungHo, 2011, [JOURNAL OF THE KOREAN SOCIETY FOR RAILWAY, 한국철도학회논문집], V14, P256; Khajehzadeh M, 2011, J ZHEJIANG UNIV-SC A, V12, P415, DOI 10.1631/jzus.A1000252; KHING KH, 1993, GEOTEXT GEOMEMBRANES, V12, P351, DOI 10.1016/0266-1144(93)90009-D; Kumar N., 2012, AM J MAT SCI, V2, P41, DOI DOI 10.5923/j.materials.20120201.08; Kurian NP, 1997, J GEOTECH GEOENVIRON, V123, P818, DOI 10.1061/(ASCE)1090-0241(1997)123:9(818); Lee K., 2011, CANADIAN GEOTECHNICA, V36, P793; Leshchinsky D, 2009, J GEOTECH GEOENVIRON, V135, P309, DOI 10.1061/(ASCE)1090-0241(2009)135:3(309); Li YP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206626; Liu SY, 2008, GEOSYNTH INT, V15, P43, DOI 10.1680/gein.2008.15.1.43; LOVE JP, 1987, CAN GEOTECH J, V24, P611, DOI 10.1139/t87-075; MANDAL JN, 1992, GEOTEXT GEOMEMBRANES, V11, P327, DOI 10.1016/0266-1144(92)90007-W; Meyerhof G. G, 1963, ULTIMATE BEARING CAP; Michalowski RL, 2004, J GEOTECH GEOENVIRON, V130, P381, DOI 10.1061/(ASCE)1090-0241(2004)130:4(381); OMAR MT, 1993, CAN GEOTECH J, V30, P545, DOI 10.1139/t93-046; Pelton M. R., 1994, P E WORKSH BLACK RES, V12, P133; Raftari M., 2013, ELECT J GEOTECHNICAL, V18; Ren Y., 2015, IMMEDIATE LOAD SETTL; Rosyidi SA, 2010, J KEJURUTER, V22, P75, DOI 10.17576/jkukm-2010-22-08; Rowe RK, 2008, GEOTEXT GEOMEMBRANES, V26, P239, DOI 10.1016/j.geotexmem.2007.10.001; Sakti J. P., 1987, TRANSPORTATION RES B; Sharma R, 2009, GEOTEXT GEOMEMBRANES, V27, P63, DOI 10.1016/j.geotexmem.2008.07.002; Shin E.C., 1993, GEOTECH TEST J, V16, P534, DOI DOI 10.1520/GTJ10293J; Sieira ACF, 2016, INT J ENG RES APPL, V6, P15; TRAUTMANN CH, 1988, J GEOTECH ENG-ASCE, V114, P168, DOI 10.1061/(ASCE)0733-9410(1988)114:2(168); Vidal M. H, 1978, P S EARTH REINF ASCE, P1; Wang C, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220643; Wang JQ, 2018, GEOTEXT GEOMEMBRANES, V46, P586, DOI 10.1016/j.geotexmem.2018.04.009; Wang YK, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227957; Wayne M. H., 1998, DESIGN GEOSYNTHETIC; Xie LQ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211312; Yang K.-H., 2013, J GEO ENG, V8, P41, DOI DOI 10.6310/JOG.2013.8(2).2; YETIMOGLU T, 1994, J GEOTECH ENG-ASCE, V120, P2083, DOI 10.1061/(ASCE)0733-9410(1994)120:12(2083); Zhou HB, 2008, GEOTEXT GEOMEMBRANES, V26, P231, DOI 10.1016/j.geotexmem.2007.10.002; Zornberg JG, 2003, P INT S EARTH REINF, V2, P1095	64	1	1	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243293	10.1371/journal.pone.0243293	http://dx.doi.org/10.1371/journal.pone.0243293			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332375	Green Published, gold			2022-12-27	WOS:000601310900113
J	Titinchi, F; Morkel, J				Titinchi, Fadi; Morkel, Jean			Residual cyst of the jaws: A clinico-pathologic study of this seemingly inconspicuous lesion	PLOS ONE			English	Article							ODONTOGENIC CYST; PREVALENCE	Objectives Residual cysts are relatively rare inflammatory cysts of the jaws. They are essentially radicular cysts without the presence of the offending dentition. These lesions have the ability to destroy bone within the jaws without any symptoms. Moreover, they can mimic more aggressive cysts and tumours on radiographs. The aim of this study was to describe the clinico-pathological features of residual cysts in order to discern them from other cystic lesions as well as analyse their management and recurrence patterns. Materials and methods Sixty-four histopathologically confirmed residual cysts were analysed based on their clinical, radiological and histopathological features. Their management and follow-up were also noted. Results The majority of lesions presented in elderly (46.8%), edentulous patients (60.9%) and were most commonly found in the posterior regions of the mandible (51.6%). Clinico-pathological features that aided in their diagnosis included long-standing history with slow growing swelling and presence of well-defined, unilocular cystic lesion associated with previously extracted dentition. Enucleation was a successful method in the management of residual cysts with very low recurrence rate (1.6%). Two patients (3.1%) developed squamous cell carcinoma from the cyst lining. Conclusion Residual cysts should be high on the list of differential diagnosis when elderly, edentulous patients present with cystic lesions in the jaws compared to dentate patients (P<0.01). All lesions should by biopsied and sent for histopathological examination along with radiological correlation as they have the potential to transform into primary intra-osseous squamous cell carcinoma with devastating consequences to the patient.	[Titinchi, Fadi; Morkel, Jean] Univ Western Cape, Tygerberg Oral Hlth Ctr, Dept Maxillofacial & Oral Surg, Fac Dent, Cape Town, South Africa; [Titinchi, Fadi; Morkel, Jean] Univ Western Cape, Tygerberg Oral Hlth Ctr, WHO Collaborating Ctr, Cape Town, South Africa	University of Limpopo; University of the Western Cape; University of the Western Cape; World Health Organization	Titinchi, F (corresponding author), Univ Western Cape, Tygerberg Oral Hlth Ctr, Dept Maxillofacial & Oral Surg, Fac Dent, Cape Town, South Africa.	ftitinchi@uwc.ac.za	Titinchi, Fadi/ABI-3758-2020	Titinchi, Fadi/0000-0003-3182-7038				Acikgoz A, 2012, MED ORAL PATOL ORAL, V17, pE108, DOI 10.4317/medoral.17088; Allon DM, 2015, J ORAL MAXIL SURG, V73, P649, DOI 10.1016/j.joms.2014.10.024; [Anonymous], 2011, NAT PHOTONICS, p[5, 15]; [Anonymous], 2014, THEORETICAL EMPIRICA, V1, P24; Avelar Rafael L, 2009, J Oral Sci, V51, P581; Bodner L, 2011, BRIT J ORAL MAX SURG, V49, P643, DOI 10.1016/j.bjoms.2010.10.009; Bodner L, 2011, J ORAL PATHOL MED, V40, P733, DOI 10.1111/j.1600-0714.2011.01058.x; Boffano P, 2010, J CRANIOFAC SURG, V21, P270, DOI 10.1097/SCS.0b013e3181c5a42b; Enislidis G, 2004, BRIT J ORAL MAX SURG, V42, P546, DOI 10.1016/j.bjoms.2004.06.020; Fomete Benjamin, 2016, Oman Med J, V31, P434, DOI 10.5001/omj.2016.87; HIGH AS, 1986, J ORAL PATHOL MED, V15, P524, DOI 10.1111/j.1600-0714.1986.tb00570.x; Hu KS, 1989, KOREAN J ORAL MAXILL, V19, P163; Jamdade A, 2012, CASE REP DENT, V2012, DOI 10.1155/2012/760571; Kambalimath DH, 2014, J MAXILLOFAC ORAL SU, V13, P10, DOI 10.1007/s12663-012-0450-y; Khosravi Negin, 2013, Dent Res J (Isfahan), V10, P162; Ledesma-Montes C, 2000, ARCH MED RES, V31, P373, DOI 10.1016/S0188-4409(00)00069-2; Mosqueda-Taylor A, 2002, Med Oral, V7, P89; Nortjé Christoffel J, 2020, S. Afr. dent. j., V75, P100, DOI 10.17159/2519-0105/2020/v75no2a7; Nunez-Urrutia S, 2010, MED ORAL PATOL ORAL, V15, pE767, DOI 10.4317/medoral.15.e767; Ochsenius German, 2007, Med Oral Patol Oral Cir Bucal, V12, pE85; Schaffer AB, 1997, ORAL SURG ORAL MED O, V83, P640, DOI 10.1016/S1079-2104(97)90309-7; Shear M., 2007, CYSTS ORAL MAXILLOFA, P123; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Sridevi K, 2014, J CLIN DIAGN RES, V8, P246, DOI 10.7860/JCDR/2014/7593.4072; Torul D., 2018, BALK J DENT MED, V22, P171; Tsvetanov TS., 2016, INT J MED DENT SCI, V1, P1341	26	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0244250	10.1371/journal.pone.0244250	http://dx.doi.org/10.1371/journal.pone.0244250			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332452	Green Published, gold			2022-12-27	WOS:000601310900093
J	Linscheid, LJ; Holliday, EB; Ahmed, A; Somerson, JS; Hanson, S; Jagsi, R; Deville, C				Linscheid, Laura J.; Holliday, Emma B.; Ahmed, Awad; Somerson, Jeremy S.; Hanson, Summer; Jagsi, Reshma; Deville, Curtiland, Jr.			Women in academic surgery over the last four decades	PLOS ONE			English	Article							GENDER-DIFFERENCES	Objective As the number of female medical students and surgical residents increases, the increasing number of female academic surgeons has been disproportionate. The purpose of this brief report is to evaluate the AAMC data from 1969 to 2018 to compare the level of female academic faculty representation for surgical specialties over the past four decades. Design The number of women as a percentage of the total surgeons per year were recorded for each year from 1969-2018, the most recent year available. Descriptive statistics were performed. Poisson regression examined the percentage of women in each field as the outcome of interest with the year and specialty (using general surgery as a reference) as two predictor variables. Setting Data from the American Association of Medical Colleges (AAMC). Participants All full-time academic faculty physicians in the specialties of obstetrics and gynecology (OB/GYN), general surgery, ophthalmology, otolaryngology (ENT), plastic surgery, plastic surgery, urology, neurosurgery, orthopaedic surgery and cardiothoracic surgery as per AAMC records. Results The percentage of women in surgery for all specialties evaluated increased from 1969 to 2018 (OR 1.04, p<0.001). Compared with general surgery, the rate of yearly percentage change increased more slowly in neurosurgery (OR 0.84; P = .004), orthopaedic surgery (OR 0.82; P = .002), urology (OR 0.59; P < .001), and cardiothoracic surgery (OR 0.38; P < .001). There was no significant difference in the rate of yearly percentage change for plastic surgery (OR 1.01; P = .840). The rate of yearly percentage change increased more rapidly in OB/GYN (OR 2.86; P < .001), ophthalmology (OR 1.79; P < .001) and ENT (OR 1.70; P < .001). Conclusions Representation of women in academic surgery is increasing overall but is increasing more slowly in orthopaedic surgery, neurosurgery, cardiothoracic surgery and urology compared with that in general surgery. These data may be used to inform and further the discussion of how mentorship and sponsorship of female students and trainees interested in surgical careers may improve gender equity in the future.	[Linscheid, Laura J.; Somerson, Jeremy S.; Deville, Curtiland, Jr.] Univ Texas Med Branch, Dept Orthopaed Surg & Rehabil, Galveston, TX 77555 USA; [Holliday, Emma B.] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA; [Ahmed, Awad] MercyOne, Dept Radiat Oncol, Waterloo, IA USA; [Hanson, Summer] Univ Texas MD Anderson Canc Ctr, Dept Plast Surg, Houston, TX 77030 USA; [Jagsi, Reshma] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA; [Deville, Curtiland, Jr.] Johns Hopkins Kimmel Canc Ctr, Dept Radiat Oncol, Baltimore, MD 21231 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Michigan System; University of Michigan; Johns Hopkins University; Johns Hopkins Medicine	Deville, C (corresponding author), Johns Hopkins Kimmel Canc Ctr, Dept Radiat Oncol, Baltimore, MD 21231 USA.	cdeville@jhmi.edu	Deville, Curtiland/B-2819-2013	Deville, Curtiland/0000-0003-4846-6486				AAMC Physician Masterfile, 2017, AAMC PHYS MAST ACT P; Baptiste D, 2017, J SURG RES, V218, P99, DOI 10.1016/j.jss.2017.05.075; Barnes K Lauren, 2019, J Surg Educ, V76, pe1, DOI 10.1016/j.jsurg.2019.07.024; Battaglia F, 2018, J AM COLL SURGEONS, V227, pE126, DOI 10.1016/j.jamcollsurg.2018.08.340; Camacci ML, 2020, JAMA OPHTHALMOL, V138, P451, DOI 10.1001/jamaophthalmol.2020.0164; Carr PL, 2017, WOMEN HEALTH ISS, V27, P374, DOI 10.1016/j.whi.2016.11.003; Chapman CH, 2019, MED EDUC ONLINE, V24, DOI 10.1080/10872981.2019.1624132; Faucett EA, 2017, AM J SURG, V214, P640, DOI 10.1016/j.amjsurg.2017.07.005; Furnas HJ, 2018, PLAST RECONSTR SURG, V142, P252, DOI 10.1097/PRS.0000000000004478; Gupta P., 2015, OPHTHALMOL MANAGE, V19, P28; Hill RG, 2021, LARYNGOSCOPE, V131, P731, DOI 10.1002/lary.28958; in ' t Veld EAH, 2017, AESTHET SURG J, V37, P466, DOI 10.1093/asj/sjw180; Majumdar S K, 2000, Bull Indian Inst Hist Med Hyderabad, V30, P59; Okafor S, 2020, LARYNGOSCOPE, V130, P1144, DOI 10.1002/lary.28189; Pan J, 2015, J LABOR ECON, V33, P365, DOI 10.1086/678518; Peck CJ, 2020, CLIN ORTHOP RELAT R, V478, P1583, DOI 10.1097/CORR.0000000000000964; Piper CL, 2016, AM J ROENTGENOL, V206, P3, DOI 10.2214/AJR.15.15116; R Core Team, 2018, R LANG ENV STAT COMP; Sarsons H., 2017, INTERPRETING SIGNALS; Singh SK, 2021, J SURG EDUC, V78, P665, DOI 10.1016/j.jsurg.2020.07.022; 2008, J NEUROSURG, V109, P378	21	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243308	10.1371/journal.pone.0243308	http://dx.doi.org/10.1371/journal.pone.0243308			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326486	Green Published, gold			2022-12-27	WOS:000600176400007
J	Mathew, EN; Hurst, MN; Wang, BL; Murthy, V; Zhang, YT; DeLong, RK				Mathew, Elza Neelima; Hurst, Miranda N.; Wang, Baolin; Murthy, Vaibhav; Zhang, Yuntao; DeLong, Robert K.			Interaction of Ras Binding Domain (RBD) by chemotherapeutic zinc oxide nanoparticles: Progress towards RAS pathway protein interference	PLOS ONE			English	Article							POLY IC RNA; MECHANISMS; ENZYME; CELLS	Zinc oxide (ZnO) NP is considered as a nanoscale chemotherapeutic. Thus, the drug delivery of this inorganic NP is of considerable importance. Ras mutations are common in cancer and the activation of this signaling pathway is a hallmark in carcinoma, melanoma and many other aggressive malignancies. Thus, here we examined the binding and delivery of Ras binding domain (RBD), a model cancer-relevant protein and effector of Ras by ZnO NP. Shifts in zeta potential in water, PBS, DMEM and DMEM supplemented with FBS supported NP interaction to RBD. Fluorescence quenching of the NP was concentration-dependent for RBD, Stern-Volmer analysis of this data was used to estimate binding strength which was significant for ZnO-RBD (K-d < 10(-5)). ZnO NP interaction to RBD was further confirmed by pull-down assay demonstrated by SDS-PAGE analysis. The ability of ZnO NP to inhibit 3-D tumor spheroid was demonstrated in HeLa cell spheroids-the ZnO NP breaking apart these structures revealing a significant (>50%) zone of killing as shown by light and fluorescence microscopy after intra-vital staining. ZnO 100 nm was superior to ZnO 14 nm in terms of anticancer activity. When bound to ZnO NP, the anticancer activity of RBD was enhanced. These data indicate the potential diagnostic application or therapeutic activity of RBD-NP complexes in vivo which demands further investigation.	[Mathew, Elza Neelima; Wang, Baolin; Zhang, Yuntao; DeLong, Robert K.] Kansas State Univ, Coll Vet Med, Dept Anat & Physiol, Nanotechnol Innovat Ctr Kansas State, Manhattan, KS 66506 USA; [Hurst, Miranda N.] Johns Hopkins Univ, Mol Biophys, Kreiger Sch Arts & Sci, Baltimore, MD USA; [Murthy, Vaibhav] Ohio State Univ, Coll Vet Med, Ctr Retrovirus Res, Columbus, OH 43210 USA	Kansas State University; Johns Hopkins University; University System of Ohio; Ohio State University	Mathew, EN (corresponding author), Kansas State Univ, Coll Vet Med, Dept Anat & Physiol, Nanotechnol Innovat Ctr Kansas State, Manhattan, KS 66506 USA.	elzamathew@ksu.edu		Mathew, Elza Neelima/0000-0002-4156-8183	Johnson Cancer Research Center Innovative Cancer Research Award; Nanotechnology Innovation Center of Kansas State; National Cancer Institute [7R15CA13939003]	Johnson Cancer Research Center Innovative Cancer Research Award; Nanotechnology Innovation Center of Kansas State; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Johnson Cancer Research Center Innovative Cancer Research Award, start-up fund from Nanotechnology Innovation Center of Kansas State and National Cancer Institute (Grant No: 7R15CA13939003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani G, 2017, CELL COMMUN SIGNAL, V15, DOI 10.1186/s12964-017-0186-x; Akhtar MJ, 2012, INT J NANOMED, V7, P845, DOI 10.2147/IJN.S29129; [Anonymous], 2012, REGEN MED S3, V7, pS14; Braun K, 2018, TOXICOL IN VITRO, V52, P214, DOI 10.1016/j.tiv.2018.06.019; Carver K, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.5; Cho EC, 2011, NAT NANOTECHNOL, V6, P385, DOI [10.1038/NNANO.2011.58, 10.1038/nnano.2011.58]; Clogston JD, 2011, METHODS MOL BIOL, V697, P63, DOI 10.1007/978-1-60327-198-1_6; Das BK, 2019, CHEM-BIOL INTERACT, V297, P141, DOI 10.1016/j.cbi.2018.11.004; DeLong RK, 2019, J PHARMACOL EXP THER, V370, P671, DOI 10.1124/jpet.118.256230; DeLong RK, 2017, J BIOMED NANOTECHNOL, V13, P221, DOI 10.1166/jbn.2017.2336; El-Boubbou K, 2018, NANOMEDICINE-UK, V13, P953, DOI 10.2217/nnm-2017-0336; Fernandez-Medarde Alberto, 2011, Genes Cancer, V2, P344, DOI 10.1177/1947601911411084; Garcia-Alvarez R, 2018, NANOSCALE, V10, P1256, DOI 10.1039/c7nr08322j; Manshian BB, 2017, ADV HEALTHC MATER, V6, DOI 10.1002/adhm.201601379; Mishra PK, 2017, DRUG DISCOV TODAY, V22, P1825, DOI 10.1016/j.drudis.2017.08.006; Vinardell MP, 2015, NANOMATERIALS-BASEL, V5, P1004, DOI 10.3390/nano5021004; Ramani M, 2017, J PHYS CHEM C, V121, P15702, DOI 10.1021/acs.jpcc.7b02954; Ramani M, 2017, MOL PHARMACEUT, V14, P614, DOI 10.1021/acs.molpharmaceut.6b00795; Rasmussen JW, 2010, EXPERT OPIN DRUG DEL, V7, P1063, DOI 10.1517/17425247.2010.502560; Ryter SW, 2007, ANTIOXID REDOX SIGN, V9, P49, DOI 10.1089/ars.2007.9.49; Sousa AA, 2015, J FLUORESC, V25, P1567, DOI 10.1007/s10895-015-1665-3; Stern O, 1919, PHYS Z, V20, P183; Thomas SE, 2018, INT J NANOMED, V13, P4523, DOI 10.2147/IJN.S152222; van Meerloo J, 2011, METHODS MOL BIOL, V731, P237, DOI 10.1007/978-1-61779-080-5_20; Zhang Y, 2013, CURR MOL MED, V13, P1633, DOI 10.2174/1566524013666131111130058	25	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243802	10.1371/journal.pone.0243802	http://dx.doi.org/10.1371/journal.pone.0243802			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326476	Green Published, gold			2022-12-27	WOS:000600176400045
J	Pirim, D; Bunker, CH; Hokanson, JE; Hamman, RF; Demirci, FY; Kamboh, MI				Pirim, Dilek; Bunker, Clareann H.; Hokanson, John E.; Hamman, Richard F.; Demirci, F. Yesim; Kamboh, M. Ilyas			Hepatic lipase (LIPC) sequencing in individuals with extremely high and low high-density lipoprotein cholesterol levels	PLOS ONE			English	Article							AFRICAN BLACKS; RARE VARIANTS; PLASMA-LIPIDS; RISK; LOCI; HDL; POLYMORPHISM; ASSOCIATION; DISEASE; POPULATION	Common variants in the hepatic lipase (LIPC) gene have been shown to be associated with plasma lipid levels; however, the distribution and functional features of rare and regulatory LIPC variants contributing to the extreme lipid phenotypes are not well known. This study was aimed to catalogue LIPC variants by resequencing the entire LIPC gene in 95 non-Hispanic Whites (NHWs) and 95 African blacks (ABs) with extreme HDL-C levels followed by in silico functional analyses. A total of 412 variants, including 43 novel variants were identified; 56 were unique to NHWs and 234 were unique to ABs. Seventy-eight variants in NHWs and 89 variants in ABs were present either in high HDL-C group or low HDL-C group. Two non-synonymous variants (p.S289F, p.T405M), found in NHWs with high HDL-C group were predicted to have damaging effect on LIPC protein by SIFT, MT2 and PP2. We also found several non-coding variants that possibly reside in the circRNA and lncRNA binding sites and may have regulatory potential, as identified in rSNPbase and RegulomeDB databases. Our results shed light on the regulatory nature of rare and non-coding LIPC variants as well as suggest their important contributions in affecting the extreme HDL-C phenotypes.	[Pirim, Dilek; Demirci, F. Yesim; Kamboh, M. Ilyas] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Pirim, Dilek] Bursa Uludag Univ, Dept Mol Biol & Genet, Fac Arts & Sci, Bursa, Turkey; [Bunker, Clareann H.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15260 USA; [Hokanson, John E.; Hamman, Richard F.] Univ Colorado Denver, Dept Epidemiol, Colorado Sch Publ Hlth, Aurora, CO USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Uludag University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Children's Hospital Colorado; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus	Kamboh, MI (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA.	kamboh@pitt.edu	PIRIM, DILEK/ABA-4957-2020	PIRIM, DILEK/0000-0002-0522-9432	National Heart, Lung and Blood Institute (NHLBI) [HL084613]	National Heart, Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the National Heart, Lung and Blood Institute (NHLBI) grant, HL084613 (M. Ilyas Kamboh). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; AMEIS D, 1990, J BIOL CHEM, V265, P6552; [Anonymous], 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-018-0474-7; [Anonymous], 2017, J OBSTET GYNECOL NEO, V46, pe125; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Below JE, 2016, SCI REP-UK, V6, DOI 10.1038/srep19429; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; BUNKER CH, 1995, HYPERTENSION, V26, P616, DOI 10.1161/01.HYP.26.4.616; Bunker CH, 1996, ATHEROSCLEROSIS, V123, P215, DOI 10.1016/0021-9150(96)05810-8; CAI SJ, 1989, BIOCHEMISTRY-US, V28, P8966, DOI 10.1021/bi00449a002; Chang TT, 2010, HEPATOLOGY, V51, P422, DOI 10.1002/hep.23327; COHEN JC, 1994, J CLIN INVEST, V94, P2377, DOI 10.1172/JCI117603; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Connelly PW, 1999, CLIN CHIM ACTA, V286, P243, DOI 10.1016/S0009-8981(99)00105-9; Dugi KA, 2001, CIRCULATION, V104, P3057, DOI 10.1161/hc5001.100795; Evans D, 2011, ATHEROSCLEROSIS, V214, P386, DOI 10.1016/j.atherosclerosis.2010.11.026; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Goodarzynejad Hamidreza, 2017, J Tehran Heart Cent, V12, P119; HAMMAN RF, 1989, AM J EPIDEMIOL, V129, P295, DOI 10.1093/oxfordjournals.aje.a115134; Harris MR, 1998, ATHEROSCLEROSIS, V137, P187, DOI 10.1016/S0021-9150(97)00230-X; Holmen OL, 2014, NAT GENET, V46, P345, DOI 10.1038/ng.2926; Isaacs A, 2004, J CLIN ENDOCR METAB, V89, P3858, DOI 10.1210/jc.2004-0188; Jansen H, 2002, J LIPID RES, V43, P1352, DOI 10.1194/jlr.R200008-JLR200; Johansen CT, 2012, CIRC-CARDIOVASC GENE, V5, P66, DOI 10.1161/CIRCGENETICS.111.960864; Kanai M, 2018, NAT GENET, V50, P390, DOI 10.1038/s41588-018-0047-6; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Katneni UK, 2019, MOL GENET GENOM MED, V7, DOI 10.1002/mgg3.840; Khovidhunkit W, 2012, AM J CARDIOL, V110, P62, DOI 10.1016/j.amjcard.2012.02.052; Klarin D, 2018, NAT GENET, V50, P1514, DOI 10.1038/s41588-018-0222-9; Kraja AT, 2011, DIABETES, V60, P1329, DOI 10.2337/db10-1011; Kulminski AM, 2018, AGING-US, V10, P492, DOI 10.18632/aging.101407; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lettre G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001300; Lu XF, 2016, CIRC-CARDIOVASC GENE, V9, P37, DOI 10.1161/CIRCGENETICS.115.001096; McCaskie PA, 2006, CLIN GENET, V70, P114, DOI 10.1111/j.1399-0004.2006.00659.x; Mohammadzadeh Ghorban, 2016, Adv Biomed Res, V5, P27, DOI 10.4103/2277-9175.176366; Moon S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37832-9; Niemsiri V, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0250-6; Niemsiri V, 2014, CIRC-CARDIOVASC GENE, V7, P838, DOI 10.1161/CIRCGENETICS.114.000559; Patel AP, 2016, ATHEROSCLEROSIS, V250, P63, DOI 10.1016/j.atherosclerosis.2016.04.011; Perret B, 2002, J LIPID RES, V43, P1163, DOI 10.1194/jlr.R100020-JLR200; Pirim D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214060; Pirim D, 2016, METABOLISM, V65, P36, DOI 10.1016/j.metabol.2015.09.020; Pirim D, 2015, EUR J HUM GENET, V23, P1244, DOI 10.1038/ejhg.2014.268; Pirim D, 2014, J LIPID RES, V55, P85, DOI 10.1194/jlr.M043265; Radwan ZH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114618; Rewers Marian, 1993, Ethnicity and Disease, V3, P44; RICHMOND W, 1973, CLIN CHEM, V19, P1350; Rosenson RS, 2018, NAT REV CARDIOL, V15, P9, DOI 10.1038/nrcardio.2017.115; Santamarina-Fojo S, 1998, CURR OPIN LIPIDOL, V9, P211, DOI 10.1097/00041433-199806000-00005; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Spracklen CN, 2017, HUM MOL GENET, V26, P1770, DOI 10.1093/hmg/ddx062; Surakka I, 2015, NAT GENET, V47, P589, DOI 10.1038/ng.3300; Verdier C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067805; Verma P, 2016, J CLIN DIAGN RES, V10, pGC1, DOI 10.7860/JCDR/2016/20496.8378; Wang J, 2007, ARTERIOSCL THROM VAS, V27, P2450, DOI 10.1161/ATVBAHA.107.150680; Weissglas-Volkov D, 2013, J MED GENET, V50, P298, DOI 10.1136/jmedgenet-2012-101461; Zambon A, 2003, CURR OPIN LIPIDOL, V14, P179, DOI 10.1097/00041433-200304000-00010; Zhao XS, 2018, LIPIDS HEALTH DIS, V17, DOI 10.1186/s12944-018-0884-4	59	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243919	10.1371/journal.pone.0243919	http://dx.doi.org/10.1371/journal.pone.0243919			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326441	Green Published, gold			2022-12-27	WOS:000600176400047
J	Yazdani, M; Shahdadfar, A; Reppe, S; Sapkota, D; Vallenari, EM; Lako, M; Connon, CJ; Figueiredo, FC; Utheim, TP				Yazdani, Mazyar; Shahdadfar, Aboulghassem; Reppe, Sjur; Sapkota, Dipak; Vallenari, Evan M.; Lako, Majlinda; Connon, Che J.; Figueiredo, Francisco C.; Utheim, Tor Paaske			Response of human oral mucosal epithelial cells to different storage temperatures: A structural and transcriptional study	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; CULTIVATED LIMBAL; CULTURED LIMBAL; VIABILITY; TRANSPLANTATION; APOPTOSIS; THERAPY; CONJUNCTIVAL; METABOLISM; EXPRESSION	Purpose Seeking to improve the access to regenerative medicine, this study investigated the structural and transcriptional effects of storage temperature on human oral mucosal epithelial cells (OMECs). Methods Cells were stored at four different temperatures (4 degrees C, 12 degrees C, 24 degrees C and 37 degrees C) for two weeks. Then, the morphology, cell viability and differential gene expression were examined using light and scanning electron microscopy, trypan blue exclusion test and TaqMan gene expression array cards, respectively. Results Cells stored at 4 degrees C had the most similar morphology to non-stored controls with the highest viability rate (58%), whereas the 37 degrees C group was most dissimilar with no living cells. The genes involved in stress-induced growth arrest (GADD45B) and cell proliferation inhibition (TGFB2) were upregulated at 12 degrees C and 24 degrees C. Upregulation was also observed in multifunctional genes responsible for morphology, growth, adhesion and motility such as EFEMP1 (12 degrees C) and EPHA4 (4 degrees C-24 degrees C). Among genes used as differentiation markers, PPARA and TP53 (along with its associated gene CDKN1A) were downregulated in all temperature conditions, whereas KRT1 and KRT10 were either unchanged (4 degrees C) or downregulated (24 degrees C and 12 degrees C; and 24 degrees C, respectively), except for upregulation at 12 degrees C for KRT1. Conclusions Cells stored at 12 degrees C and 24 degrees C were stressed, although the expression levels of some adhesion-, growth- and apoptosis-related genes were favourable. Collectively, this study suggests that 4 degrees C is the optimal storage temperature for maintenance of structure, viability and function of OMECs after two weeks.	[Yazdani, Mazyar; Reppe, Sjur; Utheim, Tor Paaske] Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway; [Yazdani, Mazyar; Shahdadfar, Aboulghassem] Oslo Univ Hosp, Ctr Eye Res, Dept Ophthalmol, Oslo, Norway; [Reppe, Sjur; Utheim, Tor Paaske] Oslo Univ Hosp, Dept Plast & Reconstruct Surg, Oslo, Norway; [Reppe, Sjur] Unger Vetlesen Inst, Lovisenberg Diaconal Hosp, Oslo, Norway; [Sapkota, Dipak; Vallenari, Evan M.; Utheim, Tor Paaske] Univ Oslo, Inst Oral Biol, Fac Dent, Oslo, Norway; [Lako, Majlinda; Connon, Che J.; Figueiredo, Francisco C.] Newcastle Univ, Int Ctr Life, Biosci Inst, Fac Med Sci, Biosci West Bldg, Newcastle Upon Tyne, Tyne & Wear, England; [Figueiredo, Francisco C.] Royal Victoria Infirm, Dept Ophthalmol, Newcastle Upon Tyne, Tyne & Wear, England; [Figueiredo, Francisco C.] Newcastle Univ, Newcastle Upon Tyne, Tyne & Wear, England; [Utheim, Tor Paaske] Stavanger Univ Hosp, Dept Ophthalmol, Stavanger, Norway; [Utheim, Tor Paaske] Sorlandet Hosp Arendal, Dept Ophthalmol, Arendal, Norway; [Utheim, Tor Paaske] Oslo Metropolitan Univ, Dept Comp Sci, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Stavanger University Hospital; Oslo Metropolitan University (OsloMet)	Yazdani, M (corresponding author), Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway.; Yazdani, M (corresponding author), Oslo Univ Hosp, Ctr Eye Res, Dept Ophthalmol, Oslo, Norway.	mazyar.yazdani.edu@gmail.com	Yazdani, Mazyar/GRJ-3086-2022	Yazdani, Mazyar/0000-0002-9187-3231; Figueiredo, Francisco/0000-0002-5876-288X; Sapkota, Dipak/0000-0003-0061-825X; Shahdadfar, Aboulghassem/0000-0001-9488-6188	South-Eastern Norway Health Authority [2017054]; MRC [G0900879, MR/S035826/1, MC_PC_16054] Funding Source: UKRI	South-Eastern Norway Health Authority; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study is financially supported by grants (Project number 2017054) from the South-Eastern Norway Health Authority (www.helsesorost.no) to Professor Tor Paaske Utheim and Dr. Aboulghassem Shahdadfar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Ahmad S, 2012, STEM CELL TRANSL MED, V1, P110, DOI 10.5966/sctm.2011-0037; Ahmad S, 2010, J CELL PHYSIOL, V225, P15, DOI 10.1002/jcp.22251; [Anonymous], 2018, NAT CLIM CHANGE, V8, P1, DOI 10.1038/s41558-017-0058-9; [Anonymous], 1998, DIABETES CARE S, V21, pB1; [Anonymous], 2008, SIGNO PENSAM, V27, P327; Armitage WJ, 2011, TRANSFUS MED HEMOTH, V38, P143, DOI 10.1159/000326632; Atallah MR, 2016, CLIN OPHTHALMOL, V10, P593, DOI 10.2147/OPTH.S83676; Atiyeh BS, 2007, BURNS, V33, P405, DOI 10.1016/j.burns.2006.11.002; Ban Y, 2003, EXP EYE RES, V76, P663, DOI 10.1016/S0014-4835(03)00054-X; Baris OR, 2011, STEM CELLS, V29, P1459, DOI 10.1002/stem.695; Baylis O, 2013, J CELL PHYSIOL, V228, P1025, DOI 10.1002/jcp.24249; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bierbaumer L, 2018, TISSUE BARRIERS, V6, DOI 10.1080/21688370.2018.1479568; Buschbeck M, 2017, NAT REV MOL CELL BIO, V18, P299, DOI 10.1038/nrm.2016.166; Daniels JT, 2006, REGEN MED, V1, P715, DOI 10.2217/17460751.1.5.715; Dhamodaran K, 2015, MOL VIS, V21, P828; Dolgin E., 2015, NEXT GENERATION STEM, DOI [10.1038/nbt0315-224, DOI 10.1038/NBT0315-224]; Dragunova J, 2012, CELL TISSUE BANK, V13, P471, DOI 10.1007/s10561-011-9275-z; Eidet JR, 2012, EXP EYE RES, V94, P109, DOI 10.1016/j.exer.2011.11.015; Eidet JR, 2015, CURR EYE RES, V40, P30, DOI 10.3109/02713683.2014.909497; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; GENG Y, 1993, P NATL ACAD SCI USA, V90, P10315, DOI 10.1073/pnas.90.21.10315; Gopinath T., 2019, SCI REP, V9, P1, DOI DOI 10.1038/s41598-018-37186-2; He H, 2014, SAUDI J OPHTHALMOL, V28, P188, DOI 10.1016/j.sjopt.2014.06.003; Henderson TRM, 2001, BRIT J OPHTHALMOL, V85, P604, DOI 10.1136/bjo.85.5.604; Hibino Y, 1996, J CRANIO MAXILL SURG, V24, P346, DOI 10.1016/S1010-5182(96)80035-7; Hu JF, 2019, CANCER MED-US, V8, P3152, DOI 10.1002/cam4.2144; HUNTER T, 1993, CELL, V75, P839, DOI 10.1016/0092-8674(93)90528-X; Islam R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128306; Jackson C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105808; Karlsson JOM, 1996, BIOMATERIALS, V17, P243, DOI 10.1016/0142-9612(96)85562-1; Kimura J, 2008, NUCLEIC ACIDS RES, V36, P5250, DOI 10.1093/nar/gkn506; Kito K, 2005, CORNEA, V24, P735, DOI 10.1097/01.ico.0000154405.68536.a4; Knapik A, 2013, J PLAST RECONSTR AES, V66, P827, DOI 10.1016/j.bjps.2013.02.003; KOFF A, 1993, SCIENCE, V260, P536, DOI 10.1126/science.8475385; Lee EJ, 2005, CRYOBIOLOGY, V50, P103, DOI 10.1016/j.cryobiol.2004.12.001; Liu B, 2015, INT J BIOL SCI, V11, P353, DOI 10.7150/ijbs.9813; Madhira SL, 2008, MOL VIS, V14, P189; Marino-Ramirez L, 2005, EXPERT REV PROTEOMIC, V2, P719, DOI 10.1586/14789450.2.5.719; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; Matylevitch NP, 1998, AM J PATHOL, V153, P567, DOI 10.1016/S0002-9440(10)65599-X; Mizzen CA, 1996, CELL, V87, P1261, DOI 10.1016/S0092-8674(00)81821-8; Nakamura T, 2003, INVEST OPHTH VIS SCI, V44, P106, DOI 10.1167/iovs.02-0195; Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455; O'Callaghan AR, 2011, STEM CELLS, V29, P1923, DOI 10.1002/stem.756; Oh JY, 2007, CORNEA, V26, P840, DOI 10.1097/ICO.0b013e318073c1ed; Oie Y, 2014, TISSUE ENG PART C-ME, V20, P373, DOI [10.1089/ten.tec.2013.0266, 10.1089/ten.TEC.2013.0266]; Pasovic L, 2013, J OPHTHALMOL, V2013, DOI 10.1155/2013/216359; PEGG DE, 1976, J CLIN PATHOL, V29, P271, DOI 10.1136/jcp.29.4.271; Pellegrini G, 1997, LANCET, V349, P990, DOI 10.1016/S0140-6736(96)11188-0; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Raeder S, 2009, INVEST OPHTH VIS SCI, V50, P1773; Raeder S, 2007, INVEST OPHTH VIS SCI, V48, P5484, DOI 10.1167/iovs.07-0494; Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955; REIM M, 1988, GRAEF ARCH CLIN EXP, V226, P353, DOI 10.1007/BF02172966; Ronquist G, 2003, EXP DERMATOL, V12, P572, DOI 10.1034/j.1600-0625.2003.00018.x; Schiozer WA, 2013, ACTA CIR BRAS, V28, P824, DOI 10.1590/S0102-86502013001200004; Sehic A, 2015, J FUNCT BIOMATER, V6, P863, DOI 10.3390/jfb6030863; Sejpal Kunjal, 2013, Middle East Afr J Ophthalmol, V20, P5, DOI 10.4103/0974-9233.106381; SHERR CJ, 1993, CELL, V73, P1059, DOI 10.1016/0092-8674(93)90636-5; Shimazaki J, 2009, INVEST OPHTH VIS SCI, V50, P5672, DOI 10.1167/iovs.09-3820; Smith ADH, 2010, PHYSIOL MEAS, V31, P95, DOI 10.1088/0967-3334/31/1/007; Sokal R.R., 2011, BIOMETRY, V4th; SPORN MB, 1992, J CELL BIOL, V119, P1017, DOI 10.1083/jcb.119.5.1017; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Stoner ML, 1996, BURNS, V22, P197, DOI 10.1016/0305-4179(95)00126-3; Timpl R, 2003, NAT REV MOL CELL BIO, V4, P479, DOI 10.1038/nrm1130; Utheim O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118517; Utheim TP, 2009, BRIT J OPHTHALMOL, V93, P980, DOI 10.1136/bjo.2008.149591; Utheim TP, 2007, BRIT J OPHTHALMOL, V91, P797, DOI 10.1136/bjo.2006.103218; Utheim TP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152526; Utheim TP, 2015, STEM CELLS, V33, P1685, DOI 10.1002/stem.1999; Vasania Viraf Sam, 2014, J Ophthalmic Vis Res, V9, P407, DOI 10.4103/2008-322X.150800; Wright B, 2012, REGEN MED, V7, P295, DOI [10.2217/RME.12.7, 10.2217/rme.12.7]; Yoo JY, 2003, J BIOL CHEM, V278, P43001, DOI 10.1074/jbc.M307869200; Zar JH., 2010, BIOSTAT ANAL, V5th	76	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243914	10.1371/journal.pone.0243914	http://dx.doi.org/10.1371/journal.pone.0243914			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326470	Green Published, gold			2022-12-27	WOS:000600176400046
J	Zhang, HY; Ke, JS; Huang, J; Xu, K; Chen, Y				Zhang, Hongyu; Ke, Junsong; Huang, Jun; Xu, Kai; Chen, Yun			Short- versus long-term dual antiplatelet therapy after second-generation drug-eluting stent implantation in patients with diabetes mellitus: A meta-analysis of randomized controlled trials	PLOS ONE			English	Article							FOCUSED UPDATE; THROMBOSIS; DURATION; PREDICTORS; 6-MONTH	Background Diabetes is considered to be a high-risk factor for thromboembolic events. However, available data about the optimal dual antiplatelet therapy (DAPT) in patients with diabetes mellitus (DM) after second-generation drug-eluting stent (DES) implantation are scant. Objective The purpose of this study was to compare the impact of various DAPT durations on clinical outcomes in patients with DM after second-generation DES implantation. Methods We searched PubMed, Embase, and the Cochrane Library for studies that compared short-term (<= 6 months) and long-term (>= 12 months) DAPT in patients with DM. The primary endpoints were late (31-365 days) and very late (> 365 days) stent thrombosis (ST). The secondary endpoints included myocardial infarction (MI), target vessel recanalization (TVR), all-cause death, and major bleeding. Results Six randomized controlled trials, with a total of 3,657 patients with DM, were included in the study. In terms of the primary endpoint, there was no significant difference between the two groups in late (OR 1.15, 95% CI: 0.42-3.19, P = 0.79) or very late (OR 2.18, 95% CI: 0.20-24.18; P = 0.53) ST. Moreover, there was no significant difference in the secondary endpoints, including MI (OR 1.11, 95% CI: 0.72-1.71, P = 0.63), TVR (OR 1.31, 95% CI: 0.82-2.07, P = 0.26), all-cause death (OR 1.03, 95% CI: 0.61-1.75, P = 0.90) and major bleeding (OR 1.07, 95% CI: 0.34-3.40, P = 0.90) between the two groups. Conclusion Our study demonstrated that compared with long-term DAPT, short-term DAPT had no significant difference in the clinical outcomes of patients with DM implanted with second-generation DES.	[Zhang, Hongyu; Ke, Junsong; Huang, Jun; Xu, Kai; Chen, Yun] Nanchang Univ, Affiliated Hosp 1, Dept Cardiol, Nanchang, Jiangxi, Peoples R China	Nanchang University	Huang, J (corresponding author), Nanchang Univ, Affiliated Hosp 1, Dept Cardiol, Nanchang, Jiangxi, Peoples R China.	junhuang918@163.com						[Anonymous], 2016, EUR J ORAL IMPLAN S1, V9, pS173; [Anonymous], 2019, BMJ-BRIT MED J, V365, pl1494, DOI 10.1136/bmj.l149430940623; Bundhun PK, 2016, BMC CARDIOVASC DISOR, V16, DOI 10.1186/s12872-016-0343-y; Capodanno D, 2015, J AM COLL CARDIOL, V66, P1639, DOI 10.1016/j.jacc.2015.05.085; CHESEBRO JH, 1987, CIRCULATION, V76, P142, DOI 10.1161/01.CIR.76.1.142; Colombo A, 2014, J AM COLL CARDIOL, V64, P2086, DOI 10.1016/j.jacc.2014.09.008; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; De Berardis G, 2012, JAMA-J AM MED ASSOC, V307, P2286, DOI 10.1001/jama.2012.5034; Feres F, 2013, JAMA-J AM MED ASSOC, V310, P2510, DOI 10.1001/jama.2013.282183; Gargiulo G, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5483; Genereux P, 2015, J AM COLL CARDIOL, V66, P1036, DOI 10.1016/j.jacc.2015.06.1323; Gilard M, 2015, J AM COLL CARDIOL, V65, P777, DOI 10.1016/j.jacc.2014.11.008; Gwon HC, 2012, CIRCULATION, V125, P505, DOI 10.1161/CIRCULATIONAHA.111.059022; Hahn JY, 2018, LANCET, V391, P1274, DOI 10.1016/S0140-6736(18)30493-8; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hong SJ, 2016, JACC-CARDIOVASC INTE, V9, P1438, DOI 10.1016/j.jcin.2016.04.036; Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126; Irimia A, 2012, NEUROIMAGE, V60, P1340, DOI 10.1016/j.neuroimage.2012.01.107; Jung JH, 2015, DIABETES METAB J, V39, P95, DOI 10.4093/dmj.2015.39.2.95; Kedhi E, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k3793; Kimura T, 2010, CIRCULATION, V122, P52, DOI 10.1161/CIRCULATIONAHA.109.903955; Krackhardt F, 2019, HERZ, V44, P433, DOI 10.1007/s00059-017-4675-x; Levine GN, 2016, J AM COLL CARDIOL, V68, P1082, DOI 10.1016/j.jacc.2016.03.513; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; Pfisterer M, 2006, J AM COLL CARDIOL, V48, P2584, DOI 10.1016/j.jacc.2006.10.026; Santilli F, 2015, PROSTAG OTH LIPID M, V120, P28, DOI 10.1016/j.prostaglandins.2015.05.002; Schulz S, 2009, EUR HEART J, V30, P2714, DOI 10.1093/eurheartj/ehp275; Sharma A, 2018, PROG CARDIOVASC DIS, V60, P500, DOI 10.1016/j.pcad.2017.12.003; Tarantini G, 2016, INT J CARDIOL, V207, P168, DOI 10.1016/j.ijcard.2016.01.068; Valgimigli M, 2018, EUR HEART J, V39, P213, DOI 10.1093/eurheartj/ehx419; Varenhorst C, 2018, CLIN RES CARDIOL, V107, P816, DOI 10.1007/s00392-018-1252-0	31	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0242845	10.1371/journal.pone.0242845	http://dx.doi.org/10.1371/journal.pone.0242845			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326442	gold, Green Published			2022-12-27	WOS:000600176400050
J	Burns, JE; Perez, DR; Li, YM; Garcia, WG; Garcia, FJ; Jimenez, JPG; Sanchez, J; Bueno, MC; Hunger, SP; Reaves, L; Gonzalez, JC; Coffin, SE; Deverlis, A; Steenhoff, AP; Fisher, BT				Burns, Julianne E.; Reyes Perez, Dominga; Li, Yimei; Gomez Garcia, Wendy; Garcia, F. Jay; Gil Jimenez, Johanna Penelope; Sanchez, Jacqueline; Castillo Bueno, Maria; Hunger, Stephen P.; Reaves, Lisa; Contreras Gonzalez, Johanny; Coffin, Susan E.; Deverlis, Adriana; Steenhoff, Andrew P.; Fisher, Brian T.			Assessment of the impact of inpatient infectious events in pediatric patients with newly diagnosed acute leukemia at Dr. Robert Reid Cabral Children's Hospital, Dominican Republic	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; TREATMENT-RELATED MORTALITY; INCOME COUNTRIES; CENTRAL-AMERICA	Survival rates for pediatric acute leukemia vary dramatically worldwide. Infections are a leading cause of morbidity and mortality, and the impact is amplified in low and middle-income countries. Defining the epidemiology of infection in a specific health care setting is paramount to developing effective interventions. This study aimed to define the epidemiology of and outcomes from infection in children with acute leukemia treated in a large public pediatric hospital in the Dominican Republic. A retrospective cohort was assembled of children newly diagnosed with acute leukemia between July 1, 2015 to June 30, 2017 at Hospital Infantil Dr. Robert Reid Cabral in Santo Domingo. Patients were identified from the Pediatric Oncology Network Database (PONDTM) and hospital admissions from the Oncology admissions logbook. Medical records and microbiology results were reviewed to identify all inpatient invasive infections. Distance from a child's home to the hospital was determined using ArcGIS by Esri. Infection rates were described in discrete time periods after diagnosis and risk factors for invasive infection were explored using negative binomial regression. Overall, invasive infections were common and a prominent source of death in this cohort. Rates were highest in the first 60 days after diagnosis. Gastroenteritis/colitis, cellulitis, and pneumonia were most frequent, with bacteremia common early on. Multidrug resistant bacteria were prevalent among a small number of positive cultures. In a multivariate negative binomial regression model, age >= 10 years and distance from the hospital > 100 km were each protective against invasive infection in the first 180 days after diagnosis, findings that were unexpected and warrant further investigation. Over one-third of patient deaths were related to infection. Interventions aimed at reducing infection should target the first 60 days after diagnosis, improved supportive care inside and outside the hospital, and increased antimicrobial stewardship and infection prevention and control measures.	[Burns, Julianne E.; Coffin, Susan E.; Steenhoff, Andrew P.; Fisher, Brian T.] Childrens Hosp Philadelphia, Dept Pediat, Div Infect Dis, Philadelphia, PA 19104 USA; [Burns, Julianne E.] Childrens Hosp Philadelphia, Dept Pediat, Div Gen Pediat, Philadelphia, PA 19104 USA; [Burns, Julianne E.; Garcia, F. Jay; Coffin, Susan E.; Steenhoff, Andrew P.; Fisher, Brian T.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Reyes Perez, Dominga; Gomez Garcia, Wendy; Gil Jimenez, Johanna Penelope; Castillo Bueno, Maria; Contreras Gonzalez, Johanny] Hosp Infantil Dr Robert Reid Cabral, Dept Oncol, Santo Domingo, National Distri, Dominican Rep; [Li, Yimei] Univ Penn, Dept Biostat Epidemiol & Informat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Li, Yimei; Hunger, Stephen P.] Childrens Hosp Philadelphia, Dept Pediat, Div Oncol, Philadelphia, PA 19104 USA; [Li, Yimei; Hunger, Stephen P.] Childrens Hosp Philadelphia, Dept Pediat, Ctr Childhood Canc Res, Philadelphia, PA 19104 USA; [Sanchez, Jacqueline] Hosp Infantil Dr Robert Reid Cabral, Dept Infect Dis, Microbiol Lab, Santo Domingo, National Distri, Dominican Rep; [Reaves, Lisa] Childrens Hosp Colorado, Ctr Canc & Blood Disorders, Colorado Springs, CO USA; [Deverlis, Adriana; Steenhoff, Andrew P.] Childrens Hosp Philadelphia, Global Hlth Ctr, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Children's Hospital Colorado; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Burns, JE (corresponding author), Childrens Hosp Philadelphia, Dept Pediat, Div Infect Dis, Philadelphia, PA 19104 USA.; Burns, JE (corresponding author), Childrens Hosp Philadelphia, Dept Pediat, Div Gen Pediat, Philadelphia, PA 19104 USA.; Burns, JE (corresponding author), Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA.	burnsje@email.chop.edu		Fisher, Brian/0000-0002-8224-4281; Gomez Garcia, Wendy Cristhyna/0000-0002-6457-3559; Burns, Julianne/0000-0003-4154-2802	T32 Infectious Diseases Epidemiology Training Grant [T32-AI-055435]; NIH National Research Service Award; Center for Clinical Epidemiology and Biostatistics at the University of Pennsylvania Perelman School of Medicine; University of Pennsylvania Center for Global Health; La Fundacion Amigos Contra el Cancer Infantil; Keira Grace Foundation	T32 Infectious Diseases Epidemiology Training Grant; NIH National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Clinical Epidemiology and Biostatistics at the University of Pennsylvania Perelman School of Medicine; University of Pennsylvania Center for Global Health; La Fundacion Amigos Contra el Cancer Infantil; Keira Grace Foundation	JEB received funding though a T32 Infectious Diseases Epidemiology Training Grant (T32-AI-055435), NIH National Research Service Award, Center for Clinical Epidemiology and Biostatistics at the University of Pennsylvania Perelman School of Medicine (https://www.cceb.med.upenn.edu).FJG received a travel stipend through the University of Pennsylvania Center for Global Health (https://www.med.upenn.edu/globalhealth/).SPH is the Jeffrey E. Perelman Distinguished Chair in Pediatrics at the Children's Hospital of Philadelphia. The oncology program at Hospital Infantil Dr. Robert Reid Cabral was supported by La Fundacion Amigos Contra el Cancer Infantil (https://www.facci.org.do) and the Keira Grace Foundation (https://www.keiragracefoundation.org).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, CHRONICLE HIGHER ED, V64, pA2; Asociacion de Hemato Oncologia Pediatrica de Centro America (AHOPCA) Protocolo AHOPCA-LMA 2007, 2009, PROT TRAT NIN CON LE; Caniza MA, 2015, EXPERT REV HEMATOL, V8, P627, DOI 10.1586/17474086.2015.1071186; Centers for Disease Control and Prevention, 2019, GROWTH CHART TRAIN S; Centers for Disease Control and Prevention (CDC) Division of Nutrition Physical Activity and Obesity National Center for Chronic Disease Prevention and Health Promotion, 2014, GROWTH CHART TRAIN R; Ceppi F, 2015, EXPERT REV HEMATOL, V8, P613, DOI 10.1586/17474086.2015.1049594; Esri. Topographic, 2012, TOP; Gavidia R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043639; Gupta S, 2009, BRIT J CANCER, V100, P1026, DOI 10.1038/sj.bjc.6604895; Gupta S, 2012, EUR J CANCER, V48, P1363, DOI 10.1016/j.ejca.2011.10.009; Gupta S, 2011, CANCER-AM CANCER SOC, V117, P4788, DOI 10.1002/cncr.26107; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hunger SP, 2012, J CLIN ONCOL, V30, P1663, DOI 10.1200/JCO.2011.37.8018; Hunger SP, 2009, PEDIATR BLOOD CANCER, V52, P559, DOI 10.1002/pbc.21889; Lam CG, 2019, SCIENCE, V363, P1182, DOI 10.1126/science.aaw4892; National Health Council, 2019, GLOSS PAT ENG TERMS; Navarrete M, 2014, PEDIATR BLOOD CANCER, V61, P803, DOI 10.1002/pbc.24911; Quintana Y, 2013, STUD HEALTH TECHNOL, V183, P251, DOI 10.3233/978-1-61499-203-5-251; The Lancet HIV, 2017, LANCET HIV, V4, pe51; Ward ZJ, 2019, LANCET ONCOL, V20, P972, DOI 10.1016/S1470-2045(19)30273-6	20	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243795	10.1371/journal.pone.0243795	http://dx.doi.org/10.1371/journal.pone.0243795			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320881	gold, Green Published			2022-12-27	WOS:000600339800003
J	Chen, Q; Luo, H; Zhou, CC; Yu, H; Yao, S; Fu, FD; Seeley, R; Ji, X; Yang, YP; Chen, PF; Jin, HT; Tong, PJ; Chen, D; Wu, CL; Du, WB; Ruan, HF				Chen, Quan; Luo, Huan; Zhou, Chengcong; Yu, Huan; Yao, Sai; Fu, Fangda; Seeley, Rebecca; Ji, Xing; Yang, Yanping; Chen, Peifeng; Jin, Hongting; Tong, Peijian; Chen, Di; Wu, Chengliang; Du, Weibin; Ruan, Hongfeng			Comparative intra-articular gene transfer of seven adeno-associated virus serotypes reveals that AAV2 mediates the most efficient transduction to mouse arthritic chondrocytes	PLOS ONE			English	Article							ANTAGONIST GENE; ARTICULAR-CARTILAGE; OSTEOARTHRITIS; THERAPY; DELIVERY; VECTOR; RECEPTOR; SAFETY; RAT; PATHOGENESIS	Osteoarthritis (OA) is the most common arthropathy, characterized by progressive degeneration of the articular cartilage. Currently, there are no disease-modifying approaches for OA treatment. Adeno-associated virus (AAV)-mediated gene therapy has recently become a potential treatment for OA due to its exceptional characteristics; however, the tropism and transduction efficiency of different AAV serotypes to articular joints and the safety profile of AAV applications are still unknown. The present study aims to screen an ideal AAV serotype to efficiently transfer genes to arthritic cartilage. AAV vectors of different serotypes expressing eGFP protein were injected into the knee joint cavities of mice, with all joint tissues collected 30 days after AAV injection. The transduction efficiency of AAVs was quantified by assessing the fluorescent intensities of eGFP in the cartilage of knee joints. Structural and morphological changes were analyzed by toluidine blue staining. Changes to ECM metabolism and pyroptosis of chondrocytes were determined by immunohistochemical staining. Fluorescence analysis of eGFP showed that eGFP was expressed in the cartilage of knee joints injected with each AAV vector. Quantification of eGFP intensity indicated that AAV2, 7 and 8 had the highest transduction efficiencies. Both toluidine blue staining and Mankin score showed that AAV6 aggravated cartilage degeneration. The analysis of key molecules in ECM metabolism suggested that AAV5 and 7 significantly reduced collagen type II, while AAV9 increased ADAMTS-4 but decreased MMP-19. In addition, transduction with AAV2, 5, 7 and 8 had no obvious effect on pyroptosis of chondrocytes. Comprehensive score analysis also showed that AAV2 had the highest score in intra-articular gene transfer. Collectively, our findings point to AAV2 as the best AAV serotype candidate for gene transfer on arthritic cartilage, resulting in minimal impact to ECM metabolism and pyroptosis of chondrocytes.	[Chen, Quan; Zhou, Chengcong; Yu, Huan; Yao, Sai; Fu, Fangda; Chen, Peifeng; Jin, Hongting; Tong, Peijian; Wu, Chengliang; Ruan, Hongfeng] Zhejiang Chinese Med Univ, Affiliated Hosp 1, Hangzhou, Zhejiang, Peoples R China; [Chen, Quan; Zhou, Chengcong; Yu, Huan; Yao, Sai; Fu, Fangda; Chen, Peifeng; Jin, Hongting; Tong, Peijian; Wu, Chengliang; Ruan, Hongfeng] Zhejiang Chinese Med Univ, Clin Med Coll 1, Hangzhou, Zhejiang, Peoples R China; [Luo, Huan] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Pharm, Hangzhou, Peoples R China; [Seeley, Rebecca; Ji, Xing] Childrens Hosp Philadelphia, Translat Res Program Pediat Orthoped, Philadelphia, PA 19104 USA; [Yang, Yanping; Ruan, Hongfeng] Shanghai Univ Tradit Chinese Med, Longhua Hosp, Shanghai, Peoples R China; [Chen, Di] Chinese Acad Sci, Shenzhen Inst Adv Technol, Res Ctr Human Tissues & Organs Degenerat, Shenzhen, Peoples R China; [Du, Weibin] Zhejiang Chinese Med Univ, Affiliated JiangNan Hosp, Res Inst Orthoped, Hangzhou, Peoples R China	Zhejiang Chinese Medical University; Zhejiang Chinese Medical University; Zhejiang University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Shanghai University of Traditional Chinese Medicine; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Zhejiang Chinese Medical University	Wu, CL; Ruan, HF (corresponding author), Zhejiang Chinese Med Univ, Affiliated Hosp 1, Hangzhou, Zhejiang, Peoples R China.; Wu, CL; Ruan, HF (corresponding author), Zhejiang Chinese Med Univ, Clin Med Coll 1, Hangzhou, Zhejiang, Peoples R China.; Ruan, HF (corresponding author), Shanghai Univ Tradit Chinese Med, Longhua Hosp, Shanghai, Peoples R China.; Du, WB (corresponding author), Zhejiang Chinese Med Univ, Affiliated JiangNan Hosp, Res Inst Orthoped, Hangzhou, Peoples R China.	wcl@zcmu.edu.cn; dwbbdm@163.com; rhf@zcmu.edu.cn		RUAN, Hongfeng/0000-0001-8868-9313; Seeley, Rebecca/0000-0002-1711-8828; Yu, Huan/0000-0002-1913-5760	National Natural Science Foundation of China [81804121, 81973870, 81573994, 81904053, 81973877, 81674006]; China Postdoctoral Science Foundation [2018M632154]; Natural Science Foundation of Zhejiang Province [LY19H270006, LY19H290004, LQ17H270005]; Traditional Chinese Medical Administration of Zhejiang Province [2021ZB090, 2017ZB026]; Zhejiang Medical and Health Science and Technology Project [2021ZB090, 2018269058]; Zhejiang Chinese Medical University Scientific Research Fund Project [2018ZG20]; Postgraduate Science Research Fund of Zhejiang Chinese Medical University [2020YKJ07]; National Undergraduate Innovation and Entrepreneurship Training Program [202010344004]; Zhejiang Provincial Preponderant and Characteristic Subject of Key University (Chinese Traditional Medicine) [ZYX2018008]; Zhejiang Chinese Medical University [ZYX2018008]; Plan Guide Project of HangZhou Technology Department [20171226Y98]; Plan technology project of Hangzhou Health Department [2018B028]; Science and Technology Innovation Program for College Students (New talent program) of Zhejiang Province [2018R410030]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Traditional Chinese Medical Administration of Zhejiang Province; Zhejiang Medical and Health Science and Technology Project; Zhejiang Chinese Medical University Scientific Research Fund Project; Postgraduate Science Research Fund of Zhejiang Chinese Medical University; National Undergraduate Innovation and Entrepreneurship Training Program; Zhejiang Provincial Preponderant and Characteristic Subject of Key University (Chinese Traditional Medicine); Zhejiang Chinese Medical University; Plan Guide Project of HangZhou Technology Department; Plan technology project of Hangzhou Health Department; Science and Technology Innovation Program for College Students (New talent program) of Zhejiang Province	This study was financially supported by the following grants: National Natural Science Foundation of China (No.: 81804121 to HR, 81973870 and 81573994 to CW, 81904053 to WD, 81973877 and 81674006 to YY); China Postdoctoral Science Foundation (No.: 2018M632154 to HR); Natural Science Foundation of Zhejiang Province (No.: LY19H270006 to CW, LY19H290004 to MY, and LQ17H270005 to HR); Traditional Chinese Medical Administration of Zhejiang Province (No.: 2021ZB090 and 2017ZB026 to HR); Zhejiang Medical and Health Science and Technology Project (No.: 2018269058 to HL and 2021ZB090 to HR); Zhejiang Chinese Medical University Scientific Research Fund Project (No.: 2018ZG20 to CW); Postgraduate Science Research Fund of Zhejiang Chinese Medical University (2020YKJ07 to CZ); National Undergraduate Innovation and Entrepreneurship Training Program (202010344004 to FF and SY); Opening Project of Zhejiang Provincial Preponderant and Characteristic Subject of Key University (Chinese Traditional Medicine) and Zhejiang Chinese Medical University (No.: ZYX2018008 to WD); Plan Guide Project of HangZhou Technology Department (No.: 20171226Y98 to WD); Plan technology project of Hangzhou Health Department (No.: 2018B028 to WD); and Science and Technology Innovation Program for College Students (New talent program) of Zhejiang Province (No.: 2018R410030 to HR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaansen J, 2005, ANN RHEUM DIS, V64, P1677, DOI 10.1136/ard.2004.035063; Akache B, 2006, J VIROL, V80, P9831, DOI 10.1128/JVI.00878-06; Apparailly F, 2005, HUM GENE THER, V16, P426, DOI 10.1089/hum.2005.16.426; Bao LZ, 2012, JOINT BONE SPINE, V79, P482, DOI 10.1016/j.jbspin.2011.10.011; Boissier MC, 2007, HUM GENE THER, V18, P525, DOI 10.1089/hum.2006.174; Rodriguez-Merchan EC, 2019, ARCH BONE JT SURG-AB, V7, P79; Chang ZK, 2018, J CELL BIOCHEM, V119, P4775, DOI 10.1002/jcb.26669; Evans CH, 2009, GENE THER, V16, P944, DOI 10.1038/gt.2009.73; Evans CH, 2018, HUM GENE THER, V29, P2, DOI 10.1089/hum.2017.181; Evans CH, 2011, NAT REV RHEUMATOL, V7, P244, DOI 10.1038/nrrheum.2010.193; Goodrich LR, 2009, HUM GENE THER, V20, P1697, DOI 10.1089/hum.2009.030; Ha CW, 2012, CYTOTHERAPY, V14, P247, DOI 10.3109/14653249.2011.629645; Hemphill DD, 2014, SCI REP-UK, V4, DOI 10.1038/srep05861; Hoyng SA, 2015, GENE THER, V22, P767, DOI 10.1038/gt.2015.47; Hu JM, 2020, J ETHNOPHARMACOL, V247, DOI 10.1016/j.jep.2019.112261; Huang J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10753-5; Huang K, 2008, J INT MED RES, V36, P1149, DOI 10.1177/147323000803600601; Hwang HS, 2015, INT J MOL SCI, V16, P26035, DOI 10.3390/ijms161125943; Jeune VL, 2013, HUM GENE THER METHOD, V24, P59, DOI 10.1089/hgtb.2012.243; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Lerch TF, 2012, STRUCTURE, V20, P1310, DOI 10.1016/j.str.2012.05.004; Levings RSW, 2018, HUM GENE THER CL DEV, V29, P90, DOI 10.1089/humc.2017.142; Levings RSW, 2018, HUM GENE THER CL DEV, V29, P101, DOI 10.1089/humc.2017.143; Li CW, 2020, NAT REV GENET, V21, P255, DOI 10.1038/s41576-019-0205-4; Li X, 2019, ARTIF CELL NANOMED B, V47, P1256, DOI 10.1080/21691401.2019.1593996; Mease PJ, 2009, ANN RHEUM DIS, V68, P1247, DOI 10.1136/ard.2008.089375; Mease PJ, 2010, J RHEUMATOL, V37, P692, DOI 10.3899/jrheum.090817; Zacaron KAM, 2018, J INTEGR MED-JIM, V16, P106, DOI 10.1016/j.joim.2018.02.002; Musumeci G, 2015, HISTOL HISTOPATHOL, V30, P1, DOI 10.14670/HH-30.1; Naito K, 2010, LIFE SCI, V86, P538, DOI 10.1016/j.lfs.2010.02.015; Ortved K, 2015, HUM GENE THER, V26, P161, DOI 10.1089/hum.2014.050; Park KM, 2017, J INTEGR MED-JIM, V15, P135, DOI 10.1016/S2095-4964(17)60316-9; Rahmati M, 2017, AGEING RES REV, V40, P20, DOI 10.1016/j.arr.2017.07.004; Strobel B, 2019, HUM GENE THER METHOD, V30, P23, DOI 10.1089/hgtb.2018.228; Summerford C, 2016, MOL THER, V24, P663, DOI 10.1038/mt.2016.49; Ulrich-Vinther M, 2007, ACTA ORTHOP, V78, P5; Verma P, 2011, J CELL BIOCHEM, V112, P3507, DOI 10.1002/jcb.23298; Wang PE, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1437-3; Watson RS, 2013, GENE THER, V20, P670, DOI 10.1038/gt.2012.81; Yla-Herttuala S, 2012, MOL THER, V20, P1831, DOI 10.1038/mt.2012.194; Zhang L, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/6326517; Zhao L, 2019, ANN RHEUM DIS, V78, P676, DOI 10.1136/annrheumdis-2018-214724; Zhao LR, 2018, MOL MED REP, V17, P5463, DOI 10.3892/mmr.2018.8520	43	1	2	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243359	10.1371/journal.pone.0243359	http://dx.doi.org/10.1371/journal.pone.0243359			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320893	gold, Green Published			2022-12-27	WOS:000600339800015
J	Kim, YS; Kim, DW; Kim, SG; Lee, SK				Kim, Yeon Sook; Kim, Dae Won; Kim, Seong-Gon; Lee, Suk Keun			4-hexylresorcinol-induced protein expression changes in human umbilical cord vein endothelial cells as determined by immunoprecipitation high-performance liquid chromatography	PLOS ONE			English	Article							SUPPRESSION; INHIBITION; CISPLATIN; APOPTOSIS; MEMBRANE; AGENT	4-Hexylresorcinol (4HR) is used as a food preservative and an ingredient of toothpaste and cosmetics. The present study was performed using 233 antisera to determine the changes in protein expression induced by 4HR in human umbilical cord vein endothelial cells (HUVECs), and evaluated the 4HR-induced effects in comparison with previous results (Kim et al., 2019). Similar to RAW 264.7 cells, 4HR-treated HUVECs showed decreases in the expression of the proliferation-related proteins, cMyc/MAX/MAD network proteins, p53/RB and Wnt/beta-catenin signaling, and they showed inactivation of DNA transcription and protein translation compared to the untreated controls. 4HR upregulated growth factors (TGF-beta 1, beta 2, beta 3, SMAD2/3, SMAD4, HGF-alpha, Met, IGF-1) and RAS signaling proteins (RAF-B, p38, p-p38, p-ERK-1, and Rab-1), and induced stronger expression of the cellular protection-, survival-, and differentiation-related proteins in HUVECs than in RAW 264.7 cells. 4HR suppressed NFkB signaling in a manner that suggests potential anti-inflammatory and wound healing effects by reducing M1 macrophage polarization and increasing M2 macrophage polarization in both cells. 4HR-treated HUVECs tended to increase the ER stress mediators by upregulating eIF2AK3, ATF4, ATF6, lysozyme, and LC3 and downregulating eIF2 alpha and GADD153 (CHOP), resulting in PARP-1/AIF-mediated apoptosis. These results indicate that 4HR has similar effects on the protein expression of HUVECs and RAW 264.7 cells, but their protein expression levels differ according to cell types. The 4HR-treated cells showed global protein expression characteristic of anticancer and wound healing effects, which could be alleviated simultaneously by other proteins exerting opposite functions. These results suggest that although 4HR has similar effects on the global protein expression of HUVECs and RAW 264.7 cells, the 4HR-induced molecular interferences in those cells are complex enough to produce variable protein expression, leading different cell functions. Moreover, HUVECs have stronger wound healing potential to overcome the impact induced by 4HR than RAW 264.7 cells.	[Kim, Yeon Sook; Kim, Seong-Gon; Lee, Suk Keun] Cheongju Univ, Coll Hlth & Med Sci, Dept Dent Hyg, Cheongju, South Korea; [Kim, Dae Won] Gangneung Wonju Natl Univ, Coll Dent, Dept Oral Biochem, Kangnung, South Korea; [Kim, Seong-Gon] Gangneung Wonju Natl Univ, Coll Dent, Dept Oral & Maxillofacial Surg, Kangnung, South Korea; [Lee, Suk Keun] Gangneung Wonju Natl Univ, Coll Dent, Dept Oral Pathol, Kangnung, South Korea; [Lee, Suk Keun] Inst Hydrogen Magnet React Gene Regulat, Kangnung, South Korea	Cheongju University; Kangnung Wonju National University; Kangnung Wonju National University; Kangnung Wonju National University	Kim, SG (corresponding author), Gangneung Wonju Natl Univ, Coll Dent, Dept Oral & Maxillofacial Surg, Kangnung, South Korea.; Lee, SK (corresponding author), Gangneung Wonju Natl Univ, Coll Dent, Dept Oral Pathol, Kangnung, South Korea.; Lee, SK (corresponding author), Inst Hydrogen Magnet React Gene Regulat, Kangnung, South Korea.	sukkeunlee2@naver.com; kimsg@gwnu.ac.kr		Kim, Seong-Gon/0000-0001-5088-2732				Ahn J, 2016, BURNS, V42, P1534, DOI 10.1016/j.burns.2016.04.016; American Institute of Ultrasound in Medicine, 2020, J ULTRASOUND MED, V21, pE1; Anderson HH, 1931, P SOC EXP BIOL MED, V28, P0609; Clarke NJ, 1998, FEBS LETT, V430, P419, DOI 10.1016/S0014-5793(98)00706-6; Dam AD, 2013, BBA-MOL CELL RES, V1833, P3426, DOI 10.1016/j.bbamcr.2013.04.014; Dittmer D, 1959, HDB TOXICOLOGY; Faust JJ, 2017, BIOMATERIALS, V128, P160, DOI 10.1016/j.biomaterials.2017.02.031; Feng S, 2012, FEBS LETT, V586, P3951, DOI 10.1016/j.febslet.2012.09.037; Feng XL, 2019, LASER SURG MED, V51, P352, DOI 10.1002/lsm.23020; Goodman L., 1975, PHARM BASIS THERAPEU; Gosselin RE, 1984, CLIN TOXICOLOGY COMM; Guandalini E, 1998, FOOD ADDIT CONTAM, V15, P171; He JF, 2017, FOOD CHEM, V214, P269, DOI 10.1016/j.foodchem.2016.07.095; Jo YY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40027-5; Kim MK, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38946-4; Kim MK, 2020, MAX PLAST RECONSTR S, V42, DOI 10.1186/s40902-020-00267-2; Kim SG, 2013, ONCOL REP, V29, P1835, DOI 10.3892/or.2013.2292; Kim SG, 2012, ONCOL REP, V28, P677, DOI 10.3892/or.2012.1845; Kim SG, 2011, ONCOL REP, V26, P1527, DOI 10.3892/or.2011.1436; Kim SG, 2011, ONCOL REP, V25, P1597, DOI 10.3892/or.2011.1218; Kim SM, 2018, J CRANIO MAXILL SURG, V46, P119, DOI 10.1016/j.jcms.2017.10.017; Kim SM, 2017, EUR ARCH OTO-RHINO-L, V274, P3485, DOI 10.1007/s00405-017-4657-x; Kim SM, 2017, WORLD J SURG ONCOL, V15, DOI 10.1186/s12957-017-1213-5; Kim SM, 2017, EUR ARCH OTO-RHINO-L, V274, P215, DOI 10.1007/s00405-016-4167-2; Kim Yeon Sook, 2015, [The Korean Journal of Oral and Maxillofacial Pathology, 대한구강악안면병리학회지], V39, P615; Kozubek A, 1999, CHEM REV, V99, P1, DOI 10.1021/cr970464o; Kweon H, 2014, BIOMATERIALS, V35, P8576, DOI 10.1016/j.biomaterials.2014.06.050; Lamson PD, 1935, J PHARMACOL EXP THER, V53, P198; Lee Sang-Woon, 2015, Maxillofac Plast Reconstr Surg, V37, P32, DOI 10.1186/s40902-015-0034-0; Lee SW, 2013, J CRANIOFAC SURG, V24, P1927, DOI 10.1097/SCS.0b013e3182a3050c; Lee SW, 2013, TUMOR BIOL, V34, P1595, DOI 10.1007/s13277-013-0690-6; Luo LP, 2013, FOOD CHEM, V138, P315, DOI 10.1016/j.foodchem.2012.10.043; Madungwe NB, 2018, AM J PHYSIOL-CELL PH, V315, pC28, DOI 10.1152/ajpcell.00230.2017; MAPLESTONE P. A., 1934, Indian Journal of Medical Research, V21, P519; McConnell VF, 1953, J CHEM EDUC, V30, P380, DOI [10.1021/ed030p380, DOI 10.1021/ED030P380]; National Toxicology Program, 1988, Natl Toxicol Program Tech Rep Ser, V330, P1; Park MH, 2018, J BIOL CHEM, V293, P18710, DOI 10.1074/jbc.TM118.003341; Robbins BH, 1931, J PHARMACOL EXP THER, V43, P325; Robbins BH, 1935, J PHARMACOL EXP THER, V53, P54; Seok H, 2016, J KOR ASSOC ORAL MAX, V42, P370, DOI 10.5125/jkaoms.2016.42.6.370; Sunshine I, 1969, CRC HDB ANAL TOXICOL; The WHO Alliance for Maternal and Newborn Health Improvement late pregnancy dating study group, 2020, LANCET GLOB HEALTH, V8, pe545; UJIIE T, 1968, CHEM PHARM BULL, V16, P165; Ortiz-Ruiz CV, 2015, J AGR FOOD CHEM, V63, P7032, DOI 10.1021/acs.jafc.5b02523; Weber R, 2016, MUSICOL AUST, V38, P29, DOI 10.1080/08145857.2016.1159649; Yamaguchi R, 2018, CYTOKINE, V108, P24, DOI 10.1016/j.cyto.2018.03.011; Yen GC, 2003, FREE RADICAL RES, V37, P509, DOI 10.1080/1071576031000083099; Yoon CS, 2018, MAX PLAST RECONSTR S, V40, DOI 10.1186/s40902-018-0183-z; Yoon CS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32014-z; Zhang FJ, 2012, TOXICOL SCI, V128, P103, DOI 10.1093/toxsci/kfs142; Zhang QH, 2019, CANCER SCI, V110, P2507, DOI 10.1111/cas.14101	51	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243975	10.1371/journal.pone.0243975	http://dx.doi.org/10.1371/journal.pone.0243975			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320912	gold, Green Published			2022-12-27	WOS:000600339800058
J	Ramsey, CB				Ramsey, Christopher Bronk			Human agency and infection rates: Implications for social distancing during epidemics	PLOS ONE			English	Article								Social distancing is an important measure in controlling epidemics. This paper presents a simple theoretical model focussed on the implications of the wide range in interaction rates between individuals, both within the workplace and in social settings. The model is based on well-mixed populations and so is not intended for studying geographic spread. The model shows that epidemic growth rate is largely determined by the upper interactivity quantiles of society, implying that the most efficient methods of epidemic control are interaction capping approaches rather than overall reductions in interaction. The theoretical model can also be applied to look at aspects of the dynamics of epidemic progression under various scenarios. The theoretical model suggests that with no intervention herd immunity would be achieved with a lower overall infection rate than if variation in interaction rate is ignored, because by this stage almost all the most interactive members of society would have had the infection; however the overall mortality with such an approach is very high. Scenarios for mitigation and suppression suggest that, by using interactivity capping, it should be possible to control an epidemic without extreme sanctions on the majority of the population if R0 of the uncontrolled infection is 2.4. However to control the infection rate to a specific level will always require measures to be switched on and off and for this reason elimination is likely to be a less costly policy in the long run. While social distancing alone can be used for elimination, it would not on its own be an efficient mechanism to prevent reinfection. The use of robust testing, quarantining, and contact tracing would strengthen any social distancing measures, speed up elimination, and be a better tool for the prevention of infection or reinfection. Because the analysis presented here is theoretical, and not data-driven, it is intended to be a stimulus for further data-collection, particularly on individual interactivity levels, and for more comprehensive modelling which takes account of the type of heterogeneity discussed here. While there are some clear lessons from the simple model presented here, policy makers should have these tested and validated by epidemiological specialists before acting on them.	[Ramsey, Christopher Bronk] Univ Oxford, Sch Archaeol, Oxford, England	University of Oxford	Ramsey, CB (corresponding author), Univ Oxford, Sch Archaeol, Oxford, England.	christopher.ramsey@arch.ox.ac.uk	Ramsey, Christopher Bronk/AAQ-2227-2021	Ramsey, Christopher Bronk/0000-0002-8641-9309				Ferguson N. M., 2020, REPORT 9 IMPACT NONP; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferretti L, 2020, SCIENCE, V368, P619, DOI 10.1126/science.abb6936; Kissler S. M., 2020, SPARKING BBC 4 PANDE, DOI [10.1101/479154, DOI 10.1101/479154]; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Pastor-Satorras R, 2015, REV MOD PHYS, V87, P925, DOI 10.1103/RevModPhys.87.925; Verity R, 2020, ESTIMATES SEVERITY C, DOI DOI 10.1101/2020.03.09.20033357	7	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243699	10.1371/journal.pone.0243699	http://dx.doi.org/10.1371/journal.pone.0243699			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320880	Green Published, gold			2022-12-27	WOS:000600339800020
J	Peltzer, S; Muller, H; Kostler, U; Schulz-Nieswandt, F; Jessen, F; Albus, C				Peltzer, Samia; Mueller, Hendrik; Koestler, Ursula; Schulz-Nieswandt, Frank; Jessen, Frank; Albus, Christian		CoRe-Net Study Grp	Detection and treatment of mental disorders in patients with coronary heart disease (MenDis-CHD): A cross-sectional study	PLOS ONE			English	Article							HOSPITAL ANXIETY; RISK-FACTOR; HEALTH; SATISFACTION; DEPRESSION; ILLNESS; CARE; METAANALYSIS; MANAGEMENT; SCALE	Mental disorders (MD) are associated with an increased risk of developing coronary heart disease (CHD) and with higher CHD-related morbidity and mortality. There is a strong recommendation to routinely screen CHD patients for MDs, diagnosis, and treatment by recent guidelines. The current study aimed at mapping CHD patients' (1) state of diagnostics and, if necessary, treatment of MDs, (2) trajectories and detection rate in healthcare, and (3) the influence of MDs and its management on quality of life and patient satisfaction. The design was a cross-sectional study in three settings (two hospitals, two rehabilitation clinics, three cardiology practices). CHD patients were screened for MDs with the Hospital Anxiety and Depression Scale (HADS), and, if screened-positive, examined for MDs with the Structured Clinical Interview for DSM-IV (SCID-I). Quality of Life (EQ-5D), Patient Assessment of Care for Chronic Conditions (PACIC), and previous routine diagnostics and treatment for MDs were examined. Descriptive statistics, Chi-squared tests, and ANOVA were used for analyses. Analyses of the data of 364 patients resulted in 33.8% positive HADS-screenings and 28.0% SCID-I diagnoses. The detection rate of correctly pre-diagnosed MDs was 49.0%. Physicians actively approached approximately thirty percent of patients on MDs; however, only 6.6% of patients underwent psychotherapy and 4.1% medication therapy through psychotherapists/psychiatrists. MD patients scored significantly lower on EQ-5D and the PACIC. The state of diagnostic and treatment of comorbid MDs in patients with CHD is insufficient. Patients showed a positive attitude towards addressing MDs and were satisfied with medical treatment, but less with MD-related advice. Physicians in secondary care need more training inadequately addressing mental comorbidity.	[Peltzer, Samia; Albus, Christian] Univ Cologne, Univ Hosp Cologne, Fac Med, Dept Psychosomat & Psychotherapy, Cologne, North Rhine Wes, Germany; [Mueller, Hendrik; Jessen, Frank] Univ Cologne, Univ Hosp Cologne, Fac Med, Dept Psychiat & Psychotherapy, Cologne, North Rhine Wes, Germany; [Koestler, Ursula; Schulz-Nieswandt, Frank] Univ Cologne, Fac Management Econ & Social Sci, Cologne, North Rhine Wes, Germany; [Jessen, Frank] German Ctr Neurodegenerat Dis DZNE, Bonn, North Rhine Wes, Germany	University of Cologne; University of Cologne; University of Cologne; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Peltzer, S (corresponding author), Univ Cologne, Univ Hosp Cologne, Fac Med, Dept Psychosomat & Psychotherapy, Cologne, North Rhine Wes, Germany.	samia.peltzer@uk-koeln.de	Schulz-Nieswandt, Frank/ABG-8401-2021	Schulz-Nieswandt, Frank/0000-0002-9820-417X; Peltzer, Samia/0000-0001-9784-6413	BMBF (Federal Ministry of Research and Education) [01GY1606]	BMBF (Federal Ministry of Research and Education)(Federal Ministry of Education & Research (BMBF))	All authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the BMBF (Federal Ministry of Research and Education [grant number: 01GY1606]. URL: https://www.bmbf.de/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albus C, 2018, UEXKULL PSYCHOSOMATI, P865; Albus C, 2019, CLIN RES CARDIOL, V108, P1175, DOI 10.1007/s00392-019-01488-w; Bishop TF, 2016, HEALTH AFFAIR, V35, P394, DOI 10.1377/hlthaff.2015.1068; Correll CU, 2017, WORLD PSYCHIATRY, V16, P163, DOI 10.1002/wps.20420; De Hert M, 2018, DIALOGUES CLIN NEURO, V20, P31; Emdin CA, 2016, AM J CARDIOL, V118, P511, DOI 10.1016/j.amjcard.2016.05.041; EuroQol Research Foundation, EQ 5D 3L USER GUIDE; Feinstein Robert E, 2006, Cardiol Rev, V14, P164, DOI 10.1097/01.crd.0000200977.41695.43; Fergusson DM, 2015, PSYCHOL MED, V45, P2427, DOI 10.1017/S0033291715000422; Fortin M, 2018, CAN J PSYCHIAT, V63, P103, DOI 10.1177/0706743717737030; Glasgow RE, 2005, MED CARE, V43, P436, DOI 10.1097/01.mlr.0000160375.47920.8c; Graf von Schulenburg J-M, 1998, GESUNDHEITSWISSENSCH, V6, P3, DOI [DOI 10.1007/BF02956350, 10.1007/BF02956350]; Henly SJ, 2011, NURS RES, V60, pS5, DOI 10.1097/NNR.0b013e318216dfd3; IBMCorp, 2013, IBM SPSS STAT WINDOW; Karbach U, 2018, Z EVIDENZ FORTBILD Q, V130, P21, DOI 10.1016/j.zefq.2017.11.005; Karbach U, 2011, DTSCH ARZTEBL INT, V108, P62, DOI 10.3238/arztebl.2011.0061; Kim SS, 2004, EVAL HEALTH PROF, V27, P237, DOI 10.1177/0163278704267037; Kuhlmann SL, 2019, PSYCHOTHER PSYCHOSOM, V88, P300, DOI 10.1159/000501502; Lichtman JH, 2014, CIRCULATION, V129, P1350, DOI 10.1161/CIR.0000000000000019; Lindberg LG, 2019, EUR J PUBLIC HEALTH, V29, P700, DOI 10.1093/eurpub/ckz090; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mykletun A, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-35; Pedersen SS, 2017, EUR J PREV CARDIOL, V24, P108, DOI 10.1177/2047487317703827; Peltzer S, 2019, BMC PSYCHOL, V7, DOI 10.1186/s40359-019-0295-y; Petermann F, 2011, Z PSYCHIATR PSYCH PS, V59, P251, DOI 10.1024/1661-4747/a000077; Piepoli MF, 2016, ATHEROSCLEROSIS, V252, P207, DOI [10.1016/j.atherosclerosis.2016.05.037, 10.1177/2047487316653709]; Pogosova N, 2017, EUR J PREV CARDIOL, V24, P1371, DOI 10.1177/2047487317711334; Priebe S, 2019, WORLD PSYCHIATRY, V18, P30, DOI 10.1002/wps.20586; Prins MA, 2009, J AFFECT DISORDERS, V119, P163, DOI 10.1016/j.jad.2009.03.019; Summerskill WSM, 2002, FAM PRACT, V19, P605, DOI 10.1093/fampra/19.6.605; Thombs BD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052654; Vaccarino V, 2020, EUR HEART J, V41, P1687, DOI 10.1093/eurheartj/ehy913; Wittchen H.-U., 1997, SKID 1 STRUKTURIERTE; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; 2018, ADV DIFFERENCE EQU, V104, P1	35	2	2	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243800	10.1371/journal.pone.0243800	http://dx.doi.org/10.1371/journal.pone.0243800			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH1MP	33315906	gold, Green Published			2022-12-27	WOS:000600186100046
J	Shen, YQ; Fang, LK; Ye, B; Yu, GC				Shen, Yanqin; Fang, Likui; Ye, Bo; Yu, Guocan			Meta-analysis of diagnostic accuracy of nucleic acid amplification tests for abdominal tuberculosis: A protocol	PLOS ONE			English	Article							INTESTINAL TUBERCULOSIS; PCR	Background Abdominal tuberculosis is a severe extrapulmonary tuberculosis, which can lead to serious complications. Early diagnosis and treatment are very important for the prognosis and the diagnosis of abdominal tuberculosis is still difficult. This study aims to evaluate the diagnostic accuracy of nucleic acid amplification tests (NAATs) for abdominal tuberculosis using meta-analysis method. Methods We will search PubMed, the Cochrane Library, Embase, China National Knowledge Infrastructure, and the Wanfang database for studies evaluating the diagnostic accuracy of NAATs for abdominal tuberculosis until May 2020. We will include a systematic review and meta-analysis that evaluated the accuracy of NAATs for abdominal tuberculosis. Any types of study design with full text will be sought and included. The risk of bias will be assessed using the Quality Assessment of Diagnostic Accuracy Studies tool. Stata version 15.0 with the midas command packages will be used to carry out meta-analyses. Results The results will provide clinical evidence for diagnostic accuracy of NAATs for abdominal tuberculosis, and this systematic review and meta-analysis will be submitted to a peer-reviewed journal for publication. Conclusion This overview will provide evidence of NAATs for diagnosis of abdominal tuberculosis. Systematic review registration INPLASY202060030.	[Shen, Yanqin; Fang, Likui; Ye, Bo; Yu, Guocan] Zhejiang Chinese Med & Western Med Integrated Hos, Zhejiang TB Diag & Treatment Ctr, Hangzhou, Zhejiang, Peoples R China		Yu, GC (corresponding author), Zhejiang Chinese Med & Western Med Integrated Hos, Zhejiang TB Diag & Treatment Ctr, Hangzhou, Zhejiang, Peoples R China.	dabaitwo@163.com	Yu, Guocan/D-2963-2014	Yu, Guocan/0000-0003-1157-4184				Ahmad QA, 2020, JCPSP-J COLL PHYSICI, V30, P129, DOI 10.29271/jcpsp.2020.02.129; [Anonymous], 2020, STRATEG COMMENTS, V26, pX, DOI 10.1080/13567888.2020.1762348; [Anonymous], 2020, LANCET INFECT DIS, V20, P192, DOI [10.1016/S1473-3099(20)30483-7, DOI 10.1016/S1473-3099(20)30483-7, DOI 10.1056/NEJMoa2021756]; Fei BY, 2014, BRAZ J MED BIOL RES, V47, P166, DOI 10.1590/1414-431X20133277; Jin XJ, 2010, WORLD J GASTROENTERO, V16, P2496, DOI 10.3748/wjg.v16.i20.2496; Leeflang MMG, 2008, ANN INTERN MED, V149, P889, DOI 10.7326/0003-4819-149-12-200812160-00008; Puhan MA, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005305.pub4; Rossignol L, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4202-1; Shen Y, INPLASY PROTOCOL, DOI 10.37766/inplasy2020.6.0030; Sivaratnam L, 2020, INT J MYCOBACT, V9, P107, DOI 10.4103/ijmy.ijmy_207_19; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; World Health Organization (WHO), 2019, TUBERCULOSIS; Zhou YC, 2020, LAB MED, V51, P606, DOI 10.1093/labmed/lmaa016	13	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243765	10.1371/journal.pone.0243765	http://dx.doi.org/10.1371/journal.pone.0243765			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315919	Green Published, gold			2022-12-27	WOS:000600186100014
J	Shi, C; Killoran, MP; Hall, MP; Otto, P; Wood, MG; Strauss, E; Encell, LP; Machleidt, T; Wood, KV; Kirkland, TA				Shi, Ce; Killoran, Michael P.; Hall, Mary P.; Otto, Paul; Wood, Monika G.; Strauss, Ethan; Encell, Lance P.; Machleidt, Thomas; Wood, Keith V.; Kirkland, Thomas A.			5,5-Dialkylluciferins are thermal stable substrates for bioluminescence-based detection systems	PLOS ONE			English	Article							FIREFLY LUCIFERASE; ATP; ASSAY; THERMOSTABILITY; DERIVATIVES; SATURATION; DESIGN; PROBES; GREEN; RED	Firefly luciferase-based ATP detection assays are frequently used as a sensitive, cost-efficient method for monitoring hygiene in many industrial settings. Solutions of detection reagent, containing a mixture of a substrate and luciferase enzyme that produces photons in the presence of ATP, are relatively unstable and maintain only a limited shelf life even under refrigerated conditions. It is therefore common for the individual performing a hygiene test to manually prepare fresh reagent at the time of monitoring. To simplify sample processing, a liquid detection reagent with improved thermal stability is needed. The engineered firefly luciferase, Ultra-Glo (TM), fulfills one aspect of this need and has been valuable for hygiene monitoring because of its high resistance to chemical and thermal inactivation. However, solutions containing both Ultra-Glo (TM) luciferase and its substrate luciferin gradually lose the ability to effectively detect ATP over time. We demonstrate here that dehydroluciferin, a prevalent oxidative breakdown product of luciferin, is a potent inhibitor of Ultra-Glo (TM) luciferase and that its formation in the detection reagent is responsible for the decreased ability to detect ATP. We subsequently found that dialkylation at the 5-position of luciferin (e.g., 5,5-dimethylluciferin) prevents degradation to dehydroluciferin and improves substrate thermostability in solution. However, since 5,5-dialkylluciferins are poorly utilized by Ultra-Glo (TM) luciferase as substrates, we used structural optimization of the luciferin dialkyl modification and protein engineering of Ultra-Glo (TM) to develop a luciferase/luciferin pair that shows improved total reagent stability in solution at ambient temperature. The results of our studies outline a novel luciferase/luciferin system that could serve as foundations for the next generation of bioluminescence ATP detection assays with desirable reagent stability.	[Shi, Ce; Kirkland, Thomas A.] Promega Biosci Inc, San Luis Obispo, CA USA; [Killoran, Michael P.; Hall, Mary P.; Otto, Paul; Wood, Monika G.; Strauss, Ethan; Encell, Lance P.; Machleidt, Thomas; Wood, Keith V.] Promega Corp, Madison, WI 53711 USA	Promega Corporation	Killoran, MP (corresponding author), Promega Corp, Madison, WI 53711 USA.	mike.killoran@promega.com			Promega Corporation	Promega Corporation	Funding was provided by Promega Corporation. The funder provided support in the form of salaries and laboratory resources for authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfa MJ, 2015, J HOSP INFECT, V90, P59, DOI 10.1016/j.jhin.2015.01.020; [Anonymous], 2010, Prescrire Int, V19, P26; [Anonymous], 2007, WESTMINSTER PAPERS C, V4, P65; Auld DS, 2009, J MED CHEM, V52, P1450, DOI 10.1021/jm8014525; Baggett B, 2004, MOL IMAGING, V3, P324, DOI 10.1162/1535350042973553; Baldwin TO, 1996, STRUCTURE, V4, P223, DOI 10.1016/S0969-2126(96)00026-3; Branchini BR, 2002, J AM CHEM SOC, V124, P2112, DOI 10.1021/ja017400m; Branchini BR, 2007, ANAL BIOCHEM, V361, P253, DOI 10.1016/j.ab.2006.10.043; Cali JJ, 2006, EXPERT OPIN DRUG MET, V2, P629, DOI 10.1517/17425255.2.4.629; Dostalek P, 2005, CZECH J FOOD SCI, V23, P85, DOI 10.17221/3376-CJFS; Duellman S, 2013, NEW LUMINESCENT ASSA; GRIFFITHS MW, 1993, J DAIRY SCI, V76, P3118, DOI 10.3168/jds.S0022-0302(93)77651-1; Hawronskyj JM, 1997, TRENDS FOOD SCI TECH, V8, P79, DOI 10.1016/S0924-2244(97)01009-1; Koksharov MI, 2011, PROTEIN ENG DES SEL, V24, P835, DOI 10.1093/protein/gzr044; Kumar M, 2007, ASSAY DRUG DEV TECHN, V5, P237, DOI 10.1089/adt.2006.055; Lundin A, 2000, METHOD ENZYMOL, V305, P346; Morciano G, 2017, NAT PROTOC, V12, P1542, DOI 10.1038/nprot.2017.052; Mortazavi M, 2011, PROTEIN ENG DES SEL, V24, P893, DOI 10.1093/protein/gzr051; Nakatsu T, 2006, NATURE, V440, P372, DOI 10.1038/nature04542; Notzel MW, 2000, J ORG CHEM, V65, P3850, DOI 10.1021/jo990170y; O'Brien MA, 2005, J BIOMOL SCREEN, V10, P137, DOI 10.1177/1087057104271865; O'Brien M, 2017, J IMMUNOL METHODS, V447, P1, DOI 10.1016/j.jim.2017.03.004; Park CW, 2014, BIOSENS BIOELECTRON, V52, P379, DOI 10.1016/j.bios.2013.09.015; Pozzo T, 2018, ACS OMEGA, V3, P2628, DOI 10.1021/acsomega.7b02068; Prescher JA, 2010, CURR OPIN CHEM BIOL, V14, P80, DOI 10.1016/j.cbpa.2009.11.001; Ramesh CH., 2015, INT J LUMIN APPL, V5, P45; Ribeiro C, 2008, PHOTOCH PHOTOBIO SCI, V7, P1085, DOI 10.1039/b809935a; Roda A, 2009, TRAC-TREND ANAL CHEM, V28, P307, DOI 10.1016/j.trac.2008.11.015; Rothweiler U, 2015, EUR J MED CHEM, V94, P140, DOI 10.1016/j.ejmech.2015.02.035; Shama G, 2013, INT J HYG ENVIR HEAL, V216, P115, DOI 10.1016/j.ijheh.2012.03.009; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; STANFIELD CF, 1986, J ORG CHEM, V51, P5153, DOI 10.1021/jo00376a019; Sundlov JA, 2012, BIOCHEMISTRY-US, V51, P6493, DOI 10.1021/bi300934s; Thorne N, 2010, CHEM BIOL, V17, P646, DOI 10.1016/j.chembiol.2010.05.012; WHITE EH, 1969, J AM CHEM SOC, V91, P2178, DOI 10.1021/ja01036a093; White PJ, 1996, BIOCHEM J, V319, P343, DOI 10.1042/bj3190343; Working Party on Thrombolysis in the Management of Limb Ischemia, 2003, J VASC INTERV RADIOL, V7, pS337; Zegzouti H, 2009, ASSAY DRUG DEV TECHN, V7, P560, DOI 10.1089/adt.2009.0222; Zhang Y, 2005, J PHARMACOL EXP THER, V313, P1075, DOI 10.1124/jpet.104.082974; Zhou WH, 2006, CHEM COMMUN, P4620, DOI 10.1039/b610682j; Zhou WH, 2006, J AM CHEM SOC, V128, P3122, DOI 10.1021/ja058519o	42	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243747	10.1371/journal.pone.0243747	http://dx.doi.org/10.1371/journal.pone.0243747			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315907	gold, Green Published			2022-12-27	WOS:000600186100059
J	Asfaw, MA; Wegayehu, T; Gezmu, T; Bekele, A; Hailemariam, Z; Gebre, T				Asfaw, Mekuria Asnakew; Wegayehu, Teklu; Gezmu, Tigist; Bekele, Alemayehu; Hailemariam, Zeleke; Gebre, Teshome			Determinants of soil-transmitted helminth infections among pre-school-aged children in Gamo Gofa zone, Southern Ethiopia: A case-control study	PLOS ONE			English	Article								Background Pre-school aged children (PSAC) are highly affected by soil-transmitted helminths (STH), particularly in areas where water, sanitation, and hygiene (WASH) are inadequate. Context-specific evidence on determinants of STH infections in PSAC has not been well established in the study area. This study, therefore, aimed to fill these gaps in Gamo Gofa zone, Southern Ethiopia. Methods A community-based unmatched case-control study, nested in a cross-sectional survey, was conducted in January 2019. Cases and controls were identified based on any STH infection status using the Kato-Katz technique in stool sample examination. Data on social, demographic, economic, behavioral, and WASH related variables were collected from primary caregivers of children using pre-tested questionnaire. Determinants of STH infections were identified using multivariable logistic regression model using SPSS version 25. Results A total of 1206 PSAC (402 cases and 804 controls) participated in this study. Our study showed that the odds of STH infection were lowest among PSAC living in urban areas (AOR = 0.55, 95% CI: 0.39-0.79), among those from households with safe water source (AOR = 0.67, 95% CI: 0.47-0.0.93), and in those PSAC from households with shorter distance from water source (<30 minutes) (AOR = 0.51, 95% CI: 0.39-0.67). On the other hand, the odds of STH infection were highest among PSAC from households that had no functional hand washing facility (AOR = 1.36, 95% CI: 1.04-1.77), in those PSAC from households that had unclean latrine (AOR: 1.82, 95% CI: 1.19-2.78), and among those PSAC under caregivers who had lower score (<= 5) on knowledge related to STH transmission (AOR = 1.85, 95% CI: 1.13-3.01). Conclusions Given efforts required eliminating STH by 2030; the existing preventive chemotherapy intervention should be substantially strengthened with WASH and behavioral interventions. Thus, an urgent call for action is required to integrate context-specific interventions, particularly in rural areas.	[Asfaw, Mekuria Asnakew; Gezmu, Tigist; Bekele, Alemayehu] Arba Minch Univ, Collaborat Res & Training Ctr NTDs, Arba Minch, Ethiopia; [Wegayehu, Teklu] Arba Minch Univ, Coll Nat Sci, Dept Biol, Arba Minch, Ethiopia; [Hailemariam, Zeleke] Arba Minch Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Arba Minch, Ethiopia; [Gebre, Teshome] Int Trachoma Initiat, Task Force Global Hlth, Addis Ababa, Ethiopia	Arba Minch University; Arba Minch University; Arba Minch University	Asfaw, MA (corresponding author), Arba Minch Univ, Collaborat Res & Training Ctr NTDs, Arba Minch, Ethiopia.	maksambaramr23@gmail.com	Kassahun, Alemayehu Bekele/ABA-5651-2021	Kassahun, Alemayehu Bekele/0000-0001-8341-4855; Gezmu, Tigist/0000-0001-5937-8452; asfaw, mekuria/0000-0002-5718-0001	Collaborative Research and Training Center, Arba Minch University, Ethiopia	Collaborative Research and Training Center, Arba Minch University, Ethiopia	This study is made possible by the generous support of the Collaborative Research and Training Center, Arba Minch University, Ethiopia.	Albonico M, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000126; Alemu A, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2864-9; [Anonymous], 2006, Wkly Epidemiol Rec, V81, P145; Asfaw MA, 2020, PREVALENCE INTENSITY, DOI [10.1101/2020.05.14.20102277, DOI 10.1101/2020.05.14.20102277]; Bartram J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000367; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Brooker S, 2010, INT J PARASITOL, V40, P1137, DOI 10.1016/j.ijpara.2010.04.004; Central Statistical Agency, 2013, POP PROJ ETH 2007 20; Echazu A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004111; Federal Ministry of Health (FMoH) Nigeria, 2016, 2 EDITION ETHIOPIA N; Freeman MC, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007201; Freeman MC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002439; Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261; Hotez PJ, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P467; Nyantekyi LA, 2010, ETHIOP J HEALTH DEV, V24, P185; Oberhelman RA, 1998, AM J TROP MED HYG, V58, P470, DOI 10.4269/ajtmh.1998.58.470; Ojja S, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3289-0; Roy E, 2011, S AFR J CHILD HEALTH, V5, P78; Sacolo-Gwebu H, 2019, INFECT DIS POVERTY, V8, DOI 10.1186/s40249-019-0561-5; Singer BH, 2007, P NATL ACAD SCI USA, V104, P16038, DOI 10.1073/pnas.0700900104; Strunz EC, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001620; Utzinger J, 2010, ADV PARASIT, V72, P1, DOI 10.1016/S0065-308X(10)72001-7; Wang XJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040084, 10.1371/journal.pone.0040711, 10.1371/journal.pone.0038932, 10.1371/journal.pone.0052707, 10.1371/journal.pone.0036663, 10.1371/journal.pone.0045380, 10.1371/journal.pone.0052082, 10.1371/journal.pone.0040857, 10.1371/journal.pone.0047429, 10.1371/journal.pone.0045939, 10.1371/journal.pone.0045036]; WHO, 2015, WAT SAN HYG ACC SUST; WHO, 2020, ENDING NEGLECT ATTAI; WHO, 2006, COORD US ANTH DRUGS; WHO, 2012, EL SOIL TRANSM HELM; World Health Organization, 1994, KAT KATZ TECHN BENCH; World Health Organization, 2017, GUID PREV CHEM CONTR; Worrell CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150744; Ziegelbauer K, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001162	31	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243836	10.1371/journal.pone.0243836	http://dx.doi.org/10.1371/journal.pone.0243836			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306738	Green Published, gold			2022-12-27	WOS:000600144200045
J	Kitonsa, PJ; Nalutaaya, A; Mukiibi, J; Nakasolya, O; Isooba, D; Kamoga, C; Baik, Y; Robsky, K; Dowdy, DW; Katamba, A; Kendall, EA				Kitonsa, Peter J.; Nalutaaya, Annet; Mukiibi, James; Nakasolya, Olga; Isooba, David; Kamoga, Caleb; Baik, Yeonsoo; Robsky, Katherine; Dowdy, David W.; Katamba, Achilles; Kendall, Emily A.			Evaluation of underweight status may improve identification of the highest-risk patients during outpatient evaluation for pulmonary tuberculosis	PLOS ONE			English	Article							BODY-MASS INDEX	Background When evaluating symptomatic patients for tuberculosis (TB) without access to same-day diagnostic test results, clinicians often make empiric decisions about starting treatment. The number of TB symptoms and/or underweight status could help identify patients at highest risk for a positive result. We sought to evaluate the usefulness of BMI assessment and a count of characteristic TB symptoms for identifying patients at highest risk for TB. Methods We enrolled adult patients receiving pulmonary TB diagnoses and a representative sample with negative TB evaluations at four outpatient health facilities in Kampala, Uganda. We asked patients about symptoms of chronic cough, night sweats, chest pain, fever, hemoptysis, or weight loss; measured height and weight; and collected sputum for mycobacterial culture. We evaluated the diagnostic accuracy (for culture-positive TB) of two simple scoring systems: (a) number of TB symptoms, and (b) number of TB symptoms plus one or more additional points for underweight status (body mass index [BMI] <= 18.5 kg/m(2)). Results We included 121 patients with culture-positive TB and 370 patients with negative culture results (44 of whom had been recommended for TB treatment by evaluating clinicians). Of the six symptoms assessed, the median number of symptoms that patients reported was two (interquartile range [IQR]: 1, 3). The median BMI was 20.9 kg/m(2) (IQR: 18.6, 24.0), and 118 (24%) patients were underweight. Counting the number of symptoms provided an area under the Receiver Operating Characteristic curve (c-statistic) of 0.77 (95% confidence interval, CI: 0.72, 0.81) for identifying culture-positive TB; adding two points for underweight status increased the c-statistic to 0.81 (95%CI: 0.76, 0.85). A cutoff of >= 3 symptoms had sensitivity and specificity of 65% and 74%, whereas a score of >= 4 on the combined score (>= 2 symptoms if underweight, >= 4 symptoms if not underweight) gave higher sensitivity and specificity of 69% and 81% respectively. A sensitivity analysis defining TB by Xpert MTB/RIF status produced similar results. Conclusion A count of patients' TB symptoms may be useful in clinical decision-making about TB diagnosis. Consideration of underweight status adds additional diagnostic value.	[Kitonsa, Peter J.; Nalutaaya, Annet; Mukiibi, James; Nakasolya, Olga; Isooba, David; Kamoga, Caleb; Dowdy, David W.; Katamba, Achilles; Kendall, Emily A.] Makerere Univ, Coll Hlth Sci, Uganda TB Implementat Res Consortium, Kampala, Uganda; [Baik, Yeonsoo; Robsky, Katherine; Dowdy, David W.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Katamba, Achilles] Makerere Univ, Coll Hlth Sci, Dept Med, Upper Mulago Hill, Kampala, Uganda; [Kendall, Emily A.] Johns Hopkins Univ, Div Infect Dis, Dept Med, Baltimore, MD USA; [Kendall, Emily A.] Johns Hopkins Univ, Ctr TB Res, Dept Med, Baltimore, MD USA	Makerere University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Makerere University; Johns Hopkins University; Johns Hopkins University	Kitonsa, PJ (corresponding author), Makerere Univ, Coll Hlth Sci, Uganda TB Implementat Res Consortium, Kampala, Uganda.	kitonsap@gmail.com		Nalutaaya, Annet/0000-0003-3903-303X; Robsky, Katherine/0000-0001-7789-5779; James Kitonsa, Peter/0000-0003-2971-216X	US National Institute of Health [R01HL138728, K08AI127908]	US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	US National Institute of Health (R01HL138728 to DWD and K08AI127908 to EAK) https://grants.nih.gov/grants/oer.htm NO - The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; [Anonymous], 2012, REGEN MED S3, V7, pS14; Buregyeya E, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-586; Casha AR, 2017, J THORAC DIS, V9, pE301, DOI 10.21037/jtd.2017.03.47; Claassens MM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172881; Diriba Getu, 2017, BMC Res Notes, V10, P181, DOI 10.1186/s13104-017-2497-9; Hajian-Tilaki K, 2014, J BIOMED INFORM, V48, P193, DOI 10.1016/j.jbi.2014.02.013; Hanrahan CF, 2010, AIDS, V24, P1501, DOI 10.1097/QAD.0b013e32833a2a4a; Hoffmann CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062211; Horne D. J., 2019, Cochrane Database of Systematic Reviews, pCD009593; Joshi B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201731; Kirenga BJ, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1376-3; Lorent N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130179; McCarthy KJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207091; Nalugwa T, 2020, BMC HEALTH SERV RES, V20, DOI 10.1186/s12913-020-4997-x; Narasimhan P, 2013, PULM MED, V2013, DOI 10.1155/2013/828939; Ogbo FA, 2018, TROP MED HEALTH, V46, DOI 10.1186/s41182-018-0114-9; Prince L, 2016, TROP MED INT HEALTH, V21, P1272, DOI 10.1111/tmi.12763; Semunigus T, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0165-x; Silva DR, 2018, J BRAS PNEUMOL, V44, P145, DOI [10.1590/s1806-37562017000000443, 10.1590/S1806-37562017000000443]; StataCorp, 2013, STAT STAT SOFTW REL; Thomas BE, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2019-001974; WHO, 2020, TUBERCULOSIS; WHO, 2015, WORLD HEAL ORGAN, V58, P7250; Wynne A., 2014, INT J AFRICA NURS SC, V1, P6, DOI [10.1016/j.ijans.2014.05.001, DOI 10.1016/J.IJANS.2014.05.001]; Yen YF, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002300; Zhang HR, 2017, SCI REP-UK, V7, DOI 10.1038/srep41933	27	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243542	10.1371/journal.pone.0243542	http://dx.doi.org/10.1371/journal.pone.0243542			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306710	gold, Green Published			2022-12-27	WOS:000600144200002
J	Nascimento, MS; Baggio, DM; Fascina, LP; do Prado, C				Nascimento, Milena Siciliano; Baggio, Diana Milena; Fascina, Linus Pauling; do Prado, Cristiane			Impact of social isolation due to COVID-19 on the seasonality of pediatric respiratory diseases	PLOS ONE			English	Article							AIR-POLLUTION; DAY-CARE; INFECTIONS; SYMPTOMS	Introduction Respiratory tract diseases are the major cause of morbidity and mortality in children under the age of 5 years, constituting the highest rate of hospitalization in this age group. Objectives To determine the prevalence of hospitalizations for respiratory diseases in childhood in the last 5 years and to assess the impact of social isolation due to COVID-19 on the seasonal behavior of these diseases. Methods A cross-sectional clinical study was carried out, with a survey of all patients aged 0 to 17 years who were admitted with a diagnosis of respiratory diseases between January 2015 and July 2020. The database was delivered to the researchers anonymized. The variables used for analysis were date of admission, date of discharge, length of stay, age, sex and diagnosis. In order to make the analysis possible, the diagnoses were grouped into upper respiratory infection (URI), asthma / bronchitis, bronchiolitis and pneumonia. Results 2236 admissions were included in the study. Children under 5 years old account for 81% of hospitalizations for respiratory disease in our population. In the adjusted model, an average reduction of 38 hospitalizations was observed in the period of social isolation (coefficient: -37.66; 95% CI (- 68.17; -7.15); p = 0.016). Conclusion The social isolation measures adopted during the COVID-19 pandemic dramatically interfered with the seasonality of childhood respiratory diseases. This was reflected in the unexpected reduction in the number of hospitalizations in the pediatric population during this period.	[Nascimento, Milena Siciliano; Baggio, Diana Milena; Fascina, Linus Pauling; do Prado, Cristiane] Hosp Israelite Albert Einstein, Dept Pediat, Sao Paulo, Brazil	Hospital Israelita Albert Einstein; Universidade Federal de Sao Paulo (UNIFESP)	Nascimento, MS (corresponding author), Hosp Israelite Albert Einstein, Dept Pediat, Sao Paulo, Brazil.	milenasn@einstein.br						Antunes Bianca Brandão de Paula, 2020, Rev. bras. ter. intensiva, V32, P213, DOI 10.5935/0103-507x.20200028; Aquino EML, 2020, CIENC SAUDE COLETIVA, V25, P2423, DOI 10.1590/1413-81232020256.1.10502020; Caudri D, 2009, AM J RESP CRIT CARE, V180, P491, DOI 10.1164/rccm.200903-0327OC; de Hoog MLA, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-107; de Oliveira TG, 2011, EINSTEIN-SAO PAULO, V9, P514, DOI [10.1590/S1679-45082011AO1908, 10.1590/s1679-45082011ao1908]; Farhat SCL, 2005, BRAZ J MED BIOL RES, V38, P227, DOI 10.1590/S0100-879X2005000200011; Fisman D, 2012, CLIN MICROBIOL INFEC, V18, P946, DOI 10.1111/j.1469-0691.2012.03968.x; Gosai A, 2009, AUST NZ J PUBL HEAL, V33, P521, DOI 10.1111/j.1753-6405.2009.00447.x; Gouveia N, 2018, ENVIRON POLLUT, V232, P385, DOI 10.1016/j.envpol.2017.08.125; Green RS, 2010, INT J PUBLIC HEALTH, V55, P113, DOI 10.1007/s00038-009-0076-0; Hatoun J, 2020, PEDIATRICS, V146, DOI 10.1542/peds.2020-006460; Itaya T, 2020, INT J INFECT DIS, V97, P78, DOI 10.1016/j.ijid.2020.05.088; Kuitunen I, 2020, PEDIATR INFECT DIS J, V39, pE423, DOI 10.1097/INF.0000000000002845; MONTO AS, 1994, EPIDEMIOL REV, V16, P351, DOI 10.1093/oxfordjournals.epirev.a036158; Natali Renata Martins de T, 2011, Rev. paul. pediatr., V29, P584; da Silva JLR, 2011, J BRAS PNEUMOL, V37, P759, DOI 10.1590/S1806-37132011000600009; Sakamoto H, 2020, JAMA-J AM MED ASSOC, V323, P1969, DOI 10.1001/jama.2020.6173; Schuez-Havupalo L, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014635; Smith B, 2020, PUBLIC HEALTH RES PR, V30, DOI 10.17061/phrp3022008; Sonego M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116380; Vissing NH, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-0933; Wilder-Smith A, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa020; Yen CY, 2019, J MICROBIOL IMMUNOL, V52, P902, DOI 10.1016/j.jmii.2019.08.013; Zomer TP, 2016, EPIDEMIOL INFECT, V144, P2552, DOI 10.1017/S0950268816000911	24	27	28	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243694	10.1371/journal.pone.0243694	http://dx.doi.org/10.1371/journal.pone.0243694			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306735	gold, Green Published			2022-12-27	WOS:000600144200063
J	Maru, S; Patil, U; Carroll-Bennett, R; Baum, A; Bohn-Hemmerdinger, T; Ditchik, A; Scanlon, ML; Krishnan, P; Bogaert, K; Woodbury, C; Maru, D; Noble, L; Wasserman, R; Brown, B; Vreeman, R; Masci, J				Maru, Sheela; Patil, Uday; Carroll-Bennett, Rachel; Baum, Aaron; Bohn-Hemmerdinger, Tracy; Ditchik, Andrew; Scanlon, Michael L.; Krishnan, Parvathy; Bogaert, Kelly; Woodbury, Carson; Maru, Duncan; Noble, Lawrence; Wasserman, Randi; Brown, Barry; Vreeman, Rachel; Masci, Joseph			Universal screening for SARS-CoV-2 infection among pregnant women at Elmhurst Hospital Center, Queens, New York	PLOS ONE			English	Article								Background Universal screening for SARS-CoV-2 infection on Labor and Delivery (L&D) units is a critical strategy to manage patient and health worker safety, especially in a vulnerable high-prevalence community. We describe the results of a SARS-CoV-2 universal screening program at the L&D Unit at Elmhurst Hospital in Queens, NY, a 545-bed public hospital serving a diverse, largely immigrant and low-income patient population and an epicenter of the global pandemic. Methods and findings We conducted a retrospective cross-sectional study. All pregnant women admitted to the L&D Unit of Elmhurst Hospital from March 29, 2020 to April 22, 2020 were included for analysis. The primary outcomes of the study were: (1) SARS-CoV-2 positivity among universally screened pregnant women, stratified by demographic characteristics, maternal comorbidities, and delivery outcomes; and (2) Symptomatic or asymptomatic presentation at the time of testing among SARS-CoV-2 positive women. A total of 126 obstetric patients were screened for SARS-CoV-2 between March 29 and April 22. Of these, 37% were positive. Of the women who tested positive, 72% were asymptomatic at the time of testing. Patients who tested positive for SARS-CoV-2 were more likely to be of Hispanic ethnicity (unadjusted difference 24.4 percentage points, CI 7.9, 41.0) and report their primary language as Spanish (unadjusted difference 32.9 percentage points, CI 15.8, 49.9) than patients who tested negative. Conclusions In this retrospective cross-sectional study of data from a universal SARS-Cov-2 screening program implemented in the L&D unit of a safety-net hospital in Queens, New York, we found over one-third of pregnant women testing positive, the majority of those asymptomatic. The rationale for universal screening at the L&D Unit at Elmhurst Hospital was to ensure safety of patients and staff during an acute surge in SARS-Cov-2 infections through appropriate identification and isolation of pregnant women with positive test results. Women were roomed by their SARS-CoV-2 status given increasing space limitations. In addition, postpartum counseling was tailored to infection status. We quickly established discharge counseling and follow-up protocols tailored to their specific social needs. The experience at Elmhurst Hospital is instructive for other L&D units serving vulnerable populations and for pandemic preparedness.	[Maru, Sheela; Baum, Aaron; Scanlon, Michael L.; Maru, Duncan; Vreeman, Rachel] Icahn Sch Med Mt Sinai, Dept Hlth Syst Design & Global Hlth, New York, NY 10029 USA; [Maru, Sheela; Baum, Aaron; Scanlon, Michael L.; Maru, Duncan; Vreeman, Rachel] Icahn Sch Med Mt Sinai, Arnhold Inst Global Hlth, New York, NY 10029 USA; [Maru, Sheela; Carroll-Bennett, Rachel; Bohn-Hemmerdinger, Tracy; Ditchik, Andrew; Bogaert, Kelly; Woodbury, Carson; Brown, Barry] Icahn Sch Med Mt Sinai, Dept Obstet Gynecol & Reprod Sci, New York, NY 10029 USA; [Maru, Sheela; Patil, Uday; Carroll-Bennett, Rachel; Bohn-Hemmerdinger, Tracy; Ditchik, Andrew; Krishnan, Parvathy; Bogaert, Kelly; Woodbury, Carson; Maru, Duncan; Noble, Lawrence; Wasserman, Randi; Brown, Barry; Masci, Joseph] New York City Hlth Hosp Elmhurst, New York, NY 11373 USA; [Patil, Uday; Krishnan, Parvathy; Maru, Duncan; Noble, Lawrence; Wasserman, Randi] Icahn Sch Med Mt Sinai, Dept Pediat, New York, NY 10029 USA; [Maru, Duncan; Masci, Joseph] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Maru, S (corresponding author), Icahn Sch Med Mt Sinai, Dept Hlth Syst Design & Global Hlth, New York, NY 10029 USA.; Maru, S (corresponding author), Icahn Sch Med Mt Sinai, Arnhold Inst Global Hlth, New York, NY 10029 USA.; Maru, S (corresponding author), Icahn Sch Med Mt Sinai, Dept Obstet Gynecol & Reprod Sci, New York, NY 10029 USA.; Maru, S (corresponding author), New York City Hlth Hosp Elmhurst, New York, NY 11373 USA.	Sheela.Maru@mssm.edu		Maru, Duncan/0000-0002-5923-6910				Andrikopoulou M, 2020, OBSTET GYNECOL, V136, P291, DOI 10.1097/AOG.0000000000003996; [Anonymous], 2019, COMM HLTH NEEDS ASS; Bianco A, 2020, OBSTET GYNECOL, V136, P283, DOI 10.1097/AOG.0000000000003985; Government of New York City, 2020, COVID 19 DEATHS RAC; Khoury R, 2020, OBSTET GYNECOL, V136, P273, DOI 10.1097/AOG.0000000000004025; Krieger N, 2020, HLTH AFFAIRS BLOG, DOI DOI 10.1377/HBL0G20200414.238084/FULL/; Miller ES, 2020, OBSTET GYNECOL, V136, P232, DOI 10.1097/AOG.0000000000003983; Mizumoto K, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.10.2000180; NYC Health, COVID 19 DAT; Rothfeld M, 2020, NEW YORK TIMES; Shear, 2020, NEW YORK TIMES; Stringer SM, 2015, NYC HOUSING BRIEF HI; Sutton D, 2020, NEW ENGL J MED, V382, P2163, DOI 10.1056/NEJMc2009316; Vintzileos WS, 2020, AM J OBSTET GYNECOLO; Wadhera RK, 2020, JAMA-J AM MED ASSOC, V323, P2192, DOI 10.1001/jama.2020.7197; Wei WE, 2020, MMWR-MORBID MORTAL W, V69, p411e5, DOI DOI 10.15585/mmwr.mm6914e1	16	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0238409	10.1371/journal.pone.0238409	http://dx.doi.org/10.1371/journal.pone.0238409			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301498	Green Published, gold, Green Submitted			2022-12-27	WOS:000600143100044
J	Ko, UW; Cho, EJ; Oh, HB; Koo, HJ; Do, KH; Song, JW				Ko, Ui Won; Cho, Eun Jung; Oh, Heung-Bum; Koo, Hyun Jung; Do, Kyung-Hyun; Song, Jin Woo			Serum Krebs von den Lungen-6 level predicts disease progression in interstitial lung disease	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; SURFACTANT-PROTEIN-A; PROGNOSTIC VALUE; ACUTE EXACERBATION; CIRCULATING KL-6; CT FINDINGS; SURVIVAL; STANDARDIZATION; PNEUMONIA; MARKER	Disease progression (DP) in interstitial lung disease (ILD) is variable and difficult to predict. In previous reports, serum Krebs von den Lungen-6 (KL-6) was suggested to be useful in diagnosing and predicting survival in ILD. The aim of our study was to investigate the usefulness of serum KL-6 as a predictor of DP in ILD. Clinical data of 199 patients with ILD (idiopathic pulmonary fibrosis: 22.8%) were prospectively collected and serum KL-6 levels were measured. DP was defined as a relative decline in forced vital capacity (FVC) >= 10%, acute exacerbation, or death during follow-up. The median follow-up period was 11.1 months. The mean age of the subjects was 62.2 years, and 59.8% were male. DP occurred in 21.6% of patients. The progressed group showed lower FVC, lower diffusing capacity for carbon monoxide, lower the minimum oxygen saturation during the 6-minute walk test, higher fibrosis scores on high-resolution computed tomography, and higher KL-6 levels (826.3 vs. 629.0 U/mL; p < 0.001) than those of the non-progressed group. In receiver operating characteristic curve analysis, serum KL-6 levels were a significant predictor of DP in ILD (area under the curve = 0.629, p = 0.009, and the optimal cut-off level was 811 U/mL). In multivariable Cox analysis, high serum KL-6 levels (>= 800 U/mL) were only independently associated with DP in ILD (HR 2.689, 95% CI 1.445-5.004, P = 0.002). Serum KL-6 levels might be useful to predict DP in patients with ILD.	[Ko, Ui Won; Song, Jin Woo] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pulm & Crit Care Med, Seoul, South Korea; [Ko, Ui Won] Gachon Univ, Gil Med Ctr, Dept Internal Med, Incheon, South Korea; [Cho, Eun Jung; Oh, Heung-Bum] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Lab Med, Seoul, South Korea; [Koo, Hyun Jung; Do, Kyung-Hyun] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul, South Korea	University of Ulsan; Asan Medical Center; Gachon University; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Song, JW (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pulm & Crit Care Med, Seoul, South Korea.	jwsongasan@gmail.com	Song, Jin/HHS-8731-2022; song, jin woo/AAW-3876-2021	ko, uiwon/0000-0002-4658-0157	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science and Technology, Seoul, Republic of Korea [NRF-2019R1A2C2008541]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science and Technology, Seoul, Republic of Korea	Reagents for KL-6 were provided by KYUNG IL MEDICAL INC. for this study. This study (JWS) was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF, https://www.nrf.re.kr/index) funded by the Ministry of Science and Technology (NRF-2019R1A2C2008541), Seoul, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Salmi QA, 2005, CHEST, V127, P403, DOI 10.1378/chest.127.1.403; Best AC, 2008, RADIOLOGY, V246, P935, DOI 10.1148/radiol.2463062200; Cho Eun Jung, 2019, Ann Lab Med, V39, P245, DOI 10.3343/alm.2019.39.3.245; Collard HR, 2016, AM J RESP CRIT CARE, V194, P265, DOI 10.1164/rccm.201604-0801CI; Collard HR, 2003, AM J RESP CRIT CARE, V168, P538, DOI 10.1164/rccm.200211-1311OC; Cottin V, 2005, EUR RESPIR J, V26, P586, DOI 10.1183/09031936.05.00021005; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Duchemann B, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.02419-2016; Honda K, 2011, BRIT J RADIOL, V84, P229, DOI 10.1259/bjr/65287605; Huang HB, 2013, BIOSCI TRENDS, V7, P172, DOI 10.5582/bst.2013.v7.4.172; Ichikado K, 1997, AM J ROENTGENOL, V168, P333, DOI 10.2214/ajr.168.2.9016201; Ishikawa N, 2012, RESPIR INVESTIG, V50, P3, DOI 10.1016/j.resinv.2012.02.001; Jegal Y, 2005, AM J RESP CRIT CARE, V171, P639, DOI 10.1164/rccm.200403-331OC; Jensen RL, 2007, CHEST, V132, P388, DOI 10.1378/chest.06-1998; Kinder BW, 2009, CHEST, V135, P1557, DOI 10.1378/chest.08-2209; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; King TE, 2001, AM J RESP CRIT CARE, V164, P1171, DOI 10.1164/ajrccm.164.7.2003140; Kinoshita F, 2004, RESP MED, V98, P1131, DOI 10.1016/j.rmed.2004.04.003; KOBAYASHI J, 1995, CHEST, V108, P311, DOI 10.1378/chest.108.2.311; KOHNO N, 1993, AM REV RESPIR DIS, V148, P637, DOI 10.1164/ajrccm/148.3.637; Lama VN, 2003, AM J RESP CRIT CARE, V168, P1084, DOI 10.1164/rccm.200302-219OC; Latsi PI, 2003, AM J RESP CRIT CARE, V168, P531, DOI 10.1164/rccm.200210-1245OC; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; Mejia M, 2009, CHEST, V136, P10, DOI 10.1378/chest.08-2306; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Nakajima H, 2000, J RHEUMATOL, V27, P1164; Ohnishi H, 2002, AM J RESP CRIT CARE, V165, P378, DOI 10.1164/ajrccm.165.3.2107134; Ohshimo S, 2014, RESP MED, V108, P1031, DOI 10.1016/j.rmed.2014.04.009; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Romei C, 2015, RADIOL MED, V120, P930, DOI 10.1007/s11547-015-0526-0; Satoh H, 2006, J INTERN MED, V260, P429, DOI 10.1111/j.1365-2796.2006.01704.x; Selman M, 2012, AM J RESP CRIT CARE, V186, P314, DOI 10.1164/rccm.201203-0513CI; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Tsing AL, 2019, COMMON KNOWL, V25, P143, DOI 10.1215/0961754X-7299210; Tzouvelekis A, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-78; Vesely R, 2004, J RHEUMATOL, V31, P795; Wanger J, 2005, EUR RESPIR J, V26, P511, DOI 10.1183/09031936.05.00035005; WELLS AU, 1993, AM REV RESPIR DIS, V148, P1076, DOI 10.1164/ajrccm/148.4_Pt_1.1076; Yokoyama A, 1998, AM J RESP CRIT CARE, V158, P1680, DOI 10.1164/ajrccm.158.5.9803115; Yokoyama A, 2006, RESPIROLOGY, V11, P164, DOI 10.1111/j.1440-1843.2006.00834.x	40	7	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0244114	10.1371/journal.pone.0244114	http://dx.doi.org/10.1371/journal.pone.0244114			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332430	Green Published, gold			2022-12-27	WOS:000601310900001
J	Li, XY; Si, HY; Chen, YM; Li, SH; Yin, NN; Wang, ZL				Li, Xiaoyuan; Si, Hongyu; Chen, Yamin; Li, Shouhao; Yin, Ningning; Wang, Zhenlong			Effects of fitness qigong and tai chi on middle-aged and elderly patients with type 2 diabetes mellitus	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; DIAGNOSTIC-CRITERIA; PREVENTION PROGRAM; ASIAN INDIANS; C-PEPTIDE; PATHOPHYSIOLOGY; POPULATION; INCREASE; OBESITY; TRIAL	Currently, qigong and tai chi exercises are the two most common preventive as well as therapeutic interventions for chronic metabolic diseases such as type 2 diabetes mellitus (T2DM). However, the quantitative evaluation of these interventions is limited. This study aimed to evaluate the therapeutic efficacy of qigong and tai chi intervention in middle-aged and older adults with T2DM. The study included 103 eligible participants, who were randomized to participate for 12 weeks, in one of the following intervention groups for the treatment of T2DM: fitness qigong, tai chi, and control group. Three biochemical measures, including fasting plasma glucose (FPG), glycated hemoglobin (HbA1C), and C-peptide (C-P) levels, assessed at baseline and 12 weeks, served as the primary outcome measures. During the training process, 16 of the 103 participants dropped out. After the 12-week intervention, there were significant influences on HbA1C (F-2,F-83 = 4.88, p = 0.010) and C-P levels (F-2,F-83 = 3.64, p = 0.031). Moreover, significant reduction in C-P levels was observed after 12-week tai chi practice (p = 0.004). Furthermore, there was a significant negative correlation between the duration of T2DM and the relative changes in FPG levels after qigong intervention, and the relative changes in HbA1C levels were positively correlated with waist-to-height ratio after tai chi practice. Our study suggests that targeted qigong exercise might have a better interventional effect on patients with a longer duration of T2DM, while tai chi might be risky for people with central obesity.	[Li, Xiaoyuan; Chen, Yamin; Li, Shouhao] Zhengzhou Univ, Sch Elect Engn, Zhengzhou, Peoples R China; [Li, Xiaoyuan; Si, Hongyu; Yin, Ningning] Zhengzhou Univ, Coll Phys Educ, Zhengzhou, Peoples R China; [Li, Xiaoyuan; Si, Hongyu] Fitness Qigong Sci Res Ctr China, Zhengzhou, Peoples R China; [Wang, Zhenlong] Zhengzhou Univ, Sch Life Sci, Zhengzhou, Peoples R China	Zhengzhou University; Zhengzhou University; Zhengzhou University	Wang, ZL (corresponding author), Zhengzhou Univ, Sch Life Sci, Zhengzhou, Peoples R China.	wzl@zzu.edu.cn			Management Center of Health-care Qigong of the National Sports Bureau [QG2017019]; Key R&D and Promotion Projects from the Science and Technology Department of Henan Province [192102310026]; Open Foundation of Henan Key laboratory of Brain Science and Brain-Computer Interface Technology [HNBBL17006]	Management Center of Health-care Qigong of the National Sports Bureau; Key R&D and Promotion Projects from the Science and Technology Department of Henan Province; Open Foundation of Henan Key laboratory of Brain Science and Brain-Computer Interface Technology	This research was supported by a grant (QG2017019) from the Management Center of Health-care Qigong of the National Sports Bureau, the Key R&D and Promotion Projects (192102310026) from the Science and Technology Department of Henan Province, and Open Foundation of Henan Key laboratory of Brain Science and Brain-Computer Interface Technology (No.HNBBL17006).	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc10-S062, 10.2337/dc13-S067, 10.2337/dc12-s064, 10.2337/dc11-S062]; [Anonymous], 2014, HAEMOPHILIA, V20, P79; [Anonymous], 2014, OBESITY SILVER SP S2, V22, pS40; [Anonymous], 2009, S AFR CRIME Q, V30, P45; Bhardwaj S, 2008, ASIA PAC J CLIN NUTR, V17, P172; Cash JC, 2017, FAMILY PRACTICE GUID; Charles MA, 1996, LANCET, V348, P1657, DOI 10.1016/S0140-6736(05)65719-4; Chen Z, 2009, CHEN STYLE TAI CHI Q; Ciulla TA, 2003, DIABETES CARE, V26, P2653, DOI 10.2337/diacare.26.9.2653; Galalain A.M., 2019, EUR J BIOL, Vl4, P1; Gavin JR, 1997, DIABETES CARE, V20, P1183; Geng T, 2008, GANSU CHIN MED, P10; Gomez-Marcos MA, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-90; Huffman FG, 2013, AM J LIFESTYLE MED, V7, P104, DOI 10.1177/1559827612469337; Imperatore G, 2012, DIABETES CARE, V35, P2515, DOI 10.2337/dc12-0669; Johnson RJ, 2013, DIABETES, V62, P3307, DOI 10.2337/db12-1814; Kan Y, 2004, JILIN J TRADIT CHIN, V24, P11; Kitabchi AE, 2009, DIABETES CARE, V32, P1335, DOI 10.2337/dc09-9032; Kramer MK, 2009, AM J PREV MED, V37, P505, DOI 10.1016/j.amepre.2009.07.020; Krentz AJ, 2005, DRUGS, V65, P385, DOI 10.2165/00003495-200565030-00005; Labocha MK, 2014, OIKOS, V123, P111, DOI 10.1111/j.1600-0706.2013.00755.x; Jorge AJL, 2013, REV PORT CARDIOL, V32, P647, DOI 10.1016/j.repc.2012.10.019; LANDINOLSSON M, 1990, DIABETOLOGIA, V33, P561, DOI 10.1007/BF00404145; Lee MS, 2015, MATURITAS, V80, P14, DOI 10.1016/j.maturitas.2014.09.008; Lee MS, 2009, COMPLEMENT THER MED, V17, P236, DOI 10.1016/j.ctim.2009.05.001; Leutholtz B. C., 2011, EXERCISE DIS MANAGEM; Li FZ, 2005, J GERONTOL A-BIOL, V60, P187, DOI 10.1093/gerona/60.2.187; Li Hongchen, 2015, CHIN J GERONTOL, V35, P1293; Lin Chia-Ling, 2013, Hu Li Za Zhi, V60, P69, DOI 10.6224/JN.60.1.69; Lindstrom J, 2003, DIABETES CARE, V26, P3230, DOI 10.2337/diacare.26.12.3230; Liu T., 2010, CHINESE MEDICAL QIGO; Maruthur NM, 2016, ANN INTERN MED, V164, P740, DOI 10.7326/M15-2650; Misra A, 2009, J Assoc Physicians India, V57, P163; Moon JS, 2014, ACTA DIABETOL, V51, P277, DOI 10.1007/s00592-013-0553-z; Ohkura T, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-21; Perera DP, 2013, E MEDITERR HEALTH J, V19, P644; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; RENDELL M, 1981, ARCH INTERN MED, V141, P1617, DOI 10.1001/archinte.141.12.1617; Resnick HE, 1999, BRIT MED J, V318, P531, DOI 10.1136/bmj.318.7182.531; Ruchat SM, 2013, DIABETES-METAB RES, V29, P334, DOI 10.1002/dmrr.2402; Saenz A, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002966.pub3; Shoback DM, 2017, GREENSPANS BASIC CLI; 송민선, 2005, Diabetes and Metabolism Journal, V29, P140; Stefan N, 2011, LANCET, V377, P1917, DOI 10.1016/S0140-6736(11)60805-2; Sterelny K, 2003, M M COG SCI, P1; TAHARA Y, 1995, DIABETES CARE, V18, P440, DOI 10.2337/diacare.18.4.440; Tfayli H, 2009, ARQ BRAS ENDOCRINOL, V53, P165, DOI 10.1590/S0004-27302009000200008; Tripathy HB., 2012, RSSDI TXB DIABETES M, DOI 10.5005/jp/books/11487; Vos T, 2017, LANCET, V390, P1211, DOI 10.1016/S0140-6736(17)32154-2; Wang CC, 2010, NEW ENGL J MED, V363, P743, DOI 10.1056/NEJMoa0912611; Wasserman DH, 2009, AM J PHYSIOL-ENDOC M, V296, pE11, DOI 10.1152/ajpendo.90563.2008; Wayne PM, 2008, J ALTERN COMPLEM MED, V14, P191, DOI 10.1089/acm.2007.7170B; Williams LB, 2013, CONTEMP CLIN TRIALS, V34, P336, DOI 10.1016/j.cct.2013.01.002; Williamson R T, 2009, Practitioner, V253, P37; Wu YM, 2008, CHIN PRIM HLTH CARE, V02, P80; Yang K, 2017, INNOV AGING, V1, P256; Yeh SH, 2009, BRIT J SPORT MED, V43, P845, DOI 10.1136/bjsm.2007.043562; Yeh SH, 2007, DIABETES CARE, V30, P716, DOI 10.2337/dc06-1507; Youngwanichsetha S., 2013, Focus on Alternative and Complementary Therapies, V18, P182, DOI 10.1111/fct.12064; Zaccardi F, 2016, POSTGRAD MED J, V92, P63, DOI 10.1136/postgradmedj-2015-133281; 吴云川, 2015, [中国老年学杂志, Chinese Journal of Gerontology], V35, P5218	61	6	6	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243989	10.1371/journal.pone.0243989	http://dx.doi.org/10.1371/journal.pone.0243989			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332396	Green Published, gold			2022-12-27	WOS:000601310900067
J	Monkley, S; Krishnaswamy, JK; Goransson, M; Clausen, M; Meuller, J; Thorn, K; Hicks, R; Delaney, S; Stjernborg, L				Monkley, Susan; Krishnaswamy, Jayendra Kumar; Goransson, Melker; Clausen, Maryam; Meuller, Johan; Thorn, Kristofer; Hicks, Ryan; Delaney, Stephen; Stjernborg, Louise			Optimised generation of iPSC-derived macrophages and dendritic cells that are functionally and transcriptionally similar to their primary counterparts	PLOS ONE			English	Article							IN-VITRO; MONOCYTES; EXPRESSION; LINES	Induced pluripotent stem cells (iPSC) offer the possibility to generate diverse disease-relevant cell types, from any genetic background with the use of cellular reprogramming and directed differentiation. This provides a powerful platform for disease modeling, drug screening and cell therapeutics. The critical question is how the differentiated iPSC-derived cells translate to their primary counterparts. Our refinement of a published differentiation protocol produces a CD14+ monocytic lineage at a higher yield, in a smaller format and at a lower cost. These iPSC-derived monocytes can be further differentiated into macrophages or dendritic cells (DC), both with similar morphological and functional profiles as compared to their primary counterparts. Transcriptomic analysis of iPSC-derived cells at different stages of differentiation as well as comparison to their blood-derived counterparts demonstrates a complete switch of iPSCs to cells expressing a monocyte, macrophage or DC specific gene profile. iPSC-derived macrophages respond to LPS treatment by inducing expression of classic macrophage pro-inflammatory response markers. Interestingly, though iPSC-derived DC show similarities to monocyte derived DC, they are more similar transcriptionally to a newly described subpopulation of AXL(+) DC. Thus, our study provides a detailed and accurate profile of iPSC-derived monocytic lineage cells.	[Monkley, Susan; Thorn, Kristofer] AstraZeneca, BioPharmaceut R&D, Translat Sci & Expt Med Res & Early Dev, Resp & Immunol R&I, Gothenburg, Sweden; [Krishnaswamy, Jayendra Kumar; Goransson, Melker; Delaney, Stephen] AstraZeneca, BioPharmaceut R&D, Biosci Res & Early Dev, Resp & Immunol R&I, Gothenburg, Sweden; [Clausen, Maryam; Meuller, Johan; Stjernborg, Louise] AstraZeneca, Discovery Biol, Discovery Sci, BioPharmaceut R&D, Gothenburg, Sweden; [Hicks, Ryan] AstraZeneca, Res & Early Dev, Cardiovasc Renal & Metab CVRM, BioPharmaceut R&D Cell Therapy, Gothenburg, Sweden; [Krishnaswamy, Jayendra Kumar] Galderma Pharma SA, Lausanne, Switzerland; [Meuller, Johan] Molnlycke Healthcare, Gothenburg, Sweden	AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca	Monkley, S (corresponding author), AstraZeneca, BioPharmaceut R&D, Translat Sci & Expt Med Res & Early Dev, Resp & Immunol R&I, Gothenburg, Sweden.	susan.monkley1@astrazeneca.com		Hicks, Ryan/0000-0002-3367-6272; Monkley, Susan/0000-0001-9174-6278; Krishnaswamy, Jayendra Kumar/0000-0002-7939-6559				Ajami B, 2018, IMMUNOL CELL BIOL, V96, P125, DOI 10.1111/imcb.12004; Alasoo K, 2015, SCI REP-UK, V5, DOI 10.1038/srep12524; [Anonymous], 2012, P NATL ACAD SCI USA, V109, pE1377; Balan S, 2014, J IMMUNOL, V193, P1622, DOI 10.4049/jimmunol.1401243; BAUER J, 1988, BLOOD, V72, P1134; Bosshart H, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.08.53; Buchrieser J, 2017, STEM CELL REP, V8, P334, DOI 10.1016/j.stemcr.2016.12.020; Dieterlen MT, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/5946807; Elkord E, 2005, IMMUNOLOGY, V114, P204, DOI 10.1111/j.1365-2567.2004.02076.x; Fugitive Literacies Collective, 2020, ENGLISH ED, V52, pN3; Geraghty RJ, 2014, BRIT J CANCER, V111, P1021, DOI 10.1038/bjc.2014.166; Gordon S, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0392-4; Guerriero JL, 2018, TRENDS MOL MED, V24, P472, DOI 10.1016/j.molmed.2018.03.006; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Gutbier S, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21134808; Haideri SS, 2017, NPJ REGEN MED, V2, DOI 10.1038/s41536-017-0017-0; Helft J, 2017, CELL REP, V20, P529, DOI 10.1016/j.celrep.2017.06.075; Huang Y, 2017, CELL TRANSPLANT, V26, P1380, DOI 10.1177/0963689717720281; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kitadani J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23120-z; Knowles A, 2015, PHILOSOPHIA-J CONT F, V5, P1; Lee CZW, 2018, NAT REV IMMUNOL, V18, P716, DOI 10.1038/s41577-018-0054-y; Lee SWL, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00416; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Li JN, 2007, J LEUKOCYTE BIOL, V81, P328, DOI 10.1189/jlb.0206124; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Malpass Katy, 2012, Nat Rev Neurol, V8, P533, DOI 10.1038/nrneurol.2012.185; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Mills CD, 2016, CANCER RES, V76, P513, DOI 10.1158/0008-5472.CAN-15-1737; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; NEWMAN SL, 1982, J EXP MED, V156, P430, DOI 10.1084/jem.156.2.430; Nikolic MZ, 2019, ERJ OPEN RES, V5, DOI 10.1183/23120541.00194-2018; Patro R, 2014, NAT BIOTECHNOL, V32, P462, DOI 10.1038/nbt.2862; Qu CF, 2014, INT J INFECT DIS, V19, P1, DOI 10.1016/j.ijid.2013.09.023; Shi Jianting, 2019, Curr Protoc Stem Cell Biol, V48, pe74, DOI 10.1002/cpsc.74; Sjogren AKM, 2014, ARCH TOXICOL, V88, P1427, DOI 10.1007/s00204-014-1265-z; Victoni T, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0613-y; Villani AC, 2017, SCIENCE, V356, DOI 10.1126/science.aah4573; Yanagimachi MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059243; Young LJ, 2007, P NATL ACAD SCI USA, V104, P17753, DOI 10.1073/pnas.0708622104; Zhang HR, 2017, ARTERIOSCL THROM VAS, V37, P2000, DOI 10.1161/ATVBAHA.117.309195; Ziegler-Heitbrock L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00023	42	8	8	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243807	10.1371/journal.pone.0243807	http://dx.doi.org/10.1371/journal.pone.0243807			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332401	Green Published, gold			2022-12-27	WOS:000601310900064
J	Wuestman, M; Frenken, K; Wanzenbock, I				Wuestman, Mignon; Frenken, Koen; Wanzenbock, Iris			A genealogical approach to academic success	PLOS ONE			English	Article							PRODUCTIVITY; PERFORMANCE; DISTANCE; INDUSTRY; NOVELTY; FIRMS; PHD	We analyse academic success using a genealogical approach to the careers of over 95,000 scientists in mathematics and associated fields in physics and chemistry. We look at the effect of Ph.D. supervisors (one's mentors) on the number of Ph.D. students that one supervises later on (one's mentees) as a measure of academic success. Supervisors generally provide important inputs in Ph.D. projects, which can have long-lasting effects on academic careers. Moreover, having multiple supervisors exposes one to a diversity of inputs. We show that Ph.D. students benefit from having multiple supervisors instead of a single one. The cognitive diversity of mentors has a subtler effect in that it increases both the likelihood of success (having many mentees later on) and failure (having no mentees at all later on). We understand the effect of diverse mentorship as a high-risk, high-gain strategy: the recombination of unrelated expertise often fails, but sometimes leads to true novelty.	[Wuestman, Mignon; Frenken, Koen; Wanzenbock, Iris] Univ Utrecht, Copernicus Inst Sustainable Dev, Innovat Studies, Utrecht, Netherlands	Utrecht University	Wanzenbock, I (corresponding author), Univ Utrecht, Copernicus Inst Sustainable Dev, Innovat Studies, Utrecht, Netherlands.	i.wanzenbock@uu.nl	; Frenken, Koen/C-4486-2017	Wanzenbock, Iris/0000-0002-1727-5567; Frenken, Koen/0000-0003-4731-0201	Netherlands Organization for Scientific Research (NWO) [453-14-014]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	Mignon Wuestman (MW) and Koen Frenken (KW) received funding from the Netherlands Organization for Scientific Research (NWO, nwo.nl) within the Vici-program (grant number 453-14-014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna DE, 2012, NATURE, V489, P201, DOI 10.1038/489201a; [Anonymous], MATH GEN PROJ; ARTHUR W. BRIAN, 2009, NATURE TECHNOLOGY WH; Baruffaldi S, 2016, RES POLICY, V45, P785, DOI 10.1016/j.respol.2015.12.006; Borrell-Damian L, 2010, HIGH EDUC POLICY, V23, P493, DOI 10.1057/hep.2010.20; Boschma RA, 2005, REG STUD, V39, P61, DOI 10.1080/0034340052000320887; Boudreau KJ, 2016, MANAGE SCI, V62, P2765, DOI 10.1287/mnsc.2015.2285; Brostrom A, 2019, RES POLICY, V48, P1647, DOI 10.1016/j.respol.2019.03.009; Cameron C. A., 1998, REGRESSION ANAL COUN; CAVALLI-SFORZA L.L, 1981, CULTURAL TRANSMISSIO; Chariker JH, 2017, SCIENTOMETRICS, V111, P1733, DOI 10.1007/s11192-017-2364-4; Darwin C., 1877, ORIGIN SPECIES; David SV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046608; Dubois P, 2014, SCIENTOMETRICS, V98, P1669, DOI 10.1007/s11192-013-1112-7; Fleming L, 2001, MANAGE SCI, V47, P117, DOI 10.1287/mnsc.47.1.117.10671; Frenken K, 2017, J INFORMETR, V11, P859, DOI 10.1016/j.joi.2017.06.006; Gargiulo F, 2016, EPJ DATA SCI, V5, DOI 10.1140/epjds/s13688-016-0088-y; Head K, 2018, DP12942 CEPR; Hull, 2010, SCI PROCESS EVOLUTIO; Klepper S, 2002, IND CORP CHANGE, V11, P645, DOI 10.1093/icc/11.4.645; Lee K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014279; Lienard JF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07034-y; Ma YF, 2020, P NATL ACAD SCI USA, V117, P14077, DOI 10.1073/pnas.1915516117; Malmgren RD, 2010, NATURE, V465, P622, DOI 10.1038/nature09040; Mangematin V, 2000, RES POLICY, V29, P741, DOI 10.1016/S0048-7333(99)00047-5; Morrison DA, 2016, EVOL BIOL, V43, P456, DOI 10.1007/s11692-016-9376-5; Nooteboom B, 2000, ADM SCI Q, V47, pxiii; Nooteboom B, 2007, RES POLICY, V36, P1016, DOI 10.1016/j.respol.2007.04.003; Paglis LL, 2006, RES HIGH EDUC, V47, P451, DOI 10.1007/s11162-005-9003-2; Phillips DJ, 2002, ADMIN SCI QUART, V47, P474, DOI 10.2307/3094848; Rossi L, 2017, J INFORMETR, V11, P564, DOI 10.1016/j.joi.2017.04.001; SERVOS JW, 1993, OSIRIS, V8, P3; Singh J, 2010, MANAGE SCI, V56, P41, DOI 10.1287/mnsc.1090.1072; Sugimoto CR, 2011, J AM SOC INF SCI TEC, V62, P1808, DOI 10.1002/asi.21568; Tenn JS, 2016, J ASTRON HIST HERIT, V19, P298; TOULMIN SE, 1967, AM SCI, V55, P456; Trapido D, 2015, RES POLICY, V44, P1488, DOI 10.1016/j.respol.2015.05.007; Waaijer CJF, 2018, HIGH EDUC POLICY, V31, P225, DOI 10.1057/s41307-017-0051-y; Weitzman ML, 1998, Q J ECON, V113, P331, DOI 10.1162/003355398555595; Wenting R, 2008, J ECON GEOGR, V8, P593, DOI 10.1093/jeg/lbn030; Wickham, 2016, RVEST EASILY HARVEST	42	1	1	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243913	10.1371/journal.pone.0243913	http://dx.doi.org/10.1371/journal.pone.0243913			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PI8BZ	33332441	gold, Green Published			2022-12-27	WOS:000601310900047
J	Zhou, SQ; Sakamoto, K				Zhou, Siqi; Sakamoto, Kazuichi			Citric acid promoted melanin synthesis in B16F10 mouse melanoma cells, but inhibited it in human epidermal melanocytes and HMV-II melanoma cells via the GSK3 beta/beta-catenin signaling pathway	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; OXIDATIVE STRESS; BETA-CATENIN; MELANOGENESIS; CYCLE; MITF; SKIN; PHOTOPROTECTION; APOPTOSIS; CITRATE	Melanin, a pigment synthesized by melanocytes in the skin, resists the damage caused by ultraviolet rays to cells. Citric acid, a well-known food additive, is commonly used as an antioxidant and is an important part of the tricarboxylic acid (TCA) cycle for energy production during cellular metabolism. Here, we aimed to investigate whether the addition of excess citric acid regulates melanin synthesis, and to delineate the underlying mechanism. First, we observed that citric acid exerts opposite redox effects on mouse and human cells. Interestingly, treatment with excess citric acid increased the melanin content in mouse cells but decreased it in human cells. Furthermore, the expression of factors important for melanin synthesis, such as microphthalmia-associated transcription factor (MITF), was also regulated by citric acid treatment-it was promoted in mouse cells and suppressed in human cells. Citric acid also impacted the upstream regulators of MITF, glycogen synthase kinase 3 beta (GSK3 beta), and beta-catenin. Second, we determined the importance of GSK3 beta in the citric acid-mediated regulation of melanin synthesis, using a GSK3 beta inhibitor (BIO). To the best of our knowledge, this is the first study to show that citric acid regulates melanin synthesis via the GSK3 beta/beta-catenin signaling pathway, and that equal amounts of exogenous citric acid exert opposing effects on mouse and human cells.	[Zhou, Siqi; Sakamoto, Kazuichi] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan	University of Tsukuba	Sakamoto, K (corresponding author), Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan.	sakamoto@biol.tsukuba.ac.jp		ZHOU, SIQI/0000-0002-5024-7269				Abdel-Salam OME, 2014, J MED FOOD, V17, P588, DOI 10.1089/jmf.2013.0065; Anderson NM, 2018, PROTEIN CELL, V9, P216, DOI 10.1007/s13238-017-0451-1; [Anonymous], 2020, CHEMCATCHEM, V12, pXXX; [Anonymous], 2019, PREV TREAT CARDIO CE, V19, P1, DOI [DOI 10.5230/jgc.2019.19.e8, DOI 10.1186/s12877-019-1185-0]; [Anonymous], 2020, WHY MOUSE MATTERS; [Anonymous], 2017, KIDNEY INT S, V7, p[1, 1], DOI DOI 10.1016/j.kisu.2017.04.001; Barillas R, 2007, ANN THORAC SURG, V84, P126, DOI 10.1016/j.athoracsur.2007.02.015; Bhatnagar V, 1998, MOL CELL BIOCHEM, V187, P57, DOI 10.1023/A:1006870621424; Brash DE, 2016, TOXICOL PATHOL, V44, P552, DOI 10.1177/0192623316632072; Brenner M, 2008, PHOTOCHEM PHOTOBIOL, V84, P539, DOI 10.1111/j.1751-1097.2007.00226.x; Chen XG, 2017, CELL J, V18, P493; Choe E, 2009, COMPR REV FOOD SCI F, V8, P345, DOI 10.1111/j.1541-4337.2009.00085.x; Cunha ES, 2012, EXP CELL RES, V318, P1913, DOI 10.1016/j.yexcr.2012.05.019; D'Mello SAN, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071144; Domoto T, 2016, CANCER SCI, V107, P1363, DOI 10.1111/cas.13028; Gallagher SJ, 2013, ONCOGENE, V32, P2230, DOI 10.1038/onc.2012.229; Geng J, 2008, J EUR ACAD DERMATOL, V22, P852, DOI 10.1111/j.1468-3083.2007.02574.x; Herbst A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-74; Hou L, 2006, P NATL ACAD SCI USA, V103, P9081, DOI 10.1073/pnas.0603114103; Hou L, 2008, CELL RES, V18, P1163, DOI 10.1038/cr.2008.303; Hu SH, 2019, J CELL PHYSIOL, V234, P7330, DOI 10.1002/jcp.27492; Icard P, 2012, BBA-REV CANCER, V1825, P111, DOI 10.1016/j.bbcan.2011.10.007; Jimenez-Cervantes C, 2001, J CELL SCI, V114, P2335; Khaled M, 2002, J BIOL CHEM, V277, P33690, DOI 10.1074/jbc.M202939200; Kim ES, 2014, PIGM CELL MELANOMA R, V27, P1051, DOI 10.1111/pcmr.12298; KOLLIAS N, 1991, J PHOTOCH PHOTOBIO B, V9, P135, DOI 10.1016/1011-1344(91)80147-A; Kumari S, 2018, ACTA DERM-VENEREOL, V98, P924, DOI 10.2340/00015555-3002; Lane BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049357; Levy C, 2003, MOL CELL BIOL, V23, P9073, DOI 10.1128/MCB.23.24.9073-9080.2003; Lu YF, 2011, ANTICANCER RES, V31, P797; Makbal R, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21072539; McNaughton BR, 2009, CHEMMEDCHEM, V4, P1583, DOI 10.1002/cmdc.200900194; Meierjohann S, 2014, EUR J CELL BIOL, V93, P36, DOI 10.1016/j.ejcb.2013.11.005; Niu C, 2017, MOLECULES, V22, DOI 10.3390/molecules22081303; Ortonne JP, 2002, BRIT J DERMATOL, V146, P7, DOI 10.1046/j.1365-2133.146.s61.3.x; Perlman RL, 2016, EVOL MED PUBLIC HLTH, P170, DOI 10.1093/emph/eow014; Pillaiyar T, 2017, J ENZYM INHIB MED CH, V32, P403, DOI 10.1080/14756366.2016.1256882; Ploper D, 2015, P NATL ACAD SCI USA, V112, pE420, DOI 10.1073/pnas.1424576112; Premi S, 2016, MOL CELL ONCOL, V3, DOI 10.1080/23723556.2015.1033588; Riley PA, 1997, INT J BIOCHEM CELL B, V29, P1235, DOI 10.1016/S1357-2725(97)00013-7; Schepsky A, 2006, MOL CELL BIOL, V26, P8914, DOI 10.1128/MCB.02299-05; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Steinbrecher KA, 2005, MOL CELL BIOL, V25, P8444, DOI 10.1128/MCB.25.19.8444-8455.2005; Wang CX, 2009, ANNU REV GENET, V43, P95, DOI 10.1146/annurev-genet-102108-134850; Wang TA, 2016, ONCOL REP, V35, P1287, DOI 10.3892/or.2015.4511; Wang XP, 2018, J HUM GENET, V63, P639, DOI 10.1038/s10038-018-0425-z; Wellbrock C, 2015, PIGM CELL MELANOMA R, V28, P390, DOI 10.1111/pcmr.12370; Widlund HR, 2002, J CELL BIOL, V158, P1079, DOI 10.1083/jcb.200202049; Yamaguchi Y, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a017046; Yang K, 2017, CELL PHYSIOL BIOCHEM, V44, P1445, DOI 10.1159/000485580; Ying TH, 2013, ANTICANCER RES, V33, P4411; Zeng H., 2017, COSMETICS-BASEL, V4, P43, DOI [10.3390/cosmetics4040043, DOI 10.3390/COSMETICS4040043]; Zhou HY, 2019, MOLECULES, V24, DOI 10.3390/molecules24183303; Zhou SQ, 2019, GENES CELLS, V24, P60, DOI 10.1111/gtc.12654	54	9	9	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243565	10.1371/journal.pone.0243565	http://dx.doi.org/10.1371/journal.pone.0243565			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332393	gold, Green Published			2022-12-27	WOS:000601310900088
J	de Oliveira, JVB; Lima, RPA; Luna, RCP; Diniz, AD; de Almeida, ATC; de Oliveira, NFP; Goncalves, MDR; de Lima, RT; Ferreira, FELD; Diniz, SCPDR; Silva, AS; Silva, AHAE; Persuhn, DC; Costa, MJD				Bernardo de Oliveira, Jessica Vicky; Ataide Lima, Raquel Patricia; Cristhine Pordeus Luna, Rafaella; Diniz, Alcides da Silva; Cavalcanti de Almeida, Alessio Tony; Paulo de Oliveira, Naila Francis; Goncalves, Maria da Conceicao Rodrigues; de Lima, Roberto Texeira; de Lima Ferreira, Flavia Emilia Leite; de Oliveira Ramalho Diniz, Sonia Cristina Pereira; Silva, Alexandre Sergio; Andrade e Silva, Ana Herminia; Persuhn, Darlene Camati; de Carvalho Costa, Maria Jose			The direct correlation between oxidative stress and LDL-C levels in adults is maintained by the Friedewald and Martin equations, but the methylation levels in the MTHFR and ADRB3 genes differ	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN-CHOLESTEROL; DNA METHYLATION; CARDIOVASCULAR RISK; AMERICAN-COLLEGE; DYSLIPIDEMIA; ASSOCIATION; BLOOD; CONSUMPTION; MANAGEMENT; RECOMMENDATIONS	Low-density lipoprotein (LDL-C) concentrations are a standard of care in the prevention of cardiovascular disease and are influenced by different factors. This study compared the LDL-C concentrations estimated by two different equations and determined their associations with inflammatory status, oxidative stress, anthropometric variables, food intake and DNA methylation levels in the LPL, ADRB3 and MTHFR genes. A cross-sectional population-based study was conducted with 236 adults (median age 37.5 years) of both sexes from the municipality of JoAo Pessoa, Paraiba, Brazil. The LDL-C concentrations were estimated according to the Friedewald and Martin equations. LPL, ADRB3 and MTHFR gene methylation levels; malondialdehyde levels; total antioxidant capacity; ultra-sensitive C-reactive protein, alpha-1-acid glycoprotein, homocysteine, cobalamin, and folic acid levels; usual dietary intake; and epidemiological variables were also determined. For each unit increase in malondialdehyde concentration there was an increase in the LDL-C concentration from 6.25 to 10.29 mg/dL (p <0.000). Based on the Martin equation (<greater than or equal to>70 mg/dL), there was a decrease in the DNA methylation levels in the ADRB3 gene and an increase in the DNA methylation levels in the MTHFR gene (p <0.05). There was a positive relation of homocysteine and cholesterol intake on LDL-C concentrations estimated according to the Friedewald equation and of waist circumference and age based on the two estimates. It is concluded the LDL-C concentrations estimated by the Friedewald and Martin equations were different, and the Friedewald equation values were significantly lower than those obtained by the Martin equation. MDA was the variable that was most positively associated with the estimated LDL-C levels in all multivariate models. Significant relationships were observed based on the two estimates and occurred for most variables. The methylation levels of the ADRB3 and MTHFR genes were different according to the Martin equation at low LDL-C concentrations (70 mg/dL).	[Bernardo de Oliveira, Jessica Vicky; Ataide Lima, Raquel Patricia; Cristhine Pordeus Luna, Rafaella; Goncalves, Maria da Conceicao Rodrigues; de Lima, Roberto Texeira; de Lima Ferreira, Flavia Emilia Leite; de Oliveira Ramalho Diniz, Sonia Cristina Pereira; Silva, Alexandre Sergio; de Carvalho Costa, Maria Jose] Univ Fed Paraiba UFPB, Fed Univ Paraiba, Postgrad Program Nutr Sci, Dept Nutr,Hlth Sci Ctr, Joao Pessoa, Paraiba, Brazil; [Diniz, Alcides da Silva] Univ Fed Pernambuco UFPE, Fed Univ Pernambuco, Postgrad Program Nutr Sci, Dept Nutr,Hlth Sci Ctr, Recife, PE, Brazil; [Cavalcanti de Almeida, Alessio Tony] Univ Fed Paraiba, Postgrad Program Appl Econ, Dept Econ, Ctr Appl Social Sci, Joao Pessoa, Paraiba, Brazil; [Paulo de Oliveira, Naila Francis; Persuhn, Darlene Camati] Univ Fed Paraiba, Dept Mol Biol, Ctr Exact & Nat Sci, Joao Pessoa, Paraiba, Brazil; [Andrade e Silva, Ana Herminia] Univ Fed Paraiba, Dept Stat, Ctr Exact & Nat Sci, Joao Pessoa, Paraiba, Brazil	Universidade Federal da Paraiba; Universidade Federal de Pernambuco; Universidade Federal da Paraiba; Universidade Federal da Paraiba; Universidade Federal da Paraiba	de Oliveira, JVB (corresponding author), Univ Fed Paraiba UFPB, Fed Univ Paraiba, Postgrad Program Nutr Sci, Dept Nutr,Hlth Sci Ctr, Joao Pessoa, Paraiba, Brazil.	jessicavickynutri@gmail.com	Silva, Alexandre S/N-8883-2014; de Oliveira, Naila FP/I-8310-2012; PERSUHN, DARLENE CAMATI/AAB-2481-2021; Paulo de Oliveira, Naila Francis/S-5993-2019; Luna, Rafaella Cristhine Pordeus/L-1733-2015	Silva, Alexandre S/0000-0003-3576-9023; de Oliveira, Naila FP/0000-0002-0855-2518; PERSUHN, DARLENE CAMATI/0000-0001-5291-5454; Paulo de Oliveira, Naila Francis/0000-0002-0855-2518; Luna, Rafaella Cristhine Pordeus/0000-0003-2477-8258				Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; [Anonymous], 2016, NAT NANOTECHNOL, V11, P1, DOI 10.1038/nnano.2015.333; [Anonymous], 2000, WHO TECH REP SER, P894; [Anonymous], 2002, UVAMGASUTTANI, V4, P1; [Anonymous], 2018, J HIST MODERN THEOLO, V25, p[1, 21]; [Anonymous], 2014, DIABETOL KLIN SA, V3, pA1; Arnett DK, 2019, J AM COLL CARDIOL, V74, P1376, DOI 10.1016/j.jacc.2019.03.009; Asciutti L.S.R, 2005, MANUAL PORCOES MEDIA; Lima RPA, 2017, CLIN EPIGENETICS, V9, DOI 10.1186/s13148-017-0407-6; Bradshaw G, 2015, META GENE, V6, P91, DOI 10.1016/j.mgene.2015.09.004; Castellano-Castillo D, 2018, CLIN CHEM, V64, P210, DOI 10.1373/clinchem.2017.277921; Catapano Alberico L, 2017, Rev Esp Cardiol (Engl Ed), V70, P115, DOI 10.1016/j.rec.2017.01.002; Chen NY, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-104; Chiu HF, 2017, PHARM BIOL, V55, P974, DOI 10.1080/13880209.2017.1285323; Coffey Michelle, 2003, Crit Care Nurse, V23, P25; Costa CJM, 2014, 2 CICLO DIAGNOSTICO; Costa MJ C., 1986, ANN NUTR METAB, V30, P21, DOI [10.1159/000177173, DOI 10.1159/000177173]; Cox's Bazar Bangladesh, 2019, GEND PROF NO 2 ROH R, V11, P1; Cavalcante IGD, 2015, EXP GERONTOL, V66, P10, DOI 10.1016/j.exger.2015.03.011; de Oliveira Y, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1529-0; Dong YH, 2018, INT J BIOL MACROMOL, V120, P1490, DOI 10.1016/j.ijbiomac.2018.09.134; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Garg G, 2018, J PHARM PHARMACOL, V70, P1572, DOI 10.1111/jphp.13004; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; Grundy SM, 2014, J CLIN LIPIDOL, V8, P29, DOI 10.1016/j.jacl.2013.12.005; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Guay SP, 2013, ATHEROSCLEROSIS, V228, P413, DOI 10.1016/j.atherosclerosis.2013.03.033; Guay SP, 2014, EPIGENOMICS-UK, V6, P33, DOI 10.2217/epi.13.82; Hamulka J, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15112530; Hong S, 2018, MOL METAB, V12, P25, DOI 10.1016/j.molmet.2018.03.012; Houde AA, 2014, J DEV ORIG HLTH DIS, V5, P132, DOI 10.1017/S2040174414000038; Jacobson TA, 2015, J CLIN LIPIDOL, V9, P129, DOI 10.1016/j.jacl.2015.02.003; Jellinger PS, 2017, ENDOCR PRACT, V23, P479, DOI 10.4158/EP171764.GL; Khan RA, 2015, TOXICOL IND HEALTH, V31, P546, DOI 10.1177/0748233713475503; Kishimoto Y, 2016, J NUTR SCI VITAMINOL, V62, P361, DOI 10.3177/jnsv.62.361; Kuo K, 1997, CLIN CHEM, V43, P1653; Kurylowicz A, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0395-2; Laclaustra M, 2018, DIABETES CARE, V41, P2195, DOI 10.2337/dc18-0372; de Lima FEL, 2008, CAD SAUDE PUBLICA, V24, P820, DOI 10.1590/S0102-311X2008000400012; Li WX, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0099-x; Lopes-Virella MF, 2012, ATHEROSCLEROSIS, V224, P526, DOI 10.1016/j.atherosclerosis.2012.08.006; Malachias Mvb, 2016, Arq Bras Cardiol, V107, P1, DOI 10.5935/abc.20160151; Martin SS, 2018, JAMA CARDIOL, V3, P749, DOI 10.1001/jamacardio.2018.1533; Martin SS, 2013, JAMA-J AM MED ASSOC, V310, P2061, DOI 10.1001/jama.2013.280532; Mikael LG, 2009, MOL GENET METAB, V98, P187, DOI 10.1016/j.ymgme.2009.05.011; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mohammadpour-Gharehbagh A, 2018, J CELL BIOCHEM, V119, P1346, DOI 10.1002/jcb.26290; Moll S, 2015, CIRCULATION, V132, pe6, DOI 10.1161/CIRCULATIONAHA.114.013311; Mora S, 2014, CIRCULATION, V129, P553, DOI 10.1161/CIRCULATIONAHA.113.005873; MSM, MULT SOURC METH; O TM, 2018, OTOLARYNGOL CLIN N A, V51, pxvii; Oliveira Cleiton da Silva, 2015, Rev. Col. Bras. Cir., V42, P305, DOI 10.1590/0100-69912015005007; Otten J.J., 2006, DIETARY REFERENCE IN, DOI DOI 10.17226/11537; Patel Y, 2018, MATER RELIG, V14, P1, DOI 10.1080/17432200.2017.1417215; Pletcher MJ, 2017, MED CLIN N AM, V101, P673, DOI 10.1016/j.mcna.2017.03.002; Pokharel Y, 2017, ATHEROSCLEROSIS, V266, P16, DOI 10.1016/j.atherosclerosis.2017.09.019; Raats M. M., 1991, Food Quality and Preference, V3, P89, DOI 10.1016/0950-3293(91)90028-D; Retterstol K, 2018, ATHEROSCLEROSIS, V279, P52, DOI 10.1016/j.atherosclerosis.2018.10.013; Sathiyakumar V, 2018, CIRCULATION, V138, P244, DOI 10.1161/CIRCULATIONAHA.117.032463; Siegel S., 1977, NONPARAMETRIC STAT B; Stanger O, 2002, J PHARMACOL EXP THER, V303, P158, DOI 10.1124/jpet.102.036715; Taguchi C, 2018, ASIA PAC J CLIN NUTR, V27, P359, DOI 10.6133/apjcn.042017.17; Tsai IJ, 2018, APPL PHYSIOL NUTR ME, V43, P669, DOI 10.1139/apnm-2017-0670; Vinci MC, 2013, STEM CELL REV REP, V9, P241, DOI 10.1007/s12015-012-9398-z; Wang YC, 2018, PHARM BIOL, V56, P325, DOI 10.1080/13880209.2018.1479868; Whelton SP, 2017, J CLIN LIPIDOL, V11, P1065, DOI 10.1016/j.jacl.2017.05.005; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wormser D, 2011, LANCET, V377, P1085, DOI 10.1016/S0140-6736(11)60105-0; Wu Y, 2007, TOXICOLOGY, V232, P50, DOI 10.1016/j.tox.2006.12.013; Wu YL, 2018, INT J BIOL MACROMOL, V118, P886, DOI 10.1016/j.ijbiomac.2018.06.140; Yang TC, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-11; Zhang QP, 2018, CHEM BIODIVERS, V15, DOI 10.1002/cbdv.201800219; Zheng CY, 2007, J LIPID RES, V48, P1190, DOI 10.1194/jlr.P600011-JLR200	74	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0239989	10.1371/journal.pone.0239989	http://dx.doi.org/10.1371/journal.pone.0239989			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326437	gold, Green Published			2022-12-27	WOS:000600176400033
J	Coppa, A; Candilio, F; Arganini, C; Machicao, ED; Terrazas, EGM; Lucci, M; Cucina, A				Coppa, Alfredo; Candilio, Francesca; Arganini, Claudia; de la Vega Machicao, Edmundo; Moreno Terrazas, Edmundo G.; Lucci, Michaela; Cucina, Andrea			Population dynamics in pre-Inca human groups from the Osmore Valley, the Azapa Valley and the coast of the South Central Andes	PLOS ONE			English	Article							MOQUEGUA VALLEY; BIOARCHAEOLOGICAL ASSESSMENT; GENETIC CONTINUITY; TIWANAKU DIASPORA; CERRO-BAUL; WARI; MIGRATION; ORIGINS; TRANSFORMATION; CHRONOLOGY	The present study applies a dental morphological perspective to the understanding of the complex pre-contact population history of the South Central Andes, through the detection of the underlying dynamics, and the assessment of the biological ties among groups. It presents an analysis of 1591 individuals from 66 sites that date from the Archaic to the Late Intermediate phases from Bolivia, Chile and Peru. The results suggest this area is characterized by significant movement of people and cultures and, at the same time, by long standing population continuity, and highlight the need for wider perspectives capable of taking into account both the different micro-regional realities and the region in its entirety.	[Coppa, Alfredo; Candilio, Francesca; Arganini, Claudia] Sapienza Univ, Dept Environm Biol, Rome, Italy; [Coppa, Alfredo] Musee Homme Paris, UMR Ecoanthropol 7206, Paris, France; [de la Vega Machicao, Edmundo] Univ Nacl Altiplano, Escuela Profes Antropol, Fac Ciencias Sociales, Puno, Peru; [Moreno Terrazas, Edmundo G.] Natl Univ Altiplano, Fac Biol Sci, Puno, Peru; [Lucci, Michaela] Sapienza Univ, Dept Hist, Anthropol, Relig,Performing Arts, Rome, Italy; [Cucina, Andrea] Univ Autonoma Yucatan, Fac Ciencias Antropol, Merida, Yucatan, Mexico; [Coppa, Alfredo; Candilio, Francesca] Univ Vienna, Dept Evolutionary Anthropol, Vienna, Austria; [Coppa, Alfredo] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Candilio, Francesca] Italian Minist Cultural Heritage, Superintendency Archaeol Fine Arts & Landscape Ci, Cagliari, Italy	Sapienza University Rome; Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Universite Paris Cite; Universidad Nacional del Altiplano; Universidad Nacional del Altiplano; Sapienza University Rome; Universidad Autonoma de Yucatan; University of Vienna; Harvard University; Harvard Medical School	Coppa, A (corresponding author), Sapienza Univ, Dept Environm Biol, Rome, Italy.; Coppa, A (corresponding author), Musee Homme Paris, UMR Ecoanthropol 7206, Paris, France.; Coppa, A (corresponding author), Univ Vienna, Dept Evolutionary Anthropol, Vienna, Austria.; Coppa, A (corresponding author), Harvard Med Sch, Dept Genet, Boston, MA 02115 USA.	alfredo.coppa@uniroma1.it	Candilio, Francesca/C-8634-2019; Moreno, Edmundo G./AAL-4165-2021	Candilio, Francesca/0000-0002-4668-1361; coppa, alfredo/0000-0002-7708-2484; DE LA VEGA, EDMUNDO/0000-0002-8297-5156; Edmundo G., Moreno-Terrazas/0000-0001-6356-8806	PRIN Project (Ministero dell'Istruzione dell'Universita e della Ricerca) "A multi-species genomic approach to assess pre-and post-Columbian population dynamics in South America" [20174BTC4R]; H2020 Programme ARIADNEplus project [H2020-INFRAIA-2018-1-823914]; CONACyT [CB-2017-2018-A1-S-10037]	PRIN Project (Ministero dell'Istruzione dell'Universita e della Ricerca) "A multi-species genomic approach to assess pre-and post-Columbian population dynamics in South America"; H2020 Programme ARIADNEplus project; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	(ACoppa) The exchange program for professors of the Ministry of Education, University and Research (MIUR) within the framework of the "IV Executive program of the Cultural Agreement between the Government of the Italian Republic and the Government of the Republic of Peru for the years 2002-2006". (ACoppa) and (ML) PRIN Project (Ministero dell'Istruzione dell'Universita e della Ricerca) "A multi-species genomic approach to assess pre-and post-Columbian population dynamics in South America" Grant N.: 20174BTC4R. (ACoppa) and (ML) H2020 Programme ARIADNEplus project, contract no. H2020-INFRAIA-2018-1-823914. (ACucina) CONACyT grant CB-2017-2018-A1-S-10037. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, CELL, V181, P1, DOI 10.1016/j.cell.2020.03.025; [Anonymous], 2020, NAT HUM BEHAV, V4, P1, DOI 10.1038/s41562-020-0818-9; Antonio ML, 2019, SCIENCE, V366, P708, DOI 10.1126/science.aay6826; Arganini C, 2006, THESIS; Arkush E, 2008, LAT AM ANTIQ, V19, P339, DOI 10.2307/25478239; BERMANN M, 1989, ECOLOGY SETTLEMENT H, P269; Blom DE, 2005, MONOGR COTSEN INST A, V53, P153; Blom DE, 2005, J ANTHROPOL ARCHAEOL, V24, P1, DOI 10.1016/j.jaa.2004.10.001; Blom DE, 1998, WORLD ARCHAEOL, V30, P238, DOI 10.1080/00438243.1998.9980409; Bonzani RM, 2014, CONTRIB GLOB HIST AR, V38, P321, DOI 10.1007/978-3-319-03128-6_13; Candilio F, 2014, AM J PHYS ANTHROPOL, V153, P90; Candilio F, 2012, AM J PHYS ANTHROPOL, V147, P111; Cavalli-Sforza LL., 1994, HIST GEOGRAPHY HUMAN; Coop G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000500; Coppa A, 2007, AM J PHYS ANTHROPOL, V133, P918, DOI 10.1002/ajpa.20620; Coppa A, 1998, AM J PHYS ANTHROPOL, V107, P371, DOI 10.1002/(SICI)1096-8644(199812)107:4<371::AID-AJPA1>3.3.CO;2-0; Cucina A, 2016, BIOLOGICAL DISTANCE ANALYSIS: FORENSIC AND BIOARCHAEOLOGICAL PERSPECTIVES, P463, DOI 10.1016/B978-0-12-801966-5.00025-1; Goldstein P.S., 2005, ANDEAN DIASPORA TIWA; Goldstein Paul, 2013, VISIONS OF TIWANAKU, P41; Goldstein PS, 2015, P NATL ACAD SCI USA, V112, P9202, DOI 10.1073/pnas.1500487112; GREEN RF, 1976, AM J PHYS ANTHROPOL, V45, P61, DOI 10.1002/ajpa.1330450108; Haak W, 2015, NATURE, V522, P207, DOI 10.1038/nature14317; Janusek John W., 2008, ANCIENT TIWANAKU; Kemp BM, 2009, AM J PHYS ANTHROPOL, V140, P80, DOI 10.1002/ajpa.21037; Knudson KJ, 2014, AM J PHYS ANTHROPOL, V155, P405, DOI 10.1002/ajpa.22584; Knudson KJ, 2011, AM J PHYS ANTHROPOL, V145, P299, DOI 10.1002/ajpa.21494; Knudson KJ, 2004, ARCHAEOMETRY, V46, P5, DOI 10.1111/j.1475-4754.2004.00140.x; Kolata Alan L., 1993, TIWANAKU PORTRAIT AN; Lewis CM, 2007, LAT AM ANTIQ, V18, P145, DOI 10.2307/25063101; Lewis CM, 2009, LAT AM ANTIQ, V20, P76, DOI 10.1017/S1045663500002522; Lipson M, 2017, NATURE, V551, P368, DOI 10.1038/nature24476; Lozada Cerna MC, 1998, THESIS; Lozada Cerna MC, 2002, SEORIO CHIRIBAYA COS; Moraga M, 2005, AM J PHYS ANTHROPOL, V127, P170, DOI 10.1002/ajpa.10438; Moseley M.E., 2017, NAWPA PACHA, V37, P25, DOI [10.1080/00776297.2017.1324010, DOI 10.1080/00776297.2017.1324010]; Moseley ME, 2005, P NATL ACAD SCI USA, V102, P17264, DOI 10.1073/pnas.0508673102; MOSELEY ME, 1991, HUARI ADM STRUCTURE, P121; Munoz Ovalle I, 2016, DIALOGO ANDINO, V49, P386; Ovalle IM, 2017, ESTUD ATACAMENOS, P5; Ovalle IM, 2016, CHUNGARA, V48, P531, DOI 10.4067/S0717-73562016005000035; Nash D.J., 2005, ARCHEOL PAP AM ANTHR, V14, P151, DOI [DOI 10.1525/ap3a.2005.14.151, 10.1525/ap3a.2005.14.151, DOI 10.1525/AP3A.2005.14.151]; NICHOL CR, 1986, AM J PHYS ANTHROPOL, V69, P299, DOI 10.1002/ajpa.1330690303; Olalde I, 2018, NATURE, V555, P190, DOI 10.1038/nature25738; Omrak A, 2016, CURR BIOL, V26, P270, DOI 10.1016/j.cub.2015.12.019; Owen BD, 2005, LAT AM ANTIQ, V16, P45, DOI 10.2307/30042486; Owen Bruce D., 1993, MODEL MULTIETHNICITY; Performance Standards for Antimicrobial Susceptibility Testing, 2012, M100S22 CLSI, V32, P169; Ponce C., 1981, TIWANAKU ESPACIO TIE; Posth C, 2018, CELL, V175, P1185, DOI 10.1016/j.cell.2018.10.027; Rice Don S., 1989, BAR INT SERIES, V545, P17; RIVERA MA, 2006, HIST MAIZE MULTIDISC, P403; ROTHHAMMER F, 1989, AM J PHYS ANTHROPOL, V78, P403, DOI 10.1002/ajpa.1330780308; Rothhammer F, 2001, LAT AM ANTIQ, V12, P59, DOI 10.2307/971757; Schreiber Katharina, 1992, WARI IMPERIALISM MID, V87; SCOTT GR, 1980, HUM BIOL, V52, P63; Sharratt N, 2009, GEOARCHAEOLOGY, V24, P792, DOI 10.1002/gea.20288; SJOVOLD T, 1977, Ossa, V4, P1; Skoglund P, 2012, SCIENCE, V336, P466, DOI 10.1126/science.1216304; Slovak NM, 2009, J ARCHAEOL SCI, V36, P157, DOI 10.1016/j.jas.2008.08.004; Stanish C, 2003, ANCIENT TITICACA: THE EVOLUTION OF COMPLEX SOCIETY IN SOUTHERN PERU AND NORTHERN BOLIVIA, P1, DOI 10.1525/california/9780520232457.001.0001; STANISH C, 1992, ANCIENT ANDEAN POLIT; Stanish C, 2010, J ANTHROPOL ARCHAEOL, V29, P524, DOI 10.1016/j.jaa.2010.09.002; Sutter RC, 2000, LAT AM ANTIQ, V11, P43, DOI 10.2307/1571670; Sutter RC, 2005, MONOGR COTSEN INST A, V53, P183; Sutter RC, 2004, AM J PHYS ANTHROPOL, V123, P130, DOI 10.1002/ajpa.10311; Sutter RC, 1999, J INDIANA ACAD SOCIA, V3, P77; Sutter RC, 2005, ANDEAN PAST, V7, P183; Sutter RC, 1997, THESIS; Sutter RC, 2010, LAT AM ANTIQ, V21, P67, DOI 10.7183/1045-6635.21.1.67; Szremski K, 2017, J ANTHROPOL ARCHAEOL, V47, P83, DOI 10.1016/j.jaa.2017.03.004; Tung TA, 2011, J ANTHROPOL ARCHAEOL, V30, P247, DOI 10.1016/j.jaa.2011.06.005; Tung Tiffiny A., 2012, VIOLENCE RITUAL WARI; TURNER CG, 1977, OROFACIAL GROWTH DEV, P229; Turner II C. G., 1991, ADV DENT ANTHR, P13; Varela HH, 2014, AM J PHYS ANTHROPOL, V155, P591, DOI 10.1002/ajpa.22614; Varela HH, 2002, AM J PHYS ANTHROPOL, V118, P259, DOI 10.1002/ajpa.10075; Vargiu R, 2009, HUM BIOL, V81, P479, DOI 10.3378/027.081.0406; Williams PR, 2001, LAT AM ANTIQ, V12, P67, DOI 10.2307/971758	78	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0229370	10.1371/journal.pone.0229370	http://dx.doi.org/10.1371/journal.pone.0229370			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH1IW	33326416	Green Published, gold, Green Submitted			2022-12-27	WOS:000600176400014
J	Meier, T; Boyd, RL; Mehl, MR; Milek, A; Pennebaker, JW; Martin, M; Wolf, M; Horn, AB				Meier, Tabea; Boyd, Ryan L.; Mehl, Matthias R.; Milek, Anne; Pennebaker, James W.; Martin, Mike; Wolf, Markus; Horn, Andrea B.			Stereotyping in the digital age: Male language is "ingenious", female language is "beautiful" - and popular	PLOS ONE			English	Article							UNIVERSAL DIMENSIONS; GENDER STEREOTYPES; BETA REGRESSION; MASCULINE; WISDOM; WORDS; OLDER; LIFE; ENVIRONMENTS; METAANALYSIS	The huge power for social influence of digital media may come with the risk of intensifying common societal biases, such as gender and age stereotypes. Speaker's gender and age also behaviorally manifest in language use, and language may be a powerful tool to shape impact. The present study took the example of TED, a highly successful knowledge dissemination platform, to study online influence. Our goal was to investigate how gender- and age-linked language styles-beyond chronological age and identified gender-link to talk impact and whether this reflects gender and age stereotypes. In a pre-registered study, we collected transcripts of TED Talks along with their impact measures, i.e., views and ratios of positive and negative talk ratings, from the TED website. We scored TED Speakers' (N = 1,095) language with gender- and age-morphed language metrics to obtain measures of female versus male, and younger versus more senior language styles. Contrary to our expectations and to the literature on gender stereotypes, more female language was linked to higher impact in terms of quantity, i.e., more talk views, and this was particularly the case among talks with a lot of views. Regarding quality of impact, language signatures of gender and age predicted different types of positive and negative ratings above and beyond main effects of speaker's gender and age. The differences in ratings seem to reflect common stereotype contents of warmth (e.g., "beautiful" for female, "courageous" for female and senior language) versus competence (e.g., "ingenious", "informative" for male language). The results shed light on how verbal behavior may contribute to stereotypical evaluations. They also illuminate how, within new digital social contexts, female language might be uniquely rewarded and, thereby, an underappreciated but highly effective tool for social influence. WC = 286 (max. 300 words).	[Meier, Tabea; Martin, Mike; Wolf, Markus; Horn, Andrea B.] Univ Zurich, Dept Psychol, Zurich, Switzerland; [Meier, Tabea; Martin, Mike; Horn, Andrea B.] Univ Zurich, Univ Res Prior Program URPP Dynam Hlth Aging, Zurich, Switzerland; [Boyd, Ryan L.] Univ Lancaster, Dept Psychol, Lancaster, Lancs, England; [Mehl, Matthias R.] Univ Arizona, Dept Psychol, Tucson, AZ 85721 USA; [Milek, Anne] Univ Munster, Dept Psychol, Munster, North Rhine Wes, Germany; [Pennebaker, James W.] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA; [Martin, Mike] Swiss Fed Inst Technol, Coll Helveticum, Zurich, Switzerland	University of Zurich; University of Zurich; Lancaster University; University of Arizona; University of Munster; University of Texas System; University of Texas Austin; Swiss Federal Institutes of Technology Domain; ETH Zurich	Meier, T; Horn, AB (corresponding author), Univ Zurich, Dept Psychol, Zurich, Switzerland.; Meier, T; Horn, AB (corresponding author), Univ Zurich, Univ Res Prior Program URPP Dynam Hlth Aging, Zurich, Switzerland.	t.meier@psychologie.uzh.ch; a.horn@psychologie.uzh.ch	Meier, Tabea/AAP-2826-2020; Pennebaker, James/GLR-6058-2022; Boyd, Ryan L./I-9148-2019; Boyd, Ryan/GZH-1468-2022	Meier, Tabea/0000-0003-2902-4113; Boyd, Ryan L./0000-0002-1876-6050; Wolf, Markus/0000-0002-5660-6824; Horn, Andrea B./0000-0003-2729-7062; Milek, Anne/0000-0001-6179-4869	Jacobs Foundation; Swiss National Science Foundation [SNF PMPDP1_164470]; National Institutes of Health [5R01GM112697-02]; John Templeton Foundation [48503, 61156]; Federal Bureau of Investigation [15F06718R0006603]; National Science Foundation [IIS1344257]	Jacobs Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John Templeton Foundation; Federal Bureau of Investigation; National Science Foundation(National Science Foundation (NSF))	Financial support by the Jacobs Foundation helped to conduct this research (https://jacobsfoundation.org/en/; doctoral fellowship awarded to TM) ABH received financial support by the Swiss National Science Foundation (https://www.snf.ch/en/; 1 grant: SNF PMPDP1_164470). Preparation of this manuscript was additionally aided by grants from the National Institutes of Health (https://www.nih.gov; 5R01GM112697-02 awarded to JWP, RLB), John Templeton Foundation (https://www.templeton.org; 2 grants #48503 and #61156 awarded to JWP, RLB), the Federal Bureau of Investigation (https://www.fbi.gov; 1 grant 15F06718R0006603 awarded to JWP, RLB), and the National Science Foundation (https://www.nsf.gov; 1 grant IIS1344257 awarded to JWP, RLB). The views, opinions, and findings contained in this document are those of the authors and should not be construed as position, policy, or decision of the aforementioned agencies, unless so designated by other documents. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshartous D, 2011, J STAT EDUC, V19, DOI 10.1080/10691898.2011.11889620; Amer Psychological Assoc, 2015, AM PSYCHOL, V70, P832, DOI 10.1037/a0039906; AVOLIO BJ, 1987, PSYCHOL AGING, V2, P56, DOI 10.1037/0882-7974.2.1.56; Berger J, 2018, PSYCHOL SCI, V29, P1178, DOI 10.1177/0956797618759465; Boyd RL, 2017, CURR OPIN BEHAV SCI, V18, P63, DOI 10.1016/j.cobeha.2017.07.017; Brescoll VL, 2008, PSYCHOL SCI, V19, P268, DOI 10.1111/j.1467-9280.2008.02079.x; Carpenter J, 2017, SOC PSYCHOL PERS SCI, V8, P310, DOI 10.1177/1948550616671998; Coppersmith Glen, 2015, P 2 WORKSH COMP LING, P1, DOI DOI 10.3115/V1/W15-1201; Cribari-Neto F, 2010, J STAT SOFTW, V34, P1; Critchley CR, 2008, PUBLIC UNDERST SCI, V17, P309, DOI 10.1177/0963662506070162; Cuddy A.J., 2002, AGEISM STEREOTYPING, P3; Cuddy AJC, 2005, J SOC ISSUES, V61, P267, DOI 10.1111/j.1540-4560.2005.00405.x; Cuddy AJC, 2008, ADV EXP SOC PSYCHOL, V40, P61, DOI 10.1016/S0065-2601(07)00002-0; DeFrank M, 2019, J LANG SOC PSYCHOL, V38, P376, DOI 10.1177/0261927X19831743; Donovan J., 2014, DELIVER TED TALK SEC; Dordoni P, 2015, AGEING INT, V40, P393, DOI 10.1007/s12126-015-9222-6; Eagly A. H., 1994, EUROPEAN REV SOCIAL, V5, P1, DOI [10.1080/14792779543000002, DOI 10.1080/14792779543000002]; EAGLY AH, 1982, J PERS SOC PSYCHOL, V43, P915, DOI 10.1037/0022-3514.43.5.915; Eagly AH, 2017, SEX ROLES, V77, P725, DOI 10.1007/s11199-017-0835-y; El-Alayli A, 2018, SEX ROLES, V79, P136, DOI 10.1007/s11199-017-0872-6; Evans JB, 2019, J APPL PSYCHOL, V104, P1077, DOI 10.1037/apl0000395; Ferrari SLP, 2004, J APPL STAT, V31, P799, DOI 10.1080/0266476042000214501; Fiske ST, 2007, TRENDS COGN SCI, V11, P77, DOI 10.1016/j.tics.2006.11.005; Fiske ST, 2017, PERSPECT PSYCHOL SCI, V12, P791, DOI 10.1177/1745691617708204; Fiske ST, 2016, CURR OPIN PSYCHOL, V11, P44, DOI 10.1016/j.copsyc.2016.05.012; Gervais SJ, 2012, SEX ROLES, V66, P479, DOI 10.1007/s11199-011-0115-1; Gheorghiu AI, 2020, SOC PSYCHOL PERS SCI, V11, P117, DOI 10.1177/1948550618810896; Gordon JK, 2017, AGING NEUROPSYCHOL C, V24, P94, DOI 10.1080/13825585.2016.1171292; Hall JA, 2015, HEALTH COMMUN, V30, P894, DOI 10.1080/10410236.2014.900892; Hurlbert SH, 2019, AM STAT, V73, P352, DOI 10.1080/00031305.2018.1543616; Jordan KN, 2019, P NATL ACAD SCI USA, V116, P3476, DOI 10.1073/pnas.1811987116; Joshi PD, 2020, J PERS SOC PSYCHOL, V118, P417, DOI 10.1037/pspa0000177; Kacewicz E, 2014, J LANG SOC PSYCHOL, V33, P125, DOI 10.1177/0261927X13502654; Koenig AM, 2011, PSYCHOL BULL, V137, P616, DOI 10.1037/a0023557; Koenker R., 2019, PACKAGE QUANTREG; Koenker R., 2005, ECONOMETRIC SOC MONO; Konrad AM, 1997, HUM RELAT, V50, P1305, DOI 10.1023/A:1016934507240; Kornadt AE, 2013, EUR J AGEING, V10, P335, DOI 10.1007/s10433-013-0281-9; Krekula C, 2018, INT PERSPECT AGING, V19, P33, DOI 10.1007/978-3-319-73820-8_3; Larrimore L, 2011, J APPL COMMUN RES, V39, P19, DOI 10.1080/00909882.2010.536844; Laserna CM, 2014, J LANG SOC PSYCHOL, V33, P328, DOI 10.1177/0261927X14526993; Lee CH, 2006, PSYCHOL REP, V99, P351, DOI 10.2466/PR0.99.2.351-356; Luo MX, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.01412; MACCOBY EE, 1990, AM PSYCHOL, V45, P513, DOI 10.1037/0003-066X.45.4.513; Markowitz DM, 2020, J APPL SOC PSYCHOL, V50, P160, DOI 10.1111/jasp.12647; Markowitz DM, 2019, J LANG SOC PSYCHOL, V38, P264, DOI 10.1177/0261927X18824859; Markowitz DM, 2018, J LANG SOC PSYCHOL, V37, P376, DOI 10.1177/0261927X17751012; Mast MS, 2018, PATIENT EDUC COUNS, V101, P1697, DOI 10.1016/j.pec.2018.06.003; Mast MS, 2008, MED CARE, V46, P1212, DOI 10.1097/MLR.0b013e31817e1877; Mehl MR, 2003, J PERS SOC PSYCHOL, V84, P857, DOI 10.1037/0022-3514.84.4.857; Meltzer A. L., 2011, J MENS STUDIES, V19, P57, DOI DOI 10.3149/JMS.1901.57; Montepare JM, 2014, J LANG SOC PSYCHOL, V33, P241, DOI 10.1177/0261927X13519080; Mulac A, 2001, HUM COMMUN RES, V27, P121, DOI 10.1093/hcr/27.1.121; Mulac A, 2013, LANG SCI, V38, P22, DOI 10.1016/j.langsci.2012.12.004; Murray D, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233515; Newman ML, 2008, DISCOURSE PROCESS, V45, P211, DOI 10.1080/01638530802073712; Newman ML, 2003, PERS SOC PSYCHOL B, V29, P665, DOI 10.1177/0146167203029005010; North MS, 2015, PSYCHOL BULL, V141, P993, DOI 10.1037/a0039469; Pattinson CL, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.13191; Pennebaker JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115844; Pennebaker JW, 2003, J PERS SOC PSYCHOL, V85, P291, DOI 10.1037/0022-3514.85.2.291; Preotiuc-Pietro D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138717; Priem J., 2010, ALTMETRICS MANIFESTO; Proudfoot D, 2015, PSYCHOL SCI, V26, P1751, DOI 10.1177/0956797615598739; QUINA K, 1987, PSYCHOL WOMEN QUART, V11, P111, DOI 10.1111/j.1471-6402.1987.tb00778.x; Ridgeway CL, 2001, J SOC ISSUES, V57, P637, DOI 10.1111/0022-4537.00233; Rosenbusch H, 2019, SOC PSYCHOL PERS SCI, V10, P1028, DOI 10.1177/1948550618820309; Rosette AS, 2015, LEADERSHIP QUART, V26, P749, DOI 10.1016/j.leaqua.2015.02.001; Salthouse TA, 2009, NEUROBIOL AGING, V30, P507, DOI 10.1016/j.neurobiolaging.2008.09.023; Sap Maarten, 2014, P 2014 C EMP METH NA, P1146, DOI DOI 10.3115/V1/D14-1121; Schler Jonathan, 2006, AAAI SPRING S COMP A, V6, P199; Schwartz HA, 2016, BIOCOMPUT-PAC SYM, P516; Schwartz HA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073791; SINGER MS, 1986, J SOC PSYCHOL, V126, P691, DOI 10.1080/00224545.1986.9713647; SPENCE JT, 1993, J PERS SOC PSYCHOL, V64, P624, DOI 10.1037/0022-3514.64.4.624; Storage D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150194; Sugimoto CR, 2017, J ASSOC INF SCI TECH, V68, P2037, DOI 10.1002/asi.23833; Sugimoto CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062403; Tsou A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093609; Van Zant AB, 2020, J PERS SOC PSYCHOL, V118, P661, DOI 10.1037/pspi0000193; Vescio TK, 2005, J PERS SOC PSYCHOL, V88, P658, DOI 10.1037/0022-3514.88.4.658; Wakslak CJ, 2014, J PERS SOC PSYCHOL, V107, P41, DOI 10.1037/a0036626; Williams MJ, 2016, PSYCHOL BULL, V142, P165, DOI 10.1037/bul0000039; Wojciszke B, 1998, PERS SOC PSYCHOL B, V24, P1251, DOI 10.1177/01461672982412001	85	7	7	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243637	10.1371/journal.pone.0243637	http://dx.doi.org/10.1371/journal.pone.0243637			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH1IW	33326456	Green Published, gold, Green Accepted			2022-12-27	WOS:000600176400063
J	Pihlstrom, HK; Ueland, T; Michelsen, AE; Aukrust, P; Gatti, F; Hammarstrom, C; Kasprzycka, M; Wang, JB; Haraldsen, G; Mjoen, G; Dahle, DO; Midtvedt, K; Eide, IA; Hartmann, A; Holdaas, H				Pihlstrom, Hege Kampen; Ueland, Thor; Michelsen, Annika E.; Aukrust, Pal; Gatti, Franscesca; Hammarstrom, Clara; Kasprzycka, Monika; Wang, Junbai; Haraldsen, Guttorm; Mjoen, Geir; Dahle, Dag Olav; Midtvedt, Karsten; Eide, Ivar Anders; Hartmann, Anders; Holdaas, Hallvard			Exploring the potential effect of paricalcitol on markers of inflammation in de novo renal transplant recipients	PLOS ONE			English	Article							VITAMIN-D DEFICIENCY; CHRONIC KIDNEY-DISEASE; ORAL PARICALCITOL; OPEN-LABEL; ANTIINFLAMMATORY PROFILE; OXIDATIVE STRESS; ALL-CAUSE; MORTALITY; ACTIVATION; RECEPTOR	Following a successful renal transplantation circulating markers of inflammation may remain elevated, and systemic inflammation is associated with worse clinical outcome in renal transplant recipients (RTRs). Vitamin D-receptor (VDR) activation is postulated to modulate inflammation and endothelial function. We aimed to explore if a synthetic vitamin D, paricalcitol, could influence systemic inflammation and immune activation in RTRs. Newly transplanted RTRs were included in an open-label randomized controlled trial on the effect of paricalcitol on top of standard care over the first post-transplant year. Fourteen pre-defined circulating biomarkers reflecting leukocyte activation, endothelial activation, fibrosis and general inflammatory burden were analyzed in 74 RTRs at 8 weeks (baseline) and 1 year post-engraftment. Mean changes in plasma biomarker concentrations were compared by t-test. The expression of genes coding for the same biomarkers were investigated in 1-year surveillance graft biopsies (n = 60). In patients treated with paricalcitol circulating osteoprotegerin levels increased by 0.19 ng/ml, compared with a 0.05 ng/ml increase in controls (p = 0.030). In graft tissue, a 21% higher median gene expression level of TNFRSF11B coding for osteoprotegerin was found in paricalcitol-treated patients compared with controls (p = 0.026). Paricalcitol treatment did not significantly affect the blood- or tissue levels of any other investigated inflammatory marker. In RTRs, paricalcitol treatment might increase both circulating and tissue levels of osteoprotegerin, a modulator of calcification, but potential anti-inflammatory treatment effects in RTRs are likely very modest. [NCT01694160 (2012/107D)]; [www.clinicaltrials.gov].	[Pihlstrom, Hege Kampen; Mjoen, Geir; Dahle, Dag Olav; Midtvedt, Karsten; Hartmann, Anders; Holdaas, Hallvard] Oslo Univ Hosp, Rikshosp, Dept Surg Inflammat Med & Transplantat, Sect Nephrol, Oslo, Norway; [Ueland, Thor; Michelsen, Annika E.; Aukrust, Pal] Oslo Univ Hosp, Rikshosp, Res Inst Internal Med, Oslo, Norway; [Ueland, Thor; Michelsen, Annika E.; Aukrust, Pal; Hartmann, Anders] Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway; [Ueland, Thor] Univ Tromso, KG Jebsen Thrombosis Res & Expertise Ctr, Tromso, Norway; [Aukrust, Pal] Oslo Univ Hosp, Rikshosp, Dept Surg Inflammat Med & Transplantat, Sect Clin Immunol & Infect Dis, Oslo, Norway; [Gatti, Franscesca; Hammarstrom, Clara; Kasprzycka, Monika; Wang, Junbai; Haraldsen, Guttorm] Oslo Univ Hosp, Dept Pathol, Oslo, Norway; [Gatti, Franscesca; Hammarstrom, Clara; Kasprzycka, Monika; Haraldsen, Guttorm] Univ Oslo, KG Jebsen Inflammat Res Ctr, Lab Immunohistochem & Immunopathol, Oslo, Norway; [Eide, Ivar Anders; Hartmann, Anders] Akershus Univ Hosp, Dept Nephrol, Div Med, Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; UiT The Arctic University of Tromso; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; University of Oslo	Pihlstrom, HK (corresponding author), Oslo Univ Hosp, Rikshosp, Dept Surg Inflammat Med & Transplantat, Sect Nephrol, Oslo, Norway.	hegphi@ous-hf.no	wang, junbai/AFQ-5325-2022; wang, junbai/B-2093-2008	wang, junbai/0000-0001-5505-5613; 	Norwegian Society of Nephrology; South Eastern Norway Regional Health Authority	Norwegian Society of Nephrology; South Eastern Norway Regional Health Authority	The trial was funded via a PhD grant to Hege K Pihlstromfrom South Eastern Norway Regional Health Authority (https://www.helsesorost.no) and received an additional research grant from the Norwegian Society of Nephrology (https://nephro.no).Norwegian Health Authorities (https://helfo.no) also funded the trial by covering all expenses associated with paricalcitol treatment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedini S, 2009, CLIN J AM SOC NEPHRO, V4, P1246, DOI 10.2215/CJN.00930209; Alborzi P, 2008, HYPERTENSION, V52, P249, DOI 10.1161/HYPERTENSIONAHA.108.113159; Amer H, 2013, AM J TRANSPLANT, V13, P1576, DOI 10.1111/ajt.12227; [Anonymous], 2015, BMJ, V2015, ph1887; Batmanov K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07226-4; Berridge MJ, 2017, BIOCHEM J, V474, P1321, DOI 10.1042/BCJ20170042; Boyce BF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2165; Cannas L, 2017, INT UROL NEPHROL, V49, P533, DOI 10.1007/s11255-016-1435-4; de Zeeuw D, 2010, LANCET, V376, P1543, DOI 10.1016/S0140-6736(10)61032-X; Donate-Correa J, 2017, NEFROLOGIA, V37, P622, DOI 10.1016/j.nefro.2017.03.028; Dunkler D, 2020, TRANSPL INT, V33, P50, DOI 10.1111/tri.13535; Eleftheriadis T, 2010, INT UROL NEPHROL, V42, P181, DOI 10.1007/s11255-009-9541-1; Feng XK, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/160123; Gonzalez E, 2013, TRANSPLANTATION, V95, pE49, DOI 10.1097/TP.0b013e3182855565; Grebe SO, 2011, CLIN TRANSPLANT, V25, P744, DOI 10.1111/j.1399-0012.2010.01345.x; Hansen D, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-130; Jonsson S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019340; Kalluri HV, 2017, CLIN TRANSPLANT, V31, DOI 10.1111/ctr.12955; Kawahara T, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011183; Lee J, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0647-6; Lund KP, 2019, TRANSPL INT, V32, P933, DOI 10.1111/tri.13425; Mansell H, 2013, CLIN TRANSPLANT, V27, pE391, DOI 10.1111/ctr.12159; Mansouri L, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0576-8; Mathieu C, 2002, TRENDS MOL MED, V8, P174, DOI 10.1016/S1471-4914(02)02294-3; Morrison MA, 2012, EUGENE O NEILL REV, V33, P159; Mortlock S, 2016, SCH J APP MED SCI, V4, P4146; Muscogiuri G, 2017, INT J CARDIOL, V230, P577, DOI 10.1016/j.ijcard.2016.12.053; Navarro-Gonzalez JF, 2013, J CLIN PHARMACOL, V53, P421, DOI 10.1002/jcph.19; Neale RE, 2016, CONTEMP CLIN TRIALS, V48, P83, DOI 10.1016/j.cct.2016.04.005; Nieuwland AJ, 2016, LAB INVEST, V96, P784, DOI 10.1038/labinvest.2016.55; Oblak M, 2017, CLIN NEPHROL, V88, pS119, DOI 10.5414/CNP88FX26; Park JW, 2010, KIDNEY INT, V77, P1076, DOI 10.1038/ki.2010.69; Perez V, 2013, EUR J PHARMACOL, V709, P72, DOI 10.1016/j.ejphar.2013.03.040; Pihlstrom H, 2014, CLIN TRANSPLANT, V28, P111, DOI 10.1111/ctr.12285; Pihlstrom HK, 2017, TRANSPL INT, V30, P827, DOI 10.1111/tri.12973; Pinera-Haces C, 2013, NEFROLOGIA, V33, P77, DOI 10.3265/Nefrologia.pre2012.Sep.11533; Ponticelli C, 2014, EXPERT REV CLIN IMMU, V10, P1375, DOI 10.1586/1744666X.2014.949674; Rochette L, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030705; Rochette L, 2018, PHARMACOL THERAPEUT, V182, P115, DOI 10.1016/j.pharmthera.2017.08.015; Sarno G, 2015, ENDOCRINE, V50, P568, DOI 10.1007/s12020-015-0632-8; Swetha R, 2018, FUTURE MED CHEM, V10, P1093, DOI 10.4155/fmc-2017-0236; Tabriziani H, 2018, CLIN KIDNEY J, V11, P130, DOI 10.1093/ckj/sfx091; Tagliabue Elena, 2015, Adv Food Nutr Res, V75, P1, DOI 10.1016/bs.afnr.2015.06.003; Tan XY, 2006, J AM SOC NEPHROL, V17, P3382, DOI 10.1681/ASN.2006050520; Toffoli B, 2011, ATHEROSCLEROSIS, V218, P61, DOI 10.1016/j.atherosclerosis.2011.05.019; Tomlinson JAP, 2017, KIDNEY INT, V92, P809, DOI 10.1016/j.kint.2017.03.053; van Gennip ACE, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222547; van Riemsdijk-van Overbeeke I C, 1998, Transpl Int, V11 Suppl 1, pS46; Vaziri ND, 2004, SEMIN NEPHROL, V24, P469, DOI 10.1016/j.semnephrol.2004.06.026; Veldman CM, 2000, ARCH BIOCHEM BIOPHYS, V374, P334, DOI 10.1006/abbi.1999.1605; Walsh JS, 2017, CURR OPIN ENDOCRINOL, V24, P389, DOI 10.1097/MED.0000000000000371; Wang J, 2008, J ENVIRON PATHOL TOX, V27, P157, DOI 10.1615/JEnvironPatholToxicolOncol.v27.i3.10; Ishikawa LLW, 2017, CLIN REV ALLERG IMMU, V52, P373, DOI 10.1007/s12016-016-8577-0; Watkins RR, 2015, CAN J PHYSIOL PHARM, V93, P363, DOI 10.1139/cjpp-2014-0352; Yeun JY, 2000, AM J KIDNEY DIS, V35, P469, DOI 10.1016/S0272-6386(00)70200-9	55	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243759	10.1371/journal.pone.0243759	http://dx.doi.org/10.1371/journal.pone.0243759			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326471	gold, Green Published			2022-12-27	WOS:000600176400015
J	Deserno, MK; Borsboom, D; Begeer, S; van Bork, R; Hinne, M; Geurts, HM				Deserno, Marie K.; Borsboom, Denny; Begeer, Sander; van Bork, Riet; Hinne, Max; Geurts, Hilde M.			Highways to happiness for autistic adults? Perceived causal relations among clinicians	PLOS ONE			English	Article							QUALITY-OF-LIFE; SYMPTOMS; HEALTH; ASD; CHALLENGES; NETWORKS; BEHAVIOR	The network approach to psychological phenomena advances our understanding of the interrelations between autism and well-being. We use the Perceived Causal Relations methodology in order to (i) identify perceived causal pathways in the well-being system, (ii) validate networks based on self-report data, and (iii) quantify and integrate clinical expertise in autism research. Trained clinicians served as raters (N = 29) completing 374 cause-effects ratings of 34 variables on well-being and symptomatology. A subgroup (N = 16) of raters chose intervention targets in the resulting network which we found to match the respective centrality of nodes. Clinicians' perception of causal relations was similar to the interrelatedness found in self-reported client data (N = 323). We present a useful tool for translating clinical expertise into quantitative information enabling future research to integrate this in scientific studies.	[Deserno, Marie K.; Geurts, Hilde M.] Dr Leo Kannerhuis & REACH AUT, Doorwerth, Netherlands; [Deserno, Marie K.; Borsboom, Denny; van Bork, Riet; Hinne, Max; Geurts, Hilde M.] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [Begeer, Sander] Vrije Univ Amsterdam, Sect Clin Dev Psychol, Amsterdam, Netherlands	University of Amsterdam; Vrije Universiteit Amsterdam	Deserno, MK (corresponding author), Dr Leo Kannerhuis & REACH AUT, Doorwerth, Netherlands.; Deserno, MK (corresponding author), Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands.	marie.deserno@gmail.com	Hinne, Max/ABD-1486-2021	Hinne, Max/0000-0002-9279-6725; Begeer, Sander/0000-0002-0572-6893	ERC [647209]; NWO VICI Grant [453-16-006]; ZonMW [70-73400-98-002]	ERC(European Research Council (ERC)European Commission); NWO VICI Grant(Netherlands Organization for Scientific Research (NWO)); ZonMW(Netherlands Organization for Health Research and Development)	DB is supported by ERC Consolidator Grant no. 647209. HMG is supported by the NWO VICI Grant no. 453-16-006. This research project is supported by ZonMW Grant no. 70-73400-98-002.	Anderson GM, 2015, J AUTISM DEV DISORD, V45, P1103, DOI 10.1007/s10803-014-2225-4; [Anonymous], 2009, STUDIES 20 21 CENTUR, V33, P47; Ayres M, 2018, AUTISM, V22, P774, DOI 10.1177/1362361317714988; Borsboom D, 2013, ANNU REV CLIN PSYCHO, V9, P91, DOI 10.1146/annurev-clinpsy-050212-185608; Borsboom D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027407; Bringmann LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060188; Cramer AOJ, 2012, EUR J PERSONALITY, V26, P414, DOI 10.1002/per.1866; De Kwaadsteniet L, 2017, CLIN PSYCHOL SCI; de Kwaadsteniet L, 2010, PSYCHOL ASSESSMENT, V22, P581, DOI 10.1037/a0019696; De Villiers MR, 2005, MED TEACH, V27, P639, DOI 10.1080/13611260500069947; de Vries M, 2015, J AUTISM DEV DISORD, V45, P2734, DOI 10.1007/s10803-015-2438-1; Deserno MK, 2018, PSYCHOL MED, V48, P1179, DOI 10.1017/S0033291717002616; Deserno MK, 2017, AUTISM, V21, P960, DOI 10.1177/1362361316660309; Epskamp S., 2011, J STAT SOFTW, V48, P1; Epskamp S, 2018, BEHAV RES METHODS, V50, P195, DOI 10.3758/s13428-017-0862-1; Flores A, 2014, J EXP PSYCHOL-APPL, V20, P175, DOI 10.1037/xap0000025; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Frewen PA, 2012, ASSESSMENT, V19, P480, DOI 10.1177/1073191111418297; Hinne M, 2014, NEUROIMAGE, V86, P294, DOI 10.1016/j.neuroimage.2013.09.075; Horwitz EH, 2016, RES AUTISM SPECT DIS, V24, P17, DOI 10.1016/j.rasd.2016.01.003; Johnson MH, 2017, DEV COGN NEUROS-NETH, V25, P5, DOI 10.1016/j.dcn.2017.02.004; Kan CC., 2013, MULTIDISCIPLINAIRE R; Kerns CM, 2019, J CLIN CHILD ADOLESC, V48, pS247, DOI 10.1080/15374416.2017.1410826; Kim NS, 2002, J EXP PSYCHOL GEN, V131, P451, DOI 10.1037//0096-3445.131.4.451; Kroeze Renske, 2017, J Pers Oriented Res, V3, P1, DOI 10.17505/jpor.2017.01; Lorber MF, 2014, DEV PSYCHOL, V50, P1854, DOI 10.1037/a0036985; Moss P, 2017, J AUTISM DEV DISORD, V47, P1830, DOI 10.1007/s10803-017-3105-5; Nicolaidis C, 2015, AUTISM, V19, P824, DOI 10.1177/1362361315576221; Priebe S, 1999, INT J SOC PSYCHIATR, V45, P7, DOI 10.1177/002076409904500102; Proctor C, 2007, PSYCHON B REV, V14, P635, DOI 10.3758/BF03196813; Ruzzano L, 2015, J AUTISM DEV DISORD, V45, P192, DOI 10.1007/s10803-014-2204-9; Sameroff A, 2010, CHILD DEV, V81, P6, DOI 10.1111/j.1467-8624.2009.01378.x; Thornley E., 2016, TRAUMATOLOGY, V22, P222, DOI [10.1037/trm0000071, DOI 10.1037/TRM0000071]; Tio P, 2016, INT J METH PSYCH RES, V25, P267, DOI 10.1002/mpr.1503; van Borkulo C, 2015, JAMA PSYCHIAT, V72, P1219, DOI 10.1001/jamapsychiatry.2015.2079; van der Maas HLJ, 2006, PSYCHOL REV, V113, P842, DOI 10.1037/0033-295X.113.4.842; Wainer A, 2017, J MENT HEALTH RES IN, V10, P178, DOI 10.1080/19315864.2017.1284289; Wing JK, 1998, BRIT J PSYCHIAT, V172, P11, DOI 10.1192/bjp.172.1.11; Yopchick JE, 2009, MEM COGNITION, V37, P29, DOI 10.3758/MC.37.1.29	39	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243298	10.1371/journal.pone.0243298	http://dx.doi.org/10.1371/journal.pone.0243298			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH3TP	33320901	Green Published, Green Submitted, gold			2022-12-27	WOS:000600339800061
J	Viana, ECRD; Oliveira, ID; Rechinelli, AB; Marques, IL; de Souza, VF; Spexoto, MCB; Pereira, TSS; Guandalini, VR				Rodrigues de Morais Viana, Eduarda Cristina; Oliveira, Isadora da Silva; Rechinelli, Ana Beatriz; Marques, Isabele Lessa; de Souza, Vanusa Felicio; Bernardes Spexoto, Maria Claudia; Silva Pereira, Taisa Sabrina; Guandalini, Valdete Regina			Malnutrition and nutrition impact symptoms (NIS) in surgical patients with cancer	PLOS ONE			English	Article								Background and aim Nutrition impact symptoms (NIS) are common in cancer patients and the negative impacts on nutritional status indicate the need for research, diagnosis and nutritional intervention in order to reduce the risk of malnutrition. We aimed to verify the presence of malnutrition, the need for nutritional intervention, NIS and their influence on the nutritional status of surgical patients with cancer. Methods This cross-sectional study was carried out in a public tertiary hospital, from March 2017 to October 2019. Nutritional status, the need for nutritional intervention and NIS were assessed through the Patient-Generated Subjective Global Assessment (PG-SGA) in the first 48 hours of hospital admission. Results Among the 135 patients evaluated, 55.6% were elderly and 51.1% were male; patients had a median age of 62 years and a predominance of cancer located in the lower gastrointestinal tract (35.6%). Malnutrition and the need for nutritional intervention were identified in 60.0% and 90.4% of cases, respectively. The presence of three or more NIS was reported by 51.9% of patients. Significant differences in NIS were observed according to sex, PG-SGA classification and PG-SGA score. After logistic regression analysis, it was determined that the symptoms that increased the chances of malnutrition were anorexia, constipation, strange taste, mouth sores and others (depression, dental or financial problems). Conclusion Malnutrition, the need for nutritional intervention and the presence of three or more NIS were elevated in the patients evaluated. Malnutrition was associated with the presence of NIS, indicating the need for attention and care in antineoplastic treatment.	[Rodrigues de Morais Viana, Eduarda Cristina; Oliveira, Isadora da Silva; Rechinelli, Ana Beatriz; Marques, Isabele Lessa; de Souza, Vanusa Felicio; Guandalini, Valdete Regina] Univ Fed Espirito Santo, Dept Integrated Educ, Vitoria, ES, Brazil; [Bernardes Spexoto, Maria Claudia] Fed Univ Grande Dourados, Fac Pharmaceut Sci, Nutr Course, Dourados, MS, Brazil; [Silva Pereira, Taisa Sabrina] Univ Americas Puebla, Cholula, Mexico; [Guandalini, Valdete Regina] Univ Fed Espirito Santo, Postgrad Program Nutr & Hlth, Vitoria, ES, Brazil	Universidade Federal do Espirito Santo; Universidade Federal da Grande Dourados; Universidad Americas Puebla (UDLAP); Universidade Federal do Espirito Santo	Guandalini, VR (corresponding author), Univ Fed Espirito Santo, Dept Integrated Educ, Vitoria, ES, Brazil.; Guandalini, VR (corresponding author), Univ Fed Espirito Santo, Postgrad Program Nutr & Hlth, Vitoria, ES, Brazil.	valdete.guandalini@ufes.br	Guandalini, Valdete Regina/E-5165-2017	Guandalini, Valdete Regina/0000-0003-2266-6113	Research and Innovation Support Foundation of Espirito Santo (FAPES)	Research and Innovation Support Foundation of Espirito Santo (FAPES)	The authors thank the Research and Innovation Support Foundation of Espirito Santo (FAPES) for their financial support.	Abernethy Amy P, 2010, Curr Opin Support Palliat Care, V4, P36, DOI 10.1097/SPC.0b013e32833575fd; Anandavadivelan P, 2018, CANCERS, V10, DOI 10.3390/cancers10090318; [Anonymous], 2006, JSP, V15, P39; [Anonymous], 2019, CONFLUENCIA, V34, P2; Galindo DEB, 2017, APPETITE, V114, P23, DOI 10.1016/j.appet.2017.03.020; Bauer J, 2002, EUR J CLIN NUTR, V56, P779, DOI 10.1038/sj.ejcn.1601412; Martins FFC, 2019, CLIN NUTR ESPEN, V31, P17, DOI 10.1016/j.clnesp.2019.03.013; de Pinho NB, 2019, CLIN NUTR, V38, P1274, DOI 10.1016/j.clnu.2018.05.010; Gervais C, 2016, B CANCER, V103, P794, DOI 10.1016/j.bulcan.2016.05.010; Gonzalez MC, 2010, REV BRAS NUTR CLIN, V25, P102; Harter J, 2017, SUPPORT CARE CANCER, V25, P2525, DOI 10.1007/s00520-017-3661-4; Knudsen AW, 2015, SCAND J GASTROENTERO, V50, P1191, DOI 10.3109/00365521.2015.1028994; Kubrak C, 2010, HEAD NECK-J SCI SPEC, V32, P290, DOI 10.1002/hed.21174; Lindqvist C, 2020, CLIN NUTR, V39, P1840, DOI 10.1016/j.clnu.2019.07.024; Lohman T. G., 1998, ANTROPOMETRIC STANDA; MacLaughlin HL, 2018, J HUM NUTR DIET, V31, P683, DOI 10.1111/jhn.12553; Omlin A, 2013, J CACHEXIA SARCOPENI, V4, P55, DOI 10.1007/s13539-012-0099-x; Pan American Health Organization/World Health Organization, FACT SHEET CANC; Pereira PL, 2015, REV BRASILEIRA CANCE, V61, P243; Planas M, 2016, SUPPORT CARE CANCER, V24, P429, DOI 10.1007/s00520-015-2813-7; Teixeira AC, 2019, NUTR CLIN DIET HOSP, V38, P95, DOI 10.12873/384valdete; Vale IA, 2015, REV BRAS CANCEROL, V61, P367; WHO, 2017, HLTH TOP AG LIF COUR; World Health Organization, 1995, PHYS STAT US INT ANT; Yang sgron, 2015, ZANGXUE YANJIU, V14, P123	25	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0241305	10.1371/journal.pone.0241305	http://dx.doi.org/10.1371/journal.pone.0241305			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320857	Green Published, gold			2022-12-27	WOS:000600339800052
J	Braunwarth, E; Rumpf, B; Primavesi, F; Pereyra, D; Hochleitner, M; Gobel, G; Gasteiger, S; Gehwolf, P; Ofner, D; Starlinger, P; Stattner, S				Braunwarth, Eva; Rumpf, Benedikt; Primavesi, Florian; Pereyra, David; Hochleitner, Margarethe; Goebel, Georg; Gasteiger, Silvia; Gehwolf, Philipp; Oefner, Dietmar; Starlinger, Patrick; Staettner, Stefan			Sex differences in disease presentation, surgical and oncological outcome of liver resection for primary and metastatic liver tumors-A retrospective multicenter study	PLOS ONE			English	Article							COLON-CANCER; HEPATOCELLULAR-CARCINOMA; GENDER-DIFFERENCES; SURGERY; INFLAMMATION; HEPATECTOMY; MORTALITY	Background Sex differences are becoming of rising interest in many fields of medicine. It remains unknown whether sex has a role in postoperative and long-term outcome after hepatic resection (HR). The aim of this study was to investigate sex differences in disease presentation, surgical and oncological outcome after curative HR. Methods Retrospective analysis of 1010 patients who underwent HR between 2005 and 2018 at two tertiary hospitals in Austria. Demographics and survival data were obtained from a prospectively maintained database. Univariate analysis was used to identify sex differences for the entire cohort and for sub-cohorts. Disease-free- and overall survival was assessed by the Kaplan-Meier estimate and results were compared by log-rank tests. Results 436 females and 574 males were analyzed. Women were younger (p<0.001), had less liver cirrhosis (p<0.001), cardiac comorbidities (p<0.001), diabetes (28 (p<0.001) and obesity (p<0.001). Type of HR and surgical management did not vary by sex. Ninety-day morbidity (p = 0.179) and -mortality (p = 0.888) were comparable. In patients with malignant disease, no differences in disease-free- and overall survival was observed, neither for the entire cohort nor for the subgroups according to tumor entity or type of resection. Only in HCC patients, females showed an inferior OS (p = 0.029). Conclusion This study delivers new insights on the impact of sex differences in liver surgery. Despite the fact that male patients have a higher incidence of preoperative morbidities, we did not observe specific disparities in terms of immediate postoperative as well as long term oncological outcome between sexes.	[Braunwarth, Eva; Primavesi, Florian; Gasteiger, Silvia; Gehwolf, Philipp; Oefner, Dietmar; Staettner, Stefan] Med Univ Innsbruck, Dept Visceral Transplantat & Thorac Surg, Innsbruck, Austria; [Rumpf, Benedikt; Pereyra, David; Starlinger, Patrick] Med Univ Vienna, Gen Hosp, Dept Surg, Vienna, Austria; [Hochleitner, Margarethe] Med Univ Innsbruck, Dept Internal Med 1, Innsbruck, Austria; [Hochleitner, Margarethe] Med Univ Innsbruck, Womens Hlth Care Ctr, Innsbruck, Austria; [Goebel, Georg] Med Univ Innsbruck, Dept Med Stat Informat & Hlth Econ, Innsbruck, Austria; [Starlinger, Patrick] Mayo Clin, Div Hepatobiliary & Pancreat Surg, Dept Surg, Rochester, MN USA; [Staettner, Stefan] Salzkammergut Klinikum, Dept Gen Vasc & Visceral Surg, Vocklabruck, Austria	Medical University of Innsbruck; Medical University of Vienna; Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck; Mayo Clinic	Stattner, S (corresponding author), Med Univ Innsbruck, Dept Visceral Transplantat & Thorac Surg, Innsbruck, Austria.; Stattner, S (corresponding author), Salzkammergut Klinikum, Dept Gen Vasc & Visceral Surg, Vocklabruck, Austria.	stefan.staettner@i-med.ac.at		Stattner, Stefan/0000-0002-5226-7597				Althans AR, 2017, AM J SURG, V214, P715, DOI 10.1016/j.amjsurg.2017.07.022; Amri R, 2014, J SURG ONCOL, V109, P645, DOI 10.1002/jso.23567; Angele MK, 2014, VIRULENCE, V5, P12, DOI 10.4161/viru.26982; Bachellier P, 2011, ANN SURG, V253, P173, DOI 10.1097/SLA.0b013e3181f193ba; Bisschop P, 2014, SOUTH ASIAN STUD, V30, P133, DOI 10.1080/02666030.2014.962302; Campbell-Thompson M, 2001, CANCER RES, V61, P632; Choudhry MA, 2005, SHOCK, V24, P101, DOI 10.1097/01.shk.0000191341.31530.5e; El-Serag H, 2003, ANN INTERN MED, V139, P817, DOI 10.7326/0003-4819-139-10-200311180-00009; Farinati F, 2009, EUR J GASTROEN HEPAT, V21, P1212, DOI 10.1097/MEG.0b013e32831a86f8; Fodor M, 2018, EUR SURG, V50, P125, DOI 10.1007/s10353-018-0536-y; Gaitonde SG, 2017, J AM COLL SURGEONS, V225, P85, DOI 10.1016/j.jamcollsurg.2017.02.019; Guy Jennifer, 2013, Gastroenterol Hepatol (N Y), V9, P633; Hsieh YC, 2007, CRIT CARE MED, V35, pS621, DOI 10.1097/01.CCM.0000278603.18687.4F; Koch M, 2011, SURGERY, V149, P680, DOI 10.1016/j.surg.2010.12.002; Ladenheim MR, 2016, BMJ OPEN GASTROENTER, V3, DOI 10.1136/bmjgast-2016-000107; Laird BJ, 2013, CLIN CANCER RES, V19, P5456, DOI 10.1158/1078-0432.CCR-13-1066; Lassen K, 2019, LANGENBECK ARCH SURG, V404, P11, DOI 10.1007/s00423-018-1737-3; Lu HT, 2006, MOL CANCER RES, V4, P221, DOI 10.1158/1541-7786.MCR-05-0261; Matsumoto T, 2000, LIVER, V20, P228, DOI 10.1034/j.1600-0676.2000.020003228.x; McArdle CS, 2003, BRIT J SURG, V90, P711, DOI 10.1002/bjs.4098; Ni TG, 2015, WORLD J GASTROENTERO, V21, P9209, DOI 10.3748/wjg.v21.i30.9209; Offner PJ, 1999, ARCH SURG-CHICAGO, V134, P935, DOI 10.1001/archsurg.134.9.935; Pang YY, 2000, HPB, V2, P333, DOI 10.1080/136518202760378489; Pringle JH, 1908, ANN SURG, V48, P541, DOI 10.1097/00000658-190810000-00005; Putzer D, 2018, EUR SURG, V50, P117, DOI 10.1007/s10353-018-0521-5; Quirt JS, 2017, CURR ONCOL, V24, pE15, DOI 10.3747/co.24.3410; Ritvo P, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-500; Roxburgh CSD, 2014, BRIT J CANCER, V110, P1409, DOI 10.1038/bjc.2014.90; Rucker D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224278; Saltzstein SL, 2007, J CLIN GASTROENTEROL, V41, P173, DOI 10.1097/01.mcg.0000225550.26751.6a; Shaukat A, 2013, NEW ENGL J MED, V369, P1106, DOI 10.1056/NEJMoa1300720; Smith NK, 2021, ANESTH ANALG, V132, P130, DOI 10.1213/ANE.0000000000004734; Statistik-Austria, STAT AUSTR MORT REG; Tanaka K, 2000, CANCER RES, V60, P5106; Vigano L, 2008, AM J SURG, V196, P195, DOI 10.1016/j.amjsurg.2007.08.062; Wichmann MW, 2003, LANGENBECK ARCH SURG, V387, P397, DOI 10.1007/s00423-002-0346-2; Yokoyama Y, 2008, ARCH SURG-CHICAGO, V143, P254, DOI 10.1001/archsurg.2007.58; Zhang H, 2019, SURGERY, V165, P516, DOI 10.1016/j.surg.2018.08.031	38	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243539	10.1371/journal.pone.0243539	http://dx.doi.org/10.1371/journal.pone.0243539			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315924	Green Published, gold			2022-12-27	WOS:000600186100010
J	Holzer, J				Holzer, Joshua			The effect of two-round presidential elections on human rights	PLOS ONE			English	Article							LIFE-INTEGRITY VIOLATIONS; NATIONAL ELECTIONS; PERSONAL INTEGRITY; VOTING PROCEDURES; MASS MURDER; REPRESSION; DEMOCRACY; RESPECT; WORLD	Recent research suggests that democratic presidential elections held using a runoff rule produce presidents that are more likely to protect human rights, in comparison to those elected under plurality rule; with this follow-up article, I seek to highlight the importance of advancing to a runoff round for those elections held using a runoff rule. I find that for presidential democracies that already have a runoff rule in place, country-years where the president has been elected after a runoff round are more likely to be associated with high government respect for human rights, in comparison to country-years where the president has been elected after only one round (that could have advanced to a runoff round, but did not). This article provides decision-makers with more information regarding the human rights consequences of runoff rounds, so that the costs and benefits of adopting (or retaining) variations of a runoff rule can be better weighed.	[Holzer, Joshua] Westminster Coll, Fulton, MO 65251 USA		Holzer, J (corresponding author), Westminster Coll, Fulton, MO 65251 USA.	joshua.holzer@gmail.com	Holzer, Joshua/V-8840-2019	Holzer, Joshua/0000-0002-3024-3703				Ahmed A, 2013, DEMOCRACY AND THE POLITICS OF ELECTORAL SYSTEM CHOICE: ENGINEERING ELECTORAL DOMINANCE, P1; Austin D, 1995, DEMOCRACY VIOLENCE I; Bellinger NM, 2017, HUM RIGHTS REV, V18, P263, DOI 10.1007/s12142-017-0451-9; Bello Walden, 1984, WORLD POLICY J, V1, P851; Booth JA, 1989, ELECTIONS DEMOCRACY; Bormann NC, DEMOCRATIC ELECTORAL; Bormann NC, 2013, ELECT STUD, V32, P360, DOI 10.1016/j.electstud.2013.01.005; Cheibub JA, 2010, PUBLIC CHOICE, V143, P67, DOI 10.1007/s11127-009-9491-2; Chilton AS, 2016, AM J POLIT SCI, V60, P575, DOI 10.1111/ajps.12239; Churchill Ward, 1990, COINTELPRO PAPERS DO; Cingranelli D, 2014, BRIT J POLIT SCI, V44, P605, DOI 10.1017/S0007123413000070; Cingranelli D, 2010, J POLIT, V72, P243, DOI 10.1017/S0022381609990594; Cingranelli David, CINGRANELLI RICHARDS; Cingranelli DL, 2019, HUM RIGHTS QUART, V41, P725, DOI 10.1353/hrq.2019.0050; Cingranelli DL, 2010, HUM RIGHTS QUART, V32, P401, DOI 10.1353/hrq.0.0141; Collier P, 2012, PUBLIC CHOICE, V153, P117, DOI 10.1007/s11127-011-9777-z; Collier Paul, 2009, WARS GUNS VOTES DEMO; Colomer JM, 2004, HANDBOOK OF ELECTORAL SYSTEM CHOICE, P1, DOI 10.1057/9780230522749; Conrad CR, 2018, J PEACE RES, V55, P3, DOI 10.1177/0022343317711240; Cox G.W., 1997, MAKING VOTES COUNT S; Crabtree C, 2017, INT STUD QUART, V61, P210, DOI 10.1093/isq/sqw056; Crabtree CD, 2015, RES POLITICS, V2, DOI 10.1177/2053168015605343; Dahl RA., 1989, DEMOCRACY ITS CRITIC; Dalton R., 1988, CITIZEN POLITICS W D; Davenport C, 2004, AM J POLIT SCI, V48, P538, DOI 10.1111/j.0092-5853.2004.00086.x; Davenport C, 1999, J CONFLICT RESOLUT, V43, P92, DOI 10.1177/0022002799043001006; DAVENPORT C, 1995, AM J POLIT SCI, V39, P683, DOI 10.2307/2111650; Davenport C, 1997, ELECT STUD, V16, P517, DOI 10.1016/S0261-3794(97)00032-2; De Mesquita BB, 2005, INT STUD QUART, V49, P439, DOI 10.1111/j.1468-2478.2005.00372.x; Doyle D, 2016, BRIT J POLIT SCI, V46, P731, DOI 10.1017/S0007123414000465; Dreher A, 2012, J CONFLICT RESOLUT, V56, P516, DOI 10.1177/0022002711420962; Drury AC, 2014, EUR J INT RELAT, V20, P463, DOI 10.1177/1354066112448200; Dugas JC, 2001, LAT AM RES REV, V36, P157; Duvall R, 1988, POLITICS TERRORISM; FEIN H, 1995, HUM RIGHTS QUART, V17, P170, DOI 10.1353/hrq.1995.0001; FISHBURN PC, 1981, PUBLIC CHOICE, V36, P89; FISHBURN PC, 1977, BEHAV SCI, V22, P178, DOI 10.1002/bs.3830220304; FISHBURN PC, 1976, BEHAV SCI, V21, P1, DOI 10.1002/bs.3830210102; FISHBURN PC, 1971, BEHAV SCI, V16, P538, DOI 10.1002/bs.3830160604; Francisco RA, 1996, AM J POLIT SCI, V40, P1179, DOI 10.2307/2111747; Franks C.E.S., 1989, DISSENT STATE; Freudenreich J, 2016, LAT AM POLIT SOC, V58, P80, DOI 10.1111/laps.12003; Ghatak S, 2019, J CONFLICT RESOLUT, V63, P439, DOI 10.1177/0022002717734285; Gleditsch NP, 2002, J PEACE RES, V39, P615, DOI 10.1177/0022343302039005007; Gleditsch NP, UCDP PRIO ARMED CONF; Gurr T., 1986, GOVT VIOLENCE REPRES, P45; Hafner-Burton EA, 2005, INT ORGAN, V59, P593, DOI 10.1017/S0020818305050216; Hafner-Burton EM, 2014, BRIT J POLIT SCI, V44, P149, DOI 10.1017/S0007123412000671; Harff B, 2003, AM POLIT SCI REV, V97, P57, DOI 10.1017/S0003055403000522; Haschke P., 2017, PEACE CONFLICT 2017; Hibbs D., 1973, MASS POLITICAL VIOLE; Hill DW, 2014, AM POLIT SCI REV, V108, P661, DOI 10.1017/S0003055414000306; Holzer J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234938; Holzer J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219409; Holzer J, 2019, POLIT SCI, V70, P253, DOI 10.1080/00323187.2018.1560590; Holzer J, 2021, SOC SCI J, V58, P237, DOI 10.1016/j.soscij.2019.04.006; Holzer J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217650; Holzer J, 2018, INT J HUM RIGHTS, V22, P1087, DOI 10.1080/13642987.2018.1499622; Jackson JL, 2018, RES POLITICS, V5, DOI 10.1177/2053168018759126; Kaminski MM, 1999, PUBLIC CHOICE, V98, P83, DOI 10.1023/A:1018343527571; KARKLINS R, 1993, J POLIT, V55, P588, DOI 10.2307/2131990; Krain M, 1997, J CONFLICT RESOLUT, V41, P331, DOI 10.1177/0022002797041003001; Lehoucq F, 2004, HANDBOOK OF ELECTORAL SYSTEM CHOICE, P133; Lewis-Beck MichaelS., 1990, EC ELECTIONS MAJOR W; LICHBACH MI, 1987, J CONFLICT RESOLUT, V31, P266, DOI 10.1177/0022002787031002003; LIJPHART A, 1990, AM POLIT SCI REV, V84, P481, DOI 10.2307/1963530; Lipset SeymourMartin., 1981, POLITICAL MAN SOCIAL; Marshall MG, 2014, OLITY 4 POLITICAL RE; Mill JohnS., 1977, COLLECTED WORKS JS M, V19, P371; Milnor AJ, 1969, ELECTIONS POLITICAL; Moller J, 2013, DEMOCRATIZATION, V20, P82, DOI 10.1080/13510347.2013.738863; Negretto GL, 2006, J POLIT, V68, P421, DOI 10.1111/j.1468-2508.2006.00417.x; Negretto GL, 2004, HDB ELECTORAL SYSTEM; Norris P, 2004, ELECTRONIC VOTING AND DEMOCRACY: A COMPARATIVE ANALYSIS, P193; NURMI H, 1983, BRIT J POLIT SCI, V13, P181, DOI 10.1017/S0007123400003215; O'Neill JC, 2007, PUBLIC CHOICE, V131, P351, DOI 10.1007/s11127-006-9120-2; PAINE NR, 1988, BRIT J POLIT SCI, V18, P281, DOI 10.1017/S000712340000510X; Perez-Linan A, 2006, ELECT STUD, V25, P129, DOI 10.1016/j.electstud.2005.04.002; Pirages D, 1976, MANAGING POLITICAL C; Piven Frances Fox, 1979, POOR PEOPLES MOVEMEN; POE SC, 1994, AM POLIT SCI REV, V88, P853, DOI 10.2307/2082712; Poe SC, 1999, INT STUD QUART, V43, P291, DOI 10.1111/0020-8833.00121; Rae D., 1971, POLITICAL CONSEQUENC; Richards DL, 2007, J PEACE RES, V44, P505, DOI 10.1177/0022343307078946; Richards DL, 2015, J HUM RIGHTS, V14, P291, DOI 10.1080/14754835.2015.1061423; Richards DL, 1999, SOC SCI QUART, V80, P648; Riker W.R., 1962, THEORY POLITICAL COA; Robinson JA, 2009, AM ECON REV, V99, P310, DOI 10.1257/aer.99.2.310; Rose R, 1980, ELECTORAL PARTICIPAT, V2; Sartori G., 1994, COMP CONSTITUTIONAL; Seligson Mitchell A., 1995, ELECTIONS DEMOCRACY; SHUGART MS, 1994, COMP POLIT STUD, V27, P323, DOI 10.1177/0010414094027003001; Sisk T, 1995, DEMOCRATIZATION S AF; Steiner HJ, 1988, HARVARD HUMAN RIGHTS, VOne; Stiefel M, 1994, CITIZEN POLITICS W D; Straffin PD., 1980, TOPICS THEORY VOTING; Tanaka Martin, 2005, DEMOCRACIA SIN PARTI; Tarrow S., 1994, POWER MOVEMENT SOCIA; The Lancet Haematology, 2018, LANCET HAEMATOL, V5, pe127; Tomz M., 2003, J STAT SOFTW, V8, P1; Walter E. V., 1969, TERROR RESISTANCE ST; Wood RM, 2010, HUM RIGHTS QUART, V32, P367, DOI 10.1353/hrq.0.0152; Zanger SC, 2000, J PEACE RES, V37, P213, DOI 10.1177/0022343300037002006; Ziegenhagen E.A., 1986, REGULATION POLITICAL	104	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243094	10.1371/journal.pone.0243094	http://dx.doi.org/10.1371/journal.pone.0243094			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH1MP	33318710	gold, Green Published			2022-12-27	WOS:000600186100025
J	Sohn, W; Ham, CB; Kim, NH; Kim, HJ; Cho, YK; Jeon, WK; Kim, BI				Sohn, Won; Ham, Cheol Bae; Kim, Nam Hee; Kim, Hong Joo; Cho, Yong Kyun; Jeon, Woo Kyu; Kim, Byung Ik			Effect of acute kidney injury on the patients with hepatocellular carcinoma undergoing transarterial chemoembolization	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; CIRRHOTIC-PATIENTS; DEFINITION; DIAGNOSIS; MORTALITY; RISK	The purpose of this study was to investigate the effect of acute kidney injury (AKI) on the prognosis of patients with hepatocellular carcinoma (HCC) undergoing transarterial chemoembolization (TACE). A total of 347 HCC patients with Child-Pugh class A and pre-TACE serum creatinine (SCr) <= 1.5 mg/dL undergoing TACE as an initial therapy 2000-2014 were analyzed. Overall survival with related risk factors including AKI was investigated. We assessed AKI based on the International Club of Ascites (ICA)-AKI criteria. The mean age was 60.9 years. Of 347 patients, death was observed in 109 patients (31.4%). The mean SCr levels at pre-TACE, one day, two months, and four months after TACE were 0.9, 0.9, 0.9, and 1.1 mg/dL, respectively. The AKI within four months after TACE developed in 37 patients (11%). The AKI stages were non-AKI in 310 (89%), stage 1 in 10 (3%), stage 2 in 10 (3%), and stage 3 in 17 patients (5%). Multivariable analysis showed that the risk factors for overall survival were serum albumin <= 3.5 g/dL (hazard ratio [HR] 1.58, p = 0.027), BCLC stage B (HR 2.07, p = 0.008), BCLC stage C (HR 3.96, p<0.001), bilobar tumor location (HR 1.66, p = 0.022), AKI stage 1 (HR 6.09, p<0.001), AKI stage 2 (HR 8.51, p<0.001), and AKI stage 3 (HR 17.64, p<0.001). AKI is a crucial prognostic factor for overall survival in HCC patients undergoing TACE. The assessment of AKI based on the ICA-AKI criteria can facilitate evaluation of the prognosis of HCC patients undergoing TACE.	[Sohn, Won; Ham, Cheol Bae; Kim, Nam Hee; Kim, Hong Joo; Cho, Yong Kyun; Jeon, Woo Kyu; Kim, Byung Ik] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Div Gastroenterol, Dept Internal Med,Sch Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, BI (corresponding author), Sungkyunkwan Univ, Kangbuk Samsung Hosp, Div Gastroenterol, Dept Internal Med,Sch Med, Seoul, South Korea.	bik.kim@samsung.com		Sohn, Won/0000-0003-3284-2715; Kim, Hong Joo/0000-0003-4121-6329				Angeli P, 2015, J HEPATOL, V62, P968, DOI 10.1016/j.jhep.2014.12.029; [Anonymous], 2015, ARCH BRONCONEUMOL S, V51, pS1; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Bucsics T, 2017, GASTROENTEROL REP, V5, P127, DOI 10.1093/gastro/gox009; de Carvalho JR, 2012, J CLIN GASTROENTEROL, V46, pE21, DOI 10.1097/MCG.0b013e31822e8e12; Desai AP, 2020, J HEPATOL, V73, P1092, DOI 10.1016/j.jhep.2020.04.043; European Assoc Study Liver, 2018, J HEPATOL, V69, P182, DOI 10.1016/j.jhep.2018.03.019; de Paredes AGG, 2018, LIVER INT, V38, P285, DOI 10.1111/liv.13515; Garcia-Tsao G, 2008, HEPATOLOGY, V48, P2064, DOI 10.1002/hep.22605; Hayashi M, 2020, JPN J CLIN ONCOL, V50, P36, DOI 10.1093/jjco/hyz129; Heimbach JK, 2018, HEPATOLOGY, V67, P358, DOI 10.1002/hep.29086; Hoste EAJ, 2006, CRIT CARE, V10, DOI 10.1186/cc4915; Hsieh YC, 2017, J GASTROEN HEPATOL, V32, P1859, DOI 10.1111/jgh.13777; Hsu CY, 2010, LIVER INT, V30, P77, DOI 10.1111/j.1478-3231.2009.02128.x; Huo TI, 2004, ALIMENT PHARM THER, V19, P999, DOI 10.1111/j.1365-2036.2004.01936.x; Kim NH, 2018, J GASTROEN HEPATOL, V33, P1397, DOI 10.1111/jgh.14083; Lee BC, 2017, EUR RADIOL, V27, P4482, DOI 10.1007/s00330-017-4893-x; Llovet JM, 2002, LANCET, V359, P1734, DOI 10.1016/S0140-6736(02)08649-X; Llovet JM, 2016, NAT REV DIS PRIMERS, V2, DOI [10.1038/nrdp.2016.18, 10.1038/nrdp.2016.19]; Lo CM, 2002, HEPATOLOGY, V35, P1164, DOI 10.1053/jhep.2002.33156; Mehran R, 2019, NEW ENGL J MED, V380, P2146, DOI 10.1056/NEJMra1805256; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Palevsky PM, 2013, AM J KIDNEY DIS, V61, P649, DOI 10.1053/j.ajkd.2013.02.349; Ronco C, 2019, LANCET, V394, P1949, DOI 10.1016/S0140-6736(19)32563-2; Russ KB, 2015, J CLIN TRANSL HEPATO, V3, P195, DOI 10.14218/JCTH.2015.00015; Salerno F, 2007, GUT, V56, P1310, DOI 10.1136/gut.2006.107789; Sieghart W, 2015, J HEPATOL, V62, P1187, DOI 10.1016/j.jhep.2015.02.010; Sohn W, 2020, J GASTROEN HEPATOL, V35, P870, DOI 10.1111/jgh.14871; Wong F, 2016, CLIN MOL HEPATOL, V22, P415, DOI 10.3350/cmh.2016.0056; Xiong J, 2018, SCAND J GASTROENTERO, V53, P1590, DOI 10.1080/00365521.2018.1545423; Zhou CZ, 2014, INT J CLIN EXP PATHO, V7, P2579	32	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243780	10.1371/journal.pone.0243780	http://dx.doi.org/10.1371/journal.pone.0243780			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315944	Green Published, gold			2022-12-27	WOS:000600186100005
J	Gonzalez-Block, MA; Gutierrez-Calderon, E; Pelcastre-Villafuerte, BE; Arroyo-Laguna, J; Comes, Y; Crocco, P; Fachel-Leal, A; Noboa, L; Riva-Knauth, D; Rodriguez-Zea, B; Ruoti, M; Sarti, E; Puentes-Rosas, E				Angel Gonzalez-Block, Miguel; Gutierrez-Calderon, Emilio; Estela Pelcastre-Villafuerte, Blanca; Arroyo-Laguna, Juan; Comes, Yamila; Crocco, Pedro; Fachel-Leal, Andrea; Noboa, Laura; Riva-Knauth, Daniela; Rodriguez-Zea, Berenice; Ruoti, Monica; Sarti, Elsa; Puentes-Rosas, Esteban			Influenza vaccination hesitancy in five countries of South America. Confidence, complacency and convenience as determinants of immunization rates	PLOS ONE			English	Article								Introduction Influenza morbidity and mortality are significant in the countries of South America, yet influenza vaccination is as low as 56.7% among pregnant women, reaching 76.7% of adults with chronic diseases. This article measures the relative values for the vaccination hesitancy indicators of confidence, complacency and convenience by risk-groups in urban areas of five countries of South America with contrasting vaccination rates, analyzing their association with sociodemographic variables and self-reported immunization status. Methods An exit survey was applied to 640 individuals per country in Brazil, Chile, Paraguay, Peru and Uruguay, distributed equally across risk groups of older adults, adults with risk factors, children <= 6 and pregnant women. Indicators were constructed for vaccine confidence, complacency and convenience. Analysis of variance and multiple logistic analysis was undertaken. Results Adults with risk factors are somewhat more confident of the influenza vaccine yet also more complacent. Convenience is higher for mothers of minors. Children and older adults report higher levels of vaccination. The 3Cs are more different across countries than across risk groups, with values for Chile higher for confidence and those for Uruguay the lowest. Complacency is lower in Brazil and higher in Uruguay. Results suggest that confidence and complacency affect vaccination rates across risk groups and countries. Conclusions Influenza vaccine confidence, complacency and convenience have to be bolstered to improve effective coverage across all risk groups in the urban areas of the countries studied. The role played by country contextual and national vaccination programs has to be further researched in relation to effective coverage of influenza vaccine.	[Angel Gonzalez-Block, Miguel] Univ Anahuac, Mexico City, DF, Mexico; [Angel Gonzalez-Block, Miguel; Estela Pelcastre-Villafuerte, Blanca] Inst Nacl Salud Publ, Cuernavaca, Morelos, Mexico; [Angel Gonzalez-Block, Miguel; Rodriguez-Zea, Berenice; Ruoti, Monica] Evisys Consulting, Mexico City, DF, Mexico; [Gutierrez-Calderon, Emilio] Univ Nacl Autonoma Mexico, Mexico City, DF, Mexico; [Arroyo-Laguna, Juan] Pontificia Univ Catolica Peru, Lima, Peru; [Comes, Yamila] Univ ISALUD, Maestria Sistemas Salud & Seguridad Social, Buenos Aires, DF, Argentina; [Crocco, Pedro] Escuela Salud Publ Chile, Santiago, Chile; [Fachel-Leal, Andrea; Riva-Knauth, Daniela] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil; [Noboa, Laura] Univ Republica, Fac Ciencias Sociales, Montevideo, Uruguay; [Sarti, Elsa] Sanofi Pasteur LATAM, Mexico City, DF, Mexico; [Puentes-Rosas, Esteban] Sanofi Pasteur LATAM, Panama City, Panama	Universidad Anahuac; Instituto Nacional de Salud Publica; Universidad Nacional Autonoma de Mexico; Pontificia Universidad Catolica del Peru; Universidade Federal do Rio Grande do Sul; Universidad de la Republica, Uruguay	Gonzalez-Block, MA (corresponding author), Univ Anahuac, Mexico City, DF, Mexico.; Gonzalez-Block, MA (corresponding author), Inst Nacl Salud Publ, Cuernavaca, Morelos, Mexico.; Gonzalez-Block, MA (corresponding author), Evisys Consulting, Mexico City, DF, Mexico.	miguel.gonzalezblock@gmail.com	Sarti, Elsa/ABB-8450-2021; Arroyo-Laguna, Juan/GLR-5662-2022; Pelcastre, Blanca/AFD-6340-2022	Gonzalez-Block, Miguel Angel/0000-0002-7215-4768; Pelcastre-Villafuerte, Blanca Estela/0000-0003-4755-1881; Rodriguez Zea, Berenice/0000-0003-3745-8878	Sanofi Pasteur	Sanofi Pasteur	Sanofi Pasteur provided support for this study in the form of a grant to Evisys Consulting and in the form of salaries for ES and EPR. Evysis Consulting provided support in the form of salaries to MAGB, EGC, BEP, JA, YC, PC, AFL, LN, DRK, BRZ and MR. BRZ and MR participated in the research as paid, pro-tempore employees of Evisys. EGC, BEP, JA, YC, PC, AFL, LN, DRK participated as Evisys consultants. The specific roles of these authors are articulated in the `author contributions' section. The grant provided by Sanofi Pasteur to Evisys was used to pay consulting fees and salaries and to pay for the data acquisition. Both Sanofi Pasteur and Evisys participated in study design and manuscript review, but had no further role in data collection and analysis, decision to publish, or preparation of the manuscript.	Betsch C., 2015, POLICY INSIGHTS BEHA, V2, P61, DOI [10.1177/2372732215600716, DOI 10.1177/2372732215600716]; Brewer NT, 2017, PSYCHOL SCI PUBL INT, V18, P149, DOI 10.1177/1529100618760521; Fauci AS, 2020, NEW ENGL J MED, V382, P1268, DOI 10.1056/NEJMe2002387; Gentile A, 2019, VACCINE, V37, P2670, DOI 10.1016/j.vaccine.2019.03.081; MacDonald NE, 2015, VACCINE, V33, P4161, DOI 10.1016/j.vaccine.2015.04.036; Palekar R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219595; Pan American Health Organization (PAHO), 2019, US IND MAP INTERNET; Quinn SC, 2019, VACCINE, V37, P1168, DOI 10.1016/j.vaccine.2019.01.033; Reinders S, 2020, VACCINE, V38, P1194, DOI 10.1016/j.vaccine.2019.11.016; Shimizu Yoshi, 2019, 8 THINGS KNOW PANDEM; The SAGE Working Group, 2014, REP SAG WORK GROUP V; Wheelock A., JOURNEY VACCINATION; World Health Organization, 2019, GLOBAL INFLUENZA STR; World Health Organization, 2013, GLOB VACC ACT PLAN M; World Health Organization, 2015, PAND H1N1 2009 UPD 1; World Health Organization, 2005, BARR INFL VACC INT B; World Health Organization, 2009, INFL SEAS FACT SHEET	17	21	21	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243833	10.1371/journal.pone.0243833	http://dx.doi.org/10.1371/journal.pone.0243833			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306744	gold, Green Published			2022-12-27	WOS:000600144200023
J	Azuma, T; Sato, Y; Ohno, T; Azuma, M; Kume, H				Azuma, Takeshi; Sato, Yujiro; Ohno, Tatsukuni; Azuma, Miyuki; Kume, Haruki			Serum soluble B7-H3 is a prognostic marker for patients with non-muscle-invasive bladder cancer	PLOS ONE			English	Article							UROTHELIAL CARCINOMA; STAGE TA; EXPRESSION; CELL; ASSOCIATION; RECURRENCE; INFLAMMATION; PROGRESSION; MOLECULE; SURVIVAL	Background B7-H3 is a member of the B7 family of immune-regulatory ligands and is a costimulatory molecule promoting the T cell response in vitro. We herein investigated the clinical utility of serum soluble B7-H3 (sB7-H3) in patients with non-muscle invasive bladder cancer (NMIBC). Methods We analyzed 555 patients in whom NMIBC was diagnosed at Tokyo Metropolitan Tama Medical Center between 2008 and 2013. We measured the serum sB7-H3 (sB7-H3) level using the enzyme-linked immunosorbent assay (ELISA) and evaluated the utility of sB7-H3 as a prognostic biomarker for NMIBC. We used the Cox proportional hazards regression model to assess recurrence-free survival (RFS) and progression-free survival (PFS) with the sB7-H3 level. Results We detected high levels of sB7-H3 in the sera of 47% of patients with NMIBC versus only 8% in healthy donors. The increase of sB7-H3 was significantly associated with poor RFS and PFS. Multivariate analysis showed that elevated sB7-H3 was an independent prognostic factor of RFS and PFS. According to the European Organization for Research and Treatment of Cancer (EORTC), in intermediate-low and intermediate-high risk groups, the presence of sB7-H3 significantly determined the rate of recurrence and progression. Conclusions Our data suggested that evaluating serum sB7-H3 expression is a useful tool for predicting the prognosis of patients with NMIBC.	[Azuma, Takeshi; Sato, Yujiro] Tokyo Metropolitan Tama Med Ctr, Dept Urol, Tokyo, Japan; [Azuma, Takeshi; Azuma, Miyuki] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Mol Immunol, Hongo, Tokyo, Japan; [Azuma, Takeshi; Kume, Haruki] Univ Tokyo, Dept Urol, Grad Sch Med, Hongo, Tokyo, Japan; [Ohno, Tatsukuni] Tokyo Dent Coll, Oral Hlth Sci Ctr, Tokyo, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); University of Tokyo; Tokyo Dental College	Azuma, T (corresponding author), Tokyo Metropolitan Tama Med Ctr, Dept Urol, Tokyo, Japan.; Azuma, T (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Mol Immunol, Hongo, Tokyo, Japan.; Azuma, T (corresponding author), Univ Tokyo, Dept Urol, Grad Sch Med, Hongo, Tokyo, Japan.	tazuma-tky@umin.ac.jp	Azuma, Miyuki/AAT-8928-2021	Azuma, Miyuki/0000-0002-3529-4585; Azuma, Takeshi/0000-0002-4921-2122	JSPS KAKENHI [16K11037, 17K11169]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by JSPS KAKENHI, Grant Number 16K11037 to Y. Sato and JSPS KAKENHI, Grant Number 17K11169 to T. Azuma. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	a R-M, 2020, J CLIN MED, V9; Allard P, 1998, BRIT J UROL, V81, P692; Babjuk M, 2011, EUR UROL, V59, P997, DOI 10.1016/j.eururo.2011.03.017; Baral A, 2014, ONCOL LETT, V8, P1195, DOI 10.3892/ol.2014.2268; Boorjian SA, 2008, CLIN CANCER RES, V14, P4800, DOI 10.1158/1078-0432.CCR-08-0731; Castriconi R, 2004, P NATL ACAD SCI USA, V101, P12640, DOI 10.1073/pnas.0405025101; Chapoval AI, 2001, NAT IMMUNOL, V2, P269, DOI 10.1038/85339; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Crispen PL, 2008, CLIN CANCER RES, V14, P5150, DOI 10.1158/1078-0432.CCR-08-0536; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Donskov F, 2006, J CLIN ONCOL, V24, P1997, DOI 10.1200/JCO.2005.03.9594; Federico A, 2007, INT J CANCER, V121, P2381, DOI 10.1002/ijc.23192; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; KURTH KH, 1995, EUR J CANCER, V31A, P1840, DOI 10.1016/0959-8049(95)00287-S; Liu H, 2011, MOL CANCER THER, V10, P960, DOI 10.1158/1535-7163.MCT-11-0072; Luo LQ, 2006, INT J CANCER, V118, P1823, DOI 10.1002/ijc.21557; Luo LQ, 2004, J IMMUNOL, V173, P5445, DOI 10.4049/jimmunol.173.9.5445; Lupu CM, 2006, J GASTROINTEST SURG, V10, P635, DOI 10.1016/j.gassur.2006.02.001; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Oblak A., 2011, CLIN DEV IMMUNOL, V2011, P2011; Roth TJ, 2007, CANCER RES, V67, P7893, DOI 10.1158/0008-5472.CAN-07-1068; Saatian B, 2004, AM J PHYSIOL-LUNG C, V287, pL217, DOI 10.1152/ajplung.00132.2003; Sakano S, 2011, BJU INT, V107, P1598, DOI 10.1111/j.1464-410X.2010.09850.x; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Steinberger P, 2004, J IMMUNOL, V172, P2352, DOI 10.4049/jimmunol.172.4.2352; Sun MY, 2002, J IMMUNOL, V168, P6294, DOI 10.4049/jimmunol.168.12.6294; Sun YP, 2006, LUNG CANCER-J IASLC, V53, P143, DOI 10.1016/j.lungcan.2006.05.012; Sylvester RJ, 2006, EUR UROL, V49, P466, DOI 10.1016/j.eururo.2005.12.031; Whiteside TL, 2008, ONCOGENE, V27, P5904, DOI 10.1038/onc.2008.271; Wu CP, 2006, WORLD J GASTROENTERO, V12, P457, DOI 10.3748/wjg.v12.i3.457; Xie C, 2016, SCI REP-UK, V6, DOI 10.1038/srep27528; Xu ZL, 2018, ONCOL LETT, V15, P6519, DOI 10.3892/ol.2018.8173; Xylinas E, 2014, EJSO-EUR J SURG ONC, V40, P121, DOI 10.1016/j.ejso.2013.08.023; Yamato I, 2009, BRIT J CANCER, V101, P1709, DOI 10.1038/sj.bjc.6605375; Zang X, 2007, P NATL ACAD SCI USA, V104, P19458, DOI 10.1073/pnas.0709802104; Zhang GB, 2008, IMMUNOLOGY, V123, P538, DOI 10.1111/j.1365-2567.2007.02723.x; Zhang GB, 2010, J IMMUNOL, V185, P3677, DOI 10.4049/jimmunol.0904020; Zhao L, 2017, J GASTROINTEST SURG, V21, P807, DOI 10.1007/s11605-017-3386-1	38	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243379	10.1371/journal.pone.0243379	http://dx.doi.org/10.1371/journal.pone.0243379			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306717	Green Published, gold			2022-12-27	WOS:000600144200053
J	Bailey, L; Harinam, V; Ariel, B				Bailey, Laura; Harinam, Vincent; Ariel, Barak			Victims, offenders and victim-offender overlaps of knife crime: A social network analysis approach using police records	PLOS ONE			English	Article							VICTIMIZATION; VIOLENCE; HOMICIDE; TRENDS; SIZE; GUNS	Knife crime is a source of concern for the police in England and Wales, however little published research exists on this crime type. Who are the offenders who use knives to commit crime, when and why? Who are their victims, and is there a victim-offender overlap? What is the social network formation for people who are exposed to knife crime? Using a multidimensional approach, our aim is to answer these questions about one of England and Wales' largest jurisdictions: Thames Valley. We first provide a state-of-the-art narrative review of the knife crime literature, followed by an analysis of population-level data on central tendency and dispersion of knife crimes reported to the police (2015-2019), on offences, offenders, victims, victim-offender overlaps and gang-related assaults. Social network analysis was used to explore the formations of offender-victim networks. Our findings show that knife crime represents a small proportion of crime (1.86%) and is associated largely with violence offenses. 16-34 year-old white males are at greatest risk of being the victims, offenders or victim-offenders of knife crime, with similar relative risks between these three categories. Both knife offenders and victims are likely to have a criminal record. Knife crimes are usually not gang-related (less than 20%), and experienced mostly between strangers, with the altercation often a non-retaliatory 'one-off event'. Even gang-related knife crimes do not follow 'tit-for-tat' relationships-except when the individuals involved have extensive offending histories and then are likely to retaliate instantaneously. We conclude that while rare, an incident of knife crime remains predicable, as a substantial ratio of offenders and victims of future knife crime can be found in police records. Prevention strategies should not be focused on gang-related criminals, but on either prolific violent offenders or repeat victims who are known to the police-and therefore more susceptible to knife crime exposure.	[Bailey, Laura; Harinam, Vincent; Ariel, Barak] Univ Cambridge, Inst Criminol, Cambridge, England; [Ariel, Barak] Hebrew Univ Jerusalem, Fac Law, Inst Criminol, Jerusalem, Israel	University of Cambridge; Hebrew University of Jerusalem	Ariel, B (corresponding author), Univ Cambridge, Inst Criminol, Cambridge, England.; Ariel, B (corresponding author), Hebrew Univ Jerusalem, Fac Law, Inst Criminol, Jerusalem, Israel.	ba285@cam.ac.uk		Ariel, Barak/0000-0002-6912-2546				[Anonymous], 2005, CRIMINOL PUBLIC POL, DOI DOI 10.1111/J.1745-9133.2005.00306.X; [Anonymous], 2002, CONNECTIONS; [Anonymous], 2019, BBC; Ariel B, 2019, SOCIOL CRIME LAW DEV, V24, P7, DOI 10.1108/S1521-613620190000024004; Ariel B, 2019, J CRIM LAW CRIM, V109, P819; Ariel B, 2019, CRIM JUSTICE BEHAV, V46, P280, DOI 10.1177/0093854818812918; Averdijk M, 2016, CRIMINOLOGY, V54, P282, DOI 10.1111/1745-9125.12102; Berger CR, 2002, COMMUN RES, V29, P99, DOI 10.1177/0093650202029002001; BIDERMAN AD, 1967, ANN AM ACAD POLIT SS, V374, P1, DOI 10.1177/000271626737400102; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Blumstein A, 1995, J CRIM LAW CRIM, V86, P10, DOI 10.2307/1143998; Borgatti SP, 2018, ANAL SOCIAL NETWORKS, V2, P1; Bowcott O, 2019, GUARDIAN; Braga AA, 2018, CRIMINOL PUBLIC POL, V17, P205, DOI 10.1111/1745-9133.12353; Crossen C., 1996, TAINTED TRUTH MANIPU; Csardi G., 2006, INTERJOURNALCOMPLEX, V1695, P1, DOI DOI 10.3724/SP.J.1087.2009.02191; Dawson EM, 2019, HELICOBACTER, V24, DOI 10.1111/hel.12587; Decker, 1993, JUSTICE Q, V10, P585, DOI DOI 10.1080/07418829300092031; Decker SH, 2010, HOMICIDE STUD, V14, P359, DOI 10.1177/1088767910385400; Diagle LE, 2019, VICTIM OFFENDER OVER; Duxbury SW, 2018, J QUANT CRIMINOL, V34, P921, DOI 10.1007/s10940-017-9359-4; Eades C, 2006, CRIMINAL JUSTICE MAT, V66, P10; Eades C., 2007, KNIFE CRIME REV EVID; Eicher S, 2019, J CHINESE HIST, V3, P1, DOI 10.1017/jch.2017.39; Everett SA, 1995, J ADOLESCENT HEALTH, V17, P345, DOI 10.1016/1054-139X(94)00185-H; Fagan AA, 2011, CRIME DELINQUENCY, V57, P732, DOI 10.1177/0011128708321322; Fleisher MS, 2002, WOMEN GANGS FIELD RE; Galvin D, 2019, RESPONDING YOUTH VIO; Goodall CA, 2019, AGGRESS VIOLENT BEH, V46, P190, DOI 10.1016/j.avb.2018.10.002; Goodreau Steven M, 2008, J Stat Softw, V24, P1; Gottfredson M.R., 1990, GEN THEORY CRIME; GOTTFREDSON MR, 1981, J CRIM LAW CRIM, V72, P714, DOI 10.2307/1143011; Graham K, 2003, BRIT J CRIMINOL, V43, P546, DOI 10.1093/bjc/azg546; Griffiths E, 2004, CRIMINOLOGY, V42, P941, DOI 10.1111/j.1745-9125.2004.tb00541.x; Haynie DL, 2001, AM J SOCIOL, V106, P1013, DOI 10.1086/320298; Hinkle JC, 2013, EVALUATION REV, V37, P213, DOI 10.1177/0193841X13519799; Home Office, 2018, SERIOUS VIOLENCE STR; Hopper S, 2018, THESIS; Humphreys DK, 2019, BMJ-BRIT MED J, V367, DOI 10.1136/bmj.l6040; Jennings WG, 2012, AGGRESS VIOLENT BEH, V17, P16, DOI 10.1016/j.avb.2011.09.003; King RD, 2007, PROCESS CRIMINOLOGIC, P18; Lauritsen J., 2007, SURVEYING CRIME 21 C, P55; Lemos G., 2004, FEAR FASHION USE KNI; Maguire M, 2012, OXFORD HDB CRIMINOLO, V5, P206; Marfleet N., 2008, WHY CARRY WEAPON STU; Marshall B., 2005, RATIONALISATION CURR; McGloin JM, 2010, J CRIM JUSTICE EDUC, V21, P169, DOI 10.1080/10511251003693694; McGloin JM, 2010, HANDBOOK OF QUANTITATIVE CRIMINOLOGY, P209, DOI 10.1007/978-0-387-77650-7_11; McGloin JM, 2010, J RES CRIME DELINQ, V47, P63, DOI 10.1177/0022427809348905; Melde C, 2009, CRIMINOLOGY, V47, P565, DOI 10.1111/j.1745-9125.2009.00148.x; Ministry of Justice, 2018, EX ED BACKGR YOUNG K; Morselli C, 2007, SOC NETWORKS, V29, P143, DOI 10.1016/j.socnet.2006.05.001; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.70.056131]; Office for National Statistics [ONS], 2019, CRIM ENGL WAL YEAR E; Olding J, 2019, SURG-J R COLL SURG E, V17, P133, DOI 10.1016/j.surge.2019.01.001; Ousey G, 2011, J QUANT CRIMINOL, V27, P53, DOI 10.1007/s10940-010-9099-1; Papachristos AV, 2015, SOC SCI MED, V125, P139, DOI 10.1016/j.socscimed.2014.01.056; Papachristos AV, 2014, AM J PUBLIC HEALTH, V104, P143, DOI 10.2105/AJPH.2013.301441; Papachristos AV, 2012, J CRIM LAW CRIM, V102, P397; Papachristos AV, 2012, J URBAN HEALTH, V89, P992, DOI 10.1007/s11524-012-9703-9; Papachristos AV, 2009, AM J SOCIOL, V115, P74, DOI 10.1086/597791; Reingle Jennifer M, 2011, J Contemp Crim Justice, V27, P361; Riley K, 2005, REDUCING GUN VIOLENC; Sandall D., 2018, CAMB J EVID-BASED PO, V2, P95, DOI [10.1007/s41887-018-0027-1, DOI 10.1007/S41887-018-0027-1]; Schreck CJ, 2004, JUSTICE Q, V21, P23, DOI 10.1080/07418820400095731; Shaffer JN, 2004, THESIS; Sherman L. W., 2007, J EXP CRIMINOL, V3, P299; SHERMAN LW, 1989, CRIMINOLOGY, V27, P27, DOI 10.1111/j.1745-9125.1989.tb00862.x; SINGER SI, 1981, J CRIM LAW CRIM, V72, P779, DOI 10.2307/1143015; Taniguchi TA, 2009, JUSTICE Q, V26, P670, DOI 10.1080/07418820802593378; Tita G, 2007, J RES CRIME DELINQ, V44, P208, DOI 10.1177/0022427806298356; Toman EL, 2019, JUSTICE Q, V36, P350, DOI 10.1080/07418825.2017.1402072; Trump D, 2018, BBC; VANDERWICKEN P, 1995, HARVARD BUS REV, V73, P144; Von Hentig H, 1948, SOCIAL FORCES, V27, P445; vonStorch H, 1995, ANALYSIS OF CLIMATE VARIABILITY, P11; Warr, 2002, COMPANIONS CRIME SOC, P59; Wellman B., 1983, SOCIOLOGICAL THEORY, P155, DOI [10.2307/202050, DOI 10.2307/202050]; Williams DJ, 2014, AGGRESS VIOLENT BEH, V19, P686, DOI 10.1016/j.avb.2014.09.011; Wilson A, 1993, HOMICIDE VICTIM OFFE; Wittebrood K, 2002, SOC INDIC RES, V59, P153, DOI 10.1023/A:1016207225351; Wolfgang, 1958, VICTIM OFFENDER RELA; Zavala E, 2018, VICTIMS OFFENDERS, V13, P1013, DOI 10.1080/15564886.2018.1520765; Zimmerman GM, 2017, J CRIM JUST, V48, P21, DOI 10.1016/j.jcrimjus.2016.11.003	85	9	9	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0242621	10.1371/journal.pone.0242621	http://dx.doi.org/10.1371/journal.pone.0242621			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH0WM	33306696	Green Published, gold			2022-12-27	WOS:000600144200031
J	Fleming, M; McLay, JS; Clark, D; King, A; Mackay, DF; Pell, JP				Fleming, Michael; McLay, James S.; Clark, David; King, Albert; Mackay, Daniel F.; Pell, Jill P.			Health, educational and employment outcomes among children treated for a skin disorder: Scotland-wide retrospective record linkage cohort study of 766,244 children	PLOS ONE			English	Article							ATOPIC-DERMATITIS; UNITED-STATES; PSORIASIS; BURDEN; ECZEMA; COMORBIDITY; ASSOCIATION; PREVALENCE; MORTALITY; RISK	Background To compare health, educational and employment outcomes of schoolchildren receiving medication for a skin disorder with peers. Methods This retrospective population cohort study linked eight Scotland-wide databases, covering dispensed prescriptions, hospital admissions, maternity records, death certificates, annual pupil census, school examinations, school absences/exclusions and unemployment to investigate educational (absence, exclusion, special educational need, academic attainment), employment, and health (admissions and mortality) outcomes of 766,244 children attending local authority run primary, secondary and special schools in Scotland between 2009 and 2013. Results After adjusting for sociodemographic and maternity confounders the 130,087 (17.0%) children treated for a skin disorder had increased hospitalisation, particularly within one year of commencing treatment (IRR 1.38, 95% CI 1.35-1.41, p<0.001) and mortality (HR 1.50, 95% CI 1.18-1.90, p<0.001). They had greater special educational need (OR 1.19, 95% CI 1.17-1.21, p<0.001) and more frequent absences from school (IRR 1.07, 95% CI 1.06-1.08, p<0.001) but did not exhibit poorer exam attainment or increased post-school unemployment. The associations remained after further adjustment for comorbid chronic conditions. Conclusions Despite increased hospitalisation, school absenteeism, and special educational need, children treated for a skin disorder did not have poorer exam attainment or employment outcomes. Whilst findings relating to educational and employment outcomes are reassuring, the association with increased risk of mortality is alarming and merits further investigation.	[Fleming, Michael; Mackay, Daniel F.; Pell, Jill P.] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland; [McLay, James S.] Univ Aberdeen, Dept Child Hlth, Aberdeen, Scotland; [Clark, David] Publ Hlth Scotland, Edinburgh, Midlothian, Scotland; [King, Albert] Scottish Govt, ScotXed, Edinburgh, Midlothian, Scotland	University of Glasgow; University of Aberdeen	Fleming, M (corresponding author), Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland.	michael.fleming@glasgow.ac.uk		fleming, michael/0000-0002-2185-4502	Health Data Research UK [MR/S003800/1]; National Institute for Health Research (England); Chief Scientist Office (Scotland); Health and Care Research Wales; Health and Social Care Research and Development Division (Public Health Agency, Northern Ireland); Engineering and Physical Sciences Research Council; Economic and Social Research Council; British Heart Foundation; Wellcome Trust; MRC [MR/S003800/1] Funding Source: UKRI	Health Data Research UK; National Institute for Health Research (England)(National Institute for Health Research (NIHR)); Chief Scientist Office (Scotland); Health and Care Research Wales; Health and Social Care Research and Development Division (Public Health Agency, Northern Ireland); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was sponsored by Health Data Research UK (www.hdruk.ac.uk) (grant reference number MR/S003800/1 awarded to Dr Michael Fleming) which is a joint investment led by the Medical Research Council, together with the National Institute for Health Research (England), the Chief Scientist Office (Scotland), Health and Care Research Wales, Health and Social Care Research and Development Division (Public Health Agency, Northern Ireland), the Engineering and Physical Sciences Research Council, the Economic and Social Research Council, the British Heart Foundation and Wellcome Trust. The sponsor and funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review or approval of the manuscript, or decision to submit the manuscript for publication.	Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Augustin M, 2010, BRIT J DERMATOL, V162, P633, DOI 10.1111/j.1365-2133.2009.09593.x; Augustin M, 2015, DERMATOLOGY, V231, P35, DOI 10.1159/000381913; Barbarot S, 2018, ALLERGY, V73, P1284, DOI 10.1111/all.13401; Brezinski EA, 2015, JAMA DERMATOL, V151, P651, DOI 10.1001/jamadermatol.2014.3593; Cui J, 2007, STATA J, V7, P209, DOI 10.1177/1536867X0700700205; Dhana A, 2019, J AM ACAD DERMATOL, V80, P1332, DOI 10.1016/j.jaad.2018.12.037; Drucker AM, 2017, J INVEST DERMATOL, V137, P26, DOI 10.1016/j.jid.2016.07.012; Feng LJ, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000020801; Ferreira Barbara Isabel Roque Cunha, 2016, J Clin Aesthet Dermatol, V9, P36; Fleming M., 2017, THESIS; Fleming M, 2020, INT J EPIDEMIOL, V49, P1380, DOI 10.1093/ije/dyaa002; Fleming M, 2019, DIABETES CARE, V42, P1700, DOI 10.2337/dc18-2423; Fleming M, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.02309-2018; Fleming M, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6888-9; Fleming M, 2017, JAMA PEDIATR, V171, DOI 10.1001/jamapediatrics.2017.0691; Horev A, 2017, ACTA DERMATOVENER CR, V25, P210; Hunt IJD, 2020, CLIN EXP DERMATOL, V45, P5, DOI 10.1111/ced.14021; Karimkhani C, 2017, JAMA DERMATOL, V153, P406, DOI 10.1001/jamadermatol.2016.5538; Kemp AS, 2003, PHARMACOECONOMICS, V21, P105, DOI 10.2165/00019053-200321020-00003; Kimball AB, 2012, J AM ACAD DERMATOL, V67, P651, DOI 10.1016/j.jaad.2011.11.948; Kuniyoshi Y, 2018, ALLERGOL INT, V67, P481, DOI 10.1016/j.alit.2018.02.009; Kuzina OE, 2020, IIOAB J, V11, P12; Kwa L, 2017, J AM ACAD DERMATOL, V77, P1023, DOI 10.1016/j.jaad.2017.08.034; Kyung Y, 2020, ANN ALLERG ASTHMA IM, V125, P55, DOI 10.1016/j.anai.2020.03.023; Kyung Y, 2020, J DERMATOL, V47, P699, DOI 10.1111/1346-8138.15386; Laughter D, 2000, J AM ACAD DERMATOL, V43, P649, DOI 10.1067/mjd.2000.107773; Lee S, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-016-1160-7; Mancini AJ, 2008, PEDIATR DERMATOL, V25, P1, DOI 10.1111/j.1525-1470.2007.00572.x; Narla S, 2019, J AM ACAD DERMATOL, V80, P382, DOI 10.1016/j.jaad.2018.09.025; Odhiambo JA, 2009, J ALLERGY CLIN IMMUN, V124, P1251, DOI 10.1016/j.jaci.2009.10.009; Olsen JR, 2016, BRIT J DERMATOL, V174, P853, DOI 10.1111/bjd.14361; Patel KR, 2019, DERMATOLOGY, V235, P276, DOI 10.1159/000499564; Randa H, 2017, ACTA DERM-VENEREOL, V97, P555, DOI 10.2340/00015555-2600; Reed B, 2018, ALLERGY ASTHMA PROC, V39, P406, DOI 10.2500/aap.2018.39.4175; Ruijsbroek A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134780; Samarasekera EJ, 2013, J INVEST DERMATOL, V133, P2340, DOI 10.1038/jid.2013.149; ScotPHO, 2016, SCOTT BURD DIS STUD; Shaker M, 2014, CURR OPIN PEDIATR, V26, P516, DOI 10.1097/MOP.0000000000000120; Smirnova J, 2019, BRIT J DERMATOL, V180, P559, DOI 10.1111/bjd.17330; Spergel JM, 2010, ANN ALLERG ASTHMA IM, V105, P99, DOI 10.1016/j.anai.2009.10.002; Springate DA, 2017, BRIT J DERMATOL, V176, P650, DOI 10.1111/bjd.15021; Strom MA, 2016, BRIT J DERMATOL, V175, P920, DOI 10.1111/bjd.14697; Thyssen JP, 2018, J AM ACAD DERMATOL, V78, P506, DOI 10.1016/j.jaad.2017.10.032; Twisk JW, 2013, APPL LONGITUDINAL DA; van der Hulst AE, 2007, J ALLERGY CLIN IMMUN, V120, P565, DOI 10.1016/j.jaci.2007.05.042; Verboom P, 2002, BRIT J DERMATOL, V147, P716, DOI 10.1046/j.1365-2133.2002.04964.x; von Kobyletzki LB, 2017, BRIT J DERMATOL, V177, pE47, DOI 10.1111/bjd.15242; Wan J, 2020, J ALLER CL IMM-PRACT, V8, P2808, DOI 10.1016/j.jaip.2020.04.032; Wan J, 2020, J AM ACAD DERMATOL, V82, P1368, DOI 10.1016/j.jaad.2019.10.019; Wood R, 2013, LANCET, V382, P10; Yaghmaie P, 2013, J ALLERGY CLIN IMMUN, V131, P428, DOI 10.1016/j.jaci.2012.10.041; Zuberbier T, 2006, J ALLERGY CLIN IMMUN, V118, P226, DOI 10.1016/j.jaci.2006.02.031	53	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243383	10.1371/journal.pone.0243383	http://dx.doi.org/10.1371/journal.pone.0243383			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306713	Green Accepted, Green Published, gold			2022-12-27	WOS:000600144200008
J	Noreen, K; Zil-e-Rubab; Umar, M; Rehman, R; Baig, M; Baig, F				Noreen, Khola; Zil-e-Rubab; Umar, Muhammad; Rehman, Rehana; Baig, Mukhtiar; Baig, Fizzah			Knowledge, attitudes, and practices against the growing threat of COVID-19 among medical students of Pakistan	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; UNIVERSITY-STUDENTS; EPIDEMIC; PREVENTION; RESPONSES; OUTBREAK; CHINESE	Background On account of the COVID-19 pandemic, many changes have been implicated in university medical students. We are cognizant that pandemic can be controlled with dedicated contributions from all involved in the healthcare profession. Therefore, it is important to know the pandemic and application of knowledge by the medical students to formulate a further line of management in Pakistan. Objective We aimed toinvestigate the knowledge, attitudes, and practices (KAP) regarding COVID-19 and its impact on medical students of Pakistan. Methods A cross-sectional survey was conducted in June 2020 by a validated self-administered questionnaire. The survey instrument was tailored from a published questionnaire comprised of questions on demographics (6), knowledge (14), attitudes (4), and practices (6). Results Of the 1474 medical students in the study, 576(39.1%) were males, and 898(60.1%) were females. Two-thirds of the participants 1057(71.7%) had adequate knowledge, and almost all the students had positive attitudes (1363(92.5%), and good practices 1406(95.4%) to COVID-19. Two-thirds of the medical students 1023(69%) believed that the COVID-19 outbreak had affected their social, mental, and psychological well-being. One-quarter of the medical students 391(26%) become more religious, 597(40%) realized the importance of life, and 1140(77%) became careless because of the pandemic. The female medical students were 2.545 times (p < .001) and 4.414 times (p < .001) more likely to have positive attitudes and good practices toward COVID-19 as compared to males. Conclusion Medical students, especially females and senior year scholars, were well-versed with desired levels of knowledge, attitudes, and preventive measures toward COVID-19. Most of them recognized COVID 19, is shaping their social, mental, and psychological well-being and encroaching on the healthcare system and economy. The information acquired by the KAP study may help to devise effective preventive strategies for future events.	[Noreen, Khola] Rawalpindi Med Univ, Dept Community Med, Rawalpindi, Pakistan; [Zil-e-Rubab; Baig, Fizzah] Ziauddin Univ, Ziauddin Med Coll, Karachi, Pakistan; [Umar, Muhammad] Rawalpindi Med Univ, Rawalpindi, Pakistan; [Rehman, Rehana] Aga Khan Univ, Dept Biol & Biomed Sci, Karachi, Pakistan; [Baig, Mukhtiar] King Abdulaziz Univ, Fac Med, Dept Clin Biochem, Jeddah, Saudi Arabia	Ziauddin University; Aga Khan University; King Abdulaziz University	Noreen, K (corresponding author), Rawalpindi Med Univ, Dept Community Med, Rawalpindi, Pakistan.	khauladr@gmail.com	Noreen, Khaula/ABF-6152-2021					Ahmad T, 2020, PAK J MED SCI, V36, pS73, DOI 10.12669/pjms.36.COVID19-S4.2638; Ajilore K, 2017, HEALTH EDUC J, V76, P648, DOI 10.1177/0017896917710969; Akan H, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-413; Al-Hazmi A, 2018, SAUDI J BIOL SCI, V25, P572, DOI 10.1016/j.sjbs.2016.01.032; Alkot M., 2016, International Journal of Medical Science and Public Health, V5, P952; Alzoubi H, 2020, J PURE APPL MICROBIO, V14, P17, DOI 10.22207/JPAM.14.1.04; Baig M, 2020, PREDICTORS MISCONCEP, DOI [10.1101/2020.05.22.20110627, DOI 10.1101/2020.05.22.20110627]; Chen Wei, 2020, Zhonghua Yufang Yixue Zazhi, V54, P239, DOI [10.3760/cma.j.issn.0253-9624.2020.03.003, 10.3760/cma.j.issn.0253.9624.2020.03.003]; CSSE J, 2020, COR COVID 19 GLOB CA; Heung Y Y Jenny, 2005, Nurse Educ Today, V25, P112, DOI 10.1016/j.nedt.2004.11.003; Hui DS, 2017, CLIN CHEST MED, V38, P71, DOI 10.1016/j.ccm.2016.11.007; Hussain I, 2021, J COMMUN HEALTH, V46, P441, DOI 10.1007/s10900-020-00879-9; Jairoun A, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6878-y; Lau JTF, 2009, J INFECTION, V59, P122, DOI 10.1016/j.jinf.2009.06.004; Lau JTF, 2003, J EPIDEMIOL COMMUN H, V57, P864, DOI 10.1136/jech.57.11.864; Leung GM, 2005, CLIN INFECT DIS, V40, P1713, DOI 10.1086/429923; Organization WH, 2020, COR DIS COVID 19 ADV, DOI [10.1093/cid/ciaa255, DOI 10.1093/CID/CIAA255]; Park JH, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-222; Plaster AN, 2018, J COMMUN HEALTH, V43, P647, DOI 10.1007/s10900-017-0463-z; Roser M, 2020, WHY DID RENEWABLES B; Rubin GJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2651; Schwartz J, 2020, CLIN INFECT DIS, V71, P858, DOI 10.1093/cid/ciaa255; Taghrir MH, 2020, ARCH IRAN MED, V23, P249, DOI [10.34172/aim.2020.06 Abstract View:, 10.34172/aim.2020.06]; Tang CSK, 2004, PREV MED, V39, P1187, DOI 10.1016/j.ypmed.2004.04.032; Tariq S, 2022, DISASTER MED PUBLIC, V16, P934, DOI 10.1017/dmp.2020.408; Velavan TP, 2020, TROP MED INT HEALTH, V25, P278, DOI 10.1111/tmi.13383; Waris A, 2020, NEW MICROB NEW INFEC, V35, DOI 10.1016/j.nmni.2020.100681; WHO, 2020, 72 WHO; World Health Organization, 2020, DIR GEN OP REM MED B; Zarocostas J, 2020, LANCET, V395, P676, DOI 10.1016/S0140-6736(20)30461-X; Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	33	34	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243696	10.1371/journal.pone.0243696	http://dx.doi.org/10.1371/journal.pone.0243696			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH0WM	33306712	gold, Green Published			2022-12-27	WOS:000600144200049
J	Robert, M; Cortay, A; Morfin, M; Simon, J; Morandeau, F; Deneubourg, JL; Vincent, B				Robert, Marianne; Cortay, Aurore; Morfin, Marie; Simon, Julien; Morandeau, Fabien; Deneubourg, Jean Louis; Vincent, Benoit			A methodological framework for characterizing fish swimming and escapement behaviors in trawls	PLOS ONE			English	Article							HADDOCK MELANOGRAMMUS-AEGLEFINUS; SQUID DORYTEUTHIS-PEALEII; COD GADUS-MORHUA; SIZE-SELECTION; SQUARE; DENSITY; VIDEO; SEPARATION; DECISION; CAPTURE	Knowledge about fish behavior is crucial to be able to influence the capture process and catch species composition. The rapid expansion of the use of underwater cameras has facilitated unprecedented opportunities for studying the behavior of species interacting with fishing gears in their natural environment. This technological advance would greatly benefit from the parallel development of dedicated methodologies accounting for right-censored observations and variable observation periods between individuals related to instrumental, environmental and behavioral events. In this paper we proposed a methodological framework, based on a parametric Weibull mixture model, to describe the process of escapement attempts through time, test effects of covariates and estimate the probability that a fish will attempt to escape. We additionally proposed to better examine the escapement process at the individual level with regard to the temporal dynamics of escapement over time. Our approach was used to analyze gadoids swimming and escapement behaviors collected using a video set up in front of a selective device known to improve selectivity on gadoids in the extension of a bottom trawl. Comparison of the fit of models indicates that i) the instantaneous rate of escape attempts is constant over time and that the escapement process can be modelled using an exponential law; ii) the mean time before attempting to escape increases with the increasing number of attempts; iii) more than 80% of the gadoids attempted to escape through the selective device; and iv) the estimated probability of success was around 15%. Effects of covariates on the probability of success were investigated using binomial regression but none of them were significant. The data set collected is insufficient to make general statements, and further observations are required to properly investigate the effect of intrinsic and extrinsic factors governing gadoids behavior in trawls. This methodology could be used to better characterize the underlying behavioral process of fish in other parts of a bottom trawl or in relation to other fishing gears.	[Robert, Marianne; Cortay, Aurore; Morfin, Marie; Simon, Julien; Morandeau, Fabien; Vincent, Benoit] IFREMER, LTBH Lab Fisheries Technol & Biol, Lorient, France; [Deneubourg, Jean Louis] Univ Libre Bruxelles, Ctr Nonlinear Phenomena & Complex Syst, Brussels, Belgium	Ifremer; Universite Libre de Bruxelles	Robert, M (corresponding author), IFREMER, LTBH Lab Fisheries Technol & Biol, Lorient, France.	marianne.robert@ifremer.fr	Robert, Marianne/V-6221-2018	Robert, Marianne/0000-0002-4727-5509; VINCENT, Benoit/0000-0002-0386-6251	France Filiere Peche; L' Institut Francais de Recherche pour l'Exploitation de la Mer	France Filiere Peche; L' Institut Francais de Recherche pour l'Exploitation de la Mer	No -the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was conducted with the financial support of France Filiere Peche (https://www.francefilierepeche.fr/) and L' Institut Francais de Recherche pour l'Exploitation de la Mer (https://wwz.ifremer.fr/).	Albert OT, 2003, J SEA RES, V50, P117, DOI 10.1016/S1385-1101(03)00063-7; Perez JAA, 2018, LAT AM J AQUAT RES, V46, P924, DOI [10.3856/vo146-issue5-fulltext-6, 10.3856/vol46-issue5-fulltext-6]; Anders N, 2017, J FISH BIOL, V91, P1569, DOI 10.1111/jfb.13453; Anders N, 2017, ICES J MAR SCI, V74, P769, DOI 10.1093/icesjms/fsw200; [Anonymous], 2015, SIGHT SOUND, V10, P18; Armstrong MJ, 1998, FISH RES, V34, P179, DOI 10.1016/S0165-7836(97)00078-7; Bayse SM, 2017, J APPL ICHTHYOL, V33, P898, DOI 10.1111/jai.13381; Bayse SM, 2016, ICES J MAR SCI, V73, P1545, DOI 10.1093/icesjms/fsw007; Bayse SM, 2016, FISH RES, V174, P1, DOI 10.1016/j.fishres.2015.08.022; Bayse SM, 2014, FISH RES, V152, P55, DOI 10.1016/j.fishres.2013.03.018; BRIGGS RP, 1992, FISH RES, V13, P133, DOI 10.1016/0165-7836(92)90023-M; Brown C, 2003, FISH FISH, V4, P280, DOI 10.1046/j.1467-2979.2003.00122.x; Catchpole TL, 2008, REV FISH BIOL FISHER, V18, P17, DOI 10.1007/s11160-007-9061-y; DeCelles GR, 2017, T AM FISH SOC, V146, P462, DOI 10.1080/00028487.2017.1282888; FAREWELL VT, 1982, BIOMETRICS, V38, P1041, DOI 10.2307/2529885; Frandsen RP, 2010, ICES J MAR SCI, V67, P1721, DOI 10.1093/icesjms/fsq050; FREON P, 1993, ICES MAR SC, V196, P190; Friard O, 2016, METHODS ECOL EVOL, V7, P1325, DOI 10.1111/2041-210X.12584; Gatti P, 2020, MAR POLICY, V116, DOI 10.1016/j.marpol.2019.103777; GearingUp, 2017, GEARINGUP; GLASS CW, 1995, FISH RES, V23, P165, DOI 10.1016/0165-7836(94)00331-P; GLASS CW, 1993, ICES MAR SC, V196, P92; Godo OR, 1999, ICES J MAR SCI, V56, P292, DOI 10.1006/jmsc.1999.0444; Graham N, 2003, FISH RES, V62, P361, DOI 10.1016/S0165-7836(02)00279-5; Grant GC, 2004, CAN J FISH AQUAT SCI, V61, P168, DOI 10.1139/F03-166; Gu Y, 2011, LIFETIME DATA ANAL, V17, P123, DOI 10.1007/s10985-010-9171-z; Hannah RW, 2012, FISH RES, V131, P39, DOI 10.1016/j.fishres.2012.07.010; Herrmann B, 2005, FISH RES, V71, P15, DOI 10.1016/j.fishres.2004.08.021; Jones EG, 2008, FISH RES, V94, P166, DOI 10.1016/j.fishres.2008.06.010; Kim YH, 2005, FISH RES, V73, P217, DOI 10.1016/j.fishres.2004.12.003; Kim YH, 2003, FISH RES, V60, P455, DOI 10.1016/S0165-7836(02)00114-5; Kim YH, 2008, FISHERIES SCI, V74, P1, DOI 10.1111/j.1444-2906.2007.01490.x; Krag LA, 2011, FISH RES, V110, P225, DOI 10.1016/j.fishres.2011.03.009; Krag LA, 2009, ICES J MAR SCI, V66, P772, DOI 10.1093/icesjms/fsp034; Melli V, 2020, FISH RES, V230, DOI 10.1016/j.fishres.2020.105686; Meuthen D, 2012, NATURWISSENSCHAFTEN, V99, P1063, DOI 10.1007/s00114-012-0980-7; Millar RB, 1999, REV FISH BIOL FISHER, V9, P89, DOI 10.1023/A:1008838220001; Nguyen KQ, 2019, REV FISH SCI AQUAC, V27, P106, DOI 10.1080/23308249.2018.1496065; O'Neill F. G., 2017, SCOTT MAR FRESHW SCI, V8, P1, DOI 10.4789/1890-1; Ozbilgin H, 2004, ICES J MAR SCI, V61, P1190, DOI 10.1016/j.icesjms.2004.07.001; Ozbilgin H, 2002, FISH RES, V58, P323, DOI 10.1016/S0165-7836(01)00394-0; Pitcher T.J., 1986, P294; Queirolo D, 2019, FISH RES, V216, P1, DOI 10.1016/j.fishres.2019.03.012; Queirolo D, 2010, FISH RES, V102, P327, DOI 10.1016/j.fishres.2009.12.005; Robert M, 2014, J THEOR BIOL, V359, P161, DOI 10.1016/j.jtbi.2014.06.010; ROBERTSON JHB, 1988, J CONSEIL, V44, P148; Rose CS, 2005, FISH RES, V76, P291, DOI 10.1016/j.fishres.2005.07.015; Ryer CH, 2008, FISH RES, V90, P138, DOI 10.1016/j.fishres.2007.10.005; Sala A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191662; Santos J, 2016, AQUAT LIVING RESOUR, V29, DOI 10.1051/alr/2016025; Simon J, 2020, MAR POLICY, V116, DOI 10.1016/j.marpol.2019.103785; Sistiaga M, 2016, FISH RES, V183, P340, DOI 10.1016/j.fishres.2016.06.022; SORIA M, 1993, ICES MAR SC, V196, P17; Stoner AW, 2006, FISH RES, V81, P202, DOI 10.1016/j.fishres.2006.07.005; Underwood MJ, 2018, ICES J MAR SCI, V75, P1393, DOI 10.1093/icesjms/fsx233; Underwood MJ, 2015, FISH B-NOAA, V113, P430, DOI 10.7755/FB.113.6; United Nations, 2015, TRANSF OUR WORLD 203; WALSH SJ, 1993, ICES MAR SC, V196, P68; Wardle CS., 1993, BEHAV TELEOST FISHES, P463, DOI DOI 10.1007/978-1-4684-8261-4_18; Widder EA, 2005, DEEP-SEA RES PT I, V52, P2077, DOI 10.1016/j.dsr.2005.06.007; Williams K, 2018, J EXP MAR BIOL ECOL, V508, P21, DOI 10.1016/j.jembe.2018.08.001; Williams K, 2010, FISH B-NOAA, V108, P352; Winger P.D., 2010, FISH BEHAV NEAR BOTT, P65, DOI [10.1002/9780813810966.CH4, DOI 10.1002/9780813810966.CH4]	63	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243311	10.1371/journal.pone.0243311	http://dx.doi.org/10.1371/journal.pone.0243311			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306703	Green Submitted, Green Published, gold			2022-12-27	WOS:000600144200016
J	Bajaj, S; Blair, KS; Schwartz, A; Dobbertin, M; Blair, RJR				Bajaj, Sahil; Blair, Karina S.; Schwartz, Amanda; Dobbertin, Matthew; Blair, R. James R.			Worry and insomnia as risk factors for depression during initial stages of COVID-19 pandemic in India	PLOS ONE			English	Article							EXCESSIVE DAYTIME SLEEPINESS; PSYCHIATRIC-DISORDERS; GENDER-DIFFERENCES; SEVERITY INDEX; STRESS; SYMPTOMS; POPULATION; ASSOCIATION; PREVALENCE; RUMINATION	The biggest nationwide COVID-19 pandemic lockdown worldwide was enforced in India for an initial period of 21-days. Emerging evidence suggests that pandemic situations and associated lockdowns have an adverse impact on sleep and mental health. However, prediction of sleep health from sociodemographic characteristics and the public's worry during the initial stages of the COVID-19 pandemic has not been extensively explored so far. It's also unclear whether sleep outcomes mediate the association between worry and mental health during pandemic situations. A web-survey (N = 391) on sociodemographic characteristics, COVID-19 related worry, sleep health (insomnia and daytime sleepiness), and depression was conducted during the initial 21-days of the COVID-19 stringent lockdown in India. Multiple regression analyses showed that variables, including sex, age, income level, and worry score, contributed to the significant regression equation for insomnia but not for daytime sleepiness. Specifically, the female, younger, lower income, and highly worried populations contributed significantly more than the male, elderly, higher income, and less worried populations, respectively, to the prediction of insomnia. Mediation analyses showed that insomnia, but not daytime sleepiness, fully mediated the relationship between worry score and severity of depressive symptoms. We provide evidence that the female, younger, lower income, and worried populations may be at higher risk for insomnia during pandemic situations. Current evidence gives hope that improving sleep may reduce depressive symptoms during a pandemic situation. This underscores the importance of the implementation of effective public health policies in conjunction with strategical responses to the COVID-19 pandemic.	[Bajaj, Sahil; Blair, Karina S.; Schwartz, Amanda; Dobbertin, Matthew; Blair, R. James R.] Boys Town Natl Res Hosp, Ctr Neurobehav Res, Multimodal Clin Neuroimaging Lab MCNL, Boys Town, NE 68010 USA; [Bajaj, Sahil; Blair, Karina S.; Schwartz, Amanda; Dobbertin, Matthew; Blair, R. James R.] Boys Town Natl Res Hosp, Ctr Neurobehav Res, Program Trauma & Anxiety PTAC, Boys Town, NE 68010 USA	Boys Town National Research Hospital; Boys Town National Research Hospital	Bajaj, S (corresponding author), Boys Town Natl Res Hosp, Ctr Neurobehav Res, Multimodal Clin Neuroimaging Lab MCNL, Boys Town, NE 68010 USA.; Bajaj, S (corresponding author), Boys Town Natl Res Hosp, Ctr Neurobehav Res, Program Trauma & Anxiety PTAC, Boys Town, NE 68010 USA.	sahil.bajaj@boystown.org	Bajaj, Sahil/C-6580-2016	Bajaj, Sahil/0000-0003-0629-6036; Blair, Robert James/0000-0002-6377-2361				Angold A, 1995, INT J METHOD PSYCH, V5, P237; Nguyen ATD, 2006, J CLIN SLEEP MED, V2, P170; [Anonymous], 2009, GUARDIAN, V5, P20; Arnett JJ, 2014, LANCET PSYCHIAT, V1, P569, DOI 10.1016/S2215-0366(14)00080-7; Baglioni C, 2011, J AFFECT DISORDERS, V135, P10, DOI 10.1016/j.jad.2011.01.011; Baglioni C, 2010, SLEEP MED REV, V14, P227, DOI 10.1016/j.smrv.2009.10.007; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Bernert RA, 2007, J FAM PSYCHOL, V21, P58, DOI 10.1037/0893-3200.21.1.58; Bernert Rebecca A, 2007, Neuropsychiatr Dis Treat, V3, P735; Besedovsky L, 2019, PHYSIOL REV, V99, P1325, DOI 10.1152/physrev.00010.2018; Besedovsky L, 2012, PFLUG ARCH EUR J PHY, V463, P121, DOI 10.1007/s00424-011-1044-0; Bixler EO, 2005, J CLIN ENDOCR METAB, V90, P4510, DOI 10.1210/jc.2005-0035; Boccabella A, 2017, J CLIN SLEEP MED, V13, P685, DOI 10.5664/jcsm.6584; Breslau N, 1996, BIOL PSYCHIAT, V39, P411, DOI 10.1016/0006-3223(95)00188-3; Breslau N, 1997, AM J PUBLIC HEALTH, V87, P1649, DOI 10.2105/AJPH.87.10.1649; Chaplin TM, 2008, ALCOHOL CLIN EXP RES, V32, P1242, DOI 10.1111/j.1530-0277.2008.00679.x; Chiang JJ, 2017, J ADOLESCENT HEALTH, V61, P501, DOI 10.1016/j.jadohealth.2017.04.011; Clancy F, 2020, HEALTH PSYCHOL REV, V14, P427, DOI 10.1080/17437199.2019.1700819; COSTELLO EJ, 1988, J AM ACAD CHILD PSY, V27, P726, DOI 10.1097/00004583-198811000-00011; Dijk DJ, 2010, SLEEP, V33, P211, DOI 10.1093/sleep/33.2.211; Fatani A, 2015, J EPIDEMIOL GLOB HEA, V5, pS59, DOI 10.1016/j.jegh.2015.05.005; Felden Erico Pereira Gomes, 2015, Rev Paul Pediatr, V33, P467, DOI 10.1016/j.rpped.2015.01.011; FOLEY DJ, 1995, SLEEP, V18, P425, DOI 10.1093/sleep/18.6.425; Goldstein AN, 2014, ANNU REV CLIN PSYCHO, V10, P679, DOI 10.1146/annurev-clinpsy-032813-153716; Goring HJ, 2008, COGNITIVE THER RES, V32, P554, DOI 10.1007/s10608-007-9146-x; Government of India Ministry of Statistics and Programme Implementation, 2019, PROV EST ANN NAT INC; Grandner MA, 2013, J CLIN SLEEP MED, V9, P897, DOI 10.5664/jcsm.2990; Grandner MA, 2010, SLEEP MED, V11, P470, DOI 10.1016/j.sleep.2009.10.006; Hall M, 2000, PSYCHOSOM MED, V62, P227, DOI 10.1097/00006842-200003000-00014; Hamilton NA, 2007, HEALTH PSYCHOL, V26, P288, DOI 10.1037/0278-6133.26.3.288; Hara C, 2004, SLEEP MED, V5, P31, DOI 10.1016/j.sleep.2003.09.009; Harvey AG, 2002, BEHAV RES THER, V40, P869, DOI 10.1016/S0005-7967(01)00061-4; Hayley AC, 2013, AUST NZ J PSYCHIAT, V47, P772, DOI 10.1177/0004867413490036; Hong RY, 2007, BEHAV RES THER, V45, P277, DOI 10.1016/j.brat.2006.03.006; Isac C, 2020, CLIN EPIDEMIOL GLOB, V8, P739, DOI 10.1016/j.cegh.2020.01.012; JOHNS MW, 1992, SLEEP, V15, P376, DOI 10.1093/sleep/15.4.376; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kalmbach DA, 2018, NAT SCI SLEEP, V10, P193, DOI 10.2147/NSS.S138823; Killgore WDS, 2020, PSYCHIAT RES, P113134, DOI [10.1016/j.psychres.2020.113134, DOI 10.1016/J.PSYCHRES.2020.1131343]; Kim HC, 2011, J OCCUP HEALTH, V53, P164, DOI 10.1539/joh.10-0032-OA; Krystal AD, 2012, NEUROL CLIN, V30, P1389, DOI 10.1016/j.ncl.2012.08.018; Lallukka T, 2012, BMC PUBLIC HEALTH, P12, DOI [10.1186/1471-2458-12-12, DOI 10.1186/1471-2458-12-12]; Lee J, 2017, ASIA PAC J CLIN NUTR, V26, P906, DOI 10.6133/apjcn.082016.04; Leggett A, 2016, J GERONTOL B-PSYCHOL, V71, P118, DOI 10.1093/geronb/gbv072; Linton SJ, 2004, BRIT J HEALTH PSYCH, V9, P127, DOI 10.1348/135910704773891005; Liu XC, 2000, PSYCHIAT RES, V93, P1, DOI 10.1016/S0165-1781(99)00119-5; Longordo F, 2009, EUR J NEUROSCI, V29, P1810, DOI 10.1111/j.1460-9568.2009.06719.x; Maggio M, 2013, MATURITAS, V76, P22, DOI 10.1016/j.maturitas.2013.06.006; Matud MP, 2004, PERS INDIV DIFFER, V37, P1401, DOI 10.1016/j.paid.2004.01.010; McCall W Vaughn, 2004, Prim Care Companion J Clin Psychiatry, V6, P9; Meerlo P, 2008, SLEEP MED REV, V12, P197, DOI 10.1016/j.smrv.2007.07.007; Meltzer H, 2011, PSYCHOL MED, V41, P771, DOI 10.1017/S0033291710001261; Morin CM, 2011, SLEEP, V34, P601, DOI 10.1093/sleep/34.5.601; Muris P, 2005, PERS INDIV DIFFER, V39, P1105, DOI 10.1016/j.paid.2005.04.005; Nishishiba M, 2017, REGRESSION ANAL RES, P253, DOI [10.4135/9781544307763, DOI 10.4135/9781544307763]; Pahwa P, 2012, CAN RESPIR J, V19, pE10, DOI 10.1155/2012/287309; Pallant J, 2001, SPSS SURVIVAL MANUAL, P85; Pallesen S, 2002, SCAND J PSYCHOL, V43, P425, DOI 10.1111/1467-9450.00311; Panda S, 2012, NEUROL INDIA, V60, P68, DOI 10.4103/0028-3886.93601; Papadopoulos D, 2018, SLEEP SCI, V11, P92, DOI 10.5935/1984-0063.20180018; Paparrigopoulos T, 2010, BMC PUBLIC HEALTH, P10, DOI [10.1186/1471-2458-10-10, DOI 10.1186/1471-2458-10-10]; Patel D, 2018, J CLIN SLEEP MED, V14, P1017, DOI 10.5664/jcsm.7172; Pharr JR., 2012, ISRN PUBLIC HLTH, V2012, P1, DOI DOI 10.5402/2012/483432; Reardon S, 2015, NATURE, V519, P13, DOI 10.1038/519013a; Riedel BW, 2000, SLEEP MED REV, V4, P277, DOI 10.1053/smrv.1999.0074; Ronnlund M, 2018, FRONT PSYCHOL, P9, DOI [10.3389/fpsyg.2018.00009, DOI 10.3389/FPSYG.2018.00009]; Rood L, 2010, COGNITIVE THER RES, V34, P333, DOI 10.1007/s10608-009-9261-y; Sareen J, 2011, ARCH GEN PSYCHIAT, V68, P419, DOI 10.1001/archgenpsychiatry.2011.15; Siegel JM, 2004, J CLIN PSYCHIAT, V65, P4; Singh LK, 2019, INDIAN J PSYCHIAT, V61, P265, DOI 10.4103/psychiatry.IndianJPsychiatry_412_18; Thabrew H, 2018, INT J METH PSYCH RES, V27, DOI 10.1002/mpr.1610; Tutek J, 2021, BEHAV SLEEP MED, V19, P192, DOI 10.1080/15402002.2020.1725012; Ursachi G, 2015, PROC ECON FINANC, V20, P679, DOI 10.1016/S2212-5671(15)00123-9; Utsugi M, 2005, SLEEP, V28, P728, DOI 10.1093/sleep/28.6.728; Veqar Zubia, 2017, Int J Adolesc Med Health, V32, DOI 10.1515/ijamh-2016-0090; Veqar Zubia, 2018, Int J Adolesc Med Health, V31, DOI 10.1515/ijamh-2016-0151; Voitsidis P, 2020, PSYCHIAT RES, V289, DOI 10.1016/j.psychres.2020.113076; Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051729; Warth J, 2019, BMC PUBLIC HEALTH, P19, DOI [10.1186/s12889-018-6340-6, DOI 10.1186/S12889-018-6340-6]; Wennberg AM, 2013, MATURITAS, V76, P247, DOI 10.1016/j.maturitas.2013.05.007; Zhang B, 2006, SLEEP, V29, P85, DOI 10.1093/sleep/29.1.85	81	10	10	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243527	10.1371/journal.pone.0243527	http://dx.doi.org/10.1371/journal.pone.0243527			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH0WB	33301508	Green Published, gold			2022-12-27	WOS:000600143100062
J	Hou, TY; Zhang, RK; Song, XR; Zhang, F; Cai, WP; Liu, Y; Dong, W; Deng, GH				Hou, Tianya; Zhang, Ruike; Song, Xiangrui; Zhang, Fan; Cai, Wenpeng; Liu, Ying; Dong, Wei; Deng, Guanghui			Self-efficacy and fatigue among non-frontline health care workers during COVID-19 outbreak: A moderated mediation model of posttraumatic stress disorder symptoms and negative coping	PLOS ONE			English	Article							PSYCHOLOGICAL IMPACT; SOCIAL SUPPORT; PREVALENCE; BELIEFS; ALCOHOL; CANCER; SAMPLE; PAIN; LIFE	Purposes Since a considerable number of health care workers (HCWs) were sent to Wuhan to aid COVID-19 control during the epidemic, non-frontline HCWs who stayed in local hospitals had to work overload to provide daily health care services for other health issues, which makes them more vulnerable to experience fatigue. Self-efficacy is suggested as a protective factor for fatigue. Nonetheless, less is known regarding the underlying mechanisms. This research aimed to explore the prevalence of fatigue among non-frontline HCWs during the pandemic, investigate the mediating effect of posttraumatic stress disorder (PTSD) symptoms and moderating effect of negative coping in the association between self-efficacy and fatigue. Methods General Self-Efficacy Scale, PTSD Checklist-Civilian Version, Simplified Coping Style Questionnaire and 14-item Fatigue Scale were administrated to 527 non-frontline HCWs from Anhui Province, China. The mediating effect was examined by Mackinnon's four-step procedure, while Hayes PROCESS macro was used to test the moderated mediation model. Results The prevalence of fatigue among non-frontline HCWs was 56.7%. The effect of self-efficacy on fatigue was partially mediated by PTSD symptoms (ab = -0.146, SE = 0.030, 95% CI = [-0.207, -0.095]). Additionally, negative coping moderated both the direct effect of self-efficacy on fatigue (beta = -0.158, P<0.001) and the mediating effect of PTSD symptoms (beta = 0.077, P = 0.008). When the standard score of negative coping increased to 1.49 and over, the direct association between self-efficacy and fatigue became insignificant. Likewise, the effect of self-efficacy on PTSD symptoms had no statistical significance when the standard score of negative coping was -1.40 and lower. Conclusions More than half non-frontline HCWs suffered from fatigue during COVID-19. For those who tend to use negative coping, it might be crucial to design programs combining the enhancement of self-efficacy, preventions for PTSD symptoms and interventions for fatigue.	[Hou, Tianya; Zhang, Ruike; Song, Xiangrui; Zhang, Fan; Cai, Wenpeng; Liu, Ying; Dong, Wei; Deng, Guanghui] Second Mil Med Univ, Fac Psychol, Shanghai, Peoples R China	Naval Medical University	Hou, TY; Dong, W; Deng, GH (corresponding author), Second Mil Med Univ, Fac Psychol, Shanghai, Peoples R China.	liumi9512@126.com; sophiedongwei@163.com; bfbedu@126.com						Aiken MP, 2015, VIRTUAL REAL-LONDON, V19, P95, DOI 10.1007/s10055-015-0260-x; Alshehri FS, 2020, SAUDI PHARM J, V28, P1666, DOI 10.1016/j.jsps.2020.10.013; AmericanPsychiatricAssociation, 2013, DIAGN STAT MAN MENT, V5TH; [Anonymous], 2005, Health News, V11, P2; [Anonymous], 2012, REGEN MED S3, V7, pS14; [Anonymous], 2013, BJU INT, V112, pE191; [Anonymous], 2011, J PHARM PRACT, V24, P251; [Anonymous], 2016, PHI DELTA KAPPAN, V98, pK7, DOI 10.1177/0031721716666049; [Anonymous], 1993, PUBLIC HIST REV, V2, pvi; [Anonymous], 2007, J CHINESE HLTH PSYCH; [Anonymous], 2018, J HIST MODERN THEOLO, V25, p[1, 21]; Aylaz R, 2015, JPN J NURS SCI, V12, P367, DOI 10.1111/jjns.12076; BANDURA A, 1982, AM PSYCHOL, V37, P122, DOI 10.1037/0003-066X.37.2.122; Barker LM, 2011, ERGONOMICS, V54, P815, DOI 10.1080/00140139.2011.597878; Blackburn L, 2015, J CLIN PSYCHOL, V71, P219, DOI 10.1002/jclp.22133; Bouwmans T, 2017, COMPUT SCI REV, V23, P1, DOI 10.1016/j.cosrev.2016.11.001; Brown AD, 2012, MEMORY, V20, P374, DOI 10.1080/09658211.2012.667110; CHALDER T, 1993, J PSYCHOSOM RES, V37, P147, DOI 10.1016/0022-3999(93)90081-P; Chan AOM, 2004, OCCUP MED-OXFORD, V54, P190, DOI 10.1093/occmed/kqh027; Cheung SK, 1999, PSYCHOL REP, V85, P1221, DOI 10.2466/pr0.1999.85.3f.1221; Chung MC, 2013, PSYCHIAT RES, V210, P1033, DOI 10.1016/j.psychres.2013.07.041; Compas BE, 2001, PSYCHOL BULL, V127, P87, DOI 10.1037//0033-2909.127.1.87; Courtney JA, 2010, AUST NZ J ORG PSYCHO, V3, P32, DOI DOI 10.1375/AJOP.3.1.32; Craig A, 2013, J PAIN, V14, P911, DOI 10.1016/j.jpain.2013.03.002; da Silva FJ, 2016, WORK, V53, P225, DOI 10.3233/WOR-152241; de Pablo GS, 2020, J AFFECT DISORDERS, V275, P48, DOI 10.1016/j.jad.2020.06.022; Demmel R, 2005, ADDICT DISORD TREAT, V4, P5, DOI 10.1097/00132576-200503000-00002; Gao Y., 2011, CLIN MED ENG, V12, P1964; Graham JD, 2017, SPORT EXERC PERFORM, V6, P70, DOI 10.1037/spy0000074; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Hou TY, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233831; Hu YY, 2020, BRAIN BEHAV IMMUN, V89, P587, DOI 10.1016/j.bbi.2020.07.016; JENKINS R, 1985, PSYCHOL MED, P1; Johansson AC, 2018, J CLIN NURS, V27, pE1537, DOI 10.1111/jocn.14300; Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976; Lazarus R. S., 1984, STRESS APPRAISAL COP, DOI 10.1007/978-1-4419-1005-9_215; Levin C, 2007, PSYCHOL ADDICT BEHAV, V21, P108, DOI 10.1037/0893-164X.21.1.108; Li ZY, 2020, BRAIN BEHAV IMMUN, V88, P916, DOI 10.1016/j.bbi.2020.03.007; Liedl A, 2010, PSYCHOL MED, V40, P1215, DOI 10.1017/S0033291709991310; Lin JY, 2020, J AFFECT DISORDERS, V265, P32, DOI 10.1016/j.jad.2020.01.026; Liu CH, 2020, PSYCHIAT RES, V290, DOI 10.1016/j.psychres.2020.113172; Liu F, 2020, CHILD ABUSE NEGLECT, V106, DOI 10.1016/j.chiabu.2020.104531; Liu NQ, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112921; Mack TM, 2005, LANCET, V365, P1370, DOI 10.1016/S0140-6736(05)66352-0; MacKinnon D.P., 2012, INTRO STAT MEDIATION; MAHASE E, 2020, BMJ-BRIT MED J, V371, DOI DOI 10.1136/BMJ.M4084; McAlonan GM, 2007, CAN J PSYCHIAT, V52, P241, DOI 10.1177/070674370705200406; Moos RH, 2003, J CLIN PSYCHOL, V59, P1387, DOI 10.1002/jclp.10229; Morina N, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1680-4; National Health Commission, 2020, 42000 MED STAFF SUPP; Nygaard E, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00913; O'Donnell EP, 2015, MAYO CLIN PROC, V90, P194, DOI 10.1016/j.mayocp.2014.12.011; Phillips SM, 2013, CANCER EPIDEM BIOMAR, V22, P773, DOI 10.1158/1055-9965.EPI-12-0983; Raftopoulos V, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-457; s NA, 2018, LANCET INFECT DIS, V18, pe228; Shigemoto Y, 2020, STRESS HEALTH, V36, P365, DOI 10.1002/smi.2935; Soderlund A, 2002, J WHIPLASH RELAT DIS, V1, P25; Tan BYQ, 2020, ANN INTERN MED, V173, P317, DOI 10.7326/M20-1083; Tang WJ, 2020, J AFFECT DISORDERS, V274, P1, DOI 10.1016/j.jad.2020.05.009; Theofilou P, 2015, HEALTH PSYCHOL RES, V3, P18, DOI 10.4081/hpr.2015.1556; Tian FQ, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00012; Titcombe-Parekh RF, 2018, J PSYCHIATR RES, V104, P58, DOI 10.1016/j.jpsychires.2018.06.009; Tu ZH, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000020769; Vlachantoni A, EUR POP C 2016; Vlachantoni A, 2020, AGEING SOC, V40, P1490, DOI 10.1017/S0144686X19000047; Wagner LI, 2004, BRIT J CANCER, V91, P822, DOI 10.1038/sj.bjc.6602012; Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9; Weathers FW, ANN M INT SOC TRAUM; Witkiewitz K, 2004, AM PSYCHOL, V59, P224, DOI 10.1037/0003-066X.59.4.224; World Health Organization, 2020, 12020 WHO; Xie, 1998, CHIN J CLIN PSYCHOL, V2, P114, DOI DOI 10.16128/j.cnki.1005-3611.1998.02.018; Yang Ting, 2015, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V33, P100; ZHANG JX, 1995, PSYCHOLOGIA, V38, P174	73	19	19	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243884	10.1371/journal.pone.0243884	http://dx.doi.org/10.1371/journal.pone.0243884			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH0WB	33301523	gold, Green Published			2022-12-27	WOS:000600143100052
J	Soholm, J; Hansen, JF; Mossner, B; Roge, BT; Lauersen, A; Hansen, JB; Weis, N; Barfod, TS; Lunding, S; Ovrehus, A; Mohey, R; Thielsen, P; Christensen, PB				Soholm, Jacob; Hansen, Janne Fuglsang; Mossner, Belinda; Roge, Birgit Thorup; Lauersen, Alex; Hansen, Jesper Bach; Weis, Nina; Barfod, Toke Seieroe; Lunding, Suzanne; Ovrehus, Anne; Mohey, Rajesh; Thielsen, Peter; Brehm Christensen, Peer			Low incidence of HCC in chronic hepatitis C patients with pretreatment liver stiffness measurements below 17.5 kilopascal who achieve SVR following DAAs	PLOS ONE			English	Article							NONINVASIVE TESTS; HEPATOCELLULAR-CARCINOMA; FIBROSIS; OUTCOMES	Background and aims To evaluate the ability of pretreatment liver stiffness measurements (pLSM) to predict hepatocellular carcinoma (HCC), incident decompensation and all-cause mortality in chronic hepatitis C (CHC) patients who achieved sustained virological response (SVR) after treatment with direct-acting antivirals (DAAs). Methods 773 CHC patients with SVR after DAA treatment and no prior liver complications were identified retrospectively. Optimized cut-off of 17.5 kPa for incident HCC was selected by maximum Youden's index. Patients were grouped by pLSM: <10 kPa [reference], 10-17.4 kPa and >= 17.5 kPa. Primary outcomes were incident hepatocellular carcinoma and secondary outcomes were incident decompensated cirrhosis and all-cause mortality, analyzed using cox-regression. Results Median follow-up was 36 months and 43.5% (336) had cirrhosis (LSM>12.5 kPa). The median pLSM was 11.6 kPa (IQR 6.7-17.8, range 2.5-75) and pLSM of <10 kPa, 10-17.4 kPa and 17.5-75 kPa was seen in 41.5%, 32.2% and 26.3%. During a median follow-up time of 36 months, 11 (1.4%) developed HCC, 14 (1.5%) developed decompensated cirrhosis, and 38 (4.9%) patients died. A pLSM of 17.5 kPa identified patients with a high risk of HCC with a negative predictive value of 98.9% and incidence rate of HCC in the 17.5-75 kPa group of 1.40/100 person years compared to 0.14/100 person years and 0.12/100 person years in the 10-17.4 kPa and <10 kPa groups, pConclusion Pretreatment LSM predicts risk of HCC, decompensation and all-cause mortality in patients with SVR after DAA treatment. Patients with a pLSM <17.5 kPa and no other risk factors for chronic liver disease appear not to benefit from HCC surveillance for the first 3 years after treatment. Longer follow-up is needed to clarify if they can be safely excluded from post treatment HCC screening hereafter.	[Soholm, Jacob; Hansen, Janne Fuglsang; Mossner, Belinda; Brehm Christensen, Peer] Odense Univ Hosp, Dept Infect Dis, Odense, Denmark; [Soholm, Jacob; Mossner, Belinda; Brehm Christensen, Peer] Odense Univ Hosp, Odense Patient Data Explorat Network, OPEN, Odense, Denmark; [Soholm, Jacob] Univ Southern Denmark, Clin Inst, Odense, Denmark; [Roge, Birgit Thorup] Lillebaelt Hosp, Dept Med, Kolding, Denmark; [Lauersen, Alex] Aarhus Univ Hosp, Dept Infect Dis, Aarhus, Denmark; [Hansen, Jesper Bach] Aalborg Univ Hosp, Dept Gastroenterol, Aalborg, Denmark; [Weis, Nina] Copenhagen Univ Hosp, Dept Infect Dis, Hvidovre, Denmark; [Weis, Nina] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark; [Barfod, Toke Seieroe] Zealand Univ Hosp, Dept Med, Roskilde, Denmark; [Lunding, Suzanne] North Zealand Univ Hosp, Dept Pulm & Infect Dis, Hillerod, Denmark; [Ovrehus, Anne] Copenhagen Univ Hosp, Dept Infect Dis, Rigshosp, Copenhagen, Denmark; [Mohey, Rajesh] Herning Hosp, Dept Med, Infect Dis Unit, Herning, Denmark; [Thielsen, Peter] Copenhagen Univ Hosp, Dept Gastroenterol, Herlev, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Aarhus University; Aalborg University; Aalborg University Hospital; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; Aarhus University; University of Copenhagen	Soholm, J (corresponding author), Odense Univ Hosp, Dept Infect Dis, Odense, Denmark.; Soholm, J (corresponding author), Odense Univ Hosp, Odense Patient Data Explorat Network, OPEN, Odense, Denmark.; Soholm, J (corresponding author), Univ Southern Denmark, Clin Inst, Odense, Denmark.	Jacob.Soeholm@rsyd.dk	Weis, Nina/GLT-4232-2022; Soholm, Jacob/D-2650-2019	Christensen, Peer Brehm/0000-0003-1394-058X; Soholm, Jacob/0000-0002-7019-2269; Ovrehus, Anne Lindebo Holm/0000-0002-2594-6500				[Anonymous], 2015, J HEPATOL, V63, P743, DOI DOI 10.1016/J.JHEP.2015.05.022.; Atiq O, 2017, HEPATOLOGY, V65, P1196, DOI 10.1002/hep.28895; Authorities TDH, 2019, NAT REG ALC TREATM; Authorities TDH, 2019, REG DRUG AB UND TREA; Backus LI, 2019, HEPATOLOGY, V69, P487, DOI 10.1002/hep.29408; Bjerregaard B, 2011, SCAND J PUBLIC HEALT, V39, P72, DOI 10.1177/1403494810393563; Boursier J, 2013, HEPATOLOGY, V57, P1182, DOI 10.1002/hep.25993; Carrat F, 2019, LANCET, V393, P1453, DOI 10.1016/S0140-6736(18)32111-1; Cheung MCM, 2016, J HEPATOL, V65, P741, DOI 10.1016/j.jhep.2016.06.019; Christensen PB, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-178; Christiansen KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111912; Conti F, 2016, J HEPATOL, V65, P727, DOI 10.1016/j.jhep.2016.06.015; Corma-Gomez A, 2020, CLIN INFECT DIS, V71, P2354, DOI 10.1093/cid/ciz1140; de Ledinghen V, 2013, ALIMENT PHARM THER, V37, P979, DOI 10.1111/apt.12307; Degasperi E, 2019, CLIN GASTROENTEROL H, V17, P1183, DOI 10.1016/j.cgh.2018.10.038; Echosens, 2019, FIBR REC; European Assoc Study Liver, 2018, J HEPATOL, V69, P461, DOI 10.1016/j.jhep.2018.03.026; Fehily SR, 2019, SEMIN LIVER DIS, V39, P341, DOI 10.1055/s-0039-1685538; Gjerstorff ML, 2011, SCAND J PUBLIC HEALT, V39, P42, DOI 10.1177/1403494810393562; Hansen JF, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212036; Ioannou GN, 2019, GASTROENTEROLOGY, V157, P1264, DOI 10.1053/j.gastro.2019.07.033; Ioannou GN, 2019, GASTROENTEROLOGY, V156, P446, DOI 10.1053/j.gastro.2018.10.033; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Lazarus JV, 2019, J INTERN MED, V286, P503, DOI 10.1111/joim.12972; Lusivika-Nzinga C, 2019, J VIRAL HEPATITIS, V26, P1489, DOI 10.1111/jvh.13186; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Nouch S, 2018, INT J DRUG POLICY, V59, P76, DOI 10.1016/j.drugpo.2018.06.019; Pons M, 2020, J HEPATOL, V72, P472, DOI 10.1016/j.jhep.2019.10.005; Ravaioli F, 2018, DIGEST LIVER DIS, V50, P573, DOI 10.1016/j.dld.2018.02.010; Rodriguez-Osorio I, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217052; Schmidt M, 2014, EUR J EPIDEMIOL, V29, P541, DOI 10.1007/s10654-014-9930-3; Shiha G, 2020, J VIRAL HEPATITIS, V27, P671, DOI 10.1111/jvh.13276; Stasi C, 2020, CURR MED RES OPIN, V36, P245, DOI 10.1080/03007995.2019.1691517; StatBank Denmark, 2019, FOLK3 POP 1; Trinchet JC, 2011, HEPATOLOGY, V54, P1987, DOI 10.1002/hep.24545; Vergniol J, 2014, HEPATOLOGY, V60, P65, DOI 10.1002/hep.27069; Vergniol J, 2011, GASTROENTEROLOGY, V140, P1970, DOI 10.1053/j.gastro.2011.02.058; Weis Nina, 2012, Ugeskr Laeger, V174, P2521; Zangneh HF, 2019, CLIN GASTROENTEROL H, V17, P1840, DOI 10.1016/j.cgh.2018.12.018	39	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243725	10.1371/journal.pone.0243725	http://dx.doi.org/10.1371/journal.pone.0243725			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301499	Green Published, gold			2022-12-27	WOS:000600143100061
J	Miyagi, M; Wilson, R; Saigusa, D; Umeda, K; Saijo, R; Hager, CL; Li, YJ; McCormick, T; Ghannoum, MA				Miyagi, Masaru; Wilson, Rachel; Saigusa, Daisuke; Umeda, Keiko; Saijo, Reina; Hager, Christopher L.; Li, Yuejin; McCormick, Thomas; Ghannoum, Mahmoud A.			Indole-3-acetic acid synthesized through the indole-3-pyruvate pathway promotes Candida tropicalis biofilm formation	PLOS ONE			English	Article							QUORUM; COMMUNICATION; GROWTH; FUNGI	We previously found that the elevated abundance of the fungus Candida tropicalis is positively correlated with the bacteria Escherichia coli and Serratia marcescens in Crohn's disease patients and the three pathogens, when co-cultured, form a robust mixed-species biofilm. The finding suggests that these three pathogens communicate and promote biofilm formation, possibly through secretion of small signaling molecules. To identify candidate signaling molecules, we carried out a metabolomic analysis of the single-species and triple-species cultures of the three pathogens. This analysis identified 15 metabolites that were highly increased in the triple-species culture. One highly induced metabolite was indole-3-acetic acid (IAA), which has been shown to induce filamentation of certain fungi. We thus tested the effect of IAA on biofilm formation of C. tropicalis and demonstrated that IAA promotes biofilm formation of C. tropicalis. Then, we carried out isotope tracing experiments using C-13-labeled-tryptophan as a precursor to uncover the biosynthesis pathway of IAA in C. tropicalis. The results indicated that C. tropicalis synthesizes IAA through the indole-3-pyruvate pathway. Further studies using inhibitors of the indole-3-pyruvate pathway are warranted to decipher the mechanisms by which IAA influences biofilm formation.	[Miyagi, Masaru] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Wilson, Rachel; Hager, Christopher L.; Li, Yuejin; McCormick, Thomas; Ghannoum, Mahmoud A.] Case Western Reserve Univ, Ctr Med Mycol, Dept Dermatol, Cleveland, OH 44106 USA; [Saigusa, Daisuke; Umeda, Keiko; Saijo, Reina] Tohoku Univ, Dept Integrat Genom, Tohoku Med Megabank Org, Sendai, Miyagi, Japan; [Ghannoum, Mahmoud A.] Univ Hosp Cleveland, Med Ctr, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Tohoku University; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland	Miyagi, M (corresponding author), Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA.; Ghannoum, MA (corresponding author), Case Western Reserve Univ, Ctr Med Mycol, Dept Dermatol, Cleveland, OH 44106 USA.; Ghannoum, MA (corresponding author), Univ Hosp Cleveland, Med Ctr, Cleveland, OH 44106 USA.	mxm356@case.edu; mag3@case.edu	LI, Yue/GRS-8071-2022		National Institutes of Health [R01AI145289-01A1]; Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [JP20km0105001, JP20km0105002]; Japan Agency for Medical Research and Development (AMED); Project for Promoting Public Utilization of Advanced Research Infrastructure from MEXT	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Project for Promoting Public Utilization of Advanced Research Infrastructure from MEXT	This work was supported in part by a National Institutes of Health Grant #R01AI145289-01A1 to M.A.G., the Tohoku Medical Megabank Project (Grant #JP20km0105001 and JP20km0105002) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) and Japan Agency for Medical Research and Development (AMED), and Project for Promoting Public Utilization of Advanced Research Infrastructure from MEXT.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Albuquerque P, 2012, MED MYCOL, V50, P337, DOI 10.3109/13693786.2011.652201; [Anonymous], 2014, PLOS ONE, V9, P1, DOI [10.1371/journal.pone.0109970, DOI 10.1371/JOURNAL.PONE.0109970, DOI 10.1371/J0URNAL.P0NE.0109970]; Chandra J, 2008, NAT PROTOC, V3, P1909, DOI 10.1038/nprot.2008.192; Chen H, 2006, GENE DEV, V20, P1150, DOI 10.1101/gad.1411806; Chiara MM, 2020, NUTRIENTS, V12; Dahlhamer JM, 2016, MMWR-MORBID MORTAL W, V65, P1166, DOI 10.15585/mmwr.mm6542a3; Hoarau G, 2016, MBIO, V7, DOI [10.1128/mBio.01250-16, 10.1128/mbio.01250-16]; Krause K, 2015, APPL ENVIRON MICROB, V81, P7003, DOI 10.1128/AEM.01991-15; Li F, 2016, P NATL ACAD SCI USA, V113, P13450, DOI 10.1073/pnas.1614947113; Li YH, 2012, SENSORS-BASEL, V12, P2519, DOI 10.3390/s120302519; Lloyd-Price J, 2019, NATURE, V569, P655, DOI 10.1038/s41586-019-1237-9; Machiels K, 2014, GUT, V63, P1275, DOI 10.1136/gutjnl-2013-304833; Nadal M, 2008, FEMS MICROBIOL LETT, V284, P127, DOI 10.1111/j.1574-6968.2008.01173.x; OBERHANSLI T, 1991, J GEN MICROBIOL, V137, P2273, DOI 10.1099/00221287-137-10-2273; Padder SA, 2018, MICROBIOL RES, V210, P51, DOI 10.1016/j.micres.2018.03.007; Prusty R, 2004, P NATL ACAD SCI USA, V101, P4153, DOI 10.1073/pnas.0400659101; Raboni S, 2009, CELL MOL LIFE SCI, V66, P2391, DOI 10.1007/s00018-009-0028-0; Ramage G, 2002, APPL ENVIRON MICROB, V68, P5459, DOI 10.1128/AEM.68.11.5459-5463.2002; Rao RP, 2010, GENETICS, V185, P211, DOI 10.1534/genetics.109.112854; Sardar P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192293; Sokol H, 2017, GUT, V66, P1039, DOI [10.1136/gutjnl-2015-310746, 10.1136/gutjnl-20]; Spaepen S, 2007, FEMS MICROBIOL REV, V31, P425, DOI 10.1111/j.1574-6976.2007.00072.x; Spaepen S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a001438; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Williams P, 2007, MICROBIOL-SGM, V153, P3923, DOI 10.1099/mic.0.2007/012856-0	26	1	1	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0244246	10.1371/journal.pone.0244246	http://dx.doi.org/10.1371/journal.pone.0244246			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332404	gold, Green Published			2022-12-27	WOS:000601310900021
J	Shao, LF; Krause, M				Shao, Liang Frank; Krause, Melanie			Rising mean incomes for whom?	PLOS ONE			English	Article							PRO-POOR; LONG-RUN; INEQUALITY; GROWTH; POLARIZATION; PANEL	Not everybody is benefiting equally from rising mean incomes. We discuss the mean-income population share (MPS), the population percentage of earners below mean income, whose evolution can capture how representative rising mean values are for middle income households. Tracking MPS and its associated income share MIS over time indicates to what extent economic growth is inclusive of both the middle and the bottom of the income distribution. We characterize MPS and MIS analytically under different growth scenarios and compare their parametric estimation using micro-level and grouped income data. Our empirical application with panel data of 16 high- and middle-income countries shows that in the last decades rising mean incomes have mostly not favored middle income households in relative perspective, while the overall welfare effects of the changes in MPS and the correlation structure with the Gini coefficient are mixed.	[Shao, Liang Frank] Henan Univ, Sch Econ, Kaifeng, Henan, Peoples R China; [Krause, Melanie] Hamburg Univ, Dept Econ, Hamburg, Germany	Henan University; University of Hamburg	Krause, M (corresponding author), Hamburg Univ, Dept Econ, Hamburg, Germany.	melanie.krause@uni-hamburg.de		SHAO, LIANG/0000-0001-7460-6724				Aaberge R, 2002, REV INCOME WEALTH, P443; Acemoglu D, 2002, J ECON LIT, V40, P7; [Anonymous], 1984, NY TIMES; Atkinson AB, 2016, SCAND J ECON, V118, P264, DOI 10.1111/sjoe.12143; Atkinson AB, 2011, J ECON LIT, V49, P3, DOI 10.1257/jel.49.1.3; Autor DH, 2006, AM ECON REV, V96, P189, DOI 10.1257/000282806777212620; Barro RJ, 2000, J ECON GROWTH, V5, P5, DOI 10.1023/A:1009850119329; Birdsall N, 2007, REFLECTIONS MACROFOU; Bluhm R, 2018, EUR ECON REV, V104, P237, DOI 10.1016/j.euroecorev.2018.03.003; Brueckner M, 2015, J ECON GROWTH, V20, P149, DOI 10.1007/s10887-015-9113-4; BUTLER RJ, 1987, J BUS ECON STAT, V5, P13, DOI 10.2307/1391210; Chakravarty SR, 2019, REV INCOME WEALTH, V65, P785, DOI 10.1111/roiw.12381; CHOTIKAPANICH D, 1993, ECON LETT, V41, P129, DOI 10.1016/0165-1765(93)90186-G; Cowell F, 2009, MEASURING INEQUALITY; Dollar D, 2002, J ECON GROWTH, V7, P195, DOI 10.1023/A:1020139631000; Dutz MarkA., 2012, PROMOTING INCLUSIVE; Egger H, 2009, INT ECON REV, V50, P187, DOI 10.1111/j.1468-2354.2008.00527.x; Essama-Nssah B, 2009, REV INCOME WEALTH, V55, P752, DOI 10.1111/j.1475-4991.2009.00335.x; Foster J, 2013, ADEPT SER, P1, DOI 10.1596/978-0-8213-8461-9; Foster JE, 2010, J ECON INEQUAL, V8, P247, DOI 10.1007/s10888-009-9122-7; Garicano L, 2006, Q J ECON, V121, P1383, DOI 10.1093/qje/121.4.1383; GASTWIRTH JL, 1971, ECONOMETRICA, V39, P1037, DOI 10.2307/1909675; Georgiadis A, 2012, PUBLIC CHOICE, V151, P537, DOI 10.1007/s11127-010-9758-7; Goos M, 2009, AM ECON REV, V99, P58, DOI 10.1257/aer.99.2.58; Grosse M, 2008, WORLD DEV, V36, P1021, DOI 10.1016/j.worlddev.2007.10.009; Helpman E, 2010, ECONOMETRICA, V78, P1239, DOI 10.3982/ECTA8640; KAKWANI N, 1980, ECONOMETRICA, V48, P437, DOI 10.2307/1911106; Kakwani N, 2008, REV INCOME WEALTH, V54, P643, DOI 10.1111/j.1475-4991.2008.00293.x; Kenworthy L., 2013, INCOME INEQUALITY EC, P101, DOI [10.11126/stanford/9780804778244.003.0004, DOI 10.11126/STANFORD/9780804778244.003.0004]; Kraay A, 2006, J DEV ECON, V80, P198, DOI 10.1016/j.jdeveco.2005.02.004; Krause M, 2014, REV INCOME WEALTH, V60, P905, DOI 10.1111/roiw.12047; Lundberg M, 2003, ECON J, V113, P326, DOI 10.1111/1468-0297.00127; Luxembourg Income Study (LIS) Database, 2018, LUXEMBOURG INCOME ST; MANKIW NG, 1992, Q J ECON, V107, P407, DOI 10.2307/2118477; Sarabia JM, 2008, ECON STUD INEQUAL SO, V5, P167, DOI 10.1007/978-0-387-72796-7_9; Minoiu C., 2009, J INCOME DISTRIB, V18, P160; Nolan B, 2019, REV INCOME WEALTH, V65, P465, DOI 10.1111/roiw.12362; OECD, 2011, DIV WE STAND WHY IN; OECD, 2015, ALL BOARD MAKING INC; Ravallion M, 2003, ECON LETT, V78, P93, DOI 10.1016/S0165-1765(02)00205-7; Rohde N, 2009, ECON LETT, V105, P61, DOI 10.1016/j.econlet.2009.05.015; Salverda W., 2014, CHANGING INEQUALITIE, P49, DOI [10.1093/acprof:oso/9780199687435.003.0003, DOI 10.1093/ACPROF:OSO/9780199687435.003.0003]; Shao LF, 2017, PANOECONOMICUS, V64, P525, DOI 10.2298/PAN150520033S; SOLOW RM, 1956, Q J ECON, V70, P65, DOI 10.2307/1884513; VILLASENOR JA, 1989, J ECONOMETRICS, V40, P327, DOI 10.1016/0304-4076(89)90089-4; Wang ZX, 2015, ECON LETT, V129, P45, DOI 10.1016/j.econlet.2015.02.008; World Bank, 2015, MEAS APPR END POV BO	47	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0242803	10.1371/journal.pone.0242803	http://dx.doi.org/10.1371/journal.pone.0242803			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH1IW	33326451	Green Published, gold			2022-12-27	WOS:000600176400026
J	Dubois, F; Gaignerie, A; Flippe, L; Heslan, JM; Tesson, L; Chesneau, M; Haspot, F; Conchon, S; David, L; Brouard, S				Dubois, Florian; Gaignerie, Anne; Flippe, Lea; Heslan, Jean-Marie; Tesson, Laurent; Chesneau, Melanie; Haspot, Fabienne; Conchon, Sophie; David, Laurent; Brouard, Sophie			Toward a better definition of hematopoietic progenitors suitable for B cell differentiation	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; ORIGIN; PHENOTYPE; DEFINES; SYSTEM	The success of inducing human pluripotent stem cells (hIPSC) offers new opportunities for cell-based therapy. Since B cells exert roles as effector and as regulator of immune responses in different clinical settings, we were interested in generating B cells from hIPSC. We differentiated human embryonic stem cells (hESC) and hIPSC into B cells onto OP9 and MS-5 stromal cells successively. We overcame issues in generating CD34(+)CD43(+) hematopoietic progenitors with appropriate cytokine conditions and emphasized the difficulties to generate proper hematopoietic progenitors. We highlight CD31(int)CD45(int) phenotype as a possible marker of hematopoietic progenitors suitable for B cell differentiation. Defining precisely proper lymphoid progenitors will improve the study of their lineage commitment and the signals needed during the in vitro process.	[Dubois, Florian; Flippe, Lea; Heslan, Jean-Marie; Tesson, Laurent; Chesneau, Melanie; Haspot, Fabienne; Conchon, Sophie; David, Laurent; Brouard, Sophie] Univ Nantes, CHU Nantes, Ctr Rech Transplantat & Immunol, INSERM,UMR 1064,ITUN, Nantes, France; [Gaignerie, Anne; Heslan, Jean-Marie; David, Laurent] Univ Nantes, CHU Nantes, SFR Sante, FED 4203,INSERM,UMS 016,CNRS,UMS 3556, Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes	Brouard, S (corresponding author), Univ Nantes, CHU Nantes, Ctr Rech Transplantat & Immunol, INSERM,UMR 1064,ITUN, Nantes, France.	sophie.brouard@univ-nantes.fr	Dubois, Florian/GYA-0494-2022; HASPOT, Fabienne/AAD-5698-2021	Haspot, Fabienne/0000-0003-0513-1387; DUBOIS, Florian/0000-0002-7034-0866; Conchon, Sophie/0000-0003-2602-3385; Flippe, Lea/0000-0002-8521-5267	French government [ANR-11-LABX-0016-01]; ANR project BIKET [ANR-17CE17-0008];  [RP10083]	French government; ANR project BIKET(French National Research Agency (ANR)); 	This work was supported in the context of the Centaure project (RP10083) and the LabEX IGO thanks to French government financial support managed by the National Research Agency via the "Investment into the Future" program (ANR-11-LABX-0016-01). The ANR project BIKET (ANR-17CE17-0008) also financially support this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, REGEN MED S3, V7, pS14; Bar S, 2017, CELL REP, V19, P957, DOI 10.1016/j.celrep.2017.04.020; Bueno C, 2016, LEUKEMIA, V30, P674, DOI 10.1038/leu.2015.294; Carpenter L, 2011, BLOOD, V117, P4008, DOI 10.1182/blood-2010-08-299941; Chadwick K, 2003, BLOOD, V102, P906, DOI 10.1182/blood-2003-03-0832; Chesneau M, 2014, AM J TRANSPLANT, V14, P144, DOI 10.1111/ajt.12508; Chesneau M, 2015, J AM SOC NEPHROL, V26, P2588, DOI 10.1681/ASN.2014040404; Chicha L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014733; Crane GM, 2017, NAT REV IMMUNOL, V17, P573, DOI 10.1038/nri.2017.53; Dzierzak E, 2018, CELL STEM CELL, V22, P639, DOI 10.1016/j.stem.2018.04.015; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; Fort A, 2015, CELL CYCLE, V14, P1148, DOI 10.4161/15384101.2014.988031; French A, 2015, STEM CELLS DEV, V24, P1082, DOI 10.1089/scd.2014.0318; Gaignerie A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32645-2; Huang K, 2014, STEM CELL REP, V2, P36, DOI 10.1016/j.stemcr.2013.11.003; Hystad ME, 2007, J IMMUNOL, V179, P3662, DOI 10.4049/jimmunol.179.6.3662; Iwata Y, 2011, BLOOD, V117, P530, DOI 10.1182/blood-2010-07-294249; Julien E, 2016, FEBS LETT, V590, P3987, DOI 10.1002/1873-3468.12389; Kaufman DS, 2009, BLOOD, V114, P3513, DOI 10.1182/blood-2009-03-191304; Kennedy M, 2007, BLOOD, V109, P2679, DOI 10.1182/blood-2006-09-047704; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kumar A, 2019, STEM CELLS INT, V2019, DOI 10.1155/2019/2141475; Larbi A, 2014, STEM CELLS DEV, V23, P2983, DOI 10.1089/scd.2014.0171; Mauri C, 2015, INT IMMUNOL, V27, P479, DOI 10.1093/intimm/dxv038; Melchers F, 2015, J CLIN INVEST, V125, P2203, DOI 10.1172/JCI78083; Merkle FT, 2017, NATURE, V545, P229, DOI 10.1038/nature22312; Nagasawa T, 2006, NAT REV IMMUNOL, V6, P107, DOI 10.1038/nri1780; Nishihara M, 1998, EUR J IMMUNOL, V28, P855, DOI 10.1002/(SICI)1521-4141(199803)28:03<855::AID-IMMU855>3.0.CO;2-X; Nutt SL, 2007, IMMUNITY, V26, P715, DOI 10.1016/j.immuni.2007.05.010; Ohkawara JI, 1998, LEUKEMIA, V12, P764, DOI 10.1038/sj.leu.2401004; Oleinika K, 2019, NAT REV NEPHROL, V15, P11, DOI 10.1038/s41581-018-0074-7; Palpant NJ, 2017, CELL REP, V20, P1597, DOI 10.1016/j.celrep.2017.07.067; Palpant NJ, 2017, NAT PROTOC, V12, DOI 10.1038/nprot.2016.153; Parrotta E, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0720-1; Pettinato G, 2014, SCI REP-UK, V4, DOI 10.1038/srep07402; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Rodriguez-Pinto D, 2005, CELL IMMUNOL, V238, P67, DOI 10.1016/j.cellimm.2006.02.005; Rosser EC, 2015, IMMUNITY, V42, P607, DOI 10.1016/j.immuni.2015.04.005; Sanz E, 2010, P NATL ACAD SCI USA, V107, P5925, DOI 10.1073/pnas.0907942107; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Slukvin II, 2016, FEBS LETT, V590, P4126, DOI 10.1002/1873-3468.12283; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vodyanik MA, 2005, BLOOD, V105, P617, DOI 10.1182/blood-2004-04-1649; Vodyanik MA, 2006, BLOOD, V108, P2095, DOI 10.1182/blood-2006-02-003327; Wasik M, 2018, MICROBIOL IMMUNOL, V62, P485, DOI 10.1111/1348-0421.12636	46	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243769	10.1371/journal.pone.0243769	http://dx.doi.org/10.1371/journal.pone.0243769			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320872	gold, Green Published			2022-12-27	WOS:000600339800007
J	Ferro, GM; Sornette, D				Ferro, Giuseppe M.; Sornette, Didier			Stochastic representation decision theory: How probabilities and values are entangled dual characteristics in cognitive processes	PLOS ONE			English	Article							SUBJECTIVE-PROBABILITY; LIKELIHOOD RATIO; PROSPECT-THEORY; FIELD-THEORY; CHOICE; UTILITY; RISK; ELICITATION; PREFERENCE; TIME	Humans are notoriously bad at understanding probabilities, exhibiting a host of biases and distortions that are context dependent. This has serious consequences on how we assess risks and make decisions. Several theories have been developed to replace the normative rational expectation theory at the foundation of economics. These approaches essentially assume that (subjective) probabilities weight multiplicatively the utilities of the alternatives offered to the decision maker, although evidence suggest that probability weights and utilities are often not separable in the mind of the decision maker. In this context, we introduce a simple and efficient framework on how to describe the inherently probabilistic human decision-making process, based on a representation of the deliberation activity leading to a choice through stochastic processes, the simplest of which is a random walk. Our model leads naturally to the hypothesis that probabilities and utilities are entangled dual characteristics of the real human decision making process. It predicts the famous fourfold pattern of risk preferences. Through the analysis of choice probabilities, it is possible to identify two previously postulated features of prospect theory: the inverse S-shaped subjective probability as a function of the objective probability and risk-seeking behavior in the loss domain. It also predicts observed violations of stochastic dominance, while it does not when the dominance is "evident". Extending the model to account for human finite deliberation time and the effect of time pressure on choice, it provides other sound predictions: inverse relation between choice probability and response time, preference reversal with time pressure, and an inverse double-S-shaped probability weighting function. Our theory, which offers many more predictions for future tests, has strong implications for psychology, economics and artificial intelligence.	[Ferro, Giuseppe M.; Sornette, Didier] ETH, Dept Management Technol & Econ, Zurich, Switzerland; [Sornette, Didier] Southern Univ Sci & Technol, Acad Adv Interdisciplinary Studies, Inst Risk Anal Predict & Management, Shenzhen, Peoples R China; [Sornette, Didier] Tokyo Inst Technol, Inst Innovat Res, Tokyo Tech World Res Hub Initiat WRHI, Tokyo, Tokyo, Japan; [Sornette, Didier] Univ Geneva, Swiss Finance Inst, Geneva, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Southern University of Science & Technology; Tokyo Institute of Technology; University of Geneva	Ferro, GM (corresponding author), ETH, Dept Management Technol & Econ, Zurich, Switzerland.	ferrog@ethz.ch		Ferro, Giuseppe/0000-0002-2088-4259				Abdellaoui M, 2000, MANAGE SCI, V46, P1497, DOI 10.1287/mnsc.46.11.1497.12080; Abdellaoui M, 2007, MANAGE SCI, V53, P1659, DOI 10.1287/mnsc.1070.0711; Academias Las, 1998, EDAD ORO, VXVII, P49; Agranov M, 2017, J POLIT ECON, V125, P40, DOI 10.1086/689774; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Al-Nowaihi A., 2010, WILEY ENCY OPERATION; Allais M, 1953, ECONOMETRICA, V21, P503, DOI 10.2307/1907921; [Anonymous], 2016, IEEE-ASME T MECH, VPP, P1, DOI DOI 10.1109/IEEESTD.2016.7460875; [Anonymous], 2008, INTRO PROBABILITY TH; [Anonymous], 2001, OVERSEAS ONLINE MAGA, V5, P10; Bachmann Kremena, 2018, BEHAV FINANCE PRIVAT; BENZUR H, 1981, ACTA PSYCHOL, V47, P89, DOI 10.1016/0001-6918(81)90001-9; Birnbaum MH, 1996, ORGAN BEHAV HUM DEC, V67, P91, DOI 10.1006/obhd.1996.0067; Birnbaum MH, 1999, ORGAN BEHAV HUM DEC, V77, P44, DOI 10.1006/obhd.1998.2816; Bossaerts P, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0138; BUSEMEYER JR, 1993, PSYCHOL REV, V100, P432, DOI 10.1037/0033-295X.100.3.432; BUSEMEYER JR, 1985, J EXP PSYCHOL LEARN, V11, P538, DOI 10.1037/0278-7393.11.3.538; Chae Y.K., 2009, PLOS ONE, V4, pe6523; CHATEAUNEUF A, 1994, J RISK UNCERTAINTY, V9, P77, DOI 10.1007/BF01073404; CHESLEY GR, 1978, J ACCOUNT RES, V16, P225, DOI 10.2307/2490564; CHEW SH, 1991, ECONOMETRICA, V59, P139, DOI 10.2307/2938244; COHEN MD, 1995, GENEVA PAP RISK INS, V20, P73, DOI 10.1007/BF01098959; DEBREU G, 1958, ECONOMETRICA, V26, P440, DOI 10.2307/1907622; Diecidue E, 2001, J RISK UNCERTAINTY, V23, P281, DOI 10.1023/A:1011877808366; Dodwell PC, 1961, REV INDIVIDUAL CHOIC; FISHBURN PC, 1978, J POLIT ECON, V86, P321, DOI 10.1086/260670; Fokker AD, 1914, ANN PHYS-BERLIN, V43, P810; HADAR J, 1969, AM ECON REV, V59, P25; HALPERN DF, 1973, J EXP PSYCHOL, V101, P105, DOI 10.1037/h0035463; HANDA J, 1977, J POLIT ECON, V85, P97, DOI 10.1086/260547; Harris AJL, 2009, COGNITION, V110, P51, DOI 10.1016/j.cognition.2008.10.006; HEY JD, 1984, KYKLOS, V37, P181, DOI 10.1111/j.1467-6435.1984.tb00748.x; Holtgrave D. R., 1990, M JUDGM MAK SOC NEW; IRWIN FW, 1953, J PERS, V21, P329, DOI 10.1111/j.1467-6494.1953.tb01775.x; Jensen JLWV, 1906, ACTA MATH-DJURSHOLM, V30, P175, DOI 10.1007/BF02418571; Jerome R Busemeyer, 1980, COMBINED EFFECTS EVE; JOPF Journal officiel de la Polynesie Francaise, 1982, JOPF, V8, P361; KADANE JB, 1988, J AM STAT ASSOC, V83, P357; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; KAHNEMAN D, 1972, COGNITIVE PSYCHOL, V3, P430, DOI 10.1016/0010-0285(72)90016-3; KARMARKAR US, 1978, ORGAN BEHAV HUM PERF, V21, P61, DOI 10.1016/0030-5073(78)90039-9; Kenneth Joseph Arrow, 1984, INDIVIDUAL CHOICE CE, V3; Kurtz-David V, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09343-2; LINK SW, 1975, PSYCHOMETRIKA, V40, P77, DOI 10.1007/BF02291481; LOOMES G, 1982, ECON J, V92, P805, DOI 10.2307/2232669; LOPES LL, 1981, J EXP PSYCHOL-HUM L, V7, P377; LUCE RD, 1977, J MATH PSYCHOL, V15, P215, DOI 10.1016/0022-2496(77)90032-3; LUCE RD, 1991, J RISK UNCERTAINTY, V4, P29, DOI 10.1007/BF00057885; MANSKI CF, 1977, THEOR DECIS, V8, P229, DOI 10.1007/BF00133443; Mata R, 2018, J ECON PERSPECT, V32, P155, DOI 10.1257/jep.32.2.155; McFadden D, 2001, AM ECON REV, V91, P351, DOI 10.1257/aer.91.3.351; Menger Karl, 1934, Z NATIONALOKONOMIE, P459; Michael D Weiss, 1987, CONCEPTUAL FDN RISK; Morgenstern Oskar, 1953, THEORY GAMES EC BEHA; Mosteller F, 1951, J POLIT ECON, V59, P371, DOI 10.1086/257106; MYERS JL, 1965, J MATH PSYCHOL, V2, P363, DOI 10.1016/0022-2496(65)90010-6; MYERS JL, 1962, PSYCHOL REP, V10, P483, DOI 10.2466/PR0.10.2.483-486; PAYNE JW, 1992, ANNU REV PSYCHOL, V43, P87, DOI 10.1146/annurev.ps.43.020192.000511; Petrovsky-Shtern Yohanan, 2004, ASS CIF JEWISH STUDI, V2, P217; PETRUSIC WM, 1978, J EXP PSYCHOL HUMAN, V4, P471, DOI 10.1037/0096-1523.4.3.471; Planck Max, 1917, SATZ STATISTISCHEN D; Pratt J.W, 1978, UNCERTAINTY EC, P59; Prelec D, 1998, ECONOMETRICA, V66, P497, DOI 10.2307/2998573; PRUITT DG, 1965, J EXP PSYCHOL, V69, P483, DOI 10.1037/h0021721; QUIGGIN J, 1982, J ECON BEHAV ORGAN, V3, P323, DOI 10.1016/0167-2681(82)90008-7; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; Robert Leslie Ellis, 1843, FDN THEORY PROBABILI; Robert Martin, 2011, STANFORD ENCY PHILOS; Roe RM, 2001, PSYCHOL REV, V108, P370, DOI 10.1037//0033-295X.108.2.370; ROTHSCHILD M, 1970, J ECON THEORY, V2, P225, DOI 10.1016/0022-0531(70)90038-4; SAVAGE LJ, 1971, J AM STAT ASSOC, V66, P783, DOI 10.2307/2284229; SCHKADE DA, 1989, ORGAN BEHAV HUM DEC, V44, P203, DOI 10.1016/0749-5978(89)90025-3; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SHAFFER JP, 1995, ANNU REV PSYCHOL, V46, P561, DOI 10.1146/annurev.ps.46.020195.003021; Simon A., 1972, DECISION ORG, P161, DOI DOI 10.1093/EREA/27.3.325; SIMONSON I, 1992, J MARKETING RES, V29, P281, DOI 10.2307/3172740; SIMONSON I, 1989, J CONSUM RES, V16, P158, DOI 10.1086/209205; SLOVIC P, 1966, IEEE TRANS HUM FACT, VHFE7, P22, DOI 10.1109/THFE.1966.231980; Tasso JKaper, 1999, ANAL MULTISCALE PHEN, V56, P85; Thurstone LL, 1927, PSYCHOL REV, V34, P273, DOI 10.1037/h0070288; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; TVERSKY A, 1993, MANAGE SCI, V39, P1179, DOI 10.1287/mnsc.39.10.1179; VUONG QH, 1989, ECONOMETRICA, V57, P307, DOI 10.2307/1912557; Wilks SS, 1938, ANN MATH STAT, V9, P60, DOI 10.1214/aoms/1177732360; Witelski T., 2009, SCHOLARPEDIA, V4, P3951; WRIGHT P, 1974, J APPL PSYCHOL, V59, P555, DOI 10.1037/h0037186; YAARI ME, 1987, ECONOMETRICA, V55, P95, DOI 10.2307/1911158	88	0	0	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243661	10.1371/journal.pone.0243661	http://dx.doi.org/10.1371/journal.pone.0243661			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH1MP	33315897	Green Published, gold			2022-12-27	WOS:000600186100006
J	Ishitani, H; Tamura, T; Kanaya, S; Fujimoto, H				Ishitani, Hayato; Tamura, Toshiyo; Kanaya, Shigehiko; Fujimoto, Hiroshi			Examination of the regression model to quantify the degree of low back pain and lower limb symptoms in patients with lumbar disc herniation by the Japanese Orthopaedic Association Back Pain Evaluation Questionnaire (JOABPEQ)	PLOS ONE			English	Article								The Japanese Orthopedic Association Back Pain Evaluation Questionnaire (JOABPEQ) was created to evaluate specific treatment outcomes in terms of physical functioning, social ability, and mental health in patients with back pain-related diseases. In this study, we investigated whether the JOABPEQ could be used to construct a regression model to quantify low back pain and lower limb symptoms in patients with lumbar disc herniation (LDH). We reviewed 114 patients with LDH scheduled to undergo surgery at our hospital. We measured the degrees of 1) lower back pain, 2) lower limb pain, and 3) lower limb numbness using the visual analog scale before the surgery. All answers and physical function data were subjected to partial least squares regression analysis. The degrees of lower back and lower limb pain could be used as a regression model from the JOABPEQ and had a significant causal relationship with them. However, the degree of lower limb numbness could not be used for the same. Based on our results, the questions of the JOABPEQ can be used to multilaterally understand the degree of lower back pain and lower limb pain in patients with LDH. However, the degree of lower limb numbness has no causal relationship, so actual measurement is essential.	[Ishitani, Hayato] Funabashi Orthoped Hosp, Nishifuna Clin, Dept Rehabil, Funabashi, Chiba, Japan; [Tamura, Toshiyo; Fujimoto, Hiroshi] Waseda Univ, Future Robot Org, Inst Healthcare Robot, Shinjuku Ku, Tokyo, Japan; [Kanaya, Shigehiko] Nara Inst Sci & Technol, Computat Syst Biol Lab, Ikoma City, Nara, Japan	Waseda University; Nara Institute of Science & Technology	Ishitani, H (corresponding author), Funabashi Orthoped Hosp, Nishifuna Clin, Dept Rehabil, Funabashi, Chiba, Japan.	hayato2020@gmail.com	Tamura, Toshiyo/C-7673-2014	Tamura, Toshiyo/0000-0002-8514-4200; Ishitani, Hayato/0000-0002-6310-3088				AFFLECK G, 1994, J PERS SOC PSYCHOL, V66, P329, DOI 10.1037/0022-3514.66.2.329; Azimi P, 2012, J ORTHOP SCI, V17, P341, DOI 10.1007/s00776-012-0232-x; Block A R, 2001, Spine J, V1, P274, DOI 10.1016/S1529-9430(01)00054-7; Chin WW, 1998, QUANT METH SER, P295; Crombez G, 1999, PAIN, V80, P329, DOI 10.1016/S0304-3959(98)00229-2; Dorow M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156647; Fors M, 2019, BMC MUSCULOSKEL DIS, V20, DOI 10.1186/s12891-019-2850-3; Hockings RL, 2008, SPINE, V33, pE494, DOI 10.1097/BRS.0b013e31817ba3bb; Ihaka R., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Li LQ, 2016, J INT MED RES, V44, P1424, DOI 10.1177/0300060516645419; Lindback Y, 2018, SPINE J, V18, P1347, DOI 10.1016/j.spinee.2017.12.009; Linton SJ, 2000, SPINE, V25, P1148, DOI 10.1097/00007632-200005010-00017; Mannion AF, 2007, EUR SPINE J, V16, P777, DOI 10.1007/s00586-006-0255-0; Poosiripinyo T, 2017, J ORTHOP SCI, V22, P34, DOI 10.1016/j.jos.2016.10.001; Sinikallio S, 2007, EUR SPINE J, V16, P905, DOI 10.1007/s00586-007-0349-3; Zanaboni P, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-1	17	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243861	10.1371/journal.pone.0243861	http://dx.doi.org/10.1371/journal.pone.0243861			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315945	gold, Green Published			2022-12-27	WOS:000600186100053
J	Noguchi-Shinohara, M; Domoto, C; Yoshida, T; Niwa, K; Yuki-Nozaki, S; Samuraki-Yokohama, M; Sakai, K; Hamaguchi, T; Ono, K; Iwasa, K; Matsunari, I; Komai, K; Nakamura, H; Yamada, M				Noguchi-Shinohara, Moeko; Domoto, Chiaki; Yoshida, Taketoshi; Niwa, Kozue; Yuki-Nozaki, Sohshi; Samuraki-Yokohama, Miharu; Sakai, Kenji; Hamaguchi, Tsuyoshi; Ono, Kenjiro; Iwasa, Kazuo; Matsunari, Ichiro; Komai, Kiyonobu; Nakamura, Hiroyuki; Yamada, Masahito			A new computerized assessment battery for cognition (C-ABC) to detect mild cognitive impairment and dementia around 5 min	PLOS ONE			English	Article							MENTAL-STATE; DIAGNOSIS; CONSENSUS	This study aimed to develop a new computerized assessment battery for cognition (C-ABC) to detect mild cognitive impairment (MCI) and dementia. We performed C-ABC in subjects with dementia (n = 422), MCI (n = 145), and normal cognition (NC; n = 574), and analyzed by age stratum (50s, 60s, and 70-85 years). To distinguish MCI from NC, the C-ABC total combined score, which were calculated by dividing the C-ABC total score by the C-ABC required time, revealed the best area under the curves (AUC) at 0.838 and 0.735 in the 50s and 60s age groups, respectively; notably, this entire procedure took approximately 5 min. To distinguish dementia from NC and MCI, the partial items of C-ABC (items 3 + 6 combined score) revealed the best AUCs at 0.910, 0.874, and 0.882 in the 50s, 60s, and 70-85 age groups, respectively. Furthermore, the items 3 + 6 combined score established the best AUC at 0.794 in the 70-85 age group to distinguish MCI from NC; this entire procedure took around 2 min. Hence, this study suggests that C-ABC could be a useful tool for detecting dementia or MCI in a short time.	[Noguchi-Shinohara, Moeko; Domoto, Chiaki; Niwa, Kozue; Yuki-Nozaki, Sohshi; Samuraki-Yokohama, Miharu; Sakai, Kenji; Hamaguchi, Tsuyoshi; Ono, Kenjiro; Iwasa, Kazuo; Yamada, Masahito] Kanazawa Univ, Grad Sch Med Sci, Dept Neurol & Neurobiol Aging, Kanazawa, Ishikawa, Japan; [Noguchi-Shinohara, Moeko] Kanazawa Univ, Grad Sch Med Sci, Dept Preempt Med Dementia, Kanazawa, Ishikawa, Japan; [Yoshida, Taketoshi] Japan Adv Inst Sci & Technol JAIST, Dept Knowledge Sci, Nomi, Ishikawa, Japan; [Ono, Kenjiro] Showa Univ, Dept Internal Med, Div Neurol, Sch Med, Tokyo, Japan; [Iwasa, Kazuo] Ishikawa Prefectural Nursing Univ, Dept Hlth & Med Sci, Kahoku, Ishikawa, Japan; [Matsunari, Ichiro] Saitama Med Univ Hosp, Dept Radiol, Div Nucl Med, Saitama, Japan; [Komai, Kiyonobu] Natl Hosp Org Iou Natl Hosp, Hokuriku Brain & Neuromuscular Dis Ctr, Dept Neurol, Kanazawa, Ishikawa, Japan; [Nakamura, Hiroyuki] Kanazawa Univ, Dept Publ Hlth, Grad Sch Adv Prevent Med Sci, Kanazawa, Ishikawa, Japan; [Nakamura, Hiroyuki] Kanazawa Univ, Adv Prevent Med Sci Res Ctr, Kanazawa, Ishikawa, Japan; [Nakamura, Hiroyuki] Kanazawa Univ, Grad Sch Med Sci, Dept Environm & Prevent Med, Kanazawa, Ishikawa, Japan	Kanazawa University; Kanazawa University; Japan Advanced Institute of Science & Technology (JAIST); Showa University; Saitama Medical University; Kanazawa University; Kanazawa University; Kanazawa University	Yamada, M (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Neurol & Neurobiol Aging, Kanazawa, Ishikawa, Japan.	m-yamada@med.kanazawa-u.ac.jp			Japan Science and Technology Corporation, Japan; Ministry of Education, Culture, Sports, Science, and Technology, Japan	Japan Science and Technology Corporation, Japan(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by a Grant for Development of Advanced Technology for Measurement and Evaluation of Brain Functions, Ishikawa Prefecture Collaboration of Regional Entities for the Advancement of Technological Excellence (to MY), from Japan Science and Technology Corporation, Japan, by a Grant for the Knowledge Cluster Initiative [High-Tech Sensing and Knowledge Handling Technology (Brain Technology)] (to MY) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. There was no additional external funding received for this study	American Psychiatric Association, 1987, DIAGN STAT MAN MENT; [Anonymous], 2013, BONE MARROW TRANSPL, V48, P452; Curiel RE, 2016, J ALZHEIMERS DIS, V54, P793, DOI 10.3233/JAD-160370; Feenstra HEM, 2017, CLIN NEUROPSYCHOL, V31, P59, DOI 10.1080/13854046.2016.1190405; FEHER EP, 1992, ARCH NEUROL-CHICAGO, V49, P87, DOI 10.1001/archneur.1992.00530250091022; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Komatsu J, 2018, AM J NEURORADIOL, V39, P473, DOI 10.3174/ajnr.A5509; Loewenstein DA, 2000, INT J GERIATR PSYCH, V15, P434, DOI 10.1002/(SICI)1099-1166(200005)15:5<434::AID-GPS137>3.0.CO;2-2; Maruff Paul, 2013, BMC Psychol, V1, P30, DOI 10.1186/2050-7283-1-30; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; Wild K, 2008, ALZHEIMERS DEMENT, V4, P428, DOI 10.1016/j.jalz.2008.07.003; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; Zygouris S, 2015, AM J ALZHEIMERS DIS, V30, P13, DOI 10.1177/1533317514522852	18	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243469	10.1371/journal.pone.0243469	http://dx.doi.org/10.1371/journal.pone.0243469			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306697	Green Published, gold			2022-12-27	WOS:000600144200005
J	Palladini, G; Ferrigno, A; Di Pasqua, LG; Berardo, C; Rizzo, V; Perlini, S; Vairetti, M				Palladini, Giuseppina; Ferrigno, Andrea; Di Pasqua, Laura Giuseppina; Berardo, Clarissa; Rizzo, Vittoria; Perlini, Stefano; Vairetti, Mariapia			Associations between serum trace elements and inflammation in two animal models of nonalcoholic fatty liver disease	PLOS ONE			English	Article							URIC-ACID; METABOLIC SYNDROME; OXIDATIVE STRESS; TISSUE METAL; ZUCKER OBESE; CALCIUM; IRON; CHROMIUM; CHOLINE; COPPER	Background The comparison of hepatic steatosis animal models has allowed the understanding of mechanisms involved in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) and the progression to nonalcoholic steatohepatitis (NASH). We investigated the changes in serum levels of trace elements and inflammation markers in fatty livers using two rat models of NAFLD, the methionine and choline deficient (MCD) diet model and Obese-Zucker rats. Material and methods NAFLD was induced in male Wistar rats by 3-week MCD diet administration, after which, blood samples were collected. 12-week old Obese (fa/fa) and Lean (fa/-) male Zucker rats were also used. Serum levels of hepatic enzymes, Urea, Uric acid, Ca-2+,Ca- Cl, Fe, K, Na, Mg and Zn were quantified, as well as the inflammation markers TNF-alpha, IL-1beta and IL-6. Results In MCD rats, a serum increase in Cl, Mg and Na and a decrease in Ca-2+,Ca- Zn were detected in comparison with control rats. An increase in only serum Ca2+ was found in Obese-Zucker rats. In MCD rat serum, Zn was inversely correlated with IL-1beta, IL-6, TNF-alpha, Urea and Uric Acid; Ca2+ was inversely correlated with IL-1beta, IL-6 and Urea; Cl and Mg were directly correlated with Uric Acid and Urea, respectively. In Obese-Zucker rats, Cl and IL-1beta were inversely correlated, whereas Ca2+ and Urea where directly correlated, as well Fe and TNF-alpha. Conclusions The serum concentrations of trace elements change significantly only in MCD rats, which spontaneously progress to NASH. The causes of these changes may be a result of defense strategies of the organism, which is regulated by immunoregulatory cytokines. These results might suggest that the impairment of trace element status should be taken into account when the effectiveness of a pharmacological treatment is under evaluation.	[Palladini, Giuseppina; Ferrigno, Andrea; Di Pasqua, Laura Giuseppina; Berardo, Clarissa; Perlini, Stefano; Vairetti, Mariapia] Univ Pavia, Dept Internal Med & Therapeut, Pavia, Italy; [Palladini, Giuseppina] Fdn IRCCS Policlin San Matteo, Pavia, Italy; [Rizzo, Vittoria] Univ Pavia, Dept Mol Med, Pavia, Italy; [Perlini, Stefano] Fdn IRCCS Policlin San Matteo, Emergency Dept, Pavia, Italy	University of Pavia; IRCCS Fondazione San Matteo; University of Pavia; IRCCS Fondazione San Matteo	Ferrigno, A (corresponding author), Univ Pavia, Dept Internal Med & Therapeut, Pavia, Italy.	andrea.ferrigno@unipv.it	Vairetti, Mariapia/AAM-1757-2020; Di Pasqua, Laura Giuseppina/Y-3987-2019; Palladini, Giuseppina/AAB-8694-2019; Ferrigno, Andrea/J-2087-2019	Vairetti, Mariapia/0000-0002-2464-6127; Di Pasqua, Laura Giuseppina/0000-0003-0103-1493; Palladini, Giuseppina/0000-0003-1312-7513; Ferrigno, Andrea/0000-0003-2337-2897				Abe N, 2019, BIOL OPEN, V8, DOI 10.1242/bio.040519; [Anonymous], 2015, CANC DISCOV, V5, pOF2; Asprouli E, 2019, BIOL TRACE ELEM RES, V188, P326, DOI 10.1007/s12011-018-1432-9; Bernardi M, 2005, LIVER INT, V25, P463, DOI 10.1111/j.1478-3231.2005.01115.x; Braunersreuther V, 2012, WORLD J GASTROENTERO, V18, P727, DOI 10.3748/wjg.v18.i8.727; Brennan P, 2020, WORLD J GASTROENTERO, V26, P1683, DOI 10.3748/wjg.v26.i15.1683; Britton LJ, 2016, WORLD J GASTROENTERO, V22, P8112, DOI 10.3748/wjg.v22.i36.8112; de Lemos ET, 2009, NUTRITION, V25, P330, DOI 10.1016/j.nut.2008.08.014; DEBACQUER D, 1994, ATHEROSCLEROSIS, V108, P193, DOI 10.1016/0021-9150(94)90114-7; Eder K, 2009, INFLAMM RES, V58, P727, DOI 10.1007/s00011-009-0060-4; Eshraghian A, 2018, UNITED EUR GASTROENT, V6, P97, DOI 10.1177/2050640617707863; FERNANDEZLOPEZ JA, 1994, BIOMETALS, V7, P117, DOI 10.1007/BF00140481; Gammoh NZ, 2017, NUTRIENTS, V9, DOI 10.3390/nu9060624; Gatiatulina ER, 2017, J TRACE ELEM MED BIO, V39, P91, DOI 10.1016/j.jtemb.2016.08.007; Glantzounis GK, 2005, CURR PHARM DESIGN, V11, P4145, DOI 10.2174/138161205774913255; Himoto T, 2018, NUTRIENTS, V10, DOI 10.3390/nu10010088; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Ibrahim SH, 2016, DIGEST DIS SCI, V61, P1325, DOI 10.1007/s10620-015-3977-1; Itagaki H, 2013, INT J CLIN EXP PATHO, V6, P2683; Ito T, 2020, EUR J GASTROEN HEPAT, V32, P748, DOI 10.1097/MEG.0000000000001587; Jahn D, 2019, BBA-MOL BASIS DIS, V1865, P943, DOI 10.1016/j.bbadis.2018.06.023; Ji GY, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0139-6; Kim MK, 2010, ATHEROSCLEROSIS, V212, P674, DOI 10.1016/j.atherosclerosis.2010.07.005; Kocyigit A, 2002, BIOL TRACE ELEM RES, V90, P47, DOI 10.1385/BTER:90:1-3:47; Kucera O, 2014, WORLD J GASTROENTERO, V20, P8364, DOI 10.3748/wjg.v20.i26.8364; Lau JKC, 2017, J PATHOL, V241, P36, DOI 10.1002/path.4829; Liu T, 2019, WORLD J GASTROENTERO, V25, P5451, DOI 10.3748/wjg.v25.i36.5451; Lombardi R, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040548; Martin-Cordero L, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-42; Mirea AM, 2020, INFLAMMATION, V43, P1054, DOI 10.1007/s10753-020-01190-4; Palladini G, 2019, NUTRIENTS, V11, DOI 10.3390/nu11040799; Perry B, 2014, J INTEGR MED-JIM, V12, P447, DOI 10.1016/S2095-4964(14)60044-3; PHILLIPS AN, 1991, J HUM HYPERTENS, V5, P479; Pickett-Blakely O, 2018, CELL MOL GASTROENTER, V6, P451, DOI 10.1016/j.jcmgh.2018.07.004; Recasens M, 2004, Rev Med Univ Navarra, V48, P49; Reyes-Esparza J, 2013, BASIC CLIN PHARMACOL, V112, P222, DOI 10.1111/bcpt.12019; Ruggiero C, 2006, EUR HEART J, V27, P1174, DOI 10.1093/eurheatj/ehi879; Sacks Gordon S, 2004, J Pediatr Pharmacol Ther, V9, P235, DOI 10.5863/1551-6776-9.4.235; Scheiner B, 2017, J HEPATOL, V67, P1062, DOI 10.1016/j.jhep.2017.06.023; SERFASS RE, 1988, P SOC EXP BIOL MED, V189, P229; Shin JY, 2015, J GASTROEN HEPATOL, V30, P733, DOI 10.1111/jgh.12832; Staniek H, 2013, BIOL TRACE ELEM RES, V151, P373, DOI 10.1007/s12011-012-9565-8; Steensberg A, 2003, EXERC IMMUNOL REV, V9, P40; Van Herck MA, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101072; Vetelainen R, 2007, J GASTROEN HEPATOL, V22, P1526, DOI 10.1111/j.1440-1746.2006.04701.x; Waring WS, 2003, CLIN SCI, V105, P425, DOI 10.1042/CS20030149; Younossi Z, 2018, NAT REV GASTRO HEPAT, V15, P11, DOI 10.1038/nrgastro.2017.109; Yuan HP, 2015, J CLIN ENDOCR METAB, V100, P4198, DOI 10.1210/jc.2015-2527; Zhao CQ, 2014, J INTEGR MED-JIM, V12, P401, DOI 10.1016/S2095-4964(14)60039-X	49	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243179	10.1371/journal.pone.0243179	http://dx.doi.org/10.1371/journal.pone.0243179			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306695	gold, Green Published			2022-12-27	WOS:000600144200048
J	Rosalem, GS; Torres, LAG; de Las Casas, EB; Mathias, FAS; Ruiz, JC; Carvalho, MGR				Rosalem, Gabriel Santos; Gonzales Torres, Libardo Andres; de Las Casas, Estevam Barbosa; Siqueira Mathias, Fernando Augusto; Ruiz, Jeronimo Conceicao; Reis Carvalho, Maria Gabriela			Microfluidics and organ-on-a-chip technologies: A systematic review of the methods used to mimic bone marrow	PLOS ONE			English	Review							3-DIMENSIONAL CELL-CULTURE; EXTRACELLULAR-MATRIX; SHEAR-STRESS; SOFT LITHOGRAPHY; STEM; NICHE; TISSUE; MODEL; DIFFERENTIATION; MECHANOTRANSDUCTION	Bone marrow (BM) is an organ responsible for crucial processes in living organs, e. g., hematopoiesis. In recent years, Organ-on-a-Chip (OoC) devices have been used to satisfy the need for in vitro systems that better mimic the phenomena occurring in the BM microenvironment. Given the growing interest in these systems and the diversity of developed devices, an integrative systematic literature review is required. We have performed this review, following the PRISMA method aiming to identify the main characteristics and assess the effectiveness of the devices that were developed to represent the BM. A search was performed in the Scopus, PubMed, Web of Science and Science Direct databases using the keywords (("bone marrow" OR "hematopoietic stem cells" OR "haematopoietic stem cells") AND ("organ in a" OR "lab on a chip" OR "microfluidic" OR "microfluidic*" OR ("bioreactor" AND "microfluidic*"))). Original research articles published between 2009 and 2020 were included in the review, giving a total of 21 papers. The analysis of these papers showed that their main purpose was to study BM cells biology, mimic BM niches, model pathological BM, and run drug assays. Regarding the fabrication protocols, we have observed that polydimethylsiloxane (PDMS) material and soft lithography method were the most commonly used. To reproduce the microenvironment of BM, most devices used the type I collagen and alginate. Peristaltic and syringe pumps were mostly used for device perfusion. Regarding the advantages compared to conventional methods, there were identified three groups of OoC devices: perfused 3D BM; co-cultured 3D BM; and perfused co-cultured 3D BM. Cellular behavior and mimicking their processes and responses were the mostly commonly studied parameters. The results have demonstrated the effectiveness of OoC devices for research purposes compared to conventional cell cultures. Furthermore, the devices have a wide range of applicability and the potential to be explored.	[Rosalem, Gabriel Santos] Univ Fed Minas Gerais, Mech Engn Grad Program, Belo Horizonte, MG, Brazil; [Gonzales Torres, Libardo Andres] Univ Fed Vales Jequitinhonha & Mucuri, Inst Sci & Technol, Diamantina, Brazil; [de Las Casas, Estevam Barbosa] Univ Fed Minas Gerais, Dept Struct Engn, Belo Horizonte, MG, Brazil; [Siqueira Mathias, Fernando Augusto; Ruiz, Jeronimo Conceicao; Reis Carvalho, Maria Gabriela] Fundacao Oswaldo Cruz, Rene Rachou Inst, Biosyst & Genom Grp, Belo Horizonte, MG, Brazil; [Ruiz, Jeronimo Conceicao] Inst Oswaldo Cruz PGBCS IOC Fiocruz, Grad Program Computat & Syst Biol, Rio De Janeiro, Brazil	Universidade Federal de Minas Gerais; Universidade Federal dos Vales do Jequitinhonha e Mucuri (UFVJM); Universidade Federal de Minas Gerais; Fundacao Oswaldo Cruz	Ruiz, JC; Carvalho, MGR (corresponding author), Fundacao Oswaldo Cruz, Rene Rachou Inst, Biosyst & Genom Grp, Belo Horizonte, MG, Brazil.; Ruiz, JC (corresponding author), Inst Oswaldo Cruz PGBCS IOC Fiocruz, Grad Program Computat & Syst Biol, Rio De Janeiro, Brazil.	jeronimo@minas.fiocruz.br; maria.gabriela@minas.fiocruz.br	Torres, Libardo Andrés González/D-9628-2015; Carvalho, Maria das Graças/AAY-1619-2021	Torres, Libardo Andrés González/0000-0003-3355-677X; /0000-0002-1361-9721; Rosalem, Gabriel/0000-0003-3509-3561; Las Casas, Estevam/0000-0001-6078-8408; Carvalho, Maria Gabriela/0000-0002-0806-2033	Fundacao Oswaldo Cruz [VPPIS-001-FIO-18-12, VPPIS-001-FIO-18-8]; Brazilian National Council for Scientific and Technological Development [310104/2018-1]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [88882.381160/2019-01]	Fundacao Oswaldo Cruz; Brazilian National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Fundacao Oswaldo Cruz, VPPIS-001-FIO-18-8, MGRC; Fundacao Oswaldo Cruz, VPPIS-001-FIO-18-12, JCR; Brazilian National Council for Scientific and Technological Development, 310104/2018-1, JCR; and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, 88882.381160/2019-01, GSR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed I, 2018, CHEMOSENSORS, V6, DOI 10.3390/chemosensors6040046; Ahmed I, 2018, ARAB J SCI ENG, V43, P23, DOI 10.1007/s13369-017-2662-4; Akhmanova M, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/167025; Aleman J, 2019, SMALL, V15, DOI 10.1002/smll.201902971; Ali U, 2015, POLYM REV, V55, P678, DOI 10.1080/15583724.2015.1031377; ANDO J, 1987, MICROVASC RES, V33, P62, DOI 10.1016/0026-2862(87)90007-0; [Anonymous], 2014, REG ANESTH PAIN MED; [Anonymous], 2019, FRONTIERS PLANT SCI; Antoni D, 2015, INT J MOL SCI, V16, P5517, DOI 10.3390/ijms16035517; Asada N, 2017, INT J HEMATOL, V106, P45, DOI 10.1007/s12185-017-2262-9; Baker BM, 2012, J CELL SCI, V125, P3015, DOI 10.1242/jcs.079509; Banerjee A, 2009, BIOMATERIALS, V30, P4695, DOI 10.1016/j.biomaterials.2009.05.050; Becker H, 2002, TALANTA, V56, P267, DOI 10.1016/S0039-9140(01)00594-X; Becker H, 2008, ANAL BIOANAL CHEM, V390, P89, DOI 10.1007/s00216-007-1692-2; Bello AB, 2018, ACTA BIOMATER, V72, P1, DOI 10.1016/j.actbio.2018.03.028; Berthier E, 2012, LAB CHIP, V12, P1224, DOI 10.1039/c2lc20982a; Bhatia SN, 2014, NAT BIOTECHNOL, V32, P760, DOI 10.1038/nbt.2989; Borysiak MD, 2013, ANAL CHEM, V85, P11700, DOI 10.1021/ac4027675; Boulais PE, 2015, BLOOD, V125, P2621, DOI 10.1182/blood-2014-09-570192; Braham MVJ, 2018, TISSUE ENG PART C-ME, V24, P300, DOI [10.1089/ten.tec.2017.0467, 10.1089/ten.TEC.2017.0467]; Breslin S, 2013, DRUG DISCOV TODAY, V18, P240, DOI 10.1016/j.drudis.2012.10.003; Brittain S, 1998, PHYS WORLD, V11, P31; Bruce A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140506; Buxboim A, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194116; Byun CK, 2014, ELECTROPHORESIS, V35, P245, DOI 10.1002/elps.201300205; Candiello J, 2013, J BIOL ENG, V7, DOI 10.1186/1754-1611-7-9; Carrion B, 2010, BIOTECHNOL BIOENG, V107, P1020, DOI 10.1002/bit.22891; Chistiakov DA, 2017, ACTA PHYSIOL, V219, P382, DOI 10.1111/apha.12725; Chou DB, 2020, NAT BIOMED ENG, DOI 10.1038/s41551-019-0495-z; Christoffersson Jonas, 2018, Bioengineering (Basel), V5, DOI 10.3390/bioengineering5020036; Christophis C, 2011, BIOPHYS J, V101, P585, DOI 10.1016/j.bpj.2011.05.045; Damiano JS, 1999, BLOOD, V93, P1658, DOI 10.1182/blood.V93.5.1658; Delalat B, 2018, ADV FUNCT MATER, V28, DOI 10.1002/adfm.201801825; Diaz MF, 2015, J EXP MED, V212, P665, DOI 10.1084/jem.20142235; Domura R, 2017, J FUNCT BIOMATER, V8, DOI 10.3390/jfb8020018; Duval K, 2017, PHYSIOLOGY, V32, P266, DOI 10.1152/physiol.00036.2016; Engler AJ, 2004, SURF SCI, V570, P142, DOI 10.1016/j.susc.2004.06.179; Esch EW, 2015, NAT REV DRUG DISCOV, V14, P248, DOI 10.1038/nrd4539; European Commission, 2000, OFFICIAL METHODS OF, VC, P1, DOI 10.1108/03090550310770974; Gattazzo F, 2014, BBA-GEN SUBJECTS, V1840, P2506, DOI 10.1016/j.bbagen.2014.01.010; Gebauer A, 2016, PERS MED, V13, P71, DOI 10.2217/pme.15.42; Glaser DE, 2020, BIORXIV; Goldmann WH, 2012, CELL BIOL INT, V36, P567, DOI 10.1042/CBI20120071; Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858; Gurkan UA, 2008, ANN BIOMED ENG, V36, P1978, DOI 10.1007/s10439-008-9577-x; Halldorsson S, 2015, BIOSENS BIOELECTRON, V63, P218, DOI 10.1016/j.bios.2014.07.029; HARRISON RG, 1959, J EXP ZOOL, V142, P5, DOI 10.1002/jez.1401420103; Herland A, 2020, NAT BIOMED ENG, DOI 10.1038/s41551-019-0498-9; Ho CMB, 2015, LAB CHIP, V15, P3627, DOI 10.1039/c5lc00685f; Hoarau-Vechot J, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010181; Houshmand M, 2017, TISSUE ENG PART C-ME, V23, P72, DOI [10.1089/ten.tec.2016.0404, 10.1089/ten.TEC.2016.0404]; Huh D, 2012, LAB CHIP, V12, P2156, DOI 10.1039/c2lc40089h; Huh D, 2011, TRENDS CELL BIOL, V21, P745, DOI 10.1016/j.tcb.2011.09.005; Humayun M, 2018, LAB CHIP, V18, P1298, DOI 10.1039/c7lc01357d; Huyer LD, 2016, ACS BIOMATER SCI ENG, V2, P780, DOI 10.1021/acsbiomaterials.5b00525; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Ingber DE, 2010, ANN BIOMED ENG, V38, P1148, DOI 10.1007/s10439-010-9946-0; Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev; Jiang B, 2014, SCI CHINA CHEM, V57, P356, DOI 10.1007/s11426-013-4971-0; Kapur S, 2003, BONE, V32, P241, DOI 10.1016/S8756-3282(02)00979-1; Khin ZP, 2014, CANCER RES, V74, P56, DOI 10.1158/0008-5472.CAN-13-2397; Kilic O, 2016, LAB CHIP, V16, P4152, DOI 10.1039/c6lc00946h; Kobel S, 2010, BIOTECHNIQUES, V48, pIX, DOI 10.2144/000113401; Kolesky DB, 2016, P NATL ACAD SCI USA, V113, P3179, DOI 10.1073/pnas.1521342113; Lam CRI, 2014, MOL PHARMACEUT, V11, P2016, DOI 10.1021/mp500059q; Lee TI, 2013, CELL, V152, P1237, DOI 10.1016/j.cell.2013.02.014; Lee Y, 2018, LAB CHIP, V18, P2433, DOI 10.1039/c8lc00336j; Leiva O, 2018, AM J HEMATOL, V93, P430, DOI 10.1002/ajh.25008; Levesque JP, 2010, LEUKEMIA, V24, P1979, DOI 10.1038/leu.2010.214; Li GQ, 2015, EXP BIOL MED, V240, P1029, DOI 10.1177/1535370215594583; Lucas D, 2017, ADV EXP MED BIOL, V1041, P5, DOI 10.1007/978-3-319-69194-7_2; Marturano-Kruik A, 2018, P NATL ACAD SCI USA, V115, P1256, DOI 10.1073/pnas.1714282115; McAleer CW, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aav1386; Miller PG, 2016, BIOTECHNOL BIOENG, V113, P2213, DOI 10.1002/bit.25989; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Mui KL, 2016, J CELL SCI, V129, P1093, DOI 10.1242/jcs.183699; Musah S, 2017, NAT BIOMED ENG, V1, DOI 10.1038/s41551-017-0069; Nelson MR, 2016, J MATER CHEM B, V4, P3490, DOI 10.1039/c5tb02644j; Nelson MR, 2019, BIORXIV, DOI [10.1101/2019.12.15.876813, DOI 10.1101/2019.12.15.876813]; Nge PN, 2013, CHEM REV, V113, P2550, DOI 10.1021/cr300337x; Nilsson SK, 2005, BLOOD, V106, P1232, DOI 10.1182/blood-2004-11-4422; Nilsson SK, 1998, J HISTOCHEM CYTOCHEM, V46, P371, DOI 10.1177/002215549804600311; Nombela-Arrieta C, 2017, BLOOD ADV, V1, P407, DOI 10.1182/bloodadvances.2016003194; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; Polacheck WJ, 2013, CELL MOL LIFE SCI, V70, P1335, DOI 10.1007/s00018-012-1115-1; Polini A, 2014, EXPERT OPIN DRUG DIS, V9, P335, DOI 10.1517/17460441.2014.886562; Pyrzynska K, 2019, SEP PURIF REV, V48, P65, DOI 10.1080/15422119.2018.1430589; Rafii S, 2016, NATURE, V529, P316, DOI 10.1038/nature17040; Raic A, 2019, MRS COMMUN, V9, P37, DOI 10.1557/mrc.2018.203; Ratner BD, 2011, J CARDIOVASC TRANSL, V4, P523, DOI 10.1007/s12265-011-9287-x; Ren KN, 2013, ACCOUNTS CHEM RES, V46, P2396, DOI 10.1021/ar300314s; Ren KN, 2010, ANAL CHEM, V82, P5965, DOI 10.1021/ac100830t; Rigat-Brugarolas LG, 2014, LAB CHIP, V14, P1715, DOI 10.1039/c3lc51449h; Ronaldson-Bouchard K, 2018, CELL STEM CELL, V22, P310, DOI 10.1016/j.stem.2018.02.011; Rous P, 1911, J EXP MED, V13, P397, DOI 10.1084/jem.13.4.397; Sackmann EK, 2014, NATURE, V507, P181, DOI 10.1038/nature13118; Sasaki H, 2010, SENSOR ACTUAT B-CHEM, V150, P478, DOI 10.1016/j.snb.2010.07.021; Shin JW, 2014, CELL STEM CELL, V14, P81, DOI 10.1016/j.stem.2013.10.009; Sieber S, 2018, J TISSUE ENG REGEN M, V12, P479, DOI 10.1002/term.2507; Siler Ulrich, 2000, Blood, V96, P4194; Sosa-Hernandez JE, 2018, MICROMACHINES-BASEL, V9, DOI 10.3390/mi9100536; Spencer JA, 2014, NATURE, V508, P269, DOI 10.1038/nature13034; Sticker D, 2015, LAB CHIP, V15, P4542, DOI 10.1039/c5lc01028d; Stucki JD, 2015, LAB CHIP, V15, P4393, DOI 10.1039/c5lc00592b; Sun J, 2012, SOFT MATTER, V8, P2398, DOI 10.1039/c2sm06869a; Sung JH, 2010, LAB CHIP, V10, P446, DOI 10.1039/b917763a; Sung JH, 2009, BIOMED MICRODEVICES, V11, P731, DOI 10.1007/s10544-009-9286-8; Sung JH, 2009, LAB CHIP, V9, P1385, DOI 10.1039/b901377f; Thon JN, 2014, BLOOD, V124, P1857, DOI 10.1182/blood-2014-05-574913; Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361; Torisawa YS, 2016, TISSUE ENG PART C-ME, V22, P509, DOI [10.1089/ten.tec.2015.0507, 10.1089/ten.TEC.2015.0507]; Torisawa YS, 2014, NAT METHODS, V11, P663, DOI [10.1038/NMETH.2938, 10.1038/nmeth.2938]; Travlos GS, 2006, TOXICOL PATHOL, V34, P548, DOI 10.1080/01926230600939856; Verhulsel M, 2014, BIOMATERIALS, V35, P1816, DOI 10.1016/j.biomaterials.2013.11.021; Wang ZJ, 2015, SENSOR MATER, V27, P487; Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058; Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335; Wielockx B, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8020155; Wu J, 2017, TRAC-TREND ANAL CHEM, V87, P19, DOI 10.1016/j.trac.2016.11.009; Wuchter P, 2016, CELL TISSUE RES, V364, P573, DOI 10.1007/s00441-015-2348-8; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153; Yourek G, 2010, REGEN MED, V5, P713, DOI 10.2217/RME.10.60; Yuan Haobo, 2018, Bioengineering-Basel, V5, P57, DOI 10.3390/bioengineering5030057; Zhang BY, 2018, NAT REV MATER, V3, P257, DOI 10.1038/s41578-018-0034-7; Zhang WT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125995; Zhang WT, 2014, TISSUE ENG PART C-ME, V20, P663, DOI [10.1089/ten.TEC.2013.0490, 10.1089/ten.tec.2013.0490]; Zheng WF, 2012, LAB CHIP, V12, P3441, DOI 10.1039/c2lc40173h; Zheng Y, 2016, ADV HEALTHC MATER, V5, P1014, DOI 10.1002/adhm.201501007	128	12	12	11	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243840	10.1371/journal.pone.0243840	http://dx.doi.org/10.1371/journal.pone.0243840			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306749	Green Published, gold			2022-12-27	WOS:000600144200038
J	Ballard, PL; Oses-Prieto, J; Chapin, C; Segal, MR; Ballard, RA; Burlingame, AL				Ballard, Philip L.; Oses-Prieto, Juan; Chapin, Cheryl; Segal, Mark R.; Ballard, Roberta A.; Burlingame, Alma L.			Composition and origin of lung fluid proteome in premature infants and relationship to respiratory outcome	PLOS ONE			English	Article							D-BINDING PROTEIN; BRONCHOALVEOLAR LAVAGE FLUID; INHALED NITRIC-OXIDE; VITAMIN-D; PRETERM INFANTS; II CELLS; BRONCHOPULMONARY DYSPLASIA; GENE-EXPRESSION; FREE HEMOGLOBIN; DIFFERENTIATION	Background Infants born at extremely low gestational age are at high risk for bronchopulmonary dysplasia and continuing lung disease. There are no early clinical biomarkers for pulmonary outcome and limited therapeutic interventions. Objectives We performed global proteomics of premature infant tracheal aspirate (TA) and plasma to determine the composition and source of lung fluid proteins and to identify potential biomarkers of respiratory outcome. Methods TA samples were collected from intubated infants in the TOLSURF cohort before and after nitric oxide treatment, and plasma was collected from NO CLD infants. Protein abundance was assayed by HPLC/tandem mass spectrometry and Protein Prospector software. mRNA abundance in mid-gestation fetal lung was assessed by RNA sequencing. Pulmonary morbidity was defined as a need for ventilatory support at term and during the first year. Results Abundant TA proteins included albumin, hemoglobin, and actin-related proteins. 96 of 137 detected plasma proteins were present in TA (r = 0.69, p<0.00001). Based on lung RNAseq data, similar to 88% of detected TA proteins in injured infant lung are derived at least in part from lung epithelium with overrepresentation in categories of cell membrane/secretion and stress/inflammation. Comparing 37 infants at study enrollment (7-14 days) who did or did not develop persistent pulmonary morbidity, candidate biomarkers of both lung (eg., annexin A5) and plasma (eg., vitamin D-binding protein) origin were identified. Notably, levels of free hemoglobin were 2.9-fold (p = 0.03) higher in infants with pulmonary morbidity. In time course studies, hemoglobin decreased markedly in most infants after enrollment coincident with initiation of inhaled nitric oxide treatment. Conclusions We conclude that both lung epithelium and plasma contribute to the lung fluid proteome in premature infants with lung injury. Early postnatal elevation of free hemoglobin and heme, which are both pro-oxidants, may contribute to persistent lung disease by depleting nitric oxide and increasing oxidative/nitrative stress.	[Ballard, Philip L.; Chapin, Cheryl; Ballard, Roberta A.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94110 USA; [Oses-Prieto, Juan; Burlingame, Alma L.] Univ Calif San Francisco, Dept Chem & Pharmaceut Chem, San Francisco, CA USA; [Segal, Mark R.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ballard, PL (corresponding author), Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94110 USA.	Phil.ballard@ucsf.edu			NIH National Heart Lung Blood Institute [R21HL129910]; Department of Pediatrics University of California, San Francisco; National Institute of General Medical Sciences [P41 GM103481]	NIH National Heart Lung Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Department of Pediatrics University of California, San Francisco; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by grants from the NIH National Heart Lung Blood Institute R21HL129910 (PLB) and the Department of Pediatrics University of California, San Francisco (PLB). ALB is director of the Bio-Organic Biomedical Mass Spectrometry Resource at UCSF, which is supported by the National Institute of General Medical Sciences (P41 GM103481). Ikaria Inc. (now part of Mallinckrodt Pharmaceuticals https://www.mallinckrodt.ca/)Biotech) and ONY Inc. (https://www.onybiotech.com/) provided drug for the conduct of the parent TOLSURF trial, but neither company had input into study design, data analysis, data interpretation, decision to publish or manuscript preparation. No authors received salary support from either commercial company.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Askie LM, 2018, J PEDIATR-US, V193, P34, DOI 10.1016/j.jpeds.2017.10.004; Ballard PL, 2019, PEDIATR RES, V85, P305, DOI 10.1038/s41390-018-0144-3; Ballard PL, 2010, AM J PHYSIOL-LUNG C, V299, pL36, DOI 10.1152/ajplung.00427.2009; Ballard RA, 2006, NEW ENGL J MED, V355, P343, DOI 10.1056/NEJMoa061088; Ballard RA, 2016, J PEDIATR-US, V168, P23, DOI 10.1016/j.jpeds.2015.09.031; Barrette AM, 2016, AM J RESP CELL MOL, V55, P623, DOI 10.1165/rcmb.2016-0068OC; Bhandari A, 2013, PAEDIATR RESPIR REV, V14, P173, DOI 10.1016/j.prrv.2013.02.008; Bhargava M, 2016, BIOL BLOOD MARROW TR, V22, P1383, DOI 10.1016/j.bbmt.2016.04.021; Bhargava M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109713; Chishimba L, 2010, THORAX, V65, P456, DOI 10.1136/thx.2009.128793; Clauser KR, 1999, ANAL CHEM, V71, P2871, DOI 10.1021/ac9810516; Collard Keith James, 2014, World J Clin Pediatr, V3, P19, DOI 10.5409/wjcp.v3.i3.19; Davis JM, 2003, PEDIATRICS, V111, P469, DOI 10.1542/peds.111.3.469; Foster MW, 2015, J PROTEOME RES, V14, P1238, DOI 10.1021/pr501149m; Gibson AM, 2015, PEDIATR PULM, V50, P987, DOI 10.1002/ppul.23093; Gonzales LW, 2002, AM J PHYSIOL-LUNG C, V283, pL940, DOI 10.1152/ajplung.00127.2002; Greenough A, 2013, J PERINAT MED, V41, P119, DOI 10.1515/jpm-2012-0084; Guan SH, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010728; HOLTER JF, 1986, J CLIN INVEST, V78, P1513, DOI 10.1172/JCI112743; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Keller RL, 2017, J PEDIATR-US, V183, P19, DOI 10.1016/j.jpeds.2016.12.059; Lei C, 2018, AM J RESP CRIT CARE, V198, P1279, DOI [10.1164/rccm.201710-2150OC, 10.1164/rccm.201708-1713RR]; Lykkedegn S, 2015, AM J PHYSIOL-LUNG C, V308, pL587, DOI 10.1152/ajplung.00117.2014; Magagnotti C, 2013, J PROTEOMICS, V94, P401, DOI 10.1016/j.jprot.2013.10.007; Malik S, 2013, CRIT REV CL LAB SCI, V50, P1, DOI 10.3109/10408363.2012.750262; Martinez-Bravo MJ, 2017, J ALLERGY CLIN IMMUN, V139, P1186, DOI 10.1016/j.jaci.2016.05.051; Nguyen EV, 2014, AM J PHYSIOL-LUNG C, V306, pL35, DOI 10.1152/ajplung.00140.2013; Nguyen EV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058782; Olmeda B, 2014, J PROTEOMICS, V101, P179, DOI 10.1016/j.jprot.2014.02.019; Pehlevan OS, 2015, J PERINATOL, V35, P763, DOI 10.1038/jp.2015.58; Pereira-Fantini PM, 2019, AM J RESP CELL MOL, V61, P631, DOI 10.1165/rcmb.2019-0084OC; Pereira-Fantini PM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30868-x; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Powe CE, 2013, NEW ENGL J MED, V369, P1991, DOI 10.1056/NEJMoa1306357; Schaer DJ, 2013, BLOOD, V121, P1276, DOI 10.1182/blood-2012-11-451229; Shaver CM, 2016, AM J PHYSIOL-LUNG C, V310, pL532, DOI 10.1152/ajplung.00155.2015; Steinhorn RH, 2011, FREE RADICAL BIO MED, V51, P1027, DOI 10.1016/j.freeradbiomed.2011.01.006; Suski M, 2018, J PERINATOL, V38, P1182, DOI 10.1038/s41372-018-0150-7; Wade KC, 2006, AM J RESP CELL MOL, V34, P727, DOI 10.1165/rcmb.2004-0389OC; Yang MX, 2018, RESP RES, V19, DOI 10.1186/s12931-017-0695-6	41	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243168	10.1371/journal.pone.0243168	http://dx.doi.org/10.1371/journal.pone.0243168			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301538	gold, Green Published			2022-12-27	WOS:000600143100051
J	Parraga, DG; Tyack, PL; Marco-Cabedo, V; Crespo-Picazo, JL; Manteca, X; Marti-Bonmati, L				Garcia Parraga, Daniel; Tyack, Peter L.; Marco-Cabedo, Vicente; Luis Crespo-Picazo, Jose; Manteca, Xavier; Marti-Bonmati, Luis			Effects of 3 Tesla magnetic resonance imaging exposure on the behavior and orientation of homing pigeons Columba livia domestica	PLOS ONE			English	Article							MAGNETORECEPTION; COMPASS	Homing pigeons (Columba livia domestica) were used to test whether clinical magnetic resonance (MR) imaging disrupts orientation of animals that sense the earth's magnetic field. Thirty young pigeons were randomly separated into three groups (n = 10/group). Two groups were anaesthetized and exposed to either a constant (no sequence) or a varying (gradient echo and echo planar sequences) magnetic field within a 3 Tesla MR unit for 15 minutes. The control group was not exposed to the MR field but shared all other aspects of the procedure. One day later, animals were released from a site they had never visited, 15 km from the home loft. Three weeks after the procedure, animals were released from a different unfamiliar site 30 km from the loft. Measured variables included the time to disappear from sight (seconds), vanishing bearing (angle), and the time interval from release to entering the home loft (hours). On first release, the group exposed to varying field gradients during image acquisition using 2 different standard sequences showed more variability in the vanishing bearing compared to the other groups (p = 0.0003 compared to control group), suggesting interference with orientation. Other measures did not show significant differences between groups. On second release, there were no significant differences between groups. Our results on homing pigeons show that regular clinical MR imaging exposure may temporarily affect the orientation of species that have magnetoreception capabilities. If exposure to MR imaging disrupted processes that are not specific to magnetoreception, then it may affect other species and other capabilities as well.	[Garcia Parraga, Daniel; Marco-Cabedo, Vicente; Luis Crespo-Picazo, Jose] Fdn Oceanog Comunidad Valenciana, Res Dept, Valencia, Spain; [Garcia Parraga, Daniel] Avanqua Oceanog SL, Biol Dept, Valencia, Spain; [Tyack, Peter L.] Univ St Andrews, Scottish Oceans Inst, Sch Biol, Sea Mammal Res Unit, St Andrews, Fife, Scotland; [Manteca, Xavier] Univ Autonoma Barcelona, Sch Vet Sci, Barcelona, Spain; [Marti-Bonmati, Luis] La Fe Univ, Med Imaging Dept, Valencia, Spain; [Marti-Bonmati, Luis] La Fe Univ, Biomed Imaging Res Grp, Valencia, Spain; [Marti-Bonmati, Luis] Polytech Hosp & Hlth Res Inst, Valencia, Spain	University of St Andrews; Autonomous University of Barcelona	Tyack, PL (corresponding author), Univ St Andrews, Scottish Oceans Inst, Sch Biol, Sea Mammal Res Unit, St Andrews, Fife, Scotland.	plt@st-andrews.ac.uk	Marti-Bonmati, Luis/A-1147-2015; Tyack, Peter/D-6209-2013	Marti-Bonmati, Luis/0000-0002-8234-010X; Crespo Picazo, Jose Luis/0000-0002-5216-044X; Tyack, Peter/0000-0002-8409-4790	US Office of Naval Research [N00014-18-1-2062, N00014-20-12709]; Fundacion Oceanografic de la Comunidad Valenciana	US Office of Naval Research(Office of Naval Research); Fundacion Oceanografic de la Comunidad Valenciana	PLT was funded by the US Office of Naval Research (https://www.onr.navy.mil) Grant Number N00014-18-1-2062 and N00014-20-12709. The employees of the Fundacion Oceanografic de la Comunidad Valenciana were funded by the Fundacion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2001, J CARDIOVASC MAGN R, V3, P171, DOI 10.1081/JCMR-100107466; [Anonymous], 2007, PLOS ONE, V2, pe779; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Chakeres DW, 2005, PROG BIOPHYS MOL BIO, V87, P255, DOI 10.1016/j.pbiomolbio.2004.08.012; de Vocht F, 2006, J MAGN RESON IMAGING, V23, P197, DOI 10.1002/jmri.20485; DUNN OJ, 1964, TECHNOMETRICS, V6, P241, DOI 10.2307/1266041; GOULD JL, 1984, ANNU REV PHYSIOL, V46, P585, DOI 10.1146/annurev.ph.46.030184.003101; Lohmann KJ, 2008, J EXP MAR BIOL ECOL, V356, P83, DOI 10.1016/j.jembe.2007.12.017; Marhold S, 1997, NATURWISSENSCHAFTEN, V84, P421, DOI 10.1007/s001140050422; Meyer CG, 2005, J R SOC INTERFACE, V2, P129, DOI 10.1098/rsif.2004.0021; Modo M, 2011, METHODS MOL BIOL; Pewsey A, 2013, CIRCULAR STAT R; Steinmetz HW, 2014, ZOO WILD ANIMAL MED, P661; Strbak O, 2011, MEAS SCI REV, V11, P85, DOI 10.2478/v10048-011-0014-1; Tsuji Y, 1996, IND HEALTH, V34, P347, DOI 10.2486/indhealth.34.347; Vacha M, 2009, J EXP BIOL, V212, P3473, DOI 10.1242/jeb.028670; Valente ALS, 2006, AM J VET RES, V67, P1347, DOI 10.2460/ajvr.67.8.1347; WALLRAFF HG, 1979, BEHAV ECOL SOCIOBIOL, V5, P201, DOI 10.1007/BF00293306; Wallraff HG., 2005, AVIAN NAVIGATION PIG; Wiltschko R, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1103; Wiltschko W, 2005, J COMP PHYSIOL A, V191, P675, DOI 10.1007/s00359-005-0627-7; Wiltschko W, 2017, J AVIAN BIOL, V48, P66, DOI 10.1111/jav.01270; Wyneken J, 2013, CURRENT THERAPY REPT, P93	24	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0241280	10.1371/journal.pone.0241280	http://dx.doi.org/10.1371/journal.pone.0241280			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8CZ	33338040	gold, Green Published			2022-12-27	WOS:000601313500027
J	Kodan, LR; Verschueren, KJC; Prust, ZD; Zuithoff, NPA; Rijken, MJ; Browne, JL; Klipstein-Grobusch, K; Bloemenkamp, KWM; Grunberg, AW				Kodan, Lachmi R.; Verschueren, Kim J. C.; Prust, Zita D.; Zuithoff, Nicolaas P. A.; Rijken, Marcus J.; Browne, Joyce L.; Klipstein-Grobusch, Kerstin; Bloemenkamp, Kitty W. M.; Grunberg, Antoon W.			Postpartum hemorrhage in Suriname: A national descriptive study of hospital births and an audit of case management	PLOS ONE			English	Article							ORGANIZATION MULTICOUNTRY SURVEY; RISK-FACTORS; EPIDEMIOLOGY; MORTALITY	Background Postpartum hemorrhage (PPH) is the leading cause of direct maternal mortality globally and in Suriname. We aimed to study the prevalence, risk indicators, causes, and management of PPH to identify opportunities for PPH reduction. Methods A nationwide retrospective descriptive study of all hospital deliveries in Suriname in 2017 was performed. Logistic regression analysis was applied to identify risk indicators for PPH (>= 500ml blood loss). Management of severe PPH (blood loss >= 1,000ml or >= 500ml with hypotension or at least three transfusions) was evaluated via a criteria-based audit using the national guideline. Results In 2017, the prevalence of PPH and severe PPH in Suriname was 9.2% (n = 808/8,747) and 2.5% (n = 220/8,747), respectively. PPH varied from 5.8% to 15.8% across the hospitals. Risk indicators associated with severe PPH included being of African descent (Maroon aOR 2.1[95%CI 1.3-3.3], Creole aOR 1.8[95%CI 1.1-3.0]), multiple pregnancy (aOR 3.4[95%CI 1.7-7.1]), delivery in Hospital D (aOR 2.4[95%CI 1.7-3.4]), cesarean section (aOR 3.9[95%CI 2.9-5.3]), stillbirth (aOR 6.4 [95%CI 3.4-12.2]), preterm birth (aOR 2.1[95%CI 1.3-3.2]), and macrosomia (aOR 2.8 [95%CI 1.5-5.0]). Uterine atony (56.7%, n = 102/180[missing 40]) and retained placenta (19.4%, n = 35/180[missing 40]), were the main causes of severe PPH. A criteria-based audit revealed that women with severe PPH received prophylactic oxytocin in 61.3% (n = 95/155[missing 65]), oxytocin treatment in 68.8% (n = 106/154[missing 66]), and tranexamic acid in 4.9% (n = 5/103[missing 117]). Conclusions PPH prevalence and risk indicators in Suriname were similar to international and regional reports. Inconsistent blood loss measurement, varied maternal and perinatal characteristics, and variable guideline adherence contributed to interhospital prevalence variation. PPH reduction in Suriname can be achieved through prevention by practicing active management of the third stage of labor in every birth and considering risk factors, early recognition by objective and consistent blood loss measurement, and prompt treatment by adequate administration of oxytocin and tranexamic acid according to national guidelines.	[Kodan, Lachmi R.] Acad Hosp Paramaribo, Dept Obstet & Gynecol, Paramaribo, Suriname, Suriname; [Kodan, Lachmi R.; Verschueren, Kim J. C.; Prust, Zita D.; Rijken, Marcus J.; Bloemenkamp, Kitty W. M.] Univ Utrecht, Univ Med Ctr Utrecht, Birth Ctr Wilhelminas Children Hosp, Div Women & Baby,Dept Obstet, Utrecht, Netherlands; [Zuithoff, Nicolaas P. A.; Rijken, Marcus J.; Browne, Joyce L.; Klipstein-Grobusch, Kerstin] Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Julius Global Hlth, Utrecht, Netherlands; [Klipstein-Grobusch, Kerstin] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Div Epidemiol & Biostat, Johannesburg, South Africa; [Grunberg, Antoon W.] Anton Kom Univ, Board Doctoral Graduat & Honorary Doctorate Award, Paramaribo, Suriname, Suriname	Anton de Kom Universiteit van Suriname; Academisch Ziekenhuis Paramaribo; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Witwatersrand; Anton de Kom Universiteit van Suriname	Kodan, LR (corresponding author), Acad Hosp Paramaribo, Dept Obstet & Gynecol, Paramaribo, Suriname, Suriname.; Kodan, LR (corresponding author), Univ Utrecht, Univ Med Ctr Utrecht, Birth Ctr Wilhelminas Children Hosp, Div Women & Baby,Dept Obstet, Utrecht, Netherlands.	lachmikodan@yahoo.com	Klipstein-Grobusch, Kerstin/F-5555-2016	Klipstein-Grobusch, Kerstin/0000-0002-5462-9889; Verschueren, Kim J.C./0000-0003-1170-6132; kodan, lachmi/0000-0003-2129-9796				Althabe F, 2020, INT J GYNECOL OBSTET, V148, P290, DOI 10.1002/ijgo.13028; [Anonymous], 2020, NAT METHODS, V17, P1, DOI 10.1038/s41592-019-0703-5; [Anonymous], 2012, WHO TECH REP SER; [Anonymous], 2020, CANC DISCOV, V10, pOF8; [Anonymous], 2013, FOCUS CATALYSTS, P2, DOI DOI 10.1016/51351-4180(13)70266-6; Bateman BT, 2010, ANESTH ANALG, V110, P1368, DOI 10.1213/ANE.0b013e3181d74898; Begley CM, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007412.pub3; Bingham D., 2010, CMQCC OBSTETRIC HEMO; Bryant A, 2012, ANESTH ANALG, V115, P1127, DOI 10.1213/ANE.0b013e3182691e62; Calvert C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041114; Carroli G, 2008, BEST PRACT RES CL OB, V22, P999, DOI 10.1016/j.bpobgyn.2008.08.004; Chaves SD, 2015, REV PANAM SALUD PUBL, V37, P203; Gyamfi-Bannerman C, 2018, AM J OBSTET GYNECOL, V219, DOI 10.1016/j.ajog.2018.04.052; Harvey Scott A, 2017, Hawaii J Med Public Health, V76, P128; Knight M, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-55; Kodan LR, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1466-6; Miller S, 2016, LANCET, V388, P2176, DOI 10.1016/S0140-6736(16)31472-6; Ministry of Social Affairs and Public Housing, 2019, SUR MULT IND CLUST S; Natrella M, 2018, J MATERN-FETAL NEO M, V31, P106, DOI 10.1080/14767058.2016.1274302; Novikova N, 2015, COCHRANE REV, P64; Obstetrics in Suriname, OBST SUR; Ononge S, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0154-8; Osanan GC, 2018, REV BRAS GINECOL OBS, V40, P103, DOI 10.1055/s-0038-1639587; PAHO, 2010, LAT AM CTR PER WOM R; Pan American Health Organization, HLTH AM SUR; Prata N, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-97; Prick BW, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0473-8; Rath WH, 2011, ACTA OBSTET GYN SCAN, V90, P421, DOI 10.1111/j.1600-0412.2011.01107.x; Rulisa S, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0619-8; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Sebghati M, 2017, WOMENS HEALTH, V13, P34, DOI 10.1177/1745505717716860; Shakur H, 2017, LANCET, V389, P2105, DOI 10.1016/S0140-6736(17)30638-4; Sheldon WR, 2014, BJOG-INT J OBSTET GY, V121, P5, DOI 10.1111/1471-0528.12636; Sosa CG, 2009, OBSTET GYNECOL, V113, P1313, DOI 10.1097/AOG.0b013e3181a66b05; van Stralen G, 2016, ACTA OBSTET GYN SCAN, V95, P1104, DOI 10.1111/aogs.12950; Verschueren KJC, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4377-6; Verschueren KJC, 2020, GLOB HLTH ACTION, P1794105, DOI [10.1080/16549716.2020.1794105, DOI 10.1080/16549716.2020.179410532777997]; von Elm E, 2014, INT J SURG, V12, P1495, DOI 10.1016/j.ijsu.2014.07.013; Watkins EJ, 2020, JAAPA-J AM ACAD PHYS, V33, P29, DOI 10.1097/01.JAA.0000657164.11635.93; WHO, 2017, REC TRAN AC TREATM P	40	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0244087	10.1371/journal.pone.0244087	http://dx.doi.org/10.1371/journal.pone.0244087			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8CZ	33338049	Green Published, gold			2022-12-27	WOS:000601313500009
J	Friedrich, MS; Studt, JD; Braun, J; Spahn, DR; Kaserer, A				Friedrich, Marie Sophie; Studt, Jan-Dirk; Braun, Julia; Spahn, Donat R.; Kaserer, Alexander			Coronavirus-induced coagulopathy during the course of disease	PLOS ONE			English	Article							FIBRINOGEN	Background A significant proportion of patients with coronavirus disease 19 (COVID-19) suffer from excessive coagulation activation and coagulopathy which is associated with an increased risk of venous and arterial thromboembolism and adverse outcome. Our study investigates coagulation markers and the incidence of thromboembolic events in COVID-19 patients receiving recommended anticoagulation strategies. Methods In a retrospective single-center analysis at the University Hospital Zurich, Switzerland, we investigated 31 adult COVID-19 patients between April 6(th) and May 13(th), 2020 and with at least one laboratory assessment of the coagulation markers prothrombin time/Quick, thrombin time, fibrinogen and D-dimers. For antithrombotic prophylaxis low-molecular-weight-heparin or unfractionated heparin was administered and two patients with heparin-induced thrombocytopenia received argatroban. Results We analyzed 31 patients (68% male, mean age 60 +/- SD 15 years). 22 (71%) of these required intensive care unit treatment, 5 (16%) were hospitalized in a ward, and 4 (13%) were outpatients. Mean fibrinogen levels were markedly elevated to 6.4 +/- SD 1.8g/l, with a peak in the third week of the disease and no significant decrease over time. D-dimers were elevated to a mean value of 5.1 +/- 4.4mg/l with peak levels of 6.8 +/- 5.3mg/l in the fourth week of disease, and a subsequent decrease. Platelet count (308 +/- 136G/l) and PT/Quick (85 +/- 22%) showed no significant changes over time. Sensitivity analyses for patients treated in the ICU showed that D-dimer levels were higher in this group. The results of other sensitivity analyses were comparable. Thromboembolic events were diagnosed in 4 (13%) patients and 5 (16%) patients died during the observation period. Conclusion We find coagulation alterations in COVID-19 patients indicating significant hypercoagulability. These alterations are visible despite antithrombotic treatment, and peak around week 3-4 of the disease.	[Friedrich, Marie Sophie; Spahn, Donat R.; Kaserer, Alexander] Univ Zurich, Inst Anesthesiol, Zurich, Switzerland; [Friedrich, Marie Sophie; Studt, Jan-Dirk; Spahn, Donat R.; Kaserer, Alexander] Univ Hosp Zurich, Zurich, Switzerland; [Studt, Jan-Dirk] Univ Zurich, Div Med Oncol & Hematol, Zurich, Switzerland; [Braun, Julia] Univ Zurich, Biostat & Prevent Inst, Dept Epidemiol & Biostat, Zurich, Switzerland; [Braun, Julia] Univ Zurich, Biostat & Prevent Inst, Dept Epidemiol, Zurich, Switzerland	University of Zurich; University of Zurich; University Zurich Hospital; University of Zurich; University of Zurich; University of Zurich	Kaserer, A (corresponding author), Univ Zurich, Inst Anesthesiol, Zurich, Switzerland.; Kaserer, A (corresponding author), Univ Hosp Zurich, Zurich, Switzerland.	alexander.kaserer@usz.ch		Kaserer, Alexander/0000-0001-9105-8328				Al-Samkari H, 2020, BLOOD, V136, P489, DOI 10.1182/blood.2020006520; Atallah B, 2021, ANAESTHESIA, V76, P327, DOI 10.1111/anae.15300; BAUMANN H, 1990, MOL BIOL MED, V7, P147; Casini Alessandro, 2020, Swiss Med Wkly, V150, pw20247, DOI 10.4414/smw.2020.20247; Connors JM, 2020, BLOOD, V135, P2033, DOI 10.1182/blood.2020006000; Franchini M, 2020, DIAGNOSIS, V7, P357, DOI 10.1515/dx-2020-0078; Gesellschaft fur Thrombose und Hamostaseforschung, AKT EMPF ZUR THROMB; Han H, 2020, CLIN CHEM LAB MED, V58, P1116, DOI 10.1515/cclm-2020-0188; HEINRICH PC, 1990, BIOCHEM J, V265, P621, DOI 10.1042/bj2650621; Helms J, 2020, INTENS CARE MED, V46, P1089, DOI 10.1007/s00134-020-06062-x; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Iba T, 2020, J THROMB HAEMOST, V18, P2103, DOI 10.1111/jth.14975; Ikewaki N, 2020, THROMB J, V18, DOI 10.1186/s12959-020-00239-6; Kattula S, 2017, ARTERIOSCL THROM VAS, V37, pE13, DOI 10.1161/ATVBAHA.117.308564; Klok FA, 2020, THROMB RES, V191, P145, DOI [10.1016/j.thromres.2020.04.041, 10.1016/j.thromres.2020.04.013]; Liao S, 2014, J THROMB HAEMOST, V12, P214, DOI 10.1111/jth.12464; Lodigiani C, 2020, THROMB RES, V191, P9, DOI 10.1016/j.thromres.2020.04.024; Maatman TK, 2020, CRIT CARE MED, V48, pE783, DOI 10.1097/CCM.0000000000004466; Machlus KR, 2011, BLOOD, V117, P4953, DOI 10.1182/blood-2010-11-316885; Poterucha TJ, 2017, THROMB HAEMOSTASIS, V117, P437, DOI 10.1160/TH16-08-0620; Ranucci M, 2020, J THROMB HAEMOST, V18, P1747, DOI 10.1111/jth.14854; Shukla D, 2001, J CLIN INVEST, V108, P503, DOI 10.1172/JCI13799; Susen S, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03000-7; Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768; Thachil J, 2020, J THROMB HAEMOST, V18, P1849, DOI 10.1111/jth.14942; Thachil J, 2020, J THROMB HAEMOST, V18, P1795, DOI 10.1111/jth.14841; Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5; Walton BL, 2015, J THROMB HAEMOST, V13, pS208, DOI 10.1111/jth.12918; Wichmann D, 2020, ANN INTERN MED, V173, P268, DOI 10.7326/M20-2003; Wool GD, 2021, PATHOBIOLOGY, V88, P15, DOI 10.1159/000512007; Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994; Zhang LT, 2020, J THROMB HAEMOST, V18, P1324, DOI 10.1111/jth.14859; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	33	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243409	10.1371/journal.pone.0243409	http://dx.doi.org/10.1371/journal.pone.0243409			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332362	Green Accepted, Green Published, gold			2022-12-27	WOS:000601310900061
J	Yu, HL; Gu, DY; Qian, PD				Yu, Hongliang; Gu, Dayong; Qian, Pudong			Prognostic value of ESR2 expression on adjuvant chemotherapy in completely resected NSCLC	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-BETA; CELL LUNG-CANCER; VINORELBINE PLUS CISPLATIN; MESSENGER-RNA EXPRESSION; SURVIVAL; IDENTIFICATION; ASSOCIATION; SIGNATURES; GENES	Background Prognostic biomarker, which can inform the treatment outcome of adjuvant chemotherapy (ACT) after complete resection of early-stage non-small cell lung cancer (NSCLC), is urgently needed for the personalized treatment of these patients. Patients and methods The prognostic value of gene expression of the estrogen receptor (ER) on the effect of ACT in completely resected NSCLC was investigated in the present study. Two independent datasets from Gene Expression Omnibus (GEO) with a total of 309 patients were included in this study. The prognostic value of ER gene expression on ACT's efficacy was evaluated by survival analysis and Cox hazards models. Results We found a consistent and significant prognostic value of ER beta (ESR2) expression for ACT's efficacy in completely resected NSCLC in both of the two independent cohorts. After multivariate adjustment, a significant survival benefit of ACT was observed in patients with low expression of ESR2, with a hazard ratio (HR) of 0.19 (95%CI 0.05-0.82, p = 0.026) in the discovery cohort and an HR of 0.27 (95%CI 0.10-0.76, p = 0.012) in the validation group. No significant benefit of ACT in the subgroup of patients with high expression of ESR2 was observed, with an HR of 0.80 (95%CI 0.31-2.09, p = 0.644) in the discovery cohort and an HR of 1.05 (95%CI 0.48-2.29, p = 0.896) in the validation group. Conclusion A significant survival benefit from ACT was observed in patients with low ESR2 expression. No significant survival benefit was observed in patients with high ESR2 expression. Detection of ESR2 expression in NSCLC may help personalize its treatment after complete resection.	[Qian, Pudong] Nanjing Med Univ, Dept Radiat Oncol, Jiangsu Canc Hosp, Nanjing, Jiangsu, Peoples R China; Nanjing Med Univ, Jiangsu Inst Canc Res, Nanjing, Jiangsu, Peoples R China; Nanjing Med Univ, Affiliated Canc Hosp, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Qian, PD (corresponding author), Nanjing Med Univ, Dept Radiat Oncol, Jiangsu Canc Hosp, Nanjing, Jiangsu, Peoples R China.	qpd201210@163.com	Qian, Pu/GZM-2400-2022	Yu, Hongliang/0000-0003-2404-4158	fund of key project of Jiangsu Cancer Hospital [ZK201607]; Natural Science Foundation of China [81701722]	fund of key project of Jiangsu Cancer Hospital; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was partially supported by the fund of key project of Jiangsu Cancer Hospital (No. ZK201607), and the Natural Science Foundation of China (No.81701722).	Atmaca A, 2014, INT J CANCER, V134, P2314, DOI 10.1002/ijc.28571; Douillard JY, 2006, LANCET ONCOL, V7, P719, DOI 10.1016/S1470-2045(06)70804-X; Ee PLR, 2004, CANCER RES, V64, P1247, DOI 10.1158/0008-5472.CAN-03-3583; Fan S, 2017, ONCOTARGET, V8, P56443, DOI 10.18632/oncotarget.16992; Le Chevalier T, 2004, NEW ENGL J MED, V350, P351, DOI 10.1056/nejmoa031644; Lee ES, 2008, CLIN CANCER RES, V14, P7397, DOI 10.1158/1078-0432.CCR-07-4937; Li WT, 2015, STEROIDS, V104, P129, DOI 10.1016/j.steroids.2015.09.005; Liu ZG, 2013, ENDOCRINE, V44, P517, DOI 10.1007/s12020-013-9916-z; Luo Z, 2015, INT J CLIN EXP MED, V8, P8686; Nose N, 2009, J CLIN ONCOL, V27, P411, DOI 10.1200/JCO.2008.18.3251; Pignon JP, 2008, J CLIN ONCOL, V26, P3552, DOI 10.1200/JCO.2007.13.9030; Raponi M, 2006, CANCER RES, V66, P7466, DOI 10.1158/0008-5472.CAN-06-1191; Sainz J, 2011, ENDOCR-RELAT CANCER, V18, P265, DOI 10.1530/ERC-10-0264; Schwartz AG, 2005, CLIN CANCER RES, V11, P7280, DOI 10.1158/1078-0432.CCR-05-0498; Siegfried JM, 2009, SEMIN ONCOL, V36, P524, DOI 10.1053/j.seminoncol.2009.10.004; Smida T, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00137; Stabile LP, 2011, CLIN CANCER RES, V17, P154, DOI 10.1158/1078-0432.CCR-10-0992; Stabile LP, 2002, CANCER RES, V62, P2141; Strauss GM, 2008, J CLIN ONCOL, V26, P5043, DOI 10.1200/JCO.2008.16.4855; Tang H, 2013, CLIN CANCER RES, V19, P1577, DOI 10.1158/1078-0432.CCR-12-2321; Verma MK, 2012, LIFE SCI, V91, P800, DOI 10.1016/j.lfs.2012.08.029; Winton T, 2005, NEW ENGL J MED, V352, P2589, DOI 10.1056/NEJMoa043623; Wu CT, 2005, J THORAC CARDIOV SUR, V130, P979, DOI 10.1016/j.jtcvs.2005.06.012; Yu HL, 2017, ONCOTARGETS THER, V10, P3017, DOI 10.2147/OTT.S132071; Zhang GF, 2010, MOL ENDOCRINOL, V24, P1737, DOI 10.1210/me.2010-0125; Zhao GF, 2012, MOL ENDOCRINOL, V26, P1304, DOI 10.1210/me.2012-1028; Zhu CQ, 2010, J CLIN ONCOL, V28, P4417, DOI 10.1200/JCO.2009.26.4325; Zhu CQ, 2009, CLIN LUNG CANCER, V10, P331, DOI 10.3816/CLC.2009.n.045	28	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243891	10.1371/journal.pone.0243891	http://dx.doi.org/10.1371/journal.pone.0243891			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332474	Green Published, gold			2022-12-27	WOS:000601310900054
J	Chibi, B; Yende-Zuma, N; Mashamba-Thompson, TP				Chibi, Buyisile; Yende-Zuma, Nonhlanhla; Mashamba-Thompson, Tivani P.			Prevalence and correlates of prescription drug diversion and misuse among people living with HIV in the eThekwini district, KwaZulu-Natal, South Africa	PLOS ONE			English	Article							COMMUNITY-BASED COHORT; POSITIVE SUBSTANCE-ABUSERS; OPIOID ANALGESIC MISUSE; MEDICATION ADHERENCE; USE HISTORY; POPULATIONS; DEPENDENCE; BEHAVIORS; MODEL; PAIN	Background Prescription drug diversion, and misuse has increased over the past decade and is notably in high-income-countries and significantly contributes to the opioid epidemic. People living with HIV (PLWH) are particularly vulnerable to prescription drug diversion, and misuse as most experience chronic pain, mental health problems and HIV-related illnesses. The researchers investigated the prevalence and correlates of prescription drug diversion, and misuse among PLWH in the eThekwini district, KwaZulu-Natal. Methods A cross-sectional study was conducted among 392 PLWH, conveniently recruited from the public healthcare facilities located in rural, semi-urban and urban areas of the eThekwini district. Participants answered questions about their background, prescription medications, substance use, and prescription drug diversion, and misuse. Descriptive analysis was performed to estimate the prevalence of prescription drug diversion, and misuse. Multivariable logistic regression was used to identify predictors of prescription drug diversion, and misuse. Findings Overall, 13% of the participants reported lifetime prescription drug diversion. The most common type of diversion was using prescription medication not prescribed by a healthcare provider (11%), followed by sharing of prescription medication (9%) and buying prescription medication without a medical script (5%). Twenty-three per cent of the participants reported prescription drug misuse in the past 90 days, with using prescription medication without a healthcare providers' guidance (9%) and not following the scheduled time periods (8%) being the most common reported types of misuse. Self-medicating was identified as a risk factor for prescription drug misuse. There was no association between ART adherence and prescription drug diversion, and misuse. Conclusion The study findings contribute to improving the limited data available on prescription drug diversion, and misuse among PLWH in South Africa. The prevalence underscores a need for urgent interventions when prescribing medications with potential risks. Addressing the risk of self-medicating is imperative for HIV care outcomes and to avert death.	[Chibi, Buyisile; Mashamba-Thompson, Tivani P.] Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Discipline Publ Hlth Med, Durban, South Africa; [Chibi, Buyisile; Yende-Zuma, Nonhlanhla] Doris Duke Med Res Inst, Ctr AIDS Programme Res South Africa, Durban, South Africa; [Mashamba-Thompson, Tivani P.] Univ Limpopo, Dept Publ Hlth, Fac Hlth Sci, Mankweng, Limpopo Provinc, South Africa	University of Kwazulu Natal; University of Limpopo	Chibi, B (corresponding author), Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Discipline Publ Hlth Med, Durban, South Africa.; Chibi, B (corresponding author), Doris Duke Med Res Inst, Ctr AIDS Programme Res South Africa, Durban, South Africa.	chibuyi@gmail.com	Mashamba-Thompson, Tivani/GRO-3709-2022	Mashamba-Thompson, Tivani/0000-0002-4193-2416; Chibi, Buyisile/0000-0003-1912-8402	Buyisile Chibi Grant [107620]; National Research Foundation Buyisile Chibi Grant	Buyisile Chibi Grant; National Research Foundation Buyisile Chibi Grant	Buyisile Chibi Grant no. 107620 National Research Foundation Buyisile Chibi Grant no. N/A University of KwaZulu-Natal, College of Health Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdool Karim SS, 2015, OVERCOMING IMPEDIMEN; [Anonymous], 2018, BRIEF REPORTS REV, V13, P12, DOI [10.1142/S1793292018500704, DOI 10.1142/S17932920185007041850070]; Assembly UN General, 2016, POL DECL HIV AIDS FA; Bulbul F, 2014, KLIN PSIKOFARMAKOL B, V24, P135, DOI 10.5455/bcp.20130925022443; Casati A, 2012, EUR ADDICT RES, V18, P228, DOI 10.1159/000337028; Centers for Disease Control and Prevention (CDC), 2012, MMWR MORB MORTAL WKL, V61, P10; Chibi B, 2019, PUBLIC HEALTH, V177, P26, DOI 10.1016/j.puhe.2019.07.017; Chibi B, 2020, INT J EVID-BASED HEA, V18, P5, DOI 10.1097/XEB.0000000000000167; Council HSR, 2018, 5 S AFR NAT HIV PREV; Dada S, 2015, SAMJ, S. Afr. med. j., V105, P776, DOI [10.7196/SAMJNEW.8172, 10.7196/SAMJnew.8172]; Daniel W. W., 2009, BIOSTATISTICS FDN AN; Deeks A, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-213; Deiss R, 2018, OPEN FORUM INFECT DI, P5; Ruiz ME, 2010, CURR DRUG SAF, V5, P315, DOI 10.2174/157488610792245966; Flores J, 2018, AIDS BEHAV, V22, P1323, DOI 10.1007/s10461-017-1842-2; Foley M, 2018, SAJP-S AFR J PSYCHI, V24, DOI 10.4102/sajpsychiatry.v24.i0.1162; Ford J, 2017, SUBST USE MISUSE, V52, P1772, DOI 10.1080/10826084.2017.1311348; Gelberg L, 2000, HEALTH SERV RES, V34, P1273; Genberg BL, 2013, ADDICT BEHAV, V38, P2868, DOI 10.1016/j.addbeh.2013.08.008; Gumede-Moyo S, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008055; Haddad M, 2017, J PUBLIC HEALTH RES, V6, P24, DOI 10.4081/jphr.2017.818; Hansen L, 2011, J PAIN SYMPTOM MANAG, V42, P893, DOI 10.1016/j.jpainsymman.2011.02.026; Inciardi JA, 2006, SUBST USE MISUSE, V41, P255, DOI 10.1080/10826080500391829; Inciardi JA, 2007, PAIN MED, V8, P171, DOI 10.1111/j.1526-4637.2006.00255.x; Jeevanjee S, 2014, AIDS BEHAV, V18, P1352, DOI 10.1007/s10461-013-0619-5; Kamangar F, 2012, ARCH IRAN MED, V15, P508, DOI 012158/AIM.0014; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Kurtz SP, 2014, AIDS CARE, V26, P411, DOI 10.1080/09540121.2013.837139; National Department of Health (NDoH) SSASS South African Medical Research Council (SAMRC) and ICF, 2019, S AFR DEM HLTH SURV; Newville H, 2015, J SUBST ABUSE TREAT, V48, P56, DOI 10.1016/j.jsat.2014.07.013; NIDA, 2020, GLOSSARY; OGRADY CL, 2014, DRUG ALCOHOL DEPEN, V140, pE164; Okie S, 2010, NEW ENGL J MED, V363, P1981, DOI 10.1056/NEJMp1011512; Parry CDH, 2017, SAMJ S AFR MED J, V107, P451, DOI [10.7196/SAMJ.2017.v107i5.12242, 10.7196/samj.2017.v107i5.12242]; Paulozzi Leonard J., 2011, Morbidity and Mortality Weekly Report, V60, P1487; Peng DD, 2018, GLOBAL HEALTH ACTION, V11, DOI 10.1080/16549716.2018.1496973; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Robinson-Papp J, 2012, JAIDS-J ACQ IMM DEF, V61, P187, DOI 10.1097/QAI.0b013e3182683c98; Rough K, 2014, AIDS BEHAV, V18, P1378, DOI 10.1007/s10461-013-0683-x; Roux P, 2011, HARM REDUCT J, V8, DOI 10.1186/1477-7517-8-31; Shirzadeh E, 2016, ACTA FAC MEDICAE NAI, V33, P287, DOI 10.1515/afmnai-2016-0030; Substance Abuse and Mental Health Services Administration, 2019, KEY SUBSTANCE USE ME, VH-54; Surratt HL, 2015, AM J PUBLIC HEALTH, V105, P1660, DOI 10.2105/AJPH.2015.302612; Surratt HL, 2015, AIDS CARE, V27, P307, DOI 10.1080/09540121.2014.967656; Surratt HL, 2013, AM J PUBLIC HEALTH, V103, P1026, DOI 10.2105/AJPH.2012.301092; Tsao JCI, 2007, PAIN, V133, P128, DOI 10.1016/j.pain.2007.03.016; Tsao Jennie C I, 2012, J Pain Manag, V5, P111; Tsao JCI, 2010, PAIN MED, V11, P815, DOI 10.1111/j.1526-4637.2010.00858.x; Tsuyuki K, 2015, AIDS BEHAV, V19, P869, DOI 10.1007/s10461-014-0969-7; Tsuyuki K, 2015, AIDS BEHAV, V19, P857, DOI 10.1007/s10461-014-0856-2; Turner AN, 2016, AIDS CARE, V28, P1559, DOI 10.1080/09540121.2016.1198746; United Nations Joint Programme on HIV/AIDS (UNAIDS), GLOB AIDS UPD 2019 C; Van Hout MC, 2017, BEHAV COGN PSYCHOTH, V45, P238, DOI 10.1017/S1352465817000030; Van Hout MC, 2017, QUAL HEALTH RES, V27, P341, DOI 10.1177/1049732315613764; Venables W, 1997, INTRO R NOTES R PROG; Vijayaraghavan M, 2014, DRUG ALCOHOL DEPEN, V143, P263, DOI 10.1016/j.drugalcdep.2014.06.044; Vijayaraghavan M, 2013, JAMA INTERN MED, V173, P235, DOI 10.1001/jamainternmed.2013.1576; Vijayaraghavan M, 2011, J GEN INTERN MED, V26, P412, DOI 10.1007/s11606-010-1555-y; Wang XM, 2017, INT J ANTIMICROB AG, V50, P441, DOI 10.1016/j.ijantimicag.2017.04.009; Wazaify M, 2014, SUBST USE MISUSE, V49, P1296, DOI 10.3109/10826084.2014.891625; Wells JSG, 2018, J PHARM PHARM SCI, V21, P286, DOI 10.18433/jpps30049; Wixson SE, 2015, MEDICATION MISADVENT; Yaylaci S, 2017, BIOMED RES-INDIA, V28, P2661	63	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243718	10.1371/journal.pone.0243718	http://dx.doi.org/10.1371/journal.pone.0243718			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH1IW	33326499	Green Published, gold			2022-12-27	WOS:000600176400072
J	Jiang, SY; Peng, M; Wang, XH				Jiang, Siyu; Peng, Ming; Wang, Xiaohui			Different influences of moral violation with and without physical impurity on face processing: An event-related potentials study	PLOS ONE			English	Article							FACIAL EXPRESSIONS; EMOTIONAL EXPRESSION; ATTENTIONAL CAPTURE; SPATIAL ATTENTION; NEURAL BASIS; TIME-COURSE; DISGUST; ANGER; ACTIVATION; ATTITUDES	It has been widely accepted that moral violations that involve impurity (such as spitting in public) induce the emotion of disgust, but there has been a debate about whether moral violations that do not involve impurity (such as swearing in public) also induce the same emotion. The answer to this question may have implication for understanding where morality comes from and how people make moral judgments. This study aimed to compared the neural mechanisms underlying two kinds of moral violation by using an affective priming task to test the effect of sentences depicting moral violation behaviors with and without physical impurity on subsequent detection of disgusted faces in a visual search task. After reading each sentence, participants completed the face search task. Behavioral and electrophysiological (event-related potential, or ERP) indices of affective priming (P2, N400, LPP) and attention allocation (N2pc) were analyzed. Results of behavioral data and ERP data showed that moral violations both with and without impurity promoted the detection of disgusted faces (RT, N2pc); moral violations without impurity impeded the detection of neutral faces (N400). No priming effect was found on P2 and LPP. The results suggest both types of moral violation influenced the processing of disgusted faces and neutral faces, but the neural activity with temporal characteristics was different.	[Jiang, Siyu; Peng, Ming; Wang, Xiaohui] Cent China Normal Univ, Minist Educ, Key Lab Adolescent Cyberpsychol & Behav, Wuhan, Peoples R China; [Jiang, Siyu; Peng, Ming; Wang, Xiaohui] Cent China Normal Univ, Sch Psychol, Wuhan, Peoples R China	Central China Normal University; Central China Normal University	Peng, M (corresponding author), Cent China Normal Univ, Minist Educ, Key Lab Adolescent Cyberpsychol & Behav, Wuhan, Peoples R China.	pengm2015@mail.ccnu.edu.cn			MOE (Ministry of Education in China) Project of Humanities and Social Sciences [18YJC90018]; self-determined research funds of CCNU from the colleges' basic research and operation of MOE [CCNU19TD018]; Fundamental Research Funds for the Central Universities [CCNU20QN024]	MOE (Ministry of Education in China) Project of Humanities and Social Sciences; self-determined research funds of CCNU from the colleges' basic research and operation of MOE; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was supported by the MOE (Ministry of Education in China) Project of Humanities and Social Sciences (No.18YJC90018), self-determined research funds of CCNU from the colleges' basic research and operation of MOE (CCNU19TD018), and Fundamental Research Funds for the Central Universities (CCNU20QN024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado L, 2013, COGN AFFECT BEHAV NE, V13, P284, DOI 10.3758/s13415-012-0137-3; [Anonymous], 2019, CANC DISCOV, V10, pOF5; Borg JS, 2008, J COGNITIVE NEUROSCI, V20, P1529, DOI 10.1162/jocn.2008.20109; Cannon PR, 2011, SOC PSYCHOL PERS SCI, V2, P325, DOI 10.1177/1948550610390525; Chapman HA, 2009, SCIENCE, V323, P1222, DOI 10.1126/science.1165565; Clark JA, 2010, BIOL PHILOS, V25, P75, DOI 10.1007/s10539-009-9170-1; [姚树霞 Yao Shuxia], 2012, [心理科学进展, Advances in Psychological Science], V20, P365; Curtis V, 2004, P ROY SOC B-BIOL SCI, V271, pS131, DOI 10.1098/rsbl.2003.0144; Curtis V, 2001, PERSPECT BIOL MED, V44, P17, DOI 10.1353/pbm.2001.0001; Dieguez-Risco T, 2013, SOC NEUROSCI-UK, V8, P601, DOI 10.1080/17470919.2013.834842; Duncan LA, 2009, ANAL SOC ISS PUB POL, V9, P97, DOI 10.1111/j.1530-2415.2009.01188.x; Eimer M, 2008, J COGNITIVE NEUROSCI, V20, P1423, DOI 10.1162/jocn.2008.20099; Eimer M, 2007, BIOL PSYCHOL, V74, P108, DOI 10.1016/j.biopsycho.2006.06.008; Eskine KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041159; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fazio RH, 2001, COGNITION EMOTION, V15, P115, DOI 10.1080/02699930125908; Frenkel TI, 2011, BIOL PSYCHOL, V88, P188, DOI 10.1016/j.biopsycho.2011.08.001; Galfano G, 2011, SOC NEUROSCI-UK, V6, P257, DOI 10.1080/17470919.2010.515722; Gibbons H, 2018, PSYCHOPHYSIOLOGY, V55, DOI 10.1111/psyp.13009; Giner-Sorolla R, 2017, PSYCHOL SCI, V28, P80, DOI 10.1177/0956797616673193; Gong H, 2012, JUDGM DECIS MAK, V7, P628; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Greene JD, 2008, COGNITION, V107, P1144, DOI 10.1016/j.cognition.2007.11.004; Gui DY, 2016, SOC NEUROSCI-UK, V11, P380, DOI 10.1080/17470919.2015.1081401; Gutierrez A, 2009, SPAN J PSYCHOL, V12, P414, DOI 10.1017/S1138741600001803; Haidt J, 2001, PSYCHOL REV, V108, P814, DOI 10.1037//0033-295X.108.4.814; Haidt J, 2003, SER AFFECTIVE SCI, P852; Haidt J., 2007, SOCIAL JUSTICE RES, V20, P98, DOI [DOI 10.1007/S11211-007-0034-Z, 10.1007/s11211-007-0034-z]; Hajcak G, 2009, CLIN NEUROPHYSIOL, V120, P505, DOI 10.1016/j.clinph.2008.11.028; Hietanen JK, 2013, BIOL PSYCHOL, V92, P114, DOI 10.1016/j.biopsycho.2012.10.005; Hirai M, 2008, BRAIN RES BULL, V77, P264, DOI 10.1016/j.brainresbull.2008.08.011; Horberg EJ, 2009, J PERS SOC PSYCHOL, V97, P963, DOI 10.1037/a0017423; Hutcherson CA, 2011, J PERS SOC PSYCHOL, V100, P719, DOI 10.1037/a0022408; Kaptein M, 2008, J MANAGE, V34, P978, DOI 10.1177/0149206308318614; Karinen AK, 2019, EMOTION, V19, P889, DOI 10.1037/emo0000489; Kelly DR, 2013, LIFE MIND-PHILOS ISS, P503; Klauer KC, 2003, PSYCHOLOGY OF EVALUATION, P7; Klein F, 2015, COGN AFFECT BEHAV NE, V15, P736, DOI 10.3758/s13415-015-0361-8; Kobylinska D, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00498; Kohlberg L., 1969, HDB SOCIALIZATION TH, P347, DOI DOI 10.12691/EDUCATION-3-9-16; Krombholz A, 2007, BIOL PSYCHOL, V76, P156, DOI 10.1016/j.biopsycho.2007.07.004; Leffel GM, 2008, J PSYCHOL THEOL, V36, P182, DOI 10.1177/009164710803600303; Li SX, 2018, PSYCHOPHYSIOLOGY, V55, DOI 10.1111/psyp.13039; Lipp OV, 2014, COGNITION EMOTION, V28, P1100, DOI 10.1080/02699931.2013.867831; Lu Y, 2011, NEUROSCI LETT, V502, P182, DOI 10.1016/j.neulet.2011.07.040; Luck S. J., 2005, INTRO EVENT RELATED; Luo Y, 2013, BIOL PSYCHOL, V94, P242, DOI 10.1016/j.biopsycho.2013.06.005; Meaux E, 2014, EUR J NEUROSCI, V39, P1349, DOI 10.1111/ejn.12496; Moll J, 2005, COGN BEHAV NEUROL, V18, P68, DOI 10.1097/01.wnn.0000152236.46475.a7; Nabi RL, 2002, COMMUN MONOGR, V69, P204, DOI 10.1080/03637750216541; Oaten M, 2009, PSYCHOL BULL, V135, P303, DOI 10.1037/a0014823; Park JH, 2007, EVOL HUM BEHAV, V28, P410, DOI 10.1016/j.evolhumbehav.2007.05.008; Paulmann S, 2010, COGN AFFECT BEHAV NE, V10, P230, DOI 10.3758/CABN.10.2.230; Paxton JM, 2010, TOP COGN SCI, V2, P511, DOI 10.1111/j.1756-8765.2010.01096.x; Peng M, 2013, EVOL HUM BEHAV, V34, P94, DOI 10.1016/j.evolhumbehav.2012.10.002; Peng XZ, 2017, PSYCHOPHYSIOLOGY, V54, P1459, DOI 10.1111/psyp.12893; Piaget J., 1965, MORAL JUDGEMENT CHIL; Righart R, 2008, SOC COGN AFFECT NEUR, V3, P270, DOI 10.1093/scan/nsn021; Rozin P, 1999, J PERS SOC PSYCHOL, V76, P574, DOI 10.1037/0022-3514.76.4.574; Rozin P., 2008, HDB EMOTIONS, P637; Russell PS, 2013, PSYCHOL BULL, V139, P328, DOI 10.1037/a0029319; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Skarlicki DP, 2013, J EXP SOC PSYCHOL, V49, P852, DOI 10.1016/j.jesp.2013.03.011; Smith FW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197160; [田学红 Tian Xuehong], 2011, [心理科学进展, Advances in Psychological Science], V19, P1426; Tracy JL, 2019, J PERS SOC PSYCHOL, V116, P15, DOI 10.1037/pspa0000141; Tybur JM, 2013, PSYCHOL REV, V120, P65, DOI 10.1037/a0030778; Tybur JM, 2009, J PERS SOC PSYCHOL, V97, P103, DOI 10.1037/a0015474; [王妍 Wang Yan], 2005, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V13, P396; Werheid K, 2005, INT J PSYCHOPHYSIOL, V55, P209, DOI 10.1016/j.ijpsycho.2004.07.006; Wessing I, 2013, NEUROIMAGE, V81, P15, DOI 10.1016/j.neuroimage.2013.04.117; Weymar M, 2011, NEUROIMAGE, V58, P946, DOI 10.1016/j.neuroimage.2011.06.061; Yang QQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01555-0; Yang Q, 2014, INT J PSYCHOPHYSIOL, V94, P84, DOI 10.1016/j.ijpsycho.2014.07.008; Yang Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065094; Zhang XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128531	76	2	2	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243929	10.1371/journal.pone.0243929	http://dx.doi.org/10.1371/journal.pone.0243929			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH1IW	33326458	Green Published, gold			2022-12-27	WOS:000600176400052
J	Armenta-Medina, D; de Leon-Castaneda, CD; Valderrama-Blanco, B				Armenta-Medina, Dagoberto; Diaz de Leon-Castaneda, Christian; Valderrama-Blanco, Brenda			Bioinformatics in Mexico: A diagnostic from the academic perspective and recommendations for a public policy	PLOS ONE			English	Article							GENOMIC MEDICINE; INNOVATION; SCIENCES	In this work, we present a diagnostic analysis of strengths, weaknesses, opportunities and threats (SWOT) of the current state of Bioinformatics in Mexico. We conducted semi-structured interviews among researchers and academics with key expertise in this field, identified by bibliometric analyses and qualitative sampling techniques. Additionally, an online survey was conducted reaching a higher number of respondents. Among the relevant findings of our study, the lack of specialized human resources and technological infrastructure stood out, along with deficiencies in the number and quality of academic programs, scarce public investment and a weak relationship between public and private institutions. However, there are great opportunities for developing a national Bioinformatics to support different economic sectors. In our opinion, this work could be useful to favor a comprehensive network among Mexican researchers, in order to lay the foundations of a national strategy towards a well designed public policy.	[Armenta-Medina, Dagoberto; Diaz de Leon-Castaneda, Christian] CONACYT Consejo Nacl Ciencia & Tecnol, Direcc Catedras, Mexico City, DF, Mexico; [Armenta-Medina, Dagoberto; Diaz de Leon-Castaneda, Christian] INFOTEC Ctr Invest & Innovac Tecnol Informac & Co, Aguascalientes, Aguascalientes, Mexico; [Valderrama-Blanco, Brenda] Univ Nacl Autonoma Mexico, Inst Biotecnol, Cuernavaca, Morelos, Mexico; [Diaz de Leon-Castaneda, Christian] Univ Michoacana, Morelia, Michoacan, Mexico	INFOTEC - Centro de Investigacion e Innovacion en Tecnologias de la Informacion y Comunicacion; Universidad Nacional Autonoma de Mexico; Universidad Michoacana de San Nicolas de Hidalgo	Armenta-Medina, D; de Leon-Castaneda, CD (corresponding author), CONACYT Consejo Nacl Ciencia & Tecnol, Direcc Catedras, Mexico City, DF, Mexico.; Armenta-Medina, D; de Leon-Castaneda, CD (corresponding author), INFOTEC Ctr Invest & Innovac Tecnol Informac & Co, Aguascalientes, Aguascalientes, Mexico.; de Leon-Castaneda, CD (corresponding author), Univ Michoacana, Morelia, Michoacan, Mexico.	dagoberto.armenta@infotec.mx; cddeleon@conacyt.mx		Diaz de Leon, Christian/0000-0001-8155-4504; Valderrama, Brenda/0000-0002-5510-9439	Catedras Conacyt program [737, 1010]	Catedras Conacyt program	We thank the Catedras Conacyt program (projects No. 737 "Modelos biocomputacionales para el analisis de datos geneticos" and No. 1010 "Apropiacion Social de Tecnologias de Informacion y Comunicacion para el Desarrollo") assigned to INFOTEC. We also thank extensively to the researchers and academics that participated in this study.	Aguilar-Diaz H, 2006, PARASITOL INT, V55, pS127, DOI 10.1016/j.parint.2005.11.020; Aills L, 2008, SURG OBES RELAT DI S, V4, pS73; Allied Market Research, DNA SEQ MARK OPP FOR; American Association of Oral and Maxillofacial Surgeons, 2017, J ORAL MAXILLOFAC SU, V75, pe12; [Anonymous], 2018, DIAGN SECT TECN INF; [Anonymous], 2016, BIOTECNOLOGIA; [Anonymous], 2018, DIAGN SECT FARM; [Anonymous], 2011, RETROSPECTIVE METHOD, V3, P7; Attwood TK, 2019, BRIEF BIOINFORM, V20, P398, DOI 10.1093/bib/bbx100; Bicudo E, 2016, PUBLIC HEALTH GENOM, V19, P81, DOI 10.1159/000443472; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Budd A, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1003972; Campoli GA, 2001, REFLEXIONES REGIMEN; Chasapi A, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1007532; Chimusa ER, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004512; Creswell J. W., 2007, HDB MIXED METHODS SO, P209, DOI DOI 10.4135/9781506335193; Cuautle-Rodriguez Patricia, 2014, Drug Metabolism and Drug Interactions, V29, P37, DOI 10.1515/dmdi-2013-0019; Davidsen AS, 2013, QUAL RES PSYCHOL, V10, P318, DOI 10.1080/14780887.2011.608466; De Las Rivas Javier, 2017, Brief Bioinform, V18, P1091, DOI 10.1093/bib/bbx114; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; Diniz WJS, 2017, GENET MOL RES, V16, DOI 10.4238/gmr16019645; Dinsdale E, 2015, CBE-LIFE SCI EDUC, V14, DOI 10.1187/cbe.15-06-0123; Favela-Mendoza A, 2018, MOL BIOL REP, V45, P2525, DOI 10.1007/s11033-018-4419-x; Oliva-Sanchez PF, 2013, SALUD PUBLICA MEXICO, V55, P16, DOI 10.1590/S0036-36342013000100005; Geer LY, 2010, NUCLEIC ACIDS RES, V38, pD492, DOI 10.1093/nar/gkp858; Gerritsen VB, 2019, BRIEF BIOINFORM, V20, P361, DOI 10.1093/bib/bbx073; Gonzalez V, 2006, P NATL ACAD SCI USA, V103, P3834, DOI 10.1073/pnas.0508502103; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; HOROWITZ IL, 1967, INT STUD QUART, V11, P32, DOI 10.2307/3013989; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Jimenez-Sanchez G, 2008, GENOME RES, V18, P1191, DOI 10.1101/gr.065359.107; Kang Byunghak, 2013, Genomics & Informatics, V11, P211, DOI 10.5808/GI.2013.11.4.211; Knoppers BM, 2014, HUM GENET, V133, P895, DOI 10.1007/s00439-014-1432-6; Krishnaswamy S, 2016, CURR SCI INDIA, V110, P556, DOI 10.18520/cs/v110/i4/556-561; Kumar A., 2017, RES REV BIOSCI, V12, P116; Lewitter F, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000368; Leyva Gaxiola M, 2016, REV GESTION PERS TEC, V9, P54; Martin P, 2009, 09006 CRB ERIC; Martin-Sanchez F, 2004, J BIOMED INFORM, V37, P30, DOI 10.1016/j.jbi.2003.09.003; Marturano A, 2009, BIOETHICS, V23, pII, DOI 10.1111/j.1467-8519.2009.01764.x; Mendoza Enríquez Olivia Andrea, 2018, Rev. IUS, V12, P267; Moreno-Estrada A, 2014, SCIENCE, V344, P1280, DOI 10.1126/science.1251688; Naranjo MEG, 2018, OMICS, V22, P575, DOI 10.1089/omi.2018.0114; Orozco A, 2013, BRIEF BIOINFORM, V14, P661, DOI 10.1093/bib/bbt033; Palacios R, 2007, PLOS COMPUT BIOL, V3, P1670, DOI 10.1371/journal.pcbi.0030143; Patton M. Q., 2001, QUALITATIVE RES EVAL; Peimbert M, 2012, ASTROBIOLOGY, V12, P648, DOI 10.1089/ast.2011.0694; Ragan MA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000068; Roberts RJ, 2001, P NATL ACAD SCI USA, V98, P381, DOI 10.1073/pnas.98.2.381; Salter B, 2016, SCI TECHNOL HUM VAL, V41, P793, DOI 10.1177/0162243916631022; Schneider MV, 2019, BRIEF BIOINFORM, V20, P384, DOI 10.1093/bib/bbx071; Sherry P, 2013, PHILOS INVEST, V36, P340, DOI 10.1111/j.1467-9205.2012.01474.x; Shoko R, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006480; Silva-Zolezzi I, 2009, P NATL ACAD SCI USA, V106, P8611, DOI 10.1073/pnas.0903045106; Tauch A, 2019, BRIEF BIOINFORM, V20, P370, DOI 10.1093/bib/bbx040; van Wijngaarden JDH, 2012, INT J HEALTH PLAN M, V27, P34, DOI 10.1002/hpm.1032; Yin R.K., 2009, CASE STUDY RES DESIG, V4th ed., DOI [10.33524/cjar.v14i1.73, DOI 10.33524/CJAR.V14I1.73]	57	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243531	10.1371/journal.pone.0243531	http://dx.doi.org/10.1371/journal.pone.0243531			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH3TP	33320879	Green Published, gold			2022-12-27	WOS:000600339800010
J	Amano, K; Xiao, K; Wuerger, S; Meyer, G				Amano, Kinjiro; Xiao, Kaida; Wuerger, Sophie; Meyer, Georg			A colorimetric comparison of sunless with natural skin tan	PLOS ONE			English	Article							COLOR; DIHYDROXYACETONE; INSIGHT	The main ingredient of sunless tanning products is dihydroxyacetone (DHA). DHA reacts with the protein and amino acid composition in the surface layers of the skin, producing melanoidins, which changes the skin colour, imitating natural skin tan caused by melanin. The purpose of this study was to characterise DHA-induced skin colour changes and to test whether we can predict the outcome of DHA application on skin tone changes. To assess the DHA-induced skin colour shift quantitatively, colorimetric and spectral measurements of the inner forearm were obtained before, four hours and 24 hours after application of a 7.5% concentration DHA gel in the experimental group (n = 100). In a control group (n = 60), the same measurements were obtained on both the inner forearm (infrequently sun-exposed) and the outer forearm (frequently sun-exposed); the difference between these two areas was defined as the naturally occurring tan. Skin colour shifts caused by DHA tanning and by natural tanning were compared in terms of lightness (L*), redness (a*) and yellowness (b*) in the standard CIELAB colour space. Naturalness of the DHA-induced skin tan was evaluated by comparing the trajectory of the chromaticity distribution in (L*, b*) space with that of naturally occurring tan. Twenty-four hours after DHA application, approximately 20% of the skin colour samples became excessively yellow, with chromaticities outside the natural range in (L*, b*) space. A principal component analysis was used to characterise the tanning pathway. Skin colour shifts induced by DHA were predicted by a multiple regression on the chromaticities and the skin properties. The model explained up to 49% of variance in colorimetric components with a median error of less than 2 Delta E. We conclude that the control of both the magnitude and the direction of the colour shift is a critical factor to achieve a natural appearance.	[Amano, Kinjiro; Wuerger, Sophie; Meyer, Georg] Univ Liverpool, Dept Psychol, Liverpool, Merseyside, England; [Xiao, Kaida] Univ Leeds, Sch Design, Leeds, W Yorkshire, England; [Amano, Kinjiro] Univ Manchester, Sch Med Sci, Manchester, Lancs, England	University of Liverpool; University of Leeds; University of Manchester	Amano, K (corresponding author), Univ Liverpool, Dept Psychol, Liverpool, Merseyside, England.; Amano, K (corresponding author), Univ Manchester, Sch Med Sci, Manchester, Lancs, England.	kinjiro.amano@manchester.ac.uk		Wuerger, Sophie/0000-0003-0080-5813; xiao, kaida/0000-0001-7197-7159	EPSRC [EP/K040057]; PZ Cussons (Manchester, UK); EPSRC [EP/K040057/1] Funding Source: UKRI	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); PZ Cussons (Manchester, UK); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The control group data were part of a larger project on skin appearance funded by the EPSRC (EP/K040057) (SW). PZ Cussons (Manchester, UK) funded the DHA induced skin colour measurements and gave advice on the study design but was not involved in data collection and analysis, or the decision to publish the results (KA, SW, GM).	Adbi A, 2018, ACAD MANAGEMENT P, V2018, P12261, DOI [10.5465/AMBPP.2018.12261abstract, DOI 10.5465/AMBPP.2018.12261ABSTRACT]; Beckmann KR, 2001, MED J AUSTRALIA, V174, P75, DOI 10.5694/j.1326-5377.2001.tb143158.x; BOBIN MF, 1984, J SOC COSMET CHEM, V35, P265; Brooks K, 2006, J AM ACAD DERMATOL, V54, P1060, DOI 10.1016/j.jaad.2006.01.014; CHARDON A, 1991, INT J COSMETIC SCI, V13, P191, DOI 10.1111/j.1467-2494.1991.tb00561.x; Chauhan T, 2019, J VISION, V19, DOI 10.1167/19.1.13; Ciriminna R, 2018, CHEMISTRYOPEN, V7, P233, DOI 10.1002/open.201700201; Commission Internationale De L'Eclairage (CIE), 2004, CIE PUB, V3rd; Del Bino S, 2013, BRIT J DERMATOL, V169, P33, DOI 10.1111/bjd.12529; Dennis Leslie K, 2009, Ped Health, V3, P565, DOI 10.2217/phe.09.55; Desmedt B, 2016, J EUR ACAD DERMATOL, V30, P943, DOI 10.1111/jdv.13595; FITZPATRICK TB, 1988, ARCH DERMATOL, V124, P869, DOI 10.1001/archderm.124.6.869; Lee G, 2014, 2014 IEEE CONGRESS ON EVOLUTIONARY COMPUTATION (CEC), P1, DOI 10.1109/CEC.2014.6900246; LEVY SB, 1992, J AM ACAD DERMATOL, V27, P989, DOI 10.1016/0190-9622(92)70300-5; Lister T, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.9.090901; Muizzuddin N, 2000, SKIN RES TECHNOL, V6, P199, DOI 10.1034/j.1600-0846.2000.006004199.x; Pollock Samara, 2021, Int J Womens Dermatol, V7, P158, DOI 10.1016/j.ijwd.2020.09.006; Rajatanavin N, 2008, INT J DERMATOL, V47, P402, DOI 10.1111/j.1365-4632.2008.03356.x; Sahn RE, 2012, ARCH DERMATOL, V148, P448, DOI 10.1001/archdermatol.2011.2072; Sohaib A, 2018, INT J ADV MANUF TECH, V96, P881, DOI 10.1007/s00170-017-1480-x; Sweet J, 2000, AVIRIS WORKSH; Wang M, 2015, COL IM C COL SCI SYS; Wang MM, 2018, COLOR RES APPL, V43, P458, DOI 10.1002/col.22230; WITTGENSTEIN E, 1960, SCIENCE, V132, P894, DOI 10.1126/science.132.3431.894; Xiao K, 2017, SKIN RES TECHNOL, V23, P21, DOI 10.1111/srt.12295; Xiao KD, 2016, OPT EXPRESS, V24, P14934, DOI 10.1364/OE.24.014934; Yoo JJ, 2018, FASH TEXT, V5, DOI 10.1186/s40691-018-0147-z; Zonios G, 2001, J INVEST DERMATOL, V117, P1452, DOI 10.1046/j.0022-202x.2001.01577.x	28	7	7	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0233816	10.1371/journal.pone.0233816	http://dx.doi.org/10.1371/journal.pone.0233816			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315862	Green Submitted, Green Published, gold			2022-12-27	WOS:000600186100060
J	Mori, A; Saito, T; Takahashi, M; Shibata, M; Tsuji, G; Hatachi, S; Takahashi, S; Kumagai, S				Mori, Ayano; Saito, Toshiharu; Takahashi, Miho; Shibata, Miho; Tsuji, Goh; Hatachi, Saori; Takahashi, Soshi; Kumagai, Shunichi			Presence of anti-nuclear antibodies is a risk factor for the appearance of anti-drug antibodies during infliximab or adalimumab therapy in patients with rheumatoid arthritis	PLOS ONE			English	Article							NECROSIS-FACTOR INHIBITORS; FACTOR-ALPHA THERAPY; IMMUNOGENICITY; LUPUS; AUTOANTIBODIES; DISEASES; UTILITY	This study aimed to directly analyze the potential relationship of anti-nuclear antibodies (ANA) before and after the administration of TNF-alpha inhibitors (TNFi) with the appearance of anti-drug antibodies (ADrA) in patients with rheumatoid arthritis (RA). A total of 121 cases, viz., 38, 53, and 30 cases treated with infliximab (IFX), adalimumab (ADA), and etanercept (ETN), respectively, were enrolled. The ANA titers were measured using indirect immunefluorescence assay (IF-ANA) and multiplex flow immunoassay (ANA Screen) before and serially during the therapy. The anti-IFX antibodies (HACA) and anti-ADA antibodies (AAA) were measured with a radioimmunoassay. ADrA turned positive in 14 (36.8%) among 38 patients treated with IFX, and 16 (30.2%) among 53 treated with ADA. All of them were positive for IF-ANA before TNFi administration, while ADrA never appeared in any of the 15 patients negative for IF-ANA (< 40). IF-ANA of high titers (<greater than or equal to> 320 and >= 640) before IFX treatment showed a significant association with the appearance of HACA 52 weeks after IFX (P = 0.040 and 0.017, respectively), whereas AAA appearance was not related to IF-ANA titers before treatment. Moreover, IF-ANA of high titers before IFX treatment was significantly associated with inefficacy and discontinuation of the treatment. The positivity of anti-SS-A antibodies before therapy might be a risk factor for ADrA appearance in patients treated with IFX or ADA. The percentage of patients whose IF-ANA titers increased was significantly higher with IFX than with ADA or ETN treatments (P = 0.026 and 0.022, respectively). High ANA titers and positive ANA Screen after IFX therapy showed a significant association with HACA appearance and possibly led to treatment failure. Among the three TNFi, only IFX showed a close relationship with IF-ANA and ADrA appearance, suggesting the interaction of immunogenicity with autoimmunity as well as the advantage of ANA measurement before TNFi therapy.	[Mori, Ayano; Saito, Toshiharu; Takahashi, Miho; Shibata, Miho; Takahashi, Soshi; Kumagai, Shunichi] Shinko Hosp, Shinko Inst Med Res, Kobe, Hyogo, Japan; [Tsuji, Goh; Hatachi, Saori; Takahashi, Soshi; Kumagai, Shunichi] Shinko Hosp, Ctr Rheumat Dis, Kobe, Hyogo, Japan		Kumagai, S (corresponding author), Shinko Hosp, Shinko Inst Med Res, Kobe, Hyogo, Japan.; Kumagai, S (corresponding author), Shinko Hosp, Ctr Rheumat Dis, Kobe, Hyogo, Japan.	kumagais@kobe-u.ac.jp						[Anonymous], 2012, DIABETES CARE S1, V35, pS12; De Bandt M, 2005, ARTHRITIS RES THER, V7, pR545, DOI 10.1186/ar1715; Garces S, 2013, ANN RHEUM DIS, V72, P1947, DOI 10.1136/annrheumdis-2012-202220; Hagiwara S, 2016, MOD RHEUMATOL, V26, P857, DOI 10.3109/14397595.2016.1153567; Hoffmann JHO, 2011, BRIT J DERMATOL, V165, P1355, DOI 10.1111/j.1365-2133.2011.10555.x; Hoxha A, 2016, JOINT BONE SPINE, V83, P167, DOI 10.1016/j.jbspin.2015.04.020; Ishikawa Y, 2019, SEMIN ARTHRITIS RHEU, V49, P204, DOI 10.1016/j.semarthrit.2019.02.003; Jani M, 2018, RHEUMATOLOGY, V57, P1896, DOI 10.1093/rheumatology/kex434; Jani M, 2015, ARTHRITIS RHEUMATOL, V67, P2011, DOI 10.1002/art.39169; Kalden JR, 2017, NAT REV RHEUMATOL, V13, P707, DOI 10.1038/nrrheum.2017.187; Matsudaira R, 2011, J RHEUMATOL, V38, P2346, DOI 10.3899/jrheum.101295; Moots RJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175207; Vaz JLP, 2016, CLIN RHEUMATOL, V35, P325, DOI 10.1007/s10067-015-3140-6; Maneiro JR, 2013, JAMA INTERN MED, V173, P1416, DOI 10.1001/jamainternmed.2013.7430; Ramos-Casals M, 2007, MEDICINE, V86, P242, DOI 10.1097/MD.0b013e3181441a68; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Takase K, 2014, ANN RHEUM DIS, V73, P1695, DOI 10.1136/annrheumdis-2014-205318; Wells G, 2009, ANN RHEUM DIS, V68, P954, DOI 10.1136/ard.2007.084459; Wetter DA, 2009, MAYO CLIN PROC, V84, P979, DOI 10.4065/84.11.979; Yukawa N, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3546	20	4	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243729	10.1371/journal.pone.0243729	http://dx.doi.org/10.1371/journal.pone.0243729			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315881	Green Published, gold			2022-12-27	WOS:000600186100088
J	Breidenbach, N; Gailing, O; Krutovsky, KV				Breidenbach, Natalie; Gailing, Oliver; Krutovsky, Konstantin, V			Genetic structure of coast redwood (Sequoia sempervirens [D. Don] Endl.) populations in and outside of the natural distribution range based on nuclear and chloroplast microsatellite markers	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; MITOCHONDRIAL-DNA; CHANGE IMPACTS; NORWAY SPRUCE; DIVERSITY; PLANT; FOREST; FOG; HETEROPLASMY; ASSIGNMENT	Coast redwood (Sequoia sempervirens) naturally growing in southern Oregon and northern California is one of the few conifer tree species that are polyploid. Despite its unique ecological and economic importance, its population genetic structure is still insufficiently studied. To obtain additional data on its population genetic structure we genotyped 317 samples collected from populations in California (data set C) and 144 trees growing in a provenance trial in France (data set F) using 12 nuclear (five random nuclear genomic nSSRs and seven expressed sequence tag EST-SSRs) and six chloroplast (cpSSRs) microsatellite or simple sequence repeat (SSR) markers, respectively. These data sets were also used as reference to infer the origin of 147 coast redwood trees growing in Germany (data set G). Coast redwood was introduced to Europe, including Germany as an ornamental species, decades ago. Due to its fast growth and high timber quality, it could be considered as a potential commercial timber species, especially in perspective to climate warming that makes more regions in Germany suitable for its growing. The well performing trees in colder Germany could be potential frost resistant genotypes, but their genetic properties and origin are mostly unknown. Within the natural range in southern Oregon and northern California, only two relatively weak clusters were identified, one northern and one southern, separated by the San Francisco Bay. High genetic diversity, but low differentiation was found based on the 12 nuclear SSR markers for all three data sets F, C and G. We found that investigated 147 German trees represented only 37 different genotypes. They showed genetic diversity at the level less than diversity observed within the natural range in the northern or southern cluster, but more similar to the diversity observed in the southern cluster. It was difficult to assign German trees to the original single native populations using the six cpSSR markers, but rather to either the northern or southern cluster. The high number of haplotypes found in the data sets based on six cpSSR markers and low genetic differentiation based on 12 nuclear SSRs found in this study helps us study and better understand population genetic structure of this complex polyploid tree and supports the selection of potential genotypes for German forestry.	[Breidenbach, Natalie; Gailing, Oliver; Krutovsky, Konstantin, V] Georg August Univ Gottingen, Dept Forest Genet & Forest Tree Breeding, Gottingen, Germany; [Gailing, Oliver; Krutovsky, Konstantin, V] Georg August Univ Gottingen, Ctr Integrated Breeding Res, Gottingen, Germany; [Krutovsky, Konstantin, V] Russian Acad Sci, Vavilov Inst Gen Genet, Lab Populat Genet, Moscow, Russia; [Krutovsky, Konstantin, V] Siberian Fed Univ, Inst Fundamental Biol & Biotechnol, Genome Res & Educ Ctr, Lab Forest Genom, Krasnoyarsk, Russia; [Krutovsky, Konstantin, V] Texas A&M Univ, Dept Ecosyst Sci & Management, College Stn, TX 77843 USA	University of Gottingen; University of Gottingen; Russian Academy of Sciences; Vavilov Institute of General Genetics; Siberian Federal University; Texas A&M University System; Texas A&M University College Station	Krutovsky, KV (corresponding author), Georg August Univ Gottingen, Dept Forest Genet & Forest Tree Breeding, Gottingen, Germany.; Krutovsky, KV (corresponding author), Georg August Univ Gottingen, Ctr Integrated Breeding Res, Gottingen, Germany.; Krutovsky, KV (corresponding author), Russian Acad Sci, Vavilov Inst Gen Genet, Lab Populat Genet, Moscow, Russia.; Krutovsky, KV (corresponding author), Siberian Fed Univ, Inst Fundamental Biol & Biotechnol, Genome Res & Educ Ctr, Lab Forest Genom, Krasnoyarsk, Russia.; Krutovsky, KV (corresponding author), Texas A&M Univ, Dept Ecosyst Sci & Management, College Stn, TX 77843 USA.	Konstantin.krutovsky@forst.uni-goettingen.de	Krutovsky, Konstantin V./A-5419-2012	Krutovsky, Konstantin V./0000-0002-8819-7084	German Federal Ministry of Food and Agriculture (Bundesministeriums fur Ernahrung und Landwirtschaft - BMEL); Fachagentur Nachwachsende Rohstoffe e. V. (FNR) [FKZ 22018614]	German Federal Ministry of Food and Agriculture (Bundesministeriums fur Ernahrung und Landwirtschaft - BMEL); Fachagentur Nachwachsende Rohstoffe e. V. (FNR)	This study is part of the "Genetische Anpassung und Variation an der Forsttoleranz beteiligter Gene in der eingefuhrten Baumart Sequoia sempervirens, einer schnell wachsenden Wertholzbaumart und ihre Perspektive fur die deutsche Forstwirtschaft" project funded by the German Federal Ministry of Food and Agriculture (Bundesministeriums fur Ernahrung und Landwirtschaft -BMEL) and managed by the Fachagentur Nachwachsende Rohstoffe e. V. (FNR), grant number FKZ 22018614 to KVK. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja MR, 2011, PLANT GENET RESOUR-C, V9, P411, DOI 10.1017/S1479262111000153; Ahuja MR, 2009, EUPHYTICA, V165, P5, DOI 10.1007/s10681-008-9813-3; Ahuja MR, 1991, WOODY PLANT BIOTECHN; [Anonymous], 2015, URBAN RAPID RAIL TRA; [Anonymous], 1905, MAKEDONYA MEKTUBU DE, V23, P1; [Anonymous], 2005, FIRE ECOL; ARNAUD Y, 1993, ANN SCI FOREST, V50, P273, DOI 10.1051/forest:19930305; Barrett S. C. H., 1990, Plant population genetics, breeding, and genetic resources., P254; Beck EH, 2007, J BIOSCIENCES, V32, P501, DOI 10.1007/s12038-007-0049-5; Bjornstad G, 2002, ANIM GENET, V33, P264, DOI 10.1046/j.1365-2052.2002.00868.x; BLANCHARD JL, 1995, J MOL EVOL, V41, P397, DOI 10.1007/BF00160310; Breidenbach N, 2019, PLANT GENET RESOUR-C, V17, P293, DOI 10.1017/S147926211800045X; Brinegar C, 2011, GEN TECHNICAL REPORT, P241; Bruno D, 2004, MOL ECOL NOTES, V4, P482, DOI 10.1111/j.1471-8286.2004.00720.x; Bruvo R, 2004, MOL ECOL, V13, P2101, DOI 10.1111/j.1365-294X.2004.02209.x; Busing RT, 2005, PLANT ECOL, V177, P177, DOI 10.1007/s11258-005-2322-8; Chakraborty D, 2016, EUR J FOREST RES, V135, P919, DOI 10.1007/s10342-016-0984-5; Clark LV, 2011, MOL ECOL RESOUR, V11, P562, DOI 10.1111/j.1755-0998.2011.02985.x; Cornuet JM, 1999, GENETICS, V153, P1989; Dawson TE, 1998, OECOLOGIA, V117, P476, DOI 10.1007/s004420050683; De Silva HN, 2005, HEREDITY, V95, P327, DOI 10.1038/sj.hdy.6800728; Douhovnikoff V, 2004, AM J BOT, V91, P1140, DOI 10.3732/ajb.91.7.1140; Douhovnikoff V, 2011, AM MIDL NAT, V165, P22, DOI 10.1674/0003-0031-165.1.22; Dufresne F, 2014, MOL ECOL, V23, P40, DOI 10.1111/mec.12581; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Echt CS, 1998, MOL ECOL, V7, P307, DOI 10.1046/j.1365-294X.1998.00350.x; Ellis JR, 2007, HEREDITY, V99, P125, DOI 10.1038/sj.hdy.6801001; Esselink GD, 2004, THEOR APPL GENET, V109, P402, DOI 10.1007/s00122-004-1645-5; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Felsenstein J, PHYLIP PHYLOGENY INF; GOLDSTEIN DB, 1995, P NATL ACAD SCI USA, V92, P6723, DOI 10.1073/pnas.92.15.6723; Hansen OK, 2005, TREE GENET GENOMES, V1, P116, DOI 10.1007/s11295-005-0016-y; HARRIS SA, 1991, TAXON, V40, P393, DOI 10.2307/1223218; Hintsteiner WJ, 2018, EUR J FOREST RES, V137, P447, DOI 10.1007/s10342-018-1115-2; Howe GT, 2003, CAN J BOT, V81, P1247, DOI [10.1139/b03-141, 10.1139/B03-141]; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; JOHNSON LB, 1989, PLANT MOL BIOL, V12, P3, DOI 10.1007/BF00017442; Johnstone JA, 2010, P NATL ACAD SCI USA, V107, P4533, DOI 10.1073/pnas.0915062107; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; Jones DA, 2012, FORESTRY, V85, P99, DOI 10.1093/forestry/cpr063; Kamvar ZN, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00208; Kamvar ZN, 2014, PEERJ, V2, DOI 10.7717/peerj.281; Kivela M, 2015, MOL ECOL RESOUR, V15, P117, DOI 10.1111/1755-0998.12290; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Krutovsky K. V., 2012, GENOMICS TREE CROPS, P71, DOI [10.1016/j.jenvrad.2011.11.013, DOI 10.1016/J.JENVRAD.2011.11.013]; Lambertini C, 2016, BIOL INVASIONS, V18, P2443, DOI 10.1007/s10530-016-1193-3; Lindner M, 2010, FOREST ECOL MANAG, V259, P698, DOI 10.1016/j.foreco.2009.09.023; Lorimer CG, 2009, FOREST ECOL MANAG, V258, P1038, DOI 10.1016/j.foreco.2009.07.008; LYNCH M, 1994, MOL ECOL, V3, P91, DOI 10.1111/j.1365-294X.1994.tb00109.x; Mason AS, 2015, METHODS MOL BIOL, V1245, P161, DOI 10.1007/978-1-4939-1966-6_12; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Nazareno AG, 2014, CONSERV GENET, V15, P441, DOI 10.1007/s10592-013-0552-1; NEALE DB, 1989, P NATL ACAD SCI USA, V86, P9347, DOI 10.1073/pnas.86.23.9347; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Neuner S, 2017, CLIMATIC CHANGE, V140, P519, DOI 10.1007/s10584-016-1891-y; Nybom H, 2004, MOL ECOL, V13, P1143, DOI 10.1111/j.1365-294X.2004.02141.x; O'Hara KL, 2017, FORESTS, V8, DOI 10.3390/f8050144; Olson DF, 1990, ENDL REDWOOD SILVICS, V654, P541; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Palmer DJ, 2012, NZ J FORESTRY SCI, V42, P81; Paradis E, 2019, BIOINFORMATICS, V35, P526, DOI 10.1093/bioinformatics/bty633; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Petit RJ, 2005, MOL ECOL, V14, P885, DOI 10.1111/j.1365-294X.2005.02446.x; Petit RJ, 2005, MOL ECOL, V14, P689, DOI 10.1111/j.1365-294X.2004.02410.x; Pettenkofer T, 2019, EUR J FOREST RES, V138, P275, DOI 10.1007/s10342-019-01167-5; Pfeiffer T, 2011, J HERED, V102, P479, DOI 10.1093/jhered/esr024; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Pompe S, 2008, BIOL LETTERS, V4, P564, DOI 10.1098/rsbl.2008.0231; Potter KM, 2013, AM J BOT, V100, P1562, DOI 10.3732/ajb.1300039; Pritchard JK, 2000, GENETICS, V155, P945; Provan J, 2001, TRENDS ECOL EVOL, V16, P142, DOI 10.1016/S0169-5347(00)02097-8; Provan J, 1999, GENETICS, V153, P943; Provan J, 2008, CONSERV GENET, V9, P1521, DOI 10.1007/s10592-007-9484-y; R Development Core Team, 2009, R LANG ENV STAT COMP; Rambaut A., FIGTREE V1 3 1; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Ribeiro MM, 2002, MOL ECOL, V11, P869, DOI 10.1046/j.1365-294X.2002.01490.x; Ribeiro MM, 2002, ANN FOR SCI, V59, P53, DOI [10.1051/forest:2001005, 10.1051/forest:2002100]; Rogers DL, 1997, HEREDITY, V78, P166, DOI 10.1038/hdy.1997.24; Rogers DL, 1999, J HERED, V90, P429, DOI 10.1093/jhered/90.3.429; Rogers DL, 2000, CAN J BOT, V78, P1408, DOI 10.1139/cjb-78-11-1408; Rogers JE, 2007, SER DEATH DYING, P59; Rousseau-Gueutin M, 2018, PLANT GROWTH REGULAT; Roy DF, 1966, SILVICAL CHARACTERIS, V28, P20; Sakai A., 1987, Frost survival of plants. Responses and adaptation to freezing stress.; Sawyer JO, 2000, REDWOOD FOREST; Scott AD, 2016, NEW PHYTOL, V211, P186, DOI 10.1111/nph.13930; Sork VL, 2013, TREE GENET GENOMES, V9, P901, DOI 10.1007/s11295-013-0596-x; Stauffer D., 1994, INTRO PERCOLATION TH; STEBBINS GL, 1948, SCIENCE, V108, P95, DOI 10.1126/science.108.2796.95; Templer PH, 2015, J ECOL, V103, P1397, DOI 10.1111/1365-2745.12462; Terrab A, 2007, TAXON, V56, P409, DOI 10.1002/tax.562012; Ibanez MT, 2009, J ZHEJIANG UNIV-SC B, V10, P112, DOI 10.1631/jzus.B0820162; Torregrosa A, 2016, EARTH SPACE SCI, V3, P46, DOI 10.1002/2015EA000119; Urli M, 2014, J VEG SCI, V25, P147, DOI 10.1111/jvs.12079; VEKEMANS X, 2002, AFLP SURV VERSION 1; Vendramin GG, 2000, GENOME, V43, P68, DOI 10.1139/gen-43-1-68; Verhaegen D, 2010, TREE GENET GENOMES, V6, P717, DOI 10.1007/s11295-010-0286-x; Wolfe AD, 2004, SYST BOT, V29, P1011, DOI 10.1600/0363644042451008; Yoshida T, 2014, DNA RES, V21, P127, DOI 10.1093/dnares/dst045; ZHIVOTOVSKY LA, 1979, ZH OBSHCH BIOL, V40, P587	105	6	6	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243556	10.1371/journal.pone.0243556	http://dx.doi.org/10.1371/journal.pone.0243556			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306715	gold, Green Published, Green Submitted			2022-12-27	WOS:000600144200022
J	Navarro, FM; Mateos, MR; de la Torre, MGMV				Molina Navarro, Francisco; Rivera Mateos, Manuel; Vazquez de la Torre, Maria Genoveva Millan			Outdoor sports and active tourism company management in Cordoba (southern Spain): An empirical study on the perception and behavior of supply	PLOS ONE			English	Article								This paper analyzes the perception and behavior of active tourism companies that provide outdoor physical sports activities in emerging tourist destinations in Cordoba, an inland province of southern Spain. The active tourism supply of registered businesses was analyzed using fieldwork data and more than 30 variables including training and qualification of human resources, business vision of demand, marketing and promotion strategies, and perceptions of supply trends. To this end, a quantitative-qualitative empirical study was performed together with in-depth interviews of key stakeholders. Official registry sources were also used to complement the data. The results show a fragmented network of micro-SMEs that are functionally isolated from the rest of the tourism supply and display an intuitive and poor market-oriented behavior due to the inadequate management of their client portfolio. Such management models make it difficult for these businesses to take advantage of key strategic assets to increase profitability and achieve a competitive and sustainable advantage.	[Molina Navarro, Francisco] Cordoba Univ, Dept Agr Econ, Cordoba, Spain; [Rivera Mateos, Manuel] Cordoba Univ, Dept Geog, Cordoba, Spain; [Vazquez de la Torre, Maria Genoveva Millan] Univ Loyola Andalucia, Dept Quantitat Methods, Cordoba, Spain	Universidad Loyola Andalucia	de la Torre, MGMV (corresponding author), Univ Loyola Andalucia, Dept Quantitat Methods, Cordoba, Spain.	gmillan@uloyola.es	Mateos, Manuel MRM Rivera/B-4135-2017; Millan Vazquez de la Torre/G-2231-2015	Mateos, Manuel MRM Rivera/0000-0003-2780-380X; Millan Vazquez de la Torre/0000-0002-6635-4456				[Anonymous], 2003, THESIS; Antar-Ecotono U.T.E., 2004, TURISMO NATURA UNPUB; Anton Clave S., 2004, PAPELES EC ESPANOLA, V102, P316; Vila NA, 2012, CONTAB NEG, V7, P59; Augustin J.P., 2007, GEOGRAPHIE SPORT SPA; Augustin J.-P., 2011, ANN GEOGR, V680, P361, DOI DOI 10.3917/ag.680.0361; Augustin J.-P., 2000, MONTAGNES MEDITERRAN, V11, P29; Bell S., 2007, LIVING REV LANDSCAPE, V1, P1, DOI [10.12942/lrlr-2007-2, DOI 10.12942/LRLR-2007-2]; Bessy O, 2004, CAHIER ESPACES SPORT, V81, P13; BETRAN Alberto, 1999, APUNTS EDUCACION FIS, V57, P86; Bote V, 2001, TURISMO ESPACIO RURA; Bourdeau P., 2004, Sport tourism: interrelationships, impacts and issues, P101; Boutroy E, 2012, J ALPINE RES, V100; Brown M., 2009, AUSTR J OUTDOOR ED, V13, P3, DOI [10.1007/BF03400882, DOI 10.1007/BF03400882]; Buckley R, 2006, ADVENTURE TOURISM AU; Caballero P, 2017, ACT C EST ED FIS NAT, P110; Chang SH, 2011, LEISURE SCI, V33, P162, DOI 10.1080/01490400.2011.550233; Corneloup J., 2005, Teoros, Revue de Recherche en Tourisme, V24, P55; Deloitte Advisory S.L, 2014, DIAGN TUR ACT PROV G; Dienot J, 1999, NOUVEAUX LOISIRS SPO; escoitar.org, 2016, ESC; Ewert A., 1987, J PARK RECREATION AD, V5, P57; Gammon S., 2003, J SPORT TOURISM, V8, P21, DOI [10.1080/14775080306236, DOI 10.1080/14775080306236]; Hay M, 2008, PROC VLDB ENDOW, V1, P102, DOI 10.14778/1453856.1453873; Hinch T., 2004, SPORT TOURISM DEV; Ingles E., 2016, APUNT ED FIS DEPORTE, V124, P89, DOI [DOI 10.5672/APUNTS.2014-0983.ES.(2016/2).124.07, 10.5672/apunts.2014-0983.es.(2016/2).124.07]; Instituto de Turismo de Espana, 2008, EST PROD TUR TUR MON; Jimenez P.J., 2005, APUNTS ED FFSICA DEP, V81, P77; Knop P. de, 1990, World Leisure & Recreation, V32, P30; Kurtzman J., 2005, Journal of Sport Tourism, V10, P21, DOI 10.1080/14775080500101478; Lacosta A.L., 2004, CUADERNOS GEOGR FICO, V34, P11; Langenbanch M, 2012, THESIS; Lebreton F, 2013, DISSIDENCES RECREATI; Loret A, 1995, GENERATION GLISSE EA; Mediavilla L, 2008, AGORA EF DEPORTE, V7-8, P63; Millington K., 2001, Travel & Tourism Analyst, P65; Molina Navarro F., 2017, INT J SCI MANAGEMENT, V3, P555; Olivera A., 1995, APUNTS EDUCACION FIS, V41, P108; Palella Stracuzzi S., 2012, METODOLOGIA INVESTIG, V3; Pigeassou C., 1997, J SPORT TOURISM, V4, P24; Pigeassou C., 1997, J SPORTS TOURISM, V4, P20; Pociello C., 1999, SPORTS SCI SOCIALES; Rivera M., 2007, TURISMO SOC ANDALUCI, P51; Rivera M., 2009, 12 C INT TUR U EMPR, P337; Rivera M, 2015, ESTUDIOS REGIONALES, V102, P17; Rivera M.., 2011, RENOVACI N DESTINOS, P701; Rivera Mateos M., 2015, Turismo y Sociedad, V16, P85, DOI 10.18601/01207555.n16.06; Rojo I. Martin, 2006, ESTUDIOS TURISTICOS, V169-170, P145; Thwaites D., 2006, SPORT TOURISM CONCEP; Vigneau F, 2006, THESIS	50	1	1	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243623	10.1371/journal.pone.0243623	http://dx.doi.org/10.1371/journal.pone.0243623			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306740	Green Published, gold			2022-12-27	WOS:000600144200006
J	Morse, JW; Gladkikh, TM; Hackenburg, DM; Gould, RK				Morse, Joshua W.; Gladkikh, Tatiana M.; Hackenburg, Diana M.; Gould, Rachelle K.			COVID-19 and human-nature relationships: Vermonters' activities in nature and associated nonmaterial values during the pandemic	PLOS ONE			English	Article							CULTURAL ECOSYSTEM SERVICES; RARE EVENTS; DISASTER; FRAMEWORK; STRESS; HEALTH; INEQUALITY; BUNDLES; PARK	The COVID-19 pandemic has rapidly modified Earth's social-ecological systems in many ways; here we study its impacts on human-nature interactions. We conducted an online survey focused on peoples' relationships with the non-human world during the pandemic and received valid responses from 3,204 adult residents of the state of Vermont (U.S.A.). We analyzed reported changes in outdoor activities and the values associated with human-nature relationships across geographic areas and demographic characteristics. We find that participation increased on average for some activities (foraging, gardening, hiking, jogging, photography and other art, relaxing alone, walking, and watching wildlife), and decreased for others (camping, relaxing with others). The values respondents ranked as more important during the pandemic factored into two groups, which we label as "Nurture and Recreation values" and "Inspiration and Nourishment values." Using multinomial logistic regression, we found that respondents' preferences for changes in activity engagement and value factors are statistically associated with some demographic characteristics, including geography, gender, income, and employment status during the pandemic. Our results suggest that nature may play an important role in coping during times of crisis, but that the specific interactions and associated values that people perceive as most important may vary between populations. Our findings emphasize for both emergency and natural resources planning the importance of understanding variation in how and why people interact with and benefit from nature during crises.	[Morse, Joshua W.; Gladkikh, Tatiana M.; Hackenburg, Diana M.; Gould, Rachelle K.] Univ Vermont, Rubenstein Sch Environm & Nat Resources, Burlington, VT 05405 USA; [Morse, Joshua W.; Gladkikh, Tatiana M.; Hackenburg, Diana M.; Gould, Rachelle K.] Gund Inst Environm, Burlington, VT 05405 USA; [Gould, Rachelle K.] Bittersweet House, Environm Program, Burlington, VT USA	University of Vermont	Morse, JW (corresponding author), Univ Vermont, Rubenstein Sch Environm & Nat Resources, Burlington, VT 05405 USA.; Morse, JW (corresponding author), Gund Inst Environm, Burlington, VT 05405 USA.	joshua.morse@uvm.edu		Morse, Joshua/0000-0002-6929-7522; Hackenburg, Diana/0000-0003-4678-8297; Marquina, Tatiana/0000-0003-0313-2028	Gund Institute for Environment COVID-19 Rapid Research Fund award; Gund Institute for Environment	Gund Institute for Environment COVID-19 Rapid Research Fund award; Gund Institute for Environment	Funding for this project was provided by a Gund Institute for Environment COVID-19 Rapid Research Fund award (RKG; no number assigned). Funder Name: Gund Institute for Environment (https://www.uvm.edu/gund).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinwande MO, 2015, OPEN J STAT, V5, P754, DOI DOI 10.4236/OJS.2015.57075; Ament J. M., 2017, Conservation Letters, V10, P439; [Anonymous], 2020, CHIN J CRIT CARE INT, V6, P1; [Anonymous], 2014, DIABETES CARE, V1, pS14; Baker R., 2013, J SURV STAT METHODOL, V1, P90, DOI [10.1093/jssam/smt008, DOI 10.1093/JSSAM/SMT008, https:/doi.org/10.1093/jssam/smt008]; Berto R, 2014, BEHAV SCI, V4, P394, DOI 10.3390/bs4040394; Bratman GN, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax0903; Cart J, 2020, TIMES SAN DIEGO; Chan KMA, 2016, P NATL ACAD SCI USA, V113, P1462, DOI 10.1073/pnas.1525002113; Chan KMA, 2012, BIOSCIENCE, V62, P744, DOI 10.1525/bio.2012.62.8.7; Council on the Future of Vermont, 2009, IM VERM VAL VIS FUT, P112; Cusatis R, 2019, SSM-POPUL HLTH, V7, DOI 10.1016/j.ssmph.2019.100387; Dandy N, 2020, ENVIRON VALUE, V29, P253, DOI 10.3197/096327120X15868540131215; Daniel TC, 2012, P NATL ACAD SCI USA, V109, P8812, DOI 10.1073/pnas.1114773109; Derks J, 2020, FOREST POLICY ECON, V118, DOI 10.1016/j.forpol.2020.102253; Diaz S, 2018, SCIENCE, V359, P270, DOI 10.1126/science.aap8826; Donner W, 2008, SOC FORCES, V87, P1089; dos Santos NB, 2018, CURR OPIN ENV SUST, V35, P124, DOI 10.1016/j.cosust.2018.10.019; Elliott MN, 2007, SURV METHODOL, V33, P211; Ernstson H, 2013, LANDSCAPE URBAN PLAN, V109, P7, DOI 10.1016/j.landurbplan.2012.10.005; Finney C., 2014, BLACK FACES WHITE SP, DOI DOI 10.5149/NORTHCAROLINA/9781469614489.001.0001; FIRTH D, 1993, BIOMETRIKA, V80, P27, DOI 10.1093/biomet/80.1.27; Fish R, 2016, ECOSYST SERV, V21, P208, DOI 10.1016/j.ecoser.2016.09.002; Fisher B., 2020, SOCARXIV, DOI [10.31235/osf.io/sd3h6, DOI 10.31235/OSF.IO/SD3H6]; Fortin Jacey, 2020, NY TIMES; Gordon JA, 2020, BIOL PSYCHIAT, V88, P130, DOI 10.1016/j.biopsych.2020.05.012; Gould RK, 2019, PEOPLE NAT, V1, P457, DOI 10.1002/pan3.10044; Gould RK, 2018, AMBIO, V47, P869, DOI 10.1007/s13280-018-1045-8; Gould RK, 2015, CONSERV BIOL, V29, P575, DOI 10.1111/cobi.12407; Haluza D, 2014, INT J ENV RES PUB HE, V11, P5445, DOI 10.3390/ijerph110505445; Herrero-Jauregui C, 2019, LANDSCAPE ECOL, V34, P1525, DOI 10.1007/s10980-018-0756-3; Himes A, 2018, CURR OPIN ENV SUST, V35, P1, DOI 10.1016/j.cosust.2018.09.005; Hirons M, 2016, ANNU REV ENV RESOUR, V41, P545, DOI 10.1146/annurev-environ-110615-085831; Hoelle J, 2018, J LAND USE SCI, V13, P166, DOI [10.1080/1747423X.2018.1475516, 10.1080/1747423x.2018.1475516]; Jennings V, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13020196; Kimmerer R.W., 2013, BRAIDING SWEETGRASS; KING G, 2001, POLITICAL ANAL, V0009; King G, 2001, INT ORGAN, V55, P693, DOI 10.1162/00208180152507597; Klain SC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183962; Klain SC, 2014, ECOL ECON, V107, P310, DOI 10.1016/j.ecolecon.2014.09.003; Knez I, 2018, J ENVIRON PSYCHOL, V55, P11, DOI 10.1016/j.jenvp.2017.11.002; Kondo MC, 2018, HEALTH PLACE, V51, P136, DOI 10.1016/j.healthplace.2018.03.001; Landry CE, 2021, APPL ECON PERSPECT P, V43, P443, DOI 10.1002/aepp.13119; Lesser IA, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17113899; Marshall BK, 2005, ENVIRON BEHAV, V37, P706, DOI 10.1177/0013916505275310; Martin-Lopez B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038970; McLaren HJ, 2020, SOC SCI-BASEL, V9, DOI 10.3390/socsci9050087; Milcu AI, 2013, ECOL SOC, V18, DOI 10.5751/ES-05790-180344; Millennium, 2005, EC HUM WELL BEING SY; Morse J, 2019, CONSERV BIOL SER, P150; Niles MT, 2020, NUTRIENTS, V12, DOI 10.3390/nu12072096; Nir S.M., 2020, NEW YORK TIMES; NYLCV, 2020, NYC SLASH INV ENV PR; Ordonez-Barona C, 2017, URBAN FOR URBAN GREE, V26, P65, DOI 10.1016/j.ufug.2017.06.006; Pascual U, 2017, CURR OPIN ENV SUST, V26-27, P7, DOI 10.1016/j.cosust.2016.12.006; Petrucci CJ, 2009, J SOC SERV RES, V35, P193, DOI 10.1080/01488370802678983; Pierce M, 2020, LANCET PSYCHIAT, V7, P567, DOI 10.1016/S2215-0366(20)30237-6; Plieninger T, 2013, LAND USE POLICY, V33, P118, DOI 10.1016/j.landusepol.2012.12.013; Puhr R, 2017, STAT MED, V36, P2302, DOI 10.1002/sim.7273; Race Bolin B., 2007, HDB DISASTER RES, P113; Randler C, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17197310; Raudsepp-Hearne C, 2010, Proc Natl Acad Sci U S A, V107, P5242, DOI 10.1073/pnas.0907284107; Reid M, 2013, SOCIOL COMPASS, V7, P984, DOI 10.1111/soc4.12080; Rice WL, 2020, LANDSCAPE RES, V45, P892, DOI 10.1080/01426397.2020.1777956; Rice WL, 2020, COVID 19 PANDEMIC IS, P15; Rojas O, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9111983; Rung AL, 2011, DISASTERS, V35, P383, DOI 10.1111/j.1467-7717.2010.01217.x; Russell R, 2013, ANNU REV ENV RESOUR, V38, P473, DOI 10.1146/annurev-environ-012312-110838; Samuelsson K., 2020, LANDSCAPE URBAN PLAN, DOI [10.31219/osf.io/3wx5a, DOI 10.31219/OSF.IO/3WX5A]; Sapra RL., 2014, CURR MED RES PRACT, V4, P130, DOI DOI 10.1016/j.cmrp.2014.06.002; Satz D, 2013, AMBIO, V42, P675, DOI 10.1007/s13280-013-0386-6; Scheufele DA, 1999, J COMMUN, V49, P103, DOI 10.1111/j.1460-2466.1999.tb02784.x; Schroter M, 2020, ECOSYST PEOPLE, V16, P50, DOI 10.1080/26395916.2019.1703039; Schulz JH, 2003, WILDLIFE SOC B, V31, P565; Scott PB, 2020, STAY HOME STAY SAFE; Smith DT, 2018, AM J MENS HEALTH, V12, P78, DOI 10.1177/1557988316630953; Stieger S, 2020, PSYARXIV, DOI [10.31234/osf.io/qjhfp, DOI 10.31234/0SF.I0/QJHFP]; Taylor D., 2016, RISE AM CONSERVATION; Tidball KG, 2012, ECOL SOC, V17, DOI 10.5751/ES-04596-170205; Tidball KG, 2010, ENVIRON EDUC RES, V16, P591, DOI 10.1080/13504622.2010.505437; U.S. Census Bureau, 2019, 2019 TIGER LIN SHAP, P138; U.S. Census Bureau, 2018, AG SEX 2018 ACS 5 YE; U.S. Census Bureau, 2018, 2018 ACS 5 YEAR EST; ULRICH RS, 1991, J ENVIRON PSYCHOL, V11, P201, DOI 10.1016/S0272-4944(05)80184-7; Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z; Venter ZS, 2020, ENVIRON RES LETT, V15, DOI 10.1088/1748-9326/abb396; Vermont Department of Forests Parks and Recreation, 2013, VERM STAT COMPR OUTD, P227; Vernon ME, 2016, HUM DIMENS WILDL, V21, P65, DOI 10.1080/10871209.2016.1099766; Walsh KC, 2012, AM POLIT SCI REV, V106, P517, DOI 10.1017/S0003055412000305; Wenham C, 2020, LANCET, V395, P846, DOI 10.1016/S0140-6736(20)30526-2; Yong AG, 2013, TUTOR QUANT METHODS, V9, P79, DOI 10.20982/tqmp.09.2.p079; Zambrano-Monserrate MA, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138813; Zoderer BM, 2019, ECOSYST SERV, V37, DOI 10.1016/j.ecoser.2019.100938	93	51	51	4	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243697	10.1371/journal.pone.0243697	http://dx.doi.org/10.1371/journal.pone.0243697			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH0WM	33306716	gold, Green Published			2022-12-27	WOS:000600144200050
J	Cardon, E; Joossen, I; Vermeersch, H; Jacquemin, L; Mertens, G; Vanderveken, OM; Topsakal, V; van de Heyning, P; Van Rompaey, V; Gilles, A				Cardon, Emilie; Joossen, Iris; Vermeersch, Hanne; Jacquemin, Laure; Mertens, Griet; Vanderveken, Olivier M.; Topsakal, Vedat; van de Heyning, Paul; Van Rompaey, Vincent; Gilles, Annick			Systematic review and meta-analysis of late auditory evoked potentials as a candidate biomarker in the assessment of tinnitus	PLOS ONE			English	Review							EVENT-RELATED POTENTIALS; SUBJECTIVE TINNITUS; COGNITIVE CONTROL; TOP-DOWN; CORTEX; ADULTS; NOISE; PREVALENCE; PERCEPT; BRAIN	Subjective tinnitus, the perception of sound in the absence of any sound source, is routinely assessed using questionnaires. The subjective nature of these tools hampers objective evaluation of tinnitus presence, severity and treatment effects. Late auditory evoked potentials (LAEPs) might be considered as a potential biomarker for assessing tinnitus complaints. Using a multivariate meta-analytic model including data from twenty-one studies, we determined the LAEP components differing systematically between tinnitus patients and controls. Results from this model indicate that amplitude of the P300 component is lower in tinnitus patients (standardized mean difference (SMD) = -0.83, p < 0.01), while latency of this component is abnormally prolonged in this population (SMD = 0.97, p < 0.01). No other investigated LAEP components were found to differ between tinnitus and non-tinnitus subjects. Additional sensitivity analyses regarding differences in experimental conditions confirmed the robustness of these results. Differences in age and hearing levels between the two experimental groups might have a considerable impact on LAEP outcomes and should be carefully considered in future studies. Although we established consistent differences in the P300 component between tinnitus patients and controls, we could not identify any evidence that this component might covary with tinnitus severity. We conclude that out of several commonly assessed LAEP components, only the P300 can be considered as a potential biomarker for subjective tinnitus, although more research is needed to determine its relationship with subjective tinnitus measures. Future trials investigating experimental tinnitus therapies should consider including P300 measurements in the evaluation of treatment effect.	[Cardon, Emilie; Jacquemin, Laure; Mertens, Griet; Vanderveken, Olivier M.; Topsakal, Vedat; van de Heyning, Paul; Van Rompaey, Vincent; Gilles, Annick] Univ Antwerp, Fac Med & Hlth Sci, Dept Translat Neurosci, Antwerp, Belgium; [Cardon, Emilie; Joossen, Iris; Vermeersch, Hanne; Jacquemin, Laure; Mertens, Griet; Vanderveken, Olivier M.; Topsakal, Vedat; van de Heyning, Paul; Van Rompaey, Vincent; Gilles, Annick] Antwerp Univ Hosp, Univ Dept Otorhinolaryngol & Head & Neck Surg, Edegem, Belgium; [Gilles, Annick] Univ Coll Ghent, Dept Educ Hlth & Social Work, Ghent, Belgium	University of Antwerp; University of Antwerp; HOGENT University College of Applied Sciences & Arts	Cardon, E (corresponding author), Univ Antwerp, Fac Med & Hlth Sci, Dept Translat Neurosci, Antwerp, Belgium.; Cardon, E (corresponding author), Antwerp Univ Hosp, Univ Dept Otorhinolaryngol & Head & Neck Surg, Edegem, Belgium.	emilie.cardon@uantwerpen.be	Mertens, Griet/M-3882-2016; Van Rompaey, Vincent/L-2450-2014	Mertens, Griet/0000-0001-8621-0292; Van Rompaey, Vincent/0000-0003-0912-7780; Topsakal, Vedat/0000-0003-0416-4005; Gilles, Annick/0000-0003-3669-6428; Jacquemin, Laure/0000-0002-3465-9386; Cardon, Emilie/0000-0002-2105-5989	Applied Biomedical Research grant of the University of Antwerp [FWO T001618 N]	Applied Biomedical Research grant of the University of Antwerp	This work was supported by an Applied Biomedical Research grant of the University of Antwerp (FWO T001618 N). The funder provided support in the form of salaries for authors EC, IJ, HV and AG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alain C, 2013, MIDDLE LONG LATENCY; Araneda R, 2015, RESTOR NEUROL NEUROS, V33, P67, DOI 10.3233/RNN-140433; Asadpour A, 2018, FRONT INTEGR NEUROSC, V12, DOI 10.3389/fnint.2018.00048; Attias J, 1996, EAR HEARING, V17, P327, DOI 10.1097/00003446-199608000-00004; ATTIAS J, 1993, HEARING RES, V71, P106, DOI 10.1016/0378-5955(93)90026-W; AXELSSON A, 1989, British Journal of Audiology, V23, P53, DOI 10.3109/03005368909077819; Bhatt JM, 2017, LARYNGOSCOPE, V127, P466, DOI 10.1002/lary.26107; Bhatt JM, 2016, JAMA OTOLARYNGOL, V142, P959, DOI 10.1001/jamaoto.2016.1700; Campbell J, 2019, AM J AUDIOL, V28, P209, DOI 10.1044/2019_AJA-TTR17-18-0036; Cardon E, 2019, OTOL NEUROTOL, V40, pE876, DOI 10.1097/MAO.0000000000002403; Das SK, 2012, LARYNGOSCOPE, V122, P2533, DOI 10.1002/lary.23555; De Ridder D, 2014, NEUROSCI BIOBEHAV R, V44, P16, DOI 10.1016/j.neubiorev.2013.03.021; Degeest S, 2017, J SPEECH LANG HEAR R, V60, P1036, DOI 10.1044/2016_JSLHR-H-16-0090; Delb W, 2008, APPL PSYCHOPHYS BIOF, V33, P211, DOI 10.1007/s10484-008-9065-y; Deniz M, 2010, OTOL NEUROTOL, V31, P19, DOI 10.1097/MAO.0b013e3181c2dcbc; Dobie R. A., 2004, TINNITUS THEORY MANA, P1; DONCHIN E, 1981, PSYCHOPHYSIOLOGY, V18, P493, DOI 10.1111/j.1469-8986.1981.tb01815.x; Donchin E, 1987, Electroencephalogr Clin Neurophysiol Suppl, V39, P338; Dornhoffer John, 2006, Int Tinnitus J, V12, P9; Durai M, 2019, EAR HEARING, V40, P345, DOI 10.1097/AUD.0000000000000620; Eggermont JJ, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00053; Fowler EP, 1944, ARCHIV OTOLARYNGOL, V39, P498; Gabr TA, 2011, AURIS NASUS LARYNX, V38, P678, DOI 10.1016/j.anl.2011.02.001; Gilles A, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00071; Gopal KV, 2017, J AM ACAD AUDIOL, V28, P742, DOI 10.3766/jaaa.16106; Hallam RS, 2004, INT J AUDIOL, V43, P218, DOI 10.1080/14992020400050030; HALLAM RS, 1988, BRIT J CLIN PSYCHOL, V27, P213, DOI 10.1111/j.2044-8260.1988.tb00778.x; Henry J.A., 2000, J AM ACAD AUDIOL, V11, P138; Henry JA, 2016, OTOL NEUROTOL, V37, pE276, DOI 10.1097/MAO.0000000000001070; Hoare DJ, 2015, COCHRANE DB SYST REV, P6, DOI [10.1002/14651858.CD011760, DOI 10.1002/14651858.CD011760]; Hong SK, 2016, HEARING RES, V342, P86, DOI 10.1016/j.heares.2016.10.002; Houdayer E, 2015, CLIN NEUROPHYSIOL, V126, P2356, DOI 10.1016/j.clinph.2015.01.027; Jacobson Gary P, 2003, J Am Acad Audiol, V14, P393; Jacobson GP, 1996, HEARING RES, V97, P66, DOI 10.1016/0378-5955(96)00055-X; Jacquemin L, 2019, HEARING RES, V382, DOI 10.1016/j.heares.2019.107796; Jacquemin L, 2019, OTOL NEUROTOL, V40, pE868, DOI 10.1097/MAO.0000000000002380; Joos K, 2014, NEUROSCI BIOBEHAV R, V42, P148, DOI 10.1016/j.neubiorev.2014.02.009; Kiehl KA, 2001, PSYCHOPHYSIOLOGY, V38, P133, DOI 10.1111/1469-8986.3810133; Leaver AM, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00021; Light R.J., 1984, SUMMING SCI REV RES; Linden DEJ, 2005, NEUROSCIENTIST, V11, P563, DOI 10.1177/1073858405280524; Lovstad M, 2012, BRAIN COGNITION, V80, P237, DOI 10.1016/j.bandc.2012.07.008; Mahmoudian S, 2015, J AM ACAD AUDIOL, V26, P408, DOI 10.3766/jaaa.26.4.8; Majhi SK, 2019, INDIAN J OTOLARYNGOL, V71, P1426, DOI 10.1007/s12070-018-1509-y; Mannarelli D, 2017, CLIN NEUROPHYSIOL, V128, P411, DOI 10.1016/j.clinph.2016.12.028; McCormack A, 2016, HEARING RES, V337, P70, DOI 10.1016/j.heares.2016.05.009; McPherson DL, 1996, LATE POTENTIALS AUDI; Meikle MB, 2012, EAR HEARING, V33, P153, DOI 10.1097/AUD.0b013e31822f67c0; Meikle Mary B, 2008, Trends Amplif, V12, P223, DOI 10.1177/1084713808319943; Meikle MB, 1997, OTOLARYNG HEAD NECK, V117, P698, DOI 10.1016/S0194-5998(97)70055-X; MEIKLE MB, 1984, OTOLARYNG HEAD NECK, V92, P689, DOI 10.1177/019459988409200617; Menon V, 1997, NEUROREPORT, V8, P3029, DOI 10.1097/00001756-199709290-00007; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Morse K, 2019, AM J AUDIOL, V28, P260, DOI 10.1044/2018_AJA-18-0074; Mueller MK, 2018, BMC PUBLIC HEALTH, V18, DOI [10.1186/s12889-018-5188-0, 10.1186/s12889-018-5585-4]; Newman CW, 1996, ARCH OTOLARYNGOL, V122, P143; Norena A, 1999, CLIN NEUROPHYSIOL, V110, P666, DOI 10.1016/S1388-2457(98)00034-0; Picton TW, 2011, HUMAN AUDITORY EVOKE; POLICH J, 1983, PSYCHOPHYSIOLOGY, V20, P665, DOI 10.1111/j.1469-8986.1983.tb00936.x; Polich John, 2004, Phys Med Rehabil Clin N Am, V15, P133, DOI 10.1016/S1047-9651(03)00109-8; Rabau S, 2015, EUR ARCH OTO-RHINO-L, V272, P573, DOI 10.1007/s00405-013-2876-3; Rauschecker JP, 2015, TRENDS COGN SCI, V19, P567, DOI 10.1016/j.tics.2015.08.002; Reinvang I, 1999, NEUROPSYCHOL REV, V9, P231, DOI 10.1023/A:1021638723486; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Riga M, 2016, INT J AUDIOL, V55, P775, DOI 10.1080/14992027.2016.1219778; Rufener KS, 2014, BRAIN BEHAV, V4, P21, DOI 10.1002/brb3.188; Sanchez TG, 2002, PRO-FONO REV ATUAL C, V14, P111; Santos Filha Valdete Alves Valentins dos, 2010, Braz. j. otorhinolaryngol., V76, P263; Schecklmann M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086944; SHIRAISHI T, 1991, AM J OTOLARYNG, V12, P267, DOI 10.1016/0196-0709(91)90004-Y; Shore SE, 2016, NAT REV NEUROL, V12, P150, DOI 10.1038/nrneurol.2016.12; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tugumia D, 2016, CODAS, V28, P27, DOI 10.1590/2317-1782/20162015113; Tunkel DE, 2014, OTOLARYNG HEAD NECK, V151, pS1, DOI 10.1177/0194599814545325; Van de Heyning P, 2015, CURR OPIN OTOLARYNGO, V23, P369, DOI 10.1097/MOO.0000000000000183; Vanneste S, 2019, J NEUROSCI, V39, P364, DOI 10.1523/JNEUROSCI.0966-18.2018; Vanneste S, 2016, BRAIN RES, V1642, P170, DOI 10.1016/j.brainres.2016.03.016; Vernon JA, 2003, OTOLARYNG CLIN N AM, V36, P293, DOI 10.1016/S0030-6665(02)00162-7; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Walpurger V, 2003, HEARING RES, V181, P57, DOI 10.1016/S0378-5955(03)00172-2; Wise K, 2016, GAMES HEALTH J, V5, P141, DOI 10.1089/g4h.2015.0068; Yang HD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070831	83	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243785	10.1371/journal.pone.0243785	http://dx.doi.org/10.1371/journal.pone.0243785			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PI8BZ	33332414	Green Published, gold			2022-12-27	WOS:000601310900003
J	Flavell, JC; McKean, B				Flavell, Jonathan Charles; McKean, Bryony			Motion fluency effects on object preference is limited to learned context	PLOS ONE			English	Article							PERCEPTION; AVOIDANCE; SHOCK; RATS	Recently, Flavell et al. (2019) demonstrated that an object's motion fluency (how smoothly and predictably it moves) influences liking of the object itself. Though the authors demonstrated learning of object-motion associations, participants only preferred fluently associated objects over disfluently associated objects when ratings followed a moving presentation but not a stationary presentation. In the presented experiment, we tested the possibility that this apparent failure of associative learning / evaluative conditioning was due to stimulus choice. To do so we replicate part of the original work but change the 'naturally stationary' household object stimuli with winged insects which move in a similar way to the original motions. Though these more ecologically valid stimuli should have facilitated object to motion associations, we again found that preference effects were only apparent following moving presentations. These results confirm the potential of motion fluency for 'in the moment' preference change, and they demonstrate a critical boundary condition that should be considered when attempting to generalise fluency effects across contexts such as in advertising or behavioural interventions.	[Flavell, Jonathan Charles; McKean, Bryony] Univ York, Dept Psychol, York, N Yorkshire, England	University of York - UK	Flavell, JC (corresponding author), Univ York, Dept Psychol, York, N Yorkshire, England.	jonathan.flavell@york.ac.uk		Flavell, Jonathan/0000-0001-9521-8827	Leverhulme Trust (leverhulme.ac.uk) [RPG-2016-068]	Leverhulme Trust (leverhulme.ac.uk)(Leverhulme Trust)	This research was supported by a Leverhulme Trust (leverhulme.ac.uk) grant awarded to Steven P Tipper and Harriet Over (grant reference no. RPG-2016-068). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X; De Houwer J, 2001, PSYCHOL BULL, V127, P853, DOI 10.1037//0033-2909.127.6.853; Endo Y, 2000, PHYSIOL BEHAV, V71, P263, DOI 10.1016/S0031-9384(00)00339-5; Erle TM, 2017, EMOTION, V17, P856, DOI 10.1037/emo0000293; Flavell JC, 2020, J EXP PSYCHOL HUMAN, V46, P231, DOI 10.1037/xhp0000702; Flavell JC, 2019, J EXP PSYCHOL LEARN, V45, P1569, DOI 10.1037/xlm0000667; Flavello JC, 2018, EMOTION, V18, P736, DOI 10.1037/emo0000386; GARCIA J, 1970, PSYCHON SCI, V20, P313, DOI 10.3758/BF03329085; Garcia J, 1968, Recent Adv Biol Psychiatry, V10, P284; Garcia J, 1967, P WORKSH C SPAC RAD, V7; GREEN L, 1973, B PSYCHONOMIC SOC, V1, P137; GREEN L, 1972, BEHAV BIOL, V7, P513, DOI 10.1016/S0091-6773(72)80213-X; GROTE FW, 1971, PSYCHON SCI, V25, P163; Kleiner M, 2007, PERCEPTION, V36, P14; Makin ADJ, 2012, NEUROPSYCHOLOGIA, V50, P3250, DOI 10.1016/j.neuropsychologia.2012.10.003; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Phaf RH, 2020, THEOR PSYCHOL, V30, P263, DOI 10.1177/0959354319898250; Reber R, 1998, PSYCHOL SCI, V9, P45, DOI 10.1111/1467-9280.00008; Winkielman P, 2003, PSYCHOLOGY OF EVALUATION, P189	20	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0244110	10.1371/journal.pone.0244110	http://dx.doi.org/10.1371/journal.pone.0244110			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PI8BZ	33332442	gold, Green Published			2022-12-27	WOS:000601310900010
J	van Leeuwen, AM; van Dieen, JH; Daffertshofer, A; Bruijn, SM				van Leeuwen, A. M.; van Dieen, J. H.; Daffertshofer, A.; Bruijn, S. M.			Active foot placement control ensures stable gait: Effect of constraints on foot placement and ankle moments	PLOS ONE			English	Article							BALANCE PERTURBATIONS; LATERAL BALANCE; STEP WIDTH; WALKING; ADJUSTMENTS; RESPONSES; STRATEGY; MUSCLES; MOTION	Step-by-step foot placement control, relative to the center of mass (CoM) kinematic state, is generally considered a dominant mechanism for maintenance of gait stability. By adequate (mediolateral) positioning of the center of pressure with respect to the CoM, the ground reaction force generates a moment that prevents falling. In healthy individuals, foot placement is complemented mainly by ankle moment control ensuring stability. To evaluate possible compensatory relationships between step-by-step foot placement and complementary ankle moments, we investigated the degree of (active) foot placement control during steady-state walking, and under either foot placement-, or ankle moment constraints. Thirty healthy participants walked on a treadmill, while full-body kinematics, ground reaction forces and EMG activities were recorded. As a replication of earlier findings, we first showed step-by-step foot placement is associated with preceding CoM state and hip ab-/adductor activity during steady-state walking. Tight control of foot placement appears to be important at normal walking speed because there was a limited change in the degree of foot placement control despite the presence of a foot placement constraint. At slow speed, the degree of foot placement control decreased substantially, suggesting that tight control of foot placement is less essential when walking slowly. Step-by-step foot placement control was not tightened to compensate for constrained ankle moments. Instead compensation was achieved through increases in step width and stride frequency.	[van Leeuwen, A. M.; van Dieen, J. H.; Daffertshofer, A.; Bruijn, S. M.] Vrije Univ Amsterdam, Fac Behav & Movement Sci, Dept Human Movement Sci, Amsterdam Movement Sci, Amsterdam, Netherlands; [van Leeuwen, A. M.; Daffertshofer, A.; Bruijn, S. M.] Inst Brain & Behav Amsterdam, Amsterdam, Netherlands; [Bruijn, S. M.] Fujian Med Univ, Biomech Lab, Quanzhou, Fujian, Peoples R China	Vrije Universiteit Amsterdam; Fujian Medical University	Bruijn, SM (corresponding author), Vrije Univ Amsterdam, Fac Behav & Movement Sci, Dept Human Movement Sci, Amsterdam Movement Sci, Amsterdam, Netherlands.; Bruijn, SM (corresponding author), Inst Brain & Behav Amsterdam, Amsterdam, Netherlands.; Bruijn, SM (corresponding author), Fujian Med Univ, Biomech Lab, Quanzhou, Fujian, Peoples R China.	s.m.bruijn@gmail.com	van Dieen, Jaap/B-3937-2013; Bruijn, Sjoerd/H-9021-2013	van Dieen, Jaap/0000-0002-7719-5585; Bruijn, Sjoerd/0000-0003-0290-2131; Daffertshofer, Andreas/0000-0001-9107-3552; van Leeuwen, Moira/0000-0001-9620-2990	Netherlands Organization for Scientific Research [Vidi.178.014]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	Sjoerd M. Bruijn and Moira van Leeuwen were supported by a grant from the Netherlands Organization for Scientific Research (016.Vidi.178.014), https://www.nwo.nl/en/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afschrift M, 2019, GAIT POSTURE, V68, P575, DOI 10.1016/j.gaitpost.2019.01.010; [Anonymous], 2014, ALZHEIMERS DEMENT J, V10, pe47; Arvin M, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01134; Barton SL, 2019, EXP BRAIN RES, V237, P1673, DOI 10.1007/s00221-019-05538-7; Bruijn SM, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2017.0816; Buurke TJW, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49033-z; de Leva P, 1996, J BIOMECH, V29, P1223, DOI 10.1016/0021-9290(95)00178-6; Donelan JM, 2001, P ROY SOC B-BIOL SCI, V268, P1985, DOI 10.1098/rspb.2001.1761; Donelan JM, 2004, J BIOMECH, V37, P827, DOI 10.1016/j.jbiomech.2003.06.002; Fettrow T, 2019, WALKING CADENCE AFFE; Fettrow T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225902; Hak L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082842; Hak L, 2013, J BIOMECH, V46, P905, DOI 10.1016/j.jbiomech.2012.12.017; Hermens HJ, 1999, EUROPEAN RECOMMENDAT, V8, P13, DOI [10.1016/S1050-6411(00)00027-4, DOI 10.1016/S1050-6411(00)00027-4]; Hof AL, 2018, HUM MOVEMENT SCI, V57, P69, DOI 10.1016/j.humov.2017.11.009; Hof AL, 2013, EXP BRAIN RES, V230, P301, DOI 10.1007/s00221-013-3655-5; HOF AL, 1996, GAIT POSTURE, V4, P222; Hof AL, 2007, J BIOMECH, V40, P451, DOI 10.1016/j.jbiomech.2005.12.016; Hof AL, 2007, GAIT POSTURE, V25, P250, DOI 10.1016/j.gaitpost.2006.04.013; Kim M, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0027-3; Mahaki M, 2019, PEERJ, V7, DOI 10.7717/peerj.7939; Matthis JS, 2017, P NATL ACAD SCI USA, V114, pE6720, DOI 10.1073/pnas.1611699114; Neptune RR, 2016, J BIOMECH, V49, P2975, DOI 10.1016/j.jbiomech.2016.07.016; Patil NS, 2019, J BIOMECH, V97, DOI 10.1016/j.jbiomech.2019.109375; Perry JA, 2018, ROY SOC OPEN SCI, V5, DOI [10.6084/m9.figshare.c.3864301, 10.1098/rsos.160627]; Rankin BL, 2014, J NEUROPHYSIOL, V112, P374, DOI 10.1152/jn.00138.2014; Rebula JR, 2017, J BIOMECH, V53, P1, DOI 10.1016/j.jbiomech.2016.11.059; Reimann H., 2018, KINESIOL REV, V7, P18, DOI [10.1123/kr.2017-0053, DOI 10.1123/KR.2017-0053]; Reimann H, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01271; Reimann H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172215; Reimold NK, 2019, ALTERED ACTIVE CONTR; Reynolds RF, 2005, CURR BIOL, V15, pR48, DOI 10.1016/j.cub.2004.12.051; Roerdink M, 2008, J BIOMECH, V41, P2628, DOI 10.1016/j.jbiomech.2008.06.023; Stimpson KH, 2018, J BIOMECH, V68, P78, DOI 10.1016/j.jbiomech.2017.12.026; Vlutters M, 2018, J BIOMECH, V68, P93, DOI 10.1016/j.jbiomech.2017.12.021; Wagenmakers EJ, 2007, PSYCHON B REV, V14, P779, DOI 10.3758/BF03194105; Wu MN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132707; Young PMM, 2012, GAIT POSTURE, V35, P472, DOI 10.1016/j.gaitpost.2011.11.010; Zatsiorsky V, 1990, CONTEMPORASY PROBLEM; Zhang YJ, 2020, J PHYSIOL-LONDON, V598, P1987, DOI 10.1113/JP278986	40	9	9	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0242215	10.1371/journal.pone.0242215	http://dx.doi.org/10.1371/journal.pone.0242215			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332421	Green Published, gold, Green Submitted			2022-12-27	WOS:000601310900009
J	Wang, J; Guo, SZ; Zhang, YL; Gao, K; Zuo, JC; Tan, NN; Du, KJ; Ma, Y; Hou, Y; Li, QT; Xu, HM; Huang, J; Huang, QH; Na, H; Wang, JW; Wang, XY; Xiao, YH; Zhu, JT; Chen, H; Liu, Z; Wang, MX; Zhang, LS; Wang, W				Wang, Juan; Guo, Shuzhen; Zhang, Yili; Gao, Kuo; Zuo, Jiacheng; Tan, Nannan; Du, Kangjia; Ma, Yan; Hou, Yong; Li, Quntang; Xu, Hongming; Huang, Jin; Huang, Qiuhua; Na, Hui; Wang, Jingwei; Wang, Xiaoyan; Xiao, Yanhua; Zhu, Junteng; Chen, Hong; Liu, Zhang; Wang, Mingxuan; Zhang, Linsong; Wang, Wei			Clinical features and risk factors for severe inpatients with COVID-19: A retrospective study in China	PLOS ONE			English	Article							SARS CORONAVIRUS; INFECTION; WUHAN; ACE2	Background A worldwide outbreak of coronavirus disease (COVID-19), since 2019, has brought a disaster to people all over the world. Many researchers carried out clinical epidemiological studies on patients with COVID-19 previously, but risk factors for patients with different levels of severity are still unclear. Methods 562 patients with laboratory-confirmed COVID-19 from 12 hospitals in China were included in this retrospective study. Related clinical information, therapies, and imaging data were extracted from electronic medical records and compared between patients with severe and non-severe status. We explored the risk factors associated with different severity of COVID-19 patients by logistic regression methods. Results Based on the guideline we cited, 509 patients were classified as non-severe and 53 were severe. The age range of whom was 5-87 years, with a median age of 47 (IQR 35.0-57.0). And the elderly patients (older than 60 years old) in non-severe group were more likely to suffer from fever and asthma, accompanied by higher level of D-dimer, red blood cell distribution width and low-density lipoprotein. Furthermore, we found that the liver and kidney function of male patients was worse than that of female patients in both severe and non-severe groups with different age levels, while the severe females had faster ESR and lower inflammatory markers. Of major laboratory markers in non-severe cases, baseline albumin and the lymphocyte percentage were higher, while the white blood cell and the neutrophil count were lower. In addition, severe patients were more likely to be accompanied by an increase in cystatin C, mean hemoglobin level and a decrease in oxygen saturation. Besides that, advanced age and indicators such as count of white blood cell, glucose were proved to be the most common risk factors preventing COVID-19 patients from aggravating. Conclusion The potential risk factors found in our study have shown great significance to prevent COVID-19 patients from aggravating and turning to critical cases during treatment. Meanwhile, focusing on gender and age factors in groups with different severity of COVID-19, and paying more attention to specific clinical symptoms and characteristics, could improve efficacy of personalized intervention to treat COVID-19 effectively.	[Wang, Juan] Beijing Univ Chinese Med, Dept Educ Adm, Beijing, Peoples R China; [Guo, Shuzhen] Beijing Univ Chinese Med, Dept Sci Res, Beijing, Peoples R China; [Zhang, Yili; Gao, Kuo; Zuo, Jiacheng; Tan, Nannan; Du, Kangjia] Beijing Univ Chinese Med, Sch Tradit Chinese Med, Beijing, Peoples R China; [Ma, Yan] China Acad Chinese Med Sci, Inst Basic Res Clin Med, Beijing, Peoples R China; [Hou, Yong] Anhui Univ Tradit Chinese Med, Affiliated Hosp 1, Hefei, Anhui, Peoples R China; [Li, Quntang] Chongqing Tradit Chinese Med Hosp, Chongqing, Peoples R China; [Xu, Hongming] Daqing Second Hosp, Dept Infect Dis, Daqing, Heilongjiang, Peoples R China; [Huang, Jin; Huang, Qiuhua] Peoples Hosp GuangXi Zhuang Autonomous Reg, Dept Tradit Chinese Med, Nanning, Guangxi, Peoples R China; [Na, Hui; Wang, Jingwei] Harbin Infect Dis Hosp, Dept Infect Dis, Harbin, Heilongjiang, Peoples R China; [Wang, Xiaoyan] Jinzhong Infect Dis Hosp, Dept Infect Dis, Jinzhong, Shanxi, Peoples R China; [Xiao, Yanhua] Mudanjiang Kangan Hosp, Dept Tradit Chinese Med, Mudanjiang, Heilongjiang, Peoples R China; [Zhu, Junteng] Putian Coll, Dept Rehabil Med, Affiliated Hosp, Putian, Fujian, Peoples R China; [Chen, Hong] First Hosp Qiqihar, Presidents Off, Qiqihar, Heilongjiang, Peoples R China; [Liu, Zhang] First Hosp Suihua City, Dept Tradit Chinese Med, Suihua, Heilongjiang, Peoples R China; [Wang, Mingxuan] Suining Cent Hosp, Dept Tradit Chinese Med, Suining, Sichuan, Peoples R China; [Zhang, Linsong] Southwest Med Univ, Dept Tradit Chinese Med, Hosp TCM, Luzhou, Sichuan, Peoples R China; [Wang, Wei] Beijing Univ Chinese Med, Presidents Off, Beijing, Peoples R China	Beijing University of Chinese Medicine; Beijing University of Chinese Medicine; Beijing University of Chinese Medicine; China Academy of Chinese Medical Sciences; Institute of Basic Research In Clinical Medicine, CACMS; Anhui University of Chinese Medicine; Putian University; Southwest Medical University; Beijing University of Chinese Medicine	Wang, W (corresponding author), Beijing Univ Chinese Med, Presidents Off, Beijing, Peoples R China.	wangwei26960@126.com	wang, jing/GVT-8700-2022; Wu, Jing/GZK-5063-2022; Wang, Jin/GYA-2019-2022	Zhang, Yili/0000-0002-0044-8759	National Key R&D Program of China [2017YFC1700100]	National Key R&D Program of China	The study was supported by National Key R&D Program of China (No. 2017YFC1700100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1001/jama.2020.2565, 10.1056/NEJMoa2001316]; Booth CM, 2003, JAMA-J AM MED ASSOC, V289, P2801, DOI 10.1001/jama.289.21.JOC30885; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Chu H, 2016, J INFECT DIS, V213, P904, DOI 10.1093/infdis/jiv380; Cook T. M, 2020, ANAESTHESIA, V75, P962; General Office of the National Health Commission, DIAGN TREATM NEW CRO; Gheblawi M, 2020, CIRC RES, V126, P1456, DOI 10.1161/CIRCRESAHA.120.317015; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Guo WN, 2020, DIABETES-METAB RES, V36, DOI 10.1002/dmrr.3319; He ZP, 2005, INT J INFECT DIS, V9, P323, DOI 10.1016/j.ijid.2004.07.014; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Ielapi N, 2020, BIOMARK MED, V14, P713, DOI 10.2217/bmm-2020-0201; Jaeckel E, 2002, ANN NY ACAD SCI, V958, P7; Jali M V, 1990, J Assoc Physicians India, V38, P663; Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; Li HD, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00190; Lian JS, 2020, INFLUENZA OTHER RESP, V14, P564, DOI 10.1111/irv.12758; Liao XL, 2020, INTENS CARE MED, V46, P357, DOI 10.1007/s00134-020-05954-2; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Lyu JL, 2020, MED HYPOTHESES, V143, DOI 10.1016/j.mehy.2020.109842; Murthy S, 2020, JAMA-J AM MED ASSOC, V323, P1499, DOI 10.1001/jama.2020.3633; Osama T, 2020, J ROY SOC MED, V113, P169, DOI 10.1177/0141076820921107; Roivainen M, 2000, J CLIN ENDOCR METAB, V85, P432, DOI 10.1210/jc.85.1.432; Ruan QR, 2020, INTENS CARE MED, V46, P846, DOI 10.1007/s00134-020-05991-x; Sarzi-Puttini P, 2020, CLIN EXP RHEUMATOL, V38, P337, DOI 10.55563/clinexprheumatol/xcdary; Swerdlow DL, 2020, JAMA-J AM MED ASSOC, V323, P1129, DOI 10.1001/jama.2020.1960; Thompson BT, 2017, NEW ENGL J MED, V377, P562, DOI [10.1056/NEJMra1608077, 10.1056/NEJMc1711824]; Wada Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035069; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; Wei M, 2020, JAMA-J AM MED ASSOC, V323, P1313, DOI 10.1001/jama.2020.2131; World Health Organization. Interium guidance, INT GUID CLIN MAN SE; Wu Z, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI [10.1001/jama.2020.2648, DOI 10.1001/JAMA.2020.2648]; Xia N., 2020, SEROLOGICAL TEST IS, DOI [10.20944/preprints202003.0184.v1, 10.20944/preprints202003.0184.v2, DOI 10.20944/PREPRINTS202003.0184.V1]; Xu Zhe, 2020, Lancet Respir Med, V8, P420, DOI 10.1016/S2213-2600(20)30076-X; Yan Ma, 2020, LANCET; Yang JK, 2006, DIABETIC MED, V23, P623, DOI 10.1111/j.1464-5491.2006.01861.x; Yang JK, 2010, ACTA DIABETOL, V47, P193, DOI 10.1007/s00592-009-0109-4; Zheng HY, 2020, CELL MOL IMMUNOL, V17, P541, DOI 10.1038/s41423-020-0401-3; Zheng MJ, 2020, CELL MOL IMMUNOL, V17, P533, DOI 10.1038/s41423-020-0402-2; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	43	9	9	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0244125	10.1371/journal.pone.0244125	http://dx.doi.org/10.1371/journal.pone.0244125			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332437	Green Published, gold			2022-12-27	WOS:000601310900019
J	Akima, H; Yoshiko, A; Radaelli, R; Ogawa, M; Shimizu, K; Tomita, A; Maeda, H; Neske, R; Teodoro, J; Maeda, K; Tanaka, N; Pinto, R				Akima, Hiroshi; Yoshiko, Akito; Radaelli, Regis; Ogawa, Madoka; Shimizu, Kaori; Tomita, Aya; Maeda, Hisashi; Neske, Rodrigo; Teodoro, Juliana; Maeda, Kazuhiro; Tanaka, Noriko; Pinto, Ronei			Comparison of muscle quality and functional capacity between Japanese and Brazilian older individuals	PLOS ONE			English	Article							ADIPOSE-TISSUE; BODY-COMPOSITION; SKELETAL-MUSCLE; ECHO INTENSITY; BIOELECTRICAL-IMPEDANCE; GLUCOSE-TOLERANCE; INTRAMUSCULAR FAT; SIZE; MEN; INFILTRATION	Muscle quality is well-known to decrease with aging and is a risk factor for metabolic abnormalities. However, there is a lack of information on race-associated differences in muscle quality and other neuromuscular features related to functional performance. This study aimed to compare muscle quality, function, and morphological characteristics in Japanese and Brazilian older individuals. Eighty-four participants aged 65-87 years were enrolled in the study (42 Japanese: 23 men, 19 women, mean age 70.4 years; 42 Brazilians: 23 men, 19 women, mean age 70.8 years). Echo intensity (EI) and muscle thickness (MT) of the quadriceps femoris were measured using B-mode ultrasonography. A stepwise multiple linear regression analysis with EI as a dependent variable revealed that MT was a significant variable for Japanese participants (R-2 = 0.424, P = 0.001), while MT and subcutaneous adipose tissue (SCAT) thickness were significant variables for Brazilian participants (R-2 = 0.490, P = 0.001). A second stepwise multiple linear regression analysis was performed after excluding MT and SCAT thickness from the independent variables. Sex and age for Japanese participants (R-2 = 0.381, P = 0.001) and lean body mass and body mass index for Brazilian participants (R-2 = 0.385, P = 0.001) were identified as significant independent variables. The present results suggest that MT is closely correlated with muscle quality in Japanese and Brazilian older individuals. Increases in muscle size may induce decreases in intramuscular adipose tissue and/or connective tissues, which are beneficial for reducing the risks of metabolic impairments in Japanese and Brazilian older individuals.	[Akima, Hiroshi; Tanaka, Noriko] Nagoya Univ, Res Ctr Hlth Phys Fitness & Sports, Nagoya, Aichi, Japan; [Akima, Hiroshi; Shimizu, Kaori; Maeda, Kazuhiro; Tanaka, Noriko] Nagoya Univ, Grad Sch Educ & Human Dev, Nagoya, Aichi, Japan; [Yoshiko, Akito; Tomita, Aya] Chukyo Univ, Sch Int Liberal Studies, Toyota, Aichi, Japan; [Radaelli, Regis; Neske, Rodrigo; Teodoro, Juliana; Pinto, Ronei] Fed Univ Rio Grande do Sul UFRGS, Exercise Res Lab LAPEX, Port Alegre, RS, Brazil; [Ogawa, Madoka] Nippon Sport Sci Univ, Fac Sport Sci, Setagaya Ku, Tokyo, Japan; [Maeda, Hisashi] Nagoya Univ, Grad Sch Med, Nagoya, Aichi, Japan; [Maeda, Hisashi] Natl Cerebral & Cardiovasc Ctr, Suita, Osaka, Japan	Nagoya University; Nagoya University; Chukyo University; Nippon Sport Science University; Nagoya University; National Cerebral & Cardiovascular Center - Japan	Akima, H (corresponding author), Nagoya Univ, Res Ctr Hlth Phys Fitness & Sports, Nagoya, Aichi, Japan.; Akima, H (corresponding author), Nagoya Univ, Grad Sch Educ & Human Dev, Nagoya, Aichi, Japan.	akima@nagoya-u.jp	Radaelli, Régis/AAZ-1362-2021; Pinto, Ronei Silveira/J-3931-2014	Radaelli, Régis/0000-0002-1521-2124; Silveira Pinto, Ronei/0000-0002-5827-5723; Neske, Rodrigo/0000-0003-4983-0374	JSPS Bilateral Open Partnership Joint Research Projects [HA 18039901-000282]	JSPS Bilateral Open Partnership Joint Research Projects	HA 18039901-000282 JSPS Bilateral Open Partnership Joint Research Projects https://www.jsps.go.jp/english/e-bilat/index.html The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akima H, 2003, MED SCI SPORT EXER, V35, P655, DOI 10.1249/01.MSS.0000058367.66796.35; Akima H, 2020, EXP GERONTOL, V138, DOI 10.1016/j.exger.2020.111015; Akima H, 2017, ARCH GERONTOL GERIAT, V70, P105, DOI 10.1016/j.archger.2017.01.014; Akima H, 2016, MAGN RESON IMAGING, V34, P397, DOI 10.1016/j.mri.2015.12.038; Akima H, 2015, EUR J APPL PHYSIOL, V115, P1627, DOI 10.1007/s00421-015-3148-2; [Anonymous], 2014, OBESITY SILVER SP S2, V22, pS40; Boettcher M, 2009, J MAGN RESON IMAGING, V29, P1340, DOI 10.1002/jmri.21754; Caresio C, 2015, CLIN PHYSIOL FUNCT I, V35, P393, DOI 10.1111/cpf.12175; Elder CP, 2004, SPINAL CORD, V42, P711, DOI 10.1038/sj.sc.3101652; Ferreira Sandra R G, 2002, J Epidemiol, V12, P431; Frontera WR, 2000, J APPL PHYSIOL, V88, P1321; Fukumoto Y, 2012, EUR J APPL PHYSIOL, V112, P1519, DOI 10.1007/s00421-011-2099-5; Gallagher D, 2005, AM J CLIN NUTR, V81, P903, DOI 10.1093/ajcn/81.4.903; Goodpaster BH, 2003, DIABETES CARE, V26, P372, DOI 10.2337/diacare.26.2.372; Hatakenaka M, 2001, INVEST RADIOL, V36, P692, DOI 10.1097/00004424-200112000-00003; Hind K, 2011, EUR J CLIN NUTR, V65, P140, DOI 10.1038/ejcn.2010.190; Leahy S, 2012, EUR J APPL PHYSIOL, V112, P589, DOI 10.1007/s00421-011-2010-4; LEXELL J, 1988, J NEUROL SCI, V84, P275, DOI 10.1016/0022-510X(88)90132-3; Lopez P, 2017, MUSCLE NERVE, V55, P9, DOI 10.1002/mus.25168; Maeda H, 2019, EUR NEUROL, V81, P56, DOI 10.1159/000500415; Marcus RL, 2010, J NUTR HEALTH AGING, V14, P362, DOI 10.1007/s12603-010-0081-2; Melvin MN, 2014, ULTRASOUND MED BIOL, V40, P1973, DOI 10.1016/j.ultrasmedbio.2014.03.012; Miljkovic I, 2009, J CLIN ENDOCR METAB, V94, P2735, DOI 10.1210/jc.2008-2541; Newman AB, 2006, J GERONTOL A-BIOL, V61, P72, DOI 10.1093/gerona/61.1.72; Park YW, 2001, OBES RES, V9, P381, DOI 10.1038/oby.2001.49; Ploutz-Snyder LL, 2000, J GERONTOL A-BIOL, V55, pB504, DOI 10.1093/gerona/55.10.B504; Radaelli R, 2019, EXP GERONTOL, V128, DOI 10.1016/j.exger.2019.110745; Radaelli R, 2014, AGE, V36, P881, DOI 10.1007/s11357-013-9611-2; Rech A, 2014, AGE, V36, DOI 10.1007/s11357-014-9708-2; Ryan AS, 1999, INT J OBESITY, V23, P126, DOI 10.1038/sj.ijo.0800777; Saltin B, 2010, COMPR PHYSIOL, P555; Sanz-Requena R, 2020, DIAGNOSTICS, V10, DOI 10.3390/diagnostics10080534; STEWART SP, 1993, BRIT J NUTR, V69, P645, DOI 10.1079/BJN19930066; Visser M, 2002, J AM GERIATR SOC, V50, P897, DOI 10.1046/j.1532-5415.2002.50217.x; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Wilhelm EN, 2014, AGE, V36, P1113, DOI 10.1007/s11357-014-9625-4; Yoshiko A, 2019, ULTRASOUND MED BIOL, V45, P2372, DOI 10.1016/j.ultrasmedbio.2019.05.029; Yoshiko A, 2018, EUR REV AGING PHYS A, V15, DOI 10.1186/s11556-018-0201-2; Yoshiko A, 2017, EXP GERONTOL, V98, P230, DOI 10.1016/j.exger.2017.08.036	39	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243589	10.1371/journal.pone.0243589	http://dx.doi.org/10.1371/journal.pone.0243589			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326469	gold, Green Published			2022-12-27	WOS:000600176400025
J	Dirwai, TL; Senzanje, A; Mabhaudhi, T				Dirwai, Tinashe Lindel; Senzanje, Aidan; Mabhaudhi, Tafadzwanashe			Moistube irrigation (MTI) discharge under variable evaporative demand	PLOS ONE			English	Article							CLASSIFICATION; WATER; SOIL	We investigated the conceptual capability of Moistube irrigation (MTI) to discharge under zero applied positive pressure and under varied climatic conditions by inducing an artificial evaporative demand (E-d) or negative pressure around Moistube tubing. This study was premised on the null hypothesis that an artificially induced E-d or negative pressure does not impact MTI discharge. Moistube tubing was enclosed in a 1 m long PVC conduit. A 20 l water reservoir placed on an electronic balance provided a continuous supply of water whilst a three-speed hot air blower facilitated the radiative factor and advection process. The procedure was conducted under varied climatic conditions with three air velocity (u(a)) treatments namely; 1.2 m.s(-1), 2.5 m.s(-1), and 3.0 m.s(-1) and the experiment run times were 159 h, 134 h and 10 h, respectively. The average temperature (T-ave) and relative humidity (RH) data for u(a) = 1.2 m.s(-1) were 53 degrees C and 7.31%, whilst for u(a) = 2.5 m.s(-1), T-ave was 56 degrees C and RH = 7.19%, and for u(a) = 3.0 m.s(-1), T-ave was 63 degrees C and RH = 6.16%. The experimental data was input into the four variable Penman-Monteith method to compute the evaporative demand (E-d). For each E-d, the instantaneous mass flow rate (<graphic id="pone.0236211.e001g" mimetype="image" position="anchor" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="info:doi/10.1371/journal.pone.0236211.e001" xlink:type="simple"></graphic>m<mml:mo></mml:mover>) was recorded using an electronic balance and subsequently converted to volumetric flow rates. For each of the air velocities, the respective E-d values obtained were 0.16, 0.31 and 0.36 mm.d(-1). The Bowen ratios (r) were well below 1 (r < 1), which suggested a sufficient supply of moisture to evaporate. For E-d = 0.16 mm.d(-1) the vapour pressure deficit (VPD) was 113.08 mbars, whilst for E-d = 0.31 mm.d(-1) and for E-d = 0.36 mm.d(-1) the VPD were 129.93 mbars and 150.14 mbars, respectively. The recorded discharges (q) at normalised time (t*) = 1 h for E-d = 0.16 mm.d(-1) was 7.67*10(-3) l.hr(-1).m(-1) length, whilst for E-d = 0.31 mm.d(-1)q = 14.5*10(-3) l.hr(-1).m(-1) length, and for E-d = 0.36 mm.d(-1)q = 20.8*10(-3) l.hr(-1).m(-1) length. The imposed negative pressure causes an exponential increase in Moistube<(TM)> discharge, thus disproving the null hypothesis. The higher the evaporative demand the higher the discharge. This phenomenon allows MTI to be used for deficit irrigation purposes and allows irrigators to capitalize on realistic soil matric potential irrigation scheduling approach.	[Dirwai, Tinashe Lindel; Senzanje, Aidan] Univ KwaZulu Natal, Sch Engn, Pietermaritzburg, Kwazulu Natal, South Africa; [Dirwai, Tinashe Lindel] VarMac Consulting Engineers, Pietermaritzburg, Kwazulu Natal, South Africa; [Mabhaudhi, Tafadzwanashe] Univ KwaZulu Natal, Ctr Transformat Agr & Food Syst, Sch Agr Earth & Environm Sci, Pietermaritzburg, Kwazulu Natal, South Africa; [Mabhaudhi, Tafadzwanashe] Univ KwaZulu Natal, Ctr Water Resources Res, Sch Agr Earth & Environm Sci, Pietermaritzburg, Kwazulu Natal, South Africa	University of Kwazulu Natal; University of Kwazulu Natal; University of Kwazulu Natal	Dirwai, TL (corresponding author), Univ KwaZulu Natal, Sch Engn, Pietermaritzburg, Kwazulu Natal, South Africa.; Dirwai, TL (corresponding author), VarMac Consulting Engineers, Pietermaritzburg, Kwazulu Natal, South Africa.	tldirwai@gmail.com	Mabhaudhi, Tafadzwanashe/AAF-2418-2019	Mabhaudhi, Tafadzwanashe/0000-0002-9323-8127; Dirwai, Tinashe Lindel/0000-0002-2617-7002	Water Research Commission of South Africa (WRC -SA) - Drainage Project; University of KwaZulu-Natal - Pietermaritzburg, South Africa	Water Research Commission of South Africa (WRC -SA) - Drainage Project; University of KwaZulu-Natal - Pietermaritzburg, South Africa	This work was supported by the Water Research Commission of South Africa (WRC -SA) - Drainage Project and by the University of KwaZulu-Natal - Pietermaritzburg, South Africa. The funder provided support in the form of a research stipend for author TLD and access to laboratory equipment, and VarMac Consulting Engineers provided support in the form of salary for author TLD. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Abu-Zreig M, 2018, APPL ENG AGRIC, V34, P707, DOI 10.13031/aea.12813; Abu-Zreig MM, 2006, AGR WATER MANAGE, V85, P272, DOI 10.1016/j.agwat.2006.05.002; [Anonymous], R LANG ENV STAT COMP; [Anonymous], 2016, IEEE-ASME T MECH, VPP, P1, DOI DOI 10.1109/IEEESTD.2016.7460875; Antohe BV, 1997, J FLUID ENG-T ASME, V119, P404, DOI 10.1115/1.2819148; Bucks D. A., 1982, Advances in Irrigation, V1, P219; Clark G. A., 1992, HORTTECHNOLOGY, V2, P32; Cross I, 2019, MEASUREMENT ESTIMATI; Donohue RJ, 2010, J HYDROL, V386, P186, DOI 10.1016/j.jhydrol.2010.03.020; FAO, 2002, PLANN DEV MON EV IRR; Itenfisu D, 2003, J IRRIG DRAIN ENG, V129, P440, DOI 10.1061/(ASCE)0733-9437(2003)129:6(440); Kanda EK, 2020, AGR RES, V9, P139, DOI 10.1007/s40003-019-00448-0; KARMELI D, 1977, J AGR ENG RES, V22, P165, DOI 10.1016/0021-8634(77)90060-9; KELLER J, 1974, T ASAE, V17, P678, DOI 10.13031/2013.36936; Khan J. N., 2013, Agricultural Engineering International: CIGR Journal, V15, P17; Luo YF, 2014, AGR WATER MANAGE, V136, P42, DOI 10.1016/j.agwat.2014.01.006; Monteith J L, 1965, Symp Soc Exp Biol, V19, P205; MORTON FI, 1983, J HYDROL, V66, P1, DOI 10.1016/0022-1694(83)90177-4; Najmaddin PM, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9080779; Niu WenQuan, 2017, Transactions of the Chinese Society of Agricultural Engineering, V33, P131; [牛文全 Niu Wenquan], 2017, [农业机械学报, Transactions of the Chinese Society for Agricultural Machinery], V48, P217; PENMAN HL, 1948, PROC R SOC LON SER-A, V193, P120, DOI 10.1098/rspa.1948.0037; PRIESTLEY CHB, 1972, MON WEATHER REV, V100, P81, DOI 10.1175/1520-0493(1972)100<0081:OTAOSH>2.3.CO;2; Thornthwaite CW, 1948, GEOGR REV, V38, P55, DOI 10.2307/210739; Wang J, 2019, J CONSTR STEEL RES, V162, DOI 10.1016/j.jcsr.2019.105743; Yang Q., 2008, J WATER RESOUR WATER, V6; Zhang ShuHan, 2002, Transactions of the Chinese Society of Agricultural Engineering, V18, P1; Zheng JH, 2013, AGR WATER MANAGE, V129, P181, DOI 10.1016/j.agwat.2013.08.001; [邹小阳 Zou Xiaoyang], 2017, [水土保持通报, Bulletin of Soil and Water Conservation], V37, P150	29	1	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0236211	10.1371/journal.pone.0236211	http://dx.doi.org/10.1371/journal.pone.0236211			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326427	Green Published, gold			2022-12-27	WOS:000600176400004
J	Wells, N; Quigley, J; Pascua, J; Pinkowski, N; Almaiman, L; Brasser, SM; Hong, MY				Wells, Nicole; Quigley, Jacqueline; Pascua, Jeremy; Pinkowski, Natalie; Almaiman, Lama; Brasser, Susan M.; Hong, Mee Young			Effects of low-to-moderate ethanol consumption on colonic growth and gene expression in young adult and middle-aged male rats	PLOS ONE			English	Article							COLORECTAL-CANCER; ALCOHOL-CONSUMPTION; LIFE-STYLE; CYCLIN-E; APOPTOSIS; DIFFERENTIATION; PROLIFERATION; RISK; CELLS; INFLAMMATION	Excessive alcohol consumption is a risk factor associated with colorectal cancer; however, some epidemiological studies have reported that moderate alcohol consumption may not contribute additional risk or may provide a protective effect reducing colorectal cancer risk. Prior research highlights the importance of proliferation, differentiation, and apoptosis as parameters to consider when evaluating colonic cell growth and tumorigenesis. The present study investigated whether chronic low-to-moderate ethanol consumption altered these parameters of colonic cell growth and expression of related genes. Twenty-four nondeprived young adult (109 days old) and 24 nondeprived middle-aged (420 days old) Wistar rats were randomly assigned to an ethanol-exposed or a water control group (n = 12/group). The ethanol group was provided voluntary access to a 20% v/v ethanol solution on alternate days for 13 weeks. Colon tissues were collected for quantitative immunohistochemical analyses of cell proliferation, differentiation and apoptosis using Ki-67, goblet cell and TUNEL, respectively. Gene expression of cyclin D1 (Ccnd1), Cdk2, Cdk4, p21(waf1/cip1) (Cdkn1a), E-cadherin (Cdh1) and p53 were determined by quantitative real-time polymerase chain reaction in colonic scraped mucosa. Ethanol treatment resulted in a lower cell proliferation index and proliferative zone, and lower Cdk2 expression in both age groups, as well as trends toward lower Ccnd1 and higher Cdkn1a expression. Cell differentiation was modestly but significantly reduced by ethanol treatment only in older animals. Overall, older rats showed decreases in apoptosis and gene expression of Cdk4, Cdh1, and p53 compared to younger rats, but there was no observed effect of ethanol exposure on these measures. These findings suggest that low-to-moderate ethanol consumption improves at least one notable parameter in colonic tumorigenesis (cell proliferation) and associated gene expression regardless of age, however, selectively decreased cell differentiation among older subjects.	[Wells, Nicole; Hong, Mee Young] San Diego State Univ, Sch Exercise & Nutr Sci, San Diego, CA 92182 USA; [Quigley, Jacqueline; Pascua, Jeremy; Pinkowski, Natalie; Almaiman, Lama; Brasser, Susan M.] San Diego State Univ, Dept Psychol, San Diego, CA 92182 USA	California State University System; San Diego State University; California State University System; San Diego State University	Hong, MY (corresponding author), San Diego State Univ, Sch Exercise & Nutr Sci, San Diego, CA 92182 USA.	mhong2@sdsu.edu		Hong, Mee Young/0000-0003-1262-0074	National Institutes of Health [R21 AA023291]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health [R21 AA023291] (SMB's grant). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL EL, 1979, PHYSIOL PSYCHOL, V7, P391; Agami R, 2000, CELL, V102, P55, DOI 10.1016/S0092-8674(00)00010-6; Allen NE, 2009, JNCI-J NATL CANCER I, V101, P296, DOI 10.1093/jnci/djn514; American Cancer Society, 2017, COL CANC FACTS FIG; Baar MP, 2017, CELL, V169, P132, DOI 10.1016/j.cell.2017.02.031; Bishehsari F, 2017, ALCOHOL RES-CURR REV, V38, P163; Boissoneault J, 2016, CURR ADDICT REP, V3, P62, DOI DOI 10.1007/s40429-016-0087-x; BOLAND CR, 1992, J CELL BIOCHEM, P103; Bongaerts BWC, 2008, INT J CANCER, V123, P2411, DOI 10.1002/ijc.23774; Brasser SM, 2004, ALCOHOL CLIN EXP RES, V28, P1074, DOI 10.1097/01.ALC.0000130802.07692.29; Calviello G, 1999, LIPIDS, V34, P599, DOI 10.1007/s11745-999-0404-6; Chang WCL, 1997, CARCINOGENESIS, V18, P721, DOI 10.1093/carcin/18.4.721; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Cippitelli A, 2012, PHARMACOL BIOCHEM BE, V100, P522, DOI 10.1016/j.pbb.2011.10.016; Crockett SD, 2011, DIS COLON RECTUM, V54, P887, DOI 10.1007/DCR.0b013e3182125577; Douaiher J, 2017, J SURG ONCOL, V115, P619, DOI 10.1002/jso.24578; DULIC V, 1992, SCIENCE, V257, P1958, DOI 10.1126/science.1329201; George O, 2012, P NATL ACAD SCI USA, V109, P18156, DOI 10.1073/pnas.1116523109; Grant BF, 2017, JAMA PSYCHIAT, V74, P911, DOI 10.1001/jamapsychiatry.2017.2161; Guo SS, 1999, AM J CLIN NUTR, V70, P405; Haupt S, 2003, J CELL SCI, V116, P4077, DOI 10.1242/jcs.00739; He GG, 2005, ONCOGENE, V24, P2929, DOI 10.1038/sj.onc.1208474; Hong MY, 2019, J FUNCT FOODS, V54, P520, DOI 10.1016/j.jff.2019.02.005; Hong MY, 1997, NUTR CANCER, V28, P20, DOI 10.1080/01635589709514548; Johnson CM, 2013, CANCER CAUSE CONTROL, V24, P1207, DOI 10.1007/s10552-013-0201-5; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Klarich DS, 2017, ALCOHOL, V61, P25, DOI 10.1016/j.alcohol.2017.02.179; Klarich DS, 2015, ALCOHOL CLIN EXP RES, V39, P1280, DOI 10.1111/acer.12778; Koivisto T, 1998, CARCINOGENESIS, V19, P2031, DOI 10.1093/carcin/19.11.2031; Kontou N, 2012, DIS COLON RECTUM, V55, P703, DOI 10.1097/DCR.0b013e31824e612a; Kyrylkova Kateryna, 2012, Methods Mol Biol, V887, P41, DOI 10.1007/978-1-61779-860-3_5; Mangoni AA, 2004, BRIT J CLIN PHARMACO, V57, P6, DOI 10.1046/j.1365-2125.2003.02007.x; MATSUSHIME H, 1992, CELL, V71, P323, DOI 10.1016/0092-8674(92)90360-O; Moorefield EC, 2017, AGING-US, V9, P1898, DOI 10.18632/aging.101279; Nan HM, 2013, ANN EPIDEMIOL, V23, P558, DOI 10.1016/j.annepidem.2013.04.011; National Institute of Alcohol Abuse and Alcoholism, DRINK LEV DEF; OTT JF, 1985, ALCOHOL CLIN EXP RES, V9, P59, DOI 10.1111/j.1530-0277.1985.tb05051.x; Park JY, 2009, CANCER EPIDEMIOL, V33, P347, DOI 10.1016/j.canep.2009.10.015; Poullis A, 2004, CANCER EPIDEM BIOMAR, V13, P279, DOI 10.1158/1055-9965.EPI-03-0160; RESNITZKY D, 1995, MOL CELL BIOL, V15, P3463; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Shin J, 2014, J BIOL CHEM, V289, P25306, DOI 10.1074/jbc.M114.557546; Shukla PK, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2180-x; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Simms JA, 2008, ALCOHOL CLIN EXP RES, V32, P1816, DOI 10.1111/j.1530-0277.2008.00753.x; Sun SY, 2004, JNCI-J NATL CANCER I, V96, P662, DOI 10.1093/jnci/djh123; Truter D, 2017, ACTA HISTOCHEM, V119, P122, DOI 10.1016/j.acthis.2016.11.014; Wang LR, 2016, CELL HOST MICROBE, V19, P227, DOI 10.1016/j.chom.2016.01.003; Wells N, 2020, FASEB J, V34, DOI [10.1096/fsb2.v34.S1, DOI 10.1096/FSB2.V34.S1]; White A, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4786-7; Xiao ZQ, 2001, MECH AGEING DEV, V122, P1849, DOI 10.1016/S0047-6374(01)00323-2	51	2	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243499	10.1371/journal.pone.0243499	http://dx.doi.org/10.1371/journal.pone.0243499			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326448	Green Published, gold			2022-12-27	WOS:000600176400048
J	Su, J; Zhou, ZH; Li, YD; Hao, B; Dong, Q; Li, XJ				Su, Jie; Zhou, Zhenghua; Li, Yuandong; Hao, Bing; Dong, Qing; Li, Xiaojun			A stable implementation measure of multi-transmitting formula in the numerical simulation of wave motion	PLOS ONE			English	Article							SATURATED POROUS-MEDIA; ABSORBING BOUNDARY-CONDITIONS; FIELD SIMULATION; PROPAGATION	The Multi-Transmitting Formula (MTF) proposed by Liao et al. is a local artificial boundary condition widely used in numerical simulations of wave propagation in an infinite medium, while the drift instability is usually caused in its numerical implementation. In view of a physical interpretation of the Gustafsson, Kreiss and Sundstrom criterion on numerical solutions of initial-boundary value problems in the hyperbolic partial differential equations, the mechanism of the drift instability of MTF was discussed, and a simple measure for eliminating the drift instability was proposed by introducing a modified operator into the MTF. Based on the theory of spherical wave propagation and damping effect of medium, the physical implication on modified operator was interpreted. And the effect of the modified operator on the reflection coefficient of MTF was discussed. Finally, the validity of the proposed stable implementation measure was verified by numerical tests of wave source problem and scattering problem.	[Su, Jie; Zhou, Zhenghua; Li, Yuandong; Hao, Bing; Dong, Qing; Li, Xiaojun] Nanjing Tech Univ, Coll Transportat Sci & Engn, Nanjing, Peoples R China; [Li, Xiaojun] Beijing Univ Technol, Fac Urban Construct, Beijing, Peoples R China	Nanjing Tech University; Beijing University of Technology	Li, XJ (corresponding author), Beijing Univ Technol, Fac Urban Construct, Beijing, Peoples R China.	beerli@vip.sina.com			National Natural Science Foundation of China [U1839202, 41374049]; National Key Research and Development Program of China [2017YFC1500400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China	National Natural Science Foundation of China (U1839202, 41374049) and the National Key Research and Development Program of China (2017YFC1500400).	Achenbach JD., 1973, WAVE PROPAGATION ELA; [Anonymous], 2020, BR J ANAESTH ADV, V125; [Anonymous], 2010, DREXEL L REV, V3, P1; Ba J, 2017, J GEOPHYS RES-SOL EA, V122, P1949, DOI 10.1002/2016JB013882; BERENGER JP, 1994, J COMPUT PHYS, V114, P185, DOI 10.1006/jcph.1994.1159; Cao SH, 1998, GEOPHYSICS, V63, P231, DOI 10.1190/1.1444317; CERJAN C, 1985, GEOPHYSICS, V50, P705, DOI 10.1190/1.1441945; [董青 Dong Qing], 2018, [震灾防御技术, Technology for Earthquake Disaster Prevention], V13, P571; GUSTAFSSON B, 1972, MATH COMPUT, V26, P649, DOI 10.1090/S0025-5718-1972-0341888-3; Heider Y, 2012, COMPUT MECH, V49, P319, DOI 10.1007/s00466-011-0647-9; HIGDON RL, 1987, MATH COMPUT, V49, P65, DOI 10.1090/S0025-5718-1987-0890254-1; Kim SH, 2002, COMPUT METHOD APPL M, V191, P4061, DOI 10.1016/S0045-7825(02)00339-0; Lan HQ, 2011, B SEISMOL SOC AM, V101, P1354, DOI 10.1785/0120100194; Li Xiao-jun, 1996, CHIN J THEOR APPL ME, V28, P627; [廉西猛 Lian Ximeng], 2015, [地球物理学进展, Progress in Geophysiscs], V30, P1725; Liao Z, 1996, INTRO WAVE MOTION TH; Liao Z.P., 1984, SCI CHINA A, V27, P556, DOI [10.1360/ya1984-27-10-1063, DOI 10.1360/YA1984-27-10-1063]; Liao Z P, 1984, EARTHQ ENG ENG VIB, V4, P1; LIAO ZP, 1992, EARTHQUAKE ENG STRUC, V21, P65, DOI 10.1002/eqe.4290210105; Liao ZP, 1998, DEV GEOTECH ENG, V83, P125; Liao ZP, 1996, WAVE MOTION, V24, P117, DOI 10.1016/0165-2125(96)00010-8; Liao ZP., 1999, EARTHQ RES CHINA, P367; Liao ZP, 1984, INT J SOIL DYNAM EAR, P174, DOI [10.1016/0261-7277(84)90033-0, DOI 10.1016/0261-7277(84)90033-0]; Liao ZP, 1992, SCIENTIA SINICA B, V8, P874; Liu Y, 2018, J GEOPHYS ENG, V15, P2602, DOI 10.1088/1742-2140/aadd31; Shi L, 2016, SOIL DYN EARTHQ ENG, V80, P11, DOI 10.1016/j.soildyn.2015.09.021; SOCHACKI J, 1987, GEOPHYSICS, V52, P60, DOI 10.1190/1.1442241; Sun ZZ, 2012, APPL MATH COMPUT, V218, P5187, DOI 10.1016/j.amc.2011.10.083; Wang XM, 2010, INT J MULTISCALE COM, V8, P207, DOI 10.1615/IntJMultCompEng.v8.i2.60; Wei CF, 2002, INT J ENG SCI, V40, P1807, DOI 10.1016/S0020-7225(02)00068-X; [谢志南 Xie Zhinan], 2008, [地震学报, Acta Seismologica Sinica], V30, P302; Xu CS, 2017, INT J NUMER METH ENG, V112, P529, DOI 10.1002/nme.5525; Yang DH, 2002, GEOPHYS J INT, V148, P320, DOI 10.1046/j.0956-540x.2001.01575.x; Zhang ZJ, 1999, PHYS EARTH PLANET IN, V114, P25, DOI 10.1016/S0031-9201(99)00043-6; 廖振鹏, 1997, 力学进展, V27, P193	35	0	1	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243979	10.1371/journal.pone.0243979	http://dx.doi.org/10.1371/journal.pone.0243979			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320914	Green Published, gold			2022-12-27	WOS:000600339800042
J	Thomson, RJ; Hunter, J; Dutton, J; Schneider, J; Khosravi, M; Casement, A; Dhadwal, K; Martin, D				Thomson, Ross J.; Hunter, Jennifer; Dutton, Jonathan; Schneider, James; Khosravi, Maryam; Casement, Alisha; Dhadwal, Kulwant; Martin, Daniel			Clinical characteristics and outcomes of critically ill patients with COVID-19 admitted to an intensive care unit in London: A prospective observational cohort study	PLOS ONE			English	Article								Background Cohorts of severely ill patients with COVID-19 have been described in several countries around the globe, but to date there have been few published reports from the United Kingdom (UK). Understanding the characteristics of the affected population admitted to intensive care units (ICUs) in the UK is crucial to inform clinical decision making, research and planning for future waves of infection. Methods We conducted a prospective observational cohort study of all patients with COVID-19 admitted to a large UK ICU from March to May 2020 with follow-up to June 2020. Data were collected from health records using a standardised template. We used multivariable logistic regression to analyse the factors associated with ICU survival. Results Of the 156 patients included, 112 (72%) were male, 89 (57%) were overweight or obese, 68 (44%) were from ethnic minorities, and 89 (57%) were aged over 60 years of age. 136 (87%) received mechanical ventilation, 77 (57% of those intubated) were placed in the prone position and 95 (70% of those intubated) received neuromuscular blockade. 154 (99%) patients required cardiovascular support and 44 (28%) required renal replacement therapy. Of the 130 patients with completed ICU episodes, 38 (29%) died and 92 (71%) were discharged alive from ICU. In multivariable models, age (OR 1.13 [95% CI 1.07-1.21]), obesity (OR 3.06 [95% CI 1.16-8.74]), lowest P/F ratio on the first day of admission (OR 0.82 [95% CI 0.67-0.98]) and PaCO2 (OR 1.52 [95% CI 1.01-2.39]) were independently associated with ICU death. Conclusions Age, obesity and severity of respiratory failure were key determinants of survival in this cohort. Multiorgan failure was prevalent. These findings are important for guiding future research and should be taken into consideration during future healthcare planning in the UK.	[Thomson, Ross J.; Khosravi, Maryam; Casement, Alisha; Dhadwal, Kulwant; Martin, Daniel] Royal Free London NHS Fdn Trust, Royal Free Hosp, Dept Intens Care Med, London, England; [Thomson, Ross J.] Queen Mary Univ London, William Harvey Res Inst, London, England; [Hunter, Jennifer; Dutton, Jonathan; Schneider, James; Dhadwal, Kulwant] Royal Free London NHS Fdn Trust, Royal Free Hosp, Dept Anaesthesia, London, England; [Khosravi, Maryam] Royal Free London NHS Fdn Trust, Royal Free Hosp, Dept Nephrol, London, England; [Martin, Daniel] Univ Plymouth, Peninsula Med Sch, Plymouth, Devon, England	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; Queen Mary University London; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of Plymouth	Thomson, RJ (corresponding author), Royal Free London NHS Fdn Trust, Royal Free Hosp, Dept Intens Care Med, London, England.; Thomson, RJ (corresponding author), Queen Mary Univ London, William Harvey Res Inst, London, England.	ross.thomson@nhs.net	Thomson, Ross/AAU-6636-2020; Thomson, Ross/GXV-0334-2022	Thomson, Ross/0000-0002-8229-8060; Martin, Daniel/0000-0001-6220-8235				Al-Hindawi A, 2020, COVID 19 LONDON CASE; Armstrong RA, 2020, ANAESTHESIA, V75, P1340, DOI 10.1111/anae.15201; Auld SC, 2020, CRIT CARE MED, V48, pE799, DOI 10.1097/CCM.0000000000004457; Aziz S, 2020, INTENS CARE MED, V46, P1303, DOI 10.1007/s00134-020-06092-5; Bhatraju PK, 2020, NEW ENGL J MED, V382, P2012, DOI 10.1056/NEJMoa2004500; Blake A, 2020, MED INTENSIVA, V44, P589, DOI 10.1016/j.medin.2020.05.003; Chen LY, 2020, J INFECTION, V81, pE82, DOI 10.1016/j.jinf.2020.05.021; Cummings Matthew J, 2020, Lancet, V395, P1763, DOI [10.1101/2020.04.15.20067157, 10.1016/S0140-6736(20)31189-2]; de Lusignan S, 2020, LANCET INFECT DIS, V20, P1034, DOI 10.1016/S1473-3099(20)30371-6; Ferguson NM, 2020, IMPACT NONPHARMACEUT, DOI [DOI 10.1007/S11538-020-00726-X, 10.1007/s11538-020-00726-x]; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1545, DOI 10.1001/jama.2020.4031; Guerin C, 2013, NEW ENGL J MED, V368, P2159, DOI 10.1056/NEJMoa1214103; Harrison E. M, 2020, ETHNICITY OUTCOMES C, DOI [10.2139/ssrn.3618215, DOI 10.2139/SSRN.3618215]; Hippensteel JA, 2020, BRIT J HAEMATOL, V190, pE134, DOI 10.1111/bjh.16908; Intensive Care National Audit and Research Centre, ICNARC RES; International Severe Acute and emerging Respiratory Infection Consortium, 2020, COVID 19 CAS REP; Klok FA, 2020, THROMB RES, V191, P145, DOI [10.1016/j.thromres.2020.04.041, 10.1016/j.thromres.2020.04.013]; Larsson E, 2021, ACTA ANAESTH SCAND, V65, P76, DOI 10.1111/aas.13694; Levi M, 2020, LANCET HAEMATOL, V7, pE438, DOI 10.1016/S2352-3026(20)30145-9; Martin Daniel, 2020, J Intensive Care Soc, V21, P99, DOI 10.1177/1751143720918517; Migdady I, 2020, CRIT CARE MED, V48; National Institute for Health and Care Excellence, 2020, COVID 19 RAP GUID CR; Public Health England, 2020, DISP RISK OUTC COVID; Qian ZZ, 2020, INTENS CARE MED, V46, P1779, DOI 10.1007/s00134-020-06150-y; Quah P, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03006-1; Richards-Belle A, 2020, INTENS CARE MED, V46, P2035, DOI 10.1007/s00134-020-06267-0; Ronco C, 2020, LANCET RESP MED, V8, P738, DOI 10.1016/S2213-2600(20)30229-0; Sovik S, 2021, ACTA ANAESTH SCAND, V65, P351, DOI 10.1111/aas.13726; The Lancet Hiv null, 2020, LANCET HIV, V7, pe75; Wang Y, 2020, AM J RESP CRIT CARE, V201, P1430, DOI 10.1164/rccm.202003-0736LE; WHO, 2020, CLIN MAN COVID 19; WHO, 2020, WEEKLY EPIDEMIOLOGIC; Xu JQ, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03098-9; Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5; Zhang J, 2021, J BIOMOL STRUCT DYN, V39, P9, DOI 10.1080/07391102.2020.1713891; Zheng Y, 2020, J ZHEJIANG UNIV-SC B, V21, P378, DOI 10.1631/jzus.B2000174	36	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243710	10.1371/journal.pone.0243710	http://dx.doi.org/10.1371/journal.pone.0243710			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320904	gold, Green Submitted, Green Published			2022-12-27	WOS:000600339800026
J	Checa, C; Medina-Perucha, L; Munoz, MA; Verdu-Rotellar, JM; Berenguera, A				Checa, Caterina; Medina-Perucha, Laura; Munoz, Miguel-Angel; Maria Verdu-Rotellar, Jose; Berenguera, Anna			Living with advanced heart failure: A qualitative study	PLOS ONE			English	Article							SELF-CARE; SOCIAL SUPPORT; BAD-NEWS; HEALTH; ILLNESS; GENDER; EXPERIENCES	Introduction Information about how patients with advanced heart failure (HF) live and cope with their disease remains scarce. The objective of this study was to explore, from phenomenological and holistic perspectives, the experiences of patients suffering from advanced HF, attended at home in the primary care setting in 2018. Materials and methods Qualitative study conducted in 4 primary healthcare centers in Barcelona (Spain). Twelve in-depth interviews were conducted in advanced HF patients, aged over 65 and visited regularly at home. We developed a purposeful sampling, accounting for variability in gender, age, and socioeconomic level. Leventhal's framework was used to analyze the interviews. Results Participants received insufficient and contradictory information about HF. They talked about their cognitive representation and claimed a better communication with healthcare professionals. Due to their advanced age, subjects considered their daily living limitations to be normal rather than as a consequence of HF. Gender differences in emotional representation were clearly observed. Women considered themselves the keystone of correct family "functioning" and thought that they were not useful if they could not correspond to gendered societal expectations. Cognitive coping strategies included specific diets, taking medication, and registering weight and blood pressure. Nevertheless, they perceived the locus of control as external and felt unable to manage HF progression. Their emotional coping strategies included some activities at home such as watching television and reading. Social support was perceived crucial to the whole process. Conclusions Locus of control in advanced HF was perceived as external. Healthcare professionals should adapt emotional health interventions in patients with advanced HF based on a gender perspective. Social support was found to be crucial in facing the disease. Patients reported poor communication with healthcare professionals.	[Checa, Caterina; Medina-Perucha, Laura; Munoz, Miguel-Angel; Maria Verdu-Rotellar, Jose; Berenguera, Anna] Fundacio Inst Univ Recerca Atencio Primaria Salut, Barcelona, Spain; [Checa, Caterina] Primary Healthcare Ctr Dreta Eixample, Barcelona, Spain; [Checa, Caterina; Munoz, Miguel-Angel; Maria Verdu-Rotellar, Jose; Berenguera, Anna] Univ Autonoma Barcelona, Dept Pediatria, Obstet & Ginecol & Med Prevent, Bellaterra, Spain; [Munoz, Miguel-Angel; Maria Verdu-Rotellar, Jose] Inst Catala Salut, Barcelona, Spain	Autonomous University of Barcelona	Checa, C (corresponding author), Fundacio Inst Univ Recerca Atencio Primaria Salut, Barcelona, Spain.; Checa, C (corresponding author), Primary Healthcare Ctr Dreta Eixample, Barcelona, Spain.; Checa, C (corresponding author), Univ Autonoma Barcelona, Dept Pediatria, Obstet & Ginecol & Med Prevent, Bellaterra, Spain.	ccheca@eapdretaeixample.cat	Muñoz, Miguel Angel/X-3511-2019; perez, miguel/GXF-5077-2022	Muñoz, Miguel Angel/0000-0002-4083-3248; Berenguera, Anna/0000-0002-0889-2002; Checa Jimenez, Caterina/0000-0003-0399-0532; Medina-Perucha, Laura/0000-0002-2981-2614	IDIAP Jordi Gol i Gurina [4R17/010]; Departament de Salut de la Generalitat de Catalunya [SLT008/18/00130]	IDIAP Jordi Gol i Gurina; Departament de Salut de la Generalitat de Catalunya(Generalitat de Catalunya)	The principal investigator (Checa C) received the following awards: This study was funded by a grant from IDIAP Jordi Gol i Gurina (reference number 4R17/010) Webpage: https://www.idiapjgol.org/index.php/ca/This study was developed with the support of the Departament de Salut de la Generalitat de Catalunya, in the call corresponding to 2018 for the granting of subsidies from the Pla Estrategic de Recerca i Innovacioen Salut (PERIS) 2019-2021, modality of "Grants for the intensification of the research activity of health professionals without specialized health training", with the file code SLT008/18/00130. Webpage: http://salutweb.gencat.cat/ca/inici/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allemann H, 2018, J CARDIOVASC NURS, V33, pE1, DOI 10.1097/JCN.0000000000000523; Aminiahidashti H, 2016, EMERGENCY, V4, P34; [Anonymous], 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI [DOI 10.1001/JAMA.2013.281053, 10.1001/jama.2013.281053]; Berenguera Osso A., 2014, APORTACIONES INVESTI; Bjork JB, 2016, J CARD FAIL, V22, P569, DOI 10.1016/j.cardfail.2016.03.003; Blumenthal JA, 2019, HEALTH PSYCHOL, V38, P502, DOI 10.1037/hea0000716; Centers for Disease Control and Prevention, 2017, SOCIAL DETERMINANTS; Checa C, 2019, J CARDIOVASC NURS, V34, pE8, DOI 10.1097/JCN.0000000000000538; Conde-Martel A, 2015, REV CLIN ESP, V215, P363, DOI 10.1016/j.rce.2015.02.010; Courtenay WH, 2000, SOC SCI MED, V50, P1385, DOI 10.1016/S0277-9536(99)00390-1; Cowie MR, 2014, ESC HEART FAIL, V1, P110, DOI 10.1002/ehf2.12021; Daley C, 2019, HEART LUNG, V49, P477, DOI 10.1016/j.hrtlng.2019.05.012; Garcia-Calvente MD, 2012, SOCIOL HEALTH ILL, V34, P911, DOI 10.1111/j.1467-9566.2011.01440.x; Dempster M, 2015, J PSYCHOSOM RES, V79, P506, DOI 10.1016/j.jpsychores.2015.10.006; den Herder-van der Eerden M, 2017, PALLIATIVE MED, V31, P946, DOI 10.1177/0269216317697898; Fivecoat HC, 2018, EUR J CARDIOVASC NUR, V17, P598, DOI 10.1177/1474515118762800; Generalitat de Catalunya, 2017, OBS SIST SAL CAT; Gerlich MG, 2012, EUR J AGEING, V9, P297, DOI 10.1007/s10433-012-0244-6; Glogowska M, 2016, BMC PALLIAT CARE, V15, DOI 10.1186/s12904-016-0074-y; Graven LJ, 2014, INT J NURS STUD, V51, P320, DOI 10.1016/j.ijnurstu.2013.06.013; Greco A, 2015, BEHAV MED, V41, P9, DOI 10.1080/08964289.2013.855159; Hahn-Goldberg S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197831; Im J, 2019, HEALTH EXPECT, V22, P1331, DOI 10.1111/hex.12980; Irani E, 2019, J CARDIOVASC NURS, V34, P319, DOI 10.1097/JCN.0000000000000581; Bermejo-Caja CJ, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4185-z; Karimi M, 2016, INT J NURS STUD, V59, P89, DOI 10.1016/j.ijnurstu.2016.03.010; Klindtworth K, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0124-y; Leventhal H, 2016, J BEHAV MED, V39, P935, DOI 10.1007/s10865-016-9782-2; Metra Marco, 2019, Card Fail Rev, V5, P5, DOI 10.15420/cfr.2018.43.1; Morgan Karen, 2014, BMC Psychol, V2, P50, DOI 10.1186/s40359-014-0050-3; Murray SA, 2007, J PAIN SYMPTOM MANAG, V34, P393, DOI 10.1016/j.jpainsymman.2006.12.009; Olano-Lizarraga M, 2016, J CLIN NURS, V25, P2413, DOI 10.1111/jocn.13285; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Reeves S, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a949; Ruiz-Romero V, 2016, REV ESP SALUD PUBLIC, V90; Samulowitz A, 2018, PAIN RES MANAG, V2018, DOI 10.1155/2018/6358624; Sandoval J, 2013, CINTA MOEBIO, V46, P37, DOI 10.4067/S0717-554X2013000100004; Seah ACW, 2016, J TRANSCULT NURS, V27, P392, DOI 10.1177/1043659615573840; Sevilla-Cazes J, 2018, J GEN INTERN MED, V33, P1700, DOI 10.1007/s11606-018-4542-3; Sobczak K, 2018, PATIENT PREFER ADHER, V12, P2397, DOI 10.2147/PPA.S183106; Spaling MA, 2015, J ADV NURS, V71, P2478, DOI 10.1111/jan.12712; Strachan PH, 2014, J CARD FAIL, V20, P448, DOI 10.1016/j.cardfail.2014.03.010; Taylor CJ, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013648; Tiede M, 2017, J TELEMED TELECARE, V23, P716, DOI 10.1177/1357633X16668436; Verulava T, 2017, Georgian Med News, P135; Virani SS, 2020, CIRCULATION, V141, pE139, DOI 10.1161/CIR.0000000000000757; Wildeboer JA, 2018, BMC FAM PRACT, V19, DOI 10.1186/s12875-017-0688-z	47	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243974	10.1371/journal.pone.0243974	http://dx.doi.org/10.1371/journal.pone.0243974			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH1MP	33315935	Green Published, gold			2022-12-27	WOS:000600186100078
J	Raymond, SJ; Maragh, J; Masic, A; Williams, JR				Raymond, Samuel J.; Maragh, Janille; Masic, Admir; Williams, John R.			Towards an understanding of the chemo-mechanical influences on kidney stone failure via the material point method	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; ELASTIC-MODULUS; THIN-FILMS; FRACTURE; NANOINDENTATION; COMMINUTION; DAMAGE; FRAGMENTATION; EPIDEMIOLOGY; INDENTATION	This paper explores the use of the meshfree computational mechanics method, the Material Point Method (MPM), to model the composition and damage of typical renal calculi, or kidney stones. Kidney stones are difficult entities to model due to their complex structure and failure behavior. Better understanding of how these stones behave when they are broken apart is a vital piece of knowledge to medical professionals whose aim is to remove these stone by breaking them within a patient's body. While the properties of individual stones are varied, the common elements and proportions are used to generate synthetic stones that are then placed in a digital experiment to observe their failure patterns. First a more traditional engineering model of a Brazil test is used to create a tensile fracture within the center of these stones to observe the effect of stone consistency on failure behavior. Next a novel application of MPM is applied which relies on an ultrasonic wave being carried by surrounding fluid to model the ultrasonic treatment of stones commonly used by medical practitioners. This numerical modeling of Extracorporeal Shock Wave Lithotripsy (ESWL) reveals how these different stones failure in a more real-world situation and could be used to guide further research in this field for safer and more effective treatments.	[Raymond, Samuel J.; Maragh, Janille; Masic, Admir; Williams, John R.] MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Raymond, Samuel J.; Williams, John R.] MIT, Ctr Computat Sci & Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Raymond, SJ (corresponding author), MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Raymond, SJ (corresponding author), MIT, Ctr Computat Sci & Engn, Cambridge, MA 02139 USA.	sjr@mit.edu	Raymond, Samuel/AAV-5908-2021	Raymond, Samuel/0000-0003-2691-652X				Aggarwal KP, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/292953; Bardenhagen SG, 2004, CMES-COMP MODEL ENG, V5, P477; Blanco F, 2015, J BIOPHOTONICS, V8, P457, DOI 10.1002/jbio.201300201; Blanco F, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.7.076027; Caballero A, 2010, INT J ENG SCI, V48, P253, DOI 10.1016/j.ijengsci.2009.11.002; Canseco G, 2011, ULTRASONICS, V51, P803, DOI 10.1016/j.ultras.2011.03.008; Cao SX, 2019, INT J SOLIDS STRUCT, V169, P55, DOI 10.1016/j.ijsolstr.2019.04.002; Chattaraj KG, 2019, J CHEM PHYS, V151, DOI 10.1063/1.5094220; Chen X, 2001, J MATER RES, V16, P2974, DOI 10.1557/JMR.2001.0408; Cleveland RO, 2005, J ACOUST SOC AM, V118, P2667, DOI 10.1121/1.2032187; Delobelle P, 2006, THIN SOLID FILMS, V515, P1385, DOI 10.1016/j.tsf.2006.03.062; Esch E, 2010, UROL RES, V38, P315, DOI 10.1007/s00240-010-0298-x; Fovargue D, 2018, INT J FRACTURE, V211, P203, DOI 10.1007/s10704-018-0283-x; Gulley-Stahl HJ, 2010, APPL SPECTROSC, V64, P15, DOI 10.1366/000370210792966161; Harrogate SR, 2016, J ENDOUROL, V30, P406, DOI 10.1089/end.2015.0388; Igarashi S, 2004, CEMENT CONCRETE COMP, V26, P977, DOI 10.1016/j.cemconcomp.2004.02.031; JOHRDE LG, 1985, J MATER SCI LETT, V4, P1264, DOI 10.1007/BF00723476; Kocaba V, 2012, CEMENT CONCRETE RES, V42, P511, DOI 10.1016/j.cemconres.2011.11.010; Lokhandwalla M, 2000, PHYS MED BIOL, V45, P1923, DOI 10.1088/0031-9155/45/7/316; Lopez M, 2010, PEDIATR NEPHROL, V25, P49, DOI 10.1007/s00467-008-0960-5; M Tanguay, 2003, PROGR MODELING SIMUL; Maeda K, 2018, P 10 INT S CAV CAV20, DOI [10.1115/1.861851_ch119, DOI 10.1115/1.861851_CH119]; Maragh JM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210710; Masic A, 2015, J STRUCT BIOL, V189, P269, DOI 10.1016/j.jsb.2014.12.005; Moe OW, 2006, LANCET, V367, P333, DOI 10.1016/S0140-6736(06)68071-9; Mota A, 2006, J PHYS CONF SER, V46, P299, DOI 10.1088/1742-6596/46/1/041; Navamathavan R, 2006, APPL SURF SCI, V253, P464, DOI 10.1016/j.apsusc.2005.12.078; Oliver WC, 2004, J MATER RES, V19, P3, DOI 10.1557/jmr.2004.19.1.3; OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564; Pishchalnikov YA, 2019, J ACOUST SOC AM, V146, P516, DOI 10.1121/1.5116693; Pruessner MW, 2003, SENSOR ACTUAT A-PHYS, V105, P190, DOI 10.1016/S0924-4247(03)00102-X; Pucetaite M, 2013, J MOL STRUCT, V1031, P38, DOI 10.1016/j.molstruc.2012.07.029; Randall NX, 2009, J MATER RES, V24, P679, DOI 10.1557/JMR.2009.0149; Raymond SJ, 2021, COMPUT PART MECH, V8, P259, DOI 10.1007/s40571-020-00327-4; Raymond SJ, 2019, COMPUT PART MECH, V6, P371, DOI 10.1007/s40571-018-00218-9; Raymond SJ, 2018, COMPUT PART MECH, V5, P49, DOI 10.1007/s40571-016-0149-9; Rho JY, 2002, J BIOMECH, V35, P189, DOI 10.1016/S0021-9290(01)00199-3; Sadeghirad A, 2013, INT J NUMER METH ENG, V95, P928, DOI 10.1002/nme.4526; Sadeghirad A, 2011, INT J NUMER METH ENG, V86, P1435, DOI 10.1002/nme.3110; Sapozhnikov OA, 2007, J ACOUST SOC AM, V121, P1190, DOI 10.1121/1.2404894; Schuetz R, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw7494; Stollberg DW, 2003, MAT SCI ENG A-STRUCT, V359, P112, DOI 10.1016/S0921-5093(03)00339-3; STRANNE SK, 1990, J BIOMED MATER RES, V24, P1049, DOI 10.1002/jbm.820240807; SULSKY D, 1994, COMPUT METHOD APPL M, V118, P179, DOI 10.1016/0045-7825(94)00033-6; Tham LM, 2007, J UROLOGY, V178, P314, DOI 10.1016/j.juro.2007.03.009; Vandamme M, 2013, CEMENT CONCRETE RES, V52, P38, DOI 10.1016/j.cemconres.2013.05.006; Volinsky AA, 2003, THIN SOLID FILMS, V429, P201, DOI 10.1016/S0040-6090(03)00406-1; Wijerathne MLL, 2010, IOP CONF SER-MAT SCI, V10, DOI 10.1088/1757-899X/10/1/012120; Zhang Y, 2016, ULTRASOUND MED BIOL, V42, P2662, DOI 10.1016/j.ultrasmedbio.2016.06.018; Zhu SL, 2002, ULTRASOUND MED BIOL, V28, P661, DOI 10.1016/S0301-5629(02)00506-9; Ziemba JB, 2017, INVESTIG CLIN UROL, V58, P299, DOI 10.4111/icu.2017.58.5.299; Zohdi TI, 2005, J BIOMED MATER RES B, V75B, P351, DOI 10.1002/jbm.b.30307	52	1	1	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0240133	10.1371/journal.pone.0240133	http://dx.doi.org/10.1371/journal.pone.0240133			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306670	gold, Green Published			2022-12-27	WOS:000600144200043
J	Young-Xu, YN; Smith, J; Mahmud, SM; Van Aalst, R; Thommes, EW; Neupane, N; Lee, JKH; Chit, A				Young-Xu, Yinong; Smith, Jeremy; Mahmud, Salaheddin M.; Van Aalst, Robertus; Thommes, Edward W.; Neupane, Nabin; Lee, Jason K. H.; Chit, Ayman			Laboratory-confirmed influenza infection and acute myocardial infarction among United States senior Veterans	PLOS ONE			English	Article							MORTALITY BENEFITS; ELDERLY-PEOPLE; VACCINATION; RISK; PNEUMONIA; DISEASE; STROKE	Background Previous studies established an association between laboratory-confirmed influenza infection (LCI) and hospitalization for acute myocardial infarction (AMI) but not causality. We aimed to explore the underlying mechanisms by adding biological mediators to an established study design used by earlier studies. Methods With data on biomarkers, we used a self-controlled case-series design to evaluate the effect of LCI on hospitalization for AMI among Veterans Health Administration (VHA) patients. We included senior Veterans (age 65 years and older) with LCI between 2010 through 2015. Patient-level data from VHA electronic medical records were used to capture laboratory results, hospitalizations, and baseline patient characteristics. We defined the "risk interval" as the first 7 days after specimen collection and the "control interval" as 1 year before and 1 year after the risk interval. More importantly, using mediation analysis, we examined the role of abnormal white blood cell (WBC) and platelet count in the relationship between LCI and AMI to explore the thrombogenic nature of this association, thus potential causality. Results We identified 391 hospitalizations for AMI that occurred within +/-1 year of a positive influenza test, of which 31 (31.1 admissions/week) occurred during the risk interval and 360 (3.5/per week) during the control interval, resulting in an incidence ratio (IR) for AMI admission of 8.89 (95% confidence interval [CI]: 6.16-12.84). In stratified analyses, AMI risk was significantly elevated among patients with high WBC count (IR, 12.43; 95% CI: 6.99-22.10) and high platelet count (IR, 15.89; 95% CI: 3.59-70.41). Conclusion We confirmed a significant association between LCI and AMI. The risk was elevated among those with high WBC or platelet count, suggesting a potential role for inflammation and platelet activation in the underlying mechanism.	[Young-Xu, Yinong; Smith, Jeremy; Neupane, Nabin] Vet Affairs Med Ctr, Clin Epidemiol Program, White River Jct, VT 05009 USA; [Mahmud, Salaheddin M.] Univ Manitoba, Coll Med, Dept Community Hlth Sci, Winnipeg, MB, Canada; [Van Aalst, Robertus] Univ Groningen, Fac Med Sci, Groningen, Netherlands; [Van Aalst, Robertus; Thommes, Edward W.; Chit, Ayman] Sanofi Pasteur, Swiftwater, PA USA; [Thommes, Edward W.] Univ Guelph, Dept Math & Stat, Guelph, ON, Canada; [Lee, Jason K. H.; Chit, Ayman] Univ Toronto, Leslie Dan Sch Pharm, Toronto, ON, Canada; [Lee, Jason K. H.] Sanofi Pasteur, Toronto, ON, Canada	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Manitoba; University of Groningen; Sanofi-Aventis; University of Guelph; University of Toronto; Sanofi-Aventis	Young-Xu, YN (corresponding author), Vet Affairs Med Ctr, Clin Epidemiol Program, White River Jct, VT 05009 USA.	Yinong.Young-Xu@va.gov		Lee, Jason/0000-0001-8875-607X; van Aalst, Robertus/0000-0003-3025-7811	Sanofi Pasteur [1037291-7]	Sanofi Pasteur	This work was supported by an unrestricted research grant (CRADA#1037291-7) from Sanofi Pasteur. The funder provided support in the form of salaries for authors RVA, EWT, JKL, and AC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P837; Corrales-Medina VF, 2009, MEDICINE, V88, P154, DOI 10.1097/MD.0b013e3181a692f0; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Eurosurveillance Editorial Team, 2020, EUROSURVEILLANCE, V25; Jackson LA, 2006, INT J EPIDEMIOL, V35, P337, DOI 10.1093/ije/dyi274; Jackson ML, 2008, LANCET, V372, P398, DOI 10.1016/S0140-6736(08)61160-5; Jansen AJG, 2020, BLOOD ADV, V4, P2967, DOI 10.1182/bloodadvances.2020001640; Koupenova M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09607-x; Koupenova M, 2018, CIRC RES, V122, P337, DOI 10.1161/CIRCRESAHA.117.310795; Kreutz RP, 2005, J THROMB HAEMOST, V3, P2108, DOI 10.1111/j.1538-7836.2005.01474.x; Kwong JC, 2018, NEW ENGL J MED, V378, P345, DOI 10.1056/NEJMoa1702090; Lucero-Obusan C, 2018, INFLUENZA OTHER RESP, V12, P293, DOI 10.1111/irv.12512; MacIntyre CR, 2013, HEART, V99, P1843, DOI 10.1136/heartjnl-2013-304320; Merekoulias G, 2010, PLOS CURR, V2, DOI [10.1371/currents.rrn1154, DOI 10.1371/CURRENTS.RRN1154]; Musher DM, 2019, NEW ENGL J MED, V380, P171, DOI 10.1056/NEJMra1808137; O TM, 2018, OTOLARYNGOL CLIN N A, V51, pxvii; Rose Stacey R, 2012, J Clin Med Res, V4, P415, DOI 10.4021/jocmr1125w; Shen HH, 2013, CLIN LAB, V59, P337, DOI 10.7754/Clin.Lab.2012.120417; Simonsen L, 2007, LANCET INFECT DIS, V7, P658, DOI 10.1016/S1473-3099(07)70236-0; Simonsen L, 2009, VACCINE, V27, P6300, DOI 10.1016/j.vaccine.2009.07.008; Smeeth L, 2004, NEW ENGL J MED, V351, P2611, DOI 10.1056/NEJMoa041747; Warren-Gash C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002604; Warren-Gash C, 2012, J INFECT DIS, V206, P1652, DOI 10.1093/infdis/jis597; Whitaker HJ, 2006, STAT MED, V25, P1768, DOI 10.1002/sim.2302; Young-Xu Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169344	26	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243248	10.1371/journal.pone.0243248	http://dx.doi.org/10.1371/journal.pone.0243248			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306675	Green Published, gold			2022-12-27	WOS:000600144200041
J	Khozaei, A; Moradi, H; Hosseini, R; Pouretemad, H; Eskandari, B				Khozaei, Aida; Moradi, Hadi; Hosseini, Reshad; Pouretemad, Hamidreza; Eskandari, Bahareh			Early screening of autism spectrum disorder using cry features	PLOS ONE			English	Article							CHILDREN; DIAGNOSIS; INFANTS	The increase in the number of children with autism and the importance of early autism intervention has prompted researchers to perform automatic and early autism screening. Consequently, in the present paper, a cry-based screening approach for children with Autism Spectrum Disorder (ASD) is introduced which would provide both early and automatic screening. During the study, we realized that ASD specific features are not necessarily observable in all children with ASD and in all instances collected from each child. Therefore, we proposed a new classification approach to be able to determine such features and their corresponding instances. To test the proposed approach a set of data relating to children between 18 to 53 months which had been recorded using high-quality voice recording devices and typical smartphones at various locations such as homes and daycares was studied. Then, after preprocessing, the approach was used to train a classifier, using data for 10 boys with ASD and 10 Typically Developed (TD) boys. The trained classifier was tested on the data of 14 boys and 7 girls with ASD and 14 TD boys and 7 TD girls. The sensitivity, specificity, and precision of the proposed approach for boys were 85.71%, 100%, and 92.85%, respectively. These measures were 71.42%, 100%, and 85.71% for girls, respectively. It was shown that the proposed approach outperforms the common classification methods. Furthermore, it demonstrated better results than the studies which used voice features for screening ASD. To pilot the practicality of the proposed approach for early autism screening, the trained classifier was tested on 57 participants between 10 to 18 months. These 57 participants consisted of 28 boys and 29 girls and the results were very encouraging for the use of the approach in early ASD screening.	[Khozaei, Aida; Moradi, Hadi; Hosseini, Reshad] Univ Tehran, Sch Elect & Comp Engn, Tehran, Iran; [Moradi, Hadi] SKKU, Intelligent Syst Res Inst, Suwon, South Korea; [Pouretemad, Hamidreza; Eskandari, Bahareh] Shahid Beheshti Univ, Dept Psychol, Tehran, Iran	University of Tehran; Sungkyunkwan University (SKKU); Shahid Beheshti University	Moradi, H (corresponding author), Univ Tehran, Sch Elect & Comp Engn, Tehran, Iran.; Moradi, H (corresponding author), SKKU, Intelligent Syst Res Inst, Suwon, South Korea.	moradih@ut.ac.ir	Hosseini, Reshad/AAD-8561-2021; Pouretemad, Hamidreza/ABB-3993-2021	Pouretemad, Hamidreza/0000-0002-7613-6778; Hosseini, Reshad/0000-0002-3669-760X; , Aida/0000-0003-3051-5358; Moradi, Hadi/0000-0003-4916-9408	Cognitive Sciences and Technology Council of Iran cogc.ir [123]	Cognitive Sciences and Technology Council of Iran cogc.ir	HM received a small fund for collecting data and for diagnosing the subjects. Grant number 123 Cognitive Sciences and Technology Council of Iran cogc.ir The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas H, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61213-w; Belalcazar-Bolanos EA, 2016, LECT NOTES ARTIF INT, V9924, P400, DOI 10.1007/978-3-319-45510-5_46; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; [Anonymous], 2012, REHABILITATION ST S1, V51, pS28; Barrow WJ, 2011, J CHILD NEUROL, V26, P619, DOI 10.1177/0883073810385344; Berk L., 2010, DEV LIFESPAN ADOLESC; Bone D, 2014, J SPEECH LANG HEAR R, V57, P1162, DOI 10.1044/2014_JSLHR-S-13-0062; Bosl WJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24318-x; Boyd BA, 2014, J AUTISM DEV DISORD, V44, P366, DOI 10.1007/s10803-013-1877-9; Brentani Helena, 2013, Braz. J. Psychiatry, V35, pS62, DOI 10.1590/1516-4446-2013-s104; Brisson J, 2014, INFANT MENT HEALTH J, V35, P285, DOI 10.1002/imhj.21442; Calderoni S, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00139; Campbell M, 1996, J AM ACAD CHILD PSY, V35, P134, DOI 10.1097/00004583-199602000-00005; Chen JL, 2015, J AUTISM DEV DISORD, V45, P3015, DOI 10.1007/s10803-015-2465-y; Constantino JN, 2016, LANCET NEUROL, V15, P279, DOI 10.1016/S1474-4422(15)00151-9; Croen LA, 2008, BIOL PSYCHIAT, V64, P583, DOI 10.1016/j.biopsych.2008.05.006; Denisova K, 2019, INFANT BEHAV DEV, V57, DOI 10.1016/j.infbeh.2019.03.008; Denisova K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09028-0; Emerson RW, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag2882; Engelhardt LE, 2017, DEV COGN NEUROS-NETH, V25, P58, DOI 10.1016/j.dcn.2017.01.011; Esposito G, 2017, INT J NEUROPSYCHOPH, V20, P498, DOI 10.1093/ijnp/pyx014; Esposito G, 2010, EARLY CHILD DEV CARE, V180, P1093, DOI 10.1080/03004430902775633; Eyben F, 2016, IEEE T AFFECT COMPUT, V7, P190, DOI 10.1109/TAFFC.2015.2457417; Fakhoury M, 2015, INT J DEV NEUROSCI, V43, P70, DOI 10.1016/j.ijdevneu.2015.04.003; Gilliam J.E., 2006, GILLIAM AUTISM RATIN, DOI DOI 10.1016/j.heares.2016.06.001; Goldstein S, 2018, ASSESSMENT OF AUTISM SPECTRUM DISORDER, 2 EDITION, P1; Greene DJ, 2016, DEV COGN NEUROS-NETH, V18, P101, DOI 10.1016/j.dcn.2015.12.005; Hansler E, 2008, SIGNALS COMMUN TECHN, P1; Hoy Matthew B., 2018, Medical Reference Services Quarterly, V37, P81, DOI 10.1080/02763869.2018.1404391; Jacobson J, 1998, BEHAV INTERV, V13, P201, DOI DOI 10.1002/(SICI)1099-078X(199811)13:4; Jacobson JW, 2000, J AUTISM DEV DISORD, V30, P585, DOI 10.1023/A:1005691411255; Jalilevand N, 2013, J CHILD LANGUAGE ACQ, V1, P1; Kupper C, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61607-w; Le Couteur A, 2003, AUTISM DIAGNOSTIC IN; Lester B.M., 1985, INFANT CRYING THEORE; Levy S, 2017, MOL AUTISM, V8, DOI 10.1186/s13229-017-0180-6; Li TL, 2011, ADV MULTIMEDIA MODEL, DOI [10.1007/978-3-642-17832-0_30, DOI 10.1007/978-3-642-17832-0_30]; Little MA, 2017, GIGASCIENCE, V6, DOI 10.1093/gigascience/gix020; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; Lund N., 1993, ASSESSING CHILDRENS; MacDonald M, 2013, RES AUTISM SPECT DIS, V7, P1383, DOI 10.1016/j.rasd.2013.07.020; Mandell DS, 2005, PEDIATRICS, V116, P1480, DOI 10.1542/peds.2005-0185; Marchi E, 2015, 16TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION (INTERSPEECH 2015), VOLS 1-5, P115; Molau S, 2001, P IEEE, DOI [10.1109/ICASSP.2001.940770, DOI 10.1109/ICASSP.2001.940770]; Momeni N, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.19; Motlagh SHRE, 2013, ASIA CONTROL CONF AS; Nakai Y, 2017, PERCEPT MOTOR SKILL, V124, P961, DOI 10.1177/0031512517716855; Oller DK, 2010, P NATL ACAD SCI USA, V107, P13354, DOI 10.1073/pnas.1003882107; Orlandi S, 2012, IEEE ENG MED BIO, P2953, DOI 10.1109/EMBC.2012.6346583; Paliwal KK, 2010, P 4 INT C SIGN PROC, DOI [10.1109/ICSPCS.2010.5709770, DOI 10.1109/ICSPCS.2010.5709770]; Paul R., 2012, LANGUAGE DISORDERS I; Peeters G., 2004, CUIDADO 1 PROJECT RE, V54, P1; Pokorny FB, 2017, INTERSPEECH, P309, DOI 10.21437/Interspeech.2017-1007; Rabiner LR, 2007, FOUND TRENDS SIGNAL, V1, P1, DOI 10.1561/2000000001; Santos JF, 2013, P INT C AC SPEECH SI, DOI [10.1109/ICASSP.2013.6639134, DOI 10.1109/ICASSP.2013.6639134]; Sheinkopf SJ, 2012, AUTISM RES, V5, P331, DOI 10.1002/aur.1244; Takahashi T, 2016, HUM BRAIN MAPP, V37, P1038, DOI 10.1002/hbm.23089; Thabtah F, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16183502; Thabtah F, 2020, HEALTH INFORM J, V26, P264, DOI 10.1177/1460458218824711; Theodoridis S., 2003, PATTERN RECOGNITION; Three Z.T., 2005, DIAGNOSTIC CLASSIFIC; Volkmar Fred, 1999, Journal of the American Academy of Child and Adolescent Psychiatry, V38, p32S; Webb SJ, 2015, J AUTISM DEV DISORD, V45, P425, DOI 10.1007/s10803-013-1916-6; Zachor DA, 2010, RES AUTISM SPECT DIS, V4, P425, DOI 10.1016/j.rasd.2009.10.013	64	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0241690	10.1371/journal.pone.0241690	http://dx.doi.org/10.1371/journal.pone.0241690			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH0WB	33301502	Green Submitted, gold, Green Published			2022-12-27	WOS:000600143100025
J	Riaz, S; Tenscher, AC; Heinitz, CC; Huerta-Acosta, KG; Walker, MA				Riaz, Summaira; Tenscher, Alan C.; Heinitz, Claire C.; Huerta-Acosta, Karla G.; Walker, M. Andrew			Genetic analysis reveals an east-west divide within North American Vitis species that mirrors their resistance to Pierce's disease	PLOS ONE			English	Article							XYLELLA-FASTIDIOSA; GRAPEVINES; COLONIZATION; SOFTWARE; PDR1	Pierce's disease (PD) caused by the bacterium Xylella fastidiosa is a deadly disease of grapevines. This study used 20 SSR markers to genotype 326 accessions of grape species collected from the southeastern and southwestern United States, Mexico and Costa Rica. Two hundred sixty-six of these accessions, and an additional 12 PD resistant hybrid cultivars developed from southeastern US grape species, were evaluated for PD resistance. Disease resistance was evaluated by quantifying the level of bacteria in stems and measuring PD symptoms on the canes and leaves. Both Bayesian clustering and principal coordinate analyses identified two groups with an east-west divide: group 1 consisted of grape species from the southeastern US and Mexico, and group 2 consisted of accessions collected from the southwestern US and Mexico. The Sierra Madre Oriental mountain range appeared to be a phylogeographic barrier. The state of Texas was identified as a potential hybridization zone. The hierarchal STRUCTURE analysis on each group showed clustering of unique grape species. An east-west divide was also observed for PD resistance. With the exception of Vitis candicans and V. cinerea accessions collected from Mexico, all other grape species as well as the resistant southeastern hybrid cultivars were susceptible to the disease. Southwestern US grape accessions from drier desert regions showed stronger resistance to the disease. Strong PD resistance was observed within three distinct genetic clusters of V. arizonica which is adapted to drier environments and hybridizes freely with other species across its wide range.	[Riaz, Summaira; Tenscher, Alan C.; Heinitz, Claire C.; Huerta-Acosta, Karla G.; Walker, M. Andrew] Univ Calif Davis, Dept Viticulture & Enol, Davis, CA 95616 USA	University of California System; University of California Davis	Walker, MA (corresponding author), Univ Calif Davis, Dept Viticulture & Enol, Davis, CA 95616 USA.	awalker@ucdavis.edu		Heinitz, Claire/0000-0003-0341-5538; Riaz, Summaira/0000-0001-7739-144X; Walker, M. Andrew/0000-0001-5422-821X	California Department of Food and Agriculture PD/GWSS Board; Rossi Endowed Chair in Viticulture funds	California Department of Food and Agriculture PD/GWSS Board; Rossi Endowed Chair in Viticulture funds	MAW received funding for this study from the California Department of Food and Agriculture PD/GWSS Board (https://www.cdfa.ca.gov/pdcp/PD_GWSS_Board.html) and the Rossi Endowed Chair in Viticulture funds were also used. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey LH, 1934, GENET HERB, V3, P149; Callen ST, 2016, AM J ENOL VITICULT, V67, P339, DOI 10.5344/ajev.2016.15110; Chatterjee S, 2008, MOL PLANT MICROBE IN, V21, P1309, DOI 10.1094/MPMI-21-10-1309; Clarke E. E., 2003, Proceedings of the Florida State Horticultural Society, V116, P32; COMEAUX B L, 1991, SIDA Contributions to Botany, V14, P459; COMEAUX B L, 1987, SIDA Contributions to Botany, V12, P273; Comeaux Barry L., 2000, SIDA Contributions to Botany, V19, P123; CRALL JM, 1957, PHYTOPATHOLOGY, V47, P518; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Escalante T, 2007, NATURWISSENSCHAFTEN, V94, P561, DOI 10.1007/s00114-007-0228-0; ESRI, 2020, ARCGIS DESKT REL 10; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Galet P., 1988, CEPAGES VIGNOBLES FR, V1; Giampetruzzi A, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2833-9; GOHEEN AC, 1979, PLANT DIS REP, V63, P788; HALFFTER G, 1987, ANNU REV ENTOMOL, V32, P95, DOI 10.1146/annurev.ento.32.1.95; HEWITT W. B., 1958, PLANT DIS REPORTER, V42, P211; Hewitt WB, 1972, VIRUS DISEASES SMALL, P196; HOPKINS DL, 1974, J AM SOC HORTIC SCI, V99, P436; Hopkins DL, 1980, P 7 INT C VIRUSES GR, P177; JIMENEZ LG, 1985, TURRIALBA, V35, P243; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Krivanek A, 2006, THEOR APPL GENET, V112, P1125, DOI 10.1007/s00122-006-0214-5; Krivanek AF, 2005, THEOR APPL GENET, V111, P110, DOI 10.1007/s00122-005-1999-3; Krivanek AF, 2005, PHYTOPATHOLOGY, V95, P44, DOI 10.1094/PHYTO-95-0044; LOOMIS N. H., 1958, PLANT DIS REPORTER, V42, P833; Loucks KW, 1938, INVESTIGATIONS FRUIT, P118; Loucks KW, 1942, INVESTIGATIONS FRUIT, P124; Morrone JJ, 2010, ECOGRAPHY, V33, P355, DOI 10.1111/j.1600-0587.2010.06266.x; MORTENSE.JA, 1968, P AM SOC HORTIC SCI, V92, P331; Mortensen JA, 1990, VITIS, P271; MORTENSEN JA, 1977, J AM SOC HORTIC SCI, V102, P695; Munson T.V., 1909, FDN AM GRAPE CULTURE; Newman KL, 2003, APPL ENVIRON MICROB, V69, P7319, DOI 10.1128/AEM.69.12.7319-7327.2003; Nunney L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015488; OLMO HP, 1986, EXPERIENTIA, V42, P921, DOI 10.1007/BF01941769; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Perrier X., 2006, DARWIN SOFTWARE; PERRY RL, 1974, PLANT DIS REP, V58, P780; Pritchard JK, 2000, GENETICS, V155, P945; Ramasamy RK, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-431; Riaz S, 2008, THEOR APPL GENET, V117, P671, DOI 10.1007/s00122-008-0802-7; Riaz S, 2006, THEOR APPL GENET, V113, P1317, DOI 10.1007/s00122-006-0385-0; Riaz S, 2018, THEOR APPL GENET, V131, P1589, DOI 10.1007/s00122-018-3100-z; Riaz S, 2020, AM J ENOLOGY VITICUL; Riaz S, 2007, AM J ENOL VITICULT, V58, P494; Schuenzel EL, 2005, APPL ENVIRON MICROB, V71, P3832, DOI 10.1128/AEM.71.7.3832-3839.2005; STONER WARREN N., 1952, FLORIDA ENT, V35, P62, DOI 10.2307/3492278; STONER WN, 1953, PHYTOPATHOLOGY, V43, P611; Sun Q, 2013, PLANT PHYSIOL, V161, P1529, DOI 10.1104/pp.112.208157; Tiffney BH, 2001, INT J PLANT SCI, V162, pS3, DOI 10.1086/323880; Varela LG, 2001, AGR NATURAL RESOURCE, V21600; Walker MA, 2019, COMPENDIUM PLANT GEN; Wan YZ, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-141; Yuan X, 2010, PHYTOPATHOLOGY, V100, P601, DOI 10.1094/PHYTO-100-6-0601	55	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0243445	10.1371/journal.pone.0243445	http://dx.doi.org/10.1371/journal.pone.0243445			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8CZ	33338052	gold, Green Published			2022-12-27	WOS:000601313500040
J	Frost, RLA; Dunn, K; Christiansen, MH; Gomez, RL; Monaghan, P				Frost, Rebecca L. A.; Dunn, Kirsty; Christiansen, Morten H.; Gomez, Rebecca L.; Monaghan, Padraic			Exploring the "anchor word" effect in infants: Segmentation and categorisation of speech with and without high frequency words	PLOS ONE			English	Article							DISTRIBUTIONAL CUES; VOWEL HARMONY; GRAMMATICAL CATEGORIES; PHONOTACTIC KNOWLEDGE; PRIOR EXPERIENCE; LANGUAGE; INFORMATION; STATISTICS; SOUND; MOMMY	High frequency words play a key role in language acquisition, with recent work suggesting they may serve both speech segmentation and lexical categorisation. However, it is not yet known whether infants can detect novel high frequency words in continuous speech, nor whether they can use them to help learning for segmentation and categorisation at the same time. For instance, when hearing "you eat the biscuit", can children use the high-frequency words "you" and "the" to segment out "eat" and "biscuit", and determine their respective lexical categories? We tested this in two experiments. In Experiment 1, we familiarised 12-month-old infants with continuous artificial speech comprising repetitions of target words, which were preceded by high-frequency marker words that distinguished the targets into two distributional categories. In Experiment 2, we repeated the task using the same language but with additional phonological cues to word and category structure. In both studies, we measured learning with head-turn preference tests of segmentation and categorisation, and compared performance against a control group that heard the artificial speech without the marker words (i.e., just the targets). There was no evidence that high frequency words helped either speech segmentation or grammatical categorisation. However, segmentation was seen to improve when the distributional information was supplemented with phonological cues (Experiment 2). In both experiments, exploratory analysis indicated that infants' looking behaviour was related to their linguistic maturity (indexed by infants' vocabulary scores) with infants with high versus low vocabulary scores displaying novelty and familiarity preferences, respectively. We propose that high-frequency words must reach a critical threshold of familiarity before they can be of significant benefit to learning.	[Frost, Rebecca L. A.] Max Planck Inst Psycholinguist, Nijmegen, Netherlands; [Dunn, Kirsty; Monaghan, Padraic] Univ Lancaster, Lancaster, England; [Christiansen, Morten H.] Cornell Univ, Ithaca, NY USA; [Gomez, Rebecca L.] Univ Arizona, Tucson, AZ USA	Max Planck Society; Lancaster University; Cornell University; University of Arizona	Frost, RLA (corresponding author), Max Planck Inst Psycholinguist, Nijmegen, Netherlands.	Rebecca.Frost@mpi.nl	Monaghan, Padraic/E-6812-2010	Monaghan, Padraic/0000-0003-3965-2682; Frost, Rebecca/0000-0002-5556-4466; Christiansen, Morten H./0000-0002-3850-0655; Dunn, Kirsty Jayne/0000-0003-0863-8757	International Centre for Language and Communicative Development (LuCiD); Economic and Social Research Council [ES/L008955/1]; ESRC [ES/L008955/1] Funding Source: UKRI	International Centre for Language and Communicative Development (LuCiD); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was supported by the International Centre for Language and Communicative Development (LuCiD). The support of the Economic and Social Research Council [ES/L008955/1] is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaans F, 2010, J MEM LANG, V62, P311, DOI 10.1016/j.jml.2009.11.007; Alcock K.J, 2017, UK CDI WORDS GESTURE; Altan A., 2016, P 40 BOST U C LANG D; Altvater-Mackensen N, 2013, DEVELOPMENTAL SCI, V16, P980, DOI 10.1111/desc.12071; Ambridge B, 2015, J CHILD LANG, V42, P239, DOI 10.1017/S030500091400049X; [Anonymous], 2015, J STAT SOFTW, DOI [DOI 10.18637/JSS.V067.I01, DOI 10.18637/jss.v067.i01]; Aslin RN, 1998, PSYCHOL SCI, V9, P321, DOI 10.1111/1467-9280.00063; Aslin RN, 1996, SIGNAL TO SYNTAX: BOOTSTRAPPING FROM SPEECH TO GRAMMAR IN EARLY ACQUISITION, P117; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Black, 1990, FESTIVAL SPEECH SYNT; Black A., 2017, 39 ANN M COGNITIVE S, P124; Boll-Avetisyan N., 2018, EMPIRICAL APPROACHES, P213; Boll-Avetisyan N, 2016, LINGUA, V171, P74, DOI 10.1016/j.lingua.2015.11.008; Boll-Avetisyan N, 2014, LANG SPEECH, V57, P394, DOI 10.1177/0023830913508074; Bortfeld H, 2005, PSYCHOL SCI, V16, P298, DOI 10.1111/j.0956-7976.2005.01531.x; Brent MR, 1996, COGNITION, V61, P93, DOI 10.1016/S0010-0277(96)00719-6; Cairns P, 1997, COGNITIVE PSYCHOL, V33, P111, DOI 10.1006/cogp.1997.0649; CASSIDY KW, 1991, J MEM LANG, V30, P348, DOI 10.1016/0749-596X(91)90041-H; Christiansen MH, 1998, LANG COGNITIVE PROC, V13, P221, DOI 10.1080/016909698386528; Christiansen MH, 2009, DEVELOPMENTAL SCI, V12, P388, DOI 10.1111/j.1467-7687.2009.00824.x; Christophe A, 1997, LANG COGNITIVE PROC, V12, P585, DOI 10.1080/016909697386637; Cohen L.B., 2004, HABIT X NEW PROGRAM; Conway CM, 2010, COGNITION, V114, P356, DOI 10.1016/j.cognition.2009.10.009; Cunillera T, 2016, NEUROPSYCHOLOGIA, V82, P189, DOI 10.1016/j.neuropsychologia.2016.01.011; Cunillera T, 2010, EXP PSYCHOL, V57, P134, DOI 10.1027/1618-3169/a000017; Curtin S, 2005, COGNITION, V96, P233, DOI 10.1016/j.cognition.2004.08.005; CUTLER A, 1993, J PSYCHOLINGUIST RES, V22, P109; DURIEUX G, 2001, APPROACHES BOOTSTRAP, V0001, P00189; Emberson LL, 2019, DEVELOPMENTAL SCI, V22, DOI 10.1111/desc.12847; Estes KG, 2016, J EXP CHILD PSYCHOL, V146, P34, DOI 10.1016/j.jecp.2016.01.012; Frost R. L. A., 2019, P 41 ANN M COGN SCI; Frost R. L. A., 2020, CURRENT PERSPECTIVES; Frost RLA, 2020, COGNITIVE PSYCHOL, V120, DOI 10.1016/j.cogpsych.2020.101291; Frost RLA, 2019, J EXP PSYCHOL LEARN, V45, P1883, DOI 10.1037/xlm0000683; Frost RLA, 2017, J EXP PSYCHOL HUMAN, V43, P466, DOI 10.1037/xhp0000325; Frost RLA, 2016, P 38 ANN M COGN SCI, P81; Gerken L, 2006, COGNITION, V98, pB67, DOI 10.1016/j.cognition.2005.03.003; Gerken L, 2005, J CHILD LANG, V32, P249, DOI 10.1017/S0305000904006786; Gerken L, 2010, COGNITION, V115, P362, DOI 10.1016/j.cognition.2010.01.006; Gleitman L., 1982, LANG ACQUIS, P3; Gomez R, 2005, INFANCY, V7, P183, DOI 10.1207/s15327078in0702_4; Gomez RL, 2004, DEVELOPMENTAL SCI, V7, P567, DOI 10.1111/j.1467-7687.2004.00381.x; Gomez RL, 2002, PSYCHOL SCI, V13, P431, DOI 10.1111/1467-9280.00476; Gonzales K, 2018, COGNITIVE PSYCHOL, V106, P1, DOI 10.1016/j.cogpsych.2018.04.003; Gonzales K, 2015, COGNITION, V140, P60, DOI 10.1016/j.cognition.2015.03.015; Gonzalez-Gomez N, 2019, J EXP CHILD PSYCHOL, V178, P170, DOI 10.1016/j.jecp.2018.08.014; Gonzalez-Gomez N, 2013, J SPEECH LANG HEAR R, V56, P840, DOI 10.1044/1092-4388(2012/12-0138); Hohenberger A., 2017, P 41 ANN BOSTON U C, P309; Houston-Price C, 2004, INFANT CHILD DEV, V13, P341, DOI 10.1002/icd.364; Hunter M.A., 1988, ADV INFANCY RES, VVol. 5, P69, DOI DOI 10.1037/0012-1649.19.3.338; Johnson EK, 2010, DEVELOPMENTAL SCI, V13, P339, DOI 10.1111/j.1467-7687.2009.00886.x; Jusczyk P., 1997, DISCOVERY SPOKEN LAN; Kabak B., 2010, LAB PHONOLOGY, V1, P207, DOI [10.1515/labphon.2010.010, DOI 10.1515/LABPHON.2010.010]; KELLY MH, 1992, PSYCHOL REV, V99, P349, DOI 10.1037/0033-295X.99.2.349; Kurumada C, 2013, COGNITION, V127, P439, DOI 10.1016/j.cognition.2013.02.002; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Lany J, 2013, COMPREHENSIVE DEVELOPMENTAL NEUROSCIENCE: NEURAL CIRCUIT DEVELOPMENT AND FUNCTION IN THE HEALTHY AND DISEASED BRAIN, P231, DOI 10.1016/B978-0-12-397267-5.00034-0; Lany J., 2019, J CHILD LANG, V13, P1; Lany J, 2007, COGNITIVE SCI, V31, P481, DOI 10.1080/15326900701326584; Lany J, 2014, CHILD DEV, V85, P1727, DOI 10.1111/cdev.12199; Lany J, 2011, DEVELOPMENTAL SCI, V14, P1207, DOI 10.1111/j.1467-7687.2011.01073.x; Lany J, 2010, PSYCHOL SCI, V21, P284, DOI 10.1177/0956797609358570; Lany J, 2008, PSYCHOL SCI, V19, P1247, DOI 10.1111/j.1467-9280.2008.02233.x; Lew-Williams C, 2012, COGNITION, V122, P241, DOI 10.1016/j.cognition.2011.10.007; Lew-Williams C, 2011, DEVELOPMENTAL SCI, V14, P1323, DOI 10.1111/j.1467-7687.2011.01079.x; Li P., 2000, ACQUISITION LEXICAL, DOI [10.1515/9783110800715, DOI 10.1515/9783110800715]; Lieven E, 2010, LINGUA, V120, P2546, DOI 10.1016/j.lingua.2010.06.005; Marchetto E, 2015, J CHILD LANG, V42, P873, DOI 10.1017/S0305000914000452; Marchetto E, 2013, COGNITIVE PSYCHOL, V67, P130, DOI 10.1016/j.cogpsych.2013.08.001; Marcus GF, 2007, PSYCHOL SCI, V18, P387, DOI 10.1111/j.1467-9280.2007.01910.x; Marcus GF, 1999, SCIENCE, V283, P77, DOI 10.1126/science.283.5398.77; Mattys SL, 2005, J EXP PSYCHOL GEN, V134, P477, DOI 10.1037/0096-3445.134.4.477; McQueen JM, 1998, J MEM LANG, V39, P21, DOI 10.1006/jmla.1998.2568; Mersad K, 2012, LANG LEARN DEV, V8, P303, DOI 10.1080/15475441.2011.609106; Mintz TH, 2003, COGNITION, V90, P91, DOI 10.1016/S0010-0277(03)00140-9; Mintz TH, 2002, MEM COGNITION, V30, P678, DOI 10.3758/BF03196424; Mintz TH, 2002, COGNITIVE SCI, V26, P393, DOI 10.1207/s15516709cog2604_1; Mintz TH, 2018, COGNITION, V171, P95, DOI 10.1016/j.cognition.2017.10.020; Monaghan P, 2005, COGNITION, V96, P143, DOI 10.1016/j.cognition.2004.09.001; Monaghan P, 2007, COGNITIVE PSYCHOL, V55, P259, DOI 10.1016/j.cogpsych.2006.12.001; Monaghan P, 2017, TOP COGN SCI, V9, P21, DOI 10.1111/tops.12239; Monaghan P, 2013, J ACOUST SOC AM, V134, pEL45, DOI 10.1121/1.4809775; Monaghan P, 2010, J CHILD LANG, V37, P545, DOI 10.1017/S0305000909990511; Morgan JL, 1996, SIGNAL TO SYNTAX: BOOTSTRAPPING FROM SPEECH TO GRAMMAR IN EARLY ACQUISITION, P263; MORGAN JL, 1996, SIGNAL SYNTAX BOOTST; NELSON DGK, 1995, INFANT BEHAV DEV, V18, P111; Onnis L, 2005, J MEM LANG, V53, P225, DOI 10.1016/j.jml.2005.02.011; Pelucchi B, 2009, CHILD DEV, V80, P674, DOI 10.1111/j.1467-8624.2009.01290.x; Perruchet P, 1998, J MEM LANG, V39, P246, DOI 10.1006/jmla.1998.2576; R Core Team, 2020, R LANG ENV STAT COMP; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Saffran JR, 1997, PSYCHOL SCI, V8, P101, DOI 10.1111/j.1467-9280.1997.tb00690.x; Sandoval M, 2016, LANG LEARN DEV, V12, P398, DOI 10.1080/15475441.2016.1162722; SERENO JA, 1990, J PSYCHOLINGUIST RES, V19, P387, DOI 10.1007/BF01068886; Shi RS, 1998, J CHILD LANG, V25, P169, DOI 10.1017/S0305000997003395; Shi R, 2008, DEVELOPMENTAL SCI, V11, P407, DOI 10.1111/j.1467-7687.2008.00685.x; St Clair MC, 2010, COGNITION, V116, P341, DOI 10.1016/j.cognition.2010.05.012; Suomi K, 1997, J MEM LANG, V36, P422, DOI 10.1006/jmla.1996.2495; Swingley D, 2005, COGNITIVE PSYCHOL, V50, P86, DOI 10.1016/j.cogpsych.2004.06.001; Tagliapietra L, 2009, Q J EXP PSYCHOL, V62, P392, DOI 10.1080/17470210801907379; Teinonen T, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-21; Trecca F, 2019, LANG LEARN, V69, P143, DOI 10.1111/lang.12325; Turk AE, 2000, J PHONETICS, V28, P397, DOI 10.1006/jpho.2000.0123; VALIAN V, 1988, J MEM LANG, V27, P71, DOI 10.1016/0749-596X(88)90049-6; Van de Weijer J., 2001, EARLY LEXICON ACQUIS; Van Kampen A., 2008, LANG ACQUIS, P313; Vroomen J, 1998, J MEM LANG, V38, P133, DOI 10.1006/jmla.1997.2548; Wang FH, 2019, COGNITIVE PSYCHOL, V113, DOI 10.1016/j.cogpsych.2019.101223; White J, 2014, COGNITION, V133, P85, DOI 10.1016/j.cognition.2014.05.020; Zipf GK, 1935, PSYCHOBIOLOGY LANGUA	111	0	0	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243436	10.1371/journal.pone.0243436	http://dx.doi.org/10.1371/journal.pone.0243436			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PI8BZ	33332419	Green Published, gold			2022-12-27	WOS:000601310900025
J	Kay, AW; Thivalapill, N; Skinner, D; Dube, GS; Dlamini, N; Mzileni, B; Fuentes, P; Ustero, P; Adams, LV; Mandalakas, AM				Kay, Alexander W.; Thivalapill, Neil; Skinner, Donald; Dube, Gloria Sisi; Dlamini, Nomathemba; Mzileni, Bulisile; Fuentes, Patricia; Ustero, Pilar; Adams, Lisa V.; Mandalakas, Anna M.			Predictors of suboptimal adherence to isoniazid preventive therapy among adolescents and children living with HIV	PLOS ONE			English	Article							TUBERCULOSIS; RIFAMPIN; REGIMEN	This study identified factors associated with adherence to a 6-month isoniazid preventive therapy (IPT) course among adolescents and children living with HIV. Forty adolescents living with HIV and 48 primary caregivers of children living with HIV completed a Likert-based survey to measure respondent opinions regarding access to care, quality of care, preferred regimens, perceived stigma, and confidence in self-efficacy. Sociodemographic data were collected and adherence measured as the average of pill counts obtained while on IPT. The rates of suboptimal adherence (< 95% adherent) were 22.5% among adolescents and 37.5% among the children of primary caregivers. Univariate logistic regression was used to model the change in the odds of suboptimal adherence. Independent factors associated with suboptimal adherence among adolescents included age, education level, the cost of coming to clinic, stigma from community members, and two variables relating to self-efficacy. Among primary caregivers, child age, concerns about stigma, and location preference for meeting a community-health worker were associated with suboptimal adherence. To determine whether these combined factors contributed different information to the prediction of suboptimal adherence, a risk score containing these predictors was constructed for each group. The risk score had an AUC of 0.87 (95% CI: 0.76, 0.99) among adolescents and an AUC of 0.76 (95% CI: 0.62, 0.90), among primary caregivers suggesting that these variables may have complementary predictive utility. The heterogeneous scope and associations of these variables in different populations suggests that interventions aiming to increase optimal adherence will need to be tailored to specific populations and multifaceted in nature. Ideally interventions should address both long-established barriers to adherence such as cost of transportation to attend clinic and more nuanced psychosocial barriers such as perceived community stigma and confidence in self-efficacy.	[Kay, Alexander W.; Fuentes, Patricia; Ustero, Pilar; Mandalakas, Anna M.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Kay, Alexander W.; Fuentes, Patricia; Ustero, Pilar; Mandalakas, Anna M.] Texas Childrens Hosp, Global TB Program, Sect Global & Immigrant Hlth, Houston, TX 77030 USA; [Kay, Alexander W.; Thivalapill, Neil; Dlamini, Nomathemba; Mzileni, Bulisile; Fuentes, Patricia; Ustero, Pilar; Mandalakas, Anna M.] Baylor Coll Med Childrens Fdn, Mbabane, South Africa; [Thivalapill, Neil] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Skinner, Donald] Human Sci Res Council, HIV AIDS STDs & TB, Cape Town, South Africa; [Dube, Gloria Sisi] Minist Hlth, Natl TB Control Program, Mbabane, South Africa; [Adams, Lisa V.] Dartmouth Coll, Geisel Sch Med, Sect Infect Dis & Int Hlth, Hanover, NH 03755 USA	Baylor College of Medicine; Baylor College of Medicine; Columbia University; Human Sciences Research Council-South Africa; Dartmouth College	Kay, AW (corresponding author), Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.; Kay, AW (corresponding author), Texas Childrens Hosp, Global TB Program, Sect Global & Immigrant Hlth, Houston, TX 77030 USA.; Kay, AW (corresponding author), Baylor Coll Med Childrens Fdn, Mbabane, South Africa.	alexander.kay@bcm.edu		Thivalapill, Neil/0000-0003-3398-6710; Adams, Lisa V./0000-0002-1303-2154	Texas Children's Hospital; National Institutes of Health [1K01TW011482-01A1]	Texas Children's Hospital; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded through an institutional grant from Texas Children's Hospital and the National Institutes of Health (grant number 1K01TW011482-01A1 to AWK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adejumo OA, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20049; Ammassari A, 2002, JAIDS, V31, pS123, DOI 10.1097/00126334-200212153-00007; Ayieko J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-91; Boffa J, 2019, PUBLIC HEALTH ACTION, V9, P24, DOI 10.5588/pha.18.0040; Briggs MA, 2015, JAIDS-J ACQ IMM DEF, V68, pS297, DOI 10.1097/QAI.0000000000000497; Cluver L, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25176; Diallo T, 2018, NEW ENGL J MED, V379, P454, DOI 10.1056/NEJMoa1714284; Hill PC, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001105; Hunter OF, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05471-z; Imperial MZ, 2018, NAT MED, V24, P1708, DOI 10.1038/s41591-018-0224-2; Japanese Gastr Canc Assoc, 2021, GASTRIC CANCER, V24, P1, DOI [10.1007/s10120-020-01042-y, 10.1007/s10120-016-0622-4]; Manoj PDS, 2015, IEEE T COMPUT, V64, P3022, DOI 10.1109/TC.2015.2389827; Mavhu W, 2020, LANCET GLOB HEALTH, V8, pE264, DOI 10.1016/S2214-109X(19)30526-1; Ngugi SK, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05011-9; Rangaka MX, 2015, LANCET, V386, P1, DOI 10.1016/S0140-6736(15)00323-2; Rutherford ME, 2012, TROP MED INT HEALTH, V17, P1264, DOI 10.1111/j.1365-3156.2012.03053.x; Skinner D, 2013, PUBLIC HEALTH ACTION, V3, P191, DOI 10.5588/pha.13.0010; Skinner D, 2013, INT J TUBERC LUNG D, V17, P175, DOI 10.5588/ijtld.12.0230; Spyridis NP, 2007, CLIN INFECT DIS, V45, P715, DOI 10.1086/520983; van Soelen N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080803; Van Wyk SS, 2010, INT J TUBERC LUNG D, V14, P650; Vernon A, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002884; Villarino ME, 2015, JAMA PEDIATR, V169, P247, DOI 10.1001/jamapediatrics.2014.3158; WHO, 2015, WORLD HEAL ORGAN, V58, P7250; World Health Organization, 2020, GLOBAL TUBERCULOSIS; World Health Organization, 2012, REC INV CONT PERS IN; World Health Organization, 2018, LAT TUB INF UPD CONS; Yotebieng M, 2015, AIDS, V29, P2055, DOI 10.1097/QAD.0000000000000791	29	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243713	10.1371/journal.pone.0243713	http://dx.doi.org/10.1371/journal.pone.0243713			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332462	Green Published, gold			2022-12-27	WOS:000601310900026
J	Kirk, U; Axelsen, JL				Kirk, Ulrich; Axelsen, Johanne L.			Heart rate variability is enhanced during mindfulness practice: A randomized controlled trial involving a 10-day online-based mindfulness intervention	PLOS ONE			English	Article							RESPIRATORY SINUS ARRHYTHMIA; AUTONOMIC NERVOUS-SYSTEM; STRESS REDUCTION; SMARTPHONE APP; WORKING-MEMORY; SLEEP QUALITY; MEDITATION; INSOMNIA; MIND; ATTENTION	Objectives The goal of the present study was to probe the effects of mindfulness practice in a naturalistic setting as opposed to a lab-based environment in the presence of continuous heart rate variability (HRV) measurements. The specific experimental goals were to examine the effects of a brief 10-day online-based mindfulness intervention on both chronic and acute HRV responses. Method We conducted a fully randomized 10-day longitudinal trial of mindfulness practice, explicitly controlling for practice effects with an active-control group (music listening) and a non-intervention control group. To assess chronic cardiovascular effects, we asked participants in the 3 groups to complete 2-day HRV pre- and post-intervention measurement sessions. Using this experimental setup enabled us to address training effects arising from mindfulness practice to assess physiological impact on daytime as well as nighttime (i.e. assessing sleep quality) on the underlying HRV response. To assess acute cardiovascular effects, we measured HRV in the 2 active intervention groups during each of the 10 daily mindfulness or music sessions. This allowed us to track the development of purported training effects arising from mindfulness practice relative to the active-control intervention in terms of changes in the HRV slope over the 10-day time-course. Results Firstly, for the acute phase we found increased HRV during the daily practice sessions in both the mindfulness and active-control group indicating that both interventions were effective in decreasing acute physiological stress. Secondly, for the chronic phase we found increased HRV in both the day- and nighttime indicating increased sleep quality, specifically in the mindfulness group. Conclusion These results suggest causal effects in both chronic and acute phases of mindfulness practice in formerly naive subjects and provides support for the argument that brief online-based mindfulness interventions exert positive impact on HRV.	[Kirk, Ulrich; Axelsen, Johanne L.] Univ Southern Denmark, Dept Psychol, Odense, Denmark	University of Southern Denmark	Kirk, U (corresponding author), Univ Southern Denmark, Dept Psychol, Odense, Denmark.	ukirk@health.sdu.dk		kirk, ulrich/0000-0002-2121-2016; Lundager Axelsen, Johanne/0000-0001-5718-3870	 [71568]		This work was supported by a grant to U. K. from Velliv Foreningen (award number 71568). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler-Neal AL, 2020, J PAIN, V21, P306, DOI 10.1016/j.jpain.2019.07.003; Ahani A, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-87; Amaral JA, 2014, FOCUS ALTERNATIVE CO, V19, P132, DOI [10.1111/fct.12124, DOI 10.1111/FCT.12124]; Arredondo M, 2017, INT J OCCUP ENV HEAL, V23, P40, DOI 10.1080/10773525.2017.1386607; Axelsen JL, 2020, J COGN ENHANCE, V4, P31, DOI 10.1007/s41465-019-00162-3; Azam MA, 2016, INT J PSYCHOPHYSIOL, V110, P66, DOI 10.1016/j.ijpsycho.2016.10.011; Baer R, 2019, CURR OPIN PSYCHOL, V28, P42, DOI 10.1016/j.copsyc.2018.10.015; Bakeman R, 2005, BEHAV RES METHODS, V37, P379, DOI 10.3758/BF03192707; Barone DA, 2015, AIMS NEUROSCI, V2, P71, DOI 10.3934/Neuroscience.2015.2.71; Baumeister RF, 2007, PERSPECT PSYCHOL SCI, V2, P396, DOI 10.1111/j.1745-6916.2007.00051.x; Bennike IH, 2017, J COGN ENHANCE, V1, P172, DOI 10.1007/s41465-017-0020-9; Berntson GG, 1997, PSYCHOPHYSIOLOGY, V34, P623, DOI 10.1111/j.1469-8986.1997.tb02140.x; Bishop SR, 2004, CLIN PSYCHOL-SCI PR, V11, P230, DOI 10.1093/clipsy/bph077; Black DS, 2015, JAMA INTERN MED, V175, P494, DOI 10.1001/jamainternmed.2014.8081; Bradt J, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006911.pub3; Brown KW, 2003, J PERS SOC PSYCHOL, V84, P822, DOI 10.1037/0022-3514.84.4.822; BROWN TE, 1993, J APPL PHYSIOL, V75, P2310, DOI 10.1152/jappl.1993.75.5.2310; Buysse D J, 1989, Psychiatry Res, V28, P193; Camm AJ, 1996, CIRCULATION, V93, P1043; Delgado-Pastor LC, 2013, INT J PSYCHOPHYSIOL, V90, P207, DOI 10.1016/j.ijpsycho.2013.07.006; Champion L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209482; Christodoulou G, 2020, MINDFULNESS, V11, P554, DOI 10.1007/s12671-019-01296-3; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Crosswell AD, 2017, PSYCHONEUROENDOCRINO, V86, P78, DOI 10.1016/j.psyneuen.2017.08.003; de Geus EJC, 2019, PSYCHOPHYSIOLOGY, V56, DOI 10.1111/psyp.13287; Ditto B, 2006, ANN BEHAV MED, V32, P227, DOI 10.1207/s15324796abm3203_9; Economides M, 2018, MINDFULNESS, V9, P1584, DOI 10.1007/s12671-018-0905-4; Eriksson T, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.02340; Farb NAS, 2007, SOC COGN AFFECT NEUR, V2, P313, DOI 10.1093/scan/nsm030; Farb NAS, 2013, SOC COGN AFFECT NEUR, V8, P15, DOI 10.1093/scan/nss066; Garland EL, 2014, PSYCHOPHARMACOLOGY, V231, P3229, DOI 10.1007/s00213-014-3504-7; Garland SN, 2014, J CLIN ONCOL, V32, P449, DOI 10.1200/JCO.2012.47.7265; Gross CR, 2011, EXPLORE-NY, V7, P76, DOI 10.1016/j.explore.2010.12.003; Grossman P, 2007, BIOL PSYCHOL, V74, P263, DOI 10.1016/j.biopsycho.2005.11.014; Halbert J.D, 2018, MUSIC MED, V10, P180, DOI [10.47513/mmd.v10i4.614, DOI 10.47513/MMD.V10I4.614]; Hansen AL, 2003, INT J PSYCHOPHYSIOL, V48, P263, DOI 10.1016/S0167-8760(03)00073-4; Hill Labarron K, 2009, Biomed Sci Instrum, V45, P71; Howells A, 2016, J HAPPINESS STUD, V17, P163, DOI 10.1007/s10902-014-9589-1; Hubbling A, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-50; Jerath R, 2006, MED HYPOTHESES, V67, P566, DOI 10.1016/j.mehy.2006.02.042; Jha AP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116889; Kabat-Zinn J, 2003, CLIN PSYCHOL-SCI PR, V10, P144, DOI 10.1093/clipsy/bpg016; Kesek M, 2009, CLIN PHYSIOL FUNCT I, V29, P309, DOI 10.1111/j.1475-097X.2009.00873.x; Kirk U, 2019, J COGNITIVE ENHANCEM; Kirk U, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43474-2; Kirk U, 2016, NEUROIMAGE, V138, P274, DOI 10.1016/j.neuroimage.2016.05.075; Kirk U, 2014, NEUROIMAGE, V100, P254, DOI 10.1016/j.neuroimage.2014.06.035; Krygier JR, 2013, INT J PSYCHOPHYSIOL, V89, P305, DOI 10.1016/j.ijpsycho.2013.06.017; Lazar SW, 2005, NEUROREPORT, V16, P1893, DOI 10.1097/01.wnr.0000186598.66243.19; Lumma AL, 2015, INT J PSYCHOPHYSIOL, V97, P38, DOI 10.1016/j.ijpsycho.2015.04.017; Lutz A, 2008, TRENDS COGN SCI, V12, P163, DOI 10.1016/j.tics.2008.01.005; Mallon L, 2002, J INTERN MED, V251, P207, DOI 10.1046/j.1365-2796.2002.00941.x; McConnell PA, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01248; Mrazek MD, 2013, PSYCHOL SCI, V24, P776, DOI 10.1177/0956797612459659; Murata T, 2004, NEUROPSYCHOBIOLOGY, V50, P189, DOI 10.1159/000079113; Nakajima Y, 2016, BEHAV NEUROL, V2016, DOI 10.1155/2016/5965894; Olex S, 2013, INT J CARDIOL, V168, P1805, DOI 10.1016/j.ijcard.2013.06.086; Ong JC, 2008, BEHAV THER, V39, P171, DOI 10.1016/j.beth.2007.07.002; Ooishi Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189075; Ottaviani C, 2015, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00433; Overbeek TJM, 2014, BIOL PSYCHOL, V99, P1, DOI 10.1016/j.biopsycho.2014.02.006; Parak J., 2013, ACCURACY FIRSTBEAT B; Parak J, 2015, IEEE ENG MED BIO, P8099, DOI 10.1109/EMBC.2015.7320273; Park T, 2013, QUAL LIFE RES, V22, P2639, DOI 10.1007/s11136-013-0395-8; Pensuksan Wipawan C, 2016, Walailak J Sci Technol, V13, P235; Peressutti C, 2012, INT J CARDIOL, V154, P210, DOI 10.1016/j.ijcard.2011.10.054; Peressutti C, 2010, INT J CARDIOL, V145, P142, DOI 10.1016/j.ijcard.2009.06.058; Puddicombe A, 2011, GET SOME HEADSPACE 1; Ralevski E, 2019, PHARMACOL BIOCHEM BE, V176, P83, DOI 10.1016/j.pbb.2018.12.003; Schmidt MH, 2014, NEUROSCI BIOBEHAV R, V47, P122, DOI 10.1016/j.neubiorev.2014.08.001; Segerstrom SC, 2007, PSYCHOL SCI, V18, P275, DOI 10.1111/j.1467-9280.2007.01888.x; Shaffer F, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01040; Sjoberg N, 2011, NICOTINE TOB RES, V13, P369, DOI 10.1093/ntr/ntr004; Spiesshoefer J, 2021, EUR J PREV CARDIOL, V28, P189, DOI 10.1177/2047487319879526; Sun SS, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00314; Suyi Y, 2017, EXPLORE-NY, V13, P319, DOI 10.1016/j.explore.2017.06.001; Tang YY, 2007, P NATL ACAD SCI USA, V104, P17152, DOI 10.1073/pnas.0707678104; Tang YY, 2009, P NATL ACAD SCI USA, V106, P8865, DOI 10.1073/pnas.0904031106; Tarvainen MP, 2014, COMPUT METH PROG BIO, V113, P210, DOI 10.1016/j.cmpb.2013.07.024; Thayer JF, 2012, NEUROSCI BIOBEHAV R, V36, P747, DOI 10.1016/j.neubiorev.2011.11.009; Thayer JF, 2009, NEUROSCI BIOBEHAV R, V33, P81, DOI 10.1016/j.neubiorev.2008.08.004; Van Dam NT, 2018, PERSPECT PSYCHOL SCI, V13, P36, DOI 10.1177/1745691617709589; Wahbeh H, 2016, J CLIN PSYCHOL, V72, P365, DOI 10.1002/jclp.22255; Wen L, 2017, ACAD PSYCHIATR, V41, P646, DOI 10.1007/s40596-017-0768-3; Wielgosz J, 2016, SCI REP-UK, V6, DOI 10.1038/srep27533; Wulff V, 2017, GEBURTSH FRAUENHEILK, V77, P967, DOI 10.1055/s-0043-118414; Wylde CM, 2017, J PEDIATR NURS, V36, P205, DOI 10.1016/j.pedn.2017.06.008; Zeidan F, 2015, J NEUROSCI, V35, P15307, DOI 10.1523/JNEUROSCI.2542-15.2015; Zeidan F, 2010, CONSCIOUS COGN, V19, P597, DOI 10.1016/j.concog.2010.03.014	90	11	11	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243488	10.1371/journal.pone.0243488	http://dx.doi.org/10.1371/journal.pone.0243488			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PI8BZ	33332403	Green Published, gold			2022-12-27	WOS:000601310900038
J	Vornholt, E; Drake, J; Mamdani, M; McMichael, G; Taylor, ZN; Bacanu, SA; Miles, MF; Vladimirov, VI				Vornholt, Eric; Drake, John; Mamdani, Mohammed; McMichael, Gowon; Taylor, Zachary N.; Bacanu, Silviu-Alin; Miles, Michael F.; Vladimirov, Vladimir I.			Network preservation reveals shared and unique biological processes associated with chronic alcohol abuse in NAc and PFC	PLOS ONE			English	Article							GENE-EXPRESSION; FRONTAL-CORTEX; USE DISORDERS; TISSUE; NEUROCIRCUITRY; NEUROBIOLOGY; MECHANISMS; PLASTICITY; ADDICTION; DRINKING	Chronic alcohol abuse has been linked to the disruption of executive function and allostatic conditioning of reward response dysregulation in the mesocorticolimbic pathway (MCL). Here, we analyzed genome-wide mRNA and miRNA expression from matched cases with alcohol dependence (AD) and controls (n = 35) via gene network analysis to identify unique and shared biological processes dysregulated in the prefrontal cortex (PFC) and nucleus accumbens (NAc). We further investigated potential mRNA/miRNA interactions at the network and individual gene expression levels to identify the neurobiological mechanisms underlying AD in the brain. By using genotyped and imputed SNP data, we identified expression quantitative trait loci (eQTL) uncovering potential genetic regulatory elements for gene networks associated with AD. At a Bonferroni corrected p <= 0.05, we identified significant mRNA (NAc = 6; PFC = 3) and miRNA (NAc = 3; PFC = 2) AD modules. The gene-set enrichment analyses revealed modules preserved between PFC and NAc to be enriched for immune response processes, whereas genes involved in cellular morphogenesis/localization and cilia-based cell projection were enriched in NAc modules only. At a Bonferroni corrected p <= 0.05, we identified significant mRNA/miRNA network module correlations (NAc = 6; PFC = 4), which at an individual transcript level implicated miR-449a/b as potential regulators for cellular morphogenesis/localization in NAc. Finally, we identified eQTLs (NAc: mRNA = 37, miRNA = 9; PFC: mRNA = 17, miRNA = 16) which potentially mediate alcohol's effect in a brain region-specific manner. Our study highlights the neurotoxic effects of chronic alcohol abuse as well as brain region specific molecular changes that may impact the development of alcohol addiction.	[Vornholt, Eric; Mamdani, Mohammed; McMichael, Gowon; Taylor, Zachary N.; Bacanu, Silviu-Alin; Miles, Michael F.; Vladimirov, Vladimir I.] Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Med Coll Virginia Campus, Richmond, VA 23284 USA; [Vornholt, Eric] Virginia Commonwealth Univ, Integrat Life Sci Doctoral Program, Med Coll Virginia Campus, Richmond, VA 23284 USA; [Drake, John; Vladimirov, Vladimir I.] Texas A&M Univ, Dept Psychiat & Behav Sci, Bryan, TX 77842 USA; [Bacanu, Silviu-Alin] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA USA; [Miles, Michael F.] Virginia Commonwealth Univ, VCU Alcohol Res Ctr, Richmond, VA USA; [Miles, Michael F.] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA USA; [Miles, Michael F.] Virginia Commonwealth Univ, Dept Neurol, Richmond, VA USA; [Vladimirov, Vladimir I.] Virginia Commonwealth Univ, Ctr Biomarker Res & Precis Med, Med Coll Virginia Campus, Richmond, VA 23284 USA; [Vladimirov, Vladimir I.] Virginia Commonwealth Univ, Dept Physiol & Biophys, Med Coll Virginia Campus, Richmond, VA 23284 USA; [Vladimirov, Vladimir I.] Virginia Commonwealth Univ, Sch Pharm, Med Coll Virginia Campus, Richmond, VA 23284 USA; [Vladimirov, Vladimir I.] Johns Hopkins Univ, Lieber Inst Brain Dev, Baltimore, MD 21218 USA	Virginia Commonwealth University; Virginia Commonwealth University; Texas A&M University System; Texas A&M University College Station; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Johns Hopkins University	Vornholt, E; Vladimirov, VI (corresponding author), Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Med Coll Virginia Campus, Richmond, VA 23284 USA.; Vornholt, E (corresponding author), Virginia Commonwealth Univ, Integrat Life Sci Doctoral Program, Med Coll Virginia Campus, Richmond, VA 23284 USA.; Vladimirov, VI (corresponding author), Texas A&M Univ, Dept Psychiat & Behav Sci, Bryan, TX 77842 USA.; Vladimirov, VI (corresponding author), Virginia Commonwealth Univ, Ctr Biomarker Res & Precis Med, Med Coll Virginia Campus, Richmond, VA 23284 USA.; Vladimirov, VI (corresponding author), Virginia Commonwealth Univ, Dept Physiol & Biophys, Med Coll Virginia Campus, Richmond, VA 23284 USA.; Vladimirov, VI (corresponding author), Virginia Commonwealth Univ, Sch Pharm, Med Coll Virginia Campus, Richmond, VA 23284 USA.; Vladimirov, VI (corresponding author), Johns Hopkins Univ, Lieber Inst Brain Dev, Baltimore, MD 21218 USA.	vornholtes@vcu.edu; vivladimirov@tamu.edu	Drake, John/HGA-1355-2022	Drake, John/0000-0002-0420-3740; Bacanu, Silviu-Alin/0000-0002-4364-1583; Vornholt, Eric/0000-0001-8406-1158	National Institute on Alcohol Abuse and Alcoholism; National Institute of Mental Health [F31AA028180, R21AA022749/R01MH118239, P50AA022537]	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institute on Alcohol Abuse and Alcoholism (https://www.niaaa.nih.gov) and National Institute of Mental Health (https://www.nimh.nih.gov).Grant numbers: F31AA028180 (Eric Vornholt), R21AA022749/R01MH118239 (Dr. Vladimir I. Vladimirov), and P50AA022537 (Dr. Michael F. Miles). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernathy K, 2010, INT REV NEUROBIOL, V91, P289, DOI 10.1016/S0074-7742(10)91009-X; Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Alasmari F, 2018, PROG NEUROBIOL, V171, P32, DOI 10.1016/j.pneurobio.2018.10.001; Ben Hamida S, 2018, BIOL PSYCHIAT, V84, P202, DOI 10.1016/j.biopsych.2018.01.026; Benowitz NL, 2009, ANNU REV PHARMACOL, V49, P57, DOI 10.1146/annurev.pharmtox.48.113006.094742; Bryant CD, 2016, GENES BRAIN BEHAV, V15, P169, DOI 10.1111/gbb.12273; Bundesarztekammer, 2014, DTSCH ARZTEBL, V111, pA1583; Chang LH, 2019, DRUG ALCOHOL DEPEN, V197, P271, DOI 10.1016/j.drugalcdep.2019.01.015; Choi MR, 2020, BASIC CLIN PHARMACOL, V126, P389, DOI 10.1111/bcpt.13342; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Edenberg HJ, 2002, ALCOHOL RES HEALTH, V26, P214; Ehrlich AT, 2018, BRAIN STRUCT FUNCT, V223, P1275, DOI 10.1007/s00429-017-1547-3; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Evangelou E, 2019, NAT HUM BEHAV, V3, P950, DOI 10.1038/s41562-019-0653-z; Fang YT, 2013, ONCOL REP, V30, P399, DOI 10.3892/or.2013.2465; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Farris SP, 2015, MOL PSYCHIATR, V20, P1438, DOI 10.1038/mp.2014.159; Flatscher-Bader T, 2005, J NEUROCHEM, V93, P359, DOI 10.1111/j.1471-4159.2004.03021.x; Garcia-Gonzalez D, 2021, MOL PSYCHIATR, V26, P4616, DOI 10.1038/s41380-020-0823-4; Ge SX, 2018, BIORXIV, DOI [10.1101/315150, DOI 10.1101/315150]; Gilpin NW, 2008, ALCOHOL RES HEALTH, V31, P185; Guemez-Gamboa A, 2014, NEURON, V82, P511, DOI 10.1016/j.neuron.2014.04.024; Harper C, 2003, PROG NEURO-PSYCHOPH, V27, P951, DOI 10.1016/S0278-5846(03)00155-6; Harper C, 2009, ALCOHOL ALCOHOLISM, V44, P136, DOI 10.1093/alcalc/agn102; Hoffman GE, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1323-z; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; JORNVALL H, 1987, EUR J BIOCHEM, V167, P195, DOI 10.1111/j.1432-1033.1987.tb13323.x; Jung M, 2010, CLIN CHEM, V56, P998, DOI 10.1373/clinchem.2009.141580; Kamarajan C, 2017, INT J PSYCHOPHYSIOL, V115, P13, DOI 10.1016/j.ijpsycho.2016.12.007; Kendler KS, 2003, ARCH GEN PSYCHIAT, V60, P929, DOI 10.1001/archpsyc.60.9.929; Koob GF, 2016, LANCET PSYCHIAT, V3, P760, DOI 10.1016/S2215-0366(16)00104-8; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Koob GF, 2005, NAT NEUROSCI, V8, P1442, DOI 10.1038/nn1105-1442; Kranzler HR, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09480-8; Langfelder P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061505; Langfelder P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001057; Lehrmann E, 2003, PHARMACOGENOMICS J, V3, P27, DOI 10.1038/sj.tpj.6500146; Li MX, 2011, AM J HUM GENET, V88, P283, DOI 10.1016/j.ajhg.2011.01.019; Liu JW, 2006, NEUROPSYCHOPHARMACOL, V31, P1574, DOI 10.1038/sj.npp.1300947; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Luo J, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00102; Mahaweni NM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34258-1; Mamdani M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137671; McBride WJ, 2013, ALCOHOL, V47, P367, DOI 10.1016/j.alcohol.2013.04.002; McMichael GO, 2019, ASSESSING ROLE LONG; Montesinos J, 2016, ALCOHOL CLIN EXP RES, V40, P2260, DOI 10.1111/acer.13208; Nery S, 2002, NAT NEUROSCI, V5, P1279, DOI 10.1038/nn971; Noonan EJ, 2009, ONCOGENE, V28, P1714, DOI 10.1038/onc.2009.19; Paoletti P, 2009, NEUROSCIENCE, V158, P126, DOI 10.1016/j.neuroscience.2008.01.061; Quintero GC, 2013, NEUROPSYCH DIS TREAT, V9, P1499, DOI 10.2147/NDT.S45963; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Ron D, 2016, NAT REV NEUROSCI, V17, P576, DOI 10.1038/nrn.2016.85; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Simmler LD, 2017, BRIT J PHARMACOL, V174, P2716, DOI 10.1111/bph.13899; Skalny AV, 2018, EUR J NUTR, V57, P2313, DOI 10.1007/s00394-017-1584-y; Smith ACW, 2015, BRAIN RES, V1628, P29, DOI 10.1016/j.brainres.2015.03.027; Stan AD, 2006, BRAIN RES, V1123, P1, DOI 10.1016/j.brainres.2006.09.025; Sutherland GT, 2014, ALCOHOL CLIN EXP RES, V38, P1, DOI 10.1111/acer.12243; Teffer K, PROGR BRAIN RES, P191; VALLEE BL, 1995, NEUROCHEM INT, V27, P23, DOI 10.1016/0197-0186(94)00165-Q; Verhulst B, 2015, PSYCHOL MED, V45, P1061, DOI 10.1017/S0033291714002165; Warden AS, 2017, NEUROPHARMACOLOGY, V122, P161, DOI 10.1016/j.neuropharm.2017.02.017; Weis S, 2007, J NEUROSCI METH, V165, P198, DOI 10.1016/j.jneumeth.2007.06.001; Whitfield JF, 2004, CELL SIGNAL, V16, P763, DOI 10.1016/j.cellsig.2003.12.002; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	66	2	2	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243857	10.1371/journal.pone.0243857	http://dx.doi.org/10.1371/journal.pone.0243857			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PI8BZ	33332381	gold, Green Published, Green Submitted			2022-12-27	WOS:000601310900112
J	Bajcar, EA; Wiercioch-Kuzianik, K; Farley, D; Adamczyk, WM; Buglewicz, E; Babel, P				Bajcar, Elzbieta A.; Wiercioch-Kuzianik, Karolina; Farley, Dominika; Adamczyk, Waclaw M.; Buglewicz, Ewa; Babel, Przemyslaw			One of us or one of them? The effects of the model's and observer's characteristics on placebo analgesia induced by observational learning	PLOS ONE			English	Article							PEER MODELS; PAIN; CONFORMITY; SEX; POWER; RACE; FEAR; IMITATION; PRESSURE; GENDER	Previous studies have proved that observational learning can induce placebo analgesia, but the factors that influence observationally induced placebo analgesia have not yet been extensively examined. The primary goal of this study was to investigate the effect of information about the role that the observed person (model) plays in the experiment on the magnitude of the observationally induced placebo effect. This study also examined the contribution of the observer's empathy, conformity and fear of pain to the placebo analgesia induced by observational learning. The effects induced in two experimental groups and one control group were compared. Participants in the experimental groups observed a model introduced as either another participant taking part in the study or a coworker of the experimenter. The model rated the intensity of pain induced by electrocutaneous stimuli preceded by color stimuli. One-half of all participants watched a model rating pain stimuli preceded by the color orange as higher than stimuli preceded by the color blue; for the other half, the ratings were the opposite. There was no observation in the control group. Subsequently, all participants received pain stimuli of the same intensity preceded by orange and blue stimuli and rated the intensity of the experienced pain. Placebo analgesia was found in both experimental groups. However, the way the observed model was introduced to participants did not affect the magnitude of placebo analgesia. Thus, the study showed that the role played by the model is not crucial for observationally induced placebo analgesia. The examined observer's individual characteristics did not predict the magnitude of placebo effect.	[Bajcar, Elzbieta A.; Wiercioch-Kuzianik, Karolina; Farley, Dominika; Buglewicz, Ewa; Babel, Przemyslaw] Jagiellonian Univ, Inst Psychol, Pain Res Grp, Krakow, Poland; [Adamczyk, Waclaw M.] Jerzy Kukuczka Acad Phys Educ, Dept Kinesiotherapy & Special Methods Physiothera, Katowice, Poland	Jagiellonian University; Akademia Wychowania Fizycznego im. Jerzego Kukuczki w Katowicach	Bajcar, EA (corresponding author), Jagiellonian Univ, Inst Psychol, Pain Res Grp, Krakow, Poland.	elzbieta.bajcar@uj.edu.pl	Adamczyk, Waclaw M./X-5590-2018	Adamczyk, Waclaw M./0000-0001-8941-8355; Wiercioch-Kuzianik, Karolina/0000-0003-1480-6569; Farley, Dominika/0000-0001-9173-324X	National Science Centre in Poland [2016/23/B/HS6/03890]	National Science Centre in Poland(National Science Centre, Poland)	The study was funded by the National Science Centre in Poland (www.ncn.gov.pl) under the grant no. 2016/23/B/HS6/03890 obtained by PB.The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASCH SE, 1956, PSYCHOL MONOGR, V70, P1, DOI 10.1037/h0093718; Bajcar EA, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.02041; Bandura A, 1994, ENCY HUMAN BEHAV, DOI DOI 10.1002/9780470479216.CORPSY0836; Bandura A., 1986, SOCIAL FDN THOUGHT A; Bandura A., 1977, SOCIAL LEARNING THEO, V1; Berger S. M., 1977, SOCIAL COMP PROCESSE, P209; Bobier DM, 2002, EASURE SUSCEPTIBILIT; BREYER NL, 1970, PSYCHOL REP, V27, P639, DOI 10.2466/pr0.1970.27.2.639; BRODY GH, 1985, J GENET PSYCHOL, V146, P161, DOI 10.1080/00221325.1985.9914443; BUSSEY K, 1984, J PERS SOC PSYCHOL, V47, P1292, DOI 10.1037/0022-3514.47.6.1292; Cialdini RB, 2004, ANNU REV PSYCHOL, V55, P591, DOI 10.1146/annurev.psych.55.090902.142015; Colloca L, 2009, PAIN, V144, P28, DOI 10.1016/j.pain.2009.01.033; Davis M. H., 1980, JSAS CATALOG SELECTE, V10, P1, DOI DOI 10.1037/0022-3514.44.1.113; Egorova N, 2015, SCI REP-UK, V5, DOI 10.1038/srep16809; Epley N, 1999, J EXP SOC PSYCHOL, V35, P578, DOI 10.1006/jesp.1999.1390; Faasse K, 2016, CURR DIR PSYCHOL SCI, V25, P438, DOI 10.1177/0963721416657316; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gibson SJ, 2001, CLIN GERIATR MED, V17, P433, DOI 10.1016/S0749-0690(05)70079-3; Gierthmuhlen J, 2015, PAIN, V156, P2203, DOI 10.1097/j.pain.0000000000000227; GUDJONSSON GH, 1989, PERS INDIV DIFFER, V10, P535, DOI 10.1016/0191-8869(89)90035-4; Haun DBM, 2011, CHILD DEV, V82, P1759, DOI 10.1111/j.1467-8624.2011.01666.x; Hunter T, 2014, EUR J PAIN, V18, P914, DOI 10.1002/j.1532-2149.2013.00436.x; Kamierczak Maria., 2007, PRZEGLAD PSYCHOLOGIC, V50, P9; Karunanayake D, 2004, CAREER DEV Q, V52, P225, DOI 10.1002/j.2161-0045.2004.tb00644.x; Koban L, 2016, EMOTION, V16, P24, DOI 10.1037/emo0000087; Lamm C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001292; Lautenbacher S, 2005, PAIN, V115, P410, DOI 10.1016/j.pain.2005.03.025; LIRGG CD, 1991, RES Q EXERCISE SPORT, V62, P217, DOI 10.1080/02701367.1991.10608713; Lyby PS, 2011, PAIN, V152, P2405, DOI 10.1016/j.pain.2011.07.010; Lyby PS, 2010, J PSYCHOSOM RES, V68, P369, DOI 10.1016/j.jpsychores.2009.10.009; MCCULLAGH P, 1986, J SPORT PSYCHOL, V8, P319, DOI 10.1123/jsp.8.4.319; McNeil DW, 1998, J BEHAV MED, V21, P389, DOI 10.1023/A:1018782831217; Miller FG, 2008, J ROY SOC MED, V101, P222, DOI 10.1258/jrsm.2008.070466; MISCHEL W, 1966, J PERS SOC PSYCHOL, V3, P197, DOI 10.1037/h0022883; Mitsikostas DD, 2020, J HEADACHE PAIN, V21, DOI 10.1186/s10194-020-01178-3; Morrison I, 2013, HUM BRAIN MAPP, V34, P1982, DOI 10.1002/hbm.22040; Osborn Jody, 2010, Pain, V148, P268, DOI 10.1016/j.pain.2009.11.007; PARADISE LV, 1986, J COUNS PSYCHOL, V33, P16; Peirce J, 2019, BEHAV RES METHODS, V51, P195, DOI 10.3758/s13428-018-01193-y; PERRY DG, 1975, J PERS SOC PSYCHOL, V31, P1083, DOI 10.1037/h0076944; Polczyk R, 2007, MECH EFEKTU DEZINFOR, DOI [10.1080/02770900701209772, DOI 10.1080/02770900701209772]; SCHUNK DH, 1987, REV EDUC RES, V57, P149, DOI 10.3102/00346543057002149; SIMON B, 1990, EUR J SOC PSYCHOL, V20, P269; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Swider K, 2013, PAIN, V154, P1312, DOI 10.1016/j.pain.2013.04.001; THELEN MH, 1971, CHILD DEV, V42, P972, DOI 10.1111/j.1467-8624.1971.tb03717.x; Turner J.C., 1991, MAPPING SOCIAL PSYCH; Vandenbroucke S, 2014, FRONT HUM NEUROSCI, P8, DOI [10.3389/fnhum.2014.00008, DOI 10.3389/FNHUM.2014.00008]; Vogtle E, 2016, J PAIN RES, V9, P241, DOI 10.2147/JPR.S96228; Vogtle E, 2013, PAIN, V154, P1427, DOI 10.1016/j.pain.2013.04.041; Wheeler L, 2005, HDB COMPETENCE MOTIV, P566; Wiercioch-Kuzianik K, 2019, PAIN MED, V20, P1955, DOI 10.1093/pm/pny285; WOODROW KM, 1972, PSYCHOSOM MED, V34, P548, DOI 10.1097/00006842-197211000-00007; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	54	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243996	10.1371/journal.pone.0243996	http://dx.doi.org/10.1371/journal.pone.0243996			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH1IW	33326481	Green Published, gold			2022-12-27	WOS:000600176400059
J	Beani, L; Lippi, MM; Mulinacci, N; Manfredini, F; Cecchi, L; Giuliani, C; Tani, C; Meriggi, N; Cavalieri, D; Cappa, F				Beani, Laura; Lippi, Marta Mariotti; Mulinacci, Nadia; Manfredini, Fabio; Cecchi, Lorenzo; Giuliani, Claudia; Tani, Corrado; Meriggi, Niccolo; Cavalieri, Duccio; Cappa, Federico			Altered feeding behavior and immune competence in paper wasps: A case of parasite manipulation?	PLOS ONE			English	Article							HOST MANIPULATION; SELF-MEDICATION; PROTEIN COSTS; INSECTS; BIOLOGY; NECTAR; STREPSIPTERA; VERBASCOSIDE; RESISTANCE; ECOLOGY	Paper wasps (Polistes dominula), parasitized by the strepsipteran Xenos vesparum, are castrated and desert the colony to gather on plants where the parasite mates and releases primary larvae, thus completing its lifecycle. One of these plants is the trumpet creeper Campsis radicans: in a previous study the majority of all wasps collected from this plant were parasitized and focused their foraging activity on C. radicans buds. The unexpected prevalence and unusual feeding strategy prompted us to investigate the influence of this plant on wasp behavior and physiology through a multidisciplinary approach. First, in a series of laboratory bioassays, we observed that parasitized wasps spent more time than non-parasitized ones on fresh C. radicans buds, rich of extra-floral nectaries (EFNs), while the same wasps ignored treated buds that lacked nectar drops. Then, we described the structure and ultra-structure of EFNs secreting cells, compatible with the synthesis of phenolic compounds. Subsequently, we analysed extracts from different bud tissues by HPLC-DAD-MS and found that verbascoside was the most abundant bioactive molecule in those tissues rich in EFNs. Finally, we tested the immune-stimulant properties of verbascoside, as the biochemical nature of this compound indicates it might function as an antibacterial and antioxidant. We measured bacterial clearance in wasps, as a proxy for overall immune competence, and observed that it was enhanced after administration of verbascoside-even more so if the wasp was parasitized. We hypothesize that the parasite manipulates wasp behavior to preferentially feed on C. radicans EFNs, since the bioactive properties of verbascoside likely increase host survival and thus the parasite own fitness.	[Beani, Laura; Lippi, Marta Mariotti; Meriggi, Niccolo; Cavalieri, Duccio; Cappa, Federico] Univ Firenze, Dipartimento Biol, Florence, Italy; [Mulinacci, Nadia; Cecchi, Lorenzo; Tani, Corrado] Univ Firenze, Dipartimento NEUROFARBA, Florence, Italy; [Manfredini, Fabio] Royal Holloway Univ London, Sch Biol Sci, Egham, Surrey, England; [Manfredini, Fabio] Univ Aberdeen, Sch Biol Sci, Aberdeen, Scotland; [Giuliani, Claudia] Univ Studi Milano, Dipartimento Sci Farmaceut, Milan, Italy	University of Florence; University of Florence; University of London; Royal Holloway University London; University of Aberdeen; University of Milan	Beani, L; Cavalieri, D (corresponding author), Univ Firenze, Dipartimento Biol, Florence, Italy.	laura.beani@unifi.it; duccio.cavalieri@unifi.it	Cecchi, Lorenzo/X-5457-2018	Cecchi, Lorenzo/0000-0002-9332-704X	University of Florence	University of Florence	Financial support to LB was provided by the University of Florence.	Abbott J, 2014, ECOL ENTOMOL, V39, P273, DOI 10.1111/een.12110; Adamo SA, 2002, BRAIN BEHAV EVOLUT, V60, P370, DOI 10.1159/000067790; Adamo SA, 2013, J EXP BIOL, V216, P1, DOI 10.1242/jeb.082511; Alaa Ahmed M, 2019, PLoS One, V14, pe0213653, DOI 10.1371/journal.pone.0213653; Alipieva K, 2014, BIOTECHNOL ADV, V32, P1065, DOI 10.1016/j.biotechadv.2014.07.001; Baracchi D, 2011, TOXICON, V58, P550, DOI 10.1016/j.toxicon.2011.08.017; Beani L, 2005, J MORPHOL, V265, P291, DOI 10.1002/jmor.10359; Beani L, 2006, ANN ZOOL FENN, V43, P564; Beani L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205201; Beani L, 2011, ANIM BEHAV, V82, P1305, DOI 10.1016/j.anbehav.2011.09.012; Bernardo MA, 2017, J EXP BIOL, V220, P2848, DOI 10.1242/jeb.143800; BERTIN RI, 1982, AM J BOT, V69, P122, DOI 10.2307/2442837; Cai YZ, 2004, LIFE SCI, V74, P2157, DOI 10.1016/j.lfs.2003.09.047; Cappa F, 2020, ETHOL ECOL EVOL, V32, P289, DOI 10.1080/03949370.2019.1695228; Cappa F, 2020, INSECT SCI, V27, P1031, DOI 10.1111/1744-7917.12732; Cappa F, 2015, BIOL J LINN SOC, V114, P274, DOI 10.1111/bij.12427; Cappa F, 2014, PARASITOLOGY, V141, P1080, DOI 10.1017/S003118201400047X; Cervo R, 1996, BEHAV PROCESS, V36, P213, DOI 10.1016/0376-6357(95)00030-5; Chambers J.M., 1992, LINEAR MODELS; Charles HM, 2015, J INSECT PHYSIOL, V81, P97, DOI 10.1016/j.jinsphys.2015.07.005; Cini A, 2018, ECOL ENTOMOL, V43, P351, DOI 10.1111/een.12507; Cook JL, 2014, COMP PARASITOL, V81, P134, DOI 10.1654/4723.1; Cotter SC, 2011, FUNCT ECOL, V25, P186, DOI 10.1111/j.1365-2435.2010.01766.x; Cuautle M, 2003, FUNCT ECOL, V17, P417, DOI 10.1046/j.1365-2435.2003.00732.x; Dapporto L, 2007, PARASITOLOGY, V134, P545, DOI 10.1017/S0031182006001739; Dawkins R., 1982, pi; Dawkins R., 2016, THE EXTENDED PHENOTY; de Roode JC, 2019, CURR OPIN INSECT SCI, V33, P1, DOI 10.1016/j.cois.2018.12.001; de Roode JC, 2013, SCIENCE, V340, P150, DOI 10.1126/science.1235824; Dohse L, 2009, CUTIS, V83, P177; EICKWORT K, 1969, INSECT SOC, V16, P67, DOI 10.1007/BF02224464; ELIAS TS, 1975, SCIENCE, V189, P289, DOI 10.1126/science.189.4199.289; ELIAS TS, 1976, AM J BOT, V63, P1349, DOI 10.2307/2441843; Fox J., 2019, R COMPANION APPL REG; Funes L, 2009, FOOD CHEM, V117, P589, DOI 10.1016/j.foodchem.2009.04.059; GALETTO L, 1995, PLANT SYST EVOL, V196, P99, DOI 10.1007/BF00985338; GALETTO L, 2009, J PLANT REPROD BIOL, V1, P1; Geffre AC, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.0029; Giusti F, 2007, ARTHROPOD STRUCT DEV, V36, P183, DOI 10.1016/j.asd.2007.01.001; Grasso DA, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plv002; Hafer N, 2015, EVOLUTION, V69, P611, DOI 10.1111/evo.12612; Hashem F. A., 2007, Journal of Medical Sciences (Pakistan), V7, P1027; Heil M, 2015, ANNU REV ENTOMOL, V60, P213, DOI 10.1146/annurev-ento-010814-020753; Hoover K, 2019, CURR OPIN INSECT SCI, V33, pVI, DOI 10.1016/j.cois.2019.06.012; Hughes D, 2013, J EXP BIOL, V216, P142, DOI 10.1242/jeb.077461; Hughes DP, 2019, CURR BIOL, V29, pR45, DOI 10.1016/j.cub.2018.12.001; Hughes DP, 2018, ANNU REV ENTOMOL, V63, P471, DOI 10.1146/annurev-ento-020117-043234; Hughes DP, 2004, BEHAV ECOL, V15, P1037, DOI 10.1093/beheco/arh111; Kathirithamby J, 2009, ANNU REV ENTOMOL, V54, P227, DOI 10.1146/annurev.ento.54.110807.090525; Kolodziejska-Degorska I, 2006, ACTA SOC BOT POL, V75, P79; Lafferty KD, 2002, TRENDS ECOL EVOL, V17, P507, DOI 10.1016/S0169-5347(02)02615-0; Lee KP, 2006, P ROY SOC B-BIOL SCI, V273, P823, DOI 10.1098/rspb.2005.3385; Lefevre T, 2009, TRENDS ECOL EVOL, V24, P41, DOI 10.1016/j.tree.2008.08.007; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Manfredini F, 2010, MICROBES INFECT, V12, P727, DOI 10.1016/j.micinf.2010.05.001; Manfredini F, 2010, J INSECT PHYSIOL, V56, P253, DOI 10.1016/j.jinsphys.2009.10.009; Meriggi N, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02320; National health commission National administration of traditional Chinese medicine, 2020, CHIN J VIRAL DIS, V10, P1, DOI [10.1016/j.joim.2020.04.001, DOI 10.1038/S41598-019-56847-4]; Nepi M, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01063; Ogle DH, 2020, FSA FISHERIES STOCK; Ponton F, 2011, INT J PARASITOL, V41, P43, DOI 10.1016/j.ijpara.2010.06.007; Poulin R, 2015, TRENDS PARASITOL, V31, P563, DOI 10.1016/j.pt.2015.07.002; Poulin R, 2010, ADV STUD BEHAV, V41, P151, DOI 10.1016/S0065-3454(10)41005-0; Povey S, 2009, J ANIM ECOL, V78, P437, DOI 10.1111/j.1365-2656.2008.01499.x; R Development Core Team, 2009, R LANG ENV STAT COMP; Rahmatullah M, 2019, ADV NAT APPL SCI, V4, P52; Schmid-Hempel P, 2005, ANNU REV ENTOMOL, V50, P529, DOI 10.1146/annurev.ento.50.071803.130420; Spivak M, 2019, CURR OPIN INSECT SCI, V33, P49, DOI 10.1016/j.cois.2019.02.009; Thomas F, 2010, OIKOS, V119, P1217, DOI 10.1111/j.1600-0706.2009.18077.x; Whitehill JGA, 2014, OECOLOGIA, V176, P1047, DOI 10.1007/s00442-014-3082-8; Wickham H., 2016, GGPLOT2 ELEGANT GRAP, DOI 10.1007/978-3-319-24277-4; WILKINSON GN, 1973, ROY STAT SOC C-APP, V22, P392; 2012, DRUG DISCOV TODAY-TE, V9	73	3	3	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0242486	10.1371/journal.pone.0242486	http://dx.doi.org/10.1371/journal.pone.0242486			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326432	Green Published, gold			2022-12-27	WOS:000600176400035
J	Hui, A				Hui, Andrew			Exploring the utility of RDoC in differentiating effectiveness amongst antidepressants: A systematic review using proposed psychometrics as the unit of analysis for the Negative Valence Systems domain	PLOS ONE			English	Review							DOUBLE-BLIND; CRITERIA RDOC; REUPTAKE INHIBITORS; EMOTIONAL DISORDERS; PANIC DISORDER; SELF-REPORT; MAJOR DEPRESSION; JOINT STRUCTURE; PLACEBO; SEROTONIN	Background RDoC conceptualises psychopathology as neurobiologically-rooted behavioural psychological "constructs" that span dimensionally from normality to pathology, but its clinical utility remains controversial. Aim To explore RDoC's potential clinical utility by examining antidepressant effectiveness through Negative Valence Systems (NVS) domain constructs. Method A systematic review was conducted on Web of Science, MEDLINE, EMBASE and PsycINFO for antidepressant trials that included psychometric instruments assessed by Watson, Stanton & Clark (2017) to represent NVS constructs of Acute Threat, Potential Threat and Loss. Results 221 citations were identified; 13 were included in qualitative synthesis, none for quantitative analysis. All suffered from significant bias risks. 9 antidepressants were investigated, most within 1 construct, and most were found to be effective. Paroxetine, citalopram and fluvoxamine were found to be effective for Acute Threat, fluoxetine, desvenlafaxine and sertraline for Potential Threat, and sertraline, fluvoxamine, fluoxetine and desvenlafaxine effective for Loss. Nefazodone was found to be ineffective for acute fear. Conclusion Preliminary evidence supports RDoC NVS constructs' clinical utility in assessing antidepressant effectiveness, but lack of discriminant validity between Potential Threat and Loss supports their recombination into a single Distress construct. Finding of effectiveness within "normal" construct levels support the utility of a dimensional approach. Testable hypotheses were generated that can further test RDoC's clinical utility.	[Hui, Andrew] Royal Melbourne Hosp, Northwestern Mental Hlth, Melbourne, Vic, Australia	Royal Melbourne Hospital	Hui, A (corresponding author), Royal Melbourne Hosp, Northwestern Mental Hlth, Melbourne, Vic, Australia.	Andrew.hui@mh.org.au						Alamy S, 2008, J PSYCHOPHARMACOL, V22, P157, DOI 10.1177/0269881107080796; Alpert M, 2003, J CLIN PSYCHOPHARM, V23, P309, DOI 10.1097/00004714-200306000-00012; APA, 1980, DSM 3 DIAGNN STAT MA; Bagby RM, 2004, AM J PSYCHIAT, V161, P2163, DOI 10.1176/appi.ajp.161.12.2163; Bandelow B, 2007, DEPRESS ANXIETY, V24, P53, DOI 10.1002/da.20141; Bardwell WA, 2001, J APPL BIOBEHAV RES, V6, P27, DOI 10.1111/j.1751-9861.2001.tb00105.x; Beique JC, 1998, EUR J PHARMACOL, V349, P129, DOI 10.1016/S0014-2999(98)00241-6; Briley M, 1998, HUM PSYCHOPHARM CLIN, V13, P99, DOI 10.1002/(SICI)1099-1077(199803)13:2<99::AID-HUP954>3.0.CO;2-2; Carcone D, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00046; Cheng RJ, 2013, CLIMACTERIC, V16, P17, DOI 10.3109/13697137.2012.672495; Chiesa A, C PUBLICATION VAR S1, V24, pS500; Christiansen OG, 2017, J PSYCHIATR RES, V94, P186, DOI 10.1016/j.jpsychires.2017.07.016; Cipriani A, 2018, LANCET, V391, P1357, DOI 10.1016/S0140-6736(17)32802-7; Cohen RA, 2001, EMOTION, V1, P38, DOI 10.1037/1528-3542.1.1.38; Cuthbert BN, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-126; de Carvalho HW, 2014, REV BRAS PSIQUIATR, V36, P285, DOI 10.1590/1516-4446-2013-1329; Jonge P, 2018, PSYCHOL MED, V48, P2073, DOI 10.1017/S0033291717003610; de Vries YA, 2018, DEPRESS ANXIETY, V35, P515, DOI 10.1002/da.22737; Dornbach-Bender A, 2017, COMPR PSYCHIAT, V79, P31, DOI 10.1016/j.comppsych.2017.06.011; Doyle MM, 2016, J ABNORM CHILD PSYCH, V44, P1559, DOI 10.1007/s10802-016-0129-9; Eaton NR, 2013, J ABNORM PSYCHOL, V122, P86, DOI 10.1037/a0029598; Evers EAT, 2009, PSYCHIAT RES-NEUROIM, V173, P52, DOI 10.1016/j.pscychresns.2008.09.006; FABRE LF, 1995, BIOL PSYCHIAT, V38, P592, DOI 10.1016/0006-3223(95)00178-8; Fava GA, 2017, PSYCHOTHER PSYCHOSOM, V86, P134, DOI 10.1159/000458458; Finkel S I, 1999, Int Psychogeriatr, V11, P85; Gainey K. E. N., 2012, DISS ABSTR INT B, V73, P3262; Goodnick PJ, 1998, J PSYCHOPHARMACOL, V12, pS5, DOI 10.1177/0269881198012003021; Goossen B, 2019, J NEURAL TRANSM, V20, P20; Helfer B, 2016, AM J PSYCHIAT, V173, P876, DOI 10.1176/appi.ajp.2016.15081035; Hirakawa H, 2016, INT J PSYCHIAT CLIN, V20, P106, DOI 10.3109/13651501.2016.1144772; Hunt M, 2003, J PERS ASSESS, V80, P26, DOI 10.1207/S15327752JPA8001_10; Insel T, 2010, AM J PSYCHIAT, V167, P748, DOI 10.1176/appi.ajp.2010.09091379; ITIL TM, 1983, BRIT J CLIN PHARMACO, V15, pS433, DOI 10.1111/j.1365-2125.1983.tb02134.x; Jordan VMB, 2017, J CLIN EPIDEMIOL, V81, P72, DOI 10.1016/j.jclinepi.2016.08.012; Kotov R, 2015, PSYCHOL MED, V45, P1687, DOI 10.1017/S0033291714002815; Kozak MJ, 2016, PSYCHOPHYSIOLOGY, V53, P286, DOI 10.1111/psyp.12518; Kroes MCW, 2019, CURR OPIN BEHAV SCI, V26, P25, DOI 10.1016/j.cobeha.2018.09.018; Kushner SC, 2012, J PSYCHOPATHOL BEHAV, V34, P22, DOI 10.1007/s10862-011-9263-4; Lee J, 2012, INT S HIGH PERF COMP, P91; Lopez-Munoz F, 2009, CURR PHARM DESIGN, V15, P1563, DOI 10.2174/138161209788168001; Lydiard RB, 1997, J CLIN PSYCHIAT, V58, P484, DOI 10.4088/JCP.v58n1104; Macaluso M, 2019, ANTIDEPRESSANTS BIOG; Mancini C, 1996, J CLIN PSYCHIAT, V57, P519, DOI 10.4088/JCP.v57n1103; MARKS IM, 1979, BEHAV RES THER, V17, P263, DOI 10.1016/0005-7967(79)90041-X; McCrae RR, 2005, J PERS ASSESS, V84, P261, DOI 10.1207/s15327752jpa8403_05; McNair D.M., 1971, MANUAL PROFILES MOOD; Murphy SE, 2009, INT J NEUROPSYCHOPH, V12, P169, DOI 10.1017/S1461145708009164; Nagamitsu S, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00016; National Institute of Mental Health, 2011, NIMH RES DOM CRIT RD; Nyenhuis DL, 1999, J CLIN PSYCHOL, V55, P79, DOI 10.1002/(SICI)1097-4679(199901)55:1<79::AID-JCLP8>3.0.CO;2-7; Ozdemir PG, 2015, J CLIN PSYCHIAT, V76, pE645, DOI 10.4088/JCP.14m09376; Perna G, 2001, PHARMACOPSYCHIATRY, V34, P85, DOI 10.1055/s-2001-14283; Pettie M, 2019, J PSYCHOPHARMACOL, V33, P355, DOI 10.1177/0269881118822156; Rasmussen K, 2006, DRUG DISCOV TODAY, V11, P623, DOI 10.1016/j.drudis.2006.05.004; Seo C, 2019, SCIENCE, V363, P538, DOI 10.1126/science.aau8722; Sharp DM, 1996, J ANXIETY DISORD, V10, P219, DOI 10.1016/0887-6185(96)00008-4; Slee A, 2019, LANCET, V393, P768, DOI 10.1016/S0140-6736(18)31793-8; Spielberger C, 1972, PROF PSYCHOL, V3, P387, DOI DOI 10.1037/H0020742; Stahl SM, 2003, J CLIN PSYCHIAT, V64, P1322, DOI 10.4088/JCP.v64n1107; Sterne JAC, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4898; Sterne JAC, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i4919; Trosper SE, 2011, DISS ABSTR INT B, V72, P3742; TRULL TJ, 1990, J PSYCHOPATHOL BEHAV, V12, P285, DOI 10.1007/BF00965984; Vaidyanathan U, 2011, SCHIZOPHRENIA BULL, V37, P65; Vaidyanathan U, 2009, PSYCHOL BULL, V135, P909, DOI 10.1037/a0017222; Van Ameringen M, 1999, J CLIN PSYCHIAT, V60, P96; Waszczuk MA, 2017, J ABNORM PSYCHOL, V126, P613, DOI 10.1037/abn0000264; Watson D., 1994, PANAS X MANUAL POSIT; Watson D, 2019, ASSESSMENT, V26, P17, DOI 10.1177/1073191117711022; Watson D, 2017, J AFFECT DISORDERS, V216, P58, DOI 10.1016/j.jad.2016.09.065; Watson D, 2015, ASSESSMENT, V22, P540, DOI 10.1177/1073191114557943; Weinberger DR, 2015, JAMA PSYCHIAT, V72, P1161, DOI 10.1001/jamapsychiatry.2015.1743; WOOD SH, 1992, OBSTET GYNECOL, V80, P339; Yager J, 2017, J CLIN PSYCHIAT, V78, P423, DOI 10.4088/JCP.15nr10476	74	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243057	10.1371/journal.pone.0243057	http://dx.doi.org/10.1371/journal.pone.0243057			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH1IW	33326436	Green Published, gold			2022-12-27	WOS:000600176400077
J	Kolte, IV; Pereira, L; Benites, A; de Sousa, IMC; Basta, PC				Kolte, Ida Viktoria; Pereira, Lucia; Benites, Aparecida; Carvalho de Sousa, Islandia Maria; Basta, Paulo Cesar			The contribution of stigma to the transmission and treatment of tuberculosis in a hyperendemic indigenous population in Brazil	PLOS ONE			English	Article							PEOPLES; PREJUDICE	Background The Guarani-Kaiowa are Brazil's second-largest indigenous group. Average annual tuberculosis (TB) incidence rates among the Guarani-Kaiowa are nearly 400/100,000 in Mato Grosso do Sul state, ten times the national average. Although stigma is considered crucial for TB control in indigenous communities, few studies have investigated TB stigma among indigenous populations. This study sought to understand the role of TB-related stigma and perceptions of TB in maintaining hyperendemic TB transmission in the Guarani-Kaiowa communities. Methods Various forms of stigma were explored through semi-structured interviews with 19 patients, 11 relatives, and 23 community members. Patients were identified from the registry of the healthcare service. Community members, selected by snowball sampling, were matched by gender and village of residence. Interviews were conducted in Guarani and Portuguese and later translated into English. Framework analysis was performed using NVivo. Results Traditional beliefs of a weakening of the body allowing the disease to enter were common, but the exact mechanism of transmission was unknown. Strong community/public stigma associated TB with uncleanliness, abuse, and irresponsibility. Anticipated stigma led to significant treatment delays for fear of exclusion and losing employment. While most patients felt supported by their families, nearly all patients related experienced/enacted stigma in the community such as gossip, avoidance, and social exclusion, leading to long-lasting internalized/self-stigma. Secondary stigmatization of relatives was widespread, and blanket latent TB infection (LTBI) treatment of patients' households was a contributing factor in treatment delay. The healthcare service unnecessarily added to stigmatization by enforcing separate utensils and sleeping arrangements for patients. Conclusions Our findings suggest that stigma is a driver for treatment delay and continued transmission of TB in the community. The stigmatization of TB was rooted in a poor understanding of TB transmission, partly because of incorrect orientation by the healthcare service. Interventions to reduce TB-associated stigma are urgently needed.	[Kolte, Ida Viktoria; Basta, Paulo Cesar] Fundacao Oswaldo Cruz, Natl Sch Publ Hlth, Rio De Janeiro, Brazil; [Pereira, Lucia] Fundacao Univ Fed Grande Dourados, Dept Ciencias Sociais, Dourados, MS, Brazil; [Benites, Aparecida] Univ Estadual Mato Grosso Sul, Dept Hist, Amambai, Brazil; [Carvalho de Sousa, Islandia Maria] Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Recife, PE, Brazil	Fundacao Oswaldo Cruz; Universidade Federal da Grande Dourados; Universidade Estadual de Mato Grosso do Sul; Fundacao Oswaldo Cruz	Kolte, IV (corresponding author), Fundacao Oswaldo Cruz, Natl Sch Publ Hlth, Rio De Janeiro, Brazil.	idakolte@hotmail.com	Basta, Paulo Cesar/AAP-5358-2021; de Sousa, Islandia Maria Carvalho/AAY-4209-2020	de Sousa, Islandia Maria Carvalho/0000-0001-9324-4896; Basta, Paulo/0000-0003-0804-0413	Programa de Apoio a Pesquisa, Desenvolvimento e Inovacao em Saude of the Escola Nacional de Saude Publica at the Oswaldo Cruz Foundation/Fundacao Oswaldo Cruz (FIOCRUZ) [ENSP-046-FIO-13]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) under the Science without Borders program [88887.091631/2014-00]	Programa de Apoio a Pesquisa, Desenvolvimento e Inovacao em Saude of the Escola Nacional de Saude Publica at the Oswaldo Cruz Foundation/Fundacao Oswaldo Cruz (FIOCRUZ); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) under the Science without Borders program	PCB received support by the Programa de Apoio a Pesquisa, Desenvolvimento e Inovacao em Saude (ENSP-046-FIO-13) of the Escola Nacional de Saude Publica at the Oswaldo Cruz Foundation/Fundacao Oswaldo Cruz (FIOCRUZ). IVK received support from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) under the Science without Borders program (88887.091631/2014-00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, ASIAN J HUMANITIES S, V2, P219; Basta PC, 2013, REV SAUDE PUBL, V47, DOI 10.1590/S0034-8910.2013047004628; Bloss E, 2011, PUBLIC HEALTH REP, V126, P677, DOI 10.1177/003335491112600510; Brasil FIAN, 2016, FIAN BRASIL; Brazil Ministry of Health, 2019, MANUAL RECOMENDACOES; Challenge TB, 2018, TB STIGM MEAS GUID; Cormier M, 2019, LANCET GLOB HEALTH, V7, pE68, DOI 10.1016/S2214-109X(18)30435-2; Sacchi FPC, 2018, AM J TROP MED HYG, V98, P372, DOI 10.4269/ajtmh.17-0480; Sacchi FPC, 2013, T ROY SOC TROP MED H, V107, P152, DOI 10.1093/trstmh/trs089; Courtwright A, 2010, PUBLIC HEALTH REP, V125, P34, DOI 10.1177/00333549101250S407; Cunha EA, 2014, MEM I OSWALDO CRUZ, V109, P108, DOI 10.1590/0074-0276130082; Daftary A, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2017-000515; Viana PVD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154658; Durham Community Research Team, 2011, COMMUNITY BASED PART; Ferreira R, 2018, POVOS INDIGENAS BRAS; Frick M, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1479; Fusch PI, 2015, QUAL REP, V20, P1408; Gibson N, 2005, SOC SCI MED, V61, P931, DOI 10.1016/j.socscimed.2004.10.026; Holkup PA, 2004, ADV NURS SCI, V27, P162, DOI 10.1097/00012272-200407000-00002; Indigenist Missionary Council (Conselho Indigenista Missionario-CIMI), 2020, REP VIOL IND PEOPL B; Instituto Brasileiro de Geografia e Estatistica, 2012, CENS BRAS 2010, P2012; Instituto Socioambiental, 2020, PLATF MON IND SIT PA; International Labour Organization, 2019, QUAL STUD STIGM DISC; Lemos EF, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-237; Long R, 2013, CAN RESPIR J, V20, P223, DOI 10.1155/2013/429496; Macq J, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-154; Malacarne J, 2018, REV INST MED TROP SP, V60, DOI [10.1590/S1678-9946201860063, 10.1590/s1678-9946201860063]; Malacarne J, 2016, REV SOC BRAS MED TRO, V49, P456, DOI 10.1590/0037-8682-0220-2016; Oliveira R.P, 2015, THESIS; Onyeneho NG, 2011, INT Q COMMUNITY HEAL, V31, P187, DOI 10.2190/IQ.31.2.f; Parker R, 2012, CAD SAUDE PUBLICA, V28, P164, DOI 10.1590/S0102-311X2012000100017; Pescosolido BA, 2008, SOC SCI MED, V67, P431, DOI 10.1016/j.socscimed.2008.03.018; Phelan JC, 2008, SOC SCI MED, V67, P358, DOI 10.1016/j.socscimed.2008.03.022; Smieja M, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001363; Sommerland N, 2017, INT J TUBERC LUNG D, V21, pS81, DOI 10.5588/ijtld.16.0788; Sotgiu G, 2020, EUROPEAN RESP J; The Stop TB Partnership UNOPS, 2015, GLOB PLAN END TB 201; Tollefson D, 2013, INT J TUBERC LUNG D, V17, P1139, DOI 10.5588/ijtld.12.0385; Toms C, 2017, CDI, V2017, P41; United Nations, 2016, REP SPEC RAPP RIGHTS; Viney KA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-467; World Health Organization, 2020, GLOB TUB REP 2020; Yuhara LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071201; Zwerling A, 2020, LANCET INFECT DIS, V20, P879, DOI 10.1016/S1473-3099(20)30316-9	44	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243988	10.1371/journal.pone.0243988	http://dx.doi.org/10.1371/journal.pone.0243988			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH1IW	33326453	gold, Green Published			2022-12-27	WOS:000600176400054
J	Ochab, M; Puszynski, K				Ochab, Magdalena; Puszynski, Krzysztof			Piece-wise linear models of biological systems-Application, analysis, and comparison with nonlinear models using the example of the p53 regulatory module	PLOS ONE			English	Article							FEEDBACK LOOP	In this paper, we propose to use a linear system with switching methodology for description and analysis of complex biological systems. We show advantages of the proposed approach over the one usually used, which is based on ODE. We propose the detailed methodology of a full analysis of developed models, including analytical determination of the location and type of equilibrium points, finding an analytical solution, stability and bifurcation analysis. We illustrate the above with the example of the well-known p53 signalling pathway comparing the results with the results of a nonlinear, ODE-based version of the proposed model. The complex methodology proposed by us, especially due to the definition of model structure, which is easy to understand for biologists and medics, may be a bridge for closer cooperation between them and engineers in the future.	[Ochab, Magdalena; Puszynski, Krzysztof] Silesian Tech Univ, Dept Syst Biol & Engn, Gliwice, Poland	Silesian University of Technology	Puszynski, K (corresponding author), Silesian Tech Univ, Dept Syst Biol & Engn, Gliwice, Poland.	krzysztof.puszynski@polsl.pl		Puszynski, Krzysztof/0000-0002-5546-4916; Ochab, Magdalena/0000-0002-3935-8750	National Science Centre Poland [2016/23/B/ST6/03455]	National Science Centre Poland(National Science Centre, Poland)	The presented work was supported by the grant funded by National Science Centre Poland, with number 2016/23/B/ST6/03455. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B., 2013, ESSENTIAL CELL BIOL; Bar-Or RL, 2000, P NATL ACAD SCI USA, V97, P11250, DOI 10.1073/pnas.210171597; Bogdal MN, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-67; Cook DA, 2010, ACAD MED, V85, P1589, DOI 10.1097/ACM.0b013e3181edfe13; Corsello SM, 2017, NAT MED, V23, P405, DOI 10.1038/nm.4306; Edwards R, 2000, PHYSICA D, V146, P165, DOI 10.1016/S0167-2789(00)00130-5; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; Jonak K, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-016-0293-0; Katiyar SK, 2005, MOL CANCER THER, V4, P207; Kozlowska E, 2016, J THEOR BIOL, V408, P213, DOI 10.1016/j.jtbi.2016.08.017; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Luo T, 2019, MICROMACHINES-BASEL, V10, DOI 10.3390/mi10020104; MESTL T, 1995, DYNAM STABIL SYST, V10, P179, DOI 10.1080/02681119508806202; MESTL T, 1995, J THEOR BIOL, V176, P291, DOI 10.1006/jtbi.1995.0199; Mullard A, 2020, NAT REV DRUG DISCOV, V19, P79, DOI 10.1038/d41573-020-00001-7; Ochab M, 2017, LECT N BIOINFORMAT, V10208, P208, DOI 10.1007/978-3-319-56148-6_18; Plahte E, 1998, J MATH BIOL, V36, P321, DOI 10.1007/s002850050103; PLAHTE E, 1994, DYNAM STABIL SYST, V9, P275, DOI 10.1080/02681119408806183; Plahte E, 2005, PHYSICA D, V201, P150, DOI 10.1016/j.physd.2004.11.014; Puszynski K, 2008, J THEOR BIOL, V254, P452, DOI 10.1016/j.jtbi.2008.05.039; Puszynski K, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003991; SNOUSSI E, 1993, B MATH BIOL, V55, P973, DOI 10.1016/S0092-8240(05)80199-5; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Zhang TL, 2007, CELL CYCLE, V6, P85, DOI 10.4161/cc.6.1.3705; Ziegenhain C, 2017, MOL CELL, V65, P631, DOI 10.1016/j.molcel.2017.01.023	25	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243823	10.1371/journal.pone.0243823	http://dx.doi.org/10.1371/journal.pone.0243823			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326446	gold, Green Published			2022-12-27	WOS:000600176400038
J	Smith, M; Mitchell, AS; Townsend, ML; Herbert, JS				Smith, Melissa; Mitchell, Annaleise S.; Townsend, Michelle L.; Herbert, Jane S.			The relationship between digital media use during pregnancy, maternal psychological wellbeing, and maternal-fetal attachment	PLOS ONE			English	Article							QUALITY-OF-LIFE; SOCIAL MEDIA; SELF-CRITICISM; INTERNET USE; ANTENATAL ATTACHMENT; DECISION-MAKING; DEPRESSION; SUPPORT; ANXIETY; ASSOCIATIONS	The widespread accessibility and use of the internet provides numerous opportunities for women to independently seek out pregnancy-related information and social and emotional support during the antenatal period. Given the heightened psychological vulnerability of the pregnancy period there is a critical need to examine digital media use within the context of the feelings that women have about themselves and towards their fetus. The current study examined the relationship between digital media use during pregnancy, psychological wellbeing and their maternal-fetal attachment using an online survey. Forty-eight pregnant women completed a self-report questionnaire on their reasons for using digital media, and standardised measures of self-criticism, negative affect, social quality of life (QOL), and maternal-fetal attachment. The mean age of participants was 29.4 years (SD = 5.26), with a mean of 24.3 weeks gestation (SD = 9.95). Information seeking, emotional support and social support were highly endorsed reasons for digital media use (85.42%, 66.67%, 62.5% respectively). However, digital media use was positively correlated with negative affect (p = .003) and self-criticism (p < .001). Digital media use was also negatively correlated with QOL (p = .007). There was no evidence of a relationship between digital media use and maternal-fetal attachment (p = .330). Digital environments may be an important social context within which a pregnant woman develops her own maternal identity and knowledge. There are a number of benefits and limitations of this medium for providing information and support for women during pregnancy. Enhancing the opportunities to promote pregnant women's wellbeing in this context is an important avenue for further research and practice.	[Smith, Melissa; Mitchell, Annaleise S.; Townsend, Michelle L.; Herbert, Jane S.] Univ Wollongong, Sch Psychol, Wollongong, NSW, Australia; [Mitchell, Annaleise S.; Herbert, Jane S.] Univ Wollongong, Early Start, Wollongong, NSW, Australia; [Townsend, Michelle L.] Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia	University of Wollongong; University of Wollongong; University of Wollongong	Herbert, JS (corresponding author), Univ Wollongong, Sch Psychol, Wollongong, NSW, Australia.; Herbert, JS (corresponding author), Univ Wollongong, Early Start, Wollongong, NSW, Australia.	herbertj@uow.edu.au	Herbert, Jane/GNP-3396-2022; Townsend, Michelle L/M-9667-2017	Herbert, Jane/0000-0002-8762-4531; Townsend, Michelle L/0000-0001-8921-781X	Australian Research Council [DP180101286]	Australian Research Council(Australian Research Council)	Data analysis and the preparation of this manuscript was supported by Discovery Project funding (DP180101286) from the Australian Research Council (arc.gov.au) awarded to JSH.	AINSWORTH MDS, 1979, AM PSYCHOL, V34, P932, DOI 10.1037/0003-066X.34.10.932; Akiki S, 2016, J AFFECT DISORDERS, V196, P260, DOI 10.1016/j.jad.2016.02.016; Alhusen JL, 2008, JOGNN-J OBST GYN NEO, V37, P315, DOI 10.1111/j.1552-6909.2008.00241.x; Alhusen JL, 2013, ARCH WOMEN MENT HLTH, V16, P521, DOI 10.1007/s00737-013-0357-8; Australian Psychological Association, 2017, DIG ME SURV EXPL EFF; BLATT SJ, 1976, J ABNORM PSYCHOL, V85, P383, DOI 10.1037/0021-843X.85.4.383; BOWLBY J, 1982, AM J ORTHOPSYCHIAT, V52, P664, DOI 10.1111/j.1939-0025.1982.tb01456.x; Branjerdporn G, 2017, MATERN CHILD HLTH J, V21, P540, DOI 10.1007/s10995-016-2138-2; Brassel A, 2020, INFANT MENT HEALTH J, V41, P69, DOI 10.1002/imhj.21827; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, https://doi.org/10.1191/1478088706qp063oa, 10.1191/1478088706qp063oa]; CACCIA N, 1991, AM J OBSTET GYNECOL, V165, P1122, DOI 10.1016/0002-9378(91)90484-9; Cannon S, 2020, WOMEN BIRTH, V33, P35, DOI 10.1016/j.wombi.2018.12.007; Carr CT, 2015, ATL J COMMUN, V23, P46, DOI 10.1080/15456870.2015.972282; Condon JT, 1997, BRIT J MED PSYCHOL, V70, P359, DOI 10.1111/j.2044-8341.1997.tb01912.x; CRANLEY MS, 1981, NURS RES, V30, P281, DOI 10.1097/00006199-198109000-00008; Crawford J, 2011, AUST PSYCHOL, V46, P3, DOI 10.1111/j.1742-9544.2010.00003.x; Delavari M, 2018, ARCH PSYCHIAT NURS, V32, P263, DOI 10.1016/j.apnu.2017.11.013; Della Vedova AM, 2011, J REPROD INFANT PSYC, V29, P208, DOI 10.1080/02646838.2011.592973; Denton LK, 2020, WOMEN BIRTH, V33, pE48, DOI 10.1016/j.wombi.2018.12.003; Downe Soo, 2018, PLoS One, V13, pe0194906, DOI 10.1371/journal.pone.0194906; Drentea P, 2005, SOCIOL HEALTH ILL, V27, P920, DOI 10.1111/j.1467-9566.2005.00464.x; Ehret AM, 2015, COGNITION EMOTION, V29, P1496, DOI 10.1080/02699931.2014.992394; Emmanuel EN, 2014, J CLIN NURS, V23, P1611, DOI 10.1111/jocn.12265; Felder JN, 2016, ARCH WOMEN MENT HLTH, V19, P687, DOI 10.1007/s00737-016-0628-2; Gavin NI, 2015, IDENTIFYING PERINATAL DEPRESSION AND ANXIETY: EVIDENCE-BASED PRACTICE IN SCREENING, PSYCHOSOCIAL ASSESSMENT, AND MANAGEMENT, P11; Ginja S, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-2049-x; Haslam DM, 2017, J CHILD FAM STUD, V26, P2026, DOI 10.1007/s10826-017-0716-6; Hopkins J, 2018, J REPROD INFANT PSYC, V36, P381, DOI 10.1080/02646838.2018.1466385; Johnson SA, 2015, CULT HEALTH SEX, V17, P237, DOI 10.1080/13691058.2014.968807; King DB, 2014, CAN PSYCHOL, V55, P240, DOI 10.1037/a0038087; Lagan BM, 2011, BIRTH-ISS PERINAT C, V38, P336, DOI 10.1111/j.1523-536X.2011.00488.x; Lagan BM, 2010, BIRTH-ISS PERINAT C, V37, P106, DOI 10.1111/j.1523-536X.2010.00390.x; Larkin F, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220948; Lin LY, 2016, DEPRESS ANXIETY, V33, P323, DOI 10.1002/da.22466; Lobo S, 2020, NUTR DIET, V77, P382, DOI 10.1111/1747-0080.12589; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Lupton D, 2017, SOCIETIES, V7, DOI 10.3390/soc7030025; Lupton D, 2016, WOMEN BIRTH, V29, P368, DOI 10.1016/j.wombi.2016.01.008; Lupton D, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0971-3; McDaniel BT, 2012, MATERN CHILD HLTH J, V16, P1509, DOI 10.1007/s10995-011-0918-2; Mcnamara J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220032; Mitchell L, 2018, BEHAV SCI-BASEL, V8, DOI 10.3390/bs8080074; Pew Research Center, 2015, SOCIAL MEDIA UPDATE; Prescott J, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.6302; Priel B, 2000, J SOC CLIN PSYCHOL, V19, P437, DOI 10.1521/jscp.2000.19.4.437; Reck C, 2008, ACTA PSYCHIAT SCAND, V118, P459, DOI 10.1111/j.1600-0447.2008.01264.x; Righetti PL, 2005, BRIT J PSYCHOL, V96, P129, DOI 10.1348/000712604X15518; Ross E., 2012, BRIT J MIDWIFERY, V20, P566, DOI [DOI 10.12968/BJOM.2012.20.8.566, 10.12968/bjom.2012.20.8.566]; Rudich Z, 2008, J PAIN, V9, P210, DOI 10.1016/j.jpain.2007.10.013; Scherr S, 2017, SOC MEDIA SOC, V3, DOI 10.1177/2056305117698495; Skevington SM, 2004, QUAL LIFE RES, V13, P299, DOI 10.1023/B:QURE.0000018486.91360.00; Staneva AA, 2017, HEALTH CARE WOMEN IN, V38, P658, DOI 10.1080/07399332.2017.1297448; Taipale S, 2016, NEW MEDIA SOC, V18, P44, DOI 10.1177/1461444814536574; Teixeira Maria Inês Félix, 2016, Rev. Enf. Ref., VserIV, P85, DOI 10.12707/RIV15025; University of New South Wales (UNSW), 2018, DASS FAQ FREQ ASK QU; Vachkova E, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-214; World Health Organization, 1996, WHOQOL BREF INTR ADM	57	6	7	5	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243898	10.1371/journal.pone.0243898	http://dx.doi.org/10.1371/journal.pone.0243898			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH1IW	33326465	gold, Green Published			2022-12-27	WOS:000600176400016
J	Ye, JW; Li, J				Ye, Jingwen; Li, Jun			First proteomic analysis of the role of lysine acetylation in extensive functions in Solenopsis invicta	PLOS ONE			English	Article							SYSTEMATIC ANALYSIS; WIDE ANALYSIS; ACETYLOME; PROTEINS; VENOM; WIDESPREAD; COMPLEXES; ALLERGENS; SILKWORM; SUGGESTS	Lysine acetylation (Kac) plays a critical role in the regulation of many important cellular processes. However, little is known about Kac in Solenopsis invicta, which is among the 100 most dangerous invasive species in the world. Kac in S. invicta was evaluated for the first time in this study. Altogether, 2387 Kac sites were tested in 992 proteins. The prediction of subcellular localization indicated that most identified proteins were located in the cytoplasm, mitochondria, and nucleus. Venom allergen Sol i 2, Sol i 3, and Sol i 4 were found to be located in the extracellular. The enriched Kac site motifs included Kac H, Kac Y, Kac G, Kac F, Kac T, and Kac W. H, Y, F, and W frequently occurred at the +1 position, whereas G, Y, and T frequently occurred at the -1 position. In the cellular component, acetylated proteins were enriched in the cytoplasmic part, mitochondrial matrix, and cytosolic ribosome. Furthermore, 25 pathways were detected to have significant enrichment. Interestingly, arginine and proline metabolism, as well as phagosome, which are related to immunity, involved several Kac proteins. Sequence alignment analyses demonstrated that V-type proton ATPase subunit G, tubulin alpha chain, and arginine kinase, the acetylated lysine residues, were evolutionarily conserved among different ant species. In the investigation of the interaction network, diverse interactions were adjusted by Kac. The results indicated that Kac may play an important role in the sensitization, cellular energy metabolism, immune response, nerve signal transduction, and response to biotic and abiotic stress of S. invicta. It may be useful to confirm the functions of Kac target proteins for the design of specific and effective drugs to prevent and control this dangerous invasive species.	[Ye, Jingwen; Li, Jun] Guangdong Acad Sci, Inst Zool, Guangdong Key Lab Anim Conservat & Resource Utili, Guangdong Publ Lab Wild Anim Conservat & Utilizat, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Sciences; Institute of Zoology, Guangdong Academy of Sciences	Li, J (corresponding author), Guangdong Acad Sci, Inst Zool, Guangdong Key Lab Anim Conservat & Resource Utili, Guangdong Publ Lab Wild Anim Conservat & Utilizat, Guangzhou, Guangdong, Peoples R China.	junl@giabr.gd.cn			GDAS' Project of Science and Technology Development [2019GDASYL-0103064, 2020GDASYL-20200301003]; Guangdong Basic and Applied Basic Research Foundation [2019A1515110795]; China Postdoctoral Science Foundation [2018M643032]; Graduate and Postdoctoral Fund of Guangdong Institute of Applied Biological Resources [GIABR-pyjj201804]; Science and Technology Planning Project of Guangdong [2018B030324003]; GDAS Special Project of Science and Technology Development [2018GDASCX-0107]	GDAS' Project of Science and Technology Development; Guangdong Basic and Applied Basic Research Foundation; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Graduate and Postdoctoral Fund of Guangdong Institute of Applied Biological Resources; Science and Technology Planning Project of Guangdong; GDAS Special Project of Science and Technology Development	The study was supported by GDAS' Project of Science and Technology Development (2019GDASYL-0103064) (JWY) and (2020GDASYL-20200301003) (XKY), Guangdong Basic and Applied Basic Research Foundation (2019A1515110795) (JWY), Project Funded by China Postdoctoral Science Foundation (2018M643032)(JWY), Graduate and Postdoctoral Fund of Guangdong Institute of Applied Biological Resources (GIABR-pyjj201804)(JWY), Science and Technology Planning Project of Guangdong (2018B030324003) (JL), and GDAS Special Project of Science and Technology Development (2018GDASCX-0107) (FSZ).	[Anonymous], 2006, MARITIME STUDIES, V4, P47; Chen J, 2018, J PROTEOMICS, V174, P61, DOI 10.1016/j.jprot.2017.12.019; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Dutcher SK, 2001, CURR OPIN CELL BIOL, V13, P49, DOI 10.1016/S0955-0674(00)00173-3; GARCIADELPORTILLO F, 1995, TRENDS MICROBIOL, V3, P373, DOI 10.1016/S0966-842X(00)88982-9; Hediger MA, 2004, PFLUG ARCH EUR J PHY, V447, P465, DOI 10.1007/s00424-003-1192-y; Henriksen P, 2012, MOL CELL PROTEOMICS, V11, P1510, DOI 10.1074/mcp.M112.017251; HOFFMAN DR, 1993, J ALLERGY CLIN IMMUN, V91, P71, DOI 10.1016/0091-6749(93)90298-T; Hong Y, 2016, J PROTEOMICS, V148, P202, DOI 10.1016/j.jprot.2016.08.008; Huang Y, 2010, MOL BIOSYST, V6, P683, DOI 10.1039/b920120c; Hui M, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4745-3; Jeffers V, 2012, EUKARYOT CELL, V11, P735, DOI 10.1128/EC.00088-12; Jeon J, 2014, PLANT PATHOLOGY J, V30, P1, DOI 10.5423/PPJ.RW.01.2014.0003; Kang LQ, 2011, COMP BIOCHEM PHYS B, V158, P230, DOI 10.1016/j.cbpb.2010.12.001; Karve Tejaswita M, 2011, J Amino Acids, V2011, P207691, DOI 10.4061/2011/207691; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; [李军 LI Jun], 2007, [广东农业科学, Guangdong Agricultural Sciences], P54; Menzies NA, 2018, LANCET INFECT DIS, V18, pE228, DOI 10.1016/S1473-3099(18)30134-8; Mitreva M, 2011, NAT GENET, V43, P228, DOI 10.1038/ng.769; Nie ZM, 2015, PROTEOMICS, V15, P3253, DOI 10.1002/pmic.201500001; Nogales E, 2001, ANNU REV BIOPH BIOM, V30, P397, DOI 10.1146/annurev.biophys.30.1.397; Nugent JS, 2004, J ALLERGY CLIN IMMUN, V114, P383, DOI 10.1016/j.jaci.2004.04.016; Pan JY, 2014, J PROTEOME RES, V13, P3294, DOI 10.1021/pr500133t; Pruett PS, 2003, J BIOL CHEM, V278, P26952, DOI 10.1074/jbc.M212931200; Rardin MJ, 2013, P NATL ACAD SCI USA, V110, P6601, DOI 10.1073/pnas.1302961110; Schmidt M, 2003, ALLERGY, V58, P342, DOI 10.1034/j.1398-9995.2003.00085.x; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; van Wijk SJL, 2010, FASEB J, V24, P981, DOI 10.1096/fj.09-136259; Verdone L, 2005, BIOCHEM CELL BIOL, V83, P344, DOI 10.1139/o05-041; Wang HC, 2009, GENE, V430, P38, DOI 10.1016/j.gene.2008.10.021; Wang H, 2013, J COMPUT BIOL, V20, P344, DOI 10.1089/cmb.2012.0273; Weinert BT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001902; Wheeler DE, 2000, J INSECT PHYSIOL, V46, P951, DOI 10.1016/S0022-1910(99)00202-4; Yang Y, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02674; Zeng L., 2005, CHINESE B ENTOMOLOGY, V42, P44; Zheng Ya-Nan, 2018, Acta Entomologica Sinica, V61, P385, DOI 10.16380/j.kcxb.2018.03.013; Zhou XW, 2016, J PROTEOME RES, V15, P2525, DOI 10.1021/acs.jproteome.6b00052	38	3	3	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243787	10.1371/journal.pone.0243787	http://dx.doi.org/10.1371/journal.pone.0243787			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326466	Green Published, gold			2022-12-27	WOS:000600176400002
J	Melkie, G; Azage, M; Gedamu, G				Melkie, Gashaw; Azage, Muluken; Gedamu, Genet			Prevalence and associated factors of active trachoma among children aged 1-9 years old in mass drug administration graduated and non-graduated districts in Northwest Amhara region, Ethiopia: A comparative cross-sectional study	PLOS ONE			English	Article							FACIAL CLEANLINESS; WATER; ZONE; RISK	Background Mass drug administration has implemented to reduce trachoma since 2001, however, trachoma is still the major public health problem in Amhara Region, Ethiopia. However, credible evidence on the prevalence of trachoma and its associated factors after the implementation of mass drug administration is limited. Objective To assess the prevalence and associated factors of active trachoma among children aged 1-9 years old in mass drug administration graduated and non-graduated districts in the Northwest Amhara Region. Methods A comparative cross-sectional study was conducted from October to November, 2019. A stratified multistage random sampling was used to select 690 households having children aged 1-9 years. Data were collected using a pretested structured questionnaire. Data were entered into Epi-data version 3.1 and exported to SPSS version 20.0 for analysis. Bivariate and multivariable logistic regressions were employed to identify factors associated with active trachoma. Crude and adjusted odds ratios with 95% confidence interval were computed to assess the degree of association between the independent variables and active trachoma. Results The overall prevalence of active trachoma was 8.3% (95% CI: 6.2% -10.5%) and showed a significant variation between graduated [3.5% (95% CI: 1.8% -5.6%)] and non-graduated [13% (95% CI: 9.7%-16.8%)] districts. Living in graduated districts (AOR = 7.39, 95% CI: 3.19, 17.09), fly presence in the house (AOR = 3.14, 95% CI: 1.43, 6.89), presence of more than two children in the family (AOR = 3.78, 95%CI: 1.79, 7.98), did not wash face daily (AOR = 6.31, 95% CI: 1.81, 21.98), did not use soap during face washing (AOR = 3.34, 95% CI: 1.37, 8.15), presence of sleep in eyes (AOR = 3.16, 95% CI: 1.42, 7.02) and presence of dirt on child face (AOR = 2.44, 95% CI: 1.08, 5.50) increased the odds of having active trachoma. Conclusion The prevalence of active trachoma was high in the study area and showed a significant variation between graduated and non-graduated districts with mass drug administration. Living in non-graduated districts, fly presence in the house, more than two children in a household, did not wash the face daily, did not use soap during face washing, presence of sleep in eyes, and dirt on the child's face were the significant predictors of active trachoma. Therefore, the identified modifiable factors are the area of intervention to reduce the burden of active trachoma.	[Melkie, Gashaw; Gedamu, Genet] Teda Hlth Sci Coll, Sch Publ Hlth, Dept Environm Hlth, Gondar, Ethiopia; [Azage, Muluken; Gedamu, Genet] Bahir Dar Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Dept Environm Hlth, Bahir Dar, Ethiopia	Bahir Dar University	Gedamu, G (corresponding author), Bahir Dar Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Dept Environm Hlth, Bahir Dar, Ethiopia.	geni_31280@yahoo.com	Azage, Muluken/AAF-6515-2020	Azage, Muluken/0000-0003-3222-0158	Bahir Dar University; Amhara Regional Health Bureau	Bahir Dar University; Amhara Regional Health Bureau	This research work is funded by Bahir Dar University and Amhara Regional Health Bureau.	Alemayehu M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/570898; Miller HA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229297; [Anonymous], 2014, Wkly Epidemiol Rec, V89, P421; [Anonymous], 2007, J ORTHOP TRAUMA, V21, pS39; [Anonymous], 2018, J ORTHOP TRAUMA, V32, pS141; Anteneh Zelalem Alamrew, 2016, Trop Dis Travel Med Vaccines, V2, P5, DOI 10.1186/s40794-016-0022-0; Asres M, 2016, PREV MED, V1, P5; Astale T, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006270; BAILEY R, 1991, T ROY SOC TROP MED H, V85, P824, DOI 10.1016/0035-9203(91)90470-J; Bamani S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000734; BRECHNER RJ, 1992, ARCH OPHTHALMOL-CHIC, V110, P687, DOI 10.1001/archopht.1992.01080170109035; Burton MJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000460; Central Gondar Zonal Health Department, 2018, CENTR GOND ZON DISTR; Delea MG, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006178; Frick KD, 2003, OPHTHAL EPIDEMIOL, V10, P121, DOI 10.1076/opep.10.2.121.13899; Golovaty I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006702; Kalua K., 2014, Health, V6, P57, DOI 10.4236/health.2014.61009; Kassim K, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3992-5; Ketema K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1105; Lakew T, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000507; Mariotti SP, 2009, BRIT J OPHTHALMOL, V93, P563, DOI 10.1136/bjo.2008.148494; Mengistu K, 2016, CLIN OPHTHALMOL, V10, P1663, DOI 10.2147/OPTH.S107619; Missamou F, 2018, OPHTHAL EPIDEMIOL, V25, P155, DOI 10.1080/09286586.2018.1546878; Mpyet C, 2018, OPHTHAL EPIDEMIOL, V25, P79, DOI 10.1080/09286586.2018.1467466; Mpyet C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040421; Nigusie Adane, 2015, BMC Res Notes, V8, P641, DOI 10.1186/s13104-015-1529-6; Oswald .WE, 2017, B WORLD HEALTH ORGAN, V95, P250, DOI [10.2471/BLT.16.177758, 10.2471/blt.16.177758]; Roba AA, 2011, J EPIDEMIOL COMMUN H, V65, P626, DOI 10.1136/jech.2009.094763; Solomon AW, 2003, LANCET, V362, P198, DOI 10.1016/S0140-6736(03)13909-8; Stewart AEP, 2019, AM J TROP MED HYG, V101, P1286, DOI 10.4269/ajtmh.19-0450; Tadesse B, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0358-3; THYLEFORS B, 1987, B WORLD HEALTH ORGAN, V65, P477; WEST SK, 1991, ARCH OPHTHALMOL-CHIC, V109, P855, DOI 10.1001/archopht.1991.01080060119038; WHO, TRACHOMA; WHO, 2016, VAL EL TRACH PUBL HL; WoldeKidan E, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4495-0; World Health Organization, 1998, WHA51 11 GLOB EL BLI; World Health Organization, 2015, PROGR SAN DRINK WAT; Yemane Berhane, 2007, Ethiopian Journal of Health Development, V21, P204; Zack R, 2008, T ROY SOC TROP MED H, V102, P426, DOI 10.1016/j.trstmh.2008.02.001	40	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243863	10.1371/journal.pone.0243863	http://dx.doi.org/10.1371/journal.pone.0243863			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320864	Green Published, gold			2022-12-27	WOS:000600339800039
J	Carlsson, ER; Fenger, M; Henriksen, T; Kjaer, LK; Worm, D; Hansen, DL; Madsbad, S; Poulsen, HE				Carlsson, Elin Rebecka; Fenger, Mogens; Henriksen, Trine; Kjaer, Laura Kofoed; Worm, Dorte; Hansen, Dorte Lindqvist; Madsbad, Sten; Poulsen, Henrik Enghusen			Reduction of oxidative stress on DNA and RNA in obese patients after Roux-en-Y gastric bypass surgery-An observational cohort study of changes in urinary markers	PLOS ONE			English	Article							BARIATRIC SURGERY; WEIGHT; DAMAGE; DETERMINANTS; PROFILE; HUMANS; PLASMA; MASS	Increased oxidative stress in obesity and diabetes is associated with morbidity and mortality risks. Levels of oxidative damage to DNA and RNA can be estimated through measurement of 8-oxo-7,8-dihydro-2 ' -deoxyguanosine (8-oxodG) and 8-oxo-7,8-dihydroguanosine (8-oxoGuo) in urine. Both markers have been associated with type 2 diabetes, where especially 8-oxoGuo is prognostic for mortality risk. We hypothesized that Roux-en-Y gastric bypass (RYGB) surgery that has considerable effects on bodyweight, hyperglycemia and mortality, might be working through mechanisms that reduce oxidative stress, thereby reducing levels of the urinary markers. We used liquid chromatography coupled with tandem mass spectrometry to analyze the content of 8-oxodG and 8-oxoGuo in urinary samples from 356 obese patients treated with the RYGB-procedure. Mean age (SD) was 44.2 (9.6) years, BMI was 42.1 (5.6) kg/m(2). Ninety-six (27%) of the patients had type 2 diabetes. Excretion levels of each marker before and after surgery were compared as estimates of the total 24-hour excretion, using a model based on glomerular filtration rate (calculated from cystatin C, age, height and weight), plasma- and urinary creatinine. The excretion of 8-oxodG increased in the first months after RYGB. For 8-oxoGuo, a gradual decrease was seen. Two years after RYGB and a mean weight loss of 35 kg, decreased hyperglycemia and insulin resistance, excretion levels of both markers were reduced by approximately 12% (P < 0.001). For both markers, mean excretion levels were about 30% lower in the female subgroup (P < 0.0001). Also, in this subgroup, excretion of 8-oxodG was significantly lower in patients with than without diabetes. We conclude, that oxidative damage to nucleic acids, reflected in the excretion of 8-oxodG and 8-oxoGuo, had decreased significantly two years after RYGB-indicating that reduced oxidative stress could be contributing to the many long-term benefits of RYGB-surgery in obesity and type 2 diabetes.	[Carlsson, Elin Rebecka; Fenger, Mogens] Copenhagen Univ Hosp Hvidovre, Dept Clin Biochem, Hvidovre, Denmark; [Carlsson, Elin Rebecka] Univ Copenhagen, Nordsjaellands Hosp, Dept Clin Biochem, Hillerod, Denmark; [Henriksen, Trine; Kjaer, Laura Kofoed; Poulsen, Henrik Enghusen] Copenhagen Univ Hosp, Bispebjerg Frederiksberg Hosp, Dept Clin Pharmacol, Copenhagen, Denmark; [Worm, Dorte] Amager Hosp, Dept Med, Copenhagen, Denmark; [Hansen, Dorte Lindqvist] Steno Diabet Ctr Copenhagen, Gentofte, Denmark; [Madsbad, Sten] Copenhagen Univ Hosp Hvidovre, Dept Endocrinol, Hvidovre, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; Steno Diabetes Center; University of Copenhagen	Carlsson, ER (corresponding author), Copenhagen Univ Hosp Hvidovre, Dept Clin Biochem, Hvidovre, Denmark.; Carlsson, ER (corresponding author), Univ Copenhagen, Nordsjaellands Hosp, Dept Clin Biochem, Hillerod, Denmark.; Poulsen, HE (corresponding author), Copenhagen Univ Hosp, Bispebjerg Frederiksberg Hosp, Dept Clin Pharmacol, Copenhagen, Denmark.	elin.rebecka.carlsson@regionh.dk; henrik.enghusen.poulsen.01@regionh.dk			Ministry of Higher Education and Science (the UNIK project)	Ministry of Higher Education and Science (the UNIK project)	The collection of samples to the biobank used in this study was partially funded by The Ministry of Higher Education and Science (the UNIK project). The authors received no specific funding for their work related to this study.	Adams TD, 2017, NEW ENGL J MED, V377, P1143, DOI 10.1056/NEJMoa1700459; [Anonymous], 2005, BUSINESS CHINA  0228, V31, P5; Bankoglu EE, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29581-6; Bankoglu EE, 2018, MUTAGENESIS, V33, P61, DOI 10.1093/mutage/gex040; Bankoglu EE, 2016, FREE RADICAL BIO MED, V94, P208, DOI 10.1016/j.freeradbiomed.2016.02.033; Bojsen-Moller KN, 2014, DIABETES, V63, P1725, DOI 10.2337/db13-1307; Broedbaek K, 2011, DIABETES CARE, V34, P2594, DOI 10.2337/dc11-1620; Broedbaek K, 2011, FREE RADICAL BIO MED, V51, P1473, DOI 10.1016/j.freeradbiomed.2011.07.007; Cabrera EJ, 2010, OBES SURG, V20, P42, DOI 10.1007/s11695-009-9988-2; Carlsson ER, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00172; Cejvanovic V, 2018, FREE RADICAL BIO MED, V129, P532, DOI 10.1016/j.freeradbiomed.2018.10.420; Cejvanovic V, 2016, SCAND J CLIN LAB INV, V76, P620, DOI 10.1080/00365513.2016.1230776; Ceriello Antonio, 2006, Endocr Pract, V12 Suppl 1, P60; Cui Hai-Feng, 2012, J Anal Methods Chem, V2012, P793468, DOI 10.1155/2012/793468; da Silva VRG, 2012, EUR J CLIN NUTR, V66, P891, DOI 10.1038/ejcn.2012.17; Dadalt C, 2013, EUR J GASTROEN HEPAT, V25, P580, DOI 10.1097/MEG.0b013e32835d0ae0; Dagan SS, 2017, ADV NUTR, V8, P382, DOI 10.3945/an.116.014258; Fenger M, 2016, BMC ENDOCR DISORD, V16, DOI 10.1186/s12902-016-0140-8; Hewitt G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1708; Hruby A, 2016, AM J PUBLIC HEALTH, V106, P1656, DOI 10.2105/AJPH.2016.303326; Jaffe M., 1886, J PHYS CHEM-US, V10, P391, DOI [DOI 10.1515/BCHM1.1886.10.5.391, 10.1515/bchm1.1886.10.5.391]; Jorgensen NB, 2012, AM J PHYSIOL-ENDOC M, V303, pE122, DOI 10.1152/ajpendo.00073.2012; Kelly AS, 2016, INT J OBESITY, V40, P275, DOI 10.1038/ijo.2015.174; Kjaer LK, 2018, FREE RADICAL BIO MED, V129, P247, DOI 10.1016/j.freeradbiomed.2018.09.030; Larsen EL, 2019, FREE RADICAL BIO MED, V145, P256, DOI 10.1016/j.freeradbiomed.2019.09.030; Leshchyns'ka I, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/6427537; Liakopoulos V, 2017, BMJ OPEN DIAB RES CA, V5, DOI 10.1136/bmjdrc-2016-000386; Lieske JC, 2014, AM J KIDNEY DIS, V64, P663, DOI 10.1053/j.ajkd.2014.06.016; LOFT S, 1992, CARCINOGENESIS, V13, P2241, DOI 10.1093/carcin/13.12.2241; Marseglia L, 2015, INT J MOL SCI, V16, P378, DOI 10.3390/ijms16010378; Matter B, 2018, FREE RADICAL BIO MED, V121, P180, DOI 10.1016/j.freeradbiomed.2018.04.561; Monzo-Beltran L, 2017, REDOX BIOL, V12, P389, DOI 10.1016/j.redox.2017.02.003; Nosso G, 2017, NUTR METAB CARDIOVAS, V27, P949, DOI 10.1016/j.numecd.2017.07.004; Park AM, 2009, J UROLOGY, V182, P2334, DOI 10.1016/j.juro.2009.07.044; Poulsen HE, 2019, FREE RADICAL BIO MED, V145, P336, DOI 10.1016/j.freeradbiomed.2019.10.001; Poulsen HE, 2014, BBA-GEN SUBJECTS, V1840, P801, DOI 10.1016/j.bbagen.2013.06.009; Poulsen HE, 2012, FREE RADICAL BIO MED, V52, P1353, DOI 10.1016/j.freeradbiomed.2012.01.009; Rani V, 2016, LIFE SCI, V148, P183, DOI 10.1016/j.lfs.2016.02.002; Rasmussen ST, 2016, REDOX BIOL, V9, P32, DOI 10.1016/j.redox.2016.05.007; Schmatz R, 2017, CLIN CHIM ACTA, V465, P72, DOI 10.1016/j.cca.2016.12.012; Setayesh T, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201900045; Sies H, 2017, ANNU REV BIOCHEM, V86, P715, DOI 10.1146/annurev-biochem-061516-045037; Spahis S, 2017, ANTIOXID REDOX SIGN, V26, P445, DOI 10.1089/ars.2016.6756; Thomas MC, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.008226; Tudor MJ, 2006, MEASUREMENT SCI TECH, V17, pR175; Tumova E, 2013, J OBES, V2013, DOI 10.1155/2013/729515; Vaurs C, 2015, DIABETES METAB, V41, P416, DOI 10.1016/j.diabet.2015.04.003; Von Scholten BJ, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0474-0; Xu XJ, 2015, DIABETES, V64, P3155, DOI 10.2337/db14-1765; 2019, ART COLL SOC CIRC, P1	50	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243918	10.1371/journal.pone.0243918	http://dx.doi.org/10.1371/journal.pone.0243918			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315915	gold, Green Published			2022-12-27	WOS:000600186100049
J	Chen, HM; Kuo, FC; Chen, CC; Wu, CF; Sun, CW; Chen, ML; Hsieh, CJ; Wang, SL; Wu, MT				Chen, Hui-Ming; Kuo, Fu-Chen; Chen, Chou-Cheng; Wu, Chia-Fang; Sun, Chien-Wen; Chen, Mei-Lien; Hsieh, Chia-Jung; Wang, Shu-Li; Wu, Ming-Tsang			New trimester-specific reference intervals for clinical biochemical tests in Taiwanese pregnant women-cohort of TMICS	PLOS ONE			English	Article							THYROID-HORMONES; REFERENCE VALUES; ESTABLISHMENT; PLATELET; INSULIN	Background Because there are no published biochemical reference intervals (RI) for pregnant Taiwanese women, we used an established islandwide birth cohort, the Taiwan Maternal and Infant Cohort Study, to establish RIs for important biochemical parameters in women during their 3rd trimester in Taiwan. Additionally, we compared the differences in these biochemical parameters between early third trimester (weeks 28 to 31) and late third trimester (weeks 37 to 40) of pregnant women as well as the differences in them between the third trimester and after delivery. Methods Between 2012 and 2015, we recruited a total of 2,136 pregnant women from nine hospitals located in northern (n = 3), central (n = 3), southern (n = 2), and eastern Taiwan (n = 1) to receive regular prenatal health examinations during their third trimester (weeks 28 to 40). After exclusion, samples obtained from 993 eligible pregnant women were analyzed. Results There were increases in both lower and upper normal limits for blood neutrophil, thyroid profile (triiodothyronine (T3) and thyroxine (T4)), testosterone, estradiol, and progesterone and decreases for RBC, hemoglobin (Hb), alanine aminotransferase (ALT) and creatinine (Cr) during their third trimesters. Women in their late third trimester (n = 378) had higher median RBC, Hb, aspartate aminotransferase (AST), Cr, thyroid-stimulating hormone (TSH), testosterone, estradiol, and progesterone and lower median platelet and insulin, compared with those in their early third trimester (n = 490). Twenty-three of the women had both third trimester and post-pregnancy data. After delivery, the women had lower median AST, ALT, insulin, T3, T4, testosterone, estradiol, and progesterone and higher median Cr, free T4, FSH, and luteinizing hormone (LH), compared to their third trimesters. Conclusions Gestation-related changes in important biochemical parameters should be considered when evaluating clinical laboratory values in pregnant women.	[Chen, Hui-Ming; Chen, Chou-Cheng; Wu, Chia-Fang; Wu, Ming-Tsang] Kaohsiung Med Univ, Res Ctr Environm Med, Kaohsiung, Taiwan; [Chen, Hui-Ming] Kaohsiung Chang Gung Mem Hosp, Dept Family Med & Occupat Med, Kaohsiung, Taiwan; [Kuo, Fu-Chen] I Shou Univ, Sch Med, Coll Med, Kaohsiung, Taiwan; [Kuo, Fu-Chen] E Da Hosp, Dept Obstet & Gynecol, Kaohsiung, Taiwan; [Wu, Chia-Fang; Wu, Ming-Tsang] Kaohsiung Med Univ, PhD Program Environm & Occupat Med, Kaohsiung, Taiwan; [Sun, Chien-Wen; Wang, Shu-Li] Natl Hlth Res Inst, Natl Inst Environm Hlth Sci, Natl Environm Hlth Res Ctr, Miaoli, Taiwan; [Chen, Mei-Lien] Natl Yang Ming Univ, Inst Environm & Occupat Hlth Sci, Coll Med, Taipei, Taiwan; [Hsieh, Chia-Jung] Tzu Chi Univ, Dept Publ Hlth, Hualien, Taiwan; [Wang, Shu-Li] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Wang, Shu-Li] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Wang, Shu-Li; Wu, Ming-Tsang] Kaohsiung Med Univ, Dept Publ Hlth, Coll Hlth Sci, Kaohsiung, Taiwan; [Wu, Ming-Tsang] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Family Med, Kaohsiung, Taiwan; [Wu, Ming-Tsang] Kaohsiung Med Univ, Grad Inst Clin Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Chang Gung Memorial Hospital; I Shou University; E-Da Hospital; Kaohsiung Medical University; National Health Research Institutes - Taiwan; National Yang Ming Chiao Tung University; Tzu Chi University; National Defense Medical Center; China Medical University Taiwan; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University	Wu, MT (corresponding author), Kaohsiung Med Univ, Res Ctr Environm Med, Kaohsiung, Taiwan.; Wu, MT (corresponding author), Kaohsiung Med Univ, PhD Program Environm & Occupat Med, Kaohsiung, Taiwan.; Wang, SL (corresponding author), Natl Hlth Res Inst, Natl Inst Environm Hlth Sci, Natl Environm Hlth Res Ctr, Miaoli, Taiwan.; Wang, SL (corresponding author), Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan.; Wang, SL (corresponding author), China Med Univ, Dept Publ Hlth, Taichung, Taiwan.; Wang, SL; Wu, MT (corresponding author), Kaohsiung Med Univ, Dept Publ Hlth, Coll Hlth Sci, Kaohsiung, Taiwan.; Wu, MT (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Family Med, Kaohsiung, Taiwan.; Wu, MT (corresponding author), Kaohsiung Med Univ, Grad Inst Clin Med, Kaohsiung, Taiwan.	slwang@nhri.org.tw; 960021@ms.kmuh.org.tw	Hsieh, Chia-Jung/AAX-3086-2020; Wu, Ming-Tsang/G-5637-2012	Hsieh, Chia-Jung/0000-0002-0381-7783; Wang, Shu-Li/0000-0002-0686-4729; Wu, Chia-Fang/0000-0002-6803-2389; Wu, Ming-Tsang/0000-0001-7307-7816	Research Center for Environmental Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan from The Featured Areas Research Center Program of the Ministry of Education (MOE) in Taiwan; Kaohsiung Medical University Research Center Grant in Taiwan [KMU-TC108A01]; Ministry of Science and Technology in Taiwan [MOST105-2632-B-037-002, MOST106 -2314-B-214-007, MOST106-2314-B037-030-MY3]; National Health Research Institutes in Taiwan [NHRI EH-102SP-02, EH-103-SP-02, NHRI-EX107-10703PI]; E-Da Hospital in Taiwan [EDAHP106046]	Research Center for Environmental Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan from The Featured Areas Research Center Program of the Ministry of Education (MOE) in Taiwan; Kaohsiung Medical University Research Center Grant in Taiwan; Ministry of Science and Technology in Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institutes in Taiwan(National Health Research Institutes - Taiwan); E-Da Hospital in Taiwan	This work was financially supported by the Research Center for Environmental Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE), Kaohsiung Medical University Research Center Grant (KMU-TC108A01), Ministry of Science and Technology (MOST105-2632-B-037-002; MOST106 -2314-B-214-007; and MOST106-2314-B037-030-MY3), grants from National Health Research Institutes (grant numbers NHRI EH-102SP-02; EH-103-SP-02; NHRI-EX107-10703PI), and E-Da Hospital (EDAHP106046), all in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbassi-Ghanavati M, 2009, OBSTET GYNECOL, V114, P1326, DOI 10.1097/AOG.0b013e3181c2bde8; [Anonymous], 2016, THE TOTAL AUDIENCE R; [Anonymous], 2012, NORDIC J AESTHETICS, V44-45, P68; Bernstein IM, 2001, OBSTET GYNECOL, V97, P669, DOI 10.1016/S0029-7844(00)01222-9; Chandra S, 2012, INDIAN J HEMATOL BLO, V28, P144, DOI 10.1007/s12288-012-0175-6; Ciampelli M, 1998, HUM REPROD UPDATE, V4, P904, DOI 10.1093/humupd/4.6.904; Costantine MM, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00065; Dai YP, 2018, ANN CLIN BIOCHEM, V55, P446, DOI 10.1177/0004563217738801; Davison AC, 1997, BOOTSTRAP METHODS TH, Vx, P582; DAVISON JM, 1984, SEMIN NEPHROL, V4, P198; GATTI L, 1994, INT J CLIN LAB RES, V24, P217, DOI 10.1007/BF02592466; Glinoer D, 1997, ENDOCR REV, V18, P404, DOI 10.1210/er.18.3.404; Gohel MG, 2013, INT J REPROD CONTRAC, V2, P616, DOI DOI 10.5455/2320-1770.IJRCOG20131225; Harel Z, 2019, JAMA-J AM MED ASSOC, V321, P205, DOI 10.1001/jama.2018.17948; Horn PS, 2001, CLIN CHEM, V47, P2137; Jin Y, 2018, CLIN CHEM LAB MED, V56, P973, DOI 10.1515/cclm-2017-0804; Kampmann U, 2019, J DIABETES RES, V2019, DOI 10.1155/2019/5320156; Klajnbard A, 2010, CLIN CHEM LAB MED, V48, P237, DOI 10.1515/CCLM.2010.033; KRUTZEN E, 1992, SCAND J CLIN LAB INV, V52, P387, DOI 10.3109/00365519209088374; Larsson A, 2008, BJOG-INT J OBSTET GY, V115, P874, DOI 10.1111/j.1471-0528.2008.01709.x; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Li AW, 2017, J CLIN LAB ANAL, V31, DOI 10.1002/jcla.22150; McDonald CJ, 2003, CLIN CHEM, V49, P624, DOI 10.1373/49.4.624; Milman N, 1999, ACTA OBSTET GYN SCAN, V78, P749, DOI 10.1034/j.1600-0412.1999.780902.x; Moon HW, 2015, ANN LAB MED, V35, P198, DOI 10.3343/alm.2015.35.2.198; Nazarpour S, 2018, CLIN BIOCHEM, V53, P49, DOI 10.1016/j.clinbiochem.2018.01.006; OLEARY P, 1991, CLIN CHEM, V37, P667; Petersen JF, 2019, CLIN CHEM LAB MED, V57, P1956, DOI 10.1515/cclm-2019-0495; Picciano MF, 2003, J NUTR, V133, p1997S, DOI 10.1093/jn/133.6.1997S; PITKIN RM, 1979, JAMA-J AM MED ASSOC, V242, P2696, DOI 10.1001/jama.242.24.2696; Sarbjit G, 2018, WILEY INTERDISCIPL R, V7, pe286, DOI 10.1002/WENE.286; Sharma K, 2018, J OBSTET GYN INDIA, V68, P27, DOI 10.1007/s13224-017-0988-1; Shehata N, 1999, CLIN OBSTET GYNECOL, V42, P327, DOI 10.1097/00003081-199906000-00017; Solberg HE, 2004, CLIN CHEM LAB MED, V42, P710, DOI 10.1515/CCLM.2004.121; SPELLACY WN, 1963, NEW ENGL J MED, V268, P988, DOI 10.1056/NEJM196305022681805; Stricker R, 2006, CLIN CHEM LAB MED, V44, P883, DOI 10.1515/CCLM.2006.160; Wickstrom K, 2004, SCAND J CLIN LAB INV, V64, P31, DOI 10.1080/00365510410003859; Wu CF, 2018, INT J EPIDEMIOL, V47, P1047, DOI 10.1093/ije/dyy067	38	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243761	10.1371/journal.pone.0243761	http://dx.doi.org/10.1371/journal.pone.0243761			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315949	gold, Green Published			2022-12-27	WOS:000600186100019
J	Galdi, S; Maass, A; Robbiani, A				Galdi, Silvia; Maass, Anne; Robbiani, Annalisa			The bright side of pessimism: Promoting wealth redistribution under (felt) economic hardship	PLOS ONE			English	Article							UNREALISTIC OPTIMISM; INCOME INEQUALITY; SOCIAL-MOBILITY; AMERICANS PERCEPTIONS; PROGRESSIVE TAXATION; RELATIVE DEPRIVATION; PREFERENCES; HEALTH; BELIEFS; SUPPORT	Economic inequality is a collective issue that affects all citizens. However, people often fail to support redistribution strategies aimed at redressing inequality. In this work we investigated personal optimism and collective pessimism as psychological processes that contribute to hampering vs. promoting the demand for redistribution. Our prediction was that support for redistribution would require both a pessimistic economic outlook at the collective level and the perception of being economically disadvantaged. In two studies, one of which pre-registered, Italian participants (Study 1: N = 306; Study 2: N = 384) were led to feel relatively poor or rich, rated their perceived control over either their personal or the nation's future and estimated either personal or national economic and general future risks. To measure support for redistribution, participants were invited to allocate their desired level of taxation to each of the five tax brackets included in the Italian personal income tax. Results showed that participants were optimistic about their personal future, but pessimistic about the fate of their nation. This difference was explained by respondents' greater perceived control over personal future than over the nation's future. Importantly, greater pessimism about national economic risks led to greater support for progressive taxation only for participants who felt relatively poor.	[Galdi, Silvia] Univ Campania Luigi Vanvitelli, Dept Psychol, Caserta, Italy; [Maass, Anne; Robbiani, Annalisa] Univ Padua, DPSS, Padua, Italy	Universita della Campania Vanvitelli; University of Padua	Galdi, S (corresponding author), Univ Campania Luigi Vanvitelli, Dept Psychol, Caserta, Italy.	silvia.galdi@unicampania.it	galdi, silvia/ABG-8837-2020	galdi, silvia/0000-0002-1343-9245	Italian Ministry of Education, University and Research (MIUR) [2017924L2B]	Italian Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	AM Grant PRIN 2017 #2017924L2B entitled "The psychology of economic inequality". Italian Ministry of Education, University and Research (MIUR). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alesina A, 2004, J PUBLIC ECON, V88, P2009, DOI 10.1016/j.jpubeco.2003.07.006; Alesina A, 2005, J PUBLIC ECON, V89, P897, DOI 10.1016/j.jpubeco.2004.05.009; Alesina A, 2004, FIGHTING POVERTY US, DOI [10.1016/j.surg.2004.06.054, DOI 10.1016/J.SURG.2004.06.054]; Alesina A, 2018, AM ECON REV, V108, P521, DOI 10.1257/aer.20162015; Armor DA, 1998, ADV EXP SOC PSYCHOL, V30, P309, DOI 10.1016/S0065-2601(08)60386-X; Augoustinos M, 2019, SOCIAL PSYCHOLOGY OF INEQUALITY, P321, DOI 10.1007/978-3-030-28856-3_20; Balestra C, 2018, OECD STAT WORKING PA, DOI [10.1787/7e1bf673-e, DOI 10.1787/7E1BF673-E]; Ballard-Rosa C, 2017, J POLIT, V79, P1, DOI 10.1086/687324; Baron J, 2006, STARVING BEAST PSYCH; Benabou R, 2001, Q J ECON, V116, P447, DOI 10.1162/00335530151144078; Benabou R, 2006, Q J ECON, V121, P699, DOI 10.1162/qjec.2006.121.2.699; BIRESSI A, 2004, MEDIACTIVE, V2, P44; Blanchet Thomas, 2019, 40 YEARS INEQUALITY; Bonniface L, 2008, AUST J SOC ISSUES, V43, P345, DOI 10.1002/j.1839-4655.2008.tb00107.x; Bullock HE, 2017, CURR OPIN PSYCHOL, V18, P141, DOI 10.1016/j.copsyc.2017.08.021; Buttrick NR, 2017, CURR OPIN PSYCHOL, V18, P15, DOI 10.1016/j.copsyc.2017.07.016; Chambers JR, 2015, PSYCHOL SCI, V26, P413, DOI 10.1177/0956797614566657; Chambers JR, 2014, PSYCHOL SCI, V25, P613, DOI 10.1177/0956797613504965; Chambers JR, 2003, PERS SOC PSYCHOL B, V29, P1343, DOI 10.1177/0146167203256870; Credit Suisse, 2019, GLOB WEALTH REP 2019; Cruces G, 2013, J PUBLIC ECON, V98, P100, DOI 10.1016/j.jpubeco.2012.10.009; Davidai S, 2018, J EXP SOC PSYCHOL, V79, P138, DOI 10.1016/j.jesp.2018.07.012; Davidai S, 2018, JUDGM DECIS MAK, V13, P297; Davidai S, 2015, PERSPECT PSYCHOL SCI, V10, P60, DOI 10.1177/1745691614562005; Dawtry RJ, 2019, SOCIAL PSYCHOLOGY OF INEQUALITY, P381, DOI 10.1007/978-3-030-28856-3_24; European Commission, 2011, SPEC EUR WAV 76 1 TN; Fereidouni HG, 2017, J REAL ESTATE FINANC, V54, P216, DOI 10.1007/s11146-015-9537-9; Galdi S, 2017, PSYCHOL WOMEN QUART, V41, P338, DOI 10.1177/0361684317709770; Garcia-Muniesa J, 2019, EUR SOC, V21, P256, DOI 10.1080/14616696.2018.1547836; Garcia-Sanchez E, 2020, BRIT J SOC PSYCHOL, V59, P111, DOI 10.1111/bjso.12326; Gaspar Vitor, 2020, FACING CRISIS ROLE T; Gelper S, 2007, APPL ECON, V39, P1, DOI 10.1080/00036840500427791; Gimpelson V, 2015, MISPERCEIVING INEQUA; Grigoli F., 2017, IMF WORKING PAPERS; Harris P, 1996, J SOC CLIN PSYCHOL, V15, P9, DOI 10.1521/jscp.1996.15.1.9; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; HEINE SJ, 1995, J PERS SOC PSYCHOL, V68, P595, DOI 10.1037/0022-3514.68.4.595; Hornsey MJ, 2016, GLOBAL ENVIRON CHANG, V39, P26, DOI 10.1016/j.gloenvcha.2016.04.003; Jost JT, 2017, CURR OPIN PSYCHOL, V18, P73, DOI 10.1016/j.copsyc.2017.08.020; Jost JT, 2017, POLIT PSYCHOL, V38, P167, DOI 10.1111/pops.12407; Kelley J., 2004, RES SOC STRAT MOBIL, V22, P319, DOI [10.1016/S0276-5624(04)22011-X, DOI 10.1016/S0276-5624(04)22011-X]; KENWORTHY L, 2008, SOCIOECONOMIC REV, V0006; Kiatpongsan S, 2014, PERSPECT PSYCHOL SCI, V9, P587, DOI 10.1177/1745691614549773; Klein CTF, 2002, PSYCHOL HEALTH, V17, P437, DOI 10.1080/0887044022000004920; Kraus MW, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01709; Kteily NS, 2017, J PERS SOC PSYCHOL, V112, P136, DOI 10.1037/pspp0000097; Kuziemko I, 2015, AM ECON REV, V105, P1478, DOI 10.1257/aer.20130360; Lench HC, 2006, J APPL SOC PSYCHOL, V36, P2963, DOI 10.1111/j.0021-9029.2006.00137.x; Lupu N, 2011, AM POLIT SCI REV, V105, P316, DOI 10.1017/S0003055411000128; MacDonald TK, 1999, PERS SOC PSYCHOL B, V25, P1417, DOI 10.1177/0146167299259007; Machin S., 2018, SOCIAL MOBILITY ITS; Marx P, 2016, SOCIO-ECON REV, V14, P97, DOI 10.1093/ser/mwu022; MCGEE HM, 1994, MED EDUC, V28, P513, DOI 10.1111/j.1365-2923.1994.tb02728.x; McKay RT, 2009, BEHAV BRAIN SCI, V32, P493, DOI 10.1017/S0140525X09990975; MCKENNA FP, 1993, BRIT J PSYCHOL, V84, P389, DOI 10.1111/j.2044-8295.1993.tb02490.x; MELTZER AH, 1981, J POLIT ECON, V89, P914, DOI 10.1086/261013; Mijs JJB, 2019, SOCIOECON REV; Norton MI, 2011, PERSPECT PSYCHOL SCI, V6, P9, DOI 10.1177/1745691610393524; Noto A., 2019, ANNO CHE VERRA ITALI; OECD, 2020, GROSS DOM PROD; Oishi S, 2018, AM PSYCHOL, V73, P157, DOI 10.1037/amp0000166; Osberg L, 2006, AM SOCIOL REV, V71, P450, DOI 10.1177/000312240607100305; Osborne D, 2019, SOCIAL PSYCHOLOGY OF INEQUALITY, P249, DOI 10.1007/978-3-030-28856-3_16; Osborne D, 2013, PERS SOC PSYCHOL B, V39, P991, DOI 10.1177/0146167213487997; Osborne D, 2012, PERS SOC PSYCHOL B, V38, P628, DOI 10.1177/0146167211432766; Osservatorio JobPricing, 2020, SALARY OUTLOOK 2020; Owens LA, 2014, SOC FORCES, V92, P1087, DOI 10.1093/sf/sot101; Oxfam, 2020, 5 SHOCK FACTS EXTR G; Oxfam, 2020, TIM CAR; Oxfam, 2020, PUBL GOOD PRIV WEALT; Payne K., 2017, BROKEN LADDER INEQUA; PERSSON T, 1994, AM ECON REV, V84, P600; PETERSON C, 1995, J CLIN PSYCHOL, V51, P128, DOI 10.1002/1097-4679(199501)51:1<128::AID-JCLP2270510120>3.0.CO;2-1; Pew Research Center, 2019, LOOK FUT PUBL SEES A; PEW Research Center, 2018, MAN IT AR DEEPL PESS; PEW Research Center, 2019, PUBL VIEWS NAT EC RE; Pickett KE, 2015, SOC SCI MED, V128, P316, DOI 10.1016/j.socscimed.2014.12.031; PIKETTY T, 1995, Q J ECON, V110, P551, DOI 10.2307/2946692; Ravallion M, 2000, J PUBLIC ECON, V76, P87, DOI 10.1016/S0047-2727(99)00064-X; Robertson L S, 1977, J Community Health, V3, P136, DOI 10.1007/BF01674235; Rodriguez-Bailon R, 2017, J SOC ISSUES, V73, P99, DOI 10.1111/josi.12206; Roser R, 2014, OPTIMISM PESSIMISM; Runciman Walter Garrison, 1966, RELATIVE DEPRIVATION; Sanchez-Rodriguez A, 2019, EUR J SOC PSYCHOL, V49, P1114, DOI 10.1002/ejsp.2557; SDG Watch Europe, 2019, FALL CRACKS EXP IN E; Shariff AF, 2016, PERSPECT PSYCHOL SCI, V11, P373, DOI 10.1177/1745691616635596; Sharot T, 2011, CURR BIOL, V21, pR941, DOI 10.1016/j.cub.2011.10.030; Sharot T, 2011, NAT NEUROSCI, V14, P1475, DOI 10.1038/nn.2949; Shayo M, 2009, AM POLIT SCI REV, V103, P147, DOI 10.1017/S0003055409090194; Shelton JE, 2009, SOCIOL PERSPECT, V52, P385, DOI 10.1525/sop.2009.52.3.385; Svallfors S, 1997, EUR SOCIOL REV, V13, P283, DOI 10.1093/oxfordjournals.esr.a018219; Swan LK, 2017, JUDGM DECIS MAK, V12, P507; United Nations, 2020, UN PUBL, VIV, P1; Vanlaer W, 2020, SOC INDIC RES, V147, P677, DOI 10.1007/s11205-019-02170-4; WEINSTEIN ND, 1980, J PERS SOC PSYCHOL, V39, P806, DOI 10.1037/0022-3514.39.5.806; Weinstein ND, 1996, J SOC CLIN PSYCHOL, V15, P1, DOI 10.1521/jscp.1996.15.1.1; WEINSTEIN ND, 1987, J BEHAV MED, V10, P481, DOI 10.1007/BF00846146; WENGLERT L, 1982, SCAND J PSYCHOL, V23, P153, DOI 10.1111/j.1467-9450.1982.tb00428.x; Wenglert L, 2000, PERS INDIV DIFFER, V28, P717, DOI 10.1016/S0191-8869(99)00133-6; Wilkinson RG, 2006, SOC SCI MED, V62, P1768, DOI 10.1016/j.socscimed.2005.08.036; Wilkinson RG, 2009, ANNU REV SOCIOL, V35, P493, DOI 10.1146/annurev-soc-070308-115926; Willis GB, 2015, SOC JUSTICE RES, V28, P493, DOI 10.1007/s11211-015-0253-7; World Economic Forum, 2020, GREAT RES MUST PLAC; Xu P, 2010, SOC SCI QUART, V91, P1220, DOI 10.1111/j.1540-6237.2010.00729.x	105	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243486	10.1371/journal.pone.0243486	http://dx.doi.org/10.1371/journal.pone.0243486			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH1MP	33315882	Green Published, gold			2022-12-27	WOS:000600186100048
J	Kilani, HA; Bataineh, MF; Al-Nawayseh, A; Atiyat, K; Obeid, O; Abu-Hilal, MM; Mansi, T; Al-Kilani, M; Al-Kitani, M; El-Saleh, M; Jaber, RM; Sweidan, A; Himsi, M; Yousef, I; Alzeer, F; Nasrallah, M; Al Dhaheri, AS; Al-Za'abi, A; Allala, O; Al-Kilani, L; Alhasan, AM; Ghieda, M; Najah, Y; Alsheekhly, S; Alhaifi, A; Shukri, R; Al Adwani, J; Waly, M; Kilani, L; Kilani, LH; al Shareef, AS; Kilani, A				Kilani, Hashem A.; Bataineh, Mo'ath F.; Al-Nawayseh, Ali; Atiyat, Khaled; Obeid, Omar; Abu-Hilal, Maher M.; Mansi, Taiysir; Al-Kilani, Maher; Al-Kitani, Mahfoodha; El-Saleh, Majed; Jaber, Ruba M.; Sweidan, Ahmad; Himsi, Mawaheb; Yousef, Iyad; Alzeer, Faten; Nasrallah, Monther; Al Dhaheri, Ayesha S.; Al-Za'abi, Abdulsalam; Allala, Osama; Al-Kilani, Laila; Alhasan, Asma M.; Ghieda, Mohamed; Najah, Yasir; Alsheekhly, Saad; Alhaifi, Ahmad; Shukri, Raghda; Al Adwani, Jamal; Waly, Mostafa; Kilani, Laila; Kilani, Leen H.; al Shareef, Ahmad S.; Kilani, Areej			Healthy lifestyle behaviors are major predictors of mental wellbeing during COVID-19 pandemic confinement: A study on adult Arabs in higher educational institutions	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; SEROTONIN; INTERVENTION; QUARANTINE; DISORDERS	Background In the past infectious diseases affected the quality of lifestyle during home confinement. The study conducted examines the influence of home confinement during the COVID-19 pandemic outbreak on lifestyle, mental wellbeing, nutritional status, and sleeping pattern. Method An online multicategorical questionnaire was distributed to collect demographic information combined with the following tools: Food Frequency Questionnaire (FFQ), International Physical Activity Questionnaire (IPAQ), WHO-5 wellbeing score, and Pittsburgh Sleep Quality Index (PSQI). A snowball non-discriminate sampling procedure was conducted to collect data from people attending or working at higher institutions from March 1, 2020 to April 24, 2020. A total of 1723 completed responses (917 males, 37.4 13.4 years old and 806 females 32.2 11.5 years old) were collected. Results The female participants had significantly lower mental health scores than males (53.9% vs. 46.1%). The mental wellbeing scores were higher among participants with medium and high physical activity (PA) levels (p < 0.00). Additionally, the mental wellbeing scores were significantly improved by dietary quality and it's sleeping score (p < 0.001). However, PA was by far the major determinant of the mental health scores. Conclusion Factors such as PA, diet, and sleeping patterns were associated with mental wellbeing during the COVID-19 confinement among Arab participants.	[Kilani, Hashem A.; Atiyat, Khaled; Mansi, Taiysir] Univ Jordan, Sch Sport Sci, Kinesiol & Training Dept, Amman, Jordan; [Bataineh, Mo'ath F.; Al-Nawayseh, Ali; Al-Kilani, Maher] Hashemite Univ, Dept Sport Rehabil, Coll Phys Educ & Sport Sci, Zarqa, Jordan; [Obeid, Omar] Amer Univ Beirut, Dept Nutr & Food Sci, Beirut, Lebanon; [Abu-Hilal, Maher M.] Sultan Qaboos Univ, Psychol Dept, Coll Educ, Muscat, Oman; [Al-Kitani, Mahfoodha] Sultan Qaboos Univ, Coll Educ, Phys Educ & Sports Sci, Muscat, Oman; [El-Saleh, Majed] Al Ain Univ, Coll Educ Humanities & Social Sci, Al Ain, U Arab Emirates; [Jaber, Ruba M.] Univ Jordan, Sch Med, Family Med, Amman, Jordan; [Sweidan, Ahmad; Alhasan, Asma M.] Minist Educ, Amman, Jordan; [Himsi, Mawaheb] Actness Acad, Wellness Dept, Amman, Jordan; [Yousef, Iyad] Beir Zeit Univ, Phys Educ Dept, Ramallah, Palestine; [Alzeer, Faten] Khadouri Univ, Phys Educ Dept, Ramallah, Palestine; [Nasrallah, Monther] Al Istiqlal Univ, Mil Phys Training Dept, Jericho, Palestine; [Al Dhaheri, Ayesha S.] United Arab Emirates Univ, Food Nutr & Hlth Dept, Al Ain, U Arab Emirates; [Al-Za'abi, Abdulsalam] UAEU, Hlth & Phys Educ Dept, Coll Educ, Abu Dhabi, U Arab Emirates; [Allala, Osama] Abu Dhabi Sports Council, Abu Dhabi, U Arab Emirates; [Al-Kilani, Laila] Princess Nourah Bint Abdulrahman Univ, Dept Phys & Sport Sci, Riyadh, Saudi Arabia; [Ghieda, Mohamed] Mansoura Univ, Sport Kinesiol Dept, Mansoura, Egypt; [Najah, Yasir] Univ Baghdad, Coll Phys Educ & Sports Sci, Baghdad, Iraq; [Alsheekhly, Saad] Univ Baghdad, Coll Polit Sci, Baghdad, Iraq; [Alhaifi, Ahmad] Publ Author Appl Educ & Training, Coll Hlth Sci, Adailiya, Kuwait; [Shukri, Raghda] Tokyo Human Hlth Sci Univ Vietnam, Nursing Dept, Ho Chi Minh City, Vietnam; [Al Adwani, Jamal] Minist Awqaf & Islamic Affairs, Kuwait, Kuwait; [Waly, Mostafa] Sultan Qaboos Univ, Food Sci & Nutr Dept, Coll Agr & Marine Sci, Muscat, Oman; [Kilani, Laila] Univ Jordan, Amman, Jordan; [Kilani, Leen H.] Univ Jordan, Coll Engn, Amman, Jordan; [al Shareef, Ahmad S.] Drassa Acad, Dubai, U Arab Emirates; [Kilani, Areej] Jordan Univ Hosp, Internal Med Dept, Amman, Jordan	University of Jordan; Hashemite University; American University of Beirut; Sultan Qaboos University; Sultan Qaboos University; University of Jordan; United Arab Emirates University; United Arab Emirates University; Princess Nourah bint Abdulrahman University; Egyptian Knowledge Bank (EKB); Mansoura University; University of Baghdad; University of Baghdad; Sultan Qaboos University; University of Jordan; University of Jordan; University of Jordan	Kilani, HA (corresponding author), Univ Jordan, Sch Sport Sci, Kinesiol & Training Dept, Amman, Jordan.	hashemkilani@gmail.com	Obeid, Omar/AAS-4457-2021; KILANI, HASHEM/AAM-9951-2021	Bataineh, Moath/0000-0001-8469-9581; KILANI, HASHEM/0000-0002-2540-3055; Mansi, Taiysir/0000-0001-7560-9855	Ministry of Higher Education and Scientific Research [84811]	Ministry of Higher Education and Scientific Research(Ministry of Higher Education & Scientific Research (MHESR))	This study was supported by the Ministry of Higher Education and Scientific Research (JO) (84811) to HAK. Additionally, MH is a paid employee of Actness, but was not representing Actness when working on this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hazzaa HM, 2010, SAUDI MED J, V31, P210; Alomari MA, 2011, CLIN EXP HYPERTENS, V33, P345, DOI 10.3109/10641963.2010.531848; Altena E, 2020, J SLEEP RES, V29, DOI 10.1111/jsr.13052; [Anonymous], 2018, ARCH RELIGIONSGESCHI, V20, P91; Brooks Samantha K, 2020, Lancet, V395, P912, DOI 10.1016/S0140-6736(20)30460-8; Chan JFW, 2013, TRENDS MICROBIOL, V21, P544, DOI 10.1016/j.tim.2013.05.005; Childs CE, 2019, NUTRIENTS, V11, DOI 10.3390/nu11081933; Duncan GE, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237695; Goethals L, 2020, JMIR AGING, V3, DOI 10.2196/19007; Gundy T, 1996, EGYPT J PSYCHIAT, V88, P167; Habsi A, 2015, SULTAN QABOOS U MED, V15, P241; Haduch A, 2016, DRUG METAB DISPOS, V44, P445, DOI 10.1124/dmd.115.067413; Huang Y, 2020, PSYCHIAT RES, V290, DOI 10.1016/j.psychres.2020.112963; Husby SR, 2020, J COMMUNITY PSYCHOL, V48, P1028, DOI 10.1002/jcop.22323; Jenkins TA, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010056; Jeong H, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016048; Josefsson T, 2014, SCAND J MED SCI SPOR, V24, P259, DOI 10.1111/sms.12050; Kilani H., 2013, EUR SCI J, V9, P156; Kilani H, 2018, EURPEAN J SPORT TECH, P2; Kilani H, 2020, WELLN JO C HLTH LIF; Kilani Hashem, 2013, Sultan Qaboos Univ Med J, V13, P510; Kim Y, 2016, ARCH CARDIOVASC DIS, V109, P39, DOI 10.1016/j.acvd.2015.09.005; Li H, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105951; Lin SH, 2014, CLIN PSYCHOPHARM NEU, V12, P196, DOI 10.9758/cpn.2014.12.3.196; Liu NQ, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112921; Mason OJ, 2012, J MENT HEALTH, V21, P274, DOI 10.3109/09638237.2011.648344; Matthews CE, 2002, MED SCI SPORT EXER, V34, P1242, DOI 10.1097/00005768-200208000-00003; McIntyre RS, 2020, PSYCHIAT RES, V290, DOI 10.1016/j.psychres.2020.113104; Nakamaru-Ogiso E, 2012, EUR J NEUROSCI, V35, P1762, DOI 10.1111/j.1460-9568.2012.08077.x; Novak CM, 2012, NEUROSCI BIOBEHAV R, V36, P1001, DOI 10.1016/j.neubiorev.2011.12.012; On the Beat, 2014, ISLAMIC STATE REPORT, V2, P5, DOI DOI 10.7243/2052-6962-2-5; Pieh C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238906; Rohr S, 2020, PSYCHIAT PRAX, V47, P179, DOI 10.1055/a-1159-5562; Schaefer C, 2017, CURR ALZHEIMER RES, V14, P1084, DOI 10.2174/1567205014666170523094938; Simpson RJ, 2020, EXERC IMMUNOL REV, V26, P8; Song B, 2020, OSF PREPR, DOI [10.31219/osf.io/umtvh, DOI 10.31219/OSF.I0/UMTVH]; Swinkels JC, 2019, GERONTOLOGIST, V59, P1103, DOI 10.1093/geront/gny132; Tejeda HA, 2014, CELL, V157, P1500, DOI 10.1016/j.cell.2014.06.009; Tognotti E, 2013, EMERG INFECT DIS, V19, P254, DOI 10.3201/eid1902.120312; Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9; Warburton DER, 2017, CURR OPIN CARDIOL, V32, P541, DOI 10.1097/HCO.0000000000000437; WHO, 2004, LANCET, V363, P902; Xu Z, 2020, LANCET RESP MED, V8, P420, DOI 10.1016/S2213-2600(20)30076-X; Zhang Y, 2020, INT J COMP METH-SING, V17, DOI 10.1142/S0219876219500312	44	32	32	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243524	10.1371/journal.pone.0243524	http://dx.doi.org/10.1371/journal.pone.0243524			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH1MP	33315880	gold, Green Submitted, Green Published			2022-12-27	WOS:000600186100015
J	Wu, VCC; Wang, CL; Gan, ST; Wu, M; Chen, SW; Kuo, CF; Huang, YT; Wen, MS; Chang, SH				Wu, Victor Chien-Chia; Wang, Chun-Li; Gan, Shu-Ting; Wu, Michael; Chen, Shao-Wei; Kuo, Chang-Fu; Huang, Yu-Tung; Wen, Ming-Shien; Chang, Shang-Hung			Efficacy and safety of NOAC versus warfarin in AF patients with left atrial enlargement	PLOS ONE			English	Article							FIBRILLATION; STROKE; RISK; DEATH	Background Little is known about the effects of anticoagulation in patients with atrial fibrillation (AF) and left atrial enlargement (LAE). Methods Data of patients with AF were retrieved from Chang Gung Research Database during 2007-2016. We excluded patients who were not using oral anticoagulants, used anticoagulants for <30 days, used <greater than or equal to>2 agents concomitantly or switched anticoagulants, had left atrial diameter missing from their data, were aged <65, had received valve surgeries, had mitral stenosis, or had a history of cancer. The primary outcomes were ischemic stroke (IS)/systemic embolism (SE), major bleeding, and death from any cause. Results We identified 40,777 patients who received a diagnosis of AF. After the exclusion criteria were applied, 6,445 patients remained, 4,922 with LAE, and they were followed up for 2.4 1.9 years. The mean age of the patients was 77.32 <plus/minus> 0.18 in the NOAC group and 76.58 +/- 6.91 in the warfarin group (p < 0.0001); 48.24% of patients in the NOAC group and 46.98% of patients in the warfarin group were men (p > 0.05). The mean CHA(2)DS(2)-VASc score was 3.26 +/- 1.05 in the NOAC group and 3.07 +/- 1.12 in the warfarin group (p < 0.0001). The mean HAS-BLED score was 3.87 <plus/minus> 3.81 in the NOAC group and 3.86 +/- 3.80 in the warfarin group (p > 0.05). Furthermore, the mean LA diameter was 4.75 +/- 0.63 cm in the warfarin group and 4.79 +/- 0.69 cm in the warfarin group (p > 0.05). Among patients with LAE, NOAC was associated with significantly reduced IS/SE events (CRR = 0.63, 95% CI = 0.52-0.77), no difference in major bleeding (CRR = 0.91, 95% CI = 0.78-1.05), and significantly reduced death from any cause (aHR = 0.65, 95% CI = 0.52-0.80) compared with warfarin. Conclusions In elderly patients with AF and LAE, NOAC was associated with reduced IS/SE and death from any cause compared with warfarin, whereas no difference in major bleeding was observed between these treatments.	[Wu, Victor Chien-Chia; Wang, Chun-Li; Wen, Ming-Shien; Chang, Shang-Hung] Chang Gung Mem Hosp, Div Cardiol, Linkou Med Ctr, Taoyuan, Taiwan; [Wu, Victor Chien-Chia; Wang, Chun-Li; Kuo, Chang-Fu; Wen, Ming-Shien; Chang, Shang-Hung] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Gan, Shu-Ting; Huang, Yu-Tung; Chang, Shang-Hung] Chang Gung Mem Hosp, Ctr Big Data Analyt & Stat, Linkou Med Ctr, Taoyuan, Taiwan; [Wu, Michael] Brown Univ, Rhode Isl Hosp, Warren Alpert Sch Med, Div Cardiovasc Med,Arrhythmia Serv Sect, Providence, RI 02903 USA; [Chen, Shao-Wei] Chang Gung Mem Hosp, Dept Cardiothorac & Vasc Surg, Linkou Med Ctr, Taoyuan, Taiwan; [Kuo, Chang-Fu] Chang Gung Mem Hosp, Dept Internal Med, Linkou Med Ctr, Div Rheumatol Allergy & Immunol, Taoyuan, Taiwan; [Kuo, Chang-Fu] Univ Nottingham, Sch Med, Div Rheumatol Orthopaed & Dermatol, Nottingham, England; [Chang, Shang-Hung] Chang Gung Univ Sci & Technol, Grad Inst Nursing, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; University of Nottingham; Chang Gung University of Science & Technology	Chang, SH (corresponding author), Chang Gung Mem Hosp, Div Cardiol, Linkou Med Ctr, Taoyuan, Taiwan.; Chang, SH (corresponding author), Chang Gung Univ, Coll Med, Taoyuan, Taiwan.; Chang, SH (corresponding author), Chang Gung Mem Hosp, Ctr Big Data Analyt & Stat, Linkou Med Ctr, Taoyuan, Taiwan.; Chang, SH (corresponding author), Chang Gung Univ Sci & Technol, Grad Inst Nursing, Taoyuan, Taiwan.	afen.chang@gmail.com	Wu, Victor Chien-Chia/GXF-4623-2022; Wu, Michael/ABL-0760-2022; Huang, Yu-Tung/S-4026-2018; Wu, Victor Chien-Chia/ABB-6872-2021	Wu, Victor Chien-Chia/0000-0002-9918-4369; Huang, Yu-Tung/0000-0003-3224-7238; Wu, Victor Chien-Chia/0000-0002-9918-4369	Center for Big Data Analytics and Statistics Grants at Chang Gung Memorial Hospital [CORPG3G0271, CLRPG3D0045]	Center for Big Data Analytics and Statistics Grants at Chang Gung Memorial Hospital	Funded by Center for Big Data Analytics and Statistics Grants, CORPG3G0271 and CLRPG3D0045, at Chang Gung Memorial Hospital, for Dr. Shang-Hung Chang. The funder plays role in the study design and monitor, data analysis and interpretation.	BENJAMIN EJ, 1995, CIRCULATION, V92, P835, DOI 10.1161/01.CIR.92.4.835; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Dakay K, 2018, J STROKE CEREBROVASC, V27, P192, DOI 10.1016/j.jstrokecerebrovasdis.2017.08.025; Freedman B, 2016, JAMA CARDIOL, V1, P366, DOI 10.1001/jamacardio.2016.0393; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Gupta DK, 2014, EUR HEART J, V35, P1457, DOI 10.1093/eurheartj/eht500; Hamatani Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep31042; January CT, 2019, J AM COLL CARDIOL, V74, P104, DOI 10.1016/j.jacc.2019.01.011; KEREN G, 1987, AM HEART J, V114, P1146, DOI 10.1016/0002-8703(87)90190-6; Kirchhof P, 2016, EUR HEART J, V37, P2893, DOI 10.1093/eurheartj/ehw210; Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014; Li Y, 2007, BASIC RES CARDIOL, V102, P245, DOI 10.1007/s00395-007-0641-8; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Maheshwari A, 2019, CIRCULATION, V139, P180, DOI 10.1161/CIRCULATIONAHA.118.035411; Ogata T, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006402; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Psaty BM, 1997, CIRCULATION, V96, P2455; Rapacciuolo A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44214-2; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Steffel J, 2018, EUR HEART J, V39, P1330, DOI 10.1093/eurheartj/ehy136; Steffel J, 2018, EUROPACE, V20, P1231, DOI 10.1093/europace/euy054; Tiwari S, 2016, OPEN HEART, V3, DOI 10.1136/openhrt-2016-000439; Tsai MS, 2017, BIOMED J, V40, P263, DOI 10.1016/j.bj.2017.08.002; Tsang TSM, 2002, J AM COLL CARDIOL, V40, P1636, DOI 10.1016/S0735-1097(02)02373-2; Wang CL, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.009263; Wang CL, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.012029; Wang CL, 2019, J THROMB THROMBOLYS, V47, P512, DOI 10.1007/s11239-018-1792-1; Yoshida C, 2009, EUR J ECHOCARDIOGR, V10, P278, DOI 10.1093/ejechocard/jen234	29	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243866	10.1371/journal.pone.0243866	http://dx.doi.org/10.1371/journal.pone.0243866			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315930	gold, Green Published			2022-12-27	WOS:000600186100057
J	Bazaid, AS; Aldarhami, A; Binsaleh, NK; Sherwani, S; Althomali, OW				Bazaid, Abdulrahman S.; Aldarhami, Abdu; Binsaleh, Naif K.; Sherwani, Subuhi; Althomali, Omar W.			Knowledge and practice of personal protective measures during the COVID-19 pandemic: A cross-sectional study in Saudi Arabia	PLOS ONE			English	Article							AWARENESS; ATTITUDES; OUTBREAK	The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is an emergent infectious pathogen causing an acute respiratory disease called corona virus disease 2019 (COVID-19). Virus transmission may occur by contact, droplet, airborne or via contaminated surfaces. In efforts to effectively control the COVID-19 outbreak, the world health organization (WHO) and the Saudi Ministry of Health (MOH) have advised the public to practice protective measures to reduce transmission of the virus and reduce incidence of infection. These measures include hand washing, wearing masks and gloves and avoidance of touching the face with unwashed hands. The current study aimed to investigate knowledge and adherence of the Saudi population to these protective actions during the pandemic. After determining the required sample size using power analysis, a cross-sectional online self-reported survey of 5105 Saudi residents was conducted between 25(th) March to 17(th) April 2020 to evaluate public knowledge of COVID-19. Participants were all aged 18 years or above, Arabic speakers and residents of Saudi Arabia. Scores were calculated based on knowledge and adherence of the individuals to protective measures. About 90% of participants exhibited a high level of knowledge (scored 2/2) and practice (scored > 3/6) in relation to hand hygiene and wearing gloves and masks. Practice scores were positively associated with females and individuals with high income. Lower practice scores were linked to youth and residents of the northern and western regions of the Kingdom. Over two thirds of participants preferred hand washing to alcohol disinfection, and the frequency and performance of hand washing improved during the pandemic for more than half of respondents. Overall, the findings reflected high public knowledge of SARS-CoV2 transmission routes and adherence to personal protective measures. However, public awareness campaigns with an emphasis on the youth and individuals with low education and income are required to improve overall practice.	[Bazaid, Abdulrahman S.; Binsaleh, Naif K.] Univ Hail, Coll Appl Med Sci, Dept Clin Lab Sci, Hail, Saudi Arabia; [Aldarhami, Abdu] Taif Univ, Turabah Univ Coll, Dept Clin Lab Sci, Turabah, Saudi Arabia; [Sherwani, Subuhi] Univ Hail, Coll Sci, Dept Biol, Hail, Saudi Arabia; [Althomali, Omar W.] Univ Hail, Coll Appl Med Sci, Dept Physiotherapy, Hail, Saudi Arabia	University Ha'il; Taif University; University Ha'il; University Ha'il	Bazaid, AS (corresponding author), Univ Hail, Coll Appl Med Sci, Dept Clin Lab Sci, Hail, Saudi Arabia.	ar.bazaid@uoh.edu.sa	binsaleh, Naif/ABB-1018-2021; Binsaleh, Naif/AAP-3838-2021; Sherwani, Subuhi/AAR-4495-2021; Aldarhami, Abdu/AFL-9810-2022; althomali, omar/AAY-7741-2021; Bazaid, Abdulrahman S/AAK-7775-2021; Althomali, Omar/GPX-3355-2022	Binsaleh, Naif/0000-0001-9001-6361; Sherwani, Subuhi/0000-0002-0631-708X; althomali, omar/0000-0003-2985-3958; Bazaid, Abdulrahman S/0000-0002-4586-7770; Aldarhami, Abdu/0000-0002-0950-9263; Bazaid, Abdulrahman/0000-0002-5884-0278	Scientific Research Deanship at University of Ha'il, Saudi Arabia [COVID-1902]	Scientific Research Deanship at University of Ha'il, Saudi Arabia	This study was funded by Scientific Research Deanship at University of Ha'il, Saudi Arabia through project number COVID-1902. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulmun'im A-N, 1993, Z ARABISCHE LINGUIST, P15; Aiello AE, 2008, AM J PUBLIC HEALTH, V98, P1372, DOI 10.2105/AJPH.2007.124610; Al-Hanawi MK, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00217; Alahdal H, 2020, J INFECT PUBLIC HEAL, V13, P1446, DOI 10.1016/j.jiph.2020.06.015; Aldarhami A, 2020, INT J GEN MED, V13, P677, DOI 10.2147/IJGM.S269716; Algaissi AA, 2020, J INFECT PUBLIC HEAL, V13, P834, DOI 10.1016/j.jiph.2020.04.016; Almutairi AF, 2020, RISK MANAG HEALTHC P, V13, P753, DOI 10.2147/RMHP.S257287; Almutairi KM, 2015, FAM COMMUNITY HEALTH, V38, P332, DOI 10.1097/FCH.0000000000000082; Azlan AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233668; Buda A. S., 2018, Journal of Public Health and Epidemiology, V10, P205, DOI 10.5897/jphe2017.0987; Centers for Disease Control and Prevention, 2020, KEEP HANDS CLEAN; Coronatraker, SAUD AR OV; Field A., 2018, DISCOVERING STAT USI; Green P, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1669; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Machida M, 2020, INT J INFECT DIS, V94, P139, DOI 10.1016/j.ijid.2020.04.014; MOH, 2020, COVID 19 DASHB SAUD; MOH, 2020, COVID 19 AW SAUD AR; Naser A.Y., 2020, KNOWLEDGE PRACTICES, DOI [10.1101/2020.04.13.20063560, DOI 10.1101/2020.04.13.20063560]; Nooh HZ, 2021, J PUBLIC HEALTH-HEID, V29, P1107, DOI 10.1007/s10389-020-01209-y; OBRIEN RG, 1979, J AM STAT ASSOC, V74, P877, DOI 10.2307/2286416; Pan XF, 2020, LANCET INFECT DIS, V20, P410, DOI 10.1016/S1473-3099(20)30114-6; Ren SY, 2020, WORLD J CLIN CASES, V8, P1391, DOI 10.12998/wjcc.v8.i8.1391; Sherwani S, 2020, J INFLAMM RES, V13, P737, DOI 10.2147/JIR.S276091; Takahashi S, 2017, J INFECT PUBLIC HEAL, V10, P637, DOI 10.1016/j.jiph.2017.04.002; van de Mortel T, 2001, AM J INFECT CONTROL, V29, P395, DOI 10.1067/mic.2001.119511; WHO, 2020, WEEKLY EPIDEMIOLOGIC; WHO-Dashboard, 2020, WHO COR DIS COVID 19; World Health Organization, 2020, COR DIS COVID 19 ADV; Yang C, 2020, GRAEF ARCH CLIN EXP, V258, P1133, DOI 10.1007/s00417-020-04652-5; Yezli S, 2020, TRAVEL MED INFECT DI, V37, DOI 10.1016/j.tmaid.2020.101692; Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221	32	42	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243695	10.1371/journal.pone.0243695	http://dx.doi.org/10.1371/journal.pone.0243695			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306718	gold, Green Published			2022-12-27	WOS:000600144200066
J	Kelarestaghi, KB; Ermagun, A; Heaslip, K; Rose, J				Kelarestaghi, Kaveh Bakhsh; Ermagun, Alireza; Heaslip, Kevin; Rose, John			Choice of speed under compromised Dynamic Message Signs	PLOS ONE			English	Article							DRIVING SIMULATOR; BEHAVIOR	This study explores speed choice behavior of travelers under realistic and fabricated Dynamic Message Signs (DMS) content. Using web-based survey information of 4,302 participants collected by Amazon Mechanical Turk in the United States, we develop a set of multivariate latent-based ordered probit models participants. Results show female, African-Americans, drivers with a disability, elderly, and drivers who trust DMS are likely to comply with the fabricated messages. Drivers who comply with traffic regulations, have a good driving record, and live in rural areas, as well as female drivers are likely to slow down under fabricated messages. We highlight that calling or texting, taking picture, and tuning the radio are distracting activities leading drivers to slow down or stop under fictitious scenarios.	[Kelarestaghi, Kaveh Bakhsh] ICF Inc LLC, Fairfax, VA 22031 USA; [Ermagun, Alireza] Mississippi State Univ, Dept Civil & Environm Engn, Starkville, MS USA; [Heaslip, Kevin] Virginia Tech, Jr Dept Civil & Environm Engn, Charles Edward Via, Clemson, VA USA; [Rose, John] Univ Technol Sydney, Business Sch, Sydney, NSW, Australia	Mississippi State University; University of Technology Sydney	Kelarestaghi, KB (corresponding author), ICF Inc LLC, Fairfax, VA 22031 USA.	kaveh.bakhshkelarestaghi@icf.com	Rose, John/AAO-2897-2021; Heaslip, Kevin P/B-1308-2010	Heaslip, Kevin P/0000-0002-3393-2627; B. Kelarestaghi, Kaveh/0000-0003-3603-3771; Rose, John/0000-0003-4211-0980				Erke A, 2007, TRANSPORT RES F-TRAF, V10, P447, DOI 10.1016/j.trf.2007.03.003; Ermagun A., 2021, INT J TRANSP SCI TEC, V10, P49, DOI [DOI 10.1016/J.IJTST.2020.05.006, 10.1016/j.ijtst.2020.05.006]; Garber N.J., 1995, TRANSPORTATION RESEA; Garber N.J., 1988, SPEED VARIANCE ITS I; Guattari C, 2012, PROCD SOC BEHV, V53, P693, DOI 10.1016/j.sbspro.2012.09.919; Harms IM, 2019, TRANSPORT RES F-TRAF, V65, P564, DOI 10.1016/j.trf.2018.09.011; Hawkins H., 1999, INNOVATIVE TRAFFIC C; Jeihani M, 2017, IATSS RES, V41, P164, DOI 10.1016/j.iatssr.2017.03.001; Kelarestaghi K., 2018, SAE INT J TRANSPORTA, V1, P75; Kelarestaghi K. B, 2019, ARXIV190301541; Kelarestaghi KB, 2021, IEEE INTEL TRANSP SY, V13, P91, DOI 10.1109/MITS.2018.2889714; Kolisetty VGB, 2006, J ADV TRANSPORT, V40, P47, DOI 10.1002/atr.5670400104; Lee C, 2008, TRANSP RES RECORD, P55, DOI 10.3141/2069-08; Luoma J., 2001, TRAFFIC ENG CONTROL, V42; Luoma J., 1997, TRANSPORTATION RES R, V1573, P72; Peeta S, 2000, TRANSPORT RES REC, P102, DOI 10.3141/1725-14; Seraj S, 2012, TRANSPORT RES REC, P46, DOI 10.3141/2323-06; Shinar D, 2002, HUM FACTORS, V44, P474, DOI 10.1518/0018720024497682; Yan XD, 2014, DISCRETE DYN NAT SOC, V2014, DOI 10.1155/2014/206805; Zeng Q, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082768; Zeng Q, 2019, ACCIDENT ANAL PREV, V127, P87, DOI 10.1016/j.aap.2019.02.029	21	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243567	10.1371/journal.pone.0243567	http://dx.doi.org/10.1371/journal.pone.0243567			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306711	gold, Green Published			2022-12-27	WOS:000600144200040
J	Mohammad, AM; Dawad, MM; Kashmoola, MA; Al-Allawi, N				Mohammad, Ameen M.; Dawad, Mohammed M.; Kashmoola, Muna A.; Al-Allawi, Nasir			Doppler-defined pulmonary hypertension in beta-thalassemia major in Kurdistan, Iraq	PLOS ONE			English	Article							ARTERIAL-HYPERTENSION; RISK-FACTORS; PLATELET ACTIVATION; ECHOCARDIOGRAPHY; COMPLICATIONS; ASSOCIATION; PREVALENCE; GUIDELINES; DIAGNOSIS	Cardiopulmonary complications are among the most important complications of thalassemia major. Pulmonary hypertension is among these complications and studies addressing its frequency and associations in the latter disorder are sparse from Iraq. For this purpose a total 100 thalassemia major patients (>= 8 years old) were enrolled from a main thalassemia center in Kurdistan, Northern Iraq. All patients had a full history and clinical examination. Full blood count, biochemical tests and viral screen including hepatitis B surface antigen and hepatitis C virus antibody, in addition to transthoracic Doppler echocardiography for tricuspid regurgitation jet velocity (TRV). The enrolled patients had a mean (SD) age of 17.6 (5.5) years, and included 52 males and 48 females. Pulmonary hypertension as defined by TRV> 2.8 m/s coupled with both exertional dyspnea and an absence of left sided heart failure, was identified in nine patients (9%). The latter subgroup of patients had significantly higher reticulocyte counts, S. LDH, S. ferritin, and hepatitis C sero-positivity compared to those without this complication by univariate analysis. While by multivariate logistic regression only reticulocytes and hepatitis C sero-positivity remained significant. Furthermore, TRV as a continuous variable was positively correlated with reticulocytes, S. bilirubin and LDH (p<0.001, p = 0.002 and p<0.001 respectively), but not with age or S. ferritin (p = 0.77, and p = 0.93 respectively). In conclusion, pulmonary hypertension is not uncommon in Iraqi patients with thalassemia major, and it appears to be linked to chronic hemolysis rather than iron overload.	[Mohammad, Ameen M.] Univ Duhok, Coll Med, Dept Internal Med, Duhok, Iraq; [Dawad, Mohammed M.] Alkhansa Teaching Hosp, Dept Hematol, Mousel, Iraq; [Kashmoola, Muna A.] Univ Mousel, Coll Med, Dept Pathol, Mousel, Iraq; [Al-Allawi, Nasir] Univ Duhok, Coll Med, Dept Pathol, Duhok, Iraq	University of Duhok; University of Duhok	Mohammad, AM (corresponding author), Univ Duhok, Coll Med, Dept Internal Med, Duhok, Iraq.	doctoramb@yahoo.com	Kashmoola, Muna/ABF-1832-2021					Aessopos A, 2004, EUR J HAEMATOL, V73, P359, DOI 10.1111/j.1600-0609.2004.00304.x; Aessopos A, 2005, ANN NY ACAD SCI, V1054, P342, DOI 10.1196/annals.1345.041; Al-Allawi N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162036; Al-Allawi NAS, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/262853; Amid A, 2015, ARCH DIS CHILD, V100, P1051, DOI 10.1136/archdischild-2014-308112; Amoozgar H, 2010, EUR J HAEMATOL, V85, P549, DOI 10.1111/j.1600-0609.2010.01509.x; Atichartakarn V, 2003, INT J HEMATOL, V78, P139, DOI 10.1007/BF02983382; Badesch DB, 2010, CHEST, V137, P376, DOI 10.1378/chest.09-1140; Barst RJ, 2004, J AM COLL CARDIOL, V43, p40S, DOI 10.1016/j.jacc.2004.02.032; Benza RL, 2012, CHEST, V142, P448, DOI 10.1378/chest.11-1460; Colah R, 2010, EXPERT REV HEMATOL, V3, P103, DOI [10.1586/ehm.09.74, 10.1586/EHM.09.74]; Cunningham MJ, 2004, BLOOD, V104, P34, DOI 10.1182/blood-2003-09-3167; Demir C, 2015, BIOMED RES-INDIA, V26, P183; Derchi G, 1999, AM HEART J, V138, P384, DOI 10.1016/S0002-8703(99)70129-8; Derchi G, 2014, CIRCULATION, V129, P338, DOI 10.1161/CIRCULATIONAHA.113.002124; Du ZD, 1997, AM HEART J, V134, P532, DOI 10.1016/S0002-8703(97)70091-7; Eldor A, 2002, BLOOD, V99, P36, DOI 10.1182/blood.V99.1.36; Fraidenburg DR, 2016, ANN NY ACAD SCI, V1368, P127, DOI 10.1111/nyas.13037; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Hagar RW, 2006, BRIT J HAEMATOL, V133, P433, DOI 10.1111/j.1365-2141.2006.06053.x; HO KKL, 1993, J AM COLL CARDIOL, V22, pA6, DOI 10.1016/0735-1097(93)90455-A; Janda S, 2011, HEART, V97, P1112, DOI 10.1136/hrt.2010.212084corr1; Karimi M, 2011, EUR J INTERN MED, V22, P607, DOI 10.1016/j.ejim.2011.05.013; Kiter G, 2010, PEDIATR HEMAT ONCOL, V27, P597, DOI 10.3109/08880018.2010.503338; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Machado RF, 2013, CLIN CHEST MED, V34, P739, DOI 10.1016/j.ccm.2013.08.006; Mandell MS, 1996, CLIN CHEST MED, V17, P17, DOI 10.1016/S0272-5231(05)70296-3; Meloni A, 2015, BLOOD CELL MOL DIS, V54, P189, DOI 10.1016/j.bcmd.2014.11.003; Morris CR, 2011, BLOOD, V118, P3794, DOI 10.1182/blood-2010-11-319152; Morris CR, 2010, ANN NY ACAD SCI, V1202, P205, DOI 10.1111/j.1749-6632.2010.05580.x; Morris CR, 2005, ANN NY ACAD SCI, V1054, P481, DOI 10.1196/annals.1345.058; Phrommintikul A, 2006, HEART, V92, P1467, DOI 10.1136/hrt.2005.079970; Pugh ME, 2010, EXPERT REV CARDIOVAS, V8, P1549, DOI [10.1586/erc.10.137, 10.1586/ERC.10.137]; Rachmilewitz EA, 2011, BLOOD, V118, P3479, DOI 10.1182/blood-2010-08-300335; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; Ruf A, 1997, BRIT J HAEMATOL, V98, P51, DOI 10.1046/j.1365-2141.1997.1502965.x; Salvi SS, 2000, GUT, V47, P595, DOI 10.1136/gut.47.4.595; Sayani FA, 2015, ANN MED, V47, P592, DOI 10.3109/07853890.2015.1091942; Singer ST, 2006, AM J HEMATOL, V81, P670, DOI 10.1002/ajh.20640; Taher AT, 2018, BLOOD, V132, P1781, DOI 10.1182/blood-2018-06-818187; Taher AT, 2010, BLOOD, V115, P1886, DOI 10.1182/blood-2009-09-243154; Thuret I, 2010, HAEMATOL-HEMATOL J, V95, P724, DOI 10.3324/haematol.2009.018051; Villagra J, 2007, BLOOD, V110, P2166, DOI 10.1182/blood-2006-12-061697	43	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243648	10.1371/journal.pone.0243648	http://dx.doi.org/10.1371/journal.pone.0243648			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301537	Green Published, gold			2022-12-27	WOS:000600143100060
J	Yildirim, U				Yildirim, Ugur			Disparate impact pandemic framing decreases public concern for health consequences	PLOS ONE			English	Article							SYMPATHY	It is known that the new coronavirus (COVID-19) is disproportionately affecting the elderly, those with underlying medical conditions, and the poor. What is the effect of informing the public about these inequalities on people's perceptions of threat and their sensitivity to the outbreak's human toll? This study answers this question using a novel survey experiment and finds that emphasis on the unequal aspect of the pandemic, especially as it relates to the elderly and those with medical conditions, could be causing the public to become less concerned about the outbreak and its human toll. Discussion situates this finding in the literature on scientific communication and persuasion and explains why language that emphasizes the impact of the virus on all of us-rather than singling out certain groups-could be more effective in increasing caution among the general public and make them take the situation more seriously.	[Yildirim, Ugur] Univ Calif Berkeley, Dept Sociol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Yildirim, U (corresponding author), Univ Calif Berkeley, Dept Sociol, Berkeley, CA 94720 USA.	ugur.yildirim@berkeley.edu			Experimental Social Science Laboratory (XLAB) at University of California Berkeley	Experimental Social Science Laboratory (XLAB) at University of California Berkeley	UY received a small grant from the Experimental Social Science Laboratory (XLAB) at University of California Berkeley (https://xlab.berkeley.edu/) to run this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler NE, 2008, ANNU REV PUBL HEALTH, V29, P235, DOI 10.1146/annurev.publhealth.29.020907.090852; [Anonymous], ARCGIS; Associates CR, 2005, CRA NEWSLETTER, V29, P4; Beyer Don, IMPACT CORONAVIRUS W; Boen C, 2020, J HEALTH SOC BEHAV, V61, P153, DOI 10.1177/0022146520924811; Braveman P., 2010, AM J PUBLIC HEALTH, V100, P1375; Brinol P, 2009, EUR REV SOC PSYCHOL, V20, P49, DOI 10.1080/10463280802643640; Centers for Disease Control Prevention, PEOPL WHO AR HIGH RI; Coppock A., 2019, RES POLITICS     JAN, P1; Haslam SA, 2011, NEW PSYCHOLOGY OF LEADERSHIP: IDENTITY, INFLUENCE, AND POWER, P1; Lenz G., 2020, WORKING PAPER; Loewenstein G, 2007, REV GEN PSYCHOL, V11, P112, DOI 10.1037/1089-2680.11.2.112; Luk J, 2001, CLIN INFECT DIS, V33, P1375, DOI 10.1086/322662; Marmot M, 2015, LANCET, V386, P2442, DOI 10.1016/S0140-6736(15)00150-6; Martin MW, 2001, J MED HUMANITIES, V22, P95, DOI DOI 10.1023/A:1009074811781; McNeil DG, 2020, NY TIMES; Nelson TE, 1996, J POLIT, V58, P1055, DOI 10.2307/2960149; Quinn SC, 2014, BIOSECUR BIOTERROR, V12, P263, DOI 10.1089/bsp.2014.0032; Scott S., 2001, BIOL PLAGUES EVIDENC; Sharot T, 2011, CURR BIOL, V21, pR941, DOI 10.1016/j.cub.2011.10.030; Siegel M, 2009, 2009 IEEE-RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, P2563, DOI 10.1109/IROS.2009.5354116; Small DA, 2007, ORGAN BEHAV HUM DEC, V102, P143, DOI 10.1016/j.obhdp.2006.01.005; Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z; von Braun J, 2020, SCIENCE, V368, P214, DOI 10.1126/science.abc2255; Wise T., CHANGES RISK PERCEPT; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	26	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0243599	10.1371/journal.pone.0243599	http://dx.doi.org/10.1371/journal.pone.0243599			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PI8CZ	33338035	Green Published, Green Submitted, gold			2022-12-27	WOS:000601313500034
J	Zhang, WH; Kuang, P; Liu, T				Zhang, Wanhua; Kuang, Pu; Liu, Ting			Role of BCR-ABL1 isoforms on the prognosis of Philadelphia chromosome positive acute lymphoblastic leukemia in the tyrosine kinase inhibitor era: A meta-analysis	PLOS ONE			English	Article							TERM-FOLLOW-UP; IKZF1 DELETION; CHEMOTHERAPY PLUS; ADULT PATIENTS; HYPER-CVAD; IMATINIB; COMBINATION; OUTCOMES; DASATINIB; ONCOGENE	BCR-ABL1 fusion gene is the driver mutation of Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL). Although the prognostic value of BCR-ABL1 isoforms in Ph+ ALL patients has been investigated in numerous studies in the tyrosine kinase inhibitor (TKI) era, the results were still conflicting. Hence we performed herein the meta-analysis to comprehensively assess the impact of BCR-ABL1 isoforms on the clinical outcomes of Ph+ ALL patients. Systematic literature review was conducted in PubMed, Embase, and Cochrane databases with the data access date up to June 15, 2020. Pooled hazard ratios (HRs) with 95% confidence intervals (CIs) were calculated with fixed-effects or random-effects models. Furthermore, subgroup analyses were performed to assess the robustness of the associations. Nine studies with a total number of 1582 patients were eligible for this meta-analysis. Combined HRs suggested that p210 was slightly associated with inferior event-free survival (EFS) (HR = 1.34, 95% CI 1.05-1.72). The overall survival (OS) was not significantly affected (HR = 1.15, 95% CI 0.92-1.45). In subgroup analyses, the HRs showed a trend toward adverse impact of p210 on clinical outcomes. However, the confidence intervals were not crossing the null value only in a minority of subgroups including Caucasian studies, first-generation TKI treated cohort and transplant cohort. Our findings suggested that p210 might pose a mild adverse impact on the EFS of Ph+ ALL patients. This effect might be compromised by the use of second- or third-generation TKIs. Further studies are needed to verify our conclusions.	[Zhang, Wanhua; Kuang, Pu; Liu, Ting] Sichuan Univ, West China Hosp, Dept Hematol, Chengdu, Sichuan, Peoples R China	Sichuan University	Zhang, WH (corresponding author), Sichuan Univ, West China Hosp, Dept Hematol, Chengdu, Sichuan, Peoples R China.	wanhua.zhang@foxmail.com		Kuang, Pu/0000-0002-1007-6784				A Concepcion, 2016, REV LAB CLIN, V9, P40; Akahoshi Y, 2019, CANCER SCI, V110, P3255, DOI 10.1111/cas.14167; Bassan R, 2019, HAEMATOLOGICA, V104, P2028, DOI 10.3324/haematol.2018.201053; Bernt KM, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00054; Burmeister T, 2008, BLOOD, V112, P918, DOI 10.1182/blood-2008-04-149286; Chiaretti S, 2016, HAEMATOLOGICA, V101, P1544, DOI 10.3324/haematol.2016.144535; Cimino G, 2006, HAEMATOLOGICA, V91, P377; Daver N, 2015, HAEMATOLOGICA, V100, P653, DOI 10.3324/haematol.2014.118588; DeBoer R, 2016, LEUKEMIA LYMPHOMA, V57, P2298, DOI 10.3109/10428194.2016.1144881; DEKLEIN A, 1982, NATURE, V300, P765, DOI 10.1038/300765a0; Dombret H, 2002, BLOOD, V100, P2357, DOI 10.1182/blood-2002-03-0704; Fedullo AL, 2019, HAEMATOLOGICA, V104, P312, DOI 10.3324/haematol.2018.196055; Fielding AK, 2009, BLOOD, V113, P4489, DOI 10.1182/blood-2009-01-199380; Gleissner B, 2002, BLOOD, V99, P1536, DOI 10.1182/blood.V99.5.1536; Gong Z, 2017, BLOOD CANCER J, V7, DOI 10.1038/bcj.2017.62; Hayden JA, 2013, ANN INTERN MED, V158, P280, DOI 10.7326/0003-4819-158-4-201302190-00009; Huang A J, 2019, Zhonghua Xue Ye Xue Za Zhi, V40, P625, DOI 10.3760/cma.j.issn.0253-2727.2019.08.001; Iacobucci I, 2011, CLIN CANCER RES, V17, P7413, DOI 10.1158/1078-0432.CCR-11-1227; Jabbour E, 2015, LANCET ONCOL, V16, P1547, DOI 10.1016/S1470-2045(15)00207-7; KELLIHER M, 1991, MOL CELL BIOL, V11, P4710, DOI 10.1128/MCB.11.9.4710; Kim DY, 2015, BLOOD, V126, P746, DOI 10.1182/blood-2015-03-636548; Kim M, 2015, BONE MARROW TRANSPL, V50, P354, DOI 10.1038/bmt.2014.281; Li H, 2018, LEUKEMIA LYMPHOMA, V59, P1890, DOI 10.1080/10428194.2017.1406933; Lim SN, 2015, AM J HEMATOL, V90, P1013, DOI 10.1002/ajh.24137; LUGO TG, 1989, MOL CELL BIOL, V9, P1263, DOI 10.1128/MCB.9.3.1263; Martinelli G, 2009, J CLIN ONCOL, V27, P5202, DOI 10.1200/JCO.2008.21.6408; Mizuta S, 2012, BLOOD CANCER J, V2, DOI 10.1038/bcj.2012.18; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Moorman AV, 2010, BLOOD, V115, P206, DOI 10.1182/blood-2009-07-232124; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Nagel I, 2017, BLOOD, V130, P2027, DOI 10.1182/blood-2017-05-782888; Pfeifer H, 2018, BLOOD, V131, P1464, DOI 10.1182/blood-2017-07-796862; Qin YZ, 2018, BRIT J HAEMATOL, V182, P693, DOI 10.1111/bjh.15453; Qiu Lan-Lan, 2016, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V24, P369, DOI 10.7534/j.issn.1009-2137.2016.02.012; Ravandi F, 2015, CANCER-AM CANCER SOC, V121, P4158, DOI 10.1002/cncr.29646; Rousselot P, 2016, BLOOD, V128, P774, DOI 10.1182/blood-2016-02-700153; Short NJ, 2017, AM J HEMATOL, V92, P238, DOI 10.1002/ajh.24625; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; VONCKEN JW, 1995, BLOOD, V86, P4603, DOI 10.1182/blood.V86.12.4603.bloodjournal86124603; Xue MX, 2019, LEUKEMIA LYMPHOMA, V60, P3051, DOI 10.1080/10428194.2019.1607329; Yu GP, 2017, ONCOTARGET, V8, P107022, DOI 10.18632/oncotarget.22206; Zhang WH, 2019, ANN MED, V51, P28, DOI 10.1080/07853890.2018.1564359; Zhang WH, 2017, ANN HEMATOL, V96, P215, DOI 10.1007/s00277-016-2869-6	43	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0243657	10.1371/journal.pone.0243657	http://dx.doi.org/10.1371/journal.pone.0243657			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8CZ	33338050	gold, Green Published			2022-12-27	WOS:000601313500018
J	Goetz, CM; Arnetz, JE; Sudan, S; Arnetz, BB				Goetz, Courtney M.; Arnetz, Judith E.; Sudan, Sukhesh; Arnetz, Bengt B.			Perceptions of virtual primary care physicians: A focus group study of medical and data science graduate students	PLOS ONE			English	Article							HEALTH-CARE; RACIAL BIAS; AI; PROFESSIONALS; PERFORMANCE; DISEASES; ETHICS	Background Artificial and virtual technologies in healthcare have advanced rapidly, and healthcare systems have been adapting care accordingly. An intriguing new development is the virtual physician, which can diagnose and treat patients independently. Methods and findings This qualitative study of advanced degree students aimed to assess their perceptions of using a virtual primary care physician as a patient. Four focus groups were held: first year medical students, fourth year medical students, first year engineering/data science graduate students, and fourth year engineering/data science graduate students. The focus groups were audiotaped, transcribed verbatim, and content analyses of the transcripts was performed using a data-driven inductive approach. Themes identified concerned advantages, disadvantages, and the future of virtual primary care physicians. Within those main categories, 13 themes emerged and 31 sub-themes. Discussion While participants appreciated that a virtual primary care physician would be convenient, efficient, and cost-effective, they also expressed concern about data privacy and the potential for misdiagnosis. To garner trust from its potential users, future virtual primary physicians should be programmed with a sufficient amount of trustworthy data and have a high level of transparency and accountability for patients.	[Goetz, Courtney M.; Arnetz, Judith E.; Sudan, Sukhesh; Arnetz, Bengt B.] Michigan State Univ, Coll Human Med, Dept Family Med, E Lansing, MI 48824 USA	Michigan State University; Michigan State University College of Human Medicine	Goetz, CM (corresponding author), Michigan State Univ, Coll Human Med, Dept Family Med, E Lansing, MI 48824 USA.	goetzcou@msu.edu	Goetz, Courtney/AAD-1270-2022; Arnetz, Bengt/G-1685-2011	Arnetz, Bengt/0000-0001-7173-4333; Goetz, Courtney/0000-0002-2960-0128	Dr. Bengt Arnetz's Michigan State University start-up funds	Dr. Bengt Arnetz's Michigan State University start-up funds	This study was funded by Dr. Bengt Arnetz's Michigan State University start-up funds.	[Anonymous], 2016, LANCET, V387, P506, DOI 10.1016/S0140-6736(16)00267-1; Berchick ER, 2019, HLTH INSURANCE COVER; Blue Cross Blue Shield Association, 2019, HLTH MILL; Bowen GA, 2008, QUAL RES, V8, P137, DOI 10.1177/1468794107085301; Boyatzis RE, 1998, TRANSFORMING QUALITA, DOI [10.1080/00221329809596155, DOI 10.1080/00221329809596155]; Centers for Disease Control and Prevention, TEST COVID 19; Davenport Thomas, 2019, Future Healthc J, V6, P94, DOI 10.7861/futurehosp.6-2-94; Dorsey ER, 2016, NEW ENGL J MED, V375, P154, DOI 10.1056/NEJMra1601705; Efimenko M, 2020, BMC BIOINFORMATICS, V21, DOI 10.1186/s12859-020-03615-1; Fagherazzi G, 2019, DIABETES METAB, V45, P322, DOI 10.1016/j.diabet.2018.08.012; Gold J, 2020, KAISER HLTH NEWS; Greenhalgh T, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1182; Guba E., 1989, 4 GENERATION EVALUAT; Haenssle HA, 2020, ANN ONCOL, V31, P137, DOI 10.1016/j.annonc.2019.10.013; Hoffman KM, 2016, P NATL ACAD SCI USA, V113, P4296, DOI 10.1073/pnas.1516047113; Israni ST, 2019, JAMA-J AM MED ASSOC, V321, P29, DOI 10.1001/jama.2018.19398; Jacewicz N., 2016, ATLANTIC; Johnson SLJ, 2019, J LEGAL MED, V39, P427, DOI 10.1080/01947648.2019.1690604; Kennedy B., 2016, 28 AM ARE STRONG EAR; Ladika S., 2020, MANAGED CARE; Lagasse J., 2019, ARTIFICIAL INTELLIGE; Lau Annie Y S, 2019, Yearb Med Inform, V28, P174, DOI 10.1055/s-0039-1677935; Lee K., 2020, WIRED; Lewis KL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132690; Lin SY, 2019, J GEN INTERN MED, V34, P1626, DOI 10.1007/s11606-019-05035-1; Liu XX, 2019, LANCET DIGIT HEALTH, V1, pE271, DOI 10.1016/S2589-7500(19)30123-2; Liyanage Harshana, 2019, Yearb Med Inform, V28, P41, DOI 10.1055/s-0039-1677901; Lysaght T, 2019, ASIAN BIOETHICS REV, V11, P299, DOI 10.1007/s41649-019-00096-0; McKinney SM, 2020, NATURE, V577, P89, DOI 10.1038/s41586-019-1799-6; National Institutes of Health, 2020, NIH HARN AI COVID 19; Obermeyer Z, 2019, SCIENCE, V366, P447, DOI 10.1126/science.aax2342; Office of Minority Health, 2018, ASTHM AFR AM; Polinski JM, 2016, J GEN INTERN MED, V31, P269, DOI 10.1007/s11606-015-3489-x; Razzaki S, 2018, ARXIV180610698; Resnick B, 2020, VOX             0317; Roger E.M, 2003, DIFFUSION INNOVATION, V5th; Roosli E, 2020, J AM MED INFORM ASSN, DOI [10.1093/jamia/ocaa210, DOI 10.1093/JAMIA/0CAA210]; Shanafelt TD, 2019, MAYO CLIN PROC, V94, P1681, DOI 10.1016/j.mayocp.2018.10.023; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Uscher-Pines L, 2014, HEALTH AFFAIR, V33, P258, DOI 10.1377/hlthaff.2013.0989; Vogels E., 2019, MILLENIALS STAND OUT; Walker RC, 2019, INT J MED INFORM, V124, P78, DOI 10.1016/j.ijmedinf.2019.01.013; White MJ, 2016, IMMUNOGENETICS, V68, P391, DOI 10.1007/s00251-016-0914-1; Whitehead PB, 2015, J NURS SCHOLARSHIP, V47, P117, DOI 10.1111/jnu.12115; Winn AN, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.18561; Wosik J, 2020, J AM MED INFORM ASSN, V27, P957, DOI 10.1093/jamia/ocaa067; Yu KH, 2018, NAT BIOMED ENG, V2, P719, DOI 10.1038/s41551-018-0305-z; Zou J, 2018, NATURE, V559, P324, DOI 10.1038/d41586-018-05707-8	48	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243641	10.1371/journal.pone.0243641	http://dx.doi.org/10.1371/journal.pone.0243641			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PI8BZ	33332409	gold, Green Published			2022-12-27	WOS:000601310900036
J	Hirano, H; Koga, K; Takemoto, K				Hirano, Hokuto; Koga, Kazuki; Takemoto, Kazuhiro			Vulnerability of deep neural networks for detecting COVID-19 cases from chest X-ray images to universal adversarial attacks	PLOS ONE			English	Article							PNEUMONIA; DISEASES	Owing the epidemic of the novel coronavirus disease 2019 (COVID-19), chest X-ray computed tomography imaging is being used for effectively screening COVID-19 patients. The development of computer-aided systems based on deep neural networks (DNNs) has become an advanced open source to rapidly and accurately detect COVID-19 cases because the need for expert radiologists, who are limited in number, forms a bottleneck for screening. However, thus far, the vulnerability of DNN-based systems has been poorly evaluated, although realistic and high-risk attacks using universal adversarial perturbation (UAP), a single (input image agnostic) perturbation that can induce DNN failure in most classification tasks, are available. Thus, we focus on representative DNN models for detecting COVID-19 cases from chest X-ray images and evaluate their vulnerability to UAPs. We consider non-targeted UAPs, which cause a task failure, resulting in an input being assigned an incorrect label, and targeted UAPs, which cause the DNN to classify an input into a specific class. The results demonstrate that the models are vulnerable to non-targeted and targeted UAPs, even in the case of small UAPs. In particular, the 2% norm of the UAPs to the average norm of an image in the image dataset achieves >85% and >90% success rates for the non-targeted and targeted attacks, respectively. Owing to the non-targeted UAPs, the DNN models judge most chest X-ray images as COVID-19 cases. The targeted UAPs allow the DNN models to classify most chest X-ray images into a specified target class. The results indicate that careful consideration is required in practical applications of DNNs to COVID-19 diagnosis; in particular, they emphasize the need for strategies to address security concerns. As an example, we show that iterative fine-tuning of DNN models using UAPs improves the robustness of DNN models against UAPs.	[Hirano, Hokuto; Koga, Kazuki; Takemoto, Kazuhiro] Kyushu Inst Technol, Dept Biosci & Bioinformat, Iizuka, Fukuoka, Japan	Kyushu Institute of Technology	Takemoto, K (corresponding author), Kyushu Inst Technol, Dept Biosci & Bioinformat, Iizuka, Fukuoka, Japan.	takemoto@bio.kyutech.ac.jp	Takemoto, Kazuhiro/H-2915-2019	Takemoto, Kazuhiro/0000-0002-6355-1366				Afshar P., 2020, COVID CAPS CAPSULE N; Ahmed F, 2020, LANCET PUBLIC HEALTH, V5, pE240, DOI 10.1016/S2468-2667(20)30085-2; Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; [Anonymous], 2020, LANCET EDITORIAL, V2, pE268, DOI 10.1016/S2589-7500(20)30113-8; Carlini N., 2017, P 10 ACM WORKSHOP AR, P3, DOI [10.1145/3128572.3140444, DOI 10.1145/3128572.3140444]; Chen JY, 2019, COMPUT SECUR, V85, P89, DOI 10.1016/j.cose.2019.04.014; Co KT, 2019, PROCEEDINGS OF THE 2019 ACM SIGSAC CONFERENCE ON COMPUTER AND COMMUNICATIONS SECURITY (CCS'19), P275, DOI 10.1145/3319535.3345660; Cohen J.P., 2020, COVID 19 IMAGE DATA; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Fang YC, 2020, RADIOLOGY, V296, pE115, DOI 10.1148/radiol.2020200432; Farooq M., 2020, ARXIV; Finlayson SG, 2019, SCIENCE, V363, P1287, DOI 10.1126/science.aaw4399; Goodfellow Ian J., 2015, INT C LEARNING REPRE; HE KM, 2016, PROC CVPR IEEE, P770, DOI DOI 10.1109/CVPR.2016.90; Hirano H, 2020, P 25 INT S ART LIF R, P426; Hirano H, 2020, ALGORITHMS, V13, DOI 10.3390/a13110268; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Hwang U, 2019, IEEE ACCESS, V7, P126582, DOI 10.1109/ACCESS.2019.2939352; Kermany DS, 2018, CELL, V172, P1122, DOI 10.1016/j.cell.2018.02.010; Krizhevsky A., 2009, HDB SYSTEMIC AUTOIMM; Litjens G, 2017, MED IMAGE ANAL, V42, P60, DOI 10.1016/j.media.2017.07.005; Liu XX, 2019, LANCET DIGIT HEALTH, V1, pE271, DOI 10.1016/S2589-7500(19)30123-2; Lv D., 2020, CASCADE NETWORK DETE; Matyasko A, 2018, IMPROVED NETWORK ROB; Moosavi-Dezfooli SM, 2017, PROC CVPR IEEE, P86, DOI 10.1109/CVPR.2017.17; Moosavi-Dezfooli SM, 2016, PROC CVPR IEEE, P2574, DOI 10.1109/CVPR.2016.282; Nicolae M.-I., 2018, 180701069 CORR, V1807.01069; Rahimzadeh M, 2020, NEW MODIFIED DEEP CO; Rudin C, 2019, NAT MACH INTELL, V1, P206, DOI 10.1038/s42256-019-0048-x; Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y; Simon-Gabriel CJ, 2019, PR MACH LEARN RES, V97; Tartaglione E, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17186933; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; Wang L., 2020, ARXIV200309871, DOI 10.1038/s41598-020-76550-z; Wang LJ, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61138-4; Xiao C., 2020, P ICLR; Xie, 2020, ARXIV200313865; Yu T, 2019, ADV NEUR IN, V32; Yu XY, 2019, IEEE T NEUR NET LEAR, V30, P2805, DOI 10.1109/TNNLS.2018.2886017; Zhang JQ, 2020, KDD '20: PROCEEDINGS OF THE 26TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY & DATA MINING, P2831, DOI 10.1145/3394486.3403334; Zhang K, 2020, CELL, V181, P1423, DOI 10.1016/j.cell.2020.04.045; Zhao H, 2019, CHIN CONT DECIS CONF, P2483, DOI 10.1109/CCDC.2019.8832713	42	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243963	10.1371/journal.pone.0243963	http://dx.doi.org/10.1371/journal.pone.0243963			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332412	Green Published, Green Submitted, gold			2022-12-27	WOS:000601310900090
J	Sasaki, K; Harada, M				Sasaki, Ken; Harada, Mariko			Dopamine production in the brain is associated with caste-specific morphology and behavior in an artificial intermediate honey bee caste	PLOS ONE			English	Article							PRIMITIVELY EUSOCIAL WASP; APIS-MELLIFERA; JUVENILE-HORMONE; REPRODUCTIVE WORKERS; AMINO-ACIDS; DIFFERENTIATION; QUEENS; IMMUNOREACTIVITY; MECHANISMS; DOMINANCE	Caste polymorphism in eusocial insects is based on morphological plasticity and linked to physiological and behavioral characteristics. To test the possibility that dopamine production in the brain is associated with the caste-specific morphology and behavior in female honey bees, an intermediate caste was produced via artificial rearing using different amounts of diet, before quantifying the dopamine levels and conducting behavioral tests. In field colonies, individual traits such as mandibular shape, number of ovarioles, diameter of spermatheca, and dopamine levels in the brain differed significantly between workers and queens. Females given 1.5 times the amount of artificial diet that control worker receives during the larval stage in the laboratory had characteristics intermediate between castes. The dopamine levels in the brain were positively correlated with the mandibular shape indexes, number of ovarioles, and spermatheca diameter among artificially reared females. The dopamine levels were significantly higher in females with mandibular notches than those without. In fighting experiments with the intermediate caste females, the winners had significantly higher dopamine levels in the brain than the losers. Brain levels of tyrosine were positively correlated with those of catecholamines but not phenolamines, thereby suggesting a strong metabolic relationship between tyrosine and dopamine. Thus, the caste-specific characteristics of the honey bee are potentially continuous in the same manner as those in primitively eusocial species. Dopamine production in the brain is associated with the continuous caste-specific morphology, as well as being linked to the amount of tyrosine taken from food, and it supports the aggressive behavior of queen-type females.	[Sasaki, Ken; Harada, Mariko] Tamagawa Univ, Dept Bioresource Sci, Machida, Tokyo, Japan; [Sasaki, Ken] Tamagawa Univ, Honeybee Sci Res Ctr, Machida, Tokyo, Japan; [Harada, Mariko] Res Inst Anim Sci Biochem & Technol, Midori Ku, Sagamihara, Kanagawa, Japan		Sasaki, K (corresponding author), Tamagawa Univ, Dept Bioresource Sci, Machida, Tokyo, Japan.; Sasaki, K (corresponding author), Tamagawa Univ, Honeybee Sci Res Ctr, Machida, Tokyo, Japan.	sasakik@agr.tamagawa.ac.jp		Sasaki, Ken/0000-0003-3515-2170	Japan Society for the Promotion of Science (JSPS) KAKENHI [JP17K07491, JP20K06077]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI grant numbers JP17K07491 (https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-17K07491/) and JP20K06077 (https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-20K06077/) to KS.	Alekseyenko OV, 2013, P NATL ACAD SCI USA, V110, P6151, DOI 10.1073/pnas.1303446110; Ali DW, 1997, J EXP BIOL, V200, P1941; [Anonymous], 1971, INSECT SOC; ASENCOT M, 1976, LIFE SCI, V18, P693, DOI 10.1016/0024-3205(76)90180-6; BAILEY L, 1952, J EXP BIOL, V29, P310; Beggs KT, 2007, P NATL ACAD SCI USA, V104, P2460, DOI 10.1073/pnas.0608224104; Bloch G, 2000, J COMP PHYSIOL A, V186, P261, DOI 10.1007/s003590050426; Boulay R, 2001, PHYSIOL ENTOMOL, V26, P294, DOI 10.1046/j.0307-6962.2001.00250.x; BRANDES C, 1990, COMP BIOCHEM PHYS C, V97, P53, DOI 10.1016/0742-8413(90)90171-5; Burrows M., 1996, NEUROBIOLOGY INSECT; Capella ICS, 1998, J INSECT PHYSIOL, V44, P385, DOI 10.1016/S0022-1910(98)00027-4; Corona M, 2016, CURR OPIN INSECT SCI, V13, P55, DOI 10.1016/j.cois.2015.12.003; Crailsheim K, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.05; Dallacqua RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098088; De Souza DA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123663; DEWILDE J, 1982, ADV INSECT PHYSIOL, V16, P167; DOGRA GS, 1977, Z NATURFORSCH C, V32, P637; Dombroski TCD, 2003, APIDOLOGIE, V34, P281, DOI 10.1051/apido:2003024; Farkhary SI, 2019, J INSECT BEHAV, V32, P218, DOI 10.1007/s10905-019-09728-7; Farkhary S, 2017, J INSECT BEHAV, V30, P717, DOI 10.1007/s10905-017-9650-0; Gotoh A, 2013, APIDOLOGIE, V44, P133, DOI 10.1007/s13592-012-0165-6; Harano K, 2008, PHYSIOL ENTOMOL, V33, P395, DOI 10.1111/j.1365-3032.2008.00644.x; HARRIS JW, 1995, COMP BIOCHEM PHYS C, V111, P271, DOI 10.1016/0742-8413(95)00048-S; Hartfelder K., 2005, P651; HAYDAK MH, 1970, ANNU REV ENTOMOL, V15, P143, DOI 10.1146/annurev.en.15.010170.001043; Hoffmann I, 1960, BEE WORLD, V41, P10, DOI [10.1080/0005772X.1960.11096760, DOI 10.1080/0005772X.1960.11096760]; Hrassnigg N, 2003, AMINO ACIDS, V24, P205, DOI 10.1007/s00726-002-0311-y; Kaftanoglu O, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.9601; Kamakura M, 2011, NATURE, V473, P478, DOI 10.1038/nature10093; Kokay IC, 1997, J COMP PHYSIOL A, V181, P415, DOI 10.1007/s003590050125; Laidlaw HH., 1997, QUEEN REARING BEE BR; Leimar O, 2012, ECOL EVOL, V2, P3098, DOI 10.1002/ece3.414; LIVINGSTONE MS, 1983, NATURE, V303, P67, DOI 10.1038/303067a0; Matsuyama S, 2015, GEN COMP ENDOCR, V211, P1, DOI 10.1016/j.ygcen.2014.11.005; MICHENER CD, 1974, SOCIAL BEHAV BEES; Mutti NS, 2011, J EXP BIOL, V214, P3977, DOI 10.1242/jeb.061499; Okada Y, 2015, J EXP BIOL, V218, P1091, DOI 10.1242/jeb.118414; Patel A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000509; Penick CA, 2014, J EXP BIOL, V217, P1496, DOI 10.1242/jeb.098301; REMBOLD H, 1974, J INSECT PHYSIOL, V20, P1193, DOI 10.1016/0022-1910(74)90225-X; Sasaki K, 2001, J INSECT PHYSIOL, V47, P1205, DOI 10.1016/S0022-1910(01)00105-6; Sasaki K, 2007, J INSECT PHYSIOL, V53, P940, DOI 10.1016/j.jinsphys.2007.03.006; Sasaki K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206624; Sasaki K, 2017, J INSECT PHYSIOL, V103, P107, DOI 10.1016/j.jinsphys.2017.10.013; Sasaki K, 2016, J INSECT PHYSIOL, V87, P45, DOI 10.1016/j.jinsphys.2016.02.003; Sasaki K, 2012, GEN COMP ENDOCR, V178, P46, DOI 10.1016/j.ygcen.2012.04.006; Sasaki K, 2009, NATURWISSENSCHAFTEN, V96, P625, DOI 10.1007/s00114-009-0510-4; SCHAFER S, 1989, J COMP NEUROL, V280, P43, DOI 10.1002/cne.902800105; SCHURMANN FW, 1989, CELL TISSUE RES, V256, P399, DOI 10.1007/BF00218898; Shimoji H, 2017, BEHAV ECOL SOCIOBIOL, V71, DOI 10.1007/s00265-016-2263-3; SHUEL RW, 1978, J APICULT RES, V17, P57, DOI 10.1080/00218839.1978.11099904; Snodgrass R.E., 1956, ANATOMY HONEY BEE; TAYLOR DJ, 1992, J COMP PHYSIOL A, V170, P715, DOI 10.1007/BF00198982; Tedjakumala SR, 2017, FRONT SYST NEUROSCI, V11, DOI 10.3389/fnsys.2017.00047; Townsend GF, 1940, BIOCHEM J, V34, P1155, DOI 10.1042/bj0341155; VANDENBERG JD, 1987, J APICULT RES, V26, P90, DOI 10.1080/00218839.1987.11100743; Vaughan P.F.T., 1988, P124; Vergoz V, 2012, INSECT MOL BIOL, V21, P21, DOI 10.1111/j.1365-2583.2011.01106.x; Waddell S, 2010, TRENDS NEUROSCI, V33, P457, DOI 10.1016/j.tins.2010.07.001; Weaver N., 1974, Journal apic Res, V13, P3; Winston M.L., 1991, BIOL HONEY BEE; Wu LM, 2009, J FOOD COMPOS ANAL, V22, P242, DOI 10.1016/j.jfca.2008.10.022	62	5	5	6	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0244140	10.1371/journal.pone.0244140	http://dx.doi.org/10.1371/journal.pone.0244140			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332426	Green Published, gold			2022-12-27	WOS:000601310900114
J	Xue, JX; Thomas, L; Rieg, JDA; Fenton, RA; Rieg, T				Xue, Jianxiang; Thomas, Linto; Dominguez Rieg, Jessica A.; Fenton, Robert A.; Rieg, Timo			Genetic deletion of connexin 37 causes polyuria and polydipsia	PLOS ONE			English	Article							SODIUM-CHLORIDE COTRANSPORTER; GAP-JUNCTION PROTEIN; PLASMA-MEMBRANE; COLLECTING DUCT; RENIN SECRETION; DIETARY SALT; VASOPRESSIN; EXPRESSION; KIDNEY; WATER	The connexin 37 (Cx37) channel is clustered at gap junctions between cells in the renal vasculature or the renal tubule where it is abundant in basolateral cell interdigitations and infoldings of epithelial cells in the proximal tubule, thick ascending limb, distal convoluted tubule and collecting duct; however, physiological data regarding its role are limited. In this study, we investigated the role of Cx37 in fluid homeostasis using mice with a global deletion of Cx37 (Cx37(-/-) mice). Under baseline conditions, Cx37(-/-) had similar to 40% higher fluid intake associated with similar to 40% lower urine osmolality compared to wild-type (WT) mice. No differences were observed between genotypes in urinary adenosine triphosphate or prostaglandin E2, paracrine factors that alter renal water handling. After 18-hours of water deprivation, plasma aldosterone and urine osmolality increased significantly in Cx37(-/-) and WT mice; however, the latter remained similar to 375 mmol/kg lower in Cx37(-/-) mice, an effect associated with a more pronounced body weight loss despite higher urinary AVP/creatinine ratios compared to WT mice. Consistent with this, fluid intake in the first 3 hours after water deprivation was 37% greater in Cx37(-/-) vs WT mice. Cx37(-/-) mice showed significantly lower renal AQP2 abundance and AQP2 phosphorylation at serine 256 than WT mice in response to vehicle or dDAVP, suggesting a partial contribution of the kidney to the lower urine osmolality. The abundance and responses of the vasopressin V-2 receptor, AQP3, NHE3, NKCC2, NCC, H+-ATPase, alpha ENaC, gamma ENaC or Na+/K+-ATPase were not significantly different between genotypes. In summary, these results demonstrate that Cx37 is important for body water handling.	[Xue, Jianxiang; Thomas, Linto; Dominguez Rieg, Jessica A.; Rieg, Timo] Univ S Florida, Morsani Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33620 USA; [Fenton, Robert A.] Aarhus Univ, Dept Biomed, Aarhus, Denmark	State University System of Florida; University of South Florida; Aarhus University	Rieg, T (corresponding author), Univ S Florida, Morsani Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33620 USA.	trieg@usf.edu	Fenton, Robert A/ABD-9824-2021; Fenton, Robert/AFR-6983-2022	Fenton, Robert/0000-0003-1623-199X; Rieg, Timo/0000-0001-6082-662X; Thomas, Linto/0000-0003-3344-1307	National Institute of Diabetes and Digestive and Kidney Diseases [1R01DK110621]; American Heart Association Transformational Research Award [19TPA34850116]; LeDucq Foundation; Danish Medical Research Council; Novo Nordisk Foundation; American Heart Association predoctoral fellowship [18PRE33990236];  [19POST34400026]	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Heart Association Transformational Research Award(American Heart Association); LeDucq Foundation(Leducq Foundation); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); American Heart Association predoctoral fellowship(American Heart Association); 	This work was supported by the National Institute of Diabetes and Digestive and Kidney Diseases grant 1R01DK110621 (to Dr. Rieg) and American Heart Association Transformational Research Award 19TPA34850116 (to Dr. Rieg). Funding (to Dr. Fenton) was provided by the LeDucq Foundation, the Danish Medical Research Council, and the Novo Nordisk Foundation. Mr. Xue was supported by an American Heart Association predoctoral fellowship (18PRE33990236) and Dr. Thomas by a postdoctoral fellowship (19POST34400026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed A, 2014, KIDNEY INT, V86, P768, DOI 10.1038/ki.2014.108; Alikhani M., 2007, AM J PHYSIOL, V292, pC850, DOI 10.1152/ajpce11.00356.2006; BARAJAS L, 1994, KIDNEY INT, V46, P621, DOI 10.1038/ki.1994.314; BARLOW ED, 1959, Q J MED, V28, P235; BUTTERWECK A, 1994, J MEMBRANE BIOL, V141, P247; Cadnapaphornchai MA, 2003, AM J PHYSIOL-RENAL, V285, pF965, DOI 10.1152/ajprenal.00085.2003; Cherian PP, 2005, MOL BIOL CELL, V16, P3100, DOI 10.1091/mbc.E04-10-0912; Collings A, 2008, CLIN CHEM LAB MED, V46, P1102, DOI 10.1515/CCLM.2008.216; Condorelli DF, 2003, EUR J NEUROSCI, V18, P1807, DOI 10.1046/j.1460-9568.2003.02910.x; COSTALES M, 1984, J PHYSIOL-LONDON, V352, P467, DOI 10.1113/jphysiol.1984.sp015303; Fang JS, 2011, AM J PHYSIOL-HEART C, V301, pH1872, DOI 10.1152/ajpheart.00683.2011; Fenton RA, 2008, CURR OPIN NEPHROL HY, V17, P513, DOI 10.1097/MNH.0b013e3283050969; Fenton RA, 2007, PHYSIOL REV, V87, P1083, DOI 10.1152/physrev.00053.2006; Fenton RA, 2007, AM J PHYSIOL-RENAL, V293, pF748, DOI 10.1152/ajprenal.00316.2006; Fenton RA, 2020, AM J PHYSIOL-CELL PH, V319, pC1, DOI 10.1152/ajpcell.00150.2020; Fenton RA, 2017, KIDNEY INT, V92, P397, DOI 10.1016/j.kint.2017.02.001; Fenton RA, 2015, AM J PHYSIOL-RENAL, V308, pF1409, DOI 10.1152/ajprenal.00129.2015; Fenton RA, 2014, J AM SOC NEPHROL, V25, P2822, DOI 10.1681/ASN.2013101102; Gooch JL, 2006, J CELL SCI, V119, P2468, DOI 10.1242/jcs.02971; Goodenough DA, 1996, ANNU REV BIOCHEM, V65, P475, DOI 10.1146/annurev.bi.65.070196.002355; Gu Y, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1493-8; Haefliger JA, 2006, J CLIN INVEST, V116, P405, DOI 10.1172/JCI23327; HAEFLIGER JA, 1992, J BIOL CHEM, V267, P2057; Hanner F, 2008, CELL COMMUN ADHES, V15, P219, DOI 10.1080/15419060802013836; Hanner F, 2008, AM J PHYSIOL-REG I, V295, pR371, DOI 10.1152/ajpregu.00468.2007; Hanner F, 2010, AM J PHYSIOL-REG I, V298, pR1143, DOI 10.1152/ajpregu.00808.2009; Hills CE, 2006, AM J PHYSIOL-RENAL, V291, pF1045, DOI 10.1152/ajprenal.00344.2005; Hisaki H, 2012, AM J PHYSIOL-RENAL, V303, pF1049, DOI 10.1152/ajprenal.00047.2012; Hoffert JD, 2008, J BIOL CHEM, V283, P24617, DOI 10.1074/jbc.M803074200; Jr1 HRF, 1995, AM J PHYSL 1, V269, pL318; Just A, 2009, J AM SOC NEPHROL, V20, P1577, DOI 10.1681/ASN.2008090943; Just AW C, 2010, ACTA PHYSL OXF, V198; Kavvadas P, 2017, J AM SOC NEPHROL, V28, P2915, DOI 10.1681/ASN.2016111211; Kennedy CRJ, 2007, AM J PHYSIOL-RENAL, V292, pF868, DOI 10.1152/ajprenal.00183.2005; Kong J, 2008, J AM SOC NEPHROL, V19, P2396, DOI 10.1681/ASN.2008010011; KUHN K, 1975, CELL TISSUE RES, V160, P193; Kurtz L, 2009, J AM SOC NEPHROL, V20, P506, DOI 10.1681/ASN.2008030252; Masilamani S, 1999, J CLIN INVEST, V104, pR19, DOI 10.1172/JCI7840; McCulloch F, 2005, AM J PHYSIOL-RENAL, V289, pF1304, DOI 10.1152/ajprenal.00203.2005; Moeller HB, 2013, ENDOCR REV, V34, P278, DOI 10.1210/er.2012-1044; NIELSEN S, 1995, P NATL ACAD SCI USA, V92, P1013, DOI 10.1073/pnas.92.4.1013; Olesen ETB, 2017, AM J PHYSIOL-RENAL, V312, pF744, DOI 10.1152/ajprenal.00010.2017; Olesen ETB, 2013, J AM SOC NEPHROL, V24, P169, DOI 10.1681/ASN.2012020217; Olesen ETB, 2011, P NATL ACAD SCI USA, V108, P12949, DOI 10.1073/pnas.1104691108; Oppermann M, 2013, AM J PHYSIOL-RENAL, V304, pF1181, DOI 10.1152/ajprenal.00721.2012; PAUL DL, 1991, J CELL BIOL, V115, P1077, DOI 10.1083/jcb.115.4.1077; Pedersen NB, 2010, KIDNEY INT, V78, P160, DOI 10.1038/ki.2010.130; Poulsen SB, 2018, CLIN SCI, V132, P1779, DOI 10.1042/CS20180060; Poulsen SB, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91042; PRICAM C, 1974, LAB INVEST, V30, P286; Rao R, 2010, J AM SOC NEPHROL, V21, P428, DOI 10.1681/ASN.2009060672; Rieg JAD, 2015, ACTA PHYSIOL, V213, P628, DOI 10.1111/apha.12446; Rieg JAD, 2016, LAB INVEST, V96, P98, DOI 10.1038/labinvest.2015.129; Rieg T, 2007, KIDNEY INT, V72, P566, DOI 10.1038/sj.ki.5002369; Rieg T, 2007, FASEB J, V21, P3717, DOI 10.1096/fj.07-8807com; Rieg T, 2013, AM J PATHOL, V182, P96, DOI 10.1016/j.ajpath.2012.09.014; Rieg T, 2010, J AM SOC NEPHROL, V21, P2059, DOI 10.1681/ASN.2010040409; SABOLIC I, 1995, J MEMBRANE BIOL, V143, P165, DOI 10.1007/BF00233445; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; SAINIO K, 1992, DEVELOPMENT, V115, P827; Seul KH, 2000, MICROVASC RES, V59, P140, DOI 10.1006/mvre.1999.2216; Sipos A, 2009, J AM SOC NEPHROL, V20, P1724, DOI 10.1681/ASN.2008101099; Sohl G, 2004, CARDIOVASC RES, V62, P228, DOI 10.1016/j.cardiores.2003.11.013; Sorensen CM, 2012, AM J PHYSIOL-RENAL, V303, pF855, DOI 10.1152/ajprenal.00026.2012; Sorensen MV, 2013, KIDNEY INT, V83, P811, DOI 10.1038/ki.2013.14; Srinivas M, 2018, BBA-BIOMEMBRANES, V1860, P192, DOI 10.1016/j.bbamem.2017.04.024; Stoessel A, 2010, AM J PHYSIOL-RENAL, V298, pF216, DOI 10.1152/ajprenal.00295.2009; Thomas L, 2019, J AM SOC NEPHROL, V30, P2128, DOI 10.1681/ASN.2018121250; Tsumura K, 2006, AM J PHYSIOL-RENAL, V290, pF478, DOI 10.1152/ajprenal.00029.2005; TUCKER MA, 1994, EXP CELL RES, V213, P224, DOI 10.1006/excr.1994.1194; Vallon V, 2011, AM J PHYSIOL-RENAL, V301, pF463, DOI 10.1152/ajprenal.00236.2011; Wagner C, 2008, KIDNEY INT, V73, P547, DOI 10.1038/sj.ki.5002720; Wagner C, 2009, PFLUG ARCH EUR J PHY, V459, P151, DOI 10.1007/s00424-009-0707-6; Willecke K, 2002, BIOL CHEM, V383, P725, DOI 10.1515/BC.2002.076; Wong CW, 2006, NAT MED, V12, P950, DOI 10.1038/nm1441; Xue JX, 2020, CLIN SCI, V134, P941, DOI 10.1042/CS20200065; YAMAMOTO T, 1995, AM J PHYSIOL-CELL PH, V268, pC1546, DOI 10.1152/ajpcell.1995.268.6.C1546; Yang BX, 2001, J BIOL CHEM, V276, P2775, DOI 10.1074/jbc.M008216200; Zhang JH, 2005, KIDNEY INT, V68, P1171, DOI 10.1111/j.1523-1755.2005.00509.x; ZHANG JT, 1989, J CELL BIOL, V109, P3391, DOI 10.1083/jcb.109.6.3391; Zheng-Fischhofer Q, 2007, EUR J CELL BIOL, V86, P683, DOI 10.1016/j.ejcb.2007.01.005	81	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0244251	10.1371/journal.pone.0244251	http://dx.doi.org/10.1371/journal.pone.0244251			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332450	Green Published, gold			2022-12-27	WOS:000601310900094
J	Province, HS; Xiao, CY; Mogul, AS; Sahoo, A; Jacobson, KA; Pinol, RA; Gavrilova, O; Reitman, ML				Province, Haley S.; Xiao, Cuiying; Mogul, Allison S.; Sahoo, Ankita; Jacobson, Kenneth A.; Pinol, Ramon A.; Gavrilova, Oksana; Reitman, Marc L.			Activation of neuronal adenosine A(1) receptors causes hypothermia through central and peripheral mechanisms	PLOS ONE			English	Article							BODY-TEMPERATURE; MICE LACKING; AGONISTS; TORPOR; SLEEP	Extracellular adenosine, a danger signal, can cause hypothermia. We generated mice lacking neuronal adenosine A(1) receptors (A(1)AR, encoded by the Adora1 gene) to examine the contribution of these receptors to hypothermia. Intracerebroventricular injection of the selective A(1)AR agonist (Cl-ENBA, 5'-chloro-5'-deoxy-N-6-endo-norbornyladenosine) produced hypothermia, which was reduced in mice with deletion of A(1)AR in neurons. A non-brain penetrant A(1)AR agonist [SPA, N-6-(p-sulfophenyl) adenosine] also caused hypothermia, in wild type but not mice lacking neuronal A(1)AR, suggesting that peripheral neuronal A(1)AR can also cause hypothermia. Mice expressing Cre recombinase from the Adora1 locus were generated to investigate the role of specific cell populations in body temperature regulation. Chemogenetic activation of Adora1-Cre-expressing cells in the preoptic area did not change body temperature. In contrast, activation of Adora1-Cre-expressing dorsomedial hypothalamus cells increased core body temperature, concordant with agonism at the endogenous inhibitory A(1)AR causing hypothermia. These results suggest that A(1)AR agonism causes hypothermia via two distinct mechanisms: brain neuronal A(1)AR and A(1)AR on neurons outside the blood-brain barrier. The variety of mechanisms that adenosine can use to induce hypothermia underscores the importance of hypothermia in the mouse response to major metabolic stress or injury.	[Province, Haley S.; Xiao, Cuiying; Mogul, Allison S.; Pinol, Ramon A.; Reitman, Marc L.] NIDDK, Diabet Endocrinol & Obes Branch, NIH, Bethesda, MD 20892 USA; [Sahoo, Ankita; Gavrilova, Oksana] NIDDK, Mouse Metab Core, NIH, Bethesda, MD 20892 USA; [Jacobson, Kenneth A.] NIDDK, Lab Bioorgan Chem, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Reitman, ML (corresponding author), NIDDK, Diabet Endocrinol & Obes Branch, NIH, Bethesda, MD 20892 USA.	marc.reitman@nih.gov	Jacobson, Kenneth Alan/A-1530-2009; Reitman, Marc/B-4448-2013	Jacobson, Kenneth Alan/0000-0001-8104-1493; Reitman, Marc/0000-0002-0426-9475; Pinol, Ramon/0000-0002-8877-8444	Intramural Research Program of the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [ZIA DK075062, ZIA DK075063, ZIA DK070002]	Intramural Research Program of the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported in part by the Intramural Research Program of the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (ZIA DK075062 and ZIA DK075063 to MLR and ZIA DK070002 to OG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R, 1994, BRIT J PHARMACOL, V113, P1386, DOI 10.1111/j.1476-5381.1994.tb17151.x; [Anonymous], 2010, SCRIBES J LEGAL WRIT, V13, P133; [Anonymous], 2011, PERSPECTIVES SCI CHR, V63, P1; [Anonymous], 2020, J GYNECOL ONCOL, V31, pe69; Arrich J, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004128.pub4; Bennet DW, 1931, J PHYSIOL-LONDON, V72, P288, DOI 10.1113/jphysiol.1931.sp002775; Boison D, 2010, CELL DEATH DIFFER, V17, P1071, DOI 10.1038/cdd.2009.131; Borea PA, 2018, PHYSIOL REV, V98, P1591, DOI 10.1152/physrev.00049.2017; Carlin JL, 2018, NEUROPHARMACOLOGY, V139, P268, DOI 10.1016/j.neuropharm.2018.02.035; Carlin JL, 2017, NEUROPHARMACOLOGY, V114, P101, DOI 10.1016/j.neuropharm.2016.11.026; Carlin JL, 2016, J PHARMACOL EXP THER, V356, P474, DOI 10.1124/jpet.115.229872; CLARK WG, 1987, NEUROSCI BIOBEHAV R, V11, P35, DOI 10.1016/S0149-7634(87)80003-9; Drew Kelly L, 2015, Temperature (Austin), V2, P168, DOI 10.4161/23328940.2014.976512; Eisner C, 2017, PFLUG ARCH EUR J PHY, V469, P339, DOI 10.1007/s00424-016-1925-3; FASTBOM J, 1987, NEUROSCIENCE, V22, P813, DOI 10.1016/0306-4522(87)92961-7; Frare C, 2019, J NEUROCHEM, V151, P316, DOI 10.1111/jnc.14814; Fredholm BB, 2014, J MOL MED, V92, P201, DOI 10.1007/s00109-013-1101-6; Glukhova A, 2017, CELL, V168, P867, DOI 10.1016/j.cell.2017.01.042; Hackett TA, 2018, ANAT REC, V301, P1882, DOI 10.1002/ar.23907; Hrvatin S, 2020, NATURE, V583, P115, DOI 10.1038/s41586-020-2387-5; Iliff BW, 2012, AM J PHYSIOL-REG I, V303, pR477, DOI 10.1152/ajpregu.00081.2012; JACOBSON KA, 1992, J MED CHEM, V35, P4143, DOI 10.1021/jm00100a020; Jain S, 2018, AM J PHYSIOL-ENDOC M, V315, pE357, DOI 10.1152/ajpendo.00024.2018; Johansson B, 2001, P NATL ACAD SCI USA, V98, P9407, DOI 10.1073/pnas.161292398; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; Lima FO, 2010, PAIN, V151, P506, DOI 10.1016/j.pain.2010.08.014; Lute B, 2014, CELL METAB, V20, P333, DOI 10.1016/j.cmet.2014.05.021; Machado NLS, 2020, J NEUROSCI, V40, P2573, DOI 10.1523/JNEUROSCI.2887-19.2020; Morrison SF, 2019, ANNU REV PHYSIOL, V81, P285, DOI 10.1146/annurev-physiol-020518-114546; MOSER GH, 1989, AM J PHYSIOL, V256, pC799, DOI 10.1152/ajpcell.1989.256.4.C799; Pinol RA, 2018, NAT NEUROSCI, V21, P1530, DOI 10.1038/s41593-018-0249-3; Salvatore CA, 2000, J BIOL CHEM, V275, P4429, DOI 10.1074/jbc.275.6.4429; Sangsiri S, 2013, J PHARMACOL EXP THER, V345, P32, DOI 10.1124/jpet.112.199612; Scammell TE, 2003, J NEUROSCI, V23, P5762; Searl TJ, 2016, J PHARMACOL EXP THER, V356, P116, DOI 10.1124/jpet.115.228882; SEBASTIAO AM, 1990, BRIT J PHARMACOL, V101, P453, DOI 10.1111/j.1476-5381.1990.tb12729.x; Shintani M, 2005, J PHARMACOL SCI, V97, P451, DOI 10.1254/jphs.SC0040178; Silvani A, 2018, PHYSIOLOGY, V33, P182, DOI 10.1152/physiol.00007.2018; Sun DQ, 2001, P NATL ACAD SCI USA, V98, P9983, DOI 10.1073/pnas.171317998; Szymczak-Workman Andrea L, 2012, Cold Spring Harb Protoc, V2012, P199, DOI 10.1101/pdb.ip067876; Takahashi TM, 2020, NATURE, V583, P109, DOI 10.1038/s41586-020-2163-6; Tan CL, 2018, NEURON, V98, P31, DOI 10.1016/j.neuron.2018.02.022; Tan CL, 2016, CELL, V167, P47, DOI 10.1016/j.cell.2016.08.028; TICHO SR, 1991, PHARMACOL BIOCHEM BE, V40, P33, DOI 10.1016/0091-3057(91)90317-U; Tupone D, 2013, J NEUROSCI, V33, P14512, DOI 10.1523/JNEUROSCI.1980-13.2013; Varani K, 2017, ADV EXP MED BIOL, V1051, P193, DOI 10.1007/5584_2017_61; Xiao CY, 2020, MOL METAB, V36, DOI 10.1016/j.molmet.2020.02.012; Xiao CY, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000161; Zaretskaia MV, 2002, BRAIN RES, V928, P113, DOI 10.1016/S0006-8993(01)03369-8; Zhang KX, 2020, NATURE, V585, P420, DOI 10.1038/s41586-020-2683-0; Zhao ZD, 2017, P NATL ACAD SCI USA, V114, P2042, DOI 10.1073/pnas.1616255114; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101	52	2	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243986	10.1371/journal.pone.0243986	http://dx.doi.org/10.1371/journal.pone.0243986			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326493	Green Published, gold			2022-12-27	WOS:000600176400053
J	Hanami, T; Tanabe, T; Hanashi, T; Yamaguchi, M; Nakata, H; Mitani, Y; Kimura, Y; Soma, T; Usui, K; Isobe, M; Ogawa, T; Itoh, M; Hayashizaki, Y; Kondo, S				Hanami, Takeshi; Tanabe, Tetsuya; Hanashi, Takuya; Yamaguchi, Mitsushiro; Nakata, Hidetaka; Mitani, Yasumasa; Kimura, Yasumasa; Soma, Takahiro; Usui, Kengo; Isobe, Michiko; Ogawa, Takashi; Itoh, Masayoshi; Hayashizaki, Yoshihide; Kondo, Seiji			Scanning single-molecule counting system for Eprobe with highly simple and effective approach	PLOS ONE			English	Article							INTENSITY DISTRIBUTION ANALYSIS; FLUORESCENCE DETECTION; DIAGNOSTICS	Here, we report a rapid and ultra-sensitive detection technique for fluorescent molecules called scanning single molecular counting (SSMC). The method uses a fluorescence-based digital measurement system to count single molecules in a solution. In this technique, noise is reduced by conforming the signal shape to the intensity distribution of the excitation light via a circular scan of the confocal region. This simple technique allows the fluorescent molecules to freely diffuse into the solution through the confocal region and be counted one by one and does not require statistical analysis. Using this technique, 28 to 62 aM fluorescent dye was detected through measurement for 600 s. Furthermore, we achieved a good signal-to-noise ratio (S/N = 2326) under the condition of 100 pM target nucleic acid by only mixing a hybridization-sensitive fluorescent probe, called Eprobe, into the target oligonucleotide solution. Combination of SSMC and Eprobe provides a simple, rapid, amplification-free, and high-sensitive target nucleic acid detection system. This method is promising for future applications to detect particularly difficult to design primers for amplification as miRNAs and other short oligo nucleotide biomarkers by only hybridization with high sensitivity.	[Hanami, Takeshi; Tanabe, Tetsuya; Hanashi, Takuya; Yamaguchi, Mitsushiro; Soma, Takahiro; Usui, Kengo; Itoh, Masayoshi] RIKEN Ctr Integrat Med Sci, Genet Diag Technol Unit, Yokohama, Kanagawa, Japan; [Hanami, Takeshi; Tanabe, Tetsuya; Hanashi, Takuya; Yamaguchi, Mitsushiro; Nakata, Hidetaka; Isobe, Michiko; Ogawa, Takashi; Itoh, Masayoshi; Kondo, Seiji] RIKEN Innovat Ctr, Wako, Saitama, Japan; [Tanabe, Tetsuya; Hanashi, Takuya; Yamaguchi, Mitsushiro; Nakata, Hidetaka; Kondo, Seiji] Olympus Corp, Med Technol R&D Div, Adv Anal Technol Dept, Hachioji, Tokyo, Japan; [Mitani, Yasumasa; Kimura, Yasumasa] KK DNAFORM, Yokohama, Kanagawa, Japan; [Itoh, Masayoshi; Hayashizaki, Yoshihide] RIKEN Prevent Med & Diag Innovat Program, Wako, Saitama, Japan	RIKEN; RIKEN; Olympus Corporation; RIKEN	Hanami, T; Tanabe, T (corresponding author), RIKEN Ctr Integrat Med Sci, Genet Diag Technol Unit, Yokohama, Kanagawa, Japan.; Hanami, T; Tanabe, T (corresponding author), RIKEN Innovat Ctr, Wako, Saitama, Japan.; Tanabe, T (corresponding author), Olympus Corp, Med Technol R&D Div, Adv Anal Technol Dept, Hachioji, Tokyo, Japan.	thanami@riken.jp; te_tanabe@ot.olympus.co.jp	Itoh, Masayoshi/N-5363-2015	Itoh, Masayoshi/0000-0002-1772-318X	RIKEN; Olympus Corporation under RIKEN Integrated Collaborative Research Program with Industry; MEXT; Olympus Corporation; K.K. DNAFORM	RIKEN; Olympus Corporation under RIKEN Integrated Collaborative Research Program with Industry; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Olympus Corporation; K.K. DNAFORM	This work was supported by a research grant from RIKEN and Olympus Corporation under RIKEN Integrated Collaborative Research Program with Industry to SK, a research grant from MEXT to the RIKEN Center for Integrative Medical Science to KU, MEXT to RIKEN Preventive Medicine and Diagnosis Innovation Program to YH. Olympus Corporation also provided funding for the study in the form of salaries for authors TT, T. Hanashi, MY, HN, and SK. Funding was also provided by K.K. DNAFORM, a company holding commercial rights to Eprobe technology, in the form of salaries for authors YM and YK. These funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Altamore I, 2013, MEAS SCI TECHNOL, V24, DOI 10.1088/0957-0233/24/6/065702; Baker M, 2012, NAT METHODS, V9, P541, DOI 10.1038/nmeth.2027; Borst A, 2004, EUR J CLIN MICROBIOL, V23, P289, DOI 10.1007/s10096-004-1100-1; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen Y, 1999, BIOPHYS J, V77, P553, DOI 10.1016/S0006-3495(99)76912-2; EIGEN M, 1994, P NATL ACAD SCI USA, V91, P5740, DOI 10.1073/pnas.91.13.5740; Fister JC, 1998, ANAL CHEM, V70, P431, DOI 10.1021/ac9707242; GOODWIN PM, 1993, NUCLEIC ACIDS RES, V21, P803, DOI 10.1093/nar/21.4.803; Hanami T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070942; Ikeda S, 2009, ANGEW CHEM INT EDIT, V48, P6480, DOI 10.1002/anie.200902000; Itoh M, 2007, KAGAKU TO SEIBUTSU, V47, P823; Kask P, 1999, P NATL ACAD SCI USA, V96, P13756, DOI 10.1073/pnas.96.24.13756; Kask P, 2000, BIOPHYS J, V78, P1703, DOI 10.1016/S0006-3495(00)76722-1; Keller RA, 1996, APPL SPECTROSC, V50, pA12, DOI 10.1366/0003702963905600; Kimura Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146950; Li HT, 2003, ANAL CHEM, V75, P1664, DOI 10.1021/ac026367z; Liao PY, 2017, MICROMACHINES-BASEL, V8, DOI 10.3390/mi8080231; Ma F, 2016, ACCOUNTS CHEM RES, V49, P1722, DOI 10.1021/acs.accounts.6b00237; Neely LA, 2006, NAT METHODS, V3, P41, DOI 10.1038/NMETH825; NIE SM, 1994, SCIENCE, V266, P1018, DOI 10.1126/science.7973650; Okamoto A, 2011, CHEM SOC REV, V40, P5815, DOI 10.1039/c1cs15025a; Pei XJ, 2018, ANAL CHEM, V90, P1376, DOI 10.1021/acs.analchem.7b04551; Quan PL, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18041271; Rigler R., 2001, FLUORESCENCE CORRELA; Sapkota K, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19163495; Satsoura D, 2007, CHEMPHYSCHEM, V8, P834, DOI 10.1002/cphc.200600589; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; SOPER SA, 1992, J OPT SOC AM B, V9, P1761, DOI 10.1364/JOSAB.9.001761; Tatulli G, 2020, NANOSCALE, V12, P15604, DOI 10.1039/d0nr03517c; Wabuyele MB, 2003, J AM CHEM SOC, V125, P6937, DOI 10.1021/ja034716g; Walt DR, 2013, ANAL CHEM, V85, P1258, DOI 10.1021/ac3027178; Wu AHB, 2006, CLIN CHEM, V52, P2157, DOI 10.1373/clinchem.2006.073163; Yamaguchi M, 2014, PROC SPIE, V8948, DOI 10.1117/12.2037645	33	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243319	10.1371/journal.pone.0243319	http://dx.doi.org/10.1371/journal.pone.0243319			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320908	Green Published, gold			2022-12-27	WOS:000600339800019
J	Chapman, TJ; Morris, MC; Xu, L; Pichichero, ME				Chapman, Timothy J.; Morris, Matthew C.; Xu, Lei; Pichichero, Michael E.			Nasopharyngeal colonization with pathobionts is associated with susceptibility to respiratory illnesses in young children	PLOS ONE			English	Article							ACUTE-OTITIS-MEDIA; BACTERIAL; RISK; MANAGEMENT; MICROBIOTA; INFECTION; DIAGNOSIS; ROCHESTER; SEVERITY; STRAINS	Some children are more susceptible to viral and bacterial respiratory infections in the first few years of life than others. However, the factors contributing to this susceptibility are incompletely understood. In a retrospective analysis of clinical samples collected from a prospectively-enrolled cohort of 358 children we sought associations between physician-attended illness visits and bacterial colonization in the first five years of life. A subset of children was identified by unsupervised clustering analysis as infection and allergy prone (IAP). Several respiratory infection- and allergy-mediated illnesses co-occurred at higher rates in IAP children, while the rates of other illnesses were not significantly different between the groups. Analyses of nasopharyngeal (NP) pathobionts and microbiota commensals showed that early age of first colonization with pathobionts Streptococcus pneumonia, non-typeable Haemophilus influenzae, and Moraxella catarrhalis was associated with IAP children, and particularly Moraxella abundance was negatively associated with NP microbiome diversity. We conclude that mucosal pathobiont exposures in early life can influence susceptibility to respiratory illnesses in children.	[Chapman, Timothy J.; Xu, Lei; Pichichero, Michael E.] Rochester Gen Hosp, Res Inst, Ctr Infect Dis & Immunol, Rochester, NY 14621 USA; [Morris, Matthew C.] Rochester Gen Hosp, Ctr Clin Syst Biol, Med Off Bldg, Rochester, NY 14621 USA	Rochester General Hospital; Rochester General Hospital	Pichichero, ME (corresponding author), Rochester Gen Hosp, Res Inst, Ctr Infect Dis & Immunol, Rochester, NY 14621 USA.	michael.pichichero@rochesterregional.org	Pichichero, Michael E/AID-7886-2022; Core, UNC Microbiome/AAB-3304-2022	Chapman, Timothy/0000-0002-2337-2136; Pichichero, Michael/0000-0002-8276-3938	NIH NIDCD [R01 08671]	NIH NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was funded in part by NIH NIDCD R01 08671 to MEP.	[Anonymous], 2019, AESTHET SURG J S1, V38, pS1; Armbruster CE, 2010, MBIO, V1, DOI 10.1128/mBio.00102-10; Biesbroek G, 2014, AM J RESP CRIT CARE, V190, P1283, DOI 10.1164/rccm.201407-1240OC; Bisgaard H, 2007, NEW ENGL J MED, V357, P1487, DOI 10.1056/NEJMoa052632; Bokulich NA, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0470-z; Bradley JS, 2011, CLIN INFECT DIS, V53, pE25, DOI [10.1093/cid/cir531, 10.1093/cid/cir625]; Budden KF, 2019, LANCET RESP MED, V7, P907, DOI 10.1016/S2213-2600(18)30510-1; Chonmaitree T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180630; Dagan R, 2016, LANCET INFECT DIS, V16, P480, DOI 10.1016/S1473-3099(15)00549-6; de Goffau MC, 2019, NATURE, V572, P329, DOI 10.1038/s41586-019-1451-5; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Dumas A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02656; Friedel V, 2013, PEDIATR INFECT DIS J, V32, P27, DOI 10.1097/INF.0b013e31826f6144; Hauk L, 2014, AM FAM PHYSICIAN, V89, P676; Kalu SU, 2011, PEDIATR INFECT DIS J, V30, P95, DOI 10.1097/INF.0b013e3181f253d5; Kassambara A, 2019, **DATA OBJECT**; Kaur R, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-0181; Kaur R, 2016, PEDIATR INFECT DIS J, V35, P901, DOI 10.1097/INF.0000000000001206; Ladogana S, 2017, BLOOD TRANSFUS-ITALY, V15, P259, DOI 10.2450/2016.0072-16; Lieberthal AS, 2013, PEDIATRICS, V131, pE964, DOI 10.1542/peds.2012-3488; Lloyd CM, 2017, IMMUNITY, V46, P549, DOI 10.1016/j.immuni.2017.04.005; Mahr TA, 2005, PEDIATR REV, V26, P284, DOI 10.1542/pir.26-8-284; Murray P, 2003, MANUAL CLIN MICROBIO, V412-429, P770; Navne JE, 2016, EPIDEMIOL INFECT, V144, P3226, DOI 10.1017/S0950268816001461; Negi S, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01142; Papadopoulos NG, 2012, ALLERGY, V67, P976, DOI 10.1111/j.1398-9995.2012.02865.x; Patel JA, 2009, PEDIATR INFECT DIS J, V28, P1002, DOI 10.1097/INF.0b013e3181aa5b13; Pichichero ME, 2020, J INFECTION, V80, P614, DOI 10.1016/j.jinf.2020.03.017; Pichichero ME, 2016, PEDIATR INFECT DIS J, V35, P1033, DOI 10.1097/INF.0000000000001217; Pichichero ME, 2016, PEDIATR INFECT DIS J, V35, P1027, DOI 10.1097/INF.0000000000001216; Pichichero ME, 2013, PEDIATR INFECT DIS J, V32, P1163, DOI 10.1097/INF.0b013e31829e887e; Piters WAAD, 2016, AM J RESP CRIT CARE, V194, P1104, DOI 10.1164/rccm.201602-0220OC; R Development Core Team, 2009, R LANG ENV STAT COMP; Ren DB, 2019, CLIN INFECT DIS, V68, P1566, DOI 10.1093/cid/ciy750; Ruohola A, 2013, J INFECTION, V66, P247, DOI 10.1016/j.jinf.2012.12.002; Teo SM, 2015, CELL HOST MICROBE, V17, P704, DOI 10.1016/j.chom.2015.03.008; Therneau T.M., 2020, PACKAGE SURVIVAL SUR, DOI DOI 10.1198/TECH.2004.S740; Therneau TM., 2000, MODELING SURVIVAL DA; Tollefson MM, 2014, PEDIATRICS, V134, pE1735, DOI 10.1542/peds.2014-2812; Wypych TP, 2019, NAT IMMUNOL, V20, P1279, DOI 10.1038/s41590-019-0451-9; Xu QF, 2012, PEDIATR INFECT DIS J, V31, P638, DOI 10.1097/INF.0b013e31824ba6f7; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Yatsyshina S, 2016, DIAGN MICR INFEC DIS, V85, P125, DOI 10.1016/j.diagmicrobio.2016.02.010	43	6	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243942	10.1371/journal.pone.0243942	http://dx.doi.org/10.1371/journal.pone.0243942			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306743	Green Published, gold			2022-12-27	WOS:000600144200004
J	Dumaidi, K; Qaraqe, H; Al-Jawabreh, A; Abu-Helu, R; Samarah, F; Al-Jawabreh, H				Dumaidi, Kamal; Qaraqe, Hayah; Al-Jawabreh, Amer; Abu-Helu, Rasmi; Samarah, Fekri; Al-Jawabreh, Hanan			Genetic diversity, haplotype analysis, and risk factor assessment of hepatitis A virus isolates from the West Bank, Palestine during the period between 2014 and 2016	PLOS ONE			English	Article							UNIVERSAL VACCINATION; MIDDLE-EAST; DNA; INFECTION; REGION; SEROPREVALENCE; EPIDEMIOLOGY; KOREA; AGE	Background Hepatitis A virus (HAV) infection is one of the major causes of acute viral hepatitis. HAV genotypes and its genetic diversity is rarely investigated in our region as well as worldwide. Aims The aims of the present study were to determine the HAV genotypes and its risk factors and to investigate the genetic diversity of the HAV isolates in the West Bank, Palestine. Study design A cohort of 161 clinically and laboratory-confirmed HAV (IgM-positive) cases and 170 apparently healthy controls from all the districts of the West Bank, Palestine during the period of 2014 to 2016 were tested for HAV infection using IgM antibodies, RT-PCR and sequence analysis of the VP3/VP1 junction region of the HAV genome. Phylogenetic analysis, genetic diversity and haplotypes analysis were used to characterize the VP3/VP1 sequences. Results All the 34 sequences of the HAV were found to be of HAV-IB sub-genotype. The phylogenetic analysis showed four main clusters with cluster III exclusively consisting of 18 Palestinian isolates (18/23-78%), but with weak bootstrap values. A high haplotype diversity (Hd) and low nucleotide diversity (pi) were observed. Cluster III showed high number of haplotypes (h = 8), but low haplotype (gene) diversity (Hd = 0.69). A total of 28 active haplotypes with some consisting of more than one sequence were observed using haplotype network analysis. The Palestinian haplotypes are characterized by closely related viral haplotypes with one SNV away from each other which ran parallel to cluster III in the phylogenetic tree. A smaller Palestinian haplotype (4 isolates) was three SNVs away from the major haplotype cluster (n = 10) and closer to others haplotypes from Iran, Spain, and South Africa. Young age, low level of parent's education, infrequent hand washing before meals, and drinking of un-treated water were considered the major HAV risk factors in the present study. Conclusion Haplotype network analysis revealed haplotype variation among the HAV Palestinian sequences despite low genetic variation and nucleotide diversity. In addition, this study reconfirmed that age and parent's level of education as HAV risk factors, while hand washing and treating drinking water as protective factors.	[Dumaidi, Kamal; Al-Jawabreh, Amer; Samarah, Fekri] Arab Amer Univ, Fac Allied Hlth Sci, Dept Med Lab Sci, Jenin, Palestine; [Qaraqe, Hayah] Palestinian Minist Hlth, Ramallah Primary Hlth Care, Ramallah, Palestine; [Al-Jawabreh, Amer; Al-Jawabreh, Hanan] Leishmaniases Res Unit, Jericho, Palestine; [Abu-Helu, Rasmi] Al Quds Univ, Fac Hlth Profess, Dept Med Lab Sci, Jerusalem, Palestine	Arab American University	Dumaidi, K (corresponding author), Arab Amer Univ, Fac Allied Hlth Sci, Dept Med Lab Sci, Jenin, Palestine.	Kamal.dumaidi@aaup.edu	Al-Jawabreh, Amer/I-9960-2019	Al-Jawabreh, Amer/0000-0001-5929-8743; samarah, fekri/0000-0003-2925-4875				[Anonymous], 2012, Wkly Epidemiol Rec, V87; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Battikhi MNG, 2004, MICROBIOLOGICA, V27, P215; Bellou M, 2013, FOOD ENVIRON VIROL, V5, P13, DOI 10.1007/s12560-012-9097-6; Bruni R, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2596-1; Cella E, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000009632; Cristina J, 2007, VIRUS RES, V127, P151, DOI 10.1016/j.virusres.2007.01.005; D'Andrea L, 2015, INT J MOL SCI, V16, P6842, DOI 10.3390/ijms16046842; de Almeida LM, 2002, T ROY SOC TROP MED H, V96, P605, DOI 10.1016/S0035-9203(02)90325-1; Dinc B, 2012, TURK J GASTROENTEROL, V23, P714, DOI 10.4318/tjg.2012.0450; Fiore AE, 2006, ADVISORY COMMITTEE I; FOULDS LR, 1979, J MOL EVOL, V13, P127, DOI 10.1007/BF01732868; Franco E, 2012, WORLD J HEPATOL, V4, P68, DOI 10.4254/wjh.v4.i3.68; Hayajneh WA, 2015, J MED VIROL, V87, P569, DOI 10.1002/jmv.24137; Heathcote J, 2007, MANAGEMENT ACUTE VIR; HUDSON RR, 1992, GENETICS, V132, P583; Hughes JA, 2014, TRANSFUSION, V54, P2202, DOI 10.1111/trf.12648; Jacobsen KH, 2010, VACCINE, V28, P6653, DOI 10.1016/j.vaccine.2010.08.037; Juniastuti,, 2019, J MED VIROL, V91, P1048, DOI 10.1002/jmv.25403; Koroglu M, 2017, J INFECT PUBLIC HEAL, V10, P513, DOI 10.1016/j.jiph.2016.09.020; Kotwal Atul, 2014, Med J Armed Forces India, V70, P225, DOI 10.1016/j.mjafi.2014.06.016; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Lee H, 2012, J CLIN MICROBIOL, V50, P1252, DOI 10.1128/JCM.01114-11; Maunula L, 2013, INT J FOOD MICROBIOL, V167, P177, DOI 10.1016/j.ijfoodmicro.2013.09.003; Melhem NM, 2014, J VIRAL HEPATITIS, V21, P605, DOI 10.1111/jvh.12282; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Nei M., 1987, MOL EVOLUTIONARY GEN; PalestineMinistryofHealth, 2018, HLTH ANN REP; PINHEIRO Raquel Silva, 2015, Arq. Gastroenterol., V52, P200, DOI 10.1590/S0004-28032015000300009; Rozas J, 2017, MOL BIOL EVOL, V34, P3299, DOI 10.1093/molbev/msx248; Seo JY, 2013, J KOREAN MED SCI, V28, P908, DOI 10.3346/jkms.2013.28.6.908; TAJIMA F, 1983, GENETICS, V105, P437; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Toukan A U, 1988, Trop Gastroenterol, V9, P76; Wang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074752; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Yassin K, 2001, EPIDEMIOL INFECT, V127, P335, DOI 10.1017/S0950268801005970	37	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0240339	10.1371/journal.pone.0240339	http://dx.doi.org/10.1371/journal.pone.0240339			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306686	Green Published, gold			2022-12-27	WOS:000600144200070
J	Li, AL; Grant, D; Gbakie, M; Kanneh, L; Mustafa, I; Bond, N; Engel, E; Schieffelin, J; Vandy, MJ; Yeh, S; Shantha, JG				Li, Alexa L.; Grant, Donald; Gbakie, Michael; Kanneh, Lansana; Mustafa, Ibrahim; Bond, Nell; Engel, Emily; Schieffelin, John; Vandy, Matthew J.; Yeh, Steven; Shantha, Jessica G.			Ophthalmic manifestations and vision impairment in Lassa fever survivors	PLOS ONE			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; CLINICAL-FEATURES; EBOLA-VIRUS; CHORIORETINITIS; EPIDEMIOLOGY; POPULATION; MANAGEMENT; DIAGNOSIS; BLINDNESS; EYE	The purpose of this study was to describe the ocular findings, structural ocular complications, and vision impairment in a cohort of Lassa fever survivors in Kenema, Sierra Leone. A retrospective, uncontrolled, cross-sectional study of 31 Lassa fever survivors (62 eyes) who underwent an ophthalmic evaluation in January 2018 at the Kenema Government Hospital in Kenema, Sierra Leone was performed. Data collection included demographic information, ocular/systemic symptoms, visual acuity (VA), and ophthalmic examination findings. Main outcome measures included anterior and posterior segment ophthalmic manifestations and level of VA impairment in Lassa fever survivors. Anterior segment findings included cataract (18%) and pterygium (2%), while posterior segment manifestations consisted of glaucoma (6%), preretinal hemorrhage (2%), and lattice degeneration (2%). Findings suggestive of prior sequelae of uveitis included chorioretinal scarring (5%), retinal fibrosis (3%), and vitreous opacity (2%). Visual acuity was normal/mildly impaired in 53 eyes (85%), moderately impaired in 6 eyes (10%), and 3 eyes (5%) were considered blind by the World Health Organization (WHO) criteria. Median VA was worse in Lassa fever survivors with ophthalmic disease findings (p<0.0001) for both anterior segment (p<0.0001) and posterior segment disease (p<0.013). Untreated cataract was a significant cause of visual acuity impairment (p<0.0001). Lassa fever survivors in this cohort were found to have cataract and posterior segment findings that potentially represent sequelae of uveitis associated with visual impairment. Future studies are warranted to improve our understanding of the spectrum of ocular disease in this emerging infectious disease of public health consequence.	[Li, Alexa L.; Yeh, Steven; Shantha, Jessica G.] Emory Univ, Sch Med, Dept Ophthalmol, Sect Vitreoretinal Dis & Surg,Emory Eye Ctr, Atlanta, GA 30322 USA; [Grant, Donald; Gbakie, Michael; Kanneh, Lansana; Mustafa, Ibrahim] Kenema Govt Hosp, Viral Hemorrhag Fever Program, Kenema, Sierra Leone; [Grant, Donald] Minist Hlth & Sanitat, Freetown, Sierra Leone; [Bond, Nell; Engel, Emily] Tulane Univ, Sch Med, Dept Microbiol & Immunol, New Orleans, LA 70112 USA; [Schieffelin, John] Tulane Univ, Sch Med, Dept Pediat, New Orleans, LA 70112 USA; [Vandy, Matthew J.] Minist Hlth & Sanitat, Natl Eye Program, Freetown, Sierra Leone	Emory University; Kenema Government Hospital; Ministry of Health & Sanitation Sierra Leone; Tulane University; Tulane University; Ministry of Health & Sanitation Sierra Leone	Yeh, S; Shantha, JG (corresponding author), Emory Univ, Sch Med, Dept Ophthalmol, Sect Vitreoretinal Dis & Surg,Emory Eye Ctr, Atlanta, GA 30322 USA.	steven.yeh@emory.edu; jshanth@emory.edu		Li, Alexa/0000-0002-5235-6741	National Eye Institute/National Institutes of Health [P30-EY06360]; National Eye Institute, National Institutes of Health [RO1 EY029594, K23 EY030158]; Research to Prevent Blindness (Emory Eye Center, Emory University School of Medicine); Retina Research Foundation - Mills and Margaret Cox Macula Society Grant; Bayer Global Ophthalmology Awards; Santen, Inc; Sitaraman Family Foundation; National Institute of Allergy and Infectious Disease [1R01AI123535-01A1]	National Eye Institute/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Eye Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness (Emory Eye Center, Emory University School of Medicine); Retina Research Foundation - Mills and Margaret Cox Macula Society Grant; Bayer Global Ophthalmology Awards; Santen, Inc; Sitaraman Family Foundation; National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was supported by the National Eye Institute/National Institutes of Health core grant P30-EY06360 (Department of Ophthalmology, Emory University School of Medicine), National Eye Institute, National Institutes of Health RO1 EY029594 (SY) and K23 EY030158 (JGS). Funding support was also provided via an Unrestricted Grant from Research to Prevent Blindness (Emory Eye Center, Emory University School of Medicine). Funding support was also provided by the Retina Research Foundation - Mills and Margaret Cox Macula Society Grant (SY), Bayer Global Ophthalmology Awards Program (SY; JGS), Santen, Inc, and the Sitaraman Family Foundation. The National Institute of Allergy and Infectious Disease under award number 1R01AI123535-01A1 (JS; DG) also provided funding support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.	Asogun DA, 2019, INFECT DIS CLIN N AM, V33, P933, DOI 10.1016/j.idc.2019.08.002; Boisen ML, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24246-w; Brezin AP, 2000, AM J OPHTHALMOL, V130, P245, DOI 10.1016/S0002-9394(00)00563-8; Budenz DL, 2012, OPHTHALMOLOGY, V119, P1744, DOI 10.1016/j.ophtha.2012.04.017; Centers for Disease Control and Prevention, INF CONTR STAND PREC; Centers for Disease Control and Prevention, 2020, LASS FEV NIG; Ezeomah C, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofz512; Gary JM, 2019, EMERG INFECT DIS, V25, P865, DOI 10.3201/eid2505.181254; Holladay JT, 2004, J CATARACT REFR SURG, V30, P287, DOI 10.1016/j.jcrs.2004.01.014; Ilori EA, 2019, EMERG INFECT DIS, V25, P1066, DOI 10.3201/eid2506.181035; KUMING BS, 1977, BRIT J OPHTHALMOL, V61, P265, DOI 10.1136/bjo.61.4.265; Malu Keziah N, 2014, Niger Med J, V55, P166, DOI 10.4103/0300-1652.129664; Mateer EJ, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006187; MCCORMICK JB, 1987, J INFECT DIS, V155, P437, DOI 10.1093/infdis/155.3.437; MCCORMICK JB, 1987, J INFECT DIS, V155, P445, DOI 10.1093/infdis/155.3.445; Mets MB, 2000, AM J OPHTHALMOL, V130, P209, DOI 10.1016/S0002-9394(00)00570-5; Prescott JB, 2017, NAT REV IMMUNOL, V17, P195, DOI 10.1038/nri.2016.138; RONDAY MJH, 1994, BRIT J OPHTHALMOL, V78, P690, DOI 10.1136/bjo.78.9.690; Shantha JG, 2018, EBIOMEDICINE, V30, P217, DOI 10.1016/j.ebiom.2018.03.020; Shantha JG, 2017, OPHTHALMOLOGY, V124, P170, DOI 10.1016/j.ophtha.2016.10.011; Shantha JG, 2016, OPHTHALMOLOGY, V123, P2626, DOI 10.1016/j.ophtha.2016.07.013; Varkey JB, 2015, NEW ENGL J MED, V372, P2423, DOI 10.1056/NEJMoa1500306; WALKER DH, 1982, J INFECT DIS, V146, P360, DOI 10.1093/infdis/146.3.360; WHITE HA, 1972, T ROY SOC TROP MED H, V66, P390, DOI 10.1016/0035-9203(72)90269-6; WHO, PRIOR DIS RES DEV EM; Wright R, 1997, PEDIATRICS, V100, part. no., DOI 10.1542/peds.100.1.e9; Yeh S, 2018, OCUL IMMUNOL INFLAMM, V26, P1128, DOI 10.1080/09273948.2018.1484493; Yun NE, 2016, J VIROL, V90, P2920, DOI 10.1128/JVI.02948-15; Yun NE, 2012, VIRUSES-BASEL, V4, P2031, DOI 10.3390/v4102031; Zinkernagel MS, 2009, J VIROL, V83, P159, DOI 10.1128/JVI.01211-08	30	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243766	10.1371/journal.pone.0243766	http://dx.doi.org/10.1371/journal.pone.0243766			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301526	gold, Green Published			2022-12-27	WOS:000600143100056
J	Black, WD				Black, Wesley D.			A comparison of several media types and basic techniques used to assess outdoor airborne fungi in Melbourne, Australia	PLOS ONE			English	Article							VIABLE MOLD PROPAGULES; INDOOR AIR; ENUMERATION; ASSOCIATIONS; TEMPERATURE; SPECTRUM; SURFACE; HOUSES	Despite the recent increase in interest in indoor air quality regarding mould, there is no universally accepted standard media for the detection of airborne fungi, nor verification of many commonly used techniques. Commonly used media including malt-extract agar (MEA), Sabouraud dextrose agar (Sab), potato dextrose agar (PDA) with and without antibiotics chloramphenicol & gentamycin (CG) were compared for their suitability in detecting a range of airborne fungi by collecting 150 L outdoor air on a number of different days and seasons via an Anderson 400-hole sampler in suburban Melbourne, Australia. There was relatively little variation in mean numbers of colony forming units (CFU) and types of fungi recovered between MEA, PDA, Sab media groups relative to variation within each group. There was a significant difference between Sab, Dichloran-18% glycerol (DG18) and V8 (R) Original juice agar media, however. Antibiotics reliably prevented the growth of bacteria that typically interfered with the growth and appearance of fungal colonies. There was no significant evidence for a growth enhancing factor from potato, mineral supplements or various vegetable juices. Differing glucose concentrations had modest effects, showing a vague ideal at 2%-4% with peptone. Sanitisation of the aluminium Andersen 400-hole sampler top-plate by flame is possible, but not strictly required nor advisable. The use of SabCG as a standard medium was generally supported.	[Black, Wesley D.] Biotopia Environm Assessment, Melbourne, Vic, Australia		Black, WD (corresponding author), Biotopia Environm Assessment, Melbourne, Vic, Australia.	wesblack@biotopia.net.au		Black, Wesley/0000-0001-6611-4404	Biotopia Environmental Assessment Pty Ltd	Biotopia Environmental Assessment Pty Ltd	Biotopia Environmental Assessment Pty Ltd provided support in the form of salary and materials to author WDB. The specific roles of this author is articulated in the 'author contributions' section. The funder had no commercial or vested interests in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aktas YD, 2018, SCI TOTAL ENVIRON, V643, P1631, DOI 10.1016/j.scitotenv.2018.06.311; ANDERSEN AA, 1958, J BACTERIOL, V76, P471, DOI 10.1128/JB.76.5.471-484.1958; Andersen B, 2011, APPL ENVIRON MICROB, V77, P4180, DOI 10.1128/AEM.02513-10; [Anonymous], 2019, ATLAS CLIN FUNGI; [Anonymous], 2009, REV DIREITO SANITARI, V10, P264; [Anonymous], 2008, GUID ASS REM FUNG IN; [Anonymous], 2006, ASS CLEAN REST HVAC; [Anonymous], 2017, D22 ASTM INT, DOI [10.1520/D7658-17, DOI 10.1520/D7658-17]; [Anonymous], 2020, D22 ASTM INT, DOI [10.1520/D7391-20, DOI 10.1520/D7391-20]; [Anonymous], 2016, DIABETES CARE S1, V39, pS1, DOI 10.2337/dc16-S001; Aryal S, 2019, POTATO DEXTROSE AGAR; Bakke M, 2019, J Prev Med Hyg, V60, pE140, DOI 10.15167/2421-4248/jpmh2019.60.2.1122; Barnett HL., 1987, ILLUSTRATED GENERA I, V4; Baudisch C, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-247; Biango-Daniels MN, 2018, FOOD MICROBIOL, V69, P89, DOI 10.1016/j.fm.2017.07.020; Borrego Sofia, 2012, ISRN Microbiol, V2012, P680598, DOI 10.5402/2012/680598; Broadwater D, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51593-z; BRUCH MK, 1968, APPL MICROBIOL, V16, P1427, DOI 10.1128/AEM.16.9.1427-1428.1968; Chain E, 1940, LANCET, V2, P226; Chang PK, 2007, LETT APPL MICROBIOL, V44, P131, DOI 10.1111/j.1472-765X.2006.02056.x; Chew GL, 2003, ALLERGY, V58, P13, DOI 10.1034/j.1398-9995.2003.00013.x; de Hoog DS., 2000, ATLAS CLIN FUNGI; Deak T, 2001, INT J FOOD MICROBIOL, V67, P49, DOI 10.1016/S0168-1605(01)00449-4; EHRLICH J, 1947, SCIENCE, V106, P417, DOI 10.1126/science.106.2757.417; Environmental Health Division, 2014, REC BEST PRACT MOLD; Evans S, 2017, ISME J, V11, P176, DOI 10.1038/ismej.2016.96; Fekadu S, 2015, ETHIOP J HEALTH SCI, V25, P117, DOI 10.4314/ejhs.v25i2.3; George D., 2010, SPSS WINDOWS STEP ST, V10; Haig CW, 2016, J HOSP INFECT, V93, P242, DOI 10.1016/j.jhin.2016.03.017; Hargreaves M, 2003, SCI TOTAL ENVIRON, V312, P89, DOI 10.1016/S0048-9697(03)00169-4; Hayleeyesus SF, 2015, INT J HEALTH SCI-IJH, V9, P249; Hayleeyesus Samuel Fekadu, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, pS312, DOI 10.12980/APJTB.4.2014C807; HEATLEY NG, 1946, BRIT J EXP PATHOL, V27, P378; HENDRICKS CW, 1995, APPL ENVIRON MICROB, V61, P2016, DOI 10.1128/AEM.61.5.2016-2019.1995; Heseltine E., 2009, WHO GUID IND AIR QUA; Hesseltine C. W., 1973, Pure and Applied Chemistry, V35, P259, DOI 10.1351/pac197335030259; HOCKING AD, 1980, APPL ENVIRON MICROB, V39, P488, DOI 10.1128/AEM.39.3.488-492.1980; House of Representatives Standing Committee on Health Aged Care and Sport, 2018, AG CAR SPORT REP INQ; Hungin APS, 2013, ALIMENT PHARM THER, V38, P864, DOI 10.1111/apt.12460; IICRC, 2015, ANSI IICRC STAND REF; ISO, 2015, 1464412015 ISO; Jansen MLA, 2004, APPL ENVIRON MICROB, V70, P1956, DOI 10.1128/AEM.70.4.1956-1963.2004; Kazemian N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220556; Kleinheinz GT, 2006, MICROBIOL RES, V161, P367, DOI 10.1016/j.micres.2006.01.002; Labs Himedia, 2020, DICHL ROS BENG CHLOR; Lee YC, 1996, CORNEA, V15, P376, DOI 10.1097/00003226-199607000-00008; Lo VC, 2014, NANOMATERIALS-BASEL, V4, P827, DOI 10.3390/nano4030827; Lobanovska M, 2017, YALE J BIOL MED, V90, P135; Lonon M K, 1998, BIOAEROSOL SAMPLING; Macindoe I, 2012, P NATL ACAD SCI USA, V109, pE804, DOI 10.1073/pnas.1114052109; Mann EE, 2014, ANTIMICROB RESIST IN, V3, DOI 10.1186/2047-2994-3-28; Met One Instruments Inc, 2012, 804 PART COUNT FIN D; Met One Instruments Inc, 2012, 831 AER MASS MON DAT; Multon J.L., 1985, PROPERTIES WATER FOO, P273, DOI DOI 10.1007/978-94-009-5103-7_17; Najotra Dipender Kaur, 2017, Int J Appl Basic Med Res, V7, P165, DOI 10.4103/ijabmr.IJABMR_281_16; Neumeister-Kemp H, 2010, AUSTR MOULD GUIDELIN; Nieguitsila A, 2011, ENVIRON RES, V111, P248, DOI 10.1016/j.envres.2010.12.005; Pinto F, 2009, LETT APPL MICROBIOL, V48, P379, DOI 10.1111/j.1472-765X.2008.02534.x; PromptCare, 2014, PROBL FOGG US BIOC M; Rao CY, 1996, J AIR WASTE MANAGE, V46, P899, DOI 10.1080/10473289.1996.10467526; Rieux A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103225; Salas ML, 2017, MICROORGANISMS, V5, DOI 10.3390/microorganisms5030037; Scott Jane Margaret, 2001, THESIS; Segers FJJ, 2016, APPL ENVIRON MICROB, V82, P5089, DOI 10.1128/AEM.00510-16; Shama G, 2013, INT J HYG ENVIR HEAL, V216, P115, DOI 10.1016/j.ijheh.2012.03.009; Shannon MW, 2006, PEDIATRICS, V118, P2582, DOI 10.1542/peds.2006-2828; Stetzenbach L, 2004, MICR MOLD IND AIR QU; Sylvain IA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213355; The Lancet Global Health, 2018, LANCET GLOB HLTH, V6, pE593; Uppala SS, 2019, PLANT DIS, V103, P504, DOI [10.1094/PDIS-05-18-0814-RE, 10.1094/pdis-05-18-0814-re]; Urbez-Torres JR, 2010, PLANT DIS, V94, P1476, DOI 10.1094/PDIS-06-10-0423; US EPA I, 2008, MOLD REM SCH COMM BU; VERHOEFF AP, 1990, ALLERGY, V45, P275, DOI 10.1111/j.1398-9995.1990.tb00496.x; VERHOEFF AP, 1992, ALLERGY, V47, P83, DOI 10.1111/j.1398-9995.1992.tb05093.x; WEI CI, 1985, J FOOD PROTECT, V48, P316, DOI 10.4315/0362-028X-48.4.316; Wirth Fernanda, 2012, Interdiscip Perspect Infect Dis, V2012, P465717, DOI 10.1155/2012/465717; Woo Koan Sik, 2015, Prev Nutr Food Sci, V20, P102, DOI 10.3746/pnf.2015.20.2.102; Wu SM, 2019, MAR DRUGS, V17, DOI 10.3390/md17040199; 2019, MICROBIOME, V7, P1	79	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0238901	10.1371/journal.pone.0238901	http://dx.doi.org/10.1371/journal.pone.0238901			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8CZ	33338037	Green Submitted, gold, Green Published			2022-12-27	WOS:000601313500021
J	Jittikoon, J; Sangroongruangsri, S; Thavorncharoensap, M; Chitpim, N; Chaikledkaew, U				Jittikoon, Jiraphun; Sangroongruangsri, Sermsiri; Thavorncharoensap, Montarat; Chitpim, Natthakan; Chaikledkaew, Usa			Economic impact of medical genetic testing on clinical applications in Thailand	PLOS ONE			English	Article							HEALTH	Background Although the clinical benefits of medical genetic testing have been proven, there has been limited evidence on its economic impact in Thai setting. Thus, this study aimed to evaluate the economic impact of genetic testing services provided by the Center for Medical Genomics (CMG) in Thailand. Methods Cost-benefit analysis was conducted from provider and societal perspectives. Cost and output data of genetic testing services provided by the CMG during 2014 to 2018 and published literature reviews were applied to estimate the costs and benefits. Monetary benefits related to genetic testing services were derived through human capital approach. Results The total operation cost was 126 million baht over five years with an average annual cost of 21 million baht per year. The net benefit, benefit-to-cost ratio, and return on investment were 5,477 million baht, 43 times, and 42 times, respectively. Productivity gain was the highest proportion (50.57%) of the total benefit. Conclusions The provision of genetic testing services at the CMG gained much more benefits than the cost. This study highlighted a good value for money in the establishment of medical genomics settings in Thailand and other developing countries.	[Jittikoon, Jiraphun] Mahidol Univ, Dept Biochem, Fac Pharm, Bangkok, Thailand; [Sangroongruangsri, Sermsiri; Thavorncharoensap, Montarat; Chaikledkaew, Usa] Mahidol Univ, Social Adm Pharm Div, Dept Pharm, Fac Pharm, Bangkok, Thailand; [Thavorncharoensap, Montarat; Chaikledkaew, Usa] Mahidol Univ, Mahidol Univ Hlth Technol Assessment MUHTA Grad P, Bangkok, Thailand; [Chitpim, Natthakan] Mahidol Univ, Dept Pharm, Social Econ & Adm Pharm SEAP Grad Program, Fac Pharm, Bangkok, Thailand	Mahidol University; Mahidol University; Mahidol University; Mahidol University	Chaikledkaew, U (corresponding author), Mahidol Univ, Social Adm Pharm Div, Dept Pharm, Fac Pharm, Bangkok, Thailand.; Chaikledkaew, U (corresponding author), Mahidol Univ, Mahidol Univ Hlth Technol Assessment MUHTA Grad P, Bangkok, Thailand.	usa.chi@mahidol.ac.th		Sangroongruangsri, Sermsiri/0000-0002-5222-8694	Thailand Center of Excellence for Life Sciences (TCELS); International Research Network of the Thailand Research Fund [IRN60W003]	Thailand Center of Excellence for Life Sciences (TCELS); International Research Network of the Thailand Research Fund	This work was supported by the Thailand Center of Excellence for Life Sciences (TCELS) and the International Research Network of the Thailand Research Fund (grant no. IRN60W003). The findings, interpretations, and conclusions expressed in this article do not necessarily reflect the views of the funding agency.	[Anonymous], 2013, NAT REV MICROBIOL, V11, P1, DOI 10.1038/nrmicro2948; Becker F, 2011, EUR J HUM GENET, V19, pS6, DOI 10.1038/ejhg.2010.249; Bureau of AIDS TB and STIs, 2013, HLTH BEN PACK PAT HI; Forero DA, 2016, J MED GENET, V53, P438, DOI 10.1136/jmedgenet-2015-103631; Human Genetics Chronic Diseases and Health Promotion World Health Organization., 2006, CHRON DIS HLTH PROM; McElreavey K, 2005, Community Genet, V8, P130, DOI 10.1159/000084784; OECD, 2013, OECD SCI TECHNOLOGY, V8, DOI 10.1787/5k424rdzj3bx-en; Seguin B, 2008, NAT REV GENET, V9, pS14, DOI 10.1038/nrg2443; Shao S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082446; Teeraananchai S, 2017, ANTIVIR THER, V22, P393, DOI 10.3851/IMP3121; Vogenberg F Randy, 2010, P T, V35, P560; Working Group on the Guidelines for Health Technology Assessment in Thailand, 2013, GUID HLTH TECHN ASS GUID HLTH TECHN ASS, V2; Yoshida S, 2016, J GLOB HEALTH, V6, DOI 10.7189/jogh.06.010508	13	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0243934	10.1371/journal.pone.0243934	http://dx.doi.org/10.1371/journal.pone.0243934			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8CZ	33338033	Green Published, gold			2022-12-27	WOS:000601313500020
J	Alex, CE; Fahsbender, E; Altan, E; Bildfell, R; Wolff, P; Jin, L; Black, W; Jackson, K; Woods, L; Munk, B; Tse, T; Delwart, E; Pesavento, PA				Alex, Charles E.; Fahsbender, Elizabeth; Altan, Eda; Bildfell, Robert; Wolff, Peregrine; Jin, Ling; Black, Wendy; Jackson, Kenneth; Woods, Leslie; Munk, Brandon; Tse, Tiffany; Delwart, Eric; Pesavento, Patricia A.			Viruses in unexplained encephalitis cases in American black bears (Ursus americanus)	PLOS ONE			English	Article							TORQUE TENO VIRUS; TT VIRUS; CIRCOVIRUS; INFECTION; PIGS; PREVALENCE; VASCULITIS; HEPATITIS; TISSUES; ARCTOS	Viral infections were investigated in American black bears (Ursus americanus) from Nevada and northern California with and without idiopathic encephalitis. Metagenomics analyses of tissue pools revealed novel viruses in the genera Circoviridae, Parvoviridae, Anelloviridae, Polyomaviridae, and Papillomaviridae. The circovirus and parvovirus were of particular interest due to their potential importance as pathogens. We characterized the genomes of these viruses and subsequently screened bears by PCR to determine their prevalence. The circovirus (Ursus americanus circovirus, UaCV) was detected at a high prevalence (10/16, 67%), and the chaphamaparvovirus (Ursus americanus parvovirus, UaPV) was found in a single bear. We showed that UaCV is present in liver, spleen/lymph node, and brain tissue of selected cases by in situ hybridization (ISH) and PCR. Infections were detected in cases of idiopathic encephalitis and in cases without inflammatory brain lesions. Infection status was not clearly correlated with disease, and the significance of these infections remains unclear. Given the known pathogenicity of a closely related mammalian circovirus, and the complex manifestations of circovirus-associated diseases, we suggest that UaCV warrants further study as a possible cause or contributor to disease in American black bears.	[Alex, Charles E.; Jackson, Kenneth; Tse, Tiffany; Pesavento, Patricia A.] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [Fahsbender, Elizabeth; Altan, Eda; Delwart, Eric] Vitalant Res Inst, San Francisco, CA USA; [Fahsbender, Elizabeth; Altan, Eda; Delwart, Eric] Univ Calif San Diego, Dept Lab Med, San Francisco, CA USA; [Bildfell, Robert; Jin, Ling] Oregon State Univ, Carlson Coll Vet Med, Dept Biomed Sci, Corvallis, OR 97331 USA; [Bildfell, Robert; Jin, Ling; Black, Wendy] Oregon State Univ, Carlson Coll Vet Med, Oregon Vet Diagnost Lab, Corvallis, OR USA; [Wolff, Peregrine] Nevada Dept Wildlife, Reno, NV USA; [Woods, Leslie] Calif Anim Hlth & Food Safety Lab, Davis, CA USA; [Munk, Brandon] Calif Dept Fish & Wildlife, Rancho Cordova, CA USA	University of California System; University of California Davis; Vitalant; Vitalant Research Institute; University of California System; University of California San Diego; Oregon State University; Oregon State University	Pesavento, PA (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA.	papesavento@ucdavis.edu	Altan, Eda/W-4368-2017; Altan, Eda/AAK-3420-2021	Altan, Eda/0000-0001-7903-6986; Altan, Eda/0000-0001-7903-6986				Bard SM, 2019, J WILDLIFE DIS, V55, P745, DOI 10.7589/2018-12-286; Black W, 2019, VIRUS RES, V259, P46, DOI 10.1016/j.virusres.2018.10.016; Breitbart M, 2017, J GEN VIROL, V98, P1997, DOI 10.1099/jgv.0.000871; Bronson E, 2014, J WILDLIFE DIS, V50, P829, DOI 10.7589/2013-07-155; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; Christensen JK, 2000, J INFECT DIS, V181, P1796, DOI 10.1086/315440; Cottrell WO, 2013, J WILDLIFE DIS, V49, P1024, DOI 10.7589/2013-02-027; De Vlaminck I, 2013, CELL, V155, P1178, DOI 10.1016/j.cell.2013.10.034; Deng XT, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv002; Devalle S, 2009, ARCH VIROL, V154, P1285, DOI 10.1007/s00705-009-0440-7; FAHSBENDER E, 2019, VIRUSES-BASEL, V11, DOI DOI 10.3390/V11050398; Garshelis D.L., 2016, IUCN RED LIST THREAT, DOI [DOI 10.2305/IUCN.UK.2016-3.RLTS.T41687A45034604.EN, 10.2305/IUCN.UK.2016-3.RLTS.T41687A45034604]; Kekarainen T, 2012, TRANSBOUND EMERG DIS, V59, P103, DOI 10.1111/j.1865-1682.2011.01289.x; Knowles S, 2018, J WILDLIFE DIS, V54, P642, DOI 10.7589/2017-10-245; Li LL, 2013, J VIROL, V87, P10912, DOI 10.1128/JVI.01839-13; Li LL, 2013, EMERG INFECT DIS, V19, P534, DOI 10.3201/eid1904.121390; Madsen Chris D, 2002, HIV Clin Trials, V3, P287; Manzin A, 2015, J INFECT DEV COUNTR, V9, P562, DOI 10.3855/jidc.6912; Meng XJ, 2013, ANNU REV ANIM BIOSCI, V1, P43, DOI 10.1146/annurev-animal-031412-103720; Niedringhaus KD, 2019, VET SCI, V6, DOI 10.3390/vetsci6040075; PENZES JJ, 2019, VIRUSES-BASEL, V11, DOI DOI 10.3390/V11060525; Penzes JJ, 2020, ARCH VIROL, V165, P2133, DOI 10.1007/s00705-020-04632-4; Ramey AM, 2019, J WILDLIFE DIS, V55, P576, DOI 10.7589/2018-07-173; Resendes AR, 2015, VET PATHOL, V52, P497, DOI 10.1177/0300985814540542; Roediger B, 2018, CELL, V175, P530, DOI 10.1016/j.cell.2018.08.013; Rosell C, 2000, VET PATHOL, V37, P687, DOI 10.1354/vp.37-6-687; Schaffer AA, 2018, BIOINFORMATICS, V34, P755, DOI 10.1093/bioinformatics/btx669; Schrenzel MD, 2008, EMERG INFECT DIS, V14, P1616, DOI 10.3201/eid1410.080703; Seeliger FA, 2007, VET PATHOL, V44, P621, DOI 10.1354/vp.44-5-621; Shibayama T, 2001, AIDS, V15, P563, DOI 10.1097/00002030-200103300-00004; Spandole S, 2015, ARCH VIROL, V160, P893, DOI 10.1007/s00705-015-2363-9; Stephenson N, 2015, VECTOR-BORNE ZOONOT, V15, P116, DOI 10.1089/vbz.2014.1671; Thom K, 2007, J MED VIROL, V79, P1, DOI 10.1002/jmv.20756; Touinssi M, 2001, J CLIN VIROL, V21, P135, DOI 10.1016/S1386-6532(01)00157-3; Watanabe Toru, 2015, World J Clin Pediatr, V4, P126, DOI 10.5409/wjcp.v4.i4.126; Wohlsein P, 2011, VET MICROBIOL, V149, P456, DOI 10.1016/j.vetmic.2010.11.024	36	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0244056	10.1371/journal.pone.0244056	http://dx.doi.org/10.1371/journal.pone.0244056			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332429	Green Published, gold			2022-12-27	WOS:000601310900042
J	Smaoui, MR; Rabasa-Lhoret, R; Haidar, A				Smaoui, Mohamed Raef; Rabasa-Lhoret, Remi; Haidar, Ahmad			Development platform for artificial pancreas algorithms	PLOS ONE			English	Article							GLYCEMIC CONTROL; CARDIOVASCULAR-DISEASE; SEVERE HYPOGLYCEMIA; INSULIN DELIVERY; GLUCOSE; THERAPY	Background and aims Assessing algorithms of artificial pancreas systems is critical in developing automated and fault-tolerant solutions that work outside clinical settings. The development and evaluation of algorithms can be facilitated with a platform that conducts virtual clinical trials. We present in this paper a clinically validated cloud-based distributed platform that supports the development and comprehensive testing of single and dual-hormone algorithms for type 1 diabetes mellitus (T1DM). Methods The platform is built on principles of object-oriented design and runs user algorithms in real-time virtual clinical trials utilizing a multi-threaded environment enabled by concurrent execution over a cloud infrastructure. The platform architecture isolates user algorithms located on personal machines from proprietary patient data running on the cloud. Users import a plugin into their algorithms (Matlab, Python, or Java) to connect to the platform. Once connected, users interact with a graphical interface to design experimental protocols for their trials. Protocols include trial duration in days, mealtimes and amounts, variability in mealtimes and amounts, carbohydrate counting errors, snacks, and onboard insulin levels. Results The platform facilitates development by solving the ODE model in the cloud on large CPU-optimized machines, providing a 62% improvement in memory, speed and CPU utilization. Users can easily debug & modify code, test multiple strategies, and generate detailed clinical performance reports. We validated and integrated into the platform a glucoregulatory system of ordinary differential equations (ODEs) parameterized with clinical data to mimic the inter and intra-day variability of glucose responses of 15 T1DM patients. Conclusion The platform utilizes the validated patient model to conduct virtual clinical trials for the rapid development and testing of closed-loop algorithms for T1DM.	[Smaoui, Mohamed Raef] Kuwait Univ, Fac Sci, Dept Comp Sci, Kuwait, Kuwait; [Rabasa-Lhoret, Remi] Univ Montreal, Fac Med, Dept Nutr, Montreal, PQ, Canada; [Rabasa-Lhoret, Remi] Inst Rech Clin Montreal, Montreal, PQ, Canada; [Haidar, Ahmad] McGill Univ, Fac Med, Dept Biomed Engn, Montreal, PQ, Canada	Kuwait University; Universite de Montreal; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; McGill University	Smaoui, MR (corresponding author), Kuwait Univ, Fac Sci, Dept Comp Sci, Kuwait, Kuwait.	msmaoui@cs.ku.edu.kw	Smaoui, Mohamed Raef/GQZ-4457-2022	Smaoui, Mohamed Raef/0000-0002-8891-7926				American Diabetes Association, 2001, Diabetes Care, V24, P775; [Anonymous], 1999, IZV VYSSH ZAVED MAT, V1, P41; BERGMAN RN, 1979, AM J PHYSIOL, V236, pE667, DOI 10.1152/ajpendo.1979.236.6.E667; Brown Sue A, 2015, J Diabetes Sci Technol, V9, P1192, DOI 10.1177/1932296815608400; Chase HP, 2001, DIABETES CARE, V24, P430, DOI 10.2337/diacare.24.3.430; Cobelli Claudio, 2009, IEEE Rev Biomed Eng, V2, P54, DOI 10.1109/RBME.2009.2036073; El Fathi A, 2018, IEEE CONTR SYST MAG, V38, P67, DOI 10.1109/MCS.2017.2766323; El-Khatib FH, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000619; Elleri D, 2013, DIABETOLOGIA, V56, P1108, DOI 10.1007/s00125-013-2852-x; Elleri D, 2013, DIABETES CARE, V36, P838, DOI 10.2337/dc12-0816; Ellingsen Christian, 2009, J Diabetes Sci Technol, V3, P536; Emami A, 2017, IEEE J BIOMED HEALTH, V21, P1163, DOI 10.1109/JBHI.2016.2593630; George P, 2013, DIABETIC MED, V30, P179, DOI 10.1111/j.1464-5491.2012.03744.x; Goudie RJB, 2014, DIABETES CARE, V37, pE121, DOI 10.2337/dc13-2535; Gruden G, 2012, DIABETES CARE, V35, P1598, DOI 10.2337/dc11-1531; Haidar A, 2016, LANCET DIABETES ENDO, V4, P476, DOI 10.1016/S2213-8587(16)30006-7; Haidar A, 2015, LANCET DIABETES ENDO, V3, P17, DOI 10.1016/S2213-8587(14)70226-8; Haidar Ahmad, 2013, J Diabetes Sci Technol, V7, P1507; Haidar A, 2013, IEEE T BIO-MED ENG, V60, P3524, DOI 10.1109/TBME.2013.2272736; Haidar A, 2013, CAN MED ASSOC J, V185, P297, DOI 10.1503/cmaj.121265; Hovorka R, 2002, AM J PHYSIOL-ENDOC M, V282, pE992, DOI 10.1152/ajpendo.00304.2001; Hovorka R, 2008, PHYSIOL MEAS, V29, P959, DOI 10.1088/0967-3334/29/8/008; Hovorka R, 2006, DIABETES RES CLIN PR, V74, pS178, DOI 10.1016/S0168-8227(06)70027-4; Hovorka R, 2011, NAT REV ENDOCRINOL, V7, P385, DOI 10.1038/nrendo.2011.32; KADISH AH, 1963, T AM SOC ART INT ORG, V9, P363; Kanderian Sami S, 2009, J Diabetes Sci Technol, V3, P1047; Kielgast U, 2011, DIABETES CARE, V34, P1463, DOI 10.2337/dc11-0096; Kovatchev Boris P, 2009, J Diabetes Sci Technol, V3, P44; Kropff J, 2015, LANCET DIABETES ENDO, V3, P939, DOI 10.1016/S2213-8587(15)00335-6; Leelarathna L, 2013, DIABETES TECHNOL THE, V15, P143, DOI 10.1089/dia.2012.0245; Lehmann Eldon D, 2003, Diabetes Technol Ther, V5, P425, DOI 10.1089/152091503765691938; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Man Chiara Dalla, 2014, J Diabetes Sci Technol, V8, P26; Miller S, 2011, DIABETES TECHNOL THE, V13, P983, DOI 10.1089/dia.2010.0216; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Nimri R, 2014, DIABETES CARE, V37, P3025, DOI 10.2337/dc14-0835; Nisly SA, 2013, AM J HEALTH-SYST PH, V70, P311, DOI 10.2146/ajhp110514; Oviedo S, 2019, INT J MED INFORM, V126, P1, DOI 10.1016/j.ijmedinf.2019.03.008; Riddell Michael C, 2015, J Diabetes Sci Technol, V9, P1217, DOI 10.1177/1932296815609370; Russell SJ, 2014, NEW ENGL J MED, V371, P313, DOI 10.1056/NEJMoa1314474; Scavone G, 2010, DIABETIC MED, V27, P477, DOI 10.1111/j.1464-5491.2010.02963.x; Sharan K., 2015, MODEL VIEW CONTROLLE; Steil GM, 2011, J CLIN ENDOCR METAB, V96, P1402, DOI 10.1210/jc.2010-2578; Tansey MJ, 2006, DIABETES CARE, V29, P20; Thabit H, 2015, NEW ENGL J MED, V373, P2129, DOI 10.1056/NEJMoa1509351; Toffanin Chiara, 2013, J Diabetes Sci Technol, V7, P1470; Van Herpe T, 2006, PHYSIOL MEAS, V27, P1057, DOI [10.1088/0967-3334/37/11/001, 10.1088/0967-3334/27/11/001]; Visentin R, 2014, DIABETES TECHNOL THE, V16, P428, DOI 10.1089/dia.2013.0377; Weaver J.L., 2007, JAVAFX SCRIPT DYNAMI, V1st edition; Wilinska Malgorzata E, 2010, J Diabetes Sci Technol, V4, P132	50	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243139	10.1371/journal.pone.0243139	http://dx.doi.org/10.1371/journal.pone.0243139			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332411	Green Published, gold			2022-12-27	WOS:000601310900050
J	Adams, D; Paterson, HM; MacDougall, HG				Adams, Delene; Paterson, Helen M.; MacDougall, Hamish G.			Law and (rec)order: Updating memory for criminal events with body-worn cameras	PLOS ONE			English	Article							EYEWITNESS MEMORY; INATTENTIONAL BLINDNESS; MODIFYING MEMORY; COMMON-SENSE; MUSEUM TOUR; POLICE; RECALL; ACCURACY; IMPACT; ADULTS	Body-worn video is increasingly relied upon in the criminal justice system, however it is unclear how viewing chest-mounted video may affect a police officer's statement about an event. In the present study, we asked whether reviewing footage from an experienced event could shape an individual's statement, and if so, whether reporting before reviewing may preserve an officer's original experience. Student participants (n = 97) were equipped with chest-mounted cameras as they viewed a simulated theft in virtual reality. One week later, half of the participants recalled the event in an initial statement while the other half did not. Participants then viewed either their body-worn video or a control video. Finally, participants provided their statement (no initial statement condition) or were given the opportunity to amend their original account (initial statement condition). Results revealed that viewing body-worn video enhanced the completeness and accuracy of individuals' free recall statements. However, whilst reviewing footage enabled individuals to exclude errors they had written in their initial statements, they also excluded true details that were uncorroborated by the camera footage (i.e., details which individuals experienced, but that their camera did not record). Such camera conformity is discussed in light of the debate on when an officer should access their body-worn video during an investigation and the influence of post-event information on memory.	[Adams, Delene; Paterson, Helen M.; MacDougall, Hamish G.] Univ Sydney, Sch Psychol, Sydney, NSW, Australia	University of Sydney	Paterson, HM (corresponding author), Univ Sydney, Sch Psychol, Sydney, NSW, Australia.	helen.paterson@sydney.edu.au		Paterson, Helen/0000-0002-9283-4349				Akhtar S, 2018, INT J EVID PROOF, V22, P289, DOI 10.1177/1365712718784045; Anderson JR, 1983, SPREADING ACTIVATION, P137; [Anonymous], LEAD C CIV HUM RIGHT; [Anonymous], 2017, J MOL BIOMARKERS DIA, V8, P1, DOI [10.4172/2155-9929.S2-026, DOI 10.4172/2155-9929.S2-026, DOI 10.5334/LABPHON.19]; [Anonymous], 2015, DIABET CARE S1, V38, pS4, DOI DOI https://doi.org/10.2337/dc15-S005; Baddeley A, 2003, J COMMUN DISORD, V36, P189, DOI 10.1016/S0021-9924(03)00019-4; Barnier AJ, 2008, MEMORY, V16, P177, DOI 10.1080/09541440701828274; Beehr TA, 2004, J OCCUP ORGAN PSYCH, V77, P217, DOI 10.1348/096317904774202153; Bjork R. A., 1988, PRACTICAL ASPECTS ME, V1, P396; Boivin R, 2017, J EXP CRIMINOL, V13, P125, DOI 10.1007/s11292-016-9270-2; BURKE A, 1992, MEM COGNITION, V20, P277, DOI 10.3758/BF03199665; Chabris CF, 2011, I-PERCEPTION, V2, P150, DOI 10.1068/i0436; Christodoulou C, 2019, CURR ISS CRIM JUSTIC, V31, P513, DOI 10.1080/10345329.2019.1639590; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Cubitt TIC, 2017, AUST NZ J CRIMINOL, V50, P379, DOI 10.1177/0004865816638909; DAMASIO AR, 1989, COGNITION, V33, P25, DOI 10.1016/0010-0277(89)90005-X; Dudai Y, 2004, NEURON, V44, P93, DOI 10.1016/j.neuron.2004.09.003; DUNNING D, 1992, APPL COGNITIVE PSYCH, V6, P643, DOI 10.1002/acp.2350060707; EASTERBROOK JA, 1959, PSYCHOL REV, V66, P183, DOI 10.1037/h0047707; Ebbinghaus H., 1885, MEMORY CONTRIBUTION; Finley JR, 2011, MEMORY, V19, P796, DOI 10.1080/09658211.2010.532807; Finn B, 2007, J EXP PSYCHOL LEARN, V33, P238, DOI 10.1037/0278-7393.33.1.238; Foley MA, 2018, REV GEN PSYCHOL, DOI [10.1037/gpr0000105, DOI 10.1037/GPR0000105]; Gaub JE, 2020, INT CRIM JUSTICE REV, V30, P136, DOI 10.1177/1057567718789237; GEISELMAN RE, 1986, AM J PSYCHOL, V99, P385, DOI 10.2307/1422492; Goldsmith AJ, 2010, BRIT J CRIMINOL, V50, P914, DOI 10.1093/bjc/azq033; Grady RH, 2016, J APPL RES MEM COGN, V5, P246; Harris CB, 2014, MEM STUD, V7, P285, DOI 10.1177/1750698014530619; HASHTROUDI S, 1994, PSYCHOL AGING, V9, P160, DOI 10.1037/0882-7974.9.1.160; Henkel LA, 2020, J APPL RES MEM COGN, V9, P480, DOI 10.1016/j.jarmac.2020.07.002; Henkel LA, 2014, PSYCHOL SCI, V25, P396, DOI 10.1177/0956797613504438; Ho J., 2015, J LAW ENFORCEMENT, V4, P1; Ho JD, 2017, PREHOSP EMERG CARE, V21, P263, DOI 10.1080/10903127.2016.1218984; Hodges S, 2011, MEMORY, V19, P685, DOI 10.1080/09658211.2011.605591; Hoffman HG, 2001, MEM COGNITION, V29, P394, DOI 10.3758/BF03196390; Hope L, 2016, LAW HUMAN BEHAV, V40, P23, DOI 10.1037/lhb0000159; Hope L, 2013, LAW HUMAN BEHAV, V37, P117, DOI 10.1037/lhb0000019; Hope L, 2012, PSYCHOL SCI, V23, P386, DOI 10.1177/0956797611431463; Hulse LM, 2006, LEGAL CRIMINOL PSYCH, V11, P313, DOI 10.1348/135532505X58062; Hyland SS, 2018, BUR JUSTICE STAT; JOHNSON MK, 1988, J EXP PSYCHOL GEN, V117, P371, DOI 10.1037/0096-3445.117.4.371; Jones KA, 2018, PSYCHOL PUBLIC POL L, V24, P259, DOI 10.1037/law0000168; Jones KA, 2017, J APPL RES MEM COGN, V6, P460, DOI 10.1016/j.jarmac.2017.07.007; Kim K, 2014, CYBERPSYCH BEH SOC N, V17, P709, DOI 10.1089/cyber.2013.0638; Klinger D., 2009, CRIMINOL PUBLIC POL, V8, P117, DOI [DOI 10.1111/J.1745-9133.2009.00537.X, 10.1111/j.1745-9133.2009.00537.x]; Koutstaal W, 1998, PSYCHOL AGING, V13, P277, DOI 10.1037/0882-7974.13.2.277; LASSITER GD, 1986, J APPL SOC PSYCHOL, V16, P268, DOI 10.1111/j.1559-1816.1986.tb01139.x; Loftus EF, 2005, LEARN MEMORY, V12, P361, DOI 10.1101/lm.94705; LOFTUS EF, 1978, J EXP PSYCHOL-HUM L, V4, P19, DOI 10.1037/0278-7393.4.1.19; LOFTUS EF, 1987, LAW HUMAN BEHAV, V11, P55, DOI 10.1007/BF01044839; McClure KA, 2020, PSYCHOL CRIME LAW, V26, P248, DOI 10.1080/1068316X.2019.1652748; Memon A, 2010, LAW HUMAN BEHAV, V34, P105, DOI 10.1007/s10979-008-9172-6; Merola LM, BODY WORN CAMERAS CO; Metropolitan Police UK, 2017, BMV CAM AR US; Miller L, 2014, PERF IMPLEMENTING BO; Morgan CA, 2004, INT J LAW PSYCHIAT, V27, P265, DOI 10.1016/j.ijlp.2004.03.004; Morrow WJ, 2016, POLICE Q, V19, P303, DOI 10.1177/1098611116652850; Penrod S., 1982, PSYCHOL COURTROOM, P119; Pezdek K, SHOULD COPS GET REV; Police Executive Research Forum, COST BEN BOD WORN CA; Porter LE, 2019, J EXP CRIMINOL, V15, P1, DOI 10.1007/s11292-018-9348-0; Review, BOD CAM; Roediger HL, 2011, TRENDS COGN SCI, V15, P20, DOI 10.1016/j.tics.2010.09.003; Roediger HL, 2001, SCI CON SER, P95, DOI 10.1037/10394-006; Rubin DC, 2003, MEM COGNITION, V31, P887, DOI 10.3758/BF03196443; Schubert T., 1999, VISUAL REPRESENTATIO, P269, DOI DOI 10.1007/978-1-4471-0563-3_30; Sekeres MJ, 2016, LEARN MEMORY, V23, P72, DOI 10.1101/lm.039057.115; Sellen A, 2007, CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1 AND 2, P81; Silva AR, 2018, NEUROPSYCHOL REHABIL, V28, P117, DOI 10.1080/09602011.2015.1128450; Simons DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022757; Simons DJ, 1999, PERCEPTION, V28, P1059, DOI 10.1068/p2952; Soderstrom NC, 2016, PSYCHOL SCI, V27, P223, DOI 10.1177/0956797615617778; St Jacques PL, 2015, MEMORY, V23, P876, DOI 10.1080/09658211.2014.933241; St Jacques PL, 2013, P NATL ACAD SCI USA, V110, P19671, DOI 10.1073/pnas.1319630110; St Jacques PL, 2013, PSYCHOL SCI, V24, P537, DOI 10.1177/0956797612457377; Stanny CJ, 2000, AM J PSYCHOL, V113, P359, DOI 10.2307/1423364; SUENGAS AG, 1988, J EXP PSYCHOL GEN, V117, P377, DOI 10.1037/0096-3445.117.4.377; Sutherland R, 2001, APPL COGNITIVE PSYCH, V15, P249, DOI 10.1002/acp.700; Theunissen TPM, 2017, APPL COGNITIVE PSYCH, V31, P164, DOI 10.1002/acp.3314; TOUSIGNANT JP, 1986, MEM COGNITION, V14, P329, DOI 10.3758/BF03202511; TULVING E, 1973, PSYCHOL REV, V80, P352, DOI 10.1037/h0020071; Tulving E, 2001, PHILOS T R SOC B, V356, P1505, DOI 10.1098/rstb.2001.0937; Turner BL, 2019, P NATL ACAD SCI USA, V116, P1201, DOI 10.1073/pnas.1805928116; van Gelder JL, 2019, J RES CRIME DELINQ, V56, P451, DOI 10.1177/0022427818819696; Vredeveldt A, 2016, J APPL RES MEM COGN, V5, P252; Wade KA, 2002, PSYCHON B REV, V9, P597, DOI 10.3758/BF03196318; Walther E, 2002, APPL COGNITIVE PSYCH, V16, P793, DOI 10.1002/acp.828; Wasserman Howard M., 2015, WASH U L REV, V92, P831; Wells GL, 1998, LAW HUMAN BEHAV, V22, P603, DOI 10.1023/A:1025750605807; Westera NJ, 2017, POLIC SOC, V27, P157, DOI 10.1080/10439463.2015.1039002; White M. D, 2014, POLICE OFFICER BODY; Willits DW, 2018, J RES CRIME DELINQ, V55, P51, DOI 10.1177/0022427817701257; Wixted JT, 1997, MEM COGNITION, V25, P731, DOI 10.3758/BF03211316; WIXTED JT, 1991, PSYCHOL SCI, V2, P409, DOI 10.1111/j.1467-9280.1991.tb00175.x; Wright AM, 2007, APPL COGNITIVE PSYCH, V21, P19, DOI 10.1002/acp.1260; Wright DB, 2009, CURR DIR PSYCHOL SCI, V18, P174, DOI 10.1111/j.1467-8721.2009.01631.x; Wright DB, 2001, APPL COGNITIVE PSYCH, V15, P471, DOI 10.1002/acp.719.abs; Zaragoza MS, 1996, PSYCHOL SCI, V7, P294, DOI 10.1111/j.1467-9280.1996.tb00377.x	98	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243226	10.1371/journal.pone.0243226	http://dx.doi.org/10.1371/journal.pone.0243226			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH1IW	33326467	Green Published, gold			2022-12-27	WOS:000600176400024
J	Hong, V; Iwamoto, SK; Goto, R; Young, S; Chomduangthip, S; Weeranakin, N; Nishi, A				Hong, Vennis; Iwamoto, Sage K.; Goto, Rei; Young, Sean; Chomduangthip, Sukhawadee; Weeranakin, Natirath; Nishi, Akihiro			Socio-demographic determinants of motorcycle speeding in Maha Sarakham, Thailand	PLOS ONE			English	Article							HEALTH-RISK BEHAVIORS; NETWORK AUTOCORRELATION; GENDER-DIFFERENCES; INJURY; DRIVERS; VIOLATIONS; MODELS; YOUTHS	Thailand has the highest road traffic fatality rate in Southeast Asia, making road safety a critical public health concern. A 2015 World Health Organization (WHO) Report showed that speeding behavior was the most important determinant for road traffic crashes in Thailand. Here, we aimed to examine associations of socio-demographic factors (gender, age, socioeconomic status) with self-reported motorcycle speeding behavior. Additionally, we examined a potential role of time discounting and risk preference as mediators in the association of socio-demographic factors with speeding. We used data obtained from the Mahasarakham University Social Network Survey 2018 (MSUSSS) (N = 150). We ran linear network autocorrelation models (lnam) to account for the data's social network structure. We found that males are more likely than females to engage in speeding behavior (beta = 0.140, p = 0.001) and to discount the future (beta = 5.175, p = 0.017). However, further causal mediation analysis showed that time discounting does not mediate the gender-speeding association (p for mediation = 0.540). Although socioeconomic status (subjective social class) was not associated with speeding (beta = 0.039, p = 0.177), age was marginally associated with speeding (beta = 0.005, p = 0.093). Future studies may consider using a larger sample.	[Hong, Vennis; Nishi, Akihiro] Kaiser Permanente, Dept Res & Evaluat, Pasadena, CA USA; [Hong, Vennis; Nishi, Akihiro] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA; [Iwamoto, Sage K.] Univ Calif Berkeley, Coll Letters & Sci, Berkeley, CA 94720 USA; [Goto, Rei] Keio Univ, Grad Sch Business Adm, Yokohama, Kanagawa, Japan; [Young, Sean] Univ Calif Irvine, Dept Informat, Donald Bren Sch Informat & Comp Sci, Irvine, CA USA; [Young, Sean] UC Irvine, Dept Emergency Med, Irvine, CA USA; [Chomduangthip, Sukhawadee] Kalasin Hosp, Dept Clin Pathol & Lab Med, Kalasin, Kalasin, Thailand; [Weeranakin, Natirath] Mahasarakham Univ, Fac Informat, Maha Sarakham, Thailand; [Nishi, Akihiro] Univ Calif Los Angeles, Calif Ctr Populat Res, Los Angeles, CA 90024 USA; [Nishi, Akihiro] Univ Calif Los Angeles, Bedari Kindness Inst, Los Angeles, CA 90024 USA	Kaiser Permanente; University of California System; University of California Los Angeles; University of California System; University of California Berkeley; Keio University; University of California System; University of California Irvine; University of California System; University of California Irvine; Mahasarakham University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Nishi, A (corresponding author), Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA.; Nishi, A (corresponding author), Univ Calif Los Angeles, Calif Ctr Populat Res, Los Angeles, CA 90024 USA.; Nishi, A (corresponding author), Univ Calif Los Angeles, Bedari Kindness Inst, Los Angeles, CA 90024 USA.	akihironishi@ucla.edu		Nishi, Akihiro/0000-0003-1629-5985; Iwamoto, Sage/0000-0002-1870-5485				Akerlund D, 2016, P NATL ACAD SCI USA, V113, P6160, DOI 10.1073/pnas.1522445113; Akesaka M, 2018, 1028 ISER; Anderson LR, 2008, J HEALTH ECON, V27, P1260, DOI 10.1016/j.jhealeco.2008.05.011; [Anonymous], 2006, PLOS CLIN TRIALS, V1, pe33, DOI 10.1371/journal.pctr.0010033; [Anonymous], 2016, UKRAINSKA ENTOMOFAUN; [Anonymous], 2016, J CETACEAN RES MANAG, V17, P80; Bank AD, 2011, TRANSPORT SECTOR ASS; Barlow P, 2017, INT J EPIDEMIOL, V46, P860, DOI 10.1093/ije/dyw233; Barlow P, 2016, OBES REV, V17, P810, DOI 10.1111/obr.12431; Charness G, 2012, J ECON BEHAV ORGAN, V83, P50, DOI 10.1016/j.jebo.2011.06.007; Chen F, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16142632; Chen F, 2011, ACCIDENT ANAL PREV, V43, P1677, DOI 10.1016/j.aap.2011.03.026; Chumpawadee U, 2015, FACTORS RELATED MOTO, V46; DEWAARD D, 1994, ACCIDENT ANAL PREV, V26, P751, DOI 10.1016/0001-4575(94)90052-3; Dittrich D, 2019, SOCIOL METHOD RES, V48, P642, DOI 10.1177/0049124117729712; Dittrich M, 2014, ECON LETT, V122, P413, DOI 10.1016/j.econlet.2014.01.002; Dow MM, 2008, CROSS-CULT RES, V42, P394, DOI 10.1177/1069397108320411; Frederick S, J EC LIT, V40, P351; Freeman J, 2017, ACCIDENT ANAL PREV, V104, P1, DOI 10.1016/j.aap.2017.03.022; Hiang TS, 2016, MATEC WEB CONF, V74, DOI 10.1051/matecconf/20167400030; Huang HL, 2016, J TRANSP GEOGR, V54, P248, DOI 10.1016/j.jtrangeo.2016.06.012; Islam S, 2017, ACCIDENT ANAL PREV, V108, P163, DOI 10.1016/j.aap.2017.08.016; Jensupakarn A, 2018, ACCIDENT ANAL PREV, V113, P317, DOI 10.1016/j.aap.2018.02.007; Khallad Y, 2013, J PSYCHOL, V147, P357, DOI 10.1080/00223980.2012.694379; Khallad Y, 2010, J HEALTH PSYCHOL, V15, P925, DOI 10.1177/1359105309359543; Korn L, 2018, SUBST USE MISUSE, V53, P59, DOI 10.1080/10826084.2017.1323924; Korn L, 2017, TRAFFIC INJ PREV, V18, P813, DOI 10.1080/15389588.2017.1316842; Leenders RTAJ, 2002, SOC NETWORKS, V24, P21, DOI 10.1016/S0378-8733(01)00049-1; Miura T, 2017, DISCUSS PAP EC BUS; Nagueh SF, 2016, J AM SOC ECHOCARDIOG, V29, P277, DOI 10.1016/j.echo.2016.01.011; NEDERHOF AJ, 1985, EUR J SOC PSYCHOL, V15, P263, DOI 10.1002/ejsp.2420150303; Olumide AO, 2017, INT J INJ CONTROL SA, V24, P198, DOI 10.1080/17457300.2015.1132733; ORD K, 1975, J AM STAT ASSOC, V70, P120, DOI 10.2307/2285387; PHILLIPS DL, 1972, AM J SOCIOL, V77, P921, DOI 10.1086/225231; Powell J, 2005, J MED INTERNET RES, V7, DOI 10.2196/jmir.7.1.e4; Prince JT, 2011, APPL ECON LETT, V18, P501, DOI 10.1080/13504851003761806; Silverman IW, 2003, GENDER DIFFERENCES D; Stephens AN, 2017, ACCIDENT ANAL PREV, V103, P56, DOI 10.1016/j.aap.2017.03.020; Swedler David I, 2012, Ann Adv Automot Med, V56, P97; Tingley D, 2014, J STAT SOFTW, V59; Waseela M, 2015, ASIA-PAC J PUBLIC HE, V27, P277, DOI 10.1177/1010539514539544; WHO, 2018, GLOBAL STATUS REPORT, DOI DOI 10.1037/COU0000248; World Bank, 2007, STRAT URB TRANSP POL; World Health Organization, 2015, ROAD SAF I LEG ASS T; World Health Organization, 2016, ROAD SAF EST NUMB RO; World Health Organization, 2016, ROAD SAF S E AS REG; Zeng Q, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082768; Zeng Q, 2020, J TRANSP SAF SECUR, V12, P566, DOI 10.1080/19439962.2018.1516259; Zeng Q, 2017, ACCIDENT ANAL PREV, V99, P184, DOI 10.1016/j.aap.2016.11.018; Zhang GN, 2014, ACCIDENT ANAL PREV, V64, P30, DOI 10.1016/j.aap.2013.11.002	50	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243930	10.1371/journal.pone.0243930	http://dx.doi.org/10.1371/journal.pone.0243930			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH1IW	33326462	Green Published, gold			2022-12-27	WOS:000600176400049
J	Webb, SJN; Schapiro, SJ; Sherwood, CC; Raghanti, MA; Hopkins, WD				Webb, Sarah J. Neal; Schapiro, Steven J.; Sherwood, Chet C.; Raghanti, Mary Ann; Hopkins, William D.			Neutrophil to Lymphocyte Ratio (NLR) in captive chimpanzees (Pan troglodytes): The effects of sex, age, and rearing	PLOS ONE			English	Article							ALLOSTATIC LOAD; DISEASE; STRESS; PLATELET; OUTCOMES; HUMANS; MARKER; CANCER	In humans, neutrophil to lymphocyte ratio (NLR) has been used as a clinical tool in diagnosis and/or prognosis of a variety of cancers and medical conditions, as well as in measuring physiological stress over time. Given the close phylogenetic relationship and physical similarities between humans and apes, NLR may similarly be a useful diagnostic tool in assessing chimpanzee health. Only one study has examined NLR in apes, reporting that NLR increased with age and was affected by body-mass index and sex. In the current study, we examined changes in NLR data from longitudinal health records for 443 chimpanzees in two captive chimpanzee populations. Using these data, we analyzed intra-individual changes and inter-individual differences in NLR as a function of age, rearing history, and sex. Contrary to previous studies in humans and the one previous study in chimpanzees, NLR values did not change over a 10-year timespan within individual chimpanzees. However, cross-sectional comparisons revealed a significant quadratic relationship between age and NLR, with the highest values during mid-life (20-30 years of age) and the lowest values in younger and older individuals. Additionally, males and mother-reared individuals had higher NLR than females and nursery-reared chimpanzees, respectively. Lastly, males and those with higher NLR values died at younger ages. These findings suggest that NLR may be useful as a predictor of longevity in chimpanzees. However, given the complexities of these relationships, more research is needed to determine the utility of NLR as a diagnostic health tool for chimpanzees.	[Webb, Sarah J. Neal; Schapiro, Steven J.; Hopkins, William D.] Univ Texas MD Anderson Canc Ctr, Michale Keeling Ctr Comparat Med & Res, Natl Ctr Chimpanzee Care, Bastrop, TX 78602 USA; [Schapiro, Steven J.] Univ Copenhagen, Dept Expt Med, Copenhagen, Denmark; [Sherwood, Chet C.] George Washington Univ, Dept Anthropol, Washington, DC USA; [Sherwood, Chet C.] George Washington Univ, Ctr Adv Study Human Paleobiol, Washington, DC USA; [Raghanti, Mary Ann] Kent State Univ, Dept Anthropol, Sch Biomed Sci, Kent, OH 44242 USA; [Raghanti, Mary Ann] Kent State Univ, Brain Hlth Res Inst, Kent, OH 44242 USA	University of Texas System; UTMD Anderson Cancer Center; University of Copenhagen; George Washington University; George Washington University; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem	Webb, SJN (corresponding author), Univ Texas MD Anderson Canc Ctr, Michale Keeling Ctr Comparat Med & Res, Natl Ctr Chimpanzee Care, Bastrop, TX 78602 USA.	sjneal@mdanderson.org		Neal Webb, Sarah/0000-0001-9393-3528	Office of Research Infrastructure Programs (ORIP) and Office of the Director (OD) [ORIP/OD P51OD011132];  [U42-OD011197]	Office of Research Infrastructure Programs (ORIP) and Office of the Director (OD); 	The National Center for Chimpanzee Care chimpanzees are supported by Cooperative Agreement U42-OD011197. The Yerkes chimpanzees are supported by the Office of Research Infrastructure Programs (ORIP) and Office of the Director (OD) ORIP/OD P51OD011132.	[Anonymous], 2018, MED BALTIMORE, V97, pe9654; [Anonymous], 2016, CANC DISCOV; [Anonymous], 2017, INADEQUATE HAND OFF, V58, P1; Association AVM, 2020, AVMA GUIDELINES EUTH; Azab B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112361; Baldessari A, 2013, PATHOBIOL AGING AGE, V3, DOI 10.3402/pba.v3i0.21073; BARD KA, 1992, INFANT BEHAV DEV, V15, P43, DOI 10.1016/0163-6383(92)90005-Q; Bhat T, 2013, EXPERT REV CARDIOVAS, V11, P55, DOI [10.1586/erc.12.159, 10.1586/ERC.12.159]; Capitanio J.P., 2006, NURSERY REARING NONH, P191, DOI [10.1007/978-0-387-25640-5_11, DOI 10.1007/978-0-387-25640-5_11]; Chmielewski PP, 2016, ANN ANAT, V204, P1, DOI 10.1016/j.aanat.2015.09.002; Conti G, 2012, P NATL ACAD SCI USA, V109, P8866, DOI 10.1073/pnas.1205340109; Council NR, 1997, CHIMPANZEES RES STRA, P38; Davis JL, 2016, BIOMARK MED, V10, P953, DOI 10.2217/bmm-2016-0103; Doane CJ, 2006, COMPARATIVE MED, V56, P512; DYKE B, 1995, AM J PRIMATOL, V37, P25, DOI 10.1002/ajp.1350370104; Edes AN, 2017, AM J PHYS ANTHROPOL, V162, P44, DOI 10.1002/ajpa.23146; Edler MK, 2017, NEUROBIOL AGING, V59, P107, DOI 10.1016/j.neurobiolaging.2017.07.006; Ely JJ, 2013, ZOO BIOL, V32, P79, DOI 10.1002/zoo.21044; Ethier JL, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-016-0794-1; Forget Patrice, 2017, BMC Res Notes, V10, P12, DOI 10.1186/s13104-016-2335-5; Guevara EE, PHILOS T ROYAL SOC B; Hajibandeh S, 2020, AM J SURG, V219, P154, DOI 10.1016/j.amjsurg.2019.04.018; Han CQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10516-6; Howell S, 2003, COMPARATIVE MED, V53, P413; Hwang SY, 2017, AM J EMERG MED, V35, P234, DOI 10.1016/j.ajem.2016.10.055; Jeon TJ, 2017, WORLD J GASTROENTERO, V23, P3883, DOI 10.3748/wjg.v23.i21.3883; Jiang JW, 2019, AM J EMERG MED, V37, P1482, DOI [10.1016/j.ajem.2018.10.057, 10.1016/ajem.2018.10.057]; Karatas MB, 2016, ACTA CARDIOL SIN, V32, P313, DOI 10.6515/ACS20151013A; Kos Fahriye Tugba, 2015, Asian Pac J Cancer Prev, V16, P3997; Kuyumcu ME, 2012, DEMENT GERIATR COGN, V34, P69, DOI 10.1159/000341583; Lambeth SP, 2013, ANIM WELFARE, V22, P429, DOI 10.7120/09627286.22.4.429; Lammey ML, 2008, COMPARATIVE MED, V58, P389; Lammey ML, 2008, J MED PRIMATOL, V37, P39, DOI 10.1111/j.1600-0684.2007.00260.x; Li J, 2015, J CLIN LAB ANAL, V29, P437, DOI 10.1002/jcla.21791; Lin BD, 2016, BIOMARK MED, V10, P1061, DOI 10.2217/bmm-2016-0147; Lowenstine LJ, 2016, VET PATHOL, V53, P250, DOI 10.1177/0300985815612154; Lubach GR, 2006, NURSERY REARING NONH, P135; Madgen E, 2017, HDB PRIMATE BEHAV MA, P201; Maestripieri D, 2011, DEV PSYCHOPATHOL, V23, P1187, DOI 10.1017/S0954579411000551; Malietzis G, 2014, ANN SURG ONCOL, V21, P3938, DOI 10.1245/s10434-014-3815-2; Nunamaker EA, 2012, COMPARATIVE MED, V62, P131; Obanda V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104602; Peng B, 2015, INT J CLIN EXP MED, V8, P3098; Proctor MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116206; Rembach A, 2014, J NEUROIMMUNOL, V273, P65, DOI 10.1016/j.jneuroim.2014.05.005; Sackett GP, 2006, DEV PRIMATOL; Sholl J, 2020, BIOGERONTOLOGY, V21, P399, DOI 10.1007/s10522-020-09872-0; Spinelli S, 2009, ARCH GEN PSYCHIAT, V66, P658, DOI 10.1001/archgenpsychiatry.2009.52; Strong VJ, 2016, J ZOO WILDLIFE MED, V47, P697; Varki N, 2009, EVOL APPL, V2, P101, DOI 10.1111/j.1752-4571.2008.00064.x; Videan EN, 2009, COMPARATIVE MED, V59, P287; Wang F, 2019, CNS NEUROSCI THER, V25, P30, DOI 10.1111/cns.12977; Zahorec R, 2001, Bratisl Lek Listy, V102, P5	53	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0244092	10.1371/journal.pone.0244092	http://dx.doi.org/10.1371/journal.pone.0244092			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326497	Green Published, gold, Green Submitted			2022-12-27	WOS:000600176400034
J	Kim, M; Park, DH				Kim, Minjung; Park, Do Hyun			A model and the behavioral implications of the calculus of consent: The dilemma of public choice before public choice	PLOS ONE			English	Article							LAW	The choice of a group decision-making rule is one of the most important political issues. Buchanan and Tullock have provided a framework for analyzing the optimal k-majority rule from the perspective of "methodological individualism." They proposed the concept of "external costs" and "decision costs" and argued that the optimal k-majority rule takes place where the sum of these two costs-"total costs"-is minimized. Despite the fact that the approach is widely accepted as a tool for dealing with public decision-making rules, the study of formalizing these two costs in a quantitative manner has been relatively rare. We propose a systematic way of modeling these costs considering the assumptions mentioned by Buchanan and Tullock. We find that the resulting shape of the graphs is generally similar to that of the Buchanan-Tullock model, except for some minor details. Then, using this analytical model, we investigate several factors that could affect Buchanan-Tullock's two costs and the optimal k-majority rule. We show that "clustering of disadvantages" (social factor) and "loss aversion" (personal factor) could increase external costs in Buchanan-Tullock's model. These factors can result in a separation between the theoretical and actual optimal k-majority rules. Meanwhile, some recent developments in information and communication technologies can not only decrease decision costs, but also increase the same costs simultaneously through amplified "group polarization" (technological factor). If the effect of the former is not the same as that of the latter, this leads to a difference in optimal k-majority rules as well. These discrepancies bring us to the dilemma of "public choice before public choice."	[Kim, Minjung; Park, Do Hyun] Sungkyunkwan Univ, Dept Phys, Suwon, South Korea; [Park, Do Hyun] Seoul Natl Univ, Dept Sch Law, Seoul, South Korea	Sungkyunkwan University (SKKU); Seoul National University (SNU)	Park, DH (corresponding author), Seoul Natl Univ, Dept Sch Law, Seoul, South Korea.	gray@snu.ac.kr		, Do Hyun/0000-0003-0199-4337; Kim, Minjung/0000-0002-1732-3418	National Research Foundation of Korea (NRF) - Korea government (MSIT) [2017R1A2B2005957, 2019R1A2C2089463]	National Research Foundation of Korea (NRF) - Korea government (MSIT)	Minjung Kim was supported by the National Research Foundation of Korea (NRF; https://www.nrf.re.kr/) grant funded by the Korea government (MSIT) Grant No.2017R1A2B2005957, and No.2019R1A2C2089463. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boettke Petter, 2014, J LAW EC POLICY, V10, P649; Boettke PJ, 2018, BUCHANANS TENSIONS R; Boudreaux K., 1998, EUROPEAN J LAW EC, V5, P133, DOI DOI 10.1023/A:1008636301079; Buchanan J. M., 1962, CALCULUS CONSENT LOG; Colleoni E, 2014, J COMMUN, V64, P317, DOI 10.1111/jcom.12084; Condorcet, 1785, ESSAY APPL ANAL PROB; Congleton RD, 2001, PUBLIC CHOICE, V107, P35, DOI 10.1023/A:1010337412291; Dougherty K. L., 2004, POLITICS PHILOS EC, V3, P161; Dougherty KL, 2015, PUBLIC CHOICE, V163, P31, DOI 10.1007/s11127-014-0191-1; Dougherty KL, 2011, STUD PUBLIC CHOICE, P1, DOI 10.1007/978-0-387-98171-0; Downs A., 1957, EC THEORY DEMOCRACY; Guttman J. M., 1998, EUROPEAN J POLITICAL, V14, P189, DOI DOI 10.1016/S0176-2680(98)00002-0; Jolls C, 1998, STANFORD LAW REV, V50, P1471, DOI 10.2307/1229304; KAFOGLIS MZ, 1981, PUBLIC CHOICE, V36, P179, DOI 10.1007/BF00163783; KAHNEMAN D, 1990, J POLIT ECON, V98, P1325, DOI 10.1086/261737; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kahneman D., 2011, THINKING FAST SLOW; L?vy P., 1997, COLLECTIVE INTELLIGE; Mueller DennisC., 2003, PUBLIC CHOICE; Pariser E., 2011, FILTER BUBBLE WHAT I; Rawls J, 1993, POLITICAL LIBERALISM; Rawls John, 1999, THEORY JUSTICE REVIS; Sunstein CR, 2002, J POLIT PHILOS, V10, P175, DOI 10.1111/1467-9760.00148; Thrasher J, 2017, OXFORD HDB CLASSICS; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; Vragov R, 2013, ELECTRON COMMER R A, V12, P440, DOI 10.1016/j.elerap.2013.06.003; Wagner RE, 2017, BUCHANAN LIBERAL POL; Wagner RE, 2019, BUCHANAN THEORIST PO; Wicksell K., 1896, FINANZTHEORETISCHE U; Wolff J., 2007, DISADVANTAGE	30	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243728	10.1371/journal.pone.0243728	http://dx.doi.org/10.1371/journal.pone.0243728			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH3TP	33320869	Green Published, gold			2022-12-27	WOS:000600339800064
J	Teh, K; Armitage, P; Tesfaye, S; Selvarajah, D; Wilkinson, ID				Teh, Kevin; Armitage, Paul; Tesfaye, Solomon; Selvarajah, Dinesh; Wilkinson, Iain D.			Imbalanced learning: Improving classification of diabetic neuropathy from magnetic resonance imaging	PLOS ONE			English	Article							MACHINE; SMOTE; SEGMENTATION; ACCURATE	One of the fundamental challenges when dealing with medical imaging datasets is class imbalance. Class imbalance happens where an instance in the class of interest is relatively low, when compared to the rest of the data. This study aims to apply oversampling strategies in an attempt to balance the classes and improve classification performance. We evaluated four different classifiers from k-nearest neighbors (k-NN), support vector machine (SVM), multilayer perceptron (MLP) and decision trees (DT) with 73 oversampling strategies. In this work, we used imbalanced learning oversampling techniques to improve classification in datasets that are distinctively sparser and clustered. This work reports the best oversampling and classifier combinations and concludes that the usage of oversampling methods always outperforms no oversampling strategies hence improving the classification results.	[Teh, Kevin; Armitage, Paul; Wilkinson, Iain D.] Univ Sheffield, Acad Unit Radiol, Dept Infect Immun & Cardiovasc Dis, Sheffield, S Yorkshire, England; [Tesfaye, Solomon; Selvarajah, Dinesh] Sheffield Teaching Hosp NHS Fdn Trust, Diabet Res Dept, Sheffield, S Yorkshire, England; [Selvarajah, Dinesh] Univ Sheffield, Dept Oncol & Metab, Sheffield, S Yorkshire, England	University of Sheffield; University of Sheffield; University of Sheffield	Teh, K (corresponding author), Univ Sheffield, Acad Unit Radiol, Dept Infect Immun & Cardiovasc Dis, Sheffield, S Yorkshire, England.	k.teh@sheffield.ac.uk		Selvarajah, Dinesh/0000-0001-7426-1105; Tesfaye, Solomon/0000-0003-1190-1472; Teh, Kevin/0000-0003-2538-5157				Akbani R., 2004, EUR C MACH LEARN; Albers JW, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0473-5; Barua Sukarna, 2013, Advances in Knowledge Discovery and Data Mining. 17th Pacific-Asia Conference (PAKDD 2013). Proceedings, P317, DOI 10.1007/978-3-642-37456-2_27; Bastyr EJ, 2005, CLIN THER, V27, P1278, DOI 10.1016/j.clinthera.2005.08.002; Batuwita R, 2010, IEEE T FUZZY SYST, V18, P558, DOI 10.1109/TFUZZ.2010.2042721; Bunkhumpornpat C, 2013, 2013 13 INT S COMM I; Campbell JN, 2006, NEURON, V52, P77, DOI 10.1016/j.neuron.2006.09.021; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Chen S, 2010, 2010 IEEE 24 INT C A; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Darasay B., 1991, NEAREST NEIGHBOR PAT; Fernandez A, 2018, J ARTIF INTELL RES, V61, P863, DOI 10.1613/jair.1.11192; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Fotouhi S, 2019, J BIOMED INFORM, V90, DOI 10.1016/j.jbi.2018.12.003; Gazzah S, 2008, PROCEEDINGS OF THE 8TH IAPR INTERNATIONAL WORKSHOP ON DOCUMENT ANALYSIS SYSTEMS, P677, DOI 10.1109/DAS.2008.74; Gu Q, 2009, INT S INT COMP APPL; Guo HX, 2017, EXPERT SYST APPL, V73, P220, DOI 10.1016/j.eswa.2016.12.035; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Han H., 2005, INT C INT COMP; He HB, 2009, IEEE T KNOWL DATA EN, V21, P1263, DOI 10.1109/TKDE.2008.239; He HB, 2008, IEEE IJCNN, P1322, DOI 10.1109/IJCNN.2008.4633969; Jeni LA, 2013, INT CONF AFFECT, P245, DOI 10.1109/ACII.2013.47; Jurgovsky J, 2018, EXPERT SYST APPL, V100, P234, DOI 10.1016/j.eswa.2018.01.037; KNOWLER WC, 1981, AM J EPIDEMIOL, V113, P144, DOI 10.1093/oxfordjournals.aje.a113079; Koto F, 2014, INT C ADV COMP SCI I, P280, DOI 10.1109/ICACSIS.2014.7065849; Kovacs G., 2019, NEUROCOMPUTING; Kovacs G, 2019, APPL SOFT COMPUT, V83, DOI 10.1016/j.asoc.2019.105662; Krawczyk B, 2016, APPL SOFT COMPUT, V38, P714, DOI 10.1016/j.asoc.2015.08.060; Kukar M, 1998, COST SENSITIVE LEARN; Lee J, 2015, P 9 INT C UB INF MAN; Lomax S, 2013, ACM COMPUT SURV, V45, DOI 10.1145/2431211.2431215; Lopez V, 2014, INFORM SCIENCES, V257, P1, DOI 10.1016/j.ins.2013.09.038; Moro R, 2008, SUPPORT VECTOR MACHI; Nekooeimehr I, 2016, EXPERT SYST APPL, V46, P405, DOI 10.1016/j.eswa.2015.10.031; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Qi ZQ, 2013, PROCEDIA COMPUT SCI, V18, P1684, DOI 10.1016/j.procs.2013.05.336; Raeder T, 2012, INTEL SYST REF LIBR, V23, P315; Ramentol E, 2016, ENG APPL ARTIF INTEL, V48, P134, DOI 10.1016/j.engappai.2015.10.009; Reuter M, 2010, NEUROIMAGE, V53, P1181, DOI 10.1016/j.neuroimage.2010.07.020; Saez JA, 2015, INFORM SCIENCES, V291, P184, DOI 10.1016/j.ins.2014.08.051; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Segonne F, 2007, IEEE T MED IMAGING, V26, P518, DOI 10.1109/TMI.2006.887364; Selvarajah D, 2011, CURR DIABETES REP, V11, P310, DOI 10.1007/s11892-011-0205-z; Sun YM, 2007, PATTERN RECOGN, V40, P3358, DOI 10.1016/j.patcog.2007.04.009; Theodoridis S., 2008, PATTERN RECOGN, V4th ed.; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Wilkinson ID, 2013, CURR DIABETES REP, V13, P509, DOI 10.1007/s11892-013-0394-8; Zacharaki EI, 2009, MAGN RESON MED, V62, P1609, DOI 10.1002/mrm.22147; Zheng Z., 2004, ACM SIGKDD EXPLOR NE, V6, P80, DOI [10.1145/1007730.1007741, DOI 10.1145/1007730.1007741]; Zhou B, 2013, IEEE IJCNN, DOI 10.1109/CLEOE-IQEC.2013.6801089	55	6	6	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243907	10.1371/journal.pone.0243907	http://dx.doi.org/10.1371/journal.pone.0243907			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320890	Green Accepted, Green Published, gold			2022-12-27	WOS:000600339800016
J	Altonen, BL; Arreglado, TM; Leroux, O; Murray-Ramcharan, M; Engdahl, R				Altonen, Brian L.; Arreglado, Tatiana M.; Leroux, Ofelia; Murray-Ramcharan, Max; Engdahl, Ryan			Characteristics, comorbidities and survival analysis of young adults hospitalized with COVID-19 in New York City	PLOS ONE			English	Article							INTERRATER RELIABILITY; OUTCOMES; CHILDREN; PREDICT; DISEASE; INDEX; SCORE	This study reviewed 395 young adults, 18-35 year-old, admitted for COVID-19 to one of the eleven hospitals in New York City public health system. Demographics, comorbidities, clinical course, outcomes and characteristics linked to hospitalization were analyzed including temporal survival analysis. Fifty-seven percent of patients had a least one major comorbidity. Mortality without comorbidity was in 3.8% patients. Further investigation of admission features and medical history was conducted. Comorbidities associated with mortality were diabetes (n = 54 deceased/73 diagnosed,74% tested POS;98.2% with diabetic history deceased; Wilcoxon p (Wp) = .044), hypertension (14/44,32% POS, 25.5%; Wp = 0.030), renal (6/16, 37.5% POS,11%; Wp = 0.000), and cardiac (6/21, 28.6% POS,11%; Wp = 0.015). Kaplan survival plots were statistically significant for these four indicators. Data suggested glucose >215 or hemoglobin A1c >9.5 for young adults on admission was associated with increased mortality. Clinically documented respiratory distress on admission was statistically significant outcome related to mortality (X-2 = 236.6842, df = 1, p < .0001). Overall, 28.9% required supportive oxygen beyond nasal cannula. Nasal cannula oxygen alone was required for 71.1%, who all lived. Non-invasive ventilation was required for 7.8%, and invasive mechanical ventilation 21.0% (in which 7.3% lived, 13.7% died). Temporal survival analysis demonstrated statistically significant response for Time to Death <10 days (X-2 = 18.508, df = 1, p = .000); risk lessened considerably for 21 day cut off (X-2 = 3.464, df = 1, p = .063), followed by 31 or more days of hospitalization (X-2 = 2.212, df = 1, p = .137).	[Altonen, Brian L.] NYC Hlth Hosp, Div Populat Hlth & Res Adm, New York, NY USA; [Arreglado, Tatiana M.] NYC Hlth Hosp, Harlem Hosp, Div Clin Informat, New York, NY USA; [Leroux, Ofelia; Murray-Ramcharan, Max; Engdahl, Ryan] NYC Hlth Hosp, Harlem Hosp, Dept Surg, New York, NY 10013 USA; [Engdahl, Ryan] NYC Hlth Hosp, Woodhull Hosp, Dept Surg, New York, NY 10013 USA		Engdahl, R (corresponding author), NYC Hlth Hosp, Harlem Hosp, Dept Surg, New York, NY 10013 USA.; Engdahl, R (corresponding author), NYC Hlth Hosp, Woodhull Hosp, Dept Surg, New York, NY 10013 USA.	ryan.engdahl@nychhc.org		Murray-Ramcharan, Max/0000-0001-7954-0621; Altonen, Brian/0000-0003-4511-3183				Adams SH, 2020, J ADOLESCENT HEALTH, V67, P362, DOI 10.1016/j.jadohealth.2020.06.025; Argenziano Michael G, 2020, medRxiv, DOI 10.1101/2020.04.20.20072116; Atri D, 2020, JACC-BASIC TRANSL SC, V5, P518, DOI 10.1016/j.jacbts.2020.04.002; Austin SR, 2015, MED CARE, V53, pE65, DOI 10.1097/MLR.0b013e318297429c; Bajwah S, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00815-2020; Bansal M, 2020, DIABETES METAB SYND, V14, P247, DOI 10.1016/j.dsx.2020.03.013; Bhatraju PK, 2020, NEW ENGL J MED, V382, P2012, DOI 10.1056/NEJMoa2004500; Boehmer TK, 2020, MMWR MORB MORTAL WKL, V23; Cheng YC, 2020, KIDNEY INT, V97, P829, DOI 10.1016/j.kint.2020.03.005; Choi Soo-Han, 2020, Clin Exp Pediatr, V63, P125, DOI 10.3345/cep.2020.00535; Danser AHJ, 2020, HYPERTENSION, V75, P1382, DOI 10.1161/HYPERTENSIONAHA.120.15082; Davenne E, 2020, Rev Med Liege, V75, P218; Ghosal S, 2020, DIABETES METAB SYND, V14, P311, DOI 10.1016/j.dsx.2020.03.017; Goyal P, 2020, NEW ENGL J MED, V382, P2372, DOI 10.1056/NEJMc2010419; Haeck G, 2020, Rev Med Liege, V75, P226; Hussain A, 2020, DIABETES RES CLIN PR, V162, DOI 10.1016/j.diabres.2020.108142; Imam Z, 2020, J INTERN MED, V288, P469, DOI 10.1111/joim.13119; Khendi White Solaru MD, 2020, EXPERT ANAL; Ladha KS, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008990; Li XC, 2020, J ALLERGY CLIN IMMUN, V146, P110, DOI 10.1016/j.jaci.2020.04.006; Messerli FH, 2020, CIRCULATION, V141, P2042, DOI 10.1161/CIRCULATIONAHA.120.047022; Muniyappa R, 2020, AM J PHYSIOL-ENDOC M, V318, pE736, DOI 10.1152/ajpendo.00124.2020; PICHI B, 2020, ORAL ONCOL, V105, DOI [10.1016/j.oraloncology.2020.104682, DOI 10.1016/J.ORALONCOLOGY.2020.104682]; Richardson S, 2020, JAMA; Sanyaolu A., 2020, CLIN MED, DOI [10.1007/s42399-020-00363-4, DOI 10.1007/S42399-020-00363-4]; Shao F, 2020, RESUSCITATION, V151, P18, DOI 10.1016/j.resuscitation.2020.04.005; Siedlecki SL, 2017, CLIN NURSE SPEC, V31, P23, DOI 10.1097/NUR.0000000000000260; Simard M, 2018, MED CARE, V56, P441, DOI 10.1097/MLR.0000000000000905; Singh AK, 2020, DIABETES METAB SYND, V14, P283, DOI 10.1016/j.dsx.2020.03.016; Su L, 2020, EMERG MICROBES INFEC, V9, P707, DOI 10.1080/22221751.2020.1744483; Su YJ, 2020, TRAVEL MED INFECT DI, V36, DOI 10.1016/j.tmaid.2020.101625; Sundararajan V, 2004, J CLIN EPIDEMIOL, V57, P1288, DOI 10.1016/j.jclinepi.2004.03.012; Tang X, 2020, CHEST, V158, P195, DOI 10.1016/j.chest.2020.03.032; Viitasalo A, 2014, DIABETOLOGIA, V57, P940, DOI 10.1007/s00125-014-3172-5; Wang LS, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm.2020.02.20; Yang X, 2020, LANCET RESP MED, V8, pE26; Yawn BP, 2005, AM J EPIDEMIOL, V161, P974, DOI 10.1093/aje/kwi122; Zhao F, 2020, CLIN RES CARDIOL, V382, P1861	38	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243343	10.1371/journal.pone.0243343	http://dx.doi.org/10.1371/journal.pone.0243343			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315929	gold, Green Published			2022-12-27	WOS:000600186100031
J	Miyamoto, T; Miura, K; Kizuka, T; Ono, S				Miyamoto, Takeshi; Miura, Kenichiro; Kizuka, Tomohiro; Ono, Seiji			Properties of smooth pursuit and visual motion reaction time to second-order motion stimuli	PLOS ONE			English	Article							EYE-MOVEMENTS; AREA MT; PERCEPTION; DIRECTION; 1ST-ORDER; SIGNALS; LESIONS; SPEED; MECHANISMS; CONTRAST	A large number of psychophysical and neurophysiological studies have demonstrated that smooth pursuit eye movements are tightly related to visual motion perception. This could be due to the fact that visual motion sensitive cortical areas such as meddle temporal (MT), medial superior temporal (MST) areas are involved in motion perception as well as pursuit initiation. Although the directional-discrimination and perceived target velocity tasks are used to evaluate visual motion perception, it is still uncertain whether the speed of visual motion perception, which is determined by visuomotor reaction time (RT) to a small target, is related to pursuit initiation. Therefore, we attempted to determine the relationship between pursuit latency/acceleration and the visual motion RT which was measured to the visual motion stimuli that moved leftward or rightward. The participants were instructed to fixate on a stationary target and press one of the buttons corresponding to the direction of target motion as soon as possible once the target starts to move. We applied five different visual motion stimuli including first- and second-order motion for smooth pursuit and visual motion RT tasks. It is well known that second-order motion induces lower retinal image motion, which elicits weaker responses in MT and MST compared to first-order motion stimuli. Our results showed that pursuit initiation including latency and initial eye acceleration were suppressed by second-order motion. In addition, second-order motion caused a delay in visual motion RT. The better performances in both pursuit initiation and visual motion RT were observed for first-order motion, whereas second-order (theta motion) induced remarkable deficits in both variables. Furthermore, significant Pearson's correlation and within-subjects correlation coefficients were obtained between visual motion RT and pursuit latency/acceleration. Our findings support the suggestion that there is a common neuronal pathway involved in both pursuit initiation and the speed of visual motion perception.	[Miyamoto, Takeshi] Univ Tsukuba, Grad Sch Comprehens Human Sci, Ibaraki, Japan; [Miura, Kenichiro] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Pathol Mental Dis, Tokyo, Japan; [Miura, Kenichiro] Kyoto Univ, Grad Sch Med, Dept Integrat Brain Sci, Kyoto, Japan; [Kizuka, Tomohiro; Ono, Seiji] Univ Tsukuba, Fac Hlth & Sport Sci, Tsukuba, Ibaraki, Japan	University of Tsukuba; National Center for Neurology & Psychiatry - Japan; Kyoto University; University of Tsukuba	Ono, S (corresponding author), Univ Tsukuba, Fac Hlth & Sport Sci, Tsukuba, Ibaraki, Japan.	ono.seiji.fp@u.tsukuba.ac.jp	Miyamoto, Takeshi/CAG-9124-2022	Miyamoto, Takeshi/0000-0002-5265-0529				ALBRIGHT TD, 1992, SCIENCE, V255, P1141, DOI 10.1126/science.1546317; [Anonymous], 2015, J CROHNS COLITIS S1, V9, pS15; Beutter BR, 2000, VISUAL NEUROSCI, V17, P139, DOI 10.1017/S0952523800171147; BLAND JM, 1995, BRIT MED J, V310, P446, DOI 10.1136/bmj.310.6977.446; Braun DI, 2008, J NEUROPHYSIOL, V100, P1287, DOI 10.1152/jn.00747.2007; CAVANAGH P, 1989, Spatial Vision, V4, P103, DOI 10.1163/156856889X00077; CHUBB C, 1988, J OPT SOC AM A, V5, P1986, DOI 10.1364/JOSAA.5.001986; Churan J, 2001, J OPT SOC AM A, V18, P2297, DOI 10.1364/JOSAA.18.002297; Churchland AK, 2003, NEURON, V37, P1001, DOI 10.1016/S0896-6273(03)00145-4; Cooper SA, 2012, J NEUROL NEUROSUR PS, V83, P229, DOI 10.1136/jnnp.2010.223727; DERRINGTON AM, 1993, VISION RES, V33, P1785, DOI 10.1016/0042-6989(93)90169-W; Ding L, 2012, CEREB CORTEX, V22, P1052, DOI 10.1093/cercor/bhr178; DURSTELER MR, 1988, J NEUROPHYSIOL, V60, P940, DOI 10.1152/jn.1988.60.3.940; Ellemberg D, 2003, VISION RES, V43, P651, DOI 10.1016/S0042-6989(03)00006-3; Gegenfurtner KR, 2003, J VISION, V3, P865, DOI 10.1167/3.11.19; Gegenfurtner KR, 1996, VISION RES, V36, P1281, DOI 10.1016/0042-6989(95)00198-0; HARRIS LR, 1992, VISUAL NEUROSCI, V9, P565, DOI 10.1017/S0952523800001802; Hawken MJ, 2001, J OPT SOC AM A, V18, P2282, DOI 10.1364/JOSAA.18.002282; Hedges JH, 2011, CURR BIOL, V21, P2023, DOI 10.1016/j.cub.2011.10.049; Hulsdunker T, 2017, MED SCI SPORT EXER, V49, P1097, DOI 10.1249/MSS.0000000000001198; Hulsdunker T, 2019, FRONT BEHAV NEUROSCI, V13, DOI 10.3389/fnbeh.2019.00165; Ilg UJ, 2004, J NEUROPHYSIOL, V92, P1512, DOI 10.1152/jn.01174.2003; Ilg UJ, 2010, DYNAMICS OF VISUAL MOTION PROCESSING: NEURONAL, BEHAVIORAL, AND COMPUTATIONAL APPROACHES, P117, DOI 10.1007/978-1-4419-0781-3_6; KELLER EL, 1991, NEUROSCI RES, V11, P79, DOI 10.1016/0168-0102(91)90048-4; Krauzlis RJ, 2004, J NEUROPHYSIOL, V91, P591, DOI 10.1152/jn.00801.2003; Krukowski AE, 2005, NEURON, V45, P315, DOI 10.1016/j.neuron.2005.01.005; Larcombe SJ, 2018, HUM BRAIN MAPP, V39, P145, DOI 10.1002/hbm.23832; Ledgeway T, 2002, VISION RES, V42, P1739, DOI 10.1016/S0042-6989(02)00106-2; Ledgeway T, 2008, VISION RES, V48, P208, DOI 10.1016/j.visres.2007.11.008; LELKENS AMM, 1984, VISION RES, V24, P1083, DOI 10.1016/0042-6989(84)90086-5; Lindner A, 2000, EXP BRAIN RES, V133, P450, DOI 10.1007/s002210000459; LISBERGER SG, 1987, ANNU REV NEUROSCI, V10, P97, DOI 10.1146/annurev.ne.10.030187.000525; Lisberger SG, 2010, NEURON, V66, P477, DOI 10.1016/j.neuron.2010.03.027; Liu LD, 2017, NEURON, V95, P436, DOI 10.1016/j.neuron.2017.06.024; Matsuda K., 2017, INT C HUMAN COMPUTER, P593; Mukherjee T, 2015, J NEUROSCI, V35, P8515, DOI 10.1523/JNEUROSCI.4320-14.2015; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; NEWSOME WT, 1985, J NEUROSCI, V5, P825; O'Keefe LP, 1998, VISUAL NEUROSCI, V15, P305, DOI 10.1017/S0952523898152094; Ono S, 2007, J NEUROPHYSIOL, V98, P2918, DOI 10.1152/jn.00115.2007; Ono S, 2019, PHYSIOL REP, V7, DOI 10.14814/phy2.14187; Ono S, 2016, J NEUROPHYSIOL, V116, P210, DOI 10.1152/jn.00203.2016; Ono S, 2015, VISION RES, V110, P257, DOI 10.1016/j.visres.2014.06.008; Ono S, 2012, CEREB CORTEX, V22, P1139, DOI 10.1093/cercor/bhr188; Osborne LC, 2004, J NEUROSCI, V24, P3210, DOI 10.1523/JNEUROSCI.5305-03.2004; Osborne LC, 2005, NATURE, V437, P412, DOI 10.1038/nature03961; Osborne LC, 2007, J NEUROSCI, V27, P2987, DOI 10.1523/JNEUROSCI.5072-06.2007; Piponnier JC, 2016, J NEUROTRAUM, V33, P242, DOI 10.1089/neu.2014.3832; Raghavan RT, 2017, J NEUROPHYSIOL, V118, P2216, DOI 10.1152/jn.00317.2017; RASHBASS C, 1961, J PHYSIOL-LONDON, V159, P326, DOI 10.1113/jphysiol.1961.sp006811; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; Schutz AC, 2010, J VISION, V10, DOI 10.1167/10.13.26; Spering M, 2005, J VISION, V5, P455, DOI 10.1167/5.5.6; Spering M, 2011, VISION RES, V51, P836, DOI 10.1016/j.visres.2010.10.017; Stone LS, 2003, J VISION, V3, P725, DOI 10.1167/3.11.7; Thier P, 2005, CURR OPIN NEUROBIOL, V15, P645, DOI 10.1016/j.conb.2005.10.013; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; van Donkelaar P, 2000, PERCEPT PSYCHOPHYS, V62, P378, DOI 10.3758/BF03205557; Watamaniuk SNJ, 1999, VISION RES, V39, P59, DOI 10.1016/S0042-6989(98)00128-X; ZANKER JM, 1993, VISION RES, V33, P553, DOI 10.1016/0042-6989(93)90258-X; Zwierko T, 2010, J HUM KINET, V23, P21, DOI 10.2478/v10078-010-0003-8	62	4	4	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243430	10.1371/journal.pone.0243430	http://dx.doi.org/10.1371/journal.pone.0243430			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315877	Green Published, gold			2022-12-27	WOS:000600186100011
J	Rayan, DM; Linkie, M				Rayan, Mark D.; Linkie, Matthew			Managing threatened ungulates in logged-primary forest mosaics in Malaysia	PLOS ONE			English	Article							TROPICAL RAIN-FOREST; GAUR BOS-GAURUS; CONSERVATION; OCCUPANCY; MAMMALS; PERSISTENCE; IMPACTS; DECLINE; TIGERS	Across the tropics, large-bodied mammals have been affected by selective logging in ways that vary with levels of timber extraction, collateral damage, species-specific traits and secondary effects of hunting, as facilitated by improved access through logging roads. In Peninsular Malaysia, 3.0 million hectares or 61 percent of its Permanent Reserved Forests is officially assigned for commercial selective logging. Understanding how wildlife adapts and uses logged forest is critical for its management and, for threatened species, their conservation. In this study, we quantify the population status of four tropical ungulate species in a large selectively logged forest reserve and an adjacent primary forest protected area. We then conduct finer scale analyses to identify the species-specific factors that determine their occurrence. A combined indirect sign-camera trapping approach with a large sampling effort (2,665 km and 27,780 trap nights surveyed) covering a wide area (560 km(2)) generated species-specific detection probabilities and site occupancies. Populations of wild boar were widespread across both logged and primary forests, whereas sambar and muntjac occupancy was lower in logged forest (48.4% and 19.2% respectively), with gaur showing no significant difference. Subsequent modelling revealed the importance of conserving lower elevation habitat in both habitat types, particularly <1,000 m asl, for which occupancies of sambar, muntjac and gaur were typically higher. This finding is important because 75 percent (similar to 13,400 km(2)) of Peninsular Malaysia's Main Range Forest (Banjaran Titiwangsa) is under 1,000 m asl and therefore at risk of being converted to industrial timber plantations, which calls for renewed thinking around forest management planning.	[Rayan, Mark D.] World Wide Fund Nat WWF Malaysia, Petaling Jaya, Selangor, Malaysia; [Rayan, Mark D.; Linkie, Matthew] Univ Kent, Durrell Inst Conservat & Ecol DICE, Canterbury, Kent, England; [Linkie, Matthew] Wildlife Conservat Soc WCS, Bogor, Indonesia	University of Kent	Rayan, DM (corresponding author), World Wide Fund Nat WWF Malaysia, Petaling Jaya, Selangor, Malaysia.; Rayan, DM (corresponding author), Univ Kent, Durrell Inst Conservat & Ecol DICE, Canterbury, Kent, England.	markrayan78@gmail.com			WWFNetherlands; U.S Fish and Wildlife Service; Mohamed bin Zayed Species Conservation Fund; Malaysian Wildlife Conservation Fund; WWF-US Kathryn Fuller Science for Nature Fellowship; Pulau Banding Foundation	WWFNetherlands; U.S Fish and Wildlife Service(US Fish & Wildlife Service); Mohamed bin Zayed Species Conservation Fund; Malaysian Wildlife Conservation Fund; WWF-US Kathryn Fuller Science for Nature Fellowship; Pulau Banding Foundation	This study was supported by WWFNetherlands, the U.S Fish and Wildlife Service, Mohamed bin Zayed Species Conservation Fund and Malaysian Wildlife Conservation Fund. D. Mark Rayan was supported by WWF-US Kathryn Fuller Science for Nature Fellowship and the Pulau Banding Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz SA, 2010, FRONT ECOL ENVIRON, V8, P178, DOI 10.1890/10.WB.014; Barbieri MM, 2004, ANN STAT, V32, P870, DOI 10.1214/009053604000000238; Bicknell JE, 2014, CURR BIOL, V24, pR1119, DOI 10.1016/j.cub.2014.10.067; Brodie JF, 2015, CONSERV BIOL, V29, P110, DOI 10.1111/cobi.12389; Brown JH, 2001, GLOBAL ECOL BIOGEOGR, V10, P101, DOI 10.1046/j.1466-822x.2001.00228.x; Burnham K.P., 2002, MODEL SELECTION MULT, VSecond edition; Cannon CH, 2007, CURR SCI INDIA, V93, P1558; Choudhury A, 2002, MAMMAL REV, V32, P199, DOI 10.1046/j.1365-2907.2002.00107.x; Cliff A. D., 1981, SPATIAL PROCESSES MO; CONRY PJ, 1989, BIOL CONSERV, V49, P47, DOI 10.1016/0006-3207(89)90112-2; Darmaraj MR, 2012, THESIS; Davies Glyn, 2001, P93; Department of Wildlife and National Parks (DWNP), 2008, NAT TIG ACT PLAN MAL; Djojosudharmo Suharto, 1992, Tropical Biodiversity, V1, P11; Dobrovolski R, 2011, BIODIVERS CONSERV, V20, P2445, DOI 10.1007/s10531-011-9997-z; FDPM, 2018, ANN REPORT; FDPM, 2003, GUID RED IMP LOGG PE; Fimbel R., 2001, CUTTING EDGE CONSERV; Fisher B, 2011, CONSERV LETT, V4, P443, DOI 10.1111/j.1755-263X.2011.00198.x; Guillera-Arroita Gurutzeta, 2010, Endangered Species Research, V11, P157, DOI 10.3354/esr00274; Heydon MJ, 1997, J APPL ECOL, V34, P484, DOI 10.2307/2404892; Hines JE, 2006, PRESENCE V4 SOFTWARE; Ickes K, 2001, J TROP ECOL, V17, P191, DOI 10.1017/S0266467401001134; ITTO, 2007, ANN REV ASS WORLD TI; Jamhuri J, 2018, BIOL CONSERV, V227, P40, DOI 10.1016/j.biocon.2018.09.004; Jetz W, 2004, SCIENCE, V306, P266, DOI 10.1126/science.1102138; Kawanishi K, 2004, BIOL CONSERV, V120, P329, DOI 10.1016/j.biocon.2004.03.005; Kawanishi K, 2013, ORYX, V47, P420, DOI 10.1017/S0030605312000294; Kawanishi Kae, 2011, Cat News, V55, P38; Kawanishi Kae, 2006, Suiform Soundings, V6, P13; Kinnaird MF, 2003, CONSERV BIOL, V17, P245, DOI 10.1046/j.1523-1739.2003.02040.x; Kushwaha SPS, 2004, CURR SCI INDIA, V86, P1390; Linkie M, 2007, BIOL CONSERV, V137, P20, DOI 10.1016/j.biocon.2007.01.016; Long RA, 2011, LANDSCAPE ECOL, V26, P327, DOI 10.1007/s10980-010-9547-1; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x; MacKenzie DI, 2005, ECOLOGY, V86, P1101, DOI 10.1890/04-1060; MacKenzie DI, 2004, J AGR BIOL ENVIR ST, V9, P300, DOI 10.1198/108571104X3361; Madhusudan MD, 2004, J APPL ECOL, V41, P858, DOI 10.1111/j.0021-8901.2004.00950.x; Meijaard E, 2008, BIOTROPICA, V40, P76, DOI 10.1111/j.1744-7429.2007.00340.x; Moore JE, 2005, J WILDLIFE MANAGE, V69, P933, DOI 10.2193/0022-541X(2005)069[0933:MPOBFR]2.0.CO;2; Plumptre Andrew J., 2001, P71; Putz FE, 2012, CONSERV LETT, V5, P296, DOI 10.1111/j.1755-263X.2012.00242.x; Rayan DM, 2016, BIOL CONSERV, V204, P360, DOI 10.1016/j.biocon.2016.11.009; Rayan DM, 2015, BIOL CONSERV, V184, P18, DOI 10.1016/j.biocon.2014.12.024; Roopsind A, 2017, BIOTROPICA, V49, P565, DOI 10.1111/btp.12446; Shearman P, 2012, BIOL CONSERV, V151, P17, DOI 10.1016/j.biocon.2011.10.036; Steinmetz R, 2008, BIOTROPICA, V40, P344, DOI 10.1111/j.1744-7429.2007.00367.x; Tan Win Sim, 2018, Journal of Threatened Taxa, V10, P11245, DOI 10.11609/jott.3519.10.2.11245-11253; WHITMORE T C, 1989, P1	50	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243932	10.1371/journal.pone.0243932	http://dx.doi.org/10.1371/journal.pone.0243932			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315909	Green Published, gold			2022-12-27	WOS:000600186100050
J	D'Amico, AR; Figueira, JEC; Candido, JF; Drumond, MA				D'Amico, Ana Rafaela; Cortes Figueira, Jose Eugenio; Candido-Jr, Jose Flavio; Drumond, Maria Auxiliadora			Environmental diagnoses and effective planning of Protected Areas in Brazil: Is there any connection?	PLOS ONE			English	Article							CONSERVATION; MANAGEMENT; OUTCOMES; INDICATORS; KNOWLEDGE; SCIENCE	Protected Areas (PAs) are essential to maintaining biodiversity, while effective management plans (MPs) are essential for the management of these areas. Thus, MPs must have relevant data analyses and diagnoses to evaluate ecological conditions of PAs. We evaluated the environmental diagnoses of 126 Brazilian federal PAs, the methods used to collect data and defined the diagnostic level of PMs according to the type and number of analyzes performed for each PA category. We found a low level of diagnosis in MPs. Primary field data or research programs resulted in environmental diagnostics of higher levels. Participatory workshops and secondary data, most used in Extractive Reserves, were related to low levels of diagnoses. The most frequent analysis was the identification of threats (97% of MPs), while the least frequent were the definition of conservation targets and future scenarios for management (1.6% of MPs). Our results show that the diagnoses of the MPs need to be more analytical to generate useful information for decision-making. MPs should prioritize data analysis and specific management studies, focused on the use of natural resources, the status of conservation targets, future scenarios, and key information to planning.	[D'Amico, Ana Rafaela] Inst Chico Mendes Conservacao Biodiversidade, Coordenacao Elaboracao & Revisao Pianos Manejo, Brasilia, DF, Brazil; [D'Amico, Ana Rafaela; Drumond, Maria Auxiliadora] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Genet, Lab Sistemas Socioecol, Belo Horizonte, MG, Brazil; [Cortes Figueira, Jose Eugenio] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Genet Ecol & Evolucao, Lab Ecol Populacoes, Belo Horizonte, MG, Brazil; [Candido-Jr, Jose Flavio] Univ Estadual Oeste Parana, Dept Ciencias Biol, Lab Ecol & Conservacao, Cascavel, Parana, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Estadual do Oeste do Parana	Drumond, MA (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Genet, Lab Sistemas Socioecol, Belo Horizonte, MG, Brazil.	alatus@ufmg.br						[Anonymous], 2000, FIELD METHOD, DOI DOI 10.1177/1525822X0001200104; [Anonymous], 2018, FUNDAM CLIN PHARM S1, V32, P6; APN, 2010, GUIA EL PLAN GEST AR; AYRES M., 2007, BIOESTAT; Barlow J, 2006, BIOL CONSERV, V128, P182, DOI 10.1016/j.biocon.2005.09.028; Bertzky B, 2012, PROTECTED PLANET REP, DOI [10.1371/journal.pone.0032529, DOI 10.1371/JOURNAL.PONE.003252922457717]; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Carranza T, 2014, BIOL CONSERV, V173, P10, DOI 10.1016/j.biocon.2014.03.004; Chape S, 2005, PHILOS T R SOC B, V360, P443, DOI 10.1098/rstb.2004.1592; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; [CMP] Conservation Measures Partnership, 2013, OP STAND PRACT CONS; Cook CN, 2012, J ENVIRON MANAGE, V113, P341, DOI 10.1016/j.jenvman.2012.09.002; Dudley N., 2008, DIRECTRICES APLICACI, DOI [10.2305/IUCN.CH.2008.PAPS.2.es, DOI 10.2305/IUCN.CH.2008.PAPS.2.ES]; Failing L, 2007, ECOL ECON, V64, P47, DOI 10.1016/j.ecolecon.2007.03.010; Fearnside PM, 2015, NATURE, V521, P423, DOI 10.1038/521423b; Ferreira J, 2014, SCIENCE, V346, P706, DOI 10.1126/science.1260194; Groves CR, 2002, BIOSCIENCE, V52, P499, DOI 10.1641/0006-3568(2002)052[0499:PFBCPC]2.0.CO;2; Hammer O, 2018, PALEONTOLOGICAL STAT; Hockings M., 2009, NEW DIR EVAL, V122, P53, DOI DOI 10.1002/EV.295; Kapos V, 2009, ORYX, V43, P336, DOI 10.1017/S0030605309990275; Kingston N, 2015, PROTECTED AREA GOVERNANCE AND MANAGEMENT, P327; Kothari A, 2015, PROTECTED AREA GOVERNANCE AND MANAGEMENT, P789; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Le Saout S, 2013, SCIENCE, V342, P803, DOI 10.1126/science.1239268; Leverington F, 2010, ENVIRON MANAGE, V46, P685, DOI 10.1007/s00267-010-9564-5; Batista EKL, 2018, J ENVIRON MANAGE, V205, P40, DOI 10.1016/j.jenvman.2017.09.053; Mathur VB, 2015, PROTECTED AREA GOVERNANCE AND MANAGEMENT, P473; McCune B, 2002, ANAL ECOLOGICAL COMM; MMA, 2019, CAD NAC UN CONS; Nolte C, 2013, CONSERV BIOL, V27, P155, DOI 10.1111/j.1523-1739.2012.01930.x; Nunez E, 2010, METODO PLANIFICACION; O'Connell M, 2017, NAT ECOL EVOL, V1, P1589, DOI 10.1038/s41559-017-0346-9; Sayre R., 2003, NATUREZA FOCO AVALIA; SINAC, 2013, GUIA DIS FORM PLAN G; Soares B, 2010, P NATL ACAD SCI USA, V107, P10821, DOI 10.1073/pnas.0913048107; Spoelder P, 2015, PROTECTED AREA GOVERNANCE AND MANAGEMENT, P381; Van Wilgen NJ, 2015, ENVIRON CONSERV, V42, P246, DOI 10.1017/S0376892914000320; Velazquez J, 2010, J NAT CONSERV, V18, P309, DOI 10.1016/j.jnc.2010.01.004; Woodley S, 2015, PROTECTED AREA GOVERNANCE AND MANAGEMENT, P651	39	0	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0242687	10.1371/journal.pone.0242687	http://dx.doi.org/10.1371/journal.pone.0242687			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306707	Green Published, gold			2022-12-27	WOS:000600144200059
J	Gomes, DF; Azevedo, J; Murta-Fonseca, R; Faurby, S; Antonelli, A; Passos, P				Gomes, Daniel Faustino; Azevedo, Josue; Murta-Fonseca, Roberta; Faurby, Soren; Antonelli, Alexandre; Passos, Paulo			Taxonomic revision of the genus Xenopholis Peters, 1869 (Serpentes: Dipsadidae): Integrating morphology with ecological niche	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; ATLANTIC FOREST; SYSTEMATIC REVISION; SCALARIS WUCHERER; SOUTH-AMERICA; ANOLE LIZARDS; FOOD-HABITS; RAIN-FOREST; SNAKES; COLUBRIDAE	A reliable identification and delimitation of species is an essential pre-requisite for many fields of science and conservation. The Neotropical herpetofauna is the world's most diverse, including many taxa of uncertain or debated taxonomy. Here we tackle one such species complex, by evaluating the taxonomic status of species currently allocated in the snake genus Xenopholis (X. scalaris, X. undulatus, and X. werdingorum). We base our conclusions on concordance between quantitative (meristic and morphometric) and qualitative (color pattern, hemipenes and skull features) analyses of morphological characters, in combination with ecological niche modeling. We recognize all three taxa as valid species and improve their respective diagnosis, including new data on color in life, pholidosis, bony morphology, and male genitalia. We find low overlap among the niches of each species, corroborating the independent source of phenotypic evidence. Even though all three species occur in the leaf litter of distinct forested habitats, Xenopholis undulatus is found in the elevated areas of the Brazilian Shield (Caatinga, Cerrado and Chaco), whereas X. scalaris occurs in the Amazon and Atlantic rainforests, and X. werdingorum in the Chiquitanos forest and Pantanal wetlands. We discuss the disjunct distribution between Amazonian and Atlantic Forest snake species in the light of available natural history and ecological aspects. This study shows the advantages of combining multiple data sources for reliable identification and circumscription of ecologically similar species.	[Gomes, Daniel Faustino; Murta-Fonseca, Roberta; Passos, Paulo] Univ Fed Rio de Janeiro, Dept Vertebrados, Museu Nacl, Rio De Janeiro, Brazil; [Azevedo, Josue; Faurby, Soren; Antonelli, Alexandre] Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden; [Azevedo, Josue; Faurby, Soren; Antonelli, Alexandre] Univ Gothenburg, Gothenburg Global Biodivers Ctr, Gothenburg, Sweden; [Azevedo, Josue] Inst Nacl de Pesquisas da Amazonia, Programa Colecoes Cient Biol, Coordenacao Biodiversidade, Manaus, Amazonas, Brazil; [Murta-Fonseca, Roberta] Univ Fed Mato Grosso do Sul, Bairro Univ, Lab Zool Campus Pantanal, Corumba, MS, Brazil; [Antonelli, Alexandre] Royal Bot Gardens, Surrey, England; [Antonelli, Alexandre] Univ Oxford, Dept Plant Sci, Oxford, England	Universidade Federal do Rio de Janeiro; University of Gothenburg; University of Gothenburg; Institute Nacional de Pesquisas da Amazonia; Universidade Federal de Mato Grosso do Sul; Royal Botanic Gardens, Kew; University of Oxford	Gomes, DF (corresponding author), Univ Fed Rio de Janeiro, Dept Vertebrados, Museu Nacl, Rio De Janeiro, Brazil.	faustino.biologia13@outlook.com		Faustino Gomes, Daniel/0000-0003-0343-1191; Murta-Fonseca, Roberta/0000-0002-3666-2087	Conselho Nacional de Pesquisa e Desenvolvimento Tecnologico e Cientifico; Fundacao Carlos Chagas Filho de Apoio a Pesquisa do Estado do Rio de Janeiro; Swedish Research Council; Knut and Alice Wallenberg Foundation; Swedish Foundation for Strategic Research; Royal Botanic Gardens, Kew	Conselho Nacional de Pesquisa e Desenvolvimento Tecnologico e Cientifico; Fundacao Carlos Chagas Filho de Apoio a Pesquisa do Estado do Rio de Janeiro; Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Royal Botanic Gardens, Kew	Financial support for P. Passos was provided by Conselho Nacional de Pesquisa (http://www.cnpq.br/) e Desenvolvimento Tecnologico e Cientifico and Fundacao Carlos Chagas Filho de Apoio a Pesquisa do Estado do Rio de Janeiro (http://www.faperj.br/).A.Antonelli is financially supported by the Swedish Research Council, the Knut and Alice Wallenberg Foundation, the Swedish Foundation for Strategic Research and the Royal Botanic Gardens, Kew (https://www.kew.org/).	Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Amaral A., 1923, Proceedings of the New England Zoological Club, V8, P85; Amaral A., 1929, MEM I BUTANTAN, V4, P126; [Anonymous], 2017, HABITAT SUITABILITY, DOI DOI 10.1017/9781139028271; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Argolo A.J., 2004, SERPENTES CACAUAIS S, P250; Azevedo JAR, 2016, J BIOGEOGR, V43, P2454, DOI 10.1111/jbi.12803; Bernarde PS, 2010, BIOTA NEOTROP, V10, P167, DOI 10.1590/S1676-06032010000100017; Boulenger G.A, 1896, CATALOGUE SNAKES BRI, VIII; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiner FT, 2015, METHODS ECOL EVOL, V6, P1210, DOI 10.1111/2041-210X.12403; Broennimann O, 2012, GLOBAL ECOL BIOGEOGR, V21, P481, DOI 10.1111/j.1466-8238.2011.00698.x; Bush Mark B., 2006, Biota Neotrop., V6, P0, DOI 10.1590/S1676-06032006000100002; Colinvaux PA, 2001, PALAEOGEOGR PALAEOCL, V166, P51, DOI 10.1016/S0031-0182(00)00201-7; Cope ED., 1874, P ACAD NAT SCI PHILA, V26, P64; Costa GC, 2018, GLOBAL ECOL BIOGEOGR, V27, P285, DOI 10.1111/geb.12694; Costa Henrique Caldeira, 2013, Herpetologia Brasileira, V2, P36; Costa HC, 2013, ZOOTAXA, V3716, P349; Costa LP, 2003, J BIOGEOGR, V30, P71, DOI 10.1046/j.1365-2699.2003.00792.x; Cundall David, 2008, Contributions to Herpetology, V23, P349; Cunha O.R., 1978, B MUSEU PARAENSE EMI, V31, P1; Prudente Ana Lúcia da Costa, 2010, Acta Amaz., V40, P381, DOI 10.1590/S0044-59672010000200016; da Silva JMC., 1996, ORNITOL NEOTROP, V7, P1; Dal Vechio F, 2018, J BIOGEOGR, V45, P2415, DOI 10.1111/jbi.13421; Danielson J.J., 2011, GLOBAL MULTIRESOLUTI, P1; de Carvalho M A, 1998, Cad Saude Publica, V14, P753, DOI 10.1590/S0102-311X1998000400017; De Lima AC, 2009, ZOOTAXA, P31, DOI 10.11646/zootaxa.2203.1.3; de Queiroz K, 1998, ENDLESS FORMS, P57; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; de Resende FC, 2015, ANAT HISTOL EMBRYOL, V44, P225, DOI 10.1111/ahe.12132; Ledo RMD, 2017, J BIOGEOGR, V44, P2551, DOI 10.1111/jbi.13049; Dixon J.R., 1993, MUSEU REGIONALE SCI, VXIII; Dowling H.G., 1960, GUIDE SNAKE HEMIPENI; Dowling Herndon G., 2003, Herpetological Review, V91, P20; DOWLING HG, 1951, COPEIA, P131; FELDKAMP LA, 1984, J OPT SOC AM A, V1, P612, DOI 10.1364/JOSAA.1.000612; Fernandes D.S., 2002, B MUS NAC, V481; Fernandes DS, 2004, HERPETOLOGICA, V60, P245, DOI 10.1655/02-85; Ficetola GF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28796-x; Franca Rafaela C., 2019, Herpetology Notes, V12, P57; Franco Francisco L., 2002, Phyllomedusa, V1, P57; Freire EMX, 2010, ZOOTAXA, P62; Gainsbury AM, 2003, BIOTROPICA, V35, P503, DOI 10.1111/j.1744-7429.2003.tb00607.x; Gotelli NJ, 2011, PRINCIPIOS ESTATISTI, DOI DOI 10.1007/s10533-006-9007-9; Grazziotin FG, 2012, CLADISTICS, V28, P437, DOI 10.1111/j.1096-0031.2012.00393.x; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; Hamdan Breno, 2015, Check List, V11, P1746; Harvey MB, 2008, HERPETOL MONOGR, V22, P54, DOI 10.1655/07-023.1; Henderson RW, 2009, COPEIA, P572, DOI 10.1643/CH-08-190; Hengl T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105992; HOGE A R, 1974, Memorias do Instituto Butantan (Sao Paulo), V38, P137; Hollis JL, 2006, HERPETOLOGICA, V62, P435, DOI 10.1655/0018-0831(2006)62[435:POTGCF]2.0.CO;2; Hoogmoed MS, 2019, S AM J HERPETOL, V14, P88, DOI 10.2994/SAJH-D-17-00014.1; Jadin RC, 2014, J ZOOL SYST EVOL RES, V52, P257, DOI 10.1111/jzs.12055; Jansen M, 2009, ZOOTAXA, P31, DOI 10.11646/zootaxa.2222.1.3; Jensen A.S, 1900, VIDENSK MEDD NATURHI, P99; Jingzhou diqu bowuguan, 1985, WENWU, V1, P1; Karger DN, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.122; Le Lay G, 2010, ECOGRAPHY, V33, P1015, DOI 10.1111/j.1600-0587.2010.06338.x; Leite YLR, 2016, P NATL ACAD SCI USA, V113, P1008, DOI 10.1073/pnas.1513062113; Lembrechts JJ, 2019, ECOGRAPHY, V42, P1267, DOI 10.1111/ecog.03947; Marques O., 2015, SERPENTES CERRADO; Marques O.A.V., 2005, SERPENTES PANTANAL G; Martins Marcio, 1999, Herpetological Natural History, V6, P78; Mayr E, 1942, SYSTEMATICS ORIGIN S; Moritz C, 2000, ANNU REV ECOL SYST, V31, P533, DOI 10.1146/annurev.ecolsys.31.1.533; Mumaw M.N., 2015, ATLAS SERPIENTES VEN; Myers CW, 2014, B AM MUS NAT HIST, P1; Naimi B, 2016, ECOGRAPHY, V39, P368, DOI 10.1111/ecog.01881; Naimi B, 2014, ECOGRAPHY, V37, P191, DOI 10.1111/j.1600-0587.2013.00205.x; Nogueira CC, 2019, S AM J HERPETOL, V14, pS1, DOI 10.2994/SAJH-D-19-00120.1; Oliveira-Filho A. T., 1995, Edinburgh Journal of Botany, V52, P141; Passos P, 2016, HERPETOL MONOGR, V30, P1, DOI 10.1655/HERPMONOGRAPHS-D-14-00009; Passos P, 2008, HERPETOL MONOGR, V22, P1; Passos P, 2009, HERPETOLOGICA, V65, P384, DOI 10.1655/08-024.1; Pellegrino KCM, 2011, MOL PHYLOGENET EVOL, V61, P446, DOI 10.1016/j.ympev.2011.07.010; PESANTES OS, 1994, J HERPETOL, V28, P93, DOI 10.2307/1564686; Peters J.A., 1970, SNAKES 1, P348; Peters J. A., 1960, SNAKES SUBFAMILY DIP; Peters W., 1869, Monatsberichte Akad Wiss Berlin, P432; Powell Randy L., 2016, Check List, V12, P1985; Prado CPA, 2012, MOL ECOL, V21, P921, DOI 10.1111/j.1365-294X.2011.05409.x; Prates I, 2017, MOL PHYLOGENET EVOL, V113, P49, DOI 10.1016/j.ympev.2017.05.009; Prates I, 2015, MOL PHYLOGENET EVOL, V82, P258, DOI 10.1016/j.ympev.2014.10.005; Pyron RA, 2009, ZOOTAXA, P22, DOI 10.11646/zootaxa.2241.1.2; Ranc N, 2017, ECOGRAPHY, V40, P1076, DOI 10.1111/ecog.02414; Raxworthy CJ, 2007, SYST BIOL, V56, P907, DOI 10.1080/10635150701775111; ROBERTO IGOR JOVENTINO, 2017, Pap. Avulsos Zool., V57, P347, DOI 10.11606/0031-1049.2017.57.27; Rodrigues MT, 2014, MOL PHYLOGENET EVOL, V81, P137, DOI 10.1016/j.ympev.2014.07.019; Sabaj MH, 2020, COPEIA, V108, P593, DOI 10.1643/ASIHCODONS2020; Schenkel E., 1902, VERHANDLUNGEN NATURF, V13, P152; SCHOENER TW, 1970, ECOLOGY, V51, P408, DOI 10.2307/1935376; Shine R, 2005, ANNU REV ECOL EVOL S, V36, P23, DOI 10.1146/annurev.ecolsys.36.102003.152631; Shine R, 2000, TRENDS ECOL EVOL, V15, P221, DOI 10.1016/S0169-5347(00)01853-X; SHINE R, 1988, J HERPETOL, V22, P307, DOI 10.2307/1564154; Magnago LFS, 2015, BIODIVERS CONSERV, V24, P2305, DOI 10.1007/s10531-015-0961-1; Soria-Auza RW, 2010, ECOL MODEL, V221, P1221, DOI 10.1016/j.ecolmodel.2010.01.004; Statsoft inc, 1998, STAT WIND VERS 5 1; Uzzell T., 1973, Postilla, VNo. 159, P1; Vanzolini P. E, 1970, Archos Zool. S. Paulo, V19, P1; Vidal N, 2010, CR BIOL, V333, P48, DOI 10.1016/j.crvi.2009.11.003; Wallach V., 2014, SNAKES WORLD CATALOG; Werner F, 1913, REPTILIEN AMPHIBIEN, P1; Werner F., 1925, SITZUNGSB AKAD WISS, P45; Wiens JJ, 2000, P ROY SOC B-BIOL SCI, V267, P631, DOI 10.1098/rspb.2000.1049; Wucherer O., 1861, ANN MAGAZINE NATURAL, V3, P318; Zaher H, 1999, J HERPETOL, V33, P698, DOI 10.2307/1565589; Zaher H, 2011, BIOTA NEOTROP, V11, P67, DOI 10.1590/S1676-06032011000500005; Zaher Hussam, 2009, Pap. Avulsos Zool., V49, P115; Zamudio KR, 1997, BIOL J LINN SOC, V62, P421, DOI 10.1111/j.1095-8312.1997.tb01634.x; Zar J.H, 1999, BIOESTATICAL ANAL, P633; Zizka A, 2020, DIVERS DISTRIB, V26, P183, DOI 10.1111/ddi.13004	113	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243210	10.1371/journal.pone.0243210	http://dx.doi.org/10.1371/journal.pone.0243210			45	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306700	Green Published, gold			2022-12-27	WOS:000600144200062
J	Hallenberg, GS; Jiwakanon, J; Angkititrakul, S; Kang-Air, S; Osbjer, K; Lunha, K; Sunde, M; Jarhult, JD; Van Boeckel, TP; Rich, KM; Magnusson, U				Hallenberg, Gunilla Strom; Jiwakanon, Jatesada; Angkititrakul, Sunpetch; Kang-Air, Seri; Osbjer, Kristina; Lunha, Kamonwan; Sunde, Marianne; Jarhult, Josef D.; Van Boeckel, Thomas P.; Rich, Karl M.; Magnusson, Ulf			Antibiotic use in pig farms at different levels of intensification-Farmers' practices in northeastern Thailand	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; ANIMALS	Understanding the patterns and drivers of antibiotic use in livestock is crucial for tailoring efficient incentives for responsible use of antibiotics. Here we compared routines for antibiotic use between pig farms of two different levels of intensification in Khon Kaen province in Thailand. Among the 113 family-owned small-scale farms (up to 50 sows) interviewed did 76% get advice from the pharmacy about how to use the antibiotics and 84% used it primarily for treating disease. Among the 51 medium-scale-farms (100-500 sows) belonging to two companies did 100% get advice about antibiotic use from the company's veterinarian (P<0.0001) and 94% used antibiotics mostly as disease preventive measure (P<0.0001). In 2 small scale farms 3(rd) generation cephalosporins, tylosin or colistin were used; antibiotics belonging to the group of highest priority critically important antimicrobials for human medicine. Enrofloxacin, belonging to the same group of antimicrobials, was used in 33% of the small-scale and 41% of the medium-scale farms. In the latter farms, the companies supplied 3-4 antibiotics belonging to different classes and those were the only antibiotics used in the farms. The median and mean estimated expenditure on antibiotics per sow was 4.8 USD (IQR = 5.8) for small-scale farms and 7 USD and 3.4 USD for the medium-scale farms belonging to the two respective companies. Our observations suggest to target the following areas when pig farming transitions from small-scale to medium-scale: (i) strengthening access to professional animal health services for all farmers, (ii) review of the competence and role of veterinary pharmacies in selling antibiotics and (iii) adjustment of farming company animal health protocols towards more medically rational use of antibiotics.	[Hallenberg, Gunilla Strom; Osbjer, Kristina; Lunha, Kamonwan; Magnusson, Ulf] Swedish Univ Agr Sci, Dept Clin Sci, Uppsala, Sweden; [Jiwakanon, Jatesada; Angkititrakul, Sunpetch] Khon Kaen Univ, Res Grp Anim Hlth Technol, Khon Kaen, Thailand; [Kang-Air, Seri] Khon Khon Univ, Fac Vet Med, Khon Kaen, Thailand; [Sunde, Marianne] Norwegian Vet Inst, Sect Food Safety & AMR, Oslo, Norway; [Jarhult, Josef D.] Uppsala Univ, Zoonosis Sci Ctr, Dept Med Sci, Uppsala, Sweden; [Van Boeckel, Thomas P.] Swiss Fed Inst Technol, Inst Environm Decis, Zurich, Switzerland; [Van Boeckel, Thomas P.] Ctr Dis Dynam Econ & Policy, Washington, DC USA; [Rich, Karl M.] Int Livestock Res Inst, Policies Inst & Livelihoods Program, West Africa Reg Off, Dakar, Senegal; [Hallenberg, Gunilla Strom] Publ Hlth Agcy Sweden, Stockholm, Sweden; [Lunha, Kamonwan] Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol BIOTEC, Pathum Thani, Thailand	Swedish University of Agricultural Sciences; Khon Kaen University; Khon Kaen University; Norwegian Veterinary Institute; Uppsala University; Swiss Federal Institutes of Technology Domain; ETH Zurich; CGIAR; International Livestock Research Institute (ILRI); Public Health Agency of Sweden; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC)	Magnusson, U (corresponding author), Swedish Univ Agr Sci, Dept Clin Sci, Uppsala, Sweden.	ulf.magnusson@slu.se	Jarhult, Josef D./ABE-8149-2020	Jarhult, Josef D./0000-0002-7075-1059; Sunde, Marianne/0000-0002-2326-4338; Osbjer, Kristina/0000-0002-0902-8232; Magnusson, Ulf/0000-0002-7087-6820; Lunha, Kamonwan/0000-0002-4080-763X	Joint Programming Initiative on antimicrobial resistance (JPIAMR)	Joint Programming Initiative on antimicrobial resistance (JPIAMR)	GSH, KO,KL,MS,JDJ,TPVB and UM were funded by the Joint Programming Initiative on antimicrobial resistance (JPIAMR)https://www.jpiamr.eu/supportedprojects/fifth-joint-callresult/The other authors received no specific funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaechi N., 2014, GLOBAL J BIOL AGR HL, V3, P50; [Anonymous], 2014, PIG PRODUCTION THAIL; Bengtsson B, 2006, ANIM BIOTECHNOL, V17, P147, DOI 10.1080/10495390600956920; Chalker J, 2005, SOC SCI MED, V60, P131, DOI 10.1016/j.socscimed.2004.04.019; Chantziaras I, 2014, J ANTIMICROB CHEMOTH, V69, P827, DOI 10.1093/jac/dkt443; Dang Pham Kim, 2013, Food and Public Health, V3, P247; FAO, 2011, 2 FAO AN PROD HLTH; FAO, 2016, DRIV DYN EP ANT RES; FAO, 2020, UNL POT AGR INN ACH; Gilbert M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133381; HNP/Agriculture Global Antimicrobial Resistance Initiative, 2017, DRUG RESISTANT INFEC; Hoelzer K, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1131-3; Lekagul A, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2019-001918; Li Y, 2019, ANTIMICROBIAL USE FA; Magnusson U., 2019, ANIMAL PRODUCTION HL; Magnusson U, 2020, J ANIM SCI, V98, pS4, DOI 10.1093/jas/skaa148; Muloi D, 2018, FOODBORNE PATHOG DIS, V15, P467, DOI 10.1089/fpd.2017.2411; ODK, 2020, OP DAT KIT 2020; Perry BD, 2013, P NATL ACAD SCI USA, V110, P20871, DOI 10.1073/pnas.1012953108; RATTANARONCHART S, 1994, PRESENT SITUATION TH; Robinson TP, 2017, ANIMAL, V11, P1, DOI 10.1017/S1751731116001828; Strom G, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-018-0328-y; Strom G, 2017, ANTIMICROB RESIST IN, V6, DOI 10.1186/s13756-017-0233-9; Tantasuparuk W, 2000, THERIOGENOLOGY, V54, P481, DOI 10.1016/S0093-691X(00)00364-2; TAS, 2019, 90322009 TAS; Thanapongtharm W, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0849-7; Thornton PK, 2010, PHILOS T R SOC B, V365, P2853, DOI 10.1098/rstb.2010.0134; Van Boeckel TP, 2019, SCIENCE, V365, P1266, DOI 10.1126/science.aaw1944; Van Boeckel TP, 2017, SCIENCE, V357, P1350, DOI 10.1126/science.aao1495; Van Boeckel TP, 2012, AGR ECOSYST ENVIRON, V149, P144, DOI 10.1016/j.agee.2011.12.019; van der Fels-Klerx HJ, 2011, J ANIM SCI, V89, P1922, DOI 10.2527/jas.2010-3046; WHO, 2019, CRIT IMP ANT HUM MED; Wieland B., 2019, AMUSE LIVESTOCK VERS	33	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243099	10.1371/journal.pone.0243099	http://dx.doi.org/10.1371/journal.pone.0243099			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306684	Green Published, gold			2022-12-27	WOS:000600144200060
J	Nowossadeck, E; Prutz, F; Teti, A				Nowossadeck, Enno; Prutz, Franziska; Teti, Andrea			Population change and the burden of hospitalization in Germany 2000-2040: Decomposition analysis and projection	PLOS ONE			English	Article							DEMOGRAPHIC TIME-BOMB; CARE; REHABILITATION; MULTIMORBIDITY; OUTPATIENT; MEDICINE.; DISEASE; IMPACT	Demographic factors, such as population aging and shrinkage, and non-demographic factors, such as hospitalization rate and length of hospital stay, generate challenges for inpatient care. This paper used decomposition analysis to assess how changes in these factors affected the number of hospital treatment days from 2000 to 2015 in Germany. Demographic aging was linked to increases in the number of treatment days for women (+10.0%) and men (+19.2%) and in hospitalization rates for women +6.0% and men +5.4%. However, these increases were offset by decreases in the number of hospital days (women: 16.5%; men: 7.3%) and length of stay (women: -27.4%; men -26.3%). For the projection up to 2040, 12 scenarios were developed (six for women and six for men) using three variants for future population demographics and two variants for future length of stay and hospitalization rates. One of the two variants for future length of stay and hospitalization rates provides for a constant value for the year 2015. For the second of these two variants variant, a logarithmic model was estimated on the basis of values from 2000 to 2015. and the trends were extrapolated using this model until 2040. The strongest overall predicted increase was 18.4% between 2015 and 2040, including a 22.4% increase for men. In two scenarios for women, only slight declines were predicted. All results, both for the decomposition analysis and projection, indicated a moderate but sustained effect of demographic aging on the number of hospital treatment days, leading to a significant increase in hospital treatment days over the study period. Non-demographic factors also had strong influences, especially in shorter time periods, but these effects offset each other over time. The change in the population size in the period under study had very little effect on the number of hospital treatment days.	[Nowossadeck, Enno] Robert Koch Inst, Dept Epidemiol & Hlth Monitoring, Unit Social Determinants Hlth, Berlin, Germany; [Prutz, Franziska] Robert Koch Inst, Dept Epidemiol & Hlth Monitoring, Unit Hlth Reporting, Berlin, Germany; [Teti, Andrea] Univ Vechta, Inst Gerontol, Vechta, Germany	Robert Koch Institute; Robert Koch Institute	Nowossadeck, E (corresponding author), Robert Koch Inst, Dept Epidemiol & Hlth Monitoring, Unit Social Determinants Hlth, Berlin, Germany.	NowossadeckE@rki.de	Nowossadeck, Enno/O-7898-2016	Nowossadeck, Enno/0000-0002-8534-0463				[Anonymous], 2013, J LABEL COMPD RADIOP, V56, pS88, DOI 10.1002/jlcr.3058; [Anonymous], 2014, J NURS REGUL, V5, pS3; [Anonymous], 2013, OFF J EUR UNION L, VL13, P46; [Anonymous], 2014, CANC DISCOV, V4, pOF1; AQUA-Institut, 2012, BESCHR QUAL ERF 2012; Astolfi R, 2012, HEALTH POLICY, V107, P1, DOI 10.1016/j.healthpol.2012.05.001; Balk BM, 2004, ECON LETT, V82, P107, DOI 10.1016/j.econlet.2003.09.006; Baumann W, 2016, ONKOLOGE, V22, P158, DOI 10.1007/s00761-016-0003-y; Biermann J, 2010, MED KLIN, V105, P876, DOI 10.1007/s00063-010-1152-1; Braun B, 2009, GESUNDHEITSVERSORGUN, P117; Braun GE, 2008, INFRASTRUKTURPROBLEM, P207; Braun T, 2008, KRANKENHAUSVERGUTUNG, P3; Busse R, 2017, LANCET, V390, P882, DOI 10.1016/S0140-6736(17)31280-1; Busse R, 2013, BMJ BRIT MED J, V346, DOI 10.1136/bmj.f3197; Christiansen M, 2018, GESUNDHEITSWESEN, V80, P489, DOI 10.1055/s-0042-121597; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; Contrast Media Research 2017 Durango CU, 2017, INVEST RADIOL, V52, P758; Dieleman JL, 2017, JAMA-J AM MED ASSOC, V318, P1668, DOI 10.1001/jama.2017.15927; Dietzenbacher E., 1998, ECON SYST RES, V10, P207, DOI [10.1080/09535319800000023, DOI 10.1080/09535319800000023]; Dinkel RH, 2008, WAS IST ALTERN NEUE, P97; Doblhammer G, 2011, BUNDESGESUNDHEITSBLA, V54, P907, DOI 10.1007/s00103-011-1315-0; Flintrop J., 2006, DTSCH ARZTEBL, V103, P46; Frank J, 2015, GESUNDHEITSWESEN, V77, P932, DOI 10.1055/s-0034-1390417; Fuchs J, 2015, ATHENS J SOCIAL SCI, V2, P109, DOI DOI 10.30958/AJSS.2-2-3; Hajjar Emily R, 2007, Am J Geriatr Pharmacother, V5, P345, DOI 10.1016/j.amjopharm.2007.12.002; Herbermann JD, 2012, B WORLD HEALTH ORGAN, V90, P6, DOI 10.2471/BLT.12.020112; Hilgers S., 2011, DRG VERGUTUNG DTSCH; Keyfitz N, 2005, STAT BIOL HEALTH, P1, DOI 10.1007/b139042; KEYFITZ N, 1972, J AM STAT ASSOC, V67, P347, DOI 10.2307/2284381; Kirchberger I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030556; Kis A, 2017, J DTSCH DERMATOL GES, V15, P1199, DOI 10.1111/ddg.13379; Klosterman RE, 1990, COMMUNITY ANAL PLANN; Knopf H, 2013, BUNDESGESUNDHEITSBLA, V56, P868, DOI 10.1007/s00103-013-1667-8; Kolb GF, 2017, Z GERONTOL GERIATR, V50, P657, DOI 10.1007/s00391-017-1281-8; Kwok CL, 2017, INT J HEALTH POLICY, V6, P155, DOI 10.15171/ijhpm.2016.108; Layzell B, 2009, STUD HEALTH TECHNOL, V146, P166, DOI 10.3233/978-1-60750-024-7-166; Lozano R, 2013, LANCET, V381, P991, DOI 10.1016/S0140-6736(13)60704-7; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; Nations United, 2013, GLOB TRENDS CHALL SU; Neiner Jennifer A, 2004, Health Promot Pract, V5, P69, DOI 10.1177/1524839903257692; Niermann I, 2007, DTSCH ARZTEBL INT, V104, P923; Ha NT, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0554-9; Nowossadeck E, 2010, BUNDESGESUNDHEITSBLA, V53, P427, DOI 10.1007/s00103-010-1048-5; Nowossadeck E, 2019, REHABILITATION, V58, P96, DOI 10.1055/a-0603-6864; Nowossadeck E, 2018, BUNDESGESUNDHEITSBLA, V61, P358, DOI 10.1007/s00103-018-2695-1; Nowossadeck E, 2012, DTSCH ARZTEBL INT, V109, P151, DOI 10.3238/arztebl.2012.0151; Potzsch O., 2015, BEV DEUTSCHL BIS 206; Reinhold T, 2009, GESUNDHEITSWESEN, V71, P306, DOI 10.1055/s-0028-1119399; Casado JMR, 2012, EUR GERIATR MED, V3, P228, DOI 10.1016/j.eurger.2012.01.002; Roeder N, 2006, INTERNIST, V47, P684, DOI 10.1007/s00108-006-1646-3; Schulz E, 2004, HEALTH POLICY, V67, P57, DOI 10.1016/S0168-8510(03)00083-6; Schulz E., 2015, DIW WOCHENBERICHT, V82, P330; Standl T, 2016, AMBULANTES OPERIEREN, V3; Statistische Amter des Bundes und der Lander, 2010, DEM WAND DEUTSCHL HE, V2, P2010; Statistisches Bundesamt, 2016, BEV ERW BEV GRUNDL Z, P2016; Statistisches Bundesamt, 2016, KRANK DIAGN PAT PAT; Stock C, 2015, GESUNDHEITSWESEN, V77, P939, DOI 10.1055/s-0034-1398605; Tikkanen T, 2011, ENABLING INNOVATION: INNOVATIVE CAPABILITY - GERMAN AND INTERNATIONAL VIEWS, P249, DOI 10.1007/978-3-642-24503-9_26; von Eiff W, 2011, DTSCH ARZTEBLATT, V108, P1164; Wiedemann A, 2015, Z ALLG MED, V91, P494; Yarnall AJ, 2017, AGE AGEING, V46, P882, DOI 10.1093/ageing/afx150	61	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243322	10.1371/journal.pone.0243322	http://dx.doi.org/10.1371/journal.pone.0243322			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH0WM	33306705	gold, Green Published			2022-12-27	WOS:000600144200037
J	Thapa, K; Thapa, GJ; Bista, D; Jnawali, SR; Acharya, KP; Khanal, K; Kandel, RC; Thapa, MK; Shrestha, S; Lama, ST; Sapkota, NS				Thapa, Kanchan; Thapa, Gokarna Jung; Bista, Damber; Jnawali, Shant Raj; Acharya, Krishna Prasad; Khanal, Kapil; Kandel, Ram Chandra; Thapa, Madhuri Karki; Shrestha, Saroj; Lama, Sonam Tashi; Sapkota, Netra Sharma			Landscape variables affecting the Himalayan red panda Ailurus fulgens occupancy in wet season along the mountains in Nepal	PLOS ONE			English	Article							ESTIMATING SITE OCCUPANCY; NATIONAL-PARK; CONSERVATION; BIODIVERSITY; VEGETATION; COMMUNITY; PATTERNS; ECOLOGY; MODELS; FIT	The Himalayan red panda is an endangered mammal endemic to Eastern Himalayan and South Western China. Data deficiency often hinders understanding of their spatial distribution and habitat use, which is critical for species conservation planning. We used sign surveys covering the entire potential red panda habitat over 22,453 km(2) along the mid-hills and high mountains encompassing six conservation complexes in Nepal. To estimate red panda distribution using an occupancy framework, we walked 1,451 km along 446 sampled grid cells out of 4,631 grid cells in the wet season of 2016. We used single-species, single-season models to make inferences regarding covariates influencing detection and occupancy. We estimated the probability of detection and occupancy based on model-averaging techniques and drew predictive maps showing site-specific occupancy estimates. We observed red panda in 213 grid cells and found covariates such as elevation, distance to water sources, and bamboo cover influencing the occupancy. Red panda detection probability (p) over cap (SE) estimated at 0.70 (0.02). We estimated red panda site occupancy (sampled grid cells) and landscape occupancy (across the potential habitat) (psi) over cap (SE) at 0.48 (0.01) and 0.40 (0.02) respectively. The predictive map shows a site-specific variation in the spatial distribution of this arboreal species along the priority red panda conservation complexes. Data on their spatial distribution may serve as a baseline for future studies and are expected to aid in species conservation planning in priority conservation complexes.	[Thapa, Kanchan; Thapa, Gokarna Jung; Jnawali, Shant Raj; Khanal, Kapil] WWF Nepal, Kathmandu, Nepal; [Bista, Damber; Shrestha, Saroj; Lama, Sonam Tashi] Red Panda Network, Kathmandu, Nepal; [Acharya, Krishna Prasad] Minist Forests & Environm, Kathmandu, Nepal; [Kandel, Ram Chandra] Dept Natl Pk & Wildlife Conservat, Kathmandu, Nepal; [Thapa, Madhuri Karki] Dept Forest & Soil Conservat, Kathmandu, Nepal; [Sapkota, Netra Sharma] US Agcy Int Dev, Kathmandu, Nepal	World Wildlife Fund; United States Agency for International Development (USAID)	Thapa, K (corresponding author), WWF Nepal, Kathmandu, Nepal.; Bista, D (corresponding author), Red Panda Network, Kathmandu, Nepal.	kanchan.thapa@wwfnepal.org; damb.2007@gmail.com	Thapa, Kanchan/AGU-3365-2022; Bista, Damber/K-1215-2019; Lama, Sonam Tashi/Z-4025-2019	Bista, Damber/0000-0003-2699-1642; Lama, Sonam Tashi/0000-0002-3390-6496	USAID's Hariyo Ban Program/WWF Nepal	USAID's Hariyo Ban Program/WWF Nepal	We are thankful to the USAID's Hariyo Ban Program/WWF Nepal for supporting this work. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya KP, 2002, INT FOREST REV, V4, P149, DOI 10.1505/IFOR.4.2.149.17447; Acharya KP, 2018, GLOB ECOL CONSERV, V15, DOI 10.1016/j.gecco.2018.e00420; Altwegg R, 2019, METHODS ECOL EVOL, V10, P8, DOI 10.1111/2041-210X.13090; [Anonymous], 2016, IEEE-ASME T MECH, VPP, P1, DOI DOI 10.1109/IEEESTD.2016.7460875; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; Barber-Meyer SM, 2013, J ZOOL, V289, P10, DOI 10.1111/j.1469-7998.2012.00956.x; Bisi F, 2019, ENVIRON CONSERV, V46, P163, DOI 10.1017/S0376892918000486; Bista D, 2020, HUM DIMENS WILDL, V25, P324, DOI 10.1080/10871209.2020.1728788; Bista D, 2019, ECOL EVOL, V9, P5260, DOI 10.1002/ece3.5116; Bista D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178797; Burnham K.P., 2002, MODEL SELECTION MULT, VSecond edition; Choudhury A, 2001, ORYX, V35, P250, DOI 10.1046/j.1365-3008.2001.00181.x; *DNPWC, 2018, RED PAND CONS ACT PL; DoF, 2018, BIJ PTER MARS ROXB C; DoFSC, 2019, RHOD CONS ACT PLAN 2; Dorji S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026483; DUPONT WD, 2002, STAT MODELING BIOMED; Efron B., 1994, INTRO BOOTSTRAP; Ferrez J, 2011, AGR FOREST METEOROL, V151, P992, DOI 10.1016/j.agrformet.2011.03.005; Fox J, 1996, CONSERV BIOL, V10, P562, DOI 10.1046/j.1523-1739.1996.10020562.x; Glatston A, 2016, IUCN RED LIST THREAT, V2015, peT714A45195924; Glatston A., 2015, IUCN RED LIST THREAT; Gopalaswamy AM, 2012, ANIM CONSERV, V15, P669, DOI 10.1111/j.1469-1795.2012.00565.x; Gray TNE, 2011, RAFFLES B ZOOL, V59, P311; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Jnawali S., 2012, RED PANDA AILURUS FU; Kandel K, 2015, BIOL CONSERV, V181, P150, DOI 10.1016/j.biocon.2014.10.007; Kandel Pratikshya, 2016, Journal of Asia-Pacific Biodiversity, V9, P1; Karanth KU, 2011, J APPL ECOL, V48, P1048, DOI 10.1111/j.1365-2664.2011.02002.x; Karanth KK, 2009, J APPL ECOL, V46, P1189, DOI 10.1111/j.1365-2664.2009.01710.x; Kendall WL, 2009, J APPL ECOL, V46, P1182, DOI 10.1111/j.1365-2664.2009.01732.x; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x; MacKenzie DI, 2004, J AGR BIOL ENVIR ST, V9, P300, DOI 10.1198/108571104X3361; MacKenzie DI, 2003, ECOLOGY, V84, P2200, DOI 10.1890/02-3090; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Manne LL, 2020, ECOL EVOL, V10, P602, DOI 10.1002/ece3.5505; Nichols JD, 2007, ECOLOGY, V88, P1395, DOI 10.1890/06-1474; Noon BR, 2012, CONSERV BIOL, V26, P432, DOI 10.1111/j.1523-1739.2012.01855.x; Panthi S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180978; Paudel PK, 2015, APPL GEOGR, V56, P127, DOI 10.1016/j.apgeog.2014.11.018; Pettorelli N, 2011, CLIM RES, V46, P15, DOI 10.3354/cr00936; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pradhan S, 2001, BIOL CONSERV, V98, P11, DOI 10.1016/S0006-3207(00)00079-3; Pradhan Sunita, 2011, Zoos' Print, V26, P11; Putkonen JK, 2004, ARCT ANTARCT ALP RES, V36, P244, DOI 10.1657/1523-0430(2004)036[0244:CSARDA]2.0.CO;2; ROBERTS M S, 1984, Mammalian Species, P1, DOI 10.2307/3503840; Schickhoff U, 2015, EARTH SYST DYNAM, V6, P1407; SD, 2001, NAT TOP BAS MAPS; Shrestha UB, 2010, MOUNTAIN RES DEV, V30, P282; Shrestha UB, 2010, MT RES DEV, V30, P282, DOI 10.1659/MRD-JOURNAL-D-10-00019.1; Sinclair ARE, 2006, WILDLIFE ECOLOGY CON; SINGH JS, 1987, BOT REV, V53, P80, DOI 10.1007/BF02858183; Srivathsa A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098803; Thapa A, 2020, GLOB ECOL CONSERV, V21, DOI 10.1016/j.gecco.2019.e00890; Thapa A, 2018, ECOL EVOL, V8, P10542, DOI 10.1002/ece3.4526; Thapa A, 2018, BIOL CONSERV, V220, P112, DOI 10.1016/j.biocon.2018.02.014; Thapa K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216504; Thapa K, 2017, INTEGR ZOOL, V12, P211, DOI 10.1111/1749-4877.12240; Wang F, 2018, DIVERS DISTRIB, V24, P415, DOI 10.1111/ddi.12692; Wang TJ, 2009, PHOTOGRAMM ENG REM S, V75, P37, DOI 10.14358/PERS.75.1.37; Yonzon P., 1989, THESIS; YONZON PB, 1991, BIOL CONSERV, V57, P1, DOI 10.1016/0006-3207(91)90104-H; Zar J.H., 2009, BIOSTATISTICAL ANAL; Zhang Y, 2016, AGR FOREST METEOROL, V224, P1, DOI 10.1016/j.agrformet.2016.04.009	66	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243450	10.1371/journal.pone.0243450	http://dx.doi.org/10.1371/journal.pone.0243450			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306732	Green Published, gold			2022-12-27	WOS:000600144200058
J	Fidalgo-Herrera, AJ; Martinez-Beltran, MJ; de la Torre-montero, JC; Moreno-Ruiz, JA; Barton, G				Fidalgo-Herrera, Alberto Javier; Martinez-Beltran, Maria Jesus; de la Torre-montero, Julio Cesar; Moreno-Ruiz, Jose Andres; Barton, Gabor			Artificial intelligence prediction of the effect of rehabilitation in whiplash associated disorder	PLOS ONE			English	Article							PROGNOSTIC-FACTORS; MODERATE/SEVERE DISABILITY; CERVICAL RANGE; FULL RECOVERY; INJURY; MOTION; VALIDATION; RELIABILITY; GONIOMETER; EXTENSION	The active cervical range of motion (aROM) is assessed by clinicians to inform their decision-making. Even with the ability of neck motion to discriminate injured from non-injured subjects, the mechanisms to explain recovery or persistence of WAD remain unclear. There are few studies of ROM examinations with precision tools using kinematics as predictive factors of recovery rate. The present paper will evaluate the performance of an artificial neural network (ANN) using kinematic variables to predict the overall change of aROM after a period of rehabilitation in WAD patients. To achieve this goal the neck kinematics of a cohort of 1082 WAD patients (55.1% females), with mean age 37.68 (SD 12.88) years old, from across Spain were used. Prediction variables were the kinematics recorded by the EBI(R) 5 in routine biomechanical assessments of these patients. These include normalized ROM, speed to peak and ROM coefficient of variation. The improvement of aROM was represented by the Neck Functional Holistic Analysis Score (NFHAS). A supervised multi-layer feed-forward ANN was created to predict the change in NFHAS. The selected architecture of the ANN showed a mean squared error of 308.07-272.75 confidence interval for a 95% in the Monte Carlo cross validation. The performance of the ANN was tested with a subsample of patients not used in the training. This comparison resulted in a medium correlation with R = 0.5. The trained neural network to predict the expected difference in NFHAS between baseline and follow up showed modest results. While the overall performance is moderately correlated, the error of this prediction is still too large to use the method in clinical practice. The addition of other clinically relevant factors could further improve prediction performance.	[Fidalgo-Herrera, Alberto Javier] RetiaTech, Biomech Dept, FisiON Hlth Grp, Las Rozas, Spain; [Martinez-Beltran, Maria Jesus; de la Torre-montero, Julio Cesar] Comillas Pontifical Univ, San Juan de Dios Sch Nursing & Phys Therapy, Madrid, Spain; [Moreno-Ruiz, Jose Andres] Univ Almeria, Dept Comp, Almeria, Spain; [Barton, Gabor] Liverpool John Moores Univ, Sch Sport & Exercise Sci, Liverpool, Merseyside, England	Comillas Pontifical University; Universidad de Almeria; Liverpool John Moores University	Fidalgo-Herrera, AJ (corresponding author), RetiaTech, Biomech Dept, FisiON Hlth Grp, Las Rozas, Spain.	afidalgo@fisi-on.com	de la Torre-Montero, Julio C./I-6095-2019	de la Torre-Montero, Julio C./0000-0001-6843-8234; Fidalgo Herrera, Alberto Javier/0000-0002-8202-2670; Martinez Beltran, Maria Jesus/0000-0003-3869-3626	RetiaTech	RetiaTech	RetiaTech provided support in the form of salaries for the author AFH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section. The author(s) received no further specific funding for this work.	Asha SE, 2013, J MANIP PHYSIOL THER, V36, P538, DOI 10.1016/j.jmpt.2013.07.005; Boggenpoel B, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-025076; Bohman T, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-264; Bussieres AE, 2016, J MANIP PHYSIOL THER, V39, P523, DOI 10.1016/j.jmpt.2016.08.007; Connelly LB, 2017, J ORTHOP SPORT PHYS, V47, P503, DOI 10.2519/jospt.2017.7533; Duc C, 2014, MED ENG PHYS, V36, P49, DOI 10.1016/j.medengphy.2013.09.002; Dvir Zeevi, 2004, Pain Res Manag, V9, P131; Farooq MN, 2016, PAK J MED SCI, V32, P457, DOI 10.12669/pjms.322.8747; Fidalgo-Herrera A, 2019, CALGARY; Fidalgo-Herrera AJ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238424; Ganesan N, 2010, INT J COMPUT APPL, V1, P76, DOI [10.5120/476-783, DOI 10.5120/476-783]; Grip H, 2003, IEEE T INF TECHNOL B, V7, P412, DOI 10.1109/TITB.2003.821322; Hendriks EJM, 2005, PAIN, V114, P408, DOI 10.1016/j.pain.2005.01.006; Kamper SJ, 2008, PAIN, V138, P617, DOI 10.1016/j.pain.2008.02.019; Krogh S, 2018, J REHABIL MED, V50, P548, DOI 10.2340/16501977-2348; La Delfa NJ, 2016, J BIOMECH, V49, P602, DOI 10.1016/j.jbiomech.2016.01.008; Lemeunier N, 2018, MUSCULOSKEL SCI PRAC, V38, P128, DOI 10.1016/j.msksp.2018.09.013; Leys C, 2013, J EXP SOC PSYCHOL, V49, P764, DOI 10.1016/j.jesp.2013.03.013; Ludvigsson ML, 2019, QUAL LIFE RES, V28, P357, DOI 10.1007/s11136-018-2004-3; Mourcou Q, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/328142; Ng TS, 2015, PHYSIOTHER RES INT, V20, P77, DOI 10.1002/pri.1598; Niederer D, 2015, EUR SPINE J, V24, P493, DOI 10.1007/s00586-014-3715-y; Ogundimu EO, 2016, J CLIN EPIDEMIOL, V76, P175, DOI 10.1016/j.jclinepi.2016.02.031; Ohberg F, 2003, IEEE T INF TECHNOL B, V7, P274, DOI 10.1109/TITB.2003.821328; Osborne JW, 2001, PRACT ASSESSMENT RES, V7, P2000; Pare C, 2019, CLIN J PAIN, V35, P880, DOI 10.1097/AJP.0000000000000749; Quek J, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-65; Ritchie C, 2016, J ORTHOP SPORT PHYS, V46, P851, DOI 10.2519/jospt.2016.6918; Ritchie C, 2015, J ORTHOP SPORT PHYS, V45, P242, DOI 10.2519/jospt.2015.5642; Ritchie C, 2013, PAIN, V154, P2198, DOI 10.1016/j.pain.2013.07.001; Rydman E, 2018, EUR SPINE J, V27, P1255, DOI 10.1007/s00586-018-5507-2; Scholten-Peeters GGM, 2003, PAIN, V104, P303, DOI 10.1016/S0304-3959(03)00050-2; Shechtman Orit, 2006, Work, V26, P335; Stenneberg MS, 2017, ARCH PHYS MED REHAB, V98, P1407, DOI 10.1016/j.apmr.2016.10.003; Sterling M, 2012, PAIN, V153, P1727, DOI 10.1016/j.pain.2012.05.004; Sterling M, 2011, SPINE, V36, pS330, DOI 10.1097/BRS.0b013e3182388523; Stove MP, 2018, KNEE, V25, P66, DOI 10.1016/j.knee.2017.11.001; Tousignant M, 2001, MANUAL THER, V6, P235, DOI 10.1054/math.2001.0419; Tousignant M, 2000, SPINE, V25, P324, DOI 10.1097/00007632-200002010-00011; Walton DM, 2017, J ORTHOP SPORT PHYS, V47, P462, DOI 10.2519/jospt.2017.7455; Walton DM, 2013, J ORTHOP SPORT PHYS, V43, P31, DOI 10.2519/jospt.2013.4507; Wilamowski BM, 2011, 2011 IEEE INTERNATIONAL CONFERENCE ON INDUSTRIAL TECHNOLOGY (ICIT)	42	1	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243816	10.1371/journal.pone.0243816	http://dx.doi.org/10.1371/journal.pone.0243816			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332408	Green Accepted, Green Published, gold			2022-12-27	WOS:000601310900018
J	Robinson, NM; Blanchard, W; MacGregor, C; Brewster, R; Dexter, N; Lindenmayer, DB				Robinson, Natasha M.; Blanchard, Wade; MacGregor, Christopher; Brewster, Rob; Dexter, Nick; Lindenmayer, David B.			Finding food in a novel environment: The diet of a reintroduced endangered meso-predator to mainland Australia, with notes on foraging behaviour	PLOS ONE			English	Article							CONSERVATION; EXPERIENCE; SURVIVAL; ANIMALS; CARNIVORES; SKILLS; QUOLL	Translocated captive-bred predators are less skilled at hunting than wild-born predators and more prone to starvation post-release. Foraging in an unfamiliar environment presents many further risks to translocated animals. Knowledge of the diet and foraging behaviour of translocated animals is therefore an important consideration of reintroductions. We investigated the diet of the endangered meso-predator, the eastern quoll Dasyurus viverrinus. We also opportunistically observed foraging behaviour, enabling us to examine risks associated with foraging. Sixty captive-bred eastern quolls were reintroduced to an unfenced reserve on mainland Australia (where introduced predators are managed) over a two year period (2018, 2019). Quolls were supplementary fed macropod meat but were also able to forage freely. Dietary analysis of scats (n = 56) revealed that quolls ate macropods, small mammals, birds, invertebrates, fish, reptiles and frogs, with some between-year differences in the frequency of different diet categories. We also observed quolls hunting live prey. Quolls utilised supplementary feeding stations, indicating that this may be an important strategy during the establishment phase. Our study demonstrated that, in a novel environment, captive-bred quolls were able to locate food and hunt live prey. However, foraging was not without risks; with the ingestion of toxic substances and foraging in dangerous environments found to be potentially harmful. Knowledge of the diet of reintroduced fauna in natural landscapes is important for understanding foraging behaviour and evaluating habitat suitability for future translocations and management.	[Robinson, Natasha M.; Blanchard, Wade; MacGregor, Christopher; Lindenmayer, David B.] Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia; [Robinson, Natasha M.; MacGregor, Christopher; Lindenmayer, David B.] Australian Natl Univ, Natl Environm Sci Program, Threatened Species Recovery Hub, Fenner Sch Environm & Soc, Canberra, ACT, Australia; [Brewster, Rob] Rewilding Australia, Sydney, NSW, Australia; [Dexter, Nick] Booderee Natl Pk, Jervis Bay, Jervis Bay Terr, Australia	Australian National University; Australian National University	Robinson, NM (corresponding author), Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia.; Robinson, NM (corresponding author), Australian Natl Univ, Natl Environm Sci Program, Threatened Species Recovery Hub, Fenner Sch Environm & Soc, Canberra, ACT, Australia.	natasha.robinson@anu.edu.au	MacGregor, Christopher/AFQ-6785-2022	MacGregor, Christopher/0000-0002-7908-204X; Brewster, Rob/0000-0001-5068-8614; Robinson, Natasha/0000-0003-0421-8683	Australian Government's National Environmental Science Program through the Threatened Species Recovery Hub	Australian Government's National Environmental Science Program through the Threatened Species Recovery Hub(Australian Government)	This research is funded by the Australian Government's National Environmental Science Program through the Threatened Species Recovery Hub. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINSON SN, 1995, FUNCT ECOL, V9, P559, DOI 10.2307/2390145; Atlas of Living Australia. Dasyurus viverrinus, DAS VIV; Baker CM, 2019, ECOL APPL, V29, DOI 10.1002/eap.1811; Baker Jack, 2009, Ecological Management & Restoration, V10, pS136, DOI 10.1111/j.1442-8903.2009.00448.x; BLACKHALL S, 1980, AUST WILDLIFE RES, V7, P191, DOI 10.1071/WR9800191; BOM, 2020, SUMM STAT 2018 2019; Burkner PC, 2017, J STAT SOFTW, V80, P1, DOI 10.18637/jss.v080.i01; Burbidge A. A., 2016, DASYURUS VIVERRINUS, DOI [10.2305/IUCN.UK.2016-1.RLTS.T6296A21947190.en, DOI 10.2305/IUCN.UK.2016-1.RLTS.T6296A21947190.EN]; CHRISTIAN JJ, 1970, SCIENCE, V168, P84, DOI 10.1126/science.168.3927.84; CONNELL JH, 1983, AM NAT, V122, P661, DOI 10.1086/284165; Dickman Christopher R., 2001, Pacific Conservation Biology, V7, P124; DNP, 2015, BOOD NAT PARK MAN PL; DoEE, 2019, OP REP FOX CONTR MON; Fancourt BA, 2018, WILDLIFE RES, V45, P737, DOI 10.1071/WR18063; Fancourt BA, 2016, WILDLIFE RES, V43, P197, DOI 10.1071/WR15188; Fancourt BA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129420; Gelman A., 2020, PRIOR CHOICE RECOMME; Gelman A., 2006, DATA ANAL USING REGR, DOI DOI 10.1017/CBO9780511790942.005; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Godsell J., 1983, ECOLOGY E QUOLL DASY; Griffin AS, 2000, CONSERV BIOL, V14, P1317, DOI 10.1046/j.1523-1739.2000.99326.x; HARPER DGC, 1982, ANIM BEHAV, V30, P575, DOI 10.1016/S0003-3472(82)80071-7; Jones ME, 1998, ANIM BEHAV, V56, P1279, DOI 10.1006/anbe.1998.0893; Jones ME, 2000, J MAMMAL, V81, P434, DOI 10.1644/1545-1542(2000)081<0434:NDASAD>2.0.CO;2; Jule KR, 2008, BIOL CONSERV, V141, P355, DOI 10.1016/j.biocon.2007.11.007; Klare U, 2011, MAMMAL REV, V41, P294, DOI 10.1111/j.1365-2907.2011.00183.x; KLEIMAN DG, 1989, BIOSCIENCE, V39, P152, DOI 10.2307/1311025; Lindenmayer DB, 2018, BIOL CONSERV, V221, P279, DOI 10.1016/j.biocon.2018.03.007; Mathews F, 2005, BIOL CONSERV, V121, P569, DOI 10.1016/j.biocon.2004.06.007; MCILROY JC, 1981, AUST WILDLIFE RES, V8, P385, DOI 10.1071/WR9810385; National Health and Medical Research Council (NHMRC) Nh, 2013, AUSTR COD CAR US AN; O'Donnell S, 2010, J APPL ECOL, V47, P558, DOI 10.1111/j.1365-2664.2010.01802.x; Owen-Smith N, 2003, ANIMAL BEHAVIOR AND WILDLIFE CONSERVATION, P93; Peacock D, 2014, AUST J ZOOL, V62, P294, DOI 10.1071/ZO14029; Peacock D, 2013, AUST J ZOOL, V61, P206, DOI 10.1071/ZO12129; PELLIS S M, 1984, Australian Mammalogy, V7, P5; R Core Team, 2020, R LANG ENV STAT COMP; Robinson NM, 2018, WILDLIFE RES, V45, P132, DOI 10.1071/WR17040; Robinson NM, 2020, RESTOR ECOL, V28, P29, DOI 10.1111/rec.13028; Robinson NH, 1988, THESIS; Rogers T, 2016, WILDLIFE RES, V43, P544, DOI 10.1071/WR15221; Short Jeff, 2001, Australian Zoologist, V31, P533; STAMPS JA, 1988, AM NAT, V131, P329, DOI 10.1086/284793; Stamps JA, 2007, APPL ANIM BEHAV SCI, V102, P392, DOI 10.1016/j.applanim.2006.05.038; Stephens D. W., 2008, FORAGING BEHAV ECOLO; Swaisgood RR, 2018, ANIM CONSERV, V21, P474, DOI 10.1111/acv.12418; Taws N., 1997, VEGETATION SURVEY MA; Teixeira CP, 2007, ANIM BEHAV, V73, P1, DOI 10.1016/j.anbehav.2006.06.002; Triggs B., 2004, TRACKS SCATS OTHER T; Vargas A, 1999, J MAMMAL, V80, P263, DOI 10.2307/1383226; West RS, 2020, AUST MAMMAL, V42, P257, DOI 10.1071/AM19041; Whiteside MA, 2015, J ANIM ECOL, V84, P1480, DOI 10.1111/1365-2656.12401	52	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243937	10.1371/journal.pone.0243937	http://dx.doi.org/10.1371/journal.pone.0243937			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332425	Green Published, gold			2022-12-27	WOS:000601310900017
J	Smith, SL; Golden, AS; Ramenzoni, V; Zemeckis, DR; Jensen, OP				Smith, Sarah Lindley; Golden, Abigail S.; Ramenzoni, Victoria; Zemeckis, Douglas R.; Jensen, Olaf P.			Adaptation and resilience of commercial fishers in the Northeast United States during the early stages of the COVID-19 pandemic	PLOS ONE			English	Article							FISHING COMMUNITIES; ADAPTIVE CAPACITY; VULNERABILITY; UNCERTAINTY; GROUNDFISH; MANAGEMENT; LESSONS	Commercial fisheries globally experienced numerous and significant perturbations during the early months of the COVID-19 pandemic, affecting the livelihoods of millions of fishers worldwide. In the Northeast United States, fishers grappled with low prices and disruptions to export and domestic markets, leaving many tied to the dock, while others found ways to adapt to the changing circumstances brought about by the pandemic. This paper investigates the short-term impacts of the early months of the COVID-19 pandemic (March-June 2020) on commercial fishers in the Northeast U.S. to understand the effects of the pandemic on participation in the fishery and fishers' economic outcomes, using data collected from an online survey of 258 Northeast U.S. commercial fishers. This research also assesses characteristics of those fishers who continued fishing and their adaptive strategies to the changing circumstances. Analysis of survey responses found the majority of fishers continued fishing during the early months of the pandemic, while a significant number had stopped fishing. Nearly all reported a loss of income, largely driven by disruptions of export markets, the loss of restaurant sales, and a resulting decline in seafood prices. Landings data demonstrate that while fishing pressure in 2020 was reduced for some species, it remained on track with previous years for others. Fishers reported engaging in a number of adaptation strategies, including direct sales of seafood, switching species, and supplementing their income with government payments or other sources of income. Many fishers who had stopped fishing indicated plans to return, suggesting refraining from fishing as a short-term adaptation strategy, rather than a plan to permanently stop fishing. Despite economic losses, fishers in the Northeast U.S. demonstrated resilience in the face of the pandemic by continuing to fish and implementing other adaptation strategies rather than switching to other livelihoods.	[Smith, Sarah Lindley; Ramenzoni, Victoria] Rutgers State Univ, Dept Human Ecol, New Brunswick, NJ 08901 USA; [Golden, Abigail S.; Jensen, Olaf P.] Rutgers State Univ, Dept Marine & Coastal Sci, New Brunswick, NJ USA; [Golden, Abigail S.] Rutgers State Univ, Grad Program Ecol & Evolut, New Brunswick, NJ USA; [Zemeckis, Douglas R.] Rutgers State Univ, Dept Agr & Nat Resources, Toms River, NJ USA; [Jensen, Olaf P.] Univ Wisconsin, Ctr Limnol, Madison, WI 53706 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of Wisconsin System; University of Wisconsin Madison	Smith, SL (corresponding author), Rutgers State Univ, Dept Human Ecol, New Brunswick, NJ 08901 USA.	sarah.l.smith@rutgers.edu		Zemeckis, Douglas/0000-0003-2857-9723	National Oceanic and Atmospheric Administration (NOAA) Coastal and Oceanic Climate Adaptations (COCA) program [2019002753]; National Socio-Environmental Synthesis Center (SESYNC) under National Science Foundation [DBI-1639145]; National Science Foundation Graduate Research Fellowship Program [NSF DGE-1842213]	National Oceanic and Atmospheric Administration (NOAA) Coastal and Oceanic Climate Adaptations (COCA) program; National Socio-Environmental Synthesis Center (SESYNC) under National Science Foundation(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF))	SLS and VR were funded by the National Oceanic and Atmospheric Administration (NOAA) Coastal and Oceanic Climate Adaptations (COCA) program (Project number 2019002753). OPJ was supported by the National Socio-Environmental Synthesis Center (SESYNC) under funding received from the National Science Foundation (DBI-1639145). ASG is supported by the National Science Foundation Graduate Research Fellowship Program (Grant No. NSF DGE-1842213). DRZ received no specific funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acheson J, 2014, MARIT STUD, V13, DOI 10.1186/2212-9790-13-8; Aguilera SE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118992; [Anonymous], 2017, J ENDOCRINOL METAB D, V22, pS1; [Anonymous], 2020, CHESAPEAKE BAY  0413; [Anonymous], 2012, REGEN MED S3, V7, pS14; Belarmino E.H., 2020, COLL AGR LIFE SCI FA; Belhabib D, 2018, FISH FISH, V19, P1092, DOI 10.1111/faf.12314; Bell RJ, 2015, ICES J MAR SCI, V72, P1311, DOI 10.1093/icesjms/fsu217; Bene C, 2020, FOOD SECUR, V12, P805, DOI 10.1007/s12571-020-01076-1; Bennett NJ, 2020, COAST MANAGE, V48, P336, DOI 10.1080/08920753.2020.1766937; Berkes F, 2007, NAT HAZARDS, V41, P283, DOI 10.1007/s11069-006-9036-7; Bittenbender S., 2020, SEAFOOD SOURCE  0626; Cinner JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011999; Clay PM, 2008, HUM ECOL REV, V15, P143; Clay PM, 2016, MAR POLICY, V74, P334, DOI 10.1016/j.marpol.2016.04.049; Clay PM, 2014, MAR POLICY, V44, P27, DOI 10.1016/j.marpol.2013.08.009; Colburn L. L., 2012, J ECOLOGICAL ANTHR, V15, P74, DOI DOI 10.5038/2162-4593.15.1.6; Colburn LL, 2015, NMFSFSPO157 NOAA, P68; Coulthard S, 2012, ECOL SOC, V17, DOI 10.5751/ES-04483-170104; Crona BI, 2016, MAR POLICY, V65, P1, DOI 10.1016/j.marpol.2015.11.016; Cumming G, 2020, J ENVIRON STUD SCI, V10, P68, DOI 10.1007/s13412-019-00577-6; Dandurant K., 2020, FOSTERS         0427; Drummond C., 2020, WESTERLY SUN    0406; FAO, 2020, FOOD OUTL BIANN REP; Ferro-Azcona H, 2019, OCEAN COAST MANAGE, V173, P36, DOI 10.1016/j.ocecoaman.2019.01.005; Fisheries NOAA, 2020, COMM LAND 2015 2020; Folke C, 2005, ANNU REV ENV RESOUR, V30, P441, DOI 10.1146/annurev.energy.30.050504.144511; Gephart JA, 2017, GLOBAL ENVIRON CHANG, V42, P24, DOI 10.1016/j.gloenvcha.2016.11.003; Goldthwait J., 2020, STATE MAINE LOBSTERM, DOI 10.1097/BPO.0000000000001610; Henry A, 2014, NMFSNE230 NOAA; Herz N., 2020, NATL PUBLIC RADIO; Himes-Cornell A, 2015, ECOL SOC, V20, DOI 10.5751/ES-07074-200209; Johnson TR, 2018, B MAR SCI, V94, P1185, DOI 10.5343/bms.2017.1108; Johnson TR, 2014, HUM ECOL REV, V20, P97; Kleisner KM, 2017, PROG OCEANOGR, V153, P24, DOI 10.1016/j.pocean.2017.04.001; Kuschner E., 2020, BOSTON GLOBE; Love DC, 2020, EMERGING COVID 19 IM, DOI [10.31235/osf.io/x8aew, DOI 10.31235/0SF.I0/X8AEW]; Marshall NA, 2007, ECOL SOC, V12, DOI 10.5751/es-01940-120101; McClenachan L, 2020, AMBIO, V49, P144, DOI 10.1007/s13280-019-01156-3; Mills KE, 2013, OCEANOGRAPHY, V26, P191, DOI 10.5670/oceanog.2013.27; Myers HJ, 2020, MAR POLICY, V118, DOI 10.1016/j.marpol.2020.104017; National Marine Fisheries Service, 2018, NMFSFSPO187 NOAA; National Marine Fisheries Service, 2009, NAT GUID MAN HIV AID; National Marine Fisheries Service (NMFS), 2018, FISH US 2017 REP; NOAA Fisheries, FISH DIS DET; Parry ML, 2007, CLIMATE CHANGE 2007; Perry RI, 2011, FISH FISH, V12, P427, DOI 10.1111/j.1467-2979.2010.00402.x; Pinsky ML, 2013, SCIENCE, V341, P1239, DOI 10.1126/science.1239352; Pollnac RB, 2008, HUM ECOL REV, V15, P194; Pollnac RB, 2015, ENVIRON IMPACT ASSES, V55, P136, DOI 10.1016/j.eiar.2015.08.006; R Development Core Team, 2009, R LANG ENV STAT COMP; Ramenzoni V.C., 2015, CLIM CHANGE CULT EC, P177, DOI [10.1108/S0190-128120150000035008, DOI 10.1108/S0190-128120150000035008]; Schoon ML, 2012, SOC NATUR RESOUR, V25, P141, DOI 10.1080/08941920.2010.549933; Scyphers SB, 2019, P NATL ACAD SCI USA, V116, P22912, DOI 10.1073/pnas.1913914116; Seara T, 2020, COAST MANAGE, V48, P418, DOI 10.1080/08920753.2020.1795969; Seara T, 2017, OCEAN COAST MANAGE, V141, P1, DOI 10.1016/j.ocecoaman.2017.02.016; Seara T, 2016, GLOBAL ENVIRON CHANG, V38, P49, DOI 10.1016/j.gloenvcha.2016.01.006; Smith CL, 2010, HUM ORGAN, V69, P158, DOI 10.17730/humo.69.2.b83x6t44878u4782; Smith Q., 2020, YACHATS COMMUNI 0607; Smith T. D., 1994, SCALING FISHERIES SC; Stoll J. S., 2020, ALTERNATIVE SEAFOOD, DOI 10.32942/osf.io/kuzwq; Stoll JS, 2018, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00239; Stoll JS, 2015, OCEAN COAST MANAGE, V116, P185, DOI 10.1016/j.ocecoaman.2015.07.019; Teh LCL, 2013, FISH FISH, V14, P77, DOI 10.1111/j.1467-2979.2011.00450.x; Thompson C, 2016, J RURAL STUD, V45, P165, DOI 10.1016/j.jrurstud.2016.03.008; U.S. Department of Agriculture (USDA), 2020, USDA ANN ADD FOOD PU; van Densen W.L.T., 2001, PERCEPTION TIME TREN; van Oostenbrugge JAE, 2004, AGR SYST, V82, P57, DOI 10.1016/j.agsy.2004.01.002; van Oostenbrugge JAE, 2003, UNCERTAINTY DAILY CA; Wells P., 2020, NEW YORK TIMES  0505; White C., 2020, SEAFOOD SOURCE  0612; White ER, 2020, EARLY EFFECTS COVID, DOI [10.31219/osf.io/9bxnh, DOI 10.31219/0SF.I0/9BXNH]; Wiedenmann J, 2018, CAN J FISH AQUAT SCI, V75, P342, DOI 10.1139/cjfas-2016-0484; Witter A, 2017, MAR POLICY, V80, P130, DOI 10.1016/j.marpol.2016.09.023	74	28	28	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243886	10.1371/journal.pone.0243886	http://dx.doi.org/10.1371/journal.pone.0243886			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PI8BZ	33332383	gold, Green Published			2022-12-27	WOS:000601310900039
J	Andreu-Ballester, JC; Galindo-Regal, L; Hidalgo-Coloma, J; Cuellar, C; Garcia-Ballesteros, C; Hurtado, C; Uribe, N; Martin, MD; Jimenez, AI; Lopez-Chulia, F; Llombart-Cussac, A				Carlos Andreu-Ballester, Juan; Galindo-Regal, Lorena; Hidalgo-Coloma, Julia; Cuellar, Carmen; Garcia-Ballesteros, Carlos; Hurtado, Carolina; Uribe, Natalia; del Carmen Martin, Maria; Isabel Jimenez, Ana; Lopez-Chulia, Francisca; Llombart-Cussac, Antonio			Differences in circulating gamma delta T cells in patients with primary colon cancer and relation with prognostic factors	PLOS ONE			English	Article							PERIPHERAL-BLOOD; INTERFERON-GAMMA; MICROVASCULAR INVASION; INDUCE APOPTOSIS; LYMPHOCYTES; PROLIFERATION; EXPRESSION; INDICATOR; ANTIGEN; DEFICIT	Downregulation of the T cell system has been proposed as a mechanism to block immunity in colonic cancer (CC). However, little has been studied about circulating alpha beta and gamma delta T cells and their immunological status in newly diagnosed patients. The aim of this study was to characterize the alpha beta and gamma delta T cell subsets in peripheral blood of patients with CC matched with healthy volunteers. In this prospective case-control study, blood samples were obtained from 96 patients with newly diagnosed treatment-naive infiltrating colonic adenocarcinoma and 48 healthy volunteers. Pathological report at surgery was obtained from all CC patients. A significant decrease in CD3+ gamma delta T cells and CD3+CD8+ gamma delta T cells (p<0.001) were observed in CC patients. Apoptosis was significantly increased in all conventional and both <alpha>beta and gamma delta T cell subsets in patients with CC vs healthy subjects. gamma delta T cells were decreased in peripheral blood of patients with microscopic infiltration in tissues, history of cancer and synchronous colon cancer (p < 0.05). IFN-<gamma> was significantly reduced in CC patients compared to controls. Cytotoxic effector gamma delta T cells TEMRA (CD8 and CD56) are the proportionally most abundant T cells in peripheral blood of CC patients. Patients with CC present a deep downregulation in the systemic T-cell immunity. These variations are evident through all tumor stages and suggest that a deficiency in gamma delta T cell populations could be preventing control of tumor progression. This fact prove the role of immunomodulation on CC carcinogenesis.	[Carlos Andreu-Ballester, Juan] Arnau de Vilanova Univ Hosp, Res Dept, Valencia, Spain; [Galindo-Regal, Lorena; Garcia-Ballesteros, Carlos; Lopez-Chulia, Francisca] Arnau de Vilanova Univ Hosp, Dept Hematol, Valencia, Spain; [Hidalgo-Coloma, Julia; Llombart-Cussac, Antonio] Arnau de Vilanova Univ Hosp, Dept Med Oncol, Valencia, Spain; [Cuellar, Carmen] Univ Complutense, Dept Microbiol & Parasitol, Fac Pharm, Madrid, Spain; [Hurtado, Carolina] Univ San Pablo CEU, Parasitol Lab, Fac Pharm, Madrid, Spain; [Uribe, Natalia; del Carmen Martin, Maria] Arnau de Vilanova Univ Hosp, Dept Gen & Digest Surg, Valencia, Spain; [Isabel Jimenez, Ana] Arnau de Vilanova Univ Hosp, Dept Pathol, Valencia, Spain	Complutense University of Madrid; San Pablo CEU University	Andreu-Ballester, JC (corresponding author), Arnau de Vilanova Univ Hosp, Res Dept, Valencia, Spain.	jcandreuballester@outlook.com	Andreu-Ballester, Juan Carlos/GPF-7094-2022; García, Carlos/GNM-5627-2022; Hurtado-Marcos, Carolina/AAH-3586-2020	Andreu-Ballester, Juan Carlos/0000-0003-3790-3054; Hurtado-Marcos, Carolina/0000-0003-0364-7742	Town Council of Lliria, Valencia, Spain	Town Council of Lliria, Valencia, Spain	"Town Council of Lliria, Valencia, Spain". "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."	Alexander AAZ, 2008, CLIN CANCER RES, V14, P4232, DOI 10.1158/1078-0432.CCR-07-4912; [Anonymous], 2014, J RETAIL CONSUM SERV, V21, P61; Caccamo N, 2005, EUR J IMMUNOL, V35, P1764, DOI 10.1002/eji.200525983; Andreu-Ballester JC, 2011, DIGEST DIS SCI, V56, P2613, DOI 10.1007/s10620-011-1636-8; Castro F, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00847; Chen SH, 2011, HEMATOLOGY, V16, P31, DOI 10.1179/102453311X12902908411832; Clark E J, 2007, HPB (Oxford), V9, P456, DOI 10.1080/13651820701774891; Contreras TN, 2000, J IMMUNOTHER, V23, P67, DOI 10.1097/00002371-200001000-00009; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Exley MA, 2001, J IMMUNOL, V167, P5531, DOI 10.4049/jimmunol.167.10.5531; Feng JF, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000257; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Ferreira LMR, 2013, INT REV IMMUNOL, V32, P223, DOI 10.3109/08830185.2013.783831; Fisher JPH, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.27572; Fleming C, 2017, TRENDS CANCER, V3, P561, DOI 10.1016/j.trecan.2017.06.003; Gaafar A, 2009, EXP HEMATOL, V37, P838, DOI 10.1016/j.exphem.2009.04.003; Gao YF, 2003, J EXP MED, V198, P433, DOI 10.1084/jem.20030584; Grimm M, 2012, CLIN TRANSL ONCOL, V14, P870, DOI 10.1007/s12094-012-0867-2; Gronke K, 2019, NATURE, V566, P249, DOI 10.1038/s41586-019-0899-7; Heinzelbecker J, 2014, J UROLOGY, V192, P593, DOI 10.1016/j.juro.2014.02.2569; Hoffmann TK, 2002, CLIN CANCER RES, V8, P2553; Huang H, 2015, INT J CLIN EXP MED, V8, P10779; Ikeda H, 2002, CYTOKINE GROWTH F R, V13, P95, DOI 10.1016/S1359-6101(01)00038-7; Katz SG, 2020, METHODS MOL BIOL, V2097, P3, DOI 10.1007/978-1-0716-0203-4_1; Kim JW, 2005, CLIN CANCER RES, V11, P1010; Kobayashi H, 2011, ANTICANCER RES, V31, P1027; Lafont V, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00622; Lam AKY, 2014, WORLD J GASTROENTERO, V20, P6815, DOI 10.3748/wjg.v20.i22.6815; Marks DJB, 2011, CURR OPIN GASTROEN, V27, P328, DOI 10.1097/MOG.0b013e3283463b45; Marth C, 2004, AM J OBSTET GYNECOL, V191, P1598, DOI 10.1016/j.ajog.2004.05.007; Martinez-Lostao L, 2015, CLIN CANCER RES, V21, P5047, DOI 10.1158/1078-0432.CCR-15-0685; Maser EA, 2013, INFLAMM BOWEL DIS, V19, P1827, DOI 10.1097/MIB.0b013e318289c166; Mirzaei HR, 2016, CANCER LETT, V380, P413, DOI 10.1016/j.canlet.2016.07.001; Mollberg NM, 2014, ANN THORAC SURG, V97, P965, DOI 10.1016/j.athoracsur.2013.11.002; Pajares JA, 2015, WORLD J GASTRO ONCOL, V7, P434, DOI 10.4251/wjgo.v7.i12.434; Ramutton T, 2014, IMMUNOTHERAPY-UK, V6, P989, DOI 10.2217/imt.14.59; Raverdeau M, 2019, CLIN TRANSL IMMUNOL, V8, DOI 10.1002/cti2.1080; Reichert TE, 2002, CLIN CANCER RES, V8, P3137; Richards CH, 2014, EUR J CANCER, V50, P309, DOI 10.1016/j.ejca.2013.09.008; Rodriguez-Peralvarez M, 2013, ANN SURG ONCOL, V20, P325, DOI 10.1245/s10434-012-2513-1; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Saroha S, 2013, J UROLOGY, V189, P454, DOI 10.1016/j.juro.2012.09.166; Silva-Santos B, 2015, NAT REV IMMUNOL, V15, P683, DOI 10.1038/nri3904; Soares TF, 2007, CLIN MICROBIOL INFEC, V13, P1083, DOI 10.1111/j.1469-0691.2007.01814.x; Takahashi A, 2001, CLIN CANCER RES, V7, P74; Testa Ugo, 2018, Med Sci (Basel), V6, DOI 10.3390/medsci6020031; Thiels CA, 2016, J SURG ONCOL, V114, P80, DOI 10.1002/jso.24258; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Wu P, 2014, IMMUNITY, V40, P785, DOI 10.1016/j.immuni.2014.03.013; Xiao YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070345; Yamamoto M, 2019, DIGEST SURG, V36, P487, DOI 10.1159/000492340; Youssef Manal M S, 2015, Egypt J Immunol, V22, P19; 2014, REG ANESTH PAIN MED, V9	54	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243545	10.1371/journal.pone.0243545	http://dx.doi.org/10.1371/journal.pone.0243545			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326443	Green Published, gold			2022-12-27	WOS:000600176400001
J	Dahl, HC; Kanchwala, M; Thomas-Jardin, SE; Sandhu, A; Kanumuri, P; Nawas, AF; Xing, C; Lin, CC; Frigo, DE; Delk, NA				Dahl, Haley C.; Kanchwala, Mohammed; Thomas-Jardin, Shayna E.; Sandhu, Amrit; Kanumuri, Preethi; Nawas, Afshan F.; Xing, Chao; Lin, Chenchu; Frigo, Daniel E.; Delk, Nikki A.			Chronic IL-1 exposure drives LNCaP cells to evolve androgen and AR independence	PLOS ONE			English	Article							PROSTATE-CANCER CELLS; TUMOR-NECROSIS-FACTOR; NEUROENDOCRINE DIFFERENTIATION; CHRONIC INFLAMMATION; RECEPTOR EXPRESSION; KAPPA-B; PROMOTES; INTERLEUKIN-1; ANTIANDROGEN; PROGRESSION	Chronic inflammation promotes prostate cancer (PCa) initiation and progression. We previously reported that acute intereluekin-1 (IL-1) exposure represses androgen receptor (AR) accumulation and activity, providing a possible mechanism for IL-1-mediated development of androgen- and AR-independent PCa. Given that acute inflammation is quickly resolved, and chronic inflammation is, instead, co-opted by cancer cells to promote tumorigenicity, we set out to determine if chronic IL-1 exposure leads to similar repression of AR and AR activity observed for acute IL-1 exposure and to determine if chronic IL-1 exposure selects for androgen- and AR-independent PCa cells. We generated isogenic sublines from LNCaP cells chronically exposed to IL-1 alpha or IL-1 beta. Cells were treated with IL-1 alpha, IL-1 beta, TNF alpha or HS-5 bone marrow stromal cells conditioned medium to assess cell viability in the presence of cytotoxic inflammatory cytokines. Cell viability was also assessed following serum starvation, AR siRNA silencing and enzalutamide treatment. Finally, RNA sequencing was performed for the IL-1 sublines. MTT, RT-qPCR and western blot analysis show that the sublines evolved resistance to inflammation-induced cytotoxicity and intracellular signaling and evolved reduced sensitivity to siRNA-mediated loss of AR, serum deprivation and enzalutamide. Differential gene expression reveals that canonical AR signaling is aberrant in the IL-1 sublines, where the cells show constitutive PSA repression and basally high KLK2 and NKX3.1 mRNA levels and bioinformatics analysis predicts that pro-survival and pro-tumorigenic pathways are activated in the sublines. Our data provide evidence that chronic IL-1 exposure promotes PCa cell androgen and AR independence and, thus, supports CRPCa development.	[Dahl, Haley C.; Thomas-Jardin, Shayna E.; Sandhu, Amrit; Kanumuri, Preethi; Nawas, Afshan F.; Delk, Nikki A.] Univ Texas Dallas, Dept Biol Sci, Richardson, TX 75080 USA; [Kanchwala, Mohammed; Xing, Chao] Univ Texas Southwestern Med Ctr Dallas, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; [Xing, Chao] Univ Texas Southwestern Med Ctr Dallas, Dept Bioinformat, Dallas, TX 75390 USA; [Xing, Chao] Univ Texas Southwestern Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Lin, Chenchu; Frigo, Daniel E.] Univ Texas MD Anderson Canc Ctr, Dept Canc Syst Imaging, Houston, TX 77030 USA; [Lin, Chenchu] Univ Texas MD Anderson Canc Ctr, UTHealth Grad Sch Biomed Sci, Houston, TX 77030 USA; [Frigo, Daniel E.] Univ Houston, Ctr Nucl Receptors & Cell Signaling, Houston, TX USA; [Frigo, Daniel E.] Univ Houston, Dept Biol & Biochem, Houston, TX USA; [Frigo, Daniel E.] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA; [Frigo, Daniel E.] Houston Methodist Res Inst, Houston, TX USA	University of Texas System; University of Texas Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Houston System; University of Houston; University of Houston System; University of Houston; University of Texas System; UTMD Anderson Cancer Center; The Methodist Hospital System; The Methodist Hospital - Houston	Delk, NA (corresponding author), Univ Texas Dallas, Dept Biol Sci, Richardson, TX 75080 USA.	nikki.delk@utdallas.edu		Thomas-Jardin, Shayna/0000-0002-2412-7562; Xing, Chao/0000-0002-1838-0502; Frigo, Daniel/0000-0002-0713-471X; Nawas, Afshan Fathima/0000-0001-5606-9603; Kanchwala, Mohammed/0000-0001-6035-2970; Delk, Nikki/0000-0001-9482-3830	University of Texas at Dallas; NIH [R01CA184208]; Prostate Cancer SPORE [P50CA140388]; Antje Wuelfrath Gee and Harry Gee, Jr. Family Legacy Scholarship; Robert Hazelwood Graduate Fellowship for Cancer Research;  [UL1TR001105]	University of Texas at Dallas; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Prostate Cancer SPORE; Antje Wuelfrath Gee and Harry Gee, Jr. Family Legacy Scholarship; Robert Hazelwood Graduate Fellowship for Cancer Research; 	ND, University of Texas at Dallas, utdallas.edu, The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. CX, UL1TR001105, NIH.gov, The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. DF, NIH R01CA184208, Prostate Cancer SPORE P50CA140388, NIH.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. CL, Antje Wuelfrath Gee and Harry Gee, Jr. Family Legacy Scholarship, Robert Hazelwood Graduate Fellowship for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammirante M, 2010, NATURE, V464, P302, DOI 10.1038/nature08782; Andrews S., 2010, FASTQC QUALITY CONTR; Aronesty E., 2013, OPEN BIOINFORM J, V7, P1, DOI 10.2174/1875036201307010001; Blaser H, 2016, TRENDS CELL BIOL, V26, P249, DOI 10.1016/j.tcb.2015.12.002; Bluemn EG, 2017, CANCER CELL, V32, P474, DOI 10.1016/j.ccell.2017.09.003; Cai T, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20153833; Chang MA, 2014, J CELL BIOCHEM, V115, P2188, DOI 10.1002/jcb.24897; Cheng I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008736; Chiao JW, 1999, INT J ONCOL, V15, P1033; Culig Z, 1998, BRIT J CANCER, V78, P1004, DOI 10.1038/bjc.1998.619; Debes JD, 2005, CANCER RES, V65, P5965, DOI 10.1158/0008-5472.CAN-04-2837; Di Donato M, 2019, CANCERS, V11, DOI 10.3390/cancers11060784; Diaz M, 1998, PROSTATE, P32; Gurel B, 2014, CANCER EPIDEM BIOMAR, V23, P847, DOI 10.1158/1055-9965.EPI-13-1126; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; HIROSE K, 1993, FASEB J, V7, P361, DOI 10.1096/fasebj.7.2.8440412; Jeong JH, 2017, MOL CELL, V65, P154, DOI 10.1016/j.molcel.2016.11.034; Kawada M, 2006, CANCER LETT, V242, P46, DOI 10.1016/j.canlet.2005.10.040; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kirby M, 2011, INT J CLIN PRACT, V65, P1180, DOI 10.1111/j.1742-1241.2011.02799.x; Ko S, 2008, MOL ENDOCRINOL, V22, P273, DOI 10.1210/me.2007-0332; Li QH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06067-7; Li YJ, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-87; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu QX, 2013, CANCER RES, V73, P3297, DOI 10.1158/0008-5472.CAN-12-3970; Liu YH, 2017, ONCOTARGET, V8, P17027, DOI 10.18632/oncotarget.15224; Mahal BA, 2018, EUR UROL, V74, P146, DOI 10.1016/j.eururo.2018.01.043; Mandel A, 2018, MOL MED, V24, P1, DOI 10.1186/s10020-018-0035-4; Moreira DM, 2014, CANCER-AM CANCER SOC, V120, P190, DOI 10.1002/cncr.28349; Multhoff G, 2012, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00098; Nawas AF, 2020, BMC CANCER, V20, DOI 10.1186/s12885-020-6529-9; Netea MG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000661; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Park HU, 2009, MOL CANCER THER, V8, P733, DOI 10.1158/1535-7163.MCT-08-0631; Perrier S, 2009, FEBS LETT, V583, P259, DOI 10.1016/j.febslet.2008.12.030; Persad S, 2000, P NATL ACAD SCI USA, V97, P3207, DOI 10.1073/pnas.060579697; Platz EA, 2017, CANCER EPIDEM BIOMAR, V26, P1549, DOI 10.1158/1055-9965.EPI-17-0503; Poluri RTK, 2019, DATA BRIEF, V25, DOI 10.1016/j.dib.2019.104372; Pyrzynska K, 2019, SEP PURIF REV, V48, P65, DOI 10.1080/15422119.2018.1430589; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; ROECKLEIN BA, 1995, BLOOD, V85, P997, DOI 10.1182/blood.V85.4.997.bloodjournal854997; Santer FR, 2015, SEMIN CANCER BIOL, V35, P133, DOI 10.1016/j.semcancer.2015.08.005; Semenas J, 2013, DRUG DES DEV THER, V7, P875, DOI 10.2147/DDDT.S45703; Shahriari K, 2017, ONCOGENE, V36, P2846, DOI 10.1038/onc.2016.436; Shen YC, 2018, PROSTATE CANCER P D, V21, P113, DOI 10.1038/s41391-017-0013-x; Staverosky JA, 2013, AM J CLIN EXP UROL, V1, P53; Tafuri A, 2020, ARAB J UROL, V18, P148, DOI 10.1080/2090598X.2020.1757335; Tazaki E, 2011, EXP THER MED, V2, P887, DOI 10.3892/etm.2011.286; THALMANN GN, 1994, CANCER RES, V54, P2577; Thomas-Jardin SE, 2020, PROSTATE, V80, P133, DOI 10.1002/pros.23925; Thomas-Jardin SE, 2018, PROSTATE, V78, P595, DOI 10.1002/pros.23504; Vander Ark A, 2018, FRONT ONCOL, P8, DOI [10.3389/fonc.2018.00008, DOI 10.3389/FONC.2018.00008]; Voronov E, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00114; Wang DP, 2009, CANCER RES, V69, P9448, DOI 10.1158/0008-5472.CAN-09-1903; Wang Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010456; Wingett S, 2011, FASTQ SCREEN QUALITY, DOI [10.3109/17435390.2011.587031, DOI 10.3109/17435390.2011.587031]; Xu Y, 1999, DNA CELL BIOL, V18, P709, DOI 10.1089/104454999314999; Yin H, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-158; Zhang BY, 2016, MOL CELL, V63, P976, DOI 10.1016/j.molcel.2016.07.025; Zhang C, 2011, PROSTATE, V71, P157, DOI 10.1002/pros.21231	62	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0242970	10.1371/journal.pone.0242970	http://dx.doi.org/10.1371/journal.pone.0242970			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326447	Green Submitted, Green Published, gold			2022-12-27	WOS:000600176400036
J	Arega, B; Mersha, A; Minda, A; Getachew, Y; Sitotaw, A; Gebeyehu, T; Agunie, A				Arega, Balew; Mersha, Amdemeskel; Minda, Abraham; Getachew, Yitagesu; Sitotaw, Alazar; Gebeyehu, Tefera; Agunie, Asnake			Epidemiology and the diagnostic challenge of extra-pulmonary tuberculosis in a teaching hospital in Ethiopia	PLOS ONE			English	Article							EXTRAPULMONARY TUBERCULOSIS; LYMPHADENITIS	Background Ethiopia reported a high rate of extra-pulmonary tuberculosis (EPTB) and the cases are increasing since the last three decades. However, diagnostic evidence to initiate TB treatment among EPTB cases is not well known. Therefore, we described the epidemiology and assessed how EPTB is diagnosed in a teaching hospital in Ethiopia. Methods We conducted a retrospective review among all adult EPTB cases diagnosed in Yekatit 12 Hospital Medical College from 2015 to 2019. Using a standardized data abstraction sheet, we collected data from patients' medical records on sociodemographic, sites, and laboratory diagnosis of EPTB cases. Results Of the 965 total TB cases, 49.8%(481) had a recorded diagnosis of EPTB during the study period. The mean age of EPTB patients was 32.9 years (SD13.9) and 50.7% were males. Tubercular lymphadenitis (40.3%), abdominal (23.4%), and pleural TB(13.5%) were the most common sites of EPTB involvement, followed in descending order by the genitourinary, skeletal, central nervous system, abscess, breast, and laryngeal TB. We found a histopathology finding consistent with EPTB in 59.1% of cases, Acid-fast bacilli positive in 1.5%, and the rest diagnosed on radiological grounds. In the majority of cases, more than one diagnostic method was used to diagnose EPTB cases. Conclusions Nearly half of TB patients had a recorded diagnosis of EPTB that comprise heterogeneous anatomical sites. All EPTB patients were started anti-TB therapy without definitive microbiology results. This indicates the diagnostic challenge of EPTB faced in our setting and proves to be significant for TB control in Ethiopia.	[Arega, Balew; Mersha, Amdemeskel; Minda, Abraham; Getachew, Yitagesu; Sitotaw, Alazar; Gebeyehu, Tefera; Agunie, Asnake] Yekatit 12 Hosp Med Coll, Addis Ababa, Ethiopia		Arega, B (corresponding author), Yekatit 12 Hosp Med Coll, Addis Ababa, Ethiopia.	balewmlt@gmail.com		Negatie, Balew Arega/0000-0002-4222-8420; Yirga, Asnake/0000-0002-9790-430X				A YX, 2011, J MODERN ONCOLOGY, V19, P111; Abdallah Taj Eldin Mohammedein, 2015, Asian Pacific Journal of Tropical Biomedicine, V5, P505, DOI 10.1016/j.apjtb.2015.02.004; Abdissa K, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0720-z; Abebe G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-504; Adada H, 2014, INT J TUBERC LUNG D, V18, P1516, DOI 10.5588/ijtld.14.0319; Adrian O, 2004, CLININFE DIS, V38, P25; Alemu A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232426; [Anonymous], 2017, BRIDGES, V21, P36; [Anonymous], 2013, KOVETZ HITZEI GIBORI, V6, P21; [Anonymous], REP TUB US 1999; Arega B, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09117-2; Beek LAMT, 2006, EMERG INFECT DIS, V12, P1375, DOI 10.3201/eid1209.050553; Bekele S, 2018, TROP DIS TRAVEL MED, V4, DOI 10.1186/s40794-018-0075-3; Berg S, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0846-7; Biadglegne F, 2014, TUBERCULOSIS, V94, P502, DOI 10.1016/j.tube.2014.05.002; Biadglegne F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081918; Biadglegne F, 2013, INT J MED SCI, V10, P1589, DOI 10.7150/ijms.6806; Biadglegne F, 2013, JPN J INFECT DIS, V66, P263, DOI 10.7883/yoken.66.263; CABIE A, 1995, PRESSE MED, V24, P601; Chander V, 2012, PUBLIC HLTH RES, V2, P185; Diedrich CR, 2011, INFECT IMMUN, V79, P1407, DOI 10.1128/IAI.01126-10; FAGIOLO U, 1993, EUR J IMMUNOL, V23, P2375, DOI 10.1002/eji.1830230950; Fain, 2000, Eur J Intern Med, V11, P145, DOI 10.1016/S0953-6205(00)00076-5; Fantahun M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222402; Federal Ministry of Health (Ethiopia), 2013, GUID CLIN PROGR MAN, V5th; Firdessa R, 2013, EMERG INFECT DIS, V19, P460, DOI 10.3201/eid1903.120256; Kandola P, 2014, ADV MAT REV, V1, P13; Kidane D, 2002, J CLIN MICROBIOL, V40, P4230, DOI 10.1128/JCM.40.11.4230-4234.2002; Korma W, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1177-4; Kruijshaar ME, 2009, THORAX, V64, P1090, DOI 10.1136/thx.2009.118133; Licastro Federico, 2005, Immun Ageing, V2, P8; Makhloufa Nahed A., 2016, AL AZHAR ASSIUT MED, V14, P132; Mesfin MM, 2005, ETH J HLTH DEV; Metaferia Y, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/8207098; Modi S, 2018, J DATTA MEGHE I MED, V13, P163; Muluye D, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-435; Noertjojo K, 2002, INT J TUBERC LUNG D, V6, P879; Ozvaran Mustafa Kursat, 2007, Ann Thorac Med, V2, P118, DOI 10.4103/1817-1737.33700; Peto HM, 2009, CLIN INFECT DIS, V49, P1350, DOI 10.1086/605559; Prakasha SR, 2013, J GLOB INFECT DIS, V5, P54, DOI 10.4103/0974-777X.112277; Purohit M, 2015, J CLIN DIAGN RES, V9, pEE1, DOI 10.7860/JCDR/2015/12422.5792; Solovic I, 2013, EUROSURVEILLANCE, V18, P34; Sreeramareddy CT, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-8; Srinidhi R, 2020, IP INDIAN J IMMUNOL, V5, P152; Suguitan Jr AL, 2011, PLOS ONE, V6; Tadesse M, 2019, CLIN MICROBIOL INFEC, V25, P1000, DOI 10.1016/j.cmi.2018.12.018; Tadesse M, 2017, INFECT GENET EVOL, V55, P251, DOI 10.1016/j.meegid.2017.09.016; Tadesse M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137471; Tahseen S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232134; Wani R. L. S., 2013, South Sudan Medical Journal, V6, P52; WHO, 2017, GLOB TUB REP; WHO W, 2012, GLOB TUB REP 2012; World Health Organization, 2011, RAP IMPL XPERT MTB R; Zewdie O, 2016, INT J TUBERC LUNG D, V20, P1529, DOI 10.5588/ijtld.15.1023; Zewdie O, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2194-2	55	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243945	10.1371/journal.pone.0243945	http://dx.doi.org/10.1371/journal.pone.0243945			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320897	gold, Green Published			2022-12-27	WOS:000600339800023
J	Barycka, K; Szarpak, L; Filipiak, KJ; Jaguszewski, M; Smereka, J; Ladny, JR; Turan, O				Barycka, Katarzyna; Szarpak, Lukasz; Filipiak, Krzysztof Jerzy; Jaguszewski, Milosz; Smereka, Jacek; Ladny, Jerzy Robert; Turan, Oguz			Comparative effectiveness of N95 respirators and surgical/face masks in preventing airborne infections in the era of SARS-CoV2 pandemic: A meta-analysis of randomized trials	PLOS ONE			English	Article							MEDICAL MASKS; CLINICAL-TRIAL; FACE MASK; INFLUENZA; TRANSMISSION	Background Recently, several randomized controlled trials (RCTs) have evaluated the effect of N95 respirators compared with medical masks to protect against acute respiratory infections. However, these studies are limited by modest sample sizes and inconclusive results. Therefore, the goal of the present study was to review the relevant and available published RCTs with the aid of the increased power of meta-analytic methods in order to assess the effectiveness of medical masks and N95 respirators in reducing the risk of respiratory infections. Methods This meta-analysis follows the recommendations of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement for conducting and reporting results. We searched PubMed, Web of Science, Embase, and Cochrane databases from inception through April 1, 2020 to identify potentially relevant studies. Two authors (LS and JS) independently searched the titles and abstracts of the potentially eligible articles. They independently retrieved required data from the eligible trials; the data were initially tabulated for statistical analysis. Two authors (JRL and LS) independently assessed the methodological quality of the included RCTs using the Cochrane Collaboration's tool for assessing risk of bias. Results Six articles met the inclusion criteria. The pooled analysis showed that N95 respirators did not reduce the risk of infection with respiratory viruses compared with medical/surgical masks (5.7% vs. 7.9%; RR = 1.12; 95% CI: 0.88-1.41; p = 0.36); however, there was no statistically significant difference in laboratory-confirmed influenza between N95 and medical masks (RR = 0.91; 95% CI: 0.77-1.07; p = 0.26). Medical masks provided similar protection against other viruses, including coronavirus (RR = 0.74; 95% CI: 0.32-1.73; p = 0.49). Respiratory illness, as well as influenza-like illness were less frequently observed with N95 respirators. Conclusions Our meta-analysis suggests that there are insufficient data to definitively determine whether N95 respirators are superior to medical masks in protection against transmissible acute respiratory infections. Further randomized trials are necessary to compare the above methods of respiratory protection in the context of COVID-19 incidence.	[Barycka, Katarzyna] Polish Soc Disaster Med, Warsaw, Poland; [Szarpak, Lukasz] Maria Sklodowska Curie Med Acad Warsaw, Warsaw, Poland; [Filipiak, Krzysztof Jerzy] Med Univ Warsaw, Chair & Dept Cardiol 1, Warsaw, Poland; [Jaguszewski, Milosz] Med Univ Gdansk, Dept Cardiol 1, Gdansk, Poland; [Smereka, Jacek] Wroclaw Med Univ, Dept Emergency Med Serv, Wroclaw, Poland; [Ladny, Jerzy Robert] Med Univ Bialystok, Clin Emergency Med, Bialystok, Poland; [Turan, Oguz] Cleveland Clin, Anesthesiol Inst, Dept Outcomes Res, Cleveland, OH 44106 USA	Medical University of Warsaw; Fahrenheit Universities; Medical University Gdansk; Wroclaw Medical University; Medical University of Bialystok; Cleveland Clinic Foundation	Szarpak, L (corresponding author), Maria Sklodowska Curie Med Acad Warsaw, Warsaw, Poland.	lukasz.szarpak@gmail.com	Jaguszewski, Milosz/AAL-3169-2020; Ladny, Jerzy/S-4769-2018	Szarpak, Lukasz/0000-0002-0973-5455; Ladny, Jerzy/0000-0003-4167-1962				[Anonymous], 2020, CORONAVIRUS COVID 19; Carenzo L, 2020, ANAESTHESIA, V75, P928, DOI 10.1111/anae.15072; Christian MD, 2004, EMERG INFECT DIS, V10, P287, DOI 10.3201/eid1002.030700; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13; Kim H, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000014250; Loeb M, 2009, JAMA-J AM MED ASSOC, V302, P1865, DOI 10.1001/jama.2009.1466; MacIntyre CR, 2014, PREV MED, V62, P1, DOI 10.1016/j.ypmed.2014.01.015; MacIntyre CR, 2013, AM J RESP CRIT CARE, V187, P960, DOI 10.1164/rccm.201207-1164OC; MacIntyre CR, 2011, INFLUENZA OTHER RESP, V5, P170, DOI 10.1111/j.1750-2659.2011.00198.x; Maclntyre CR, 2009, EMERG INFECT DIS, V15, P233, DOI 10.3201/eid1502.081167; Radonovich LJ, 2019, JAMA-J AM MED ASSOC, V322, P824, DOI 10.1001/jama.2019.11645; Radonovich LJ, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1494-2; Ruetzler K, 2020, DISASTER EMERG MED J, V5, P106; Sandaradura I, 2020, J HOSP INFECT, V104, P529, DOI 10.1016/j.jhin.2020.01.006; Shamseer L, 2015, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7647; Smereka J, 2020, AM J EMERG MED, V38, P2232, DOI 10.1016/j.ajem.2020.03.038; Stower H, 2020, NAT MED, V26, P465, DOI 10.1038/s41591-020-0850-3; Suen LKP, 2020, J HOSP INFECT, V104, P336, DOI 10.1016/j.jhin.2019.09.014; Szarpak L, 2020, CARDIOL J, V27, P218, DOI 10.5603/CJ.a2020.0054; Vuma CD, 2019, ANN WORK EXPOS HEAL, V63, P930, DOI 10.1093/annweh/wxz060; Wang J, 2020, J HOSP INFECT, V105, P100, DOI 10.1016/j.jhin.2020.03.002; Zhang L, 2020, J MED VIROL, V92, P479, DOI 10.1002/jmv.25707; Zhou SS, 2018, J THORAC DIS, V10, P2059, DOI 10.21037/jtd.2018.03.103	24	11	11	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0242901	10.1371/journal.pone.0242901	http://dx.doi.org/10.1371/journal.pone.0242901			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320847	gold, Green Published			2022-12-27	WOS:000600339800018
J	De Brier, N; Stroobants, S; Vandekerckhove, P; De Buck, E				De Brier, Niels; Stroobants, Stijn; Vandekerckhove, Philippe; De Buck, Emmy			Factors affecting mental health of health care workers during coronavirus disease outbreaks (SARS, MERS & COVID-19): A rapid systematic review	PLOS ONE			English	Review							ACUTE-RESPIRATORY-SYNDROME; PSYCHOLOGICAL IMPACT; HOSPITAL WORKERS; EMERGENCY NURSES; MEDICAL STAFF; PREVALENCE; BURNOUT; RISK; DEPRESSION; STRESS	Introduction The novel Coronavirus Disease (COVID-19) outbreak currently puts health care workers at high risk of both physical and mental health problems. This study aimed to identify the risk and protective factors for mental health outcomes in health care workers during coronavirus epidemics. Methods A rapid systematic review was performed in three databases (March 24, 2020) and a current COVID-19 resource (May 28, 2020). Following study selection, study characteristics and effect measures were tabulated, and data were synthesized by using vote counting. Meta-analysis was not possible because of high variation in risk factors, outcomes and effect measures. Risk of bias of each study was assessed and the certainty of evidence was appraised according to the GRADE methodology. Results Out of 2605 references, 33 observational studies were selected and the identified risk and protective factors were categorized in ten thematic categories. Most of these studies (n = 23) were performed during the SARS outbreak, seven during the current COVID-19 pandemic and three during the MERS outbreak. The level of disease exposure and health fear were significantly associated with worse mental health outcomes. There was evidence that clear communication and support from the organization, social support and personal sense of control are protective factors. The evidence was of very low certainty, because of risk of bias and imprecision. Conclusion Safeguarding mental health of health care workers during infectious disease outbreaks should not be treated as a separate mental health intervention strategy, but could benefit from a protective approach. This study suggests that embedding mental health support in a safe and efficient working environment which promotes collegial social support and personal sense of control could help to maximize resilience of health care workers. Low quality cross-sectional studies currently provide the best possible evidence, and further research is warranted to confirm causality.	[De Brier, Niels; De Buck, Emmy] Belgian Red Cross, Ctr Evidence Based Practice, Mechelen, Belgium; [Stroobants, Stijn] Belgian Red Cross, Humanitarian Serv, Mechelen, Belgium; [Vandekerckhove, Philippe] Belgian Red Cross, Mechelen, Belgium; [Vandekerckhove, Philippe; De Buck, Emmy] Katholieke Univ Leuven, Dept Publ Hlth & Primary Care, Fac Med, Leuven, Belgium; [De Buck, Emmy] Cochrane First Aid, Mechelen, Belgium	KU Leuven	De Brier, N (corresponding author), Belgian Red Cross, Ctr Evidence Based Practice, Mechelen, Belgium.	Niels.Debrier@rodekruis.be	De Brier, Niels/T-7063-2017	De Brier, Niels/0000-0002-0605-2376	Foundation for Scientific Research of the Belgian Red Cross	Foundation for Scientific Research of the Belgian Red Cross(Fonds de la Recherche Scientifique - FNRS)	This work was made possible through funding from the Foundation for Scientific Research of the Belgian Red Cross. All authors are in employment at Belgian Red Cross and receive no other funding. No external funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RM, 2004, PHILOS T R SOC B, V359, P1091, DOI 10.1098/rstb.2004.1490; Arabi YM, 2020, INTENS CARE MED, V46, P833, DOI 10.1007/s00134-020-05955-1; Arpacioglu S, 2021, INT J SOC PSYCHIATR, V67, P84, DOI 10.1177/0020764020940742; Bai Y, 2004, PSYCHIAT SERV, V55, P1055, DOI 10.1176/appi.ps.55.9.1055; Bao YP, 2020, LANCET, V395, pE37, DOI 10.1016/S0140-6736(20)30309-3; Brooks SK, 2018, J OCCUP ENVIRON MED, V60, P248, DOI 10.1097/JOM.0000000000001235; Cai Q, 2020, J AFFECT DISORDERS, V275, P210, DOI 10.1016/j.jad.2020.06.031; Chan AOM, 2004, OCCUP MED-OXFORD, V54, P190, DOI 10.1093/occmed/kqh027; Chang KH, 2006, HEALTH CARE MANAGE R, V31, P26, DOI 10.1097/00004010-200601000-00005; Chen CS, 2005, PSYCHIAT SERV, V56, P76, DOI 10.1176/appi.ps.56.1.76; Chen NH, 2007, INFECT CONT HOSP EP, V28, P75, DOI 10.1086/508824; Chen QN, 2020, LANCET PSYCHIAT, V7, pE15, DOI 10.1016/S2215-0366(20)30078-X; Chen R, 2006, INT J NURS STUD, V43, P215, DOI 10.1016/j.ijnurstu.2005.03.006; Chong MY, 2004, BRIT J PSYCHIAT, V185, P127, DOI 10.1192/bjp.185.2.127; Clough BA, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-017-0526-3; Cucinotta Domenico, 2020, Acta Biomed, V91, P157, DOI 10.23750/abm.v91i1.9397; de Boer J, 2011, SOC SCI MED, V73, P316, DOI 10.1016/j.socscimed.2011.05.009; de Pablo GS, 2020, J AFFECT DISORDERS, V275, P48, DOI 10.1016/j.jad.2020.06.022; Garcia-Fernandez L, 2022, PSYCHOL MED, V52, P195, DOI 10.1017/S0033291720002019; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Ho SMY, 2005, J CONSULT CLIN PSYCH, V73, P344, DOI 10.1037/0022-006X.73.2.344; HUANG L, 2020, EMOTIONAL RESPONSES, DOI DOI 10.1101/2020.03.05.20031898; Kang LJ, 2020, BRAIN BEHAV IMMUN, V87, P11, DOI 10.1016/j.bbi.2020.03.028; Kim JS, 2016, ASIAN NURS RES, V10, P295, DOI 10.1016/j.anr.2016.10.002; Koh D, 2005, MED CARE, V43, P676, DOI 10.1097/01.mlr.0000167181.36730.cc; Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976; Lancee WJ, 2008, PSYCHIAT SERV, V59, P91, DOI 10.1176/ps.2008.59.1.91; Li H, 2018, INT EMERG NURS, V39, P46, DOI 10.1016/j.ienj.2017.12.005; Li W, 2020, INT J BIOL SCI, V16, P1732, DOI 10.7150/ijbs.45120; Liu XH, 2012, COMPR PSYCHIAT, V53, P15, DOI 10.1016/j.comppsych.2011.02.003; Lu W, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112936; Maciaszek J, 2020, J CLIN MED, V9, DOI 10.3390/jcm9082527; Mackay IM, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0439-5; Malave Adriel, 2010, Virtual Mentor, V12, P719, DOI 10.1001/virtualmentor.2010.12.9.cprl1-1009; Marjanovic Z, 2007, INT J NURS STUD, V44, P991, DOI 10.1016/j.ijnurstu.2006.02.012; Maunder RG, 2004, PSYCHOSOM MED, V66, P938, DOI 10.1097/01.psy.0000145673.84698.18; Maunder RG, 2006, EMERG INFECT DIS, V12, P1924; McAlonan GM, 2007, CAN J PSYCHIAT, V52, P241, DOI 10.1177/070674370705200406; McKenzie J, 2019, COCHRANE HDB SYSTEMA; Mo YY, 2020, J NURS MANAGE, V28, P1002, DOI 10.1111/jonm.13014; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Nickell LA, 2004, CAN MED ASSOC J, V170, P793, DOI 10.1503/cmaj.1031077; NIPH, 2020, NIPH SYST LIV MAP CO; Pan R, 2020, PSYCHIAT INVEST, V17, P475, DOI 10.30773/pi.2020.0127; Pappa S, 2020, BRAIN BEHAV IMMUN, V88, P901, DOI [10.1016/j.bbi.2020.05.026, 10.1016/j.bbi.2020.11.023]; Park JE, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5484-8; Park JS, 2018, ARCH PSYCHIAT NURS, V32, P2, DOI 10.1016/j.apnu.2017.09.006; de la Cruz SP, 2020, J CLIN MED, V9, DOI 10.3390/jcm9041007; Rotenstein LS, 2018, JAMA-J AM MED ASSOC, V320, P1131, DOI 10.1001/jama.2018.12777; Shanghai Clinical Treatment Expert Group for corona virus disease, 2020, CHIN J INFECT DIS, V38; Sim K, 2004, J CLIN PSYCHIAT, V65, P1120; Skoda EM, 2020, J PUBLIC HLTH, DOI [10.1093/pubmed/fdaa124, DOI 10.1093/PUBMED/FDAA12432766787]; Son H, 2019, SOC BEHAV PERSONAL, V47, DOI 10.2224/sbp.7228; Styra R, 2008, J PSYCHOSOM RES, V64, P177, DOI 10.1016/j.jpsychores.2007.07.015; Su TP, 2007, J PSYCHIATR RES, V41, P119, DOI 10.1016/j.jpsychires.2005.12.006; Tam CWC, 2004, PSYCHOL MED, V34, P1197, DOI 10.1017/S0033291704002247; da Silva FCT, 2021, PROG NEURO-PSYCHOPH, V104, DOI 10.1016/j.pnpbp.2020.110057; Wankowicz P, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17165849; WHO, 2020, MENT HLTH PSYCH CONS; Wong TW, 2005, EUR J EMERG MED, V12, P13, DOI 10.1097/00063110-200502000-00005; Wong WCW, 2007, AM J INFECT CONTROL, V35, P50, DOI 10.1016/j.ajic.2006.06.009; Woo T, 2020, J PSYCHIATR RES, V123, P9, DOI 10.1016/j.jpsychires.2019.12.015; Wu P, 2009, CAN J PSYCHIAT, V54, P302, DOI 10.1177/070674370905400504; Xiang YT, 2020, LANCET PSYCHIAT, V7, P228, DOI 10.1016/S2215-0366(20)30046-8; Xiao H, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.923921; Xie JF, 2020, INTENS CARE MED, V46, P837, DOI 10.1007/s00134-020-05979-7; Xu J, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112955; Zhang C, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01295; Zhang J, 2021, PSYCHOL HEALTH MED, V26, P595, DOI 10.1080/13548506.2020.1849748; Zhu JH, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00386	70	76	77	11	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0244052	10.1371/journal.pone.0244052	http://dx.doi.org/10.1371/journal.pone.0244052			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH3TP	33320910	Green Published, gold			2022-12-27	WOS:000600339800008
J	Christoforou, AN; Armstrong, MJ; Bergin, MJG; Robbins, A; Merillat, SA; Erwin, P; Getchius, TSD; McCrea, M; Markowitz, AJ; Manley, GT; Giacino, JT				Christoforou, Andrea N.; Armstrong, Melissa J.; Bergin, Michael J. G.; Robbins, Ann; Merillat, Shannon A.; Erwin, Patricia; Getchius, Thomas S. D.; McCrea, Michael; Markowitz, Amy J.; Manley, Geoffrey T.; Giacino, Joseph T.			An evidence-based methodology for systematic evaluation of clinical outcome assessment measures for traumatic brain injury	PLOS ONE			English	Article							SEVERE HEAD-INJURY; HEALTH-STATUS; COSMIN; RECOMMENDATIONS; PROGRESS; QUALITY; DISORDERS; CHECKLIST; REVIEWS; SCALES	Introduction The high failure rate of clinical trials in traumatic brain injury (TBI) may be attributable, in part, to the use of untested or insensitive measurement instruments. Of more than 1,000 clinical outcome assessment measures (COAs) for TBI, few have been systematically vetted to determine their performance within specific "contexts of use (COU)." As described in guidance issued by the U.S. Food and Drug Administration (FDA), the COU specifies the population of interest and the purpose for which the COA will be employed. COAs are commonly used for screening, diagnostic categorization, outcome prediction, and establishing treatment effectiveness. COA selection typically relies on expert consensus; there is no established methodology to match the appropriateness of a particular COA to a specific COU. We developed and pilot-tested the Evidence-Based Clinical Outcome assessment Platform (EB-COP) to systematically and transparently evaluate the suitability of TBI COAs for specific purposes. Methods and findings Following a review of existing literature and published guidelines on psychometric standards for COAs, we developed a 6-step, semi-automated, evidence-based assessment platform to grade COA performance for six specific purposes: diagnosis, symptom detection, prognosis, natural history, subgroup stratification and treatment effectiveness. Mandatory quality indicators (QIs) were identified for each purpose using a modified Delphi consensus-building process. The EB-COP framework was incorporated into a Qualtrics software platform and pilot-tested on the Glasgow Outcome Scale-Extended (GOSE), the most widely-used COA in TBI clinical studies. Conclusion The EB-COP provides a systematic methodology for conducting more precise, evidence-based assessment of COAs by evaluating performance within specific COUs. The EB-COP platform was shown to be feasible when applied to a TBI COA frequently used to detect treatment effects and can be modified to address other populations and COUs. Additional testing and validation of the EB-COP are warranted.	[Christoforou, Andrea N.; Bergin, Michael J. G.; Giacino, Joseph T.] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Charlestown, MA 02129 USA; [Christoforou, Andrea N.; Bergin, Michael J. G.; Giacino, Joseph T.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Armstrong, Melissa J.] Univ Florida, Coll Med, Dept Neurol, Gainesville, FL 32611 USA; [Robbins, Ann] Ann Robbins LLC, Bradenton, FL USA; [Merillat, Shannon A.; Getchius, Thomas S. D.] Amer Acad Neurol, Minneapolis, MN USA; [Erwin, Patricia] Mayo Clin, Rochester, MN USA; [Getchius, Thomas S. D.] Amer Heart Assoc, Amer Coll Cardiol, Dallas, TX USA; [McCrea, Michael] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Markowitz, Amy J.] Univ Calif San Francisco, Brain & Spinal Injury Ctr, San Francisco, CA 94143 USA; [Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA USA	Harvard University; Spaulding Rehabilitation Hospital; Harvard University; Harvard Medical School; State University System of Florida; University of Florida; Mayo Clinic; Medical College of Wisconsin; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Giacino, JT (corresponding author), Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Charlestown, MA 02129 USA.; Giacino, JT (corresponding author), Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA.; Markowitz, AJ (corresponding author), Univ Calif San Francisco, Brain & Spinal Injury Ctr, San Francisco, CA 94143 USA.	amymarkowitz@gmail.com; jgiacino@mgh.harvard.edu	Giacino, Joseph/AAF-1952-2021	Giacino, Joseph/0000-0002-7916-9698; Armstrong, Melissa/0000-0002-2163-1907	University of California at San Francisco (UCSF) (TBI Endpoint Development Initiative) [W81XWH-14-2-0176]; DoD grant	University of California at San Francisco (UCSF) (TBI Endpoint Development Initiative); DoD grant	This study was supported by a seed grant awarded to JTG by the University of California at San Francisco (UCSF) as part of a prime award (TBI Endpoint Development Initiative; URL: https://tbiendpoints.ucsf.edu/) issued to UCSF by the U.S. Department of Defense (DoD) Army Medical Research and Materiel Command (W81XWH-14-2-0176; URL: https://mrdc.amedd.army.mil/).GM served as the PI on the primary DoD grant. The funder provided support in the form of salaries [JTG, AC, MJB, GM, AM] and consulting fees [MJA, AR, SM, PE, TSG, MM] for authors. The specific roles of these authors are articulated in the `author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. One author [AR] has a commercial interest as the President of Ann Robbins, LLC, a regulatory affairs consulting company that provides regulatory consulting services to drug development and non-profit research organizations. Dr. Robbins' commercial affiliation did not play any role in this study and she was not compensated for her participation.	[Anonymous], 2011, CLIN PRACTICE GUIDEL, DOI DOI 10.17226/13058; Bragge P, 2016, J NEUROTRAUM, V33, P1461, DOI 10.1089/neu.2015.4233; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; FDA, 2017, FDA CDRH QUALIFICATI; Fitzpatrick R, 1998, Health Technol Assess, V2, P1; Friedman JH, 2010, MOVEMENT DISORD, V25, P805, DOI 10.1002/mds.22989; Gronseth GS., 2017, CLIN PRACTICE GUIDEL, V2nd; GUYATT GH, 1992, J CLIN EPIDEMIOL, V45, P1341, DOI 10.1016/0895-4356(92)90194-R; Hayden JA, 2013, ANN INTERN MED, V158, P280, DOI 10.7326/0003-4819-158-4-201302190-00009; Hicks R, 2013, J NEUROTRAUM, V30, P1852, DOI 10.1089/neu.2013.2938; Husted JA, 2000, J CLIN EPIDEMIOL, V53, P459, DOI 10.1016/S0895-4356(99)00206-1; Institute of Medicine, 2011, FIND WHAT WORKS HLTH, DOI [10.17226/13059., DOI 10.17226/13059, 10.17226/13059]; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kirkham JJ, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002447; Kirkham JJ, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002148; Kucukdeveci AA, 2011, J REHABIL MED, V43, P661, DOI 10.2340/16501977-0844; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Manley GT, 2017, J NEUROTRAUM, V34, P2721, DOI 10.1089/neu.2016.4729; McMillan T, 2016, NAT REV NEUROL, V12, P477, DOI 10.1038/nrneurol.2016.89; Meeuws S, 2020, J NEUROTRAUM, V37, P1283, DOI 10.1089/neu.2019.6867; Menon DK, 2015, NAT REV NEUROL, V11, P71, DOI 10.1038/nrneurol.2014.261; Menon DK, 2009, CRIT CARE MED, P37; Mokkink LB., 2012, COSMIN CHECKLIST MAN; Mokkink LB, 2010, J CLIN EPIDEMIOL, V63, P737, DOI 10.1016/j.jclinepi.2010.02.006; Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8; Moore JL, 2014, ARCH PHYS MED REHAB, V95, P197, DOI 10.1016/j.apmr.2013.09.010; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; Pettigrew LEL, 2003, J HEAD TRAUMA REHAB, P18; Prinsen CAC, 2018, QUAL LIFE RES, V27, P1147, DOI 10.1007/s11136-018-1798-3; Salter K, 2017, EVIDENCE BASED REV M, P1; Schmidt M., 1996, W PSYCHOL SERVICES; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Terwee CB, 2009, QUAL LIFE RES, V18, P1115, DOI 10.1007/s11136-009-9528-5; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; U.S. Food and Drug Administration, 2016, DRUG DEV TOOLS QUAL; U.S. Food and Drug Administration, 2016, CLIN OUTC ASS COMP; U.S. Food and Drug Administration, 2016, PIL CLIN OUTC ASS CO; Venderbos LDF, 2015, PSYCHO-ONCOLOGY, V24, P348, DOI 10.1002/pon.3657; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	46	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0242811	10.1371/journal.pone.0242811	http://dx.doi.org/10.1371/journal.pone.0242811			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH1MP	33315925	Green Published, gold			2022-12-27	WOS:000600186100030
J	Kakita, M; Mikami, Y; Ibusuki, T; Shimoe, T; Kamijo, Y; Hoekstra, SP; Tajima, F				Kakita, Mari; Mikami, Yukio; Ibusuki, Tatsuru; Shimoe, Takashi; Kamijo, Yoshi-ichiro; Hoekstra, Sven P.; Tajima, Fumihiro			The prevalence of ulnar neuropathy at the elbow and ulnar nerve dislocation in recreational wheelchair marathon athletes	PLOS ONE			English	Article							CUBITAL TUNNEL-SYNDROME; RISK-FACTORS; ENTRAPMENT NEUROPATHIES; MONONEUROPATHY; COMPRESSION	Background Ulnar neuropathy at the elbow is an entrapment neuropathy, while ulnar nerve dislocation might also be involved in its incidence and severity. Wheelchair marathon athletes may be at an increased risk for Ulnar Neuropathy. However, there is a paucity of research into the prevalence of Ulnar Neuropathy and ulnar nerve dislocation in this population. Objective To investigate the prevalence of ulnar neuropathy at the elbow and ulnar nerve dislocation in wheelchair marathon athletes. Participants Wheelchair marathon athletes (N = 38) who participated in the 2017, 2018, and 2019 Oita International Wheelchair Marathon. 2 athletes participated only one time, 36 athletes repeatedly. Data from athletes`latest assessment were used. Methods The day before the race, questionnaires, physical examinations, and ultrasonography were conducted to screen for Ulnar Neuropathy in both upper limbs. Ulnar nerve dislocation was confirmed by physical examination and ultrasonography. Results 11 (29%) athletes were diagnosed with Ulnar Neuropathy. There were no significant differences in age, height, weight, Body Mass Index, or history of primary illness between athletes with and without Ulnar Neuropathy. In the group without Ulnar Neuropathy, 44% of athletes reported to have been engaging in other wheelchair sports, compared to 9% in the group with Ulnar Neuropathy (p = 0.037). Ulnar nerve dislocation was diagnosed in 15 (39%) athletes by ultrasonography. Out of the 14 elbows of 11 athletes diagnosed with Ulnar Neuropathy, 9 (64%) elbows had ulnar nerve dislocation. Conclusion The prevalence of Ulnar Neuropathy in wheelchair marathon athletes was higher than previously reported in able-bodied, non-athlete individuals and lower than in non-athletes with lower limb dysfunction. Therefore, while wheelchair sports may provide some protection against Ulnar Neuropathy, this study further supports the importance of screening for Ulnar Neuropathy, as well as for ulnar nerve dislocation as a potential risk factor for the development of Ulnar Neuropathy.	[Kakita, Mari] Kansai Elect Power Hosp, Dept Rehabil Med, Osaka, Osaka, Japan; [Kakita, Mari; Mikami, Yukio; Ibusuki, Tatsuru; Kamijo, Yoshi-ichiro; Hoekstra, Sven P.; Tajima, Fumihiro] Wakayama Med Univ, Dept Rehabil Med, Wakayama, Wakayama, Japan; [Shimoe, Takashi] Wakayama Med Univ, Dept Orthoped Surg, Wakayama, Wakayama, Japan; [Hoekstra, Sven P.; Tajima, Fumihiro] Loughborough Univ, Peter Harrison Ctr Disabil Sport, Loughborough, Leics, England	Wakayama Medical University; Wakayama Medical University; Loughborough University	Kakita, M (corresponding author), Kansai Elect Power Hosp, Dept Rehabil Med, Osaka, Osaka, Japan.; Kakita, M (corresponding author), Wakayama Med Univ, Dept Rehabil Med, Wakayama, Wakayama, Japan.	sun10139656@yahoo.co.jp	Shimoe, Takashi/ABI-7901-2020	Shimoe, Takashi/0000-0002-5678-572X; kakita, mari/0000-0003-4384-6156				An TW, 2017, J BONE JOINT SURG AM, V99, P408, DOI 10.2106/JBJS.15.01162; Aoki M, 2005, ARTHROSCOPY, V21, P758, DOI 10.1016/j.artho.2005.03.030; Bales J, 2012, CLIN J SPORT MED, V22, P126, DOI 10.1097/JSM.0b013e3182427003; Bartels RHMA, 2007, ACTA NEUROCHIR, V149, P669, DOI 10.1007/s00701-007-1166-5; Bartels RHMA, 1998, J NEUROSURG, V89, P722, DOI 10.3171/jns.1998.89.5.0722; Boninger ML, 1996, AM J PHYS MED REHAB, V75, P170, DOI 10.1097/00002060-199605000-00002; Bruce SL, 1997, J ATHL TRAINING, V32, P151; BURNHAM RS, 1994, ARCH PHYS MED REHAB, V75, P519; CAMPBELL WW, 1992, MUSCLE NERVE, V15, P1050, DOI 10.1002/mus.880150910; Charness ME, 1996, MUSCLE NERVE, V19, P431, DOI 10.1002/mus.880190403; Conti MS, 2016, WORLD J ORTHOP, V7, P650, DOI 10.5312/wjo.v7.i10.650; Cornelson SM, 2019, J ULTRASOUND, V22, P337, DOI 10.1007/s40477-019-00370-9; Croisier P.J.L., 2004, INT SPORTMED J, V5, P169; DAWSON DM, 1993, NEW ENGL J MED, V329, P2013, DOI 10.1056/NEJM199312303292707; DeGeorge BR, 2019, J WRIST SURG, V8, P168, DOI 10.1055/s-0038-1665548; Descatha A, 2004, SCAND J WORK ENV HEA, V30, P234, DOI 10.5271/sjweh.784; Goosey VL, 1998, ERGONOMICS, V41, P1810, DOI 10.1080/001401398185983; Heyward OW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188410; Kane SF, 2014, AM FAM PHYSICIAN, V89, P649; Kang S, 2019, PEERJ, V7, DOI 10.7717/peerj.6972; King NA, 2008, INT J OBESITY, V32, P177, DOI 10.1038/sj.ijo.0803712; Kouwijzer I, 2020, ARCH PHYS MED REHAB, V101, P1017, DOI 10.1016/j.apmr.2019.12.015; Leis AA, 2017, MUSCLE NERVE, V56, P242, DOI 10.1002/mus.25483; Martin A, 1998, J AM ACAD ORTHOP SUR, V6, P282, DOI [10.5435/00124635-199809000-00003, DOI 10.5435/00124635-199809000-00003]; OKUMA H, 1989, PARAPLEGIA, V27, P237, DOI 10.1038/sc.1989.35; Omejec G, 2016, MUSCLE NERVE, V53, P255, DOI 10.1002/mus.24786; Omejec G, 2016, CLIN NEUROPHYSIOL, V127, P919, DOI 10.1016/j.clinph.2015.05.027; Omejec G, 2015, CLIN NEUROPHYSIOL, V126, P1797, DOI 10.1016/j.clinph.2014.12.001; Pyo J, 2010, PM&R, V2, P14, DOI 10.1016/j.pmrj.2009.10.002; Richardson JK, 2004, AM J PHYS MED REHAB, V83, P730, DOI 10.1097/01.PHM.0000137316.54347.B8; Richardson JK, 2001, MUSCLE NERVE, V24, P551, DOI 10.1002/mus.1039; Rydberg M, 2020, BMJ OPEN DIAB RES CA, V8, DOI 10.1136/bmjdrc-2020-001298; Stewart JD, 2010, FOCAL PERIPHERAL NEU, P196; Tsai HC, 2009, J REHABIL MED, V41, P26, DOI 10.2340/16501977-0290; Tsujino A, 2001, Hand Surg, V6, P205, DOI 10.1142/S0218810401000722; van der Woude LHV, 2001, MED ENG PHYS, V23, P713, DOI 10.1016/S1350-4533(01)00083-2	36	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243324	10.1371/journal.pone.0243324	http://dx.doi.org/10.1371/journal.pone.0243324			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315922	Green Published, gold			2022-12-27	WOS:000600186100036
J	Miao, R; Xiang, XH; Wu, Q; Jiang, ZB				Miao, Rui; Xiang, Xiaohao; Wu, Qi; Jiang, Zhibin			Evaluation method of medical service system based on DEMATEL and the information entropy: A case study of hypertension diagnosis and treatment in China	PLOS ONE			English	Article							HEALTH-CARE; PAIN; ALLOCATION; ANXIETY; COST	Precise and reasonable evaluation of the multi-attribute value of medical system is the basis for hospitals to implement total quality management. Excellent medical system is necessary as a part of modern urban governance. However, most of medical value evaluation work relies on scale and artificial scoring at present, lacking in objectivity. Therefore, a scientific and comprehensive medical value evaluation system is needed urgently to give full play to the guiding role of value evaluation and promote the improvement of the medical service system. In this study, DEMATEL and information entropy are used to quantify the degree of mutual influence between system indicators and the differences in medical market performance respectively, so as to obtain the objective index weight. Hypertension has the highest incidence in the whole chronic disease system, which seriously affects people's daily life. Based on the existing hypertension diagnosis and treatment index system, a comprehensive and objective evaluation model is established to evaluate the hypertension diagnosis and treatment behaviors of different medical institutions, which achieves good result. This method has effectively improved the relative deficiency of one-sided subjective evaluation and has a great guiding significance for the comparison of treatment in departments and the economical use of medical resources.	[Miao, Rui] Shanghai Jiao Tong Univ, Sch Naval Architecture Ocean & Civil Engn, Shanghai, Peoples R China; [Miao, Rui] Shanghai Jiao Tong Univ, China Inst Urban Governance, Shanghai, Peoples R China; [Xiang, Xiaohao; Wu, Qi] Shanghai Jiao Tong Univ, Sch Mech Engn, Shanghai, Peoples R China; [Jiang, Zhibin] Shanghai Jiao Tong Univ, Antai Coll Econ & Management, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Miao, R (corresponding author), Shanghai Jiao Tong Univ, Sch Naval Architecture Ocean & Civil Engn, Shanghai, Peoples R China.; Miao, R (corresponding author), Shanghai Jiao Tong Univ, China Inst Urban Governance, Shanghai, Peoples R China.	miaorui@sjtu.edu.cn			National Natural Science Foundation, China [71971139,71432006]	National Natural Science Foundation, China(National Natural Science Foundation of China (NSFC))	This study was supported by a grant from the National Natural Science Foundation, China (No. 71971139,71432006).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar V, 2015, PHYSICA A, V423, P72, DOI 10.1016/j.physa.2014.12.031; Albasan H, 2013, ANKARA UNIV VET FAK, V60, P297, DOI 10.1501/Vetfak_0000002594; [Anonymous], 2020, DIABETES TECHNOL THE, V22, pA1, DOI 10.1089/dia.2020.2525.abstracts; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI [10.1055/s-0043-115953, DOI 10.1055/S-0043-115953]; Berwick D, 2016, MILBANK Q, V94, P237, DOI 10.1111/1468-0009.12189; BioCentury, 2010, BIOCENTURY, V18, pB16; Brugnoli MP, 2018, ANN PALLIAT MED, V7, P17, DOI 10.21037/apm.2017.10.03; Cai HF, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00463; Dagenais S, 2008, SPINE J, V8, P8, DOI 10.1016/j.spinee.2007.10.005; Du T, 2014, EC GEOGRAPHY, V34, P40; Eggleston K, 2008, HEALTH ECON, V17, P149, DOI 10.1002/hec.1306; GILLON R, 1985, BRIT MED J, V291, P266, DOI 10.1136/bmj.291.6490.266; Gilson L, 2003, SOC SCI MED, V56, P1453, DOI 10.1016/S0277-9536(02)00142-9; Gu Qian, 2019, MODERN HOSP MANAGEME, V17, P20; Hauser D, 2018, HEALTH AFFAIR, V37, P793, DOI 10.1377/hlthaff.2017.1548; Hsu CW, 2013, J CLEAN PROD, V56, P164, DOI 10.1016/j.jclepro.2011.09.012; Jiang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064589; Lakdawalla DN, 2018, VALUE HEALTH, V21, P131, DOI 10.1016/j.jval.2017.12.007; Lesne A, 2014, MATH STRUCT COMP SCI, V24, DOI 10.1017/S0960129512000783; LIN JH, 1991, IEEE T INFORM THEORY, V37, P145, DOI 10.1109/18.61115; Liu CM, 2021, J HEALTH PSYCHOL, V26, P2822, DOI 10.1177/1359105320934158; Liu Y, 2013, IEEE T SOFTWARE ENG, V39, P1018, DOI 10.1109/TSE.2012.82; Mantzorou M, 2018, PHYTOTHER RES, V32, P957, DOI 10.1002/ptr.6037; Michael E, 2006, REDEFINING HLTH CARE; Morton A, 2016, J HEALTH ECON, V49, P97, DOI 10.1016/j.jhealeco.2016.06.001; Osamy W, 2020, WIREL NETW, V26, P1869, DOI 10.1007/s11276-018-1877-y; Porter ME, 2010, NEW ENGL J MED, V363, P2477, DOI 10.1056/NEJMp1011024; Shahidi F, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061573; Shu C, 2018, MODERN MED HLTH, V20, P166; Song WC, 2011, CHINESE HLTH EC, V30, P57; Su W, 2014, CHINESE HLTH INSURAN; Taylor M, 2017, VALUE HEALTH, V20, P224, DOI 10.1016/j.jval.2016.12.009; Tian C, 2014, CHINESE HOSP, V18, P28; Tian CJ, 2014, CHIN HOSP, V18, P28; Tzeng GH, 2010, SOFT COMPUT, V14, P1141, DOI 10.1007/s00500-009-0507-0; Verguet S, 2016, PHARMACOECONOMICS, V34, P913, DOI 10.1007/s40273-016-0414-z; Wang J, 2018, MODERN MED HLTH, V19, P138; Williams SE, 2009, PAIN, V146, P283, DOI 10.1016/j.pain.2009.07.039; Wu WW, 2008, EXPERT SYST APPL, V35, P828, DOI 10.1016/j.eswa.2007.07.025; Xia Feng, 2019, CHINESE HOSP MANAGEM, V39, P13; Zhou XB, 2011, J ECON STUD, V38, P17, DOI 10.1108/01443581111096123; 王舟强, 2017, [中国卫生统计, Chinese Journal of Health Statistics], V34, P604	42	2	2	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243832	10.1371/journal.pone.0243832	http://dx.doi.org/10.1371/journal.pone.0243832			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH1MP	33318708	Green Published, gold			2022-12-27	WOS:000600186100042
J	Chen, HJ; Tu, CY; Huang, KY; Chien, CR; Hsia, TC				Chen, Hung-Jen; Tu, Chih-Yen; Huang, Kuo-Yang; Chien, Chun-Ru; Hsia, Te-Chun			Early serum tumor marker levels after fourteen days of tyrosine kinase inhibitor targeted therapy predicts outcomes in patients with advanced lung adenocarcinoma	PLOS ONE			English	Article							EGFR-TKI; CANCER; GEFITINIB; ERLOTINIB; AFATINIB; CEA; MULTICENTER; CRIZOTINIB; MUTATIONS	Objective Image evaluation strategy for lung cancer patients has difficulty obtaining the appropriate quantity of diffuse lung nodules and bone metastases. The study was to demonstrate whether early variations in the levels of serum 4-tumor markers (4-TMs)(carcinoembryonic antigen [CEA], cancer antigen [CA]125, CA19-9, and CA15-3) after TKI targeted therapy were associated with treatment response in patients with lung adenocarcinoma. Methods Patients with stage IIIB-IV lung adenocarcinoma taking epidermal growth factor receptor (EGFR) TKIs or anaplastic lymphoma kinase (ALK) inhibitors were enrolled prospectively from June 2012 to February 2015. According to the variations of the percentage of change in 4-TM levels (4-TMpc), we divided patients into ascending (increases in 4-TMpc over the 7th- 14th day) and descending (decreases in 4-TMpc over the 7th- 14th day) groups. Results 184 patients were enrolled, and 89% had at least one of the pre-treatment evaluable TMs and were further analyzed. An excellent response to the TKI targeted therapy was accurately predicted in the descending group, as determined using receiver operating characteristic curve analysis (an area under the curve, 0.83). Multivariate Cox hazards model analyses demonstrated that the type of 4-TMpc and mutation status were the strongest predictors of progression-free survival (PFS)(descending versus ascending, hazard ratios [HR] 0.30, 95% confidence interval [CI], 0.19-0.47; sensitive mutation versus wide type, HR 0.30, 95% CI, 0.19-0.48). Conclusions Type of 4-TMpc 14 days after TKI targeted therapy is associated with an image response and PFS, without regarding mutation status, in patients with advanced lung adenocarcinoma.	[Chen, Hung-Jen; Tu, Chih-Yen; Hsia, Te-Chun] Div Pulm & Crit Care Med, Taichung, Taiwan; [Chen, Hung-Jen; Tu, Chih-Yen; Chien, Chun-Ru; Hsia, Te-Chun] China Med Univ Hosp, Taichung, Taiwan; [Chen, Hung-Jen; Tu, Chih-Yen; Chien, Chun-Ru] China Med Univ, Coll Med, Sch Med, Taichung, Taiwan; [Huang, Kuo-Yang] Changhua Christian Hosp, Dept Internal Med, Div Chest Med, Changhua, Taiwan; [Chien, Chun-Ru] China Med Univ Hosp, Dept Radiat Oncol, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Changhua Christian Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan	Chen, HJ (corresponding author), Div Pulm & Crit Care Med, Taichung, Taiwan.; Chen, HJ (corresponding author), China Med Univ Hosp, Taichung, Taiwan.; Chen, HJ (corresponding author), China Med Univ, Coll Med, Sch Med, Taichung, Taiwan.	redman0127@gmail.com	Huang, Kuo-Yang/GSM-6858-2022	Chen, Hung-Jen/0000-0001-6000-9021				Cappuzzo F, 2010, LANCET ONCOL, V11, P521, DOI 10.1016/S1470-2045(10)70112-1; Chiu CH, 2007, LUNG CANCER, V57, P213, DOI 10.1016/j.lungcan.2007.02.016; Chiu CH, 2015, J THORAC ONCOL, V10, P793, DOI 10.1097/JTO.0000000000000504; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Facchinetti F, 2015, TUMOR BIOL, V36, P5943, DOI 10.1007/s13277-015-3269-6; FERRIGNO D, 1995, RESP MED, V89, P587, DOI 10.1016/0954-6111(95)90225-2; FRITSCHE HA, 1993, CLIN CHEM, V39, P2431; Grunnet M, 2012, LUNG CANCER, V76, P138, DOI 10.1016/j.lungcan.2011.11.012; Huang SF, 2004, CLIN CANCER RES, V10, P8195, DOI 10.1158/1078-0432.CCR-04-1245; John T, 2009, ONCOGENE, V28, pS14, DOI 10.1038/onc.2009.197; Joshi M, 2015, CANCER MANAG RES, V7, P75, DOI 10.2147/CMAR.S51808; Kim HS, 2009, BREAST CANCER RES TR, V118, P89, DOI 10.1007/s10549-009-0377-2; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Li TH, 2013, J CLIN ONCOL, V31, P1039, DOI 10.1200/JCO.2012.45.3753; Marchetti A, 2016, J THORAC ONCOL, V11, P487, DOI 10.1016/j.jtho.2015.12.111; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Peters S, 2017, NEW ENGL J MED, V377, P829, DOI 10.1056/NEJMoa1704795; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Sequist LV, 2013, J CLIN ONCOL, V31, P3327, DOI 10.1200/JCO.2012.44.2806; Shaw AT, 2014, NEW ENGL J MED, V371, P1963, DOI 10.1056/NEJMoa1406766; Shaw AT, 2014, NEW ENGL J MED, V370, P2537, DOI 10.1056/NEJMc1404894; Shen YC, 2017, LUNG CANCER, V110, P56, DOI 10.1016/j.lungcan.2017.06.007; Soria JC, 2018, NEW ENGL J MED, V378, P113, DOI 10.1056/NEJMoa1713137; Sturgeon CM, 2001, CLIN BIOCHEM, V34, P353, DOI 10.1016/S0009-9120(01)00199-0; Tso E, 2006, GYNECOL ONCOL, V103, P141, DOI 10.1016/j.ygyno.2006.02.010; Tuxen MK, 1999, GYNECOL ONCOL, V74, P12, DOI 10.1006/gyno.1999.5414; Zhang YW, 2014, TUMOR BIOL, V35, P4921, DOI 10.1007/s13277-014-1646-1	27	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0240736	10.1371/journal.pone.0240736	http://dx.doi.org/10.1371/journal.pone.0240736			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306683	gold, Green Published			2022-12-27	WOS:000600144200068
J	Fomeju, BF; Brunel, D; Berard, A; Rivoal, JB; Gallois, P; Le Paslier, MC; Bouverat-Bernier, JP				Fomeju, Berline Fopa; Brunel, Dominique; Berard, Aurelie; Rivoal, Jean-Baptiste; Gallois, Philippe; Le Paslier, Marie-Christine; Bouverat-Bernier, Jean-Pierre			Quick and efficient approach to develop genomic resources in orphan species: Application in Lavandula angustifolia	PLOS ONE			English	Article							FUNCTIONAL-CHARACTERIZATION; SESQUITERPENE SYNTHASE; GLANDULAR TRICHOMES; TRANSCRIPTOME; DISCOVERY; GENERATION; CLONING; RECONSTRUCTION; ORGANIZATION; ANNOTATION	Next-Generation Sequencing (NGS) technologies, by reducing the cost and increasing the throughput of sequencing, have opened doors to generate genomic data in a range of previously poorly studied species. In this study, we propose a method for the rapid development of a large-scale molecular resources for orphan species. We studied as an example the true lavender (Lavandula angustifolia Mill.), a perennial sub-shrub plant native from the Mediterranean region and whose essential oil have numerous applications in cosmetics, pharmaceuticals, and alternative medicines. The heterozygous clone "Maillette" was used as a reference for DNA and RNA sequencing. We first built a reference Unigene, compound of coding sequences, thanks to de novo RNA-seq assembly. Then, we reconstructed the complete genes sequences (with introns and exons) using an Unigene-guided DNA-seq assembly approach. This aimed to maximize the possibilities of finding polymorphism between genetically close individuals despite the lack of a reference genome. Finally, we used these resources for SNP mining within a collection of 16 commercial lavender clones and tested the SNP within the scope of a genetic distance analysis. We obtained a cleaned reference of 8, 030 functionally in silico annotated genes. We found 359K polymorphic sites and observed a high SNP frequency (mean of 1 SNP per 90 bp) and a high level of heterozygosity (more than 60% of heterozygous SNP per genotype). On overall, we found similar genetic distances between pairs of clones, which is probably related to the out-crossing nature of the species and the restricted area of cultivation. The proposed method is transferable to other orphan species, requires little bioinformatics resources and can be realized within a year. This is also the first reported large-scale SNP development on Lavandula angustifolia. All the genomics resources developed herein are publicly available and provide a rich pool of molecular resources to explore and exploit lavender genetic diversity in breeding programs.	[Fomeju, Berline Fopa; Gallois, Philippe; Bouverat-Bernier, Jean-Pierre] ITEIPMAI, Chemille En Anjou, France; [Fomeju, Berline Fopa; Brunel, Dominique; Berard, Aurelie; Le Paslier, Marie-Christine] Univ Paris Saclay, INRA, US1279 Etud Polymorphisme Genomes Vegetaux EPGV, Evry, France; [Rivoal, Jean-Baptiste] CRIEPPAM, Quintrands, Manosque, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay	Fomeju, BF (corresponding author), ITEIPMAI, Chemille En Anjou, France.; Fomeju, BF; Le Paslier, MC (corresponding author), Univ Paris Saclay, INRA, US1279 Etud Polymorphisme Genomes Vegetaux EPGV, Evry, France.	berline.fopa-fomeju@iteipmai.fr; marie-christine.le-paslier@inrae.fr		Berline, FOPA FOMEJU/0000-0002-7187-7278	Trust account for "Agricultural and Rural Development"(CASDAR) [C-201705]	Trust account for "Agricultural and Rural Development"(CASDAR)	This project was funded by the Trust account for "Agricultural and Rural Development"(CASDAR), project number C-201705, on behalf of French Ministry of Agriculture. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adal AM, 2015, PLANTA, V241, P987, DOI 10.1007/s00425-014-2226-8; [Anonymous], 2016, EUR J ORAL IMPLAN S1, V9, pS173; [Anonymous], 2018, LANCET HAEMATOL, V5, P378; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Cabau C, 2017, PEERJ, V5, DOI 10.7717/peerj.2988; Cavanagh HMA, 2002, PHYTOTHER RES, V16, P301, DOI 10.1002/ptr.1103; Cerveau N, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1406-x; Chaisse E., 2012, INNOVATIONS AGRONOMI, V25, P179; Chen X, 2017, ASIA-PAC CONF COMMUN, P47; Cogan NOI, 2006, MOL GENET GENOMICS, V276, P101, DOI 10.1007/s00438-006-0126-8; Conesa A, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0881-8; Darwish O, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1221-1; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Demissie ZA, 2013, J BIOL CHEM, V288, P6333, DOI 10.1074/jbc.M112.431171; Demissie ZA, 2012, PLANT MOL BIOL, V79, P393, DOI 10.1007/s11103-012-9920-3; Demissie ZA, 2011, PLANTA, V233, P685, DOI 10.1007/s00425-010-1332-5; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; FranceAgriMer, 2020, MARCH PLANT PARF AR; Frazer KA, 2003, GENOME RES, V13, P1, DOI 10.1101/gr.222003; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Honaas LA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146062; Huang X, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2923-8; Humble Emily, 2016, BMC Research Notes, V9, P418, DOI 10.1186/s13104-016-2209-x; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; Jullien F, 2014, PLANT MOL BIOL, V84, P227, DOI 10.1007/s11103-013-0131-3; Kamvar ZN, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00208; Kamvar ZN, 2014, PEERJ, V2, DOI 10.7717/peerj.281; Lane A, 2010, PLANTA, V231, P835, DOI 10.1007/s00425-009-1090-4; Leggett RM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S4-S10; MacManes M. D., 2016, BIORXIV, DOI [10.1101/035642, DOI 10.1101/035642]; Malli RPN, 2019, PLANTA, V249, P251, DOI 10.1007/s00425-018-3012-9; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; PREVOSTI A, 1975, THEOR APPL GENET, V45, P231, DOI 10.1007/BF00831894; Sarker LS, 2015, PLANTA, V242, P709, DOI 10.1007/s00425-015-2325-1; Sarker LS, 2013, PLANTA, V238, P983, DOI 10.1007/s00425-013-1937-6; Sarker LS, 2012, ARCH BIOCHEM BIOPHYS, V528, P163, DOI 10.1016/j.abb.2012.09.013; Scheben A, 2017, PLANT BIOTECHNOL J, V15, P149, DOI 10.1111/pbi.12645; Semetey O, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.01507-18; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Smith-Unna R, 2016, GENOME RES, V26, P1134, DOI 10.1101/gr.196469.115; Soltani R, 2013, INT J PEDIATR OTORHI, V77, P1579, DOI 10.1016/j.ijporl.2013.07.014; Tanwar UK, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00091; Trapp SC, 2001, GENETICS, V158, P811; Unamba CIN, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01074; Upson T, 2004, THE GENUS LAVANDULA; Van Bel M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r134; Stormo Gary D, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1110s43, 10.1002/0471250953.bi1201s43]; Wang BB, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-17; Yates SA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-453; Zhao QY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S14-S2	57	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243853	10.1371/journal.pone.0243853	http://dx.doi.org/10.1371/journal.pone.0243853			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306734	Green Submitted, Green Published, gold			2022-12-27	WOS:000600144200054
J	Tiba, MH; McCracken, BM; Dickson, RP; Nemzek, JA; Colmenero, CI; Leander, DC; Flott, TL; Daniels, RC; Konopka, KE; VanEpps, JS; Stringer, KA; Ward, KR				Tiba, Mohamad Hakam; McCracken, Brendan M.; Dickson, Robert P.; Nemzek, Jean A.; Colmenero, Carmen, I; Leander, Danielle C.; Flott, Thomas L.; Daniels, Rodney C.; Konopka, Kristine E.; VanEpps, J. Scott; Stringer, Kathleen A.; Ward, Kevin R.			A comprehensive assessment of multi-system responses to a renal inoculation of uropathogenic E. coli in swine	PLOS ONE			English	Article							PATHOGENICITY ISLAND; PORCINE MODEL; UNITED-STATES; SEVERE SEPSIS; SEPTIC SHOCK; OVINE MODEL; SEQUENCES; CFT073	Background The systemic responses to infection and its progression to sepsis remains poorly understood. Progress in the field has been stifled by the shortcomings of experimental models which include poor replication of the human condition. To address these challenges, we developed and piloted a novel large animal model of severe infection that is capable of generating multi-system clinically relevant data. Methods Male swine (n = 5) were anesthetized, mechanically ventilated, and surgically instrumented for continuous hemodynamic monitoring and serial blood sampling. Animals were inoculated with uropathogenic E. coli by direct injection into the renal parenchyma and were maintained until a priori endpoints were met. The natural history of the infection was studied. Animals were not resuscitated. Multi-system data were collected hourly to 6 hours; all animals were euthanized at predetermined physiologic endpoints. Results Core body temperature progressively increased from mean (SD) 37.9(0.8)degrees C at baseline to 43.0(1.2)degrees C at experiment termination (p = 0.006). Mean arterial pressure did not begin to decline until 6h post inoculation, dropping from 86(9) mmHg at baseline to 28(5) mmHg (p = 0.005) at termination. Blood glucose progressively declined but lactate levels did not elevate until the last hours of the experiment. There were also temporal changes in whole blood concentrations of a number of metabolites including increases in the catecholamine precursors, tyrosine (p = 0.005) and phenylalanine (p = 0.005). Lung, liver, and kidney function parameters worsened as infection progressed and at study termination there was histopathological evidence of injury in these end-organs. Conclusion We demonstrate a versatile, multi-system, longitudinal, swine model of infection that could be used to further our understanding of the mechanisms that underlie infection-induced multi-organ dysfunction and failure, optimize resuscitation protocols and test therapeutic interventions. Such a model could improve translation of findings from the bench to the bedside, circumventing a significant obstacle in sepsis research.	[Tiba, Mohamad Hakam; McCracken, Brendan M.; Colmenero, Carmen, I; Leander, Danielle C.; VanEpps, J. Scott; Ward, Kevin R.] Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA; [Tiba, Mohamad Hakam; McCracken, Brendan M.; Dickson, Robert P.; Nemzek, Jean A.; Colmenero, Carmen, I; Leander, Danielle C.; Daniels, Rodney C.; Konopka, Kristine E.; VanEpps, J. Scott; Stringer, Kathleen A.; Ward, Kevin R.] Univ Michigan, Michigan Ctr Integrat Res Crit Care, Ann Arbor, MI 48109 USA; [Dickson, Robert P.; Stringer, Kathleen A.] Univ Michigan, Dept Internal Med, Div Pulm & Crit Care Med, Ann Arbor, MI USA; [Nemzek, Jean A.] Univ Michigan, Unit Lab Anim Med, Ann Arbor, MI USA; [Nemzek, Jean A.; Konopka, Kristine E.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Flott, Thomas L.; Stringer, Kathleen A.] Univ Michigan, Coll Pharm, Dept Clin Pharm, Ann Arbor, MI USA; [Daniels, Rodney C.] Univ Michigan, Dept Pediat, Pediat Crit Care Med, Ann Arbor, MI USA; [Daniels, Rodney C.; VanEpps, J. Scott; Ward, Kevin R.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI USA; [VanEpps, J. Scott] Univ Michigan, Biointerfaces Inst, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Tiba, MH (corresponding author), Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA.; Tiba, MH (corresponding author), Univ Michigan, Michigan Ctr Integrat Res Crit Care, Ann Arbor, MI 48109 USA.	tibam@med.umich.edu		VanEpps, J. Scott/0000-0002-0805-0913; Flott, Thomas/0000-0002-3962-6014; Tiba, Mohamad/0000-0002-6789-7532; Dickson, Robert/0000-0002-6875-4277; Stringer, Kathleen/0000-0003-0238-7774	Michigan Center for Integrative Research in Critical Care; National Institute of General Medical Sciences (NIGMS) [R01GM111400, R35GM13631201]; National Institute of Allergy and Infectious Diseases (NIAID) [K08AI128006]; NIGMS [R01GM112799]	Michigan Center for Integrative Research in Critical Care; National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported in full by the Michigan Center for Integrative Research in Critical Care (https://mcircc.umich.edu/); K.A. Stringer's contribution was supported, in part, by grants from the National Institute of General Medical Sciences (NIGMS; R01GM111400 and R35GM13631201; https://www.nigms.nih.gov/); J. VanEpps' effort was supported, in part, by a grant from the National Institute of Allergy and Infectious Diseases (NIAID; K08AI128006; https://www.niaid.nih.gov/); J. Nemzek's effort was supported, in part, by a grant from the NIGMS (R01GM112799). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIGMS, NIAID, or the National Institutes of Health. With the exception of MCIRCC, none of the sponsors played any role in the study design. None of the sponsors played any role in data collection and analysis, decision to publish or the preparation of the manuscript. The authors declare no conflict of interest.	Alverdy JC, 2020, INFECT IMMUN, V88, DOI 10.1128/IAI.00942-19; [Anonymous], 2020, CHEMCATCHEM, V12, pXXX; [Anonymous], 2016, SEPS DAT REP; Bellomo R, 2011, CRIT CARE MED, V39, P2367, DOI 10.1097/CCM.0b013e31822a5be5; Benschop RJ, 1996, BRAIN BEHAV IMMUN, V10, P77, DOI 10.1006/brbi.1996.0009; Boerio D, 2018, MUSCLE NERVE, V57, P808, DOI 10.1002/mus.26013; Byrne L, 2018, SHOCK, V49, P99, DOI 10.1097/SHK.0000000000000904; Castegren M, 2012, SHOCK, V37, P501, DOI 10.1097/SHK.0b013e318249bb0d; Czaja CA, 2007, CLIN INFECT DIS, V45, P273, DOI 10.1086/519268; Fernstrom JD, 2007, J NUTR, V137, p1539S, DOI 10.1093/jn/137.6.1539S; Ferrario M, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00011; Fink MP, 2014, VIRULENCE, V5, P143, DOI 10.4161/viru.26083; Gattinoni L, 2019, AM J RESP CRIT CARE, V200, P582, DOI 10.1164/rccm.201812-2342OC; Goldfarb RD, 2005, SHOCK, V24, P75, DOI 10.1097/01.shk.0000191337.01036.b7; Goldfarb RD, 1996, SHOCK, V6, P442, DOI 10.1097/00024382-199612000-00009; Guyer DM, 1998, INFECT IMMUN, V66, P4411; Hackam DG, 2006, JAMA-J AM MED ASSOC, V296, P1731, DOI 10.1001/jama.296.14.1731; Hajjar AM, 2002, NAT IMMUNOL, V3, P354, DOI 10.1038/ni777; Kao JS, 1997, INFECT IMMUN, V65, P2812, DOI 10.1128/IAI.65.7.2812-2820.1997; KARJALAINEN J, 1986, ARCH INTERN MED, V146, P1169, DOI 10.1001/archinte.146.6.1169; KAZARIAN KK, 1994, SHOCK, V1, P201, DOI 10.1097/00024382-199403000-00008; Lagu T, 2012, CRIT CARE MED, V40, P754, DOI 10.1097/CCM.0b013e318232db65; Libert C, 2019, SHOCK, V51, P23, DOI 10.1097/SHK.0000000000001242; Ljungstrom L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181704; Machado FR, 2018, CRIT CARE MED, V46, P454, DOI 10.1097/CCM.0000000000002899; [National Research Council (U.S.) Institute for Laboratory Animal Research (U.S.) & National Academies Press (U.S.).], 2011, COMM UPD GUID CAR US; Osuchowski MF, 2018, SHOCK, V50, P377, DOI 10.1097/SHK.0000000000001212; Passmore MR, 2019, THROMB RES, V176, P39, DOI 10.1016/j.thromres.2019.02.015; Perel P, 2007, BMJ-BRIT MED J, V334, P197, DOI 10.1136/bmj.39048.407928.BE; Pound P, 2004, BMJ-BRIT MED J, V328, P514, DOI 10.1136/bmj.328.7438.514; Rhodes A, 2017, INTENS CARE MED, V43, P304, DOI 10.1007/s00134-017-4683-6; Rimmele T, 2006, J INFECTION, V53, P199, DOI 10.1016/j.jinf.2005.10.023; Rudd KE, 2020, LANCET, V395, P200, DOI 10.1016/S0140-6736(19)32989-7; Schneemann M, 2002, NAT IMMUNOL, V3, P102, DOI 10.1038/ni0202-102a; Schulte W, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/165974; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Srisangthong P, 2013, 33 INT S INT CAR EM, pS13; Suffredini AF, 2011, JAMA-J AM MED ASSOC, V306, P194, DOI 10.1001/jama.2011.909; Swindle M M, 1988, J Invest Surg, V1, P65, DOI 10.3109/08941938809141077; Torio C. M., 2011, NATL INPATIENT HOSP; Toth J, 2017, THROMB RES, V158, P25, DOI 10.1016/j.thromres.2017.07.030; Venkata C, 2013, J INTENSIVE CARE, V1, DOI 10.1186/2052-0492-1-9; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Walkey AJ, 2015, ANN AM THORAC SOC, V12, P216, DOI 10.1513/AnnalsATS.201411-498BC; Walter EJ, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1375-5; Wiles TJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003175; Zhang Y, 2011, CRIT CARE, V15, DOI 10.1186/cc10059	48	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243577	10.1371/journal.pone.0243577	http://dx.doi.org/10.1371/journal.pone.0243577			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306742	Green Published, gold			2022-12-27	WOS:000600144200052
J	Castellvi, I; Simeon, CP; Sarmiento, M; Casademont, J; Corominas, H; Fonollosa, V				Castellvi, Ivan; Simeon, Carmen Pilar; Sarmiento, Monica; Casademont, Jordi; Corominas, Hector; Fonollosa, Vicenc			Effect of bosentan in pulmonary hypertension development in systemic sclerosis patients with digital ulcers	PLOS ONE			English	Article							BRAIN NATRIURETIC PEPTIDE; PLACEBO-CONTROLLED TRIAL; ARTERIAL-HYPERTENSION; DOUBLE-BLIND; SCLERODERMA PATIENTS; DISEASE; SURVIVAL; PREVENTION; THERAPY; CLASSIFICATION	Systemic sclerosis is a disease where microcirculation damage is critical in their beginning and vascular complications have similar pathogenic findings. Digital ulcers are a frequent complication in systemic sclerosis patients and pulmonary hypertension is one of the leading causes of death. The use of bosentan has been shown to be useful for the treatment of pulmonary arterial hypertension and to prevent new digital ulcers. However, is unknown if bosentan can prevent pulmonary hypertension. Our objective was to determine if bosentan is useful to prevent pulmonary hypertension in SSc patients. A retrospective study in 237 systemic sclerosis patients with digital ulcers history treated or not with bosentan to prevent it was made. We analyzed the occurrence of pulmonary hypertension defined by an echocardiogram pulmonary arterial pressure > 40 mmHg in the entire cohort. Demographic, clinical, and treatment variables were recorded for all patients. Statistical significance was denoted by p values < 0.05. Fifty-nine patients were treated with bosentan a median of 34 months. 13.8% of treated patients had pulmonary hypertension vs 23.7% of untreated patients (p 0.13) during the follow up. In multivariate analysis patients not treated with bosentan had 3.9fold-increased risk of pulmonary hypertension compared with patients under bosentan treatment (p < 0.02). Moreover the percentage carbon monoxide diffusing capacity (DLCO) in bosentan treated patients did not decrease from baseline to the end of follow-up (61.8 +/- 14% vs 57 +/- 20.1%, p = 0.89). We concluded that Systemic sclerosis patients with digital ulcers treated with bosentan seems to have less risk to develop pulmonary hypertension and to stabilize DLCO	[Castellvi, Ivan; Sarmiento, Monica; Corominas, Hector] Hosp Univ Santa Creu & St Pau, Dept Rheumatol, Barcelona, Spain; [Simeon, Carmen Pilar; Fonollosa, Vicenc] Hosp Univ Vall Hebron, Dept Internal Med, Barcelona, Spain; [Casademont, Jordi] Hosp Univ Santa Creu & St Pau, Dept Internal Med, Barcelona, Spain	Hospital Universitari Vall d'Hebron	Castellvi, I (corresponding author), Hosp Univ Santa Creu & St Pau, Dept Rheumatol, Barcelona, Spain.	icastellvi@santpau.cat	Corominas, Hèctor/P-5045-2019; Casademont, Jordi/GPK-8669-2022	Corominas, Hèctor/0000-0002-7738-6787; Casademont, Jordi/0000-0002-8100-1827; Castellvi, Ivan/0000-0002-5410-5807				Abraham D, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2186; Agard C, 2014, SCAND J RHEUMATOL, V43, P398, DOI 10.3109/03009742.2014.887768; Airo P, 2007, CLIN EXP RHEUMATOL, V25, P722; Allanore Y, 2008, ARTHRITIS RHEUM-US, V58, P284, DOI 10.1002/art.23187; Allanore Y, 2018, ARTHRITIS RHEUMATOL, V70, P162, DOI 10.1002/art.40377; Amanzi L, 2010, RHEUMATOLOGY, V49, P1374, DOI 10.1093/rheumatology/keq097; Avouac J, 2010, J RHEUMATOL, V37, P2290, DOI 10.3899/jrheum.100245; Baron M, 2014, CLIN RHEUMATOL, V33, P207, DOI 10.1007/s10067-013-2460-7; Berezne A, 2011, ARTHRIT CARE RES, V63, P277, DOI 10.1002/acr.20342; Caramaschi P, 2012, RHEUMATOL INT, V32, P1933, DOI 10.1007/s00296-011-1878-y; Cavagna L, 2010, J RHEUMATOL, V37, P2064, DOI 10.3899/jrheum.090997; Channick RN, 2001, LANCET, V358, P1119, DOI 10.1016/S0140-6736(01)06250-X; Chung L, 2010, CHEST, V138, P1383, DOI 10.1378/chest.10-0260; Condliffe R, 2009, AM J RESP CRIT CARE, V179, P151, DOI 10.1164/rccm.200806-953OC; Cozzi F, 2013, CLIN RHEUMATOL, V32, P679, DOI 10.1007/s10067-013-2172-z; Denton CP, 1997, BRIT J RHEUMATOL, V36, P239; Ferri C, 2002, MEDICINE, V81, P139, DOI 10.1097/00005792-200203000-00004; Galie N, 2008, LANCET, V371, P2093, DOI 10.1016/S0140-6736(08)60919-8; Gliddon AE, 2007, ARTHRITIS RHEUM, V56, P3837, DOI 10.1002/art.22965; Hachulla E, 2005, ARTHRITIS RHEUM-US, V52, P3792, DOI 10.1002/art.21433; Hachulla E, 2007, J RHEUMATOL, V34, P2423; Khimdas S, 2011, ARTHRIT CARE RES, V63, P142, DOI 10.1002/acr.20336; Korn JH, 2004, ARTHRITIS RHEUM-US, V50, P3985, DOI 10.1002/art.20676; Kovacs G, 2012, ARTHRITIS RHEUM-US, V64, P1257, DOI 10.1002/art.33460; Mathai SC, 2010, EUR RESPIR J, V35, P95, DOI 10.1183/09031936.00074309; Matucci-Cerinic M, 2013, ARTHRITIS RHEUM-US, V65, P1953, DOI 10.1002/art.37988; Matucci-Cerinic M, 2011, ANN RHEUM DIS, V70, P32, DOI 10.1136/ard.2010.130658; McLaughlin VV, 2006, EUR J CLIN INVEST, V36, P10, DOI 10.1111/j.1365-2362.2006.01688.x; Murdaca G, 2016, J INT MED RES, V44, P85, DOI 10.1177/0300060515593257; Romaniello A, 2014, RHEUMATOLOGY, V53, P570, DOI 10.1093/rheumatology/ket424; Rubenfire M, 2013, CHEST, V144, P1282, DOI 10.1378/chest.12-0653; Rubin LJ, 2002, NEW ENGL J MED, V346, P896, DOI 10.1056/NEJMoa012212; Seibold JR, 2010, ARTHRITIS RHEUM-US, V62, P2101, DOI 10.1002/art.27466; Steen V, 2005, ARTHRITIS RHEUM, V52, P3698, DOI 10.1002/art.21613; Steen V, 2003, ARTHRITIS RHEUM, V48, P516, DOI 10.1002/art.10775; Steen V, 2009, RHEUMATOLOGY, V48, P19, DOI 10.1093/rheumatology/kep105; Steen VD, 2007, ANN RHEUM DIS, V66, P940, DOI 10.1136/ard.2006.066068; Sunderkotter C, 2009, BRIT J DERMATOL, V160, P835, DOI 10.1111/j.1365-2133.2008.09004.x; Thakkar V, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4383; Tiev KP, 2009, J RHEUMATOL, V36, P1470, DOI 10.3899/jrheum.081044; Tolosa-Vilella C, 2016, SEMIN ARTHRITIS RHEU, V46, P200, DOI 10.1016/j.semarthrit.2016.04.007; Tyndall AJ, 2010, ANN RHEUM DIS, V69, P1809, DOI 10.1136/ard.2009.114264; van den Hoogen F, 2013, ANN RHEUM DIS, V72, P1747, DOI [10.1136/annrheumdis-2013-204424, 10.1002/art.38098]; Williams MH, 2006, EUR HEART J, V27, P1485, DOI 10.1093/eurheartj/ehi891	44	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243651	10.1371/journal.pone.0243651	http://dx.doi.org/10.1371/journal.pone.0243651			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301540	gold, Green Published			2022-12-27	WOS:000600143100085
J	Guo, E; Guo, HL				Guo, Elisa; Guo, Hailong			CD8 T cell epitope generation toward the continually mutating SARS-CoV-2 spike protein in genetically diverse human population: Implications for disease control and prevention	PLOS ONE			English	Article							SARS-COV; IMMUNE-RESPONSE; NEURAL-NETWORKS; CORONAVIRUS; LYMPHOCYTE; SEQUENCE; ESCAPE; IDENTIFICATION; PNEUMONIA; VACCINE	The ongoing pandemic of SARS-CoV-2 has brought tremendous crisis on global health care systems and industrial operations that dramatically affect the economic and social life of numerous individuals worldwide. Understanding anti-SARS-CoV-2 immune responses in population with different genetic backgrounds and tracking the viral evolution are crucial for successful vaccine design. In this study, we reported the generation of CD8 T cell epitopes by a total of 80 alleles of three major class I HLAs using NetMHC 4.0 algorithm for the SARS-CoV-2 spike protein, which can be targeted by both B cells and T cells. We found diverse capacities of S protein specific epitope presentation by different HLA alleles with very limited number of predicted epitopes for HLA-B*2705, HLA-B*4402 and HLA-B*4403 and as high as 132 epitopes for HLA-A*6601. Our analysis of 1000 S protein sequences from field isolates collected globally over the past few months identified three recurrent point mutations including L5F, D614G and G1124V. Differential effects of these mutations on CD8 T cell epitope generation by corresponding HLA alleles were observed. Finally, our multiple alignment analysis indicated the absence of seasonal CoV induced cross-reactive CD8 T cells to drive these mutations. Our findings suggested that individuals with certain HLA alleles, such as B*44 are more prone to SARS-CoV-2 infection. Studying anti-S protein specific CD8 T cell immunity in diverse genetic background is critical for better control and prevention of the SARS-CoV-2 pandemic.	[Guo, Elisa] Mounds View High Sch, Arden Hills, MN USA			jhguo2000@gmail.com		Guo, Hailong/0000-0003-2619-335X				Andreatta M, 2016, BIOINFORMATICS, V32, P511, DOI 10.1093/bioinformatics/btv639; [Anonymous], 2020, CHIN J CRIT CARE INT, V6, P1; Banerjee A, 2020, LANCET, V395, P1715, DOI 10.1016/S0140-6736(20)30854-0; Becerra-Flores M, 2020, INT J CLIN PRACT, V74, DOI 10.1111/ijcp.13525; Berkhoff EGM, 2004, J VIROL, V78, P5216, DOI 10.1128/JVI.78.10.5216-5222.2004; Cao YL, 2020, CELL, V182, P73, DOI 10.1016/j.cell.2020.05.025; Channappanavar R, 2014, J VIROL, V88, P11034, DOI 10.1128/JVI.01505-14; Channappanavar R, 2014, IMMUNOL RES, V59, P118, DOI 10.1007/s12026-014-8534-z; Chen YZ, 2010, INT J IMMUNOPATH PH, V23, P165, DOI 10.1177/039463201002300115; Correale P, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21155205; Du LY, 2009, NAT REV MICROBIOL, V7, P226, DOI 10.1038/nrmicro2090; El Hage F, 2008, P NATL ACAD SCI USA, V105, P10119, DOI 10.1073/pnas.0802753105; Enjuanes L, 2016, ADV VIRUS RES, V96, P245, DOI 10.1016/bs.aivir.2016.08.003; Fehr AR, 2015, METHODS MOL BIOL, V1282, P1, DOI 10.1007/978-1-4939-2438-7_1; Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; HOMBACH J, 1995, J EXP MED, V182, P1615, DOI 10.1084/jem.182.5.1615; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Laha S, 2020, INFECT GENET EVOL, V85, DOI 10.1016/j.meegid.2020.104445; Lau SY, 2020, EMERG MICROBES INFEC, V9, P837, DOI 10.1080/22221751.2020.1756700; Lima NS, 2020, J IMMUNOL, V205, P699, DOI 10.4049/jimmunol.1900811; Lissina A, 2016, CURR OPIN VIROL, V16, P77, DOI 10.1016/j.coviro.2016.01.017; Liu YC, 2020, BIOMED J, V43, P328, DOI 10.1016/j.bj.2020.04.007; Lv YB, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-61; McMichael A, 2002, ARTHRITIS RES THER, V4, pS153, DOI 10.1186/ar571; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Poh CM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16638-2; Price GE, 2000, J EXP MED, V191, P1853, DOI 10.1084/jem.191.11.1853; Rogers Thomas F, 2020, bioRxiv, DOI 10.1101/2020.05.11.088674; Saha P, 2020, BIOSCIENCE REP, V40, DOI 10.1042/BSR20201312; Sun XM, 2016, CELL REP, V15, P2279, DOI 10.1016/j.celrep.2016.05.017; Timm J, 2015, MED MICROBIOL IMMUN, V204, P29, DOI 10.1007/s00430-014-0372-z; Phan T, 2020, INFECT GENET EVOL, V81, DOI 10.1016/j.meegid.2020.104260; Urra JM, 2020, CLIN IMMUNOL, V217, DOI 10.1016/j.clim.2020.108486; Walls AC, 2017, P NATL ACAD SCI USA, V114, P11157, DOI 10.1073/pnas.1708727114; Wang BM, 2004, BLOOD, V104, P200, DOI 10.1182/blood-2003-11-4072; Wang MJ, 2020, J VIROL, V94, DOI 10.1128/JVI.00567-20; Wang YD, 2004, J VIROL, V78, P5612, DOI 10.1128/JVI.78.11.5612-5618.2004; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Xu X, 2020, NAT MED, V26, P1193, DOI 10.1038/s41591-020-0949-6; Yin SX, 2020, J INFECTION, V81, pE31, DOI 10.1016/j.jinf.2020.06.076; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhang Lizhou, 2020, bioRxiv, DOI 10.1101/2020.06.12.148726; Zhao K, 2010, VACCINE, V28, P6666, DOI 10.1016/j.vaccine.2010.08.013; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	48	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0239566	10.1371/journal.pone.0239566	http://dx.doi.org/10.1371/journal.pone.0239566			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301503	Green Published, Green Submitted, gold			2022-12-27	WOS:000600143100017
J	Lawal, MA; Adeniyi, OF; Akintan, PE; Salako, AO; Omotosho, OS; Temiye, EO				Lawal, Mary Adetola; Adeniyi, Oluwafunmilayo Funke; Akintan, Patricia Eyanya; Salako, Abideen Olurotimi; Omotosho, Olorunfemi Sunday; Temiye, Edamisan Olusoji			Prevalence of and risk factors for hepatitis B and C viral co-infections in HIV infected children in Lagos, Nigeria	PLOS ONE			English	Article							VIRUS-INFECTION; ANTIRETROVIRAL THERAPY; SEROPREVALENCE; EPIDEMIOLOGY; VACCINE; BURDEN	Introduction The study was carried out to determine the prevalence of and risk factors for hepatitis B and C viral co-infections in HIV infected children in Lagos. Method A cross-sectional study conducted to determine the prevalence and risk factors for hepatitis B and C viral co-infection in children aged 2 months to 13 years. There were 187 HIV infected and 187 HIV naive age, sex-matched controls. Blood samples of participants were assayed for the serologic markers [HBsAg, anti-HBc, and anti-HCV)] of HBV and HCV viral infections using the Enzyme-Linked Immunosorbent assay (ELISA) method. Result The prevalence of HBV infection using HBsAg was 5.3% and 4.8% (p = 0.814), among HIV-infected and HIV naive children respectively, while using anti-HBc the prevalence was 7.0% and 7.5% (p = 0.842) among HIV- infected and HIV naive children respectively. The prevalence of HCV infection among HIV- infected and HIV naive children were equal to 0.5% (p = 1.000). There was also no significant association with the identifiable risk factors (sharing of a toothbrush, sharing of needles, incision marks/tattoo, hepatitis B immunization status, history of blood transfusion, previous surgical operation, sexual exposure/abuse, history of jaundice, and genital circumcision) and the HBV and or HCV status among both groups of children. History of sexual exposure/abuse and history of jaundice were however found to be predictors of the presence of HBsAg among HIV infected children only, using a binary logistic regression model. Conclusion The prevalence of HBV and or HCV infection among HIV-infected children is similar to the prevalence among HIV naive children, suggesting that HIV-infected children are not more predisposed to viral hepatitis than healthy children. Also, there was no significant difference in the prevalence of HBV infection irrespective of the use of HBsAg or anti-HBc.	[Lawal, Mary Adetola; Adeniyi, Oluwafunmilayo Funke; Akintan, Patricia Eyanya; Salako, Abideen Olurotimi; Temiye, Edamisan Olusoji] Lagos Univ, Dept Paediat, Teaching Hosp, Lagos, Nigeria; [Adeniyi, Oluwafunmilayo Funke; Akintan, Patricia Eyanya; Temiye, Edamisan Olusoji] Univ Lagos, Coll Med, Dept Paediat, Lagos, Nigeria; [Omotosho, Olorunfemi Sunday] Obafemi Awolowo Univ, Dept Community Hlth, Teaching Hosp, Ife, Osun State, Nigeria; [Lawal, Mary Adetola] Massey St Childrens Hosp, Dept Paediat, Lagos, Nigeria; [Salako, Abideen Olurotimi] GlaxoSmithKline, Lagos, Nigeria; [Omotosho, Olorunfemi Sunday] Nigeria Inst Med Res, Dept Clin Sci, Lagos, Nigeria	University of Lagos; Obafemi Awolowo University	Lawal, MA (corresponding author), Lagos Univ, Dept Paediat, Teaching Hosp, Lagos, Nigeria.; Lawal, MA (corresponding author), Massey St Childrens Hosp, Dept Paediat, Lagos, Nigeria.	shalomti@yahoo.com	Adeniyi, Oluwafunmilayo/CAF-6583-2022	Adeniyi, Oluwafunmilayo/0000-0003-2564-6118				Abera Bayeh, 2014, BMC Res Notes, V7, P838, DOI 10.1186/1756-0500-7-838; Adeyinka D, 2016, NATL GUIDELINES HIV, P13; Agostoni C, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2815; [Anonymous], 2011, ICON-INT J CONST LAW, V9, P1, DOI 10.1093/icon/mor030; [Anonymous], 2015, OFITSIINYI VISNYK PR, V2, P14; [Anonymous], 2017, INNOV SURG SCI, V2, P1, DOI DOI 10.5334/gjgl.276; [Anonymous], 2015, NIGERIAN J PAEDIAT; [Anonymous], 2014, PLOS ONE, V9, P1, DOI [10.1371/journal.pone.0109970, DOI 10.1371/JOURNAL.PONE.0109970, DOI 10.1371/J0URNAL.P0NE.0109970]; [Anonymous], 2013, GASTROENTEROL HEP S3, P1, DOI DOI 10.1017/S1743923X12000670; Ashir G M, 2009, Niger J Med, V18, P260; Askari A, 2014, IRAN J PUBLIC HEALTH, V43, P705; AWOLEYE OJ, 2015, J AIDS HIV RES, V7, P117; Balogun TM, 2012, PAN AFR MED J, V12; Chakraborty R, 2003, CLIN INFECT DIS, V36, P922, DOI 10.1086/368207; Charan Jaykaran, 2013, Indian J Psychol Med, V35, P121, DOI 10.4103/0253-7176.116232; Cooper CL, 2009, INT J INFECT DIS, V13, P302, DOI 10.1016/j.ijid.2008.06.042; Durowaye MO, 2014, INT J CLIN MED RES, V1, P42; EJELIOGU EU, 2014, OPEN SCI J CLIN MED, V2, P69; Ejeliogu EU, 2014, INT J TROP DIS HLTH, V4, P773; Eke CB, 2015, J TROP PEDIATRICS, V61, P407, DOI 10.1093/tropej/fmv035; Esan A., 2014, AM J BIOMEDICAL RES, V2, P11, DOI [10.12691/ajbr-2-1-3, DOI 10.12691/AJBR-2-1-3]; Fox JM, 2015, TROP MED INT HEALTH, V20, P638, DOI 10.1111/tmi.12465; Freitas SZ, 2014, BRAZ J INFECT DIS, V18, P473, DOI 10.1016/j.bjid.2014.01.005; Hamza M., 2013, NIGER J BASIC CLIN S, V10, P76, DOI [10.4103/0331-8540.122765, DOI 10.4103/0331-8540.122765]; Ikobah J, 2016, PAN AFR MED J, V23, DOI 10.11604/pamj.2016.23.128.8756; Ikpeme EE, 2013, AFR HEALTH SCI, V13, P955, DOI 10.4314/ahs.v13i4.14; Isa MA, 2015, INT J ADV RES BIO SC, V2, P128; Jhaveri R, 2006, J PEDIATR-US, V148, P353, DOI 10.1016/j.jpeds.2005.10.031; Khaderi S, 2014, WORLD J GASTROENTERO, V20, P11281, DOI 10.3748/wjg.v20.i32.11281; Khakshour A, 2014, INT J PEDIATR-MASSHA, V2, P145; Kliegman R, 2007, NELSON TXB PEDIAT, P1680; Lar P. M., 2013, African Journal of Clinical and Experimental Microbiology, V14, P120; Lemoine M, 2015, J HEPATOL, V62, P469, DOI 10.1016/j.jhep.2014.10.008; Mdlalose N, 2016, AFR J LAB MED, V5, DOI 10.4102/ajlm.v5i1.283; Muriuki Beatrice Mukami, 2013, BMC Res Notes, V6, P363, DOI 10.1186/1756-0500-6-363; National Blood Transfusion Service Federal Ministry of Health [Nigeria], 2006, NAT BLOOD POL; National Population Commission ICF, 2019, NAT SPEC LIST KOR 3, P224; Nel E, 2012, J PEDIATR GASTR NUTR, V55, P500, DOI 10.1097/MPG.0b013e318272aee7; Nigeria, 2017, WHO UNICEF ESTIMATES; Nwolisa E, 2013, PAN AFR MED J, V14, DOI 10.11604/pamj.2013.14.89.1711; O'Leary M, 2017, J INFECT PUBLIC HEAL, V10, P470, DOI 10.1016/j.jiph.2016.08.001; Odusanya OO, 2011, HUM VACCINES, V7, P625, DOI 10.4161/hv.7.6.14990; Ogboghodo BC, 2009, AFR J BIOMED RES, V12, P1; Omeje KN., 2017, NIGER J PAEDIAT, V44, P14, DOI [10.4314/njp.v44i1.3, DOI 10.4314/NJP.V44I1.3]; Oni AO, 1996, J MED VIROL, V49, P178, DOI 10.1002/(SICI)1096-9071(199607)49:3&lt;178::AID-JMV4&gt;3.0.CO;2-1; Ott JJ, 2012, VACCINE, V30, P2212, DOI 10.1016/j.vaccine.2011.12.116; Oyedeji G.A., 1985, NIG J PAEDIAT, V12, P111; Paganelli M, 2012, J HEPATOL, V57, P885, DOI 10.1016/j.jhep.2012.03.036; Puoti M, 2008, CLIN INFECT DIS, V46, P367, DOI 10.1086/525532; Rouet F, 2008, CLIN INFECT DIS, V46, P361, DOI 10.1086/525531; Sadoh AE, 2011, S AFR J CHILD HEALTH, V5, P7; Sadoh AE, 2014, AFR HEALTH SCI, V14, P377, DOI 10.4314/ahs.v14i2.13; Schuval S, 2004, ARCH PEDIAT ADOL MED, V158, P1007, DOI 10.1001/archpedi.158.10.1007; Telatela SP, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-338; Thio CL, 2009, HEPATOLOGY, V49, pS138, DOI 10.1002/hep.22883; Toussi SS, 2007, CLIN INFECT DIS, V45, P795, DOI 10.1086/521169; Ugwuja E, 2008, INTERNET J TROPICAL, V6, P1; Zhou ST, 2010, JAIDS-J ACQ IMM DEF, V54, P191, DOI 10.1097/QAI.0b013e3181c99226	58	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243656	10.1371/journal.pone.0243656	http://dx.doi.org/10.1371/journal.pone.0243656			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301507	Green Published, gold			2022-12-27	WOS:000600143100075
J	House, NCM; Parasuram, R; Layer, JV; Price, BD				House, Nealia C. M.; Parasuram, Ramya; Layer, Jacob V.; Price, Brendan D.			Site-specific targeting of a light activated dCas9-KillerRed fusion protein generates transient, localized regions of oxidative DNA damage	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; BASE EXCISION-REPAIR; HOMOLOGOUS RECOMBINATION; BIOLOGICAL CONSEQUENCES; STRUCTURAL BASIS; CHROMATIN; MECHANISMS; INDUCTION; GENOME; H2A.Z	DNA repair requires reorganization of the local chromatin structure to facilitate access to and repair of the DNA. Studying DNA double-strand break (DSB) repair in specific chromatin domains has been aided by the use of sequence-specific endonucleases to generate targeted breaks. Here, we describe a new approach that combines KillerRed, a photosensitizer that generates reactive oxygen species (ROS) when exposed to light, and the genome-targeting properties of the CRISPR/Cas9 system. Fusing KillerRed to catalytically inactive Cas9 (dCas9) generates dCas9-KR, which can then be targeted to any desired genomic region with an appropriate guide RNA. Activation of dCas9-KR with green light generates a local increase in reactive oxygen species, resulting in "clustered" oxidative damage, including both DNA breaks and base damage. Activation of dCas9-KR rapidly (within minutes) increases both gamma H2AX and recruitment of the KU70/80 complex. Importantly, this damage is repaired within 10 minutes of termination of light exposure, indicating that the DNA damage generated by dCas9-KR is both rapid and transient. Further, repair is carried out exclusively through NHEJ, with no detectable contribution from HR-based mechanisms. Surprisingly, sequencing of repaired DNA damage regions did not reveal any increase in either mutations or INDELs in the targeted region, implying that NHEJ has high fidelity under the conditions of low level, limited damage. The dCas9-KR approach for creating targeted damage has significant advantages over the use of endonucleases, since the duration and intensity of DNA damage can be controlled in "real time" by controlling light exposure. In addition, unlike endonucleases that carry out multiple cut-repair cycles, dCas9-KR produces a single burst of damage, more closely resembling the type of damage experienced during acute exposure to reactive oxygen species or environmental toxins. dCas9-KR is a promising system to induce DNA damage and measure site-specific repair kinetics at clustered DNA lesions.	[House, Nealia C. M.; Parasuram, Ramya; Price, Brendan D.] Harvard Med Sch, Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA; [Layer, Jacob V.] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Layer, Jacob V.] eGenesis, Cambridge, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Price, BD (corresponding author), Harvard Med Sch, Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA.	Brendan_price@dfci.harvard.edu		House, Nealia/0000-0003-1264-7699	NIH [CA177804, CA93602]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grants CA177804 (BDP) and CA93602 (BDP). One of us (JVL) is currently employed by eGenesis, Cambridge, MA. However, JVL's contribution to the current work was solely carried out while he was an employee of the Dana-Farber Cancer Institute and was completed prior to JVL's departure from the DFCI. "eGenesis did not provide support in the form of salaries to either JVL or other workers, and did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Alatwi HE, 2015, EMBO REP, V16, P986, DOI 10.15252/embr.201540330; Atamna H, 2000, P NATL ACAD SCI USA, V97, P686, DOI 10.1073/pnas.97.2.686; Aymard F, 2014, NAT STRUCT MOL BIOL, V21, P366, DOI 10.1038/nsmb.2796; Ayrapetov MK, 2014, P NATL ACAD SCI USA, V111, P9169, DOI 10.1073/pnas.1403565111; Brinkman EK, 2018, MOL CELL, V70, P801, DOI 10.1016/j.molcel.2018.04.016; Brown AJ, 2018, METHOD ENZYMOL, V601, P111, DOI 10.1016/bs.mie.2017.11.028; Budworth H, 2005, J MOL BIOL, V351, P1020, DOI 10.1016/j.jmb.2005.06.069; Bulina ME, 2006, NAT BIOTECHNOL, V24, P95, DOI 10.1038/nbt1175; Cannan WJ, 2016, J CELL PHYSIOL, V231, P3, DOI 10.1002/jcp.25048; Cannan WJ, 2014, J BIOL CHEM, V289, P19881, DOI 10.1074/jbc.M114.571588; Carpentier P, 2009, FEBS LETT, V583, P2839, DOI 10.1016/j.febslet.2009.07.041; Ceccaldi R, 2016, TRENDS CELL BIOL, V26, P52, DOI 10.1016/j.tcb.2015.07.009; Chan KKL, 2006, MUTAGENESIS, V21, P173, DOI 10.1093/mutage/gel020; Chen SH, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav4340; Chiolo I, 2011, CELL, V144, P732, DOI 10.1016/j.cell.2011.02.012; Clouaire T, 2019, TRENDS GENET, V35, P330, DOI 10.1016/j.tig.2019.02.003; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Dhar S, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0284; Dickinson BC, 2011, NAT CHEM BIOL, V7, P504, DOI [10.1038/nchembio.607, 10.1038/NCHEMBIO.607]; Eccles LJ, 2011, MUTAT RES-FUND MOL M, V711, P134, DOI 10.1016/j.mrfmmm.2010.11.003; Fajrial AK, 2020, THERANOSTICS, V10, P5532, DOI 10.7150/thno.43465; Forkink M, 2010, BBA-BIOENERGETICS, V1797, P1034, DOI 10.1016/j.bbabio.2010.01.022; Gangopadhyay SA, 2019, BIOCHEMISTRY-US, V58, P234, DOI 10.1021/acs.biochem.8b01202; Georgakilas AG, 2013, RADIAT RES, V180, P100, DOI 10.1667/RR3041.1; Glaser A, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.48; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Gursoy-Yuzugullu O, 2015, P NATL ACAD SCI USA, V112, P7507, DOI 10.1073/pnas.1504868112; Hauer MH, 2017, GENE DEV, V31, P2204, DOI 10.1101/gad.307702.117; Hegde ML, 2016, ONCOTARGET, V7, P54430, DOI 10.18632/oncotarget.9914; House NCM, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00296; Iacovoni JS, 2010, EMBO J, V29, P1446, DOI 10.1038/emboj.2010.38; Iliakis G, 2004, CYTOGENET GENOME RES, V104, P14, DOI 10.1159/000077461; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; Jasin M, 2016, DNA REPAIR, V44, P6, DOI 10.1016/j.dnarep.2016.05.001; Jeggo PA, 2011, RADIOTHER ONCOL, V101, P7, DOI 10.1016/j.radonc.2011.06.019; Kalocsay M, 2009, MOL CELL, V33, P335, DOI 10.1016/j.molcel.2009.01.016; Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497; Lan L, 2014, NUCLEIC ACIDS RES, V42, P2330, DOI 10.1093/nar/gkt1233; Layer JV, 2018, P NATL ACAD SCI USA, V115, P10076, DOI 10.1073/pnas.1801591115; Lemaitre C, 2014, GENE DEV, V28, P2450, DOI 10.1101/gad.248369.114; Liu Y, 2020, SCIENCE, V368, P1265, DOI 10.1126/science.aay8204; Luijsterburg MS, 2016, MOL CELL, V61, P547, DOI 10.1016/j.molcel.2016.01.019; Magnander K, 2012, CANCER LETT, V327, P90, DOI 10.1016/j.canlet.2012.02.013; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Martin LJ, 2008, J NEUROPATH EXP NEUR, V67, P377, DOI 10.1097/NEN.0b013e31816ff780; Mehta A, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016428; Mitrentsi I, 2020, CURR OPIN CELL BIOL, V64, P58, DOI 10.1016/j.ceb.2020.02.014; Moore S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08111-y; Morillo-Huesca M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012143; Murai J, 2012, CANCER RES, V72, P5588, DOI 10.1158/0008-5472.CAN-12-2753; Murga M, 2007, J CELL BIOL, V178, P1101, DOI 10.1083/jcb.200704140; Nickoloff JA, 2020, GENES-BASEL, V11, DOI 10.3390/genes11010099; Nishibuchi I, 2014, INT J RADIAT ONCOL, V89, P736, DOI 10.1016/j.ijrobp.2014.03.031; Ochs F, 2019, NATURE, V574, P571, DOI 10.1038/s41586-019-1659-4; Peng JC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000435; Petrova NV, 2016, AGING-US, V8, P2449, DOI 10.18632/aging.101065; Price BD, 2013, CELL, V152, P1344, DOI 10.1016/j.cell.2013.02.011; Sage E, 2011, MUTAT RES-FUND MOL M, V711, P123, DOI 10.1016/j.mrfmmm.2010.12.010; Sedelnikova OA, 2010, MUTAT RES-REV MUTAT, V704, P152, DOI 10.1016/j.mrrev.2009.12.005; Sharma V, 2016, ONCOTARGET, V7, P25377, DOI 10.18632/oncotarget.8298; Shikazono N, 2009, J RADIAT RES, V50, P27, DOI 10.1269/jrr.08086; Singleton BK, 2002, CANCER RES, V62, P6263; Strom CE, 2011, NUCLEIC ACIDS RES, V39, P3166, DOI 10.1093/nar/gkq1241; Sun LX, 2015, NUCLEIC ACIDS RES, V43, P6334, DOI 10.1093/nar/gkv598; Tan R, 2017, METHODS MOL BIOL, V1587, P139, DOI 10.1007/978-1-4939-6892-3_14; Tan R, 2016, ACTA BIOCH BIOPH SIN, V48, P617, DOI 10.1093/abbs/gmw040; Tsouroula K, 2016, MOL CELL, V63, P293, DOI 10.1016/j.molcel.2016.06.002; Vilenchik MM, 2003, P NATL ACAD SCI USA, V100, P12871, DOI 10.1073/pnas.2135498100; Vitor AC, 2020, FRONT MOL BIOSCI, V7, DOI 10.3389/fmolb.2020.00024; Watts FZ, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6040047; Wei LZ, 2015, P NATL ACAD SCI USA, V112, pE3495, DOI 10.1073/pnas.1507105112; Whitefield DB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-36343-x; Wilson MD, 2016, NATURE, V536, P100, DOI 10.1038/nature18951; Wu YJ, 2020, MOL THER-NUCL ACIDS, V19, P922, DOI 10.1016/j.omtn.2019.12.026; Xu Y, 2012, MOL CELL, V48, P723, DOI 10.1016/j.molcel.2012.09.026; Yang C, 2017, J AGR FOOD CHEM, V65, P818, DOI 10.1021/acs.jafc.6b04962; Yang JL, 2020, NEUROPATH APPL NEURO, V46, P375, DOI 10.1111/nan.12584; Yang XH, 2013, J BIOL CHEM, V288, P18271, DOI 10.1074/jbc.M113.473199	79	3	3	5	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0237759	10.1371/journal.pone.0237759	http://dx.doi.org/10.1371/journal.pone.0237759			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332350	Green Published, gold, Green Submitted			2022-12-27	WOS:000601310900086
J	Naroda, Y; Endo, Y; Yoshimura, K; Ishii, H; Ei, SI; Miura, T				Naroda, Yuto; Endo, Yoshie; Yoshimura, Kenji; Ishii, Hiroshi; Ei, Shin-Ichiro; Miura, Takashi			Noise-induced scaling in skull suture interdigitation	PLOS ONE			English	Article							MECHANICAL-BEHAVIOR; FRACTAL DIMENSIONS; CRANIAL SUTURES; MODEL	Sutures, the thin, soft tissue between skull bones, serve as the major craniofacial growth centers during postnatal development. In a newborn skull, the sutures are straight; however, as the skull develops, the sutures wind dynamically to form an interdigitation pattern. Moreover, the final winding pattern had been shown to have fractal characteristics. Although various molecules involved in suture development have been identified, the mechanism underlying the pattern formation remains unknown. In a previous study, we reproduced the formation of the interdigitation pattern in a mathematical model combining an interface equation and a convolution kernel. However, the generated pattern had a specific characteristic length, and the model was unable to produce a fractal structure with the model. In the present study, we focused on the anterior part of the sagittal suture and formulated a new mathematical model with time-space-dependent noise that was able to generate the fractal structure. We reduced our previous model to represent the linear dynamics of the centerline of the suture tissue and included a time-space-dependent noise term. We showed theoretically that the final pattern from the model follows a scaling law due to the scaling of the dispersion relation in the full model, which we confirmed numerically. Furthermore, we observed experimentally that stochastic fluctuation of the osteogenic signal exists in the developing skull, and found that actual suture patterns followed a scaling law similar to that of the theoretical prediction.	[Naroda, Yuto] Kyushu Univ, Sch Med, Fukuoka, Fukuoka, Japan; [Endo, Yoshie; Miura, Takashi] Kyushu Univ, Grad Sch Med Sci, Fukuoka, Fukuoka, Japan; [Yoshimura, Kenji] Osaka City Gen Hosp, Dept Neurol, Osaka, Japan; [Ishii, Hiroshi; Ei, Shin-Ichiro] Hokkaido Univ, Fac Sci, Sapporo, Hokkaido, Japan; [Naroda, Yuto] Matsuyama Red Cross Hosp, Matsuyama, Ehime, Japan	Kyushu University; Kyushu University; Osaka City General Hospital; Hokkaido University; Matsuyama Red Cross Hospital	Miura, T (corresponding author), Kyushu Univ, Grad Sch Med Sci, Fukuoka, Fukuoka, Japan.	miura_t@anat1.med.kyushu-u.ac.jp	Miura, Takashi/AAF-3003-2021	Miura, Takashi/0000-0002-9465-275X; Yoshimura, Kenji/0000-0001-5033-3346; Ishii, Hiroshi/0000-0002-6834-6644	JSPS KAKENHI [15KT0018]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	TM: JSPS KAKENHI Grant Number 15KT0018.	Barabasi A.-L., 1995, FRACTAL CONCEPTS SUR; Cohen M.M., 2000, DIAGNOSIS EVALUATION; Di Ieva A, 2013, CHILD NERV SYST, V29, P893, DOI 10.1007/s00381-013-2061-4; Eden M., 1961, P 4 BERK S MATH STAT, V4, P223; Falconer K., 2003, FRACTAL GEOMETRY; GIBERT J, 1995, J HUM EVOL, V28, P561, DOI 10.1006/jhev.1995.1042; Gorski AZ, 2006, J ANAT, V208, P353, DOI 10.1111/j.1469-7580.2006.00529.x; Huang S, 2009, DEVELOPMENT, V136, P3853, DOI 10.1242/dev.035139; JASLOW CR, 1990, J BIOMECH, V23, P313, DOI 10.1016/0021-9290(90)90059-C; Kamioka Y, 2012, CELL STRUCT FUNCT, V37, P65, DOI 10.1247/csf.11045; Khoshhesab MM, 2018, EXTREME MECH LETT, V24, P58, DOI 10.1016/j.eml.2018.09.003; Krug J, 1997, ADV PHYS, V46, P139, DOI 10.1080/00018739700101498; Lin E, 2014, J MATER RES, V29, P1867, DOI 10.1557/jmr.2014.175; LONG CA, 1985, J MORPHOL, V185, P285, DOI 10.1002/jmor.1051850303; LONG CA, 1992, ACTA ANAT, V145, P201; Lynnerup N, 2003, AM J PHYS ANTHROPOL, V121, P332, DOI 10.1002/ajpa.10260; MASUDA Y, 1987, Okajimas Folia Anatomica Japonica, V64, P39; Miura T, 2009, J ANAT, V215, P642, DOI 10.1111/j.1469-7580.2009.01148.x; Monteiro L. R., 2000, Revista Brasileira de Biologia, V60, P689, DOI 10.1590/S0034-71082000000400021; Oota Y, 2006, PHYSICA A, V359, P538, DOI 10.1016/j.physa.2005.05.095; OOTA Y, 2004, FORMA, V19, P197; Opreanu C, 1994, EPHEMERIS NAPOCENSIS, V4, P193; Pozzi F, 2012, EUR PHYS J B, V85, DOI 10.1140/epjb/e2012-20697-x; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Takayasu H, 1986, FRACTALS; Torimitsu S, 2015, FORENSIC SCI INT, V249, P101, DOI 10.1016/j.forsciint.2015.01.030; Ungari C, 2012, EUR REV MED PHARMACO, V16, P1559; Yoshimura K, 2016, J THEOR BIOL, V408, P66, DOI 10.1016/j.jtbi.2016.08.003; Yu JC, 2003, CLEFT PALATE-CRAN J, V40, P409, DOI 10.1597/1545-1569(2003)040<0409:AFAOHC>2.0.CO;2; Zollikofer CPE, 2011, J ANAT, V219, P100, DOI 10.1111/j.1469-7580.2011.01386.x	30	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0235802	10.1371/journal.pone.0235802	http://dx.doi.org/10.1371/journal.pone.0235802			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332349	Green Submitted, Green Published, gold			2022-12-27	WOS:000601310900014
J	Joshi, A; Thaploo, D; Yan, XG; Herrmann, T; Khabour, HA; Hummel, T				Joshi, Akshita; Thaploo, Divesh; Yan, Xiaoguang; Herrmann, Theresa; Khabour, Hudaa Alrahman; Hummel, Thomas			A novel technique for olfactory bulb measurements	PLOS ONE			English	Article							VOLUME; NEUROGENESIS; NEURONS	Background To introduce new ways to calculate OB volumes, checking their validity and comparing them to already established technique i.e. OB volumetric based on manual segmentation of OB boundaries. Methods Two approaches were used to calculate OB volumes (1) Manual Segmentation using planimetric manual contouring; (2) Box-frame method, calculating the parameters based on a box placed around the OB. Results We calculated OB volumes using both techniques and found comparable outcomes. High inter-observer reliability was found for volumes calculated by both observers. For manual segmentation, Cronbach's alpha (alpha) was 0.91 and 0.93 for right and left OB volume, respectively, whereas for the box-frame method alpha was 0.94 and 0.90 for right and left OB, respectively. Conclusions The simple box-frame method of OB volume calculation appears reliable. Its results are comparable to an established technique.	[Joshi, Akshita; Thaploo, Divesh; Yan, Xiaoguang; Herrmann, Theresa; Hummel, Thomas] Tech Univ Dresden, Dept Otorhinolaryngol, Smell & Taste Clin, Dresden, Germany; [Khabour, Hudaa Alrahman] Jordan Univ Sci & Technol, Irbid, Jordan	Technische Universitat Dresden; Jordan University of Science & Technology	Joshi, A (corresponding author), Tech Univ Dresden, Dept Otorhinolaryngol, Smell & Taste Clin, Dresden, Germany.	joshiakshita93@gmail.com		Joshi, Akshita/0000-0002-1861-4698				Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; [Anonymous], 2020, J CLIN ENDOCRINOL ME, V105, pe32; Bergmann O, 2012, NEURON, V74, P634, DOI 10.1016/j.neuron.2012.03.030; Breton-Provencher V, 2012, BEHAV BRAIN RES, V227, P480, DOI 10.1016/j.bbr.2011.08.001; Breton-Provencher V, 2009, J NEUROSCI, V29, P15245, DOI 10.1523/JNEUROSCI.3606-09.2009; Buschuter D, 2008, NEUROIMAGE, V42, P498, DOI 10.1016/j.neuroimage.2008.05.004; Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science.1136281; Gudziol V, 2009, J NEUROLOGY; Haehner A, 2008, ARCH OTOLARYNGOL, V134, P621, DOI 10.1001/archotol.134.6.621; Han P, 2019, NEURAL PROCESSING OD, DOI [10.1007/s11682-019-00062-2, DOI 10.1007/S11682-019-00062-2]; HINDS JW, 1981, J COMP NEUROL, V203, P441, DOI 10.1002/cne.902030308; Hummel T, 2013, NEUROSCIENCE, V237, P51, DOI [10.1016/J.neuroscience.2013.01.044, 10.1016/j.neuroscience.2013.01.044]; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Lledo PM, 2004, NEUROSCIENTIST, V10, P292, DOI 10.1177/1073858404263460; Lledo PM, 2003, NEUROREPORT, V14, P1655, DOI 10.1097/00001756-200309150-00001; Lotsch J, 2014, BRAIN STRUCT FUNCT, V219, P1991, DOI 10.1007/s00429-013-0618-3; Mazal PP, 2016, EUR ARCH OTO-RHINO-L, V273, P1, DOI 10.1007/s00405-014-3325-7; Mueller A, 2005, J NEURAL TRANSM, V112, P1363, DOI 10.1007/s00702-005-0280-x; Oleszkiewicz A, 2019, EUR ARCH OTO-RHINO-L, V276, P719, DOI 10.1007/s00405-018-5248-1; Patterson A, 2015, EUR ARCH OTO-RHINO-L, V272, P3593, DOI 10.1007/s00405-015-3524-x; Rombaux P, 2007, AM J RHINOL, V21, P548, DOI 10.2500/ajr.2007.21.3067; Rombaux P, 2012, OTOLARYNG HEAD NECK, V147, P1136, DOI 10.1177/0194599812459704; Slotnick B, 2004, J NEUROSCI, V24, P9195, DOI 10.1523/JNEUROSCI.1936-04.2004; Yousem DM, 1997, ACAD RADIOL, V4, P264, DOI 10.1016/S1076-6332(97)80027-X; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	25	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243941	10.1371/journal.pone.0243941	http://dx.doi.org/10.1371/journal.pone.0243941			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326498	Green Published, gold			2022-12-27	WOS:000600176400037
J	Umeki, M; Yamashita, H; Suzuki, G; Sato, T; Ohara, S; Koike, K				Umeki, Masami; Yamashita, Hiroshi; Suzuki, Go; Sato, Taiki; Ohara, Shizuka; Koike, Kazuhiko			Fecal pellets of giant clams as a route for transporting Symbiodiniaceae to corals	PLOS ONE			English	Article							FREE-LIVING SYMBIODINIUM; ZOOXANTHELLAE; DIVERSITY; SYMBIOSIS; MICROADRIATICUM; FLEXIBILITY; DINOPHYCEAE; TEMPERATURE; MECHANISM; SEDIMENT	Because more than 80% of species of gamete-spawning corals, including most Acroporidae species, do not inherit Symbiodiniaceae from their parents, they must acquire symbiont cells from sources in their environment. To determine whether photosynthetically competent Symbiodiniaceae expelled as fecal pellets from giant clams are capable of colonizing corals, we conducted laboratory experiments in which planula larvae of Acropora tenuis were inoculated with the cells in fecal pellets obtained from Tridacna crocea. T. crocea fecal pellets were administered once a day, and three days later, cells of Symbiodiniaceae from the fecal pellets had been taken up by the coral larvae. T. crocea fecal pellets were not supplied from the 4th day until the 8th day, and the cell densities in the larvae increased until the 8th day, which indicated the successful colonization by Symbiodiniaceae. The control group exhibited the highest mean percentage of larvae (100%) that were successfully colonized by culture strains of Symbiodiniaceae, and larvae inoculated with fecal pellets reached a colonization percentage of 66.7 similar to 96.7% on the 8th day. The highest colonization rate was achieved with the fecal pellets containing cells with high photosynthetic competency (Fv/Fm). Interestingly, the genetic composition of Symbiodiniaceae in the larvae retrieved on the 8th day differed from that in the fecal pellets and showed exclusive domination of the genus Symbiodinium. A minor but significant population of the genus Cladocopium in the fecal pellets was not inherited by the larvae. These experiments provided the first demonstration that the Symbiodiniaceae from tridacnine clams provided via fecal pellets can colonize and even proliferate in coral larvae.	[Umeki, Masami; Sato, Taiki; Ohara, Shizuka; Koike, Kazuhiko] Hiroshima Univ, Grad Sch Integrated Sci Life, Higashihiroshima, Hiroshima, Japan; [Yamashita, Hiroshi; Suzuki, Go] Japan Fisheries Res & Educ Agcy, Fisheries Technol Inst, Onna, Okinawa, Japan	Hiroshima University; Japan Fisheries Research & Education Agency (FRA)	Koike, K (corresponding author), Hiroshima Univ, Grad Sch Integrated Sci Life, Higashihiroshima, Hiroshima, Japan.	kazkoike@hiroshima-u.ac.jp		Kazuhiko, Koike/0000-0001-5380-5839; Ohara, Shizuka/0000-0002-1207-6921	MEXT/JSPS KAKENHI [18K19232]; Japan Science Society	MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Science Society	This work was supported by MEXT/JSPS KAKENHI Grant Number 18K19232 to KK and Sasakawa Scientific Research Grant fDrom The Japan Science Society to MU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LM, 2009, MAR ECOL PROG SER, V377, P149, DOI 10.3354/meps07834; Baghdasarian G, 2000, BIOL BULL-US, V199, P278, DOI 10.2307/1543184; Baird AH, 2009, ANNU REV ECOL EVOL S, V40, P551, DOI 10.1146/annurev.ecolsys.110308.120220; Bay Line Kolind, 2011, Diversity, V3, P356; Bhagooli R, 2004, MAR BIOL, V145, P329, DOI 10.1007/s00227-004-1309-7; BLANK RJ, 1986, TAXON, V35, P286, DOI 10.2307/1221270; Brooks ME, 2017, R J, V9, P378, DOI 10.32614/RJ-2017-066; Cantin NE, 2009, CORAL REEFS, V28, P405, DOI 10.1007/s00338-009-0478-8; Cumbo VR, 2013, CORAL REEFS, V32, P111, DOI 10.1007/s00338-012-0951-7; Dunn SR, 2009, ENVIRON MICROBIOL, V11, P268, DOI 10.1111/j.1462-2920.2008.01774.x; FITT WK, 1986, AQUACULTURE, V55, P5, DOI 10.1016/0044-8486(86)90051-7; Franklin EC, 2012, MOL ECOL RESOUR, V12, P369, DOI 10.1111/j.1755-0998.2011.03081.x; Fujise L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114321; Fukami H, 2004, EVOLUTION, V58, P324, DOI 10.1111/j.0014-3820.2004.tb01648.x; Gabay Y, 2019, ISME J, V13, P2489, DOI 10.1038/s41396-019-0429-5; Hardin JW., 2007, GEN LINEAR MODELS EX, V2, DOI DOI 10.1016/j.marpol.2012.12.026; Ikeda S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172285; Knowlton Nancy, 2010, P65, DOI 10.1002/9781444325508.ch4; LaJeunesse TC, 2004, MAR ECOL PROG SER, V284, P147, DOI 10.3354/meps284147; LaJeunesse TC, 2018, CURR BIOL, V28, P2570, DOI 10.1016/j.cub.2018.07.008; Lee SY, 2015, EUR J PHYCOL, V50, P155, DOI 10.1080/09670262.2015.1018336; Littman RA, 2008, J EXP MAR BIOL ECOL, V364, P48, DOI 10.1016/j.jembe.2008.06.034; Manning MM, 2008, LIMNOL OCEANOGR, V53, P1853, DOI 10.4319/lo.2008.53.5.1853; Maruyama T, 1997, MAR BIOL, V127, P473, DOI 10.1007/s002270050035; Mies M, 2019, CORAL REEFS, V38, P1067, DOI 10.1007/s00338-019-01857-x; Morishima SY, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220141; Nitschke MR, 2015, CORAL REEFS, V34, P161, DOI 10.1007/s00338-014-1220-8; NORTON JH, 1992, BIOL BULL, V183, P503, DOI 10.2307/1542028; Oh-Uchi, 2007, GALAXEA, V9, P1, DOI DOI 10.3755/JCRS.9.1; Pochon X, 2010, MOL PHYLOGENET EVOL, V56, P492, DOI 10.1016/j.ympev.2010.03.040; Pochon X, 2010, J PHYCOL, V46, P53, DOI 10.1111/j.1529-8817.2009.00797.x; Quigley KM, 2018, HEREDITY, V121, P524, DOI 10.1038/s41437-018-0059-0; Quigley KM, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00401; R Core Team, 2020, R LANG ENV STAT COMP; Ralph PJ, 2001, MAR ECOL PROG SER, V220, P163, DOI 10.3354/meps220163; Reaka-Kudla ML, 1997, GLOBAL BIODIVERSITY, P83; Reaka-Kudla ML, 2005, CARIBBEAN MARINE BIO, P259; Reimer James Davis, 2010, Marine Biodiversity, V40, P237, DOI 10.1007/s12526-010-0044-1; Rowan R, 1998, J PHYCOL, V34, P407, DOI 10.1046/j.1529-8817.1998.340407.x; Suzuki G, 2020, FISHERIES SCI, V86, P665, DOI 10.1007/s12562-020-01425-1; Takabayashi M, 2012, CORAL REEFS, V31, P157, DOI 10.1007/s00338-011-0832-5; TRENCH RK, 1981, BIOL BULL-US, V161, P180, DOI 10.2307/1541117; Yamashita H, 2013, CORAL REEFS, V32, P355, DOI 10.1007/s00338-012-0980-2; Yamashita H, 2018, MAR ECOL PROG SER, V592, P119, DOI 10.3354/meps12474; Yamashita H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097003; Yamashita H, 2013, PHYCOL RES, V61, P68, DOI 10.1111/pre.12004; Yamashita H, 2011, MAR BIOL, V158, P87, DOI 10.1007/s00227-010-1544-z; Yuyama I, 2005, BIOCHEM BIOPH RES CO, V336, P793, DOI 10.1016/j.bbrc.2005.08.174	48	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243087	10.1371/journal.pone.0243087	http://dx.doi.org/10.1371/journal.pone.0243087			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326418	gold, Green Published			2022-12-27	WOS:000600176400013
J	Zhu, KX; Jiang, S; Han, L; Wang, MM; Wang, XY				Zhu, Ke-Xin; Jiang, Shan; Han, Lei; Wang, Ming-Ming; Wang, Xing-Ya			Fine-scale genetic structure of the overwintering Chilo suppressalis in the typical bivoltine areas of northern China	PLOS ONE			English	Article							RICE STEM BORER; SPATIAL AUTOCORRELATION ANALYSIS; POPULATION-STRUCTURE; MICROSATELLITE LOCI; WALKER LEPIDOPTERA; SOFTWARE; DISPERSAL; DISTANCE	The rice stem borer (RSB), Chilo suppressalis (Lepidoptera: Pyralidae), is an important agricultural pest that has caused serious economic losses in the major rice-producing areas of China. To effectively control this pest, we investigated the genetic diversity, genetic differentiation and genetic structure of 16 overwintering populations in the typical bivoltine areas of northern China based on 12 nuclear microsatellite loci. Moderate levels of genetic diversity and genetic differentiation among the studied populations were detected. Neighbour-joining dendrograms, Bayesian clustering and principal coordinate analysis (PCoA) consistently divided these populations into three genetic clades: western, eastern and northern/central. Isolation by distance (IBD) and spatial autocorrelation analyses demonstrated no correlation between genetic distance and geographic distance. Bottleneck analysis illustrated that RSB populations had not undergone severe bottleneck effects in these regions. Accordingly, our results provide new insights into the genetic relationships of overwintering RSB populations and thus contribute to developing effective management strategies for this pest.	[Zhu, Ke-Xin; Jiang, Shan; Han, Lei; Wang, Ming-Ming; Wang, Xing-Ya] Shenyang Agr Univ, Coll Plant Protect, Shenyang, Liaoning, Peoples R China	Shenyang Agricultural University	Wang, XY (corresponding author), Shenyang Agr Univ, Coll Plant Protect, Shenyang, Liaoning, Peoples R China.	wangxingya20081@163.com		Jiang, Shan/0000-0002-1976-1278	Scientific Research Project of Education Department of Liaoning Province (Basic Research Program of Natural Science) [LSNJC202008]; National Key Research and Development Program of China [2018YFD0200200]; National Natural Science Foundation of China [31871950]; Science and Technology Plan of Liaoning Province [2019JH2/10200012]	Scientific Research Project of Education Department of Liaoning Province (Basic Research Program of Natural Science); National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Plan of Liaoning Province	This work was supported by the Scientific Research Project of Education Department of Liaoning Province (Basic Research Program of Natural Science) (LSNJC202008); The National Key Research and Development Program of China (2018YFD0200200); The National Natural Science Foundation of China (Grant No. 31871950); The Science and Technology Plan of Liaoning Province 2019JH2/10200012).	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Aggarwal RAK, 2007, CURR SCI INDIA, V92, P1133; Andras JP, 2018, MOL ECOL, V27, P1371, DOI 10.1111/mec.14545; [Anonymous], 2012, Regen Med, V7, pS14, DOI 10.2217/rme.12.38; [Anonymous], 2018, J EARLY REPUBLIC, V38, P61; Avise JC, 2000, PHYLOGEOGRAPHY HIST, V447; Behura SK, 2006, MOL ECOL, V15, P3087, DOI 10.1111/j.1365-294X.2006.03014.x; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Chen WenMing, 2009, Scientia Agricultura Sinica, V42, P1100; Cornuet JM, 1996, GENETICS, V144, P2001; Dean CB, 2007, LIFETIME DATA ANAL, V13, P497, DOI 10.1007/s10985-007-9065-x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Epperson BK, 1997, EVOLUTION, V51, P672, DOI 10.1111/j.1558-5646.1997.tb03651.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fairley TL, 2000, J MED ENTOMOL, V37, P754, DOI 10.1603/0022-2585-37.5.754; Falush D, 2003, GENETICS, V164, P1567; Farahpour Haghani A, 2014, PLANT PROTECT SCI, V50, P26, DOI 10.17221/5/2013-PPS; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; HEARNE CM, 1992, TRENDS GENET, V8, P288, DOI 10.1016/0168-9525(92)90256-4; Ishiguro N, 2006, APPL ENTOMOL ZOOL, V41, P565, DOI 10.1303/aez.2006.565; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Ju MM, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00965; Khan ZR, 1991, WORLD BIBLIO RICE ST; Kim KS, 2013, J ASIA-PAC ENTOMOL, V16, P87, DOI 10.1016/j.aspen.2012.11.004; KIRITANI K, 1979, ANNU REV ENTOMOL, V24, P279, DOI 10.1146/annurev.en.24.010179.001431; Li AX, 1996, CHILO SUPPRESSALIS I; Li GL, 1999, J SHENYANG AGR U, P93; Liu YD, 2013, J INTEGR AGR, V12, P1033, DOI 10.1016/S2095-3119(13)60481-5; Liu YD, 2009, MOL ECOL RESOUR, V9, P180, DOI 10.1111/j.1755-0998.2008.02432.x; Lohman TM, 2008, NAT REV MOL CELL BIO, V9, P391, DOI 10.1038/nrm2394; Meng XF, 2008, MOL ECOL, V17, P2880, DOI 10.1111/j.1365-294X.2008.03792.x; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; PAETKAU D, 1995, MOL ECOL, V4, P347, DOI 10.1111/j.1365-294X.1995.tb00227.x; PATHAK MD, 1968, ANNU REV ENTOMOL, V13, P257, DOI 10.1146/annurev.en.13.010168.001353; Pauls SU, 2013, MOL ECOL, V22, P925, DOI 10.1111/mec.12152; Peakall R, 2003, EVOLUTION, V57, P1182, DOI 10.1111/j.0014-3820.2003.tb00327.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Peterson MA, 1998, AM NAT, V152, P428, DOI 10.1086/286180; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Pritchard JK., 2010, DOCUMENTATION STRUCT; Prugh LR, 2008, P NATL ACAD SCI USA, V105, P20770, DOI 10.1073/pnas.0806080105; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Rashed R, 2014, ARAB SCI PHILOS, V24, P1, DOI 10.1017/S0957423913000088; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Shayanmehr M., 2016, Journal of Entomological and Acarological Research, V48, P360, DOI 10.4081/jear.2016.5507; Smouse PE, 1999, HEREDITY, V82, P561, DOI 10.1038/sj.hdy.6885180; Su JW, 2003, ENTOMOLOGICAL KNOWLE, P323; Takezaki N, 2010, MOL BIOL EVOL, V27, P747, DOI 10.1093/molbev/msp312; Tang XT, 2016, MITOCHONDRIAL DNA A, V27, P1567, DOI 10.3109/19401736.2014.958670; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Yeh Francis C., 1997, Belgian Journal of Botany, V129, P157; Yin LA, 2001, LIAONING AGR SCI, P52, DOI DOI 10.3969/J.ISSN.1002-1728.2001.05.020	54	0	1	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243999	10.1371/journal.pone.0243999	http://dx.doi.org/10.1371/journal.pone.0243999			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326485	gold, Green Published			2022-12-27	WOS:000600176400062
J	Dagnew, GW; Asresie, MB; Fekadu, GA; Gelaw, YM				Dagnew, Gizachew Worku; Asresie, Melash Belachew; Fekadu, Gedefaw Abeje; Gelaw, Yared Mulu			Factors associated with divorce from first union among women in Ethiopia: Further analysis of the 2016 Ethiopia demographic and health survey data	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; INTIMATE PARTNER VIOLENCE; EARLY MARRIAGE; CHILD-MORTALITY; CONSEQUENCES; DETERMINANTS; DISSOLUTION; SEXUALITY; EDUCATION; OUTCOMES	Background Globally, divorce is a common phenomenon in couples' marital life. As a result, many divorced couples and their children face several social, economic, and health problems after dissolution. There is little information on the magnitude and determinants of divorce in developing countries including Ethiopia. Therefore, this study aimed to estimate the prevalence of divorce from the first union and its predictors among reproductive-age women in Ethiopia. Methods We used the 2016 Ethiopia demographic and health survey data for this analysis. The survey was a community-based cross-sectional study conducted from January 18 to June 27, 2016. The survey employed a two-stage stratified cluster sampling technique. A total of 11,646 ever-married women were included in the analysis. Bivariate and multivariable logistics regression was done to identify the determinants of divorce from the first marriage. A p-value < 0.05 was used to declare statistical significance. Results About 25% (95%CI: 23.4% - 26.6%) ever-married women were divorced from their first marital relationship. Women who were married at age < 15 years (AOR = 1.34; 95%CI: 1.07-1.68), urban women (AOR = 1.69; 95%CI: 1.22-2.35), women who did not attend formal education (AOR = 4.36; 95%CI: 3.14-6.05), women who were employed (AOR = 1.51; 95%CI: 1.31-1.73), and being childless (AOR = 1.34; 95%CI: 1.07-1.69) had higher odds of experiencing a divorce. Similarly, women who experienced partner violence, women with no house ownership, and women in the Amhara region had higher odds of divorce from their first marital union. Conversely, women in Oromia, SNNPR, the metropolis, and the pastoral regions had lower odds of divorce from their first marital union. Conclusion Divorce from the first marriage is high in Ethiopia. Preventing early marriage and partner violence and promoting girls' education would reduce the divorce rate in Ethiopia.	[Dagnew, Gizachew Worku; Asresie, Melash Belachew; Fekadu, Gedefaw Abeje] Bahir Dar Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Dept Reprod Hlth & Populat Studies, Bahir Dar, Ethiopia; [Gelaw, Yared Mulu] Bahir Dar Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Dept Hlth Serv Management, Bahir Dar, Ethiopia	Bahir Dar University; Bahir Dar University	Dagnew, GW (corresponding author), Bahir Dar Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Dept Reprod Hlth & Populat Studies, Bahir Dar, Ethiopia.	giz.work12@gmail.com	Dagnew, Gizachew Worku/ABE-7194-2021; Abeje, Gedefaw/AAL-1098-2021	Dagnew, Gizachew Worku/0000-0003-2043-3041; Asresie, Melash Belachew/0000-0002-4173-0646				Abalos JB, 2017, DEMOGR RES, V36, P1515, DOI 10.4054/demres.2017.36.50; Adegoke TG., 2010, STUDIES TRIBES TRIBA, V8, P107, DOI [10.1080/0972639X.2010.11886617, DOI 10.1080/0972639X.2010.11886617]; Akinyemi JO, 2017, DEV SO AFR, V34, P752, DOI 10.1080/0376835X.2017.1351871; Alemu B., 2008, Exchange on HIV/AIDS, Sexuality and Gender, P4; Amato P. R., 2014, CONT ISSUES FAMILY S, P227; Amato PR, 2014, DRUS ISTRAZ, V23, P5, DOI 10.5559/di.23.1.01; Amato PR, 2010, J MARRIAGE FAM, V72, P650, DOI 10.1111/j.1741-3737.2010.00723.x; Anderson R. T., 2013, MARRIAGE WHAT IT IS, P2775; [Anonymous], 2018, CHINA PHARM, V27, P32; [Anonymous], 2019, CANC DISCOV, V9, pOF3, DOI 10. 1158/2159-8290. CD-NB2018-158; Arugu L.O., 2014, BUS MANAG REV, V4, P374; Bereket Tessema Zewude Ashine KM, 2016, J CULTURE SOC DEV, P24; Chandra-Mouli V, 2013, J ADOLESCENT HEALTH, V52, P517, DOI 10.1016/j.jadohealth.2013.03.002; Cherlin A., 2009, MARRIAGE DIVORCE REM; Clark S, 2015, POPUL DEV REV, V41, P583, DOI 10.1111/j.1728-4457.2015.00086.x; Clark S, 2013, DEMOGRAPHY, V50, P1521, DOI 10.1007/s13524-013-0220-6; CSA Ethiopia and ICF, 2016, ETH DEM HLTH SURV 20; Damota MD, 2019, ACAD ED, P46; Dasarband B, 2018, COMMUNITY HLTH SALAM, V5, P94; DeLongis A, 2017, CURR OPIN PSYCHOL, V13, P158, DOI 10.1016/j.copsyc.2016.11.003; Delprato M, 2017, WORLD DEV, V91, P173, DOI 10.1016/j.worlddev.2016.11.010; Division UNS, 2001, PRINC REC VIT STAT S; Emire G., 2014, COUNTRY REPORT SHAPI, P1; Erulkar A, 2013, INT PERSPECT SEX R H, V39, P6, DOI 10.1363/3900613; Fagan P.F., 2012, MARRI RES, V1, P1; Fledderjohann J, 2017, EUR J POPUL, V33, P129, DOI 10.1007/s10680-016-9401-5; Gonzalez-Val R, 2017, REV ECON HOUSEHOLD, V15, P879, DOI 10.1007/s11150-016-9329-x; Harris PG., 2012, J DIGITAL INVESTIGAT, DOI 10.2307/j.ctt1t89jf5; Hollos M, 2014, HUM FERTIL, V17, P188, DOI 10.3109/14647273.2014.936052; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Isen A, 2010, 08982937 NAT BUR EC; Kefalas MJ, 2011, J FAM ISSUES, V32, P845, DOI 10.1177/0192513X10397277; Kelly JB, 2003, FAM RELAT, V52, P352, DOI 10.1111/j.1741-3729.2003.00352.x; Kim HS, 2011, AM SOCIOL REV, V76, P487, DOI 10.1177/0003122411407748; Kreager DA, 2013, J MARRIAGE FAM, V75, P565, DOI 10.1111/jomf.12018; Kumar N, 2012, WORLD DEV, V40, P2478, DOI 10.1016/j.worlddev.2012.08.001; Lowenstein L. F., 2005, J DIVORCE REMARRIAGE, V42, P153, DOI DOI 10.1300/J087V42N03_09; Mahmood Z, 2016, J CULTURE SOC DEV, P19; Manoj PDS, 2015, IEEE T COMPUT, V64, P3022, DOI 10.1109/TC.2015.2389827; Mo L., 2016, INT J SOCIOL FAM, V42, P29; Mugarura A, 2015, AFRICAN J EC REV, V3, P125; Newton-Levinson A, 2014, CULT HEALTH SEX, V16, P916, DOI 10.1080/13691058.2014.921838; Nour NM, 2006, EMERG INFECT DIS, V12, P1644, DOI 10.3201/eid1211.060510; Ntoimo LFC, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1145; OECD, 2014, FAM SOC GLANC 2014 O, DOI [10.1787/soc_glance-2014-10-en, DOI 10.1787/SOC_GLANCE-2014-10-EN]; Olaniyi A.A., 2015, RES HUM SOCI SCIE, V5, P18; Paik A, 2011, J MARRIAGE FAM, V73, P472, DOI 10.1111/j.1741-3737.2010.00819.x; Raz-Yurovich L, 2012, EUR J POPUL, V28, P177, DOI 10.1007/s10680-012-9256-3; Rennison CM, 2013, VIOLENCE AGAINST WOM, V19, P1312, DOI 10.1177/1077801213514487; Sandstrom G, 2011, HIST FAM, V16, P292, DOI 10.1016/j.hisfam.2011.06.003; Santhya KG, 2010, INT PERSPECT SEX R H, V36, P132, DOI 10.1363/ipsrh.36.132.10; Schoen R, 2002, SOC FORCES, V81, P643, DOI 10.1353/sof.2003.0019; Seid Jibril Mohammed Yehualashet YW, 2016, INNOVARE J SOCIAL SC, V4, P6; Thiombiano BG, 2013, DEMOGR RES, V29, P797, DOI 10.4054/DemRes.2013.29.29; Tilson D, 2000, J BIOSOC SCI, V32, P355, DOI 10.1017/S0021932000003552; Trivedi J K, 2009, Mens Sana Monogr, V7, P37, DOI 10.4103/0973-1229.40648; Unsar S., 2016, INT J CARING SCI, V9, P249, DOI DOI 10.1111/1540-4560.00282; Wagman JA, 2016, INT J PUBLIC HEALTH, V61, P961, DOI 10.1007/s00038-016-0891-z; Yang R., 2006, INT J SOCIOL FAMILY, V32, P113	59	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0244014	10.1371/journal.pone.0244014	http://dx.doi.org/10.1371/journal.pone.0244014			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH3TP	33320894	Green Published, gold			2022-12-27	WOS:000600339800054
J	Schweiss, VR; Rakocinski, CF				Schweiss, Virginia R.; Rakocinski, Chet F.			Destabilizing effects on a classic tri-trophic oyster-reef cascade	PLOS ONE			English	Article							MEDIATED INDIRECT INTERACTIONS; PREDATOR-PREY INTERACTIONS; COMPLEXITY; INTERFERENCE; COMMUNITY; OMNIVORY; FISH; FACILITATION; SURVIVAL; CRABS	How interactions among multiple predators affect the stability of trophic cascades is a topic of special ecological interest. To examine factors affecting the stability of the classic tri-trophic oyster reef cascade within a different context, configurations of three predators, including the Gulf toadfish, Gulf stone crab, and oystershell mud crab, were manipulated together with either oyster shell or limestone gravel substrate within a multiple predator effects (MPE) experiment. Additionally, a complimentary set of trait-mediated-indirect interaction (TMII) experiments examined the inhibition of oyster consumption relative to mud-crab size and top predator identity in the absence of other cues and factors. The classic tri-trophic cascade formed by the toadfish-mud crab-oyster configuration was potentially weakened by several interactions within the MPE experiment. Consumption of oysters and mud crabs by the intraguild stone crab was undeterred by the presence of toadfish. Although mud crab feeding was inhibited in the presence of both toadfish and stone crabs, estimated non-consumptive effects (NCEs) were weaker for stone crabs in the MPE experiment. Consequently, the total effect was destabilizing when all three predator species were together. Inhibition of mud crab feeding was inversely related to direct predation on mud crabs within the MPE experiment. Complimentary TMII experiments revealed greater inhibition of mud crab feeding in response to stone crabs under sparse conditions. TMII experiments also implied that inhibition of mud crab feeding could have largely accounted for NCEs relative to oysters within the MPE experiment, as opposed to interference by other mud crabs or top predators. An inverse relationship between mud crab size and NCE strength in the TMII experiment disclosed another potentially destabilizing influence on the tri-trophic-cascade. Finally, although habitat complexity generally dampened the consumption of oysters across MPE treatments, complex habitat promoted mud crab feeding in the presence of toadfish alone. This study underscores how ecological interactions can mediate trophic cascades and provides some additional insights into the trophic dynamics of oyster reefs for further testing under natural conditions.	[Schweiss, Virginia R.; Rakocinski, Chet F.] Univ Southern Mississippi, Gulf Coast Res Lab, Sch Ocean Sci & Engn, Div Coastal Sci, Ocean Springs, MS 39564 USA	University of Southern Mississippi	Rakocinski, CF (corresponding author), Univ Southern Mississippi, Gulf Coast Res Lab, Sch Ocean Sci & Engn, Div Coastal Sci, Ocean Springs, MS 39564 USA.	chet.rakocinski@usm.edu						ABBE GR, 1992, AQUACULTURE, V107, P21, DOI 10.1016/0044-8486(92)90047-O; ABRAMS PA, 1995, AM NAT, V146, P112, DOI 10.1086/285789; Beukers JS, 1998, OECOLOGIA, V114, P50, DOI 10.1007/s004420050419; BISKER R, 1989, Journal of Shellfish Research, V8, P25; Bruno JF, 2005, ECOL LETT, V8, P1048, DOI 10.1111/j.1461-0248.2005.00808.x; CARPENTER SR, 1985, BIOSCIENCE, V35, P634, DOI 10.2307/1309989; CROWDER LB, 1982, ECOLOGY, V63, P1802, DOI 10.2307/1940122; Crowder LB, 1997, ECOLOGY, V78, P1796; DIEHL S, 1992, ECOLOGY, V73, P1646, DOI 10.2307/1940017; Fleer VR, 2017, THESIS; Fodrie FJ, 2008, ECOLOGY, V89, P3268, DOI 10.1890/07-1679.1; Freeman A, 2006, BEHAV ECOL, V17, P182, DOI 10.1093/beheco/arj014; Geraldi NR, 2015, ECOLOGY, V96, P2533, DOI 10.1890/14-1026.1; Grabowski JH, 2005, ECOLOGY, V86, P1926, DOI 10.1890/04-0690; Grabowski JH, 2004, MAR ECOL PROG SER, V277, P291, DOI 10.3354/meps277291; Grabowski JH, 2004, ECOLOGY, V85, P995, DOI 10.1890/03-0067; Grabowski JH, 2008, ECOLOGY, V89, P3413, DOI 10.1890/07-1057.1; Grason EW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051322; Griffen BD, 2006, OECOLOGIA, V146, P608, DOI 10.1007/s00442-005-0211-4; Hermann SL, 2017, CURR OPIN INSECT SCI, V20, P54, DOI 10.1016/j.cois.2017.03.010; HIDU H, 1974, Proceedings National Shellfisheries Association, V65, P13; Hill JM, 2013, MAR ECOL PROG SER, V488, P209, DOI 10.3354/meps10386; Hill JM, 2013, OECOLOGIA, V172, P79, DOI 10.1007/s00442-012-2488-4; HOLM S, 1979, SCAND J STAT, V6, P65; Hughes AR, 2006, OECOLOGIA, V149, P256, DOI 10.1007/s00442-006-0439-7; Hughes AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044839; Ives AR, 2005, ECOL LETT, V8, P102, DOI 10.1111/j.1461-0248.2004.00698.x; Johnson KD, 2014, MAR ECOL PROG SER, V507, P197, DOI 10.3354/meps10815; Krause AE, 2003, NATURE, V426, P282, DOI 10.1038/nature02115; Kuykendall KM, 2015, J SHELLFISH RES, V34, P217, DOI 10.2983/035.034.0203; La Peyre M, 2014, OCEAN COAST MANAGE, V89, P20, DOI 10.1016/j.ocecoaman.2013.12.002; LITTLER MM, 1989, OECOLOGIA, V80, P331, DOI 10.1007/BF00379034; Macreadie PI, 2012, MAR ECOL PROG SER, V466, P145, DOI 10.3354/meps09986; MCQUEEN DJ, 1989, ECOL MONOGR, V59, P289, DOI 10.2307/1942603; MURDOCH W W, 1975, P1; O'Connor NE, 2008, ECOLOGY, V89, P428, DOI 10.1890/06-2029.1; Pace ML, 1999, TRENDS ECOL EVOL, V14, P483, DOI 10.1016/S0169-5347(99)01723-1; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; PAINE RT, 1974, OECOLOGIA, V15, P93, DOI 10.1007/BF00345739; Raffaelli D, 2007, ENERGETICS ECOSYSTEM; Rindone RR, 2011, J EXP MAR BIOL ECOL, V407, P216, DOI 10.1016/j.jembe.2011.06.018; SCHMITT RJ, 1987, ECOLOGY, V68, P1887, DOI 10.2307/1939880; Schmitz OJ, 2004, ECOL LETT, V7, P153, DOI 10.1111/j.1461-0248.2003.00560.x; Schmitz OJ, 1998, AM NAT, V151, P327, DOI 10.1086/286122; Schneider FD, 2012, ECOL LETT, V15, P436, DOI 10.1111/j.1461-0248.2012.01750.x; SCHRIVER P, 1995, FRESHWATER BIOL, V33, P255, DOI 10.1111/j.1365-2427.1995.tb01166.x; Shervette VR, 2004, J CRUSTACEAN BIOL, V24, P652, DOI 10.1651/C-2453; Sih A, 2010, OIKOS, V119, P610, DOI 10.1111/j.1600-0706.2009.18039.x; SOLUK DA, 1988, OIKOS, V52, P94, DOI 10.2307/3565987; SONIAT T M, 1991, Journal of Shellfish Research, V10, P405; STRONG DR, 1992, ECOLOGY, V73, P747, DOI 10.2307/1940154; Swisher BJ, 1998, OIKOS, V81, P30, DOI 10.2307/3546464; Werner EE, 2003, ECOLOGY, V84, P1083, DOI 10.1890/0012-9658(2003)084[1083:AROTII]2.0.CO;2; Wong MC, 2010, MAR ECOL PROG SER, V409, P143, DOI 10.3354/meps08621; WOOTTON JT, 1993, AM NAT, V141, P71, DOI 10.1086/285461	55	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0242965	10.1371/journal.pone.0242965	http://dx.doi.org/10.1371/journal.pone.0242965			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320866	gold, Green Published			2022-12-27	WOS:000600339800034
J	Yong, JH; Liu, JF; Guan, CL; Dai, YF; Li, F; Fan, ZB				Yong, Jiahao; Liu, Junfeng; Guan, Chaoliang; Dai, Yifan; Li, Fei; Fan, Zhanbin			Fabrication and evaluation of complicated microstructures on cylindrical surface	PLOS ONE			English	Article							FAST TOOL SERVO	Various items of roll molds are popularly used to fabricate different kinds of optical films for optoelectronic information and other new and high-tech fields, while the fabrication and evaluation of optical microstructures on a cylindrical roller surface is more difficult than ecumenically manufactured products. In this study, the machinability of microstructures on the roll based on a fast tool servo (FTS) system is investigated. First, the flexible hinge holder for a FTS is designed and its structural parameters are optimized with finite-element analysis and fatigue reliability theory. The tool radius compensation algorithm for complicated microstructures is then deduced based on the surface fitting and bilinear interpolation algorithm of discrete data. Meanwhile, the evaluation index and method are proposed by the medium section method. Finally, a machining test of aspheric arrays on a cylindrical aluminum surface is carried out, and the high quality of the microstructure indicates that the proposed method is able to be used to fabricate optical microstructures.	[Yong, Jiahao; Liu, Junfeng; Guan, Chaoliang; Dai, Yifan; Li, Fei; Fan, Zhanbin] Natl Univ Def Technol, Coll Artificial Intelligence, Lab Sci & Technol Integrated Logist Support, Changsha, Peoples R China	National University of Defense Technology - China	Liu, JF (corresponding author), Natl Univ Def Technol, Coll Artificial Intelligence, Lab Sci & Technol Integrated Logist Support, Changsha, Peoples R China.	ljf20090702122@163.com			Science Challenge Project of China [TZ2018006-0202-03/-0102-04]; Science and Technology Foundation of State Key laboratory [6142003190101]; Natural National Science Foundation of China [51991372/51991371]	Science Challenge Project of China; Science and Technology Foundation of State Key laboratory; Natural National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by Science Challenge Project of China under grant number TZ2018006-0202-03/-0102-04 awarded to CG, Science and Technology Foundation of State Key laboratory under grant number No.6142003190101 awarded to JL and Natural National Science Foundation of China (https://isisn.nsfc.gov.cn/egrantweb/) under grant number No.51991372/51991371 awarded to YD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, OCCASIONAL PAPER INT, V7, P1; [Anonymous], 2012, TELECOMMUNICATION EN, V52, P13; [Anonymous], 2012, RECORDS AUCKLAND MUS, V48, P5; Fan Z, 2014, THESIS; Gao W, 2014, CHIN J MECH ENG-EN, V27, P14, DOI 10.3901/CJME.2014.01.014; Lee J, 2007, OPT EXPRESS, V15, P8609, DOI 10.1364/OE.15.008609; Lu H, 2014, PRECIS ENG, V38, P212, DOI 10.1016/j.precisioneng.2013.06.004; Lu H, 2012, T NONFERR METAL SOC, V22, pS820, DOI 10.1016/S1003-6326(12)61810-X; Ma HQ, 2013, MECH SYST SIGNAL PR, V41, P705, DOI 10.1016/j.ymssp.2013.08.011; Mochizuki H, 2009, THIN SOLID FILMS, V518, P714, DOI 10.1016/j.tsf.2009.07.076; Oh Jeong Seok, 2013, [Journal of the Korean Society for Precision Engineering, 한국정밀공학회지], V30, P1303; Sun LM, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/25/255302; Wang GL, 2011, MACH SCI TECHNOL, V15, P324, DOI 10.1080/10910344.2011.600199; Wang GL, 2019, OPTIK, V178, P698, DOI 10.1016/j.ijleo.2018.10.054; Wang QL, 2015, REV SCI INSTRUM, V86, DOI 10.1063/1.4933387; Wu L.Q., 2017, MACH TOOL HYDRAUL, V45, P57; [赵清亮 ZHAO Qingliang], 2009, [机械工程学报, Chinese Journal of Mechanical Engineering], V45, P173; Zhong ZW, 2012, J MICROMECH MICROENG, V22, DOI 10.1088/0960-1317/22/8/085010; Zhu WH, 2001, INT J MACH TOOL MANU, V41, P953, DOI 10.1016/S0890-6955(00)00118-8; Zhu ZW, 2017, INT J MACH TOOL MANU, V122, P98, DOI 10.1016/j.ijmachtools.2017.06.004	20	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0242918	10.1371/journal.pone.0242918	http://dx.doi.org/10.1371/journal.pone.0242918			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320845	Green Published, gold			2022-12-27	WOS:000600339800022
J	Fisher, M; Nyabaro, V; Mendum, R; Osiru, M				Fisher, Monica; Nyabaro, Violet; Mendum, Ruth; Osiru, Moses			Making it to the PhD: Gender and student performance in sub-Saharan Africa	PLOS ONE			English	Article							DOCTORAL STUDENTS; TO-DEGREE; SCIENCE; WOMEN; TIME; COMPLETION; POLICY; GHANA	Women's underrepresentation in science, technology, engineering, and mathematics (STEM) impedes progress in solving Africa's complex development problems. As in other regions, women's participation in STEM drops progressively moving up the education and career ladder, with women currently constituting 30% of Africa's STEM researchers. This study elucidates gender-based differences in PhD performance using new survey data from 227 alumni of STEM PhD programs in 17 African countries. We find that, compared to their male counterparts, sampled women had about one less paper accepted for publication during their doctoral studies and took about half a year longer to finish their PhD training. Negative binomial regression models provide insights on the observed differences in women's and men's PhD performance. Results indicate that the correlates of publication productivity and time to PhD completion are very similar for women and men, but some gender-based differences are observed. For publication output, we find that good supervision had a stronger impact for men than women; and getting married during the PhD reduced women's publication productivity but increased that of men. Becoming a parent during the PhD training was a key reason that women took longer to complete the PhD, according to our results. Findings suggest that having a female supervisor, attending an institution with gender policies in place, and pursuing the PhD in a department where sexual harassment by faculty was perceived as uncommon were enabling factors for women's timely completion of their doctoral studies. Two priority interventions emerge from this study: (1) family-friendly policies and facilities that are supportive of women's roles as wives and mothers and (2) fostering broader linkages and networks for women in STEM, including ensuring mentoring and supervisory support that is tailored to their specific needs and circumstances.	[Fisher, Monica; Nyabaro, Violet] Int Ctr Insect Physiol & Ecol, Social Sci & Impact Assessment Unit, Nairobi, Kenya; [Mendum, Ruth] Penn State Univ, Coll Agr Sci, Off Int Programs, Philadelphia, PA USA; [Osiru, Moses] Int Ctr Insect Physiol & Ecol, Reg Coordinat Unit Reg Scholarship & Innovat Fund, Nairobi, Kenya	International Centre of Insect Physiology & Ecology (ICIPE); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; International Centre of Insect Physiology & Ecology (ICIPE)	Fisher, M (corresponding author), Int Ctr Insect Physiol & Ecol, Social Sci & Impact Assessment Unit, Nairobi, Kenya.	monica.fisher@oregonstate.edu		Fisher, Monica/0000-0002-6669-6261	World Bank IDA Grant [IDA D347-3A]	World Bank IDA Grant	Funding for this study was from the World Bank IDA Grant to the International Centre of Insect Physiology and Ecology (icipe) -Grant IDA D347-3A (Africa Regional Scholarship and Innovation Fund for Applied Sciences, Engineering and Technology Project in Sub-Saharan Africa). https://www.rsif-paset.org/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, NAT MATER, V16, P1, DOI 10.1038/nmat4841; Baker M, 2010, J COMP FAM STUD, V41, P1; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Bayer A, 2016, J ECON PERSPECT, V30, P221, DOI 10.1257/jep.30.4.221; Bench SW, 2015, SEX ROLES, V72, P536, DOI 10.1007/s11199-015-0486-9; Bianchi SM, 2012, SOC FORCES, V91, P55, DOI 10.1093/sf/sos120; Blackburn Heidi, 2017, Science & Technology Libraries, V36, P235, DOI 10.1080/0194262X.2017.1371658; Blake-Beard S, 2011, J SOC ISSUES, V67, P622, DOI 10.1111/j.1540-4560.2011.01717; Blickenstaff JC, 2005, GENDER EDUC, V17, P369, DOI 10.1080/09540250500145072; Boakye O, 2018, GHANAIAN FEMALE STEM; Budig MJ, 2012, SOC POLIT, V19, P163, DOI 10.1093/sp/jxs006; Budig MJ, 2014, IGARSS 2014; Bunting I, 2014, EMPIRICAL OVERVIEW 8; Cameron A.C., 2014, REGRESSION ANAL COUN; Cameron A. C., 2010, MICROECONOMETRICS US; Campion P, 2004, SCI TECHNOL HUM VAL, V29, P459, DOI 10.1177/0162243904265895; Canaan S., 2019, SSRN ELECT J, DOI DOI 10.2139/SSRN.3396119; Ceci SJ, 2014, PSYCHOL SCI PUBL INT, V15, P75, DOI 10.1177/1529100614541236; Ceci SJ, 2009, PSYCHOL BULL, V135, P218, DOI 10.1037/a0014412; de Valero YF, 2001, J HIGH EDUC, V72, P341, DOI 10.2307/2649335; EHRENBERG RG, 1995, J HUM RESOUR, V30, P581, DOI 10.2307/146036; Gupta S, 1999, J MARRIAGE FAM, V61, P700, DOI 10.2307/353571; Horta H, 2019, RES EVALUAT, V28, P182, DOI 10.1093/reseval/rvz002; Jiang SH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202463; Khisa AM, 2019, GLOBAL HEALTH ACTION, V12, DOI 10.1080/16549716.2019.1670002; Kim D, 2010, J HIGH EDUC-UK, V81, P1; KING G, 2001, POLITICAL ANAL, V0009; Lubienski ST, 2018, EDUC RESEARCHER, V47, P76, DOI 10.3102/0013189X17738746; Maher MA, 2004, REV HIGH EDUC, V27, P385, DOI 10.1353/rhe.2004.0003; Manderson L., 2017, J HIGHER ED AFRICA, V15, P23; Martin DP, 2015, J SCHOOL PSYCHOL, V53, P359, DOI 10.1016/j.jsp.2015.07.001; Mendoza-Denton R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174296; Mlambo Y.A., 2017, THESIS MICHIGAN STAT; Molla T, 2016, POLICY FUTURES EDUC, V14, P635, DOI 10.1177/1478210316641567; Ngabaza S, 2013, REPROD HEALTH MATTER, V21, P106, DOI 10.1016/S0968-8080(13)41683-X; Nkosi Khothasane B., 2019, Curationis, V42, P1, DOI 10.4102/curationis.v42i1.1880; Oni TH, 2019, AFR HEALTH SCI, V19, P1478, DOI 10.4314/ahs.v19i1.21; Pezzoni M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145146; Rarau P, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211068; Seagram BC, 1998, RES HIGH EDUC, V39, P319, DOI 10.1023/A:1018781118312; Su R, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00189; Tiedeu BA, 2019, LANCET, V393, P504, DOI 10.1016/S0140-6736(19)30284-3; UNESCO, 2015, IS GEND GAP NARR SCI; van de Schoot R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068839; Van Lill MH, 2019, STUDY DOCTORAL PIPEL; Wang MT, 2017, EDUC PSYCHOL REV, V29, P119, DOI 10.1007/s10648-015-9355-x; Williams M.M., 2014, J WOMEN MINORITIES S, V20, P99, DOI [10.1615/JWomenMinorScienEng.2014004477, DOI 10.1615/JWOMENMINORSCIENENG.2014004477]; Williams WM, 2018, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.02352; Wright T, 2000, STUD HIGH EDUC, V25, P181, DOI 10.1080/713696139; Zeiser K.L., 2012, LONG DOES IT TAKE ST	50	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0241915	10.1371/journal.pone.0241915	http://dx.doi.org/10.1371/journal.pone.0241915			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH1MP	33315871	Green Published, gold			2022-12-27	WOS:000600186100009
J	Shih, KT; Huang, YY; Yang, CY; Cheng, MF; Tien, YW; Shiue, CY; Yen, RF; Hsin, LW				Shih, Kai-Ting; Huang, Ya-Yao; Yang, Chia-Ying; Cheng, Mei-Fang; Tien, Yu-Wen; Shiue, Chyng-Yann; Yen, Rouh-Fang; Hsin, Ling-Wei			Synthesis and analysis of 4-(3-fluoropropyl)-glutamic acid stereoisomers to determine the stereochemical purity of (4S)-4-(3-[F-18]fluoropropyl)-L-glutamic acid ([F-18]FSPG) for clinical use	PLOS ONE			English	Article							X(C)(-) TRANSPORTER ACTIVITY; SYSTEM XC(-); PET; (4S)-4-(3-F-18-FLUOROPROPYL)-L-GLUTAMATE	(4S)-4-(3-[F-18]Fluoropropyl)-L-glutamic acid ([F-18]FSPG) is a positron emission tomography (PET) imaging agent for measuring the system x(C)(-) transporter activity. It has been used for the detection of various cancers and metastasis in clinical trials. [F-18]FSPG is also a promising diagnostic tool for evaluation of multiple sclerosis, drug resistance in chemotherapy, inflammatory brain diseases, and infectious lesions. Due to the very short half-life (110 min) of F-18 nuclide, [F-18]FSPG needs to be produced on a daily basis; therefore, fast and efficient synthesis and analytical methods for quality control must be established to assure the quality and safety of [F-18]FSPG for clinical use. To manufacture cGMP-compliant [F-18]FSPG, all four nonradioactive stereoisomers of FSPG were prepared as reference standards for analysis. (2S,4S)-1 and (2R,4R)-1 were synthesized starting from protected L- and D-glutamate derivatives in three steps, whereas (2S,4R)-1 and (2R,4S)-1 were prepared in three steps from protected (S)- and (R)-pyroglutamates. A chiral HPLC method for simultaneous determination of four FSPG stereoisomers was developed by using a 3-cm Chirex 3126 column and a MeCN/CuSO4(aq) mobile phase. In this method, (2R,4S)-1, (2S,4S)-1, (2R,4R)-1, and (2S,4R)-1 were eluted in sequence with sufficient resolution in less than 25 min without derivatization. Scale-up synthesis of intermediates for the production of [F-18]FSPG in high optical purity was achieved via stereo-selective synthesis or resolution by recrystallization. The enantiomeric excess of intermediates was determined by HPLC using a Chiralcel OD column and monitored at 220 nm. The nonradioactive precursor with >98% ee can be readily distributed to other facilities for the production of [F-18]FSPG. Based on the above accomplishments, cGMP-compliant [F-18]FSPG met the acceptance criteria in specifications and was successfully manufactured for human use. It has been routinely prepared and used in several pancreatic ductal adenocarcinoma metastasis-related clinical trials.	[Shih, Kai-Ting; Yang, Chia-Ying; Hsin, Ling-Wei] Natl Taiwan Univ, Coll Med, Sch Pharm, Taipei, Taiwan; [Huang, Ya-Yao; Cheng, Mei-Fang; Shiue, Chyng-Yann; Yen, Rouh-Fang; Hsin, Ling-Wei] Natl Taiwan Univ Hosp, Dept Nucl Med, Taipei, Taiwan; [Huang, Ya-Yao; Shiue, Chyng-Yann; Yen, Rouh-Fang; Hsin, Ling-Wei] Natl Taiwan Univ, Mol Imaging Ctr, Mol Probes Dev Core, Taipei, Taiwan; [Huang, Ya-Yao] Natl Taiwan Univ, Coll Med, Inst Med Device & Imaging, Taipei, Taiwan; [Tien, Yu-Wen] Natl Taiwan Univ Hosp, Dept Surg, Taipei, Taiwan; [Hsin, Ling-Wei] Natl Taiwan Univ, Ctr Innovat Therapeut Discovery, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Hsin, LW (corresponding author), Natl Taiwan Univ, Coll Med, Sch Pharm, Taipei, Taiwan.; Hsin, LW (corresponding author), Natl Taiwan Univ Hosp, Dept Nucl Med, Taipei, Taiwan.; Hsin, LW (corresponding author), Natl Taiwan Univ, Mol Imaging Ctr, Mol Probes Dev Core, Taipei, Taiwan.; Hsin, LW (corresponding author), Natl Taiwan Univ, Ctr Innovat Therapeut Discovery, Taipei, Taiwan.	lwhsin@ntu.edu.tw	CHENG, MEIFANG/AAV-8665-2021	CHENG, MEIFANG/0000-0002-9359-0606; HSIN, LING-WEI/0000-0001-5018-4491; YEN, RUOH-FANG/0000-0003-1648-6482; TIEN, YU-WEN/0000-0002-9126-2705	Ministry of Science and Technology of the Republic of China [MOST 103-2320-B002-012-MY3, 105-2321-B-002-040]	Ministry of Science and Technology of the Republic of China(Ministry of Science and Technology, Taiwan)	This study was financially supported by the Ministry of Science and Technology of the Republic of China (Grant No. MOST 103-2320-B002-012-MY3 and 105-2321-B-002-040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek S, 2013, J NUCL MED, V54, P117, DOI 10.2967/jnumed.112.108704; Baek S, 2012, CLIN CANCER RES, V18, P5427, DOI 10.1158/1078-0432.CCR-12-0214; Berndt M, 2013, Method for production of f-18 labeled glutamic acid derivatives patent, Patent No. [US20130149243A1, 20130149243]; Chae SY, 2016, J NUCL MED, V57, P67, DOI 10.2967/jnumed.115.164020; Cheng MF, 2019, EUR J NUCL MED MOL I, V46, P810, DOI 10.1007/s00259-018-4251-5; Domercq M, 2016, THERANOSTICS, V6, P1753, DOI 10.7150/thno.15616; Estrela JM, 2006, CRIT REV CL LAB SCI, V43, P143, DOI 10.1080/10408360500523878; EZQUERRA J, 1992, TETRAHEDRON LETT, V33, P5589, DOI 10.1016/S0040-4039(00)61153-X; EZQUERRA J, 1993, TETRAHEDRON, V49, P8665, DOI 10.1016/S0040-4020(01)96272-6; Greenwood HE, 2019, CLIN CANCER RES, V25, P2471, DOI 10.1158/1078-0432.CCR-18-3423; Hoehne A, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1080-1; Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038; Kavanaugh G, 2016, MOL IMAGING BIOL, V18, P924, DOI 10.1007/s11307-016-1007-0; Koglin N, 2011, CLIN CANCER RES, V17, P6000, DOI 10.1158/1078-0432.CCR-11-0687; Lee HS, 2019, CANCER RES, V79, P701, DOI 10.1158/0008-5472.CAN-18-4034; Lyons SA, 2007, CANCER RES, V67, P9463, DOI 10.1158/0008-5472.CAN-07-2034; Magarik MA, 2018, CLIN NUCL MED, V43, P28, DOI 10.1097/RLU.0000000000001883; Martin A, 2016, EUR J NUCL MED MOL I, V43, P1124, DOI 10.1007/s00259-015-3275-3; McCormick PN, 2019, CANCER RES, V79, P853, DOI 10.1158/0008-5472.CAN-18-2634; Mittra ES, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148628; Mosci C, 2016, RADIOLOGY, V279, P898, DOI 10.1148/radiol.2015142000; Qu WC, 2011, J AM CHEM SOC, V133, P1122, DOI 10.1021/ja109203d; Sato H, 1999, J BIOL CHEM, V274, P11455, DOI 10.1074/jbc.274.17.11455; Shooli H, 2019, QUANT IMAG MED SURG, V9, P1597, DOI 10.21037/qims.2019.08.16	24	1	1	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243831	10.1371/journal.pone.0243831	http://dx.doi.org/10.1371/journal.pone.0243831			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315962	gold, Green Published			2022-12-27	WOS:000600186100041
J	Xia, X; Yu, CY; Bian, MJ; Sun, CB; Tanasa, B; Chang, KC; Bruffett, DM; Thakur, H; Shah, SH; Knasel, C; Cameron, EG; Kapiloff, MS; Goldberg, JL				Xia, Xin; Yu, Caroline Y.; Bian, Minjuan; Sun, Catalina B.; Tanasa, Bogdan; Chang, Kun-Che; Bruffett, Dawn M.; Thakur, Hrishikesh; Shah, Sahil H.; Knasel, Cara; Cameron, Evan G.; Kapiloff, Michael S.; Goldberg, Jeffrey L.			MEF2 transcription factors differentially contribute to retinal ganglion cell loss after optic nerve injury	PLOS ONE			English	Article							NEURONAL SURVIVAL; PHOTORECEPTOR; PHOSPHORYLATION; NEUROTOXICITY; EXPRESSION; PLAYS	Loss of retinal ganglion cells (RGCs) in optic neuropathies results in permanent partial or complete blindness. Myocyte enhancer factor 2 (MEF2) transcription factors have been shown to play a pivotal role in neuronal systems, and in particular MEF2A knockout was shown to enhance RGC survival after optic nerve crush injury. Here we expanded these prior data to study bi-allelic, tri-allelic and heterozygous allele deletion. We observed that deletion of all MEF2A, MEF2C, and MEF2D alleles had no effect on RGC survival during development. Our extended experiments suggest that the majority of the neuroprotective effect was conferred by complete deletion of MEF2A but that MEF2D knockout, although not sufficient to increase RGC survival on its own, increased the positive effect of MEF2A knockout. Conversely, MEF2A over-expression in wildtype mice worsened RGC survival after optic nerve crush. Interestingly, MEF2 transcription factors are regulated by post-translational modification, including by calcineurin-catalyzed dephosphorylation of MEF2A Ser-408 known to increase MEF2A-dependent transactivation in neurons. However, neither phospho-mimetic nor phospho-ablative mutation of MEF2A Ser-408 affected the ability of MEF2A to promote RGC death in vivo after optic nerve injury. Together these findings demonstrate that MEF2 gene expression opposes RGC survival following axon injury in a complex hierarchy, and further support the hypothesis that loss of or interference with MEF2A expression might be beneficial for RGC neuroprotection in diseases such as glaucoma and other optic neuropathies.	[Xia, Xin; Yu, Caroline Y.; Bian, Minjuan; Sun, Catalina B.; Tanasa, Bogdan; Chang, Kun-Che; Bruffett, Dawn M.; Thakur, Hrishikesh; Shah, Sahil H.; Knasel, Cara; Cameron, Evan G.; Kapiloff, Michael S.; Goldberg, Jeffrey L.] Stanford Univ, Sch Med, Mary M & Sash A Spencer Ctr Vis Res, Dept Ophthalmol,Byers Eye Inst, Palo Alto, CA 94304 USA; [Kapiloff, Michael S.] Stanford Univ, Sch Med, Dept Med, Palo Alto, CA 94304 USA; [Kapiloff, Michael S.] Stanford Univ, Sch Med, Stanford Cardiovasc Inst, Palo Alto, CA 94304 USA	Stanford University; Stanford University; Stanford University	Kapiloff, MS; Goldberg, JL (corresponding author), Stanford Univ, Sch Med, Mary M & Sash A Spencer Ctr Vis Res, Dept Ophthalmol,Byers Eye Inst, Palo Alto, CA 94304 USA.; Kapiloff, MS (corresponding author), Stanford Univ, Sch Med, Dept Med, Palo Alto, CA 94304 USA.; Kapiloff, MS (corresponding author), Stanford Univ, Sch Med, Stanford Cardiovasc Inst, Palo Alto, CA 94304 USA.	kapiloff@stanford.edu; jlgoldbe@stanford.edu		Shah, Sahil/0000-0002-6601-219X; Kapiloff, Michael/0000-0002-7005-6953; Goldberg, Jeffrey/0000-0002-1390-7360; Chang, Kun-Che/0000-0002-0871-5612	National Institutes of Health [EY026766, EY031167, P30EY026877]; Medical Technologies Enterprise Consortium; Research to Prevent Blindness, Inc..	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Technologies Enterprise Consortium; Research to Prevent Blindness, Inc..(Research to Prevent Blindness (RPB))	This work was supported in part by National Institutes of Health Grants EY026766 (M. S.K. and J.L.G.), EY031167 (M.S.K.), P30EY026877 to Stanford University, the Medical Technologies Enterprise Consortium, and an unrestricted grant from Research to Prevent Blindness, Inc.. M.S.K., and J.L.G. designed research; M.S.K., and J.L.G. wrote and revised the paper; M.S.K., and J.L.G made decision to publish.	Akhtar MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034863; Andzelm MM, 2015, NEURON, V86, P247, DOI 10.1016/j.neuron.2015.02.038; Barbosa AC, 2008, P NATL ACAD SCI USA, V105, P9391, DOI 10.1073/pnas.0802679105; Boczek T, 2019, J NEUROSCI, V39, P5466, DOI 10.1523/JNEUROSCI.2752-18.2019; Cameron EG, 2020, BIO-PROTOCOL, V10, DOI 10.21769/BioProtoc.3559; Chan SF, 2014, J NEUROSCI, V34, P4640, DOI 10.1523/JNEUROSCI.2510-12.2014; Chang EE, 2012, OPHTHALMOLOGY, V119, P979, DOI 10.1016/j.ophtha.2011.11.003; Flavell SW, 2008, NEURON, V60, P1022, DOI 10.1016/j.neuron.2008.11.029; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Galvao J, 2018, INVEST OPHTH VIS SCI, V59, P2736, DOI 10.1167/iovs.17-23319; Gong XM, 2003, NEURON, V38, P33, DOI 10.1016/S0896-6273(03)00191-0; Gregoire S, 2006, J BIOL CHEM, V281, P4423, DOI 10.1074/jbc.M509471200; He AB, 2011, P NATL ACAD SCI USA, V108, P5632, DOI 10.1073/pnas.1016959108; Kim Y, 2008, J CLIN INVEST, V118, P124, DOI 10.1172/JCI33255; Li JL, 2019, J BIOL CHEM, V294, P2543, DOI 10.1074/jbc.RA118.005465; Liu LD, 2003, P NATL ACAD SCI USA, V100, P8532, DOI 10.1073/pnas.1332804100; Majidi SP, 2019, CELL REP, V29, P2001, DOI 10.1016/j.celrep.2019.10.033; Mao ZX, 1999, J BIOL CHEM, V274, P31102, DOI 10.1074/jbc.274.43.31102; Masuda T, 2015, NEURON, V86, P7, DOI 10.1016/j.neuron.2015.03.057; Nagar S, 2017, INVEST OPHTH VIS SCI, V58, P3741, DOI 10.1167/iovs.17-21767; Okamoto S, 2002, P NATL ACAD SCI USA, V99, P3974, DOI 10.1073/pnas.022036399; Omori Y, 2015, GENES CELLS, V20, P408, DOI 10.1111/gtc.12233; Pazyra-Murphy MF, 2009, J NEUROSCI, V29, P6700, DOI 10.1523/JNEUROSCI.0233-09.2009; Perry RLS, 2009, MOL CELL BIOL, V29, P3355, DOI 10.1128/MCB.00227-08; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Prasov L, 2012, DEV BIOL, V368, P214, DOI 10.1016/j.ydbio.2012.05.005; Pulipparacharuvil S, 2008, NEURON, V59, P621, DOI 10.1016/j.neuron.2008.06.020; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Rashid AJ, 2014, GENES BRAIN BEHAV, V13, P118, DOI 10.1111/gbb.12058; Rowan S, 2004, DEV BIOL, V271, P388, DOI 10.1016/j.ydbio.2004.03.039; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Smith PD, 2006, J NEUROSCI, V26, P440, DOI 10.1523/JNEUROSCI.2875-05.2006; Tang XL, 2005, J NEUROSCI, V25, P4823, DOI 10.1523/JNEUROSCI.1331-05.2005; Vargas MAX, 2012, CELL SIGNAL, V24, P1496, DOI 10.1016/j.cellsig.2012.03.017; Wang XM, 2009, J BIOL CHEM, V284, P32619, DOI 10.1074/jbc.M109.067785; Wang Y, 2015, EBIOMEDICINE, V2, P1880, DOI 10.1016/j.ebiom.2015.10.025; Welsbie DS, 2017, NEURON, V94, P1142, DOI 10.1016/j.neuron.2017.06.008; Wolf A, 2017, BIOCHEM BIOPH RES CO, V483, P346, DOI 10.1016/j.bbrc.2016.12.141; Wu QM, 2017, MOL NEUROBIOL, V54, P6970, DOI 10.1007/s12035-016-0199-2	39	3	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0242884	10.1371/journal.pone.0242884	http://dx.doi.org/10.1371/journal.pone.0242884			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315889	Green Published, gold			2022-12-27	WOS:000600186100081
J	Xu, XQ; Zhu, TT; Shi, TT; Chen, J; Jin, L				Xu, Xiaoqiong; Zhu, Tiantian; Shi, Tingting; Chen, Juan; Jin, Ling			Quality suitability regionalization analysis of Angelica sinensis in Gansu, China	PLOS ONE			English	Article							ROOT	The genus Angelica encompasses 80 species worldwide. Among them, only Angelica sinensis is widely used in China and Japan. To explore the quality and geographical distribution of A. sinensis, we collected 1,530 plants from Gansu Province and analyzed them for their contents of chlorogenic acid (CA), ferulic acid (FA), senkyunolide I(SI), senkyunolide A(SA), senkyunolide H (SH), coniferyl ferulate (CF), ligustilide (LI), and butenyl phthalide (BP) using UPLC. We also assessed the relationship between the ecological environment and quality of A. sinensis through maximum entropy modeling and a geographical information system. The habitat suitability distribution demonstrated that the most influential ecological factors for the growth of A. sinensis were altitude, precipitation during March, May, and December, precipitation during the wettest month, and the soil pH. The most suitable areas for cultivation are concentrated to the south of Gansu Province, including Linxia Hui Autonomous Prefecture, Dingxi City, Tianshui City, south of Wuwei City, east of Gannan Tibetan Autonomous Prefecture, north of Longnan City, and northwest of Pingliang City. The quality suitability regionalization analysis divulged that the most influential ecological factors for the index components of A. sinensis were the altitude, sunshine, rainfall, temperature, and soil pH. The highest quality A. sinensis grow in Dingxi City, Tangchang, Lixian, and Wen counties in Longnan City, Wushan County in Tianshui City, Lintan, Zhouqu, and Zhuoni counties in Gannan Tibetan Autonomous Prefecture, Kangle and Linxia counties in Linxia Hui Autonomous Prefecture. The experiment yielded highly accurate results (accuracy of 0.955), suggesting that the results were consistent with the actual distribution of A. sinensis in Gansu. The inferences of this research will naturally draw the attention of the authorities in the fields of natural resources and agriculture departments and provide a scientific basis for the rational selection of A. sinensis cultivation areas.	[Xu, Xiaoqiong; Zhu, Tiantian; Jin, Ling] Gansu Univ Chinese Med, Sch Pharm, Lanzhou, Gansu, Peoples R China; [Xu, Xiaoqiong] Gansu Med Coll, Pingliang, Gansu, Peoples R China; [Shi, Tingting] China Acad Chinese Med Sci, Natl Resource Ctr Chinese Mat, State Key Lab Breeding Base Dao Di Herbs, Beijing, Peoples R China; [Chen, Juan] Lanzhou Univ, Sch Pharm, Lanzhou, Gansu, Peoples R China; [Jin, Ling] Res Inst Chinese Tibetan Med Resources, Lanzhou, Gansu, Peoples R China	Gansu University of Chinese Medicine; Gansu Medical College; China Academy of Chinese Medical Sciences; Lanzhou University	Jin, L (corresponding author), Gansu Univ Chinese Med, Sch Pharm, Lanzhou, Gansu, Peoples R China.; Jin, L (corresponding author), Res Inst Chinese Tibetan Med Resources, Lanzhou, Gansu, Peoples R China.	xxq198498@163.com		xu, xiaoqiong/0000-0002-7624-2976	National Natural Science Foundation of China [81360615];  [Y520000]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 	Initials of the author who received each award: L J Grant number awarded to the author: 81360615 The full name of each funder: National Natural Science Foundation of China URL of each funder website: http://www.nsfc.gov.cn/Specific grant numbers: Y520000.	Chinese Academy of Sciences China vegetation map editor commttee, 2007, VEG MAP PEOPL REP CH; Computer network information center Chinese academy of sciences., 2015, GEOSPATIAL DATA CLOU; de Oliveira JB, 2019, FOOD RES INT, V121, P870, DOI 10.1016/j.foodres.2019.01.011; Hook ILI, 2014, J ETHNOPHARMACOL, V152, P1, DOI 10.1016/j.jep.2013.12.018; Jeong SY, 2015, CHEM PHARM BULL, V63, P504, DOI 10.1248/cpb.c15-00081; Kan WLT, 2008, J ETHNOPHARMACOL, V120, P36, DOI 10.1016/j.jep.2008.07.027; Katoh A, 2011, AM J CHINESE MED, V39, P757, DOI 10.1142/S0192415X11009172; Li ZY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48397-6; Lima VA, 2017, AN ACAD BRAS CIENC, V89, P1167, DOI 10.1590/0001-3765201720150770; National Meteorological Information Center China Meteorological Administration., 2015, CHIN MET DAT NETW; Shang Zhong-hui, 2015, Zhong Yao Cai, V38, P1370; Shao M, 2011, PLANTA MED, V77, P809, DOI 10.1055/s-0030-1250573; Tang SN, 2015, CANCER PREV RES, V8, P835, DOI 10.1158/1940-6207.CAPR-15-0051; The Lancet Global Health, 2016, LANCET GLOB HEALTH, V4, pe427; The Office for the second National Soil Survey of China, 1996, SOIL SER CHIN; Walden-Schreiner C, 2017, J ENVIRON MANAGE, V193, P52, DOI 10.1016/j.jenvman.2017.01.076; Wei WL, 2016, J ETHNOPHARMACOL, V190, P116, DOI 10.1016/j.jep.2016.05.023; Yan Hui, 2016, Zhongguo Zhong Yao Za Zhi, V41, P3139, DOI 10.4268/cjcmm20161705; Yan JJ, 2013, BIOL PHARM BULL, V36, P140, DOI 10.1248/bpb.b12-00798; Ojeda-Perez ZZ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186540; Zhao L, 2012, FITOTERAPIA, V83, P1712, DOI 10.1016/j.fitote.2012.09.029; Zhu SD, 2017, SCI REP-UK, V7, DOI 10.1038/srep42417	22	4	5	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243750	10.1371/journal.pone.0243750	http://dx.doi.org/10.1371/journal.pone.0243750			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315941	Green Published, gold			2022-12-27	WOS:000600186100068
J	Bae, IS; Bak, KH; Chun, HJ; Il Ryu, J; Park, SJ; Lee, SJ				Bae, In-Suk; Bak, Koang-Hum; Chun, Hyoung-Joon; Il Ryu, Je; Park, Sung-Jae; Lee, Sung-Jae			Biomechanical analysis of a newly developed interspinous process device conjunction with interbody cage based on a finite element model	PLOS ONE			English	Article							PEDICLE SCREW FIXATION; ADJACENT SEGMENT DISEASE; LUMBAR SPINE; INVITED SUBMISSION; PERIPHERAL-NERVES; IN-VITRO; FUSION; SYSTEM; DISC; STABILIZATION	Purpose This study aimed to investigate the biomechanical effects of a newly developed interspinous process device (IPD), called TAU. This device was compared with another IPD (SPIRE) and the pedicle screw fixation (PSF) technique at the surgical and adjacent levels of the lumbar spine. Materials and methods A three-dimensional finite element model analysis of the L1-S1 segments was performed to assess the biomechanical effects of the proposed IPD combined with an interbody cage. Three surgical models-two IPD models (TAU and SPIRE) and one PSF model-were developed. The biomechanical effects, such as range of motion (ROM), intradiscal pressure (IDP), disc stress, and facet loads during extension were analyzed at surgical (L3-L4) and adjacent levels (L2-L3 and L4-L5). The study analyzed biomechanical parameters assuming that the implants were perfectly fused with the lumbar spine. Results The TAU model resulted in a 45%, 49%, 65%, and 51% decrease in the ROM at the surgical level in flexion, extension, lateral bending, and axial rotation, respectively, when compared to the intact model. Compared to the SPIRE model, TAU demonstrated advantages in stabilizing the surgical level, in all directions. In addition, the TAU model increased IDP at the L2-L3 and L4-L5 levels by 118.0% and 78.5% in flexion, 92.6% and 65.5% in extension, 84.4% and 82.3% in lateral bending, and 125.8% and 218.8% in axial rotation, respectively. Further, the TAU model exhibited less compensation at adjacent levels than the PSF model in terms of ROM, IDP, disc stress, and facet loads, which may lower the incidence of the adjacent segment disease (ASD). Conclusion The TAU model demonstrated more stabilization at the surgical level than SPIRE but less stabilization than the PSF model. Further, the TAU model demonstrated less compensation at adjacent levels than the PSF model, which may lower the incidence of ASD in the long term. The TAU device can be used as an alternative system for treating degenerative lumbar disease while maintaining the physiological properties of the lumbar spine and minimizing the degeneration of adjacent segments.	[Bae, In-Suk] Eulji Univ, Dept Neurosurg, Eulji Hosp, Seoul, South Korea; [Bak, Koang-Hum; Chun, Hyoung-Joon] Hanyang Univ, Dept Neurosurg, Med Ctr, Seoul, South Korea; [Il Ryu, Je] Hanyang Univ, Dept Neurosurg, Guri Hosp, Guri, Gyonggi Do, South Korea; [Park, Sung-Jae] GS Med Co Ltd, R&D Ctr, Cheongju, Chungcheongbuk, South Korea; [Lee, Sung-Jae] Inje Univ, Coll Biomed Sci & Engn, Dept Biomed Engn, Gimhae Si, Gyeongsangnam D, South Korea	Eulji University; Hanyang University; Hanyang University; Inje University	Bak, KH (corresponding author), Hanyang Univ, Dept Neurosurg, Med Ctr, Seoul, South Korea.	pkh2325@hanyang.ac.kr			Hanyang University [HY201900000003361]; GS Medical Co., Ltd.	Hanyang University; GS Medical Co., Ltd.	This work was supported by the research fund of Hanyang University (HY201900000003361). This work was also supported by a grant from the GS Medical Co., Ltd. The funder provided support in the form of salaries for authors [S-J, Park], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Barbagallo GMV, 2009, NEUROSURGERY, V65, P111, DOI 10.1227/01.NEU.0000346254.07116.31; Bellini CM, 2007, J SPINAL DISORD TECH, V20, P423, DOI 10.1097/BSD.0b013e318031af6f; Bono CM, 2007, J SPINAL DISORD TECH, V20, P255, DOI 10.1097/BSD.0b013e3180331352; Bono CM, 2004, SPINE, V29, P455, DOI 10.1097/01.BRS.0000090825.94611.28; Chen WM, 2009, SPINE, V34, pE716, DOI 10.1097/BRS.0b013e3181ae23d1; Choi J, 2016, J KOREAN NEUROSURG S, V59, P91, DOI 10.3340/jkns.2016.59.2.91; Erbulut DU, 2013, ADV ORTHOP, V2013, DOI 10.1155/2013/451956; Gaines RW, 2000, J BONE JOINT SURG AM, V82A, P1458, DOI 10.2106/00004623-200010000-00013; Gazzeri R, 2015, NEUROSURG FOCUS, V39, DOI 10.3171/2015.7.FOCUS15244; Godzik J, 2016, SPINE, V41, pE902, DOI 10.1097/BRS.0000000000001480; GOEL VK, 1995, SPINE, V20, P689, DOI 10.1097/00007632-199503150-00010; Hilibrand Alan S, 2004, Spine J, V4, p190S, DOI 10.1016/j.spinee.2004.07.007; Jutte PC, 2002, EUR SPINE J, V11, P594, DOI 10.1007/s00586-002-0469-8; Karahalios DG, 2010, J NEUROSURG-SPINE, V12, P372, DOI 10.3171/2009.10.SPINE09305; Kim HJ, 2012, J KOREAN NEUROSURG S, V52, P359, DOI 10.3340/jkns.2012.52.4.359; Kim HJ, 2010, MED BIOL ENG COMPUT, V48, P703, DOI 10.1007/s11517-010-0621-2; Kim TY, 2012, SPINE, V37, P1456, DOI 10.1097/BRS.0b013e31824da81d; Kim YH, 2015, INT J PRECIS ENG MAN, V16, P997, DOI 10.1007/s12541-015-0129-7; Nakashima H, 2015, SPINE, V40, pE831, DOI 10.1097/BRS.0000000000000917; Panjabi M, 2007, SPINE, V32, P959, DOI 10.1097/01.brs.0000260792.13893.88; Panjabi MM, 2007, CLIN BIOMECH, V22, P257, DOI 10.1016/j.clinbiomech.2006.08.006; Papp T, 1997, SPINE, V22, P151, DOI 10.1097/00007632-199701150-00005; Park P, 2004, SPINE, V29, P1938, DOI 10.1097/01.brs.0000137069.88904.03; Richards JC, 2005, SPINE, V30, P744, DOI 10.1097/01.brs.0000157483.28505.e3; Swanson KE, 2003, SPINE, V28, P26, DOI 10.1097/00007632-200301010-00008; Techy F, 2013, SPINE J, V13, P572, DOI 10.1016/j.spinee.2013.01.042; Wang JC, 2006, J NEUROSURG-SPINE, V4, P132, DOI 10.3171/spi.2006.4.2.132; Wang JC, 2006, J NEUROSURG-SPINE, V4, P160, DOI 10.3171/spi.2006.4.2.160; WEINSTEIN JN, 1988, SPINE, V13, P1012, DOI 10.1097/00007632-198809000-00008; Wilke HJ, 2008, EUR SPINE J, V17, P1049, DOI 10.1007/s00586-008-0657-2; Wilke HJ, 2001, SPINE, V26, P636, DOI 10.1097/00007632-200103150-00014; YAMAMOTO I, 1989, SPINE, V14, P1256, DOI 10.1097/00007632-198911000-00020; Zander T, 2001, CLIN BIOMECH, V16, pS73, DOI 10.1016/S0268-0033(00)00108-X	33	1	1	7	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243771	10.1371/journal.pone.0243771	http://dx.doi.org/10.1371/journal.pone.0243771			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306706	Green Published, gold			2022-12-27	WOS:000600144200061
J	Erlandsson, A; Wingren, M; Andersson, PA				Erlandsson, Arvid; Wingren, Mattias; Andersson, Per A.			Type and amount of help as predictors for impression of helpers	PLOS ONE			English	Article							PROPORTION DOMINANCE; MORAL CHARACTER; COMPASSION FADE; ALTRUISM; CONSEQUENTIALIST; CONSEQUENCES; INFERENCES; JUDGMENTS; RESPONSES; HARMLESS	Impression of helpers can vary as a function of the magnitude of helping (amount of help) and of situational and motivational aspects (type of help). Over three studies conducted in Sweden and the US, we manipulated both the amount and the type of help in ten diverse vignettes and measured participants' impressions of the described helpers. Impressions were almost unaffected when increasing the amount of help by 500%, but clearly affected by several type of help-manipulations. Particularly, helpers were less positively evaluated if they had mixed motives for helping, did not experience intense emotions or empathy, or if helping involved no personal sacrifice. In line with the person-centered theory of moral judgment, people seem to form impressions of helpers primarily based on the presumed underlying processes and motives of prosociality rather than its consequences.	[Erlandsson, Arvid; Wingren, Mattias; Andersson, Per A.] Linkoping Univ, Dept Behav Sci & Learning, Linkoping, Sweden	Linkoping University	Erlandsson, A (corresponding author), Linkoping Univ, Dept Behav Sci & Learning, Linkoping, Sweden.	arvid.erlandsson@liu.se		Andersson, Per/0000-0001-7445-2008; Erlandsson, Arvid/0000-0001-7875-269X	Swedish Research Council [2017-01827]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the Swedish Research Council under Grant number 2017-01827 (AE). https://www.vr.se/english The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames DL, 2013, PSYCHOL SCI, V24, P1755, DOI 10.1177/0956797613480507; Ames DR, 2009, PSYCHOL SCI, V20, P586, DOI 10.1111/j.1467-9280.2009.02330.x; Ames DR, 2004, PERS SOC PSYCHOL B, V30, P461, DOI 10.1177/0146167203261890; Anderson RA, 2020, TRENDS COGN SCI, V24, P694, DOI 10.1016/j.tics.2020.06.008; [Anonymous], 2007, TF1, V20, P53; [Anonymous], 2011, J SOCIO-ECON, DOI DOI 10.1016/J.SOCEC.2010.10.008; Barasch A, 2014, J PERS SOC PSYCHOL, V107, P393, DOI 10.1037/a0037207; Bartels DM, 2008, COGNITION, V108, P381, DOI 10.1016/j.cognition.2008.03.001; Bartels DM, 2006, ORGAN BEHAV HUM DEC, V100, P76, DOI 10.1016/j.obhdp.2005.10.004; Bartels DM, 2011, COGNITION, V121, P154, DOI 10.1016/j.cognition.2011.05.010; Batson C.D., 2011, ALTRUISM HUMANS; Berman JZ, 2015, J MARKETING RES, V52, P90, DOI 10.1509/jmr.14.0002; Butts MM, 2019, ORGAN BEHAV HUM DEC, V151, P16, DOI 10.1016/j.obhdp.2018.12.006; Capraro V, 2018, JUDGM DECIS MAK, V13, P99; Carlson RW, 2018, J EXP SOC PSYCHOL, V75, P36, DOI 10.1016/j.jesp.2017.11.005; Chaudhry SJ, 2019, PSYCHOL REV, V126, P313, DOI 10.1037/rev0000139; Cialdini RB, 1997, J PERS SOC PSYCHOL, V73, P481, DOI 10.1037/0022-3514.73.3.481; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Cramwinckel FM, 2015, CURR OPIN PSYCHOL, V6, P150, DOI 10.1016/j.copsyc.2015.08.007; Critcher CR, 2011, J EXP SOC PSYCHOL, V47, P1207, DOI 10.1016/j.jesp.2011.05.001; Croson R, 2009, NONPROFIT MANAG LEAD, V19, P467, DOI 10.1002/nml.232; Cushman F, 2015, CURR OPIN PSYCHOL, V6, P97, DOI 10.1016/j.copsyc.2015.06.003; Dickert S, 2015, J APPL RES MEM COGN, V4, P248, DOI 10.1016/j.jarmac.2014.09.002; Dickert S, 2012, SYNTHESE, V189, P681, DOI 10.1007/s11229-012-0137-4; Dovidio JF, 2006, SOCIAL PSYCHOL PROSO, Vxiv, DOI [10.1007/s00425-006-0235-y, DOI 10.1007/S00425-006-0235-Y]; Elliot AJ, 2001, PSYCHOL SCI, V12, P505, DOI 10.1111/1467-9280.00393; Erlandsson A, 2018, J APPL SOC PSYCHOL, V48, P618, DOI 10.1111/jasp.12552; Erlandsson A, 2015, ORGAN BEHAV HUM DEC, V127, P1, DOI 10.1016/j.obhdp.2014.11.003; Erlandsson A, 2014, J BEHAV DECIS MAKING, V27, P37, DOI 10.1002/bdm.1789; Everett JAC, 2018, J EXP SOC PSYCHOL, V79, P200, DOI 10.1016/j.jesp.2018.07.004; Everett JAC, 2016, J EXP PSYCHOL GEN, V145, P772, DOI 10.1037/xge0000165; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Friedrich J., 1999, J CONSUM PSYCHOL, V8, P277, DOI [DOI 10.1207/S15327663JCP0803_05, 10.1207/s15327663jcp0803_05]; Futamura I, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196340; Gautier A, 2015, J BUS ETHICS, V126, P343, DOI 10.1007/s10551-013-1969-7; Gino F, 2010, ORGAN BEHAV HUM DEC, V111, P93, DOI 10.1016/j.obhdp.2009.11.001; Gneezy A, 2014, SOC PSYCHOL PERS SCI, V5, P796, DOI 10.1177/1948550614533134; Gneezy A, 2012, MANAGE SCI, V58, P179, DOI 10.1287/mnsc.1110.1437; Goodwin GP, 2015, CURR DIR PSYCHOL SCI, V24, P38, DOI 10.1177/0963721414550709; Gray K, 2011, J EXP SOC PSYCHOL, V47, P516, DOI 10.1016/j.jesp.2010.12.012; Greene JD, 2009, COGNITION, V111, P364, DOI 10.1016/j.cognition.2009.02.001; Gromet DM, 2016, PERS SOC PSYCHOL B, V42, P1077, DOI 10.1177/0146167216651408; Guglielmo S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213544; Hamilton DL, 1996, PSYCHOL REV, V103, P336, DOI 10.1037/0033-295X.103.2.336; Hart PS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199535; Hester N, 2020, J EXP SOC PSYCHOL, V86, DOI 10.1016/j.jesp.2019.103910; Hsee CK, 2010, PERSPECT PSYCHOL SCI, V5, P343, DOI 10.1177/1745691610374586; Hsee CK, 2004, J PERS SOC PSYCHOL, V86, P680, DOI 10.1037/0022-3514.86.5.680; Ioannidis JPA, 2019, AM STAT, V73, P20, DOI 10.1080/00031305.2018.1447512; Johnson S., 2018, DIMENSIONS ALTRUISM; Johnson SG, 2019, MORAL SIGNALING DONA, DOI [10.31234/osf.io/tg9xs, DOI 10.31234/OSF.IO/TG9XS]; Klein N, 2016, SOC COGNITION, V34, P149; Klein N, 2014, J EXP PSYCHOL GEN, V143, P2366, DOI 10.1037/xge0000025; Kogut T, 2015, CURR OPIN PSYCHOL, V6, P145, DOI 10.1016/j.copsyc.2015.08.005; Kohlberg L., 1977, THEOR PRACT, V16, P53, DOI [https://doi.org/10.1080/00405847709542675, DOI 10.1080/00405847709542675, 10.2307/1475172]; Krull DS, 2008, J EXP SOC PSYCHOL, V44, P735, DOI 10.1016/j.jesp.2007.05.004; Landy JF, 2018, ATLAS OF MORAL PSYCHOLOGY, P121; Law KF, 2019, BIASED BENEVOLENCE M, DOI [10.31234/osf.io/qzx67, DOI 10.31234/OSF.IO/QZX67]; Lee H, 2009, J BUS RES, V62, P939, DOI 10.1016/j.jbusres.2008.08.007; Lee S, 2016, SOC INFLUENCE, V11, P199, DOI 10.1080/15534510.2016.1216891; Lin-Healy F, 2012, ORGAN BEHAV HUM DEC, V117, P269, DOI 10.1016/j.obhdp.2011.11.006; MacAskill William, 2015, DOING GOOD BETTER EF; Makov T, 2016, NAT CLIM CHANGE, V6, P844, DOI 10.1038/NCLIMATE3033; Malle BF, 2014, PSYCHOL INQ, V25, P147, DOI 10.1080/1047840X.2014.877340; Markowitz EM, 2013, JUDGM DECIS MAK, V8, P397; Martin MW, 2008, J HAPPINESS STUD, V9, P171, DOI 10.1007/s10902-007-9056-3; Mata A, 2016, JUDGM DECIS MAK, V11, P441; McShane BB, 2019, AM STAT, V73, P235, DOI 10.1080/00031305.2018.1527253; Minson JA, 2012, SOC PSYCHOL PERS SCI, V3, P200, DOI 10.1177/1948550611415695; Newman GE, 2019, NONPROF VOLUNT SEC Q, V48, P71, DOI 10.1177/0899764018794903; Newman GE, 2014, PSYCHOL SCI, V25, P648, DOI 10.1177/0956797613504785; Paharia N, 2009, ORGAN BEHAV HUM DEC, V109, P134, DOI 10.1016/j.obhdp.2009.03.002; Parks CD, 2010, J PERS SOC PSYCHOL, V99, P303, DOI 10.1037/a0018403; Raihani NJ, 2015, CURR BIOL, V25, P1183, DOI 10.1016/j.cub.2015.02.042; Reed A, 2007, J MARKETING, V71, P178, DOI 10.1509/jmkg.71.1.178; Reeder GD, 2009, PSYCHOL INQ, V20, P1, DOI 10.1080/10478400802615744; Richardson JTE, 2011, EDUC RES REV-NETH, V6, P135, DOI 10.1016/j.edurev.2010.12.001; Ritov I, 2011, COGNITION EMOTION, V25, P657, DOI 10.1080/02699931.2010.512512; Robinson JS, 2017, J EXP SOC PSYCHOL, V73, P50, DOI 10.1016/j.jesp.2017.06.005; Rom SC, 2017, J EXP SOC PSYCHOL, V69, P44, DOI 10.1016/j.jesp.2016.09.007; Saiia D.H., 2003, BUS SOC, V42, P169, DOI [DOI 10.1177/0007650303042002002, 10.1177/0007650303042002002]; Schweinsberg M, 2016, J EXP SOC PSYCHOL, V66, P55, DOI 10.1016/j.jesp.2015.10.001; Scopelliti I, 2015, PSYCHOL SCI, V26, P903, DOI 10.1177/0956797615573516; Scott S, 2016, STUDIES SYMBOLIC INT, DOI [10.1002/symb.218, DOI 10.1002/SYMB.218]; Sharps DL, 2019, J PERS SOC PSYCHOL, V117, P954, DOI 10.1037/pspi0000179; Siegel JZ, 2017, COGNITION, V167, P201, DOI 10.1016/j.cognition.2017.05.004; Singer P., 2015, BOSTON REV; Sinnott-Armstrong W., 2008, MORAL PSYCHOL, P35; SKOWRONSKI JJ, 1989, PSYCHOL BULL, V105, P131, DOI 10.1037/0033-2909.105.1.131; Slovic P, 2007, JUDGM DECIS MAK, V2, P79; Small DA, 2003, J RISK UNCERTAINTY, V26, P5, DOI 10.1023/A:1022299422219; Szymanska E., 2011, SCI GIVING EXPT APPR, P215; Trafimow D, 2014, BASIC APPL SOC PSYCH, V36, P1, DOI [10.1080/01973533.2014.865505, 10.1080/01973533.2015.1064290]; Uhlmann EL, 2015, PERSPECT PSYCHOL SCI, V10, P72, DOI 10.1177/1745691614556679; Uhlmann EL, 2014, SOC PSYCHOL PERS SCI, V5, P279, DOI 10.1177/1948550613497238; Uhlmann EL, 2014, EUR J SOC PSYCHOL, V44, P23, DOI 10.1002/ejsp.1987; Van Vugt M, 2013, BRIT J PSYCHOL, V104, P3, DOI 10.1111/j.2044-8295.2011.02093.x; Vastfjall D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100115; West H., 2006, BLACKWELL GUIDE MILL, P217; Zagefka H, 2019, J THEOR SOC PSYCHOL, V3, P62, DOI 10.1002/jts5.26	100	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243808	10.1371/journal.pone.0243808	http://dx.doi.org/10.1371/journal.pone.0243808			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH0WM	33306708	Green Published, gold			2022-12-27	WOS:000600144200073
J	Lee, S; Kim, JH; Moon, H; Lee, HJ; Han, JK				Lee, Seunghyun; Kim, Jung Hoon; Moon, Hyungwon; Lee, Hak Jong; Han, Joon Koo			Combined treatment of sorafenib and doxorubicin-loaded microbubble-albumin nanoparticle complex for hepatocellular carcinoma: A feasibility study	PLOS ONE			English	Article							CONTRAST-ENHANCED ULTRASOUND; TREATMENT RESPONSE; THERAPY; RESISTANCE; DELIVERY	Purpose To assess the feasibility of the combined sorafenib (SOR) and doxorubicin-loaded microbubble-albumin nanoparticle complex (DOX-MAC) treatment effect in an orthotopic rat model of hepatocellular carcinoma (HCC). Materials and methods Sixty-two rats with N1-S1 hepatoma were divided into four groups according to the treatment methods, i.e. G1 (SOR and DOX-MAC; n = 12), G2 (SOR; n = 15), G3 (DOX-MAC; n = 12), G4 (DOX; n = 11), and G5 (normal saline; n = 12). We performed the theragnostic, contrast-enhanced ultrasound examination and treatment at the baseline, one-week, and two-weeks. Tumor volume and perfusion parameters were compared at each time point and the differences between all of the groups over time were analyzed using repeated measures ANOVA. We also analyzed the apoptotic index and microvessel density (MVD) per each tumor specimen in all of the groups. Results The tumors increased from the beginning in all of the groups to the final follow-up, whereas the tumor growth in the G1 group and the G2 group was inhibited during the treatment period compared to the baseline tumor volume (P = 0.016 and P = 0.031). The G1 group resulted in tumor growth inhibition compared to the control group (P = 0.008). The G1 group showed that the peak enhancement and wash-in area under the curve were lower than that of the G4 group (P = 0.010 and 0.022). However, there was no difference in perfusion parameters in the other treated group compared to control group. The MVD of the G1 group tumor was lower than that of the G4 group (P = .016). Conclusion Our results suggest that the combination therapy of SOR and DOX-MAC can cause inhibition of tumor growth after treatment and that this therapy can be adequately monitored using the theragnostic DOX-MAC agent.	[Lee, Seunghyun; Kim, Jung Hoon; Han, Joon Koo] Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea; [Kim, Jung Hoon; Lee, Hak Jong; Han, Joon Koo] Seoul Natl Univ, Dept Radiol, Coll Med, Seoul, South Korea; [Kim, Jung Hoon; Han, Joon Koo] Seoul Natl Univ, Inst Radiat Med, Med Res Ctr, Seoul, South Korea; [Moon, Hyungwon; Lee, Hak Jong] IMGT Co Ltd, Seongnam, South Korea; [Lee, Hak Jong] Seoul Natl Univ, Dept Radiol, Bundang Hosp, Seongnam, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Kim, JH (corresponding author), Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea.; Kim, JH (corresponding author), Seoul Natl Univ, Dept Radiol, Coll Med, Seoul, South Korea.; Kim, JH (corresponding author), Seoul Natl Univ, Inst Radiat Med, Med Res Ctr, Seoul, South Korea.	jhkim2008@gmail.com		Lee, Seunghyun/0000-0003-1858-0640	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2017R1A2B4004951]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	This research was supported by a grant from the research supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2017R1A2B4004951).The IGMT Co. (Seongnam, Republic of Korea, http://nanoimgt.com) provided support in the form of salaries for authors [H.M., and H.J.L.], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abou-Alfa G, 2016, P AM SOC CLIN ONC S4, V34, P192, DOI DOI 10.1200/jco.2016.34.4_suppl.192; Abou-Alfa GK, 2010, JAMA-J AM MED ASSOC, V304, P2154, DOI 10.1001/jama.2010.1672; Buijs M, 2012, J VASC INTERV RADIOL, V23, P1685, DOI 10.1016/j.jvir.2012.08.025; CHEN Y, 1994, J CONTROL RELEASE, V31, P49, DOI 10.1016/0168-3659(94)90250-X; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Choi JW, 2016, ABDOM RADIOL, V41, P257, DOI 10.1007/s00261-015-0591-9; Chowdhury SM, 2016, J CONTROL RELEASE, V238, P272, DOI 10.1016/j.jconrel.2016.08.005; Cochran MC, 2011, ACAD RADIOL, V18, P1341, DOI 10.1016/j.acra.2011.06.013; Duan WD, 2018, DRUG DES DEV THER, V12, P2149, DOI 10.2147/DDDT.S166402; Froehlich E, 2015, J ULTRAS MED, V34, P179, DOI 10.7863/ultra.34.2.179; Goetti R, 2012, INVEST RADIOL, V47, P18, DOI 10.1097/RLI.0b013e318229ff0d; Golla K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051960; Hoyt K, 2010, J ULTRAS MED, V29, P577, DOI 10.7863/jum.2010.29.4.577; Ignee A, 2010, EUR J RADIOL, V73, P153, DOI 10.1016/j.ejrad.2008.10.016; Kang JA, 2010, J ULTRAS MED, V29, P61, DOI 10.7863/jum.2010.29.1.61; Kim DW, 2017, J GASTROINTEST ONCOL, V8, P256, DOI 10.21037/jgo.2016.09.07; Kim YI, 2014, ANTICANCER RES, V34, P1715; Kuczynski EA, 2015, CANCER RES, V75, P2510, DOI 10.1158/0008-5472.CAN-14-3687; Kudo M, 2018, CANCERS, V10, DOI 10.3390/cancers10110412; Lassau N, 2010, CLIN CANCER RES, V16, P1216, DOI 10.1158/1078-0432.CCR-09-2175; Lee JH, 2019, CANCERS, V11, DOI 10.3390/cancers11040581; Lee S, 2018, EUR RADIOL, V28, P372, DOI 10.1007/s00330-017-4960-3; Lee TK, 2014, NUCL MED MOLEC IMAG, V48, P173, DOI 10.1007/s13139-014-0288-y; McCubrey JA, 2006, ADV ENZYME REGUL, V46, P249, DOI 10.1016/j.advenzreg.2006.01.004; Merz M, 2012, INVEST RADIOL, V47, P422, DOI 10.1097/RLI.0b013e31824f635a; Moon H, 2015, J BIOMED NANOTECHNOL, V11, P1183, DOI 10.1166/jbn.2015.2056; Mullick S, 2017, LASER ENG, V36, P3; Sirsi SR, 2014, ADV DRUG DELIVER REV, V72, P3, DOI 10.1016/j.addr.2013.12.010; Tinkov S, 2010, J CONTROL RELEASE, V148, P368, DOI 10.1016/j.jconrel.2010.09.004; WEIDNER N, 1995, AM J PATHOL, V147, P9; Yoon YI, 2014, THERANOSTICS, V4, P1133, DOI 10.7150/thno.9945; Zhai B, 2013, WORLD J HEPATOL, V5, P345, DOI 10.4254/wjh.v5.i7.345; Zhu FY, 2015, J DRUG TARGET, V23, P323, DOI 10.3109/1061186X.2014.996759	33	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243815	10.1371/journal.pone.0243815	http://dx.doi.org/10.1371/journal.pone.0243815			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306731	gold, Green Published			2022-12-27	WOS:000600144200010
J	Mouritzen, NJ; Larsen, LH; Lauritzen, MH; Kjaer, TW				Mouritzen, Nanna J.; Larsen, Lisbeth H.; Lauritzen, Maja H.; Kjaer, Troels W.			Assessing the performance of a commercial multisensory sleep tracker	PLOS ONE			English	Article							POLYSOMNOGRAPHY; ACTIGRAPHY; ACCELEROMETER; RELIABILITY; VALIDATION; AGREEMENT; CHILDREN	Wearable sleep technology allows for a less intruding sleep assessment than PSG, especially in long-term sleep monitoring. Though such devices are less accurate than PSG, sleep trackers may still provide valuable information. This study aimed to validate a commercial sleep tracker, Garmin Vivosmart 4 (GV4), against polysomnography (PSG) and to evaluate intra-device reliability (GV4 vs. GV4). Eighteen able-bodied adults (13 females, M = 56.1 +/- 12.0 years) with no self-reported sleep disorders were simultaneously sleep monitored by GV4 and PSG for one night while intra-device reliability was monitored in one participant for 23 consecutive nights. Intra-device agreement was considered sufficient (observed agreement = 0.85 +/- 0.13, Cohen's kappa = 0.68 +/- 0.24). GV4 detected sleep with high accuracy (0.90) and sensitivity (0.98) but low specificity (0.28). Cohen's kappa was calculated for sleep/wake detection (0.33) and sleep stage detection (0.20). GV4 significantly underestimated time awake (p = 0.001) including wake after sleep onset (WASO) (p = 0.001), and overestimated light sleep (p = 0.045) and total sleep time (TST) (p = 0.001) (paired t-test). Sleep onset and sleep end differed insignificantly from PSG values. Our results suggest that GV4 is not able to reliably describe sleep architecture but may allow for detection of changes in sleep onset, sleep end, and TST (ICC >= 0.825) in longitudinally followed groups. Still, generalizations are difficult due to our sample limitations.	[Mouritzen, Nanna J.; Larsen, Lisbeth H.; Lauritzen, Maja H.; Kjaer, Troels W.] Zealand Univ Hosp, Ctr Neurophysiol, Dept Neurol, Roskilde, Denmark; [Mouritzen, Nanna J.; Kjaer, Troels W.] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark	University of Copenhagen	Mouritzen, NJ (corresponding author), Zealand Univ Hosp, Ctr Neurophysiol, Dept Neurol, Roskilde, Denmark.; Mouritzen, NJ (corresponding author), Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark.	namou@regionsjaelland.dk			EU Interreg Deutschland-Danmark [087-1.1-18]; Lundbeck Foundation	EU Interreg Deutschland-Danmark; Lundbeck Foundation(Lundbeckfonden)	The project was funded by the EU Interreg Deutschland-Danmark (087-1.1-18) and a pre-graduate research scholarship was awarded by the Lundbeck Foundation to NJM.	Agnew H W Jr, 1966, Psychophysiology, V2, P263, DOI 10.1111/j.1469-8986.1966.tb02650.x; [Anonymous], 2018, VIVOSMART 4 OWNERS M; [Anonymous], 2017, NATL SUNDHEDSPROFIL; Beattie Z, 2017, PHYSIOL MEAS, V38, P1968, DOI 10.1088/1361-6579/aa9047; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cook JD, 2019, J SLEEP RES, V28, DOI 10.1111/jsr.12789; De Zambotti M, 2019, MED SCI SPORT EXER, V51, P1538, DOI 10.1249/MSS.0000000000001947; de Zambotti M, 2018, CHRONOBIOL INT, V35, P465, DOI 10.1080/07420528.2017.1413578; de Zambotti M, 2018, NEUROSCI BIOBEHAV R, V90, P84, DOI 10.1016/j.neubiorev.2018.03.027; de Zambotti M, 2015, SLEEP, V38, P1461, DOI 10.5665/sleep.4990; de Zambotti M, 2015, CHRONOBIOL INT, V32, P1024, DOI 10.3109/07420528.2015.1054395; Deng SJ, 2019, SLEEP BREATH, V23, P719, DOI 10.1007/s11325-019-01801-x; Edinger JD, 1997, SLEEP, V20, P1119, DOI 10.1093/sleep/20.12.1119; Evenson KR, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0183-7; FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L; Gruwez A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210569; Gruwez A, 2017, INT J MED INFORM, V102, P87, DOI 10.1016/j.ijmedinf.2017.03.008; Kahawage P, 2020, J SLEEP RES, V29, DOI 10.1111/jsr.12931; Kang SG, 2017, J PSYCHOSOM RES, V97, P38, DOI 10.1016/j.jpsychores.2017.03.009; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Mansukhani MP, 2017, CLEV CLIN J MED, V84, P451, DOI 10.3949/ccjm.84a.15173; Mantua J, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16050646; Matthews KA, 2018, SLEEP HEALTH, V4, P96, DOI 10.1016/j.sleh.2017.10.011; Meltzer LJ, 2015, SLEEP, V38, P1323, DOI 10.5665/sleep.4918; Miglis MG, 2017, SLEEP AND NEUROLOGIC DISEASE, P227, DOI 10.1016/B978-0-12-804074-4.00018-2; Montgomery-Downs HE, 2012, SLEEP BREATH, V16, P913, DOI 10.1007/s11325-011-0585-y; Paquet J, 2007, SLEEP, V30, P1362, DOI 10.1093/sleep/30.10.1362; Rosenberg RS, 2013, J CLIN SLEEP MED, V9, P81, DOI 10.5664/jcsm.2350; Sim I, 2019, NEW ENGL J MED, V381, P956, DOI 10.1056/NEJMra1806949; Stevens S, 2019, NEUROLOGY, V92; Su H, 2011, NEURAL COMPUT APPL, V20, P183, DOI 10.1007/s00521-010-0512-3; Toon E, 2016, J CLIN SLEEP MED, V12, P343, DOI 10.5664/jcsm.5580	32	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243214	10.1371/journal.pone.0243214	http://dx.doi.org/10.1371/journal.pone.0243214			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306678	gold, Green Published			2022-12-27	WOS:000600144200051
J	O'Donnell, A; Wilson, L; Bosch, JA; Borrows, R				O'Donnell, Alice; Wilson, Lydia; Bosch, Jos A.; Borrows, Richard			Life satisfaction and happiness in patients shielding from the COVID-19 global pandemic: A randomised controlled study of the 'mood as information' theory	PLOS ONE			English	Article							JUDGMENTS	Objectives To extrapolate the 'mood as information' theory to the unique and ecologically relevant setting of the COVID-19 pandemic; the specific aim was to inform health care providers of the impact of bringing the pandemic to salience during life satisfaction evaluations, assessing whether this 'prime' results in increased or decreased reports of satisfaction which are derived unconsciously. Design Prospective Randomised Interventional Study. Setting Renal Transplant Department in a tertiary centre in the United Kingdom. Participants 200 Renal transplant patients aged between 20 and 88 years. Telephone interviews were undertaken between 1(st) May, 2020 and 29(th) May, 2020, at the height of 'shielding' from COVID-19. Interventions Participants were randomised into 2 groups, with 1 group receiving a simple 'priming question' regarding the COVID pandemic and the other group having no prior contact. Main outcome measurements Individuals were then asked to rate their own overall lifetime happiness; desire to change; overall life satisfaction and momentary happiness on a scale of 1 to 10 for each measure. Independent sample t-tests were used to compare results between the two groups, with a type 1 error rate below 5% considered statistically significant. Results Participants' overall happiness with their life as a whole revealed that individuals who were primed with a question about COVID-19 reported increased overall happiness with their life compared to individuals who had not been primed (+0.88, 95% confidence interval 0.42 to 1.35, p = 0.0002). In addition, participants in the primed group reported less desire to change their life when compared to the non-primed group (-1.35, 95% confidence interval -2.06 to -0.65, p = 0.0002). Participants who were primed with the COVID-19 question also reported a higher overall satisfaction with their life than individuals who had not been primed (+1.01, 95% confidence interval 0.50 to 1.52, p = 0.0001). Finally, the participants who received the priming question demonstrated increased reported momentary happiness (+0.64, 95% confidence interval 0.03 to 1.24, p = 0.04). Conclusions The results demonstrated that bringing salience to the COVID-19 pandemic with a simple question leads to positive changes in both momentary happiness and other components of global life satisfaction, thereby extrapolating evidence for the application of the mood-as-information theory to more extreme life circumstances. Given the importance of patient-reported evaluations, these findings have implications for how, when and where accurate and reproducible measurements of life satisfaction should be obtained.	[O'Donnell, Alice; Wilson, Lydia] Univ Birmingham, Med Sch, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Bosch, Jos A.] Univ Amsterdam, Fac Maatschappij Gedragswetenschappen, Programmagrp Clin Psychol, Amsterdam, Netherlands; [Borrows, Richard] Queen Elizabeth Hosp Birmingham, Dept Nephrol & Kidney Transplantat, Birmingham, W Midlands, England	University of Birmingham; University of Amsterdam; University of Birmingham	Borrows, R (corresponding author), Queen Elizabeth Hosp Birmingham, Dept Nephrol & Kidney Transplantat, Birmingham, W Midlands, England.	Richard.Borrows@uhb.nhs.uk		O'Donnell, Alice/0000-0002-9849-3100	renal department at the Queen Elizabeth Hospital	renal department at the Queen Elizabeth Hospital	This work was funded by the renal department at the Queen Elizabeth Hospital. This research was independent from external funders.	ABRAMSON LY, 1978, J ABNORM PSYCHOL, V87, P49, DOI 10.1037/0021-843X.87.1.49; Diener E, 2015, PERS SOC PSYCHOL REV, V19, P235, DOI 10.1177/1088868314544467; Gong JJ, 2013, EXCLI J, V12, P20; Local Government Association, 2020, COVID 19 INF COUNC; Lucas RE, 2013, J PERS SOC PSYCHOL, V104, P872, DOI 10.1037/a0032124; NICE, 2020, RATIONALES COVID 19; Riis J, 2005, J EXP PSYCHOL GEN, V134, P3, DOI 10.1037/0096-3445.134.1.3; Rutledge RB, 2014, P NATL ACAD SCI USA, V111, P12252, DOI 10.1073/pnas.1407535111; SCHWARZ N, 1983, J PERS SOC PSYCHOL, V45, P513, DOI 10.1037/0022-3514.45.3.513; Schwarz N, 2003, PSYCHOL INQ, V14, P296, DOI 10.1207/S15327965PLI1403&4_20; STEELE CM, 1995, J PERS SOC PSYCHOL, V69, P797, DOI 10.1037/0022-3514.69.5.797; STRACK F, 1988, EUR J SOC PSYCHOL, V18, P429, DOI 10.1002/ejsp.2420180505; TAYLOR SE, 1991, PSYCHOL BULL, V110, P67, DOI 10.1037/0033-2909.110.1.67; Von Soest T, 2020, TIDSSKRIFTET NORSKE; Zhang SX, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112958	15	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243278	10.1371/journal.pone.0243278	http://dx.doi.org/10.1371/journal.pone.0243278			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH0WM	33306679	Green Published, gold			2022-12-27	WOS:000600144200015
J	Layton, JB; Li, WH; Yuan, JC; Gilman, JP; Horton, DB; Setoguchi, S				Layton, J. Bradley; Li, Wenhong; Yuan, Jiacan; Gilman, Joshua P.; Horton, Daniel B.; Setoguchi, Soko			Heatwaves, medications, and heat-related hospitalization in older Medicare beneficiaries with chronic conditions	PLOS ONE			English	Article							RISK; MORTALITY; ILLNESS; WAVE; MORBIDITY; DEHYDRATION; ADMISSIONS; MEDICINES; CLAIMS	Background Heatwaves kill more people than floods, tornadoes, and earthquakes combined and disproportionally affect older persons and those with chronic conditions. Commonly used medications for chronic conditions, e.g., diuretics, antipsychotics disrupt thermoregulation or fluid/electrolyte balance and may sensitive patients to heat. However, the effect of heat-sensitizing medications and their interactions with heatwaves are not well-quantified. We evaluated effects of potentially heat-sensitizing medications in vulnerable older patients. Methods US Medicare data were linked at the zip code level to climate data with surface air temperatures for June-August of 2007-2012. Patients were Medicare beneficiaries aged >= 65 years with chronic conditions including diabetes, dementia, and cardiovascular, lung, or kidney disease. Exposures were potentially heat-sensitizing medications including diuretics, anticholinergics, antipsychotics, beta blockers, stimulants, and anti-hypertensives. A heatwave was defined as >= 2 days above the 95(th) percentile of historical zip code-specific surface air temperatures. We estimated associations of heat-sensitizing medications and heatwaves with heat-related hospitalization using self-controlled case series analysis. Results We identified 9,721 patients with at least one chronic condition and heat-related hospitalization; 42.1% of these patients experienced a heatwave. Heatwaves were associated with an increase in heat-related hospitalizations ranging from 21% (95% CI: 7% to 38%) to 33% (95% CI: 14% to 55%) across medication classes. Several drug classes were associated with moderately elevated risk of heat-related hospitalization in the absence of heatwaves, with rate ratios ranging from 1.16 (95% CI: 1.00 to 1.35) to 1.37 (95% CI: 1.14 to 1.66). We did not observe meaningful synergistic interactions between heatwaves and medications. Conclusions Older patients with chronic conditions may be at heightened risk for heat-related hospitalization due to the use of heat-sensitizing medications throughout the summer months, even in the absence of heatwaves. Further studies are needed to confirm these findings and also to understand the effect of milder and shorter heat exposure.	[Layton, J. Bradley] RTI Hlth Solut, Raleigh, NC USA; [Li, Wenhong; Yuan, Jiacan] Duke Univ, Nicholas Sch Environm, Earth & Ocean Sci, Durham, NC 27708 USA; [Gilman, Joshua P.] Rutgers Robert Wood Johnson Med Sch, New Brunswick, NJ USA; [Gilman, Joshua P.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Horton, Daniel B.] Rutgers Robert Wood Johnson Med Sch, Dept Pediat, New Brunswick, NJ USA; [Horton, Daniel B.; Setoguchi, Soko] Rutgers Ctr Pharmacoepidemiol & Treatment Sci, New Brunswick, NJ 08901 USA; [Setoguchi, Soko] Rutgers Robert Wood Johnson Med Sch, Dept Med, New Brunswick, NJ 08901 USA	Research Triangle Institute; Duke University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Boston University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Setoguchi, S (corresponding author), Rutgers Ctr Pharmacoepidemiol & Treatment Sci, New Brunswick, NJ 08901 USA.; Setoguchi, S (corresponding author), Rutgers Robert Wood Johnson Med Sch, Dept Med, New Brunswick, NJ 08901 USA.	ss2894@rwjms.rutgers.edu	Layton, J. Bradley/B-4950-2018; Yuan, Jiacan/AAI-5731-2021; Horton, Daniel/R-5623-2017	Layton, J. Bradley/0000-0003-0994-5820; Yuan, Jiacan/0000-0003-3847-4490; Horton, Daniel/0000-0002-1831-1339	National Institutes of Health, National Institute on Aging [R21 AG044294]; National Institute of Arthritis and Musculoskeletal and Skin Diseases [K23 AR070286]; Pharmacoepidemiology Gillings Innovation Lab (PEGIL) for the Population-Based Evaluation of Drug Benefits and Harms in Older US Adults [GIL 200811.0010]; Center for Pharmacoepidemiology, Department of Epidemiology, University of North Carolina (UNC) Gillings School of Global Public Health; CER Strategic Initiative of UNC's Clinical & Translational Science Award [UL1TR001111]; Cecil G. Sheps Center for Health Services Research, UNC; UNC School of Medicine; National Institutes of Health; Cystic Fibrosis Foundation; Pfizer Inc.,; Bristol-Myers Squibb	National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Pharmacoepidemiology Gillings Innovation Lab (PEGIL) for the Population-Based Evaluation of Drug Benefits and Harms in Older US Adults; Center for Pharmacoepidemiology, Department of Epidemiology, University of North Carolina (UNC) Gillings School of Global Public Health; CER Strategic Initiative of UNC's Clinical & Translational Science Award; Cecil G. Sheps Center for Health Services Research, UNC; UNC School of Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Pfizer Inc.,(Pfizer); Bristol-Myers Squibb(Bristol-Myers Squibb)	This work was supported by the National Institutes of Health, National Institute on Aging (grant number R21 AG044294) and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (grant number K23 AR070286). The sponsor had no role in the study design, data collection, analysis, interpretation, study report writing, or publication decision. The database infrastructure used for this project was funded by the Pharmacoepidemiology Gillings Innovation Lab (PEGIL) for the Population-Based Evaluation of Drug Benefits and Harms in Older US Adults (GIL 200811.0010), Center for Pharmacoepidemiology, Department of Epidemiology, University of North Carolina (UNC) Gillings School of Global Public Health; the CER Strategic Initiative of UNC's Clinical & Translational Science Award (UL1TR001111); the Cecil G. Sheps Center for Health Services Research, UNC; and the UNC School of Medicine. Portions of this work were presented as a poster at the 35th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Montreal, August 2019. JBL was formerly employed by UNC where he received unrestricted salary support from the Center for Pharmacoepidemiology in the UNC Department of Epidemiology; member companies at the time included GlaxoSmithKline, Merck, and UCB Biosciences. JBL is currently an employee of RTI International, an independent, non-profit research organization which performs research for governmental and commercial clients, including pharmaceutical companies. SS has served as a member of the US FDA advisory committee and a consultant for Pfizer Inc., Medtronic, and Merck. SS has also received research funding from the National Institutes of Health, the Cystic Fibrosis Foundation, Pfizer Inc., and Bristol-Myers Squibb. All other authors have no conflicts to declare.	Anderson GB, 2011, ENVIRON HEALTH PERSP, V119, P210, DOI 10.1289/ehp.1002313; [Anonymous], 2009, W STAR CORNER B 0310, V10, P3; [Anonymous], 2009, ENV PROT, V18, P7; Astrom DO, 2011, MATURITAS, V69, P99, DOI 10.1016/j.maturitas.2011.03.008; Bierbaum R, 2014, CLIMATE CHANGE IMPAC; Bobb JF, 2014, JAMA-J AM MED ASSOC, V312, P2659, DOI 10.1001/jama.2014.15715; Boyer EW, 2005, NEW ENGL J MED, V352, P1112, DOI 10.1056/NEJMra041867; Ellett LMK, 2016, J CLIN PHARM THER, V41, P503, DOI 10.1111/jcpt.12418; Farrington CP, 2006, J R STAT SOC C-APPL, V55, P553, DOI 10.1111/j.1467-9876.2006.00554.x; Haines A, 2019, NEW ENGL J MED, V380, P263, DOI 10.1056/NEJMra1807873; Hajjar Emily R, 2007, Am J Geriatr Pharmacother, V5, P345, DOI 10.1016/j.amjopharm.2007.12.002; Hallas J, 2014, J INTERN MED, V275, P581, DOI 10.1111/joim.12186; Hansen J, 2012, P NATL ACAD SCI USA, V109, pE2415, DOI 10.1073/pnas.1205276109; Hopp S, 2018, PREV MED, V110, P81, DOI 10.1016/j.ypmed.2018.02.001; JONES TS, 1982, JAMA-J AM MED ASSOC, V247, P3327, DOI 10.1001/jama.247.24.3327; KILBOURNE EM, 1982, JAMA-J AM MED ASSOC, V247, P3332, DOI 10.1001/jama.247.24.3332; Kumamaru H, 2014, CIRC-CARDIOVASC QUAL, V7, P611, DOI 10.1161/CIRCOUTCOMES.113.000743; Kwok JSS, 2005, ANN PHARMACOTHER, V39, P1940, DOI 10.1345/aph.1G130; Levitan EB, 2017, BMC CARDIOVASC DISOR, V17, DOI 10.1186/s12872-017-0682-3; Liss A, 2017, SCI REP-UK, V7, DOI 10.1038/srep39581; Majeed H, 2020, GEOHEALTH, V4, DOI 10.1029/2019GH000220; Martiello MA, 2010, SCAND J PUBLIC HEALT, V38, P826, DOI 10.1177/1403494810377685; Martin-Latry K, 2007, EUR PSYCHIAT, V22, P335, DOI 10.1016/j.eurpsy.2007.03.007; McCloskey A, 2000, COST OVERDOSE GROWTH; McCormick N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104519; Mora C, 2017, NAT CLIM CHANGE, V7, P501, DOI [10.1038/NCLIMATE3322, 10.1038/nclimate3322]; Morano LH, 2017, PUBLIC HEALTH REP, V132, P326, DOI 10.1177/0033354917699826; ONEILL PA, 1990, AGE AGEING, V19, P68, DOI 10.1093/ageing/19.1.68; Pillai SK, 2014, J COMMUN HEALTH, V39, P90, DOI 10.1007/s10900-013-9743-4; Rebholz CM, 2015, AM J KIDNEY DIS, V66, P231, DOI 10.1053/j.ajkd.2015.01.016; Robinson PJ, 2001, J APPL METEOROL, V40, P762, DOI 10.1175/1520-0450(2001)040<0762:OTDOAH>2.0.CO;2; RUBIN RM, 1995, J GERONTOL B-PSYCHOL, V50, pS291, DOI 10.1093/geronb/50B.5.S291; Sheffield J, 2006, J CLIMATE, V19, P3088, DOI 10.1175/JCLI3790.1; Sica D A, 2001, Congest Heart Fail, V7, P325, DOI 10.1111/j.1527-5299.2001.00274.x; Smith TT, 2013, CLIMATIC CHANGE, V118, P811, DOI 10.1007/s10584-012-0659-2; Sommet A, 2012, PHARMACOEPIDEM DR S, V21, P285, DOI 10.1002/pds.2307; Sturmer T, 2010, AM J EPIDEMIOL, V172, P843, DOI 10.1093/aje/kwq198; Szekely Miklos, 2015, Temperature (Austin), V2, P452, DOI 10.1080/23328940.2015.1051207; Taylor DH, 2009, J ALZHEIMERS DIS, V17, P807, DOI 10.3233/JAD-2009-1099; Thornton PE, 1997, J HYDROL, V190, P214, DOI 10.1016/S0022-1694(96)03128-9; U.S. Global Change Research Program, 2016, IMPACTS CLIMATE CHAN, P54; Walsh J, 2014, HIGHER EDUCATION IN IRELAND: PRACTICES, POLICIES AND POSSIBILITIES, P5; Westaway K, 2015, J CLIN PHARM THER, V40, P363, DOI 10.1111/jcpt.12294; Whitaker HJ, 2006, STAT MED, V25, P1768, DOI 10.1002/sim.2302; Whitaker HJ, 2015, USING SAS SELF CONTR	45	7	7	5	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243665	10.1371/journal.pone.0243665	http://dx.doi.org/10.1371/journal.pone.0243665			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH0WB	33301532	Green Published, gold			2022-12-27	WOS:000600143100003
J	Mao, YH; Zhao, Y; Zhang, Y; Yang, H				Mao, Yonghong; Zhao, Yang; Zhang, Yong; Yang, Hao			In-depth characterization and comparison of the N-glycosylated proteome of two-dimensional- and three-dimensional-cultured breast cancer cells and xenografted tumors	PLOS ONE			English	Article							IDENTIFICATION; DIGESTION	Native intact N-glycopeptide analysis can provide access to the comprehensive characteristics of N-glycan occupancy, including N-glycosites, N-glycan compositions, and N-glycoproteins for complex samples. The sample pre-processing method used for the analysis of intact N-glycopeptides usually depends on the enrichment of low abundance N-glycopeptides from a tryptic peptide mixture using hydrophilic substances before LC-MS/MS detection. However, the number of identified intact N-glycopeptides remains inadequate to achieve an in-depth profile of the N-glycosylation landscape. Here, we optimized the sample preparation workflow prior to LC-MS/MS analysis by systematically comparing different analytical methods, including the use of different sources of trypsin, combinations of different proteases, and different enrichment materials. Finally, we found that the combination of Trypsin (B)/Lys-C digestion and zwitterionic HILIC (Zic-HILIC) enrichment significantly improved the mass spectrometric characterization of intact N-glycopeptides, increasing the number of identified intact N-glycopeptides and offering better analytical reproducibility. Furthermore, the optimized workflow was applied to the analysis of intact N-glycopeptides in two-dimensional (2D) and three-dimensional (3D)-cultured breast cancer cells in vitro and xenografted tumors in mice. These results indicated that the same breast cancer cells, when cultured in different microenvironments, can show different N-glycosylation patterns. This study also provides an interesting comparison of the N-glycoproteome of breast cancer cells cultured in different growth conditions, indicating the important role of N-glycosylated proteins in cancer cell growth and the choice of the cell culture model for studies in tumor biology and drug evaluation.	[Mao, Yonghong] Sichuan Univ, West China Hosp, Inst Thorac Oncol, Chengdu, Peoples R China; [Mao, Yonghong] Sichuan Univ, West China Hosp, Dept Thorac Surg, Chengdu, Peoples R China; [Zhao, Yang] Natl Inst Metrol, Mass Spectrometry Engn Technol Res Ctr, Ctr Adv Measurement Sci, Beijing, Peoples R China; [Zhang, Yong; Yang, Hao] Sichuan Univ, West China Hosp, Key Lab Transplant Engn & Immunol, MOH, Chengdu, Peoples R China; [Zhang, Yong; Yang, Hao] Sichuan Univ, West China Hosp, Inst Syst Genet, Chengdu, Peoples R China; [Zhang, Yong; Yang, Hao] Sichuan Univ, West China Hosp, Frontiers Sci Ctr Dis Related Mol Network, Chengdu, Peoples R China	Sichuan University; Sichuan University; National Institute of Metrology China; Sichuan University; Sichuan University; Sichuan University	Zhang, Y; Yang, H (corresponding author), Sichuan Univ, West China Hosp, Key Lab Transplant Engn & Immunol, MOH, Chengdu, Peoples R China.; Zhang, Y; Yang, H (corresponding author), Sichuan Univ, West China Hosp, Inst Syst Genet, Chengdu, Peoples R China.; Zhang, Y; Yang, H (corresponding author), Sichuan Univ, West China Hosp, Frontiers Sci Ctr Dis Related Mol Network, Chengdu, Peoples R China.	nankai1989@foxmail.com; yanghao@scu.edu.cn	Yang, Hao/ABV-4834-2022	Zhang, Yong/0000-0003-0513-8941	National Natural Science Foundation of China [31901038]; China Postdoctoral Science Foundation [2019M653438]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	(Yong Zhang) National Natural Science Foundation of China (grant number 31901038) and the China Postdoctoral Science Foundation (2019M653438).	[Anonymous], 2012, J LOW GENIT TRACT DI, V16, P1, DOI 10.1097/LGT.0b013e31823abb27; Bakheet TM, 2009, BIOINFORMATICS, V25, P451, DOI 10.1093/bioinformatics/btp002; Chen YH, 2011, TALANTA, V85, P70, DOI 10.1016/j.talanta.2011.03.029; Chen YX, 2019, ANAL CHEM, V91, P4047, DOI 10.1021/acs.analchem.8b05578; Di Palma S, 2011, ANAL CHEM, V83, P3440, DOI 10.1021/ac103312e; Glatter T, 2012, J PROTEOME RES, V11, P5145, DOI 10.1021/pr300273g; Ham SL, 2016, EXP BIOL MED, V241, P939, DOI 10.1177/1535370216643772; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Katt ME, 2016, FRONT BIOENG BIOTECH, V4, DOI 10.3389/fbioe.2016.00012; Liu X, 2013, ANAL CHEM, V85, P6295, DOI 10.1021/ac400519c; MEDZIHRADSZKY KF, 2014, MOL CELL PROTEOMI S1, V13, pS36; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun NR, 2019, CHEM COMMUN, V55, P10359, DOI 10.1039/c9cc04124a; Suttapitugsakul S, 2020, ANAL CHEM, V92, P267, DOI 10.1021/acs.analchem.9b04651; Wang SS, 2018, ANAL CHEM, V90, P11124, DOI 10.1021/acs.analchem.8b03065; Watson ME, 2015, J GASTROINTEST LIVER, V24, P349, DOI 10.15403/jgld.2014.1121.243.mew; Wu Z, 2018, ANAL CHEM, V90, P9700, DOI 10.1021/acs.analchem.8b02448; Xiao KJ, 2019, ANAL CHIM ACTA, V1091, P1, DOI 10.1016/j.aca.2019.10.007; Young Eun, SCI REP UK; Yue XS, 2016, J PROTEOME RES, V15, P4265, DOI 10.1021/acs.jproteome.6b00342; Zhang Y, 2021, MOL CELL PROTEOMICS, V20, DOI 10.1074/mcp.RA120.002295; Zhang Y, 2020, J PROTEOME RES, V19, P655, DOI 10.1021/acs.jproteome.9b00557; Zhang Y, 2020, J CHROMATOGR A, V1610, DOI 10.1016/j.chroma.2019.460545	23	6	6	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243789	10.1371/journal.pone.0243789	http://dx.doi.org/10.1371/journal.pone.0243789			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301522	gold, Green Published			2022-12-27	WOS:000600143100008
J	Chan, J; Svensson, M; Jenssen, T; Schmidt, EB; Eide, IA				Chan, Joe; Svensson, My; Jenssen, Trond; Schmidt, Erik B.; Eide, Ivar A.			Marine n-3 fatty acid consumption in a Norwegian renal transplant cohort: Comparison of a food frequency questionnaire with plasma phospholipid marine n-3 levels	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; VALIDATION; OMEGA-3-FATTY-ACIDS; ADULTS; OMEGA; TRIAL; WOMEN; FISH	Background High levels of plasma marine n-3 fatty acids (n-3FAs) are associated with improved patient and graft survival in renal transplant recipients (RTRs). The aim of this study was to evaluate the utility of a new food frequency questionnaire (FFQ) to estimate marine n-3FA consumption in future epidemiological research. Methods We developed an FFQ with a simple design of 10 questions to assess intake of marine sources of n-3FAs. RTRs included in the recent ORENTRA trial (n = 132) completed the study FFQ at the baseline visit eight weeks after engraftment and at the end of study visit one year post-transplant. We measured the reference biomarker plasma phospholipid (PL) marine n-3FA levels by gas chromatography at the same time points to evaluate association and degree of agreement between FFQ based marine n-3FA consumption estimates and the biomarker. Results The median plasma PL marine n-3FA level was 6.0 weight percentage (wt)% (interquartile range [IQR] 4.7 to 7.3) at baseline and 6.3 wt% (IQR 4.8 to 7.4) at end of study. Median FFQ based marine n-3FA consumption estimates were 22.8 g/month (IQR 13.0 to 34.0) at baseline and 20.3 g/month (IQR 14.5 to 32.3) at end of study. FFQ based marine n-3FA consumption estimates showed a moderate correlation with plasma PL marine n-3FA levels at baseline (Spearman's correlation coefficient r(s) = 0.43, p<0.001) and a stronger correlation at end of study (r(s) = 0.62, p<0.001). Bland Altman plots showed a reasonable degree of agreement between the two methods at both time points. Conclusions Marine n-3FA consumption estimates based on the FFQ showed a moderate correlation with the reference biomarker plasma PL marine n-3FA levels. The FFQ might be useful in epidemiological studies where resources are limited.	[Chan, Joe; Svensson, My; Eide, Ivar A.] Akershus Univ Hosp, Dept Renal Med, Lorenskog, Norway; [Chan, Joe; Svensson, My; Jenssen, Trond] Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway; [Jenssen, Trond; Eide, Ivar A.] Oslo Univ Hosp, Rikshosp, Dept Transplantat Med, Oslo, Norway; [Schmidt, Erik B.] Aalborg Univ Hosp, Dept Clin Med, Aalborg, Denmark	University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; Aalborg University; Aalborg University Hospital	Chan, J (corresponding author), Akershus Univ Hosp, Dept Renal Med, Lorenskog, Norway.; Chan, J (corresponding author), Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway.	joe.chan@ahus.no		Chan, Joe/0000-0002-3978-3300	Gidske and Peter Jacob Sorensen Research Fund; South-Eastern Norway Regional Health Authority	Gidske and Peter Jacob Sorensen Research Fund; South-Eastern Norway Regional Health Authority	We thank coworkers Rikke Bulow Eschen, Annette Andreassen, Birthe H. Thomsen and Inge Aardestrup at The Lipid Research Laboratory, Aalborg University Hospital, Denmark for analyzing plasma phospholipid fatty acids. We thank statistician Owen Thomas and colleague dr. Anupam Chandra at Akershus University Hospital for their contribution to this manuscript. We thank the funding sources Gidske and Peter Jacob Sorensen Research Fund and the South-Eastern Norway Regional Health Authority. Finally, we thank the study participants in the ORENTRA trial.	Allaire J, 2015, EUR J CLIN NUTR, V69, P1004, DOI 10.1038/ejcn.2015.7; [Anonymous], 2019, NEW ENGL J MED, V380, P11; [Anonymous], 2016, EVIDENCE, V8, pe1000; Bork CS, 2020, P NUTR SOC, V79, P428, DOI 10.1017/S0029665120006886; Bosch J, 2012, NEW ENGL J MED, V367, P309, DOI 10.1056/NEJMoa1203859; Bowman L, 2018, NEW ENGL J MED, V379, P1540, DOI 10.1056/NEJMoa1804989; Brunvoll SH, 2018, NUTR J, V17, DOI 10.1186/s12937-018-0402-6; BURR ML, 1989, LANCET, V2, P757; Cade J, 2002, PUBLIC HEALTH NUTR, V5, P567, DOI 10.1079/PHN2001318; Eide IA, 2019, AM J TRANSPLANT, V19, P790, DOI 10.1111/ajt.15080; Eide IA, 2016, NEPHROL DIAL TRANSPL, V31, P160, DOI 10.1093/ndt/gfv339; Eide IA, 2015, CLIN J AM SOC NEPHRO, V10, P1246, DOI 10.2215/CJN.11931214; Engeset D, 2005, EUR J CLIN NUTR, V59, P675, DOI 10.1038/sj.ejcn.1602129; Galan P, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6273; Giovannelli J, 2014, J ACAD NUTR DIET, V114, P552, DOI 10.1016/j.jand.2013.07.002; Heydari B, 2016, CIRCULATION, V134, P378, DOI 10.1161/CIRCULATIONAHA.115.019949; Hoogeveen EK, 2014, CLIN J AM SOC NEPHRO, V9, P1676, DOI 10.2215/CJN.10441013; Hu Y, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.013543; Kobayashi M, 2017, J EPIDEMIOL, V27, P30, DOI 10.1016/j.je.2016.07.001; Kromhout D, 2010, NEW ENGL J MED, V363, P2015, DOI 10.1056/NEJMoa1003603; Lassale C, 2016, J ACAD NUTR DIET, V116, P427, DOI 10.1016/j.jand.2015.09.017; Laursen UB, 2018, DAN MED J, V65; Lepsch J, 2015, J HUM NUTR DIET, V28, P85, DOI 10.1111/jhn.12225; Lim AKH, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005282.pub3; Lindberg M, 2013, BRIT J NUTR, V109, P1123, DOI 10.1017/S0007114512002759; MacLean GM, 2004, RISE OF ORIENTAL TRAVEL: ENGLISH VISITORS TO THE OTTOMAN EMPIRE, 1580-1720, P1, DOI 10.1057/9780230511767; Mai XM, 2013, THORAX, V68, P25, DOI 10.1136/thoraxjnl-2012-202061; Manson JE, 2019, NEW ENGL J MED, V380, P23, DOI 10.1056/NEJMoa1811403; Micha Renata, 2014, BMJ, V348, pg2272, DOI 10.1136/bmj.g2272; Rauch B, 2010, CIRCULATION, V122, P2152, DOI 10.1161/CIRCULATIONAHA.110.948562; Schumacher TL, 2016, EUR J CLIN NUTR, V70, P1433, DOI 10.1038/ejcn.2016.144; Shen W, 2019, NUTRIENTS, V11, DOI 10.3390/nu11071470; Sluik D, 2016, BRIT J NUTR, V116, P913, DOI 10.1017/S0007114516002749; Tavazzi L, 2008, LANCET, V372, P1223, DOI 10.1016/S0140-6736(08)61239-8; Whitton C, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101059; Willett WC., 2013, NUTR EPIDEMIOLOGY, V3rd, P529; Yokoyama M, 2007, LANCET, V369, P1090, DOI 10.1016/S0140-6736(07)60527-3; Zhou YB, 2017, NUTRIENTS, V9, DOI 10.3390/nu9111256	38	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0244089	10.1371/journal.pone.0244089	http://dx.doi.org/10.1371/journal.pone.0244089			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332416	Green Published, gold			2022-12-27	WOS:000601310900028
J	Espersen, J; Weber, U; Romer-Franz, A; Lenarz, T; Stolle, SRO; Warnecke, A				Espersen, Julia; Weber, Ursula; Romer-Franz, Ariane; Lenarz, Thomas; Stolle, Stefan R. O.; Warnecke, Athanasia			Level of sex hormones and their association with acetylsalicylic acid intolerance and nasal polyposis	PLOS ONE			English	Article							EXACERBATED RESPIRATORY-DISEASE; DIAGNOSIS	Background Chronic rhinosinusitis may be associated with nasal polyposis. Recurrence of disease is often observed and may be due to an intolerance of acetylsalicylic acid. Sex hormones are known to modulate allergic reactions and inflammation. Whether they may be involved in the development and progression of nasal polyposis has not been investigated yet. Aim Examine the relationship between levels of sex hormones and nasal polyposis. Methods Hormonal levels (estradiol, testosterone and progesterone) in patients with nasal polyposis (n = 26) with or without acetylsalicylic acid-intolerance were determined and compared to hormonal levels in patients with septal deviation (n = 35). Cone-beam computed tomography scans were analysed by using scores as defined by Lund and Mackay and by Kennedy. Results Our results show a 5 times greater odds (p = 0.01) for developing nasal polyposis in the presence of lowered estradiol plasma levels than in the presence of normal / elevated levels. When analyzing females and males separately, a 6 times greater odds for females to develop nasal polyposis in the presence of lowered estradiol plasma levels was calculated (p = 0.02). Thus, females are more likely to develop nasal polyposis when they have lowered estradiol levels than males. In addition, female patients showed an increased risk for developing ASA intolerance (p = 0.01). Conclusion Variation of sex hormones may be involved in nasal polyposis. Further studies including more patients to validate the presented results are required. Significance Retrospective clinical investigation suggesting a correlation between varying sex hormones and nasal polyposis.	[Espersen, Julia; Weber, Ursula; Romer-Franz, Ariane; Lenarz, Thomas; Stolle, Stefan R. O.; Warnecke, Athanasia] Hannover Med Sch, Dept Otolaryngol, Hannover, Germany; [Espersen, Julia] Clin Reg Hannover, Hannover, Germany; [Romer-Franz, Ariane] Private Phoniatr Off Hanover, Hannover, Germany; [Stolle, Stefan R. O.] Private ENT Off Hanover, Hannover, Germany	Hannover Medical School	Warnecke, A (corresponding author), Hannover Med Sch, Dept Otolaryngol, Hannover, Germany.	Warnecke.Athanasia@mh-hannover.de	Warnecke, Athanasia/HHC-6174-2022					Almeida-Pereira G, 2019, J ENDOCRINOL, V240, P345, DOI 10.1530/JOE-18-0095; [Anonymous], 2019, NAT METHODS, V16, P1, DOI 10.1038/s41592-018-0292-8; [Anonymous], 2019, FRONTIERS PLANT SCI; Ashraf N, 2001, OTOLARYNG HEAD NECK, V125, P483, DOI 10.1067/mhn.2001.119324; Bankova LG, 2020, ANN ALLERGY ASTHMA I; Blesson CS, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-3; Bonfils P, 2008, ACTA OTO-LARYNGOL, V128, P318, DOI 10.1080/00016480701551760; Bonfils P, 2008, ACTA OTO-LARYNGOL, V128, P186, DOI 10.1080/00016480701387165; Case Allison M., 2001, Comprehensive Therapy, V27, P65, DOI 10.1007/s12019-001-0010-8; Cox's Bazar Bangladesh, 2019, GEND PROF NO 2 ROH R, V11, P1; Baldacara RPD, 2017, SAO PAULO MED J, V135, P4, DOI 10.1590/1516-3180.2016.011827016; Frump AL, 2016, RESPIR MED SER, P27, DOI 10.1007/978-3-319-23998-9_2; Fuseini H, 2017, CURR ALLERGY ASTHM R, V17, DOI 10.1007/s11882-017-0686-1; Kennedy JL, 2016, AM J RHINOL ALLERGY, V30, P407, DOI 10.2500/ajra.2016.30.4370; Keselman A, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00568; Kirsche H, 2015, HNO, V63, P357, DOI 10.1007/s00106-015-0008-7; Koper I, 2017, WORLD ALLERGY ORGAN, V10, DOI 10.1186/s40413-017-0177-9; Kovats S, 2015, CELL IMMUNOL, V294, P63, DOI 10.1016/j.cellimm.2015.01.018; Laidlaw TM, 2016, NEW ENGL J MED, V374, P484, DOI 10.1056/NEJMcibr1514013; Lund Valerie J., 1993, Rhinology (Utrecht), V31, P183; Lund VJ, 1997, OTOLARYNG HEAD NECK, V117, pS35, DOI 10.1016/S0194-5998(97)70005-6; Machado-Carvalho L, 2016, RHINOLOGY, V54, P254, DOI 10.4193/Rhino15.207; Meng J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082373; Mitts KB, 2020, J ALLERGY CLIN IMMUN, V145, P777, DOI 10.1016/j.jaci.2020.01.029; Mudo G, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1417-4; Oertelt-Prigione S, 2012, AUTOIMMUN REV, V11, pA486, DOI 10.1016/j.autrev.2011.11.023; Park SK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181806; PATRIARCA G, 1986, ARCH OTO-RHINO-LARYN, V243, P16, DOI 10.1007/BF00457900; Sakalar EG, 2017, EUR ARCH OTO-RHINO-L, V274, P1291, DOI 10.1007/s00405-016-4273-1; Schleimer RP, 2017, ANNU REV PATHOL-MECH, V12, P331, DOI 10.1146/annurev-pathol-052016-100401; Simsek E, 2016, ACTA OTO-LARYNGOL, V136, P1180, DOI 10.1080/00016489.2016.1186833; Song WJ, 2019, CURR ALLERGY ASTHM R, V19, DOI 10.1007/s11882-019-0880-4; Stubner UP, 1999, ALLERGY, V54, P865, DOI 10.1034/j.1398-9995.1999.00961.x; Yoo F, 2019, INT FORUM ALLERGY RH, V9, P1135, DOI 10.1002/alr.22406; Zhang H, 2011, MENOPAUSE, V18, P1001, DOI 10.1097/gme.0b013e3182127c9b; 2019, BRAIN STIMUL MAR, V12	36	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243732	10.1371/journal.pone.0243732	http://dx.doi.org/10.1371/journal.pone.0243732			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332460	gold, Green Published			2022-12-27	WOS:000601310900109
J	Maharaj, AD; Evans, SM; Zalcberg, JR; Ioannou, LJ; Graco, M; Croagh, D; Pilgrim, CHC; Dodson, T; Goldstein, D; Philip, J; Kench, JG; Merrett, ND; Neale, RE; White, K; Evans, P; Leong, T; Green, SE				Maharaj, Ashika D.; Evans, Sue M.; Zalcberg, John R.; Ioannou, Liane J.; Graco, Marnie; Croagh, Daniel; Pilgrim, Charles H. C.; Dodson, Theresa; Goldstein, David; Philip, Jennifer; Kench, James G.; Merrett, Neil D.; Neale, Rachel E.; White, Kate; Evans, Peter; Leong, Trevor; Green, Sally E.			Barriers and enablers to the implementation of protocol-based imaging in pancreatic cancer: A qualitative study using the theoretical domains framework	PLOS ONE			English	Article							AMERICAN SOCIETY; DIAGNOSIS; PANCREATICODUODENECTOMY; MULTIDISCIPLINARY; MANAGEMENT; CARE; CT	Background Accurate pre-operative imaging plays a vital role in patient selection for surgery and in allocating stage-appropriate therapies to patients diagnosed with pancreatic cancer (PC). This study aims to: (1) understand the current diagnosis and staging practices for PC; and (2) explore the factors (barriers and enablers) that influence the use of a pancreatic protocol computed tomography (PPCT) or magnetic resonance imaging (MRI) to confirm diagnosis and/or accurately stage PC. Methods Semi-structured interviews were conducted with radiologists, surgeons, gastroenterologists, medical and radiation oncologists from the states of New South Wales (NSW) and Victoria, Australia. Interviews were conducted either in person or via video conferencing. All interviews were recorded, transcribed verbatim, de-identified and data were thematically coded according to the 12 domains explored within the Theoretical Domains Framework (TDF). Common belief statements were generated to compare the variation between participant responses. Findings In total, 21 clinicians (5 radiologists, 10 surgeons, 2 gastroenterologists, 4 medical and radiation oncologists) were interviewed over a four-month-period. Belief statements relevant to the TDF domains were generated. Across the 11 relevant domains, 20 themes and 30 specific beliefs were identified. All TDF domains, with the exception of social influences were identified by participants as relevant to protocol-based imaging using either a PPCT or MRI, with the domains of knowledge, skills and environmental context and resources being offered by most participants as being relevant in influencing their decisions. Conclusions To maximise outcomes and personalise therapy it is imperative that diagnosis and staging investigations using the most appropriate imaging modalities are conducted in a timely, efficient and effective manner. The results provide an understanding of specialists' opinion and behaviour in relation to a PPCT or MRI and should be used to inform the design of future interventions to improve compliance with this practice.	[Maharaj, Ashika D.; Evans, Sue M.; Zalcberg, John R.; Ioannou, Liane J.; Green, Sally E.] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [Evans, Sue M.] Canc Council Victoria, Melbourne, Vic, Australia; [Zalcberg, John R.; Graco, Marnie; Pilgrim, Charles H. C.] Alfred Hlth, Melbourne, Vic, Australia; [Croagh, Daniel; Dodson, Theresa] Monash Hlth, Clayton, Vic, Australia; [Goldstein, David] Univ New South Wales, Prince Wales Clin Sch, Randwick, NSW, Australia; [Philip, Jennifer] St Vincents Hosp Melbourne, Melbourne, Vic, Australia; [Philip, Jennifer; Leong, Trevor] Univ Melbourne, Melbourne, Vic, Australia; [Kench, James G.] Royal Prince Alfred Hosp, Camperdown, NSW, Australia; [Merrett, Neil D.] Univ Western Sydney, Sch Med, Penrith, NSW, Australia; [Neale, Rachel E.] QIMR Berghofer Med Res Inst, Herston, Qld, Australia; [White, Kate] Univ Sydney, Sydney Nursing Sch, Sydney, NSW, Australia; [Evans, Peter] Peninsula Hlth, Frankston, Vic, Australia; [Leong, Trevor] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia	Monash University; Cancer Council Victoria; University of New South Wales Sydney; St Vincent's Hospital Melbourne; University of Melbourne; University of Sydney; Western Sydney University; QIMR Berghofer Medical Research Institute; University of Sydney; Peter Maccallum Cancer Center	Green, SE (corresponding author), Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia.	sally.green@monash.edu	goldstein, david/J-6711-2012; Graco, Marnie/AAA-1334-2020; Maharaj, Ashika/ABD-7648-2021; Merrett, Neil/ABB-4342-2021; Merrett, Neil/H-8033-2019	Graco, Marnie/0000-0001-6048-0147; Merrett, Neil/0000-0002-8370-0293; Merrett, Neil/0000-0002-8370-0293; Zalcberg, John/0000-0002-6624-0782; Evans, Sue/0000-0003-2962-8400; Maharaj, Ashika/0000-0002-4725-613X; Philip, Jennifer/0000-0002-3312-0645	Australian National Health and Medical Research Council (NHMRC) [PCR4QI, APP1125395]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	The authors of this study would like to acknowledge the Australian National Health and Medical Research Council (NHMRC) for the Pancreatic Cancer Registry for Quality Improvement (PCR4QI) grant [grant number APP1125395].	Al-Hawary MM, 2014, GASTROENTEROLOGY, V146, P291, DOI 10.1053/j.gastro.2013.11.004; Atkins L, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0589-5; Australian Gastro-Intestinal Trials Group (AGITG), 2015, CONS STAT DEF SURG S; Balaban EP, 2016, J CLIN ONCOL, V34, P2654, DOI 10.1200/JCO.2016.67.5561; Brook OR, 2015, RADIOLOGY, V274, P464, DOI 10.1148/radiol.14140206; Burge ME, 2015, HPB, V17, P624, DOI 10.1111/hpb.12418; Feldman MK, 2016, SURG CLIN N AM, V96, P1235, DOI 10.1016/j.suc.2016.07.007; Francis JJ, 2009, BRIT J HEALTH PSYCH, V14, P625, DOI 10.1348/135910708X397025; French SD, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-38; Gagliardi AR, 2016, PANCREAS, V45, P161, DOI 10.1097/MPA.0000000000000484; Gandy RC, 2016, MED J AUSTRALIA, V204, P419, DOI 10.5694/mja16.00061; Graco M, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4197-8; Hata T, 2016, ANN SURG, V263, P664, DOI 10.1097/SLA.0000000000001437; Horlait M, 2019, J MULTIDISCIP HEALTH, V12, P159, DOI 10.2147/JMDH.S196660; Jeong SA, 2019, EXPERT OPIN BIOL TH, V19, P1085, DOI 10.1080/14712598.2019.1554052; Johnson MJ, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008592; Kartalis N, 2018, EUR RADIOL, V28, P3482, DOI 10.1007/s00330-018-5486-z; Khorana AA, 2017, J CLIN ONCOL, V35, P2324, DOI 10.1200/JCO.2017.72.4948; Kim FJ, 2015, PATIENT SAF SURG, V9, DOI 10.1186/s13037-015-0067-4; Lacey K, 2016, MED J AUSTRALIA, V205, P66, DOI 10.5694/mja15.01169; Lee ES, 2014, WORLD J GASTROENTERO, V20, P7864, DOI 10.3748/wjg.v20.i24.7864; Liles JS, 2014, EXPERT REV ANTICANC, V14, P919, DOI 10.1586/14737140.2014.919860; Maharaj AD, 2021, BMJ QUAL SAF, V30, P792, DOI 10.1136/bmjqs-2020-011793; Maharaj AD, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-031434; Maharaj AD, 2019, HPB, V21, P444, DOI 10.1016/j.hpb.2018.08.016; Michie S, 2005, QUAL SAF HEALTH CARE, V14, P26, DOI 10.1136/qshc.2004.011155; Palinkas LA, 2015, ADM POLICY MENT HLTH, V42, P533, DOI 10.1007/s10488-013-0528-y; Saunders B, 2018, QUAL QUANT, V52, P1893, DOI 10.1007/s11135-017-0574-8; Slavova-Azmanova NS, 2015, MED J AUSTRALIA, V202, P144, DOI 10.5694/mja14.00768; Sohal DPS, 2018, J CLIN ONCOL, V36, P2545, DOI 10.1200/JCO.2018.78.9636; Torgeson A, 2018, ESMO OPEN, V3, DOI 10.1136/esmoopen-2017-000282; Tummers WS, 2018, PANCREAS, V47, P675, DOI 10.1097/MPA.0000000000001075; Woolf SH, 1999, BRIT MED J, V318, P527, DOI 10.1136/bmj.318.7182.527; Zhang LL, 2018, WORLD J GASTROENTERO, V24, P2047, DOI 10.3748/wjg.v24.i19.2047; Zins M, 2018, RADIOLOGY, V287, P374, DOI 10.1148/radiol.2018171670	35	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243312	10.1371/journal.pone.0243312	http://dx.doi.org/10.1371/journal.pone.0243312			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332372	Green Published, gold			2022-12-27	WOS:000601310900023
J	Jaffey, JA; Matheson, J; Shumway, K; Pacholec, C; Ullal, T; Van den Bossche, L; Fieten, H; Ringold, R; Lee, KJ; DeClue, AE				Jaffey, Jared A.; Matheson, Jodi; Shumway, Kate; Pacholec, Christina; Ullal, Tarini; Van den Bossche, Lindsay; Fieten, Hille; Ringold, Randy; Lee, Keun Jung; DeClue, Amy E.			Serum 25-hydroxyvitamin D concentrations in dogs with gallbladder mucocele	PLOS ONE			English	Article							VITAMIN-D CONCENTRATIONS; GALL-BLADDER MUCOCELES; RECEPTOR 4 EXPRESSION; CLINICAL FINDINGS; CYTOKINE PRODUCTION; BILIARY SLUDGE; D DEFICIENCY; BILE-SALTS; ASSOCIATION; DISEASE	Gallbladder mucocele (GBM) is a common biliary disorder in dogs. Gallbladder hypokinesia has been proposed to contribute to its formation and progression. The specific cause of gallbladder stasis in dogs with GBM as well as viable treatment options to resolve dysmotility remains unknown. Vitamin D deficiency is one of the many potential causes of gallbladder hypokinesia in humans and repletion results in complete resolution of stasis. Improving our understanding of the relationship between serum vitamin D and GBM could help identify dogs as a model for humans with gallbladder hypokinesia. Furthermore, this relationship could provide insight into the pathogenesis of GBM and support the need for future studies to investigate vitamin D as a novel treatment target. Therefore, goals of this study were i) to determine if serum 25-hydroxyvitamin(OH)D concentrations were decreased in dogs with GBM, ii) if serum 25(OH)D concentrations were different in clinical versus dogs subclinical for GBM, and iii) to determine if serum 25(OH)D concentrations could predict the ultrasonographic type of GBM. Sixty-two dogs (clinical, n = 26; subclinical, n = 36) with GBM and 20 healthy control dogs were included in this prospective observational study. Serum 25(OH)D concentrations were measured with a competitive chemiluminescence immunoassay. Overall, dogs with GBM had lower serum 25(OH)D concentrations than control dogs (P = 0.004). Subsequent subgroup analysis indicated that this difference was only significant in the subclinical group compared to the control dogs (P = 0.008), and serum 25(OH)D concentrations did not significantly differ between dogs clinical for GBM versus subclinical or control dogs, indicating that inflammatory state in clinical dogs was not the major constituent of the observed findings. Decreasing serum 25(OH)D concentrations, but not clinical status, was associated with a more advanced developmental stage of GBM type determined by ultrasonography. Our results indicate that vitamin D has a role in dogs with GBM. Additional studies are needed to assess if reduced vitamin D in dogs with GBM is a cause or effect of their biliary disease and to investigate if vitamin D supplementation could be beneficial for dogs with GBM.	[Jaffey, Jared A.] Midwestern Univ, Coll Vet Med, Dept Specialty Med, Glendale, AZ 85308 USA; [Matheson, Jodi; Shumway, Kate; Pacholec, Christina; DeClue, Amy E.] Univ Missouri, Dept Vet Med & Surg, Vet Hlth Ctr, Columbia, MO USA; [Ullal, Tarini] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Clin Sci, Ft Collins, CO 80523 USA; [Van den Bossche, Lindsay; Fieten, Hille] Univ Utrecht, Dept Clin Sci Compan Anim, Fac Vet Med, Yalelaan, Utrecht, Netherlands; [Ringold, Randy] VDI Lab LLC, Simi Valley, CA USA; [Lee, Keun Jung] Midwestern Univ, Coll Vet Med, Dept Pathol & Populat Med, Glendale, AZ USA	Midwestern University; University of Missouri System; University of Missouri Columbia; Colorado State University; Utrecht University; Midwestern University	Jaffey, JA (corresponding author), Midwestern Univ, Coll Vet Med, Dept Specialty Med, Glendale, AZ 85308 USA.	jjaffe@midwestern.edu		Ullal, Tarini/0000-0002-8728-3706; Jaffey, Jared/0000-0002-0270-4728	VDI Laboratory, LLC	VDI Laboratory, LLC	VDI Laboratory, LLC provided funding for this study in the form of salary for author RR. This study was not supported by a grant or any other source of external funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agborsangaya C, 2010, NUTR CANCER, V62, P51, DOI 10.1080/01635580903191460; Aguirre AL, 2007, JAVMA-J AM VET MED A, V231, P79, DOI 10.2460/javma.231.1.79; Allerton F, 2018, J VET INTERN MED, V32, P1618, DOI 10.1111/jvim.15249; Anwar E, 2017, NUTR CLIN PRACT, V32, P378, DOI 10.1177/0884533616671741; Barko PC, 2018, J VET INTERN MED, V32, P1600, DOI 10.1111/jvim.15292; Behar J, 2013, NEUROGASTROENT MOTIL, V25, P283, DOI 10.1111/nmo.12094; Besso JG, 2000, VET RADIOL ULTRASOUN, V41, P261, DOI 10.1111/j.1740-8261.2000.tb01489.x; Bhattacharya, 2013, INDIAN J GASTROENTER, V32, pA1; Bolukbas FF, 2006, J GASTROEN HEPATOL, V21, P1150, DOI 10.1111/j.1440-1746.2006.04444.x; Boyan BD, 2003, CONNECT TISSUE RES, V44, P130, DOI 10.1080/03008200390152214; Ceglia L, 2009, CURR OPIN CLIN NUTR, V12, P628, DOI 10.1097/MCO.0b013e328331c707; Ceglia L, 2008, MOL ASPECTS MED, V29, P407, DOI 10.1016/j.mam.2008.07.002; Center SA, 2009, VET CLIN N AM-SMALL, V39, P543, DOI 10.1016/j.cvsm.2009.01.004; Choi J, 2014, VET RADIOL ULTRASOUN, V55, P202, DOI 10.1111/vru.12120; Crews LJ, 2009, JAVMA-J AM VET MED A, V234, P359, DOI 10.2460/javma.234.3.359; DEBOER SY, 1994, DIABETOLOGIA, V37, P75, DOI 10.1007/s001250050075; Edwards MA, 2014, DIGEST DIS SCI, V59, P2773, DOI 10.1007/s10620-014-3213-4; Grobman M, 2017, J VET INTERN MED, V31, P1430, DOI 10.1111/jvim.14787; Hookey TJ, 2018, J NUTR SCI, V7, DOI 10.1017/jns.2018.7; HOW KL, 1994, GEN COMP ENDOCR, V96, P12, DOI 10.1006/gcen.1994.1154; Hurst EA, 2020, VET CLIN PATH, V49, P279, DOI 10.1111/vcp.12859; Jacobs ET, 2016, CANCER PREV RES, V9, P589, DOI 10.1158/1940-6207.CAPR-16-0033; Jaffey JA, 2019, VET J, V251, DOI 10.1016/j.tvjl.2019.105350; Jaffey JA, 2018, VET REC, V183, P26, DOI 10.1016/j.tvjl.2018.04.010; Jaffey JA, 2018, J VET INTERN MED, V32, P195, DOI 10.1111/jvim.14898; Jaffey JA, 2018, AM J VET RES, V79, P1071, DOI 10.2460/ajvr.79.10.1071; Jaffey JA, 2018, AM J VET RES, V79, P1064, DOI 10.2460/ajvr.79.10.1064; Jaffey JA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194062; Jonkers IJAM, 2003, GUT, V52, P109, DOI 10.1136/gut.52.1.109; Kesimer M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138988; Klenk J, 2013, AGE AGEING, V42, P404, DOI 10.1093/ageing/aft042; Kutsunai M, 2014, VET J, V199, P76, DOI 10.1016/j.tvjl.2013.10.019; LAMORTE WW, 1985, SURGERY, V98, P445; Laukkarinen J, 2003, SURGERY, V133, P288, DOI 10.1067/msy.2003.77; Leary PF, 2017, J AM OSTEOPATH ASSOC, V117, P433, DOI 10.7556/jaoa.2017.089; Makishima M, 2002, SCIENCE, V296, P1313, DOI 10.1126/science.1070477; Malek S, 2013, VET SURG, V42, P418, DOI 10.1111/j.1532-950X.2012.01072.x; Merg AR, 2002, J GASTROINTEST SURG, V6, P432, DOI 10.1016/S1091-255X(01)00061-0; Mesich MLL, 2009, J SMALL ANIM PRACT, V50, P630, DOI 10.1111/j.1748-5827.2009.00811.x; Nishida S, 2009, DRUG METAB DISPOS, V37, P2037, DOI 10.1124/dmd.109.027334; Nykjaer A, 1999, CELL, V96, P507, DOI 10.1016/S0092-8674(00)80655-8; Parkanzky M, 2019, J VET INTERN MED, V33, P2057, DOI 10.1111/jvim.15611; Pike FS, 2004, JAVMA-J AM VET MED A, V224, P1615, DOI 10.2460/javma.2004.224.1615; Reid D, 2011, AM J CLIN NUTR, V93, P1006, DOI 10.3945/ajcn.110.008490; Selting KA, 2016, VET COMP ONCOL, V14, P295, DOI 10.1111/vco.12101; Singla R, 2015, DIGEST DIS SCI, V60, P2793, DOI 10.1007/s10620-015-3678-9; SVANVIK J, 1986, J SURG RES, V41, P425, DOI 10.1016/0022-4804(86)90057-0; Thompson PD, 2002, BIOCHEM BIOPH RES CO, V299, P730, DOI 10.1016/S0006-291X(02)02742-0; Tsukagoshi T, 2012, VET RADIOL ULTRASOUN, V53, P84, DOI 10.1111/j.1740-8261.2011.01868.x; van Erpecum KJ, 2006, J LIPID RES, V47, P32, DOI 10.1194/jlr.M500180-JLR200; Walsh JS, 2017, CURR OPIN ENDOCRINOL, V24, P389, DOI 10.1097/MED.0000000000000371; Weidner N, 2017, J VET INTERN MED, V31, P1796, DOI 10.1111/jvim.14834; Worley DR, 2004, JAVMA-J AM VET MED A, V225, P1418, DOI 10.2460/javma.2004.225.1418; Xiao ZL, 2003, HEPATOLOGY, V37, P1442, DOI 10.1053/jhep.2003.50243; Xiao ZL, 2001, AM J PHYSIOL-GASTR L, V281, pG490, DOI 10.1152/ajpgi.2001.281.2.G490; Yoshida T, 2001, BBA-MOL CELL BIOL L, V1530, P199, DOI 10.1016/S1388-1981(00)00183-9	56	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0244102	10.1371/journal.pone.0244102	http://dx.doi.org/10.1371/journal.pone.0244102			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326487	Green Published, gold			2022-12-27	WOS:000600176400051
J	Saudek, K; Treat, R; Rogers, A; Hahn, D; Lauck, S; Saudek, D; Weisgerber, M				Saudek, Kris; Treat, Robert; Rogers, Amanda; Hahn, Danita; Lauck, Sara; Saudek, David; Weisgerber, Michael			A novel faculty development tool for writing a letter of recommendation	PLOS ONE			English	Article							PREDICT PERFORMANCE; SELECTION CRITERIA; RESIDENCY; DIRECTORS; STUDENT; COUNCIL	Objective Based on a national survey of program directors we developed a letter of recommendation (LOR) scoring rubric (SR) to assess LORs submitted to a pediatric residency program. The objective was to use the SR to analyze: the consistency of LOR ratings across raters and LOR components that contributed to impression of the LOR and candidate. Methods We graded 30 LORs submitted to a pediatric residency program that were evenly distributed based on final rank by our program. The SR contained 3 sections (letter features, phrases, and applicant abilities) and 2 questions about the quality of the LOR (LORQ) and impression of the candidate (IC) after reading the LOR on a 5-point Likert scale. Inter-rater reliability was calculated with intraclass correlation coefficients (ICC(2,1)). Pearson (r) correlations and stepwise multivariate linear regression modeling predicted LORQ and IC. Mean scores of phrases, features, and applicant abilities were analyzed with ANOVA and Bonferroni correction. Results Phrases (ICC(2,1) = 0.82, p<0.001)) and features (ICC(2,1) = 0.60, p<0.001)) were rated consistently, while applicant abilities were not (ICC(2,1) = 0.28, p<0.001)). For features, LORQ (R-2 = 0.75, p<0.001) and IC (R-2 = 0.58, p<0.001) were best predicated by: writing about candidates' abilities, strength of recommendation, and depth of interaction with the applicant. For abilities, LORQ (R-2 = 0.47, p<0.001) and IC (R-2 = 0.51, p<0.001) were best predicted by: clinical reasoning, leadership, and communication skills (0.2). There were significant differences for phrases and features (p<0.05). Conclusions The SR was consistent across raters and correlates with impression of LORQ and IC. This rubric has potential as a faculty development tool for writing LORS.	[Saudek, Kris] Med Coll Wisconsin, Dept Pediat, Div Neonatol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Treat, Robert] Med Coll Wisconsin, Dept Acad Affairs, Milwaukee, WI 53226 USA; [Rogers, Amanda; Hahn, Danita; Lauck, Sara; Weisgerber, Michael] Div Hosp Med, Dept Pediat, Milwaukee, WI USA; [Saudek, David] Dept Pediat, Div Cardiol, Milwaukee, WI USA	Medical College of Wisconsin; Medical College of Wisconsin	Saudek, K (corresponding author), Med Coll Wisconsin, Dept Pediat, Div Neonatol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	ksaudek@mcw.edu		Treat, Robert/0000-0003-2291-3858; Rogers, Amanda/0000-0002-8320-9293; saudek, kris/0000-0003-4997-1927				Blechman A, 2008, J REPROD MED, V53, P793; Dayal A, 2017, JAMA INTERN MED, V177, P651, DOI 10.1001/jamainternmed.2016.9616; DeZee KJ, 2014, ACAD MED, V89, P1408, DOI 10.1097/ACM.0000000000000425; DeZee KJ, 2009, TEACH LEARN MED, V21, P153, DOI 10.1080/10401330902791347; Dirschl DR, 2000, ACAD MED, V75, P1029, DOI 10.1097/00001888-200010000-00022; FRIEDMAN RB, 1983, NEW ENGL J MED, V308, P651, DOI 10.1056/NEJM198303173081110; Grall KH, 2014, WEST J EMERG MED, V15, P419, DOI 10.5811/westjem.2014.2.19158; Green M, 2009, ACAD MED, V84, P362, DOI 10.1097/ACM.0b013e3181970c6b; Hartman Nicholas D, 2019, J Grad Med Educ, V11, P268, DOI 10.4300/JGME-D-18-00979.3; Hegarty Cullen B, 2014, J Grad Med Educ, V6, P301, DOI 10.4300/JGME-D-13-00299; Holmes AV, 2014, PEDIATRICS, V133, P766, DOI 10.1542/peds.2014-0418; Kenny S, 2013, MED EDUC, V47, P790, DOI 10.1111/medu.12234; Love JN, 2013, ACAD EMERG MED, V20, P926, DOI 10.1111/acem.12214; Lye PS, 2001, AMBUL PEDIATR, V1, P128, DOI 10.1367/1539-4409(2001)001<0128:APTWWA>2.0.CO;2; Mueller Anna S, 2017, J Grad Med Educ, V9, P577, DOI 10.4300/JGME-D-17-00126.1; National Resident Matching Program, RES DAT 2020 MAIN RE; National Resident Matching Program, 2018, RES 2018 NRMP PROGR; Nehler Mark, 2018, J Grad Med Educ, V10, P267, DOI 10.4300/JGME-D-18-00258.1; Puscas Liana, 2016, J Grad Med Educ, V8, P314, DOI 10.4300/JGME-D-16-00237.1; Raman T, 2016, CLIN ORTHOP RELAT R, V474, P908, DOI 10.1007/s11999-015-4317-7; Ross DA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181659; Saudek K, 2019, ACAD MED, V94, pS64, DOI 10.1097/ACM.0000000000002919; Saudek Kris, 2018, J Grad Med Educ, V10, P261, DOI 10.4300/JGME-D-17-00712.1; SCHNEIDERMAN H, 1988, JAMA-J AM MED ASSOC, V259, P87, DOI 10.1001/jama.259.1.87; Stohl Hindi E, 2011, J Grad Med Educ, V3, P387, DOI 10.4300/JGME-D-11-00010.1	25	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0244016	10.1371/journal.pone.0244016	http://dx.doi.org/10.1371/journal.pone.0244016			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326489	gold, Green Published			2022-12-27	WOS:000600176400067
J	Zhang, RF; Cheng, G; Chen, XL				Zhang, Ruofei; Cheng, Gary; Chen, Xieling			Game-based self-regulated language learning: Theoretical analysis and bibliometrics	PLOS ONE			English	Article							EFFICACY; ENGLISH; TECHNOLOGY; STRATEGIES	Game-based learning and self-regulated learning have long been valued as effective approaches to language education. However, little research has been conducted to investigate their integration, namely, game-based self-regulated language learning (GBSRLL). This study aims to conceptualise GBSRLL based on the combination of theoretical analysis, thematic evolution analysis, and social network analysis on the research articles in the fields of game-based language learning and self-regulated language learning. The results show that GBSRLL is a new interdisciplinary field emerging since the period from 2018 to 2019. Self-regulated learning strategies that can be performed in GBSRLL, the effects of GBSRLL on learners' affective states, and the features in GBSRLL were the prominent research topics in this field. Its theoretical foundation centres on the positive correlations between learner motivation, self-efficacy, and autonomy and the implementation of game-based learning and self-regulated learning. It is feasible to conduct GBSRLL due to the strong supportiveness of game mechanics for various phases and strategies of self-regulated learning. More contributions to this new interdisciplinary field are called for, especially from the aspects of the long-term effects of GBSRLL on academic performance and the useful tools and technologies for implementing GBSRLL.	[Zhang, Ruofei] Educ Univ Hong Kong, Dept English Language Educ, Hong Kong, Peoples R China; [Cheng, Gary; Chen, Xieling] Educ Univ Hong Kong, Dept Math & Informat Technol, Hong Kong, Peoples R China	Education University of Hong Kong (EdUHK); Education University of Hong Kong (EdUHK)	Cheng, G (corresponding author), Educ Univ Hong Kong, Dept Math & Informat Technol, Hong Kong, Peoples R China.	chengks@eduhk.hk		Cheng, Gary/0000-0002-5614-3348	One-off Special Fund from Central and Faculty Fund [MIT02/19-20]; Research Cluster Fund of The Education University of Hong Kong [RG 78/2019-2020R]	One-off Special Fund from Central and Faculty Fund; Research Cluster Fund of The Education University of Hong Kong	This study was supported by One-off Special Fund from Central and Faculty Fund in Support of Research from 2019/20 to 2021/22 (MIT02/19-20) and Research Cluster Fund (RG 78/2019-2020R) of The Education University of Hong Kong. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annetta LA, 2010, REV GEN PSYCHOL, V14, P105, DOI 10.1037/a0018985; [Anonymous], 2019, INT WORKSH HUM BRAIN; Bai B, 2020, LANG TEACH RES, DOI 10.1177/1362168820933190; Bai B, 2018, READ WRIT Q, V34, P523, DOI 10.1080/10573569.2018.1499058; Bandura A., 1997, SELF EFFICACY EXERCI, P36, DOI 10.1007/SpringerReference_223312; Bastian M., 2009, ICWSM, V3, P361, DOI 10.13140/2.1.1341.1520; Braghirolli LF, 2016, COMPUT HUM BEHAV, V58, P315, DOI 10.1016/j.chb.2015.12.063; Broadbent J, 2015, INTERNET HIGH EDUC, V27, P1, DOI 10.1016/j.iheduc.2015.04.007; Chen X, 2020, COMPUT EDUC, V151, DOI 10.1016/j.compedu.2020.103855; Chen XL, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231192; Chen XL, 2020, BRIT J EDUC TECHNOL, V51, P692, DOI 10.1111/bjet.12907; Chen YL, 2020, COMPUT EDUC, V154, DOI 10.1016/j.compedu.2020.103910; Chik A, 2014, LANG LEARN TECHNOL, V18, P85; Dent AL, 2016, EDUC PSYCHOL REV, V28, P425, DOI 10.1007/s10648-015-9320-8; Fu QK, 2018, COMPUT EDUC, V119, P129, DOI 10.1016/j.compedu.2018.01.004; Garcia R, 2018, COMPUT EDUC, V123, P150, DOI 10.1016/j.compedu.2018.05.006; Godwin-Jones R, 2011, LANG LEARN TECHNOL, V15, P4; Goudarzi E, 2014, PRAGMAT COGN, V22, P325, DOI 10.1075/pc.22.3.03gou; Guo YR, 2017, ASLIB J INFORM MANAG, V69, P46, DOI 10.1108/AJIM-08-2016-0131; Hromalik CD, 2018, DISTANCE EDUC, V39, P528, DOI 10.1080/01587919.2018.1520044; Hsu TC, 2017, COMPUT EDUC, V106, P137, DOI 10.1016/j.compedu.2016.12.007; Hung HT, 2018, COMPUT EDUC, V126, P89, DOI 10.1016/j.compedu.2018.07.001; Khodarahmi E, 2016, CURR PSYCHOL, V35, P700, DOI 10.1007/s12144-015-9340-z; Lai C, 2017, ADV DIGIT LANG LEARN, P1; Lin V, 2020, COMPUT ASSIST LANG L, V2020, P1; Liu YC, 2021, J EDUC COMPUT RES, V59, P3, DOI 10.1177/0735633120952044; Mahayanti NWS, 2020, ASIAN ESP J, V5, P5; Malone T.W., 1987, APTITUDE LEARNING IN, V1st ed., P223, DOI [10.4324/9781003163244, DOI 10.4324/9781003163244]; Mizumoto A, 2013, INNOV LANG LEARN TEA, V7, P253, DOI 10.1080/17501229.2013.836206; Panadero E, 2017, EDUC RES REV-NETH, V22, P74, DOI 10.1016/j.edurev.2017.08.004; Park J, 2019, COMPUT EDUC, V139, P1, DOI 10.1016/j.compedu.2019.04.016; Perttula A, 2017, INT J SERIOUS GAMES, V4, P57, DOI 10.17083/ijsg.v4i1.151; Prell C, 2009, SOC NATUR RESOUR, V22, P501, DOI 10.1080/08941920802199202; Schunk DH, 2016, EDUC PSYCHOL HANDB, P34; Serrat O., 2017, KNOWLEDGE SOLUTIONS, DOI [10.1007/978-981-10-0983-9_9, DOI 10.1007/978-981-10-0983-9_9]; Teng LS, 2016, MOD LANG J, V100, DOI 10.1111/modl.12339; TOBLER WR, 1970, ECON GEOGR, V46, P234, DOI 10.2307/143141; Tseng WT, 2006, APPL LINGUIST, V27, P78, DOI 10.1093/applin/ami046; Vandercruysse S, 2013, ETR&D-EDUC TECH RES, V61, P927, DOI 10.1007/s11423-013-9314-5; Warschauer M, 2011, STUD SELF-ACCESS LEA, V2, P107; Yang JC, 2016, J EDUC COMPUT RES, V54, P371, DOI 10.1177/0735633115620433; Yang QF, 2020, COMPUT EDUC, V148, DOI 10.1016/j.compedu.2020.103808; Yukselturk E, 2018, EDUC TECHNOL SOC, V21, P159; Zhang LJ, 2008, BRIT J EDUC PSYCHOL, V78, P245, DOI 10.1348/000709907X218179; Zhang R, 2020, COMPUT ASSIST LANG L, V2020, P1; Zimmerman B., 2000, HDB SELF REGULATION, P13, DOI [DOI 10.1016/B978-012109890-2/50031-7, 10.1016/B978-012109890-2/50031-7]; Zimmerman BJ, 2002, THEOR PRACT, V41, P64, DOI 10.1207/s15430421tip4102_2; ZIMMERMAN BJ, 1986, AM EDUC RES J, V23, P614, DOI 10.3102/00028312023004614; Zou D, 2019, CRIT REV MICROBIOL, V45, P239, DOI 10.1080/1040841X.2019.1575793	49	3	3	12	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243827	10.1371/journal.pone.0243827	http://dx.doi.org/10.1371/journal.pone.0243827			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH1IW	33326464	Green Published, gold			2022-12-27	WOS:000600176400044
J	Correa, TD; Cordioli, RL; Guerra, JCC; da Silva, BC; Rodrigues, RD; de Souza, GM; Midega, TD; Campos, NS; Carneiro, BV; Campos, FND; Guimaraes, HP; de Matos, GFJ; de Aranda, VF; Ferraz, LJR				Correa, Thiago Domingos; Cordioli, Ricardo Luiz; Campos Guerra, Joao Carlos; da Silva, Bruno Caldin; Rodrigues, Roseny dos Reis; de Souza, Guilherme Martins; Midega, Thais Dias; Campos, Niklas Soderberg; Carneiro, Barbara Vieira; Dias Campos, Flavia Nunes; Guimaraes, Helio Penna; Janot de Matos, Gustavo Faissol; de Aranda, Valdir Fernandes; Rolim Ferraz, Leonardo Jose			Coagulation profile of COVID-19 patients admitted to the ICU: An exploratory study	PLOS ONE			English	Article							PROTEIN-C CONCENTRATIONS; INTENSIVE-CARE; DISEASE; SCORE	Background Coagulation abnormalities in COVID-19 patients have not been addressed in depth. Objective To perform a longitudinal evaluation of coagulation profile of patients admitted to the ICU with COVID-19. Methods Conventional coagulation tests, rotational thromboelastometry (ROTEM), platelet function, fibrinolysis, antithrombin, protein C and S were measured at days 0, 1, 3, 7 and 14. Based on median total maximum SOFA score, patients were divided in two groups: SOFA <= 10 and SOFA > 10. Results Thirty patients were studied. Some conventional coagulation tests, as aPTT, PT and INR remained unchanged during the study period, while alterations on others coagulation laboratory tests were detected. Fibrinogen levels were increased in both groups. ROTEM maximum clot firmness increased in both groups from Day 0 to Day 14. Moreover, ROTEM-FIBTEM maximum clot firmness was high in both groups, with a slight decrease from day 0 to day 14 in group SOFA <= 10 and a slight increase during the same period in group SOFA > 10. Fibrinolysis was low and decreased over time in all groups, with the most pronounced decrease observed in INTEM maximum lysis in group SOFA > 10. Also, D-dimer plasma levels were higher than normal reference range in both groups and free protein S plasma levels were low in both groups at baseline and increased over time, Finally, patients in group SOFA > 10 had lower plasminogen levels and Protein C than patients with SOFA <10, which may represent less fibrinolysis activity during a state of hypercoagulability. Conclusion COVID-19 patients have a pronounced hypercoagulability state, characterized by impaired endogenous anticoagulation and decreased fibrinolysis. The magnitude of coagulation abnormalities seems to correlate with the severity of organ dysfunction. The hypercoagulability state of COVID-19 patients was not only detected by ROTEM but it much more complex, where changes were observed on the fibrinolytic and endogenous anticoagulation system.	[Correa, Thiago Domingos; Cordioli, Ricardo Luiz; da Silva, Bruno Caldin; Rodrigues, Roseny dos Reis; de Souza, Guilherme Martins; Midega, Thais Dias; Campos, Niklas Soderberg; Carneiro, Barbara Vieira; Dias Campos, Flavia Nunes; Guimaraes, Helio Penna; Janot de Matos, Gustavo Faissol; Rolim Ferraz, Leonardo Jose] Hosp Israelita Albert Einstein, Dept Crit Care Med, Sao Paulo, Brazil; [Campos Guerra, Joao Carlos; de Aranda, Valdir Fernandes] Hosp Israelita Albert Einstein, Dept Lab Ctr, Sao Paulo, Brazil	Hospital Israelita Albert Einstein; Hospital Israelita Albert Einstein	Cordioli, RL (corresponding author), Hosp Israelita Albert Einstein, Dept Crit Care Med, Sao Paulo, Brazil.	ricardo.cordioli@einstein.br	Midega, Thais/HGB-9347-2022; Silva, Bruno C/AAE-6350-2020	Silva, Bruno C/0000-0001-9568-0974; Martins de Souza, Guilherme/0000-0002-0643-2723				Barrett CD, 2020, J THROMB HAEMOST, V18, P2060, DOI 10.1111/jth.14860; Berlin DA, 2020, N ENGL J MED; BERTOZZI P, 1990, NEW ENGL J MED, V322, P890, DOI 10.1056/NEJM199003293221304; Bikdeli B, 2020, J AM COLL CARDIOL, V75, P2950, DOI 10.1016/j.jacc.2020.04.031; Brunkhorst F, 2007, ANESTHESIOLOGY, V107, P15, DOI 10.1097/01.anes.0000267531.39410.d3; Chen T, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m1091, 10.1136/bmj.m1295]; Collett LW, 2020, AUST CRIT CARE; Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045; Creel-Bulos C, 2021, SHOCK, V55, P316, DOI 10.1097/SHK.0000000000001635; Crochemore T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192965; Crochemore T, 2017, EINSTEIN-SAO PAULO, V15, P380, DOI [10.1590/S1679-45082017MD3130, 10.1590/s1679-45082017md3130]; Dolhnikoff M, 2020, J THROMB HAEMOST, V18, P1517, DOI 10.1111/jth.14844; Escher R, 2020, THROMB RES, V190, P62, DOI 10.1016/j.thromres.2020.04.014; Gralinski LE, 2013, MBIO, V4, DOI 10.1128/mBio.00271-13; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Han H, 2020, CLIN CHEM LAB MED, V58, P1116, DOI 10.1515/cclm-2020-0188; Hardy M, 2020, J THROMB HAEMOST, V18, P3121, DOI 10.1111/jth.15061; Helms J, 2020, INTENS CARE MED, V46, P1089, DOI 10.1007/s00134-020-06062-x; Ibanez C, 2021, J THROMB THROMBOLYS, V51, P308, DOI 10.1007/s11239-020-02226-0; Joly BS, 2020, INTENS CARE MED, V46, P1603, DOI 10.1007/s00134-020-06088-1; Klok FA, 2020, THROMB RES, V191, P145, DOI [10.1016/j.thromres.2020.04.041, 10.1016/j.thromres.2020.04.013]; Lier H, 2013, HAMOSTASEOLOGIE, V33, P51, DOI 10.5482/HAMO-12-05-0011; Lippi G, 2020, CLIN CHIM ACTA, V506, P145, DOI 10.1016/j.cca.2020.03.022; Lodigiani C, 2020, THROMB RES, V191, P9, DOI 10.1016/j.thromres.2020.04.024; Medcalf RL, 2020, J THROMB HAEMOST, V18, P2118, DOI 10.1111/jth.14960; Mesters RM, 2000, CRIT CARE MED, V28, P2209, DOI 10.1097/00003246-200007000-00005; Moreno R, 1999, INTENS CARE MED, V25, P686, DOI 10.1007/s001340050931; Moreno RP, 2005, INTENS CARE MED, V31, P1345, DOI 10.1007/s00134-005-2763-5; Mortus JR, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.11192; Nougier C, 2020, J THROMB HAEMOST, V18, P2215, DOI 10.1111/jth.15016; Panigada M, 2020, J THROMB HAEMOST, V18, P1738, DOI 10.1111/jth.14850; Pavoni V, 2020, J THROMB THROMBOLYS, V50, P281, DOI 10.1007/s11239-020-02130-7; Petricevic M, 2016, ANAESTHESIA, V71, P636, DOI 10.1111/anae.13303; Petrilli CM, 2020, BMJ-BRIT MED J, V369, DOI [10.1136/bmj.m1966, 10.12890/2020_001747]; Ranucci M, 2020, J THROMB HAEMOST, V18, P1747, DOI 10.1111/jth.14854; Sarangi PP, 2010, BRIT J HAEMATOL, V148, P817, DOI 10.1111/j.1365-2141.2009.08020.x; Semeraro F, 2018, CRIT CARE MED, V46, pe221, DOI 10.1097/CCM.0000000000002919; Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]; Whiting D, 2014, AM J HEMATOL, V89, P228, DOI 10.1002/ajh.23599; Wool GD, 2021, PATHOBIOLOGY, V88, P15, DOI 10.1159/000512007; Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994; Yan SB, 2001, CHEST, V120, P915, DOI 10.1378/chest.120.3.915; Zampieri Fernando Godinho, 2017, Rev. bras. ter. intensiva, V29, P418, DOI [10.5935/0103-507X.20170062, 10.5935/0103-507x.20170062]; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	47	25	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243604	10.1371/journal.pone.0243604	http://dx.doi.org/10.1371/journal.pone.0243604			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320874	Green Published, gold			2022-12-27	WOS:000600339800051
J	Morean, ME; Bold, KW; Kong, G; Camenga, DR; Jackson, A; Simon, P; Davis, DR; Krishnan-Sarin, S				Morean, Meghan E.; Bold, Krysten W.; Kong, Grace; Camenga, Deepa R.; Jackson, Asti; Simon, Patricia; Davis, Danielle R.; Krishnan-Sarin, Suchitra			High school students' use of JUUL pod flavors before and after JUUL implemented voluntary sales restrictions on certain flavors in 2018	PLOS ONE			English	Article							UNITED-STATES	Objectives In November 2018, JUUL, Inc. restricted sales of mango, fruit medley, creme brulee, and cucumber pods to its website. Physical/online sales of tobacco, menthol, and mint pods continued. We examined rates of adolescent JUUL device and flavored pod use before and after restrictions were implemented to examine their potential impact. Methods Students from 4 Connecticut high schools completed cross-sectional surveys in 2018 (N = 3170) and 2019 (N = 3074). Results Compared to 2018, current (past-month) JUUL use decreased in 2019 (30.2-25.6%). Among current JUUL users, restricted flavor use (mango [62.8-36.9%]; cucumber [27.7-11.9%]; fruit [23.5-11.4%]; creme brulee [12.3-5.0%]) and the total number of flavors used (2.09[SD = 1.71]-1.51[SD = 1.33]) decreased (p-values < .001), while mint pod use increased (62.0-68.6%, p < .01). Tobacco and menthol pod use remained stable. Conclusions Following voluntary sales restrictions implemented by JUUL, Inc., restricted flavor use and the total number of flavors used decreased among JUUL users while mint use increased. Results suggest flavor restrictions may impact adolescents' e-cigarette use. While 2020 Food and Drug Administration restrictions on mint pods may further limit youth JUUL use, research is needed to determine where youth acquire restricted flavors and if restrictions prompt increased popularity of unrestricted devices/e-liquids.	[Morean, Meghan E.; Bold, Krysten W.; Kong, Grace; Jackson, Asti; Simon, Patricia; Davis, Danielle R.; Krishnan-Sarin, Suchitra] Yale Sch Med, Dept Psychiat, New Haven, CT 06510 USA; [Camenga, Deepa R.] Yale Sch Med, Dept Emergency Med, New Haven, CT USA; [Camenga, Deepa R.] Yale Sch Med, Dept Pediat, New Haven, CT USA	Yale University; Yale University; Yale University	Morean, ME (corresponding author), Yale Sch Med, Dept Psychiat, New Haven, CT 06510 USA.	meghan.morean@yale.edu		morean, meghan/0000-0003-4865-1155	NIDA [P50DA036151, U54DA036151]; FDA Center for Tobacco Products (CTP)	NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); FDA Center for Tobacco Products (CTP)(United States Department of Health & Human Services)	Research reported in this publication was supported by grant numbers P50DA036151 and U54DA036151 from the NIDA and FDA Center for Tobacco Products (CTP). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or the Food and Drug Administration. These grants were received by SKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Administration UFaD, 2020, ENF PRIOR EL NIC DEL; [Anonymous], 2019, NATL YOUTH TOBACCO S; Barrington-Trimis JL, 2018, NEW ENGL J MED, V379, P1099, DOI 10.1056/NEJMp1805758; Cullen KA, 2019, JAMA-J AM MED ASSOC, V322, P2095, DOI 10.1001/jama.2019.18387; Delnevo C, 2020, TOB CONTROL, V29, pE150, DOI 10.1136/tobaccocontrol-2019-055485; Erythropel HC, 2019, AM J PREV MED, V57, P425, DOI 10.1016/j.amepre.2019.04.004; Johnson AL, 2018, NICOTINE TOB RES, V1, P1; JUUL Inc, 2019, UPD JUUL COMS ONL AG; Kong G, 2019, DRUG ALCOHOL DEPEN, V205, DOI 10.1016/j.drugalcdep.2019.107691; Krishnan-Sarin S, 2019, DRUG ALCOHOL DEPEN, V194, P395, DOI 10.1016/j.drugalcdep.2018.10.022; Leavens ELS, 2019, ADDICT BEHAV, V95, P178, DOI 10.1016/j.addbeh.2019.02.011; Leventhal AM, 2019, JAMA-J AM MED ASSOC, V322, P2132, DOI 10.1001/jama.2019.17968; Liber A, 2020, AM J PUBLIC HEALTH, V110, P785, DOI 10.2105/AJPH.2020.305667; Walley SC, 2019, PEDIATRICS, V143, DOI 10.1542/peds.2018-2741; Wang TW, 2019, MMWR SURVEILL SUMM, V68, P1, DOI 10.15585/mmwr.ss6812a1	15	5	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243368	10.1371/journal.pone.0243368	http://dx.doi.org/10.1371/journal.pone.0243368			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH3TP	33320885	Green Published, gold			2022-12-27	WOS:000600339800030
J	Olakunde, BO; Pharr, JR; Chien, LC; Benfield, RD; Sy, FS				Olakunde, Babayemi O.; Pharr, Jennifer R.; Chien, Lung-Chang; Benfield, Rebecca D.; Sy, Francisco S.			Individual- and country-level correlates of female permanent contraception use in sub-Saharan Africa	PLOS ONE			English	Article							MULTILEVEL LOGISTIC-REGRESSION; BRIEF CONCEPTUAL TUTORIAL; TUBAL-LIGATION; SOCIAL EPIDEMIOLOGY; FERTILITY DESIRES; BEHAVIORAL-MODEL; STERILIZATION; WOMEN; ACCESS; HEALTH	Background Female permanent contraception is a cost-effective contraceptive method that can help clients with the desire to limit childbearing achieve their reproductive intention. However, despite its benefits, the use of FPC remains low in sub-Saharan Africa (SSA), and limited studies have examined the correlates of its uptake. In this study, we assessed the individual- and country-level factors associated with the use of FPC among married or in-union women using modern contraceptive methods to limit childbearing in SSA. Methods This study was a secondary data analysis of individual- and country-level data obtained from the Demographic and Health Surveys (DHS) Program and three open data repositories. The study included 29,777 married or in-union women aged 15-49 years using modern contraceptive methods to limit childbearing from DHS conducted in 33 sub-Sahara African countries between 2010 and 2018. We performed descriptive statistics and fitted multilevel logistic regression models to determine the predisposing, enabling, and need factors associated with the use of FPC. Results Approximately 13% of the women used FPC. About 20% of the variance in the odds of using FPC was attributable to between-country differences. In the full model, the significant individual-level factors associated with the use of FPC compared with other modern contraceptive methods were: age (odds ratio [OR] = 1.10; 95%CI = 1.08-1.12), living children (OR = 1.11, 95%CI = 1.04-1.16), high household wealth (OR = 1.39, 95%CI = 1.18-1.64), rural residence (OR = 0.83, 95% CI = 0.71-0.97), joint contraceptive decision with partner (OR = 1.68, 95% = 1.43-1.99), contraceptive decision by partner and others (OR = 2.46, 95% = 1.97-3.07), and the number of living children less than the ideal number of children (OR = 1.40, 95%CI = 1.21-1.62). The significantly associated country-level factors were births attended by skilled health providers (OR = 1.03, 95%CI = 1.00-1.05) and density of medical doctors (OR = 1.37, 95%CI = 1.01-1.85). Conclusions Our results suggest that both individual- and country-level factors affect uptake of FPC in SSA. Increasing geographic, economic, and psychosocial access to FPC may improve its uptake in SSA.	[Olakunde, Babayemi O.; Pharr, Jennifer R.; Sy, Francisco S.] Univ Nevada, Sch Publ Hlth, Dept Environm & Occupat Hlth, Las Vegas, NV 89154 USA; [Olakunde, Babayemi O.] Natl Agcy Control AIDS, Dept Community Prevent & Care Serv, Abuja, Nigeria; [Chien, Lung-Chang] Univ Nevada, Sch Publ Hlth, Dept Epidemiol & Biostat, Las Vegas, NV 89154 USA; [Benfield, Rebecca D.] Univ Nevada, Sch Nursing, Las Vegas, NV 89154 USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Olakunde, BO (corresponding author), Univ Nevada, Sch Publ Hlth, Dept Environm & Occupat Hlth, Las Vegas, NV 89154 USA.; Olakunde, BO (corresponding author), Natl Agcy Control AIDS, Dept Community Prevent & Care Serv, Abuja, Nigeria.	olakunde@unlv.nevada.edu		Pharr, Jennifer/0000-0002-0383-2641				Adegoke A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040220; Alemayehu M, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-6; Andersen R, 1968, BEHAV MODEL FAMILIES BEHAV MODEL FAMILIES; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Andersen RM, 2008, MED CARE, V46, P647, DOI [10.1097/MLR.0b013e31817a835d, 10.1097/MLR.0b013e31817f4d48]; Anderson JE, 2012, CONTRACEPTION, V85, P552, DOI 10.1016/j.contraception.2011.10.009; Austin PC, 2017, STAT MED, V36, P3257, DOI 10.1002/sim.7336; Baatiema L, 2019, ADV PUBLIC HEAL, V2019, P1; Balogun OR, 2017, J MED BIOMED SCI, V6, P1, DOI 10.4314/jmbs.v6i3.1; Bass LE, 2013, SOCIOL FOCUS, V46, P47; Blackstone SR, 2017, INT Q COMMUNITY HEAL, V37, P79, DOI 10.1177/0272684X16685254; Blanc AK, 2001, STUD FAMILY PLANN, V32, P189, DOI 10.1111/j.1728-4465.2001.00189.x; Borrero S, 2007, OBSTET GYNECOL, V109, P94, DOI 10.1097/01.AOG.0000249604.78234.d3; Bradley SEK, 2011, DHS ANAL STUDIES; Casterline JB, 2017, DEMOGR RES, V36, P427, DOI 10.4054/DemRes.2017.36.14; Channon MD, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219736; CHIBALONZA K, 1989, STUD FAMILY PLANN, V20, P273, DOI 10.2307/1966764; Choi Y, 2019, CONTRACEPTION, V99, P131, DOI 10.1016/j.contraception.2018.10.006; Croft TN, 2018, GUIDE DHS STAT; Daniele MAS, 2018, B WORLD HEALTH ORGAN, V96, P450, DOI [10.2471/BLT.17.206466, 10.2471/blt.17.206466]; Darroch J.E., 2017, ADDING IT INVESTING; de Oliveira IT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086654; Dereuddre R, 2016, SOC SCI MED, V161, P1, DOI [10.10161/j.socscimed.2016.05.030, 10.1016/j.socscimed.2016.05.030]; EASTERLIN RA, 1988, STUD FAMILY PLANN, V19, P257, DOI 10.2307/1966791; EASTERLIN RA, 1975, STUD FAMILY PLANN, V6, P54, DOI 10.2307/1964934; Edmeades J, 2011, GLOB PUBLIC HEALTH, V6, P407, DOI 10.1080/17441692.2010.533686; EngenderHealth, 2002, CONTR STER GLOB ISS; Fabic MS, 2019, GLOB HEALTH-SCI PRAC, V7, P564, DOI 10.9745/GHSP-D-19-00298; Festin MPR, 2016, CONTRACEPTION, V94, P289, DOI 10.1016/j.contraception.2016.05.015; Ghosh S, 2017, J BIOSOC SCI, V49, P48, DOI 10.1017/S0021932016000080; Gordon-Maclean C, 2014, INT J GYNECOL OBSTET, V124, P34, DOI 10.1016/j.ijgo.2013.07.016; Guttmacher Institute, 2017, ADD IT INV CONTR MAT; Jacobs C, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00011; Jacobstein R, 2013, STUD FAMILY PLANN, V44, P85, DOI 10.1111/j.1728-4465.2013.00345.x; Kriel Y, 2019, REPROD HEALTH, V16, DOI 10.1186/s12978-019-0749-y; Larsen K, 2005, AM J EPIDEMIOL, V161, P81, DOI 10.1093/aje/kwi017; Lunde B, 2013, OBSTET GYNECOL, V122, P304, DOI 10.1097/AOG.0b013e31829b5a11; Lutala PM, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-38; Marie Stopes International EngenderHealth  International IntraHealth  International Planned Parenthood Federation Population Council Jhpiego, 2014, INCR ACC HIGH QUAL V; Mengesha ZB, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0598-9; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P729, DOI 10.1136/jech.2004.023929; Merlo J, 2006, J EPIDEMIOL COMMUN H, V60, P290, DOI 10.1136/jech.2004.029454; Micks EA, 2015, WOMENS HEALTH, V11, P769, DOI 10.2217/whe.15.69; Midi H, 2010, J INTERDISCIP MATH, V13, P253, DOI 10.1080/09720502.2010.10700699; Mohanty SK, 2020, BMC WOMENS HEALTH, V20, DOI 10.1186/s12905-020-0884-1; Musalia JM, 2005, SEX ROLES, V53, P835, DOI 10.1007/s11199-005-8296-0; Nuccio O, 2017, HEALTH POLICY PLANN, V32, P163, DOI 10.1093/heapol/czw105; Nyongesa C, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1727-z; Olakunde BO, 2019, CONTRACEPTION, V99, P205, DOI 10.1016/j.contraception.2018.12.007; Perpetuo HIO, 2003, POVERTY FERTILITY FA, P311; Ren R., NOTE DHS STANDARD WE; RODRIGUES J, 1995, J BIOSOC SCI, V27, P339, DOI 10.1017/S0021932000022860; Rutaremwa G, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1611-y; Seiber EE, 2007, INT FAM PLAN PERSPEC, V33, P117, DOI 10.1363/3311707; Sennott C, 2012, INT PERSPECT SEX R H, V38, P34, DOI 10.1363/3803412; Shattuck D, 2011, AM J PUBLIC HEALTH, V101, P1089, DOI 10.2105/AJPH.2010.300091; Sonfield A, 2013, SOCIAL EC BENEFITS W; Speizer IS, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0729-3; Speizer IS, 2000, INT FAM PLAN PERSPEC, V26, P13, DOI 10.2307/2648285; Stephenson R, 2006, J HEALTH POPUL NUTR, V24, P100; The RESPOND Project, 2014, MATT FACT MATT CHOIC; Thind A, 2005, J FAM PLAN REPROD H, V31, P34, DOI 10.1783/0000000052972762; Tumlinson K, 2015, CONTRACEPTION, V92, P143, DOI 10.1016/j.contraception.2015.04.002; United Nations Department of Economic and Social Affairs Population Division., 2019, CONTR US METH 2019 D; United Nations Department of Economic and Social Affairs Population Division, 2015, TRENDS CONTR US WORL; Van Lith LM, 2013, GLOB HEALTH-SCI PRAC, V1, P97, DOI 10.9745/GHSP-D-12-00036; von Lengerke T., 2014, HLTH CARE UTILIZATIO, DOI DOI 10.1007/978-1-4614-9191-0_2; Westoff CF, 2000, INT FAM PLAN PERSPEC, V26, P56, DOI 10.2307/2648268; Westoff CF, 2012, UNMET NEED MODERN CO; White K, 2015, WOMEN HEALTH ISS, V25, P628, DOI 10.1016/j.whi.2015.06.011; World Health Organization, 2012, WHO REC OPT HLTH WOR	71	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243316	10.1371/journal.pone.0243316	http://dx.doi.org/10.1371/journal.pone.0243316			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH3TP	33320877	gold, Green Published			2022-12-27	WOS:000600339800005
J	Ali, N; Bello, GL; Rossetti, MLR; Krieger, MA; Costa, ADT				Ali, Nasir; Bello, Graziele Lima; Rosa Rossetti, Maria Lucia; Krieger, Marco Aurelio; Tavares Costa, Alexandre Dias			Demonstration of a fast and easy sample-to-answer protocol for tuberculosis screening in point-of-care settings: A proof of concept study	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; PCR; DNA; DIAGNOSTICS; EXTRACTION; SEQUENCE; CULTURE; SYSTEM; IS6110	We sought to develop a smooth and low cost sample preparation and DNA extraction protocol, streamlined with a ready-to-use qPCR in a portable instrument to overcome some of the existing hurdles. Several solutions were evaluated as to their ability to liquefy a mucin-based matrix. Each liquefied matrix, supplemented with either Mycobacterium tuberculosis (MTB) H37Rv strain DNA or intact cells, was aliquoted onto a filter paper embedded with solubilizing agents, and was subsequently dried up. Most of the nucleic acids, including genomic DNA from the bacilli and the host, binds to the filter paper. Next, several protocols were evaluated to elute the DNA from the paper, using qPCR to detect the insertion sequence IS6110, a M. tuberculosis complex genomic marker. The limit of detection (LOD) of the best protocol was then evaluated using parallel seeding and colony counting. The protocol was also evaluated using seventeen sputum samples, previously characterized by the GeneXpert or culture. Two instruments (the ABI7500 Standard and the Q3-Plus system) and two reagents storage formats (frozen or ready-to-use) were evaluated. Solutions containing guanidine isothiocyanate exerted the best liquefying effect on the mucin-based matrix extracted from one 6-mm punches, followed by a brief incubation at 95 degrees C. The resulting DNA contained impurities, but a simple 1:10 dilution elicited the detection of MTB and human genomic targets. The described protocol presented an apparent LOD of 02 CFU/mL of MTB. Challenging the protocol with previously characterized samples showed substantial agreement with GeneXpert MTB/RIF results (sensitivity of 90%, agreement of 88.9%, kappa coefficient of 0.77), and moderate agreement with culture results (sensitivity of 100%, agreement of 78.9%, kappa coefficient of 0.58). This work presents a sensitive proof-of-concept protocol for sputum liquefaction and decontamination followed by a simple DNA extraction procedure, in which the extraction steps are streamlined with a ready-to-use qPCR in a portable instrument that can be employed in low infrastructure settings.	[Ali, Nasir; Krieger, Marco Aurelio; Tavares Costa, Alexandre Dias] Inst Biol Mol Parana IBMP, Curitiba, Parana, Brazil; [Ali, Nasir; Krieger, Marco Aurelio] Univ Fed Parana UFPR, Dept Engn Bioproc & Biotecnol, Curitiba, Parana, Brazil; [Bello, Graziele Lima; Rosa Rossetti, Maria Lucia] Ctr Desenvolvimento Cient & Tecnol, Secretaria Estadual Saude, Porto Alegre, RS, Brazil; [Bello, Graziele Lima; Rosa Rossetti, Maria Lucia] Univ Luterana Brasil, Programa Posgrad Biol Celular & Mol Aplicado Saud, Canoas, RS, Brazil; [Krieger, Marco Aurelio; Tavares Costa, Alexandre Dias] Fundacao Oswaldo Cruz FIOCRUZ, Inst Carlos Chagas ICC, Curitiba, Parana, Brazil	Universidade Federal do Parana; Universidade Luterana do Brasil; Fundacao Oswaldo Cruz	Costa, ADT (corresponding author), Inst Biol Mol Parana IBMP, Curitiba, Parana, Brazil.; Costa, ADT (corresponding author), Fundacao Oswaldo Cruz FIOCRUZ, Inst Carlos Chagas ICC, Curitiba, Parana, Brazil.	alexandre.costa@fiocruz.br	Costa, Alexandre Dias Tavares/ABB-1896-2021; Costa, Alexandre Augusto da/HCJ-0140-2022	Costa, Alexandre Dias Tavares/0000-0001-8434-2152; Costa, Alexandre Augusto da/0000-0001-7558-5435; Bello, Graziele/0000-0001-8537-8413; Krieger, Marco Aurelio/0000-0003-0030-3952	Brazilian funding agency CNPq; Brazilian funding agency CAPES; Banco Nacional de Desenvolvimento Economico e Social (BNDES) [15.2.0473.1, 4.816.864]; Fundacao de Amparo a Pesquisa do Rio Grande do Sul (FAPERGS) [17/25510001542-8]	Brazilian funding agency CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian funding agency CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Banco Nacional de Desenvolvimento Economico e Social (BNDES); Fundacao de Amparo a Pesquisa do Rio Grande do Sul (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS))	Several authors received grants or fellowships from the Brazilian funding agencies CNPq and CAPES. This work was funded by a grant from the Banco Nacional de Desenvolvimento Economico e Social (BNDES), contract no. 15.2.0473.1 (Operation #4.816.864), and by a grant from the Fundacao de Amparo a Pesquisa do Rio Grande do Sul (FAPERGS grant #17/25510001542-8). There was no additional external funding received for this study. IBMP, BNDES, FAPERGS, CAPES or CNPq had no participation in the present study's design, data collection, analysis or interpretation, or writing of the report and decision to submit for publication.	Ali N, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/9306564; Allen V., 2016, RES REV J MICROBIOL, V5, P96; [Anonymous], 2017, EPLASTY, V17, pic25; Arora J, 2020, INFECT GENET EVOL, V81, DOI 10.1016/j.meegid.2020.104230; Aziz M, 2007, INT J TUBERC LUNG D, V11, P247; Brasil M da S, 2008, MANUAL NACL VIGILANC; Castan P, 2014, J CLIN MICROBIOL, V52, P502, DOI 10.1128/JCM.02209-13; Cereda M, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18082583; Clinghan R, 2013, J CLIN MICROBIOL, V51, P2010, DOI 10.1128/JCM.00923-13; Manta FSD, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008325; EISENACH KD, 1990, J INFECT DIS, V161, P977, DOI 10.1093/infdis/161.5.977; Ferguson TM, 2016, SCI REP-UK, V6, DOI 10.1038/srep19541; Govindarajan AV, 2012, LAB CHIP, V12, P174, DOI 10.1039/c1lc20622b; Guio H, 2006, INT J TUBERC LUNG D, V10, P906; Huckle D, 2015, EXPERT REV MOL DIAGN, V15, P815, DOI 10.1586/14737159.2015.1033405; Iglesias N, 2014, PARASITOL RES, V113, P2587, DOI 10.1007/s00436-014-3911-z; Khan IUH, 2004, J CLIN MICROBIOL, V42, P453, DOI 10.1128/JCM.42.1.453-457.2004; Kolia-Diafouka P, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02224; KUBICA GP, 1963, AM REV RESPIR DIS, V87, P775; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Machado D, 2019, INFECT GENET EVOL, V72, P93, DOI 10.1016/j.meegid.2018.11.021; Millan-Lou MI, 2013, J CLIN MICROBIOL, V51, P3631, DOI 10.1128/JCM.00970-13; Pawlowski DR, 2012, JOVE-J VIS EXP, DOI 10.3791/4202; Rampazzo RDP, 2017, VET PARASITOL, V246, P100, DOI 10.1016/j.vetpar.2017.09.009; Rampazzo RCP, 2019, J MOL DIAGN, V21, P839, DOI 10.1016/j.jmoldx.2019.04.008; Reed JL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03930-3; Rosado P.M.F.S., 2002, Patent No. [02/072002A3, 02072002]; Sambrook J., 2001, MOL CLONING LAB MANU; Sankar S, 2011, BIOINFORMATION, V6, P283, DOI 10.6026/97320630006283; Spositto FLE, 2014, BRAZ J MICROBIOL, V45, P841, DOI 10.1590/S1517-83822014000300012; Stop TB Partnership, 2014, MYC LAB IN, P147; Sun Y, 2013, LAB CHIP, V13, P1509, DOI 10.1039/c2lc41386h; Walzl G, 2018, LANCET INFECT DIS, V18, pE199, DOI 10.1016/S1473-3099(18)30111-7; Wang SQ, 2016, EXPERT REV MOL DIAGN, V16, P449, DOI 10.1586/14737159.2016.1142877; Wolfgramm ED, 2009, FORENSIC SCI INT-GEN, V3, P125, DOI 10.1016/j.fsigen.2008.11.008; World Health Organization (WHO), 2019, TUBERCULOSIS; 2012, DRUG DISCOV TODAY TE, V9	37	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0242408	10.1371/journal.pone.0242408	http://dx.doi.org/10.1371/journal.pone.0242408			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315885	gold, Green Published			2022-12-27	WOS:000600186100062
J	Kim, W; Choi, D; Jang, Y; Nam, CM; Hur, SH; Hong, MK				Kim, Wonho; Choi, Donghoon; Jang, Yangsoo; Nam, Chung Mo; Hur, Seung-Ho; Hong, Myeong-Ki			Effect of intentional restriction of venous return on tissue oxygenation in a porcine model of acute limb ischemia	PLOS ONE			English	Article							CORONARY-SINUS; ARTERY; OCCLUSION; DISEASE; INJURY; LOCUS; SWINE; FLOW	Introduction A sufficient oxygen supply to ischemic limb tissue is the most important requirement for wound healing and limb salvage. We investigated whether partial venous occlusion in the common iliac vein (CIV) causes a further increase of venous oxygenation in a porcine model of acute hindlimb ischemia. Materials and methods In 7 pigs, the model of acute hindlimb ischemia was created with intra-vascular embolization of the common iliac artery (CIA). The arterial and venous oxygen saturation was evaluated at different moments. Oxygen saturation was evaluated at baseline (T0), just after the arterial embolization (T1), at 10 minutes (T2), at 20 minutes (T3), and at 40 minutes (T4). Next, an intentional partial venous occlusion was achieved by inflating the vascular balloon at the level of the right CIV. Then, blood sampling was repeated at 5 minutes (T5), at 15 minutes (T6), and at 25 minutes (T7). Results The arterial oxygen saturation in the right SFA was similar during all phases. In contrast, after arterial embolization, an immediate reduction of venous oxygen saturation was observed (from 85.57 1.72 at T0 to 71.86 +/- 7.58 at T4). After the partial venous occlusion, interestingly, the venous oxygen saturations (T5-T7) were significantly increased, again. The venous oxygen saturations evaluated in the hindlimb ischemia with partial venous occlusion and in the control limb (without partial venous occlusion) were significantly over time. Venous oxygen saturations in the experimental limbs were higher than those in the control limbs (79.28 +/- 4.82 vs 59.00 +/- 2.82, p-value <0.001, 79.71 <plus/minus> 4.78 vs 60.00 +/- 4.24 at T7, p-value <0.001). Conclusions Partial venous occlusion results in an increase of venous oxygen saturation in the ischemic limb, while significant changes in venous oxygen saturation are not observed in the control limb. An explanation for this may be that the oxygen consumption in the limb tissue is increased because it gets congested with the partial venous occlusion in the right CIV.	[Kim, Wonho] Yonsei Univ, Coll Med, Grad Sch, Dept Internal Med, Seoul, South Korea; [Kim, Wonho] Eulji Univ, Eulji Univ Hosp, Sch Med, Div Cardiol, Daejeon, South Korea; [Choi, Donghoon; Jang, Yangsoo; Hong, Myeong-Ki] Yonsei Univ Hlth Syst, Severance Cardiovasc Hosp, Div Cardiol, Seoul, South Korea; [Nam, Chung Mo] Yonsei Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Hur, Seung-Ho] Keimyung Univ, Dongsan Med Ctr, Dept Internal Med, Div Cardiol, Daegu, South Korea	Yonsei University; Yonsei University Health System; Eulji University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Keimyung University	Kim, W (corresponding author), Yonsei Univ, Coll Med, Grad Sch, Dept Internal Med, Seoul, South Korea.; Kim, W (corresponding author), Eulji Univ, Eulji Univ Hosp, Sch Med, Div Cardiol, Daejeon, South Korea.; Hong, MK (corresponding author), Yonsei Univ Hlth Syst, Severance Cardiovasc Hosp, Div Cardiol, Seoul, South Korea.	cardiokwh@gmail.com; mkhong61@yuhs.ac		Choi, Donghoon/0000-0002-2009-9760; Jang, Yangsoo/0000-0002-2169-3112; Nam, Chung Mo/0000-0003-0985-0928; Hong, Myeong-Ki/0000-0002-2090-2031				Aboyans V, 2018, EUR HEART J, V39, P763, DOI 10.1093/eurheartj/ehx095; BECK CS, 1955, JAMA-J AM MED ASSOC, V159, P1264, DOI 10.1001/jama.1955.02960300008003; Beckert S, 2004, DIABETES CARE, V27, P2863, DOI 10.2337/diacare.27.12.2863; Chen M, 2017, MICROVASC RES, V110, P48, DOI 10.1016/j.mvr.2016.12.006; Diaz JA, 2012, ARTERIOSCL THROM VAS, V32, P556, DOI 10.1161/ATVBAHA.111.244608; Fadini GP, 2010, ATHEROSCLEROSIS, V209, P10, DOI 10.1016/j.atherosclerosis.2009.08.033; Fowkes FGR, 2013, LANCET, V382, P1329, DOI 10.1016/S0140-6736(13)61249-0; Gao Y, 2020, J SURG RES, V249, P168, DOI 10.1016/j.jss.2019.12.005; Institute for Laboratory Animal Resources (US), 1996, GUIDE CARE USE LAB A; Kapanadze T, 2019, THERANOSTICS, V9, P152, DOI 10.7150/thno.27175; Lelasi A, 2016, INT J CARDIOL, V209, P122, DOI 10.1016/j.ijcard.2016.02.018; Long CA, 2017, J VASC SURG, V66, P891, DOI 10.1016/j.jvs.2016.07.127; McClung JM, 2016, J VASC SURG, V64, P1101, DOI 10.1016/j.jvs.2015.06.139; Md AOD, 2008, CIRCULATION, V117, P1207, DOI 10.1161/CIRCULATIONAHA.107.736447; Naehle CP, 2015, J VASC SURG, V61, P1312, DOI 10.1016/j.jvs.2013.11.094; Nakamura H, 2020, INT J LOW EXTR WOUND, V19, P57, DOI 10.1177/1534734619868925; Rajagopalan S, 2003, CIRCULATION, V108, P1933, DOI 10.1161/01.CIR.0000093398.16124.29; Romiti M, 2008, J VASC SURG, V47, P975, DOI 10.1016/j.jvs.2008.01.005; Rushing AM, 2019, J VASC SURG, V69, P1924, DOI 10.1016/j.jvs.2018.08.172; Sealock R, 2014, CIRC RES, V114, P660, DOI 10.1161/CIRCRESAHA.114.302931; Shi WY, 2015, THROMB RES, V135, P1172, DOI 10.1016/j.thromres.2015.03.006; Tang GL, 2005, J VASC SURG, V41, P312, DOI 10.1016/j.jvs.2004.11.012; Verheye S, 2015, NEW ENGL J MED, V372, P519, DOI 10.1056/NEJMoa1402556; Ziegler MA, 2010, MICROCIRCULATION, V17, P3, DOI 10.1111/j.1549-8719.2010.00008.x	24	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243033	10.1371/journal.pone.0243033	http://dx.doi.org/10.1371/journal.pone.0243033			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33318709	gold, Green Published			2022-12-27	WOS:000600186100043
J	Wagner, DR; Teramoto, M				Wagner, Dale R.; Teramoto, Masaru			Interrater reliability of novice examiners using A-mode ultrasound and skinfolds to measure subcutaneous body fat	PLOS ONE			English	Article							GENERALIZED EQUATIONS; DENSITY	Examiners with minimal training and skill are often called upon to make body composition assessments using field methods. This study compared the interrater reliability of novice examiners for the skinfold (SKF) and A-mode ultrasound (US) methods of body composition assessment. Undergraduate Kinesiology majors (48 males, 32 females) with minimal training took both SKF and US measurements at three sites (males: chest, abdomen, thigh; females: triceps, suprailiac, thigh). Interrater reliability was significantly better for US compared to SKF at the thigh (ICCUS = 0.975, ICCSKF = 0.912) and abdomen (ICCUS = 0.984, ICCSKF = 0.693) for men and suprailiac (ICCUS = 0.978, ICCSKF = 0.883) for women. Additionally, interrater reliability of the US method was superior to the SKF method for the estimate of male body fat percentage (ICCUS = 0.990, ICCSKF = 0.862). The 95% CI was generally narrower for the US method than the SKF method at each site. The interrater reliability of the US method was superior to or equal to the SKF method for measuring subcutaneous body fat when novice examiners took the measurements.	[Wagner, Dale R.] Utah State Univ, Kinesiol & Hlth Sci Dept, Logan, UT 84322 USA; [Teramoto, Masaru] Univ Utah, Div Phys Med & Rehabil, Salt Lake City, UT USA	Utah System of Higher Education; Utah State University; Utah System of Higher Education; University of Utah	Wagner, DR (corresponding author), Utah State Univ, Kinesiol & Hlth Sci Dept, Logan, UT 84322 USA.	dale.wagner@usu.edu		Wagner, Dale/0000-0003-1575-1555				American College of Sports Medicine, 2018, ACSMS GUIDELINES EXE, V10th ed., P143; Beaton DE, 2001, J RHEUMATOL, V28, P400; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1177/096228029900800204; de Vet HW, 2011, MEASUREMENT MED PRAC; Gibson AL., 2019, ADV FITNESS ASSESSME, V8; Hendrickson N, 2019, J ORTHOP TRAUMA, V33, P472, DOI 10.1097/BOT.0000000000001498; Heyward V.H., 2004, APPL BODY COMPOSITIO, V2nd ed.; Hume P.A., 2018, BEST PRACTICE PROTOC, P61; Hume P, 2008, J SPORT SCI, V26, P1333, DOI 10.1080/02640410802165707; JACKSON AS, 1985, PHYSICIAN SPORTSMED, V13, P76, DOI 10.1080/00913847.1985.11708790; JACKSON AS, 1978, BRIT J NUTR, V40, P497, DOI 10.1079/BJN19780152; JACKSON AS, 1980, MED SCI SPORT EXER, V12, P175; JACKSON AS, 1978, RES QUART, V49, P546, DOI 10.1080/10671315.1978.10615569; KERR L, 1994, ISOKINET EXERC SCI, V4, P137, DOI 10.3233/IES-1994-4402; KISPERT CP, 1987, PHYS THER, V67, P917, DOI 10.1093/ptj/67.6.917; Lee SY, 2008, CURR OPIN CLIN NUTR, V11, P566, DOI 10.1097/MCO.0b013e32830b5f23; LOHMAN TG, 1981, HUM BIOL, V53, P181; Lohman TG, 2020, ACSMS BODY COMPOSITI; Meyer NL, 2013, BRIT J SPORT MED, V47, P1044, DOI 10.1136/bjsports-2013-092561; Milliken L.A., 2020, ACSMS BODY COMPOSITI, P59; Muller W, 2013, BRIT J SPORT MED, V47, P1028, DOI 10.1136/bjsports-2013-092232; Buxade CPC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205226; Portney LG, 2009, FDN CLIN RES APPL PR, V3rd, DOI DOI 10.1016/S0039-6257(02)00362-4; RUIZ L, 1971, BRIT J PREV SOC MED, V25, P165; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Siri W., 1961, TECHNIQUES MEASURING, P223; Stewart A., 2011, INT STANDARDS ANTHRO, V137; Wagner DR, 2020, ULTRASOUND MED BIOL, V46, P944, DOI 10.1016/j.ultrasmedbio.2019.11.018; Wagner DR, 2019, EUR J CLIN NUTR, V73, P518, DOI 10.1038/s41430-018-0085-2; Wagner DR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153146; Wagner DR, 2013, J OBES, V2013, DOI 10.1155/2013/280713; Wagner DR, 1999, RES Q EXERCISE SPORT, V70, P135, DOI 10.1080/02701367.1999.10608031	32	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0244019	10.1371/journal.pone.0244019	http://dx.doi.org/10.1371/journal.pone.0244019			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315956	gold, Green Published			2022-12-27	WOS:000600186100070
J	Wood, KM; Spear, ED; Mossberg, OW; Odinammadu, KO; Xu, WX; Michaelis, S				Wood, Kaitlin M.; Spear, Eric D.; Mossberg, Otto W.; Odinammadu, Kamsi O.; Xu, Wenxin; Michaelis, Susan			Defining substrate requirements for cleavage of farnesylated prelamin A by the integral membrane zinc metalloprotease ZMPSTE24	PLOS ONE			English	Article							LAMIN-A; SACCHAROMYCES-CEREVISIAE; RESTRICTIVE DERMOPATHY; PROTEIN; MUTATIONS; STE24P; PROTEOLYSIS; PROGERIA; BIOGENESIS; MATURATION	The integral membrane zinc metalloprotease ZMPSTE24 plays a key role in the proteolytic processing of farnesylated prelamin A, the precursor of the nuclear scaffold protein lamin A. Failure of this processing step results in the accumulation of permanently farnesylated forms of prelamin A which cause the premature aging disease Hutchinson-Gilford Progeria Syndrome (HGPS), as well as related progeroid disorders, and may also play a role in physiological aging. ZMPSTE24 is an intriguing and unusual protease because its active site is located inside of a closed intramembrane chamber formed by seven transmembrane spans with side portals in the chamber permitting substrate entry. The specific features of prelamin A that make it the sole known substrate for ZMPSTE24 in mammalian cells are not well-defined. At the outset of this work it was known that farnesylation is essential for prelamin A cleavage in vivo and that the C-terminal region of prelamin A (41 amino acids) is sufficient for recognition and processing. Here we investigated additional features of prelamin A that are required for cleavage by ZMPSTE24 using a well-established humanized yeast system. We analyzed the 14-residue C-terminal region of prelamin A that lies between the ZMPSTE24 cleavage site and the farnesylated cysteine, as well 23-residue region N-terminal to the cleavage site, by generating a series of alanine substitutions, alanine additions, and deletions in prelamin A. Surprisingly, we found that there is considerable flexibility in specific requirements for the length and composition of these regions. We discuss how this flexibility can be reconciled with ZMPSTE24's selectivity for prelamin A.	[Wood, Kaitlin M.; Spear, Eric D.; Mossberg, Otto W.; Odinammadu, Kamsi O.; Xu, Wenxin; Michaelis, Susan] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21218 USA; [Xu, Wenxin] Southern Univ Sci & Technol, Dept Biol, Shenzhen, Peoples R China	Johns Hopkins University; Southern University of Science & Technology	Michaelis, S (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21218 USA.	michaelis@jhmi.edu		Michaelis, Susan/0000-0001-5851-5021	National Institute of Health (NIH) [5R35GM127073]; Hay Fellowship from the Department of Cell Biology, Johns Hopkins School of Medicine	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hay Fellowship from the Department of Cell Biology, Johns Hopkins School of Medicine	This work was funded by a National Institute of Health (NIH) grant to SM (5R35GM127073). Kaitlin Wood was funded in part by a Hay Fellowship from the Department of Cell Biology, Johns Hopkins School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of salaries for author [KMW], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Agarwal AK, 2003, HUM MOL GENET, V12, P1995, DOI 10.1093/hmg/ddg213; Ast T, 2016, CELL, V164, P103, DOI 10.1016/j.cell.2015.11.053; Babatz TD, 2020, BIORXIV, DOI [10.1101/2020.08.17.254532, DOI 10.1101/2020.08.17.254532]; Barrowman J, 2011, ENZYMES, V30, P13, DOI 10.1016/B978-0-12-415922-8.00002-1; Barrowman J, 2012, HUM MOL GENET, V21, P4084, DOI 10.1093/hmg/dds233; Barrowman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032120; Barrowman J, 2009, BIOL CHEM, V390, P761, DOI 10.1515/BC.2009.080; Barrowman J, 2008, MOL BIOL CELL, V19, P5398, DOI 10.1091/mbc.E08-07-0704; BECK LA, 1990, J CELL BIOL, V110, P1489, DOI 10.1083/jcb.110.5.1489; Berger BM, 2018, GENETICS, V210, P1301, DOI 10.1534/genetics.118.301454; Bergo MO, 2002, P NATL ACAD SCI USA, V99, P13049, DOI 10.1073/pnas.192460799; Butin-Israeli V, 2012, TRENDS GENET, V28, P464, DOI 10.1016/j.tig.2012.06.001; Cerda-Costa N, 2014, PROTEIN SCI, V23, P123, DOI 10.1002/pro.2400; Chen P, 1997, J CELL BIOL, V136, P251, DOI 10.1083/jcb.136.2.251; Clark KM, 2017, PROTEIN SCI, V26, P242, DOI 10.1002/pro.3074; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; Dittmer T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-222; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Feral J, 2002, SUB-STANCE, P94; Fu BS, 2017, J EXP MED, V214, P919, DOI 10.1084/jem.20161270; FujimuraKamada K, 1997, J CELL BIOL, V136, P271, DOI 10.1083/jcb.136.2.271; Fukumori A, 2020, SEMIN CELL DEV BIOL, V105, P54, DOI 10.1016/j.semcdb.2020.03.006; Gerace L, 2012, J STRUCT BIOL, V177, P24, DOI 10.1016/j.jsb.2011.11.007; Goblirsch BR, 2020, J MOL BIOL, V432, P5079, DOI 10.1016/j.jmb.2020.03.016; Gordon LB, 2014, CELL, V156, P400, DOI 10.1016/j.cell.2013.12.028; Gruenbaum Y, 2015, ANNU REV BIOCHEM, V84, P131, DOI 10.1146/annurev-biochem-060614-034115; Hildebrandt ER, 2016, J BIOL CHEM, V291, P14185, DOI 10.1074/jbc.M116.718197; HOLTZ D, 1989, CELL, V59, P969, DOI 10.1016/0092-8674(89)90753-8; HOOPER NM, 1994, FEBS LETT, V354, P1, DOI 10.1016/0014-5793(94)01079-X; Hosomi A, 2020, J BIOL CHEM, V295, P10406, DOI 10.1074/jbc.RA120.012575; Huyer G, 2004, J BIOL CHEM, V279, P38369, DOI 10.1074/jbc.M402468200; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Kayatekin C, 2018, CELL, V173, P62, DOI 10.1016/j.cell.2018.02.026; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Li ST, 2017, DNA CELL BIOL, V36, P513, DOI 10.1089/dna.2017.3791; Lopez-Otin C, 2008, J BIOL CHEM, V283, P30433, DOI 10.1074/jbc.R800035200; Mallampalli MP, 2005, P NATL ACAD SCI USA, V102, P14416, DOI 10.1073/pnas.0503712102; Mehmood S, 2016, NAT CHEM, V8, P1152, DOI [10.1038/NCHEM.2591, 10.1038/nchem.2591]; Michaelis S, 2013, SCIENCE, V339, P1529, DOI 10.1126/science.1236764; Moulson CL, 2005, J INVEST DERMATOL, V125, P913, DOI 10.1111/j.0022-202X.2005.23846.x; Navarro CL, 2005, HUM MOL GENET, V14, P1503, DOI 10.1093/hmg/ddi159; Navarro CL, 2014, EUR J HUM GENET, V22, DOI 10.1038/ejhg.2013.258; Nie L, 2020, BIORXIV, DOI [10.1101/2020.05.13.093849, DOI 10.1101/2020.05.13.093849]; Palsuledesai CC, 2015, ACS CHEM BIOL, V10, P51, DOI 10.1021/cb500791f; Pryor EE, 2013, SCIENCE, V339, P1600, DOI 10.1126/science.1232048; Quigley A, 2013, SCIENCE, V339, P1604, DOI 10.1126/science.1231513; Ragnauth CD, 2010, CIRCULATION, V121, P2200, DOI 10.1161/CIRCULATIONAHA.109.902056; Schmidt WK, 2000, J BIOL CHEM, V275, P6227, DOI 10.1074/jbc.275.9.6227; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Smigiel R, 2010, AM J MED GENET A, V152A, P447, DOI 10.1002/ajmg.a.33221; Spear ED, 2019, METHODS, V157, P47, DOI 10.1016/j.ymeth.2019.01.001; Spear ED, 2018, DIS MODEL MECH, V11, DOI 10.1242/dmm.033670; Tam A, 2001, J BIOL CHEM, V276, P46798, DOI 10.1074/jbc.M106150200; Tam A, 1998, J CELL BIOL, V142, P635, DOI 10.1083/jcb.142.3.635; Tipper DJ, 2002, MOL BIOL CELL, V13, P1158, DOI 10.1091/mbc.01-10-0488; Turk B, 2012, EMBO J, V31, P1630, DOI 10.1038/emboj.2012.42; VORBURGER K, 1989, EMBO J, V8, P4007, DOI 10.1002/j.1460-2075.1989.tb08583.x; Wang M, 2016, NAT REV MOL CELL BIO, V17, P110, DOI 10.1038/nrm.2015.11; WEBER K, 1989, FEBS LETT, V257, P411, DOI 10.1016/0014-5793(89)81584-4; Wolfe MS, 2020, SEMIN CELL DEV BIOL, V105, P3, DOI 10.1016/j.semcdb.2020.01.005; Worman HJ, 2009, J CLIN INVEST, V119, P1825, DOI 10.1172/JCI37679	61	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0239269	10.1371/journal.pone.0239269	http://dx.doi.org/10.1371/journal.pone.0239269			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315887	gold, Green Published, Green Submitted			2022-12-27	WOS:000600186100020
J	Al-Ashwal, FY; Kubas, M; Zawiah, M; Bitar, AN; Saeed, RM; Sulaiman, SAS; Khan, AH; Ghadzi, SMS				Al-Ashwal, Fahmi Y.; Kubas, Mohammed; Zawiah, Mohammed; Bitar, Ahmad Naoras; Saeed, Ramzi Mukred; Sulaiman, Syed Azhar Syed; Khan, Amer Hayat; Ghadzi, Siti Maisharah Sheikh			Healthcare workers' knowledge, preparedness, counselling practices, and perceived barriers to confront COVID-19: A cross-sectional study from a war-torn country, Yemen	PLOS ONE			English	Article							SELF-ASSESSMENT; INFECTION; GENDER	Background The coronavirus disease of 2019 (COVID-19) represents a difficult challenge and could have devastating consequences for the healthcare system and healthcare workers in war-torn countries with poor healthcare facilities such as Yemen. Our study aimed to evaluate the knowledge, preparedness, counselling practices of healthcare workers regarding COVID-19, and the perceived barriers to adequately prevent and control COVID-19 in Yemen. Methods Healthcare workers (HCWs) from major healthcare facilities participated in this cross-sectional study. A self-administered questionnaire comprising of five main domains (demographics, knowledge, self-preparedness, counselling practice, perceived barriers) was distributed among HCWs after obtaining informed consent. A convenient sampling technique was used. Descriptive and inferential analyses were applied using SPSS software. Results A total of 1000 participants were initially targeted to participate in the study with 514 (51.4%) responding, of which 55.3% were female. Physicians and nurses constituted the largest proportion of participants, with 39.5% and 33.3%, respectively. The median scores for knowledge, self-preparedness, and counselling practice were 8 (out of 9), 9 (out of 15), and 25 (out of 30), respectively. The physician group showed a statistically significant association with better knowledge compared to the nurse group only, P<0.001. Males had higher preparedness scores than females, p<0.001. Also, the intensive care unit (ICU) and emergency departments presented a statistically significant difference by which the participants from these departments were more prepared compared to the others (e.g. outpatients, paediatrics and surgery) with P < 0.0001. The lack of awareness among the general population about COVID-19 preventive measures was perceived as the most common barrier for the adequate prevention and control of COVID-19 in Yemen (89.1%). Conclusion The major highlight of this study is that HCWs have, overall, good knowledge, suboptimal preparedness, and adequate counselling practices prior to the outbreak of COVID-19 in Yemen, despite the high number of perceived barriers. However, urgent action and interventions are needed to improve the preparedness of HCWs to manage COVID-19. The perceived barriers also need to be fully addressed by the local healthcare authorities and international organisations working in Yemen for adequate prevention and control measures to be in place in managing COVID-19.	[Al-Ashwal, Fahmi Y.; Kubas, Mohammed] Univ Sci & Technol Hosp USTH, Clin Pharm Dept, Sanaa, Yemen; [Al-Ashwal, Fahmi Y.; Zawiah, Mohammed; Bitar, Ahmad Naoras; Sulaiman, Syed Azhar Syed; Khan, Amer Hayat; Ghadzi, Siti Maisharah Sheikh] Univ Sains Malaysia, Sch Pharmaceut Sci, Discipline Clin Pharm, George Town, Malaysia; [Kubas, Mohammed] Int Islamic Univ Malaysia IIUM, Pharm Practice Dept, Kulliyyah Pharm, Kuantan, Pahang, Malaysia; [Zawiah, Mohammed] Univ Hodeida, Coll Clin Pharm, Dept Pharm Practice, Al Hodeida, Yemen; [Saeed, Ramzi Mukred] Univ Sci & Technol UST, Dept Clin Pharm & Pharm Practice, Sanaa, Yemen; [Saeed, Ramzi Mukred] Univ Jordan, Sch Pharm, Dept Pharmaceut Sci, Amman, Jordan; [Sulaiman, Syed Azhar Syed] Univ Sains Malaysia, Adv Med & Dent Inst, Kepala Batas, Penang, Malaysia	Universiti Sains Malaysia; International Islamic University Malaysia; University of Jordan; Universiti Sains Malaysia	Zawiah, M (corresponding author), Univ Sains Malaysia, Sch Pharmaceut Sci, Discipline Clin Pharm, George Town, Malaysia.; Zawiah, M (corresponding author), Univ Hodeida, Coll Clin Pharm, Dept Pharm Practice, Al Hodeida, Yemen.	mhzawiah@gmail.com	Sheikh Ghadzi, Siti Maisharah/E-5100-2012; Khan, Amer Hayat/O-5310-2018; Sheikh Ghadzi, Siti Maisharah/AID-2687-2022; Bitar, Ahmad Naoras/O-5682-2018; Al-Ashwal, Fahmi/AAX-5385-2021	Sheikh Ghadzi, Siti Maisharah/0000-0001-8855-8954; Khan, Amer Hayat/0000-0003-4802-6181; Bitar, Ahmad Naoras/0000-0003-0125-2683; Al-Ashwal, Fahmi/0000-0003-2076-0771; Syed Sulaiman, Syed Azhar/0000-0002-0775-859X; Saeed, Ramzi Mukred/0000-0001-9796-1622; Zawiah, Mohammed/0000-0002-3325-1442; Kubas, Mohammed Abdullah Ali/0000-0002-6031-2634	University of Sciences and Technology, Sana'a, Yemen	University of Sciences and Technology, Sana'a, Yemen	Printing the study questionnaires was funded by University of Sciences and Technology, Sana'a, Yemen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Razik M.S., INT J HEALTHC MANAG, V14, P99, DOI [10.1080/20479700.2019.1616386, DOI 10.1080/20479700.2019.1616386]; Al-Hunaishi W, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-030547; Al-Waleedi AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241260; Allegranzi B, 2007, INFECT CONT HOSP EP, V28, P1323, DOI 10.1086/521656; [Anonymous], 2020, NAT PHYS, V16, P1, DOI 10.1038/s41567-019-0781-4; [Anonymous], 2018, ARCH BRONCONEUMOL, V5, P5; Bhagavathula Akshaya Srikanth, 2020, JMIR Public Health Surveill, V6, pe19160, DOI 10.2196/19160; Blanch DC, 2008, PATIENT EDUC COUNS, V72, P374, DOI 10.1016/j.pec.2008.05.021; Boyce MR, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00062; Coutts L, 1999, ACAD MED, V74, pS128, DOI 10.1097/00001888-199910000-00062; Elhadi M, 2020, AM J TROP MED HYG, V103, P828, DOI 10.4269/ajtmh.20-0330; Gandhi M, 2020, NEW ENGL J MED, V382, P2158, DOI 10.1056/NEJMe2009758; Harapan H, 2020, J INFECT PUBLIC HEAL, V13, P667, DOI 10.1016/j.jiph.2020.03.019; Holst J, 2012, INT J HEALTH PLAN M, V27, P198, DOI 10.1002/hpm.2107; IFRC, 2019, FRC YEM HEALTHC SYST; International Federation of Red Cross And Red Crescent Societies, 2020, AW CAMP RUM BUST COV; Lavezzo E, 2020, NATURE, V584, P425, DOI 10.1038/s41586-020-2488-1; Looi MK, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2997; LSHTM CMMID, 2020, MOD PROJ COVID19 EP; Medecins Sans Frontieres, 2020, COVID 19 HAS MAD HLT; Minter RM, 2005, AM J SURG, V189, P647, DOI 10.1016/j.amjsurg.2004.11.035; Nussbaumer-Streit B, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013574; Olum R, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00181; Oran DP, 2020, ANN INTERN MED, V173, P362, DOI 10.7326/M20-3012; Prescott K, 2020, J HOSP INFECT, V105, P142, DOI 10.1016/j.jhin.2020.04.031; Qirbi N, 2017, HEALTH POLICY PLANN, V32, P911, DOI 10.1093/heapol/czx031; Rajiah K, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7030087; UN Children's Fund, 2020, ADV BRIEF WAT CRIS T; UN Office for the Coordination of Humanitarian Affairs, 2020, YEM COVID 19 PREP RE; UN Office of the Resident Coordinator and Humanitarian Coordinator for Yemen, 2020, MIN HLTH AD CONF 1 C; United Nations Development Group-Western and Central Africa (UNDG-WCA), 2015, SOC EC IMP EB VIR DI, DOI [10.13140/RG.2.2.29620.04481, DOI 10.13140/RG.2.2.29620.04481]; Vetter P, 2016, ANTIMICROB RESIST IN, V5, DOI 10.1186/s13756-016-0112-9; WHO, 2019, YEM HLTH RES SERV AV; WHO, 2020, 82 WHO; WHO, 2020, COVID 19 WHAT WE KNO; World Health Organization, WHO DIR GEN OP REM M, DOI DOI 10.1016/J.ENVPOL.2020.114280; World Health Organization, 2020, 175 WHO; World Health Organization, 2019, YEM HLTH CLUST B; Zawiah M, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00419; Zhang M, 2020, J HOSP INFECT, V105, P183, DOI 10.1016/j.jhin.2020.04.012; Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221	41	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243962	10.1371/journal.pone.0243962	http://dx.doi.org/10.1371/journal.pone.0243962			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306750	Green Published, gold			2022-12-27	WOS:000600144200039
J	Mostowy, J; Malca, E; Rasmuson, L; Vasquez-Yeomans, L; Gerard, T; Cordero, ES; Carrillo, L; Lamkin, JT				Mostowy, Jason; Malca, Estrella; Rasmuson, Leif; Vasquez-Yeomans, Lourdes; Gerard, Trika; Sosa Cordero, Eloy; Carrillo, Laura; Lamkin, John T.			Early life ecology of the invasive lionfish (Pterois spp.) in the western Atlantic	PLOS ONE			English	Article							CORAL-REEF FISH; GULF-OF-MEXICO; DENDROCHIRUS-BRACHYPTERUS; RECRUITMENT SUCCESS; VERTICAL MIGRATIONS; SALINITY TOLERANCE; SPAWN-FORMATION; GROWTH; LARVAE; VOLITANS	The invasion of the western Atlantic by the Indo-Pacific lionfish (Pterois volitans/miles) is a serious threat to the ecological stability of the region. The early life history of the lionfish remains poorly understood despite the important role that larval supply plays reef fish population dynamics. In this study, we characterized patterns in the horizontal and vertical distributions of larval lionfish collected in the western Caribbean, US Caribbean, and the Gulf of Mexico from 19 ichthyoplankton surveys conducted from 2009-2016. Using generalized additive models (GAMs), we assessed the relative effects of spatiotemporal and environmental variation on the distribution of lionfish larvae. We also examined otoliths to determine larval ages and report the first larval growth rate estimates for this species. Lionfish larvae were present at 7.8% of all stations sampled and our model suggests that lionfish presence is related to sea surface temperature and the lunar cycle. Year and location also strongly affected the larval distribution, likely reflecting the ongoing expansion of the species during our sampling timeframe. Much of the variation in larval lionfish presence remained unexplained, and future studies should incorporate additional environmental factors to improve model predictions. This study improves our understanding of the lionfish life cycle and accentuates the need for further research into the early life history of this invasive species. The design and implementation of effective long-term lionfish control mechanisms will require an understanding of their entire life history.	[Mostowy, Jason] Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA; [Mostowy, Jason; Malca, Estrella; Rasmuson, Leif] Univ Miami, Cooperat Inst Marine & Atmospher Studies, Miami, FL 33146 USA; [Malca, Estrella; Rasmuson, Leif; Gerard, Trika; Lamkin, John T.] NOAA, Southeast Fisheries Sci Ctr, Natl Marine Fisheries Serv, Miami, FL USA; [Rasmuson, Leif] Oregon Dept Fish & Wildlife, Marine Resources Program, Newport, OR USA; [Vasquez-Yeomans, Lourdes; Sosa Cordero, Eloy] Colegio Frontera Sur, Dept Sistemat & Ecol Acuat, Chetmal, Quintana Roo, Mexico; [Gerard, Trika] Univ Phoenix, South Florida Campus, Miramar, FL USA; [Carrillo, Laura] Colegio Frontera Sur, Dept Observac & Estudio Tierra, Atmosfera & Oceano, Chetmal, Quintana Roo, Mexico	Texas A&M University System; University of Miami; National Oceanic Atmospheric Admin (NOAA) - USA; El Colegio de la Frontera Sur (ECOSUR); El Colegio de la Frontera Sur (ECOSUR)	Mostowy, J (corresponding author), Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA.; Mostowy, J (corresponding author), Univ Miami, Cooperat Inst Marine & Atmospher Studies, Miami, FL 33146 USA.	jmostowy@tamu.edu	Carrillo, Laura/AAC-5556-2022	Carrillo, Laura/0000-0001-8296-007X; Mostowy, Jason/0000-0003-1601-7141	National Aeronautics and Space Administration [NNX11AP76G]; National Oceanographic and Atmospheric Administration	National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); National Oceanographic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA)	National Aeronautics and Space Administration (Grant No. NNX11AP76G) National Oceanographic and Atmospheric Administration; Institutional support for TG, JL University of Miami Cooperative Institute for Marine and Atmospheric Studies; Institutional support for JM, EM, LR El Colegio de la Frontera Sur, Unidad Chetumal; Institutional support for LVY, FESC, LC The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Amante C., 2009, NOAA TECHNICAL MEMOR, V1, P1, DOI 10.7289/V5C8276M; American Fisheries Society, 2014, GUIDELINES USE FISHE; Andradi-Brown DA, 2017, BIOL INVASIONS, V19, P939, DOI 10.1007/s10530-016-1358-0; [Anonymous], 2011, J MARITIME RES, V13, P21; [Anonymous], 2012, ANNUAIRE FRANCAISE D, VLVIII, P1; BAILEY KM, 1989, ADV MAR BIOL, V25, P1; Barbour AB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019666; Bergenius MAJ, 2005, MAR BIOL, V147, P291, DOI 10.1007/s00227-005-1575-z; Bergenius MAJ, 2002, OECOLOGIA, V131, P521, DOI 10.1007/s00442-002-0918-4; BURNHAM K.P., 2002, MODEL SELECTION MULT, V2nd, DOI DOI 10.1007/B97636; CASTONGUAY M, 1987, J PLANKTON RES, V9, P195, DOI 10.1093/plankt/9.1.195; CHANG WYB, 1982, CAN J FISH AQUAT SCI, V39, P1208, DOI 10.1139/f82-158; Claydon JAB, 2012, MAR ECOL PROG SER, V448, P119, DOI 10.3354/meps09534; COLIN PL, 1987, B MAR SCI, V40, P220; Cote IM, 2010, MAR ECOL PROG SER, V404, P219, DOI 10.3354/meps08458; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Cressie N., 1992, TERRA NOVA, V4, P613, DOI DOI 10.1111/J.1365-3121.1992.TB00605.X; D'Alessandro EK, 2010, MAR ECOL PROG SER, V410, P159, DOI 10.3354/meps08632; Dahl KA, 2019, MAR ECOL PROG SER, V623, P145, DOI 10.3354/meps13028; Dahl KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105852; Donelson JM, 2008, J EXP MAR BIOL ECOL, V360, P109, DOI 10.1016/j.jembe.2008.04.007; Estudillo CB, 2000, AQUACULTURE, V190, P155, DOI 10.1016/S0044-8486(00)00390-2; Ferreira CEL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123002; Fishelson L, 1997, ENVIRON BIOL FISH, V50, P391, DOI 10.1023/A:1007331304122; FISHELSON L, 1978, MAR BIOL, V46, P341, DOI 10.1007/BF00391406; Fishelson L., 1975, Pubblicazioni Staz Zool Napoli, V39, P635; Fisher R, 2000, MAR ECOL PROG SER, V202, P163, DOI 10.3354/meps202163; Fogg AQ, 2017, B MAR SCI, V93, P791, DOI 10.5343/bms.2016.1095; Fogg Alexander Q., 2013, Gulf and Caribbean Research, V25, P111; Gardner PG, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00007; Harms-Tuohy CA, 2016, MAR ECOL PROG SER, V558, P181, DOI 10.3354/meps11738; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Hosmer DavidW., 2000, APPL LOGISTIC REGRES; Huebert KB, 2011, LIMNOL OCEANOGR, V56, P1653, DOI 10.4319/lo.2011.56.5.1653; HYCOM Consortium, HYBR COORD OC MOD; Imamura Hisashi, 1996, Bulletin of the Faculty of Fisheries Hokkaido University, V47, P41; Irisson JO, 2010, LIMNOL OCEANOGR, V55, P909, DOI 10.4319/lo.2009.55.2.0909; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Johnston MW, 2011, MAR POLLUT BULL, V62, P1218, DOI 10.1016/j.marpolbul.2011.03.028; Jud ZR, 2015, ENVIRON BIOL FISH, V98, P135, DOI 10.1007/s10641-014-0242-y; Kimball ME, 2004, MAR ECOL PROG SER, V283, P269, DOI 10.3354/meps283269; Kitchens LL, 2017, BIOL INVASIONS, V19, P1971, DOI 10.1007/s10530-017-1417-1; Kulbicki M, 2012, MAR ECOL PROG SER, V446, P189, DOI 10.3354/meps09442; LEIS JM, 1986, MAR BIOL, V90, P505, DOI 10.1007/BF00409271; Leis JM, 1999, MAR BIOL, V134, P51, DOI 10.1007/s002270050524; Llopiz JK, 2013, J MARINE SYST, V109, P69, DOI 10.1016/j.jmarsys.2012.05.002; Malca E, 2017, FISH RES, V190, P24, DOI 10.1016/j.fishres.2017.01.019; McCormick MI, 2004, OIKOS, V106, P225, DOI 10.1111/j.0030-1299.2004.13131.x; MCCORMICK MI, 1995, MAR ECOL PROG SER, V118, P59, DOI 10.3354/meps118059; Morris JA, 2011, SCI MAR, V75, P147, DOI 10.3989/scimar.2011.75n1147; Morris JA, 2009, ENVIRON BIOL FISH, V86, P389, DOI 10.1007/s10641-009-9538-8; Muhling BA, 2013, FISH OCEANOGR, V22, P409, DOI 10.1111/fog.12031; Muhling BA, 2012, MAR ECOL PROG SER, V450, P37, DOI 10.3354/meps09540; NASA, NASA AQ MODIS MOD RE; Olney J.E., 2006, EARLY STAGES ATLANTI, P1019; Paris CB, 2004, LIMNOL OCEANOGR, V49, P1964, DOI 10.4319/lo.2004.49.6.1964; Peake J, 2018, BIOL INVASIONS, V20, P2567, DOI 10.1007/s10530-018-1720-5; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; ROBERTSON DR, 1992, MAR BIOL, V114, P527, DOI 10.1007/BF00357250; Rooker JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034180; RUMRILL SS, 1990, OPHELIA, V32, P163, DOI 10.1080/00785236.1990.10422030; SCHEIRER CJ, 1976, BIOMETRICS, V32, P429, DOI 10.2307/2529511; Schmitz WJ, 2005, GEOPH MONOG SERIES, V161, P11; Schofield PJ, 2017, PTEROIS VOLITANS MIL; Searcy SP, 2001, ECOLOGY, V82, P2452; Simms JR, 2010, FISH B-NOAA, V108, P478; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Slominski AT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009907; Sponaugle S, 2006, MAR ECOL PROG SER, V308, P1, DOI 10.3354/meps308001; Sponaugle S, 2005, J FISH BIOL, V66, P822, DOI 10.1111/j.0022-1112.2005.00657.x; Sponaugle S, 2019, BIOL INVASIONS, V21, P3013, DOI 10.1007/s10530-019-02070-1; Takemura A, 2004, FISH FISH, V5, P317, DOI 10.1111/j.1467-2679.2004.00164.x; Tregarot Ewan, 2015, Marine Biodiversity Records, V8, pe1, DOI 10.1017/S1755267214001341; U.S. Office of Science and Technology Policy, 1985, Fed Regist, V50, P20864; Arellano-Mendez LU, 2017, BIOINVASIONS REC, V6, P255, DOI 10.3391/bir.2017.6.3.11; USNO, USNO ASTR APPL DEP P; Valdez-Moreno M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036636; Vasquez-Yeomans L, 2011, BIOL INVASIONS, V13, P2635, DOI 10.1007/s10530-011-9968-z; Wessel P, 1996, J GEOPHYS RES-SOL EA, V101, P8741, DOI 10.1029/96JB00104; Wood S., 2012, MGCV MIXED GAM COMPU; Zuur Alain F., 2009, P1	82	1	1	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243138	10.1371/journal.pone.0243138	http://dx.doi.org/10.1371/journal.pone.0243138			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301531	gold, Green Published			2022-12-27	WOS:000600143100073
J	Meng, GY; Zheng, RQ; Chen, HP; Ma, GH; Wei, ZW; Xiang, GH; Zhou, J				Meng, Guiyuan; Zheng, Rongqian; Chen, Haiping; Ma, Guohui; Wei, Zhongwei; Xiang, Guohong; Zhou, Jing			Plant-atmosphere and soil-atmosphere temperature differences and their impact on grain yield of super hybrid rice under different irrigation conditions	PLOS ONE			English	Article							RADIATION USE EFFICIENCY; WATER-USE; LODGING RESISTANCE; CANOPY TEMPERATURE; DROUGHT; STRESS; ACHIEVEMENTS; AGRICULTURE; PERFORMANCE; CULTIVARS	Continued drought during the late growth stage of super hybrid rice (SHR) markedly reduces yield, and management practices that use water more efficiently can contribute greatly to high and stable yields from SHR. The absolute temperature differences (ATDs) between the rice plant and the atmosphere and between the soil and the atmosphere are believed to be important determinants of grain yield. However, it has not previously been determined whether these ATDs have any effect on SHR yields under water-saving cultivation. A two-year field experiment involving two SHR varieties, Liangyoupeijiu (LYPJ) and Y-Liangyou 9000 (YLY900), evaluated the effects of reducing water supply from mid-booting to maturity on grain yield, canopy relative humidity (CRH), leaf area index (LAI), and ATDs between the ambient temperature and the leaf surface, panicles, canopy, and soil. Grain yield increased significantly under shallow water irrigation (SW), by 8.84% (YLY900) and 12.26% (LYPJ), but decreased significantly under mild water stress (MS, -20 to -30 kPa), by 14.36% (YLY900) and 9.47% (LYPJ), as well as severe water stress (SS, -40 to -50 kPa), by 35.06% (YLY900) and 28.74% (LYPJ). As water supply decreased, so did the CRH and the ATDs, with significant decreases under MS and SS. The temperature differences were significantly and positively correlated with grain yield (P < 0.01) in both cultivars. LAI was increased under SW conditions, but was significantly decreased under MS and SS. Our study suggests that the dual goal of saving water while maintaining high yield can be achieved by applying SW irrigation from mid-booting to maturity and by adopting cultivation measures that maintain high CRH and high plant-atmosphere and soil-atmosphere ATDs in order to alleviate water stress. YLY900 has a higher yield potential than LYPJ under SW conditions, suggesting that its wide cultivation may help achieve this dual goal.	[Meng, Guiyuan; Zheng, Rongqian; Chen, Haiping; Xiang, Guohong; Zhou, Jing] Hunan Univ Humanities Sci & Technol, Coll Agr & Biotechnol, Loudi, Hunan, Peoples R China; [Meng, Guiyuan; Ma, Guohui; Wei, Zhongwei; Zhou, Jing] State Key Lab Hybrid Rice, Changsha, Hunan, Peoples R China; [Ma, Guohui; Wei, Zhongwei] Hunan Hybrid Rice Res Ctr, Changsha, Hunan, Peoples R China	Hunan University Of Humanities, Science & Technology; Hunan Academy of Agricultural Sciences	Zhou, J (corresponding author), Hunan Univ Humanities Sci & Technol, Coll Agr & Biotechnol, Loudi, Hunan, Peoples R China.; Zhou, J (corresponding author), State Key Lab Hybrid Rice, Changsha, Hunan, Peoples R China.	kiki010206@163.com			National Natural Science Foundation of China [31701375]; National Key R&D Plan: Focus on Science and Technology Innovation for High Grain Efficiency [2018YFD0301002, 2018YFD0301004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Plan: Focus on Science and Technology Innovation for High Grain Efficiency	This work was funded by funded by the National Natural Science Foundation of China (Grant no. 31701375), A National Key R&D Plan: Focus on Science and Technology Innovation for High Grain Efficiency (2018YFD0301002, 2018YFD0301004).	[Anonymous], 2012, Z DIALEKTISCHE THEOL, V28, P86; Areum Chun, 2015, Journal of Agricultural and Food Chemistry, V63, P3085; Barnaby JY, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20081846; Belder P, 2004, AGR WATER MANAGE, V65, P193, DOI 10.1016/j.agwat.2003.09.002; Bouman BAM, 2007, AGR SYST, V93, P43, DOI 10.1016/j.agsy.2006.04.004; Bouman BAM, 2005, AGR WATER MANAGE, V74, P87, DOI 10.1016/j.agwat.2004.11.007; Cabuslay GS, 2002, PLANT SCI, V163, P815, DOI 10.1016/S0168-9452(02)00217-0; Centritto M, 2009, J EXP BOT, V60, P2325, DOI 10.1093/jxb/erp123; Cheng SH, 2007, J INTEGR PLANT BIOL, V49, P805, DOI [10.1111/j.1744-7909.2007.00514.x, 10.1111/j.1672-9072.2007.00514.x]; Duan Hua, 2012, Acta Agronomica Sinica, V38, P107, DOI 10.3724/SP.J.1006.2012.00107; Experimental drug may change the treatment of osteoporosis, 2014, DUKEMEDICINE HEALTHN, V20, P7; Fu CX, 2010, RURAL WATER CONSERVA, V12, P31; [高继平 Gao Jiping], 2016, [核农学报, Journal of Nuclear Agricultural Sciences], V30, P596; Gao JiPing, 2011, Journal of Shenyang Agricultural University, V42, P399; GARRITY DP, 1995, AGRON J, V87, P773, DOI 10.2134/agronj1995.00021962008700040027x; Haefele SM, 2016, FIELD CROP RES, V190, P60, DOI 10.1016/j.fcr.2016.02.001; Han Y., 2006, CHINESE AGR SCI B, V22, P214; He C. X, 1998, HYBRID RICE, V13, P29; Huang M, 2017, J INTEGR AGR, V16, P1009, DOI 10.1016/S2095-3119(16)61535-6; Huang M, 2016, FIELD CROP RES, V193, P87, DOI 10.1016/j.fcr.2016.03.009; Lal R, 2012, J SOIL WATER CONSERV, V67, p162A, DOI 10.2489/jswc.67.6.162A; LEE B., 2007, PATTERN RECOGN, V4, P327; [刘斐 Liu Fei], 2013, [干旱地区农业研究, Agricultural Research in the Arid Areas], V31, P95; Liu K, 2020, FIELD CROP RES, V253, DOI 10.1016/j.fcr.2020.107804; Liu K, 2019, AGRON J, V111, P1788, DOI 10.2134/agronj2018.10.0662; Ma GH, 2015, J INTEGR AGR, V14, P197, DOI 10.1016/S2095-3119(14)60922-9; Marcaida M, 2014, FIELD CROP RES, V162, P30, DOI 10.1016/j.fcr.2014.03.013; Peng S., 1994, BREAKING YIELD BARRI; Peng SB, 2009, PLANT PROD SCI, V12, P3, DOI 10.1626/pps.12.3; Pimentel D, 1997, BIOSCIENCE, V47, P97, DOI 10.2307/1313020; Singh N, 2005, FOOD CHEM, V89, P253, DOI 10.1016/j.foodchem.2004.02.032; TURNER NC, 1986, FIELD CROP RES, V13, P257, DOI 10.1016/0378-4290(86)90027-4; Wang JL, 2005, CHINESE J RICE SCI, V46, P1046, DOI [10.1360/aps040074, DOI 10.1360/APS040074]; [王泽杰 WANG Zejie], 2008, [干旱地区农业研究, Agricultural Research in the Arid Areas], V26, P138; Weerakoon WMW, 2008, J AGRON CROP SCI, V194, P135, DOI 10.1111/j.1439-037X.2008.00293.x; Yan Chuan, 2008, Agricultural Sciences in China, V7, P678, DOI 10.1016/S1671-2927(08)60102-9; Yan C, 2012, PLANT PROD SCI, V15, P92, DOI 10.1626/pps.15.92; Yang JC, 2007, J EXP BOT, V58, P1545, DOI 10.1093/jxb/erm032; Yang JC, 2010, J EXP BOT, V61, P1, DOI 10.1093/jxb/erp348; Yao FX, 2012, FIELD CROP RES, V126, P16, DOI 10.1016/j.fcr.2011.09.018; Yuan L.P., 1997, HYBRID RICE, V12, P1, DOI DOI 10.16267/J.CNKI.1005-3956.1997.06.001; Yuan L.P., 2018, J AGRONOMY, V8, P71, DOI 10.1016/s1672-6308(07)60011-0; Yuan LP, 2015, ENGINEERING, V1, P13, DOI 10.15302/J-ENG-2015021; Zhang H, 2009, FIELD CROP RES, V113, P31, DOI 10.1016/j.fcr.2009.04.004; Zhang J, 2014, FIELD CROP RES, V161, P64, DOI 10.1016/j.fcr.2014.01.012; Zhang WZ, 2007, RICE SCI, V14, P67, DOI 10.1016/S1672-6308(07)60010-9; Zhang WJ, 2014, J INTEGR AGR, V13, P63, DOI 10.1016/S2095-3119(13)60388-3; Zhou Q, 2017, J INTEGR AGR, V16, P1028, DOI 10.1016/S2095-3119(16)61506-X; 陈健晓, 2016, [杂交水稻, Hybrid Rice], V31, P40; 2014, N PLUS ONE, V20, P1	50	0	0	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243580	10.1371/journal.pone.0243580	http://dx.doi.org/10.1371/journal.pone.0243580			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332448	gold, Green Published			2022-12-27	WOS:000601310900070
J	Min, JW				Min, Jungwon			Does social trust slow down or speed up the transmission of COVID-19?	PLOS ONE			English	Article							GENERALIZED TRUST; UNITED-STATES; COHESION	Social trust has been an important mechanism in overcoming crises throughout history. Several societies are now emphasizing its role in combating the COVID-19 pandemic. This study aims to investigate how variations in social trust across 68 countries are related to the transmission speed of COVID-19. Specifically, using cross-national index data from the World Value Survey, the study tests how variations in social trust across countries generate different time durations at which each country reaches the peak in terms of increases in new infections of COVID-19. Using data drawn between December 31, 2019 and July 31, 2020, this study found that in countries with a high level of social trust, particularly trust among ingroup members, or with a narrower or wider range than the intermediate range of trustees, the number of new infections tended to reach the first peak within a shorter time duration than in other countries. These results imply that in such societies, on the one hand, high cooperation among people to achieve common goals and strong compliance to social norms may allow them to begin neutralizing COVID-19 faster. On the other hand, however, the low risk perception and prevalence of cohesive relationships among people may lead to speedier transmission of COVID-19 before neutralization takes place.	[Min, Jungwon] Sophia Univ, Fac Econ & Management, Tokyo, Japan	Sophia University	Min, JW (corresponding author), Sophia Univ, Fac Econ & Management, Tokyo, Japan.	j-min-2k4@sophia.ac.jp		Min, Jungwon/0000-0002-7420-2807	JSPS; JSPS KAKENHI [19H01507]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The study is supported by JSPS Grant-inAid for Young Scientists-KAKENHI and JSPS KAKENHI Grant Number 19H01507. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, MODERN PRACTICAL MED, V21, P814; [Anonymous], 2000, BOWLING ALONE; [Anonymous], 2012, REGEN MED S3, V7, pS14; [Anonymous], 2018, OXFORD HDB SOCIAL PO; [Anonymous], 1991, CREDIBILITY TRUST RI; Bjornskov C, 2007, PUBLIC CHOICE, V130, P1, DOI 10.1007/s11127-006-9069-1; Bjornskov C, 2012, SOUTH ECON J, V78, P1346, DOI 10.4284/0038-4038-78.4.1346; Chen XY, 2020, CORP SOC RESP ENV MA, V27, P485, DOI 10.1002/csr.1814; COLEMAN JS, 1988, AM J SOCIOL, V94, pS95, DOI 10.1086/228943; Cox D., 1972, REGRESSION MODELS LI, V34, P187; Delhey J, 2005, EUR SOCIOL REV, V21, P311, DOI 10.1093/esr/jci022; Delhey J, 2016, INT J PSYCHOL, V51, P163, DOI 10.1002/ijop.12149; Delhey J, 2011, AM SOCIOL REV, V76, P786, DOI 10.1177/0003122411420817; Fan Y, 2020, 27211 NBER; Fukuyama F., 1995, TRUST SOCIAL VIRTUES; Galasso V., 2020, 27359 NBER; Gheorghiu MA, 2009, SOC PSYCHOL QUART, V72, P365, DOI 10.1177/019027250907200408; Google LLC, GOOGL COVID 19 COMM; Gundelach B, 2016, POLITICAL STUDIES, V65, P413; Helliwell JF, 2014, J HAPPINESS STUD, V15, P145, DOI 10.1007/s10902-013-9441-z; Islam MK, 2006, INT J EQUITY HLTH, DOI 10.1186%2F1475-9276-5-3; Kanagaretnam K, 2019, J FINANC QUANT ANAL, V54, P275, DOI 10.1017/S0022109018000455; Kennedy BP, 1998, WORLD DEV, V26, P2029, DOI 10.1016/S0305-750X(98)00094-1; Knack S, 1997, Q J ECON, V112, P1251, DOI 10.1162/003355300555475; Kye B, 2020, RES SOC STRAT MOBIL, V68, DOI 10.1016/j.rssm.2020.100523; Langfred CW, 2004, ACAD MANAGE J, V47, P385, DOI 10.2307/20159588; Lind JT, 2010, OXFORD B ECON STAT, V72, P109, DOI 10.1111/j.1468-0084.2009.00569.x; Messner SF, 2004, AM SOCIOL REV, V69, P882, DOI 10.1177/000312240406900607; Newton K, 2011, EUR POLIT SCI REV, V3, P169, DOI 10.1017/S1755773910000330; Paxton P, 2002, AM SOCIOL REV, V67, P254, DOI 10.2307/3088895; Paxton P, 2007, SOC FORCES, V86, P47, DOI 10.1353/sof.2007.0107; Persson T, 2017, PUBLIC ADMIN, V95, P97, DOI 10.1111/padm.12295; Putnam R.D., 1994, MAKING DEMOCRACY WOR, DOI DOI 10.2307/206637; Rousseau DM, 1998, ACAD MANAGE REV, V23, P393, DOI 10.5465/AMR.1998.926617; Schiefer D, 2017, SOC INDIC RES, V132, P579, DOI 10.1007/s11205-016-1314-5; Schrad ML., 2020, FOREIGNPOLICY; Siegrist M, 2005, J RISK RES, V8, P145, DOI 10.1080/1366987032000105315; Su K, 2019, MANAG DECIS ECON, V40, P596, DOI 10.1002/mde.3030; The Economist Intelligence Unit, DEM IND 2019; Uzzi B, 1996, AM SOCIOL REV, V61, P674, DOI 10.2307/2096399; Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z; Van Bavel JJ, 2020, NATL IDENTITY PREDIC, DOI [10.31234/osf.io/ydt95, DOI 10.31234/OSF.IO/YDT95.2020]; World Bank, WORLD DEV IND; Molina-Morales FX, 2011, LONG RANGE PLANN, V44, P118, DOI 10.1016/j.lrp.2011.01.001; YAMAGISHI T, 1994, MOTIV EMOTION, V18, P129, DOI 10.1007/BF02249397	45	14	14	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0244273	10.1371/journal.pone.0244273	http://dx.doi.org/10.1371/journal.pone.0244273			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PI8BZ	33332467	gold, Green Published			2022-12-27	WOS:000601310900069
J	Pham, TA; Tran, VQ; Vu, HLT; Ly, HB				Pham, Tuan Anh; Tran, Van Quan; Vu, Huong-Lan Thi; Ly, Hai-Bang			Design deep neural network architecture using a genetic algorithm for estimation of pile bearing capacity	PLOS ONE			English	Article							COMPRESSIVE STRENGTH; DRIVEN PILES; PREDICTION; SIMULATION	Determination of pile bearing capacity is essential in pile foundation design. This study focused on the use of evolutionary algorithms to optimize Deep Learning Neural Network (DLNN) algorithm to predict the bearing capacity of driven pile. For this purpose, a Genetic Algorithm (GA) was developed to select the most significant features in the raw dataset. After that, a GA-DLNN hybrid model was developed to select optimal parameters for the DLNN model, including: network algorithm, activation function for hidden neurons, number of hidden layers, and the number of neurons in each hidden layer. A database containing 472 driven pile static load test reports was used. The dataset was divided into three parts, namely the training set (60%), validation (20%) and testing set (20%) for the construction, validation and testing phases of the proposed model, respectively. Various quality assessment criteria, namely the coefficient of determination (R-2), Index of Agreement (IA), mean absolute error (MAE) and root mean squared error (RMSE), were used to evaluate the performance of the machine learning (ML) algorithms. The GA-DLNN hybrid model was shown to exhibit the ability to find the most optimal set of parameters for the prediction process.The results showed that the performance of the hybrid model using only the most critical features gave the highest accuracy, compared with those obtained by the hybrid model using all input variables.	[Pham, Tuan Anh; Tran, Van Quan; Vu, Huong-Lan Thi; Ly, Hai-Bang] Univ Transport Technol, Hanoi, Vietnam		Pham, TA (corresponding author), Univ Transport Technol, Hanoi, Vietnam.	anhpt@utt.edu.vn	Pham, Tuan Anh/AAH-3985-2020	Tran, Van Quan/0000-0002-4157-7717; Anh, Pham Tuan/0000-0001-9484-1916				Abusamra H, 2013, PROCEDIA COMPUT SCI, V23, P5, DOI 10.1016/j.procs.2013.10.003; [Anonymous], IEEE J MAGAZINE; [Anonymous], 2018, BIZNES, V16-17, P6; [Anonymous], 2017, ONCOGENESIS, V6, pe345; [Anonymous], 1995, NCSUIE TR; Architectural Institute of Japan (AIJ), 2004, REC DES BUILD FDN; Ardalan H, 2009, COMPUT GEOTECH, V36, P616, DOI 10.1016/j.compgeo.2008.09.003; Ardalan H., 2008, 12 INT C INT ASS COM, P1850; Armaghani DJ, 2017, NEURAL COMPUT APPL, V28, P391, DOI 10.1007/s00521-015-2072-z; Asteris PG, 2020, NEURAL COMPUT APPL, V32, P11807, DOI 10.1007/s00521-019-04663-2; Asteris PG, 2019, COMPUT CONCRETE, V24, P469, DOI 10.12989/cac.2019.24.5.469; Asteris PG, 2019, COMPUT CONCRETE, V24, P329, DOI 10.12989/cac.2019.24.4.329; Asteris PG, 2019, COMPUT CONCRETE, V24, P137, DOI 10.12989/cac.2019.24.2.137; Asteris PG, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9020243; Asteris PG, 2019, MECH ADV MATER STRUC, V26, P1146, DOI 10.1080/15376494.2018.1430874; Asteris PG, 2019, NEURAL COMPUT APPL, V31, P409, DOI 10.1007/s00521-017-3007-7; Baginska M, 2019, KSCE J CIV ENG, V23, P130, DOI 10.1007/s12205-018-2636-4; Bazaraa AR, 1986, N VALUES USED PREDIC, P462; Pham BT, 2019, SCI TOTAL ENVIRON, V679, P172, DOI 10.1016/j.scitotenv.2019.05.061; Birid KC, 2018, SUSTAIN CIV INFRASTR, P1, DOI 10.1007/978-3-319-61642-1_1; Bond A.J., 2013, EUROCODE 7 GEOTECHNI, DOI DOI 10.2788/3398; Bouafia A, 2002, ASSESSMENT SPT BASED, P369; CFA Institute CFA Program Curriculum, 2020, CFA PROGR CURR 2020; Chai T, 2014, GEOSCI MODEL DEV, V7, P1247, DOI 10.5194/gmd-7-1247-2014; Chen H, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9061042; Decourt L., 1985, CICLO CONFERENCIAS I, P85; Dimiduk DM, 2018, INTEGR MATER MANUF I, V7, P157, DOI 10.1007/s40192-018-0117-8; Dao DV, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9061113; Dao DV, 2019, MATERIALS, V12, DOI 10.3390/ma12060983; Drusa M, 2016, CIV ENVIRON ENG, V12, P128, DOI 10.1515/cee-2016-0018; Ezzat D., 2020, ARXIV200405084; Goh ATC, 2005, J GEOTECH GEOENVIRON, V131, P84, DOI 10.1061/(ASCE)1090-0241(2005)131:1(84); GOH ATC, 1995, ARTIF INTELL ENG, V9, P143, DOI 10.1016/0954-1810(94)00011-S; Ly HB, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9245458; Ly HB, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19224941; Ly HB, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9183841; Ly HB, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9112258; Hajihassani M, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9214650; Hastie T., INFERENCE PREDICTION; Hegazy T, 2003, J CONSTR ENG M, V129, P698, DOI 10.1061/(ASCE)0733-9364(2003)129:6(698); Nguyen HL, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9214715; Nguyen HL, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9153172; Holland J. H., 1992, ADAPTATION NATURAL A, DOI 10.7551/mitpress/1090.001.0001; Hopgood AA, 2012, INTELLIGENT SYSTEMS FOR ENGINEERS AND SCIENTISTS, 3RD EDITION, P1; Huang L, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9245372; Kozlowski W, 2016, PROCEDIA ENGINEER, V161, P1001, DOI [10.1016/j.proeng.2016.08.839, 10.1016/j.procng.2016.08.839]; LE LM, 2019, MATERIALS, V12, DOI DOI 10.3390/MA1210167031121948; Liang X., 2020, ARXIV200407700PHYSIC; Liptak B.G., 1995, PROCESS CONTROL INST; Liu LQ, 2020, ENG COMPUT-GERMANY, V36, P421, DOI 10.1007/s00366-019-00767-4; Lopes F.R., 1988, P INT GEOT SEM DEEP, P537; Marto A, 2014, APPL MECH MATER, V567, P681, DOI 10.4028/www.scientific.net/AMM.567.681; Meyerhof GG, 1976, ASCE J GEOTECH ENG D, V102; Moayedi H, 2020, ENG COMPUT-GERMANY, V36, P227, DOI 10.1007/s00366-018-00694-w; Momeni E, 2014, MEASUREMENT, V57, P122, DOI 10.1016/j.measurement.2014.08.007; Momeni E, 2020, ARAB J SCI ENG, V45, P8255, DOI 10.1007/s13369-020-04683-4; Momeni E, 2018, ENG COMPUT-GERMANY, V34, P319, DOI 10.1007/s00366-017-0542-x; Momeni E, 2015, EARTH SCI RES J, V19, P85, DOI 10.15446/esrj.v19n1.38712; Nawari N, 1999, ELECTRON J GEOTECH E, V4, P1; Nejad FP, 2009, COMPUT GEOTECH, V36, P1125, DOI 10.1016/j.compgeo.2009.04.003; Nhu VH, 2020, ENG COMPUT-GERMANY, V36, P603, DOI 10.1007/s00366-019-00718-z; PHAM BT, 2020, SUSTAINABILITY-BASEL, V12, DOI DOI 10.3390/SU12062218; Qi CC, 2020, CHEMOSPHERE, V244, DOI 10.1016/j.chemosphere.2019.125450; Robert Y, 1997, CAN GEOTECH J, V34, P560, DOI 10.1139/t97-024; Rojas F, 2020, MON NOT R ASTRON SOC, V494, P3741, DOI 10.1093/mnras/staa1009; Shahin MA, 2005, COMPUT GEOTECH, V32, P153, DOI 10.1016/j.compgeo.2005.02.003; Shahin MA, 2016, GEOSCI FRONT, V7, P33, DOI 10.1016/j.gsf.2014.10.002; Shahin MA, 2010, CAN GEOTECH J, V47, P230, DOI 10.1139/T09-094; Shahinn MA, 2014, SOILS FOUND, V54, P515, DOI 10.1016/j.sandf.2014.04.015; Shariatmadari N, 2008, IRAN J SCI TECHNOL B, V32, P125; Shioi Y, 1982, P 2 EUROPEAN S PENET, P159; Shooshpasha I, 2013, INT J GEOMATE, V4, P560; Sommers GM, 2020, PHYS CHEM CHEM PHYS, V22, P10592, DOI 10.1039/d0cp01893g; Teh CI, 1997, J COMPUT CIVIL ENG, V11, P129, DOI 10.1061/(ASCE)0887-3801(1997)11:2(129); Ting CK, 2005, LECT NOTES ARTIF INT, V3630, P403, DOI 10.1007/11553090_41; Pham TA, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10051871; Van Der Malsburg C., 1986, BRAIN THEORY, P245, DOI [10.1007/978-3-642-70911-1_20, DOI 10.1007/978-3-642-70911-1_20]; Willmott C.J., 1980, PHYS GEOGR, V1, P59, DOI DOI 10.1080/02723646.1980.10642189; Willmott C.J., 1981, PHYS GEOGR, V2, P184, DOI [10.1080/02723646.1981.10642213, DOI 10.1080/02723646.1981.10642213]; Xu H, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9183715; Zemouri R, 2020, NEURAL COMPUT APPL, V32, P18143, DOI 10.1007/s00521-019-04196-8; Zhou YJ, 2019, ADV DIFFER EQU-NY, DOI 10.1186/s13662-018-1939-6	82	19	19	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243030	10.1371/journal.pone.0243030	http://dx.doi.org/10.1371/journal.pone.0243030			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332377	gold, Green Published			2022-12-27	WOS:000601310900027
J	Tordjman, M; Mekki, A; Mali, RD; Saab, I; Chassagnon, G; Guillo, E; Burns, R; Eshagh, D; Beaune, S; Madelin, G; Bessis, S; Feydy, A; Mihoubi, F; Doumenc, B; Mouthon, L; Carlier, RY; Drape, JL; Revel, MP				Tordjman, Mickael; Mekki, Ahmed; Mali, Rahul D.; Saab, Ines; Chassagnon, Guillaume; Guillo, Enora; Burns, Robert; Eshagh, Deborah; Beaune, Sebastien; Madelin, Guillaume; Bessis, Simon; Feydy, Antoine; Mihoubi, Fadila; Doumenc, Benoit; Mouthon, Luc; Carlier, Robert-Yves; Drape, Jean-Luc; Revel, Marie-Pierre			Pre-test probability for SARS-Cov-2-related infection score: The PARIS score	PLOS ONE			English	Article							CHEST CT	Introduction In numerous countries, large population testing is impossible due to the limited availability of RT-PCR kits and CT-scans. This study aimed to determine a pre-test probability score for SARS-CoV-2 infection. Methods This multicenter retrospective study (4 University Hospitals) included patients with clinical suspicion of SARS-CoV-2 infection. Demographic characteristics, clinical symptoms, and results of blood tests (complete white blood cell count, serum electrolytes and CRP) were collected. A pre-test probability score was derived from univariate analyses of clinical and biological variables between patients and controls, followed by multivariate binary logistic analysis to determine the independent variables associated with SARS-CoV-2 infection. Results 605 patients were included between March 10(th) and April 30(th), 2020 (200 patients for the training cohort, 405 consecutive patients for the validation cohort). In the multivariate analysis, lymphocyte (<1.3 G/L), eosinophil (<0.06 G/L), basophil (<0.04 G/L) and neutrophil counts (<5 G/L) were associated with high probability of SARS-CoV-2 infection but no clinical variable was statistically significant. The score had a good performance in the validation cohort (AUC = 0.918 (CI: [0.891-0.946]; STD = 0.014) with a Positive Predictive Value of high-probability score of 93% (95%CI: [0.89-0.96]). Furthermore, a low-probability score excluded SARS-CoV-2 infection with a Negative Predictive Value of 98% (95%CI: [0.93-0.99]). The performance of the score was stable even during the last period of the study (15-30(th) April) with more controls than infected patients. Conclusions The PARIS score has a good performance to categorize the pre-test probability of SARS-CoV-2 infection based on complete white blood cell count. It could help clinicians adapt testing and for rapid triage of patients before test results.	[Tordjman, Mickael; Saab, Ines; Chassagnon, Guillaume; Guillo, Enora; Burns, Robert; Feydy, Antoine; Mihoubi, Fadila; Drape, Jean-Luc; Revel, Marie-Pierre] Cochin Hosp, AP HP, Dept Radiol, Paris, France; [Mekki, Ahmed; Carlier, Robert-Yves] Ambroise Pare Hosp, AP HP, Dept Radiol, Boulogne, France; [Mali, Rahul D.; Madelin, Guillaume] NYU, Sch Med, Dept Radiol, Ctr Biomed Imaging, New York, NY USA; [Chassagnon, Guillaume; Feydy, Antoine; Drape, Jean-Luc; Revel, Marie-Pierre] Univ Paris, Paris, France; [Eshagh, Deborah] St Antoine Hosp, AP HP, Dept Internal Med, Paris, France; [Beaune, Sebastien] Ambroise Pare Hosp, AP HP, Emergency Dept, Boulogne, France; [Bessis, Simon] Hop Raymond Poincare, AP HP, Dept Infect Dis, Garches, France; [Doumenc, Benoit] Cochin Hosp, AP HP, Emergency Dept, Paris, France; [Mouthon, Luc] Cochin Hosp, AP HP, Dept Internal Med, Paris, France; [Carlier, Robert-Yves] Hop Raymond Poincare, AP HP, Dept Radiol, Garches, France; [Carlier, Robert-Yves] AP HP, DMU Smart Imaging, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; New York University; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; Assistance Publique Hopitaux Paris (APHP)	Tordjman, M (corresponding author), Cochin Hosp, AP HP, Dept Radiol, Paris, France.	mickael_tordjman@hotmail.com	Bessis, Simon/AAD-9786-2022; SAAB, Ines/AGT-6261-2022	Madelin, Guillaume/0000-0002-5556-5792; TORDJMAN, Mickael/0000-0001-8212-7790				Ai T, 2020, RADIOLOGY, V296, pE32, DOI 10.1148/radiol.2020200642; Alkhalil M, 2019, AM J MED, V132, pE827, DOI 10.1016/j.amjmed.2019.05.021; [Anonymous], 2014, BMJ, V348, pg2991; Bai HX, 2020, RADIOLOGY, V296, pE46, DOI 10.1148/radiol.2020200823; Barton LM, 2020, AM J CLIN PATHOL, V153, P725, DOI [10.1093/AJCP/AQAA062, 10.1093/ajcp/aqaa062]; CHEN G, 2020, J CLIN INVEST, DOI [DOI 10.1172/JCI137244, 10.1101/2020.02.16.20023903]; Cloyd Miles W., 2001, Current Molecular Medicine (Hilversum), V1, P545, DOI 10.2174/1566524013363320; Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Fang YC, 2020, RADIOLOGY, V296, pE115, DOI 10.1148/radiol.2020200432; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Gil H, 2019, REV MED INTERNE, V40, P173, DOI 10.1016/j.revmed.2018.11.008; Grattan CEH, 2003, CLIN EXP ALLERGY, V33, P337, DOI 10.1046/j.1365-2222.2003.01589.x; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; HOSMER DW, 1980, COMMUN STAT A-THEOR, V9, P1043, DOI 10.1080/03610928008827941; Ji D, CLIN INFECT DIS; Juneja S, 1995, CLIN LAB HAEMATOL, V17, P335; Khoury P, 2018, ALLERGY, V73, P2076, DOI 10.1111/all.13497; Kim Hyungjin, 2020, Radiology, V296, pE145, DOI 10.1148/radiol.2020201343; Le Gal G, 2006, ANN INTERN MED, V144, P165, DOI 10.7326/0003-4819-144-3-200602070-00004; Li YX, 2020, ZHONGHUA NEI KE ZA Z, V59, pE003; Lindsley AW, 2020, J ALLERGY CLIN IMMUN, V146, P1, DOI 10.1016/j.jaci.2020.04.021; Liu F, 2020, INT J INFECT DIS, V95, P183, DOI 10.1016/j.ijid.2020.03.013; Liu YX, 2020, SCI CHINA LIFE SCI, V63, P364, DOI 10.1007/s11427-020-1643-8; Martin M, 2017, REV MED INTERNE, V38, P603, DOI 10.1016/j.revmed.2017.01.005; Mathew D, 2020, CLIN RADIOL, V75, DOI 10.1016/j.crad.2020.03.017; Mo P., 2020, CLIN INFECT DIS, DOI [10.1093/cid/ciaa270, DOI 10.1093/CID/CIAA270]; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Nakajima K, 2020, JPN J RADIOL, V38, P391, DOI 10.1007/s11604-020-00948-y; Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683; Qin C, 2020, CLIN INFECT DIS, V71, P762, DOI 10.1093/cid/ciaa248; Strati P, 2015, BLOOD, V126, P454, DOI 10.1182/blood-2015-02-585059; Tanni F, 2020, J AM OSTEOPATH ASSOC, V120, P504, DOI 10.7556/jaoa.2020.091; Wang F, 2020, J INFECT DIS, V221, P1762, DOI 10.1093/infdis/jiaa150; Wang LH, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofaa169; Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994; Wynants L, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1328; Yin Z, 2020, ELECTRON J QUAL THEO, P1, DOI 10.14232/ejqtde.2020.1.7; Zhang JJ, 2020, ALLERGY, V75, P1730, DOI 10.1111/all.14238; Zheng MJ, 2020, CELL MOL IMMUNOL, V17, P533, DOI 10.1038/s41423-020-0402-2; Zhou MW, 2020, ACTA PHOTONICA SINIC, V49, DOI 10.3788/gzxb20204905.0506005; Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737	42	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243342	10.1371/journal.pone.0243342	http://dx.doi.org/10.1371/journal.pone.0243342			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332360	gold, Green Published, Green Submitted			2022-12-27	WOS:000601310900075
J	Hernandez-Rubio, JC; Abad, MSC; Leon, AY; Higuera, GD; Rodriguez, LG; Torrejon, CG; Cacho, AM; Rodriguez, AJ; Martin, MGS				Carrillo Hernandez-Rubio, Javier; Sanchez-Carpintero Abad, Maria; Yordi Leon, Andrea; Doblare Higuera, Guillermo; Garcia Rodriguez, Leticia; Garcia Torrejon, Carmen; Mayor Cacho, Alejandro; Jimenez Rodriguez, Angel; Garcia-Salmones Martin, Mercedes			Outcomes of an intermediate respiratory care unit in the COVID-19 pandemic	PLOS ONE			English	Article							NONINVASIVE VENTILATION	Background 15% of COVID-19 patients develop severe pneumonia. Non-invasive mechanical ventilation and high-flow nasal cannula can reduce the rate of endotracheal intubation in adult respiratory distress syndrome, although failure rate is high. Objective To describe the rate of endotracheal intubation, the effectiveness of treatment, complications and mortality in patients with severe respiratory failure due to COVID-19. Methods Prospective cohort study in a first-level hospital in Madrid. Patients with a positive polymerase chain reaction for SARS-CoV-2 and admitted to the Intermediate Respiratory Care Unit with tachypnea, use of accessory musculature or Sp(O2) <92% despite Fi(O2)> 0.5 were included. Intubation rate, medical complications, and 28-day mortality were recorded. Statistical analysis through association studies, logistic and Cox regression models and survival analysis was performed. Results Seventy patients were included. 37.1% required endotracheal intubation, 58.6% suffered medical complications and 24.3% died. Prone positioning was independently associated with lower need for endotracheal intubation (OR 0.05; 95% CI 0.005 to 0.54, p = 0.001). The adjusted HR for death at 28 days in the group of patients requiring endotracheal intubation was 5.4 (95% CI 1.51 to 19.5; p = 0.009). Conclusions The rate of endotracheal intubation in patients with severe respiratory failure from COVID-19 was 37.1%. Complications and mortality were lower in patients in whom endotracheal intubation could be avoided. Prone positioning could reduce the need for endotracheal intubation.	[Carrillo Hernandez-Rubio, Javier] Rey Juan Carlos Univ Hosp, Dept Pulmonol & Resp Med, Madrid, Spain; [Sanchez-Carpintero Abad, Maria; Yordi Leon, Andrea; Doblare Higuera, Guillermo; Garcia Rodriguez, Leticia; Garcia-Salmones Martin, Mercedes] Infanta Elena Univ Hosp, Dept Pulmonol & Resp Med, Madrid, Spain; [Garcia Torrejon, Carmen] Infanta Elena Univ Hosp, Dept Intens Care Med, Madrid, Spain; [Mayor Cacho, Alejandro] Infanta Elena Univ Hosp, Dept Anesthesiol, Madrid, Spain; [Jimenez Rodriguez, Angel] Infanta Elena Univ Hosp, Dept Internal Med, Madrid, Spain		Hernandez-Rubio, JC (corresponding author), Rey Juan Carlos Univ Hosp, Dept Pulmonol & Resp Med, Madrid, Spain.	jcarrillohr@gmail.com		Carrillo Hernandez-Rubio, Javier/0000-0001-5083-9902				[Anonymous], 2020, LANCET, V395, P1054; [Anonymous], 2020, ACAD EMERG MED, V27, pS7, DOI 10.1111/acem.13961; [Anonymous], JAMA J AM MED ASSOC, DOI [10.3760/cma.j.issn.1009-9921.2017.11.016, DOI 10.3760/CMA.J.ISSN.1009-9921.2017.11.016]; [Anonymous], 2016, REV ESP ANESTESIOL R, V63, pe23; [Anonymous], 2019, AM J RESP CRIT CARE, V200, pe70, DOI 10.1164/rccm.201908-1590ST; [Anonymous], 2020, ACTUALIZACION N 109; [Anonymous], 2020, JAMA-J AM MED ASSOC, V323, P1574; Brochard L, 2014, SEMIN RESP CRIT CARE, V35, P492, DOI 10.1055/s-0034-1383863; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Carteaux G, 2016, CRIT CARE MED, V44, P282, DOI 10.1097/CCM.0000000000001379; Gomez CC, 2020, REV ESP ANEST REANIM, V67, P261, DOI 10.1016/j.redar.2020.03.006; Coudroy R, 2020, RESP CARE, V65, P525, DOI 10.4187/respcare.07104; Ding L, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-2738-5; Frat JP, 2015, NEW ENGL J MED, V372, P2185, DOI 10.1056/NEJMoa1503326; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Hui DS, 2015, CHEST, V147, P1336, DOI 10.1378/chest.14-1934; McGonagle D, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102537; Patel BK, 2016, JAMA-J AM MED ASSOC, V315, P2435, DOI 10.1001/jama.2016.6338; Rochwerg B, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.02426-2016; Satou T, 2020, ACUTE MED SURG, V7, DOI 10.1002/ams2.465; Slutsky AS, 2014, NEW ENGL J MED, V370, P1668; Slutsky AS, 2013, NEW ENGL J MED, V369, P2126, DOI 10.1056/NEJMra1208707; Taccone P, 2009, JAMA-J AM MED ASSOC, V302, P1977, DOI 10.1001/jama.2009.1614; Tay MZ, 2020, NAT REV IMMUNOL, V20, P363, DOI 10.1038/s41577-020-0311-8; Wan SX, 2020, BRIT J HAEMATOL, V189, P428, DOI 10.1111/bjh.16659; Wang Y, 2020, NPJ SCHIZOPHR, V6, DOI 10.1038/s41537-020-0095-7; Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5; Ye Q, 2020, J INFECTION, V80, P607, DOI 10.1016/j.jinf.2020.03.037; Zhang JJY, 2020, CLIN INFECT DIS, V71, P2199, DOI 10.1093/cid/ciaa576	30	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243968	10.1371/journal.pone.0243968	http://dx.doi.org/10.1371/journal.pone.0243968			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326484	gold, Green Published			2022-12-27	WOS:000600176400078
J	Choi, JM; Lee, SH; Kang, M; Choi, JH				Choi, Jung Min; Lee, Seung-Hwa; Kang, Mira; Choi, Jin-Ho			Impact of medication adherence to dual antiplatelet therapy on the long-term outcome of drug-eluting or bare-metal stents	PLOS ONE			English	Article							CORONARY STENTS; CLOPIDOGREL USE; DURATION; NONADHERENCE; POLYMER; EVENTS	Background In percutaneous coronary intervention, drug-eluting stent (DES) showed better clinical outcome compared to bare-metal stent (BMS) but mostly with different DAPT durations. Hypothesis The clinical superiority of DES over BMS may depend on the medication adherence to dual antiplatelet therapy (DAPT). Methods We retrospectively enrolled all Koreans PCI patients in year 2011 (n = 47,291). Medication adherence to DAPT was assessed by proportion of days covered (PDC) per 6 months. Analysis adjusted with the clinical propensity for receiving DES or BMS and DAPT PDC of the first 6 month was performed. Primary outcome was the 5-year major adverse clinical event (MACE) risk consisting all-cause death, revascularization, shock, or stroke. Results Patients with DES (n = 46,356) showed higher PDC (78% versus 60%, p<0.001) and lower MACE risk (39% versus 56%, p<0.001) compared to patients with BMS (n = 935). In the propensity-matched 1,868 patients, MACE risk was lower with DES than BMS (46% versus 54%, HR = 0.80, 95% CI = 0.70-0.91, p<0.001). In both DES and BMS, patients with good medication adherence (PDC <greater than or equal to>80%) showed much lower MACE risk compared to patients with PDC <80% (HR = 0.36, 95% CI = 0.30-0.44; HR = 0.40, 95%CI = 0.33-0.48, p<0.001, all). Patients with DES and PDC <80% showed higher MACE risk compared to BMS with and PDC <greater than or equal to>80% (HR = 1.30, 95%CI = 1.03-1.64, p = 0.027). Conclusions Good medication adherence to DAPT in the first 6 month was prerequisite for better clinical outcome in both DES and BMS. DES with poor adherence to DAPT showed worse outcome compared with BMS with good adherence.	[Choi, Jung Min; Kang, Mira; Choi, Jin-Ho] Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Dept Med Device Management & Res, Seoul, South Korea; [Lee, Seung-Hwa] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul, South Korea; [Kang, Mira] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Healthcare Ctr, Seoul, South Korea; [Choi, Jin-Ho] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Emergency Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Choi, JH (corresponding author), Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Dept Med Device Management & Res, Seoul, South Korea.; Choi, JH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Emergency Med, Seoul, South Korea.	jhchoimd@gmail.com		Choi, Jin-Ho/0000-0003-4839-913X; Choi, Jung Min/0000-0002-6837-3132; Lee, Seung Hwa/0000-0001-5508-7519	National Research Foundation of Korea [2017R1A2B310918]; Multi-Ministry development program for AI-Bio-Robot-Medicine Convergence [20001234]	National Research Foundation of Korea(National Research Foundation of Korea); Multi-Ministry development program for AI-Bio-Robot-Medicine Convergence	This study was supported by National Research Foundation of Korea (2017R1A2B310918) and Multi-Ministry development program for AI-Bio-Robot-Medicine Convergence (#20001234) to Jin-Ho Choi. The funders had no role in study design, data collectionand analysis, decision to publish, or preparation of the manuscript.	BANGALORE S, 2013, BMJ-BRIT MED J, V347, DOI DOI 10.1136/BMJ.F6625; Bonaa KH, 2016, NEW ENGL J MED, V375, P1242, DOI 10.1056/NEJMoa1607991; Brar SS, 2008, J AM COLL CARDIOL, V51, P2220, DOI 10.1016/j.jacc.2008.01.063; Bueno H, 2017, HEART, V103, P132, DOI 10.1136/heartjnl-2016-309509; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cutlip DE, 2015, JACC-CARDIOVASC INTE, V8, P404, DOI 10.1016/j.jcin.2014.10.017; Eisenstein EL, 2007, JAMA-J AM MED ASSOC, V297, P159, DOI 10.1001/jama.297.2.joc60179; Faxon DP, 2012, CIRC-CARDIOVASC INTE, V5, P372, DOI 10.1161/CIRCINTERVENTIONS.111.967257; Kaiser C, 2010, NEW ENGL J MED, V363, P2310, DOI 10.1056/NEJMoa1009406; Kereiakes DJ, 2015, JAMA-J AM MED ASSOC, V313, P1113, DOI 10.1001/jama.2015.1671; Kolandaivelu K, 2014, EUR HEART J, V35, P3267, DOI 10.1093/eurheartj/ehu364; Mehran R, 2013, LANCET, V382, P1714, DOI 10.1016/S0140-6736(13)61720-1; Monnette A, 2018, PHARMACOECONOMICS, V36, P17, DOI 10.1007/s40273-017-0570-9; Palmerini T, 2015, LANCET, V385, P2371, DOI 10.1016/S0140-6736(15)60263-X; Palmerini T, 2015, J AM COLL CARDIOL, V65, P2496, DOI 10.1016/j.jacc.2015.04.017; Piccolo R, 2019, LANCET, V393, P2503, DOI 10.1016/S0140-6736(19)30474-X; Pinho-Gomes AC, 2018, J AM COLL CARDIOL, V71, P591, DOI 10.1016/j.jacc.2017.11.068; Raber L, 2012, JAMA-J AM MED ASSOC, V308, P777, DOI 10.1001/jama.2012.10065; Ribera A, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-028114; Shah R, 2018, JAMA CARDIOL, V3, P1050, DOI 10.1001/jamacardio.2018.3551; Sherman RE, 2016, NEW ENGL J MED, V375, P2293, DOI 10.1056/NEJMsb1609216; Sorrentino S, 2018, AM J CARDIOL, V122, P1638, DOI 10.1016/j.amjcard.2018.07.041; Urban P, 2015, NEW ENGL J MED, V373, P2038, DOI 10.1056/NEJMoa1503943; Yin SHL, 2019, BMJ	24	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0244062	10.1371/journal.pone.0244062	http://dx.doi.org/10.1371/journal.pone.0244062			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326492	Green Published, gold			2022-12-27	WOS:000600176400017
J	Belay, A; Ashagrie, M; Seyoum, B; Alemu, M; Tsegaye, A				Belay, Assefa; Ashagrie, Melaku; Seyoum, Berhanu; Alemu, Mekuanent; Tsegaye, Aster			Prevalence of enteric pathogens, intestinal parasites and resistance profile of bacterial isolates among HIV infected and non-infected diarrheic patients in Dessie Town, Northeast Ethiopia	PLOS ONE			English	Article							HIV/AIDS PATIENTS; GLOBAL BURDEN; ETIOLOGIES; SHIGELLA; CHILDREN; DISEASE	Background Enteric pathogens like Salmonella and Shigella species as well as intestinal parasites (IPs) are among the main causative agents of diarrhea in people with human immunodeficiency virus (HIV)/acquired immune deficiency syndrome (AIDS), particularly in low income countries like Ethiopia. Antimicrobial resistance against commonly prescribed drugs has become a major global threat. This study, therefore, aimed at determining the magnitude of Salmonella, Shigella and IPs infections, their predicting factors, and antimicrobial susceptibility pattern among HIV infected and non-infected diarrheic patients in Dessie town, Northeast Ethiopia. Methods A cross sectional study was conducted at three health facilities in Northeast Ethiopia between January 2018 and March 2018. Data on socio-demographic and associated risk factors were collected using structured questionnaire from 354 HIV infected and non-infected diarrheic outpatients. Fresh stool specimen was processed according to standard operating procedures. Data were entered and analyzed using SPSS version 22. Descriptive statistics was used to determine frequency, Bivariate and multivariate logistic regression analyses were performed to identify predicting factors associated with the outcome variable. P-value <0.05 were used to declare statistical significance. Results Among 354 diarrheic patients, 112 were HIV infected and 242 were HIV non-infected. The overall prevalence of intestinal parasite and bacterial infection among HIV infected versus non-infected, respectively, was 26 (23.2%) and 8 (7.1%) versus 50 (20.7) and 16 (6.6%). Salmonella was the highest in both groups, 6 (5.4%) vs 11 (4.5%). Most prevalent parasite was C. parvum, 9 (8%) among HIV+ while E. histolytica/dispar 39 (16.1%) among HIV-. Having bloody plus mucoid diarrhea, not utilizing latrine and drinking river or spring water were factors significantly associated with bacterial infection. Whereas, being illiterate or having primary level education, diarrhea lasting for 6-10 days, CD4 level between 200-500 cells/<mu>l, not washing hand with soap showed significant association with IPs. The bacterial isolates were 100% susceptible to Ceftriaxone and 95.4% to Ciprofloxacin, while 100% resistant to Ampicillin and Amoxicillin. MDR was observed among 19 (79.2%) isolates. Conclusion Preventing and controlling infection by enteric pathogens as well as IPs require strengthening intervention measures. The 100% resistance of isolates to commonly prescribed antibiotics calls for expanding antimicrobial susceptibility testing so as to select appropriate antimicrobial agent and prevent emergence of drug resistant bacteria.	[Belay, Assefa; Alemu, Mekuanent] Dessie Hlth Sci Coll, Dept Med Lab Sci, Dessie, Ethiopia; [Ashagrie, Melaku] Wollo Univ, Coll Med & Hlth Sci, Dept Med Lab Sci, Dessie, Ethiopia; [Seyoum, Berhanu] Armauer Hansen Res Inst, Addis Ababa, Ethiopia; [Tsegaye, Aster] Addis Ababa Univ, Coll Hlth Sci, Dept Med Lab Sci, Addis Ababa, Ethiopia	Addis Ababa University	Tsegaye, A (corresponding author), Addis Ababa Univ, Coll Hlth Sci, Dept Med Lab Sci, Addis Ababa, Ethiopia.	tsegayeaster@yahoo.com	Belete, Melaku Ashagrie/ABA-4783-2020	Belete, Melaku Ashagrie/0000-0002-0706-9903; Tsegaye, Aster/0000-0002-9026-4629				Adamu H, 2009, ETHIOP J HEALTH DEV, V23, P133; Adekunle O. T., 2015, International Journal of Biomedical and Advance Research, V6, P413; AIDS info, 2017, GUID PREV TREATM OPP, P1; Alemu A, 2011, ASIAN PAC J TROP MED, V4, P661, DOI 10.1016/S1995-7645(11)60168-5; ANDUALEM B, 2006, ETHIOP J HEALTH DEV, V20, P100; [Anonymous], 2008, PHARMACOLOGYONLINE; [Anonymous], 2019, CDC TRAV REL INF DIS; Ao TT, 2015, EMERG INFECT DIS, V21, P941, DOI 10.3201/eid2106.140999; Assefa S, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-155; Awole M., 2003, ETHIOP J HEALTH DEV, V17, P71; Beyene G, 2014, ANN CLIN MICROB ANTI, V13, DOI 10.1186/1476-0711-13-10; Carcamo C, 2005, J INFECT DIS, V191, P11, DOI 10.1086/426508; Cheesbrough M, 2006, MED LAB MAN TROPICAL, P179; CLSI, 2021, PERFORMANCE STANDARD, VM100, 31st ed; Dikman AE, 2015, DIGEST DIS SCI, V60, P2236, DOI 10.1007/s10620-015-3615-y; Ethiopia Food Medicine and Health Care Administration and Control Authority, 2014, STAND TREATM GUID GE; Fisseha B, 1999, ETHIOP J HEALTH DEV, V13, P163; Gebrekidan Atsebaha, 2015, BMC Res Notes, V8, P611, DOI 10.1186/s13104-015-1606-x; Gosa Girma, 2015, Research Journal of Microbiology, V10, P288; Ketema T, 2017, AFRICAN J BASIC APPL, V9, P118; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; MENGISTU G, 2014, J MICROBIAL BIOCH S, V2, P1, DOI DOI 10.4172/1948-5948.S2-006; Missaye A, 2013, AIDS RES THER, V10, DOI 10.1186/1742-6405-10-7; Mulatu Getamesay, 2014, Ethiop J Health Sci, V24, P101, DOI 10.4314/ejhs.v24i2.1; Musiime Victor, 2009, J Int Assoc Physicians AIDS Care (Chic), V8, P185, DOI 10.1177/1545109709333082; Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9; Nkenfou CN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057914; Pickering AJ, 2012, ENVIRON SCI TECHNOL, V46, P5736, DOI 10.1021/es300022c; Reda A.A., 2011, J INFECT DIS IMMUN, V3, P134; Saeed A, 2015, J MED MICROBIOL, V64, P432, DOI 10.1099/jmm.0.000043; Samiel A, 2014, SE ASIAN J TROP MED, V45, P783; Shah S, 2016, CUREUS, V8, DOI 10.7759/cureus.807; Tambe AB., 2015, CHALLENGES, V6, P229, DOI [DOI 10.3390/CHALLE6020229, 10.3390/challe6020229]; Troeger C, 2018, LANCET INFECT DIS, V18, P1211, DOI 10.1016/S1473-3099(18)30362-1; UNICEF/WHO, 2009, WHY CHILDR STILL DYI; Urio EM, 2001, TROP MED INT HEALTH, V6, P55, DOI 10.1046/j.1365-3156.2001.00668.x; Vouking MZ, 2014, PAN AFR MED J, V18, DOI 10.11604/pamj.2014.18.136.3052; WHO (World Health Organization), 2003, BASIC LAB PROCEDURES, V2nd; world health organization, DIARRH DIS FACT SHEE; World Health Organization, 2005, WHO GUID CONTR SHIG; World Health Organization, 2013, POCK BOOK HOSP CAR C	41	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243479	10.1371/journal.pone.0243479	http://dx.doi.org/10.1371/journal.pone.0243479			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320909	gold, Green Published			2022-12-27	WOS:000600339800014
J	Hobbs, RS; Hall, JR; Graham, LA; Davies, PL; Fletcher, GL				Hobbs, Rod S.; Hall, Jennifer R.; Graham, Laurie A.; Davies, Peter L.; Fletcher, Garth L.			Antifreeze protein dispersion in eelpouts and related fishes reveals migration and climate alteration within the last 20 Ma	PLOS ONE			English	Article							ANTARCTIC EEL POUT; ICE-BINDING; PEPTIDE HETEROGENEITY; CONVERGENT EVOLUTION; FREEZING RESISTANCE; THERMAL HYSTERESIS; CRYSTAL-STRUCTURE; GENE; SEA; DIVERSIFICATION	Antifreeze proteins inhibit ice growth and are crucial for the survival of supercooled fish living in icy seawater. Of the four antifreeze protein types found in fishes, the globular type III from eelpouts is the one restricted to a single infraorder (Zoarcales), which is the only clade know to have antifreeze protein-producing species at both poles. Our analysis of over 60 unique antifreeze protein gene sequences from several Zoarcales species indicates this gene family arose around 18 Ma ago, in the Northern Hemisphere, supporting recent data suggesting that the Arctic Seas were ice-laden earlier than originally thought. The Antarctic was subject to widespread glaciation over 30 Ma and the Notothenioid fishes that produce an unrelated antifreeze glycoprotein extensively exploited the adjoining seas. We show that species from one Zoarcales family only encroached on this niche in the last few Ma, entering an environment already dominated by ice-resistant fishes, long after the onset of glaciation. As eelpouts are one of the dominant benthic fish groups of the deep ocean, they likely migrated from the north to Antarctica via the cold depths, losing all but the fully active isoform gene along the way. In contrast, northern species have retained both the fully active (QAE) and partially active (SP) isoforms for at least 15 Ma, which suggests that the combination of isoforms is functionally advantageous.	[Hobbs, Rod S.; Fletcher, Garth L.] Mem Univ Newfoundland, Dept Ocean Sci, St John, NF, Canada; [Hall, Jennifer R.] Mem Univ Newfoundland, Aquat Res Cluster, CREAIT Network, St John, NF, Canada; [Graham, Laurie A.; Davies, Peter L.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada	Memorial University Newfoundland; Memorial University Newfoundland; Queens University - Canada	Graham, LA (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.	grahamla@queensu.ca		Davies, Peter/0000-0002-8026-7818	Canadian Institutes of Health Research [FRN 148422]; Natural Sciences and Engineering Research Council [6836-06]; Canada Research Chair in Protein Engineering	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair in Protein Engineering(Canada Research Chairs)	This research was supported by the Canadian Institutes of Health Research (https://cihr-irsc.gc.ca/e/193.html)(Foundation Grant FRN 148422 to P.L.D.) and the Natural Sciences and Engineering Research Council (https://www.nserccrsng.gc.ca/index_eng.asp) (Discovery Grant 6836-06 to G.L.F.). P.L.D. holds the Canada Research Chair in Protein Engineering (https://www.chairs-chaires.gc.ca/home-accueil-eng.aspx).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, EBIOMEDICINE, V14, P1, DOI DOI 10.2903/J.EFSA.2016.4418; Antson AA, 2001, J MOL BIOL, V305, P875, DOI 10.1006/jmbi.2000.4336; Baalsrud HT, 2018, MOL BIOL EVOL, V35, P593, DOI 10.1093/molbev/msx311; Baardsnes J, 2002, BBA-PROTEINS PROTEOM, V1601, P49, DOI 10.1016/S1570-9639(02)00431-4; Baardsnes J, 2001, TRENDS BIOCHEM SCI, V26, P468, DOI 10.1016/S0968-0004(01)01879-5; Bar Dolev M, 2016, ANNU REV BIOCHEM, V85, P515, DOI 10.1146/annurev-biochem-060815-014546; Betancur-R R, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-0958-3; Betancur-R R, 2013, PLOS CURR-TREE LIFE, DOI 10.1371/currents.tol.53ba26640df0ccaee75bb165c8c26288; Biscoito M, 2004, COPEIA, P562, DOI 10.1643/CI-03-031R2; Briggs JC, 2003, J BIOGEOGR, V30, P1, DOI 10.1046/j.1365-2699.2003.00810.x; Briggs JC, 2012, J BIOGEOGR, V39, P12, DOI 10.1111/j.1365-2699.2011.02613.x; CHAO H, 1994, PROTEIN SCI, V3, P1760, DOI 10.1002/pro.5560031016; Charmantier Guy, 2009, P165; Chen LB, 1997, P NATL ACAD SCI USA, V94, P3811, DOI 10.1073/pnas.94.8.3811; Chen LB, 1997, P NATL ACAD SCI USA, V94, P3817, DOI 10.1073/pnas.94.8.3817; CHENG CHC, 1989, BIOCHIM BIOPHYS ACTA, V997, P55, DOI 10.1016/0167-4838(89)90135-0; Cheng CHC, 2006, P NATL ACAD SCI USA, V103, P10491, DOI 10.1073/pnas.0603796103; Corbella C, 2015, MAR BIOL RES, V11, P180, DOI 10.1080/17451000.2014.894245; Davies PL, 2018, SYST BIOL REPROD MED, V64, P403, DOI 10.1080/19396368.2018.1511764; Davies PL, 2002, PHILOS T R SOC B, V357, P927, DOI 10.1098/rstb.2002.1081; DAVIES PL, 1988, CAN J ZOOL, V66, P2611, DOI 10.1139/z88-385; DeLano W.L., 2002, CCP4 NEWSL PROTEIN C, V40, P82; Deng C, 2010, P NATL ACAD SCI USA, V107, P21593, DOI 10.1073/pnas.1007883107; Desjardins M, 2012, FEBS J, V279, P2215, DOI 10.1111/j.1742-4658.2012.08605.x; Donnelly J, 2004, POLAR BIOL, V27, P637, DOI 10.1007/s00300-004-0632-2; DOOLITTLE RF, 1994, TRENDS BIOCHEM SCI, V19, P15, DOI 10.1016/0968-0004(94)90167-8; Ewart KV, 1999, CELL MOL LIFE SCI, V55, P271, DOI 10.1007/s000180050289; Fletcher GL, 2001, ANNU REV PHYSIOL, V63, P359, DOI 10.1146/annurev.physiol.63.1.359; FLETCHER GL, 1986, CAN J ZOOL, V64, P1897, DOI 10.1139/z86-284; Froese R., FISHBASE; Garnham CP, 2012, FEBS LETT, V586, P3876, DOI 10.1016/j.febslet.2012.09.017; Garnham CP, 2010, BIOCHEMISTRY-US, V49, P9063, DOI 10.1021/bi100516e; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gladenkov AY, 2002, PALAEOGEOGR PALAEOCL, V183, P321, DOI 10.1016/S0031-0182(02)00249-3; GONG ZY, 1992, CAN J ZOOL, V70, P810, DOI 10.1139/z92-114; Graham LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081285; Graham LA, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-190; Graham LA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002616; Hagemans D, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00056; Hamada T, 2006, PROTEIN SCI, V15, P1010, DOI 10.1110/ps.051700406; Hansen J, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2012.0294; Harding MM, 1999, EUR J BIOCHEM, V264, P653, DOI 10.1046/j.1432-1327.1999.00617.x; HEW CL, 1988, J BIOL CHEM, V263, P12049; Hobbs RS, 2013, COMP BIOCHEM PHYS A, V164, P111, DOI 10.1016/j.cbpa.2012.10.017; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Kelley JL, 2010, J MOL EVOL, V71, P111, DOI 10.1007/s00239-010-9367-6; KNIGHT CA, 1991, BIOPHYS J, V59, P409, DOI 10.1016/S0006-3495(91)82234-2; Ko TP, 2003, BIOPHYS J, V84, P1228, DOI 10.1016/S0006-3495(03)74938-8; Kristiansson E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-345; Kumar D, 2016, J MOL ENDOCRINOL, V56, pT63, DOI 10.1530/JME-15-0266; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LI XM, 1985, J BIOL CHEM, V260, P2904; Marincovich L, 2001, QUATERNARY SCI REV, V20, P329, DOI 10.1016/S0277-3791(00)00113-X; Marincovich L, 1999, NATURE, V397, P149, DOI 10.1038/16446; Matschiner M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018911; McCusker MR, 2010, J HERED, V101, P591, DOI 10.1093/jhered/esq062; Miller GH, 2010, QUATERNARY SCI REV, V29, P1679, DOI 10.1016/j.quascirev.2010.03.001; Moller PR, 2003, MOL PHYLOGENET EVOL, V26, P369, DOI 10.1016/S1055-7903(02)00362-7; Nazarkin M. V., 2002, J ICHTHYOL+, V42, P279; Near TJ, 2013, P NATL ACAD SCI USA, V110, P12738, DOI 10.1073/pnas.1304661110; Near TJ, 2012, P NATL ACAD SCI USA, V109, P3434, DOI 10.1073/pnas.1115169109; Nishimiya Y, 2005, FEBS J, V272, P482, DOI 10.1111/j.1742-4658.2004.04490.x; OSUGA DT, 1978, J BIOL CHEM, V253, P5338; Pross J, 2012, NATURE, V488, P73, DOI 10.1038/nature11300; Radchenko OA, 2015, RUSS J GENET+, V51, P1096, DOI 10.1134/S1022795415100130; Radchenko OA, 2014, RUSS J MAR BIOL+, V40, P473, DOI 10.1134/S1063074014060194; Radchenko O.A., 2016, J ICHTHYOL+, V56, P556, DOI [10.1134/S0032945216040123, DOI 10.1134/S0032945216040123]; RAYMOND JA, 1977, P NATL ACAD SCI USA, V74, P2589, DOI 10.1073/pnas.74.6.2589; Salim D, 2019, CHROMOSOME RES, V27, P73, DOI 10.1007/s10577-018-9599-7; SCHOLANDER PF, 1957, J CELL COMPAR PHYSL, V49, P5, DOI 10.1002/jcp.1030490103; SCHRAG JD, 1983, COMP BIOCHEM PHYS A, V74, P381, DOI 10.1016/0300-9629(83)90619-9; SCHRAG JD, 1987, BIOCHIM BIOPHYS ACTA, V915, P357, DOI 10.1016/0167-4838(87)90021-5; SCOTT GK, 1988, MOL CELL BIOL, V8, P3670, DOI 10.1128/MCB.8.9.3670; SCOTT GK, 1986, CAN J FISH AQUAT SCI, V43, P1028, DOI 10.1139/f86-128; Scott W.B., 1988, CAN B FISH AQUAT SCI, V219, P1; Shears Margaret A., 1993, Molecular Marine Biology and Biotechnology, V2, P104; Sievers F, 2014, METHODS MOL BIOL, V1079, P105, DOI 10.1007/978-1-62703-646-7_6; Stickley CE, 2009, NATURE, V460, P376, DOI 10.1038/nature08163; Takamichi M, 2009, FEBS J, V276, P1471, DOI 10.1111/j.1742-4658.2009.06887.x; Trend-Staid M, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2000PA000506; Tripati A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03180-5; Wang L, 2005, BIOCHEMISTRY-US, V44, P10305, DOI 10.1021/bi050728y; WANG X, 1995, BBA-PROTEIN STRUCT M, V1247, P163, DOI 10.1016/0167-4838(94)00205-U; WANG X, 1995, MOL MAR BIOL BIOTECH, V4, P135; Wilkens C, 2014, CRYOBIOLOGY, V69, P163, DOI 10.1016/j.cryobiol.2014.07.003; WILSON PW, 1993, CRYO-LETT, V14, P31; Windisch HS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-549; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588; Zhang JF, 2009, POLAR BIOL, V32, P35, DOI 10.1007/s00300-008-0499-8; Zhuang X, 2019, P NATL ACAD SCI USA, V116, P4400, DOI 10.1073/pnas.1817138116	92	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243273	10.1371/journal.pone.0243273	http://dx.doi.org/10.1371/journal.pone.0243273			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320906	Green Published, gold			2022-12-27	WOS:000600339800027
J	Saito, E; Tang, XH; Abe, SK; Sawada, N; Ishihara, J; Takachi, R; Iso, H; Shimazu, T; Yamaji, T; Iwasaki, M; Inoue, M; Tsugane, S				Saito, Eiko; Tang, Xiaohe; Abe, Sarah Krull; Sawada, Norie; Ishihara, Junko; Takachi, Ribeka; Iso, Hiroyasu; Shimazu, Taichi; Yamaji, Taiki; Iwasaki, Motoki; Inoue, Manami; Tsugane, Shoichiro		JPHC Study Grp	Association between meat intake and mortality due to all-cause and major causes of death in a Japanese population	PLOS ONE			English	Article							FOOD FREQUENCY QUESTIONNAIRE; HETEROCYCLIC AMINE CONTENT; CORONARY-HEART-DISEASE; N-NITROSO COMPOUNDS; FOLLOW-UP SURVEY; RED MEAT; CARDIOVASCULAR-DISEASE; VARYING DEGREES; PROTEIN-INTAKE; COHORT-I	Purpose We examined the association between meat intake and mortality due to all-cause and major causes of death using a population-based cohort study in Japan. Methods 87,507 Japanese aged between 45 and 74 years old at 5-year follow-up study were followed for 14.0 years on average. Associations between meat intake and mortality risk were assessed using a Cox proportional hazards model. Results A heavy intake of total meat was associated with a higher risk of all-cause mortality relative to the lowest quartile intake in men (Q4: HR,1.18; 95%CIs, 1.06-1.31). A higher intake of total meat was associated with a lower risk of stroke mortality in women (Q2: HR, 0.70; 95%CIs, 0.51-0.94, Q3: HR, 0.68; 95%CIs, 0.50-0.95, Q4: HR, 0.66; 95%CIs, 0.44-0.99). A heavy intake of red meat was also associated with all-cause mortality (Q4: HR, 1.13; 95%CIs, 1.02-1.26) and heart disease mortality (Q4: HR, 1.51; 95%CIs, 1.11-2.06) in men but not in women. Heavy intake of chicken was inversely associated with cancer mortality in men. Conclusions Heavy intakes of total and red meat were associated with an increase in all-cause and heart disease mortality in men, while total meat intake was associated with a lower risk of stroke mortality in women.	[Saito, Eiko] Natl Canc Ctr, Div Canc Stat Integrat, Ctr Canc Control & Informat Serv, Chuo Ku, Tokyo, Japan; [Saito, Eiko; Abe, Sarah Krull; Sawada, Norie; Shimazu, Taichi; Yamaji, Taiki; Iwasaki, Motoki; Inoue, Manami; Tsugane, Shoichiro] Natl Canc Ctr, Epidemiol & Prevent Grp, Ctr Publ Hlth Sci, Chuo Ku, Tokyo, Japan; [Tang, Xiaohe] Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Bunkyo Ku, Tokyo, Japan; [Ishihara, Junko] Azabu Univ, Sch Life & Environm Sci, Dept Food & Life Sci, Sagamihara, Kanagawa, Japan; [Takachi, Ribeka] Nara Womens Univ, Fac Human Life & Environm, Dept Food Sci & Nutr, Nara, Nara, Japan; [Iso, Hiroyasu] Osaka Univ, Dept Social & Environm Med, Publ Hlth, Grad Sch Med, Suita, Osaka, Japan	National Cancer Center - Japan; National Cancer Center - Japan; University of Tokyo; Azabu University; Nara Womens University; Osaka University	Inoue, M (corresponding author), Natl Canc Ctr, Epidemiol & Prevent Grp, Ctr Publ Hlth Sci, Chuo Ku, Tokyo, Japan.	mnminoue@ncc.go.jp	Shimazu, Taichi/A-4470-2015	Shimazu, Taichi/0000-0001-6000-9830; Saito, Eiko/0000-0002-4550-9631	National Cancer Center Research and Development Fund [23-A-31, 26-A-2, 29-A-4]; Ministry of Health, Labour and Welfare of Japan	National Cancer Center Research and Development Fund(National Cancer Center - Japan); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by National Cancer Center Research and Development Fund (23-A-31[toku], 26-A-2 and 29-A-4) (since 2011) and a Grant-in-Aid for Cancer Research from the Ministry of Health, Labour and Welfare of Japan (from 1989 to 2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abete I, 2014, BRIT J NUTR, V112, P762, DOI 10.1017/S000711451400124X; [Anonymous], 2003, DIET NUTR PREV CHRON; Aune D, 2009, DIABETOLOGIA, V52, P2277, DOI 10.1007/s00125-009-1481-x; Budhathoki S, 2019, JAMA INTERN MED, V179, P1509, DOI 10.1001/jamainternmed.2019.2806; Center for Cancer Control and Information Services National Cancer Center, 2016, MON CANC INC JAP SUR; Chan DSM, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020456, 10.1371/journal.pone.0027218]; Cross AJ, 2004, ENVIRON MOL MUTAGEN, V44, P44, DOI 10.1002/em.20030; Daniel CR, 2011, PUBLIC HEALTH NUTR, V14, P575, DOI 10.1017/S1368980010002077; Daniel CR, 2011, CANCER PREV RES, V4, P1903, DOI 10.1158/1940-6207.CAPR-11-0241; Fung TT, 2004, STROKE, V35, P2014, DOI 10.1161/01.STR.0000135762.89154.92; Hebels DGAJ, 2009, TOXICOL SCI, V108, P290, DOI 10.1093/toxsci/kfp035; Huang X, 2003, MUTAT RES-FUND MOL M, V533, P153, DOI 10.1016/j.mrfmmm.2003.08.023; Hughes R, 2001, CARCINOGENESIS, V22, P199, DOI 10.1093/carcin/22.1.199; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2018, IARC MONOGRAPHS EVAL; Inoue M, 2008, ANN EPIDEMIOL, V18, P522, DOI 10.1016/j.annepidem.2008.03.008; Ishihara J, 2003, J EPIDEMIOL, V13, pS134; Iso H, 2001, CIRCULATION, V103, P856, DOI 10.1161/01.CIR.103.6.856; Iso H, 2011, J ATHEROSCLER THROMB, V18, P83, DOI 10.5551/jat.6866; Kelemen LE, 2005, AM J EPIDEMIOL, V161, P239, DOI 10.1093/aje/kwi038; Khan M M H, 2004, Asian Pac J Cancer Prev, V5, P58; Larsson SC, 2014, AM J EPIDEMIOL, V179, P282, DOI 10.1093/aje/kwt261; Lee JE, 2013, AM J CLIN NUTR, V98, P1032, DOI 10.3945/ajcn.113.062638; Matsuda T, 2011, JPN J CLIN ONCOL, V41, P40, DOI 10.1093/jjco/hyq167; McCord JM, 1998, SEMIN HEMATOL, V35, P5; Micha R, 2010, CIRCULATION, V121, P2271, DOI 10.1161/CIRCULATIONAHA.109.924977; Ministry of Health Labour and Welfare of Japan, 2005, NAT HLTH NUTR SURV; MIRVISH SS, 1977, J TOXICOL ENV HEALTH, V2, P1267, DOI 10.1080/15287397709529529; Nagao M, 2012, EUR J CLIN NUTR, V66, P687, DOI 10.1038/ejcn.2012.6; Nanri A, 2012, J EPIDEMIOL, V22, P205, DOI 10.2188/jea.JE20110087; Pan A, 2011, AM J CLIN NUTR, V94, P1088, DOI 10.3945/ajcn.111.018978; Pan A, 2012, ARCH INTERN MED, V172, P555, DOI 10.1001/archinternmed.2011.2287; Sasaki S, 2003, J EPIDEMIOL, V13, pS115; Sasaki S, 2003, J EPIDEMIOL, V13, pS57; Sauvaget C, 2003, INT J EPIDEMIOL, V32, P536, DOI 10.1093/ije/dyg151; Sinha R, 1998, FOOD CHEM TOXICOL, V36, P279, DOI 10.1016/S0278-6915(97)00162-2; Sinha R, 1998, FOOD CHEM TOXICOL, V36, P289, DOI 10.1016/S0278-6915(97)00159-2; Sinha R, 2009, ARCH INTERN MED, V169, P562, DOI 10.1001/archinternmed.2009.6; SKOG K, 1995, CARCINOGENESIS, V16, P861, DOI 10.1093/carcin/16.4.861; Takachi R, 2011, ASIA PAC J CLIN NUTR, V20, P603; Tsugane S, 2014, JPN J CLIN ONCOL, V44, P777, DOI 10.1093/jjco/hyu096; Umesawa M, 2009, AM J CLIN NUTR, V90, P377, DOI 10.3945/ajcn.2008.27109; Watanabe S, 2001, J Epidemiol, V11, pS3; World Cancer Research Fund & American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; World Health Organization, 2009, INT STAT CLASS DIS R; Yamagishi K, 2013, EUR HEART J, V34, P1225, DOI 10.1093/eurheartj/eht043; Zheng W, 2009, NUTR CANCER, V61, P437, DOI 10.1080/01635580802710741; Zheng Y, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l2110	47	5	5	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0244007	10.1371/journal.pone.0244007	http://dx.doi.org/10.1371/journal.pone.0244007			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320898	Green Published, gold			2022-12-27	WOS:000600339800025
J	Aguilar, MO; Gobbi, A; Browne, PD; Ellegaard-Jensen, L; Hansen, LH; Semorile, L; Pistorio, M				Aguilar, Monica Oyuela; Gobbi, Alex; Browne, Patrick D.; Ellegaard-Jensen, Lea; Hansen, Lars Hestbjerg; Semorile, Liliana; Pistorio, Mariano			Influence of vintage, geographic location and cultivar on the structure of microbial communities associated with the grapevine rhizosphere in vineyards of San Juan Province, Argentina	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; VITIS-VINIFERA L.; RNA GENES DIFFERENTIATION; SOIL BACTERIAL DIVERSITY; SOLUBILIZATION; TERROIR	Soil microbiomes, as a primary reservoir for plant colonizing fungi and bacteria, play a major role in determining plant productivity and preventing invasion by pathogenic microorganisms. The use of 16S rRNA and ITS high-throughput amplicon sequencing for analysis of complex microbial communities have increased dramatically in recent years, establishing links between wine specificity and, environmental and viticultural factors, which are framed into the elusive terroir concept. Given the diverse and complex role these factors play on microbial soil structuring of agricultural crops, the main aim of this study is to evaluate how external factors, such as vintage, vineyard location, cultivar and soil characteristics, may affect the diversity of the microbial communities present. Additionally, we aim to compare the influence these factors have on the structuring of bacterial and fungal populations associated with Malbec grapevine rhizosphere with that of the more widespread Cabernet Sauvignon grapevine cultivar. Samples were taken from Malbec and Cabernet Sauvignon cultivars from two different vineyards in the San Juan Province of Argentina. Total DNA extracts from the rhizosphere soil samples were sequenced using Illumina's Miseq technology, targeting the V3-V4 hypervariable 16S rRNA region in prokaryotes and the ITS1 region in yeasts. The major bacterial taxa identified were Proteobacteria, Bacteroidetes and Firmicutes, while the major fungal taxa were Ascomycetes, Basidiomycetes, Mortierellomycetes and a low percentage of Glomeromycetes. Significant differences in microbial community composition were found between vintages and vineyard locations, whose soils showed variances in pH, organic matter, and content of carbon, nitrogen, and absorbable phosphorus.	[Aguilar, Monica Oyuela; Pistorio, Mariano] UNLP, Inst Biotecnol & Biol Mol IBBM, CCT La Plata, CONICET,Dept Cs Biol,Fac Cs Exactas, La Plata, Argentina; [Gobbi, Alex; Browne, Patrick D.; Hansen, Lars Hestbjerg] Univ Copenhagen, Sect Microbial Ecol & Biotechnol, Dept Plant & Environm Sci, Frederiksberg, Denmark; [Ellegaard-Jensen, Lea] Aarhus Univ, Dept Environm Sci, Roskilde, Denmark; [Semorile, Liliana] Univ Nacl Quilmes UNQ, Lab Microbiol Mol, Dept Ciencia & Tecnol, Inst Microbiol Basica & Aplicada, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; University of Copenhagen; Aarhus University	Pistorio, M (corresponding author), UNLP, Inst Biotecnol & Biol Mol IBBM, CCT La Plata, CONICET,Dept Cs Biol,Fac Cs Exactas, La Plata, Argentina.	pistorio@biol.unlp.edu.ar	Ellegaard, Lea/ABG-4693-2021	Pistorio, Mariano/0000-0001-7931-8721; Browne, Patrick/0000-0001-8300-7758; Hestbjerg Hansen, Lars/0000-0003-0027-1524; Ellegaard-Jensen, Lea/0000-0002-7235-9026; Gobbi, Alex/0000-0003-3541-4732	Horizon 2020 Programme of the European Commission within the Marie Sklodowska-Curie Innovative Training Network "MicroWine" [643063]; Agencia Nacional de Promocion Cientifica y Tecnica [PICT-2017-2833]	Horizon 2020 Programme of the European Commission within the Marie Sklodowska-Curie Innovative Training Network "MicroWine"; Agencia Nacional de Promocion Cientifica y Tecnica(ANPCyT)	This study was funded by the Horizon 2020 Programme of the European Commission within the Marie Sklodowska-Curie Innovative Training Network "MicroWine" (grant number 643063), and by Agencia Nacional de Promocio ' n Cienti ' fica y Te ' cnica PICT-2017-2833 to MP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alori ET, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00971; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Azziz G, 2012, APPL SOIL ECOL, V61, P320, DOI 10.1016/j.apsoil.2011.10.004; Bacon CW, 2016, SYMBIOSIS, V68, P87, DOI 10.1007/s13199-015-0350-2; Balestrini R, 2010, ENV MICROBIOL REP, V2, P594, DOI 10.1111/j.1758-2229.2010.00160.x; Barata A, 2012, INT J FOOD MICROBIOL, V153, P243, DOI 10.1016/j.ijfoodmicro.2011.11.025; Beckers B, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0241-2; Belda I., 2021, COMPREHENSIVE FOODOM, P438, DOI [10.1016/B978-0-08-100596-5.22875-8., DOI 10.1016/B978-0-08-100596-5.22875-8]; Belda I, 2017, FRONT MICROBIOL, V8, DOI [10.3389/fmicb.2017.00821, 10.3389/fmicb.2017.01065]; Belda I, 2016, YEAST, V33, P329, DOI 10.1002/yea.3165; Bokulich NA, 2016, MBIO, V7, DOI 10.1128/mBio.00631-16; Bokulich NA, 2014, P NATL ACAD SCI USA, V111, pE139, DOI 10.1073/pnas.1317377110; BRAY RH, 1945, SOIL SCI, V59, P39, DOI 10.1097/00010694-194501000-00006; Bremner JM, 1960, DETERMINATION NITROG, DOI [10.1017/S0021859600021572, DOI 10.1017/S0021859600021572]; Bulgari D, 2011, APPL ENVIRON MICROB, V77, P5018, DOI 10.1128/AEM.00051-11; Burns KN, 2016, SOIL BIOL BIOCHEM, V103, P337, DOI 10.1016/j.soilbio.2016.09.007; Burns KN, 2015, SOIL BIOL BIOCHEM, V91, P232, DOI 10.1016/j.soilbio.2015.09.002; Campisano A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112763; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Castagno LN, 2011, J APPL MICROBIOL, V110, P1151, DOI 10.1111/j.1365-2672.2011.04968.x; Chen J, 2012, BIOINFORMATICS, V28, P2106, DOI 10.1093/bioinformatics/bts342; Chou MY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29346-1; DAVIES BE, 1974, SOIL SCI SOC AM J, V38, P150, DOI 10.2136/sssaj1974.03615995003800010046x; Deacon LJ, 2006, SOIL BIOL BIOCHEM, V38, P7, DOI 10.1016/j.soilbio.2005.04.013; Del Frari G, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00910; Edgar RC., 2016, BIORXIV, DOI [10.1101/074161, DOI 10.1101/074161, 10.1101/2020.05.12.088096]; Edgar RC, 2015, BIOINFORMATICS, V31, P3476, DOI 10.1093/bioinformatics/btv401; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Frac M, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00707; Gilbert JA, 2014, P NATL ACAD SCI USA, V111, P5, DOI 10.1073/pnas.1320471110; Gobbi A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-56741-z; Gobbi A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0200979; Gupta VVSR, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01607; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; INV, 2018, INF AN SUP 2018; Jacoby R, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01617; KILMER VJ, 1949, SOIL SCI, V68, P15, DOI 10.1097/00010694-194907000-00003; Knight S, 2015, SCI REP-UK, V5, DOI 10.1038/srep14233; Koorem K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091998; Kruger M, 2009, NEW PHYTOL, V183, P212, DOI 10.1111/j.1469-8137.2009.02835.x; Lagkouvardos I, 2017, PEERJ, V5, DOI 10.7717/peerj.2836; Likar M, 2013, MYCORRHIZA, V23, P209, DOI 10.1007/s00572-012-0463-x; Linu MS, 2019, COMMUN SOIL SCI PLAN, V50, P444, DOI 10.1080/00103624.2019.1566469; Marasco R, 2018, MICROBIOME, V6, DOI 10.1186/s40168-017-0391-2; Marban L, 2005, AACS, VII, P65; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mozell M. R., 2014, Wine Economics and Policy, V3, P81, DOI 10.1016/j.wep.2014.08.001; Muller LM, 2019, CURR OPIN PLANT BIOL, V50, P132, DOI 10.1016/j.pbi.2019.05.004; Novello G, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01528; Oteino N, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00745; Perazzolli M, 2014, APPL ENVIRON MICROB, V80, P3585, DOI 10.1128/AEM.00415-14; Pieterse CMJ, 2016, TRENDS PLANT SCI, V21, P171, DOI 10.1016/j.tplants.2016.01.018; Pinto C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085622; Roca P., 2019, STATE VITIVINICULTUR; Schreiner RP, 2009, MYCOLOGIA, V101, P599, DOI 10.3852/08-169; Schreiter S, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00144; Setati ME, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01358; Setati ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052609; Singh P, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50839-0; Singh P, 2018, MICROORGANISMS, V6, DOI 10.3390/microorganisms6040096; Smith SE, 2008, MYCORRHIZAL SYMBIOSIS, 3RD EDITION, P1; Son HJ, 2006, BIORESOURCE TECHNOL, V97, P204, DOI 10.1016/j.biortech.2005.02.021; Steenwerth KL, 2008, SOIL BIOL BIOCHEM, V40, P1330, DOI 10.1016/j.soilbio.2007.04.031; Tak H. I., 2012, International Journal of Plant Research, V2, P6; Takahashi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105592; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; Trouvelot S, 2015, AGRON SUSTAIN DEV, V35, P1449, DOI 10.1007/s13593-015-0329-7; Vega-Avila AD, 2015, ANTON LEEUW INT J G, V107, P575, DOI 10.1007/s10482-014-0353-7; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; Wei YJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193097; Zarraonaindia I, 2015, MBIO, V6, DOI 10.1128/mBio.02527-14; Zhang XX, 2014, INT J SYST EVOL MICR, V64, P1373, DOI 10.1099/ijs.0.056325-0; Zuccaro A, 2020, EMBO J, V39, DOI 10.15252/embj.2019104144	74	10	10	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243848	10.1371/journal.pone.0243848	http://dx.doi.org/10.1371/journal.pone.0243848			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315910	Green Published, gold			2022-12-27	WOS:000600186100087
J	Horiuchi, S; Shinohara, R; Otawa, S; Akiyama, Y; Ooka, T; Kojima, R; Yokomichi, H; Miyake, K; Yamagata, Z				Horiuchi, Sayaka; Shinohara, Ryoji; Otawa, Sanae; Akiyama, Yuka; Ooka, Tadao; Kojima, Reiji; Yokomichi, Hiroshi; Miyake, Kunio; Yamagata, Zentaro			Caregivers' mental distress and child health during the COVID-19 outbreak in Japan	PLOS ONE			English	Article							PARENTAL PSYCHOPATHOLOGY; SOCIAL PHOBIA; K6; POPULATION; SCALE	To clarify the physical and mental conditions of children during the coronavirus disease 2019 pandemic and consequent social distancing in relation to the mental condition of their caregivers. This internet-based nationwide cross-sectional study was conducted between April 30 and May 13, 2020. The participants were 1,200 caregivers of children aged 3-14 years. Child health issues were categorized into "at least one" or "none" according to caregivers' perception. Caregivers' mental status was assessed using the Japanese version of the Kessler Psychological Distress Scale-6. The association between caregivers' mental status and child health issues was analyzed using logistic regression models. Among the participants, 289 (24.1%) had moderate and 352 (29.3%) had severe mental distress and 69.8% of children in their care had health issues. The number of caregivers with mental distress was more than double that reported during the 2016 national survey. After adjusting for covariates, child health issues increased among caregivers with moderate mental distress (odds ratio 2.24, 95% confidence interval 1.59-3.16) and severe mental distress (odds ratio 3.05, 95% confidence interval 2.17-4.29) compared with caregivers with no mental distress. The results highlight parents' psychological stress during the pandemic, suggesting the need for adequate parenting support. However, our study did not consider risk factors of caregivers' mental distress such as socioeconomic background. There is an urgent need for further research to identify vulnerable populations and children's needs to develop sustainable social support programs for those affected by the outbreak.	[Horiuchi, Sayaka; Shinohara, Ryoji; Otawa, Sanae] Univ Yamanashi, Ctr Birth Cohort Studies, Chuo, Yamanashi, Japan; [Akiyama, Yuka; Ooka, Tadao; Kojima, Reiji; Yokomichi, Hiroshi; Miyake, Kunio; Yamagata, Zentaro] Univ Yamanashi, Sch Med, Dept Hlth Sci, Chuo, Yamanashi, Japan	University of Yamanashi; University of Yamanashi	Horiuchi, S (corresponding author), Univ Yamanashi, Ctr Birth Cohort Studies, Chuo, Yamanashi, Japan.	Sayakahoriuchi@gmail.com	Ooka, Tadao/AAR-1205-2021; Yokomichi, Hiroshi/B-2816-2013	Yokomichi, Hiroshi/0000-0001-7369-155X	University of Yamanashi	University of Yamanashi(University of Yamanashi)	The study was funded by the running expense of University of Yamanashi. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, RES REPORT EARLY DET; Fegert JM, 2020, CHILD ADOL PSYCH MEN, V14, DOI 10.1186/s13034-020-00329-3; Flouri E, 2019, J AM ACAD CHILD PSY, V58, P453, DOI 10.1016/j.jaac.2018.06.041; Furukawa TA, 2008, INT J METH PSYCH RES, V17, P152, DOI 10.1002/mpr.257; Green P, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1669; Gulenc A, 2018, CHILD CARE HLTH DEV, V44, P892, DOI 10.1111/cch.12607; Human Rights Watch, COVID 19 CHILDR RIGH; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kessler RC, 2010, INT J METH PSYCH RES, V19, P4, DOI 10.1002/mpr.310; Knappe S, 2009, DEPRESS ANXIETY, V26, P363, DOI 10.1002/DA.20527; Lieb R, 2000, ARCH GEN PSYCHIAT, V57, P859, DOI 10.1001/archpsyc.57.9.859; Lissak G, 2018, ENVIRON RES, V164, P149, DOI 10.1016/j.envres.2018.01.015; Luo M, 2020, PSYCHIAT RES, V291, DOI 10.1016/j.psychres.2020.113190; Marques ES, 2020, CAD SAUDE PUBLICA, V36, DOI 10.1590/0102-311X00074420; McDermott BM, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-55; Ministry of Education Culture Sports Science and Technology, INF MEXTS MEAS COVID; Ministry of Health Labour and Welfare, COMPR SURV LIV COND; Najman JM, 2001, SOC PSYCH PSYCH EPID, V36, P186, DOI 10.1007/s001270170062; National Center for Child Health and Development, NAT ONL SURV CHILDR; Prime Minister of Japan and His Cabinet, COVID 19 DECL LIFT S; Prime Minister of Japan and his Cabinet, COVID 19 DECL STAT E; Prochaska JJ, 2012, INT J METH PSYCH RES, V21, P88, DOI 10.1002/mpr.1349; Radesky J, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-2591; Sampasa-Kanyinga H, 2019, J PRIM PREV, V40, P189, DOI 10.1007/s10935-019-00543-6; Sandro G, 2005, EPIDEMIOL REV, V27, P78, DOI [10.1093/epirev/mxi003, DOI 10.1093/EPIREV/MXI003]; Talevi D, 2020, RIV PSICHIATR, V55, P137, DOI 10.1708/3382.33569; The Lancet, 2020, LANCET PLANET HLTH, V4, pe168; Torales J, 2020, INT J SOC PSYCHIATR, V66, P317, DOI 10.1177/0020764020915212; Vindegaard N, 2020, BRAIN BEHAV IMMUN, V89, P531, DOI 10.1016/j.bbi.2020.05.048; Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051729; Wang GH, 2020, LANCET, V395, P945, DOI 10.1016/S0140-6736(20)30547-X	31	22	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243702	10.1371/journal.pone.0243702	http://dx.doi.org/10.1371/journal.pone.0243702			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH0WB	33301517	Green Published			2022-12-27	WOS:000600143100010
J	Beck, MA; Liu, CY; Bidinosti, CP; Henry, CJ; Godee, CM; Ajmani, M				Beck, Michael A.; Liu, Chen-Yi; Bidinosti, Christopher P.; Henry, Christopher J.; Godee, Cara M.; Ajmani, Manisha			An embedded system for the automated generation of labeled plant images to enable machine learning applications in agriculture	PLOS ONE			English	Article							PRECISION AGRICULTURE; ARABIDOPSIS-THALIANA; COMPUTER VISION; FIELD; PLATFORM; CROP; CLASSIFICATION; OPERATIONS; ROBOTS	A lack of sufficient training data, both in terms of variety and quantity, is often the bottleneck in the development of machine learning (ML) applications in any domain. For agricultural applications, ML-based models designed to perform tasks such as autonomous plant classification will typically be coupled to just one or perhaps a few plant species. As a consequence, each crop-specific task is very likely to require its own specialized training data, and the question of how to serve this need for data now often overshadows the more routine exercise of actually training such models. To tackle this problem, we have developed an embedded robotic system to automatically generate and label large datasets of plant images for ML applications in agriculture. The system can image plants from virtually any angle, thereby ensuring a wide variety of data; and with an imaging rate of up to one image per second, it can produce lableled datasets on the scale of thousands to tens of thousands of images per day. As such, this system offers an important alternative to time- and cost-intensive methods of manual generation and labeling. Furthermore, the use of a uniform background made of blue keying fabric enables additional image processing techniques such as background replacement and image segementation. It also helps in the training process, essentially forcing the model to focus on the plant features and eliminating random correlations. To demonstrate the capabilities of our system, we generated a dataset of over 34,000 labeled images, with which we trained an ML-model to distinguish grasses from non-grasses in test data from a variety of sources. We now plan to generate much larger datasets of Canadian crop plants and weeds that will be made publicly available in the hope of further enabling ML applications in the agriculture sector.	[Beck, Michael A.; Bidinosti, Christopher P.; Ajmani, Manisha] Univ Winnipeg, Dept Phys, Winnipeg, MB, Canada; [Beck, Michael A.; Bidinosti, Christopher P.; Henry, Christopher J.; Ajmani, Manisha] Univ Winnipeg, Dept Appl Comp Sci, Winnipeg, MB, Canada; [Liu, Chen-Yi; Bidinosti, Christopher P.] Univ Manitoba, Dept Elect & Comp Engn, Winnipeg, MB, Canada; [Godee, Cara M.] Univ Winnipeg, Dept Biol, Winnipeg, MB, Canada	University of Winnipeg; University of Winnipeg; University of Manitoba; University of Winnipeg	Beck, MA (corresponding author), Univ Winnipeg, Dept Phys, Winnipeg, MB, Canada.; Beck, MA (corresponding author), Univ Winnipeg, Dept Appl Comp Sci, Winnipeg, MB, Canada.	m.beck@uwinnipeg.ca		Henry, Christopher/0000-0002-2624-1502	George Weston Limited -Seeding Food Innovation [SFI18-0276]; Western Economic Diversification Canada -Regional Innovation Ecosystems Program [15453]; Mitacs -Accelerate [IT14120]	George Weston Limited -Seeding Food Innovation; Western Economic Diversification Canada -Regional Innovation Ecosystems Program; Mitacs -Accelerate	M.B., C.B., C.H., C.-Y., and C.G. received funding from: George Weston Limited -Seeding Food Innovation SFI18-0276, https://www.weston.ca; Mitacs -Accelerate IT14120, https://www.mitacs.ca; and Western Economic Diversification Canada -Regional Innovation Ecosystems Program 15453, https://www.wd-deo.gc.ca/eng/19775.asp The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	a R-M, 2020, J CLIN MED, V9; [Anonymous], 2019, NAT ELECTRON, V2, P1, DOI 10.1038/s41928-019-0203-8; [Anonymous], 2015, Prescrire Int, V24, P93; [Anonymous], 2018, PLOS ONE, V13, P1, DOI DOI 10.3171/2018.1.JNS172645; Antonacci A, 2018, TRAC-TREND ANAL CHEM, V98, P95, DOI 10.1016/j.trac.2017.10.022; Antoniou A, 2018, 171104340 ARXIV; Barbedo JGA, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-660; Bacco Manlio., 2019, ARRAY, V3-4, P100009, DOI [DOI 10.1016/J.ARRAY.2019.100009, 10.1016/j.array.2019.100009]; Bah MD, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10111690; Bai G, 2016, COMPUT ELECTRON AGR, V128, P181, DOI 10.1016/j.compag.2016.08.021; Barker J, 2016, COMPUT ELECTRON AGR, V122, P74, DOI 10.1016/j.compag.2016.01.017; Bechar A, 2017, BIOSYST ENG, V153, P110, DOI 10.1016/j.biosystemseng.2016.11.004; Bechar A, 2016, BIOSYST ENG, V149, P94, DOI 10.1016/j.biosystemseng.2016.06.014; Beck MB, 2020, EAGL 1; Binch A, 2017, COMPUT ELECTRON AGR, V140, P123, DOI 10.1016/j.compag.2017.05.018; Bojarski Mariusz, 2016, arXiv; Bosilj P, 2018, IEEE ROBOT AUTOM LET, V3, P2950, DOI 10.1109/LRA.2018.2848305; Bradski G, 2008, LEARNING OPENCV COMP; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Chene Y, 2012, COMPUT ELECTRON AGR, V82, P122, DOI 10.1016/j.compag.2011.12.007; Crimmins MA, 2008, ENVIRON MANAGE, V41, P949, DOI 10.1007/s00267-008-9086-6; Cubuk ED, 2019, 180509501 ARXIV; Dobrescu A, 2017, PLANT METHODS, V13, DOI 10.1186/s13007-017-0247-6; Duckett T, 2020, 2018 INT ROB SHOWC U; Dutta Abhishek, 2019, MM '19: Proceedings of the 27th ACM International Conference on Multimedia, P2276, DOI 10.1145/3343031.3350535; Gehan MA, 2017, PEERJ, V5, DOI 10.7717/peerj.4088; Gehan MA, 2017, AM J BOT, V104, P505, DOI 10.3732/ajb.1700044; Giselsson T. M., 2017, PUBLIC IMAGE DATABAS; Giuffrida MV, 2018, PLANT METHODS, V14, DOI 10.1186/s13007-018-0278-7; Granier C, 2006, NEW PHYTOL, V169, P623, DOI 10.1111/j.1469-8137.2005.01609.x; Han DM, 2018, EXPERT SYST APPL, V95, P43, DOI 10.1016/j.eswa.2017.11.028; Haug S, 2015, LECT NOTES COMPUT SC, V8928, P105, DOI [10.1007/978-3-319-16220-1_8, 10.1007/978-3-319-16220-1-8]; He KM, 2015, IEEE I CONF COMP VIS, P1026, DOI 10.1109/ICCV.2015.123; HE KM, 2016, PROC CVPR IEEE, P770, DOI DOI 10.1109/CVPR.2016.90; Henry CJ, 2019, INT J REMOTE SENS, V40, P4416, DOI 10.1080/01431161.2018.1563840; Iandola FN, 160207360 ARXIV; Jansen M, 2009, FUNCT PLANT BIOL, V36, P902, DOI 10.1071/FP09095; Jiang Y, 2016, COMPUT ELECTRON AGR, V130, P57, DOI 10.1016/j.compag.2016.09.017; Jimenez-Berni JA, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00237; Kamilaris A, 2018, COMPUT ELECTRON AGR, V147, P70, DOI 10.1016/j.compag.2018.02.016; Khanna A, 2019, COMPUT ELECTRON AGR, V157, P218, DOI 10.1016/j.compag.2018.12.039; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lemley J, 2017, IEEE ACCESS, V5, P5858, DOI 10.1109/ACCESS.2017.2696121; Liakos KG, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18082674; Lobet G, 2017, TRENDS PLANT SCI, V22, P559, DOI 10.1016/j.tplants.2017.05.002; Lottes P, 2016, IEEE INT CONF ROBOT, P5157, DOI 10.1109/ICRA.2016.7487720; Manoj PDS, 2015, IEEE T COMPUT, V64, P3022, DOI 10.1109/TC.2015.2389827; Mikolajczyk A., 2018, 2018 INT INTERDISCIP, P117, DOI DOI 10.1109/IIPHDW.2018.8388338; Minervini M, 2017, PLANT J, V90, P204, DOI 10.1111/tpj.13472; Mingxing T, 190511946 ARXIV; Oberti R, 2016, BIOSYST ENG, V146, P1, DOI 10.1016/j.biosystemseng.2016.05.010; Patricio DI, 2018, COMPUT ELECTRON AGR, V153, P69, DOI 10.1016/j.compag.2018.08.001; Rapson, 2018, P 2018 11 INT C MOB, P1, DOI [10.1109/IVCNZ.2018.8634750, DOI 10.1109/IVCNZ.2018.8634750]; Relf-Eckstein JE, 2019, NJAS-WAGEN J LIFE SC, V90-91, DOI 10.1016/j.njas.2019.100307; Ren SQ, 2015, ADV NEUR IN, V28, DOI 10.1109/TPAMI.2016.2577031; Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y; Russell BC, 2008, INT J COMPUT VISION, V77, P157, DOI 10.1007/s11263-007-0090-8; Schenk E., 2009, WORKSH OP SOURC INN, V72, P3; Shakoor N, 2017, CURR OPIN PLANT BIOL, V38, P184, DOI 10.1016/j.pbi.2017.05.006; Shamshiri RR, 2018, INT J AGR BIOL ENG, V11, P1, DOI 10.25165/j.ijabe.20181104.4278; Singh A, 2016, TRENDS PLANT SCI, V21, P110, DOI 10.1016/j.tplants.2015.10.015; Sixt L, 2017, 161101331 ARXIV; Story D, 2015, MACH VISION APPL, V26, P495, DOI 10.1007/s00138-015-0670-5; Taigman Y., 2014, P IEEE COMP SOC C CO; Tardieu F, 2017, CURR BIOL, V27, pR770, DOI 10.1016/j.cub.2017.05.055; Tisne S, 2013, PLANT J, V74, P534, DOI 10.1111/tpj.12131; Ubbens J, 2018, PLANT METHODS, V14, DOI 10.1186/s13007-018-0273-z; Ubbens JR, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01190; Unal I, 2015, INT J ADV ROBOT SYST, V12, DOI 10.5772/62059; Vazquez-Arellano M, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16050618; Vinyals O, 2015, P IEEE COMP SOC C CO; Waldchen J, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1005993; Xie S, 161105431 ARXIV; Narvaez FY, 2017, IEEE-ASME T MECH, V22, P2428, DOI 10.1109/TMECH.2017.2760866	75	4	4	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243923	10.1371/journal.pone.0243923	http://dx.doi.org/10.1371/journal.pone.0243923			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332382	gold, Green Submitted, Green Published			2022-12-27	WOS:000601310900040
J	Kazmi, SZH; Habib, N; Riaz, R; Rizvi, SS; Abbas, SA; Chung, TS				Kazmi, Syed Zaki Hassan; Habib, Nazneen; Riaz, Rabia; Rizvi, Sanam Shahla; Abbas, Syed Ali; Chung, Tae-Sun			Multiscale based nonlinear dynamics analysis of heart rate variability signals	PLOS ONE			English	Article							TIME-SERIES; ENTROPY; HEALTHY; INDEX	Acceleration change index (ACI) is a fast and easy to understand heart rate variability (HRV) analysis approach used for assessing cardiac autonomic control of the nervous systems. The cardiac autonomic control of the nervous system is an example of highly integrated systems operating at multiple time scales. Traditional single scale based ACI did not take into account multiple time scales and has limited capability to classify normal and pathological subjects. In this study, a novel approach multiscale ACI (MACI) is proposed by incorporating multiple time scales for improving the classification ability of ACI. We evaluated the performance of MACI for classifying, normal sinus rhythm (NSR), congestive heart failure (CHF) and atrial fibrillation subjects. The findings reveal that MACI provided better classification between healthy and pathological subjects compared to ACI. We also compared MACI with other scale-based techniques such as multiscale entropy, multiscale permutation entropy (MPE), multiscale normalized corrected Shannon entropy (MNCSE) and multiscale permutation entropy (IMPE). The preliminary results show that MACI values are more stable and reliable than IMPE and MNCSE. The results show that MACI based features lead to higher classification accuracy.	[Kazmi, Syed Zaki Hassan; Riaz, Rabia; Abbas, Syed Ali] Univ Azad Jammu & Kashmir, Dept Comp Sci & Informat Technol, Muzaffarabad, Pakistan; [Habib, Nazneen] Univ Azad Jammu & Kashmir, Dept Sociol & Rural Dev, Muzaffarabad, Pakistan; [Rizvi, Sanam Shahla] Raptor Interact Pty Ltd, Centurion, South Africa; [Chung, Tae-Sun] Ajou Univ, Dept Software, Suwon, South Korea	University of Azad Jammu & Kashmir; University of Azad Jammu & Kashmir; Ajou University	Chung, TS (corresponding author), Ajou Univ, Dept Software, Suwon, South Korea.	tschung@ajou.ac.kr	Rizvi, Sanam Shahla/GQQ-8390-2022	Rizvi, Sanam Shahla/0000-0003-4694-3250	National Research Foundation of Korea (NRF) - Ministry of Education [2019R1F1A1058548]; Raptor Interactive (Pty) Ltd.	National Research Foundation of Korea (NRF) - Ministry of Education; Raptor Interactive (Pty) Ltd.	Basic Science Research provided support for this study through the National Research Foundation of Korea (NRF) funded by the Ministry of Education in the form of a grant awarded to TSC (2019R1F1A1058548). This funder played a role in study design, decision to publish, and preparation of the manuscript, but did not play a role in data collection or analysis. Raptor Interactive (Pty) Ltd. provided support in the form of a salary for SSR. The specific roles of this author are articulated in the `author contributions' section. This funder played a major role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas SA, 2018, IEEE ACCESS, V6, P67555, DOI 10.1109/ACCESS.2018.2879115; Arif M, 2005, PHYSIOL MEAS, V26, P653, DOI 10.1088/0967-3334/26/5/007; Ashkenazy Y, 2000, COMPUT CARDIOL, V27, P139, DOI 10.1109/CIC.2000.898475; Awan I, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196823; Costa M, 2002, COMPUT CARDIOL, V29, P137, DOI 10.1109/CIC.2002.1166726; de Geus EJC, 2019, PSYCHOPHYSIOLOGY, V56, DOI 10.1111/psyp.13287; Valencia JF, 2009, IEEE T BIO-MED ENG, V56, P2202, DOI 10.1109/TBME.2009.2021986; Garcia-Gonzalez MA, 2003, PHYSIOL MEAS, V24, P819, DOI 10.1088/0967-3334/24/4/301; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Guzman-Vargas L, 2008, NAT HAZARD EARTH SYS, V8, P855, DOI 10.5194/nhess-8-855-2008; Humeau-Heurtier A, 2014, ENTROPY-SWITZ, V16, P5777, DOI 10.3390/e16115777; Hussain L, 2018, BIOMED ENG-BIOMED TE, V63, P481, DOI 10.1515/bmt-2017-0041; Kazmi SZH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157557; Massaro S., 2016, ORGAN RES METHODS, V22, P354, DOI DOI 10.1177/1094428116681072; Nikulin VV, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.089803; Niu H, 2015, COMMUN NONLINEAR SCI, V22, P375, DOI 10.1016/j.cnsns.2014.08.038; Pan YH, 2011, J MAR SCI TECH-TAIW, V19, P107; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; Salmoirago-Blotcher E., 2019, PSYCHOSOMATIC MED; Shah SAA, 2020, TRAIT SIGNAL, V37, P355, DOI 10.18280/ts.370302; Wu SD, 2013, PHYSICA A, V392, P5865, DOI 10.1016/j.physa.2013.07.075; Wu SD, 2013, ENTROPY-SWITZ, V15, P1069, DOI 10.3390/e15031069	22	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243441	10.1371/journal.pone.0243441	http://dx.doi.org/10.1371/journal.pone.0243441			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332361	Green Published, gold			2022-12-27	WOS:000601310900097
J	de Castro, ACV; Fuchs, D; Morello, GM; Pastur, S; de Sousa, L; Olsson, IAS				de Castro, Ana Catarina Vieira; Fuchs, Danielle; Morello, Gabriela Munhoz; Pastur, Stefania; de Sousa, Liliana; Olsson, I. Anna S.			Does training method matter? Evidence for the negative impact of aversive-based methods on companion dog welfare	PLOS ONE			English	Article							CANIS-FAMILIARIS; SALIVA CORTISOL; PLASMA-CORTISOL; COGNITIVE BIAS; BEHAVIOR; STRESS; RESPONSES; BENEFITS; COLLAR	Dog training methods range broadly from those using mostly positive punishment and negative reinforcement (aversive-based) to those using primarily positive reinforcement (reward-based). Although aversive-based training has been strongly criticized for negatively affecting dog welfare, there is no comprehensive research focusing on companion dogs and mainstream techniques, and most studies rely on owner-reported assessment of training methods and dog behavior. The aim of the present study was to evaluate the effects of aversive- and reward-based training methods on companion dog welfare within and outside the training context. Ninety-two companion dogs were recruited from three reward-based schools (Group Reward, n = 42), and from four aversive-based schools, two using low proportions of aversive-based methods (Group Mixed, n = 22) and two using high proportions of aversive-based methods (Group Aversive, n = 28). For evaluating welfare during training, dogs were video recorded for three sessions and six saliva samples were collected, three at home (baseline levels) and three after training (post-training levels). Video recordings were used to examine the frequency of stress-related behaviors (e.g., lip lick, yawn) and the overall behavioral state of the dog (e.g., tense, relaxed), and saliva samples were analyzed for cortisol concentration. For evaluating welfare outside the training context, dogs participated in a cognitive bias task. Results showed that dogs from Group Aversive displayed more stress-related behaviors, were more frequently in tense and low behavioral states and panted more during training, and exhibited higher post-training increases in cortisol levels than dogs from Group Reward. Additionally, dogs from Group Aversive were more 'pessimistic' in the cognitive bias task than dogs from Group Reward. Dogs from Group Mixed displayed more stress-related behaviors, were more frequently in tense states and panted more during training than dogs from Group Reward. Finally, although Groups Mixed and Aversive did not differ in their performance in the cognitive bias task nor in cortisol levels, the former displayed more stress-related behaviors and was more frequently in tense and low behavioral states. These findings indicate that aversive-based training methods, especially if used in high proportions, compromise the welfare of companion dogs both within and outside the training context.	[de Castro, Ana Catarina Vieira; Fuchs, Danielle; Morello, Gabriela Munhoz; Pastur, Stefania; Olsson, I. Anna S.] Univ Porto, Inst Biol Mol & Celular, Porto, Portugal; [de Castro, Ana Catarina Vieira; Fuchs, Danielle; Morello, Gabriela Munhoz; Pastur, Stefania; Olsson, I. Anna S.] Univ Porto, I3S, Porto, Portugal; [de Castro, Ana Catarina Vieira; de Sousa, Liliana] Univ Porto, Inst Ciencias Biomed Abel Salazar, Porto, Portugal; [Fuchs, Danielle] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh, Midlothian, Scotland; [Pastur, Stefania] Univ Trieste, Trieste, Italy	Universidade do Porto; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; University of Edinburgh; University of Trieste	de Castro, ACV (corresponding author), Univ Porto, Inst Biol Mol & Celular, Porto, Portugal.; de Castro, ACV (corresponding author), Univ Porto, I3S, Porto, Portugal.; de Castro, ACV (corresponding author), Univ Porto, Inst Ciencias Biomed Abel Salazar, Porto, Portugal.	ana.castro@ibmc.up.pt	Morello, Gabriela/P-1005-2017	Morello, Gabriela/0000-0002-5439-969X; Olsson, Anna/0000-0002-4369-8723; Vieira de Castro, Ana/0000-0002-3357-7282	FCT -Fundacao Portuguesa para a Ciencia e Tecnologia; UFAW -Universities Federation for Animal Welfare [14-16/17]; PIPOL Regione Friuli Venezia Giulia	FCT -Fundacao Portuguesa para a Ciencia e Tecnologia; UFAW -Universities Federation for Animal Welfare; PIPOL Regione Friuli Venezia Giulia(Regione Friuli Venezia Giulia)	The current research study was supported by FCT -Fundacao Portuguesa para a Ciencia e Tecnologia (Fellowship SFRH/BPD/111509/2015) and UFAW -Universities Federation for Animal Welfare (Grant 14-16/17), with grants awarded to ACVC. SP was supported by PIPOL Regione Friuli Venezia Giulia. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. FCT -Fundacao Portuguesa para a Ciencia e Tecnologia: https://www.fct.pt/index.phtml.pt UFAW - Universities Federation for Animal Welfare: https://www.ufaw.org.uk/.	Arhant C, 2010, APPL ANIM BEHAV SCI, V123, P131, DOI 10.1016/j.applanim.2010.01.003; Barker SB, 2008, J VET MED EDUC, V35, P487, DOI 10.3138/jvme.35.4.487; Beerda B, 1998, APPL ANIM BEHAV SCI, V58, P365, DOI 10.1016/S0168-1591(97)00145-7; Beerda B, 1997, APPL ANIM BEHAV SCI, V52, P307, DOI 10.1016/S0168-1591(96)01131-8; Blackwell EJ, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-93; Blackwell EJ, 2008, J VET BEHAV, V3, P207, DOI 10.1016/j.jveb.2007.10.008; Boissy A, 2014, GENETICS AND THE BEHAVIOR OF DOMESTIC ANIMALS, 2ND EDITION, P81, DOI 10.1016/B978-0-12-394586-0.00003-2; Buttner AP, 2015, PHYSIOL BEHAV, V147, P54, DOI 10.1016/j.physbeh.2015.04.010; China L, 2020, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.00508; Christiansen FO, 2001, APPL ANIM BEHAV SCI, V72, P131, DOI 10.1016/S0168-1591(00)00203-3; Companion Animal Welfare Council , 2012, US EL PULS TRAIN AID; Cooper JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102722; Crawford EK, 2006, ANTHROZOOS, V19, P98, DOI 10.2752/089279306785593757; Deakin A, 2018, BIOL LETTERS, V14, DOI 10.1098/rsbl.2017.0779; Deldalle S, 2014, J VET BEHAV, V9, P58, DOI 10.1016/j.jveb.2013.11.004; Dreschel NA, 2009, HORM BEHAV, V55, P163, DOI 10.1016/j.yhbeh.2008.09.010; Fernandes JG, 2017, APPL ANIM BEHAV SCI, V196, P1, DOI 10.1016/j.applanim.2017.07.001; Feuerbacher EN, 2012, J EXP ANAL BEHAV, V98, P105, DOI 10.1901/jeab.2012.98-105; Harding EJ, 2004, NATURE, V427, P312, DOI 10.1038/427312a; HARLOW HF, 1949, PSYCHOL REV, V56, P51, DOI 10.1037/h0062474; Haverbeke A, 2008, APPL ANIM BEHAV SCI, V113, P110, DOI 10.1016/j.applanim.2007.11.010; Haverbeke A, 2010, J VET BEHAV, V5, P112, DOI 10.1016/j.jveb.2009.08.008; Hennessy MB, 1998, APPL ANIM BEHAV SCI, V61, P63, DOI 10.1016/S0168-1591(98)00179-8; Herron ME, 2009, APPL ANIM BEHAV SCI, V117, P47, DOI 10.1016/j.applanim.2008.12.011; Hiby EF, 2004, ANIM WELFARE, V13, P63; Horvath M, 2016, APPL ANIM BEHAV SCI, V185, P121, DOI 10.1016/j.applanim.2016.09.007; Iigaya K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165840; Jokinen I, 2017, APPL ANIM BEHAV SCI, V195, P87, DOI 10.1016/j.applanim.2017.06.003; Kobelt AJ, 2003, RES VET SCI, V75, P157, DOI 10.1016/S0034-5288(03)00080-8; Lattal K. A., 2013, APA HDB BEHAV ANAL, V1, P483, DOI [10.1037/13937-021, DOI 10.1037/13937-021]; Marshall-Pescini S, 2008, BEHAV PROCESS, V78, P449, DOI 10.1016/j.beproc.2008.02.022; Mendl M, 2020, NEUROSCI BIOBEHAV R, V112, P144, DOI 10.1016/j.neubiorev.2020.01.025; Mendl M, 2010, CURR BIOL, V20, pR839, DOI 10.1016/j.cub.2010.08.030; Mendl M, 2009, APPL ANIM BEHAV SCI, V118, P161, DOI 10.1016/j.applanim.2009.02.023; Meyer I, 2014, J VET BEHAV, V9, P143, DOI 10.1016/j.jveb.2014.03.002; Mills DS, 2020, J VET BEHAV CLIN AP, V5, P60; National health commission National administration of traditional Chinese medicine, 2020, CHIN J VIRAL DIS, V10, P1, DOI [10.1016/j.joim.2020.04.001, DOI 10.1038/S41598-019-56847-4]; Neville V, 2020, NEUROSCI BIOBEHAV R, V108, P269, DOI 10.1016/j.neubiorev.2019.11.008; Piotti P, 2018, LEARN BEHAV, V46, P537, DOI 10.3758/s13420-018-0357-7; Reid P, 2007, BEHAVIOURAL BIOLOGY OF DOGS, P120, DOI 10.1079/9781845931872.0120; Reisner I, 2017, DOMESTIC DOG: ITS EVOLUTION, BEHAVIOR AND INTERACTIONS WITH PEOPLE, 2ND EDITION, P210; REUL JMHM, 1991, J STEROID BIOCHEM, V40, P63, DOI 10.1016/0960-0760(91)90168-5; Rooney NJ, 2011, APPL ANIM BEHAV SCI, V132, P169, DOI 10.1016/j.applanim.2011.03.007; Salgirli Y, 2012, REV MED VET-TOULOUSE, V163, P530; Sankey C, 2010, ANIM COGN, V13, P753, DOI 10.1007/s10071-010-0326-9; Schalke E, 2007, APPL ANIM BEHAV SCI, V105, P369, DOI 10.1016/j.applanim.2006.11.002; Schilder MBH, 2004, APPL ANIM BEHAV SCI, V85, P319, DOI 10.1016/j.applanim.2003.10.004; Schoberl I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170707; Skinner BF., 1953, SCI HUMAN BEHAV; Steiss JE, 2007, APPL ANIM BEHAV SCI, V106, P96, DOI 10.1016/j.applanim.2006.06.018; Tiira K, 2014, APPL ANIM BEHAV SCI, V155, P82, DOI 10.1016/j.applanim.2014.03.007; Turcsan B, 2011, APPL ANIM BEHAV SCI, V132, P61, DOI 10.1016/j.applanim.2011.03.006; Visser EK, 2009, VET J, V181, P48, DOI 10.1016/j.tvjl.2009.03.009; Voith VL, 1996, READINGS COMPANION A, P140; Zidar J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23545-6	55	12	12	5	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0225023	10.1371/journal.pone.0225023	http://dx.doi.org/10.1371/journal.pone.0225023			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH1IW	33326450	gold, Green Published, Green Submitted			2022-12-27	WOS:000600176400043
J	Liu, ZM; Zhang, M; Shen, ZB; Ke, JR; Zhang, D; Yin, F				Liu, Zhiming; Zhang, Min; Shen, Zhubin; Ke, Junran; Zhang, Ding; Yin, Fei			Efficacy and safety of 18 anti-osteoporotic drugs in the treatment of patients with osteoporosis caused by glucocorticoid: A network meta-analysis of randomized controlled trials	PLOS ONE			English	Article							BONE-MINERAL DENSITY; CORTICOSTEROID-INDUCED OSTEOPOROSIS; DOUBLE-BLIND; VITAMIN-D; POSTMENOPAUSAL WOMEN; CYCLICAL ETIDRONATE; RECEIVING GLUCOCORTICOIDS; INTRAVENOUS PAMIDRONATE; VERTEBRAL FRACTURE; PRIMARY PREVENTION	Background Glucocorticoids are widely used in a variety of diseases, especially autoimmune diseases and inflammatory diseases, so the incidence of glucocorticoid-induced osteoporosis is high all over the world. Objectives The purpose of this paper is to use the method of network meta-analysis (NMA) to compare the efficacy of anti-osteoporosis drugs directly and indirectly, and to explore the advantages of various anti-osteoporosis drugs based on the current evidence. Methods We searched PubMed, Embase and Cochrane Library for randomized controlled trials (RCTs), of glucocorticoid-induced osteoporosis (GIOP) and compared the efficacy and safety of these drugs by NMA. The risk ratio (RR) and its 95% confidence interval (CI) are used as the influence index of discontinuous data, and the standardized mean difference (SMD) and its 95% CI are used as the influence index of continuous data. The statistical heterogeneity was evaluated by the calculated estimated variance (tau (2)), and the efficacy and safety of drugs were ranked by the surface under the cumulative ranking curve (SUCRA). The main outcome of this study was the incidence of vertebral fracture after taking several different types of drugs, and the secondary results were the incidence of non-vertebral fracture and adverse events, mean percentage change of lumbar spine (LS) and total hip (TH)bone mineral density (BMD) from baseline to at least 12 months. Results Among the different types of anti-GIOP, teriparatide (SUCRA 95.9%) has the lowest incidence of vertebral fracture; ibandronate (SUCRA 75.2%) has the lowest incidence of non-vertebral fracture; raloxifene (SUCRA 98.5%) has the best effect in increasing LS BMD; denosumab (SUCRA 99.7%) is the best in increasing TH BMD; calcitonin (SUCRA 92.4%) has the lowest incidence of serious adverse events. Conclusions Teriparatide and ibandronate are effective drugs to reduce the risk of vertebral and non-vertebral fractures in patients with GIOP. In addition, long-term use of raloxifene and denosumab can increase the BMD of LS and TH.	[Liu, Zhiming; Shen, Zhubin; Ke, Junran; Zhang, Ding; Yin, Fei] Jilin Univ, China Japan Union Hosp, Dept Spinal Surg, Changchun, Peoples R China; [Zhang, Min] Shanghai Jiao Tong Univ, Shanghai Childrens Hosp, Dept Neonatol, Shanghai, Peoples R China	Jilin University; Shanghai Jiao Tong University	Yin, F (corresponding author), Jilin Univ, China Japan Union Hosp, Dept Spinal Surg, Changchun, Peoples R China.	yinfei999@jlu.edu.cn						Abitbol V, 2007, CLIN GASTROENTEROL H, V5, P1184, DOI 10.1016/j.cgh.2007.05.016; Adachi JD, 2001, ARTHRITIS RHEUM, V44, P202, DOI 10.1002/1529-0131(200101)44:1<202::AID-ANR27>3.0.CO;2-W; Amiche MA, 2016, OSTEOPOROSIS INT, V27, P1989, DOI 10.1007/s00198-015-3476-4; Amiche MA, 2016, OSTEOPOROSIS INT, V27, P1709, DOI 10.1007/s00198-015-3455-9; Bianda T, 2000, CALCIFIED TISSUE INT, V67, P116, DOI 10.1007/s00223001126; Bischoff-Ferrari H A, 2009, BMJ, V339, pb3692, DOI 10.1136/bmj.b3692; Boutsen Y, 2001, J BONE MINER RES, V16, P104, DOI 10.1359/jbmr.2001.16.1.104; Boutsen Y, 1997, CALCIFIED TISSUE INT, V61, P266, DOI 10.1007/s002239900334; Brown JP, 2001, J CLIN DENSITOM, V4, P363, DOI 10.1385/JCD:4:4:363; Burshell AL, 2010, BONE, V46, P935, DOI 10.1016/j.bone.2009.12.032; Chesnut CH, 2008, OSTEOPOROSIS INT, V19, P479, DOI 10.1007/s00198-007-0490-1; Chiodini I, 2020, EXPERT OPIN PHARMACO, V21, P721, DOI 10.1080/14656566.2020.1721467; Cosman F, 2014, OSTEOPOROSIS INT, V25, P2359, DOI 10.1007/s00198-014-2794-2; de Nijs RNJ, 2006, NEW ENGL J MED, V355, P675, DOI 10.1056/NEJMoa053569; Delmas PD, 2002, J CLIN ENDOCR METAB, V87, P3609, DOI 10.1210/jc.87.8.3609; Deng J, 2020, RHEUMATOLOGY, pkeaa228, DOI [10.1093/rheumatology/keaa228, DOI 10.1093/RHEUMAT0L0GY/KEAA228]; Devogelaer JP, 2010, J RHEUMATOL, V37, P141, DOI 10.3899/jrheum.090411; Diedhiou D, 2015, ANN ENDOCRINOL-PARIS, V76, P650, DOI 10.1016/j.ando.2015.10.009; Ding LL, 2020, J CLIN ENDOCR METAB, V105, P600, DOI 10.1210/clinem/dgz023; Eastell R, 2000, OSTEOPOROSIS INT, V11, P331, DOI 10.1007/s001980070122; Fujii N, 2007, NEPHROL DIAL TRANSPL, V22, P1601, DOI 10.1093/ndt/gfl567; GarciaDelgado I, 1997, CALCIFIED TISSUE INT, V60, P155, DOI 10.1007/s002239900206; Gluer CC, 2013, J BONE MINER RES, V28, P1355, DOI 10.1002/jbmr.1870; Guadalix S, 2011, TRANSPL INT, V24, P657, DOI 10.1111/j.1432-2277.2011.01253.x; GuaydierSouquieres G, 1996, OSTEOPOROSIS INT, V6, P171, DOI 10.1007/BF01623943; Hakala M, 2012, SCAND J RHEUMATOL, V41, P260, DOI 10.3109/03009742.2012.664647; Hu K, 2019, EXPERT REV ENDOCRINO, V14, P259, DOI 10.1080/17446651.2019.1617131; Iacopo C, 2020, EXPERT REV ENDOCRINO, V15, P283, DOI 10.1080/17446651.2020.1772051; Iseri K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193846; Jacobs JWG, 2007, J RHEUMATOL, V34, P1051; Kim SH, 2004, AM J MED, V116, P524, DOI 10.1016/j.amjmed.2003.12.019; Kitazaki S, 2009, ALIMENT PHARM THER, V29, P424, DOI 10.1111/j.1365-2036.2008.03899.x; Lane NE, 1998, J CLIN INVEST, V102, P1627, DOI 10.1172/JCI3914; Langdahl BL, 2009, OSTEOPOROSIS INT, V20, P2095, DOI 10.1007/s00198-009-0917-y; Lems WF, 1997, ANN RHEUM DIS, V56, P357, DOI 10.1136/ard.56.6.357; Lems WF, 1997, OSTEOPOROSIS INT, V7, P575, DOI 10.1007/BF02652565; Losada BR, 2009, J CLIN DENSITOM, V12, P63, DOI 10.1016/j.jocd.2008.10.002; Matsumoto T, 2020, J BONE MINER METAB, V38, P522, DOI 10.1007/s00774-020-01091-4; Mazziotti G, 2007, ARQ BRAS ENDOCRINOL, V51, P1404, DOI 10.1590/S0004-27302007000800028; Mok CC, 2013, LUPUS, V22, P1470, DOI 10.1177/0961203313507987; Mok CC, 2011, ANN RHEUM DIS, V70, P778, DOI 10.1136/ard.2010.143453; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Pitt P, 1998, THORAX, V53, P351, DOI 10.1136/thx.53.5.351; Reginster JY, 2019, OSTEOPOROSIS INT, V30, P1465, DOI 10.1007/s00198-019-04947-2; Reid DM, 2009, LANCET, V373, P1253, DOI 10.1016/S0140-6736(09)60250-6; Reid DM, 2000, J BONE MINER RES, V15, P1006, DOI 10.1359/jbmr.2000.15.6.1006; Ringe JD, 1999, CALCIFIED TISSUE INT, V65, P337, DOI 10.1007/s002239900708; Ringe JD, 2004, RHEUMATOL INT, V24, P63, DOI 10.1007/s00296-003-0361-9; RIZZOLI R, 1995, OSTEOPOROSIS INT, V5, P39, DOI 10.1007/BF01623657; Roux C, 1998, J CLIN ENDOCR METAB, V83, P1128, DOI 10.1210/jc.83.4.1128; Saag KG, 2007, NEW ENGL J MED, V357, P2028, DOI 10.1056/NEJMoa071408; Saag KG, 2019, ARTHRITIS RHEUMATOL, V71, P1174, DOI 10.1002/art.40874; Saag KG, 2016, ARTHRITIS RHEUMATOL, V68, P2122, DOI 10.1002/art.39726; Saag KG, 2009, ARTHRITIS RHEUM-US, V60, P3346, DOI 10.1002/art.24879; Saag KG, 1998, NEW ENGL J MED, V339, P292, DOI 10.1056/NEJM199807303390502; Sambrook PN, 2012, BONE, V50, P289, DOI 10.1016/j.bone.2011.10.024; Sambrook PN, 2003, J BONE MINER RES, V18, P919, DOI 10.1359/jbmr.2003.18.5.919; Siffledeen JS, 2005, CLIN GASTROENTEROL H, V3, P122, DOI 10.1016/S1542-3565(04)00663-9; Soen S, 2020, J BONE MINER METAB, V38, P511, DOI 10.1007/s00774-019-01077-x; Stoch SA, 2009, J RHEUMATOL, V36, P1705, DOI 10.3899/jrheum.081207; Takeda S, 2008, MOD RHEUMATOL, V18, P271, DOI 10.1007/s10165-008-0055-y; Tan X, 2019, MENOPAUSE, V26, P929, DOI 10.1097/GME.0000000000001321; Tascioglu F, 2005, RHEUMATOL INT, V26, P21, DOI 10.1007/s00296-004-0496-3; Torres A, 2004, KIDNEY INT, V65, P705, DOI 10.1111/j.1523-1755.2004.00432.x; Toukap AN, 2005, LUPUS, V14, P517, DOI 10.1191/0961203305lu2149oa; Wang YK, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000012691; Yamada S, 2007, YAKUGAKU ZASSHI, V127, P1491, DOI 10.1248/yakushi.127.1491; Yamaguchi Y, 2020, RHEUMATOL ADV PRACT, V4, DOI 10.1093/rap/rkaa008; Yeap SS, 2008, J RHEUMATOL, V35, P2344, DOI 10.3899/jrheum.080634	69	5	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243851	10.1371/journal.pone.0243851	http://dx.doi.org/10.1371/journal.pone.0243851			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326444	gold, Green Published			2022-12-27	WOS:000600176400073
J	Vernice, NA; Pereira, NM; Wang, AS; Demetres, M; Adams, LV				Vernice, Nicholas A.; Pereira, Nicola M.; Wang, Anson; Demetres, Michelle; Adams, Lisa V.			The adverse health effects of punitive immigrant policies in the United States: A systematic review	PLOS ONE			English	Review							IMPACT; CARE; PROPOSITION-187; CALIFORNIA; CHILDREN; ACCESS; FEAR; LAW; US; ASSOCIATION	Background Immigrants in the United States (US) today are facing a dynamic policy landscape. The Trump administration has threatened or curtailed access to basic services for 10.5 million undocumented immigrants currently in the US. We sought to examine the historical effects that punitive laws have had on health outcomes in US immigrant communities. Methods In this systematic review, we searched the following databases from inception-May 2020 for original research articles with no language restrictions: Ovid MEDLINE, Ovid EMBASE, Cochrane Library (Wiley), Web of Science Core Collection (Clarivate), CINAHL (EBSCO), and Social Work Abstracts (Ovid). This study is registered with PROSPERO, CRD42019138817. Articles with cohort sizes >10 that directly evaluated the health-related effects of a punitive immigrant law or policy within the US were included. Findings 6,357 studies were screened for eligibility. Of these, 32 studies were selected for inclusion and qualitatively synthesized based upon four themes that appeared throughout our analysis: (1) impact on healthcare utilization, (2) impact on women's and children's health, (3) impact on mental health services, and (4) impact on public health. The impact of each law, policy, mandate, and directive since 1990 is briefly discussed, as are the limitations and risk of bias of each study. Interpretation Many punitive immigrant policies have decreased immigrant access to and utilization of basic healthcare services, while instilling fear, confusion, and anxiety in these communities. The federal government should preserve and expand access for undocumented individuals without threat of deportation to improve health outcomes for US citizens and noncitizens.	[Vernice, Nicholas A.; Adams, Lisa V.] Geisel Sch Med Dartmouth, Ctr Global Hlth Equ, Hanover, NH 03755 USA; [Vernice, Nicholas A.; Pereira, Nicola M.; Wang, Anson] Weill Cornell Med, Dept Med, New York, NY 10065 USA; [Demetres, Michelle] Weill Cornell Med, Samuel J Wood Lib, New York, NY USA; [Demetres, Michelle] Weill Cornell Med, CV Starr Biomed Informat Ctr, New York, NY USA	Dartmouth College; Cornell University; Cornell University; Cornell University	Vernice, NA (corresponding author), Geisel Sch Med Dartmouth, Ctr Global Hlth Equ, Hanover, NH 03755 USA.; Vernice, NA (corresponding author), Weill Cornell Med, Dept Med, New York, NY 10065 USA.	nav4001@med.cornell.edu		Demetres, Michelle/0000-0002-4997-7707; Vernice, Nicholas/0000-0002-5385-1680				Almeida J, 2016, SSM-POPUL HLTH, V2, P897, DOI 10.1016/j.ssmph.2016.11.003; Amuedo-Dorantes C, 2013, DEMOGRAPHY, V50, P1067, DOI 10.1007/s13524-013-0200-x; ANDERSEN R, 1981, J HEALTH SOC BEHAV, V22, P78, DOI 10.2307/2136370; Anderson KF, 2014, SOCIOL SPECTRUM, V34, P526, DOI 10.1080/02732173.2014.947452; Angus L, 2010, HEALTH AFFAIR, V29, P690, DOI 10.1377/hlthaff.2008.0843; [Anonymous], 1991, J BONE MINER RES, V6, pS1; [Anonymous], COVID TRACK PROJ ATL; [Anonymous], UNITED STATES COVID; ASCH S, 1994, WESTERN J MED, V161, P373; Batalova J., 2020, FREQUENTLY REQUESTED; Beniflah JD, 2013, CLIN PEDIATR, V52, P1122, DOI 10.1177/0009922813493496; Berk M L, 2001, J Immigr Health, V3, P151; Brabeck K, 2010, HISPANIC J BEHAV SCI, V32, P341, DOI 10.1177/0739986310374053; Chavez LR, 2012, SOC SCI MED, V74, P887, DOI 10.1016/j.socscimed.2011.05.023; Cleaveland C, 2012, J HUM BEHAV SOC ENVI, V22, P771, DOI 10.1080/10911359.2012.704781; El Chaar M, 2020, SURG OBES RELAT DIS; Fazel-Zarandi MM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201193; Fenton JJ, 1997, WESTERN J MED, V166, P16; Fenton JJ, 1996, HEALTH AFFAIR, V15, P182, DOI 10.1377/hlthaff.15.1.182; Flores RD, 2015, SOC PROBL, V62, P363, DOI 10.1093/socpro/spv012; GELLERT GA, 1993, SOC SCI MED, V37, P1489, DOI 10.1016/0277-9536(93)90183-5; Gomez S, 2019, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00383; Gurrola MA, 2018, RACE SOC PROBL, V10, P209, DOI 10.1007/s12552-018-9239-z; Hatzenbuehler ML, 2017, SOC SCI MED, V174, P169, DOI 10.1016/j.socscimed.2016.11.040; Joseph TD, 2017, J HEALTH POLIT POLIC, V42, P961, DOI 10.1215/03616878-3940495; Kline N, 2017, MED ANTHROPOL, V36, P396, DOI 10.1080/01459740.2016.1259621; Loue S, 2000, J Immigr Health, V2, P23, DOI 10.1023/A:1009535322184; Loue Sana, 2005, J Immigr Health, V7, P37, DOI 10.1007/s10903-005-1389-6; Lurie IZ, 2008, J HEALTH ECON, V27, P786, DOI 10.1016/j.jhealeco.2007.10.009; Marx JL, 1996, OPHTHALMOLOGY, V103, P847; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1186/2046-4053-4-1, 10.1136/bmj.b2535]; Moss N, 1996, J Am Med Womens Assoc (1972), V51, P161; Page KR, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMp2005953; Park L S, 2000, J Immigr Health, V2, P5; Passel J.S., 2019, MEASURING ILLEGAL IM; Potochnick SR., 2017, J IMMIGR MINOR HEALT, V19, P1049, DOI [DOI 10.1007/S10903-016-0464-5, 10.1007/s10903-016-0464-5]; Rhodes SD, 2015, AM J PUBLIC HEALTH, V105, P329, DOI 10.2105/AJPH.2014.302218; Roche KM, 2020, JAMA PEDIATR, V174, P478, DOI 10.1001/jamapediatrics.2020.0014; Rubio-Hernandez SP, 2016, CHILD YOUTH SERV REV, V60, P20, DOI 10.1016/j.childyouth.2015.11.013; Santos CE, 2018, ETHNIC RACIAL STUD, V41, P1672, DOI 10.1080/01419870.2017.1311021; Spetz J, 2000, J Immigr Health, V2, P203, DOI 10.1023/A:1009540313141; Toomey RB, 2014, AM J PUBLIC HEALTH, V104, pS28, DOI 10.2105/AJPH.2013.301655; Torche F, 2019, AM J EPIDEMIOL, V188, P24, DOI 10.1093/aje/kwy218; US Citizenship and Immigration Services, PUBL CHARG; Vargas ED, 2017, POLITICS POLICY, V45, P312, DOI 10.1111/polp.12203; Vargas ED, 2017, J HEALTH POLIT POLIC, V42, P459, DOI 10.1215/03616878-3802940; Wang JSH, 2019, INT MIGR REV, V53, P970, DOI 10.1177/0197918318791978; White K, 2014, J HEALTH CARE POOR U, V25, P1844, DOI 10.1353/hpu.2014.0194; White K, 2014, AM J PUBLIC HEALTH, V104, P397, DOI 10.2105/AJPH.2013.301560; ZIV TA, 1995, NEW ENGL J MED, V332, P1095, DOI 10.1056/NEJM199504203321612	51	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0244054	10.1371/journal.pone.0244054	http://dx.doi.org/10.1371/journal.pone.0244054			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH1IW	33326463	Green Published, gold			2022-12-27	WOS:000600176400012
J	Mallia, V; Verhaegen, S; Styrishave, B; Eriksen, GS; Johannsen, ML; Ropstad, E; Uhlig, S				Mallia, Vittoria; Verhaegen, Steven; Styrishave, Bjarne; Eriksen, Gunnar Sundstol; Johannsen, Malene Louise; Ropstad, Erik; Uhlig, Silvio			Microcystins and Microcystis aeruginosa PCC7806 extracts modulate steroidogenesis differentially in the human H295R adrenal model	PLOS ONE			English	Article							BLUE-GREEN-ALGA; IN-VITRO; CYANOBACTERIAL BLOOMS; PROTEIN PHOSPHATASES; HORMONE SYNTHESIS; CELL-LINE; PCC 7806; ENDOCRINE; TOXICITY; LR	The aim of this study was to investigate the potential interference of cyanobacterial metabolites, in particular microcystins (MCs), with steroid hormone biosynthesis. Steroid hormones control many fundamental processes in an organism, thus alteration of their tissue concentrations may affect normal homeostasis. We used liquid chromatography-tandem mass spectrometry (LC-MS/MS) to investigate the modulation of 14 hormones involved in the adrenal steroid biosynthesis pathway using forskolin-treated H295R cells, following exposure with either microcystin-LR (MC-LR) alone, a mixture made up of MC-LR together with eight other MCs and nodularin-R (NOD-R), or extracts from the MC-LR-producing Microcystis aeruginosa PCC7806 strain or its MC-deficient mutant PCC7806mcyB-. Production of 17-hydroxypregnenolone and dehydroepiandrosterone (DHEA) was increased in the presence of MC-LR in a dose-dependent manner, indicating an inhibitory effect on 3 beta -hydroxysteroid dehydrogenase (3 beta -HSD). This effect was not observed following exposure with a MCs/NOD-R mixture, and thus the effect of MC-LR on 3 beta -HSD appears to be stronger than for other congeners. Exposure to extracts from both M. aeruginosa PCC7806 and M. aeruginosa PCC7806mcyB- had an opposite effect on 3 beta -HSD, i.e. concentrations of pregnenolone, 17-hydroxypregnenolone and DHEA were significantly decreased, showing that there are other cyanobacterial metabolites that outcompete the effect of MC-LR, and possibly result instead in net-induction. Another finding was a possible concentration-dependent inhibition of CYP21A2 or CYP11 beta 1, which catalyse oxidation reactions leading to cortisol and cortisone, by MC-LR and the MCs/NOD-R mixture. However, both M. aeruginosa PCC7806 and M. aeruginosa PCC7806mcyB- extracts had an opposite effect resulting in a substantial increase in cortisol levels. Our results suggest that MCs can modulate steroidogenesis, but the net effect of the M. aeruginosa metabolome on steroidogenesis is different from that of pure MC-LR and independent of MC production.	[Mallia, Vittoria; Eriksen, Gunnar Sundstol; Uhlig, Silvio] Norwegian Vet Inst, Toxinol Res Grp, Oslo, Norway; [Mallia, Vittoria] Univ Oslo, Dept Chem, Oslo, Norway; [Verhaegen, Steven; Ropstad, Erik] Norwegian Univ Life Sci, Dept Prod Anim Clin Sci, Fac Vet Med, Oslo, Norway; [Styrishave, Bjarne; Johannsen, Malene Louise] Univ Copenhagen, Fac Hlth & Med Sci, Dept Pharm, Toxicol & Drug Metab Grp, Copenhagen, Denmark	Norwegian Veterinary Institute; University of Oslo; Norwegian University of Life Sciences; University of Copenhagen	Uhlig, S (corresponding author), Norwegian Vet Inst, Toxinol Res Grp, Oslo, Norway.	silvio.uhlig@vetinst.no	Eriksen, Gunnar/GOP-0440-2022	Styrishave, Bjarne/0000-0003-1619-2468; Eriksen, Gunnar Sundstol/0000-0002-4944-3393	European Union [722634]	European Union(European Commission)	This project has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No. 722634.	Ahmed KEM, 2018, TOXICOL IN VITRO, V52, P332, DOI 10.1016/j.tiv.2018.07.002; Asif AR, 2005, PFLUG ARCH EUR J PHY, V450, P88, DOI 10.1007/s00424-004-1373-3; Bernard C., 2017, HDB CYANOBACTERIAL M; Blasco H, 2015, J BIOMED INFORM, V53, P291, DOI 10.1016/j.jbi.2014.12.001; BOTES DP, 1982, TOXICON, V20, P945, DOI 10.1016/0041-0101(82)90097-6; BOTES DP, 1982, TOXICON, V20, P1037, DOI 10.1016/0041-0101(82)90105-2; Bouaicha N, 2019, TOXINS, V11, DOI 10.3390/toxins11120714; Briand E, 2016, ENVIRON MICROBIOL, V18, P384, DOI 10.1111/1462-2920.12904; Buratti FM, 2017, ARCH TOXICOL, V91, P1049, DOI 10.1007/s00204-016-1913-6; Carmichael WW, 2001, ENVIRON HEALTH PERSP, V109, P663, DOI 10.2307/3454781; Chen L, 2016, J HAZARD MATER, V301, P381, DOI 10.1016/j.jhazmat.2015.08.041; Dittmann E, 1997, MOL MICROBIOL, V26, P779, DOI 10.1046/j.1365-2958.1997.6131982.x; (EMA) EMA, ICH Q2 R1 VAL AN PRO; Fontanillo M, 2018, BIOORGAN MED CHEM, V26, P1118, DOI 10.1016/j.bmc.2017.08.040; Garcia A, 2003, BIOCHIMIE, V85, P721, DOI 10.1016/j.biochi.2003.09.004; GAZDAR AF, 1990, CANCER RES, V50, P5488; Gracia T, 2006, ECOTOX ENVIRON SAFE, V65, P293, DOI 10.1016/j.ecoenv.2006.06.012; Hecker M, 2008, ANAL BIOANAL CHEM, V390, P287, DOI 10.1007/s00216-007-1657-5; Hecker M, 2006, TOXICOL APPL PHARM, V217, P114, DOI 10.1016/j.taap.2006.07.007; Hinson JP, 2006, BEST PRACT RES CL EN, V20, P111, DOI 10.1016/j.beem.2005.09.006; Hou J, 2016, ENVIRON POLLUT, V208, P477, DOI 10.1016/j.envpol.2015.10.018; Huisman J, 2018, NAT REV MICROBIOL, V16, P471, DOI 10.1038/s41579-018-0040-1; IPCS, 2002, GLOBAL ASSESSMENT ST; Janssen EML, 2019, WATER RES, V151, P488, DOI 10.1016/j.watres.2018.12.048; Jia XY, 2018, ENVIRON POLLUT, V236, P12, DOI 10.1016/j.envpol.2018.01.057; Jochimsen EM, 1998, NEW ENGL J MED, V338, P873, DOI 10.1056/NEJM199803263381304; Jonas A, 2015, CHEMOSPHERE, V120, P321, DOI 10.1016/j.chemosphere.2014.07.074; Kellogg JJ, 2016, J NAT PROD, V79, P376, DOI 10.1021/acs.jnatprod.5b01014; Kotai J., 1972, PUBLICATION B, VB-11/69; La Merrill MA, 2020, NAT REV ENDOCRINOL, V16, P45, DOI 10.1038/s41574-019-0273-8; Lee JW, 2018, MOLECULES, V23, DOI 10.3390/molecules23082062; Lee TC, 1999, J CLIN ENDOCR METAB, V84, P2104, DOI 10.1210/jc.84.6.2104; Li L, 2005, TOXICON, V46, P533, DOI 10.1016/j.toxicon.2005.06.025; Liu WJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep22819; MACKINTOSH C, 1990, FEBS LETT, V264, P187, DOI 10.1016/0014-5793(90)80245-E; Mallia V, 2020, TOXINS, V12, DOI 10.3390/toxins12040228; Mallia V, 2019, MAR DRUGS, V17, DOI 10.3390/md17110643; Merel S, 2013, ENVIRON INT, V59, P303, DOI 10.1016/j.envint.2013.06.013; Miller WL, 2013, MOL CELL ENDOCRINOL, V379, P62, DOI 10.1016/j.mce.2013.04.014; Niedermeyer THJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091476; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Organisation for Economic Co-operation and Development (OECD), 2018, REV GUID DOC 150 STA; Oziol L, 2010, J HAZARD MATER, V174, P610, DOI 10.1016/j.jhazmat.2009.09.095; Paerl HW, 2013, MICROB ECOL, V65, P995, DOI 10.1007/s00248-012-0159-y; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; Portmann C, 2008, J NAT PROD, V71, P1891, DOI 10.1021/np800409z; Portmann C, 2008, J NAT PROD, V71, P1193, DOI 10.1021/np800118g; RAINEY WE, 1994, MOL CELL ENDOCRINOL, V100, P45, DOI 10.1016/0303-7207(94)90277-1; RAINEY WE, 1993, J CLIN ENDOCR METAB, V77, P731, DOI 10.1210/jc.77.3.731; Rogers ED, 2011, ENVIRON SCI TECHNOL, V45, P1962, DOI 10.1021/es103538b; Sanderson JT, 2002, TOXICOL APPL PHARM, V182, P44, DOI 10.1006/taap.2002.9420; Stefanelli M, 2014, CHEM-BIOL INTERACT, V215, P54, DOI 10.1016/j.cbi.2014.03.006; Stepankova T, 2011, AQUAT TOXICOL, V105, P497, DOI 10.1016/j.aquatox.2011.08.002; Stocco DM, 2001, ANNU REV PHYSIOL, V63, P193, DOI 10.1146/annurev.physiol.63.1.193; Sychrova E, 2012, ENVIRON INT, V39, P134, DOI 10.1016/j.envint.2011.10.004; Tillett D, 2000, CHEM BIOL, V7, P753, DOI 10.1016/S1074-5521(00)00021-1; Tonk L, 2009, HARMFUL ALGAE, V8, P219, DOI 10.1016/j.hal.2008.05.005; Tournebize R, 1997, EMBO J, V16, P5537, DOI 10.1093/emboj/16.18.5537; Wang LH, 2013, ECOTOXICOLOGY, V22, P1555, DOI 10.1007/s10646-013-1141-2; Wang LK, 2020, TOXINS, V12, DOI 10.3390/toxins12050282; Weisser JJ, 2016, ANAL BIOANAL CHEM, V408, P4883, DOI 10.1007/s00216-016-9575-z; World Health Organization, 2017, DEPRESSION OTHER COM; Worley B, 2013, CURR METABOL, V1, P92, DOI 10.2174/2213235X11301010092; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; Yan Y, 1999, J BIOL CHEM, V274, P31917, DOI 10.1074/jbc.274.45.31917; YOSHIZAWA S, 1990, J CANCER RES CLIN, V116, P609, DOI 10.1007/BF01637082; Zhao YY, 2015, CHEMOSPHERE, V120, P115, DOI 10.1016/j.chemosphere.2014.06.028; 2011, PLACENTA S2, V32, P81	69	3	3	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0244000	10.1371/journal.pone.0244000	http://dx.doi.org/10.1371/journal.pone.0244000			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320886	Green Published, gold			2022-12-27	WOS:000600339800028
J	Bassis, S; Fischer, S; Kohler, H; Reinhold, P				Bassis, Stefanie; Fischer, Sina; Koehler, Heike; Reinhold, Petra			Acid-base variables in acute and chronic form of nontuberculous mycobacterial infection in growing goats experimentally inoculated with Mycobacterium avium subsp. hominissuis or Mycobacterium avium subsp. paratuberculosis	PLOS ONE			English	Article							ANION GAP; PATHOLOGICAL-CHANGES; BLOOD-CHEMISTRY; CARBON-DIOXIDE; SEPTIC SHOCK; ANIMALS BODY; SERUM; PROTEIN; PH; MODEL	In current literature, data assessing the acid-base equilibrium in animals and humans during bacterial infection are rare. This study aimed to evaluate acid-base deteriorations in growing goats with experimentally induced NTM (nontuberculous mycobacteria) infections by application of the traditional Henderson-Hasselbalch approach and the strong ion model. NTM-challenged animals were orally inoculated with either Mycobacterium avium subsp. hominissuis (MAH; n = 18) or Mycobacterium avium subsp. paratuberculosis (MAP; n = 48). Twenty-five goats served as non-infected controls. Until 51(st) week post-inoculation (wpi), blood gas analysis, serum biochemical analysis, and serum electrophoresis were performed on venous blood. Fifty percent (9/18) of goats inoculated with MAH developed acute clinical signs like apathy, fever, and diarrhea. Those animals died or had to be euthanized within 11 weeks post-inoculation. This acute form of NTM-infection was characterized by significantly lower concentrations of sodium, calcium, albumin, and total protein, as well as significantly higher concentrations of gamma globulin, associated with reduced albumin/globulin ratio. Acid-base status indicated alkalosis, but normal base excess and HCO3- concentrations, besides significantly reduced levels of SID (strong ion difference), A(tot Alb) (total plasma concentration of weak non-volatile acids, based on albumin), A(tot TP) (A(tot) based on total protein) and markedly lower SIG (strong ion gap). The remaining fifty percent (9/18) of MAH-infected goats and all goats challenged with MAP survived and presented a more sub-clinical, chronic form of infection mainly characterized by changes in serum protein profiles. With the progression of the disease, concentrations of gamma globulin, and total protein increased while albumin remained lower compared to controls. Consequently, significantly reduced albumin/globulin ratio and lower A(tot Alb) as well as higher A(tot TP) were observed. Changes were fully compensated with no effect on blood pH. Only the strong ion variables differentiated alterations in acid-base equilibrium during acute and chronic NTM-infection.	[Bassis, Stefanie; Fischer, Sina; Koehler, Heike; Reinhold, Petra] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Mol Pathogenesis, Jena, Germany; [Koehler, Heike] Natl Reference Lab ParaTB, Jena, Germany; [Bassis, Stefanie] Univ Vet Med Vienna, Clin Unit Anesthesiol & Perioperat Intens Care Me, Emergency Clin Small Anim, Vienna, Austria; [Fischer, Sina] Chem & Vet Invest Off CVUA Karlsruhe, Karlsruhe, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Friedrich Loeffler Institute; University of Veterinary Medicine Vienna	Reinhold, P (corresponding author), Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Mol Pathogenesis, Jena, Germany.	petra.reinhold@fli.de						Agdestein A, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-46; Agdestein A, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-63; [Anonymous], 2002, ACHAEMENID HIST, V12, P113; AUSTIN WH, 1963, J APPL PHYSIOL, V18, P301, DOI 10.1152/jappl.1963.18.2.301; Bellocq A, 1998, J BIOL CHEM, V273, P5086, DOI 10.1074/jbc.273.9.5086; Bidani A, 1998, LUNG, V176, P111, DOI 10.1007/PL00007593; Borrmann E, 2011, VET MICROBIOL, V152, P101, DOI 10.1016/j.vetmic.2011.04.002; CAMERON JN, 1989, PHYSIOL ZOOL, V62, P845, DOI 10.1086/physzool.62.4.30157933; Clarke CJ, 1997, J COMP PATHOL, V116, P217, DOI 10.1016/S0021-9975(97)80001-1; Constable P.D., 2000, VET CLIN PATHOL, V29, P1; Constable PD, 2005, J VET INTERN MED, V19, P581, DOI 10.1892/0891-6640(2005)19[581:UOAQSI]2.0.CO;2; Constable PD, 1997, J APPL PHYSIOL, V83, P297, DOI 10.1152/jappl.1997.83.1.297; Constable PD, 1997, J VET INTERN MED, V11, P71, DOI 10.1111/j.1939-1676.1997.tb00076.x; Constable PD, 1998, AM J VET RES, V59, P881; Cullen GE, 1925, J BIOL CHEM, V66, P301; Day TK, 2002, VET CLIN N AM-SMALL, V32, P1031, DOI 10.1016/S0195-5616(02)00035-9; Elisaf M, 1993, Eur J Med, V2, P404; Feldman M, 2005, J LAB CLIN MED, V146, P317, DOI 10.1016/j.lab.2005.07.008; Fencl V, 2000, AM J RESP CRIT CARE, V162, P2246, DOI 10.1164/ajrccm.162.6.9904099; FENCL V, 1993, RESP PHYSIOL, V91, P1, DOI 10.1016/0034-5687(93)90085-O; Figge J, 1998, CRIT CARE MED, V26, P1807, DOI 10.1097/00003246-199811000-00019; Funk GC, 2007, WIEN KLIN WOCHENSCHR, V119, P390, DOI 10.1007/s00508-007-0811-6; Haist V, 2008, EMERG INFECT DIS, V14, P988, DOI 10.3201/eid1406.071463; Heming TA, 2001, CLIN SCI, V101, P267, DOI 10.1042/CS20010139; Herdt TH, 2013, CUNNINGHAMS TXB VET, P297; HERRMANN FR, 1992, ARCH INTERN MED, V152, P125, DOI 10.1001/archinte.152.1.125; Hotchkiss RS, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.45; Johansen TB, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/189649; Kellum JA, 2005, CRIT CARE, V9, P500, DOI 10.1186/cc3789; Kellum JA, 2000, CRIT CARE, V4, P6, DOI 10.1186/cc644; Kellum JA, 2004, CRIT CARE, V8, P331, DOI 10.1186/cc2900; Kellum JA, 2004, AM J PHYSIOL-REG I, V286, pR686, DOI 10.1152/ajpregu.00564.2003; KELLUM JA, 1995, J APPL PHYSIOL, V78, P2212, DOI 10.1152/jappl.1995.78.6.2212; Klang A, 2014, WIEN TIERARZTL MONAT, V101, P74; Kriz P, 2010, EMERG INFECT DIS, V16, P1328, DOI 10.3201/eid1608.100097; Kruger C, 2015, VET PATHOL, V52, P276, DOI 10.1177/0300985814533804; Lardner A, 2001, J LEUKOCYTE BIOL, V69, P522; LOKEN HF, 1960, J BIOL CHEM, V235, P3654; MCAULIFFE JJ, 1986, AM J MED, V81, P86, DOI 10.1016/0002-9343(86)90187-7; MIYAZAWA K, 1990, J IMMUNOL, V145, P650; Noritomi DT, 2009, CRIT CARE MED, V37, P2733, DOI 10.1097/CCM.0b013e3181a59165; Ostermann C, 2014, MULTIDISCIP RESP MED, V9, DOI 10.1186/2049-6958-9-10; Petersen HH, 2004, VET RES, V35, P163, DOI 10.1051/vetres:2004002; Putnam RW, 1991, WHICH VALUE 1 DISSOC; Raphael KL, 2016, CLIN J AM SOC NEPHRO, V11, P308, DOI 10.2215/CJN.06200615; Redlberger S, 2017, VET J, V229, P45, DOI 10.1016/j.tvjl.2017.10.017; Reinhold P, 2010, VET J, V184, P212, DOI 10.1016/j.tvjl.2009.02.005; Robinson NE, 2013, CUNNINGHAMS TXB VET, P549; ROSSING TH, 1986, J APPL PHYSIOL, V61, P2260, DOI 10.1152/jappl.1986.61.6.2260; Schinkothe J, 2016, J COMP PATHOL, V155, P218, DOI 10.1016/j.jcpa.2016.06.008; Schinkothe J, 2016, COMP IMMUNOL MICROB, V47, P41, DOI 10.1016/j.cimid.2016.05.006; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Smith I, 2001, INTENS CARE MED, V27, P74, DOI 10.1007/s001340051352; Stampfli HR, 2014, VET CLIN PATH, V43, P547, DOI 10.1111/vcp.12200; STEWART PA, 1983, CAN J PHYSIOL PHARM, V61, P1444, DOI 10.1139/y83-207; STOGDALE L, 1981, J S AFR VET ASSOC, V52, P155; STOGDALE L, 1981, J S AFR VET ASSOC, V52, P57; van Coppenraet LESB, 2008, EUR J CLIN MICROBIOL, V27, P293, DOI 10.1007/s10096-007-0440-z; Van Slyke DD, 1928, J BIOL CHEM, V78, P765; Vincent JL, 2003, ANN SURG, V237, P319, DOI 10.1097/00000658-200303000-00005; Wilkes P, 1998, J APPL PHYSIOL, V84, P1740, DOI 10.1152/jappl.1998.84.5.1740; Willard MD, 2006, LABORDIAGNOSTIK KLEI, P305; Wohl JS, 1997, AM J VET RES, V58, P910; Zampieri FG, 2014, CRIT CARE, V18, DOI 10.1186/cc13993; 2014, INT J RES PHARM SCI, V4, P40	65	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243892	10.1371/journal.pone.0243892	http://dx.doi.org/10.1371/journal.pone.0243892			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315933	gold, Green Published			2022-12-27	WOS:000600186100026
J	Gadicherla, S; Krishnappa, L; Madhuri, B; Mitra, SG; Ramaprasad, A; Seevan, R; Sreeganga, SD; Thodika, NK; Mathew, S; Suresh, V				Gadicherla, Suman; Krishnappa, Lalitha; Madhuri, Bindu; Mitra, Susanna G.; Ramaprasad, Arkalgud; Seevan, Raja; Sreeganga, S. D.; Thodika, Nibras K.; Mathew, Salu; Suresh, Vani			Envisioning a learning surveillance system for tuberculosis	PLOS ONE			English	Article								Surveillance is critical for interrupting transmission of global epidemics. Research has highlighted gaps in the surveillance for tuberculosis that range from failure to collect real-time data to lack of standardization of data for informed decision-making at different levels of the health system. Our research aims to advance conceptual and methodological foundations for the development of a learning surveillance system for Tuberculosis, that involves systematic collection, analysis, interpretation, and feedback of outcome-specific data. It would concurrently involve the health care delivery system, public health laboratory, and epidemiologists. For our study, we systemically framed the cyber environment of TB surveillance as an ontology of the learning surveillance system. We validated the ontology by binary coding of dimensions and elements of the ontology with the metadata from an existing surveillance platform-GPMS TB Transportal. Results show GPMS TB Transportal collects a critical range of data for active case investigation and presumptive case screening for identifying and detecting confirmed TB cases. It is therefore targeted at assisting the Active Case Finding program. Building on the results, we demonstrate enhanced surveillance strategies for GPMS that are enumerated as pathways in the ontology. Our analysis reveals the scope for embedding learning surveillance pathways for digital applications in Direct Benefit Transfer, and Drug Resistance Treatment in National TB Elimination Programme in India. We discuss the possibilities of developing the transportal into a multi-level computer-aided decision support system for TB, using the innumerable pathways encapsulated in the ontology.	[Gadicherla, Suman; Krishnappa, Lalitha] MS Ramaiah Med Coll, Dept Community Med, Bengaluru, Karnataka, India; [Madhuri, Bindu; Seevan, Raja; Mathew, Salu; Suresh, Vani] Indian Ctr Social Transformat Indian CST, Bengaluru, Karnataka, India; [Mitra, Susanna G.; Ramaprasad, Arkalgud; Sreeganga, S. D.; Thodika, Nibras K.] Ramaiah Publ Policy Ctr, Bengaluru, Karnataka, India; [Ramaprasad, Arkalgud] Univ Illinois, Informat & Decis Sci, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Mitra, SG (corresponding author), Ramaiah Publ Policy Ctr, Bengaluru, Karnataka, India.	susanna.mitra@rppc.ac.in		Ramaprasad, Arkalgud/0000-0003-1551-6854; Sreeganga, S D/0000-0001-7308-6851; K. Thodika, Nibras/0000-0001-9115-6382; G. Mitra, Susanna/0000-0001-5784-5950				[Anonymous], 2019, CANC DISCOV, V9, pOF3, DOI 10. 1158/2159-8290. CD-NB2018-158; [Anonymous], 2019, BRAIN STIMUL MAR; Balsari S, 2018, J MED INTERNET RES, V20, DOI 10.2196/10725; Brooks I, 2008, ADV DIS SURVEILLANCE, P5; Cabibbe A M, 2016, Int J Mycobacteriol, V5 Suppl 1, pS40, DOI 10.1016/j.ijmyco.2016.09.010; Cameron JD, 2017, INT J MED INFORM, V100, P16, DOI 10.1016/j.ijmedinf.2017.01.007; Degeling C, 2020, BMC MED ETHICS, V21, DOI 10.1186/s12910-020-00474-6; Goel S, 2018, INT J NONCOMMUNICABL, V3, P9; Gopichandran V, 2019, ETHICAL CHALLENGES D; Groseclose SL, 2017, ANNU REV PUBL HEALTH, V38, P57, DOI 10.1146/annurev-publhealth-031816-044348; Institute of Medicine (US) Forum on Drug Discovery D Africa A of S of S, 2011, EM THREAT DRUG RES T; Jeon Pil-Hyun, 2018, [Journal of Radiation Protection and Research, 방사선방어학회지], V43, P1, DOI 10.14407/jrpr.2018.43.1.1; John TJ, 2013, INDIAN PEDIATR, V50, P93, DOI 10.1007/s13312-013-0021-4; Kendall AE, 2012, GLOBAL CHALLENGE HIV, P55; Lee Y, 2020, J MED INTERNET RES, V22, DOI 10.2196/15727; Lessard L, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-026204; Mani M, 2019, LUNG INDIA, V36, P28, DOI 10.4103/lungindia.lungindia_324_18; Migliori GB, 2020, INT J INFECT DIS, V92, pS15, DOI 10.1016/j.ijid.2020.01.042; Ministry of Health and Family Welfare (MoHFW) Central TB Division, 2017, TB IND 2017 ANN STAT; Mitra SG, 2020, ONTOLOGY CYBERENVIRO; Mondaca AN, 2015, STUD HEALTH TECHNOL, V216, P1105, DOI 10.3233/978-1-61499-564-7-1105; NTEP, 2020, NAT STRAT PLAN END T; Nunez A, 2021, J PUBLIC HEALTH-HEID, V29, P1411, DOI 10.1007/s10389-020-01265-4; Polonsky J, 2019, WEEKLY EPIDEMIOLOGIC, V94, P23; Ragonnet R, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1452-0; Rajarajan K, 2016, J Family Med Prim Care, V5, P817, DOI 10.4103/2249-4863.201146; Ramanathan SK, 2016, EPM GLOCAL PROJECT M; RAMAPRASAD A, 1983, BEHAV SCI, V28, P4, DOI 10.1002/bs.3830280103; Rosenthal A, 2017, J CLIN MICROBIOL, V55, P3267, DOI 10.1128/JCM.01013-17; Saunders MJ, 2019, LANCET INFECT DIS, V19, P519, DOI 10.1016/S1473-3099(18)30753-9; Shriraam Vanishree, 2020, Indian J Tuberc, V67, P38, DOI 10.1016/j.ijtb.2019.09.003; Sreeganga SD, 2020, ARKALGUD RAMAPRASAD	32	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243610	10.1371/journal.pone.0243610	http://dx.doi.org/10.1371/journal.pone.0243610			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315902	Green Published, gold			2022-12-27	WOS:000600186100077
J	McKechnie, S; Fletcher, D; Newman, J; Bragg, C; Dillingham, PW; Clucas, R; Scott, D; Uhlmann, S; Lyver, P; Gormley, A; Moller, H				McKechnie, Sam; Fletcher, David; Newman, Jamie; Bragg, Corey; Dillingham, Peter W.; Clucas, Rosemary; Scott, Darren; Uhlmann, Sebastian; Lyver, Phil; Gormley, Andrew; Moller, Henrik		Rakiura Titi Islands Administering	Separating the effects of climate, bycatch, predation and harvesting on tt (Ardenna grisea) population dynamics in New Zealand: A model-based assessment	PLOS ONE			English	Article							SHEARWATER PUFFINUS-GRISEUS; STATE-SPACE MODELS; SOOTY SHEARWATER; INTRODUCED PREDATORS; RAKIURA-MAORI; FISHERIES; ISLAND; CONSERVATION; SEABIRD; ALBATROSSES	A suite of factors may have contributed to declines in the tt (sooty shearwater; Ardenna grisea) population in the New Zealand region since at least the 1960s. Recent estimation of the magnitude of most sources of non-natural mortality has presented the opportunity to quantitatively assess the relative importance of these factors. We fit a range of population dynamics models to a time-series of relative abundance data from 1976 until 2005, with the various sources of mortality being modelled at the appropriate part of the life-cycle. We present estimates of effects obtained from the best-fitting model and using model averaging. The best-fitting models explained much of the variation in the abundance index when survival and fecundity were linked to the Southern Oscillation Index, with strong decreases in adult survival, juvenile survival and fecundity being related to El Nino-Southern Oscillation (ENSO) events. Predation by introduced animals, harvesting by humans, and bycatch in fisheries also appear to have contributed to the population decline. It is envisioned that the best-fitting models will form the basis for quantitative assessments of competing management strategies. Our analysis suggests that sustainability of the New Zealand tt population will be most influenced by climate, in particular by how climate change will affect the frequency and intensity of ENSO events in the future. Removal of the effects of both depredation by introduced predators and harvesting by humans is likely to have fewer benefits for the population than alleviating climate effects.	[McKechnie, Sam] Pacific Community, Noumea, New Caledonia; [Fletcher, David] David Fletcher Consulting Ltd, Karitane, Aotearoa, New Caledonia; [Newman, Jamie] Parliamentary Commissioner Environm, Wellington, Aotearoa, New Zealand; [Bragg, Corey] Tokona Ao Tribal Econ, Dunedin, Aotearoa, New Zealand; [Dillingham, Peter W.] Univ Otago, Dept Math & Stat, Dunedin, Aotearoa, New Zealand; [Uhlmann, Sebastian] Flanders Res Inst Agr Fisheries & Food, Fisheries & Aquat Prod, Oostende, Belgium; [Lyver, Phil; Gormley, Andrew] Manaaki Whenua Landcare Res, Lincoln, Aotearoa, New Zealand; [Moller, Henrik] Univ Otago, Ctr Sustainabil, Dunedin, Aotearoa, New Zealand	University of Otago; Institute For Agricultural & Fisheries Research; Landcare Research - New Zealand; University of Otago	Fletcher, D (corresponding author), David Fletcher Consulting Ltd, Karitane, Aotearoa, New Caledonia.	david@davidfletcher.consulting	Dillingham, Peter/AAC-6856-2022	Dillingham, Peter/0000-0001-6302-3275; Fletcher, David/0000-0003-1988-5796; Uhlmann, Sven Sebastian/0000-0003-2830-5845	New Zealand Ministry of Business, Innovation and Employment: Strategic Science Investment Fund [MWLR-2019/20]	New Zealand Ministry of Business, Innovation and Employment: Strategic Science Investment Fund	The New Zealand Ministry of Business, Innovation and Employment: Strategic Science Investment Fund (www.mbie.govt.nz) provided support for this study in the form of a grant awarded to PL (MWLR-2019/20). David Fletcher Consulting Limited provided support in the form of a salary to DF. The specific roles of this author are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham ER, 2019, 226 NZ MIN PRIM IND; Ainley DG, 2009, FISH FISH, V10, P13, DOI 10.1111/j.1467-2979.2008.00293.x; [Anonymous], 2000, MILL PULP PAP WEEK, V22, P5; Artukhin YB, 2010, ACCIDENTAL CATCH MAR; Baker GB, 2002, EMU, V102, P71, DOI 10.1071/MU01036; Barbraud C, 2012, MAR ECOL PROG SER, V454, P285, DOI 10.3354/meps09616; Besbeas P, 2012, J R STAT SOC C-APPL, V61, P151, DOI 10.1111/j.1467-9876.2011.01012.x; Bragg C, 2007, 210 U OT WILDL MAN; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Buckland ST, 2004, ECOL MODEL, V171, P157, DOI 10.1016/j.ecolmodel.2003.08.002; Caswell, 2000, MATRIX POPULATION MO; Clucas RJ, 2008, EMU, V108, P237, DOI 10.1071/MU07069; Croxall JP, 2012, BIRD CONSERV INT, V22, P1, DOI 10.1017/S0959270912000020; Devney CA, 2009, ECOLOGY, V90, P1175, DOI 10.1890/08-0634.1; Dillingham P, 2007, 206 U OT WILDL; Dillingham PW, 2016, ECOL APPL, V26, P322, DOI 10.1890/14-1990; Dillingham PW, 2011, BIOL CONSERV, V144, P1885, DOI 10.1016/j.biocon.2011.04.014; Fasiolo M, 2016, STAT SCI, V31, P96, DOI 10.1214/15-STS534; Fletcher D, 2018, SPRINGERBRIEF STAT, P1, DOI 10.1007/978-3-662-58541-2; Fletcher D, 2013, CONDOR, V115, P465, DOI 10.1525/cond.2013.110151; Fukami T, 2006, ECOL LETT, V9, P1299, DOI 10.1111/j.1461-0248.2006.00983.x; Gelman A, 2013, BAYESIAN DATA ANAL, V3rd; Grosbois V, 2008, BIOL REV, V83, P357, DOI 10.1111/j.1469-185X.2008.00047.x; Hallett TB, 2004, NATURE, V430, P71, DOI 10.1038/nature02708; Harper GA, 2007, WILDLIFE RES, V34, P443, DOI 10.1071/WR07037; Hawke D, 2003, J ROY SOC NEW ZEAL, V33, P497, DOI 10.1080/03014223.2003.9517740; Humphries GR, 2018, MACHINE LEARNING ECO, P263; Humphries GRW, 2017, MAR BIOL, V164, DOI 10.1007/s00227-017-3182-1; Hunter CM, 2000, ECOL MODEL, V134, P299, DOI 10.1016/S0304-3800(00)00344-6; Jenouvrier S, 2005, ECOLOGY, V86, P2889, DOI 10.1890/05-0514; Jones C, 2000, NEW ZEAL J ZOOL, V27, P327, DOI 10.1080/03014223.2000.9518242; King R, 2010, INTERD STAT, P1; Linden A, 2009, OIKOS, V118, P675, DOI 10.1111/j.1600-0706.2008.17250.x; Ludwig SC, 2012, IBIS, V154, P74, DOI 10.1111/j.1474-919X.2011.01199.x; Lyver P. O'B., 2000, Pacific Conservation Biology, V5, P347; Lyver PO, 1999, MAR ECOL PROG SER, V188, P237, DOI 10.3354/meps188237; Lyver POB, 2002, WILDLIFE SOC B, V30, P29; Magnusson A, 2007, FISH FISH, V8, P337, DOI 10.1111/j.1467-2979.2007.00258.x; Mckechnie S, 2007, J WILDLIFE MANAGE, V71, P1325, DOI 10.2193/2006-018; McKechnie S, 2006, NEW ZEAL J ZOOL, V33, P259, DOI 10.1080/03014223.2006.9518455; Mckechnie S, 2010, J WILDLIFE MANAGE, V74, P828, DOI 10.2193/2007-530; Methot RD, 2013, FISH RES, V142, P86, DOI 10.1016/j.fishres.2012.10.012; Millar RB, 2000, CAN J FISH AQUAT SCI, V57, P43, DOI 10.1139/f99-169; Moller H, 2006, DONG WU XUE BAO, V52, P649; Nevins HM, 2009, J ROY SOC NEW ZEAL, V39, P183, DOI 10.1080/03014220909510576; Newman J, 2009, NEW ZEAL J ZOOL, V36, P307, DOI 10.1080/03014220909510157; Newman J, 2009, WILDLIFE RES, V36, P159, DOI 10.1071/WR06074; Newman KB, 2006, ECOL APPL, V16, P74, DOI 10.1890/04-0592; Orwin KH, 2016, OECOLOGIA, V180, P217, DOI 10.1007/s00442-015-3437-9; Owen-Smith N, 2006, ECOL MONOGR, V76, P93, DOI 10.1890/05-0765; Pedersen MW, 2011, ECOL MODEL, V222, P1394, DOI 10.1016/j.ecolmodel.2011.01.007; POLACHECK T, 1993, CAN J FISH AQUAT SCI, V50, P2597, DOI 10.1139/f93-284; Polansky L, 2008, THEOR ECOL-NETH, V1, P221, DOI 10.1007/s12080-008-0022-4; Polansky L, 2009, ECOLOGY, V90, P2313, DOI 10.1890/08-1461.1; PRINCE PA, 1994, IBIS, V136, P50, DOI 10.1111/j.1474-919X.1994.tb08131.x; R Development Core Team, 2009, R LANG ENV STAT COMP; RICHDALE L. E., 1963, PROC ZOOL SOC LONDON, V141, P1; Robertson G, 2006, BIOL CONSERV, V132, P458, DOI 10.1016/j.biocon.2006.05.003; SCHNUTE JT, 1994, CAN J FISH AQUAT SCI, V51, P1676, DOI 10.1139/f94-168; Scofield R. Paul, 2002, Notornis, V49, P158; Scott Darren, 2008, Papers and Proceedings of the Royal Society of Tasmania, V142, P185; Shaffer SA, 2006, P NATL ACAD SCI USA, V103, P12799, DOI 10.1073/pnas.0603715103; Sibly RM, 2005, SCIENCE, V309, P607, DOI 10.1126/science.1110760; Snover ML, 2008, ECOL MODEL, V212, P545, DOI 10.1016/j.ecolmodel.2007.11.002; Spiridonov VA, 2004, DRIFTNET FISHERY SAL; Starfield A. M., 1986, BUILDING MODELS CONS; Thompson DR, 2015, MAR ECOL PROG SER, V521, P277, DOI 10.3354/meps11128; TROUP AJ, 1965, Q J ROY METEOR SOC, V91, P490, DOI 10.1002/qj.49709139009; Uhlmann S, 2005, BIOL CONSERV, V123, P151, DOI 10.1016/j.biocon.2004.11.003; Uhlmann SS, 2011, BIOL CONSERV, V144, P1859, DOI 10.1016/j.biocon.2011.02.025; Veit RR, 1997, GLOB CHANGE BIOL, V3, P23, DOI 10.1046/j.1365-2486.1997.d01-130.x; Watanabe S, 2010, J MACH LEARN RES, V11, P3571; Yao YL, 2018, BAYESIAN ANAL, V13, P917, DOI 10.1214/17-BA1091; Zydelis R, 2009, CONSERV BIOL, V23, P608, DOI 10.1111/j.1523-1739.2009.01172.x	74	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243794	10.1371/journal.pone.0243794	http://dx.doi.org/10.1371/journal.pone.0243794			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315952	gold, Green Published			2022-12-27	WOS:000600186100012
J	von Lassberg, C; Campos, JL; Beykirch, KA				von Lassberg, Christoph; Campos, Jennifer L.; Beykirch, Karl A.			Long term measures of vestibulo-ocular reflex function in high level male gymnasts and its possible role during context specific rotational tasks	PLOS ONE			English	Article							OCULAR REFLEX; EYE-MOVEMENTS; ADAPTATION; HABITUATION; SOMERSAULT; MOTION	In a prior publication, we described a previously unknown eye movement phenomenon during the execution of actively performed multiaxial rotations in high level gymnasts. This phenomenon was consistently observed during the phase of fast free flight rotations and was marked by a prolonged and complete suppression of nystagmus and gaze stabilizing "environment referenced eye movements" (EREM; such as the vestibulo-ocular reflex, optokinetic reflex, smooth pursuit and others). Instead, these eye movements were coupled with intersegmental body movements. We have therefore called it "spinal motor-coupled eye movements" (SCEM) and have interpreted the phenomenon to likely be caused by anti-compensatory functions of more proprioceptive mediated reflexes and perhaps other mechanisms (e.g., top-down regulation as part of a motor plan) to effectively cope with a new-orientation in space, undisturbed by EREM functions. In the phase before landing, the phenomenon was replaced again by the known gaze-stabilizing EREM functions. The present study specifically evaluated long-term measures of vestibulo-ocular reflex functions (VOR) in high level gymnasts and controls during both passively driven monoaxial rotations and context-specific multiaxial somersault simulations in a vestibular lab. This approach provided further insights into the possible roles of adaptive or mental influences concerning the VOR function and how they are associated with the described phenomenon of SCEM. Results showed high inter-individual variability of VOR function in both gymnasts and controls, but no systematic adaptation of the VOR in gymnasts, neither compared to controls nor over a period of three years. This might generally support the hypothesis that the phenomenon of SCEM might indeed be driven more by proprioceptively mediated and situationally dominant eye movement functions than by adaptative processes of the VOR.	[von Lassberg, Christoph] Univ Tubingen, Dept Sports Med, Med Clin, Tubingen, Germany; [Campos, Jennifer L.] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada; [Campos, Jennifer L.] Univ Toronto, Dept Psychol, Toronto, ON, Canada; [Beykirch, Karl A.] Max Planck Inst Biol Cybernet, Tubingen, Germany	Eberhard Karls University of Tubingen; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute; University of Toronto; Max Planck Society	von Lassberg, C (corresponding author), Univ Tubingen, Dept Sports Med, Med Clin, Tubingen, Germany.	cvl-lassberg@t-online.de			Bundesinstitut fur Sportwissenschaft, Bonn, Germany (Federal Institute of Sport Science) [AZ: VF0407/06/51/03-04, IIA1-070603/11]; University of Tubingen, Germany	Bundesinstitut fur Sportwissenschaft, Bonn, Germany (Federal Institute of Sport Science); University of Tubingen, Germany	This work was supported by the Bundesinstitut fur Sportwissenschaft, Bonn, Germany (Federal Institute of Sport Science; AZ: VF0407/06/51/03-04 and IIA1-070603/11). We further acknowledge support by Open Access Publishing Fund of University of Tubingen, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SC, 2000, J VESTIBUL RES-EQUIL, V10, P17; Ahn SC, 2003, AVIAT SPACE ENVIR MD, V74, P285; Alpini D, 2009, SPORT SCI HLTH, V5, P129, DOI DOI 10.1007/S1S1332-009-00888-4; BALOH RW, 1982, AM J OTOLARYNG, V3, P235, DOI 10.1016/S0196-0709(82)80061-6; BALOH RW, 1980, AVIAT SPACE ENVIR MD, V51, P563; Bechert K, 1996, NEURO-OPHTHALMOLOGY, V16, P163, DOI 10.3109/01658109609009677; Beykirch K, 2006, 20032005 M PLANCK I, P43; Clement G, 2008, EXP BRAIN RES, V190, P307, DOI 10.1007/s00221-008-1471-0; COLLEWIJN H, 1989, PROG BRAIN RES, V80, P197; Curtis CE, 2003, J COGNITIVE NEUROSCI, V15, P409, DOI 10.1162/089892903321593126; Davlin CD, 2001, MOTOR CONTROL, V5, P337, DOI 10.1123/mcj.5.4.337; Eggers SDZ, 2003, ANN NY ACAD SCI, V1004, P94, DOI 10.1196/annals.1303.010; Hamilton AC, 2005, COGN AFFECT BEHAV NE, V5, P1; Hartmann M, 2014, EXP BRAIN RES, V232, P1249, DOI 10.1007/s00221-014-3841-0; Heinen T, 2011, MOTOR CONTROL, V15, P267, DOI 10.1123/mcj.15.2.267; Hondzinski JM, 2001, MOTOR CONTROL, V5, P281, DOI 10.1123/mcj.5.3.281; JONES GM, 1984, EXP BRAIN RES, V56, P149; Koenig E, 1996, NEURO-OPHTHALMOLOGY, V16, P157, DOI 10.3109/01658109609009676; LEE DN, 1992, J EXP PSYCHOL HUMAN, V18, P1195, DOI 10.1037/0096-1523.18.4.1195; Lee MY, 2004, LARYNGOSCOPE, V114, P897, DOI 10.1097/00005537-200405000-00021; Leigh R. J., 2006, NEUROLOGY EYE MOVEME; Lewis RF, 2003, CEREBELLUM, V2, P123, DOI 10.1080/14734220309407; Luis M, 2008, MOTOR CONTROL, V12, P210, DOI 10.1123/mcj.12.3.210; McDowell JE, 2008, BRAIN COGNITION, V68, P255, DOI 10.1016/j.bandc.2008.08.016; Natrup J, 2020, HUM MOVEMENT SCI, V70, DOI 10.1016/j.humov.2020.102589; Oppenheim Alan V., 1999, DISCRETE TIME SIGNAL; ORNITZ EM, 1985, ACTA OTO-LARYNGOL, V100, P180, DOI 10.3109/00016488509104780; Osterhammel P, 1968, Acta Otolaryngol, V66, P221, DOI 10.3109/00016486809126289; Osterhammel P, 1968, Acta Otolaryngol, V66, P145, DOI 10.3109/00016486809126282; Quarck G, 2015, SCI MOTRICITE, V55, P101; Sakaguchi M, 1997, ACTA OTO-LARYNGOL, P70; Sato Y, 2017, PERCEPT MOTOR SKILL, V124, P248, DOI 10.1177/0031512516676148; SCHWARZ U, 1989, AVIAT SPACE ENVIR MD, V60, P755; Shelhamer M, 1992, J Vestib Res, V2, P89; Stangl W., 2000, LEISTUNGSSPORT, V30, P58; Tanguy S, 2008, EUR J APPL PHYSIOL, V104, P1031, DOI 10.1007/s00421-008-0859-7; von Lassberg C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095450; von Lassberg C, 2012, MOTOR CONTROL, V16, P176, DOI 10.1123/mcj.16.2.176; WASSERTHEIL S, 1970, BIOMETRICS, V26, P588, DOI 10.2307/2529115	39	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243752	10.1371/journal.pone.0243752	http://dx.doi.org/10.1371/journal.pone.0243752			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315913	gold, Green Published			2022-12-27	WOS:000600186100064
J	Ehrenfeld, V; Heusel, JR; Fulda, S; van Wijk, SJL				Ehrenfeld, Vanessa; Heusel, Jan R.; Fulda, Simone; van Wijk, Sjoerd J. L.			ATM inhibition enhances Auranofin-induced oxidative stress and cell death in lung cell lines	PLOS ONE			English	Article							ATAXIA-TELANGIECTASIA; DNA-DAMAGE; THIOREDOXIN; ACTIVATION; GLUTAREDOXIN; PROGRESSION; DISEASE; SYSTEM	Ataxia-Telangiectasia (A-T), a pleiotropic chromosomal breakage syndrome, is caused by the loss of the kinase Ataxia-telangiectasia mutated (ATM). ATM is not only involved in the response to DNA damage, but also in sensing and counteracting oxidative stress. Since a disturbed redox balance has been implicated in the pathophysiology of A-T lung disease, we aimed to further explore the interplay between ATM and oxidative stress in lung cells. Using a kinetic trapping approach, we could demonstrate an interaction between the trapping mutant TRX1-CS and ATM upon oxidative stress. We could further show that combined inhibition of thioredoxin reductase (TrxR) and ATM kinase activity, using Auranofin and KU55933 respectively, induced an increase in cellular reactive oxygen species (ROS) levels and protein oxidation in lung cells. Furthermore, ATM inhibition sensitized lung cells to Auranofin-induced cell death that could be rescued by ROS scavengers. As a consequence, targeted reduction of ATM by TRX1 could serve as a regulator of oxidative ATM activation and contribute to the maintenance of the cellular redox homeostasis. These results highlight the importance of the redox-active function of ATM in preventing ROS accumulation and cell death in lung cells.	[Ehrenfeld, Vanessa; Heusel, Jan R.; Fulda, Simone; van Wijk, Sjoerd J. L.] Goethe Univ Frankfurt, Inst Expt Canc Res Pediat, Frankfurt, Germany; [Fulda, Simone] Partner Site Frankfurt, German Canc Consortium DKTK, Frankfurt, Germany; [Fulda, Simone] German Canc Res Ctr, Heidelberg, Germany	Goethe University Frankfurt; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	van Wijk, SJL (corresponding author), Goethe Univ Frankfurt, Inst Expt Canc Res Pediat, Frankfurt, Germany.	s.wijk@kinderkrebsstiftung-frankfurt.de	van Wijk, Sjoerd/AAL-6680-2021	van Wijk, Sjoerd/0000-0001-6532-7651; Fulda, Simone/0000-0002-0459-6417	Deutsche Forschungsgemeinschaft [SFB 815, FU 436/21-1]; Bundesministerium fur Bildung und Forschung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This work has been supported by grants from the Deutsche Forschungsgemeinschaft (https://www.dfg.de), grant numbers SFB 815 (to S.F and to V.E.) and FU 436/21-1 (to S.F. and S.J.L. v.W.) Bundesministerium fur Bildung und Forschung (https://www.bmbf.de), no grant number available (to S.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; [Anonymous], 2018, BIG DATA RES, V11, piii, DOI 10.1016/S2214-5796(18)30058-3; Arodin L, 2014, FREE RADICAL BIO MED, V73, P328, DOI 10.1016/j.freeradbiomed.2014.05.011; Arodin L, 2014, J ALZHEIMERS DIS, V39, P787, DOI 10.3233/JAD-131814; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Barlow C, 1999, P NATL ACAD SCI USA, V96, P9915, DOI 10.1073/pnas.96.17.9915; Barzilai A, 2002, DNA REPAIR, V1, P3, DOI 10.1016/S1568-7864(01)00007-6; Blackford AN, 2017, MOL CELL, V66, P801, DOI 10.1016/j.molcel.2017.05.015; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Collet JF, 2010, ANTIOXID REDOX SIGN, V13, P1205, DOI 10.1089/ars.2010.3114; Cosentino C, 2011, EMBO J, V30, P546, DOI 10.1038/emboj.2010.330; Duecker R, 2018, REDOX BIOL, V14, P645, DOI 10.1016/j.redox.2017.11.006; Fulda S, 1997, CANCER RES, V57, P3823; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Hampton MB, 2018, ANTIOXID REDOX SIGN, V28, P591, DOI 10.1089/ars.2017.7422; Hastings TG, 2009, J BIOENERG BIOMEMBR, V41, P469, DOI 10.1007/s10863-009-9257-z; Haydn T, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.239; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Kamsler A, 2001, CANCER RES, V61, P1849; Kumar JK, 2004, P NATL ACAD SCI USA, V101, P3759, DOI 10.1073/pnas.0308701101; Kurz EU, 2004, DNA REPAIR, V3, P889, DOI 10.1016/j.dnarep.2004.03.029; Lee JH, 2007, ONCOGENE, V26, P7741, DOI 10.1038/sj.onc.1210872; Lovell MA, 2000, FREE RADICAL BIO MED, V28, P418, DOI 10.1016/S0891-5849(99)00258-0; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; Maciejczyk M, 2017, REDOX BIOL, V11, P375, DOI 10.1016/j.redox.2016.12.030; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; MCFARLIN DE, 1972, MEDICINE, V51, P281, DOI 10.1097/00005792-197207000-00002; McKinnon PJ, 2004, EMBO REP, V5, P772, DOI 10.1038/sj.embor.7400210; Patra KC, 2014, TRENDS BIOCHEM SCI, V39, P347, DOI 10.1016/j.tibs.2014.06.005; Peskin AV, 2013, J BIOL CHEM, V288, P14170, DOI 10.1074/jbc.M113.460881; Reichenbach J, 2002, ANTIOXID REDOX SIGN, V4, P465, DOI 10.1089/15230860260196254; Reliene R, 2004, CANCER RES, V64, P5148, DOI 10.1158/0008-5472.CAN-04-0442; Rigobello MP, 2005, FREE RADICAL RES, V39, P687, DOI 10.1080/10715760500135391; Rotman G, 1997, BIOESSAYS, V19, P911, DOI 10.1002/bies.950191011; Schroeder SA, 2005, PEDIATR PULM, V39, P537, DOI 10.1002/ppul.20209; Schroeder SA, 2014, PEDIATR PULM, V49, P389, DOI 10.1002/ppul.22817; Schwertassek U, 2007, EMBO J, V26, P3086, DOI 10.1038/sj.emboj.7601746; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Siliciano JD, 1997, GENE DEV, V11, P3471, DOI 10.1101/gad.11.24.3471; Taylor AMR, 2015, CLIN GENET, V87, P199, DOI 10.1111/cge.12453; Yin H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024080; Zhang YC, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aaq0702	44	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0244060	10.1371/journal.pone.0244060	http://dx.doi.org/10.1371/journal.pone.0244060			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8CZ	33338048	Green Published, gold			2022-12-27	WOS:000601313500022
J	Hussain, S; Ahmad, S; Akhtar, S; Javed, A; Yasmeen, U				Hussain, Sardar; Ahmad, Sohaib; Akhtar, Sohail; Javed, Amara; Yasmeen, Uzma			Estimation of finite population distribution function with dual use of auxiliary information under non-response	PLOS ONE			English	Article							CRASH RATES; RATIO; MODEL	In this paper, we propose two new families of estimators for estimating the finite population distribution function in the presence of non-response under simple random sampling. The proposed estimators require information on the sample distribution functions of the study and auxiliary variables, and additional information on either sample mean or ranks of the auxiliary variable. We considered two situations of non-response (i) non-response on both study and auxiliary variables, (ii) non-response occurs only on the study variable. The performance of the proposed estimators are compared with the existing estimators available in the literature, both theoretically and numerically. It is also observed that proposed estimators are more precise than the adapted distribution function estimators in terms of the percentage relative efficiency.	[Hussain, Sardar; Ahmad, Sohaib] Quaid I Azam Univ, Dept Stat, Islamabad, Pakistan; [Akhtar, Sohail; Javed, Amara] Govt Coll Univ, Dept Stat, Lahore, Pakistan; [Javed, Amara] Minhaj Univ, Sch Stat, Lahore, Pakistan; [Yasmeen, Uzma] Univ Lahore, Inst Mol Biol & Biotechnol, Lahore, Pakistan	Quaid I Azam University; Government College University Lahore; Minhaj University; University of Lahore	Akhtar, S (corresponding author), Govt Coll Univ, Dept Stat, Lahore, Pakistan.	s.akhtar@gcu.edu.pk	Hussain, Sardar/CAE-8609-2022	Akhtar, Sohail/0000-0003-4870-152X				Ahmad S, 2018, J RELIAB STAT STUD, V11, P99; Ahmed M. S., 2001, STAT TRANSITION, V5, P501; [Anonymous], 2007, J BRAS PNEUMOL S2, V33, pS51; [Anonymous], 2014, FRONTIERS ARCHITECTU, V3, P1, DOI DOI 10.1520/C1557-03R13.2; [Anonymous], 2018, DIABETES CARE S1, V2018, pS1; CHAMBERS RL, 1986, BIOMETRIKA, V73, P597; Chen F, 2018, J SAFETY RES, V65, P153, DOI 10.1016/j.jsr.2018.02.010; Chen F, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13060609; Chiu DKY, 2002, PROCEEDINGS OF THE 6TH JOINT CONFERENCE ON INFORMATION SCIENCES, P1223; Cochran WG, 1940, J AGR SCI, V30, P262, DOI 10.1017/S0021859600048012; Grover LK, 2014, COMMUN STAT-SIMUL C, V43, P1552, DOI 10.1080/03610918.2012.736579; Gujarati D., 2009, BASIC ECONOMETRICS; HANSEN MH, 1946, J AM STAT ASSOC, V41, P517, DOI 10.2307/2280572; Haq A, 2017, COMMUN STAT-THEOR M, V46, P4425, DOI 10.1080/03610926.2015.1083112; Hussain S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239098; Khare B. B., 2011, STAT TRANSITION NEW, V1, P45; Khare B B, 2009, STAT TRANSIT, V10, P3, DOI DOI 10.21307/STATTRANS-2019-025; Khare BB, 1997, COMMUN STAT-THEOR M, V26, P1779, DOI 10.1080/03610929708832012; KUK AYC, 1993, BIOMETRIKA, V80, P385, DOI 10.2307/2337208; Muneer S, 2017, COMMUN STAT-THEOR M, V46, P2181, DOI 10.1080/03610926.2015.1035394; Murthy M., 1964, SANKHYA 5E INDIAN A, V26, P69; Pal SK, 2018, COMMUN STAT-SIMUL C, V47, P143, DOI 10.1080/03610918.2017.1280161; Plewes TJ, 2013, NONRESPONSE SOCIAL S; Rao J., 1994, J OFF STAT, V10, P153; RAO JNK, 1990, BIOMETRIKA, V77, P365, DOI 10.1093/biomet/77.2.365; Rao P S R S, 1986, SURV METHODOL, V12, P217; RAO TJ, 1991, COMMUN STAT THEORY, V20, P3325, DOI 10.1080/03610929108830705; Rueda M, 2007, J STAT PLAN INFER, V137, P435, DOI 10.1016/j.jspi.2005.12.011; Singh HP, 2008, ACTA APPL MATH, V104, P115, DOI 10.1007/s10440-008-9243-1; Singh S., 2003, J IND STAT ASS, DOI 10.1007/978-94-007-0789-4; SS V et al. on behalf of the American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee, 2020, CIRCULATION, V2020, pe1; Yaqub M, 2018, HACET J MATH STAT, V47, P471, DOI 10.15672/HJMS.201613118919; Zeng Q, 2019, TRANSPORTMETRICA A, V15, P1867, DOI 10.1080/23249935.2019.1652867; Zeng Q, 2020, J TRANSP SAF SECUR, V12, P566, DOI 10.1080/19439962.2018.1516259; Zeng Q, 2017, ACCIDENT ANAL PREV, V99, P184, DOI 10.1016/j.aap.2016.11.018	35	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243584	10.1371/journal.pone.0243584	http://dx.doi.org/10.1371/journal.pone.0243584			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332445	Green Published, gold			2022-12-27	WOS:000601310900076
J	Islam, MS; Chughtai, AA; Nazneen, A; Chowdhury, KIA; Islam, MT; Tarannum, S; Islam, SMH; Banu, S; Seale, H				Islam, Md Saiful; Chughtai, Abrar Ahmad; Nazneen, Arifa; Chowdhury, Kamal Ibne Amin; Islam, Muhammad Tauhidul; Tarannum, Sayeeda; Islam, S. M. Hasibul; Banu, Sayera; Seale, Holly			A tuberculin skin test survey among healthcare workers in two public tertiary care hospitals in Bangladesh	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; RESISTANT TUBERCULOSIS; INFECTION; RISK; PRACTITIONERS; POPULATION; PREVENTION; PREVALENCE; GUIDELINES; CONVERSION	In Bangladesh, there is currently no data on the burden of latent TB infection (LTBI) amongst hospital healthcare workers (HCWs). This study aimed to determine the prevalence of LTBI and compare the prevalence among HCWs in two public tertiary care hospitals. Between September 2018 and August 2019, we conducted a cross-sectional study in two public tertiary care general hospitals. Using a survey and tuberculin skin test (TST), we assessed risk factors for LTBI, adjusting for known and plausible confounders. In addition, a facility assessment was undertaken to understand the implementation of relevant IPC measures. The prevalence of LTBI among HCWs was 42%. HCWs spent a median of 6 hours (SD = 1.76, IQR 2.00) per day and attended an average of 1.87 pulmonary TB patients per week. HCWs did not receive any TB IPC training, the wards lacked a symptom checklist to screen patients for TB, and no masks were available for coughing patients. Seventy-seven percent reportedly did not use any facial protection (masks or respirators) while caring for patients. In the multivariable model adjusting for hospital level clustering effect, TST positivity was significantly higher among HCWs aged 35-45 years (aOR1.36, 95% CI: 1.06-1.73) and with >3 years of service (aOR 1.67, 95% CI: 1.62-1.72). HCWs working in the medicine ward had 3.65 (95% CI: 2.20-6.05) times, and HCWs in the gynecology and obstetrics ward had 2.46 (95% CI: 1.42-4.27) times higher odds of TST positivity compared to HCWs working in administrative areas. This study identified high prevalence of LTBI among HCWs. This may be due to the level of exposure to pulmonary TB patients, and/or limited use of personal protective equipment along with poor implementation of TB IPC in the hospitals. Considering the high prevalence of LTBI, we recommend the national TB program consider providing preventative therapy to the HCWs as the high-risk group, and implement TB IPC in the hospitals.	[Islam, Md Saiful; Nazneen, Arifa; Chowdhury, Kamal Ibne Amin; Islam, Muhammad Tauhidul; Tarannum, Sayeeda; Islam, S. M. Hasibul; Banu, Sayera] Icddr B, Infect Dis Div, Program Emerging Infect, Dhaka, Bangladesh; [Islam, Md Saiful; Chughtai, Abrar Ahmad; Seale, Holly] Univ New South Wales, Sch Populat Hlth, Sydney, NSW, Australia	International Centre for Diarrhoeal Disease Research (ICDDR); University of New South Wales Sydney	Islam, MS (corresponding author), Icddr B, Infect Dis Div, Program Emerging Infect, Dhaka, Bangladesh.; Islam, MS (corresponding author), Univ New South Wales, Sch Populat Hlth, Sydney, NSW, Australia.	saiful@icddrb.org	Islam, Saiful/GOH-2641-2022	Islam, Md Saiful/0000-0002-5690-5971	United States Centers for Disease Control and Prevention (CDC) [5U01GH1207]; Government of Bangladesh; Government of Canada; Government of Sweden; Government of UK	United States Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Government of Bangladesh; Government of Canada(CGIAR); Government of Sweden; Government of UK	This research protocol was funded by the United States Centers for Disease Control and Prevention (CDC), through the cooperative agreement grant number 5U01GH1207. icddr,b acknowledges with gratitude the commitment of CDC to its research efforts. icddr,b is also grateful to the Governments of Bangladesh, Canada, Sweden, and the UK for providing core/unrestricted support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, MMWR Recomm Rep, V49, P1; Andalib A, 2020, INT J PERCEPTIONS PU, V1, P9; [Anonymous], 2016, EUR J ORAL IMPLAN S1, V9, pS173; CDC, 1994, GUID PREV TRANSM MYC; Centers for Disease Control and Prevention, 2016, TB RISK FACT ATL; Chae Y.K., 2009, PLOS ONE, V4, pe6523; Chen B, 2019, INT J INFECT DIS, V79, P26, DOI 10.1016/j.ijid.2018.11.010; Clark TG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083012; Dagnew Alemnew F, 2012, BMC Res Notes, V5, P415, DOI 10.1186/1756-0500-5-415; Donald PR, 2009, NEW ENGL J MED, V360, P2393, DOI 10.1056/NEJMp0903806; EFSA FEEDAP, 2014, EFSA J, V12, P1, DOI DOI 10.2903/j.efsa.2014.3547; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; Franchi A, 2007, INT ARCH OCC ENV HEA, V80, P533, DOI 10.1007/s00420-006-0160-1; Franchi A, 2009, AM J IND MED, V52, P297, DOI 10.1002/ajim.20680; Gajalakshmi V, 2003, LANCET, V362, P507, DOI 10.1016/S0140-6736(03)14109-8; Gao L, 2015, LANCET INFECT DIS, V15, P310, DOI 10.1016/S1473-3099(14)71085-0; Getahun H, 2015, NEW ENGL J MED, V372, P2127, DOI 10.1056/NEJMra1405427; Gopinath KG, 2004, J HOSP INFECT, V57, P339, DOI 10.1016/j.jhin.2004.03.029; Gruen R, 2002, SOC SCI MED, V54, P267, DOI 10.1016/S0277-9536(01)00026-0; Horton KC, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1002119, 10.1371/journal.pmed.1002152]; Islam MS, 2020, PREVALENCE INC UNPUB; Jo KW, 2017, TUBERC RESPIR DIS, V80, P21, DOI 10.4046/trd.2017.80.1.21; Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494; Kizza FN, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0904-1; Klopper M, 2013, EMERG INFECT DIS, V19, P449, DOI [10.3201/EID1903.120246, 10.3201//EID1903.120246]; Knight GM, 2019, LANCET INFECT DIS, V19, P903, DOI 10.1016/S1473-3099(19)30307-X; Kumar MG, 2019, INDIAN J OCCUP ENVIR, V23, P83, DOI 10.4103/ijoem.IJOEM_269_18; Kwon YS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129792; Lewinsohn DM, 2017, CLIN INFECT DIS, V64, P111, DOI 10.1093/cid/ciw778; Lillebaek T, 2002, J INFECT DIS, V185, P401, DOI 10.1086/338342; Menzies D, 2007, INT J TUBERC LUNG D, V11, P593; Menzies D, 1999, AM J RESP CRIT CARE, V159, P15, DOI 10.1164/ajrccm.159.1.9801120; Nasreen S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164034; Nathavitharana RR, 2017, PRESSE MED, V46, pE53, DOI 10.1016/j.lpm.2017.01.014; National Institute of Population Research and Training Associates for Community and Population Research ICF International, 2016, BANGL HLTH FAC SURV; Nazneen A, 2020, ASSESSING IMPLEMENTA; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Rangaka MX, 2015, LANCET, V386, P1, DOI 10.1016/S0140-6736(15)00323-2; Raviglione M, 2006, INT J TUBERC LUNG D, V10, P1185; Rieder HL, 2011, INT J TUBERC LUNG D, V15, pS1; Rimi NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089085; Rutanga C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124485; Sabri A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221081; Sadaf R, 2020, PAK J MED SCI, V36, P198, DOI 10.12669/pjms.36.2.936; Sarkar PK., 2017, BANGLADESH J CHILD H, V39, P93, DOI DOI 10.3329/BJCH.V39I2.31540; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; Uden L, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx137; Ullah AZ, 2010, WORLD MED HEALTH POL, V2, P217, DOI 10.2202/1948-4682.1029; Vinton P, 2009, INFECT CONT HOSP EP, V30, P215, DOI 10.1086/595695; Weber AM, 2008, INFECT CONT HOSP EP, V29, P648, DOI 10.1086/588684; WHO, 2020, GLOB TUB REP; WHO, 2010, REP NAT TUB DIS CUM; World Health Organization, 2019, WHOCDSTB20191; World Health Organization, 2015, CHECKL PER EV TB INF; World Health Organization, 2018, WHOCDSTB20184; Zwerling A, 2012, THORAX, V67, P62, DOI 10.1136/thx.2010.143180	56	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243951	10.1371/journal.pone.0243951	http://dx.doi.org/10.1371/journal.pone.0243951			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332458	Green Published, gold			2022-12-27	WOS:000601310900024
J	Johansson, M; Karlsson, T; Finizia, C				Johansson, Mia; Karlsson, Therese; Finizia, Caterina			Further validation of the Gothenburg Trismus Questionnaire (GTQ)	PLOS ONE			English	Article							QUALITY-OF-LIFE; HEAD; DEPRESSION; QLQ-C30; ANXIETY	This study aimed to update and, if necessary, revise the Gothenburg Trismus Questionnaire (GTQ), the only existing trismus-specific questionnaire, and retest its psychometric properties. Semi-structured interviews were performed with 10 trismus patients of which 5 had head and neck cancer (HNC) and 5 suffered from benign temporomandibular disorders. Trismus was defined as a maximal incisal opening of <= 35mm. An expert panel discussed and revised the GTQ based on interview information, expertise knowledge and the original questionnaire. The revised questionnaire was then tested in a study sample consisting of benign jaw-related conditions (n = 26), patients treated for HNC (n = 90) and an age- and gender-matched control group with no trismus (n = 116). The revised version of the GTQ (GTQ 2) was well accepted by patients. The original three domains continued to show high internal consistency (Cronbach's alpha 0.74-0.94) and construct validity. Two dually posed single items were split into four questions and the wording was altered in another three items. Moreover, a new domain (Facial pain) was identified, which had excellent internal consistency (alpha = 0.96) and good construct validity. The revision of the original Gothenburg Trismus Questionnaire (GTQ 1) with inclusion of patient-input, resulted in splitting of ambiguous items, identifying a fourth domain named Facial pain and the recall time shortened for some items. Additionally, the remaining domains and items were re-confirmed as strong in the psychometric analysis. Henceforth, the new version, GTQ 2 should be used.	[Johansson, Mia] Gothenburg Univ, Sahlgrenska Acad, Inst Clin Sci, Dept Oncol, Gothenburg, Sweden; [Johansson, Mia; Karlsson, Therese; Finizia, Caterina] Sahlgrens Univ Hosp, Dept Otorhinolaryngol, Reg Vastra Gotaland, Gothenburg, Sweden; [Karlsson, Therese; Finizia, Caterina] Gothenburg Univ, Sahlgrenska Acad, Inst Clin Sci, Dept Otorhinolaryngol Head & Neck Surg, Gothenburg, Sweden	University of Gothenburg; Sahlgrenska University Hospital; University of Gothenburg	Karlsson, T (corresponding author), Sahlgrens Univ Hosp, Dept Otorhinolaryngol, Reg Vastra Gotaland, Gothenburg, Sweden.; Karlsson, T (corresponding author), Gothenburg Univ, Sahlgrenska Acad, Inst Clin Sci, Dept Otorhinolaryngol Head & Neck Surg, Gothenburg, Sweden.	therese.r.karlsson@vgregion.se			Swedish Cancer Society; Healthcare Board, Region Vastra Gotaland; Medical Faculty of Gothenburg University, Sweden; Swedish government [ALFGBG-773871]; Swedish county councils, the ALF-agreement [ALFGBG-773871]	Swedish Cancer Society(Swedish Cancer Society); Healthcare Board, Region Vastra Gotaland; Medical Faculty of Gothenburg University, Sweden; Swedish government; Swedish county councils, the ALF-agreement	This work was supported by the Swedish Cancer Society (CF, www.cancerfonden.se); The Healthcare Board, Region Vastra Gotaland and the Medical Faculty of Gothenburg University (CF), Sweden. In addition, the study was financed by grants from the Swedish state under the agreement between the Swedish government and the county councils (CF), the ALF-agreement (grant number: ALFGBG-773871, www.alfvastragotaland.se).	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Bensadoun RJ, 2010, SUPPORT CARE CANCER, V18, P1033, DOI 10.1007/s00520-010-0847-4; Bjordal K, 2000, EUR J CANCER, V36, P1796, DOI 10.1016/S0959-8049(00)00186-6; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Dijkstra PU, 2006, INT J ORAL MAX SURG, V35, P337, DOI 10.1016/j.ijom.2005.08.001; Fayers PM MD, 2007, QUALITY LIFE ASSESSM; Galvez-Sanchez CM, 2020, J AFFECT DISORDERS, V265, P486, DOI 10.1016/j.jad.2020.01.129; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Johnson J, 2012, ORAL ONCOL, V48, P730, DOI 10.1016/j.oraloncology.2012.02.013; Kent ML, 2008, SUPPORT CARE CANCER, V16, P305, DOI 10.1007/s00520-007-0345-5; Scott B, 2008, ORAL ONCOL, V44, P430, DOI 10.1016/j.oraloncology.2007.06.015; Stull DE, 2009, CURR MED RES OPIN, V25, P929, DOI 10.1185/03007990902774765 ; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	13	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243805	10.1371/journal.pone.0243805	http://dx.doi.org/10.1371/journal.pone.0243805			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332402	gold, Green Published			2022-12-27	WOS:000601310900062
J	Merz, EC; Monk, C; Bansal, R; Sawardekar, S; Lee, SJ; Feng, TS; Spann, M; Foss, S; McDonough, L; Werner, E; Peterson, BS				Merz, Emily C.; Monk, Catherine; Bansal, Ravi; Sawardekar, Siddhant; Lee, Seonjoo; Feng, Tianshu; Spann, Marisa; Foss, Sophie; McDonough, Laraine; Werner, Elizabeth; Peterson, Bradley S.			Neonatal brain metabolite concentrations: Associations with age, sex, and developmental outcomes	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; FALSE DISCOVERY RATE; WHITE-MATTER; N-ACETYLASPARTATE; INTELLECTUAL ABILITY; MR SPECTROSCOPY; PRETERM INFANTS; IN-VIVO; TERM; IMPACT	Age and sex differences in brain metabolite concentrations in early life are not well understood. We examined the associations of age and sex with brain metabolite levels in healthy neonates, and investigated the associations between neonatal brain metabolite concentrations and developmental outcomes. Forty-one infants (36-42 gestational weeks at birth; 39% female) of predominantly Hispanic/Latina mothers (mean 18 years of age) underwent MRI scanning approximately two weeks after birth. Multiplanar chemical shift imaging was used to obtain voxel-wise maps of N-acetylaspartate (NAA), creatine, and choline concentrations across the brain. The Bayley Scales of Infant and Toddler Development, a measure of cognitive, language, and motor skills, and mobile conjugate reinforcement paradigm, a measure of learning and memory, were administered at 4 months of age. Findings indicated that postmenstrual age correlated positively with NAA concentrations in multiple subcortical and white matter regions. Creatine and choline concentrations showed similar but less pronounced age related increases. Females compared with males had higher metabolite levels in white matter and subcortical gray matter. Neonatal NAA concentrations were positively associated with learning and negatively associated with memory at 4 months. Age-related increases in NAA, creatine, and choline suggest rapid development of neuronal viability, cellular energy metabolism, and cell membrane turnover, respectively, during early life. Females may undergo earlier and more rapid regional developmental increases in the density of viable neurons compared to males.	[Merz, Emily C.] Colorado State Univ, Dept Psychol, Ft Collins, CO 80523 USA; [Monk, Catherine; Lee, Seonjoo; Spann, Marisa; Foss, Sophie; Werner, Elizabeth] Columbia Univ, Dept Psychiat, Irving Med Ctr, New York, NY USA; [Monk, Catherine; Werner, Elizabeth] Columbia Univ, Dept Obstet & Gynecol, Irving Med Ctr, New York, NY USA; [Monk, Catherine; Feng, Tianshu; Spann, Marisa] New York State Psychiat Inst & Hosp, New York, NY 10032 USA; [Bansal, Ravi; Sawardekar, Siddhant; Peterson, Bradley S.] Childrens Hosp Los Angeles, Dept Pediat, Los Angeles, CA 90027 USA; [Bansal, Ravi; Sawardekar, Siddhant; Peterson, Bradley S.] Univ Southern Calif, Los Angeles, CA 90007 USA; [Bansal, Ravi; Peterson, Bradley S.] Childrens Hosp Los Angeles, Inst Dev Mind, Los Angeles, CA 90027 USA; [McDonough, Laraine] CUNY Brooklyn Coll, Dept Psychol, New York, NY USA; [McDonough, Laraine] CUNY, Grad Ctr, New York, NY USA; [Peterson, Bradley S.] Univ Southern Calif, Keck Sch Med, Dept Psychiat, Div Child & Adolescent Psychiat, Los Angeles, CA 90007 USA	Colorado State University; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; New York State Psychiatry Institute; Children's Hospital Los Angeles; University of Southern California; Children's Hospital Los Angeles; City University of New York (CUNY) System; City University of New York (CUNY) System; University of Southern California	Merz, EC (corresponding author), Colorado State Univ, Dept Psychol, Ft Collins, CO 80523 USA.	emily.merz@colostate.edu	Monk, Catherine/X-2277-2019	Monk, Catherine/0000-0001-7827-2602; Merz, Emily/0000-0003-1950-2345; lee, seonjoo/0000-0003-3177-6357; Foss, Sophie/0000-0001-8918-2899	National Institute of Health (NIH) [R01MH093677-01]	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding for this research was provided by a National Institute of Health (NIH) grant (R01MH093677-01) awarded to C. Monk and B. Peterson. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or other funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers CA, 2007, J PSYCHOEDUC ASSESS, V25, P180, DOI 10.1177/0734282906297199; Alexander B, 2019, NEUROIMAGE, V185, P654, DOI 10.1016/j.neuroimage.2018.07.021; Allen PJ, 2012, NEUROSCI BIOBEHAV R, V36, P1442, DOI 10.1016/j.neubiorev.2012.03.005; Amaral AI, 2017, NEUROCHEM RES, V42, P827, DOI 10.1007/s11064-016-1985-y; Anderson PJ, 2017, CLIN NEUROPSYCHOL, V31, P371, DOI 10.1080/13854046.2016.1216518; Anderson PJ, 2010, ARCH PEDIAT ADOL MED, V164, P352, DOI 10.1001/archpediatrics.2010.20; [Anonymous], 2014, CINEASTE, V39, P1; [Anonymous], 2019, BIOL PSYCHIAT; Augustine EM, 2008, J PERINATOL, V28, P611, DOI 10.1038/jp.2008.66; Bapat R, 2014, PEDIATR NEUROL, V51, P53, DOI 10.1016/j.pediatrneurol.2014.03.011; Baslow MH, 2003, NEUROCHEM RES, V28, P941, DOI 10.1023/A:1023250721185; Bayley N, 1993, BAYLEY SCALES INFANT; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benjamini Y, 2010, J R STAT SOC B, V72, P405, DOI 10.1111/j.1467-9868.2010.00746.x; Bjartmar C, 2002, ANN NEUROL, V51, P51, DOI 10.1002/ana.10052; Blackmon LR, 2004, PEDIATRICS, V114, P1362, DOI 10.1542/peds.2004-1915; Bluml S, 2013, CEREB CORTEX, V23, P2944, DOI 10.1093/cercor/bhs283; Chau V, 2013, NEUROLOGY, V81, P2082, DOI 10.1212/01.wnl.0000437298.43688.b9; Chen SY, 2017, J THORAC DIS, V9, P1725, DOI 10.21037/jtd.2017.05.34; Chumbley J, 2010, NEUROIMAGE, V49, P3057, DOI 10.1016/j.neuroimage.2009.10.090; Cohen-Gilbert JE, 2014, DEV PSYCHOPATHOL, V26, P405, DOI 10.1017/S0954579414000030; Deoni SCL, 2012, NEUROIMAGE, V63, P1038, DOI 10.1016/j.neuroimage.2012.07.037; Dipietro JA, 2017, NEUROSCIENCE, V342, P4, DOI 10.1016/j.neuroscience.2015.07.068; Dong ZC, 2007, MAGN RESON IMAGING, V25, P1148, DOI 10.1016/j.mri.2007.01.005; Dubois J, 2014, NEUROSCIENCE, V276, P48, DOI 10.1016/j.neuroscience.2013.12.044; Durazzo TC, 2016, BIOL PSYCHIAT, V79, P481, DOI 10.1016/j.biopsych.2015.03.029; Else-Quest NM, 2006, PSYCHOL BULL, V132, P33, DOI 10.1037/0033-2909.132.1.33; Eriksson M, 2012, BRIT J DEV PSYCHOL, V30, P326, DOI 10.1111/j.2044-835X.2011.02042.x; Gadin E, 2012, PEDIATR PHYS THER, V24, P38, DOI 10.1097/PEP.0b013e31823e069d; Galsworthy MJ, 2000, DEVELOPMENTAL SCI, V3, P206, DOI 10.1111/1467-7687.00114; Gilmore JH, 2018, NAT REV NEUROSCI, V19, P123, DOI 10.1038/nrn.2018.1; Goh S, 2014, JAMA PSYCHIAT, V71, P665, DOI 10.1001/jamapsychiatry.2014.179; Goh S, 2011, DEV COGN NEUROS-NETH, V1, P305, DOI 10.1016/j.dcn.2011.03.001; Hao XJ, 2013, HUM BRAIN MAPP, V34, P253, DOI 10.1002/hbm.21440; Karl A, 2010, NEUROSCI BIOBEHAV R, V34, P7, DOI 10.1016/j.neubiorev.2009.06.008; Kelly CE, 2016, BRAIN IMAGING BEHAV, V10, P41, DOI 10.1007/s11682-015-9361-0; Kendall GS, 2014, RADIOLOGY, V271, P230, DOI 10.1148/radiol.13122679; Knickmeyer RC, 2017, CEREB CORTEX, V27, P5616, DOI 10.1093/cercor/bhw331; Knickmeyer RC, 2014, CEREB CORTEX, V24, P2721, DOI 10.1093/cercor/bht125; Kraemer HC, 2000, AM J PSYCHIAT, V157, P163, DOI 10.1176/appi.ajp.157.2.163; Kreis R, 2002, MAGNET RESON MED, V48, P949, DOI 10.1002/mrm.10304; Lally PJ, 2019, LANCET NEUROL, V18, P35, DOI 10.1016/S1474-4422(18)30325-9; Lebel C, 2018, NEUROIMAGE, V182, P207, DOI 10.1016/j.neuroimage.2017.12.097; Lombardo MV, 2012, J NEUROSCI, V32, P674, DOI 10.1523/JNEUROSCI.4389-11.2012; McCarthy MM, 2019, CURR OPIN BEHAV SCI, V25, P83, DOI 10.1016/j.cobeha.2018.10.005; McCarthy MM, 2017, NAT REV NEUROSCI, V18, P471, DOI 10.1038/nrn.2017.61; McCarthy MM, 2012, J NEUROSCI, V32, P2241, DOI 10.1523/JNEUROSCI.5372-11.2012; Merz EC, 2017, DEV PSYCHOBIOL, V59, DOI 10.1002/dev.21520; Meyerhoff DJ, 2013, CURR TOP BEHAV NEURO, V13, P511, DOI 10.1007/7854_2011_131; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; Moore T, 2012, J PEDIATR-US, V160, P553, DOI 10.1016/j.jpeds.2011.09.047; Nelson MB, 2019, J NEUROSCI, V39, P8362, DOI 10.1523/JNEUROSCI.2422-18.2019; O'Neill J, 2020, BIOL PSYCHIAT, V87, P174, DOI 10.1016/j.biopsych.2019.06.010; Ozcaliskan S, 2010, DEVELOPMENTAL SCI, V13, P752, DOI 10.1111/j.1467-7687.2009.00933.x; Pouwels PJW, 1998, MAGN RESON MED, V39, P53, DOI 10.1002/mrm.1910390110; Pouwels PJW, 1997, NMR BIOMED, V10, P73, DOI 10.1002/(SICI)1099-1492(199704)10:2<73::AID-NBM448>3.0.CO;2-4; Qiu AQ, 2013, NEUROIMAGE, V65, P315, DOI 10.1016/j.neuroimage.2012.09.032; Rovee-Collier C, 1999, DEV PSYCHOBIOL, V35, P91, DOI 10.1002/(SICI)1098-2302(199909)35:2<91::AID-DEV2>3.0.CO;2-U; Rubinow DR, 2019, NEUROPSYCHOPHARMACOL, V44, P111, DOI 10.1038/s41386-018-0148-z; Ruigrok ANV, 2014, NEUROSCI BIOBEHAV R, V39, P34, DOI 10.1016/j.neubiorev.2013.12.004; Shaw P, 2006, NATURE, V440, P676, DOI 10.1038/nature04513; Tanifuji S, 2017, BRAIN DEV-JPN, V39, P196, DOI 10.1016/j.braindev.2016.10.006; Tau GZ, 2010, NEUROPSYCHOPHARMACOL, V35, P147, DOI 10.1038/npp.2009.115; Taylor MJ, 2018, NEURORADIOLOGY, V60, P1063, DOI 10.1007/s00234-018-2064-7; Tomiyasu M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082746; Van Kooij BJM, 2012, DEV MED CHILD NEUROL, V54, P260, DOI 10.1111/j.1469-8749.2011.04168.x; Wheelock MD, 2019, DEV COGN NEUROS-NETH, V36, DOI 10.1016/j.dcn.2019.100632; Wijtenburg SA, 2013, NEUROIMAGE, V66, P161, DOI 10.1016/j.neuroimage.2012.10.014; Yekutieli D, 1999, J STAT PLAN INFER, V82, P171, DOI 10.1016/S0378-3758(99)00041-5; Zhao Q, 2007, 3D INTERACTIVE CHEM; Zhu H, 2011, METHODS MOL BIOL, V711, P203, DOI 10.1007/978-1-61737-992-5_9	71	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243255	10.1371/journal.pone.0243255	http://dx.doi.org/10.1371/journal.pone.0243255			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PI8BZ	33332379	Green Published, gold			2022-12-27	WOS:000601310900059
J	Pinchoff, J; Santhya, KG; White, C; Rampal, S; Acharya, R; Ngo, TD				Pinchoff, Jessie; Santhya, K. G.; White, Corinne; Rampal, Shilpi; Acharya, Rajib; Ngo, Thoai D.			Gender specific differences in COVID-19 knowledge, behavior and health effects among adolescents and young adults in Uttar Pradesh and Bihar, India	PLOS ONE			English	Article								On March 24, 2020 India implemented a national lockdown to prevent spread of the novel Coronavirus disease (COVID-19) among its 1.3 billion people. As the pandemic may disproportionately impact women and girls, this study examines gender differences in knowledge of COVID-19 symptoms and preventive behaviors, as well as the adverse effects of the lockdown among adolescents and young adults. A mobile phone-based survey was implemented from April 3-22, 2020 in Uttar Pradesh and Bihar among respondents randomly selected from an existing cohort study. Respondents answered questions related to demographics, COVID-19 knowledge, attitudes, and preventive behaviors practiced, and impacts on social, economic and health outcomes. Descriptive analyses and linear probability regression models were performed for all participants and separately for men and women. A total of 1,666 adolescents and young adults (18-24 years old) were surveyed; 70% were women. While most participants had high awareness of disease symptoms and preventive behaviors, there was variation by gender. Compared to men, women were seven percentage points (pp) less likely to know the main symptoms of COVID-19 (coeff = -0.071; 95% confidence interval: -0.122 - -0.021). Among women, there was variation in knowledge by education level, urban residence, and household wealth. Women were 22 pp less likely to practice key preventive behaviors compared to men (coeff = -0.222; 95% CIL -0.263, -0.181). Women were also more likely to report recent depressive symptoms than men (coeff = 0.057; 95% CI: 0.004, 0.109). Our findings underscore that COVID-19 is already disproportionately impacting adolescent girls and young women and that they may require additional targeted, gender-sensitive messaging to foster behavior change. Gender-sensitive information campaigns and provision of health services must be accessible and provide women and girls with needed resources and support during the pandemic to ensure gains in public health and gender equity are not lost.	[Pinchoff, Jessie; White, Corinne; Ngo, Thoai D.] Populat Council, One Dag Hammarskjold Plaza, New York, NY 10017 USA; [Santhya, K. G.; Rampal, Shilpi; Acharya, Rajib] Populat Council, India Habitat Ctr, Delhi, India	Population Council	Pinchoff, J (corresponding author), Populat Council, One Dag Hammarskjold Plaza, New York, NY 10017 USA.	jpinchoff@popcouncil.org		Pinchoff, Jessie/0000-0003-3155-595X	Bill and Melinda Gates Foundation; Packard Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Packard Foundation(The David & Lucile Packard Foundation)	The initial UDAYA cohort was funded by the Bill and Melinda Gates Foundation and Packard Foundation. No additional funds were received for the COVID-19 survey.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Akseer N, 2020, AM J CLIN NUTR, V112, P251, DOI 10.1093/ajcn/nqaa171; [Anonymous], 2020, LANCET, V395, P1315, DOI 10.1016/S0140-6736(20)30938-7; [Anonymous], 2020, LANCET EDITORIAL, V2, pE268, DOI 10.1016/S2589-7500(20)30113-8; Cash R, 2020, LANCET, V395, P1687, DOI 10.1016/S0140-6736(20)31089-8; Davies SE, 2016, INT AFF, V92, P1041, DOI 10.1111/1468-2346.12704; GSM Association, 2020, CONN WOM MOB GEND GA; John N, 2020, DEV WORLD BIOETH, V20, P65, DOI 10.1111/dewb.12261; Johns Hopkins Coronavirus Resource Center, COVID 19 MAP; Kamate SK, 2010, J INFECT DEV COUNTR, V4, P7, DOI 10.3855/jidc.501; Kapoor M, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-026850; Kelley M, 2020, LANCET GLOB HEALTH, V8, pE888, DOI 10.1016/S2214-109X(20)30249-7; Liu NQ, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112921; Ministry of Housing Communities and Local Government, 2020, GUID INF PREV CONTR, P1; Mobarak AM, FOREIGN POLICY; Parker W, RETHINKING CONCEPTUA, V7; Prochaska JO, 1997, AM J HEALTH PROMOT, V12, P38, DOI 10.4278/0890-1171-12.1.38; Roberton T, 2020, LANCET GLOB HEALTH, V8, pE901, DOI 10.1016/S2214-109X(20)30229-1; Saikarthik J, 2020, MED RXIV, DOI [10.1101/2020.06.13.20130153., DOI 10.1101/2020.06.13.20130153, 10.1101/2020.06.13.20130153]; Santhya KG, 2017, J BIOSOC SCI, V49, pS74, DOI 10.1017/S0021932017000360; Undie C-C, 2020, SEXUAL VIOLENCE RES; UNICEF, 2017, CHILDR DIG WORLD; Wanqing Zhang, 2020, DOMESTIC VIOLENCE CA; World Health Organization, 2019, MENT HLTH EM; World Health Organization, 2020, COVID 19 VIOL WOM WH	25	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0244053	10.1371/journal.pone.0244053	http://dx.doi.org/10.1371/journal.pone.0244053			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PI8BZ	33332461	Green Published, gold			2022-12-27	WOS:000601310900041
J	Rieg, T; Frick, J; Baumgartl, H; Buettner, R				Rieg, Thilo; Frick, Janek; Baumgartl, Hermann; Buettner, Ricardo			Demonstration of the potential of white-box machine learning approaches to gain insights from cardiovascular disease electrocardiograms	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; ATRIAL-FIBRILLATION; DIABETIC-RETINOPATHY; P-WAVE; CLASSIFICATION; MANAGEMENT; VALIDATION; FEATURES; MODELS; CARE	We present the results from a white-box machine learning approach to detect cardiac arrhythmias using electrocardiographic data. A C5.0 is trained to recognize four classes using common features. The four classes are (i) atrial fibrillation and atrial flutter, (ii) tachycardias (iii), sinus bradycardia and (iv) sinus rhythm. Data from 10,646 subjects, 83% of whom have at least one arrhythmia and 17% of whom exhibit a normal sinus rhythm, are used. The C5.0 is trained using 10-fold cross-validation and is able to achieve a balanced accuracy of 95.35%. By using the white-box machine learning approach, a clear and comprehensible tree structure can be revealed, which has selected the 5 most important features from a total of 24 features. These 5 features are ventricular rate, RR-Interval variation, atrial rate, age and difference between longest and shortest RR-Interval. The combination of ventricular rate, RR-Interval variation and atrial rate is especially relevant to achieve classification accuracy, which can be disclosed through the tree. The tree assigns unique values to distinguish the classes. These findings could be applied in medicine in the future. It can be shown that a white-box machine learning approach can reveal granular structures, thus confirming known linear relationships and also revealing nonlinear relationships. To highlight the strength of the C5.0 with respect to this structural revelation, the results of further white-box machine learning and black-box machine learning algorithms are presented.	[Rieg, Thilo; Frick, Janek; Baumgartl, Hermann; Buettner, Ricardo] Aalen Univ, Machine Learning Res Grp, Aalen, Germany	Hochschule Aalen	Rieg, T (corresponding author), Aalen Univ, Machine Learning Res Grp, Aalen, Germany.	thilo.rieg@gmx.de		Rieg, Thilo/0000-0001-5295-7021; Baumgartl, Hermann/0000-0001-8918-3197	Carl Zeiss Foundation; German Federal Ministry of Education and Research [13FH4E05IA]	Carl Zeiss Foundation; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This research is funded by the Carl Zeiss Foundation and the German Federal Ministry of Education and Research (13FH4E05IA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afkhami RG, 2016, PATTERN RECOGN LETT, V70, P45, DOI 10.1016/j.patrec.2015.11.018; Alcaraz R, 2010, BIOMED SIGNAL PROCES, V5, P1, DOI 10.1016/j.bspc.2009.11.001; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; Banerjee S, 2012, MEASUREMENT, V45, P474, DOI 10.1016/j.measurement.2011.10.025; Barrett TW, 2012, AM J CARDIOL, V110, P1315, DOI 10.1016/j.amjcard.2012.06.037; Ben-Tal A, 2012, J PHYSIOL-LONDON, V590, P1989, DOI 10.1113/jphysiol.2011.222422; BOINEAU JP, 1989, J ELECTROCARDIOL, V22, P189; Castellanos A, 1998, AM J CARDIOL, V82, P531, DOI 10.1016/S0002-9149(98)00373-7; Celin S, 2018, J MED SYST, V42, DOI 10.1007/s10916-018-1083-6; Chen B, 2016, LECT NOTES COMPUT SC, V9728, P239, DOI 10.1007/978-3-319-41561-1_18; Chilamkurthy S, 2018, LANCET, V392, P2388, DOI 10.1016/S0140-6736(18)31645-3; Christov I, 2018, PHYSIOL MEAS, V39, DOI 10.1088/1361-6579/aad9f0; Denver JW, 2007, BIOL PSYCHOL, V74, P286, DOI 10.1016/j.biopsycho.2005.09.005; Elola A, 2019, MED BIOL ENG COMPUT, V57, P453, DOI 10.1007/s11517-018-1892-2; FRIEDMAN HS, 1974, CHEST, V66, P172, DOI 10.1378/chest.66.2.172; Goodacre S, 2002, BRIT MED J, V324, P594, DOI 10.1136/bmj.324.7337.594; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; Hannun AY, 2019, NAT MED, V25, P65, DOI 10.1038/s41591-018-0268-3; Haque A, 2020, NATURE, V585, P193, DOI 10.1038/s41586-020-2669-y; Hennig T, 2006, J BIOL PHYS, V32, P383, DOI 10.1007/s10867-006-9022-z; James AF, 2007, PROG BIOPHYS MOL BIO, V94, P265, DOI 10.1016/j.pbiomolbio.2005.05.010; January CT, 2014, J AM COLL CARDIOL, V64, P2246, DOI [10.1016/j.jacc.2014.03.022, 10.1016/j.jacc.2014.03.021, 10.1161/CIR.0000000000000041, 10.1161/CIR.0000000000000142]; Kerr AJ, 2001, AM J CARDIOL, V87, P1116, DOI 10.1016/S0002-9149(01)01475-8; Kirchhof P, 2016, EUROPACE, V18, DOI [10.1016/j.rec.2016.11.033, 10.1093/europace/euw295, 10.5603/KP.2016.0172]; Lee H, 2016, SCI REP-UK, V6, DOI 10.1038/srep25835; Loyola-Gonzalez O, 2019, IEEE ACCESS, V7, P154096, DOI 10.1109/ACCESS.2019.2949286; Luz EJD, 2013, EXPERT SYST APPL, V40, P3561, DOI 10.1016/j.eswa.2012.12.063; Lyon A, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2017.0821; Mangrum JM, 2000, NEW ENGL J MED, V342, P703, DOI 10.1056/NEJM200003093421006; McLachlan Craig S, 2010, Proc (Bayl Univ Med Cent), V23, P368; McManus DD, 2013, HEART RHYTHM, V10, P315, DOI 10.1016/j.hrthm.2012.12.001; MORILLO CA, 1994, CIRCULATION, V90, P873, DOI 10.1161/01.CIR.90.2.873; Murdoch WJ, 2019, P NATL ACAD SCI USA, V116, P22071, DOI 10.1073/pnas.1900654116; Nattel S, 2002, NATURE, V415, P219, DOI 10.1038/415219a; Olshansky B, 2013, J AM COLL CARDIOL, V61, P793, DOI 10.1016/j.jacc.2012.07.074; Page RL, 2016, CIRCULATION, V133, pE506, DOI 10.1161/CIR.0000000000000311; Pandya R., 2015, INT J COMPUT APPL, V117, P18, DOI DOI 10.5120/20639-3318; Parry RM, 2010, PHARMACOGENOMICS J, V10, P292, DOI 10.1038/tpj.2010.56; Podgorelec Vili, 2002, J Med Syst, V26, P445, DOI 10.1023/A:1016409317640; Popper K., 1959, LOGIC SCI DISCOVERY; Popper K. R., 1963, CONJECTURES REFUTAT; Price WN, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao5333; Rajesh KNVPS, 2017, COMPUT BIOL MED, V87, P271, DOI 10.1016/j.compbiomed.2017.06.006; Rudin C, 2019, NAT MACH INTELL, V1, P206, DOI 10.1038/s42256-019-0048-x; Salles GF, 2004, AM J CARDIOL, V93, P1136, DOI 10.1016/j.amjcard.2004.01.040; Schlapfer J, 2017, J AM COLL CARDIOL, V70, P1183, DOI 10.1016/j.jacc.2017.07.723; Shah AP, 2007, J ELECTROCARDIOL, V40, P385, DOI 10.1016/j.jelectrocard.2007.03.008; Shi HT, 2019, COMPUT METH PROG BIO, V171, P1, DOI 10.1016/j.cmpb.2019.02.005; Srinivasan NT, 2019, HEART RHYTHM, V16, P943, DOI 10.1016/j.hrthm.2018.12.006; Tateno K, 2001, MED BIOL ENG COMPUT, V39, P664, DOI 10.1007/BF02345439; Ting DSW, 2017, JAMA-J AM MED ASSOC, V318, P2211, DOI 10.1001/jama.2017.18152; Valdes G, 2016, SCI REP-UK, V6, DOI 10.1038/srep37854; vandenBerg MP, 1997, CIRCULATION, V96, P1209, DOI 10.1161/01.CIR.96.4.1209; Yan D, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000015536; Zhang J, 2007, J MANIP PHYSIOL THER, V30, P374, DOI 10.1016/j.jmpt.2007.04.001; Zheng JW, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-0386-x; Zimmer K, 2016, INT J CARDIOL, V212, P59, DOI 10.1016/j.ijcard.2016.03.031	57	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243615	10.1371/journal.pone.0243615	http://dx.doi.org/10.1371/journal.pone.0243615			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332440	gold, Green Published			2022-12-27	WOS:000601310900111
J	Thakwalakwa, C; Flax, VL; Phuka, JC; Garcia, H; Jaacks, LM				Thakwalakwa, Chrissie; Flax, Valerie L.; Phuka, John C.; Garcia, Harrison; Jaacks, Lindsay M.			Drivers of food consumption among overweight mother-child dyads in Malawi	PLOS ONE			English	Article							VEGETABLE CONSUMPTION; NUTRITION; OBESITY; WOMEN; HIV; PATTERNS; FRUIT; MALNUTRITION; PREFERENCES; PERCEPTIONS	To address the increase in overweight and obesity among mothers and children in sub-Saharan Africa, an understanding of the factors that drive their food consumption is needed. We hypothesized food consumption in Malawi is driven by a combination of factors, including season, food accessibility (area of residence, convenience of purchasing food, female autonomy), food affordability (household resources, food expenditures, household food insecurity), food desirability (taste preferences, body size preferences), demographics, and morbidity. Participants in Lilongwe and Kasungu Districts were enrolled across three types of mother-child dyads: either the mother (n = 120), child (n = 80), or both (n = 74) were overweight. Seven-day dietary intake was assessed using a quantitative food frequency questionnaire during the dry and rainy seasons. Drivers associated with intake of calories, macronutrients, and 11 food groups at p<0.1 in univariate models were entered into separate multivariate linear regression models for each dietary intake outcome. Mother-child dyads with an overweight child had a higher percent of calories from carbohydrates and lower percent of calories from fat compared to dyads with a normal weight child (both p<0.01). These mothers also had the highest intake of grains (p<0.01) and their children had the lowest intake of oil/fat (p = 0.01). Household food insecurity, maternal taste preferences, and maternal body size preferences were the most consistent predictors of food group consumption. Household food insecurity was associated with lower intake of grains, fruits, meat and eggs, oil/fat, and snacks. Maternal taste preferences predicted increased consumption of grains, legumes/nuts, vegetables, fish, and oil/fat. Maternal body size preferences for herself and her child were associated with consumption of grains, legumes/nuts, dairy, and sweets. Predictors of food consumption varied by season, across food groups, and for mothers and children. In conclusion, indicators of food affordability and desirability were the most common predictors of food consumption among overweight mother-child dyads in Malawi.	[Thakwalakwa, Chrissie] Univ Malawi, Chancellor Coll, Ctr Social Res, Zomba, Malawi; [Flax, Valerie L.] RTI Int, Res Triangle Pk, NC 27709 USA; [Phuka, John C.] Univ Malawi, Coll Med, Blantyre, Malawi; [Garcia, Harrison; Jaacks, Lindsay M.] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA	University of Malawi; Research Triangle Institute; University of Malawi; Harvard University; Harvard T.H. Chan School of Public Health	Flax, VL (corresponding author), RTI Int, Res Triangle Pk, NC 27709 USA.	vflax@rti.org		Phuka, John/0000-0003-4951-8145; Jaacks, Lindsay/0000-0002-7791-5167; Flax, Valerie/0000-0003-0200-3355	Drivers of Food Choice (DFC) Competitive Grants Programs; Bill & Melinda Gates Foundation; UK Government's Department for International Development	Drivers of Food Choice (DFC) Competitive Grants Programs; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); UK Government's Department for International Development	This research was funded by the Drivers of Food Choice (DFC) Competitive Grants Programs, which is funded by the UK Government's Department for International Development and the Bill & Melinda Gates Foundation, and managed by the University of South Carolina, Arnold School of Public Health, USA; however, the views expressed do not necessarily reflect the UK Government's official policies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala R, 2006, SOC FORCES, V84, P2077, DOI 10.1353/sof.2006.0079; Amo-Adjei J, 2015, J BIOSOC SCI, V47, P613, DOI 10.1017/S002193201400025X; Angeles G, 2015, BASELINE REPORT IMPA; [Anonymous], 2019, TR2195 3GPP; [Anonymous], 2019, INTEL 64 IA 32 ARCHI, V3; [Anonymous], 2017, LANCET HIV, V2, pe115; [Anonymous], 2007, EUR J NUCL MED MOL I; [Anonymous], 2017, CANC DISCOVERY, V7, pOF12; Azupogo F, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5845-3; Bentley ME, 2005, J NUTR, V135, P945; BOWKER AH, 1948, J AM STAT ASSOC, V43, P572, DOI 10.2307/2280710; Brown C, 2015, APPETITE, V95, P29, DOI 10.1016/j.appet.2015.06.018; Chakona G, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112668; Croffut SE, 2018, MATERN CHILD NUTR, V14, DOI 10.1111/mcn.12446; Drewnowski A, 2000, J AM DIET ASSOC, V100, P1325, DOI 10.1016/S0002-8223(00)00375-8; Farris AR, 2019, J HUNGER ENV NUTR, P1, DOI DOI 10.1080/19320248.2019; FERGUSON EL, 1995, EUR J CLIN NUTR, V49, P565; FERGUSON EL, 1993, ECOL FOOD NUTR, V29, P219, DOI 10.1080/03670244.1993.9991307; Flax V, 2020, MATERNAL CHILD NUTR; Flax VL, 2015, MATERN CHILD NUTR, V11, P104, DOI 10.1111/mcn.12073; Gissing SC, 2017, PUBLIC HEALTH NUTR, V20, P2104, DOI 10.1017/S1368980017000970; Hager ER, 2010, OBESITY, V18, P397, DOI 10.1038/oby.2009.293; Heim A, 2020, APPETITE, V151, DOI 10.1016/j.appet.2020.104709; Heim A, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4408-8; Hemsworth J, 2016, J NUTR, V146, P326, DOI 10.3945/jn.115.215327; Hotz C, 2001, EUR J CLIN NUTR, V55, P841, DOI 10.1038/sj.ejcn.1601239; Hunter-Adams J, 2019, APPETITE, V137, P244, DOI 10.1016/j.appet.2019.03.012; Independent Expert Group of the Global Nutrition Report, 2020, GLOB NUTR REP ACT EQ; Kearney J, 2010, PHILOS T R SOC B, V365, P2793, DOI 10.1098/rstb.2010.0149; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Kodish SR, 2016, MATERN CHI NUTR 0119; Lukmanji Z., 2008, TANZANIA FOOD COMPOS; Maleta K, 2003, ACTA PAEDIATR, V92, P491, DOI 10.1111/j.1651-2227.2003.tb00584.x; Maleta T, 2004, J PEDIATR GASTR NUTR, V38, P152; Miller V, 2016, LANCET GLOB HEALTH, V4, pE695, DOI 10.1016/S2214-109X(16)30186-3; Mndala L, 2019, EPIDEMIOL HEALTH, V41, DOI 10.4178/epih.e2019039; Msambichaka B, 2018, NUTRIENTS, V10, DOI 10.3390/nu10020222; Nago ES, 2012, J NUTR EDUC BEHAV, V44, P548, DOI 10.1016/j.jneb.2011.06.006; National Statistical Office (NSO) [Malawi] and ICF, 2017, MALAWI DEMOGRAPHIC H; Office MNS Demographic MIIfRD Surveys H, 2010, DEM MIIFRD SURV H; Okop KJ, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7254-7; Okoro CS, 2017, AM J MENS HEALTH, V11, P1713, DOI 10.1177/1557988315625775; Peltzer K, 2015, INT J PUBLIC HEALTH, V60, P79, DOI 10.1007/s00038-014-0631-1; Peltzer K, 2012, GLOBAL HEALTH ACTION, V5, DOI [10.3402/gha.v5i0.18545, 10.3402/gha.v5i0.18668]; PERYAM DR, 1957, FOOD TECHNOL-CHICAGO, V11, P32; Pisa PT, 2017, EUR J PUBLIC HEALTH, V27, P404, DOI 10.1093/eurpub/ckw119; Pisa PT, 2015, NUTRIENTS, V7, P3464, DOI 10.3390/nu7053464; Popkin BM, 2020, LANCET, V395, P65, DOI 10.1016/S0140-6736(19)32497-3; Prynn JE, 2018, AM J CLIN NUTR, V108, P587, DOI 10.1093/ajcn/nqy125; Ramlal RT, 2015, NUTRIENTS, V7, P584, DOI 10.3390/nu7010584; Rodas-Moya S, 2016, PUBLIC HEALTH NUTR, V19, P693, DOI 10.1017/S1368980015001822; Ruel M.T., 2005, PATTERNS DETERMINANT; Steyn N.P., 2005, GUIDE USE DIETARY AS; Steyn NP, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-104; Thakwalakwa CM, 2015, MATERN CHI NUTR, V11, P326; Turner C, 2018, GLOB FOOD SECUR-AGR, V18, P93, DOI 10.1016/j.gfs.2018.08.003; Voorend CGN, 2013, PUBLIC HEALTH NUTR, V16, P559, DOI 10.1017/S1368980012003254; Wojcicki JM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1124; Wrottesley SV, 2014, PUBLIC HEALTH NUTR, V17, P1603, DOI 10.1017/S1368980013001808; Zingoni C, 2009, ECOL FOOD NUTR, V48, P178, DOI 10.1080/03670240902794713; 2018, INT J COMMUN SYST, V31	61	4	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243721	10.1371/journal.pone.0243721	http://dx.doi.org/10.1371/journal.pone.0243721			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332387	gold, Green Published			2022-12-27	WOS:000601310900089
J	Torti, M; Fossati, C; Casali, M; De Pandis, MF; Grassini, P; Radicati, FG; Stirpe, P; Vacca, L; Iavicoli, I; Leso, V; Ceppi, M; Bruzzone, M; Bonassi, S; Stocchi, F				Torti, Margherita; Fossati, Chiara; Casali, Miriam; De Pandis, Maria Francesca; Grassini, Paola; Radicati, Fabiana Giada; Stirpe, Paola; Vacca, Laura; Iavicoli, Ivo; Leso, Veruscka; Ceppi, Marcello; Bruzzone, Marco; Bonassi, Stefano; Stocchi, Fabrizio			Effect of family history, occupation and diet on the risk of Parkinson disease: A case-control study	PLOS ONE			English	Article							PESTICIDE EXPOSURE; INFLAMMATION; METAANALYSIS; SOLVENTS; METALS; COPPER; IRON	Background The aetiology of Parkinson's disease (PD) is still very controversial, with a peculiar lack of established risk factors or protective behavior. Methods We carried out a case-control study of 634 idiopathic PD patients admitted from 2011 to 2015 to two hospitals located in central Italy and 532 controls matched by hospital, gender and age (+/- 5 years). The study questionnaire included questions on host factors, family history, residence, occupation and lifestyle. Odds ratios (ORs) for PD and 95% confidence intervals (CIs) were estimated with logistic regression, adjusting for actual and potential confounders. Results A lower OR was observed in females (0.74; 95%CI:0.58-0.96), while older age classes showed a constantly increased risk for PD (p<0.005) starting from the class 65-69 years. Subjects who reported a first degree relative affected by PD showed a borderline increase which was more evident in those enrolled in the urban center of Rome (OR = 1.65; 95%CI: 1.09-2.50). Significant reduction of the risk was associated to current smoking (OR = 0.48; 95%CI: 0.24-0.54), and to vegetables consumption (p<0.03), while borderline increases were associated to meat and cold cut consumption. Occupational activities classified according to ISCO-08 categories did not show increased risk, while higher ORs' were found for pilots and physicians. Conclusions The results from this study confirmed the higher risk of PD in males and in elderly, and the inverse association with smoking habit. The possible etiological role of familial clustering, dietary habit, and some job tasks is suggested.	[Torti, Margherita; Casali, Miriam; Grassini, Paola; Radicati, Fabiana Giada; Stirpe, Paola; Vacca, Laura; Stocchi, Fabrizio] San Raffaele Pisana Inst Res & Med Care, Clin Trial Ctr, Rome, Italy; [Fossati, Chiara] Univ Rome Foro Italico, Dept Movement Human & Hlth Sci, Rome, Italy; [De Pandis, Maria Francesca] San Raffaele Cassino, Cassino, Italy; [Iavicoli, Ivo; Leso, Veruscka] Univ Naples Federico II, Dept Publ Hlth, Naples, Italy; [Ceppi, Marcello; Bruzzone, Marco] Osped Policlin San Martino, Clin Epidemiol Unit, Genoa, Italy; [Bonassi, Stefano] San Raffaele Pisana, Inst Res & Med Care, Unit Clin & Mol Epidemiol, Rome, Italy; [Bonassi, Stefano; Stocchi, Fabrizio] San Raffaele Univ, Dept Human Sci & Qual Life Promot, Rome, Italy	Foro Italico University of Rome; University of Naples Federico II; IRCCS San Raffaele Pisana; Vita-Salute San Raffaele University	Torti, M (corresponding author), San Raffaele Pisana Inst Res & Med Care, Clin Trial Ctr, Rome, Italy.	margherita.torti@sanraffaele.it	De Pandis, Maria Francesca/GPC-8167-2022; Iavicoli, Ivo/K-9062-2016; stocchi, fabrizio/K-5089-2016; Casali, Massimiliano/AAK-3309-2021	Iavicoli, Ivo/0000-0003-0444-3792; stocchi, fabrizio/0000-0002-5763-0033; Casali, Massimiliano/0000-0003-3832-8696; bonassi, stefano/0000-0003-3833-6717; Vacca, Laura/0000-0002-6634-4119; Bruzzone, Marco/0000-0002-8821-4542; Radicati, Fabiana Giada/0000-0001-9930-6656	INAIL (Istituto Nazionale Assicurazione Infortuni sul Lavoro)	INAIL (Istituto Nazionale Assicurazione Infortuni sul Lavoro)	Funding: The study has been supported with grants funded by INAIL (Istituto Nazionale Assicurazione Infortuni sul Lavoro).	[Anonymous], 2017, NAT REV NEUROL, V13, P707, DOI 10.1038/nrneurol.2017.155; [Anonymous], 2012, ISCO08, V1; Ascherio A, 2006, ANN NEUROL, V60, P197, DOI 10.1002/ana.20904; Beard JD, 2017, MMWR-MORBID MORTAL W, V66, P718, DOI 10.15585/mmwr.mm6627a2; Breckenridge CB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151841; Brouwer M, 2017, ENVIRON INT, V107, P100, DOI 10.1016/j.envint.2017.07.001; Caudle WM, 2012, NEUROTOXICOLOGY, V33, P585, DOI 10.1016/j.neuro.2012.04.011; Caudle WM, 2012, NEUROTOXICOLOGY, V33, P178, DOI 10.1016/j.neuro.2012.01.010; Cote ML, 2012, EUR J CANCER, V48, P1957, DOI 10.1016/j.ejca.2012.01.038; Erro R, 2018, J NEUROL, V265, P12, DOI 10.1007/s00415-017-8639-0; Fenech M, 2005, CARCINOGENESIS, V26, P991, DOI 10.1093/carcin/bgi042; Firestone JA, 2010, AM J IND MED, V53, P217, DOI 10.1002/ajim.20788; Frigerio R, 2006, MOVEMENT DISORD, V21, P1688, DOI 10.1002/mds.21009; Gorell JM, 1999, NEUROTOXICOLOGY, V20, P239; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; JL Fleiss B, 2003, PAIK STAT METHODS RA; Kamel F, 2007, AM J EPIDEMIOL, V165, P364, DOI 10.1093/aje/kwk024; Lai BCL, 2002, PARKINSONISM RELAT D, V8, P297, DOI 10.1016/S1353-8020(01)00054-2; Lan AP, 2016, BIOMETALS, V29, P665, DOI 10.1007/s10534-016-9942-4; Lesage S, 2009, HUM MOL GENET, V18, pR48, DOI 10.1093/hmg/ddp012; McDonnell L, 2003, NEUROLOGY, V61, P716, DOI 10.1212/WNL.61.5.716; McGeer PL, 2004, PARKINSONISM RELAT D, V10, pS3, DOI 10.1016/j.parkreldis.2004.01.005; Moisan F, 2015, ENVIRON HEALTH PERSP, V123, P1123, DOI 10.1289/ehp.1307970; Nandipati S, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13090881; Nielsen LA, 2015, OBESITY FACTS, V8, P319, DOI 10.1159/000441375; Park J, 2005, NEUROTOXICOLOGY, V26, P99, DOI 10.1016/j.neuro.2004.07.001; Pringsheim T, 2014, MOVEMENT DISORD, V29, P1583, DOI 10.1002/mds.25945; Priyadarshi A, 2000, NEUROTOXICOLOGY, V21, P435; Qi H, 2014, GERIATR GERONTOL INT, V14, P430, DOI 10.1111/ggi.12123; Santangelo G, 2017, J NEUROL SCI, V374, P17, DOI 10.1016/j.jns.2017.01.013; StataCorp, 2015, STAT STAT SOFTW REL; Thacker EL, 2008, MOVEMENT DISORD, V23, P1174, DOI 10.1002/mds.22067; Tsui JKC, 1999, CAN J PUBLIC HEALTH, V90, P334, DOI 10.1007/BF03404523; Valdes EG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106676; van der Mark M, 2015, PARKINSONISM RELAT D, V21, P635, DOI 10.1016/j.parkreldis.2015.03.025; van der Mark M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095297; Weisskopf MG, 2010, NEUROLOGY, V74, P1055, DOI 10.1212/WNL.0b013e3181d76a93; Whitton PS, 2007, BRIT J PHARMACOL, V150, P963, DOI 10.1038/sj.bjp.0707167; Zhang DF, 2014, MOVEMENT DISORD, V29, P819, DOI 10.1002/mds.25863	39	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243612	10.1371/journal.pone.0243612	http://dx.doi.org/10.1371/journal.pone.0243612			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332388	Green Published, gold			2022-12-27	WOS:000601310900110
J	Bell, NAW; Molloy, JE				Bell, Nicholas A. W.; Molloy, Justin E.			Microfluidic flow-cell with passive flow control for microscopy applications	PLOS ONE			English	Article							SINGLE-MOLECULE	We present a fast, inexpensive and robust technique for constructing thin, optically transparent flow-cells with pump-free flow control. Using layers of glass, patterned adhesive tape and polydimethylsiloxane (PDMS) connections, we demonstrate the fabrication of planar devices with chamber height as low as 25 mu m and with millimetre-scale (x,y) dimensions for wide-field microscope observation. The method relies on simple benchtop equipment and does not require microfabrication facilities, glass drilling or other workshop infrastructure. We also describe a gravity perfusion system that exploits the strong capillary action in the flow chamber as a passive limit-valve. Our approach allows simple sequential sample exchange with controlled flow rates, sub-5 mu L sample chamber size and zero dead volume. We demonstrate the system in a single-molecule force spectroscopy experiment using magnetic tweezers.	[Bell, Nicholas A. W.; Molloy, Justin E.] Francis Crick Inst, London, England	Francis Crick Institute	Bell, NAW (corresponding author), Francis Crick Inst, London, England.	nicholas.bell@crick.ac.uk		Molloy, Justin/0000-0002-8307-2450	AstraZeneca-Crick collaborative grant [FC001632]; Francis Crick Institute from CRUK [FC001119]; MRC [FC001119]; Wellcome Trust [FC001119]; AstraZeneca	AstraZeneca-Crick collaborative grant; Francis Crick Institute from CRUK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); AstraZeneca(AstraZeneca)	NAWB was supported by an AstraZeneca-Crick collaborative grant (FC001632) and also by the Francis Crick Institute, which receives core funding from CRUK (FC001119), MRC (FC001119) and the Wellcome Trust (FC001119). The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. AstraZeneca provided support in the form of funding for the research and salary for an author [NAWB]. AstraZeneca reviewed the final draft of the paper and approved its submission without amendments. The specific roles of NAWB are articulated in the `author contributions' section.	Ahmadi A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53151-z; [Anonymous], 2015, NUCLEIC ACIDS RES, V43, pD204; Beebe DJ, 2002, ANNU REV BIOMED ENG, V4, P261, DOI 10.1146/annurev.bioeng.4.112601.125916; Bewersdorf J, 2006, J MICROSC-OXFORD, V222, P105, DOI 10.1111/j.1365-2818.2006.01578.x; Brewer LR, 2008, NAT METHODS, V5, P517, DOI 10.1038/nmeth.1217; Charmet J, 2018, J MOL BIOL, V430, P565, DOI 10.1016/j.jmb.2017.12.015; Courson DS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006479; Forget AL, 2013, NAT PROTOC, V8, P525, DOI 10.1038/nprot.2013.016; Forget AL, 2012, NATURE, V482, P423, DOI 10.1038/nature10782; Gale B., 2018, INVENTIONS, V3, P1; Gravesen P., 1993, Journal of Micromechanics and Microengineering, V3, P168, DOI 10.1088/0960-1317/3/4/002; Lionnet Timothee, 2012, Cold Spring Harb Protoc, V2012, P133, DOI 10.1101/pdb.prot067496; Lipfert J, 2009, BIOPHYS J, V96, P5040, DOI 10.1016/j.bpj.2009.03.055; Miller H, 2018, REP PROG PHYS, V81, DOI 10.1088/1361-6633/aa8a02; Neuman KC, 2008, NAT METHODS, V5, P491, DOI 10.1038/NMETH.1218; Pereiro I, 2019, LAB CHIP, V19, P2296, DOI 10.1039/c9lc00211a; Schrader M, 1997, OPT LETT, V22, P436, DOI 10.1364/OL.22.000436; Toleikis A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18817-6; Xiong K, 2017, JOVE-J VIS EXP, DOI 10.3791/55923; Yardimci H, 2012, METHODS, V57, P179, DOI 10.1016/j.ymeth.2012.03.033; Zamora V., 2017, PROCEEDINGS, V1, P606, DOI DOI 10.3390/proceedings1040606	21	2	2	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0244103	10.1371/journal.pone.0244103	http://dx.doi.org/10.1371/journal.pone.0244103			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320916	Green Published, gold			2022-12-27	WOS:000600339800032
J	Burleigh, MC; Sculthorpe, N; Henriquez, FL; Easton, C				Burleigh, Mia C.; Sculthorpe, Nicholas; Henriquez, Fiona L.; Easton, Chris			Nitrate-rich beetroot juice offsets salivary acidity following carbohydrate ingestion before and after endurance exercise in healthy male runners	PLOS ONE			English	Article							DIETARY NITRATE; INORGANIC NITRATE; PLASMA NITRITE; ORAL-HEALTH; BLOOD-PRESSURE; DENTAL PLAQUE; DOUBLE-BLIND; SUPPLEMENTATION; PERFORMANCE; FLOW	There have been recent calls for strategies to improve oral health in athletes. High carbohydrate diets, exercise induced dehydration and transient perturbations to immune function combine to increase oral disease risk in this group. We tested whether a single dose of nitrate (NO3-) would offset the reduction in salivary pH following carbohydrate ingestion before and after an exercise bout designed to cause mild dehydration. Eleven trained male runners ((V)over dotO(2max) 53 +/- 9 ml.kg(-1).min(-1), age 30 +/- 7 years) completed a randomised placebo-controlled study comprising four experimental trials. Participants ingested the following fluids one hour before each trial: (a) 140 ml of water (negative-control), (b) 140 ml of water (positive-control), (c) 140 ml of NO3- rich beetroot juice (similar to 12.4 mmol NO3-) (NO3- trial) or (d) 140 ml NO3- depleted beetroot juice (placebo-trial). During the negative-control trial, participants ingested 795 ml of water in three equal aliquots: before, during, and after 90 min of submaximal running. In the other trials they received 795 ml of carbohydrate supplements in the same fashion. Venous blood was collected before and after the exercise bout and saliva was sampled before and repeatedly over the 20 min following carbohydrate or water ingestion. As expected, nitrite (NO2-) and NO3- were higher in plasma and saliva during the NO3- trial than all other trials (all P<0.001). Compared to the negative-control, salivary-pH was significantly reduced following the ingestion of carbohydrate in the positive-control and placebo trials (both P < 0.05). Salivary-pH was similar between the negative-control and NO3- trials before and after exercise despite ingestion of carbohydrate in the NO3- trial (both P >= 0.221). Ingesting NO3- attenuates the expected reduction in salivary-pH following carbohydrate supplements and exercise-induced dehydration. NO3- should be considered by athletes as a novel nutritional strategy to reduce the risk of developing acidity related oral health conditions.	[Burleigh, Mia C.; Sculthorpe, Nicholas; Easton, Chris] Univ West Scotland, Inst Clin Hlth & Exercise Sci, Blantyre, Scotland; [Henriquez, Fiona L.] Univ West Scotland, Inst Biomed & Environm Hlth Res, Blantyre, Scotland		Easton, C (corresponding author), Univ West Scotland, Inst Clin Hlth & Exercise Sci, Blantyre, Scotland.	chris.easton@uws.ac.uk		Sculthorpe, Nicholas/0000-0001-8235-8580; Henriquez, Fiona/0000-0002-5534-1019; Burleigh, Mia Cousins/0000-0002-0569-4895; Easton, Chris/0000-0003-4808-1287	Hannah Dairy Research Foundation	Hannah Dairy Research Foundation	This project was funded by a grant from the Hannah Dairy Research Foundation (https://www.hannahdairyresearch.org.uk/) awarded to CE, MB, NS, FH. The funder had no involvement in study design, data collection, or the writing of this report.	Abbate G M, 2014, J Clin Dent, V25, P71; [Anonymous], 2009, J ATHL TRAINING, V44, P538; Ashley P, 2015, BRIT J SPORT MED, V49, P14, DOI 10.1136/bjsports-2014-093617; Bahadoran Z, 2015, NUTR METAB, V12, DOI 10.1186/s12986-015-0013-6; Bailey SJ, 2010, J APPL PHYSIOL, V109, P135, DOI 10.1152/japplphysiol.00046.2010; Bailey SJ, 2009, J APPL PHYSIOL, V107, P1144, DOI 10.1152/japplphysiol.00722.2009; Bayindir YZ, 2005, CARIES RES, V39, P130, DOI 10.1159/000083158; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020, DOI 10.1152/jappl.1986.60.6.2020; BERGSTROM J, 1967, SCAND J CLIN LAB INV, V19, P218, DOI 10.3109/00365516709090629; Berry MJ, 2015, NITRIC OXIDE-BIOL CH, V48, P22, DOI 10.1016/j.niox.2014.10.007; Bowen WH, 2013, ODONTOLOGY, V101, P2, DOI 10.1007/s10266-012-0092-z; Bryant S, 2011, INT J SPORTS MED, V32, P720, DOI 10.1055/s-0031-1277192; Burleigh M, 2019, NITRIC OXIDE-BIOL CH, V89, P54, DOI 10.1016/j.niox.2019.04.010; Burleigh MC, 2018, FREE RADICAL BIO MED, V120, P80, DOI 10.1016/j.freeradbiomed.2018.03.023; Cochrane NJ, 2012, AUST DENT J, V57, P359, DOI 10.1111/j.1834-7819.2012.01708.x; COYLE EF, 1984, SPORTS MED, V1, P446, DOI 10.2165/00007256-198401060-00004; de Melo Mary Anne Sampaio, 2016, Restor Dent Endod, V41, P246; Doel JJ, 2004, EUR J ORAL SCI, V112, P424, DOI 10.1111/j.1600-0722.2004.00153.x; Ehlen LA, 2008, NUTR RES, V28, P299, DOI 10.1016/j.nutres.2008.03.001; Erdemir U, 2016, WORLD J STOMATOL, V5, P1, DOI DOI 10.5321/WJS.V5.I1.1; Ferguson SK, 2013, J PHYSIOL-LONDON, V591, P547, DOI 10.1113/jphysiol.2012.243121; Gallagher J, 2017, BRIT J SPORT MED, V51, P3203, DOI [10.1136/bjsports-2016-097372.94, DOI 10.1136/BJSP0RTS-2016-097372.94]; Gallagher J, 2018, COMMUNITY DENT ORAL, V46, P563, DOI 10.1111/cdoe.12392; Gilchrist M, 2011, CARDIOVASC RES, V89, P492, DOI 10.1093/cvr/cvq309; Hans R, 2016, SCIENTIFICA, V2016, DOI 10.1155/2016/5027283; HASE JC, 1988, ARCH ORAL BIOL, V33, P875, DOI 10.1016/0003-9969(88)90016-7; Hernandez A, 2012, J PHYSIOL-LONDON, V590, P3575, DOI 10.1113/jphysiol.2012.232777; Hohensinn B, 2016, NITRIC OXIDE-BIOL CH, V60, P10, DOI 10.1016/j.niox.2016.08.006; Jarvinen VK, 2016, RISK FACTORS DENT ER, DOI [10.1177/00220345910700060601, DOI 10.1177/00220345910700060601]; Jeukendrup AE, 2004, NUTRITION, V20, P669, DOI 10.1016/j.nut.2004.04.017; Jeukendrup AE, 2008, EUR J SPORT SCI, V8, P77, DOI 10.1080/17461390801918971; Kapil V, 2014, NITRIC OXIDE-BIOL CH, V38, P45, DOI 10.1016/j.niox.2014.03.162; Kelly J, 2014, AM J PHYSIOL-REG I, V307, pR920, DOI 10.1152/ajpregu.00068.2014; Kleinbongard P, 2006, FREE RADICAL BIO MED, V40, P295, DOI 10.1016/j.freeradbiomed.2005.08.025; Koch CD, 2017, FREE RADICAL BIO MED, V105, P48, DOI 10.1016/j.freeradbiomed.2016.12.015; Koopman JE, 2016, MICROB ECOL, V72, P479, DOI 10.1007/s00248-016-0775-z; Kragt L, 2019, PHYSICIAN SPORTSMED, V47, P182, DOI 10.1080/00913847.2018.1546105; Larsen FJ, 2007, ACTA PHYSIOL, V191, P59, DOI 10.1111/j.1748-1716.2007.01713.x; Larsen FJ, 2011, CELL METAB, V13, P149, DOI 10.1016/j.cmet.2011.01.004; Li H, 2007, ORAL MICROBIOL IMMUN, V22, P67, DOI 10.1111/j.1399-302X.2007.00313.x; Liddle L, 2018, NITRIC OXIDE-BIOL CH, V72, P59, DOI 10.1016/j.niox.2017.11.008; Lukacs JR, 2006, AM J HUM BIOL, V18, P540, DOI 10.1002/ajhb.20530; Lussi A, 2008, CLIN ORAL INVEST, V12, pS5, DOI 10.1007/s00784-007-0179-z; Lutovac Mitar, 2017, Open Access Maced J Med Sci, V5, P987, DOI 10.3889/oamjms.2017.180; Mcllvenna LC, 2017, NITRIC OXIDE-BIOL CH, V64, P61, DOI 10.1016/j.niox.2016.12.006; McMahon NF, 2017, SPORTS MED, V47, P735, DOI 10.1007/s40279-016-0617-7; Milosevic A, 1997, BRIT J SPORT MED, V31, P28, DOI 10.1136/bjsm.31.1.28; Muggeridge DJ, 2017, J SCI MED SPORT, V20, P92, DOI 10.1016/j.jsams.2016.04.014; Mulic A, 2012, BMC ORAL HEALTH, V12, DOI 10.1186/1472-6831-12-8; Murtaza N, 2019, NUTRIENTS, V11, DOI 10.3390/nu11030614; Navazesh M, 2008, J AM DENT ASSOC, V139, p35S, DOI 10.14219/jada.archive.2008.0353; NAVIA JM, 1994, AM J CLIN NUTR, V59, p719S, DOI 10.1093/ajcn/59.3.719S; Needleman I, 2014, BRIT DENT J, V217, DOI 10.1038/sj.bdj.2014.1000; Needleman I, 2013, BRIT J SPORT MED, V47, P1054, DOI 10.1136/bjsports-2013-092891; Petersson J, 2007, AM J PHYSIOL-GASTR L, V292, pG718, DOI 10.1152/ajpgi.00435.2006; Rees Jeremy, 2005, Eur J Prosthodont Restor Dent, V13, P186; Rosier BT, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-69931-x; Rosier BT, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.555465; Saluja Pulin, 2014, J Clin Diagn Res, V8, pZC81, DOI 10.7860/JCDR/2014/9935.5071; Scardina GA, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/720692; Senthil Eagappan A R, 2016, Dent Res J (Isfahan), V13, P338; Staff report, 2007, MODERN POWER SYSTEMS, V27, P33; Tanabe M, 2013, J INT SOC SPORT NUTR, V10, DOI 10.1186/1550-2783-10-49; Tiso M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119712; Touger-Decker R, 2003, AM J CLIN NUTR, V78, p881S, DOI 10.1093/ajcn/78.4.881S; Touger-Decker R, 2003, J AM DIET ASSOC, V103, P615, DOI 10.1053/jada.2003.50130; Tungare S, 2019, DIET NUTR PREVENT DE, DOI [10.1177/2380084419892550, DOI 10.1177/2380084419892550]; URBANIAK GC, 2013, RES RANDOMIZER; Vanhatalo A, 2018, FREE RADICAL BIO MED, V124, P21, DOI 10.1016/j.freeradbiomed.2018.05.078; Velmurugan S, 2016, AM J CLIN NUTR, V103, P25, DOI 10.3945/ajcn.115.116244; Wadhwani S, 2015, MENSTRUAL CYCLE RELA; Wang YL, 2014, J FORMOS MED ASSOC, V113, P850, DOI 10.1016/j.jfma.2014.06.002; Webb AJ, 2008, HYPERTENSION, V51, P784, DOI 10.1161/HYPERTENSIONAHA.107.103523; Wightman EL, 2015, PHYSIOL BEHAV, V149, P149, DOI 10.1016/j.physbeh.2015.05.035; Williamson S, 2012, NURS RES PRACT, V2012, DOI 10.1155/2012/246178; Wylie LJ, 2013, J APPL PHYSIOL, V115, P325, DOI 10.1152/japplphysiol.00372.2013	76	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243755	10.1371/journal.pone.0243755	http://dx.doi.org/10.1371/journal.pone.0243755			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320868	gold, Green Published			2022-12-27	WOS:000600339800045
J	Toparslan, E; Karabag, K; Bilge, U				Toparslan, Emine; Karabag, Kemal; Bilge, Ugur			A workflow with R: Phylogenetic analyses and visualizations using mitochondrial cytochrome b gene sequences	PLOS ONE			English	Article							POPULATION-GENETICS; PACKAGE	Phylogenetic analyses can provide a wealth of information about the past demography of a population and the level of genetic diversity within and between species. By using special computer programs developed in recent years, large amounts of data have been produced in the molecular genetics area. To analyze these data, powerful new methods based on large computations have been applied in various software packages and programs. But these programs have their own specific input and output formats, and users need to create different input formats for almost every program. R is an open source software environment, and it supports open contribution and modification to its libraries. Furthermore, it is also possible to perform several analyses using a single input file format. In this article, by using the multiple sequences FASTA format file (.fas extension) we demonstrate and share a workflow of how to extract haplotypes and perform phylogenetic analyses and visualizations in R. As an example dataset, we used 120 Bombus terrestris dalmatinus mitochondrial cytochrome b gene (cyt b) sequences (373 bp) collected from eight different beehives in Antalya. This article presents a short guide on how to perform phylogenetic analyses using R and RStudio.	[Toparslan, Emine; Bilge, Ugur] Akdeniz Univ, Inst Nat & Appl Sci, Antalya, Turkey; [Toparslan, Emine; Karabag, Kemal] Akdeniz Univ, Dept Agr Biotechnol, Fac Agr, Antalya, Turkey; [Bilge, Ugur] Akdeniz Univ, Dept Biostat & Med Informat, Fac Med, Antalya, Turkey	Akdeniz University; Akdeniz University; Akdeniz University	Bilge, U (corresponding author), Akdeniz Univ, Dept Biostat & Med Informat, Fac Med, Antalya, Turkey.	ubilge@akdeniz.edu.tr	Bilge, Ugur/C-1044-2016	Bilge, Ugur/0000-0002-5186-1092; TOPARSLAN, Emine/0000-0001-8194-7842	Scientific Research Projects Coordination Unit of Akdeniz University [FYL-2016-1502]	Scientific Research Projects Coordination Unit of Akdeniz University(Akdeniz University)	The data used in this project were provided by the project numbered FYL-2016-1502, supported by the Scientific Research Projects Coordination Unit of Akdeniz University. We would like to thank Philippa Price for proofreading this article.	Aktas C., 2020, HAPLOTYPES MANIPULAT; Bodenhofer U, 2015, BIOINFORMATICS, V31, P3997, DOI 10.1093/bioinformatics/btv494; Excoffier L, 2006, NAT REV GENET, V7, P745, DOI 10.1038/nrg1904; Gentleman R., 2020, BIOSTRINGS STRING OB; Gupta A, 2015, J BIODIVERS ENDANGER, VS1, P6; Heibl C, 2019, PACKAGEIPSVERSION 0; Jombart T, 2020, ADEGENET EXPLORATORY; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; KIMURA M, 1981, P NATL ACAD SCI-BIOL, V78, P454, DOI 10.1073/pnas.78.1.454; Kress WJ, 2002, AM J BOT, V89, P1682, DOI 10.3732/ajb.89.10.1682; Morandat F, 2012, LECT NOTES COMPUT SC, V7313, P104, DOI 10.1007/978-3-642-31057-7_6; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; Pele J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-133; Pinheiro HP, 2005, J STAT PLAN INFER, V130, P325, DOI 10.1016/j.jspi.2003.03.002; Popescu AA, 2012, BIOINFORMATICS, V28, P1536, DOI 10.1093/bioinformatics/bts184; R Development Core Team, 2009, R LANG ENV STAT COMP; Racine JS, 2012, J APPL ECONOMET, V27, P167, DOI 10.1002/jae.1278; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Wang LG, 2020, MOL BIOL EVOL, V37, P599, DOI 10.1093/molbev/msz240; Wickham H, 2011, WIRES COMPUT STAT, V3, P180, DOI 10.1002/wics.147; Xie Y, 2020, KNITR GEN PURPOSE PA; Xie Y., 2018, R MARKDOWN DEFINITIV, DOI [10.1201/9781138359444, DOI 10.1201/9781138359444]; Yu Guangchuang, 2020, Curr Protoc Bioinformatics, V69, pe96, DOI 10.1002/cpbi.96; Yu GC, 2017, METHODS ECOL EVOL, V8, P28, DOI 10.1111/2041-210X.12628	25	6	6	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243927	10.1371/journal.pone.0243927	http://dx.doi.org/10.1371/journal.pone.0243927			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320915	Green Published, gold			2022-12-27	WOS:000600339800037
J	Gao, JW; Yang, L; Zhao, JH; Wang, L; Zou, J; Wang, CX; Fan, XT				Gao, Junwei; Yang, Ling; Zhao, Jinghui; Wang, Lian; Zou, Jiao; Wang, Chunxiang; Fan, Xiaotang			Comparison of problem-based learning and traditional teaching methods in medical psychology education in China: A systematic review and meta-analysis	PLOS ONE			English	Review								Background PBL approach has been widely used in many Chinese universities over the past decade. However, the effects of PBL approach on medical psychology education in China are inconsistent. The purpose of this study was to ascertain whether the PBL approach was superior to the lecture-based teaching method in the context of the medical psychology curriculum in China. Methods A systematic review and meta-analysis was performed to confirm the effectiveness of PBL in Chinese medical psychology. Corresponding databases were searched for available studies, where data were extracted to calculated Hedges' g and its 95% confidence interval in total and subgroup analyses. Subgroup analyses were also carried out. Results Nine studies with 551 cases and 496 controls were identified. The total examination scores of students in the PBL approach group were significantly higher compared with students in the traditional lecture-based teaching group under the random effect model (Hedges' g = 1.510, 95%CI 0.792-2.227, p<0.001). Subgroup analyses based on major and school system exhibited similar results. Conclusions Our study supported the notion that the PBL approach may be applicable to Chinese medical psychology education.	[Gao, Junwei; Yang, Ling; Zhao, Jinghui; Wang, Lian; Zou, Jiao; Wang, Chunxiang; Fan, Xiaotang] Army Med Univ, Third Mil Med Univ, Sch Psychol, Dept Dev Neuropsychol, Chongqing, Peoples R China	Army Medical University	Fan, XT (corresponding author), Army Med Univ, Third Mil Med Univ, Sch Psychol, Dept Dev Neuropsychol, Chongqing, Peoples R China.	fanxiaotang2005@163.com	Gao, Junwei/GXF-2694-2022		Teaching Foundation of School of Psychology, Army Medical University, China [XJ2017206]	Teaching Foundation of School of Psychology, Army Medical University, China	Our study was supported by the Teaching Foundation of School of Psychology, Army Medical University, China under Grant (XJ2017206).	Alrahlah A, 2016, SAUDI DENT J, V28, P155, DOI 10.1016/j.sdentj.2016.08.003; Bodagh N, 2017, BRIT J HOSP MED, V78, pC167, DOI 10.12968/hmed.2017.78.11.C167; Dang H, 2014, J XINJIANG MED U, V37, P1096; Dring JC, 2019, ANN MED SURG, V47, P27, DOI 10.1016/j.amsu.2019.09.004; Duvivier RJ, 2014, MED EDUC, V48, P860, DOI 10.1111/medu.12499; Gao Xiaolin, 2016, J Evid Based Med, V9, P136, DOI 10.1111/jebm.12190; Holen A, 2015, INT J MED EDUC, V6, P84, DOI 10.5116/ijme.558e.6451; Huang L, 2014, MED INFORM, V27, P14, DOI [10.3969/j.issn.1006-1959.2014.21.015, DOI 10.3969/J.ISSN.1006-1959.2014.21.015]; Jones RW, 2006, ANAESTH INTENS CARE, V34, P485, DOI 10.1177/0310057X0603400417; Kwan CY, 2019, ADV HEALTH SCI EDUC, V24, P893, DOI 10.1007/s10459-019-09920-6; Lim WK, 2012, BMC MED EDUC, V12, DOI 10.1186/1472-6920-12-89; Long J, 2012, PROCEEDINGS OF INTERNATIONAL CONFERENCE ON COMPUTER VISION IN REMOTE SENSING, P132; Pan H, 2009, CHINA HIGHER MED ED; Qian Y, 2018, J INT MED RES, V46, P3507, DOI 10.1177/0300060518790415; ROSSMANITH S, 1990, PSYCHOTHER PSYCHOSOM, V53, P108, DOI 10.1159/000288350; Somporn P, 2018, MED EDUC, V52, P791, DOI 10.1111/medu.13580; Soons P, 2009, J CLIN PSYCHOL MED S, V16, P161, DOI 10.1007/s10880-009-9158-7; Tsai TI, 2018, J HEALTH COMMUN, V23, P340, DOI 10.1080/10810730.2018.1445798; WALTON HJ, 1989, MED EDUC, V23, P542, DOI 10.1111/j.1365-2923.1989.tb01581.x; Wang X, 2019, ED TEACHING FORUM, V52, P198; Wang Y, 2017, HLTH VOCATIONAL ED, V35; Yang M, 2019, BMC MED EDUC, V19, DOI 10.1186/s12909-018-1452-3; Yi G, 2007, ACTA ACAD MED QINGDA, V43, P80, DOI [10.3969/j.issn.1672-4488.2007.01.034, DOI 10.3969/J.ISSN.1672-4488.2007.01.034]; [张建松 Zhang Jiansong], 2011, [灾害学, Journal of Catastrophology], V26, P91; Zhou JY, 2016, BMC MED EDUC, V16, DOI 10.1186/s12909-016-0546-z	25	3	4	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243897	10.1371/journal.pone.0243897	http://dx.doi.org/10.1371/journal.pone.0243897			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH1MP	33315939	gold, Green Published			2022-12-27	WOS:000600186100022
J	Koponen, M; Marjamaa, A; Tuiskula, AM; Viitasalo, M; Nallinmaa-Luoto, T; Leinonen, JT; Widen, E; Toivonen, L; Kontula, K; Swan, H				Koponen, Mikael; Marjamaa, Annukka; Tuiskula, Annukka M.; Viitasalo, Matti; Nallinmaa-Luoto, Terhi; Leinonen, Jaakko T.; Widen, Elisabeth; Toivonen, Lauri; Kontula, Kimmo; Swan, Heikki			Genealogy and clinical course of catecholaminergic polymorphic ventricular tachycardia caused by the ryanodine receptor type 2 P2328S mutation	PLOS ONE			English	Article							SUDDEN CARDIAC DEATH; MOLECULAR CHARACTERIZATION; BETA-BLOCKERS; ARRHYTHMIAS; GENE; ASSOCIATION; FLECAINIDE; CHILDREN; THERAPY; EVENTS	Background Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a severe inherited arrhythmic disease associated with a risk of syncope and sudden cardiac death (SCD). Aims We aimed at identifying RYR2 P2328S founder mutation carriers and describing the clinical course associated with the mutation. Methods The study population was drawn from the Finnish Inherited Cardiac Disorder Research Registry, and from the present genealogical study. Kaplan-Meier graphs, log-rank test and Cox regression model were used to evaluate the clinical course. Results Genealogical study revealed a common ancestor couple living in the late 17(th) century. A total of 1837 living descendants were tested for RYR2 P2328S mutation unveiling 62 mutation carriers aged mean 3923 years old. No arrhythmic deaths were documented among genotyped subjects, but 11 SCDs were detected in non-genotyped family members since 1970. Three genotyped patients (5%) suffered an aborted cardiac arrest (ACA), and 15 (25%) had a syncope triggered by exercise or stress. Rate of cardiac events was higher among patients who in exercise stress test showed a maximum rate of premature ventricular contractions >30/min (68% vs 17%, p<0.01; hazard ratio = 7.1, p = 0.02), in comparison to patients without the respective finding. A cardioverter-defibrillator (ICD) was implanted to 13 (22%) patients, with an appropriate ICD shock in four (31%) subjects. All ICD shocks, one ACA, and one syncope occurred during <beta>-blocker medication. Conclusions Previously undiagnosed CPVT patients may be identified by well-conducted genealogical studies. The RYR2 P2328S mutation causes a potentially severe phenotype, but its expression is variable, thus calling for additional studies on modifying factors.	[Koponen, Mikael; Marjamaa, Annukka; Viitasalo, Matti; Toivonen, Lauri] Helsinki Univ Hosp, Heart & Lung Ctr, Helsinki, Finland; [Koponen, Mikael; Tuiskula, Annukka M.; Kontula, Kimmo; Swan, Heikki] Univ Helsinki, Helsinki, Finland; [Tuiskula, Annukka M.; Kontula, Kimmo] Helsinki Univ Hosp, Dept Med, Helsinki, Finland; [Tuiskula, Annukka M.] Helsinki Univ Hosp, Genet Lab, HUSLAB, Helsinki, Finland; [Nallinmaa-Luoto, Terhi] Univ Turku, Turku, Finland; [Leinonen, Jaakko T.; Widen, Elisabeth] Univ Helsinki, Inst Mol Med Finland, FIMM, Helsinki, Finland	University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Turku; University of Helsinki	Koponen, M (corresponding author), Helsinki Univ Hosp, Heart & Lung Ctr, Helsinki, Finland.; Koponen, M (corresponding author), Univ Helsinki, Helsinki, Finland.	mikael.koponen@helsinki.fi		Tuiskula, Annukka/0000-0002-6538-635X				Ackerman MJ, 2017, HEART RHYTHM, V14, pE41, DOI 10.1016/j.hrthm.2016.09.012; Coumel P., 1978, BRIT HEART J, V40, P28; Hayashi M, 2009, CIRCULATION, V119, P2426, DOI 10.1161/CIRCULATIONAHA.108.829267; Hayashi M, 2012, EUROPACE, V14, P1344, DOI 10.1093/europace/eus031; Kannankeril PJ, 2017, JAMA CARDIOL, V2, P759, DOI 10.1001/jamacardio.2017.1320; Kujala K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044660; Kuokkanen M, 2003, GUT, V52, P647, DOI 10.1136/gut.52.5.647; Laitinen PJ, 2001, CIRCULATION, V103, P485, DOI 10.1161/01.CIR.103.4.485; LEENHARDT A, 1995, CIRCULATION, V91, P1512, DOI 10.1161/01.CIR.91.5.1512; Lehnart SE, 2004, CIRCULATION, V109, P3208, DOI 10.1161/01.CIR.0000132472.98675.EC; Leren IS, 2016, HEART RHYTHM, V13, P433, DOI 10.1016/j.hrthm.2015.09.029; Lieve KV, 2016, CIRC J, V80, P1285, DOI 10.1253/circj.CJ-16-0326; Mohamed U, 2006, HEART RHYTHM, V3, P1486, DOI 10.1016/j.hrthm.2006.08.018; Paavola J, 2007, EUR HEART J, V28, P1135, DOI 10.1093/eurheartj/ehl543; Paavola J, 2016, EUROPACE, V18, P1599, DOI 10.1093/europace/euv380; Penttinen K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125366; Perez-Riera AR, 2018, ANN NONINVAS ELECTRO, V23, DOI 10.1111/anec.12512; Priori SG, 2002, CIRCULATION, V106, P69, DOI 10.1161/01.CIR.0000020013.73106.D8; Priori SG, 2001, CIRCULATION, V103, P196; Priori SG, 2015, EUR HEART J, V36, P2793, DOI 10.1093/eurheartj/ehv316; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; REID DS, 1975, BRIT HEART J, V37, P339; Roston TM, 2018, HEART RHYTHM, V15, P1791, DOI 10.1016/j.hrthm.2018.06.046; Roston TM, 2015, CIRC-ARRHYTHMIA ELEC, V8, P633, DOI 10.1161/CIRCEP.114.002217; Swan H, 1999, J AM COLL CARDIOL, V34, P2035, DOI 10.1016/S0735-1097(99)00461-1; van der Werf C, 2019, EUR HEART J, V40, P2953, DOI 10.1093/eurheartj/ehz309; van der Werf C, 2012, CIRC-ARRHYTHMIA ELEC, V5, P748, DOI 10.1161/CIRCEP.112.970517; van der Werf C, 2012, EUROPACE, V14, P175, DOI 10.1093/europace/eur277; van der Werf C, 2011, J AM COLL CARDIOL, V57, P2244, DOI 10.1016/j.jacc.2011.01.026; Venetucci L, 2012, NAT REV CARDIOL, V9, P561, DOI 10.1038/nrcardio.2012.93; Viitasalo M, 2008, HEART RHYTHM, V5, P1382, DOI 10.1016/j.hrthm.2008.06.011; Wanguemert F, 2015, HEART RHYTHM, V12, P1636, DOI 10.1016/j.hrthm.2015.03.033; Zhang YM, 2011, CARDIOVASC RES, V89, P794, DOI 10.1093/cvr/cvq229	33	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243649	10.1371/journal.pone.0243649	http://dx.doi.org/10.1371/journal.pone.0243649			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315912	gold, Green Published			2022-12-27	WOS:000600186100027
J	Stasila-Sieradzka, M; Chudzicka-Czupala, A; Znajmiecka-Sikora, M				Stasila-Sieradzka, Marta; Chudzicka-Czupala, Agata; Znajmiecka-Sikora, Marta			Work safety climate. Comparison of selected occupational groups	PLOS ONE			English	Article							CULTURE	Implementation of effective programs to improve occupational safety should be linked to an understanding of the specific nature of the given job. The aim of the research was to compare occupational groups with different job-related specificities: industrial production line workers, retail workers and mine rescuers, in terms of their assessment of the work safety climate. The survey covered 2,995 respondents with diversified demographic characteristics. The study used an abridged version of the Safety Climate Questionnaire by Znajmiecka-Sikora (2019) to assess 10 separate safety climate dimensions. The results of the MANOVA multivariate analysis, Wilks' multivariate F-tests and univariate F tests prove that there is a statistically significant difference between the respondents representing the three occupational groups collectively in terms of global assessment of all work safety climate dimensions, and also indicate significant differences between workers belonging to the three occupational groups in terms of their assessment of the individual dimensions of the work safety climate, except the organization's occupational health and safety management policy as well as technical facilities and ergonomics, which may be due to the universality of the requirements set for organizations with regard to these two aspects of safe behavior. The differences observed in the assessment of the remaining work safety climate dimensions induces one to promote more differentiated and individualized activities, taking into account the work specificity and the nature of the threats occurring in the respective working environment of the representatives of the different occupations. The difference in assessment of the work safety climate found in the research encourages one to create practical programs for safety, not only in the procedural and technical dimension, but also in the social and psychological one.	[Stasila-Sieradzka, Marta] Univ Silesia Katowice, Fac Social Sci, Inst Psychol, Katowice, Poland; [Chudzicka-Czupala, Agata] SWPS Univ Social Sci & Humanities, Katowice Fac Psychol, Dept Social & Org Behav Psychol, Katowice, Poland; [Znajmiecka-Sikora, Marta] Univ Lodz, Inst Psychol, Lodz, Poland	University of Silesia in Katowice; SWPS University of Social Sciences & Humanities; University of Lodz	Stasila-Sieradzka, M (corresponding author), Univ Silesia Katowice, Fac Social Sci, Inst Psychol, Katowice, Poland.	marta.stasila-sieradzka@us.edu.pl	Chudzicka-Czupała, Agata Ewa/ABG-4823-2021	Chudzicka-Czupała, Agata Ewa/0000-0002-6517-5018; Stasila-Sieradzka, Marta Aleksandra/0000-0003-2917-9617	Institute of Psychology, Faculty of Social Sciences, University of Silesia in Katowice, Katowice, Poland; Institute of Psychology, University of Lodz in Lodz, Poland; Ministry of Science and Higher Education in Poland under the 2019-2022 program "Regional Initiative of Excellence" [012/RID/2018/19]	Institute of Psychology, Faculty of Social Sciences, University of Silesia in Katowice, Katowice, Poland; Institute of Psychology, University of Lodz in Lodz, Poland; Ministry of Science and Higher Education in Poland under the 2019-2022 program "Regional Initiative of Excellence"	The following institutions provided funding for publication fees: Institute of Psychology, Faculty of Social Sciences, University of Silesia in Katowice, Katowice, Poland, awarded to MSS; and Institute of Psychology, University of Lodz in Lodz, Poland, awarded to MZS. The Ministry of Science and Higher Education in Poland provided support for this study to ACC, under the 2019-2022 program "Regional Initiative of Excellence", project number 012/RID/2018/19.	Aranowska E, 2010, PSYCHOL SPOLECZNA, V5, P117; Boczkowska K., 2014, NOWE SPOJRZENIE KULT, P9; Boczkowska K., 2019, PRZEGL D ORGAN, V7, P38, DOI [10.33141/po.2019.07.06, DOI 10.33141/PO.2019.07.06]; Casey T, 2017, J OCCUP HEALTH PSYCH, V22, P341, DOI 10.1037/ocp0000072; Chen YT, 2017, J SAFETY RES, V61, P167, DOI 10.1016/j.jsr.2017.02.014; Chudzicka-Czupala A, 2019, INT J OCCUP MED ENV, V32, P569, DOI [10.13075/ijomeh.1896.1406, 10.13075/ijomeh.1896.01406]; Cooper D., 1998, IMPROVING SAFETY CUL; Dobrowolska M, 2015, SWIATOWY DZIEN BEZPI, P15; Dobrowolska M., 2019, ZARZDZANIE ZASOBAMI, V3-4, P87; Dollard M.F., 2019, PSYCHOSOCIAL SAFETY, V1st ed., P3; Fedorczuk W., 2011, HYGEIA PUBLIC HLTH, V46, P437; Flin R, 2000, SAFETY SCI, V34, P177, DOI 10.1016/S0925-7535(00)00012-6; Geller ES., 2001, PSYCHOL SAFETY HDB; Geller ES, 1996, PSYCHOL SAFETY; Hofmann DA, 2017, J APPL PSYCHOL, V102, P375, DOI 10.1037/apl0000114; Kolodziej A., 2019, ZARZADZANIE ZASOBAMI, V3-4, P11; Lakomy K, 2016, ZESZYTY NAUKOWE MALO, V31, P131; Mamcarz P., 2016, PSYCHOL ZAGROZEN ZAW; Mearns K, 1998, WORK STRESS, V12, P238, DOI 10.1080/02678379808256864; Milczarek M., 2001, BEZPIECZE STWO PRACT, V5, P17; Milczarek M., 2000, BEZPIECZE STWO PRACT, V10, P17; Milczarek M., 2002, KULTURA BEZPIECZENST; Mocek P., 2019, ZARZADZANIE ZASOBAMI, V3-4, P43; Noort Mark C, 2016, J Occup Organ Psychol, V89, P515; Ocieczek W., 2016, ORGAN ZARZ DZANIE, V70, P165, DOI [10.21008/j.0239-9415.2016.070.12, DOI 10.21008/J.0239-9415.2016.070.12]; Oginska-Bulik N., 2009, STRES ZAWODOWY SLUZB; Oginska-Bulik N., 2015, DWA OBLICZA TRAUMY N; Petitta L, 2017, ACCIDENT ANAL PREV, V99, P77, DOI 10.1016/j.aap.2016.11.012; Rakowska A., 2013, KULTURA BEZPIECZENST, P47; Schwatka NV, 2016, ANN OCCUP HYG, V60, P537, DOI 10.1093/annhyg/mew020; Sikora MZ, 2016, OCCUPATIONAL SAFETY AND HYGIENE IV, P349; Skorupa A., 2019, ZARZADZANIE ZASOBAMI, V3-4, P29; Stasila-Sieradzka M., 2016, PRZEGL D G RNICZY, V12, P54; Stasila-Sieradzka M, 2015, SWIATOWY DZIEN BEZPI, P117; Stasila-Sieradzka M, 2016, SPOLECZENSTWO EDUKAC, V21, P471; Stasila-Sieradzka M, 2017, ZARZADZANIE ZASOBAMI, V5, P39; Stasila-Sieradzka M, 2017, ZARZADZANIE ZASOBAMI, V5, P169; Stasila-Sieradzka M, 2019, MED PR, V70, P295, DOI 10.13075/mp.5893.00779; Stasila-Sieradzka M, 2018, MED PR, V69, P45, DOI 10.13075/mp.5893.00640; Studenski R., 2000, BEZPIECZE STWO PRACT, V9, P1; Szlazak J., 2016, PSYCHOL ASPEKTY AKCJ; Vierendeels G, 2018, SAFETY SCI, V103, P323, DOI 10.1016/j.ssci.2017.12.021; Yari Saeed, 2019, Asian Pac J Cancer Prev, V20, P961; Znajmiecka-Sikora M., 2019, ORG ZARZADZANIE, V72, P73; Znajmiecka-Sikora M, 2010, ANALIZA OCENA STOPNI; Znajmiecka-Sikora M., 2014, NOWE SPOJRZENIE KULT, P53; Znajmiecka-Sikora M., 2017, ORG ZARZADZANIE, V69, P129; Znajmiecka-Sikora M, 2017, BEZPIECZENSTWO PRACY, V3, P10; Zohar D., 1980, SAFETY SCI, V34, P99	49	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243056	10.1371/journal.pone.0243056	http://dx.doi.org/10.1371/journal.pone.0243056			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH1MP	33315928	gold, Green Published			2022-12-27	WOS:000600186100083
J	Tucker, CJ; Melocik, KA; Anyamba, A; Linthicum, KJ; Fagbo, SF; Small, JL				Tucker, Compton J.; Melocik, Katherine A.; Anyamba, Assaf; Linthicum, Kenneth J.; Fagbo, Shamsudeen F.; Small, Jennifer L.			Reanalysis of the 2000 Rift Valley fever outbreak in Southwestern Arabia	PLOS ONE			English	Article							ECOLOGICAL CONDITIONS; VEGETATION INDEX; SAUDI-ARABIA; RAINFALL; DESERT; VIRUS; RISK; AFRICA; SYSTEM; DAMBO	The first documented Rift Valley hemorrhagic fever outbreak in the Arabian Peninsula occurred in northwestern Yemen and southwestern Saudi Arabia from August 2000 to September 2001. This Rift Valley fever outbreak is unique because the virus was introduced into Arabia during or after the 1997-1998 East African outbreak and before August 2000, either by wind-blown infected mosquitos or by infected animals, both from East Africa. A wet period from August 2000 into 2001 resulted in a large number of amplification vector mosquitoes, these mosquitos fed on infected animals, and the outbreak occurred. More than 1,500 people were diagnosed with the disease, at least 215 died, and widespread losses of domestic animals were reported. Using a combination of satellite data products, including 2 x 2 m digital elevation images derived from commercial satellite data, we show rainfall and potential areas of inundation or water impoundment were favorable for the 2000 outbreak. However, favorable conditions for subsequent outbreaks were present in 2007 and 2013, and very favorable conditions were also present in 2016-2018. The lack of subsequent Rift Valley fever outbreaks in this area suggests that Rift Valley fever has not been established in mosquito species in Southwest Arabia, or that strict animal import inspection and quarantine procedures, medical and veterinary surveillance, and mosquito control efforts put in place in Saudi Arabia following the 2000 outbreak have been successful. Any area with Rift Valley fever amplification vector mosquitos present is a potential outbreak area unless strict animal import inspection and quarantine proceedures are in place.	[Tucker, Compton J.; Melocik, Katherine A.; Anyamba, Assaf; Small, Jennifer L.] NASA, Earth Sci Div, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Linthicum, Kenneth J.] USDA, Ctr Med Agr & Vet Entomol, Gainesville, FL USA; [Fagbo, Shamsudeen F.] Natl Ctr Dis Prevent & Control, Execut Directorate Response & Surveillance, Hlth Unit, Riyadh, Saudi Arabia; [Fagbo, Shamsudeen F.] Nigerian Inst Med Res, Dept Publ Hlth, Lagos, Nigeria	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; United States Department of Agriculture (USDA)	Tucker, CJ (corresponding author), NASA, Earth Sci Div, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA.	compton.j.tucker@nasa.gov	Fagbo, Shamsudeen/GYE-1971-2022	Tucker, Compton/0000-0002-4366-112X; Anyamba, Assaf/0000-0003-0932-9585; Fagbo, Shamsudeen/0000-0003-3448-6136; Melocik, Katherine/0000-0002-6146-877X	U.S. Army Medical Command [DHA-2018-770]	U.S. Army Medical Command	AA: U.S. Army Medical Command contract DHA-2018-770 for Global Emerging Infectious Disease Surveillance.	Abdo-Salem S, 2011, VECTOR-BORNE ZOONOT, V11, P773, DOI 10.1089/vbz.2010.0084; Ageel ARM, 1997, ANN TROP MED PARASIT, V91, P907, DOI 10.1080/00034989760293; Al-Afaleq AI, 2012, TROP ANIM HEALTH PRO, V44, P1535, DOI 10.1007/s11250-012-0100-x; [Anonymous], 2000, REUTERS; [Anonymous], 2003, ARAB NEWS; [Anonymous], 2008, SAUDI GAZETTE; [Anonymous], 2009, MIDDLE E ONLINE; [Anonymous], 2004, SAUDI GAZETTE; Anyamba A, 2006, EMERG INFECT DIS, V12, P518, DOI 10.3201/eid1203.050973; Anyamba A, 2002, PHOTOGRAMM ENG REM S, V68, P137; Anyamba A, 2012, P IEEE, V100, P2824, DOI 10.1109/JPROC.2012.2194469; Balkhy HH, 2003, INT J ANTIMICROB AG, V21, P153, DOI 10.1016/S0924-8579(02)00295-9; Britch SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066626; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P905; Daubney R, 1931, J PATHOL BACTERIOL, V34, P545, DOI 10.1002/path.1700340418; Donlon C, 2012, REMOTE SENS ENVIRON, V120, P37, DOI 10.1016/j.rse.2011.07.024; Europa Press, 2000, EUROPA PRESS    0920; Fagbo S., 2000, ARAB NEWS; Fagbo S., 2010, E COMMUNICATION 0506; Goward SN, 2001, REMOTE SENS ENVIRON, V78, P2; Haddad O., 1990, ANN SAUDI MED, V15, P348; Herrmann SM, 2005, GLOBAL ENVIRON CHANG, V15, P394, DOI 10.1016/j.gloenvcha.2005.08.004; HIELKEMA JU, 1986, INT J REMOTE SENS, V7, P1609, DOI 10.1080/01431168608948956; Hou AY, 2014, B AM METEOROL SOC, V95, P701, DOI 10.1175/BAMS-D-13-00164.1; Jupp PG, 2002, MED VET ENTOMOL, V16, P245, DOI 10.1046/j.1365-2915.2002.00371.x; Justice CO, 1998, IEEE T GEOSCI REMOTE, V36, P1228, DOI 10.1109/36.701075; Li J, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9090902; Linthicum K.J., 1994, SISTEMA TERRA, V3, P44; Linthicum KJ, 2016, ANNU REV ENTOMOL, V61, P395, DOI 10.1146/annurev-ento-010715-023819; LINTHICUM KJ, 1985, J HYG-CAMBRIDGE, V95, P197, DOI 10.1017/S0022172400062434; LINTHICUM KJ, 1987, SCIENCE, V235, P1656, DOI 10.1126/science.3823909; LINTHICUM KJ, 1984, MOSQ NEWS, V44, P228; LINTHICUM KJ, 1983, MOSQ NEWS, V43, P464; Linthicum KJ, 1999, SCIENCE, V285, P397, DOI 10.1126/science.285.5426.397; Little PD, 2001, CROSS BORDER LIVESTO; Meegan J. M., 1989, The arboviruses: epidemiology and ecology. Volume IV., P51; MEEGAN JM, 1979, VET REC, V105, P124, DOI 10.1136/vr.105.6.124; Miller BR, 2002, EMERG INFECT DIS, V8, P1492, DOI 10.3201/eid0812.020194; NICHOLSON SE, 1990, CLIMATIC CHANGE, V17, P209, DOI 10.1007/BF00138369; Noh MJ, 2017, ISPRS J PHOTOGRAMM, V129, P55, DOI 10.1016/j.isprsjprs.2017.04.019; Peters C. J., 1994, HDB ZOONOSES B, P125; Pinzon JE, 2014, REMOTE SENSING, V2014, DOI [10.3390/rs50x000x, DOI 10.3390/RS50X000X]; SAINT G, 1995, ADV SPACE RES, V17, P107; Salem SA, 2011, TROPICAL ANIMAL HLTH, V42, P471; Samy AM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005226; Samy AM, 2014 AM SOC TROP MED; Shoemaker T, 2002, EMERG INFECT DIS, V8, P1415, DOI 10.3201/eid0812.020195; Simpson J, 1996, METEOROL ATMOS PHYS, V60, P19, DOI 10.1007/BF01029783; TUCKER CJ, 1985, INT J REMOTE SENS, V6, P127, DOI 10.1080/01431168508948429; TUCKER CJ, 1979, REMOTE SENS ENVIRON, V8, P127, DOI 10.1016/0034-4257(79)90013-0; Tucker CJ, 1999, AMBIO, V28, P587; Tucker MR, 2001, METEOROL APPL, V8, P107, DOI 10.1017/S1350482701001098; TURELL M, 1982, AM J EPIDEMIOL, V116, P556; WHO, RIFT VALL FEV FACT S; WILSON ML, 1994, AM J TROP MED HYG, V50, P663, DOI 10.4269/ajtmh.1994.50.663; Woods CW, 2002, EMERG INFECT DIS, V8, P138, DOI 10.3201/eid0802.010023	56	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0233279	10.1371/journal.pone.0233279	http://dx.doi.org/10.1371/journal.pone.0233279			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315866	gold, Green Published			2022-12-27	WOS:000600186100069
J	Dai, YN; Zhou, H; Zhang, QQ; Chu, ZD; de Koo, LCO; Chao, JR; Rezaei, KA; Saraf, SS; Wang, RKK				Dai, Yining; Zhou, Hao; Zhang, Qinqin; Chu, Zhongdi; de Koo, Lisa C. Olmos; Chao, Jennifer R.; Rezaei, Kasra A.; Saraf, Steven S.; Wang, Ruikang K.			Quantitative assessment of choriocapillaris flow deficits in diabetic retinopathy: A swept-source optical coherence tomography angiography study	PLOS ONE			English	Article							CAPILLARY NETWORKS; MACULAR EDEMA; VASCULATURE; MECHANISMS; RETINA	Purpose To quantitatively assess choriocapillaris (CC) flow deficits in eyes with diabetic retinopathy (DR) using swept-source optical coherence tomography angiography (SS-OCTA). Methods Diabetic subjects with different stages of DR and age-matched healthy subjects were recruited and imaged with SS-OCTA. The en face CC blood flow images were generated using previously published and validated algorithms. The percentage of CC flow deficits (FD%) and the mean CC flow deficit size were calculated in a 5-mm-diameter circle centered on the fovea from the 6x6-mm scans. Results Forty-five diabetic subjects and 27 control subjects were included in the study. The CC FD% in diabetic eyes was on average 1.4-fold greater than in control eyes (12.34 +/- 4.14% vs 8.82 +/- 2.61%, P < 0.001). The mean CC FD size in diabetic eyes was on average 1.4-fold larger than in control eyes (2151.3 +/- 650.8 mu m(2) vs 1574.4 +/- 255.0 mu m(2), P < 0.001). No significant difference in CC FD% or mean CC FD size was observed between eyes with nonproliferative DR and eyes with proliferative DR (P = 1.000 and P = 1.000, respectively). Conclusions CC perfusion in DR can be objectively and quantitatively assessed with FD% and FD size. In the macular region, both CC FD% and CC FD size are increased in eyes with DR. SS-OCTA provides new insights for the investigations of CC perfusion status in diabetes in vivo.	[Dai, Yining; Zhou, Hao; Zhang, Qinqin; Chu, Zhongdi; Wang, Ruikang K.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Dai, Yining; de Koo, Lisa C. Olmos; Chao, Jennifer R.; Rezaei, Kasra A.; Saraf, Steven S.; Wang, Ruikang K.] Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Wang, RKK (corresponding author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.; Wang, RKK (corresponding author), Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA.	wangrk@uw.edu	Wang, Ruikang/L-3889-2019	Wang, Ruikang/0000-0001-5169-8822; Chao, Jennifer/0000-0002-6859-5552; Olmos de Koo, Lisa/0000-0002-8146-4653	National Institutes of Health [NIH R01EY028753, R01AG060942]; Carl Zeiss Meditec; Research to Prevent Blindness	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carl Zeiss Meditec; Research to Prevent Blindness(Research to Prevent Blindness (RPB))	This work was supported by grants (RKW) from the National Institutes of Health (NIH R01EY028753, R01AG060942) (https://www.nidcr.nih.gov), Carl Zeiss Meditec (https://www.zeiss.com), and an unrestricted grant from the Research to Prevent Blindness (https://www.rpbusa.org/rpb/grants-and-research/grants).There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckman JA, 2016, CIRC RES, V118, P1771, DOI 10.1161/CIRCRESAHA.115.306884; Cao JT, 1998, ARCH OPHTHALMOL-CHIC, V116, P589, DOI 10.1001/archopht.116.5.589; Chan G, 2015, MICROVASC RES, V100, P32, DOI 10.1016/j.mvr.2015.04.006; Chen CL, 2017, BIOMED OPT EXPRESS, V8, P1056, DOI 10.1364/BOE.8.001056; Choi W, 2017, RETINA-J RET VIT DIS, V37, P11, DOI 10.1097/IAE.0000000000001250; Conti FF, 2019, BRIT J OPHTHALMOL, V103, P452, DOI 10.1136/bjophthalmol-2018-311903; Dai YN, 2020, INVEST OPHTH VIS SCI, V61, DOI 10.1167/iovs.61.3.50; Forte R, 2020, RETINA-J RET VIT DIS, V40, P333, DOI 10.1097/IAE.0000000000002376; FRYCZKOWSKI AW, 1989, INT OPHTHALMOL, V13, P269, DOI 10.1007/BF02280087; FRYCZKOWSKI AW, 1988, ANN OPHTHALMOL, V20, P299; Fukushima I, 1997, AM J OPHTHALMOL, V124, P473, DOI 10.1016/S0002-9394(14)70863-3; Gendelman I, 2020, INT J RETINA VITR, V6, DOI 10.1186/s40942-020-00209-0; Giovanni Staurenghi FB, 2018, RYANS RETINA, V6th, P46; Grant MB, 2018, RYANS RETINA, P488; HIDAYAT AA, 1985, OPHTHALMOLOGY, V92, P512; Hosseini H, 2010, RETINA-J RET VIT DIS, V30, P1084, DOI 10.1097/IAE.0b013e3181d8e7d1; Kur J, 2012, PROG RETIN EYE RES, V31, P377, DOI 10.1016/j.preteyeres.2012.04.004; MCLEOD DS, 1994, INVEST OPHTH VIS SCI, V35, P3799; Nassisi M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207638; Nesper PL, 2017, INVEST OPHTH VIS SCI, V58, P307, DOI 10.1167/iovs.17-21787; OLVER JM, 1990, EYE, V4, P262, DOI 10.1038/eye.1990.38; Reiner A, 2018, PROG RETIN EYE RES, V64, P96, DOI 10.1016/j.preteyeres.2017.12.001; Spaide RF, 2016, AM J OPHTHALMOL, V170, P58, DOI 10.1016/j.ajo.2016.07.023; Stitt AW, 2016, PROG RETIN EYE RES, V51, P156, DOI 10.1016/j.preteyeres.2015.08.001; THULLIEZ M, 2019, IMAGING OPHTHALMOL R, V3, P478, DOI DOI 10.1016/j.oret.2019.01.024; Wang RK, 2010, OPT LETT, V35, P1467, DOI 10.1364/OL.35.001467; Weinberger D, 1998, AM J OPHTHALMOL, V126, P238, DOI 10.1016/S0002-9394(98)00148-2; Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5; Yin X, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.8.086020; Zhang QQ, 2018, QUANT IMAG MED SURG, V8, P658, DOI 10.21037/qims.2018.08.10; Zhang QQ, 2018, INVEST OPHTH VIS SCI, V59, P203, DOI 10.1167/iovs.17-22953; Zheng F, 2019, AM J OPHTHALMOL, V200, P110, DOI 10.1016/j.ajo.2018.12.025	32	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243830	10.1371/journal.pone.0243830	http://dx.doi.org/10.1371/journal.pone.0243830			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306736	Green Published, gold			2022-12-27	WOS:000600144200020
J	Montoya-Williams, D; Passarella, M; Lorch, SA				Montoya-Williams, Diana; Passarella, Molly; Lorch, Scott A.			Retrospective development of a novel resilience indicator using existing cohort data: The adolescent to adult health resilience instrument	PLOS ONE			English	Article							CONNOR-DAVIDSON RESILIENCE; SCALE CD-RISC; YOUNG ADULTHOOD; DEPRESSION; COMMUNITY; SYMPTOMS; LATINO	Background Cohort studies represent rich sources of data that can be used to link components of resilience to a variety of health-related outcomes. The Adolescent to Adult Health (Add Health) cohort study represents one of the largest data sets of the health and social context of adolescents transitioning into adulthood. It did not however use validated resilience scales in its data collection process. This study aimed to retrospectively create and validate a resilience indicator using existing data from the cohort to better understand the resilience of its participants. Methods Questions asked of participants during one Add Health data collection time period (N = 15,701) were matched to items on a well-known and widely validated resilience scale called the Connor Davidson Resilience Scale. Factor analysis and psychometric analyses were used to refine and validate this novel Adolescent to Adult Health Resilience Instrument. Construct validity utilized participants' answers to the 10 item Center for Epidemiologic Studies Depression Scale, which has been used to validate other resilience scales. Results Factor analysis yielded an instrument with 13 items that showed appropriate internal consistency statistics. Resilience scores in our study were normally distributed with no ceiling or floor effects. Our instrument had appropriate construct validity, negatively correlating to answers on the depression scale (r = -0.64, p<0.001). We also found demographic differences in mean resilience scores: lower resilience scores were seen among women and those who reported lower levels of education and household income. Conclusions It is possible to retrospectively construct a resilience indicator from existing cohort data and achieve good psychometric properties. The Adolescent to Adult Health Resilience Instrument can be used to better understand the relationship between resilience, social determinants of health and health outcomes among young adults using existing data, much of which is publicly available.	[Montoya-Williams, Diana; Passarella, Molly; Lorch, Scott A.] Childrens Hosp Philadelphia, Div Neonatol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Montoya-Williams, D (corresponding author), Childrens Hosp Philadelphia, Div Neonatol, Philadelphia, PA 19104 USA.	montoyawid@email.chop.edu			Eunice Kennedy Shriver National Institute of Child Health and Human Development [P01-HD31921]	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research uses data from Add Health, a program project directed by Kathleen Mullan Harris and designed by J. Richard Udry, Peter S. Bearman, and Kathleen Mullan Harris at the University of North Carolina at Chapel Hill, and funded by grant P01-HD31921 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, with cooperative funding from 23 other federal agencies and foundations. Special acknowledgment is due Ronald R. Rindfuss and Barbara Entwisle for assistance in the original design. Information on how to obtain the Add Health data files is available on the Add Health website (http://www.cpc.unc.edu/addhealth).No direct support was received from grant P01-HD31921 for this analysis.	ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; [Anonymous], 2008, COMP 2008 AM COMM SU; [Anonymous], 2010, NMOC OPERATIONS B, V83, P1; Barnert ES, 2019, ACAD PEDIATR, V19, P342, DOI 10.1016/j.acap.2018.06.005; Blanco V., 2017, AGING MENT HEALTH, V8, P1; BRIGGS SR, 1986, J PERS, V54, P106, DOI 10.1111/j.1467-6494.1986.tb00391.x; Brody GH, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-1042; Campbell-Sills L, 2007, J TRAUMA STRESS, V20, P1019, DOI 10.1002/jts.20271; Cardoso JB, 2010, FAM SOC, V91, P257, DOI 10.1606/1044-3894.4003; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Solano JPC, 2016, SAO PAULO MED J, V134, P400, DOI 10.1590/1516-3180.2015.02290512; Crockett LJ, 2005, J CONSULT CLIN PSYCH, V73, P47, DOI 10.1037/0022-006X.73.1.47; Eaton WW, 2004, USE PSYCHOL TESTING, V3, P363; Frankenberg E, 2013, ECOL SOC, V18, DOI 10.5751/ES-05377-180216; Fu C, 2014, J AFFECT DISORDERS, V155, P149, DOI 10.1016/j.jad.2013.10.041; Green KT, 2014, ASSESSMENT, V21, P443, DOI 10.1177/1073191114524014; Harris KM., 2013, ADD HLTH STUDY DESIG, P1, DOI [10.17615/C6TW87, DOI 10.17615/C6TW87]; Harris KM, 2009, NATL LONGITUDINAL ST; Hitlin S., 2006, ADV LIFE COURSE RES, V11, P33, DOI [10.1016/S1040-2608(06)11002-3, DOI 10.1016/S1040-2608(06)11002-3]; Hu TQ, 2015, PERS INDIV DIFFER, V76, P18, DOI 10.1016/j.paid.2014.11.039; Kane R, 1997, OUTCOME MEASURES; Kishore MT, 2018, INT J SOC PSYCHIATR, V64, P570, DOI 10.1177/0020764018789193; Kurtz SP, 2019, J SUBST ABUSE TREAT, V101, P18, DOI 10.1016/j.jsat.2019.03.009; Lee J, 2018, DISASTER MED PUBLIC, V12, P241, DOI 10.1017/dmp.2017.61; MacLeod S, 2016, GERIATR NURS, V37, P266, DOI 10.1016/j.gerinurse.2016.02.014; Mc Gee SL, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00378; Min JA, 2015, COMPR PSYCHIAT, V56, P103, DOI 10.1016/j.comppsych.2014.07.022; Mittelmark MB, 2013, GLOB HEALTH PROMOT, V20, P30, DOI 10.1177/1757975913486684; Newsome J, 2014, J YOUTH ADOLESCENCE, V43, P1080, DOI 10.1007/s10964-014-0108-9; Notario-Pacheco B, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-63; Primack BA, 2009, ARCH GEN PSYCHIAT, V66, P181, DOI 10.1001/archgenpsychiatry.2008.532; Reyes MF, 2020, J APPL GERONTOL, V39, P269, DOI 10.1177/0733464819867554; ROBERTS RE, 1991, J AM ACAD CHILD PSY, V30, P58, DOI 10.1097/00004583-199101000-00009; Rodriguez-Rey R, 2016, PSYCHOL ASSESSMENT, V28, pE101, DOI 10.1037/pas0000191; Rosenberg AR, 2018, CANCER-AM CANCER SOC, V124, P3909, DOI 10.1002/cncr.31666; Schwartz CE, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-025602; Smith BW, 2008, INT J BEHAV MED, V15, P194, DOI 10.1080/10705500802222972; Solivan AE, 2015, FAM SYST HEALTH, V33, P349, DOI 10.1037/fsh0000141; Stainton A, 2019, EARLY INTERV PSYCHIA, V13, P725, DOI 10.1111/eip.12726; Streiner D. L., 2015, HLTH MEASUREMENT SCA, V5<feminine, DOI [10.1093/med/9780199685219.001.0001, DOI 10.1093/MED/9780199685219.001.0001, 10.1093/MED/9780199685219.001.0001]; Suglia SF, 2016, AM J EPIDEMIOL, V183, P269, DOI 10.1093/aje/kwv149; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Thompson NJ, 2018, J AFFECT DISORDERS, V225, P153, DOI 10.1016/j.jad.2017.08.049; Topel ML, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.011633; Wickrama KAS, 2003, J MARRIAGE FAM, V65, P850, DOI 10.1111/j.1741-3737.2003.00850.x; Williams AL, 2014, J YOUTH ADOLESCENCE, V43, P1563, DOI 10.1007/s10964-014-0141-8; Windle G, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-8	47	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243564	10.1371/journal.pone.0243564	http://dx.doi.org/10.1371/journal.pone.0243564			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH0WB	33301500	gold, Green Published			2022-12-27	WOS:000600143100050
J	Szymanska, KJ; Goker, M; Bol, M; Van Dorpe, J; Weyers, S; Leybaert, L				Szymanska, Katarzyna J.; Goker, Menekse; Bol, Melissa; Van Dorpe, Jo; Weyers, Steven; Leybaert, Luc			Targeting connexins with Gap27 during cold storage of the human donor uterus protects against cell death	PLOS ONE			English	Article							REPERFUSION INJURY; DNA-DAMAGE; TRANSPLANTATION; ISCHEMIA; HEMICHANNELS; TRANSIENT; CHANNELS; TIME; RETRIEVAL; OCCLUSION	Uterus transplantation is an experimental infertility treatment for women with uterine factor infertility. During donor uterus retrieval and subsequent storage, ischemia and other stressors are likely to occur, resulting in the delayed restoration of organ function and increased graft rejection. The uterus expresses connexin-based hemichannels, the opening of which can promote ischemic cell death, as well as gap junctions that may expand cell death by bystander signaling. We investigated if connexin channel inhibition with connexin channel inhibitor Gap27 could protect the uterus against cell death during the storage period. The study involved 9 female patients undergoing gender-change surgery. Before uterus removal, it was exposed to in situ warm ischemia with or without reperfusion. Uterus biopsies were taken before, during, and after ischemia, with or without reperfusion, and were subsequently stored under cold (4C) or warm (37C) conditions. TUNEL cell death assay was done at various time points along the combined in vivo/ex vivo experimental timeline. We found that Gap27 protected against storage-related cell death under cold but not warm conditions when the uterus had experienced in situ ischemia/reperfusion. For in situ brief ischemia without reperfusion, Gap27 reduction of cell death was delayed and significantly less, suggesting that protection critically depends on processes initiated when the organ was still in the donor. Thus, the inclusion of the connexin channel inhibitor Gap27 during cold storage protects the uterus against cell death, and the degree of protection depends on the history of exposure to warm ischemia. Gap27 protection may be indicated for uteri from deceased donors, in which ischemia is likely because life-saving organs have retrieval priority.	[Szymanska, Katarzyna J.; Bol, Melissa; Leybaert, Luc] Univ Ghent, Dept Basic & Appl Med Sci, Ghent, Belgium; [Goker, Menekse; Weyers, Steven] Univ Ghent, Dept Obstet & Gynecol, Ghent, Belgium; [Van Dorpe, Jo] Univ Ghent, Dept Pathol, Ghent, Belgium; [Szymanska, Katarzyna J.] Yale Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06510 USA	Ghent University; Ghent University; Ghent University; Yale University	Szymanska, KJ; Leybaert, L (corresponding author), Univ Ghent, Dept Basic & Appl Med Sci, Ghent, Belgium.; Szymanska, KJ (corresponding author), Yale Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06510 USA.	katarzyna.s-v@yale.edu; luc.leybaert@ugent.be		Szymanska, Katarzyna/0000-0002-5932-8030				Adachi M, 2016, ACTA OBSTET GYN SCAN, V95, P991, DOI 10.1111/aogs.12943; Alexander DB, 2003, CURR MED CHEM, V10, P2045, DOI 10.2174/0929867033456927; [Anonymous], 2016, IEEE T MED IMAGING, V35, pn2; Bol M, 2013, EUR J VASC ENDOVASC, V45, P382, DOI 10.1016/j.ejvs.2012.12.012; Brannstrom M, 2020, J CLIN MED, V9, DOI 10.3390/jcm9082338; Brannstrom M, 2017, J MATER SCI-MATER M, V28, DOI 10.1007/s10856-017-5872-0; Brannstrom M, 2015, LANCET, V385, P607, DOI 10.1016/S0140-6736(14)61728-1; Brannstrom M, 2014, FERTIL STERIL, V101, P1228, DOI 10.1016/j.fertnstert.2014.02.024; Brannstrom M, 2012, FERTIL STERIL, V97, P1269, DOI 10.1016/j.fertnstert.2012.04.001; Cea LA, 2016, CELL MOL LIFE SCI, V73, P2583, DOI 10.1007/s00018-016-2132-2; Chaytor AT, 1997, J PHYSIOL-LONDON, V503, P99, DOI 10.1111/j.1469-7793.1997.099bi.x; Contreras JE, 2004, BRAIN RES REV, V47, P290, DOI 10.1016/j.brainresrev.2004.08.002; de Groot H, 2007, TRANSPL P, V39, P481, DOI 10.1016/j.transproceed.2006.12.012; Decrock E, 2009, CELL DEATH DIFFER, V16, P524, DOI 10.1038/cdd.2008.196; Del Priore G, 2007, OBSTET GYNECOL, V109, P101, DOI 10.1097/01.AOG.0000248535.58004.2f; Diaz-Garcia C, 2012, MOL HUM REPROD, V18, P68, DOI 10.1093/molehr/gar055; Ejzenberg D, 2018, LANCET; Feine I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041633; Flyckt R, 2020, AM J OBSTET GYNECOL, V223, P143, DOI 10.1016/j.ajog.2020.03.001; Gadicherla AK, 2017, BASIC RES CARDIOL, V112, DOI 10.1007/s00395-017-0618-1; Garcia-Dorado D, 2004, CARDIOVASC RES, V61, P386, DOI 10.1016/j.cardiores.2003.11.039; Goncharenko K, 2014, J NEUROPHYSIOL, V112, P2067, DOI 10.1152/jn.00037.2013; Hauet T, 2001, NEPHROL DIAL TRANSPL, V16, P1982, DOI 10.1093/ndt/16.10.1982; Hawat G, 2012, J MOL CELL CARDIOL, V53, P559, DOI 10.1016/j.yjmcc.2012.07.008; Hawat G, 2010, PFLUG ARCH EUR J PHY, V460, P583, DOI 10.1007/s00424-010-0849-6; Ichim G, 2015, MOL CELL, V57, P860, DOI 10.1016/j.molcel.2015.01.018; Kisu I, 2017, HUM REPROD, V32, P2026, DOI 10.1093/humrep/dex250; Kwon YS, 2013, J LAPAROENDOSC ADV S, V23, P679, DOI 10.1089/lap.2012.0540; Laskowski I, 2000, Ann Transplant, V5, P29; Li XJ, 2015, GLIA, V63, P1553, DOI 10.1002/glia.22826; Liu LB, 2011, FERTIL STERIL, V95, P254, DOI 10.1016/j.fertnstert.2010.05.006; Ozkan O, 2013, FERTIL STERIL, V99, P470, DOI 10.1016/j.fertnstert.2012.09.035; Puntambekar S, 2018, J MINIM INVAS GYN, V25, P571, DOI 10.1016/j.jmig.2017.11.001; Retamal MA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00411; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; Sieunarine K, 2008, INT SURG, V93, P366; Tang HL, 2012, MOL BIOL CELL, V23, P2240, DOI 10.1091/mbc.E11-11-0926; Tang HM, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.180442; Testa G, 2018, AM J TRANSPLANT, V18, P1270, DOI 10.1111/ajt.14737; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Wang Chin-Jung, 2008, Chang Gung Med J, V31, P463; Wang N, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-012-0309-x; Wang N, 2013, BBA-BIOMEMBRANES, V1828, P35, DOI 10.1016/j.bbamem.2012.07.002; Winterhager E, 2015, HUM REPROD UPDATE, V21, P340, DOI 10.1093/humupd/dmv007; Wranning CA, 2005, HUM REPROD, V20, P2736, DOI 10.1093/humrep/dei125; Wranning CA, 2008, FERTIL STERIL, V90, P817, DOI 10.1016/j.fertnstert.2007.07.1340; Zitkute V, 2020, TRANSPLANT REV-ORLAN, V34, DOI 10.1016/j.trre.2020.100550	47	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243663	10.1371/journal.pone.0243663	http://dx.doi.org/10.1371/journal.pone.0243663			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301511	gold, Green Published			2022-12-27	WOS:000600143100002
J	Barberi, T; Cui, C; Friedman, AD				Barberi, Theresa; Cui, Cheng; Friedman, Alan D.			C/EBP alpha induces Ebf1 gene expression in common lymphoid progenitors	PLOS ONE			English	Article							BINDING PROTEIN-ALPHA; B-CELL FACTOR; REGULATORY NETWORK; DISTAL ENHANCER; TRANSCRIPTION; SPECIFICATION; INTERLEUKIN-7; COMMITMENT; ABSENCE; DIFFERENTIATION	C/EBP alpha is required for formation of granulocyte-monocyte progenitors (GMP) and also participates in B lymphopoiesis. The common lymphoid progenitor (CLP) and preproB populations but not proB cells express Cebpa, and pan-hematopoietic deletion of the +37 kb Cebpa enhancer using Mx1-Cre leads not only to reduced GMP but also to 2-fold reduced marrow preproB and >15-fold reduced proB and preB cells. We now show that IL7R alpha-Cre-mediated deletion of the +37 kb Cebpa enhancer, which occurs in 89% of Ly6D(+) and 65% of upstream Ly6D(-) CLP, leads to a 2-fold reduction of both preproB and proB cells, and a 3-fold reduction in preB cells, with no impact on GMP numbers. These data support a direct role for C/EBP alpha during B lineage development, with reduced enhancer deletion in Ly6D(-) CLP mediated by IL7R alpha-Cre diminishing the effect on B lymphopoiesis compared to that seen with Mx1-Cre. Amongst mRNAs encoding key transcriptional regulators that initiate B lymphoid specification (PU.1, E2A, IKAROS, EBF1, FOXO1, and BACH2), only Ebf1 levels are altered in CLP upon Mx1-Cre-mediated Cebpa enhancer deletion, with Ebf1 reduced similar to 40-fold in Flt3(+)Sca-1(int)c-kit(int)IL7R alpha(+) CLP. In addition, Cebpa and Ebf1 RNAs were 4- and 14-fold higher in hCD4(+) versus hCD4(-) CLP from Cebpa-hCD4 transgenic mice. Histone modification ChIP-Seq data for CLP indicate the presence of active, intronic Ebf1 enhancers located 270 and 280 kb upstream of the transcription start sites. We identified a cis element in this region that strongly binds C/EBP alpha using the electrophoretic mobility shift assay. Mutation of this C/EBP alpha-binding site in an Ebf1 enhancer-TK-luciferase reporter leads to a 4-fold reduction in C/EBP alpha-mediated trans-activation. These findings support a model of B lymphopoiesis in which induction of Ebf1 by C/EBP alpha in a subset of CLP contributes to initiation of B lymphopoiesis.	[Barberi, Theresa; Cui, Cheng; Friedman, Alan D.] Johns Hopkins Univ, Sch Med, Div Pediat Oncol, Baltimore, MD 21218 USA; [Cui, Cheng] China Med Univ, Dept Physiol, Shenyang, Peoples R China	Johns Hopkins University; China Medical University	Friedman, AD (corresponding author), Johns Hopkins Univ, Sch Med, Div Pediat Oncol, Baltimore, MD 21218 USA.	afriedm2@jhmi.edu			National Institutes of Health [R01 HL130034, P30 CA006973]; Giant Food Children's Cancer Research Fund	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Giant Food Children's Cancer Research Fund	This work was support by National Institutes of Health grants R01 HL130034 to ADF and P30 CA006973 (www.nih.gov) and the Giant Food Children's Cancer Research Fund (www.giantfood.com).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Avellino R, 2016, BLOOD, V127, P2991, DOI 10.1182/blood-2016-01-695759; BIRKENMEIER EH, 1989, GENE DEV, V3, P1146, DOI 10.1101/gad.3.8.1146; Collins C, 2014, P NATL ACAD SCI USA, V111, P9899, DOI 10.1073/pnas.1402238111; Cooper S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126385; Decker T, 2009, IMMUNITY, V30, P508, DOI 10.1016/j.immuni.2009.01.012; Dias S, 2008, IMMUNITY, V29, P217, DOI 10.1016/j.immuni.2008.05.015; Flodby P, 1996, J BIOL CHEM, V271, P24753, DOI 10.1074/jbc.271.40.24753; Giladi A, 2018, NAT CELL BIOL, V20, P836, DOI 10.1038/s41556-018-0121-4; Guo H, 2018, J IMMUNOL, V201, P1692, DOI 10.4049/jimmunol.1800244; Guo H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150809; Guo H, 2014, J LEUKOCYTE BIOL, V96, P419, DOI 10.1189/jlb.2AB0314-145R; Guo H, 2012, BLOOD, V119, P4408, DOI 10.1182/blood-2011-12-397091; HAGMAN J, 1993, GENE DEV, V7, P760, DOI 10.1101/gad.7.5.760; Hagman J, 2012, CURR TOP MICROBIOL, V356, P17, DOI 10.1007/82_2011_139; Hsu CL, 2006, P NATL ACAD SCI USA, V103, P672, DOI 10.1073/pnas.0510304103; Inlay MA, 2009, GENE DEV, V23, P2376, DOI 10.1101/gad.1836009; Itoh-Nakadai A, 2017, CELL REP, V18, P2401, DOI 10.1016/j.celrep.2017.02.029; Jack GD, 2009, BLOOD, V114, P2172, DOI 10.1182/blood-2008-11-191536; Jensen CT, 2018, J EXP MED, V215, P1947, DOI 10.1084/jem.20171384; Karamitros D, 2018, NAT IMMUNOL, V19, P85, DOI 10.1038/s41590-017-0001-2; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; Mansson R, 2012, P NATL ACAD SCI USA, V109, P21028, DOI 10.1073/pnas.1211427109; Medina KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078408; Medina KL, 2004, DEV CELL, V7, P607, DOI 10.1016/j.devcel.2004.08.006; Nechanitzky R, 2013, NAT IMMUNOL, V14, P867, DOI 10.1038/ni.2641; Oelgeschlager M, 1996, MOL CELL BIOL, V16, P4717; Pang SHM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01264; Paz-Priel I, 2009, LEUKEMIA, V23, P365, DOI 10.1038/leu.2008.297; Pongubala JMR, 2008, NAT IMMUNOL, V9, P203, DOI 10.1038/ni1555; Roessler S, 2007, MOL CELL BIOL, V27, P579, DOI 10.1128/MCB.01192-06; Schlenner SM, 2010, IMMUNITY, V32, P426, DOI 10.1016/j.immuni.2010.03.005; SCOTT LM, 1992, BLOOD, V80, P1725; Seet CS, 2004, J EXP MED, V199, P1689, DOI 10.1084/jem.20032202; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tsapogas P, 2011, BLOOD, V118, P1283, DOI 10.1182/blood-2011-01-332189; VALTIERI M, 1987, J IMMUNOL, V138, P3829; Vilagos B, 2012, J EXP MED, V209, P775, DOI 10.1084/jem.20112422; von Muenchow L, 2016, P NATL ACAD SCI USA, V113, pE8122, DOI 10.1073/pnas.1613316113; Welner RS, 2013, BLOOD, V121, P4073, DOI 10.1182/blood-2012-10-463448; Welner RS, 2009, J IMMUNOL, V183, P7768, DOI 10.4049/jimmunol.0902333; Yeamans C, 2007, BLOOD, V110, P3136, DOI 10.1182/blood-2007-03-080291; Yoshida T, 2006, NAT IMMUNOL, V7, P382, DOI 10.1038/ni1314; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569; Zhang P, 2004, IMMUNITY, V21, P853, DOI 10.1016/j.immuni.2004.11.006; Zhang Z, 2003, EMBO J, V22, P4759, DOI 10.1093/emboj/cdg464	48	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0244161	10.1371/journal.pone.0244161	http://dx.doi.org/10.1371/journal.pone.0244161			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332417	Green Published, gold			2022-12-27	WOS:000601310900083
J	Boukthir, S; Moullec, S; Cariou, ME; Meygret, A; Morcet, J; Faili, A; Kayal, S				Boukthir, Sarrah; Moullec, Severine; Cariou, Marie-Estelle; Meygret, Alexandra; Morcet, Jeff; Faili, Ahmad; Kayal, Samer			A prospective survey of Streptococcus pyogenes infections in French Brittany from 2009 to 2017: Comprehensive dynamic of new emergent emm genotypes	PLOS ONE			English	Article							GROUP-A STREPTOCOCCUS; CLUSTER TYPING SYSTEM; MOLECULAR EPIDEMIOLOGY; DISEASE; SEQUENCE; SEPSIS; SKIN	Streptococcus pyogenes or group A Streptococcus (GAS) causes diseases ranging from uncomplicated pharyngitis to life-threatening infections. It has complex epidemiology driven by the diversity, the temporal and geographical fluctuations of the circulating strains. Despite the global burden of GAS diseases, there is currently no available vaccination strategy against GAS infections. This study, based on a longitudinal population survey, aimed to understand the dynamic of GAS emm types and to give leads to better recognition of underlying mechanisms for the emergence of successful clones. From 2009 to 2017, we conducted a systematic culture-based diagnosis of GAS infections in a French Brittany population with a prospective recovery of clinical data. The epidemiological analysis was performed using emm typing combined with the structural and functional cluster-typing system for all the recovered strains. Risk factors for the invasiveness, identified by univariate analysis, were computed in a multiple logistic regression analysis, and the only independent risk factor remaining in the model was the age (OR for the entire range [CI95%] = 6.35 [3.63, 11.10]; p<0.0001). Among the 61 different emm types identified, the most prevalent were emm28 (16%), emm89 (15%), emm1 (14%), and emm4 (8%), which accounted for more than 50% of circulating strains. During the study period, five genotypes identified as emm44, 66, 75, 83, 87 emerged successively and belonged to clusters D4, E2, E3, and E6 that were different from those gathering "Prevalent" emm types (clusters A-C3 to 5, E1 and E4). We previously reported significant genetic modifications for emm44, 66, 83 and 75 types resulting possibly from a short adaptive evolution. Herein we additionally observed that the emergence of a new genotype could occur in a susceptible population having specific risk factors or probably lacking a naturally-acquired cluster-specific immune cross-protection. Among emergent emm types, emm75 and emm87 tend to become prevalent with a stable annual incidence and the risk of a clonal expansion have to be considered.	[Boukthir, Sarrah; Meygret, Alexandra; Morcet, Jeff; Kayal, Samer] CHU Rennes, Serv Bacteriol Hyg Hosp, Rennes, France; [Boukthir, Sarrah; Moullec, Severine; Morcet, Jeff; Faili, Ahmad; Kayal, Samer] Inserm, CIC 1414, Rennes, France; [Boukthir, Sarrah; Moullec, Severine; Meygret, Alexandra; Kayal, Samer] Univ Rennes 1, Fac Med, Rennes, France; [Cariou, Marie-Estelle] Ctr Hosp Bretagne Sud, Lab Biol, Lorient, France; [Faili, Ahmad] Univ Rennes 1, Fac Pharm, Rennes, France; [Meygret, Alexandra] Ctr Hosp Basse Terre, Serv Bacteriol, Basse Terre, Guadeloupe, France	CHU Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Universite de Rennes	Kayal, S (corresponding author), CHU Rennes, Serv Bacteriol Hyg Hosp, Rennes, France.; Kayal, S (corresponding author), Inserm, CIC 1414, Rennes, France.; Kayal, S (corresponding author), Univ Rennes 1, Fac Med, Rennes, France.	samer.kayal@univ-rennes1.fr			University Rennes-1 Medical School; University Hospital Center of Rennes-France	University Rennes-1 Medical School; University Hospital Center of Rennes-France	This work was supported by the University Rennes-1 Medical School, and by University Hospital Center of Rennes-France and did not receive any specific grant from funding agencies in the public, commercial, or not-forprofit sectors.	Baroux N, 2014, CLIN INFECT DIS, V59, pE84, DOI 10.1093/cid/ciu490; BEACHEY EH, 1981, NATURE, V292, P457, DOI 10.1038/292457a0; Beall B, 1996, J CLIN MICROBIOL, V34, P953, DOI 10.1128/JCM.34.4.953-958.1996; Bessen DE, 2000, J INFECT DIS, V182, P1109, DOI 10.1086/315842; Bessen DE, 2015, INFECT GENET EVOL, V33, P393, DOI 10.1016/j.meegid.2014.10.011; Bessen DE, 2010, FUTURE MICROBIOL, V5, P623, DOI [10.2217/fmb.10.28, 10.2217/FMB.10.28]; Bessen DE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-59; Cady A, 2011, EMERG INFECT DIS, V17, P315, DOI 10.3201/eid1702.101022; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Cohen R, 2015, CLIN INFECT DIS, V60, P267, DOI 10.1093/cid/ciu794; Dale JB, 2017, VACCINE, V35, P19, DOI 10.1016/j.vaccine.2016.11.065; Darenberg J, 2007, CLIN INFECT DIS, V45, P450, DOI 10.1086/519936; Davies HD, 1996, NEW ENGL J MED, V335, P547, DOI 10.1056/NEJM199608223350803; Friaes A, 2015, SCI REP-UK, V5, DOI 10.1038/srep12057; Frost HR, 2017, CLIN INFECT DIS, V65, P1523, DOI 10.1093/cid/cix599; Gallo V, 2012, EUR J CLIN INVEST, V42, P1, DOI 10.1111/j.1365-2362.2011.02561.x; Green NM, 2005, J INFECT DIS, V192, P760, DOI 10.1086/430618; Koutouzi F, 2015, J CLIN MICROBIOL, V53, P2015, DOI 10.1128/JCM.00301-15; Lamagni T L, 2005, Euro Surveill, V10, P179; Lamagni TL, 2008, J CLIN MICROBIOL, V46, P2359, DOI 10.1128/JCM.00422-08; LANCEFIELD RC, 1959, J EXP MED, V110, P271, DOI 10.1084/jem.110.2.271; Luca-Harari B, 2008, J CLIN MICROBIOL, V46, P79, DOI 10.1128/JCM.01626-07; Luca-Harari B, 2009, J CLIN MICROBIOL, V47, P1155, DOI 10.1128/JCM.02155-08; Mason KL, 2012, AM J REPROD IMMUNOL, V67, P91, DOI 10.1111/j.1600-0897.2011.01083.x; Meisal R, 2010, J CLIN MICROBIOL, V48, P842, DOI 10.1128/JCM.01312-09; Meygret A, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00689-16; O'Loughlin RE, 2007, CLIN INFECT DIS, V45, P853, DOI 10.1086/521264; Plainvert C, 2014, ARCH PEDIATRIE, V21, pS62, DOI 10.1016/S0929-693X(14)72262-6; Rattanavong S, 2016, EPIDEMIOL INFECT, V144, P1770, DOI 10.1017/S0950268815002927; Rochefort A, 2017, GENOME ANNOUNCEMENTS, V5, DOI [10.1128/genomeA.00957-17, 10.1128/genomea.00957-17]; Sanderson-Smith M, 2014, J INFECT DIS, V210, P1325, DOI 10.1093/infdis/jiu260; Sheel M, 2016, EXPERT REV VACCINES, V15, P227, DOI 10.1586/14760584.2016.1116946; Shulman ST, 2014, CLIN INFECT DIS, V59, P1651, DOI 10.1093/cid/ciu649; Shulman ST, 2009, CLIN INFECT DIS, V49, P78, DOI 10.1086/599344; Sitkiewicz I, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-65; Smeesters PR, 2008, VACCINE, V26, P5835, DOI 10.1016/j.vaccine.2008.08.037; Smit PW, 2015, EUR J CLIN MICROBIOL, V34, P2131, DOI 10.1007/s10096-015-2462-2; Soriano N, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01174-14; Soriano N, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.01459-14; Steer AC, 2009, LANCET INFECT DIS, V9, P611, DOI 10.1016/S1473-3099(09)70178-1; Turner CE, 2015, MBIO, V6, DOI 10.1128/mBio.00622-15; Walker MJ, 2014, CLIN MICROBIOL REV, V27, P264, DOI 10.1128/CMR.00101-13	42	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0244063	10.1371/journal.pone.0244063	http://dx.doi.org/10.1371/journal.pone.0244063			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332468	Green Published, gold			2022-12-27	WOS:000601310900052
J	Burlando, B; Milanese, M; Giordano, G; Bonifacino, T; Ravera, S; Blanchini, F; Bonanno, G				Burlando, Bruno; Milanese, Marco; Giordano, Giulia; Bonifacino, Tiziana; Ravera, Silvia; Blanchini, Franco; Bonanno, Giambattista			A multistationary loop model of ALS unveils critical molecular interactions involving mitochondria and glucose metabolism	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; ACTIVATED PROTEIN-KINASE; OXIDATIVE STRESS; MOTOR-NEURONS; DYSFUNCTION; DISEASE; SOD1; PHOSPHORYLATION; EXCITOTOXICITY; STIMULATION	Amyotrophic lateral sclerosis (ALS) is a poor-prognosis disease with puzzling pathogenesis and inconclusive treatments. We develop a mathematical model of ALS based on a system of interactive feedback loops, focusing on the mutant SOD1(G93A) mouse. Misfolded mutant SOD1 aggregates in motor neuron (MN) mitochondria and triggers a first loop characterized by oxidative phosphorylation impairment, AMP kinase over-activation, 6-phosphofructo-2-kinase (PFK3) rise, glucose metabolism shift from pentose phosphate pathway (PPP) to glycolysis, cell redox unbalance, and further worsening of mitochondrial dysfunction. Oxidative stress then triggers a second loop, involving the excitotoxic glutamatergic cascade, with cytosolic Ca2+ overload, increase of PFK3 expression, and further metabolic shift from PPP to glycolysis. Finally, cytosolic Ca2+ rise is also detrimental to mitochondria and oxidative phosphorylation, thus closing a third loop. These three loops are overlapped and positive (including an even number of inhibitory steps), hence they form a candidate multistationary (bistable) system. To describe the system dynamics, we model the interactions among the functional agents with differential equations. The system turns out to admit two stable equilibria: the healthy state, with high oxidative phosphorylation and preferential PPP, and the pathological state, with AMP kinase activation, PFK3 over expression, oxidative stress, excitotoxicity and MN degeneration. We demonstrate that the loop system is monotone: all functional agents consistently act toward the healthy or pathological condition, depending on low or high mutant SOD1 input. We also highlight that molecular interactions involving PFK3 are crucial, as their deletion disrupts the system's bistability leading to a single healthy equilibrium point. Hence, our mathematical model unveils that promising ALS management strategies should be targeted to mechanisms that keep low PFK3 expression and activity within MNs.	[Burlando, Bruno; Milanese, Marco; Bonifacino, Tiziana; Bonanno, Giambattista] Univ Genoa, Dept Pharm, Genoa, Italy; [Giordano, Giulia] Univ Trento, Dept Ind Engn, Trento, Italy; [Giordano, Giulia] Delft Univ Technol, Delft Ctr Syst & Control, Delft, Netherlands; [Ravera, Silvia] Univ Genoa, Dept Expt Med, Genoa, Italy; [Blanchini, Franco] Univ Udine, Dipartimento Sci Matemat Informat & Fis, Udine, Italy; [Bonanno, Giambattista] IRCCS Osped Policlin San Martino, Genoa, Italy	University of Genoa; University of Trento; Delft University of Technology; University of Genoa; University of Udine	Giordano, G (corresponding author), Univ Trento, Dept Ind Engn, Trento, Italy.; Giordano, G (corresponding author), Delft Univ Technol, Delft Ctr Syst & Control, Delft, Netherlands.	g.giordano@tudelft.nl	Ravera, Silvia/AAA-7982-2019; Bonifacino, Tiziana/AAA-5471-2019; Giordano, Giulia/L-5209-2015; Milanese, Marco/AAB-2238-2021; Blanchini, Franco/A-6513-2008	Ravera, Silvia/0000-0002-0803-1042; Bonifacino, Tiziana/0000-0002-3966-9874; Giordano, Giulia/0000-0002-8600-1738; Milanese, Marco/0000-0003-3384-0666; Blanchini, Franco/0000-0002-4109-5531; Burlando, Bruno/0000-0001-7545-0311	Italian Ministry of Education, University and Research (SIR project) [RBSI14B1Z1]; Fondazione Compagnia di San Paolo [2018.AAI629. U730/SD/pv]; Motor Neurone Disease Association [April16/848-791]	Italian Ministry of Education, University and Research (SIR project); Fondazione Compagnia di San Paolo(Compagnia di San Paolo); Motor Neurone Disease Association	Study financially supported by the Italian Ministry of Education, University and Research (SIR project n.RBSI14B1Z1) (MM), the Fondazione Compagnia di San Paolo (project n.2018.AAI629. U730/SD/pv) (GB), and the Motor Neurone Disease Association (project n. April16/848-791) (GB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, INT LEGAL MAT, V43, P5; Barber SC, 2010, FREE RADICAL BIO MED, V48, P629, DOI 10.1016/j.freeradbiomed.2009.11.018; Bhattacharya S, 2010, TOXICOL SCI, V115, P51, DOI 10.1093/toxsci/kfq035; Bilsland LG, 2010, P NATL ACAD SCI USA, V107, P20523, DOI 10.1073/pnas.1006869107; Blanchini F, 2014, B MATH BIOL, V76, P2542, DOI 10.1007/s11538-014-0023-y; Bonifacino T, 2016, NEUROBIOL DIS, V95, P122, DOI 10.1016/j.nbd.2016.07.011; Bozzo F, 2017, NEUROSCI LETT, V636, P3, DOI 10.1016/j.neulet.2016.04.065; Carriedo SG, 2000, J NEUROSCI, V20, P240, DOI 10.1523/JNEUROSCI.20-01-00240.2000; Choi SY, 2019, NAT NEUROSCI, V22, P851, DOI 10.1038/s41593-019-0397-0; de Carvalho M, 2008, CLIN NEUROPHYSIOL, V119, P497, DOI 10.1016/j.clinph.2007.09.143; Deng JW, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005357; Dervishi I, 2018, DRUG DISCOV TODAY, V23, P696, DOI 10.1016/j.drudis.2018.01.027; Dhariwala FA, 2008, CELL MOL NEUROBIOL, V28, P351, DOI 10.1007/s10571-007-9242-1; Doig AJ, 2018, J ALZHEIMERS DIS, V66, P25, DOI 10.3233/JAD-180583; Geloso MC, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00242; Gesztelyi R, 2012, ARCH HIST EXACT SCI, V66, P427, DOI 10.1007/s00407-012-0098-5; Giordano G, 2016, J MATH BIOL, V72, P1927, DOI 10.1007/s00285-015-0933-9; Giza CC, 2001, J ATHL TRAINING, V36, P228; Guo CY, 2013, NEURAL REGEN RES, V8, P2003, DOI 10.3969/j.issn.1673-5374.2013.21.009; Gurney ME, 1997, J NEUROL SCI, V152, pS67, DOI 10.1016/S0022-510X(97)00247-5; Hall MC, 2004, CELL CYCLE, V3, P1278, DOI 10.4161/cc.3.10.1153; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; Hegedus J, 2008, J PHYSIOL-LONDON, V586, P3337, DOI 10.1113/jphysiol.2007.149286; Herrero-Mendez A, 2009, NAT CELL BIOL, V11, P747, DOI 10.1038/ncb1881; Holecek V, 2017, NEUROENDOCRINOL LETT, V38, P528; Hounoum BM, 2017, GLIA, V65, P592, DOI 10.1002/glia.23114; Hoye ML, 2018, BRAIN, V141, P2561, DOI 10.1093/brain/awy182; Islam MT, 2017, NEUROL RES, V39, P73, DOI 10.1080/01616412.2016.1251711; Kaneb HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024189; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Le Masson G, 2014, NEURON, V83, P975, DOI 10.1016/j.neuron.2014.07.001; Lin CLG, 1998, NEURON, V20, P589, DOI 10.1016/S0896-6273(00)80997-6; Maestre C, 2008, EMBO J, V27, P2736, DOI 10.1038/emboj.2008.195; Marsin AS, 2000, CURR BIOL, V10, P1247, DOI 10.1016/S0960-9822(00)00742-9; Marsin AS, 2002, J BIOL CHEM, V277, P30778, DOI 10.1074/jbc.M205213200; Medinas DB, 2018, P NATL ACAD SCI USA, V115, P8209, DOI 10.1073/pnas.1801109115; Mejzini R, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01310; Muyderman H, 2014, BRIT J PHARMACOL, V171, P2191, DOI 10.1111/bph.12476; Nicholls DG, 2004, CURR MOL MED, V4, P149, DOI 10.2174/1566524043479239; Pasinelli P, 2004, NEURON, V43, P19, DOI 10.1016/j.neuron.2004.06.021; Perera ND, 2016, NEUROCHEM RES, V41, P544, DOI 10.1007/s11064-015-1665-3; Pun S, 2006, NAT NEUROSCI, V9, P408, DOI 10.1038/nn1653; Rao SD, 2003, J NEUROSCI, V23, P2627; Ravera S, 2019, J NEUROCHEM, V151, P336, DOI 10.1111/jnc.14819; Ravera S, 2018, MOL NEUROBIOL, V55, P9220, DOI 10.1007/s12035-018-1059-z; Rodriguez-Rodriguez P, 2012, CELL DEATH DIFFER, V19, P1582, DOI 10.1038/cdd.2012.33; Rothstein JD, 1996, CLIN NEUROSCI, V3, P348; Schousboe A, 2014, ADV NEUROBIOL, V11, P13, DOI 10.1007/978-3-319-08894-5_2; Stifanese R, 2014, ARCH BIOCHEM BIOPHYS, V562, P1, DOI 10.1016/j.abb.2014.08.006; Stifanese R, 2010, J BIOL CHEM, V285, P631, DOI 10.1074/jbc.M109.031674; Su SC, 2011, ANNU REV CELL DEV BI, V27, P465, DOI 10.1146/annurev-cellbio-092910-154023; Swinnen B, 2014, NAT REV NEUROL, V10, P661, DOI 10.1038/nrneurol.2014.184; Taylor AA, 2016, ANN CLIN TRANSL NEUR, V3, P866, DOI 10.1002/acn3.348; Tonnies E, 2017, J ALZHEIMERS DIS, V57, P1105, DOI 10.3233/JAD-161088; Vandoorne T, 2018, ACTA NEUROPATHOL, V135, P489, DOI 10.1007/s00401-018-1835-x; Voit EO, 2017, WIRES SYST BIOL MED, V9, DOI 10.1002/wsbm.1391; Wang P, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1007947; Yamanaka K, 2008, P NATL ACAD SCI USA, V105, P7594, DOI 10.1073/pnas.0802556105; Yamanaka K, 2018, NEUROSCI RES, V126, P31, DOI 10.1016/j.neures.2017.09.011; Zarei Sara, 2015, Surg Neurol Int, V6, P171, DOI 10.4103/2152-7806.169561	61	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0244234	10.1371/journal.pone.0244234	http://dx.doi.org/10.1371/journal.pone.0244234			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332476	Green Published, gold			2022-12-27	WOS:000601310900013
J	de Almeida-Neto, PF; da Silva, LF; de Matos, DG; Jeffreys, I; Cesario, TD; Neto, RB; Barbosa, WD; Aidar, FJ; Dantas, PMS; Cabral, BGDT				de Almeida-Neto, Paulo Francisco; da Silva, Luiz Felipe; de Matos, Dihogo Gama; Jeffreys, Ian; Cesario, Tatianny de Macedo; Neto, Rui Barboza; Barbosa, Wagner de Almeida; Aidar, Felipe J.; Dantas, Paulo Moreira Silva; Cabral, Breno Guilherme de Araujo Tinoco			Equation for analyzing the peak power in aquatic environment: An alternative for olympic rowing athletes	PLOS ONE			English	Article							ERGOMETER PERFORMANCE	Purpose To develop an equation to provide the peak power (PP) through a specific stimulus performed in an aquatic environment, as well as to correlate morphological, anthropometric and strength variables with rowing performance. Methods The sample consisted of 16 elite young rowing athletes of both sexes (15.7 +/- 1.21 years). The strength of upper limbs and lower limbs was verified. To analyze the PP, a 100-m Sprint test was performed on an indoor rowing type ergometer, and after a 72-hour wash-out, the test was repeated in an aquatic environment on a vessel equipped with a global position system. Body composition was analyzed by examining bone densitometry with an X-ray source and maturation was verified by anthropometry. Results The tests for water sprint and indoor rowing showed significant reliability (ICC = 0.695; p = 0.0007). The PP aquatic showed reliability with that acquired in indoor rowing (ICC = 0.897; p<0.0001) and was related to maturation (p<0.05). The morphology, anthropometry and strength of the upper limbs were related to the sprint and peak strength in both tests (p<0.05). Conclusion The equation for the PP in aquatic environment presented by the present study is highly reliable with an indoor ergometer digital ergometer.	[de Almeida-Neto, Paulo Francisco; da Silva, Luiz Felipe; Cesario, Tatianny de Macedo; Neto, Rui Barboza; Dantas, Paulo Moreira Silva; Cabral, Breno Guilherme de Araujo Tinoco] Univ Fed Rio Grande do Norte, Dept Phys Educ, Natal, RN, Brazil; [de Matos, Dihogo Gama] Tras dos Montes & Alto Douro Univ, Res Ctr Sports Sci Hlth Sci & Human Dev, CIDESD, Vila Real, Portugal; [de Matos, Dihogo Gama; Aidar, Felipe J.] Fed Univ Sergipe UFS, Grp Studies & Res Performance Sport Healt & Paral, Sao Cristovao, Sergipe, Brazil; [Jeffreys, Ian] Univ South Wales, Fac Life Sci & Educ, Pontypridd, M Glam, Wales; [Barbosa, Wagner de Almeida] Univ Fed Rio Grande do Norte, Dept Theoret & Expt Phys, UFRN, Natal, RN, Brazil; [Aidar, Felipe J.] Fed Univ Sergipe UFS, Dept Phys Educ, Sao Cristovao, Sergipe, Brazil; [Aidar, Felipe J.] Fed Univ Sergipe UFS, Grad Program Masters Level, Dept Phys Educ, Sao Cristovao, Sergipe, Brazil; [Aidar, Felipe J.] Fed Univ Sergipe UFS, Program Physiol Sci, Sao Cristovao, Sergipe, Brazil	Universidade Federal do Rio Grande do Norte; University of Tras-os-Montes & Alto Douro; University of South Wales; Universidade Federal do Rio Grande do Norte	de Almeida-Neto, PF (corresponding author), Univ Fed Rio Grande do Norte, Dept Phys Educ, Natal, RN, Brazil.	paulojitte@ufrn.edu.br	cao, xiaoxiang/AAR-9291-2021; Almeida-Neto, Paulo Francisco de/AAZ-4182-2020; de Matos, Dihogo/D-3273-2013; Aidar, Felipe J./AAO-2744-2020	Almeida-Neto, Paulo Francisco de/0000-0002-2860-2260; Silva, Luiz Felipe/0000-0002-1825-8443; de Matos, Dihogo/0000-0002-7394-8527; Aidar, Felipe J./0000-0001-7378-4529	Federal University of Rio Grande do Norte (UFRN); Physical Activity and Health (AFISA) research base; Higher Education Personnel Improvement Coordination (CAPES); Remo Sport club, Natal-Brazil; Child and Adolescent Maturation Research Group (GEPMAC); National Council for Scientific Development (CNPQ)	Federal University of Rio Grande do Norte (UFRN); Physical Activity and Health (AFISA) research base; Higher Education Personnel Improvement Coordination (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Remo Sport club, Natal-Brazil; Child and Adolescent Maturation Research Group (GEPMAC); National Council for Scientific Development (CNPQ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	For your support and encouragement for the development of this academic article, we thank the Federal University of Rio Grande do Norte (UFRN), the Physical Activity and Health (AFISA) research base, the Child and Adolescent Maturation Research Group (GEPMAC). The National Council for Scientific Development (CNPQ). The Higher Education Personnel Improvement Coordination (CAPES) and the Remo Sport club, Natal-Brazil for their support and encouragement for the development of research.	de Almeida-Neto PF, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12176696; [Anonymous], 2018, DIABETES CARE, V41, pS4, DOI [10.2337/dc18-SREV01, 10.2337/dc18-Srev01]; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bourdin M, 2017, INT J SPORTS MED, V38, P1023, DOI 10.1055/s-0043-118849; Caporaso T, 2018, INT J INTERACT DES M, V12, P1211, DOI 10.1007/s12008-018-0483-7; Cataldo A, 2015, J SPORT MED PHYS FIT, V55, P872; Cuijpers LS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133527; Da Silva FM, 2015, MOTRICIDADE, V11, P190; Dantas MP., 2018, MOTRICIDADE, V14, P4; de Almeida-Neto PF, 2021, J SPORT MED PHYS FIT, V61, P829, DOI 10.23736/S0022-4707.20.11497-X; de Almeida-Neto PF, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17165637; de Almeida-Neto PF, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093277; Cesario TD, 2021, AM J HUM BIOL, V33, DOI 10.1002/ajhb.23503; Durkalec-Michalski K, 2019, J SPORT MED PHYS FIT, V59, P1526, DOI 10.23736/S0022-4707.19.08951-5; Forza J, 2019, J MULT ENG SCI TECH, V6, P9982; Freeze J, 2018, PROCEEDINGS OF THE 51ST ANNUAL HAWAII INTERNATIONAL CONFERENCE ON SYSTEM SCIENCES (HICSS), P913; Hatchett A, 2019, J SPORTS RES, V6, P29, DOI [10.18488/journal.90.2019.61.29.32, DOI 10.18488/J0URNAL.90.2019.61.29.32]; Karupaiah T., 2018, J RENAL NUTR METABOL, V3, P11, DOI DOI 10.4103/2395-1540.232541; Keenan KG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191504; Lee PH, 2014, SCI REP-UK, V4, DOI 10.1038/srep06085; Maciejewski H, 2019, J STRENGTH COND RES, V33, P3000, DOI 10.1519/JSC.0000000000002406; Maia S, 2017, REV BRASILEIRA MED E, V23, P1806, DOI [10.1590/1517-869220172306165108, DOI 10.1590/1517-869220172306165108]; Majumdar P., 2017, J PHYS ED SPORT, V17, P2502, DOI 10.7752/jpes.2017.04281; Mello FD, 2009, EUR J APPL PHYSIOL, V107, P615, DOI 10.1007/s00421-009-1172-9; Mello Júlio Brugnara, 2016, Rev. bras. cineantropom. desempenho hum., V18, P658, DOI 10.5007/1980-0037.2016v18n6p658; Metikos B, 2015, J STRENGTH COND RES, V29, P2919, DOI 10.1519/JSC.0000000000000944; Miot Hélio Amante, 2016, J. vasc. bras., V15, P89, DOI 10.1590/1677-5449.004216; Mirwald RL, 2002, MED SCI SPORT EXER, V34, P689, DOI 10.1097/00005768-200204000-00020; Pearl J, 2009, CAUSALITY, DOI 10.1017/CBO9780511803161; Penichet-Tomas A, 2019, J SPORT MED PHYS FIT, V59, P767, DOI 10.23736/S0022-4707.18.08524-9; Perini Talita Adão, 2005, Rev Bras Med Esporte, V11, P81, DOI 10.1590/S1517-86922005000100009; Raymond-Pope CJ, 2020, J STRENGTH COND RES, V34, P1690, DOI 10.1519/JSC.0000000000002688; Reed KE, 2017, SCAND J MED SCI SPOR, V27, P2070, DOI 10.1111/sms.12815; Reijnierse EM, 2017, J CACHEXIA SARCOPENI, V8, P466, DOI 10.1002/jcsm.12181; Riechman SE, 2002, J SPORT SCI, V20, P681, DOI 10.1080/026404102320219383; Schober P, 2018, ANESTH ANALG, V126, P1763, DOI 10.1213/ANE.0000000000002864; Siahkouhian M, 2016, S AFR J RES SPORT PH, V38, P179; Strobe, 2014, STROBE CHECKLIST STR; Warmenhoven J, 2018, SPORTS MED, V48, P2703, DOI 10.1007/s40279-018-0992-3; Wasserman H, 2017, BONE, V104, P84, DOI 10.1016/j.bone.2016.12.008; Wolf A., 2016, STRENGTH CONDITIONIN, P589; Worsey MTO, 2019, ELECTRONICS-SWITZ, V8, DOI 10.3390/electronics8111304	42	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243157	10.1371/journal.pone.0243157	http://dx.doi.org/10.1371/journal.pone.0243157			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332449	gold, Green Published			2022-12-27	WOS:000601310900020
J	Hirabayashi, A; Yahara, K; Kajihara, T; Sugai, M; Shibayama, K				Hirabayashi, Aki; Yahara, Koji; Kajihara, Toshiki; Sugai, Motoyuki; Shibayama, Keigo			Geographical distribution of Enterobacterales with a carbapenemase IMP-6 phenotype and its association with antimicrobial use: An analysis using comprehensive national surveillance data on antimicrobial resistance	PLOS ONE			English	Article							ESCHERICHIA-COLI; DISSEMINATION; EMERGENCE; SEQUENCE; JAPAN	Enterobacterales resistant to carbapenems, a class of last-resort antimicrobials, are ranked as an "urgent" and "critical" public health hazard by CDC and WHO. IMP-type carbapenemase-containing Enterobacterales are endemic in Japan, and bla(IMP-6) is one of the notable carbapenemase genes responsible for the resistance. The gene is plasmid-encoded and confers resistance to meropenem, but not to imipenem. Therefore, IMP-6-producing Enterobacterales isolates are occasionally overlooked in clinical laboratories and are referred to as 'stealth-type'. Since previous reports in Japan were confined only to some geographical regions, their distribution across prefectures and the factors affecting the distribution remain unclear. Here, we revealed the dynamics of the geographical distribution of Enterobacterales with IMP-6 phenotype associated with antimicrobial use in Japan. We utilized comprehensive national surveillance data of all routine bacteriological test results from more than 1,400 hospitals in 2015 and 2016 to enumerate Escherichia coli and Klebsiella pneumoniae isolates with the antimicrobial susceptibility pattern (phenotype) characteristic of IMP-6 (imipenem susceptible, meropenem resistant), and to tabulate the frequency of isolates with the phenotype for each prefecture. Isolates were detected in approximately half of all prefectures, and combined analysis with the national data of antimicrobial usage revealed a statistically significant association between the frequency and usage of not carbapenems but third-generation cephalosporins (p = 0.006, logistic mixed-effect regression) and a weaker association between the frequency and usage of fluoroquinolones (p = 0.043). The usage of third-generation cephalosporins and fluoroquinolones may select the strains with the IMP-6 phenotype, and contribute to their occasional spread. We expect the findings will promote antimicrobial stewardship to reduce the spread of the notable carbapenemase gene.	[Hirabayashi, Aki; Yahara, Koji; Kajihara, Toshiki; Sugai, Motoyuki; Shibayama, Keigo] Natl Inst Infect Dis, Antimicrobial Resistance Res Ctr, Tokyo, Japan; [Shibayama, Keigo] Natl Inst Infect Dis, Dept Bacteriol 2, Tokyo, Japan	National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID)	Hirabayashi, A; Yahara, K (corresponding author), Natl Inst Infect Dis, Antimicrobial Resistance Res Ctr, Tokyo, Japan.	akihira@nih.go.jp; k-yahara@nih.go.jp		Kajihara, Toshiki/0000-0002-7576-2654	Research Program on Emerging and Re-emerging Infectious Diseases from the Japan Agency for Medical Research and Development (AMED) [JP19fk0108061]	Research Program on Emerging and Re-emerging Infectious Diseases from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This study was supported by Research Program on Emerging and Re-emerging Infectious Diseases from the Japan Agency for Medical Research and Development (AMED) under grant number JP19fk0108061.	Abe R, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4779-x; Albiger B, 2015, EUROSURVEILLANCE, V20, P17, DOI 10.2807/1560-7917.ES.2015.20.45.30062; Aldred KJ, 2014, BIOCHEMISTRY-US, V53, P1565, DOI 10.1021/bi5000564; [Anonymous], 2015, Arthritis Rheumatol, V67 Suppl 10, P1, DOI 10.1002/art.39448; [Anonymous], 2007, REV CUB ALIMENT NU S, V17, pS20; [Anonymous], 2005, LANCET, V365, P579; [Anonymous], 2019, INFECT AGENTS SURVEI, V40, P157; Bell BG, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-13; Chen Y, 2014, EUR J CLIN MICROBIOL, V33, P1181, DOI 10.1007/s10096-014-2063-5; Clinical and Laboratory Standards Institute, 2016, M100S26 CLSI; Coque TM, 2008, EMERG INFECT DIS, V14, P195, DOI 10.3201/eid1402.070350; FRANKO M, 1994, TDR-DRAMA REV-J PERF, V38, P71, DOI 10.2307/1146425; Gbaguidi-Haore H, 2009, J MED MICROBIOL, V58, P1337, DOI 10.1099/jmm.0.010116-0; Hagiya H, 2018, J INFECT CHEMOTHER, V24, P769, DOI 10.1016/j.jiac.2018.03.009; Hosaka Y, 2019, THESIS, P2; Kajihara T, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228234; Kanazawa S, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.00576-17; Kayama S, 2015, ANTIMICROB AGENTS CH, V59, P1356, DOI 10.1128/AAC.04759-14; Komatsu Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202276; Matsumura Y, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.02729-16; Matsumura Y, 2013, ANTIMICROB AGENTS CH, V57, P4736, DOI 10.1128/AAC.00641-13; McDonnell L, 2017, J ANTIMICROB CHEMOTH, V72, P3199, DOI 10.1093/jac/dkx248; Nicolas-Chanoine MH, 2008, J ANTIMICROB CHEMOTH, V61, P273, DOI 10.1093/jac/dkm464; Nordmann P, 2012, TRENDS MOL MED, V18, P263, DOI 10.1016/j.molmed.2012.03.003; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; Ohno Y, 2017, J INFECT CHEMOTHER, V23, P224, DOI 10.1016/j.jiac.2016.12.013; Poirel L, 2008, CLIN MICROBIOL INFEC, V14, P295, DOI 10.1111/j.1469-0691.2007.01930.x; Shigemoto N, 2012, DIAGN MICR INFEC DIS, V72, P109, DOI 10.1016/j.diagmicrobio.2011.09.019; Teramae M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20205162; Uchida Y, 2010, INT J ANTIMICROB AG, V35, P444, DOI 10.1016/j.ijantimicag.2009.12.012; Yano H, 2001, ANTIMICROB AGENTS CH, V45, P1343, DOI 10.1128/AAC.45.5.1343-1348.2001; Yano H, 2012, ANTIMICROB AGENTS CH, V56, P4554, DOI 10.1128/AAC.00617-12; Yoo JS, 2012, INT J ANTIMICROB AG, V39, P300, DOI 10.1016/j.ijantimicag.2011.11.018	33	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243630	10.1371/journal.pone.0243630	http://dx.doi.org/10.1371/journal.pone.0243630			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332370	Green Published, gold			2022-12-27	WOS:000601310900080
J	Tawab, F; Munir, I; Nasim, Z; Khan, MS; Tawab, S; Nasim, A; Iqbal, A; Ahmad, MA; Ali, W; Munir, R; Munir, M; Asim, N				Tawab, Faiza; Munir, Iqbal; Nasim, Zeeshan; Khan, Mohammad Sayyar; Tawab, Saleha; Nasim, Adnan; Iqbal, Aqib; Ahmad, Mian Afaq; Ali, Waqar; Munir, Raheel; Munir, Maria; Asim, Noreen			Identification and characterization of a novel multi-stress responsive gene in Arabidopsis	PLOS ONE			English	Article							SALT STRESS; DROUGHT STRESS; OSMOTIC-STRESS; ORYZA-SATIVA; SALINITY; EXPRESSION; ACID; GERMINATION; TOLERANCE; PROLINE	Abiotic stresses especially salinity, drought and high temperature result in considerable reduction of crop productivity. In this study, we identified AT4G18280 annotated as a glycine-rich cell wall protein-like (hereafter refer to as GRPL1) protein as a potential multistress-responsive gene. Analysis of public transcriptome data and GUS assay of pGRPL1::GUS showed a strong induction of GRPL1 under drought, salinity and heat stresses. Transgenic plants overexpressing GRPL1-3HA showed significantly higher germination, root elongation and survival rate under salt stress. Moreover, the 35S::GRPL1-3HA transgenic lines also showed higher survival rates under drought and heat stresses. GRPL1 showed similar expression patterns with Abscisic acid (ABA)-pathway genes under different growth and stress conditions, suggesting a possibility that GRPL1 might act in the ABA pathway that is further supported by the inability of ABA-deficient mutant (aba2-1) to induce GRPL1 under drought stress. Taken together, our data presents GRPL1 as a potential multi-stress responsive gene working downstream of ABA.	[Tawab, Faiza; Munir, Iqbal; Nasim, Zeeshan; Iqbal, Aqib; Ahmad, Mian Afaq; Munir, Raheel; Munir, Maria] Univ Agr, Inst Biotechnol & Genet Engn IBGE, Div Biochem, Peshawar, Khyber Pakhtunk, Pakistan; [Khan, Mohammad Sayyar; Asim, Noreen] Univ Agr, Inst Biotechnol & Genet Engn IBGE, Genom & Bioinformat Div, Peshawar, Khyber Pakhtunk, Pakistan; [Tawab, Saleha; Nasim, Adnan] Agr Res Syst, Peshawar, Khyber Pakhtunk, Pakistan; [Ali, Waqar] Univ Malakand, Dept Biotechnol, Lower Dir, Khyber Pakhtunk, Pakistan	Agricultural University Peshawar; University of Agriculture Faisalabad; Agricultural University Peshawar; University of Agriculture Faisalabad	Munir, I (corresponding author), Univ Agr, Inst Biotechnol & Genet Engn IBGE, Div Biochem, Peshawar, Khyber Pakhtunk, Pakistan.	iqmunir@aup.edu.pk	Iqbal, Aqib/GVU-1049-2022	Munir, Iqbal/0000-0002-5359-6333; , Noreen/0000-0001-9233-5681				Abraham E, 2010, METHODS MOL BIOL, V639, P317, DOI 10.1007/978-1-60761-702-0_20; Adams E., 2014, ISRN BOT, V2014, P490252, DOI [10.1155/2014/490252, DOI 10.1155/2014/490252]; [Anonymous], 2011, CANC DISCOV; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Bayuelo-Jimenez JS, 2002, CROP SCI, V42, P1584, DOI 10.2135/cropsci2002.1584; Burssens S, 2000, PLANTA, V211, P632, DOI 10.1007/s004250000334; Bustos D, 2008, ANN BOT-LONDON, V102, P551, DOI 10.1093/aob/mcn141; Czolpinska M, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00302; Dar M.I., 2016, OSMOLYTES PLANTS ACC, P155, DOI DOI 10.1007/978-81-322-2616-1_9; De Leonardis AM, 2007, PLANT SCI, V172, P1005, DOI 10.1016/j.plantsci.2007.02.002; Ding F, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-431; Fan XD, 2013, GENE, V512, P392, DOI 10.1016/j.gene.2012.09.100; Fedoroff NV, 2010, SCIENCE, V327, P833, DOI 10.1126/science.1186834; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; Gulzar S, 2001, SEED SCI TECHNOL, V29, P21; Hazman M, 2015, J EXP BOT, V66, P3339, DOI 10.1093/jxb/erv142; Hernandez JA, 2002, PHYSIOL PLANTARUM, V115, P251, DOI 10.1034/j.1399-3054.2002.1150211.x; Hirayama T, 2007, TRENDS PLANT SCI, V12, P343, DOI 10.1016/j.tplants.2007.06.013; Hirayama T, 2010, PLANT J, V61, P1041, DOI 10.1111/j.1365-313X.2010.04124.x; Huang J, 1995, CAN J PLANT SCI, V75, P815, DOI 10.4141/cjps95-137; Jiang KN, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00081; Kim JY, 2010, J EXP BOT, V61, P2317, DOI 10.1093/jxb/erq058; Kim SG, 2008, PLANT SIGNAL BEHAV, V3, P877, DOI 10.4161/psb.3.10.6247; Koca H, 2007, ENVIRON EXP BOT, V60, P344, DOI 10.1016/j.envexpbot.2006.12.005; Lee S, 2010, NEW PHYTOL, V188, P626, DOI 10.1111/j.1469-8137.2010.03378.x; Liu WW, 2014, NEW PHYTOL, V201, P1192, DOI 10.1111/nph.12607; Liu ZY, 2020, MOL BIOL REP, V47, P497, DOI 10.1007/s11033-019-05156-0; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Nachappa P, 2012, MOL GENET GENOMICS, V287, P803, DOI 10.1007/s00438-012-0713-9; NEUMANN PM, 1995, CROP SCI, V35, P1258, DOI 10.2135/cropsci1995.0011183X003500050002x; Newton AC, 2011, EUPHYTICA, V179, P3, DOI 10.1007/s10681-011-0359-4; Niu CF, 2012, PLANT CELL ENVIRON, V35, P1156, DOI 10.1111/j.1365-3040.2012.02480.x; Park HJ, 2016, MOL CELLS, V39, P447, DOI 10.14348/molcells.2016.0083; Qin F, 2011, PLANT CELL PHYSIOL, V52, P1569, DOI 10.1093/pcp/pcr106; Sachetto-Martins G, 2000, BBA-GENE STRUCT EXPR, V1492, P1, DOI 10.1016/S0167-4781(00)00064-6; Sharma P, 2016, BMC COMPLEM ALTERN M, DOI [10.1186/s12906-016-1240-8, DOI 10.1186/S12906-016-1240-8]; Shen Y, 2013, PHYSIOL PLANTARUM, V147, P270, DOI 10.1111/j.1399-3054.2012.01670.x; Shinde S, 2016, PLANT PHYSIOL, V172, P1074, DOI 10.1104/pp.16.01097; Smirnoff N, 1996, ANN BOT-LONDON, V78, P661, DOI 10.1006/anbo.1996.0175; Su ZX, 2017, SCI REP-UK, V7, P1, DOI 10.1038/srep43026; Suzuki N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147625; Taffouo V. D., 2010, International Journal of Botany, V6, P53; Takeda S, 2008, NAT REV GENET, V9, P444, DOI 10.1038/nrg2342; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Turan M. A., 2007, Journal of Agronomy, V6, P378; Ullah A, 2018, PHYSIOL PLANTARUM, V162, P439, DOI 10.1111/ppl.12651; Umezawa T, 2010, PLANT CELL PHYSIOL, V51, P1821, DOI 10.1093/pcp/pcq156; Van Breusegem F, 2006, PLANT PHYSIOL, V141, P384, DOI 10.1104/pp.106.078295; Vishwakarma K, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00161; Wang WX, 2003, PLANTA, V218, P1, DOI 10.1007/s00425-003-1105-5; Wang XS, 2012, MOL BIOL REP, V39, P8147, DOI 10.1007/s11033-012-1662-4; WERNER JE, 1995, PHYSIOL PLANTARUM, V93, P659, DOI 10.1111/j.1399-3054.1995.tb05114.x; Yang DH, 2014, PLANT SCI, V214, P106, DOI 10.1016/j.plantsci.2013.10.006; Yu SC, 2012, PLANT MOL BIOL REP, V30, P17, DOI 10.1007/s11105-011-0313-6; Zeller G, 2009, PLANT J, V58, P1068, DOI 10.1111/j.1365-313X.2009.03835.x; Zhang SW, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01405; Zhou YJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-266; Zhu JK, 2016, CELL, V167, P313, DOI 10.1016/j.cell.2016.08.029	61	3	3	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0244030	10.1371/journal.pone.0244030	http://dx.doi.org/10.1371/journal.pone.0244030			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332435	gold, Green Published			2022-12-27	WOS:000601310900068
J	Martin-Castro, A; Ucar, I				Martin-Castro, Almudena; Ucar, Inaki			Conductors' tempo choices shed light over Beethoven's metronome	PLOS ONE			English	Article								During most part of Western classical music history, tempo, the speed of music, was not specified, for it was considered obvious from musical context. Only in 1815, Maelzel patented the metronome. Beethoven immediately embraced it, so much as to add tempo marks to his already published eight symphonies. However, these marks are still under dispute, as many musicians consider them too quick to be played and even unmusical, whereas others claim them as Bethoven's supposedly written will. In this work, we develop a methodology to extract and analyze the performed tempi from 36 complete symphonic recordings by different conductors. Our results show that conductor tempo choices reveal a systematic deviation from Beethoven's marks, which highlights the salience of "correct tempo" as a perceptive phenomenon shaped by cultural context. The hasty nature of these marks could be explained by the metronome's ambiguous scale reading point, which Beethoven probably misinterpreted.	[Martin-Castro, Almudena] Univ Nacl Educ Distancia, Fac Ciencias, Madrid, Spain; [Ucar, Inaki] Univ Carlos III Madrid, UC3M Santander Big Data Inst, Getafe, Spain	Universidad Nacional de Educacion a Distancia (UNED); Universidad Carlos III de Madrid	Ucar, I (corresponding author), Univ Carlos III Madrid, UC3M Santander Big Data Inst, Getafe, Spain.	inaki.ucar@uc3m.es	Ucar, Iñaki/L-6174-2014	Ucar, Iñaki/0000-0001-6403-5550				[Anonymous], 1982, SOUNDINGS CARDIFF, V9, P38; [Anonymous], 2013, PEDIAT BLOOD CANC S1, V60, pS1; Beck H, 1954, STUDIEN TEMPOPROBLEM; Beethoven Lv, 1822, SINFONIE NR 9 D MOLL, V125; Beethoven Lv, 1961, LETT BEETHOVEN; Berlioz H, 1932, MEMOIRS H BERLIOZ 18; Bingham T, 2017, METRONOMES MUSICAL T; Boltz MG, 2011, MUSIC PERCEPT, V28, P367, DOI 10.1525/MP.2011.28.4.367; Bowen JA, 1993, PERFORMANCE PRACTICE, V6, P77, DOI 10.5642/perfpr.199306.01.04; Budenbender N, 2017, PSYCHOL MUSIC, V45, P665, DOI 10.1177/0305735616671408; Carr V, 2001, BOHMS EROICA; Font F, 2016, 17 INT SOC MUS INF R; G Wilkie T, 1818, REPERTORY PATENT INV; Galton F, 1907, NATURE, V75, P450, DOI 10.1038/075450a0; GELFAND Y, 1985, COLL MUSIC SYM, V25, P92; HALPERN AR, 1988, MUSIC PERCEPT, V6, P193; Iwanaga M, 1998, PERCEPT MOTOR SKILL, V86, P31, DOI 10.2466/pms.1998.86.1.31; Kolisch R, 1943, MUSICAL Q, V29, P169, DOI [10.1093/mq/XXIX.2.169, DOI 10.1093/MQ/XXIX.2.169]; Madison G, 2010, J ACOUST SOC AM, V128, P3032, DOI 10.1121/1.3493462; Noorduin M, 2016, BEETHOVENS TEMPO IND; Nottebohm Gustav, 1872, BEETHOVENIANA AUFSAT; Osborne R, 2007, SURPRISES STORE PLET; Osborne R, 2011, CHAILLYS 1 BEETHOVEN; Percival G, 2014, IEEE-ACM T AUDIO SPE, V22, P1765, DOI 10.1109/TASLP.2014.2348916; Quinn S, 2012, J ACOUST SOC AM, V131, P3595, DOI 10.1121/1.3651236; Schindelin J, 2015, MOL REPROD DEV, V82, P518, DOI 10.1002/mrd.22489; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schindler A, 1966, BEETHOVEN I KNEW HIM; STADLEN P, 1977, MUSIC TIMES, V118, P549, DOI 10.2307/958094; Stadlen P., 1967, MUSIC LETT, Vxlviii, P330, DOI 10.1093/ml/XLVIII.4.330; TALBOT L, 1971, J SOUND VIB, V17, P323, DOI 10.1016/0022-460X(71)90644-4; Temperley N, 1966, MUSIC LETT, V47, P323, DOI [DOI 10.1093/ML/47.4.323, 10.1093/ml/47.4.323]; Tzanetakis G, 2013, INT CONF ACOUST SPEE, P241, DOI 10.1109/ICASSP.2013.6637645; Tzanetakis G., 2000, ORGAN SOUND, V4, P169, DOI DOI 10.1017/S1355771800003071; Young LD, 1991, PROBLEMS REGARDING M	35	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243616	10.1371/journal.pone.0243616	http://dx.doi.org/10.1371/journal.pone.0243616			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326433	Green Published, gold			2022-12-27	WOS:000600176400057
J	Ambel, AA; Mugera, HK; Bain, RES				Ambel, Alemayehu Azeze; Mugera, Harriet Kasidi; Bain, Robert E. S.			Accounting for drinking water quality in measuring multidimensional poverty in Ethiopia	PLOS ONE			English	Article							DEVELOPING-COUNTRIES	The Multidimensional Poverty Index is used increasingly to measure poverty in developing countries. The index is constructed using selected indicators that cover health, education, and living standards dimensions. The accuracy of this tool, however, depends on how each indicator is measured. This study explores the effect of accounting for water quality in multidimensional poverty measurement. Access to drinking water is traditionally measured by water source types. The study uses a more comprehensive measure, access to safely managed drinking water services, which are free from E. coli contamination, available when needed and accessible on premises in line with Sustainable Development Goal target 6.1. The study finds that the new measure increases national multidimensional headcount poverty by 5-13 percentage points, which would mean that 5-13 million more people are multidimensionally poor. It also increases the poverty level in urban areas to a greater extent than in rural areas. The finding is robust to changes in water contamination risk levels and Multidimensional Poverty Index aggregation approaches and weighting structures.	[Ambel, Alemayehu Azeze] World Bank, Dev Data Grp, 1818 H St NW, Washington, DC 20433 USA; [Mugera, Harriet Kasidi] World Bank, Dev Data Grp, Copenhagen, Denmark; [Bain, Robert E. S.] United Nations Childrens Fund UNICEF, Div Data Anal Planning & Monitoring, New York, NY USA	The World Bank; UNICEF	Ambel, AA (corresponding author), World Bank, Dev Data Grp, 1818 H St NW, Washington, DC 20433 USA.	aambel@worldbank.org		Ambel, Alemayehu/0000-0002-0990-4466; Bain, Robert/0000-0001-6577-2923				Alkire S., 2019, OPHI MPI METHODOLOGI, P47; Alkire S, 2014, WORLD DEV, V59, P251, DOI 10.1016/j.worlddev.2014.01.026; Alkire S, 2011, J PUBLIC ECON, V95, P476, DOI 10.1016/j.jpubeco.2010.11.006; Alkire S, 2007, OXF DEV STUD, V35, P347, DOI 10.1080/13600810701701863; Ambel A, 2015, WORLD BANK POLICY RE, P7417; [Anonymous], 2017, DRINKING WATER QUALI; Bain RES, 2012, B WORLD HEALTH ORGAN, V90, P228, DOI 10.2471/BLT.11.094284; Bruck T., 2013, 7364 IZA; Carranza E, POVERTY REDUCTION EC; Carranza E., 2013, ETHIOPIA TRENDS WELL; Central Statistical Agency, 2017, DRINK WAT QUAL ETH R; Dotter C, 2017, DISCUSSION PAPERS, V233; Glewwe P, 2016, HBK ECON, V5, P653, DOI 10.1016/B978-0-444-63459-7.00010-5; IEA, 2011, WORLD EN OUTL; Kostyla C, 2015, SCI TOTAL ENVIRON, V514, P333, DOI 10.1016/j.scitotenv.2015.01.018; Landrine H, 2016, TOB CONTROL, V25, pe142; Oxford Poverty and Human Development Initiative (OPHI), 2019, GLOB MPI COUNTR BRIE; RAVALLION M, 1991, REV INCOME WEALTH, P345; Ronoh P, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17176355; Santos M., 2019, STAT SERIES; Sen A., 1983, POVERTY FAMINES ESSA; WHO/UNICEF, 2018, COR QUEST DRINK WAT; World Bank,, 2015, ETH POV ASS; World Health Organization, 2012, RAP ASS DRINK WAT QU; World Health Organization, 2017, DEPRESSION OTHER COM; Wright JA, 2012, POPUL SPACE PLACE, V18, P116, DOI 10.1002/psp.681	26	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243921	10.1371/journal.pone.0243921	http://dx.doi.org/10.1371/journal.pone.0243921			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH3TP	33320919	Green Published, gold			2022-12-27	WOS:000600339800031
J	Getie, A; Baylie, A; Bante, A; Geda, B; Mesfin, F				Getie, Asmare; Baylie, Amsalu; Bante, Agegnehu; Geda, Biftu; Mesfin, Firehiwot			Pressure ulcer prevention practices and associated factors among nurses in public hospitals of Harari regional state and Dire Dawa city administration, Eastern Ethiopia	PLOS ONE			English	Article							KNOWLEDGE; CARE	Introduction Pressure ulcer is one of the major challenges in hospitals; which endanger patient safety, prolonging hospital stay and contributed to disability and death. Data regarding to pressure ulcer prevention practice are very important to take action. However in Ethiopia, there are limited researches that have been conducted and there is clearly paucity of information on this regard. Hence, this study aimed to assess pressure ulcer prevention practice and associated factors among nurses in public hospitals of Eastern Ethiopia. Methods A cross-sectional study was conducted among randomly selected 422 nurses who were working in the public hospitals of Eastern Ethiopia. Data were collected from the 1(st) February to the 1(st) March 2018 using pretested structured self-administered questionnaire and observational checklist. The collected data were entered into EpiData version 3.1 and exported to SPSS version 22.0 for analysis. Bivariable and multivariable logistic regression with crude and adjusted odds ratios along with the 95% confidence interval was computed and interpreted accordingly. Pressure ulcer prevention was determined based on mean calculation; a result above the mean value was categorized as good pressure ulcer prevention practice, and a P-value of <0.05 was considered to declare a result as statistically significant. Results In this study 51.9% (95% CI: 47.1%, 56.4%) of nurses were reported that they have good pressure ulcer prevention practice. On observation 45.2% of nurses were practicing proper pressure ulcer prevention activities. Pressure ulcer prevention practice were statistically associated with nurses with bachelor degree and above qualification level (AOR = 1.7, 95% CI: 1.02, 2.83), availability of pressure-relieving devices (AOR = 2.2, 95% CI: 1.34, 3.63), being satisfied with their job (AOR = 1.65, 95% CI: 1.09, 2.52) and good knowledge (AOR = 2.3, 95% CI: 1.48, 3.55). Conclusions In this study the self-reported practice and results from observation was substantially low. Continuing education and training should be considered for nurses to enhance their practice regarding pressure ulcer prevention practice.	[Getie, Asmare; Bante, Agegnehu] Arba Minch Univ, Sch Nursing, Coll Med & Hlth Sci, Arba Minch, Ethiopia; [Baylie, Amsalu] Bahir Dar Univ, Sch Nursing, Coll Med & Hlth Sci, Bahir Dar, Ethiopia; [Geda, Biftu; Mesfin, Firehiwot] Haramaya Univ, Sch Publ Hlth, Coll Hlth & Med Sci, Harar, Ethiopia	Arba Minch University; Bahir Dar University; Haramaya University	Getie, A (corresponding author), Arba Minch Univ, Sch Nursing, Coll Med & Hlth Sci, Arba Minch, Ethiopia.	asmaregetie2017@gmail.com		Bante, Agegnehu/0000-0003-0583-6635; Getie, Asmare/0000-0002-4078-0078				Al-Ghamdi A, 2017, AM J NURSING SCI, V6, P387; Albuquerque M A., 2014, J NURSING, V8, P229; [Anonymous], 2013, PANCREATOLOGY, V13, pe1; [Anonymous], 2017, EUR GERIATR MED, V8, pS98; [Anonymous], 2017, COMMUN MATH STAT, V5, P1, DOI DOI 10.1007/S40304-017-0103-Z; Baghaei R, 2016, INT J MED RES HEALTH, V5, P215; Bains Puneet, 2011, Indian J Community Med, V36, P114, DOI 10.4103/0970-0218.84129; Central Statistical Agency (Ethiopia), 2007, POPULATION HOUSING C; Cho I, 2011, INT J MED INFORM, V80, P47, DOI 10.1016/j.ijmedinf.2010.10.019; Edsberg LE, 2016, J WOUND OSTOMY CONT, V43, P585, DOI 10.1097/WON.0000000000000281; Fuel Cells Bulletin, 2015, FUEL CELLS B, V2015, P1, DOI DOI 10.1155/2015/528103; Gunningberg L, 2015, BMJ OPEN; Iacus SM, 2012, POLIT ANAL, V20, P1, DOI 10.1093/pan/mpr013; Johansen E, 2015, HEALTHCARE-BASEL, V3, P417, DOI 10.3390/healthcare3020417; Kallman U, 2009, SCAND J CARING SCI, V23, P334, DOI 10.1111/j.1471-6712.2008.00627.x; Kose I, 2016, INT J CARING SCI, V9, P677; Lupear SK, 2015, NURS CLIN N AM, V50, P411, DOI 10.1016/j.cnur.2015.03.006; Mwebaza I, 2014, NURS RES PRACT, V2014, DOI 10.1155/2014/973602; NPUAP/EPUAP, 2014, EUR PRESS ULC ADV PA; Nurhusien N, 2015, BMC NURS, V14, P34; Ozyurek P, 2016, E J MED, V21, P1; Pancorbo-Hidalgo PL, 2007, J ADV NURS, V58, P327, DOI 10.1111/j.1365-2648.2007.04236.x; Saleh MYN, 2013, J TISSUE VIABILITY, V22, P1, DOI 10.1016/j.jtv.2013.01.003; Sawant N, 2017, INT J SCI REIJSR, V6, P739; Shrestha N, 2016, J- GMC- N., V9, P47; Spector P. E., 2011, JOB SATISFACTION SUR; Strand Tillan, 2010, Intensive Crit Care Nurs, V26, P335, DOI 10.1016/j.iccn.2010.08.006; Taha A S., 2014, NURSES KNOWLEDGE PRA, V2, P247; Tayyib N, 2016, INT WOUND J, V13, P912, DOI 10.1111/iwj.12406; Uba M.N., 2015, INERNATIONAL J NURS, V7, P54, DOI [DOI 10.5897/IJNM2014.0155, 10.5897/ijnm2014.0155, DOI 10.5897/IJNM2014]; World Health Organization, 2017, DEPR OTH COMM MENT D, DOI DOI 10.1109/IEEESTD.2017.7920364; 2017, AM SOC TEST MAT, V3, P520	32	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243875	10.1371/journal.pone.0243875	http://dx.doi.org/10.1371/journal.pone.0243875			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320888	Green Published, gold			2022-12-27	WOS:000600339800044
J	Mumang, AA; Liaury, K; Syamsuddin, S; Maria, IL; Tanra, AJ; Ishida, T; Shimizu-Furusawa, H; Yusuf, I; Furusawa, T				Mumang, Andi Agus; Liaury, Kristian; Syamsuddin, Saidah; Maria, Ida Leida; Tanra, A. Jayalangkara; Ishida, Takafumi; Shimizu-Furusawa, Hana; Yusuf, Irawan; Furusawa, Takuro			Socio-economic-demographic determinants of depression in Indonesia: A hospital-based study	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; LOW-INCOME; PSYCHIATRIC-DISORDERS; NATIONAL SAMPLE; MISSING DATA; HEALTH; SYMPTOMS; RISK; ASSOCIATION; PREVALENCE	The association of socio-economic-demographic (SED; e.g., income-related) factors with depression is widely confirmed in the literature. We conducted a hospital-based case-control study of 160 patients with psychiatrist-diagnosed clinical depression. The control group comprised 160 participants recruited from local communities. We used a questionnaire to collect SED data from all participants. We replaced missing values using multiple imputation analyses and further analyzed the pooled data of five imputations. We also recorded the results from the original analysis and each imputation. Univariate analyses showed income was associated with depression. Multiple logistic regression analyses revealed that, among all SED variables, high income (odds ratio = 2.088 [95% confidence interval = 1.178-3.700]; p = 0.012), middle-level (completed junior or senior high school) education (1.688 [1.042-2.734]; p = 0.033) and cohabitating with four or more family members (1.632 [1.025-2.597]; p = 0.039) were significant predictors for the case group. We conclude that cash income is a determinant of depression in hospital outpatients in Indonesia. This study suggests health policy implications toward better hospital access and service for people with depression in middle- or low-income households, and recommends considering high income as correlated with a high risk of depression, owing to socio-cultural changes.	[Mumang, Andi Agus] Hasanuddin Univ, Med Fac, Postgrad Doctoral Program, Makassar, South Sulawesi, Indonesia; [Liaury, Kristian; Syamsuddin, Saidah; Tanra, A. Jayalangkara] Hasanuddin Univ, Med Fac, Dept Psychiat, Makassar, South Sulawesi, Indonesia; [Maria, Ida Leida] Hasanuddin Univ, Publ Hlth Fac, Dept Epidemiol, Makassar, South Sulawesi, Indonesia; [Ishida, Takafumi] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo, Japan; [Shimizu-Furusawa, Hana] Nippon Med Sch, Dept Analyt Human Pathol, Tokyo, Japan; [Yusuf, Irawan] Hasanuddin Univ, Med Fac, Dept Physiol, Makassar, South Sulawesi, Indonesia; [Furusawa, Takuro] Kyoto Univ, Grad Sch Asian & African Area Studies, Dept Ecol & Environm, Kyoto, Japan	Universitas Hasanuddin; Universitas Hasanuddin; Universitas Hasanuddin; University of Tokyo; Nippon Medical School; Universitas Hasanuddin; Kyoto University	Mumang, AA (corresponding author), Hasanuddin Univ, Med Fac, Postgrad Doctoral Program, Makassar, South Sulawesi, Indonesia.	andiagusmumang93@gmail.com	Usman, Andi Nilawati/AEZ-7198-2022; Mumang, Andi Agus/AAD-7531-2021	Mumang, Andi Agus/0000-0003-1050-8812	JSPS KAKENHI [19KK0239, 16H05828]; Public Health Research Foundation; SPIRITS 2016 of Kyoto University	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Public Health Research Foundation; SPIRITS 2016 of Kyoto University	This study was financially supported by SPIRITS 2016 of Kyoto University and JSPS KAKENHI (Grant Number_16H05828 (leader: T. Ishida) and 19KK0239 (T. Furusawa)) and Public Health Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar-Danesh Noori, 2007, Int J Ment Health Syst, V1, P4, DOI 10.1186/1752-4458-1-4; Andersen I, 2009, J EPIDEMIOL COMMUN H, V63, P575, DOI 10.1136/jech.2008.082719; [Anonymous], 2018, NAT CLIM CHANGE, V8, P1, DOI 10.1038/s41558-017-0058-9; [Anonymous], 2018, J ORTHOP TRAUMA, V32, pS141; Assari S, 2018, J RACIAL ETHN HEALTH, V5, P808, DOI 10.1007/s40615-017-0426-1; Assari S, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9020029; Assari S, 2017, J RACIAL ETHN HEALTH, V4, P385, DOI 10.1007/s40615-016-0239-7; Bailey RK, 2019, NEUROPSYCH DIS TREAT, V15, P603, DOI 10.2147/NDT.S128584; Bannai A, 2014, SCAND J WORK ENV HEA, V40, P5, DOI 10.5271/sjweh.3388; Braithwaite J, 2005, INT J QUAL HEALTH C, V17, P541, DOI 10.1093/intqhc/mzi060; Christiani Y, 2015, J AFFECT DISORDERS, V182, P76, DOI 10.1016/j.jad.2015.04.042; DOHRENWEND BP, 1990, SOC PSYCH PSYCH EPID, V25, P41; DOHRENWEND BP, 1992, SCIENCE, V255, P946, DOI 10.1126/science.1546291; EASTERLIN RA, 1995, J ECON BEHAV ORGAN, V27, P35, DOI 10.1016/0167-2681(95)00003-B; Easterlin RA, 2010, P NATL ACAD SCI USA, V107, P22463, DOI 10.1073/pnas.1015962107; Economou M, 2019, PSYCHIAT RES, V279, P172, DOI 10.1016/j.psychres.2019.02.058; Egede LE, 2003, DIABETES CARE, V26, P104, DOI 10.2337/diacare.26.1.104; Ekawati Fitriana Murriya, 2017, Asia Pac Fam Med, V16, P4, DOI 10.1186/s12930-017-0034-6; Freeman A, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3638-0; Sharma Gautam D, 2019, HEALTH CARE WOMEN IN, V40, P914, DOI 10.1080/07399332.2019.1597366; GEERTZ C, 1984, MAN, V19, P511, DOI 10.2307/2802324; Gero K, 2017, SOC SCI MED, V189, P138, DOI 10.1016/j.socscimed.2017.07.028; GOLDBERG EM, 1963, BRIT J PSYCHIAT, V109, P785, DOI 10.1192/bjp.109.463.785; Hailemichael Y, 2019, INT J EQUITY HEALTH, V18, DOI 10.1186/s12939-019-1020-4; Han KM, 2018, J PSYCHIATR RES, V98, P133, DOI 10.1016/j.jpsychires.2018.01.002; Hidaka BH, 2012, J AFFECT DISORDERS, V140, P205, DOI 10.1016/j.jad.2011.12.036; Hoebel J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169764; Hong JH, 2011, WORLD PSYCHIATRY, V10, P40; Honjo K, 2018, SOC SCI MED, V217, P65, DOI 10.1016/j.socscimed.2018.09.043; Hounkpatin HO, 2015, SOC INDIC RES, V124, P637, DOI 10.1007/s11205-014-0795-3; Hudson CG, 2005, AM J ORTHOPSYCHIAT, V75, P3, DOI 10.1037/0002-9432.75.1.3; Hudson DL, 2012, SOC PSYCH PSYCH EPID, V47, P373, DOI 10.1007/s00127-011-0348-x; Jakobsen JC, 2017, BMC MED RES METHODOL, V17, DOI 10.1186/s12874-017-0442-1; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Larrimore J, 2011, MILBANK Q, V89, P694, DOI 10.1111/j.1468-0009.2011.00647.x; Lee KJ, 2010, AM J EPIDEMIOL, V171, P624, DOI 10.1093/aje/kwp425; Li NP, 2018, CURR DIR PSYCHOL SCI, V27, P38, DOI 10.1177/0963721417731378; Liggins J, 2005, GEN HOSP PSYCHIAT, V27, P359, DOI 10.1016/j.genhosppsych.2005.05.006; Liu QQ, 2020, J PSYCHIATR RES, V126, P134, DOI 10.1016/j.jpsychires.2019.08.002; Liu Yang, 2015, Int J Stat Med Res, V4, P287; Lorant V, 2003, AM J EPIDEMIOL, V157, P98, DOI 10.1093/aje/kwf182; Lorant V, 2007, BRIT J PSYCHIAT, V190, P293, DOI 10.1192/bjp.bp.105.020040; Mahendradhata Y, 2017, HLTH SYSTEMS TRANSIT, V7; Marmot M, 2002, HEALTH AFFAIR, V21, P31, DOI 10.1377/hlthaff.21.2.31; Maselko J, 2018, SSM-POPUL HLTH, V4, P1, DOI 10.1016/j.ssmph.2017.10.004; Mossakowski K. N., 2014, WILEY BLACKWELL ENCY, DOI [10.1002/9781118410868.wbehibs262, DOI 10.1002/9781118410868.WBEHIBS262]; Pabayo R, 2014, J EPIDEMIOL COMMUN H, V68, P110, DOI 10.1136/jech-2013-203093; Peltzer K, 2018, ASIAN J PSYCHIATR, V33, P52, DOI 10.1016/j.ajp.2018.03.017; Perkins NJ, 2018, AM J EPIDEMIOL, V187, P568, DOI 10.1093/aje/kwx348; Polo AJ, 2019, CLIN PSYCHOL REV, V67, P22, DOI 10.1016/j.cpr.2018.09.004; Pols H, 2007, HIST PSYCHOL, V10, P111, DOI 10.1037/1093-4510.10.2.111; Pond E, 2019, J ATTEN DISORD, V23, P940, DOI 10.1177/1087054716653214; Richters JE, 1999, J ABNORM PSYCHOL, V108, P438; Riskesdas, 2018, RIS KES DAS 2018; ROSS CE, 1985, J HEALTH SOC BEHAV, V26, P312, DOI 10.2307/2136655; RUSHING WA, 1979, AM J SOCIOL, V84, P1175, DOI 10.1086/226905; Shelton RC, 2011, HEALTH EDUC BEHAV, V38, P471, DOI 10.1177/1090198110382502; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Subandi MA, 2021, TRANSCULT PSYCHIATRY, V58, P3, DOI 10.1177/1363461520916290; Sun J, 2012, J PUBLIC HEALTH-UK, V34, P340, DOI 10.1093/pubmed/fdr107; Tampubolon G, 2014, SOC SCI MED, V106, P20, DOI 10.1016/j.socscimed.2014.01.012; ten Kate J, 2017, SOCIOL SPECTRUM, V37, P63, DOI 10.1080/02732173.2016.1274248; Ulya Z, 2019, INT J LAW PSYCHIAT, V66, DOI 10.1016/j.ijlp.2019.101477; Wilkinson R, 2019, SOC MENT HEALTH, V9, P95, DOI 10.1177/2156869318761781; Williamson DL, 2006, HEALTH POLICY, V76, P106, DOI 10.1016/j.healthpol.2005.05.005; Zimmerman FJ, 2005, HEALTH ECON, V14, P1197, DOI 10.1002/hec.1011	67	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0244108	10.1371/journal.pone.0244108	http://dx.doi.org/10.1371/journal.pone.0244108			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH3TP	33320917	gold, Green Published			2022-12-27	WOS:000600339800033
J	Plymoth, M; Sanders, EJ; Van der Elst, EM; Medstrand, P; Tesfaye, F; Winqvist, N; Balcha, T; Bjorkman, P				Plymoth, Martin; Sanders, Eduard J.; Van der Elst, Elise M.; Medstrand, Patrik; Tesfaye, Fregenet; Winqvist, Niclas; Balcha, Taye; Bjorkman, Per			Socio-economic condition and lack of virological suppression among adults and adolescents receiving antiretroviral therapy in Ethiopia	PLOS ONE			English	Article							SOCIAL DETERMINANTS; DRUG-RESISTANCE; HIV; INCOME; RISK; TUBERCULOSIS; INDIVIDUALS; ADHERENCE; MIGRATION; VALIDITY	Introduction The potential impact of socio-economic condition on virological suppression during antiretroviral treatment (ART) in sub-Saharan Africa is largely unknown. In this case-control study, we compared socio-economic factors among Ethiopian ART recipients with lack of virological suppression to those with undetectable viral load (VL). Methods Cases (VL>1000 copies/ml) and controls (VL<150 copies/ml) aged <greater than or equal to>15years, with ART for >6 months and with available VL results within the last 3 months, were identified from registries at public ART clinics in Central Ethiopia. Questionnaire-based interviews on socio-economic characteristics, health condition and transmission risk behavior were conducted. Univariate variables associated with VL>1000 copies/ml (p<0.25) were added to a multivariable logistic regression model. Results Among 307 participants (155 cases, 152 controls), 61.2% were female, and the median age was 38 years (IQR 32-46). Median HIV-RNA load among cases was 6,904 copies/ml (IQR 2,843-26,789). Compared to controls, cases were younger (median 36 vs. 39 years; p = 0.004), more likely to be male (46.5% vs. 30.9%; p = 0.005) and had lower pre-ART CD4 cell counts (170 vs. 220 cells/<mu>l; p = 0.009). In multivariable analysis of urban residents (94.8%), VL>1000 copies/ml was associated with lower relative wealth (adjusted odds ratio [aOR] 2.98; 95% CI 1.49-5.94; p = 0.016), geographic work mobility (aOR 6.27, 95% CI 1.82-21.6; p = 0.016), younger age (aOR 0.94 [year], 95% CI 0.91-0.98; p = 0.011), longer duration of ART (aOR 1.19 [year], 95% CI 1.07-1.33; p = 0.020), and suboptimal (aOR 3.83, 95% CI 1.33-10.2; p = 0.048) or poor self-perceived wellbeing (aOR 9.75, 95% CI 2.85-33.4; p = 0.012), after correction for multiple comparisons. High-risk sexual behavior and substance use was not associated with lack of virological suppression. Conclusion Geographic work mobility and lower relative wealth were associated with lack of virological suppression among Ethiopian ART recipients in this predominantly urban population. These characteristics indicate increased risk of treatment failure and the need for targeted interventions for persons with these risk factors.	[Plymoth, Martin; Tesfaye, Fregenet; Winqvist, Niclas; Balcha, Taye; Bjorkman, Per] Lund Univ, Clin Infect Med, Dept Translat Med, Malmo, Sweden; [Sanders, Eduard J.; Van der Elst, Elise M.] Kenya Med Res Inst KEMRI, Ctr Geog Med Res, Kilifi, Kenya; [Sanders, Eduard J.] Univ Oxford, Nuffield Dept Clin Med, Oxford, England; [Medstrand, Patrik] Lund Univ, Clin Virol, Dept Translat Med, Malmo, Sweden; [Bjorkman, Per] Skane Univ Hosp, Dept Infect Dis, Malmo, Sweden	Lund University; Kenya Medical Research Institute; University of Oxford; Lund University; Lund University; Skane University Hospital	Plymoth, M (corresponding author), Lund Univ, Clin Infect Med, Dept Translat Med, Malmo, Sweden.	martin.plymoth@gmail.com		Plymoth, Martin/0000-0002-2036-0383; Sanders, Eduard/0000-0002-1062-8921	Swedish government [40103]; Swedish county councils, the ALF-agreement [40103]	Swedish government; Swedish county councils, the ALF-agreement	The authors declare no conflicts of interest. This work was supported by the Swedish State under the agreement between the Swedish government and the county councils, the ALF-agreement [reference no 40103]; and a private donation to Lund University. PB was the recipient of both these grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aickin M, 1996, AM J PUBLIC HEALTH, V86, P726, DOI 10.2105/AJPH.86.5.726; Almeida-Brasil CC, 2018, AIDS, V32, P1323, DOI [10.1097/QAD.0000000000001822, 10.1097/qad.0000000000001822]; [Anonymous], 2017, J PEDIAT REHAB MED, V10, ps1; [Anonymous], 2018, DEV COGN NEUROSCI, V21, DOI 10.1016/S1878-9293(18)30129-4; Arimide DA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205446; Assefa Y, 2017, INT J INFECT DIS, V60, P70, DOI 10.1016/j.ijid.2017.05.012; Bernard C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181960; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Bulage L, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2428-3; Burch LS, 2016, LANCET PUBLIC HEALTH, V1, pE26, DOI 10.1016/S2468-2667(16)30002-0; Burch LS, 2016, AIDS, V30, P1147, DOI 10.1097/QAD.0000000000001068; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Bygrave H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013198; Camlin CS, 2019, CURR HIV-AIDS REP, V16, P314, DOI 10.1007/s11904-019-00457-2; Camlin CS, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25136; Central statistical agency (CSA) [Ethiopia] and ICF, 2016, ETH DEM HLTH SURV 20; Chakraborty NM, 2016, GLOB HEALTH-SCI PRAC, V4, P141, DOI 10.9745/GHSP-D-15-00384; Cherutich P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154318; Davey DJ, 2018, INT J STD AIDS, V29, P603, DOI 10.1177/0956462417748859; Deeks SG, 2000, CLIN INFECT DIS, V30, pS177, DOI 10.1086/313855; Degarege A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211205; Desta AA, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-019-4732-6; Di Gennaro F, 2017, TUBERCULOSIS, V103, P44, DOI 10.1016/j.tube.2017.01.002; Dobra A, 2017, AIDS, V31, P137, DOI 10.1097/QAD.0000000000001292; Duarte R, 2018, PULMONOLOGY, V24, P115, DOI 10.1016/j.rppnen.2017.11.003; Edwards JK, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25226; Ethiopian Federal Ministry of Health, 2017, NAT GUID COMPR HIV P; Faturiyele IO, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5961-0; Faturiyele I, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5594-3; Federal Statistical Office, 2018, JAARRAPPORT INTEGRAT; Flynn AG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189055; Franklin ST G., 2016, MONITORING EVALUATIN; Gelaye B, 2013, PSYCHIAT RES, V210, P653, DOI 10.1016/j.psychres.2013.07.015; Green D, 2019, SYST REV-LONDON, V8, DOI 10.1186/s13643-019-1024-6; Hodgson R, 2002, ALCOHOL ALCOHOLISM, V37, P61, DOI 10.1093/alcalc/37.1.61; Hunt J, 2008, FINAL EVALUATION USA; IBM Corp. Released, 2017, IBM SPSS STAT WIND V; Jain V, 2017, LANCET HIV, V4, pE122, DOI 10.1016/S2352-3018(16)30220-X; Joint United Nations Programme on HIV/AIDS, 2017, FACT SHEET ETH; Joint United Nations Programme on HIV/AIDS, 2019, AIDSINFO 2019; Katz IT, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18640; Kennedy MC, 2018, AIDS, V32, P1059, DOI [10.1097/QAD.0000000000001777, 10.1097/qad.0000000000001777]; Kibret GD, 2019, INFECT DIS POVERTY, V8, DOI 10.1186/s40249-019-0594-9; Lalla-Edward ST, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156975; Lingappa JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012598; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Marukutira T, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000015994; Metrics for Management, 2018, METR MAN; Minior T, 2017, J INFECT DIS, V216, pS812, DOI 10.1093/infdis/jix403; Mooney A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-771; Mulu A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186619; Nyongesa MK, 2019, BMC PSYCHIATRY, V19, DOI 10.1186/s12888-019-2339-5; Olawore O, 2018, LANCET HIV, V5, pE181, DOI 10.1016/S2352-3018(18)30009-2; Orrell C, 2003, AIDS, V17, P1369, DOI 10.1097/00002030-200306130-00011; Paik M. C., 2013, STAT METHODS RATES P; Peltzer K, 2013, J HEALTH POPUL NUTR, V31, P150; Pizzol Damiano, 2018, BMC Res Notes, V11, P99, DOI 10.1186/s13104-018-3209-9; Powers KA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192785; Raho-Moussa M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213019; Reepalu A, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx219; Reepalu A, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu039; Rohr JK, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20987; Stirratt MJ, 2018, SEX TRANSM INFECT, V94, P206, DOI 10.1136/sextrans-2017-053178; Telele NF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200505; The World Bank, 2018, WORLD DEV IND; Tiruneh K, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1468-0; Tiyou A, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-39; United Nations Development Programme Ethiopia, 2018, ETH PROGR ER POV; Weine SM, 2012, AIDS BEHAV, V16, P1605, DOI 10.1007/s10461-012-0183-4	69	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0244066	10.1371/journal.pone.0244066	http://dx.doi.org/10.1371/journal.pone.0244066			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH3TP	33320900	gold, Green Published			2022-12-27	WOS:000600339800013
J	Zhang, MC; He, SY; Qin, B; Jin, XJ; Wang, MX; Ren, CY; Cao, L; Zhang, YX				Zhang, Mingcong; He, Songyu; Qin, Bin; Jin, Xijun; Wang, Mengxue; Ren, Chunyuan; Cao, Liang; Zhang, Yuxian			Exogenous melatonin reduces the inhibitory effect of osmotic stress on antioxidant properties and cell ultrastructure at germination stage of soybean	PLOS ONE			English	Article							LIPID-PEROXIDATION; DROUGHT STRESS; SEED-GERMINATION; HYDROGEN-PEROXIDE; ENZYME-ACTIVITIES; WATER-DEFICIT; TOLERANCE; PROLINE; GROWTH; ELONGATION	Understanding the relationship between exogenous melatonin and water deficit stress is crucial for alleviating the effects of water deficit stress at germination stage of soybean (Glycine max (L.) Merrill) in agriculture. This study investigated the effects of exogenous melatonin on soybean antioxidant properties and cell ultrastructure under water deficit stress induced by polyethylene glycol (PEG) 6000. The drought-sensitive soybean variety Suinong 26 was used as the material to study the effects of different concentrations of melatonin (0, 300, 500 mu mol.L-1) soaking soybean seeds under drought stress (PEG-6000: 3% and 6%). The results showed that the germination rate (GR), germination potential (GP), germination index (GI) and radicle shape of soybean were affected negatively to different degrees under PEG stress. Moreover, stress induced by different PEG concentrations overproduced the content of reactive oxygen species (H2O2, O-2.(-)) in cells, leading to increased lipid membrane peroxidation as electrolyte leakage (EL) and malondialdehyde (MDA) content, which resulted in impaired cell integrity. However, after seeds soaking with melatonin, the lipid peroxidation of the cell membrane was reduced, and the activities of antioxidant enzymes such as superoxide dismutase (SOD), peroxidase (POD), catalase (CAT), and ascorbate peroxidase (APX) further increased to minimize the excessive generation of ROS. Similar results were obtained for soluble protein and proline, that may help in regulating the osmotic pressure and maintain cellular integrity. With the interaction of these enzymes, compared with 300 mu mol.L-1 melatonin, 500 mu mol.L-1 melatonin could more effective to remove the ROS and reduce cell peroxidation. Overall, 500 mu mol.L-1 melatonin performed better than 300 mu mol.L-1. In conclusion, the seed soaking with melatonin promoted the germination of soybean seeds under water stress.	[Zhang, Mingcong; He, Songyu; Qin, Bin; Jin, Xijun; Wang, Mengxue; Ren, Chunyuan; Cao, Liang; Zhang, Yuxian] Heilongjiang Bayi Agr Univ, Coll Agron, Daqing, Peoples R China	Heilongjiang Bayi Agricultural University	Zhang, YX (corresponding author), Heilongjiang Bayi Agr Univ, Coll Agron, Daqing, Peoples R China.	zyx_lxy@126.com			National Natural Science Foundation of China [31801303]; China Postdoctoral Science Foundation [2016M591561]; Natural Science Foundation of Heilongjiang Province of China [C2016042]; Doctoral Scientific Research Start-up Foundation of Heilongjiang Bayi Agricultural University of China [XYB2014-04]; Key Scientific Research Projects of Heilongjiang Farms and Land Reclamation administration [HKKY190206-1]; Applied Technology Research and Development Project of Heilongjiang Province [GA19B101-02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Foundation of Heilongjiang Province of China(Natural Science Foundation of Heilongjiang Province); Doctoral Scientific Research Start-up Foundation of Heilongjiang Bayi Agricultural University of China; Key Scientific Research Projects of Heilongjiang Farms and Land Reclamation administration; Applied Technology Research and Development Project of Heilongjiang Province	The sequencing and analysis were financially supported by the National Natural Science Foundation of China (No. 31801303), the China Postdoctoral Science Foundation (No. 2016M591561), the Natural Science Foundation of Heilongjiang Province of China (No. C2016042), the Doctoral Scientific Research Start-up Foundation of Heilongjiang Bayi Agricultural University of China (No. XYB2014-04), the Key Scientific Research Projects of Heilongjiang Farms and Land Reclamation administration (No. HKKY190206-1), and Applied Technology Research and Development Project of Heilongjiang Province (No. GA19B101-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedi T, 2010, CZECH J GENET PLANT, V46, P27, DOI 10.17221/67/2009-CJGPB; Ahmad P, 2008, J PLANT BIOL, V51, P167, DOI 10.1007/BF03030694; AKINCI S, 2014, APPROACHES PLANT STR, DOI DOI 10.1007/978-81-322-1620-9_8; Anjum SA, 2012, SCI HORTIC-AMSTERDAM, V140, P66, DOI 10.1016/j.scienta.2012.03.028; Arnao MB, 2007, J PINEAL RES, V42, P147, DOI 10.1111/j.1600-079X.2006.00396.x; Arnao MB, 2009, J PINEAL RES, V46, P295, DOI 10.1111/j.1600-079X.2008.00660.x; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; BEERS RF, 1952, J BIOL CHEM, V195, P133; CHAITANYA KSK, 1994, NEW PHYTOL, V126, P623, DOI 10.1111/j.1469-8137.1994.tb02957.x; Chaoui A, 1997, PLANT SCI, V127, P139, DOI 10.1016/S0168-9452(97)00115-5; Cui GB, 2017, PLANT PHYSIOL BIOCH, V118, P138, DOI 10.1016/j.plaphy.2017.06.014; Das K, 2014, FRONT ENV SCI-SWITZ, V2, DOI 10.3389/fenvs.2014.00053; Devi M. K. Akitha, 2015, Proceedings of the Indian National Science Academy Part B Biological Sciences, V85, P35, DOI 10.1007/s40011-013-0244-0; Ding F, 2017, MECH MELATONIN ALLEV, P15; EGLEY GH, 1983, PLANTA, V157, P224, DOI 10.1007/BF00405186; EMMERICH WE, 1990, AGRON J, V82, P1103, DOI 10.2134/agronj1990.00021962008200060015x; FOYER CH, 1994, PLANT CELL ENVIRON, V17, P507, DOI 10.1111/j.1365-3040.1994.tb00146.x; Fukao T, 2011, PLANT CELL, V23, P412, DOI 10.1105/tpc.110.080325; Gao WY, 2018, MOLECULES, V23, DOI 10.3390/molecules23071580; Gong Biao, 2017, Scientia Agricultura Sinica, V50, P2326; Grigorova B, 2011, BIOL PLANTARUM, V55, P105, DOI 10.1007/s10535-011-0014-x; Guo YY, 2018, RUSS J PLANT PHYSL+, V65, P244, DOI 10.1134/S1021443718020127; Hameed A, 2013, BIOL PLANTARUM, V57, P370, DOI 10.1007/s10535-012-0286-9; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Hernandez-Ruiz J, 2008, J AGR FOOD CHEM, V56, P10567, DOI 10.1021/jf8022063; Hoekstra FA, 2001, TRENDS PLANT SCI, V6, P431, DOI 10.1016/S1360-1385(01)02052-0; Kala S., 2011, J SCI RES, V55, P65, DOI DOI 10.1080/02827581.2011.517949; Kaya MD, 2006, EUR J AGRON, V24, P291, DOI 10.1016/j.eja.2005.08.001; Khalid KA, 2010, SCI HORTIC-AMSTERDAM, V125, P159, DOI 10.1016/j.scienta.2010.03.009; Khan MN, 2019, IND CROP PROD, V140, DOI 10.1016/j.indcrop.2019.111597; Kumar S., 2014, SABRAO Journal of Breeding and Genetics, V46, P217; LERNER AB, 1958, J AM CHEM SOC, V80, P2587, DOI 10.1021/ja01543a060; Li L, 2014, SCI REP-UK, V4, DOI 10.1038/srep05859; Lum MS, 2014, J ANIM PLANT SCI, V24, P1487; Man D, 2011, HORTSCIENCE, V46, P1027, DOI 10.21273/HORTSCI.46.7.1027; Meher, 2018, SAUDI J BIOL SCI, V25, P285, DOI 10.1016/j.sjbs.2017.04.008; Meng JF, 2014, J PINEAL RES, V57, P200, DOI 10.1111/jpi.12159; MICHEL BE, 1973, PLANT PHYSIOL, V51, P914, DOI 10.1104/pp.51.5.914; MISRA HP, 1972, J BIOL CHEM, V247, P3170; MUKHERJEE SP, 1983, PHYSIOL PLANTARUM, V58, P166, DOI 10.1111/j.1399-3054.1983.tb04162.x; Muscolo A, 2014, J PLANT INTERACT, V9, P354, DOI 10.1080/17429145.2013.835880; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Ni ZY, 2013, PLANT MOL BIOL, V82, P113, DOI 10.1007/s11103-013-0040-5; Okcu Gamze, 2005, Turkish Journal of Agriculture and Forestry, V29, P237; Park S, 2012, J PINEAL RES, V53, P385, DOI 10.1111/j.1600-079X.2012.01008.x; Patane C, 2016, ACTA PHYSIOL PLANT, V38, DOI 10.1007/s11738-016-2135-5; Posmyk MM, 2009, J PINEAL RES, V46, P214, DOI 10.1111/j.1600-079X.2008.00652.x; Qayyum A, 2011, AFR J BIOTECHNOL, V10, P14038, DOI 10.5897/AJB11.2220; Reiter RJ, 2007, ACTA BIOCHIM POL, V54, P1; Rezayian M, 2018, SOIL SCI PLANT NUTR, V64, P360, DOI 10.1080/00380768.2018.1436407; Sandalio LM, 2008, METHOD ENZYMOL, V440, P397, DOI 10.1016/S0076-6879(07)00825-7; Sethy Sunil Kumar, 2013, J Nat Sci Biol Med, V4, P272, DOI 10.4103/0976-9668.116964; SHIDA CS, 1994, J PINEAL RES, V16, P198, DOI 10.1111/j.1600-079X.1994.tb00102.x; Silva EN, 2010, J PLANT PHYSIOL, V167, P1157, DOI 10.1016/j.jplph.2010.03.005; Sofo A, 2015, INT J MOL SCI, V16, P13561, DOI 10.3390/ijms160613561; Stajner D, 2011, AFR J BIOTECHNOL, V10, P1609; SUTINEN ML, 1992, TREE PHYSIOL, V11, P241, DOI 10.1093/treephys/11.3.241; Suzuki N, 2012, PLANT CELL ENVIRON, V35, P259, DOI 10.1111/j.1365-3040.2011.02336.x; Tan DX, 2000, FREE RADICAL BIO MED, V29, P1177, DOI 10.1016/S0891-5849(00)00435-4; Turkan I, 2005, PLANT SCI, V168, P223, DOI 10.1016/j.plantsci.2004.07.032; Velazquez-Marquez S, 2015, PLANT PHYSIOL BIOCH, V96, P29, DOI 10.1016/j.plaphy.2015.07.006; Wang WB, 2009, PLANT PHYSIOL BIOCH, V47, P570, DOI 10.1016/j.plaphy.2009.02.009; Wu CH, 2011, AFR J BIOTECHNOL, V10, P17954, DOI 10.5897/AJB11.2018; [邢国芳 Xing Guofang], 2015, [植物生理学报, Plant Physiology Journal], V51, P2101; Xiong L, 2002, PLANT CELL ENVIRON, V25, P131, DOI 10.1046/j.1365-3040.2002.00782.x; Yamamoto Y, 2001, PLANT PHYSIOL, V125, P199, DOI 10.1104/pp.125.1.199; Yang W, 2020, TRENDS MICROBIOL, V28, P68, DOI 10.1016/j.tim.2019.08.002; Yang Y, 2008, ACTA PHYSIOL PLANT, V30, P433, DOI 10.1007/s11738-008-0140-z; Zhang HJ, 2014, J PINEAL RES, V57, P269, DOI 10.1111/jpi.12167; Zhang HM, 2014, J PINEAL RES, V57, P131, DOI 10.1111/jpi.12162; Zhang JT, 2009, SOIL SCI PLANT NUTR, V55, P685, DOI 10.1111/j.1747-0765.2009.00411.x; Zhang MC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226542; Zhang N, 2013, J PINEAL RES, V54, P15, DOI 10.1111/j.1600-079X.2012.01015.x; Zhao MS, 2010, SCIENCE, V329, P940, DOI [10.1126/science.1192666, 10.1126/science.1189590]; Zou JN, 2019, PHOTOSYNTHETICA, V57, P512, DOI 10.32615/ps.2019.066; Zou JingNan, 2020, Acta Agronomica Sinica, V46, P745, DOI 10.3724/SP.J.1006.2020.94111	76	12	12	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243537	10.1371/journal.pone.0243537	http://dx.doi.org/10.1371/journal.pone.0243537			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320882	Green Published, gold			2022-12-27	WOS:000600339800012
J	Almomani, BA; Khasawneh, RA; Saqan, R; Alnajjar, MS; Al-Natour, L				Almomani, Basima A.; Khasawneh, Rawand A.; Saqan, Rola; Alnajjar, Munther S.; Al-Natour, Lara			Predictive utility of prior positive urine culture of extended- spectrum beta -lactamase producing strains	PLOS ONE			English	Article							ESCHERICHIA-COLI; TRACT-INFECTION; RISK-FACTORS; ENTEROBACTERIACEAE; EPIDEMIOLOGY; SUSCEPTIBILITY; COLONIZATION; BACTEREMIA; OUTCOMES; IMPACT	Rising incidence of extended- spectrum beta-lactamase (ESBL) induced urinary tract infections (UTIs) is an increasing concern worldwide. Thus, it is of paramount importance to investigate novel approaches that can facilitate the identification and guide empiric antibiotic therapy in such episodes. The study aimed to evaluate the usability of antecedent ESBL-positive urine culture to predict the pathogenic identity of future ones. Moreover, the study evaluated the accuracy of selected empiric therapy in index episodes. This was a retrospective study that included 693 cases with paired UTI episodes, linked to two separate hospital admissions within 12 month-period, and a conditional previous ESBL positive episode. Pertinent information was obtained by reviewing patients' medical records and computerized laboratory results. Multivariate analysis showed that shorter interval between index and previous episodes was significantly associated with increased chance of ESBL-positive results in current culture (OR = 0.912, 95CI% = 0.863-0.963, p = 0.001). Additionally, cases with ESBL-positive results in current culture were more likely to have underlying urological/surgical condition (OR = 1.416, 95CI% = 1.018-1.969, p = 0.039). Investigations of the accuracy of current empirical therapy revealed that male patients were less accurately treated compared to female patients (OR = 0.528, 95CI% = 0.289-0.963, p = 0.037). Furthermore, surgical patients were treated less accurately compared to those treated in internal ward (OR = 0.451, 95CI% = 0.234-0.870, p = 0.018). Selecting an agent concordant with previous microbiologic data significantly increased the accuracy of ESBL-UTIs therapy (p<0.001). A quick survey of the previous ESBL urine culture results can guide practitioners in the selection of empiric therapy for the pending current culture and thus improve treatment accuracy.	[Almomani, Basima A.; Khasawneh, Rawand A.; Al-Natour, Lara] Jordan Univ Sci & Technol, Fac Pharm, Dept Clin Pharm, Irbid, Jordan; [Saqan, Rola] Jordan Univ Sci & Technol, Fac Med, Dept Pediat & Neonatol, Irbid, Jordan; [Alnajjar, Munther S.] Al Ahliyya Amman Univ, Coll Pharm, Dept Biopharmaceut & Clin Pharm, Amman, Jordan	Jordan University of Science & Technology; Jordan University of Science & Technology; Al-Ahliyya Amman University	Almomani, BA (corresponding author), Jordan Univ Sci & Technol, Fac Pharm, Dept Clin Pharm, Irbid, Jordan.	baalmomani1@just.edu.jo		Almomani, Basima/0000-0002-2229-5837; Alnajjar, Munther/0000-0002-8472-0173	Jordan University of Science and Technology, Irbid, Jordan [379/2019]	Jordan University of Science and Technology, Irbid, Jordan	Basima Almomani (BA) received a grant (reference number 379/2019) from Deanship of Research at Jordan University of Science and Technology, Irbid, Jordan. http://www.just.edu.jo/Pages/Default.aspx.The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript The funder provided support in the form of salaries for authors [BA, RK, RS and LA], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section".	Akram Mohammed, 2007, Ann Clin Microbiol Antimicrob, V6, P4, DOI 10.1186/1476-0711-6-4; Almomani BA, 2018, INFECTION, V46, P495, DOI 10.1007/s15010-018-1148-y; Alnajjar MS, 2019, INFECTION, V47, P781, DOI 10.1007/s15010-019-01305-6; Amin O, 2020, PEDIATR INFECT DIS J, V39, P211, DOI 10.1097/INF.0000000000002531; Anesi JA, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3804-y; [Anonymous], 2019, MEDICINA LITHUANIA, DOI DOI 10.3390/MEDICINA55070356; [Anonymous], 2019, QUALITY MANAGEMENT, V11, pS1007; Batchoun Raymond G, 2009, Int J Microbiol, V2009, P513874, DOI 10.1155/2009/513874; Behzadi P, 2021, ADV EXP MED BIOL, V1323, P35, DOI 10.1007/5584_2020_566; Briongos-Figuero LS, 2012, INT J CLIN PRACT, V66, P891, DOI 10.1111/j.1742-1241.2012.02991.x; Christiaens G, 2006, J HOSP INFECT, V62, P386, DOI 10.1016/j.jhin.2005.09.014; Chu CM, 2018, AM J OBSTET GYNECOL, V219, P40, DOI 10.1016/j.ajog.2017.12.231; Clinical and Laboratory Standards Institute (CLSI), 2014, M100S24 CLSI S; Dason S, 2011, CUAJ-CAN UROL ASSOC, V5, P316, DOI 10.5489/cuaj.11214; Dickstein Y, 2016, ANTIMICROB AGENTS CH, V60, P4717, DOI 10.1128/AAC.00202-16; Eisenbeiss W, 2012, INT J BURNS TRAUMA, V2, P71; Fan NC, 2014, J MICROBIOL IMMUNOL, V47, P399, DOI 10.1016/j.jmii.2013.05.006; Flores-Mireles AL, 2015, NAT REV MICROBIOL, V13, P269, DOI 10.1038/nrmicro3432; Gajdacs M, 2020, LIFE-BASEL, V10, DOI 10.3390/life10020016; Garcia-Tello A, 2018, SCAND J UROL, V52, P70, DOI 10.1080/21681805.2017.1373698; Goulenok T, 2013, J HOSP INFECT, V84, P294, DOI 10.1016/j.jhin.2013.04.018; Goyal D, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofy357; Hoban DJ, 2011, DIAGN MICR INFEC DIS, V70, P507, DOI 10.1016/j.diagmicrobio.2011.03.021; Lee DS, 2010, KOREAN J UROL, V51, P492, DOI 10.4111/kju.2010.51.7.492; Leekha S, 2011, MAYO CLIN PROC, V86, P156, DOI 10.4065/mcp.2010.0639; Linsenmeyer K, 2015, ANTIMICROB AGENTS CH, V59, P7593, DOI 10.1128/AAC.01638-15; MacFadden DR, 2014, CLIN INFECT DIS, V59, P1265, DOI 10.1093/cid/ciu588; Marchaim D, 2010, ANTIMICROB AGENTS CH, V54, P5099, DOI 10.1128/AAC.00565-10; Ortega M, 2009, J ANTIMICROB CHEMOTH, V63, P568, DOI 10.1093/jac/dkn514; Peeters P, 2019, INFECT DRUG RESIST, V12, P329, DOI 10.2147/IDR.S184116; Picozzi SCM, 2014, UROL ANNALS, V6, P107, DOI 10.4103/0974-7796.130536; Schulz LT, 2012, PHARMACOTHERAPY, V32, P668, DOI 10.1002/j.1875-9114.2012.01163.x; Schweizer ML, 2008, INFECT CONT HOSP EP, V29, P972, DOI 10.1086/590665; Taneja N, 2008, INDIAN J MED RES, V127, P85; van Duin D, 2013, DIAGN MICR INFEC DIS, V75, P115, DOI 10.1016/j.diagmicrobio.2012.11.009; Zilberberg MD, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2383-z	36	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243741	10.1371/journal.pone.0243741	http://dx.doi.org/10.1371/journal.pone.0243741			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315921	gold, Green Published			2022-12-27	WOS:000600186100054
J	de los Campos, G; Pook, T; Gonzalez-Reymundez, A; Simianer, H; Mias, G; Vazquez, AI				de los Campos, Gustavo; Pook, Torsten; Gonzalez-Reymundez, Agustin; Simianer, Henner; Mias, George; Vazquez, Ana I.			ANOVA-HD: Analysis of variance when both input and output layers are high-dimensional	PLOS ONE			English	Article							GENOTYPE IMPUTATION; GENETIC VALUES; REGRESSION; PREDICTION; INFORMATION; MATRIX; TOOL	Modern genomic data sets often involve multiple data-layers (e.g., DNA-sequence, gene expression), each of which itself can be high-dimensional. The biological processes underlying these data-layers can lead to intricate multivariate association patterns. We propose and evaluate two methods to determine the proportion of variance of an output data set that can be explained by an input data set when both data panels are high dimensional. Our approach uses random-effects models to estimate the proportion of variance of vectors in the linear span of the output set that can be explained by regression on the input set. We consider a method based on an orthogonal basis (Eigen-ANOVA) and one that uses random vectors (Monte Carlo ANOVA, MC-ANOVA) in the linear span of the output set. Using simulations, we show that the MC-ANOVA method gave nearly unbiased estimates. Estimates produced by Eigen-ANOVA were also nearly unbiased, except when the shared variance was very high (e.g., >0.9). We demonstrate the potential insight that can be obtained from the use of MC-ANOVA and Eigen-ANOVA by applying these two methods to the study of multi-locus linkage disequilibrium in chicken (Gallus gallus) genomes and to the assessment of inter-dependencies between gene expression, methylation, and copy-number-variants in data from breast cancer tumors from humans (Homo sapiens). Our analyses reveal that in chicken breeding populations &SIM50,000 evenly-spaced SNPs are enough to fully capture the span of whole-genome-sequencing genomes. In the study of multi-omic breast cancer data, we found that the span of copy-number-variants can be fully explained using either methylation or gene expression data and that roughly 74% of the variance in gene expression can be predicted from methylation data.	[de los Campos, Gustavo; Vazquez, Ana I.] Michigan State Univ, Epidemiol & Biostat, E Lansing, MI 48824 USA; [de los Campos, Gustavo] Michigan State Univ, Stat & Probabil, E Lansing, MI 48824 USA; [de los Campos, Gustavo; Mias, George; Vazquez, Ana I.] Inst Quantitat Hlth Sci & Engn, E Lansing, MI 48824 USA; [Pook, Torsten; Simianer, Henner] Univ Goettingen, Ctr Integrated Breeding Res, Dept Anim Sci, Gottingen, Germany; [Gonzalez-Reymundez, Agustin] Michigan State Univ, Genet & Genome Sci Grad Program, E Lansing, MI 48824 USA; [Mias, George] Michigan State Univ, Biochem & Mol Biol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; University of Gottingen; Michigan State University; Michigan State University	de los Campos, G (corresponding author), Michigan State Univ, Epidemiol & Biostat, E Lansing, MI 48824 USA.; de los Campos, G (corresponding author), Michigan State Univ, Stat & Probabil, E Lansing, MI 48824 USA.; de los Campos, G (corresponding author), Inst Quantitat Hlth Sci & Engn, E Lansing, MI 48824 USA.; Pook, T (corresponding author), Univ Goettingen, Ctr Integrated Breeding Res, Dept Anim Sci, Gottingen, Germany.	gustavoc@msu.edu; torsten.pook@agr.uni-goettingen.de	Gonzalez-Reymundez, Agustin/AAK-2074-2020	de los Campos, Gustavo/0000-0001-5692-7129; Pook, Torsten/0000-0001-7874-8500; Mias, George/0000-0002-9083-1216	Mercatorfellowship of the German Research Foundation (DFG) within the Research Training Group 1644, "Scaling problems in statistics" at the University of Goettingen [152112243]; Zoetis	Mercatorfellowship of the German Research Foundation (DFG) within the Research Training Group 1644, "Scaling problems in statistics" at the University of Goettingen(German Research Foundation (DFG)); Zoetis	GDLC was supported by a Mercatorfellowship of the German Research Foundation (DFG) within the Research Training Group 1644, "Scaling problems in statistics" (grant no. 152112243) at the University of Goettingen. AIV, AGR and GDLC received support from a research grant sponsored by Zoetis. The funder provided support in the form of a research grant, the funds were used to cover university salaries for GDLC, AIV, and AGR. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	[Anonymous], **DATA OBJECT**; Boichard D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034130; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Crossa J, 2010, GENETICS, V186, P713, DOI 10.1534/genetics.110.118521; de los Campos G, 2009, J ANIM SCI, V87, P1883, DOI 10.2527/jas.2008-1259; de los Campos G, 2010, GENET RES, V92, P295, DOI 10.1017/S0016672310000285; Du P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-587; Erbe M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081046; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Izenman A. J., 1975, Journal of Multivariate Analysis, V5, P248, DOI 10.1016/0047-259X(75)90042-1; Kranis A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-59; Krzanowski W. J., 1988, PRINCIPLES MULTIVARI; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lazar C, 2013, BRIEF BIOINFORM, V14, P469, DOI 10.1093/bib/bbs037; Mardia K V, 1979, MULTIVARIATE ANAL; Martini JWR, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-016-1439-1; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; Mevik BH, 2007, J STAT SOFTW, V18, P1, DOI 10.18637/jss.v018.i02; Misztal I, 2016, GENETICS, V202, P401, DOI 10.1534/genetics.115.182089; Ni GY, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2059-2; Ober U, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002685; PATTERSON HD, 1971, BIOMETRIKA, V58, P545, DOI 10.1093/biomet/58.3.545; Perez P, 2014, GENETICS, V198, P483, DOI 10.1534/genetics.114.164442; Pocrnic I, 2016, GENETICS, V203, P573, DOI 10.1534/genetics.116.187013; Rencher A.C., 2012, METHODS MULTIVARIATE, DOI DOI 10.1002/9781118391686; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Unterseer S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-823; Vazquez AI, 2010, J DAIRY SCI, V93, P5942, DOI 10.3168/jds.2010-3335; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Weigel KA, 2010, J DAIRY SCI, V93, P5423, DOI 10.3168/jds.2010-3149; Witte T, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0066-6; Witten DM, 2009, BIOSTATISTICS, V10, P515, DOI 10.1093/biostatistics/kxp008; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1	33	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243251	10.1371/journal.pone.0243251	http://dx.doi.org/10.1371/journal.pone.0243251			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315963	Green Published, gold			2022-12-27	WOS:000600186100051
J	Kosaka, Y; Aoki, W; Mori, M; Aburaya, S; Ohtani, Y; Minakuchi, H; Ueda, M				Kosaka, Yuishin; Aoki, Wataru; Mori, Megumi; Aburaya, Shunsuke; Ohtani, Yuta; Minakuchi, Hiroyoshi; Ueda, Mitsuyoshi			Selected reaction monitoring for the quantification of Escherichia coli ribosomal proteins	PLOS ONE			English	Article							UNNATURAL AMINO-ACIDS; ORTHOGONAL TRANSLATION; MASS-SPECTROMETRY; GENETIC-CODE; COMPLETE SET; ACTIVE-SITE; RNA; PROTEOMICS; RECONSTITUTION; BIOGENESIS	Ribosomes are the sophisticated machinery that is responsible for protein synthesis in a cell. Recently, quantitative mass spectrometry (qMS) have been successfully applied for understanding the dynamics of protein complexes. Here, we developed a highly specific and reproducible method to quantify all ribosomal proteins (r-proteins) by combining selected reaction monitoring (SRM) and isotope labeling. We optimized the SRM methods using purified ribosomes and Escherichia coli lysates and verified this approach as detecting 41 of the 54 r-proteins separately synthesized in E. coli S30 extracts. The SRM methods will enable us to utilize qMS as a highly specific analytical tool in the research of E. coli ribosomes, and this methodology have potential to accelerate the understanding of ribosome biogenesis, function, and the development of engineered ribosomes with additional functions.	[Kosaka, Yuishin; Aoki, Wataru; Mori, Megumi; Aburaya, Shunsuke; Ohtani, Yuta; Ueda, Mitsuyoshi] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Kyoto, Japan; [Aoki, Wataru; Ueda, Mitsuyoshi] Kyoto Integrated Sci & Technol Bioanal Ctr, Kyoto, Japan; [Minakuchi, Hiroyoshi] Kyoto Monotech, Kyoto, Japan	Kyoto University	Aoki, W (corresponding author), Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Kyoto, Japan.; Aoki, W (corresponding author), Kyoto Integrated Sci & Technol Bioanal Ctr, Kyoto, Japan.	aoki.wataru.6a@kyoto-u.ac.jp		Aburaya, Shunsuke/0000-0001-6194-9664; Aoki, Wataru/0000-0002-3118-9390	Japan Society for the Promotion of Science [19K16109, 26830139]; Sugiyama Chemical & Industrial Laboratory; JGC-S Scholarship Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Sugiyama Chemical & Industrial Laboratory; JGC-S Scholarship Foundation	W.A. was supported by the Japan Society for the Promotion of Science (grant No. 19K16109 and 26830139; https://www.jsps.go.jp/english/), Sugiyama Chemical & Industrial Laboratory (http://www.sugiyama-c-i-l.or.jp/), and the JGC-S Scholarship Foundation (https://www.jgcs.or.jp/en/).Kyoto-monotech provided a monolithic column and support in the form of salaries for HM. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Al-Majdoub ZM, 2014, J PROTEOME RES, V13, P1211, DOI 10.1021/pr400667h; Aleksashin NA, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15756-1; Aleksashin NA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08892-w; Anderson L, 2006, MOL CELL PROTEOMICS, V5, P573, DOI 10.1074/mcp.M500331-MCP200; Ban N, 2014, CURR OPIN STRUC BIOL, V24, P165, DOI 10.1016/j.sbi.2014.01.002; Bernardo A. S., 2005, F PETRARCH LETT OLD, VI, p[10, 159]; Bourmaud A, 2016, PROTEOMICS, V16, P2146, DOI 10.1002/pmic.201500543; Brown CW, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3676-8; Carlson ED, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11427-y; Caschera F, 2018, ACS SYNTH BIOL, V7, P2481, DOI 10.1021/acssynbio.8b00276; Charollais J, 2003, MOL MICROBIOL, V48, P1253, DOI 10.1046/j.1365-2958.2003.03513.x; Chen SS, 2013, J MOL BIOL, V425, P767, DOI 10.1016/j.jmb.2012.11.040; Chen SS, 2012, MOL BIOSYST, V8, P3325, DOI 10.1039/c2mb25310k; Chubiz LM, 2008, NUCLEIC ACIDS RES, V36, P4038, DOI 10.1093/nar/gkn354; Culver GM, 1999, RNA, V5, P832, DOI 10.1017/S1355838299990714; d'Aquino AE, 2020, NUCLEIC ACIDS RES, V48, P2777, DOI 10.1093/nar/gkaa001; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davydov II, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2373; Fried SD, 2015, ANGEW CHEM INT EDIT, V54, P12791, DOI 10.1002/anie.201506311; Fritz BR, 2015, NUCLEIC ACIDS RES, V43, P4774, DOI 10.1093/nar/gkv329; Fritz BR, 2014, NUCLEIC ACIDS RES, V42, P6774, DOI 10.1093/nar/gku307; Giansanti P, 2016, NAT PROTOC, V11, P993, DOI 10.1038/nprot.2016.057; Ishihama Y, 2006, J PROTEOME RES, V5, P988, DOI 10.1021/pr050385q; Ishizuka N, 2000, ANAL CHEM, V72, P1275, DOI 10.1021/ac990942q; Jewett MC, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.31; Kaczanowska M, 2007, MICROBIOL MOL BIOL R, V71, P477, DOI 10.1128/MMBR.00013-07; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Kuhn E, 2004, PROTEOMICS, V4, P1175, DOI 10.1002/pmic.200300670; Levy M, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz6020; Li J, 2017, ACS SYNTH BIOL, V6, P1327, DOI 10.1021/acssynbio.6b00342; Liu Y, 2015, ACS SYNTH BIOL, V4, P454, DOI 10.1021/sb5002467; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Maki JA, 2002, MOL CELL, V10, P129, DOI 10.1016/S1097-2765(02)00562-2; Minton AP, 2000, CURR OPIN STRUC BIOL, V10, P34, DOI 10.1016/S0959-440X(99)00045-7; Murase Y, 2018, ACS SYNTH BIOL, V7, P576, DOI 10.1021/acssynbio.7b00333; Neumann H, 2010, NATURE, V464, P441, DOI 10.1038/nature08817; NIERHAUS KH, 1974, P NATL ACAD SCI USA, V71, P4713, DOI 10.1073/pnas.71.12.4713; Orelle C, 2015, NATURE, V524, P119, DOI 10.1038/nature14862; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Pei HR, 2017, FEBS LETT, V591, P3421, DOI 10.1002/1873-3468.12840; Picotti P, 2013, NAT METHODS, V10, P24, DOI 10.1038/nmeth.2291; Picotti P, 2012, NAT METHODS, V9, P555, DOI [10.1038/NMETH.2015, 10.1038/nmeth.2015]; Picotti P, 2009, CELL, V138, P795, DOI 10.1016/j.cell.2009.05.051; Pronobis MI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160509; Sashital DG, 2014, ELIFE, V3, DOI 10.7554/eLife.04491; Schmied WH, 2018, NATURE, V564, P444, DOI 10.1038/s41586-018-0773-z; Shieh YW, 2015, SCIENCE, V350, P678, DOI 10.1126/science.aac8171; Shilling PJ, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-0939-8; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Shimojo M, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-0874-8; SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342; Tamaru D, 2018, RNA, V24, P1512, DOI 10.1261/rna.065615.118; The Gene Ontology Consortium, 2019, NUCLEIC ACIDS RES, V47, pD330; Thompson J, 2001, P NATL ACAD SCI USA, V98, P9002, DOI 10.1073/pnas.151257098; TRAUB P, 1968, P NATL ACAD SCI USA, V59, P777, DOI 10.1073/pnas.59.3.777; Wang KH, 2007, NAT BIOTECHNOL, V25, P770, DOI 10.1038/nbt1314; Wang KH, 2014, NAT CHEM, V6, P393, DOI [10.1038/nchem.1919, 10.1038/NCHEM.1919]; Wang KH, 2012, ANGEW CHEM INT EDIT, V51, P2288, DOI 10.1002/anie.201105016; Youngman EM, 2004, CELL, V117, P589, DOI 10.1016/S0092-8674(04)00411-8	59	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0236850	10.1371/journal.pone.0236850	http://dx.doi.org/10.1371/journal.pone.0236850			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315868	Green Published, gold, Green Submitted			2022-12-27	WOS:000600186100040
J	Roelen, K; Taylor, E				Roelen, Keetie; Taylor, Emily			Assessing mental health in a context of extreme poverty: Validation of the rosenberg self-esteem scale in rural Haiti	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; ILLNESS; DISORDERS; ATTITUDES; DISTRESS; INCOME	A widening evidence base across low- and middle-income countries (LMICs) points towards mutually reinforcing linkages between poverty and mental health problems. The use of validated and culturally relevant measures of mental health outcomes is crucial to the expansion of evidence. At present, there is a paucity of measures that have been tested and validated in contexts of extreme poverty. Using data from adult women living in extreme poverty in rural Haiti this study assesses the cross-cultural validity of the widely used Rosenberg Self-Esteem Scale (RSES) and its applicability in assessing linkages between poverty and mental health outcomes. We find no evidence for a one-dimensional 10-factor structure of the RSES within our data and agree with other authors that the standard self-esteem model does not fit well in this cultural context. Comparisons with another widely used measure of mental health-the K6 measure-indicate that the RSES cannot be used as a proxy for mental health outcomes. We conclude that the use of the RSES in different cultural contexts and with samples with different socioeconomic characteristics should be undertaken with caution; and that greater consideration of the validity of psychosocial constructs and their measurement is vital for gaining robust and replicable insights into breaking the cycle between poverty and mental health problems.	[Roelen, Keetie] Inst Dev Studies, Brighton, E Sussex, England; [Taylor, Emily] Univ Edinburgh, Edinburgh, Midlothian, Scotland	University of Edinburgh	Roelen, K (corresponding author), Inst Dev Studies, Brighton, E Sussex, England.	k.roelen@ids.ac.uk		Roelen, Keetie/0000-0001-7801-3096	W.K. Kellogg Foundation	W.K. Kellogg Foundation	This survey was made possible with funding from W.K. Kellogg Foundation (URL: https://www.wkkf.org/).Funding was provided to K. Roelen at the Institute of Development Studies through an institutional contract with implementing partner Fonkoze in Haiti. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was made possible with funding from W.K. Kellogg Foundation.	[Anonymous], 2015, INT J ENG INNOVATIVE, V5, P109; [Anonymous], 2012, J OPT COMMUN NETW, V4, pB94; Beals J, 2003, CULT MED PSYCHIAT, V27, P259, DOI 10.1023/A:1025347130953; Bedoya G, 2019, NO HOUSEHOLD LEFT BE; Bleidorn W, 2016, J PERS SOC PSYCHOL, V111, P396, DOI 10.1037/pspp0000078; Comrey AL., 1992, 1 COURSE FACTOR ANAL, V2nd ed., DOI DOI 10.4324/9781315827506; Cooper S, 2012, SOC PSYCH PSYCH EPID, V47, P1499, DOI 10.1007/s00127-011-0457-6; Corrigall J, 2008, SOC SCI MED, V66, P2061, DOI 10.1016/j.socscimed.2008.01.005; Das J, 2008, SOC SCI MED, V66, P2064, DOI 10.1016/j.socscimed.2008.01.004; Das J, 2007, SOC SCI MED, V65, P467, DOI 10.1016/j.socscimed.2007.02.037; Di Paula A, 2002, J PERS SOC PSYCHOL, V83, P711, DOI 10.1037//0022-3514.83.3.711; Du HF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183958; EVERITT BS, 1975, BRIT J PSYCHIAT, V126, P237, DOI 10.1192/bjp.126.3.237; Farruggia SP, 2004, J CROSS CULT PSYCHOL, V35, P719, DOI 10.1177/0022022104270114; Freitas ND, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190747; Fromont A, 2017, J PSYCHOL AFR, V27, P316, DOI 10.1080/14330237.2017.1347751; Hanandita W, 2014, SOC SCI MED, V113, P59, DOI 10.1016/j.socscimed.2014.05.005; Haushofer J., 2018, LONG TERM IMPACT UNC; Haushofer J, 2016, Q J ECON, V131, P1973, DOI 10.1093/qje/qjw025; Hewitt J, 2002, HDB POSITIVE PSYCHOL; James C, 2020, INT J PSYCHOL, V55, P435, DOI 10.1002/ijop.12613; Joshi M, 2020, J AFFECT DISORDERS, V260, P238, DOI 10.1016/j.jad.2019.09.004; Juan C, 2019, J CHILD ADOLESC MENT, V31, P201, DOI 10.2989/17280583.2019.1678476; Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184; Kessler RC, 2010, INT J METH PSYCH RES, V19, P4, DOI 10.1002/mpr.310; Keys HM, 2012, SOC SCI MED, V75, P555, DOI 10.1016/j.socscimed.2012.03.040; Kheswa JG, 2017, J PSYCHOL AFR, V27, P477, DOI 10.1080/14330237.2017.1375206; Li JB, 2015, PERS INDIV DIFFER, V82, P20, DOI 10.1016/j.paid.2015.02.036; Lund C, 2011, LANCET, V378, P1502, DOI 10.1016/S0140-6736(11)60754-X; Lund C, 2010, SOC SCI MED, V71, P517, DOI 10.1016/j.socscimed.2010.04.027; Mruk CJ, 2017, HUMANIST PSYCHOL, V45, P313; Natali L, 2018, SSM-POPUL HLTH, V4, P225, DOI 10.1016/j.ssmph.2018.02.002; Oladipo S E., 2014, GENDER AND BEHAV, V12, P6027; Orth U, 2013, CURR DIR PSYCHOL SCI, V22, P455, DOI 10.1177/0963721413492763; Satorra A, 2001, PSYCHOMETRIKA, V66, P507, DOI 10.1007/BF02296192; Schmitt DP, 2005, J PERS SOC PSYCHOL, V89, P623, DOI 10.1037/0022-3514.89.4.623; Schreiner M, 2016, HAITI 2012 PROGR OUT; Sedikides C., 2003, SAGE HDB SOCIAL PSYC, P110, DOI DOI 10.4135/9781848608221.N5; Severe L, 2014, AIDS EDUC PREV, V26, P158, DOI 10.1521/aeap.2014.26.2.158; Silverstone Peter H, 2003, Ann Gen Hosp Psychiatry, V2, P2, DOI 10.1186/1475-2832-2-2; Tampubolon G, 2014, SOC SCI MED, V106, P20, DOI 10.1016/j.socscimed.2014.01.012; Tesfaye M, 2016, HEALTH QUAL LIFE OUT, V14, DOI 10.1186/s12955-016-0440-8; Tymejczyk O, 2020, J AFFECT DISORDERS, V263, P241, DOI 10.1016/j.jad.2019.11.103; WATERNAUX CM, 1976, BIOMETRIKA, V63, P639, DOI 10.2307/2335746; Watson LK, 2020, INT J PSYCHOL, V55, P425, DOI 10.1002/ijop.12604; Werlin S, 2018, FONKOZES CLM PROGRAM; WINCH RF, 1965, SOC FORCES, V44, P255; Wu Y, 2017, J PERS ASSESS, V99, P83, DOI 10.1080/00223891.2016.1217420	48	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243457	10.1371/journal.pone.0243457	http://dx.doi.org/10.1371/journal.pone.0243457			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH1MP	33315898	Green Published, gold			2022-12-27	WOS:000600186100037
J	Dagnew, GW; Asresie, MB				Dagnew, Gizachew Worku; Asresie, Melash Belachew			Factors associated with chronic energy malnutrition among reproductive-age women in Ethiopia: An analysis of the 2016 Ethiopia demographic and health survey data	PLOS ONE			English	Article							CHILD UNDERNUTRITION; RISK-FACTORS; NUTRITION; BURDEN; UNDERWEIGHT; PREVALENCE; OVERWEIGHT; COUNTRIES; OBESITY; BIRTH	Background Women with chronic-energy malnutrition persists in many developing countries, including Ethiopia. To avert this problem identifying the predictor variables for a high magnitude of underweight is paramount. Consequently, this study aimed to assess the factors associated with chronic energy malnutrition among reproductive-age women in Ethiopia. Methods We used the 2016 Ethiopia demographic health survey data. The survey was a community-based cross-sectional study conducted from January 18 to June 27, 2016. A two-stage stratified cluster sampling technique was employed to select Participants. A total of 13,451 reproductive-age group women (age 15-49 years and who were not pregnant and < 2 months of postpartum) were included in the analysis. Both descriptive and analytical analyses were performed. A P-value of less than 0.05 was used to declare statistical significance. Results About 22.6% (95%CI: 21.5%-23.6%) of reproductive-age women were underweight. The magnitude of underweight is highest in the Afar region (39.6%) and lowest in Addis Ababa city administration (13.5%). Women who lived in the rural area (AOR = 1.59; 95%CI: 1.19-2.12), those who did not attend formal education (AOR = 1.23; 95%CI: 1.01-1.50), unemployed women (AOR = 1.28; 95%CI:1.13-1.44), women who belong to the poorest household wealth index (AOR = 1.42; 95%CI:1.04-1.94), women who were not married (AOR = 1.41; 95%CI: 1.18-2.69), women who lived in Tigray and the pastoral regions have higher odds of underweight. On the other hand, women who lived in southern nations nationalities and people's region, and women whose age group 25-34 years had lower odds of underweight. Conclusions Chronic-energy malnutrition among reproductive-age women is high in Ethiopia. Improving the food security of rural, never married, and unemployed women would reduce the magnitude of underweight. Moreover, strengthening girls' education, creating employment opportunities for women, and enhancing household income can further reduce the problem of chronic energy malnutrition.	[Dagnew, Gizachew Worku; Asresie, Melash Belachew] Bahir Dar Univ, Coll & Hlth Sci, Sch Publ Hlth, Dept Reprod Hlth & Populat Studies, Bahir Dar, Ethiopia	Bahir Dar University	Dagnew, GW (corresponding author), Bahir Dar Univ, Coll & Hlth Sci, Sch Publ Hlth, Dept Reprod Hlth & Populat Studies, Bahir Dar, Ethiopia.	giz.work12@gmail.com	Dagnew, Gizachew Worku/ABE-7194-2021	Dagnew, Gizachew Worku/0000-0003-2043-3041; Asresie, Melash Belachew/0000-0002-4173-0646				Abdullah A, 2015, CURR OBES REP, V4, P337, DOI 10.1007/s13679-015-0170-y; Abraham Saba., 2015, BMC NUTR, V1, P12, DOI [10.1186/s40795-015-0005-y, DOI 10.1186/S40795-015-0005-Y]; Abrha S, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3315-3; Ahmed T, 2012, ANN NUTR METAB, V61, P8, DOI 10.1159/000345165; Al Kibria GM, 2019, GLOBAL HLTH RES POLI, V4, P1; Anne Bossuyt, 2019, Agriculture for improved nutrition: seizing the momentum, P165, DOI 10.1079/9781786399311.0165; [Anonymous], 2018, DIABETES CARE S1, V2018, pS1; [Anonymous], 2000, WHO TECHN REP SER; Birhane T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-680; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Central Statistical Agency [Ethiopia] and ORC Macro, 2006, ETH DEM HLTH SURV 20; Chaparro C, 2011, HLTH LIFE COURSE PAN, P12; CSA Ethiopia and ICF, 2016, ETH DEM HLTH SURV 20; Desyibelew HD, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221712; Devgun P, 2014, SCI INT J RES HLTH, V2, P527; Dewey KG, 2011, MATERN CHILD NUTR, V7, P5, DOI 10.1111/j.1740-8709.2011.00349.x; Engidaw MT., 2019, J FAMILY MED HLTH CA, V5, P1, DOI [10.11648/j.jfmhc.20190501.11, DOI 10.11648/J.JFMHC.20190501.11, 10.11648/j. jfmhc.20190501.11]; Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3; Fanzo J, 2018, 2018 GLOBAL NUTR REP; Ferede A, 2017, PUBLIC HEALTH, V152, P1, DOI 10.1016/j.puhe.2017.06.011; Franklin B, 2012, J COMMUN HEALTH, V37, P253, DOI 10.1007/s10900-011-9420-4; Hashan MR, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-034321; Hoddinott J, 2013, ROAD TO GOOD NUTRITION: A GLOBAL PERSPECTIVE, P64; Hong SA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194454; Imdad A, 2012, PAEDIATR PERINAT EP, V26, P178, DOI 10.1111/j.1365-3016.2012.01308.x; JAMES WPT, 1988, EUR J CLIN NUTR, V42, P969; Julla BW., 2018, WORLD SCI RES, V5, P13, DOI [10.20448/journal.510.2018.51.13.23, DOI 10.20448/JOURNAL.510.2018.51.13.23]; Kamal SMM, 2015, J HEALTH POPUL NUTR, V33, P92; Kumera Gemechu, 2018, Matern Health Neonatol Perinatol, V4, P18, DOI 10.1186/s40748-018-0087-z; Lartey A, 2008, P NUTR SOC, V67, P105, DOI 10.1017/S0029665108006083; Lopez-Arana S, 2013, OBES REV, V14, P806, DOI 10.1111/obr.12051; Mbagaya G, 2014, PROTEIN ENERGY MALNU; Mtumwa AH, 2016, S AFR J CLIN NUTR, V29, P75, DOI 10.1080/16070658.2016.1216509; Napoli M., 2011, MASTER HUMAN DEV FOO, P1; Praskova DM, 2018, AUC GEOGR, V53, P193, DOI 10.14712/23361980.2018.19; Rashid S, 2018, GLOB FOOD SECUR-AGR, V19, P31, DOI 10.1016/j.gfs.2018.09.002; Razak F, 2013, LANCET, V381, P626, DOI 10.1016/S0140-6736(13)60344-X; Regassa N, 2012, J BIOSOC SCI, V44, P537, DOI 10.1017/S002193201200017X; Steyn NP, 2014, ANN NY ACAD SCI, V1311, P88, DOI 10.1111/nyas.12433; Tanwi TS, 2019, BMC WOMENS HEALTH, V19, DOI 10.1186/s12905-019-0725-2; Tebekaw Y, 2011, DEMOGRAPHIC TRANSITION AND DEVELOPMENT IN AFRICA: THE UNIQUE CASE OF ETHIOPIA, P105, DOI 10.1007/978-90-481-8918-2_6; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; World Health Organization, 2014, ACC NUTR IMPR ANI MA; World Health Organization, 2016, ACC NUTR IMPR ANI MA	44	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243148	10.1371/journal.pone.0243148	http://dx.doi.org/10.1371/journal.pone.0243148			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH0WM	33306693	Green Published, gold			2022-12-27	WOS:000600144200003
J	Jacobs, LG; Paleoudis, EG; Lesky-Di Bari, D; Nyirenda, T; Friedman, T; Gupta, A; Rasouli, L; Zetkulic, M; Balani, B; Ogedegbe, C; Bawa, H; Berrol, L; Qureshi, N; Aschner, JL				Jacobs, Laurie G.; Paleoudis, Elli Gourna; Lesky-Di Bari, Dineen; Nyirenda, Themba; Friedman, Tamara; Gupta, Anjali; Rasouli, Lily; Zetkulic, Marygrace; Balani, Bindu; Ogedegbe, Chinwe; Bawa, Harinder; Berrol, Lauren; Qureshi, Nabiha; Aschner, Judy L.			Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; WOMEN	Background Characterizing the prevalence and persistence of symptoms associated with COVID-19 infection following hospitalization and their impact is essential to planning post-acute community-based clinical services. This study seeks to identify persistent COVID-19 symptoms in patients 35 days post-hospitalization and their impact on quality of life, health, physical, mental, and psychosocial function. Methods and findings This prospective cohort study used the PROMIS (R) Instruments to identify symptoms and quality of life parameters in consecutively enrolled patients between March 22 and April 16, 2020, in New Jersey. The 183 patients (median age 57 years; 61.5% male, 54.1% white) reported persistent symptoms at 35 days, including fatigue (55.0%), dyspnea (45.3%), muscular pain (51%), associated with a lower odds rating general health (41.5%, OR 0.093 [95% CI: 0.026, 0.329], p = 0.0002), quality of life (39.8%; OR 0.116 [95% CI: 0.038, 0.364], p = 0.0002), physical health (38.7%, OR 0.055 [95% CI: 0.016, 0.193], p <0.0001), mental health (43.7%, OR 0.093 [95% CI: 0.021, 0.418], p = 0.0019) and social active role (38.7%, OR 0.095 [95% CI: 0.031, 0.291], p<0.0001), as very good/excellent, particularly adults aged 65 to 75 years (OR 8 center dot 666 [95% CI: 2 center dot 216, 33 center dot 884], p = 0 center dot 0019). Conclusions COVID-19 symptoms commonly persist to 35 days, impacting quality of life, health, physical and mental function. Early post-acute evaluation of symptoms and their impact on function is necessary to plan community-based services.	[Jacobs, Laurie G.; Gupta, Anjali; Zetkulic, Marygrace; Balani, Bindu; Bawa, Harinder] Hackensack Meridian Sch Med, Dept Internal Med, Nutley, NJ 07110 USA; [Jacobs, Laurie G.; Gupta, Anjali; Rasouli, Lily; Zetkulic, Marygrace; Bawa, Harinder; Qureshi, Nabiha] Hackensack Univ, Dept Internal Med, Med Ctr, Hackensack, NJ 07601 USA; [Paleoudis, Elli Gourna; Nyirenda, Themba; Friedman, Tamara] Off Res Adm, Hackensack Meridian Hlth, Edison, NJ USA; [Lesky-Di Bari, Dineen] Hackensack Univ, Dept Res, Joseph M Sanzari Childrens Hosp, Med Ctr, Hackensack, NJ USA; [Balani, Bindu] Hackensack Univ, Dept Internal Med, Div Infect Dis, Med Ctr, Hackensack, NJ USA; [Ogedegbe, Chinwe] Hackensack Meridian Sch Med, Dept Emergency Med, Nutley, NJ USA; [Ogedegbe, Chinwe] Hackensack Univ, Med Ctr, Hackensack, NJ USA; [Bawa, Harinder; Aschner, Judy L.] Hackensack Meridian Sch Med, Dept Pediat, Nutley, NJ USA; [Bawa, Harinder; Aschner, Judy L.] Hackensack Univ, Joseph M Sanzari Childrens Hosp, Med Ctr, Hackensack, NJ USA; [Berrol, Lauren] Hackensack Univ, Dept Anesthesiol, Med Ctr, Hackensack, NJ USA	Hackensack University Medical Center; Hackensack University Medical Center; Hackensack University Medical Center; Hackensack University Medical Center; Hackensack University Medical Center; Hackensack University Medical Center	Jacobs, LG (corresponding author), Hackensack Meridian Sch Med, Dept Internal Med, Nutley, NJ 07110 USA.; Jacobs, LG (corresponding author), Hackensack Univ, Dept Internal Med, Med Ctr, Hackensack, NJ 07601 USA.	Laurie.Jacobs@HackensackMeridian.org	Gupta, Anjali/HCH-5986-2022	Jacobs, Laurie G./0000-0003-3609-2157				Ahmed H, 2020, J REHABIL MED, V52, DOI 10.2340/16501977-2694; [Anonymous], 2020, R D BLUEPR NOV COR C, P6; Barsky AJ, 2001, J GEN INTERN MED, V16, P266, DOI 10.1046/j.1525-1497.2001.016004266.x; Bikdeli B, 2020, J AM COLL CARDIOL, V75, P2950, DOI 10.1016/j.jacc.2020.04.031; Carfi A, 2020, JAMA-J AM MED ASSOC, V324, P603, DOI 10.1001/jama.2020.12603; Centers for Disease Control and Prevention, 2020, CORONAVIRUS DIS 2019; Centers for Disease Control and Prevention, HLTH WEIGHT ASS YOUR; CMS Learning Network, 2017, MLN BOOKL HOM OX THE, P3; Cydulka RK, 2001, ANN EMERG MED, V38, P123, DOI 10.1067/mem.2001.114305; DeSalvo KB, 2005, HEALTH SERV RES, V40, P1234, DOI 10.1111/j.1475-6773.2005.00404.x; Fugitive Literacies Collective, 2020, ENGLISH ED, V52, pN3; Gebhard C, 2020, BIOL SEX DIFFER, V11, DOI 10.1186/s13293-020-00304-9; Gonzalez-Reiche AS, 2020, SCIENCE, V369, P297, DOI 10.1126/science.abc1917; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hendren NS, 2020, CIRCULATION, V141, P1903, DOI 10.1161/CIRCULATIONAHA.120.047349; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Jin JM, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00152; Keeley P, 2020, BMJ SUPPORT PALLIAT; Lam MHB, 2009, ARCH INTERN MED, V169, P2142, DOI 10.1001/archinternmed.2009.384; Ngai JC, 2010, RESPIROLOGY, V15, P543, DOI 10.1111/j.1440-1843.2010.01720.x; Park SY, 2020, KOREAN J INTERN MED, V35, P793, DOI 10.3904/kjim.2020.203; Potere N, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03022-1; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; Simmons RK, 2010, DIABETOLOGIA, V53, P600, DOI 10.1007/s00125-009-1620-4; World Health Organization, 159 WHO	26	109	112	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243882	10.1371/journal.pone.0243882	http://dx.doi.org/10.1371/journal.pone.0243882			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306721	Green Published, gold			2022-12-27	WOS:000600144200044
J	Sellers, RA; Robertson, DL; Tassabehji, M				Sellers, Robert A.; Robertson, David L.; Tassabehji, May			Ancestry of the AUTS2 family-A novel group of polycomb-complex proteins involved in human neurological disease	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; PROTOCEREBRAL BRIDGE; GENETIC-VARIATION; PREDICTION; EXPRESSION; DROSOPHILA; IDENTIFICATION; DUPLICATION; PROTEOME; YEAST	Autism susceptibility candidate 2 (AUTS2) is a neurodevelopmental regulator associated with an autosomal dominant intellectual disability syndrome, AUTS2 syndrome, and is implicated as an important gene in human-specific evolution. AUTS2 exists as part of a tripartite gene family, the AUTS2 family, which includes two relatively undefined proteins, Fibrosin (FBRS) and Fibrosin-like protein 1 (FBRSL1). Evolutionary ancestors of AUTS2 have not been formally identified outside of the Animalia clade. A Drosophila melanogaster protein, Tay bridge, with a role in neurodevelopment, has been shown to display limited similarity to the C-terminal of AUTS2, suggesting that evolutionary ancestors of the AUTS2 family may exist within other Protostome lineages. Here we present an evolutionary analysis of the AUTS2 family, which highlights ancestral homologs of AUTS2 in multiple Protostome species, implicates AUTS2 as the closest human relative to the progenitor of the AUTS2 family, and demonstrates that Tay bridge is a divergent ortholog of the ancestral AUTS2 progenitor gene. We also define regions of high relative sequence identity, with potential functional significance, shared by the extended AUTS2 protein family. Using structural predictions coupled with sequence conservation and human variant data from 15,708 individuals, a putative domain structure for AUTS2 was produced that can be used to aid interpretation of the consequences of nucleotide variation on protein structure and function in human disease. To assess the role of AUTS2 in human-specific evolution, we recalculated allele frequencies at previously identified human derived sites using large population genome data, and show a high prevalence of ancestral alleles, suggesting that AUTS2 may not be a rapidly evolving gene, as previously thought.	[Sellers, Robert A.; Tassabehji, May] Univ Manchester, Evolut & Genom Sci, Sch Biol Sci, Manchester, Lancs, England; [Robertson, David L.] MRC Univ Glasgow, Ctr Virus Res, Garscube Campus, Glasgow, Lanark, Scotland	University of Manchester; University of Glasgow	Tassabehji, M (corresponding author), Univ Manchester, Evolut & Genom Sci, Sch Biol Sci, Manchester, Lancs, England.	m.Tassabehji@manchester.ac.uk						Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; An LL, 2005, LEUKEMIA RES, V29, P535, DOI 10.1016/j.leukres.2004.11.009; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021; Banerjee S, 2017, DNA RES, V24, P435, DOI 10.1093/dnares/dsx015; Ben-David E, 2011, HUM MOL GENET, V20, P3632, DOI 10.1093/hmg/ddr283; Beunders G, 2016, J MED GENET, V53, P523, DOI 10.1136/jmedgenet-2015-103601; Beunders G, 2013, AM J HUM GENET, V92, P210, DOI 10.1016/j.ajhg.2012.12.011; Boratyn GM, 2013, NUCLEIC ACIDS RES, V41, pW29, DOI 10.1093/nar/gkt282; Brameier M, 2007, BIOINFORMATICS, V23, P1159, DOI 10.1093/bioinformatics/btm066; Brown NP, 1998, BIOINFORMATICS, V14, P380, DOI 10.1093/bioinformatics/14.4.380; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Dickerson JE, 2012, MOL BIOL EVOL, V29, P61, DOI 10.1093/molbev/msr111; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Ebina T, 2009, BIOPOLYMERS, V92, P1, DOI 10.1002/bip.21105; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gao ZH, 2014, NATURE, V516, P349, DOI 10.1038/nature13921; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Holland LZ, 2008, BRAIN BEHAV EVOLUT, V72, P91, DOI 10.1159/000151470; Hori K, 2014, CELL REP, V9, P2166, DOI 10.1016/j.celrep.2014.11.045; Horn H, 2014, NAT METHODS, V11, P603, DOI 10.1038/nmeth.2968; Hu H, 2004, PROTEOMICS, V4, P643, DOI 10.1002/pmic.200300632; Kasahara M, 2007, CURR OPIN IMMUNOL, V19, P547, DOI 10.1016/j.coi.2007.07.009; Kondrychyn I, 2017, G3-GENES GENOM GENET, V7, P2577, DOI 10.1534/g3.117.042622; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lin CY, 2013, CELL REP, V3, P1739, DOI 10.1016/j.celrep.2013.04.022; Makino T, 2012, GENOME RES, V22, P2427, DOI 10.1101/gr.131953.111; McLysaght A, 2014, P NATL ACAD SCI USA, V111, P361, DOI 10.1073/pnas.1309324111; Meszaros B, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000376; Miyazawa S, 1996, J MOL BIOL, V256, P623, DOI 10.1006/jmbi.1996.0114; Molnar C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003982; Neme R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-117; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Oksenberg N, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.78; Oksenberg N, 2013, TRENDS GENET, V29, P600, DOI 10.1016/j.tig.2013.08.001; Oksenberg N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003221; OP026, 2016, J CROHNS COLITIS, V10, pS21; Poeck B, 2008, DEV NEUROBIOL, V68, P1046, DOI 10.1002/dneu.20643; Polyakova V, 2011, INT J CARDIOL, V151, P18, DOI 10.1016/j.ijcard.2010.04.053; Prakash S, 2007, EXP MOL PATHOL, V82, P42, DOI 10.1016/j.yexmp.2006.06.008; Singh PP, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004394; Staby L, 2017, BIOCHEM J, V474, P2509, DOI 10.1042/BCJ20160631; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Varjosalo M, 2013, NAT METHODS, V10, P307, DOI [10.1038/NMETH.2400, 10.1038/nmeth.2400]; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wolff T, 2015, J COMP NEUROL, V523, P997, DOI 10.1002/cne.23705; Xie T, 2016, MOL BIOL EVOL, V33, P2368, DOI 10.1093/molbev/msw108; Yeates DK, 2005, EVOLUTIONARY BIOL FL; Zhu YS, 2016, NEUROSCIENCE, V333, P35, DOI 10.1016/j.neuroscience.2016.07.007	52	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0232101	10.1371/journal.pone.0232101	http://dx.doi.org/10.1371/journal.pone.0232101			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306672	Green Published, Green Accepted, gold			2022-12-27	WOS:000600144200036
J	Chae, SM; Choi, J; Lim, S; Choi, HJ; Park, J; Hong, SH; Park, CS; Choi, JH; Chae, MS				Chae, Sumin; Choi, Junghee; Lim, Sujin; Choi, Ho Joong; Park, Jaesik; Hong, Sang Hyun; Park, Chul Soo; Choi, Jong Ho; Chae, Min Suk			Stress burden related to postreperfusion syndrome may aggravate hyperglycemia with insulin resistance during living donor liver transplantation: A propensity score-matching analysis	PLOS ONE			English	Article							C-PEPTIDE; BLOOD-GLUCOSE; ACTIVATION	Background We investigated the impact of postreperfusion syndrome (PRS) on hyperglycemia occurrence and connecting (C) peptide release, which acts as a surrogate marker for insulin resistance, during the intraoperative period after graft reperfusion in patients undergoing living donor liver transplantation (LDLT) using propensity score (PS)-matching analysis. Patients and methods Medical records from 324 adult patients who underwent elective LDLT were retrospectively reviewed, and their data were analyzed according to PRS occurrence (PRS vs. non-PRS groups) using the PS-matching method. Intraoperative levels of blood glucose and C-peptide were measured through the arterial or venous line at each surgical phase. Hyperglycemia was defined as a peak glucose level >200 mg/dL, and normal plasma concentrations of C-peptide in the fasting state were taken to range between 0.5 and 2.0 ng/mL. Results After PS matching, there were no significant differences in pre- and intra-operative recipient findings and donor-graft findings between groups. Although glucose and C-peptide levels continuously increased through the surgical phases in both groups, glucose and C-peptide levels during the neohepatic phase were significantly higher in the PRS group than in the non-PRS group, and larger changes in levels were observed between the preanhepatic and neohepatic phases. There were higher incidences of C-peptide levels >2.0 ng/mL and peak glucose levels >200 mg/dL in the neohepatic phase in patients with PRS than in those without. PRS adjusted for PS with or without exogenous insulin infusion was significantly associated with hyperglycemia occurrence during the neohepatic phase. Conclusions Elucidating the association between PRS and hyperglycemia occurrence will help with establishing a standard protocol for intraoperative glycemic control in patients undergoing LDLT.	[Chae, Sumin] United Hosp, Dept Anesthesiol & Pain Med, Seoul, South Korea; [Choi, Junghee; Lim, Sujin; Park, Jaesik; Hong, Sang Hyun; Park, Chul Soo; Choi, Jong Ho; Chae, Min Suk] Catholic Univ Korea, Coll Med, Dept Anesthesiol & Pain Med, Seoul St Marys Hosp, Seoul, South Korea; [Choi, Ho Joong] Catholic Univ Korea, Coll Med, Dept Surg, Seoul St Marys Hosp, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital	Chae, MS (corresponding author), Catholic Univ Korea, Coll Med, Dept Anesthesiol & Pain Med, Seoul St Marys Hosp, Seoul, South Korea.	shscms@gmail.com		Chae, Min Suk/0000-0002-1426-4651				Banu S, 2011, CNS NEUROL DISORD-DR, V10, P921, DOI 10.2174/187152711799219271; Bezinover D, 2011, LIVER TRANSPLANT, V17, P324, DOI 10.1002/lt.22227; Bo S, 2012, EUR J ENDOCRINOL, V167, P173, DOI 10.1530/EJE-12-0085; Carli F, 2015, CAN J ANESTH, V62, P110, DOI 10.1007/s12630-014-0264-0; Chae MS, 2018, ANN TRANSPL, V23, DOI 10.12659/AOT.908787; Chae MS, 2018, LIVER TRANSPLANT, V24, P623, DOI 10.1002/lt.25022; Chung HS, 2015, TRANSPL P, V47, P1877, DOI 10.1016/j.transproceed.2015.03.052; Chung HS, 2015, ANN TRANSPL, V20, P303, DOI 10.12659/AOT.893648; Chung IS, 2012, CLIN TRANSPLANT, V26, P539, DOI 10.1111/j.1399-0012.2011.01568.x; Cines DB, 1998, BLOOD, V91, P3527; Erice E, 2012, AM J PHYSIOL-GASTR L, V302, pG1458, DOI 10.1152/ajpgi.00389.2011; Fiegel M, 2012, SEMIN CARDIOTHORAC V, V16, P106, DOI 10.1177/1089253212444791; Garcia-Compean D, 2009, ANN HEPATOL, V8, P13, DOI 10.1016/S1665-2681(19)31805-8; Girn Hardev Ramandeep Singh, 2007, Vasc Endovascular Surg, V41, P277; Gresele P, 2003, J AM COLL CARDIOL, V41, P1013, DOI 10.1016/S0735-1097(02)02972-8; Hilmi I, 2008, LIVER TRANSPLANT, V14, P504, DOI 10.1002/lt.21381; Jeong SM, 2015, KOREAN J ANESTHESIOL, V68, P527, DOI 10.4097/kjae.2015.68.6.527; Konrad T, 2001, TRANSPLANT P, V33, P2576, DOI 10.1016/S0041-1345(01)02102-9; Leighton E, 2017, DIABETES THER, V8, P475, DOI 10.1007/s13300-017-0265-4; Marchetti P, 2005, LIVER TRANSPLANT, V11, P612, DOI 10.1002/lt.20439; Marvin MR, 2013, DIABETES TECHNOL THE, V15, P246, DOI 10.1089/dia.2012.0277; Monnier L, 2006, JAMA-J AM MED ASSOC, V295, P1681, DOI 10.1001/jama.295.14.1681; Nagueh SF, 2016, J AM SOC ECHOCARDIOG, V29, P277, DOI 10.1016/j.echo.2016.01.011; Nanashima A, 2001, J Hepatobiliary Pancreat Surg, V8, P557, DOI 10.1007/s005340100025; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Palermo NE, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-016-0721-y; Park CS, 2015, WORLD J GASTROENTERO, V21, P6835, DOI 10.3748/wjg.v21.i22.6835; Park J, 2020, BMC SURG, V20, DOI 10.1186/s12893-019-0658-6; Park J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215603; Patel N, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.003152; Ryu HG, 2012, LIVER TRANSPLANT, V18, P1430, DOI 10.1002/lt.23511; Turton JL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194987; VILSTRUP H, 1986, EUR J CLIN INVEST, V16, P193, DOI 10.1111/j.1365-2362.1986.tb01328.x; Xu ZD, 2012, HEPATOB PANCREAT DIS, V11, P34, DOI 10.1016/S1499-3872(11)60123-9; Yan YK, 2019, CARDIOVASC DIABETOL, V18, DOI 10.1186/s12933-019-0913-2; Yaribeygi H, 2019, LIFE SCI, V237, DOI 10.1016/j.lfs.2019.116950	36	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243873	10.1371/journal.pone.0243873	http://dx.doi.org/10.1371/journal.pone.0243873			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301501	Green Published, gold			2022-12-27	WOS:000600143100021
J	Kern, A; Shanahan, D; Buesen, R; Geiger, D				Kern, Andreas; Shanahan, Diane; Buesen, Roland; Geiger, Dominik			Safety evaluation of a beta-mannanase enzyme preparation produced with Thermothelomyces thermophilus expressing a protein-engineered beta-mannanase gene	PLOS ONE			English	Article							MYCELIOPHTHORA; DIETS	Mannanase 19287 enzyme is an engineered beta-mannanase that can be added to diets for animals raised for human consumption to hydrolyze beta-mannans. Established toxicological analyses were conducted with the enzyme preparation to ensure the safety of this product for the intended use. The mannanase 19287 preparation was produced with Thermothelomyces thermophilus strain DSM 33149. In vitro toxicity studies presented here used dosages of the mannanase 19287 test articles up to 5000 mu g/plate. For in vivo toxicity studies in Wistar rats, test articles were administered at 5.1 mg/L for inhalation toxicity and up to 15,000 mg/kg rat feed for oral toxicity, based on the Total Organic Solids (TOS) content in each test article. No treatment related adverse effects were reported in any study. The No Observed Adverse Effect Levels in the high dose group of the subchronic oral toxicity study were calculated as 1117-1298 mg TOS/kg bw/day in rats. Comparing these values to an Estimated Daily Intake for poultry demonstrated safety factors larger than 5000. Our results confirm that T. thermophilus fulfills the recognized safety criteria for the manufacture of food enzyme preparations and represent the first peer-reviewed safety evaluation of an enzyme preparation by T. thermophilus. The results of the toxicity studies presented herein attest to the safety of the mannanase 19287 enzyme for its intended use.	[Kern, Andreas; Shanahan, Diane] BASF Corp, San Diego, CA 92121 USA; [Buesen, Roland] BASF SE, Expt Toxicol & Ecol, Ludwigshafen, Germany; [Geiger, Dominik] BASF SE, Global Serv Cluster Safety, Ludwigshafen, Germany	BASF; BASF; BASF	Kern, A (corresponding author), BASF Corp, San Diego, CA 92121 USA.	andreas.a.kern@basf.com			BASF Corp., San Diego, CA; BASF SE, Ludwigshafen, Germany	BASF Corp., San Diego, CA(BASF); BASF SE, Ludwigshafen, Germany(BASF)	BASF Corp., San Diego, CA, and BASF SE, Ludwigshafen, Germany, the study sponsor, financially supported this project including the writing of this manuscript and paying third party costs. BASF SE, Experimental Toxicology and Ecology, an inspection body accredited by the national accreditation body of Germany, was paid to execute the toxicology studies, collect, analyze, and interpret data. The funders provided support in the form of salaries for authors [AK, DS, RB, DG], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AISE, 2017, GUID SAF HANDL ENZ D; AMES BN, 1975, MUTAT RES, V31, P347, DOI 10.1016/0165-1161(75)90046-1; AMFEP, 2013, GUID SAF HANDL IND E; [Anonymous], 2015, BMJ, V2015, ph1887; Aunstrup K, 1979, APPL BIOCHEM BIOENG, P28; Aunstrup K, 1979, MICROBIAL TECHNOLOGY, P281; Barry M. A., 2006, Morbidity and Mortality Weekly Report, V55, P563; Brinch DS, 2002, REGUL TOXICOL PHARM, V35, P296, DOI 10.1006/rtph.2002.1538; Bukhtojarov FE, 2004, BIOCHEMISTRY-MOSCOW+, V69, P542, DOI 10.1023/B:BIRY.0000029853.34093.13; Chauhan PS, 2012, APPL MICROBIOL BIOT, V93, P1817, DOI 10.1007/s00253-012-3887-5; COUCH J. R., 1967, BRIT POULTRY SCI, V8, P243, DOI 10.1080/00071666708415675; Dyadic International (USA) Inc, 2009, GRAS NOT 292 CELL EN; Enzyme Technical Association, 2018, WORK SAF ENZ; FAO WHO, 2004, 61 M JOINT FAO WHO E, V922; FAO/WHO, 2006, COMP FOOD ADD SPEC, P63; FAO/WHO, 2009, FOOD DER MOD BIOT, VSecond; FDA, 2003, TOX PRINC SAF ASS FO; FDA Center for Food Safety and Applied Nutrition (CFSAN), 2009, AG RESP LETT GRAS NO; GREEN MHL, 1976, MUTAT RES, V38, P3, DOI 10.1016/0165-1161(76)90076-5; GRUBER F, 1990, CURR GENET, V18, P71, DOI 10.1007/BF00321118; Henrissat B, 2020, GLYCOSYL HYDROLASE F; HYNES MJ, 1983, MOL CELL BIOL, V3, P1430, DOI 10.1128/MCB.3.8.1430; International Food Biotechnology Council, 1990, REGUL TOXICOL PHARM, V12, pS114; Lee JT, 2003, POULTRY SCI, V82, P1925, DOI 10.1093/ps/82.12.1925; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Mann-Felix Y, 2015, MYCOLOGIA, V107, P619, DOI [10.3852/14-288, 10.3852/14-228]; Nomenclature Committee of the International Union of Biochemistry and Molecular Biology (NC-IUBMB), 2019, ENZ NOM; Nourrisson C, 2017, CLIN MICROBIOL INFEC, V23, P338, DOI 10.1016/j.cmi.2016.10.025; Pariza MW, 2010, REGUL TOXICOL PHARM, V56, P332, DOI 10.1016/j.yrtph.2009.10.005; PARIZA MW, 1983, J FOOD PROTECT, V46, P453, DOI 10.4315/0362-028X-46.5.453; Pariza MW, 2001, REGUL TOXICOL PHARM, V33, P173, DOI 10.1006/rtph.2001.1466; Ross, 2020, ROSS 708 BROIL PERF; Srivastava PK, 2017, BIOTECHNOL ADV, V35, P1, DOI 10.1016/j.biotechadv.2016.11.001; U.S.Pharmacopeial Convention, 2018, FOOD CHEM COD, P413; van den Brink J, 2012, FUNGAL DIVERS, V52, P197, DOI 10.1007/s13225-011-0107-z; van Zyl WH, 2010, PROCESS BIOCHEM, V45, P1203, DOI 10.1016/j.procbio.2010.05.011; VERMA SVS, 1982, BRIT POULTRY SCI, V23, P95, DOI 10.1080/00071688208447935; Visser H., 2011, IND BIOTECHNOL, V7, P214, DOI [10.1089/ind.2011.7.214, DOI 10.1089/IND.2011.7.214]; Wu G, 2005, POULTRY SCI, V84, P894, DOI 10.1093/ps/84.6.894; Yoon SY, 2010, J ANIM SCI, V88, P181, DOI 10.2527/jas.2008-1741	40	1	1	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243647	10.1371/journal.pone.0243647	http://dx.doi.org/10.1371/journal.pone.0243647			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301505	Green Published, gold			2022-12-27	WOS:000600143100059
J	Slebarska, K; Soucek, R				Slebarska, Katarzyna; Soucek, Roman			Change of organizational newcomers' unmet expectations: Does proactive coping matter?	PLOS ONE			English	Article							JOB-SATISFACTION; MET EXPECTATIONS; MEDIATING ROLE; SOCIALIZATION; WORK; OUTCOMES; PERFORMANCE; ADJUSTMENT; PREDICTORS; COMMITMENT	Unmet expectations are one of the major sources of strain for organizational newcomers. We explore the change of newcomers' expectations over time and propose that proactive coping should restrict the amount of unmet expectations. We recruited participants among employees from newly opened retail stores (N = 172) and accompanied them for six months after organizational entry. The results revealed a change of unmet expectations over time. Though proactive coping was related to a lower amount of unmet expectations right after organizational entry, unmet expectations increased after six months, especially in case of high proactive coping.	[Slebarska, Katarzyna] Univ Silesia Katowice, Inst Psychol, Katowice, Poland; [Soucek, Roman] Friedrich Alexander Univ Erlangen Nurnberg, Sch Business Econ & Soc, Nurnberg, Germany	University of Silesia in Katowice; University of Erlangen Nuremberg	Slebarska, K (corresponding author), Univ Silesia Katowice, Inst Psychol, Katowice, Poland.	katarzyna.slebarska@us.edu.pl	Ślebarska, Katarzyna/AAT-6717-2020	Ślebarska, Katarzyna/0000-0003-2032-0469; Soucek, Roman/0000-0002-9877-1414	Polish National Science Center (NCN) [2013/10/M/HS6/00550]; German Academic Exchange Service (DAAD)	Polish National Science Center (NCN); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This work has been supported by the Polish National Science Center (NCN) within the project "Proactive coping with an adaptation to a new workplace after reemployment" (Project No. 2013/10/M/HS6/00550). The first author was also funded by the German Academic Exchange Service (DAAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashforth BE, 2007, J VOCAT BEHAV, V70, P447, DOI 10.1016/j.jvb.2007.02.001; Aspinwall LG, 1997, PSYCHOL BULL, V121, P417, DOI 10.1037//0033-2909.121.3.417; Bauer TN, 2007, J APPL PSYCHOL, V92, P707, DOI 10.1037/0021-9010.92.3.707; Bindl U.K., 2010, APA HDB IND ORG PSYC, V2, P567, DOI DOI 10.1037/12170-019; Boswell WR, 2005, J APPL PSYCHOL, V90, P882, DOI 10.1037/0021-9010.90.5.882; CHATMAN JA, 1989, ACAD MANAGE REV, V14, P333, DOI 10.5465/AMR.1989.4279063; Cooper-Thomas HD, 2014, J VOCAT BEHAV, V84, P318, DOI 10.1016/j.jvb.2014.02.007; Demerouti E, 2014, EUR PSYCHOL, V19, P237, DOI 10.1027/1016-9040/a000188; Earnest DR, 2011, PERS PSYCHOL, V64, P865, DOI 10.1111/j.1744-6570.2011.01230.x; Griffin MA, 2007, ACAD MANAGE J, V50, P327, DOI 10.5465/AMJ.2007.24634438; HELMREICH RL, 1986, J APPL PSYCHOL, V71, P185, DOI 10.1037/0021-9010.71.2.185; IRVING PG, 1995, J MANAGE, V21, P1159, DOI 10.1016/0149-2063(95)90027-6; Jiang Z, 2018, J VOCAT BEHAV, V104, P59, DOI 10.1016/j.jvb.2017.10.006; Jusoh M, 2011, EDUC TRAIN, V53, P515, DOI 10.1108/00400911111159476; Korte R, 2015, HUM RESOUR DEV Q, V26, P185, DOI 10.1002/hrdq.21206; Lait J, 2002, RELAT IND-IND RELAT, V57, P463, DOI 10.7202/006886ar; LEITER MP, 1991, J ORGAN BEHAV, V12, P123, DOI 10.1002/job.4030120205; Li WD, 2014, J APPL PSYCHOL, V99, P948, DOI 10.1037/a0036169; Lucas R.E., 2018, HDB WELL BEING; MAJOR DA, 1995, J APPL PSYCHOL, V80, P418, DOI 10.1037/0021-9010.80.3.418; Moser K, 2005, INT J SELECT ASSESS, V13, P188, DOI 10.1111/j.1468-2389.2005.00314.x; Neff LA, 2013, J PERS SOC PSYCHOL, V105, P38, DOI 10.1037/a0032600; NELSON DL, 1990, ACAD MANAGE J, V33, P859, DOI 10.2307/256295; Parker S.K., 2015, INT COACH PSYCHOL RE, V10, P62; Pasikowski T, 2002, POL PSYCHOL B, V33, P41; Paulus D. L., 2009, HDB RES METHODS PERS, P224; PORTER LW, 1973, PSYCHOL BULL, V80, P151, DOI 10.1037/h0034829; Saks AM, 2011, J VOCAT BEHAV, V79, P36, DOI 10.1016/j.jvb.2010.12.007; Saks AM, 2000, J ORGAN BEHAV, V21, P43, DOI 10.1002/(SICI)1099-1379(200002)21:1<43::AID-JOB985>3.0.CO;2-W; Saks AM, 1997, J VOCAT BEHAV, V51, P234, DOI 10.1006/jvbe.1997.1614; Schwarzer R., 2002, COPING M GOALS VISIO, P19, DOI [10.1093/med:psych/9780198508144.003.0002, DOI 10.1093/MED:PSYCH/9780198508144.003.0002]; Searle BJ, 2015, INT J STRESS MANAGE, V22, P46, DOI 10.1037/a0038439; Singer J.D., 2003, APPL LONGITUDINAL DA; Slebarska K, 2019, J CAREER DEV, V46, P295, DOI 10.1177/0894845318763947; Wanberg CR, 2000, J APPL PSYCHOL, V85, P373, DOI 10.1037//0021-9010.85.3.373; Wang PY, 2016, SOC INDIC RES, V127, P401, DOI 10.1007/s11205-015-0952-3; WANOUS JP, 1992, J APPL PSYCHOL, V77, P288, DOI 10.1037/0021-9010.77.3.288; Xu Huang, 2006, Asia Pacific Journal of Management, V23, P345, DOI 10.1007/s10490-006-9006-3	38	0	0	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243234	10.1371/journal.pone.0243234	http://dx.doi.org/10.1371/journal.pone.0243234			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH0WB	33301519	Green Published, gold			2022-12-27	WOS:000600143100019
J	Duorui, N; Shi, B; Zhang, T; Chen, CY; Fang, CK; Yue, ZJ; Wu, P; Wu, ZM; Huang, XW; Li, M				Duorui, Nie; Shi, Bin; Zhang, Tao; Chen, Chuyao; Fang, Chongkai; Yue, Zhijun; Wu, Peng; Wu, Zhiming; Huang, Xuewu; Li, Meng			The contemporary trend in worsening prognosis of pancreatic acinar cell carcinoma: A population-based study	PLOS ONE			English	Article							MARITAL-STATUS; INSTITUTIONAL SERIES; SURVIVAL; CANCER; OUTCOMES; PATIENT	Background Primary acinar cell carcinoma (ACC) is a rare exocrine tumor of the pancreas with unclear clinical characteristics. Our goal was to determine the incidence and update the clinical characteristics and outcomes of ACC. Methods Through the Surveillance, Epidemiology, and End Results (SEER) database, we identified 252 patients with the latest diagnosis of ACC (2004-2016). The age-adjusted incidence (AAI) was calculated using the SEER*Stat Software version 8.3.6. The Kaplan-Meier method was used to draw survival curves and differences among them were compared by the log-rank test. Cox proportional hazards models were used to evaluate factors that had independent predictive effects on the overall survival. Results The AAI of pancreatic ACC was on the rise with the mean age at diagnosis of 63.79 +/- 14.79 years. Most patients (15.9%) had poorer differentiated tumors. The patients presented with distant stage were 54.4% compared with 53.1% between 1988 and 2003. The 1-, 2-, and 5-years survival rates for pancreatic ACC patients were 53.5%, 34.6%,17.5%, respectively (compared with 78.5%, 67.0%, and 42.8%, between 1988 and 2003). The multivariate COX analysis showed that the patient's age, surgery, chemotherapy, and summary stage, but not marital status were independent prognosis factors for ACC. Conclusions Pancreatic ACC is a highly malignant tumor with an increasing incidence in recent years. The rate of distant metastasis is increasing and the survival rate is worse than in the past, suggesting that it may require more aggressive treatment and follow-up. Surgery, radiotherapy, and chemotherapy are all effective treatments, but prospective studies are still needed to verify them.	[Duorui, Nie; Shi, Bin; Zhang, Tao; Chen, Chuyao; Fang, Chongkai; Yue, Zhijun; Wu, Peng; Wu, Zhiming] Guangzhou Univ Chinese Med, Clin Med Coll 1, Guangzhou, Guangdong, Peoples R China; [Huang, Xuewu] Guangzhou Univ Tradit Chinese Med, Affiliated Hosp 1, Ctr Canc, Guangzhou, Guangdong, Peoples R China; [Li, Meng] Guangzhou Univ Chinese Med, Shenzhen Hosp Futian, Dept Oncol, Shenzhen, Guangdong, Peoples R China	Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine	Huang, XW (corresponding author), Guangzhou Univ Tradit Chinese Med, Affiliated Hosp 1, Ctr Canc, Guangzhou, Guangdong, Peoples R China.; Li, M (corresponding author), Guangzhou Univ Chinese Med, Shenzhen Hosp Futian, Dept Oncol, Shenzhen, Guangdong, Peoples R China.	drhuangxw@163.com; lemondxx@outlook.com	Nie, Duorui/CAH-8713-2022; fang, chongkai/GLV-2993-2022; Nie, Duorui/CAF-2721-2022	fang, chongkai/0000-0001-8319-5189; Nie, Duorui/0000-0003-3412-1196				Aizer AA, 2013, J CLIN ONCOL, V31, P3869, DOI 10.1200/JCO.2013.49.6489; Al-Hader A, 2017, WORLD J GASTROENTERO, V23, P7945, DOI 10.3748/wjg.v23.i45.7945; Baine M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021052; Brunetti O, 2018, PANCREAS, V47, P759, DOI 10.1097/MPA.0000000000001063; Butturini G, 2011, LANGENBECK ARCH SURG, V396, P363, DOI 10.1007/s00423-010-0706-2; Canadian Diabetes Association Clinical Practice Guidelines Expert Committee, 2003, CAN J DIABETES S2, V27, pS37; Du LJ, 2017, ONCOTARGET, V8, P95965, DOI 10.18632/oncotarget.21609; Egal A, 2019, PANCREAS, V48, P1393, DOI 10.1097/MPA.0000000000001440; Fang W, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02308-w; Furukawa T, 2015, SCI REP-UK, V5, DOI 10.1038/srep08829; Glazer ES, 2016, CANCER CONTROL, V23, P446, DOI 10.1177/107327481602300417; GOODWIN JS, 1987, JAMA-J AM MED ASSOC, V258, P3125, DOI 10.1001/jama.258.21.3125; He CB, 2018, J CANCER, V9, P4117, DOI 10.7150/jca.26936; Holen KD, 2002, J CLIN ONCOL, V20, P4673, DOI 10.1200/JCO.2002.02.005; Jauch SF, 2016, PANCREATOLOGY, V16, P153, DOI 10.1016/j.pan.2015.09.006; Jin JJ, 2016, CANCER MED-US, V5, P1821, DOI 10.1002/cam4.758; Kryklyva V, 2019, CANCER BIOL THER, V20, P949, DOI 10.1080/15384047.2019.1595274; Landa K, 2019, HPB, V21, P687, DOI 10.1016/j.hpb.2018.10.014; Lowery MA, 2011, ONCOLOGIST, V16, P1714, DOI 10.1634/theoncologist.2011-0231; Mohammed S, 2017, Mymensingh Med J, V26, P684; Schmidt CM, 2008, J GASTROINTEST SURG, V12, P2078, DOI 10.1007/s11605-008-0705-6; Seo S, 2017, J DIGEST DIS, V18, P480, DOI 10.1111/1751-2980.12505; Seth AK, 2008, J GASTROINTEST SURG, V12, P1061, DOI 10.1007/s11605-007-0338-1; Thompson ED, 2019, ARCH PATHOL LAB MED, DOI 10.5858/arpa.2019-0472-RA; Toll AD, 2013, KOREAN J PATHOL, V47, P93, DOI 10.4132/KoreanJPathol.2013.47.2.93; Virlos I T, 2002, HPB (Oxford), V4, P87, DOI 10.1080/136518202760378452; Wasif N, 2010, ANN SURG ONCOL, V17, P2312, DOI 10.1245/s10434-010-1071-7; Wisnoski NC, 2008, SURGERY, V144, P141, DOI 10.1016/j.surg.2008.03.006; Yoo C, 2017, CANCER RES TREAT, V49, P759, DOI 10.4143/crt.2016.371; Yoshihiro T, 2017, MOL CLIN ONCOL, V6, P866, DOI 10.3892/mco.2017.1240; Zhang SL, 2019, CANCER MED-US, V8, P465, DOI 10.1002/cam4.1802; Zhang XM, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-5008-z; Zhou HQ, 2017, CLIN RES HEPATOL GAS, V41, P476, DOI 10.1016/j.clinre.2017.02.008	33	6	7	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243164	10.1371/journal.pone.0243164	http://dx.doi.org/10.1371/journal.pone.0243164			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332471	Green Published, gold			2022-12-27	WOS:000601310900096
J	Kan, CK; Ragan, EJ; Sarkar, S; Knudsen, S; Forsyth, M; Muthuraj, M; Vinod, K; Jenkins, HE; Horsburgh, CR; Salgame, P; Roy, G; Ellner, JJ; Jacobson, KR; Sahu, S; Hochberg, NS				Kan, Carolyn K.; Ragan, Elizabeth J.; Sarkar, Sonali; Knudsen, Selby; Forsyth, Megan; Muthuraj, Muthaiah; Vinod, Kumar; Jenkins, Helen E.; Horsburgh, C. Robert; Salgame, Padmini; Roy, Gautam; Ellner, Jerrold J.; Jacobson, Karen R.; Sahu, Swaroop; Hochberg, Natasha S.			Alcohol use and tuberculosis clinical presentation at the time of diagnosis in Puducherry and Tamil Nadu, India	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; RISK-FACTORS; AUDIT; PREVENTION; OUTCOMES; DISEASE; ADULTS	Setting Alcohol use increases the risk of tuberculosis (TB) disease and is associated with worse outcomes. Objective To determine whether alcohol use affects TB severity at diagnosis in a high-burden setting. Design Participants were smear-positive people living with TB (PLWTB) in India. Disease severity was assessed as 1) high versus low smear grade, 2) time to positivity (TTP) on liquid culture, 3) chest radiograph cavitation, and 4) percent lung affected. Alcohol use and being at-risk for alcohol use disorders (AUD) were assessed using the AUDIT-C. Univariable and multivariable analyses were conducted. Results Of 1166 PLWTB, 691 (59.3%) were drinkers; of those, 518/691 (75.0%) were at-risk for AUD. Drinkers had more lung affected than non-drinkers (adjusted mean difference 10.8%, p<0.0001); this was not significant for those at-risk for AUD (adjusted mean difference 3.7%, p = 0.11). High smear grade (aOR 1.0, 95%CI: 0.7-1.4), cavitation (aOR 0.8, 95%CI 0.4-1.8), and TTP (mean difference 5.2 hours, p = 0.51) did not differ between drinkers and non-drinkers, nor between those at-risk and not at-risk for AUD. Conclusions A large proportion of PLWTB were drinkers and were at-risk for AUD. Alcohol drinkers had more lung affected than non-drinkers. Studies are needed to explore mechanisms of this association.	[Kan, Carolyn K.; Ragan, Elizabeth J.; Knudsen, Selby; Forsyth, Megan; Horsburgh, C. Robert; Jacobson, Karen R.; Hochberg, Natasha S.] Boston Univ, Sch Med, Sect Infect Dis, Boston, MA 02118 USA; [Kan, Carolyn K.; Ragan, Elizabeth J.; Knudsen, Selby; Forsyth, Megan; Horsburgh, C. Robert; Jacobson, Karen R.; Hochberg, Natasha S.] Boston Med Ctr, Boston, MA 02118 USA; [Sarkar, Sonali; Roy, Gautam; Sahu, Swaroop] Jawaharlal Inst Postgrad Med Educ & Res, Dept Prevent & Social Med, Gorimedu, Puducherry, India; [Muthuraj, Muthaiah] Govt Hosp Chest Dis, Intermediate Reference Lab, Gorimedu, Puducherry, India; [Vinod, Kumar] Jawaharlal Inst Postgrad Med Educ & Res, Dept Pulm Med, Gorimedu, Puducherry, India; [Jenkins, Helen E.; Horsburgh, C. Robert] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Horsburgh, C. Robert] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Horsburgh, C. Robert] Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA USA; [Salgame, Padmini; Ellner, Jerrold J.] Rutgers State Univ, New Jersey Med Sch, Dept Med, Div Infect Dis, Newark, NJ USA	Boston University; Boston Medical Center; Jawaharlal Institute of Postgraduate Medical Education & Research; Jawaharlal Institute of Postgraduate Medical Education & Research; Boston University; Boston University; Boston University; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center	Hochberg, NS (corresponding author), Boston Univ, Sch Med, Sect Infect Dis, Boston, MA 02118 USA.; Hochberg, NS (corresponding author), Boston Med Ctr, Boston, MA 02118 USA.	nhoch@bu.edu	Jacobson, Karen/AAX-9461-2021	Jenkins, Helen/0000-0003-4749-1591; Ragan, Elizabeth/0000-0001-6062-0058; Hochberg, Natasha/0000-0002-5449-9973; Jacobson, Karen/0000-0003-4239-3685	US Civilian Research & Development Foundation (CRDF Global) [USB-31150-XX-13]; National Science Foundation [OISE-9531011]; Federal funds from the Government of India's (GOI) Department of Biotechnology (DBT); Indian Council of Medical Research (ICMR); United States National Institutes of Health (NIH); National Institute of Allergy and Infectious Diseases (NIAID); Office of AIDS Research (OAR); Warren Alpert Foundation; Boston University School of Medicine	US Civilian Research & Development Foundation (CRDF Global); National Science Foundation(National Science Foundation (NSF)); Federal funds from the Government of India's (GOI) Department of Biotechnology (DBT); Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Office of AIDS Research (OAR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Warren Alpert Foundation; Boston University School of Medicine	This project has been funded by Award No. USB-31150-XX-13 of the US Civilian Research & Development Foundation (CRDF Global) and by the National Science Foundation under Cooperative Agreement No. OISE-9531011 with Federal funds from the Government of India's (GOI) Department of Biotechnology (DBT), the Indian Council of Medical Research (ICMR), the United States National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID), Office of AIDS Research (OAR), and distributed in part by CRDF Global to SS, JE, PS, GR, CRH, and NSH. The contents of this publication are solely the responsibility of the authors and do not represent the official views of the DBT, the ICMR, the NIH, or CRDF Global. NSH is also supported in part by a grant from the Warren Alpert Foundation and Boston University School of Medicine.	Aalto M, 2009, DRUG ALCOHOL DEPEN, V103, P25, DOI 10.1016/j.drugalcdep.2009.02.013; [Anonymous], 2014, OBESITY SILVER SP S2, V22, pS40; [Anonymous], 2013, INT UROGYNECOL J S1, V24, pS1; [Anonymous], 2010, ESPANA MEDIEVAL, V33, P97; [Anonymous], 2012, KIDNEY INT, V2, ps1; [Anonymous], 2018, J CANC RES THER, V14, pS622; Barr T, 2016, PROG NEURO-PSYCHOPH, V65, DOI 10.1016/j.pnpbp.2015.09.001; Barve S, 2017, ALCOHOL RES-CURR REV, V38, P289; BERMUDEZ LE, 1994, ALCOHOL, V11, P69, DOI 10.1016/0741-8329(94)90046-9; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; Eashwar VMA, 2020, J FAM MED PRIM CARE, V9, P49, DOI 10.4103/jfmpc.jfmpc_873_19; Eashwar VMA, 2019, J FAM MED PRIM CARE, V8, P2029, DOI 10.4103/jfmpc.jfmpc_226_19; Eashwar VMA, 2019, J FAM MED PRIM CARE, V8, P1098, DOI 10.4103/jfmpc.jfmpc_390_18; Fiske CT, 2009, J INFECTION, V58, P395, DOI 10.1016/j.jinf.2009.02.015; Fok A, 2008, INT J TUBERC LUNG D, V12, P480; Gamble L, 2006, MED MALADIES INFECT, V36, P72, DOI 10.1016/j.medmal.2005.08.010; Hargreaves NJ, 2001, INT J TUBERC LUNG D, V5, P847; Hochberg NS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183195; Imtiaz S, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00216-2017; Kumar SG, 2013, J CLIN DIAGN RES, V7, P1637, DOI 10.7860/JCDR/2013/5521.3216; Lewinsohn DM, 2017, CLIN INFECT DIS, V64, pE1, DOI 10.1093/cid/ciw694; Lonnroth K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-289; Matsuoka S, 2004, CLIN IMAG, V28, P119, DOI 10.1016/S0899-7071(03)00148-7; Melsew YA, 2018, EPIDEMIOL INFECT, V146, P345, DOI 10.1017/S0950268817003041; Moran A, 2007, ALCOHOL CLIN EXP RES, V31, P33, DOI 10.1111/j.1530-0277.2006.00262.x; Murthy SE, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1053-3; National Institute on Alcohol Abuse and Alcoholism, 2020, RETH DRINK ALC YOUR; O'Shea MK, 2014, CLIN INFECT DIS, V59, P177, DOI 10.1093/cid/ciu244; Ragan EJ, 2020, INT J TUBERC LUNG D, V24, P73, DOI 10.5588/ijtld.19.0080; Ramanan V Vijay, 2016, J Family Med Prim Care, V5, P804, DOI 10.4103/2249-4863.201175; Rathman G, 2003, INT J TUBERC LUNG D, V7, P942; Ravimohan S, 2018, EUR RESPIR REV, V27, DOI 10.1183/16000617.0077-2017; Rehm J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-450; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Scriba TJ, 2017, MICROBIOL SPECTR, V5, DOI 10.1128/microbiolspec.TBTB2-0016-2016; Silva DR, 2018, J BRAS PNEUMOL, V44, P145, DOI [10.1590/s1806-37562017000000443, 10.1590/S1806-37562017000000443]; Sinha P, 2019, J INFECT DIS, V219, P1356, DOI 10.1093/infdis/jiy675; SOBELL LC, 1992, MEASURING ALCOHOL CONSUMPTION, P41, DOI 10.1007/978-1-4612-0357-5_3; Society for Maternal-Fetal Medicine (SMFM) Publications Committee, 2017, AM J OBSTET GYNECOL, V216, pB8; Suhadev M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019485; Van Ness SE, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2629-9; Veerakumar A M, 2015, Indian J Tuberc, V62, P171, DOI 10.1016/j.ijtb.2015.07.017; Volkmann T, 2015, INT J TUBERC LUNG D, V19, P111, DOI 10.5588/ijtld.14.0516; WHO, 2021, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.21.286807; World Health Organization, 2018, AIR POLL CHILD HLTH; Yang ZH, 2018, INT J TUBERC LUNG D, V22, P628, DOI 10.5588/ijtld.17.0413; 2010, AM PSYCHOL, V65, P863	48	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0240595	10.1371/journal.pone.0240595	http://dx.doi.org/10.1371/journal.pone.0240595			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332367	Green Published, gold			2022-12-27	WOS:000601310900074
J	Kardos, J; Rose, TL; Manocha, U; Wobker, SE; Damrauer, JS; Bivalaqua, TJ; Kates, M; Moore, KJ; Parker, JS; Kim, WY				Kardos, Jordan; Rose, Tracy L.; Manocha, Ujjawal; Wobker, Sara E.; Damrauer, Jeffrey S.; Bivalaqua, Trinity J.; Kates, Max; Moore, Kristin J.; Parker, Joel S.; Kim, William Y.			Development and validation of a NanoString BASE47 bladder cancer gene classifier	PLOS ONE			English	Article							SUBTYPES; SURVIVAL	Background Recent molecular characterization of urothelial cancer (UC) has suggested potential pathways in which to direct treatment, leading to a host of targeted therapies in development for UC. In parallel, gene expression profiling has demonstrated that high-grade UC is a heterogeneous disease. Prognostic basal-like and luminal-like subtypes have been identified and an accurate transcriptome BASE47 classifier has been developed. However, these phenotypes cannot be broadly investigated due to the lack of a clinically viable diagnostic assay. We sought to develop and evaluate a diagnostic classifier of UC subtype with the goal of accurate classification from clinically available specimens. Methods Tumor samples from 52 patients with high-grade UC were profiled for BASE47 genes concurrently by RNAseq as well as NanoString. After design and technical validation of a BASE47 NanoString probeset, results from the RNAseq and NanoString were used to translate diagnostic criteria to the Nanostring platform. Evaluation of repeatability and accuracy was performed to derive a final Nanostring based classifier. Diagnostic classification resulting from the NanoString BASE47 classifier was validated on an independent dataset (n = 30). The training and validation datasets accurately classified 87% and 93% of samples, respectively. Results Here we have derived a NanoString-platform BASE47 classifier that accurately predicts basal-like and luminal-like subtypes in high grade urothelial cancer. We have further validated our new NanoString BASE47 classifier on an independent dataset and confirmed high accuracy when compared with our original Transcriptome BASE47 classifier. Conclusions The NanoString BASE47 classifier provides a faster turnaround time, a lower cost per sample to process, and maintains the accuracy of the original subtype classifier for better clinical implementation.	[Kardos, Jordan; Rose, Tracy L.; Manocha, Ujjawal; Wobker, Sara E.; Damrauer, Jeffrey S.; Parker, Joel S.; Kim, William Y.] Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA; [Rose, Tracy L.; Kim, William Y.] Univ North Carolina Chapel Hill, Div Oncol, Dept Med, Chapel Hill, NC 27515 USA; [Rose, Tracy L.; Kim, William Y.] Univ North Carolina Chapel Hill, Dept Urol, Chapel Hill, NC 27515 USA; [Wobker, Sara E.] Univ North Carolina Chapel Hill, Dept Pathol & Lab Med, Chapel Hill, NC USA; [Bivalaqua, Trinity J.; Kates, Max] Johns Hopkins Univ, Sch Med, Dept Urol, James Buchanan Brady Urol Inst, Baltimore, MD 21205 USA; [Moore, Kristin J.] Univ North Carolina Chapel Hill, Dept Epidemiol, Chapel Hill, NC USA; [Kardos, Jordan] Gilead Sci, Foster City, CA USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Johns Hopkins University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Gilead Sciences	Parker, JS; Kim, WY (corresponding author), Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA.; Kim, WY (corresponding author), Univ North Carolina Chapel Hill, Div Oncol, Dept Med, Chapel Hill, NC 27515 USA.; Kim, WY (corresponding author), Univ North Carolina Chapel Hill, Dept Urol, Chapel Hill, NC 27515 USA.	wykim@med.unc.edu; parkerjs@email.unc.edu	, Pathology Services Core/CEZ-2246-2022	Rose, Tracy/0000-0003-1411-2487	University Cancer Research Fund (UCRF); American Cancer Society [RSG-14-219-01-TBG]; National Cancer Institute at the National Institutes of Health K08 Mentored Clinical Scientist Research Career Development Award [1K08CA248967-01]; Doris Duke Charitable Foundation [2015213]; NCI [P30-CA016086, R01-CA241810]	University Cancer Research Fund (UCRF); American Cancer Society(American Cancer Society); National Cancer Institute at the National Institutes of Health K08 Mentored Clinical Scientist Research Career Development Award; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the University Cancer Research Fund (UCRF) [WYK and JSP], the NCI P30-CA016086 (JSP), the American Cancer Society grant RSG-14-219-01TBG [WYK]. TLR is supported by the National Cancer Institute at the National Institutes of Health K08 Mentored Clinical Scientist Research Career Development Award (1K08CA248967-01) and Grant 2015213 from the Doris Duke Charitable Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge the entire Kim Lab for their continued help throughout the project. This work was supported by the University Cancer Research Fund (UCRF) [WYK and JSP], the NCI P30-CA016086 (JSP), R01-CA241810 (WYK), the American Cancer Society grant RSG-14-219-01-TBG [WYK]. TLR is supported by the National Cancer Institute at the National Institutes of Health K08 Mentored Clinical Scientist Research Career Development Award (1K08CA248967-01) and Grant 2015213 from the Doris Duke Charitable Foundation. JK is an employee of Gilead Sciences, although the work done within this study was completed while he was a student at University of North Carolina and Gilead Sciences had no role in funding, study design, data collection and analysis, decision to publish, or preparation of the manuscript. The above funders also had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Choi W, 2014, CANCER CELL, V25, P152, DOI 10.1016/j.ccr.2014.01.009; Damrauer JS, 2014, P NATL ACAD SCI USA, V111, P3110, DOI 10.1073/pnas.1318376111; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Guo CC, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66747-7; Huang W, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-1; Kamoun A, 2020, EUR UROL, V77, P420, DOI 10.1016/j.eururo.2019.09.006; Kardos J, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85902; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Reis PP, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-46; Robertson AG, 2017, CELL, V171, P540, DOI 10.1016/j.cell.2017.09.007; Rosenberg JE, 2016, LANCET, V387, P1909, DOI 10.1016/S0140-6736(16)00561-4; Seiler Roland, 2017, Eur Urol, V72, P544, DOI 10.1016/j.eururo.2017.03.030; Sharma P, 2017, LANCET ONCOL, V18, P312, DOI 10.1016/S1470-2045(17)30065-7; Sjodahl G, 2012, CLIN CANCER RES, V18, P3377, DOI 10.1158/1078-0432.CCR-12-0077-T; Volkmer JP, 2012, P NATL ACAD SCI USA, V109, P2078, DOI 10.1073/pnas.1120605109; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq622	18	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243935	10.1371/journal.pone.0243935	http://dx.doi.org/10.1371/journal.pone.0243935			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332422	Green Published, gold			2022-12-27	WOS:000601310900015
J	Yu, B; Liu, ZY; Zhang, CY; Wu, Y; Han, JS; Li, HJ; Xu, B; Guo, HY; Zhang, K				Yu, Bo; Liu, Zhongyu; Zhang, Chunyu; Wu, Yu; Han, Jinsong; Li, Huajun; Xu, Bing; Guo, Hongyan; Zhang, Kun			Allogeneic uterus transplantation in a rhesus model: A short-term graft viability study	PLOS ONE			English	Article							UTERINE TRANSPLANTATION; PREGNANCY; PRIMATES	Objective This study examined the feasibility and safety of allogeneic uterus transplantation (UTx) from a living donor and assessed short-term graft viability in a rhesus model. This research is an important step towards further clinical application of UTx in humans. Materials and methods Four female rhesus monkeys with regular menstrual cycles were used in this study, the animals were either donors or recipients depending on ABO blood type compatibility. Retrieval surgery was performed to connect the uterus and uterine arteries together with the ovarian uterine vein from the living donor, and the vagina of the recipient was excised. After the back table had been prepared, bilateral uterine arteries were anastomosed end-to-side with the iliac externa arteries, and bilateral ovarian uterine veins were anastomosed end-to-side with the iliac externa vena. The transplanted uterus was evaluated based on the conditions of arterial blood, and flow was evaluated by transabdominal ultrasonography one month post operation. The conditions of the transplanted uterus were examined by secondary laparotomy. The reproductive function of rhesus monkeys was evaluated on the basis of the menstrual cycle. Results All 4 rhesus monkeys received the transplantation surgery without any surgical complications. No injury occurred in the other organs, and no vascular injury was observed in the allogeneic uterus. All recipients survived after the surgery with a 100% short-term survival rate. All recipients resumed normal menstruation within two months after surgery. Conclusions Our short follow-up shows that allogeneic UTx surgery is a safe and feasible technology in the rhesus model. The arterial conditions and blood flow of the grafted uterus can be monitored by ultrasonography examination.	[Yu, Bo; Liu, Zhongyu; Zhang, Chunyu; Wu, Yu; Han, Jinsong; Li, Huajun; Xu, Bing; Guo, Hongyan; Zhang, Kun] Peking Univ Third Hosp, Dept Gynecol & Obstet, Beijing, Peoples R China		Guo, HY; Zhang, K (corresponding author), Peking Univ Third Hosp, Dept Gynecol & Obstet, Beijing, Peoples R China.	bysyghy@163.com; bysyzk@163.com	Zhang, Chun-yu/HDP-5776-2022		Peking University Third hospital	Peking University Third hospital	This study is supported by Peking University Third hospital. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, Fertil Steril, V81 Suppl 4, pS9; [Anonymous], 2013, FERTIL STERIL, V100, pS51; Brannstrom M, 2019, FERTIL STERIL, V112, P3, DOI 10.1016/j.fertnstert.2019.05.030; Brannstrom M, 2018, FERTIL STERIL, V109, P256, DOI 10.1016/j.fertnstert.2017.12.007; Brannstrom M, 2017, J MATER SCI-MATER M, V28, DOI 10.1007/s10856-017-5872-0; Brannstrom M, 2014, FERTIL STERIL, V101, P1228, DOI 10.1016/j.fertnstert.2014.02.024; Brinsden PR, 2003, HUM REPROD UPDATE, V9, P483, DOI 10.1093/humupd/dmg033; Chmel R, 2019, AM J TRANSPLANT, V19, P855, DOI 10.1111/ajt.15096; Diaz-Garcia C, 2014, FERTIL STERIL, V102, P1545, DOI 10.1016/j.fertnstert.2014.09.010; Ejzenberg D, 2018, LANCET, V392, P2697, DOI 10.1016/S0140-6736(18)31766-5; El-Akouri RR, 2003, HUM REPROD, V18, P2018, DOI 10.1093/humrep/deg396; Hanafy A, 2011, AUST NZ J OBSTET GYN, V51, P199, DOI 10.1111/j.1479-828X.2010.01283.x; Jones BP, 2019, BJOG-INT J OBSTET GY, V126, P1310, DOI 10.1111/1471-0528.15863; Jones BP, 2016, BJOG-INT J OBSTET GY, V123, P1434, DOI 10.1111/1471-0528.13963; Kisu I, 2018, BJOG-INT J OBSTET GY, V125, P1352, DOI 10.1111/1471-0528.15230; Kisu I, 2013, FERTIL STERIL, V100, P280, DOI 10.1016/j.fertnstert.2013.03.004; Perez-Aytes A, 2017, EUR J MED GENET, V60, P16, DOI 10.1016/j.ejmg.2016.09.014; Puntambekar S, 2019, J MINIM INVAS GYN, V26, P628, DOI 10.1016/j.jmig.2018.11.021; Puntambekar S, 2018, J MINIM INVAS GYN, V25, P622, DOI 10.1016/j.jmig.2018.01.009; Ramirez ER, 2011, J MINIM INVAS GYN, V18, P238, DOI 10.1016/j.jmig.2010.11.006; Semba Y, 2010, BIOETHICS, V24, P348, DOI 10.1111/j.1467-8519.2009.01780.x; Testa G, 2017, AM J TRANSPLANT, V17, P2901, DOI 10.1111/ajt.14326; Tocci LJ, 2009, J VET EMERG CRIT CAR, V19, P66, DOI 10.1111/j.1476-4431.2009.00387.x; Tzakis AG, 2013, FERTIL STERIL, V100, P61, DOI 10.1016/j.fertnstert.2013.03.041; Westhoff CM, 2019, BLOOD, V133, P1814, DOI 10.1182/blood-2018-11-833954	25	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243140	10.1371/journal.pone.0243140	http://dx.doi.org/10.1371/journal.pone.0243140			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332374	Green Published, gold			2022-12-27	WOS:000601310900008
J	Zhang, Y; Zhao, MC; Cheng, J; Liu, S; Yuan, HB				Zhang, Ying; Zhao, Min-chi; Cheng, Jia; Liu, Shuo; Yuan, Hai-bin			Population dynamics and species composition of maize field parasitoids attacking aphids in northeastern China	PLOS ONE			English	Article								Maize, Zea mays L., is the most abundant field crop in China. Aphids are the most economically damaging pest on maize, particularly in the maize agri-ecosystems of Jilin Province, northeastern China. Parasitic wasps are important natural enemies of aphids, but limited information exists about their species composition, richness and seasonal dynamics in northeastern China. In this study, the population dynamics of maize aphids and parasitoid wasps were assessed in relation to each other during the summer seasons of two consecutive years, 2018 and 2019. We selected maize fields in the Changchun, Songyuan, Huinan and Gongzhuling areas of Jilin Province. Four species of aphids were recorded from these maize fields: Rhopalosiphum padi (L), Rhopalosiphum maidis (Fitch), Aphis gossypii Glover and Macrosiphum miscanthi (Takahashi). The dominant species in each of the four areas were R. maids (Filch) and R. padi in Changchun, R. padi in Songyuan, A. gossypii and R. padi in Huinan, and A.gossypii and R. padi in Gongzhuling. We delineated a species complex made up of primary parasitoids and hyperparasitoids associated with maize aphids. The primary parasitoids Lysiphlebus testaceipes, Binodoxys communis and Aphelinus albipodus together formed approximately 85.3% of the parasitoid complex. Pachyneuron aphidis, Phaenoglyphis villosa, Syrphophagus taeniatus and Asaphes suspensus made up the hyperparasitoids. Of the primary parasitoids, L. testaceipes was the dominant species (81.31%). Of the hyperparasitoid group, P. villosa was the dominant species (68.42%). Parasitism rates followed the fluctuation of the aphid population. The highest parasitic rate was observed during the peak period of cotton aphids. In this paper, the occurrence dynamics and dominant species of aphids and the dynamics of parasitic natural enemies of aphids in maize fields in Jilin Province are, for the first time, systematically reported. This study provides important information for the establishment and promotion of aphid biological control in maize fields.	[Zhang, Ying; Zhao, Min-chi; Cheng, Jia; Liu, Shuo; Yuan, Hai-bin] Jilin Agr Univ, Dept Plant Protect, Changchun, Peoples R China	Jilin Agricultural University	Yuan, HB (corresponding author), Jilin Agr Univ, Dept Plant Protect, Changchun, Peoples R China.	yhb-74@163.com			National Science and Technology major project of China [2019ZX08012004-009]; National Key Research and Development Program of China [2017YFD0300606]	National Science and Technology major project of China; National Key Research and Development Program of China	This research was funded by the The National Science and Technology major project of China (Grant No.2019ZX08012004-009), and the National Key Research and Development Program of China (Grant No.2017YFD0300606).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abid A, 2018, KEY APHID NATURAL EN, V266, P1; Ali A, 2016, SCI REP-UK, V6, DOI 10.1038/srep24273; Alichi M., 2008, Journal of Science and Technology of Agriculture and Natural Resources, V12, P287; [Anonymous], 2012, THESIS; [Anonymous], 2003, GUYANA MUSLIM J, V6, P10; Ansell-Pearson Keith., 1991, NIETZSCHE STUDIEN, V20, P267, DOI DOI 10.1515/9783110244397; ARCHER TL, 1974, ANN ENTOMOL SOC AM, V67, P11, DOI 10.1093/aesa/67.1.11; Asin L, 2001, ENVIRON ENTOMOL, V30, P1127, DOI 10.1603/0046-225X-30.6.1127; BING JW, 1991, J ECON ENTOMOL, V84, P625, DOI 10.1093/jee/84.2.625; Blum B, 2003, BIOCONTROL, V48, P477; Chen CY, 2009, SYMBIOSIS, V49, P53, DOI 10.1007/s13199-009-0011-4; Ding Wei, 2003, Yingyong Shengtai Xuebao, V14, P1481; El-Muadhidi M. A., 2001, Phytopathologia Mediterranea, V40, P224; Gagic V, 2012, OECOLOGIA, V170, P1099, DOI 10.1007/s00442-012-2366-0; Han BY, 2000, ACTA ENTOMOL SINICA, V1, P143; Hopkinson J, 2010, COTTON, V130, P325; Huang W L, 1997, B AGR SCI TECHNOLOGY, V7, P31; Judenko E, 1973, ANAL METHOD ASSESSIN, P24; Kamenova S, 2018, MOL ECOLOGY RESOURCE; Klimenta D, 2018, IET GENER TRANSM DIS, V12, P2968, DOI 10.1049/iet-gtd.2017.1298; Kraaijeveld D, 2006, VIDA RURAL; Li HP, 2018, HEILONGJIANG AGR SCI, V285, P49; Patil V. P., 2012, POPULATION DYNAMICS, V7, P107; PONS JM, 1994, ETHOL ECOL EVOL, V6, P1, DOI 10.1080/08927014.1994.9523003; Pons X, 2011, J PEST SCI, V84, P437, DOI 10.1007/s10340-011-0383-0; Rusk R, 2010, MANAGEMENT CORN APHI; Sahaza JH, 2014, COMP IMMUNOL MICROB, V37, P143, DOI 10.1016/j.cimid.2014.03.002; Shelby T., 2012, LAW ETHICS HUMAN RIG, V6, P70, DOI [DOI 10.1515/1938-2545.1068, https://doi.org/10.1515/1938-2545.1068]; Shiyomi M., 1964, RES POPUL ECOL, V6, P79; Sigsgaard L, 2010, J APPL ENTOMOL, V126, P101; Stary DP, 2010, J APPL ENTOMOL, V105, P74; [王永宏 Wang Yonghong], 2002, [西北农林科技大学学报. 自然科学版, Journal of northwest sci-tech university of agriculture and forestry], V30, P55; Watson R.T., 2000, IMPL DIFF DEF GEN IS, P375; Yan Zhimiao, 2011, THESIS; Yang F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10345-7; Yang J., 2013, THESIS; ZHANG YS, 2009, CHINA TROP AGR, V4, P15; Zhu T, 2019, WATER RESOUR RES, V55, P28; Zou Yunding, 2005, Yingyong Shengtai Xuebao, V16, P631	39	2	2	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0241530	10.1371/journal.pone.0241530	http://dx.doi.org/10.1371/journal.pone.0241530			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332420	Green Published, gold			2022-12-27	WOS:000601310900030
J	Koo, KI; Hwang, CH				Koo, Kyo-in; Hwang, Chang Ho			Five-day rehabilitation of patients undergoing total knee arthroplasty using an end-effector gait robot as a neuromodulation blending tool for deafferentation, weight offloading and stereotyped movement: Interim analysis	PLOS ONE			English	Article							NEUROMUSCULAR ELECTRICAL-STIMULATION; DEPENDENT PLASTICITY; SENSORIMOTOR CORTEX; MUSCLE ACTIVATION; ASSISTED WALKING; RAPID PLASTICITY; REFLEX PATHWAYS; SKELETAL-MUSCLE; MODULATION; PATTERNS	Deafferentation and weight offloading can increase brain and spinal motor neuron excitability, respectively. End-effector gait robots (EEGRs) can blend these effects with stereotyped movement-induced neuroplasticity. The authors aimed to evaluate the usefulness of EEGRs as a postoperative neuro-muscular rehabilitation tool. This prospective randomized controlled trial included patients who had undergone unilateral total knee arthroplasty (TKA). Patients were randomly allocated into two groups: one using a 200-step rehabilitation program in an EEGR or the other using a walker on a floor (WF) three times a day for five weekdays. The two groups were compared by electrophysiological and biomechanical methods. Since there were no more enrollments due to funding issues, interim analysis was performed. Twelve patients were assigned to the EEGR group and eight patients were assigned to the WF group. Although the muscle volume of the quadriceps and hamstring did not differ between the two groups, the normalized peak torque of the operated knee flexors (11.28 +/- 16.04 Nm/kg) was improved in the EEGR group compared to that of the operated knee flexors in the WF group (4.25 +/- 14.26 Nm/kg) (p = 0.04). The normalized compound motor action potentials of the vastus medialis (VM) and biceps femoris (BF) were improved in the EEGR group (p < 0.05). However, the normalized real-time peak amplitude and total, mean area under the curve of VM were decreased during rehabilitation in the EEGR group (p < 0.05). No significant differences were found between operated and non-operated knees in the EEGR group. Five-day EEGR-assisted rehabilitation induced strengthening in the knee flexors and the muscular reactivation of the BF and VM after TKA, while reducing the real-time use of the VM. This observation may suggest the feasibility of this technique: EEGR modulated the neuronal system of the patients rather than training their muscles. However, because the study was underpowered, all of the findings should be interpreted with the utmost caution.	[Koo, Kyo-in] Univ Ulsan, Sch Elect Engn, Dept Biomed Engn, Ulsan, South Korea; [Hwang, Chang Ho] Chungnam Natl Univ, Sejong Hosp, Coll Med, Dept Phys & Rehabil Med, Sejong, South Korea	University of Ulsan; Chungnam National University	Hwang, CH (corresponding author), Chungnam Natl Univ, Sejong Hosp, Coll Med, Dept Phys & Rehabil Med, Sejong, South Korea.	chhwang1220@cnu.ac.kr		Hwang, Chang Ho/0000-0003-0444-3602	Chungnam National University	Chungnam National University	This work was supported by research fund of Chungnam National University. Initials of the authors who received each award: CHH Grant numbers awarded to each author: N/A The full name of each funder: Chungnam National University URL of each funder website; http://iuc.cnu.ac.kr/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard P, 2002, J APPL PHYSIOL, V93, P1318, DOI 10.1152/japplphysiol.00283.2002; ALTMAN DG, 1991, STAT MED, V10, P1897, DOI 10.1002/sim.4780101206; [Anonymous], 2001, SAGGIATORE MUSICALE, VVIII, p[1, 121]; [Anonymous], 2002, PSYCHIAT NEWS, V37, P25; [Anonymous], 2009, INT COMP LAW Q, V23, P143; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Berth A, 2002, ARCH PHYS MED REHAB, V83, P1432, DOI 10.1053/apmr.2002.34829; Borzelli D, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00186; Butefisch CM, 2000, P NATL ACAD SCI USA, V97, P3661, DOI 10.1073/pnas.050350297; Calancie B, 2005, CLIN NEUROPHYSIOL, V116, P75, DOI 10.1016/j.clinph.2004.07.018; Carson RG, 2004, J PHYSIOL-LONDON, V560, P929, DOI 10.1113/jphysiol.2004.069088; Do Cho S, 2013, KNEE SURG SPORT TR A, V21, P2744, DOI 10.1007/s00167-012-2144-x; Classen J, 1998, J NEUROPHYSIOL, V79, P1117, DOI 10.1152/jn.1998.79.2.1117; Coenen P, 2012, J REHABIL MED, V44, P331, DOI 10.2340/16501977-0954; Cruz-Jentoft AJ, 2019, AGE AGEING, V48, P16, DOI 10.1093/ageing/afy169; Dietz V, 2000, GAIT POSTURE, V11, P102, DOI 10.1016/S0966-6362(99)00052-1; Dietz V, 2002, BRAIN, V125, P2626, DOI 10.1093/brain/awf273; Floyer-Lea A, 2006, J NEUROPHYSIOL, V95, P1639, DOI 10.1152/jn.00346.2005; Frontera WR, 2010, DELISAS PHYS MED REH, P2187; Gill SV, 2017, OSTEOARTHR CARTILAGE, V25, P60, DOI 10.1016/j.joca.2016.07.011; Hawker GA, 2011, ARTHRIT CARE RES, V63, pS240, DOI 10.1002/acr.20543; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Hidler JM, 2005, CLIN BIOMECH, V20, P184, DOI 10.1016/j.clinbiomech.2004.09.016; HNIK P., 1956, PHYSIOL BOHEMOSL, V5, P305; Hof AL, 2002, GAIT POSTURE, V16, P78, DOI 10.1016/S0966-6362(01)00206-5; Hong S-J, 2010, 2010 10 IEEE C NAN N; Huber EO, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-157; Hussein S, 2008, IEEE ENG MED BIO, P1961, DOI 10.1109/IEMBS.2008.4649572; Hwang CH, 2019, WORLD J CLIN CASES, V7, P2976, DOI 10.12998/wjcc.v7.i19.2976; Israel JF, 2006, PHYS THER, V86, P1466, DOI 10.2522/ptj.20050266; Kantak SS, 2013, NEUROSCIENCE, V247, P55, DOI 10.1016/j.neuroscience.2013.05.001; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; KHUDOROZHEVA A T, 1962, Tr Inst Fiziol Im I P Pavlova, V10, P369; Kim HY, 2016, NEUROREHABILITATION, V38, P171, DOI 10.3233/NRE-161307; Kim J, 2019, CLIN REHABIL, V33, P516, DOI 10.1177/0269215518806563; Knaepen K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140626; Kraus VB, 2005, ARTHRITIS RHEUM, V52, P1730, DOI 10.1002/art.21100; Krishnan C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077370; Lamont HS, 2010, J STRENGTH COND RES, V24, P171, DOI 10.1519/JSC.0b013e3181c3b641; Levy LM, 2002, ANN NEUROL, V52, P755, DOI 10.1002/ana.10372; Li Jianhua, 2014, Eur J Orthop Surg Traumatol, V24, P203, DOI 10.1007/s00590-012-1159-9; Li JS, 2019, GAIT POSTURE, V68, P461, DOI 10.1016/j.gaitpost.2018.12.031; MACEFIELD VG, 1993, J PHYSIOL-LONDON, V471, P429, DOI 10.1113/jphysiol.1993.sp019908; Marchal-Crespo L, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-25; Mazzocchio R, 2006, CLIN NEUROPHYSIOL, V117, P1682, DOI 10.1016/j.clinph.2006.04.019; McGinnis K, 2013, CLIN BIOMECH, V28, P205, DOI 10.1016/j.clinbiomech.2012.11.008; Melander H, 2003, BMJ-BRIT MED J, V326, P1171, DOI 10.1136/bmj.326.7400.1171; MENDELSON J H, 1962, Prog Neurobiol, V5, P178; Nakajima T, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00368; Neckel ND, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-19; Nguyen USDT, 2011, ANN INTERN MED, V155, P725, DOI 10.7326/0003-4819-155-11-201112060-00004; Norkin C.W., 1995, MEASUREMENT JOINT MO; Pamukoff DN, 2016, MUSCLE NERVE, V54, P469, DOI 10.1002/mus.25081; Perez MA, 2004, EXP BRAIN RES, V159, P197, DOI 10.1007/s00221-004-1947-5; Rossi S, 1998, NEUROIMAGE, V8, P163, DOI 10.1006/nimg.1998.0352; Saleh Khaled J, 2010, Instr Course Lect, V59, P119; Schweitzer L, 2015, AM J CLIN NUTR, V102, P58, DOI 10.3945/ajcn.115.111203; Stevens JE, 2004, J ORTHOP SPORT PHYS, V34, P21, DOI 10.2519/jospt.2004.34.1.21; Stevens-Lapsley JE, 2012, PHYS THER, V92, P210, DOI 10.2522/ptj.20110124; TAUB E, 1974, PERCEPTION, V3, P393, DOI 10.1068/p030393; ter Braack EM, 2016, CLIN NEUROPHYSIOL, V127, P3025, DOI 10.1016/j.clinph.2016.06.003; Tomelleri C, 2012, IEEE INT C REH ROB P, V2011; Van Kammen K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107323; Walls RJ, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-119; Whelan PJ, 1997, J NEUROPHYSIOL, V78, P1643, DOI 10.1152/jn.1997.78.3.1643; Xerri C, 1998, J NEUROPHYSIOL, V79, P2119, DOI 10.1152/jn.1998.79.4.2119; Yang HE, 2017, NEUROSCI LETT, V637, P114, DOI 10.1016/j.neulet.2016.11.039; Zehr EP, 2004, NEUROSCIENTIST, V10, P347, DOI 10.1177/1073858404264680; Ziemann U, 2001, BRAIN, V124, P1171, DOI 10.1093/brain/124.6.1171	69	0	1	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0241117	10.1371/journal.pone.0241117	http://dx.doi.org/10.1371/journal.pone.0241117			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326434	gold, Green Published			2022-12-27	WOS:000600176400018
J	Ma, Y; Song, Z; Li, SQ; Jiang, TY				Ma, Yan; Song, Zhe; Li, Shuangqi; Jiang, Tangyang			Dynamic evolution analysis of the factors driving the growth of energy-related CO2 emissions in China: An input-output analysis	PLOS ONE			English	Article							CARBON-DIOXIDE EMISSIONS; RENEWABLE ENERGY; ECONOMIC-GROWTH; DECOMPOSITION ANALYSIS; NONRENEWABLE ENERGY; CONSUMPTION STRUCTURE; REDUCTION; PANEL; COUNTRIES; INDUSTRY	In recent years, the global greenhouse effect caused by excessive energy-related carbon emissions has attracted more and more attention. In this paper, we studied the dynamic evolution of factors driving China's energy-related CO2 emissions growth from 2007 to 2015 by using energy consumption method and input-output analysis and used the IO-SDA model to decompose the energy carbon emissions. Within the research interval, the results showed that (1) on the energy supply-side, the high carbon energy represented by raw coal was still the main factor to promote the growth of energy-related CO2 emissions. However, the optimization of energy consumption structure is conducive to reducing emissions. Specifically, the high carbon energy represented by raw coal exhibited a downward trend in promoting the increment of energy-related CO2 emissions, while the clean energy represented by natural gas showed an upward trend in promoting the increment of CO2 emissions. It is worth noting that there is still a lot of room for optimization of China's energy consumption structure to reduce emissions. (2) On the energy demand-side, the final demand effect is the main driving force of the growth of carbon emissions from fossil energy. Among them, the secondary industry plays a major role in the final demand effect. The "high carbonization" of the final product reflects the characteristics of China's high energy input in the process of industrialization. At the same time, since the carbon emission efficiency of the tertiary industry and the primary industry is better than that of the secondary industry, actively optimizing the industrial structure is conducive to slowing down the growth of carbon emission brought by the demand effect. (3) The input structure effect is the main restraining factor for the growth of energy carbon emissions, while the energy intensity effect has a slight driving effect on the growth of energy carbon emissions. The results show that China's "extensive" economic growth model has been effectively reversed, but the optimization of fossil energy utilization efficiency is still not obvious, and there is still a large space to curb carbon emissions by improving fossil energy utilization efficiency in the future.	[Ma, Yan; Li, Shuangqi; Jiang, Tangyang] Zhongnan Univ Econ & Law, Postdoctoral Res Stn Appl Econ, Wuhan, Peoples R China; [Ma, Yan] Zhongnan Univ Econ & Law, Sch Business Adm, Wuhan, Peoples R China; [Song, Zhe] Chongqing Univ, Sch Econ & Business Adm, Chongqing, Peoples R China; [Li, Shuangqi] Chongqing Technol & Business Univ, Sch Accounting, Chongqing, Peoples R China; [Jiang, Tangyang] Anhui Univ, Sch Internet, Hefei, Anhui, Peoples R China	Zhongnan University of Economics & Law; Zhongnan University of Economics & Law; Chongqing University; Chongqing Technology & Business University; Anhui University	Li, SQ (corresponding author), Chongqing Technol & Business Univ, Sch Accounting, Chongqing, Peoples R China.; Jiang, TY (corresponding author), Anhui Univ, Sch Internet, Hefei, Anhui, Peoples R China.	lsqwuhan@163.com; jiang_tangyang@163.com		Li, Shuangqi/0000-0002-1705-1256	China Postdoctoral Science Foundation [2020M672459]; Fundamental Research Funds for the Central Universities of China [2722020PY056]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	The authors are grateful to the financial support provided by China Postdoctoral Science Foundation (2020M672459) and by the Fundamental Research Funds for the Central Universities of China (Grant No. 2722020PY056).	An RY, 2018, APPL ENERG, V226, P862, DOI 10.1016/j.apenergy.2018.06.044; Bilgili F, 2016, RENEW SUST ENERG REV, V54, P838, DOI 10.1016/j.rser.2015.10.080; Boontome P, 2017, ENRGY PROCED, V138, P925, DOI 10.1016/j.egypro.2017.10.141; Chen YL, 2019, RENEW ENERG, V140, P341, DOI 10.1016/j.renene.2019.03.058; Chen ZF, 2017, ENERG ECON, V68, P89, DOI 10.1016/j.eneco.2017.09.015; Dong KY, 2017, ENERGY, V141, P1466, DOI 10.1016/j.energy.2017.11.092; Du G, 2018, J CLEAN PROD, V184, P1102, DOI 10.1016/j.jclepro.2018.02.304; Du Q, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15061220; Du ZL, 2018, J CLEAN PROD, V176, P1177, DOI 10.1016/j.jclepro.2017.11.178; Duan Wen-biao, 2017, Forest Research, V30, P268, DOI 10.13275/j.cnki.lykxyj.2017.02.012; Feng C, 2018, RESOUR POLICY, V59, P487, DOI 10.1016/j.resourpol.2018.09.003; Gao C., 2009, MODERN CHEM IND, V81, P337, DOI [10.2307/3547054, DOI 10.2307/3547054]; Gao ZY, 2019, J CLEAN PROD, V223, P94, DOI 10.1016/j.jclepro.2019.03.092; Henson SA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14682; Jia JS, 2018, J CLEAN PROD, V183, P843, DOI 10.1016/j.jclepro.2018.02.116; Jiang TY, 2020, J CLEAN PROD, V264, DOI 10.1016/j.jclepro.2020.121507; Jiang TY, 2019, J CLEAN PROD, V240, DOI 10.1016/j.jclepro.2019.118116; Jiang XM, 2018, CLIM POLICY, V18, P889, DOI 10.1080/14693062.2017.1388211; Nguyen KH, 2019, RENEW ENERG, V132, P1049, DOI 10.1016/j.renene.2018.08.069; Ko L, 2013, ENERG POLICY, V61, P551, DOI 10.1016/j.enpol.2013.05.120; Li JL, 2018, CHINA ECON REV, V50, P17, DOI 10.1016/j.chieco.2018.03.006; LIAO M, 2017, STAT RES, V34, P62; Lin BQ, 2015, ENERG POLICY, V86, P483, DOI 10.1016/j.enpol.2015.07.030; [刘宇 Liu Yu], 2015, [中国人口·资源与环境, China Population Resources and Environment], V25, P21; Liu Z, 2015, NATURE, V524, P335, DOI 10.1038/nature14677; Long XL, 2015, RENEW SUST ENERG REV, V52, P680, DOI 10.1016/j.rser.2015.07.176; Moutinho V, 2018, RENEW SUST ENERG REV, V90, P605, DOI 10.1016/j.rser.2018.02.009; Muhammad B, 2019, ENERGY, V179, P232, DOI 10.1016/j.energy.2019.03.126; Pata UK, 2018, J CLEAN PROD, V187, P770, DOI 10.1016/j.jclepro.2018.03.236; Risinger CF., 2009, SOC EDUC, V73, P279; Shafiei S, 2014, ENERG POLICY, V66, P547, DOI 10.1016/j.enpol.2013.10.064; Sharif A, 2019, RENEW ENERG, V133, P685, DOI 10.1016/j.renene.2018.10.052; Sheinbaum C, 2011, ENERGY, V36, P3629, DOI 10.1016/j.energy.2010.07.023; Shi YR, 2012, ENRGY PROCED, V16, P121, DOI 10.1016/j.egypro.2012.01.022; Shrestha RM, 2005, ENERG POLICY, V33, P815, DOI 10.1016/j.enpol.2003.10.007; Su B, 2017, ENERG POLICY, V105, P484, DOI 10.1016/j.enpol.2017.03.027; Tang CC, 2017, ENERG POLICY, V109, P704, DOI 10.1016/j.enpol.2017.07.050; Wang CH, 2017, APPL ENERG, V194, P223, DOI 10.1016/j.apenergy.2017.02.045; Wang XW, 2015, J CLEAN PROD, V103, P705, DOI 10.1016/j.jclepro.2014.10.030; Wang ZX, 2017, J CLEAN PROD, V142, P600, DOI 10.1016/j.jclepro.2016.08.067; Xia FQ, 2020, SCI TOTAL ENVIRON, V708, DOI 10.1016/j.scitotenv.2019.134587; Xie YY, 2017, ENVIRON POLLUT, V225, P338, DOI 10.1016/j.envpol.2017.02.059; Xu SC, 2017, J CLEAN PROD, V142, P3061, DOI 10.1016/j.jclepro.2016.10.161; Xu SC, 2014, APPL ENERG, V127, P182, DOI 10.1016/j.apenergy.2014.03.093; Yang LS, 2016, RENEW SUST ENERG REV, V60, P258, DOI 10.1016/j.rser.2016.01.058; Yu SW, 2018, ENERG ECON, V74, P693, DOI 10.1016/j.eneco.2018.07.017; Zhang YJ, 2015, RENEW SUST ENERG REV, V41, P1255, DOI 10.1016/j.rser.2014.09.021; Zhao X, 2018, ENERGY STRATEG REV, V22, P303, DOI 10.1016/j.esr.2018.10.003	48	6	6	8	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243557	10.1371/journal.pone.0243557	http://dx.doi.org/10.1371/journal.pone.0243557			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH1IW	33326468	Green Published, gold			2022-12-27	WOS:000600176400079
J	Mitikie, KA; Wassie, GT; Beyene, MB				Mitikie, Kassahun Asres; Wassie, Gizachew Tadesse; Beyene, Melkamu Bedemo			Institutional delivery services utilization and associated factors among mothers who gave birth in the last year in Mandura district, Northwest Ethiopia	PLOS ONE			English	Article								Background The risk of death from complications relating to pregnancy and childbirth for women's lifetime is higher in developing countries. Improving maternal and child health through a well-organized institutional delivery service is central to achieving reduced maternal and child mortality. Despite the efforts that have been made to improve maternal health outcomes in Ethiopia, institutional delivery is still unacceptably low. Objective This study was conducted to assess institutional delivery service utilization and associated factors in the study area. Methods A Community-based cross-sectional study was conducted. A multi-stage sampling technique was used to employ a total of 546 women. Data were collected using an interviewer-administered questionnaire and entered into EpiData version 3.1 and then exported to SPSS version 23.0. for analysis. Logistic regression models were used to determine factors associated with the outcome variable. Adjusted Odds ratios with 95% CI were computed to measure the strength of association and statistical significance was declared at p-value <0.05. Results The Prevalence of institutional delivery in the study area was 38% (34%-42%). Factors significantly associated with institutional delivery were ANC visit 1.80 (1.12-2.91), knowledge of danger sign during pregnancy 3.60 (2.25-5.76), urban residency 2.09 (1.15-3.81), Parity 0.49 (0.25-0.95) accessibility of health facility 4.60 (2.01-10.89), husbands educational level: primary 2.50 (1.27-4.91), secondary and above 2.36 (1.24-4.48), mothers occupation: governmental employee 2.05 (1.00-4.18), and Private employee 2.42 (1.09-5.35). Conclusions The prevalence of institutional delivery in the District was low. Antenatal visits, residency, knowledge of pregnancy danger signs, parity, and accessibility of health facilities, maternal occupation, and husband education were factors significantly associated with institutional delivery.	[Mitikie, Kassahun Asres] Mandura Dist Hlth Off, Metekel Zone, Benishangul Gum, Ethiopia; [Wassie, Gizachew Tadesse; Beyene, Melkamu Bedemo] Bahir Dar Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Coll Med & Hlth Sci, Bahir Dar, Ethiopia	Bahir Dar University	Wassie, GT (corresponding author), Bahir Dar Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Coll Med & Hlth Sci, Bahir Dar, Ethiopia.	leulgzat@gmail.com		Beyene, Melkamu Bedimo/0000-0003-4349-9887				Alemayehu M, 2015, BIOMED RES INT, V2015; Amentie M, 2016, GLOB J MED RES; Amouzou A, 2017, J GLOB HEALTH, V7, DOI 10.7189/jogh.07.020504; [Anonymous], 2016, NAT PHOTONICS, V10, P1, DOI 10.1038/nphoton.2015.265; [Anonymous], 2014, OBESITY SILVER SP S2, V22, pS40; [Anonymous], 2018, BNJ M; Arba MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151082; Buta B, 2018, FACTORS ASS DELIVERY; Demilew YM, 2016, AFR HEALTH SCI, V16, P10, DOI 10.4314/ahs.v16i1.2; Devkota B, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228440; Di Gennaro F, 2020, EPIDEMIOL INFECT, V148, DOI 10.1017/S0950268820000370; Eshete T, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4450-6; Exavery A, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/1475-9276-13-48; Fekadu M, 2014, AFR HEALTH SCI, V14, DOI 10.4314/ahs.v14i4.29; Gedefaw G, 2018, GYNECOL OBSTET SUNNY, V8, P2161; Habte F, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0716-8; ICF TDP, 2019, MIN DEM HLTH SURV 20; ICF TDP, 2016, HLTH SURV EDHS 2016; KELEBORE WG, 2016, SCI J PUBLIC HLTH, V4, P458, DOI DOI 10.11648/J.SJPH.20160406.17; Kinney MV, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000294; MA Daniel Abeba, 2018, ANN MED HLTH SCI RES; Ministry of Health and Family Welfare Bangladesh World Health Organization World Bank, 2015, SUCC FACT WOM CHILDR; Mohammed MJ., 2017, MED RES CHRONICLES, V4, P363; MSH-GTR, 2017, OV SIT MAT MORB MORT; Olgira L, 2018, MEDICO RES CHRONICLE, V5, P202; Shehu C. E., 2016, Journal of Public Health and Epidemiology, V8, P91, DOI 10.5897/JPHE2016.0817; Tadele A, 2019, REPROD HEALTH, V16, DOI 10.1186/s12978-019-0813-7; Tadele N, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2057-y; Tadese F., 2014, CLIN MOTHER CHILD HL, V11, P164; Teferra AS, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-74; Way C., 2015, MILL DEV GOALS REP 2; WHO (World Health Organization), 2015, TRENDS MATERNAL MORT; Zepro NB, 2016, INT J WOMENS HEALTH, V8, P705, DOI 10.2147/IJWH.S123189	33	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243466	10.1371/journal.pone.0243466	http://dx.doi.org/10.1371/journal.pone.0243466			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326426	gold, Green Published, Green Submitted			2022-12-27	WOS:000600176400023
J	Petrozziello, T; Dios, AM; Mueller, KA; Vaine, CA; Hendriks, WT; Glajch, KE; Mills, AN; Mangkalaphiban, K; Penney, EB; Ito, N; Fernandez-Cerado, C; Legarda, GPA; Velasco-Andrada, MS; Acuna, PJ; Ang, MA; Munoz, EL; Diesta, CCE; Macalintal-Canlas, R; Acuna, G; Sharma, N; Ozelius, LJ; Bragg, DC; Sadri-Vakili, G				Petrozziello, Tiziana; Dios, Amanda M.; Mueller, Kaly A.; Vaine, Christine A.; Hendriks, William T.; Glajch, Kelly E.; Mills, Alexandra N.; Mangkalaphiban, Kotchaphorn; Penney, Ellen B.; Ito, Naoto; Fernandez-Cerado, Cara; Legarda, Gierold Paul A.; Velasco-Andrada, M. Salvie; Acuna, Patrick J.; Ang, Mark A.; Munoz, Edwin L.; Diesta, Cid Czarina E.; Macalintal-Canlas, Regina; Acuna, Geraldine; Sharma, Nutan; Ozelius, Laurie J.; Bragg, D. Cristopher; Sadri-Vakili, Ghazaleh			SVA insertion in X-linked Dystonia Parkinsonism alters histone H3 acetylation associated with TAF1 gene	PLOS ONE			English	Article							HUNTINGTONS-DISEASE; ACETYLTRANSFERASE ACTIVITY; SODIUM PHENYLBUTYRATE; TAF(II)250; GENOME; CELLS; RETROTRANSPOSONS; DEACETYLATION; DYSREGULATION; ACTIVATION	X-linked Dystonia-Parkinsonism (XDP) is a neurodegenerative disease linked to an insertion of a SINE-VNTR-Alu (SVA)-type retrotransposon within an intron of TAF1. This SVA insertion induces aberrant TAF1 splicing and partial intron retention, thereby decreasing levels of the full-length transcript. Here we sought to determine if these altered transcriptional dynamics caused by the SVA are also accompanied by local changes in histone acetylation, given that these modifications influence gene expression. Because TAF1 protein may itself exhibit histone acetyltransferase activity, we also examined whether decreased TAF1 expression in XDP cell lines and post-mortem brain affects global levels of acetylated histone H3 (AcH3). The results demonstrate that total AcH3 are not altered in XDP post-mortem prefrontal cortex or cell lines. We also did not detect local differences in AcH3 associated with TAF1 exons or intronic sites flanking the SVA insertion. There was, however, a decrease in AcH3 association with the exon immediately proximal to the intronic SVA, and this decrease was normalized by CRISPR/Cas-excision of the SVA. Collectively, these data suggest that the SVA insertion alters histone status in this region, which may contribute to the dysregulation of TAF1 expression.	[Petrozziello, Tiziana; Dios, Amanda M.; Mueller, Kaly A.; Glajch, Kelly E.; Mills, Alexandra N.; Sadri-Vakili, Ghazaleh] Massachusetts Gen Hosp, Healey Ctr ALS Mass Gen, NeuroEpigenet Lab, Boston, MA 02114 USA; [Vaine, Christine A.; Hendriks, William T.; Mangkalaphiban, Kotchaphorn; Penney, Ellen B.; Ito, Naoto; Acuna, Patrick J.; Acuna, Geraldine; Sharma, Nutan; Ozelius, Laurie J.; Bragg, D. Cristopher] Massachusetts Gen Hosp, Dept Neurol, Collaborat Ctr X Linked Dystonia Parkinsonism, Boston, MA 02114 USA; [Fernandez-Cerado, Cara; Legarda, Gierold Paul A.; Velasco-Andrada, M. Salvie] Sunshine Care Fdn, Roxas City, Capiz, Philippines; [Ang, Mark A.; Munoz, Edwin L.] Univ Philippines, Dept Pathol, Coll Med, Manila, Philippines; [Diesta, Cid Czarina E.; Macalintal-Canlas, Regina] Makati Med Ctr, Dept Neurosci, Makati, Philippines	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of the Philippines System; University of the Philippines Manila; Makati Medical Center	Sadri-Vakili, G (corresponding author), Massachusetts Gen Hosp, Healey Ctr ALS Mass Gen, NeuroEpigenet Lab, Boston, MA 02114 USA.	gsadrivakili@mgh.harvard.edu	Petrozziello, Tiziana/GNM-6238-2022; Bragg, D. Cristopher/AGT-6759-2022	Mangkalaphiban, Kotchaphorn/0000-0002-5341-9329; Petrozziello, Tiziana/0000-0002-5487-1667	 [2015S002822]		GSV was founded by the MGH Collaborative Center for X-linked Dystonia Parkinsonism, https://www.massgeneral.org/neurology/xdp-center (2015S002822). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aneichyk T, 2018, CELL, V172, P897, DOI 10.1016/j.cell.2018.02.011; [Anonymous], 2011, J DIAGN MED SONOG, V27, P14, DOI 10.1177/8756479310393510; [Anonymous], 2014, CANC DISCOV, V4, pOF1; [Anonymous], 2018, J EUROPEAN COMPETITI, V9, P579, DOI [10.1093/jeclap/lpy066, DOI 10.1093/JECLAP/LPY066]; Atluri VSR, 2020, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00342; Benoy V, 2017, NEUROTHERAPEUTICS, V14, P417, DOI 10.1007/s13311-016-0501-z; Bragg DC, 2019, CURR OPIN NEUROL, V32, P604, DOI 10.1097/WCO.0000000000000708; Bragg DC, 2017, P NATL ACAD SCI USA, V114, pE11020, DOI 10.1073/pnas.1712526114; Brunmeir R, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000927; Chuang DM, 2009, TRENDS NEUROSCI, V32, P591, DOI 10.1016/j.tins.2009.06.002; Cook C, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt259; Cook C, 2014, HUM MOL GENET, V23, P104, DOI 10.1093/hmg/ddt402; Cudkowicz ME, 2009, AMYOTROPH LATERAL SC, V10, P99, DOI 10.1080/17482960802320487; De Cecco M, 2019, NATURE, V566, P73, DOI 10.1038/s41586-018-0784-9; Dios AM, 2019, MUSCLE NERVE, V60, P443, DOI 10.1002/mus.26620; Domingo A, 2015, EUR J HUM GENET, V23, P1334, DOI 10.1038/ejhg.2014.292; Dunphy EL, 2000, MOL CELL BIOL, V20, P1134, DOI 10.1128/MCB.20.4.1134-1139.2000; Fan J, 2016, METHOD ENZYMOL, V574, P125, DOI 10.1016/bs.mie.2016.01.007; Ferrari R, 2020, MOL CELL, V77, P475, DOI 10.1016/j.molcel.2019.10.020; Ganesan A, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-019-0776-0; Gianfrancesco O, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20235977; Gianfrancesco O, 2017, NEUROPEPTIDES, V64, P3, DOI 10.1016/j.npep.2016.09.006; Goodier JL, 2016, MOBILE DNA-UK, V7, DOI 10.1186/s13100-016-0070-z; Goto S, 2005, ANN NEUROL, V58, P7, DOI 10.1002/ana.20513; Guedes-Dias P, 2015, BBA-MOL BASIS DIS, V1852, P2484, DOI 10.1016/j.bbadis.2015.08.012; Gupta R, 2020, LIFE SCI, V243, DOI 10.1016/j.lfs.2020.117278; Hancks DC, 2016, MOBILE DNA-UK, V7, DOI 10.1186/s13100-016-0065-9; Harrison IF, 2013, PHARMACOL THERAPEUT, V140, P34, DOI 10.1016/j.pharmthera.2013.05.010; Herzfeld T, 2007, MAMM GENOME, V18, P787, DOI 10.1007/s00335-007-9063-z; Hilton TL, 2005, MOL CELL BIOL, V25, P4321, DOI 10.1128/MCB.25.10.4321-4332.2005; Hogarth P, 2007, MOVEMENT DISORD, V22, P1962, DOI 10.1002/mds.21632; Ito N, 2016, DIS MODEL MECH, V9, P451, DOI 10.1242/dmm.022590; Jacobs FMJ, 2014, NATURE, V516, P242, DOI 10.1038/nature13760; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Kim DS, 2010, INT J MOL MED, V26, P151, DOI 10.3892/ijmm_00000447; Kouzarides T, 2007, CELL, V128, P802, DOI 10.1016/j.cell.2007.02.018; Krosschell KJ, 2018, MUSCLE NERVE, V57, P193, DOI 10.1002/mus.25776; Kurdistani SK, 2003, NAT REV MOL CELL BIO, V4, P276, DOI 10.1038/nrm1075; Kwon Yun-Jeong, 2013, Genomics & Informatics, V11, P142, DOI 10.5808/GI.2013.11.3.142; Leaf healthcare, 2015, CISC VIS NETW IND GL, P1; Lee CY, 2019, TOXICOEPIGENETICS: CORE PRINCIPLES AND APPLICATIONS, P3, DOI 10.1016/B978-0-12-812433-8.00001-0; Lee L V, 1976, Adv Neurol, V14, P137; Lee Lillian V, 2011, Int J Neurosci, V121 Suppl 1, P3, DOI 10.3109/00207454.2010.526728; Li AG, 2007, MOL CELL, V28, P408, DOI 10.1016/j.molcel.2007.09.006; Louder RK, 2016, NATURE, V531, P604, DOI 10.1038/nature17394; Makino S, 2007, AM J HUM GENET, V80, P393, DOI 10.1086/512129; McFarland KN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041423; Valor LM, 2017, ONCOTARGET, V8, P5660, DOI 10.18632/oncotarget.13924; Mita P, 2016, CURR OPIN GENET DEV, V37, P90, DOI 10.1016/j.gde.2016.01.001; Mizzen CA, 1996, CELL, V87, P1261, DOI 10.1016/S0092-8674(00)81821-8; Montoya-Durango DE, 2009, MUTAT RES-FUND MOL M, V665, P20, DOI 10.1016/j.mrfmmm.2009.02.011; Nolte D, 2003, P NATL ACAD SCI USA, V100, P10347, DOI 10.1073/pnas.1831949100; Park G, 2016, J BIOL CHEM, V291, P3531, DOI 10.1074/jbc.M115.675488; Percharde M, 2018, CELL, V174, P391, DOI 10.1016/j.cell.2018.05.043; Pirooznia SK, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00030; Rakovic A, 2018, MOVEMENT DISORD, V33, P1108, DOI 10.1002/mds.27441; Rebollo R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002301; Robbez-Masson L, 2018, GENOME RES, V28, P836, DOI 10.1101/gr.228171.117; Rossaert E, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0750-2; Sadri-Vakili G, 2007, HUM MOL GENET, V16, P1293, DOI 10.1093/hmg/ddm078; Saleh A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00894; Savage AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090833; Savage AL, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-101; Sharma S, 2015, PHARMACOL RES, V100, P157, DOI 10.1016/j.phrs.2015.08.002; Strichman-Almashanu LZ, 2002, GENOME RES, V12, P543, DOI 10.1101/gr.224102; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Turelli P, 2014, GENOME RES, V24, P1260, DOI 10.1101/gr.172833.114; Vaine CA, 2017, NEUROBIOL DIS, V100, P108, DOI 10.1016/j.nbd.2016.12.016; Valor LM, 2013, J NEUROSCI, V33, P10471, DOI 10.1523/JNEUROSCI.0670-13.2013; Verrijzer CP, 1996, TRENDS BIOCHEM SCI, V21, P338, DOI 10.1016/0968-0004(96)10044-X; Wang H, 2014, CELL RES, V24, P1433, DOI 10.1038/cr.2014.148; Wassarman DA, 2001, J CELL SCI, V114, P2895; Westenberger A, 2019, ANN NEUROL, V85, P812, DOI 10.1002/ana.25488; Wood Jason G., 2013, Frontiers in Genetics, V4, P274, DOI 10.3389/fgene.2013.00274; Wu QM, 2017, MOL NEUROBIOL, V54, P6970, DOI 10.1007/s12035-016-0199-2; Zhang M, 2014, MOL CELL, V55, P31, DOI 10.1016/j.molcel.2014.04.028	76	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243655	10.1371/journal.pone.0243655	http://dx.doi.org/10.1371/journal.pone.0243655			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315879	Green Published, gold			2022-12-27	WOS:000600186100021
J	Zimmermann, GG; Jasper, SP; Kmiecik, LL; Neto, LS; da Silva, TX; Oiole, YA				Zimmermann, Gabriel Ganancini; Jasper, Samir Paulo; Kmiecik, Leonardo Leonidas; Neto, Lauro Strapasson; da Silva, Thiago Xavier; Oiole, Yasser Alabi			Development of test bench to determine the distribution of granular fertilizers in planting rows using spiral roller, two spiral rollers and fluted roller	PLOS ONE			English	Article							SYSTEM	The success of the application of granular fertilizers (GFs) in planting rows depends on the uniformity and performance of product dispensing systems, which are influenced by external factors. The objective of this study was to determine the outflow rates of two GF formulations (GF(1) 04-14-08 and GF(2) 04-30-10) using three types of fertilizer spreader-with one spiral roller (A), two spiral rollers (B), or a fluted roller (C)-and three operating speeds (1,11, 1.94, and 2.77 m s(-1)). The following parameters were determined in GFs: density, angle of repose, water content, and segregation (particle size). In the designed test bench, GFs were transferred from a reservoir to a spreader, and ultimately to a container, where they were weighed, and data were transmitted to the data acquisition system (DAS). A total of 7,560 outflow data points were collected (g s(-1)) and subjected to descriptive analysis of measures of central tendency, dispersion, asymmetry, and kurtosis, and Shewhart control charts were generated. Particle density and segregation were significantly different between the GFs, whereas the angle of repose and water content were not significantly different. The bench design and the DAS allowed measuring the outflow of GFs in different spreaders and demonstrated that this parameter was influenced by particle segregation. The segregation of GF(1) was higher than that of GF(2). The outflow variability at the speed of 1.11 m s(-1) was lower, and the spreader with a fluted roller had the highest uniformity and was the most suitable for application with variable rates.	[Zimmermann, Gabriel Ganancini; Jasper, Samir Paulo; Kmiecik, Leonardo Leonidas; Oiole, Yasser Alabi] Univ Fed Parana, Soil & Engn Dept Agr, Grad Program Soil Sci, Agr Sci Sect, Curitiba, Parana, Brazil; [Neto, Lauro Strapasson; da Silva, Thiago Xavier] Univ Fed Parana, Agron, Gearing Farm Tractor Lab, Agr Sci Sect, Curitiba, Parana, Brazil	Universidade Federal do Parana; Universidade Federal do Parana	Zimmermann, GG (corresponding author), Univ Fed Parana, Soil & Engn Dept Agr, Grad Program Soil Sci, Agr Sci Sect, Curitiba, Parana, Brazil.	gabrielganancini@gmail.com		Zimmermann, Gabriel/0000-0002-9709-4458				Dalacort R, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18113991; Noronha RHD, 2011, BRAGANTIA, V70, P931, DOI 10.1590/S0006-87052011000400028; Franck CJ, 2015, REV BRAS ENG AGR AMB, V19, P512, DOI 10.1590/1807-1929/agriambi.v19n5p512-518; Ministerio da Agricultura, 2017, MAP MAN MET AN OF FE; Osaki M, 2014, AGR SYST, V127, P178, DOI 10.1016/j.agsy.2014.02.002; Roy ED, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.43, 10.1038/nplants.2016.43]; Su N, 2015, INT J AGR BIOL ENG, V8, P19, DOI 10.3965/j.ijabe.20150804.1644; Wijekularathna DK, 2022, COMMUN STAT-SIMUL C, V51, P757, DOI 10.1080/03610918.2019.1658780	8	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243799	10.1371/journal.pone.0243799	http://dx.doi.org/10.1371/journal.pone.0243799			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315901	gold, Green Published			2022-12-27	WOS:000600186100001
J	Braun, RG; Kittner, SJ; Ryan, KA; Cole, JW				Braun, Robynne G.; Kittner, Steven J.; Ryan, Kathleen A.; Cole, John W.			Effects of the BDNF Val66Met polymorphism on functional status and disability in young stroke patients	PLOS ONE			English	Article							ISCHEMIC-STROKE; SEX	Background and purpose The preponderance of evidence from recent studies in human subjects supports a negative effect of the BDNF Val66Met polymorphism on motor outcomes and motor recovery. However prior studies have generally reported the effect of the Met allele in older stroke patients, while potential effects in younger stroke patients have remained essentially unexamined. The lack of research in younger patients is significant since aging effects on CNS repair and functional recovery after stroke are known to interact with the effects of genetic polymorphisms. Here we present a study of first-ever ischemic stroke patients aged 15-49 years that examines the effect of Met carrier status on functional disability. Methods 829 patients with a first ischemic stroke (Average age = 41.4 years, SD = 6.9) were recruited from the Baltimore-Washington region. Genotyping was performed at the Johns Hopkins University Center for Inherited Disease Research (CIDR). Data cleaning and harmonization were done at the GEI-funded GENEVA Coordinating Center at the University of Washington. Our sample contained 165 Met carriers and 664 non-Met carriers. Modified Rankin scores as recorded at discharge were obtained from the hospital records by study personnel blinded to genotype, and binarized into "Good" versus "Poor" outcomes (mRS 0-2 vs. 3+), with mRS scores 3+ reflecting a degree of disability that causes loss of independence. Results Our analysis showed that the Met allele conveyed a proportionally greater risk for poor outcomes and disability-related loss of independence with mRS scores 3+ (adjusted OR 1.73, 95% CI 1.13-2.64, p = 0.01). Conclusions The BDNF Val66Met polymorphism was negatively associated with functional outcomes at discharge in our sample of 829 young stroke patients. This finding stands in contrast to what would be predicted under the tenets of the resource modulation hypothesis (i.e. that younger patients would be spared from the negative effect of the Met allele on recovery since it is posited to arise as a manifestation of age-related decline in physiologic resources).	[Braun, Robynne G.; Kittner, Steven J.; Cole, John W.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Kittner, Steven J.; Ryan, Kathleen A.; Cole, John W.] Vet Affairs Maryland Hlth Care Syst, Baltimore, MD USA	University System of Maryland; University of Maryland Baltimore	Braun, RG (corresponding author), Univ Maryland, Sch Med, Baltimore, MD 21201 USA.	robynne.braun@umm.edu	Braun, Robynne/AAD-5391-2021	Braun, Robynne/0000-0002-3579-6665	NIH National Center for Medical Rehabilitation Research [K12HD093427]; NIH National Institute of Neurological Disorders and Stroke [R01NS45012, R01NS105150]; American Heart Association [17IBDG33700328]; Bayer Pharmaceuticals [17IBDG33700328]	NIH National Center for Medical Rehabilitation Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Heart Association(American Heart Association); Bayer Pharmaceuticals(Bayer AG)	RGB: Grant #K12HD093427, NIH National Center for Medical Rehabilitation Research (https://www.nichd.nih.gov/about/org/ncmrr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SJK: Grant #R01NS45012 and Grant #R01NS105150, NIH National Institute of Neurological Disorders and Stroke (https://www.ninds.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. JWC: Grant #17IBDG33700328, American Heart Association and Bayer Pharmaceuticals. (https://www.heart.org/en/professional/institute/grants/aha-bayer-innovation-and-discovery-grants). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SJK, JWC and KAR: This material is the result of work supported with resources and the use of facilities at the VA Maryland Health Care System, Baltimore, Maryland. The contents do not represent the views of the U.S. Department of Veterans Affairs or the United States Government. The funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Balkaya M, 2019, NEUROBIOL DIS, V126, P36, DOI 10.1016/j.nbd.2018.08.009; Begliuomini S, 2007, HUM REPROD, V22, P995, DOI 10.1093/humrep/del479; Charalambous CC, 2018, J PHYSIOL-LONDON, V596, P1999, DOI 10.1113/JP275881; Cheng YC, 2011, G3-GENES GENOM GENET, V1, P505, DOI 10.1534/g3.111.001164; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; French MA, 2018, TOP STROKE REHABIL, V25, P276, DOI 10.1080/10749357.2018.1437938; Fridriksson J, 2018, BRAIN STIMUL, V11, P1276, DOI 10.1016/j.brs.2018.08.009; Helm EE, 2016, EXP BRAIN RES, V234, P341, DOI 10.1007/s00221-015-4465-8; Kennedy KM, 2015, BRAIN RES, V1612, P104, DOI 10.1016/j.brainres.2014.09.044; Kim DY, 2016, PHYS THER, V96, P533, DOI 10.2522/ptj.20150135; Kim EJ, 2016, EUR J NEUROL, V23, P76, DOI 10.1111/ene.12791; Koellhoffer EC, 2013, TRANSL STROKE RES, V4, P390, DOI 10.1007/s12975-012-0230-5; Lindenberger U, 2008, FRONT NEUROSCI-SWITZ, V2, P234, DOI 10.3389/neuro.01.039.2008; Mirowsha-Guzel D, 2014, TOP STROKE REHABIL, V21, pS33, DOI 10.1310/tsr21S1-S33; Qin LY, 2014, J NEUROSCI, V34, P2493, DOI 10.1523/JNEUROSCI.4140-13.2014; Shiner CT, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00069; Smith EE, 2010, CIRCULATION, V122, P1496, DOI 10.1161/CIRCULATIONAHA.109.932822; Spencer-Segal JL, 2011, J NEUROSCI, V31, P6780, DOI 10.1523/JNEUROSCI.0910-11.2011; Tsai SJ, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00156; van der Vliet R, 2017, BRAIN STIMUL, V10, P882, DOI 10.1016/j.brs.2017.07.004	20	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0237033	10.1371/journal.pone.0237033	http://dx.doi.org/10.1371/journal.pone.0237033			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306691	gold, Green Published			2022-12-27	WOS:000600144200035
J	Chiu, TJ; Chen, YJ; Kuo, FY; Chen, YY				Chiu, Tai-Jan; Chen, Yi-Ju; Kuo, Fang-Ying; Chen, Yen-Yang			Elevated neutrophil-to-lymphocyte ratio and predominance of intrahepatic cholangiocarcinoma prediction of poor hepatectomy outcomes in patients with combined hepatocellular-cholangiocarcinoma	PLOS ONE			English	Article							HEPATIC RESECTION; CARCINOMA; PROGNOSIS; INFLAMMATION; FEATURES; CANCER; RECURRENCE; PATTERNS; SYSTEM; IMPACT	Objectives Although elevated neutrophil-to-lymphocyte ratio (NLR) has been associated with survival in some liver cancers, its prognostic relevance has not been studied in the context of combined hepatocellular cholangiocarcinoma CHCC-CC, a rare primary liver cancer. We investigated whether elevated NLR and a predominance of cholangiocarcinoma might predict poor prognosis in patients with resectable CHCC-CC. Methods We retrospectively reviewed the clinicopathologic data of forty-two patients with CHCC-CC receiving hepatectomies at our hospital. We used Kaplan-Meier and Cox regression to analyze survival. Results Two-year disease-free survival and five-year overall survival rates were 43.2% and 32.9%, respectively. Univariate analyses showed that patients with NLR >= 3 had significantly worse 2-year DFS and 5-year OS rates. Univariant Kaplan-Meier survival analysis also associated these rates with a predominance in intrahepatic cholangiocarcinoma, AJCC tumor stage, pathological T stage and lymph-vascular invasion. However, our multivariate analysis found NLR >= 3 to be the only independent predictor of disease recurrence and poorer survival. Conclusions Neutrophil-to-lymphocyte ratio was the most important independent predictor of poorer survival in patients with resectable CHCC-CC. Predominance of intrahepatic cholangiocarcinoma, advanced AJCC tumor stage and pathological T stage, and lymph-vascular invasion also may affect poor prognosis in patients receiving complete tumor resections.	[Chiu, Tai-Jan; Chen, Yen-Yang] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hematol Oncol, Kaohsiung, Taiwan; [Chiu, Tai-Jan; Chen, Yen-Yang] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Chiu, Tai-Jan; Chen, Yen-Yang] Kaohsiung Chang Gung Mem Hosp, Canc Ctr, Kaohsiung Chang Gung Cholangiocarcinoma & Pancrea, Kaohsiung, Taiwan; [Chiu, Tai-Jan] Chang Gung Univ, Inst Clin Med Sci, Kaohsiung, Taiwan; [Chen, Yi-Ju] I Shou Univ, E Da Hosp, Dept Anat Pathol, Kaohsiung, Taiwan; [Kuo, Fang-Ying] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Pathol, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; E-Da Hospital; I Shou University; Chang Gung Memorial Hospital; Chang Gung University	Chen, YY (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hematol Oncol, Kaohsiung, Taiwan.; Chen, YY (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung, Taiwan.; Chen, YY (corresponding author), Kaohsiung Chang Gung Mem Hosp, Canc Ctr, Kaohsiung Chang Gung Cholangiocarcinoma & Pancrea, Kaohsiung, Taiwan.	chen.y9964@gmail.com			Kaohsiung Chang Gung Memorial Hospital Taiwan [CMRPG8E0811/0812/0813, CMRPG8C0531, CMRPG8D0801]	Kaohsiung Chang Gung Memorial Hospital Taiwan	This study was funded by grant obtained by Dr. Yen-Yang Chen from Kaohsiung Chang Gung Memorial Hospital Taiwan (Grant nos. CMRPG8E0881, CMRPG8F1771/1772). This study was also funded by grants obtained by Dr. Tai-Jan Chiu from Kaohsiung Chang Gung Memorial Hospital Taiwan (Grant CMRPG8E0811/0812/0813, CMRPG8C0531 and CMRPG8D0801).	ALLEN RA, 1949, AM J PATHOL, V25, P647; [Anonymous], 2007, REV GERMANIQUE INT, VVI, P161; [Anonymous], 1998, CONTINUITY CHANGE, V13, P34; ARII S, 1992, CANCER, V69, P913, DOI 10.1002/1097-0142(19920215)69:4<913::AID-CNCR2820690413>3.0.CO;2-T; Ariizumi S, 2012, ANN SURG ONCOL, V19, P1628, DOI 10.1245/s10434-011-2150-0; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Borsig L, 2014, ONCOGENE, V33, P3217, DOI 10.1038/onc.2013.272; Brunt E, 2018, HEPATOLOGY, V68, P113, DOI 10.1002/hep.29789; Chen Q, 2015, TUMOR BIOL, V36, P5283, DOI 10.1007/s13277-015-3188-6; Chok KSH, 2009, WORLD J SURG, V33, P1916, DOI 10.1007/s00268-009-0112-5; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Croker BA, 2011, J IMMUNOL, V186, P1131, DOI 10.4049/jimmunol.1002702; De Lu C, 2016, J GASTROEN HEPATOL, V31, P1330, DOI 10.1111/jgh.13309; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Feng F, 2017, ONCOTARGET, V8, P5281, DOI 10.18632/oncotarget.14136; Gomez D, 2008, J SURG ONCOL, V97, P513, DOI 10.1002/jso.21001; GOODMAN ZD, 1985, CANCER-AM CANCER SOC, V55, P124, DOI 10.1002/1097-0142(19850101)55:1<124::AID-CNCR2820550120>3.0.CO;2-Z; He CB, 2018, ONCOL LETT, V15, P4262, DOI 10.3892/ol.2018.7882; Ikai I, 2004, CANCER-AM CANCER SOC, V101, P796, DOI 10.1002/cncr.20426; Ishizuka M, 2012, AM J SURG, V203, P101, DOI 10.1016/j.amjsurg.2010.09.030; Jackson JR, 1997, FASEB J, V11, P457, DOI 10.1096/fasebj.11.6.9194526; Jaiswal M, 2000, CANCER RES, V60, P184; Jarnagin WR, 2002, CANCER-AM CANCER SOC, V94, P2040, DOI 10.1002/cncr.10392; Kassahun WT, 2008, INT J CLIN PRACT, V62, P1271, DOI 10.1111/j.1742-1241.2007.01694.x; Lee JH, 2011, J CLIN GASTROENTEROL, V45, P69, DOI 10.1097/MCG.0b013e3181ce5dfa; Lee SD, 2014, HEPATOB PANCREAT DIS, V13, P594, DOI 10.1016/S1499-3872(14)60275-7; Lee WS, 2006, SURG TODAY, V36, P892, DOI 10.1007/s00595-006-3276-8; Li SH, 2017, WORLD J GASTROENTERO, V23, P3122, DOI 10.3748/wjg.v23.i17.3122; Liu CL, 2003, ARCH SURG-CHICAGO, V138, P86, DOI 10.1001/archsurg.138.1.86; Liver Cancer Study Group of Japan, 1990, Ann Surg, V211, P277; Ma MC, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4146-7; MAEDA T, 1995, HUM PATHOL, V26, P956, DOI 10.1016/0046-8177(95)90084-5; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Nozawa H, 2006, P NATL ACAD SCI USA, V103, P12493, DOI 10.1073/pnas.0601807103; Omichi K, 2017, SURGERY, V162, P752, DOI 10.1016/j.surg.2017.05.015; Sanada Y, 2005, HEPATOL RES, V32, P185, DOI 10.1016/j.hepres.2005.04.003; Shin CI, 2007, J COMPUT ASSIST TOMO, V31, P109, DOI 10.1097/01.rct.0000235072.34808.9b; Taguchi J, 1996, J GASTROEN HEPATOL, V11, P758, DOI 10.1111/j.1440-1746.1996.tb00327.x; Tang D, 2006, J GASTROINTEST SURG, V10, P987, DOI 10.1016/j.gassur.2006.01.018; Wang YJ, 2018, INT J SURG, V55, P73, DOI 10.1016/j.ijsu.2018.05.022; Yano Y, 2003, JPN J CLIN ONCOL, V33, P283, DOI 10.1093/jjco/hyg056; Yin X, 2012, ANN SURG ONCOL, V19, P2869, DOI 10.1245/s10434-012-2328-0	42	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0240791	10.1371/journal.pone.0240791	http://dx.doi.org/10.1371/journal.pone.0240791			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306714	Green Published, gold			2022-12-27	WOS:000600144200001
J	Shi, Y; Gong, WH; Gong, XR; Wang, P; Zhao, X				Shi, Ying; Gong, Weihua; Gong, Xiangrong; Wang, Ping; Zhao, Xin			Genome-wide DNA methylation analysis of breast cancer MCF-7 / Taxol cells with MeDIP-Seq	PLOS ONE			English	Article							IMMUNOPRECIPITATION MEDIP; MIGRATION	Breast cancer (BC) is the most frequently diagnosed tumor in women worldwide. Although the combination of surgery and Taxol chemotherapy can achieve a certain therapeutic effect, patients often develop drug-resistance, resulting in a poor prognosis. Therefore, it is significative to seek the molecular mechanism of chemotherapy resistance. Recent studies have found that abnormal epigenetic regulation in breast cells changes the expression of key genes, which can lead to the occurrence, development, and maintenance of cancer, even related to the development of drug-resistance. Therefore, in this study, we performed methylated DNA immunoprecipitation-sequencing (MeDIP-seq) to reveal the difference in methylation between breast cancer drug-resistant cells and sensitive cells. A total of 55076 differentially methylated genes (DMGs) were detected, including 21061 hypermethylated DMGs and 34015 hypomethylated DMGs. Moreover, Gene Ontology (GO) analysis and KEGG pathway analysis reveal the function and pathway of screening genes. These results indicate that DNA methylation may be involved in regulating the occurrence and development of breast cancer.	[Shi, Ying; Gong, Weihua; Wang, Ping] Zhengzhou Univ, Clin Lab, Affiliated Hosp 3, Zhengzhou, Peoples R China; [Gong, Xiangrong] Zhengzhou Univ, Internal Med Dept, Affiliated Hosp 1, Zhengzhou, Peoples R China; [Zhao, Xin] Zhengzhou Univ, Dept Radiol, Affiliated Hosp 3, Zhengzhou, Peoples R China	Zhengzhou University; Zhengzhou University; Zhengzhou University	Zhao, X (corresponding author), Zhengzhou Univ, Dept Radiol, Affiliated Hosp 3, Zhengzhou, Peoples R China.	zdsfyzx@zzu.edu.cn			key scientific research project plan of colleges and universities in Henan Province [19A320055]	key scientific research project plan of colleges and universities in Henan Province	This work is supported by the key scientific research project plan of colleges and universities in Henan Province. The project number is: 19A320055. The project name is: The mechanism of pyroptosis in drug resistance of breast tumor cells.	Al Emran A, 2019, TRENDS IMMUNOL, V40, P328, DOI 10.1016/j.it.2019.02.004; [Anonymous], 2001, PALESTINE ISRAEL J, VViii, P115; [Anonymous], 2019, CIRCULATION, V2019; Attwood JT, 2002, CELL MOL LIFE SCI, V59, P241, DOI 10.1007/s00018-002-8420-z; Castroviejo-Bermejo M, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201809172; Chen JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126403; Denkert C, 2017, LANCET, V389, P2430, DOI 10.1016/S0140-6736(16)32454-0; Du Q, 2009, ONCOL REP, V22, P659, DOI 10.3892/or_00000486; Dworkin AM, 2009, SEMIN CANCER BIOL, V19, P165, DOI 10.1016/j.semcancer.2009.02.007; Esteller M, 2005, ANNU REV PHARMACOL, V45, P629, DOI 10.1146/annurev.pharmtox.45.120403.095832; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Gomez-Miragaya J, 2019, MOL CANCER RES, V17, P2063, DOI 10.1158/1541-7786.MCR-19-0040; Gonzalez N, 2017, CELL SIGNAL, V30, P154, DOI 10.1016/j.cellsig.2016.12.002; Gradishar WJ, 2016, J NATL COMPR CANC NE, V14, P324, DOI 10.6004/jnccn.2016.0037; Gusyatiner O, 2018, SEMIN CANCER BIOL, V51, P50, DOI 10.1016/j.semcancer.2017.11.010; Jacinto FV, 2008, BIOTECHNIQUES, V44, P35, DOI 10.2144/000112708; Kanwal R, 2015, METHODS MOL BIOL, V1238, P3, DOI 10.1007/978-1-4939-1804-1_1; Li QJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15308-7; Liu XY, 2018, THERANOSTICS, V8, P6386, DOI 10.7150/thno.29164; Lo PK, 2008, PHARMACOGENOMICS, V9, P1879, DOI 10.2217/14622416.9.12.1879; Luo XG, 2014, CANCER LETT, V344, P129, DOI 10.1016/j.canlet.2013.10.026; Matveev I, 2017, SOCIOL OBOZR, V16, P29, DOI 10.17323/1728-192X-2017-2-29-53; Nair SS, 2011, EPIGENETICS-US, V6, P34, DOI 10.4161/epi.6.1.13313; Olova N, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1408-2; Paul MR, 2020, J CLIN INVEST, V130, P4252, DOI 10.1172/JCI129941; Pettitt SJ, 2019, CURR OPIN GENET DEV, V54, P55, DOI 10.1016/j.gde.2019.03.001; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Scarano MI, 2005, J CELL PHYSIOL, V204, P21, DOI 10.1002/jcp.20280; SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Taiwo O, 2012, NAT PROTOC, V7, P617, DOI 10.1038/nprot.2012.012; Torre LA, 2016, CANCER EPIDEM BIOMAR, V25, P16, DOI 10.1158/1055-9965.EPI-15-0578; Turnham DJ, 2020, CARCINOGENESIS, V41, P1432, DOI 10.1093/carcin/bgaa005; Wang B, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4711-0; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Weng YI, 2009, METHODS MOL BIOL, V590, P165, DOI 10.1007/978-1-60327-378-7_10; Yotani T, 2018, CANCER SCI, V109, P1690, DOI 10.1111/cas.13566; Yu J, 2018, J CLIN INVEST, V128, P2376, DOI 10.1172/JCI97924; Yu PA, 2019, ACTA PHARMACOL SIN, V40, P1237, DOI 10.1038/s41401-019-0222-z; Zhang F, 2019, ONCOL LETT, V18, P1287, DOI 10.3892/ol.2019.10405; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhong P, 2020, MOL PHARMACEUT, V17, P1114, DOI 10.1021/acs.molpharmaceut.9b01148	43	0	0	4	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0241515	10.1371/journal.pone.0241515	http://dx.doi.org/10.1371/journal.pone.0241515			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306680	gold, Green Published			2022-12-27	WOS:000600144200009
J	Drozd, D; Wolf, H; Stemme, T				Drozd, Denise; Wolf, Harald; Stemme, Torben			Structure of the pecten neuropil pathway and its innervation by bimodal peg afferents in two scorpion species	PLOS ONE			English	Article							SPIDER CUPIENNIUS-SALEI; CENTRAL-NERVOUS-SYSTEM; ELAPHUS POCOCK ARACHNIDA; CENTRAL PROJECTIONS; OLFACTORY SYSTEMS; SENSORY NEURONS; FORELEGS WHIPS; ANTENNAL LOBE; MECHANOSENSORY NEURONS; CONTACT CHEMORECEPTION	The pectines of scorpions are comb-like structures, located ventrally behind the fourth walking legs and consisting of variable numbers of teeth, or pegs, which contain thousands of bimodal peg sensillae. The associated neuropils are situated ventrally in the synganglion, extending between the second and fourth walking leg neuromeres. While the general morphology is consistent among scorpions, taxon-specific differences in pecten and neuropil structure remain elusive but are crucial for a better understanding of chemosensory processing. We analysed two scorpion species (Mesobuthus eupeus and Heterometrus petersii) regarding their pecten neuropil anatomy and the respective peg afferent innervation with anterograde and lipophilic tracing experiments, combined with immunohistochemistry and confocal laser-scanning microscopy. The pecten neuropils consisted of three subcompartments: a posterior pecten neuropil, an anterior pecten neuropil and a hitherto unknown accessory pecten neuropil. These subregions exhibited taxon-specific variations with regard to compartmentalisation and structure. Most notable were structural differences in the anterior pecten neuropils that ranged from ovoid shape and strong fragmentation in Heterometrus petersii to elongated shape with little compartmentalisation in Mesobuthus eupeus. Labelling the afferents of distinct pegs revealed a topographic organisation of the bimodal projections along a medio-lateral axis. At the same time, all subregions along the posterior-anterior axis were innervated by a single peg's afferents. The somatotopic projection pattern of bimodal sensillae appears to be common among arachnids, including scorpions. This includes the structure and organisation of the respective neuropils and the somatotopic projection patterns of chemosensory afferents. Nonetheless, the scorpion pecten pathway exhibits unique features, e.g. glomerular compartmentalisation superimposed on somatotopy, that are assumed to allow high resolution of substrate-borne chemical gradients.	[Drozd, Denise; Wolf, Harald; Stemme, Torben] Univ Ulm, Inst Neurobiol, Ulm, Germany	Ulm University	Drozd, D; Wolf, H; Stemme, T (corresponding author), Univ Ulm, Inst Neurobiol, Ulm, Germany.	denise.drozd@uni-ulm.de; harald.wolf@uni-ulm.de; torben.stemme@uni-ulm.de		Drozd, Denise/0000-0002-0607-1665	German Science Foundation, Deutsche Forschungsgemeinschaft [STE2826-1-1]	German Science Foundation, Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	TS and HW were funded by the German Science Foundation, Deutsche Forschungsgemeinschaft, grant STE2826-1-1 (https://www.dfg.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ache BW, 2005, NEURON, V48, P417, DOI 10.1016/j.neuron.2005.10.022; Ai H, 2007, J COMP NEUROL, V502, P1030, DOI 10.1002/cne.21341; AKKERHUIS G J O, 1985, Experimental and Applied Acarology, V1, P235, DOI 10.1007/BF01198521; [Anonymous], 1999, VIERTELJAHRSHEFTE ZE, V47, P401; ANTON S, 1994, CELL TISSUE RES, V278, P399; ANTON S, 1993, ZOOMORPHOLOGY, V113, P21, DOI 10.1007/BF00430974; Babu K. S., 1965, Zoologische Jahrbuecher (Anatomie), V82, P1; Babu K.S., 1985, P3; BABU KS, 1993, J BIOSCIENCES, V18, P247, DOI 10.1007/BF02703122; BABU KS, 1989, CELL TISSUE RES, V258, P69, DOI 10.1007/BF00223146; Barth FG, 2004, CURR OPIN NEUROBIOL, V14, P415, DOI 10.1016/j.conb.2004.07.005; Barth FG, 2002, SPIDERS WORLD; BAUCHHENSS E, 1983, INT J INSECT MORPHOL, V12, P129, DOI 10.1016/0020-7322(83)90005-3; BROWNELL P, 1988, CHEM SENSES, V13, P677; BROWNELL PH, 1974, TISSUE CELL, V6, P471, DOI 10.1016/0040-8166(74)90039-1; Brownell PH, 1998, ANN NY ACAD SCI, V855, P502, DOI 10.1111/j.1749-6632.1998.tb10614.x; CARTHY JD, 1966, EXPERIENTIA, V22, P89, DOI 10.1007/BF01900166; CLOUDSLEY-THOMPSON J. L., 1955, ANN AND MAG NAT HIST, V8, P556; Cushing PE, 2012, J ARACHNOL, V40, P123, DOI 10.1636/B11-71.1; Derby CD, 2016, CHEM SENSES, V41, P381, DOI 10.1093/chemse/bjw057; Dethier VG, 1947, REV ENTOMOL, V1, P181; Drozd D., 2019, TOPOGRAPHIC ORG PECT; DUYJACQUEMIN MN, 1991, INT J INSECT MORPHOL, V20, P205, DOI 10.1016/0020-7322(91)90010-7; EDGECOMB RS, 1992, J COMP NEUROL, V315, P431, DOI 10.1002/cne.903150406; Eisenbeis G, 1987, ATLAS BIOL SOIL, DOI [10.1007/978-3-642-72634-7, DOI 10.1007/978-3-642-72634-7]; Eisthen HL, 2002, BRAIN BEHAV EVOLUT, V59, P273, DOI 10.1159/000063564; Fabian-Fine R, 1999, CELL TISSUE RES, V295, P13, DOI 10.1007/s004410051208; Borges LMF, 2016, REV BRAS PARASITOL V, V25, P217, DOI 10.1590/S1984-29612016039; Fet V, 1998, J ARID ENVIRON, V39, P609, DOI 10.1006/jare.1997.0386; Fet Victor, 2006, Boletin de la SEA, P269; Foelix R., 1983, Bulletin of the British Arachnological Society, V6, P68; Foelix R.F., 1985, P118; Foelix R.F., 1983, Bulletin of the British Arachnological Society, V6, P53; Foelix Rainer, 2001, Andrias, V15, P129; FOELIX RF, 1970, J EXP ZOOL, V175, P99, DOI 10.1002/jez.1401750106; Gaffin D, 2001, SCORPION BIOLOGY AND RESEARCH, P184; Gaffin DD, 2002, MICROSC RES TECHNIQ, V58, P325, DOI 10.1002/jemt.10140; Gaffin DD, 1997, J COMP PHYSIOL A, V181, P291, DOI 10.1007/s003590050115; GAFFIN DD, 1992, ETHOLOGY, V91, P59; Gaffin DD., 1994, THESIS; Gaffin DD, 2017, J ARACHNOL, V45, P265, DOI 10.1636/JoA-S-16-070.1; Gaffin DD, 2012, ANIM BEHAV, V83, P429, DOI 10.1016/j.anbehav.2011.11.014; Gainett G, 2017, ARTHROPOD STRUCT DEV, V46, P178, DOI 10.1016/j.asd.2016.12.005; Galizia CG, 2001, J INSECT PHYSIOL, V47, P115, DOI 10.1016/S0022-1910(00)00106-2; Galizia CG, 2000, CURR OPIN NEUROBIOL, V10, P504, DOI 10.1016/S0959-4388(00)00109-4; GHYSEN A, 1980, DEV BIOL, V78, P521, DOI 10.1016/0012-1606(80)90351-6; GORB SN, 1993, J MORPHOL, V217, P129, DOI 10.1002/jmor.1052170202; Groh C, 2011, ARTHROPOD STRUCT DEV, V40, P358, DOI 10.1016/j.asd.2010.12.002; Hallberg E, 1999, MICROSC RES TECHNIQ, V47, P428, DOI 10.1002/(SICI)1097-0029(19991215)47:6<428::AID-JEMT6>3.0.CO;2-P; Hansson BS, 2011, NEURON, V72, P698, DOI 10.1016/j.neuron.2011.11.003; Hansson Bill S., 1999, P125; Hansson BS, 2000, ANNU REV ENTOMOL, V45, P203, DOI 10.1146/annurev.ento.45.1.203; Harzsch S, 2018, PROG NEUROBIOL, V161, P23, DOI 10.1016/j.pneurobio.2017.11.005; Harzsch S, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-58; HAUPT J, 1982, ROUX ARCH DEV BIOL, V191, P137, DOI 10.1007/BF00848452; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; HOMBERG U, 1989, ANNU REV ENTOMOL, V34, P477, DOI 10.1146/annurev.en.34.010189.002401; Hughes KL, 2019, INVERTEBR NEUROSCI, V19, DOI 10.1007/s10158-019-0228-8; Hummel NA, 2007, EXP APPL ACAROL, V43, P265, DOI 10.1007/s10493-007-9120-z; IGELMUND P, 1987, J MORPHOL, V193, P75, DOI 10.1002/jmor.1051930108; IGELMUND P, 1991, J COMP PHYSIOL A, V168, P63, DOI 10.1007/BF00217104; IGELMUND P, 1991, J COMP PHYSIOL A, V168, P75, DOI 10.1007/BF00217105; Ignell R, 2001, BRAIN BEHAV EVOLUT, V57, P1, DOI 10.1159/000047222; Ivanov V., 1979, FAUNA ECOLOGY ARACHN, P73; Jackson G. J., 1974, Acarologia, V16, P583; Jedrzejowska I, 2016, ARTHROPOD STRUCT DEV, V45, P488, DOI 10.1016/j.asd.2016.09.001; KENT KS, 1988, J COMP NEUROL, V271, P559, DOI 10.1002/cne.902710407; Kladt N, 2007, J COMP PHYSIOL A, V193, P1033, DOI 10.1007/s00359-007-0254-6; Klagges BRE, 1996, J NEUROSCI, V16, P3154; Klann AE, 2008, ARTHROPOD STRUCT DEV, V37, P3, DOI 10.1016/j.asd.2007.04.001; Knowlton ED, 2011, J COMP PHYSIOL A, V197, P895, DOI 10.1007/s00359-011-0650-9; KRAPF D, 1986, ZOOL ANZ, V217, P119; KREIS TE, 1987, EMBO J, V6, P2597, DOI 10.1002/j.1460-2075.1987.tb02550.x; Krieger J, 2015, PEERJ, V3, DOI 10.7717/peerj.1433; Kvello P, 2010, J NEUROPHYSIOL, V103, P2965, DOI 10.1152/jn.00985.2009; LEVINE RB, 1985, J COMP PHYSIOL A, V157, P1; Loesel Rudolf, 2013, P299; MAHSBERG D, 1990, Acta Zoologica Fennica, P267; Matsubayashi Y, 2008, J NEUROSCI METH, V174, P71, DOI 10.1016/j.jneumeth.2008.07.003; Maurer M, 2019, ZOOL LETT, V5, DOI 10.1186/s40851-019-0151-1; Mellon D, 2012, J EXP BIOL, V215, P2163, DOI 10.1242/jeb.069492; Melville J.M., 2000, DISSERTATION; Melville JM, 2003, J INSECT BEHAV, V16, P97, DOI 10.1023/A:1022853413104; Mineo MF, 2006, ACTA ETHOL, V9, P79, DOI 10.1007/s10211-006-0021-7; MORO SD, 1985, MONIT ZOOL ITAL, V19, P207; Musaelian A., 2020, BIORXIV, DOI [10.1101/2020.06.17.156612, DOI 10.1101/2020.06.17.156612]; NEWLAND PL, 1991, J COMP NEUROL, V312, P493, DOI 10.1002/cne.903120402; Newland PL, 2000, J COMP NEUROL, V425, P82; Nishino H, 2005, J COMP NEUROL, V493, P291, DOI 10.1002/cne.20757; OBENCHAIN FD, 1974, J MORPHOL, V142, P205, DOI 10.1002/jmor.1051420207; PETERSON BA, 1988, J COMP NEUROL, V275, P128, DOI 10.1002/cne.902750111; PFLUGER HJ, 1988, PHILOS T R SOC B, V321, P1, DOI 10.1098/rstb.1988.0090; POLIS GA, 1987, ECOLOGY, V68, P332, DOI 10.2307/1939264; Prevost ED, 2020, ANIM COGN, V23, P1215, DOI 10.1007/s10071-020-01386-z; Punzo Fred, 1998, Bulletin of the British Arachnological Society, V11, P111; Rogers SM, 2003, ADV INSECT PHYSIOL, V31, P141, DOI 10.1016/S0065-2806(03)31003-3; Ruano F, 2000, BEHAV ECOL, V11, P396, DOI 10.1093/beheco/11.4.396; Ruhlemann H, 1908, Z WISS ZOOL ABT A, V91, P599; Runia E, 2006, HIST THEORY, V45, P1, DOI 10.1111/j.1468-2303.2006.00346.x; Schachtner J, 2005, ARTHROPOD STRUCT DEV, V34, P257, DOI 10.1016/j.asd.2005.04.003; SCHMIDT M, 1992, J COMP NEUROL, V318, P277, DOI 10.1002/cne.903180305; Sharma PP, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2953; SHULTZ JW, 1989, ZOOL J LINN SOC-LOND, V97, P1, DOI 10.1111/j.1096-3642.1989.tb00552.x; SLIFER EH, 1970, ANNU REV ENTOMOL, V15, P121, DOI 10.1146/annurev.en.15.010170.001005; Sombke A, 2019, ZOOL LETT, V5, DOI 10.1186/s40851-019-0137-z; Sombke A, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-1; Sombke A, 2011, CHEM SENSES, V36, P43, DOI 10.1093/chemse/bjq096; Stegner MEJ, 2011, ARTHROPOD STRUCT DEV, V40, P221, DOI 10.1016/j.asd.2011.04.001; Steinbrecht R.A., 1987, P353; Steinmetz Steffany B., 2004, Euscorpius, V12-17, P1; Stemme T, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-119; Stemme T, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-168; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; Strausfeld N, 2009, ANN NY ACAD SCI, V1170, P487, DOI 10.1111/j.1749-6632.2009.04020.x; Strausfeld NJ, 1999, CURR OPIN NEUROBIOL, V9, P634, DOI 10.1016/S0959-4388(99)00019-7; TICHY H, 1992, MICROSC RES TECHNIQ, V22, P372, DOI 10.1002/jemt.1070220406; Tuchina O, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00094; van Wijk M, 2006, EXP APPL ACAROL, V40, P217, DOI 10.1007/s10493-006-9038-x; Vj R, 2014, J CLIN DIAGN RES, V8, P25; Weygoldt P., 2000, THEIR BIOL MORPHOLOG; Willemart RH, 2007, ENTOMOL EXP APPL, V123, P73, DOI 10.1111/j.1570-7458.2007.00527.x; Willemart RH, 2009, ACTA ZOOL-STOCKHOLM, V90, P209, DOI 10.1111/j.1463-6395.2008.00341.x; Wlllemart RH, 2004, ZOOL ANZ, V242, P353, DOI 10.1078/0044-5231-00109; Wolf H, 2008, ARTHROPOD STRUCT DEV, V37, P67, DOI 10.1016/j.asd.2007.05.003; Wolf H, 2017, ARTHROPOD STRUCT DEV, V46, P753, DOI 10.1016/j.asd.2017.10.002; Wolf H, 2012, ZOOLOGY, V115, P151, DOI 10.1016/j.zool.2011.10.002; ZACHARUK RY, 1980, ANNU REV ENTOMOL, V25, P27, DOI 10.1146/annurev.en.25.010180.000331	127	8	8	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243753	10.1371/journal.pone.0243753	http://dx.doi.org/10.1371/journal.pone.0243753			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301509	Green Published, gold			2022-12-27	WOS:000600143100023
J	Lucidarme, J; Zhu, BQ; Xu, L; Bai, XL; Gao, Y; Gonzalez-Lopez, JJ; Mulhall, R; Scott, KJ; Smith, A; Stefanelli, P; Stenmark, B; Torpiano, P; Tzanakaki, G; Borrow, R; Shao, ZJ				Lucidarme, Jay; Zhu, Bingqing; Xu, Li; Bai, Xilian; Gao, Yuan; Jose Gonzalez-Lopez, Juan; Mulhall, Robert; Scott, Kevin J.; Smith, Andrew; Stefanelli, Paola; Stenmark, Bianca; Torpiano, Paul; Tzanakaki, Georgina; Borrow, Ray; Shao, Zhujun			Genomic analysis of the meningococcal ST-4821 complex-Western clade, potential sexual transmission and predicted antibiotic susceptibility and vaccine coverage	PLOS ONE			English	Article							NEISSERIA-MENINGITIDIS; SEROGROUP-B; CIPROFLOXACIN-RESISTANT; CHINA; EMERGENCE; CARRIAGE; STRAINS; PROTEIN	Introduction The ST-4821 complex (cc4821) is a leading cause of serogroup C and serogroup B invasive meningococcal disease in China where diverse strains in two phylogenetic groups (groups 1 and 2) have acquired fluoroquinolone resistance. cc4821 was recently prevalent among carriage isolates in men who have sex with men in New York City (USA). Genome-level population studies have thus far been limited to Chinese isolates. The aim of the present study was to build upon these with an extended panel of international cc4821 isolates. Methods Genomes of isolates from Asia (1972 to 2017), Europe (2011 to 2018), North America (2007), and South America (2014) were sequenced or obtained from the PubMLST Neisseria database. Core genome comparisons were performed in PubMLST. Results Four lineages were identified. Western isolates formed a distinct, mainly serogroup B sublineage with alleles associated with fluoroquinolone susceptibility (MIC <0.03 mg/L) and reduced penicillin susceptibility (MIC 0.094 to 1 mg/L). A third of these were from anogenital sites in men who have sex with men and had unique denitrification gene alleles. Generally 4CMenB vaccine strain coverage was reliant on strain-specific NHBA peptides. Discussion The previously identified cc4821 group 2 was resolved into three separate lineages. Clustering of western isolates was surprising given the overall diversity of cc4821. Possible association of this cluster with the anogenital niche is worthy of monitoring given concerns surrounding antibiotic resistance and potential subcapsular vaccine escape.	[Lucidarme, Jay; Bai, Xilian; Borrow, Ray] Manchester Royal Infirm, Meningococcal Reference Unit, Publ Hlth England, Manchester, Lancs, England; [Zhu, Bingqing; Xu, Li; Gao, Yuan; Shao, Zhujun] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, Beijing, Peoples R China; [Jose Gonzalez-Lopez, Juan] Hosp Univ Vail dHebron, Dept Clin Microbiol, Barcelona, Spain; [Mulhall, Robert] Childrens Hlth Ireland, Irish Meningitis & Sepsis Reference Lab, Temple St, Dublin, Ireland; [Scott, Kevin J.; Smith, Andrew] Glasgow Royal Infirm, Bacterial Resp Infect Serv, Scottish Microbiol Reference Lab, Glasgow, Lanark, Scotland; [Smith, Andrew] Univ Glasgow, Glasgow Dent Hosp & Sch, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Stefanelli, Paola] Ist Super Sanita, Dept Infect Dis, Rome, Italy; [Stenmark, Bianca] Orebro Univ, Fac Med & Hlth, Dept Lab Med, Orebro, Sweden; [Torpiano, Paul] Mater Dei Hosp, Dept Child & Adolescent Hlth, Msida, Malta; [Tzanakaki, Georgina] Univ West Attica, Sch Publ Hlth, Dept Publ Hlth Policy, Natl Meningitis Reference Lab, Athens, Greece	Public Health England; University of Manchester; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; University of Glasgow; University of Glasgow; Istituto Superiore di Sanita (ISS); Orebro University; University of West Attica	Lucidarme, J (corresponding author), Manchester Royal Infirm, Meningococcal Reference Unit, Publ Hlth England, Manchester, Lancs, England.; Shao, ZJ (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, Beijing, Peoples R China.	jay.lucidarme@phe.gov.uk; shaozhujun@icdc.cn	STEFANELLI, PAOLA/B-8729-2016; Stenmark, Bianca/HHZ-7971-2022; González-López, Juanjo/C-5366-2014; Tzanakaki, Georgina/AAZ-6598-2021	STEFANELLI, PAOLA/0000-0003-1620-4385; Stenmark, Bianca/0000-0003-4637-8626; González-López, Juanjo/0000-0003-2419-5909; Scott, Kevin/0000-0003-3338-9967	National Key Program for Infectious Disease of China [2013ZX10004221, 2018ZX10714002-001]	National Key Program for Infectious Disease of China	This work was supported by grants (ZS) from the National Key Program for Infectious Disease of China (contract no. 2013ZX10004221 and 2018ZX10714002-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2019, HIST NEWS, V74, P22; [Anonymous], 2012, CLIN EXP RHEUMAT S70, V30, pS77; Belkacem N, 2016, ANTIMICROB AGENTS CH, V60, P4023, DOI 10.1128/AAC.00378-16; Bratcher HB, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1138; Brooks A, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.15.2000375; Chiou CS, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-25; Donnelly J, 2010, P NATL ACAD SCI USA, V107, P19490, DOI 10.1073/pnas.1013758107; Guo QL, 2018, EMERG INFECT DIS, V24, P683, DOI 10.3201/eid2404.171744; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95; Harrison LH, 2015, J INFECT DIS, V211, P1761, DOI 10.1093/infdis/jiu679; Harrison OB, 2017, SEX TRANSM INFECT, V93, P445, DOI 10.1136/sextrans-2016-052781; He BH, 2014, INT J INFECT DIS, V29, P113, DOI 10.1016/j.ijid.2014.08.022; Hong E, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.00831-18, 10.1128/aac.00831-18]; Hong E, 2013, ANTIMICROB AGENTS CH, V57, P1961, DOI 10.1128/AAC.02184-12; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; Jiang HQ, 2010, VACCINE, V28, P6086, DOI 10.1016/j.vaccine.2010.06.083; Jolley Keith A, 2018, Wellcome Open Res, V3, P124, DOI 10.12688/wellcomeopenres.14826.1; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Lucidarme J, 2016, EUROSURVEILLANCE, V21, P15, DOI 10.2807/1560-7917.ES.2016.21.45.30395; Lucidarme J, 2017, J INFECTION, V75, P95, DOI 10.1016/j.jinf.2017.05.015; Lucidarme J, 2015, J INFECTION, V71, P544, DOI 10.1016/j.jinf.2015.07.007; Lucidarme J, 2011, CLIN VACCINE IMMUNOL, V18, P1002, DOI 10.1128/CVI.00055-11; Ma KC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17980-1; McNamara LA, 2020, MMWR-MORBID MORTAL W, V69, P735, DOI 10.15585/mmwr.mm6924a2; McNeil LK, 2018, MBIO, V9, DOI 10.1128/mBio.00036-18; Muzzi A, 2019, VACCINE, V37, P991, DOI 10.1016/j.vaccine.2018.12.061; Ngai S, 2020, SEX TRANSM DIS, V47, P541, DOI 10.1097/OLQ.0000000000001205; Retchless AC, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4560-x; Shao ZJ, 2006, LANCET, V367, P419, DOI 10.1016/S0140-6736(06)68141-5; Shultz TR, 2001, ANTIMICROB AGENTS CH, V45, P734, DOI 10.1128/AAC.45.3.734-738.2001; Moura ARSS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185038; Taha MK, 2007, ANTIMICROB AGENTS CH, V51, P2784, DOI 10.1128/AAC.00412-07; Taha MK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154047; Tsang RSW, 2017, CAN J MICROBIOL, V63, P265, DOI 10.1139/cjm-2016-0716; Tzanakaki G, 2020, EUR J CLIN MICROBIOL, V39, P2467, DOI 10.1007/s10096-020-03965-x; Tzeng YL, 2017, P NATL ACAD SCI USA, V114, P4237, DOI 10.1073/pnas.1620971114; Vacca P, 2019, J GLOB ANTIMICROB RE, V18, P177, DOI 10.1016/j.jgar.2019.07.010; Wang X, 2011, VACCINE, V29, P4739, DOI 10.1016/j.vaccine.2011.04.092; Zhang XB, 2007, J MED MICROBIOL, V56, P1224, DOI 10.1099/jmm.0.47263-0; Zhao P, 2020, BMC MICROBIOL, V20, DOI 10.1186/s12866-020-01751-5; Zhou HJ, 2015, J INFECTION, V70, P37, DOI 10.1016/j.jinf.2014.07.022; Zhu BQ, 2015, EMERG INFECT DIS, V21, P925, DOI 10.3201/eid2106.140687; ZHU PX, 1995, J CLIN MICROBIOL, V33, P458, DOI 10.1128/JCM.33.2.458-462.1995	43	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243426	10.1371/journal.pone.0243426	http://dx.doi.org/10.1371/journal.pone.0243426			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301524	gold, Green Accepted, Green Published			2022-12-27	WOS:000600143100009
J	VanKoevering, KK; Yalamanchi, P; Haring, CT; Phillips, AG; Harvey, SL; Rojas-Pena, A; Zopf, DA; Green, GE				VanKoevering, Kyle K.; Yalamanchi, Pratyusha; Haring, Catherine T.; Phillips, Anne G.; Harvey, Stephen Lewis; Rojas-Pena, Alvaro; Zopf, David A.; Green, Glenn E.			Delivery system can vary ventilatory parameters across multiple patients from a single source of mechanical ventilation	PLOS ONE			English	Article								Background Current limitations in the supply of ventilators during the Covid19 pandemic have limited respiratory support for patients with respiratory failure. Split ventilation allows a single ventilator to be used for more than one patient but is not practicable due to requirements for matched patient settings, risks of cross-contamination, harmful interference between patients and the inability to individualize ventilator support parameters. We hypothesized that a system could be developed to circumvent these limitations. Methods and findings A novel delivery system was developed to allow individualized peak inspiratory pressure settings and PEEP using a pressure regulatory valve, developed de novo, and an inline PEEP 'booster'. One-way valves, filters, monitoring ports and wye splitters were assembled in-line to complete the system and achieve the design targets. This system was then tested to see if previously described limitations could be addressed. The system was investigated in mechanical and animal trials (ultimately with a pig and sheep concurrently ventilated from the same ventilator). The system demonstrated the ability to provide ventilation across clinically relevant scenarios including circuit occlusion, unmatched physiology, and a surgical procedure, while allowing significantly different pressures to be safely delivered to each animal for individualized support. Conclusions In settings of limited ventilator availability, systems can be developed to allow increased delivery of ventilator support to patients. This enables more rapid deployment of ventilator capacity under constraints of time, space and financial cost. These systems can be smaller, lighter, more readily stored and more rapidly deployable than ventilators. However, optimizing ventilator support for patients with individualized ventilation parameters will still be dependent upon ease of use and the availability of medical personnel.	[VanKoevering, Kyle K.; Yalamanchi, Pratyusha; Haring, Catherine T.; Zopf, David A.; Green, Glenn E.] Univ Michigan, Dept Otolaryngol Head & Neck Surg, Michigan Med, Ann Arbor, MI 48109 USA; [VanKoevering, Kyle K.] Ohio State Univ, Wexner Med Ctr, Dept Otolaryngol Head & Neck Surg, Columbus, OH 43210 USA; [Phillips, Anne G.; Harvey, Stephen Lewis; Rojas-Pena, Alvaro] Univ Michigan, Dept Surg, Sect Transplantat, Michigan Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University System of Ohio; Ohio State University; University of Michigan System; University of Michigan	VanKoevering, KK (corresponding author), Univ Michigan, Dept Otolaryngol Head & Neck Surg, Michigan Med, Ann Arbor, MI 48109 USA.; VanKoevering, KK (corresponding author), Ohio State Univ, Wexner Med Ctr, Dept Otolaryngol Head & Neck Surg, Columbus, OH 43210 USA.	kylevk@umich.edu		Rojas-Pena, Alvaro/0000-0002-6197-8892; Yalamanchi, Pratyusha/0000-0003-0776-3759; Haring, Catherine/0000-0002-9317-6536				Ajao A, 2015, DISASTER MED PUBLIC, V9, P634, DOI 10.1017/dmp.2015.105; Anesthesia Patient Safety Foundation, 2020, JOINT STAT MULT PAT; Neyman G, 2006, ACAD EMERG MED, V13, P1246, DOI 10.1197/j.aem.2006.05.009; Srinivasan SS, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.abb9401; White DB, 2020, JAMA-J AM MED ASSOC, V323, P1773, DOI 10.1001/jama.2020.5046	5	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243601	10.1371/journal.pone.0243601	http://dx.doi.org/10.1371/journal.pone.0243601			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301512	gold, Green Published			2022-12-27	WOS:000600143100055
J	Whang, YH; Kim, SK; Yoon, H; Choi, SK; Baik, YO; Lee, C; Lee, I				Whang, Yoon Hee; Kim, Soo Kyung; Yoon, Hyeseon; Choi, Seuk Keun; Baik, Yeong Ok; Lee, Chankyu; Lee, Inhwan			Reduction of free polysaccharide contamination in the production of a 15-valent pneumococcal conjugate vaccine	PLOS ONE			English	Article							PNEUMONIAE VIRULENCE FACTORS; PROTEIN-CONJUGATE; COLONIZATION; VALIDATION; PATHOGENS	Glycoconjugate vaccines are vaccines in which a bacterial polysaccharide antigen is conjugated to a carrier protein to enhance immunogenicity by promoting T cell-dependent immune response. However, the free (unreacted) polysaccharides remaining after the conjugation process can inhibit the immunogenicity of a conjugate vaccine. Thus, we aimed to reduce the unbound free polysaccharides in the polysaccharide-protein conjugation process for the development of a new 15-valent pneumococcal conjugate vaccine (PCV15) by varying some factors that may affect the conjugation results such as polysaccharide/protein ratio, polysaccharide size, and concentration of a coupling agent in a conjugation reaction mixture. Concentrations of a coupling agent, carbodiimide (EDAC), and a carrier protein (CRM197) used in PCV15 production, during the conjugation process, had little effect on the content of free polysaccharides. However, the size of the polysaccharide was identified as the critical factor to control the free polysaccharide content, with an inverse relationship observed between the molecular weight of the polysaccharide and the residual free polysaccharide content after conjugation. Based on these results, a new PCV15 with low free polysaccharide contamination was produced and tested for immunogenicity using a rabbit model to show that it induces similar level of immune responses in rabbits compared to a comparator vaccine Prevnar13(R).	[Whang, Yoon Hee; Kim, Soo Kyung; Yoon, Hyeseon; Choi, Seuk Keun; Baik, Yeong Ok; Lee, Chankyu; Lee, Inhwan] EuBiol Co Ltd, R&D Ctr, Chunchon, South Korea		Lee, C; Lee, I (corresponding author), EuBiol Co Ltd, R&D Ctr, Chunchon, South Korea.	cklee@eubiologics.com; inhwan@eubiologics.com			Korea Health Technology R&D project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI14C2711]	Korea Health Technology R&D project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant of the Korea Health Technology R&D project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grand number: HI14C2711). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Authors Yoon Hee Whang, Soo Kyung Kim, Hyeseon Yoon, Seuk Keun Choi, Yeong Ok Baik, Chankyu Lee, and Inhwan Lee are employees of Eubiologics. Eubiologics provided support in the form of salaries for authors YH Whang, SK Kim, H Yoon, SK Choi, YO Baik, C Lee, and I Lee, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	[Anonymous], 1994, LESBIAN FEMINIST FLY, V20, P1; Burton RL, 2006, CLIN VACCINE IMMUNOL, V13, P1004, DOI 10.1128/CVI.00112-06; Chalmers JD, 2016, BMC PULM MED, V16, DOI 10.1186/s12890-016-0242-0; Clutterbuck EA, 2012, J INFECT DIS, V205, P1408, DOI 10.1093/infdis/jis212; Concepcion NF, 2001, CLIN DIAGN LAB IMMUN, V8, P266, DOI 10.1128/CDLI.8.2.266-272.2001; Domenech M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125636; DOUGLAS RM, 1983, J INFECT DIS, V148, P131, DOI 10.1093/infdis/148.1.131; Dransfield MT, 2009, AM J RESP CRIT CARE, V180, P499, DOI 10.1164/rccm.200903-0488OC; Geno KA, 2017, J CLIN MICROBIOL, V55, P1416, DOI 10.1128/JCM.00054-17; Hermanson GT, 2013, BIOCONJUGATE TECHNIQUES, 3RD EDITION, P1; Hessling M, 2017, BIOSCI BIOTECH RES C, V10, P1; JONSSON S, 1985, J INFECT DIS, V152, P4, DOI 10.1093/infdis/152.1.4; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; KOEHLER LH, 1952, ANAL CHEM, V24, P1576, DOI 10.1021/ac60070a014; Kumar R, 2005, ANAL BIOCHEM, V336, P132, DOI 10.1016/j.ab.2004.09.038; Lees A, 1996, VACCINE, V14, P190, DOI 10.1016/0264-410X(95)00195-7; Lesinski GB, 2001, J MICROBIOL METH, V47, P135, DOI 10.1016/S0167-7012(01)00290-1; Malenovic A., 2005, Farmaco (Lausanne), V60, P157, DOI 10.1016/j.farmac.2004.11.004; McElligott M, 2014, VACCINE, V32, P3495, DOI 10.1016/j.vaccine.2014.04.047; Mitchell AM, 2010, CLIN MICROBIOL INFEC, V16, P411, DOI 10.1111/j.1469-0691.2010.03183.x; PEETERS CCAM, 1992, VACCINE, V10, P833, DOI 10.1016/0264-410X(92)90046-M; Siegel SJ, 2015, ANNU REV MICROBIOL, V69, P425, DOI 10.1146/annurev-micro-091014-104209; SNYDER SL, 1975, ANAL BIOCHEM, V64, P284, DOI 10.1016/0003-2697(75)90431-5; Weintraub A, 2003, CARBOHYD RES, V338, P2539, DOI 10.1016/j.carres.2003.07.008; Weiser JN, 2010, J MOL MED, V88, P97, DOI 10.1007/s00109-009-0557-x; Yoo SH, 2002, CARBOHYD POLYM, V49, P307, DOI 10.1016/S0144-8617(01)00339-3	26	2	2	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243909	10.1371/journal.pone.0243909	http://dx.doi.org/10.1371/journal.pone.0243909			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301525	gold, Green Published			2022-12-27	WOS:000600143100049
J	Asefa, F; Cummins, A; Dessie, Y; Foureu, M; Hayen, A				Asefa, Fekede; Cummins, Allison; Dessie, Yadeta; Foureu, Maralyn; Hayen, Andrew			Midwives' and obstetricians' perspectives about pregnancy related weight management in Ethiopia: A qualitative study	PLOS ONE			English	Article							GAIN; HEALTH; OUTCOMES; ASSOCIATIONS; EDUCATION; WOMEN; CARE	Background Midwives and obstetricians are key maternity care providers; they are the most trusted source of information regarding nutrition and gestational weight gain. However, their views, practices and perceived barriers to managing pregnancy related weight gain have not been studied in Ethiopia. The aim of this study was to explore midwives' and obstetricians' observations and perspectives about gestational weight gain and postpartum weight management in Ethiopia. Methods We conducted face-to-face interviews with 11 midwives and 10 obstetricians, from January 2019 to March 2019. All interview data were transcribed verbatim. We analysed the data using thematic analysis with an inductive approach. Results We identified three themes and associated subthemes. Midwives and obstetricians had limited knowledge of the optimal gestational weight gain. Almost all participants were unaware of the presence of the Institute of Medicine recommendations for optimal weight gain in pregnancy. According to the study participants, women in Ethiopia do not want to gain weight during pregnancy, but do want to gain weight after the birth. Counselling about gestational weight gain and postpartum weight management was not routinely provided for pregnant women. This is mostly because gestational weight gain counselling was not considered to be a priority by maternity care providers in Ethiopia. Conclusions The limited knowledge of and low attention to pregnancy related weight management by midwives and obstetricians in this setting needs appropriate intervention. Adapting a guideline for pregnancy weight management and integrating it into antenatal care is essential.	[Asefa, Fekede; Dessie, Yadeta] Haramaya Univ, Coll Hlth & Med Sci, Sch Publ Hlth, Harar, Ethiopia; [Asefa, Fekede; Cummins, Allison; Foureu, Maralyn] Univ Technol Sydney, Fac Hlth, Ctr Midwifery Child & Family Hlth, Sydney, NSW, Australia; [Asefa, Fekede; Hayen, Andrew] Univ Technol Sydney, Fac Hlth, Sch Publ Hlth, Sydney, NSW, Australia; [Foureu, Maralyn] Univ Newcastle, Hunter New England Hlth Nursing & Midwifery Res C, Newcastle, NSW, Australia	Haramaya University; University of Technology Sydney; University of Technology Sydney; University of Newcastle	Asefa, F (corresponding author), Haramaya Univ, Coll Hlth & Med Sci, Sch Publ Hlth, Harar, Ethiopia.; Asefa, F (corresponding author), Univ Technol Sydney, Fac Hlth, Ctr Midwifery Child & Family Hlth, Sydney, NSW, Australia.; Asefa, F (corresponding author), Univ Technol Sydney, Fac Hlth, Sch Publ Hlth, Sydney, NSW, Australia.	sinboona@gmail.com	Bacha, Yadeta/AAF-8849-2021; Cummins, Allison M/G-8614-2015; asefa, fekede/AAE-1700-2020	Cummins, Allison M/0000-0003-0626-3365; asefa, fekede/0000-0002-6700-4810; Hayen, Andrew/0000-0003-4046-8030	Australian Government Research Training Program; Haramaya University [HURG_2018_02_01_30]; Centre for Midwifery, Child and Family Health, University of Technology Sydney	Australian Government Research Training Program(Australian Government); Haramaya University; Centre for Midwifery, Child and Family Health, University of Technology Sydney	An Australian Government Research Training Program provided a full scholarship for the corresponding author. This study was partially funded by the Haramaya University as a part of staff grant [grant number: HURG_2018_02_01_30]. The Centre for Midwifery, Child and Family Health, University of Technology Sydney provided financial support for data transcription purpose. There was no additional external funding received for this study.	Alavi N, 2013, OBES REV, V14, P68, DOI 10.1111/j.1467-789X.2012.01059.x; Anon, 2013, MACQUARIE DISPATCH, V12, P1; [Anonymous], 2018, Obstet Gynecol, V132, pe181, DOI 10.1097/AOG.0000000000002897; [Anonymous], 2017, INT J RES HUMANITIES, V46, P1; [Anonymous], 2019, PREV TREAT CARDIO CE, V19, P1, DOI [DOI 10.5230/jgc.2019.19.e8, DOI 10.1186/s12877-019-1185-0]; [Anonymous], 2013, U VERMONT HIST REV, VXXIV, P1; Arrish J, 2014, WOMEN BIRTH, V27, P2, DOI 10.1016/j.wombi.2013.02.003; Asefa F, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0225-x; Ashley-Martin J, 2014, MATERN CHILD HLTH J, V18, P1927, DOI 10.1007/s10995-014-1438-7; Bookari K, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/4856527; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, https://doi.org/10.1191/1478088706qp063oa, 10.1191/1478088706qp063oa]; Campbell F, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-491; Central Statistical Agency, 2016, ETHIOPIA DEM HLTH SU ETHIOPIA DEM HLTH SU; Christensen AP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166167; Clarke V, 2013, PSYCHOLOGIST, V26, P120; Cole KOW, 2017, J WOMENS HEALTH, V26, P1123, DOI 10.1089/jwh.2016.6115; Committee on Practice Bulletins-Obstetrics, 2018, OBSTET GYNECOL, V131, pe49; Criss S, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1118-2; de la Torre L, 2011, AM J PERINAT, V28, P285, DOI 10.1055/s-0030-1271211; Duthie EA, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-231; Ehrenberg HM, 2003, AM J OBSTET GYNECOL, V189, P1726, DOI 10.1016/S0002-9378(03)00860-3; Gedamu H, 2016, INT J REPROD MED, V2018, P1, DOI [10.1155/2018/5945060, DOI 10.1155/2018/5945060]; Goldstein RF, 2017, JAMA-J AM MED ASSOC, V317, P2207, DOI 10.1001/jama.2017.3635; Haugen M, 2015, BMC PREGNANCY CHILDB, V14, P1; Hickey CA, 2000, AM J CLIN NUTR, V71, p1364S, DOI 10.1093/ajcn/71.5.1364s; Institute of Medicine, 2009, WEIGHT GAIN PREGNANC; Johnson J, 2013, OBSTET GYNECOL, V121, P969, DOI 10.1097/AOG.0b013e31828aea03; Lindsay AC, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14111412; Macleod M, 2013, MATERN CHILD NUTR, V9, P467, DOI 10.1111/j.1740-8709.2011.00396.x; Magilvy JK, 2009, J SPEC PEDIATR NURS, V14, P298, DOI 10.1111/j.1744-6155.2009.00212.x; Mamun AA, 2010, AM J CLIN NUTR, V91, P1336, DOI 10.3945/ajcn.2009.28950; Mcphie S, 2015, AUST NZ J OBSTET GYN, V55, P21, DOI 10.1111/ajo.12265; Mitchell LJ, 2017, J ACAD NUTR DIET, V117, P1941, DOI 10.1016/j.jand.2017.06.364; Moos MK, 2008, AM J OBSTET GYNECOL, V199, pS280, DOI 10.1016/j.ajog.2008.08.060; Morris J, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-018527; Mwape L, 2018, OPEN J PSYCHIAT, V8, P152; Nemomsa D., 2018, E AFR J HLTH BIOMED, V2, P1; Oken E, 2007, AM J PREV MED, V32, P305, DOI 10.1016/j.amepre.2006.11.012; Olander EK, 2011, SEX REPROD HEALTHC, V2, P43, DOI 10.1016/j.srhc.2010.10.004; QSR International Pty Ltd, 2018, NVIVO; Sandall J, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004667.pub5; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Sandelowski M, 2010, RES NURS HEALTH, V33, P77, DOI 10.1002/nur.20362; Schmied VA, 2011, MIDWIFERY, V27, P424, DOI 10.1016/j.midw.2010.02.010; Scott C, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-167; Seifu B., 2017, ASSESMENT GESTATIONA; Shub Alexis, 2013, BMC Res Notes, V6, P278, DOI 10.1186/1756-0500-6-278; Tela FG, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212424; ten Hoope-Bender P, 2014, LANCET, V384, P1226, DOI 10.1016/S0140-6736(14)60930-2; Timmerman GM, 2017, J PERINAT EDUC, V26, P70, DOI 10.1891/1058-1243.26.2.70; Tovar A, 2010, MATERN CHILD HLTH J, V14, P938, DOI 10.1007/s10995-009-0524-8; Tully KP, 2017, AM J OBSTET GYNECOL, V217, P37, DOI 10.1016/j.ajog.2017.03.032; van Nes F, 2010, EUR J AGEING, V7, P313, DOI 10.1007/s10433-010-0168-y; Weeks A, 2018, OBSTET GYNECOL SURV, V73, P486, DOI 10.1097/OGX.0000000000000588; WHO, 2022, WHO RECOMMENDATIONS; Willcox JC, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-102; World Health Organization, 2017, MAN COMPL PREG CHILD; World Health Organization Department of Maternal N, 2013, WHO REC POSTN CAR MO; Yigzaw T, 2016, INT J WOMENS HEALTH, V8, P181, DOI 10.2147/IJWH.S105046; Zerfu TA, 2016, J HEALTH POPUL NUTR, V35, DOI 10.1186/s41043-016-0059-8; 2015, MEDICC REV, V17, P5	61	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0244221	10.1371/journal.pone.0244221	http://dx.doi.org/10.1371/journal.pone.0244221			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PI8BZ	33332406	gold, Green Published			2022-12-27	WOS:000601310900056
J	Hotaling, A; Bagrow, JP				Hotaling, Abigail; Bagrow, James P.			Efficient crowdsourcing of crowd-generated microtasks	PLOS ONE			English	Article								Allowing members of the crowd to propose novel microtasks for one another is an effective way to combine the efficiencies of traditional microtask work with the inventiveness and hypothesis generation potential of human workers. However, microtask proposal leads to a growing set of tasks that may overwhelm limited crowdsourcer resources. Crowdsourcers can employ methods to utilize their resources efficiently, but algorithmic approaches to efficient crowdsourcing generally require a fixed task set of known size. In this paper, we introduce cost forecasting as a means for a crowdsourcer to use efficient crowdsourcing algorithms with a growing set of microtasks. Cost forecasting allows the crowdsourcer to decide between eliciting new tasks from the crowd or receiving responses to existing tasks based on whether or not new tasks will cost less to complete than existing tasks, efficiently balancing resources as crowdsourcing occurs. Experiments with real and synthetic crowdsourcing data show that cost forecasting leads to improved accuracy. Accuracy and efficiency gains for crowd-generated microtasks hold the promise to further leverage the creativity and wisdom of the crowd, with applications such as generating more informative and diverse training data for machine learning applications and improving the performance of user-generated content and question-answering platforms.	[Hotaling, Abigail; Bagrow, James P.] Univ Vermont, Dept Math & Stat, Burlington, VT 05405 USA; [Hotaling, Abigail; Bagrow, James P.] Univ Vermont, Vermont Complex Syst Ctr, Burlington, VT 05405 USA	University of Vermont; University of Vermont	Bagrow, JP (corresponding author), Univ Vermont, Dept Math & Stat, Burlington, VT 05405 USA.; Bagrow, JP (corresponding author), Univ Vermont, Vermont Complex Syst Ctr, Burlington, VT 05405 USA.	james.bagrow@uvm.edu	Bagrow, James/E-1701-2016	Bagrow, James/0000-0002-4614-0792	National Science Foundation [IIS-1447634]	National Science Foundation(National Science Foundation (NSF))	This material is based upon work supported by the National Science Foundation under Grant No. IIS-1447634 (JB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alstott J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085777; [Anonymous], 2018, GIN SURG RES COMMUN, V2, P24; Audibert JY, 2009, THEOR COMPUT SCI, V410, P1876, DOI 10.1016/j.tcs.2009.01.016; Aydin BI, 2021, CONCURR COMP-PRACT E, V33, DOI 10.1002/cpe.4168; Behrend TS, 2011, BEHAV RES METHODS, V43, P800, DOI 10.3758/s13428-011-0081-0; Bernstein M, 2010, S USER INTERFACE SOF, P313, DOI [10.1145/1866029.1866078, DOI 10.1145/1866029.1866078]; Bian J., 2008, P 17 INT C WORLD WID, P467, DOI DOI 10.1145/1367497.1367561; Bongard JC, 2013, IEEE T SYST MAN CY-S, V43, P176, DOI 10.1109/TSMCA.2012.2195168; Brabham D.C., 2008, CONVERGENCE-US, V14, P75, DOI DOI 10.1177/1354856507084420; Chen Xi, 2013, P 30 INT C MACHINE L, P64; Dagan I, 2006, LECT NOTES ARTIF INT, V3944, P177; Dai P, 2013, ARTIF INTELL, V202, P52, DOI 10.1016/j.artint.2013.06.002; Dawid A.P., 1979, J ROYAL STAT SOC C, V28, P20, DOI [10.2307/2346806, DOI 10.2307/2346806]; Franzoni C, 2014, RES POLICY, V43, P1, DOI 10.1016/j.respol.2013.07.005; Goh KI, 2008, EPL-EUROPHYS LETT, V81, DOI 10.1209/0295-5075/81/48002; Karger DR, 2014, OPER RES, V62, P1, DOI 10.1287/opre.2013.1235; Kittur A, 2013, C COMPUTER SUPPORTED, P1301, DOI [DOI 10.1145/2441776.2441923, 10.1145/2441776.2441923]; Kittur A, 2011, S USER INTERFACE SOF, P43, DOI DOI 10.1145/2047196.2047202; Li Q, 2016, PROCEEDINGS OF THE NINTH ACM INTERNATIONAL CONFERENCE ON WEB SEARCH AND DATA MINING (WSDM'16), P237, DOI 10.1145/2835776.2835797; Liu Y., 2018, 32 AAAI C ART INT; Maurer A, 2009, P 22 ANN C LEARN THE; McAndrew TC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182662; Salganik MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123483; Sheng V. S., 2008, P 14 ACM SIGKDD INT, P614, DOI DOI 10.1145/1401890.1401965; Shtok A., 2012, P 21 INT C WORLD WID, P759, DOI DOI 10.1145/2187836.2187939; Snow R., 2008, P C EMP METH NAT LAN, P254, DOI DOI 10.3115/1613715.1613751; Wagy MD, 2018, IEEE SYST J, V12, P3151, DOI 10.1109/JSYST.2017.2778144; Welinder P., 2010, ADV NEURAL INFORM PR, V23, P2424; Zhang J., 2007, P 16 INT C WORLD WID, P221, DOI DOI 10.1145/1242572.1242603	30	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0244245	10.1371/journal.pone.0244245	http://dx.doi.org/10.1371/journal.pone.0244245			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332455	gold, Green Published, Green Submitted			2022-12-27	WOS:000601310900032
J	Nehoya, KN; Hamatui, N; Shilangale, RP; Onywera, H; Kennedy, J; Mwapagha, LM				Nehoya, Kaarina N.; Hamatui, Ndinomholo; Shilangale, Renatus P.; Onywera, Harris; Kennedy, Jeya; Mwapagha, Lamech M.			Characterization of Shiga toxin-producing Escherichia coli in raw beef from informal and commercial abattoirs	PLOS ONE			English	Article							O157-H7 REQUIRES INTIMIN; REAL-TIME PCR; MULTIPLEX PCR; INFECTIONS; CATTLE; PATHOGENICITY; PREVALENCE; EMERGENCE; CARCASSES; GENES	Shiga toxin-producing Escherichia coli are foodborne pathogens that are mostly associated with beef products and have been implicated in human illness. E.coli-associated illness range from asymptomatic conditions of mild diarrhoea to haemorrhagic colitis which can progress into life threatening haemolytic uremic syndrome (HUS). Beef from cattle are regarded as the main reservoir of Shiga toxin-producing E. coli (STEC) pathogen. The aim of this study was to assess the level and sources of contamination of raw beef with STEC, and determine the incidences of STEC strains in raw beef from informal and commercial abattoirs in Windhoek, Namibia. A total of 204 raw beef samples, 37 equipment and 29 hand swabs were collected and tested for STEC. The meat samples were first enriched with pre-warmed buffered peptone water, cultured on Tryptone Bile X-Glucuronide and CHROMagar STEC, and then sub-cultured on nutrient agar. The presence of E.coli in the samples was confirmed by using VITEK 2 E.coli identification cards and PCR. The overall prevalence of STEC in the meat samples from both the abattoirs was 41.66% raw beef samples; 5.40% equipment swabs; and none of the hand swabs was STEC positive. From the STEC positive meat samples 29.41% contained one of the major STEC strains. Moreover, 52% of the 25 samples that contained the major STECs were characterised by eae and stx(1), 8% characterised by eae and stx(2) while 40% were characterised by eae, stx(1) and stx(2) virulence genes. This study has revealed the necessity for proper training on meat safety (for meat handlers) as well as the development, implementation and maintenance of effective sanitary dressing procedures at abattoirs to eliminate beef contamination by STECs thereby ensuring the production of wholesome meat, and to prevent the occurrences of STEC infections.	[Nehoya, Kaarina N.; Hamatui, Ndinomholo] Namibia Univ Sci & Technol, Fac Hlth & Appl Sci, Dept Hlth Sci, Windhoek, Namibia; [Nehoya, Kaarina N.] Minist Agr Water & Forestry, Directorate Vet Serv, Windhoek, Namibia; [Shilangale, Renatus P.] Minist Agr Water & Forestry, Cent Vet Lab, Windhoek, Namibia; [Onywera, Harris] Univ Cape Town, Inst Infect Dis & Mol Med, Cape Town, South Africa; [Onywera, Harris] Univ Cape Town, Fac Hlth Sci, Dept Pathol, Div Med Virol, Cape Town, South Africa; [Kennedy, Jeya; Mwapagha, Lamech M.] Namibia Univ Sci & Technol, Fac Hlth & Appl Sci, Dept Nat & Appl Sci, Windhoek, Namibia	Namibia University of Science & Technology; University of Cape Town; University of Cape Town; Namibia University of Science & Technology	Mwapagha, LM (corresponding author), Namibia Univ Sci & Technol, Fac Hlth & Appl Sci, Dept Nat & Appl Sci, Windhoek, Namibia.	lmwapa@gmail.com	Onywera, Harris/AAM-6198-2021	Onywera, Harris/0000-0002-7298-4921; Hamatui, Ndinomholo/0000-0002-6397-8597; Mwapagha, Lamech/0000-0003-1048-1787				Arthur TM, 2002, APPL ENVIRON MICROB, V68, P4847, DOI 10.1128/AEM.68.10.4847-4852.2002; Montero DA, 2019, EMERG MICROBES INFEC, V8, P486, DOI 10.1080/22221751.2019.1595985; Bai JF, 2012, FOODBORNE PATHOG DIS, V9, P541, DOI 10.1089/fpd.2011.1082; Bai JF, 2010, J MICROBIOL METH, V82, P85, DOI 10.1016/j.mimet.2010.05.003; Baumgartner A, 2016, J VERBRAUCH LEBENSM, V11, P353, DOI 10.1007/s00003-016-1053-1; Bertrand R, 2007, WATER RES, V41, P1280, DOI 10.1016/j.watres.2006.11.027; Bettelheim KA, 2000, J APPL MICROBIOL, V88, p38S, DOI 10.1111/j.1365-2672.2000.tb05331.x; Blanco M, 1997, VET MICROBIOL, V54, P309, DOI 10.1016/S0378-1135(96)01292-8; Bollinger LM, 2004, EFFECTS SEASON ANIMA; Brooks JT, 2005, J INFECT DIS, V192, P1422, DOI 10.1086/466536; Brusa V, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2012.00171; Cook EAJ, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-016-3923-y; Dean-Nystrom EA, 1998, INFECT IMMUN, V66, P4560; Effler P, 2001, EMERG INFECT DIS, V7, P812; Fleiss J., 1981, STAT METHODS RATES P, P870; Franco MG, 2017, J BLACK PSYCHOL, V43, P435, DOI 10.1177/0095798416657260; Hassanien A, CONTAMINATION BEEF C; Hedican EB, 2009, CLIN INFECT DIS, V49, P358, DOI 10.1086/600302; Hernandez Marta, 2009, P427, DOI 10.1007/978-0-387-89026-5_16; Hussein HS, 2007, J ANIM SCI, V85, pE63, DOI 10.2527/jas.2006-421; Islam MA, 2010, FOODBORNE PATHOG DIS, V7, P1381, DOI 10.1089/fpd.2010.0569; Jenkins C, 2020, J MED MICROBIOL, V69, P487, DOI 10.1099/jmm.0.001136; Kothari C.R., 2014, REMETHODOLOGY METH; Koyange L, 2004, EMERG INFECT DIS, V10, P968, DOI 10.3201/eid1005.031034; Llorente P, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/795104; Majowicz SE, 2014, FOODBORNE PATHOG DIS, V11, P447, DOI 10.1089/fpd.2013.1704; McEvoy JM, 2000, LETT APPL MICROBIOL, V30, P390, DOI [10.1046/j.1472-765x.2000.00739.x, 10.1046/j.1472-765X.2000.00739.x]; MCKEE ML, 1995, INFECT IMMUN, V63, P3739, DOI 10.1128/IAI.63.9.3739-3744.1995; Montero DA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06999-y; Mwai C, 2011, RISK CONTAMINATION B; Nigri F, 2016, SURG NEUROL INT S31, V7, pS785; Nowicki S., 2010, Morbidity and Mortality Weekly Report, V59, P557; Oloyede A R, 2016, NIGERIAN J BIOTECHNO, V31, P15; Rigobelo E. C., 2012, J MICROBIOLOGY RES, V2, P103; Sarimehmetoglu B, 2009, FOOD CONTROL, V20, P357, DOI 10.1016/j.foodcont.2008.06.002; Svoboda AL, 2013, FOODBORNE PATHOG DIS, V10, P789, DOI 10.1089/fpd.2012.1445; Tau NP, 2012, EMERG INFECT DIS, V18, P1314, DOI 10.3201/eid1808.111616; Woodward MJ, 2003, INT J MED MICROBIOL, V293, P299, DOI 10.1078/1438-4221-00264; Xia XD, 2010, APPL ENVIRON MICROB, V76, P1709, DOI 10.1128/AEM.01968-09	39	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243828	10.1371/journal.pone.0243828	http://dx.doi.org/10.1371/journal.pone.0243828			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332397	Green Published, gold			2022-12-27	WOS:000601310900034
J	Pattabiraman, C; Habib, F; Harsha, PK; Rasheed, R; Prasad, P; Reddy, V; Dinesh, P; Damodar, T; Hosallimath, K; George, AK; Reddy, NVK; John, B; Pattanaik, A; Kumar, N; Mani, RS; Venkataswamy, MM; Hameed, SSK; Kumar, BGP; Desai, A; Vasanthapuram, R				Pattabiraman, Chitra; Habib, Farhat; Harsha, P. K.; Rasheed, Risha; Prasad, Pramada; Reddy, Vijayalakshmi; Dinesh, Prameela; Damodar, Tina; Hosallimath, Kiran; George, Anson K.; Kiran Reddy, Nakka Vijay; John, Banerjee; Pattanaik, Amrita; Kumar, Narendra; Mani, Reeta S.; Venkataswamy, Manjunatha M.; Shahul Hameed, Shafeeq K.; Kumar, Prakash B. G.; Desai, Anita; Vasanthapuram, Ravi			Genomic epidemiology reveals multiple introductions and spread of SARS-CoV-2 in the Indian state of Karnataka	PLOS ONE			English	Article								Karnataka, a state in south India, reported its first case of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection on March 8, 2020, more than a month after the first case was reported in India. We used a combination of contact tracing and genomic epidemiology to trace the spread of SARS-CoV-2 in the state up until May 21, 2020 (1578 cases). We obtained 91 genomes of SARS-CoV-2 which clustered into seven lineages (Pangolin lineages-A, B, B.1, B.1.80, B.1.1, B.4, and B.6). The lineages in Karnataka were known to be circulating in China, Southeast Asia, Iran, Europe and other parts of India and are likely to have been imported into the state both by international and domestic travel. Our sequences grouped into 17 contact clusters and 24 cases with no known contacts. We found 14 of the 17 contact clusters had a single lineage of the virus, consistent with multiple introductions and most (12/17) were contained within a single district, reflecting local spread. In most of the 17 clusters, the index case (12/17) and spreaders (11/17) were symptomatic. Of the 91 sequences, 47 belonged to the B.6 lineage, including eleven of 24 cases with no known contact, indicating ongoing transmission of this lineage in the state. Genomic epidemiology of SARS-CoV-2 in Karnataka suggests multiple introductions of the virus followed by local transmission in parallel with ongoing viral evolution. This is the first study from India combining genomic data with epidemiological information emphasizing the need for an integrated approach to outbreak response.	[Pattabiraman, Chitra; Harsha, P. K.; Rasheed, Risha; Prasad, Pramada; Reddy, Vijayalakshmi; Damodar, Tina; Hosallimath, Kiran; George, Anson K.; Kiran Reddy, Nakka Vijay; John, Banerjee; Pattanaik, Amrita; Kumar, Narendra; Mani, Reeta S.; Venkataswamy, Manjunatha M.; Shahul Hameed, Shafeeq K.; Desai, Anita; Vasanthapuram, Ravi] Natl Inst Mental Hlth & Neurosci, Dept Neurovirol, Bengaluru, India; [Habib, Farhat] TruFactor InMobi Grp, Bengaluru, India; [Dinesh, Prameela; Kumar, Prakash B. G.] Govt Karnataka, Directorate Hlth & Family Welf Serv, Bengaluru, India	National Institute of Mental Health & Neurosciences - India	Vasanthapuram, R (corresponding author), Natl Inst Mental Hlth & Neurosci, Dept Neurovirol, Bengaluru, India.	virusravi@gmail.com	P, Dinesh/AFP-6053-2022; Pattanaik, Amrita/AGR-4884-2022; Habib, Farhat/AAP-5421-2021; K Shahul Hameed, Shafeeq/GRX-8518-2022	P, Dinesh/0000-0003-4195-9536; Habib, Farhat/0000-0002-4295-2750; K Shahul Hameed, Shafeeq/0000-0002-3976-1443; Kumar, Narendra/0000-0002-4787-355X; Pattanaik, Amrita/0000-0002-1562-0347; PRASAD, PRAMADA/0000-0003-0933-3728; Pattabiraman, Chitra/0000-0002-9707-3358; Mani, Reeta/0000-0001-6039-1187; Damodar, Tina/0000-0002-7658-3367	NIMHANS; DBT/Wellcome Trust India Alliance Fellowship [IA/E/15/1/502336]; TruFactor-InMobi Group	NIMHANS; DBT/Wellcome Trust India Alliance Fellowship; TruFactor-InMobi Group	This work was supported by core funds of NIMHANS to the Department of Neurovirology and the DBT/Wellcome Trust India Alliance Fellowship IA/E/15/1/502336 awarded to Chitra P. YTruFactor-InMobi Group provided support in the form of salary for author FH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of FH are articulated in the `author contributions' section.	Banu S, 2020, DISTINCT PHYLOGENETI; Bedford T, 2020, CRYPTIC TRANSMISSION; Bell S. M, 2020, GENOMIC ANAL COVID 1; Biswas NK, 2020, INDIAN J MED RES, V151, P450, DOI 10.4103/ijmr.IJMR_1125_20; Bostock M, 2011, IEEE T VIS COMPUT GR, V17, P2301, DOI 10.1109/TVCG.2011.185; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elbe S, 2017, GLOB CHALLENGES; Fauver JR, 2020, CELL, V181, P990, DOI 10.1016/j.cell.2020.04.021; Gudbjartsson DF, 2020, NEW ENGL J MED, V382, P2302, DOI 10.1056/NEJMoa2006100; Hadfield J, 2018, BIOINFORMATICS, V34, P4121, DOI 10.1093/bioinformatics/bty407; Hodcroft E., 2020, GENOMIC ANAL COVID 1; ICMR Covid Study Grp, 2020, INDIAN J MED RES, V151, P424, DOI 10.4103/ijmr.IJMR_1896_20; Korber B, 2020, SPIKE MUTATION PIPEL; Lu J, 2020, CELL, V181, P997, DOI 10.1016/j.cell.2020.04.023; MacLean OA, 2020, VIRUS EVOL, V6, DOI 10.1093/ve/veaa034; Mondal M, 2020, CURR SCI; Nguyen Lam-Tung, 2015, Mol Biol Evol, V32, P268, DOI 10.1093/molbev/msu300; Potdar V, 2020, INDIAN J MED RES, V151, P255, DOI 10.4103/ijmr.IJMR_1058_20; Quick J, 2020, NCOV 2019 SEQUENCING, DOI [10.17504/protocols.io.bdp7i5rn, DOI 10.17504/PROTOCOLS.IO.BDP7I5RN]; Rambaut A., 2020, PHYLODYNAMIC ANAL; Rambaut A, 2020, DYNAMIC NOMENCLATURE, V5, P1403, DOI 10.1101/2020.04.17.046086; Singer J., 2020, COV GLUE WEB APPL TR, DOI [10.20944/preprints202006.0225.v1, DOI 10.20944/PREPRINTS202006.0225.V1]; WHO, 2020, 5 WHO; Yadav PD, 2020, INDIAN J MED RES, V151, P200, DOI 10.4103/ijmr.IJMR_663_20; Zhang Lizhou, 2020, bioRxiv, DOI 10.1101/2020.06.12.148726; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	26	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243412	10.1371/journal.pone.0243412	http://dx.doi.org/10.1371/journal.pone.0243412			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332472	Green Published, Green Submitted, gold			2022-12-27	WOS:000601310900049
J	Sherman, CS; Heupel, MR; Johnson, M; Kaimuddin, M; Qamar, LMS; Chin, A; Simpfendorfer, CA				Sherman, C. Samantha; Heupel, Michelle R.; Johnson, Mohini; Kaimuddin, Muslimin; Qamar, L. M. Sjamsul; Chin, Andrew; Simpfendorfer, Colin A.			Repeatability of baited remote underwater video station (BRUVS) results within and between seasons	PLOS ONE			English	Article							REEF SHARKS; FISH ASSEMBLAGES; VERTICAL MIGRATION; RHINCODON-TYPUS; WHALE SHARKS; HABITAT USE; RAY; VARIABILITY; STINGRAY; CHONDRICHTHYES	Baited remote underwater video stations (BRUVS) are increasingly being used to evaluate and monitor reef communities. Many BRUVS studies compare multiple sites sampled at single time points that may differ from the sampling time of another site. As BRUVS use grows in its application to provide data relevant to sustainable management, marine protected area success, and overall reef health, understanding repeatability of sampling results is vital. We examined the repeatability of BRUVS results for the elasmobranch community both within and between seasons and years, and explored environmental factors affecting abundances at two sites in Indonesia. On 956 BRUVS, 1139 elasmobranchs (69% rays, 31% sharks) were observed. We found consistent results in species composition and abundances within a season and across years. However, elasmobranch abundances were significantly higher in the wet season. The elasmobranch community was significantly different between the two sites sampled, one site being more coastal and easily accessed by fishermen. Our results demonstrate that while BRUVS are a reliable and repeatable method for surveying elasmobranchs, care must be taken in the timing of sampling between different regions to ensure that any differences observed are due to inherent differences amongst sampling areas as opposed to seasonal dissimilarities.	[Sherman, C. Samantha; Chin, Andrew; Simpfendorfer, Colin A.] James Cook Univ, Coll Sci & Engn, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld, Australia; [Sherman, C. Samantha] James Cook Univ, DB17 063, AIMS JCU, Townsville, Qld, Australia; [Sherman, C. Samantha] Simon Fraser Univ, Earth Oceans Res Grp, Dept Biol Sci, Burnaby, BC, Canada; [Heupel, Michelle R.; Chin, Andrew] Australian Inst Marine Sci, Cape Cleveland, Qld, Australia; [Johnson, Mohini] Operat Wallacea, Spilsby, Lincs, England; [Kaimuddin, Muslimin] Wasage Divers, Wakatobi, Southeast Sulaw, Indonesia; [Kaimuddin, Muslimin] Wasage Divers, Buton, Southeast Sulaw, Indonesia; [Qamar, L. M. Sjamsul] Univ Dayanu Ikhsanuddin, Fisheries Dept, Bau Bau, Southeast Sulaw, Indonesia	James Cook University; James Cook University; Simon Fraser University; Australian Institute of Marine Science	Sherman, CS (corresponding author), James Cook Univ, Coll Sci & Engn, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld, Australia.; Sherman, CS (corresponding author), James Cook Univ, DB17 063, AIMS JCU, Townsville, Qld, Australia.; Sherman, CS (corresponding author), Simon Fraser Univ, Earth Oceans Res Grp, Dept Biol Sci, Burnaby, BC, Canada.	sammsherman27@gmail.com		Sherman, C. Samantha/0000-0002-7150-1035	Paul G. Allen Philanthropies; Global FinPrint project; Operation Wallacea; Wasage Divers	Paul G. Allen Philanthropies; Global FinPrint project; Operation Wallacea; Wasage Divers	This work was funded by Paul G. Allen Philanthropies and the Global FinPrint project (https://www.pgafamilyfoundation.org) awarded to CAS and MRH. Additional project support was provided by Operation Wallacea (https://www.opwall.com) and Wasage Divers (http://wasagedivers.com/en/home/) to CSS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. One of the funders (Wasage Divers) provided support in the form of salaries for authors M.K., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the `author contributions' section.	Ackerman JT, 2000, ENVIRON BIOL FISH, V58, P33, DOI 10.1023/A:1007657019696; Akaike H, 1973, P 2 INT S INF THEOR, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Akinwande MO, 2015, OPEN J STAT, V5, P754, DOI DOI 10.4236/OJS.2015.57075; Anderson RC, 2011, FISH OCEANOGR, V20, P104, DOI 10.1111/j.1365-2419.2011.00571.x; Anderson RC, 1996, MAR FRESHWATER RES, V47, P605, DOI 10.1071/MF9960605; [Anonymous], 1998, CERCETARI ISTORICE, V17, P101; [Anonymous], 2014, ANN FAM MED, V12, piii; [Anonymous], 2012, EUROPEAN J NUCL MED, V39, pS493; Asut H, 2019, WORLD NEWS NATURAL S, V24, P89; Barausse A, 2014, ICES J MAR SCI, V71, P1593, DOI 10.1093/icesjms/fst222; Barnett A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036574; Baum G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138271; Bernard ATF, 2012, MAR ECOL PROG SER, V471, P235, DOI 10.3354/meps10039; Birt MJ, 2012, J EXP MAR BIOL ECOL, V416, P92, DOI 10.1016/j.jembe.2012.02.011; Bouyoucos IA, 2018, CONSERV PHYSIOL, V6, DOI 10.1093/conphys/coy053; Brinton CP, 2017, MAR FRESHWATER RES, V68, P1716, DOI 10.1071/MF16073; Brooks ME, 2017, R J, V9, P378, DOI 10.32614/RJ-2017-066; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Cartamil DP, 2003, MAR BIOL, V142, P841, DOI 10.1007/s00227-003-1014-y; Cassey P, 2006, BIOSCIENCE, V56, P958, DOI 10.1641/0006-3568(2006)56[958:RARIE]2.0.CO;2; Chin A, 2013, AQUAT CONSERV, V23, P468, DOI 10.1002/aqc.2349; Chin A, 2016, MAR ECOL PROG SER, V544, P197, DOI 10.3354/meps11545; Cinner JE, 2018, P NATL ACAD SCI USA, V115, pE6116, DOI 10.1073/pnas.1708001115; Condie SA, 2006, MAR FRESHWATER RES, V57, P569, DOI 10.1071/MF06009; Crow G.L., 2004, ELASMOBRANCH HUSBAND, V1st ed., P467; D'Croz L, 2007, ESTUAR COAST SHELF S, V73, P325, DOI 10.1016/j.ecss.2007.01.013; Dabruzzi TF, 2013, HYDROBIOLOGIA, V701, P37, DOI 10.1007/s10750-012-1249-z; Davy LE, 2015, MAR FRESHWATER RES, V66, P481, DOI 10.1071/MF14028; Eckert SA, 2001, ENVIRON BIOL FISH, V60, P299, DOI 10.1023/A:1007674716437; Ellison AM, 2010, ECOLOGY, V91, P2536, DOI 10.1890/09-0032.1; Elphick CS, 2008, J APPL ECOL, V45, P1313, DOI 10.1111/j.1365-2664.2008.01545.x; Fitzpatrick R, 2011, CORAL REEFS, V30, P569, DOI 10.1007/s00338-011-0769-8; Gill H., 2004, ELASMOBRANCHS FITZRO; Goetze JS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200960; Greenwell B, 2018, GEN BOOSTED REGRESSI; Heagney EC, 2007, MAR ECOL PROG SER, V350, P255, DOI 10.3354/meps07193; Heithaus MR, 2009, LIMNOL OCEANOGR, V54, P472, DOI 10.4319/lo.2009.54.2.0472; Heupel MR, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00012; HOPKINS TE, 1994, COPEIA, P529, DOI 10.2307/1447005; Hunter E, 2005, J MAR BIOL ASSOC UK, V85, P1199, DOI 10.1017/S0025315405012300; Hunter E, 2006, J APPL ECOL, V43, P710, DOI 10.1111/j.1365-2664.2006.01194.x; Janse M, 2010, J MAR BIOL ASSOC UK, V90, P353, DOI 10.1017/S002531540999035X; Kane C, 2014, B MAR SCI, V90, P693, DOI 10.5343/bms.2013.1053; Karl DM, 1996, DEEP-SEA RES PT II, V43, P129, DOI 10.1016/0967-0645(96)00005-7; Kilfoil JP, 2017, MAR ECOL PROG SER, V585, P113, DOI 10.3354/meps12395; Knip DM, 2011, MAR FRESHWATER RES, V62, P658, DOI 10.1071/MF10136; Last P. R., 2016, P1; MacNeil MA, 2020, NATURE; Merkel A, CLIMATE BAU BAU; Mourier J, 2013, MOL ECOL, V22, P201, DOI 10.1111/mec.12103; Nadon MO, 2012, CONSERV BIOL, V26, P493, DOI 10.1111/j.1523-1739.2012.01835.x; Papastamatiou YP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127807; Papastamatiou YP, 2009, ECOLOGY, V90, P996, DOI 10.1890/08-0491.1; Parsons GR, 1998, FISH PHYSIOL BIOCHEM, V19, P189, DOI 10.1023/A:1007730308184; Pierce SJ, 2009, J FISH BIOL, V75, P2490, DOI 10.1111/j.1095-8649.2009.02435.x; Pomilla C, 2005, BIOL LETTERS, V1, P476, DOI 10.1098/rsbl.2005.0351; REYES E, 1991, ESTUARIES, V14, P372, DOI 10.2307/1352262; Rokhim R, 2017, J ENTERP COMMUNITIES, V11, P438, DOI 10.1108/JEC-09-2015-0049; Schlaff AM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231142; Schlaff AM, 2014, REV FISH BIOL FISHER, V24, P1089, DOI 10.1007/s11160-014-9364-8; Schroeder T, 2012, MAR POLLUT BULL, V65, P210, DOI 10.1016/j.marpolbul.2012.02.022; Sellas AB, 2015, J HERED, V106, P266, DOI 10.1093/jhered/esv011; Sherman CS, 2020, MAR ECOL PROG SER, V641, P145, DOI 10.3354/meps13307; Sherman CS, 2018, J EXP MAR BIOL ECOL, V503, P80, DOI 10.1016/j.jembe.2018.03.002; Simmonds M.P., 2014, J OCEAN TECHNOL, V9, P71; Sims DW, 2006, J ANIM ECOL, V75, P176, DOI 10.1111/j.1365-2656.2005.01033.x; SMITH AFM, 1992, AM STAT, V46, P84, DOI 10.2307/2684170; Speed CW, 2012, MAR ECOL PROG SER, V463, P231, DOI 10.3354/meps09864; Stuber EF, 2013, BEHAV ECOL, V24, P1092, DOI 10.1093/beheco/art035; Taylor MD, 2013, FISH RES, V140, P96, DOI 10.1016/j.fishres.2012.12.013; Tickler DM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177374; Tjasyono H.K.B, 2008, INT S EQ MONS SYST Y; Udyawer V, 2013, MAR ECOL PROG SER, V480, P171, DOI 10.3354/meps10244; Barbosa MLV, 2016, MAR POLICY, V73, P210, DOI 10.1016/j.marpol.2016.08.007; Varkey DA, 2010, MAR POLICY, V34, P228, DOI 10.1016/j.marpol.2009.06.009; Vaudo JJ, 2009, MAR BIOL, V156, P2579, DOI 10.1007/s00227-009-1282-2; White J, 2013, J EXP MAR BIOL ECOL, V448, P281, DOI 10.1016/j.jembe.2013.08.004; White W.T., 2006, EC IMPORTANT SHARKS; Whitmarsh SK, 2017, REV FISH BIOL FISHER, V27, P53, DOI 10.1007/s11160-016-9450-1; Whitney NM, 2007, AQUAT LIVING RESOUR, V20, P299, DOI 10.1051/alr:2008006; Wolak ME, 2012, METHODS ECOL EVOL, V3, P129, DOI 10.1111/j.2041-210X.2011.00125.x; Wraith J, 2013, MAR ECOL PROG SER, V477, P189, DOI 10.3354/meps10137	82	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0244154	10.1371/journal.pone.0244154	http://dx.doi.org/10.1371/journal.pone.0244154			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332427	Green Published, Green Accepted, gold			2022-12-27	WOS:000601310900072
J	Shigetoh, H; Nishi, Y; Osumi, M; Morioka, S				Shigetoh, Hayato; Nishi, Yuki; Osumi, Michihiro; Morioka, Shu			Combined abnormal muscle activity and pain-related factors affect disability in patients with chronic low back pain: An association rule analysis	PLOS ONE			English	Article							FLEXION-RELAXATION; SURFACE-EMG; TRIAXIAL ACCELEROMETER; MUSCULOSKELETAL PAIN; PROGNOSTIC-FACTOR; JAPANESE VERSION; LUMBAR FLEXION; FEAR-AVOIDANCE; SHORT-FORM; MOVEMENT	Objectives In patients with chronic low back pain (CLBP), reduced lumbar flexion-relaxation and reduced variability of muscle activity distribution are reported as abnormal muscle activity. It is not known how abnormal muscle activity and pain-related factors are related to CLBP-based disability. Here, we performed an association rule analysis to investigated how CLBP disability, muscle activity, and pain-related factors in CLBP patients are related. Methods Surface electromyographic signals were recorded from over the bilateral lumbar erector spinae muscle with four-channel electrodes from 24 CLBP patients while they performed a trunk flexion re-extension task. We calculated the average value of muscle activities of all channels and then calculated the flexion relaxation ratio (FRR) and the spatial variability of muscle activities. We also assessed the pain-related factors and CLBP disability by a questionnaire method. A clustering association rules analysis was performed to determine the relationships among pain-related factors, the FRR, and the variability of muscle activity distribution. Results The association rules of severe CLBP disability were divisible into five classes, including 'low FRR-related rules.' The rules of the mild CLBP disability were divisible into four classes, including 'high FRR-related rules' and 'high muscle variability-related rules.' When we combined pain-related factors with the FRR and muscle variability, the relationship between abnormal FRR/muscle variability and CLBP disability became stronger. Discussion Our findings thus highlight the importance of focusing on not only the patients' pain-related factors but also the abnormal motor control associated with CLBP, which causes CLBP disability.	[Shigetoh, Hayato; Nishi, Yuki; Morioka, Shu] Kio Univ, Grad Sch Hlth Sci, Dept Neurorehabil, Koryo, Nara, Japan; [Shigetoh, Hayato] Miura Internal Med Michiko Pediat Clin, Marugame, Kagawa, Japan; [Osumi, Michihiro; Morioka, Shu] Kio Univ, Neuro Rehabil Res Ctr, Koryo, Nara, Japan		Shigetoh, H (corresponding author), Kio Univ, Grad Sch Hlth Sci, Dept Neurorehabil, Koryo, Nara, Japan.; Shigetoh, H (corresponding author), Miura Internal Med Michiko Pediat Clin, Marugame, Kagawa, Japan.	hayato.pt1121@gmail.com		Morioka, Shu/0000-0003-2853-1789; Shigetoh, Hayato/0000-0002-1290-3579				Abboud J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149076; Abboud J, 2014, EUR J APPL PHYSIOL, V114, P2645, DOI 10.1007/s00421-014-2985-8; Agrawal R., 1993, SIGMOD Record, V22, P207, DOI 10.1145/170036.170072; AHERN DK, 1988, PAIN, V34, P153, DOI 10.1016/0304-3959(88)90160-1; AHERN DK, 1990, SPINE, V15, P92, DOI 10.1097/00007632-199002000-00008; [Anonymous], 2014, Hosp Case Manag, V22, P145; [Anonymous], 2010, OFFICIAL GAZETTE REP, V5, P46; Chou R, 2010, JAMA-J AM MED ASSOC, V303, P1295, DOI 10.1001/jama.2010.344; Clarke CL, 2017, AGING CLIN EXP RES, V29, P451, DOI 10.1007/s40520-016-0604-8; Descarreaux M, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-10; Dubois JD, 2014, J ELECTROMYOGR KINES, V24, P550, DOI 10.1016/j.jelekin.2014.04.012; Dubois JD, 2011, J ELECTROMYOGR KINES, V21, P774, DOI 10.1016/j.jelekin.2011.05.004; Falla D, 2020, J ELECTROMYOGR KINES, V52, DOI 10.1016/j.jelekin.2020.102422; Falla D, 2014, PAIN, V155, P944, DOI 10.1016/j.pain.2014.01.027; Ferrari S, 2016, PAIN PRACT, V16, P1040, DOI 10.1111/papr.12397; FLOYD WF, 1955, J PHYSIOL-LONDON, V129, P184, DOI 10.1113/jphysiol.1955.sp005347; Geisser ME, 2004, CLIN J PAIN, V20, P61, DOI 10.1097/00002508-200403000-00001; Hahsler M, 2007, INTELL DATA ANAL, V11, P437, DOI 10.3233/IDA-2007-11502; Hartvigsen J, 2003, EUR SPINE J, V12, P528, DOI 10.1007/s00586-003-0542-y; Hartvigsen J, 2018, LANCET, V391, P2356, DOI 10.1016/S0140-6736(18)30480-X; Hodges PW, 2015, CLIN J PAIN, V31, P97, DOI 10.1097/AJP.0000000000000098; Hoy D, 2012, ARTHRITIS RHEUM-US, V64, P2028, DOI 10.1002/art.34347; Hoy D, 2014, ANN RHEUM DIS, V73, P968, DOI 10.1136/annrheumdis-2013-204428; Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504; Kamper SJ, 2016, BRAZ J PHYS THER, V20, P275, DOI 10.1590/bjpt-rbf.2014.0149; Karantonis DM, 2006, IEEE T INF TECHNOL B, V10, P156, DOI 10.1109/TITB.2005.856864; Kenett R, 2008, LECT NOTES ARTIF INT, V5077, P189, DOI 10.1007/978-3-540-70720-2_15; Laird RA, 2019, BMC MUSCULOSKEL DIS, V20, DOI 10.1186/s12891-018-2387-x; Marshall PWM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180788; Maruo T, 2013, PAIN RES, V28, P43, DOI 10.11154/pain.28.43; Masse-Alarie H, 2016, J ELECTROMYOGR KINES, V27, P87, DOI 10.1016/j.jelekin.2016.02.004; Meier ML, 2019, NEUROSCIENTIST, V25, P583, DOI 10.1177/1073858418809074; Neblett R, 2017, SPINE J, V17, P1819, DOI 10.1016/j.spinee.2017.06.008; Neblett R, 2013, CLIN J PAIN, V29, P334, DOI 10.1097/AJP.0b013e318267252d; Neblett R, 2010, CLIN J PAIN, V26, P403, DOI 10.1097/AJP.0b013e3181d2bd8c; Nicholas MK, 2015, J PAIN, V16, P153, DOI 10.1016/j.jpain.2014.11.002; Nishigami T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200152; Nishigami T, 2018, PAIN PRACT, V18, P170, DOI 10.1111/papr.12586; Owens EF, 2011, J MANIP PHYSIOL THER, V34, P594, DOI 10.1016/j.jmpt.2011.05.008; Pinheiro MB, 2016, SPINE J, V16, P105, DOI 10.1016/j.spinee.2015.10.037; Pouretezad Mohammad, 2018, J Phys Ther Sci, V30, P744, DOI 10.1589/jpts.30.744; Ritvanen T, 2007, J MANIP PHYSIOL THER, V30, P31, DOI 10.1016/j.jmpt.2006.11.010; Salamat S, 2017, J BODYW MOV THER, V21, P860, DOI 10.1016/j.jbmt.2017.02.005; Sanderson A, 2019, J ANAT, V234, P532, DOI 10.1111/joa.12935; SHIRADO O, 1995, AM J PHYS MED REHAB, V74, P139, DOI 10.1097/00002060-199503000-00010; Snelgrove S, 2013, CHRONIC ILLN, V9, P283, DOI 10.1177/1742395313476901; Suzukamo Yoshimi, 2003, J Orthop Sci, V8, P543, DOI 10.1007/s00776-003-0679-x; Tkachuk GA, 2012, J PAIN, V13, P970, DOI 10.1016/j.jpain.2012.07.001; TRIANO JJ, 1987, SPINE, V12, P561, DOI 10.1097/00007632-198707000-00010; van den Hoorn W, 2012, J BIOMECH, V45, P342, DOI 10.1016/j.jbiomech.2011.10.024; van Dieen JH, 2019, J ORTHOP SPORT PHYS, V49, P370, DOI 10.2519/jospt.2019.7917; van Dieen JH, 2003, J ELECTROMYOGR KINES, V13, P333, DOI 10.1016/S1050-6411(03)00041-5; VINK P, 1989, HUM MOVEMENT SCI, V8, P67, DOI 10.1016/0167-9457(89)90024-9; Vlaeyen JWS, 2000, PAIN, V85, P317, DOI 10.1016/S0304-3959(99)00242-0; Wand BM, 2014, J BACK MUSCULOSKELET, V27, P463, DOI 10.3233/BMR-140467; Watson PJ, 1997, CLIN BIOMECH, V12, P165, DOI 10.1016/S0268-0033(97)00065-X; Wertli MM, 2014, SPINE J, V14, P2639, DOI 10.1016/j.spinee.2014.03.003; Wertli MM, 2014, SPINE J, V14, P816, DOI 10.1016/j.spinee.2013.09.036; Wong AYL, 2015, SPINE, V40, P1329, DOI 10.1097/BRS.0000000000000981; Wu Y, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000017504; Xia T, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1821-1; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zwarts MJ, 2003, MUSCLE NERVE, V28, P1, DOI 10.1002/mus.10358	63	4	4	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0244111	10.1371/journal.pone.0244111	http://dx.doi.org/10.1371/journal.pone.0244111			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332431	Green Published, gold			2022-12-27	WOS:000601310900012
J	Zanetti, M; Barazzoni, R; Kiwanuka, E; Vettore, M; Vedovato, M; Tessari, P				Zanetti, Michela; Barazzoni, Rocco; Kiwanuka, Edward; Vettore, Monica; Vedovato, Monica; Tessari, Paolo			Accelerated whole-body protein catabolism in subjects with type 2 Diabetes Mellitus and albuminuria	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; AMINO-ACID-METABOLISM; STAGE RENAL-DISEASE; PHENYLALANINE HYDROXYLATION; CARDIOVASCULAR RISK; INSULIN-RESISTANCE; TYROSINE; KIDNEY; CONVERSION; LEUCINE	Background Albuminuria develops in similar to 40% of subjects with Type 2 Diabetes Mellitus (T2DM), and is often associated with malnutrition, severe comorbidities and decreased life expectancy. The association between albuminuria and altered whole body protein turnover in T2DM is currently unknown. Objective To assess whole body protein degradation and synthesis in type 2 diabetes with and without albuminuria. Methods Fourteen T2DM male subjects, with either increased [AER+] or normal [AER-] urinary albumin excretion rate, and eleven age-matched male healthy controls, were infused with phenylalanine [Phe] and tyrosine [Tyr] tracers. Post-absorptive rates of appearance (Ra) of Phe (= protein degradation) and Tyr, Phe hydroxylation to Tyr (Hy) (catabolic pathway), and Phe disposal to protein synthesis [PS], were determined. Results Phe and Tyr Ra were not different among the groups. However, in T2DM [AER+], the fraction of Phe disposal to hydroxylation was similar to 50% and similar to 25% greater than that of both controls and T2DM [AER-] (p<0.006 and p = 0.17, respectively). Conversely, as compared to controls, the fractional Phe disposal to PS was similar to 10% lower in T2DM [AER+] (p<0.006), and not different from that in T2DM [AER-]. As a consequence, in T2DM [AER+], the ratio between the fractional Phe disposal to hydroxylation and that to PS was similar to 70% greater (p = 0.005) than that in healthy controls, whereas in the T2DM [AER-] this ratio was similar to 30% greater than in controls (p = 0.19). Conclusions On the basis of the kinetics of the essential amino acid phenylalanine, T2DM subjects with increased AER exhibit a catabolic pattern of whole body protein turnover.	[Zanetti, Michela; Barazzoni, Rocco; Kiwanuka, Edward; Vettore, Monica; Vedovato, Monica; Tessari, Paolo] Univ Padua, Dept Med, Metab Div, Padua, Italy; [Zanetti, Michela; Barazzoni, Rocco] Univ Trieste, DSM, Trieste, Italy	University of Padua; University of Trieste	Zanetti, M; Tessari, P (corresponding author), Univ Padua, Dept Med, Metab Div, Padua, Italy.; Zanetti, M (corresponding author), Univ Trieste, DSM, Trieste, Italy.	zanetti@units.it; paolo.tessari@unipd.it		ZANETTI, MICHELA/0000-0002-2634-6363	2002-2003 "FIRB" Grant of the Italian Minister for University and Research Project title "Molecular mechanisms of the pathogenesis and progression of diabetic nephropathy"	2002-2003 "FIRB" Grant of the Italian Minister for University and Research Project title "Molecular mechanisms of the pathogenesis and progression of diabetic nephropathy"	PT - 2002-2003 "FIRB" Grant of the Italian Minister for University and Research Project title "Molecular mechanisms of the pathogenesis and progression of diabetic nephropathy". The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAWI J, 1990, DIABETIC MED, V7, P115, DOI 10.1111/j.1464-5491.1990.tb01344.x; Berhane AM, 2011, CLIN J AM SOC NEPHRO, V6, P2444, DOI 10.2215/CJN.00580111; BERKELHAMMER CH, 1987, AM J CLIN NUTR, V46, P778, DOI 10.1093/ajcn/46.5.778; BIOLO G, 1992, AM J PHYSIOL, V263, pE877, DOI 10.1152/ajpendo.1992.263.5.E877; BIOLO G, 1992, AM J PHYSIOL, V262, pE455, DOI 10.1152/ajpendo.1992.262.4.E455; Boirie Y, 2004, KIDNEY INT, V66, P591, DOI 10.1111/j.1523-1755.2004.00778.x; CASTELLINO P, 1992, AM J PHYSIOL, V262, pF168, DOI 10.1152/ajprenal.1992.262.2.F168; CLARKE JTR, 1982, METABOLISM, V31, P999, DOI 10.1016/0026-0495(82)90142-1; de Zeeuw D, 2007, SEMIN NEPHROL, V27, P172, DOI 10.1016/j.semnephrol.2007.01.002; DEFERRARI G, 1988, AM J CLIN NUTR, V48, P72, DOI 10.1093/ajcn/48.1.72; Giordano M, 2008, DIABETOLOGIA, V51, P21, DOI 10.1007/s00125-007-0874-y; GOODSHIP THJ, 1990, J AM SOC NEPHROL, V1, P66; Han E, 2016, METABOLISM, V65, P1531, DOI 10.1016/j.metabol.2016.07.003; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Hoffmann MR, 2016, EUR J CLIN NUTR, V70, P743, DOI 10.1038/ejcn.2015.185; HUME R, 1971, J CLIN PATHOL, V24, P234, DOI 10.1136/jcp.24.3.234; JONES MR, 1978, KIDNEY INT, V14, P169, DOI 10.1038/ki.1978.104; Karalliedde J, 2010, J AM SOC NEPHROL, V21, P2020, DOI 10.1681/ASN.2010030250; Khan SM, 2009, J RENAL NUTR, V19, P275, DOI 10.1053/j.jrn.2009.01.026; Kopple JD, 2007, J NUTR, V137, p1586S, DOI 10.1093/jn/137.6.1586S; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; LUZI L, 1993, DIABETES, V42, P1868, DOI 10.2337/diabetes.42.12.1868; Mancia G, 2005, ACTA DIABETOL, V42, pS17, DOI 10.1007/s00592-005-0177-z; Maroni BJ, 1997, J CLIN INVEST, V99, P2479, DOI 10.1172/JCI119432; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Moller N, 2000, P NATL ACAD SCI USA, V97, P1242, DOI 10.1073/pnas.97.3.1242; Pereira S, 2008, DIABETES, V57, P56, DOI 10.2337/db07-0887; Pugliese G, 2014, NUTR METAB CARDIOVAS, V24, P815, DOI 10.1016/j.numecd.2014.02.013; REAICH D, 1992, AM J PHYSIOL, V263, pE735, DOI 10.1152/ajpendo.1992.263.4.E735; REAICH D, 1993, AM J PHYSIOL, V265, pE230, DOI 10.1152/ajpendo.1993.265.2.E230; Rosenberg LE, 1980, METABOLIC CONTROL DI, P707; SCHWENK WF, 1984, ANAL BIOCHEM, V141, P101; Sun X, 2015, DIABETES RES CLIN PR, V110, pE22, DOI 10.1016/j.diabres.2015.09.012; Tessari P, 2006, DIABETOLOGIA, V49, P1955, DOI 10.1007/s00125-006-0288-2; Tessari P, 2003, AM J PHYSIOL-ENDOC M, V284, pE1037, DOI 10.1152/ajpendo.00416.2002; Tessari P, 1999, KIDNEY INT, V56, P2168, DOI 10.1038/sj.ki.4491156; Tessari P, 2015, J CLIN ENDOCR METAB, V100, P4098, DOI 10.1210/jc.2015-2172; TIZIANELLO A, 1980, AM J CLIN NUTR, V33, P1354, DOI 10.1093/ajcn/33.7.1354; Wolfe RR, 1992, RADIOACTIVE STABLE I, P62; YOUNG GA, 1973, CLIN SCI MOL MED, V45, P89, DOI 10.1042/cs0450089; Zanetti M, 2001, AM J PHYSIOL-ENDOC M, V280, pE591, DOI 10.1152/ajpendo.2001.280.4.E591	41	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243638	10.1371/journal.pone.0243638	http://dx.doi.org/10.1371/journal.pone.0243638			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332405	gold, Green Published			2022-12-27	WOS:000601310900046
J	Linda, R; Kunes, I; Balas, M				Linda, Rostislav; Kunes, Ivan; Balas, Martin			Genetic and morphometric variability between populations of Betula xoycoviensis from Poland and Czechia: A revised view of the taxonomic treatment of the Ojcow birch	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; PHYLOGENETIC-RELATIONSHIPS; EST-SSRS; INFERENCE; PROGRAM	Birches are generally known for their high genetic and morphological variability, which has resulted in the description of many species. Ojcow birch was described in 1809 by Willibald Suibert Joseph Gottlieb Besser in Poland. Since then, several studies assessing its taxonomy were conducted. Today, various authors present Ojcow birch at different taxonomic ranks. In Czechia, the Ojcow birch is classified a critically endangered taxon and confirmed at one locality consisting of several tens of individuals. However, before a strategy for its conservation can be applied, we consider it necessary to assess the taxonomic position of the endangered Czech population and to evaluate its relationship to the original Polish population. This study aimed to evaluate the morphometric and genetic variability between populations of B. xoycoviensis in Poland and the Czechia and their relationship to regional populations of B. pendula, one of the putative parental species of the Ojcow birch. Altogether, 106 individuals were sampled, including the holotype of B. szaferi, the second putative parental species of B. xoycoviensis, received from the herbarium of W. Szafer, which is deposited at the Institute of Botany in Krakow. Morphological analyses identified differences in leaves between B. xoycoviensis and B. pendula. However, no significant differences were found in genome size between selected taxa/working units except for B. pendula sampled in Czechia. The identified difference of the Czech population of B. pendula is probably caused by population variability. Genetic variability between all the taxa under comparison, regardless of their origin, was also very low; only the benchmark taxa (B. nana and B. humilis) clearly differed from all samples analyzed. The results indicate minute morphological and negligible genetic variability between the Czech and Polish populations of B. xoycoviensis. In light of our results, the classification of B. xoycoviensis as B. pendula var. oycoviensis seems more accurate than all hitherto presented alternatives (e.g. B. xoycoviensis as a separate species).	[Linda, Rostislav; Kunes, Ivan; Balas, Martin] Czech Univ Life Sci, Fac Forestry & Wood Sci, Dept Silviculture, Prague, Suchdol, Czech Republic	Czech University of Life Sciences Prague	Linda, R (corresponding author), Czech Univ Life Sci, Fac Forestry & Wood Sci, Dept Silviculture, Prague, Suchdol, Czech Republic.	lindar@fld.czu.cz		Kunes, Ivan/0000-0002-1875-384X	Technology Agency of the Czech Republic [TACR TH03030339]; Internal Grant Agency of Faculty of Forestry and Wood Sciences [A_19_24]	Technology Agency of the Czech Republic; Internal Grant Agency of Faculty of Forestry and Wood Sciences	The research activities were supported by Technology Agency of the Czech Republic: grant project No. TACR TH03030339 (Ivan Kunes.) and by Internal Grant Agency of Faculty of Forestry and Wood Sciences No. A_19_24 (Martin Balas.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaa Ahmed M, 2019, PLoS One, V14, pe0213653, DOI 10.1371/journal.pone.0213653; Anamthawat-Jonsson K, 2003, PLANT CELL TISS ORG, V75, P99, DOI 10.1023/A:1025063123552; [Anonymous], 2012, J MIDWIFERY WOM HEAL, V57, P112, DOI 10.1111/j.1542-2011.2011.00163.x; Ashburner K, 2013, GENUS BETULA TAXONOM; ATKINSON M D, 1986, Watsonia, V16, P75; Bala M, 2019, VYSKYT JEDINCU S FEN; Balas M, 2016, DENDROBIOLOGY, V76, P117, DOI 10.12657/denbio.076.011; Besser WSJG, 1809, PRIMITIAE FLORAE GAL; Biemont C, 2008, HEREDITY, V101, P297, DOI 10.1038/hdy.2008.80; DOMIN KAREL, 1927, ROZPRAVY CESKI AKAD VED A UMENI, V36, P1; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Fiek E, 1888, JAHRES BERICHT SCHLE, V65, P310; Franiel I., 2009, Fragmenta Floristica et Geobotanica Polonica, V16, P27; FURLOW JJ, 1990, J ARNOLD ARBORETUM, V71, P1; Gardiner AS, 1962, SILVAE GENET, V11, P125; GILL JA, 1983, NEW PHYTOL, V94, P433, DOI 10.1111/j.1469-8137.1983.tb03457.x; Goudet J, 1996, GENETICS, V144, P1933; Greilhuber J, 2005, ANN BOT-LONDON, V95, P255, DOI 10.1093/aob/mci019; Grimm GW, 2013, BOT J LINN SOC, V172, P465, DOI 10.1111/boj.12065; Grulich, 2017, PRIRODA, V35, P75; Hejtmanek J., 1956, Preslia, V28, P245; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jarvinen P, 2004, AM J BOT, V91, P1834, DOI 10.3732/ajb.91.11.1834; JENTYS-SZAFEROWA J, 1974, Fragmenta Floristica et Geobotanica, V20, P203; Jentys-Szaferowa J, 1921, FLORA POLSKA 2, P3; Jentys-Szaferowa J, 1967, ROCZ SEKC DENDROL PO, V2, P5; Jentys-Szaferowa J, 1928, ROCZ POL TOW DENDROL, V2, P69; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jombart T, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-94; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; Kamvar ZN, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00208; Kamvar ZN, 2014, PEERJ, V2, DOI 10.7717/peerj.281; Kaplan Z., 2019, KLI KE KVETENE ESKE; Ki Z, 2003, KVETENA ESKE REPUBLI, P36; Korczyk A., 1967, Ochrona Przyrody, V32, P133; Koutecky P, 2015, PLANT SYST EVOL, V301, P1115, DOI 10.1007/s00606-014-1153-2; Kulju KKM, 2004, MOL ECOL NOTES, V4, P471, DOI 10.1111/j.1471-8286.2004.00704.x; Linda Rostislav, 2017, Journal of Forest Science (Prague), V63, P531, DOI [10.17221/105/2017-jfs, 10.17221/105/2017-JFS]; Mallet J, 2007, ENCY BIODIVERSITY, V5, P1, DOI [10.1016/B0-12-226865-2/00261-3, DOI 10.1016/B0-12-226865-2/00261-3]; Olshanskyi I. G., 2016, Ukrayins'kyi Botanichnyi Zhurnal, V73, P401, DOI 10.15407/ukrbotj73.04.401; Otto F, 1990, Methods Cell Biol, V33, P105; Pawowska L, 1980, ACTA SOC BOT POL, V49, P311; Pritchard JK, 2000, GENETICS, V155, P945; R Development Core Team, 2009, R LANG ENV STAT COMP; Rivers M.C., 2019, EUROPEAN RED LIST TR, P60, DOI [10.2305/IUCN.CH.2019.ERL.1.en, DOI 10.2305/IUCN.CH.2019.ERL.1.EN]; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rutkowski L, 2018, KLUCZ OZNACZANIA ROL; Schenk MF, 2008, TREE GENET GENOMES, V4, P911, DOI 10.1007/s11295-008-0162-0; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shaw K, 2014, BETULACEAE; Siegel S., 1988, NONPARAMETRIC STAT B; STASZKIEWICZ J, 1986, ACTA SOC BOT POL, V55, P361, DOI 10.5586/asbp.1986.033; Staszkiewicz J, 1985, CHROMY PRZYR OJCZYST, V41, P36; Staszkiewicz J, 1992, VEROFFENTLICHUNGEN G, V107, P94; Staszkiewicz J, 2013, BRZOZA OJCOWSKA BETU; Suda J, 2010, PRESLIA, V82, P1; Sykora T, 1983, ZPR CS BOT SPOLEC, V18, P1; SZWABOWICZ A, 1976, Acta Societatis Botanicorum Poloniae, V45, P169, DOI 10.5586/4970; Thorsson AETH, 2007, ANN BOT-LONDON, V99, P1183, DOI 10.1093/aob/mcm060; Tsuda Y, 2009, CONSERV GENET, V10, P1385, DOI 10.1007/s10592-008-9701-3; Tsuda Y, 2009, CONSERV GENET, V10, P661, DOI 10.1007/s10592-008-9608-z; Vaut RJ, 2019, KLI KE KVETENE ESKE, P1172; Wickham H., 2016, GGPLOT2 ELEGANT GRAP, DOI 10.1007/978-3-319-24277-4; Willdenow CL, 1805, CAROLI LINNE SPECIES, P1805, DOI [10.5962/bhl.title.727, DOI 10.5962/BHL.TITLE.727]; WRIGHT S, 1950, NATURE, V166, P247, DOI 10.1038/166247a0; Zachos FE., 2016, SPECIES CONCEPTS BIO	69	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243310	10.1371/journal.pone.0243310	http://dx.doi.org/10.1371/journal.pone.0243310			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326473	gold, Green Published			2022-12-27	WOS:000600176400006
J	Ognibene, M; Pezzolo, A				Ognibene, Marzia; Pezzolo, Annalisa			Ezrin interacts with the tumor suppressor CHL1 and promotes neuronal differentiation of human neuroblastoma	PLOS ONE			English	Article							ERM PROTEINS; MESENCHYMAL TRANSITION; ACTIVATION; PATTERN; GROWTH; MAP2	In a previous study, we demonstrated that CHL1, the neuronal cell adhesion molecule close homolog of L1, acts as a tumor suppressor in human neuroblastoma (NB), a still highly lethal childhood malignancy, influencing its differentiation and proliferation degree. Here we found that ezrin, one of the ERM (ezrin, radixin, moesin) proteins involved in cytoskeleton organization, strongly interacts with CHL1. The low expression of EZRIN, as well as the low expression of CHL1 and of the neuronal differentiation marker MAP2, correlates with poor outcome in NB patients. Knock-down of ezrin in HTLA-230 cell line induces neurite retraction, enhances cell proliferation and migration, and triggers anchorage-independent growth, with effects very similar to those already obtained by CHL1 silencing. Furthermore, lack of ezrin inhibits the expression of MAP2 and of the oncosuppressor molecule p53, whereas it enhances MAPK activation, all typical features of tumor aggressiveness. As already described, CHL1 overexpression in IMR-32 cell line provokes an opposite trend, but the co-silencing of ezrin reduces these effects, confirming the hypothesis that CHL1 acts in close connection with ezrin. Overall, our data show that ezrin reinforces the differentiating and oncosuppressive functions of CHL1, identifying this ERM protein as a new targetable molecule for NB therapy.	[Ognibene, Marzia] IRCCS Ist Giannina Gaslini, UOC Genet Med, Genoa, Italy; [Pezzolo, Annalisa] IRCCS Ist Giannina Gaslini, Lab Cellule Staminali Post Natali & Terapie Cellu, Genoa, Italy	University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini	Ognibene, M (corresponding author), IRCCS Ist Giannina Gaslini, UOC Genet Med, Genoa, Italy.	marziaognibene@gaslini.org	Ognibene, Marzia/AAA-7275-2020	Ognibene, Marzia/0000-0003-3698-9319	Compagnia San Paolo [ROL 20207]; Italian Ministry of Health [MSALRC18]	Compagnia San Paolo(Compagnia di San Paolo); Italian Ministry of Health(Ministry of Health, Italy)	This research was funded by Compagnia San Paolo (ID ROL 20207) (AP) and by Finanziamento Ricerca Corrente 2018, Italian Ministry of Health (MSALRC18) (AP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson G, 2014, BMC UROL, V14, DOI 10.1186/1471-2490-14-36; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; BRODEUR GM, 1993, J CLIN ONCOL, V11, P1466, DOI 10.1200/JCO.1993.11.8.1466; Brooks CL, 2010, CELL RES, V20, P614, DOI 10.1038/cr.2010.53; Cheung NKV, 2013, NAT REV CANCER, V13, P397, DOI 10.1038/nrc3526; Culmsee C, 2001, J NEUROCHEM, V77, P220, DOI 10.1046/j.1471-4159.2001.00220.x; Depuydt P, 2018, JNCI-J NATL CANCER I, V110, DOI 10.1093/jnci/djy022; Dickson TC, 2002, J CELL BIOL, V157, P1105, DOI 10.1083/jcb.200111076; Guo JC, 2017, J MOL MED, V95, P1355, DOI 10.1007/s00109-017-1595-4; Haas MA, 2007, J NEUROSCI RES, V85, P34, DOI 10.1002/jnr.21102; He J, 2017, MED SCI MONITOR, V23, P1583, DOI 10.12659/MSM.904124; IZANT JG, 1980, P NATL ACAD SCI-BIOL, V77, P4741, DOI 10.1073/pnas.77.8.4741; Janoueix-Lerosey I, 2009, J CLIN ONCOL, V27, P1026, DOI 10.1200/JCO.2008.16.0630; Katic J, 2014, J NEUROSCI, V34, P14606, DOI 10.1523/JNEUROSCI.3280-13.2014; Lane J, 2012, ENRICH COMMUN, V6; Li JW, 2015, SCI REP-UK, V5, DOI 10.1038/srep17903; Liu P, 2018, MED SCI MONITOR, V24, P2098, DOI 10.12659/MSM.906945; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Matsumoto Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105435; MATSUSHIMA H, 1992, INT J CANCER, V51, P250, DOI 10.1002/ijc.2910510214; Matthay KK, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.78; McMullen ME, 2005, J BIOL CHEM, V280, P20995, DOI 10.1074/jbc.M407060200; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Ognibene M, 2020, CANCER BIOL THER, V21, P391, DOI 10.1080/15384047.2019.1704122; Ognibene M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20194764; Ognibene Marzia, 2018, Oncotarget, V9, P25903, DOI 10.18632/oncotarget.25403; Ognibene M, 2011, J BIOL CHEM, V286, P29973, DOI 10.1074/jbc.M111.270785; Oh JE, 2006, AMINO ACIDS, V31, P289, DOI 10.1007/s00726-005-0256-z; Quang CT, 2000, EMBO J, V19, P4565, DOI 10.1093/emboj/19.17.4565; Riecken LB, 2015, HUM MUTAT, V36, P270, DOI 10.1002/humu.22737; Sanchez C, 2000, PROG NEUROBIOL, V61, P133, DOI 10.1016/S0301-0082(99)00046-5; Schlatter MC, 2008, J NEUROCHEM, V104, P731, DOI 10.1111/j.1471-4159.2007.05013.x; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Tolbert VP, 2018, CELL TISSUE RES, V372, P195, DOI 10.1007/s00441-018-2821-2; TURUNEN O, 1994, J CELL BIOL, V126, P1445, DOI 10.1083/jcb.126.6.1445; Valentijn LJ, 2012, P NATL ACAD SCI USA, V109, P19190, DOI 10.1073/pnas.1208215109; Wachowiak R, 2019, OPEN MED-WARSAW, V14, P920, DOI 10.1515/med-2019-0109; Wennersten C, 2014, DIAGN PATHOL, V9, DOI 10.1186/s13000-014-0189-5; Zhang WW, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0581-9	40	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0244069	10.1371/journal.pone.0244069	http://dx.doi.org/10.1371/journal.pone.0244069			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326488	Green Published, gold			2022-12-27	WOS:000600176400020
J	Freitas, DA; Souza-Santos, R; Carvalho, LMA; Barros, WB; Neves, LM; Brasil, P; Wakimoto, MD				Freitas, Danielle A.; Souza-Santos, Reinaldo; Carvalho, Liege M. A.; Barros, Wagner B.; Neves, Luiza M.; Brasil, Patricia; Wakimoto, Mayumi D.			Congenital Zika syndrome: A systematic review	PLOS ONE			English	Article							VIRUS-INFECTION; BRAZIL; TRANSMISSION; CHIKUNGUNYA; OUTBREAK; INFANTS; DENGUE	Background The signs and symptoms of Zika virus infection are usually mild and self-limited. However, the disease has been linked to neurological complications such as Guillain-Barre syndrome and peripheral nerve involvement, and also to abortion and fetal deaths due to vertical transmission, resulting in various congenital malformations in newborns, including microcephaly. This review aimed to describe the o signs and symptoms that characterize the congenital Zika syndrome. Methods and findings A systematic review was performed with a protocol and described according to the recommendations of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. The search strategy yielded 2,048 studies. After the exclusion of duplicates and application of inclusion criteria, 46 studies were included. The main signs and symptoms associated with the congenital Zika syndrome were microcephaly, parenchymal or cerebellar calcifications, ventriculomegaly, central nervous system hypoplasia or atrophy, arthrogryposis, ocular findings in the posterior and anterior segments, abnormal visual function and low birthweight for gestational age. Conclusions Zika virus infection during pregnancy can cause a series of changes in the growth and development of children, while impacting the healthcare system due to the severity of cases. Our findings outline the disease profile in newborns and infants and may contribute to the development and updating of more specific clinical protocols.	[Freitas, Danielle A.; Souza-Santos, Reinaldo] Fundacao Oswaldo Cruz, Natl Sch Publ Hlth, Rio De Janeiro, RJ, Brazil; [Carvalho, Liege M. A.; Barros, Wagner B.; Brasil, Patricia; Wakimoto, Mayumi D.] Fundacao Oswaldo Cruz, Evandro Chagas Natl Inst Infect Dis, Rio De Janeiro, RJ, Brazil; [Neves, Luiza M.] Fundacao Oswaldo Cruz, Fernandes Figueira Inst, Rio De Janeiro, RJ, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Freitas, DA; Souza-Santos, R (corresponding author), Fundacao Oswaldo Cruz, Natl Sch Publ Hlth, Rio De Janeiro, RJ, Brazil.; Wakimoto, MD (corresponding author), Fundacao Oswaldo Cruz, Evandro Chagas Natl Inst Infect Dis, Rio De Janeiro, RJ, Brazil.	dafufrj@gmail.com; rssantos@ensp.fiocruz.br; mayumidw@gmail.com	Brasil, Patricia/P-3536-2014	Amaral de Freitas, Danielle/0000-0002-5460-8316; Brasil, Patricia/0000-0001-9555-7976	Coordination for the Improvement of Higher Education Personnel (CAPES)	Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	We are grateful for support from the Coordination for the Improvement of Higher Education Personnel (CAPES).	Abbasi Aziz-un-Nisa, 2016, J Ayub Med Coll Abbottabad, V28, P1; Al BDF, 2011, EMERGING INFECT DIS, V17; Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.3201/eid2206.160062, 10.32032/eid2206.160062]; Bastos LFCS, 2016, OPAS OMS BRASIL OMS; Braga JU, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179725; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636; Brito C, 2015, ACTA MEDICA PORT, V28, P679; Coelho AVC, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081714; Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167; Counotte Michel Jacques, 2018, F1000Res, V7, P196, DOI 10.12688/f1000research.13704.1; de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8; de Paula Freitas Bruno, 2016, JAMA Ophthalmol, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267; de Souza WV, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00017216; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824; Duarte G, 2017, REV BRAS GINECOL OBS, V39, P235, DOI 10.1055/s-0037-1603450; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Egger M., 2009, SYSTEMATIC REV HLTH; Faluyi U, 2016, AM SCI RES J ENG TEC, V24, P151; da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703; Galvao TF, 2015, EPIDEMIOL SERV SAUDE, V24, DOI [10.5123/S1679-49742015000200017, DOI 10.5123/S1679-49742015000200017]; Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894; Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1; Higgins JPT, 2019, COCHRANE HDB SYSTEMA; Johnson AJ, 2000, J CLIN MICROBIOL, V38, P1827, DOI 10.1128/JCM.38.5.1827-1831.2000; Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2; Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203; Lannuzel A, 2019, NEUROLOGY, V92, pE2406, DOI 10.1212/WNL.0000000000007536; MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1; MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411; Marinho F, 2016, EPIDEMIOL SERV SAUDE, V25, P701, DOI [10.5123/S1679-49742016000400004, 10.5123/s1679-49742016000400004]; Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2; Microcephaly Epidemic Research Group, 2016, EMERGING INFECT DIS, V22; Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115; Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707; Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15; Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363; Nishiura H, 2016, INT J INFECT DIS, V45, P95, DOI 10.1016/j.ijid.2016.02.017; Nithiyanantham SF, 2019, CAN J PUBLIC HEALTH, V110, P638, DOI 10.17269/s41997-019-00215-2; Oehler E, 2014, Euro Surveill, V19; PAHO, 2015, EP AL NEUR SYNDR CON; Robinson N, 2018, REV MED VIROL, V28, DOI 10.1002/rmv.1985; Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P177, DOI 10.1016/j.tmaid.2016.05.004; SMITHBURN KC, 1951, P SOC EXP BIOL MED, V77, P130, DOI 10.3181/00379727-77-18700; Update Russell K., 2016, MMWR-MORBID MORTAL W, P65, DOI [10.15585/mmwr.mm6533e2, DOI 10.15585/MMWR.MM6533E2]; Ventura C, 2016, OPHTHALMOLOGICA, V236, P33; Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002; WHO, 2019, ZIK VIR; WHO, 2016, DIR GEN OMS RES RES; Wilder-Smith A, 2018, J TRAVEL MED, V25, DOI DOI 10.1093/JTM/TAY044; Ximenes RAD, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007763	52	28	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0242367	10.1371/journal.pone.0242367	http://dx.doi.org/10.1371/journal.pone.0242367			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320867	Green Published, gold			2022-12-27	WOS:000600339800021
J	Akerlund, CA; Donnelly, J; Zeiler, FA; Helbok, R; Holst, A; Cabeleira, M; Guiza, F; Meyfroidt, G; Czosnyka, M; Smielewski, P; Stocchetti, N; Ercole, A; Nelson, DW				AI Akerlund, Cecilia; Donnelly, Joseph; Zeiler, Frederick A.; Helbok, Raimund; Holst, Anders; Cabeleira, Manuel; Guiza, Fabian; Meyfroidt, Geert; Czosnyka, Marek; Smielewski, Peter; Stocchetti, Nino; Ercole, Ari; Nelson, David W.		CENTER TBI High	Impact of duration and magnitude of raised intracranial pressure on outcome after severe traumatic brain injury: A CENTER-TBI high-resolution group study	PLOS ONE			English	Article							CEREBRAL PERFUSION-PRESSURE; THRESHOLDS; HYPERTENSION; REACTIVITY; BURDEN; CARE	Magnitude of intracranial pressure (ICP) elevations and their duration have been associated with worse outcomes in patients with traumatic brain injuries (TBI), however published thresholds for injury vary and uncertainty about these levels has received relatively little attention. In this study, we have analyzed high-resolution ICP monitoring data in 227 adult patients in the CENTER-TBI dataset. Our aim was to identify thresholds of ICP intensity and duration associated with worse outcome, and to evaluate the uncertainty in any such thresholds. We present ICP intensity and duration plots to visualize the relationship between ICP events and outcome. We also introduced a novel bootstrap technique to evaluate uncertainty of the equipoise line. We found that an intensity threshold of 18 +/- 4 mmHg (2 standard deviations) was associated with worse outcomes in this cohort. In contrast, the uncertainty in what duration is associated with harm was larger, and safe durations were found to be population dependent. The pressure and time dose (PTD) was also calculated as area under the curve above thresholds of ICP. A relationship between PTD and mortality could be established, as well as for unfavourable outcome. This relationship remained valid for mortality but not unfavourable outcome after adjusting for IMPACT core variables and maximum therapy intensity level. Importantly, during periods of impaired autoregulation (defined as pressure reactivity index (PRx)>0.3) ICP events were associated with worse outcomes for nearly all durations and ICP levels in this cohort and there was a stronger relationship between outcome and PTD. Whilst caution should be exercised in ascribing causation in observational analyses, these results suggest intracranial hypertension is poorly tolerated in the presence of impaired autoregulation. ICP level guidelines may need to be revised in the future taking into account cerebrovascular autoregulation status considered jointly with ICP levels.	[AI Akerlund, Cecilia; Nelson, David W.] Karolinska Inst, Dept Physiol & Pharmacol, Sect Perioperat Med & Intens Care, Stockholm, Sweden; [AI Akerlund, Cecilia; Holst, Anders] KTH Royal Inst Technol, Sch Comp Sci & Commun, Stockholm, Sweden; [Donnelly, Joseph; Cabeleira, Manuel; Czosnyka, Marek; Smielewski, Peter] Univ Cambridge, Clin Neurosci, Cambridge, England; [Zeiler, Frederick A.] Univ Manitoba, Sect Neurosurg, Dept Surg, Rady Fac Hlth Sci, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Manitoba, Dept Anat & Cell Sci, Rady Fac Hlth Sci, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Manitoba, Biomed Engn, Fac Engn, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Manitoba, Ctr Aging, Winnipeg, MB, Canada; [Zeiler, Frederick A.; Ercole, Ari] Univ Cambridge, Div Anaesthesia, Cambridge, England; [Helbok, Raimund] Med Univ Innsbruck, Neurol Intens Care Unit, Dept Neurol, Innsbruck, Austria; [Guiza, Fabian; Meyfroidt, Geert] Univ Hosp Leuven, Dept & Lab Intens Care Med, Leuven, Belgium; [Guiza, Fabian; Meyfroidt, Geert] Katholieke Univ Leuven, Leuven, Belgium; [Czosnyka, Marek] Warsaw Univ Technolol, Inst Elect Syst, Warsaw, Poland; [Stocchetti, Nino] Univ Milan, Dept Pathophysiol & Transplants, Milan, Italy; [Stocchetti, Nino] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Neurosci Intens Care Unit, Milan, Italy	Karolinska Institutet; Royal Institute of Technology; University of Cambridge; University of Manitoba; University of Manitoba; University of Manitoba; University of Manitoba; University of Cambridge; Medical University of Innsbruck; KU Leuven; University Hospital Leuven; KU Leuven; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico	Akerlund, CA (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Sect Perioperat Med & Intens Care, Stockholm, Sweden.; Akerlund, CA (corresponding author), KTH Royal Inst Technol, Sch Comp Sci & Commun, Stockholm, Sweden.	cecilia.akerlund@sll.se	Ercole, Ari/B-6288-2009	Ercole, Ari/0000-0001-8350-8093; Nelson, David/0000-0003-2530-8207; Meyfroidt, Geert/0000-0003-4259-3935; Zeiler, Frederick/0000-0003-1737-0510; Smielewski, Peter/0000-0001-5096-3938	European Union 7th Framework program (EC) [602150]; Hannelore Kohl Stiftung (Germany); OneMind (USA); Integra LifeSciences Corporation (USA); Manitoba Public Insurance (MPI) Neuroscience/TBI Research Endowment; Health Sciences Centre Foundation Winnipeg; United States National Institutes of Health (NIH) through the National Institute of Neurological Disorders and Stroke (NINDS); Canadian Institutes for Health Research (CIHR); Canadian Foundation for Innovation (CFI); University of Manitoba Centre on Aging; University of Manitoba VPRI Research Investment Fund (RIF); University of Manitoba Rudy Falk Clinician-Scientist Professorship; Stockholm City Council; Integra LifeSciences	European Union 7th Framework program (EC); Hannelore Kohl Stiftung (Germany); OneMind (USA); Integra LifeSciences Corporation (USA); Manitoba Public Insurance (MPI) Neuroscience/TBI Research Endowment; Health Sciences Centre Foundation Winnipeg; United States National Institutes of Health (NIH) through the National Institute of Neurological Disorders and Stroke (NINDS); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); University of Manitoba Centre on Aging; University of Manitoba VPRI Research Investment Fund (RIF); University of Manitoba Rudy Falk Clinician-Scientist Professorship; Stockholm City Council; Integra LifeSciences	Data used in preparation of this manuscript were obtained in the context of CENTER-TBI, a large collaborative project with the support of the European Union 7th Framework program (EC grant 602150). Additional funding was obtained from the Hannelore Kohl Stiftung (Germany), from OneMind (USA) and from Integra LifeSciences Corporation (USA). FAZ receives research support from the Manitoba Public Insurance (MPI) Neuroscience/TBI Research Endowment, the Health Sciences Centre Foundation Winnipeg, the United States National Institutes of Health (NIH) through the National Institute of Neurological Disorders and Stroke (NINDS), the Canadian Institutes for Health Research (CIHR), the Canadian Foundation for Innovation (CFI), the University of Manitoba Centre on Aging, the University of Manitoba VPRI Research Investment Fund (RIF), and the University of Manitoba Rudy Falk Clinician-Scientist Professorship. DN has also been funded by the Regional Research Agreement (ALF) with Stockholm City Council. Integra LifeSciences provided financial support in respect to data curation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams H, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002353; Aiolfi A, 2017, WORLD J SURG, V41, P1543, DOI 10.1007/s00268-017-3898-6; [Anonymous], 2019, PRESSURE REACTIVITY; Carney N, 2016, NEUROSURGERY, DOI [10.1227/NEU.0000000000001432, DOI 10.1227/NEU.0000000000001432]; CENTER-TBI, CTR TBI ETH APPR; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Donnelly J, 2020, BRIT J ANAESTHESIA; Donnelly J, 2017, CRIT CARE MED, V45, P1464, DOI 10.1097/CCM.0000000000002575; Farahvar A, 2012, J NEUROSURG, V117, P729, DOI 10.3171/2012.7.JNS111816; Guiza F, 2015, INTENS CARE MED, V41, P1067, DOI 10.1007/s00134-015-3806-1; Helbok R, 2018, INTENS CARE MED, V44, P1318, DOI 10.1007/s00134-018-5249-y; Hemphill JC, 2005, PHYSIOL MEAS, V26, P373, DOI 10.1088/0967-3334/26/4/004; Kahraman S, 2010, J TRAUMA, V69, P110, DOI 10.1097/TA.0b013e3181c99853; Lazaridis C, 2014, J NEUROSURG, V120, P893, DOI 10.3171/2014.1.JNS131292; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Maas AIR, 2011, J NEUROTRAUM, V28, P177, DOI 10.1089/neu.2010.1617; Magni F, 2015, STROKE, V46, P2464, DOI 10.1161/STROKEAHA.115.010219; McFadyen CA, 2021, J NEUROTRAUM, V38, P1124, DOI 10.1089/neu.2018.6052; Nourallah B, 2018, ACTA NEUROCHIR, V160, P1315, DOI 10.1007/s00701-018-3555-3; R Core Team, 2018, R LANG ENV STAT COMP; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Sheth KN, 2013, NEUROCRIT CARE, V18, P26, DOI 10.1007/s12028-012-9780-3; Smith M, 2019, INTENS CARE MED, V45, P1819, DOI 10.1007/s00134-019-05818-4; Society for Endocrinology MaDoSAS, 2017, J ENDOCRINOL METAB D, V21, pS1; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Steyerberg EW, 2008, PREDICTING OUTCOME T; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678; Zacchetti L, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1137-9; Zanier ER, 2007, CRIT CARE, V11, DOI 10.1186/cc5155; Zeiler FA, 2020, J NEUROTRAUM, V37, P1306, DOI 10.1089/neu.2019.6726; Zeiler FA, 2018, J NEUROTRAUM, V35, P1107, DOI 10.1089/neu.2017.5472	36	24	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243427	10.1371/journal.pone.0243427	http://dx.doi.org/10.1371/journal.pone.0243427			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315872	Green Submitted, gold, Green Published			2022-12-27	WOS:000600186100002
J	Lenz, M; Schulz, A; Koeck, T; Rapp, S; Nagler, M; Sauer, M; Eggebrecht, L; Ten Cate, V; Panova-Noeva, M; Prochaska, JH; Lackner, KJ; Munzel, T; Leineweber, K; Wild, PS; Andrade-Navarro, MA				Lenz, Michael; Schulz, Andreas; Koeck, Thomas; Rapp, Steffen; Nagler, Markus; Sauer, Madeleine; Eggebrecht, Lisa; Ten Cate, Vincent; Panova-Noeva, Marina; Prochaska, Juergen H.; Lackner, Karl J.; Muenzel, Thomas; Leineweber, Kirsten; Wild, Philipp S.; Andrade-Navarro, Miguel A.			Missing value imputation in proximity extension assay-based targeted proteomics data	PLOS ONE			English	Article								Targeted proteomics utilizing antibody-based proximity extension assays provides sensitive and highly specific quantifications of plasma protein levels. Multivariate analysis of this data is hampered by frequent missing values (random or left censored), calling for imputation approaches. While appropriate missing-value imputation methods exist, benchmarks of their performance in targeted proteomics data are lacking. Here, we assessed the performance of two methods for imputation of values missing completely at random, the previously top-benchmarked 'missForest' and the recently published 'GSimp' method. Evaluation was accomplished by comparing imputed with remeasured relative concentrations of 91 inflammation related circulating proteins in 86 samples from a cohort of 645 patients with venous thromboembolism. The median Pearson correlation between imputed and remeasured protein expression values was 69.0% for missForest and 71.6% for GSimp (p = 5.8e-4). Imputation with missForest resulted in stronger reduction of variance compared to GSimp (median relative variance of 25.3% vs. 68.6%, p = 2.4e-16) and undesired larger bias in downstream analyses. Irrespective of the imputation method used, the 91 imputed proteins revealed large variations in imputation accuracy, driven by differences in signal to noise ratio and information overlap between proteins. In summary, GSimp outperformed missForest, while both methods show good overall imputation accuracy with large variations between proteins.	[Lenz, Michael; Andrade-Navarro, Miguel A.] Johannes Gutenberg Univ Mainz, Inst Organism & Mol Evolut, Mainz, Germany; [Lenz, Michael; Schulz, Andreas; Koeck, Thomas; Rapp, Steffen; Nagler, Markus; Eggebrecht, Lisa; Ten Cate, Vincent; Panova-Noeva, Marina; Prochaska, Juergen H.; Wild, Philipp S.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Ctr Cardiol, Prevent Cardiol & Prevent Med, Mainz, Germany; [Koeck, Thomas; Rapp, Steffen; Panova-Noeva, Marina; Prochaska, Juergen H.; Muenzel, Thomas; Wild, Philipp S.] German Ctr Cardiovasc Res DZHK, Partner Site Rhine Main, Mainz, Germany; [Sauer, Madeleine; Leineweber, Kirsten] Bayer AG, Dis Genom, Wuppertal, Germany; [Eggebrecht, Lisa; Ten Cate, Vincent; Panova-Noeva, Marina; Prochaska, Juergen H.; Wild, Philipp S.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Ctr Thrombosis & Hemostasis, Mainz, Germany; [Lackner, Karl J.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Clin Chem & Lab Med, Mainz, Germany; [Muenzel, Thomas] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Ctr Cardiol, Cardiol 1, Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; German Centre for Cardiovascular Research; Bayer AG; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Lenz, M (corresponding author), Johannes Gutenberg Univ Mainz, Inst Organism & Mol Evolut, Mainz, Germany.; Lenz, M (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Ctr Cardiol, Prevent Cardiol & Prevent Med, Mainz, Germany.	michael.l.lenz@gmail.com	Panova-Noeva, Marina/AAJ-1478-2020; Cate, Vincent Ten/AAS-7189-2021; Lenz, Michael/J-4401-2016	Prochaska, Jurgen/0000-0001-5078-9992; Wild, Philipp/0000-0003-4413-9752; Lenz, Michael/0000-0002-6319-6480	German Federal Ministry of Education and Research [BMBF 01EO1003]; internal funds of the Clinical Epidemiology; Center for Thrombosis 676 and Hemostasis Mainz; Bayer AG	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); internal funds of the Clinical Epidemiology; Center for Thrombosis 676 and Hemostasis Mainz; Bayer AG(Bayer AG)	The GMP-VTE project, on which this study is based, was funded by the German Federal Ministry of Education and Research (BMBF 01EO1003), internal funds of the Clinical Epidemiology, Center for Thrombosis 676 and Hemostasis Mainz and a grant from Bayer AG. The funder (Bayer AG) provided support in the form of salaries for authors M.S. and K.L., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; Enders CK, 2001, STRUCT EQU MODELING, V8, P128, DOI 10.1207/S15328007SEM0801_7; Frank B, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008157; He TL, 2019, PROTEOM CLIN APPL, V13, DOI 10.1002/prca.201800198; Hughes RA, 2019, INT J EPIDEMIOL, V48, P1294, DOI 10.1093/ije/dyz032; Kokla M, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-3110-0; Konstantinides SV, 2016, J THROMB THROMBOLYS, V42, P600, DOI 10.1007/s11239-016-1415-7; Leys C, 2019, INT REV SOC PSYCHOL, V32, DOI 10.5334/irsp.289; Lundberg M, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr424; Pedersen AB, 2017, CLIN EPIDEMIOL, V9, P157, DOI 10.2147/CLEP.S129785; Stekhoven D.J, 2013, MISSFOREST NONPARAME; Stekhoven DJ, 2012, BIOINFORMATICS, V28, P112, DOI 10.1093/bioinformatics/btr597; Ten Cate V, 2019, THROMB RES, V181, P84, DOI 10.1016/j.thromres.2019.07.019; Tromp J, 2018, EUR HEART J, V39, P4269, DOI 10.1093/eurheartj/ehy712; Waljee AK, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002847; Webb-Robertson BJM, 2015, J PROTEOME RES, V14, P1993, DOI 10.1021/pr501138h; Wei RM, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1005973; Wei RM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-19120-0	19	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243487	10.1371/journal.pone.0243487	http://dx.doi.org/10.1371/journal.pone.0243487			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315883	gold, Green Published			2022-12-27	WOS:000600186100045
J	Kalia, V; Knauft, K; Hayatbini, N				Kalia, Vrinda; Knauft, Katherine; Hayatbini, Niki			Cognitive flexibility and perceived threat from COVID-19 mediate the relationship between childhood maltreatment and state anxiety	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; AMYGDALA REACTIVITY; EMOTION REGULATION; EXPERIENCES; ADVERSITY; STRESS; TRAUMA; RISK; LIFE; ATTENTION	Converging empirical evidence indicates that exposure to adversity in childhood is associated with increased vulnerability to mental health problems in adulthood. As early life adversity has the potential to alter an individual's appraisal of threat, we hypothesized that individuals exposed to adversity in childhood may also exhibit increased threat from environmental stressors, which in turn may impact their state anxiety levels. We examined the relations between adverse childhood experiences, assessed using the Adverse Childhood Experiences Scale (ACEs), perceived threat from COVID-19, and state anxiety in a sample of adults. Additionally, flexibility is implicated in adaptive coping with life's stressors so we also assessed participants' cognitive flexibility. Parallel mediation regression analyses revealed that both perceived threat from COVID-19 and flexibility in the appraisal of challenges mediated the influence of maltreatment, but not household dysfunction, on state anxiety. Our data indicate that experience with early life adversity in the form of maltreatment is associated with increased perceived threat from COVID-19, which results in higher anxiety levels for the individual. In contrast, childhood maltreatment is associated with reduced flexibility in appraising challenges, which in turn mediates the relationship between maltreatment and anxiety. The findings of this study adds to the limited literature on the impact of early life adversity on cognitive flexibility and highlights the psychological toll of COVID-19 on individuals who have been exposed to adverse childhood experiences.	[Kalia, Vrinda; Knauft, Katherine; Hayatbini, Niki] Miami Univ, Psychol Dept, Oxford, OH 45056 USA	University System of Ohio; Miami University	Kalia, V (corresponding author), Miami Univ, Psychol Dept, Oxford, OH 45056 USA.	kaliav@miamioh.edu		Kalia, Vrinda/0000-0001-6667-9659				Aldao A, 2010, CLIN PSYCHOL REV, V30, P217, DOI 10.1016/j.cpr.2009.11.004; Anda RF, 2006, EUR ARCH PSY CLIN N, V256, P174, DOI 10.1007/s00406-005-0624-4; Anda RF, 2008, AM J PREV MED, V34, P396, DOI 10.1016/j.amepre.2008.02.002; Anda RF, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-106; Andersen BL, 2004, J CLIN ONCOL, V22, P3570, DOI 10.1200/JCO.2004.06.030; [Anonymous], 2010, LANCET INFECT DIS, V10, P139, DOI 10.1016/S1473-3099(10)70033-5; [Anonymous], 2009, CHINESE J ENV SCI, V29, P496; [Anonymous], 2017, LANCET HIV, V2, pe115; [Anonymous], 2020, BMC PEDIATR, V20, P1, DOI DOI 10.1016/J.CLAE.2020.04.011; Beversdorf DQ, 1999, NEUROREPORT, V10, P2763, DOI 10.1097/00001756-199909090-00012; Blair C, 2012, AM PSYCHOL, V67, P309, DOI 10.1037/a0027493; Bonanno GA, 2004, AM PSYCHOL, V59, P20, DOI 10.1037/0003-066X.59.1.20; Bonanno GA, 2013, PERSPECT PSYCHOL SCI, V8, P591, DOI 10.1177/1745691613504116; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Canton-Cortes D, 2019, CHILD ABUSE NEGLECT, V97, DOI 10.1016/j.chiabu.2019.104148; Chapman DP, 2004, J AFFECT DISORDERS, V82, P217, DOI 10.1016/j.jad.2003.12.013; Cheng C, 2001, J PERS SOC PSYCHOL, V80, P814, DOI 10.1037//3415.80.5.814; Clark DA, 2010, TRENDS COGN SCI, V14, P418, DOI 10.1016/j.tics.2010.06.007; Curtiss G, 1993, WISCONSIN CARD SORTI; Dajani DR, 2015, TRENDS NEUROSCI, V38, P571, DOI 10.1016/j.tins.2015.07.003; Danese A, 2012, PHYSIOL BEHAV, V106, P29, DOI 10.1016/j.physbeh.2011.08.019; Dennis JP, 2010, COGNITIVE THER RES, V34, P241, DOI 10.1007/s10608-009-9276-4; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Edmiston EK, 2013, PSYCHIAT RES-NEUROIM, V212, P36, DOI 10.1016/j.pscychresns.2012.11.009; Edwards VJ, 2003, AM J PSYCHIAT, V160, P1453, DOI 10.1176/appi.ajp.160.8.1453; Evans GW, 2013, CHILD DEV PERSPECT, V7, P43, DOI 10.1111/cdep.12013; Genet JJ, 2011, COGNITION EMOTION, V25, P380, DOI 10.1080/02699931.2010.491647; Glaser JP, 2006, J PSYCHOSOM RES, V61, P229, DOI 10.1016/j.jpsychores.2006.04.014; Grupe DW, 2013, NAT REV NEUROSCI, V14, P488, DOI 10.1038/nrn3524; Hald OH, 1998, INVERSE PROBL, V14, P245, DOI 10.1088/0266-5611/14/2/003; Harkness KL, 2006, J ABNORM PSYCHOL, V115, P730, DOI 10.1037/0021-843X.115.4.730; Hayes A.F., 2013, INTRO MEDIATION MODE; Hein TC, 2017, J CHILD PSYCHOL PSYC, V58, P222, DOI 10.1111/jcpp.12651; Ionescu T, 2012, NEW IDEAS PSYCHOL, V30, P190, DOI 10.1016/j.newideapsych.2011.11.001; Johnco C, 2014, BEHAV RES THER, V57, P55, DOI 10.1016/j.brat.2014.04.005; Kalia V, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235412; Kalia V, 2019, J COGN PSYCHOL, V31, P370, DOI 10.1080/20445911.2019.1604527; Kashdan TB, 2010, CLIN PSYCHOL REV, V30, P865, DOI 10.1016/j.cpr.2010.03.001; Kong J, 2021, J INTERPERS VIOLENCE, V36, P9580, DOI 10.1177/0886260519869068; Liao QY, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-169; Linley PA, 2004, J TRAUMA STRESS, V17, P11, DOI 10.1023/B:JOTS.0000014671.27856.7e; MARTEAU TM, 1992, BRIT J CLIN PSYCHOL, V31, P301, DOI 10.1111/j.2044-8260.1992.tb00997.x; Mathews A, 2002, COGNITION EMOTION, V16, P331, DOI 10.1080/02699930143000518; McCrory Eamon, 2011, Front Psychiatry, V2, P48, DOI 10.3389/fpsyt.2011.00048; McLaughlin KA, 2016, CURR DIR PSYCHOL SCI, V25, P239, DOI 10.1177/0963721416655883; McLaughlin KA, 2016, J CLIN CHILD ADOLESC, V45, P361, DOI 10.1080/15374416.2015.1110823; Miyake A, 2012, CURR DIR PSYCHOL SCI, V21, P8, DOI 10.1177/0963721411429458; Naicker SN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181522; Nurius PS, 2015, CHILD ABUSE NEGLECT, V45, P143, DOI 10.1016/j.chiabu.2015.03.008; Ochsner KN, 2008, CURR DIR PSYCHOL SCI, V17, P153, DOI 10.1111/j.1467-8721.2008.00566.x; Ochsner KN, 2007, HDB EMOTION REGULATI, P135; Okon-Singer H, 2018, CURR OPIN BEHAV SCI, V19, P26, DOI 10.1016/j.cobeha.2017.09.008; Palan S, 2018, J BEHAV EXP FINANC, V17, P22, DOI 10.1016/j.jbef.2017.12.004; Park J, 2017, NEUROSCIENCE, V345, P193, DOI 10.1016/j.neuroscience.2016.06.013; Petruccelli K, 2019, CHILD ABUSE NEGLECT, V97, DOI 10.1016/j.chiabu.2019.104127; Pichon S, 2012, CEREB CORTEX, V22, P274, DOI 10.1093/cercor/bhr060; Pollak SD, 2003, ANN NY ACAD SCI, V1008, P102, DOI 10.1196/annals.1301.011; Poole JC, 2017, CHILD ABUSE NEGLECT, V64, P89, DOI 10.1016/j.chiabu.2016.12.012; Shackman JE, 2007, EMOTION, V7, P838, DOI 10.1037/1528-3542.7.4.838; Sheridan MA, 2014, TRENDS COGN SCI, V18, P580, DOI 10.1016/j.tics.2014.09.001; Silvers JA, 2017, DEV COGN NEUROS-NETH, V25, P128, DOI 10.1016/j.dcn.2016.06.005; Spielberger CD, 1970, MANUAL STATE TRAIT A; Sussman TJ, 2016, BIOL PSYCHOL, V121, P160, DOI 10.1016/j.biopsycho.2016.08.006; Taylor MR, 2012, MED J AUSTRALIA, V197, P561, DOI 10.5694/mja11.11623; Troy AS, 2013, PSYCHOL SCI, V24, P2505, DOI 10.1177/0956797613496434; van der Feltz-Cornelis CM, 2019, J AFFECT DISORDERS, V246, P458, DOI 10.1016/j.jad.2018.12.096; van Harmelen AL, 2013, SOC COGN AFFECT NEUR, V8, P362, DOI 10.1093/scan/nss007; van Wingen GA, 2011, MOL PSYCHIATR, V16, P664, DOI 10.1038/mp.2010.132; Vilsaint CL, 2019, COMPR PSYCHIAT, V89, P52, DOI 10.1016/j.comppsych.2018.12.008; Whitmer AJ, 2007, PSYCHOL SCI, V18, P546, DOI 10.1111/j.1467-9280.2007.01936.x; Wilson CG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204694	71	17	17	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243881	10.1371/journal.pone.0243881	http://dx.doi.org/10.1371/journal.pone.0243881			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH0WM	33306748	Green Published, gold			2022-12-27	WOS:000600144200042
J	Luong, XG; Stevens, SK; Jekle, A; Lin, TI; Gupta, K; Misner, D; Chanda, S; Mukherjee, S; Williams, C; Stoycheva, A; Blatt, LM; Beigelman, LN; Symons, JA; Raboisson, P; McGowan, D; Vandyck, K; Deval, J				Luong, Xuan G.; Stevens, Sarah K.; Jekle, Andreas; Lin, Tse-, I; Gupta, Kusum; Misner, Dinah; Chanda, Sushmita; Mukherjee, Sucheta; Williams, Caroline; Stoycheva, Antitsa; Blatt, Lawrence M.; Beigelman, Leonid N.; Symons, Julian A.; Raboisson, Pierre; McGowan, David; Vandyck, Koen; Deval, Jerome			Regulation of gene transcription by thyroid hormone receptor beta agonists in clinical development for the treatment of non-alcoholic steatohepatitis (NASH)	PLOS ONE			English	Article							FATTY LIVER-DISEASE; MALIC ENZYME; IN-VITRO; EXPRESSION; ACID; MODELS; EPIDEMIOLOGY; DEIODINASE; MECHANISMS; MGL-3196	Thyroid hormones are important modulators of metabolic activity in mammals and alter cholesterol and fatty acid levels through activation of the nuclear thyroid hormone receptor (THR). Currently, there are several THR beta agonists in clinical trials for the treatment of non-alcoholic steatohepatitis (NASH) that have demonstrated the potential to reduce liver fat and restore liver function. In this study, we tested three THR beta-agonism-based NASH treatment candidates, GC-1 (sobetirome), MGL-3196 (resmetirom), and VK2809, and compared their selectivity for THR beta and their ability to modulate the expression of genes specific to cholesterol and fatty acid biosynthesis and metabolism in vitro using human hepatic cells and in vivo using a rat model. Treatment with GC-1 upregulated the transcription of CPT1A in the human hepatocyte-derived Huh-7 cell line with a dose-response comparable to that of the native THR ligand, triiodothyronine (T3). VK2809A (active parent of VK2809), MGL-3196, and VK2809 were approximately 30-fold, 1,000-fold, and 2,000-fold less potent than T3, respectively. Additionally, these relative potencies were confirmed by quantification of other direct gene targets of THR, namely, ANGPTL4 and DIO1. In primary human hepatocytes, potencies were conserved for every compound except for VK2809, which showed significantly increased potency that was comparable to that of its active counterpart, VK2809A. In high-fat diet fed rats, a single dose of T3 significantly reduced total cholesterol levels and concurrently increased liver Dio1 and Me1 RNA expression. MGL-3196 treatment resulted in concentration-dependent decreases in total and low-density lipoprotein cholesterol with corresponding increases in liver gene expression, but the compound was significantly less potent than T3. In conclusion, we have implemented a strategy to rank the efficacy of THR beta agonists by quantifying changes in the transcription of genes that lead to metabolic alterations, an effect that is directly downstream of THR binding and activation.	[Luong, Xuan G.; Stevens, Sarah K.; Jekle, Andreas; Gupta, Kusum; Misner, Dinah; Chanda, Sushmita; Mukherjee, Sucheta; Williams, Caroline; Stoycheva, Antitsa; Blatt, Lawrence M.; Beigelman, Leonid N.; Symons, Julian A.; Deval, Jerome] Aligos Therapeut Inc, San Francisco, CA 94080 USA; [Lin, Tse-, I; Raboisson, Pierre; McGowan, David; Vandyck, Koen] Aligos Belgium BV, Leuven, Belgium		Luong, XG; Deval, J (corresponding author), Aligos Therapeut Inc, San Francisco, CA 94080 USA.	xluong@aligos.com; jdeval@aligos.com		Luong, Xuan/0000-0003-0600-8778	Aligos Therapeutics, Inc.	Aligos Therapeutics, Inc.	Aligos Therapeutics, Inc. provided funding for this study. The funder provided support in the form of salaries for XGL, SKS, AJ, KG, D. Misner, SC, SM, CW, AS, LMB, LNB, JAS, JD, TL, PR, D. McGowan, and KV, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Anderson GW, 2009, MOL CELL ENDOCRINOL, V302, P99, DOI 10.1016/j.mce.2009.01.005; [Anonymous], 2000, ARCH IBADAN MED ONCO, V1, P9; Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; Attia SL, 2021, CTS-CLIN TRANSL SCI, V14, P11, DOI 10.1111/cts.12839; Bianco AC, 2002, ENDOCR REV, V23, P38, DOI 10.1210/er.23.1.38; Boyer SH, 2008, J MED CHEM, V51, P7075, DOI 10.1021/jm800824d; Brent GA, 2012, J CLIN INVEST, V122, P3035, DOI 10.1172/JCI60047; Chan IH, 2009, MOL ENDOCRINOL, V23, P1758, DOI 10.1210/me.2009-0025; Chavez-Tapia NC, 2011, CURR MED CHEM, V18, P1079; Cheng SY, 2010, ENDOCR REV, V31, P139, DOI 10.1210/er.2009-0007; Chiellini G, 1998, CHEM BIOL, V5, P299, DOI 10.1016/S1074-5521(98)90168-5; Columbano Amedeo, 2017, Gene Expression-The Journal of Liver Research, V17, P265, DOI 10.3727/105221617X14968563796227; Erion MD, 2007, P NATL ACAD SCI USA, V104, P15490, DOI 10.1073/pnas.0702759104; Eshraghian A, 2017, WORLD J GASTROENTERO, V23, P7495, DOI 10.3748/wjg.v23.i42.7495; GOODRIDGE AG, 1976, J BIOL CHEM, V251, P3027; Haning H, 2005, BIOORG MED CHEM LETT, V15, P1835, DOI 10.1016/j.bmcl.2005.02.028; Harrison SA, 2019, LANCET, V394, P2012, DOI 10.1016/S0140-6736(19)32517-6; IRITANI N, 1992, EUR J BIOCHEM, V205, P433, DOI 10.1111/j.1432-1033.1992.tb16797.x; Jakobsson T, 2017, DRUGS, V77, P1613, DOI 10.1007/s40265-017-0791-4; Jansen MS, 2000, J BIOL CHEM, V275, P34989, DOI 10.1074/jbc.M001752200; Kalliokoski A, 2009, BRIT J PHARMACOL, V158, P693, DOI 10.1111/j.1476-5381.2009.00430.x; Kanuri G, 2013, INT J MOL SCI, V14, P11963, DOI 10.3390/ijms140611963; Kelly MJ, 2014, J MED CHEM, V57, P3912, DOI 10.1021/jm4019299; Kim KH, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00485; Kirschberg TA, 2020, BIOORG MED CHEM LETT, V30, DOI 10.1016/j.bmcl.2020.127465; Lee K, 2011, J BIOL CHEM, V286, P25655, DOI 10.1074/jbc.M111.228692; Lian B, 2016, J AM COLL CARDIOL, V67, P1932, DOI 10.1016/S0735-1097(16)31933-7; Loomba R, 2019, J HEPATOL, V70, pE150, DOI 10.1016/S0618-8278(19)30266-X; MAIA AL, 1995, ENDOCRINOLOGY, V136, P4842, DOI 10.1210/en.136.11.4842; Matos SL, 2005, BRAZ ARCH BIOL TECHN, V48, P203, DOI 10.1590/S1516-89132005000200006; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; Mengeling BJ, 2008, MOL CELL ENDOCRINOL, V280, P47, DOI 10.1016/j.mce.2007.09.011; Musso G, 2016, NAT REV DRUG DISCOV, V15, P249, DOI 10.1038/nrd.2015.3; Oetting A, 2007, BEST PRACT RES CL EN, V21, P193, DOI 10.1016/j.beem.2007.04.004; Pedrelli M, 2010, WORLD J GASTROENTERO, V16, P5958, DOI 10.3748/wjg.v16.i47.5958; Perumpail BJ, 2017, WORLD J GASTROENTERO, V23, P8263, DOI 10.3748/wjg.v23.i47.8263; Rodriguez-Antona C, 2002, XENOBIOTICA, V32, P505, DOI 10.1080/00498250210128675; SAMUELS HH, 1979, ENDOCRINOLOGY, V105, P80, DOI 10.1210/endo-105-1-80; Saponaro F, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00331; Scanlan TS, 2010, HEART FAIL REV, V15, P177, DOI 10.1007/s10741-008-9122-x; Schneider MJ, 2006, ENDOCRINOLOGY, V147, P580, DOI 10.1210/en.2005-0739; Shimomura I, 1998, J BIOL CHEM, V273, P35299, DOI 10.1074/jbc.273.52.35299; Sinha RA, 2018, NAT REV ENDOCRINOL, V14, P259, DOI 10.1038/nrendo.2018.10; Taub R, 2013, ATHEROSCLEROSIS, V230, P373, DOI 10.1016/j.atherosclerosis.2013.07.056; Thakran S, 2013, J BIOL CHEM, V288, P807, DOI 10.1074/jbc.M112.437970; TOWLE HC, 1980, BIOCHEMISTRY-US, V19, P579, DOI 10.1021/bi00544a029; Wagner RL, 2001, MOL ENDOCRINOL, V15, P398, DOI 10.1210/me.15.3.398; Williams GR, 2000, MOL CELL BIOL, V20, P8329, DOI 10.1128/MCB.20.22.8329-8342.2000; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Yuan C, 2012, ENDOCRINOLOGY, V153, P501, DOI 10.1210/en.2011-1325; Zavacki AM, 2005, ENDOCRINOLOGY, V146, P1568, DOI 10.1210/en.2004-1392; Zhou J, 2019, THYROID, V29, P1158, DOI 10.1089/thy.2019.0007	53	9	9	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0240338	10.1371/journal.pone.0240338	http://dx.doi.org/10.1371/journal.pone.0240338			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306682	gold, Green Published, Green Submitted			2022-12-27	WOS:000600144200072
J	Ross, KM; Eastman, A; Ugwoaba, UA; Demos, KE; Lillis, J; Wing, RR				Ross, Kathryn M.; Eastman, Abraham; Ugwoaba, Umelo A.; Demos, Kathryn E.; Lillis, Jason; Wing, Rena R.			Food reward sensitivity, impulsivity, and weight change during and after a 3-month weight loss program	PLOS ONE			English	Article							DELAYED HYPOTHETICAL MONEY; HEDONIC HUNGER; ENERGY-INTAKE; RESPONSE-INHIBITION; OBESE; REINFORCEMENT; WOMEN; INDIVIDUALS; DISCOUNT; FUTURE	Background Greater sensitivity to food rewards and higher levels of impulsivity (and an interaction between these variables, termed "reinforcement pathology") have been associated with obesity in cross-sectional studies. Less is known regarding how these constructs may impact attempts at weight loss or longer-term weight loss maintenance. Methods We provided 75 adults (69%Female, 84%White, age = 50.8y, BMI = 31.2kg/m(2)) with a 3-month Internet-based weight loss program and assessed weight, food reward sensitivity (via the Power of Food Scale [PFS]), and impulsivity (via Go No-Go [GNG] and Delay Discounting [DD] computer tasks) at baseline and at Months 3, 6, 9, and 12. No additional intervention was provided Months 3-12. Multi-level mixed-effect models were used to examine changes in PFS, GNG, and DD over time and associations between these measures and weight loss/regain. Results Participants lost 6.0 +/- 1.1kg Months 0-3 and regained 2.4 +/- 1.1kg Months 3-12. Across time points, higher PFS scores were associated with higher weight, p = .007; however, there were no significant associations between GNG or DD and weight nor between the interactions of PFS and GNG or DD and weight, ps>.05. There were significant decreases from Months 0-3 in PFS, GNG, and DD, ps < .05; however, neither baseline values nor changes were significantly associated with weight change and there were no significant associations between the interactions of PFS and GNG or DD and weight change, ps>.05. Conclusion Results demonstrated an association between food reward sensitivity and weight. Further, decreases in both food reward sensitivity and impulsivity were observed during an initial weight loss program, but neither baseline levels nor improvements were associated with weight change. Taken together, results suggest that the constructs of food reward sensitivity, impulsivity, and reinforcement pathology may have limited clinical utility within behavioral weight management interventions. Future intervention studies should examine whether food-related impulsivity tasks lead to a similar pattern of results.	[Ross, Kathryn M.; Eastman, Abraham; Ugwoaba, Umelo A.] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Clin & Hlth Psychol, Gainesville, FL 32611 USA; [Ross, Kathryn M.; Demos, Kathryn E.; Lillis, Jason; Wing, Rena R.] Brown Univ, Dept Psychiat & Human Behav, Warren Alpert Med Sch, Miriam Hosp,Weight Control & Diabet Res Ctr, Providence, RI 02912 USA	State University System of Florida; University of Florida; Brown University; Lifespan Health Rhode Island; Miriam Hospital	Ross, KM (corresponding author), Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Clin & Hlth Psychol, Gainesville, FL 32611 USA.; Ross, KM (corresponding author), Brown Univ, Dept Psychiat & Human Behav, Warren Alpert Med Sch, Miriam Hosp,Weight Control & Diabet Res Ctr, Providence, RI 02912 USA.	kmross@phhp.ufl.edu	Ross, Kathryn/AAK-5068-2020	Ross, Kathryn/0000-0002-3628-766X	Lifespan Corporation; National Institutes of Health, National Institute of Diabetes Digestive and Kidney Diseases [F32DK100069, R21DK109205, R01DK119244]	Lifespan Corporation; National Institutes of Health, National Institute of Diabetes Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Lifespan Corporation, and by the National Institutes of Health, National Institute of Diabetes Digestive and Kidney Diseases, under awards F32DK100069, R21DK109205, and R01DK119244. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Appelhans BM, 2011, OBESITY, V19, P2175, DOI 10.1038/oby.2011.57; Appelhans BM, 2009, OBESITY, V17, P640, DOI 10.1038/oby.2008.638; Brancati F, 2003, CONTROL CLIN TRIALS, V24, P610, DOI 10.1016/S0197-2456(03)00064-3; Burke LE, 2011, J AM DIET ASSOC, V111, P92, DOI 10.1016/j.jada.2010.10.008; Butryn ML, 2011, PSYCHIAT CLIN N AM, V34, P841, DOI 10.1016/j.psc.2011.08.006; Cappelleri JC, 2009, INT J OBESITY, V33, P913, DOI 10.1038/ijo.2009.107; Carr KA, 2014, OBESITY, V22, P254, DOI 10.1002/oby.20392; Carr Katelyn A, 2011, Curr Drug Abuse Rev, V4, P190; Chen Z, 2016, J EXP PSYCHOL GEN, V145, P1687, DOI 10.1037/xge0000236; DPP Res Grp, 2002, DIABETES CARE, V25, P2165; Ely AV, 2015, EAT BEHAV, V19, P72, DOI 10.1016/j.eatbeh.2015.06.015; Epstein LH, 2007, BEHAV NEUROSCI, V121, P877, DOI 10.1037/0735-7044.121.5.877; Epstein LH, 2014, OBESITY, V22, P1394, DOI 10.1002/oby.20661; Epstein LH, 2012, OBESITY, V20, P1815, DOI 10.1038/oby.2012.2; Epstein LH, 2010, PHYSIOL BEHAV, V100, P438, DOI 10.1016/j.physbeh.2010.04.029; Estle SJ, 2007, PSYCHOL SCI, V18, P58, DOI 10.1111/j.1467-9280.2007.01849.x; Gettens KM, 2017, J BEHAV MED, V40, P687, DOI 10.1007/s10865-017-9831-5; Giesen JCAH, 2010, OBESITY, V18, P966, DOI 10.1038/oby.2010.20; Green L, 1997, MEM COGNITION, V25, P715, DOI 10.3758/BF03211314; Guerrieri R, 2007, APPETITE, V49, P66, DOI 10.1016/j.appet.2006.11.008; Johnson MW, 2002, J EXP ANAL BEHAV, V77, P129, DOI 10.1901/jeab.2002.77-129; Kiehl KA, 2000, PSYCHOPHYSIOLOGY, V37, P216, DOI 10.1111/1469-8986.3720216; Koffarnus MN, 2014, EXP CLIN PSYCHOPHARM, V22, P222, DOI 10.1037/a0035973; Kollei I, 2018, INT J EAT DISORDER, V51, P233, DOI 10.1002/eat.22824; Kozak AT, 2017, J BEHAV MED, V40, P99, DOI 10.1007/s10865-016-9805-z; Kulendran M, 2014, INT J OBESITY, V38, P507, DOI 10.1038/ijo.2013.198; Kulendran M, 2017, SURG OBES RELAT DIS, V13, P1033, DOI 10.1016/j.soard.2016.12.031; Leahey TM, 2014, AM J PUBLIC HEALTH, V104, P1300, DOI 10.2105/AJPH.2014.301870; Lowe MR, 2009, APPETITE, V53, P114, DOI 10.1016/j.appet.2009.05.016; MacLean PS, 2015, OBESITY, V23, P7, DOI 10.1002/oby.20967; Meule A, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00190; Mobbs O, 2011, APPETITE, V57, P263, DOI 10.1016/j.appet.2011.04.023; Moore WJ, 2015, EAT BEHAV, V19, P33, DOI 10.1016/j.eatbeh.2015.06.011; Murawski ME, 2009, EAT BEHAV, V10, P146, DOI 10.1016/j.eatbeh.2009.03.005; Myerson J, 2001, J EXP ANAL BEHAV, V76, P235, DOI 10.1901/jeab.2001.76-235; Nederkoorn C, 2007, BEHAV RES THER, V45, P1071, DOI 10.1016/j.brat.2006.05.009; Nederkoorn C, 2006, APPETITE, V47, P253, DOI 10.1016/j.appet.2006.05.008; Nederkoorn C, 2010, HEALTH PSYCHOL, V29, P389, DOI 10.1037/a0019921; O'Neil PM, 2012, EAT BEHAV, V13, P354, DOI 10.1016/j.eatbeh.2012.06.002; Odum AL, 2003, BEHAV PROCESS, V64, P305, DOI 10.1016/S0376-6357(03)00145-1; Odum AL, 2006, BEHAV PROCESS, V73, P278, DOI 10.1016/j.beproc.2006.06.008; Price M, 2016, INT J OBESITY, V40, P877, DOI 10.1038/ijo.2015.235; Rasmussen EB, 2010, BEHAV PROCESS, V83, P23, DOI 10.1016/j.beproc.2009.09.001; Rollins BY, 2010, APPETITE, V55, P420, DOI 10.1016/j.appet.2010.07.014; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; Ross KM, 2019, HEALTH PSYCHOL, V38, P1150, DOI 10.1037/hea0000798; Ross KM, 2018, OBESITY, V26, P318, DOI 10.1002/oby.22083; Ross KM, 2016, J OBES, V2016, DOI 10.1155/2016/9372515; Saelens BE, 1996, APPETITE, V27, P41, DOI 10.1006/appe.1996.0032; SAS Institute Inc, 2013, SAS VERS 9 4; Simmonds DJ, 2008, NEUROPSYCHOLOGIA, V46, P224, DOI 10.1016/j.neuropsychologia.2007.07.015; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Teslovich T, 2014, PSYCHIAT RES, V219, P166, DOI 10.1016/j.psychres.2014.04.053; Theim KR, 2013, BEHAV MODIF, V37, P790, DOI 10.1177/0145445513501319; Thomas JG, 2015, OBES SCI PRACT, V1, P131, DOI 10.1111/osp4.12; Thomas JG, 2015, DIABETES CARE, V38, P9, DOI 10.2337/dc14-1474; Ullrich J, 2013, OBES SURG, V23, P50, DOI 10.1007/s11695-012-0754-5; Weller RE, 2008, APPETITE, V51, P563, DOI 10.1016/j.appet.2008.04.010	59	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243530	10.1371/journal.pone.0243530	http://dx.doi.org/10.1371/journal.pone.0243530			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH0WM	33306690	Green Published, gold			2022-12-27	WOS:000600144200065
J	Owusu, M; Sylverken, AA; Ankrah, ST; El-Duah, P; Ayisi-Boateng, NK; Yeboah, R; Gorman, R; Asamoah, J; Binger, T; Acheampong, G; Bekoe, FA; Ohene, SA; Larsen-Reindorf, R; Awuah, AAA; Amuasi, J; Owusu-Dabo, E; Adu-Sarkodie, Y; Phillips, RO				Owusu, Michael; Sylverken, Augustina Angelina; Ankrah, Sampson Twumasi; El-Duah, Philip; Ayisi-Boateng, Nana Kwame; Yeboah, Richmond; Gorman, Richmond; Asamoah, Jesse; Binger, Tabea; Acheampong, Godfred; Bekoe, Franklin Asiedu; Ohene, Sally-Ann; Larsen-Reindorf, Rita; Awuah, Anthony Afum-Adjei; Amuasi, John; Owusu-Dabo, Ellis; Adu-Sarkodie, Yaw; Phillips, Richard Odame			Epidemiological profile of SARS-CoV-2 among selected regions in Ghana: A cross-sectional retrospective study	PLOS ONE			English	Article							CORONAVIRUS	Background Global cases of COVID-19 continue to rise, causing havoc to several economies. So far, Ghana has recorded 48,643 confirmed cases with 320 associated deaths. Although summaries of data are usually provided by the Ministry of Health, detailed epidemiological profile of cases are limited. This study sought to describe the socio-demographic features, pattern of COVID-19 spread and the viral load dynamics among subjects residing in northern, middle and part of the southern belt of Ghana. Methods This was a cross-sectional retrospective study that reviewed records of samples collected from February to July, 2020. Respiratory specimens such as sputum, deep-cough saliva and nasopharyngeal swabs were collected from suspected COVID-19 subjects in 12 regions of Ghana for laboratory analysis and confirmation by real-time reverse transcription polymerase chain reaction (RT-PCR). Results A total of 72,434 samples were collected during the review period, with majority of the sampled individuals being females (37,464; 51.9%). The prevalence of SARS-CoV-2 identified in the study population was 13.2% [95%CI: 12.9, 13.4). Males were mostly infected (4,897; 51.5%) compared to females. Individuals between the ages 21-30 years recorded the highest number of infections (3,144, 33.4%). Symptomatic subjects had higher viral loads (1479.7 copies/mu l; IQR = 40.6-178919) than asymptomatic subjects (49.9; IQR = 5.5-3641.6). There was significant association between gender or age and infection with SARS-CoV-2 (p<0.05). Among all the suspected clinical presentations, anosmia was the strongest predictor of SARS-CoV-2 infection (Adj. OR (95%CI): 24.39 (20.18, 29.49). We observed an average reproductive number of 1.36 with a minimum of 1.28 and maximum of 1.43. The virus trajectory shows a gradual reduction of the virus reproductive number. Conclusion This study has described the epidemiological profile of COVID-19 cases in northern, middle and part of the southern belt of Ghana, with males and younger individuals at greater risk of contracting the disease. Health professionals should be conscious of individuals presenting with anosmia since this was seen as the strongest predictor of virus infection.	[Owusu, Michael] Kwame Nkrumah Univ Sci & Technol, Dept Med Diagnost, Kumasi, Ghana; [Owusu, Michael; Sylverken, Augustina Angelina; El-Duah, Philip; Yeboah, Richmond; Gorman, Richmond; Asamoah, Jesse; Binger, Tabea; Awuah, Anthony Afum-Adjei; Amuasi, John; Phillips, Richard Odame] Kwame Nkrumah Univ Sci & Technol, Kumasi Ctr Collaborat Res Trop Med, Kumasi, Ghana; [Sylverken, Augustina Angelina] Kwame Nkrumah Univ Sci & Technol, Dept Theoret & Appl Biol, Kumasi, Ghana; [Ankrah, Sampson Twumasi] Kwame Nkrumah Univ Sci & Technol, Dept Stat & Actuarial Sci, Kumasi, Ghana; [El-Duah, Philip] Charite Univ Med Berlin, Inst Virol, Berlin, Germany; [Ayisi-Boateng, Nana Kwame; Phillips, Richard Odame] Kwame Nkrumah Univ Sci & Technol, Dept Med, Kumasi, Ghana; [Acheampong, Godfred] Ctr Hlth Syst Strengthening, Kumasi, Ghana; [Bekoe, Franklin Asiedu] Ghana Hlth Serv, Dis Surveillance Unit, Accra, Ghana; [Ohene, Sally-Ann] World Hlth Org Off, Accra, Ghana; [Larsen-Reindorf, Rita] Ghana Hlth Serv, Ashanti Reg Hlth Directorate, Accra, Ghana; [Awuah, Anthony Afum-Adjei] Kwame Nkrumah Univ Sci & Technol, Dept Mol Med, Kumasi, Ghana; [Amuasi, John; Owusu-Dabo, Ellis] Kwame Nkrumah Univ Sci & Technol, Dept Global & Int Hlth, Kumasi, Ghana; [Adu-Sarkodie, Yaw] Kwame Nkrumah Univ Sci & Technol, Dept Clin Microbiol, Kumasi, Ghana	Kwame Nkrumah University Science & Technology; Kumasi Center for Collaborative Research; Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Kwame Nkrumah University Science & Technology; Ghana Health Service; Ghana Health Service; Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology	Owusu, M (corresponding author), Kwame Nkrumah Univ Sci & Technol, Dept Med Diagnost, Kumasi, Ghana.; Owusu, M (corresponding author), Kwame Nkrumah Univ Sci & Technol, Kumasi Ctr Collaborat Res Trop Med, Kumasi, Ghana.	michaelowusu80@gmail.com	El-Duah, Philip/AAN-7425-2021; Phillips, Richard Odame/ABD-5394-2021	El-Duah, Philip/0000-0003-1671-0755; Phillips, Richard Odame/0000-0001-8992-0222; YEBOAH, RICHMOND/0000-0002-2765-6179; Acheampong, Godfred/0000-0003-2495-9235; Gorman, Richmond/0000-0002-6831-3375	MRC [MR/J01477X/1] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Anjorin AA, 2021, TROP MED INT HEALTH, V26, P2, DOI 10.1111/tmi.13504; Channappanavar R, 2017, J IMMUNOL, V198, P4046, DOI 10.4049/jimmunol.1601896; Chen WJ, 2006, CLIN INFECT DIS, V42, P1561, DOI 10.1086/503843; Corman VM, 2016, CLIN INFECT DIS, V62, P477, DOI 10.1093/cid/civ951; Cummings Matthew J, 2020, Lancet, V395, P1763, DOI [10.1101/2020.04.15.20067157, 10.1016/S0140-6736(20)31189-2]; Di Castelnuovo A, 2020, NUTR METAB CARDIOVAS, V30, P1899, DOI 10.1016/j.numecd.2020.07.031; Di Gennaro F, 2020, TROP MED INFECT DIS, V5, DOI 10.3390/tropicalmed5030141; Foundation QDTOOSG, 2009, QGIS GEOGR INF SYST; Genot L, 2020, BRAZIL COVID 19 HITT; Gerna G, 2006, J MED VIROL, V78, P938, DOI 10.1002/jmv.20645; GHS, 2020, GHAN HLTH SERV COVID; GHS, 2020, IMM REL GHAN CONF 2, V2020, P1; Giacomelli A, 2020, CLIN INFECT DIS, V71, P889, DOI 10.1093/cid/ciaa330; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Guan WJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00597-2020; Heidari F, 2020, RHINOLOGY, V58, P302, DOI 10.4193/Rhin20.140; Hogan AB, 2020, LANCET GLOB HEALTH, V8, pE1132, DOI 10.1016/S2214-109X(20)30288-6; Hopkins C, 2020, LOSS SENSE SMELL MAR, V26, P2020; Jin JM, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00152; Lavezzo E, 2020, NATURE, V584, P425, DOI 10.1038/s41586-020-2488-1; Li MY, 2020, NUTR METAB CARDIOVAS, V30, P1061, DOI 10.1016/j.numecd.2020.04.013; Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316; Liu Y, 2020, LANCET INFECT DIS, V20, P656, DOI 10.1016/S1473-3099(20)30232-2; Manoj PDS, 2015, IEEE T COMPUT, V64, P3022, DOI 10.1109/TC.2015.2389827; Marchese-Ragona R., 2020, SUDDEN HYPOSMIA PREV, DOI [DOI 10.1101/2020.04.06.20045393, 10.1101/2020.04.06.20045393]; Meng XM, 2020, AM J OTOLARYNG, V41, DOI 10.1016/j.amjoto.2020.102581; Moeser A, 2020, COVID 19 AFFECTS MEN; Mwiine AmonAshaba., 2020, CHIK WORLDW OV; NYC-Health, 2020, COR DIS 2019 COVID 1; Sahu KK, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm-20-2793; Sanyaolu Adekunle, 2020, SN Compr Clin Med, V2, P1069, DOI 10.1007/s42399-020-00363-4; Soler ZM, 2020, INT FORUM ALLERGY RH, V10, P814, DOI 10.1002/alr.22578; Statista, 2020, FEDERALISM COVID 19; WHO, 2020, MENT HLTH PSYCH CONS; WHO/Europe, 2020, SUPP OLD PEOPL COVID; Wolfel R, 2020, NATURE, V581, P465, DOI 10.1038/s41586-020-2196-x; World Health Organization,, 2020, TAIL MAL INT COVID 1; Yu FT, 2020, CLIN INFECT DIS, V71, P793, DOI 10.1093/cid/ciaa345; Yuki K, 2020, CLIN IMMUNOL, V215, DOI 10.1016/j.clim.2020.108427; Zhang JJ, 2020, ALLERGY, V75, P1730, DOI 10.1111/all.14238; Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737	41	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243711	10.1371/journal.pone.0243711	http://dx.doi.org/10.1371/journal.pone.0243711			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301533	Green Published, gold			2022-12-27	WOS:000600143100026
J	Wang, G; Wang, QB; Bai, J; Li, G; Tao, KX; Wang, GB; Xia, ZF				Wang, Geng; Wang, Qingbo; Bai, Jie; Li, Gang; Tao, Kaixiong; Wang, Guobin; Xia, Zefeng			RYGB increases postprandial gastric nesfatin-1 and rapid relieves NAFLD via gastric nerve detachment	PLOS ONE			English	Article							FATTY LIVER-DISEASE; BARIATRIC SURGERY; NONALCOHOLIC STEATOHEPATITIS; SLEEVE GASTRECTOMY; BYPASS-SURGERY; WEIGHT-LOSS; RAT MODEL; OBESITY; IDENTIFICATION; PREVALENCE	Background Roux-en-Y gastric bypass (RYGB) could reduce nonalcoholic fatty liver disease (NAFLD) ahead of the weight-loss effects. But the detailed mechanisms remain unclear. Material and methods A high-fat diet (HFD) was fed to induce obesity. RYGB was then performed. Gastric nesfatin-1 was measured by enzyme-linked immunosorbent assay (ELISA) in portal vein and polymerase chain reaction (PCR) in gastric tissues. Modified surgeries including vagus-preserved bypass and vagectomy were performed and postprandial gastric nesfatin-1 were analyzed. The effects of nesfatin-1 on hepatocytes were studied by PCR and immunohistochemistry. Both intraperitoneal and intracerebroventricular injection (ICV) were performed to analyze the in vivo effects on liver lipid metabolism. Results Increased postprandial portal vein nesfatin-1 was observed in RYGB but not in control groups. This increase is mainly due to induction of gastric nesfatin-1. A modified RYGB in which the gastric vagus is preserved is conducted and, in this case, this nesfatin-1 induction effect is diminished. Mere vagectomy could also induce a similar nesfatin-1 increase pattern. The infusion of nesfatin-1 in the brain could inhibit the expression of gastric nesfatin-1, and the effects are diminished after gastric vagectomy. In vivo and in vitro nesfatin-1 stimulation in the liver resulted in improvements in lipid metabolism. Conclusions Severing the gastric vagus during RYGB could cut off the negative control from the central nervous system (CNS) and result in increased postprandial gastric nesfatin-1 post surgery, which in turn, improves NAFLD.	[Wang, Geng; Bai, Jie; Li, Gang; Tao, Kaixiong; Wang, Guobin; Xia, Zefeng] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Gastrointestinal Surg, Wuhan, Peoples R China; [Wang, Qingbo] Wuhan Univ, Dept Gastrointestinal Surg 2, Renmin Hosp, Wuhan, Peoples R China	Huazhong University of Science & Technology; Wuhan University	Xia, ZF (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Gastrointestinal Surg, Wuhan, Peoples R China.	xiazefe0521@sina.com			National Key Basic Research Program of China [2015CB5540007]; National Natural Science Foundation of China [81472740, 81200276, 81700488]; Natural Science Foundation of Hubei Province of China [2014CFA060]; Natural Science Foundation of Huazhong University of Science and Technology [5001530030]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province of China(Natural Science Foundation of Hubei Province); Natural Science Foundation of Huazhong University of Science and Technology	Guobin Wang, the National Key Basic Research Program of China (No.2015CB5540007); National Natural Science Foundation of China (No.81472740);Natural Science Foundation of Hubei Province of China (No.2014CFA060);Natural Science Foundation of Huazhong University of Science and Technology (No.5001530030). Zefeng Xia, National Natural Science Foundation of China (No. 81200276). Geng Wang, National Natural Science Foundation of China (No. 81700488).	Adams TD, 2012, JAMA-J AM MED ASSOC, V308, P1122, DOI 10.1001/2012.jama.11164; Alizai PH, 2015, OBES SURG, V25, P2047, DOI 10.1007/s11695-015-1664-0; [Anonymous], 2012, AM J PHYSIOL-ENDOC M, V303, pE410; [Anonymous], 2011, J CLIN ENDOCR METAB, V96, pE304; Arterburn DE, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g3961; Barker KB, 2006, AM J GASTROENTEROL, V101, P368, DOI 10.1111/j.1572-0241.2006.00419.x; Basar O, 2012, SCAND J CLIN LAB INV, V72, P479, DOI 10.3109/00365513.2012.699097; Bedogni G, 2005, HEPATOLOGY, V42, P44, DOI 10.1002/hep.20734; Bueter M, 2012, JOVE-J VIS EXP, DOI 10.3791/3940; Caiazzo R, 2014, ANN SURG, V260, P893, DOI 10.1097/SLA.0000000000000945; Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001; Chen X, 2015, NEUROPEPTIDES, V53, P45, DOI 10.1016/j.npep.2015.07.004; Chen Z, 2018, CELL MOL NEUROBIOL, V38, P627, DOI 10.1007/s10571-017-0509-x; Choi YK, 2001, J CLIN MICROBIOL, V39, P3311, DOI 10.1128/JCM.39.9.3311-3315.2001; Dore R, 2017, J ENDOCRINOL, V232, pR45, DOI 10.1530/JOE-16-0361; Du JP, 2018, OBES SURG, V28, P3851, DOI 10.1007/s11695-018-3351-4; Fan JG, 2009, J HEPATOL, V50, P204, DOI 10.1016/j.jhep.2008.10.010; Froylich D, 2016, SURG OBES RELAT DIS, V12, P127, DOI 10.1016/j.soard.2015.04.004; Guo FF, 2015, J NEUROCHEM, V132, P266, DOI 10.1111/jnc.12973; Hankir MK, 2017, CELL METAB, V25, P335, DOI 10.1016/j.cmet.2016.12.006; Huang B, 2017, 2017 INTERNATIONAL CONFERENCE ON MECHANICAL, SYSTEM AND CONTROL ENGINEERING (ICMSC), P333, DOI 10.1109/ICMSC.2017.7959496; Lassailly G, 2015, GASTROENTEROLOGY, V149, P379, DOI 10.1053/j.gastro.2015.04.014; Maggard-Gibbons M, 2013, JAMA-J AM MED ASSOC, V309, P2250, DOI 10.1001/jama.2013.4851; Malek N, 2016, PHARMACOL RES, V111, P251, DOI 10.1016/j.phrs.2016.06.012; Milic S, 2014, WORLD J GASTROENTERO, V20, P9330, DOI 10.3748/wjg.v20.i28.9330; Mortazavi S, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00022; Oh-I S, 2006, NATURE, V443, P709, DOI 10.1038/nature05162; Salgado W, 2016, OBES SURG, V26, P2718, DOI 10.1007/s11695-016-2176-2; Sasaki T, 2016, EXP NEUROL, V275, P220, DOI 10.1016/j.expneurol.2015.11.003; SCHOLTENS E, 1983, EXPERIENTIA, V39, P1176, DOI 10.1007/BF01943169; Shao YK, 2017, OBES SURG, V27, P295, DOI 10.1007/s11695-016-2297-7; Skinner AC, 2014, JAMA PEDIATR, V168, P561, DOI 10.1001/jamapediatrics.2014.21; Stengel A, 2013, HISTOCHEM CELL BIOL, V139, P909, DOI 10.1007/s00418-013-1087-8; Tang CH, 2012, PEPTIDES, V36, P39, DOI 10.1016/j.peptides.2012.04.014; van Dammen L, 2018, OBES REV, V19, P1679, DOI 10.1111/obr.12752; Verbeek J, 2015, GUT, V64, P673, DOI 10.1136/gutjnl-2014-306748; Wang H, 2012, BMC PUBLIC HEALTH, V12, DOI [10.1186/1471-2458-12-967, 10.1186/1471-2407-12-528]; Wang QB, 2019, OBES SURG, V29, P1681, DOI 10.1007/s11695-019-03789-5; Wolfe BM, 2016, CIRC RES, V118, P1844, DOI 10.1161/CIRCRESAHA.116.307591; Xia ZF, 2015, CURR PHARM DESIGN, V21, P1464, DOI 10.2174/1381612821666141219125527; Yin Y, 2015, MOL CELL ENDOCRINOL, V417, P20, DOI 10.1016/j.mce.2015.09.006; Yuan FH, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0190-y; Zhang YX, 2011, J BIOL CHEM, V286, P29635, DOI 10.1074/jbc.M111.253039	43	4	4	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243640	10.1371/journal.pone.0243640	http://dx.doi.org/10.1371/journal.pone.0243640			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301513	Green Published, gold			2022-12-27	WOS:000600143100067
J	Hodlmoser, S; Winkelmayer, WC; Zee, J; Pecoits, R; Pisoni, RL; Port, FK; Robinson, BM; Ristl, R; Krenn, S; Kurnikowski, A; Lewandowski, M; Ton, A; Carrero, JJ; Schernhammer, ES; Hecking, M				Hoedlmoser, Sebastian; Winkelmayer, Wolfgang C.; Zee, Jarcy; Pecoits-Filho, Roberto; Pisoni, Ronald L.; Port, Friedrich K.; Robinson, Bruce M.; Ristl, Robin; Krenn, Simon; Kurnikowski, Amelie; Lewandowski, Michal; Ton, Allison; Carrero, Juan Jesus; Schernhammer, Eva S.; Hecking, Manfred			Sex differences in chronic kidney disease awareness among US adults, 1999 to 2018	PLOS ONE			English	Article							UNITED-STATES; DIALYSIS; TRENDS; PREVALENCE; HEALTH; RISK	Background Chronic kidney disease (CKD) is less prevalent among men than women, but more men than women initiate kidney replacement therapy. Differences in CKD awareness may contribute to this gender gap, which may further vary by race/ethnicity. We aimed to investigate trends in CKD awareness and the association between individual characteristics and CKD awareness among US men versus women. Methods and findings We conducted a serial, cross-sectional analysis of 10 cycles (1999-2018) from the National Health and Nutrition Examination Survey (NHANES). Adult participants with CKD stages G3-G5 (estimated glomerular filtration rate [eGFR] <60 mL/min/1.73m(2)) were included, unless they were on dialysis or medical information was missing. Serum creatinine was measured during NHANES medical exams. CKD stage was classified by eGFR, based on the CKD-EPI formula. CKD awareness was assessed with the question: "Have you ever been told by a health care professional you had weak or failing kidneys", asked in standardized NHANES questionnaires on each survey. Using logistic regression models, we evaluated the association between sex and CKD awareness, adjusting for potential confounders including age, race/ethnicity and comorbidities. We stratified CKD awareness by 5 pre-defined calendar-year periods and conducted all analyses for the complete study population as well as the Caucasian and African American subpopulations. We found that among 101871 US persons participating in NHANES, 4411 (2232 women) had CKD in stages G3-G5. These participants were, on average, 7310 years old, 25.3% reported diabetes, 78.0% reported hypertension or had elevated blood pressure during medical examinations and 39.8% were obese (percentages were survey-weighted). CKD awareness was more prevalent among those with higher CKD stage, younger age, diabetes, hypertension and higher body mass index. CKD awareness was generally low (<22.5%), though it increased throughout the study period, remaining consistently higher among men compared to women, with a decreasing gender gap over time (adjusted odds ratio [men-to-women] for CKD awareness = 2.71 [1.31-5.64] in period 1; = 1.32 [0.82-2.12] in period 5). The sex difference in CKD awareness was smaller in African American participants, in whom CKD awareness was generally higher. Using serum creatinine rather than eGFR as the CKD-defining exposure, CKD awareness increased with rising serum creatinine, in a close to identical fashion among both sexes during 1999-2008, while during 2009-2018, CKD awareness among women increased earlier than among men (i.e. with lower serum creatinine levels). Conclusions CKD awareness is lower among US women than men. The narrowing gap between the sexes in more recent years and the results on CKD awareness by serum creatinine indicate that health care professionals have previously been relying on serum creatinine to inform patients about their condition, but in more recent years have been using eGFR, which accounts for women's lower serum creatinine levels due to their lower muscle mass. Additional efforts should be made to increase CKD awareness among both sexes.	[Hoedlmoser, Sebastian; Schernhammer, Eva S.] Med Univ Vienna, Ctr Publ Hlth, Dept Epidemiol, Vienna, Austria; [Hoedlmoser, Sebastian; Krenn, Simon; Kurnikowski, Amelie; Lewandowski, Michal; Ton, Allison; Hecking, Manfred] Med Univ Vienna, Clin Div Nephrol & Dialysis, Dept Internal Med 3, Vienna, Austria; [Winkelmayer, Wolfgang C.] Baylor Coll Med, Nephrol Sect, Selzman Inst Kidney Hlth, Houston, TX 77030 USA; [Zee, Jarcy; Pecoits-Filho, Roberto; Pisoni, Ronald L.; Port, Friedrich K.; Robinson, Bruce M.] Arbor Res Collaborat Hlth, Ann Arbor, MI USA; [Pecoits-Filho, Roberto] Pontificia Univ Catolica Parana, Sch Med, Curitiba, Parana, Brazil; [Ristl, Robin] Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst, Vienna, Austria; [Ton, Allison] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW, Australia; [Carrero, Juan Jesus] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Schernhammer, Eva S.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Schernhammer, Eva S.] Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Schernhammer, Eva S.] Harvard Med Sch, Boston, MA 02115 USA	Medical University of Vienna; Medical University of Vienna; Baylor College of Medicine; Arbor Research Collaborative for Health; Pontificia Universidade Catolica do Parana; Medical University of Vienna; University of Sydney; Karolinska Institutet; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Schernhammer, ES (corresponding author), Med Univ Vienna, Ctr Publ Hlth, Dept Epidemiol, Vienna, Austria.; Schernhammer, ES (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.; Schernhammer, ES (corresponding author), Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA.; Schernhammer, ES (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	eva.schernhammer@meduniwien.ac.at	Hecking/AAK-7399-2021	Robinson, Bruce/0000-0003-0749-1714; Hodlmoser, Sebastian/0000-0003-2441-1210; Krenn, Simon/0000-0003-0899-9085; Zee, Jarcy/0000-0003-0586-1160	Austrian Science Fund	Austrian Science Fund(Austrian Science Fund (FWF))	This study was supported by a grant from the Austrian Science Fund https://m.fwf.ac.at/en/with grant No. KL754-B, received by MH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2019, R LANG ENV STAT COMP; [Anonymous], 2018, US RENAL DATA SYSTEM; [Anonymous], 2019, CHRON KIDN DIS US; [Anonymous], 2019, US RENAL DATA SYSTEM; [Anonymous], 2006, NATL HLTH NUTR EXAMI; [Anonymous], 2020, NATL HLTH NUTR EXAMI; Antlanger M, 2019, CLIN J AM SOC NEPHRO, V14, P1616, DOI 10.2215/CJN.04400419; Arhuidese IJ, 2020, ANN VASC SURG, V65, P196, DOI 10.1016/j.avsg.2019.08.083; Bikbov B, 2020, LANCET, V395, P709, DOI 10.1016/S0140-6736(20)30045-3; Carrero JJ, 2018, NAT REV NEPHROL, V14, P151, DOI 10.1038/nrneph.2017.181; (CDC) CfDCaP, 2020, NAT HLTH NUTR EX SUR; Centers for Disease Control and Prevention, 2022, NHANES SURV METH AN; Chu CD, 2020, AM J KIDNEY DIS, DOI [10.1053/j.ajkd.2020.01.007, DOI 10.1053/J.AJKD.2020.01.00732305206]; Coresh J, 2005, J AM SOC NEPHROL, V16, P180, DOI 10.1681/ASN.2004070539; Crews DC, 2014, J AM SOC NEPHROL, V25, P370, DOI 10.1681/ASN.2013050567; Curtis S, 2020, CURR OPIN NEPHROL HY, V29, P333, DOI 10.1097/MNH.0000000000000597; den Hartog JR, 2009, CLIN J AM SOC NEPHRO, V4, P419, DOI 10.2215/CJN.04080808; Division of the National Health and Nutrition Examination Surveys, 2018, NATL HLTH NUTR EXAMI; Froissart M, 2005, J AM SOC NEPHROL, V16, P763, DOI 10.1681/ASN.2004070549; Glassock R, 2015, JAMA-J AM MED ASSOC, V314, P559, DOI 10.1001/jama.2015.6731; Hecking M, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001750; Imai E, 2010, CLIN EXP NEPHROL, V14, P558, DOI 10.1007/s10157-010-0328-6; Kainz A, 2019, NEPHROL DIAL TRANSPL, V34, P1026, DOI 10.1093/ndt/gfy322; Kausz AT, 2000, J AM SOC NEPHROL, V11, P2351, DOI 10.1681/ASN.V11122351; Kidney Disease Improving Global Outcomes (KDIGO), 2013, KDIGO 2012 CLIN PRAC; KJELLSTRAND CM, 1987, NEPHRON, V45, P257, DOI 10.1159/000184160; Lash JP, 2009, CLIN J AM SOC NEPHRO, V4, P1302, DOI 10.2215/CJN.00070109; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2012, KIDNEY INT S, V2013, P1, DOI DOI 10.1038/kisup.2012.73; Levin A, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-121; Lumley T., 2019, SURVEY ANAL COMPLEX; McDonough DP, 2007, CLIN J AM SOC NEPHRO, V2, P1355, DOI 10.2215/CJN.01570407; Muntner P, 2012, CLIN J AM SOC NEPHRO, V7, P101, DOI 10.2215/CJN.06450611; Murphy D, 2016, ANN INTERN MED, V165, P473, DOI 10.7326/M16-0273; Nitsch D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f324; Plantinga LC, 2008, ARCH INTERN MED, V168, P2268, DOI 10.1001/archinte.168.20.2268; Slinin Y, 2014, CLIN J AM SOC NEPHRO, V9, P310, DOI 10.2215/CJN.04190413; Stengel B, 2019, NEPHROL DIAL TRANSPL, V34, P277, DOI 10.1093/ndt/gfy058; Swedko P, 2003, ARCH INTERN MED, V163, P356, DOI 10.1001/archinte.163.3.356; Tarver-Carr ME, 2002, J AM SOC NEPHROL, V13, P2363, DOI 10.1097/01.ASN.0000026493.18542.6A; Titze S, 2015, NEPHROL DIAL TRANSPL, V30, P441, DOI 10.1093/ndt/gfu294; Tuot DS, 2019, KIDNEY MED, V1, P43, DOI 10.1016/j.xkme.2019.01.005; Tuot DS, 2016, CLIN J AM SOC NEPHRO, V11, P1566, DOI 10.2215/CJN.00490116; Wetzels JFM, 2007, KIDNEY INT, V72, P632, DOI 10.1038/sj.ki.5002374; Wheeler W, 2013, MMWR-MORBID MORTAL W, V62, P245; Xie Y, 2018, KIDNEY INT, V94, P567, DOI 10.1016/j.kint.2018.04.011; Yuan J, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0441-9; 2008, NATL HLTH NUTR EXAMI	48	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0243431	10.1371/journal.pone.0243431	http://dx.doi.org/10.1371/journal.pone.0243431			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8CZ	33338051	gold, Green Published			2022-12-27	WOS:000601313500010
J	Liu, W; Livesey, EJ; Lachnit, H; Don, HJ; Thorwart, A				Liu, Wei; Livesey, Evan J.; Lachnit, Harald; Don, Hilary J.; Thorwart, Anna			Does learning history shape the associability of outcomes? Further tests of the outcome predictability effect	PLOS ONE			English	Article							CONFIDENCE-INTERVALS; PREEXPOSURE PHENOMENON; STATISTICAL POWER; PREDICTIVENESS; BLOCKING; REINFORCEMENT; DISTRIBUTIONS; ACQUISITION; INTENSITY; STIMULI	In recent years, several studies of human predictive learning demonstrated better learning about outcomes that have previously been experienced as consistently predictable compared to outcomes previously experienced as less predictable, namely the outcome predictability effect. As this effect may have wide-reaching implications for current theories of associative learning, the present study aimed to examine the generality of the effect with a human goal-tracking paradigm, employing three different designs to manipulate the predictability of outcomes in an initial training phase. In contrast to the previous studies, learning in a subsequent phase, when every outcome was equally predictable by novel cues, was not reliably affected by the outcomes' predictability in the first phase. This lack of an outcome predictability effect provides insights into the parameters of the effect and its underlying mechanisms.	[Liu, Wei; Lachnit, Harald; Thorwart, Anna] Philipps Univ Marburg, Dept Psychol, Marburg, Germany; [Livesey, Evan J.; Don, Hilary J.] Univ Sydney, Sch Psychol, Sydney, NSW, Australia; [Liu, Wei] Philipps Univ Marburg, Sch Med, Marburg, Germany	Philipps University Marburg; University of Sydney; Philipps University Marburg	Liu, W (corresponding author), Philipps Univ Marburg, Dept Psychol, Marburg, Germany.; Liu, W (corresponding author), Philipps Univ Marburg, Sch Med, Marburg, Germany.	wei.liu@staff.uni-marburg.de	Lachnit, Harald/A-9640-2008; Thorwart, Anna/E-1237-2017	Lachnit, Harald/0000-0003-0182-838X; Thorwart, Anna/0000-0002-7620-4427	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [256632786]	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG))	The study reported in this article was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) - Project number 256632786 (grant recipient: AT).	Ahrens AM, 2016, BEHAV BRAIN RES, V296, P418, DOI 10.1016/j.bbr.2015.07.055; ANNAU Z, 1961, J COMP PHYSIOL PSYCH, V54, P428, DOI 10.1037/h0042199; [Anonymous], 2017, DISCOUR CONTEXT MEDI, V19, P1, DOI DOI 10.1080/14613808.2015.1077799; Arcediano F, 1997, LEARN MOTIV, V28, P188, DOI 10.1006/lmot.1996.0957; BAKER AG, 1981, J EXP PSYCHOL ANIM B, V7, P109, DOI 10.1037/0097-7403.7.2.109; Beckmann JS, 2015, LEARN MEMORY, V22, P116, DOI 10.1101/lm.037382.114; Beesley T, 2010, Q J EXP PSYCHOL, V63, P108, DOI 10.1080/17470210902831767; Boakes RA, 2015, J EXP PSYCHOL-ANIM L, V41, P52, DOI 10.1037/xan0000046; Brandstatter E., 1999, METHODS PSYCHOL RES, V4, P33; Bulloch MC, 2015, EXP BRAIN RES, V233, P3413, DOI 10.1007/s00221-015-4413-7; Bush Robert R., 1955, STOCHASTIC MODELS LE; Campbell JID, 2012, BEHAV RES METHODS, V44, P1255, DOI 10.3758/s13428-012-0186-0; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; De Houwer J, 2009, LEARN BEHAV, V37, P1, DOI 10.3758/LB.37.1.1; Denniston JC, 1996, PSYCHOL SCI, V7, P325, DOI 10.1111/j.1467-9280.1996.tb00383.x; Don HJ, 2015, Q J EXP PSYCHOL, V68, P1327, DOI 10.1080/17470218.2014.979212; Dopson JC, 2010, J EXP PSYCHOL ANIM B, V36, P258, DOI 10.1037/a0016588; Doya K, 2002, NEURAL COMPUT, V14, P1347, DOI 10.1162/089976602753712972; Fanelli D, 2012, SCIENTOMETRICS, V90, P891, DOI 10.1007/s11192-011-0494-7; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gottlieb DA, 2005, J EXP PSYCHOL-ANIM B, V31, P319, DOI 10.1037/0097-7403.31.3.319; Gottlieb DA, 2010, J EXP PSYCHOL ANIM B, V36, P217, DOI 10.1037/a0016425; Griffiths O, 2019, J EXP PSYCHOL-ANIM L, V45, P1, DOI 10.1037/xan0000195; Griffiths O, 2018, J EXP PSYCHOL LEARN, V44, P1215, DOI 10.1037/xlm0000529; Griffiths O, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00511; Griffiths O, 2015, J EXP PSYCHOL-ANIM L, V41, P1, DOI 10.1037/xan0000042; Gunther LM, 1997, J EXP PSYCHOL ANIM B, V23, P15, DOI 10.1037/0097-7403.23.1.15; Harris JA, 2013, J EXP PSYCHOL ANIM B, V39, P107, DOI 10.1037/a0031315; HINCHY J, 1995, Q J EXP PSYCHOL-B, V48, P2; Ioannidis JPA, 2008, EPIDEMIOLOGY, V19, P640, DOI 10.1097/EDE.0b013e31818131e7; Jain Aditya, 2015, Int J Appl Basic Med Res, V5, P124, DOI 10.4103/2229-516X.157168; Jeffreys H., 1961, THEORY PROBABILITY; Kamin L. J., 1969, PUNISHMENT AVERSIVE, P279, DOI DOI 10.2105/AJPH.2006.090910; KAMIN LJ, 1961, CAN J PSYCHOLOGY, V15, P176, DOI 10.1037/h0083217; Kleiner M, 2007, PERCEPTION, V36, P14; Koenig S, 2011, J EXP PSYCHOL LEARN, V37, P1164, DOI 10.1037/a0023718; Le Pelley ME, 2003, Q J EXP PSYCHOL-B, V56, P68, DOI 10.1080/02724990244000179; Lesaint F, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003466; Livesey EJ, 2007, J EXP PSYCHOL-ANIM B, V33, P148, DOI 10.1037/0097-7403.33.2.148; Lochmann T, 2003, P EUROCOGSCI 03 EUR, P217; MACKINTOSH NJ, 1975, PSYCHOL REV, V82, P276, DOI 10.1037/h0076778; MACKINTOSH NJ, 1971, Q J EXP PSYCHOL, V23, P359, DOI 10.1080/14640747108400245; MAIER SF, 1976, J EXP PSYCHOL GEN, V105, P3, DOI 10.1037/0096-3445.105.1.3; Mair MM, 2020, ENVIRON TOXICOL CHEM, V39, P2109, DOI 10.1002/etc.4847; Mathot S, 2017, BAYES BAWS INTERPRET; Mennie N, 2007, EXP BRAIN RES, V179, P427, DOI 10.1007/s00221-006-0804-0; Mitchell CJ, 2012, J EXP PSYCHOL ANIM B, V38, P191, DOI 10.1037/a0027385; Morrison SE, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00468; Park I, 1999, MEAS PHYS ED EXERC S, V3, P249; Pavlov IP, 2010, ANN NEUROSCI, V17, P136, DOI 10.5214/ans.0972-7531.1017309; Pearce JM, 2001, ANNU REV PSYCHOL, V52, P111, DOI 10.1146/annurev.psych.52.1.111; PEARCE JM, 1987, PSYCHOL REV, V94, P61, DOI 10.1037/0033-295X.94.1.61; Potvin PJ, 2000, BEHAV RES METH INS C, V32, P347, DOI 10.3758/BF03207805; RANDICH A, 1981, LEARN MOTIV, V12, P321, DOI 10.1016/0023-9690(81)90012-6; RANDICH A, 1979, PSYCHOL BULL, V86, P523, DOI 10.1037/0033-2909.86.3.523; Rescorla R.A., 1972, THEORY PAVLOVIAN CON, P64; Rode AN, 2020, FRONT BEHAV NEUROSCI, V13, DOI 10.3389/fnbeh.2019.00291; Shelton J., 2010, NEUROSCIENCE MED, V1, P30, DOI [10.4236/nm.2010.11004, DOI 10.4236/NM.2010.11004]; Shone LT, 2015, J EXP PSYCHOL-ANIM L, V41, P18, DOI 10.1037/xan0000047; Simonsohn U, 2014, PERSPECT PSYCHOL SCI, V9, P666, DOI 10.1177/1745691614553988; Smithson M, 2001, EDUC PSYCHOL MEAS, V61, P605, DOI 10.1177/00131640121971392; Steiger JH, 2004, PSYCHOL METHODS, V9, P164, DOI 10.1037/1082-989X.9.2.164; Sutton R.S., 1990, LEARNING COMPUTATION, P497; TAYLOR JA, 1956, J EXP PSYCHOL, V51, P127, DOI 10.1037/h0042941; Thorwart A, 2017, J EXP PSYCHOL-ANIM L, V43, P341, DOI 10.1037/xan0000150; Thorwart A, 2017, Q J EXP PSYCHOL, V70, P1366, DOI 10.1080/17470218.2016.1184290; Waldmann MR, 1996, PSYCHOL LEARN MOTIV, V34, P47, DOI 10.1016/S0079-7421(08)60558-7; Wetzels R, 2012, AM STAT, V66, P104, DOI 10.1080/00031305.2012.695956	68	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0243434	10.1371/journal.pone.0243434	http://dx.doi.org/10.1371/journal.pone.0243434			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PI8CZ	33338047	Green Published, gold			2022-12-27	WOS:000601313500007
J	Chuerduangphui, J; Ekalaksananan, T; Heawchaiyaphum, C; Vatanasapt, P; Pientong, C				Chuerduangphui, Jureeporn; Ekalaksananan, Tipaya; Heawchaiyaphum, Chukkris; Vatanasapt, Patravoot; Pientong, Chamsai			Peroxiredoxin 2 is highly expressed in human oral squamous cell carcinoma cells and is upregulated by human papillomavirus oncoproteins and arecoline, promoting proliferation	PLOS ONE			English	Article							OXIDATIVE-STRESS; CANCER CELLS; COLORECTAL-CANCER; RISK FACTOR; ARECA NUT; SURVIVAL; PRDX2	Peroxiredoxin 2 (PRDX2) is upregulated in various cancers including oral squamous cell carcinoma (OSCC). It is a known tumor promoter in some cancers, but its role in OSCC is unclear. This study aimed to investigate the effect of arecoline, an alkaloid of the betel nut, and human papillomavirus type 16 (HPV16) E6/E7 oncoproteins on induction of PRDX2 expression, and also the effects of PRDX2 overexpression in oral cell lines. Levels of PRDX2 protein were determined using western blot analysis of samples of exfoliated normal oral cells (n = 75) and oral lesion cells from OSCC cases (n = 75). Some OSCC cases were positive for HPV infection and some patients had a history of betel quid chewing. To explore the level of PRDX2 by western blot, the proteins were extracted from oral cell lines that were treated with arecoline or retroviruses containing HPV16 E6 gene and HPV16 E6/E7 expressing vector. For analysis of PRDX2 functions, cell proliferation, cell-cycle progression, apoptosis and migration was compared between oral cells overexpressing PRDX2 and cells with PRDX2-knockdown. PRDX2 expression levels tended to be higher in OSCC samples that were positive for HPV infection and had history of betel quid chewing. Arecoline treatment in vitro at low concentrations and overexpression of HPV16 E6 or E6/E7 in oral cells induced PRDX2 overexpression. Interestingly, in oral cells, PRDX2 promoted cell proliferation, cell-cycle progression (G2/M phase), cell migration and inhibited apoptosis. Upregulation of PRDX2 in oral cells was induced by arecoline and HPV16 oncoproteins and promoted growth of OSCC cells.	[Chuerduangphui, Jureeporn] Kasetsart Univ, Fac Sci, Dept Microbiol, Bangkok, Thailand; [Chuerduangphui, Jureeporn; Ekalaksananan, Tipaya; Heawchaiyaphum, Chukkris; Vatanasapt, Patravoot; Pientong, Chamsai] Khon Kaen Univ, HPV & EBV & Carcinogenesis Res Grp, Khon Kaen, Thailand; [Ekalaksananan, Tipaya; Heawchaiyaphum, Chukkris; Pientong, Chamsai] Khon Kaen Univ, Fac Med, Dept Microbiol, Khon Kaen, Thailand; [Vatanasapt, Patravoot] Khon Kaen Univ, Fac Med, Dept Otorhinolaryngol, Khon Kaen, Thailand	Kasetsart University; Khon Kaen University; Khon Kaen University; Khon Kaen University	Pientong, C (corresponding author), Khon Kaen Univ, HPV & EBV & Carcinogenesis Res Grp, Khon Kaen, Thailand.; Pientong, C (corresponding author), Khon Kaen Univ, Fac Med, Dept Microbiol, Khon Kaen, Thailand.	chapie@kku.ac.th			Health Systems Research Institute (HSRI), Thailand; Khon Kaen University [I62-00-18-03]	Health Systems Research Institute (HSRI), Thailand; Khon Kaen University	This study was supported by Health Systems Research Institute (HSRI), Thailand, in the form of funding for CP; and Khon Kaen University in the form of a grant (Grant number I62-00-18-03) for TE.	Agrawal-Singh S, 2012, BLOOD, V119, P2346, DOI 10.1182/blood-2011-06-358705; [Anonymous], 2018, PHARMACOTHERAPY, V38, pe29, DOI 10. 1002/phar. 2101; Bara R, 2018, NEOPLASIA, V20, P1106, DOI 10.1016/j.neo.2018.08.013; Chernov IP, 2008, BIOTECHNIQUES, V44, P775, DOI 10.2144/000112732; Chikara S, 2018, CANCER LETT, V413, P122, DOI 10.1016/j.canlet.2017.11.002; Chuerduangphui J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192009; Chuerduangphui J, 2016, MED ONCOL, V33, DOI 10.1007/s12032-016-0800-6; Cui JD, 2015, INT J CLIN EXP PATHO, V8, P12400; De Franceschi L, 2011, HAEMATOL-HEMATOL J, V96, P1595, DOI 10.3324/haematol.2011.043612; De Marco F, 2013, VIRUSES-BASEL, V5, P708, DOI 10.3390/v5020708; Duan T, 2016, MOL MED REP, V13, P4807, DOI 10.3892/mmr.2016.5147; Durzynska J, 2017, MUTAT RES-REV MUTAT, V772, P36, DOI 10.1016/j.mrrev.2016.09.006; Feng K, 2020, ROUTL FRONT BUS MANA, P1; Hall A, 2009, FEBS J, V276, P2469, DOI 10.1111/j.1742-4658.2009.06985.x; Hamid S, 2007, INT J MOL MED, V19, P453; Han XL, 2007, CHINESE MED J-PEKING, V120, P405; Heawchaiyaphum C, 2018, J PROTEOMICS, V173, P52, DOI 10.1016/j.jprot.2017.11.022; Kesarwala AH, 2016, ORAL DIS, V22, P9, DOI 10.1111/odi.12300; Kikuta K, 2010, PROTEOM CLIN APPL, V4, P560, DOI 10.1002/prca.200900172; Kim Y, 2019, J CANCER PREV, V24, P65, DOI 10.15430/JCP.2019.24.2.65; Lee SS, 2010, ORAL DIS, V16, P696, DOI 10.1111/j.1601-0825.2010.01680.x; Li W, 2010, J CLIN INVEST, V120, P3996, DOI 10.1172/JCI42823; Lin PC, 2011, J TOXICOL ENV HEAL A, V74, P737, DOI 10.1080/15287394.2011.539123; Lu WD, 2014, MOL CELL BIOCHEM, V387, P261, DOI 10.1007/s11010-013-1891-4; Luo WB, 2016, ONCOTARGET, V7, P6379, DOI 10.18632/oncotarget.7142; Lv ZB, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1357-7; Maliekal TT, 2008, ONCOGENE, V27, P5110, DOI 10.1038/onc.2008.224; Miller CS, 2001, ORAL SURG ORAL MED O, V91, P622, DOI 10.1067/moe.2001.115392; Nicolussi A, 2017, MOL CLIN ONCOL, V6, P139, DOI 10.3892/mco.2017.1129; Park MH, 2016, PHARMACOL THERAPEUT, V163, P1, DOI 10.1016/j.pharmthera.2016.03.018; Peng LL, 2017, ONCOTARGET, V8, P15057, DOI 10.18632/oncotarget.14801; Phalen TJ, 2006, J CELL BIOL, V175, P779, DOI 10.1083/jcb.200606005; Shih YT, 2010, FREE RADICAL BIO MED, V49, P1471, DOI 10.1016/j.freeradbiomed.2010.07.017; Sonini Y, 2006, APMIS, V114, P329; Stresing V, 2013, ONCOGENE, V32, P724, DOI 10.1038/onc.2012.93; Tamm I, 2002, CANCER GENE THER, V9, P641, DOI 10.1038/sj.cgt.7700480; Thangjam GS, 2009, J PERIODONTAL RES, V44, P673, DOI 10.1111/j.1600-0765.2008.01176.x; Tomar S, 2016, HEAD NECK-J SCI SPEC, V38, pE694, DOI 10.1002/hed.24072; Wang S, 2020, REDOX BIOL, V28, DOI 10.1016/j.redox.2019.101319; Warnakulasuriya S, 2002, BMJ-BRIT MED J, V324, P799, DOI 10.1136/bmj.324.7341.799; Williams VM, 2014, J VIROL, V88, P6751, DOI 10.1128/JVI.03355-13; Wu F, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.301; Yang Y, 2018, INT J MOL MED, V41, P3366, DOI 10.3892/ijmm.2018.3519; Zhang EY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103440; Zhao X, 2018, NAT COMMUN, V9, P1	45	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0242465	10.1371/journal.pone.0242465	http://dx.doi.org/10.1371/journal.pone.0242465			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332365	Green Published, gold			2022-12-27	WOS:000601310900029
J	Danstrup, CS; Marcussen, M; Pedersen, IS; Jacobsen, H; Dybkaer, K; Gaihede, M				Danstrup, Christian Sander; Marcussen, Mette; Pedersen, Inge Sokilde; Jacobsen, Henrik; Dybkaer, Karen; Gaihede, Michael			DNA methylation biomarkers in peripheral blood of patients with head and neck squamous cell carcinomas. A systematic review	PLOS ONE			English	Review							P16 PROMOTER METHYLATION; HUMAN-PAPILLOMAVIRUS; GENE METHYLATION; HUMAN CANCER; SERUM; PLASMA; SURVIVAL; HYPERMETHYLATION; HYPOMETHYLATION; VALIDATION	Background Head and neck squamous cell carcinomas (HNSCC) are often diagnosed in advanced stages. In search of new diagnostic tools, focus has shifted towards the biological properties of the HNSCC, and the number of different biomarkers under investigation is rapidly growing. Objectives The objective was to review the current literature regarding aberrantly methylated DNA found in peripheral blood plasma or serum in patients with HNSCC and to evaluate the diagnostic accuracy of these changes. Methods The inclusion criteria were clinical studies involving patients with verified HNSCC that reported findings of aberrantly methylated DNA in peripheral blood serum or plasma. We systematically searched PubMed, OVID Embase and Cochrane Library. In addition to the search, we performed forward and backward chaining in references and Web of Science. The protocol was registered in PROSPERO: CRD42019135406. Two authors independently extracted data. The quality and the risk of bias of the included studies were assessed by the QUADAS-2 tool. Results A total of 1,743 studies were found eligible for screening, while ultimately seven studies were included. All studies were found to have methodological weaknesses, mainly concerning patient selection bias. The best individual marker of HNSCC was Septin 9 in plasma with a sensitivity of 57% and a specificity of 95%. Conclusions None of the aberrantly methylated genes found in the retrieved studies are applicable as single diagnostic markers for HNSCC and the best gene-panels still lack diagnostic accuracy. Future studies may benefit from newer sequencing techniques but validation studies with well-designed cohorts are also needed in the process of developing epigenetic based diagnostic tests for HNSCC.	[Danstrup, Christian Sander; Jacobsen, Henrik; Gaihede, Michael] Aalborg Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg & Audiol, Aalborg, Denmark; [Danstrup, Christian Sander; Marcussen, Mette; Pedersen, Inge Sokilde; Dybkaer, Karen] Aalborg Univ Hosp, Clin Canc Res Ctr, Aalborg, Denmark; [Pedersen, Inge Sokilde] Aalborg Univ Hosp, Dept Mol Diagnost, Aalborg, Denmark; [Pedersen, Inge Sokilde; Dybkaer, Karen; Gaihede, Michael] Aalborg Univ, Dept Clin Med, Aalborg, Denmark; [Dybkaer, Karen] Aalborg Univ Hosp, Dept Hematol, Aalborg, Denmark	Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University; Aalborg University Hospital	Danstrup, CS (corresponding author), Aalborg Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg & Audiol, Aalborg, Denmark.; Danstrup, CS (corresponding author), Aalborg Univ Hosp, Clin Canc Res Ctr, Aalborg, Denmark.	csd@rn.dk	Pedersen, Inge Søkilde/ABB-1019-2020	Pedersen, Inge Søkilde/0000-0002-9902-8040; Dybkaer, Karen/0000-0003-2488-435X; Danstrup, Christian/0000-0001-5675-5769	Department of Clinical Medicine, Aalborg University; Department of Otorhinolaryngology - Head & Neck Surgery and Audiology, Aalborg University Hospital, Denmark	Department of Clinical Medicine, Aalborg University; Department of Otorhinolaryngology - Head & Neck Surgery and Audiology, Aalborg University Hospital, Denmark	This study has been supported by Department of Clinical Medicine, Aalborg University and Department of Otorhinolaryngology - Head & Neck Surgery and Audiology, Aalborg University Hospital, Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin MB, 2017, AJCC CANC STAGING MA, V8th; ANTEQUERA F, 1993, P NATL ACAD SCI USA, V90, P11995, DOI 10.1073/pnas.90.24.11995; ARMSTRONG WB, 1995, OTOLARYNG CLIN N AM, V28, P685; Basu B, 2017, CLIN EPIGENETICS, V9, DOI 10.1186/s13148-017-0314-x; Bestor TH, 2015, P NATL ACAD SCI USA, V112, P6796, DOI 10.1073/pnas.1415301111; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; BLOT WJ, 1988, CANCER RES, V48, P3282; Braakhuis BJM, 2014, ORAL ONCOL, V50, P670, DOI 10.1016/j.oraloncology.2014.03.008; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Carvalho AL, 2008, CLIN CANCER RES, V14, P97, DOI 10.1158/1078-0432.CCR-07-0722; Chang HSW, 2004, CANCER-AM CANCER SOC, V101, P125, DOI 10.1002/cncr.20323; Church TR, 2014, GUT, V63, P317, DOI 10.1136/gutjnl-2012-304149; Clark C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050233; de Vos L, 2017, CLIN EPIGENETICS, V9, DOI 10.1186/s13148-017-0425-4; Diehl F, 2005, P NATL ACAD SCI USA, V102, P16368, DOI 10.1073/pnas.0507904102; El-Naggar AK, 2012, HEAD NECK-J SCI SPEC, V34, P459, DOI 10.1002/hed.21974; Junior JCEM, 2017, CLIN COSMET INVESTIG, V9, P33, DOI 10.2147/CCIDE.S134125; Fakhry C, 2008, JNCI-J NATL CANCER I, V100, P261, DOI 10.1093/jnci/djn011; FEINBERG AP, 1983, BIOCHEM BIOPH RES CO, V111, P47, DOI 10.1016/S0006-291X(83)80115-6; Gatta G, 2015, EUR J CANCER, V51, P2130, DOI 10.1016/j.ejca.2015.07.043; Hasegawa M, 2002, ONCOGENE, V21, P4231, DOI 10.1038/sj.onc.1205528; Hayashi M, 2015, CANCER-AM CANCER SOC, V121, P1957, DOI 10.1002/cncr.29303; Henriksen T.V, 2019, EFFECT SURG TRAUMA P; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hoadley KA, 2018, CELL, V173, P291, DOI 10.1016/j.cell.2018.03.022; Howlader NR, 2020, BREAST CANCER RES TR, V182, P739, DOI 10.1007/s10549-020-05738-8; Imperiale TF, 2014, NEW ENGL J MED, V370, P1287, DOI 10.1056/NEJMoa1311194; Issa IA, 2017, WORLD J GASTROENTERO, V23, P5086, DOI 10.3748/wjg.v23.i28.5086; Jahr S, 2001, CANCER RES, V61, P1659; Jakobsen KK, 2018, ACTA ONCOL, V57, P1143, DOI 10.1080/0284186X.2018.1438657; Janz TA, 2019, OTOLARYNG HEAD NECK, V160, P284, DOI DOI 10.1177/0194599818792205; Jung M, 2003, CLIN CHEM, V49, P1028, DOI 10.1373/49.6.1028; Kristensen LS, 2009, CLIN CHEM, V55, P1471, DOI 10.1373/clinchem.2008.121962; Lassen P, 2014, RADIOTHER ONCOL, V113, P310, DOI 10.1016/j.radonc.2014.11.032; Lassen P, 2010, RADIOTHER ONCOL, V95, P371, DOI 10.1016/j.radonc.2010.04.022; Liu MC, 2020, ANN ONCOL, V31, P745, DOI 10.1016/j.annonc.2020.02.011; Lu YF, 2018, J EXP CLIN CANC RES, P37, DOI [10.1186/s13046-018-0689-3, DOI 10.1186/S13046-018-0689-3]; Mancini M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21186542; Misawa K, 2016, ONCOTARGET, V7, P26087, DOI 10.18632/oncotarget.8317; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Mulero-Navarro S, 2008, CRIT REV ONCOL HEMAT, V68, P1, DOI 10.1016/j.critrevonc.2008.03.001; Mydlarz WK, 2016, HEAD NECK-J SCI SPEC, V38, P9, DOI 10.1002/hed.23842; Nakahara Y, 2006, INT J ORAL MAX SURG, V35, P362, DOI 10.1016/j.ijom.2005.08.005; Nakayama H, 2002, CANCER LETT, V188, P115, DOI 10.1016/S0304-3835(01)00839-4; Ooki A, 2017, CLIN CANCER RES, V23, P7141, DOI 10.1158/1078-0432.CCR-17-1222; Orntoft MBW, 2017, EPIGENETICS-US, V12, P626, DOI 10.1080/15592294.2017.1334024; Partin AW, 2014, J UROLOGY, V192, P1081, DOI 10.1016/j.juro.2014.04.013; Pedersen IS, 2012, BMC MOL BIOL, V13, DOI 10.1186/1471-2199-13-12; Pulte D, 2010, ONCOLOGIST, V15, P994, DOI 10.1634/theoncologist.2009-0289; Queimado LV, 2013, CANCER RES, V73, P4299, DOI [10.1158/1538-7445.am2013-4299, DOI 10.1158/1538-7445.AM2013-4299]; Roh JL, 2013, CLIN CANCER RES, V19, P2528, DOI 10.1158/1078-0432.CCR-12-3047; Sanchez-Cespedes M, 2000, CANCER RES, V60, P892; Schrock A, 2017, CLIN CHEM, V63, P1288, DOI 10.1373/clinchem.2016.270207; Shen SY, 2018, NATURE, V563, P579, DOI 10.1038/s41586-018-0703-0; Sidransky D, 2002, NAT REV CANCER, V2, P210, DOI 10.1038/nrc755; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sun WY, 2010, CLIN CANCER RES, V16, P857, DOI 10.1158/1078-0432.CCR-09-2604; Symonds EL, 2018, CLIN EPIGENETICS, V10, DOI 10.1186/s13148-018-0500-5; Tanaka K, 2007, BIOORG MED CHEM LETT, V17, P1912, DOI 10.1016/j.bmcl.2007.01.040; Thompson-Harvey A, 2020, CANCER-AM CANCER SOC, V126, P1090, DOI 10.1002/cncr.32583; van Kessel KEM, 2017, J UROLOGY, V197, P590, DOI 10.1016/j.juro.2016.09.118; Vidal E, 2017, ONCOGENE, V36, P5648, DOI 10.1038/onc.2017.176; Virani S, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1806-8; Weiss G, 2017, J THORAC ONCOL, V12, P77, DOI 10.1016/j.jtho.2016.08.123; Westra William H, 2012, Head Neck Pathol, V6 Suppl 1, pS48, DOI 10.1007/s12105-012-0371-6; Wong TS, 2003, EUR J CANCER, V39, P1881, DOI 10.1016/S0959-8049(03)00428-3; Yokoi K, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040735; Zuo CL, 2004, CANCER EPIDEM BIOMAR, V13, P967	68	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0244101	10.1371/journal.pone.0244101	http://dx.doi.org/10.1371/journal.pone.0244101			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332423	Green Published, gold			2022-12-27	WOS:000601310900057
J	Biswas, A; Divya, S; Sharmila, P; Pardha-Saradhi, P				Biswas, Abhishek; Divya, Subramaniyan; Sharmila, Peddisetty; Pardha-Saradhi, Peddisetty			Light promoted brown staining of protoplasm by Ag+ is ideal to test wheat pollen viability rapidly	PLOS ONE			English	Article							SILVER; NANOPARTICLES	Pollen viability is crucial for wheat breeding programs. The unique potential of the protoplasm of live cells to turn brown due to the synthesis of silver nanoparticles (AgNPs) through rapid photoreduction of Ag+, was exploited for testing wheat pollen viability. Ag+-viability test medium (consisting of 0.5 mM AgNO3 and 300 mM KNO3) incubated with wheat pollen turned brown within 2 min under intense light (similar to 600 mu mol photon flux density m(-2)s(-1)), but not in dark. The brown medium displayed AgNPs-specific surface plasmon resonance band in its absorption spectrum. Light microscopic studies showed the presence of uniformly stained brown protoplasm in viable pollen incubated with Ag+-viability medium in the presence of light. Investigations with transmission electron microscope coupled with energy dispersive X-ray established the presence of distinct 5-35 nm NPs composed of Ag. Powder X-ray diffraction analysis revealed that AgNPs were crystalline and biphasic composed of Ag-0 and Ag2O. Conversely, non-viable pollen and heat-killed pollen did not turn brown on incubation with Ag(+-)medium in light. We believe that the viable wheat pollen turn brown rapidly by bio-transforming Ag+ to AgNPs through photoreduction. Our findings furnish a novel simplest and rapid method for testing wheat pollen viability.	[Biswas, Abhishek; Divya, Subramaniyan; Sharmila, Peddisetty; Pardha-Saradhi, Peddisetty] Univ Delhi, Dept Environm Studies, Delhi, India	University of Delhi	Pardha-Saradhi, P (corresponding author), Univ Delhi, Dept Environm Studies, Delhi, India.	ppsaradhi@gmail.com		Biswas, Abhishek/0000-0001-8125-1167; Pardha-Saradhi, P./0000-0001-7122-7518				Beattie IR, 2011, METALLOMICS, V3, P628, DOI 10.1039/c1mt00044f; Dafni A, 2000, PLANT SYST EVOL, V222, P113, DOI 10.1007/BF00984098; Firon N, 2012, ANN BOT-LONDON, V109, P1201, DOI 10.1093/aob/mcs070; Guo HY, 2019, ENVIRON SCI-NANO, V6, P1099, DOI [10.1039/C9EN00088G, 10.1039/c9en00088g]; Heidmann I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165531; HESLOPHARRISON J, 1984, THEOR APPL GENET, V67, P367, DOI 10.1007/BF00272876; Impe D, 2020, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01588; Maillard M, 2003, NANO LETT, V3, P1611, DOI 10.1021/nl034666d; Mesihovic A, 2016, PLANT REPROD, V29, P93, DOI 10.1007/s00497-016-0281-y; Mohan S, 2014, CARBOHYD POLYM, V106, P469, DOI 10.1016/j.carbpol.2014.01.008; Pacini E, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00679; Pardha-Saradhi P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106715; Rodriguez-Riano T, 2000, SEX PLANT REPROD, V12, P241, DOI 10.1007/s004970050008; Shabnam N, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01052; Shabnam N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167937; Speranza A, 1997, SEX PLANT REPROD, V10, P110, DOI 10.1007/s004970050076; STONE JL, 1995, AM J BOT, V82, P1186, DOI 10.2307/2446073; Yamal G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061750	18	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243856	10.1371/journal.pone.0243856	http://dx.doi.org/10.1371/journal.pone.0243856			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326483	gold, Green Published			2022-12-27	WOS:000600176400074
J	Kolewe, EL; Stillman, Z; Woodward, IR; Fromen, CA				Kolewe, Emily L.; Stillman, Zachary; Woodward, Ian R.; Fromen, Catherine A.			Check the gap: Facemask performance and exhaled aerosol distributions around the wearer	PLOS ONE			English	Article							PARTICLE-SIZE; RESPIRATOR; LEAKAGE; FILTER; MASKS; EFFICIENCY	Current facemask research focuses on material characterization and efficiency; however, facemasks are often not tested such that aerosol distributions are evaluated from the gaps in the sides, bottom, and nose areas. Poor evaluation methods could lead to misinformation on optimal facemasks use; a high-throughput, reproducible method which illuminates the issue of fit influencing aerosol transmission is needed. To this end, we have created an in vitro model to quantify particle transmission by mimicking exhalation aerosols in a 3D printed face-nose-mouth replica via a nebulizer and quantifying particle counts using a hand-held particle counter. A sewn, sewn with pipe cleaner nose piece, and sewn with a coffee filter facemask were used to evaluate current common homemade sewn facemask designs, benchmarked against industry standard surgical, N95 respirator tightly fit, and N95 respirator loosely fit facemasks. All facemasks have significantly reduced particle counts in front of the facemask, but the side and top of the facemask showed increases in particle counts over the no facemask condition at that same position, suggesting that some proportion of aerosols are being redirected to these gaps. An altered size distribution of aerosols that escape at the vulnerable positions was observed; escaped particles have larger count median diameters, with a decreased ratio of smaller to larger particles, possibly due to hygroscopic growth or aggregation. Of the homemade sewn facemasks, the facemask with a coffee filter insert performed the best at reducing escaped aerosols, with increased efficiency also observed for sewn masks with a pipe cleaner nose piece. Importantly, there were minimal differences between facemasks at increasing distances, which supports that social distance is a critical element in reducing aerosol transmission. This work brings to light the importance of quantifying particle count in positions other than directly in front of the facemask and identifies areas of research to be explored.	[Kolewe, Emily L.; Stillman, Zachary; Woodward, Ian R.; Fromen, Catherine A.] Univ Delaware, Dept Chem & Biomol Engn, Newark, DE 19711 USA	University of Delaware	Fromen, CA (corresponding author), Univ Delaware, Dept Chem & Biomol Engn, Newark, DE 19711 USA.	cfromen@udel.edu		Woodward, Ian/0000-0003-4471-3734	University of Delaware; Delaware INBRE program; National Institute of General Medical Sciences-NIGMS from the National Institutes of Health [P20 GM103446]; NIGMS [T32GM008550]; State of Delaware	University of Delaware; Delaware INBRE program; National Institute of General Medical Sciences-NIGMS from the National Institutes of Health; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); State of Delaware	This work was supported in part by internal University of Delaware (https://www.udel.edu/) funds received by C.A.F. and by the Delaware INBRE program supported by a grant from the National Institute of General Medical SciencesNIGMS (https://www.nigms.nih.gov/) Award Number P20 GM103446 - from the National Institutes of Health and the State of Delaware received by C.A.F.. Z.S.S. was supported by a NIGMS training grant Award Number T32GM008550. The content is solely the responsibility of the authors and does not necessarily represent the official views of NIGMS or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlawat A, AEROSOL AIR QUALITY, P20; [Anonymous], 1994, ARCHIVUM HIST PONTIF, p254s; Brooks JT, 2020, JAMA-J AM MED ASSOC, V324, P635, DOI 10.1001/jama.2020.13107; Cherrie JW, 2019, J EXPO SCI ENV EPID, V29, P578, DOI 10.1038/s41370-018-0089-y; Cho HW, 2011, ANN OCCUP HYG, V55, P666, DOI 10.1093/annhyg/mer032; Davies A, 2013, DISASTER MED PUBLIC, V7, P413, DOI 10.1017/dmp.2013.43; Davies C N, 1953, P I MECH ENG, V167, P185, DOI DOI 10.1177/095440545300100113; Davies J, NEBULIZER PERFORMANC, pA2193; Dbouk T, 2020, PHYS FLUIDS, V32, DOI 10.1063/5.0015044; Fabian P, 2011, J AEROSOL MED PULM D, V24, P137, DOI 10.1089/jamp.2010.0815; Feng Yu, 2017, Bioengineering-Basel, V4, P90, DOI 10.3390/bioengineering4040090; Fischer EP, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abd3083; FURUHASHI M, 1978, Bulletin of Tokyo Medical and Dental University, V25, P7; Gordon CC., 1989, ANTHROPOMETRIC SURVE; Hinds WC, 2022, AEROSOL TECHNOLOGY P, V3; HOLTON PM, 1987, AM IND HYG ASSOC J, V48, P848, DOI 10.1202/0002-8894(1987)048<0848:PSLALO>2.0.CO;2; Howard JR, 2020, SUNY Series Afr Amer, P1; Jain M, 2020, CUREUS, V12, DOI 10.7759/cureus.10423; Kahler CJ, 2020, J AEROSOL SCI, V148, DOI 10.1016/j.jaerosci.2020.105617; Kim JH, 2015, INT J OCCUP MED ENV, V28, P71, DOI 10.13075/ijomeh.1896.00153; Konda A, 2020, ACS NANO, V14, P6339, DOI 10.1021/acsnano.0c03252; Leaks Jr CR, COVID 19 AD HOC SUBC; Lei ZP, 2013, ANN OCCUP HYG, V57, P493, DOI 10.1093/annhyg/mes085; Lenth R. V, 2022, EMMEANS ESTIMATED MA; Leung NHL, 2020, NAT MED, V26, P676, DOI 10.1038/s41591-020-0843-2; Liloia GJ, 1965, Face mask patent, Patent No. [US3220409, 3220409]; Maurer L, 2021, J AEROSOL MED PULM D, V34, P11, DOI 10.1089/jamp.2020.1635; Mueller AV, 2020, MATTER-US, V3, P950, DOI 10.1016/j.matt.2020.07.006; Oberg T, 2008, AM J INFECT CONTROL, V36, P276, DOI 10.1016/j.ajic.2007.07.008; OESTENSTAD RK, 1990, AM IND HYG ASSOC J, V51, P285, DOI 10.1202/0002-8894(1990)051<0285:DOFLSO>2.0.CO;2; Prather KA, 2020, SCIENCE, V368, P1422, DOI 10.1126/science.abc6197; R Core Team, 2015, R LANGUAGE ENV STAT; Rengasamy S, 2012, ANN OCCUP HYG, V56, P568, DOI 10.1093/annhyg/mer122; Rengasamy S, 2010, ANN OCCUP HYG, V54, P789, DOI 10.1093/annhyg/meq044; SAWCHUK WS, 1989, ARCH DERMATOL, V125, P1689, DOI 10.1001/archderm.125.12.1689; Scheuch G, 2020, J AEROSOL MED PULM D, V33, P230, DOI 10.1089/jamp.2020.1616; Schwarz K, 2010, J AEROSOL MED PULM D, V23, P371, DOI 10.1089/jamp.2009.0809; Setti L, 2020, ENVIRON RES, V188, DOI 10.1016/j.envres.2020.109754; Sickbert-Bennett EE, 2020, JAMA INTERN MED, V180, P1607, DOI 10.1001/jamainternmed.2020.4221; Simha PP, 2020, PHYS FLUIDS, V32, DOI 10.1063/5.0021666; STAFFORD RG, 1972, ATMOS ENVIRON, V6, P353, DOI 10.1016/0004-6981(72)90201-6; Tang JW, 2011, J HOSP INFECT, V77, P213, DOI 10.1016/j.jhin.2010.09.037; Tellier R, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3707-y; Tellier R, 2009, J R SOC INTERFACE, V6, pS783, DOI 10.1098/rsif.2009.0302.focus; TUOMI T, 1985, AM IND HYG ASSOC J, V46, P308, DOI 10.1080/15298668591394879; Verma S, 2020, PHYS FLUIDS, V32, DOI 10.1063/5.0016018; Wagner SL, 1980, PROTECTIVE FACE MASK; Wang DJ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240285; White K A, 1985, West Pa Hist Mag, V68, P221; Wickham H., 2019, J OPEN SOURCE SOFTW, V4, P1686, DOI [DOI 10.21105/JOSS.01686, 10.21105/joss.01686]; Wilkinson IJ, 2010, INFECT CONT HOSP EP, V31, P918, DOI 10.1086/655460; Wong P, 2020, J ANESTH, V34, P924, DOI 10.1007/s00540-020-02819-2; World Health Organization, 2020, TRANSM SARS COV2 IMP; World Health Organization, 2020, ADVICE USE MASKS CON; World Health Organization (WHO), 2014, GUID VOL ORG VOL PRA; Zemouri C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178007; Zhang YP, 2013, NICOTINE TOB RES, V15, P501, DOI 10.1093/ntr/nts165; 2014, REG ANESTH PAIN MED, V9	58	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243885	10.1371/journal.pone.0243885	http://dx.doi.org/10.1371/journal.pone.0243885			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326449	Green Published, gold			2022-12-27	WOS:000600176400008
J	Diani-Moore, S; Marques Pedro, T; Rifkind, AB				Diani-Moore, Silvia; Marques Pedro, Tiago; Rifkind, Arleen B.			Organ-specific effects on glycolysis by the dioxin-activated aryl hydrocarbon receptor	PLOS ONE			English	Article							T-CELL DEVELOPMENT; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN TCDD; AEROBIC GLYCOLYSIS; GENE-EXPRESSION; THYMIC ATROPHY; AH RECEPTOR; FATTY LIVER; IL-7; METABOLISM; SIRT6	Activation of the aryl hydrocarbon receptor (AHR) by the environmental toxin dioxin (2,3,7,8-tetrachlorodibenzo-p-dioxin, TCDD) causes diverse toxicities, including thymus atrophy and hepatosteatosis. The mechanisms by which AHR activation by TCDD leads to these toxicities are not fully understood. Here we studied the effects of TCDD on a major energy pathway, glycolysis, using the chick embryo close to hatching, a well-established model for studying dioxin toxicity. We showed that 24 hr of TCDD treatment causes changes in glycolysis in both thymus and liver. In thymus glands, TCDD decreased mRNAs for glycolytic genes and glucose transporters, glycolytic indices and levels of IL7 mRNA, phosphorylated AKT (pAKT) and HIF1A, stimulators of glycolysis and promoters of survival and proliferation of thymic lymphocytes. In contrast, in liver, TCDD increased mRNA levels for glycolytic genes and glucose transporters, glycolytic endpoints and pAKT levels. Similarly, increases by TCDD in mRNA levels for glycolytic genes and glucose transporters in human primary hepatocytes showed that effects in chick embryo liver pertain also to human cells. Treatment with the glycolytic inhibitor 2-deoxy-d-glucose exacerbated the effects on thymus atrophy by TCDD, supporting a role for decreased glycolysis in thymus atrophy by TCDD, but did not prevent hepatosteatosis. NAD(+) precursors abolished TCDD effects on glycolytic endpoints in both thymus and liver. In summary, we report here that dioxin disrupts glycolysis mediated energy metabolism in both thymus and liver, and that it does so in opposite ways, decreasing it in the thymus and increasing it in the liver. Further, the findings support NAD(+) boosting as a strategy against metabolic effects of environmental pollutants such as dioxins.	[Diani-Moore, Silvia; Marques Pedro, Tiago; Rifkind, Arleen B.] Weill Cornell Med, Dept Pharmacol, New York, NY 10065 USA; [Diani-Moore, Silvia; Marques Pedro, Tiago; Rifkind, Arleen B.] Weill Cornell Med, Pharmacol PhD Program, New York, NY USA	Cornell University; Cornell University	Rifkind, AB (corresponding author), Weill Cornell Med, Dept Pharmacol, New York, NY 10065 USA.	arifkind@med.cornell.edu		Marques Pedro, Tiago/0000-0002-1767-0321	NIH [ES-027488]; Winston Foundation; Winston Foundation's gift	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Winston Foundation; Winston Foundation's gift	This research was supported by NIH grant ES-027488 (A.B.R.) and by funds from The Winston Foundation (A.B.R.). Portions of salaries for AB Rifkind and S Diani-Moore were paid with the NIH grant ES-027488 and The Winston Foundation's gift. A portion of T Marques Pedro's salary was paid with The Winston Foundation's gift. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew D, 2002, EXP GERONTOL, V37, P455, DOI 10.1016/S0531-5565(01)00213-3; Angrish MM, 2013, TOXICOL SCI, V131, P108, DOI 10.1093/toxsci/kfs277; [Anonymous], 2017, ONCOGENESIS, V6, pe345; Beamer CA, 2019, ARCH TOXICOL, V93, P355, DOI 10.1007/s00204-018-2366-x; Bock KW, 2006, BIOCHEM PHARMACOL, V72, P393, DOI 10.1016/j.bcp.2006.01.017; Canto C, 2013, MOL ASPECTS MED, V34, P1168, DOI 10.1016/j.mam.2013.01.004; Canto C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023; Carbo R, 2010, DIABETOL METAB SYNDR, V2, DOI 10.1186/1758-5996-2-64; Diani-Moore S, 2006, TOXICOL SCI, V90, P96, DOI 10.1093/toxsci/kfj065; Diani-Moore S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02332-9; Diani-Moore S, 2010, J BIOL CHEM, V285, P38801, DOI 10.1074/jbc.M110.131573; Dimmer KS, 2000, BIOCHEM J, V350, P219, DOI 10.1042/0264-6021:3500219; ElKassar N, 2010, J IMMUNOTOXICOL, V7, P1, DOI 10.3109/15476910903453296; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Finlay DK, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00247; Frericks M, 2008, TOXICOL APPL PHARM, V232, P268, DOI 10.1016/j.taap.2008.07.009; Germain RN, 2002, NAT REV IMMUNOL, V2, P309, DOI 10.1038/nri798; Hale LP, 2002, AM J PHYSIOL-HEART C, V282, pH1467, DOI 10.1152/ajpheart.00682.2001; Han M, 2017, TOXICOL LETT, V273, P10, DOI 10.1016/j.toxlet.2017.03.013; Hantzidiamantis PJ, 2022, PHYSL GLUCOSE STATPE, P2022; Henao-Mejia J, 2013, IMMUNITY, V38, P984, DOI 10.1016/j.immuni.2013.02.021; Humphrey BD, 2008, J NUTR, V138, P1153, DOI 10.1093/jn/138.6.1153; Imai S, 2016, NPJ AGING MECH DIS, V2, DOI 10.1038/npjamd.2016.17; Jacobs SR, 2010, J IMMUNOL, V184, P3461, DOI 10.4049/jimmunol.0902593; KENNEDY SW, 1995, ANAL BIOCHEM, V226, P362, DOI 10.1006/abio.1995.1237; Kim HS, 2010, CELL METAB, V12, P224, DOI 10.1016/j.cmet.2010.06.009; Laiosa MD, 2003, J IMMUNOL, V171, P4582, DOI 10.4049/jimmunol.171.9.4582; LENGLE EE, 1978, CANCER RES, V38, P1113; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Lynch HE, 2009, TRENDS IMMUNOL, V30, P366, DOI 10.1016/j.it.2009.04.003; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Masoud GN, 2015, ACTA PHARM SIN B, V5, P378, DOI 10.1016/j.apsb.2015.05.007; Massudi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042357; McNamee EN, 2013, IMMUNOL RES, V55, P58, DOI 10.1007/s12026-012-8349-8; Nadtochiy SM, 2018, J MOL CELL CARDIOL, V121, P155, DOI 10.1016/j.yjmcc.2018.06.007; Nagai H, 2006, INT IMMUNOPHARMACOL, V6, P279, DOI 10.1016/j.intimp.2005.08.015; OKEY AB, 1994, TOXICOL LETT, V70, P1, DOI 10.1016/0378-4274(94)90139-2; Okey AB, 2007, TOXICOL SCI, V98, P5, DOI 10.1093/toxsci/kfm096; Palmer DB, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00316; POLAND A, 1982, ANNU REV PHARMACOL, V22, P517, DOI 10.1146/annurev.pa.22.040182.002505; Rajman L, 2018, CELL METAB, V27, P529, DOI 10.1016/j.cmet.2018.02.011; RIFKIND AB, 1994, J BIOL CHEM, V269, P3387; Sebastian C, 2012, CELL, V151, P1185, DOI 10.1016/j.cell.2012.10.047; TeSlaa T, 2014, METHOD ENZYMOL, V542, P91, DOI 10.1016/B978-0-12-416618-9.00005-4; Trauner M, 2010, BBA-MOL CELL BIOL L, V1801, P299, DOI 10.1016/j.bbalip.2009.10.007; Viluksela M, 1995, TOXICOL APPL PHARM, V135, P308, DOI 10.1006/taap.1995.1237; Volz DC, 2005, TOXICOL SCI, V85, P572, DOI 10.1093/toxsci/kfi109; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Wang WQ, 2015, J BIOL CHEM, V290, P26163, DOI 10.1074/jbc.M115.662916; Wofford JA, 2008, BLOOD, V111, P2101, DOI 10.1182/blood-2007-06-096297; Zhang L, 2020, P NATL ACAD SCI USA, V117, P13447, DOI 10.1073/pnas.1921815117; Zhong L, 2010, TRANSCR-AUSTIN, V1, P17, DOI 10.4161/trns.1.1.12143	53	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243842	10.1371/journal.pone.0243842	http://dx.doi.org/10.1371/journal.pone.0243842			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320884	Green Published, gold			2022-12-27	WOS:000600339800048
J	Nagata, JM; Ganson, KT; Cunningham, ML; Mitchison, D; Lavender, JM; Blashill, AJ; Gooding, HC; Murray, SB				Nagata, Jason M.; Ganson, Kyle T.; Cunningham, Mitchell L.; Mitchison, Deborah; Lavender, Jason M.; Blashill, Aaron J.; Gooding, Holly C.; Murray, Stuart B.			Associations between legal performance-enhancing substance use and future cardiovascular disease risk factors in young adults: A prospective cohort study	PLOS ONE			English	Article							ANABOLIC-ANDROGENIC STEROIDS; CREATINE SUPPLEMENTATION; NUTRITIONAL SUPPLEMENTS; HEALTH; TERM; CONSEQUENCES; ADOLESCENTS; PREVALENCE; DRUGS; ADHD	Background Legal performance-enhancing substances (PES), such as creatine, are commonly used by adolescents and young adults. As PES are mostly unregulated by the US Food and Drug Administration, there has been limited empirical attention devoted to examining their long-term safety and health outcomes. Preliminary studies have demonstrated associations between PES use and severe medical events, including hospitalizations and death. PES could be linked to cardiovascular disease (CVD), the most common cause of mortality in the US, by altering the myocardium, vasculature, or metabolism. The objective of this study was to examine prospective associations between the use of legal PES in young adulthood and CVD risk factors at seven-year follow-up. Materials and methods Nationally representative longitudinal cohort data from the National Longitudinal Study of Adolescent to Adult Health, Waves III (2001-2002) and IV (2008), were analyzed. Regression models determined the prospective association between the use of legal PES (e.g. creatine monohydrate) and CVD risk factors (e.g. body mass index, diabetes, hypertension, hyperlipidemia), adjusting for relevant covariates. Results Among the diverse sample of 11,996 male and female participants, no significant differences by PES use in body mass index, diabetes, hypertension, or hyperlipidemia were noted at Wave III. In unadjusted comparisons, legal PES users (versus non-users) were more likely to be White, be male, be college educated, drink alcohol, and engage in weightlifting, exercise, individual sports, team sports, and other strength training. There were no significant prospective associations between legal PES use at Wave III and body mass index, hemoglobin A1c, systolic and diastolic blood pressure, and cholesterol (total, HDL, LDL, triglycerides) deciles at seven-year follow-up (Wave IV), adjusting for demographics, health behaviors, and Wave III CVD risk factors. Similarly, there were no significant prospective associations between legal PES use and diabetes, hypertension, or hyperlipidemia based on objective measures or self-reported medications and diagnoses, adjusting for demographics, health behaviors, and Wave III CVD risk. Conclusions We do not find evidence for a prospective association between legal PES use and CVD risk factors in young adults over seven years of follow-up, including BMI, diabetes, hypertension, or hyperlipidemia. It should be noted that legal PES use was operationalized dichotomously and as one broad category, which did not account for frequency, amount, or duration of use. Given the lack of regulation and clinical trials data, observational studies can provide much needed data to inform the safety and long-term health associations of legal PES use and, in turn, inform clinical guidance and policy.	[Nagata, Jason M.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Ganson, Kyle T.] Univ Toronto, Factor Inwentash Fac Social Work, Toronto, ON, Canada; [Cunningham, Mitchell L.] Univ Sydney, Sch Psychol, Sydney, NSW, Australia; [Mitchison, Deborah] Univ Western Sydney, Sch Med, Translat Hlth Res Inst, Sydney, NSW, Australia; [Mitchison, Deborah] Macquarie Univ, Dept Psychol, Sydney, NSW, Australia; [Lavender, Jason M.] Uniformed Serv Univ Hlth Sci, Mil Cardiovasc Outcomes Res Program MiCOR, Dept Med, Bethesda, MD 20814 USA; [Lavender, Jason M.] Metis Fdn, San Antonio, TX USA; [Blashill, Aaron J.] San Diego State Univ, Dept Psychol, San Diego, CA 92182 USA; [Blashill, Aaron J.] San Diego State Univ, San Diego Joint Doctoral Program Clin Psychol, San Diego, CA 92182 USA; [Blashill, Aaron J.] Univ Calif San Diego, San Diego Joint Doctoral Program Clin Psychol, San Diego, CA 92103 USA; [Gooding, Holly C.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA; [Murray, Stuart B.] Univ Southern Calif, Dept Psychiat & Behav Sci, Los Angeles, CA 90007 USA	University of California System; University of California San Francisco; University of Toronto; University of Sydney; Western Sydney University; Macquarie University; Uniformed Services University of the Health Sciences - USA; California State University System; San Diego State University; California State University System; San Diego State University; University of California System; University of California San Diego; Emory University; University of Southern California	Nagata, JM (corresponding author), Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA.	jasonmnagata@gmail.com	Mitchison, Deborah/AAH-4842-2021	Nagata, Jason/0000-0002-6541-0604; MITCHISON, DEBORAH/0000-0002-6736-7937	American Heart Association [CDA34760281]; National Institutes of Health [K23 MH115184, P01-HD31921, K23 HL122361]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [P01-HD31921]	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	J.M.N was a participant in the Pediatric Scientist Development Program and is supported by the American Heart Association (CDA34760281, https://www.heart.org/).H.C.G.is supported by the National Institutes of Health K23 HL122361 (https://www.nih.gov/).S.B.M.is supported by the National Institutes of Health K23 MH115184. This research uses data from Add Health, a program project directed by Kathleen Mullan Harris and designed by J. Richard Udry, Peter S. Bearman, and Kathleen Mullan Harris at the University of North Carolina at Chapel Hill, and funded by grant P01-HD31921 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, with cooperative funding from 23 other federal agencies and foundations. No direct support was received from grant P01-HD31921 for this analysis. The opinions and assertions expressed herein are those of the authors and do not necessarily reflect the official policy or position of the Uniformed Services University or the U.S. Department of Defense. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackard DM, 2003, PEDIATRICS, V111, P67, DOI 10.1542/peds.111.1.67; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc10-S062, 10.2337/dc13-S067, 10.2337/dc12-s064, 10.2337/dc11-S062]; Angell P, 2012, SPORTS MED, V42, P119, DOI 10.2165/11598060-000000000-00000; Bibbins-Domingo K, 2007, NEW ENGL J MED, V357, P2371, DOI 10.1056/NEJMsa073166; Block G, 2007, NUTR J, P6, DOI [10.1186/1475-2891-6-6, DOI 10.1186/1475-2891-6-6]; Brenu EW, 2011, MINI-REV MED CHEM, V11, P438; Chen P., 2020, GUIDELINES ANAL ADD; Cohen PA, 2009, NEW ENGL J MED, V361, P1523, DOI 10.1056/NEJMp0904768; Eisenberg ME, 2012, PEDIATRICS, V130, P1019, DOI 10.1542/peds.2012-0095; Ganson KT, 2020, PEDIATRICS, V146, DOI 10.1542/peds.2020-0409; Ganson KT, 2020, LANCET CHILD ADOLESC, V4, P13, DOI 10.1016/S2352-4642(19)30345-1; Geyer H, 2004, INT J SPORTS MED, V25, P124, DOI 10.1055/s-2004-819955; Geyer H, 2008, J MASS SPECTROM, V43, P892, DOI 10.1002/jms.1452; Gooding HC, 2016, J ADOLESCENT HEALTH, V58, P119, DOI 10.1016/j.jadohealth.2015.09.011; Grasser EK, 2016, ADV NUTR, V7, P950, DOI 10.3945/an.116.012526; Green GA, 2001, CLIN J SPORT MED, V11, P254, DOI 10.1097/00042752-200110000-00008; Hamad R, 2020, JAMA CARDIOL, V5, P899, DOI 10.1001/jamacardio.2020.1458; Harris KM, 2017, NATL LONGITUDINAL ST; Harty PS, 2018, J INT SOC SPORT NUTR, V15, DOI 10.1186/s12970-018-0247-6; Hennissen L, 2017, CNS DRUGS, V31, P199, DOI 10.1007/s40263-017-0410-7; Kanayama G, 2008, DRUG ALCOHOL DEPEN, V98, P1, DOI 10.1016/j.drugalcdep.2008.05.004; Kreider RB, 2003, MOL CELL BIOCHEM, V244, P95, DOI 10.1023/A:1022469320296; Kreider RB, 2017, J INT SOC SPORT NUTR, V14, DOI 10.1186/s12970-017-0173-z; La Gerche A, 2017, CIRCULATION, V135, P89, DOI 10.1161/CIRCULATIONAHA.116.022535; LaBotz M, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-1300; Liu JD, 2019, CHINESE MED J-PEKING, V132, P2229, DOI 10.1097/CM9.0000000000000407; Lundholm L, 2010, DRUG ALCOHOL DEPEN, V111, P222, DOI 10.1016/j.drugalcdep.2010.04.020; Mathews NM, 2018, SPORTS HEALTH, V10, P19, DOI 10.1177/1941738117727736; Martinez-Sanz JM, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101093; Murray SB, 2017, CLIN PSYCHOL REV, V57, P1, DOI 10.1016/j.cpr.2017.08.001; Nagata Jason M, 2020, Int J Adolesc Med Health, V34, P119, DOI 10.1515/ijamh-2020-0001; Nagata JM, 2020, JAMA PEDIATR, V174, P992, DOI 10.1001/jamapediatrics.2020.0883; Nagata JM, 2021, EAT DISORD, V29, P599, DOI 10.1080/10640266.2020.1712637; Nagata JM, 2019, J GEN INTERN MED, V34, P2756, DOI 10.1007/s11606-019-05317-8; Nagata JM, 2019, LANCET CHILD ADOLESC, V3, P444, DOI 10.1016/S2352-4642(19)30147-6; Nagata JM, 2018, INT J EAT DISORDER, V51, P931, DOI 10.1002/eat.22927; Nikolopoulos DD, 2011, FUND CLIN PHARMACOL, V25, P535, DOI 10.1111/j.1472-8206.2010.00881.x; Or F, 2019, J ADOLESC HEAL PUBL, DOI [10.1016/j.jadohealth.2019.03.005, DOI 10.1016/J.JAD0HEALTH.2019.03.005]; dos Santos MAP, 2014, SUBST USE MISUSE, V49, P1132, DOI 10.3109/10826084.2014.903751; Perry JC, 2020, CUREUS, V12, DOI 10.7759/cureus.9333; Pickering C, 2019, SPORTS MED, V49, P1007, DOI 10.1007/s40279-019-01101-0; Pinto CL, 2016, AMINO ACIDS, V48, P2103, DOI 10.1007/s00726-016-2277-1; Pope HG, 2014, ENDOCR REV, V35, P341, DOI 10.1210/er.2013-1058; Pope HG, 2000, ARCH GEN PSYCHIAT, V57, P133, DOI 10.1001/archpsyc.57.2.133; Qato DM, 2018, JAMA PEDIATR, V172, P780, DOI 10.1001/jamapediatrics.2018.1008; Sachs KV, 2016, INT J EAT DISORDER, V49, P238, DOI 10.1002/eat.22481; Shay CM, 2012, CIRCULATION, V125, P45, DOI 10.1161/CIRCULATIONAHA.111.035733; Torres-Acosta N, 2020, J AM COLL CARDIOL, V76, P858, DOI 10.1016/j.jacc.2020.05.081; Van Poucke C, 2007, ANAL CHIM ACTA, V586, P35, DOI 10.1016/j.aca.2006.09.050; Van Wagoner RM, 2017, JAMA-J AM MED ASSOC, V318, P2004, DOI 10.1001/jama.2017.17069; Vanberg Paul, 2010, Handb Exp Pharmacol, P411, DOI 10.1007/978-3-540-79088-4_18; Virani SS, 2020, CIRCULATION, V141, pE139, DOI 10.1161/CIR.0000000000000757; Whelton PK, 2018, HYPERTENSION, V71, pE13, DOI [10.1161/HYP.0000000000000065, 10.1161/HYP.0000000000000066]	53	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0244018	10.1371/journal.pone.0244018	http://dx.doi.org/10.1371/journal.pone.0244018			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH3TP	33320903	Green Published, gold			2022-12-27	WOS:000600339800047
J	Sedghizadeh, MJ; Hojjati, H; Ezzatdoost, K; Aghajan, H; Vahabi, Z; Tarighatnia, H				Sedghizadeh, Mohammad Javad; Hojjati, Hadi; Ezzatdoost, Kiana; Aghajan, Hamid; Vahabi, Zahra; Tarighatnia, Heliya			Olfactory response as a marker for Alzheimer's disease: Evidence from perceptual and frontal lobe oscillation coherence deficit	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; SMELL IDENTIFICATION TEST; CROSS-MODAL INTERACTIONS; NEURONAL-ACTIVITY; EEG SYNCHRONIZATION; WORKING-MEMORY; DEMENTIA; CIRCUITS; TAU; NEURODEGENERATION	High-frequency oscillations of the frontal cortex are involved in functions of the brain that fuse processed data from different sensory modules or bind them with elements stored in the memory. These oscillations also provide inhibitory connections to neural circuits that perform lower-level processes. Deficit in the performance of these oscillations has been examined as a marker for Alzheimer's disease (AD). Additionally, the neurodegenerative processes associated with AD, such as the deposition of amyloid-beta plaques, do not occur in a spatially homogeneous fashion and progress more prominently in the medial temporal lobe in the early stages of the disease. This region of the brain contains neural circuitry involved in olfactory perception. Several studies have suggested that olfactory deficit can be used as a marker for early diagnosis of AD. A quantitative assessment of the performance of the olfactory system can hence serve as a potential biomarker for Alzheimer's disease, offering a relatively convenient and inexpensive diagnosis method. This study examines the decline in the perception of olfactory stimuli and the deficit in the performance of high-frequency frontal oscillations in response to olfactory stimulation as markers for AD. Two measurement modalities are employed for assessing the olfactory performance: 1) An interactive smell identification test is used to sample the response to a sizable variety of odorants, and 2) Electroencephalography data are collected in an olfactory perception task with a pair of selected odorants in order to assess the connectivity of frontal cortex regions. Statistical analysis methods are used to assess the significance of selected features extracted from the recorded modalities as Alzheimer's biomarkers. Olfactory decline regressed to age in both healthy and mild AD groups are evaluated, and single- and multi-modal classifiers are also developed. The novel aspects of this study include: 1) Combining EEG response to olfactory stimulation with behavioral assessment of olfactory perception as a marker of AD, 2) Identification of odorants most significantly affected in mild AD patients, 3) Identification of odorants which are still adequately perceived by mild AD patients, 4) Analysis of the decline in the spatial coherence of different oscillatory bands in response to olfactory stimulation, and 5) Being the first study to quantitatively assess the performance of olfactory decline due to aging and AD in the Iranian population.	[Sedghizadeh, Mohammad Javad; Hojjati, Hadi; Ezzatdoost, Kiana; Aghajan, Hamid] Sharif Univ Technol, Dept Elect Engn, Tehran, Iran; [Vahabi, Zahra; Tarighatnia, Heliya] Univ Tehran Med Sci, Ziaeian Hosp, Dept Geriatr Med, Tehran, Iran; [Vahabi, Zahra] Univ Tehran Med Sci, Roozbeh Hosp, Memory & Behav Neurol Div, Tehran, Iran	Sharif University of Technology; Tehran University of Medical Sciences; Tehran University of Medical Sciences	Aghajan, H (corresponding author), Sharif Univ Technol, Dept Elect Engn, Tehran, Iran.	aghajan@ee.sharif.edu	Hojjati, Hadi/GQP-2765-2022	Hojjati, Hadi/0000-0001-7271-0587; Sedghizadeh, Mohammad Javad/0000-0003-2888-7240	Cognitive Sciences & Technologies Council of Iran [G970736]; Sharif University of Technology	Cognitive Sciences & Technologies Council of Iran; Sharif University of Technology	This work was partially funded by the Cognitive Sciences & Technologies Council of Iran. This work was also partially supported by grant G970736 from Sharif University of Technology. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACSJCaWSC T. S. Lorig, B PSYCHONOMIC SOC, V131-134, P131; Adler G, 2003, J NEURAL TRANSM, V110, P1051, DOI 10.1007/s00702-003-0024-8; [Anonymous], 2011, MOL CELLULAR PROTEOM, V10, pR110; [Anonymous], 2011, J CLIN HYPERTENSI S1, V13, pA155; [Anonymous], 2004, J NEUROSCI METH, V134, P9; Attems J, 2006, CLIN NEUROPATHOL, V25, P265; Bero AW, 2011, NAT NEUROSCI, V14, P750, DOI 10.1038/nn.2801; Borgers C, 2005, P NATL ACAD SCI USA, V102, P7002, DOI 10.1073/pnas.0502366102; BRUN A, 1976, ARCH PSYCHIAT NERVEN, V223, P15, DOI 10.1007/BF00367450; Buzsaki G., 2006, RHYTHMS BRAIN; Caminiti F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103151; Canter RG, 2016, NATURE, V539, P187, DOI 10.1038/nature20412; Chen CC, 2015, J FORMOS MED ASSOC, V114, P729, DOI 10.1016/j.jfma.2013.07.008; Chua XY, 2019, INT PSYCHOGERIATR, V31, P147, DOI 10.1017/S1041610218000704; Ciceliene J, 2018, MEDICINA-LITHUANIA, V54, DOI 10.3390/medicina54020013; Cole A, 2018, ALZHEIMERS DEMENT, V14, P1180; Counts SE, 2017, NEUROTHERAPEUTICS, V14, P35, DOI 10.1007/s13311-016-0481-z; Custers, 2019, BIBLIOTHECA ORIENTAL, V76, p422a; Devanand DP, 2000, AM J PSYCHIAT, V157, P1399, DOI 10.1176/appi.ajp.157.9.1399; Doty RL, 1995, SMELL IDENTIFICATION, VThird; Efron B., 2010, LARGE SCALE INFERENC; Fell J, 2001, NAT NEUROSCI, V4, P1259, DOI 10.1038/nn759; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; Gillespie AK, 2016, NEURON, V90, P740, DOI 10.1016/j.neuron.2016.04.009; Hojjati H, 2019, AUSTR INT BIOM ENG C; Hyvarinen E. 0. Aapo, 2000, INDEPENDENT COMPONEN; Iaccarino HF, 2016, NATURE, V540, P230, DOI 10.1038/nature20587; Invitto S, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00272; Invitto S, 2019, RESP PHYSIOL NEUROBI, V259, P37, DOI 10.1016/j.resp.2018.07.002; Jack CR, 2019, JAMA-J AM MED ASSOC, V321, P2316, DOI 10.1001/jama.2019.7437; Jack CR, 2018, ALZHEIMERS DEMENT, V14, P535, DOI 10.1016/j.jalz.2018.02.018; Kjelvik G, 2007, INT J GERIATR PSYCH, V22, P1020, DOI 10.1002/gps.1783; Koenig T, 2005, NEUROBIOL AGING, V26, P165, DOI 10.1016/j.neurobiolaging.2004.03.008; LEUCHTER AF, 1987, ARCH GEN PSYCHIAT, V44, P993; Luck S. J., 2005, INTRO EVENT RELATED; Makowska I, 2011, ARCH CLIN NEUROPSYCH, V26, P270, DOI 10.1093/arclin/acr011; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mesholam RI, 1998, ARCH NEUROL-CHICAGO, V55, P84, DOI 10.1001/archneur.55.1.84; Mishra J, 2007, J NEUROSCI, V27, P4120, DOI 10.1523/JNEUROSCI.4912-06.2007; Mishra J, 2006, NEURAL NETWORKS, V19, P1329, DOI 10.1016/j.neunet.2006.08.005; Morgan CD, 2002, J INT NEUROPSYCH SOC, V8, P753, DOI 10.1017/S1355617702860039; Musaeus CS, 2019, CLIN NEUROPHYSIOL, V130, P1889, DOI 10.1016/j.clinph.2019.07.016; Musaeus CS, 2018, J ALZHEIMERS DIS, V65, P475, DOI 10.3233/JAD-180384; Musaeus CS, 2018, J ALZHEIMERS DIS, V64, P1359, DOI 10.3233/JAD-180300; Nancy K, 1975, ELECTROENCEPHALOGRAP, P387; Oniz A, 2013, J NEUROL SCI-TURK, V30, P270; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; Pijnenburg YAL, 2004, CLIN NEUROPHYSIOL, V115, P1332, DOI 10.1016/j.clinph.2003.12.029; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; REISBERG B, 1988, PSYCHOPHARMACOL BULL, V24, P653; Samper-Gonzalez J, 2018, NEUROIMAGE, V183, P504, DOI 10.1016/j.neuroimage.2018.08.042; Seitz DP, 2018, COCHRANE SYSTEMATIC, P1465; Selkoe DJ, 1996, ANN NY ACAD SCI, V777, P57, DOI 10.1111/j.1749-6632.1996.tb34401.x; Shaw LM, 2018, ALZHEIMERS DEMENT, V14, P1505, DOI 10.1016/j.jalz.2018.07.220; Silva Maren de Moraes e, 2018, Dement. neuropsychol., V12, P123, DOI 10.1590/1980-57642018dn12-020004; Silveira-Moriyama L, 2010, ARQ NEURO-PSIQUIAT, V68, P700, DOI 10.1590/S0004-282X2010000500005; Tadayon R, 2019, PROCEEDINGS OF THE 4TH INTERNATIONAL WORKSHOP ON MULTIMEDIA FOR PERSONAL HEALTH & HEALTH CARE (HEALTHMEDIA'19), P16, DOI 10.1145/3347444.3356239; Taherkhani S, 2015, CHEMOSENS PERCEPT, V8, P183, DOI 10.1007/s12078-015-9192-9; TALAMO BR, 1989, NATURE, V337, P736, DOI 10.1038/337736a0; Taylor K, 2005, CEREB CORTEX, V15, P1424, DOI 10.1093/cercor/bhi023; Tremblay C, 2018, CHEM SENSES, V43, P611, DOI 10.1093/chemse/bjy049; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; Velayudhan L, 2013, INT PSYCHOGERIATR, V25, P1157, DOI 10.1017/S1041610213000446; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Wang RF, 2014, CHAOS, V24, DOI 10.1063/1.4896095; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; Wespatat V, 2004, J NEUROSCI, V24, P9067, DOI 10.1523/JNEUROSCI.2221-04.2004; Wolk D, 2019, JAMA-J AM MED ASSOC, V321, P2289, DOI 10.1001/jama.2019.7534; Yuval-Greenberg S, 2007, J NEUROSCI, V27, P1090, DOI 10.1523/JNEUROSCI.4828-06.2007; Zou YM, 2016, NEUROPSYCH DIS TREAT, V12, P869, DOI 10.2147/NDT.S104886	73	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243535	10.1371/journal.pone.0243535	http://dx.doi.org/10.1371/journal.pone.0243535			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH3TP	33320870	Green Published, gold			2022-12-27	WOS:000600339800011
J	Souris, M; Gonzalez, JP				Souris, Marc; Gonzalez, Jean-Paul			COVID-19: Spatial analysis of hospital case-fatality rate in France	PLOS ONE			English	Article								When the population risk factors and reporting systems are similar, the assessment of the case-fatality (or lethality) rate (ratio of cases to deaths) represents a perfect tool for analyzing, understanding and improving the overall efficiency of the health system. The objective of this article is to estimate the influence of the hospital care system on lethality in metropolitan France during the inception of the COVID-19 epidemic, by analyzing the spatial variability of the hospital case-fatality rate (CFR) between French districts. In theory, the hospital age-standardized CFR should not display significant differences between districts, since hospital lethality depends on the virulence of the pathogen (the SARS-CoV-2 virus), the vulnerability of the population (mainly age-related), the healthcare system quality, and cases and deaths definition and the recording accuracy. We analyzed hospital data on COVID-19 hospitalizations, severity (admission to intensive care units for reanimation or endotracheal intubation) and mortality, from March 19 to May 8 corresponding to the first French lockdown. All rates were age-standardized to eliminate differences in districts age structure. The results show that the higher case-fatality rates observed by districts are mostly related to the level of morbidity. Time analysis shows that the case-fatality rate has decreased over time, globally and in almost all districts, showing an improvement in the management of severe patients during the epidemic. In conclusion, it appears that during the first critical phase of COVID-19 ramping epidemic in metropolitan France, the higher case-fatality rates were generally related to the higher level of hospitalization, then potentially related to the overload of healthcare system. Also, low hospitalization with high case-fatality rates were mostly found in districts with low population density, and could due to some limitation of the local healthcare access. However, the magnitude of this increase of case-fatality rate represents less than 10 per cent of the average case-fatality rate, and this variation is small compared to much greater variation across countries reported in the literature.	[Souris, Marc] UVE Aix Marseille Univ, UMR Unite Virus Emergents, IRD 190, Inserm 1207,IHU Mediterranee Infect, Marseille, France; [Gonzalez, Jean-Paul] Georgetown Univ, Sch Med, Dept Microbiol & Immunol, Washington, DC USA; [Gonzalez, Jean-Paul] Commonwealth Trade Partners Inc, Alexandria, VA USA; [Gonzalez, Jean-Paul] Centaurus Biotech LLC, Manassas, VA USA	Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Georgetown University	Souris, M (corresponding author), UVE Aix Marseille Univ, UMR Unite Virus Emergents, IRD 190, Inserm 1207,IHU Mediterranee Infect, Marseille, France.	marc.souris@ird.fr		Gonzalez, Jean-Paul/0000-0003-3063-1770				Allard T, 2020, INSEE ANAL ILE DE FR; Baud D, 2020, LANCET INFECT DIS, V20, P773, DOI 10.1016/S1473-3099(20)30195-X; Bouyer J, 1993, EPIDEMIOLOGIE PRINCI; Breslow N E, 1980, IARC Sci Publ, P5; BRESLOW NE, 1987, IARC SCI PUBLICATION, V82; Collier L, 2016, HUMAN VIROLOGY; Hurraux JM, 2003, TRAITE VIROLOGIE HUM; Khafaie Morteza Abdullatif, 2020, Osong Public Health Res Perspect, V11, P74, DOI 10.24171/j.phrp.2020.11.2.03; Lipsitch M, 2020, LANCET INFECT DIS, V20, P775, DOI [10.1016/S1473-3099(20)30246-2, 10.1016/S1473-3099(20)30245-0]; Miller RG, 1996, SIMULTANEOUS STAT IN; Pfeiffer DU, 2008, Spatial Analysis in Epidemiology, P1, DOI 10.1093/acprof:oso/9780198509882.001.0001; Porta M, 2008, DICT EPIDEMIOLOGY; Rinaldia G, EMPIRICAL ESTIMATE I; Robert-Bobee, 2020, INSEE FOCUS; Salie H, 2020, SCIENCE         0513, DOI [10.1126/science.abc3517, DOI 10.1126/SCIENCE.ABC3517]; Saluzzo J-F, 2004, VIRUS EMERGENTS; SAMUELS SJ, 1991, AM J EPIDEMIOL, V133, P1191, DOI 10.1093/oxfordjournals.aje.a115831; Souris M, 2019, EPIDEMIOLOGY AND GEOGRAPHY: PRINCIPLES, METHODS AND TOOLS OF SPATIAL ANALYSIS, P1, DOI 10.1002/9781119528203; Temps, TEMPS	19	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243606	10.1371/journal.pone.0243606	http://dx.doi.org/10.1371/journal.pone.0243606			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320895	gold, Green Published, Green Submitted			2022-12-27	WOS:000600339800063
J	Hutson, SP; Golden, A; Odoi, A				Hutson, Sadie P.; Golden, Ashley; Odoi, Agricola			Geographic distribution of hospice, homecare, and nursing home facilities and access to end-of-life care among persons living with HIV/AIDS in Appalachia	PLOS ONE			English	Article							HEALTH; DISPARITIES; TENNESSEE; STROKE; GIS	Background Access to healthcare services, from diagnosis through end of life (EOL), is important among persons living with Human Immunodeficiency Syndrome (HIV) and Acquired Immunodeficiency Syndrome (AIDS) (PLWHA). However, little is known about the availability of hospice services in Appalachian areas. Therefore, the objective of this study is to describe the geographic distribution of hospice, homecare and nursing home facilities in order to demonstrate current existence of and access to resources for EOL care among PLWHA in the Appalachian regions of Tennessee and Alabama. Methods This paper reports on the second aim of a larger sequential, mixed methods qualitative-quantitative (qual -> quan) study. Data from advance care planning (ACP) surveys were collected by both electronic (n = 28) and paper copies (n = 201) and, among other things, obtained information on zip codes of residence of PLWHA. This enabled assessment of the geographic distribution of residences of PLWHA in relation to the distribution of healthcare services such as hospice and home healthcare services. Hospice and Home Healthcare data were obtained from the Tennessee and Alabama Departments of Health. The street addresses of these facilities were used to geocode and map the geographic distributions of the facilities using Street Map USA. Travel times to Hospice and Home Healthcare facilities were computed and mapped using ArcGIS 10.3. Results We identified a total of 32 hospice and 69 home healthcare facilities in the Tennessee Appalachian region, while the Alabama Appalachian region had a total of 110 hospice and 86 home healthcare facilities. Most care facilities were located in urban centers. The distribution of care facilities was worse in Tennessee with many counties having no facilities, requiring up to an hour drive time to reach patients. A total of 86% of the PLWHA indicated preference to die at home. Conclusions Persons living with HIV/AIDS in Appalachia face a number of challenges at the end of life that make access to EOL services difficult. Although respondents indicated a preference to die at home, the hospice/homecare infrastructure and resources are overwhelmingly inadequate to meet this need. There is need to improve access to EOL care in the Appalachian regions of both Tennessee and Alabama although the need is greater in Tennessee.	[Hutson, Sadie P.] Univ Tennessee, Coll Nursing, Knoxville, TN 37901 USA; [Golden, Ashley] Oak Ridge Associated Univ, Oak Ridge, TN USA; [Odoi, Agricola] Univ Tennessee, Inst Agr, Coll Vet Med, Dept Biomed & Diagnost Sci, Knoxville, TN 37901 USA	University of Tennessee System; University of Tennessee Knoxville; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Hutson, SP (corresponding author), Univ Tennessee, Coll Nursing, Knoxville, TN 37901 USA.	shutson@utk.edu	Odoi, Agricola/I-9532-2019; Golden, Ashley/AAG-9445-2021	Odoi, Agricola/0000-0001-5050-6737; Golden, Ashley/0000-0002-9430-7702	National Institute of Nursing Research of the National Institutes of Health [R21NR014055]	National Institute of Nursing Research of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This work was funded by the National Institute of Nursing Research of the National Institutes of Health under Award Number R21NR014055 to SPH. ninr.nih.gov The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appalachian Regional Commission, 2017, CREAT CULT HLTH APP; Bone AE, 2018, PALLIATIVE MED, V32, P329, DOI 10.1177/0269216317734435; Busingye D, 2011, SPAT SPATIO-TEMPORAL, V2, P247, DOI 10.1016/j.sste.2011.07.010; Campbell CL, 2009, J NURS SCHOLARSHIP, V41, P420, DOI 10.1111/j.1547-5069.2009.01310.x; Carlson MDA, 2010, J PALLIAT MED, V13, P1331, DOI 10.1089/jpm.2010.0209; Casey Michelle M, 2005, Am J Hosp Palliat Care, V22, P363, DOI 10.1177/104990910502200509; Centers for Disease Control and Prevention, 2016, HIV SURV REP, V28; Centers for Disease Control and Prevention (CDC) National HIV Surveillance System, 2012, 2012 HIV PREV RAT PE; Chukwusa E, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231666; Chukwusa E, 2019, INT J HEALTH GEOGR, V18, DOI 10.1186/s12942-019-0172-1; ESRI, 2015, ARCGIS DESKT REL 10; Finucane AM, 2019, BMC PALLIAT CARE, V18, DOI 10.1186/s12904-019-0490-x; Gatrell AC, 2012, HEALTH PLACE, V18, P832, DOI 10.1016/j.healthplace.2012.03.009; Gomes B, 2013, BMC PALLIAT CARE, V12, DOI 10.1186/1472-684X-12-7; Griffith BN, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-229; Hawley P., 2017, BARRIERS ACCESS PALL, DOI [10.1177/1178224216688887, DOI 10.1177/1178224216688887]; Heckman TG, 1998, AIDS CARE, V10, P365, DOI 10.1080/713612410; Jenkins TM, 2009, PREV CHRONIC DIS, P6; Kohli S, 1995, J Med Syst, V19, P425, DOI 10.1007/BF02260846; Lindley LC, 2015, AM J HOSP PALLIAT ME, V32, P849, DOI 10.1177/1049909114543641; Lyon ME, 2008, J PALLIAT MED, V11, P459, DOI 10.1089/jpm.2007.0148; Madigan Elizabeth A, 2009, Policy Polit Nurs Pract, V10, P71, DOI 10.1177/1527154409333861; McLafferty SL, 2003, ANNU REV PUBL HEALTH, V24, P25, DOI 10.1146/annurev.publhealth.24.012902.141012; Medicare Payment Advisory Commission, 2009, C MED PAYM POL; Pedigo AS, 2010, ANN EPIDEMIOL, V20, P924, DOI 10.1016/j.annepidem.2010.06.013; Rainsford S, 2018, HEALTH SOC CARE COMM, V26, P273, DOI 10.1111/hsc.12385; Rainsford S, 2017, PALLIATIVE MED, V31, P895, DOI 10.1177/0269216316685234; Ray N, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-63; Rhodes RL, 2016, J PAIN SYMPTOM MANAG, V51, P120, DOI 10.1016/j.jpainsymman.2015.08.010; Schuurman Nadine, 2006, Int J Health Geogr, V5, P43, DOI 10.1186/1476-072X-5-43; Tansley G, 2019, CAN J SURG, V62, P123, DOI 10.1503/cjs.004218; Tansley G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141113; US Census Bureau Geography Division, 2016, CART BOUNDR FIL DESC; Virnig BA, 2006, J PALLIAT MED, V9, P1292, DOI 10.1089/jpm.2006.9.1292; Walker BB, 2017, RURAL REMOTE HEALTH, V17, DOI 10.22605/RRH4210; World Health Organization, 2020, PALLI8 ENS PALL CAR	36	0	0	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243814	10.1371/journal.pone.0243814	http://dx.doi.org/10.1371/journal.pone.0243814			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH1MP	33315923	gold, Green Published			2022-12-27	WOS:000600186100038
J	Chen, ZS; Chen, XL; Balezentis, T; Gan, XQ; Valdmanis, V				Chen, Zhensheng; Chen, Xueli; Balezentis, Tomas; Gan, Xiaoqing; Valdmanis, Vivian			Productivity change and its driving forces in Chinese healthcare sector	PLOS ONE			English	Article							HOSPITAL SERVICES; PUBLIC HOSPITALS; EFFICIENCY; LUENBERGER; PERFORMANCE; INDICATOR; COUNTRIES; ONTARIO; GROWTH; REFORM	Since the last medical reform in 2009, China's public hospitals have been facing the changes in the institutional environment. However, the effects of reforms have not been received enough attention to deliver evidence-based implications. In this paper, we first assess the efficiency of regional public hospitals from 2011 to 2018, employing a proposed method based on an additive indicator and an aggregate directional distance function (DDF). The method applied allows for decomposing total factor productivity (TFP) indicator into three components, including technical efficiency change (TEC), total productivity (TP) and scale efficiency change (SEC). Second, following the efficiency assessment, we carry post-efficiency analysis to identify the determinants of efficiency of the public hospitals. The results show that annual average TFP growth rate is 1.38%, which is driven mainly by TEC. Regional disparities of public hospitals' performance are expanding. Almost 75% of the regions considered show a positive TFP growth. The regression results show that the significant determinants of efficiency of regional public hospitals include the price of and demand for health services.	[Chen, Zhensheng; Gan, Xiaoqing] Nanchang Univ, Sch Management, Nanchang, Jiangxi, Peoples R China; [Chen, Xueli] Anhui Univ Finance & Econ, Bengbu, Peoples R China; [Chen, Xueli] Chinese Acad Social Sci, Beijing, Peoples R China; [Balezentis, Tomas] Lithuanian Inst Agr Econ, Vilnius, Lithuania; [Valdmanis, Vivian] Western Michigan Univ, Kalamazoo, MI 49008 USA	Nanchang University; Anhui University of Finance & Economics; Chinese Academy of Social Sciences; Lithuanian Institute of Agrarian Economics; Western Michigan University	Chen, XL (corresponding author), Anhui Univ Finance & Econ, Bengbu, Peoples R China.; Chen, XL (corresponding author), Chinese Acad Social Sci, Beijing, Peoples R China.	chenxueli05@126.com	Balezentis, Tomas/D-8609-2015	Balezentis, Tomas/0000-0002-3906-1711	National Natural Science Foundation of China [NSFC 71663034]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is supported by the National Natural Science Foundation of China (Grant ID: NSFC 71663034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso A, 2011, APPL ECON LETT, V18, P1427, DOI 10.1080/13504851.2010.541149; Ajlouni M.M., 2013, GLOBAL J BUSINESS RE, V7, P59; Ang F, 2017, EUR J OPER RES, V260, P359, DOI 10.1016/j.ejor.2016.12.015; Biorn E, 2010, HEALTH CARE MANAG SC, V13, P1, DOI 10.1007/s10729-009-9106-y; Boussemart JP, 2015, CHINA ECON REV, V34, P1, DOI 10.1016/j.chieco.2015.03.003; Briec W, 2004, ECON THEOR, V23, P925, DOI 10.1007/s00199-003-0403-2; Cavalieri M, 2018, PUBLIC FINANC REV, V46, P117, DOI 10.1177/1091142116651487; Chambers RG, 1996, J ECON THEORY, V70, P407, DOI 10.1006/jeth.1996.0096; Charners A, 1978, EUROPEAN J OPERATION, V2; CHEN XL, 2020, SUSTAINABILITY-BASEL, V12, DOI DOI 10.3390/SU12083080; Cheng ZH, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007267; Chilingerian J., 2011, HDB DATA ENVELOPMENT; Cho NE, 2014, AM J MANAG CARE, V20, pESP9; Chowdhury H, 2016, OMEGA-INT J MANAGE S, V63, P111, DOI 10.1016/j.omega.2015.10.007; Chowdhury H, 2011, INT J PRODUCT PERFOR, V60, P721, DOI 10.1108/17410401111167807; Czypionka T, 2014, HEALTH CARE MANAG SC, V17, P331, DOI 10.1007/s10729-013-9256-9; Delibasic M, 2019, TRANSFORM BUS ECON, V18, P323; GU XY, 1995, HEALTH POLICY, V32, P181, DOI 10.1016/0168-8510(95)00735-B; Hackman S. T., 2008, PRODUCTION EC INTEGR; Hu HH, 2012, CHINA ECON REV, V23, P865, DOI 10.1016/j.chieco.2012.04.008; Kerstens K, 2018, INT J PROD ECON, V195, P311, DOI 10.1016/j.ijpe.2017.10.010; Kohl S, 2019, HEALTH CARE MANAG SC, V22, P245, DOI 10.1007/s10729-018-9436-8; Lu Y, 2019, CHIN J POPUL RESOUR, V17, P184, DOI 10.1080/10042857.2019.1610651; Minbashrazgah MM, 2019, MANAG ENVIRON QUAL, V30, P137, DOI 10.1108/MEQ-07-2017-0073; Ministry of Health, 2019, CHIN HLTH STAT YB 20; O'Donnell CJ, 2012, J PROD ANAL, V38, P255, DOI 10.1007/s11123-012-0275-1; Rego G, 2010, EUR J HEALTH ECON, V11, P367, DOI 10.1007/s10198-009-0198-6; Sheikhzadeh Y, 2012, HEALTH PROMOT PERSPE, V2, P28, DOI 10.5681/hpp.2012.004; Shen ZY, 2019, CHINA ECON REV, V57, DOI 10.1016/j.chieco.2019.101315; Shen ZY, 2020, HEALTH CARE MANAG SC, V23, P142, DOI 10.1007/s10729-019-09482-4; Shen ZY, 2018, CHINA ECON REV, V51, P83, DOI 10.1016/j.chieco.2018.04.014; Sulku SN, 2012, EUR J PUBLIC HEALTH, V22, P634, DOI 10.1093/eurpub/ckr163; Sultan WI, 2016, INT J BUS MANAG, V12, P68, DOI [10.5539/ijbm.v12n1p68, DOI 10.5539/IJBM.V12N1P68]; Sun Bin, 2016, Transactions of Tianjin University, V22, P182, DOI 10.1007/s12209-016-2725-8; Xu GC, 2015, CHINESE MED J-PEKING, V128, P3185, DOI 10.4103/0366-6999.170279; 2013, CLIN MED INSIGHTS GA, V6, P1	36	2	2	7	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243460	10.1371/journal.pone.0243460	http://dx.doi.org/10.1371/journal.pone.0243460			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH0WM	33306702	gold, Green Published			2022-12-27	WOS:000600144200007
J	Shen, Z; Zhang, YH; Zhang, L; Li, Y; Sun, YD; Li, ZY				Shen, Zhan; Zhang, Yan-hua; Zhang, Lei; Li, Yuan; Sun, Ya-dong; Li, Zu-yao			Changes in the distribution of endogenous hormones in Phyllostachys edulis 'Pachyloen' during bamboo shooting	PLOS ONE			English	Article							ABA; STRESS; COLD	In this study, we investigated the changes in the distribution and regulation of endogenous hormones in Phyllostachys edulis 'Pachyloen' during bamboo shooting. Enzyme-linked immunosorbent assay was used to measure the mass fractions of indole-3-acetic acid (IAA), gibberellic acid (GA), zeatin riboside (ZR), and abscisic acid (ABA) in rhizomes, shoots, and maternal bamboo organs during shoot sprouting, shoot growth, and new-bamboo formation. Measurements were compared among bamboo parts and developmental periods. The overall mass fractions of IAA and ABA were significantly higher than those of ZR and GA, driven by differences among bamboo parts and developmental periods. The abundance of each endogenous hormone varied among bamboo parts and developmental periods. During bamboo shooting, ABA had the highest mass fraction in all bamboo parts sampled, followed by IAA, GA, and ZR. Among bamboo parts, rhizomes had more IAA, ZR, and GA than the other parts, but significantly less ABA. Winter shoots had higher ZR: IAA and GA: IAA ratios than rhizomes and maternal bamboo organs. During shoot growth, ABA was the most abundant hormone in rhizomes and maternal bamboo organs, followed by IAA, ZR, and GA. In contrast, IAA was the most abundant hormone in spring shoots, followed by ABA, ZR, and GA. Maternal bamboo organs had a significantly higher ZR: GA ratio, and significantly lower IAA: ABA, ZR: ABA, and GA: ABA ratios than rhizomes. Spring shoots had significantly higher IAA: ABA, ZR: ABA, and GA: ABA ratios than rhizomes and maternal bamboo organs; significantly higher ZR mass fractions, and ZR: GA and ZR: IAA ratios and significantly lower ABA mass fractions than rhizomes; and significantly higher GA: IAA ratio than maternal bamboo organs. During new-bamboo formation, ABA was the most abundant hormone in rhizomes, winter shoots, and maternal bamboo organs, followed by IAA, ZR, and GA. Maternal bamboo organs had significantly lower IAA mass fractions and significantly higher ABA mass fractions than rhizomes and new bamboo tissue. IAA and ABA abundances exhibited an inverse relationship in rhizomes and maternal bamboo organs. GA: ABA and GA: IAA ratios decreased gradually and other hormone ratios exhibited parabolic trends over the bamboo-shooting period, with the highest ratios observed in new bamboo tissues. Overall, the coordination or antagonism among endogenous hormones plays a key regulatory role in bamboo shoot growth. The formation of thick walls in P. edulis 'Pachyloen', one of its major traits, may be partially attributed to the relatively high IAA and ZR and low GA mass fractions.	[Shen, Zhan; Li, Yuan; Sun, Ya-dong; Li, Zu-yao] Jiangxi Agr Univ, Coll Forestry, Nanchang, Jiangxi, Peoples R China; [Shen, Zhan; Li, Zu-yao] Jiangxi Prov Key Lab Bamboo Germplasm Resources &, Nanchang, Jiangxi, Peoples R China; [Zhang, Yan-hua; Zhang, Lei] Nanjing Forestry Univ, Coll Forestry, Nanjing, Jiangsu, Peoples R China	Jiangxi Agricultural University; Nanjing Forestry University	Li, ZY (corresponding author), Jiangxi Agr Univ, Coll Forestry, Nanchang, Jiangxi, Peoples R China.; Li, ZY (corresponding author), Jiangxi Prov Key Lab Bamboo Germplasm Resources &, Nanchang, Jiangxi, Peoples R China.	jxlizuyao@126.com			Key Technologies Research and Development Program of China [2015BAD04B01]	Key Technologies Research and Development Program of China(National Key Technology R&D Program)	The study was financially supported by the Key Technologies Research and Development Program of China (2015BAD04B01).	[Anonymous], 2013, RIGAKU J, V29, P26; Baron KN, 2012, PLANT SCI, V188, P48, DOI 10.1016/j.plantsci.2012.03.001; Beemster GTS, 2000, PLANT PHYSIOL, V124, P1718, DOI 10.1104/pp.124.4.1718; [陈建华 CHEN Jianhua], 2011, [中南林业科技大学学报, Journal of Central South University of Forestry & Technology], V31, P70; Chen Ting, 2015, Journal of Zhejiang A&F University, V32, P181; Du H, 2013, PLANT MOL BIOL, V83, P475, DOI 10.1007/s11103-013-0103-7; Durbak A, 2012, CURR OPIN PLANT BIOL, V15, P92, DOI 10.1016/j.pbi.2011.12.004; Fang Kai, 2012, Acta Agriculturae Universitatis Jiangxiensis, V34, P54; Fang Kai, 2011, Acta Agriculturae Universitatis Jiangxiensis, V33, P1107; Franklin DC, 2004, J BIOGEOGR, V31, P773, DOI 10.1111/j.1365-2699.2003.01057.x; Ghanem ME, 2011, J PLANT GROWTH REGUL, V30, P144, DOI 10.1007/s00344-010-9178-4; [何奇江 HE Qijiang], 2006, [科技通报, Bulletin of Science and Technology], V22, P477; Huang JianQin, 2002, Scientia Silvae Sinicae, V38, P38; Kim TW, 2010, ANNU REV PLANT BIOL, V61, P681, DOI 10.1146/annurev.arplant.043008.092057; Kof EM, 2006, RUSS J PLANT PHYSL+, V53, P359, DOI 10.1134/S1021443706030113; Kucera B, 2005, SEED SCI RES, V15, P281, DOI 10.1079/SSR2005218; Li Jian, 2011, Acta Agriculturae Universitatis Jiangxiensis, V33, P537; Li Y, 2017, NONWOOD FOREST RES, V35, P147; Li Ying-chun, 2009, Forest Research, V22, P608; Li ZY, 2013, NONWOOD FOREST RES, V31, P167; Liu XH, 2013, SPECTROSC SPECT ANAL, V33, P2512, DOI 10.3964/j.issn.1000-0593(2013)09-2512-07; Lou GH, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0289-z; Peleg Z, 2011, CURR OPIN PLANT BIOL, V14, P290, DOI 10.1016/j.pbi.2011.02.001; Roldan V G, 2008, NATURE, V455, P189; Santner A, 2009, NAT CHEM BIOL, V5, P301, DOI 10.1038/nchembio.165; Shi JianMin, 2009, Forest Research, Beijing, V22, P872; Sunayana MR, 2005, BIOTECHNOL LETT, V27, P1897, DOI 10.1007/s10529-005-3900-5; Wang Bo, 2015, Journal of Zhejiang Forestry Science and Technology, V35, P13; Wang CR, 2008, J INTEGR PLANT BIOL, V50, P427, DOI 10.1111/j.1774-7909.2008.00638.x; Wu XingBo, 2016, Journal of Zhejiang A&F University, V33, P209; Yang G., 1997, J JIANGXI AGR U, V19, P97; Yang RongChao, 2012, Acta Agrestia Sinica, V20, P1; Yu ShuHong, 2016, Journal of Zhejiang A&F University, V33, P807; Zheng YS, 1998, SCI SILVAE SINICAE, V34, P100	34	4	4	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0241806	10.1371/journal.pone.0241806	http://dx.doi.org/10.1371/journal.pone.0241806			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306692	gold, Green Published			2022-12-27	WOS:000600144200033
J	Doku, DT; Neupane, S; Dobewall, H; Rimpela, A				Doku, David Teye; Neupane, Subas; Dobewall, Henrik; Rimpela, Arja			Alcohol-related mortality and all-cause mortality following bereavement in two successive generations	PLOS ONE			English	Article							DEATH; PARENTS; CHILD; GRIEF; RISK; LIFE	Background and aim Bereavement affects the health of the bereaved both emotionally and physically. Bereavement resulting from alcohol-related death of the previous generation (parents-first generation) may increase the risk of alcohol abuse and consequently alcohol-related mortality as well as all-cause mortality in the next generation (offspring-second generation). Furthermore, these associations can be bi-directional. However, there is no conclusive evidence of these effects, and studies exploring these intergenerational effects are rare. This study investigates these associations. Methods A longitudinal data were constructed by linking participants from the Adolescent Health and Lifestyle Surveys (AHLS) from 1979 to 1997 with census and registry-based data from Statistics Finland containing the socioeconomic status of the survey participants and their parents (N = 78610) to investigate these associations. Multivariate Cox proportional hazards models were used to calculate hazard ratios with 95% confidence intervals to determine the effect of bereavement with alcohol-related mortality and all-cause mortality. Results The findings suggest that bereavement following the death of an offspring increases the risk of both alcohol-related and all-cause mortality among both parents. The magnitude of the risk of mortality following the death of an offspring is higher for mothers than for fathers. There were no clear associations of a parent's death with an offspring's alcohol-related or all-cause mortality. However, generally, a father's death seems to be protective of the risk of mortality among the offspring while a mother's alcohol-related death slightly increased the risk of alcohol-related mortality among their offspring. Conclusions These findings emphasise the role of bereavement, particularly resulting from the death of an offspring, on alcohol-related and all-cause mortality and therefore inequalities in mortality. Furthermore, the findings highlighting the need for alcohol abuse intervention and emotional support for bereaved persons following the death of an offspring.	[Doku, David Teye] Univ Cape Coast, Dept Populat & Hlth, Cape Coast, Ghana; [Doku, David Teye; Neupane, Subas; Dobewall, Henrik; Rimpela, Arja] Tampere Univ, Fac Social Sci Hlth Sci, Tampere, Finland; [Rimpela, Arja] Tampere Univ, PERLA Tampere Ctr Childhood Youth & Family Res, Tampere, Finland; [Rimpela, Arja] Tampere Univ Hosp, Dept Adolescent Psychiat, Pitkaniemi, Finland	University of Cape Coast; Tampere University; Tampere University; Tampere University; Tampere University Hospital	Doku, DT (corresponding author), Univ Cape Coast, Dept Populat & Hlth, Cape Coast, Ghana.; Doku, DT (corresponding author), Tampere Univ, Fac Social Sci Hlth Sci, Tampere, Finland.	dokudavid@gmail.com		Dobewall, Henrik/0000-0003-3515-2138; Rimpela, Arja/0000-0003-3273-6226; Doku, David/0000-0001-9503-2520	Ministry of Social Affairs and Health, Finland; Competitive State Research Financing of the Expert Responsibility Area of Tampere University Hospital [9S055, 9L084]; Juho Vainio Foundation [201810302]	Ministry of Social Affairs and Health, Finland; Competitive State Research Financing of the Expert Responsibility Area of Tampere University Hospital; Juho Vainio Foundation	Ministry of Social Affairs and Health, Finland; Competitive State Research Financing of the Expert Responsibility Area of Tampere University Hospital (9S055, 9L084); and Juho Vainio Foundation (Grant number 201810302). Dr. David Teye Doku received eight months of researcher's salary from the Juho Vainio Foundation (Grant number 201810302).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg L, 2014, PEDIATRICS, V133, P682, DOI 10.1542/peds.2013-2771; Clark TG, 2003, BRIT J CANCER, V89, P232, DOI 10.1038/sj.bjc.6601118; Dutton YC, 2005, DEATH STUD, V29, P877, DOI 10.1080/07481180500298826; Hendrickson Karrie Cummings, 2009, Palliat Support Care, V7, P109, DOI 10.1017/S1478951509000133; Holland JM, 2014, J GERONTOL B-PSYCHOL, V69, P4, DOI 10.1093/geronb/gbt051; Keyes KM, 2014, AM J PSYCHIAT, DOI [10.1176/appi.ajp.2014.130811320, DOI 10.1176/APPI.AJP.2014.130811320]; Khanfer R, 2011, BRAIN BEHAV IMMUN, V25, P1182, DOI 10.1016/j.bbi.2011.03.008; Koivusilta LK, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-711; Li J, 2005, NEW ENGL J MED, V352, P1190, DOI 10.1056/NEJMoa033160; Li J, 2003, LANCET, V361, P363, DOI 10.1016/S0140-6736(03)12387-2; Meert KL, 2010, ARCH PEDIAT ADOL MED, V164, P1045, DOI 10.1001/archpediatrics.2010.187; Moon JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023465; Rogers CH, 2008, J FAM PSYCHOL, V22, P203, DOI 10.1037/0893-3200.22.2.203; Rossow I, 2016, ADDICTION, V111, P204, DOI 10.1111/add.13097; Rostila M, 2012, J EPIDEMIOL COMMUN H, V66, P927, DOI 10.1136/jech-2011-200339; Savikko N, 2006, INT J OLDER PEOPLE N, V1, P17, DOI 10.1111/j.1748-3743.2006.00001.x; Shah SM, 2012, AM J EPIDEMIOL, V176, P689, DOI 10.1093/aje/kws162; Sirkia K, 2000, ACTA PAEDIATR, V89, P717, DOI 10.1080/080352500750044070; Zisook S, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-014-0482-8	19	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243290	10.1371/journal.pone.0243290	http://dx.doi.org/10.1371/journal.pone.0243290			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH0WB	33301516	gold, Green Published			2022-12-27	WOS:000600143100087
J	Gibeau, P; Bradford, MJ; Palen, WJ				Gibeau, Pascale; Bradford, Michael J.; Palen, Wendy J.			Can the creation of new freshwater habitat demographically offset losses of Pacific salmon from chronic anthropogenic mortality?	PLOS ONE			English	Article							COHO SALMON; ONCORHYNCHUS-KISUTCH; LIFE-HISTORY; BIODIVERSITY OFFSETS; BRITISH-COLUMBIA; FISH POPULATIONS; CARNATION CREEK; CHINOOK SALMON; RIVER; SURVIVAL	Over 1 billion USD are devoted annually to rehabilitating freshwater habitats to improve survival for the recovery of endangered salmon populations. Mitigation often requires the creation of new habitat (e.g. habitat offsetting) to compensate population losses from human activities, however offsetting schemes are rarely evaluated. Anadromous Pacific salmon are ecologically, culturally, and economically important in the US and Canada, and face numerous threats from degradation of freshwater habitats. Here we used a matrix population model of coho salmon (Oncorhynchus kisutch) to determine the amount of habitat offsetting needed to compensate mortality (2-20% per year) caused by a range of development activities. We simulated chronic mortality to three different life stages (egg, parr, smolt/adult), individually and simultaneously, to mimic impacts from development, and evaluated if the number of smolts produced from constructed side-channels demographically offset losses. We show that under ideal conditions, the typical size of a constructed side-channel in the Pacific Northwest (PNW) (3405 m(2)) is sufficient to compensate for only relatively low levels of chronic mortality to either the parr or smolt/adult stages (2-7% per year), but populations do not recover if mortality is >10% per year. When we assumed lower productivity (e.g.; 25(th) percentile), we found that constructed channels would need to be 2.5-4.5 fold larger as compared to the typical size built in the PNW, respectively, to maintain population sizes. Moreover, when we imposed mortality to parr and smolt/adult stages simultaneously, we found that constructed side-channels would need to be between 1.8- and 2.3- fold larger that if the extra chronic mortality was imposed to one life stage only. We conclude that habitat offsetting has the potential to mitigate chronic mortality to early life stages, but that realistic assumptions about productivity of constructed side-channels and cumulative effects of anthropogenic disturbances on multiple life stages need to be considered.	[Gibeau, Pascale; Palen, Wendy J.] Simon Fraser Univ, Earth Ocean Res Grp, Dept Biol Sci, Burnaby, BC, Canada; [Bradford, Michael J.] Fisheries & Ocean Canada, Pacific Sci Enterprise Ctr, W Vancouver, BC, Canada	Simon Fraser University; Fisheries & Oceans Canada	Gibeau, P (corresponding author), Simon Fraser Univ, Earth Ocean Res Grp, Dept Biol Sci, Burnaby, BC, Canada.	pgibeau@sfu.ca		Bradford, Michael/0000-0002-4810-0495	NSERC Discovery Grant; Gordon and Betty Moore Foundation; Wilburforce Foundation	NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Wilburforce Foundation	NSERC Discovery Grant, the Gordon and Betty Moore, and Wilburforce Foundations to WJP.	Achord S, 2003, ECOL LETT, V6, P335, DOI 10.1046/j.1461-0248.2003.00438.x; Anderson D, 2015, WATER ENVIRON J, V29, P268, DOI 10.1111/wej.12101; Baisez Aurore, 2011, Endangered Species Research, V15, P265, DOI 10.3354/esr00384; Barnthouse LW, 2019, ENVIRON MANAGE, V64, P593, DOI 10.1007/s00267-019-01214-2; Barnthouse LW, 2013, ENVIRON SCI POLICY, V31, P149, DOI 10.1016/j.envsci.2013.03.001; BECKER CD, 1985, ENVIRON BIOL FISH, V12, P33, DOI 10.1007/BF00007708; Beechie TJ, 2010, BIOSCIENCE, V60, P209, DOI 10.1525/bio.2010.60.3.7; Beverton R.J.H., 1957, FISH INVEST SER, P19; Booth DB, 2016, WATER-SUI, V8, DOI 10.3390/w8050174; Bradford MJ, 2000, CAN J FISH AQUAT SCI, V57, P677, DOI 10.1139/cjfas-57-4-677; BRADFORD MJ, 1995, CAN J FISH AQUAT SCI, V52, P1327, DOI 10.1139/f95-129; Bradford MJ, 2000, CAN J FISH AQUAT SCI, V57, P13, DOI 10.1139/cjfas-57-1-13; Bull JW, 2013, ORYX, V47, P369, DOI 10.1017/S003060531200172X; Casas-Mulet R, 2015, RIVER RES APPL, V31, P433, DOI 10.1002/rra.2827; CHAPMAN DW, 1962, J FISH RES BOARD CAN, V19, P1047, DOI 10.1139/f62-069; Chittenden CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010869; CRONE RA, 1976, FISH B-NOAA, V74, P897; Crozier LG, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217711; Gibeau P, 2017, CAN J FISH AQUAT SCI, V74, P1135, DOI 10.1139/cjfas-2016-0253; Goodwin NB, 2006, CAN J FISH AQUAT SCI, V63, P494, DOI 10.1139/f05-234; Greene CM, 2004, CAN J FISH AQUAT SCI, V61, P590, DOI 10.1139/F04-024; Groot C., 1995, PHYSL ECOLOGY PACIFI; Hall J.D., 2008, HYDROLOGICAL BIOL RE, P78; Hartman GF, 1996, CAN J FISH AQUAT SCI, V53, P237, DOI 10.1139/cjfas-53-S1-237; Hayes D, 2009, REV FISH BIOL FISHER, V19, P295, DOI 10.1007/s11160-009-9103-8; Hodgson EE, 2017, ECOLOGY, V98, P2673, DOI 10.1002/ecy.1961; HOLTBY LB, 1990, ECOLOGY, V71, P678, DOI 10.2307/1940322; Keeley E. R., 1996, 4 MIN ENV LANDS PARK; Korman J., 2019, 2019001 CAN SCI ADV; Korman J, 2014, 2014089 CAN SCI ADV; Levin PS, 2001, ANIM CONSERV, V4, P291, DOI 10.1017/S1367943001001342; McCay DPF, 2003, MAR ECOL PROG SER, V264, P177; McKenney BA, 2010, ENVIRON MANAGE, V45, P165, DOI 10.1007/s00267-009-9396-3; Milner NJ, 2003, FISH RES, V62, P111, DOI 10.1016/S0165-7836(02)00157-1; Morley SA, 2005, CAN J FISH AQUAT SCI, V62, P2811, DOI 10.1139/F05-185; Morris W. F., 2002, QUANTITATIVE CONSERV; Muir WD, 2001, N AM J FISH MANAGE, V21, P135, DOI 10.1577/1548-8675(2001)021<0135:SOJSPT>2.0.CO;2; Nagrodski A, 2012, J ENVIRON MANAGE, V103, P133, DOI 10.1016/j.jenvman.2012.03.007; Naiman RJ, 2000, BIOSCIENCE, V50, P996, DOI 10.1641/0006-3568(2000)050[0996:REAMIT]2.0.CO;2; Naiman RJ, 2008, CR GEOSCI, V340, P629, DOI 10.1016/j.crte.2008.01.002; Nickelson TE, 1998, CAN J FISH AQUAT SCI, V55, P2383, DOI 10.1139/cjfas-55-11-2383; Nislow KH, 2004, T AM FISH SOC, V133, P79, DOI 10.1577/T02-168; Ogston L, 2015, CAN J FISH AQUAT SCI, V72, P479, DOI 10.1139/cjfas-2014-0189; Pascoe S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025762; Quetier F, 2011, BIOL CONSERV, V144, P2991, DOI 10.1016/j.biocon.2011.09.002; Quigley JT, 2006, ENVIRON MANAGE, V37, P351, DOI 10.1007/s00267-004-0263-y; R Development Core Team, 2009, R LANG ENV STAT COMP; Roni P, 2006, T AM FISH SOC, V135, P1398, DOI 10.1577/T05-296.1; Roni P, 2010, N AM J FISH MANAGE, V30, P1469, DOI 10.1577/M09-162.1; Rose KA, 2001, FISH FISH, V2, P293, DOI 10.1046/j.1467-2960.2001.00056.x; Rosenfeld JS, 2008, N AM J FISH MANAGE, V28, P1108, DOI 10.1577/M07-027.1; Schreck CB, 2006, T AM FISH SOC, V135, P457, DOI 10.1577/T05-184.1; SCRIVENER JC, 1989, CAN J FISH AQUAT SCI, V46, P681, DOI 10.1139/f89-087; Shapovalov L., 1954, FISH B, V98; Spidle AP, 1998, J FISH BIOL, V52, P907, DOI 10.1111/j.1095-8649.1998.tb00591.x; TANG J, 1987, PROG FISH CULT, V49, P167, DOI 10.1577/1548-8640(1987)49&lt;167:EOTEOT&gt;2.0.CO;2; Tschaplinski PJ, 2017, ECOHYDROLOGY, V10, DOI 10.1002/eco.1812; Walters AW, 2013, ECOL FRESHW FISH, V22, P508, DOI 10.1111/eff.12046; Waples RS, 2009, ECOL SOC, V14; Ward B.R., 1993, Canadian Special Publication of Fisheries and Aquatic Sciences, V118, P209; Wisdom MJ, 2000, ECOLOGY, V81, P628, DOI 10.1890/0012-9658(2000)081[0628:LSSAEV]2.0.CO;2	61	0	0	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0237052	10.1371/journal.pone.0237052	http://dx.doi.org/10.1371/journal.pone.0237052			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332352	Green Submitted, gold, Green Published			2022-12-27	WOS:000601310900105
J	Hirabayashi, G; Saito, M; Terayama, S; Akihisa, Y; Maruyama, K; Andoh, T				Hirabayashi, Go; Saito, Minami; Terayama, Sachiko; Akihisa, Yuki; Maruyama, Koichi; Andoh, Tomio			Lung-protective properties of expiratory flow-initiated pressure-controlled inverse ratio ventilation: A randomised controlled trial	PLOS ONE			English	Article							LAPAROSCOPIC RADICAL PROSTATECTOMY; PULMONARY GAS-EXCHANGE; CO2 ELIMINATION; OXYGENATION; PAUSE	Background Expiratory flow-initiated pressure-controlled inverse ratio ventilation (EF-initiated PC-IRV) reduces physiological dead space. We hypothesised that EF-initiated PC-IRV would be lung protective compared with volume-controlled ventilation (VCV). Methods Twenty-eight men undergoing robot-assisted laparoscopic radical prostatectomy were enrolled in this randomised controlled trial. The EF-initiated PC-IRV group (n = 14) used pressure-controlled ventilation with the volume guaranteed mode. The inspiratory to expiratory (I:E) ratio was individually adjusted by observing the expiratory flow-time wave. The VCV group (n = 14) used the volume control mode with a 1:2 I:E ratio. The Mann-Whitney U test was used to compare differences in the serum cytokine levels. Results There were no significant differences in serum IL-6 between the EF-initiated PC-IRV (median 34 pg ml(-1) (IQR 20.5 to 63.5)) and VCV (31 pg ml(-1) (24.5 to 59)) groups (P = 0.84). The physiological dead space rate (physiological dead space/expired tidal volume) was significantly reduced in the EF-initiated PC-IRV group as compared with that in the VCV group (0.31 +/- 0.06 vs 0.4 +/- 0.07; P<0.001). The physiological dead space rate was negatively correlated with the forced vital capacity (% predicted) in the VCV group (r = -0.85, P<0.001), but not in the EF-initiated PC-IRV group (r = 0.15, P = 0.62). Two patients in the VCV group had permissive hypercapnia with low forced vital capacity (% predicted). Conclusions There were no differences in the lung-protective properties between the two ventilatory strategies. However, EF-initiated PC-IRV reduced physiological dead space rate; thus, it may be useful for reducing the ventilatory volume that is necessary to maintain normocapnia in patients with low forced vital capacity (% predicted) during robot-assisted laparoscopic radical prostatectomy.	[Hirabayashi, Go; Saito, Minami; Terayama, Sachiko; Akihisa, Yuki; Maruyama, Koichi; Andoh, Tomio] Teikyo Univ, Mizonokuchi Hosp, Sch Med, Dept Anaesthesiol, Sagamiko, Kanagawa, Japan	Teikyo University	Hirabayashi, G (corresponding author), Teikyo Univ, Mizonokuchi Hosp, Sch Med, Dept Anaesthesiol, Sagamiko, Kanagawa, Japan.	goh@med.teikyo-u.ac.jp			Department of Anaesthesiology, Mizonokuchi Hospital Teikyo University School of Medicine, Kanagawa, Japan	Department of Anaesthesiology, Mizonokuchi Hospital Teikyo University School of Medicine, Kanagawa, Japan	This study was financially supported by internal funding from the Department of Anaesthesiology, Mizonokuchi Hospital Teikyo University School of Medicine, Kanagawa, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM E, 1990, CHEST, V98, P1445, DOI 10.1378/chest.98.6.1445; Balick-Weber CC, 2007, BRIT J ANAESTH, V99, P429, DOI 10.1093/bja/aem166; Cadi P, 2008, BRIT J ANAESTH, V100, P709, DOI 10.1093/bja/aen067; CHAN K, 1992, CHEST, V102, P1556, DOI 10.1378/chest.102.5.1556; Choi EM, 2011, J CLIN ANESTH, V23, P183, DOI 10.1016/j.jclinane.2010.08.006; Devaquet J, 2008, J APPL PHYSIOL, V105, P1944, DOI 10.1152/japplphysiol.90682.2008; Gainsburg DM, 2012, MINERVA ANESTESIOL, V78, P596; Hirabayashi G, 2018, EUR J ANAESTH, V35, P307, DOI 10.1097/EJA.0000000000000732; Kalmar AF, 2010, BRIT J ANAESTH, V104, P433, DOI 10.1093/bja/aeq018; Kim MS, 2018, INT J MED SCI, V15, P1522, DOI 10.7150/ijms.28442; Lestar M, 2011, ANESTH ANALG, V113, P1069, DOI 10.1213/ANE.0b013e3182075d1f; Markstrom Agneta M., 1996, Upsala Journal of Medical Sciences, V101, P257; MERCAT A, 1993, CHEST, V104, P871, DOI 10.1378/chest.104.3.871; Michelet P, 2006, ANESTHESIOLOGY, V105, P911, DOI 10.1097/00000542-200611000-00011; Ogurlu M, 2010, J MINIM INVAS GYN, V17, P295, DOI 10.1016/j.jmig.2009.10.007; Prella M, 2002, CHEST, V122, P1382, DOI 10.1378/chest.122.4.1382; Sturesson LW, 2016, BRIT J ANAESTH, V117, P243, DOI 10.1093/bja/aew194; THARRATT RS, 1988, CHEST, V94, P755, DOI 10.1378/chest.94.4.755; TWEED WA, 1992, CAN J ANAESTH, V39, P1036, DOI 10.1007/BF03008371; TWEED WA, 1991, CAN J ANAESTH, V38, P311, DOI 10.1007/BF03007620; Uttman L, 2003, CLIN PHYSIOL FUNCT I, V23, P252, DOI 10.1046/j.1475-097X.2003.00498.x; Wang SH, 2002, AM J SURG, V183, P151, DOI 10.1016/S0002-9610(01)00870-4; Zavala E, 1998, ANESTHESIOLOGY, V88, P35, DOI 10.1097/00000542-199801000-00008	23	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243971	10.1371/journal.pone.0243971	http://dx.doi.org/10.1371/journal.pone.0243971			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332454	gold, Green Published			2022-12-27	WOS:000601310900104
J	Kinshella, MLW; Salimu, S; Chiwaya, B; Chikoti, F; Chirambo, L; Mwaungulu, E; Banda, M; Newberry, L; Njirammadzi, J; Hiwa, T; Vidler, M; Molyneux, EM; Dube, Q; Mfutso-Bengo, J; Goldfarb, DM; Kawaza, K; Nyondo-Mipando, AL				Kinshella, Mai-Lei Woo; Salimu, Sangwani; Chiwaya, Brandina; Chikoti, Felix; Chirambo, Lusungu; Mwaungulu, Ephrida; Banda, Mwai; Newberry, Laura; Njirammadzi, Jenala; Hiwa, Tamanda; Vidler, Marianne; Molyneux, Elizabeth M.; Dube, Queen; Mfutso-Bengo, Joseph; Goldfarb, David M.; Kawaza, Kondwani; Nyondo-Mipando, Alinane Linda			"So sometimes, it looks like it's a neglected ward": Health worker perspectives on implementing kangaroo mother care in southern Malawi	PLOS ONE			English	Article							DISTRICT	Introduction Kangaroo mother care (KMC) involves continuous skin-to-skin contact of baby on mother's chest to provide warmth, frequent breastfeeding, recognizing danger signs of illness, and early discharge. Though KMC is safe, effective and recommended by the World Health Organization, implementation remains limited in practice. The objective of this study is to understand barriers and facilitators to KMC practice at tertiary and secondary health facilities in southern Malawi from the perspective of health workers. Methods This study is part of the "Integrating a neonatal healthcare package for Malawi" project in the Innovating for Maternal and Child Health in Africa initiative. In-depth interviews were conducted between May-Aug 2019 with a purposively drawn sample of service providers and supervisors working in newborn health at a large tertiary hospital and three district-level hospitals in southern Malawi. Data were analyzed using a thematic approach using NVivo 12 software (QSR International, Melbourne, Australia). Findings A total of 27 nurses, clinical officers, paediatricians and district health management officials were interviewed. Staff attitudes, inadequate resources and reliance on families emerged as key themes. Health workers from Malawi described KMC practice positively as a low-cost, low-technology solution appropriate for resource-constrained health settings. However, staff perceptions that KMC babies were clinically stable was associated with lower prioritization in care and poor monitoring practices. Neglect of the KMC ward by medical staff, inadequate staffing and reliance on caregivers for supplies were associated with women self-discharging early. Conclusion Though routine uptake of KMC was policy for stable low birthweight and preterm infants in the four hospitals, there were gaps in monitoring and maintenance of practice. While conceptualized as a low-cost intervention, sustainable implementation requires investments in technologies, staffing and hospital provisioning of basic supplies such as food, bedding, and KMC wraps. Strengthening hospital capacities to support KMC is needed as part of a continuum of care for premature infants.	[Kinshella, Mai-Lei Woo; Vidler, Marianne] BC Childrens & Womens Hosp, Dept Obstet & Gynaecol, Vancouver, BC, Canada; [Kinshella, Mai-Lei Woo; Vidler, Marianne] Univ British Columbia, Vancouver, BC, Canada; [Salimu, Sangwani; Chiwaya, Brandina; Chikoti, Felix; Chirambo, Lusungu; Mwaungulu, Ephrida; Banda, Mwai; Newberry, Laura; Njirammadzi, Jenala; Hiwa, Tamanda; Molyneux, Elizabeth M.; Kawaza, Kondwani] Univ Malawi, Coll Med, Dept Pediat & Child Hlth, Blantyre, Malawi; [Dube, Queen; Kawaza, Kondwani] Queen Elizabeth Cent Hosp, Pediat, Blantyre, Malawi; [Mfutso-Bengo, Joseph; Nyondo-Mipando, Alinane Linda] Univ Malawi, Dept Hlth Syst & Policy, Sch Publ Hlth & Family Med, Coll Med, Blantyre, Malawi; [Mfutso-Bengo, Joseph] Ctr Bioeth Eastern & Southern Africa CEBESA, Blantyre, Malawi; [Goldfarb, David M.] BC Childrens & Womens Hosp, Dept Pathol & Lab Med, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of Malawi; University of Malawi; University of Malawi; University of British Columbia	Kinshella, MLW (corresponding author), BC Childrens & Womens Hosp, Dept Obstet & Gynaecol, Vancouver, BC, Canada.; Kinshella, MLW (corresponding author), Univ British Columbia, Vancouver, BC, Canada.	maggie.kinshella@cw.bc.ca	Goldfarb, David/ABD-4623-2021; Nyondo, Alinane/AFN-8844-2022; Kinshella, Mai-Lei Woo/AAA-8117-2022	Nyondo, Alinane/0000-0002-3572-3810; Kinshella, Mai-Lei Woo/0000-0001-5846-3014; Vidler, Marianne/0000-0002-7633-8812; Goldfarb, David/0000-0003-0835-9504	Canadian International Development Research Centre (IDRC); Global Affairs Canada (GAC); Canadian Institutes for Health Research (CIHR) [108030]	Canadian International Development Research Centre (IDRC); Global Affairs Canada (GAC)(CGIAR); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	MWK, ALNM, KK, QD and DG were funded by the Canadian International Development Research Centre (IDRC), Global Affairs Canada (GAC) and the Canadian Institutes for Health Research (CIHR). Project ID is 108030. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akseer N, 2015, INT J GYNECOL OBSTET, V131, pS43, DOI 10.1016/j.ijgo.2015.03.017; [Anonymous], 2018, CANC DISCOV, V8, pOF6; [Anonymous], 2016, WHO REC INT IMPR PRE; [Anonymous], 2017, CANC DISCOVERY, V7, pOF12; [Anonymous], 2010, EUR J VASC MED, V39, pS/78; Bergh AM, 2003, ACTA PAEDIATR, V92, P709, DOI 10.1080/08035250310002399; Bergh AM, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-75; Bergh AM, 2008, HUM RESOUR HEALTH, V6, DOI 10.1186/1478-4491-6-13; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Boundy EO, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2238; Chan GJ, 2016, B WORLD HEALTH ORGAN, V94, P130, DOI 10.2471/BLT.15.157818; Charpak N, 2020, ACTA PAEDIATR, V109, P2278, DOI 10.1111/apa.15214; Conde-Agudelo A, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002771.pub4; Department for Maternal NC& AHW, ONG RES PROJ OV IMM; Feucht U, 2016, SAMJ S AFR MED J, V106, P49, DOI [10.7196/SAMJ.2016.v106i1.10149, 10.7196/SAMJ.2016.V106I1.10149]; Gondwe A, 2016, MATERN CHILD HLTH J, V20, P1441, DOI 10.1007/s10995-016-1942-z; Hobart City Council, 2009, HOBART CITY COUNCIL, V5, P48; Hodgins S, 2018, J GLOB HEALTH, V8, DOI 10.7189/jogh.08.010306; Kambarami R. A., 1999, Central African Journal of Medicine, V45, P56; Kampekete G. S. M., 2018, African Journal of Midwifery and Women's Health, V12, P178, DOI 10.12968/ajmw.2018.12.4.178; Lancet Global Health, 2019, LANCET GLOB HEALTH, V7, pe1; Leonard A, 2008, HEALTH SA GESONDHEID, V13; Lincetto O, 2000, J TROP PEDIATRICS, V46, P293, DOI 10.1093/tropej/46.5.293; Medvedev MM, 2020, TRIALS, V21, DOI 10.1186/s13063-019-4044-6; National Statistical Office Malawi ICF, 2017, MAL DEM HLTH SURV 20; Nyqvist KH, 2016, ACTA PAEDIATR, V105, P341, DOI 10.1111/apa.13236; Okoh BA., 2016, NIGER J PAEDIAT, V43, P252, DOI [DOI 10.4314/NJP.V43I4.4, 10.4314/njp.v43i4.4]; Phaphali Adzitey S, 2017, ANN MED HLTH SCI RES; Reddy J., 2007, EXPERIENCES MOTHERS, DOI DOI 10.4102/CURATIONIS.V30I3.1104; Seidman G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125643; Solomons N, 2012, S AFR J CLIN NUTR, V25, P33; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Vesel L, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/1471-2393-15-S2-S5; Watkins HC, 2018, ACTA PAEDIATR, V107, P1541, DOI 10.1111/apa.14344; Weldearegay HG, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225258	35	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243770	10.1371/journal.pone.0243770	http://dx.doi.org/10.1371/journal.pone.0243770			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332395	Green Published, gold			2022-12-27	WOS:000601310900055
J	Melo, G; Oliveira, T; Alencar, P; Cowan, D				Melo, Glaucia; Oliveira, Toacy; Alencar, Paulo; Cowan, Donald			Knowledge reuse in software projects: Retrieving software development Q&A posts based on project task similarity	PLOS ONE			English	Article							SEARCH	Software developers need to cope with a massive amount of knowledge throughout the typical life cycle of modern projects. This knowledge includes expertise related to the software development phases (e.g., programming, testing) using a wide variety of methods and tools, including development methodologies (e.g., waterfall, agile), software tools (e.g., Eclipse), programming languages (e.g., Java, SQL), and deployment strategies (e.g., Docker, Jenkins). However, there is no explicit integration of these various types of knowledge with software development projects so that developers can avoid having to search over and over for similar and recurrent solutions to tasks and reuse this knowledge. Specifically, Q&A sites such as Stack Overflow are used by developers to share software development knowledge through posts published in several categories, but there is no link between these posts and the tasks developers perform. In this paper, we present an approach that (i) allows developers to associate project tasks with Stack Overflow posts, and (ii) recommends which Stack Overflow posts might be reused based on task similarity. We analyze an industry dataset, which contains project tasks associated with Stack Overflow posts, looking for the similarity of project tasks that reuse a Stack Overflow post. The approach indicates that when a software developer is performing a task, and this task is similar to another task that has been associated with a post, the same post can be recommended to the developer and possibly reused. We believe that this approach can significantly advance the state of the art of software knowledge reuse by supporting novel knowledge-project associations.	[Melo, Glaucia; Alencar, Paulo; Cowan, Donald] Univ Waterloo, David R Cheriton Sch Comp Sci, Waterloo, ON, Canada; [Oliveira, Toacy] Univ Fed Rio de Janeiro, Syst Engn & Comp Sci Program, Rio De Janeiro, Brazil	University of Waterloo; Universidade Federal do Rio de Janeiro	Melo, G (corresponding author), Univ Waterloo, David R Cheriton Sch Comp Sci, Waterloo, ON, Canada.	gmelo@uwaterloo.ca	Oliveira, Toacy/AAG-2789-2019	Oliveira, Toacy/0000-0001-8184-2442; Melo dos Santos, Glaucia/0000-0003-0092-2171	MITACS Accelerate [IT11814]; NSERC, Natural Sciences and Engineering Research Council of Canada; COMAP - Centre for Community Mapping; ELAP - Emerging Leaders in the Americas, Global Affairs Canada	MITACS Accelerate; NSERC, Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); COMAP - Centre for Community Mapping; ELAP - Emerging Leaders in the Americas, Global Affairs Canada	MITACS Accelerate. Funding Number: IT11814. GMS. NSERC, Natural Sciences and Engineering Research Council of Canada. PA. COMAP - Centre for Community Mapping. GMS. https://comap.ca/ELAP - Emerging Leaders in the Americas, Global Affairs Canada. GMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Batlaa A, 2019, 2019 JOINT 8TH INTERNATIONAL CONFERENCE ON INFORMATICS, ELECTRONICS & VISION (ICIEV) AND 2019 3RD INTERNATIONAL CONFERENCE ON IMAGING, VISION & PATTERN RECOGNITION (ICIVPR) WITH INTERNATIONAL CONFERENCE ON ACTIVITY AND BEHAVIOR COMPUTING (ABC), P169, DOI 10.1109/ICIEV.2019.8858514; Amintabar V, 2015, INT C PROGRAM COMPRE, P299, DOI 10.1109/ICPC.2015.45; [Anonymous], 2016, EUR J ORAL IMPLAN S1, V9, pS173; Antunes B, 2007, LECT NOTES ARTIF INT, V4874, P357; Bacchelli A., 2012, 2012 Third International Workshop on Recommendation Systems for Software Engineering (RSSE), P26, DOI 10.1109/RSSE.2012.6233404; BARNES BH, 1991, IEEE SOFTWARE, V8, P13, DOI 10.1109/52.62928; Barros-Justo JL, 2018, SOFTWARE PATTERNS RE; Borg M, 2014, RECOMMENDATION SYSTE, P477; Brandt J, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P513; Cai L, 2019, ESEC/FSE'2019: PROCEEDINGS OF THE 2019 27TH ACM JOINT MEETING ON EUROPEAN SOFTWARE ENGINEERING CONFERENCE AND SYMPOSIUM ON THE FOUNDATIONS OF SOFTWARE ENGINEERING, P1075, DOI 10.1145/3338906.3341174; Campos EC, 2016, J SOFTW-EVOL PROC, V28, P863, DOI 10.1002/smr.1800; Capilla R, 2019, J SOFTW-EVOL PROC, V31, DOI 10.1002/smr.2217; Cordeiro J., 2012, 2012 Third International Workshop on Recommendation Systems for Software Engineering (RSSE), P85, DOI 10.1109/RSSE.2012.6233418; Correa D, 2013, IEEE AUS SOFT ENGR, P88, DOI 10.1109/ASWEC.2013.20; Cubranic D, 2005, IEEE T SOFTWARE ENG, V31, P446, DOI 10.1109/TSE.2005.71; Cubranic D, 2004, LEARNING PROJECT HIS, P82; Davenport T. H., 1998, WORKING KNOWLEDGE OR, DOI DOI 10.1109/EMR.2003.1267012; de Souza L. B. L., 2014, PROC 22 INT C PROGRA, P72; Di Ciccio C, 2015, J DATA SEMANT, V4, P29, DOI 10.1007/s13740-014-0038-4; Fraga A, 2019, INFORM SYST FRONT, V21, P5, DOI 10.1007/s10796-018-9862-7; Fumin S, 2016, INT C COLL COMP NETW, P521; Garousi V., 2016, P 20 INT C EV ASS SO, P26; Greco C, 2018, PROC IEEE ACM INT C, P5, DOI 10.1145/3183440.3183477; Kersten M, 2005, P INT C ASPECT ORIEN, P159, DOI [10.1145/1052898.1052912, DOI 10.1145/1052898.1052912]; Kochhar P.S., 2016, P 5 INT WORKSHOP SOF, P32; Li J, 2019, WORLD WIDE WEB, V22, P1699, DOI 10.1007/s11280-018-0621-y; Li J, 2021, IEEE T SERV COMPUT, V14, P472, DOI 10.1109/TSC.2018.2812729; Li J, 2018, J ASSOC INF SCI TECH, V69, P1460, DOI 10.1002/asi.24067; Li J, 2018, INFORM SCIENCES, V448, P36, DOI 10.1016/j.ins.2018.03.014; Lin YS, 2014, IEEE T KNOWL DATA EN, V26, P1575, DOI 10.1109/TKDE.2013.19; Lindvall M, 2003, MANAGING SOFTWARE ENGINEERING KNOWLEDGE, P73; Liu XN, 2016, ASIA PAC SOFWR ENG, P25, DOI 10.1109/APSEC.2016.13; Mamykina L, 2011, 29TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P2857; Melo G, 2018, IB C SOFTW ENG CIBSE, P199; Meyer AN, 2017, IEEE T SOFTWARE ENG, V43, P1178, DOI 10.1109/TSE.2017.2656886; Minelli R, 2015, INT C PROGRAM COMPRE, P25, DOI 10.1109/ICPC.2015.12; Murphy GC, 2019, 2019 IEEE/ACM 41ST INTERNATIONAL CONFERENCE ON SOFTWARE ENGINEERING: NEW IDEAS AND EMERGING RESULTS (ICSE-NIER 2019), P73, DOI 10.1109/ICSE-NIER.2019.00027; Pai M, 2004, NATL MED J INDIA, V17, P86; Petersen K, 2015, INFORM SOFTWARE TECH, V64, P1, DOI 10.1016/j.infsof.2015.03.007; Ponzanelli L., 2014, P 11 WORK C MIN SOFT, P102, DOI DOI 10.1145/2597073.2597077; Ponzanelli L, 2014, PROC IEEE INT CONF S, P577, DOI 10.1109/ICSME.2014.99; Ponzanelli L, 2013, PROCEEDINGS OF THE 35TH INTERNATIONAL CONFERENCE ON SOFTWARE ENGINEERING (ICSE 2013), P1295, DOI 10.1109/ICSE.2013.6606701; Ponzanelli L, 2013, EUR CON SFTWR MTNCE, P57, DOI 10.1109/CSMR.2013.16; Rahman MM, 2019, EMPIR SOFTW ENG, V24, P1869, DOI 10.1007/s10664-018-9671-0; Rahman MM, 2019, 2019 IEEE/ACM 41ST INTERNATIONAL CONFERENCE ON SOFTWARE ENGINEERING: COMPANION PROCEEDINGS (ICSE-COMPANION 2019), P226, DOI 10.1109/ICSE-Companion.2019.00088; Rahman MM, 2017, PROC IEEE ACM INT C, P51, DOI 10.1109/ICSE-C.2017.11; Rahman MM, 2014, PROC IEEE INT CONF S, P617, DOI 10.1109/ICSME.2014.109; Rahman MM, 2014, 2014 SOFTWARE EVOLUTION WEEK - IEEE CONFERENCE ON SOFTWARE MAINTENANCE, REENGINEERING, AND REVERSE ENGINEERING (CSMR-WCRE), P194, DOI 10.1109/CSMR-WCRE.2014.6747170; Santoro FM, 2006, INT C COMP SUPP COOP, P377; Schlitter N., 2013, P 4 RAPIDMINDER COMM, P81; Shani G, 2011, RECOMMENDER SYSTEMS HANDBOOK, P257, DOI 10.1007/978-0-387-85820-3_8; Silva RFG, 2019, INT C PROGRAM COMPRE, P358, DOI 10.1109/ICPC.2019.00054; Tan P. N, 2006, PEARSON, P37; Uddin G, 2020, INFORM SOFTWARE TECH, V122, DOI 10.1016/j.infsof.2020.106277; Van Solingen R., 2002, ENCY SOFTWARE ENG; Vasanthapriyan S, 2015, 2015 IEEE INTERNATIONAL CONFERENCE ON SOFTWARE QUALITY, RELIABILITY AND SECURITY - COMPANION (QRS-C 2015), P237, DOI 10.1109/QRS-C.2015.48; von Krogh G, 2005, P 38 ANN HAWAII INT, p198b; Wallace DP, 2007, LIB UNLIMITED; Wang HM, 2018, IEEE T SERV COMPUT, V11, P782, DOI 10.1109/TSC.2015.2473847; Wang T, 2014, LINKING STACK OVERFL, P11; Wang T, 2015, 9TH IEEE INTERNATIONAL SYMPOSIUM ON SERVICE-ORIENTED SYSTEM ENGINEERING (SOSE 2015), P107, DOI 10.1109/SOSE.2015.34; Wang W, 2015, 12TH WORKING CONFERENCE ON MINING SOFTWARE REPOSITORIES (MSR 2015), P224, DOI 10.1109/MSR.2015.28; Wohlin Claes, 2012, EXPT SOFTWARE ENG IN, DOI DOI 10.1007/978-3-642-29044-2; Wu D, 2018, PROC IEEE ACM INT C, P270, DOI 10.1145/3183440.3194965; Yin H, 2019, IEEE WORLD CONGR SER, P358, DOI 10.1109/SERVICES.2019.00102; Zhang F, 2018, IEEE T SOFTWARE ENG, V44, P1070, DOI 10.1109/TSE.2017.2750682	66	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243852	10.1371/journal.pone.0243852	http://dx.doi.org/10.1371/journal.pone.0243852			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332398	Green Published, gold			2022-12-27	WOS:000601310900107
J	Perry, G; Taylor, NW; Bothwell, PCH; Milbourn, CC; Powell, G; Singh, KD				Perry, Gavin; Taylor, Nathan W.; Bothwell, Philippa C. H.; Milbourn, Colette C.; Powell, Georgina; Singh, Krish D.			The gamma response to colour hue in humans: Evidence from MEG	PLOS ONE			English	Article							VISUAL-CORTEX; OSCILLATIONS; FREQUENCY; POWER; SYNCHRONIZATION; MECHANISMS; LFP; V1	It has recently been demonstrated through invasive electrophysiology that visual stimulation with extended patches of uniform colour generates pronounced gamma oscillations in the visual cortex of both macaques and humans. In this study we sought to discover if this oscillatory response to colour can be measured non-invasively in humans using magnetoencephalography. We were able to demonstrate increased gamma (40-70 Hz) power in response to full-screen stimulation with four different colour hues and found that the gamma response is particularly strong for long wavelength (i.e. red) stimulation, as was found in previous studies. However, we also found that gamma power in response to colour was generally weaker than the response to an identically sized luminance-defined grating. We also observed two additional responses in the gamma frequency: a lower frequency response around 25-35 Hz that showed fewer clear differences between conditions than the gamma response, and a higher frequency response around 70-100 Hz that was present for red stimulation but not for other colours. In a second experiment we sought to test whether differences in the gamma response between colour hues could be explained by their chromatic separation from the preceding display. We presented stimuli that alternated between each of the three pairings of the three primary colours (red, green, blue) at two levels of chromatic separation defined in the CIELUV colour space. We observed that the gamma response was significantly greater to high relative to low chromatic separation, but that at each level of separation the response was greater for both red-blue and red-green than for blue-green stimulation. Our findings suggest that the stronger gamma response to red stimulation cannot be wholly explained by the chromatic separation of the stimuli.	[Perry, Gavin; Taylor, Nathan W.; Bothwell, Philippa C. H.; Milbourn, Colette C.; Powell, Georgina; Singh, Krish D.] Cardiff Univ, Sch Psychol, Cardiff Univ Brain Res Imaging Ctr CUBRIC, Cardiff, Wales	Cardiff University	Perry, G (corresponding author), Cardiff Univ, Sch Psychol, Cardiff Univ Brain Res Imaging Ctr CUBRIC, Cardiff, Wales.	perryg@cardiff.ac.uk	Powell, Georgina/GXM-7788-2022	Milbourn, Colette/0000-0002-1305-8127	Medical Research Council [MR/K005464/1]; MRC [MR/K005464/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The research was funded by a Medical Research Council partnership grant (MR/K005464/1) awarded to Krish D Singh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjamian P, 2004, EUR J NEUROSCI, V20, P587, DOI 10.1111/j.1460-9568.2004.03495.x; Adjamian P, 2008, J VISION, V8, DOI 10.1167/8.7.4; [Anonymous], 2018, NAT CLIM CHANGE, V8, P1, DOI 10.1038/s41558-017-0058-9; Bartoli E, 2019, CURR BIOL, V29, P3345, DOI 10.1016/j.cub.2019.08.004; Brunet NM, 2019, NEUROIMAGE, V200, P635, DOI 10.1016/j.neuroimage.2019.06.051; Gail A, 2000, CEREB CORTEX, V10, P840, DOI 10.1093/cercor/10.9.840; Gieselmann MA, 2008, EUR J NEUROSCI, V28, P447, DOI 10.1111/j.1460-9568.2008.06358.x; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Hadjipapas A, 2015, NEUROIMAGE, V112, P327, DOI 10.1016/j.neuroimage.2015.02.062; Haigh SM, 2018, NEUROPSYCHOLOGIA, V108, P1, DOI 10.1016/j.neuropsychologia.2017.11.020; Hall SD, 2005, NEUROIMAGE, V26, P13, DOI 10.1016/j.neuroimage.2005.01.009; Henrie JA, 2005, J NEUROPHYSIOL, V94, P479, DOI 10.1152/jn.00919.2004; Hermes D, 2015, CEREB CORTEX, V25, P2951, DOI 10.1093/cercor/bhu091; Hermes D, 2017, CURR BIOL, V27, pR336, DOI 10.1016/j.cub.2017.03.076; Hoogenboom N, 2006, NEUROIMAGE, V29, P764, DOI 10.1016/j.neuroimage.2005.08.043; Huang MX, 1999, PHYS MED BIOL, V44, P423, DOI 10.1088/0031-9155/44/2/010; Jia XX, 2013, J NEUROSCI, V33, P17, DOI 10.1523/JNEUROSCI.1687-12.2013; Jia XX, 2011, J NEUROSCI, V31, P9390, DOI 10.1523/JNEUROSCI.0645-11.2011; Johnson EN, 2004, J NEUROPHYSIOL, V91, P2501, DOI 10.1152/jn.01043.2003; Johnson EN, 2001, NAT NEUROSCI, V4, P409, DOI 10.1038/86061; Kayser C, 2003, J NEUROPHYSIOL, V90, P1910, DOI 10.1152/jn.00195.2003; Koelewijn L, 2011, NEUROIMAGE, V54, P2983, DOI 10.1016/j.neuroimage.2010.11.045; LENNIE P, 1990, J NEUROSCI, V10, P649; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Muthukumaraswamy SD, 2008, NEUROIMAGE, V40, P1552, DOI 10.1016/j.neuroimage.2008.01.052; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Orekhova EV, 2019, HUM BRAIN MAPP, V40, P1583, DOI 10.1002/hbm.24469; Parra J, 2007, BRAIN, V130, P1679, DOI 10.1093/brain/awm103; Perry G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124798; Perry G, 2014, EPILEPSY RES, V108, P1076, DOI 10.1016/j.eplepsyres.2014.04.012; Perry G, 2013, NEUROIMAGE, V68, P83, DOI 10.1016/j.neuroimage.2012.11.043; Peter A, 2019, ELIFE, V8, DOI 10.7554/eLife.42101; Ray S, 2010, NEURON, V67, P885, DOI 10.1016/j.neuron.2010.08.004; Robinson S.E., 1999, RECENT ADV BIOMAGNET, P302; Rols G, 2001, VISUAL NEUROSCI, V18, P527, DOI 10.1017/S0952523801184038; Shirakawa S, 2001, EPILEPSIA, V42, P922, DOI 10.1046/j.1528-1157.2001.042007922.x; Shirhatti V, 2018, P NATL ACAD SCI USA, V115, P4489, DOI 10.1073/pnas.1717334115; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Swettenham JB, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00076; Swettenham JB, 2009, J NEUROPHYSIOL, V102, P1241, DOI 10.1152/jn.91044.2008; TAKAHASHI T, 1976, ELECTROEN CLIN NEURO, V41, P124, DOI 10.1016/0013-4694(76)90040-7; Takahashi Y, 1999, NEUROLOGY, V53, P926, DOI 10.1212/WNL.53.5.926; Tobimatsu S, 1999, ANN NEUROL, V45, P790, DOI 10.1002/1531-8249(199906)45:6<790::AID-ANA14>3.0.CO;2-7; Veit J, 2017, NAT NEUROSCI, V20, P951, DOI 10.1038/nn.4562; Vrba J, 2001, METHODS, V25, P249, DOI 10.1006/meth.2001.1238	46	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243237	10.1371/journal.pone.0243237	http://dx.doi.org/10.1371/journal.pone.0243237			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332389	Green Published, gold, Green Accepted			2022-12-27	WOS:000601310900081
J	Dencker, T; Klinkisch, P; Maul, SM; Ommer, B				Dencker, Tobias; Klinkisch, Pablo; Maul, Stefan M.; Ommer, Bjoern			Deep learning of cuneiform sign detection with weak supervision using transliteration alignment	PLOS ONE			English	Article								The cuneiform script provides a glimpse into our ancient history. However, reading age-old clay tablets is time-consuming and requires years of training. To simplify this process, we propose a deep-learning based sign detector that locates and classifies cuneiform signs in images of clay tablets. Deep learning requires large amounts of training data in the form of bounding boxes around cuneiform signs, which are not readily available and costly to obtain in the case of cuneiform script. To tackle this problem, we make use of existing transliterations, a sign-by-sign representation of the tablet content in Latin script. Since these do not provide sign localization, we propose a weakly supervised approach: We align tablet images with their corresponding transliterations to localize the transliterated signs in the tablet image, before using these localized signs in place of annotations to re-train the sign detector. A better sign detector in turn boosts the quality of the alignments. We combine these steps in an iterative process that enables training a cuneiform sign detector from transliterations only. While our method works weakly supervised, a small number of annotations further boost the performance of the cuneiform sign detector which we evaluate on a large collection of clay tablets from the Neo-Assyrian period. To enable experts to directly apply the sign detector in their study of cuneiform texts, we additionally provide a web application for the analysis of clay tablets with a trained cuneiform sign detector.	[Dencker, Tobias; Klinkisch, Pablo; Ommer, Bjoern] Heidelberg Univ, Heidelberg Collaboratory Image Proc, Interdisciplinary Ctr Sci Comp, Heidelberg, Germany; [Maul, Stefan M.] Heidelberg Univ, Inst Assyriol, Dept Languages & Cultures Near East, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Dencker, T (corresponding author), Heidelberg Univ, Heidelberg Collaboratory Image Proc, Interdisciplinary Ctr Sci Comp, Heidelberg, Germany.	tobias.dencker@iwr.uni-heidelberg.de		Dencker, Tobias/0000-0003-4237-2710	German Research Foundation (DFG) [421703927]; German Excellence Initiative II - Innovation Fund FRONTIER	German Research Foundation (DFG)(German Research Foundation (DFG)); German Excellence Initiative II - Innovation Fund FRONTIER	This work was supported by 1) German Research Foundation (DFG) -project number 421703927 https://www.dfg.de 2) German Excellence Initiative II -Innovation Fund FRONTIER https://www.uni-heidelberg.de/excellenceinitiative/institutionalstrategy/frontier.html The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RG, 1925, TRANSLATION ROSETTA; Anderson SE, 2002, IEEE COMPUT GRAPH, V22, P82, DOI 10.1109/MCG.2002.1046632; Berg-Kirkpatrick Taylor, 2013, P 51 ANN M ASS COMP, V1, P207; Bogacz B, 2016, INT CONF FRONT HAND, P301, DOI [10.1109/ICFHR.2016.0064, 10.1109/ICFHR.2016.59]; Bogasz B, 2015, P 20 COMP VIS WINT W; Borger R, 2004, MESOPOTAMISCHES ZEIC; Chammas E, 2018, 2018 13TH IAPR INTERNATIONAL WORKSHOP ON DOCUMENT ANALYSIS SYSTEMS (DAS), P43, DOI 10.1109/DAS.2018.15; Charpin Dominique, 2010, READING WRITING BABY; Cohen A, 2004, MOL B INT U, P135; Demoli N, 1996, APPL OPTICS, V35, P5811, DOI 10.1364/AO.35.005811; DUDA RO, 1972, COMMUN ACM, V15, P11, DOI 10.1145/361237.361242; Edan NM, 2013, AL RAFIDAIN J COMPUT, V10, P195, DOI [10.33899/csmj.2013.163436, DOI 10.33899/CSMJ.2013.163436]; Felzenszwalb PF, 2005, INT J COMPUT VISION, V61, P55, DOI 10.1023/B:VISI.0000042934.15159.49; Finkel Irving, 2015, CUNEIFORM; Fisseler D, 2013, SCI COMPUTING CULTUR, P16; Graves A, 2009, IEEE T PATTERN ANAL, V31, P855, DOI 10.1109/TPAMI.2008.137; Gupta A., 2018, ARXIV180908675; Gupta A, 2016, PROC CVPR IEEE, P2315, DOI 10.1109/CVPR.2016.254; Hoiem D, 2012, LECT NOTES COMPUT SC, V7574, P340, DOI 10.1007/978-3-642-33712-3_25; Homburg T, 2016, LREC 2016 - TENTH INTERNATIONAL CONFERENCE ON LANGUAGE RESOURCES AND EVALUATION, P4067; Hu H, 2017, IEEE I CONF COMP VIS, P4950, DOI 10.1109/ICCV.2017.529; Jaderberg M, 2014, LECT NOTES COMPUT SC, V8692, P512, DOI 10.1007/978-3-319-10593-2_34; Kriege NM, 2018, ARXIV180205908; LIN TY, 2017, PROC CVPR IEEE, P936, DOI DOI 10.1109/CVPR.2017.106; Liu Y, 2018, LECT NOTES COMPUT SC, V11209, P449, DOI 10.1007/978-3-030-01228-1_27; Mara H, 2013, PROC INT CONF DOC, P62, DOI 10.1109/ICDAR.2013.21; Mishra A., 2012, P IEEE C COMP VIS PA; Page-Perron E., 2017, P JOINT SIGHUMWORKSH, P10, DOI [10.18653/v1/W17-2202, DOI 10.18653/V1/W17-2202]; Papadopoulos DP, 2016, PROC CVPR IEEE, P854, DOI 10.1109/CVPR.2016.99; Parkinson R.B., 1999, CRACKING CODES ROSET; Parpola S, 2015, STATE ARCH ASSYRIA, VI-XX; Radner K., 2011, OXFORD HDB CUNEIFORM, P33557; Rothacker Leonard, 2015, P 3 INT WORKSHOP HIS, P129; Rusakov E, 2019, PROCEEDINGS OF THE 2019 WORKSHOP ON HISTORICAL DOCUMENT IMAGING AND PROCESSING (HIP' 19), P19, DOI 10.1145/3352631.3352632; Russakovsky O, 2015, PROC CVPR IEEE, P2121, DOI 10.1109/CVPR.2015.7298824; Sandler M, 2018, PROC CVPR IEEE, P4510, DOI 10.1109/CVPR.2018.00474; Selvaraju RR, 2020, INT J COMPUT VISION, V128, P336, DOI 10.1007/s11263-019-01228-7; Siva P, 2011, IEEE I CONF COMP VIS, P343, DOI 10.1109/ICCV.2011.6126261; Tian SX, 2017, IEEE I CONF COMP VIS, P1501, DOI 10.1109/ICCV.2017.166; Tinney S, 2018, ORACC OPEN DATA BRIE; Uijlings JRR, 2018, PROC CVPR IEEE, P1101, DOI 10.1109/CVPR.2018.00121; Wang K, 2011, IEEE I CONF COMP VIS, P1457, DOI 10.1109/ICCV.2011.6126402; Wang T, 2012, INT C PATT RECOG, P3304; Wei Liu, 2016, Computer Vision - ECCV 2016. 14th European Conference. Proceedings: LNCS 9905, P21, DOI 10.1007/978-3-319-46448-0_2; Wigington C, 2018, P EUROPEAN C COMPUTE, P367; Yamauchi K, 2018, PROCEEDINGS OF THE ELEVENTH INTERNATIONAL CONFERENCE ON LANGUAGE RESOURCES AND EVALUATION (LREC 2018), P719; Ye H, 2017, IEEE TRANSP EL ASIA, P1196; Zhou X, 2017, IEEE IMAGE PROC, P555	48	3	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243039	10.1371/journal.pone.0243039	http://dx.doi.org/10.1371/journal.pone.0243039			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326435	Green Published, gold			2022-12-27	WOS:000600176400041
J	Gerasimenko, M; Lopatina, O; Shabalova, AA; Cherepanov, SM; Salmina, AB; Yokoyama, S; Goto, H; Okamoto, H; Yamamoto, Y; Ishihara, K; Higashida, H				Gerasimenko, Maria; Lopatina, Olga; Shabalova, Anna A.; Cherepanov, Stanislav M.; Salmina, Alla B.; Yokoyama, Shigeru; Goto, Hisanori; Okamoto, Hiroshi; Yamamoto, Yasuhiko; Ishihara, Katsuhiko; Higashida, Haruhiro			Distinct physical condition and social behavior phenotypes of CD157 and CD38 knockout mice during aging	PLOS ONE			English	Article							OXYTOCIN LEVELS; AGE; MEMORY; DECLINE; ADULTS; DYSFUNCTION; ACTIVATION; DEFICITS; DEFECTS; ANXIETY	The ability of CD38 and CD157 to utilize nicotinamide adenine dinucleotide (NAD) has received much attention because the aging-induced elevation of CD38 expression plays a role in the senescence-related decline in NAD levels. Therefore, it is of interest to examine and compare the effects of age-associated changes on the general health and brain function impairment of Cd157 and Cd38 knockout (CD157 KO and CD38 KO) mice. The body weight and behaviors were measured in 8-week-old (young adult) or 12-month-old (middle-aged) male mice of both KO strains. The locomotor activity, anxiety-like behavior, and social behavior of the mice were measured in the open field and three-chamber tests. The middle-aged CD157 KO male mice gained more body weight than young adult KO mice, while little or no body weight gain was observed in the middle-aged CD38 KO mice. Middle-aged CD157 KO mice displayed increased anxiety-like behavior and decreased sociability and interaction compared with young adult KO mice. Middle-aged CD38 KO mice showed less anxiety and hyperactivity than CD157 KO mice, similar to young adult CD38 KO mice. The results reveal marked age-dependent changes in male CD157 KO mice but not in male CD38 KO mice. We discuss the distinct differences in aging effects from the perspective of inhibition of NAD metabolism in CD157 and CD38 KO mice, which may contribute to differential behavioral changes during aging.	[Gerasimenko, Maria; Lopatina, Olga; Shabalova, Anna A.; Cherepanov, Stanislav M.; Salmina, Alla B.; Yokoyama, Shigeru; Higashida, Haruhiro] Kanazawa Univ, Res Ctr Child Mental Dev, Dept Basic Res Social Recognit & Memory, Kanazawa, Ishikawa, Japan; [Lopatina, Olga; Salmina, Alla B.; Higashida, Haruhiro] Krasnoyarsk State Med Univ, Res Inst Mol Med & Pathobiochem, Lab Social Brain Studies, Krasnoyarsk, Russia; [Lopatina, Olga; Salmina, Alla B.; Higashida, Haruhiro] Krasnoyarsk State Med Univ, Dept Biochem, Krasnoyarsk, Russia; [Goto, Hisanori; Okamoto, Hiroshi; Yamamoto, Yasuhiko] Kanazawa Univ, Grad Sch Med Sci, Dept Biochem & Mol Vasc Biol, Kanazawa, Ishikawa, Japan; [Ishihara, Katsuhiko] Kawasaki Med Sch, Dept Immunol & Mol Genet, Kurashiki, Okayama, Japan	Kanazawa University; Krasnoyarsk State Medical University; Krasnoyarsk State Medical University; Kanazawa University; Kawasaki Medical School	Higashida, H (corresponding author), Kanazawa Univ, Res Ctr Child Mental Dev, Dept Basic Res Social Recognit & Memory, Kanazawa, Ishikawa, Japan.; Higashida, H (corresponding author), Krasnoyarsk State Med Univ, Res Inst Mol Med & Pathobiochem, Lab Social Brain Studies, Krasnoyarsk, Russia.; Higashida, H (corresponding author), Krasnoyarsk State Med Univ, Dept Biochem, Krasnoyarsk, Russia.	haruhiro@med.kanazawa-u.ac.jp	Salmina, Alla B./L-7977-2013; Ishihara, Katsuhiko/AAL-8175-2021	Cherepanov, Stanislav/0000-0001-5093-3480; Gerasimenko, Maria/0000-0002-6344-9900	Kanazawa University SAKIGAKE project 2018; Takeda Science Foundation, Japan; Japan Society for Promotion of Sciences;  [24590375];  [25461335];  [18K06889]	Kanazawa University SAKIGAKE project 2018; Takeda Science Foundation, Japan(Takeda Science Foundation (TSF)); Japan Society for Promotion of Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; ; 	We acknowledge financial supports from the Kanazawa University SAKIGAKE project 2018 and Takeda Science Foundation, Japan. We thank the Grants-in-Aid for Scientific Research (24590375, 25461335 and 18K06889) and Program for Fostering Globally Talented Researchers from the Japan Society for Promotion of Sciences.	[Anonymous], 2014, DAM, V3, P6; Associated Press, 2014, BLOOMINGTON HER 0602, V6, pB5; Bach ME, 1999, P NATL ACAD SCI USA, V96, P5280, DOI 10.1073/pnas.96.9.5280; Barnard-Brak L, 2019, ADV AUTISM, V5, P293, DOI 10.1108/AIA-11-2018-0045; Boyer F, 2019, FRONT BEHAV NEUROSCI, V13, DOI 10.3389/fnbeh.2019.00055; Burke LK, 2014, ENDOCRINOLOGY, V155, P3732, DOI 10.1210/en.2014-1223; Camacho-Pereira J, 2016, CELL METAB, V23, P1127, DOI 10.1016/j.cmet.2016.05.006; Chiang SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134927; Chini C, 2019, BIOCHEM BIOPH RES CO, V513, P486, DOI 10.1016/j.bbrc.2019.03.199; Chini EN, 2018, TRENDS PHARMACOL SCI, V39, P424, DOI 10.1016/j.tips.2018.02.001; Dutta S, 2016, LIFE SCI, V152, P244, DOI 10.1016/j.lfs.2015.10.025; Fahlstrom A, 2011, NEUROBIOL AGING, V32, P1868, DOI 10.1016/j.neurobiolaging.2009.11.003; Flurkey K, 2007, MOUSE BIOMEDICAL RES, P637, DOI DOI 10.1016/B978-012369454-6/50074-1; FRICK KM, 1995, NEUROBIOL AGING, V16, P149, DOI 10.1016/0197-4580(94)00155-3; Garaschuk O, 2018, AGEING RES REV, V43, P26, DOI 10.1016/j.arr.2018.02.003; Gargiulo S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/253067; Gerasimenko M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-57236-7; Gorina YV, 2017, ADV GERONTOL, V7, P137, DOI 10.1134/S2079057017020060; Guerreiro S, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9020471; Hamrick MW, 2006, BONE, V39, P845, DOI 10.1016/j.bone.2006.04.011; Happe F, 2012, GERONTOLOGY, V58, P70, DOI 10.1159/000329720; Harada CN, 2013, CLIN GERIATR MED, V29, P737, DOI 10.1016/j.cger.2013.07.002; Higashida H, 2019, CELLS, V9, P62; Higashida H, 2017, BMC NEUROSCI, V18, DOI 10.1186/s12868-017-0350-7; Higashida H, 2011, BIOL PHARM BULL, V34, P1369, DOI 10.1248/bpb.34.1369; Hirvikoski T, 2016, BRIT J PSYCHIAT, V208, P232, DOI 10.1192/bjp.bp.114.160192; Hogan KA, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01187; Ishihara K, 2000, CHEM IMMUNOL, V75, P235; Ishimori N, 2004, J LIPID RES, V45, P1624, DOI 10.1194/jlr.M400098-JLR200; Jin D, 2007, NATURE, V446, P41, DOI 10.1038/nature05526; Kasai S, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00075; Kato I, 1999, J BIOL CHEM, V274, P1869, DOI 10.1074/jbc.274.4.1869; LAMBERTY Y, 1992, PHYSIOL BEHAV, V51, P81, DOI 10.1016/0031-9384(92)90206-H; Lee HC, 2012, J BIOL CHEM, V287, P31633, DOI 10.1074/jbc.R112.349464; Lessard-Beaudoin M, 2015, EXP GERONTOL, V63, P27, DOI 10.1016/j.exger.2015.01.003; Lever AG, 2016, AUTISM RES, V9, P666, DOI 10.1002/aur.1545; Lever AG, 2016, J AUTISM DEV DISORD, V46, P1916, DOI 10.1007/s10803-016-2722-8; Lezak KR, 2017, DIALOGUES CLIN NEURO, V19, P181; Liu HX, 2008, NEUROSCI LETT, V448, P67, DOI 10.1016/j.neulet.2008.09.084; Lopatina O, 2011, J NEUROENDOCRINOL, V23, P1125, DOI 10.1111/j.1365-2826.2011.02136.x; Lopatina O, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00133; Lopatina OL, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00266; Magnusson KR, 2003, BEHAV NEUROSCI, V117, P485, DOI 10.1037/0735-7044.117.3.485; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; McQuail JA, 2015, TRENDS MOL MED, V21, P450, DOI 10.1016/j.molmed.2015.05.002; Mizuno A, 2015, BRAIN SCI, V5, P3, DOI 10.3390/brainsci5010003; Oizumi H, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222076; Pagni BA, 2020, FRONT INTEGR NEUROSC, V14, DOI 10.3389/fnint.2020.571408; Pappas LE, 2019, EUR J CLIN NUTR, V73, P172, DOI 10.1038/s41430-018-0324-6; Peters R, 2006, POSTGRAD MED J, V82, P84, DOI 10.1136/pgmj.2005.036665; Powell PS, 2017, J AUTISM DEV DISORD, V47, P3204, DOI 10.1007/s10803-017-3238-6; Quarona V, 2013, CYTOM PART B-CLIN CY, V84B, P207, DOI 10.1002/cyto.b.21092; Ring M, 2016, AUTISM RES, V9, P97, DOI 10.1002/aur.1493; Sheth KA, 2018, NEUROBIOL AGING, V67, P128, DOI 10.1016/j.neurobiolaging.2018.03.016; Shoji Hirotaka, 2019, Neuropsychopharmacology Reports, V39, P100, DOI 10.1002/npr2.12052; Shoji H, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0191-9; Singhal G, 2020, BEHAV BRAIN RES, V383, DOI 10.1016/j.bbr.2020.112501; Sjogren K, 2001, J NUTR, V131, P2963, DOI 10.1093/jn/131.11.2963; Sultana R, 2019, ROY SOC OPEN SCI, V6, DOI 10.1098/rsos.190574; Tarrago MG, 2018, CELL METAB, V27, P1081, DOI 10.1016/j.cmet.2018.03.016; Wang LF, 2018, J CELL MOL MED, V22, P101, DOI 10.1111/jcmm.13297; Weber M, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0047-15.2015; Wise EA, 2017, J AUTISM DEV DISORD, V47, P1708, DOI 10.1007/s10803-017-3095-3; Wyss-Coray T, 2016, NATURE, V539, P180, DOI 10.1038/nature20411; Zhong J, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00304	65	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0244022	10.1371/journal.pone.0244022	http://dx.doi.org/10.1371/journal.pone.0244022			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326496	Green Published, Green Submitted, gold			2022-12-27	WOS:000600176400075
J	Tovar-Sanchez, A; Sparaventi, E; Gaudron, A; Rodriguez-Romero, A				Tovar-Sanchez, Antonio; Sparaventi, Erica; Gaudron, Amandine; Rodriguez-Romero, Araceli			A new approach for the determination of sunscreen levels in seawater by ultraviolet absorption spectrophotometry	PLOS ONE			English	Article							ORGANIC UV FILTERS; MYTILUS-GALLOPROVINCIALIS; ECOTOXICOLOGICAL EVALUATION; ISOCHRYSIS-GALBANA; MARINE ORGANISMS	Sunscreen is released into the marine environment and is considered toxic for marine life. The current analytical methods for the quantification of sunscreen are mostly specific to individual chemical ingredients and based on complex analytical and instrumental techniques. A simple, selective, rapid, reproducible and low-cost spectrophotometric procedure for the quantification of commercial sunscreen in seawater is described here. The method is based on the inherent properties of these cosmetics to absorb in the wavelength of 300-400 nm. The absorption at 303 nm wavelength correlates with the concentration of most commercial sunscreens. This method allows the determination of sunscreens in the range of 2.5-1500 mg L-1, it requires no sample pretreatment and offers a precision of up to 0.2%. The spectrophotometric method was applied to quantify sunscreen concentrations at an Atlantic Beach with values ranging from 10 to 96.7 mg L-1 in the unfiltered fraction and from the undetectable value to 75.7 mg L-1 in the dissolved fraction. This method is suggested as a tool for sunscreen quantifications in environmental investigations and monitoring programs.	[Tovar-Sanchez, Antonio; Sparaventi, Erica; Gaudron, Amandine; Rodriguez-Romero, Araceli] ICMAN CSIC, Inst Marine Sci Andalusia, Dept Ecol & Coastal Management, Cadiz, Spain; [Rodriguez-Romero, Araceli] Univ Cadiz, Fac Marine & Environm Sci, Dept Analyt Chem, Cadiz, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias Marinas de Andalucia (ICMAN); Universidad de Cadiz	Tovar-Sanchez, A (corresponding author), ICMAN CSIC, Inst Marine Sci Andalusia, Dept Ecol & Coastal Management, Cadiz, Spain.	a.tovar@csic.es	Rodríguez, Araceli/GXM-7707-2022	Rodríguez, Araceli/0000-0002-6718-1040; Sparaventi, Erica/0000-0002-7578-8918; Tovar-Sanchez, Antonio/0000-0003-4375-1982	2014-2020 ERDF Operational Programme; Department of Economy, Knowledge, Business and the University of the Regional Government of Andalusia [FEDER-UCA18106672]; Spanish grant Juan de la Cierva Incorporacion [IJC2018-037545-I]	2014-2020 ERDF Operational Programme; Department of Economy, Knowledge, Business and the University of the Regional Government of Andalusia; Spanish grant Juan de la Cierva Incorporacion	This work has been co-financed by the 2014-2020 ERDF Operational Programme and by the Department of Economy, Knowledge, Business and the University of the Regional Government of Andalusia. Project reference: FEDER-UCA18106672. A. Rodri ' guez-Romero is supported by the Spanish grant Juan de la Cierva Incorporacio ' n referenced as IJC2018-037545-I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed FK, 2008, WORLDWIDE REGULATION, P65, DOI [10.3109/9781420080858.005, DOI 10.3109/9781420080858.005]; Angrish A, 2020, SPECTROCHIM ACTA A, V242, DOI 10.1016/j.saa.2020.118708; Araujo CVM, 2020, CHEMOSPHERE, V257, DOI 10.1016/j.chemosphere.2020.127190; Benede JL, 2014, ANAL CHIM ACTA, V812, P50, DOI 10.1016/j.aca.2013.12.033; Benede JL, 2018, J CHROMATOGR A, V1564, P25, DOI 10.1016/j.chroma.2018.06.003; Corinaldesi C, 2018, SCI TOTAL ENVIRON, V637, P1279, DOI 10.1016/j.scitotenv.2018.05.108; Downs CA, 2016, ARCH ENVIRON CON TOX, V70, P265, DOI 10.1007/s00244-015-0227-7; Downs CA, 2014, ECOTOXICOLOGY, V23, P175, DOI 10.1007/s10646-013-1161-y; Gago-Ferrero P, 2012, ANAL BIOANAL CHEM, V404, P2597, DOI 10.1007/s00216-012-6067-7; Giokas DL, 2007, TRAC-TREND ANAL CHEM, V26, P360, DOI 10.1016/j.trac.2007.02.012; Giraldo A, 2017, ARCH ENVIRON CON TOX, V72, P606, DOI 10.1007/s00244-017-0399-4; Molins-Delgado D, 2018, SCI TOTAL ENVIRON, V618, P451, DOI 10.1016/j.scitotenv.2017.11.033; Moschino V, 2017, MAR POLLUT BULL, V122, P306, DOI 10.1016/j.marpolbul.2017.06.062; NOAA, 2020, SKINC CHEM COR REEFS; Paredes E, 2014, CHEMOSPHERE, V104, P44, DOI 10.1016/j.chemosphere.2013.10.053; Rodriguez-Romero A, 2019, ENVIRON SCI TECHNOL, V53, P10177, DOI 10.1021/acs.est.9b02739; Sanchez-Brunete C, 2011, J CHROMATOGR A, V1218, P4291, DOI 10.1016/j.chroma.2011.05.030; Sanchez-Quiles D, 2015, ENVIRON INT, V83, P158, DOI 10.1016/j.envint.2015.06.007; Tarazona I, 2014, ANAL METHODS-UK, V6, P7772, DOI 10.1039/c4ay01403k; Tovar-Sanchez A., SUNSCREENS COASTAL E; Tovar-Sanchez A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065451; Vidal-Linan L, 2018, CHEMOSPHERE, V190, P267, DOI 10.1016/j.chemosphere.2017.09.144	22	4	4	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243591	10.1371/journal.pone.0243591	http://dx.doi.org/10.1371/journal.pone.0243591			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326482	Green Published, gold			2022-12-27	WOS:000600176400028
J	Kazibwe, G; Katami, P; Alinaitwe, R; Alafi, S; Nanteza, A; Nakavuma, JL				Kazibwe, George; Katami, Phionah; Alinaitwe, Ruth; Alafi, Stephen; Nanteza, Ann; Nakavuma, Jesca Lukanga			Bacteriophage activity against and characterisation of avian pathogenic Escherichia coli isolated from colibacillosis cases in Uganda	PLOS ONE			English	Article							VIRULENCE-ASSOCIATED GENES; BROILER-CHICKENS; POULTRY; PREVALENCE; EPIDEMIOLOGY; RESISTANCE; PHYLOGENY; GENOTYPES; THERAPY; FOOD	Avian Pathogenic Escherichia coli (APEC) cause colibacillosis leading to significant economic losses in the poultry industry. This laboratory-based study aimed at establishing stocks of avian pathogenic Escherichia coli lytic bacteriophages, for future development of cocktail products for colibacillosis management. The study determined the antibiotic susceptibility; phylogenetic categories, occurrence of selected serotypes and virulence genes among Escherichia coli stock isolates from chicken colibacillosis cases; and evaluated bacteriophage activity against the bacteria. Escherichia coli characterization was done through phenotypic and multiplex PCR methods. Bacteriophage isolation and preliminary characterization was achieved using the spot assay and overlay plating techniques. Fifty-six (56) isolates were phenotypically confirmed as E. coli and all exhibited resistance to at least one antimicrobial agent; while multi-drug resistance (at least three drugs) was encountered in 50 (89.3%) isolates. The APEC isolates mainly belonged to phylogroups A and D, representing 44.6% and 39.3%, respectively; whereas serotypes O1, O2 and O78 were not detected. Of the 56 isolates, 69.6% harbored at least one virulence gene, while 50% had at least four virulence genes; hence confirmed as APEC. Virulence genes, ompT and iutA were the most frequent in 33 (58.9%) and 32 (57.1%) isolates respectively; while iroN least occurred in 23 (41.1%) isolates. Seven lytic bacteriophages were isolated and their host range, at 1x10(8) PFU/ml, varied from 1.8% to 17.9% of the 56 APEC isolates, while the combined lytic spectrum was 25%. Phage stability was negatively affected by increasing temperatures with both UPEC04 and UPEC10 phages being undetectable at 70 degrees C; whereas activity was detected between pH 2 and 12. The high occurrence of APEC isolates resistant against the commonly used antibiotics supports the need for alternative strategies of bacterial infections control in poultry. The low host range exhibited by the phages necessitates search for more candidates before in-depth phage characterization and application.	[Kazibwe, George; Katami, Phionah; Alinaitwe, Ruth; Alafi, Stephen; Nanteza, Ann; Nakavuma, Jesca Lukanga] Makerere Univ, Coll Vet Med Anim Resources & Biosecur, Sch Biosecur Biotech & Lab Sci, Kampala, Uganda	Makerere University	Nakavuma, JL (corresponding author), Makerere Univ, Coll Vet Med Anim Resources & Biosecur, Sch Biosecur Biotech & Lab Sci, Kampala, Uganda.	JLNakavuma@covab.mak.ac.ug		Nakavuma, Jesca/0000-0002-4585-5163	Competitive Small Grants of the Makerere-Sweden Bilateral Research Program	Competitive Small Grants of the Makerere-Sweden Bilateral Research Program	The research was financed under the Competitive Small Grants of the Makerere-Sweden Bilateral Research Program Call 2018. The funders had no role in the study design, data collection and analysis; decision to publish or preparation of the manuscript.	Abalaka S. E., 2017, Sokoto Journal of Veterinary Sciences, V15, P95, DOI 10.4314/sokjvs.v15i3.14; Abedon ST, 2009, FOODBORNE PATHOG DIS, V6, P807, DOI 10.1089/fpd.2008.0242; [Anonymous], 2017, NAT MATER, V16, P1, DOI 10.1038/nmat4841; [Anonymous], 2018, ADV CIV ENG, V2018, P1, DOI DOI 10.1017/S1473550418000022; [Anonymous], 2017, LANCET HIV, V2017, pPE475; [Anonymous], 2016, IEEE-ASME T MECH, VPP, P1, DOI DOI 10.1109/IEEESTD.2016.7460875; [Anonymous], 2016, BRIDGES WEEKLY, V20, P1, DOI DOI 10.1007/s10120-016-0622-4; [Anonymous], 2016, J NANOMED NANOTECHNO, V7, P5, DOI [10.4172/2157-7439.1000407, DOI 10.4172/2157-7439.1000407]; [Anonymous], 2017, JAP CLASS ES CANC, V14, P1, DOI [DOI 10.1007/s10388-016-0551-7, DOI 10.1093/GERONT/GNY014]; [Anonymous], 2014, CANC DISCOV, V4, pOF1; [Anonymous], 2015, CONCURR COMPUT PRACT, V27, pi; Asadi A, 2018, VET RES FORUM, V9, P211, DOI 10.30466/vrf.2018.30827; Azeem T, 2017, WORLD POULTRY SCI J, V73, P29, DOI [10.1017/s0043933916000866, 10.1017/S0043933916000866]; Barnes H.J., 2008, DIS POULTRY, P691; Byaruhanga J, 2017, INT J VET SCI MED, V5, P168, DOI 10.1016/j.ijvsm.2017.07.001; Carey-Smith GV, 2006, FEMS MICROBIOL LETT, V258, P182, DOI 10.1111/j.1574-6968.2006.00217.x; Casey E, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040163; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; COLLINGWOOD C, 2014, FRONT VET SCI, V1, P1, DOI DOI 10.3389/FVETS.2014.00005; Delicato ER, 2003, VET MICROBIOL, V94, P97, DOI 10.1016/S0378-1135(03)00076-2; Dissanayake DRA, 2008, VET MICROBIOL, V132, P355, DOI 10.1016/j.vetmic.2008.05.024; Doffkay Zsolt, 2015, Acta Biologica Szegediensis, V59, P291; Dou XH, 2016, GENE, V576, P244, DOI 10.1016/j.gene.2015.10.012; Dziva F, 2008, AVIAN PATHOL, V37, P355, DOI 10.1080/03079450802216652; Ewers C, 2004, VET MICROBIOL, V104, P91, DOI 10.1016/j.vetmic.2004.09.008; Gill JJ, 2016, J ANIM SCI, V94, P57, DOI 10.2527/ssasas2015-118; Halfaoui Z, 2017, VET WORLD, V10, P830, DOI 10.14202/vetworld.2017.830-835; Hyman P, 2019, PHARMACEUTICALS-BASE, V12, DOI 10.3390/ph12010035; Johnson JR, 2000, J INFECT DIS, V181, P261, DOI 10.1086/315217; Johnson TJ, 2008, J CLIN MICROBIOL, V46, P3987, DOI 10.1128/JCM.00816-08; Johnson TJ, 2006, J BACTERIOL, V188, P745, DOI 10.1128/JB.188.2.745-758.2006; Kabir SML, 2010, INT J ENV RES PUB HE, V7, P89, DOI 10.3390/ijerph7010089; Kariyawasam S, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-81; Kemmett K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067749; Knobl T, 2012, SCI WORLD J, DOI 10.1100/2012/437342; Kuhnert P, 2000, FEMS MICROBIOL REV, V24, P107, DOI 10.1111/j.1574-6976.2000.tb00535.x; Landman WJM, 2015, AVIAN PATHOL, V44, P370, DOI 10.1080/03079457.2015.1060584; Limbago B., 2001, CLIN MICROBIOL NEWSL, V23, P49, DOI [10.1016/S0196-4399(01)88009-0, DOI 10.1016/S0196-4399(01)88009-0]; Lu Z, 2003, INT J FOOD MICROBIOL, V84, P225, DOI 10.1016/S0168-1605(03)00111-9; Majalija S., 2010, Veterinary Research (Pakistan), V3, P75; Matin MA, 2017, VET WORLD, V10, P29, DOI 10.14202/vetworld.2017.29-33; Mbanga J, 2015, ONDERSTEPOORT J VET, V82, DOI 10.4102/ojvr.v82i1.850; Miller RW, 2010, AVIAN DIS, V54, P33, DOI 10.1637/8953-060509-Reg.1; Mirzaei MK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127606; Mukonzo JK, 2013, J MULTIDISCIP HEALTH, V6, P303, DOI 10.2147/JMDH.S49075; Naghizadeh M, 2019, POULTRY SCI, V98, P653, DOI 10.3382/ps/pey414; Nhung NT, 2017, FRONT VET SCI, V4, DOI 10.3389/fvets.2017.00126; Olarinmoye AO, 2013, MALAYS J MICROBIOL, V9, P317, DOI 10.21161/mjm.53013; Oliveira A, 2009, J APPL MICROBIOL, V106, P1919, DOI 10.1111/j.1365-2672.2009.04145.x; Paixao AC, 2016, POULTRY SCI, V95, P1646, DOI 10.3382/ps/pew087; Patey O, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010018; Picard B, 1999, INFECT IMMUN, V67, P546, DOI 10.1128/IAI.67.2.546-553.1999; Rodriguez-Siek KE, 2004, VET RES, V35, P467; Shende RK, 2017, VET WORLD, V10, P973, DOI 10.14202/vetworld.2017.973-978; Sola-Gines M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143191; Stacy AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086565; Subedi M, 2018, BMC VET RES, V14, DOI 10.1186/s12917-018-1442-z; Thapa D.B., 2020, INT J APPL SCI BIOTE, V8, P52, DOI [10.3126/ijasbt.v8i1.28254, DOI 10.3126/IJASBT.V8I1.28254]; Wang SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096904; Wang XM, 2010, FOODBORNE PATHOG DIS, V7, P1099, DOI 10.1089/fpd.2010.0542; Yu YP, 2013, FEMS MICROBIOL LETT, V348, P112, DOI 10.1111/1574-6968.12277; Yuvraj Panth, 2019, Journal of Agriculture and Natural Resources, V2, P301, DOI 10.3126/janr.v2i1.26094	62	4	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0239107	10.1371/journal.pone.0239107	http://dx.doi.org/10.1371/journal.pone.0239107			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320859	Green Submitted, Green Published, gold			2022-12-27	WOS:000600339800055
J	Yamamoto, H; Uchida, Y; Chiba, T; Kurimoto, R; Matsushima, T; Inotsume, M; Ishikawa, C; Li, HY; Shiga, T; Muratani, M; Uchida, T; Asahara, H				Yamamoto, Hiroto; Uchida, Yutaro; Chiba, Tomoki; Kurimoto, Ryota; Matsushima, Takahide; Inotsume, Maiko; Ishikawa, Chihiro; Li, Haiyan; Shiga, Takashi; Muratani, Masafumi; Uchida, Tokujiro; Asahara, Hiroshi			Transcriptome analysis of sevoflurane exposure effects at the different brain regions	PLOS ONE			English	Article							POSTOPERATIVE DELIRIUM; ANESTHESIA; EXPRESSION; INDUCTION; PROPOFOL; NEURONS; CELLS	Backgrounds Sevoflurane is a most frequently used volatile anesthetics, but its molecular mechanisms of action remain unclear. We hypothesized that specific genes play regulatory roles in brain exposed to sevoflurane. Thus, we aimed to evaluate the effects of sevoflurane inhalation and identify potential regulatory genes by RNA-seq analysis. Methods Eight-week old mice were exposed to sevoflurane. RNA from medial prefrontal cortex, striatum, hypothalamus, and hippocampus were analysed using RNA-seq. Differently expressed genes were extracted and their gene ontology terms were analysed using Metascape. These our anesthetized mouse data and the transcriptome array data of the cerebral cortex of sleeping mice were compared. Finally, the activities of transcription factors were evaluated using a weighted parametric gene set analysis (wPGSA). JASPAR was used to confirm the existence of binding motifs in the upstream sequences of the differently expressed genes. Results The gene ontology term enrichment analysis result suggests that sevoflurane inhalation upregulated angiogenesis and downregulated neural differentiation in each region of brain. The comparison with the brains of sleeping mice showed that the gene expression changes were specific to anesthetized mice. Focusing on individual genes, sevoflurane induced Klf4 upregulation in all sampled parts of brain. wPGSA supported the function of KLF4 as a transcription factor, and KLF4-binding motifs were present in many regulatory regions of the differentially expressed genes. ConclusionsKlf4 was upregulated by sevoflurane inhalation in the mouse brain. The roles of KLF4 might be key to elucidating the mechanisms of sevoflurane induced functional modification in the brain.	[Yamamoto, Hiroto; Uchida, Yutaro; Chiba, Tomoki; Kurimoto, Ryota; Matsushima, Takahide; Inotsume, Maiko; Asahara, Hiroshi] Tokyo Med & Dent Univ TMDU, Dept Syst BioMed, Tokyo, Japan; [Yamamoto, Hiroto; Uchida, Tokujiro] Tokyo Med & Dent Univ TMDU, Dept Anesthesiol, Tokyo, Japan; [Ishikawa, Chihiro; Li, Haiyan; Shiga, Takashi] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan; [Shiga, Takashi] Univ Tsukuba, Dept Neurobiol, Fac Med, Tsukuba, Ibaraki, Japan; [Muratani, Masafumi] Univ Tsukuba, Dept Genome Biol, Fac Med, Tsukuba, Ibaraki, Japan; [Asahara, Hiroshi] Scripps Res Inst, Dept Mol Med, La Jolla, CA 92037 USA	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); University of Tsukuba; University of Tsukuba; University of Tsukuba; Scripps Research Institute	Uchida, T; Asahara, H (corresponding author), Tokyo Med & Dent Univ TMDU, Dept Syst BioMed, Tokyo, Japan.; Uchida, T (corresponding author), Tokyo Med & Dent Univ TMDU, Dept Anesthesiol, Tokyo, Japan.; Asahara, H (corresponding author), Scripps Res Inst, Dept Mol Med, La Jolla, CA 92037 USA.	uchida.mane@tmd.ac.jp; asahara@scripps.edu		Uchida, Yutaro/0000-0002-2790-6879	Japan Society for the Promotion of Science KAKENHI [20H00547, 19KK0227, 18K19603, 15H02560]; AMED-CREST from AMED [JP20gm0810008]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); AMED-CREST from AMED	This work was supported by Japan Society for the Promotion of Science KAKENHI (URL:https://www.jsps.go.jp/english/index.html, Grant Nos. 20H00547, 19KK0227, 18K19603 and 15H02560 to HA) and AMED-CREST from AMED (URL: https://www.amed.go.jp/en/index.html, Grant No. JP20gm0810008 to HA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya NK, 2015, BRAIN RES, V1620, P29, DOI 10.1016/j.brainres.2015.04.054; Ando N, 2014, EUR J NEUROSCI, V40, P3147, DOI 10.1111/ejn.12691; [Anonymous], 2015, INT J COMPUTER APPL, V121, P661; [Anonymous], 2013, FARMERS 1, V29, P15; Ansaloni L, 2010, BRIT J SURG, V97, P273, DOI 10.1002/bjs.6843; Bellesi M, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0176-7; Chung W, 2017, ANESTHESIOLOGY, V126, P288, DOI 10.1097/ALN.0000000000001470; Evans PM, 2007, J BIOL CHEM, V282, P33994, DOI 10.1074/jbc.M701847200; Fukuda M, 2019, EUR J NEUROSCI, V50, P3520, DOI 10.1111/ejn.14524; Ge SX, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2486-6; Geiman DE, 2000, NUCLEIC ACIDS RES, V28, P1106, DOI 10.1093/nar/28.5.1106; Ghaleb AM, 2017, GENE, V611, P27, DOI 10.1016/j.gene.2017.02.025; Hayase T, 2016, MED GAS RES, V6, P70, DOI 10.4103/2045-9912.184715; Ishikawa C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177833; Jenkins A, 1999, ANESTHESIOLOGY, V90, P484, DOI 10.1097/00000542-199902000-00024; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Jiang-Xie LF, 2019, NEURON, V102, P1053, DOI 10.1016/j.neuron.2019.03.033; Kaisti KK, 2002, ANESTHESIOLOGY, V96, P1358, DOI 10.1097/00000542-200206000-00015; Kawakami E, 2016, NUCLEIC ACIDS RES, V44, P5010, DOI 10.1093/nar/gkw355; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liang P, 2017, BRIT J ANAESTH, V119, P1047, DOI 10.1093/bja/aex043; Mori K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087319; Neufeld KJ, 2013, ANESTH ANALG, V117, P471, DOI 10.1213/ANE.0b013e3182973650; Plourde G, 2003, BRIT J ANAESTH, V91, P583, DOI 10.1093/bja/aeg209; Rodriques SG, 2019, SCIENCE, V363, P1463, DOI 10.1126/science.aaw1219; Rudolph JL, 2011, ANESTH ANALG, V112, P1202, DOI 10.1213/ANE.0b013e3182147f6d; Sebel LE, 2006, ANESTHESIOLOGY, V104, P1176, DOI 10.1097/00000542-200606000-00012; Stucke AG, 2002, ANESTHESIOLOGY, V96, P955, DOI 10.1097/00000542-200204000-00025; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Wu J, 1996, BRIT J PHARMACOL, V119, P1013, DOI 10.1111/j.1476-5381.1996.tb15772.x; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6	31	4	4	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0236771	10.1371/journal.pone.0236771	http://dx.doi.org/10.1371/journal.pone.0236771			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320849	Green Published, gold, Green Submitted			2022-12-27	WOS:000600339800043
J	Zylbersztejn, A; Gilbert, R; Hardelid, P				Zylbersztejn, Ania; Gilbert, Ruth; Hardelid, Pia			Developing a national birth cohort for child health research using a hospital admissions database in England: The impact of changes to data collection practices	PLOS ONE			English	Article								Background National birth cohorts derived from administrative health databases constitute unique resources for child health research due to whole country coverage, ongoing follow-up and linkage to other data sources. In England, a national birth cohort can be developed using Hospital Episode Statistics (HES), an administrative database covering details of all publicly funded hospital activity, including 97% of births, with longitudinal follow-up via linkage to hospital and mortality records. We present methods for developing a national birth cohort using HES and assess the impact of changes to data collection over time on coverage and completeness of linked follow-up records for children. Methods We developed a national cohort of singleton live births in 1998-2015, with information on key risk factors at birth (birth weight, gestational age, maternal age, ethnicity, area-level deprivation). We identified three changes to data collection, which could affect linkage of births to follow-up records: (1) the introduction of the "NHS Numbers for Babies (NN4B)", an on-line system which enabled maternity staff to request a unique healthcare patient identifier (NHS number) immediately at birth rather than at civil registration, in Q4 2002; (2) the introduction of additional data quality checks at civil registration in Q3 2009; and (3) correcting a postcode extraction error for births by the data provider in Q2 2013. We evaluated the impact of these changes on trends in two outcomes in infancy: hospital readmissions after birth (using interrupted time series analyses) and mortality rates (compared to published national statistics). Results The cohort covered 10,653,998 babies, accounting for 96% of singleton live births in England in 1998-2015. Overall, 2,077,929 infants (19.5%) had at least one hospital readmission after birth. Readmission rates declined by 0.2% percentage points per annual quarter in Q1 1998 to Q3 2002, shifted up by 6.1% percentage points (compared to the expected value based on the trend before Q4 2002) to 17.7% in Q4 2002 when NN4B was introduced, and increased by 0.1% percentage points per annual quarter thereafter. Infant mortality rates were under-reported by 16% for births in 1998-2002 and similar to published national mortality statistics for births in 2003-2015. The trends in infant readmission were not affected by changes to data collection practices in Q3 2009 and Q2 2013, but the proportion of unlinked mortality records in HES and in ONS further declined after 2009. Discussion HES can be used to develop a national birth cohort for child health research with follow-up via linkage to hospital and mortality records for children born from 2003 onwards. Re-linking births before 2003 to their follow-up records would maximise potential benefits of this rich resource, enabling studies of outcomes in adolescents with over 20 years of follow-up.	[Zylbersztejn, Ania; Gilbert, Ruth; Hardelid, Pia] UCL Great Ormond St Inst Child Hlth, Populat Policy & Practice Res & Teaching Dept, London, England; [Zylbersztejn, Ania; Gilbert, Ruth; Hardelid, Pia] UCL Great Ormond St Inst Child Hlth, NIHR Children & Families Policy Res Unit, London, England; [Gilbert, Ruth] UCL, Hlth Data Res UK London, London, England	University of London; University College London; University of London; University College London; University of London; University College London	Zylbersztejn, A (corresponding author), UCL Great Ormond St Inst Child Hlth, Populat Policy & Practice Res & Teaching Dept, London, England.; Zylbersztejn, A (corresponding author), UCL Great Ormond St Inst Child Hlth, NIHR Children & Families Policy Res Unit, London, England.	ania.zylbersztejn@ucl.ac.uk		Zylbersztejn, Ania/0000-0003-1035-1448; Gilbert, Ruth/0000-0001-9347-2709	Medical Research Council; Arthritis Research UK; British Heart Foundation; Cancer Research UK; Chief Scientist Office; National Institute for Health Research, National Institute for Social Care and Health Research; Wellcome Trust [MR/K006584/1]; National Institute for Health Research (NIHR) Children and Families Policy Research Unit; NIHR Great Ormond Street Hospital Biomedical Research Centre; Health Data Research UK; Economic and Social Research Council; Engineering and Physical Sciences Research Council	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arthritis Research UK(Versus Arthritis); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Chief Scientist Office; National Institute for Health Research, National Institute for Social Care and Health Research; Wellcome Trust(Wellcome Trust); National Institute for Health Research (NIHR) Children and Families Policy Research Unit(National Institute for Health Research (NIHR)); NIHR Great Ormond Street Hospital Biomedical Research Centre; Health Data Research UK; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	AZ was funded by a PhD studentship funded from awards to the Farr Institute of Health Informatics Research, London, from the Medical Research Council, Arthritis Research UK, British Heart Foundation, Cancer Research UK, Chief Scientist Office, Economic and Social Research Council, Engineering and Physical Sciences Research Council, National Institute for Health Research, National Institute for Social Care and Health Research, and Wellcome Trust (grant no MR/K006584/1). This research benefits from and contributes to the National Institute for Health Research (NIHR) Children and Families Policy Research Unit, but was not commissioned by the NIHR Policy Research Programme. The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care. Research at UCL Great Ormond Street Institute of Child Health is supported by the NIHR Great Ormond Street Hospital Biomedical Research Centre. RG receives funding from Health Data Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, CONTINUING ED ANAEST, V13, P200; [Anonymous], 2018, CANC DISCOV, V8, pOF6; [Anonymous], 2013, U VERMONT HIST REV, VXXIV, P1; Ball SJ, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4333; Besselink M, 2013, PANCREATOLOGY, V13, pE1, DOI 10.1016/j.pan.2013.07.063; Cromwell DA, 2014, J CLIN EPIDEMIOL, V67, P578, DOI 10.1016/j.jclinepi.2013.10.011; Dattani Nirupa, 2011, Health Stat Q, P53, DOI 10.1057/hsq.2011.3; Department for Communities and Local Government, 2015, ENGL IND DEPR 2015; Department of Health, 2012, SIMPL GUID PAYM RES; Digital NHS, 2019, MAT SERV DAT SET; Hagger-Johnson G, 2015, HEALTH SERV RES, V50, P1162, DOI 10.1111/1475-6773.12272; Hardelid P, 2013, OVERVIEW CHILD DEATH; Hardelid P, 2019, EUROSURVEILLANCE, V24, P7, DOI 10.2807/1560-7917.ES.2019.24.1.1800046; Hardelid P, 2018, J ANTIMICROB CHEMOTH, V73, P779, DOI 10.1093/jac/dkx463; Hardelid P, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005331; Harron K, 2018, BMJ QUAL SAF, V27, P31, DOI 10.1136/bmjqs-2016-006253; Harron K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164667; Health & Social Care Information Centre, 2014, METH CREAT HES PAT I; Health The and Social Care Information Centre (HSCIC), 2015, GUIDE LINKED MORTALI; Herbert A, 2017, INT J EPIDEMIOL, V46, P1093, DOI 10.1093/ije/dyx015; Knight H, 2013, PATTERNS MATERNITY C; Linden A, 2015, STATA J, V15, P480, DOI 10.1177/1536867X1501500208; Manoj PDS, 2015, IEEE T COMPUT, V64, P3022, DOI 10.1109/TC.2015.2389827; Maret-Ouda J, 2017, SCAND J PUBLIC HEALT, V45, P14, DOI 10.1177/1403494817702336; Marquis S, 2020, RES DEV DISABIL, V96, DOI 10.1016/j.ridd.2019.103516; Moore HC, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-028710; Moser K, 2008, HLTH STAT Q; Murray J, 2013, J PUBLIC HEALTH-UK, V35, P298, DOI 10.1093/pubmed/fds077; NCCN Clinical Practice, 2018, ACUTE MYELOID LEUKEM, VV2, pMS28; Nguyen D., 2011, CELL DEATH DIS, V2, pe240; NHS Digital, 2020, OPCS CLASS INT PROC, VI; Office for National Statistics, 2014, BIRTH STAT MET; Relph S, 2020, NHS MATERNITY CARE W; Swiss Re Report, 2018, SIGMA, V3148, DOI DOI 10.2218/PIHPH.3.2018.2602; The WHO Alliance for Maternal and Newborn Health Improvement late pregnancy dating study group, 2020, LANCET GLOB HLTH, V8, pe545; Thygesen LC, 2014, EUR J EPIDEMIOL, V29, P551, DOI 10.1007/s10654-013-9873-0; Verfurden ML, 2018, ARCH DIS CHILD, V103, P1125, DOI 10.1136/archdischild-2017-314098; Wijlaars LPMM, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-021015; Wood AM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1552; Yu YF, 2017, JAMA PEDIATR, V171, P538, DOI 10.1001/jamapediatrics.2017.0197; Zylbersztejn A., 2018, USING ADM LINKED DAT; Zylbersztejn A, 2020, PAEDIATR PERINAT EP, V34, P21, DOI 10.1111/ppe.12627; Zylbersztejn A, 2018, LANCET, V391, P2008, DOI [10.1016/S0140-6736(18)30670-6, 10.1016/s0140-6736(18)30670-6]; 2019, MICROBIOME, V7, P1	44	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243843	10.1371/journal.pone.0243843	http://dx.doi.org/10.1371/journal.pone.0243843			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320878	Green Published, gold			2022-12-27	WOS:000600339800050
J	Rivard, RS; Morris, JM; Youngman, MJ				Rivard, Rebecca S.; Morris, Julia M.; Youngman, Matthew J.			The PP2A/4/6 subfamily of phosphoprotein phosphatases regulates DAF-16 and confers resistance to environmental stress in postreproductive adult C. elegans	PLOS ONE			English	Article							PROTEIN PHOSPHATASE-4; AKT PHOSPHORYLATION; DNA-DAMAGE; 2A; KINASE; COMPLEX; MECHANISM; SPECIFICITY; ACTIVATION; INTERACTS	Insulin and insulin-like growth factors are longevity determinants that negatively regulate Forkhead box class O (FoxO) transcription factors. In C. elegans mutations that constitutively activate DAF-16, the ortholog of mammalian FoxO3a, extend lifespan by two-fold. While environmental insults induce DAF-16 activity in younger animals, it also becomes activated in an age-dependent manner in the absence of stress, modulating gene expression well into late adulthood. The mechanism by which DAF-16 activity is regulated during aging has not been defined. Since phosphorylation of DAF-16 generally leads to its inhibition, we asked whether phosphatases might be necessary for its increased transcriptional activity in adult C. elegans. We focused on the PP2A/4/6 subfamily of phosphoprotein phosphatases, members of which had been implicated to regulate DAF-16 under low insulin signaling conditions but had not been investigated during aging in wildtype animals. Using reverse genetics, we functionally characterized all C. elegans orthologs of human catalytic, regulatory, and scaffolding subunits of PP2A/4/6 holoenzymes in postreproductive adults. We found that PP2A complex constituents PAA-1 and PPTR-1 regulate DAF-16 transcriptional activity during aging and that they cooperate with the catalytic subunit LET-92 to protect adult animals from ultraviolet radiation. PP4 complex members PPH-4.1/4.2, and SMK-1 also appear to regulate DAF-16 in an age-dependent manner, and together with PPFR-2 they contribute to innate immunity. Interestingly, SUR-6 but no other subunit of the PP2A complex was necessary for the survival of pathogen-infected animals. Finally, we found that PP6 complex constituents PPH-6 and SAPS-1 contribute to host defense during aging, apparently without affecting DAF-16 transcriptional activity. Our studies indicate that a set of PP2A/4/6 complexes protect adult C. elegans from environmental stress, thus preserving healthspan. Therefore, along with their functions in cell division and development, the PP2A/4/6 phosphatases also appear to play critical roles later in life.	[Rivard, Rebecca S.; Morris, Julia M.; Youngman, Matthew J.] Villanova Univ, Dept Biol, Villanova, PA 19085 USA	Villanova University	Youngman, MJ (corresponding author), Villanova Univ, Dept Biol, Villanova, PA 19085 USA.	matthew.youngman@villanova.edu		Youngman, Matthew/0000-0002-9889-3323				Abiru N, 2020, DIABETOL INT, V11, P1, DOI 10.1007/s13340-019-00415-8; Afshar K, 2010, DEVELOPMENT, V137, P237, DOI 10.1242/dev.042754; Alper S, 2007, MOL CELL BIOL, V27, P5544, DOI 10.1128/MCB.02070-06; Andreeva AV, 2001, MOL BIOL EVOL, V18, P448, DOI 10.1093/oxfordjournals.molbev.a003823; Bansal Ankita, 2014, Longev Healthspan, V3, P5, DOI 10.1186/2046-2395-3-5; Barreyro FJ, 2007, J BIOL CHEM, V282, P27141, DOI 10.1074/jbc.M704391200; Bertoli C, 2009, ONCOGENE, V28, P721, DOI 10.1038/onc.2008.425; BRENNER S, 1974, GENETICS, V77, P71; Carnegie GK, 2003, J CELL SCI, V116, P1905, DOI 10.1242/jcs.00409; Chao Y, 2006, MOL CELL, V23, P535, DOI 10.1016/j.molcel.2006.07.027; Chen GI, 2008, J BIOL CHEM, V283, P29273, DOI 10.1074/jbc.M803443200; Dues DJ, 2016, AGING-US, V8, P777, DOI 10.18632/aging.100939; Fellner T, 2003, GENE DEV, V17, P2138, DOI 10.1101/gad.259903; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Frenk S, 2018, BIOGERONTOLOGY, V19, P547, DOI 10.1007/s10522-018-9750-z; Glatter T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.75; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; GUO H, 1993, P NATL ACAD SCI USA, V90, P2500, DOI 10.1073/pnas.90.6.2500; Haccard O, 2011, RESULTS PROBL CELL D, V53, P219, DOI 10.1007/978-3-642-19065-0_11; Hall ET, 2017, BIOL OPEN, V6, P1165, DOI 10.1242/bio.025221; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Hervera A, 2019, EMBO J, V38, DOI 10.15252/embj.2018101032; Hunt Tim, 2013, Adv Biol Regul, V53, P173, DOI 10.1016/j.jbior.2013.04.001; Jacinto E, 2001, MOL CELL, V8, P1017, DOI 10.1016/S1097-2765(01)00386-0; Jia SJ, 2012, DEV CELL, V22, P1065, DOI 10.1016/j.devcel.2012.03.001; Jiang L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2663; Jiang Y, 1999, EMBO J, V18, P2782, DOI 10.1093/emboj/18.10.2782; Kajino T, 2006, J BIOL CHEM, V281, P39891, DOI 10.1074/jbc.M608155200; Kamoun M, 2013, BIOCHEM BIOPH RES CO, V440, P306, DOI 10.1016/j.bbrc.2013.09.068; Kao GT, 2004, DEVELOPMENT, V131, P755, DOI 10.1242/dev.00987; Kato H, 2015, CANCER LETT, V365, P223, DOI 10.1016/j.canlet.2015.05.022; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kim SH, 2007, J CELL BIOL, V179, P41, DOI 10.1083/jcb.200705182; Kotak S, 2016, J CELL SCI, V129, P3015, DOI 10.1242/jcs.184416; Li J, 2008, PLOS BIOL, V6, P1870, DOI 10.1371/journal.pbio.0060233; Li ST, 2019, AGING CELL, V18, DOI 10.1111/acel.12896; Lim SH, 2013, DEVELOPMENT, V140, P3079, DOI 10.1242/dev.091744; Longin S, 2004, BIOCHEM J, V380, P111, DOI 10.1042/BJ20031643; Lyu J, 2013, CELL REP, V5, P593, DOI 10.1016/j.celrep.2013.09.034; McHugh DR, 2020, G3-GENES GENOM GENET, V10, P1521, DOI 10.1534/g3.120.401166; Mendoza MC, 2005, MOL CELL BIOL, V25, P7839, DOI 10.1128/MCB.25.17.7839-7853.2005; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; Nakada S, 2008, EMBO REP, V9, P1019, DOI 10.1038/embor.2008.162; Nanahoshi M, 1999, FEBS LETT, V446, P108, DOI 10.1016/S0014-5793(99)00189-1; Nematullah M, 2018, MOL NEUROBIOL, V55, P1750, DOI 10.1007/s12035-017-0444-3; Ogoh H, 2016, MECH DEVELOP, V139, P1, DOI 10.1016/j.mod.2016.02.001; Okamura H, 2017, J CLIN MED, V6, DOI 10.3390/jcm6030023; Padmanabhan S, 2009, CELL, V136, P939, DOI 10.1016/j.cell.2009.01.025; Podshivalova K, 2017, CELL REP, V19, P441, DOI 10.1016/j.celrep.2017.03.062; Porta-de-la-Riva M, 2012, JOVE-J VIS EXP, DOI 10.3791/4019; Prasanth MI, 2016, AGE, V38, DOI 10.1007/s11357-016-9889-y; Reynhout S, 2019, BBA-MOL CELL RES, V1866, P31, DOI 10.1016/j.bbamcr.2018.07.010; Rinner O, 2007, NAT BIOTECHNOL, V25, P345, DOI 10.1038/nbt1289; Rusin SF, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab3138; Sato-Carlton A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004638; Shay KP, 2009, BIOGERONTOLOGY, V10, P443, DOI 10.1007/s10522-008-9187-x; Shen Y, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.126; Shui JW, 2007, MOL CELL BIOL, V27, P79, DOI 10.1128/MCB.00799-06; Singh A, 2010, MOL BIOL CELL, V21, P1140, DOI 10.1091/mbc.E09-09-0795; Stefansson B, 2008, BIOCHEMISTRY-US, V47, P1442, DOI 10.1021/bi7022877; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Tepper RG, 2013, CELL, V154, P676, DOI 10.1016/j.cell.2013.07.006; VANHOOF C, 1994, EUR J BIOCHEM, V226, P899; Wengrod J, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa0899; Wlodarchak N, 2016, CRIT REV BIOCHEM MOL, V51, P162, DOI 10.3109/10409238.2016.1143913; Wolff S, 2006, CELL, V124, P1039, DOI 10.1016/j.cell.2005.12.042; Wu CG, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.27; Xing YN, 2008, CELL, V133, P154, DOI 10.1016/j.cell.2008.02.041; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; Yadav L, 2017, CELL SYST, V4, P430, DOI 10.1016/j.cels.2017.02.011; Yan L, 2008, J BIOL CHEM, V283, P7411, DOI 10.1074/jbc.M708083200; Zeng K, 2010, J CELL BIOL, V191, P1315, DOI 10.1083/jcb.201008106; Zhang WQ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00286-0; Zhang XH, 2005, GENE DEV, V19, P827, DOI 10.1101/gad.1286005	76	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0229812	10.1371/journal.pone.0229812	http://dx.doi.org/10.1371/journal.pone.0229812			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315870	Green Published, gold, Green Submitted			2022-12-27	WOS:000600186100017
J	Shioi, R; Karaki, F; Yoshioka, H; Noguchi-Yachide, T; Ishikawa, M; Dodo, K; Hashimoto, Y; Sodeoka, M; Ohgane, K				Shioi, Ryuta; Karaki, Fumika; Yoshioka, Hiromasa; Noguchi-Yachide, Tomomi; Ishikawa, Minoru; Dodo, Kosuke; Hashimoto, Yuichi; Sodeoka, Mikiko; Ohgane, Kenji			Image-based screen capturing misfolding status of Niemann-Pick type C1 identifies potential candidates for chaperone drugs	PLOS ONE			English	Article							DISEASE TYPE-C; RETICULUM-ASSOCIATED DEGRADATION; SIZE-EXCLUSION CHROMATOGRAPHY; PURIFIED NPC1 PROTEIN; PHARMACOLOGICAL CHAPERONES; 3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE; ALPHA-GALACTOSIDASE; CHOLESTEROL EXPORT; QUALITY-CONTROL; STEROL-BINDING	Niemann-Pick disease type C is a rare, fatal neurodegenerative disorder characterized by massive intracellular accumulation of cholesterol. In most cases, loss-of-function mutations in the NPC1 gene that encodes lysosomal cholesterol transporter NPC1 are responsible for the disease, and more than half of the mutations are considered to interfere with the biogenesis or folding of the protein. We previously identified a series of oxysterol derivatives and phenanthridine-6-one derivatives as pharmacological chaperones, i.e., small molecules that can rescue folding-defective phenotypes of mutated NPC1, opening up an avenue to develop chaperone therapy for Niemann-Pick disease type C. Here, we present an improved image-based screen for NPC1 chaperones and we describe its application for drug-repurposing screening. We identified some azole antifungals, including itraconazole and posaconazole, and a kinase inhibitor, lapatinib, as probable pharmacological chaperones. A photo-crosslinking study confirmed direct binding of itraconazole to a representative folding-defective mutant protein, NPC1-I1061T. Competitive photo-crosslinking experiments suggested that oxysterol-based chaperones and itraconazole share the same or adjacent binding site(s), and the sensitivity of the crosslinking to P691S mutation in the sterol-sensing domain supports the hypothesis that their binding sites are located near this domain. Although the azoles were less effective in reducing cholesterol accumulation than the oxysterol-derived chaperones or an HDAC inhibitor, LBH-589, our findings should offer new starting points for medicinal chemistry efforts to develop better pharmacological chaperones for NPC1.	[Shioi, Ryuta; Karaki, Fumika; Yoshioka, Hiromasa; Noguchi-Yachide, Tomomi; Hashimoto, Yuichi; Ohgane, Kenji] Univ Tokyo, Inst Quantitat Biosci, Bunkyo Ku, Tokyo, Japan; [Ishikawa, Minoru] Tohoku Univ, Grad Sch Life Sci, Aoba Ku, Sendai, Miyagi, Japan; [Dodo, Kosuke; Sodeoka, Mikiko; Ohgane, Kenji] RIKEN, Synthet Organ Chem Lab, Cluster Pioneering Res, Wako, Saitama, Japan; [Karaki, Fumika] Kitasato Univ, Sch Pharm, Lab Med Chem, Minato Ku, Tokyo, Japan; [Ohgane, Kenji] Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biosci, Noda, Chiba, Japan	University of Tokyo; Tohoku University; RIKEN; Kitasato University; Tokyo University of Science	Ohgane, K (corresponding author), Univ Tokyo, Inst Quantitat Biosci, Bunkyo Ku, Tokyo, Japan.; Ohgane, K (corresponding author), RIKEN, Synthet Organ Chem Lab, Cluster Pioneering Res, Wako, Saitama, Japan.; Ohgane, K (corresponding author), Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biosci, Noda, Chiba, Japan.	ohgane@rs.tus.ac.jp	Ohgane, Kenji/Q-9964-2019; Dodo, Kosuke/G-2264-2012; Yoshioka, Hiromasa/AIF-1555-2022; Sodeoka, Mikiko/A-9952-2008; Yoshioka, Hiromasa/AGV-3971-2022	Ohgane, Kenji/0000-0003-0565-6503; Dodo, Kosuke/0000-0001-6008-2915; Yoshioka, Hiromasa/0000-0002-9281-9982; Sodeoka, Mikiko/0000-0002-1344-364X; Yoshioka, Hiromasa/0000-0002-9281-9982; Karaki, Fumika/0000-0002-3815-713X; Ishikawa, Minoru/0000-0002-3937-2261	RIKEN; JSPS (JSPS KAKENHI Grant) [17K15487]; JSPS (JSPS KAKENHI Grant) from Japan Society for the Promotion of Science [JP17H03996]	RIKEN; JSPS (JSPS KAKENHI Grant); JSPS (JSPS KAKENHI Grant) from Japan Society for the Promotion of Science	The work described in this article was supported in part by Incentive Research Grant (2014) for K.O. from RIKEN (https://www.riken.jp/en/), JSPS Grant-in-Aid for Young Scientists B for K.O. (JSPS KAKENHI Grant number 17K15487) and JSPS Grants-in-Aid for Scientific Research B for Y.H. (JSPS KAKENHI Grant number JP17H03996) from Japan Society for the Promotion of Science (https://www.jsps.go.jp/english/index.html).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Chiba T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116162; Coma I, 2009, METHODS MOL BIOL, V565, P69, DOI 10.1007/978-1-60327-258-2_4; Davies JP, 2000, J BIOL CHEM, V275, P24367, DOI 10.1074/jbc.M002184200; Fan JQ, 1999, NAT MED, V5, P112, DOI 10.1038/4801; Fukuda H, 2017, BIOORG MED CHEM LETT, V27, P2781, DOI 10.1016/j.bmcl.2017.04.062; Garcia-Calvo M, 2005, P NATL ACAD SCI USA, V102, P8132, DOI 10.1073/pnas.0500269102; Gelsthorpe ME, 2008, J BIOL CHEM, V283, P8229, DOI 10.1074/jbc.M708735200; Gong X, 2016, CELL, V165, P1467, DOI 10.1016/j.cell.2016.05.022; Hattori M, 2012, STRUCTURE, V20, P1293, DOI 10.1016/j.str.2012.06.009; Head SA, 2017, ACS CHEM BIOL, V12, P174, DOI 10.1021/acschembio.6b00849; Herner A, 2016, J AM CHEM SOC, V138, P14609, DOI 10.1021/jacs.6b06645; Hong V, 2009, ANGEW CHEM INT EDIT, V48, P9879, DOI 10.1002/anie.200905087; Hosoya T, 2005, BIOORG MED CHEM LETT, V15, P1289, DOI 10.1016/j.bmcl.2005.01.041; Huang EY, 2018, MOL BIOL CELL, V29, P1021, DOI 10.1091/mbc.E17-08-0514; Ihara M, 2011, ANAL BIOCHEM, V412, P217, DOI 10.1016/j.ab.2011.01.038; Infante RE, 2008, J BIOL CHEM, V283, P1064, DOI 10.1074/jbc.M707944200; Infante RE, 2008, J BIOL CHEM, V283, P1052, DOI 10.1074/jbc.M707943200; ISHII S, 1993, BIOCHEM BIOPH RES CO, V197, P1585, DOI 10.1006/bbrc.1993.2659; Karaki F, 2014, THESIS, DOI [10.15083/00007033, DOI 10.15083/00007033]; Karaki F, 2014, BIOORGAN MED CHEM, V22, P3587, DOI 10.1016/j.bmc.2014.05.022; Karaki F, 2013, BIOORGAN MED CHEM, V21, P5297, DOI 10.1016/j.bmc.2013.06.022; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Kozakov D, 2015, NAT PROTOC, V10, P733, DOI 10.1038/nprot.2015.043; Kwon HJ, 2009, CELL, V137, P1213, DOI 10.1016/j.cell.2009.03.049; Ladner CL, 2004, ANAL BIOCHEM, V326, P13, DOI 10.1016/j.ab.2003.10.047; Li J, 2015, P NATL ACAD SCI USA, V112, P14876, DOI 10.1073/pnas.1520490112; Li XC, 2016, P NATL ACAD SCI USA, V113, P8212, DOI 10.1073/pnas.1607795113; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; Long T, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13917-5; Loo TW, 1997, J BIOL CHEM, V272, P709, DOI 10.1074/jbc.272.2.709; Lord SJ, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.202001064; Lu FR, 2015, ELIFE, V4, DOI 10.7554/eLife.12177; Mackinnon Andrew L, 2009, Curr Protoc Chem Biol, V1, P55; Morello JP, 2000, J CLIN INVEST, V105, P887, DOI 10.1172/JCI8688; Munkacsi AB, 2011, J BIOL CHEM, V286, P23842, DOI 10.1074/jbc.M111.227645; Nacev BA, 2011, J BIOL CHEM, V286, P44045, DOI 10.1074/jbc.M111.278754; Nachtergaele S, 2012, NAT CHEM BIOL, V8, P211, DOI 10.1038/nchembio.765; Nakasone N, 2014, J BIOL CHEM, V289, P19714, DOI 10.1074/jbc.M114.549915; Naureckiene S, 2000, SCIENCE, V290, P2298, DOI 10.1126/science.290.5500.2298; Ohgami N, 2004, P NATL ACAD SCI USA, V101, P12473, DOI 10.1073/pnas.0405255101; Ohgane K, 2019, QUANTIFICATION GEL B, DOI [10.17504/protocols.io.7vghn3w, DOI 10.17504/PROTOCOLS.IO.7VGHN3W]; Ohgane K, Japan patent Application, Patent No. [JP-2017-105738A, JP-2015-242513A, 2017105738]; Ohgane K, 2014, BIOORG MED CHEM LETT, V24, P3480, DOI 10.1016/j.bmcl.2014.05.064; Ohgane K, 2013, CHEM BIOL, V20, P391, DOI 10.1016/j.chembiol.2013.02.009; Parks DR, 2006, CYTOM PART A, V69A, P541, DOI 10.1002/cyto.a.20258; Pau G, 2010, BIOINFORMATICS, V26, P979, DOI 10.1093/bioinformatics/btq046; Pfeffer SR, 2019, J BIOL CHEM, V294, P1706, DOI 10.1074/jbc.TM118.004165; Pipalia NH, 2011, P NATL ACAD SCI USA, V108, P5620, DOI 10.1073/pnas.1014890108; Pugach EK, 2018, HUM MOL GENET, V27, P2101, DOI 10.1093/hmg/ddy117; Rudolf AF, 2019, NAT CHEM BIOL, V15, P975, DOI 10.1038/s41589-019-0370-y; Saha P, 2020, ELIFE, V9, DOI 10.7554/eLife.57089; Saliba RS, 2002, J CELL SCI, V115, P2907; Sawkar AR, 2002, P NATL ACAD SCI USA, V99, P15428, DOI 10.1073/pnas.192582899; Schultz ML, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06115-2; Schultz ML, 2016, BRAIN RES, V1649, P181, DOI 10.1016/j.brainres.2016.03.035; Sever N, 2003, J BIOL CHEM, V278, P52479, DOI 10.1074/jbc.M310053200; Shammas H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41707-y; Storch J, 2009, BBA-MOL CELL BIOL L, V1791, P671, DOI 10.1016/j.bbalip.2009.02.001; Strittmatter SM, 2014, NAT MED, V20, P590, DOI 10.1038/nm.3595; Suzuki N, 2018, ANAL BIOCHEM, V548, P7, DOI 10.1016/j.ab.2018.02.007; Takada T, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010329; Tanio M, 2012, ANAL BIOCHEM, V431, P106, DOI 10.1016/j.ab.2012.09.012; Trinh MN, 2017, P NATL ACAD SCI USA, V114, P89, DOI 10.1073/pnas.1619571114; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Vanier MT, 2015, METHOD CELL BIOL, V126, P357, DOI 10.1016/bs.mcb.2014.10.028; Wang C, 2020, HUM MOL GENET, V29, P1, DOI 10.1093/hmg/ddz215; Wang ML, 2010, CELL METAB, V12, P166, DOI 10.1016/j.cmet.2010.05.016; WARD CL, 1994, J BIOL CHEM, V269, P25710; Winkler MBL, 2019, CELL, V179, P485, DOI 10.1016/j.cell.2019.08.038; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Xie XF, 2011, P NATL ACAD SCI USA, V108, P15330, DOI 10.1073/pnas.1112751108; Yamamoto T, 2000, J MED GENET, V37, P707, DOI 10.1136/jmg.37.9.707; Yamamoto T, 2004, BRAIN DEV-JPN, V26, P245, DOI 10.1016/S0387-7604(03)00162-1; Yu T, 2012, HUM MOL GENET, V21, P3205, DOI 10.1093/hmg/dds145; Zhang DL, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00176; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang YX, 2018, CELL, V175, P1352, DOI 10.1016/j.cell.2018.10.026	79	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243746	10.1371/journal.pone.0243746	http://dx.doi.org/10.1371/journal.pone.0243746			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315900	Green Published, gold			2022-12-27	WOS:000600186100058
J	Ahmad, A; Almsned, F; Ghazal, P; Ahmed, MW; Jafri, MS; Bokhari, H				Ahmad, Aftab; Almsned, Fahad; Ghazal, Pasha; Ahmed, Malik Waqar; Jafri, M. Saleet; Bokhari, Habib			Neuropeptide S receptor gene Asn107 polymorphism in obese male individuals in Pakistan	PLOS ONE			English	Article							ASSOCIATION; STRESS; SYSTEM; VARIANTS; DYNAMICS; PEPTIDE	Neuropeptide S (NPS) is a naturally occurring appetite stimulant, associated with anxiety, stress, and excitement regulation. Neuropeptide S serves as a hypothalamic energy regulator that enhances food intake with a reduced level of satiety. NPS activates fat angiogenesis and the proliferation of new adipocytes in obesity. NPS has an established role in energy regulation by many pre-clinical investigations; however we have limited data available to support this notion in humans. We found significant association of Neuropeptide S receptor (NPSR1) Asn107Ile (rs324981, A>T) polymorphism with obese male participants. The current investigation carried out genotype screening of NPSR1 allele to assess the spectrum of the Asn107Ile polymorphism in obese and healthy Pakistani individuals. We revealed a significant (p = 0.04) difference between AA vs TT + AT genotype distribution of NPSR1 (SNP rs324981,) between obese and healthy individuals (p = 0.04). In this genotype analysis of (SNP rs324981) of the NPSR1 gene, T allele was marked as risk allele with higher frequency in the obese (38%) compared to its frequency in the controls (25%). Single Nucleotide Polymorphism (SNP, rs324981) Asn107Ile of NPSR1gene, that switches an amino acid from Asn to Ile, has been found associated with increased susceptibility to obesity in Pakistani individuals. Furthermore, molecular simulation studies predicted a lower binding affinity of NPSR1 Asn107Ile variant to NPS than the wild-type consistent with the genotype studies. These molecular simulation studies predict a possible molecular mechanism of this interaction by defining the key amino acid residues. However, a significantly (p<0.0001) lower concentration of NPS was recorded independent of genotype frequencies in obese subjects compared to healthy controls. We believe that large scale polymorphism data of population for important gene players including NPSR1 will be more useful to understand obesity and its associated risk factors.	[Ahmad, Aftab; Ghazal, Pasha; Ahmed, Malik Waqar; Bokhari, Habib] COMSATS Univ Islamabad, Dept Biosci, Islamabad, Pakistan; [Almsned, Fahad; Jafri, M. Saleet] George Mason Univ, Sch Syst Biol, Fairfax, VA 22030 USA; [Almsned, Fahad; Jafri, M. Saleet] George Mason Univ, Krasnow Inst Adv Study, Fairfax, VA 22030 USA; [Almsned, Fahad] King Fahad Specialist Hosp Dammam, Dammam, Saudi Arabia; [Jafri, M. Saleet; Bokhari, Habib] Univ Maryland, Sch Med, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA	COMSATS University Islamabad (CUI); George Mason University; George Mason University; University System of Maryland; University of Maryland Baltimore	Bokhari, H (corresponding author), COMSATS Univ Islamabad, Dept Biosci, Islamabad, Pakistan.; Bokhari, H (corresponding author), Univ Maryland, Sch Med, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA.	habib@comsats.edu.pk		, Malik Waqar Ahmed/0000-0002-2430-7475; bokhari, habib/0000-0002-2171-6062; Jafri, Mohsin/0000-0003-3174-1007	Higher Education Commision, Pakistan [IRSIP36-BMS71]	Higher Education Commision, Pakistan	The study was supported by the Higher Education Commision, Pakistan (Grant #IRSIP36-BMS71) received by Aftab Ahmad. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anedda F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029523; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Ballantyne GH, 2006, OBES SURG, V16, P651, DOI 10.1381/096089206776944959; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Beste C, 2013, NEUROIMAGE, V71, P1, DOI 10.1016/j.neuroimage.2013.01.004; Boughton CK, 2013, BRIT J PHARMACOL, V170, P1333, DOI 10.1111/bph.12037; Camilleri M, 2010, GASTROENTEROLOGY, V138, P98, DOI 10.1053/j.gastro.2009.08.051; Deng C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083009; Dimitriadis GK, 2017, CURR OBES REP, V6, P253, DOI 10.1007/s13679-017-0276-5; Domschke K, 2011, MOL PSYCHIATR, V16, P938, DOI 10.1038/mp.2010.81; Domschke K, 2011, BEHAV NEUROGENETICS, P463; Domschke K, 2015, CEREB CORTEX, V27, P554; Donner J, 2010, BIOL PSYCHIAT, V68, P474, DOI 10.1016/j.biopsych.2010.05.039; Feng Y, 2006, J ALLERGY CLIN IMMUN, V117, P612, DOI 10.1016/j.jaci.2005.11.045; Gafarov V, 2017, EUR NEUROPSYCHOPHARM, V27, pS453, DOI 10.1016/j.euroneuro.2016.09.522; Ghazal P, 2016, CURR PROTEIN PEPT SC, V17, P380, DOI 10.2174/1389203717666151218150704; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; Helble M, IMMINENT OBESITY CRI; Howe AS, 2016, MOL PSYCHIATR, V21, P665, DOI 10.1038/mp.2015.138; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Josephson CB, 2013, NEUROLOGY, V80, P1669, DOI 10.1212/WNL.0b013e3182904f82; Karvonen MK, 1998, NAT MED, V4, P1434, DOI 10.1038/4027; Klauke B, 2014, WORLD J BIOL PSYCHIA, V15, P17, DOI 10.3109/15622975.2011.646302; Laas K, 2015, J PSYCHOPHARMACOL, V29, P878, DOI 10.1177/0269881115573803; Laas K, 2014, INT J NEUROPSYCHOPH, V17, P541, DOI 10.1017/S1461145713001478; Laas K, 2014, J PSYCHOPHARMACOL, V28, P227, DOI 10.1177/0269881112472562; Lin XJ, 2018, MED SCI MONITOR, V24, P6680, DOI 10.12659/MSM.910432; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Okamura N, 2007, PROG NEURO-PSYCHOPH, V31, P1444, DOI 10.1016/j.pnpbp.2007.06.026; Pape HC, 2010, NEUROPHARMACOLOGY, V58, P29, DOI 10.1016/j.neuropharm.2009.06.001; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Reinscheid Rainer K., 2008, V46, P145, DOI 10.1007/400_2007_051; Reinscheid RK, 2005, J PHARMACOL EXP THER, V315, P1338, DOI 10.1124/jpet.105.093427; RStudio, 2021, RSTUDIO INT DEV ENV; Ruland T, 2015, EUR NEUROPSYCHOPHARM, V25, P1677, DOI 10.1016/j.euroneuro.2015.07.011; Slattery DA, 2015, J NEUROSCI, V35, P4599, DOI 10.1523/JNEUROSCI.4764-13.2015; Streit F, 2017, PSYCHONEUROENDOCRINO, V76, P49, DOI 10.1016/j.psyneuen.2016.10.027; Tupak SV, 2013, NEUROIMAGE, V66, P353, DOI 10.1016/j.neuroimage.2012.10.033; WHO, FACT SHEET; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Zankert S, 2015, PSYCHONEUROENDOCRINO, V61, P59, DOI 10.1016/j.psyneuen.2015.07.550; Zhang CX, 2017, NUCLEIC ACIDS RES, V45, pW291, DOI 10.1093/nar/gkx366; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	44	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243205	10.1371/journal.pone.0243205	http://dx.doi.org/10.1371/journal.pone.0243205			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332443	Green Published, gold			2022-12-27	WOS:000601310900091
J	Walker, MR; Knudsen, AS; Partey, FD; Bassi, MR; Frank, AM; Castberg, FC; Sarbah, EW; Ofori, MF; Hviid, L; Barfod, L				Walker, Melanie R.; Knudsen, Anne S.; Partey, Frederica D.; Bassi, Maria R.; Frank, Asger M.; Castberg, Filip C.; Sarbah, Edem W.; Ofori, Michael F.; Hviid, Lars; Barfod, Lea			Acquisition and decay of IgM and IgG responses to merozoite antigens after Plasmodium falciparum malaria in Ghanaian children	PLOS ONE			English	Article							NATURALLY ACQUIRED ANTIBODIES; MEMBRANE ANTIGEN; IMMUNITY; PROTECTION; VACCINE; VIRUS; RESISTANCE; INVASION; IDENTIFICATION; MAGNITUDE	Developing a vaccine against Plasmodium falciparum malaria has been challenging, primarily due to high levels of antigen polymorphism and a complex parasite lifecycle. Immunization with the P. falciparum merozoite antigens PfMSRP5, PfSERA9, PfRAMA, PfCyRPA and PfRH5 has been shown to give rise to growth inhibitory and synergistic antisera. Therefore, these five merozoite proteins are considered to be promising candidates for a second-generation multivalent malaria vaccine. Nevertheless, little is known about IgG and IgM responses to these antigens in populations that are naturally exposed to P. falciparum. In this study, serum samples from clinically immune adults and malaria exposed children from Ghana were studied to compare levels of IgG and IgM specific for PfMSRP5, PfSERA9, PfRAMA, PfCyRPA and PfRH5. All five antigens were found to be specifically recognized by both IgM and IgG in serum from clinically immune adults and from children with malaria. Longitudinal analysis of the latter group showed an early, transient IgM response that was followed by IgG, which peaked 14 days after the initial diagnosis. IgG levels and parasitemia did not correlate, whereas parasitemia was weakly positively correlated with IgM levels. These findings show that IgG and IgM specific for merozoite antigens PfMSRP5, PfSERA9, PfRAMA, PfCyRPA and PfRH5 are high in children during P. falciparum malaria, but that the IgM induction and decline occurs earlier in infection than that of IgG.	[Walker, Melanie R.; Knudsen, Anne S.; Bassi, Maria R.; Frank, Asger M.; Hviid, Lars; Barfod, Lea] Univ Copenhagen, Dept Immunol & Microbiol, Ctr Med Parasitol, Fac Hlth & Med Sci, Copenhagen, Denmark; [Partey, Frederica D.; Sarbah, Edem W.; Ofori, Michael F.] Univ Ghana, Noguchi Mem Inst Med Res, Legon, Ghana; [Castberg, Filip C.] Copenhagen Univ Hosp, Rigshosp, Dept Clin Microbiol, Copenhagen, Denmark	University of Copenhagen; University of Ghana; Rigshospitalet; University of Copenhagen	Barfod, L (corresponding author), Univ Copenhagen, Dept Immunol & Microbiol, Ctr Med Parasitol, Fac Hlth & Med Sci, Copenhagen, Denmark.	lbarfod@sund.ku.dk	Ofori, Michael F/H-9072-2013; Hviid, Lars/G-3705-2012	Ofori, Michael F/0000-0003-2341-7514; Hviid, Lars/0000-0002-1698-4927; Knudsen, Anne Schlitterlau/0000-0003-3234-9082; Bassi, Maria Rosaria/0000-0001-6736-6152; Walker, Melanie/0000-0002-9731-9880; Barfod, Lea/0000-0001-6510-495X; Castberg, Filip Christian/0000-0002-1140-5527	Novo Nordisk Foundation [NNF170C0026778]; Danida [17-02-KU, 12-081RH]	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danida	The work was supported by the Novo Nordisk Foundation (NNF170C0026778) as well as Danida (17-02-KU and 12-081RH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adepoju P, 2019, LANCET, V393, P1685, DOI 10.1016/S0140-6736(19)30937-7; Adu B, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1146-4; Akpogheneta OJ, 2008, INFECT IMMUN, V76, P1748, DOI 10.1128/IAI.01333-07; [Anonymous], 2014, PREV CHRONIC DIS, V11, pE62; [Anonymous], 1991, FRONTIERS, V12, pix; Arama C, 2014, J INTERN MED, V275, P456, DOI 10.1111/joim.12223; Arama C, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv118; Baum J, 2009, INT J PARASITOL, V39, P371, DOI 10.1016/j.ijpara.2008.10.006; Baumgarth N, 2017, J IMMUNOL, V199, P3387, DOI 10.4049/jimmunol.1700943; Boyle MJ, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax4489; Busch MP, 2008, J INFECT DIS, V198, P984, DOI 10.1086/591467; Bustamante LY, 2017, P NATL ACAD SCI USA, V114, P12045, DOI 10.1073/pnas.1702944114; Castberg FC, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2609-6; Chua CL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171989; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Collins AM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00235; Crompton PD, 2014, ANNU REV IMMUNOL, V32, P157, DOI 10.1146/annurev-immunol-032713-120220; Crompton PD, 2010, INFECT IMMUN, V78, P737, DOI 10.1128/IAI.00960-09; Crosnier C, 2011, NATURE, V480, P534, DOI 10.1038/nature10606; Diamond MS, 2003, J EXP MED, V198, P1853, DOI 10.1084/jem.20031223; Dodoo D, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-142; Dondorp AM, 2013, TRENDS PARASITOL, V29, P359, DOI 10.1016/j.pt.2013.05.005; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Douglas AD, 2015, CELL HOST MICROBE, V17, P130, DOI 10.1016/j.chom.2014.11.017; Escalante AA, 1998, GENETICS, V149, P189; Finney OC, 2014, MOL CELL PROTEOMICS, V13, P2646, DOI 10.1074/mcp.M113.036632; Fowkes FJI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000218; Gilson PR, 2006, MOL CELL PROTEOMICS, V5, P1286, DOI 10.1074/mcp.M600035-MCP200; Gong S, 2018, AIDS, V32, pF5, DOI [10.1097/qad.0000000000001857, 10.1097/QAD.0000000000001857]; Griffin DO, 2011, J EXP MED, V208, P67, DOI 10.1084/jem.20101499; Gupta S, 1999, P ROY SOC B-BIOL SCI, V266, P33, DOI 10.1098/rspb.1999.0600; Haldar K, 2018, NAT REV MICROBIOL, V16, P156, DOI 10.1038/nrmicro.2017.161; Healer J, 2019, CELL MICROBIOL, V21, DOI 10.1111/cmi.13030; Hjerrild KA, 2016, SCI REP-UK, V6, DOI 10.1038/srep30357; Janeway CA Jr TP, 2001, DISTRIBUTION FUNCTIO; Jiang LB, 2011, P NATL ACAD SCI USA, V108, P7553, DOI 10.1073/pnas.1104050108; Jin J, 2018, NPJ VACCINES, V3, DOI 10.1038/s41541-018-0071-7; Kinyanjui SM, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-82; Krishnamurty AT, 2016, IMMUNITY, V45, P402, DOI 10.1016/j.immuni.2016.06.014; Moyron-Quiroz JE, 2009, VACCINE, V28, P140, DOI 10.1016/j.vaccine.2009.09.086; Mugyenyi CK, 2017, J INFECT DIS, V216, P887, DOI 10.1093/infdis/jix370; Neafsey DE, 2015, NEW ENGL J MED, V373, P2025, DOI 10.1056/NEJMoa1505819; Nixon CP, 2005, J INFECT DIS, V192, P861, DOI 10.1086/432550; Osier FH, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008705; Osier FHA, 2008, INFECT IMMUN, V76, P2240, DOI 10.1128/IAI.01585-07; Partey FD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198371; Payne RO, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.96381; Quach TD, 2016, J IMMUNOL, V196, P1060, DOI 10.4049/jimmunol.1501843; Richards JS, 2013, J IMMUNOL, V191, P795, DOI 10.4049/jimmunol.1300778; Richards JS, 2010, CLIN INFECT DIS, V51, pE50, DOI 10.1086/656413; Rodriguez M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003300; Schofield L, 2006, CURR MOL MED, V6, P205, DOI 10.2174/156652406776055221; Siciliano G, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00391; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Skountzou I, 2014, CLIN VACCINE IMMUNOL, V21, P1481, DOI 10.1128/CVI.00374-14; Soares IS, 1999, AM J TROP MED HYG, V60, P357, DOI 10.4269/ajtmh.1999.60.357; Stanisic DI, 2015, INFECT IMMUN, V83, P646, DOI 10.1128/IAI.02398-14; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08; Topolska AE, 2004, INFECT IMMUN, V72, P3325, DOI 10.1128/IAI.72.6.3325-3330.2004; Tran TM, 2014, J INFECT DIS, V209, P789, DOI 10.1093/infdis/jit553; Uwimana A, 2020, NAT MED, V26, P1602, DOI 10.1038/s41591-020-1005-2; Walke RMR, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12010075; Weaver R, 2016, SCI REP-UK, V6, DOI 10.1038/srep33094; White MT, 2015, LANCET INFECT DIS, V15, P1450, DOI 10.1016/S1473-3099(15)00239-X; WHO, 2019, WORLD MALARIA REPORT; Wright KE, 2014, NATURE, V515, P427, DOI 10.1038/nature13715; Zenonos ZA, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-93	67	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243943	10.1371/journal.pone.0243943	http://dx.doi.org/10.1371/journal.pone.0243943			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332459	Green Published, gold			2022-12-27	WOS:000601310900007
J	Dhongde, S				Dhongde, Shatakshee			Multidimensional economic deprivation during the coronavirus pandemic: Early evidence from the United States	PLOS ONE			English	Article							POVERTY	The coronavirus pandemic led to a severe economic shock in the United States. This paper uses a unique survey data collected early on in the pandemic to measure economic deprivation among individuals. The Federal Reserve Board fielded a Survey of Household Economics and Decision-making (SHED) in April 2020. This survey is used to compile data on four indicators of economic deprivation, namely: i) Overall financial condition, ii) Loss of employment, iii) Reduction in income and iv) Inability to pay bills in full. Data on these indicators is compiled for each individual and is used in a novel way to construct a set of multidimensional deprivation indices. These indices measure the overlap of deprivations experienced by an individual. Results show that almost 25 percent of the respondents faced hardships in at least two of the four indicators. More than 13 percent of adults reported their inability to pay monthly bills and struggled to make ends meet financially. One in four respondents had lower income compared to income from previous month. The economic shock affected Hispanics in a more profound way. More than 37 percent Hispanics reported hardship in two or more indicators and 8 percent reported hardship in all four indicators. Higher proportion of young adults and those without a college degree suffered multiple hardships. The paper highlights the plight of Americans during the early months of the economic crisis set in motion amid the coronavirus pandemic and sheds light on how economic disparities deepened along racial/ethnic lines.	[Dhongde, Shatakshee] Georgia Inst Technol, Sch Econ, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Dhongde, S (corresponding author), Georgia Inst Technol, Sch Econ, Atlanta, GA 30332 USA.	shatakshee.dhongde@econ.gatech.edu		Dhongde, Shatakshee/0000-0003-2587-9528				Abedi V, 2021, J RACIAL ETHN HEALTH, V8, P732, DOI [10.1007/s40615-020-00833-4, 10.1101/2020.04.26.20079756]; Alexander D, 2020, 3583625 SSRN, DOI [10.21033/wp-2020-12, DOI 10.21033/WP-2020-12]; Alkire S., 2015, MULTIDIMENSIONAL POV, DOI [10.1093/acprof:oso/9780199689491.001.0001, DOI 10.1093/ACPROF:OSO/9780199689491.001.0001]; Alkire S., 2011, J PUBLIC EC, V95, P476, DOI [DOI 10.1016/J.JPUBEC0.2010.11.006, 10.1016/j.jpubeco.2010.11.006]; [Anonymous], 2017, GALLUP HEALTHWAYS RE; [Anonymous], 2020, NY TIMES; Bartik A., 2020, BROOKINGS PAPERS EC; Bonaccorsi G, 2020, P NATL ACAD SCI USA, V117, P15530, DOI 10.1073/pnas.2007658117; Brodeur A, 2021, J ECON SURV, V35, P1007, DOI 10.1111/joes.12423; Carlsson-Szlezak P., 2020, HARVARD BUS REV, V3, P1; Chetty R., 2020, EC IMPACTS COVID 19; Coibion O., 2020, LABOR MARKETS COVID, DOI 10.3386/w27017; Cox N., 2020, BROOKINGS PAPERS EC; Dhongde S, 2019, REV INCOME WEALTH, V65, pS281, DOI 10.1111/roiw.12411; Dhongde S, 2017, SOC INDIC RES, V133, P477, DOI 10.1007/s11205-016-1379-1; Dotter C., 2017, COURANT RES CTR POVE, V233; Evans D, 2020, EC IMPACT COVID 19 L; Federal Reserve Board (FRB), 2020, REPORT EC WELL BEING; Federal Reserve Board Report, 2020, REP EC WELL BEING US; Ferreira FHG, 2013, WORLD BANK RES OBSER, V28, P220, DOI 10.1093/wbro/lks013; Glassman B., 2019, AM COMMUNITY SURVEY, V-40; Gupta S., 2020, NBER WORKING PAPER; Martin Amory, 2020, Econ Disaster Clim Chang, V4, P453, DOI 10.1007/s41885-020-00070-3; Mitra S, 2019, ECON BULL, V39, P1272; Mitra S, 2017, SOC SCI QUART, V98, P37, DOI 10.1111/ssqu.12291; Moore JT, 2020, MMWR-MORBID MORTAL W, V69, P1122, DOI 10.15585/mmwr.mm6933e1; National Bureau of Economics Research, WORK PAP COVID 19; Pattanaik PK, 2018, J ECON LIT, V56, P657, DOI 10.1257/jel.20161454; Seth S., 2019, 132 OXF POV HUM DEV; Stokes EK, 2020, MMWR-MORBID MORTAL W, V69, P759, DOI 10.15585/mmwr.mm6924e2	30	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0244130	10.1371/journal.pone.0244130	http://dx.doi.org/10.1371/journal.pone.0244130			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH1IW	33326495	Green Published, gold			2022-12-27	WOS:000600176400069
J	Ishihara, T; Ohkochi, T; Yamaguchi, A; Kotani, Y; Oura, M				Ishihara, Tomoko; Ohkochi, Takuo; Yamaguchi, Akinobu; Kotani, Yoshinori; Oura, Masaki			Visualization of elemental distributions and local analysis of element-specific chemical states of an Arachnoidiscus sp. frustule using soft X-ray spectromicroscopy	PLOS ONE			English	Article							DIATOMS; TRANSMISSION; ACID; FLUORESCENCE; SPECTROSCOPY; MICROSCOPY; BIOSILICA; SILICA	Using soft X-ray (SX) spectromicroscopy, we show maps of the spatial distribution of constituent elements and local analysis of the density of states (DOS) related to the element-specific chemical states of diatom frustules, which are composed of naturally grown nanostructured hydrogenated amorphous silica. We applied X-ray photoemission electron microscopy (X-PEEM) as well as microprobe X-ray fluorescence (mu XRF) analysis to characterize the surfaces of diatom frustules by means of X-ray absorption spectroscopy (XAS) and X-ray emission spectroscopy (XES). We successfully demonstrated that SX spectromicroscopy is able to participate in potential observation tools as a new method to spectroscopically investigate diatom frustules.	[Ishihara, Tomoko; Ohkochi, Takuo; Yamaguchi, Akinobu; Oura, Masaki] RIKEN, Soft Xray Spect Instrumentat Team, Phys & Chem Res Infrastruct Grp, Adv Photon Technol Div,SPring 8 Ctr, Sayo, Hyogo, Japan; [Ohkochi, Takuo; Kotani, Yoshinori] Japan Synchrotron Radiat Res Inst JASRI, Spect & Imaging Div, Spectroscop Anal Grp 2, Sayo, Hyogo, Japan; [Yamaguchi, Akinobu] Univ Hyogo, Lab Adv Sci & Technol Ind LASTI, Kobe, Hyogo, Japan	Japan Synchrotron Radiation Research Institute; RIKEN; Japan Synchrotron Radiation Research Institute; University of Hyogo	Oura, M (corresponding author), RIKEN, Soft Xray Spect Instrumentat Team, Phys & Chem Res Infrastruct Grp, Adv Photon Technol Div,SPring 8 Ctr, Sayo, Hyogo, Japan.	oura@spring8.or.jp	Oura, Masaki/A-2057-2014	Oura, Masaki/0000-0002-9999-5612	JSPS KAKENHI [17H02755]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	AY acknowledges JSPS KAKENHI Grants-in-Aid for Scientific Research B (No. 17H02755) for partially supporting the research and development in this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Alipour L, 2016, APPL SPECTROSC, V70, P427, DOI 10.1177/0003702815626665; Armbrust EV, 2009, NATURE, V459, P185, DOI 10.1038/nature08057; Brun N, 1996, MICROSC MICROANAL M, V7, P161, DOI 10.1051/mmm:1996112; Chaffin JD, 2012, J APPL PHYCOL, V24, P1045, DOI 10.1007/s10811-011-9732-x; Chauton MS, 2015, J APPL PHYCOL, V27, P777, DOI 10.1007/s10811-014-0373-8; d'Ippolito G, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0212-4; de Jonge MD, 2010, P NATL ACAD SCI USA, V107, P15676, DOI 10.1073/pnas.1001469107; Ferrara MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103750; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Gu B, 2014, BIOGEOSCIENCES, V11, P5259, DOI 10.5194/bg-11-5259-2014; HAMALAINEN K, 1991, PHYS REV LETT, V67, P2850, DOI 10.1103/PhysRevLett.67.2850; HECKY RE, 1973, MAR BIOL, V19, P323, DOI 10.1007/BF00348902; HENKE BL, 1993, ATOM DATA NUCL DATA, V54, P181, DOI 10.1006/adnd.1993.1013; Hildebrand M, 2008, CHEM REV, V108, P4855, DOI 10.1021/cr078253z; HIMPSEL FJ, 1991, PHYS REV B, V43, P6899, DOI 10.1103/PhysRevB.43.6899; Hirai A, 1999, JPN J APPL PHYS 1, V38, P274, DOI 10.1143/JJAP.38.274; Hirata A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11591; Hitchcock AP, 2012, ENVIRON SCI TECHNOL, V46, P2821, DOI 10.1021/es202238k; Jiang WK, 2015, J APPL PHYCOL, V27, P243, DOI 10.1007/s10811-014-0324-4; Jiang WK, 2014, J APPL PHYCOL, V26, P1511, DOI 10.1007/s10811-013-0192-3; Kobayashi A., 1998, DIATOM, V14, P25; KRAUSE MO, 1979, J PHYS CHEM REF DATA, V8, P307, DOI 10.1063/1.555594; LI D, 1994, AM MINERAL, V79, P622; Losic D, 2007, J POROUS MAT, V14, P61, DOI 10.1007/s10934-006-9009-y; Losic D, 2007, LANGMUIR, V23, P5014, DOI 10.1021/la062666y; Losic D, 2009, ADV MATER, V21, P2947, DOI 10.1002/adma.200803778; Martens I, 2019, J PHYS CHEM C, V123, P16023, DOI 10.1021/acs.jpcc.9b03924; Menzel A, 2010, ULTRAMICROSCOPY, V110, P1143, DOI 10.1016/j.ultramic.2010.04.007; Mishra M, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01239; NELSON DM, 1995, GLOBAL BIOGEOCHEM CY, V9, P359, DOI 10.1029/95GB01070; Ohashi H, 2007, AIP CONF PROC, V879, P523; Ohashi H, 2006, PROC SPIE, V6317, DOI 10.1117/12.682329; Ohkochi T, 2019, JPN J APPL PHYS, V58, DOI 10.7567/1347-4065/ab4b12; Oura M, 2007, J SYNCHROTRON RADIAT, V14, P483, DOI 10.1107/S0909049507040289; Oura M, 2020, JPN J APPL PHYS, V59, DOI 10.35848/1347-4065/ab9461; Oura M, 2020, J SYNCHROTRON RADIAT, V27, P664, DOI 10.1107/S1600577520002258; Parkinson J, 1999, TRENDS BIOTECHNOL, V17, P190, DOI 10.1016/S0167-7799(99)01321-9; Senba Y, 2007, AIP CONF PROC, V879, P718; Suzuki M, 2019, MOLECULES, V24, DOI 10.3390/molecules24193488; Umemura K, 2008, J BIOL PHYS, V34, P189, DOI 10.1007/s10867-008-9086-z; Wang J, 2009, J ELECTRON SPECTROSC, V170, P25, DOI 10.1016/j.elspec.2008.01.002; Wang J, 2009, J PHYS CHEM B, V113, P1869, DOI 10.1021/jp808289e; Wang Y, 2013, APPL MICROBIOL BIOT, V97, P453, DOI 10.1007/s00253-012-4568-0; Wolfe AP, 2009, AM J BOT, V96, P487, DOI 10.3732/ajb.0800307; Yamane H, 2020, J PHYS CHEM C, V124, P9622, DOI 10.1021/acs.jpcc.0c02838; Yamane H, 2019, J ELECTRON SPECTROSC, V232, P11, DOI 10.1016/j.elspec.2018.12.005; Yogi C, 2014, R1405 SYNCHR RAD CTR	47	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243874	10.1371/journal.pone.0243874	http://dx.doi.org/10.1371/journal.pone.0243874			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326474	Green Published, gold			2022-12-27	WOS:000600176400058
J	Manjarin, R; Maj, MA; La Frano, MR; Glanz, H				Manjarin, Rodrigo; Maj, Magdalena A.; La Frano, Michael R.; Glanz, Hunter			%polynova_2way: A SAS macro for implementation of mixed models for metabolomics data	PLOS ONE			English	Article								The generation of large metabolomic data sets has created a high demand for software that can fit statistical models to one-metabolite-at-a-time on hundreds of metabolites. We provide the %polynova_2way macro in SAS to identify metabolites differentially expressed in study designs with a two-way factorial treatment and hierarchical design structure. For each metabolite, the macro calculates the least squares means using a linear mixed model with fixed and random effects, runs a 2-way ANOVA, corrects the P-values for the number of metabolites using the false discovery rate or Bonferroni procedure, and calculate the P-value for the least squares mean differences for each metabolite. Finally, the %polynova_2way macro outputs a table in excel format that combines all the results to facilitate the identification of significant metabolites for each factor. The macro code is freely available in the Supporting Information.	[Manjarin, Rodrigo] Calif Polytech State Univ San Luis Obispo, Dept Anim Sci, San Luis Obispo, CA 93407 USA; [Maj, Magdalena A.] Calif Polytech State Univ San Luis Obispo, Dept Biol Sci, San Luis Obispo, CA 93407 USA; [Maj, Magdalena A.] Calif Polytech State Univ San Luis Obispo, Ctr Applicat Biotechnol, San Luis Obispo, CA 93407 USA; [La Frano, Michael R.] Calif Polytech State Univ San Luis Obispo, Dept Food Sci & Nutr, San Luis Obispo, CA 93407 USA; [La Frano, Michael R.] Calif Polytech State Univ San Luis Obispo, Ctr Hlth Res, San Luis Obispo, CA 93407 USA; [Glanz, Hunter] Calif Polytech State Univ San Luis Obispo, Dept Stat, San Luis Obispo, CA 93407 USA	California State University System; California Polytechnic State University San Luis Obispo; California State University System; California Polytechnic State University San Luis Obispo; California State University System; California Polytechnic State University San Luis Obispo; California State University System; California Polytechnic State University San Luis Obispo; California State University System; California Polytechnic State University San Luis Obispo; California State University System; California Polytechnic State University San Luis Obispo	Glanz, H (corresponding author), Calif Polytech State Univ San Luis Obispo, Dept Stat, San Luis Obispo, CA 93407 USA.	hglanz@calpoly.edu		Glanz, Hunter/0000-0001-6726-8261	California State University Agricultural Research Institute; ARI [58913, 58873]	California State University Agricultural Research Institute; ARI	R.M. ARI#58873, California State University Agricultural Research Institute https://www2.calstate.edu/impact-of-the-csu/research/ari M.M. ARI#58913 California State University Agricultural Research Institute https://www2.calstate.edu/impact-of-the-csu/research/ari The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, AM J PHYSIOL-CELL PH, V318, pC137; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Broadhurst D, 2018, METABOLOMICS, V14, DOI 10.1007/s11306-018-1367-3; Milliken GA, 2009, ANAL MESSY DATA, V1, P43; Pang ZQ, 2020, METABOLITES, V10, DOI 10.3390/metabo10050186; Piepho HP, 2009, AGRON J, V101, P865, DOI 10.2134/agronj2008.0226x; SAS Institute Inc, 2015, SAS STAT 14 1 USERS; Schrimpe-Rutledge AC, 2016, J AM SOC MASS SPECTR, V27, P1897, DOI 10.1007/s13361-016-1469-y; Wanichthanarak K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171046	10	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0244013	10.1371/journal.pone.0244013	http://dx.doi.org/10.1371/journal.pone.0244013			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320899	Green Published, gold			2022-12-27	WOS:000600339800053
J	Nowak-Kornicka, J; Borkowska, B; Pawlowski, B				Nowak-Kornicka, Judyta; Borkowska, Barbara; Pawlowski, Boguslaw			Masculinity and immune system efficacy in men	PLOS ONE			English	Article							DIGIT RATIO 2D4D; MUSCLE STRENGTH; HANDGRIP STRENGTH; SEXUAL-DIMORPHISM; PRENATAL TESTOSTERONE; REPRODUCTIVE SUCCESS; ANDROGEN TREATMENT; GRIP STRENGTH; T-CELL; BODY	Masculinity-related morphological traits are supposed to be honest indicators of a man's biological quality. While some studies showed that sexually dimorphic traits are related to various aspects of biological condition such as general health, immunity or fertility, still little is known about the relationship between masculine traits and the effectiveness of innate and adaptive immunity in humans. The aim of this study was to see if masculine traits, which are dependent on androgen levels in foetal and pubertal stages of development, are related to the immune quality in healthy men. The immune quality was evaluated for 91 healthy men aged 19-36 years. Immunity measurements included innate and adaptive parameters. General health status, age, testosterone level, BMI, physical activity, and smoking were controlled. The shoulder-to-hip ratio (SHR), 2D:4D digit ratio and hand-grip strength (HGS) were used as markers of masculinization. The regressions showed that when controlling for confounds, masculinity-related traits were in general not related to innate and adaptive immunity. Only a weak association was observed for right 2D:4D ratio and T-lymphocyte counts (but it becomes non-significant after adjustment for multiple comparisons). Our results do not support the premise that masculinity is a cue for immunological quality in men. However, the positive association between right 2D:4D and T lymphocytes might suggest that further studies are needed to verify if androgen stimulation in prenatal development might be related to immunity in adulthood.	[Nowak-Kornicka, Judyta; Borkowska, Barbara; Pawlowski, Boguslaw] Univ Wroclaw, Dept Human Biol, Wroclaw, Poland	University of Wroclaw	Pawlowski, B (corresponding author), Univ Wroclaw, Dept Human Biol, Wroclaw, Poland.	boguslaw.pawlowski@uwr.edu.pl		Nowak-Kornicka, Judyta/0000-0002-3468-8128; Pawlowski, Boguslaw/0000-0002-7418-475X	BP National Science Centre, Poland [OPUS 4 2012/07/B/NZ8/02666]	BP National Science Centre, Poland	BP National Science Centre, Poland. Grant number: OPUS 4 2012/07/B/NZ8/02666. https://ncn.gov.pl/?language=en The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Alvarez C., 2006, P ROYAL SOC B, V274, P819; Anderson M., 1994, SEXUAL SELECTION, DOI 10.1515/9780691207278; [Anonymous], 2013, TREAT GUIDEL MED LET, V11, pe1; [Anonymous], 2017, ECONOMICS-KIEL, V6, P1, DOI 10.1057/s11369-017-0051-3; Apicella CL, 2014, EVOL HUM BEHAV, V35, P508, DOI 10.1016/j.evolhumbehav.2014.07.001; Arnocky S, 2018, EVOL HUM BEHAV, V39, P602, DOI 10.1016/j.evolhumbehav.2018.06.003; Bhongade MB, 2015, ANDROLOGIA, V47, P336, DOI 10.1111/and.12268; Chiu HT, 2020, AGING MALE, V23, P915, DOI 10.1080/13685538.2019.1632282; Darwin C., 1871, P475; Demirci BG, 2018, EXP CLIN TRANSPLANT, V16, P75, DOI 10.6002/ect.TOND-TDTD2017.O31; Fink B, 2005, P ROY SOC B-BIOL SCI, V272, P1995, DOI 10.1098/rspb.2005.3179; Fink B, 2007, AM J HUM BIOL, V19, P82, DOI 10.1002/ajhb.20583; Fink B, 2006, AM J HUM BIOL, V18, P776, DOI 10.1002/ajhb.20549; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Foo YZ, 2017, BIOL REV, V92, P551, DOI 10.1111/brv.12243; Furman D, 2014, P NATL ACAD SCI USA, V111, P869, DOI 10.1073/pnas.1321060111; Gallup AC, 2007, EVOL HUM BEHAV, V28, P423, DOI 10.1016/j.evolhumbehav.2007.07.001; Garvin JC, 2008, BEHAV ECOL, V19, P54, DOI 10.1093/beheco/arm099; Gettler LT, 2011, P NATL ACAD SCI USA, V108, P16194, DOI 10.1073/pnas.1105403108; Gettler LT, 2010, AM J PHYS ANTHROPOL, V142, P590, DOI 10.1002/ajpa.21282; Hackney AC, 1998, J SPORT MED PHYS FIT, V38, P138; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; Hansen L, 1999, J APPL PHYSIOL, V87, P1141, DOI 10.1152/jappl.1999.87.3.1141; Hiort O, 2002, BEST PRACT RES CL EN, V16, P31, DOI 10.1053/beem.2002.0178; Hodges-Simeon CR, 2019, AM J HUM BIOL, V31, DOI 10.1002/ajhb.23284; Hogrel JY, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0612-4; Hone LSE, 2012, EVOL HUM BEHAV, V33, P780, DOI 10.1016/j.evolhumbehav.2012.07.003; Honekopp J, 2010, AM J HUM BIOL, V22, P619, DOI 10.1002/ajhb.21054; Hughes SM, 2003, EVOL HUM BEHAV, V24, P173, DOI 10.1016/S1090-5138(02)00149-6; Kilgour AHM, 2013, IMMUN AGEING, V10, DOI 10.1186/1742-4933-10-33; Kissick HT, 2014, P NATL ACAD SCI USA, V111, P9887, DOI 10.1073/pnas.1402468111; KONSTADOULAKIS MM, 1995, HORM METAB RES, V27, P275, DOI 10.1055/s-2007-979958; Lamason R, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-2; Lassek WD, 2009, EVOL HUM BEHAV, V30, P322, DOI 10.1016/j.evolhumbehav.2009.04.002; LEHMANN D, 1988, CLIN IMMUNOL IMMUNOP, V46, P122, DOI 10.1016/0090-1229(88)90012-8; Mann DR, 1999, AM J REPROD IMMUNOL, V42, P175; Manning JT, 2000, EVOL HUM BEHAV, V21, P163, DOI 10.1016/S1090-5138(00)00029-5; Manning JT, 1998, HUM REPROD, V13, P3000, DOI 10.1093/humrep/13.11.3000; Markle JG, 2014, TRENDS IMMUNOL, V35, P97, DOI 10.1016/j.it.2013.10.006; Martin JT, 2000, EUR J PHARMACOL, V405, P251, DOI 10.1016/S0014-2999(00)00557-4; McMurray RW, 2001, PATHOBIOLOGY, V69, P44, DOI 10.1159/000048757; Mougeot F, 2004, J AVIAN BIOL, V35, P425, DOI 10.1111/j.0908-8857.2004.03256.x; Muehlenbein MP, 2005, AM J HUM BIOL, V17, P527, DOI 10.1002/ajhb.20419; Muller MN, 2009, P ROY SOC B-BIOL SCI, V276, P347, DOI 10.1098/rspb.2008.1028; Neave N, 2003, P ROY SOC B-BIOL SCI, V270, P2167, DOI 10.1098/rspb.2003.2502; Nowak J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25694-0; Oken O, 2008, RHEUMATOL INT, V29, P163, DOI 10.1007/s00296-008-0661-1; Ottenbacher KJ, 2006, J AM GERIATR SOC, V54, P1666, DOI 10.1111/j.1532-5415.2006.00938.x; Page ST, 2005, J CLIN ENDOCR METAB, V90, P1502, DOI 10.1210/jc.2004-1933; Pawlowski B, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.1372; Phalane KG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08015-9; Puts DA, 2010, EVOL HUM BEHAV, V31, P157, DOI 10.1016/j.evolhumbehav.2010.02.005; Rantala MJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1696; Raso V, 2013, CLINICS, V68, P359, DOI 10.6061/clinics/2013(03)OA12; Ribeiro E, 2016, EARLY HUM DEV, V100, P21, DOI 10.1016/j.earlhumdev.2016.04.003; Richards G, 2019, J DEV ORIG HLTH DIS, V10, P362, DOI 10.1017/S2040174418000752; Richards G, 2017, EARLY HUM DEV, V113, P75, DOI 10.1016/j.earlhumdev.2017.09.004; Ripple MO, 1997, JNCI-J NATL CANCER I, V89, P40, DOI 10.1093/jnci/89.1.40; Roberts ML, 2004, ANIM BEHAV, V68, P227, DOI 10.1016/j.anbehav.2004.05.001; Ronay R, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00030; Saino N, 2003, J EVOLUTION BIOL, V16, P1127, DOI 10.1046/j.1420-9101.2003.00616.x; Schaap LA, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.10.049; Scott IML, 2013, BEHAV ECOL, V24, P579, DOI 10.1093/beheco/ars092; Sell A, 2009, P R SOC B, V276, P575, DOI 10.1098/rspb.2008.1177; Sim K., 2013, J SOC EVOL CULT PSYC, V7, P97, DOI [10.1037/h0099207, DOI 10.1037/H0099207]; TANNER JM, 1981, NUTR REV, V39, P43, DOI 10.1111/j.1753-4887.1981.tb06734.x; The Abu Dhabi Declaration, 2010, J NATL COMPR CANC S3, V8, pS1; Thornhill R, 2006, EVOL HUM BEHAV, V27, P131, DOI 10.1016/j.evolhumbehav.2005.06.001; Trumble BC, 2016, AM J PHYS ANTHROPOL, V161, P494, DOI 10.1002/ajpa.23054; Ventura T, 2013, EARLY HUM DEV, V89, P107, DOI 10.1016/j.earlhumdev.2012.08.009; Wang C, 2000, J CLIN ENDOCR METAB, V85, P2839, DOI 10.1210/jc.85.8.2839; Wind AE, 2010, EUR J PEDIATR, V169, P281, DOI 10.1007/s00431-009-1010-4; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3; Zuk M, 1998, P ROY SOC B-BIOL SCI, V265, P1631, DOI 10.1098/rspb.1998.0481	74	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243777	10.1371/journal.pone.0243777	http://dx.doi.org/10.1371/journal.pone.0243777			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315964	gold, Green Published			2022-12-27	WOS:000600186100024
J	Iqbal, J; Al-Awadhi, M; Ahmad, S				Iqbal, Jamshaid; Al-Awadhi, Mohammad; Ahmad, Suhail			Decreasing trend of imported malaria cases but increasing influx of mixed P. falciparum and P. vivax infections in malaria-free Kuwait	PLOS ONE			English	Article							REGION; INDIA	Malaria still continues to be the most important parasitic disease worldwide, affecting 228 million people and causing 405,000 deaths each year. In this retrospective study during 2013 to 2018, we documented the incidence of imported malaria infection and evaluated the impact of malaria preventive measures in Kuwait, a non-endemic country. The epidemiologic and demographic data of all malaria cases was collected from the Infectious Diseases Hospital, Kuwait where all suspected cases of malaria are referred for confirmation and therapeutic intervention. The diagnosis of malaria infection was done by microscopy of Giemsa stained blood films. Selected samples were retested with BinaxNOW(R) Malaria rapid test and molecular assay to reconfirm the Plasmodium spp. or mixed infection. Overall, 1913 (25.9%) malaria cases were detected, 81.5% of which were among male subjects. Male subjects had higher incidence of P. vivax malaria (113; 91.1%) and mixed infection with P. falciparum and P. vivax (1245; 90.0%) compared to females who had higher rate of P. falciparum infection (52.4%). An overwhelming majority of malaria cases (1895; 99.1%) were detected among expatriates from malaria-endemic countries; India (1012; 52.9%), Pakistan (390; 20.4%), Afghanistan (94; 4.9%) and African countries (313; 16.3%). Only 18 cases involved Kuwaiti nationals, all with a history of travel to African countries. The majority of malaria cases were detected during the summer and fall months (May-October). Our data showed that the incidence rate of imported malaria cases was stable during 2013 to 2018, however, the incidence of total malaria cases showed a declining trend over the years. This study confirms that the preventive program has been successful in reducing the incidence of imported malaria infections in Kuwait. The most striking finding of this study was high incidence of mixed infection with P. falciparum and P. vivax, with almost all (97%) cases among workers from India.	[Iqbal, Jamshaid; Al-Awadhi, Mohammad; Ahmad, Suhail] Kuwait Univ, Fac Med, Dept Microbiol, Kuwait, Kuwait	Kuwait University	Iqbal, J (corresponding author), Kuwait Univ, Fac Med, Dept Microbiol, Kuwait, Kuwait.	jamshaid.rafique@ku.edu.kw	Ahmad, Suhail/AAJ-5456-2021		Research Sector and College of Graduate Studies, Kuwait University, Kuwait [YM 06/14]	Research Sector and College of Graduate Studies, Kuwait University, Kuwait	The financial support for this study was provided by the Research Sector and College of Graduate Studies, Kuwait University, Kuwait under the Research Project YM 06/14. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya A, 2018, PATHOG GLOB HEALTH, V112, P57, DOI 10.1080/20477724.2017.1399234; Ahmad S, 2018, EXPERT REV ANTI-INFE, V16, P709, DOI 10.1080/14787210.2018.1519393; Al-Awadhi M, 2020, MED PRIN PRACT, V29, P347, DOI 10.1159/000504625; Al-Kuwari MG, 2009, J TRAVEL MED, V16, P119, DOI 10.1111/j.1708-8305.2008.00285.x; Al-Rumhi A, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05111-6; Alshahrani A M, 2019, Malar Control Elimin, V5, P144, DOI 10.4172/2470-6965/1000144; Alshahrani AM, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1581-2; Ashley EA, 2019, J INFECT DIS, V220, P100, DOI 10.1093/infdis/jiz052; Bashawri LA, 2001, SAUDI MED J, V22, P133; Bin Dajem SM, 2015, SAUDI MED J, V36, P248, DOI 10.15537/smj.2015.2.10874; Coleman M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105980; Dayanand KK, 2019, AM J TROP MED HYG, V100, P275, DOI 10.4269/ajtmh.18-0005; El Hassan IM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0858-1; Farag E, 2018, MEDITERR J HEMATOL I, V10, DOI 10.4084/MJHID.2018.050; Guerin PJ, 2019, J VECTOR DIS, V56, P41, DOI 10.4103/0972-9062.257773; Guerra CA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10339-1; Gupta B, 2010, TROP MED INT HEALTH, V15, P819, DOI 10.1111/j.1365-3156.2010.02549.x; Haanshuus CG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158816; Soliman RH, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2438-7; Hawash Y, 2019, KOREAN J PARASITOL, V57, P233, DOI 10.3347/kjp.2019.57.3.233; Iqbal J, 2003, J TRAVEL MED, V10, P324, DOI 10.2310/7060.2003.9291; Ismaeel AY, 2004, J TRAVEL MED, V11, P97, DOI 10.2310/7060.2004.17059; Lee RA, 2020, P NATL ACAD SCI USA, V117, P25722, DOI 10.1073/pnas.2010196117; Loutan L, 2003, INT J ANTIMICROB AG, V21, P158, DOI 10.1016/S0924-8579(02)00367-9; Ramirez AM, 2020, MALARIA J, V19, DOI 10.1186/s12936-020-03326-1; Mischlinger J, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00104-19; Murray CJL, 2014, LANCET, V384, P1005, DOI 10.1016/S0140-6736(14)60844-8; National Vector Borne Disease Control Program/Ministry of Health and Family Welfare Government of India, 2020, MAL REP 2020; Nilles EJ, 2014, J TRAVEL MED, V21, P201, DOI 10.1111/jtm.12110; Norman FF, 2020, FUTURE MICROBIOL, V15, P213, DOI 10.2217/fmb-2019-0212; Ota-Sullivan K, 2013, J CLIN MICROBIOL, V51, P1567, DOI 10.1128/JCM.00293-13; Punnath K, 2020, PARASITOL RES, V119, P1043, DOI 10.1007/s00436-019-06540-2; Simon B, 2017, PARASITE, V24, DOI 10.1051/parasite/2017028; Siwal N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193046; Snow RW, 2013, ADV PARASIT, V82, P205, DOI 10.1016/B978-0-12-407706-5.00003-4; Swan H, 2005, AM J TROP MED HYG, V73, P850, DOI 10.4269/ajtmh.2005.73.850; The Public Authority for Civil Information, 2019, 2019 STAT REP; World Health Organization, 2003, WORLD MALARIA REPORT	38	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243617	10.1371/journal.pone.0243617	http://dx.doi.org/10.1371/journal.pone.0243617			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306727	gold, Green Published			2022-12-27	WOS:000600144200011
J	Lima, SIVC; Martins, RR; Saldanha, V; Silbiger, VN; dos Santos, ICC; de Araujo, IB; Oliveira, AG				Vieira Cunha Lima, Sara Iasmin; Martins, Rand Randall; Saldanha, Valdjane; Silbiger, Vivian Nogueira; Clemente dos Santos, Isabelle Cristina; de Araujo, Ivonete Batista; Oliveira, Antonio Gouveia			Development and validation of a clinical instrument to predict risk of an adverse drug reactions in hospitalized patients	PLOS ONE			English	Article							OLDER PATIENTS; EVENTS; PREVALENCE; REDUCE	Objective Development and internal validation of a clinical tool for assessment of the risk of adverse drug reactions (ADR) in hospitalized patients. Methodology Nested case-control study in an open cohort of all patients admitted to a general hospital. Cases of ADR were matched to two controls. Eighty four patient variables collected at the time of the ADR were analyzed by conditional logistic regression. Multivariate logistic regression with clustering of cases in a random sample of 2/3 of the cases and respective controls, with baseline odds-ratio corrected with an estimate of ADR incidence, was used to obtain regression coefficients for each risk factor and to develop a risk score. The clinical tool was validated in the remaining 1/3 observations. The study was approved by the institution's research ethics committee. Results In the 8060 hospitalized patients, ADR occurred in 343 (5.31%), who were matched to 686 controls. Fourteen variables were identified as independent risk factors of ADR: female, past history of ADR, heart rate >= 72 bpm, systolic blood pressure >= 148 mmHg, diastolic blood pressure <79 mmHg, diabetes mellitus, serum urea >= 67 mg/dL, serum sodium >= 141 mmol/L, serum potassium >= 4.9 mmol/L, main diagnosis of neoplasia, prescription of >= 3 ATC class B drugs, prescription of ATC class R drugs, prescription of intravenous drugs and >= 6 oral drugs. In the validation sample, the ADR risk tool based on those variables showed sensitivity 61%, specificity 73% and area under the ROC curve 0.73. Conclusion We report a clinical tool for ADR risk stratification in patients hospitalized in general wards based on 14 variables.	[Vieira Cunha Lima, Sara Iasmin; Saldanha, Valdjane; Clemente dos Santos, Isabelle Cristina; Oliveira, Antonio Gouveia] Univ Fed Rio Grande do Norte, Hlth Sci Ctr, Grad Program Pharmaceut Sci, Natal, RN, Brazil; [Martins, Rand Randall; de Araujo, Ivonete Batista; Oliveira, Antonio Gouveia] Univ Fed Rio Grande do Norte, Hlth Sci Ctr, Pharm Dept, Natal, RN, Brazil; [Silbiger, Vivian Nogueira] Univ Fed Rio Grande do Norte, Hlth Sci Ctr, Dept Clin & Toxicol Anal, Natal, RN, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte	Lima, SIVC (corresponding author), Univ Fed Rio Grande do Norte, Hlth Sci Ctr, Grad Program Pharmaceut Sci, Natal, RN, Brazil.	sivclima@gmail.com	Silbiger, Vivian/AAO-1027-2021; Silbiger, Vivian/E-9400-2010; Martins, Rand Randall/X-8188-2019	Martins, Rand Randall/0000-0001-9668-0482; Nogueira Silbiger, Vivian/0000-0002-9252-0278; Lima, Sara/0000-0002-4127-7909	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) - Finance Code 001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Hamid A, 2014, BRIT J CLIN PHARMACO, V78, P202, DOI 10.1111/bcp.12293; Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; Bates DW, 1999, ARCH INTERN MED, V159, P2553, DOI 10.1001/archinte.159.21.2553; Brier G.W., 1950, MON WEATHER REV, V78, P1, DOI [10.1175/1520-0493(1950)0782.0.CO,2, DOI 10.1175/1520-0493(1950)078<0001:VOFEIT>2.0.CO;2, 10.1175/1520-0493(1950)0782.0.CO;2]; Centre for Drug Statistics Methodology (NO), 2019, AN THER CHEM COD; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Claydon-Platt K, 2012, DIABETES RES CLIN PR, V97, P223, DOI 10.1016/j.diabres.2012.03.003; Donsa K, 2016, INT J MED INFORM, V90, P58, DOI 10.1016/j.ijmedinf.2016.03.007; DUPONT WD, 1988, BIOMETRICS, V44, P1157, DOI 10.2307/2531743; Evans RS, 2005, ANN PHARMACOTHER, V39, P1161, DOI 10.1345/aph.1E642; Gallagher RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028096; Griffin F, 2009, IHI INNOVATION SERIE, Vsecond; Haile DB, 2013, ETHIOP J HEALTH SCI, V23, P39; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Klopotowska JE, 2013, EUR J CLIN PHARMACOL, V69, P75, DOI 10.1007/s00228-012-1316-4; Lexicomp Online, 2019, LEX ONL DRUG INT; McElnay JC, 1997, CLIN DRUG INVEST, V13, P47, DOI 10.2165/00044011-199713010-00006; Miguel A, 2012, PHARMACOEPIDEM DR S, V21, P1139, DOI 10.1002/pds.3309; Moons KGM, 2012, HEART, V98, P683, DOI 10.1136/heartjnl-2011-301246; Nair NP, 2016, CLIN INTERV AGING, V11, P497, DOI 10.2147/CIA.S99097; O'Connor MN, 2012, AGE AGEING, V41, P771, DOI 10.1093/ageing/afs046; Onder G, 2013, AGE AGEING, V42, P284, DOI 10.1093/ageing/aft038; Onder G, 2010, ARCH INTERN MED, V170, P1142, DOI 10.1001/archinternmed.2010.153; Pedros C, 2014, EUR J CLIN PHARMACOL, V70, P361, DOI 10.1007/s00228-013-1630-5; Reach G, 2013, DIABETES METAB, V39, P50, DOI 10.1016/j.diabet.2012.08.009; Suggett Emma, 2016, Drugs Real World Outcomes, V3, P241; Tandon VR, 2015, INDIAN J PHARMACOL, V47, P65, DOI 10.4103/0253-7613.150344; Tangiisuran B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111254; Trivalle C, 2010, J NUTR HEALTH AGING, V14, P57, DOI 10.1007/s12603-010-0010-4; Wong B, 2017, AM J MED, V130, P366, DOI 10.1016/j.amjmed.2016.09.034; World Health Organization (WHO), 1975, REQ ADV REACT; YOUDEN W. J., 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; 2014, REG ANESTH PAIN MED, V9	34	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243714	10.1371/journal.pone.0243714	http://dx.doi.org/10.1371/journal.pone.0243714			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306728	gold, Green Published			2022-12-27	WOS:000600144200027
J	Fraeulin, L; Holzgreve, F; Brinkbaumer, M; Dziuba, A; Friebe, D; Klemz, S; Schmitt, M; Theis, AAL; Tenberg, S; van Mark, A; Maurer-Grubinger, C; Ohlendorf, D				Fraeulin, Laura; Holzgreve, Fabian; Brinkbaeumer, Mark; Dziuba, Anna; Friebe, David; Klemz, Stefanie; Schmitt, Marco; Theis, Anna-Lena A.; Tenberg, Sarah; van Mark, Anke; Maurer-Grubinger, Christian; Ohlendorf, Daniela			Intra- and inter-rater reliability of joint range of motion tests using tape measure, digital inclinometer and inertial motion capturing	PLOS ONE			English	Article							LUMBAR SPINE; CLINICAL MEASUREMENT; CONCURRENT VALIDITY; SHOULDER; HIP; MOBILITY; REPRODUCIBILITY; FLEXIBILITY; SYSTEM; RESPONSIVENESS	Background In clinical practice range of motion (RoM) is usually assessed with low-cost devices such as a tape measure (TM) or a digital inclinometer (DI). However, the intra- and inter-rater reliability of typical RoM tests differ, which impairs the evaluation of therapy progress. More objective and reliable kinematic data can be obtained with the inertial motion capture system (IMC) by Xsens. The aim of this study was to obtain the intra- and inter-rater reliability of the TM, DI and IMC methods in five RoM tests: modified Thomas test (DI), shoulder test modified after Janda (DI), retroflexion of the trunk modified after Janda (DI), lateral inclination (TM) and fingertip-to-floor test (TM). Methods Two raters executed the RoM tests (TM or DI) in a randomized order on 22 healthy individuals while, simultaneously, the IMC data (Xsens MVN) was collected. After 15 warm-up repetitions, each rater recorded five measurements. Findings Intra-rater reliabilities were (almost) perfect for tests in all three devices (ICCs 0.886-0.996). Inter-rater reliability was substantial to (almost) perfect in the DI (ICCs 0.71-0.87) and the IMC methods (ICCs 0.61-0.993) and (almost) perfect in the TM methods (ICCs 0.923-0.961). The measurement error (ME) for the tests measured in degree (degrees) was 0.9-3.3 degrees for the DI methods and 0.5-1.2 degrees for the IMC approaches. In the tests measured in centimeters the ME was 0.5-1.3cm for the TM methods and 0.6-2.7cm for the IMC methods. Pearson correlations between the results of the DI or the TM respectively with the IMC results were significant in all tests except for the shoulder test on the right body side (r = 0.41-0.81). Interpretation Measurement repetitions of either one or multiple trained raters can be considered reliable in all three devices.	[Fraeulin, Laura; Holzgreve, Fabian; van Mark, Anke; Maurer-Grubinger, Christian; Ohlendorf, Daniela] Goethe Univ Frankfurt, Inst Occupat Med Social Med & Environm Med, Frankfurt, Germany; [Brinkbaeumer, Mark; Dziuba, Anna; Friebe, David; Klemz, Stefanie; Schmitt, Marco; Theis, Anna-Lena A.; Tenberg, Sarah] Goethe Univ Frankfurt, Inst Sports Sci, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt	Fraeulin, L (corresponding author), Goethe Univ Frankfurt, Inst Occupat Med Social Med & Environm Med, Frankfurt, Germany.	fraeulin@med.uni-frankfurt.de	Maurer, Christian/AAS-9688-2020; Holzgreve, Fabian/ABA-7388-2020	Maurer, Christian/0000-0002-8426-813X; Holzgreve, Fabian/0000-0002-1115-131X; Maltry, Laura/0000-0001-5214-5963; Dziuba, Anna/0000-0002-8151-4622				Al-Amri M, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18030719; ALARANTA H, 1994, SCAND J REHABIL MED, V26, P147; [Anonymous], 2020, STRATEG COMMENTS, V26, pX, DOI 10.1080/13567888.2020.1762348; [Anonymous], 2000, NAT BIOTECHNOL, V18, pIT18; Bierma-Zeinstra SMA, 1998, CLIN REHABIL, V12, P497, DOI 10.1191/026921598677459668; Bland JM, 1996, BRIT MED J, V313, P41, DOI 10.1136/bmj.313.7048.41; Bland JM, 1996, BRIT MED J, V313, P744; BOONE DC, 1978, PHYS THER, V58, P1355, DOI 10.1093/ptj/58.11.1355; Boyce David, 2008, Physiotherapy Theory and Practice, V24, P113, DOI 10.1080/09593980701378298; BURDETT RG, 1986, PHYS THER, V66, P677, DOI 10.1093/ptj/66.5.677; Chen SPC, 1997, J OCCUP ENVIRON MED, V39, P217, DOI 10.1097/00043764-199703000-00011; Clapis Phyllis A., 2008, Physiotherapy Theory and Practice, V24, P135, DOI 10.1080/09593980701378256; Clarkson HM, 2005, JOINT MOTION FUNCTIO; Cloete T, 2010, IEEE ENG MED BIO, P5125, DOI 10.1109/IEMBS.2010.5626196; de Winter AF, 2004, BMC MUSCULOSKEL DIS, V5, DOI 10.1186/1471-2474-5-18; Dogan M, 2019, GAIT POSTURE, V70, P141, DOI 10.1016/j.gaitpost.2019.02.024; Ekedahl H, 2012, ARCH PHYS MED REHAB, V93, P2210, DOI 10.1016/j.apmr.2012.04.020; Evans J, 1996, STRAIGHT FORWARD STA, V1st; FITZGERALD GK, 1983, PHYS THER, V63, P1776, DOI 10.1093/ptj/63.11.1776; FROST M, 1982, PHYS THER, V62, P1431, DOI 10.1093/ptj/62.10.1431; GAUVIN MG, 1990, PHYS THER, V70, P443, DOI 10.1093/ptj/70.7.443; GILL K, 1988, SPINE, V13, P50, DOI 10.1097/00007632-198801000-00012; Grabe M., 2014, MEASUREMENT UNCERTAI, DOI 10.1007/978-3-319-04888-8; Green S, 1998, ARTHRIT CARE RES, V11, P43, DOI 10.1002/art.1790110108; Hatano G, 2019, J SPORT REHABIL, V28, P325, DOI 10.1123/jsr.2017-0203; Heikkila S, 2000, J RHEUMATOL, V27, P1251; Holzgreve F, 2018, J OCCUP MED TOXICOL, V13, DOI 10.1186/s12995-018-0220-y; Hoving JL, 2002, ANN RHEUM DIS, V61, P612, DOI 10.1136/ard.61.7.612; HYYTIAINEN K, 1991, SCAND J REHABIL MED, V23, P3; Inokuchi H, 2015, EUR SPINE J, V24, P2807, DOI 10.1007/s00586-015-3913-2; JONSSON E, 1990, UPSALA J MED SCI, V95, P75, DOI 10.3109/03009739009178578; Karatsidis A, 2019, MED ENG PHYS, V65, P68, DOI 10.1016/j.medengphy.2018.12.021; Keogh JWL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215806; KIPPERS V, 1987, PHYS THER, V67, P1680, DOI 10.1093/ptj/67.11.1680; Kolber Morey J., 2009, Physiotherapy Theory and Practice, V25, P572, DOI 10.3109/09593980802667995; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Mavor MP, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20154280; MELLIN G, 1991, SPINE, V16, P1108, DOI 10.1097/00007632-199109000-00016; MERRITT JL, 1986, MAYO CLIN PROC, V61, P192, DOI 10.1016/S0025-6196(12)61848-5; Mundt M, 2019, J BIOMECH, V84, P81, DOI 10.1016/j.jbiomech.2018.12.023; Ng JKF, 2001, SPINE, V26, P53, DOI 10.1097/00007632-200101010-00011; Nguyen, 1999, HDB TIME SERIES ANAL; Nuesch C, 2017, J BIOMECH, V57, P32, DOI 10.1016/j.jbiomech.2017.03.015; Perret C, 2001, ARCH PHYS MED REHAB, V82, P1566, DOI 10.1053/apmr.2001.26064; PETHERICK M, 1988, PHYS THER, V68, P966, DOI 10.1093/ptj/68.6.966; PORTEK I, 1983, BRIT J RHEUMATOL, V22, P197; Rigoni M, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19081781; Roach S, 2013, INT J SPORTS PHYS TH, V8, P680; Roach SM, 2015, INT J SPORTS PHYS TH, V10, P13; Robert-Lachaine X, 2017, MED BIOL ENG COMPUT, V55, P609, DOI 10.1007/s11517-016-1537-2; s NA, 2018, LANCET INFECT DIS, V18, pe228; Saur PMM, 1996, SPINE, V21, P1332, DOI 10.1097/00007632-199606010-00011; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Smolenski U, 2016, JANDA MANUELLE MUSKE; Strand LI, 2011, PHYS THER, V91, P404, DOI 10.2522/ptj.20100016; Uswr PT, 2015, RELIABILITY BUBBLE I; Valentine RE, 2006, ARCH PHYS MED REHAB, V87, P1242, DOI 10.1016/j.apmr.2006.05.008; van der Straaten R, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19010141; Vigotsky AD, 2016, PEERJ, V4, DOI 10.7717/peerj.2325; Zhang JT, 2013, PHYSIOL MEAS, V34, pN63, DOI 10.1088/0967-3334/34/8/N63	60	6	6	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243646	10.1371/journal.pone.0243646	http://dx.doi.org/10.1371/journal.pone.0243646			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301541	Green Published, gold			2022-12-27	WOS:000600143100057
J	Perez-San Martin, S; Suberviola, B; Garcia-Unzueta, MT; Lavin, BA; Campos, S; Santibanez, M				Perez-San Martin, S.; Suberviola, B.; Garcia-Unzueta, M. T.; Lavin, B. A.; Campos, S.; Santibanez, M.			Prognostic value of plasma pentraxin 3 levels in patients with septic shock admitted to intensive care	PLOS ONE			English	Article							EARLY LACTATE CLEARANCE; C-REACTIVE PROTEIN; SEVERE SEPSIS; INNATE IMMUNITY; MORTALITY; PTX3; INFLAMMATION; BIOMARKERS; MANAGEMENT; INFECTION	Objective To evaluate the usefulness of a new marker, pentraxin, as a prognostic marker in septic shock patients. Materials and methods Single-centre prospective observational study that included all consecutive patients 18 years or older who were admitted to the intensive care unit (ICU) with septic shock. Serum levels of procalcitonin (PCT), C-reactive protein (CRP) and pentraxin (PTX3) were measured on ICU admission. Results Seventy-five septic shock patients were included in the study. The best predictors of in-hospital mortality were the severity scores: SAPS II (AUC = 0.81), SOFA (AUC = 0.79) and APACHE II (AUC = 0.73). The ROC curve for PTX3 (ng/mL) yielded an AUC of 0.70, higher than the AUC for PCT (0.43) and CRP (0.48), but lower than lactate (0.79). Adding PTX3 to the logistic model increased the predictive capacity in relation to SAPS II, SOFA and APACHE II for in-hospital mortality (AUC 0.814, 0.795, and 0.741, respectively). In crude regression models, significant associations were found between in-hospital mortality and PTX3. This positive association increased after adjusting for age, sex and immunosuppression: adjusted OR T3 for PTX3 = 7.83, 95% CI 1.35-45.49, linear P trend = 0.024. Conclusion Our results support the prognostic value of a single determination of plasma PTX3 as a predictor of hospital mortality in septic shock patients.	[Perez-San Martin, S.; Garcia-Unzueta, M. T.; Lavin, B. A.] Univ Hosp Marques Valdecilla IDIVAL, Dept Clin Biochem, Santander, Spain; [Suberviola, B.; Campos, S.] Univ Hosp Marques Valdecilla IDIVAL, Intens Care Dept, Santander, Spain; [Santibanez, M.] Univ Cantabria, Sch Nursing, Hlth Res Inst Valdecilla IDIVAL, Santander, Spain	Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria	Suberviola, B (corresponding author), Univ Hosp Marques Valdecilla IDIVAL, Intens Care Dept, Santander, Spain.	borja.suberviola@scsalud.es		Lavin-Gomez, Bernardo Alio/0000-0001-7279-7643				Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; ALLES VV, 1994, BLOOD, V84, P3483; [Anonymous], 2014, OBESITY SILVER SP S2, V22, pS40; Arnold RC, 2009, SHOCK, V32, P35, DOI 10.1097/SHK.0b013e3181971d47; Arora S, 2015, SHOCK, V43, P212, DOI 10.1097/SHK.0000000000000305; Bastrup-Birk S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073119; Becker KL, 2008, CRIT CARE MED, V36, P941, DOI 10.1097/CCM.0B013E318165BABB; Caironi P, 2017, EUR J CLIN INVEST, V47, P73, DOI 10.1111/eci.12704; Casserly B, 2015, CRIT CARE MED, V43, P567, DOI 10.1097/CCM.0000000000000742; Daigo K, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00378; Fleischmann C, 2016, AM J RESP CRIT CARE, V193, P259, DOI 10.1164/rccm.201504-0781OC; Garcia-Alvarez M, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0503-3; Garlanda C, 2005, ANNU REV IMMUNOL, V23, P337, DOI 10.1146/annurev.immunol.23.021704.115756; Global Sepsis Alliance, WHA AD RES SEPS; Haas SA, 2016, INTENS CARE MED, V42, P202, DOI 10.1007/s00134-015-4127-0; Hamed S, 2018, CLIN LAB, V64, P999, DOI 10.7754/Clin.Lab.2018.180116; Hu CG, 2018, ONCOTARGET, V9, P5125, DOI 10.18632/oncotarget.23701; Jaillon S, 2007, J EXP MED, V204, P793, DOI 10.1084/jem.20061301; Jie HY, 2017, AM J MED SCI, V353, P242, DOI 10.1016/j.amjms.2017.01.003; Kibe S, 2011, J ANTIMICROB CHEMOTH, V66, pII33, DOI 10.1093/jac/dkq523; Kim SB, 2017, YONSEI MED J, V58, P370, DOI 10.3349/ymj.2017.58.2.370; LEE GW, 1993, J IMMUNOL, V150, P1804; Lee YT, 2018, J INFECTION, V76, P1, DOI 10.1016/j.jinf.2017.10.016; Levy B, 2005, LANCET, V365, P871, DOI 10.1016/S0140-6736(05)71045-X; Mantovani A, 2008, J CLIN IMMUNOL, V28, P1, DOI 10.1007/s10875-007-9126-7; Mauri T, 2010, INTENS CARE MED, V36, P621, DOI 10.1007/s00134-010-1752-5; Muller B, 2001, CRIT CARE MED, V29, P1404, DOI 10.1097/00003246-200107000-00017; Nassar AP, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.08.016; Nguyen HB, 2004, CRIT CARE MED, V32, P1637, DOI 10.1097/01.CCM.0000132904.35713.A7; Patel PA, 1999, INTENS CARE MED, V25, P977, DOI 10.1007/s001340050992; Pierrakos C, 2010, CRIT CARE, V14, DOI 10.1186/cc8872; Porte R, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00794; Rhodes A, 2017, INTENS CARE MED, V43, P304, DOI 10.1007/s00134-017-4683-6; Rivers EP, 2011, CHEST, V140, P1408, DOI 10.1378/chest.11-2563; Salluh JIF, 2014, CURR OPIN CRIT CARE, V20, P557, DOI 10.1097/MCC.0000000000000135; Samsudin Intan, 2017, Clin Biochem Rev, V38, P59; Schuetz P, 2017, EXPERT REV MOL DIAGN, V17, P593, DOI 10.1080/14737159.2017.1324299; Silvestre J, 2009, INTENS CARE MED, V35, P909, DOI 10.1007/s00134-009-1402-y; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Song J, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000020495; Song J, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4618-7; Uusitalo-Seppala R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053661; van Engelen TSR, 2018, CRIT CARE CLIN, V34, P139, DOI 10.1016/j.ccc.2017.08.010; Yamasaki K, 2009, CLIN CHEM LAB MED, V47, P471, DOI 10.1515/CCLM.2009.110	44	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243849	10.1371/journal.pone.0243849	http://dx.doi.org/10.1371/journal.pone.0243849			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301518	Green Published, gold			2022-12-27	WOS:000600143100090
J	Yuan, XY; Chen, LZ; Deng, JL				Yuan, Xiaoyi; Chen, Longzhu; Deng, Jianliang			Calculation of displacements and internal forces of anchored retaining piles	PLOS ONE			English	Article							FLEXIBILITY NUMBER; WALL; EXCAVATION	Pile-anchor retaining structures are widely used in excavation engineering. The evaluation of lateral displacements, the internal forces of piles are extremely important for the performance of the structure. Most of the existing methods are empirical, semiempirical or FEM methods, while analytic calculation methods for this evaluation are rare. This paper presents an analytic method to calculate the displacements and internal forces of anchored retaining piles based on the existing design code. In the calculation method, the singular function is applied to evaluate the effect of segmented loading on the deflection of a beam with a nonuniform cross section. The load concentration function, expressed by the singular function, can describe the segmented load and be integrated without a complicated procedure for determining the integral constants. The method is applied to a structure in Wenzhou, China, and the calculation results are compared to the field measurement results. This method is only valid for pre-failure predictions.	[Yuan, Xiaoyi; Chen, Longzhu; Deng, Jianliang] Shanghai Jiao Tong Univ, Sch Naval Architechture Ocean & Civil Engn, Shanghai, Peoples R China	Shanghai Jiao Tong University	Yuan, XY (corresponding author), Shanghai Jiao Tong Univ, Sch Naval Architechture Ocean & Civil Engn, Shanghai, Peoples R China.	xiaoyi_9002@sjtu.edu.cn		Yuan, Xiaoyi/0000-0002-5779-5954	National Natural Science Foundation of China [51379122]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research work is financially supported by the National Natural Science Foundation of China with Grant No. 51379122, the URL of which is http://www.nsfc.gov.cn/. The author that received this award is Longzhu Chen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	ADDENBROOKE TI, 1994, GROUND ENG, V27, P41; Addenbrooke TI, 2000, J GEOTECH GEOENVIRON, V126, P718, DOI 10.1061/(ASCE)1090-0241(2000)126:8(718); [Anonymous], 2012, 202012 JGJ; [别社安 Bie Shean], 2003, [土木工程学报, China Civil Engineering Journal], V36, P19; Jin Y, 2009, GLOBAL GEOLOGY, V12, P236; Liang FY, 2014, APPL MATH MODEL, V38, P5198, DOI 10.1016/j.apm.2014.03.052; Likitlersuang S, 2013, SOILS FOUND, V53, P756, DOI 10.1016/j.sandf.2013.08.013; Mazurek, 2012, MECH MATER; Moormann C, 2004, SOILS FOUND, V44, P87, DOI 10.3208/sandf.44.87; Song Y, 2010, ENG SCI, V8, P71; Xu HY, 2013, ROCK SOIL MECH, V34, P2323; Xu S, 2017, CHARACTERISTIC RES P; Zhang WG, 2015, COMPUT GEOTECH, V63, P67, DOI 10.1016/j.compgeo.2014.09.001	13	0	0	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243659	10.1371/journal.pone.0243659	http://dx.doi.org/10.1371/journal.pone.0243659			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301535	gold, Green Published			2022-12-27	WOS:000600143100077
J	Armstrong, G; Sutherland, G; Pross, E; Mackinnon, A; Reavley, N; Jorm, AF				Armstrong, Gregory; Sutherland, Georgina; Pross, Eliza; Mackinnon, Andrew; Reavley, Nicola; Jorm, Anthony F.			Talking about suicide: An uncontrolled trial of the effects of an Aboriginal and Torres Strait Islander mental health first aid program on knowledge, attitudes and intended and actual assisting actions	PLOS ONE			English	Article							AUSTRALIAN NATIONAL-SURVEY; PREVENTION STRATEGIES; BEHAVIOR; BELIEFS; INTERVENTION; INTENTIONS; DISORDERS; SAMPLE	Objective Suicide is a leading cause of death among Aboriginal and Torres Strait Islander people. Friends, family and frontline workers (for example, teachers, youth workers) are often best positioned to provide initial assistance if someone is at risk of suicide. We developed culturally appropriate expert consensus guidelines on how to provide mental health first aid to Australian Aboriginal and Torres Strait Islander people experiencing suicidal thoughts or behaviour and used this as the basis for a 5-hour suicide gatekeeper training course called Talking About Suicide. This paper describes the outcomes for participants in an uncontrolled trial of this training course. Methods We undertook an uncontrolled trial of the Talking About Suicide course, delivered by Aboriginal and Torres Strait Islander Mental Health First Aid instructors to 192 adult (i.e. 18 years of age or older) Aboriginal and Torres Strait Islander (n = 110) and non-Indigenous (n = 82) participants. Questionnaires capturing self-report outcomes were self-administered immediately before (n = 192) and after attending the training course (n = 188), and at four-months follow-up (n = 98). Outcome measures were beliefs about suicide, stigmatising attitudes, confidence in ability to assist, and intended and actual actions to assist a suicidal person. Results Despite a high level of suicide literacy among participants at pre-course measurement, improvements at post-course were observed in beliefs about suicide, stigmatising attitudes, confidence in ability to assist and intended assisting actions. While attrition at follow-up decreased statistical power, some improvements in beliefs about suicide, stigmatising attitudes and intended assisting actions remained statistically significant at follow-up. Importantly, actual assisting actions taken showed dramatic improvements between pre-course and follow-up. Participants reported feeling more confident to assist a suicidal person after the course and this was maintained at follow-up. The course was judged to be culturally appropriate by those participants who identified as Aboriginal and/or Torres Strait Islanders. Implications The results of this uncontrolled trial were encouraging, suggesting that the Talking About Suicide course was able to improve participants' knowledge, attitudes, and intended assisting actions as well as actual actions taken.	[Armstrong, Gregory] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Nossal Inst Global Hlth, Melbourne, Vic, Australia; [Sutherland, Georgina] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Hlth Equ, Melbourne, Vic, Australia; [Pross, Eliza] Mental Hlth First Aid Australia, Parkville, Vic, Australia; [Mackinnon, Andrew; Reavley, Nicola; Jorm, Anthony F.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Mental Hlth, Melbourne, Vic, Australia	University of Melbourne; University of Melbourne; University of Melbourne	Armstrong, G (corresponding author), Univ Melbourne, Melbourne Sch Populat & Global Hlth, Nossal Inst Global Hlth, Melbourne, Vic, Australia.	g.armstrong@unimelb.edu.au	Jorm, Anthony F/B-5555-2009; Armstrong, Gregory/K-1068-2015	Jorm, Anthony F/0000-0002-1424-4116; Armstrong, Gregory/0000-0002-8073-9213	National Health and Medical Research Council [1076796]; National Health and Medical Research Council in Australia [GNT1138096]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council in Australia(National Health and Medical Research Council (NHMRC) of Australia)	The study was funded by a National Health and Medical Research Council grant (#1076796) funded under the grant scheme "Mental Health Targeted Call for Research into Suicide Prevention in Aboriginal and Torres Strait Islander Youth". The lead author is funded by an Early Career Fellowship (GNT1138096) from the National Health and Medical Research Council in Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboriginal and Torres Strait Islander Suicide Prevention Evaluation Project, 2016, SOL WORK WHAT EV OUR; Adams Y, 2014, WORKING TOGETHER ABO, P271; Armstrong G, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1809-5; Armstrong G, 2018, AUST NZ J PUBL HEAL, V42, P412, DOI 10.1111/1753-6405.12795; Armstrong G, 2017, AUST NZ J PSYCHIAT, V51, P1240, DOI 10.1177/0004867417704059; Armstrong G, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1465-1; Barlow A, 2012, AM J DRUG ALCOHOL AB, V38, P403, DOI 10.3109/00952990.2012.696757; Chalmers KJ, 2014, INT J MENT HEALTH SY, V8, DOI 10.1186/1752-4458-8-6; Clifford AC, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-463; Coupe N M, 2000, Pac Health Dialog, V7, P25; Cwik M, 2015, ARCH SUICIDE RES, V19, P172, DOI 10.1080/13811118.2015.1004472; Day A, AUSTR NZ J PUBLIC HL; Elias B, 2012, SOC SCI MED, V74, P1560, DOI 10.1016/j.socscimed.2012.01.026; Elliott-Farrelly T., 2004, AUSTR E J ADV MENTAL, V3, P1; Ferguson CJ, 2019, SUICIDE LIFE-THREAT, V49, P1178, DOI 10.1111/sltb.12517; Gracey M, 2009, LANCET, V374, P65, DOI 10.1016/S0140-6736(09)60914-4; Hadlaczky G, 2014, INT REV PSYCHIATR, V26, P467, DOI 10.3109/09540261.2014.924910; Hart LM, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-47; Hawton K, 2009, LANCET, V373, P1372, DOI 10.1016/S0140-6736(09)60372-X; Hunter Ernest, 2002, Emerg Med (Fremantle), V14, P14, DOI 10.1046/j.1442-2026.2002.00281.x; Isaac M, 2009, CAN J PSYCHIAT, V54, P260, DOI 10.1177/070674370905400407; Jorm AF, 1997, MED J AUSTRALIA, V166, P182, DOI 10.5694/j.1326-5377.1997.tb140071.x; Jorm AF, 2007, EARLY INTERV PSYCHIA, V1, P61, DOI 10.1111/j.1751-7893.2007.00012.x; Jorm AF, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1722-y; Kanowski Len G, 2009, Int J Ment Health Syst, V3, P10, DOI 10.1186/1752-4458-3-10; Kelly CM, 2011, INT J MENT HEALTH SY, V5, DOI 10.1186/1752-4458-5-4; Kelly CM, 2017, TALKING SUICIDE MENT; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; King M, 2009, LANCET, V374, P76, DOI 10.1016/S0140-6736(09)60827-8; Kitchener B.A., 2015, MENTAL HLTH 1 AID IN; Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064; McLoughlin AB, 2015, QJM-INT J MED, V108, P765, DOI 10.1093/qjmed/hcv026; McNamara BJ, 2018, AUST NZ J PUBL HEAL, V42, P145, DOI 10.1111/1753-6405.12766; Morgan AJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197102; [Anonymous], 2014, Manag Care, V23, P49; Ridani R, 2015, SUICIDE LIFE-THREAT, V45, P111, DOI 10.1111/sltb.12121; Rossetto A, 2016, PSYCHIAT RES, V240, P170, DOI 10.1016/j.psychres.2016.04.037; SMITH ML, 1977, AM PSYCHOL, V32, P752, DOI 10.1037/0003-066X.32.9.752; StataCorp, 2015, STAT STAT SOFTW REL; Westerman T., 2004, AUSTR E J ADV MENTAL, V3, P3; Yap MBH, 2012, PSYCHIAT RES, V196, P315, DOI 10.1016/j.psychres.2011.10.004; Zalsman G, 2016, LANCET PSYCHIAT, V3, P646, DOI 10.1016/S2215-0366(16)30030-X; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	43	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0244091	10.1371/journal.pone.0244091	http://dx.doi.org/10.1371/journal.pone.0244091			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PI8BZ	33332464	Green Published, gold			2022-12-27	WOS:000601310900099
J	Zhu, SY; Gao, Q; Yang, L; Yang, YH; Xia, WG; Cai, XG; Hui, YP; Zhu, D; Zhang, YY; Zhang, GQ; Wu, S; Wang, YL; Zhou, ZQ; Liu, HF; Zhang, CJ; Zhang, B; Yang, JR; Feng, M; Ni, Z; Chen, BY; Du, CP; He, HC; Qu, Y; Wei, Q; He, CQ; Reinhardt, JD				Zhu, Siyi; Gao, Qiang; Yang, Lin; Yang, Yonghong; Xia, Wenguang; Cai, Xiguo; Hui, Yanping; Zhu, Di; Zhang, Yanyan; Zhang, Guiqing; Wu, Shuang; Wang, Yiliang; Zhou, Zhiqiang; Liu, Hongfei; Zhang, Changjie; Zhang, Bo; Yang, Jianrong; Feng, Mei; Ni, Zhong; Chen, Baoyu; Du, Chunping; He, Hongchen; Qu, Yun; Wei, Quan; He, Chengqi; Reinhardt, Jan D.			Prevalence and risk factors of disability and anxiety in a retrospective cohort of 432 survivors of Coronavirus Disease-2019 (Covid-19) from China	PLOS ONE			English	Article							PNEUMONIA; STIGMA; STROKE; HEALTH	Objective To estimate the prevalence of disability and anxiety in Covid-19 survivors at discharge from hospital and analyze relative risk by exposures. Design Multi-center retrospective cohort study. Setting Twenty-eight hospitals located in eight provinces of China. Methods A total of 432 survivors with laboratory-confirmed SARS CoV-2 infection participated in this study. At discharge, we assessed instrumental activities of daily living (IADL) with Lawton's IADL scale, dependence in activities of daily living (ADL) with the Barthel Index, and anxiety with Zung's self-reported anxiety scale. Exposures included comorbidity, smoking, setting (Hubei vs. others), disease severity, symptoms, and length of hospital stay. Other risk factors considered were age, gender, and ethnicity (Han vs. Tibetan). Results Prevalence of at least one IADL problem was 36.81% (95% CI: 32.39-41.46). ADL dependence was present in 16.44% (95% CI: 13.23-20.23) and 28.70% (95% CI: 24.63-33.15) were screened positive for clinical anxiety. Adjusted risk ratio (RR) of IADL limitations (RR 2.48, 95% CI: 1.80-3.40), ADL dependence (RR 2.07, 95% CI 1.15-3.76), and probable clinical anxiety (RR 2.53, 95% CI 1.69-3.79) were consistently elevated in survivors with severe Covid-19. Age was an additional independent risk factor for IADL limitations and ADL dependence; and setting (Hubei) for IADL limitations and anxiety. Tibetan ethnicity was a protective factor for anxiety but a risk factor for IADL limitations. Conclusion A significant proportion of Covid-19 survivors had disability and anxiety at discharge from hospital. Health systems need to be prepared for an additional burden resulting from rehabilitation needs of Covid-19 survivors.	[Zhu, Siyi; Gao, Qiang; Yang, Lin; Yang, Yonghong; Chen, Baoyu; Du, Chunping; He, Hongchen; Qu, Yun; Wei, Quan; He, Chengqi] Sichuan Univ, West China Hosp, Rehabil Med Ctr, Chengdu, Peoples R China; [Zhu, Siyi; Gao, Qiang; Yang, Lin; Yang, Yonghong; Du, Chunping; He, Hongchen; Qu, Yun; Wei, Quan; He, Chengqi] Sichuan Univ, Rehabil Med Key Lab Sichuan Prov, Chengdu, Peoples R China; [Xia, Wenguang] Hubei Hosp Integrated Tradit Chinese & Western Me, Wuhan, Hubei, Peoples R China; [Cai, Xiguo] Henan Prov Peoples Hosp, Zhengzhou, Henan, Peoples R China; [Hui, Yanping] Xi An Jiao Tong Univ, Med Coll, Affiliated Hosp 2, Xian, Shanxi, Peoples R China; [Zhu, Di] Zhejiang Prov Peoples Hosp, Hangzhou, Zhejiang, Peoples R China; [Zhang, Yanyan] Shandong Univ, Qilu Hosp, Jinan, Shandong, Peoples R China; [Zhang, Guiqing] Shihezi Univ, Sch Med, Affiliated Hosp 1, Xinjiang, Peoples R China; [Wu, Shuang] Guizhou Med Univ, Affiliated Hosp, Guiyang, Guizhou, Peoples R China; [Wang, Yiliang] Chongqing Three Gorges Cent Hosp, Chongqing, Peoples R China; [Zhou, Zhiqiang] Inner Mongolia Autonomous Reg Baotou Cent Hosp, Baotou, Peoples R China; [Liu, Hongfei] Gen Hosp, Gen Bur Agr Reclamat Heilongjiang Prov, Harbin, Peoples R China; [Zhang, Changjie] Cent South Univ, Xiangya Hosp 2, Changsha, Peoples R China; [Zhang, Bo] Nanchong Cent Hosp, Nanchong, Sichuan, Peoples R China; [Yang, Jianrong] Garze Peoples Hosp, Garze Tibetan Autonomous, Sichuan, Peoples R China; [Feng, Mei; Ni, Zhong] Sichuan Univ, West China Hosp, Dept Crit Care Med, Chengdu, Peoples R China; [He, Chengqi; Reinhardt, Jan D.] Sichuan Univ, Inst Disaster Management & Reconstruct, Chengdu, Peoples R China; [He, Chengqi; Reinhardt, Jan D.] Sichuan Univ, Hong Kong Polytech Univ, Chengdu, Peoples R China; [Reinhardt, Jan D.] Swiss Parapleg Res, Nottwil, Switzerland; [Reinhardt, Jan D.] Univ Lucerne, Dept Hlth Sci & Med, Luzern, Switzerland; [Reinhardt, Jan D.] Xidian Hosp Grp, Xian, Shaanxi, Peoples R China	Sichuan University; Sichuan University; Zhengzhou University; Xi'an Jiaotong University; Zhejiang Provincial People's Hospital; Shandong University; Shihezi University; Guizhou Medical University; Chongqing Three Gorges University; Central South University; North Sichuan Medical University; Sichuan University; Sichuan University; Hong Kong Polytechnic University; Sichuan University; Swiss Paraplegic Research; University of Lucerne	He, CQ (corresponding author), Sichuan Univ, West China Hosp, Rehabil Med Ctr, Chengdu, Peoples R China.; He, CQ (corresponding author), Sichuan Univ, Rehabil Med Key Lab Sichuan Prov, Chengdu, Peoples R China.; He, CQ; Reinhardt, JD (corresponding author), Sichuan Univ, Inst Disaster Management & Reconstruct, Chengdu, Peoples R China.; He, CQ; Reinhardt, JD (corresponding author), Sichuan Univ, Hong Kong Polytech Univ, Chengdu, Peoples R China.; Reinhardt, JD (corresponding author), Swiss Parapleg Res, Nottwil, Switzerland.; Reinhardt, JD (corresponding author), Univ Lucerne, Dept Hlth Sci & Med, Luzern, Switzerland.; Reinhardt, JD (corresponding author), Xidian Hosp Grp, Xian, Shaanxi, Peoples R China.	hxkfhcq@126.com; jan.reinhardt@paraplegie.ch	Zhou, Zhiqiang/HIR-4954-2022	Yang, YongHong/0000-0003-3547-4858	National Natural Science Foundation [81972146, 82002393]; Department of Science and Technology of Sichuan Province [20YYJC3320, 21ZDYF1918/21YYJC2860]; China Postdoctoral Science Foundation [2020M673251]; Health Commission of Sichuan Province [20PJ034]; Xi'an Bureau of Technology [XA2020-HWYZ-0043]; Fundamental Research Funds for the Central Universities, China [20827041D4161]; West China Hospital of Sichuan University [HX-2019-nCoV-011, 2019HXBH058]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Department of Science and Technology of Sichuan Province; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Health Commission of Sichuan Province; Xi'an Bureau of Technology; Fundamental Research Funds for the Central Universities, China(Fundamental Research Funds for the Central Universities); West China Hospital of Sichuan University(Sichuan University)	This study was supported by the National Natural Science Foundation (81972146 to CH; 82002393 to SZ), the Department of Science and Technology of Sichuan Province (20YYJC3320 to CH; 21ZDYF1918/21YYJC2860 to SZ), China Postdoctoral Science Foundation (2020M673251), Health Commission of Sichuan Province (20PJ034), Xi'an Bureau of Technology to JDR (XA2020-HWYZ-0043), the Fundamental Research Funds for the Central Universities, China to JDR (20827041D4161), and West China Hospital of Sichuan University (HX-2019-nCoV-011 to CH; 2019HXBH058 to SZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alger HM, 2020, CIRC-CARDIOVASC QUAL, V13, P264, DOI 10.1161/CIRCOUTCOMES.120.006766; [Anonymous], 2011, THER ADV MED ONCOL, V3, pS7; Armitage R, 2020, LANCET PUBLIC HEALTH, V5, pE257, DOI 10.1016/S2468-2667(20)30076-1; Batawi S, 2019, HEALTH QUAL LIFE OUT, V17, DOI 10.1186/s12955-019-1165-2; Bishop GD, 2005, EFFECTS PSYCHOSOCIAL; Brooks Samantha K, 2020, Lancet, V395, P912, DOI 10.1016/S0140-6736(20)30460-8; Center for Evidence Based Medicine (CEBM), 2020, GLOB COVID 19 CAS FA; Chen LJ, 2020, EMERG MICROBES INFEC, V9, P313, DOI 10.1080/22221751.2020.1725399; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Dunstan DA, 2020, BMC PSYCHIATRY, V20, DOI 10.1186/s12888-019-2427-6; Fraser E, 2020, LONG TERM RESP COMPL; Giummarra MJ, 2018, CLIN PSYCHOL REV, V62, P11, DOI 10.1016/j.cpr.2018.05.001; Gonzalez-Jaramillo N, 2020, EUR J EPIDEMIOL, V35, P335, DOI 10.1007/s10654-020-00628-1; Griffiths J, 2013, CRIT CARE, V17, DOI 10.1186/cc12745; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Guan WJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00597-2020; James SL, 2018, LANCET, V392, P1789, DOI 10.1016/s0140-6736(18)32279-7; Kyu HH, 2018, LANCET, V392, P1859, DOI [10.1016/S0140-6736(18)32335-3, 10.1016/s0140-6736(18)32335-3]; Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976; Lee S, 2005, SOC SCI MED, V61, P2038, DOI 10.1016/j.socscimed.2005.04.010; Li C, 2014, ASIA-PAC PSYCHIAT, V6, P161, DOI 10.1111/appy.12084; Liang W-h, 2020, EUROPEAN RESP J, V55; Mak IWC, 2009, GEN HOSP PSYCHIAT, V31, P318, DOI 10.1016/j.genhosppsych.2009.03.001; Metlay JP, 2019, AM J RESP CRIT CARE, V200, pE45, DOI 10.1164/rccm.201908-1581ST; National Health Commission of the PR China, DIAGN CRIT NOV COR P; Patel  P., 2017, OPEN J INTERNET THIN, V3, P75; Ryrso CK, 2018, BMC PULM MED, V18, DOI 10.1186/s12890-018-0718-1; Siu JYM, 2008, QUAL HEALTH RES, V18, P729, DOI 10.1177/1049732308318372; Solomon MZ, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2008300; Sze KH, 2000, ARCH PHYS MED REHAB, V81, P876, DOI 10.1053/apmr.2000.6279; Tansey CM, 2007, ARCH INTERN MED, V167, P1312, DOI 10.1001/archinte.167.12.1312; Tong AYC, 2002, OTJR-OCCUP PART HEAL, V22, P132, DOI 10.1177/153944920202200402; Tucci V, 2017, J GLOB INFECT DIS, V9, P151, DOI 10.4103/jgid.jgid_66_17; Vogiatzis I, 2016, EUR RESPIR J, V47, P1336, DOI 10.1183/13993003.02151-2015; WADE DT, 1987, J NEUROL NEUROSUR PS, V50, P177, DOI 10.1136/jnnp.50.2.177; WHO, 2020, DIS CONS COVID 19 OU; World Health Organization, 2001, INT CLASS FUNCT DIS; Wunderink RG, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j2471; Zhang L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223185; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090; ZUNG WWK, 1971, PSYCHOSOMATICS, V12, P371	43	19	19	5	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243883	10.1371/journal.pone.0243883	http://dx.doi.org/10.1371/journal.pone.0243883			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PI8BZ	33332386	Green Published, gold, Green Submitted			2022-12-27	WOS:000601310900037
J	Donders, HCM; IJzerman, LM; Soffner, M; van't Hof, AWJ; Loos, BG; de Lange, J				Donders, H. C. M.; IJzerman, L. M.; Soffner, M.; van't Hof, A. W. J.; Loos, B. G.; de Lange, J.			Elevated Coronary Artery Calcium scores are associated with tooth loss	PLOS ONE			English	Article							APICAL PERIODONTITIS; RISK MARKERS; ATHEROSCLEROSIS; DISEASE; CALCIFICATION; EPIDEMIOLOGY; EVENTS; ZERO	Aim This study explores the association between Coronary Artery Calcium (CAC) scores and dental pathology such as missing teeth, the (peri-apical) health status and restoration grade of the teeth, and the grade of alveolar bone loss seen on a dental panoramic radiograph (Orthopantomograph-OPG). Materials and methods In this retrospective cross-sectional study, data was collected from three hospitals spread in the Netherlands. Patients were included when a CAC score and an OPG were available, both recorded within a maximum period of 365 days from 2009-2017. The CAC score was measured on a CT scan, using the Agatston method. To assess dental pathology, the number of missing teeth, the number of dental implants, alveolar bone loss, caries, endodontic treatments, peri-apical radiolucencies, bone loss at implants, impacted teeth and dental cysts, were determined on the OPG. All observers were calibrated. The electronic health records provided information about: gender, age, smoking, Diabetes Mellitus, hypercholesterolemia, hypertension and Body Mass Index (BMI). Results 212 patients were included. We found a statistically significant association between the number of missing teeth and the CAC score. When modeling age, sex, and other well-known risk factors for cardiovascular disease, the significant correlation was no longer present after multivariate correction. Furthermore, the results showed a trend for more teeth with peri-apical lesions and a higher percentage of mean alveolar bone loss in the group with the highest CAC scores. Conclusion This study showed that being edentulous or missing teeth is correlated to higher CAC scores however failed to be an independent predictor of atherosclerotic cardiovascular diseases. The number of (missing) teeth is an easily accessible marker and could be used as a marker for atherosclerotic cardiovascular disease (ACVD) risk by almost any healthcare worker. The current study needs to be considered as an explorative pilot study and could contribute to the design of further (prospective) studies on the relationship between dental pathology and coronary artery calcification by adding clinical information and extra cardiovascular biomarkers.	[Donders, H. C. M.; de Lange, J.] Univ Amsterdam, Acad Ctr Dent Amsterdam ACTA, Dept Oral & Maxillofacial Surg, Amsterdam UMC, Amsterdam, Netherlands; [Donders, H. C. M.] Isala Hosp Zwolle, Dept Oral & Maxillofacial Surg, Zwolle, Netherlands; [IJzerman, L. M.; Loos, B. G.] Univ Amsterdam, Acad Ctr Dent Amsterdam ACTA, Dept Periodontol, Amsterdam, Netherlands; [IJzerman, L. M.; Loos, B. G.] Vrije Univ Amsterdam, Amsterdam, Netherlands; [Soffner, M.] TSC Hoorn, Practice Endodontol, Hoorn, Netherlands; [van't Hof, A. W. J.] Maastricht Univ, Dept Cardiol, Med Ctr, Maastricht, Netherlands; [van't Hof, A. W. J.] Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands; [van't Hof, A. W. J.] Zuyderland MC, Dept Cardiol, Heerlen, Netherlands	Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Maastricht University; Maastricht University	Donders, HCM (corresponding author), Univ Amsterdam, Acad Ctr Dent Amsterdam ACTA, Dept Oral & Maxillofacial Surg, Amsterdam UMC, Amsterdam, Netherlands.; Donders, HCM (corresponding author), Isala Hosp Zwolle, Dept Oral & Maxillofacial Surg, Zwolle, Netherlands.	h.c.m.donders@isala.nl		Donders, Marie-Chris/0000-0003-3750-8513; van 't Hof, Arnoud/0000-0002-2344-7564				AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Berlin-Broner Y, 2017, INT ENDOD J, V50, P847, DOI 10.1111/iej.12710; Blaha MJ, 2016, CIRCULATION, V133, P849, DOI 10.1161/CIRCULATIONAHA.115.018524; Budoff MJ, 2017, CIRCULATION, V136, P1993, DOI 10.1161/CIRCULATIONAHA.117.030578; Cardiovascular Diseases (CVDs), 2015, CARD DIS CVDS FACT S; Cheng F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194563; Donders H., 2012, J CRANIO MAXILLARY D, V1, P17; Fleiss JL., 1986, DESIGN ANAL CLIN EXP, DOI [10.1002/9781118032923.ch1, DOI 10.1002/9781118032923.CH1, DOI 10.1002/9781118032923]; Frencken JE, 2017, J CLIN PERIODONTOL, V44, pS94, DOI 10.1111/jcpe.12677; Georgiou AC, 2019, J ENDODONT, V45, P1279, DOI 10.1016/j.joen.2019.07.017; Gerritsen AE, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-126; Gimbrone MA, 2016, CIRC RES, V118, P620, DOI 10.1161/CIRCRESAHA.115.306301; Greenland P, 2018, J AM COLL CARDIOL, V72, P434, DOI 10.1016/j.jacc.2018.05.027; Groves DW, 2015, AM J CARDIOL, V116, P833, DOI 10.1016/j.amjcard.2015.06.006; Hulten EA, 2011, J AM COLL CARDIOL, V57, P2544, DOI 10.1016/j.jacc.2011.03.018; Kvist T, 2015, INT ENDOD J, V48, P913, DOI 10.1111/iej.12505; Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009; Liljestrand JM, 2015, J DENT RES, V94, P1055, DOI 10.1177/0022034515586352; MATTILA KJ, 1989, BRIT MED J, V298, P779, DOI 10.1136/bmj.298.6676.779; Moriya J, 2019, J CARDIOL, V73, P22, DOI 10.1016/j.jjcc.2018.05.010; Nakib SA, 2004, J PERIODONTOL, V75, P505, DOI 10.1902/jop.2004.75.4.505; Nardi C, 2018, J ENDODONT, V44, P1500, DOI 10.1016/j.joen.2018.07.003; Nardi C, 2017, J ENDODONT, V43, P1640, DOI 10.1016/j.joen.2017.06.020; Papapanou PN, 2017, PERIODONTOL 2000, V75, P45, DOI 10.1111/prd.12200; Paraskevas S, 2008, J CLIN PERIODONTOL, V35, P277, DOI 10.1111/j.1600-051X.2007.01173.x; Persson RE, 2003, J CLIN PERIODONTOL, V30, P833, DOI 10.1034/j.1600-051X.2003.00379.x; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Rushton VE, 1996, J DENT, V24, P185, DOI 10.1016/0300-5712(95)00055-0; Sanz M, 2020, J CLIN PERIODONTOL, V47, P268, DOI 10.1111/jcpe.13189; Schei O, 1959, J PERIODONTOLOGY, V30, P7, DOI DOI 10.1902/JOP.1959.30.1.7; Schenkein Harvey A, 2013, J Clin Periodontol, V40 Suppl 14, pS51, DOI [10.1902/jop.2013.134006, 10.1111/jcpe.12060]; Schmitt A, 2015, J CLIN PERIODONTOL, V42, P977, DOI 10.1111/jcpe.12467; Seidelmann SB, 2018, LANCET PUBLIC HEALTH, V3, pE419, DOI 10.1016/S2468-2667(18)30135-X; Teeuw WJ, 2009, J PERIODONTAL RES, V44, P94, DOI 10.1111/j.1600-0765.2008.01111.x; Tonetti MS, 2007, NEW ENGL J MED, V356, P911, DOI 10.1056/NEJMoa063186; Xin HH, 2016, IEEE T SMART GRID, V7, P3, DOI 10.1109/TSG.2015.2473096; Yeboah J, 2012, JAMA-J AM MED ASSOC, V308, P788, DOI 10.1001/jama.2012.9624	37	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243232	10.1371/journal.pone.0243232	http://dx.doi.org/10.1371/journal.pone.0243232			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326424	Green Published, gold			2022-12-27	WOS:000600176400029
J	Kumar, A; Kasloff, SB; Leung, A; Cutts, T; Strong, JE; Hills, K; Gu, FX; Chen, P; Vazquez-Grande, G; Rush, B; Lother, S; Malo, K; Zarychanski, R; Krishnan, J				Kumar, Anand; Kasloff, Samantha B.; Leung, Anders; Cutts, Todd; Strong, James E.; Hills, Kevin; Gu, Frank X.; Chen, Paul; Vazquez-Grande, Gloria; Rush, Barret; Lother, Sylvain; Malo, Kimberly; Zarychanski, Ryan; Krishnan, Jay			Decontamination of N95 masks for re-use employing 7 widely available sterilization methods	PLOS ONE			English	Article							THERMAL INACTIVATION; CORONAVIRUS; MECHANISMS; VIRUSES	The response to the COVID-19 epidemic is generating severe shortages of personal protective equipment around the world. In particular, the supply of N95 respirator masks has become severely depleted, with supplies having to be rationed and health care workers having to use masks for prolonged periods in many countries. We sought to test the ability of 7 different decontamination methods: autoclave treatment, ethylene oxide gassing (ETO), low temperature hydrogen peroxide gas plasma (LT-HPGP) treatment, vaporous hydrogen peroxide (VHP) exposure, peracetic acid dry fogging (PAF), ultraviolet C irradiation (UVCI) and moist heat (MH) treatment to decontaminate a variety of different N95 masks following experimental contamination with SARS-CoV-2 or vesicular stomatitis virus as a surrogate. In addition, we sought to determine whether masks would tolerate repeated cycles of decontamination while maintaining structural and functional integrity. All methods except for UVCI were effective in total elimination of viable virus from treated masks. We found that all respirator masks tolerated at least one cycle of all treatment modalities without structural or functional deterioration as assessed by fit testing; filtration efficiency testing results were mostly similar except that a single cycle of LT-HPGP was associated with failures in 3 of 6 masks assessed. VHP, PAF, UVCI, and MH were associated with preserved mask integrity to a minimum of 10 cycles by both fit and filtration testing. A similar result was shown with ethylene oxide gassing to the maximum 3 cycles tested. Pleated, layered non-woven fabric N95 masks retained integrity in fit testing for at least 10 cycles of autoclaving but the molded N95 masks failed after 1 cycle; filtration testing however was intact to 5 cycles for all masks. The successful application of autoclaving for layered, pleated masks may be of particular use to institutions globally due to the virtually universal accessibility of autoclaves in health care settings. Given the ability to modify widely available heating cabinets on hospital wards in well-resourced settings, the application of moist heat may allow local processing of N95 masks.	[Kumar, Anand] Univ Manitoba, Dept Med, Sect Crit Care Med, Winnipeg, MB, Canada; [Kumar, Anand] Univ Manitoba, Dept Med Microbiol, Sect Crit Care Med, Winnipeg, MB, Canada; [Kumar, Anand] Univ Manitoba, Dept Pharmacol, Sect Crit Care Med, Winnipeg, MB, Canada; [Kumar, Anand] Univ Manitoba, Dept Med, Sect Infect Dis, Winnipeg, MB, Canada; [Kumar, Anand] Univ Manitoba, Dept Med Microbiol, Sect Infect Dis, Winnipeg, MB, Canada; [Kumar, Anand] Univ Manitoba, Dept Pharmacol, Sect Infect Dis, Winnipeg, MB, Canada; [Kasloff, Samantha B.; Leung, Anders; Cutts, Todd; Strong, James E.; Krishnan, Jay] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Hills, Kevin] Canadian Food Inspect Agcy, Natl Ctr Foreign Anim Dis, Winnipeg, MB, Canada; [Gu, Frank X.; Chen, Paul] Univ Toronto, Toronto, ON, Canada; [Vazquez-Grande, Gloria; Rush, Barret; Lother, Sylvain] Univ Manitoba, Sect Crit Care Med, Dept Med, Winnipeg, MB, Canada; [Malo, Kimberly] Winnipeg Reg Hlth Author, Occupat & Environm Safety & Hlth, Winnipeg, MB, Canada; [Zarychanski, Ryan] Univ Manitoba, Dept Med, Sect Crit Care, Winnipeg, MB, Canada; [Zarychanski, Ryan] Univ Manitoba, Dept Community Hlth Sci, Sect Crit Care, Winnipeg, MB, Canada; [Zarychanski, Ryan] Univ Manitoba, Dept Med, Sect Hematol, Winnipeg, MB, Canada; [Zarychanski, Ryan] Univ Manitoba, Dept Community Hlth Sci, Sect Hematol, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba; University of Manitoba; University of Manitoba; University of Manitoba; University of Manitoba; Public Health Agency of Canada; Canadian Food Inspection Agency; University of Toronto; University of Manitoba; University of Manitoba; University of Manitoba; University of Manitoba; University of Manitoba	Kumar, A (corresponding author), Univ Manitoba, Dept Med, Sect Crit Care Med, Winnipeg, MB, Canada.; Kumar, A (corresponding author), Univ Manitoba, Dept Med Microbiol, Sect Crit Care Med, Winnipeg, MB, Canada.; Kumar, A (corresponding author), Univ Manitoba, Dept Pharmacol, Sect Crit Care Med, Winnipeg, MB, Canada.; Kumar, A (corresponding author), Univ Manitoba, Dept Med, Sect Infect Dis, Winnipeg, MB, Canada.; Kumar, A (corresponding author), Univ Manitoba, Dept Med Microbiol, Sect Infect Dis, Winnipeg, MB, Canada.; Kumar, A (corresponding author), Univ Manitoba, Dept Pharmacol, Sect Infect Dis, Winnipeg, MB, Canada.	akumar61@yahoo.com	Vazquez-Grande, Gloria/GZK-8271-2022; Zarychanski, Ryan/AAB-6369-2022; Strong, Jim/ABA-1881-2021; Cutts, Todd/G-6296-2017	Vazquez-Grande, Gloria/0000-0001-5866-1045; Strong, Jim/0000-0002-0658-6669; Cutts, Todd/0000-0001-7691-5619				Anderegg L, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234851; [Anonymous], 2020, EMERG INFECT DIS, V26, P2253; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Araud E, 2016, APPL ENVIRON MICROB, V82, P2086, DOI 10.1128/AEM.03573-15; Bergman Michael, 2015, J Int Soc Respir Prot, V32, P50; Bergman MS, 2012, AM J INFECT CONTROL, V40, P375, DOI 10.1016/j.ajic.2011.05.003; Bopp NE, 2020, APPL BIOSAF, V25, P150, DOI 10.1177/1535676020924171; Fischer Robert J, 2020, medRxiv, DOI 10.1101/2020.04.11.20062018; Frey G, 2020, APPL BIOSAF, V25, P48, DOI 10.1177/1535676019890975; Gordon D, 2012, APPL BIOSAF, V17, P31, DOI DOI 10.1177/153567601201700107; Hankenson FC, 2020, APPL BIOSAF, V25, P142, DOI 10.1177/1535676020936381; Jinot J, 2018, TOXICOL MECH METHOD, V28, P386, DOI 10.1080/15376516.2017.1414343; Krishnan J., 2006, APPL BIOSAF, V11, P74; Krishnan J, 2012, APPL BIOSAFETY, V17, P132, DOI [DOI 10.1177/153567601201700305, 10.1177/153567601201700305]; LAUDE H, 1981, J GEN VIROL, V56, P235, DOI 10.1099/0022-1317-56-2-235; Leclercq I, 2014, INFLUENZA OTHER RESP, V8, P585, DOI 10.1111/irv.12261; Letchworth GJ, 1999, VET J, V157, P239, DOI 10.1053/tvjl.1998.0303; Lore MB, 2012, ANN OCCUP HYG, V56, P92, DOI 10.1093/annhyg/mer054; Lowe JJ, 2020, TECH REP; Mendes GCC, 2007, AM J INFECT CONTROL, V35, P574, DOI 10.1016/j.ajic.2006.10.014; Mills D, 2018, AM J INFECT CONTROL, V46, pE49, DOI 10.1016/j.ajic.2018.02.018; Okpara-Hofmann J, 2005, J HOSP INFECT, V59, P280, DOI 10.1016/j.jhin.2004.10.002; Pfaender S, 2015, APPL ENVIRON MICROB, V81, P1616, DOI 10.1128/AEM.03580-14; Pratelli A, 2008, VET J, V177, P71, DOI 10.1016/j.tvjl.2007.03.019; Rabenau HF, 2005, MED MICROBIOL IMMUN, V194, P1, DOI 10.1007/s00430-004-0219-0; Ranney ML, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMp2006141; REED L. J., 1938, AMER JOUR HYG, V27, P493; Salter WB, 2010, J OCCUP ENVIRON HYG, V7, P437, DOI [10.1080/15459624.2010.484794, 10.1080/15459624.2010484794]; Sattar SA, 2003, J VIROL METHODS, V112, P3, DOI 10.1016/S0166-0934(03)00192-7; Schwartz A, 2020, APPL BIOSAF, V25, P67, DOI 10.1177/1535676020919932; Slominski AT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009907; Smith JS, 2020, EFFECT VARIOUS DECON; Tcharkhtchi A, 2021, BIOACT MATER, V6, P106, DOI 10.1016/j.bioactmat.2020.08.002; Tseng CC, 2007, J OCCUP ENVIRON HYG, V4, P400, DOI 10.1080/15459620701329012; Viscusi DJ, 2009, ANN OCCUP HYG, V53, P815, DOI 10.1093/annhyg/mep070	35	30	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243965	10.1371/journal.pone.0243965	http://dx.doi.org/10.1371/journal.pone.0243965			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326504	gold, Green Published			2022-12-27	WOS:000600176400068
J	Lee, J; Lee, W; Lee, YJ; Sim, H; Lee, WK				Lee, Joongyub; Lee, Woojoo; Lee, Yu Jin; Sim, Hyunman; Lee, Won Kyung			Effectiveness of bystander cardiopulmonary resuscitation in improving the survival and neurological recovery of patients with out-of-hospital cardiac arrest: A nationwide patient cohort study	PLOS ONE			English	Article							ASSOCIATION; PREDICTORS; LOCATION; GENDER	Introduction Few studies have focused on enhancing causality and yielding unbiased estimates on the effectiveness of bystander cardiopulmonary resuscitation (BCPR) on the outcomes of out-of-hospital cardiac arrest (OHCA) in a real-world setting. Therefore, this study evaluated the effect of BCPR on the outcomes of OHCA and its differences according to the characteristics of OHCA. Methods This study enrolled all patients with OHCA of cardiac etiology treated by emergency medical services (EMS) in Korea from 2012 to 2015. The endpoints were survival and neurological recovery at discharge, and the main exposure was BCPR conducted by a layperson. The effect of BCPR was analyzed after adjusting for confounders, determined using a directed acyclic graph, by inverse probability of treatment weighting (IPTW) and model-based standardization (STR). Moreover, differences in subgroups and time trends were evaluated. Results Among 10,505 eligible patients after excluding those with missing data on BCPR, 7,721 patients received BCPR, accounting for 74.3% of EMS-treated OHCA patients. BCPR increased the odds of survival and good neurological recovery at discharge by 1.67- (95% confidence interval (CI): 1.44-1.93) and 1.93- (95% CI: 1.56-2.39) fold, respectively, in the IPTW analysis. These findings were comparable to those obtained with STR. The odds ratios were 2.39 (95% CI: 1.91-2.94) and 2.70 (95% CI: 1.94-3.41), respectively, in the sensitivity analysis of the missing BCPR information considering confounders and the outcome variable. However, the effect of qualified BCPR was not evenly distributed, and it did not increase with time. BCPR was likely to be more effective in male patients aged <65 years, those who experienced an OHCA in a private place or non-capital region, and those with shockable rhythm at the scene. Conclusion Based on data from a nationwide registry, the estimated effect of BCPR on survival and neurological recovery was moderate and did not improve from 2012 to 2015.	[Lee, Joongyub] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Lee, Woojoo; Sim, Hyunman] Seoul Natl Univ, Grad Sch Publ Hlth, Dept Publ Hlth Sci, Seoul, South Korea; [Lee, Yu Jin] Inha Univ, Inha Univ Hosp, Sch Med, Dept Emergency Med, Incheon, South Korea; [Lee, Won Kyung] Inha Univ, Inha Univ Hosp, Sch Med, Dept Prevent & Management, Incheon, South Korea	Seoul National University (SNU); Seoul National University (SNU); Inha University; Inha University Hospital; Inha University; Inha University Hospital	Lee, WK (corresponding author), Inha Univ, Inha Univ Hosp, Sch Med, Dept Prevent & Management, Incheon, South Korea.	bluewhale65@inha.ac.kr		Lee, Won Kyung/0000-0002-6014-8854; Lee, Woojoo/0000-0001-7447-7045	Bio & Medical Technology Development Program of the National Research Foundation - Korean government (MSIT) [2019M3E5D1A0206962012]	Bio & Medical Technology Development Program of the National Research Foundation - Korean government (MSIT)	WKL received funding for this work by the Bio & Medical Technology Development Program of the National Research Foundation funded by the Korean government (MSIT) (2019M3E5D1A0206962012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHA, 2018, AHA RELEASES LATEST; Atwood C, 2005, RESUSCITATION, V67, P75, DOI 10.1016/j.resuscitation.2005.03.021; Berdowski J, 2010, RESUSCITATION, V81, P1479, DOI 10.1016/j.resuscitation.2010.08.006; Blewer AL, 2018, CIRC-CARDIOVASC QUAL, V11, DOI 10.1161/CIRCOUTCOMES.118.004710; Bougouin W, 2015, RESUSCITATION, V94, P55, DOI 10.1016/j.resuscitation.2015.06.018; Chen KY, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211792; Coute RA, 2019, CIRC-CARDIOVASC QUAL, V12, DOI 10.1161/CIRCOUTCOMES.118.004677; Eftestol T, 2004, CIRCULATION, V110, P10, DOI 10.1161/01.CIR.0000133323.15565.75; Fukuda T, 2016, EUR J INTERN MED, V30, P61, DOI 10.1016/j.ejim.2016.01.022; Gharibzadeh S, 2016, ARCH IRAN MED, V19, P666, DOI 0161909/AIM.0011; Graham R M.M., 2015, STRATEGIES IMPROVE C, P456; Hagihara A, 2018, INT J CARDIOL, V265, P240, DOI 10.1016/j.ijcard.2018.04.067; Han KS, 2019, J CLIN MED, V8, DOI 10.3390/jcm8050644; Holmberg M, 2001, EUR HEART J, V22, P511, DOI 10.1053/euhj.2000.2421; Hyman MC, 2019, EUR HEART J, V40, P3835, DOI 10.1093/eurheartj/ehz504; Iwami T, 2007, CIRCULATION, V116, P2900, DOI 10.1161/CIRCULATIONAHA.107.723411; Kim DK, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232999; Kim YT, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016925; Korea_Centers_for_Disease_Control_and_Prevention, 2019, WEEKL HLTH DIS, P35; Lee DE, 2019, J KOREAN MED SCI, V34, DOI 10.3346/jkms.2019.34.e134; Lee DW, 2019, AM J EMERG MED, V37, P1999, DOI 10.1016/j.ajem.2019.02.021; Lee SY, 2019, RESUSCITATION, V138, P198, DOI 10.1016/j.resuscitation.2019.01.045; Martinell L, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1677-2; Maurer H, 2019, RESUSCITATION, V136, P78, DOI 10.1016/j.resuscitation.2018.12.009; Moon S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211804; Nikolaou N, 2019, RESUSCITATION, V138, P82, DOI 10.1016/j.resuscitation.2019.02.035; Park JH, 2018, RESUSCITATION, V125, P1, DOI 10.1016/j.resuscitation.2018.01.026; Rajan S, 2016, CIRCULATION, V134, P2095, DOI 10.1161/CIRCULATIONAHA.116.024400; Ro YS, 2017, ANN EMERG MED, V69, P52, DOI 10.1016/j.annemergmed.2016.07.028; Ro YS, 2016, AM J EMERG MED, V34, P1331, DOI 10.1016/j.ajem.2015.12.001; Shah M, 2018, PREHOSP EMERG CARE, V22, P222, DOI 10.1080/10903127.2017.1376133; Shimamoto T, 2020, INT HEART J, V61, P46, DOI 10.1536/ihj.19-301; Song J, 2018, SCANDINAVIAN J TRAUM; Song KJ, 2014, RESUSCITATION, V85, P34, DOI 10.1016/j.resuscitation.2013.06.004; Stecker EC, 2014, CIRC-ARRHYTHMIA ELEC, V7, P212, DOI 10.1161/CIRCEP.113.001034; Suttorp MM, 2015, NEPHROL DIAL TRANSPL, V30, P1418, DOI 10.1093/ndt/gfu325; Tanaka Y, 2015, RESUSCITATION, V86, P74, DOI 10.1016/j.resuscitation.2014.11.004; van Nieuwenhuizen BP, 2019, RESUSCITATION, V141, P44, DOI 10.1016/j.resuscitation.2019.05.018; Zhang ZW, 2016, STAT METHODS MED RES, V25, P2053, DOI 10.1177/0962280213513758	39	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243757	10.1371/journal.pone.0243757	http://dx.doi.org/10.1371/journal.pone.0243757			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326454	Green Published, gold			2022-12-27	WOS:000600176400061
J	Rainkie, DC; Abedini, ZS; Abdelkader, NN				Rainkie, Daniel Christopher; Abedini, Zeinab Salman; Abdelkader, Nada Nabil			Reporting and methodological quality of systematic reviews and meta-analysis with protocols in Diabetes Mellitus Type II: A systematic review	PLOS ONE			English	Review							PEPTIDE-1 RECEPTOR AGONISTS; SGLT-2 INHIBITORS; INSULIN; ASSOCIATION; OUTCOMES; EFFICACY; ADHERENCE; THERAPY; PEOPLE; SAFETY	Background Systematic reviews with or without meta-analyses (SR/MAs) are strongly encouraged to work from a protocol to facilitate high quality, transparent methodology. The completeness of reporting of a protocol (PRISMA-P) and manuscript (PRISMA) is essential to the quality appraisal (AMSTAR-2) and appropriate use of SR/MAs in making treatment decisions. Objectives The objectives of this study were to describe the completeness of reporting and quality of SR/MAs, assess the correlations between PRISMA-P, PRISMA, and AMSTAR-2, and to identify reporting characteristics between similar items of PRISMA-P and PRISMA. Methods We performed a systematic review of Type 2 Diabetes Mellitus SR/MAs of hypoglycemic agents with publicly available protocols. Cochrane reviews, guidelines, and specific types of MA were excluded. Two reviewers independently, (i) searched PubMed and Embase between 1/1/2015 to 20/3/2019; (ii) identified protocols of included studies by searching the manuscript bibliography, supplementary material, PROSPERO, and Google; (iii) completed PRISMA-P, PRISMA, and AMSTAR-2 tools. Data analysis included descriptive statistics, Pearson correlation, and multivariable linear regression. Results Of 357 relevant SR/MAs, 51 had available protocols and were included. The average score for PRISMA-P was 15.83.3 (66%; maximum 24) and 25.2 +/- 1.1 (93%; maximum 27) for PRISMA. The quality of SR/MAs assessed using the AMSTAR-2 tool identified an overall poor quality (63% critically low, 18% low, 8% moderate, 12% high). The correlation between the PRISMA-P and PRISMA was not significant (r = 0.264; p = 0.06). Correlation was significant between PRISMA-P and AMSTAR-2 (r = 0.333; p = 0.02) and PRISMA and AMSTAR-2 (r = 0.555; p<0.01). Discrepancies in reporting were common between similar PRISMA-P and PRISMA items. Conclusion Adherence to protocol reporting guidance was poor while manuscript reporting was comprehensive. Protocol completeness is not associated with a completely reported manuscript. Independently, PRISMA-P and PRISMA scores were weakly associated with higher quality assessments but insufficient as a surrogate for quality. Critical areas for quality improvement include protocol description, investigating causes of heterogeneity, and the impact of risk of bias on the evidence synthesis.	[Rainkie, Daniel Christopher; Abedini, Zeinab Salman; Abdelkader, Nada Nabil] Qatar Univ, Coll Pharm, Hlth Cluster, Doha, Qatar	Qatar University	Rainkie, DC (corresponding author), Qatar Univ, Coll Pharm, Hlth Cluster, Doha, Qatar.	drainkie@qu.edu.qa		Rainkie, Daniel/0000-0002-9744-1069	Qatar University [QUST-1-CPH2020-17]	Qatar University(Qatar National Research Fund (QNRF))	This project is funded by Qatar University Undergraduate Student Grant number QUST-1-CPH2020-17. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adil M, 2018, CLIN EPIDEMIOL GLOB, V6, P61, DOI 10.1016/j.cegh.2017.08.002; Agoritsas T, 2015, USERS GUIDES MED LIT, P43; Andreadis P, 2018, DIABETES OBES METAB, V20, P2255, DOI 10.1111/dom.13361; [Anonymous], 2016, NAT MATER, V15, P1, DOI 10.1038/nmat4533; [Anonymous], 2017, BMJ-BRIT MED J, V358, P1, DOI DOI 10.1136/bmj.j3119; [Anonymous], 2009, KIDNEY INT, V6, pS1; Anyanwagu U, 2016, DIABETES RES CLIN PR, V121, P69, DOI 10.1016/j.diabres.2016.09.002; Black CD, 2017, DIABETES THER, V8, P23, DOI 10.1007/s13300-016-0220-9; Cai XL, 2018, J DIABETES INVEST, V9, P850, DOI 10.1111/jdi.12760; Cai XL, 2018, OBESITY, V26, P70, DOI 10.1002/oby.22066; Cai XL, 2017, EXPERT OPIN PHARMACO, V18, P1789, DOI 10.1080/14656566.2017.1400011; Cai XL, 2017, J DIABETES INVEST, V8, P510, DOI 10.1111/jdi.12625; Cai XL, 2016, DIABETES TECHNOL THE, V18, P784, DOI 10.1089/dia.2016.0302; Cai XL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166625; Cai XL, 2016, EXPERT OPIN PHARMACO, V17, P1591, DOI 10.1080/14656566.2016.1202921; Campbell JM, 2017, AGEING RES REV, V40, P31, DOI 10.1016/j.arr.2017.08.003; Cardiovascular Disease and Risk Management, 2019, DIABETES CARE, V2, pS103, DOI 10.2337/dc19-S010; Castellana M, 2019, DIABETES-METAB RES, V35, DOI 10.1002/dmrr.3082; Crowley MJ, 2017, ANN INTERN MED, V166, P191, DOI 10.7326/M16-1901; de Wit HM, 2016, BRIT J CLIN PHARMACO, V82, P301, DOI 10.1111/bcp.12925; Dicembrini I, 2017, ACTA DIABETOL, V54, P933, DOI 10.1007/s00592-017-1031-9; Elgebaly A, 2021, EXP CLIN ENDOCR DIAB, V129, P56, DOI 10.1055/a-0579-7860; Elgendy IY, 2017, AM J CARDIOVASC DRUG, V17, P143, DOI 10.1007/s40256-016-0208-x; Farah D, 2019, DIABETES RES CLIN PR, V149, P47, DOI 10.1016/j.diabres.2019.01.025; Ge L, 2018, J CLIN EPIDEMIOL, V93, P45, DOI 10.1016/j.jclinepi.2017.10.012; Giugliano D, 2016, ENDOCRINE, V51, P417, DOI 10.1007/s12020-015-0718-3; Glechner A, 2015, DIABETOLOGIA, V58, P242, DOI 10.1007/s00125-014-3439-x; Gray LJ, 2015, DIABETES OBES METAB, V17, P639, DOI 10.1111/dom.12462; Group EBMW, 2015, JAMA-J AM MED ASSOC, V268, P327; Group TP, PRISMA END; Hansen M, 2017, J DIABETES COMPLICAT, V31, P918, DOI 10.1016/j.jdiacomp.2017.01.011; Khunti K, 2018, DIABETES OBES METAB, V20, P427, DOI 10.1111/dom.13088; Khunti K, 2017, DIABETES CARE, V40, P1588, DOI 10.2337/dc16-1925; Li XX, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00449; Li XJ, 2018, ENDOCRINE, V62, P535, DOI 10.1007/s12020-018-1708-z; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Maiorino MI, 2018, DIABETES OBES METAB, V20, P2309, DOI 10.1111/dom.13343; Maiorino MI, 2017, DIABETES CARE, V40, P614, DOI 10.2337/dc16-1957; Mazidi M, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.004007; Mazidi Mohsen, 2017, J Diabetes Complications, V31, P1237, DOI 10.1016/j.jdiacomp.2016.05.022; McGovern A, 2018, DIABETES OBES METAB, V20, P1040, DOI 10.1111/dom.13160; Meng Q, 2016, J DIABETES INVEST, V7, P359, DOI 10.1111/jdi.12417; Min SH, 2018, J DIABETES INVEST, V9, P893, DOI 10.1111/jdi.12754; Mishriky BM, 2019, DIABETES METAB, V45, P102, DOI 10.1016/j.diabet.2018.09.002; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1186/2046-4053-4-1, 10.1136/bmj.b2535]; Monami M, 2018, DIABETES OBES METAB, V20, P1213, DOI 10.1111/dom.13221; Monami M, 2017, ACTA DIABETOL, V54, P1101, DOI 10.1007/s00592-017-1054-2; Monami M, 2017, DIABETES RES CLIN PR, V130, P53, DOI 10.1016/j.diabres.2017.04.017; Ostawal A, 2016, DIABETES THER, V7, P411, DOI 10.1007/s13300-016-0180-0; Page MJ, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-017-0663-8; Page MJ, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002028; Peter EL, 2019, J ETHNOPHARMACOL, V231, P311, DOI 10.1016/j.jep.2018.10.033; Price HI, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006341; Rios P, 2019, SYST REV-LONDON, V8, DOI 10.1186/s13643-019-1163-9; Saad M, 2017, INT J CARDIOL, V228, P352, DOI 10.1016/j.ijcard.2016.11.181; Sharma M, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017260; Shea BJ, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j4008; Shi FH, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00576; Storgaard H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166125; Tang GH, 2018, CANCER EPIDEM BIOMAR, V27, P627, DOI 10.1158/1055-9965.EPI-17-0936; Tunis AS, 2013, RADIOLOGY, V269, P413, DOI 10.1148/radiol.13130273; Wang C, 2019, DIABETES OBES METAB, V21, P1018, DOI 10.1111/dom.13620; Wang XY, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011946; Zhang FR, 2018, EVID-BASED COMPL ALT, V2018, DOI 10.1155/2018/8791538; Zhang H, 2016, J CLIN EPIDEMIOL, V70, P4, DOI 10.1016/j.jclinepi.2015.06.009	67	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243091	10.1371/journal.pone.0243091	http://dx.doi.org/10.1371/journal.pone.0243091			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326429	Green Published, gold			2022-12-27	WOS:000600176400021
J	Bello-Chavolla, OY; Antonio-Villa, NE; Ortiz-Brizuela, E; Vargas-Vazquez, A; Gonzalez-Lara, MF; de Leon, AP; Sifuentes-Osornio, J; Aguilar-Salinas, CA				Yaxmehen Bello-Chavolla, Omar; Antonio-Villa, Neftali E.; Ortiz-Brizuela, Edgar; Vargas-Vazquez, Arsenio; Fernanda Gonzalez-Lara, Maria; Ponce de Leon, Alfredo; Sifuentes-Osornio, Jose; Aguilar-Salinas, Carlos A.			Validation and repurposing of the MSL-COVID-19 score for prediction of severe COVID-19 using simple clinical predictors in a triage setting: The Nutri-CoV score	PLOS ONE			English	Article								Background During the COVID-19 pandemic, risk stratification has been used to decide patient eligibility for inpatient, critical and domiciliary care. Here, we sought to validate the MSL-COVID-19 score, originally developed to predict COVID-19 mortality in Mexicans. Also, an adaptation of the formula is proposed for the prediction of COVID-19 severity in a triage setting (Nutri-CoV). Methods We included patients evaluated from March 16(th) to August 17(th), 2020 at the Instituto Nacional de Ciencias Medicas y Nutricion, defining severe COVID-19 as a composite of death, ICU admission or requirement for intubation (n = 3,007). We validated MSL-COVID-19 for prediction of mortality and severe disease. Using Elastic Net Cox regression, we trained (n = 1,831) and validated (n = 1,176) a model for prediction of severe COVID-19 using MSL-COVID-19 along with clinical assessments obtained at a triage setting. Results The variables included in MSL-COVID-19 are: pneumonia, early onset type 2 diabetes, age > 65 years, chronic kidney disease, any form of immunosuppression, COPD, obesity, diabetes, and age <40 years. MSL-COVID-19 had good performance to predict COVID-19 mortality (c-statistic = 0.722, 95%CI 0.690-0.753) and severity (c-statistic = 0.777, 95%CI 0.753-0.801). The Nutri-CoV score includes the MSL-COVID-19 plus respiratory rate, and pulse oximetry. This tool had better performance in both training (c-statistic = 0.797, 95%CI 0.765-0.826) and validation cohorts (c-statistic = 0.772, 95%CI 0.0.745-0.800) compared to other severity scores. Conclusions MSL-COVID-19 predicts inpatient COVID-19 lethality. The Nutri-CoV score is an adaptation of MSL-COVID-19 to be used in a triage environment. Both scores have been deployed as web-based tools for clinical use in a triage setting.	[Yaxmehen Bello-Chavolla, Omar; Antonio-Villa, Neftali E.; Vargas-Vazquez, Arsenio; Aguilar-Salinas, Carlos A.] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Unidad Invest Enfermedades Metab, Mexico City, DF, Mexico; [Yaxmehen Bello-Chavolla, Omar] Inst Nacl Geriatria, Div Invest, Mexico City, DF, Mexico; [Antonio-Villa, Neftali E.; Vargas-Vazquez, Arsenio] Univ Nacl Autonoma Mexico, Fac Med, PECEM, Mexico City, DF, Mexico; [Ortiz-Brizuela, Edgar; Fernanda Gonzalez-Lara, Maria; Ponce de Leon, Alfredo; Sifuentes-Osornio, Jose] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Infectol, Mexico City, DF, Mexico; [Sifuentes-Osornio, Jose] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Direcc Med, Mexico City, DF, Mexico; [Aguilar-Salinas, Carlos A.] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Direcc Nutr, Mexico City, DF, Mexico; [Aguilar-Salinas, Carlos A.] Tecnol Monterrey, Escuela Med & Ciencias Salud, Zapopan, Mexico	Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Universidad Nacional Autonoma de Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Tecnologico de Monterrey	Aguilar-Salinas, CA (corresponding author), Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Unidad Invest Enfermedades Metab, Mexico City, DF, Mexico.; Aguilar-Salinas, CA (corresponding author), Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Direcc Nutr, Mexico City, DF, Mexico.; Aguilar-Salinas, CA (corresponding author), Tecnol Monterrey, Escuela Med & Ciencias Salud, Zapopan, Mexico.	caguilarsalinas@yahoo.com	Ortiz-Brizuela, Edgar/U-6302-2019; Antonio-Villa, Neftali Eduardo/GQH-1097-2022; Bello-Chavolla, Omar/AAB-7118-2019; Antonio-Villa, Neftali Eduardo/AAX-2970-2020	Ortiz-Brizuela, Edgar/0000-0001-7169-8459; Antonio-Villa, Neftali Eduardo/0000-0002-6879-1078; Bello-Chavolla, Omar/0000-0003-3093-937X; Antonio-Villa, Neftali Eduardo/0000-0002-6879-1078; Ponce-de-Leon, Alfredo/0000-0003-2640-2916; Sifuentes-Osornio, Jose/0000-0001-9584-1360	CONACyT	CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	AVV, NEAV are enrolled at the PECEM program of the Faculty of Medicine at UNAM. NEAV and AVV are supported by CONACyT. The authors would like to acknowledge the invaluable work of all healthcare workers at the Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran for its community in managing the COVID-19 epidemic. Its participation in the COVID-19 surveillance program has made this work a reality, we are thankful for your effort.	Abrams EM, 2020, LANCET RESP MED, V8, P659, DOI 10.1016/S2213-2600(20)30234-4; Bello-Chavolla OY, 2021, J GERONTOL A-BIOL, V76, pE52, DOI 10.1093/gerona/glaa163; Brown MJ, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2009666; Cariou B, 2020, DIABETOLOGIA, V63, P1500, DOI 10.1007/s00125-020-05180-x; Clark A, 2020, LANCET GLOB HEALTH, V8, P1003, DOI 10.1016/S2214-109X(20)30264-3; Dixon AE, 2018, EXPERT REV RESP MED, V12, P755, DOI 10.1080/17476348.2018.1506331; Farrell TW, 2020, J AM GERIATR SOC, V68, P1143, DOI 10.1111/jgs.16539; Gattinoni L, 2020, INTENS CARE MED, V46, P1099, DOI 10.1007/s00134-020-06033-2; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1545, DOI 10.1001/jama.2020.4031; Grein J, 2020, NEW ENGL J MED, V382, P2327, DOI 10.1056/NEJMoa2007016; Guan WJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00597-2020; Gupta RK, 2020, DEV VALIDATION 4C DE, DOI [10.1101/2020.10.09.20209957, DOI 10.1101/2020.10.09.20209957]; Li MY, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00662-x; Liang WH, 2020, JAMA INTERN MED, V180, P1081, DOI 10.1001/jamainternmed.2020.2033; Marini JJ, 2020, JAMA-J AM MED ASSOC, V323, P2329, DOI 10.1001/jama.2020.6825; Mejia-Vilet J. M., 2020, RISK SCORE PREDICT A, DOI [10.1101/2020.05.12.20099416, DOI 10.1101/2020.05.12.20099416]; Ortiz-Brizuela E, 2020, REV INVEST CLIN, V72, P165, DOI [10.24875/ric.20000334, 10.24875/RIC.20000334, 10.24875/RIC.20000211, 10.24875/ric.20000211]; Rao ST, 2020, DIABETES CARE, V43, P1416, DOI 10.2337/dc20-0643; Riley RD, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m441; Roca O, 2019, AM J RESP CRIT CARE, V199, P1368, DOI 10.1164/rccm.201803-0589OC; Seymour CW, 2016, JAMA-J AM MED ASSOC, V315, P762, DOI 10.1001/jama.2016.0288; Shen CG, 2020, JAMA-J AM MED ASSOC, V323, P1582, DOI 10.1001/jama.2020.4783; Simonnet A, 2020, OBESITY, V28, P1195, DOI 10.1002/oby.22831; Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7; Wilkerson RG, 2020, AM J EMERG MED, V38, DOI 10.1016/j.ajem.2020.05.044; Wynants, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2810; Bello-Chavolla OY, 2020, J CLIN ENDOCR METAB, V105, P2752, DOI 10.1210/clinem/dgaa346; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Ziehr DR, 2020, AM J RESP CRIT CARE, V201, P1560, DOI 10.1164/rccm.202004-1163LE	29	10	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0244051	10.1371/journal.pone.0244051	http://dx.doi.org/10.1371/journal.pone.0244051			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326502	Green Published, gold			2022-12-27	WOS:000600176400011
J	Albadr, MAA; Tiun, S; Ayob, M; AL-Dhief, FT; Omar, K; Hamzah, FA				Albadr, Musatafa Abbas Abbood; Tiun, Sabrina; Ayob, Masri; AL-Dhief, Fahad Taha; Omar, Khairuddin; Hamzah, Faizal Amri			Optimised genetic algorithm-extreme learning machine approach for automatic COVID-19 detection	PLOS ONE			English	Article							ORIENTED GRADIENTS; FEATURES; CLASSIFICATION; HISTOGRAMS; EXTRACTION; PNEUMONIA; DIAGNOSIS; NETWORKS	The coronavirus disease (COVID-19), is an ongoing global pandemic caused by severe acute respiratory syndrome. Chest Computed Tomography (CT) is an effective method for detecting lung illnesses, including COVID-19. However, the CT scan is expensive and time-consuming. Therefore, this work focus on detecting COVID-19 using chest X-ray images because it is widely available, faster, and cheaper than CT scan. Many machine learning approaches such as Deep Learning, Neural Network, and Support Vector Machine; have used X-ray for detecting the COVID-19. Although the performance of those approaches is acceptable in terms of accuracy, however, they require high computational time and more memory space. Therefore, this work employs an Optimised Genetic Algorithm-Extreme Learning Machine (OGA-ELM) with three selection criteria (i.e., random, K-tournament, and roulette wheel) to detect COVID-19 using X-ray images. The most crucial strength factors of the Extreme Learning Machine (ELM) are: (i) high capability of the ELM in avoiding overfitting; (ii) its usability on binary and multi-type classifiers; and (iii) ELM could work as a kernel-based support vector machine with a structure of a neural network. These advantages make the ELM efficient in achieving an excellent learning performance. ELMs have successfully been applied in many domains, including medical domains such as breast cancer detection, pathological brain detection, and ductal carcinoma in situ detection, but not yet tested on detecting COVID-19. Hence, this work aims to identify the effectiveness of employing OGA-ELM in detecting COVID-19 using chest X-ray images. In order to reduce the dimensionality of a histogram oriented gradient features, we use principal component analysis. The performance of OGA-ELM is evaluated on a benchmark dataset containing 188 chest X-ray images with two classes: a healthy and a COVID-19 infected. The experimental result shows that the OGA-ELM achieves 100.00% accuracy with fast computation time. This demonstrates that OGA-ELM is an efficient method for COVID-19 detecting using chest X-ray images.	[Albadr, Musatafa Abbas Abbood; Tiun, Sabrina; Ayob, Masri; Omar, Khairuddin] Univ Kebangsaan Malaysia, Fac Informat Sci & Technol, CAIT, Bangi, Selangor, Malaysia; [AL-Dhief, Fahad Taha] Univ Teknol Malaysia, Sch Elect Engn, Dept Commun Engn, Utm Johor Bahru, Johor, Malaysia; [Hamzah, Faizal Amri] Univ Kebangsaan Malaysia, Med Ctr, Hosp Canselor Tuanku Muhriz, Dept Emergency Med, Kuala Lumpur, Malaysia	Universiti Kebangsaan Malaysia; Universiti Teknologi Malaysia; Universiti Kebangsaan Malaysia	Albadr, MAA (corresponding author), Univ Kebangsaan Malaysia, Fac Informat Sci & Technol, CAIT, Bangi, Selangor, Malaysia.	mustafa_abbas1988@yahoo.com	Omar, Khairuddin/C-3534-2017; Hamzah, Faizal Amri/AAM-8817-2020	Omar, Khairuddin/0000-0003-1794-019X; Hamzah, Faizal Amri/0000-0001-6309-6394; Albadr, Musatafa/0000-0003-2062-688X	Universiti Kebangsaan Malaysia [GUP2020-063]	Universiti Kebangsaan Malaysia	This project was funded by Universiti Kebangsaan Malaysia with research code GUP2020-063.	Abbas A, 2021, APPL INTELL, V51, P854, DOI 10.1007/s10489-020-01829-7; Abdel-Nasser M, 2019, ELECTRONICS-SWITZ, V8, DOI 10.3390/electronics8010100; Abdel-Nasser M, 2016, EXPERT SYST APPL, V64, P365, DOI 10.1016/j.eswa.2016.08.026; Al-Dhief FT, 2020, IEEE ACCESS, V8, P64514, DOI 10.1109/ACCESS.2020.2984925; Albadr MAA, 2020, CIRC SYST SIGNAL PR, V39, P4596, DOI 10.1007/s00034-020-01388-9; Albadr MAA, 2019, INT J SPEECH TECHNOL, V22, P711, DOI 10.1007/s10772-019-09621-w; Albadr MAA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194770; Albadra MAA, 2017, INT J APPL ENG RES, V12, P4610; Alqudah AM, 2020, JORDAN J ELECTR ENG, V6, P168, DOI 10.5455/jjee.204-1585312246; Apostolopoulos ID, 2020, PHYS ENG SCI MED, V43, P635, DOI 10.1007/s13246-020-00865-4; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1001/jama.2020.2565, 10.1056/NEJMoa2001316]; Beale MH, 2012, NEURAL NETWORK TOOLB; Bukhari S. U. K., 2020, MEDRXIV2020032620044; Celik HI, 2014, J TEXT I, V105, P575, DOI 10.1080/00405000.2013.827393; Chen HJ, 2020, LANCET, V395, P809, DOI 10.1016/S0140-6736(20)30360-3; Cherian T, 2005, B WORLD HEALTH ORGAN, V83, P353; Cohen JP, 2020, 200611988 ARXIV; DALAL N, 2005, PROC CVPR IEEE, P886, DOI DOI 10.1109/CVPR.2005.177; Dong J, 2017, J MATER CHEM C, V5, P10023, DOI 10.1039/c7tc03343e; Elmousalami H., 2020, MEDRXIV; Ezzat D., 2020, ARXIV200405084; Fang YC, 2020, RADIOLOGY, V296, pE115, DOI 10.1148/radiol.2020200432; Franquet T, 2001, EUR RESPIR J, V18, P196, DOI 10.1183/09031936.01.00213501; Ghoshal B., 2020, ESTIMATING UNCERTAIN, P1; Gozes, 2020, ARXIV200305037, P1; Hemdan E.E.D., 2020, ARXIV; Huang GB, 2006, NEUROCOMPUTING, V70, P489, DOI 10.1016/j.neucom.2005.12.126; Huang GB, 2006, IEEE T NEURAL NETWOR, V17, P879, DOI 10.1109/TNN.2006.875977; Huang GB, 2014, COGN COMPUT, V6, P376, DOI 10.1007/s12559-014-9255-2; Huang GB, 2012, IEEE T SYST MAN CY B, V42, P513, DOI 10.1109/TSMCB.2011.2168604; Khan AI, 2020, COMPUT METH PROG BIO, V196, DOI 10.1016/j.cmpb.2020.105581; Kumar P., 2020, PREPRINT; Lu SY, 2018, J MED IMAG HEALTH IN, V8, P1486, DOI 10.1166/jmihi.2018.2459; Maghdid HS, 2021, PROC SPIE, V11734, DOI 10.1117/12.2588672; Marsboom C, 2018, ECOL INDIC, V87, P209, DOI 10.1016/j.ecolind.2017.10.049; May RJ, 2010, NEURAL NETWORKS, V23, P283, DOI 10.1016/j.neunet.2009.11.009; Meyer D, 2015, INTERFACE LIBSVM PAC, Ve1071, P28; Mu YS, 2018, INFORM SCIENCES, V435, P40, DOI 10.1016/j.ins.2017.12.059; Narin A., 2020, ARXIV200310849; Niu PF, 2016, NEURAL PROCESS LETT, V44, P813, DOI 10.1007/s11063-016-9496-z; Nour M, 2020, APPL SOFT COMPUT, V97, DOI 10.1016/j.asoc.2020.106580; Obaid OI, 2018, INT J ENG TECHNOLOGY, V7, P160, DOI DOI 10.14419/IJET.V7I4.36.23737; Ozturk T, 2020, COMPUT BIOL MED, V121, DOI 10.1016/j.compbiomed.2020.103792; Pakyurek M, 2020, ELEKTRON ELEKTROTECH, V26, P46, DOI 10.5755/j01.eie.26.1.25309; Phung S.L., 2009, MATLAB LIB CONVOLUTI; Punn NS, 2021, APPL INTELL, V51, P2689, DOI 10.1007/s10489-020-01900-3; Shi F, 2021, IEEE REV BIOMED ENG, V14, P4, DOI 10.1109/RBME.2020.2987975; Sokolova M, 2006, LECT NOTES COMPUT SC, V4304, P1015; Sun YN, 2020, IEEE T CYBERNETICS, V50, P3840, DOI 10.1109/TCYB.2020.2983860; Bao TQ, 2020, J INFORM TELECOMMUN, V4, P140, DOI 10.1080/24751839.2019.1666625; Vapnik VN, 1999, IEEE T NEURAL NETWOR, V10, P988, DOI 10.1109/72.788640; Wang SA, 2017, J ADV TRANSPORT, P1, DOI 10.1155/2017/8608032; World Health Organization, 2017, DEPR OTH COMM MENT D, DOI DOI 10.1109/IEEESTD.2017.7920364; Xu M, 2018, IEEE T IMAGE PROCESS, V27, P5044, DOI 10.1109/TIP.2018.2847035; Yu T, 2018, OPT LETT, V43, P1107, DOI 10.1364/OL.43.001107; Zeng JY, 2019, INT J ENTERP INF SYS, V15, P100, DOI 10.4018/IJEIS.2019010106; Zhang J., 2020, ARXIV PREPRINT ARXIV; Zhang YD, 2018, MULTIMED TOOLS APPL, V77, P22629, DOI 10.1007/s11042-017-5023-0; Zhou W, 2020, IEEE T CIRCUITS-II, V67, P946, DOI 10.1109/TCSII.2020.2980557	59	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0242899	10.1371/journal.pone.0242899	http://dx.doi.org/10.1371/journal.pone.0242899			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320858	Green Published, gold			2022-12-27	WOS:000600339800040
J	Nielsen, MBM; Pedersen, T; Mouritzen, A; Vitger, AD; Nielsen, LN; Poulsen, HH; Miles, JE				Nielsen, Michelle Bronniche Moller; Pedersen, Tenna; Mouritzen, Amalie; Vitger, Anne Desire; Nielsen, Lise Nikolic; Poulsen, Helle Harding; Miles, James Edward			Kinetic gait analysis in healthy dogs and dogs with osteoarthritis: An evaluation of precision and overlap performance of a pressure-sensitive walkway and the use of symmetry indices	PLOS ONE			English	Article							GROUND REACTION FORCES; VERTICAL FORCES; LIMB FUNCTION; LAMENESS; VARIANCE; VELOCITY; OBESITY; PADS; SIDE	In veterinary practice, a thorough gait examination is essential in the clinical workup of any orthopedic patient, including the large population of dogs with chronic pain as a result of osteoarthritis. The traditional visual gait examination is, however, a subjective discipline, and systems for kinetic gait analysis may potentially offer an objective alternative for gait assessment by the measurement of ground reaction forces. In order to avoid unnecessary testing of patients, a thorough, stepwise evaluation of the diagnostic performance of each system is recommended before clinical use for diagnostic purposes. The aim of the study was to evaluate the Tekscan pressure-sensitive walkway system by assessing precision (agreement between repetitive measurements in individual dogs) and overlap performance (the ability to distinguish dogs with lameness due to osteoarthritis from clinically healthy dogs). Direction of travel over the walkway was investigated as a possible bias. Symmetry indices are commonly used to assess lameness by comparing ground reaction forces across different combinations of limbs in each dog. However, SIs can be calculated in several different ways and specific recommendations for optimal use of individual indices are currently lacking. Therefore the present study also compared indices in order to recommend a specific index preferable for future studies of canine osteoarthritis. Forty-one clinically healthy dogs and 21 dogs with osteoarthritis were included in the study. High precision was demonstrated. The direction of travel over the walkway was excluded as a possible bias. A significant overlap was observed when comparing ground reaction forces measured in dogs with osteoarthritis compared to clinically healthy dogs. In some affected dogs, symmetry indices comparing contralateral limbs differed from clinically healthy dogs, but in general, the overlap performance was insufficient and, consequently, general use of this method for diagnostic purposes in dogs with osteoarthritis cannot be recommended.	[Nielsen, Michelle Bronniche Moller; Pedersen, Tenna; Mouritzen, Amalie; Vitger, Anne Desire; Nielsen, Lise Nikolic; Poulsen, Helle Harding; Miles, James Edward] Univ Copenhagen, Dept Vet Clin Sci, Frederiksberg, Denmark; [Pedersen, Tenna] Tvingstrup Anim Clin, Horsens, Denmark; [Mouritzen, Amalie] Holstebro Anim Hosp, Holstebro, Denmark	University of Copenhagen	Nielsen, MBM (corresponding author), Univ Copenhagen, Dept Vet Clin Sci, Frederiksberg, Denmark.	mic@sund.ku.dk		Nielsen, Lise Nikolic/0000-0002-3988-0979; Poulsen, Helle Harding/0000-0001-9000-9030; Miles, James/0000-0002-4377-1572; Vitger, Anne Desire/0000-0001-8620-4669	Agria/Swedish Kennel Club; Danish Kennel Club	Agria/Swedish Kennel Club; Danish Kennel Club	This work was supported by the Agria/Swedish Kennel Club (https://www.agria.dk/forskning/om-forskningsfonden/) research fund and the Danish Kennel Club (https://www.dkk.dk/).Authors JEM, HHP, LNN and ADV were involved in the funding process. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinho FS, 2015, VET COMP ORTHOPAED, V28, P25, DOI 10.3415/VCOT-14-05-0081; Souza ANA, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-51; Amimoto H, 2019, AM J VET RES, V80, P461, DOI 10.2460/ajvr.80.5.461; Appelgrein C, 2019, VET COMP ORTHOPAED, V32, P97, DOI 10.1055/s-0038-1677492; Escobar ASA, 2017, ACTA VET SCAND, V59, DOI 10.1186/s13028-017-0344-6; Besancon MF, 2004, AM J VET RES, V65, P1497, DOI 10.2460/ajvr.2004.65.1497; Besancon MF, 2018, VET COMP ORTHOPAED T, V16, P153; Brown DC, 2013, J VET INTERN MED, V27, P22, DOI 10.1111/jvim.12004; Carr J DDL, 2016, RECOVERY REHAB, P93; Cooper C, 1998, AM J EPIDEMIOL, V147, P516; Gibert S, 2010, COMPUT METHOD BIOMEC, V13, P61, DOI 10.1080/10255842.2010.493724; Gillette RL, 2008, VET J, V178, P165, DOI 10.1016/j.tvjl.2008.01.009; Gordon-Evans WJ, 2009, AM J VET RES, V70, P1444, DOI 10.2460/ajvr.70.12.1444; Hoffman CL, 2018, AM J VET RES, V79, P546, DOI 10.2460/ajvr.79.5.546; Johnston SA, 1997, VET CLIN N AM-SMALL, V27, P699, DOI 10.1016/S0195-5616(97)50076-3; Kano WT, 2016, BMC VET RES, V12, DOI 10.1186/s12917-015-0631-2; Keebaugh AE, 2015, JAVMA-J AM VET MED A, V246, P1215, DOI 10.2460/javma.246.11.1215; Khan KS, 2004, BJOG-INT J OBSTET GY, V111, P638, DOI 10.1111/j.1471-0528.2004.00218.x; Khan KS, 2001, BRIT J OBSTET GYNAEC, V108, P562; Kieves NR, 2019, AM J VET RES, V80, P265, DOI 10.2460/ajvr.80.3.265; Kim J, 2011, AM J VET RES, V72, P1171, DOI 10.2460/ajvr.72.9.1171; Kjelgaard-Hansen M, 2011, CLIN LAB MED, V31, P51, DOI 10.1016/j.cll.2010.10.002; Lascelles BDX, 2006, AM J VET RES, V67, P277, DOI 10.2460/ajvr.67.2.277; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; Maitre P, 2008, COMPUT METHOD BIOMEC, V11, P153, DOI 10.1080/10255840802297036; Maitre P., 2007, Computer Methods in Biomechanics and Biomedical Engineering, V10, P111, DOI 10.1080/10255840701479263; Marshall WG, 2009, VET COMP ORTHOPAED, V22, P339, DOI 10.3415/VCOT-08-08-0069; Miles J.E., 2018, P 2018 BRIT SMALL AN, P474; Nordquist B, 2011, VET COMP ORTHOPAED, V24, P435, DOI 10.3415/VCOT-11-01-0015; Quinn MM, 2007, VET SURG, V36, P360, DOI 10.1111/j.1532-950X.2007.00276.x; Sandberg G, 2018, VET COMP ORTHOPAED, V31, P327, DOI 10.1055/s-0038-1666875; Schnabl-Feichter E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208085; Scott H, 2011, IN PRACTICE, V33, P20, DOI 10.1136/inp.c7447; Souza ANA, 2013, VET COMP ORTHOPAED, V26, P6, DOI 10.3415/VCOT-11-07-0100; Volstad N, 2016, VET J, V207, P80, DOI 10.1016/j.tvjl.2015.08.014; Voss K, 2010, VET SURG, V39, P863, DOI 10.1111/j.1532-950X.2010.00729.x; Waxman AS, 2008, VET SURG, V37, P241, DOI 10.1111/j.1532-950X.2008.00372.x; Wilson ML, 2019, AM J VET RES, V80, P403, DOI 10.2460/ajvr.80.4.403; Witte P, 2011, IN PRACTICE, V33, P58, DOI 10.1136/inp.d453	39	5	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243819	10.1371/journal.pone.0243819	http://dx.doi.org/10.1371/journal.pone.0243819			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320889	gold, Green Published			2022-12-27	WOS:000600339800024
J	Phetcharaburanin, J; Deewai, S; Kulthawatsiri, T; Moolpia, K; Suksawat, M; Promraksa, B; Klanrit, P; Namwat, N; Loilome, W; Poopasit, K; Katekaew, S; Phetcharaburanin, P				Phetcharaburanin, Jutarop; Deewai, Suthicha; Kulthawatsiri, Thanaporn; Moolpia, Komkid; Suksawat, Manida; Promraksa, Bundit; Klanrit, Poramate; Namwat, Nisana; Loilome, Watcharin; Poopasit, Kitisak; Katekaew, Somporn; Phetcharaburanin, Penprapa			H-1 NMR metabolic phenotyping of Dipterocarpus alatus as a novel tool for age and growth determination	PLOS ONE			English	Article							MULTIVARIATE STATISTICAL-ANALYSIS; NMR-SPECTROSCOPY; QUALITY	Dipterocarpus alatus belongs to Family Dipterocarpaceae that can be commonly found in Southeast Asian countries. It is a perennial plant with oval-shaped leaves and oleoresin-rich wood. It has been considered as a multipurpose plant since all parts can be practically utilized. One of the major problems for utilizing Dipterocarpus alatus is the difficulty knowing the exact age as this kind of plant is ready for multipurpose use after 20 years of age. At present, the most commonly used method for determining age of Dipterocarpus alatus is the annual ring estimation. However, this conventional method is unable to provide the high precision and accuracy of age determination due to its limitation including blurry annual rings caused by enriched oleoresin in the wood. The current study aimed to investigate the differences of H-1 -NMR spectroscopy-based metabolic profiles from bark and leaf of Dipterocarpus alatus at different ages including 2, 7, 15 and 25 years. Our findings demonstrated that there is a total of 56 metabolites shared between bark and leaf. It is noticeable that bark at different ages exhibited the strongest variation and sugar or sugar derivatives that were found in higher concentrations in bark compared with those in leaf. We found that decreasing levels of certain metabolites including tagatose, 1'kestose and 2'-fucosyllactose exhibited the promising patterns. In conclusion, panel metabolites involved in the sucrose biosynthesis can precisely determine the age and growth of Dipterocarpus alatus.	[Phetcharaburanin, Jutarop; Kulthawatsiri, Thanaporn; Suksawat, Manida; Promraksa, Bundit; Klanrit, Poramate; Namwat, Nisana; Loilome, Watcharin] Khon Kaen Univ, Dept Biochem, Fac Med, Khon Kaen, Thailand; [Phetcharaburanin, Jutarop; Kulthawatsiri, Thanaporn; Suksawat, Manida; Promraksa, Bundit; Klanrit, Poramate; Namwat, Nisana; Loilome, Watcharin] Khon Kaen Univ, Cholangiocarcinoma Res Inst, Fac Med, Khon Kaen, Thailand; [Phetcharaburanin, Jutarop; Deewai, Suthicha; Kulthawatsiri, Thanaporn; Suksawat, Manida; Promraksa, Bundit; Klanrit, Poramate; Namwat, Nisana; Loilome, Watcharin] Khon Kaen Univ, Int Phenome Lab, Northeastern Sci Pk, Khon Kaen, Thailand; [Phetcharaburanin, Jutarop] Khon Kaen Univ, Ctr Excellence Innovat Chem, Fac Sci, Khon Kaen, Thailand; [Deewai, Suthicha; Moolpia, Komkid; Katekaew, Somporn] Khon Kaen Univ, Dept Biochem, Fac Sci, Khon Kaen, Thailand; [Moolpia, Komkid; Phetcharaburanin, Penprapa] Khon Kaen Univ, Museum & Lifelong Learning Ctr, Khon Kaen, Thailand; [Poopasit, Kitisak] Khon Kaen Univ, Dept Chem, Fac Sci, Khon Kaen, Thailand; [Phetcharaburanin, Penprapa] Khon Kaen Univ, Dept Environm Sci, Fac Sci, Khon Kaen, Thailand; [Phetcharaburanin, Penprapa] Khon Kaen Univ, Coordinat Ctr Royal Initiat Projects, Khon Kaen, Thailand	Khon Kaen University; Khon Kaen University; Khon Kaen University; Khon Kaen University; Khon Kaen University; Khon Kaen University; Khon Kaen University; Khon Kaen University; Khon Kaen University	Phetcharaburanin, P (corresponding author), Khon Kaen Univ, Museum & Lifelong Learning Ctr, Khon Kaen, Thailand.; Phetcharaburanin, P (corresponding author), Khon Kaen Univ, Dept Environm Sci, Fac Sci, Khon Kaen, Thailand.; Phetcharaburanin, P (corresponding author), Khon Kaen Univ, Coordinat Ctr Royal Initiat Projects, Khon Kaen, Thailand.	penprapa@kku.ac.th	katekaew, somporn/AAP-2904-2021; Loilome, Watcharin/AAW-6203-2021; Promraksa, Bundit/AAI-5552-2021	katekaew, somporn/0000-0002-0651-0787; Klanrit, Poramate/0000-0003-0209-3901; Phetcharaburanin, Jutarop/0000-0003-4727-8395	Khon Kaen University [KKU62]	Khon Kaen University	This study was funded by a grant from Khon Kaen University (KKU62) to PP.	Ankarfjard R, 1998, ECON BOT, V52, P7, DOI 10.1007/BF02861291; [Anonymous], 2016, PLANT GENETIC CONSER; Barcelo AR, 1997, INT REV CYTOL, V176, P87, DOI 10.1016/S0074-7696(08)61609-5; Bawa K.S., 1998, REV DIPTEROCARPS TAX; Beckonert O, 2010, NAT PROTOC, V5, P1019, DOI 10.1038/nprot.2010.45; Cho LH, 2018, J PLANT BIOL, V61, P121, DOI 10.1007/s12374-018-0081-z; Dona AC, 2014, ANAL CHEM, V86, P9887, DOI 10.1021/ac5025039; Ducatez-Boyer L., MULTIPLE FUNCTIONS T, P7; Dyrmose A.-M. H., EC IMPORTANCE OLEORE, V19; EQ W, 2012, AM J THER, V19, pe157; Gao S, 2017, ANN FOREST SCI, V74, DOI 10.1007/s13595-017-0623-4; Harman R., MULTIVARIATE STAT AN, P57, DOI [10.1016/j.foodres.2020.109299, DOI 10.1016/J.FOODRES.2020.109299]; Khiev P, 2012, CHEM PHARM BULL, V60, P955, DOI 10.1248/cpb.c12-00012; Kim HK, 2010, NAT PROTOC, V5, P536, DOI 10.1038/nprot.2009.237; Kim JH, 2005, HYDROL PROCESS, V19, P1261, DOI 10.1002/hyp.5565; Liu QQ, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020335; Menges M, 2006, PLANT CELL, V18, P893, DOI 10.1105/tpc.105.039636; Muhtadi K.H.Y., 2014, J ADV CHEM, V9, P1861; Noori R, 2010, DESALINATION, V260, P129, DOI 10.1016/j.desal.2010.04.053; Orwa, 2009, AGROFORESTRY DATABAS; Orwa C, 2009, AGROFORESTRY TREE DA; Paine CET, 2010, FUNCT ECOL, V24, P1202, DOI 10.1111/j.1365-2435.2010.01736.x; Paul MJ, 2001, J EXP BOT, V52, P1383, DOI 10.1093/jexbot/52.360.1383; Press MC, 1999, NEW PHYTOL, V143, P213, DOI 10.1046/j.1469-8137.1999.00432.x; Promraksa B, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216721; Rivera-Mondragon A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38334-4; Thitisaksakul M., 2017, 318428 PLANT BIOCH, P74; Tognetti JA, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.23316; WOLF S, 1993, POTATO RES, V36, P253, DOI 10.1007/BF02360534; Yongram C, 2019, MOLECULES, V24, DOI 10.3390/molecules24173083	30	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243432	10.1371/journal.pone.0243432	http://dx.doi.org/10.1371/journal.pone.0243432			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320902	gold, Green Published			2022-12-27	WOS:000600339800002
J	Romeo, M; Yepes-Baldo, M; Westerberg, K; Nordin, M				Romeo, Marina; Yepes-Baldo, Montserrat; Westerberg, Kristina; Nordin, Maria			Cognitive job crafting as mediator between behavioral job crafting and quality of care in residential homes for the elderly	PLOS ONE			English	Article							NURSE BURNOUT; WORK; HEALTH; EMPLOYEES; STAFF; SATISFACTION; PERFORMANCE; ENVIRONMENT; VALIDATION; ATTITUDES	Extending previous studies on job crafting, the aim of the present study is to analyze the effect of job crafting on quality of care in residential homes for elderly people in two European countries (Spain and Sweden). We hypothesize that cognitive crafting could be a consequence of behavioral crafting and that it will mediate the relationship between behavioral crafting and the perception of quality of care. A correlational design was used, with two-waves approximately 12 months apart (n = 226). Our results indicate that behavioral job crafting at T1 had an effect on cognitive job crafting at T2, relational job crafting at T1 increases quality of care at T2, and the mediation effect of cognitive job crafting. These results indicate that we must differentiate between the two forms of crafting (behavioral and cognitive), not as indicators of the same latent construct, but as aggregates. Additionally, we point out two main implications for managerial practice. First, as relational job crafting has a direct effect on quality of care, it is important to assure an organizational culture oriented towards employees. Secondly, due to the mediation effect of cognitive job crafting, managers should facilitate meaningful work environments. To do so, jobs should be re-designed, increasing skills variety, identity and significance.	[Romeo, Marina; Yepes-Baldo, Montserrat] Univ Barcelona, Fac Psychol, Res Grp Social Environm & Org Psychol 2014SGR992, Barcelona, Spain; [Westerberg, Kristina; Nordin, Maria] Umea Univ, Dept Psychol, Umea, Sweden	University of Barcelona; Umea University	Yepes-Baldo, M (corresponding author), Univ Barcelona, Fac Psychol, Res Grp Social Environm & Org Psychol 2014SGR992, Barcelona, Spain.	myepes@ub.edu	Romeo, Marina/G-8953-2011; Yepes-Baldó, Montserrat/G-2207-2011	Romeo, Marina/0000-0002-6961-6626; Yepes-Baldó, Montserrat/0000-0002-7374-433X	Swedish Research Council for Health, Working Life and Welfare - FORTE [2015-00708]	Swedish Research Council for Health, Working Life and Welfare - FORTE	KW received funding from the Swedish Research Council for Health, Working Life and Welfare - FORTE (Forte Dnr 2015-00708). https://forte.se/en/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACME Resistance, 2018, ACME, V17, P1; Aiken LH, 2002, JAMA-J AM MED ASSOC, V288, P1987, DOI 10.1001/jama.288.16.1987; Ashforth BE, 1999, ACAD MANAGE REV, V24, P413, DOI 10.5465/AMR.1999.2202129; Associacio Catalana de Recursos Assistencials, 2016, INF EC SOC ACRA; Avey JB, 2008, J APPL BEHAV SCI, V44, P48, DOI 10.1177/0021886307311470; Bakker AB, 2018, J NURS MANAGE, V26, P321, DOI 10.1111/jonm.12551; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Berdicchia D, 2016, J MANAGE PSYCHOL, V31, P318, DOI 10.1108/JMP-01-2014-0019; Berg JM, 2010, ORGAN SCI, V21, P973, DOI 10.1287/orsc.1090.0497; Bindl UK, 2019, J APPL PSYCHOL, V104, P605, DOI 10.1037/apl0000362; Brenninkmeijer V, 2015, CAREER DEV INT, V20, P147, DOI 10.1108/CDI-12-2014-0162; Cenciotti R, 2017, J LEADERSH ORG STUD, V24, P372, DOI 10.1177/1548051816680558; Crant JM, 2000, J MANAGE, V26, P435, DOI 10.1177/014920630002600303; DECI EL, 1989, J APPL PSYCHOL, V74, P580, DOI 10.1037/0021-9010.74.4.580; Den Hartog DN, 2007, J APPL PSYCHOL, V92, P1131, DOI 10.1037/0021-9010.92.4.1131; EC, 2021, 2018 AG REP EC BUDG; French F, 2007, HEALTH SERV MANAG RE, V20, P153, DOI 10.1258/095148407781395982; Gagne M, 2003, MOTIV EMOTION, V27, P199, DOI 10.1023/A:1025007614869; Ghitulescu B, 2006, SHAPING TASKS UNPUB, DOI [10.1007/s00464-005-3008-y, DOI 10.1007/S00464-005-3008-Y]; Gordon HJ, 2015, J PERS PSYCHOL, V14, P192, DOI 10.1027/1866-5888/a000138; Grant AM, 2008, RES ORGAN BEHAV, V28, P3, DOI 10.1016/j.riob.2008.04.002; Hackman J.R., 1980, WORK REDESIGN; HACKMAN JR, 1975, J APPL PSYCHOL, V60, P159, DOI 10.1037/h0076546; Halbesleben JRB, 2011, EUR J WORK ORGAN PSY, V20, P68, DOI 10.1080/1359432X.2010.514327; Hannan S., 2001, REV CLIN GERONTOLOGY, V11, P189, DOI 10.1017/S0959259801112104; Hasson H, 2009, INT J NURS STUD, V46, P470, DOI 10.1016/j.ijnurstu.2008.04.007; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Hayes AF, 2017, AUSTRALAS MARK J, V25, P76, DOI 10.1016/j.ausmj.2017.02.001; Hofstede G, 1998, ORGAN STUD, V19, P477, DOI 10.1177/017084069801900305; Hoftede G., 2010, CULTURES ORG SOFTWAR; Leana C, 2009, ACAD MANAGE J, V52, P1169, DOI 10.5465/AMJ.2009.47084651; Letona-Ibanez O, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223539; Lichtenthaler PW, 2019, EUR J WORK ORGAN PSY, V28, P30, DOI 10.1080/1359432X.2018.1527767; Loerbroks A, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3016-y; MacKenzie SB, 2005, J APPL PSYCHOL, V90, P710, DOI 10.1037/0021-9010.90.4.710; Majeed A, 2007, BMJ-BRIT MED J, V335, P916, DOI 10.1136/bmj.39337.539120.AD; Marshall M, 2003, MEASURING GEN PRACTI; McKenzie JAL, 2011, J NURS SCHOLARSHIP, V43, P181, DOI 10.1111/j.1547-5069.2011.01387.x; Molina A, 2015, EUR J WORK ORGAN PSY, V24, P627, DOI 10.1080/1359432X.2014.960401; Nielsen K, 2012, WORK STRESS, V26, P91, DOI 10.1080/02678373.2012.682721; Niessen C, 2016, HUM RELAT, V69, P1287, DOI 10.1177/0018726715610642; Parker SK, 2010, J MANAGE, V36, P633, DOI 10.1177/0149206308321554; Petrou P, 2013, GEDRAG ORGAN, V26, P32; Plomp J, 2016, CAREER DEV INT, V21, P587, DOI 10.1108/CDI-08-2016-0145; Poghosyan L, 2010, RES NURS HEALTH, V33, P288, DOI 10.1002/nur.20383; Purdy N, 2010, J NURS MANAGE, V18, P901, DOI 10.1111/j.1365-2834.2010.01172.x; RKA, 2019, COUNC PROM MUN AN; Rofcanin Y, 2019, HUM RELAT, V72, P859, DOI 10.1177/0018726718779121; Romeo M, 2018, PSYCHOLOGY, V9, P2649, DOI [10.4236/psych.2018.912151, DOI 10.4236/PSYCH.2018.912151]; Rudolph CW, 2017, J VOCAT BEHAV, V102, P112, DOI 10.1016/j.jvb.2017.05.008; Slemp G.R., 2013, INT J WELLBEING, V3, P126, DOI [10.5502/ijw.v3i2.1, DOI 10.5502/IJW.V3I2.1, https://doi.org/10.5502/ijw.v3i2.1]; Slemp GR, 2014, J HAPPINESS STUD, V15, P957, DOI 10.1007/s10902-013-9458-3; Teoh K, 2019, WORK STRESS, V33, P385, DOI 10.1080/02678373.2019.1598514; Tims M, 2015, EUR J WORK ORGAN PSY, V24, P914, DOI 10.1080/1359432X.2014.969245; Tims M, 2012, J VOCAT BEHAV, V80, P173, DOI 10.1016/j.jvb.2011.05.009; Tims M, 2010, SA J IND PSYCHOL, V36, DOI 10.4102/sajip.v36i2.841; Unsworth K, 2004, 18 ANN AUSTR NZ AC M, P1; Vermooten N, 2019, SA J IND PSYCHOL, V45, DOI 10.4102/sajip.v45i0.1567; Weigl M, 2015, EUR J PEDIATR, V174, P1237, DOI 10.1007/s00431-015-2529-1; Westerberg K, 2014, HEALTH SOC CARE COMM, V22, P461, DOI 10.1111/hsc.12084; Wrzesniewski A, 2001, ACAD MANAGE REV, V26, P179, DOI 10.2307/259118; Wrzesniewski A, 2010, HARV BUS REV, V88; Yepes-Baldo M, 2018, WESTERN J NURS RES, V40, P52, DOI 10.1177/0193945916680614; Zhang FF, 2019, J ORGAN BEHAV, V40, P126, DOI 10.1002/job.2332	64	4	4	7	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243726	10.1371/journal.pone.0243726	http://dx.doi.org/10.1371/journal.pone.0243726			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH3TP	33320911	gold, Green Published			2022-12-27	WOS:000600339800062
J	Macdonald, KE; Stacey, HJ; Harkin, G; Hall, LML; Young, MJ; Jones, JD				Macdonald, Katherine E.; Stacey, Helen J.; Harkin, Gillian; Hall, Lesley M. L.; Young, Matthew J.; Jones, Joshua D.			Patient perceptions of phage therapy for diabetic foot infection	PLOS ONE			English	Article								Infections of diabetic foot ulcers are common, generally recalcitrant and often complicated by antibiotic resistance. Alternative antimicrobial strategies are needed. Phage therapy is a promising alternative that is being rediscovered. Despite phage therapy's 100-year history, there have been no investigations into patient thoughts and concerns. This study aimed to explore patient awareness of and concern about antibiotic resistance and gain insight into the perceptions of phage therapy among a patient group that could potentially benefit from phage therapy. Patients with an active or resolved (healed or amputated) diabetic foot ulcer were eligible to participate. A survey was distributed digitally to eligible patients across Scotland via the NHS Research Scotland Diabetes Network and hard copies were available in diabetic foot clinics at the Royal Infirmary of Edinburgh and Queen Elizabeth University Hospital, Glasgow. A focus group of five survey respondents was held in Glasgow. Fifty-five survey responses were obtained. There was a high level of awareness (76.4%; N = 55) and concern (83.3%; N = 54) about antibiotic resistance. While largely aware of viruses, most patients had not heard of phage or phage therapy. Patients were no more concerned about phage than antibiotic therapy, with most suggesting more information could alleviate any concerns. Patient acceptability of phage therapy was high, a finding confirmed by the focus group. Patients are concerned about antibiotic resistance and supportive of 'new' antimicrobials. We have demonstrated that patients are supportive, enthusiastic and accepting of phage therapy. Although 'Western' phage therapy remains in its infancy, an understanding of patient ideas, concerns and expectations will be important in eventually shaping and successfully reintroducing phage therapy.	[Macdonald, Katherine E.; Jones, Joshua D.] Univ Edinburgh, Edinburgh Med Sch Biomed Sci, Infect Med, Edinburgh, Midlothian, Scotland; [Stacey, Helen J.] Univ Edinburgh, Edinburgh Med Sch, Edinburgh, Midlothian, Scotland; [Harkin, Gillian; Hall, Lesley M. L.] Queen Elizabeth Univ Hosp, Diabet & Endocrinol, Glasgow, Lanark, Scotland; [Young, Matthew J.] Royal Infirm Edinburgh NHS Trust, Outpatient Dept 2, Diabet Foot Clin, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; Queen Elizabeth University Hospital (QEUH); Royal Infirmary of Edinburgh; University of Edinburgh	Jones, JD (corresponding author), Univ Edinburgh, Edinburgh Med Sch Biomed Sci, Infect Med, Edinburgh, Midlothian, Scotland.	josh.jones@ed.ac.uk			University of Edinburgh/Medical Research Council Confidence in Concept Grant [MC_PC_18046]; NHS Research Scotland (NRS), through Diabetes Network; MRC [MC_PC_18046] Funding Source: UKRI	University of Edinburgh/Medical Research Council Confidence in Concept Grant; NHS Research Scotland (NRS), through Diabetes Network; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was part of a University of Edinburgh/Medical Research Council Confidence in Concept Grant awarded to JDJ (MC_PC_18046). We also acknowledge the financial support of NHS Research Scotland (NRS), through Diabetes Network. The funders had no role in the design of the study and collection, analysis, or interpretation of data nor in writing the manuscript.	Abedon ST, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00981; Armstrong DG, 2017, NEW ENGL J MED, V376, P2367, DOI 10.1056/NEJMra1615439; Brookes-Howell L, 2012, J GEN INTERN MED, V27, P766, DOI 10.1007/s11606-011-1916-1; Comeau AM, 2008, RES MICROBIOL, V159, P306, DOI 10.1016/j.resmic.2008.05.001; Dedrick RM, 2019, NAT MED, V25, P730, DOI 10.1038/s41591-019-0437-z; Eleftheriadou L, 2010, DRUGS, V70, P1785, DOI 10.2165/11538070-000000000-00000; Fish R, 2016, J WOUND CARE, V25, pS27, DOI 10.12968/jowc.2016.25.Sup7.S27; Goettsche LS, 2019, J DERMATOL TREAT, V30, P92, DOI 10.1080/09546634.2018.1473549; Gupta P, 2019, INT J LOW EXTR WOUND, V18, P171, DOI 10.1177/1534734619835115; Henig O, 2018, OPEN FORUM INFECT DI, P5, DOI [10.1093/ofid/ofy245, DOI 10.1093/0FID/0FY245]; Jault P, 2019, LANCET INFECT DIS, V19, P35, DOI 10.1016/S1473-3099(18)30482-1; Kortright KE, 2019, CELL HOST MICROBE, V25, P219, DOI 10.1016/j.chom.2019.01.014; Morozova VV, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01696; Patel DR, 2021, INT J LOW EXTR WOUND, V20, P37, DOI 10.1177/1534734619881076; Prompers L, 2007, DIABETOLOGIA, V50, P18, DOI 10.1007/s00125-006-0491-1; Ray A, 2015, J AM PODIAT MED ASSN, V105, P520, DOI 10.7547/14-036.1; Rhoads D D, 2009, J Wound Care, V18, P237; Rogoz P, 2019, PHAGE THERAPY: A PRACTICAL APPROACH, P189, DOI 10.1007/978-3-030-26736-0_8; Schooley RT, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.00954-17; Scottish Diabetes Survey Monitoring Group, 2018, SCOTT DIAB SURV 2018; Stacey HJ, 2019, ACTA DIABETOL, V56, P907, DOI 10.1007/s00592-019-01301-0; Tascini C, 2011, DIABETES RES CLIN PR, V94, P133, DOI 10.1016/j.diabres.2011.07.017; The International Diabetes Federation, 2020, DIAB FACTS FIG; Weber-Dabrowska B., 2001, Clinical and Applied Immunology Reviews, V1, P131, DOI 10.1016/S1529-1049(01)00015-0; Wright A, 2009, CLIN OTOLARYNGOL, V34, P349, DOI 10.1111/j.1749-4486.2009.01973.x; Young MJ, 2020, CLIN AUDIT DAT UNPUB	26	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243947	10.1371/journal.pone.0243947	http://dx.doi.org/10.1371/journal.pone.0243947			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315926	gold, Green Published			2022-12-27	WOS:000600186100044
J	Togao, O; Chikui, T; Tokumori, K; Kami, Y; Kikuchi, K; Momosaka, D; Kikuchi, Y; Kuga, D; Hata, N; Mizoguchi, M; Iihara, K; Hiwatashi, A				Togao, Osamu; Chikui, Toru; Tokumori, Kenji; Kami, Yukiko; Kikuchi, Kazufumi; Momosaka, Daichi; Kikuchi, Yoshitomo; Kuga, Daisuke; Hata, Nobuhiro; Mizoguchi, Masahiro; Iihara, Koji; Hiwatashi, Akio			Gamma distribution model of diffusion MRI for the differentiation of primary central nerve system lymphomas and glioblastomas	PLOS ONE			English	Article							INTRAVOXEL INCOHERENT MOTION; PRIMARY CNS LYMPHOMA; DIAGNOSTIC PERFORMANCE; WEIGHTED MRI; PERFUSION; BRAIN; CANCER; GLIOMA; TUMORS; DWI	The preoperative imaging-based differentiation of primary central nervous system lymphomas (PCNSLs) and glioblastomas (GBs) is of high importance since the therapeutic strategies differ substantially between these tumors. In this study, we investigate whether the gamma distribution (GD) model is useful in this differentiation of PNCSLs and GBs. Twenty-seven patients with PCNSLs and 57 patients with GBs were imaged with diffusion-weighted imaging using 13 b-values ranging from 0 to 1000 sec/mm(2). The shape parameter (kappa) and scale parameter (theta) were obtained with the GD model. Fractions of three different areas under the probability density function curve (f1, f2, f3) were defined as follows: f1, diffusion coefficient (D) <1.0x10(-3) mm(2)/sec; f2, D >1.0x10(-3) and <3.0x10(-3) mm(2)/sec; f3, D >3.0x10(-3) mm(2)/sec. The GD model-derived parameters were compared between PCNSLs and GBs. Receiver operating characteristic (ROC) curve analyses were performed to assess diagnostic performance. The correlations with intravoxel incoherent motion (IVIM)-derived parameters were evaluated. The PCNSL group's kappa (2.26 +/- 1.00) was significantly smaller than the GB group's (3.62 +/- 2.01, p = 0.0004). The PCNSL group's f1 (0.542 +/- 0.107) was significantly larger than the GB group's (0.348 +/- 0.132, p<0.0001). The PCNSL group's f2 (0.372<plus/minus>0.098) was significantly smaller than the GB group's (0.508 +/- 0.127, p<0.0001). The PCNSL group's f3 (0.086<plus/minus>0.043) was significantly smaller than the GB group's (0.144 +/- 0.062, p<0.0001). The combination of <kappa>, f1, and f3 showed excellent diagnostic performance (area under the curve, 0.909). The f1 had an almost perfect inverse correlation with D. The f2 and f3 had very strong positive correlations with D and f, respectively. The GD model is useful for the differentiation of GBs and PCNSLs.	[Togao, Osamu] Kyushu Univ, Grad Sch Med Sci, Dept Mol Imaging & Diag, Fukuoka, Japan; [Chikui, Toru; Kami, Yukiko] Kyushu Univ, Fac Dent Sci, Dept Oral & Maxillofacial Radiol, Fukuoka, Japan; [Tokumori, Kenji] Teikyo Univ, Fac Med Technol, Dept Clin Radiol, Fukuoka, Japan; [Kikuchi, Kazufumi; Momosaka, Daichi; Kikuchi, Yoshitomo; Hiwatashi, Akio] Kyushu Univ, Grad Sch Med Sci, Dept Clin Radiol, Fukuoka, Japan; [Kuga, Daisuke; Hata, Nobuhiro; Mizoguchi, Masahiro; Iihara, Koji] Kyushu Univ, Grad Sch Med Sci, Dept Neurosurg, Fukuoka, Japan	Kyushu University; Kyushu University; Teikyo University; Kyushu University; Kyushu University	Togao, O (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Mol Imaging & Diag, Fukuoka, Japan.	togao@radiol.med.kyushu-u.ac.jp	Kikuchi, Kazufumi/AAP-4286-2021; Hata, Nobuhiro/AAF-3034-2021; Togao, Osamu/AAE-4702-2022	Kikuchi, Kazufumi/0000-0003-1292-1846; Hata, Nobuhiro/0000-0002-5523-7166; Togao, Osamu/0000-0002-5910-7852	JSPS KAKENHI [JP17K10410, JP20K08111]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number JP17K10410 and JP20K08111. O.T. recieved these grants. https://www.jsps.go.jp/j-grantsinaid/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, MAT SCI SEMICON PROC, V44, P30; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; Bao SX, 2019, MAGN RESON MED SCI, V18, P53, DOI 10.2463/mrms.mp.2017-0135; Borlinhas F, 2019, J MAGN RESON IMAGING, V50, P230, DOI 10.1002/jmri.26599; Cha S, 2002, RADIOLOGY, V223, P11, DOI 10.1148/radiol.2231010594; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Doskaliyev A, 2012, EUR J RADIOL, V81, P339, DOI 10.1016/j.ejrad.2010.11.005; Efroymson MA, 1960, MATH METHODS DIGITAL; El Khouli RH, 2009, J MAGN RESON IMAGING, V30, P999, DOI 10.1002/jmri.21947; Grinberg F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089225; Guo AC, 2002, RADIOLOGY, V224, P177, DOI 10.1148/radiol.2241010637; Hardee ME, 2012, AM J PATHOL, V181, P1126, DOI 10.1016/j.ajpath.2012.06.030; Hartmann M, 2003, NEUROSCI LETT, V338, P119, DOI 10.1016/S0304-3940(02)01367-8; Jensen JH, 2010, NMR BIOMED, V23, P698, DOI 10.1002/nbm.1518; Kickingereder P, 2014, RADIOLOGY, V272, P843, DOI 10.1148/radiol.14132740; Koh DM, 2011, AM J ROENTGENOL, V196, P1351, DOI 10.2214/AJR.10.5515; Latt J, 2008, MAGN RESON IMAGING, V26, P77, DOI 10.1016/j.mri.2007.04.001; Law M, 2002, RADIOLOGY, V222, P715, DOI 10.1148/radiol.2223010558; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671; LEBIHAN D, 1991, JMRI-J MAGN RESON IM, V1, P7, DOI 10.1002/jmri.1880010103; Lee B, 2018, AM J NEURORADIOL, V39, P1415, DOI 10.3174/ajnr.A5732; Lu XY, 2019, NEUROL SCI, V40, P947, DOI 10.1007/s10072-019-03732-7; Minosse S, 2017, MAGN RESON IMAGING, V42, P114, DOI 10.1016/j.mri.2017.06.006; Oshio K, 2014, MAGN RESON MED SCI, V13, P191, DOI 10.2463/mrms.2014-0016; Ostrom QT, 2019, NEURO-ONCOLOGY, V21, pV1, DOI 10.1093/neuonc/noz150; PEKAR J, 1992, MAGNET RESON MED, V23, P122, DOI 10.1002/mrm.1910230113; Schaff LR, 2018, CURR ONCOL REP, V20, DOI 10.1007/s11912-018-0666-1; Server A, 2009, ACTA RADIOL, V50, P682, DOI 10.1080/02841850902933123; Shinmoto H, 2015, J MAGN RESON IMAGING, V42, P56, DOI 10.1002/jmri.24761; Smith G, 2018, J BIG DATA-GER, V5, DOI 10.1186/s40537-018-0143-6; Suchorska B, 2016, NEURO-ONCOLOGY, V18, P549, DOI 10.1093/neuonc/nov326; Tomita H, 2020, MAGN RESON MED SCI, V19, P40, DOI 10.2463/mrms.mp.2018-0124; Yamada K, 2016, MAGN RESON MED SCI, V15, P237, DOI 10.2463/mrms.mp.2015-0067; Yamashita K, 2016, J MAGN RESON IMAGING, V44, P1256, DOI 10.1002/jmri.25261; Yamashita K, 2013, NEURORADIOLOGY, V55, P135, DOI 10.1007/s00234-012-1089-6; YOUDEN W. J., 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Yuan J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087024	38	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243839	10.1371/journal.pone.0243839	http://dx.doi.org/10.1371/journal.pone.0243839			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315914	gold, Green Published			2022-12-27	WOS:000600186100076
J	Mead, C; Supriya, K; Zheng, Y; Anbar, AD; Collins, JP; LePore, P; Brownell, SE				Mead, Chris; Supriya, K.; Zheng, Yi; Anbar, Ariel D.; Collins, James P.; LePore, Paul; Brownell, Sara E.			Online biology degree program broadens access for women, first-generation to college, and low-income students, but grade disparities remain	PLOS ONE			English	Article							STEREOTYPE THREAT; GENDER GAPS; STEM MAJORS; PARTICIPATION; COMMUNITY; COURSES; ACHIEVEMENT; PERFORMANCE; IMPACT; ETHNICITY	Online education has grown rapidly in recent years with many universities now offering fully online degree programs even in STEM disciplines. These programs have the potential to broaden access to STEM degrees for people with social identities currently underrepresented in STEM. Here, we ask to what extent is that potential realized in terms of student enrollment and grades for a fully online degree program. Our analysis of data from more than 10,000 course-enrollments compares student demographics and course grades in a fully online biology degree program to demographics and grades in an equivalent in-person biology degree program at the same university. We find that women, first-generation to college students and students eligible for federal Pell grants constitute a larger proportion of students in the online program compared to the in-person mode. However, the online mode of instruction is associated with lower course grades relative to the in-person mode. Moreover, African American/Black, Hispanic/Latinx, Native American, and Pacific Islander students as well as federal Pell grant eligible students earned lower grades than white students and non-Pell grant eligible students, respectively, but the grade disparities were similar among both in-person and online student groups. Finally, we find that grade disparities between men and women are larger online compared to in-person, but that for first-generation to college women, the online mode of instruction is associated with little to no grade gap compared to continuing generation women. Our findings indicate that although this online degree program broadens access for some student populations, inequities in the experience remain and need to be addressed in order for online education to achieve its inclusive mission.	[Mead, Chris] Arizona State Univ, Ctr Educ Explorat, Sch Earth & Space Explorat, Tempe, AZ USA; [Supriya, K.; Brownell, Sara E.] Arizona State Univ, Res Inclus STEM Educ Ctr, Sch Life Sci, Biol Educ Res Lab, Tempe, AZ 85281 USA; [Zheng, Yi] Arizona State Univ, Mary Lou Fulton Teachers Coll, Sch Math & Stat Sci, Tempe, AZ USA; [Anbar, Ariel D.] Arizona State Univ, Ctr Educ Explorat, Sch Earth & Space Explorat, Sch Mol Sci, Tempe, AZ USA; [Collins, James P.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [LePore, Paul] Arizona State Univ, Coll Liberal Arts & Sci, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Brownell, SE (corresponding author), Arizona State Univ, Res Inclus STEM Educ Ctr, Sch Life Sci, Biol Educ Res Lab, Tempe, AZ 85281 USA.	Sara.Brownell@asu.edu		Mead, Chris/0000-0003-4547-6830; Zheng, Yi/0000-0003-2671-0820; Anbar, Ariel/0000-0002-6015-7750	Howard Hughes Medical Institute [GT11046]; National Science Foundation [1711272]	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Science Foundation(National Science Foundation (NSF))	This work was supported by grant #GT11046 from the Howard Hughes Medical Institute (www.hhmi.org), awarded to JPC, SEB, PL, and ADA and grant #1711272 from the National Science Foundation (www.nsf.gov), awarded to SEB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon S, 2007, SOC SCI RES, V36, P1475, DOI 10.1016/j.ssresearch.2007.01.006; Alpert WT, 2016, AM ECON REV, V106, P378, DOI 10.1257/aer.p20161057; [Anonymous], 2015, CRIT CARE S1, V19, pP1; [Anonymous], 2019, LANCET DIGITAL HLTH; [Anonymous], 2020, NY TIMES; Ashby J, 2011, J INTERACT ONLINE LE, V10, P128; Bailey A.N, 2018, MAKING DIGITAL LEARN; Bailey T., 2005, WHAT WE KNOW COMMUNI; Ballen CJ, 2019, BIOSCIENCE, V69, P669, DOI 10.1093/biosci/biz069; Barto K., 2019, MUMIN MULTIMODEL INF; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bensimon EM, 2016, MISBEGOTTEN URM DATA; Bettinger EP, 2017, AM ECON REV, V107, P2855, DOI 10.1257/aer.20151193; Carey RL, 2014, URBAN EDUC, V49, P440, DOI 10.1177/0042085913507459; Caspi A, 2008, COMPUT EDUC, V50, P718, DOI 10.1016/j.compedu.2006.08.003; COLLINS PH, 1986, SOC PROBL, V33, pS14, DOI 10.1525/sp.1986.33.6.03a00020; Combahee River Collective, 1977, COMBAHEE RIVER COLLE; Conger D, 2010, ANN AM ACAD POLIT SS, V627, P184, DOI 10.1177/0002716209348751; Cooper KM, 2019, ADV PHYSIOL EDUC, V43, P221, DOI 10.1152/advan.00028.2019; Cooper KM, 2018, ADV PHYSIOL EDUC, V42, P200, DOI 10.1152/advan.00085.2017; Cotner S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189610; Crenshaw K., 1989, UNIV CHICAGO LEG FOR, V8, P139, DOI DOI 10.4324/9780429500480-5; DAVIS Angela, 1981, WOMEN RACE CLASS; Drew JC, 2016, CBE-LIFE SCI EDUC, V15, DOI 10.1187/cbe.16-01-0065; Eddy SL, 2016, PHYS REV PHYS EDUC R, V12, DOI 10.1103/PhysRevPhysEducRes.12.020106; Eddy SL, 2015, CBE-LIFE SCI EDUC, V14, DOI 10.1187/cbe.15-05-0108; Eddy SL, 2014, CBE-LIFE SCI EDUC, V13, P453, DOI 10.1187/cbe.14-03-0050; Eddy SL, 2014, CBE-LIFE SCI EDUC, V13, P478, DOI 10.1187/cbe.13-10-0204; Enders CK, 2007, PSYCHOL METHODS, V12, P121, DOI 10.1037/1082-989X.12.2.121; Farooq F, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.1737; Figlio D, 2013, J LABOR ECON, V31, P763, DOI 10.1086/669930; Flowers L. O, 2011, DIVERSE ISSUES HIGHE, V28, P19; Ginder SA, 2019, 2019021 NCES; Harackiewicz JM, 2016, J PERS SOC PSYCHOL, V111, P745, DOI 10.1037/pspp0000075; Harackiewicz JM, 2014, J EDUC PSYCHOL, V106, P375, DOI 10.1037/a0034679; Harding S, 1995, SYNTHESE, V104, P331, DOI 10.1007/BF01064504; Hart CMD, 2018, EDUC FINANC POLICY, V13, P42, DOI 10.1162/edfp_a_00218; Hillman Nicholas., 2016, ED DESERTS CONTINUED; Hillman NW, 2016, AM EDUC RES J, V53, P987, DOI 10.3102/0002831216653204; Huberth M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137001; IBGE Instituto Brasileiro de Geografia e Estatistica, 2019, CENS AGR 2017 RES DE, V8, P1, DOI [10.5603/DK.2019.0001, DOI 10.5603/DK.2019.0001]; Intemann K., 2009, SOC EPISTEMOL, V23, P249, DOI [10.1080/02691720903364134, DOI 10.1080/02691720903364134]; Jaggars S., 2011, COMMUNITY COLL RES C, V52, P1; Johnson Hans, 2014, ONLINE LEARNING STUD; Jordan K, 2015, INT REV RES OPEN DIS, V16, DOI 10.19173/irrodl.v16i3.2112; Kaupp R., 2012, J APPL RES COMMUNITY, V19, P3; Kolak M, 2018, HEALTH PLACE, V52, P231, DOI 10.1016/j.healthplace.2018.06.003; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Lopez N, 2018, RACE ETHNIC EDUC-UK, V21, P180, DOI 10.1080/13613324.2017.1375185; Ludecke D., 2020, J OPEN SOURCE SOFTW; Matz RL, 2017, AERA OPEN, V3, DOI 10.1177/2332858417743754; Morante A, 2017, AUST J ADULT LEARN, V57, P266; Morrison J. L., 2003, On the Horizon, V11, P6, DOI 10.1108/10748120310698307; Nakagawa S, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2017.0213; National Science Foundation, 2019, 19304 NSF NAT CTR SC; Nguyen HHD, 2008, J APPL PSYCHOL, V93, P1314, DOI 10.1037/a0012702; Niu F., 2017, COLL STUD J, V51, P298; Olson S., 2012, ENG EXC PROD ON MILL; Perera V, 2017, CBE-LIFE SCI EDUC, V16, DOI 10.1187/cbe.16-11-0316; Protopsaltis S., 2019, DOES ONLINE ED LIVE; R Development Core Team, 2009, R LANG ENV STAT COMP; Rosenboom Victoria., 2018, DISCONNECTED HIGHER; S BE, 2018, J CROHNS COLITIS, V12, pS049; Soja EW, 2013, SEEKING SPATIAL JUST; Spencer SJ, 1999, J EXP SOC PSYCHOL, V35, P4, DOI 10.1006/jesp.1998.1373; STEELE CM, 1995, J PERS SOC PSYCHOL, V69, P797, DOI 10.1037/0022-3514.69.5.797; Teranishi R.T., 2002, EQUITY EXCELLENCE ED, V35, P144, DOI [10.1080/713845281, DOI 10.1080/713845281]; Theobald EJ, 2020, P NATL ACAD SCI USA, V117, P6476, DOI 10.1073/pnas.1916903117; Tieken MC, 2019, REV EDUC RES, V89, P917, DOI 10.3102/0034654319877151; Van Dusen B, 2020, J RES SCI TEACH, V57, P33, DOI 10.1002/tea.21584; Varty AK, 2016, CBE-LIFE SCI EDUC, V15, DOI 10.1187/cbe.16-01-0075; Washington HA., 2006, MED APARTHEID DARK H, Ved 1, DOI DOI 10.1007/S10943-020-01090-9; Williams Tiffani, 2020, UNDERREPRESENTED MIN; Wladis C., 2013, AM J ED STUDIES, V6, P65; Wladis C, 2015, COMMUNITY COLL REV, V43, P142, DOI 10.1177/0091552115571729; Wladis C, 2015, COMMUNITY COLL REV, V43, P89, DOI 10.1177/0091552114555904; Wladis C, 2015, COMPUT EDUC, V87, P285, DOI 10.1016/j.compedu.2015.06.010; Wright CD, 2016, CBE-LIFE SCI EDUC, V15, DOI 10.1187/cbe.15-12-0246; Xu D., 2019, PROMISES LIMITS ONLI; Xu D, 2014, J HIGH EDUC, V85, P633, DOI 10.1353/jhe.2014.0028; Xu D, 2013, ECON EDUC REV, V37, P46, DOI 10.1016/j.econedurev.2013.08.001	81	10	10	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243916	10.1371/journal.pone.0243916	http://dx.doi.org/10.1371/journal.pone.0243916			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH0WM	33306720	Green Published, gold			2022-12-27	WOS:000600144200046
J	Basnet, TB; Srijana, GC; Basnet, R; Neupane, B				Basnet, Til Bahadur; Srijana, G. C.; Basnet, Rajesh; Neupane, Bidusha			Dietary nutrients of relative importance associated with coronary artery disease: Public health implication from random forest analysis	PLOS ONE			English	Article							FOOD FREQUENCY QUESTIONNAIRE; CARDIOVASCULAR-DISEASE; HEART-DISEASE; FATTY-ACIDS; VITAMIN-A; RISK; MORTALITY; INFLAMMATION; METAANALYSIS; CONSUMPTION	Dietary nutrients have significant effects on the risk of cardiovascular diseases. However, the results were not uniform across different countries. The study aims to determine the relative importance of dietary nutrients associated with coronary artery disease (CAD) among the Nepalese population. A hospital-based matched case-control study was carried out at Shahid Gangalal National Heart Center in Nepal. In the present study, patients with more than seventy percent stenosis in any main coronary artery branch in angiography were defined as cases, while those presenting normal coronary angiography or negative for stressed exercise test were considered controls. Dietary intakes of 612 respondents over the past 12 months were evaluated using a semi-quantitative customized food frequency questionnaire. In conditional regression model, the daily average dietary intake of beta-carotene (OR: 0.54; 95%CI: 0.34, 0.87), and vitamin C (OR: 0.96; 95%CI: 0.93, 0.99) were inversely, whereas dietary carbohydrate (OR: 1.16; 95%CI: 1.1, 1.24), total fat/oil (OR: 1.47; 95%CI: 1.27, 1.69), saturated fatty acid (SFA) (OR: 1.2; 95%CI: 1.11, 1.3), cholesterol (OR: 1.01; 95%CI: 1.001, 1.014), and iron intakes (OR: 1.11; 95%CI: 1.03, 1.19) were positively linked with CAD. Moreover, in random forest analysis, the daily average dietary intakes of SFA, vitamin A, total fat/oil, beta-carotene, and cholesterol were among the top five nutrients (out of 12 nutrients variables) of relative importance associated with CAD. The nutrients of relative importance imply a reasonable preventive measure in public health nutrients specific intervention to prevent CAD in a resource-poor country like Nepal. The findings are at best suggestive of a possible relationship between these nutrients and the development of CAD, but prospective cohort studies and randomized control trials will need to be performed in the Nepalese population.	[Basnet, Til Bahadur] Prubanchal Univ, Little Buddha Coll Hlth Sci, Kathmandu, Nepal; [Srijana, G. C.] Tribhuvan Univ, Maharajgunj Nursing Campus, Kathmandu, Nepal; [Basnet, Rajesh; Neupane, Bidusha] Tribhuvan Univ, Inst Med, Kathmandu, Nepal	Tribhuvan University; Tribhuvan University; Institute of Medicine (IoM) - Nepal	Basnet, TB (corresponding author), Prubanchal Univ, Little Buddha Coll Hlth Sci, Kathmandu, Nepal.	ddst19asnet@hotmail.com	Basnet, Til Bahadur/ABG-7507-2020	Basnet, Til Bahadur/0000-0003-4638-4874; BASNET, RAJESH/0000-0002-0128-8590; Neupane, Bidusha/0000-0003-2569-4937				Aidinoff E, 2017, SPINAL CORD, V55, P321, DOI 10.1038/sc.2016.109; Al-Attas O, 2014, CLIN MED INSIGHTS-EN, V7, P1, DOI 10.4137/CMED.S13573; Alissa EM, 2005, ASIA PAC J CLIN NUTR, V14, P137; Anderson JJB, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003815; [Anonymous], 2011, J AM DIET ASSOC, V111, P762, DOI 10.1016/j.jada.2011.03.022; [Anonymous], 2000, OB PREV MAN GLOB EP; [Anonymous], 2012, GLOB REP MORT ATTR T; [Anonymous], 2012, REGEN MED S3, V7, pS14; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Berger S, 2015, AM J CLIN NUTR, V102, P276, DOI 10.3945/ajcn.114.100305; Beunza JJ, 2019, J BIOMED INFORM, V97, DOI 10.1016/j.jbi.2019.103257; Brenna JT, 2009, ANN NUTR METAB, V55, P97, DOI 10.1159/000228998; Campbell RK, 2015, ECOL FOOD NUTR, V54, P314, DOI 10.1080/03670244.2014.990635; Chagas P, 2017, CLIN NUTR, V36, P1036, DOI 10.1016/j.clnu.2016.06.017; Choi Y, 2015, AM J CARDIOL, V116, P520, DOI 10.1016/j.amjcard.2015.05.005; Chowdhury R, 2014, ANN INTERN MED, V160, P398, DOI 10.7326/M13-1788; Clar C, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004467.pub3; de Souza RJ, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3978; Desai K, 2005, PLOS MED, V2, pe142; Doi-Kanno Mana, 2016, J Med Dent Sci, V63, P37; Eshak ES, 2018, J NUTR BIOCHEM, V56, P126, DOI 10.1016/j.jnutbio.2018.02.008; Farvid MS, 2014, CIRCULATION, V130, P1568, DOI 10.1161/CIRCULATIONAHA.114.010236; Gautham A, 2013, INT RES J PHARM, V4, P16, DOI [10.7897/2230-8407.04505, DOI 10.7897/2230-8407.04505]; Go AS, 2013, CIRCULATION, V127, P143, DOI 10.1161/CIR.0b013e318282ab8f; Guasch-Ferre M, 2015, AM J CLIN NUTR, V102, P1563, DOI 10.3945/ajcn.115.116046; Hooper L, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD011834, 10.1002/14651858.CD002137.pub2]; Hu T, 2014, NUTR METAB CARDIOVAS, V24, P337, DOI 10.1016/j.numecd.2013.12.008; Hu T, 2019, BRIT J NUTR, V121, P461, DOI [10.1017/s0007114518003513, 10.1017/S0007114518003513]; Hunnicutt J, 2014, J NUTR, V144, P359, DOI 10.3945/jn.113.185124; Ishihara J, 2008, J AM COLL NUTR, V27, P127, DOI 10.1080/07315724.2008.10719684; Iyengar SS, 2017, INDIAN HEART J, V69, P211, DOI 10.1016/j.ihj.2016.09.009; Jang Y, 2001, ARTERIOSCL THROM VAS, V21, P2065, DOI 10.1161/hq1201.100258; Kaluza J, 2010, AM J EPIDEMIOL, V171, P801, DOI 10.1093/aje/kwp467; Koju R, 2014, Kathmandu Univ Med J (KUMJ), V12, P137; Kong SH, 2017, AM J CLIN NUTR, V106, P27, DOI 10.3945/ajcn.116.148171; La Torre G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193360; Loewen OK, 2019, NUTRIENTS, V11, DOI 10.3390/nu11102529; Marventano S, 2015, INT J FOOD SCI NUTR, V66, P611, DOI 10.3109/09637486.2015.1077790; Matos A, 2018, NUTR HOSP, V35, P1215, DOI 10.20960/nh.1804; Mayen AL, 2014, AM J CLIN NUTR, V100, P1520, DOI 10.3945/ajcn.114.089029; Mensah GA, 2017, CIRC RES, V120, P366, DOI 10.1161/CIRCRESAHA.116.309115; Nettleton JA, 2013, ANN NUTR METAB, V63, P96, DOI 10.1159/000353207; North CJ, 2009, EUR J CLIN NUTR, V63, P921, DOI 10.1038/ejcn.2009.8; Oikonomou E, 2018, ANGIOLOGY, V69, P339, DOI 10.1177/0003319717721603; Otto MCD, 2012, J NUTR, V142, P526, DOI 10.3945/jn.111.149781; Ruiz-Nunez B, 2016, J NUTR BIOCHEM, V36, P1, DOI 10.1016/j.jnutbio.2015.12.007; Shrestha A, 2017, INT J FOOD SCI NUTR, V68, P605, DOI 10.1080/09637486.2016.1268099; Sun Q, 2011, AM J CLIN NUTR, V94, P534, DOI 10.3945/ajcn.110.008763; Superko HR, 2017, J CLIN LIPIDOL, V11, P1309, DOI 10.1016/j.jacl.2017.08.005; Virtanen JK, 2016, AM J CLIN NUTR, V103, P895, DOI 10.3945/ajcn.115.122317; Virtanen JK, 2014, ARTERIOSCL THROM VAS, V34, P2679, DOI 10.1161/ATVBAHA.114.304082; Worknop C, 2017, GLOB HLTH GOV, V11, P7; World Health Organization, 2017, FACT SHEET; World Health Organization, 2017, NONC DIS PROGR MON; World Health Organization (WHO), 2005, STEPS SURV MAN WHO S; Wu YH, 2015, CLIN NUTR, V34, P603, DOI 10.1016/j.clnu.2014.05.009; Zang JJ, 2019, NUTR J, V18, DOI 10.1186/s12937-019-0454-2; Zhang X, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm.2020.01.08; Zhao LG, 2017, J EPIDEMIOL, V27, P89, DOI 10.1016/j.je.2016.10.002; Zock PL, 2016, CURR CARDIOL REP, V18, DOI 10.1007/s11886-016-0793-y; Zong G, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5796	61	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243063	10.1371/journal.pone.0243063	http://dx.doi.org/10.1371/journal.pone.0243063			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301496	Green Published, gold			2022-12-27	WOS:000600143100013
J	Grandjean, D; Sarkis, R; Lecoq-Julien, C; Benard, A; Roger, V; Levesque, E; Bernes-Luciani, E; Maestracci, B; Morvan, P; Gully, E; Berceau-Falancourt, D; Haufstater, P; Herin, G; Cabrera, J; Muzzin, Q; Gallet, C; Bacque, H; Broc, JM; Thomas, L; Lichaa, A; Moujaes, G; Saliba, M; Kuhn, A; Galey, M; Berthail, B; Lapeyre, L; Capelli, A; Renault, S; Bachir, K; Kovinger, A; Comas, E; Stainmesse, A; Etienne, E; Voeltzel, S; Mansouri, S; Berceau-Falancourt, M; Dami, A; Charlet, L; Ruau, E; Issa, M; Grenet, C; Billy, C; Tourtier, JP; Desquilbet, L				Grandjean, Dominique; Sarkis, Riad; Lecoq-Julien, Clothilde; Benard, Aymeric; Roger, Vinciane; Levesque, Eric; Bernes-Luciani, Eric; Maestracci, Bruno; Morvan, Pascal; Gully, Eric; Berceau-Falancourt, David; Haufstater, Pierre; Herin, Gregory; Cabrera, Joaquin; Muzzin, Quentin; Gallet, Capucine; Bacque, Helene; Broc, Jean-Marie; Thomas, Leo; Lichaa, Anthony; Moujaes, Georges; Saliba, Michele; Kuhn, Aurore; Galey, Mathilde; Berthail, Benoit; Lapeyre, Lucien; Capelli, Anthoni; Renault, Steevens; Bachir, Karim; Kovinger, Anthony; Comas, Eric; Stainmesse, Aymeric; Etienne, Erwan; Voeltzel, Sebastien; Mansouri, Sofiane; Berceau-Falancourt, Marlene; Dami, Aime; Charlet, Lary; Ruau, Eric; Issa, Mario; Grenet, Carine; Billy, Christophe; Tourtier, Jean-Pierre; Desquilbet, Loic			Can the detection dog alert on COVID-19 positive persons by sniffing axillary sweat samples? A proof-of-concept study	PLOS ONE			English	Article							CANINE OLFACTORY DETECTION; PROSTATE-CANCER; SCENT-DETECTION; BLADDER-CANCER; LUNG; IDENTIFICATION; DIAGNOSIS; IDENTIFY; URINE; SPECTROMETRY	The aim of this proof-of-concept study was to evaluate if trained dogs could discriminate between sweat samples from symptomatic COVID-19 positive individuals (SARS-CoV-2 PCR positive) and those from asymptomatic COVID-19 negative individuals. The study was conducted at 2 sites (Paris, France, and Beirut, Lebanon), followed the same training and testing protocols, and involved six detection dogs (three explosive detection dogs, one search and rescue dog, and two colon cancer detection dogs). A total of 177 individuals were recruited for the study (95 symptomatic COVID-19 positive and 82 asymptomatic COVID-19 negative individuals) from five hospitals, and one underarm sweat sample per individual was collected. The dog training sessions lasted between one and three weeks. Once trained, the dog had to mark the COVID-19 positive sample randomly placed behind one of three or four olfactory cones (the other cones contained at least one COVID-19 negative sample and between zero and two mocks). During the testing session, a COVID-19 positive sample could be used up to a maximum of three times for one dog. The dog and its handler were both blinded to the COVID-positive sample location. The success rate per dog (i.e., the number of correct indications divided by the number of trials) ranged from 76% to 100%. The lower bound of the 95% confidence interval of the estimated success rate was most of the time higher than the success rate obtained by chance after removing the number of mocks from calculations. These results provide some evidence that detection dogs may be able to discriminate between sweat samples from symptomatic COVID-19 individuals and those from asymptomatic COVID-19 negative individuals. However, due to the limitations of this proof-of-concept study (including using some COVID-19 samples more than once and potential confounding biases), these results must be confirmed in validation studies.	[Grandjean, Dominique; Lecoq-Julien, Clothilde; Roger, Vinciane; Cabrera, Joaquin; Muzzin, Quentin; Gallet, Capucine; Bacque, Helene; Desquilbet, Loic] Univ Paris Est, Ecole Natl Vet Alfort, Maisons Alfort, France; [Sarkis, Riad; Lichaa, Anthony; Moujaes, Georges; Saliba, Michele; Issa, Mario] Univ Franco Libanaise St Joseph, Fac Med, Beirout, Lebanon; [Benard, Aymeric; Bernes-Luciani, Eric; Maestracci, Bruno; Dami, Aime] Serv Incendie & Secours Corse Sud, Ajaccio, France; [Levesque, Eric; Lapeyre, Lucien; Tourtier, Jean-Pierre] Univ Paris Est Creteil, Ctr Hosp Univ Henri Mondor, Maisons Alfort, France; [Morvan, Pascal; Capelli, Anthoni; Renault, Steevens; Bachir, Karim; Kovinger, Anthony] DiagNose, Neuvy, France; [Gully, Eric; Comas, Eric; Stainmesse, Aymeric; Etienne, Erwan; Voeltzel, Sebastien; Mansouri, Sofiane; Charlet, Lary; Ruau, Eric] Serv Dept Incendie & Secours Seine & Marne, Melun, France; [Berceau-Falancourt, David] Compagnie Cynophile Prefecture Police, Paris, France; [Haufstater, Pierre] Hop Univ Pitie Salpetriere, Paris, France; [Herin, Gregory] Biodes SAS, Strasbourg, France; [Broc, Jean-Marie; Thomas, Leo; Kuhn, Aurore; Galey, Mathilde; Berthail, Benoit] Hop Instruct Armees Begin, St Mande, France; [Berceau-Falancourt, Marlene] Cynopro Dectect Dogs, Paris, France; [Grenet, Carine] Grand Hop Est Francilien, Jossigny, France; [Billy, Christophe] Ctr Hosp Francois Quesnay, Mantes La Jolie, France	Ecole Nationale Veterinaire d'Alfort (ENVA); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Grandjean, D (corresponding author), Univ Paris Est, Ecole Natl Vet Alfort, Maisons Alfort, France.	dominique.grandjean@vet-alfort.fr	Mjaess, Georges/AAB-3350-2021	Mjaess, Georges/0000-0002-8703-4611; Lichaa, Anthony/0000-0002-3582-4187; GRANDJEAN, Dominique/0000-0002-8408-8358				Amann A, 2014, J BREATH RES, V8, DOI 10.1088/1752-7155/8/3/034001; Angle C, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00047; Angle TC, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2015.00079; [Anonymous], 2005, J PEDIAT GASTROENTER, V41, pS39; Bernier UR, 2000, ANAL CHEM, V72, P747, DOI 10.1021/ac990963k; Bijland LR, 2013, NETH J MED, V71, P300; Bjartell AS, 2011, EUR UROL, V59, P202, DOI 10.1016/j.eururo.2010.10.033; Boedeker E, 2012, INTERACT CARDIOV TH, V14, P511, DOI 10.1093/icvts/ivr070; Bomers MK, 2014, J INFECTION, V69, P456, DOI 10.1016/j.jinf.2014.05.017; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Buszewski B, 2012, ANAL BIOANAL CHEM, V404, P141, DOI 10.1007/s00216-012-6102-8; Campbell Leon Frederick, 2013, BMJ Case Rep, V2013, DOI 10.1136/bcr-2013-008566; Centers for Disease Control and Prevention, 2020, COVID 19 AN; Chen D, 2000, PERCEPT MOTOR SKILL, V91, P771, DOI 10.2466/pms.2000.91.3.771; Concha A, 2014, CHEM SENSES, V39, P749, DOI 10.1093/chemse/bju045; Cornu JN, 2011, EUR UROL, V59, P197, DOI 10.1016/j.eururo.2010.10.006; Edwards TL, 2017, J VET BEHAV, V20, P59, DOI 10.1016/j.jveb.2017.05.002; Ehmann R, 2012, EUR RESPIR J, V39, P669, DOI 10.1183/09031936.00051711; Elliker KR, 2014, BMC UROL, V14, DOI 10.1186/1471-2490-14-22; Grabowska-Polanowska B, 2017, BIOANALYSIS, V9, P1465, DOI 10.4155/bio-2017-0128; Guest C, 2019, LANCET INFECT DIS, V19, P578, DOI 10.1016/S1473-3099(19)30220-8; Hasegawa Y, 2004, CHEM BIODIVERS, V1, P2042, DOI 10.1002/cbdv.200490157; Hasell J., 2020, TESTING EARLY TESTIN; Haze S, 2001, J INVEST DERMATOL, V116, P520, DOI 10.1046/j.0022-202x.2001.01287.x; Jendrny P, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05281-3; Johnen D, 2017, APPL ANIM BEHAV SCI, V189, P1, DOI 10.1016/j.applanim.2017.01.001; Kirton A, 2008, EPILEPSY BEHAV, V13, P499, DOI 10.1016/j.yebeh.2008.05.011; Kitiyakara T, 2017, J BREATH RES, V11, DOI 10.1088/1752-7163/aa7b8e; Li YF, 2020, J MED VIROL, V92, P903, DOI 10.1002/jmv.25786; Lippi G, 2012, CLIN CHEM LAB MED, V50, P435, DOI 10.1515/CCLM.2011.672; Maurer M, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw051; McCulloch M, 2006, INTEGR CANCER THER, V5, P30, DOI 10.1177/1534735405285096; Mitro S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038110; Murota H, 2015, J DERMATOL SCI, V77, P3, DOI 10.1016/j.jdermsci.2014.08.011; Pickel D, 2004, APPL ANIM BEHAV SCI, V89, P107, DOI 10.1016/j.applanim.2004.04.008; Pirrone F, 2017, J VET BEHAV, V19, P105, DOI 10.1016/j.jveb.2017.03.004; Propper RE, 2020, EXP BIOL MED, V245, P997, DOI 10.1177/1535370220935409; Ren SY, 2020, WORLD J CLIN CASES, V8, P1391, DOI 10.12998/wjcc.v8.i8.1391; Richards KM, 2008, J VET BEHAV, V3, P25, DOI 10.1016/j.jveb.2007.10.006; Rooney NJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210092; Rooney NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069921; Sit THC, 2020, NATURE, V586, P776, DOI 10.1038/s41586-020-2334-5; Sonoda H, 2011, GUT, V60, P814, DOI 10.1136/gut.2010.218305; Tahamtan A, 2020, EXPERT REV MOL DIAGN, V20, P453, DOI 10.1080/14737159.2020.1757437; Taverna G, 2015, J UROLOGY, V193, P1382, DOI 10.1016/j.juro.2014.09.099; Taylor NAS, 2013, EXTREME PHYSIOL MED, V2, DOI 10.1186/2046-7648-2-4; Temmam S., 2020, NAT COMMUN, V10, P100164, DOI [10.1016/j.onehlt.2020.100164, DOI 10.1016/J.ONEHLT.2020.100164]; Troccaz M, 2004, CHEM BIODIVERS, V1, P1022, DOI 10.1002/cbdv.200490077; Venter M, 2020, J CLIN PATHOL, V73, P370, DOI 10.1136/jclinpath-2020-206685; Walczak M, 2012, J VET BEHAV, V7, P283, DOI 10.1016/j.jveb.2012.01.001; WALLNER WE, 1976, ENVIRON ENTOMOL, V5, P183, DOI 10.1093/ee/5.1.183; WILLIAMS H, 1989, LANCET, V1, P734; Williams M, 2002, APPL ANIM BEHAV SCI, V78, P55, DOI 10.1016/S0168-1591(02)00081-3; Willis CM, 2010, CANCER BIOMARK, V8, P145, DOI 10.3233/CBM-2011-0208; Willis CM, 2004, BMJ-BRIT MED J, V329, P712, DOI 10.1136/bmj.329.7468.712; Wilson C, 2019, FRONT VET SCI, V6, DOI 10.3389/fvets.2019.00091; Woidtke L, 2018, FORENSIC SCI INT, V282, P111, DOI 10.1016/j.forsciint.2017.11.021; Wysocki CJ, 2004, ANAT REC PART A, V281A, P1201, DOI 10.1002/ar.a.20125; Xiao AT, 2020, J MED VIROL, V92, P1755, DOI 10.1002/jmv.25855; ZENG XN, 1991, J CHEM ECOL, V17, P1469, DOI 10.1007/BF00983777; Zeng XN, 1996, J CHEM ECOL, V22, P237, DOI 10.1007/BF02055096	61	32	32	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243122	10.1371/journal.pone.0243122	http://dx.doi.org/10.1371/journal.pone.0243122			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301539	Green Published, gold, Green Submitted			2022-12-27	WOS:000600143100066
J	Pourcher, V; Gourmelen, J; Bureau, I; Bouee, S				Pourcher, Valerie; Gourmelen, Julie; Bureau, Isabelle; Bouee, Stephane			Comorbidities in people living with HIV: An epidemiologic and economic analysis using a claims database in France	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; MYOCARDIAL-INFARCTION; INFECTED PERSONS; NONINFECTIOUS COMORBIDITIES; UNINFECTED INDIVIDUALS; CARDIOVASCULAR-DISEASE; GENERAL-POPULATION; RISK-FACTORS; PREVALENCE; AGE	Objectives As people living with HIV (PLHIV) age, the burden of non-HIV related comorbidities increases resulting in additional healthcare costs. The present study aimed to describe the profile, the prevalence and the incremental costs of non-HIV related comorbidities in PLHIV compared to non-HIV matched controls (1:2 ratio) in France. Methods The French permanent sample of health beneficiaries (Echantillon generaliste de beneficiaires [EGB]), a claims database representative of the national population, was used to assess comorbidities in PLHIV which were identified by the ICD-10 diagnosis codes of hospitalization, full healthcare coverage, and drug reimbursements between 2011 and 2014. The control group was matched by year of birth, gender, region of residence, and economic status. Total costs of outpatient care and hospitalizations were analysed from a societal perspective. A general linear model was used to assess the incremental cost per patient in PLHIV. Results A total of 1,091 PLHIV and 2,181 matched controls were identified with a mean +/- standard deviation age of 46.7 +/- 11.5 years. The prevalence of alcohol abuse (5.8% vs 3.1%; p<0.001), chronic renal disease (1.2% vs 0.3%; p = 0.003), cardiovascular disease (7.4% vs 5.1%; p = 0.009), dyslipidaemia (22% vs 15.9%; p<0.001), hepatitis B (3.8% vs 0.1%; p<0.001) and hepatitis C (12.5% vs 0.6%; p<0.001) was significantly higher in PLHIV compared with non-HIV controls. Other comorbidities such as anaemia, malnutrition, psychiatric diseases, and neoplasms were also more prevalent in PLHIV. Hospitalizations were significantly increased in PLHIV compared to controls (33.2% vs 16%; p<0.001). Mean total cost was 6 times higher for PLHIV compared to controls and 4 times higher after excluding antiretroviral drugs (9,952euro vs. 2,593euro; p<0.001). Higher costs per person in PLHIV were significantly associated to aging (42euro per patient/year), chronic cardiovascular disease (3,003euro), hepatitis C (6,705euro), metastatic carcinoma (6,880euro) and moderate or severe liver disease (6,299euro). Conclusion Our results demonstrated an increase in non-HIV related comorbidities among PLHIV compared to matched controls. This study contributes to raise awareness on the burden of chronic comorbidities.	[Pourcher, Valerie] Sorbonne Univ, Hop Pitie Salpetriere, AP HP, Serv Malad Infect & Trop, Paris, France; [Gourmelen, Julie] INSERM, UMS 011, Villejuif, France; [Bureau, Isabelle; Bouee, Stephane] CEMKA, Real World Evidence, Bourg La Reine, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Bouee, S (corresponding author), CEMKA, Real World Evidence, Bourg La Reine, France.	Stephane.bouee@cemka.fr	Pourcher, Valérie/AGZ-6964-2022		Gilead	Gilead(Gilead Sciences)	This study was funded by Gilead who gave a grant to CEMKA to perform the analysis. Stephane Bouee and Isabelle Bureau are employed by CEMKA, a consultancy which works for pharmaceutical compagnies as Gilead. CEMKA received honoraria to perform the study and the analysis. Gilead, had a role in review of protocols, results and manuscript.	Bernaud C, 2020, MED MALADIES INFECT, V50, P43, DOI 10.1016/j.medmal.2019.04.001; Blin P, 2012, DIABETOLOGIA, V55, P644, DOI 10.1007/s00125-011-2429-5; Brown TT, 2006, AIDS, V20, P2165, DOI 10.1097/QAD.0b013e32801022eb; Chaponda M, 2018, INT J STD AIDS, V29, P704, DOI 10.1177/0956462417750708; Croxford S, 2017, LANCET PUBLIC HEALTH, V2, pE35, DOI 10.1016/S2468-2667(16)30020-2; Currier Judith S, 2008, Circulation, V118, pe29, DOI 10.1161/CIRCULATIONAHA.107.189624; de Leotoing L, 2018, AIDS, V32, P2059, DOI 10.1097/QAD.0000000000001907; Deeks SG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3172; Demir OM, 2018, INT J CARDIOL, V265, P195, DOI 10.1016/j.ijcard.2018.03.137; Drozd DR, 2017, JAIDS-J ACQ IMM DEF, V75, P568, DOI [10.1097/QAI.0000000000001450, 10.1097/qai.0000000000001450]; Effros RB, 2008, CLIN INFECT DIS, V47, P542, DOI 10.1086/590150; Ford N, 2015, LANCET HIV, V2, pE438, DOI 10.1016/S2352-3018(15)00137-X; Gallant J, 2018, CURR MED RES OPIN, V34, P13, DOI 10.1080/03007995.2017.1383889; Guaraldi G, 2013, CLINICOECONOMIC OUTC, V5, P481, DOI 10.2147/CEOR.S40607; Guaraldi G, 2011, CLIN INFECT DIS, V53, P1120, DOI 10.1093/cid/cir627; Hasse B, 2011, CLIN INFECT DIS, V53, P1130, DOI 10.1093/cid/cir626; Hemkens LG, 2014, EUR HEART J, V35, P1373, DOI 10.1093/eurheartj/eht528; Hjalte F, 2018, AIDS CARE, V30, P1090, DOI 10.1080/09540121.2018.1476661; Hleyhel M, 2014, AIDS, V28, P2109, DOI 10.1097/QAD.0000000000000382; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Islam FM, 2012, HIV MED, V13, P453, DOI 10.1111/j.1468-1293.2012.00996.x; Islam FM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-234; Knudsen AD, 2018, JAIDS-J ACQ IMM DEF, V79, P381, DOI 10.1097/QAI.0000000000001795; Krentz HB, 2015, HIV MED, V16, P38, DOI 10.1111/hiv.12176; Moulis G, 2015, REV MED INTERNE, V36, P411, DOI 10.1016/j.revmed.2014.11.009; Nishijima T, 2014, AIDS, V28, P1903, DOI 10.1097/QAD.0000000000000347; Obel N, 2007, CLIN INFECT DIS, V44, P1625, DOI 10.1086/518285; Papot E, 2017, AIDS, V31, P1271, DOI 10.1097/QAD.0000000000001467; Patel P, 2008, ANN INTERN MED, V148, P728, DOI 10.7326/0003-4819-148-10-200805200-00005; Pelchen-Matthews A, 2018, AIDS; Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433; Quantin C, 2015, CNAMTS ETUDES ALGORI; Quiros-Roldan E, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3804-4; Rapport Morlat, 2017, RAPPORT MORLAT PRISE; Rasmussen LD, 2015, LANCET HIV, V2, pE288, DOI 10.1016/S2352-3018(15)00077-6; Ryom L, 2018, LANCET HIV, V5, pE291, DOI 10.1016/S2352-3018(18)30043-2; Sabin CA, 2008, LANCET, V371, P1417, DOI 10.1016/S0140-6736(08)60423-7; Schouten J, 2014, CLIN INFECT DIS, V59, P1787, DOI 10.1093/cid/ciu701; Schranz AJ, 2015, AIDS PATIENT CARE ST, V29, P117, DOI 10.1089/apc.2014.0199; Smit M, 2015, LANCET INFECT DIS, V15, P810, DOI 10.1016/S1473-3099(15)00056-0; Tossonian H, 2017, 9 IAS C HIV SCI PAR; Trapero-Bertran M, 2014, HEALTH ECON REV, V4, DOI 10.1186/s13561-014-0015-5; Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190; Tuppin P, 2010, REV EPIDEMIOL SANTE, V58, P286, DOI 10.1016/j.respe.2010.04.005; Wada N, 2013, AM J EPIDEMIOL, V177, P116, DOI 10.1093/aje/kws321; Xu YN, 2017, J AM SOC HYPERTENS, V11, P530, DOI 10.1016/j.jash.2017.06.004; Zingmond DS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189392	47	18	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243529	10.1371/journal.pone.0243529	http://dx.doi.org/10.1371/journal.pone.0243529			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332394	gold, Green Published			2022-12-27	WOS:000601310900060
J	Straw, I; Callison-Burch, C				Straw, Isabel; Callison-Burch, Chris			Artificial Intelligence in mental health and the biases of language based models	PLOS ONE			English	Article							GENDER BIAS; EXPRESSION; DISTRESS; IDIOMS; DISORDERS; SCIENCE; RACE	Background The rapid integration of Artificial Intelligence (AI) into the healthcare field has occurred with little communication between computer scientists and doctors. The impact of AI on health outcomes and inequalities calls for health professionals and data scientists to make a collaborative effort to ensure historic health disparities are not encoded into the future. We present a study that evaluates bias in existing Natural Language Processing (NLP) models used in psychiatry and discuss how these biases may widen health inequalities. Our approach systematically evaluates each stage of model development to explore how biases arise from a clinical, data science and linguistic perspective. Design/Methods A literature review of the uses of NLP in mental health was carried out across multiple disciplinary databases with defined Mesh terms and keywords. Our primary analysis evaluated biases within 'GloVe' and 'Word2Vec' word embeddings. Euclidean distances were measured to assess relationships between psychiatric terms and demographic labels, and vector similarity functions were used to solve analogy questions relating to mental health. Results Our primary analysis of mental health terminology in GloVe and Word2Vec embeddings demonstrated significant biases with respect to religion, race, gender, nationality, sexuality and age. Our literature review returned 52 papers, of which none addressed all the areas of possible bias that we identify in model development. In addition, only one article existed on more than one research database, demonstrating the isolation of research within disciplinary silos and inhibiting cross-disciplinary collaboration or communication. Conclusion Our findings are relevant to professionals who wish to minimize the health inequalities that may arise as a result of AI and data-driven algorithms. We offer primary research identifying biases within these technologies and provide recommendations for avoiding these harms in the future.	[Straw, Isabel] Univ Penn, Perelman Sch Med, Dept Publ Hlth, Philadelphia, PA 19104 USA; [Callison-Burch, Chris] Univ Penn, Comp & Informat Sci Dept, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Straw, I (corresponding author), Univ Penn, Perelman Sch Med, Dept Publ Hlth, Philadelphia, PA 19104 USA.	isabelstraw@doctors.org.uk		Straw, Isabel/0000-0003-0003-3550				Access Evolved Universal Terrestrial Radio, 2010, 36 3GPP TS, pV9; Alabas Oras A, 2018, J AM HEART ASS; Anderson HD, 2015, J AM BOARD FAM MED, V28, P65, DOI 10.3122/jabfm.2015.01.140181; [Anonymous], 2014, CSCW 14 COMP SUPP CO; [Anonymous], 2019, NAT LANG PROC SENT A; [Anonymous], 2009, EJSO S, V35, pS1; [Anonymous], 2019, COMP LING STUD PERS; Bandyopadhyay S, 2001, QJM-INT J MED, V94, P127, DOI 10.1093/qjmed/94.3.127; Bar K, 2019, SEMANTIC CHARACTERIS; Baziska Julia, 2020, LAMYIOWCE WORD2VIZ 2; BECKER D, 1994, PROF PSYCHOL-RES PR, V25, P55, DOI 10.1037/0735-7028.25.1.55; Byrd WM, 2001, J NATL MED ASSOC, V93, P11; Calvo RA, 2017, NAT LANG ENG, V23, P649, DOI 10.1017/S1351324916000383; Chaplin TM, 2015, EMOT REV, V7, P14, DOI 10.1177/1754073914544408; Choudhury MD, 2013, P SIGCHI C HUM FACT; Conway Mike, 2019, Yearb Med Inform, V28, P208, DOI 10.1055/s-0039-1677918; Coppersmith G, 2015, PROC 2 WORKSHOP COMP, P31, DOI [10.3115/v1/W15-1204, DOI 10.3115/V1/W15-1204]; Coppersmith G, 2018, BIOMED INFORM INSIGH, V10, DOI 10.1177/1178222618792860; Cork C, 2019, GLOB MENT HEALTH, V6, DOI 10.1017/gmh.2019.5; De Choudhury M, 2013, P 5 ANN ACM WEB SCI, P47; Denecke K, 2015, ARTIF INTELL MED, V64, P17, DOI 10.1016/j.artmed.2015.03.006; Desai G, 2017, J NEUROSCI RURAL PRA, V8, P94, DOI 10.4103/jnrp.jnrp_235_17; Dowling Maura, 2006, Nurse Res, V13, P7; Drescher J, 2015, BEHAV SCI-BASEL, V5, P565, DOI 10.3390/bs5040565; Ethayarajh Duvenaud, 2019, UNDERSTANDING LINEAR, P19; Finley G, 2017, P 6 JOINT C LEX COMP, P1, DOI [10.18653/v1/S17-1001, DOI 10.18653/V1/S17-1001]; Garg N, 2018, P NATL ACAD SCI USA, V115, pE3635, DOI 10.1073/pnas.1720347115; Gonen Hila, 2019, ARXIV190303862CS; Hamberg K, 2008, WOMENS HEALTH, V4, P237, DOI 10.2217/17455057.4.3.237; Hinton DE, 2010, CULT MED PSYCHIAT, V34, P209, DOI 10.1007/s11013-010-9175-x; Institute of Medicine (US) Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care, 2003, UNEQUAL TREATMENT CO; Jane JS, 2007, J ABNORM PSYCHOL, V116, P166, DOI 10.1037/0021-843X.116.1.166; Kalyan KS, 2020, J BIOMED INFORM, V101, DOI 10.1016/j.jbi.2019.103323; Kato, 2018, J ETHNIC CULT STUD, V5, P58; Kleiman EM, 2018, DEPRESS ANXIETY, V35, P601, DOI 10.1002/da.22730; Kohrt BA, 2014, INT J EPIDEMIOL, V43, P365, DOI 10.1093/ije/dyt227; Krieger N, 2005, AM J PUBLIC HEALTH, V95, P2155, DOI 10.2105/AJPH.2005.067108; KRIEGER N, 1994, INT J HEALTH SERV, V24, P265, DOI 10.2190/LWLH-NMCJ-UACL-U80Y; Krieger N, 1996, J Am Med Womens Assoc (1972), V51, P133; Lester D, 1997, PSYCHOL REP, V80, P1302, DOI 10.2466/pr0.1997.80.3c.1302; McGregor AJ, 2013, BIOL SEX DIFFER, V4, DOI 10.1186/2042-6410-4-11; Mikolov T., 2013, P NAACL 2013, P746; Mullner M, 2007, INT J CLIN PHARM TH, V45, P477; NICHTER M, 1981, CULT MED PSYCHIAT, V5, P379, DOI 10.1007/BF00054782; ONEil CATHY, 2016, WEAPONS MATH DESTRUC, P85; Pennebaker JW, 2003, ANNU REV PSYCHOL, V54, P547, DOI 10.1146/annurev.psych.54.101601.145041; Pennington J., 2014, P 2014 C EMP METH NA, P1532, DOI [10.3115/v1/D14-1162, DOI 10.3115/V1/D14-1162]; Pestian JP, 2016, SUICIDE LIFE-THREAT, V46, P154, DOI 10.1111/sltb.12180; Poria S, 2019, IEEE ACCESS, V7, P100943, DOI 10.1109/ACCESS.2019.2929050; Radford K, 2018, P 5 WORKSH COMP LING, P126, DOI [10.18653/v1/W18-0614, DOI 10.18653/V1/W18-0614]; Ramasubbu K, 2001, J WOMEN HEALTH GEN-B, V10, P757, DOI 10.1089/15246090152636514; Roth A, 2018, FRONTIERS FAIRNESS M; Skoppy N, 2018, DO GENDER STEREOTYPE; SLATER ETO, 1965, J PSYCHOSOM RES, V9, P9, DOI 10.1016/0022-3999(65)90004-8; Smirnova D, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00105; Snowden LR, 2003, AM J PUBLIC HEALTH, V93, P239, DOI 10.2105/AJPH.93.2.239; Sun T, 2019, P 57 ANN M ASS COMP, P19; Trotzek M, UTILIZING NEURAL NET, DOI [10.1109/TKDE.2018.2885515, DOI 10.1109/TKDE.2018.2885515]; Using natural language processing to classify suicide notes, 2008, US NAT LANG PROC CLA; Vyas DA, 2020, NEW ENGL J MED, V383, P874, DOI 10.1056/NEJMms2004740; WALKER DE, 1981, J AM SOC INFORM SCI, V32, P347, DOI 10.1002/asi.4630320516; Wang YS, 2018, J BIOMED INFORM, V87, P12, DOI 10.1016/j.jbi.2018.09.008; Zhang YY, 2019, HEALTH INFORM J, V25, P1846, DOI 10.1177/1460458218796598; Zirikly A., 2019, PROC 6 WORKSHOP COMP, P24, DOI [10.18653/v1/W19-3003, DOI 10.18653/V1/W19-3003]; Zou J., 2016, ARXIV160706520CSSTAT	67	10	10	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0240376	10.1371/journal.pone.0240376	http://dx.doi.org/10.1371/journal.pone.0240376			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PI8BZ	33332380	Green Published, gold			2022-12-27	WOS:000601310900043
J	Xu, JL; Zhang, XD; Liu, H; Yang, KG; Ma, FC; Li, HR; Sun, YF				Xu, Jinliang; Zhang, Xiaodong; Liu, Huan; Yang, Kaige; Ma, Fangchen; Li, Haoru; Sun, Yufei			Physiological indices and driving performance of drivers at tunnel entrances and exits: A simulated driving study	PLOS ONE			English	Article							TRAFFIC ACCIDENTS; HEART-RATE; REAL	The entrance and exit sections of a tunnel are the accident black-spots in an expressway. For a safe operation of road tunnels, it is necessary to understand a driver's physiological indices and driving performance when driving through tunnels. In this study, the UC-Win/Road simulation software was used to build 12 tunnel models of different lengths. A simulated driving experiment was carried out in a 6-DoF motion platform. The lateral position of vehicles characterizing the driving performance was measured using the motion platform. Electrocardiogram and eye movement data of 25 recruited drivers were collected simultaneously through the experiment. The spatial changes in a driver's heart rate (HR) growth rate, RMSSD, pupil diameter growth rate and vehicle lateral deviation within 300 m before and after the tunnel entrance and exit were analyzed to determine the variation rules in the different tunnels. The study identified the length range in the tunnel entrance and exit sections that influences the drivers. A quantitative analysis was further carried out to analyze the relationship between the physiological indices and the driving performance indicator. The results showed that a driver's heart rate fluctuates significantly 250 m before the tunnel entrance and 50 m before the exit. In this region, the pupil diameter increases gradually, and drivers tend to shift the vehicle to the left. At the tunnel exit, the HR and RMSSD are affected significantly by the tunnel length, and the variation is higher in longer tunnels. In comparison, the tunnel length has no significant effect on the physiological indicators and driving performance of the drivers at the entrance and exit.	[Xu, Jinliang; Zhang, Xiaodong; Liu, Huan; Yang, Kaige; Ma, Fangchen; Li, Haoru; Sun, Yufei] Changan Univ, Sch Highway, Xian, Shaanxi, Peoples R China; [Yang, Kaige] China Railway First Survey & Design Inst Grp Co L, Xian, Shaanxi, Peoples R China	Chang'an University	Zhang, XD (corresponding author), Changan Univ, Sch Highway, Xian, Shaanxi, Peoples R China.	2017021039@chd.edu.cn		ZHANG, XIAODONG/0000-0002-9358-8231	Department of Transportation of Shaanxi Province [18-23R]; Shandong Hi-speed Company Limited [220221200522]; Department of Transportation of Shaanxi Province; Shangdong Hi-speed Company Limited; China Railway First Survey and Design Institute Group Company Limited	Department of Transportation of Shaanxi Province; Shandong Hi-speed Company Limited; Department of Transportation of Shaanxi Province; Shangdong Hi-speed Company Limited; China Railway First Survey and Design Institute Group Company Limited	This research was supported by the Department of Transportation of Shaanxi Province to JX (Grant No. 18-23R) and Shandong Hi-speed Company Limited to JX (Grant No. 220221200522). China Railway First Survey and Design Institute Group Company Limited provided support for this study in the form of salaries for KY. The specific role of these author is articulated in the 'author contributions' section. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.; The opportunity to research this topic is made possible by funding provided by the Department of Transportation of Shaanxi Province and Shangdong Hi-speed Company Limited. Meanwhile, we thank the drivers for their cooperation during the driving simulation experiment.	Akamatsu M., 2003, DRIV SIM C N AM DSC; Amundsen FH, 2000, TUNN UNDERGR SP TECH, V15, P3, DOI 10.1016/S0886-7798(00)00024-9; ANON, 2002, CDR WEEKLY, V12, P3; [Anonymous], 2011, ZH MOSKOVSKOY PATRIA, V3, P27; [Anonymous], 2020, CHIN J CRIT CARE INT, V6, P1; [Anonymous], 2017, CRIT CARE NURSE, V37, pe19; [Anonymous], 1986, HDB PERCEPTION PERFO; Appelhans BM, 2006, REV GEN PSYCHOL, V10, P229, DOI 10.1037/1089-2680.10.3.229; Caird JK, 2008, ACCIDENT ANAL PREV, V40, P1282, DOI 10.1016/j.aap.2008.01.009; Calvi A., 2013, ADV TRANSPORTATION S, V30, P59, DOI DOI 10.4399/97888548611764; Chang S, 2006, P DRIV SIM C PAR FRA, P103; Chen F, 2019, TUNN UNDERGR SP TECH, V92, DOI 10.1016/j.tust.2019.103034; Chen PY, 2020, TUNN UNDERGR SP TECH, V99, DOI 10.1016/j.tust.2020.103362; Clarke DD, 2010, ACCIDENT ANAL PREV, V42, P764, DOI 10.1016/j.aap.2009.11.008; Dijksterhuis C, 2011, ACCIDENT ANAL PREV, V43, P1074, DOI 10.1016/j.aap.2010.12.014; Ding G, 2011, STUDY IMPACT FREEWAY; [丁光明 Ding Guangming], 2011, [长安大学学报. 自然科学版, Journal of Chang'An University. Natural Science Edition], V31, P77; Du Z., 2014, PROMET-ZAGREB, V26, P641; Fu X, 2020, J SPORT REHABIL, V29, P820, DOI 10.1123/jsr.2019-0095; Gemou M, 2013, EUR TRANSP RES REV, V5, P217, DOI 10.1007/s12544-013-0105-1; Helland A, 2013, ACCIDENT ANAL PREV, V53, P9, DOI 10.1016/j.aap.2012.12.042; ISO, 1007512017 ISO CEN; Kircher K, 2012, ACCIDENT ANAL PREV, V47, P153, DOI 10.1016/j.aap.2012.01.019; Lemke K, 2000, TRANSPORT RES REC, P170; LIU HX, 2011, J TRANSP SAF SECUR, V3, P27, DOI DOI 10.1080/19439962.2011.532298; Luo J, 2018, 2018 3 INT C SMART C; Luo WJ, 2017, NANOTECHNOLOGY, V28, DOI 10.1088/1361-6528/aa76ae; Miller EE, 2015, TRANSPORT RES REC, P60, DOI 10.3141/2518-08; Ottaviani C, 2019, J PSYCHOPHYSIOL, V33, P198, DOI 10.1027/0269-8803/a000222; PORGES SW, 1992, PEDIATRICS, V90, P498; Qi W, 2020, J ADV TRANSPORT, P1; ROSCOE AH, 1992, BIOL PSYCHOL, V34, P259, DOI 10.1016/0301-0511(92)90018-P; SHIMOJO A, 1995, 1995 VEHICLE NAVIGATION & INFORMATION SYSTEMS CONFERENCE PROCEEDINGS - 6TH INTERNATIONAL VNIS/PACIFIC RIM TRANSTECH CONFERENCE, P96, DOI 10.1109/VNIS.1995.518824; Shimojo A, 1995, VEH NAV INF SYST C; Staubach M, 2009, ACCIDENT ANAL PREV, V41, P1025, DOI 10.1016/j.aap.2009.06.014; Tornros J, 1998, ACCIDENT ANAL PREV, V30, P497, DOI 10.1016/S0001-4575(97)00099-7; WANG HL, 2015, TRANSPORT RES REC, V2485, P1, DOI DOI 10.3141/2485-01; Wang YJ, 2016, STROKE VASC NEUROL, V1, P1, DOI 10.1136/svn-2016-000007; World Health Organization, 2017, DEPR OTH COMM MENT D, DOI DOI 10.1109/IEEESTD.2017.7920364; Yan Y, 2015, ADV MECH ENG, V7, DOI 10.1155/2014/273427; Yeung JS, 2013, TUNN UNDERGR SP TECH, V38, P534, DOI 10.1016/j.tust.2013.09.002	41	3	3	6	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243931	10.1371/journal.pone.0243931	http://dx.doi.org/10.1371/journal.pone.0243931			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PI8BZ	33332428	gold, Green Published			2022-12-27	WOS:000601310900051
J	Leng, XB; Wohl, M; Ishii, K; Nayak, P; Asahina, K				Leng, Xubo; Wohl, Margot; Ishii, Kenichi; Nayak, Pavan; Asahina, Kenta			Quantifying influence of human choice on the automated detection of Drosophila behavior by a supervised machine learning algorithm	PLOS ONE			English	Article							TRACKING; REQUIRES; SYSTEM	Automated quantification of behavior is increasingly prevalent in neuroscience research. Human judgments can influence machine-learning-based behavior classification at multiple steps in the process, for both supervised and unsupervised approaches. Such steps include the design of the algorithm for machine learning, the methods used for animal tracking, the choice of training images, and the benchmarking of classification outcomes. However, how these design choices contribute to the interpretation of automated behavioral classifications has not been extensively characterized. Here, we quantify the effects of experimenter choices on the outputs of automated classifiers of Drosophila social behaviors. Drosophila behaviors contain a considerable degree of variability, which was reflected in the confidence levels associated with both human and computer classifications. We found that a diversity of sex combinations and tracking features was important for robust performance of the automated classifiers. In particular, features concerning the relative position of flies contained useful information for training a machine-learning algorithm. These observations shed light on the importance of human influence on tracking algorithms, the selection of training images, and the quality of annotated sample images used to benchmark the performance of a classifier (the 'ground truth'). Evaluation of these factors is necessary for researchers to accurately interpret behavioral data quantified by a machine-learning algorithm and to further improve automated classifications.	[Leng, Xubo; Wohl, Margot; Ishii, Kenichi; Nayak, Pavan; Asahina, Kenta] Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Leng, Xubo] Univ Calif San Diego, Dept Elect & Comp Engn, La Jolla, CA 92093 USA; [Wohl, Margot] Univ Calif San Diego, Neurosci Grad Program, La Jolla, CA 92093 USA	Salk Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Asahina, K (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	kasahina@salk.edu		Leng, Xubo/0000-0002-1124-6941; Asahina, Kenta/0000-0001-6359-4369	Naito Foundation; Japan Society for the Promotion of Science Postdoctoral Fellowship Abroad; Mary K. Chapman Foundation; Rose Hills Foundation; NIH NIGMS [R35 GM119844]; Helen McLoraine Development Chair of Neurobiology at the Salk Institute	Naito Foundation(Naito Memorial Foundation); Japan Society for the Promotion of Science Postdoctoral Fellowship Abroad(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Mary K. Chapman Foundation; Rose Hills Foundation; NIH NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Helen McLoraine Development Chair of Neurobiology at the Salk Institute	K.I. was supported by the Naito Foundation and the Japan Society for the Promotion of Science Postdoctoral Fellowship Abroad. M.W. was supported by the Mary K. Chapman Foundation and the Rose Hills Foundation. This work was supported by NIH NIGMS R35 GM119844 to K.A. K.A. is a recipient of the Helen McLoraine Development Chair of Neurobiology at the Salk Institute.	Al-Anzi B, 2010, CURR BIOL, V20, P969, DOI 10.1016/j.cub.2010.04.039; Anderson DJ, 2014, NEURON, V84, P18, DOI 10.1016/j.neuron.2014.09.005; Asahina K, 2014, CELL, V156, P221, DOI 10.1016/j.cell.2013.11.045; Azim E, 2014, NATURE, V508, P357, DOI 10.1038/nature13021; Berman GJ, 2018, BMC BIOL, V16, DOI 10.1186/s12915-018-0494-7; Berman GJ, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0672; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; Briggman KL, 2005, SCIENCE, V307, P896, DOI 10.1126/science.1103736; Buolamwini J., 2018, P 1 C FAIRN ACC TRAN, P77; Burgos-Artizzu XP, 2012, PROC CVPR IEEE, P1322, DOI 10.1109/CVPR.2012.6247817; Calhoun AJ, 2019, NAT NEUROSCI, V22, P2040, DOI 10.1038/s41593-019-0533-x; Chen S, 2002, P NATL ACAD SCI USA, V99, P5664, DOI 10.1073/pnas.082102599; Datta SR, 2019, NEURON, V104, P11, DOI 10.1016/j.neuron.2019.09.038; Dell AI, 2014, TRENDS ECOL EVOL, V29, P417, DOI 10.1016/j.tree.2014.05.004; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Deng J., 2009, 2009 IEEE C COMP VIS; Egnor SER, 2016, ANNU REV NEUROSCI, V39, P217, DOI 10.1146/annurev-neuro-070815-013845; Eyjolfsdottir E, 2014, LECT NOTES COMPUT SC, V8690, P772, DOI 10.1007/978-3-319-10605-2_50; Fujiwara T, 2017, NAT NEUROSCI, V20, P72, DOI 10.1038/nn.4435; Garcia VA, 2010, IEEE ENG MED BIO, P6603, DOI 10.1109/IEMBS.2010.5627131; Gomez-Marin A, 2014, NAT NEUROSCI, V17, P1455, DOI 10.1038/nn.3812; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Hattori D, 2009, NATURE, V461, P644, DOI 10.1038/nature08431; Hong WZ, 2015, P NATL ACAD SCI USA, V112, pE5351, DOI 10.1073/pnas.1515982112; Hoopfer ED, 2015, ELIFE, V4, DOI 10.7554/eLife.11346; Ishii K, 2020, ELIFE, V9, DOI 10.7554/eLife.52701; JACOBS ME, 1960, ECOLOGY, V41, P182, DOI 10.2307/1931952; Jin X, 2010, NATURE, V466, P457, DOI 10.1038/nature09263; Jourjine N, 2016, CELL, V166, P855, DOI 10.1016/j.cell.2016.06.046; Kabra M, 2013, NAT METHODS, V10, P64, DOI [10.1038/nmeth.2281, 10.1038/NMETH.2281]; Kain J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2908; Krakauer JW, 2017, NEURON, V93, P480, DOI 10.1016/j.neuron.2016.12.041; Marin EC, 2005, DEVELOPMENT, V132, P725, DOI 10.1242/dev.01614; Markowitz JE, 2018, CELL, V174, P44, DOI 10.1016/j.cell.2018.04.019; Mathis A, 2018, NAT NEUROSCI, V21, P1281, DOI 10.1038/s41593-018-0209-y; Monfort M., 2019, MOMENTS TIME DATASET; Murthy M, 2010, CURR OPIN NEUROBIOL, V20, P281, DOI 10.1016/j.conb.2010.02.016; Nilsen SP, 2004, P NATL ACAD SCI USA, V101, P12342, DOI 10.1073/pnas.0404693101; Olveczky BP, 2005, PLOS BIOL, V3, P902, DOI 10.1371/journal.pbio.0030153; Pereira TD, 2019, NAT METHODS, V16, P117, DOI 10.1038/s41592-018-0234-5; Rezaval C, 2014, CURR BIOL, V24, P725, DOI 10.1016/j.cub.2013.12.051; Robie AA, 2017, CELL, V170, P393, DOI 10.1016/j.cell.2017.06.032; Robie AA, 2017, J EXP BIOL, V220, P25, DOI 10.1242/jeb.142281; Sanders JI, 2016, NEURON, V90, P499, DOI 10.1016/j.neuron.2016.03.025; Shirangi TR, 2016, DEV CELL, V37, P533, DOI 10.1016/j.devcel.2016.05.012; Simon JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008793; SOSSINKA R, 1980, Z TIERPSYCHOL, V53, P123; Szigeti B, 2016, BIORXIV; Ueda A, 2002, PHYSIOL ENTOMOL, V27, P21, DOI 10.1046/j.1365-3032.2002.00262.x; Wiltschko AB, 2015, NEURON, V88, P1121, DOI 10.1016/j.neuron.2015.11.031; Wohl M, 2020, ELIFE, V9, DOI 10.7554/eLife.52702; Yu JY, 2010, CURR BIOL, V20, P1602, DOI 10.1016/j.cub.2010.08.025	53	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0241696	10.1371/journal.pone.0241696	http://dx.doi.org/10.1371/journal.pone.0241696			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326445	Green Published, gold			2022-12-27	WOS:000600176400064
J	Moazzami, B; Chaichian, S; Kasaeian, A; Djalalinia, S; Akhlaghdoust, M; Eslami, M; Broumand, B				Moazzami, Bahram; Chaichian, Shahla; Kasaeian, Amir; Djalalinia, Shirin; Akhlaghdoust, Meisam; Eslami, Masoud; Broumand, Behrooz			Metabolic risk factors and risk of Covid-19: A systematic review and meta-analysis	PLOS ONE			English	Review							INFECTION; OUTCOMES	Objective Based on the epidemiologic findings of Covid-19 incidence; illness and mortality seem to be associated with metabolic risk factors. This systematic review and meta-analysis aimed to assess the association of metabolic risk factors and risk of Covid-19. Methods This study was designed according to PRISMA guidelines. Two independent researchers searched for the relevant studies using PubMed, Web of Science, Cochrane Library, and Scopus. The search terms developed focusing on two main roots of "Covid-19" and "metabolic risk factors". All relevant observational, analytical studies, review articles, and a meta-analysis on the adult population were included in this meta-analysis. Meta-analysis was performed using the random effect model for pooling proportions to address heterogeneity among studies. Data were analyzed using STATA package version 11.2, (StataCorp, USA). Results Through a comprehensive systematic search in the targeted databases we found 1124 papers, after running the proses of refining, 13 studies were included in the present meta-analysis. The pooled prevalence of obesity in Covid-19 patients was 29% (95% CI: 14-47%). For Diabetes and Hypertension, these were 22% (95% CI: 12% 33%) and 32% (95% CI: 12% 56%), respectively. There was significant heterogeneity in the estimates of the three pooled prevalence without any significant small-study effects. Such warning points, to some extent, guide physicians and clinicians to better understand the importance of controlling co-morbid risk factors in prioritizing resource allocation and interventions. Conclusion The meta-analysis showed that hypertension is more prevalent than obesity and diabetes in patients with Covid-19 disease. The prevalence of co-morbid metabolic risk factors must be adopted for better management and priority settings of public health vaccination and other required interventions. The results may help to improve services delivery in COVID-19 patients, while helping to develop better policies for prevention and response to COVID-19 and its critical outcomes.	[Moazzami, Bahram; Chaichian, Shahla; Akhlaghdoust, Meisam; Broumand, Behrooz] Pars Hosp, Pars Adv & Minimally Invas Med Manners Res Ctr, Tehran, Iran; [Kasaeian, Amir] Univ Tehran Med Sci, Hematol Oncol & Stem Cell Transplantat Res Ctr, Tehran, Iran; [Kasaeian, Amir] Univ Tehran Med Sci, Digest Dis Res Inst, Digest Dis Res Ctr, Tehran, Iran; [Djalalinia, Shirin] Minist Hlth & Med Educ, Dev Res & Technol Ctr, Deputy Res & Technol, Tehran, Iran; [Djalalinia, Shirin] Univ Tehran Med Sci, Endocrinol & Metab Populat Sci Inst, Noncommunicable Dis Res Ctr, Tehran, Iran; [Eslami, Masoud] Univ Tehran Med Sci, Tehran, Iran	Tehran University of Medical Sciences; Tehran University of Medical Sciences; Ministry of Health & Medical Education (MOHME); Tehran University of Medical Sciences; Tehran University of Medical Sciences	Chaichian, S (corresponding author), Pars Hosp, Pars Adv & Minimally Invas Med Manners Res Ctr, Tehran, Iran.	shchaichian@gmail.com	Akhlaghdoust, Meisam/O-3134-2018; Kasaeian, Amir/C-8290-2017; Chaichian, Shahla/S-9196-2017	Akhlaghdoust, Meisam/0000-0003-0484-9098; Kasaeian, Amir/0000-0003-2018-9368; Chaichian, Shahla/0000-0001-5772-8711				Alattar R, 2020, J MED VIROL, V92, P2042, DOI 10.1002/jmv.25964; Barrasa H, 2020, ANAESTH CRIT CARE PA, V39, P553, DOI 10.1016/j.accpm.2020.04.001; Cai QX, 2020, DIABETES CARE, V43, P1392, DOI 10.2337/dc20-0576; Chow N, 2020, MMWR-MORBID MORTAL W, V69, P382, DOI 10.15585/mmwr.mm6913e2; DerSimonian R, 2015, CONTEMP CLIN TRIALS, V45, P139, DOI 10.1016/j.cct.2015.09.002; Dixon AE, 2018, EXPERT REV RESP MED, V12, P755, DOI 10.1080/17476348.2018.1506331; Drucker DJ, 2020, ENDOCR REV, V41, P457, DOI 10.1210/endrev/bnaa011; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gentile S, 2020, DIABETES RES CLIN PR, V164, DOI 10.1016/j.diabres.2020.108195; Guan WJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00597-2020; Guo WN, 2020, DIABETES-METAB RES, V36, DOI 10.1002/dmrr.3319; Hastie CE, 2020, DIABETES METAB SYND, V14, P561, DOI 10.1016/j.dsx.2020.04.050; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hong KS, 2020, YONSEI MED J, V61, P431, DOI 10.3349/ymj.2020.61.5.431; Huang ZY, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm.2020.03.229; Joensen LE, 2020, DIABETIC MED, V37, P1146, DOI 10.1111/dme.14319; Kalligeros M, 2020, OBESITY, V28, P1200, DOI 10.1002/oby.22859; Lighter J, 2020, CLIN INFECT DIS, V71, P896, DOI 10.1093/cid/ciaa415; Guzman-Flores JM, 2012, GAC MED MEX, V148, P381; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Nikpouraghdam M, 2020, J CLIN VIROL, V127, DOI 10.1016/j.jcv.2020.104378; Nyaga VN, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-39; Ong SWX, 2020, CLIN INFECT DIS OFFI; Shi Q, 2020, DIABETES CARE, V43, P1382, DOI 10.2337/dc20-0598; Shi Y, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-2833-7; Simonnet A, 2020, OBESITY, V28, P1195, DOI 10.1002/oby.22831; Singh AK, 2020, DIABETES METAB SYND, V14, P283, DOI 10.1016/j.dsx.2020.03.016; Sterne J, 2011, RECOMMENDATIONS EXAM; The WHO Alliance for Maternal and Newborn Health Improvement late pregnancy dating study group, 2020, LANCET GLOB HLTH, V8, pe545; Wang X, 2020, DIABETES RES CLIN PR, V164, DOI 10.1016/j.diabres.2020.108200; Wang XH, 2020, RESEARCH-CHINA, V2020, DOI 10.34133/2020/2402961; Yu T, 2020, CLIN THER, V42, P964, DOI 10.1016/j.clinthera.2020.04.009; Zhang JJ, 2020, ALLERGY, V75, P1730, DOI 10.1111/all.14238; Zhang Y, 2020, DIABETES OBES METAB, V22, P1443, DOI 10.1111/dom.14086; Zheng Y, 2020, PHARMACOL RES, V157, DOI 10.1016/j.phrs.2020.104821; Zhou X, 2020, CLIN EXP HYPERTENS, V42, P656, DOI 10.1080/10641963.2020.1764018	36	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243600	10.1371/journal.pone.0243600	http://dx.doi.org/10.1371/journal.pone.0243600			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320875	Green Published, gold			2022-12-27	WOS:000600339800049
J	Kengne-Nde, C; Kenmoe, S; Modiyinji, AF; Njouom, R				Kengne-Nde, Cyprien; Kenmoe, Sebastien; Modiyinji, Abdou Fatawou; Njouom, Richard			Prevalence of respiratory viruses using polymerase chain reaction in children with wheezing, a systematic review and meta-analysis	PLOS ONE			English	Article							SYNCYTIAL VIRUS; HUMAN METAPNEUMOVIRUS; HUMAN BOCAVIRUS; VIRAL-INFECTIONS; YOUNG-CHILDREN; LUNG-FUNCTION; RISK-FACTORS; RHINOVIRUS; ASTHMA; BRONCHIOLITIS	Introduction Wheezing is a major problem in children, and respiratory viruses are often believed to be the causative agent. While molecular detection tools enable identification of respiratory viruses in wheezing children, it remains unclear if and how these viruses are associated with wheezing. The objective of this systematic review is to clarify the prevalence of different respiratory viruses in children with wheezing. Methods We performed an electronic in Pubmed and Global Index Medicus on 01 July 2019 and manual search. We performed search of studies that have detected common respiratory viruses in children <= 18 years with wheezing. We included only studies using polymerase chain reaction (PCR) assays. Study data were extracted and the quality of articles assessed. We conducted sensitivity, subgroup, publication bias, and heterogeneity analyses using a random effects model. Results The systematic review included 33 studies. Rhinovirus, with a prevalence of 35.6% (95% CI 24.6-47.3, I-2 98.4%), and respiratory syncytial virus, at 31.0% (95% CI 19.9-43.3, I-2 96.4%), were the most common viruses detected. The prevalence of other respiratory viruses was as follows: human bocavirus 8.1% (95% CI 5.3-11.3, I-2 84.6%), human adenovirus 7.7% (95% CI 2.6-15.0, I-2 91.0%), influenza virus6.5% (95% CI 2.2-12.6, I-2 92.4%), human metapneumovirus5.8% (95% CI 3.4-8.8, I-2 89.0%), enterovirus 4.3% (95% CI 0.1-12.9, I-2 96.2%), human parainfluenza virus 3.8% (95% CI 1.5-6.9, I-2 79.1%), and human coronavirus 2.2% (95% CI 0.6-4.4, I-2 79.4%). Conclusions Our results suggest that rhinovirus and respiratory syncytial virus may contribute to the etiology of wheezing in children. While the clinical implications of molecular detection of respiratory viruses remains an interesting question, this study helps to illuminate the potential of role respiratory viruses in pediatric wheezing. Review registration PROSPERO, CRD42018115128.	[Kengne-Nde, Cyprien] Natl AIDS Control Comm, Epidemiol Surveillance Evaluat & Res Unit, Yaounde, Cameroon; [Kenmoe, Sebastien; Modiyinji, Abdou Fatawou; Njouom, Richard] Ctr Pasteur Cameroon, Dept Virol, Yaounde, Cameroon; [Modiyinji, Abdou Fatawou] Univ Yaounde I, Dept Anim Biol & Physiol, Fac Sci, Yaounde, Cameroon	University of Yaounde I	Njouom, R (corresponding author), Ctr Pasteur Cameroon, Dept Virol, Yaounde, Cameroon.	njouom@pasteur-yaounde.org		KENGNE NDE, CYPRIEN/0000-0002-8338-2221; KENMOE, SEBASTIEN/0000-0002-5536-080X				Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Allander T, 2007, CLIN INFECT DIS, V44, P904, DOI 10.1086/512196; Alvarez-Alvarez I, 2018, ALLERGOL IMMUNOPATH, V46, P210, DOI 10.1016/j.aller.2016.08.011; [Anonymous], 2012, INT J SPORTS MED, V33, P36; [Anonymous], 2017, CANC DISCOVERY, V7, pOF12; Backman K, 2018, CLIN EXP ALLERGY, V48, P138, DOI 10.1111/cea.13062; Barendregt JJ, 2013, J EPIDEMIOL COMMUN H, V67, P974, DOI 10.1136/jech-2013-203104; Bedolla-Barajas M, 2017, GAC MED MEX, V153, P329; Bosis S, 2008, CLIN MICROBIOL INFEC, V14, P677, DOI 10.1111/j.1469-0691.2008.02016.x; Broccolo F, 2015, J CLIN VIROL, V72, P75, DOI 10.1016/j.jcv.2015.09.008; Camara AA, 2004, J ALLERGY CLIN IMMUN, V113, P551, DOI 10.1016/j.jaci.2003.11.027; Chung JY, 2007, J MED VIROL, V79, P1238, DOI 10.1002/jmv.20926; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; Cox DW, 2013, AM J RESP CRIT CARE, V188, P1358, DOI 10.1164/rccm.201303-0498OC; de Winter JJH, 2015, IMMUN INFLAMM DIS, V3, P398, DOI 10.1002/iid3.77; Deng Yu, 2007, Zhonghua Er Ke Za Zhi, V45, P732; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Faux CE, 2011, EMERG INFECT DIS, V17, P296, DOI 10.3201/eid1702.101123; Fjaerli Hans-Olav, 2004, BMC Pediatr, V4, P25, DOI 10.1186/1471-2431-4-25; Fuenzalida L, 2010, CLIN MICROBIOL INFEC, V16, P1663, DOI 10.1111/j.1469-0691.2010.03192.x; Fujitsuka A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-168; Garcia-Garcia ML, 2010, PEDIATR PULM, V45, P585, DOI 10.1002/ppul.21225; Gern JE, 2010, J VIROL, V84, P7418, DOI 10.1128/JVI.02290-09; Gern JE, 2000, J ALLERGY CLIN IMMUN, V106, P201, DOI 10.1067/mai.2000.108604; Ginocchio CC, 2007, J CLIN VIROL, V40, pS11, DOI 10.1016/S1386-6532(07)70004-5; Hancerli-Torun S, 2015, TURKISH J PEDIATR, V57, P367; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hoek L. van der, 2004, Nature Medicine, V10, P368, DOI 10.1038/nm1024; Hoy D, 2012, J CLIN EPIDEMIOL, V65, P934, DOI 10.1016/j.jclinepi.2011.11.014; Inoue Y, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00391; Jartti T, 2004, EMERG INFECT DIS, V10, P1095, DOI 10.3201/eid1006.030629; Jartti T, 2002, LANCET, V360, P1393, DOI 10.1016/S0140-6736(02)11391-2; Johnston SL, 1996, AM J RESP CRIT CARE, V154, P654, DOI 10.1164/ajrccm.154.3.8810601; Johnston SL, 1999, PEDIATR PULM, P141; Johnston SL, 1997, PEDIATR PULM, P88; Korppi M, 2004, PEDIATR INFECT DIS J, V23, P995, DOI 10.1097/01.inf.0000143642.72480.53; Kotaniemi-Syrjanen A, 2003, J ALLERGY CLIN IMMUN, V111, P66, DOI 10.1067/mai.2003.33; Lethbridge R, 2018, VIRAL IMMUNOL, V31, P299, DOI 10.1089/vim.2017.0152; Lieberthal AS, 2006, PEDIATRICS, V118, P1774, DOI 10.1542/peds.2006-2223; Martinez FD, 2002, PEDIATRICS, V109, P362; MCINTOSH K, 1973, J PEDIATR-US, V82, P578, DOI 10.1016/S0022-3476(73)80582-7; Message SD, 2002, BRIT MED BULL, V61, P29, DOI 10.1093/bmb/61.1.29; Moattari A, 2010, IRAN J ALLERGY ASTHM, V9, P251, DOI 09.04/ijaai.251254; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Mummidi PS, 2017, INDIAN J MED RES, V145, P188, DOI 10.4103/ijmr.IJMR_840_15; Noor A, 2018, EXPERT OPIN BIOL TH, V18, P1247, DOI 10.1080/14712598.2018.1544239; Ong B. H., 2007, SMJ Singapore Medical Journal, V48, P291; Ouzzani M, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0384-4; PATTEMORE PK, 1992, CLIN EXP ALLERGY, V22, P325, DOI 10.1111/j.1365-2222.1992.tb03094.x; Piotrowska Z, 2009, PEDIATR INFECT DIS J, V28, P25, DOI 10.1097/INF.0b013e3181861da0; R Development Core Team, 2009, R LANG ENV STAT COMP; Reijonen TM, 2000, PEDIATRICS, V106, P1406, DOI 10.1542/peds.106.6.1406; Rylander E, 1996, PEDIATR ALLERGY IMMU, V7, P6, DOI 10.1111/j.1399-3038.1996.tb00099.x; Sackesen C, 2005, TURKISH J PEDIATR, V47, P227; Sakthivel SK, 2012, J VIROL METHODS, V185, P259, DOI 10.1016/j.jviromet.2012.07.010; Savolainen C, 2002, J GEN VIROL, V83, P333, DOI 10.1099/0022-1317-83-2-333; Schauer U, 2002, EUR RESPIR J, V20, P1277, DOI 10.1183/09031936.02.00019902; Schwarzer G., 2007, R NEWS, V7, P40; Shen J, 2013, INT J MOL MED, V32, P1415, DOI 10.3892/ijmm.2013.1512; Sigurs N, 2000, AM J RESP CRIT CARE, V161, P1501, DOI 10.1164/ajrccm.161.5.9906076; Smuts H, 2008, J MED VIROL, V80, P906, DOI 10.1002/jmv.21135; Smuts HE, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-65; Stenberg-Hammar K, 2016, ALLERGY, V71, P1728, DOI 10.1111/all.12991; Stenberg-Hammar K, 2017, PEDIAT ALLERG IMM-UK, V28, P513, DOI 10.1111/pai.12740; Stewart PS, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MB-0010-2014; Sun HQ, 2016, BRAZ J INFECT DIS, V20, P179, DOI 10.1016/j.bjid.2015.12.005; Takeyama A, 2014, EUR J PEDIATR, V173, P959, DOI 10.1007/s00431-014-2277-7; Teeratakulpisarn J, 2014, ASIAN PAC J ALLERGY, V32, P226, DOI [10.12932/ap0417.32.3.2014, 10.12932/AP0417.32.3.2014]; Tuffaha A, 2000, CLIN CHEST MED, V21, P289, DOI 10.1016/S0272-5231(05)70267-7; Turunen R, 2014, PEDIAT ALLERG IMM-UK, V25, P796, DOI 10.1111/pai.12318; van der Schee MP, 2015, EUR RESPIR J, V45, P440, DOI 10.1183/09031936.00044414; van der Zalm MM, 2011, AM J RESP CRIT CARE, V183, P262, DOI 10.1164/rccm.200905-0716OC; Viera AJ, 2005, FAM MED, V37, P360; Zheng XY, 2018, ARCH VIROL, V163, P845, DOI 10.1007/s00705-017-3700-y	74	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243735	10.1371/journal.pone.0243735	http://dx.doi.org/10.1371/journal.pone.0243735			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315873	gold, Green Published			2022-12-27	WOS:000600186100079
J	Kim, J; Lee, Y; Kim, ML				Kim, Jeeyoon; Lee, Younghan; Kim, Mi-Lyang			Investigating 'Fear of Missing Out' (FOMO) as an extrinsic motive affecting sport event consumer's behavioral intention and FOMO-driven consumption's influence on intrinsic rewards, extrinsic rewards, and consumer satisfaction	PLOS ONE			English	Article							MODELS; CONSTRAINTS; NEGOTIATION; MOTIVATION; QUALITY; FANS; SELF; EYE	This study posits that Fear of Missing Out (FOMO) can function as an extrinsic motive stimulating sport event consumption by inducing consumers to overcome leisure constraints. Also, FOMO-driven consumption is proposed to affect consumption experience for being grounded on extrinsic than intrinsic rewards. In Study 1, the moderation of FOMO between intrapersonal and structural constraints and sport media viewing intention are tested. In Study 2, the relations among FOMO-driven consumption, intrinsic rewards (i.e., enjoyment), extrinsic rewards (i.e., social adherence), and consumer satisfaction are assessed. Study 1 results support the notion that FOMO can boost sport media viewing intention through two mechanisms: by directly stimulating intention and by lifting the negative effect of constraints on intention. In Study 2, FOMO-driven consumption shows a stronger link to extrinsic than intrinsic rewards, extrinsic reward is marginally but negatively associated with intrinsic reward, and intrinsic reward is a stronger predictor of satisfaction. Overall, FOMO is identified as a meaningful extrinsic motive for sport event consumption though its effects on consumer satisfaction are arguable. Implications for FOMO-driven marketing are discussed.	[Kim, Jeeyoon] Syracuse Univ, Falk Coll Sport & Human Dynam, Dept Sport Management, New York, NY USA; [Lee, Younghan] Mississippi State Univ, Dept Kinesiol, Starkville, MS USA; [Kim, Mi-Lyang] Soonchunhyang Univ, Dept Sport Leisure & Recreat, Asan, Choong Nam, South Korea	Syracuse University; Mississippi State University; Soonchunhyang University	Kim, ML (corresponding author), Soonchunhyang Univ, Dept Sport Leisure & Recreat, Asan, Choong Nam, South Korea.	mlkim@sch.ac.kr		Lee, Younghan/0000-0002-4735-4450; Kim, Jeeyoon/0000-0003-3279-9286	National Research Foundation of Korea - Korean Government (MOE) [NRF-2017S1A2A2039405]; Soonchunhyang University	National Research Foundation of Korea - Korean Government (MOE); Soonchunhyang University	This work was supported by the National Research Foundation of Korea Grant funded by the Korean Government (MOE) (NRF-2017S1A2A2039405). Y. Lee and M.L Kim jointly received the fund (URL: https://www.nrf.re.kr/eng/index).M.L Kim also received a research fund from Soonchunhyang University in support to this project (URL: https://homepage.sch.ac.kr/sch/index.jsp).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel J.P., 2016, J BUSINESS EC RES JB, V14, P33, DOI [DOI 10.19030/JBER.V14I1.9554, 10.19030/jber.v14i1.9554]; Alexandris K., 2004, LOISIR SOC-SOC LEIS, V27, P197, DOI [DOI 10.1080/07053436.2004.10707647, 10.1080/07053436.2004.10707647]; Alt D, 2018, CURR PSYCHOL, V37, P128, DOI 10.1007/s12144-016-9496-1; Alt D, 2015, COMPUT HUM BEHAV, V49, P111, DOI 10.1016/j.chb.2015.02.057; [Anonymous], 2013, FOMO MARK TIPS YOU D; Apostolopoulou A., 2006, SPORT MARKET Q, V15, P223; Argan M., 2018, INT J MARKETING STUD, V10, P109; Asada A, 2020, J SPORT MANAGE, V34, P103, DOI 10.1123/jsm.2019-0055; Asada A, 2019, J SPORT MANAGE, V33, P530, DOI 10.1123/jsm.2018-0362; Bartholomew K.J., 2009, INT REV SPORT EXER P, V2, P215, DOI [10.1080/17509840903235330, DOI 10.1080/17509840903235330]; Beyens I, 2016, COMPUT HUM BEHAV, V64, P1, DOI 10.1016/j.chb.2016.05.083; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Burke Peter J., 2009, IDENTITY THEORY; Crane J, 2015, EUR PHYS EDUC REV, V21, P114, DOI 10.1177/1356336X14555294; CRAWFORD DW, 1991, LEISURE SCI, V13, P309, DOI 10.1080/01490409109513147; Cronin JJ, 2000, J RETAILING, V76, P193, DOI 10.1016/S0022-4359(00)00028-2; Cumming G, 2009, STAT MED, V28, P205, DOI 10.1002/sim.3471; Cunningham G. B., 2003, Sport Management Review, V6, P127, DOI 10.1016/S1441-3523(03)70056-4; de Ruyter K, 2000, J ECON PSYCHOL, V21, P387, DOI 10.1016/S0167-4870(00)00010-6; Deci E. L., 1985, INTRINSIC MOTIVATION; Deci EL, 1999, PSYCHOL BULL, V125, P627, DOI 10.1037/0033-2909.125.6.627; Deci EL, 2002, HDB SELF DETERMINATI; Deci EL, 1972, E PSYCHOL ASS; Dogan V, 2019, J CROSS CULT PSYCHOL, V50, P524, DOI 10.1177/0022022119839145; Eventbrite, 2014, MILL FUEL EXP EC; FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312; Funk D. C., 2003, Sport Management Review, V6, P1, DOI 10.1016/S1441-3523(03)70051-5; Funk D. C., 2001, Sport Management Review, V4, P119; Groves R.M., 2004, SURVEY ERRORS SURVEY; Guay F, 2000, MOTIV EMOTION, V24, P175, DOI 10.1023/A:1005614228250; Hayes A., 2017, INTRO MEDIATION MODE; Hayran C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232318; Hodkinson C., 2016, J MARK COMMUN, V25, P65, DOI [10.1080/13527266.2016.1234504, DOI 10.1080/13527266.2016.1234504]; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hubbard J, 2001, LEISURE SCI, V23, P145, DOI 10.1080/014904001316896846; Hung K, 2012, TOURISM MANAGE, V33, P855, DOI 10.1016/j.tourman.2011.09.007; IPG Media, 2014, ANN SURV AM FOOTB CO; Jackson EL, 1997, J LEISURE RES, V29, P458, DOI 10.1080/00222216.1997.11949809; JACKSON EL, 1993, LEISURE SCI, V15, P1, DOI 10.1080/01490409309513182; Kahneman D., 2011, THINKING FAST SLOW; Kang I, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11174734; Kim J.J., 2018, BUILDING SPORT PARTI; Kim J, 2019, J SPORT MANAGE, V33, P119, DOI 10.1123/jsm.2018-0071; Kim YK, 2010, J SPORT MANAGE, V24, P190, DOI 10.1123/jsm.24.2.190; Kline R.B., 2011, PRINCIPLES PRACTICE; Larkin BA, 2016, J SPORT MANAGE, V30, P643, DOI 10.1123/jsm.2015-0344; Mardia KV, 1985, ENCY STAT SCI, V5, P217; Martela F, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.02174; Caro LM, 2007, J BUS RES, V60, P108, DOI 10.1016/j.jbusres.2006.10.008; Milyavskaya M, 2018, MOTIV EMOTION, V42, P725, DOI 10.1007/s11031-018-9683-5; Nielsen, 2014, YEAR SPORTS MEDIA RE; Podsakoff PM, 2012, ANNU REV PSYCHOL, V63, P539, DOI 10.1146/annurev-psych-120710-100452; Przybylski AK, 2016, COMPUT HUM BEHAV, V29, P1841; Real M. R., 2017, SPORT MEDIA MEGA EVE, P199; Reinecke L, 2014, J COMMUN, V64, P417, DOI 10.1111/jcom.12099; Satorra A, 2001, PSYCHOMETRIKA, V66, P507, DOI 10.1007/BF02296192; Seale A., 2015, YAHOO FINANCE   0312; Stanis SAW, 2009, LEISURE SCI, V31, P287, DOI 10.1080/01490400902837886; Stride CB, 2018, MPLUS CODE MEDIATION; Tabachnick B. G.., 2012, USING MULTIVARIATE S; Trail G. T., 2015, SPORT CONSUMER BEHAV; Trail GT, 2011, INT J SPORT MARK SPO, V13, P60, DOI 10.1108/IJSMS-13-01-2011-B006; United States Census, QUICKFACTS; Wang TR, 2013, SOC BEHAV PERSONAL, V41, P1421, DOI 10.2224/sbp.2013.41.9.1421; Wann DL, 2006, GROUP DYN-THEOR RES, V10, P272, DOI 10.1037/1089-2699.10.4.272; Wegmann Elisa, 2017, Addict Behav Rep, V5, P33, DOI 10.1016/j.abrep.2017.04.001	66	9	9	8	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243744	10.1371/journal.pone.0243744	http://dx.doi.org/10.1371/journal.pone.0243744			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH1MP	33315890	Green Published, gold			2022-12-27	WOS:000600186100056
J	Kosgei, RJ; Callens, S; Gichangi, P; Temmerman, M; Kihara, AB; David, G; Omesa, EN; Masini, E; Carter, EJ				Kosgei, Rose J.; Callens, Steven; Gichangi, Peter; Temmerman, Marleen; Kihara, Anne-Beatrice; David, Gathara; Omesa, Eunice Nyaboe; Masini, Enos; Carter, E. Jane			Gender difference in mortality among pulmonary tuberculosis HIV co-infected adults aged 15-49 years in Kenya	PLOS ONE			English	Article							TREATMENT OUTCOMES; EPIDEMIOLOGY; MALNUTRITION; TRANSMISSION; RISK	Setting Kenya, 2012-2015 Objective To explore whether there is a gender difference in all-cause mortality among smear positive pulmonary tuberculosis (PTB)/ HIV co-infected patients treated for tuberculosis (TB) between 2012 and 2015 in Kenya. Design Retrospective cohort of 9,026 smear-positive patients aged 15-49 years. All-cause mortality during TB treatment was the outcome of interest. Time to start of antiretroviral therapy (ART) initiation was considered as a proxy for CD4 cell count. Those who took long to start of ART were assumed to have high CD4 cell count. Results Of the 9,026 observations analysed, 4,567(51%) and 4,459(49%) were women and men, respectively. Overall, out of the 9,026 patients, 8,154 (90%) had their treatment outcome as cured, the mean age in years (SD) was 33.3(7.5) and the mean body mass index (SD) was 18.2(3.4). Men were older (30% men' vs 17% women in those >= 40 years, p = <0.001) and had a lower BMI <18.5 (55.3% men vs 50.6% women, p = <0.001). Men tested later for HIV: 29% (1,317/4,567) of women HIV tested more than 3 months prior to TB treatment, as compared to 20% (912/4,459) men (p<0.001). Mortality was higher in men 11% (471/4,459) compared to women 9% (401/4,567, p = 0.004). There was a 17% reduction in the risk of death among women (adjusted HR 0.83; 95% CI 0.72-0.96; p = 0.013). Survival varied by age-groups, with women having significantly better survival than men, in the age-groups 40 years and over (log-rank p = 0.006). Conclusion Women with sputum positive PTB/HIV co-infection have a significantly lower risk of all-cause mortality during TB treatment compared to men. Men were older, had lower BMI and tested later for HIV than women.	[Kosgei, Rose J.; Kihara, Anne-Beatrice] Univ Nairobi, Dept Obstet & Gynaecol, Nairobi, Kenya; [Callens, Steven; Temmerman, Marleen] Univ Ghent, Fac Med & Hlth Sci, Ghent, Belgium; [Gichangi, Peter] Univ Nairobi, Dept Human Anat, Nairobi, Kenya; [Temmerman, Marleen] Aga Khan Univ, Fac Hlth Sci, Nairobi, Kenya; [David, Gathara] Ruby Med Ctr, Kiambu West, Kenya; [Omesa, Eunice Nyaboe; Masini, Enos] Natl TB Leprosy & Lung Dis Program, Nairobi, Kenya; [Carter, E. Jane] Brown Univ, Alpert Sch Med, Providence, RI 02912 USA	University of Nairobi; Ghent University; University of Nairobi; Aga Khan University; Brown University	Kosgei, RJ (corresponding author), Univ Nairobi, Dept Obstet & Gynaecol, Nairobi, Kenya.	salilkabon@gmail.com		Gathara, David/0000-0002-0958-0713				Balasubramanian R, 2004, INT J TUBERC LUNG D, V8, P323; Bhargava A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077979; Chi BH, 2013, CURR OPIN HIV AIDS, V8, P498, DOI 10.1097/COH.0b013e3283637f7a; Faustini A, 2008, INT J INFECT DIS, V12, P611, DOI 10.1016/j.ijid.2007.12.012; Feng JY, 2012, CLIN MICROBIOL INFEC, V18, pE331, DOI 10.1111/j.1469-0691.2012.03931.x; Gathara D, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0850-8; Gopalan N, 2016, AIDS RES THER, V13, DOI 10.1186/s12981-016-0118-7; Gunda DW, 2017, J TROP MED-US, V2017, DOI 10.1155/2017/5352906; Hanrahan CF, 2010, AIDS, V24, P1501, DOI 10.1097/QAD.0b013e32833a2a4a; Hodgkinson LM, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000020328; Islam QS, 2013, PUBLIC HEALTH ACTION, V3, P136, DOI 10.5588/pha.13.0005; Jimenez-Corona ME, 2006, THORAX, V61, P348, DOI 10.1136/thx.2005.049452; Kerschberger B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046988; Kosgei RJ, 2015, INT J TUBERC LUNG D, V19, P1176, DOI 10.5588/ijtld.15.0070; Lai RPJ, 2016, SEMIN IMMUNOPATHOL, V38, P185, DOI 10.1007/s00281-015-0532-2; Lonnroth K, 2008, SEMIN RESP CRIT CARE, V29, P481, DOI 10.1055/s-0028-1085700; Manosuthi W, 2016, AIDS RES THER, V13, DOI 10.1186/s12981-016-0106-y; MOH. Ministry of Health, 2012, DIV LEPR TUB LUNG DI; Neyrolles O, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000199; Nglazi MD, 2012, SAMJ S AFR MED J, V102, P936, DOI [10.7196/SAMJ.6024, 10.7196/samj.6024]; Nhamoyebonde S, 2014, J INFECT DIS, V209, pS100, DOI 10.1093/infdis/jiu147; Pakasi TA, 2009, INT J TUBERC LUNG D, V13, P755; Pepper DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019484; Shah NS, 2007, EMERG INFECT DIS, V13, P380, DOI 10.3201/eid1303.061400; Sharma SK, 2011, INDIAN J MED RES, V134, P866, DOI 10.4103/0971-5916.92632; Vandenbroucke JP, 2014, INT J SURG, V12, P1500, DOI 10.1016/j.ijsu.2014.07.014; WHO, 2010, ANT THER HIV INF AD; WHO, 2017, GLOB TUB REP 2017; WHO, 2018, ANT THER HIV INF AD; WHO, 2015, GEND STAT MAN INT GE; WHO, 2018, DEF REP FRAM TUB 201; Yang CH, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-304; Yen YF, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002300; Zachariah R, 2002, T ROY SOC TROP MED H, V96, P291, DOI 10.1016/S0035-9203(02)90103-3	34	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243977	10.1371/journal.pone.0243977	http://dx.doi.org/10.1371/journal.pone.0243977			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315954	gold, Green Published			2022-12-27	WOS:000600186100080
J	Li, C; Liu, Y; Tian, J; Zhu, YS; Fan, JJ				Li, Cong; Liu, Yu; Tian, Jing; Zhu, Yanshu; Fan, Jinjuan			Changes in sucrose metabolism in maize varieties with different cadmium sensitivities under cadmium stress	PLOS ONE			English	Article							GENE-EXPRESSION; ACCUMULATION; TOLERANCE; TRANSPORTERS; ENZYMES; SYSTEMS; PLANTS; ROLES; CULTIVARS; DROUGHT	Sucrose metabolism contributes to the growth and development of plants and helps plants cope with abiotic stresses, including stress from Cd. Many of these processes are not well-defined, including the mechanism underlying the response of sucrose metabolism to Cd stress. In this study, we investigated how sucrose metabolism in maize varieties with low (FY9) and high (SY33) sensitivities to Cd changed in response to different levels of Cd (0 (control), 5, 10, and 20 mg L-1 Cd). The results showed that photosynthesis was impaired, and the biomass decreased, in both varieties of maize at different Cd concentrations. Cd inhibited the activities of sucrose phosphate synthase (SPS) and sucrose synthase (SS) (sucrose synthesis), and stimulated the activities of acid invertase (AI) and SS (sucrose hydrolysis). The total soluble sugar contents were higher in the Cd-treated seedlings than in the control. Also, Cd concentrations in the shoots were higher in SY33 than in FY9, and in the roots were lower in SY33 than in FY9. The decreases in the photosynthetic rate, synthesis of photosynthetic products, enzyme activity in sucrose synthesis direction, and increases in activity in hydrolysis direction were more obvious in SY33 (the sensitive variety) than in FY9 (the tolerant variety), and more photosynthetic products were converted into soluble sugar in SY33 than in FY9 as the Cd stress increased. The transcript levels of the sugar transporter genes also differed between the two varieties at different concentrations of Cd. These results suggest that sucrose metabolism may be a secondary response to Cd additions, and that the Cd-sensitive variety used more carbohydrates to defend against Cd stress rather than to support growth than the Cd-tolerant variety.	[Li, Cong; Liu, Yu; Tian, Jing; Zhu, Yanshu; Fan, Jinjuan] Shenyang Agr Univ, Coll Biol Sci & Technol, Shenyang, Liaoning, Peoples R China; [Li, Cong; Tian, Jing; Zhu, Yanshu; Fan, Jinjuan] Shenyang Key Lab Maize Genom Select Breeding, Shenyang, Liaoning, Peoples R China	Shenyang Agricultural University	Fan, JJ (corresponding author), Shenyang Agr Univ, Coll Biol Sci & Technol, Shenyang, Liaoning, Peoples R China.; Fan, JJ (corresponding author), Shenyang Key Lab Maize Genom Select Breeding, Shenyang, Liaoning, Peoples R China.	jinjuanf@hotmail.com			scientific research projects of Liaoning Provincial Department of Education, China [LSNZD201608, LSNYB201607]	scientific research projects of Liaoning Provincial Department of Education, China	This research was financially supported by the scientific research projects of Liaoning Provincial Department of Education, China (No. LSNZD201608 and LSNYB201607). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdElgawad H, 2020, ENVIRON POLLUT, V258, DOI 10.1016/j.envpol.2019.113705; [Anonymous], 2012, SESTRINSTVO, V32, P4; [Anonymous], 2015, REINFORCED PLASTIC, V59, P171; Ayre BG, 2011, MOL PLANT, V4, P377, DOI 10.1093/mp/ssr014; Bonfig KB, 2010, MOL PLANT, V3, P1037, DOI 10.1093/mp/ssq053; Chaoui A, 2005, CR BIOL, V328, P23, DOI 10.1016/j.crvi.2004.10.001; Chardon F, 2013, CURR BIOL, V23, P697, DOI 10.1016/j.cub.2013.03.021; Clemens S, 2006, BIOCHIMIE, V88, P1707, DOI 10.1016/j.biochi.2006.07.003; Durand M, 2016, PLANT PHYSIOL, V170, P1460, DOI 10.1104/pp.15.01926; Eom JS, 2015, CURR OPIN PLANT BIOL, V25, P53, DOI 10.1016/j.pbi.2015.04.005; Faller P, 2005, BBA-BIOENERGETICS, V1706, P158, DOI 10.1016/j.bbabio.2004.10.005; GEIGENBERGER P, 1993, PLANTA, V189, P329, DOI 10.1007/BF00194429; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Guo JJ, 2019, ECOTOX ENVIRON SAFE, V172, P380, DOI 10.1016/j.ecoenv.2019.01.069; Guo Q, 2014, BIOL PLANTARUM, V58, P174, DOI 10.1007/s10535-013-0359-4; Guo Q, 2017, ECOTOX ENVIRON SAFE, V139, P50, DOI 10.1016/j.ecoenv.2016.12.013; Hanikenne M, 2011, CURR OPIN PLANT BIOL, V14, P252, DOI 10.1016/j.pbi.2011.04.003; Hir R, 2015, MOL PLANT, V8, P1687, DOI DOI 10.1016/J.MOLP.2015.08.007; Kakumanu A, 2012, PLANT PHYSIOL, V160, P846, DOI 10.1104/pp.112.200444; Kamnev AA, 2000, BIOSCIENCE REP, V20, P239, DOI 10.1023/A:1026436806319; Khan KY, 2020, ECOTOX ENVIRON SAFE, V200, DOI 10.1016/j.ecoenv.2020.110748; Liu JG, 2007, J HAZARD MATER, V143, P443, DOI 10.1016/j.jhazmat.2006.09.057; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MCCREADY RM, 1950, ANAL CHEM, V22, P1156, DOI 10.1021/ac60045a016; MOYA JL, 1993, PHOTOSYNTH RES, V36, P75, DOI 10.1007/BF00016271; Nagele T, 2012, PLANT J, V72, P102, DOI 10.1111/j.1365-313X.2012.05064.x; OBENLAND DM, 1993, PLANT PHYSIOL, V101, P1331, DOI 10.1104/pp.101.4.1331; Patrick JW, 2013, PLANT BIOTECHNOL J, V11, P142, DOI 10.1111/pbi.12002; Ranwala AP, 1998, PHYSIOL PLANTARUM, V103, P541, DOI 10.1034/j.1399-3054.1998.1030413.x; Ruan YL, 2014, ANNU REV PLANT BIOL, V65, P33, DOI 10.1146/annurev-arplant-050213-040251; Ruan YL, 2012, TRENDS PLANT SCI, V17, P656, DOI 10.1016/j.tplants.2012.06.005; Ruan YL, 2010, MOL PLANT, V3, P942, DOI 10.1093/mp/ssq044; Saher S, 2005, PLANT PHYSIOL BIOCH, V43, P573, DOI 10.1016/j.plaphy.2005.05.006; Sanchez-Linares L, 2012, J EXP BOT, V63, P4513, DOI 10.1093/jxb/ers130; Sfaxi-Bousbih A, 2010, ECOTOX ENVIRON SAFE, V73, P1123, DOI 10.1016/j.ecoenv.2010.01.005; Shah K, 1998, ACTA PHYSIOL PLANT, V20, P189, DOI 10.1007/s11738-998-0013-5; Sharma SS, 2009, TRENDS PLANT SCI, V14, P43, DOI 10.1016/j.tplants.2008.10.007; Slewinski TL, 2011, MOL PLANT, V4, P641, DOI 10.1093/mp/ssr051; Tamas L, 2010, PLANTA, V231, P221, DOI 10.1007/s00425-009-1042-z; Vatehova Z, 2016, PLANT PHYSIOL BIOCH, V108, P90, DOI 10.1016/j.plaphy.2016.06.035; Verma S, 2001, BIOL PLANTARUM, V44, P117, DOI 10.1023/A:1017938809311; WAGNER GJ, 1993, ADV AGRON, V51, P173, DOI 10.1016/S0065-2113(08)60593-3; Wang M, 2007, BIORESOURCE TECHNOL, V98, P82, DOI 10.1016/j.biortech.2005.11.028; Wang ZF, 2017, ECOTOX ENVIRON SAFE, V135, P75, DOI 10.1016/j.ecoenv.2016.09.013; Woolhouse HW, 1983, ENCY PLANT PHYSL C, V12C, P245, DOI DOI 10.1007/978-3-642-68153-0_; Wu ZC, 2015, CHEMOSPHERE, V138, P526, DOI 10.1016/j.chemosphere.2015.06.080; Xiang L, 2011, J EXP BOT, V62, P3849, DOI 10.1093/jxb/err069; XU DP, 1989, PLANT PHYSIOL, V89, P1106, DOI 10.1104/pp.89.4.1106; Xu XH, 2014, B ENVIRON CONTAM TOX, V93, P618, DOI 10.1007/s00128-014-1361-z; Yang LM, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00190; Yuan HM, 2016, PLANT CELL ENVIRON, V39, P120, DOI 10.1111/pce.12597; Zhang FQ, 2009, J HAZARD MATER, V168, P76, DOI 10.1016/j.jhazmat.2009.02.002; [张宇 Zhang Yu], 2015, [海洋湖沼通报, Transactions of Oceanology and Limnology], P50; Zhao XW, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-017-4395-x	54	12	12	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243835	10.1371/journal.pone.0243835	http://dx.doi.org/10.1371/journal.pone.0243835			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306745	gold, Green Published			2022-12-27	WOS:000600144200026
J	Ma, TL; Matsuoka, S; Drummond-Barbosa, D				Ma, Tianlu; Matsuoka, Shinya; Drummond-Barbosa, Daniela			RNAi-based screens uncover a potential new role for the orphan neuropeptide receptor Moody in Drosophila female germline stem cell maintenance	PLOS ONE			English	Article							EGG-LAYING RHYTHM; EXPRESSION; NEURONS; MORPHOGENESIS; REPRODUCTION; TEMPERATURE; MELATONIN; DEFENSE; PATHWAY; INSULIN	Reproduction is highly sensitive to changes in physiology and the external environment. Neuropeptides are evolutionarily conserved signaling molecules that regulate multiple physiological processes. However, the potential reproductive roles of many neuropeptide signaling pathways remain underexplored. Here, we describe the results of RNAi-based screens in Drosophila melanogaster to identify neuropeptides/neuropeptide receptors with potential roles in oogenesis. The screen read-outs were either the number of eggs laid per female per day over time or fluorescence microscopy analysis of dissected ovaries. We found that the orphan neuropeptide receptor encoded by moody (homologous to mammalian melatonin receptors) is likely required in somatic cells for normal egg production and proper germline stem cell maintenance. However, the egg laying screens had low signal-to-noise ratio and did not lead to the identification of additional candidates. Thus, although egg count assays might be useful for large-scale screens to identify oogenesis regulators that result in dramatic changes in oogenesis, more labor-intensive microscopy-based screen are better applicable for identifying new physiological regulators of oogenesis with more subtle phenotypes.	[Ma, Tianlu; Matsuoka, Shinya; Drummond-Barbosa, Daniela] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21218 USA; [Matsuoka, Shinya] AstraZeneca KK, Osaka, Japan	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; AstraZeneca	Drummond-Barbosa, D (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21218 USA.	dbarbosa@jhu.edu			National Institutes of Health (NIH) [R01 GM069875, R01 GM125121, T32 CA009110]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health (NIH) grants R01 GM069875 (D.D.-B) and R01 GM125121 (D.D.-B.). T.M. was supported by NIH training grant T32 CA009110. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Rodriguez A, 2018, J NEUROENDOCRINOL, V30, DOI 10.1111/jne.12590; Agapite J, 2020, NUCLEIC ACIDS RES, V48, pD650, DOI 10.1093/nar/gkz813; Ameku T, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005004; Ameku T, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006123; [Anonymous], 2019, CANC DISCOV, V10, pOF5; Armstrong AR, 2018, DEV BIOL, V440, P31, DOI 10.1016/j.ydbio.2018.04.028; Armstrong AR, 2014, DEVELOPMENT, V141, P4479, DOI 10.1242/dev.116467; Azizi V, 2021, INT J NEUROSCI, V131, P780, DOI 10.1080/00207454.2020.1758085; Bainton RJ, 2005, CELL, V123, P145, DOI 10.1016/j.cell.2005.07.029; Barson JR, 2016, PROG NEURO-PSYCHOPH, V65, DOI 10.1016/j.pnpbp.2015.02.006; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Burbach JPH, 2011, METHODS MOL BIOL, V789, P1, DOI 10.1007/978-1-61779-310-3_1; Comeras LB, 2019, ANN NY ACAD SCI, V1455, P59, DOI 10.1111/nyas.14179; de Cuevas M, 1998, DEVELOPMENT, V125, P2781; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Drummond-Barbosa D, 2001, DEV BIOL, V231, P265, DOI 10.1006/dbio.2000.0135; Drummond-Barbosa D, 2019, GENETICS, V213, P9, DOI 10.1534/genetics.119.300234; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; Ekmekcioglu C, 2006, BIOMED PHARMACOTHER, V60, P97, DOI 10.1016/j.biopha.2006.01.002; Evangelou A, 2019, G3-GENES GENOM GENET, V9, P3877, DOI 10.1534/g3.119.400715; Fergani C, 2018, ELIFE, V7, DOI 10.7554/eLife.40476; Gizowski C, 2017, BEST PRACT RES CL EN, V31, P535, DOI 10.1016/j.beem.2017.11.001; Goda T, 2018, GENE DEV, V32, P140, DOI 10.1101/gad.307884.117; Green EW, 2014, NAT METHODS, V11, P222, DOI 10.1038/nmeth.2856; Guobis Z, 2012, J ORAL MAXILLOFAC RE, V3, pe2; Hardeland R, 2011, PROG NEUROBIOL, V93, P350, DOI 10.1016/j.pneurobio.2010.12.004; Harter CJL, 2018, J ENDOCRINOL, V238, pR173, DOI 10.1530/JOE-18-0108; Head LM, 2015, CURR BIOL, V25, P1063, DOI 10.1016/j.cub.2015.02.038; Hegazi S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092363; Holtzman S, 2010, FLY, V4, P349, DOI 10.4161/fly.4.4.13304; Howlader G, 2006, J BIOL RHYTHM, V21, P13, DOI 10.1177/0748730405282882; Hoxha V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003217; Hsu HJ, 2009, P NATL ACAD SCI USA, V106, P1117, DOI 10.1073/pnas.0809144106; Hu XY, 2019, ECOTOX ENVIRON SAFE, V171, P871, DOI 10.1016/j.ecoenv.2019.01.029; Hussain A, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002455; Jasienska G, 2017, LANCET, V390, P510, DOI [10.1016/S0140-6736(17)30573-1, 10.1016/s0140-6736(17)30573-1]; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Jevitt A, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000538; Kaprara A, 2018, METABOLISM, V86, P3, DOI 10.1016/j.metabol.2017.11.018; Kim WJ, 2013, NEURON, V80, P1190, DOI 10.1016/j.neuron.2013.09.034; Kormos V, 2013, NEUROPEPTIDES, V47, P401, DOI 10.1016/j.npep.2013.10.014; Kubiak TM, 2002, BIOCHEM BIOPH RES CO, V291, P313, DOI 10.1006/bbrc.2002.6459; LaFever L, 2005, SCIENCE, V309, P1071, DOI 10.1126/science.1111410; Lainez NM, 2019, ENDOCRINOLOGY, V160, P2719, DOI 10.1210/en.2019-00487; LaJeunesse Dennis R., 2010, BMC Physiology, V10, P14, DOI 10.1186/1472-6793-10-14; Leader DP, 2018, NUCLEIC ACIDS RES, V46, pD809, DOI 10.1093/nar/gkx976; Lee KM, 2015, CURR BIOL, V25, P790, DOI 10.1016/j.cub.2015.01.050; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Li C, 2010, ADV EXP MED BIOL, V692, P98; Limmer S, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00365; LIN HF, 1994, DEVELOPMENT, V120, P947; Luque RM, 2007, ENDOCRINOLOGY, V148, P4601, DOI 10.1210/en.2007-0500; Manjunatha T, 2008, J GENET, V87, P495, DOI 10.1007/s12041-008-0072-9; Martelli C, 2017, CELL REP, V20, P464, DOI 10.1016/j.celrep.2017.06.043; Matsuoka S, 2017, GENETICS, V206, P953, DOI 10.1534/genetics.117.201921; Mazzalupo S, 2006, CELL DEATH DIFFER, V13, P1950, DOI 10.1038/sj.cdd.4401892; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Meiselman M, 2017, P NATL ACAD SCI USA, V114, pE3849, DOI 10.1073/pnas.1620760114; Nassel DR, 2019, PROG NEUROBIOL, V179, DOI 10.1016/j.pneurobio.2019.02.003; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Pauli A, 2008, DEV CELL, V14, P239, DOI 10.1016/j.devcel.2007.12.009; Perkins LA, 2015, GENETICS, V201, P843, DOI 10.1534/genetics.115.180208; Pinho-Ribeiro FA, 2017, TRENDS IMMUNOL, V38, P5, DOI 10.1016/j.it.2016.10.001; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Rodriguez AD, 2012, NAT METHODS, V9, P47, DOI [10.1038/NMETH.1800, 10.1038/nmeth.1800]; Russo AF, 2017, HEADACHE, V57, P37, DOI 10.1111/head.13084; Saedi S, 2018, J CHEM NEUROANAT, V92, P71, DOI 10.1016/j.jchemneu.2018.07.001; Sakamoto K, 2012, J REPROD DEVELOP, V58, P700, DOI 10.1262/jrd.2011-038; Schwabe T, 2005, CELL, V123, P133, DOI 10.1016/j.cell.2005.08.037; Sun TC, 2020, CRYOBIOLOGY, V95, P1, DOI 10.1016/j.cryobiol.2020.01.018; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Vimal D, 2019, CHEMOSPHERE, V225, P247, DOI 10.1016/j.chemosphere.2019.02.134; Vissers JHA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10368; Weaver LN, 2020, G3-GENES GENOM GENET, V10, P4147, DOI 10.1534/g3.120.401676; Weaver LN, 2019, DEV BIOL, V456, P179, DOI 10.1016/j.ydbio.2019.08.015; Wu XD, 2008, SEMIN CELL DEV BIOL, V19, P271, DOI 10.1016/j.semcdb.2008.01.004; Yang CH, 2008, SCIENCE, V319, P1679, DOI 10.1126/science.1151842; Zer-Krispil S, 2018, CURR BIOL, V28, P1445, DOI 10.1016/j.cub.2018.03.039	78	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243756	10.1371/journal.pone.0243756	http://dx.doi.org/10.1371/journal.pone.0243756			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33307547	Green Published, gold			2022-12-27	WOS:000600144200024
J	Montagu, D; Giessler, K; Nakphong, MK; Roy, KP; Sahu, AB; Sharma, K; Green, C; Sudhinaraset, M				Montagu, Dominic; Giessler, Katie; Nakphong, Michelle Kao; Roy, Kali Prasad; Sahu, Ananta Basudev; Sharma, Kovid; Green, Cathy; Sudhinaraset, May			Results of a person-centered maternal health quality improvement intervention in Uttar Pradesh, India	PLOS ONE			English	Article							CHILDBIRTH; AFRICA; CARE	Background Poor patient experiences during delivery in Uttar Pradesh, India is a common problem. It delays presentation at facilities after the onset of labor and contributes to poor maternal health outcomes. Patient-centered maternity care (PCMC) is recognized by the World Health Organization as critical to overall quality. Changing PCMC requires changing the process of care, and is therefore especially challenging. Methods We used a matched case-control design to evaluate a quality improvement process directed at PCMC and based on widely established team-based methods used in many OECD countries. The intervention was introduced into three government facilities and teams supported to brainstorm and test improvements over 12 months. Progress was measured through pre-post interviews with new mothers, scored using a validated PCMC scale. Analysis included chi-squared and difference-in-difference tests. Findings On a scale to 100, the PCMC score of the intervention group increased 22.9 points compared to controls. Deliveries attended by midwives, dais, ASHAs or non-skilled providers resulted in significantly higher PCMC scores than those attended to by nurses or doctors. The intervention was associated with one additional visit from a doctor and over two additional visits from nurses per day, compared to the control group. Interpretation This study has demonstrated the effectiveness of a team-based quality improvement intervention to ameliorate women's childbirth experiences. These improvements were locally designed and led, and offer a model for potential replication.	[Montagu, Dominic; Giessler, Katie] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94110 USA; [Nakphong, Michelle Kao; Sudhinaraset, May] Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA 90024 USA; [Roy, Kali Prasad; Sahu, Ananta Basudev; Sharma, Kovid] Populat Serv Int, New Delhi, India	University of California System; University of California San Francisco; University of California System; University of California Los Angeles	Montagu, D (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94110 USA.	dominic.montagu@ucsf.edu		Nakphong, Michelle/0000-0003-2632-8007	Bill and Melinda Gates Foundation [INV-009179]; David and Lucile Packard Foundation [2017-66201]; UCSF; UCLA; PSI	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); UCSF; UCLA; PSI	Funding for this study was received from the Bill and Melinda Gates Foundation (award INV-009179) and the David and Lucile Packard Foundation (award 2017-66201). Both grants were awarded to UCSF with DM as PI, and MS as Co-PI. URLs: www.gatesfoundation.org www.packard.org Neither donor was involved in any aspect of the research or intervention. The funders provided support in the form of funding for partial or full salaries of all co-authors -either directly through grants to UCSF (DM, KG), or indirectly through a sub-grant to UCLA (MS, MKN), subcontract to PSI (KPR, KS, ABS) or direct individual subcontract (KG). The funders did not have any additional role in the study design, data collection and analysis, decisions to publish, or in preparation of the manuscript. The specific roles of all authors are articulated in the 'author contributions' section.	Afulani PA, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0591-7; Agarwalla R, 2019, PAN ASIAN J OBSTET G, V2, P37; Ahmad J, 2016, J INTERPERS VIOLENCE, V31, P3111, DOI 10.1177/0886260515584341; [Anonymous], 2016, INT I POP SCI; Bhattacharyya S, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0839-6; Bhattacharyya S, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1077-8; Diamond-Smith N, 2015, REPROD HEALTH, V12, DOI 10.1186/1742-4755-12-6; Expert Panel on Neurologic Imaging, 2017, J AM COLL RADIOL, V14, pS550; Gabrysch S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-34; Gawande AA, 2018, INT J GYNECOL OBSTET, V143, P514; IHI's Collaborative Model for Achieving Breakthrough Improvement, 2003, CISC VIS NETW IND GL; Kruk ME, 2016, LANCET, V388, P2296, DOI 10.1016/S0140-6736(16)31395-2; Montagu D, 2019, HEALTH POLICY PLANN, V34, P574, DOI 10.1093/heapol/czz067; Montagu D, 2017, HEALTH POLICY PLANN, V32, P1146, DOI 10.1093/heapol/czx060; Office of the Registrar General & Census Commissioner, 2013, ANN HLTH SURV 2012 1; Office of the Registrar General & Census Commissioner, 2018, MMR B 2014 16 PDF; Phillips B, 2018, LANCET GLOB HEALTH, V6, pS46, DOI 10.1016/S2214-109X(18)30175-X; Raj A, 2017, MATERN CHILD HLTH J, V21, P1821, DOI 10.1007/s10995-017-2298-8; Ruxton GD, 2008, BEHAV ECOL, V19, P690, DOI 10.1093/beheco/arn020; s NA, 2018, LANCET INFECT DIS, V18, pe228; Semrau KEA, 2017, NEW ENGL J MED, V377, P2313, DOI 10.1056/NEJMoa1701075; Sharma G, 2019, REPROD HEALTH, V16, DOI 10.1186/s12978-019-0668-y; Sharma G, 2017, B WORLD HEALTH ORGAN, V95, P419, DOI [10.2471/BLT.16.179291, 10.2471/blt.16.179291]; Singh S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159793; Sudhinaraset M, 2020, INT J GYNECOL OBSTET, V148, P27, DOI 10.1002/ijgo.12978; Sudhinaraset M, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1124-4; Sudhinaraset M, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0942-8; TUNCALP, 2015, BJOG, V122, P1045, DOI DOI 10.1111/1471-0528.13451; Wells S, 2018, BMJ QUAL SAF, V27, P226, DOI 10.1136/bmjqs-2017-006926	29	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0242909	10.1371/journal.pone.0242909	http://dx.doi.org/10.1371/journal.pone.0242909			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306689	gold, Green Published, Green Submitted			2022-12-27	WOS:000600144200047
J	Narita, D; Sato, I; Ogawada, D; Matsumura, A				Narita, Daiju; Sato, Ichiro; Ogawada, Daikichi; Matsumura, Akiko			Integrating economic measures of adaptation effectiveness into climate change interventions: A case study of irrigation development in Mwea, Kenya	PLOS ONE			English	Article							AFRICA; CONSTRAINTS; IMPACTS; RISKS	As climate change adaptation is becoming a recognized policy issue, the need is growing for quantitative economic evaluation of adaptation-related public investment, particularly in the context of climate finance. Funds are meant to be allocated not to any types of beneficial investments with or without climate change but to projects regarded as effective for climate change adaptation based on some metrics. But attempts at such project-specific evaluation of adaptation effects are few, in part because such assessments require an integration of various types of simulation analyses. Against this background, we conduct a case study of a Kenyan irrigation development project using a combination of downscaled climate data, runoff simulations, yield forecasting, and local socioeconomic projections to examine the effects of interventions specifically attributable to climate change adaptation, i.e., how much irrigation development can reduce the negative effects of climate change in the future. The results show that despite the uncertainties in precipitation trends, increased temperatures due to climate change have a general tendency to reduce rice yields, and that irrigation development will mitigate income impacts from the yield loss-for example, for the median scenario, the household income loss of 6% in 2050 due to climate change without irrigation development is flipped to become positive with the project. This means that the irrigation development project will likely be effective as a means for climate change adaptation.	[Narita, Daiju] Univ Tokyo, Grad Sch Arts & Sci, Tokyo, Japan; [Narita, Daiju] JICA Ogata Res Inst, Tokyo, Japan; [Narita, Daiju] Kiel Inst World Econ, Kiel, Germany; [Sato, Ichiro] Japan Int Cooperat Agcy JICA, Sendai, Miyagi, Japan; [Ogawada, Daikichi; Matsumura, Akiko] Nippon Koei Co Ltd, Tsukuba, Ibaraki, Japan	University of Tokyo; Institut fur Weltwirtschaft an der Universitat Kiel (IFW); Nippon Koei Co., Ltd.	Narita, D (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Tokyo, Japan.; Narita, D (corresponding author), JICA Ogata Res Inst, Tokyo, Japan.; Narita, D (corresponding author), Kiel Inst World Econ, Kiel, Germany.	daiju.narita@global.c.u-tokyo.ac.jp	Sato, Ichiro/HGU-7251-2022; Narita, Daiju/G-7125-2016	Sato, Ichiro/0000-0001-7253-2178; Narita, Daiju/0000-0001-5695-9913	JICA; JICA Ogata Research Institute (JICA-RI); JSPS Kakenhi [17KT0066, 17K00677]	JICA; JICA Ogata Research Institute (JICA-RI); JSPS Kakenhi(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study is funded by JICA and the JICA Ogata Research Institute (JICA-RI), which also provided various logistical support. Daiju Narita acknowledges financial support from JSPS Kakenhi (Grant Numbers: 17KT0066 and 17K00677) for his research activities. Besides logistical support, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawala S., 2008, EC ASPECTS ADAPTATIO; Amaru S, 2013, APPL GEOGR, V39, P128, DOI 10.1016/j.apgeog.2012.12.006; [Anonymous], 2015, ENERGY STORAGE SCI T, V4, P110; [Anonymous], 2014, JPN J MED ULTRASON, V41, P405; Atera E. A., 2018, Journal of Development and Agricultural Economics, V10, P64, DOI 10.5897/jdae2017.0881; Burke M, 2015, REV ECON STAT, V97, P461, DOI 10.1162/REST_a_00478; Da Cunha DA, 2015, ENVIRON DEV ECON, V20, P57, DOI 10.1017/S1355770X14000102; Doorenbos J., 1977, FAO Irrigation and Drainage Paper; Elliott J, 2014, P NATL ACAD SCI USA, V111, P3239, DOI 10.1073/pnas.1222474110; Finger R, 2010, AGR SYST, V103, P666, DOI 10.1016/j.agsy.2010.08.005; Hallegatte S., 2012, Policy Research Working Paper - World Bank; Herath S., 1990, P 5 INT C URB STORM, P111; JICA, 2017, TERM EV REP RIC BAS; JICA and Nippon Koei, 2018, EC EV AD MEAS CLIM C; Jones JW, 2003, EUR J AGRON, V18, P235, DOI 10.1016/S1161-0301(02)00107-7; Kenya Ministry of Agriculture Livestock and Fisheries, 2014, NAT RIC DEV STRAT 20; Lempert R., 2013, 6465 WORLD BANK, DOI [10.1596/18139450-6465, DOI 10.1596/1813-9450-6465]; Lobell DB, 2014, GLOB FOOD SECUR-AGR, V3, P72, DOI 10.1016/j.gfs.2014.05.002; Lobell DB, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/3/034007; Mendelsohn R, 2012, CLIM CHANG ECON, V3, DOI 10.1142/S2010007812500066; Muller C, 2011, P NATL ACAD SCI USA, V108, P4313, DOI 10.1073/pnas.1015078108; Nyang'au WO, 2014, INT J AGRON, V2014, DOI 10.1155/2014/849496; Organization for Economic Co-operation and Development (OECD), 2015, EC CONS CLIM CHANG; Prudhomme C, 2010, J HYDROL, V390, P198, DOI 10.1016/j.jhydrol.2010.06.043; Rosenzweig C, 2014, P NATL ACAD SCI USA, V111, P3268, DOI 10.1073/pnas.1222463110; Samejima H, 2020, PLANT PROD SCI, V23, P297, DOI 10.1080/1343943X.2020.1727752; Schlenker W, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/1/014010; Seo SN, 2009, ENVIRON RESOUR ECON, V43, P313, DOI 10.1007/s10640-009-9270-z; Short C., 2012, TECHNICAL NOTES SERI; UNEP-DTU, 2016, AD FIN GAP REP 2016; van Ittersum MK, 2016, P NATL ACAD SCI USA, V113, P14964, DOI 10.1073/pnas.1610359113; van Oort PAJ, 2018, GLOBAL CHANGE BIOL, V24, P1029, DOI 10.1111/gcb.13967; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0152-3, 10.1007/s10584-011-0157-y]; Weedon GP, 2014, WATER RESOUR RES, V50, P7505, DOI 10.1002/2014WR015638; You LZ, 2014, FOOD POLICY, V47, P34, DOI 10.1016/j.foodpol.2014.04.006; You LZ, 2011, FOOD POLICY, V36, P770, DOI 10.1016/j.foodpol.2011.09.001	36	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243779	10.1371/journal.pone.0243779	http://dx.doi.org/10.1371/journal.pone.0243779			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH0WM	33306704	gold, Green Published			2022-12-27	WOS:000600144200055
J	Van de Walle, P; Munoz-Jimenez, C; Askjaer, P; Schoofs, L; Temmerman, L				Van de Walle, Pieter; Munoz-Jimenez, Celia; Askjaer, Peter; Schoofs, Liliane; Temmerman, Liesbet			DamID identifies targets of CEH-60/PBX that are associated with neuron development and muscle structure in Caenorhabditis elegans	PLOS ONE			English	Article							HEAVY-CHAIN ISOFORMS; C-ELEGANS; TRANSCRIPTION FACTOR; NUCLEAR-ORGANIZATION; HOMEODOMAIN PROTEIN; HOX GENES; TGF-BETA; PBX; EXPRESSION; HOMOLOG	Transcription factors govern many of the time- and tissue-specific gene expression events in living organisms. CEH-60, a homolog of the TALE transcription factor PBX in vertebrates, was recently characterized as a new regulator of intestinal lipid mobilization in Caenorhabditis elegans. Because CEH-60's orthologs and paralogs exhibit several other functions, notably in neuron and muscle development, and because ceh-60 expression is not limited to the C. elegans intestine, we sought to identify additional functions of CEH-60 through DNA adenine methyltransferase identification (DamID). DamID identifies protein-genome interaction sites through GATC-specific methylation. We here report 872 putative CEH-60 gene targets in young adult animals, and 587 in L2 larvae, many of which are associated with neuron development or muscle structure. In light of this, we investigate morphology and function of ceh-60 expressing AWC neurons, and contraction of pharyngeal muscles. We find no clear functional consequences of loss of ceh-60 in these assays, suggesting that in AWC neurons and pharyngeal muscle, CEH-60 function is likely more subtle or redundant with other factors.	[Van de Walle, Pieter; Schoofs, Liliane; Temmerman, Liesbet] Univ Leuven, Anim Physiol & Neurobiol, KU Leuven, Leuven, Belgium; [Munoz-Jimenez, Celia; Askjaer, Peter] CSIC JA Univ Pablo Olavide, Andalusian Ctr Dev Biol CABD, Seville, Spain	KU Leuven; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD)	Temmerman, L (corresponding author), Univ Leuven, Anim Physiol & Neurobiol, KU Leuven, Leuven, Belgium.	Liesbet.Temmerman@kuleuven.be	Van de Walle, Pieter/AAH-4563-2021; Askjaer, Peter/I-3316-2012	Van de Walle, Pieter/0000-0002-6020-7885; Temmerman, Liesbet/0000-0002-1249-3995; Askjaer, Peter/0000-0003-3192-4428	FWO Flanders [G095915, 1S00617N]; KU Leuven [C16/19/003]; Spanish Ministry of Science and Innovation [PID2019-105069GB-I00, MDM-2016-0687]; Spanish Research Council [2019AEP142]; Genie COST action [BM1408]	FWO Flanders(FWO); KU Leuven(KU Leuven); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Research Council; Genie COST action	PVdW is an n SB PhD fellow of the FWO Flanders (1S00617N, https://www.fwo.be).The authors are grateful to the FWO Flanders (G095915) and KU Leuven (https://www.kuleuven.be, C16/19/003), the Spanish Ministry of Science and Innovation (PID2019-105069GB-I00 and MDM-2016-0687 to PA) and the Spanish Research Council (2019AEP142 to PA) for financial support. We are especially grateful to the Genie COST action (BM1408) for supporting this research.	Altun Z.F., 2009, WORMATLAS; Amaratunga C, 2019, BMC MED, V17, DOI 10.1186/s12916-018-1207-3; [Anonymous], 2013, CLIN DIABETOLOGY, V2, pA12; [Anonymous], 2018, FARSOTTAFRETTIR, V11, P1, DOI DOI 10.1186/s13071-017-2573-y; ARDIZZI JP, 1987, J CELL BIOL, V105, P2763, DOI 10.1083/jcb.105.6.2763; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; BENIAN GM, 1989, NATURE, V342, P45, DOI 10.1038/342045a0; Benian GM, 2010, ENCY MOV DISORD, V132, P171, DOI [10.1016/B978-0-12-374105-9.00223-9, DOI 10.1016/B978-0-12-374105-9.00223-9]; Berkes CA, 2004, MOL CELL, V14, P465, DOI 10.1016/S1097-2765(04)00260-6; Beverly M, 2011, J NEUROSCI, V31, P11718, DOI 10.1523/JNEUROSCI.1098-11.2011; Bloom L, 1997, P NATL ACAD SCI USA, V94, P3414, DOI 10.1073/pnas.94.7.3414; Bryantsev AL, 2012, DEV CELL, V23, P664, DOI 10.1016/j.devcel.2012.08.004; Cao JY, 2017, SCIENCE, V357, P661, DOI 10.1126/science.aam8940; Cassata G, 2000, NEURON, V25, P587, DOI 10.1016/S0896-6273(00)81062-4; Cheetham SW, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.170209; Cho OH, 2015, DEV DYNAM, V244, P43, DOI 10.1002/dvdy.24217; Clark SG, 2003, DEVELOPMENT, V130, P3781, DOI 10.1242/dev.00571; Crump JG, 2001, NEURON, V29, P115, DOI 10.1016/S0896-6273(01)00184-2; Davis MW, 2010, FISH FISH, V11, P1, DOI 10.1111/j.1467-2979.2009.00331.x; Dowen RH, 2019, DEV CELL, V49, P235, DOI 10.1016/j.devcel.2019.03.002; Erickson T, 2011, GENESIS, V49, P725, DOI 10.1002/dvg.20781; Fernandez-Aranda F, 2016, ENDOCRINE, V51, P256, DOI 10.1007/s12020-015-0684-9; Gabel CV, 2007, J NEUROSCI, V27, P7586, DOI 10.1523/JNEUROSCI.0775-07.2007; Gieseler K, 2001, J MOL BIOL, V307, P107, DOI 10.1006/jmbi.2000.4480; Gomez-Saldivar G, 2016, METHODS MOL BIOL, V1411, P341, DOI 10.1007/978-1-4939-3530-7_22; Goszczynski B, 2016, DEV BIOL, V413, P112, DOI 10.1016/j.ydbio.2016.02.031; Guan G, 2019, BIORXIV; Gutierrez-Triana JA, 2016, DEVELOPMENT, V143, P4272, DOI 10.1242/dev.139261; Hall DH., 2011, WORMATLAS; Hendriks GJ, 2014, MOL CELL, V53, P380, DOI 10.1016/j.molcel.2013.12.013; HORVITZ HR, 1982, SCIENCE, V216, P1012, DOI 10.1126/science.6805073; Hristova M, 2005, MOL CELL BIOL, V25, P11059, DOI 10.1128/MCB.25.24.11059-11072.2005; Hughes S, 2013, BIOL OPEN, V2, P718, DOI 10.1242/bio.20134549; Jia LY, 2006, GENETICS, V173, P1241, DOI 10.1534/genetics.106.057000; Jiang Y, 2008, MECH DEVELOP, V125, P451, DOI 10.1016/j.mod.2008.01.009; Jiang Y, 2009, DEV BIOL, V334, P535, DOI 10.1016/j.ydbio.2009.07.034; KAGAWA H, 1989, J MOL BIOL, V207, P311, DOI 10.1016/0022-2836(89)90257-X; Katidou M, 2013, DEV BIOL, V373, P184, DOI 10.1016/j.ydbio.2012.10.027; Kauffman A, 2011, JOVE-J VIS EXP, DOI 10.3791/2490; Lewis JA, 1995, METHOD CELL BIOL, V48, P3; Liu HR, 2006, DEVELOPMENT, V133, P641, DOI 10.1242/dev.02234; Liu J, 2000, DEVELOPMENT, V127, P5179; Longobardi E, 2014, DEV DYNAM, V243, P59, DOI 10.1002/dvdy.24016; Matsunaga Y, 2017, MOL BIOL CELL, V28, P1591, DOI 10.1091/mbc.E16-10-0707; Matsuo Kanae, 2019, MicroPubl Biol, V2019, DOI 10.17912/micropub.biology.000110; Maves L, 2007, DEVELOPMENT, V134, P3371, DOI 10.1242/dev.003905; McArdle K, 1998, J CELL BIOL, V143, P1201, DOI 10.1083/jcb.143.5.1201; McKeown CR, 2006, DEV DYNAM, V235, P530, DOI 10.1002/dvdy.20633; Mercer KB, 2007, MOL BIOL CELL, V18, P976, DOI [10.1091/mbc.e06-09-0813, DOI 10.1091/MBC.E06-09-0813]; MILLER DM, 1986, P NATL ACAD SCI USA, V83, P2305, DOI 10.1073/pnas.83.8.2305; MOERMAN DG, 1982, CELL, V29, P773, DOI 10.1016/0092-8674(82)90439-1; Mosbech MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070087; Munoz-Jimenez C, 2017, GENETICS, V206, P1763, DOI 10.1534/genetics.117.201012; Mutlu AS, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15296-8; Nash B, 2000, GENE DEV, V14, P2486, DOI 10.1101/gad.831500; Orian A, 2003, GENE DEV, V17, P1101, DOI 10.1101/gad.1066903; Remesal L, 2020, DEVELOPMENT, V147, DOI 10.1242/dev.186841; Ruksana R, 2005, GENES CELLS, V10, P261, DOI 10.1111/j.1365-2443.2005.00829.x; Rushforth AM, 1998, GENETICS, V150, P1067; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schultz RD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101929; Schuster E, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.54; Sen SQ, 2019, ELIFE, V8, DOI 10.7554/eLife.44036; Sharma R, 2016, GENESIS, V54, P151, DOI 10.1002/dvg.22925; Shen K, 2004, CELL, V116, P869, DOI 10.1016/S0092-8674(04)00251-X; Small TM, 2004, J MOL BIOL, V342, P91, DOI 10.1016/j.jmb.2004.07.006; Sparacio AP, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233059; Spooner PM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040182; Thiebaud N, 2014, J NEUROSCI, V34, P6970, DOI 10.1523/JNEUROSCI.3366-13.2014; Tosti L, 2018, GENOME RES, V28, P592, DOI 10.1101/gr.227124.117; Trojanowski NF, 2016, SCI REP-UK, V6, DOI 10.1038/srep22940; Van Auken K, 2002, DEVELOPMENT, V129, P5255; Van Nostrand EL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003325; Van Rompay L, 2015, SCI REP-UK, V5, DOI 10.1038/srep16381; Van Sinay E, 2017, P NATL ACAD SCI USA, V114, pE4065, DOI 10.1073/pnas.1617392114; van Steensel B, 2000, NAT BIOTECHNOL, V18, P424, DOI 10.1038/74487; Vissers JHA, 2018, CELL REP, V25, P1561, DOI 10.1016/j.celrep.2018.10.038; Vogel MJ, 2007, NAT PROTOC, V2, P1467, DOI 10.1038/nprot.2007.148; Wang XL, 2005, DEV BIOL, V284, P273, DOI 10.1016/j.ydbio.2005.05.020; Waskiewicz AJ, 2002, DEV CELL, V3, P723, DOI 10.1016/S1534-5807(02)00319-2; Wolf FW, 1998, NEURON, V20, P655, DOI 10.1016/S0896-6273(00)81006-5; Yao ZZ, 2013, BIOL OPEN, V2, P546, DOI 10.1242/bio.20133921; Zhang XD, 2012, P NATL ACAD SCI USA, V109, P17081, DOI 10.1073/pnas.1205982109; Zheng CG, 2015, CELL REP, V13, P1343, DOI 10.1016/j.celrep.2015.10.044; Zheng CG, 2015, NEURON, V88, P514, DOI 10.1016/j.neuron.2015.09.049	85	2	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0242939	10.1371/journal.pone.0242939	http://dx.doi.org/10.1371/journal.pone.0242939			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306687	gold, Green Published			2022-12-27	WOS:000600144200032
J	Mugnier, A; Morin, A; Cellard, F; Devaux, L; Delmas, M; Adib-Lesaux, A; Flanagan, J; Laxalde, J; Chastant, S; Grellet, A				Mugnier, Amelie; Morin, Anthony; Cellard, Fanny; Devaux, Loic; Delmas, Magalie; Adib-Lesaux, Achraf; Flanagan, John; Laxalde, Jeremy; Chastant, Sylvie; Grellet, Aurelien			Association between birth weight and risk of overweight at adulthood in Labrador dogs	PLOS ONE			English	Article							VETERINARY PRACTICES; DEVELOPMENTAL ORIGINS; OBESITY; PREVALENCE; QUALITY; MUSCLE; MEN; FAT	Several studies in humans indicate that low birth weight predisposes individuals to obesity in later life. Despite the constant increase in prevalence of obesity in the canine population and the major health consequences of this affection, few investigations have been carried out on the association between birth weight and the development of overweight in dogs. The purpose of the current study was to examine the association between birth weight and some other neonatal characteristics and overweight at adulthood in a population of purebred Labrador dogs. Information was collected about the sex, age, neuter status, birth weight, and growth rates (between 0-2 days and 2-15 days of age) in 93 Labrador dogs raised under similar environmental conditions until two months old. The body condition scores (BCS, scale of 1-9) of these dogs at adulthood were recorded, with BCS equal to or greater than 6 classified as overweight. Dogs were split into two groups based on the median birth weight in the population: lower than the median (LTM) and higher than the median (HTM). A logistic regression model was applied to analyse associations between the general characteristics of the dogs (sex, age, neuter status), early life parameters (birth weight, growth rates) and overweight at adulthood. Birth weight was the only early-life parameter found to be associated with overweight (p value = 0.032) with a prevalence of overweight of 70% among the dogs with LTM birth weight vs. 47% in dogs born with HTM birth weight. Overweight was also associated with age and neuter status (p value = 0.029 and 0.005 respectively). Our results suggest that, as in humans, dogs with the lowest birth weights are more likely to become overweight at adulthood. More studies are needed to further examine this relationship and to explore the underlying mechanisms. A subsequent objective could be to identify preventive strategies such as an adapted early nutrition programme for at-risk individuals.	[Mugnier, Amelie; Cellard, Fanny; Devaux, Loic; Chastant, Sylvie; Grellet, Aurelien] Univ Toulouse, ENVT, NeoCare, Toulouse, France; [Morin, Anthony] CESECAH, Lieu Dit Monsable, Lezoux, France; [Delmas, Magalie] Ecole Chiens Guides Aveugles Grand Sud Ouest, Toulouse, France; [Adib-Lesaux, Achraf; Flanagan, John; Laxalde, Jeremy] Royal Canin, Aimargues, France	Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse	Mugnier, A (corresponding author), Univ Toulouse, ENVT, NeoCare, Toulouse, France.	amelie.mugnier@envt.fr	CHASTANT, Sylvie/ABG-2003-2020; Mugnier, Amélie/AAQ-2305-2020	CHASTANT, Sylvie/0000-0003-0790-6377; Mugnier, Amélie/0000-0001-9711-1679	Royal Canin SAS (Aimargues, France)	Royal Canin SAS (Aimargues, France)	This study was partially funded by Royal Canin SAS (Aimargues, France). The funder provided support in the form of salaries for AM. Moreover, AAL, JL and JF participated in the analyses of the data and in the reviewing of the paper. There was no additional external funding received for this study.	[Anonymous], 2021, LANG ENV STAT COMP; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Barker DJP, 1998, MOTHERS BABIES HLTH; Beauchamp B, 2015, INT J OBESITY, V39, P702, DOI 10.1038/ijo.2014.120; Bland IM, 2010, PREV VET MED, V94, P310, DOI 10.1016/j.prevetmed.2010.01.013; Colliard L, 2006, J NUTR, V136, p1951S, DOI 10.1093/jn/136.7.1951S; Corbee RJ, 2013, J ANIM PHYSIOL AN N, V97, P904, DOI 10.1111/j.1439-0396.2012.01336.x; Courcier EA, 2011, PREV VET MED, V102, P66, DOI 10.1016/j.prevetmed.2011.06.010; Desai M, 2005, AM J PHYSIOL-REG I, V288, pR91, DOI 10.1152/ajpregu.00340.2004; Desai M, 2013, CURR DIABETES REP, V13, P27, DOI 10.1007/s11892-012-0344-x; Druet C, 2012, PAEDIATR PERINAT EP, V26, P19, DOI 10.1111/j.1365-3016.2011.01213.x; EDNEY ATB, 1986, VET REC, V118, P391, DOI 10.1136/vr.118.14.391; Fowden AL, 2006, PHYSIOLOGY, V21, P29, DOI 10.1152/physiol.00050.2005; Gale CR, 2001, J CLIN ENDOCR METAB, V86, P267, DOI 10.1210/jc.86.1.267; German AJ, 2012, VET J, V192, P428, DOI 10.1016/j.tvjl.2011.09.015; German AJ, 2006, J NUTR, V136, p1940S, DOI 10.1093/jn/136.7.1940S; Gondret F, 2006, J ANIM SCI, V84, P93, DOI 10.2527/2006.84193x; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Jeusette I, 2004, J ANIM PHYSIOL AN N, V88, P117, DOI 10.1111/j.1439-0396.2003.00467.x; JONES AP, 1982, SCIENCE, V215, P1518, DOI 10.1126/science.7063860; Jornayvaz FR, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0389-2; Laflamme D, 1997, CANINE PRACT, V22, P10; Laflamme DP, 2005, VET CLIN N AM-SMALL, V35, P713, DOI 10.1016/j.cvsm.2004.12.011; Le Gal A, 2016, P 8 INT S CAN FEL RE, P157; Leclerc L, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-0994-7; Lund E. M., 2006, International Journal of Applied Research in Veterinary Medicine, V4, P177; Lung T, 2019, INT J OBESITY, V43, P782, DOI 10.1038/s41366-018-0210-2; Mao JF, 2013, PREV VET MED, V112, P438, DOI 10.1016/j.prevetmed.2013.08.012; Mawby DI, 2004, J AM ANIM HOSP ASSOC, V40, P109, DOI 10.5326/0400109; McGreevy PD, 2005, VET REC, V156, P695, DOI 10.1136/vr.156.22.695; Poore KR, 2004, J PHYSIOL-LONDON, V558, P295, DOI 10.1113/jphysiol.2004.061390; Rasmussen EL, 2005, DIABETES CARE, V28, P151, DOI 10.2337/diacare.28.1.151; RAVELLI GP, 1976, NEW ENGL J MED, V295, P349, DOI 10.1056/NEJM197608122950701; Rehfeldt C, 2008, MEAT SCI, V78, P170, DOI 10.1016/j.meatsci.2007.05.029; Rehfeldt C, 2006, J Anim Sci, V84 Suppl, pE113; Sarr O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098433; SONNENSCHEIN EG, 1991, AM J EPIDEMIOL, V133, P694, DOI 10.1093/oxfordjournals.aje.a115944	37	2	2	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243820	10.1371/journal.pone.0243820	http://dx.doi.org/10.1371/journal.pone.0243820			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301504	Green Published, gold			2022-12-27	WOS:000600143100004
J	Gunaratne, C; Garibay, I				Gunaratne, Chathika; Garibay, Ivan			Evolutionary model discovery of causal factors behind the socio-agricultural behavior of the Ancestral Pueblo	PLOS ONE			English	Article							ALGORITHMS; SOFTWARE	Agent-based modeling of artificial societies allows for the validation and analysis of human-interpretable, causal explanations of human behavior that generate society-scale phenomena. However, parameter calibration is insufficient to conduct data-driven explorations that are adequate in evaluating the importance of causal factors that constitute agent rules that match real-world individual-scale generative behaviors. We introduce evolutionary model discovery, a framework that combines genetic programming and random forest regression to evaluate the importance of a set of causal factors hypothesized to affect the individual's decision-making process. With evolutionary model discovery, we investigated the farm plot seeking behavior of the Ancestral Pueblo of the Long House Valley simulated in the Artificial Anasazi model. We evaluated the importance of causal factors unconsidered in the original model, which we hypothesized to have affected the decision-making process. Our findings, concur with other archaeological studies on the Ancestral Pueblo communities during the Pueblo II period, which indicate the existence of cross-village polities, hierarchical organization, and dependence on the viability of the agricultural niche. Contrary to the original Artificial Anasazi model, where closeness was the sole factor driving farm plot selection, selection of higher quality land, distancing from failed farm plots, and desire for social presence are found to be more important. Finally, models updated with farm selection strategies designed by incorporating these insights showed significant improvements in accuracy and robustness over the original Artificial Anasazi model.	[Gunaratne, Chathika; Garibay, Ivan] Univ Cent Florida, Dept Ind Engn & Management Syst, Complex Adapt Syst Lab, Orlando, FL 32816 USA; [Gunaratne, Chathika] MIT, Comp Sci & Artificial Intelligence Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA	State University System of Florida; University of Central Florida; Massachusetts Institute of Technology (MIT)	Garibay, I (corresponding author), Univ Cent Florida, Dept Ind Engn & Management Syst, Complex Adapt Syst Lab, Orlando, FL 32816 USA.	ivan.garibay@ucf.edu		Garibay, Ivan/0000-0002-3302-9382; Gunaratne, Chathika/0000-0002-2508-8745	Defense Advanced Research Projects Agency [HR001117S0018]; Amazon Web Services	Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Amazon Web Services	DARPA SocialSim program: Awarded to IG, DARPA program HR001117S0018, Defense Advanced Research Projects Agency https://www.darpa.mil/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. AWS Research Grant Awarded to IG, N/A, Amazon Web Services https://aws.amazon.com/grants/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastrakova E, 2017, IMPROVING INTERPRETA; Beillevaire M, 2018, INSIDE BLACK BOX EXP; Bocinsky RK, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501532; Bocinsky RK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6618; Borshchev A., 2013, BIG BOOK SIMULATION; Breiman L., 2002, MANUAL SETTING USING; Crabtree SA, 2017, AM ANTIQUITY, V82, P71, DOI 10.1017/aaq.2016.18; Dang N, 2018, INT C LEARN INT OPT, P288; Dean JS, 2000, SFI STU SCI, P179; Dedeo S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000782; Epstein J. M., 1999, Complexity, V4, P41, DOI 10.1002/(SICI)1099-0526(199905/06)4:5<41::AID-CPLX9>3.0.CO;2-F; Epstein J.M., 2013, AGENT ZERO NEUROCOGN; Fortin FA, 2012, J MACH LEARN RES, V13, P2171; Genuer R, 2010, PATTERN RECOGN LETT, V31, P2225, DOI 10.1016/j.patrec.2010.03.014; Granetz R, 2018, P 27 IAEA FUS EN C I; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Grune-Yanoff T, 2009, SYNTHESE, V169, P539, DOI 10.1007/s11229-008-9429-0; Gunaratne C, 2019, THESIS; Gunaratne C, 2017, PROCEEDINGS OF THE 2017 GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE (GECCO'17), P115, DOI 10.1145/3071178.3071332; Hold-Geoffroy Yannick, 2014, P 2014 ANN C EXTR EN, P60, DOI DOI 10.1145/2616498.2616565; Hutter F., 2014, 31 INT C MACHINE LEA, VVolume 32, P754; Janssen MA, 2009, JASSS-J ARTIF SOC S, V12, P3; Kidder AV, 1927, NEW SERIES, V66, P489; Kohler TA, 2012, ORIG HUM BEHAV, V6, P1, DOI 10.1525/california/9780520270145.001.0001; Korobov M, 2019, PERMUTATION IMPORTAN; KOZA JR, 1994, STAT COMPUT, V4, P87, DOI 10.1007/BF00175355; Laguna M, 2003, OPTIMIZATION SOFTWAR, P193; Langdon WB, 2015, IEEE T EVOLUT COMPUT, V19, P118, DOI 10.1109/TEVC.2013.2281544; Louppe G., 2014, ARXIV14077502, DOI [10. 13140/2.1.1570.5928, DOI 10.13140/2.1.1570.5928]; Lundberg S.M, 2018, CONSISTENT INDIVIDUA; Manson SM, 2006, INT J GEOGR INF SCI, V20, P991, DOI 10.1080/13658810600830566; Manson SM, 2005, AGR ECOSYST ENVIRON, V111, P47, DOI 10.1016/j.agee.2005.04.024; Morice-Atkinson X, 2018, MON NOT R ASTRON SOC, V481, P4194, DOI 10.1093/mnras/sty2575; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Petke J, 2018, IEEE T EVOLUT COMPUT, V22, P415, DOI 10.1109/TEVC.2017.2693219; Rea C, 2018, P 45 EPS C PLASM PHY, V42; Saabas A, 2014, DIVING DATA 24, V24; Saabas A, 2019, TREEINTERPRETER; Smith EM, 2017, 8 INT C PATT REC SYS, P1; Stonedahl F, 2010, ARTIFICIAL ANASAZI M; Stonedahl F, 2010, BEHAVIORSEARCH COMPU; Stonedahl F., 2010, AAAI FALL S COMPL AD, P120; Stratton RJ, 2015, THESIS; Wilensky U, 1999, NETLOGO; Zhong JH, 2014, AAMAS'14: PROCEEDINGS OF THE 2014 INTERNATIONAL CONFERENCE ON AUTONOMOUS AGENTS & MULTIAGENT SYSTEMS, P1125	45	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0239922	10.1371/journal.pone.0239922	http://dx.doi.org/10.1371/journal.pone.0239922			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PI8CZ	33338054	Green Published, gold, Green Submitted			2022-12-27	WOS:000601313500033
J	Dervishi, A				Dervishi, Albion			A deep learning backcasting approach to the electrolyte, metabolite, and acid-base parameters that predict risk in ICU patients	PLOS ONE			English	Article							HOSPITAL MORTALITY; VALIDATION; ADMISSION; DEATH	Background A powerful risk model allows clinicians, at the bedside, to ensure the early identification of and decision-making for patients showing signs of developing physiological instability during treatment. The aim of this study was to enhance the identification of patients at risk for deterioration through an accurate model using electrolyte, metabolite, and acid-base parameters near the end of patients' intensive care unit (ICU) stays. Methods This retrospective study included 5157 adult patients during the last 72 hours of their ICU stays. The patients from the MIMIC-III database who had serum lactate, pH, bicarbonate, potassium, calcium, glucose, chloride, and sodium values available, along with the times at which those data were recorded, were selected. Survivor data from the last 24 hours before discharge and four sets of nonsurvivor data from 48-72, 24-48, 8-24, and 0-8 hours before death were analyzed. Deep learning (DL), random forest (RF) and generalized linear model (GLM) analyses were applied for model construction and compared in terms of performance according to the area under the receiver operating characteristic curve (AUC). A DL backcasting approach was used to assess predictors of death vs. discharge up to 72 hours in advance. Results The DL, RF and GLM models achieved the highest performance for nonsurvivors 0-8 hours before death versus survivors compared with nonsurvivors 8-24, 24-48 and 48-72 hours before death versus survivors. The DL assessment outperformed the RF and GLM assessments and achieved discrimination, with an AUC of 0.982, specificity of 0.947, and sensitivity of 0.935. The DL backcasting approach achieved discrimination with an AUC of 0.898 compared with the DL native model of nonsurvivors from 8-24 hours before death versus survivors with an AUC of 0.894. The DL backcasting approach achieved discrimination with an AUC of 0.871 compared with the DL native model of nonsurvivors from 48-72 hours before death versus survivors with an AUC of 0.846. Conclusions The DL backcasting approach could be used to simultaneously monitor changes in the electrolyte, metabolite, and acid-base parameters of patients who develop physiological instability during ICU treatment and predict the risk of death over a period of hours to days.	[Dervishi, Albion] Univ Tubingen, Acad Teaching Hosp, Medius Clin Nurtingen, Dept Anesthesiol & Intens Care Med, Tubingen, Germany	Eberhard Karls University of Tubingen	Dervishi, A (corresponding author), Univ Tubingen, Acad Teaching Hosp, Medius Clin Nurtingen, Dept Anesthesiol & Intens Care Med, Tubingen, Germany.	albiondervishi@gmail.com		Dervishi, Albion/0000-0001-7140-836X				A A., 2016, DEEP LEARNING H2O; Al-Jaghbeer M., 2015, NEPHROLOGY DIALYSIS; Asadollahi K, 2011, EMERG MED AUSTRALAS, V23, P354, DOI 10.1111/j.1742-6723.2011.01410.x; Atkins TEH, 2018, EUR J INTERN MED, V51, P25, DOI 10.1016/j.ejim.2017.12.008; Bakker J, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-12; Bandak Ghassan, 2017, F1000Res, V6, P1930, DOI 10.12688/f1000research.11401.1; Basile-Filho Anibal, 2016, J Clin Med Res, V8, P141, DOI 10.14740/jocmr2425w; Bauer DT, 2010, J AM MED INFORM ASSN, V17, P416, DOI 10.1136/jamia.2009.000505; Boroujeni AM, 2019, AM J CLIN PATHOL, V151, P452, DOI 10.1093/ajcp/aqy163; Brabrand M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002890; Brameld KJ, 2003, INT J EPIDEMIOL, V32, P617, DOI 10.1093/ije/dyg191; Campbell C. A., 2016, CLIN CHEM; Chaiyakulsil C, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4770-6; Chien D. K., 2010, INT J GERONTOL; Collins A. J., 2017, AM J NEPHROL; Dervishi A., 2020, GITHUB REPOSITORY DE; Doering TA, 2014, AM J CLIN PATHOL, V142, P617, DOI 10.1309/AJCPDI0FYZ4UNWEQ; Donnino MW, 2014, CRIT CARE MED, V42, P1804, DOI 10.1097/CCM.0000000000000332; Egi M, 2011, CRIT CARE MED, V39, P314, DOI 10.1097/CCM.0b013e3181ffe23e; Egi M, 2010, MAYO CLIN PROC, V85, P217, DOI 10.4065/mcp.2009.0394; Epskamp S., 2012, J STAT SOFTW; Florkowski C., 2017, CRIT REV CL LAB SCI; Gujadhur Anuksha, 2015, World J Crit Care Med, V4, P71, DOI 10.5492/wjccm.v4.i1.71; Gunnerson Kyle J, 2003, Curr Opin Crit Care, V9, P468, DOI 10.1097/00075198-200312000-00002; Hessels L, 2015, CRIT CARE, V19, DOI 10.1186/s13054-014-0720-9; Ho KL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02292-0; Holmberg J., 2000, INT J SUSTAIN DEV WO; Hu J., 2017, INT J CLIN EXP MED; Jarvis SW, 2013, RESUSCITATION, V84, P1494, DOI 10.1016/j.resuscitation.2013.05.018; Johnson AEW, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.35; Khonsary S., 2017, SURG NEUROL INT; Larsson J., 2018, J CLEAN PROD; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; LeDell E., 2019, CRAN; Lier H., 2008, J TRAUMA INJ INFECT; Loekito E, 2013, EMERG MED AUSTRALAS, V25, P132, DOI 10.1111/1742-6723.12040; Loekito E, 2013, RESUSCITATION, V84, P280, DOI 10.1016/j.resuscitation.2012.07.025; Marshall DC, 2017, J CRIT CARE, V40, P63, DOI 10.1016/j.jcrc.2017.02.012; Martin J, 2013, CLIN CHEM LAB MED, V51, P405, DOI 10.1515/cclm-2012-0258; Nichol AD, 2010, CRIT CARE, V14, DOI 10.1186/cc8888; Park B. S., 2013, DIABETES METAB J; Ratnayake H, 2021, INTERN MED J, V51, P746, DOI 10.1111/imj.14613; Ravi D, 2017, IEEE J BIOMED HEALTH, V21, P4, DOI 10.1109/JBHI.2016.2636665; Redfern OC, 2018, RESUSCITATION, V133, P75, DOI 10.1016/j.resuscitation.2018.09.021; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Robinson J. B., 1990, FUTURES; Sedlacek M, 2006, SEMIN DIALYSIS, V19, P496, DOI 10.1111/j.1525-139X.2006.00212.x; Shankar-Hari M, 2016, JAMA-J AM MED ASSOC, V315, P775, DOI 10.1001/jama.2016.0289; Stelfox HT, 2008, CRIT CARE, V12, DOI 10.1186/cc7162; Tan EH, 2019, AM J CLIN PATHOL, V152, P177, DOI [10.1093/AJCP/AQZ026, 10.1093/ajcp/aqz026]; Thongprayoon C, 2017, PLOS ONE, V12, DOI DOI 10.1371/JOURNAL.PONE.0174430; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Wang YM, 2019, J INVEST MED, V67, P750, DOI 10.1136/jim-2018-000900; Zhang ZH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095204; Zhou BC, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/8014213	55	1	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0242878	10.1371/journal.pone.0242878	http://dx.doi.org/10.1371/journal.pone.0242878			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332413	Green Published, gold			2022-12-27	WOS:000601310900092
J	Jokic-Begic, N; Korajlija, AL; Mikac, U				Jokic-Begic, Natasa; Lauri Korajlija, Anita; Mikac, Una			Cyberchondria in the age of COVID-19	PLOS ONE			English	Article								The global epidemic of (mis)information, spreading rapidly via social media platforms and other outlets, can be a risk factor for the development of anxiety disorders among vulnerable individuals. Cyberchondria can be a vulnerability factor for developing anxiety in a pandemic situation, particularly when the Internet is flooded with (mis)information. The aim of our study was to examine how cyberchondria is related to changes in levels of COVID-19 concern and safety behaviours among persons living in Croatia during the period in which the first COVID-19 case was identified and when the country recorded its first fatality. Repeated cross-sectional data collection was conducted during two waves over a period of three weeks (N1 = 888; N2 = 966). The first began on the day of the first confirmed case of COVID-19 in Croatia (February 24th, 2020) and the second wave began three weeks later, on the day the first COVID-19 fatality was recorded in Croatia (March 19th, 2020). Participants completed an online questionnaire regarding various COVID-19 concerns and safety behaviours aimed at disease prevention (information seeking, avoidance and hygiene) and a measure of cyberchondria (Short Cyberchondria Scale, SCS). We analysed whether changes to the epidemiological situation during the period between the two waves of data collection led to an increase in COVID-19 related behaviour directly and indirectly via an increase in COVID-19 concerns. The results indicated that, between the two waves of research, there was a pronounced increase in concerns regarding COVID-19 (b = 1.11, p < .001) as well as significant behavioural changes (b = 1.18-2.34, p < .001). Also, results demonstrated that cyberchondria plays a moderating role in these changes. In the first wave, persons with severe cyberchondria were already intensely concerned with safety behaviours. High cyberchondria and high levels of concern about the COVID-19 are associated with intense avoidance behaviours, R-2 = .63, p < .001. A moderated partial mediation model was confirmed, in which the effect of the epidemiological situation was weaker for those with higher results on the SCS (as indicated by index of moderated mediation between -.10 and -.15, p < .05). As such, cyberchondria is a contributing factor to long-term anxiety and its impact during pandemic on the general mental health burden should therefore be further investigated.	[Jokic-Begic, Natasa; Lauri Korajlija, Anita; Mikac, Una] Univ Zagreb, Dept Psychol, Fac Humanities & Social Sci, Zagreb, Croatia	University of Zagreb	Jokic-Begic, N (corresponding author), Univ Zagreb, Dept Psychol, Fac Humanities & Social Sci, Zagreb, Croatia.	njbegic@ffzg.hr	Mikac, Una/AHE-6126-2022	Mikac, Una/0000-0001-9369-6462; Jokic-Begic, Natasa/0000-0003-2597-535X				Abel T, 2020, INT J PUBLIC HEALTH, V65, P231, DOI 10.1007/s00038-020-01366-7; Ahorsu DK, 2022, INT J MENT HEALTH AD, V20, P1537, DOI 10.1007/s11469-020-00270-8; [Anonymous], R LANG ENV STAT COMP; Bagaric B., 2019, SOCIJALNA PSIHIJATRI, V7, P28; Bessiere Katie, 2010, J Med Internet Res, V12, pe6, DOI 10.2196/jmir.1149; Blakey SM, 2015, COGNITIVE THER RES, V39, P816, DOI 10.1007/s10608-015-9701-9; Brown RJ, 2020, CLIN PSYCHOL-SCI PR, V27, DOI 10.1111/cpsp.12299; Cao WJ, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112934; Clements John M, 2020, JMIR Public Health Surveill, V6, pe19161, DOI 10.2196/19161; Faasse K, 2020, PUBLIC PERCEPTIONS C, DOI 10.1101/2020.04.25.20079996; Farooq A, 2020, J MED INTERNET RES, V22, DOI 10.2196/19128; Garfin DR, 2020, HEALTH PSYCHOL, V39, P355, DOI 10.1037/hea0000875; Government of the Republic of Croatia, COR PROT MEAS; Hashemi SGS, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e05135; Hayes A., 2017, INTRO MEDIATION MODE; Jokic-Begic, 2020, LIJE VJESN, V142, P189, DOI [10.26800/LV-142-7-8-32, DOI 10.26800/LV-142-7-8-32]; Jokic-Begic N, 2019, J PSYCHOPATHOL BEHAV, V41, P662, DOI 10.1007/s10862-019-09744-z; Jungmann SM, 2020, J ANXIETY DISORD, V73, DOI 10.1016/j.janxdis.2020.102239; Kim SW, 2020, BRAIN BEHAV IMMUN, V87, P4, DOI 10.1016/j.bbi.2020.03.025; Laato S, 2020, EUR J INFORM SYST, V29, P288, DOI 10.1080/0960085X.2020.1770632; Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976; Lau JTF, 2003, J EPIDEMIOL COMMUN H, V57, P864, DOI 10.1136/jech.57.11.864; Lauri Korajlija A, 2020, BR J HLTH PSYCHOL, DOI 10.1111/bjhp.12425; Little T.D., 2013, LONGITUDINAL STRUCTU; Meier K, 2020, PUBLIC PERSPECTIVES; Newman DA, 2014, ORGAN RES METHODS, V17, P372, DOI 10.1177/1094428114548590; Pulido CM, 2020, INT SOCIOL, V35, P377, DOI 10.1177/0268580920914755; Putnick DL, 2016, DEV REV, V41, P71, DOI 10.1016/j.dr.2016.06.004; RStudio Team RStudio, 2016, INT DEV R; Schimmenti A, 2008, CLIN NEUROPSYCHIATRY, V5, P263; Singer M, 2009, MED ANTHROPOL, V28, P199, DOI 10.1080/01459740903070451; Starcevic V, 2013, EXPERT REV NEUROTHER, V13, P205, DOI [10.1586/ERN.12.162, 10.1586/ern.12.162]; Taylor S, 2020, FEM PSYCHOL, V30, P63, DOI 10.1177/0959353519864390; te Poel F, 2016, J ANXIETY DISORD, V43, P32, DOI 10.1016/j.janxdis.2016.07.009; Thompson RR, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav3502; Vismara M, 2020, COMPR PSYCHIAT, V99, DOI 10.1016/j.comppsych.2020.152167; Wang JL, 2020, INT J NURS STUD, V102, DOI 10.1016/j.ijnurstu.2019.103472; Wheaton MG, 2012, COGNITIVE THER RES, V36, P210, DOI 10.1007/s10608-011-9353-3; World Health Organization, 2020, 13 WHO	39	29	29	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243704	10.1371/journal.pone.0243704	http://dx.doi.org/10.1371/journal.pone.0243704			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PI8BZ	33332400	Green Published, gold			2022-12-27	WOS:000601310900033
J	Mengistu, G; Dejenu, G; Tesema, C; Arega, B; Awoke, T; Alemu, K; Moges, F				Mengistu, Getachew; Dejenu, Getiye; Tesema, Cheru; Arega, Balew; Awoke, Tadesse; Alemu, Kassahun; Moges, Feleke			Epidemiology of streptomycin resistant Salmonella from humans and animals in Ethiopia: A systematic review and meta-analysis	PLOS ONE			English	Review							HEALTHY SLAUGHTERED CATTLE; ANTIMICROBIAL RESISTANCE; NONTYPHOIDAL SALMONELLA; DRUG-RESISTANCE; PREVALENCE; SEROVARS; PATTERNS; POULTRY; AFRICA; BEEF	Background Streptomycin is used as an epidemiological marker in monitoring programs for antimicrobial resistance in Salmonella serovars and indicates the presence of pentaresistance. However, comprehensive data on streptomycin resistant Salmonella among human, animal, and animal products is lacking in Ethiopia. In this review, we aimed to assess heterogeneity and pooled proportion of Salmonella serovars to streptomycin resistance among human, animal and animal products in Ethiopia. Methods We conducted a systematic review and meta-analysis of published literature from Ethiopia. We used the MEDLINE/ PubMed, Embase, Cochrane Library, and Google Scholar databases to identify genetic and phenotypic data on Salmonella isolates. To determine the heterogeneity and pooled proportion, we used metaprop commands and the random-effects model. Relative and cumulative frequencies were calculated to describe the overall preponderance of streptomycin resistance isolates after arcsine-transformed data. Metan funnel and meta-bias using a begg test were performed to check for publication bias. Results Overall, we included 1475 Salmonella serovars in this meta-analysis. The pooled proportion of streptomycin resistance was 47% (95% CI: 35-60%). Sub-group analysis by target population showed that the proportion of streptomycin resistance in Salmonella serovars was 54% (95% CI: 35-73%) in animal, 44% (95% Cl: 33-59%) in humans and 39% (95% CI: 24-55%) in animals products. The streptomycin resistant Salmonella serovars were statistically increasing from 0.35(95% CI: 0.12-0.58) in 2003 to 0.77(95% CI: 0.64-0.89) in 2018. The level of multidrug-resistant (MDR) Salmonella serovars was 50.1% in the meta-analysis. Conclusion We found a high level of streptomycin resistance, including multidrug, Salmonella serovars among human, animals, and animal products. This resistance was significantly increasing in the last three decades (1985-2018). The resistance to streptomycin among Salmonella serovars isolated from animals was higher than humans. This mandates the continuous monitoring of streptomycin use and practicing one health approach to preventing further development of resistance in Ethiopia. Registration We conducted a systematic review and meta-analysis after registration of the protocol in PROSPERO (CRD42019135116) following the MOOSE (Meta-Analysis of Observational Studies in Epidemiology).	[Mengistu, Getachew] DebreMarkos Univ, Coll Hlth Sci, Med Lab Sci, Debre Marqos, Ethiopia; [Mengistu, Getachew; Moges, Feleke] Univ Gondar, Coll Med & Hlth Sci, Sch Lab & Biomed Sci, Dept Med Microbiol, Gondar, Ethiopia; [Dejenu, Getiye; Tesema, Cheru] DebreMarkos Univ, Coll Hlth Sci, Dept Publ Hlth, Debre Marqos, Ethiopia; [Arega, Balew] Yekatit 12 Hosp Med Coll, Addis Ababa, Ethiopia; [Awoke, Tadesse; Alemu, Kassahun] Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Epidemiol & Biostat, Gondar, Ethiopia	University of Gondar; University of Gondar	Mengistu, G (corresponding author), DebreMarkos Univ, Coll Hlth Sci, Med Lab Sci, Debre Marqos, Ethiopia.; Mengistu, G (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Sch Lab & Biomed Sci, Dept Med Microbiol, Gondar, Ethiopia.	gechomlt@gmail.com	Kibret, Getiye Dejenu/ACX-4494-2022; Moges, Feleke/GXW-1995-2022; Mengistu, Getachew/GRF-0245-2022	Kibret, Getiye Dejenu/0000-0002-1374-5744; Mengistu, Getachew/0000-0002-3556-3650				ABATE AA, 2013, INT J ADV LIFE SCI, V6, P192; Abdissa R, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2372-2; Abebe M., 2014, World Journal of Medical Sciences, V11, P342; Abunna F., 2016, Journal of Animal and Poultry Sciences, V5, P21; Addis Z, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-222; Alemayehu D, 2003, TROP ANIM HEALTH PRO, V35, P309, DOI 10.1023/A:1025189204496; Alemu S, 2012, TROP ANIM HEALTH PRO, V44, P595, DOI 10.1007/s11250-011-9941-y; [Anonymous], 2007, Wkly Epidemiol Rec, V82, P252; [Anonymous], 2016, THE TOTAL AUDIENCE R; [Anonymous], 2009, DIABETES CARE S1, V27, ps5; [Anonymous], 2016, THE TOTAL AUDIENCE R; ASHENAFI M, 1985, T ROY SOC TROP MED H, V79, P719, DOI 10.1016/0035-9203(85)90201-9; Barendregt JJ, 2013, J EPIDEMIOL COMMUN H, V67, P974, DOI 10.1136/jech-2013-203104; Bayleyegn Molla, 2003, Ethiopian Journal of Health Development, V17, P131; Bekele B, 2010, TROP ANIM HEALTH PRO, V42, P857, DOI 10.1007/s11250-009-9499-0; Bernal-Bayard J, 2018, CURR ISSUES MOL BIOL, V25, P133, DOI 10.21775/cimb.025.133; Beyan Ahmed Mustefa, 2018, Ethiopian Veterinary Journal, V22, P94, DOI 10.4314/evj.v22i2.8; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Dagnachew D, 2017, J PARASITOLOGY VECTO, V9, P64; Djeffal S, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1050-3; ECDC E. EFSA (European Food Safety Authority) and ECDC (European Centre for Disease Prevention and Control), 2015, EUR UN SUMM REP TREN, V13, P4036; Eguale T, 2014, J APPL MICROBIOL, V117, P961, DOI 10.1111/jam.12579; Eguale T, 2018, ZOONOSES PUBLIC HLTH, V65, P766, DOI 10.1111/zph.12490; Eguale T, 2018, BMC VET RES, V14, DOI 10.1186/s12917-018-1539-4; Eguale T, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0638-2; Eguale T, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1235-y; Feasey NA, 2012, LANCET, V379, P2489, DOI 10.1016/S0140-6736(11)61752-2; Ferede B., 2015, J MICROBIOLOGY ANTIM, V7, P1, DOI [10.5897/JMA2014.0331, DOI 10.5897/JMA2014.0331]; Founou LL, 2018, MICROB DRUG RESIST, V24, P648, DOI 10.1089/mdr.2017.0383; Frye JG, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00135; Fufa Abunna, 2017, Ethiopian Veterinary Journal, V21, P92, DOI 10.4314/evj.v21i2.7; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Huehn S, 2010, FOODBORNE PATHOG DIS, V7, P523, DOI 10.1089/fpd.2009.0447; Igoraite Margarita, 2016, INDEPENDENT J MANAGE, V7, P320; Kale Janhavi, 2017, COMP DIFFERENT METHO; Kemal J, 2016, J INFECT DEV COUNTR, V10, P1230, DOI 10.3855/jidc.7885; Ketema L, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/9794869; Kiflu B, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1055-y; Kore K, 2017, PREV VET MED, V147, P11, DOI 10.1016/j.prevetmed.2017.08.018; Michael GB, 2016, CLIN MICROBIOL INFEC, V22, P968, DOI 10.1016/j.cmi.2016.07.033; Moher D., 2015, STATEMENT SYSTEMATIC, V4, DOI [10.1186/2046-4053-4-1, DOI 10.1186/2046-4053-4-12-S2.0-84920780781, DOI 10.14306/RENHYD.20.2.223]; Molla B, 2006, J VET MED B, V53, P28, DOI 10.1111/j.1439-0450.2006.00900.x; Muhie OA, 2019, INT J MICROBIOL, V2019, DOI 10.1155/2019/2489063; Oloso NO, 2019, ANTIBIOTICS-BASEL, V8, DOI 10.3390/antibiotics8020075; Page MJ, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-017-0663-8; Reddy EA, 2010, LANCET INFECT DIS, V10, P417, DOI 10.1016/S1473-3099(10)70072-4; Schatz A, 2005, CLIN ORTHOP RELAT R, P3; Sibhat B, 2011, ZOONOSES PUBLIC HLTH, V58, P102, DOI 10.1111/j.1863-2378.2009.01305.x; Singh BR, 2007, FOODBORNE PATHOG DIS, V4, P233, DOI 10.1089/fpd.2006.0082; Tadesse G, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0835-x; Tadesse G, 2014, BMC PHARMACOL TOXICO, V15, DOI 10.1186/2050-6511-15-51; Takele S, 2018, TROP DIS TRAVEL MED, V4, DOI 10.1186/s40794-018-0072-6; Tesfaye Wolde, 2016, African Journal of Microbiology Research, V10, P1555; Teshome Tadesse, 2012, Journal of Medical Sciences (Pakistan), V12, P224, DOI 10.3923/jms.2012.224.228; Tilahun H, 2012, SPATIAL ANAL LIVESTO; Tsegaye S, 2016, AFR J BASIC APPL SCI, V8, P180; Voss-Rech D, 2017, FOODBORNE PATHOG DIS, V14, P116, DOI 10.1089/fpd.2016.2228; Wabeto W, 2017, J HEALTH POPUL NUTR, V36, DOI 10.1186/s41043-017-0131-z; Zewdu E, 2009, TROP ANIM HEALTH PRO, V41, P241, DOI 10.1007/s11250-008-9181-y; Zou W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059224	60	4	4	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0244057	10.1371/journal.pone.0244057	http://dx.doi.org/10.1371/journal.pone.0244057			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332438	Green Published, gold			2022-12-27	WOS:000601310900044
J	Thapa-Magar, KB; Davis, TS; Kondratieff, B				Thapa-Magar, Khum Bahadur; Davis, Thomas Seth; Kondratieff, Boris			Livestock grazing is associated with seasonal reduction in pollinator biodiversity and functional dispersion but cheatgrass invasion is not: Variation in bee assemblages in a multi-use shortgrass prairie	PLOS ONE			English	Article							WILD BEES; INSECT POLLINATORS; BROMUS-TECTORUM; DIVERSITY; PLANT; COMMUNITIES; IMPACTS; CONSERVATION; RESOURCES; INTENSITY	Livestock grazing and non-native plant species affect rangeland habitats globally. These factors may have important effects on ecosystem services including pollination, yet, interactions between pollinators, grazing, and invasive plants are poorly understood. To address this, we tested the hypothesis that cattle grazing and site colonization by cheatgrass (Bromus tectorum) impact bee foraging and nesting habitats, and the biodiversity of wild bee communities, in a shortgrass prairie system. Bee nesting habitats (litter and wood cover) were marginally improved in non-grazed sites with low cheatgrass cover, though foraging habitat (floral cover and richness, bare soil) did not differ among cattle-grazed sites or non-grazed sites with low or high cheatgrass cover. However, floral cover was a good predictor of bee abundance and functional dispersion. Mean bee abundance, richness, diversity and functional diversity were significantly lower in cattle-grazed habitats than in non-grazed habitats. Differences in bee diversity among habitats were pronounced early in the growing season (May) but by late-season (August) these differences eroded as Melissodes spp. and Bombus spp. became more abundant at study sites. Fourth-corner analysis revealed that sites with high floral cover tended to support large, social, polylectic bees; sites with high grass cover tended to support oligolectic solitary bees. Both cattle-grazed sites and sites with high cheatgrass cover were associated with lower abundances of above-ground nesting bees but higher abundance of below-ground nesters than non-grazed sites with low cheatgrass cover. We conclude that high cheatgrass cover is not associated with reduced bee biodiversity or abundance, but cattle grazing was negatively associated with bee abundances and altered species composition. Although floral cover is an important predictor of bee assemblages, this was not impacted by cattle grazing and our study suggests that cattle likely impact bee communities through effects other than those mediated by forbs, including soil disturbance or nest destruction. Efforts aimed at pollinator conservation in prairie habitats should focus on managing cattle impacts early in the growing season to benefit sensitive bee species.	[Thapa-Magar, Khum Bahadur; Davis, Thomas Seth] Colorado State Univ, Warner Coll Nat Resources, Dept Forest & Rangeland Stewardship, Ft Collins, CO 80523 USA; [Kondratieff, Boris] Colorado State Univ, Coll Agr Sci, Agr Biol, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University	Davis, TS (corresponding author), Colorado State Univ, Warner Coll Nat Resources, Dept Forest & Rangeland Stewardship, Ft Collins, CO 80523 USA.	seth.davis@colostate.edu		Davis, Thomas/0000-0002-9901-2516	McIntire-Stennis appropriations (USDA NIFA) [COL 00767]	McIntire-Stennis appropriations (USDA NIFA)	Funding was provided by McIntire-Stennis appropriations (USDA NIFA COL 00767) to TSD.	Alkemade R, 2013, P NATL ACAD SCI USA, V110, P20900, DOI 10.1073/pnas.1011013108; Baker WL, 2009, NAT AREA J, V29, P204, DOI 10.3375/043.029.0301; Balch JK, 2013, GLOBAL CHANGE BIOL, V19, P173, DOI 10.1111/gcb.12046; Banks ER, 2011, NAT AREA J, V31, P377, DOI 10.3375/043.031.0408; Bauer AA, 2017, AM J BOT, V104, P772, DOI 10.3732/ajb.1600405; Bhandari KB, 2018, CROP SCI, V58, P2665, DOI 10.2135/cropsci2018.06.0393; Bonte D, 2008, BASIC APPL ECOL, V9, P726, DOI 10.1016/j.baae.2007.09.008; Brown AM, 2014, METHODS ECOL EVOL, V5, P344, DOI 10.1111/2041-210X.12163; Burke I. C., 2008, ECOLOGY SHORTGRASS S, P484; Cariveau DP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151482; Carvell C, 2002, BIOL CONSERV, V103, P33, DOI 10.1016/S0006-3207(01)00114-8; Cockerell T. D. A, 1907, 373 U COL STUD 4; Cook W., 1993, RANGELANDS, V15, P204; Cox RD, 2004, J RANGE MANAGE, V57, P203, DOI 10.2307/4003920; Danforth B.N., 2019, SOLITARY BEES BIOL E; Goergen EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018145; Greenleaf SS, 2006, P NATL ACAD SCI USA, V103, P13890, DOI 10.1073/pnas.0600929103; Hall M, 2018, AGR FOREST ENTOMOL, V20, P487, DOI 10.1111/afe.12281; Hall MA, 2019, BIOL CONSERV, V231, P1, DOI 10.1016/j.biocon.2018.12.032; Hsieh TC, 2016, METHODS ECOL EVOL, V7, P1451, DOI 10.1111/2041-210X.12613; Jones PL, 2017, ANNU REV ENTOMOL, V62, P53, DOI 10.1146/annurev-ento-031616-034903; Kearns CA, 1998, ANNU REV ECOL SYST, V29, P83, DOI 10.1146/annurev.ecolsys.29.1.83; Kearns CA, 2009, J INSECT CONSERV, V13, P655, DOI 10.1007/s10841-009-9215-4; Kimoto C, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00118.1; Kremen C, 2007, ECOL LETT, V10, P299, DOI 10.1111/j.1461-0248.2007.01018.x; Kruess A, 2002, BIOL CONSERV, V106, P293, DOI 10.1016/S0006-3207(01)00255-5; Kruess A, 2002, CONSERV BIOL, V16, P1570, DOI 10.1046/j.1523-1739.2002.01334.x; Laliberte E., 2015, R PACKAGEVERSION 10; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Lazaro A, 2016, ECOL ENTOMOL, V41, P400, DOI 10.1111/een.12310; Legendre P, 1997, ECOLOGY, V78, P547; Levine JM, 2003, P ROY SOC B-BIOL SCI, V270, P775, DOI 10.1098/rspb.2003.2327; MacInnis G, 2019, J APPL ECOL, V56, P824, DOI 10.1111/1365-2664.13344; Martins KT, 2015, AGR ECOSYST ENVIRON, V200, P12, DOI 10.1016/j.agee.2014.10.018; Michener C.D., 2007, BEES WORLD, Vsecond; Michener CD, 1999, APIDOLOGIE, V30, P67, DOI 10.1051/apido:19990108; MILCHUNAS DG, 1988, AM NAT, V132, P87, DOI 10.1086/284839; Moreira X, 2019, ECOLOGY, V100, DOI 10.1002/ecy.2707; Murray TE, 2012, J APPL ECOL, V49, P998, DOI 10.1111/j.1365-2664.2012.02175.x; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Parkinson H, 2013, RANGELAND ECOL MANAG, V66, P174, DOI 10.2111/REM-D-11-00028.1; Portman ZM, 2020, ANN ENTOMOL SOC AM, V113, P337, DOI 10.1093/aesa/saaa010; Potts SG, 2005, ECOL ENTOMOL, V30, P78, DOI 10.1111/j.0307-6946.2005.00662.x; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Prendergast KS, 2020, ECOSPHERE, V11, DOI 10.1002/ecs2.3076; Rafferty NE, 2017, CURR OPIN INSECT SCI, V23, P22, DOI 10.1016/j.cois.2017.06.009; Rhoades P, 2017, J INSECT CONSERV, V21, P703, DOI 10.1007/s10841-017-0013-0; Rhoades PR, 2018, ANN ENTOMOL SOC AM, V111, P278, DOI 10.1093/aesa/say021; Roulston TH, 2011, ANNU REV ENTOMOL, V56, P293, DOI 10.1146/annurev-ento-120709-144802; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scott V. L., 2011, NATURAL HIST INVENTO, P101; Sjodin NE, 2008, J APPL ECOL, V45, P763, DOI 10.1111/j.1365-2664.2007.01443.x; Sjodin NE, 2007, BIODIVERS CONSERV, V16, P2103, DOI 10.1007/s10531-006-9103-0; SUGDEN EA, 1985, GREAT BASIN NAT, V45, P299; Vanbergen AJ, 2013, FRONT ECOL ENVIRON, V11, P251, DOI 10.1890/120126; Vulliamy B, 2006, OIKOS, V114, P529, DOI 10.1111/j.2006.0030-1299.14004.x; Wang J, 2020, FIRE MATER, V44, P1, DOI 10.1002/fam.2884; Westphal C, 2008, ECOL MONOGR, V78, P653, DOI 10.1890/07-1292.1; Young J. A., 2000, Rangelands, V22, P3	59	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0237484	10.1371/journal.pone.0237484	http://dx.doi.org/10.1371/journal.pone.0237484			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332351	Green Published, Green Submitted, gold			2022-12-27	WOS:000601310900048
J	Bhanot, SP; Chang, D; Cunningham, JL; Ranson, M				Bhanot, Syon P.; Chang, Daphne; Cunningham, Julia Lee; Ranson, Matthew			Emotions and decisions in the real world: What can we learn from quasi-field experiments?	PLOS ONE			English	Article							RISK-TAKING; GENDER-DIFFERENCES; BEHAVIOR; MOOD; IMPACT; FOOTBALL; WEATHER; PERCEPTIONS; INDUCTION; ECONOMICS	Researchers in the social sciences have increasingly studied how emotions influence decision-making. We argue that research on emotions arising naturally in real-world environments is critical for the generalizability of insights in this domain, and therefore to the development of this field. Given this, we argue for the increased use of the "quasi-field experiment" methodology, in which participants make decisions or complete tasks after as-if-random real-world events determine their emotional state. We begin by providing the first critical review of this emerging literature, which shows that real-world events provide emotional shocks that are at least as strong as what can ethically be induced under laboratory conditions. However, we also find that most previous quasi-field experiment studies use statistical techniques that may result in biased estimates. We propose a more statistically-robust approach, and illustrate it using an experiment on negative emotion and risk-taking, in which sports fans completed risk-elicitation tasks immediately after watching a series of NFL games. Overall, we argue that when appropriate statistical methods are used, the quasi-field experiment methodology represents a powerful approach for studying the impact of emotion on decision-making.	[Bhanot, Syon P.] Swarthmore Coll, Dept Econ, Swarthmore, PA 19081 USA; [Chang, Daphne] Carnegie Mellon Univ, Heinz Coll Informat Syst & Publ Policy, Pittsburgh, PA 15213 USA; [Cunningham, Julia Lee] Univ Michigan, Ross Sch Business, Management & Org Area, Ann Arbor, MI 48109 USA; [Ranson, Matthew] Athenahealth, Watertown, MA USA	Swarthmore College; Carnegie Mellon University; University of Michigan System; University of Michigan	Bhanot, SP (corresponding author), Swarthmore Coll, Dept Econ, Swarthmore, PA 19081 USA.	sbhanot1@swarthmore.edu		Bhanot, Syon/0000-0003-2765-0532	Harvard Mind-Brain-Behavior grant; Harvard Program on Negotiation grant	Harvard Mind-Brain-Behavior grant; Harvard Program on Negotiation grant	This research was supported by a Harvard Mind-Brain-Behavior grant and a Harvard Program on Negotiation grant. This funding was used for study implementation costs and subject payments, and not salaries of or payments to the study authors. The funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Matthew Ranson is an employee of a commercial company, athenahealth (and formerly Abt Associates). However, neither athenahealth or Abt Associates provided salary support for Matthew related to this work (the bulk of Matthew's work on the project predates his commercial affiliations), nor did the organizations play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CA, 1999, CURR DIR PSYCHOL SCI, V8, P3, DOI 10.1111/1467-8721.00002; Andrade EB, 2009, ORGAN BEHAV HUM DEC, V109, P1, DOI 10.1016/j.obhdp.2009.02.003; [Anonymous], 1995, HARVARD UKRAINIAN ST, V19, P555; Bardsley N, 2005, J ECON METHODOL, V12, P239, DOI 10.1080/13501780500086115; Bassi A, 2019, J EXP POLIT SCI, V6, P17, DOI 10.1017/XPS.2018.13; Berument MH, 2012, SOC SCI J, V49, P368, DOI 10.1016/j.soscij.2012.03.003; BOUND J, 1995, J AM STAT ASSOC, V90, P443, DOI 10.2307/2291055; BRIEF AP, 1995, ORGAN BEHAV HUM DEC, V62, P55, DOI 10.1006/obhd.1995.1030; Brody LR, 2010, HANDBOOK OF GENDER RESEARCH IN PSYCHOLOGY, VOL 1, P429, DOI 10.1007/978-1-4419-1465-1_21; Busse MR, 2015, Q J ECON, V130, P371, DOI 10.1093/qje/qju033; Byrnes JP, 1999, PSYCHOL BULL, V125, P367, DOI 10.1037/0033-2909.125.3.367; Callen M, 2014, AM ECON REV, V104, P123, DOI 10.1257/aer.104.1.123; Camerer Colin., 2011, PROMISE SUCCESS LAB; Cameron L, 2015, J HUM RESOUR, V50, P484, DOI 10.3368/jhr.50.2.484; Campos-Vazquez RM, 2014, J BEHAV EXP ECON, V50, P1, DOI 10.1016/j.socec.2014.01.001; Capra CM, 2004, AM ECON REV, V94, P367, DOI 10.1257/0002828041301885; Card D, 2011, Q J ECON, V126, P103, DOI 10.1093/qje/qjr001; Celse J, 2017, J BEHAV EXP ECON, V67, P122, DOI 10.1016/j.socec.2016.12.004; Charness G, 2012, J ECON BEHAV ORGAN, V83, P50, DOI 10.1016/j.jebo.2011.06.007; Clore G. L., 2000, SER AFFECTIVE SCI, P24; Coan J.A., 2007, HDB EMOTION ELICITAT; Coan J. A., 2007, HDB EMOTION ELICITAT; Conte A, 2018, ECONOMICA, V85, P305, DOI 10.1111/ecca.12209; CUNNINGHAM MR, 1979, J PERS SOC PSYCHOL, V37, P1947, DOI 10.1037/0022-3514.37.11.1947; Daly M, 2009, J EUR ECON ASSOC, V7, P659, DOI 10.1162/JEEA.2009.7.2-3.659; DELDIN PJ, 1986, B PSYCHONOMIC SOC, V24, P4; Eckel CC, 2009, J ECON BEHAV ORGAN, V69, P110, DOI 10.1016/j.jebo.2007.08.012; Eren O, 2018, AM ECON J-APPL ECON, V10, P171, DOI 10.1257/app.20160390; Fessler DMT, 2004, ORGAN BEHAV HUM DEC, V95, P107, DOI 10.1016/j.obhdp.2004.06.006; Fischer AH, 2004, EMOTION, V4, P87, DOI 10.1037/1528-3542.4.1.87; Frijda N. H., 1993, HDB EMOTIONS, P381; Gneezy U., 2017, HDB EC FIELD EXPT, V1, P439, DOI DOI 10.1016/BS.HEFE.2016.08.003; Gneezy U, 2014, MANAGE SCI, V60, P2645, DOI 10.1287/mnsc.2014.1942; GROSS JJ, 1995, COGNITION EMOTION, V9, P87, DOI 10.1080/02699939508408966; Guiso L, 2018, J FINANC ECON, V128, P403, DOI 10.1016/j.jfineco.2018.02.007; Haggag K, 2019, REV ECON STUD, V86, P2136, DOI 10.1093/restud/rdy054; Harrison GW, 2007, ECONOMETRICA, V75, P433, DOI 10.1111/j.1468-0262.2006.00753.x; Heilman RM, 2010, EMOTION, V10, P257, DOI 10.1037/a0018489; Hirshleifer D, 2003, J FINANC, V58, P1009, DOI 10.1111/1540-6261.00556; Holt CA, 2002, AM ECON REV, V92, P1644, DOI 10.1257/000282802762024700; Ibanez L, 2017, J BEHAV EXP ECON, V66, P150, DOI 10.1016/j.socec.2016.04.003; ISEN AM, 1983, ORGAN BEHAV HUM PERF, V31, P194, DOI 10.1016/0030-5073(83)90120-4; JOHNSON EJ, 1983, J PERS SOC PSYCHOL, V45, P20, DOI 10.1037/0022-3514.45.1.20; KENEALY PM, 1986, MOTIV EMOTION, V10, P315, DOI 10.1007/BF00992107; Kessler J. B, 2015, EXTERNAL VALIDITY LA; Kirby S, 2014, J RES CRIME DELINQ, V51, P259, DOI 10.1177/0022427813494843; Koellinger P.D., 2016, SCHMALENBACH BUSINES, V17, P309, DOI [10.1007/s41464-016-0018-3, DOI 10.1007/S41464-016-0018-3]; Krekel C, 2019, 4 WP SAID BUS SCH; Lang P.J., 2005, INT AFFECTIVE PICTUR; Larrick RP, 2011, PSYCHOL SCI, V22, P423, DOI 10.1177/0956797611399292; Leith KP, 1996, J PERS SOC PSYCHOL, V71, P1250, DOI 10.1037/0022-3514.71.6.1250; Lejuez CW, 2002, J EXP PSYCHOL-APPL, V8, P75, DOI 10.1037//1076-898X.8.2.75; Lerner JS, 2000, COGNITION EMOTION, V14, P473, DOI 10.1080/026999300402763; Lerner JS, 2001, J PERS SOC PSYCHOL, V81, P146, DOI 10.1037//0022-3514.81.1.146; Lerner JS, 2004, PSYCHOL SCI, V15, P337, DOI 10.1111/j.0956-7976.2004.00679.x; Levitt SD, 2007, CAN J ECON, V40, P347, DOI 10.1111/j.1365-2966.2007.00412.x; Liberini F, 2017, J PUBLIC ECON, V146, P41, DOI 10.1016/j.jpubeco.2016.11.013; Loewenstein G, 2000, AM ECON REV, V90, P426, DOI 10.1257/aer.90.2.426; MARTIN M, 1990, CLIN PSYCHOL REV, V10, P669, DOI 10.1016/0272-7358(90)90075-L; Meier AN, 2019, SOEPPAPERS MULTIDISC; Metcalfe R, 2011, ECON J, V121, pF81, DOI 10.1111/j.1468-0297.2010.02416.x; Miller MK, 2013, SOC SCI QUART, V94, P59, DOI 10.1111/j.1540-6237.2012.00898.x; Mitchell G, 2012, PERSPECT PSYCHOL SCI, V7, P109, DOI 10.1177/1745691611432343; Mittal V, 1998, ORGAN BEHAV HUM DEC, V76, P298, DOI 10.1006/obhd.1998.2808; Nummenmaa L, 2004, EMOTION, V4, P207, DOI 10.1037/1528-3542.4.2.207; Page L, 2014, EUR ECON REV, V71, P121, DOI 10.1016/j.euroecorev.2014.04.009; Pettersson E, 2013, J PERS SOC PSYCHOL, V105, P285, DOI 10.1037/a0033046; Rees DI, 2009, J SPORT ECON, V10, P68, DOI 10.1177/1527002508327389; Reuben E, 2010, J ECON PSYCHOL, V31, P908, DOI 10.1016/j.joep.2010.08.001; Riener G, 2012, J SOCIO-ECON, V41, P476, DOI 10.1016/j.socec.2011.07.003; Rottenstreich Y, 2001, PSYCHOL SCI, V12, P185, DOI 10.1111/1467-9280.00334; SCHACHTER S, 1962, PSYCHOL REV, V69, P379, DOI 10.1037/h0046234; Small DA, 2006, POLIT PSYCHOL, V27, P289, DOI 10.1111/j.1467-9221.2006.00007.x; Stanton SJ, 2014, JUDGM DECIS MAK, V9, P167; Tiedens LZ, 2001, J PERS SOC PSYCHOL, V81, P973, DOI 10.1037//0022-3514.81.6.973; Torgerson WS, THEORY METHODS SCALI; Tyszka T, 2006, J ECON PSYCHOL, V27, P518, DOI 10.1016/j.joep.2006.01.004; van den Berg GJ, 2017, ECON J, V127, P1794, DOI 10.1111/ecoj.12399; Voors MJ, 2012, AM ECON REV, V102, P941, DOI 10.1257/aer.102.2.941; WANN DL, 1994, J SPORT EXERCISE PSY, V16, P347, DOI 10.1123/jsep.16.4.347; Weber BJ, 2005, ORGAN BEHAV HUM DEC, V97, P31, DOI 10.1016/j.obhdp.2005.03.001; Westermann R, 1996, EUR J SOC PSYCHOL, V26, P557, DOI 10.1002/(SICI)1099-0992(199607)26:4<557::AID-EJSP769>3.0.CO;2-4; Yuen KSL, 2003, J AFFECT DISORDERS, V75, P11, DOI 10.1016/S0165-0327(02)00022-8	84	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243044	10.1371/journal.pone.0243044	http://dx.doi.org/10.1371/journal.pone.0243044			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH1IW	33326430	Green Published, gold			2022-12-27	WOS:000600176400071
J	Pierzak, M; Kubala-Kukus, A; Banas, D; Stabrawa, I; Wudarczyk-Mocko, J; Gluszek, S				Pierzak, Monika; Kubala-Kukus, Aldona; Banas, Dariusz; Stabrawa, Ilona; Wudarczyk-Mocko, Jolanta; Gluszek, Stanislaw			Study of chromium, selenium and bromine concentrations in blood serum of patients with parenteral nutrition treatment using total reflection X-ray fluorescence analysis	PLOS ONE			English	Article							TRACE-ELEMENTS; TXRF	Total reflection X-ray fluorescence analysis (TXRF) was used to determine chromium, selenium and bromine concentrations in blood serum samples of 50 patients with parenteral nutrition treatment. The concentrations were measured two times, namely in the first day (I measurement) of the treatment and the seventh day (II measurement) after the chromium and selenium supplementation. For comparison purposes also serum samples of 50 patients without nutritional disorders, admitted to a planned surgical procedure to remove the gall bladder (cholecystectomy), were analyzed and treated as the control group. Descriptive statistics of measured concentrations of Cr, Se and Br both for the studied and control groups was determined. In order to check the effectiveness of Cr and Se supplementation, the results of the first and seventh day measurements for studied group were statistically compared with each other, with literature reference values and with the results of the control group (two-group comparison). These comparisons indicate the effectiveness of selenium supplementation in the applied treatment procedure. In the case of Cr and Br concentrations no statistically significant differences were observed. We conclude that monitoring of the concentration of the important trace elements in human serum should be standard procedure in parenteral nutrition treatment. In this monitoring the TXRF technique can be successfully used.	[Pierzak, Monika; Kubala-Kukus, Aldona] Jan Kochanowski Univ Humanities & Sci, Inst Hlth Sci, Kielce, Poland; [Kubala-Kukus, Aldona; Banas, Dariusz; Stabrawa, Ilona] Jan Kochanowski Univ Humanities & Sci, Inst Phys, Kielce, Poland; [Kubala-Kukus, Aldona; Banas, Dariusz; Stabrawa, Ilona; Wudarczyk-Mocko, Jolanta] Holycross Canc Ctr, Kielce, Poland; [Gluszek, Stanislaw] Jan Kochanowski Univ Humanities & Sci, Inst Med Sci, Kielce, Poland; [Gluszek, Stanislaw] Reg Hosp, Clin Gen Oncol & Endocrinol Surg, Kielce, Poland	Jan Kochanowski University; Jan Kochanowski University; Jan Kochanowski University	Kubala-Kukus, A (corresponding author), Jan Kochanowski Univ Humanities & Sci, Inst Phys, Kielce, Poland.; Kubala-Kukus, A (corresponding author), Holycross Canc Ctr, Kielce, Poland.	aldona.kubala-kukus@ujk.edu.pl	Banaś, Dariusz/F-5025-2011	Banaś, Dariusz/0000-0003-1566-5446; Gluszek, Stanislaw/0000-0001-7752-0459; Pierzak, Monika/0000-0002-4367-4465; Kubala-Kukus, Aldona/0000-0003-1547-3348	European Regional Development Fund in the framework of the Polish Innovative Economy Operational Program [WNP-POIG.02.02.00-26-023/08]; Development of Eastern Poland Program (Jan Kochanowski University, Kielce, Poland) [POPW.01.01.00-26-013/09-04]	European Regional Development Fund in the framework of the Polish Innovative Economy Operational Program; Development of Eastern Poland Program (Jan Kochanowski University, Kielce, Poland)	European Regional Development Fund in the framework of the Polish Innovative Economy Operational Program (contract no. WNP-POIG.02.02.00-26-023/08) and the Development of Eastern Poland Program (contract no. POPW.01.01.00-26-013/09-04) (Jan Kochanowski University, Kielce, Poland).	Ashraf A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37431-8; Duntas LH, 2015, ENDOCRINE, V48, P756, DOI 10.1007/s12020-014-0477-6; Fairweather-Tait SJ, 2011, ANTIOXID REDOX SIGN, V14, P1337, DOI 10.1089/ars.2010.3275; Fernandes AP, 2015, BBA-GEN SUBJECTS, V1850, P1642, DOI 10.1016/j.bbagen.2014.10.008; Godzialska A, 2013, WSPOLCZESNE KIERUNKI; Jeffery J, 2019, ANN CLIN BIOCHEM, V56, P170, DOI 10.1177/0004563218793163; Kabata-Pendias A., 2007, TRACE ELEMEN SOIL HU, DOI [10.1007/978-3-540-32714-1, DOI 10.1007/978-3-540-32714-1, 10.1007/978-3-540-32714-1_20]; Klecha Barbara, 2016, Bromatologia i Chemia Toksykologiczna, V49, P818; Klockenkamper R, 2015, CHEM ANAL SERIES MON, V181; Klockenkamper R., 1997, TOTAL REFLECTION XRA; Kubala-Kukus A, 2017, X-RAY SPECTROM, V46, P412, DOI 10.1002/xrs.2778; Kubala-Kukus A, 2004, SPECTROCHIM ACTA B, V59, P1283, DOI 10.1016/j.sab.2004.05.020; Kubala-Kukus A, 2014, BIOL TRACE ELEM RES, V158, P22, DOI 10.1007/s12011-013-9884-4; Lee H, 1990, SPRINGER SCI; Liui Y, 2015, ADV XRAY CHEM ANAL J, V46, P13; Magalhaes T, 2010, SPECTROCHIM ACTA B, V65, P493, DOI 10.1016/j.sab.2010.04.001; Majewska U, 2018, SPECTROCHIM ACTA B, V147, P121, DOI 10.1016/j.sab.2018.05.014; Majewska U, 2016, SPECTROCHIM ACTA B, V122, P56, DOI 10.1016/j.sab.2016.05.001; Majewska U, 2014, ACTA PHYS POL A, V125, P864, DOI 10.12693/APhysPolA.125.864; McCall AS, 2014, CELL, V157, P1380, DOI 10.1016/j.cell.2014.05.009; Pertkiewicz M, 2005, STANDARDY ZYWIENIA P; Salomone V.N., 2017, INT J EXP SPECTROSC, V2, P1; Solecka M, 2018, MED STUD, V34, P153, DOI 10.5114/ms.2018.76877; Spodaryk M, 2008, PRAKTYCZNE ASPEKTY L; Steinbrenner H, 2015, ADV NUTR, V6, P73, DOI 10.3945/an.114.007575; Stosnach H, 2009, SPECTROCHIM ACTA B, V64, P354, DOI 10.1016/j.sab.2009.03.019; User Manual S2 PICOFOX, 2012, US MAN S2 PICOFOX TX; User Manual SPECTRA 7, 2011, US MAN SPECTRA 7 SOF; Wrzochal A, 2019, MED STUD, V35, P128, DOI 10.5114/ms.2019.86332; Zarkadas C, 2001, SPECTROCHIM ACTA B, V56, P2219, DOI 10.1016/S0584-8547(01)00343-3	30	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243492	10.1371/journal.pone.0243492	http://dx.doi.org/10.1371/journal.pone.0243492			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320863	Green Published, gold			2022-12-27	WOS:000600339800035
J	Lin, ZB; Song, JY; Li, AC; Chen, C; Huang, XX; Xu, BH				Lin, Zhuang-Bin; Song, Jian-Yuan; Li, An-Chuan; Chen, Cheng; Huang, Xiao-Xue; Xu, Ben-Hua			The benefit of adjuvant radiotherapy on overall survival in resected stage I to II pancreatic cancer: A propensity-adjusted analysis	PLOS ONE			English	Article							CURATIVE RESECTION; CHEMOTHERAPY; ADENOCARCINOMA; RADIATION; EPIDEMIOLOGY; SURVEILLANCE; CHEMORADIOTHERAPY; GEMCITABINE; OUTCOMES; SURGERY	Background The survival time of patients with early pancreatic cancer (PC) is still disappointing, even after surgical resection. PC has an extremely poor prognosis. Herein, we aimed to investigate the survival effect of postoperative radiotherapy (PORT) on resected stage I to II PC. Material and methods A large eligible sample of patients was identified from 2010 to 2015 from the Surveillance, Epidemiology, and End Results (SEER) registry. Survival analysis was conducted to evaluate the efficiency of PORT. Propensity score matching (PSM) analysis was used to reduce selection bias and to make the groups comparable. Results A total of 3219 patients with resected stage I to II PC was included after rigid screening. The median overall survival (OS) was 26 months with PORT (n = 1055) versus 21 months with non-PORT (n = 2164) before matching (p<0.001). By multivariable analysis, PORT remained a favorable prognostic predictor for OS. In PSM analysis, receiving PORT was associated with improved OS (median, 26 months vs. 23 months; at 2 years, 51.7% vs. 46.7%; at 5 years, 23.3% vs. 17.4% (P = 0.006). After further meticulous exploration, only the stage IIB subgroup benefited from PORT (p<0.001). This result was due to the positive lymph node state (N+), whose mortality risk was cut by 23.4% (p<0.001) by PORT. Conclusion Addition of PORT to the treatment of patients with resected stage I to II PC conveys a survival benefit, particularly among those with N-positive or stage IIB disease.	[Lin, Zhuang-Bin; Huang, Xiao-Xue; Xu, Ben-Hua] Fujian Med Univ, Grad Sch, Fuzhou, Peoples R China; [Lin, Zhuang-Bin; Song, Jian-Yuan; Li, An-Chuan; Chen, Cheng; Huang, Xiao-Xue; Xu, Ben-Hua] Fujian Med Univ, Union Hosp, Dept Radiat Oncol, Fuzhou, Peoples R China; [Lin, Zhuang-Bin; Song, Jian-Yuan; Li, An-Chuan; Chen, Cheng; Huang, Xiao-Xue; Xu, Ben-Hua] Fujian Med Univ, Union Clin Med Coll, Fuzhou, Peoples R China; [Song, Jian-Yuan; Chen, Cheng; Xu, Ben-Hua] Fujian Med Univ, Coll Med Technol & Engn, Fuzhou, Peoples R China; [Li, An-Chuan; Xu, Ben-Hua] Fujian Med Univ, Sch Clin Med, Fuzhou, Peoples R China	Fujian Medical University; Fujian Medical University; Fujian Medical University; Fujian Medical University; Fujian Medical University	Xu, BH (corresponding author), Fujian Med Univ, Union Hosp, Dept Radiat Oncol, Fuzhou, Peoples R China.; Xu, BH (corresponding author), Fujian Med Univ, Union Clin Med Coll, Fuzhou, Peoples R China.; Xu, BH (corresponding author), Fujian Med Univ, Coll Med Technol & Engn, Fuzhou, Peoples R China.; Xu, BH (corresponding author), Fujian Med Univ, Sch Clin Med, Fuzhou, Peoples R China.	benhuaxu@sina.com		Song, Jianyuan/0000-0003-4987-4975	Joint Funds for the innovation of science and Technology, Fujian province [2017Y9061]; Natural Science Foundation of Fujian province [2019J01149]; Training project of Middle-aged and Young Core Talents in health system of Fujian Province [2019-ZQN-44]	Joint Funds for the innovation of science and Technology, Fujian province; Natural Science Foundation of Fujian province(Natural Science Foundation of Fujian Province); Training project of Middle-aged and Young Core Talents in health system of Fujian Province	Y Benhua Xu, Joint Funds for the innovation of science and Technology, Fujian province [grant number 2017Y9061]. Jianyuan Song, the Natural Science Foundation of Fujian province [grant number 2019J01149], the Training project of Middle-aged and Young Core Talents in health system of Fujian Province [grant number 2019-ZQN-44]. Benhua Xu plays a role in conception and design of the paper; Jian-Yuan Song plays a role in analysis and interpretation.	Frakes J, 2017, J GASTROINTEST ONCOL, V8, P758, DOI 10.21037/jgo.2017.08.05; Franko J, 2012, ANN SURG ONCOL, V19, P26, DOI 10.1245/s10434-011-1898-6; GRIFFIN JF, 1990, CANCER, V66, P56, DOI 10.1002/1097-0142(19900701)66:1<56::AID-CNCR2820660112>3.0.CO;2-6; Hazard L, 2007, CANCER, V110, P2191, DOI 10.1002/cncr.23047; KALSER MH, 1985, ARCH SURG-CHICAGO, V120, P899; Kantor O, 2016, SURGERY, V160, P1466, DOI 10.1016/j.surg.2016.07.033; Klinkenbijl JH, 1999, ANN SURG, V230, P776, DOI 10.1097/00000658-199912000-00006; Kooby DA, 2013, ANN SURG ONCOL, V20, P3634, DOI 10.1245/s10434-013-3047-x; Lim YJ, 2015, J GASTROINTEST SURG, V19, P2183, DOI 10.1007/s11605-015-2941-x; McDade TP, 2010, CANCER-AM CANCER SOC, V116, P3257, DOI 10.1002/cncr.25069; McDonald Andrew M, 2015, J Gastrointest Cancer, V46, P149, DOI 10.1007/s12029-015-9702-7; Mellon EA, 2014, CANCER-AM CANCER SOC, V120, P1171, DOI 10.1002/cncr.28543; Moody JS, 2009, J GASTROENTEROL, V44, P84, DOI 10.1007/s00535-008-2280-8; Neoptolemos JP, 2004, NEW ENGL J MED, V350, P1200, DOI 10.1056/NEJMoa032295; NITECKI SS, 1995, ANN SURG, V221, P59, DOI 10.1097/00000658-199501000-00007; Oettle H, 2007, JAMA-J AM MED ASSOC, V297, P267, DOI 10.1001/jama.297.3.267; Opfermann KJ, 2014, AM J CLIN ONCOL-CANC, V37, P112, DOI 10.1097/COC.0b013e31826e0570; Ostapoff KT, 2017, HPB, V19, P587, DOI 10.1016/j.hpb.2017.03.002; Rutter CE, 2015, CANCER-AM CANCER SOC, V121, P4141, DOI 10.1002/cncr.29652; Shinde A, 2019, J GASTROINTEST ONCOL, V10, P462, DOI 10.21037/jgo.2019.01.19; Showalter TN, 2011, INT J RADIAT ONCOL, V81, P1328, DOI 10.1016/j.ijrobp.2010.07.1993; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Simons JP, 2010, CANCER-AM CANCER SOC, V116, P1681, DOI 10.1002/cncr.24918; Sohn TA, 2000, J GASTROINTEST SURG, V4, P567, DOI 10.1016/S1091-255X(00)80105-5; Sugawara A, 2014, J SURG ONCOL, V110, P960, DOI 10.1002/jso.23752; Tempero M, 2019, J NATL COMPR CANC NE, V17, P1, DOI 10.6004/jnccn.2019.0003; Van Laethem JL, 2010, J CLIN ONCOL, V28, P4450, DOI 10.1200/JCO.2010.30.3446	27	1	1	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243170	10.1371/journal.pone.0243170	http://dx.doi.org/10.1371/journal.pone.0243170			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315874	gold, Green Published			2022-12-27	WOS:000600186100085
J	Perez-Gracia, J; Avila, FJ; Ares, J; Valles, JA; Remon, L				Perez-Gracia, Jesus; Avila, Francisco J.; Ares, Jorge; Valles, Juan A.; Remon, Laura			Misalignment and tilt effect on aspheric intraocular lens designs after a corneal refractive surgery	PLOS ONE			English	Article							SPHERICAL-ABERRATION; IMAGE QUALITY; PUPIL SIZE; DECENTRATION; MODEL; OPTICS; IMPACT	Purpose To numerically evaluate and compare the tolerance to misalignment and tilt of aspheric intraocular lenses (10Ls) designed for three eyes: with standard cornea and with simulated corneas after myopic and hyperopic laser ablation surgery. Methods Three aspheric 10Ls of +20.00 diopter (D) with different spherical aberration (SA) (4) values have been designed using a theoretical model eye. Drastic changes on the theoretical eye anterior corneal asphericity have been performed to simulate myopic and hyperopic refractive surgeries. The effect of IOL misalignment and tilt on the image quality has been evaluated using a commercial optical software design for the three eye models. Image quality was assessed from the modulation transfer function (MTF), root mean square (RMS) values of defocus, astigmatism, coma and spherical aberration (4), and retinal images obtained from a visual simulator using an aleatory optotype of 0.00 LogMar visual acuity (VA). Results IOL misalignment and tilt reduced MTF values in general, and increased wavefront aberrations errors. Aberration-freel0Ls maintained best the MTF values when misalignments were applied, together with good on -axis optical quality.I0Ls with negative SA (4) correction decreased the MTF value under 0.43 for misalignments values higher than 0.50 mm with the three corneas. The effect of misalignment on RMS astigmatism and coma was correlated with the IOL SA (4) and with the three corneas. Conclusions This theoretical study shows that the largest degradation in image quality arises for the IOL with the highest amount of spherical aberration (4). Moreover, it has been found that the aspherical design has a more influential role in misalignment tolerance than in tilt tolerance.	[Perez-Gracia, Jesus; Avila, Francisco J.; Ares, Jorge; Valles, Juan A.; Remon, Laura] Univ Zaragoza, Dept Fis Aplicada, Zaragoza, Spain	University of Zaragoza	Remon, L (corresponding author), Univ Zaragoza, Dept Fis Aplicada, Zaragoza, Spain.	lauremar@unizar.es	Avila, Francisco/AAD-7785-2021; REMON MARTIN, LAURA/L-7922-2017	Avila, Francisco/0000-0002-9068-7728; Perez-Gracia, Jesus/0000-0002-1959-6559; REMON MARTIN, LAURA/0000-0002-3979-4528	Spanish Ministry of Economy and Competitiveness [DI-16-08888, DPI2017-84047-R]; Department of Industry and Innovation (Government of Aragon) [E24-17R]; Feder 2014-2020: Construyendo Europa desde Aragon	Spanish Ministry of Economy and Competitiveness(Spanish Government); Department of Industry and Innovation (Government of Aragon); Feder 2014-2020: Construyendo Europa desde Aragon	This study was supported by the Spanish Ministry of Economy and Competitiveness (Grant DPI2017-84047-R) and the Department of Industry and Innovation (Government of Aragon) through the research group Grant E24-17R (cofinanciando con Feder 2014-2020: Construyendo Europa desde Aragon). J. Perez-Gracia was supported by the Spanish Ministry of Economy and Competitiveness, DI-16-08888.	Ahn Hyun Seok, 2013, Korean J Ophthalmol, V27, P81, DOI 10.3341/kjo.2013.27.2.81; Al-Sayyari TM, 2014, SAUDI J OPHTHALMOL, V28, P274, DOI 10.1016/j.sjopt.2014.06.005; Anera RG, 2003, J CATARACT REFR SURG, V29, P762, DOI 10.1016/S0886-3350(02)01895-3; ANSI, 2017, Z80282017 ANSI; Artal P, 2001, J VISION, V1, DOI 10.1167/1.1.1; Barbero S, 2011, OPT EXPRESS, V19, P6215, DOI 10.1364/OE.19.006215; Baumeister M, 2009, J CATARACT REFR SURG, V35, P1006, DOI 10.1016/j.jcrs.2009.01.023; Beiko GHH, 2007, J CATARACT REFR SURG, V33, P1455, DOI 10.1016/j.jcrs.2007.04.019; Bottos KM, 2011, J CATARACT REFR SURG, V37, P1109, DOI 10.1016/j.jcrs.2010.12.058; Bozukova D, 2013, J CATARACT REFR SURG, V39, P1404, DOI 10.1016/j.jcrs.2013.01.050; Cabeza-Gil I, 2020, ANN BIOMED ENG, V48, P1127, DOI 10.1007/s10439-019-02432-9; Calvo R, 2010, AM J OPHTHALMOL, V149, P785, DOI 10.1016/j.ajo.2009.12.023; Chang PY, 2017, J FORMOS MED ASSOC, V116, P177, DOI 10.1016/j.jfma.2016.04.003; Chassagne B, 2020, BIOMED OPT EXPRESS, V11, P850, DOI 10.1364/BOE.382162; Du W, 2019, INT J OPHTHALMOL-CHI, V12, P1788, DOI 10.18240/ijo.2019.11.19; Eppig T, 2009, J CATARACT REFR SURG, V35, P1091, DOI 10.1016/j.jcrs.2009.01.034; Forbes GW, 2007, OPT EXPRESS, V15, P5218, DOI 10.1364/OE.15.005218; Holladay JT, 2002, J REFRACT SURG, V18, P683; International Organization for Standardization, 2014, 119792 ISO; Ivarsen A, 2012, INVEST OPHTH VIS SCI, V53, P6011, DOI 10.1167/iovs.12-10208; Iwama Y, 2020, JPN J OPHTHALMOL, V64, P359, DOI 10.1007/s10384-020-00737-0; Jia LX, 2014, INT J OPHTHALMOL-CHI, V7, P816, DOI 10.3980/j.issn.2222-3959.2014.05.14; Kohnen T, 2009, OPHTHALMOLOGY, V116, P1697, DOI 10.1016/j.ophtha.2009.03.052; Langenbucher A, 2017, Z MED PHYS, V27, P255, DOI 10.1016/j.zemedi.2017.03.003; Lawu T, 2019, J CATARACT REFR SURG, V45, P662, DOI 10.1016/j.jcrs.2018.10.049; Lee H, 2018, J CATARACT REFR SURG, V44, P725, DOI 10.1016/j.jcrs.2018.03.028; Leisser C, 2020, OPHTHALMOLOGICA, V243, P37, DOI [10.1159/000498898, 10.1159/000499116]; Li MY, 2019, ACTA OPHTHALMOL, V97, pE373, DOI 10.1111/aos.14017; Lim SJ, 1998, J CATARACT REFR SURG, V24, P397, DOI 10.1016/S0886-3350(98)80330-1; Madrid-Costa D, 2012, J CATARACT REFR SURG, V38, P774, DOI 10.1016/j.jcrs.2011.11.036; McKelvie J, 2011, OPHTHALMOLOGY, V118, P1724, DOI 10.1016/j.ophtha.2011.02.025; Munoz G, 2010, J CATARACT REFR SURG, V36, P1934, DOI 10.1016/j.jcrs.2010.06.062; NAVARRO R, 1985, J OPT SOC AM A, V2, P1273, DOI 10.1364/JOSAA.2.001273; Ortiz S, 2013, BIOMED OPT EXPRESS, V4, P387, DOI 10.1364/BOE.4.000387; Perches S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150204; Perez-Gracia J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232546; Perez-Merino P, 2018, J CATARACT REFR SURG, V44, P889, DOI 10.1016/j.jcrs.2018.02.025; Perez-Vives C, 2018, J OPHTHALMOL, V2018, DOI 10.1155/2018/2687385; Piers PA, 2007, J REFRACT SURG, V23, P374; Remon L, 2018, J BIOMED OPT, V23, DOI 10.1117/1.JBO.23.3.035003; RIDLEY H, 1952, LANCET, V262, P118; Singh K, 2017, INDIAN J OPHTHALMOL, V65, P1281, DOI 10.4103/ijo.IJO_863_17; Solomon JD, 2010, J REFRACT SURG, V26, P863, DOI 10.3928/1081597X-20100129-01; Taketani F, 2004, J CATARACT REFR SURG, V30, P2158, DOI 10.1016/j.jcrs.2004.02.072; Tandogan T, 2017, J REFRACT SURG, V33, P808, DOI 10.3928/1081597X-20171004-02; Uzel MM, 2018, SEMIN OPHTHALMOL, V33, P766, DOI 10.1080/08820538.2018.1443146; Vega-Estrada A, 2020, EUR J OPHTHALMOL, V30, P446, DOI 10.1177/1120672119834478; Wang J, 2012, OPT EXPRESS, V20, P11652, DOI 10.1364/OE.20.011652; Wang L, 2019, J CATARACT REFR SURG, V45, P35, DOI 10.1016/j.jcrs.2018.08.025; Zvornicanin J, 2018, J CURR OPHTHALMOL, V30, P287, DOI 10.1016/j.joco.2018.04.003	50	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243740	10.1371/journal.pone.0243740	http://dx.doi.org/10.1371/journal.pone.0243740			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315894	Green Published, gold			2022-12-27	WOS:000600186100052
J	Stomp, M; d'Ingeo, S; Henry, S; Lesimple, C; Cousillas, H; Hausberger, M				Stomp, Mathilde; d'Ingeo, Serenella; Henry, Severine; Lesimple, Clemence; Cousillas, Hugo; Hausberger, Martine			EEG individual power profiles correlate with tension along spine in horses	PLOS ONE			English	Article							BACK-PAIN SUBJECTS; ELECTROMYOGRAPHIC RECORDINGS; RESOLUTION; DISORDERS; INTENSITY; ATTENTION; LAMENESS	Assessing chronic pain is a challenge given its subjective dimension. In humans, resting state electroencephalography (EEG) is a promising tool although the results of various studies are contradictory. Spontaneous chronic pain is understudied in animals but could be of the highest interest for a comparative study. Riding horses show a very high prevalence of back disorders thought to be associated with chronic pain. Moreover, horses with known back problems show cognitive alterations, such as a lower attentional engagement. Therefore, we hypothesized that the individual EEG power profiles resting state (i.e. quiet standing) of different horses could reflect the state of their back, that we measured using static sEMG, a tool first promoted to assess lower back pain in human patients. Results show that 1) EEG profiles are highly stable at the intra-individual level, 2) horses with elevated back tension showed resting state EEG profiles characterized by more fast (beta and gamma) and less slow (theta and alpha) waves. The proportion of theta waves was particularly negatively correlated with muscular tension along the spine. Moreover, elevated back tension was positively correlated with the frequency of stereotypic behaviours (an "addictive- like" repetitive behavior) performed by the horses in their stall. Resting state quantitative EEG appears therefore as a very promising tool that may allow to assess individual subjective chronic pain experience, beyond more objective measures of tension. These results open new lines of research for a multi-species comparative approach and might reveal very important in the context of animal welfare.	[Stomp, Mathilde; d'Ingeo, Serenella; Henry, Severine; Lesimple, Clemence; Cousillas, Hugo; Hausberger, Martine] Normandie Univ, EthoS Ethol Anim & Humaine UMR 6552, Univ Rennes, CNRS, Paimpont, France; [d'Ingeo, Serenella] Univ Bari Aldo Moro, Dept Vet Med, Sect Anim Physiol & Behav, Bari, Italy	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universita degli Studi di Bari Aldo Moro	Stomp, M (corresponding author), Normandie Univ, EthoS Ethol Anim & Humaine UMR 6552, Univ Rennes, CNRS, Paimpont, France.	mathilde.stomp@hotmail.fr	d'Ingeo, Serenella/HDM-8609-2022	/0000-0003-0664-1151	Institut francais du cheval et de l'equitation, Universite de Rennes 1; Centre National de la Recherche Scientifique; Fonds Eperon	Institut francais du cheval et de l'equitation, Universite de Rennes 1; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Fonds Eperon	Institut francais du cheval et de l'equitation, Universite de Rennes 1, and Centre National de la Recherche Scientifique provided support for this study in the form of funding awarded to MH, SH and MS, and Fonds Eperon provided support for this study in the form of funding awarded to MS.	Aftanas LI, 2001, NEUROSCI LETT, V310, P57, DOI 10.1016/S0304-3940(01)02094-8; Andrew Richard J., 2002, P94, DOI 10.1017/CBO9780511546372.005; [Anonymous], 2017, FRONTIERS MED, V4, P57; [Anonymous], 2012, REGEN MED S3, V7, pS14; Apkarian AV, 2011, PAIN, V152, pS49, DOI 10.1016/j.pain.2010.11.010; ARENA JG, 1989, PAIN, V37, P57, DOI 10.1016/0304-3959(89)90153-X; ARENA JG, 1991, PAIN, V45, P23, DOI 10.1016/0304-3959(91)90160-Y; Basar E, 2001, INT J PSYCHOPHYSIOL, V39, P241, DOI 10.1016/S0167-8760(00)00145-8; Basile M, 2009, ANIM COGN, V12, P611, DOI 10.1007/s10071-009-0220-5; Benhajali H, 2014, APPL ANIM BEHAV SCI, V153, P36, DOI 10.1016/j.applanim.2014.01.002; BROOM DM, 1986, BRIT VET J, V142, P524, DOI 10.1016/0007-1935(86)90109-0; Cauvin E, 1997, IN PRACTICE, V19, P522; Chae Y.K., 2009, PLOS ONE, V4, pe6523; DAVIDSON RJ, 1992, PSYCHOL SCI, V3, P39, DOI 10.1111/j.1467-9280.1992.tb00254.x; DUNNETT SB, 1987, NEUROSCIENCE, V20, P653, DOI 10.1016/0306-4522(87)90117-5; Dyson S, 2018, J VET BEHAV, V26, P64, DOI 10.1016/j.jveb.2018.05.001; Fonseca BPA, 2006, J EQUINE VET SCI, V26, P507, DOI 10.1016/j.jevs.2006.09.007; Fureix C, 2011, NATURWISSENSCHAFTEN, V98, P583, DOI 10.1007/s00114-011-0803-2; Greve L, 2014, EQUINE VET J, V46, P687, DOI 10.1111/evj.12222; Harris C, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10030428; Hausberger M, 2019, NEUROSCI BIOBEHAV R, V107, P540, DOI 10.1016/j.neubiorev.2019.08.022; Hausberger M, 2007, APPL ANIM BEHAV SCI, V107, P299, DOI 10.1016/j.applanim.2006.10.003; Hausberger M, 2016, APPL ANIM BEHAV SCI, V175, P41, DOI 10.1016/j.applanim.2015.09.005; Haussler KK, 1996, J EQUINE VET SCI, V16, P279, DOI 10.1016/S0737-0806(96)80220-6; Haussler KK, 2006, EQUINE VET J, V38, P76, DOI 10.2746/042516406775374225; JEFFCOTT LB, 1979, EQUINE VET J, V11, P129, DOI 10.1111/j.2042-3306.1979.tb01324.x; JEFFCOTT LB, 1980, EQUINE VET J, V12, P197, DOI 10.1111/j.2042-3306.1980.tb03427.x; Koyama S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34594-2; Kujala MV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061818; Lesimple C, 2016, APPL ANIM BEHAV SCI, V181, P105, DOI 10.1016/j.applanim.2016.04.015; Lesimple C., 2016, ANIM BEHAV COGN, V3, P159, DOI [10.12966/abc.05.08.2016, DOI 10.12966/ABC.05.08.2016]; Lesimple C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044604; Levitt J, 2019, NEUROSCI LETT, V702, P40, DOI 10.1016/j.neulet.2018.11.038; May ES, 2019, HUM BRAIN MAPP, V40, P293, DOI 10.1002/hbm.24373; MCGREEVY PD, 1995, EQUINE VET J, V27, P86, DOI 10.1111/j.2042-3306.1995.tb03041.x; Mills DS, 2005, DOMESTIC HORSE: THE ORIGINS, DEVELOPMENT AND MANAGEMENT OF ITS BEHAVIOUR, P212; Murrell JC, 2003, VET ANAESTH ANALG, V30, P138, DOI 10.1046/j.1467-2995.2003.00138.x; Nguyen MN, 2010, PLOS ONE, V5, pe9907; Nickel MM, 2017, NEUROIMAGE, V148, P141, DOI 10.1016/j.neuroimage.2017.01.011; Ong RM, 1997, AUST VET J, V75, P189, DOI 10.1111/j.1751-0813.1997.tb10064.x; Parker M, 2008, BEHAV BRAIN RES, V191, P137, DOI 10.1016/j.bbr.2008.03.009; Putman P, 2010, BIOL PSYCHOL, V83, P73, DOI 10.1016/j.biopsycho.2009.10.008; Rapin V, 2007, SCHWEIZ ARCH TIERH, V149, P77, DOI 10.1024/0036-7281.149.2.77; Reddan MC, 2019, NEUROSCI LETT, V702, P24, DOI 10.1016/j.neulet.2018.11.047; Reddan MC, 2018, NEUROSCI BULL, V34, P208, DOI 10.1007/s12264-017-0150-1; Rochais C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28334-9; Rochais C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15654-5; Rochais C, 2016, SCI REP-UK, V6, DOI 10.1038/srep20117; Schulz E, 2015, CEREB CORTEX, V25, P4407, DOI 10.1093/cercor/bhv043; Shearar KA, 2005, J MANIP PHYSIOL THER, V28, P493, DOI 10.1016/j.jmpt.2005.07.006; Siegel S., 1988, NONPARAMETRIC STAT B; Stubbs N C, 2006, Equine Vet J Suppl, P393; Sun XJ, 2017, IEEE ENG MED BIO, P479, DOI 10.1109/EMBC.2017.8036866; The Royal College of Radiologists Clinical Oncology Information Network, 1999, CLIN ONCOL R COLL RA, V11, pS1; Visser EK, 2014, J ANIM SCI, V92, P844, DOI 10.2527/jas.2013-6692; Wickens C., 2009, INVESTIGATING SPECIF; Yates WR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080287	57	3	3	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243970	10.1371/journal.pone.0243970	http://dx.doi.org/10.1371/journal.pone.0243970			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315932	gold, Green Published			2022-12-27	WOS:000600186100084
J	Yuan, Y; Naito, H; Kitamori, K; Hashimoto, S; Asano, T; Nakajima, T				Yuan, Yuan; Naito, Hisao; Kitamori, Kazuya; Hashimoto, Sayuki; Asano, Tomomi; Nakajima, Tamie			The antihypertensive agent hydralazine reduced extracellular matrix synthesis and liver fibrosis in nonalcoholic steatohepatitis exacerbated by hypertension	PLOS ONE			English	Article							FATTY LIVER; TISSUE INHIBITOR; DISEASE; METALLOPROTEINASE-1; SERUM; EXPRESSION; STEATOSIS; INJURY	Hypertension is an important risk factor for nonalcoholic steatohepatitis. We have previously demonstrated that hypertensive rats fed a high fat and cholesterol (HFC) diet incurred a more severe hepatic inflammatory response and fibrosis. Here we investigated the role of hypertension in NASH by comparing HFC-induced hepatic fibrogenesis between spontaneously hypertensive rats (SHRs) and their normotensive Wistar Kyoto counterpart. Compared to the counterpart, the HFC diet led to stronger aggregation of CD68-positive macrophages in SHRs. HFC feeding also resulted in significantly higher upregulation of the fibrosis-related gene alpha-smooth muscle actin in SHR. The HFC diet induced higher overexpression of serum tissue inhibitor of metalloproteinase-1 (TIMP1) and greater suppression of matrix metalloproteinase-2 (MMP2):TIMP1, MMP8:TIMP1, and MMP9:TIMP1 ratios, as a proxy of the activities of these MMPs in SHR. Administration of the antihypertensive agent hydralazine to SHRs significantly ameliorated HFC-induced liver fibrosis; it suppressed the aggregation of CD68-positive macrophages and the upregulation of platelet-derived growth factor receptor beta, and collagen, type 1, alpha-1 chain. In conclusion, a hypertensive environment exacerbated the hepatic fibrogenetic effects of the HFC diet; while the effects were partially reversed by the antihypertensive agent hydralazine. Our data suggest that antihypertensive drugs hold promise for treating NASH exacerbated by hypertension.	[Yuan, Yuan; Nakajima, Tamie] Chubu Univ, Coll Life & Hlth Sci, Kasugai, Aichi, Japan; [Naito, Hisao] Fujita Hlth Univ, Sch Med, Dept Publ Hlth, Toyoake, Aichi, Japan; [Naito, Hisao; Kitamori, Kazuya; Hashimoto, Sayuki; Asano, Tomomi] Kinjo Gakuin Univ, Coll Human Life & Environm, Nagoya, Aichi, Japan; [Yuan, Yuan] Shenzhen Univ, Sch Med, Dept Pathol, Shenzhen, Guangdong, Peoples R China; [Hashimoto, Sayuki] Kobe Shoin Womens Univ, Fac Human Sci, Kobe, Hyogo, Japan	Chubu University; Fujita Health University; Shenzhen University	Nakajima, T (corresponding author), Chubu Univ, Coll Life & Hlth Sci, Kasugai, Aichi, Japan.	tnasu23@med.nagoya-u.ac.jp		Nakajima, Tamie/0000-0002-0474-7019	 [B15H04788];  [C16K00877];  [C18K10033];  [C19K10583]	; ; ; 	The work has been supported by Grants-in-Aid for Scientific Research (B15H04788, C16K00877, C18K10033, and C19K10583).	[Anonymous], 2016, LANCET HIV, V3, pE191, DOI 10.1016/S2352-3018(16)30020-0; Arata M, 2014, WORLD J DIABETES, V5, P917, DOI 10.4239/wjd.v5.i6.917; Barbuio R, 2007, J ENDOCRINOL, V194, P539, DOI 10.1677/JOE-07-0234; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Donati G, 2004, GUT, V53, P1020, DOI 10.1136/gut.2003.027086; Duarte N, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/984578; Duarte S, 2015, MATRIX BIOL, V44-46, P147, DOI 10.1016/j.matbio.2015.01.004; Feng M, 2018, INT J BIOL SCI, V14, P1033, DOI 10.7150/ijbs.25589; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gandhi CR, 2017, J HEPATOL, V67, P1104, DOI 10.1016/j.jhep.2017.06.001; Ghadir MR, 2010, HEPAT MON, V10, P285; Ikuta T, 2012, HEPATOL RES, V42, P310, DOI 10.1111/j.1872-034X.2011.00920.x; Iredale JP, 1996, HEPATOLOGY, V24, P176, DOI 10.1002/hep.510240129; Jiao JJ, 2009, CURR OPIN GASTROEN, V25, P223, DOI 10.1097/MOG.0b013e3283279668; Kasahara A, 1997, J HEPATOL, V26, P574, DOI 10.1016/S0168-8278(97)80423-0; Kitamori Kazuya, 2012, Environmental Health and Preventive Medicine, V17, P173, DOI 10.1007/s12199-011-0235-9; Koyama Y, 2017, J CLIN INVEST, V127, P55, DOI 10.1172/JCI88881; Kozono M, 2016, MOL MED REP, V14, P5385, DOI 10.3892/mmr.2016.5875; Leroux A, 2012, J HEPATOL, V57, P141, DOI 10.1016/j.jhep.2012.02.028; Lindquist JN, 2000, AM J PHYSIOL-GASTR L, V279, pG471, DOI 10.1152/ajpgi.2000.279.3.G471; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; Murawaki Y, 1997, J HEPATOL, V26, P1213, DOI 10.1016/S0168-8278(97)80454-0; Naito H, 2016, ENVIRON HEALTH PREV, V21, P368, DOI 10.1007/s12199-016-0539-x; OKAMOTO KOZO, 1963, JAPAN CIRCULATION JOUR, V27, P282; Poli Giuseppe, 2000, Molecular Aspects of Medicine, V21, P49, DOI 10.1016/S0098-2997(00)00004-2; Prystupa A, 2015, ANN AGR ENV MED, V22, P325, DOI 10.5604/12321966.1152088; Robitaille J, 2004, J HUM GENET, V49, P482, DOI 10.1007/s10038-004-0177-9; Sanchez-Valle V, 2012, CURR MED CHEM, V19, P4850, DOI 10.2174/092986712803341520; Toyoda H, 2013, BIOMARKERS, V18, P82, DOI 10.3109/1354750X.2012.738249; Wang YH, 2016, HEPATOL RES, V46, P1304, DOI 10.1111/hepr.12688; Ying HZ, 2017, MOL MED REP, V16, P7879, DOI 10.3892/mmr.2017.7641; Yoshiji H, 2000, HEPATOLOGY, V32, P1248, DOI 10.1053/jhep.2000.20521; Yuan Y, 2017, NUTRIENTS, V9, DOI 10.3390/nu9091018	34	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243846	10.1371/journal.pone.0243846	http://dx.doi.org/10.1371/journal.pone.0243846			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315911	Green Published, gold			2022-12-27	WOS:000600186100073
J	Chaniad, P; Tewtrakul, S; Sudsai, T; Langyanai, S; Kaewdana, K				Chaniad, Prapaporn; Tewtrakul, Supinya; Sudsai, Teeratad; Langyanai, Supat; Kaewdana, Kantarakorn			Anti-inflammatory, wound healing and antioxidant potential of compounds from Dioscorea bulbifera L. bulbils	PLOS ONE			English	Article							FLAVONOIDS; EXTRACT; INTEGRASE	Background Dioscorea bulbifera L. (Dioscoreaceae) has been traditionally used in Thai folk medicine as a diuretic and anthelmintic, for longevity preparations, and for wound and inflammation treatment. This plant is also commonly used in traditional Indian and Chinese medicines in the treatment of sore throat, gastric cancer, rectal carcinoma and goiters. However, the wound healing effects of the active compounds in this plant have not been investigated. Objective This study aimed to identify compounds responsible for the wound healing activity of D. bulbifera and determine their potential anti-inflammatory and antioxidant activities. Methods Crude extracts of D. bulbifera bulbils, their derived fractions and eleven purified compounds were tested for anti-inflammatory activity against LPS-induced NO production in RAW264.7 macrophages. The wound healing effects were evaluated via cell proliferation and migration assays using human dermal fibroblasts (HDFs), and the antioxidant effects were determined using 2,2-diphenyl-1-picrylhydrazyl (DPPH) and hydroxyl radical ((OH)-O-center dot) scavenging activity assays. Results 15,16-Epoxy-6 alpha-O-acetyl-8 beta-hydroxy-19-nor-clero-13(16),14-diene-17,12;18,2-diolide (2), (+)-catechin (5), quercetin (6) and myricetin (11) exhibited significantly potent wound healing effects and promoted marked cell proliferation, resulting in % viabilities of 107.4-137.6, 121.1-151.9, 98.0-131.9, 90.9-115.9, respectively. Among them, (+)-catechin produced the highest % cell migration, resulting in 100.0% wound closure sooner (at day 2) than the other compounds. In addition, 1 mu g/ml (+)-catechin significantly increased fibroblast migration by 2.4-fold compared to that in the control after 24 h. Regarding anti-inflammatory properties, kaempferol (7) and quercetin (6) decreased (p < 0.005) NO production, with IC50 values of 46.6 and 56.2 mu M, respectively. In addition, the crude extracts, solvent fractions and flavonoid compounds were also found to possess marked antioxidant activity in both DPPH and (OH)-O-center dot radical scavenging assays. Conclusions These findings provide more evidence to support the traditional use of D. bulbifera for the treatment of wounds and inflammation.	[Chaniad, Prapaporn; Kaewdana, Kantarakorn] Walailak Univ, Sch Med, Nakhon Si Thammarat, Thailand; [Tewtrakul, Supinya; Sudsai, Teeratad; Langyanai, Supat] Prince Songkla Univ, Fac Pharmaceut Sci, Hat Yai, Songkhla, Thailand	Walailak University; Prince of Songkla University	Chaniad, P (corresponding author), Walailak Univ, Sch Med, Nakhon Si Thammarat, Thailand.	prapaporn.ch@wu.ac.th			Research Institute for Health Sciences, Walailak University, Nakhon Si Thammarat, Thailand [WU-IRG-62-049]	Research Institute for Health Sciences, Walailak University, Nakhon Si Thammarat, Thailand	This work was supported by a grant from the Research Institute for Health Sciences, Walailak University, Nakhon Si Thammarat, Thailand (Grant No. WU-IRG-62-049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Zabeer, 2009, Diabetologia Croatica, V38, P63; Alsawalha M, 2019, PHARMACOGN MAG, V15, P483, DOI 10.4103/pm.pm_81_19; Ambiga S, 2007, ANC SCI LIFE, V26, P45; Sanchez MC, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7080098; Chaniad P., 2016, Songklanakarin Journal of Science and Technology, V38, P229; Chaniad P, 2016, PHARM BIOL, V54, P1077, DOI 10.3109/13880209.2015.1103272; Dey P, 2016, PHARM BIOL, V54, P1474, DOI 10.3109/13880209.2015.1104702; Dioscorea bulbifera L, 2010, DIOSC BULB L; Dunnill C, 2015, INT WOUND J, P14; Fu R, 2013, J ETHNOPHARMACOL, V147, P517, DOI 10.1016/j.jep.2013.03.058; Gadkari PV, 2015, FOOD BIOPROD PROCESS, V93, P122, DOI 10.1016/j.fbp.2013.12.004; Garcia-Aranda MI, 2020, BIOORGAN MED CHEM, V28, DOI 10.1016/j.bmc.2020.115427; Ghosh S, 2012, EVID-BASED COMPL ALT, V2012, P1, DOI 10.1155/2012/929051; Gopalakrishnan A, 2016, INDIAN J EXP BIOL, V54, P187; Harper D, 2014, SURGERY OXFORD, V32, P445, DOI DOI 10.1016/j.mpsur.2014.06.010; Hwang KA, 2019, J CHIN MED ASSOC, V82, P251, DOI 10.1097/JCMA.0000000000000051; Jarbrink K, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0329-y; Jing LL, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0820-3; Kim HH, 2013, ARCH PHARM RES, V36, P1533, DOI 10.1007/s12272-013-0147-x; Lim JS, 2018, J MED FOOD, V21, P1204, DOI 10.1089/jmf.2018.4187; Liu HY, 2018, ONCOTARGET, V9, P2887, DOI 10.18632/oncotarget.20812; Mandal S, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep072; Mbiantcha M, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/912935; Muzolf-Panek M, 2012, EUR FOOD RES TECHNOL, V235, P1001, DOI 10.1007/s00217-012-1826-4; Nagaraja S, 2014, J IMMUNOL, V192, P1824, DOI 10.4049/jimmunol.1302481; Okigbo R, 2009, INT J INTEGR BIOL, P6; Panduraju T., 2010, Journal of Pharmacy Research, V3, P3138; Schmidt CA, 2010, J NAT PROD, V73, P2035, DOI 10.1021/np100523s; Sharifi R, 2013, PHARM BIOL, V51, P298, DOI 10.3109/13880209.2012.721789; Sinno Hani, 2013, Plast Surg Int, V2013, P146764, DOI 10.1155/2013/146764; Sorg H, 2017, EUR SURG RES, V58, P81, DOI 10.1159/000454919; Sudsai T, 2013, J ETHNOPHARMACOL, V150, P223, DOI 10.1016/j.jep.2013.08.038; Takano-Ishikawa Y, 2006, PHYTOMEDICINE, V13, P310, DOI 10.1016/j.phymed.2005.01.016; Thiruvoth FM, 2015, PLAST AESTHET RES, V2, P250, DOI [10.4103/2347-9264.158851, DOI 10.4103/2347-9264.158851]; Treml J, 2016, COMPR REV FOOD SCI F, V15, P720, DOI 10.1111/1541-4337.12204; Wild T, 2010, NUTRITION, V26, P862, DOI 10.1016/j.nut.2010.05.008	36	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243632	10.1371/journal.pone.0243632	http://dx.doi.org/10.1371/journal.pone.0243632			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306733	Green Published, gold			2022-12-27	WOS:000600144200019
J	Drew, DA; Katz, R; Kritchevsky, S; Ix, JH; Shlipak, M; Newman, AB; Hoofnagle, A; Fried, L; Gutierrez, OM; Sarnak, M				Drew, David A.; Katz, Ronit; Kritchevsky, Stephen; Ix, Joachim H.; Shlipak, Michael; Newman, Anne B.; Hoofnagle, Andy; Fried, Linda; Gutierrez, Orlando M.; Sarnak, Mark			Fibroblast growth factor 23 and cognitive impairment: The health, aging, and body composition study	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; VASCULAR RISK-FACTORS; SERUM CREATININE; CYSTATIN-C; INDIVIDUALS; PHOSPHATE; EVENTS; FGF-23; FGF23; TIME	Background Concentrations of fibroblast growth factor 23 (FGF-23), a hormone that regulates phosphorus and vitamin D metabolism, increase as kidney function declines. Excess fibroblast growth factor 23 may impact brain function through promotion of vascular disease or through direct effects on neuronal tissue. Methods In the Healthy Aging and Body Composition Study, a longitudinal observational cohort of well-functioning older adults, intact serum FGF-23 was assayed in 2,738 individuals. Cognitive function was assessed at baseline and longitudinally at years 3, 5, and 8 by administration of the Modified Mini Mental State Examination (3MSE), a test of global cognitive function, and the Digit Symbol Substitution Test (DSST), a test primarily of executive function. The associations between FGF-23 and baseline cognitive function and incident cognitive impairment were evaluated using logistic and Poisson regression respectively, and were adjusted for demographics, baseline estimated glomerular filtration rate (eGFR), urine albumin/creatinine ratio, comorbidity, and other measures of mineral metabolism including soluble klotho. Results The mean (SD) age was 74(3) years, with 51% female, and 39% black. The median (25th, 75th) FGF-23 concentration was 47 pg/mL (37, 60). Three hundred ninety-two individuals had prevalent cognitive impairment by the 3MSE and 461 by the DSST. There was no observed association between FGF-23 and baseline cognitive function for either cognitive test. There were 277 persons with incident cognitive impairment by 3MSE, and 333 persons with incident cognitive impairment by DSST. In fully adjusted models, each two-fold higher concentration of baseline FGF-23 was not associated with incident cognitive impairment by the 3MSE (IRR = 1.02[0.88, 1.19] fully adjusted model) or by the DSST (IRR = 0.98 [0.84, 1.15]. We saw no difference when analyses were stratified by eGFR greater than or less than 60 ml/min/1.73m(2). Conclusion Intact FGF-23 was not associated with baseline cognitive function or incident cognitive impairment in this cohort well-functioning older adults.	[Drew, David A.; Sarnak, Mark] Tufts Med Ctr, Boston, MA 02111 USA; [Katz, Ronit; Hoofnagle, Andy] Univ Washington, Seattle, WA 98195 USA; [Kritchevsky, Stephen] Wake Forest Sch Med, Winston Salem, NC 27101 USA; [Ix, Joachim H.] Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA; [Shlipak, Michael] San Francisco VA Hlth Care Syst, Kidney Hlth Res Collaborat, San Francisco, CA USA; [Shlipak, Michael] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Newman, Anne B.] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA 15260 USA; [Fried, Linda] VA Pittsburgh Healthcare Syst, Pittsburgh, PA USA; [Fried, Linda] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Gutierrez, Orlando M.] Univ Alabama Birmingham, Birmingham, AL USA	Tufts Medical Center; University of Washington; University of Washington Seattle; Wake Forest University; University of California System; University of California San Diego; University of California System; University of California San Francisco; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Alabama System; University of Alabama Birmingham	Drew, DA (corresponding author), Tufts Med Ctr, Boston, MA 02111 USA.	ddrew@tuftsmedicalcenter.org	Katz, Ronit/ABA-1880-2021	Gutierrez, Orlando/0000-0001-6593-3571	Intramural Research Program of National Institutes of Health (NIH); National Institute on Aging (NIA) [N01-AG-6-2101, N01-AG-6-2103, N01-AG-6-2106]; NIA [R01-AG02805, 5R01AG027002-07]; NINR [R01-NR012459]; NIDDK [K23DK105327]; NORC [P30 DK035816];  [K24 DK11042];  [K24DK116180]	Intramural Research Program of National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NORC; ; 	This research was supported in part by the Intramural Research Program of the National Institutes of Health (NIH) and the National Institute on Aging (NIA) Contracts N01-AG-6-2101; N01-AG-6-2103; N01-AG-6-2106; NIA grant R01-AG028050, and NINR grant R01-NR012459. Dr. Drew was supported by NIDDK grant K23DK105327. Drs Shlipak, Sarnak, Ix, and Katz were supported by NIA grant 5R01AG027002-07. Dr. Ix was supported by grant K24 DK110427. Dr. Gutierrez was supported by grant K24DK116180. Dr. Hoofnagle was supported by NORC grant P30 DK035816. The study sponsors had no role in study design; collection, analysis, and interpretation of the data; writing the report; and the decision to submit the report for publication.	Badea AC, 2015, INT MULTI SCI GEOCO, P21; Bouma-de Krijger A, 2014, NEPHROL DIAL TRANSPL, V29, P88, DOI 10.1093/ndt/gft456; BUSCHKE H, 1974, NEUROLOGY, V24, P1019, DOI 10.1212/WNL.24.11.1019; Di Tullio MR, 2003, STROKE, V34, P2380, DOI 10.1161/01.STR.0000089680.77236.60; Drew DA, 2014, HEMODIAL INT, V18, P78, DOI 10.1111/hdi.12100; El-Maouche D, 2016, OSTEOPOROSIS INT, V27, P2345, DOI 10.1007/s00198-016-3543-5; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Ferrari SL, 2005, J CLIN ENDOCR METAB, V90, P1519, DOI 10.1210/jc.2004-1039; Gutierrez OM, 2009, CIRCULATION, V119, P2545, DOI 10.1161/CIRCULATIONAHA.108.844506; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Isakova T, 2011, KIDNEY INT, V79, P1370, DOI 10.1038/ki.2011.47; Ix JH, 2012, J AM COLL CARDIOL, V60, P200, DOI 10.1016/j.jacc.2012.03.040; Jovanovich AJ, 2014, CLIN NEPHROL, V82, pS1, DOI 10.5414/CN108365; Kurella M, 2005, J AM SOC NEPHROL, V16, P2127, DOI 10.1681/ASN.2005010005; McGrath ER, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213321; Ohira T, 2006, STROKE, V37, P2493, DOI 10.1161/01.STR.0000239694.19359.88; Panwar B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165671; ROYALL DR, 1992, J AM GERIATR SOC, V40, P1221, DOI 10.1111/j.1532-5415.1992.tb03646.x; Salthouse TA, 1996, J GERONTOL B-PSYCHOL, V51, pP30, DOI 10.1093/geronb/51B.1.P30; Stevens LA, 2008, AM J KIDNEY DIS, V51, P395, DOI 10.1053/j.ajkd.2007.11.018; Tamura MK, 2011, CLIN J AM SOC NEPHRO, V6, P248, DOI 10.2215/CJN.02660310; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; Teng EL, 1987, CAN J PSYCHIAT, V41, P114; Unverzagt FW, 2011, NEUROLOGY, V77, P1729, DOI 10.1212/WNL.0b013e318236ef23; van Ballegooijen AJ, 2016, J AM SOC NEPHROL, V27, P392, DOI 10.1681/ASN.2014121253; Wechsler D, 2002, WAIS 3 WECHSLER ADUL, V3; Wright CB, 2016, STROKE, V47, P923, DOI 10.1161/STROKEAHA.115.012379; Yaffe K, 2008, ANN NEUROL, V63, P798, DOI 10.1002/ana.21383; Yaffe K, 2010, J AM GERIATR SOC, V58, P338, DOI 10.1111/j.1532-5415.2009.02670.x; Yamashita T, 2000, BIOCHEM BIOPH RES CO, V277, P494, DOI 10.1006/bbrc.2000.3696; Yamazaki Y, 2010, BIOCHEM BIOPH RES CO, V398, P513, DOI 10.1016/j.bbrc.2010.06.110	31	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243872	10.1371/journal.pone.0243872	http://dx.doi.org/10.1371/journal.pone.0243872			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH0WM	33306729	Green Published, gold			2022-12-27	WOS:000600144200014
J	Megersa, BS; Bussmann, H; Barnighausen, T; Muche, AA; Alemu, K; Deckert, A				Megersa, Bikila Soboka; Bussmann, Hermann; Baernighausen, Till; Muche, Achenef Asmamaw; Alemu, Kassahun; Deckert, Andreas			Community cervical cancer screening: Barriers to successful home-based HPV self-sampling in Dabat district, North Gondar, Ethiopia. A qualitative study	PLOS ONE			English	Article							COST-EFFECTIVENESS; WOMEN; PREVENTION; RISK; FACILITATORS; POPULATION; COLLECTION; SPECIMENS; COUNTRIES; ATTITUDES	Objective To explore the barriers to successful home-based human papillomavirus (HPV) self-sampling in North Gondar, Ethiopia. Methods The study participants were women who had previously participated in a community-wide home-based HPV self-sampling pilot study, community health workers, women's development army leaders, and the sample collectors of the home-based HPV self-sampling pilot study. A community based qualitative descriptive study was conducted. We applied purposive and convenience sampling. In total, 47 women participated in the study (in-depth interviews n = 22, four focus group discussions n = 25, 6-7 participants each). The study employed thematic analysis for clustering the emerged themes. Results Husband disapproval was identified as the main barrier to the acceptance of home-based HPV self-sampling. Social influence, lack of knowledge about cervical cancer and screening, lack of health education on cervical cancer and HPV-based screening, feeling healthy, and religious influence were identified as additional barriers. Fear of using Evalyn brush (R) for self-sampling was found to be the main barrier to the provision of a quality sample. The inability of the sample collectors to check the proper utilization of Evalyn brush (R) and the difficulty in understanding the instructions did also contribute to the low-quality. Providing health education concerning cervical cancer and HPV self-sapling to women, male involvement in the screening program, and linking the screening service to existing local health facilities were suggested to guarantee the success of home-based HPV self-sampling. Conclusions Educating women regarding cervical cancer and HPV testing, providing clear instructions on how to collect self-sample, and male involvement in the screening program are prerequisites for a successful implementation of home-based HPV testing. Women empowerment should also be focused to overcome the identified sociocultural barriers. Furthermore, the screening program should guarantee the timely provision of the test results and offering women follow-up examinations and treatment for abnormal findings.	[Megersa, Bikila Soboka; Baernighausen, Till; Deckert, Andreas] Heidelberg Univ, Heidelberg Inst Global Hlth, Heidelberg, Germany; [Bussmann, Hermann] Heidelberg Univ, Inst Pathol, Dept Appl Tumor Biol, Heidelberg, Germany; [Muche, Achenef Asmamaw; Alemu, Kassahun] Univ Gondar, Inst Publ Hlth, Dept Epidemiol & Biostat, Gondar, Ethiopia	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Gondar	Megersa, BS (corresponding author), Heidelberg Univ, Heidelberg Inst Global Hlth, Heidelberg, Germany.	bikila070@gmail.com		Soboka, Bikila/0000-0002-7227-9560; Muche, Achenef/0000-0001-7971-3537	Open Society Foundation; Baden-Wurttemberg Ministry of Science, Research and the Arts; Ruprecht-Karls-Universitat Heidelberg	Open Society Foundation; Baden-Wurttemberg Ministry of Science, Research and the Arts; Ruprecht-Karls-Universitat Heidelberg	The project was funded by the Open Society Foundation as part of the Civil Society Leadership Award for a master thesis to BSM. In addition, we acknowledge financial support by the Baden-Wurttemberg Ministry of Science, Research and the Arts and by Ruprecht-Karls-Universitat Heidelberg.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate S. M., 2015, GYNECOLOGY OBSTET TR, DOI [10.4172/2161-0932.S3, DOI 10.4172/2161-0932.S3]; Abiodun OA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-814; Allen-Leigh B, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3723-5; Anaman-Torgbor JA, 2017, EUR J ONCOL NURS, V31, P22, DOI 10.1016/j.ejon.2017.09.005; Arbyn M, 2012, VACCINE, V30, pF88, DOI 10.1016/j.vaccine.2012.06.095; Austad K, 2018, J GLOB ONCOL, V4, DOI 10.1200/JGO.17.00228; Aweke YH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181415; Ayres L, 2007, J WOUND OSTOMY CONT, V34, P131, DOI 10.1097/01.WON.0000264823.57743.5f; Bayu H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149908; BERHANE Y, 2006, ETHIOP J HLTH DEV, V0020, P00135; Birhanu Z, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-83; Boyce CNP., 2006, PATHFINDER INT TOOL; Brandt T, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7354-4; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, https://doi.org/10.1191/1478088706qp063oa, 10.1191/1478088706qp063oa]; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Broquet C, 2015, AFR HEALTH SCI, V15, P755, DOI 10.4314/ahs.v15i3.8; Bruni L, 2019, HUMAN PAPILLIMAVIRUS; Bruni L AG, 2018, HUMAN PAPILLOMAVIRUS, P17; Burger EA, 2017, CANCER EPIDEM BIOMAR, V26, P95, DOI 10.1158/1055-9965.EPI-16-0350; Campos NG, 2017, HEALTH POLICY PLANN, V32, P956, DOI 10.1093/heapol/czw182; Catarino R, 2015, WORLD J CLIN ONCOL, V6, P281, DOI 10.5306/wjco.v6.i6.281; Crofts V, 2015, INT J WOMENS HEALTH, V7, P149, DOI 10.2147/IJWH.S56307; Dareng EO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141679; Defo VF, 2020, AMA J ETHICS, V22, P116; Domgue JF, 2020, INT J CANCER, V147, P128, DOI 10.1002/ijc.32746; Domgue JF, 2017, J GLOB ONCOL, V4, DOI 10.1200/JGO.17.00048; Duggleby W, 2005, QUAL HEALTH RES, V15, P832, DOI 10.1177/1049732304273916; Duke P, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0206-1; Ethiopian Federal Ministry of Health, 2015, NAT CANC CONTR PLAN; Etikan I., 2016, AM J THEORETICAL APP, V5, P1, DOI [10.11648/j.ajtas.20160501.11, DOI 10.11648/J.AJTAS.20160501.11]; Fall NS, 2019, AM J TROP MED HYG, V100, P1552, DOI 10.4269/ajtmh.19-0045; Olaza-Maguina AF, 2019, ECANCERMEDICALSCIENC, V13, DOI 10.3332/ecancer.2019.901; Fitzpatrick MB, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6810-5; Garrett JJ, 2013, CULT HEALTH SEX, V15, P637, DOI 10.1080/13691058.2012.760206; Gelibo T, 2017, J ONCOL RES TREAT, V2, P115; Geremew AB, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0471-1; Getachew S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216522; Getahun F, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-2; Gizaw M, 2019, CANCER PREV RES, V12, P609, DOI 10.1158/1940-6207.CAPR-19-0156; Glanz K., 2008, HLTH BEHAV HLTH ED T; Gravitt PE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013711; Guvenc G, 2011, J ADV NURS, V67, P428, DOI 10.1111/j.1365-2648.2010.05450.x; Habtu Y, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4203-2; Hernández- Márquez Clara I, 2014, Rev. salud pública, V16, P697, DOI 10.15446/rsap.v16n5.30071; Huynh J, 2010, J LOW GENIT TRACT DI, V14, P356, DOI 10.1097/LGT.0b013e3181dc115b; Jede F, 2020, PAPILLOMAVIRUS RES, V9, DOI 10.1016/j.pvr.2020.100198; Johnson CE, 2008, J LOW GENIT TRACT DI, V12, P232, DOI 10.1097/LGT.0b013e31815d8d88; Kabalika Chiluba, 2018, Int J MCH AIDS, V7, P17, DOI 10.21106/ijma.223; Lazcano-Ponce E, 2011, LANCET, V378, P1868, DOI 10.1016/S0140-6736(11)61522-5; Legard R., 2003, QUALITATIVE RES PRAC, P138, DOI DOI 10.1080/09687637.2016.1189876; Lehmann U, 2007, STATE EVIDENCE PROGR, P1; Lyimo FS, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-22; Maes K, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5159-5; Malone C, 2020, PREV MED, V132, DOI 10.1016/j.ypmed.2019.105953; Marlow LAV, 2015, J FAM PLAN REPROD H, V41, P248, DOI 10.1136/jfprhc-2014-101082; Mayrand M, 2007, NEW ENGL J MED, V357, P1579, DOI 10.1056/NEJMoa071430; Mbachu C, 2017, BMC WOMENS HEALTH, V17, DOI 10.1186/s12905-017-0399-6; Medhanyie A, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-352; Memirie ST, 2018, J GLOB ONCOL, V4, DOI 10.1200/JGO.17.00175; Mesafint Z, 2018, ETHIOP J HEALTH SCI, V28, P111, DOI 10.4314/ejhs.v28i2.2; Mezei AK, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020484; Mezei AK, 2017, INT J CANCER, V141, P437, DOI 10.1002/ijc.30695; Mitchell S, 2011, INT J GYNECOL OBSTET, V114, P111, DOI 10.1016/j.ijgo.2011.01.028; Mitiku I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163136; Modibbo F, 2017, INFECT AGENTS CANCER, V12, DOI 10.1186/s13027-017-0123-z; Modibbo FI, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-008533; Morse JM, 2000, DETERMINING SAMPLE S; Ndikom CM, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-11; Nega AD, 2018, BMC WOMENS HEALTH, V18, DOI 10.1186/s12905-018-0579-z; Ngugi CW, 2012, HEALTH CARE WOMEN IN, V33, P595, DOI 10.1080/07399332.2011.646367; Olaniran A, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1272223; Penaranda E, 2015, J LOW GENIT TRACT DI, V19, P323, DOI 10.1097/LGT.0000000000000134; Racey CS, 2016, J RURAL HEALTH, V32, P136, DOI 10.1111/jrh.12136; Ritchie J., 2013, QUALITATIVE RES PRAC; Ronco G, 2014, LANCET, V383, P524, DOI 10.1016/S0140-6736(13)62218-7; Sankaranarayanan R, 2014, ANN GLOB HEALTH, V80, P412, DOI 10.1016/j.aogh.2014.09.014; Snijders PJF, 2013, INT J CANCER, V132, P2223, DOI 10.1002/ijc.27790; Sudenga SL, 2013, INT J GYNECOL CANCER, V23, P895, DOI 10.1097/IGC.0b013e31828e425c; Tamalet C, 2013, CLIN MICROBIOL INFEC, V19, pE44, DOI 10.1111/1469-0691.12063; WHO, 2013, WHO GUID SCREEN TREA; World Health Organization Africa, 2018, ETH LAUNCH HUM PAP V; Bosch FX, 2013, VACCINE, V31, pH1, DOI [10.1016/j.vaccine.2013.10.003, 10.1016/j.vaccine.2013.07.026]; Yang H, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-026413; Yitbarek K, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-025937	84	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243036	10.1371/journal.pone.0243036	http://dx.doi.org/10.1371/journal.pone.0243036			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH0WM	33306681	gold, Green Published			2022-12-27	WOS:000600144200013
J	Prathapan, S; Fernando, GVMC; Matthias, AT; Charuni, YBMA; Abeygunawardhana, HMG; Somathilake, BGGK				Prathapan, Shamini; Fernando, Gunasekara Vidana Mestrige Chamath; Matthias, Anne Thushara; Charuni, Yashodara Bentota Mallawa Arachchige; Abeygunawardhana, Herath Mudiyanselage Gayan; Somathilake, Batheegama Gamarachchige Gayasha Kavindi			The rising complexity and burden of multimorbidity in a middle-income country	PLOS ONE			English	Article							PRIMARY-CARE; OLDER; EPIDEMIOLOGY	Background The limited knowledge on aetiology, epidemiology and risk factors for multimorbidity especially evident from low and middle-income countries curtail the development and implementation of sustainable healthcare models. Sri Lanka, boasting for one of South Asia's most efficient public health systems that is accessible free-of-charge by the citizens is presently transitioning from lower-middle to upper-middle-income tier. Faced with the triple burden of disease, it is imperative for Sri Lanka to incorporate an integrated model to manage multimorbidity. Methods A descriptive cross-sectional study was carried out in medical clinics of a tertiary care hospital and a University primary care department. Data were extracted on to a form from the clinical records of patients over the age of 20 years with at least one non-communicable disease (NCD) and analysed. Results Multimorbidity was present among 64.1% of patients (n = 1600). Nearly 44.44% of the patients aged 20-35 years have a minimum of two disorders, and by the time they reach 50 years, nearly 64% of the patients have two or more non-communicable diseases. Nearly 7% of those aged over 65 years were diagnosed with four or more disorders. A fourth of the sample was affected by co-morbid diabetes mellitus and hypertension, whereas the combinations of coronary heart disease with hypertension and diabetes mellitus were also found to be significantly prevalent. A salient revelation of the binomial logistic regression analysis was that the number of disorders was positively correlated to the presence of mental disorders 7.25 (95% CI = 5.82-8.68). Conclusion Multimorbidity is highly prevalent among this population and seemingly has a detrimental effect on the psychological wellbeing of those affected. Therefore, the need for horizontal integration of all primary to tertiary care disciplines, including mental health, to manage multimorbidity by policymakers is emphasized as a priority task.	[Prathapan, Shamini] Univ Sri Jayewardenepura, Fac Med Sci, Dept Community Med, Nugegoda, Sri Lanka; [Fernando, Gunasekara Vidana Mestrige Chamath; Somathilake, Batheegama Gamarachchige Gayasha Kavindi] Univ Sri Jayewardenepura, Natl Ctr Primary Care & Allergy Res, Nugegoda, Sri Lanka; [Fernando, Gunasekara Vidana Mestrige Chamath; Abeygunawardhana, Herath Mudiyanselage Gayan] Univ Sri Jayewardenepura, Fac Med Sci, Dept Family Med, Nugegoda, Sri Lanka; [Matthias, Anne Thushara; Charuni, Yashodara Bentota Mallawa Arachchige] Univ Sri Jayewardenepura, Fac Med Sci, Dept Med, Nugegoda, Sri Lanka	University Sri Jayewardenepura; University Sri Jayewardenepura; University Sri Jayewardenepura; University Sri Jayewardenepura	Fernando, GVMC (corresponding author), Univ Sri Jayewardenepura, Natl Ctr Primary Care & Allergy Res, Nugegoda, Sri Lanka.; Fernando, GVMC (corresponding author), Univ Sri Jayewardenepura, Fac Med Sci, Dept Family Med, Nugegoda, Sri Lanka.	chemetf@sjp.ac.lk	FERNANDO, GVM CHAMATH/L-8729-2018	FERNANDO, GVM CHAMATH/0000-0003-2689-7306				Afshar S, 2017, APPL DEMOG SER, V8, P381, DOI 10.1007/978-3-319-43688-3_21; Agrawal Sutapa, 2016, Int J Med Public Health, V6, P73, DOI 10.5530/ijmedph.2016.2.5; [Anonymous], 2017, IDF DIABETES ATLAS; [Anonymous], 2019, CANC DISCOV, V9, pOF3, DOI 10. 1158/2159-8290. CD-NB2018-158; Arokiasamy P, 2013, MULTIPLE CHRONIC DIS; Arokiasamy P, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0402-8; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Bell SP, 2016, CLIN GERIATR MED, V32, P215, DOI 10.1016/j.cger.2016.01.013; Cardiovascular Disease and Risk Management, 2019, DIABETES CARE, V2, pS103, DOI 10.2337/dc19-S010; Chen FM, AM BOARD FAM MED, DOI [10.3122/jabfm.18.6.449, DOI 10.3122/JABFM.18.6.449]; Ebrahim S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000268; Fabbri E, 2015, J AM MED DIR ASSOC, V16, P640, DOI 10.1016/j.jamda.2015.03.013; Feng L, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-030584; Goryakin Y, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238565; Johnston MC, 2019, EUR J PUBLIC HEALTH, V29, P182, DOI 10.1093/eurpub/cky098; Joshi K, 2003, INT J EPIDEMIOL, V32, P978, DOI 10.1093/ije/dyg204; Long AN, 2011, J CLIN HYPERTENS, V13, P244, DOI 10.1111/j.1751-7176.2011.00434.x; Lyness JM, 2006, PSYCHOSOMATICS, V47, P435, DOI 10.1176/appi.psy.47.5.435; Navickas Rokas, 2016, J Comorb, V6, P4, DOI 10.15256/joc.2016.6.72; Panagioti M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135947; Pati S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183966; Pati S, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007235; Phillips RL, 2004, QUAL SAF HEALTH CARE, V13, P121, DOI 10.1136/qshc.2003.008029; Quinones AR, 2019, J GEN INTERN MED, V34, P944, DOI 10.1007/s11606-019-04896-w; Shaw J, PRACTICE PZ D RES CL; Singh K, 2019, J PUBLIC HEALTH-UK, V41, P80, DOI 10.1093/pubmed/fdy017; Taylor AW, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-718; Violan C, PREVALENCE DETERMINA; Whitty CJM, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.l6964; World Health Statistics Overview, 2019, WHODAD20191 WHO; Yarnall AJ, 2017, AGE AGEING, V46, P882, DOI 10.1093/ageing/afx150	31	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243614	10.1371/journal.pone.0243614	http://dx.doi.org/10.1371/journal.pone.0243614			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306724	Green Published, gold			2022-12-27	WOS:000600144200056
J	Shearer, TR; Hwang, TS; Steinkamp, PN; Azuma, M				Shearer, Thomas R.; Hwang, Thomas S.; Steinkamp, Peter N.; Azuma, Mitsuyoshi			Segmenting OCT for detecting drug efficacy in CRAO	PLOS ONE			English	Article							RETINAL ARTERY-OCCLUSION; NERVE-FIBER LAYER; INDUCED PROTEOLYSIS; THICKNESS	Purpose Thinning of the inner layers of the retina occurs in patients with central retinal artery occlusion (CRAO). The mechanism for such thinning may be partially due to proteolysis by a calcium-activated protease called calpain. Calpain inhibitor SNJ-1945 ameliorated the proteolysis in a past series of model experiments. The purposes of the present retrospective study were to: 1) use segmentation analysis of optical coherence tomography (OCT) images to mathematically model the loss of specific retinal layers in CRAO patients, and 2) predict the number of patients and days of observation needed for clinical trials of inhibitors against CRAO. Methods A retrospective case control study was conducted by computer-aided search for CRAO (ICD10 H43.1) with at least one OCT procedure (CPT: 92134) in the OHSU Epic patient data base. Results After initial swelling, thinning of the inner retinal layers, especially the ganglion cell (GCL) layer followed exponential decay curves. Using sample size statistics and GCL thickness as a marker in a 30-day clinical trial, 19 eyes/group could theoretically detect a 20% beneficial effect of an inhibitor against CRAO. Other markers, such as the whole retinal thickness and combined inner layers could also be used as less-specific markers. Conclusions Using thickness changes in the GCL layer to monitor the efficacy of potential inhibitors against CRAO is practical in human trials requiring a reasonable number of patients and relatively short trial period. Translational relevance Measurement of GCL thickness would be a useful indicator of CRAO progression in a clinical trial of putative inhibitors.	[Shearer, Thomas R.] Oregon Hlth & Sci Univ, Dept Integrat Biomed & Diagnost Sci, Portland, OR 97201 USA; [Hwang, Thomas S.; Steinkamp, Peter N.] OHSU, Dept Ophthalmol, Portland, OR USA; [Azuma, Mitsuyoshi] Senju Lab Ocular Sci, Portland, OR USA	Oregon Health & Science University; Oregon Health & Science University	Shearer, TR (corresponding author), Oregon Hlth & Sci Univ, Dept Integrat Biomed & Diagnost Sci, Portland, OR 97201 USA.	shearert@ohsu.edu		Shearer, Thomas/0000-0002-1123-0878	Senju Pharmaceutical Co. [GSODO0069A]	Senju Pharmaceutical Co.	This research was supported in part by contract #GSODO0069A from Senju Pharmaceutical Co. to TRS. TRS, TSH and PNS are paid consultants for Senju Pharmaceutical Co., Ltd. Additionally, funding for this study is provided by Senju Pharmaceutical Co., Ltd in the form of salary for MA. The specific roles of these authors are articulated in the `author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Ahn SJ, 2015, AM J OPHTHALMOL, V159, P667, DOI 10.1016/j.ajo.2015.01.001; Azuma M, 2014, CURR EYE RES, V39, P421, DOI 10.3109/02713683.2013.845225; Chen HY, 2015, SCI REP-UK, V5, DOI 10.1038/srep09269; Ding SLS, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081406; Farris W, CENTRAL RETINAL ARTE; Fraser SG, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001989.pub2; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Hayreh SS, 2005, AM J OPHTHALMOL, V140, P376, DOI 10.1016/j.ajo.2005.03.038; Hirata M, 2015, INVEST OPHTH VIS SCI, V56, P6049, DOI 10.1167/iovs.15-17360; Ikeda F, 2010, JPN J OPHTHALMOL, V54, P423, DOI 10.1007/s10384-010-0841-x; Invernizzi A, 2018, OPHTHALMOL RETINA, V2, P808, DOI 10.1016/j.oret.2017.12.012; Nieves-Moreno M, 2018, TRANSL VIS SCI TECHN, V7, DOI 10.1167/tvst.7.1.20; Oka T, 2006, J NEUROSCI RES, V83, P1342, DOI 10.1002/jnr.20827; Paquet-Durand F, 2007, J NEUROSCI RES, V85, P693, DOI 10.1002/jnr.21151; Sakamoto Y, 2000, CURR EYE RES, V21, P571, DOI 10.1076/0271-3683(200007)21:1;1-Z;FT571; Shin HJ, 2014, INVEST OPHTH VIS SCI, V55, P2403, DOI 10.1167/iovs.13-13769; Shinoda K, 2008, GRAEF ARCH CLIN EXP, V246, P949, DOI 10.1007/s00417-008-0791-x; Sim S, DIAGNOSIS MANAGEMENT; Varma DD, 2013, EYE, V27, P688, DOI 10.1038/eye.2013.25; Zar JH, 1974, BIOSTATISTICAL ANAL, V5th, P147	21	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0242920	10.1371/journal.pone.0242920	http://dx.doi.org/10.1371/journal.pone.0242920			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306701	gold, Green Published, Green Submitted			2022-12-27	WOS:000600144200057
J	Megreya, AM; Latzman, RD				Megreya, Ahmed M.; Latzman, Robert D.			Individual differences in emotion regulation and face recognition	PLOS ONE			English	Article							WORKING-MEMORY; UNFAMILIAR FACES; DEVELOPMENTAL PROSOPAGNOSIA; EYEWITNESS IDENTIFICATION; REGULATION QUESTIONNAIRE; SEX-DIFFERENCES; PERSONALITY; PERFORMANCE; ABILITY; CONSEQUENCES	Face recognition ability is highly variable among neurologically intact populations. Across three experiments, this study examined for the first time associations between individual differences in a range of adaptive versus maladaptive emotion regulation strategies and face recognition. Using an immediate face-memory paradigm, in which observers had to identify a self-paced learned unfamiliar face from a 10-face target-present/ target-absent line-up, Experiment 1 (N = 42) found high levels of expressive suppression (the ongoing efforts to inhibit emotion-expressive behaviors), but not cognitive reappraisal (the cognitive re-evaluation of emotional events to change their emotional consequences), were associated with a lower level of overall face-memory accuracy and higher rates of misidentifications and false positives. Experiment 2 (N = 53) replicated these finding using a range of face-matching tasks, where observers were asked to match pairs of same-race or different-race face images taken on the same day or during different times. Once again, high levels of expressive suppression were associated with a lower level of overall face-matching performance and higher rates of false positives, but cognitive reappraisal did not correlate with any face-matching measure. Finally, Experiment 3 (N = 52) revealed that the higher use of maladaptive cognitive emotion regulation strategies, especially catastrophizing, was associated with lower levels of overall face-matching performances and higher rates of false positives. All told, the current research provides new evidence concerning the important associations between emotion and cognition.	[Megreya, Ahmed M.] Qatar Univ, Coll Educ, Dept Psychol Sci, Doha, Qatar; [Latzman, Robert D.] Georgia State Univ, Dept Psychol, Univ Plaza, Atlanta, GA 30303 USA	Qatar University; University System of Georgia; Georgia State University	Megreya, AM (corresponding author), Qatar Univ, Coll Educ, Dept Psychol Sci, Doha, Qatar.	amegreya@qu.edu.qa		Megreya, Ahmed/0000-0002-5530-5202	UREP grant from the Qatar national research fund (Qatar foundation) [UREP26-008-5-003]	UREP grant from the Qatar national research fund (Qatar foundation)	This report was made possible by an UREP grant #(UREP26-008-5-003) from the Qatar national research fund (a member of Qatar foundation) to Professor Ahmed M. Megreya. The statements made herein are solely the responsibility of the authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldao A, 2010, CLIN PSYCHOL REV, V30, P217, DOI 10.1016/j.cpr.2009.11.004; [Anonymous], 2010, CONSTITUTIONAL COURT, V3, P295; Bate S, 2010, PERS INDIV DIFFER, V48, P239, DOI 10.1016/j.paid.2009.10.005; Bindemann M, 2012, J APPL RES MEM COGN, V1, P96, DOI 10.1016/j.jarmac.2012.02.001; Bindemann M, 2012, J EXP PSYCHOL-APPL, V18, P277, DOI 10.1037/a0029635; Blair KS, 2007, NEUROIMAGE, V35, P430, DOI 10.1016/j.neuroimage.2006.11.048; Bobak AK, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01378; BOTHWELL RK, 1987, J SOC BEHAV PERS, V2, P335; BRIGHAM JC, 1983, BASIC APPL SOC PSYCH, V4, P279, DOI 10.1207/s15324834basp0403_6; Bruce V, 1999, J EXP PSYCHOL-APPL, V5, P339, DOI 10.1037/1076-898X.5.4.339; Burton AM, 2010, BEHAV RES METHODS, V42, P286, DOI 10.3758/BRM.42.1.286; Butler EA, 2003, EMOTION, V3, P48, DOI 10.1037/1528-3542.3.1.48; Cheung CHM, 2010, SOC NEUROSCI-UK, V5, P351, DOI 10.1080/17470911003597377; Davis JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028800; Deffenbacher KA, 2004, LAW HUMAN BEHAV, V28, P687, DOI 10.1007/s10979-004-0565-x; Dennett HW, 2012, BEHAV RES METHODS, V44, P587, DOI 10.3758/s13428-011-0160-2; Druzgal TJ, 2003, J COGNITIVE NEUROSCI, V15, P771, DOI 10.1162/089892903322370708; Druzgal TJ, 2001, COGNITIVE BRAIN RES, V10, P355, DOI 10.1016/S0926-6410(00)00056-2; Garnefski N, 2001, PERS INDIV DIFFER, V30, P1311, DOI 10.1016/S0191-8869(00)00113-6; Garnefski N., 2002, CERQ MANUAL USE COGN; Garnefski N, 2007, EUR J PSYCHOL ASSESS, V23, P141, DOI 10.1027/1015-5759.23.3.141; Germine LT, 2011, COGNITION, V118, P201, DOI 10.1016/j.cognition.2010.11.002; Gratz KL, 2004, J PSYCHOPATHOL BEHAV, V26, P41, DOI 10.1023/B:JOBA.0000007455.08539.94; Gross J. J., 2014, HDB EMOTION REGULATI, P3, DOI DOI 10.1080/00140130600971135; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Gross JJ, 1998, J PERS SOC PSYCHOL, V74, P224, DOI 10.1037/0022-3514.74.1.224; Gross JJ, 2001, CURR DIR PSYCHOL SCI, V10, P214, DOI 10.1111/1467-8721.00152; Hills PJ, 2019, ACTA PSYCHOL, V196, P118, DOI 10.1016/j.actpsy.2019.04.012; Jackson MC, 2008, J EXP PSYCHOL HUMAN, V34, P556, DOI 10.1037/0096-1523.34.3.556; Kanwisher N, 2000, NAT NEUROSCI, V3, P759, DOI 10.1038/77664; Kappas A, 2011, EMOT REV, V3, P17, DOI 10.1177/1754073910380971; Kivity Y, 2019, COGNITION EMOTION, V33, P213, DOI 10.1080/02699931.2018.1446414; Kokje E, 2018, ACTA PSYCHOL, V185, P13, DOI 10.1016/j.actpsy.2018.01.006; Kraaij V, 2019, PERS INDIV DIFFER, V137, P56, DOI 10.1016/j.paid.2018.07.036; Kress T, 2003, BEHAV NEUROL, V14, P109, DOI 10.1155/2003/520476; Lander K, 2018, COGN RES, V3, DOI 10.1186/s41235-018-0115-6; Lander K, 2015, Q J EXP PSYCHOL, V68, P1769, DOI 10.1080/17470218.2014.988737; Leigh E, 2018, CLIN CHILD FAM PSYCH, V21, P388, DOI 10.1007/s10567-018-0258-5; Lewin C, 2002, BRAIN COGNITION, V50, P121, DOI 10.1016/S0278-2626(02)00016-7; Marceau EM, 2018, DRUG ALCOHOL DEPEN, V182, P58, DOI 10.1016/j.drugalcdep.2017.10.008; McCaffery JM, 2018, COGN RES, V3, DOI 10.1186/s41235-018-0112-9; McRae K, 2012, J RES PERS, V46, P2, DOI 10.1016/j.jrp.2011.10.003; Megreya AM, 2007, PERCEPT PSYCHOPHYS, V69, P1175, DOI 10.3758/BF03193954; Megreya AM, 2006, MEM COGNITION, V34, P865, DOI 10.3758/BF03193433; Megreya AM, 2018, MOTIV EMOTION, V42, P566, DOI 10.1007/s11031-018-9682-6; Megreya AM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193455; Megreya AM, 2018, PEERJ, V6, DOI 10.7717/peerj.4437; Megreya AM, 2016, J CROSS CULT PSYCHOL, V47, P875, DOI 10.1177/0022022116644785; Megreya AM, 2013, APPL COGNITIVE PSYCH, V27, P700, DOI 10.1002/acp.2965; Megreya AM, 2013, J COGN PSYCHOL, V25, P30, DOI 10.1080/20445911.2012.739153; Megreya AM, 2012, BRIT J PSYCHOL, V103, P439, DOI 10.1111/j.2044-8295.2011.02084.x; Megreya AM, 2012, APPL COGNITIVE PSYCH, V26, P308, DOI 10.1002/acp.1826; Megreya AM, 2011, Q J EXP PSYCHOL, V64, P1473, DOI 10.1080/17470218.2011.575228; Megreya AM, 2011, ACTA PSYCHOL, V137, P83, DOI 10.1016/j.actpsy.2011.03.003; Megreya AM, 2009, PERCEPTION, V38, P1831, DOI 10.1068/p6385; Megreya AM, 2008, J EXP PSYCHOL-APPL, V14, P364, DOI 10.1037/a0013464; Megreyal AM, 2015, PERCEPTION, V44, P5, DOI 10.1068/p7825; Mobini S, 2013, COGNITIVE THER RES, V37, P173, DOI 10.1007/s10608-012-9445-8; MUELLER JH, 1979, BRIT J PSYCHOL, V70, P511, DOI 10.1111/j.2044-8295.1979.tb01724.x; NOWICKI S, 1979, J RES PERS, V13, P460, DOI 10.1016/0092-6566(79)90008-4; Noyes E., 2017, FACE PROCESSING SYST, P173; Pessoa L, 2008, NAT REV NEUROSCI, V9, P148, DOI 10.1038/nrn2317; Pozzulo JD, 2007, PERS INDIV DIFFER, V43, P1656, DOI 10.1016/j.paid.2007.05.001; Ramon M, 2019, BRIT J PSYCHOL, V110, P461, DOI 10.1111/bjop.12368; Rehnman J, 2006, MEMORY, V14, P289, DOI 10.1080/09658210500233581; Richards JM, 2000, J PERS SOC PSYCHOL, V79, P410, DOI 10.1037//0022-3514.79.3.410; Robertson DJ, 2020, APPL COGNITIVE PSYCH, V34, P205, DOI 10.1002/acp.3608; ROSE SA, 1995, DEV PSYCHOL, V31, P685, DOI 10.1037/0012-1649.31.4.685; Rose SA, 2003, DEV PSYCHOL, V39, P563, DOI 10.1037/0012-1649.39.3.563; Saito Takako, 2005, Shinrigaku Kenkyu, V75, P517; Schmeichel BJ, 2008, J PERS SOC PSYCHOL, V95, P1526, DOI 10.1037/a0013345; Schweizer S, 2013, J NEUROSCI, V33, P5301, DOI 10.1523/JNEUROSCI.2593-12.2013; Stacchi L, 2020, COGN RES, V5, DOI 10.1186/s41235-019-0205-0; Susilo T, 2013, CURR OPIN NEUROBIOL, V23, P423, DOI 10.1016/j.conb.2012.12.011; Thompson RA, 2011, EMOT REV, V3, P53, DOI 10.1177/1754073910380969; THOMPSON WB, 1984, BRAIN COGNITION, V3, P239, DOI 10.1016/0278-2626(84)90019-8; Towler A, 2017, J EXP PSYCHOL-APPL, V23, P47, DOI 10.1037/xap0000108; TROUVE RJ, 1992, AM J PSYCHOL, V105, P417, DOI 10.2307/1423196; Valentine T, 2009, APPL COGNITIVE PSYCH, V23, P151, DOI 10.1002/acp.1463; Verhallen RJ, 2017, VISION RES, V141, P217, DOI 10.1016/j.visres.2016.12.014; WARD RA, 1985, J GEN PSYCHOL, V112, P191, DOI 10.1080/00221309.1985.9711003; White D, 2014, PSYCHON B REV, V21, P100, DOI 10.3758/s13423-013-0475-3; Wilhelm O, 2010, J PERS SOC PSYCHOL, V99, P530, DOI 10.1037/a0019972; Wilmer JB, 2017, CURR DIR PSYCHOL SCI, V26, P225, DOI 10.1177/0963721417710693; Wilmer JB, 2010, P NATL ACAD SCI USA, V107, P5238, DOI 10.1073/pnas.0913053107; WOODHEAD MM, 1981, MEM COGNITION, V9, P368, DOI 10.3758/BF03197561; Xiu LC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31495-2; Xiu LC, 2016, PHYSIOL BEHAV, V155, P25, DOI 10.1016/j.physbeh.2015.12.004; Xu BY, 2017, J COGNITIVE NEUROSCI, V29, P1368, DOI 10.1162/jocn_a_01126; Yovel G, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00562	90	0	0	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243209	10.1371/journal.pone.0243209	http://dx.doi.org/10.1371/journal.pone.0243209			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH0WB	33301521	Green Published, gold			2022-12-27	WOS:000600143100088
J	Chimoyi, L; Velen, K; Churchyard, GJ; Wallis, R; Lewis, JJ; Charalambous, S				Chimoyi, Lucy; Velen, Kavindhran; Churchyard, Gavin J.; Wallis, Robert; Lewis, James J.; Charalambous, Salome			An ecological study to evaluate the association of Bacillus Calmette-Guerin (BCG) vaccination on cases of SARS-CoV2 infection and mortality from COVID-19	PLOS ONE			English	Article							CANCER	As the SARS-CoV2 pandemic has progressed, there have been marked geographical differences in the pace and extent of its spread. We evaluated the association of BCG vaccination on morbidity and mortality of SARS-CoV2, adjusted for country-specific responses to the epidemic, demographics and health. SARS-CoV2 cases and deaths as reported by 31 May 2020 in the World Health Organization situation reports were used. Countries with at least 28 days following the first 100 cases, and available information on BCG were included. We used log-linear regression models to explore associations of cases and deaths with the BCG vaccination policy in each country, adjusted for population size, gross domestic product, proportion aged over 65 years, stringency level measures, testing levels, smoking proportion, and the time difference from date of reporting the 100th case to 31 May 2020. We further looked at the association that might have been found if the analyses were done at earlier time points. The study included 97 countries with 73 having a policy of current BCG vaccination, 13 having previously had BCG vaccination, and 11 having never had BCG vaccination. In a log-linear regression model there was no effect of country-level BCG status on SARS-CoV2 cases or deaths. Univariable log-linear regression models showed a trend towards a weakening of the association over time. We found no statistical evidence for an association between BCG vaccination policy and either SARS-CoV2 morbidity or mortality. We urge countries to rather consider alternative tools with evidence supporting their effectiveness for controlling SARS-CoV2 morbidity and mortality.	[Chimoyi, Lucy; Velen, Kavindhran; Churchyard, Gavin J.; Wallis, Robert; Charalambous, Salome] Aurum Inst, Johannesburg, South Africa; [Velen, Kavindhran] Univ Sydney, Fac Med & Hlth, Cent Clin Sch, Sydney Sch Med, Sydney, NSW, Australia; [Churchyard, Gavin J.; Charalambous, Salome] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Lewis, James J.] Cardiff Univ, Sch Social Sci, Publ Serv Innovat Lab Wales, Lab Y, Cardiff, S Glam, Wales	University of Sydney; University of Witwatersrand; Cardiff University	Chimoyi, L (corresponding author), Aurum Inst, Johannesburg, South Africa.	lchimoyi@auruminstitute.org	Wallis, Robert S./A-8018-2009	Wallis, Robert S./0000-0001-6152-5183; Velen, Kavindhran/0000-0001-8577-3915; Chimoyi, Lucy/0000-0002-0083-8319; Charalambous, Salome/0000-0001-7143-1009	MRC [MR/K007467/1] Funding Source: UKRI; Medical Research Council [MR/K007467/1] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		[Anonymous], 2017, DATABASE GLOBAL BCG; [Anonymous], GLOB TUB REP; Arlehamn CSL, 2020, P NATL ACAD SCI USA, V117, P25203, DOI 10.1073/pnas.2016733117; de Chaisemartin C, 2021, CLIN INFECT DIS, V72, pE501, DOI 10.1093/cid/ciaa1223; Ebina-Shibuya R, 2020, RESPIROLOGY, DOI [10.1111/resp.13885, DOI 10.1111/RESP.1388532558034]; ECDC, 2020, TUB REC VACC 2020; Environmental Systems Research Institute, 2019, ARCGIS REL 10 7 1; Hamiel U, 2020, JAMA-J AM MED ASSOC, V323, P2340, DOI 10.1001/jama.2020.8189; Miller A, 2020, CORRELATION UNIVERSA; Miyasaka M, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.202012661; Moorlag SJCFM, 2019, CLIN MICROBIOL INFEC, V25, P1473, DOI 10.1016/j.cmi.2019.04.020; Nemes E, 2018, NEW ENGL J MED, V379, P138, DOI [10.1056/NEJMoa1714021, 10.1056/nejmoa1714021]; Pai M., BCG CORONAVIRUS LESS; Redelman-Sidi G, 2014, NAT REV UROL, V11, P153, DOI 10.1038/nrurol.2014.15; Ricco Matteo, 2020, Acta Biomed, V91, P207, DOI 10.23750/abm.v91i2.9700; Sala G, 2020, ASS BCG VACCINATION; Schaaf HS, 2020, INT J TUBERC LUNG D, V24, P732, DOI 10.5588/ijtld.20.0267; Shann F, 2013, CLIN THER, V35, P109, DOI 10.1016/j.clinthera.2013.01.007; Shann F, 2010, ARCH DIS CHILD, V95, P662, DOI 10.1136/adc.2009.157537; Shet A, 2020, DIFFERENTIAL COVID 1; StataCorp, 2014, REL 15; Thomas H., OXFORD COVID 19 GOVT; Tian JB, 2020, LANCET ONCOL, V21, P893, DOI 10.1016/S1470-2045(20)30309-0; Wardhana, 2011, Acta Med Indones, V43, P185; WHO, 2020, POL BRIEF ACC ASS TE; Wilder-Smith A, 2020, LANCET INFECT DIS, V20, pE102, DOI 10.1016/S1473-3099(20)30129-8; World Health Organization, COR DIS 2019 COVID 1; World Health Organization, 2020, 157 WHO; Zhao LP, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0226803; Zwerling A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001012	30	13	13	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243707	10.1371/journal.pone.0243707	http://dx.doi.org/10.1371/journal.pone.0243707			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332418	gold, Green Published			2022-12-27	WOS:000601310900035
J	Kamgang, VW; Bennett, NC; Hart, DW; van der Goot, AC; Ganswindt, A				Kamgang, Vanessa W.; Bennett, Nigel C.; Hart, Daniel W.; van der Goot, Annemieke C.; Ganswindt, Andre			Reproductive events and respective faecal androgen metabolite concentrations in captive male roan antelope (Hippotragus equinus)	PLOS ONE			English	Article							TESTOSTERONE LEVELS; AFRICAN ELEPHANTS; SEASONAL-CHANGES; BEHAVIOR; ENDOCRINE; PATTERNS; EXCRETION; CYCLE; PARK; PHOTOPERIOD	Understanding the reproductive biology of the roan antelope (Hippotragus equinus) (e. Geoffroy Saint-Hilaire, 1803) is crucial to optimise breeding success in captive breeding programmes of this threatened species. In this study, the pattern of faecal androgen metabolite (fAM) production related to reproductive events (calving or birthing, mating, gestation, and lactation), sexual behaviours as well as environmental cues were studied in captive adult male roan antelope. Faecal sample collection and behavioural observations were carried out from August 2017 to July 2018 for three reproductive males participating in a conservation breeding programme at the Lapalala Wilderness Nature Reserve in South Africa. As a prerequisite, the enzyme immunoassay used in this study was biologically validated for the species by demonstrating a significant difference between fAM concentrations in non-breeding adults, breeding adults and juvenile males. Results revealed that in adults males, the overall mean fAM levels were 73% higher during the breeding period compared to the non-breeding periods, and 85% higher when exclusively compared to the lactation/gestation periods, but only 5.3% higher when compared to the birthing period. Simultaneously, fAM concentrations were lower during the wet season compared to the dry season, increasing with a reduction in photoperiod. With the exception of courtship, frequencies of sexual behaviours monitored changed in accordance with individual mean fAM concentrations in male roan antelope, the findings suggest that androgen production varies with the occurrence of mating activity and may be influenced by photoperiod but not with rainfall.	[Kamgang, Vanessa W.; Bennett, Nigel C.; Ganswindt, Andre] Univ Pretoria, Mammal Res Inst, Pretoria, South Africa; [Hart, Daniel W.] Univ Pretoria, Dept Zool & Entomol, Pretoria, South Africa; [van der Goot, Annemieke C.] Lapalala Wilderness Nat Reserve, Melkrevier, Limpopo, South Africa	University of Pretoria; University of Pretoria	Kamgang, VW (corresponding author), Univ Pretoria, Mammal Res Inst, Pretoria, South Africa.	vanessa.wandja@gmail.com	; Ganswindt, Andre/G-9856-2014	wandja kamgang, Vanessa/0000-0001-8837-2113; Ganswindt, Andre/0000-0002-1474-7602	DST-NRF SARChI chair for Mammal Behavioural Ecology and Physiology [64756]; DST-NRF SARChI chair for Mammal Behavioural Ecology and Physiology	DST-NRF SARChI chair for Mammal Behavioural Ecology and Physiology; DST-NRF SARChI chair for Mammal Behavioural Ecology and Physiology	This work was supported by a DST-NRF SARChI chair for Mammal Behavioural Ecology and Physiology attributed to NCB (Grant number 64756), and a bursary provided by the DST-NRF SARChI chair for Mammal Behavioural Ecology and Physiology to VWK.	ALMEIDA OFX, 1982, BIOL REPROD, V27, P1062, DOI 10.1095/biolreprod27.5.1062; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; [Anonymous], 2016, IEEE-ASME T MECH, VPP, P1, DOI DOI 10.1109/IEEESTD.2016.7460875; ASCHOFF J, 1978, NATURWISSENSCHAFTEN, V65, P80, DOI 10.1007/BF00440545; Bales KL, 2006, HORM BEHAV, V49, P88, DOI 10.1016/j.yhbeh.2005.05.006; Brockman DK, 2001, BEHAV ECOL SOCIOBIOL, V49, P117, DOI 10.1007/s002650000287; Bronson FH, 2009, PHILOS T R SOC B, V364, P3331, DOI 10.1098/rstb.2009.0140; BROWN JL, 1991, J REPROD FERTIL, V93, P497; BROWN JL, 1991, J REPROD FERTIL, V92, P47, DOI 10.1530/jrf.0.0920047; Burgess EA, 2012, REPRODUCTION, V143, P683, DOI 10.1530/REP-11-0434; Chan JPW, 2009, THERIOGENOLOGY, V71, P1156, DOI 10.1016/j.theriogenology.2008.12.007; Charlier TD, 2013, GEN COMP ENDOCR, V190, P24, DOI 10.1016/j.ygcen.2013.03.003; Comizzoli P, 2019, BIOL REPROD, V101, P514, DOI 10.1093/biolre/ioz031; Conde DA, 2011, SCIENCE, V331, P1390, DOI 10.1126/science.1200674; Delgadillo JA, 2004, REPROD NUTR DEV, V44, P183, DOI 10.1051/rnd:2004024; Duncan C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051490; FAIRALL N, 1972, Zoologica Africana, V7, P167; Fiess M, 1999, GEN COMP ENDOCR, V115, P76, DOI 10.1006/gcen.1999.7287; Ganswindt A, 2002, ZOO BIOL, V21, P27, DOI 10.1002/zoo.10034; Ganswindt A, 2010, HORM BEHAV, V57, P506, DOI 10.1016/j.yhbeh.2010.02.009; Girard-Buttoz C, 2009, PHYSIOL BEHAV, V98, P168, DOI 10.1016/j.physbeh.2009.05.005; Grant C. C., 2002, Koedoe, V45, P45; Group ISAS, 2017, HIPP EQ; Harrington R, 1999, BIOL CONSERV, V90, P69, DOI 10.1016/S0006-3207(98)00120-7; Havemann CP, 2016, MAMMAL REV, V46, P144, DOI 10.1111/mam.12061; Hodges Keith, 2010, P447; Hull EM, 2017, HORMONES, BRAIN AND BEHAVIOR, VOL 1: MAMMALIAN HORMONE-BEHAVIOR SYSTEMS, 3RD EDITION, P1, DOI 10.1016/B978-0-12-803592-4.00001-8; Hunter P, 2007, EMBO REP, V8, P316, DOI 10.1038/sj.embor.7400951; IUCN, IUCN RED LIST THREAT; Joubert S.C.J., 1970, THESIS; Joubert SCJ., 1976, THESIS; Kersey DC, 2015, ZOO BIOL, V34, P183, DOI 10.1002/zoo.21199; Khonmee J, 2014, ANIM REPROD SCI, V146, P70, DOI 10.1016/j.anireprosci.2014.02.008; Kindahl H, 2002, DOMEST ANIM ENDOCRIN, V23, P321, DOI 10.1016/S0739-7240(02)00167-4; Kingdom J, 2013, MAMMALS AFRICA, P544; Kretzschmar P, 2004, HORM BEHAV, V45, P1, DOI 10.1016/j.yhbeh.2003.08.001; Kupika O.L., 2017, SELECTED STUDIES BIO; Leus K, 2011, ZOOL MIDDLE EAST, P151; LINCOLN GA, 1977, J REPROD FERTIL, V49, P267, DOI 10.1530/jrf.0.0490267; Loeding E, 2011, J APPL ANIM WELF SCI, V14, P220, DOI 10.1080/10888705.2011.576968; Mauget R, 2007, MAMM BIOL, V72, P14, DOI 10.1016/j.mambio.2006.04.005; Mccoy JC, 2012, WILDLIFE SOC B, V36, P641, DOI 10.1002/wsb.190; Medger K, 2012, J ZOOL, V286, P243, DOI 10.1111/j.1469-7998.2011.00872.x; Midgley GF, 2011, REG ENVIRON CHANGE, V11, pS127, DOI 10.1007/s10113-010-0191-8; Mooring MS, 2004, HORM BEHAV, V46, P392, DOI 10.1016/j.yhbeh.2004.03.008; Mosase E, 2018, WATER-SUI, V10, DOI 10.3390/w10040364; Ogutu JO, 2003, ECOL LETT, V6, P412, DOI 10.1046/j.1461-0248.2003.00447.x; Ogutu JO, 2014, WILDLIFE RES, V41, P323, DOI 10.1071/WR13211; Ostner J, 2008, BEHAV ECOL SOCIOBIOL, V62, P627, DOI 10.1007/s00265-007-0487-y; PALME R, 1994, ADVANCES IN STEROID ANALYSIS '93, P111; Palme R, 2005, ANN NY ACAD SCI, V1046, P75, DOI 10.1196/annals.1343.007; Patton ML, 2001, ZOO BIOL, V20, P375, DOI 10.1002/zoo.1036; Pelletier F, 2003, CAN J ZOOL, V81, P1678, DOI 10.1139/Z03-156; Pereira RJG, 2005, THERIOGENOLOGY, V63, P2113, DOI 10.1016/j.theriogenology.2004.08.014; Preston BT, 2012, J ANIM ECOL, V81, P296, DOI 10.1111/j.1365-2656.2011.01907.x; RAHBEK C, 1993, BIODIVERS CONSERV, V2, P426, DOI 10.1007/BF00114044; Rajagopal T, 2018, INDIAN J EXP BIOL, V56, P781; Ralls K., 2013, ENCY BIODIVERSITY, V1, P662, DOI DOI 10.1016/B978-0-12-384719-5.00268-9; Rasmussen HB, 2008, HORM BEHAV, V54, P539, DOI 10.1016/j.yhbeh.2008.05.008; Rodrigues, 2015, RES REV J ZOOLOGICAL, V4, P43; Santymire RM, 2016, J ZOO AQUAR RES, V4, P30; Scheun J, 2017, J ZOOL, V301, P263, DOI 10.1111/jzo.12420; Schradin C, 2008, HORM BEHAV, V53, P573, DOI 10.1016/j.yhbeh.2008.01.003; Schwarzenberger F, 2013, WIEN TIERARZTL MONAT, V100, P209; Seeber PA, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0396; Skinner JD, 2005, THE MAMMALS OF THE S; SPINAGE C A, 1973, Mammal Review, V3, P71, DOI 10.1111/j.1365-2907.1973.tb00174.x; Thitaram C., 2009, THESIS; Touma C, 2005, ANN NY ACAD SCI, V1046, P54, DOI 10.1196/annals.1343.006; Ungerfeld R., 2012, LIVESTOCK REPROD BOV; Ververs C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187751; Walton JC, 2011, FRONT NEUROENDOCRIN, V32, P303, DOI 10.1016/j.yfrne.2010.12.003; Weems PW, 2015, FRONT NEUROENDOCRIN, V37, P43, DOI 10.1016/j.yfrne.2014.12.002; Weinbauer GF, 2010, ANDROLOGY: MALE REPRODUCTIVE HEALTH AND DYSFUNCTION, THIRD EDITION, P11, DOI 10.1007/978-3-540-78355-8_2; Wilson D. E., 1977, WILDLIFE MONOGR, V54, P3; Wolf TE, 2018, GEN COMP ENDOCR, V255, P19, DOI 10.1016/j.ygcen.2017.09.028; Zarazaga LA, 2010, SMALL RUMINANT RES, V93, P110, DOI 10.1016/j.smallrumres.2010.05.008; Zerbe P, 2012, BIOL REV, V87, P965, DOI 10.1111/j.1469-185X.2012.00238.x; Zhang GQ, 2004, ZOO BIOL, V23, P15, DOI 10.1002/zoo.10118	79	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243277	10.1371/journal.pone.0243277	http://dx.doi.org/10.1371/journal.pone.0243277			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332371	Green Published, gold			2022-12-27	WOS:000601310900031
J	Liu, YH; Li, HC; Li, H				Liu, Yuhui; Li, Hecheng; Li, Hong			Evolutionary algorithm using surrogate models for solving bilevel multiobjective programming problems	PLOS ONE			English	Article							EXACT PENALTY	A bilevel programming problem with multiple objectives at the leader's and/or follower's levels, known as a bilevel multiobjective programming problem (BMPP), is extraordinarily hard as this problem accumulates the computational complexity of both hierarchical structures and multiobjective optimisation. As a strongly NP-hard problem, the BMPP incurs a significant computational cost in obtaining non-dominated solutions at both levels, and few studies have addressed this issue. In this study, an evolutionary algorithm is developed using surrogate optimisation models to solve such problems. First, a dynamic weighted sum method is adopted to address the follower's multiple objective cases, in which the follower's problem is categorised into several single-objective ones. Next, for each the leader's variable values, the optimal solutions to the transformed follower's programs can be approximated by adaptively improved surrogate models instead of solving the follower's problems. Finally, these techniques are embedded in MOEA/D, by which the leader's non-dominated solutions can be obtained. In addition, a heuristic crossover operator is designed using gradient information in the evolutionary procedure. The proposed algorithm is executed on some computational examples including linear and nonlinear cases, and the simulation results demonstrate the efficiency of the approach.	[Liu, Yuhui] Qinghai Normal Univ, Sch Comp Sci & Technol, Xining, Peoples R China; [Li, Hecheng] Qinghai Normal Univ, Sch Math & Stat, Xining, Peoples R China; [Li, Hong] Xidian Univ, Sch Math & Stat, Xian, Peoples R China	Qinghai Normal University; Qinghai Normal University; Xidian University	Li, HC (corresponding author), Qinghai Normal Univ, Sch Math & Stat, Xining, Peoples R China.	lihecheng@qhnu.edu.cn			National Natural Science Foundation of China [61966030, 11661067]; Natural Science Foundation of Qinghai Province [2018-ZJ-901]; Key Laboratory of IoT of Qinghai [2020-ZJ-Y16]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Qinghai Province; Key Laboratory of IoT of Qinghai	The research work was supported by the National Natural Science Foundation of China under Grant Nos. 61966030 and 11661067, the Natural Science Foundation of Qinghai Province under Grant No. 2018-ZJ-901 and the Key Laboratory of IoT of Qinghai under grant 2020-ZJ-Y16.	Alves MJ, 2012, LECT NOTES COMPUT SC, V7461, P332, DOI 10.1007/978-3-642-32650-9_35; Ankhili Z, 2009, EUR J OPER RES, V197, P36, DOI 10.1016/j.ejor.2008.06.026; [Anonymous], 2019, NAT ELECTRON, V2, P1, DOI 10.1038/s41928-019-0203-8; [Anonymous], 2014, IEEE T EVOLUT COMPUT, V18, P577; [Anonymous], 2009, RUSIN, V1, P110; [Anonymous], 2014, SCI BACKGR NOBEL PRI, V2014, P1, DOI DOI 10.1186/1687-1847-2014-1; [Anonymous], 2018, PLOS ONE, V13, P1, DOI DOI 10.3171/2018.1.JNS172645; [Anonymous], 2018, 7 SER FPGAS DAT SHEE, V2, P1; Bard JF, 1998, PRACTICAL AILEVEL OP; Brian D, 2014, STRUCTURAL MULTIDISC, V50, P663, DOI [10.1007/s00158-014-1120-0, DOI 10.1007/S00158-014-1120-0]; Calvete HI, 2011, OMEGA-INT J MANAGE S, V39, P33, DOI 10.1016/j.omega.2010.02.002; Chakraborti D., 2017, INT C COMP INT COMM, P423; CONAB-Companhia Nacional de Abastecimento, 2017, AC SAFR BRAS GRAOS 2, V5, P1, DOI DOI 10.3389/fnut.2018.00001; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; Deb K, 2010, EVOL COMPUT, V18, P403, DOI 10.1162/EVCO_a_00015; Dupin R, 2019, IEEE T POWER SYST, V34, P2836, DOI 10.1109/TPWRS.2018.2889973; Eichfelder G, 2010, MATH PROGRAM, V123, P419, DOI 10.1007/s10107-008-0259-0; FANG KT, 1994, STAT SCI, V9, P416, DOI 10.1214/ss/1177010392; Japanese Gastr Canc Assoc, 2021, GASTRIC CANCER, V24, P1, DOI [10.1007/s10120-020-01042-y, 10.1007/s10120-016-0622-4]; Jensen TV, 2018, IEEE T POWER SYST, V33, P3624, DOI 10.1109/TPWRS.2017.2786940; Jia LP, 2016, INT J COMPUT SCI ENG, V12, P38, DOI 10.1504/IJCSE.2016.074562; Kim Katalin, 2017, MUHELYTANULMANYOK 18, V2, P129; Li H, 2009, IEEE T EVOLUTIONARY, V18, P450; Li He-Cheng, 2008, Chinese Journal of Computers, V31, P910; Li H, 2016, KNOWL-BASED SYST, V107, P271, DOI 10.1016/j.knosys.2016.06.018; Liu HL, 2009, INTELL AUTOM SOFT CO, V15, P361, DOI 10.1080/10798587.2009.10643036; Liu June, 2018, Wuhan University Journal of Natural Sciences, V23, P480, DOI 10.1007/s11859-018-1352-8; Liu June, 2018, Wuhan University Journal of Natural Sciences, V23, P328, DOI 10.1007/s11859-018-1330-1; Lv YB, 2015, J INEQUAL APPL, DOI 10.1186/s13660-015-0780-7; Nasrolahpour E, 2018, IEEE T SUSTAIN ENERG, V9, P582, DOI 10.1109/TSTE.2017.2749434; Pieume C.O., 2013, AM J OPERATIONS RES, V3, P289, DOI [https://doi.org/10.4236/ajor.2013.32026, DOI 10.4236/AJOR.2013.32026]; Qi PX, 2017, FOOD HYDROCOLLOID, V67, P1, DOI 10.1016/j.foodhyd.2016.12.032; Raganato A, 2017, 15TH CONFERENCE OF THE EUROPEAN CHAPTER OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (EACL 2017), VOL 1: LONG PAPERS, P99; Sinha A., 2017, IEEE T EVOLUTIONARY, V22, P276, DOI DOI 10.1109/TEVC.2017.2712906; Sinha A, 2019, SWARM EVOL COMPUT, V44, P496, DOI 10.1016/j.swevo.2018.06.004; Sinha A, 2017, EUR J OPER RES, V257, P395, DOI 10.1016/j.ejor.2016.08.027; Sinha A, 2017, COMPUT OPER RES, V77, P194, DOI 10.1016/j.cor.2016.08.001; Stromberg AJ, 1996, TECHNOMETRICS, V38, P189, DOI [10.1080/00401706.1996.10484478, DOI 10.1080/00401706.1996.10484478]; Sun J, 2017, CHEMOSPHERE, V168, P1, DOI 10.1016/j.chemosphere.2016.10.031; Swiss Re Report, 2018, SIGMA, V3148, DOI DOI 10.2218/PIHPH.3.2018.2602; Ulbrich M, 2017, NUMERICAL ALGEBRA CO, V2, P105; US Foodlink, 2016, US FOODLINK, V12, P1, DOI DOI 10.1016/j.jalz.2016.03.001; WANG Y, 1990, CHINESE ANN MATH B, V11, P51; Wang YP, 2005, IEEE T SYST MAN CY C, V35, P221, DOI 10.1109/TSMCC.2004.841908; Wang ZK, 2016, IEEE T CYBERNETICS, V46, P474, DOI 10.1109/TCYB.2015.2403849; Xu P, 2014, COMPUT OPER RES, V41, P309, DOI 10.1016/j.cor.2013.07.016; Yang K, 2017, J INTELL MANUF, V28, P667, DOI 10.1007/s10845-014-0993-5; Ye J. J., 1995, Optimization, V33, P9, DOI 10.1080/02331939508844060; Zhang QF, 2007, IEEE T EVOLUT COMPUT, V11, P712, DOI 10.1109/TEVC.2007.892759; Zhang T, 2012, J APPL MATH, V1, P359; Zhang T, 2013, KNOWL-BASED SYST, V53, P13, DOI 10.1016/j.knosys.2013.07.015; Zhang WN, 2016, IEEE T KNOWL DATA EN, V28, P888, DOI 10.1109/TKDE.2015.2502944; Zitzler E, 1999, IEEE T EVOLUT COMPUT, V3, P257, DOI 10.1109/4235.797969	53	0	0	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243926	10.1371/journal.pone.0243926	http://dx.doi.org/10.1371/journal.pone.0243926			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332433	Green Published, gold			2022-12-27	WOS:000601310900063
J	Wieczorek, M; Silka, J; Polap, D; Wozniak, M; Damasevicius, R				Wieczorek, Michal; Silka, Jakub; Polap, Dawid; Wozniak, Marcin; Damasevicius, Robertas			Real-time neural network based predictor for cov19 virus spread	PLOS ONE			English	Article								Since the epidemic outbreak in early months of 2020 the spread of COVID-19 has grown rapidly in most countries and regions across the World. Because of that, SARS-CoV-2 was declared as a Public Health Emergency of International Concern (PHEIC) on January 30, 2020, by The World Health Organization (WHO). That's why many scientists are working on new methods to reduce further growth of new cases and, by intelligent patients allocation, reduce number of patients per doctor, what can lead to more successful treatments. However to properly manage the COVID-19 spread there is a need for real-time prediction models which can reliably support various decisions both at national and international level. The problem in developing such system is the lack of general knowledge how the virus spreads and what would be the number of cases each day. Therefore prediction model must be able to conclude the situation from past data in the way that results will show a future trend and will possibly closely relate to the real numbers. In our opinion Artificial Intelligence gives a possibility to do it. In this article we present a model which can work as a part of an online system as a real-time predictor to help in estimation of COVID-19 spread. This prediction model is developed using Artificial Neural Networks (ANN) to estimate the future situation by the use of geo-location and numerical data from past 2 weeks. The results of our model are confirmed by comparing them with real data and, during our research the model was correctly predicting the trend and very closely matching the numbers of new cases in each day.	[Wieczorek, Michal; Silka, Jakub; Polap, Dawid; Wozniak, Marcin] Silesian Tech Univ, Fac Appl Math, Gliwice, Poland; [Damasevicius, Robertas] Vytautas Magnus Univ, Dept Appl Informat, Kaunas, Lithuania	Silesian University of Technology; Vytautas Magnus University	Wieczorek, M (corresponding author), Silesian Tech Univ, Fac Appl Math, Gliwice, Poland.	michal_wieczorek@hotmail.com	Damaševičius, Robertas/E-1387-2017; Połap, Dawid/D-1547-2017; Wieczorek, Michał/AAC-7230-2021; Wozniak, Marcin/L-6640-2013	Damaševičius, Robertas/0000-0001-9990-1084; Połap, Dawid/0000-0003-1972-5979; Wieczorek, Michał/0000-0002-5319-3366; Silka, Jakub/0000-0001-9133-4388; Wozniak, Marcin/0000-0002-9073-5347	Polish Ministry of Science and Higher Education [MNiSW/2020/43/DIR/NN4]; Silesian University of Technology under program "Initiative of Excellence-Research University" [08/IDUB/2019/84]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Silesian University of Technology under program "Initiative of Excellence-Research University"	This study was supported by the Polish Ministry of Science and Higher Education under grant no. MNiSW/2020/43/DIR/NN4.; Authors would like to acknowledge contribution to this project from the Rector of the Silesian University of Technology under program "Initiative of Excellence-Research University" grant no. 08/IDUB/2019/84.	Al-Waeli AHA, 2020, RENEW ENERG, V145, P963, DOI 10.1016/j.renene.2019.06.099; Anastassopoulou C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230405; Bertozzi AL, 2020, P NATL ACAD SCI USA, V117, P16732, DOI 10.1073/pnas.2006520117; Bogard N, 2019, CELL, V178, P91, DOI 10.1016/j.cell.2019.04.046; Choudhury A, 2019, ADV INTELL SYST COMP, V740, P67, DOI 10.1007/978-981-13-1280-9_6; Daoud M, 2019, ARTIF INTELL MED; Das A, 2019, FUTURE GENER COMP SY, V93, P486, DOI 10.1016/j.future.2018.10.050; Elmousalami HH., 2020, ARXIV200307778; Fanelli D, 2020, CHAOS SOLITON FRACT, V134, DOI 10.1016/j.chaos.2020.109761; Ganggayah MD, 2019, BMC MED INFORM DECIS, V19, DOI 10.1186/s12911-019-0801-4; Gatto M, 2020, P NATL ACAD SCI USA, V117, P10484, DOI 10.1073/pnas.2004978117; Gupta R, 2021, INDIAN J SURG, V83, P338, DOI 10.1007/s12262-020-02368-8; Hannun AY, 2019, NAT MED, V25, P65, DOI 10.1038/s41591-018-0268-3; Ivanov D, 2020, TRANSPORT RES E-LOG, V136, DOI 10.1016/j.tre.2020.101922; Kaji DA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211057; King DB, 2015, ACS SYM SER, V1214, P1; Li LX, 2020, INFECT DIS MODEL, V5, P282, DOI 10.1016/j.idm.2020.03.002; Liao YH, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19081866; Lin K, 2019, INT J MED INFORM, V125, P55, DOI 10.1016/j.ijmedinf.2019.02.002; Maragatham G, 2019, J MED SYST, V43, DOI 10.1007/s10916-019-1243-3; Pandey G, 2020, ARXIV200400958; Pathak Y, 2020, IRBM; Petropoulos F, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231236; Reddy BK, 2019, HEALTH INFORM J, V25, P1201, DOI 10.1177/1460458217751015; Ren YF, 2019, BMC MED INFORM DECIS, V19, DOI 10.1186/s12911-019-0765-4; Sanderson M, 2020, J AFFECT DISORDERS, V264, P107, DOI 10.1016/j.jad.2019.12.024; Sayeed A, 2020, NEURAL NETWORKS, V121, P396, DOI 10.1016/j.neunet.2019.09.033; Singh D, 2020, EUR J CLIN MICROBIOL, V39, P1379, DOI 10.1007/s10096-020-03901-z; Singh G, 2020, NEURAL COMPUT APPL, V32, P12417, DOI 10.1007/s00521-019-04695-8; Vasquez-Morales GR, 2019, IEEE ACCESS, V7, P152900, DOI 10.1109/ACCESS.2019.2948430; Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9; Zhang XL, 2020, CHAOS SOLITON FRACT, V135, DOI 10.1016/j.chaos.2020.109829	32	19	19	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243189	10.1371/journal.pone.0243189	http://dx.doi.org/10.1371/journal.pone.0243189			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332363	Green Published, gold			2022-12-27	WOS:000601310900078
J	Liu, LF; Liu, C; Zhao, MY; Zhang, QR; Lu, Y; Liu, P; Yang, H; Yang, JL; Chen, XX; Yao, YQ				Liu, Linfu; Liu, Chuang; Zhao, Manyu; Zhang, Qianru; Lu, Ying; Liu, Ping; Yang, Hua; Yang, Jinliang; Chen, Xiaoxin; Yao, Yuqin			The pharmacodynamic and differential gene expression analysis of PPAR alpha/delta agonist GFT505 in CDAHFD-induced NASH model	PLOS ONE			English	Article							NONALCOHOLIC STEATOHEPATITIS; METHIONINE; CHOLINE; DEFICIENT; FIBROSIS; ALPHA; IMPACT; DELTA; DIET	Peroxisome proliferator-activated receptor alpha/delta (PPAR alpha/delta), regulating glucolipid metabolism and immune inflammation, has been identified as an effective therapeutic target in non-alcoholic steatohepatitis (NASH). Dual PPAR alpha/delta agonist, such as GFT505 (also known as elafibranor), demonstrated potential therapeutic effect for NASH in clinical trials. To profile the regulatory network of PPAR alpha/delta agonist in NASH, the choline-deficient, L-amino acid-defined, high-fat diet (CDAHFD) induced NASH model was used to test the pharmacodynamics and transcriptome regulation of GFT505 in this study. The results showed that GFT505 ameliorated hepatic steatosis, inflammation and fibrosis in CDAHFD mice model. RNA-sequencing yielded 3995 up-regulated and 3576 down-regulated genes with GFT505 treatment. And the most significant differentialy expressed genes involved in glucolipid metabolism (Ppar alpha, Acox1, Cpt1b, Fabp4, Ehhadh, Fabp3), inflammation (Ccl6, Ccl9, Cxcl14) and fibrosis (Timp1, Lamc3, Timp2, Col3a1, Col1a2, Col1a1, Hapln4, Timp3, Pik3r5, Pdgf alpha, Pdgf beta, Tgf beta 1, Tgf beta 2) were confirmed by RT-qPCR. The down-regulated genes were enriched in cytokine-cytokine receptor interaction pathway and ECM-receptor interaction pathway, while the up-regulated genes were enriched in PPAR signaling pathway and fatty acid degradation pathway. This study provides clues and basis for further understanding on the mechanism of PPAR alpha/delta agonist on NASH.	[Liu, Linfu; Liu, Chuang; Zhao, Manyu; Yang, Hua; Yao, Yuqin] Sichuan Univ, West China Sch Publ Hlth, Chengdu, Peoples R China; [Liu, Linfu; Liu, Chuang; Zhao, Manyu; Yang, Hua; Yao, Yuqin] Sichuan Univ, West China Hosp 4, Chengdu, Peoples R China; [Liu, Linfu; Liu, Chuang; Zhang, Qianru; Lu, Ying; Yang, Jinliang; Yao, Yuqin] Sichuan Univ, West China Hosp, Collaborat Innovat Ctr Biotherapy, Chengdu, Peoples R China; [Liu, Linfu; Liu, Chuang; Zhang, Qianru; Lu, Ying; Yang, Jinliang; Yao, Yuqin] Sichuan Univ, West China Hosp, Ctr Canc, Chengdu, Peoples R China; [Zhang, Qianru; Chen, Xiaoxin] Guangdong Zhongsheng Pharmaceut Co Ltd, Guangzhou, Guangdong, Peoples R China; [Liu, Ping; Yang, Jinliang; Chen, Xiaoxin] Sichuan Univ, West China Hosp 2, Dept Gynecol & Obstet, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University; Sichuan University; Sichuan University; Sichuan University	Yao, YQ (corresponding author), Sichuan Univ, West China Sch Publ Hlth, Chengdu, Peoples R China.; Yao, YQ (corresponding author), Sichuan Univ, West China Hosp 4, Chengdu, Peoples R China.; Yao, YQ (corresponding author), Sichuan Univ, West China Hosp, Collaborat Innovat Ctr Biotherapy, Chengdu, Peoples R China.; Yao, YQ (corresponding author), Sichuan Univ, West China Hosp, Ctr Canc, Chengdu, Peoples R China.; Chen, XX (corresponding author), Guangdong Zhongsheng Pharmaceut Co Ltd, Guangzhou, Guangdong, Peoples R China.; Chen, XX (corresponding author), Sichuan Univ, West China Hosp 2, Dept Gynecol & Obstet, Chengdu, Sichuan, Peoples R China.	chenzhenyu2000@zspcl.com; yuqin_yao@scu.edu.cn			National Major Scientific and Technological Special Project [2018ZX09201002, 2018ZX09711001-011, 2019ZX09201001]; National Science Foundation of China [81773375]	National Major Scientific and Technological Special Project; National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Major Scientific and Technological Special Project (Nos. 2018ZX09201002, 2018ZX09711001-011 and 2019ZX09201001) and the National Science Foundation of China (No. 81773375). The authors thank the research platform provided by Public Health and Preventive Medicine Provincial Experiment Teaching Center at Sichuan University.	Agarwal N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13835-w; Bugianesi E, 2002, GASTROENTEROLOGY, V123, P134, DOI 10.1053/gast.2002.34168; Caballero F, 2010, J BIOL CHEM, V285, P18528, DOI 10.1074/jbc.M109.099333; Cariou B, 2013, DIABETES CARE, V36, P2923, DOI 10.2337/dc12-2012; Cariou B, 2011, DIABETES CARE, V34, P2008, DOI 10.2337/dc11-0093; Deng QG, 2005, HEPATOLOGY, V42, P905, DOI 10.1002/hep.20877; Fan JG, 2013, J GASTROEN HEPATOL, V28, P81, DOI 10.1111/jgh.12244; Farrell GC, 2018, ADV EXP MED BIOL, V1061, P19, DOI 10.1007/978-981-10-8684-7_3; Gao B, 2019, J HEPATOL, V70, P249, DOI 10.1016/j.jhep.2018.10.023; HF H, 2017, BIOCH CELL BIO, V95, P400; Jeong H, 2018, AM J CHINESE MED, V46, P1581, DOI 10.1142/S0192415X18500817; Li MH, 2019, J PHARMACOL EXP THER, V369, P67, DOI 10.1124/jpet.118.255216; Liu XJ, 2018, LAB INVEST, V98, P1184, DOI 10.1038/s41374-018-0074-z; Makled MN, 2019, N-S ARCH PHARMACOL, V392, P1569, DOI 10.1007/s00210-019-01703-5; Matsumoto M, 2013, INT J EXP PATHOL, V94, P93, DOI 10.1111/iep.12008; Nagasawa T, 2006, EUR J PHARMACOL, V536, P182, DOI 10.1016/j.ejphar.2006.02.028; Naito Y, 2020, AM J PHYSIOL-RENAL, V318, pF238, DOI 10.1152/ajprenal.00313.2019; Pawlak M, 2015, J HEPATOL, V62, P720, DOI 10.1016/j.jhep.2014.10.039; Qin SM, 2016, LIPIDS, V51, P797, DOI 10.1007/s11745-016-4160-y; Ratziu V, 2016, GASTROENTEROLOGY, V150, P1147, DOI 10.1053/j.gastro.2016.01.038; Rinella ME, 2004, J HEPATOL, V40, P47, DOI 10.1016/j.jhep.2003.09.020; Rizki G, 2006, J LIPID RES, V47, P2280, DOI 10.1194/jlr.M600198-JLR200; Rodriguez MA, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4834-3; Rotman Y, 2017, GUT, V66, P180, DOI 10.1136/gutjnl-2016-312431; Seelige R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32011-2; Song HZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149670; Staels B, 2013, HEPATOLOGY, V58, P1941, DOI 10.1002/hep.26461; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; Younossi Z, 2019, HEPATOLOGY, V69, P2672, DOI 10.1002/hep.30251; YU JY, 2019, VIRUSES-BASEL, V11, DOI DOI 10.3390/V11111020; Zhong F, 2020, DIGESTION, V101, P522, DOI 10.1159/000501851	32	8	9	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243911	10.1371/journal.pone.0243911	http://dx.doi.org/10.1371/journal.pone.0243911			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326461	Green Published, gold			2022-12-27	WOS:000600176400027
J	Ricard, A; Saint Priest, BD; Chassier, M; Sabbagh, M; Danvy, S				Ricard, Anne; Saint Priest, Bernard Dumont; Chassier, Marjorie; Sabbagh, Margot; Danvy, Sophie			Genetic consistency between gait analysis by accelerometry and evaluation scores at breeding shows for the selection of jumping competition horses	PLOS ONE			English	Article							STUDBOOK-ENTRY INSPECTION; GENOME-WIDE ASSOCIATION; BIOKINEMATIC VARIABLES; PERFORMANCE TRAITS; MIXED-MODEL; PARAMETERS; DRESSAGE; SPECIALIZATION; LOCOMOTION; MOVEMENT	The aim was to assess the efficiency of gaits characteristics in improving jumping performance of sport horses and confront accelerometers and judge scores for this purpose. A sample of 1,477 young jumping horses were measured using accelerometers for walk, trot, and canter. Of these, 702 were genotyped with 541,175 SNPs after quality control. Dataset of 26,914 horses scored by judges in breeding shows for gaits and dataset of 142,682 horses that performed in jumping competitions were used. Analysis of accelerometric data defined three principal components from 64% to 89% of variability explained for each gait. Animal mixed models were used to estimate genetic parameters with the inclusion to up 308,105 ancestors for the relationship matrix. Fixed effects for the accelerometric variables included velocity, gender, age, and event. A GWAS was performed on residuals with the fixed effect of each SNP. The GWAS did not reveal other QTLs for gait traits than the one related to the height at withers. The accelerometric principal components were highly heritable for the one linked to stride frequency and dorsoventral displacement at trot (0.53) and canter (0.41) and moderately for the one linked to longitudinal activities (0.33 for trot, 0.19 for canter). Low heritabilities were found for the walk traits. The genetic correlations of the accelerometric principal components with the jumping competition were essentially nil, except for a negative correlation with longitudinal activity at canter (-0.19). The genetic correlation between the judges' scores and the jumping competition reached 0.45 for canter (0.31 for trot and 0.17 for walk). But these correlations turned negative when the scores were corrected for the known parental breeding value for competition at the time of the judging. In conclusion, gait traits were not helpful to select for jumping performances. Different gaits may be suitable for a good jumping horse.	[Ricard, Anne; Chassier, Marjorie] Univ Paris Saclay, AgroParisTech, Inst Natl Rech Agr Alimentat & Environm, Genet Anim & Biol Integrat, Jouy En Josas, France; [Ricard, Anne; Saint Priest, Bernard Dumont; Sabbagh, Margot; Danvy, Sophie] Inst Francais Cheval & Equitat, Pole Dev Innovat & Rech, Exmes, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Ricard, A (corresponding author), Univ Paris Saclay, AgroParisTech, Inst Natl Rech Agr Alimentat & Environm, Genet Anim & Biol Integrat, Jouy En Josas, France.; Ricard, A (corresponding author), Inst Francais Cheval & Equitat, Pole Dev Innovat & Rech, Exmes, France.	anne.ricard@inrae.fr			IFCE (Institut Francais du Cheval et de l'Equitation); INRAE (Institut National de Recherche pour l'Agriculture, l'alimentation et l'Environnement); Fonds Eperon	IFCE (Institut Francais du Cheval et de l'Equitation); INRAE (Institut National de Recherche pour l'Agriculture, l'alimentation et l'Environnement); Fonds Eperon	This work was founded by IFCE (Institut Francais du Cheval et de l'Equitation), INRAE (Institut National de Recherche pour l'Agriculture, l'alimentation et l'Environnement) and Fonds Eperon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablondi M, 2019, GENES-BASEL, V10, DOI 10.3390/genes10120976; Andersson LS, 2012, NATURE, V488, P642, DOI 10.1038/nature11399; Aulchenko YS, 2007, GENETICS, V177, P577, DOI 10.1534/genetics.107.075614; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Barrey E, 1999, VET J, V157, P7, DOI 10.1053/tvjl.1998.0297; BARREY E., 2014, EQUINE SPORTS MED SU, V2nd, P189, DOI [10.1016/B978-0-7020-4771-8.00010-7, DOI 10.1016/B978-0-7020-4771-8.00010-7]; Barrey E., 1994, EQUINE VET J, V26, P7, DOI DOI 10.1111/j.2042-3306.1994.tb04864.x; Barrey E., 1995, EQUINE VET J, V27, P156, DOI [10.1111/j.2042-3306.1995.tb04910.x, DOI 10.1111/J.2042-3306.1995.TB04910.X]; Becker AC, 2012, J ANIM BREED GENET, V129, P390, DOI 10.1111/j.1439-0388.2011.00980.x; Ducro BJ, 2007, LIVEST SCI, V107, P227, DOI 10.1016/j.livsci.2006.09.018; Duensing J, 2014, J EQUINE VET SCI, V34, P360, DOI 10.1016/j.jevs.2013.09.002; Egan S, 2019, EQUINE VET J, V51, P813, DOI 10.1111/evj.13076; Frischknecht M, 2016, ANIM GENET, V47, P227, DOI 10.1111/age.12406; Gianola D, 2004, GENETICS, V167, P1407, DOI 10.1534/genetics.103.025734; Karin Meyer, 2007, Journal of Zhejiang University-Science B, V8, P815, DOI 10.1631/jzus.2007.B0815; Koenen EPC, 2004, LIVEST PROD SCI, V88, P77, DOI 10.1016/j.livprodsci.2003.10.011; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Leleu C, 2004, VET J, V168, P160, DOI 10.1016/S1090-0233(03)00109-6; Makvandi-Nejad S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039929; Molina A, 2008, LIVEST SCI, V116, P137, DOI 10.1016/j.livsci.2007.09.021; Novotna A, 2017, LIVEST SCI, V202, P1, DOI 10.1016/j.livsci.2017.05.012; Pfau T, 2006, J EXP BIOL, V209, P3742, DOI 10.1242/jeb.02439; Promerova M, 2014, ANIM GENET, V45, P274, DOI 10.1111/age.12120; Robilliard JJ, 2007, J EXP BIOL, V210, P187, DOI 10.1242/jeb.02611; Rosa GJM, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-6; Rovere G, 2017, J ANIM BREED GENET, V134, P162, DOI 10.1111/jbg.12241; Rovere G, 2015, J ANIM BREED GENET, V132, P441, DOI 10.1111/jbg.12166; Rustin M, 2009, J ANIM BREED GENET, V126, P378, DOI 10.1111/j.1439-0388.2008.00798.x; Schopke K, 2013, ARCH TIERZUCHT, V56, P658, DOI 10.7482/0003-9438-56-066; Signer-Hasler H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037282; Sole M, 2014, ANIMAL, V8, P192, DOI 10.1017/S1751731113002036; Teyssedre S, 2012, GENET SEL EVOL, V44, DOI 10.1186/1297-9686-44-32; Valera M, 2008, VET J, V178, P219, DOI 10.1016/j.tvjl.2007.07.031; Viklund A, 2018, J ANIM BREED GENET, V135, P62, DOI 10.1111/jbg.12311; Viklund A, 2010, ANIMAL, V4, P1823, DOI 10.1017/S1751731110001175; Viklund A, 2010, ANIMAL, V4, P682, DOI 10.1017/S1751731110000017; Wallin L, 2003, LIVEST PROD SCI, V82, P61, DOI 10.1016/S0301-6226(02)00307-X; Welker V, 2018, LIVEST SCI, V212, P93, DOI 10.1016/j.livsci.2018.04.002; Witte TH, 2006, J EXP BIOL, V209, P4389, DOI 10.1242/jeb.02518	39	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0244064	10.1371/journal.pone.0244064	http://dx.doi.org/10.1371/journal.pone.0244064			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326505	Green Published, gold			2022-12-27	WOS:000600176400019
J	Thorson, JLM; Beck, D; Ben Maamar, M; Nilsson, EE; McBirney, M; Skinner, MK				Thorson, Jennifer L. M.; Beck, Daniel; Ben Maamar, Millissia; Nilsson, Eric E.; McBirney, Margaux; Skinner, Michael K.			Epigenome-wide association study for atrazine induced transgenerational DNA methylation and histone retention sperm epigenetic biomarkers for disease	PLOS ONE			English	Article							ENDOCRINE DISRUPTOR VINCLOZOLIN; EXPOSURE; OBESITY; CHEMICALS; INHERITANCE; PACKAGE; GENES	Atrazine is a common agricultural herbicide previously shown to promote epigenetic transgenerational inheritance of disease to subsequent generations. The current study was designed as an epigenome-wide association study (EWAS) to identify transgenerational sperm disease associated differential DNA methylation regions (DMRs) and differential histone retention regions (DHRs). Gestating female F0 generation rats were transiently exposed to atrazine during the period of embryonic gonadal sex determination, and then subsequent F1, F2, and F3 generations obtained in the absence of any continued exposure. The transgenerational F3 generation males were assessed for disease and sperm collected for epigenetic analysis. Pathology was observed in pubertal onset and for testis disease, prostate disease, kidney disease, lean pathology, and multiple disease. For these pathologies, sufficient numbers of individual males with only a single specific disease were identified. The sperm DNA and chromatin were isolated from adult one-year animals with the specific diseases and analyzed for DMRs with methylated DNA immunoprecipitation (MeDIP) sequencing and DHRs with histone chromatin immunoprecipitation (ChIP) sequencing. Transgenerational F3 generation males with or without disease were compared to identify the disease specific epimutation biomarkers. All pathologies were found to have disease specific DMRs and DHRs which were found to predominantly be distinct for each disease. No common DMRs or DHRs were found among all the pathologies. Epimutation gene associations were identified and found to correlate to previously known disease linked genes. This is one of the first observations of potential sperm disease biomarkers for histone retention sites. Although further studies with expanded animal numbers are required, the current study provides evidence the EWAS analysis is effective for the identification of potential pathology epimutation biomarkers for disease susceptibility.	[Thorson, Jennifer L. M.; Beck, Daniel; Ben Maamar, Millissia; Nilsson, Eric E.; McBirney, Margaux; Skinner, Michael K.] Washington State Univ, Sch Biol Sci, Ctr Reprod Biol, Pullman, WA 99164 USA	Washington State University	Skinner, MK (corresponding author), Washington State Univ, Sch Biol Sci, Ctr Reprod Biol, Pullman, WA 99164 USA.	skinner@wsu.edu	Ben Maamar, Millissia/D-8094-2015	Ben Maamar, Millissia/0000-0002-2022-922X; Nilsson, Eric/0000-0001-8894-4054	John Templeton Foundation [50183, 61174]; NIH [ES012974]	John Templeton Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by John Templeton Foundation (50183 and 61174) (https://templeton.org/) grants to MKS and NIH (ES012974) (https://www.nih.gov/) grant to MKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, CANC DISCOV, V8, pOF6; [Anonymous], 2019, PROG RETIN EYE RES; [Anonymous], 2014, PLOS ONE, V9, P1, DOI [10.1371/journal.pone.0109970, DOI 10.1371/JOURNAL.PONE.0109970, DOI 10.1371/J0URNAL.P0NE.0109970]; [Anonymous], 2018, PLOS ONE, V13, P1, DOI DOI 10.3171/2018.1.JNS172645; [Anonymous], 2018, DIAB PRAKT, V4, P1, DOI DOI 10.1186/s40798-017-0116-x; Anway MD, 2008, PROSTATE, V68, P517, DOI 10.1002/pros.20724; Anway MD, 2006, ENDOCRINOLOGY, V147, P5515, DOI 10.1210/en.2006-0640; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Barakat R, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62584-w; Ben Maamar M, 2020, GLYPHOSATE INDUCED T; Ben Maamar M, 2020, DEV BIOL, V465, P31, DOI 10.1016/j.ydbio.2020.06.008; Ben Maamar M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23612-y; Bock C, 2009, EPIGENOMICS-UK, V1, P99, DOI 10.2217/EPI.09.6; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Braun JM, 2017, NAT REV ENDOCRINOL, V13, P161, DOI 10.1038/nrendo.2016.186; Brehm E, 2019, ENDOCRINOLOGY, V160, P1421, DOI 10.1210/en.2019-00034; Bretz F, 2005, METHOD INFORM MED, V44, P431; Calvin H I, 1976, Methods Cell Biol, V13, P85, DOI 10.1016/S0091-679X(08)61798-7; Casati L, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00037; Cleary JA, 2019, ENVIRON POLLUT, V251, P639, DOI 10.1016/j.envpol.2019.05.013; Cummings AM, 2000, TOXICOL SCI, V58, P135, DOI 10.1093/toxsci/58.1.135; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Davis LK, 2011, REPROD TOXICOL, V32, P43, DOI 10.1016/j.reprotox.2011.04.004; Devlin B, 2003, GENET EPIDEMIOL, V25, P36, DOI 10.1002/gepi.10237; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Eldridge JC, 2008, REV ENVIRON CONTAM T, V196, P147, DOI 10.1007/978-0-387-78444-1_6; Expert Panel on Women's I, 2018, J AM COLL RADIOL, V15, pS365, DOI DOI 10.1016/J.JACR.2018.09.023; Fudvoye J, 2019, BEST PRACT RES CL EN, V33, DOI 10.1016/j.beem.2019.101300; Gillette R, 2018, EPIGENETICS-US, V13, P1106, DOI 10.1080/15592294.2018.1543506; Gore AC, 2015, ENDOCR REV, V36, pE1, DOI 10.1210/er.2015-1010; GUSTAFSSON P., 2012, PLOS ONE, V7, P1; Hayes TB, 2011, J STEROID BIOCHEM, V127, P64, DOI 10.1016/j.jsbmb.2011.03.015; Heindel JJ, 2019, ANNU REV PHARMACOL, V59, P89, DOI 10.1146/annurev-pharmtox-010818-021304; Higdon R, 2008, BIOINFORMATICS, V24, P1225, DOI 10.1093/bioinformatics/btn120; Hill NR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158765; Howard SG, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00513; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; HUANG TTF, 1985, AM J ANAT, V174, P249, DOI 10.1002/aja.1001740307; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Jowa L, 2011, J ENVIRON SCI HEAL C, V29, P91, DOI 10.1080/10590501.2011.577681; Jung SH, 2010, METHODS MOL BIOL, V620, P203, DOI 10.1007/978-1-60761-580-4_5; Kabir ER, 2015, ENVIRON TOXICOL PHAR, V40, P241, DOI 10.1016/j.etap.2015.06.009; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lienhard M, 2014, BIOINFORMATICS, V30, P284, DOI 10.1093/bioinformatics/btt650; Lin ZM, 2013, TOXICOL APPL PHARM, V273, P140, DOI 10.1016/j.taap.2013.08.010; Lin ZM, 2013, NEUROTOXICOL TERATOL, V39, P26, DOI 10.1016/j.ntt.2013.06.002; Manikkam M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055387; Manikkam M, 2012, REPROD TOXICOL, V34, P708, DOI 10.1016/j.reprotox.2012.08.010; Martini M, 2020, HORM BEHAV, V119, DOI 10.1016/j.yhbeh.2020.104677; McAllister EJ, 2009, CRIT REV FOOD SCI, V49, P868, DOI 10.1080/10408390903372599; McBirney M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184306; Mennigen JA, 2018, ENVIRON HEALTH-GLOB, V17, DOI 10.1186/s12940-018-0362-5; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Morris DL, 2016, TRANSL RES, V172, P1, DOI 10.1016/j.trsl.2016.02.010; Namulanda G, 2017, ENVIRON RES, V156, P420, DOI 10.1016/j.envres.2017.04.004; Nilsson EE, 2008, REPRODUCTION, V135, P713, DOI 10.1530/REP-07-0542; Nilsson R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-38; Official Publication of Joint Commission Requirements, 2017, JT COMM PERSPECT, V37, P3; Phillips LK, 2008, CURR HYPERTENS REP, V10, P156, DOI 10.1007/s11906-008-0029-7; Rattan S, 2019, BIOL REPROD, V101, P635, DOI 10.1093/biolre/ioz081; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saalfeld GQ, 2019, ENVIRON SCI POLLUT R, V26, P34953, DOI 10.1007/s11356-019-06577-x; Sanchez OF, 2020, ENVIRON POLLUT, V258, DOI 10.1016/j.envpol.2019.113712; Skinner MK, 2008, REPROD TOXICOL, V25, P2, DOI 10.1016/j.reprotox.2007.09.001; Skinner MK, 2018, EPIGENET CHROMATIN, V11, DOI 10.1186/s13072-018-0178-0; Skinner MK, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-228; Skinner MK, 2011, REPROD TOXICOL, V31, P337, DOI 10.1016/j.reprotox.2010.10.012; Skinner MK, 2010, TRENDS ENDOCRIN MET, V21, P214, DOI 10.1016/j.tem.2009.12.007; Solomon KR, 2013, ENVIRON TOXICOL CHEM, V32, P10, DOI 10.1002/etc.2050; Stone WW, 2014, WATERSHED REGRESSION; Stouder C, 2010, REPRODUCTION, V139, P373, DOI 10.1530/REP-09-0340; Taylor JA, 2011, J STEROID BIOCHEM, V127, P83, DOI 10.1016/j.jsbmb.2011.07.005; Tracey R, 2013, REPROD TOXICOL, V36, P104, DOI 10.1016/j.reprotox.2012.11.011; UGAZIO G, 1991, RES COMMUN CHEM PATH, V74, P349; van Steenwyk G, 2018, ENVIRON EPIGENETICS, V4, DOI 10.1093/eep/dvy023; Wang DD, 2019, CELL MOL NEUROBIOL, V39, P1003, DOI 10.1007/s10571-019-00695-3; Winston JJ, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0161-9; Xie F, 2012, CELL PHYSIOL BIOCHEM, V29, P111, DOI 10.1159/000337592; Xin F, 2015, SEMIN CELL DEV BIOL, V43, P66, DOI 10.1016/j.semcdb.2015.05.008; Yang HU, 2007, BIOINFORMATICS, V23, P38, DOI 10.1093/bioinformatics/btl548; Yilmaz B, 2020, REV ENDOCR METAB DIS, V21, P127, DOI 10.1007/s11154-019-09521-z; 2010, SLUZBENI GLASNIK RS, V5, P1	86	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0239380	10.1371/journal.pone.0239380	http://dx.doi.org/10.1371/journal.pone.0239380			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326428	gold, Green Published			2022-12-27	WOS:000600176400009
J	Rodriguez, DM; Ryff, K; Sanchez-Gonzalez, L; Rivera-Amill, V; Paz-Bailey, G; Adams, L				Rodriguez, Dania M.; Ryff, Kyle; Sanchez-Gonzalez, Liliana; Rivera-Amill, Vanessa; Paz-Bailey, Gabriela; Adams, Laura			HTrack: A new tool to facilitate public health field visits and electronic data capture	PLOS ONE			English	Article								Many applications have been developed for electronic data collection. However, offline field navigation tools incorporating secure electronic data capture and field visit tracking are currently scarce. We created an R-Shiny application, HTrack (Household Tracking), for use on encrypted Android devices in the field. The application was implemented in the Communities Organized to Prevent Arboviruses (COPA) project, a study beginning in 2018 to better understand arboviral disease incidence in 38 communities in Puerto Rico. The application was used to navigate to randomly selected structures and capture visit outcomes after conducting multiple visits for participant recruitment. It also served as a bridge to an alternate software, Epi Info, to collect participant-level questionnaire data. This application successfully captured each visit outcome and improved the logistics of field level activities for the COPA project, eliminating the use of paper maps for navigation. We show the development of HTrack and comment on the limitations and strengths of this application and further improvements.	[Rodriguez, Dania M.; Ryff, Kyle; Sanchez-Gonzalez, Liliana; Paz-Bailey, Gabriela; Adams, Laura] Ctr Dis Control & Prevent, Div Vector Borne Dis, San Juan, PR 00920 USA; [Rivera-Amill, Vanessa] Ponce Hlth Sci Univ, Ponce Res Inst, Ponce, PR USA	Centers for Disease Control & Prevention - USA; Ponce Health Sciences University	Rodriguez, DM (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Dis, San Juan, PR 00920 USA.	DRodriguezVargas@cdc.gov	Sánchez-González, Liliana/GZK-6297-2022	Sánchez-González, Liliana/0000-0001-8289-8587; Rodriguez, Dania/0000-0003-2837-3629	 [U01CK000437]		All authors who are federal employees have nothing to disclose and wish to declare no conflicts of interest. Authors who are not federal employees (VR) wish to provide acknowledgement to grant number U01CK000437. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], R LANG ENV STAT COMP; Camp B, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2334-8; Carrasco-Escobar G, 2019, PEERJ, V7, DOI 10.7717/peerj.6298; Chang W, SHINYDASHBOARD CREAT; Chang W., Shiny: Web Application Framework for R2020 R Package Version 1.4.0.2 2021; Cheng J., 2018, LEAFLET CREATE INTER; Dean A, 2011, EPI INFO DATABASE ST; DroidScript Ltd Future Business Centre, 2013, DROIDSCRIPT JAVASCRI; Esri, COLL ARCGIS OV; Esri, NAV ARCGIS; Esri, INTRODUCTION; Esri, SURVEY123 ARCGIS; Esri, 2011, ARCGIS DESKT; Esri, ARCGIS; Esri, QUICKCAPTURE ARCGIS; Ferreira D, 2012, GPS CONNECTED VERSIO; Fornace KM, 2018, INT J HEALTH GEOGR, V17, DOI 10.1186/s12942-018-0141-0; Karambelkar B., 2018, LEAFLET EXTRAS EXTRA; Loecher M., 2016, RGOOGLEMAPS OVERLAYS; Nowak MM, 2020, GLOB ECOL CONSERV, V23, DOI 10.1016/j.gecco.2020.e01089; Raja A, 2014, Online J Public Health Inform, V5, P228, DOI 10.5210/ojphi.v5i3.4996; Su Y, 2003, AMIA Annu Symp Proc, P1023; UserLAnd Technologies, 2018, USERLAND VERS 2 7 2; van Rossum G., 1995, CENTRUM WISKUNDE INF; Xie Y., 2018, **DATA OBJECT**	25	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0244028	10.1371/journal.pone.0244028	http://dx.doi.org/10.1371/journal.pone.0244028			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320896	gold, Green Published			2022-12-27	WOS:000600339800057
J	Santos, CM; Palinkas, M; Mestriner, W; Regalo, IH; de Vasconcelos, PB; Dias, FJ; Hallak, JEC; Siessere, S; Regalo, SCH				Santos, Carla Moreto; Palinkas, Marcelo; Mestriner-Junior, Wilson; Regalo, Isabela Hallak; de Vasconcelos, Paulo Batista; Jose Dias, Fernando; Cecilio Hallak, Jaime Eduardo; Siessere, Selma; Hallak Regalo, Simone Cecilio			Stomathognatic system function in indigenous people from Brazilian Xingu villages: An electromyographic analysis	PLOS ONE			English	Article							MASTICATORY MUSCLE-ACTIVITY; CHILDREN; RECOMMENDATIONS; COMMUNICATION; ADAPTATION; PATTERNS	The maintenance of postural balance can be influenced by the lifestyle of a population. This study aimed to determine the electromyographic activity of the masseter and temporalis muscles during mandibular tasks and habitual and non-habitual chewing in indigenous individuals to reveal the differences among white Brazilian individuals. Sixty Brazilians (18 and 28 years) were divided into two groups: 30 Xingu indigenous individuals and 30 white Brazilian individuals, with 20 men and 10 women in each group. The individuals were assessed using the normalized electromyographic activity of mandibular tasks (rest, protrusion, right and left laterality) and electromyographic activity of masticatory cycles in habitual (peanuts and raisins) and non-habitual (Parafilm M) chewing. Data were analyzed using Student's t-test (p < .05). Comparisons between the groups demonstrated significant differences. Indigenous individuals group presented a decrease in the normalized electromyographic activity of the masticatory muscles during mandibular rest [right masseter (p = .002) and left masseter (p = .004) muscles]. There was increase in the normalized electromyographic activity during protrusion [left temporal (p = .03) muscle]. There was increase in the electromyographic activity during chewing: peanuts [right masseter (p = .001), left masseter (p = .001) and right temporal (p = .01) muscles], raisins [right masseter (p = .001), left masseter (p = .002), right temporal (p = .008), left temporal (p = .01) muscles] and Parafilm M [left masseter muscle (p = .05)]. From the findings of this study, we concluded that in the comparison between indigenous and white individuals, positive changes were observed in the electromyographic pattern of the masticatory muscles in the mandibular postural conditions, with greater masticatory efficiency in the indigenous group.	[Santos, Carla Moreto; Palinkas, Marcelo; Mestriner-Junior, Wilson; Regalo, Isabela Hallak; de Vasconcelos, Paulo Batista; Siessere, Selma; Hallak Regalo, Simone Cecilio] Univ Sao Paulo, Ribeirao Preto Sch Dent, Dept Basic & Oral Biol, Sao Paulo, Brazil; [Palinkas, Marcelo] Fac Anhanguera, Dept Nursing, Ribeirao Preto, Brazil; [Palinkas, Marcelo; Regalo, Isabela Hallak; Cecilio Hallak, Jaime Eduardo; Siessere, Selma; Hallak Regalo, Simone Cecilio] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Neurosci & Behav Sci, Ribeirao Preto, Brazil; [Palinkas, Marcelo; Regalo, Isabela Hallak; Cecilio Hallak, Jaime Eduardo; Siessere, Selma; Hallak Regalo, Simone Cecilio] Natl Inst & Technol Translational Med INCT TM, Ribeirao Preto, Brazil; [Jose Dias, Fernando] Univ La Frontera, Dent Sch, Res Ctr Dent Sci CICO, Dept Integral Adults Dent, Temuco, Chile	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidad de La Frontera	Palinkas, M (corresponding author), Univ Sao Paulo, Ribeirao Preto Sch Dent, Dept Basic & Oral Biol, Sao Paulo, Brazil.; Palinkas, M (corresponding author), Fac Anhanguera, Dept Nursing, Ribeirao Preto, Brazil.; Palinkas, M (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Neurosci & Behav Sci, Ribeirao Preto, Brazil.; Palinkas, M (corresponding author), Natl Inst & Technol Translational Med INCT TM, Ribeirao Preto, Brazil.	marcelopalinkas@hotmail.com	Regalo, Simone Cecilio Hallak/AAJ-9773-2021; Siessere, Selma/B-7943-2012; Dias, Fernando Jose/AAP-7420-2020; Regalo, Simone Cecilio Hallak/B-8097-2012; Dias, Fernando Jose/D-8228-2014; Palinkas, Marcelo/C-4167-2015	Regalo, Simone Cecilio Hallak/0000-0003-4110-8299; Siessere, Selma/0000-0001-9756-3771; Dias, Fernando Jose/0000-0001-9945-9185; Palinkas, Marcelo/0000-0002-3445-8154	Sao Paulo Research Foundation (FAPESP, Brazil) [04/11748-7]	Sao Paulo Research Foundation (FAPESP, Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by the Sao Paulo Research Foundation (FAPESP, Brazil - #04/11748-7).	Abdalla HB, 2021, J PROSTHODONT, V30, P142, DOI 10.1111/jopr.13235; Abu Serdaneh S, 2020, INT J PAEDIATR DENT, V30, P303, DOI 10.1111/ipd.12611; Ambrose SH, 2006, SCIENCE, V314, P930, DOI 10.1126/science.1135741; Andrade GC, 2018, NUTRIENTS, V10, DOI 10.3390/nu10020218; [Anonymous], 2020, CHEMCATCHEM, V12, pXXX; Cecilio FA, 2010, J ORAL REHABIL, V37, P248, DOI 10.1111/j.1365-2842.2010.02051.x; de Lacerda AT, 2020, REV PAUL PEDIATR, V38, DOI 10.1590/1984-0462/2020/38/2019034; Di Palma Elena, 2017, J Clin Exp Dent, V9, pe886, DOI 10.4317/jced.53986; Dworkin Samuel F., 1992, Journal of Craniomandibular Disorders, V6, P301; Fagundes Ulysses, 2002, J. Pediatr. (Rio J.), V78, P383, DOI 10.1590/S0021-75572002000500008; Florindo AA, 2013, BMC PUBLIC HEALTH, V13, DOI [10.1186/1471-2458-13-794, 10.1186/1471-2458-13-1066, 10.1186/1471-2458-13-52]; Greenstein C, 2016, J PHYSIOTHER, V62, P42, DOI 10.1016/j.jphys.2015.08.010; Grillo CM, 2015, J ACUPUNCT MERIDIAN, V8, P192, DOI 10.1016/j.jams.2014.12.001; Regalo SCH, 2008, ARCH ORAL BIOL, V53, P282, DOI 10.1016/j.archoralbio.2007.10.003; Regalo SCH, 2018, J OROFAC ORTHOP, V79, P39, DOI 10.1007/s00056-017-0117-x; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Hoogmartens M J, 1987, Electromyogr Clin Neurophysiol, V27, P3; Koolstra JH, 2002, CRIT REV ORAL BIOL M, V13, P366, DOI 10.1177/154411130201300406; Le Reverend B, 2016, PHYSIOL BEHAV, V165, P136, DOI 10.1016/j.physbeh.2016.07.010; Mattos A, 1999, J AM COLL NUTR, V18, P88, DOI 10.1080/07315724.1999.10718832; Normando D, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230809; Normando D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028387; Orchardson R, 1998, FRONT ORAL BIOL, V9, P76; Pereira TS, 2017, CODAS, V29, DOI 10.1590/2317-1782/20172015301; Popkin BM, 2018, OBES REV, V19, P1028, DOI 10.1111/obr.12694; Qaisar R, 2016, FREE RADICAL BIO MED, V98, P56, DOI 10.1016/j.freeradbiomed.2016.03.025; Rathee M., 2020, STATPEARLS; Safari Anahita, 2013, J Contemp Dent Pract, V14, P616; Schiffman E, 2014, J ORAL FACIAL PAIN H, V28, P6, DOI 10.11607/jop.1151; SHAH H, 1991, INT J INTERCULT REL, V15, P311, DOI 10.1016/0147-1767(91)90004-Z; Sierpinska T, 2015, ARCH ORAL BIOL, V60, P1346, DOI 10.1016/j.archoralbio.2015.06.006; Siessere S, 2009, OSTEOPOROSIS INT, V20, P1847, DOI 10.1007/s00198-009-0885-2; Tomonari H, 2019, CLIN ORAL INVEST, V23, P3445, DOI 10.1007/s00784-018-2754-x; Ushimura A, 2015, BEHAV BRAIN RES, V278, P520, DOI 10.1016/j.bbr.2014.10.031; Verri ED, 2019, J ORAL REHABIL, V46, P912, DOI 10.1111/joor.12824; Vieira EP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116138; Welch JR, 2009, HUM ECOL, V37, P13, DOI 10.1007/s10745-009-9216-7	37	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243495	10.1371/journal.pone.0243495	http://dx.doi.org/10.1371/journal.pone.0243495			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320876	Green Published, gold			2022-12-27	WOS:000600339800036
J	Koene, FM; Amano, E; Smidt, ED; Ribas, LLF				Koene, Franciele Marx; Amano, Erika; Smidt, Eric de Camargo; Fortes Ribas, Luciana Lopes			Asymbiotic germination and morphological studies of seeds of Atlantic Rainforest micro-orchids (Pleurothallidinae)	PLOS ONE			English	Article							VITRO SEEDLING DEVELOPMENT; NATIVE CALIFORNIA; MORPHOMETRY; EMBRYOLOGY; CALYPSO	The morphological and morphometric characters of seeds belonging to 11 species of the subtribe Pleurothallidinae using light and scanning electron microscopy were studied to understand the in vitro germination process. Qualitative data (color, shape, ornamentation) and quantitative ones were also evaluated in seeds and embryos (length, width, volume and air space percentage between the integument and the embryo). The viability of the seeds was evaluated by in vitro germination in woody plant medium (WPM), and by analysis of the developmental stages of protocorms until seedling formation (two to 24 weeks). Morphometric data showed variations within the genus Acianthera and between species of different genera. The best germination and protocorm formation responses occurred with Acianthera prolifera (92%) and Acianthera ochreata (86%), with the formation of seedlings after 12 and 16 weeks of sowing, respectively. The seeds and embryos of A. prolifera and A. ochreata were larger (length, width, and volume) with a structural polarity that may have facilitated their germination comparing to others studied species. Other characteristics of A. prolifera seeds that may have contributed to these results include the presence of a thin testa without ornamentation and a suspensor. The protocorms of Anathalis obovata, Dryadella liliputiana, and Octomeria gracillis developed slowly in the WPM, not reaching the seedling stage in 24 weeks of cultivation. This morphological and morphometric study contributes to the understanding of asymbiotic germination of some micro-orchid species.	[Koene, Franciele Marx; Amano, Erika; Smidt, Eric de Camargo; Fortes Ribas, Luciana Lopes] Univ Fed Parana, Setor Ciencias Biol, Dept Bot, Curitiba, PR, Brazil	Universidade Federal do Parana	Ribas, LLF (corresponding author), Univ Fed Parana, Setor Ciencias Biol, Dept Bot, Curitiba, PR, Brazil.	llfribas@ufpr.br	Smidt, Eric C/F-7632-2011	Smidt, Eric C/0000-0002-1177-1682; Ribas, Luciana/0000-0003-1099-1090	CNPQ	CNPQ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors would like to thank CNPQ for the Master's scholarship granted to Franciele Marx Koene.	[Anonymous], 2020, ZENODO, V21, P1; Arditti J, 2000, NEW PHYTOL, V145, P367, DOI 10.1046/j.1469-8137.2000.00587.x; ARDITTI J, 1979, AM J BOT, V66, P1128, DOI 10.2307/2442211; ARDITTI J, 1980, AM J BOT, V67, P347, DOI 10.2307/2442345; Aybeke M, 2014, PLANT SYST EVOL, V300, P91, DOI 10.1007/s00606-013-0862-2; Balilashaki K, 2020, J HORTIC SCI BIOTECH, V95, P542, DOI 10.1080/14620316.2020.1727782; Barman D., 2013, Journal of Crop and Weed, V9, P1; Barthlott Wilhelm, 2014, V32, P1; CHASE MW, 1988, SYST BOT, V13, P313, DOI 10.2307/2419295; Dangat BT., 2016, RICHARDIANA, V16, P174; Diantina S, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9020161; Endres D, 2014, ACTA BOT BRAS, V28, P489, DOI 10.1590/0102-33062014abb3158; [Anonymous], 2018, Rodriguésia, V69, P1513, DOI 10.1590/2175-7860201869402; Gamarra R, 2007, BOT J LINN SOC, V153, P133, DOI 10.1111/j.1095-8339.2006.00603.x; Gamarra R, 2018, PLANT SYST EVOL, V304, P665, DOI 10.1007/s00606-018-1497-0; Guler Necmettin, 2016, PhytoKeys, P9; Hosomi ST, 2011, SEED SCI TECHNOL, V39, P178, DOI 10.15258/sst.2011.39.1.15; Karremans Adam P., 2016, Lankesteriana, V16, P219, DOI 10.15517/lank.v16i2.26008; Kauth P.J., 2008, FLORICULTURE ORNAMEN, P375; Knudson Lewis, 1946, AMER ORCHID SOC BULL, V15, P214; Koene FM, 2019, S AFR J BOT, V121, P83, DOI 10.1016/j.sajb.2018.07.019; Lee YI, 2008, BOT STUD, V49, P139; Lloyd G., 1980, Combined Proceedings, International Plant Propagators' Society, V30, P421; Menini Neto L., 2009, RODRIGUEISIA, V60, P461, DOI [10.1590/2175-7860200960216, DOI 10.1590/2175-7860200960216]; Millner HJ, 2008, J TORREY BOT SOC, V135, P497, DOI 10.3159/08-RA-059R1.1; Molvray M, 2003, GENERA ORCHIDACEARUM, P59, DOI [10.3732/ajb.90.3.429, DOI 10.3732/AJB.90.3.429]; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Pence Valerie C., 2010, Kew Bulletin, V65, P539, DOI 10.1007/s12225-011-9245-4; Phillips GC, 2019, IN VITRO CELL DEV-PL, V55, P242, DOI 10.1007/s11627-019-09983-5; Pridgeon A. M., 2005, GENERA ORCHIDACEAR 1, V4, P319; Pridgeon A.M., 1999, GENERA ORCHIDACEARUM; Reddy J., 2016, WORLD J PHARM RES, V5, P1719; Santos S. A. dos, 2016, African Journal of Biotechnology, V15, P134; Simonelli M., 2007, ESPECIES FLORA AMEAC; Suzuki RM, 2012, IN VITRO CELL DEV-PL, V48, P500, DOI 10.1007/s11627-012-9460-1; Swamy K. Krishna, 2004, Taiwania, V49, P124; Tsutsumi C, 2007, J PLANT RES, V120, P405, DOI 10.1007/s10265-007-0077-0; VACIN EF, 1949, BOT GAZ, V110, P605, DOI 10.1086/335561; Vij S. P., 2012, Proceedings of the National Academy of Sciences India. Section B, Biological Sciences, V82, P295; Vij SP, 1992, ORCHID NEWS, V8, P12; Vudala SM, 2017, S AFR J BOT, V108, P1, DOI 10.1016/j.sajb.2016.09.008; YEUNG EC, 1992, CAN J BOT, V70, P461, DOI 10.1139/b92-061; Yeung EC, 2018, SPRINGER PROTOC HAND, P3, DOI 10.1007/978-1-4939-7771-0_1; Yeung EC, 2017, BOT STUD, V58, DOI 10.1186/s40529-017-0188-4; Zappi Daniela C., 2015, Rodriguésia, V66, P1085, DOI 10.1590/2175-7860201566411; Zeng SJ, 2014, CRIT REV BIOTECHNOL, V34, P358, DOI 10.3109/07388551.2013.841117	47	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243297	10.1371/journal.pone.0243297	http://dx.doi.org/10.1371/journal.pone.0243297			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315920	gold, Green Published			2022-12-27	WOS:000600186100082
J	Umezawa, K; Niikura, M; Kojima, Y; Goodell, B; Yoshida, M				Umezawa, Kiwamu; Niikura, Mai; Kojima, Yuka; Goodell, Barry; Yoshida, Makoto			Transcriptome analysis of the brown rot fungus Gloeophyllum trabeum during lignocellulose degradation	PLOS ONE			English	Article							WOOD DECAY; POSTIA-PLACENTA; POLYSACCHARIDE MONOOXYGENASE; SECRETOME ANALYSIS; WOLFIPORIA-COCOS; BIODEGRADATION; MECHANISMS; EXPRESSION; SPECIFICITY; PROTEINS	Brown rot fungi have great potential in biorefinery wood conversion systems because they are the primary wood decomposers in coniferous forests and have an efficient lignocellulose degrading system. Their initial wood degradation mechanism is thought to consist of an oxidative radical-based system that acts sequentially with an enzymatic saccharification system, but the complete molecular mechanism of this system has not yet been elucidated. Some studies have shown that wood degradation mechanisms of brown rot fungi have diversity in their substrate selectivity. Gloeophyllum trabeum, one of the most studied brown rot species, has broad substrate selectivity and even can degrade some grasses. However, the basis for this broad substrate specificity is poorly understood. In this study, we performed RNA-seq analyses on G. trabeum grown on media containing glucose, cellulose, or Japanese cedar (Cryptomeria japonica) as the sole carbon source. Comparison to the gene expression on glucose, 1,129 genes were upregulated on cellulose and 1,516 genes were upregulated on cedar. Carbohydrate Active enZyme (CAZyme) genes upregulated on cellulose and cedar media by G. trabeum included glycoside hyrolase family 12 (GH12), GH131, carbohydrate esterase family 1 (CE1), auxiliary activities family 3 subfamily 1 (AA3_1), AA3_2, AA3_4 and AA9, which is a newly reported expression pattern for brown rot fungi. The upregulation of both terpene synthase and cytochrome P450 genes on cedar media suggests the potential importance of these gene products in the production of secondary metabolites associated with the chelator-mediated Fenton reaction. These results provide new insights into the inherent wood degradation mechanism of G. trabeum and the diversity of brown rot mechanisms.	[Umezawa, Kiwamu; Niikura, Mai; Kojima, Yuka; Yoshida, Makoto] Tokyo Univ Agr & Technol, Dept Environm & Nat Resource Sci, Tokyo, Japan; [Umezawa, Kiwamu] Kindai Univ, Dept Appl Biol Chem, Nara, Japan; [Goodell, Barry] Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA	Tokyo University of Agriculture & Technology; Kindai University (Kinki University); University of Massachusetts System; University of Massachusetts Amherst	Umezawa, K (corresponding author), Tokyo Univ Agr & Technol, Dept Environm & Nat Resource Sci, Tokyo, Japan.; Umezawa, K (corresponding author), Kindai Univ, Dept Appl Biol Chem, Nara, Japan.	umezawa@nara.kindai.ac.jp	Goodell, Barry/CAI-6720-2022; Yoshida, Makoto/E-8017-2013	Goodell, Barry/0000-0002-7798-7419; Umezawa, Kiwamu/0000-0003-1277-0558	JSPS KAKENHI [18H02252, 18H04148]; National Institute of Food and Agriculture, U.S. Department of Agriculture; Center for Agriculture, Food and the Environment; Microbiology department at University of Massachusetts Amherst [S1075 -MAS00503]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); National Institute of Food and Agriculture, U.S. Department of Agriculture(United States Department of Agriculture (USDA)); Center for Agriculture, Food and the Environment; Microbiology department at University of Massachusetts Amherst	This study was finantially supported by by JSPS KAKENHI Grant-in-Aid for Scientific Research (B) Grant Number 18H02252 and Grantin-Aid for Scientific Research (A) 18H04148 to M. Y. and the National Institute of Food and Agriculture, U.S. Department of Agriculture, the Center for Agriculture, Food and the Environment, and the Microbiology department at University of Massachusetts Amherst, under project number S1075 -MAS00503 to B. G.. The contents are solely the responsibility of the authors and do not necessarily represent the official views of the USDA or NIFA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, NUCLEIC ACIDS RES, V40, pD71; Arantes V, 2008, J APPL MICROBIOL, V104, P185, DOI 10.1111/j.1365-2672.2007.03540.x; Arantes V, 2006, J CHEM TECHNOL BIOT, V81, P413, DOI 10.1002/jctb.1417; Arantes V, 2012, APPL MICROBIOL BIOT, V94, P323, DOI 10.1007/s00253-012-3954-y; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Bromann K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035450; Busch A, 2019, BMC EVOL BIOL, V19, DOI 10.1186/s12862-019-1429-9; Cohen R, 2004, APPL ENVIRON MICROB, V70, P324, DOI 10.1128/AEM.70.1.324-331.2004; Couturier M, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0407-8; Daniel G, 2007, APPL ENVIRON MICROB, V73, P6241, DOI 10.1128/AEM.00977-07; Danilewicz JC, 2014, J AGR FOOD CHEM, V62, P5149, DOI 10.1021/jf5007402; Eastwood DC, 2011, SCIENCE, V333, P762, DOI 10.1126/science.1205411; Eriksson K-EL., 1990, MICROBIAL ENZYMATIC, P1, DOI DOI 10.1007/978-3-642-46687-8; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Gaskell J, 2016, APPL ENVIRON MICROB, V82, P3979, DOI 10.1128/AEM.00639-16; Giffhorn F, 2000, APPL MICROBIOL BIOT, V54, P727, DOI 10.1007/s002530000446; Goodell B, 1997, J BIOTECHNOL, V53, P133, DOI 10.1016/S0168-1656(97)01681-7; Goodell B, 2003, ACS SYM SER, V845, P97; Goodell B, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-017-0865-2; Hammel KE, 2002, ENZYME MICROB TECH, V30, P445, DOI 10.1016/S0141-0229(02)00011-X; Hatakka A, 2010, MYCOTA, V10, P319; Hegnar OA, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.02612-18; Henriksson G, 2000, J BIOTECHNOL, V78, P93, DOI 10.1016/S0168-1656(00)00206-6; Heritier J, 2016, FOOD CHEM, V211, P957, DOI 10.1016/j.foodchem.2016.05.009; Highley T. L., 1973, Wood and Fiber, V5, P50; Hori C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004759; Ide M, 2012, ARCH MICROBIOL, V194, P243, DOI 10.1007/s00203-011-0753-2; Jawallapersand P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107209; Jensen KA, 2002, APPL ENVIRON MICROB, V68, P2699, DOI 10.1128/AEM.68.6.2699-2703.2002; Kaffenberger JT, 2013, APPL MICROBIOL BIOT, V97, P8831, DOI 10.1007/s00253-013-5142-0; Kamada F, 2002, MICROBIOL-SGM, V148, P1939, DOI 10.1099/00221287-148-6-1939; Kerem Z, 1999, FEBS LETT, V446, P49, DOI 10.1016/S0014-5793(99)00180-5; Kojima Y, 2016, APPL ENVIRON MICROB, V82, P6557, DOI 10.1128/AEM.01768-16; Krah FS, 2018, BMC EVOL BIOL, V18, DOI 10.1186/s12862-018-1229-7; Kuuskeri J, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0608-9; Lafond M, 2012, APPL ENVIRON MICROB, V78, P8540, DOI 10.1128/AEM.02572-12; Levasseur A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-41; Lim YR, 2012, ARCH BIOCHEM BIOPHYS, V528, P111, DOI 10.1016/j.abb.2012.09.001; Lo CC, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0366-2; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Marinovic M, 2018, FUNGAL GENET BIOL, V112, P47, DOI 10.1016/j.fgb.2017.07.004; Martinez D, 2009, P NATL ACAD SCI USA, V106, P1954, DOI 10.1073/pnas.0809575106; Nurika I, 2020, J IND MICROBIOL BIOT, V47, P145, DOI 10.1007/s10295-019-02238-7; Paszczynski A, 1999, APPL ENVIRON MICROB, V65, P674; Pedrini N, 2015, P NATL ACAD SCI USA, V112, pE3651, DOI 10.1073/pnas.1504552112; Phillips CM, 2011, ACS CHEM BIOL, V6, P1399, DOI 10.1021/cb200351y; Presley GN, 2018, APPL ENVIRON MICROB, V84, DOI [10.1128/aem.00159-18, 10.1128/AEM.00159-18]; Presley GN, 2018, INT J MICROBIOL, V2018, DOI 10.1155/2018/4961726; Quin MB, 2014, NAT PROD REP, V31, P1449, DOI 10.1039/c4np00075g; Riley R, 2014, P NATL ACAD SCI USA, V111, P9923, DOI 10.1073/pnas.1400592111; Ryu JS, 2011, APPL ENVIRON MICROB, V77, P7933, DOI 10.1128/AEM.05496-11; Syed K, 2012, CRIT REV MICROBIOL, V38, P339, DOI 10.3109/1040841X.2012.682050; Tamaru Y, 2019, INT J BIOL MACROMOL, V128, P340, DOI 10.1016/j.ijbiomac.2019.01.149; Tanaka H, 2007, J BIOTECHNOL, V128, P500, DOI 10.1016/j.jbiotec.2006.12.010; Troya MT, 2009, INVEST AGRAR-SIST R, V18, P289; Vanden Wymelenberg A, 2006, APPL ENVIRON MICROB, V72, P4871, DOI 10.1128/AEM.00375-06; Varela E, 2003, APPL ENVIRON MICROB, V69, P6025, DOI 10.1128/AEM.69.10.6025-6031.2003; Wei DS, 2010, APPL ENVIRON MICROB, V76, P2091, DOI 10.1128/AEM.02929-09; Williamson G, 1998, MICROBIOL-SGM, V144, P2011, DOI 10.1099/00221287-144-8-2011; Wu BJ, 2018, APPL ENVIRON MICROB, V84, DOI [10.1128/AEM.00991-18, 10.1128/aem.00991-18]; Wymelenberg AV, 2011, APPL ENVIRON MICROB, V77, P4499, DOI 10.1128/AEM.00508-11; Wymelenberg AV, 2010, APPL ENVIRON MICROB, V76, P3599, DOI 10.1128/AEM.00058-10; Zhang JW, 2016, P NATL ACAD SCI USA, V113, P10968, DOI 10.1073/pnas.1608454113; Zhuang LP, 2015, RSC ADV, V5, P104043, DOI 10.1039/c5ra19203j	64	7	7	5	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243984	10.1371/journal.pone.0243984	http://dx.doi.org/10.1371/journal.pone.0243984			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315957	gold, Green Published			2022-12-27	WOS:000600186100055
J	Zhang, Z; Li, Q				Zhang, Zhen; Li, Qiang			The ratio of expansion to compression: A new measure of lifespan disparity	PLOS ONE			English	Article							AGE; EXPECTANCY; DEMOGRAPHY	Numerous studies have shown that high life expectancy is closely related to low life disparity. Unlike life expectancy, which can be increased by mortality decline at any age, life disparity can either increase or decrease in response to mortality decline. Disparity can thus be decomposed into two opposite components, called compression and expansion, depending on the effect of mortality decline on the age distribution of mortality. Without specifying the two components, various conventional measures of disparity may provide misleading information relating to how life chances in society can be equalized. Based on the relevant properties of changes in disparity, we develop a new measure of disparity-the ratio of expansion to compression-that can account for the relative importance of the two components. This simple measure not only provides a clear view of the evolution of disparity, but also permits changes in disparity related to mortality decline to be interpreted in a consistent manner similar to life expectancy. Simulations and an empirical analysis demonstrated the advantages of this new measure over conventional measures of disparity.	[Zhang, Zhen] Fudan Univ, Sch Social Dev & Publ Policy, Inst Populat Res, Shanghai, Peoples R China; [Li, Qiang] East China Normal Univ, Sch Social Dev, Populat Res Inst, Shanghai, Peoples R China	Fudan University; East China Normal University	Li, Q (corresponding author), East China Normal Univ, Sch Social Dev, Populat Res Inst, Shanghai, Peoples R China.	qli@soci.ecnu.edu.cn			National Natural Science Foundation of China [71473044]; Shanghai Planning Office of Philosophy and Social Science [2019BSH002, 2020BSH014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Planning Office of Philosophy and Social Science	This work was supported by the National Natural Science Foundation of China to ZZ (Grant No. 71473044) and Shanghai Planning Office of Philosophy and Social Science to QL (2019BSH002) and to ZZ (2020BSH014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburto JM, 2020, P NATL ACAD SCI USA, V117, P5250, DOI 10.1073/pnas.1915884117; Aburto JM, 2019, DEMOGR RES, V41, P83, DOI 10.4054/DemRes.2019.41.4; Barbi E, 2018, SCIENCE, V360, P1459, DOI 10.1126/science.aat3119; Canudas-Romo V, 2005, DEMOGR RES, V13, P63, DOI 10.4054/DemRes.2005.13.3; Cheung SLK, 2005, DEMOGRAPHY, V42, P243, DOI 10.1353/dem.2005.0012; Dong X, 2016, NATURE, V538, P257, DOI 10.1038/nature19793; Edwards RD, 2005, POPUL DEV REV, V31, P645, DOI 10.1111/j.1728-4457.2005.00092.x; GOLDMAN N, 1986, DEMOGRAPHY, V23, P275, DOI 10.2307/2061621; Human MD, 2020, HUMAN MORTALITY DATA; Keyfitz N, 2005, STAT BIOL HEALTH, P1, DOI 10.1007/b139042; Oeppen J, 2002, SCIENCE, V296, P1029, DOI 10.1126/science.1069675; Shkolnikov V.M., 2003, DEMOGR RES, V8, P305, DOI [DOI 10.4054/DEMRES.2003.8.11, 10.4054/DemRes.2003.8.11]; Shkolnikov VM, 2011, DEMOGRAPHY, V48, P211, DOI 10.1007/s13524-011-0015-6; SILER W, 1979, ECOLOGY, V60, P750, DOI 10.2307/1936612; Tuljapurkar S, 2000, NATURE, V405, P789, DOI 10.1038/35015561; van Raalte AA, 2018, SCIENCE, V362, P1002, DOI 10.1126/science.aau5811; van Raalte AA, 2013, DEMOGRAPHY, V50, P1615, DOI 10.1007/s13524-013-0223-3; Vaupel JW, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000128; Vaupel JW, 2003, DEMOGRAPHY, V40, P201, DOI 10.1353/dem.2003.0018; VAUPEL JW, 1986, POP STUD-J DEMOG, V40, P147, DOI 10.1080/0032472031000141896; Walberg P, 1998, BRIT MED J, V317, P312, DOI 10.1136/bmj.317.7154.312; Zhang Z, 2009, DEMOGR RES, V20, P721, DOI 10.4054/DemRes.2009.20.29	22	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243482	10.1371/journal.pone.0243482	http://dx.doi.org/10.1371/journal.pone.0243482			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH1MP	33315959	Green Published, gold			2022-12-27	WOS:000600186100047
J	Hindriks, R				Hindriks, Rikkert			Lag-invariant detection of interactions in spatially-extended systems using linear inverse modeling	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; MEG; EEG; REGULARIZATION; COMMUNICATION; NETWORKS	Measurements on physical systems result from the systems' activity being converted into sensor measurements by a forward model. In a number of cases, inversion of the forward model is extremely sensitive to perturbations such as sensor noise or numerical errors in the forward model. Regularization is then required, which introduces bias in the reconstruction of the systems' activity. One domain in which this is particularly problematic is the reconstruction of interactions in spatially-extended complex systems such as the human brain. Brain interactions can be reconstructed from non-invasive measurements such as electroencephalography (EEG) or magnetoencephalography (MEG), whose forward models are linear and instantaneous, but have large null-spaces and high condition numbers. This leads to incomplete unmixing of the forward models and hence to spurious interactions. This motivated the development of interaction measures that are exclusively sensitive to lagged, i.e. delayed interactions. The drawback of such measures is that they only detect interactions that have sufficiently large lags and this introduces bias in reconstructed brain networks. We introduce three estimators for linear interactions in spatially-extended systems that are uniformly sensitive to all lags. We derive some basic properties of and relationships between the estimators and evaluate their performance using numerical simulations from a simple benchmark model.	[Hindriks, Rikkert] Vrije Univ Amsterdam, Dept Math, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Hindriks, R (corresponding author), Vrije Univ Amsterdam, Dept Math, Amsterdam, Netherlands.	r.hindriks@vu.nl		Hindriks, Rikkert/0000-0003-3575-186X	NWO-Wiskundeclusters grant [613.009.105]	NWO-Wiskundeclusters grant	R.H. Rikkert Hindriks is supported by the NWO-Wiskundeclusters grant nr. 613.009.105, made available by the Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) www.nwo.nl.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlot S, 2010, STAT SURV, V4, P40, DOI 10.1214/09-SS054; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Basti A, 2018, NEUROIMAGE, V175, P161, DOI 10.1016/j.neuroimage.2018.03.004; Bastos AM, 2016, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00175; Brookes MJ, 2011, P NATL ACAD SCI USA, V108, P16783, DOI 10.1073/pnas.1112685108; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Colclough GL, 2015, NEUROIMAGE, V117, P439, DOI 10.1016/j.neuroimage.2015.03.071; de Haan W, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-101; Drakesmith M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081553; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 2015, NEURON, V88, P220, DOI 10.1016/j.neuron.2015.09.034; Gohel B, 2017, IRBM, V38, P127, DOI 10.1016/j.irbm.2017.03.002; Gratiy SL, 2017, EUR J NEUROSCI, V45, P1013, DOI 10.1111/ejn.13534; Grech R, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-25; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Hansen P. C., 2010, DISCRETE INVERSE PRO; HANSEN PC, 1993, SIAM J SCI COMPUT, V14, P1487, DOI 10.1137/0914086; Hassan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105041; Hauk O., 2019, OBJECTIVE EVALUATION; Hauk O, 2011, NEUROIMAGE, V54, P1966, DOI 10.1016/j.neuroimage.2010.09.053; Hincapie A.-S., 2016, PARAMETERS, V2016, P12; Hindriks R, 2017, BIORXIV; Hindriks R, 2011, HUM BRAIN MAPP, V32, P1161, DOI 10.1002/hbm.21099; Hipp JF, 2012, NAT NEUROSCI, V15, P884, DOI 10.1038/nn.3101; Mitsuhata Y, 2004, GEOPHYS PROSPECT, V52, P213, DOI 10.1111/j.1365-2478.2004.00412.x; Nicholson C, 1975, J CLIN NEUROPHYSIOL; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; Nolte G, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.051913; O'Neill GC, 2015, PHYS MED BIOL, V60, pR271, DOI 10.1088/0031-9155/60/21/R271; Ossadtchi A, 2018, NEUROIMAGE, V183, P950, DOI 10.1016/j.neuroimage.2018.08.031; Palva JM, 2018, NEUROIMAGE, V173, P632, DOI 10.1016/j.neuroimage.2018.02.032; Palva S, 2012, TRENDS COGN SCI, V16, P219, DOI 10.1016/j.tics.2012.02.004; Pascual-marqui RD, 2017, INNOVATIONS ORTHOGON, P1; Pereda E, 2005, PROG NEUROBIOL, V77, P1, DOI 10.1016/j.pneurobio.2005.10.003; Rizkallah J, 2019, BIORXIV, DOI [10.1101/617118, DOI 10.1101/617118]; Schoffelen JM, 2009, HUM BRAIN MAPP, V30, P1857, DOI 10.1002/hbm.20745; Shen YZ, 2012, J GEODESY, V86, P597, DOI 10.1007/s00190-012-0542-y; Pereira SS, 2017, BRAIN CONNECT, V7, P541, DOI 10.1089/brain.2017.0525; Stam CJ, 2007, HUM BRAIN MAPP, V28, P1178, DOI 10.1002/hbm.20346; Vallarino E, 2019, 2 STEP ESTIMATION CR, P1; Wang SH, 2018, NEUROIMAGE, V173, P610, DOI 10.1016/j.neuroimage.2018.01.056; Wens V, 2015, HUM BRAIN MAPP, V36, P4604, DOI 10.1002/hbm.22943; Wens V, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.012823	43	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0242715	10.1371/journal.pone.0242715	http://dx.doi.org/10.1371/journal.pone.0242715			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306719	gold, Green Published			2022-12-27	WOS:000600144200069
J	Kim, W; Lee, H; Chung, YD				Kim, Wooil; Lee, Hyubjin; Chung, Yon Dohn			Safe contact tracing for COVID-19: A method without privacy breach using functional encryption techniques based-on spatio-temporal trajectory data	PLOS ONE			English	Article								The COVID-19 pandemic has spread all over the globe. In the absence of a vaccine, a small number of countries have managed to control the diffusion of viruses by early detection and early quarantine. South Korea, one of the countries which have kept the epidemics well-controlled, has opened the infected patients' trajectory to the public. Such a reaction has been regarded as an effective method, however, serious privacy breach cases have been issued in South Korea. Furthermore, some suspected contacts have refused to take infection tests because they are afraid of being exposed. To solve this problem, we propose a privacy-preserving contact tracing method based on spatio-temporal trajectory which can be practically used in many quarantine systems. In addition, we develop a system to visualize the contact tracing workflow.	[Kim, Wooil; Lee, Hyubjin; Chung, Yon Dohn] Korea Univ, Dept Comp Sci & Engn, Seoul, South Korea	Korea University	Chung, YD (corresponding author), Korea Univ, Dept Comp Sci & Engn, Seoul, South Korea.	ydchung@korea.ac.kr			MSIT (Ministry of Science and ICT), Korea, under the ICT Creative Consilience program [IITP-2020-0-01819]; National Research Foundation of Korea [NRF-2020K2A9A1A01095894]	MSIT (Ministry of Science and ICT), Korea, under the ICT Creative Consilience program; National Research Foundation of Korea(National Research Foundation of Korea)	This research was supported by a grant from the MSIT (Ministry of Science and ICT), Korea, under the ICT Creative Consilience program (IITP-2020-0-01819) supervised by the IITP (Institute for Information & communications Technology Planning & Evaluation) for WK, HL and YDC, and under the framework of international cooperation program managed by the National Research Foundation of Korea (NRF-2020K2A9A1A01095894) for WK and YDC.	[Anonymous], 2020, UPD COVID 19 REP KOR; [Anonymous], 2020, EP UPD MONK MULT OUT; [Anonymous], 2020, TIMES; [Anonymous], 2020, TIMES NY; Boneh D, 2011, LECT NOTES COMPUT SC, V6597, P253, DOI 10.1007/978-3-642-19571-6_16; Canetti R., 2020, ANONYMOUS COLLOCATIO; Carreno B., 2020, REUTERS 0311; Douriez M, 2016, PROCEEDINGS OF 3RD IEEE/ACM INTERNATIONAL CONFERENCE ON DATA SCIENCE AND ADVANCED ANALYTICS, (DSAA 2016), P140, DOI 10.1109/DSAA.2016.21; goverment agency S, 2020, TRACETOGETHER; He H, 2020, EFFICIENT SUSPECTED; Information SV, 2020, SCHENG AR CRIS EU ST; Jazeera A, 2020, JAZEERA A; Journal WS, 2020, J WS; Kim S, 2018, LECT NOTES COMPUT SC, V11035, P544, DOI 10.1007/978-3-319-98113-0_29; Li Y, 2019, PROCEEDINGS OF THE 2019 ACM ASIA CONFERENCE ON COMPUTER AND COMMUNICATIONS SECURITY (ASIACCS '19), P134, DOI 10.1145/3321705.3329829; Troncoso C., 2020, ARXIV; Wikipedia, 2020, COVID 19 PAND; World Health Organization, 2020, MENT HLTH PSYCH CONS; Yu Y.W., 2020, ARXIV PREPRINT ARXIV	19	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0242758	10.1371/journal.pone.0242758	http://dx.doi.org/10.1371/journal.pone.0242758			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306698	Green Submitted, gold, Green Published			2022-12-27	WOS:000600144200071
J	Yan, J; Zhang, HW; Hui, B				Yan, Jiao; Zhang, Hongwei; Hui, Bing			Analysis of the lateral slope's impact on the calculation of water-filled rut depth	PLOS ONE			English	Article							VISUAL INTERVENTION INFLUENCE; RUTTING MITIGATION; CRASH RATES; PAVEMENT	Accurate calculation of the water-filled rut depth is critical for assessing hydroplaning potential. Nevertheless, due to the difficulty in collecting and calculating the water-filled rut depth, most transportation agencies do not use i, especially in the case of lateral slopes, although water-filled rut depth is a key parameter that impacts driving safety. Contributions of this paper are development of a methodology to reliably compute the water-filled rut depth and quantitatively evaluate the influence of lateral slope on the water-filled rut depth. The proposed method include: 1) acquisition of the high-resolution 3D point cloud data of rut, 2) smooth processing of rut profile through moving average method with Matlab programming, 3) water-filled rut depth computation at different lateral slopes with the assistance of key points based on rut sections. With the variation of water-filled rut depth (Delta WD), its change rate (delta WD), and the calculation error between the rut depth and the water-filled rut depth (Delta(n)) as evaluation indexes, the variation law of water-filled rut depth under different lateral slopes is analyzed when considering the severity level and rut shape of the rut profile. Results show that: 1) the increase in lateral slope leads to the reduction of water-filled rut depth; 2) the water-filled rut depth is affected by the rut shape, including rut side wall's slope and the key points' elevation. The accurate calculation of the water-filled rut depth can provide reliable suggestions for safe driving.	[Yan, Jiao] Xian Aeronaut Univ, Sch Vehicle Engn, Xian, Shaanxi, Peoples R China; [Zhang, Hongwei] Key Lab Rd Struct & Mat Inner Mongolia, Hohhot, Peoples R China; [Zhang, Hongwei] Inner Mongolia Commun Construct Engn Qual Supervi, Hohhot, Peoples R China; [Hui, Bing] Changan Univ, Sch Highway, Xian, Shaanxi, Peoples R China	Xi'an Aeronautical University; Chang'an University	Yan, J (corresponding author), Xian Aeronaut Univ, Sch Vehicle Engn, Xian, Shaanxi, Peoples R China.	201901006@xaau.edu.cn			Key Laboratory of Transport Industry of Management, Control and Cycle Repair Technology for Traffic Network Facilities in Ecological Security Barrier Area (Inner Mongolia Transport Development Research Center) [2019KFJJ-004]; Key Research and Development Program of Shaanxi [2020ZDLGY16-01]	Key Laboratory of Transport Industry of Management, Control and Cycle Repair Technology for Traffic Network Facilities in Ecological Security Barrier Area (Inner Mongolia Transport Development Research Center); Key Research and Development Program of Shaanxi	The work described in this paper was sponsored by the Key Laboratory of Transport Industry of Management, Control and Cycle Repair Technology for Traffic Network Facilities in Ecological Security Barrier Area (Inner Mongolia Transport Development Research Center), Grant No. 2019KFJJ-004, Key Research and Development Program of Shaanxi (Program No. 2020ZDLGY16-01).	American Association of State and Highway Transportation Officials (AASHTO), 2014, PP6914 AASHTO; American Association of State and Highway Transportation Officials (AASHTO), 2017, PP7014 AASHTO; American Society for Testing and Materials (ASTM), 2015, E1703E1703M10 ASTM; [Anonymous], 2006, DIVERSE ISSUES HIGHE, V23, P14; CCCC First Highway Consultants, 2006, D202006 JTG CCCC 1 H; Cenek P.D., 2014, RELATIONSHIP CRASH R; CENEK PD, 1994, CONF PROC TRANSP RES, P265; Chen F, 2020, J CLEAN PROD, V256, DOI 10.1016/j.jclepro.2020.120669; Chen F, 2019, TRANSPORT RES C-EMER, V103, P17, DOI 10.1016/j.trc.2019.04.001; Florida Department of Transportation, 2012, FLEX PAV COND SURV H; Glenda J, 2009, EC134 TRANSP RES BOA; Guo Y, 2020, SIMULATION MODELLING, V106; Guo YY, 2019, TRANSPORT RES C-EMER, V101, P96, DOI 10.1016/j.trc.2019.02.009; Hui B., 2013, THESIS; Kamplade J., 1990, SURFACE CHARACTERIST, P211; Li QH, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/26/265101; Luo W., 2015, THESIS; Paterson W, 1988, ROAD DETERIORATION M; Qiu S, 2015, TRANSPORTATION RES B; Research Institute of Highway Ministry of Transport, 2008, E602008 NTG RES I HI; Research Institute of Highway Ministry of Transport, 2007, H202007 JTG RES I HI; Shanghai Highway Administration Bureau, 2001, 07322001 JTJ SHANGH; Shi LW, 2012, SPSS19 0 STAT ANAL E; Simpson A, 2013, IMPROVING FHWAS ABIL; Simpson A, 2001, CHARACTERIZATION TRA; Start MR, 1998, TRANSPORT RES REC, P208, DOI 10.3141/1629-23; Wang C, 2017, SPATIOTEMPORAL METHO; Wu G, 2019, INT J PAVEMENT ENG, V20, P734, DOI 10.1080/10298436.2017.1334460; Zeng Q, 2019, TRANSPORTMETRICA A, V15, P1867, DOI 10.1080/23249935.2019.1652867; Zeng Q, 2020, J TRANSP SAF SECUR, V12, P566, DOI 10.1080/19439962.2018.1516259; Zeng Q, 2017, ACCIDENT ANAL PREV, V99, P184, DOI 10.1016/j.aap.2016.11.018; Zhu XY, 2019, INT J PAVEMENT ENG, V20, P573, DOI 10.1080/10298436.2017.1316646	32	2	2	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243952	10.1371/journal.pone.0243952	http://dx.doi.org/10.1371/journal.pone.0243952			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306737	gold, Green Published			2022-12-27	WOS:000600144200021
J	Kajungu, D; Muhoozi, M; Stark, J; Weibel, D; Sturkenboom, MCJM				Kajungu, Dan; Muhoozi, Michael; Stark, James; Weibel, Daniel; Sturkenboom, Miriam C. J. M.			Vaccines safety and maternal knowledge for enhanced maternal immunization acceptability in rural Uganda: A qualitative study approach	PLOS ONE			English	Article							ACELLULAR PERTUSSIS-VACCINE; PREGNANT-WOMEN; INFANTS; SURVEILLANCE; DELIVERY	Background Maternal immunization is a successful and cost-effective public health strategy. It protects pregnant women and their infants from vaccine-preventable diseases. Uganda is exploring new vaccines for pregnant women like replacing Tetanus Toxoid (TT) with Tetanus-Diphtheria (Td). Research on knowledge, attitudes, beliefs, and willingness among pregnant women is needed before the introduction of vaccines for pregnant women. This study was aimed at exploring maternal knowledge, attitudes, willingness, and beliefs towards maternal immunization among pregnant women in rural Uganda. Methods This was a qualitative descriptive study. Ten focus group discussions (FGDs) were conducted at antenatal care (ANC) clinics and in a rural community of Uganda. Five key informant interviews (KIIs) were done with health workers, for triangulation. Considering context and research characteristics, data were collected and thematically analyzed. Results Women were familiar with the importance of maternal vaccines, had positive attitudes, and expressed willingness to take them. Acceptance of a new vaccine could be affected by worries of pregnant women and that of their partners, who influence health seeking decisions in a home concerning adverse events, following the maternal immunization (AEFI). There were misconceptions about introduction of vaccines such as the belief that vaccines treat malaria and general body weakness, and being used as guinea pigs to test for the vaccine before its introduction to the larger population. Conclusion A range of diverse sentiments and beliefs may affect uptake and acceptability of vaccines that are introduced in communities. For instance, ignoring vaccine safety concerns may impede maternal immunization acceptability, because pregnant women and their husbands are concerned about AEFI. Moreover, husbands make all health-seeking decisions at home, and their opinion is key, when considering such interventions.	[Kajungu, Dan; Muhoozi, Michael] Makerere Univ, Ctr Hlth & Populat Res MUCHAP, Kampala, Uganda; [Kajungu, Dan; Sturkenboom, Miriam C. J. M.] Univ Utrecht, Julius Global Hlth, Med Ctr, Utrecht, Netherlands; [Stark, James] Putnam Associates, Boston, MA USA; [Weibel, Daniel] Weibel Consulting, The Hague, Netherlands	Makerere University; Utrecht University	Kajungu, D (corresponding author), Makerere Univ, Ctr Hlth & Populat Res MUCHAP, Kampala, Uganda.; Kajungu, D (corresponding author), Univ Utrecht, Julius Global Hlth, Med Ctr, Utrecht, Netherlands.	dan.kajungu@gmail.com	Muhoozi, Michael/AAD-4563-2022	Muhoozi, Michael/0000-0003-2460-9980; Kajungu PhD, Dan/0000-0002-3363-7062	GCRF Networks in Vaccines Research and Development - MRC; BBSRC [ITCR079018]	GCRF Networks in Vaccines Research and Development - MRC; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the GCRF Networks in Vaccines Research and Development which was co-funded by the MRC and BBSRC. Grant Number: IMPRINT Network-ITCR079018. The funder provided support in the form of salaries for authors DK and MM but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Abimbola JM, 2016, AFR HEALTH SCI, V16, P962, DOI 10.4314/ahs.v16i4.12; ANDERSEN R, 1973, MILBANK FUND Q, V51, P95, DOI 10.2307/3349613; [Anonymous], 2014, SAF IMM PREGN REV EV; Babirye JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035432; Babirye JN, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-723; Cassidy C, 2015, PHARMACOEPIDEM DR S, V24, P361, DOI 10.1002/pds.3754; Chimatiro CS, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0605-5; Das S, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4097-y; Davis J, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1759-4; Ding XX, 2014, J AFFECT DISORDERS, V159, P103, DOI 10.1016/j.jad.2014.02.027; Ditekemena J, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-32; Ellingson MK, 2019, EXPERT REV VACCINES, V18, P191, DOI 10.1080/14760584.2019.1562907; Englund J.A, 2015, MATERNAL IMMUNIZATIO; Foo DYP, 2020, PEDIATRICS, V146, DOI 10.1542/peds.2020-0375; Fouda Genevieve G, 2018, Immunohorizons, V2, P14, DOI 10.4049/immunohorizons.1700057; Furuta M, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1559-2; Gavi The Vaccine Alliance, 2019, COFINANCING INFORM S; Gebremichael MW, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-2026-4; Giles ML, 2020, VACCINE, V38, P5278, DOI 10.1016/j.vaccine.2020.05.025; Giles ML, 2019, HUM VACC IMMUNOTHER, V15, P687, DOI 10.1080/21645515.2018.1540807; Handy LK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180759; Kajungu D, 2020, INT J EPIDEMIOLOGY; Khan AA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-322; Kilich E, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234827; Krishnaswamy S, 2019, HUM VACC IMMUNOTHER, V15, P942, DOI 10.1080/21645515.2018.1564433; Lorini C, 2018, HUM VACC IMMUNOTHER, V14, P478, DOI 10.1080/21645515.2017.1392423; Macdonald V, 2007, SEX HEALTH, V4, P27, DOI 10.1071/SH06008; MacDougall DM, 2016, HUM VACC IMMUNOTHER, V12, P857, DOI 10.1080/21645515.2015.1101524; Maluka SO, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-020-2823-4; Mannava P, 2015, GLOBALIZATION HEALTH, V11, DOI 10.1186/s12992-015-0117-9; Marak Anju R, 2017, Indian J Public Health, V61, P146, DOI 10.4103/ijph.IJPH_222_16; Marti M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172310; New S, 2018, MMWR-MORBID MORTAL W, V67, P1068, DOI 10.15585/mmwr.mm6738a6; Nganga SW, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4537-8; Nunes MC, 2018, HUM VACC IMMUNOTHER, V14, P758, DOI 10.1080/21645515.2017.1345385; Odeny B, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2438-9; OLeary S., 2017, OPEN FORUM INFECT DI, DOI [10.1093/ofid/ofx163.1338, DOI 10.1093/OFID/OFX163.1338]; Omer SB, 2009, NEW ENGL J MED, V360, P1981, DOI 10.1056/NEJMsa0806477; Phillips E, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1546-7; PIVI, 2018, BUILD FLU VACC PROGR; Poliquin V, 2019, J OBSTET GYNAECOL CA, V41, P1344, DOI 10.1016/j.jogc.2018.05.042; Pugliese-Garcia M, 2018, VACCINE, V36, P5617, DOI [10.1016/j.vaccine.2017.10.108, 10.1016/j.vaccine.2018.07.042]; Sawyer M, 2013, MMWR-MORBID MORTAL W, V62, P131; Shewamene Z, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1886-x; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Stark JH, 2019, INT HEALTH, V11, P128, DOI 10.1093/inthealth/ihy066; UNEPI, 2012, UG NAT EXP PROGR IMM; Varan AK, 2014, VACCINE, V32, P785, DOI 10.1016/j.vaccine.2013.12.054; Vygen-Bonnet S, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-4824-3; Waldman EA, 2011, REV SAUDE PUBL, V45, P173, DOI 10.1590/S0034-89102011000100020; WHO, 2017, CAUS CHILD MORT; WHO, 2018, FIELD GUID QUAL RES; WHO/UNICEF, 2019, ENS SUST PROT DIPHTH; Williams AL, 2019, HUM VACC IMMUNOTHER, V15, P283, DOI 10.1080/21645515.2018.1526589; Williams AL, 2018, VACCINE, V36, P3048, DOI 10.1016/j.vaccine.2018.03.081; World Hlth Org, 2018, VACCINE, V36, P3573, DOI 10.1016/j.vaccine.2017.02.034	56	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243834	10.1371/journal.pone.0243834	http://dx.doi.org/10.1371/journal.pone.0243834			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301495	Green Published, gold			2022-12-27	WOS:000600143100030
J	Kim, YN; Kim, H; Shin, HS; Lee, S; Lee, N; Park, MJ; Song, W; Jeong, S				Kim, Ye Na; Kim, Hyoung; Shin, Ho Sik; Lee, Sangjin; Lee, Nuri; Park, Min-Jeong; Song, Wonkeun; Jeong, Seri			The risk factors for treatment-related mortality within first three months after kidney transplantation	PLOS ONE			English	Article							RENAL-TRANSPLANTATION; PATIENT SURVIVAL; GRAFT LOSS; DEATH; OUTCOMES; AMINOTRANSFERASE; DEFINITION; DIALYSIS; PROGRESS; IMPACT	Mortality at an early stage after kidney transplantation is a disastrous event. Treatment-related mortality (TRM) within 1 or 3 months after kidney transplantation has been rarely reported. We designed a cohort study using the national Korean Network for Organ Sharing database that includes information about kidney recipients between 2002 and 2016. Their demographic, and laboratory data were collected to analyze risk factors of TRM. A total of 19,815 patients who underwent kidney transplantation in any of 40 medical centers were included. The mortality rates 1 month (early TRM) and 3 months (TRM) after transplantation were 1.7% (n = 330) and 4.1% (n = 803), respectively. Based on a multivariate analysis, older age (hazard ratio [HR] = 1.044), deceased donor (HR = 2.210), re-transplantation (HR = 1.675), ABO incompatibility (HR = 1.811), higher glucose (HR = 1.002), and lower albumin (HR = 0.678) were the risk factors for early TRM. Older age (HR = 1.014), deceased donor (HR = 1.642), and hyperglycemia (HR = 1.003) were the common independent risk factors for TRM. In contrast, higher serum glutamic oxaloacetic transaminase (HR = 1.010) was associated with TRM only. The identified risk factors should be considered in patient counselling, and management to prevent TRM. The recipients assigned as the high-risk group require intensive management including glycemic control at the initial stage after transplant.	[Kim, Ye Na; Shin, Ho Sik] Kosin Univ, Gospel Hosp, Dept Internal Med, Div Nephrol Transplantat,Coll Med, Busan, South Korea; [Kim, Hyoung] Hallym Univ, Hallym Kidney Res Inst, Dept Internal Med, Coll Med, Seoul, South Korea; [Lee, Sangjin] Pusan Natl Univ, Grad Sch, Dept Stat, Busan, South Korea; [Lee, Nuri; Park, Min-Jeong; Song, Wonkeun; Jeong, Seri] Hallym Univ, Kangnam Sacred Heart Hosp, Dept Lab Med, Coll Med, Seoul, South Korea	Hallym University; Pusan National University; Hallym University	Jeong, S (corresponding author), Hallym Univ, Kangnam Sacred Heart Hosp, Dept Lab Med, Coll Med, Seoul, South Korea.	hehebox@naver.com	Lee, Nuri/AAE-7551-2022; LEE, SANGJIN/GLT-9252-2022; Kim, Do Hyoung/AAE-7557-2022	LEE, SANGJIN/0000-0001-5646-8276; Kim, Do Hyoung/0000-0002-8664-8830; Jeong, Seri/0000-0002-4199-7033	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [NRF-2017R1C1B2004597]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	This work was supported by the National Research Foundation of Korea (NRF) grant, funded by the Ministry of Science, ICT & Future Planning (grant No. NRF-2017R1C1B2004597]. SJ received this fund. URL: http://www.nrf.re.kr/index The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	a R-M, 2020, J CLIN MED, V9; Akirov A, 2017, AM J MED, V130, DOI 10.1016/j.amjmed.2017.07.020; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; Arend SM, 1997, NEPHROL DIAL TRANSPL, V12, P1672, DOI 10.1093/ndt/12.8.1672; Baek CH, 2018, KOREAN J INTERN MED, V33, P356, DOI 10.3904/kjim.2016.067; Begg CB, 1998, JAMA-J AM MED ASSOC, V280, P1747, DOI 10.1001/jama.280.20.1747; Bilo H, 2015, NEPHROL DIAL TRANSPL, V30, P1, DOI 10.1093/ndt/gfv100; Briggs JD, 2001, NEPHROL DIAL TRANSPL, V16, P1545, DOI 10.1093/ndt/16.8.1545; Chapman JR, 2017, AM J KIDNEY DIS, V69, P287, DOI 10.1053/j.ajkd.2016.08.024; Choi H, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236274; de Weerd AE, 2018, CLIN J AM SOC NEPHRO, V13, P1234, DOI 10.2215/CJN.00540118; DELMONICO FL, 1994, ARCH SURG-CHICAGO, V129, P354; DIETHELM AG, 1995, ANN SURG, V221, P446, DOI 10.1097/00000658-199505000-00002; Doshi MD, 2007, AM J TRANSPLANT, V7, P122, DOI 10.1111/j.1600-6143.2006.01587.x; Ethier MC, 2011, BLOOD, V118, P5080, DOI 10.1182/blood-2011-07-363333; Farrugia D, 2014, TRANSPL INT, V27, P262, DOI 10.1111/tri.12218; Finlayson E V, 2001, Eff Clin Pract, V4, P172; Fourtounas Costas, 2014, World J Transplant, V4, P102, DOI 10.5500/wjt.v4.i2.102; Gatta A, 2012, INTERN EMERG MED, V7, pS193, DOI 10.1007/s11739-012-0802-0; Gill JS, 2003, TRANSPLANTATION, V75, P113, DOI 10.1097/00007890-200301150-00021; Harciarek M, 2011, KIDNEY INT, V79, P1353, DOI 10.1038/ki.2011.40; Hariharan S, 2000, NEW ENGL J MED, V342, P605, DOI 10.1056/NEJM200003023420901; Howard RJ, 2002, TRANSPLANTATION, V73, P1923, DOI 10.1097/00007890-200206270-00013; Hu YN, 2014, ANN THORAC SURG, V97, P973, DOI 10.1016/j.athoracsur.2013.12.016; Hung KY, 1997, NEPHROL DIAL TRANSPL, V12, P180, DOI 10.1093/ndt/12.1.180; Kim CS, 2018, KOREAN J INTERN MED, V33, P293, DOI 10.3904/kjim.2018.024; Kim MK, 2019, DIABETES METAB J, V43, P398, DOI 10.4093/dmj.2019.0137; Loupy A, 2007, NEPHROL DIAL TRANSPL, V22, P2693, DOI 10.1093/ndt/gfm226; Morales JM, 2012, NEPHROL DIAL TRANSPL, V27, piv39, DOI 10.1093/ndt/gfs544; Mayo SC, 2011, HPB, V13, P473, DOI 10.1111/j.1477-2574.2011.00326.x; Mazzucchi E, 2006, TRANSPLANTATION, V81, P840, DOI 10.1097/01.tp.0000203559.57088.f6; Mise Y, 2015, ANN SURG, V262, P1071, DOI 10.1097/SLA.0000000000001048; Molnar MZ, 2011, AM J TRANSPLANT, V11, P1006, DOI 10.1111/j.1600-6143.2011.03480.x; Rao PS, 2005, NEPHROL DIAL TRANSPL, V20, P387, DOI 10.1093/ndt/gfh595; Ravel V, 2016, NEPHROL DIAL TRANSPL, V31, P814, DOI 10.1093/ndt/gfv310; Schaapherder A, 2018, ECLINICALMEDICINE, V4-5, P25, DOI 10.1016/j.eclinm.2018.09.007; Tonelli M, 2011, AM J TRANSPLANT, V11, P2093, DOI 10.1111/j.1600-6143.2011.03686.x; Visser BC, 2009, ARCH SURG-CHICAGO, V144, P1021, DOI 10.1001/archsurg.2009.197; Wang JH, 2016, ADV CHRONIC KIDNEY D, V23, P281, DOI 10.1053/j.ackd.2016.07.001; Welch HG, 2002, J NATL CANCER I, V94, P1066; Yildirim A, 2006, TRANSPLANT P, V38, P2831, DOI 10.1016/j.transproceed.2006.08.162	42	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243586	10.1371/journal.pone.0243586	http://dx.doi.org/10.1371/journal.pone.0243586			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301510	Green Published, gold			2022-12-27	WOS:000600143100001
J	Okawara, M; Nagata, T; Nagata, M; Otani, M; Mori, K; Fujino, Y				Okawara, Makoto; Nagata, Tomohisa; Nagata, Masako; Otani, Makoto; Mori, Koji; Fujino, Yoshihisa			Association between the course of hypnotics treatment for insomnia and work functioning impairment in Japanese workers	PLOS ONE			English	Article							HEALTH; PRODUCTIVITY; COST	Study objectives This cross-sectional study analyzed the effect of treatment with hypnotics for sleep disorders, particularly insomnia, on daytime work functioning by phase of treatment in Japanese workers. Methods Subjects were respondents (n = 36,375) to a questionnaire survey conducted in 2015 to assess work functioning impairment in 15 companies in Japan. The questionnaire results were analyzed together with the respondents' healthcare data extracted from public health insurance claims. Work functioning impairment was measured using the Work Functioning Impairment Scale (WFun). The status of treatment for insomnia was determined using data on diseases and prescribed drugs extracted from health insurance claims from the past 16 months. The odds ratio of severe work functioning impairment according to on-treatment duration and off-treatment duration was estimated using logistic regression analysis. Results The risk of severe work functioning impairment was significantly higher in subjects with insomnia who were being treated with hypnotics for 1 month or longer compared to non-insomnia subjects. This increased risk tended to be reduced with longer on-treatment duration. For subjects who had previously received hypnotics treatment for insomnia, the risk of severe work functioning impairment was significantly increased in all subgroups stratified by time from discontinuation of the prescription. This increased risk tended to be reduced with longer off-treatment duration. Conclusions Workers who are or were receiving hypnotics to treat insomnia may have a higher risk of daytime functioning impairment. Those with protracted insomnia require careful assessment of the risks and benefits of prescription hypnotics.	[Okawara, Makoto; Fujino, Yoshihisa] Univ Occupat & Environm Hlth, Inst Ind Ecol Sci, Dept Environm Epidemiol, Kitakyushu, Fukuoka, Japan; [Nagata, Tomohisa; Nagata, Masako; Mori, Koji] Univ Occupat & Environm Hlth, Inst Ind Ecol Sci, Dept Occupat Hlth Practice & Management, Kitakyushu, Fukuoka, Japan; [Otani, Makoto] Univ Occupat & Environm Hlth, Data Sci Ctr Occupat Hlth, Kitakyushu, Fukuoka, Japan	University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan	Okawara, M (corresponding author), Univ Occupat & Environm Hlth, Inst Ind Ecol Sci, Dept Environm Epidemiol, Kitakyushu, Fukuoka, Japan.	makotouoeh@med.uoeh-u.ac.jp	Okawara, Makoto/AAG-2516-2022; Okawara, Makoto/ACJ-5728-2022	Okawara, Makoto/0000-0002-2777-743X; Okawara, Makoto/0000-0002-2777-743X	JSPS KAKENHI [JP 18K10079]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number JP 18K10079. This grant was awarded to Yoshihisa Fujino. https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-18K10079/The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	[Anonymous], 2000, J EPIDEMIOL, V10, P79; DiBonaventura M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137117; Fortier-Brochu E, 2012, SLEEP MED REV, V16, P83, DOI 10.1016/j.smrv.2011.03.008; Fujino Y, 2015, J OCCUP HEALTH, V57, P521, DOI 10.1539/joh.15-0135-OA; Goetzel RZ, 2004, J OCCUP ENVIRON MED, V46, P398, DOI 10.1097/01.jom.0000121151.40413.bd; Ishak Waguih W, 2012, Innov Clin Neurosci, V9, P13; Kim K, 2000, SLEEP, V23, P41; Leger D, 2014, J SLEEP RES, V23, P143, DOI 10.1111/jsr.12104; Loeppke R, 2009, J OCCUP ENVIRON MED, V51, P411, DOI 10.1097/JOM.0b013e3181a39180; Mishima Kazuo, 2015, Nihon Rinsho, V73, P1036; Nagata T, 2018, J OCCUP ENVIRON MED, V60, pE273, DOI 10.1097/JOM.0000000000001291; Nagata T, 2017, J OCCUP ENVIRON MED, V59, P557, DOI 10.1097/JOM.0000000000001025; Qaseem A, 2016, ANN INTERN MED, V165, P125, DOI 10.7326/M15-2175; Rosekind MR, 2010, J OCCUP ENVIRON MED, V52, P91, DOI 10.1097/JOM.0b013e3181c78c30; Schutte-Rodin S, 2008, J CLIN SLEEP MED, V4, P487; Staner L, 2005, PSYCHOPHARMACOLOGY, V181, P790, DOI 10.1007/s00213-005-0082-8; Takemura S, 2007, GERIATR MED, V45, P679; Takeshima N, 2016, PSYCHIAT RES, V237, P201, DOI 10.1016/j.psychres.2016.01.040; 2005, EVANGELIKUS ELET, V43, P3	19	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243635	10.1371/journal.pone.0243635	http://dx.doi.org/10.1371/journal.pone.0243635			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301520	gold, Green Published			2022-12-27	WOS:000600143100028
J	Wang, Y; Yalcin, A; VandeWeerd, C				Wang, Yan; Yalcin, Ali; VandeWeerd, Carla			An entropy-based approach to the study of human mobility and behavior in private homes	PLOS ONE			English	Article								Understanding human mobility in outdoor environments is critical for many applications including traffic modeling, urban planning, and epidemic modeling. Using data collected from mobile devices, researchers have studied human mobility in outdoor environments and found that human mobility is highly regular and predictable. In this study, we focus on human mobility in private homes. Understanding this type of human mobility is essential as smart-homes and their assistive applications become ubiquitous. We model the movement of a resident using ambient motion sensor data and construct a chronological symbol sequence that represents the resident's movement trajectory. Entropy rate is used to quantify the regularity of the resident's mobility patterns, and an upper bound of predictability is estimated. However, the presence of visitors and malfunctioning sensors result in data that is not representative of the resident's mobility patterns. We apply a change-point detection algorithm based on penalized contrast function to detect these changes, and to identify the time periods when the data do not completely reflect the resident's activities. Experimental results using the data collected from 10 private homes over periods of 178 to 713 days show that human mobility at home is also highly predictable in the range of 70% independent of variations in floor plans and individual daily routines.	[Wang, Yan] Citibank NA, Tampa, FL USA; [Yalcin, Ali; VandeWeerd, Carla] Univ S Florida, Dept Ind & Management Syst Engn, Tampa, FL 33620 USA; [VandeWeerd, Carla] Univ Florida, Coll Med, Dept Hlth Outcomes & Biomed Informat, Gainesville, FL USA; [Wang, Yan] 3800 Citibank Ctr, Tampa, FL USA; [Yalcin, Ali; VandeWeerd, Carla] 4202 E Fowler Ave, Tampa, FL 33620 USA; [VandeWeerd, Carla] 2004 Mowry Rd, Gainesville, FL USA	State University System of Florida; University of South Florida; State University System of Florida; University of Florida	Yalcin, A (corresponding author), Univ S Florida, Dept Ind & Management Syst Engn, Tampa, FL 33620 USA.; Yalcin, A (corresponding author), 4202 E Fowler Ave, Tampa, FL 33620 USA.	ayalcin@usf.edu		Wang, Yan/0000-0002-4999-3686				Abowd G, 2002, WS0202 AAAI; Agoulmine N., 2011, IEEE Nanotechnology Magazine, V5, P6, DOI 10.1109/MNANO.2011.941951; Alam MR, 2012, IEEE T SYST MAN CY C, V42, P1190, DOI 10.1109/TSMCC.2012.2189204; [Anonymous], 2000, Contracept Technol Update, V21, P33; [Anonymous], 2013, POLAR GEOPOLITICS NE, V3, P1, DOI DOI 10.4236/NJGC.2013.31001; [Anonymous], 2010, SCIENCE, V327, P1018; [Anonymous], 2017, LANCET GLOBAL HLTH, V5, pe428; [Anonymous], 2005, GENOME BIOL, V6, P1; Austin D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090256; Barbosa H, 2018, PHYS REP, V734, P1, DOI 10.1016/j.physrep.2018.01.001; Barraquand F, 2008, ECOLOGY, V89, P3336, DOI 10.1890/08-0162.1; Belik V, 2011, PHYS REV X, V1, DOI 10.1103/PhysRevX.1.011001; Bengtsson L, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001083; Cai HX, 2004, IEEE T INFORM THEORY, V50, P1551, DOI 10.1109/TIT.2004.830771; Calenge C, 2011, ANAL ANIMAL MOVEMENT; Chan M, 2009, IFMBE PROC, V23, P1014; CHAN M, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON SYSTEMS, MAN AND CYBERNETICS, VOLS 1-5, P1586, DOI 10.1109/ICSMC.1995.537998; Cover TM, 1991, ELEMENTS INFORM THEO, P63; Cuttone A, 2018, EPJ DATA SCI, V7, DOI 10.1140/epjds/s13688-017-0129-1; Das S. K., 2014, P 2 INT C SMART HOM, P3; Das SK, 2002, IEEE WIREL COMMUN, V9, P77, DOI 10.1109/MWC.2002.1160085; Deen MJ, 2015, PERS UBIQUIT COMPUT, V19, P573, DOI 10.1007/s00779-015-0856-x; Feuz KD, 2015, IEEE T HUM-MACH SYST, V45, P575, DOI 10.1109/THMS.2014.2362529; Gazeaux J, 2013, J GEOPHYS RES-SOL EA, V118, P2397, DOI 10.1002/jgrb.50152; Ge Y., 2010, PROC 16 ACM SIGKDD I, P899, DOI [10.1145/1835804.1835918, DOI 10.1145/1835804.1835918]; Goulet-Langlois G, 2018, IEEE T INTELL TRANSP, V19, P1583, DOI 10.1109/TITS.2017.2728704; Guande Qi, 2011, 2011 IEEE International Conference on Pervasive Computing and Communications Workshops (PerCom Workshops 2011). PerCom-Workshops 2011: 2011 IEEE International Conference on Pervasive Computing and Communications Workshops (PERCOM Workshops 2011), P384, DOI 10.1109/PERCOMW.2011.5766912; Hao JG, 2016, INT CONF INTEL ENVIR, P103, DOI 10.1109/IE.2016.24; Helal S, 2005, COMPUTER, V38, P50, DOI 10.1109/MC.2005.107; Ikanovic EL, 2017, EPJ DATA SCI, V6, DOI 10.1140/epjds/s13688-017-0107-7; Intille SS, 2006, LECT NOTES COMPUT SC, V3968, P349; Jacobs PG, 2015, J AM ACAD AUDIOL, V26, P777, DOI 10.3766/jaaa.15010; Kaibin Bao, 2011, 2011 Eighth International Conference on Fuzzy Systems and Knowledge Discovery (FSKD 2011), P1335, DOI 10.1109/FSKD.2011.6019758; Kim J, 2010, P IEEE INT S WORLD W, P14; Lavielle M, 1999, STOCH PROC APPL, V83, P79, DOI 10.1016/S0304-4149(99)00023-X; Lavielle M, 2005, SIGNAL PROCESS, V85, P1501, DOI 10.1016/j.sigpro.2005.01.012; Lee D, 2015, IEEE T HUM-MACH SYST, V45, P624, DOI 10.1109/THMS.2015.2443712; Lee S, 2013, IEEE T HUM-MACH SYST, V43, P535, DOI 10.1109/THMS.2013.2285921; Lu CH, 2018, IEEE T HUM-MACH SYST, V48, P380, DOI 10.1109/THMS.2018.2844119; Majumder S, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17010130; McInerney J, 2013, PERVASIVE MOB COMPUT, V9, P808, DOI 10.1016/j.pmcj.2013.07.016; Mozer M. C., 1998, Intelligent Environments. Papers from the 1998 AAAI Symposium, P110; Niu YS, 2016, STAT SCI, V31, P611, DOI 10.1214/16-STS587; Rantz MJ, 2009, IEEE ENG MED BIO, P6159, DOI 10.1109/IEMBS.2009.5334587; Rao S. P., 2004, International Journal on Artificial Intelligence Tools (Architectures, Languages, Algorithms), V13, P81, DOI 10.1142/S0218213004001533; Remagnino P, 2005, IEEE T SYST MAN CY A, V35, P1, DOI 10.1109/TSMCA.2004.838456; Romig S., 2017, IEEE INFOCOM 2017 IE, P1, DOI DOI 10.1109/INFOCOM.2017.8057234; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Strang G., 1991, CALCULUS; Stute M, 2017, PROCEEDINGS OF THE 20TH ACM INTERNATIONAL CONFERENCE ON MODELLING, ANALYSIS AND SIMULATION OF WIRELESS AND MOBILE SYSTEMS (MSWIM'17), P219, DOI 10.1145/3127540.3127542; Sur M, 2014, ECOL INFORM, V20, P47, DOI 10.1016/j.ecoinf.2014.01.007; Truong C, 2020, SIGNAL PROCESS, V167, DOI 10.1016/j.sigpro.2019.107299; VandeWeerd C, 2020, HEALTH TECHNOL-GER, V10, P1291, DOI 10.1007/s12553-019-00404-6; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Williams JA, 2017, TECHNOL HEALTH CARE, V25, P89, DOI 10.3233/THC-161255; YAO YC, 1988, STAT PROBABIL LETT, V6, P181, DOI 10.1016/0167-7152(88)90118-6; Zhang SM, 2017, IEEE T HUM-MACH SYST, V47, P814, DOI 10.1109/THMS.2017.2693238; Zhao Z, 2018, TRANSPORT RES B-METH, V112, P73, DOI 10.1016/j.trb.2018.03.017; Zheng Y, 2008, PROCEEDINGS OF THE 10TH INTERNATIONAL CONFERENCE ON UBIQUITOUS COMPUTING (UBICOMP 2008), P312, DOI 10.1145/1409635.1409677	59	0	0	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243503	10.1371/journal.pone.0243503	http://dx.doi.org/10.1371/journal.pone.0243503			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301515	gold, Green Published			2022-12-27	WOS:000600143100007
J	Okamoto, N; Vengrenyuk, Y; Fuster, V; Samady, H; Yasumura, K; Baber, U; Barman, N; Suleman, J; Sweeny, J; Krishnan, P; Mehran, R; Sharma, SK; Narula, J; Kini, AS				Okamoto, Naotaka; Vengrenyuk, Yuliya; Fuster, Valentin; Samady, Habib; Yasumura, Keisuke; Baber, Usman; Barman, Nitin; Suleman, Javed; Sweeny, Joseph; Krishnan, Prakash; Mehran, Roxana; Sharma, Samin K.; Narula, Jagat; Kini, Annapoorna S.			Relationship between high shear stress and OCT-verified thin-cap fibroatheroma in patients with coronary artery disease	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; INTRAVASCULAR ULTRASOUND; ATHEROSCLEROTIC PLAQUE; ANGIOGRAPHY; ACQUISITION; PROGRESSION; PREDICTION; STANDARDS; CONSENSUS; BURDEN	High-risk coronary plaques have been considered predictive of adverse cardiac events. Both wall shear stress (WSS) in patients with hemodynamically significant lesions and optical coherence tomography (OCT) -verified thin-cap fibroatheroma (TCFA) are associated with plaque rupture, the most common underlying mechanism of acute coronary syndrome. The aim of the study was to test the hypothesis that invasive coronary angiography-based high WSS is associated with the presence of TCFA detected by OCT in obstructive lesions. From a prospective study of patients who underwent OCT examination for angiographically obstructive lesions (Yellow II), we selected patients who had two angiographic projections to create a 3-dimensional reconstruction model to allow assessment of WSS. The patients were divided into 2 groups according to the presence and absence of TCFA. Mean WSS was assessed in the whole lesion and in the proximal, middle and distal segments. Of 70 patients, TCFA was observed in 13 (19%) patients. WSS in the proximal segment (WSSproximal) (10.20 [5.01, 16.93Pa]) and the whole lesion (WSSlesion) (12.37 [6.36, 14.55Pa]) were significantly higher in lesions with TCFA compared to WSSproximal (5.84 [3.74, 8.29Pa], p = 0.02) and WSSlesion (6.95 [4.41, 11.60], p = 0.04) in lesions without TCFA. After multivariate analysis, WSSproximal was independently associated with the presence of TCFA (Odds ratio 1.105; 95%CI 1.007-1.213, p = 0.04). The optimal cutoff value of WSSproximal to predict TCFA was 6.79 Pa (AUC: 0.71; sensitivity: 0.77; specificity: 0.63 p = 0.02). Our results demonstrate that high WSS in the proximal segments of obstructive lesions is an independent predictor of OCT-verified TCFA.	[Okamoto, Naotaka; Vengrenyuk, Yuliya; Fuster, Valentin; Yasumura, Keisuke; Baber, Usman; Barman, Nitin; Suleman, Javed; Sweeny, Joseph; Krishnan, Prakash; Mehran, Roxana; Sharma, Samin K.; Narula, Jagat; Kini, Annapoorna S.] Mt Sinai Hosp, Div Cardiol, New York, NY 10029 USA; [Okamoto, Naotaka; Vengrenyuk, Yuliya; Fuster, Valentin; Yasumura, Keisuke; Baber, Usman; Barman, Nitin; Suleman, Javed; Sweeny, Joseph; Krishnan, Prakash; Mehran, Roxana; Sharma, Samin K.; Narula, Jagat; Kini, Annapoorna S.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Samady, Habib] Emory Univ, Sch Med, Dept Med, Div Cardiol, Atlanta, GA USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Emory University	Kini, AS (corresponding author), Mt Sinai Hosp, Div Cardiol, New York, NY 10029 USA.; Kini, AS (corresponding author), Icahn Sch Med Mt Sinai, New York, NY 10029 USA.	annapoorna.kini@mountsinai.org	Fuster, Valentin/H-4319-2015; Mehran, Roxana/ABF-4160-2021	Fuster, Valentin/0000-0002-9043-9986; krishnan, prakash/0000-0003-2871-3689				Ahmadi A, 2015, CIRC RES, V117, P99, DOI 10.1161/CIRCRESAHA.117.305637; Bourantas CV, 2020, JACC-CARDIOVASC IMAG, V13, P2206, DOI 10.1016/j.jcmg.2020.02.028; Castier Y, 2005, CIRC RES, V97, P533, DOI 10.1161/01.RES.0000181759.63239.21; Chatzizisis YS, 2007, J AM COLL CARDIOL, V49, P2379, DOI 10.1016/j.jacc.2007.02.059; Corban MT, 2014, ATHEROSCLEROSIS, V232, P271, DOI 10.1016/j.atherosclerosis.2013.11.049; Eshtehardi P, 2017, INT J CARDIOVAS IMAG, V33, P1089, DOI 10.1007/s10554-016-1055-1; Fukumoto Y, 2008, J AM COLL CARDIOL, V51, P645, DOI 10.1016/j.jacc.2007.10.030; Gijsen F, 2013, J BIOMECH, V46, P240, DOI 10.1016/j.jbiomech.2012.11.006; Gijsen FJH, 2011, EUROINTERVENTION, V7, P121, DOI 10.4244/EIJV7I1A20; GLAGOV S, 1987, NEW ENGL J MED, V316, P1371, DOI 10.1056/NEJM198705283162204; Hartman EMJ, 2021, J CARDIOVASC TRANSL, V14, P416, DOI 10.1007/s12265-020-10072-x; Kini AS, 2017, J AM COLL CARDIOL, V69, P644, DOI 10.1016/j.jacc.2016.10.028; Kini AS, 2017, J AM COLL CARDIOL, V69, P628, DOI 10.1016/j.jacc.2016.10.029; Kini AS, 2013, J AM COLL CARDIOL, V62, P21, DOI 10.1016/j.jacc.2013.03.058; Kumar A, 2018, J AM COLL CARDIOL, V72, P1926, DOI 10.1016/j.jacc.2018.07.075; Lee JM, 2019, JACC-CARDIOVASC IMAG, V12, P1032, DOI 10.1016/j.jcmg.2018.01.023; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Lijnen HR, 2001, THROMB HAEMOSTASIS, V86, P324; Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5; Murata N, 2019, HEART VESSELS, V34, P1429, DOI 10.1007/s00380-019-01389-y; Murray CD, 1926, P NATL ACAD SCI USA, V12, P207, DOI 10.1073/pnas.12.3.207; Park JB, 2016, HEART, V102, P1655, DOI 10.1136/heartjnl-2016-309299; Samady H, 2011, CIRCULATION, V124, P779, DOI 10.1161/CIRCULATIONAHA.111.021824; Schuurman AS, 2018, EUR HEART J, V39, P295, DOI 10.1093/eurheartj/ehx247; Stone PH, 2018, JACC-CARDIOVASC IMAG, V11, P462, DOI 10.1016/j.jcmg.2017.01.031; Tearney GJ, 2012, J AM COLL CARDIOL, V59, P1058, DOI 10.1016/j.jacc.2011.09.079; Toba T, 2021, JACC-CARDIOVASC IMAG, V14, P315, DOI 10.1016/j.jcmg.2020.07.034; Tu SX, 2010, CATHETER CARDIO INTE, V76, P291, DOI 10.1002/ccd.22502; Vergallo R, 2014, CIRC-CARDIOVASC IMAG, V7, P905, DOI 10.1161/CIRCIMAGING.114.001932; Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065; White SJ, 2011, J CELL PHYSIOL, V226, P2841, DOI 10.1002/jcp.22629; Xing L, 2017, J AM COLL CARDIOL, V69, P2502, DOI 10.1016/j.jacc.2017.03.556; Yamamoto E, 2019, JACC-CARDIOVASC IMAG, V12, P374, DOI 10.1016/j.jcmg.2018.07.024	33	4	5	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0244015	10.1371/journal.pone.0244015	http://dx.doi.org/10.1371/journal.pone.0244015			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332434	Green Published, gold			2022-12-27	WOS:000601310900087
J	Richards, KL; Karvelis, P; Lawrie, SM; Series, P				Richards, Katie L.; Karvelis, Povilas; Lawrie, Stephen M.; Series, Peggy			Visual statistical learning and integration of perceptual priors are intact in attention deficit hyperactivity disorder	PLOS ONE			English	Article							REACTION-TIME VARIABILITY; DEFICIT/HYPERACTIVITY DISORDER; DECISION-MAKING; COMPUTATIONAL MODELS; ADULT ADHD; CHILDREN; AUTISM; METAANALYSIS; INHIBITION; DOPAMINE	Background Deficits in visual statistical learning and predictive processing could in principle explain the key characteristics of inattention and distractibility in attention deficit hyperactivity disorder (ADHD). Specifically, from a Bayesian perspective, ADHD may be associated with flatter likelihoods (increased sensory processing noise), and/or difficulties in generating or using predictions. To our knowledge, such hypotheses have never been directly tested. Methods We here test these hypotheses by evaluating whether adults diagnosed with ADHD (n = 17) differed from a control group (n = 30) in implicitly learning and using low-level perceptual priors to guide sensory processing. We used a visual statistical learning task in which participants had to estimate the direction of a cloud of coherently moving dots. Unbeknown to the participants, two of the directions were more frequently presented than the others, creating an implicit bias (prior) towards those directions. This task had previously revealed differences in other neurodevelopmental disorders, such as autistic spectrum disorder and schizophrenia. Results We found that both groups acquired the prior expectation for the most frequent directions and that these expectations substantially influenced task performance. Overall, there were no group differences in how much the priors influenced performance. However, subtle group differences were found in the influence of the prior over time. Conclusion Our findings suggest that the symptoms of inattention and hyperactivity in ADHD do not stem from broad difficulties in developing and/or using low-level perceptual priors.	[Richards, Katie L.; Lawrie, Stephen M.] Univ Edinburgh, Royal Edinburgh Hosp, Dept Psychiat, Edinburgh, Midlothian, Scotland; [Richards, Katie L.] Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England; [Karvelis, Povilas; Series, Peggy] Univ Edinburgh, Inst Adapt & Neural Computat, Edinburgh, Midlothian, Scotland; [Lawrie, Stephen M.] Univ Edinburgh, Patrick Wild Ctr, Edinburgh, Midlothian, Scotland	Royal Infirmary of Edinburgh; University of Edinburgh; University of London; King's College London; University of Edinburgh; University of Edinburgh	Series, P (corresponding author), Univ Edinburgh, Inst Adapt & Neural Computat, Edinburgh, Midlothian, Scotland.	pseries@inf.ed.ac.uk	Richards, Katie L/GXV-3017-2022; Lawrie, Stephen MacGregor/AAD-1607-2021	Richards, Katie L/0000-0003-3826-6317; Lawrie, Stephen MacGregor/0000-0002-2444-5675; Series, Peggy/0000-0002-8580-7975	Health Foundation Scaling Up Award; Engineering and Physical Sciences Research Council; Patrick Wild Centre; Janssen; Lundbeck	Health Foundation Scaling Up Award; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Patrick Wild Centre; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Lundbeck(Lundbeck Corporation)	KR is supported by the Health Foundation Scaling Up Award. PK was funded by Engineering and Physical Sciences Research Council. This study was supported by funding from the Patrick Wild Centre. SML reports receiving, in the past three years, personal fees from Janssen, Otsuka and Sunovion, and research funding from Janssen and Lundbeck. The other authors have no conflict of interest to declare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advokat C, 2010, NEUROSCI BIOBEHAV R, V34, P1256, DOI 10.1016/j.neubiorev.2010.03.006; Agnew-Blais JC, 2016, JAMA PSYCHIAT, V73, P713, DOI 10.1001/jamapsychiatry.2016.0465; American Psychiatric A, 2013, DIAGN STAT MAN MENT, VFifth; [Anonymous], 1999, HESPERIA, V2, P79; [Anonymous], 2013, PREDICTIVE MIND, DOI DOI 10.1093/ACPROF:OSO/9780199682737.001.0001; Barnes KA, 2010, DEV NEUROPSYCHOL, V35, P494, DOI 10.1080/87565641.2010.494750; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Berniker M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012686; Bijlenga D, 2017, EUR PSYCHIAT, V43, P51, DOI 10.1016/j.eurpsy.2017.02.481; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Chalk M, 2010, J VISION, V10, DOI 10.1167/10.8.2; Cheng CH, 2016, NEUROSCI LETT, V612, P132, DOI 10.1016/j.neulet.2015.11.033; Chevrier A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0206780; Coghill DR, 2014, PSYCHOL MED, V44, P1989, DOI 10.1017/S0033291713002547; Cortese S, 2012, AM J PSYCHIAT, V169, P1038, DOI 10.1176/appi.ajp.2012.11101521; Dankner Y, 2017, PSYCHOL SCI, V28, P835, DOI 10.1177/0956797617694863; del Campo N, 2011, BIOL PSYCHIAT, V69, pE145, DOI 10.1016/j.biopsych.2011.02.036; DELANEY HD, 1981, MULTIVAR BEHAV RES, V16, P105, DOI 10.1207/s15327906mbr1601_6; Domuta A, 2000, IMPLICIT LEARNING AD; Durston S, 2007, DEV REV, V27, P374, DOI 10.1016/j.dr.2007.05.001; Fair DA, 2012, P NATL ACAD SCI USA, V109, P6769, DOI 10.1073/pnas.1115365109; First MB, 2002, STRUCTURED CLIN INTE; Frank MJ, 2007, NEUROPSYCHOPHARMACOL, V32, P1583, DOI 10.1038/sj.npp.1301278; Fried M, 2014, VISION RES, V101, P62, DOI 10.1016/j.visres.2014.05.004; Friston K, 2016, SCHIZOPHR RES, V176, P83, DOI 10.1016/j.schres.2016.07.014; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Gonen-Yaacovi G, 2016, CORTEX, V81, P50, DOI 10.1016/j.cortex.2016.04.010; Hart H, 2013, JAMA PSYCHIAT, V70, P185, DOI 10.1001/jamapsychiatry.2013.277; Hasler R, 2016, NEUROPSYCHOLOGIA, V87, P120, DOI 10.1016/j.neuropsychologia.2016.05.008; Hauser TU, 2016, TRENDS NEUROSCI, V39, P63, DOI 10.1016/j.tins.2015.12.009; Hauser TU, 2014, JAMA PSYCHIAT, V71, P1165, DOI 10.1001/jamapsychiatry.2014.1093; Huang-Pollock CL, 2014, NEUROPSYCHOLOGY, V28, P594, DOI 10.1037/neu0000075; Johnstone SJ, 2013, CLIN NEUROPHYSIOL, V124, P644, DOI 10.1016/j.clinph.2012.09.006; Karalunas SL, 2014, J CHILD PSYCHOL PSYC, V55, P685, DOI 10.1111/jcpp.12217; Karatekin C, 2009, NEUROPSYCHOLOGY, V23, P445, DOI 10.1037/a0015562; Karvelis P, 2018, ELIFE, V7, DOI 10.7554/eLife.34115; Kessler RC, 2007, INT J METH PSYCH RES, V16, P52, DOI 10.1002/mpr.208; Kim Soyeon, 2015, J Optom, V8, P116, DOI 10.1016/j.optom.2014.10.002; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; Kofler MJ, 2013, CLIN PSYCHOL REV, V33, P795, DOI 10.1016/j.cpr.2013.06.001; Kok P., 2015, INTRO MODEL BASED CO, P221, DOI DOI 10.1007/978-1-4939-2236-9_11; Kollins SH, 2014, PROG NEURO-PSYCHOPH, V52, P70, DOI 10.1016/j.pnpbp.2014.02.002; Kooij J.J.S., 2012, ADULT ADHD DIAGNOSTI; Laquitaine S, 2018, NEURON, V97, P462, DOI 10.1016/j.neuron.2017.12.011; Lee M. D., 2013, BAYESIAN DATA ANAL C; Leow LA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179977; Little LM, 2018, PHYS OCCUP THER PEDI, V38, P243, DOI 10.1080/01942638.2017.1390809; Luman M, 2010, NEUROSCI BIOBEHAV R, V34, P744, DOI 10.1016/j.neubiorev.2009.11.021; Gonzalez-Gadea ML, 2015, J NEUROPHYSIOL, V114, P2625, DOI 10.1152/jn.00543.2015; McCarthy H, 2014, PSYCHOL MED, V44, P869, DOI 10.1017/S0033291713001037; Micoulaud-Franchi JA, 2019, J ATTEN DISORD, V23, P1199, DOI 10.1177/1087054716629716; Mihali Andra, 2018, Comput Psychiatr, V2, P141, DOI 10.1162/cpsy_a_00018; Mueller A, 2017, TRENDS COGN SCI, V21, P474, DOI 10.1016/j.tics.2017.03.009; Munoz DP, 2003, J NEUROPHYSIOL, V90, P503, DOI 10.1152/jn.00192.2003; Nigg JT, 2005, DEV PSYCHOPATHOL, V17, P785, DOI 10.1017/S0954579405050376; Panagiotidi M, 2018, COMPR PSYCHIAT, V80, P179, DOI 10.1016/j.comppsych.2017.10.008; Parks KMA, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.02502; Parr T, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00061; Pedersen A, 2018, J ATTEN DISORD, V22, P250, DOI 10.1177/1087054712464392; Plichta MM, 2014, NEUROSCI BIOBEHAV R, V38, P125, DOI 10.1016/j.neubiorev.2013.07.012; Sato Y, 2014, J VISION, V14, DOI 10.1167/14.13.13; Silvetti M, 2013, NEURAL NETWORKS, V46, P199, DOI 10.1016/j.neunet.2013.05.008; Takacs A, 2017, BRAIN COGNITION, V117, P33, DOI 10.1016/j.bandc.2017.06.009; Turk-Browne NB, 2009, J COGNITIVE NEUROSCI, V21, P1934, DOI 10.1162/jocn.2009.21131; Valton V, 2019, BRAIN, V142, P2523, DOI 10.1093/brain/awz171; Vloet TD, 2010, J ABNORM CHILD PSYCH, V38, P961, DOI 10.1007/s10802-010-9422-1; Wechsler D, 1999, MANUAL WECHSLER ABBR; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Yang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042993; Ziegler S, 2016, NEUROSCI BIOBEHAV R, V71, P633, DOI 10.1016/j.neubiorev.2016.09.002; Zimmer L, 2017, TRENDS PHARMACOL SCI, V38, P608, DOI 10.1016/j.tips.2017.04.001	71	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243100	10.1371/journal.pone.0243100	http://dx.doi.org/10.1371/journal.pone.0243100			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PI8BZ	33332378	Green Published, Green Submitted, gold			2022-12-27	WOS:000601310900077
J	Xu, LF; Huang, ZS; Yang, ZZ; Ding, WL; Buck-Sorlin, GH				Xu, Lifeng; Huang, Zusheng; Yang, Zhongzhu; Ding, Weilong; Buck-Sorlin, Gerhard Hartwig			Optimization study on spatial distribution of rice based on a virtual plant approach	PLOS ONE			English	Article							YIELD	How to increase crop yield is the most important issue in agricultural production. Many studies have been devoted to optimizing spatial distribution of crops, to improve light interception and increase photosynthetic assimilation. However, finding an optimal solution based on field experiments is almost impossible since the large number of combinations of factors that are related, and the cost in terms of finances and time are prohibitive. A new optimization strategy was proposed in this study, integrating a Functional-Structural Model of rice with a workflow based on a Mixed Particle Swarm Optimization (MPSO) algorithm. The 3D modelling platform GroIMP was used to implement the model and optimization workflow. MPSO is a new Particle Swarm Optimization-based algorithm with multistage disturbances, which has improved abilities to get rid of local optima and to explore solution space. Spacing between plants was used as optimization target in the first example. An optimal plant spacing was obtained within the model framework of current environmental settings together with the functional and structural modules. Simulation results indicate that the optimized plant spacing could increase rice yield, and that the optimization results remain stable.	[Xu, Lifeng; Huang, Zusheng; Yang, Zhongzhu; Ding, Weilong] Zhejiang Univ Technol, Coll Comp Sci & Technol, Hangzhou, Peoples R China; [Buck-Sorlin, Gerhard Hartwig] Univ Angers, Inst Agro, Angers, France	Zhejiang University of Technology; Institut Agro; Universite d'Angers	Buck-Sorlin, GH (corresponding author), Univ Angers, Inst Agro, Angers, France.	gerhard.buck-sorlin@agrocampus-ouest.fr		Buck-Sorlin, Gerhard/0000-0002-7077-498X; Xu, Lifeng/0000-0003-4957-7559	National Natural Science Foundation of China [61702456, 61571400]; Scientific Research Fund of Zhejiang Provincial Education Department [Y201224867]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Fund of Zhejiang Provincial Education Department	X. L. and D. W. received funding from the National Natural Science Foundation of China (http://www.nsfc.gov.cn) with grant numbers 61571400; X. L. also received funding from the National Natural Science Foundation of China with grant numbers 61702456 and the Scientific Research Fund of Zhejiang Provincial Education Department (http://jyt.zj.gov.cn) with grant number Y201224867. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buck Sorlin GH, 2010, P 6 INT WORKSH FUNCT, P222; Clerc M, 2002, IEEE T EVOLUT COMPUT, V6, P58, DOI 10.1109/4235.985692; Dong N, 2017, ECOLOGICAL MECH YIEL; Dunn BW, 2020, CROP PASTURE SCI, V71, P219, DOI 10.1071/CP19421; Ehsanullah, 2007, Pakistan Journal of Agricultural Sciences, V44, P597; Evers JB, 2007, NEW PHYTOL, V176, P325, DOI 10.1111/j.1469-8137.2007.02168.x; Grahmann K., 2013, CAB Reviews, V8, P1, DOI 10.1079/PAVSNNR20138053; Hardke J, 2016, ARKANSAS RICE PRODUC, DOI 10.3390/insects7020027; Henke M, 2016, FRONT COMPUT SCI-CHI, V10, P1103, DOI 10.1007/s11704-015-4472-8; Henke M, 2014, PLANT SOIL, V385, P49, DOI 10.1007/s11104-014-2221-7; Hu N, 2014, TRANSGENIC RES, V23, P795, DOI 10.1007/s11248-014-9810-3; Jiang Z, 2009, OPTIMIZE SIMULATE PL; Kang W. G., 2014, J CLIN ACUPUNCTURE M, V30, P35; Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/icnn.1995.488968; Kniemeyer O, 2008, FAKULTAT MATH; Langensiepen M, 2020, ENVIRON EXP BOT, V178, DOI 10.1016/j.envexpbot.2020.104125; Li T, 2015, EFFECTS PLANTING DEN; Li XP, 2015, CHIN J CHROMATOGR, V33, P58, DOI 10.3724/SP.J.1123.2014.09018; Liver and atherosclerosis, 2015, GASTROENTEROLOGIYA, V51, P14; Long Q, 2018, ACM IEEA 18, V107, P113, DOI 10.1145/3208854.3208875; Luo D, 2014, AGR RES, V3, P313, DOI 10.1007/s40003-014-0132-8; Marcelis LFM, 1998, SCI HORTIC-AMSTERDAM, V74, P83, DOI 10.1016/S0304-4238(98)00083-1; Morley JE, 2013, J FRALITY AGING, V2, P121; Nakano H, 2012, CROP SCI, V52, P2800, DOI 10.2135/cropsci2012.05.0328; Perez RPA, 2018, AGR FOREST METEOROL, V249, P250, DOI 10.1016/j.agrformet.2017.11.008; Vos J, 2010, J EXP BOT, V61, P2101, DOI 10.1093/jxb/erp345; Xu Li-Feng, 2019, Journal of Software, V30, P1835, DOI 10.13328/j.cnki.jos.005600; Xu LF, 2011, ANN BOT-LONDON, V107, P817, DOI 10.1093/aob/mcq264; [杨蕊菊 Yang Ruiju], 2005, [西北农业学报, Acat Agriculturae Boreali-Occidentalis Sinica], V14, P44; Zhang H, 2012, J NANOMATER, V2012, DOI [10.1155/2012/217412, 10.1186/2049-1891-3-26]; Zhu XingTao, 2014, Soybean Science, V33, P35	31	0	0	10	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243717	10.1371/journal.pone.0243717	http://dx.doi.org/10.1371/journal.pone.0243717			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332473	Green Published, gold			2022-12-27	WOS:000601310900101
J	Kruseova, J; Kovacova, AS; Zapotocky, M; Sumerauer, D; Pernikova, I; Starkova, D; Misove, A; Zichova, A; Capek, V; Langer, T; Zehnhoff-Dinnesen, AA; Eckschlager, T; Kyncl, M				Kruseova, Jarmila; Kovacova, Anna Sarah; Zapotocky, Michal; Sumerauer, David; Pernikova, Ivana; Starkova, Darja; Misove, Adela; Zichova, Andrea; Capek, Vaclav; Langer, Thorsten; Zehnhoff-Dinnesen, Antoinette am; Eckschlager, Tomas; Kyncl, Martin			Older age is a protective factor for academic achievements irrespective of treatment modalities for posterior fossa brain tumours in children	PLOS ONE			English	Article							WHITE-MATTER ANISOTROPY; HEARING-LOSS; RADIATION-THERAPY; SURVIVORS; CNS; MEDULLOBLASTOMA; NEUROTOXICITY; OUTCOMES; ASSOCIATION; IRRADIATION	The treatment of children with posterior fossa brain tumours (PFBT) impacts their long term functional and imaging outcomes. This study aimed to evaluate academic achievement correlated with long-term sequelae after different PFBT treatment modalities. The study cohort consisted of 110 survivors (median age at diagnosis 10.1 years and median time of follow up 13.2 years) who completed hearing questionnaires, neurological assessment and MRI of the brain >= 5 years after the end of treatment. There were three treatment groups. A cisplatin group which underwent cisplatin chemotherapy, radiotherapy and surgery (medulloblastoma N = 40), a radiotherapy group which underwent radiotherapy and surgery (astrocytoma/ependymoma N = 30), and a surgery group (astrocytoma N = 40). Academic achievement was correlated to the age at diagnosis, ototoxicity, Karnofsky score (KS), and MRI findings (Fazekas Score (FS)- treatment related parenchymal changes). For a modelled age at diagnosis of five years, the cisplatin group had lower academic achievements compared to the radiotherapy (p = 0.028) and surgery (p = 0.014) groups. Academic achievements evaluated at a modelled age of 10 years at diagnosis did not significantly differ among the treatment groups. The cisplatin group exhibited a higher occurrence of ototoxicity than the radiotherapy (p<0.019) and surgery groups (p<0.001); however, there was no correlation between ototoxicity and academic achievements (p = 0.722) in older age at diagnosis. The radiotherapy group exhibited lower KS than the surgery group (p<0.001). KS significantly influenced academic achievements in all groups (p<0.000). The cisplatin group exhibited higher FS than the surgery group (p<0.001) while FS did not correlate with academic achievement (p = 0.399). Older age is a protective factor for academic achievements irrespective of a treatment modality.	[Kruseova, Jarmila; Zapotocky, Michal; Sumerauer, David; Misove, Adela; Zichova, Andrea; Eckschlager, Tomas] Charles Univ Prague, Fac Med 2, Dept Paediat Haematol & Oncol, Prague, Czech Republic; [Kruseova, Jarmila; Kovacova, Anna Sarah; Zapotocky, Michal; Sumerauer, David; Pernikova, Ivana; Starkova, Darja; Misove, Adela; Zichova, Andrea; Capek, Vaclav; Eckschlager, Tomas; Kyncl, Martin] Univ Hosp Motol, Prague, Czech Republic; [Kovacova, Anna Sarah; Starkova, Darja; Kyncl, Martin] Charles Univ Prague, Fac Med 2, Dept Radiol, Prague, Czech Republic; [Pernikova, Ivana] Charles Univ Prague, Fac Med 2, Dept Paediat Neurol, Prague, Czech Republic; [Capek, Vaclav] Charles Univ Prague, Fac Med 2, Bioinformat Ctr, Prague, Czech Republic; [Langer, Thorsten] Univ Hosp Children & Adolescents, Pediat Oncol & Hematol, Lubeck, Germany; [Zehnhoff-Dinnesen, Antoinette am] Univ Hosp Munster, Dept Phoniatr & Pedaudiol, Munster, Germany	Charles University Prague; Motol University Hospital; Charles University Prague; Charles University Prague; Charles University Prague; University of Munster	Kruseova, J (corresponding author), Charles Univ Prague, Fac Med 2, Dept Paediat Haematol & Oncol, Prague, Czech Republic.; Kruseova, J (corresponding author), Univ Hosp Motol, Prague, Czech Republic.	jarmila.kruseova@fnmotol.cz	Kruseova, Jarmila/AAS-1036-2021; kruseova, jarmila/AAS-1653-2021; Capek, Vaclav/D-8555-2016	Kruseova, Jarmila/0000-0002-6576-7048; Capek, Vaclav/0000-0002-8574-7001	European Union's Seventh Framework Programme for Research, Technological Development and Demonstration [602030]; Ministry of Education, Youth and Sport of the Czech Republic; Ministry of Health, Czech Republic -Conceptual Development of Research Organization, University Hospital Motol, Prague, Czech Republic [00064203]	European Union's Seventh Framework Programme for Research, Technological Development and Demonstration; Ministry of Education, Youth and Sport of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Ministry of Health, Czech Republic -Conceptual Development of Research Organization, University Hospital Motol, Prague, Czech Republic	This project has received funding from the European Union's Seventh Framework Programme for Research, Technological Development and Demonstration under grant agreement no 602030. This study has received funding from the Ministry of Education, Youth and Sport of the Czech Republic. Supported by Ministry of Health, Czech Republic -Conceptual Development of Research Organization, University Hospital Motol, Prague, Czech Republic, #00064203.	Armstrong GT, 2011, NEURO-ONCOLOGY, V13, P223, DOI 10.1093/neuonc/noq178; Armstrong GT, 2009, JNCI-J NATL CANCER I, V101, P946, DOI 10.1093/jnci/djp148; Bass JK, 2016, J CLIN ONCOL, V34, P1248, DOI 10.1200/JCO.2015.63.6738; Boman KK, 2009, EUR J CANCER, V45, P2552, DOI 10.1016/j.ejca.2009.06.008; Brinkman TM, 2015, CANCER-AM CANCER SOC, V121, P4053, DOI 10.1002/cncr.29604; Duffner PK, 2010, EUR J PAEDIATR NEURO, V14, P106, DOI 10.1016/j.ejpn.2009.10.005; Forbes K, 2017, J ROY COLL PHYS EDIN, V47, P271, DOI 10.4997/JRCPE.2017.313; Froklage FE, 2014, J NEURO-ONCOL, V116, P387, DOI 10.1007/s11060-013-1310-4; Khong PL, 2006, J CLIN ONCOL, V24, P884, DOI 10.1200/JCO.2005.02.4505; Khong PL, 2005, RADIOLOGY, V236, P647, DOI 10.1148/radiol.2362041066; Korlimarla A, 2020, NEUROLOGY, V95, pE718, DOI 10.1212/WNL.0000000000009979; Lassaletta A, 2015, CHILD NERV SYST, V31, P1877, DOI 10.1007/s00381-015-2829-9; Leung LHT, 2004, NEUROIMAGE, V21, P261, DOI 10.1016/j.neuroimage.2003.09.020; Monje M, 2011, J PEDIATR REHAB MED, V4, P31, DOI 10.3233/PRM-2011-0150; Musial-Bright L, 2011, CHILD NERV SYST, V27, P407, DOI 10.1007/s00381-010-1300-1; Orgel E, 2016, PEDIATR BLOOD CANCER, V63, P527, DOI 10.1002/pbc.25804; Orgel E, 2012, PEDIATR BLOOD CANCER, V58, P953, DOI 10.1002/pbc.23275; Rowe LS, 2017, ONCOLOGY-NY, V31, P182; Rueckriegel SM, 2012, INT J RADIAT ONCOL, V82, P1135, DOI 10.1016/j.ijrobp.2011.04.017; Rueckriegel SM, 2010, INT J RADIAT ONCOL, V76, P859, DOI 10.1016/j.ijrobp.2009.02.054; SCHAG CC, 1984, J CLIN ONCOL, V2, P187, DOI 10.1200/JCO.1984.2.3.187; Scobioala S, 2017, STRAHLENTHER ONKOL, V193, P910, DOI 10.1007/s00066-017-1205-y; Shan ZYY, 2006, MAGN RESON IMAGING, V24, P1015, DOI 10.1016/j.mri.2006.04.015; Sleurs C, 2016, CRIT REV ONCOL HEMAT, V103, P37, DOI 10.1016/j.critrevonc.2016.05.001; Tabori U, 2005, CANCER-AM CANCER SOC, V103, P1874, DOI 10.1002/cncr.21003; Vargo Mary, 2011, Am J Phys Med Rehabil, V90, pS50, DOI 10.1097/PHM.0b013e31820be31f; Winick N, 2011, CURR OPIN PEDIATR, V23, P27, DOI 10.1097/MOP.0b013e32834255e9; Zou P, 2005, NEUROIMAGE, V24, P61, DOI 10.1016/j.neuroimage.2004.08.030	28	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243998	10.1371/journal.pone.0243998	http://dx.doi.org/10.1371/journal.pone.0243998			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326475	gold, Green Published			2022-12-27	WOS:000600176400060
J	Mostaghim, A; Sinha, P; Bielick, C; Knudsen, S; Beeram, I; White, LF; Apovian, C; Sagar, M; Hochberg, NS				Mostaghim, Anahita; Sinha, Pranay; Bielick, Catherine; Knudsen, Selby; Beeram, Indeevar; White, Laura F.; Apovian, Caroline; Sagar, Manish; Hochberg, Natasha S.			Clinical outcomes and inflammatory marker levels in patients with Covid-19 and obesity at an inner-city safety net hospital	PLOS ONE			English	Article							CYTOKINE RELEASE SYNDROME; LACTATE-DEHYDROGENASE; MANAGEMENT	Objectives Patients with Covid-19 and obesity have worse clinical outcomes which may be driven by increased inflammation. This study aimed to characterize the association between clinical outcomes in patients with obesity and inflammatory markers. Methods We analyzed data for patients aged >= 18 years admitted with a positive SARS-CoV-2 PCR test. We used multivariate logistic regression to determine the association between BMI and intensive care unit (ICU) transfer and all-cause mortality. Inflammatory markers (C-reactive protein [CRP], lactate dehydrogenase [LDH], ferritin, and D-dimer) were compared between patients with and without obesity (body mass index [BMI] >= 30 kg/m(2)). Results Of 791 patients with Covid-19, 361 (45.6%) had obesity. In multivariate analyses, BMI >= 35 was associated with a higher odds of ICU transfer (adjusted odds ratio [aOR] 2.388 (95% confidence interval [CI]: 1.074-5.310) and hospital mortality (aOR = 4.3, 95% CI: 1.69-10.82). Compared to those with BMI<30, patients with obesity had lower ferritin (444 vs 637 ng/mL; p<0.001) and lower D-dimer (293 vs 350 mcg/mL; p = 0.009), non-significant differences in CRP (72.8 vs 84.1 mg/L, p = 0.099), and higher LDH (375 vs 340, p = 0.009) on the first hospital day. Conclusions Patients with obesity were more likely to have poor outcomes even without increased inflammation.	[Mostaghim, Anahita; Bielick, Catherine] Boston Univ, Sch Med, Dept Internal Med, Boston, MA 02118 USA; [Sinha, Pranay; Knudsen, Selby; Sagar, Manish; Hochberg, Natasha S.] Boston Univ, Sch Med, Dept Internal Med, Sect Infect Dis, Boston, MA 02118 USA; [Beeram, Indeevar] Boston Univ, Sch Med, Boston, MA 02118 USA; [White, Laura F.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Apovian, Caroline] Boston Univ, Sch Med, Dept Internal Med, Sect Endocrinol Diabet Nutr & Weight Management, Boston, MA 02118 USA; [Hochberg, Natasha S.] Boston Med Ctr, Boston, MA 02118 USA	Boston University; Boston University; Boston University; Boston University; Boston University; Boston Medical Center	Hochberg, NS (corresponding author), Boston Univ, Sch Med, Dept Internal Med, Sect Infect Dis, Boston, MA 02118 USA.; Hochberg, NS (corresponding author), Boston Med Ctr, Boston, MA 02118 USA.	nhoch@bu.edu		Bielick, Catherine/0000-0003-1871-3909; White, Laura F/0000-0002-0588-8235; Sinha, Pranay/0000-0002-4233-0871; Apovian, Caroline/0000-0002-8029-1922; Hochberg, Natasha/0000-0002-5449-9973	Boston Obesity Nutrition Research Center [P30DK046200]; NIH [5T32AI152074-13, K24 AI-145661]; Warren Alpert Foundation	Boston Obesity Nutrition Research Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Warren Alpert Foundation	Boston Obesity Nutrition Research Center P30DK046200 (CA), NIH K24 AI-145661 (MS), NIH 5T32AI152074-13 (PS), Warren Alpert Foundation (NSH).	AbdelMassih AF, 2020, CARDIOVASC ENDOCR ME, V9, P102, DOI 10.1097/XCE.0000000000000218; Ades PA, 2010, MAYO CLIN PROC, V85, P112, DOI 10.4065/mcp.2009.0777; Al-Benna Sammy, 2020, Obes Med, V19, P100283, DOI 10.1016/j.obmed.2020.100283; Anderson MR, 2020, ANN INTERN MED, V173, P782, DOI 10.7326/M20-3214; Audit ICN  Centre R, 2020, ICNARC REP COVID 19; Boutens L, 2018, DIABETOLOGIA, V61, P942, DOI 10.1007/s00125-017-4526-6; Bozkurt B, 2016, CIRCULATION, V134, pE535, DOI 10.1161/CIR.0000000000000450; Budu-Aggrey A, 2019, PLOS MED, V16, DOI [10.1371/journal., 10.1371/journal.pmed.1002739]; Cai QX, 2020, DIABETES CARE, V43, P1392, DOI 10.2337/dc20-0576; Chiappetta S, 2020, INT J OBESITY, V44, P1790, DOI 10.1038/s41366-020-0597-4; Ciceri F, 2020, CRIT CARE RESUSC, V22, P95; Cure MC, CLIN RHEUMATOLOGY, V2020, P1; Dickerson RN, 2013, CRIT CARE, V17, DOI 10.1186/cc12715; Drent M, 1996, EUR RESPIR J, V9, P1736, DOI 10.1183/09031936.96.09081736; Epidemiology Working Group for NCIP Epidemic Response Chinese Center for Disease Control and Prevention, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P145, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003; Fitzgerald JC, 2017, CRIT CARE MED, V45, pE124, DOI 10.1097/CCM.0000000000002053; Geleris J, 2020, NEW ENGL J MED, V382, P2411, DOI 10.1056/NEJMoa2012410; Green WD, 2017, CURR OPIN IMMUNOL, V46, P1, DOI 10.1016/j.coi.2017.03.008; Hirano T, 2020, IMMUNITY, V52, P731, DOI 10.1016/j.immuni.2020.04.003; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Inamura N, 2014, J INFECT CHEMOTHER, V20, P270, DOI 10.1016/j.jiac.2014.01.001; Jamal AJ, 2021, CLIN INFECT DIS, V72, P1064, DOI 10.1093/cid/ciaa848; Janeway C, 2008, JANEWAYS IMMUNO BIOL; Johns Hopkins University of Medicine, 2020, MORT AN; Kalligeros M, 2020, OBESITY, V28, P1200, DOI 10.1002/oby.22859; Lee DW, 2014, BLOOD, V124, P188, DOI 10.1182/blood-2014-05-552729; Lighter J, 2020, CLIN INFECT DIS, V71, P896, DOI 10.1093/cid/ciaa415; Luzi L, 2020, ACTA DIABETOL, V57, P759, DOI 10.1007/s00592-020-01522-8; Moore JB, 2020, SCIENCE, V368, P473, DOI 10.1126/science.abb8925; Norelli M, 2018, NAT MED, V24, P739, DOI 10.1038/s41591-018-0036-4; Parameswaran Krishnan, 2006, Can Respir J, V13, P203; Petrilli CM, 2020, BMJ-BRIT MED J, V369, DOI [10.1136/bmj.m1966, 10.12890/2020_001747]; Popkin BM, 2020, OBES REV, V21, DOI 10.1111/obr.13128; Public Health England, 2020, COVID 19 INS NEW EV; Rodriguez-Morales AJ, 2020, TRAVEL MED INFECT DI, V34, DOI 10.1016/j.tmaid.2020.101623; Rosenberg ES, 2020, JAMA-J AM MED ASSOC, V323, P2493, DOI 10.1001/jama.2020.8630; Ryan PM, 2020, OBESITY, V28, P1191, DOI 10.1002/oby.22843; Sattar N, 2020, CIRCULATION, V142, P4, DOI 10.1161/CIRCULATIONAHA.120.047659; Sheridan PA, 2012, INT J OBESITY, V36, P1072, DOI 10.1038/ijo.2011.208; Simonnet A, 2020, OBESITY, V28, P1195, DOI 10.1002/oby.22831; Sinha P, 2020, INT J INFECT DIS, V99, P28, DOI 10.1016/j.ijid.2020.07.023; Wang F, 2020, ENDOCR PRACT, V26, P668, DOI 10.4158/EP-2020-0108; Watanabe M, 2020, METABOLISM, V111, DOI 10.1016/j.metabol.2020.154319; Webb Hooper M, 2020, JAMA-J AM MED ASSOC, V323, P2466, DOI 10.1001/jama.2020.8598; Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Zhang T, 2020, Zhonghua Jie He He Hu Xi Za Zhi, V43, P496, DOI 10.3760/cma.j.cn112147-20200311-00312; Zheng KI, 2020, METABOLISM, V108, DOI 10.1016/j.metabol.2020.154244; Zheng MJ, 2020, CELL MOL IMMUNOL, V17, P533, DOI 10.1038/s41423-020-0402-2	49	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243888	10.1371/journal.pone.0243888	http://dx.doi.org/10.1371/journal.pone.0243888			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326480	gold, Green Published			2022-12-27	WOS:000600176400010
J	Sobrino, A; Walker, ME; Colas, RA; Dalli, J				Sobrino, Agua; Walker, Mary E.; Colas, Romain A.; Dalli, Jesmond			Protective activities of distinct omega-3 enriched oils are linked to their ability to upregulate specialized pro-resolving mediators	PLOS ONE			English	Article							DOUBLE-BLIND; FATTY-ACIDS; INFLAMMATION; ATHEROSCLEROSIS; IDENTIFICATION; EXPRESSION; RESOLUTION	Clinical studies using a range of omega-3 supplements have yielded conflicting results on their efficacy to control inflammation. Omega-3 fatty acids are substrate for the formation of potent immune-protective mediators, termed as specialized pro-resolving mediators (SPM). Herein, we investigated whether observed differences in the potencies of distinct omega-3 supplements were linked with their ability to upregulate SPM formation. Using lipid mediator profiling we found that four commercially available supplements conferred a unique SPM signature profile to human macrophages, with the overall increases in SPM concentrations being different between the four supplements. These increases in SPM concentrations were linked with an upregulation of macrophage phagocytosis and a decreased uptake of oxidized low-density lipoproteins. Pharmacological inhibition of two key SPM biosynthetic enzymes 5-Lipoxygenase or 15-Lipoxygenase reversed the macrophage-directed actions of each of the omega-3 supplements. Furthermore, administration of the two supplements that most potently upregulated macrophage SPM formation and reprogrammed their responses in vitro, to APOE(-/-) mice fed a western diet, increased plasma SPM concentrations and reduced vascular inflammation. Together these findings support the utility of SPM as potential prognostic markers in determining the utility of a given supplement to regulate macrophage responses and inflammation.	[Sobrino, Agua; Walker, Mary E.; Colas, Romain A.; Dalli, Jesmond] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London, England; [Dalli, Jesmond] Queen Mary Univ London, Ctr Inflammat & Therapeut Innovat, London, England	University of London; Queen Mary University London; University of London; Queen Mary University London	Dalli, J (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London, England.; Dalli, J (corresponding author), Queen Mary Univ London, Ctr Inflammat & Therapeut Innovat, London, England.	j.dalli@qmul.ac.uk		Dalli, Jesmond/0000-0001-6328-3640	European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme [677542]; Barts Charity [MGU0343]; Sir Henry Dale Fellowship - Wellcome Trust; Royal Society [107613/Z/15/Z]; Standard Process Inc.	European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme(European Research Council (ERC)); Barts Charity; Sir Henry Dale Fellowship - Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); Standard Process Inc.	This work was supported by funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant no: 677542) and the Barts Charity (grant no: MGU0343) to JD. JD is also supported by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust; the Royal Society (grant 107613/Z/15/Z); and a grant from Standard Process Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	31st Annual Scientific Sessions: Transforming the Future of Nursing Research: Imagination Innovation and Engagement, 2019, NURS RES, V68, pE21, DOI 10.1097/NNR.0000000000000351; American Institute of Ultrasound in Medicine, 2020, J ULTRASOUND MED, V21, pE1; [Anonymous], 2019, NEW ENGL J MED, V380, P11; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; [Anonymous], 2018, BIG DATA RES, V11, piii, DOI 10.1016/S2214-5796(18)30058-3; [Anonymous], 2017, DTSCH ZRZTEBLATT JG, V114, pA741; [Anonymous], 2017, ADHD ATTENTION DE S1, V9, pS1, DOI 10.1007/s12402-017-0224-y; [Anonymous], 2018, CIRCULATION, V138, pe751, DOI 10.1161/CIR.0000000000000636; [Anonymous], 2018, CIRCULATION, V137, pe67, DOI [10. 1161/CIR. 0000000000000558, DOI 10.1161/CIR.0000000000000558]; [Anonymous], 2013, CLIN DIABETOLOGY, V2, pA12; Bernasconi AA, 2021, MAYO CLIN PROC, V96, P304, DOI 10.1016/j.mayocp.2020.08.034; Bosch J, 2012, NEW ENGL J MED, V367, P309, DOI 10.1056/NEJMoa1203859; Brancaleone V, 2013, BLOOD, V122, P608, DOI 10.1182/blood-2013-04-496661; Budoff MJ, 2020, EUR HEART J, V41, P3925, DOI 10.1093/eurheartj/ehaa652; Cai BS, 2016, P NATL ACAD SCI USA, V113, P6526, DOI 10.1073/pnas.1524292113; Chiang N, 2015, J EXP MED, V212, P1203, DOI 10.1084/jem.20150225; Colas RA, 2018, CIRC RES, V122, P855, DOI 10.1161/CIRCRESAHA.117.312472; Colas RA, 2014, AM J PHYSIOL-CELL PH, V307, pC39, DOI 10.1152/ajpcell.00024.2014; Colin S, 2014, IMMUNOL REV, V262, P153, DOI 10.1111/imr.12218; Dalli J, 2019, ADV EXP MED BIOL, V1161, P65, DOI 10.1007/978-3-030-21735-8_7; Dalli J, 2019, BRIT J PHARMACOL, V176, P1024, DOI 10.1111/bph.14336; Dalli J, 2018, METHODS MOL BIOL, V1730, P59, DOI 10.1007/978-1-4939-7592-1_4; Dalli J, 2012, BLOOD, V120, pE60, DOI 10.1182/blood-2012-04-423525; De Caterina R, 2018, J AM COLL CARDIOL, V72, P1585, DOI 10.1016/j.jacc.2018.07.044; Fredman G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12859; Freire MO, 2017, J IMMUNOL, V198, P718, DOI 10.4049/jimmunol.1601543; Gibson MS, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00654; Hansson GK, 2015, J INTERN MED, V278, P483, DOI 10.1111/joim.12406; Harris WS, 2019, P NUTR SOC, V78, P526, DOI 10.1017/S0029665118002902; Kunjathoor VV, 2002, J BIOL CHEM, V277, P49982, DOI 10.1074/jbc.M209649200; Kwak SM, 2012, ARCH INTERN MED, V172, P686, DOI 10.1001/archinternmed.2012.262; Laguna-Fernandez A, 2018, CIRCULATION, V138, P1693, DOI 10.1161/CIRCULATIONAHA.117.032801; Leong TSH, 2009, ULTRASON SONOCHEM, V16, P721, DOI 10.1016/j.ultsonch.2009.02.008; Lichtenstein AH, 2006, ARTERIOSCL THROM VAS, V26, P2186, DOI 10.1161/01.ATV.0000238352.25222.5e; Ruiz-Leon AM, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00837; Meital LT, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49362-z; Merched AJ, 2008, FASEB J, V22, P3595, DOI 10.1096/fj.08-112201; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Natto ZS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54535-x; Pal A, 2020, FASEB J, V34, P10640, DOI 10.1096/fj.202000830R; Roncaglioni MC, 2013, NEW ENGL J MED, V368, P1800, DOI 10.1056/NEJMoa1205409; Roth GA, 2015, NEW ENGL J MED, V372, P1333, DOI 10.1056/NEJMoa1406656; Salic K, 2016, ATHEROSCLEROSIS, V250, P158, DOI 10.1016/j.atherosclerosis.2016.05.001; Serhan CN, 2018, MOL ASPECTS MED, V64, P1, DOI 10.1016/j.mam.2017.08.002; Sha YH, 2015, INT J CLIN EXP PATHO, V8, P6708; Simiele F, 2012, FASEB J, V26, P1323, DOI 10.1096/fj.11-198069; Souza PR, 2020, CIRC RES, V126, P75, DOI 10.1161/CIRCRESAHA.119.315506; Sperling LS, 2016, CURR MED RES OPIN, V32, P301, DOI 10.1185/03007995.2015.1120190; Statistics Committee and Stroke Statistics Subcommittee, 2017, CIRCULATION, V135, pe146; Viola JR, 2016, CIRC RES, V119, P1030, DOI 10.1161/CIRCRESAHA.116.309492; Walker CG, 2015, NUTRIENTS, V7, P6281, DOI 10.3390/nu7085285; Welsh P, 2017, BRIT J PHARMACOL, V174, P3898, DOI 10.1111/bph.13818; Woo MS, 2016, J BIOL CHEM, V291, P23654, DOI 10.1074/jbc.M116.750018; Zizzo G, 2018, INFLAMMATION, V41, P2206, DOI 10.1007/s10753-018-0864-x	54	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0242543	10.1371/journal.pone.0242543	http://dx.doi.org/10.1371/journal.pone.0242543			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326419	gold, Green Published			2022-12-27	WOS:000600176400065
J	Wongkaewkhiaw, S; Taweechaisupapong, S; Thanaviratananich, S; Bolscher, JGM; Nazmi, K; Anutrakunchai, C; Chareonsudjai, S; Kanthawong, S				Wongkaewkhiaw, Saharut; Taweechaisupapong, Suwimol; Thanaviratananich, Sanguansak; Bolscher, Jan G. M.; Nazmi, Kamran; Anutrakunchai, Chitchanok; Chareonsudjai, Sorujsiri; Kanthawong, Sakawrat			D-LL-31 enhances biofilm-eradicating effect of currently used antibiotics for chronic rhinosinusitis and its immunomodulatory activity on human lung epithelial cells	PLOS ONE			English	Article							BACTERIAL BIOFILMS; ANTIMICROBIAL PEPTIDES; STAPHYLOCOCCUS-AUREUS; TISSUE INHIBITOR; CHRONIC SINUSITIS; LL-37; MICROBIOLOGY; EXPRESSION; SPECIMENS; FAMILY	Chronic rhinosinusitis (CRS) is a chronic disease that involves long-term inflammation of the nasal cavity and paranasal sinuses. Bacterial biofilms present on the sinus mucosa of certain patients reportedly exhibit resistance against traditional antibiotics, as evidenced by relapse, resulting in severe disease. The aim of this study was to determine the killing activity of human cathelicidin antimicrobial peptides (LL-37, LL-31) and their D-enantiomers (D-LL-37, D-LL-31), alone and in combination with conventional antibiotics (amoxicillin; AMX and tobramycin; TOB), against bacteria grown as biofilm, and to investigate the biological activities of the peptides on human lung epithelial cells. D-LL-31 was the most effective peptide against bacteria under biofilm-stimulating conditions based on IC50 values. The synergistic effect of D-LL-31 with AMX and TOB decreased the IC50 values of antibiotics by 16-fold and could eliminate the biofilm matrix in all tested bacterial strains. D-LL-31 did not cause cytotoxic effects in A549 cells at 25 mu M after 24 h of incubation. Moreover, a cytokine array indicated that there was no significant induction of the cytokines involving in immunopathogenesis of CRS in the presence of D-LL-31. However, a tissue-remodeling-associated protein was observed that may prevent the progression of nasal polyposis in CRS patients. Therefore, a combination of D-LL-31 with AMX or TOB may improve the efficacy of currently used antibiotics to kill biofilm-embedded bacteria and eliminate the biofilm matrix. This combination might be clinically applicable for treatment of patients with biofilm-associated CRS.	[Wongkaewkhiaw, Saharut; Chareonsudjai, Sorujsiri; Kanthawong, Sakawrat] Khon Kaen Univ, Fac Med, Dept Microbiol, Khon Kaen, Thailand; [Taweechaisupapong, Suwimol; Anutrakunchai, Chitchanok; Chareonsudjai, Sorujsiri; Kanthawong, Sakawrat] Khon Kaen Univ, Biofilm Res Grp, Fac Dent, Khon Kaen, Thailand; [Thanaviratananich, Sanguansak] Khon Kaen Univ, Dept Otorhinolaryngol, Fac Med, Khon Kaen, Thailand; [Bolscher, Jan G. M.; Nazmi, Kamran] Univ Amsterdam, Dept Oral Biochem, Acad Ctr Dent Amsterdam ACTA, Amsterdam, Netherlands; [Bolscher, Jan G. M.; Nazmi, Kamran] Vrije Univ Amsterdam, Amsterdam, Netherlands	Khon Kaen University; Khon Kaen University; Khon Kaen University; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Kanthawong, S (corresponding author), Khon Kaen Univ, Fac Med, Dept Microbiol, Khon Kaen, Thailand.; Kanthawong, S (corresponding author), Khon Kaen Univ, Biofilm Res Grp, Fac Dent, Khon Kaen, Thailand.	sakawrat@kku.ac.th	Wongkaewkhiaw, Saharut/AAC-3083-2022; Bolscher, Jan/ABF-6102-2021; Wongkaewkhiaw, Saharut/GXW-0778-2022	Wongkaewkhiaw, Saharut/0000-0002-9581-3383; Bolscher, Jan/0000-0001-5669-6164; Wongkaewkhiaw, Saharut/0000-0002-9581-3383	Khon Kaen University, Thailand [61003402, 6200021004]; Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand	Khon Kaen University, Thailand; Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand	SK was supported by grant fund under Khon Kaen University, Thailand (61003402 and 6200021004) https://www.kku.ac.th/SW was supported by grant fund under Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand https://www.md.kku.ac.th/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis CA, 2013, J ALLERGY CLIN IMMUN, V131, P1479, DOI 10.1016/j.jaci.2013.02.036; Antunes MB, 2007, AM J RHINOL, V21, P423, DOI 10.2500/ajr.2007.21.3046; Barshak Miriam Baron, 2017, Laryngoscope Investig Otolaryngol, V2, P36, DOI 10.1002/lio2.61; Batoni G, 2016, BBA-BIOMEMBRANES, V1858, P1044, DOI 10.1016/j.bbamem.2015.10.013; Beaudoin T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33016-7; Bendouah Z, 2006, OTOLARYNG HEAD NECK, V134, P991, DOI 10.1016/j.otohns.2006.03.001; Billings N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003526; Bolscher J, 2012, BIOCHEM CELL BIOL, V90, P378, DOI [10.1139/O11-085, 10.1139/o11-085]; Brook I, 2016, EUR J CLIN MICROBIOL, V35, P1059, DOI 10.1007/s10096-016-2640-x; Ceri H, 1999, J CLIN MICROBIOL, V37, P1771, DOI 10.1128/JCM.37.6.1771-1776.1999; Chan C, 2004, J BIOL CHEM, V279, P38749, DOI 10.1074/jbc.M406044200; Chen YS, 2007, ALLERGY, V62, P66, DOI 10.1111/j.1398-9995.2006.01255.x; Corso-Radu A, 2010, ICSOFT 2010: PROCEEDINGS OF THE FIFTH INTERNATIONAL CONFERENCE ON SOFTWARE AND DATA TECHNOLOGIES, VOL 2, P512; de la Fuente-Nunez C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004152; Deng DM, 2009, J ENDODONT, V35, P1249, DOI 10.1016/j.joen.2009.05.038; Desrosiers M, 2007, AM J RHINOL, V21, P149, DOI 10.2500/ajr.2007.21.3007; Dlugaszewska J, 2016, EUR ARCH OTO-RHINO-L, V273, P1989, DOI 10.1007/s00405-015-3650-5; Durr UHN, 2006, BBA-BIOMEMBRANES, V1758, P1408, DOI 10.1016/j.bbamem.2006.03.030; Dworniczek E, 2009, FOLIA MICROBIOL, V54, P559, DOI 10.1007/s12223-009-0082-x; Eyibilen A, 2011, HISTOL HISTOPATHOL, V26, P615, DOI 10.14670/HH-26.615; Ferguson BJ, 2005, AM J RHINOL, V19, P452, DOI 10.1177/194589240501900506; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Foreman A, 2012, CURR ALLERGY ASTHM R, V12, P127, DOI 10.1007/s11882-012-0246-7; Goldstein EJC, 1999, ANTIMICROB AGENTS CH, V43, P705, DOI 10.1128/AAC.43.3.705; Gordon YJ, 2005, CURR EYE RES, V30, P385, DOI 10.1080/02713680590934111; Grassi L, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02409; Hwang PH, 2003, OTOLARYNG HEAD NECK, V128, P489, DOI 10.1016/S0194-5998(02)23295-7; Ivanchenko OA, 2016, RHINOLOGY, V54, P68, DOI [10.4193/Rhin15.018, 10.4193/Rhino15.018]; Jamal M, 2018, J CHIN MED ASSOC, V81, P7, DOI 10.1016/j.jcma.2017.07.012; Kanthawong S, 2012, INT J ANTIMICROB AG, V39, P39, DOI 10.1016/j.ijantimicag.2011.09.010; Kanthawong S, 2009, INT J ANTIMICROB AG, V34, P309, DOI 10.1016/j.ijantimicag.2009.05.012; Karunasagar A, 2018, INDIAN J OTOLARYNGOL, V70, P43, DOI 10.1007/s12070-017-1208-0; Kato A, 2008, J ALLERGY CLIN IMMUN, V121, P1385, DOI 10.1016/j.jaci.2008.03.002; Kifer D, 2016, J ANTIBIOT, V69, P689, DOI 10.1038/ja.2016.10; Kristy L, 2018, PERFORMANCE STANDARD; Li XY, 2010, J ALLERGY CLIN IMMUN, V125, P1061, DOI 10.1016/j.jaci.2010.02.023; Luo Y, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00544; Mahlapuu M, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00194; Mantovani K, 2010, BRAZ J OTORHINOLAR, V76, P548, DOI 10.1590/S1808-86942010000500002; Molhoek EM, 2011, PEPTIDES, V32, P875, DOI 10.1016/j.peptides.2011.02.017; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; Overhage J, 2008, INFECT IMMUN, V76, P4176, DOI 10.1128/IAI.00318-08; Bezerra TFP, 2011, OTOLARYNG HEAD NECK, V144, P612, DOI 10.1177/0194599811399536; Pothoven KL, 2015, J ALLERGY CLIN IMMUN, V136, P737, DOI 10.1016/j.jaci.2015.01.043; Pourmousa Rostam, 2015, Glob J Health Sci, V8, P239, DOI 10.5539/gjhs.v8n5p239; Psaltis AJ, 2008, AM J RHINOL, V22, P1, DOI 10.2500/ajr.2008.22.3119; Puknun A, 2013, WORLD J MICROB BIOT, V29, P1217, DOI 10.1007/s11274-013-1284-6; Rasmussen TB, 2006, INT J MED MICROBIOL, V296, P149, DOI 10.1016/j.ijmm.2006.02.005; Rosenfeld RM, 2015, OTOLARYNG HEAD NECK, V152, P598, DOI 10.1177/0194599815574247; Rudack C, 2006, CLIN EXP ALLERGY, V36, P748, DOI 10.1111/j.1365-2222.2006.02501.x; Rudmik L, 2014, LARYNGOSCOPE, V124, P2007, DOI 10.1002/lary.24630; Sanclement JA, 2005, LARYNGOSCOPE, V115, P578, DOI 10.1097/01.mlg.0000161346.30752.18; Sawasdidoln C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009196; Schleimer RP, 2017, ANNU REV PATHOL-MECH, V12, P331, DOI 10.1146/annurev-pathol-052016-100401; Soyka MB, 2012, J ALLERGY CLIN IMMUN, V130, P1087, DOI 10.1016/j.jaci.2012.05.052; Suh Jeffrey D, 2011, Proc Am Thorac Soc, V8, P132, DOI 10.1513/pats.201003-028RN; Thomas AJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183542; Tsai PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017755; Vuong C, 2004, CELL MICROBIOL, V6, P269, DOI 10.1046/j.1462-5822.2004.00367.x; Watelet JB, 2004, ALLERGY, V59, P54, DOI 10.1046/j.1398-9995.2003.00364.x; Wiens JR, 2014, MBIO, V5, DOI 10.1128/mBio.01010-13; Wongkaewkhiaw S, 2019, BIOFOULING, V35, P573, DOI 10.1080/08927014.2019.1632835; Young FM, 2005, TOXICOL IN VITRO, V19, P1051, DOI 10.1016/j.tiv.2005.05.001; Yu YS, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.100999; Zhang Z, 2015, INT FORUM ALLERGY RH, V5, P643, DOI 10.1002/alr.21505; Zhu C, 2013, J SURG RES, V183, P204, DOI 10.1016/j.jss.2012.11.048	66	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0243315	10.1371/journal.pone.0243315	http://dx.doi.org/10.1371/journal.pone.0243315			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326455	gold, Green Published			2022-12-27	WOS:000600176400005
J	Akomoneh, EA; Esemu, SN; Kfusi, AJ; Ndip, RN; Ndip, LM				Akomoneh, Elvis Achondou; Esemu, Seraphine Nkie; Kfusi, Achah Jerome; Ndip, Roland N.; Ndip, Lucy M.			Prevalence and virulence gene profiles of Escherichia coli O157 from cattle slaughtered in Buea, Cameroon	PLOS ONE			English	Article							SHIGA TOXIN; MEAT-PRODUCTS; OUTBREAK; EXPOSURE; HEALTH	BackgroundEscherichia coli O157 is an emerging foodborne pathogen of great public health concern. It has been associated with bloody diarrhoea, haemorrhagic colitis and haemolytic uremic syndrome in humans. Most human infections have been traced to cattle and the consumption of contaminated cattle products. In order to understand the risk associated with the consumption of cattle products, this study sought to investigate the prevalence and identify virulence genes in E. coli O157 from cattle in Cameroon. Method A total of 512 rectal samples were obtained and analysed using conventional bacteriological methods (enrichment on modified Tryptone Soy Broth and selective plating on Cefixime-Tellurite Sorbitol Mac-Conkey Agar) for the isolation of E. coli O157. Presumptive E. coli O157 isolates were confirmed serologically using E. COLIPROTM O157 latex agglutination test and molecularly using PCR targeting the rfb gene in the isolates. Characterisation of the confirmed E. coli O157 strains was done by amplification of stx1, stx2, eaeA and hlyA virulence genes using both singleplex and multiplex PCR. ResultsE. coli O157 was detected in 56 (10.9%) of the 512 samples examined. The presence of the virulence genes stx2, eaeA and hylA was demonstrated in 96.4% (54/56) of the isolates and stx1 in 40 (71.4%) of the 54. The isolates exhibited three genetic profiles (I-III) with I (stx1, stx2, eaeA and hlyA) being the most prevalent (40/56; 71.4%) while two isolates had none of the virulence genes tested. Conclusion A proportion of cattle slaughtered in abattoirs in Buea are infected with pathogenic E. coli O157 and could be a potential source of human infections. We recommend proper animal food processing measures and proper hygiene be prescribed and implemented to reduce the risk of beef contamination.	[Akomoneh, Elvis Achondou] Univ Bamenda, Dept Biol Sci, Fac Sci, Bamenda, Cameroon; [Esemu, Seraphine Nkie; Kfusi, Achah Jerome; Ndip, Roland N.; Ndip, Lucy M.] Univ Buea, Dept Microbiol & Parasitol, Fac Sci, Buea, Cameroon; [Esemu, Seraphine Nkie; Kfusi, Achah Jerome; Ndip, Roland N.; Ndip, Lucy M.] Univ Buea, Lab Emerging Infect Dis, Buea, Cameroon; [Ndip, Lucy M.] Univ Texas Med Branch, Ctr Trop Dis, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Akomoneh, EA (corresponding author), Univ Bamenda, Dept Biol Sci, Fac Sci, Bamenda, Cameroon.	eakomoneh@gmail.com	Esemu, Seraphine N./AAI-5972-2021	Esemu, Seraphine N./0000-0003-2497-4689; Akomoneh, Elvis/0000-0003-3882-2600				Afnabi R. B., 2015, International Journal of Veterinary Science, V4, P183; Asongwe G. A., 2014, International Journal of Current Microbiology and Applied Sciences, V3, P682; Bekele T., 2014, International Journal of Food Contamination, V1; Beutin L, 2006, J VET MED B, V53, P299, DOI 10.1111/j.1439-0450.2006.00968.x; Bibbal D, 2015, APPL ENVIRON MICROB, V81, P1397, DOI 10.1128/AEM.03315-14; Cagney C, 2004, FOOD MICROBIOL, V21, P203, DOI 10.1016/S0740-0020(03)00052-2; Callaway TR, 2009, CURR ISSUES MOL BIOL, V11, P67; Chagomoka T, 2014, TRADITIONAL VEGETABL, P14; Dhaka Pankaj, 2016, Infection Ecology & Epidemiology, V6, P31055, DOI 10.3402/iee.v6.31055; Gautam R, 2015, EPIDEMIOL INFECT, V143, P274, DOI 10.1017/S0950268814000867; Gimou MM, 2014, FOOD ADDIT CONTAM A, V31, P1064, DOI 10.1080/19440049.2014.909953; Gyles CL, 1998, ESCHERICHIA COLI O15, P434; Hale CR, 2012, CLIN INFECT DIS, V54, pS472, DOI 10.1093/cid/cis051; Hashemi M., 2010, World Applied Sciences Journal, V10, P703; Hessain AM, 2015, SAUDI J BIOL SCI, V22, P725, DOI 10.1016/j.sjbs.2015.06.009; Hiko A, 2008, J INFECT DEV COUNTR, V2, P389; Johannes L, 2010, NAT REV MICROBIOL, V8, P105, DOI 10.1038/nrmicro2279; Leotta GA, 2008, BMC MICROBIOL, P8, DOI [10.1186/1471-2180-8-8, DOI 10.1186/1471-2180-8-8]; LOUISE CB, 1995, J INFECT DIS, V172, P1397, DOI 10.1093/infdis/172.5.1397; Luga I., 2007, Nigerian Veterinary Journal, V28, P6; Luna S, 2018, MMWR-MORBID MORTAL W, V67, P659, DOI 10.15585/mmwr.mm6723a2; Luna-Guevara JJ, 2019, INT J MICROBIOL, V2019, DOI 10.1155/2019/2894328; Mashood A, 2006, CHINESE MED J, V119, P217; Melton-Celsa AR, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.EHEC-0024-2013; Mohammad TA, 2015, JUNDISHAPUR J MICROB, V8, P25317; Munyua P, 2010, AM J TROP MED HYG, V83, P58, DOI 10.4269/ajtmh.2010.09-0292; Ngalim A.N., 2015, J ED POLICY ENTREPRE, V2, P175; Omisakin F, 2003, APPL ENVIRON MICROB, V69, P2444, DOI 10.1128/AEM.69.5.2444-2447.2003; Oswald E, 2000, INFECT IMMUN, V68, P64, DOI [10.1128/IAI.68.1.64-71.2000, 10.1128/IAI.68.11.6402-6410.2000]; Paton AW, 1998, J CLIN MICROBIOL, V36, P598, DOI 10.1128/JCM.36.2.598-602.1998; Persad AK, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.EHEC-0027-2014; Roger D. D., 2015, International Journal of Current Microbiology and Applied Sciences, V4, P441; Sallam KI, 2013, INT J FOOD MICROBIOL, V165, P295, DOI 10.1016/j.ijfoodmicro.2013.05.024; Sandvig K, 2002, HISTOCHEM CELL BIOL, V117, P131, DOI 10.1007/s00418-001-0346-2; Schwidder M, 2019, TOXINS, V11, DOI 10.3390/toxins11090502; Smith JL, 2014, ADV APPL MICROBIOL, V86, P145, DOI 10.1016/B978-0-12-800262-9.00003-2; Synge BA, 2000, ZOONOTIC INFECT LIVE, P10; Uyttendaele M, 2016, PROC FOOD SCI, V6, P16, DOI 10.1016/j.profoo.2016.02.003; Wasey A, 2018, STATPEARLS; Water Watch, 2018, E COL; WELLS JG, 1991, J CLIN MICROBIOL, V29, P985, DOI 10.1128/JCM.29.5.985-989.1991; Zadik PM, 1999, J MED MICROBIOL, V39, P155	42	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0235583	10.1371/journal.pone.0235583	http://dx.doi.org/10.1371/journal.pone.0235583			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320853	Green Published, gold, Green Submitted			2022-12-27	WOS:000600339800009
J	Asfaw, MA; Gezmu, T; Wegayehu, T; Bekele, A; Hailemariam, Z; Masresha, N; Gebre, T				Asfaw, Mekuria Asnakew; Gezmu, Tigist; Wegayehu, Teklu; Bekele, Alemayehu; Hailemariam, Zeleke; Masresha, Nebiyu; Gebre, Teshome			Soil-transmitted helminth infections among pre-school aged children in Gamo Gofa zone, Southern Ethiopia: Prevalence, intensity and intervention status	PLOS ONE			English	Article								Background Soil-transmitted helminths (STH), i.e., Ascaris lumbricoides, Trichuris trichiura and hookworms are among the most prevalent Neglected Tropical Diseases (NTDs) in Ethiopia. Although pre-school aged children pay a high morbidity toll associated with STH infections, evidence on prevalence, intensity and intervention status is lacking in Ethiopia. This study, therefore, aimed to address these gaps to inform decision made on STH. Methods We did a community-based cross-sectional study in five districts of Gamo Gofa zone, Southern Ethiopia; in January 2019. Data were collected using pre-tested questionnaire, and the Kato-Katz technique was used to diagnose parasites eggs in stool. Then, collected data were edited and entered into EpiData 4.4.2, and exported to SPSS software (IBM, version 25) for analysis. Results A total of 2462 PSAC participated in this study. Overall, the prevalence of STH was 23.5% (578/2462) (95% confidence interval (CI) = 21.8%-25.2%). As caris lumbricoides was the most prevalent (18.6%), followed by Trichuris trichiura (9.2%), and hookworms (3.1%). Of the total, 7.4% PSAC were infected with two STH species. Most of the positive cases with STH showed low infection intensities, while 15.1% ascariasis cases showed moderate infection intensities. The study found that 68.7% of PSAC were treated with albendazole. Also, household's level data showed that 39.4% used water from hand-dug well; 52.5% need to travel >= 30 minutes to collect water; 77.5% did not treat water, and 48.9% had no hand washing facility. In addition, almost 93% care givers achieved less than the mean knowledge and practice score (<= 5) on STH prevention. Conclusions This study showed that significant proportions of pre-school aged children are suffering from STH infections despite preventive chemotherapy exist at the study area. Also, gaps in the interventions against STH were highlighted. Thus, a call for action is demanding to eliminate STH among PSAC in Ethiopia by 2030.	[Asfaw, Mekuria Asnakew; Gezmu, Tigist; Bekele, Alemayehu] Arba Minch Univ, Collaborat Res & Training Ctr NTDs, Arba Minch, Ethiopia; [Wegayehu, Teklu] Arba Minch Univ, Coll Nat Sci, Dept Biol, Arba Minch, Ethiopia; [Hailemariam, Zeleke] Arba Minch Univ, Sch Publ Hlth, Coll Med & Hlth Sci, Arba Minch, Ethiopia; [Masresha, Nebiyu] Ethiopian Publ Hlth Inst, Addis Ababa, Ethiopia; [Gebre, Teshome] Int Trachoma Initiat, Task Force Global Hlth, Addis Ababa, Ethiopia	Arba Minch University; Arba Minch University; Arba Minch University	Asfaw, MA (corresponding author), Arba Minch Univ, Collaborat Res & Training Ctr NTDs, Arba Minch, Ethiopia.	maksambaramr23@gmail.com	Kassahun, Alemayehu Bekele/ABA-5651-2021	Kassahun, Alemayehu Bekele/0000-0001-8341-4855; Gezmu, Tigist/0000-0001-5937-8452; asfaw, mekuria/0000-0002-5718-0001	collaborative research and training center for NTDs, Arba Minch University, Ethiopia	collaborative research and training center for NTDs, Arba Minch University, Ethiopia	This study is made possible by the generous research grant support of collaborative research and training center for NTDs, Arba Minch University, Ethiopia.	Albonico M, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000126; [Anonymous], 2006, Wkly Epidemiol Rec, V81, P145; [Anonymous], 2014, J CLIN DIAGN RES, V8; [Anonymous], 2013, BMC P S6, V7, pO1; Asfaw MA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235281; Becker SL, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006606; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Brooker S, 2010, INT J PARASITOL, V40, P1137, DOI 10.1016/j.ijpara.2010.04.004; Central Statistical Agency, 2013, POP PROJ ETH 2007 20; Dana D, 2015, T ROY SOC TROP MED H, V109, P225, DOI 10.1093/trstmh/tru178; Davis SM, 2014, AM J TROP MED HYG, V91, P1002, DOI 10.4269/ajtmh.14-0060; de Silva NR, 2003, TRENDS PARASITOL, V19, P547, DOI 10.1016/j.pt.2003.10.002; Ethiopian Federal Minstry of Health, 2013, NAT MAST PLAN NEGL T; Federal Democratic Republic of Ethiopia Ministry of Health, 2016, ETH NAT MAST PLAN NE; Freeman MC, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007201; Ghiwot Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109793; Gizaw Z, 2018, ENVIRON HEALTH PREV, V23, DOI 10.1186/s12199-018-0714-3; Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261; Hotez PJ, 2009, LANCET, V373, P1570, DOI 10.1016/S0140-6736(09)60233-6; Leta GT, NATL MAPPING SOIL TR; Moncayo AL, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-021319; Montresor A, 2017, T ROY SOC TROP MED H, V111, P457, DOI 10.1093/trstmh/trx082; Nyantekyi LA, 2010, ETHIOP J HEALTH DEV, V24, P185; Ojja S, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3289-0; Pullan RL, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-81; Shumbej T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136342; SOERIPTO N, 1991, Southeast Asian Journal of Tropical Medicine and Public Health, V22, P216; Sowemimo OA, 2011, J HELMINTHOL, V85, P234, DOI 10.1017/S0022149X10000489; Stephenson LS, 2000, PARASITOLOGY, V121, pS1, DOI 10.1017/S0031182000009410; Tchuente LAT, 2012, CURRENT TOPICS IN TROPICAL MEDICINE, P359; Tekalign E, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/3687873; Wang XJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040084, 10.1371/journal.pone.0040711, 10.1371/journal.pone.0038932, 10.1371/journal.pone.0052707, 10.1371/journal.pone.0036663, 10.1371/journal.pone.0045380, 10.1371/journal.pone.0052082, 10.1371/journal.pone.0040857, 10.1371/journal.pone.0047429, 10.1371/journal.pone.0045939, 10.1371/journal.pone.0045036]; WHO, 2020, ENDING NEGLECT ATTAI; WHO, 2006, COORD US ANTH DRUGS; WHO, SOIL TRANSM HELM EL; WHO Expert Committee, 2002, World Health Organ Tech Rep Ser, V912, pi; World Health Organization, 1994, KAT KATZ TECHN BENCH; World Health Organization, 2011, INT WORMS SOIL TRANS; World Health Organization, 2019, UN HLTH COV WHO FACT; World Health Organization, 2017, GUID PREV CHEM CONTR; Ziegelbauer K, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001162; 2010, LASER PHOTON REV, V4	42	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243946	10.1371/journal.pone.0243946	http://dx.doi.org/10.1371/journal.pone.0243946			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320918	Green Published, gold			2022-12-27	WOS:000600339800029
J	Cheng, LN; Ye, YS; Zhong, ZY; Zhang, FY; Hu, XY; Cui, RS; Chen, Q				Cheng, Linan; Ye, Yansheng; Zhong, Zhaoyang; Zhang, Fengying; Hu, Xiuying; Cui, Renshan; Chen, Qian			Mediating effects of general self-efficacy on the relationship between the source of meaning in life and prosocial behaviours in vocational college nursing students: A cross-sectional study	PLOS ONE			English	Article							ADOLESCENTS; BELIEFS; ROLES	Objectives To examine the mediating effect of general self-efficacy on the relationship between the source of meaning in life (SML) and prosocial behaviours in vocational college nursing students. Methods Between March and June 2019, a cross-sectional descriptive study was conducted, and 799 nursing students from three vocational colleges completed the Source of Meaning in Life Scale, General Self-Efficacy Scale and Prosocial Behaviours Scale. Data were analyzed using structural equation modelling and statistical analysis by SPSS (version 23.0, IBM). Results The average SML, general self-efficacy and prosocial behaviours scores of the 799 nursing students were 6.430.83, 2.48 +/- 0.59 and 3.69 +/- 0.62, respectively. Correlation analysis showed that SML, general self-efficacy and prosocial behaviours were positively correlated (P<0.01). General self-efficacy partially mediated the relationship between SML and prosocial behaviours (P<0.01); this mediating effect contributed 22.97% of the total effect and explained 17.6% of the variance in the dependent variable. Conclusions Educators should focus on cultivating nursing students' cognition and experience of meaning in life and their efficacy in life, study and work, which can improve students' "people-oriented" service and prosocial behaviour and the quality of nursing services.	[Cheng, Linan; Ye, Yansheng; Zhang, Fengying; Hu, Xiuying; Chen, Qian] Sichuan Univ, West China Sch Nursing, West China Hosp, Chengdu, Sichuan, Peoples R China; [Zhong, Zhaoyang] Shanxi Med Univ, Fenyang Coll, Fenyang, Shanxi, Peoples R China; [Cui, Renshan] Jiaxing Univ, Coll Med, Jiaxing, Zhejiang, Peoples R China; [Ye, Yansheng] Kunming Med Univ, Peoples Hosp Yuxi City, Affiliated Hosp 6, Yuxi, Yunnan, Peoples R China	Sichuan University; Shanxi Medical University; Jiaxing University; Kunming Medical University	Chen, Q (corresponding author), Sichuan Univ, West China Sch Nursing, West China Hosp, Chengdu, Sichuan, Peoples R China.; Cui, RS (corresponding author), Jiaxing Univ, Coll Med, Jiaxing, Zhejiang, Peoples R China.	2594793790@qq.com; chen_qian@scu.edu.cn			Science & Technology Department of Sichuan Province [2019YFS0386]	Science & Technology Department of Sichuan Province	This work was supported by Science & Technology Department of Sichuan Province,in the framework of assessment of symptoms and establishment of a multidisciplinary palliative care model for elderly patients with terminal frailty (2019YFS0386). The person in charge of the project is corresponding author Qian Chen in the manuscript. And there was no additional external funding received for this study.	Bains KK, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.01787; Carlo G, 2002, J YOUTH ADOLESCENCE, V31, P31, DOI 10.1023/A:1014033032440; Chen D, 2020, THESIS; Chen S, 2019, THESIS; Cheng M, 2015, POSITIVE MEANING LIF; [程明明 Cheng Mingming], 2011, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V19, P591; Cui YX, 2011, J NURSING SCI, V26, P79, DOI [10.3870/hlxzz.2011.08.079, DOI 10.3870/HLXZZ.2011.08.079]; Cuneo T, 2011, BRIT J HIST PHILOS, V19, P963, DOI 10.1080/09608788.2011.599571; Deng H, 2020, J JIAMUSI VOCATIONAL, V36, P228; Einaudi MA, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-58; Falanga R, 2014, PROCD SOC BEHV, V127, P214, DOI 10.1016/j.sbspro.2014.03.243; Fang JD, 2019, PSYCHOL DEV ED, V35, P303; FRANKL VE, 1966, AM J PSYCHOTHER, V20, P252, DOI 10.1176/appi.psychotherapy.1966.20.2.252; Gherghel C, 2020, ETHICS BEHAV, V30, P126, DOI 10.1080/10508422.2019.1651651; Tabares ASG, 2019, REV CRIM, V61, P221; Jafary F, 2011, AGING MENT HEALTH, V15, P630, DOI 10.1080/13607863.2010.548056; Javaeed A, 2020, CUREUS, V12, DOI 10.7759/cureus.7733; Kou Y., 2007, PSYCHOL DEV ED, V1, P112, DOI DOI 10.3969/J.ISSN.1001-4918.2007.01.020; Landale S, 2014, INT REV SOCIOL SPORT, V49, P468, DOI 10.1177/1012690213507273; Lee HJ, 2001, INT J HUM RESOUR MAN, V12, P1029, DOI 10.1080/713769686; Li JJ, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.01140; [李露 Li Lu], 2020, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V28, P178; Li W., 2019, CHINA POLICY REV, P62, DOI [10.3969/j.issn.1008-7370.2019.08.019, DOI 10.3969/J.ISSN.1008-7370.2019.08.019]; Li WY, 2015, CHIN J NURSING SCI, V30, P107, DOI DOI 10.3870/HLXZZ.2015.06.107; Liu Y, 2019, CHILD INDIC RES, V12, P1735, DOI 10.1007/s12187-018-9607-7; Loeffler S, 2018, EUR J CANCER CARE, V27, DOI 10.1111/ecc.12841; McMahon SD, 2013, AM J COMMUN PSYCHOL, V51, P407, DOI 10.1007/s10464-012-9560-4; MIDLARSKY E, 1985, DEV PSYCHOL, V21, P534, DOI 10.1037/0012-1649.21.3.534; Patrick RB, 2018, J GENET PSYCHOL, V179, P231, DOI 10.1080/00221325.2018.1491472; Roberts AEK, 2018, CAN J OCCUP THER, V85, P386, DOI 10.1177/0008417418820358; Rodgers S., 2015, ATHENS J HLTH, V2, P177; Sari SV, 2019, CURR PSYCHOL, V38, P1245, DOI 10.1007/s12144-017-9672-y; Schreiber JB, 2017, RES SOC ADMIN PHARM, V13, P634, DOI 10.1016/j.sapharm.2016.06.006; Schwarzer R, 1997, APPL PSYCHOL-INT REV, V46, P69, DOI 10.1111/j.1464-0597.1997.tb01096.x; Sheng Z, 2007, THESIS; Shin JY, 2018, J COLL STUDENT DEV, V59, P734; [谭蔓 Tan Man], 2018, [西南大学学报. 自然科学版, Journal of Southwest University. Natural Science Edition], V40, P146; Wang C.K., 2001, CHINESE J APPL PSYCH, V7, P37, DOI [DOI 10.3969/J.ISSN.1006-6020.2001.01.007, 10.3969/j.issn.1006-6020.2001.01.007]; Wang W., 2018, PSYCHOL DEV ED, V34, P112; Welter PR, 1987, COUNSELING SEARCH ME; West SG, 2010, APPL PSYCH MEAS, V34, P211, DOI 10.1177/0146621609360954; Xiang XF, 2018, J CHENGDE PETROLEUM, V20, P71, DOI [10.3969/j.issn.1008-9446.2018.01.018, DOI 10.3969/J.ISSN.1008-9446.2018.01.018]; Yang Y, 2017, J HAPPINESS STUD, V18, P1747, DOI 10.1007/s10902-016-9794-1; Yao ZJ, 2020, ETHICS BEHAV, V30, P97, DOI 10.1080/10508422.2019.1591963; Ye YS, 2018, NURS EDUC TODAY, V71, P157, DOI 10.1016/j.nedt.2018.09.036; Zeng YL, 2019, PSYCHOL HEALTH MED, V24, P798, DOI 10.1080/13548506.2019.1574358; Zhou L., 2019, THESIS; Zhuang J, 2015, THESIS	48	3	3	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243796	10.1371/journal.pone.0243796	http://dx.doi.org/10.1371/journal.pone.0243796			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH3TP	33320873	Green Published, gold			2022-12-27	WOS:000600339800004
J	Yuan, W; Gong, SY; Han, YM				Yuan, Wei; Gong, Shuying; Han, Yimin			How does rising housing price affect the health of middle-aged and elderly people? The complementary mediators of social status seeking and competitive saving motive	PLOS ONE			English	Article							INCOME INEQUALITY; GROWTH; SEX	Under the backdrop of China's aging population and continuous rising housing price and base on theories pertaining to social status seeking, marriage matching and intergenerational family relationships, use the 2010 and 2014 CFPS national survey micro data, we examine the impact of rising housing price on the health of middle-aged and elderly people and the underlying mechanisms. Rising housing price has a significant negative impact on the health of middle-aged and elderly people, and this effect is also reflected in their physical health, mental acuity and emotional well-being. The internal mechanism is that social status seeking motivation plays a significant mediator role. Through further analysis, we find that competitive saving motive is another intermediate mechanism that causes rising housing price to affect the health of middle-aged and elderly people; it is complementary to the social status seeking motivation. What's more, the mediation effect of the competitive saving motive is notably heterogeneous, as it exists only for middle-aged and elderly people with male or noncollege educated child but does not exist for those with female or college educated child.	[Yuan, Wei; Gong, Shuying; Han, Yimin] Hubei Univ Econ, Sch Business Adm, Wuhan, Peoples R China; [Gong, Shuying; Han, Yimin] Shanghai Univ Finance & Econ, Coll Business, Shanghai, Peoples R China	Hubei University of Economics; Shanghai University of Finance & Economics	Gong, SY; Han, YM (corresponding author), Shanghai Univ Finance & Econ, Coll Business, Shanghai, Peoples R China.	swugsy@163.com; gracehanhan@126.com		Gong, Shuying/0000-0002-8515-306X	Innovation foundation of Chinese National Funding of social science [18CJL036]; Shanghai University of Finance and Economics [CXJJ-2019-324, CXJJ-2019-343]	Innovation foundation of Chinese National Funding of social science; Shanghai University of Finance and Economics	This paper is supported by the Innovation foundation of Chinese National Funding of social science(Grant No.18CJL036); Shanghai University of Finance and Economics (No. CXJJ-2019-324; CXJJ-2019-343) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, IEEE SIGNAL PROCESS, V30, P14; BARKOW JH, 1991, BEHAV BRAIN SCI, V14, P295, DOI 10.1017/S0140525X00066711; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bartley M, 2012, SOC SCI MED, V74, P658, DOI 10.1016/j.socscimed.2011.12.015; Campbell JY, 2007, J MONETARY ECON, V54, P591, DOI 10.1016/j.jmoneco.2005.10.016; Chang SM, 2015, J ECON BEHAV ORGAN, V116, P292, DOI 10.1016/j.jebo.2015.05.004; Chen D., 2015, J FINANC RES, V12, P1; Conti G, 2010, AM ECON REV, V100, P234, DOI 10.1257/aer.100.2.234; Corneo G, 1999, INT ECON REV, V40, P711, DOI 10.1111/1468-2354.00036; Deng J, 2011, MANAGEMENT WORLD, P171; Du Q, 2011, SEX RATIOS ENTREPREN; Gerdtham UG, 2004, J HUM RESOUR, V39, P228, DOI 10.2307/3559011; Griskevicius V, 2013, J CONSUM PSYCHOL, V23, P372, DOI 10.1016/j.jcps.2013.03.003; Hang B., 2015, STAT RES, V32, P68; He L., 2019, J FINANCE EC, V45, P122, DOI [10.16538/j.cnki.jfe.2019.01.008, DOI 10.16538/J.CNKI.JFE.2019.01.008]; He Xuefeng, 2009, SOC SCI RES, P84; Hopkins E, 2004, AM ECON REV, V94, P1085, DOI 10.1257/0002828042002705; Inglehart R., 2018, CULTURE SHIFT ADV IN; [金晓彤 Jin Xiaotong], 2017, [心理学报, Acta Psychologica Sinica], V49, P273; Jin Y., 2011, CHINA EC Q, V10, P887; Koivusilta LK, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-110; Leadebal WV, 2018, J BRAZ SOC MECH SCI, V40, DOI 10.1007/s40430-017-0922-6; Li H. B., 2008, J COMP COMP EC, V34, P668; Li LX, 2017, REV INCOME WEALTH, V63, P378, DOI 10.1111/roiw.12215; Li S., 2011, CHIN J POPULAT SCI, V111, P26; Li ZF., 2016, J FINANCE EC, V42, P122; Liang Yunfang., 2007, EC RES J, V8, P133; Lynch J, 2004, MILBANK Q, V82, P5, DOI 10.1111/j.0887-378X.2004.00302.x; Mao Y., 2011, POPUL EC, V3, P87; MICHALOS AC, 1995, SOC INDIC RES, V34, P1, DOI 10.1007/BF01078965; Modigliani F, 2004, J ECON LIT, V42, P145, DOI 10.1257/002205104773558074; Ni XY, 2014, J AGROTECHNICAL EC, P65; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Qi L.S., 2006, ECON, V11, P16; Schultz TP., 2004, PAC ECON REV, V9, P245, DOI [10.1111/j.1468-0106.2004.00247.x, DOI 10.1111/J.1468-0106.2004.00247.X]; Sokoll LJ, 2008, CANCER BIOMARK, V4, P135; Subramanian SV, 2004, EPIDEMIOL REV, V26, P78, DOI 10.1093/epirev/mxh003; Tao ZX, 2011, FOLKLORE STUDIES, P259; Wagstaff A, 2003, J ECONOMETRICS, V112, P207, DOI 10.1016/S0304-4076(02)00161-6; Wang SX, 2018, CIRCUIT WORLD, V44, P53, DOI 10.1108/CW-11-2017-0064; Wei SJ, 2011, J POLIT ECON, V119, P511, DOI 10.1086/660887; Weiss Y, 1998, EUR ECON REV, V42, P801, DOI 10.1016/S0014-2921(97)00137-2; Wu WX., 2014, SCI DECISION MAKING, V11, P52; Wu X., 2014, EC RES J, V49, P121; Yu LT, 2017, J FINANCE EC, V43, P17; Yu Y., 2006, EC PERSPECTIVES, P92; Yu Y.Y., 2007, EC RES J, V42, P79; Yuan W, 2018, SCI TECHNOLOGY PROGR, V35, P7; Yun C, 2013, PR INT CONF INF MANA, P34, DOI 10.1109/ICIII.2013.6702868; Zhang CY, 2014, J FINANC RES, V12, P86; Zhao XS, 2010, J CONSUM RES, V37, P197, DOI 10.1086/651257; Zhou GS, 2014, MANAGEMENT WORLD; Zuo SB, 2012, CRYST RES TECHNOL, V47, P139, DOI 10.1002/crat.201100502	53	2	2	7	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243982	10.1371/journal.pone.0243982	http://dx.doi.org/10.1371/journal.pone.0243982			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH3TP	33320920	Green Published, gold			2022-12-27	WOS:000600339800038
J	Khayyeri, H; Hammerman, M; Turunen, MJ; Blomgran, P; Notermans, T; Guizar-Sicairos, M; Eliasson, P; Aspenberg, P; Isaksson, H				Khayyeri, Hanifeh; Hammerman, Malin; Turunen, Mikael J.; Blomgran, Parmis; Notermans, Thomas; Guizar-Sicairos, Manuel; Eliasson, Pernilla; Aspenberg, Per; Isaksson, Hanna			Diminishing effects of mechanical loading over time during rat Achilles tendon healing	PLOS ONE			English	Article							MECHANOBIOLOGY; PARATENON; MATRIX; CELLS	Mechanical loading affects tendon healing and recovery. However, our understanding about how physical loading affects recovery of viscoelastic functions, collagen production and tissue organisation is limited. The objective of this study was to investigate how different magnitudes of loading affects biomechanical and collagen properties of healing Achilles tendons over time. Achilles tendon from female Sprague Dawley rats were cut transversely and divided into two groups; normal loading (control) and reduced loading by Botox (unloading). The rats were sacrificed at 1, 2- and 4-weeks post-injury and mechanical testing (creep test and load to failure), small angle x-ray scattering (SAXS) and histological analysis were performed. The effect of unloading was primarily seen at the early time points, with inferior mechanical and collagen properties (SAXS), and reduced histological maturation of the tissue in unloaded compared to loaded tendons. However, by 4 weeks no differences remained. SAXS and histology revealed heterogeneous tissue maturation with more mature tissue at the peripheral region compared to the center of the callus. Thus, mechanical loading advances Achilles tendon biomechanical and collagen properties earlier compared to unloaded tendons, and the spatial variation in tissue maturation and collagen organization across the callus suggests important regional (mechano-) biological activities that require more investigation.	[Khayyeri, Hanifeh; Hammerman, Malin; Notermans, Thomas; Isaksson, Hanna] Lund Univ, Dept Biomed Engn, Lund, Sweden; [Hammerman, Malin; Blomgran, Parmis; Eliasson, Pernilla; Aspenberg, Per] Linkoping Univ, Dept Biomed & Clin Sci, Linkoping, Sweden; [Turunen, Mikael J.] Univ Eastern Finland, Dept Appl Phys, Kuopio, Finland; [Guizar-Sicairos, Manuel] Paul Scherrer Inst, Swiss Light Source, Villigen, Switzerland	Lund University; Linkoping University; University of Eastern Finland; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Isaksson, H (corresponding author), Lund Univ, Dept Biomed Engn, Lund, Sweden.	Hanna.Isaksson@bme.lth.se	Guizar-Sicairos, Manuel/AAB-3793-2019; Isaksson, Hanna/L-1340-2015	Guizar-Sicairos, Manuel/0000-0002-8293-3634; Isaksson, Hanna/0000-0002-9690-8907; Blomgran, Parmis/0000-0002-2654-1361; Turunen, Mikael/0000-0003-1093-1178; Eliasson, Pernilla/0000-0001-6718-034X	European Community's Seventh Framework Program (FP7/2007-2013) [262348]; Marie Curie Intra-European Fellowship for Career Development [PIEF-GA-2012-626941]; Knut and Alice Wallenberg Foundation [2017.0221]	European Community's Seventh Framework Program (FP7/2007-2013); Marie Curie Intra-European Fellowship for Career Development; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	The authors would like to thank the European Community's Seventh Framework Program (FP7/2007-2013) under grant agreement no. 262348 (ESMI, European Soft Matter Infrastructure Network) that enabled beamtime at the cSAXS beamline of the Swiss Light Source at the Paul Scherrer Institut, Villigen, Switzerland. The authors are grateful for the financial support by the Marie Curie Intra-European Fellowship for Career Development (PIEF-GA-2012-626941) (HK) and the Knut and Alice Wallenberg Foundation (Wallenberg Academy Fellows 2017.0221, HI).	ABRAHAMS M, 1967, MED BIOL ENG, V5, P433, DOI 10.1007/BF02479137; Angele P, 2004, BIORHEOLOGY, V41, P335; [Anonymous], 2018, NAT CLIM CHANGE, V8, P1, DOI 10.1038/s41558-017-0058-9; Aubry S, 2015, RADIOLOGY, V274, P821, DOI 10.1148/radiol.14140434; BUCK RC, 1980, EXP CELL RES, V127, P470, DOI 10.1016/0014-4827(80)90456-5; Chiquet M, 2003, MATRIX BIOL, V22, P73, DOI 10.1016/S0945-053X(03)00004-0; CICHON JV, 1995, LARYNGOSCOPE, V105, P144, DOI 10.1288/00005537-199502000-00006; COHEN RE, 1976, J BIOMECH, V9, P175, DOI 10.1016/0021-9290(76)90002-6; Dyment NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059944; Eliasson P, 2007, J APPL PHYSIOL, V103, P459, DOI 10.1152/japplphysiol.01333.2006; Eliasson P, 2009, J APPL PHYSIOL, V107, P399, DOI 10.1152/japplphysiol.91563.2008; Freedman BR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29060-y; Freedman BR, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2017.0880; Hammerman M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201211; Hammerman M, 2015, J APPL PHYSIOL, V119, P534, DOI 10.1152/japplphysiol.00239.2015; Hillin CD, 2019, J ORTHOP RES, V37, P562, DOI 10.1002/jor.24241; Huegel J, 2019, J BIOMECH, V88, P194, DOI 10.1016/j.jbiomech.2019.03.029; Julkunen P, 2010, OSTEOARTHR CARTILAGE, V18, P406, DOI 10.1016/j.joca.2009.11.007; Khayyeri H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13107-7; Killian ML, 2012, J SHOULDER ELB SURG, V21, P228, DOI 10.1016/j.jse.2011.11.002; Kukreti U, 2000, J BIOMECH, V33, P1569, DOI 10.1016/S0021-9290(00)00150-0; Lavagnino M, 2015, J ORTHOP RES, V33, P813, DOI 10.1002/jor.22871; Lyras DN, 2016, ARCH BONE JT SURG-AB, V4, P156; Miller KS, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4006340; Momose T, 2002, CLIN ANAT, V15, P199, DOI 10.1002/ca.10009; Muller SA, 2018, AM J SPORT MED, V46, P1214, DOI 10.1177/0363546518756093; RIGBY BJ, 1959, J GEN PHYSIOL, V43, P265, DOI 10.1085/jgp.43.2.265; Sasaki K, 2012, J ELECTRON MICROSC, V61, P327, DOI 10.1093/jmicro/dfs057; Svensson RB, 2019, TRANSL SPORTS MED, V2, P316, DOI 10.1002/tsm2.103; Turunen MJ, 2017, J STRUCT BIOL, V199, P209, DOI 10.1016/j.jsb.2017.07.009; Turunen MJ, 2012, J ORTHOP RES, V30, P435, DOI 10.1002/jor.21538; Wall ME, 2016, ADV EXP MED BIOL, V920, P79, DOI 10.1007/978-3-319-33943-6_7; Wren TAL, 2000, J REHABIL RES DEV, V37, P135	33	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0236681	10.1371/journal.pone.0236681	http://dx.doi.org/10.1371/journal.pone.0236681			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315857	gold, Green Published, Green Submitted			2022-12-27	WOS:000600186100028
J	Morris, E; Hippman, C; Albert, A; Slomp, C; Inglis, A; Carrion, P; Batallones, R; Andrighetti, H; Ross, C; Dyer, R; Honer, W; Austin, J				Morris, Emily; Hippman, Catriona; Albert, Arianne; Slomp, Caitlin; Inglis, Angela; Carrion, Prescilla; Batallones, Rolan; Andrighetti, Heather; Ross, Colin; Dyer, Roger; Honer, William; Austin, Jehannine			A prospective study to explore the relationship between MTHFR C677T genotype, physiological folate levels, and postpartum psychopathology in at-risk women	PLOS ONE			English	Article							GENE-ENVIRONMENT INTERACTION; NEGATIVE SYNDROME SCALE; METHYLENETETRAHYDROFOLATE-REDUCTASE; BIPOLAR DISORDER; 2 POLYMORPHISMS; MTHFR GENE; DEPRESSION; SCHIZOPHRENIA; HOMOCYSTEINE; PREGNANCY	Background The etiology of postpartum psychopathologies are not well understood, but folate metabolism pathways are of potential interest. Demands for folate increase dramatically during pregnancy, low folate level has been associated with psychiatric disorders, and supplementation may improve symptomatology. The MTHFR C677T variant influences folate metabolism and has been implicated in depression during pregnancy. Objective To conduct a prospective longitudinal study to explore the relationship between MTHFR C677T genotype, folate levels, and postpartum psychopathology in at-risk women. Hypothesis In the first three months postpartum, folate will moderate a relationship between MTHFR genotype and depression, with TT homozygous women having more symptoms than CC homozygous women. Methods We recruited 365 pregnant women with a history of mood or psychotic disorder, and at 3 postpartum timepoints, administered the Edinburgh Postnatal Depression Scale (EPDS); Clinician-Administered Rating Scale for Mania (CARS-M) and the Positive and Negative Symptom Scale (PANSS) and drew blood for genotype/folate level analysis. We used robust linear regression to investigate interactions between genotype and folate level on the highest EPDS and CARS-M scores, and logistic regression to explore interactions with PANSS psychosis scores above/below cut-off. Results There was no significant interaction effect between MTHFR genotype and folate level on highest EPDS (p = 0.36), but there was a significant interaction between genotype, folate level and log(CARS-M) (p = 0.02); post-hoc analyses revealed differences in the effect of folate level between CC/CT, and TT genotypes, with folate level in CC and CT having an inverse relationship with symptoms of mania, while there was no relationship in participants with TT genotype. There was no significant interaction between MTHFR genotype and folate level on the likelihood of meeting positive symptom criteria for psychosis on the PANSS (p = 0.86). Discussion These data suggest that perhaps there is a relationship between MTHFR C677T, folate level and some symptoms of postpartum psychopathology.	[Morris, Emily; Inglis, Angela; Austin, Jehannine] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [Morris, Emily; Hippman, Catriona; Slomp, Caitlin; Inglis, Angela; Carrion, Prescilla; Batallones, Rolan; Andrighetti, Heather; Honer, William; Austin, Jehannine] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Albert, Arianne] Womens Hlth Res Inst, Vancouver, BC, Canada; [Ross, Colin] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada; [Ross, Colin] BC Childrens Hosp, Res Inst, Vancouver, BC, Canada; [Dyer, Roger] BC Childrens Hosp, Res Inst, Analyt Core Metabol & Nutr ACMaN, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia; BC Childrens Hospital; University of British Columbia; BC Childrens Hospital; University of British Columbia	Austin, J (corresponding author), Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada.; Austin, J (corresponding author), Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada.	jehannine.austin@ubc.ca	Hippman, Catriona/AAW-5828-2020	Hippman, Catriona/0000-0002-1676-5548; Dyer, Roger/0000-0003-2009-1563; Slomp, Caitlin/0000-0003-4063-2937; Albert, Arianne/0000-0002-3050-0888; Carrion, Prescilla/0000-0003-4965-9175; Austin, Jehannine/0000-0003-0338-7055	Canadian Institutes of Health Research (CIHR); BC Mental Health and Substance Use Services; Canada Research Chairs Program; Michael Smith Foundation for Health Research; CIHR; Canadian Institutes of Health Research [CIHR MOP 82750]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); BC Mental Health and Substance Use Services; Canada Research Chairs Program(Canada Research Chairs); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was made possible through funding from the Canadian Institutes of Health Research (CIHR), JA was supported by BC Mental Health and Substance Use Services, the Canada Research Chairs Program, the Michael Smith Foundation for Health Research, and CIHR. JA received funding from the Canadian Institutes of Health Research (https://cihrirsc.gc.ca/e/193.html) to conduct this work (CIHR MOP 82750). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida OP, 2005, NEUROBIOL AGING, V26, P251, DOI 10.1016/j.neurobiolaging.2004.03.007; ALTMAN EG, 1994, BIOL PSYCHIAT, V36, P124, DOI 10.1016/0006-3223(94)91193-2; Arinami T, 1997, AM J MED GENET, V74, P526, DOI 10.1002/(SICI)1096-8628(19970919)74:5<526::AID-AJMG14>3.0.CO;2-E; Assary E, 2018, SEMIN CELL DEV BIOL, V77, P133, DOI 10.1016/j.semcdb.2017.10.016; Bakker RC, 1997, PHARM WORLD SCI, V19, P126, DOI 10.1023/A:1008634632501; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bjelland I, 2003, ARCH GEN PSYCHIAT, V60, P618, DOI 10.1001/archpsyc.60.6.618; Bodnar LM, 2005, BIOL PSYCHIAT, V58, P679, DOI 10.1016/j.biopsych.2005.05.009; Bosanac P, 2003, AUST NZ J PSYCHIAT, V37, P24, DOI 10.1046/j.1440-1614.2003.01104.x; Bray Nicholas J, 2019, Brain Neurosci Adv, V2, DOI 10.1177/2398212818799271; Couto TCE, 2015, WORLD J PSYCHIATR, V5, P103, DOI 10.5498/wjp.v5.i1.103; Chen EYH, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4024; Chong MFF, 2014, J PSYCHIATR RES, V55, P110, DOI 10.1016/j.jpsychires.2014.04.006; Comasco E, 2011, PSYCHIAT GENET, V21, P19, DOI 10.1097/YPG.0b013e328341a3c1; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Coyle N, 2000, LANCET, V356, P1490, DOI 10.1016/S0140-6736(00)02877-4; DAVIES A, 1995, SCHIZOPHR RES, V16, P25, DOI 10.1016/0920-9964(94)00062-D; Dawson JF, 2014, J BUS PSYCHOL, V29, P1, DOI 10.1007/s10869-013-9308-7; Devlin AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012201; First M. B., 1997, STRUCTURED CLIN INTE; Fox J., 2016, APPL REGRESSION ANAL, V3rd; Freeman MP, 2002, AM J PSYCHIAT, V159, P1609, DOI 10.1176/appi.ajp.159.9.1609; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Howard L, 2005, POSTNATAL DEPRESSION, V72; Hui CLM, 2013, SCHIZOPHR RES, V150, P297, DOI 10.1016/j.schres.2013.08.010; Jones I, 2000, AM J MED GENET, V96, P850, DOI 10.1002/1096-8628(20001204)96:6<850::AID-AJMG31>3.0.CO;2-1; Jones I, 2001, AM J PSYCHIAT, V158, P913, DOI 10.1176/appi.ajp.158.6.913; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; KAY SR, 1988, PSYCHIAT RES, V23, P99, DOI 10.1016/0165-1781(88)90038-8; Kempisty B, 2006, NEUROSCI LETT, V400, P267, DOI 10.1016/j.neulet.2006.02.055; KENDELL RE, 1987, BRIT J PSYCHIAT, V150, P662, DOI 10.1192/bjp.150.5.662; Koller M, 2011, COMPUT STAT DATA AN, V55, P2504, DOI 10.1016/j.csda.2011.02.014; Lewis SJ, 2012, EUR J CLIN NUTR, V66, P97, DOI 10.1038/ejcn.2011.136; Lewis SJ, 2006, MOL PSYCHIATR, V11, P352, DOI 10.1038/sj.mp.4001790; Lewis SJ, 2005, AM J MED GENET B, V135B, P2, DOI 10.1002/ajmg.b.30170; Maechler Martin, 2020, ROBUSTBASE BASIC ROB; MARKS MN, 1992, J AFFECT DISORDERS, V24, P253, DOI 10.1016/0165-0327(92)90110-R; McGuffin P, 2005, HUM MOL GENET, V14, P3337, DOI 10.1093/hmg/ddi363; Middle F, 2000, PSYCHIATR GENET, V10, P195, DOI 10.1097/00041444-200010040-00008; Mighton CE, 2016, ARCH WOMEN MENT HLTH, V19, P253, DOI 10.1007/s00737-015-0561-9; Monji A, 2005, J CLIN PSYCHOPHARM, V25, P3, DOI 10.1097/01.jcp.0000150225.76748.73; Muntjewerff JW, 2005, AM J MED GENET B, V135B, P69, DOI 10.1002/ajmg.b.30179; Muntjewerff JW, 2006, MOL PSYCHIATR, V11, P143, DOI 10.1038/sj.mp.4001746; Nishio K, 2008, J EPIDEMIOL, V18, P125, DOI 10.2188/jea.JE2007417; Peerbooms OLJ, 2011, BRAIN BEHAV IMMUN, V25, P1530, DOI 10.1016/j.bbi.2010.12.006; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Robertson E, 2003, ACTA PSYCHIAT SCAND, V108, P387, DOI 10.1034/j.1600-0447.2003.00167.x; Shelnutt KP, 2004, J NUTR BIOCHEM, V15, P554, DOI 10.1016/j.jnutbio.2004.04.003; THORNTON WE, 1977, AM J OBSTET GYNECOL, V129, P222, DOI 10.1016/0002-9378(77)90752-9; Viguera AC, 2002, AM J PSYCHIAT, V159, P2102, DOI 10.1176/appi.ajp.159.12.2102; Wan L, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0276-6; Wisner KL, 2004, BIOL PSYCHIAT, V56, P592, DOI 10.1016/j.biopsych.2004.07.022; Wray NR, 2018, NAT GENET, V50, P668, DOI 10.1038/s41588-018-0090-3; Yang FZ, 2015, J AFFECT DISORDERS, V183, P339, DOI 10.1016/j.jad.2015.05.033; Yaremco E, 2013, BIRTH DEFECTS RES A, V97, P416, DOI 10.1002/bdra.23144; Yim IS, 2015, ANNU REV CLIN PSYCHO, V11, P99, DOI 10.1146/annurev-clinpsy-101414-020426; YOHAI VJ, 1987, ANN STAT, V15, P642, DOI 10.1214/aos/1176350366; Yonkers KA, 2001, AM J PSYCHIAT, V158, P1856, DOI 10.1176/appi.ajp.158.11.1856; Zhang XL, 2014, J AFFECT DISORDERS, V165, P208, DOI 10.1016/j.jad.2014.04.049	59	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243936	10.1371/journal.pone.0243936	http://dx.doi.org/10.1371/journal.pone.0243936			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH1MP	33315905	gold, Green Published			2022-12-27	WOS:000600186100039
J	Mude, W; Oguoma, VM; Gesesew, HA; Ameyaw, EK; Njue, C; Nyanhanda, T; Adeleye, AO; Dune, T; Kaambwa, B; Mwanri, L				Mude, William; Oguoma, Victor M.; Gesesew, Hailay Abrha; Ameyaw, Edward K.; Njue, Carolyne; Nyanhanda, Tafadzwa; Adeleye, Adeniyi O.; Dune, Tinashe; Kaambwa, Billingsley; Mwanri, Lillian			HIV/AIDS knowledge and attitudes assessment among women of child-bearing age in South Sudan: Findings from a Household Survey	PLOS ONE			English	Article							STIGMA; PREVENTION; REGRESSION; HEALTH	This study assessed the determinants that shape HIV knowledge and attitudes among South Sudanese women by analysing a Multiple Indicator Cluster Survey collected from 9,061 women in 9,369 households. Generalised linear mixed model regression was performed. Fifty percent of respondents were aware of HIV/AIDS, with 21% and 22% exhibiting good knowledge and positive attitudes towards people with HIV/AIDS, respectively. When controlled for individual and community-level variables, younger women (AOR = 1.28, 95% CI: 1.01-162), women with primary (AOR = 2.19; 95% CI: 1.86-2.58) and secondary (AOR = 4.48; 95% CI: 3.38-5.93) education, and those living in urban areas (AOR = 1.40; 95% CI: 1.12-1.76) had significantly good knowledge. Women in the richer (AOR = 1.60; 95% CI: 1.08-2.36) and the richest (AOR = 2.02; 95% CI: 1.35-3.02) wealth quintiles had significant positive attitudes towards people with HIV/AIDS. Well-designed social and behavioural campaigns targeting uneducated women and those living in rural and remote settings will enhance knowledge of perceived risk, awareness, and ability to carry out preventive behaviours.	[Mude, William] Cent Queensland Univ, Sch Hlth Med & Appl Sci, Sydney, NSW, Australia; [Oguoma, Victor M.] Univ Canberra, Hlth Res Inst, Canberra, ACT, Australia; [Gesesew, Hailay Abrha; Kaambwa, Billingsley; Mwanri, Lillian] Flinders Univ S Australia, Coll Med & Publ Hlth, Adelaide, SA, Australia; [Gesesew, Hailay Abrha] Mekelle Univ, Sch Hlth Sci, Mekelle, Ethiopia; [Ameyaw, Edward K.; Njue, Carolyne] Univ Technol Sydney, Sch Publ Hlth, Australian Ctr Publ & Populat Hlth Res ACPPHR, Sydney, NSW, Australia; [Nyanhanda, Tafadzwa] Cent Queensland Univ, Sch Hlth Med & Appl Sci, Melbourne, Vic, Australia; [Adeleye, Adeniyi O.] Cent Queensland Univ, Sch Nursing Midwifery & Social Sci, MacKay, Australia; [Dune, Tinashe] Western Sydney Univ, Sch Hlth Sci, Sydney, NSW, Australia	Central Queensland University; University of Canberra; Flinders University South Australia; Mekelle University; University of Technology Sydney; Central Queensland University; Central Queensland University; Western Sydney University	Mude, W (corresponding author), Cent Queensland Univ, Sch Hlth Med & Appl Sci, Sydney, NSW, Australia.	w.mude@cqu.edu.au	Mude, William/Z-3597-2019; Oguoma, Victor/I-9177-2014; Mwanri, Lillian/AGG-3711-2022	Oguoma, Victor/0000-0001-9505-7197; Nyanhanda, Tafadzwa/0000-0001-6502-5645; Njue, Carolyne/0000-0001-9325-3565; Mude, William/0000-0003-1961-5681; Gesesew, Hailay/0000-0002-3531-4400; Mwanri, Lillian/0000-0002-5792-7785; KAAMBWA, BILLINGSLEY/0000-0002-2128-3404; Ameyaw, Edward Kwabena/0000-0002-6617-237X				Ali NM, 2012, HOPE PAIN PATIENCE L, P111; Alwafi HA, 2018, J INFECT PUBLIC HEAL, V11, P80, DOI 10.1016/j.jiph.2017.04.005; Alwano MG, 2019, INCREASING KNOWLEDGE, V14; Amoah PA, 2018, PUBLIC HEALTH, V159, P40, DOI 10.1016/j.puhe.2018.03.002; [Anonymous], 2018, J PUBLIC HLTH EMERG; Baba SP, 2013, MMWR-MORBID MORTAL W, V62, P453; Banagi Yathiraj Arjun, 2017, J Int Assoc Provid AIDS Care, V16, P615, DOI 10.1177/2325957417742671; Barkan SE, 1998, EPIDEMIOLOGY, V9, P117, DOI 10.1097/00001648-199803000-00004; Begg MD, 2003, STAT MED, V22, P2591, DOI 10.1002/sim.1524; Burgoyne Amy D, 2008, Afr J Reprod Health, V12, P14; Carey MP, 2002, AIDS EDUC PREV, V14, P172, DOI 10.1521/aeap.14.2.172.23902; Center for Disease Control and Prevention, 2022, SOCIAL DETERMINANTS; Courtney LP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187689; Dai XC, 2019, LANCET GLOB HEALTH, V7, pS4, DOI 10.1016/S2214-109X(19)30089-0; Downie R., 2012, STATE PUBLIC HLTH S; Edward JK, 2014, J WEEKLY REV; El Fadl RKA, 2019, HIV AIDS-RES PALLIAT, V11, P83, DOI 10.2147/HIV.S195984; Gilbert L, 2010, HEALTH SOC CARE COMM, V18, P139, DOI 10.1111/j.1365-2524.2009.00881.x; Jesmin SS, 2013, HEALTH CARE WOMEN IN, V34, P303, DOI 10.1080/07399332.2012.736571; Jones A, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009296; Kalichman SC, 2005, AIDS BEHAV, V9, P135, DOI 10.1007/s10461-005-3895-x; Khalid F, 2013, COMMUNITY MED HLTH E, V3, P2161; Larsen K, 2005, AM J EPIDEMIOL, V161, P81, DOI 10.1093/aje/kwi017; Levi J, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2015-000010; Liu HJ, 2006, AIDS PATIENT CARE ST, V20, P133, DOI 10.1089/apc.2006.20.133; Mach BS, 2017, J HEALTH RES, V31, pS65, DOI 10.14456/jhr.2017.69; Merakou K, 2002, EUR J PUBLIC HEALTH, V12, P90, DOI 10.1093/eurpub/12.2.90; Merlo J, 2006, J EPIDEMIOL COMMUN H, V60, P290, DOI 10.1136/jech.2004.029454; Ministry of Health and National Bureau of Statistics, 2013, S SUD HOUS SURV JUB; Poni-Gore R, 2015, STIGMA DISCRIMINATIO; Ramjee G, 2013, AIDS RES THER, V10, DOI 10.1186/1742-6405-10-30; Setswe G, 2016, MILLENNIUM DEV GOAL; Skinner D, 2004, SAHARA J, V1, P157; Snijders T.A., 1999, INTRO BASIC ADV MULT; Sullivan MC, 2020, FALLING SHORT 1 90 H; Taylor J, 2018, AUST J PRIM HEALTH, V24, P14, DOI [10.1071/py16147, 10.1071/PY16147]; Teshome R., 2016, J AIDS CLIN RES, V07, P1, DOI [10.4172/2155-6113.1000559, DOI 10.4172/2155-6113.1000559]; UNAIDS, 2018, UNAIDS S SUD; UNAIDS, 2014, UND FAST TRACK ACC A; UNICEF, 2010, MICS 4 TOOLS; WHO, 2020, S SUD COUNTR RESP	41	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243969	10.1371/journal.pone.0243969	http://dx.doi.org/10.1371/journal.pone.0243969			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH1MP	33315916	gold, Green Published			2022-12-27	WOS:000600186100086
J	Peng, LY; Li, LJ; Wang, P; Chong, W; Li, Y; Zha, X; Deng, HD; Fan, HQ; Zhang, Y				Peng, Liyuan; Li, Linjie; Wang, Peng; Chong, Weelic; Li, Yin; Zha, Xi; Deng, Haidong; Fan, Huaqian; Zhang, Yu			Association between Vitamin D supplementation and mortality in critically ill patients: A systematic review and meta-analysis of randomized clinical trials	PLOS ONE			English	Review							LENGTH-OF-STAY; ADULTS	Background Observational studies suggest that low 25-hydroxyvitamin D status is common and has been associated with higher mortality in critically ill patients. This study aim to investigate whether vitamin D supplementation is associated with lower mortality in critically ill patients. Method We searched Medline, Embase, and Cochrane databases from inception to January 12, 2020, without language restrictions, for randomized controlled trials comparing the effect of vitamin D supplementation with placebo in critically ill patients. Two authors independently performed data extraction and assessed study quality. The primary outcome was all-cause mortality at the longest follow-up. Result We identified nine trials with a total of 2066 patients. Vitamin D supplementation was not associated with reduced all-cause mortality at the longest follow-up (RR 0.90, 95% CI 0.74 to 1.09, I-2 = 20%), at 30 days (RR 0.81, 95% CI 0.56 to 1.15), at 90 days (RR 1.15, 95% CI 0.92 to 1.44), and at 180 days (RR 0.82, 95% CI 0.65 to 1.03). Results were similar in the sensitivity analysis. The sample size met the optimum size in trial sequential analysis. Similarly, supplemental vitamin D was not associated with length of ICU stay, hospital stay, or mechanical ventilation. Conclusion Vitamin D supplement was not associated with reduced all-cause mortality in critically ill patients. Systematic review registration Open Science Framework https://osf.io/bgsjq	[Peng, Liyuan; Wang, Peng; Li, Yin; Zha, Xi; Deng, Haidong; Fan, Huaqian; Zhang, Yu] Chengdu Univ, Affiliated Hosp, Chengdu, Sichuan, Peoples R China; [Li, Linjie; Zhang, Yu] Sichuan Univ, West China Hosp, Chengdu, Sichuan, Peoples R China; [Chong, Weelic] Thomas Jefferson Univ, Philadelphia, PA 19107 USA	Chengdu University; Sichuan University; Jefferson University	Zhang, Y (corresponding author), Chengdu Univ, Affiliated Hosp, Chengdu, Sichuan, Peoples R China.; Zhang, Y (corresponding author), Sichuan Univ, West China Hosp, Chengdu, Sichuan, Peoples R China.	tnt1057@outlook.com	peng, li/GQH-5153-2022	Zhang, Yu/0000-0002-4714-2167				Amrein K, 2014, JAMA-J AM MED ASSOC, V312, P1520, DOI 10.1001/jama.2014.13204; Amrein K, 2011, CRIT CARE, V15, DOI 10.1186/cc10120; Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; Bikle DD, 2014, CHEM BIOL, V21, P319, DOI 10.1016/j.chembiol.2013.12.016; Ginde AA, 2019, NEW ENGL J MED, V381, P2529, DOI 10.1056/NEJMoa1911124; Grossmann RE, 2012, DERM-ENDOCRINOL, V4, P191, DOI 10.4161/derm.20332; Karsy Michael, 2019, J Neurosurg, P1, DOI 10.3171/2018.11.JNS182713; Langlois PL, 2018, CLIN NUTR, V37, P1238, DOI 10.1016/j.clnu.2017.05.006; Leaf DE, 2014, AM J RESP CRIT CARE, V190, P533, DOI 10.1164/rccm.201405-0988OC; Miri M, 2019, IRAN J PHARM RES, V18, P1067, DOI 10.22037/ijpr.2019.1100647; Miroliaee AE, 2018, J CRIT CARE, V44, P300, DOI 10.1016/j.jcrc.2017.08.040; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1186/2046-4053-4-1, 10.1136/bmj.b2535]; Putzu A, 2017, J CRIT CARE, V38, P109, DOI 10.1016/j.jcrc.2016.10.029; Quraishi SA, 2015, CRIT CARE MED, V43, P1928, DOI 10.1097/CCM.0000000000001148; Sriram K, 2015, NUTRITION, V31, P820, DOI 10.1016/j.nut.2014.11.022; Thacher TD, 2011, MAYO CLIN PROC, V86, P50, DOI 10.4065/mcp.2010.0567; Upala S, 2015, BMC ANESTHESIOL, V15, DOI 10.1186/s12871-015-0063-3; Weng H, 2017, INTENS CARE MED, V43, P277, DOI 10.1007/s00134-016-4591-1; Wondimkun Z.T., 2016, AM J APPL CHEM, V4, P59, DOI [DOI 10.11648/J.AJAC.20160402.14, 10.11648/j.ajac.20160402.14]	19	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243768	10.1371/journal.pone.0243768	http://dx.doi.org/10.1371/journal.pone.0243768			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315950	Green Published, gold			2022-12-27	WOS:000600186100016
J	Stroman, PW; Warren, HJM; Ioachim, G; Powers, JM; McNeil, K				Stroman, Patrick W.; Warren, Howard J. M.; Ioachim, Gabriela; Powers, Jocelyn M.; McNeil, Kaitlin			A comparison of the effectiveness of functional MRI analysis methods for pain research: The new normal	PLOS ONE			English	Article							HUMAN BRAIN-STEM; SPINAL-CORD; TEMPORAL SUMMATION; 2ND PAIN; FMRI; MODULATION; CONNECTIVITY; PERCEPTION; NETWORKS; SYSTEM	Studies of the neural basis of human pain processing present many challenges because of the subjective and variable nature of pain, and the inaccessibility of the central nervous system. Neuroimaging methods, such as functional magnetic resonance imaging (fMRI), have provided the ability to investigate these neural processes, and yet commonly used analysis methods may not be optimally adapted for studies of pain. Here we present a comparison of model-driven and data-driven analysis methods, specifically for the study of human pain processing. Methods are tested using data from healthy control participants in two previous studies, with separate data sets spanning the brain, and the brainstem and spinal cord. Data are analyzed by fitting time-series responses to predicted BOLD responses in order to identify significantly responding regions (model-driven), as well as with connectivity analyses (data-driven) based on temporal correlations between responses in spatially separated regions, and with connectivity analyses based on structural equation modeling, allowing for multiple source regions to explain the signal variations in each target region. The results are assessed in terms of the amount of signal variance that can be explained in each region, and in terms of the regions and connections that are identified as having BOLD responses of interest. The characteristics of BOLD responses in identified regions are also investigated. The results demonstrate that data-driven approaches are more effective than model-driven approaches for fMRI studies of pain.	[Stroman, Patrick W.; Warren, Howard J. M.; Ioachim, Gabriela; Powers, Jocelyn M.; McNeil, Kaitlin] Queens Univ, Ctr Neurosci Studies, Kingston, ON, Canada; [Stroman, Patrick W.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Stroman, Patrick W.] Queens Univ, Dept Phys, Kingston, ON, Canada; [McNeil, Kaitlin] Royal Mil Coll Canada, Kingston, ON, Canada	Queens University - Canada; Queens University - Canada; Queens University - Canada; Royal Military College - Canada	Stroman, PW (corresponding author), Queens Univ, Ctr Neurosci Studies, Kingston, ON, Canada.; Stroman, PW (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.; Stroman, PW (corresponding author), Queens Univ, Dept Phys, Kingston, ON, Canada.	stromanp@queensu.ca		Stroman, Patrick/0000-0002-9814-260X; Warren, Howard/0000-0003-2966-169X; Ioachim, Gabriela/0000-0003-1750-2341	Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN/06221-2015]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding was provided by the Natural Sciences and Engineering Research Council of Canada (NSERC), grant number RGPIN/06221-2015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1979, Pain, V6, P249; [Anonymous], 2014, DIABETOL KLIN SA, V3, pA1; [Anonymous], 1994, THE NEWS DIGEST 0601, VVII, P12; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; BANDETTINI PA, 1992, MAGNET RESON MED, V25, P390, DOI 10.1002/mrm.1910250220; Barry RL, 2016, NEUROIMAGE, V133, P31, DOI 10.1016/j.neuroimage.2016.02.058; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bosma RL, 2014, MAGN RESON IMAGING, V32, P473, DOI 10.1016/j.mri.2014.01.007; Bosma RL, 2016, HUM BRAIN MAPP, V37, P1349, DOI 10.1002/hbm.23106; Bosma RL, 2015, HUM BRAIN MAPP, V36, P5038, DOI 10.1002/hbm.22993; Bosma RL, 2015, J MAGN RESON IMAGING, V41, P1318, DOI 10.1002/jmri.24656; Cadotte DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045560; Cadotte DW, 2012, J NEUROSURG-SPINE, V17, P102, DOI 10.3171/2012.5.AOSPINE1278; Chiang MC, 2019, J NEUROSCI, V39, P8225, DOI 10.1523/JNEUROSCI.1162-19.2019; De Leener B, 2018, NEUROIMAGE, V165, P170, DOI 10.1016/j.neuroimage.2017.10.041; De Leener B, 2017, NEUROIMAGE, V145, P24, DOI 10.1016/j.neuroimage.2016.10.009; Dobek CE, 2014, J PAIN, V15, P1057, DOI 10.1016/j.jpain.2014.07.006; Edlow BL, 2012, J NEUROPATH EXP NEUR, V71, P531, DOI 10.1097/NEN.0b013e3182588293; Eippert F, 2009, SCIENCE, V326, P404, DOI 10.1126/science.1180142; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; Frith CD, 1995, HUM BRAIN MAPP, V3, P153, DOI 10.1002/hbm.460030209; Geuter S, 2013, J NEUROSCI, V33, P13784, DOI 10.1523/JNEUROSCI.2191-13.2013; Harita S, 2019, NEUROSCIENCE, V404, P71, DOI 10.1016/j.neuroscience.2019.02.009; Harita S, 2017, MAGN RESON MED, V78, P2149, DOI 10.1002/mrm.26606; Ioachim G, 2019, BRAIN CONNECT, V9, P415, DOI 10.1089/brain.2018.0659; Iraji A, 2016, NEUROIMAGE, V134, P494, DOI 10.1016/j.neuroimage.2016.04.006; Keren NI, 2009, NEUROIMAGE, V47, P1261, DOI 10.1016/j.neuroimage.2009.06.012; Khan HS, 2015, NEUROSCIENCE, V307, P231, DOI 10.1016/j.neuroscience.2015.08.059; Kong YZ, 2014, P NATL ACAD SCI USA, V111, P18067, DOI 10.1073/pnas.1414293111; Kwon M, 2014, PAIN PRACT, V14, P656, DOI 10.1111/papr.12145; Lang J, 1982, Gegenbaurs Morphol Jahrb, V128, P417; Legrain V, 2011, PROG NEUROBIOL, V93, P111, DOI 10.1016/j.pneurobio.2010.10.005; Leijnse JN, 2016, J ANAT, V229, P384, DOI 10.1111/joa.12493; Leung Roxanne H., 2016, Critical Reviews in Biomedical Engineering, V44, P47, DOI 10.1615/CritRevBiomedEng.2016016541; Liebe T, 2020, HUM BRAIN MAPP, V41, P2136, DOI 10.1002/hbm.24935; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; MCARDLE JJ, 1984, BRIT J MATH STAT PSY, V37, P234, DOI 10.1111/j.2044-8317.1984.tb00802.x; McIver TA, 2018, EUR J PAIN, V22, P319, DOI 10.1002/ejp.1122; Millan MJ, 2002, PROG NEUROBIOL, V66, P355, DOI 10.1016/S0301-0082(02)00009-6; Myronenko A, 2010, IEEE T MED IMAGING, V29, P1882, DOI 10.1109/TMI.2010.2053043; Naidich TP, 2009, INTERNAL ARCHITECTUR, P79; Naidich TP DH, 2009, INTERNAL ARCHITECTUR, P79; Norris DG, 2002, NEUROIMAGE, V15, P719, DOI 10.1006/nimg.2001.1005; Ossipov MH, 2014, CURR OPIN SUPPORT PA, V8, P143, DOI 10.1097/SPC.0000000000000055; Pauli WM, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.63; Ploghaus A, 1999, SCIENCE, V284, P1979, DOI 10.1126/science.284.5422.1979; Powers JM, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8090173; Rempe T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112325; Sprenger C, 2012, CURR BIOL, V22, P1019, DOI 10.1016/j.cub.2012.04.006; Stroman PW, 2018, PAIN, V159, P2012, DOI 10.1097/j.pain.0000000000001302; Stroman Patrick W., 2016, Critical Reviews in Biomedical Engineering, V44, P227, DOI 10.1615/CritRevBiomedEng.2017020438; Stroman PW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167317; Stroman PW, 2016, J NEUROTRAUM, V33, P1450, DOI 10.1089/neu.2015.4257; Stroman PW, 2017, CRITICAL REV BIOMEDI; Talairach J, 1988, COPLANAR STEREOTAXIC, DOI DOI 10.1016/0028-3932(88)90040-1; The Canadian Pain Coalition, 2010, STAT PAIN CAN MOV CA; Tinnermann A, 2017, SCIENCE, V358, P105, DOI 10.1126/science.aan1221; Tracey I, 2009, J PAIN, V10, P1113, DOI 10.1016/j.jpain.2009.09.001; Vierck CJ, 1997, J NEUROPHYSIOL, V78, P992, DOI 10.1152/jn.1997.78.2.992; Wager TD, 2013, NEW ENGL J MED, V368, P1388, DOI 10.1056/NEJMoa1204471; Wei PX, 2010, EUR J APPL PHYSIOL, V108, P265, DOI 10.1007/s00421-009-1205-4; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023	63	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243723	10.1371/journal.pone.0243723	http://dx.doi.org/10.1371/journal.pone.0243723			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315886	Green Published, gold			2022-12-27	WOS:000600186100071
J	Ndiaye, A; Niang, EA; Diene, AN; Nourdine, MA; Sarr, PC; Konate, L; Faye, O; Gaye, O; Sy, O				Ndiaye, Assane; Niang, El Hadji Amadou; Diene, Aminata Niang; Nourdine, Mohamed Abderemane; Sarr, Pape Cheikh; Konate, Lassana; Faye, Ousmane; Gaye, Oumar; Sy, Ousmane			Mapping the breeding sites of Anopheles gambiae s. l. in areas of residual malaria transmission in central western Senegal	PLOS ONE			English	Article								Despite the deployment of several effective control interventions in central-western Senegal, residual malaria transmission is still occurring in some hotspots. To better tailor targeted control actions, it is critical to unravel the underlying environmental and geographical factors that cause the persistence infection in hotspot villages. "Hotspots villages" were defined in our study as those reporting more than six indigenous malaria cases during the previous year. A total of ten villages, including seven hotspots and three non-hotspots, were surveyed. All potential mosquito breeding sites identified in and around the ten study villages were regularly monitored between 2013 and 2017. Monitoring comprised the detection of anopheline larvae and the collection of epidemiological, hydrogeological, topographical, and biogeographical data. The number of larval breeding sites described and monitored during the study period ranged from 50 to 62. Breeding sites were more numerous in hotspot sites in each year of monitoring, with 90.3% (56/62) in 2013, 90.9% (50/55) in 2014, 90.3% (56/62) in 2015 and 86% (43/50) in 2017 (Fisher exact test; p = 1). In the non-hotspot areas, the data for the same years were, respectively, 9.7% (6/62), 9.1% (5/55), 9.7% (6/62) and 14% (7/50) (p = 1). The Hotspot villages were characterized mostly by saline or moderately saline hydro-morphic and halomorphic soils allowing water retention and a potential larval breeding sites. By contrast, non-hotspot villages were characterized mainly by a high proportion of extremely permeable sandy-textured soils, which due to their porosity had low water retention. The annual number of confirmed malaria cases was correlated with the frequency and extent of breeding sites. Malaria cases were significantly more frequent in the hamlets located near breeding sites of An. gambiae s.l., gradually decreasing with increasing remoteness. This study shows that the characteristics of larval breeding sites, as measured by their longevity, stability, proximity to human habitation, and their positivity in Anopheles larvae are likely determining factors in the persistence of malaria hotspots in central-western Senegal. The results of this study shed more light on the environmental factors underlying the residual transmission and should make it possible to better target vector control interventions for malaria elimination in west-central Senegal.	[Ndiaye, Assane; Diene, Aminata Niang] Univ Cheikh Anta Diop Dakar, Fac Lettres & Sci Humaines, Dept Geog, Dakar, Senegal; [Niang, El Hadji Amadou; Nourdine, Mohamed Abderemane; Sarr, Pape Cheikh; Konate, Lassana; Faye, Ousmane; Sy, Ousmane] Univ Cheikh Anta Diop, Fac Sci & Tech, Lab Ecol Vectorielle & Parasitaire, Dakar, Senegal; [Nourdine, Mohamed Abderemane; Sarr, Pape Cheikh; Gaye, Oumar; Sy, Ousmane] Univ Cheikh Anta Diop, Fac Med, Lab Parasitol Med Pharm & Odontostomatol, Dakar, Senegal	University Cheikh Anta Diop Dakar; University Cheikh Anta Diop Dakar; University Cheikh Anta Diop Dakar	Sy, O (corresponding author), Univ Cheikh Anta Diop, Fac Sci & Tech, Lab Ecol Vectorielle & Parasitaire, Dakar, Senegal.; Sy, O (corresponding author), Univ Cheikh Anta Diop, Fac Med, Lab Parasitol Med Pharm & Odontostomatol, Dakar, Senegal.	syousmane7@gmail.com		Sarr, Pape Cheikh/0000-0003-3570-9901	DELTAS Africa Initiative [DEL-15-010]; African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust [WT: 107741/A/15/Z]; UK government	DELTAS Africa Initiative; African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust(Wellcome TrustEuropean Commission); UK government	This work was supported through the DELTAS Africa Initiative [MARCAD Grant Number: DEL-15-010]. The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA) and supported by the New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust [WT: 107741/A/15/Z] and the UK government.	Ageep TB, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-123; Akasso R.J, 2005, LIAISON NEWSLETTER O; [Anonymous], 1975, MANUAL PRACTICAL ENT; [Anonymous], 2006, GPSMAP 60CSX SENS MA; [Anonymous], 1987, JPSAIM; [Anonymous], 2019, REP PAL MOND; Brahmin, 2006, THESIS; Carter R, 2000, B WORLD HEALTH ORGAN, V78, P1401; Cisse B, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002175; DELMONT J, 1982, CAH ETUD AFR, V22, P117, DOI 10.3406/cea.1982.2276; Depinay JMO, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-29; Djamouko-Djonkam L, 2019, INFECT DIS POVERTY, V8, DOI 10.1186/s40249-019-0597-6; Fillinger Ulrike, 2006, Trop Med Int Health, V11, P1629, DOI 10.1111/j.1365-3156.2006.01733.x; Gaudart J, 2009, ANAL CLIMATIC CHANGE; Geissbuhler Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005107; Gillies MT, 1968, ANOPHELINE AFRICA S, V54, P122; Kweka EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052084; Minakawa N, 2005, J MED ENTOMOL, V42, P295, DOI 10.1603/0022-2585(2005)042[0295:RBOOAG]2.0.CO;2; Minakawa N, 1999, AM J TROP MED HYG, V61, P1010, DOI 10.4269/ajtmh.1999.61.1010; Mlacha YP, 2017, GEOSPATIAL HEALTH, V12, P74, DOI 10.4081/gh.2017.494; Ndiaye, 2001, CLIMATIC VARIATIONS, P25; Niang EA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104622; NPFAM, 2017, ANN EP REC 2017 MAL; Pierrat C, 2010, THESIS; Rabe T, 2003, THESIS; Rippstein, 2004, DEV FODDER CROPS GRO, DOI [10.1055/s-2004-822821, DOI 10.1055/S-2004-822821]; Sagna P, 2005, THESIS; Shililu J, 2007, AM J TROP MED HYG, V76, P103, DOI 10.4269/ajtmh.2007.76.103; Staedke SG, 2003, AM J TROP MED HYG, V69, P244, DOI 10.4269/ajtmh.2003.69.244; Stefani A, 2011, THESIS; Sy O., 2016, Bulletin de la Societe de Pathologie Exotique, V109, P31, DOI 10.1007/s13149-016-0469-2; Sy O, 2015, Bull Soc Pathol Exot, V108, P213, DOI 10.1007/s13149-015-0431-8; Sy O, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2212-x; Thompson R, 1997, AM J TROP MED HYG, V57, P550, DOI 10.4269/ajtmh.1997.57.550; van der Hoek W, 2003, INT J EPIDEMIOL, V32, P280, DOI 10.1093/ije/dyg055; World Health Organization, 2018, MALARIA; Yaro AS, 2012, J INSECT PHYSIOL, V58, P1050, DOI 10.1016/j.jinsphys.2012.04.002	37	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0236607	10.1371/journal.pone.0236607	http://dx.doi.org/10.1371/journal.pone.0236607			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306671	gold, Green Submitted, Green Published			2022-12-27	WOS:000600144200067
J	Noll, C; Nasruddin-Yekta, A; Sternisek, P; Weig, M; Gross, U; Schilling, AF; Beil, FT; Bader, O				Noll, Christine; Nasruddin-Yekta, Azadda; Sternisek, Pia; Weig, Michael; Gross, Uwe; Schilling, Arndt F.; Beil, Frank Timo; Bader, Oliver			Rapid direct detection of pathogens for diagnosis of joint infections by MALDI-TOF MS after liquid enrichment in the BacT/Alert blood culture system	PLOS ONE			English	Article							FLIGHT MASS-SPECTROMETRY; DIRECT IDENTIFICATION; PERFORMANCE; BOTTLES; BONE	Pathogen identification is a critical step during diagnosis of infectious diseases. Matrix-Assisted Laser Desorption/Ionization Time-Of-Flight mass spectrometry (MALDI-TOF-MS) has become the gold standard for identification of microorganisms cultured on solid media in microbiology laboratories. Direct identification of microbes from liquid specimen, circumventing the need for the additional overnight cultivation step, has been successfully established for blood culture, urine and liquor. Here, we evaluate the ability of MALDI-TOF MS for direct identification of pathogens in synovial fluid after liquid enrichment in BacT/Alert blood culture bottles. Influence of synovial specimen quality on direct species identification with the MALDI BioTyper/Sepsityper was tested with samples inoculated from pretested native synovia with concomitant inoculation of blood or pus, or highly viscous fluid. Here, we achieved >90% concordance with culture on solid medium, and only mixed-species samples posed significant problems. Performance in routine diagnostics was tested prospectively on bottles inoculated by treating physicians on ward. There, we achieved >70% concordance with culture on solid media. The major contributors to test failure were the absence of a measurable mass signal and mixed-specimen samples. The Sepsityper workflow worked well on samples derived from BacT/Alert blood culture bottles inoculated with synovial fluid, giving concordant results to identification from solid media. Host remnant material in the inoculum, such as blood or pus, had no detrimental effect on identification score values of the BioTyper system after processing with the Sepsityper workflow, and neither had the initial viscosity of the synovial sample.	[Noll, Christine; Nasruddin-Yekta, Azadda; Sternisek, Pia; Weig, Michael; Gross, Uwe; Bader, Oliver] Univ Med Ctr Gottingen, Inst Med Microbiol, Gottingen, Germany; [Schilling, Arndt F.] Univ Med Ctr Gottingen, Dept Trauma Surg Orthoped & Plast Surg, Gottingen, Germany; [Beil, Frank Timo] Univ Med Ctr Hamburg Eppendorf, Dept Orthoped, Hamburg, Germany	University of Gottingen; University of Gottingen; University of Hamburg; University Medical Center Hamburg-Eppendorf	Noll, C (corresponding author), Univ Med Ctr Gottingen, Inst Med Microbiol, Gottingen, Germany.	Christine.Noll@med.uni-goettingen.de	Bader, Oliver/C-7650-2015	Bader, Oliver/0000-0002-1534-440X	AO Trauma foundation through the AOT CPP program [FP00006675_SA002]	AO Trauma foundation through the AOT CPP program	This study was supported through a grant of the AO Trauma foundation (grant number FP00006675_SA002) through the AOT CPP program. Conceived the study: CN, UG, AS, FTB, OB Provided samples: CN, MW, AS, FTB Performed experiments: AN, PS Evaluated data: CN, AN, OB Wrote the manuscript: CN, AN, OB.	[Anonymous], 2015, BMJ, V2015, ph1887; Bogut A, 2014, J MED MICROBIOL, V63, P176, DOI 10.1099/jmm.0.066068-0; Font-Vizcarra L, 2010, CLIN ORTHOP RELAT R, V468, P2238, DOI 10.1007/s11999-010-1254-3; Harju I, 2017, J CLIN MICROBIOL, V55, P914, DOI 10.1128/JCM.01990-16; Jmir Editorial Office, 2018, JMIR Public Health Surveill, V4, pe53, DOI 10.2196/publichealth.9932; Lallemand E, 2016, EUR J CLIN MICROBIOL, V35, P857, DOI 10.1007/s10096-016-2608-x; Lallemand E, 2017, RES MICROBIOL, V168, P122, DOI 10.1016/j.resmic.2016.09.005; Larsen LH, 2012, J MED MICROBIOL, V61, P309, DOI 10.1099/jmm.0.035303-0; Leitner L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23266-w; Metsemakers WJ, 2018, INJURY, V49, P511, DOI 10.1016/j.injury.2016.09.019; Mortelmaier C, 2019, ANAL BIOANAL CHEM, V411, P7027, DOI 10.1007/s00216-019-02080-x; Parvizi J, 2010, J AM ACAD ORTHOP SUR, V18, P771, DOI 10.5435/00124635-201012000-00007; Riederer K, 2015, DIAGN MICR INFEC DIS, V82, P105, DOI 10.1016/j.diagmicrobio.2015.03.003; Ruiz-Aragon J, 2018, ENFERM INFEC MICR CL, V36, P484, DOI 10.1016/j.eimc.2017.08.012; Schafer P, 2008, CLIN INFECT DIS, V47, P1403, DOI 10.1086/592973; Schubert S, 2011, J MOL DIAGN, V13, P701, DOI 10.1016/j.jmoldx.2011.07.004; Scott JS, 2016, INFECT DIS-NOR, V48, P530, DOI 10.3109/23744235.2016.1165350; Szabados F, 2011, CLIN MICROBIOL INFEC, V17, P192, DOI 10.1111/j.1469-0691.2010.03229.x; Tsuchida S, 2018, J MICROBIOL METH, V148, P40, DOI 10.1016/j.mimet.2018.03.014	19	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243790	10.1371/journal.pone.0243790	http://dx.doi.org/10.1371/journal.pone.0243790			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306699	gold, Green Published			2022-12-27	WOS:000600144200029
J	Lee, S; Park, S; Kim, Y; Lee, Y; Kang, MW; Cho, S; Kim, YC; Han, SS; Lee, H; Lee, JP; Joo, KW; Lim, CS; Kim, YS; Han, K; Kim, DK				Lee, Soojin; Park, Sehoon; Kim, Yaerim; Lee, Yeonhee; Kang, Min Woo; Cho, Semin; Kim, Yong Chul; Han, Seung Seok; Lee, Hajeong; Lee, Jung Pyo; Joo, Kwon Wook; Lim, Chun Soo; Kim, Yon Su; Han, Kyungdo; Kim, Dong Ki			Impact of variability in estimated glomerular filtration rate on major clinical outcomes: A nationwide population-based study	PLOS ONE			English	Article							BLOOD-PRESSURE VARIABILITY; VISIT-TO-VISIT; CHRONIC KIDNEY-DISEASE; COLLABORATIVE METAANALYSIS; CARDIOVASCULAR OUTCOMES; SOCIOECONOMIC-STATUS; HIGHER ALBUMINURIA; HIGH-RISK; ALL-CAUSE; MORTALITY	Background The estimated glomerular filtration rate (eGFR), commonly estimated using the serum creatinine value, often fluctuates throughout the serial measurement. The clinical significance of GFR variation among the general population with normal renal function has not yet been demonstrated. Thus, we explored the impact of GFR variability on adverse clinical outcomes. Methods A nationwide retrospective cohort study using the Korean National Health Insurance System database was performed. National health screening examinees who underwent creatinine measurement >= 3 times between 2012 and 2016 were considered. Those with eGFR under 60 mL/min/m(2) were excluded. The fluctuation of eGFR was represented with variability independent of the mean (VIM) index; which was calculated by the standard deviation divided by the exponent of the regression coefficient of the mean. Then, the risks of myocardial infarction (MI), stroke and death were assessed according to the quartiles of the VIM Results Of total 3,538,500 participants, 0.29% of myocardial infarction (MI), 0.14% of stroke, 0.36% of deaths were observed during the median follow up of 3.27 years. Participants with the highest VIM index, which represents the highest eGFR variability, were significantly associated with an increased risk of MI (hazard ratio [HR]; 1.10, 95% confidence interval [95% CI]; 1.04-1.16), stroke (HR: 1.16; 95% CI 1.09-1.23), and death (HR: 1.18; 95% CI 1.12-1.24). The elevated risk of adverse events was consistent after the multivariate adjustment with potential confounding factors, except the risk of MI (HR 1.06; 95% 1.00-1.06). Conclusions Increased eGFR variability exhibited an association with major clinical outcomes, indicating that monitoring eGFR variability might be a useful parameter for predicting the adverse outcomes.	[Lee, Soojin; Lee, Yeonhee; Kang, Min Woo; Cho, Semin; Kim, Yong Chul; Han, Seung Seok; Lee, Hajeong; Lee, Jung Pyo; Joo, Kwon Wook; Lim, Chun Soo; Kim, Yon Su; Kim, Dong Ki] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea; [Lee, Soojin; Lee, Yeonhee; Kang, Min Woo; Cho, Semin; Joo, Kwon Wook; Kim, Yon Su; Kim, Dong Ki] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Park, Sehoon; Kim, Yon Su] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea; [Park, Sehoon] Armed Forces Capital Hosp, Dept Internal Med, Gyeonggi Do, South Korea; [Kim, Yaerim] Keimyung Univ, Sch Med, Dept Internal Med, Daegu, South Korea; [Han, Seung Seok; Lee, Jung Pyo; Joo, Kwon Wook; Lim, Chun Soo; Kim, Yon Su; Kim, Dong Ki] Seoul Natl Univ, Coll Med, Kidney Res Inst, Seoul, South Korea; [Lee, Jung Pyo; Lim, Chun Soo] Seoul Natl Univ, Boramae Med Ctr, Dept Internal Med, Seoul, South Korea; [Han, Kyungdo] Soongsil Univ, Dept Stat & Actuarial Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Keimyung University; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Soongsil University	Kim, DK (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea.; Kim, DK (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea.; Kim, DK (corresponding author), Seoul Natl Univ, Coll Med, Kidney Res Inst, Seoul, South Korea.; Han, K (corresponding author), Soongsil Univ, Dept Stat & Actuarial Sci, Seoul, South Korea.	hkd917@naver.com; dkkim73@gmail.com	Kim, Dong Ki/J-5389-2012; Han, Seung Seok/HGD-2825-2022	Kim, Dong Ki/0000-0002-5195-7852; Kim, Yaerim/0000-0003-1596-1528	Seoul National University Hospital [3020180050]	Seoul National University Hospital	The present study was funded from Seoul National University Hospital (3020180050). The funders had no role in the study design, data collection and analysis, or decision to submit for publication.	[Anonymous], 2017, J OBSTET GYNECOL NEO, V46, pe125; Asayama K, 2013, HYPERTENSION, V61, P61, DOI 10.1161/HYPERTENSIONAHA.111.00138; Astor BC, 2011, KIDNEY INT, V79, P1331, DOI 10.1038/ki.2010.550; Coresh J, 2014, JAMA-J AM MED ASSOC, V311, P2518, DOI 10.1001/jama.2014.6634; Diaz KM, 2012, HYPERTENS RES, V35, P55, DOI 10.1038/hr.2011.135; Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group, 2013, KIDNEY INT S, P31; Kim MK, 2018, CIRCULATION, V138, P2627, DOI [10.1161/CIRCULATIONAHA.118.034978, 10.1161/circulationaha.118.034978]; Kim MK, 2017, EUR HEART J, V38, P3560, DOI 10.1093/eurheartj/ehx585; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Matsushita K, 2015, LANCET DIABETES ENDO, V3, P514, DOI 10.1016/S2213-8587(15)00040-6; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Matsushita K, 2009, J AM SOC NEPHROL, V20, P2617, DOI 10.1681/ASN.2009010025; Muntner P, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133745; Muntner P, 2011, HYPERTENSION, V57, P160, DOI 10.1161/HYPERTENSIONAHA.110.162255; Nagai M, 2011, J AM SOC HYPERTENS, V5, P184, DOI 10.1016/j.jash.2011.03.001; Nam GE, 2019, INT J OBESITY, V43, P412, DOI 10.1038/s41366-018-0079-0; Parati G, 2013, DIABETES CARE, V36, pS312, DOI 10.2337/dcS13-2043; Perkins RM, 2011, CLIN J AM SOC NEPHRO, V6, P1879, DOI 10.2215/CJN.00470111; Rothwell PM, 2010, LANCET, V375, P895, DOI 10.1016/S0140-6736(10)60308-X; Shlipak MG, 2009, J AM SOC NEPHROL, V20, P2625, DOI 10.1681/ASN.2009050546; Sohel BM, 2016, CLIN EXP NEPHROL, V20, P379, DOI 10.1007/s10157-015-1213-0; Turin TC, 2013, KIDNEY INT, V83, P684, DOI 10.1038/ki.2012.443; van der Velde M, 2011, KIDNEY INT, V79, P1341, DOI 10.1038/ki.2010.536; Vart P, 2015, AM J EPIDEMIOL, V181, P385, DOI 10.1093/aje/kwu316; Yu JH, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000016317; Zeng XX, 2018, J EPIDEMIOL COMMUN H, V72, P270, DOI 10.1136/jech-2017-209815	27	1	1	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0244156	10.1371/journal.pone.0244156	http://dx.doi.org/10.1371/journal.pone.0244156			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332407	gold, Green Published			2022-12-27	WOS:000601310900073
J	Zafar, N; Ul Haq, I				Zafar, Noureen; Ul Haq, Irfan			Traffic congestion prediction based on Estimated Time of Arrival	PLOS ONE			English	Article							TRANSPORTATION; TRAVEL	With the rapid expansion of sensor technologies and wireless network infrastructure, research and development of traffic associated applications, such as real-time traffic maps, on-demand travel route reference and traffic forecasting are gaining much more attention than ever before. In this paper, we elaborate on our traffic prediction application, which is based on traffic data collected through Google Map API. Our application is a desktop-based application that predicts traffic congestion state using Estimated Time of Arrival (ETA). In addition to ETA, the prediction system takes into account various features such as weather, time period, special conditions, holidays, etc. The label of the classifier is identified as one of the five traffic states i.e. smooth, slightly congested, congested, highly congested or blockage. The results demonstrate that the random forest classification algorithm has the highest prediction accuracy of 92 percent followed by XGBoost and KNN respectively.	[Zafar, Noureen; Ul Haq, Irfan] Pakistan Inst Engn & Appl Sci, Islamabad, Pakistan	Pakistan Institute of Engineering & Applied Science	Zafar, N; Ul Haq, I (corresponding author), Pakistan Inst Engn & Appl Sci, Islamabad, Pakistan.	noureen_zafar@uaar.edu.pk; irfanulhaq@pieas.edu.pk		zafar, noureen/0000-0002-3181-8118	Higher Education Commission of Pakistan [TDF02-261]	Higher Education Commission of Pakistan(Higher Education Commission of Pakistan)	This research work is funded by Higher Education Commission of Pakistan's TDF02-261 Project. Rs 50000($300) will be covered by HEC whereas any amount above this will be taken care of by Authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, NAT HUM BEHAV, V4, P1, DOI 10.1038/s41562-020-0818-9; Bharathi BD, 2020, TRANSPORTMETRICA A, V16, P807, DOI 10.1080/23249935.2020.1720864; Borhan MN, 2014, SCI WORLD J, DOI 10.1155/2014/784145; Candel A, 2017, DEEP LEARNING H2O 20; Chan ND, 2012, TRANSPORT REV, V32, P93, DOI 10.1080/01441647.2011.621557; Chen X, 2017, TRANSPORT RES C-EMER, V76, P51, DOI 10.1016/j.trc.2016.12.018; Chen YY, 2016, 2016 IEEE 19TH INTERNATIONAL CONFERENCE ON INTELLIGENT TRANSPORTATION SYSTEMS (ITSC), P132, DOI 10.1109/ITSC.2016.7795543; Gal A, 2017, INFORM SYST, V64, P266, DOI 10.1016/j.is.2015.12.001; Grengs J, 2010, J PLAN EDUC RES, V29, P427, DOI 10.1177/0739456X10363278; Kapoor V., P 2018 IEEE INT C PE, P770, DOI [10.1109/PERCOMW.2018.8480324, DOI 10.1109/PERCOMW.2018.8480324]; Lee J, 2015, 2015 IEEE INTERNATIONAL CONFERENCE ON DATA SCIENCE AND DATA INTENSIVE SYSTEMS, P81, DOI 10.1109/DSDIS.2015.96; Liu HJ, 2020, IEEE ACCESS, V8, P11917, DOI 10.1109/ACCESS.2020.2965094; Liu LJ, 2017, TRANSPORT RES C-EMER, V84, P74, DOI 10.1016/j.trc.2017.08.001; Liu YX, 2017, INT SYM COMPUT INTEL, P361, DOI 10.1109/ISCID.2017.216; Min W., 2015, U.S. Patent, Patent No. [9,177,473, 9177473]; Mishra S, 2018, ADAPTIVE TRAFFIC LIG; Mishra S, 2018, DATA, V3, DOI 10.3390/data3040067; Mondschein A, 2017, J TRANSP GEOGR, V64, P65, DOI 10.1016/j.jtrangeo.2017.08.007; Noor R.M, 2020, PREDICT ARRIVAL TIME; Othman Mohamed A. K., 2017, 2017 IEEE International Conference on Plasma Science (ICOPS), DOI 10.1109/PLASMA.2017.8496284; Rahmat MF, 2018, 2018 5TH INTERNATIONAL CONFERENCE ON ELECTRICAL ENGINEERING, COMPUTER SCIENCE AND INFORMATICS (EECSI 2018), P1, DOI 10.1109/EECSI.2018.8752807; Soe NC, 2018, 2018 18TH INTERNATIONAL SYMPOSIUM ON COMMUNICATIONS AND INFORMATION TECHNOLOGIES (ISCIT), P327, DOI 10.1109/ISCIT.2018.8587943; Sun N, 2020, IEEE ACCESS, V8, P15907, DOI 10.1109/ACCESS.2020.2966995; Sweet MN, 2014, J TRANSP GEOGR, V35, P40, DOI 10.1016/j.jtrangeo.2014.01.005; Talen E., 2013, INT J SUSTAINABLE LA, V1, P42; Tan HC, 2016, IEEE T INTELL TRANSP, V17, P2123, DOI 10.1109/TITS.2015.2513411; Wang F., 2011, ANN GIS, V17, P199, DOI [10.1080/19475683.2011.625977, DOI 10.1080/19475683.2011.625977]; Wang JQ, 2016, ENG APPL ARTIF INTEL, V52, P145, DOI 10.1016/j.engappai.2016.02.012; Wang J, 2013, TRANSPORT RES C-EMER, V27, P219, DOI 10.1016/j.trc.2012.08.004; Xu HT, 2017, CLUSTER COMPUT, V20, P3099, DOI 10.1007/s10586-017-1006-1; Yang XX, 2020, J ADV TRANSPORT, V2020, DOI 10.1155/2020/9628957; Zhao L., 2019, IEEE T INTELLIGENT T; Zou YJ, 2015, CAN J CIVIL ENG, V42, P570, DOI 10.1139/cjce-2014-0447	33	9	9	6	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0238200	10.1371/journal.pone.0238200	http://dx.doi.org/10.1371/journal.pone.0238200			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326460	Green Published, gold			2022-12-27	WOS:000600176400030
J	Coventry, PA; McMillan, D; Clegg, A; Brown, L; van der Feltz-Cornelis, C; Gilbody, S; Ali, S				Coventry, Peter A.; McMillan, Dean; Clegg, Andrew; Brown, Lesley; van der Feltz-Cornelis, Christina; Gilbody, Simon; Ali, Shehzad			Frailty and depression predict instrumental activities of daily living in older adults: A population-based longitudinal study using the CARE75+cohort	PLOS ONE			English	Article							LATE-LIFE; SCALE; PEOPLE; CARE; LONELINESS; STRENGTH; GENDER; COHORT	Objectives To evaluate if depression contributes, independently and/or in interaction with frailty, to loss of independence in instrumental activities of daily living (ADL) in older adults with frailty. Methods Longitudinal cohort study of people aged >= 75 years living in the community. We used multi-level linear regression model to quantify the relationship between depression (>= 5 Geriatric Depression Scale) and frailty (electronic frailty index), and instrumental activities of daily living (Nottingham Extended Activities of Daily Living scale; range: 0-66; higher score implies greater independence). The model was adjusted for known confounders (age; gender; ethnicity; education; living situation; medical comorbidity). Results 553 participants were included at baseline; 53% were female with a mean age of 81 (5.0 SD) years. Depression and frailty (moderate and severe levels) were independently associated with reduced instrumental activities of daily living scores. In the adjusted analysis, the regression coefficient was -6.4 (95% CI: -8.3 to -4.5, p<0.05) for depression, -1.5 (95% CI: -3.8 to 0.9, p = 0.22) for mild frailty, -6.1 (95% CI: -8.6 to -3.6, p<0.05) for moderate frailty, and -10.1 (95% CI: -13.5 to -6.8, p<0.05) for severe frailty. Moreover, depression interacted with frailty to further reduce instrumental activities of daily living score in individuals with mild or moderate frailty. These relationships remained significant after adjusting for confounders. Conclusion Frailty and depression are independently associated with reduced independence in instrumental activities of daily living. Also, depression interacts with frailty to further reduce independence for mild to moderately frail individuals, suggesting that clinical management of frailty should integrate physical and mental health care.	[Coventry, Peter A.] Univ York, Dept Hlth Sci, York, N Yorkshire, England; [McMillan, Dean; van der Feltz-Cornelis, Christina; Gilbody, Simon] Univ York, Dept Hlth Sci, York, N Yorkshire, England; [McMillan, Dean; van der Feltz-Cornelis, Christina; Gilbody, Simon] Univ York, Hull York Med Sch, York, N Yorkshire, England; [Clegg, Andrew] Univ Leeds, Acad Unit Elderly Care & Rehabil, Bradford, W Yorkshire, England; [Brown, Lesley] Inst Hlth Res, Acad Unit Elderly Care & Rehabil, Bradford, W Yorkshire, England; [Ali, Shehzad] Western Univ, Dept Epidemiol & Biostat, London, ON, Canada	University of York - UK; University of York - UK; University of Hull; University of York - UK; University of Leeds; Western University (University of Western Ontario)	Coventry, PA (corresponding author), Univ York, Dept Hlth Sci, York, N Yorkshire, England.	peter.coventry@york.ac.uk	Gilbody, Simon/AAY-3720-2021; Van der Feltz-Cornelis, Christina/R-7107-2016; Coventry, Peter/H-6714-2014	Gilbody, Simon/0000-0002-8236-6983; Van der Feltz-Cornelis, Christina/0000-0001-6925-8956; Brown, Lesley/0000-0001-5499-9145; Clegg, Andrew/0000-0001-5972-1097; Coventry, Peter/0000-0003-0625-3829	NIHR Applied Research Collaboration Yorkshire; NIHR Applied Research Collaboration Humber	NIHR Applied Research Collaboration Yorkshire; NIHR Applied Research Collaboration Humber	The research was funded by the NIHR Applied Research Collaboration Yorkshire and Humber https://www.arc-yh.nihr.ac.uk/.The views expressed are those of the author(s), and not necessarily those of the NIHR or the Department of Health and Social Care.	Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Blakemore A, 2014, INT J CHRONIC OBSTR, V9, P501, DOI 10.2147/COPD.S58136; Brundle C, 2019, AGE AGEING, V48, P152, DOI 10.1093/ageing/afy162; Chatterji S, 2015, LANCET, V385, P563, DOI 10.1016/S0140-6736(14)61462-8; Chiesi F, 2018, PSYCHOL REP, V121, P1167, DOI 10.1177/0033294117745561; Chiesi F, 2018, J AFFECT DISORDERS, V227, P471, DOI 10.1016/j.jad.2017.11.045; Clegg A, 2016, AGE AGEING, V45, P353, DOI 10.1093/ageing/afw039; Clegg A, 2015, AGE AGEING, V44, P547, DOI 10.1093/ageing/afv044; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; Coventry P, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h638; Coventry PA, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-49; Crocker TF, 2019, QUAL LIFE RES, V28, P2041, DOI 10.1007/s11136-019-02149-1; de Keijzer C, 2019, ENVIRON INT, V122, P346, DOI 10.1016/j.envint.2018.11.046; Dunlop DD, 1997, AM J PUBLIC HEALTH, V87, P378, DOI 10.2105/AJPH.87.3.378; Farmer C, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4843; Feng ZY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178383; Fukumori N, 2015, AGE AGEING, V44, P592, DOI 10.1093/ageing/afv013; Gierveld JDJ, 2010, EUR J AGEING, V7, P121, DOI 10.1007/s10433-010-0144-6; GLADMAN JRF, 1993, AGE AGEING, V22, P419, DOI 10.1093/ageing/22.6.419; Harrison JK, 2015, AGE AGEING, V44, P732, DOI 10.1093/ageing/afv085; Hartig T, 2014, ANNU REV PUBL HEALTH, V35, P207, DOI 10.1146/annurev-publhealth-032013-182443; Katon WJ, 2010, NEW ENGL J MED, V363, P2611, DOI 10.1056/NEJMoa1003955; Katz JN, 1996, MED CARE, V34, P73, DOI 10.1097/00005650-199601000-00006; Kojima G, 2017, DISABIL REHABIL, V39, P1897, DOI 10.1080/09638288.2016.1212282; Lohman M, 2016, J GERONTOL B-PSYCHOL, V71, P630, DOI 10.1093/geronb/gbu180; Lohman MC, 2017, AGING MENT HEALTH, V21, P399, DOI 10.1080/13607863.2015.1102199; Mezuk B, 2013, AM J GERIAT PSYCHIAT, V21, P560, DOI 10.1016/j.jagp.2012.12.019; NHS England, 2014, 5 YEAR FORW VIEW; Office for National Statistics, 2018, LIV LONG OUR POP IS; Orgeta V, 2017, BRIT J PSYCHIAT, V211, P274, DOI 10.1192/bjp.bp.117.205021; Perissinotto CM, 2012, ARCH INTERN MED, V172, P1078, DOI 10.1001/archinternmed.2012.1993; Prince MJ, 2015, LANCET, V385, P549, DOI 10.1016/S0140-6736(14)61347-7; Rantanen T, 1999, JAMA-J AM MED ASSOC, V281, P558, DOI 10.1001/jama.281.6.558; Ryan A, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0355-9; Soysal P, 2017, AGEING RES REV, V36, P78, DOI 10.1016/j.arr.2017.03.005; Testa G, 2011, EUR J CLIN INVEST, V41, P1310, DOI 10.1111/j.1365-2362.2011.02544.x; Verger P, 2009, EUR J PUBLIC HEALTH, V19, P618, DOI 10.1093/eurpub/ckp057; Vetrano D. L., 2018, J GERONTOL A-BIOL, V74, P659, DOI DOI 10.1093/GERONA/GLY110; Wancata J, 2006, ACTA PSYCHIAT SCAND, V114, P398, DOI 10.1111/j.1600-0447.2006.00888.x; Wang D, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015794; YESAVAGE JA, 1988, PSYCHOPHARMACOL BULL, V24, P709; Yu RB, 2018, J AM MED DIR ASSOC, V19, P528, DOI 10.1016/j.jamda.2017.12.015	42	8	8	6	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243972	10.1371/journal.pone.0243972	http://dx.doi.org/10.1371/journal.pone.0243972			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH3TP	33320913	Green Accepted, Green Published, gold			2022-12-27	WOS:000600339800056
J	Mills, C; Muruganujan, A; Ebert, D; Marconett, CN; Lewinger, JP; Thomas, PD; Mi, HY				Mills, Caitlin; Muruganujan, Anushya; Ebert, Dustin; Marconett, Crystal N.; Lewinger, Juan Pablo; Thomas, Paul D.; Mi, Huaiyu			PEREGRINE: A genome-wide prediction of enhancer to gene relationships supported by experimental evidence	PLOS ONE			English	Article							EXPRESSION; DISTANCE; VARIANTS; ONTOLOGY; ELEMENTS; DATABASE; PATHWAY; LINKING; BINDING; GALNT2	Enhancers are powerful and versatile agents of cell-type specific gene regulation, which are thought to play key roles in human disease. Enhancers are short DNA elements that function primarily as clusters of transcription factor binding sites that are spatially coordinated to regulate expression of one or more specific target genes. These regulatory connections between enhancers and target genes can therefore be characterized as enhancer-gene links that can affect development, disease, and homeostatic cellular processes. Despite their implication in disease and the establishment of cell identity during development, most enhancer-gene links remain unknown. Here we introduce a new, publicly accessible database of predicted enhancer-gene links, PEREGRINE. The PEREGRINE human enhancer-gene links interactive web interface incorporates publicly available experimental data from ChIA-PET, eQTL, and Hi-C assays across 78 cell and tissue types to link 449,627 enhancers to 17,643 protein-coding genes. These enhancer-gene links are made available through the new Enhancer module of the PANTHER database and website where the user may easily access the evidence for each enhancer-gene link, as well as query by target gene and enhancer location.	[Mills, Caitlin; Lewinger, Juan Pablo] Univ Southern Calif, Keck Sch Med, Dept Prevent Med, Div Biostat, Los Angeles, CA 90007 USA; [Muruganujan, Anushya; Ebert, Dustin; Thomas, Paul D.; Mi, Huaiyu] Univ Southern Calif, Keck Sch Med, Dept Prevent Med, Div Bioinformat, Los Angeles, CA 90007 USA; [Marconett, Crystal N.] Univ Southern Calif, Keck Sch Med, Dept Surg, Los Angeles, CA 90007 USA; [Marconett, Crystal N.] USC, Keck Sch Med, Dept Biochem & Mol Med, Los Angeles, CA USA; [Marconett, Crystal N.] USC, Keck Sch Med, Norris Canc Ctr, Los Angeles, CA USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California Keck Hospital; University of Southern California; University of Southern California Keck Hospital	Mi, HY (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Prevent Med, Div Bioinformat, Los Angeles, CA 90007 USA.	huaiyumi@usc.edu		Thomas, Paul/0000-0002-9074-3507; Marconett, Crystal/0000-0002-8463-7126; Ebert, Dustin/0000-0002-6659-0416; Lewinger, Juan Pablo/0000-0002-0692-2570	National Institute of Health [P01CA196569]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	HM, AM, DE, JPL, PDT, CM P01CA196569 National Institute of Health https://www.nih.gov/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, J NATL COMPR CANC NE, V9; [Anonymous], 2015, MEDICINE, V94, pe1435; Apache Solr, 2020, APACHE SOLR; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Attema JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075517; BANERJI J, 1981, CELL, V27, P299, DOI 10.1016/0092-8674(81)90413-X; Blackwood EM, 1998, SCIENCE, V281, P60, DOI 10.1126/science.281.5373.60; Bulger M, 1999, GENE DEV, V13, P2465, DOI 10.1101/gad.13.19.2465; Burke K, 2020, FLASK RESTFUL; Carbon S, 2019, NUCLEIC ACIDS RES, V47, pD330, DOI 10.1093/nar/gky1055; Cavalli M, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0183-x; Chen JY, 2017, BIOMEDICINES, V5, DOI 10.3390/biomedicines5030043; Corradin O, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0085-3; de Laat W, 2008, CURR TOP DEV BIOL, V82, P117, DOI 10.1016/S0070-2153(07)00005-1; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fabregat A, 2018, NUCLEIC ACIDS RES, V46, pD649, DOI [10.1093/nar/gkz1031, 10.1093/nar/gkx1132]; Fishilevich S, 2017, DATABASE-OXFORD, DOI 10.1093/database/bax028; Fraser J, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156492; Fullwood MJ, 2009, J CELL BIOCHEM, V107, P30, DOI 10.1002/jcb.22116; Gao TS, 2020, NUCLEIC ACIDS RES, V48, pD58, DOI 10.1093/nar/gkz980; Gao TS, 2016, BIOINFORMATICS, V32, P3543, DOI 10.1093/bioinformatics/btw495; Gasperini M, 2020, NAT REV GENET, V21, P292, DOI 10.1038/s41576-019-0209-0; Ghavi-Helm Y, 2014, NATURE, V512, P96, DOI 10.1038/nature13417; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Jiang Y, 2019, NUCLEIC ACIDS RES, V47, pD235, DOI 10.1093/nar/gky1025; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Liu Q, 2018, CLIN CANCER RES, V24, P4602, DOI 10.1158/1078-0432.CCR-17-3678; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Makino T, 2008, MOL BIOL EVOL, V25, P1855, DOI 10.1093/molbev/msn137; Marsman J, 2012, BBA-GENE REGUL MECH, V1819, P1217, DOI 10.1016/j.bbagrm.2012.10.008; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Mi HY, 2019, NAT PROTOC, V14, P703, DOI 10.1038/s41596-019-0128-8; Mi HY, 2019, NUCLEIC ACIDS RES, V47, pD419, DOI 10.1093/nar/gky1038; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Mi HY, 2009, METHODS MOL BIOL, V563, P123, DOI 10.1007/978-1-60761-175-2_7; Murray A, 2009, EUR HEART J, V30, P1711, DOI 10.1093/eurheartj/ehp161; Nica AC, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0362; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Phanstiel DH, 2015, BIOINFORMATICS, V31, P3092, DOI 10.1093/bioinformatics/btv336; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Roman TS, 2015, AM J HUM GENET, V97, P801, DOI 10.1016/j.ajhg.2015.10.016; Ron G, 2017, NAT COMMUN, V8, DOI [10.1038/s41467-017-02386-3, 10.1038/s41467-017-023863]; Schoenfelder S, 2018, JOVE-J VIS EXP, DOI 10.3791/57320; Thomas MF, 2014, TRENDS GENET, V30, P298, DOI 10.1016/j.tig.2014.05.003; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Wang J, 2019, NUCLEIC ACIDS RES, V47, pD106, DOI 10.1093/nar/gky864; Wang ML, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11478; Wang Z, 2018, NUCLEIC ACIDS RES, V46, pD113, DOI 10.1093/nar/gkx988; Ward LD, 2012, NAT BIOTECHNOL, V30, P1095, DOI 10.1038/nbt.2422; West AG, 2002, GENE DEV, V16, P271, DOI 10.1101/gad.954702; Yao LJ, 2015, CRIT REV BIOCHEM MOL, V50, P550, DOI 10.3109/10409238.2015.1087961; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098	56	5	5	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2020	15	12							e0243791	10.1371/journal.pone.0243791	http://dx.doi.org/10.1371/journal.pone.0243791			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH3TP	33320871	Green Published, gold			2022-12-27	WOS:000600339800006
J	Barrera, SM; Byrum, S; Mackintosh, SG; Kozubowski, L				Barrera, Stephani Martinez; Byrum, Stephanie; Mackintosh, Samuel G.; Kozubowski, Lukasz			Registered report protocol: Quantitative analysis of septin Cdc10-associated proteome in Cryptococcus neoformans	PLOS ONE			English	Article							YEAST; VIRULENCE; MODEL; PHAGOSOME; BINDING; FUNGUS	Cryptococcus neoformans is a pathogenic basidiomycetous yeast that primarily infects immunocompromised individuals. C. neoformans can thrive during infections due to its three main virulence-related characteristics: the ability to grow at host temperature (37 degrees C), formation of carbohydrate capsule, and its ability to produce melanin. C. neoformans strains lacking septin proteins Cdc3 or Cdc12 are viable at 25 degrees C; however, they fail to proliferate at 37 degrees C and are avirulent in the murine model of infection. The basis of septin contribution to growth at host temperature remains unknown. Septins are a family of conserved filament-forming GTPases with roles in cytokinesis and morphogenesis. In the model organism Saccharomyces cerevisiae septins are essential. S. cerevisiae septins form a higher order complex at the mother-bud neck to scaffold over 80 proteins, including those involved in cell wall organization, cell polarity, and cell cycle control. In C. neoformans, septins also form a complex at the mother-bud neck but the septin interacting proteome in this species remains largely unknown. Moreover, it remains possible that septins play other roles important for high temperature stress that are independent of their established role in cytokinesis. Therefore, we propose to perform a global analysis of septin Cdc10 binding partners in C. neoformans, including those that are specific to high temperature stress. This analysis will shed light on the underlying mechanism of survival of this pathogenic yeast during infection and can potentially lead to the discovery of novel drug targets.	[Barrera, Stephani Martinez; Kozubowski, Lukasz] Clemson Univ, Dept Genet & Biochem, Eukaryot Pathogens Innovat Ctr, Clemson, SC 29634 USA; [Byrum, Stephanie; Mackintosh, Samuel G.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA	Clemson University; University of Arkansas System; University of Arkansas Medical Sciences	Kozubowski, L (corresponding author), Clemson Univ, Dept Genet & Biochem, Eukaryot Pathogens Innovat Ctr, Clemson, SC 29634 USA.	lkozubo@clemson.edu		Martinez Barrera, Stephani/0000-0002-9350-3576	National Institutes of Health (NIGMS) [5P20GM109094-05]	National Institutes of Health (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	LK is funded by the National Institutes of Health (NIGMS) as a Target Investigator on a grant #5P20GM109094-05. (https://www.nigms.nih.gov).The funders had and will not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alspaugh JA, 2015, FUNGAL GENET BIOL, V78, P55, DOI 10.1016/j.fgb.2014.09.004; [Anonymous], 2011, OFFICIAL J EUROPEA L, VL 23, P1; [Anonymous], 2016, NUCLEIC ACIDS RES, V44, pD7; Barve G, 2018, CURR GENET, V64, P1037, DOI 10.1007/s00294-018-0834-8; Barve G, 2018, J CELL SCI, V131, DOI 10.1242/jcs.209098; Bojarczuk A, 2016, SCI REP-UK, V6, DOI 10.1038/srep21489; Bridges AA, 2016, J CELL BIOL, V213, P23, DOI 10.1083/jcb.201512029; Bridges AA, 2014, P NATL ACAD SCI USA, V111, P2146, DOI 10.1073/pnas.1314138111; Brown SM, 2007, CURR OPIN MICROBIOL, V10, P320, DOI 10.1016/j.mib.2007.05.014; Byrum SD, 2018, J PROTEOME RES, V17, P3384, DOI 10.1021/acs.jproteome.8b00288; Byrum SD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174771; Denham ST, 2018, J FUNGI, V4, DOI 10.3390/jof4010025; Douglas LM, 2005, EUKARYOT CELL, V4, P1503, DOI 10.1128/EC.4.9.1503-1512.2005; Estey MP, 2011, CURR BIOL, V21, pR384, DOI 10.1016/j.cub.2011.03.067; Fung KYY, 2014, INT REV CEL MOL BIO, V310, P289, DOI 10.1016/B978-0-12-800180-6.00007-4; Gladfelter AS, 2001, CURR OPIN MICROBIOL, V4, P681, DOI 10.1016/S1369-5274(01)00269-7; Glomb O, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00123; Gonczi M, 2021, J MUSCLE RES CELL M, V42, P251, DOI 10.1007/s10974-020-09573-8; Hecht M, 2019, G3-GENES GENOM GENET, V9, P1869, DOI 10.1534/g3.119.400197; Huang YW, 2008, MOL BIOL CELL, V19, P1717, DOI 10.1091/mbc.E07-07-0641; Husain S, 2001, EMERG INFECT DIS, V7, P375; Idnurm A, 2005, NAT REV MICROBIOL, V3, P753, DOI 10.1038/nrmicro1245; Janbon G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004261; Johnston SA, 2013, CELL MICROBIOL, V15, P403, DOI 10.1111/cmi.12067; Kozubowski L, 2012, FEMS MICROBIOL REV, V36, P78, DOI 10.1111/j.1574-6976.2011.00286.x; Kozubowski L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025280; Kozubowski L, 2010, MOL MICROBIOL, V75, P658, DOI 10.1111/j.1365-2958.2009.06983.x; Ma HS, 2006, CURR BIOL, V16, P2156, DOI 10.1016/j.cub.2006.09.032; McMurray MA, 2011, DEV CELL, V20, P540, DOI 10.1016/j.devcel.2011.02.004; Mednick AJ, 2005, INFECT IMMUN, V73, P2012, DOI 10.1128/IAI.73.4.2012-2019.2005; MITCHELL TG, 1995, CLIN MICROBIOL REV, V8, P515, DOI 10.1128/CMR.8.4.515; Mostowy S, 2012, NAT REV MOL CELL BIO, V13, P183, DOI 10.1038/nrm3284; Nagaraj S, 2008, MOL CELL BIOL, V28, P5120, DOI 10.1128/MCB.00786-08; Nakahira M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013799; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Neubauer K, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00003; Pan FF, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-103; Perfect JR, 2006, FEMS YEAST RES, V6, P463, DOI 10.1111/j.1567-1364.2006.00051.x; PERFECT JR, 1993, J CLIN MICROBIOL, V31, P3305, DOI 10.1128/JCM.31.12.3305-3309.1993; Rajasingham R, 2017, LANCET INFECT DIS, V17, P873, DOI [10.1016/S1473-3099(17)30243-8, 10.1016/s1473-3099(17)30243-8]; Renz C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148340; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Tanaka-Takiguchi Y, 2009, CURR BIOL, V19, P140, DOI 10.1016/j.cub.2008.12.030; Tokhtaeva E, 2015, J BIOL CHEM, V290, P5280, DOI 10.1074/jbc.M114.616201; Vazquez JH, 2020, TOXICOL SCI, V173, P244, DOI 10.1093/toxsci/kfz222; Versele M, 2004, J CELL BIOL, V164, P701, DOI 10.1083/jcb.200312070; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Voelz K, 2010, EUKARYOT CELL, V9, P835, DOI 10.1128/EC.00039-10; Weirich CS, 2008, NAT REV MOL CELL BIO, V9, P478, DOI 10.1038/nrm2407; Wloka C, 2011, BIOL CHEM, V392, P813, DOI 10.1515/BC.2011.083; Zaragoza O, 2019, VIRULENCE, V10, P490, DOI 10.1080/21505594.2019.1614383	52	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0242381	10.1371/journal.pone.0242381	http://dx.doi.org/10.1371/journal.pone.0242381			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315917	Green Published, gold			2022-12-27	WOS:000600186100034
J	Beumeler, LFE; van Wieren, A; Buter, H; van Zutphen, T; Bruins, NA; de Jager, CM; Koopmans, M; Navis, GJ; Boerma, EC				Beumeler, Lise F. E.; van Wieren, Anja; Buter, Hanneke; van Zutphen, Tim; Bruins, Nynke A.; de Jager, Corine M.; Koopmans, Matty; Navis, Gerjan J.; Boerma, E. Christiaan			Patient-reported physical functioning is limited in almost half of critical illness survivors 1-year after ICU-admission: A retrospective single-centre study	PLOS ONE			English	Article							QUALITY-OF-LIFE; INTENSIVE-CARE; MENTAL-HEALTH; DISABILITY; MORTALITY; IMPACT	Post-intensive care unit (ICU) sequelae, including physical and mental health problems, are relatively unexplored. Characteristics commonly used to predict outcome lack prognostic value when it comes to long-term physical recovery. Therefore, the objective of this study was to assess the incidence of non-recovery in long-stay ICU-patients. In this single-centre study, retrospective data of adults with an ICU stay >48 hours who visited the specialized post-ICU clinic, and completed the Dutch RAND 36-item Short Form questionnaire at 3 and 12 months post-ICU, were retrieved from electronic patient records. In cases where physical functioning scores at 12 months were below reference values, patients were allocated to the physical non-recovery (NR) group. Significantly different baseline and (post-)ICU-characteristics were assessed for correlations with physical recovery at 12 months post-ICU. Of 250 patients, 110 (44%) fulfilled the criteria for the NR-group. Neither the severity of illness, type of admission, nor presence of sepsis did not differ between groups. However, NR-patients had a higher age, were more often female, and had a higher incidence of co-morbidities. Shorter LOS ICU, lower incidence of medical comorbidities, and better physical performance at 3 months were significantly correlated with 1-year physical recovery. Comorbidities and reduced physical functioning at 3 months were identified as independent risk-factors for long-term physical non-recovery. In conclusion, a substantial proportion of long-stay ICU-patients who visited the standard care post-ICU clinic did not fulfil the criteria for full physical recovery at 12 months post-ICU. Commonly used ICU-characteristics, such as severity of illness, do not have sufficient prognostic value when it comes to long-term recovery of health-related quality of life.	[Beumeler, Lise F. E.; van Zutphen, Tim] Univ Groningen, Campus Fryslan, Leeuwarden, Netherlands; [van Wieren, Anja; Buter, Hanneke; Bruins, Nynke A.; de Jager, Corine M.; Koopmans, Matty; Boerma, E. Christiaan] Med Ctr Leeuwarden, Dept Intens Care, Leeuwarden, Netherlands; [Navis, Gerjan J.] Univ Med Ctr Groningen, Fac Med Sci, Groningen, Netherlands	University of Groningen; Medical Center Leeuwarden; University of Groningen	Beumeler, LFE (corresponding author), Univ Groningen, Campus Fryslan, Leeuwarden, Netherlands.	lisebeumeler@gmail.com		Beumeler, Lise/0000-0002-6513-3635				Alison JA, 2012, PHYS THER, V92, P1556, DOI 10.2522/ptj.20110410; Baldwin CE, 2013, J CRIT CARE, V28, P77, DOI 10.1016/j.jcrc.2012.03.001; Denehy L, 2017, INTENS CARE MED, V43, P1881, DOI 10.1007/s00134-017-4942-6; Dowdy DW, 2005, INTENS CARE MED, V31, P611, DOI 10.1007/s00134-005-2592-6; Gerth AMJ, 2019, ANAESTHESIA, V74, P100, DOI 10.1111/anae.14444; Hermans G, 2014, AM J RESP CRIT CARE, V190, P410, DOI 10.1164/rccm.201312-2257OC; Hodgson CL, 2017, INTENS CARE MED, V43, P992, DOI 10.1007/s00134-017-4830-0; Hofhuis J, 2003, INTENS CARE MED, V29, P974, DOI 10.1007/s00134-003-1763-6; Hofhuis JGM, 2008, CHEST, V133, P377, DOI 10.1378/chest.07-1217; Honselmann KC, 2015, J CRIT CARE, V30, P721, DOI 10.1016/j.jcrc.2015.03.009; Hutchings A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4353; Jackson JC, 2015, PSYCHIAT CLIN N AM, V38, P91, DOI 10.1016/j.psc.2014.11.002; Jaitovich A, 2018, CHEST; Kaarlola A, 2004, INTENS CARE MED, V30, P2245, DOI 10.1007/s00134-004-2471-6; Kahn JM, 2014, CURR OPIN CRIT CARE, V20, P542, DOI 10.1097/MCC.0000000000000140; Minne L, 2011, INTENS CARE MED, V37, P1258, DOI 10.1007/s00134-011-2265-6; Muir SW, 2008, PHYS THER, V88, P449, DOI 10.2522/ptj.20070251; Myhren H, 2010, CRIT CARE MED, V38, P1554, DOI 10.1097/CCM.0b013e3181e2c8b1; Oeyen S, 2018, J CRIT CARE, V43, P133, DOI 10.1016/j.jcrc.2017.09.006; Orwelius L, 2010, CRIT CARE, V14, DOI 10.1186/cc8967; Pettila V, 2000, INTENS CARE MED, V26, P1473, DOI 10.1007/s001340000629; Schmidt K, 2016, JAMA-J AM MED ASSOC, V315, P2703, DOI 10.1001/jama.2016.7207; Sommers J, 2016, PHYS THER, V96, P1658, DOI 10.2522/ptj.20150339; Turnbull AE, 2016, CRIT CARE MED, V44, P1267, DOI 10.1097/CCM.0000000000001651; van der Schaaf M, 2009, J REHABIL MED, V41, P360, DOI 10.2340/16501977-0333; van der Zee KI., 2012, MEASURING GEN HLTH S, V2nd; Weinert CR, 1997, AM J RESP CRIT CARE, V156, P1120, DOI 10.1164/ajrccm.156.4.9611047; Da Silveira LTY, 2018, INT J QUAL HEALTH C, V30, P265, DOI 10.1093/intqhc/mzx203; Zimmerman JE, 2013, CRIT CARE, V17, DOI 10.1186/cc12695	29	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243981	10.1371/journal.pone.0243981	http://dx.doi.org/10.1371/journal.pone.0243981			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315942	gold, Green Published			2022-12-27	WOS:000600186100061
J	Kimura, N; Aso, Y; Yabuuchi, K; Matsubara, E				Kimura, Noriyuki; Aso, Yasuhiro; Yabuuchi, Kenichi; Matsubara, Etsuro			Association between objectively measured walking steps and sleep in community-dwelling older adults: A prospective cohort study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; POOR SLEEP; QUALITY; INSOMNIA; MEN; METAANALYSIS; PERFORMANCE; DURATION; DECLINE	Physical inactivity and sleep disturbances are major problems in an ageing society. There is increasing evidence that physical activity is associated with sleep quality. However, the association between daily walking steps and sleep remain unclear. This prospective study examined the relationship between objectively measured daily walking steps and sleep parameters in Japanese community-dwelling older adults. In total, 855 community-dwelling individuals aged 65 and above, with an uninterrupted follow-up from August 2015 to March 2016, were enrolled. The participants wore a wristband sensor for an average of 7.8 days every three months. Multiple linear regression analysis was performed to examine the relationship between daily walking steps and sleep parameters, including the total sleep time, sleep efficiency, time awake after sleep onset (WASO), awakening time count during the night, and naptime. The median (interquartile range, IQR) age of the participants was 73 (69-78) years, with 317 (37.1%) men and 538 (62.9%) women. The median (IQR) educational level was 12 (11-12) years, and the median (IQR) Mini-Mental State Examination score was 29 (27-30) points. The number of daily walking steps showed a positive correlation with sleep efficiency and an inverse correlation with WASO, awakening time count, and naptime, after adjusting for covariates and correcting for the false discovery rate (beta = 0.098, 95% confidence interval [CI]: 0.034 to 0.162, p = 0.003; beta = -0.107, 95% CI: -0.172 to -0.043, p = 0.001; beta = -0.105, 95% CI: -0.17 to -0.04, p = 0.002; and beta = -0.31, 95% CI: -0.371 to -0.249, p < 0.001, respectively). Our results can help promote walking as an intervention for preventing sleep disturbances in community-dwelling older adults.	[Kimura, Noriyuki; Aso, Yasuhiro; Yabuuchi, Kenichi; Matsubara, Etsuro] Oita Univ, Dept Neurol, Fac Med, Oita, Japan	Oita University	Kimura, N (corresponding author), Oita Univ, Dept Neurol, Fac Med, Oita, Japan.	noriyuki@oita-u.ac.jp		Kimura, Noriyuki/0000-0001-7137-7268	Japan Agency for Medical Research and Development [18he1402003, 19K07916]	Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	The present study was supported by Japan Agency for Medical Research and Development grants no.18he1402003 and Scientific Research (C) grants no. 19K07916. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; Barnes DE, 2008, J AM GERIATR SOC, V56, P1658, DOI 10.1111/j.1532-5415.2008.01841.x; Bisson ANS, 2019, SLEEP HEALTH, V5, P487, DOI 10.1016/j.sleh.2019.06.003; Brychta RJ, 2016, J CLIN SLEEP MED, V12, P203, DOI 10.5664/jcsm.5486; Cappuccio FP, 2010, SLEEP, V33, P585, DOI 10.1093/sleep/33.5.585; Chen T, 2015, J SPORT SCI MED, V14, P507; Dam TTL, 2008, J AM GERIATR SOC, V56, P1665, DOI 10.1111/j.1532-5415.2008.01846.x; Foley D, 2004, J PSYCHOSOM RES, V56, P497, DOI 10.1016/j.jpsychores.2004.02.010; FOLEY DJ, 1995, SLEEP, V18, P425, DOI 10.1093/sleep/18.6.425; Gabriel KP, 2017, SLEEP HEALTH, V3, P49, DOI 10.1016/j.sleh.2016.10.001; Goldman SE, 2007, SLEEP, V30, P1317, DOI 10.1093/sleep/30.10.1317; Haario P, 2013, J SLEEP RES, V22, P89, DOI 10.1111/j.1365-2869.2012.01043.x; Hamer M, 2008, BRIT J SPORT MED, V42, P238, DOI 10.1136/bjsm.2007.039974; Kim K, 2000, SLEEP, V23, P41; Kim M, 2015, J KOREAN MED SCI, V30, P199, DOI 10.3346/jkms.2015.30.2.199; Kimura N, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00401; Lambiase MJ, 2013, MED SCI SPORT EXER, V45, P2362, DOI 10.1249/MSS.0b013e31829e4cea; Malinowska KB, 2017, GERIATR GERONTOL INT, V17, P1808, DOI 10.1111/ggi.12965; Master L, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44059-9; Miyata S, 2013, J SLEEP RES, V22, P535, DOI 10.1111/jsr.12054; Morris JN, 1997, SPORTS MED, V23, P306, DOI 10.2165/00007256-199723050-00004; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; Peng X, 2019, SLEEP BREATH, V23, P679, DOI 10.1007/s11325-018-1749-9; Seol J, 2020, NURS HEALTH SCI, V22, P64, DOI 10.1111/nhs.12647; Sherrill DL, 1998, ARCH INTERN MED, V158, P1894, DOI 10.1001/archinte.158.17.1894; Spira AP, 2012, J AM GERIATR SOC, V60, P1092, DOI 10.1111/j.1532-5415.2012.03968.x; Stenholm S, 2011, SLEEP, V34, P1583, DOI 10.5665/sleep.1402; Stenholm S, 2010, J GERONTOL A-BIOL, V65, P649, DOI 10.1093/gerona/glq017; Tsunoda K, 2015, AM J PREV MED, V48, P662, DOI 10.1016/j.amepre.2014.12.006; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351	30	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243910	10.1371/journal.pone.0243910	http://dx.doi.org/10.1371/journal.pone.0243910			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH1MP	33315927	gold, Green Published			2022-12-27	WOS:000600186100033
J	Laplana, M; Yuguero, O; Fibla, J				Laplana, Marina; Yuguero, Oriol; Fibla, Joan			Lack of protective effect of chloroquine derivatives on COVID-19 disease in a Spanish sample of chronically treated patients	PLOS ONE			English	Article							OLD DRUG	Background The search for a SARS-CoV-2 treatment has emerged as a worldwide priority. We evaluated the role of chloroquine and its derivatives in COVID-19 in Spanish individuals. Methods We performed a survey addressed to patients regularly taking chloroquine and its derivatives for the control of their autoimmune diseases. The survey was distributed with special attention to Spanish patient associations centred on autoimmune diseases and rheumatology and to the general population. A sample of untreated subjects was matched to the treated group according to sex, age range and incidence region. COVID-19 disease prevalence was compared between treated and untreated-matched control sample. Results A total of 319 surveys of patients regularly taking chloroquine and its derivatives were recovered for further analysis. The prevalence of declared COVID-19 status in the treated group was 5.3% and the mean prevalence among the untreated-matched groups was 3.4%. A community exposition to COVID-19 was associated with a greater prevalence of COVID-19 in both, treated (17.0% vs. 3.2%; p-value<0.001) and untreated groups (13.4% vs. 1.1%; p-value = 0.027). Conclusion We did not find differences of reported COVID-19 cases between treated and untreated groups, indicating a lack of protection by regular administration of chloroquine and its derivative drugs on COVID-19 infection. Of relevance, data indicates that patients that regularly take chloroquine derivatives are exposed to SARS-CoV-2 infection and must take the same protection measures as the general population.	[Laplana, Marina] Univ Lleida, Dept Ciencia Anim, Lleida, Spain; [Yuguero, Oriol] Hosp Univ Arnau Vilanova Lleida, Lleida, Spain; [Yuguero, Oriol; Fibla, Joan] Inst Recerca Biomed Lleida, Lleida, Spain; [Fibla, Joan] Dept Ciencies Med Basiques, Unitat Genet Humana, Lleida, Spain	Universitat de Lleida; University Hospital Arnau de Vilanova; Institut de Recerca Biomedica - IRB Lleida	Fibla, J (corresponding author), Inst Recerca Biomed Lleida, Lleida, Spain.; Fibla, J (corresponding author), Dept Ciencies Med Basiques, Unitat Genet Humana, Lleida, Spain.	joan.fibla@udl.cat	Fibla, Joan/C-5561-2008; Yuguero, Oriol/AAV-3749-2021; Laplana, Marina/G-2653-2010	Fibla, Joan/0000-0002-3255-2227; Laplana, Marina/0000-0002-2548-0704				Al-Bari MAA, 2017, PHARMACOL RES PERSPE, V5, DOI 10.1002/prp2.293; [Anonymous], 2020, ESTUDIO ENE COVID19, P1; Boulware DR, 2020, NEW ENGL J MED, pNEJMoa2016638; Centro de Coordinacion de Alertas y Emergencias Sanitarias. Secretaria General de Sanidad. Direccion general de Salud Publica Calidad e Innovacion, 2020, ACT 123 ENF COR COVI, P1; Devaux Christian A, 2020, Int J Antimicrob Agents, V55, P105938, DOI 10.1016/j.ijantimicag.2020.105938; Emmi G, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102575; Gao JJ, 2020, BIOSCI TRENDS, V14, P72, DOI 10.5582/bst.2020.01047; Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949; Hassani RTJ, 2020, J INFECT PUBLIC HEAL, V13, P865, DOI [10.1016/j.jiph.2020.05.005, 10.1016/j.ijph.2020.05.005]; Infante M, 2021, EXPERT REV ANTI-INFE, V19, P5, DOI 10.1080/14787210.2020.1799785; Keyaerts E, 2004, BIOCHEM BIOPH RES CO, V323, P264, DOI 10.1016/j.bbrc.2004.08.085; Principi N, 2020, LANCET INFECT DIS, V20, P1118, DOI 10.1016/S1473-3099(20)30296-6; Savarino A, 2003, LANCET INFECT DIS, V3, P722, DOI 10.1016/S1473-3099(03)00806-5; Thangaraju P, 2020, J INFECT PUBLIC HEAL, V13, P899, DOI 10.1016/j.jiph.2020.05.006; Touret F, 2020, ANTIVIR RES, V177, DOI 10.1016/j.antiviral.2020.104762	15	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243598	10.1371/journal.pone.0243598	http://dx.doi.org/10.1371/journal.pone.0243598			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315903	Green Submitted, Green Published, gold			2022-12-27	WOS:000600186100032
J	Sangla, F; Legouis, D; Marti, PE; Sgardello, SD; Brebion, A; Saint-Sardos, P; Adda, M; Lautrette, A; Pereira, B; Souweine, B				Sangla, Frederic; Legouis, David; Marti, Pierre-Emmanuel; Sgardello, Sebastian D.; Brebion, Amelie; Saint-Sardos, Pierre; Adda, Mireille; Lautrette, Alexandre; Pereira, Bruno; Souweine, Bertrand			One year after ICU admission for severe community-acquired pneumonia of bacterial, viral or unidentified etiology. What are the outcomes?	PLOS ONE			English	Article							QUALITY-OF-LIFE; LONG-TERM OUTCOMES; RESPIRATORY VIRUSES; SAMPLE-SIZE; LOGISTIC-REGRESSION; MORTALITY; SURVIVORS; HOSPITALIZATION; PREDICTORS; INFECTION	Introduction Multiplex polymerase chain reaction (mPCR) for respiratory virus testing is increasingly used in community-acquired pneumonia (CAP), however data on one-year outcome in intensive care unit (ICU) patients with reference to the causative pathogen are scarce. Materials and methods We performed a single-center retrospective study in 123 ICU patients who had undergone respiratory virus testing for CAP by mPCR and with known one-year survival status. Functional status including dyspnea (mMRC score), autonomy (ADL Katz score) and need for new home-care ventilatory support was assessed at a one-year post-ICU follow-up. Mortality rates and functional status were compared in patients with CAP of a bacterial, viral or unidentified etiology one year after ICU admission. Results The bacterial, viral and unidentified groups included 19 (15.4%), 37 (30.1%), and 67 (54.5%) patients, respectively. In multivariate analysis, one-year mortality in the bacterial group was higher compared to the viral group (HR 2.92, 95% CI 1.71-7.28, p = 0.02) and tended to be higher compared to the unidentified etiology group (p = 0.06); but no difference was found between the viral and the unidentified etiology group (p = 0.43). In 64/83 one-year survivors with a post-ICU follow-up consultation, there were no differences in mMRC score, ADL Katz score and new home-care ventilatory support between the groups (p = 0.52, p = 0.37, p = 0.24, respectively). Severe dyspnea (mMRC score = 4 or death), severe autonomy deficiencies (ADL Katz score <= 2 or death), and major adverse respiratory events (new home-care ventilatory support or death) were observed in 52/104 (50.0%), 47/104 (45.2%), and 65/104 (62.5%) patients, respectively; with no difference between the bacterial, viral and unidentified group: p = 0.58, p = 0.06, p = 0.61, respectively. Conclusions CAP of bacterial origin had a poorer outcome than CAP of viral or unidentified origin. At one-year, impairment of functional status was frequently observed, with no difference according to the etiology.	[Sangla, Frederic; Adda, Mireille; Lautrette, Alexandre; Souweine, Bertrand] CHU Gabriel Montpied, Serv Med Intens & Reanimat, Clermont Ferrand, France; [Legouis, David; Marti, Pierre-Emmanuel; Sgardello, Sebastian D.] Hop Univ Geneve, Serv Soins Intensifs Adultes, Geneva, Switzerland; [Brebion, Amelie] CHU Gabriel Montpied, Lab Virol, Clermont Ferrand, France; [Saint-Sardos, Pierre] CHU Gabriel Montpied, Lab Bacteriol, Clermont Ferrand, France; [Pereira, Bruno] CHU Gabriel Montpied, Dept Biostat, Clermont Ferrand, France	CHU Clermont Ferrand; University of Geneva; CHU Clermont Ferrand; CHU Clermont Ferrand; CHU Clermont Ferrand	Sangla, F (corresponding author), CHU Gabriel Montpied, Serv Med Intens & Reanimat, Clermont Ferrand, France.	fred.sangla@gmail.com	Legouis, David/ABF-8069-2020; souweine, bertrand/HHR-8972-2022	Sangla, Frederic/0000-0002-2672-1952; Legouis, David/0000-0002-2924-9737				Adamuz J, 2014, J INFECTION, V68, P534, DOI 10.1016/j.jinf.2014.02.006; Angus DC, 2002, AM J RESP CRIT CARE, V166, P717, DOI 10.1164/rccm.2102084; Bein T, 2018, CURR OPIN CRIT CARE, V24, P35, DOI 10.1097/MCC.0000000000000476; Biehl M, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1062-y; Cameron RJ, 2006, INTENS CARE MED, V32, P1022, DOI 10.1007/s00134-006-0202-x; Celli BR, 2010, RESP MED, V104, P773, DOI 10.1016/j.rmed.2009.12.017; Choi SH, 2012, AM J RESP CRIT CARE, V186, P325, DOI 10.1164/rccm.201112-2240OC; Cilloniz C, 2018, CURR OPIN CRIT CARE, V24, P531, DOI 10.1097/MCC.0000000000000550; Cilloniz C, 2011, CRIT CARE, V15, DOI 10.1186/cc10444; Combes A, 2003, CRIT CARE MED, V31, P1373, DOI 10.1097/01.CCM.0000065188.87029.C3; Davidson TA, 1999, JAMA-J AM MED ASSOC, V281, P354, DOI 10.1001/jama.281.4.354; Demidenko E, 2008, STAT MED, V27, P36, DOI 10.1002/sim.2980; Demidenko E, 2007, STAT MED, V26, P3385, DOI 10.1002/sim.2771; Ferrer M, 2018, PLOS ONE, V13, DOI [10.1371/journal.pone.0191721, 10.1371/journ]; FLETCHER CM, 1959, BMJ-BRIT MED J, V2, P257, DOI 10.1136/bmj.2.5147.257; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; Holter JC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148741; Honselmann KC, 2015, J CRIT CARE, V30, P721, DOI 10.1016/j.jcrc.2015.03.009; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; Jartti T, 2008, PEDIATR INFECT DIS J, V27, P1103, DOI 10.1097/INF.0b013e31817e695d; Karhu J, 2014, CLIN INFECT DIS, V59, P62, DOI 10.1093/cid/ciu237; Karhu J, 2011, ACTA ANAESTH SCAND, V55, P1254, DOI 10.1111/j.1399-6576.2011.02535.x; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Laporte L, 2018, ANN INTENSIVE CARE, V8, DOI 10.1186/s13613-018-0430-6; Luyt CE, 2012, CHEST, V142, P583, DOI 10.1378/chest.11-2196; Marti J, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0178-8; McDonald MD, 2019, J CARDIOTHOR VASC AN, V33, P72, DOI 10.1053/j.jvca.2018.05.023; Montull B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145929; Ong KC, 2005, CHEST, V128, P3810, DOI 10.1378/chest.128.6.3810; Piralla A, 2017, J CLIN VIROL, V92, P48, DOI 10.1016/j.jcv.2017.05.004; Prina E, 2015, LANCET, V386, P1097, DOI 10.1016/S0140-6736(15)60733-4; Restrepo MI, 2010, CHEST, V137, P552, DOI 10.1378/chest.09-1547; Restrepo MI, 2009, INFECT DIS CLIN N AM, V23, P503, DOI 10.1016/j.idc.2009.04.003; Siow WT, 2016, RESPIRATION, V92, P286, DOI 10.1159/000448555; Torres A, 2019, INTENS CARE MED, V45, P159, DOI 10.1007/s00134-019-05519-y; Tosteson TD, 2003, STAT MED, V22, P1069, DOI 10.1002/sim.1388; Voiriot G, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1517-9; Walden AP, 2014, CRIT CARE, V18, DOI 10.1186/cc13812; Wiemken T, 2013, EUR J CLIN MICROBIOL, V32, P705, DOI 10.1007/s10096-012-1802-8	39	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243762	10.1371/journal.pone.0243762	http://dx.doi.org/10.1371/journal.pone.0243762			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315946	Green Published, gold			2022-12-27	WOS:000600186100013
J	Muro, RP; Masoza, TS; Kasanga, G; Kayange, N; Kidenya, BR				Muro, Restituta Phabian; Masoza, Tulla Sylvester; Kasanga, Godfrey; Kayange, Neema; Kidenya, Benson R.			Predictors and outcome of first line treatment failure among under-five children with community acquired severe pneumonia at Bugando Medical Centre, Mwanza, Tanzania: A prospective cohort study	PLOS ONE			English	Article							HOSPITALIZED CHILDREN; MORTALITY; MANAGEMENT; ETIOLOGY; RISK	Background Despite recent advances in management and preventive strategies, high rates of first line antibiotics treatment failure and case fatality for Severe Community Acquired Pneumonia (SCAP) continue to occur in children in low and middle-income countries. This study aimed to identify the predictors and outcome of first line antibiotics treatment failure among children under-five years of age with SCAP admitted at Bugando Medical Centre (BMC) in Mwanza, Tanzania. Methods The study involved under-five children admitted with SCAP, treated with first line antibiotics as recommended by WHO. Patients with treatment failure at 48 hours were shifted to second line of antibiotics treatment and followed up for 7 days. Generalized linear model was used to determine predictors of first line antibiotics treatment failure for SCAP. Results A total of 250 children with SCAP with a median age of 18 [IQR 9-36] months were enrolled, 8.4% had HIV infection and 28% had acute malnutrition. The percentage of first line antibiotics treatment failure for the children with SCAP was 50.4%. Predictors of first line treatment failure were; presentation with convulsion (RR 1.55; 95% CI [1.11-2.16]; p-value 0.009), central cyanosis (RR 1.55; 95% CI [1.16-2.07]; p-value 0.003), low oxygen saturation (RR 1.28; 95% CI [1.01-1.62]; p-value 0.04), abnormal chest X-ray (RR 1.71; 95% CI [1.28-2.29]; p-value <0.001), HIV infection (RR 1.80; 95% CI [1.42-2.27]; p-value 0.001), moderate acute malnutrition (RR 1.48; 95% CI [1.04-2.12]; p-value = 0.030) and severe acute malnutrition (RR 2.02; 95% CI [1.56-2.61]; p-value<0.001). Mortality in children who failed first line treatment was 4.8%. Conclusion Half of the children with SCAP at this tertiary center had first line antibiotics treatment failure. HIV infection, acute malnutrition, low oxygen saturation, convulsions, central cyanosis, and abnormal chest X-ray were independently predictive of first line treatment failure. We recommend consideration of second line treatment and clinical trials for patients with SCAP to reduce associated morbidity and mortality.	[Muro, Restituta Phabian; Masoza, Tulla Sylvester; Kayange, Neema] Bugando Med Ctr, Dept Pediat & Child Hlth, Mwanza, Tanzania; [Masoza, Tulla Sylvester; Kayange, Neema] Catholic Univ Hlth & Allied Sci Bugando, Dept Pediat & Child Hlth, Mwanza, Tanzania; [Kasanga, Godfrey] Bugando Med Ctr, Dept Radiol, Mwanza, Tanzania; [Kidenya, Benson R.] Catholic Univ Hlth & Allied Sci Bugando, Dept Biochem & Mol Biol, Mwanza, Tanzania		Masoza, TS (corresponding author), Bugando Med Ctr, Dept Pediat & Child Hlth, Mwanza, Tanzania.; Masoza, TS (corresponding author), Catholic Univ Hlth & Allied Sci Bugando, Dept Pediat & Child Hlth, Mwanza, Tanzania.	sylvestertullah@gmail.com						Addo-Yobo E, 2004, LANCET, V364, P1141, DOI 10.1016/S0140-6736(04)17100-6; Daw Mohamed A, 2017, BMC Res Notes, V10, P170, DOI [10.1186/s13104-017-2389-z, 10.1186/s13104-017-2491-2]; [Anonymous], 2013, WHO POCKET BOOK HOSP, P80; [Anonymous], 2006, PEDIATRICS, V118, pe934; Bahwere P, 2004, PEDIATR INFECT DIS J, V23, P739, DOI 10.1097/01.inf.0000135663.17018.51; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Chisti MJ, 2010, PEDIATR INFECT DIS J, V29, P174, DOI 10.1097/INF.0b013e3181b9a4d5; Chisti MJ, 2009, TROP MED INT HEALTH, V14, P1173, DOI 10.1111/j.1365-3156.2009.02364.x; Craig A, 2009, INFECT IMMUN, V77, P568, DOI 10.1128/IAI.00832-08; D'Acremont V, 2014, NEW ENGL J MED, V370, P809, DOI 10.1056/NEJMoa1214482; Forsberg P, 2012, PNEUMONIA HOSPITALIZ, P1; Gray D, 2009, EXPERT REV ANTI-INFE, V7, P437, DOI [10.1586/eri.09.14, 10.1586/ERI.09.14]; Jain DL, 2013, INDIAN PEDIATR, V50, P787; Jeena P, 2006, FAILURE STANDARD ANT, V015222, P269, DOI [10.2471/blt.04.015222, DOI 10.2471/BLT.04.015222]; Korppi Matti, 2003, Paediatr Drugs, V5, P821, DOI 10.2165/00148581-200305120-00005; Light R B, 1999, Semin Respir Infect, V14, P218; Marchisio P, 2002, CLIN INFECT DIS, V35, P168, DOI 10.1086/341028; McNally LM, 2007, LANCET, V369, P1440, DOI 10.1016/S0140-6736(07)60670-9; Rudan I, 2011, WHO GLOBAL ESTIMATE, P6163; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Tiewsoh K, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-15; Webb C, 2012, PEDIATR INFECT DIS J, V31, pE152, DOI 10.1097/INF.0b013e3182638012; WHO, 1990, AC RESP INF CHILDR C; Wilber ST, 2010, ACAD EMERG MED, V17, P649, DOI 10.1111/j.1553-2712.2010.00773.x	24	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243636	10.1371/journal.pone.0243636	http://dx.doi.org/10.1371/journal.pone.0243636			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306722	Green Published, gold			2022-12-27	WOS:000600144200025
J	Gunther, J; Reichensdorfer, E; Pilarski, PM; Diepold, K				Gunther, Johannes; Reichensdoerfer, Elias; Pilarski, Patrick M.; Diepold, Klaus			Interpretable PID parameter tuning for control engineering using general dynamic neural networks: An extensive comparison	PLOS ONE			English	Article							DESIGN; SYSTEM; STABILIZATION; FEEDBACK	Modern automation systems largely rely on closed loop control, wherein a controller interacts with a controlled process via actions, based on observations. These systems are increasingly complex, yet most deployed controllers are linear Proportional-Integral-Derivative (PID) controllers. PID controllers perform well on linear and near-linear systems but their simplicity is at odds with the robustness required to reliably control complex processes. Modern machine learning techniques offer a way to extend PID controllers beyond their linear control capabilities by using neural networks. However, such an extension comes at the cost of losing stability guarantees and controller interpretability. In this paper, we examine the utility of extending PID controllers with recurrent neural networks--namely, General Dynamic Neural Networks (GDNN); we show that GDNN (neural) PID controllers perform well on a range of complex control systems and highlight how they can be a scalable and interpretable option for modern control systems. To do so, we provide an extensive study using four benchmark systems that represent the most common control engineering benchmarks. All control environments are evaluated with and without noise as well as with and without disturbances. The neural PID controller performs better than standard PID control in 15 of 16 tasks and better than model-based control in 13 of 16 tasks. As a second contribution, we address the lack of interpretability that prevents neural networks from being used in real-world control processes. We use bounded-input bounded-output stability analysis to evaluate the parameters suggested by the neural network, making them understandable for engineers. This combination of rigorous evaluation paired with better interpretability is an important step towards the acceptance of neural-network-based control approaches for real-world systems. It is furthermore an important step towards interpretable and safely applied artificial intelligence.	[Gunther, Johannes; Pilarski, Patrick M.] Univ Alberta, Dept Comp Sci, Edmonton, AB, Canada; [Gunther, Johannes; Pilarski, Patrick M.] Alberta Machine Intelligence Inst, Edmonton, AB, Canada; [Reichensdoerfer, Elias; Diepold, Klaus] Tech Univ Munich, Dept Elect & Comp Engn, Munich, Bavaria, Germany	University of Alberta; Technical University of Munich	Gunther, J (corresponding author), Univ Alberta, Dept Comp Sci, Edmonton, AB, Canada.; Gunther, J (corresponding author), Alberta Machine Intelligence Inst, Edmonton, AB, Canada.	gunther@ualberta.ca						Ang KH, 2005, IEEE T CONTR SYST T, V13, P559, DOI 10.1109/TCST.2005.847331; Astrom KJ, 2000, EUR J CONTROL, V6, P2, DOI 10.1016/S0947-3580(00)70906-X; Bergstra J, 2013, JMLR; Berkenkamp Felix, 2017, ADV NEURAL INFORM PR, P908; Boskovic DM, 2000, IEEE DECIS CONTR P, P4777, DOI 10.1109/CDC.2001.914683; Chen X, 2012, INT C MANAGE SCI ENG, P194, DOI 10.1109/ICMSE.2012.6414182; CREVELING HF, 1975, J FLUID MECH, V67, P65, DOI 10.1017/S0022112075000171; De Jesus O, 2007, IEEE T NEURAL NETWOR, V18, P14, DOI 10.1109/TNN.2006.882371; Rubio JD, 2018, APPL SOFT COMPUT, V68, P821, DOI 10.1016/j.asoc.2017.04.056; Rubio JD, 2017, NEUROCOMPUTING, V227, P113, DOI 10.1016/j.neucom.2016.09.101; Deflorian M., 2011, IFAC P VOL, V44, P13179, DOI [10.3182/20110828-6-it-1002.01502, DOI 10.3182/20110828-6-IT-1002.01502]; ElMaraghy W, 2012, CIRP ANN-MANUF TECHN, V61, P793, DOI 10.1016/j.cirp.2012.05.001; Glasmachers T., 2017, P MACHINE LEARNING R, V77, P17; Gunther J, 2018, THESIS; Jaleel JA, 2013, 2013 INTERNATIONAL CONFERENCE ON CONTROL COMMUNICATION AND COMPUTING (ICCC), P204, DOI 10.1109/ICCC.2013.6731651; Kalman B. L., 1992, IJCNN International Joint Conference on Neural Networks (Cat. No.92CH3114-6), P578, DOI 10.1109/IJCNN.1992.227257; Kim S, 2017, IEEE-ASME T MECH, V22, P2803, DOI 10.1109/TMECH.2017.2767085; Klatt KU, 2009, COMPUT CHEM ENG, V33, P536, DOI 10.1016/j.compchemeng.2008.09.002; Kui Zhang, 2010, 2010 2nd International Conference on Intelligent Human-Machine Systems and Cybernetics (IHMSC 2010), P95, DOI 10.1109/IHMSC.2010.123; Leveson N., 2003, SYSTEMS THEORETIC AP, P16; Liang H, 2020, IEEE T FUZZY SYSTEMS; Liu L, 2020, IEEE-CAA J AUTOMATIC, V7, P1335, DOI 10.1109/JAS.2020.1003213; Majstorovic M, 2008, NEUREL 2008: NINTH SYMPOSIUM ON NEURAL NETWORK APPLICATIONS IN ELECTRICAL ENGINEERING, PROCEEDINGS, P203; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; Mascolo S, 1999, INT J BIFURCAT CHAOS, V9, P1425, DOI 10.1142/S0218127499000973; Pan HH, 2005, CONTROL ENG PRACT, V13, P27, DOI 10.1016/j.conengprac.2003.12.019; Parmas P, 2018, PR MACH LEARN RES, V80; Pirabakaran K., 2002, IFAC P, V35, P451; Rumelhart DE., 1995, BACKPROPAGATION THEO, P1, DOI DOI 10.5555/201784.201785; Sandner C, 2017, TECHNICAL REPORT; Smith O. J., 1957, CHEMICAL ENGINEERING, V53, P217; Stojic MR, 2001, IEEE T AUTOMAT CONTR, V46, P1293, DOI 10.1109/9.940937; Takagi T, 2014, INT C ADV MECH SYST, P254, DOI 10.1109/ICAMechS.2014.6911660; Tavakoli S., 2003, P 2003 4 INT C CONTR, P942, DOI DOI 10.1109/ICCA.2003.1595161; Vazquez R, 2006, SYST CONTROL LETT, V55, P624, DOI 10.1016/j.sysconle.2005.09.019; Vazquez R, 2010, IEEE T CONTR SYST T, V18, P789, DOI 10.1109/TCST.2009.2028549; Wang CY, 2013, CHIN CONT DECIS CONF, P3259; Wang JJ, 2011, SIMUL MODEL PRACT TH, V19, P440, DOI 10.1016/j.simpat.2010.08.003; WANG YZ, 1992, J FLUID MECH, V237, P479, DOI 10.1017/S0022112092003501; Wuest T, 2016, PROD MANUF RES, V4, P23, DOI 10.1080/21693277.2016.1192517; Yang Z, 2019, ARXIV190103838; Yu A. W., 2014, P ADV NEUR INF PROC, P1350; Zhang MG, 2006, PROCEEDINGS OF 2006 INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND CYBERNETICS, VOLS 1-7, P3016	44	3	3	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243320	10.1371/journal.pone.0243320	http://dx.doi.org/10.1371/journal.pone.0243320			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301494	Green Published, Green Submitted, gold			2022-12-27	WOS:000600143100065
J	Kinney, MV; Ajayi, G; de Graft-Johnson, J; Hill, K; Khadka, N; Om'Iniabohs, A; Mukora-Mutseyekwa, F; Tayebwa, E; Shittu, O; Lipingu, C; Kerber, K; Nyakina, JD; Ibekwe, PC; Sayinzoga, F; Madzima, B; George, AS; Thapa, K				Kinney, Mary V.; Ajayi, Gbaike; de Graft-Johnson, Joseph; Hill, Kathleen; Khadka, Neena; Om'Iniabohs, Alyssa; Mukora-Mutseyekwa, Fadzai; Tayebwa, Edwin; Shittu, Oladapo; Lipingu, Chrisostom; Kerber, Kate; Nyakina, Juma Daimon; Ibekwe, Perpetus Chudi; Sayinzoga, Felix; Madzima, Bernard; George, Asha S.; Thapa, Kusum			"It might be a statistic to me, but every death matters.": An assessment of facility-level maternal and perinatal death surveillance and response systems in four sub-Saharan African countries	PLOS ONE			English	Article							OBSTETRIC AUDIT; SCALING-UP; REVIEWS; ACCOUNTABILITY; LESSONS; IMPLEMENTATION; EXPERIENCES; PROGRESS	Background Maternal and perinatal death surveillance and response (MPDSR) systems aim to understand and address key contributors to maternal and perinatal deaths to prevent future deaths. From 2016-2017, the US Agency for International Development's Maternal and Child Survival Program conducted an assessment of MPDSR implementation in Nigeria, Rwanda, Tanzania, and Zimbabwe. Methods A cross-sectional, mixed-methods research design was used to assess MPDSR implementation. The study included a desk review, policy mapping, semistructured interviews with 41 subnational stakeholders, observations, and interviews with key informants at 55 purposefully selected facilities. Using a standardised tool with progress markers defined for six stages of implementation, each facility was assigned a score from 0-30. Quantitative and qualitative data were analysed from the 47 facilities with a score above 10 ('evidence of MPDSR practice'). Results The mean calculated MPDSR implementation progress score across 47 facilities was 18.98 out of 30 (range: 11.75-27.38). The team observed variation across the national MPDSR guidelines and tools, and inconsistent implementation of MPDSR at subnational and facility levels. Nearly all facilities had a designated MPDSR coordinator, but varied in their availability and use of standardised forms and the frequency of mortality audit meetings. Few facilities (9%) had mechanisms in place to promote a no-blame environment. Some facilities (44%) could demonstrate evidence that a change occurred due to MPDSR. Factors enabling implementation included clear support from leadership, commitment from staff, and regular occurrence of meetings. Barriers included lack of health worker capacity, limited staff time, and limited staff motivation. Conclusion This study was the first to apply a standardised scoring methodology to assess subnational- and facility-level MPDSR implementation progress. Structures and processes for implementing MPDSR existed in all four countries. Many implementation gaps were identified that can inform priorities and future research for strengthening MPDSR in low-capacity settings.	[Kinney, Mary V.; de Graft-Johnson, Joseph; Khadka, Neena; Om'Iniabohs, Alyssa; Kerber, Kate] Save Children US, Washington, DC 20002 USA; [Kinney, Mary V.; George, Asha S.] Univ Western Cape, Cape Town, South Africa; [Ajayi, Gbaike; de Graft-Johnson, Joseph; Hill, Kathleen; Khadka, Neena; Om'Iniabohs, Alyssa; Thapa, Kusum] US Agcy Int Dev USAID, Maternal & Child Survival Program MCSP, Washington, DC USA; [Ajayi, Gbaike; Hill, Kathleen; Thapa, Kusum] Jhpiego, Baltimore, MD USA; [Mukora-Mutseyekwa, Fadzai] USAID, Maternal & Child Hlth Integrated Program, Harare, Zimbabwe; [Mukora-Mutseyekwa, Fadzai] John Snow Inc, Harare, Zimbabwe; [Tayebwa, Edwin] USAID, MCSP, Kigali, Rwanda; [Tayebwa, Edwin] Jhpiego, Kigali, Rwanda; [Shittu, Oladapo] Ahmadu Bello Univ, Zaria, Kaduna State, Nigeria; [Lipingu, Chrisostom; Nyakina, Juma Daimon] Bukoba Reg Referral Hosp, Kagera, Tanzania; [Ibekwe, Perpetus Chudi] Maternal & Perinatal Death Surveillance & Respons, Abakaliki, Ebonyi State, Nigeria; [Sayinzoga, Felix] Rwanda Biomed Ctr, Maternal Child & Community Hlth Div, Kigali, Rwanda; [Madzima, Bernard] Minist Hlth & Child Care, Family Hlth Directorate, Harare, Zimbabwe	Save the Children; University of the Western Cape; Jhpiego; United States Agency for International Development (USAID); United States Agency for International Development (USAID); Jhpiego; Ahmadu Bello University; Rwanda Biomedical Center	Kinney, MV (corresponding author), Save Children US, Washington, DC 20002 USA.	mkinney@uwc.ac.za	Kinney, Mary/M-6952-2013	Kinney, Mary/0000-0002-2903-0161; George, Asha/0000-0002-5968-1424	US Agency for International Development (USAID) [AID-OAA-A-14-00028]; South African Research Chair's Initiative of the Department of Science and Technology; National Research Foundation of South Africa [82769]; South African Medical Research Council	US Agency for International Development (USAID)(United States Agency for International Development (USAID)); South African Research Chair's Initiative of the Department of Science and Technology; National Research Foundation of South Africa(National Research Foundation - South Africa); South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was made possible by the generous support of the American people through the US Agency for International Development (USAID) under the terms of the Cooperative Agreement AID-OAA-A-14-00028 (www.usaid.gov). The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government. AG is supported by the South African Research Chair's Initiative of the Department of Science and Technology and National Research Foundation of South Africa (Grant No. 82769) (www.nrf.ac.za/tags/dst), and the South African Medical Research Council (www.mrc.ac.za). Any opinion, finding, and conclusion or recommendation expressed in this material is that of the author, and the National Research Foundation of South Africa does not accept any liability in this regard.	Abebe B, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2016-000199; Agaro C, 2016, BMC WOMENS HEALTH, V16, DOI 10.1186/s12905-016-0315-5; Akachi Y, 2017, B WORLD HEALTH ORGAN, V95, P465, DOI 10.2471/BLT.16.180190; [Anonymous], 2017, LANCET GLOBAL HLTH, V5, pe428; Armstrong CE, 2014, TROP MED INT HEALTH, V19, P1087, DOI 10.1111/tmi.12353; Bakker W, 2011, TROP MED INT HEALTH, V16, P1243, DOI 10.1111/j.1365-3156.2011.02832.x; Bandali S, 2016, INT J GYNECOL OBSTET, V135, P365, DOI 10.1016/j.ijgo.2016.10.002; Bayley O, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007753; Belizan M, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-243; Bergh AM, 2005, ACTA PAEDIATR, V94, P1102, DOI 10.1080/08035250510028380; Bergh AM, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-293; Blencowe H, 2016, LANCET GLOB HEALTH, V4, pE98, DOI 10.1016/S2214-109X(15)00275-2; Chou D, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4255; Commission on Information and Accountability, 2011, KEEP PROM MEAS RES C; Congo B, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0379-1; Dartey AF, 2012, ROLE MIDWIVES IMPLEM; De Brouwere V, 2014, BJOG-INT J OBSTET GY, V121, P71, DOI 10.1111/1471-0528.12902; de Kok B, 2017, HEALTH POLICY PLANN, V32, P1083, DOI 10.1093/heapol/czx012; Every Woman Every Child, 2015, GLOBAL STRATEGY WOME; Evidence 4 Action, 2017, MDSR ACT NETW; Filippi V, 2004, HEALTH POLICY PLANN, V19, P57, DOI 10.1093/heapol/czh007; Healthy Newborn Network, 2018, NEWB NUMB DAT; Hilber AM, 2016, INT J GYNECOL OBSTET, V135, P345, DOI 10.1016/j.ijgo.2016.09.008; Hofman JJ, 2014, INT J GYNECOL OBSTET, V126, P111, DOI [10.1016/j.ijgo.2014.02.014, 10.1016/]; Independent Accountability Panel, 2016, OLD CHALL NEW HOP AC; Kerber KJ, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/1471-2393-15-S2-S9; Kongnyuy E J, 2008, Women Birth, V21, P149, DOI 10.1016/j.wombi.2008.08.002; Kongnyuy Eugene J, 2008, BMC Pregnancy Childbirth, V8, P42, DOI 10.1186/1471-2393-8-42; Kruk ME, 2018, LANCET GLOB HEALTH, V6, pE1196, DOI 10.1016/S2214-109X(18)30386-3; Lawn JE, 2016, LANCET, V387, P587, DOI 10.1016/S0140-6736(15)00837-5; Lewis G, 2014, BJOG-INT J OBSTET GY, V121, P24, DOI 10.1111/1471-0528.12801; Magoma M, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0781-z; Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6; Muffler N, 2007, TROP MED INT HEALTH, V12, P1248, DOI 10.1111/j.1365-3156.2007.01911.x; MUTSIGIRIMUREWANHE, 2017, PAN AFR MED J, V27, DOI DOI 10.11604/PAMJ.2017.27.204.721028904729; Nigeria National Bureau of Statistics, 2019, NAT POP COMM NAT BUR; Nyamtema AS, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-29; Oza S, 2015, B WORLD HEALTH ORGAN, V93, P19, DOI 10.2471/BLT.14.139790; Patrick Habecker, 2017, THESIS U NEBRASKA LI; Purandare C, 2014, INT J GYNECOL OBSTET, V127, pS35, DOI 10.1016/j.ijgo.2014.09.003; Rhoda NR, 2014, BJOG-INT J OBSTET GY, V121, P160, DOI 10.1111/1471-0528.12997; Richard F, 2009, BJOG-INT J OBSTET GY, V116, P38, DOI 10.1111/j.1471-0528.2008.01741.x; Smith H, 2017, GLOB HEALTH-SCI PRAC, V5, P345, DOI 10.9745/GHSP-D-17-00130; Smith H, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1405-6; Tanzania National Bureau of Statistics, 2019, SUBD POP PROJ YEAR 2; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; TUNCALP, 2015, BJOG, V122, P1045, DOI DOI 10.1111/1471-0528.13451; van Hamersveld KT, 2012, TROP MED INT HEALTH, V17, P652, DOI 10.1111/j.1365-3156.2012.02972.x; WHO, 2014, EV NEWB ACT PLAN PRE; WHO, 2019, WORLD HLTH STAT 2019; WHO, 2016, MAK EV BAB COUNT AUD; WHO, 2017, GLOB MON IMPL MAT DE; WHO, 2013, MAT DEATH SURV RESP; WHO, 2016, WHO APPL ICD 10 PER; WHO (World Health Organization), 2015, STRAT END PREV MAT M; World Bank, 2019, PAK NURS MIDW; World Health Organization, 2004, NUMB REV MAT DEATHS; World Health Organization, 2016, TIM RESP REP GLOB IM; World Health Organization, 2012, WHO APPL ICD 10 DEAT; World Health Organization (WHO), 2016, STANDARDS IMPROVING	60	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0243722	10.1371/journal.pone.0243722	http://dx.doi.org/10.1371/journal.pone.0243722			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8CZ	33338039	Green Published, gold			2022-12-27	WOS:000601313500041
J	Zandonadi, FS; Ferreira, SP; Alexandrino, AV; Carnielli, CM; Artier, J; Barcelos, MP; Nicolela, NCS; Prieto, EL; Goto, LS; Belasque, J; Novo-Mansur, MTM				Zandonadi, Flavia S.; Ferreira, Silvia P.; Alexandrino, Andre V.; Carnielli, Carolina M.; Artier, Juliana; Barcelos, Mariana P.; Nicolela, Nicole C. S.; Prieto, Evandro L.; Goto, Leandro S.; Belasque, Jose, Jr.; Marques Novo-Mansur, Maria Teresa			Periplasm-enriched fractions from Xanthomonas citri subsp. citri type A and X. fuscans subsp. aurantifolii type B present distinct proteomic profiles under in vitro pathogenicity induction	PLOS ONE			English	Article							ENTNER-DOUDOROFF PATHWAY; PSEUDOMONAS-AERUGINOSA; MOONLIGHTING PROTEINS; ALPHA-ENOLASE; CAMPESTRIS; SURFACE; REVEALS; IDENTIFICATION; SECRETION; GLUCOSE	The causative agent of Asiatic citrus canker, the Gram-negative bacterium Xanthomonas citri subsp. citri (XAC), produces more severe symptoms and attacks a larger number of citric hosts than Xanthomonas fuscans subsp. aurantifolii XauB and XauC, the causative agents of cancrosis, a milder form of the disease. Here we report a comparative proteomic analysis of periplasmic-enriched fractions of XAC and XauB in XAM-M, a pathogenicity- inducing culture medium, for identification of differential proteins. Proteins were resolved by two-dimensional electrophoresis combined with liquid chromatography-mass spectrometry. Among the 12 proteins identified from the 4 unique spots from XAC in XAM-M (p<0.05) were phosphoglucomutase (PGM), enolase, xylose isomerase (XI), transglycosylase, NAD(P)H-dependent glycerol 3-phosphate dehydrogenase, succinyl-CoA synthetase <beta> subunit, 6-phosphogluconate dehydrogenase, and conserved hypothetical proteins XAC0901 and XAC0223; most of them were not detected as differential for XAC when both bacteria were grown in NB medium, a pathogenicity non-inducing medium. XauB showed a very different profile from XAC in XAM-M, presenting 29 unique spots containing proteins related to a great diversity of metabolic pathways. Preponderant expression of PGM and XI in XAC was validated by Western Blot analysis in the periplasmic-enriched fractions of both bacteria. This work shows remarkable differences between the periplasmic-enriched proteomes of XAC and XauB, bacteria that cause symptoms with distinct degrees of severity during citrus infection. The results suggest that some proteins identified in XAC can have an important role in XAC pathogenicity.	[Zandonadi, Flavia S.; Ferreira, Silvia P.; Alexandrino, Andre V.; Carnielli, Carolina M.; Artier, Juliana; Barcelos, Mariana P.; Nicolela, Nicole C. S.; Prieto, Evandro L.; Goto, Leandro S.; Marques Novo-Mansur, Maria Teresa] Univ Fed Sao Carlos, Dept Genet & Evolucao, Lab Bioquim & Biol Mol Aplicada, UFSCar, Sao Carlos, SP, Brazil; [Belasque, Jose, Jr.] Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Dept Fitopatol & Nematol, USP, Piracicaba, SP, Brazil; [Ferreira, Silvia P.] Univ Estadual Campinas, UNICAMP, Dept Quim Analit, Lab Bioanal & Integracao Omica LaBIOm,Inst Quim, Campinas, SP, Brazil; [Carnielli, Carolina M.; Goto, Leandro S.] CNPEM, LNBio, Lab Nacl Biociencias, Campinas, SP, Brazil; [Artier, Juliana] Univ Colorado, Renewable & Sustainable Energy Inst, Boulder, CO 80309 USA; [Barcelos, Mariana P.; Nicolela, Nicole C. S.] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Ribeirao Preto, SP, Brazil	Universidade Federal de Sao Carlos; Universidade de Sao Paulo; Universidade Estadual de Campinas; University of Colorado System; University of Colorado Boulder; Universidade de Sao Paulo	Novo-Mansur, MTM (corresponding author), Univ Fed Sao Carlos, Dept Genet & Evolucao, Lab Bioquim & Biol Mol Aplicada, UFSCar, Sao Carlos, SP, Brazil.	marinovo@ufscar.br	Artier, Juliana/AHB-7769-2022; Mansur, Maria Teresa Marques Novo/G-4779-2012; Alexandrino, André Vessoni/M-9295-2016; Belasque, Jose/B-7753-2015	Artier, Juliana/0000-0001-5519-6627; Mansur, Maria Teresa Marques Novo/0000-0003-0308-6287; Alexandrino, André Vessoni/0000-0002-0111-3491; S. Zandonadi, Flavia/0000-0002-5166-6019; Belasque, Jose/0000-0001-6059-2173; Moretto Carnielli, Carolina/0000-0001-8336-7390	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); Fundecitrus (Fundo de Defesa da Citricultura, Araraquara-SP); FAPESP [2010/04546-0, 2017/17470-0, 2013/16082-6]; CAPES [1770850]; CAPES (PNPD) [23038.006942/2011-31]; FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil/Young Investigators) [07/509102]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brazil (CAPES) [001]	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundecitrus (Fundo de Defesa da Citricultura, Araraquara-SP); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES (PNPD)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil/Young Investigators)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brazil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	JA, FSZ and CMC received fellowships from CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), Fundecitrus (Fundo de Defesa da Citricultura, Araraquara-SP), and FAPESP (for FSZ, 2010/04546-0). AVA and ELP received CAPES (1770850) and FAPESP (2017/17470-0) fellowships, respectively. SPF and LSG received PosDoc fellowships from FAPESP (2013/16082-6) and CAPES (PNPD, 23038.006942/2011-31), respectively. -Finantial support: FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil/Young Investigators, 07/509102) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brazil (CAPES/ Finance Code 001). - websites of each funder: FAPESP (http://www.fapesp.br/) and CAPES (https://www.capes.gov.br/) - funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agriculture UDo, 2020, CITR WORLD MARK TRAD; Aragao AZB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043521; Artier J, 2018, MOL PLANT PATHOL, V19, P143, DOI 10.1111/mpp.12507; Bahar O, 2014, PEERJ, V2, DOI 10.7717/peerj.242; Barabote RD, 2003, J BACTERIOL, V185, P5772, DOI 10.1128/JB.185.19.5772-5778.2003; Bergmann S, 2003, MOL MICROBIOL, V49, P411, DOI 10.1046/j.1365-2958.2003.03557.x; Beveridge TJ, 1999, J BACTERIOL, V181, P4725, DOI 10.1128/JB.181.16.4725-4733.1999; BJELLQVIST B, 1993, ELECTROPHORESIS, V14, P1357, DOI 10.1002/elps.11501401209; Blanvillain S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000224; Boleij A, 2011, INFECT IMMUN, V79, P4777, DOI 10.1128/IAI.05572-11; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buttner D, 2010, FEMS MICROBIOL REV, V34, P107, DOI 10.1111/j.1574-6976.2009.00192.x; Butler GS, 2009, NAT REV DRUG DISCOV, V8, P935, DOI 10.1038/nrd2945; Cork AJ, 2009, J BIOL CHEM, V284, P17129, DOI 10.1074/jbc.M109.004317; da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a; Daiyasu Hiromi, 2005, Archaea, V1, P399, DOI 10.1155/2005/452563; De Angelis M, 2015, PROTEOMICS, V15, P2244, DOI 10.1002/pmic.201400363; Dejean G, 2013, NEW PHYTOL, V198, P899, DOI 10.1111/nph.12187; Dogan T, 2016, BIOINFORMATICS, V32, P2264, DOI 10.1093/bioinformatics/btw114; Facincani AP, 2014, FUNCT INTEGR GENOMIC, V14, P205, DOI 10.1007/s10142-013-0340-5; Ferreira RM, 2016, PEERJ, V4, DOI 10.7717/peerj.1734; Frankel D, 1987, PENTOSE PHOSPHATE PA; GIANAZZA E, 1985, ELECTROPHORESIS, V6, P53, DOI 10.1002/elps.1150060113; Gil-Bona A, 2018, J PROTEOMICS, V180, P70, DOI 10.1016/j.jprot.2017.12.002; Goto LS, 2016, BBA-PROTEINS PROTEOM, V1864, P1658, DOI 10.1016/j.bbapap.2016.08.014; GOTO M, 1980, Annals of the Phytopathological Society of Japan, V46, P329, DOI 10.3186/jjphytopath.46.329; Hanna SL, 2000, MICROBIOL-UK, V146, P2495, DOI 10.1099/00221287-146-10-2495; Henderson B, 2011, INFECT IMMUN, V79, P3476, DOI 10.1128/IAI.00179-11; Honzatko RB, 1999, ARCH BIOCHEM BIOPHYS, V370, P1, DOI 10.1006/abbi.1999.1383; HU NT, 1995, MICROBIOL-UK, V141, P1395, DOI 10.1099/13500872-141-6-1395; Hung CH, 2002, BIOCHEM BIOPH RES CO, V291, P338, DOI 10.1006/bbrc.2002.6440; Imperi F, 2009, PROTEOMICS, V9, P1901, DOI 10.1002/pmic.200800618; Jeffery C, 2015, BIOPHYS J, V108, p534A, DOI 10.1016/j.bpj.2014.11.2928; Jeffery CJ, 2018, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0523; Joyce MA, 1999, BIOCHEMISTRY-US, V38, P7273, DOI 10.1021/bi990527s; Kapatral V, 2000, J BACTERIOL, V182, P1333, DOI 10.1128/JB.182.5.1333-1339.2000; Kim SY, 2010, BIOTECHNOL LETT, V32, P527, DOI 10.1007/s10529-009-0193-0; KOPLIN R, 1992, J BACTERIOL, V174, P191; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee SW, 2009, SCIENCE, V326, P850, DOI 10.1126/science.1173438; Lu GT, 2007, MICROBIOL-SGM, V153, P4284, DOI 10.1099/mic.0.2007/010538-0; Macek B, 2008, MOL CELL PROTEOMICS, V7, P299, DOI 10.1074/mcp.M700311-MCP200; Mani M, 2015, NUCLEIC ACIDS RES, V43, pD277, DOI 10.1093/nar/gku954; Mercado-Lubo R, 2009, INFECT IMMUN, V77, P1397, DOI 10.1128/IAI.01335-08; Moreira LM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-238; Natale P, 2008, BBA-BIOMEMBRANES, V1778, P1735, DOI 10.1016/j.bbamem.2007.07.015; Nieves W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014361; Paes Leme AF, 2011, J PROTEOME RES, V11, P279, DOI 10.1021/pr2006439; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; Patra T, 2012, J BACTERIOL, V194, P3377, DOI 10.1128/JB.06379-11; Pedras MSC, 2012, MOL PLANT PATHOL, V13, P483, DOI 10.1111/j.1364-3703.2011.00765.x; Peifer S, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-138; Perez-Dorado I, 2012, MOL ORAL MICROBIOL, V27, P221, DOI 10.1111/j.2041-1014.2012.00655.x; Reddy JD, 2007, MOL PLANT MICROBE IN, V20, P403, DOI 10.1094/MPMI-20-4-0403; Ribeiro DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050571; Richarme G, 1998, BIOCHEM BIOPH RES CO, V252, P156, DOI 10.1006/bbrc.1998.9591; Schatschneider S, 2014, MOL BIOSYST, V10, P2663, DOI 10.1039/c4mb00198b; Searle BC, 2010, PROTEOMICS, V10, P1265, DOI 10.1002/pmic.200900437; Sidhu VK, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-87; SIMPSON RJ, 2004, PURIFYING PROTEINS P; SOFIA HJ, 1994, NUCLEIC ACIDS RES, V22, P2576, DOI 10.1093/nar/22.13.2576; Vanden Bergh P, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-44; Wang WF, 2016, MOL BIOSYST, V12, P1420, DOI 10.1039/c5mb00550g; Zimaro T, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-186; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	65	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0243867	10.1371/journal.pone.0243867	http://dx.doi.org/10.1371/journal.pone.0243867			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8CZ	33338036	Green Published, gold			2022-12-27	WOS:000601313500028
J	Burkholder, E; Blackmon, L; Wieman, C				Burkholder, Eric; Blackmon, Lena; Wieman, Carl			What factors impact student performance in introductory physics?	PLOS ONE			English	Article							GAP	In a previous study, we found that students' incoming preparation in physics-crudely measured by concept inventory prescores and math SAT or ACT scores-explains 34% of the variation in Physics 1 final exam scores at Stanford University. In this study, we sought to understand the large variation in exam scores not explained by these measures of incoming preparation. Why are some students' successful in physics 1 independent of their preparation? To answer this question, we interviewed 34 students with particularly low concept inventory prescores and math SAT/ACT scores about their experiences in the course. We unexpectedly found a set of common practices and attitudes. We found that students' use of instructional resources had relatively little impact on course performance, while student characteristics, student attitudes, and students' interactions outside the classroom all had a more substantial impact on course performance. These results offer some guidance as to how instructors might help all students succeed in introductory physics courses.	[Burkholder, Eric; Wieman, Carl] Stanford Univ, Dept Phys, Stanford, CA 94305 USA; [Blackmon, Lena] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Wieman, Carl] Stanford Univ, Grad Sch Educ, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Burkholder, E (corresponding author), Stanford Univ, Dept Phys, Stanford, CA 94305 USA.	eburkhol@stanford.edu		Burkholder, Eric/0000-0001-7420-4290; Wieman, Carl/0000-0003-1449-9319				Astin A. W., 1970, SOCIOL EDUC, V43, P451; Ballen CJ, 2017, CBE-LIFE SCI EDUC, V16, DOI 10.1187/cbe.16-12-0344; Ballen CJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186419; Beichner R. J., 2007, RES BASED REFORM U P, V1, P2; Binning K. R, CHANGING SOCIA UNPUB; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cottrell S., 2001, TEACHING STUDY SKILL; Drummond I., 1999, MANAGING CURRICULUM; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330; Freeman Scott, 2007, CBE Life Sci Educ, V6, P132, DOI 10.1187/cbe.06-09-0194; Gurung R.A.R., 2012, EVIDENCE BASED TEACH, P99, DOI [10.1037/13745-006, DOI 10.1037/13745-006]; Haak DC, 2011, SCIENCE, V332, P1213, DOI 10.1126/science.1204820; Kalender ZY, 2020, PHYS REV PHYS EDUC R, V16, DOI 10.1103/PhysRevPhysEducRes.16.010118; Kolb D. A., 1974, APPL THEORY EXPERIEN; Lorenzo M, 2006, AM J PHYS, V74, P118, DOI 10.1119/1.2162549; Nielsen H. D., 1978, RES HIGH EDUC, V9, P97; Plant EA, 2005, CONTEMP EDUC PSYCHOL, V30, P96, DOI 10.1016/j.cedpsych.2004.06.001; Pollock Steven J., 2020, PHYS REV PHYS EDUC R, V16, P010140; Salehi S., 2020, FRONTIERS EDUCATIO; Salehi S, 2019, PHYS REV PHYS EDUC R, V15, DOI 10.1103/PhysRevPhysEducRes.15.020114; Thornton RK, 1998, AM J PHYS, V66, P338, DOI 10.1119/1.18863; Welsh A., 2010, THESIS; Wingate U, 2006, TEACH HIGH EDUC, V11, P457, DOI 10.1080/13562510600874268; 2013, SURG OBES RELAT DIS, V9	24	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0244146	10.1371/journal.pone.0244146	http://dx.doi.org/10.1371/journal.pone.0244146			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PI8BZ	33332432	Green Published, gold			2022-12-27	WOS:000601310900115
J	Dabirian, Y; Skrekas, C; David, F; Siewers, V				Dabirian, Yasaman; Skrekas, Christos; David, Florian; Siewers, Verena			Does co-expression of Yarrowia lipolytica genes encoding Yas1p, Yas2p and Yas3p make a potential alkane-responsive biosensor in Saccharomyces cerevisiae?	PLOS ONE			English	Article							YEAST; EXPRESSION; INOSITOL; CHOLINE; DESIGN	Alkane-based biofuels are desirable to produce at a commercial scale as these have properties similar to current petroleum-derived transportation fuels. Rationally engineering microorganisms to produce a desirable compound, such as alkanes, is, however, challenging. Metabolic engineers are therefore increasingly implementing evolutionary engineering approaches combined with high-throughput screening tools, including metabolite biosensors, to identify productive cells. Engineering Saccharomyces cerevisiae to produce alkanes could be facilitated by using an alkane-responsive biosensor, which can potentially be developed from the native alkane-sensing system in Yarrowia lipolytica, a well-known alkane-assimilating yeast. This putative alkane-sensing system is, at least, based on three different transcription factors (TFs) named Yas1p, Yas2p and Yas3p. Although this system is not fully elucidated in Y. lipolytica, we were interested in evaluating the possibility of translating this system into an alkane-responsive biosensor in S. cerevisiae. We evaluated the alkane-sensing system in S. cerevisiae by developing one sensor based on the native Y. lipolytica ALK1 promoter and one sensor based on the native S. cerevisiae CYC1 promoter. In both systems, we found that the TFs Yas1p, Yas2p and Yas3p do not seem to act in the same way as these have been reported to do in their native host. Additional analysis of the TFs suggests that more knowledge regarding their mechanism is needed before a potential alkane-responsive sensor based on the Y. lipolytica system can be established in S. cerevisiae.	[Dabirian, Yasaman; Skrekas, Christos; David, Florian; Siewers, Verena] Chalmers Univ Technol, Dept Biol & Biol Engn, Gothenburg, Sweden; [Dabirian, Yasaman; David, Florian; Siewers, Verena] Chalmers Univ Technol, Novo Nordisk Fdn Ctr Biosustainabil, Gothenburg, Sweden	Chalmers University of Technology; Chalmers University of Technology; Technical University of Denmark	Dabirian, Y (corresponding author), Chalmers Univ Technol, Dept Biol & Biol Engn, Gothenburg, Sweden.; Dabirian, Y (corresponding author), Chalmers Univ Technol, Novo Nordisk Fdn Ctr Biosustainabil, Gothenburg, Sweden.	dabirian@chalmers.se			Novo Nordisk Foundation [NNF10CC1016517]; AForsk	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); AForsk	V.S; Novo Nordisk Foundation (grant no. NNF10CC1016517) F.D; AForsk funding The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abatemarco J, 2013, BIOTECHNOL J, V8, P1397, DOI 10.1002/biot.201300021; Andre C, 2013, P NATL ACAD SCI USA, V110, P3191, DOI 10.1073/pnas.1218769110; Bredeweg EL, 2017, BIOTECHNOL BIOFUELS, V10, DOI [10.1186/s13068-017-0731-2, 10.1186/s13068-016-0687-7]; Buijs NA, 2015, BIOTECHNOL BIOENG, V112, P1275, DOI 10.1002/bit.25522; Buijs NA, 2013, CURR OPIN CHEM BIOL, V17, P480, DOI 10.1016/j.cbpa.2013.03.036; Casini A, 2015, NAT REV MOL CELL BIO, V16, P568, DOI 10.1038/nrm4014; Chen XY, 2013, ADV DRUG DELIVER REV, V65, P1357, DOI 10.1016/j.addr.2012.09.039; Chen X, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov061; Dabirian Y, 2019, ACS SYNTH BIOL, V8, P1968, DOI 10.1021/acssynbio.9b00144; Dabirian Y, 2019, ACS SYNTH BIOL, V8, P1788, DOI 10.1021/acssynbio.9b00118; David F, 2016, ACS SYNTH BIOL, V5, P224, DOI 10.1021/acssynbio.5b00161; De Paepe B, 2017, J IND MICROBIOL BIOT, V44, P623, DOI 10.1007/s10295-016-1862-3; Endoh-Yamagami S, 2007, EUKARYOT CELL, V6, P734, DOI 10.1128/EC.00412-06; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Hirakawa K, 2009, J BIOL CHEM, V284, P7126, DOI 10.1074/jbc.M806864200; Hoppen J, 2005, YEAST, V22, P601, DOI 10.1002/yea.1209; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hubmann G, 2014, METHODS MOL BIOL, V1152, P17, DOI 10.1007/978-1-4939-0563-8_2; Kerkhoven EJ, 2017, MBIO, V8, DOI 10.1128/mBio.00857-17; Kobayashi S, 2015, YEAST, V32, P691, DOI 10.1002/yea.3096; Lim HG, 2018, CURR OPIN BIOTECH, V54, P18, DOI 10.1016/j.copbio.2018.01.011; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Nielsen J, 2016, CELL, V164, P1185, DOI 10.1016/j.cell.2016.02.004; Packer MS, 2015, NAT REV GENET, V16, P379, DOI 10.1038/nrg3927; Rogers JK, 2016, CURR OPIN BIOTECH, V42, P84, DOI 10.1016/j.copbio.2016.03.005; Santiago TC, 2003, J BIOL CHEM, V278, P38723, DOI 10.1074/jbc.M303008200; SCHWANK S, 1995, NUCLEIC ACIDS RES, V23, P230, DOI 10.1093/nar/23.2.230; Skjoedt ML, 2016, NAT CHEM BIOL, V12, P951, DOI [10.1038/NCHEMBIO.2177, 10.1038/nchembio.2177]; Sumita T, 2002, BIOCHEM BIOPH RES CO, V294, P1071, DOI 10.1016/S0006-291X(02)00607-1; Tao Yu, 2019, Current Opinion in Systems Biology, V15, P30, DOI 10.1016/j.coisb.2019.03.004; van Dijken JP, 2000, ENZYME MICROB TECH, V26, P706, DOI 10.1016/S0141-0229(00)00162-9; Wu W, 2015, SCI REP-UK, V5, DOI 10.1038/srep10907; Yamagami S, 2004, J BIOL CHEM, V279, P22183, DOI 10.1074/jbc.M313313200; Zhou YJ, 2018, NAT ENERGY, V3, P925, DOI 10.1038/s41560-018-0197-x; Zhou YJ, 2016, J AM CHEM SOC, V138, P15368, DOI 10.1021/jacs.6b07394	36	0	0	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0239882	10.1371/journal.pone.0239882	http://dx.doi.org/10.1371/journal.pone.0239882			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332385	Green Submitted, gold, Green Published			2022-12-27	WOS:000601310900079
J	Khan, A; Nawaz, U; Ulhaq, A; Robinson, RW				Khan, Asim; Nawaz, Umair; Ulhaq, Anwaar; Robinson, Randall W.			Real-time plant health assessment via implementing cloud-based scalable transfer learning on AWS DeepLens	PLOS ONE			English	Article							IMAGE; REGISTRATION	The control of plant leaf diseases is crucial as it affects the quality and production of plant species with an effect on the economy of any country. Automated identification and classification of plant leaf diseases is, therefore, essential for the reduction of economic losses and the conservation of specific species. Various Machine Learning (ML) models have previously been proposed to detect and identify plant leaf disease; however, they lack usability due to hardware sophistication, limited scalability and realistic use inefficiency. By implementing automatic detection and classification of leaf diseases in fruit trees (apple, grape, peach and strawberry) and vegetable plants (potato and tomato) through scalable transfer learning on Amazon Web Services (AWS) SageMaker and importing it into AWS DeepLens for real-time functional usability, our proposed DeepLens Classification and Detection Model (DCDM) addresses such limitations. Scalability and ubiquitous access to our approach is provided by cloud integration. Our experiments on an extensive image data set of healthy and unhealthy fruit trees and vegetable plant leaves showed 98.78% accuracy with a real-time diagnosis of diseases of plant leaves. To train DCDM deep learning model, we used forty thousand images and then evaluated it on ten thousand images. It takes an average of 0.349s to test an image for disease diagnosis and classification using AWS DeepLens, providing the consumer with disease information in less than a second.	[Khan, Asim; Ulhaq, Anwaar; Robinson, Randall W.] Victoria Univ, Coll Engn & Sci, Inst Sustainable Ind & Liveable Cities ISILC, Melbourne, Vic, Australia; [Nawaz, Umair] Namal Inst Mianwali, Dept Elect Engn, Mianwali, Pakistan; [Ulhaq, Anwaar] Charles Sturt Univ, Sch Comp & Math, Port Macquarie, NSW, Australia	Victoria University; Charles Sturt University	Khan, A (corresponding author), Victoria Univ, Coll Engn & Sci, Inst Sustainable Ind & Liveable Cities ISILC, Melbourne, Vic, Australia.	asim.khan@vu.edu.au	Khan, Asim/AAW-4316-2021	Khan, Asim/0000-0003-0543-3350; Ulhaq, Anwaar/0000-0002-5145-7276				Abadi M, 2016, PROCEEDINGS OF OSDI'16: 12TH USENIX SYMPOSIUM ON OPERATING SYSTEMS DESIGN AND IMPLEMENTATION, P265; Alam MN, 2019, 2019 IEEE INTERNATIONAL CONFERENCE ON ENVIRONMENT AND ELECTRICAL ENGINEERING AND 2019 IEEE INDUSTRIAL AND COMMERCIAL POWER SYSTEMS EUROPE (EEEIC / I&CPS EUROPE); Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; AWS, 2018, CREAT PUBL AWS DEEPL; AWS, 2019, AWS DEEPLENS DEV GUI; AWS, 2018, AWS DEEPLENS DEEP LE; AWS, 2019, INV AWS LAMBD FUNCT; Bay H, 2008, COMPUT VIS IMAGE UND, V110, P346, DOI 10.1016/j.cviu.2007.09.014; Belli G, 2010, J PLANT PATHOL, V92, P303; Boulent J, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00941; Butt C, 2020, APPL INTELL, DOI 10.1007/s10489-020-01714-3; Cruz A, 2019, COMPUT ELECTRON AGR, V157, P63, DOI 10.1016/j.compag.2018.12.028; Dai J., 2016, NIPS, P379; DALAL N, 2005, PROC CVPR IEEE, P886, DOI DOI 10.1109/CVPR.2005.177; Dubey SR, 2012, 2012 THIRD INTERNATIONAL CONFERENCE ON COMPUTER AND COMMUNICATION TECHNOLOGY (ICCCT), P346, DOI 10.1109/ICCCT.2012.76; Eicher S, 2019, J CHINESE HIST, V3, P1, DOI 10.1017/jch.2017.39; Feng RT, 2019, ISPRS J PHOTOGRAMM, V151, P15, DOI 10.1016/j.isprsjprs.2019.03.002; Ferentinos KP, 2018, COMPUT ELECTRON AGR, V145, P311, DOI 10.1016/j.compag.2018.01.009; Galkin M, 2019, HYGIENE MONITORING S; Girshick R, 2015, IEEE I CONF COMP VIS, P1440, DOI 10.1109/ICCV.2015.169; He KM, 2015, IEEE I CONF COMP VIS, P1026, DOI 10.1109/ICCV.2015.123; HE KM, 2016, PROC CVPR IEEE, P770, DOI DOI 10.1109/CVPR.2016.90; Hearst MA, 1998, IEEE INTELL SYST APP, V13, P18, DOI 10.1109/5254.708428; Huang G., 2018, ARXIV160806993, V5, P1, DOI DOI 10.3969/J.ISSN.1673-4254.2018.06.04; Iandola FN., 2016, ARXIV; Islam M., 2017, 2017 IEEE 30 CANADIA, P1, DOI [10.1109/CCECE.2017.7946594, DOI 10.1109/CCECE.2017.7946594]; Jaworek-Korjakowska J, 2019, P IEEE CVF C COMP VI; Ji M, 2019, INFORM PROCESSING AG; Joshi A.V, 2020, MACHINE LEARNING ART, V64, DOI [10.1007/978-3-030-26622-6, DOI 10.1007/978-3-030-26622-6]; Khan MI, 2019, CONTRIB MANAG SCI, P269, DOI 10.1007/978-3-030-11766-5_9; Khan S, 2019, PATTERN RECOGN LETT, V125, P1, DOI 10.1016/j.patrec.2019.03.022; Kleinberg R., 2018, ARXIV180206175; Krizhevsky A., P 25 INT C NEUR INF, P1097; LeCun Y, 1989, NEURAL COMPUT, V1, P541, DOI 10.1162/neco.1989.1.4.541; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; Liu TR, 2020, INT CONF ACOUST SPEE, P3867, DOI 10.1109/ICASSP40776.2020.9054437; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Michie D., 1994, MACHINE LEARNING NEU; Mohanty SP, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01419; OShea K., 2015, INT J COMPUTER VISIO, P2; Park H, 2017, I C INF COMM TECH CO, P129; Redmon J., 2013, DARKNET OPEN SOURCE; Ruder S., 2016, ARXIV; Saleem MH, 2019, PLANTS-BASEL, V8, DOI 10.3390/plants8110468; Sharif M, 2018, COMPUT ELECTRON AGR, V150, P220, DOI 10.1016/j.compag.2018.04.023; Shorten C, 2019, J BIG DATA-GER, V6, DOI 10.1186/s40537-019-0197-0; Sladojevic S, 2016, COMPUT INTEL NEUROSC, V2016, DOI 10.1155/2016/3289801; Sorguc A., 2018, P INT S AUT ROB CONS, V35, P1, DOI DOI 10.22260/ISARC2018/0094; Sun Y, 2019, POSTHARVEST BIOL TEC, V151, P68, DOI 10.1016/j.postharvbio.2019.01.011; Tan CQ, 2018, LECT NOTES COMPUT SC, V11141, P270, DOI 10.1007/978-3-030-01424-7_27; Tumen V, 2017, 2017 INTERNATIONAL ARTIFICIAL INTELLIGENCE AND DATA PROCESSING SYMPOSIUM (IDAP); UniofGeorgia, 2019, 2017 GEORG PLANT DIS; Wei Liu, 2016, Computer Vision - ECCV 2016. 14th European Conference. Proceedings: LNCS 9905, P21, DOI 10.1007/978-3-319-46448-0_2; Xie GT, 2019, PATTERN RECOGN, V91, P391, DOI 10.1016/j.patcog.2019.01.044; Xie X, 2020, FRONT PLANT SCI, V11, DOI [10.3389/fpls.2020.00751, DOI 10.3389/FPLS.2020.007513]; Zeiler MD, 2014, LECT NOTES COMPUT SC, V8689, P818, DOI 10.1007/978-3-319-10590-1_53; Zhang SW, 2019, COGN SYST RES, V53, P31, DOI 10.1016/j.cogsys.2018.04.006; Zhao JL, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9080936; Zitova B, 2003, IMAGE VISION COMPUT, V21, P977, DOI 10.1016/S0262-8856(03)00137-9	62	11	11	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243243	10.1371/journal.pone.0243243	http://dx.doi.org/10.1371/journal.pone.0243243			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	33332376	Green Submitted, Green Published, gold			2022-12-27	WOS:000601310900045
J	Kaushal, S; Rajput, AS; Bhattacharya, S; Vidyasagar, M; Kumar, A; Prakash, MK; Ansumali, S				Kaushal, Shaurya; Rajput, Abhineet Singh; Bhattacharya, Soumyadeep; Vidyasagar, M.; Kumar, Aloke; Prakash, Meher K.; Ansumali, Santosh			Estimating the herd immunity threshold by accounting for the hidden asymptomatics using a COVID-19 specific model	PLOS ONE			English	Article								A quantitative COVID-19 model that incorporates hidden asymptomatic patients is developed, and an analytic solution in parametric form is given. The model incorporates the impact of lock-down and resulting spatial migration of population due to announcement of lock-down. A method is presented for estimating the model parameters from real-world data, and it is shown that the various phases in the observed epidemiological data are captured well. It is shown that increase of infections slows down and herd immunity is achieved when active symptomatic patients are 10-25% of the population for the four countries we studied. Finally, a method for estimating the number of asymptomatic patients, who have been the key hidden link in the spread of the infections, is presented.	[Kaushal, Shaurya; Prakash, Meher K.; Ansumali, Santosh] Jawaharlal Nehru Ctr Adv Sci Res, Bangalore, Karnataka, India; [Rajput, Abhineet Singh; Kumar, Aloke] Indian Inst Sci, Bengaluru, India; [Bhattacharya, Soumyadeep; Ansumali, Santosh] Sankhya Sutra Labs, Manyata Embassy Business Pk, Bengaluru, Karnataka, India; [Vidyasagar, M.] Indian Inst Technol Hyderabad, Kandi, India; [Prakash, Meher K.] Bangalore Bioinnovat Ctr, VNIR Biotechnol Pvt Ltd, Helix Biotech Pk,Elect City Phase 1, Bangalore, Karnataka, India	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Indian Institute of Science (IISC) - Bangalore; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Hyderabad	Prakash, MK (corresponding author), Jawaharlal Nehru Ctr Adv Sci Res, Bangalore, Karnataka, India.; Prakash, MK (corresponding author), Bangalore Bioinnovat Ctr, VNIR Biotechnol Pvt Ltd, Helix Biotech Pk,Elect City Phase 1, Bangalore, Karnataka, India.	meher@jncasr.ac.in	Ansumali, Santosh/A-7602-2010	Ansumali, Santosh/0000-0002-6938-233X; Kaushal, Shaurya/0000-0002-0488-2413; Prakash, Meher/0000-0002-0091-4158; Kumar, Aloke/0000-0002-7797-8336	Science and Engineering Research Board (SERB)	Science and Engineering Research Board (SERB)	Sankhya Sutra Labs provided support for the study in the form of salaries for authors [SB and SA]. The specific roles of these authors are articulated in the 'author contributions' section. Science and Engineering Research Board (SERB) provided additional funding to MV. No additional funding was received for this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam D, 2020, NATURE, V580, P316, DOI 10.1038/d41586-020-01003-6; [Anonymous], 2017, BR J ANAESTH, V119, pe31; [Anonymous], 2020, LANCET MICROBE, V1, pe99, DOI 10.1016/S2666-5247(20)30054-9; Ansumali S, 2020, MINIMAL ADAPTIVE PRE; Bendavid E, 2020, COVID 19 ANTIBODY SE, DOI 10.1101/2020.04.14.20062463v2; Carvalho AM, 2016, ARXIV160909313; Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; COVID I., 2020, FORECASTING COVID 19; Enserink M, 2020, SCI MAGAZINE; Ferguson, 2020, IMPERIAL COLL LONDON, DOI 10.25561/77482; Gao M, 2020, RESP MED, V169, DOI 10.1016/j.rmed.2020.106026; He X, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0869-5; Inaba H, 2017, AGE STRUCTURED POPUL, P287; Kermack W. O., 1991, CONTRIBUTIONS MATH T; Kwok KO, 2020, J INFECTION, V80, pE32, DOI 10.1016/j.jinf.2020.03.027; Li J, 2019, PHYSICA A, V516, P423, DOI 10.1016/j.physa.2018.10.042; Li RY, 2020, SCIENCE, V368, P489, DOI [10.1126/science.abb3221, 10.1101/2020.02.14.20023127]; Nishiura H, 2020, ESTIMATION ASYMPTOMA; Prakash M.K., 2020, QUANTITATIVE COVID 1; Randolph HE, 2020, IMMUNITY, V52, P737, DOI 10.1016/j.immuni.2020.04.012; Robinson M, 2013, MATH BIOSCI, V243, P163, DOI 10.1016/j.mbs.2013.03.003; Rock K, 2014, REP PROG PHYS, V77, DOI 10.1088/0034-4885/77/2/026602; Singh R., 2020, AGE STRUCTURED IMPAC; Vallance SP, CORONAVIRUS SCI CHIE; Wu XD, 2020, J MED VIROL, V92, P1795, DOI 10.1002/jmv.25904	25	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0242132	10.1371/journal.pone.0242132	http://dx.doi.org/10.1371/journal.pone.0242132			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326421	gold, Green Published, Green Accepted			2022-12-27	WOS:000600176400022
J	Tan, SY; Tey, HL; Lim, ETH; Toh, ST; Chan, YH; Tan, PT; Lee, SA; Tan, CX; Koh, GCH; Tan, TY; Siau, C				Tan, Seow Yen; Tey, Hong Liang; Lim, Ernest Tian Hong; Toh, Song Tar; Chan, Yiong Huak; Tan, Pei Ting; Lee, Sing Ai; Tan, Cheryl Xiaotong; Koh, Gerald Choon Huat; Tan, Thean Yen; Siau, Chuin			The accuracy of healthcare worker versus self collected (2-in-1) Oropharyngeal and Bilateral Mid-Turbinate (OPMT) swabs and saliva samples for SARS-CoV-2	PLOS ONE			English	Article								Background Self-sampling for SARS-CoV-2 would significantly raise testing capacity and reduce healthcare worker (HCW) exposure to infectious droplets personal, and protective equipment (PPE) use. Methods We conducted a diagnostic accuracy study where subjects with a confirmed diagnosis of COVID-19 (n = 401) and healthy volunteers (n = 100) were asked to self-swab from their oropharynx and mid-turbinate (OPMT), and self-collect saliva. The results of these samples were compared to an OPMT performed by a HCW in the same patient at the same session. Results In subjects confirmed to have COVID-19, the sensitivities of the HCW-swab, self-swab, saliva, and combined self-swab plus saliva samples were 82.8%, 75.1%, 74.3% and 86.5% respectively. All samples obtained from healthy volunteers were tested negative. Compared to HCW-swab, the sensitivities of a self-swab sample and saliva sample were inferior by 8.7% (95%CI: 2.4% to 15.0%, p = 0.006) and 9.5% (95%CI: 3.1% to 15.8%, p = 0.003) respectively. The combined detection rate of self-swab and saliva had a sensitivity of 2.7% (95%CI: -2.6% to 8.0%, p = 0.321). The sensitivity of both the self-collection methods are higher when the Ct value of the HCW swab is less than 30. The specificity of both the self-swab and saliva testing was 100% (95% CI 96.4% to 100%). Conclusion Our study provides evidence that sensitivities of self-collected OPMT swab and saliva samples were inferior to a HCW swab, but they could still be useful testing tools in the appropriate clinical settings.	[Tan, Seow Yen] Changi Gen Hosp, Dept Infect Dis, Singapore, Singapore; [Tey, Hong Liang] Natl Skin Ctr, Dept Dermatol, Singapore, Singapore; [Lim, Ernest Tian Hong] Woodlands Hlth Campus, Emergency Dept, Singapore, Singapore; [Toh, Song Tar] Singapore Gen Hosp, Dept Otorhinolaryngol Head & Neck Surg, Singapore, Singapore; [Chan, Yiong Huak] Yong Loo Lin Sch Med, Biostat Unit, Singapore, Singapore; [Tan, Pei Ting] Changi Gen Hosp, Clin Trials & Res Unit, Singapore, Singapore; [Lee, Sing Ai] Sheares Healthcare Grp Pte Ltd, Singapore, Singapore; [Tan, Cheryl Xiaotong] Temasek Int Pte Ltd, Singapore, Singapore; [Koh, Gerald Choon Huat] MOH Off Healthcare Transformat, Singapore, Singapore; [Tan, Thean Yen] Changi Gen Hosp, Dept Lab Med, Singapore, Singapore; [Siau, Chuin] Changi Gen Hosp, Dept Resp & Crit Care Med, Singapore, Singapore	Changi General Hospital; National Skin Centre; Singapore General Hospital; National University of Singapore; Changi General Hospital; Changi General Hospital; Changi General Hospital	Tan, SY (corresponding author), Changi Gen Hosp, Dept Infect Dis, Singapore, Singapore.	tan.seow.yen@singhealth.com.sg	Tey, Hong Liang/GON-9676-2022	Tan, Thean Yen/0000-0003-4358-1098; Tan, Seow Yen/0000-0001-7870-2879	Sheares Healthcare Group Pte Ltd.	Sheares Healthcare Group Pte Ltd.	This study was funded by Sheares Healthcare Group Pte Ltd. The funder provided support in the form of salaries for authors SAL and CXT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section. Besides that, author CXT is employed by Temasek International Pte Ltd, and was acting on behalf of Sheares Healthcare Group Pte Ltd for the study. Temasek International Pte Ltd did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, POS STAT NAT CTR INF; Azzi L, 2020, J INFECTION, V81, pE45, DOI 10.1016/j.jinf.2020.04.005; Czumbel LM, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00465; Iwasaki S, 2020, J INFECTION, V81, pE145, DOI 10.1016/j.jinf.2020.05.071; Jamal A.J., 2020, CLIN INFECT DIS, DOI [10.1101/2020.05.01.20081026., DOI 10.1093/CID/CIAA848]; LeBlanc JJ, 2020, J CLIN VIROL, V128, DOI [DOI 10.1016/J.JCV.2020.104442, 10.1016/j.jcv.2020.104442]; Rao MH, 2021, CLIN INFECT DIS, V72, pE352, DOI 10.1093/cid/ciaa1156; To KKW, 2020, LANCET INFECT DIS, V20, P565, DOI 10.1016/S1473-3099(20)30196-1; To KKW, 2020, CLIN INFECT DIS, V71, P841, DOI 10.1093/cid/ciaa149; Wehrhahn Michael C, 2020, J Clin Virol, V128, P104417, DOI 10.1016/j.jcv.2020.104417; Wyllie AL, 2020, NEW ENGL J MED, V383, P1283, DOI 10.1056/NEJMc2016359; Young BE, 2020, IMMUNOLOGICAL VIRAL, DOI [10.2139/ssrn.3576846, DOI 10.2139/SSRN.3576846]	12	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2020	15	12							e0244417	10.1371/journal.pone.0244417	http://dx.doi.org/10.1371/journal.pone.0244417			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1IW	33326503	Green Published, Green Submitted, gold			2022-12-27	WOS:000600176400031
J	Willemink, MJ; Coolen, BF; Dyvorne, H; Robson, PM; Bander, I; Ishino, S; Pruzan, A; Sridhar, A; Zhang, B; Balchandani, P; Mani, V; Strijkers, GJ; Nederveen, AJ; Leiner, T; Fayad, ZA; Mulder, WJM; Calcagno, C				Willemink, Martin J.; Coolen, Bram F.; Dyvorne, Hadrien; Robson, Philip M.; Bander, Ilda; Ishino, Seigo; Pruzan, Alison; Sridhar, Arthi; Zhang, Bei; Balchandani, Priti; Mani, Venkatesh; Strijkers, Gustav J.; Nederveen, Aart J.; Leiner, Tim; Fayad, Zahi A.; Mulder, Willem J. M.; Calcagno, Claudia			Ultra-high resolution, 3-dimensional magnetic resonance imaging of the atherosclerotic vessel wall at clinical 7T	PLOS ONE			English	Article							CONTRAST-ENHANCED MRI; SPIN-ECHO TSE; CAROTID-ARTERY; NONINVASIVE ASSESSMENT; RABBIT MODEL; VASA VASORUM; PLAQUE; DISEASE; INFLAMMATION; QUANTIFICATION	Accurate quantification and characterization of atherosclerotic plaques with MRI requires high spatial resolution acquisitions with excellent image quality. The intrinsically better signal-to-noise ratio (SNR) at high-field clinical 7T compared to the widely employed lower field strengths of 1.5 and 3T may yield significant improvements to vascular MRI. However, 7T atherosclerosis imaging also presents specific challenges, related to local transmit coils and B1 field inhomogeneities, which may overshadow these theoretical gains. We present the development and evaluation of 3D, black-blood, ultra-high resolution vascular MRI on clinical high-field 7T in comparison lower-field 3T. These protocols were applied for in vivo imaging of atherosclerotic rabbits, which are often used for development, testing, and validation of translatable cardiovascular MR protocols. Eight atherosclerotic New Zealand White rabbits were imaged on clinical 7T and 3T MRI scanners using 3D, isotropic, high (0.6(3) mm(3)) and ultra-high (0.4(3) mm(3)) spatial resolution, black-blood MR sequences with extensive spatial coverage. Following imaging, rabbits were sacrificed for validation using fluorescence imaging and histology. Image quality parameters such as SNR and contrast-to-noise ratio (CNR), as well as morphological and functional plaque measurements (plaque area and permeability) were evaluated at both field strengths. Using the same or comparable imaging parameters, SNR and CNR were in general higher at 7T compared to 3T, with a median (interquartiles) SNR gain of +40.3 (35.3-80.1)%, and a median CNR gain of +68.1 (38.5-95.2)%. Morphological and functional parameters, such as vessel wall area and permeability, were reliably acquired at 7T and correlated significantly with corresponding, widely validated 3T vessel wall MRI measurements. In conclusion, we successfully developed 3D, black-blood, ultra-high spatial resolution vessel wall MRI protocols on a 7T clinical scanner. 7T imaging was in general superior to 3T with respect to image quality, and comparable in terms of plaque area and permeability measurements.	[Willemink, Martin J.; Leiner, Tim] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Willemink, Martin J.] Stanford Univ, Sch Med, Dept Radiol, Stanford, CA 94305 USA; [Coolen, Bram F.; Strijkers, Gustav J.] Univ Amsterdam, Amsterdam UMC, Dept Biomed Engn & Phys, Amsterdam, Netherlands; [Coolen, Bram F.; Nederveen, Aart J.] Univ Amsterdam, Amsterdam UMC, Dept Radiol & Nucl Med, Amsterdam, Netherlands; [Dyvorne, Hadrien; Robson, Philip M.; Bander, Ilda; Ishino, Seigo; Pruzan, Alison; Sridhar, Arthi; Zhang, Bei; Balchandani, Priti; Mani, Venkatesh; Fayad, Zahi A.; Mulder, Willem J. M.; Calcagno, Claudia] Icahn Sch Med Mt Sinai, BioMed Engn & Imaging Inst, New York, NY 10029 USA; [Dyvorne, Hadrien; Robson, Philip M.; Bander, Ilda; Ishino, Seigo; Pruzan, Alison; Sridhar, Arthi; Zhang, Bei; Balchandani, Priti; Mani, Venkatesh; Fayad, Zahi A.; Calcagno, Claudia] Icahn Sch Med Mt Sinai, Dept Radiol, New York, NY 10029 USA; [Mulder, Willem J. M.] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Stanford University; University of Amsterdam; University of Amsterdam; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Amsterdam; Academic Medical Center Amsterdam	Calcagno, C (corresponding author), Icahn Sch Med Mt Sinai, BioMed Engn & Imaging Inst, New York, NY 10029 USA.; Calcagno, C (corresponding author), Icahn Sch Med Mt Sinai, Dept Radiol, New York, NY 10029 USA.	claudia.calcagno@mssm.edu	Mulder, Willem J.M./B-7232-2009; Willemink, Martin/GRX-4798-2022; Mani, Venkatesh/B-8939-2011	Mulder, Willem J.M./0000-0001-8665-3878; Willemink, Martin/0000-0002-6991-6557; Sridhar, Arthi/0000-0002-8139-3322; Mani, Venkatesh/0000-0002-0432-2918; Coolen, Bram/0000-0003-3946-653X; Nederveen, Aart/0000-0002-5477-973X	American Heart Association (AHA) Postdoctoral Fellowship [18POST34030192]; Fulbright Scholarship; Niels Stensen Fellowship; Dutch Research Council (NWO) Veni [14348]; American Heart Association (AHA) [17GRNT33420119]; National Heart Lung and Blood Institute (NHLBI) - National Institutes of Health (NIH) [R01 HL125703, R01 HL071021, R01 HL135878, P01 HL131478]; National Heart Lung and Blood Institute (NHLBI) National Institutes of Health (NIH) [R01 HL128056]; National Institute of Biomedical Imaging and Bioengineering -National Institutes of Health (NIH) [R01 EB009638]; Dutch Research Council (NWO) Vidi; American Heart Association (AHA) Scientist Development Grant [16SDG27250090]	American Heart Association (AHA) Postdoctoral Fellowship(American Heart Association); Fulbright Scholarship; Niels Stensen Fellowship; Dutch Research Council (NWO) Veni; American Heart Association (AHA)(American Heart Association); National Heart Lung and Blood Institute (NHLBI) - National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Heart Lung and Blood Institute (NHLBI) National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Biomedical Imaging and Bioengineering -National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Dutch Research Council (NWO) Vidi; American Heart Association (AHA) Scientist Development Grant(American Heart Association)	This study was funded by the American Heart Association (AHA) Postdoctoral Fellowship 18POST34030192 (M.J.W.), Fulbright Scholarship (M.J.W.), Niels Stensen Fellowship (M.J.W.), Dutch Research Council (NWO) Veni 14348 (B.F. C), American Heart Association (AHA) Grant in Aid 17GRNT33420119 (V.M.), National Heart Lung and Blood Institute (NHLBI) - National Institutes of Health (NIH) R01 HL125703 (W.J.M.M.), National Heart Lung and Blood Institute (NHLBI) - National Institutes of Health (NIH) R01 HL071021 (Z.A.F), National Heart Lung and Blood Institute (NHLBI) National Institutes of Health (NIH) R01 HL128056 (Z.A.F.), National Heart Lung and Blood Institute (NHLBI) - National Institutes of Health (NIH) R01 HL135878 (Z.A.F.), National Institute of Biomedical Imaging and Bioengineering -National Institutes of Health (NIH) R01 EB009638 (Z.A.F.), National Heart Lung and Blood Institute (NHLBI) - National Institutes of Health (NIH) P01 HL131478 (W.J.M. M., Z.A.F.), Dutch Research Council (NWO) Vidi (W.J.M.M.), American Heart Association (AHA) Scientist Development Grant 16SDG27250090 (C. C.). Takeda Pharmaceutical Company Limited provided support in the form of salary for IS; Hyperfine Research Inc. provided support in the form of salary for HD. The specific roles of these authors are articulated in the `author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam SR, 2015, J CARDIOVASC MAGN R, V17, DOI 10.1186/s12968-015-0183-4; Balu N, 2011, MAGN RESON MED, V65, P627, DOI 10.1002/mrm.22642; Brown RW, 2014, MAGNETIC RESONANCE I, DOI 10.1002/9781118633953.ch18; Calcagno C, 2008, ARTERIOSCL THROM VAS, V28, P1311, DOI 10.1161/ATVBAHA.108.166173; Calcagno C, 2018, JACC-CARDIOVASC IMAG, V11, P291, DOI 10.1016/j.jcmg.2017.11.030; Calcagno C, 2015, NMR BIOMED, V28, P1304, DOI 10.1002/nbm.3369; Chen HJ, 2013, QUANT IMAGING MED SU, V3, P298, DOI 10.3978/j.issn.2223-4292.2013.12.01; Chen HJ, 2013, MAGN RESON MED, V69, P1712, DOI 10.1002/mrm.24415; Coolen BF, 2018, MAGN RESON MATER PHY, V31, P201, DOI 10.1007/s10334-017-0644-x; Coolen BF, 2016, MAGN RESON MED, V75, P1008, DOI 10.1002/mrm.25634; Cornily JC, 2008, J MAGN RESON IMAGING, V27, P1406, DOI 10.1002/jmri.21369; Cuadrado I, 2016, EXPERT REV MOL MED, V18, DOI 10.1017/erm.2016.5; Dong L, 2011, RADIOLOGY, V260, P224, DOI 10.1148/radiol.11101264; Dweck MR, 2016, J AM COLL CARDIOL, V68, P2201, DOI 10.1016/j.jacc.2016.08.047; Dweck MR, 2016, CIRC RES, V119, P330, DOI 10.1161/CIRCRESAHA.116.307971; Fan ZY, 2010, J MAGN RESON IMAGING, V31, P645, DOI 10.1002/jmri.22058; Fayad ZA, 2011, LANCET, V378, P1547, DOI 10.1016/S0140-6736(11)61383-4; Harteveld AA, 2018, ATHEROSCLEROSIS, V273, P106, DOI 10.1016/j.atherosclerosis.2018.04.023; Harteveld AA, 2017, STROKE, V48, P2601, DOI 10.1161/STROKEAHA.117.017868; Kerwin W, 2003, CIRCULATION, V107, P851, DOI 10.1161/01.CIR.0000048145.52309.31; Kerwin WS, 2008, MAGN RESON MED, V59, P507, DOI 10.1002/mrm.21532; Kerwin WS, 2006, RADIOLOGY, V241, P459, DOI 10.1148/radiol.2412051336; Kim WY, 2002, CIRCULATION, V106, P296, DOI 10.1161/01.CIR.0000025629.85631.1E; Kim Y, 2014, P NATL ACAD SCI USA, V111, P1078, DOI 10.1073/pnas.1322725111; Kolodgie FD, 2017, SEMIN VASC SURG, V30, P31, DOI 10.1053/j.semvascsurg.2017.04.008; Koning W, 2015, J MAGN RESON IMAGING, V41, P773, DOI 10.1002/jmri.24601; Kraff O, 2017, J MAGN RESON IMAGING, V46, P1573, DOI 10.1002/jmri.25723; Kroner ESJ, 2012, INVEST RADIOL, V47, P697, DOI 10.1097/RLI.0b013e31826dc174; Lobatto ME, 2015, NANOMED-NANOTECHNOL, V11, P1133, DOI 10.1016/j.nano.2015.02.020; Lobatto ME, 2015, ACS NANO, V9, P1837, DOI 10.1021/nn506750r; Lobatto ME, 2012, METHOD ENZYMOL, V508, P211, DOI 10.1016/B978-0-12-391860-4.00011-2; Lobatto ME, 2010, MOL PHARMACEUT, V7, P2020, DOI 10.1021/mp100309y; Mani V, 2009, J CARDIOVASC MAGN R, V11, DOI 10.1186/1532-429X-11-10; McDermott MM, 2017, JACC-CARDIOVASC IMAG, V10, P1003, DOI 10.1016/j.jcmg.2016.08.012; Mihai G, 2012, J MAGN RESON IMAGING, V35, P449, DOI 10.1002/jmri.22839; Millon A, 2014, VASCULAR, V22, P221, DOI 10.1177/1708538113478758; Molony DS, 2019, J BIOMECH ENG-T ASME, V141, DOI 10.1115/1.4041222; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Papini GDE, 2017, J COMPUT ASSIST TOMO, V41, P321, DOI 10.1097/RCT.0000000000000506; Papoutsis K, 2017, MAGN RESON IMAGING, V40, P53, DOI 10.1016/j.mri.2017.04.011; Patel AK, 2016, CURR ATHEROSCLER REP, V18, DOI 10.1007/s11883-016-0635-9; Phinikaridou A, 2010, CIRC-CARDIOVASC IMAG, V3, P323, DOI 10.1161/CIRCIMAGING.109.918524; Phinikaridou A, 2009, J LIPID RES, V50, P787, DOI 10.1194/jlr.M800460-JLR200; Qi HK, 2018, MAGN RESON MED, V80, P2598, DOI 10.1002/mrm.27361; Ripa RS, 2016, PET CLIN, V11, P479, DOI 10.1016/j.cpet.2016.05.009; Senders ML, 2018, METHODS MOL BIOL, V1816, P385, DOI 10.1007/978-1-4939-8597-5_30; SPAGNOLI LG, 1991, ATHEROSCLEROSIS, V89, P11, DOI 10.1016/0021-9150(91)90003-L; Tang TY, 2009, J AM COLL CARDIOL, V53, P2039, DOI 10.1016/j.jacc.2009.03.018; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; Umutlu L, 2013, ACAD RADIOL, V20, P628, DOI 10.1016/j.acra.2012.12.012; van der Valk FM, 2015, NANOMED-NANOTECHNOL, V11, P1039, DOI 10.1016/j.nano.2015.02.021; van Hoof RHM, 2016, CURR ATHEROSCLER REP, V18, DOI 10.1007/s11883-016-0583-4; Vucic E, 2012, JACC-CARDIOVASC IMAG, V5, P819, DOI 10.1016/j.jcmg.2011.11.025; Vucic E, 2011, JACC-CARDIOVASC IMAG, V4, P1100, DOI 10.1016/j.jcmg.2011.04.020; Wang J, 2007, MAGN RESON MED, V58, P973, DOI 10.1002/mrm.21385; Wang YXJ, 2006, CARDIOVASC INTER RAD, V29, P605, DOI 10.1007/s00270-005-0073-5; Xu DX, 2014, JACC-CARDIOVASC IMAG, V7, P366, DOI 10.1016/j.jcmg.2013.09.022	57	2	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0241779	10.1371/journal.pone.0241779	http://dx.doi.org/10.1371/journal.pone.0241779			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315867	Green Published, gold			2022-12-27	WOS:000600186100074
J	Bonfim, AP; Sakita, KM; Faria, DR; Arita, GS; Vendramini, FAVR; Capoci, IRG; Braga, AG; dos Santos, RS; Bruschi, ML; Becker, TCA; de Oliveira, AG; Kioshima, ES; Bonfim-Mendonca, PD; Svidzinski, TIE				Bonfim, Amanda Pohlmann; Sakita, Karina Mayumi; Faria, Daniella Renata; Arita, Glaucia Sayuri; Vilugron Rodrigues Vendramini, Franciele Abigail; Grenier Capoci, Isis Regina; Braga, Andressa Gimenes; dos Santos, Rafaela Said; Bruschi, Marcos Luciano; Alexandrino Becker, Tania Cristina; de Oliveira Junior, Admilton Goncalves; Kioshima, Erika Seki; Bonfim-Mendonca, Patricia de Souza; Estivalet Svidzinski, Terezinha Inez			Preclinical approaches in vulvovaginal candidiasis treatment with mucoadhesive thermoresponsive systems containing propolis	PLOS ONE			English	Article							ALBICANS; PREVALENCE; RESISTANCE; PLATFORMS; EFFICACY; NITRATE	Vulvovaginal candidiasis (VVC) is a common vaginitis that affects women, especially in childbearing age, caused by Candida albicans in almost 80% of cases. Considering the limited drug arsenal available and the increasing fungal resistance profile, the search for new therapeutic sources with low toxicity and easy administration should be supported. Propolis has been used as a traditional medicine for multiple diseases, considering its particular composition and pharmaceutical properties that permits its wide applicability; it has also emerged as a potential antifungal agent. Thus, this study performed an in vitro and in vivo investigation into the efficacy of a new mucoadhesive thermoresponsive platform for propolis delivery (MTS-PRPe) in a preclinical murine model of VVC treatment caused by C. albicans. The methodologies involved chemical analysis, an assessment of the rheological and mucoadhesive properties of propolis formulations, in vitro and in vivo antifungal evaluations, histological evaluations and electron microscopy of the vaginal mucosa. The results demonstrated the antifungal activity of propolis extract and MTS-PRP against the standard strain and a fluconazole-resistant clinical isolate of C. albicans, in both in vitro and in vivo assays. These results were similar and even better, depending on the propolis concentration, when compared to nystatin. Thus, the formulation containing propolis exhibited good performance against C. albicans in a vulvovaginal candidiasis experimental model, representing a promising opportunity for the treatment of this infection.	[Bonfim, Amanda Pohlmann; Sakita, Karina Mayumi; Faria, Daniella Renata; Arita, Glaucia Sayuri; Vilugron Rodrigues Vendramini, Franciele Abigail; Grenier Capoci, Isis Regina; Braga, Andressa Gimenes; Kioshima, Erika Seki; Bonfim-Mendonca, Patricia de Souza; Estivalet Svidzinski, Terezinha Inez] Univ Estadual Maringa, Clin Anal & Biomed Dept, Med Mycol Lab, Maringa, Parana, Brazil; [dos Santos, Rafaela Said; Bruschi, Marcos Luciano] Univ Estadual Maringa, Dept Pharm, Maringa, Parana, Brazil; [Alexandrino Becker, Tania Cristina] Univ Estadual Maringa, Hlth Basic Sci Dept, Gen Pathol Lab, Maringa, Parana, Brazil; [de Oliveira Junior, Admilton Goncalves] Univ Estadual Londrina, Electron Microscopy & Microanal Lab, Londrina, Parana, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Maringa; Universidade Estadual de Maringa; Universidade Estadual de Londrina	Svidzinski, TIE (corresponding author), Univ Estadual Maringa, Clin Anal & Biomed Dept, Med Mycol Lab, Maringa, Parana, Brazil.	tiesvidzinski@uem.br	Bruschi, Marcos Luciano/J-1871-2012	Bruschi, Marcos Luciano/0000-0002-4838-5742; Arita, Glaucia Sayuri/0000-0002-0334-7566; Sakita, Karina/0000-0003-2899-2657	Laboratory of Medical Mycology and Laboratory of Research and Development of Drug Delivery Systems of Universidade Estadual de Maringa	Laboratory of Medical Mycology and Laboratory of Research and Development of Drug Delivery Systems of Universidade Estadual de Maringa	This study was supported by efforts from the Laboratory of Medical Mycology and Laboratory of Research and Development of Drug Delivery Systems of Universidade Estadual de Maringa, with own resources.	Andrews GP, 2009, EUR J PHARM BIOPHARM, V71, P505, DOI 10.1016/j.ejpb.2008.09.028; [Anonymous], 2015, AM J KIDNEY DIS, V66, pS79; [Anonymous], 2015, US PHARM CONV; Berretta AA, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/641480; Bruschi ML, 2007, J PHARM SCI-US, V96, P2074, DOI 10.1002/jps.20843; Bruschi Marcos Luciano, 2006, Rev. Bras. Cienc. Farm., V42, P29, DOI 10.1590/S1516-93322006000100004; Carvalho FC, 2013, DRUG DEV IND PHARM, V39, P1750, DOI 10.3109/03639045.2012.734510; Choi HG, 1999, INT J PHARM, V190, P13, DOI 10.1016/S0378-5173(99)00225-2; Clinical and Laboratory Standards Institute, 2008, M38A2 CLSI; CLSI, 2008, M27A3 CLSI; Dalben-Dota KF, 2010, J ALTERN COMPLEM MED, V16, P285, DOI 10.1089/acm.2009.0281; Pereira RRD, 2013, J PHARM SCI-US, V102, P1222, DOI 10.1002/jps.23451; de Oliveira AG, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00113; Ferreira SBD, 2016, J MECH BEHAV BIOMED, V55, P164, DOI 10.1016/j.jmbbm.2015.10.026; Fan SR, 2015, GYNECOL OBSTET INVES, V80, P113, DOI 10.1159/000371759; Fatahinia M, 2012, J MYCOL MED, V22, P237, DOI 10.1016/j.mycmed.2012.05.004; Fidel PL, 1997, ANTIMICROB AGENTS CH, V41, P1455, DOI 10.1128/AAC.41.7.1455; Foxman B, 2013, J LOW GENIT TRACT DI, V17, P340, DOI 10.1097/LGT.0b013e318273e8cf; Capoci IRG, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/287693; Guinea J, 2014, CLIN MICROBIOL INFEC, V20, P5, DOI 10.1111/1469-0691.12539; HEMPHILL T, 1993, OIL GAS J, V91, P45; Hiller E, 2011, INT J MED MICROBIOL, V301, P384, DOI 10.1016/j.ijmm.2011.04.004; Hosnuter M, 2004, BURNS, V30, P121, DOI 10.1016/j.burns.2003.09.022; HUPPERT M, 1978, J CLIN MICROBIOL, V8, P598; Ilkit M, 2011, CRIT REV MICROBIOL, V37, P250, DOI 10.3109/1040841X.2011.576332; Institute of Laboratory Animal Resources (US). Committee on Care Use of Laboratory Animals & National Institutes of Health (US). Division of Research Resources., 1985, GUIDE CARE USE LAB A; Jastrzebska-Stojko Z, 2013, MOLECULES, V18, P14397, DOI 10.3390/molecules181114397; Jones DS, 2009, INT J PHARMACEUT, V372, P49, DOI 10.1016/j.ijpharm.2009.01.006; Khosravi A R, 2014, J Mycol Med, V24, pe143, DOI 10.1016/j.mycmed.2014.05.002; Marchaim D, 2012, OBSTET GYNECOL, V120, P1407, DOI [10.1097/AOG.0b013e31827307b2, http://10.1097/AOG.0b013e31827307b2]; Naglik JR, 2003, MICROBIOL MOL BIOL R, V67, P400, DOI 10.1128/MMBR.67.3.400-428.2003; Nash EE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147969; Olczyk P, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/290675; Oryan A, 2018, BIOMED PHARMACOTHER, V98, P469, DOI 10.1016/j.biopha.2017.12.069; Perea S, 2001, ANTIMICROB AGENTS CH, V45, P2676, DOI 10.1128/AAC.45.10.2676-2684.2001; Pfaller MA, 2004, J CLIN MICROBIOL, V42, P4419, DOI 10.1128/JCM.42.10.4419-4431.2004; Rocha BA, 2012, J THERM ANAL CALORIM, V108, P87, DOI 10.1007/s10973-011-1713-4; Sobel JD, 2014, PATIENT PREFER ADHER, V8, P31, DOI 10.2147/PPA.S38984; Swiss Re Report, 2018, SIGMA, V3148; Tobaldini-Valerio FK, 2016, FUTURE MICROBIOL, V11, P1035, DOI 10.2217/fmb-2015-0016; Pessolato AGT, 2011, BURNS, V37, P1192, DOI 10.1016/j.burns.2011.05.016; Veiga FF, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00779; Volpi N, 2006, J PHARMACEUT BIOMED, V42, P354, DOI 10.1016/j.jpba.2006.04.017; Xuan HZ, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/280120; Yano J, 2011, JOVE-J VIS EXP, DOI 10.3791/3382	45	6	6	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243197	10.1371/journal.pone.0243197	http://dx.doi.org/10.1371/journal.pone.0243197			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306677	gold, Green Published			2022-12-27	WOS:000600144200030
J	Mesa-Varona, O; Kaspar, H; Grobbel, M; Tenhagen, BA				Mesa-Varona, Octavio; Kaspar, Heike; Grobbel, Mirjam; Tenhagen, Bernd-Alois			Phenotypical antimicrobial resistance data of clinical and non-clinical Escherichia coli from poultry in Germany between 2014 and 2017	PLOS ONE			English	Article							FLUOROQUINOLONE RESISTANCE; BROILER-CHICKENS; ANIMALS; GENES	Antimicrobial resistance (AMR) is a global threat in humans and animals, and antimicrobial usage (AMU) has been identified as a main trigger of AMR. The purpose of this work was to compare data on AMR in clinical and non-clinical isolates of Escherichia coli in German broilers and turkeys between 2014 and 2017. Furthermore, we investigated AMR changes over time and the association of changes in AMU with changes in AMR. Data on clinical and non-clinical isolates together with data on therapy frequency of broilers and turkeys were collected from German monitoring systems. Logistic regression analyses were performed to assess the association between the explanatory factors (AMU, year and isolate type) and the dependent variable (AMR). In broilers, the analysis showed lower resistance proportions of clinical isolates of E. coli to ampicillin and colistin (ampicillin: Odds ratio (OR) and 95% confidence interval (CI) = 0.44 (0.3-0.64), p<0.001; colistin: OR and 95% CI = 0.75 (0.73-0.76), p<0.001) but higher proportions for cefotaxime (OR and 95% CI = 4.58 (1.56-15.1), p = 0.007). Resistance to ampicillin, gentamicin and tetracycline was less frequent in clinical isolates in turkeys (ampicillin: OR and 95% CI = 0.4 (0.29-0.53), p<0.001; gentamicin: OR and 95% CI = 0.5 (0.26-0.94), p = 0.035; tetracycline: OR and 95% CI = 0.4 (0.29-0.55), p<0.001). The analysis found decreasing associations of AMU with resistance to tetracycline in turkeys and to colistin in broilers. Year was associated with a decrease in resistance to colistin in broilers and to tetracycline in turkeys. Differences in resistance found in this study between clinical and non-clinical isolates might play an important role in resistance prevalence. This study indicated that further data analyses over longer time intervals are required to clarify the differences found between clinical and non-clinical isolates and to assess the long-term effects of changes in AMU on the prevalence of AMR.	[Mesa-Varona, Octavio; Grobbel, Mirjam; Tenhagen, Bernd-Alois] German Fed Inst Risk Assessment, Dept Biol Safety, Berlin, Germany; [Kaspar, Heike] Resistance Antibiot, Dept Method Standardisat, Reference Labs, Berlin, Germany; [Kaspar, Heike] Fed Off Consumer Protect & Food Safety, Unit Monitoring Resistance Antibiot, Berlin, Germany	Federal Institute for Risk Assessment	Mesa-Varona, O (corresponding author), German Fed Inst Risk Assessment, Dept Biol Safety, Berlin, Germany.	Octavio.Mesa-Varona@bfr.bund.de	Grobbel, Mirjam/AAP-2541-2021; Grobbel, Mirjam/B-3928-2010	Grobbel, Mirjam/0000-0002-8619-1498; Mesa-Varona, Octavio/0000-0001-7519-6931	European Union [773830]	European Union(European Commission)	Mesa-Varona O. This work was carried out within the framework of the ARDIG project, the European Joint Programme (EJP) on AMU and AMR in humans, food and animals. ARDIG project has received funding from the European Union's Horizon 2020 research and innovation programme under Grant Agreement No 773830. URL: https://ec.europa.eu/programmes/horizon2020/en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasmae B, 2019, ACTA VET SCAND, V61, DOI 10.1186/s13028-019-0441-9; Agunos A, 2019, FRONT VET SCI, V6, DOI 10.3389/fvets.2019.00131; Agyare C., 2018, INTECHOPEN; ALBERT A, 1984, BIOMETRIKA, V71, P1; Amer MM, 2018, VET WORLD, V11, P1082, DOI 10.14202/vetworld.2018.1082-1088; Association of Poultry Processors and Poultry Trade in the EU Countries, 2019, AVEC VOIC EUR S POUL; Bundesamt fur Verbarucherschutz und Lebensmittelsicherheit (BVL), ZOON MON; Bundesamt fur Verbraucherschutz und Lebensmittelsicherkeit (BVL), 2018, BER GERM VET MON PRO; Burow E, 2017, MICROB DRUG RESIST, V23, P194, DOI 10.1089/mdr.2015.0318; Cameron A, 2016, J ANIM SCI BIOTECHNO, V7, DOI 10.1186/s40104-016-0127-3; Caucci C, 2019, J ANTIMICROB CHEMOTH, V74, P2784, DOI 10.1093/jac/dkz212; Ceccarelli D, 2020, J MED MICROBIOL, V69, P537, DOI 10.1099/jmm.0.001176; Chantziaras I, 2014, J ANTIMICROB CHEMOTH, V69, P827, DOI 10.1093/jac/dkt443; Cheng AC, 2012, EMERG INFECT DIS, V18, P1453, DOI 10.3201/eid1809.111515; DANMAP, 2017, US ANT AG OCC ANT RE; Djordjevic SP, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00086; EFSA, 2017, EUR UN SUMM REP ANT; El Garch F, 2016, VET MICROBIOL, V194, P11, DOI 10.1016/j.vetmic.2016.04.009; Elmofti H, 2019, ACTA SCI NUTR HLTH; Enli L, 2019, ANTIMICROBIAL USAGE; European Commission, EUR ON HLTH ACT PLAN; European Food Safety Authority (EFSA), 2020, EFSA J, DOI [10.2903/j.efsa.2020.6007, DOI 10.2903/J.EFSA.2020.600732874244]; European Food Safety Authority (EFSA), 2018, 5182 EFSA; European Food Safety Authority (EFSA), 2019, 5598 EFSA; European Food Safety Authority (EFSA), 2016, 4380 EFSA; European Food Safety Authority (EFSA), 2018, 5500 EFSA; European Medicines Agency (EMA), JIACRA REP; European Medicines Agency (EMA), 2019, EUR SURV VET ANT CON; FIRTH D, 1993, BIOMETRIKA, V80, P27, DOI 10.1093/biomet/80.1.27; French Agency for Food Environmental and Occupational Health & Safety (ANSES)-French Agency for Veterinary Medicinal Products (ANMV), 2019, SAL SURV VET MED PRO; Ibrahim RA, 2019, BMC VET RES, V15, DOI 10.1186/s12917-019-1901-1; Irrgang A, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02256; Irrgang A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159863; Koper LM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237459; Landers TF, 2012, PUBLIC HEALTH REP, V127, P4, DOI 10.1177/003335491212700103; Luiken REC, 2019, J ANTIMICROB CHEMOTH, V74, P2596, DOI 10.1093/jac/dkz235; Manishimwe R., 2017, Revue d'Elevage et de Medecine Veterinaire des Pays Tropicaux, V70, P13, DOI 10.19182/remvt.31392; MARAN, 2018, MON ANT RES ANT US A; Mihai FC, 2019, ELECTRONIC WASTE MANAGEMENT AND TREATMENT TECHNOLOGY, P1, DOI 10.1016/B978-0-12-816190-6.00001-7; Nhung NT, 2016, ANTIBIOTICS-BASEL, V5, DOI 10.3390/antibiotics5040037; Projahn M, 2018, MICROB BIOTECHNOL, V11, P1017, DOI 10.1111/1751-7915.13040; Projahn M, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.02364-16; Public Health Agency of Sweden & National Veterinary Institute, 2019, SAL ANT OCC ANT RES; QS, LEIFT KONTR ANT MAST; Reygaert WC, 2018, AIMS MICROBIOL, V4, P482, DOI 10.3934/microbiol.2018.3.482; Roca I., 2015, New Microbes and New Infections, V6, P22, DOI 10.1016/j.nmni.2015.02.007; Roth N, 2019, POULTRY SCI, V98, P1791, DOI 10.3382/ps/pey539; Schrijver R, 2018, CLIN MICROBIOL INFEC, V24, P577, DOI 10.1016/j.cmi.2017.09.013; Schulz J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41528-z; Sciberras M., 2019, Folia Veterinaria, V63, P1; SDa, 2017, US ANT AGR LIV NETH; Suzuki K, 2019, JPN J INFECT DIS, V72, P179, DOI 10.7883/yoken.JJID.2018.277; Taylor NM, 2016, AVIAN PATHOL, V45, P559, DOI 10.1080/03079457.2016.1185510; Valentin L, 2014, INT J MED MICROBIOL, V304, P805, DOI 10.1016/j.ijmm.2014.07.015; Van Boeckel TP, 2015, P NATL ACAD SCI USA, V112, P5649, DOI 10.1073/pnas.1503141112; Varga C, 2019, BMC VET RES, V15, DOI 10.1186/s12917-019-2187-z; Varga C, 2018, AVIAN DIS, V62, P291, DOI 10.1637/11834-032818-Reg.1; Varona OM, 2020, INFECT DRUG RESIST, V13, P957, DOI 10.2147/IDR.S237038; VMD, 2019, UK VET ANT RES SAL S; Williams HE, 2018, J ANIM SCI, V96, P5166, DOI 10.1093/jas/sky370; World Health Organization, GLOB ACT PLAN ANT RE	61	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243772	10.1371/journal.pone.0243772	http://dx.doi.org/10.1371/journal.pone.0243772			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306730	Green Published, gold			2022-12-27	WOS:000600144200064
J	Goad, J; Rudolph, J; Rajkovic, A				Goad, Jyoti; Rudolph, Joshua; Rajkovic, Aleksandar			Female reproductive tract has low concentration of SARS-CoV2 receptors	PLOS ONE			English	Article								There has been significant concern regarding fertility and reproductive outcomes during the SARS-CoV2 pandemic. Recent data suggests a high concentration of SARS-Cov2 receptors, ACE2 or TMPRSS2, in nasal epithelium and cornea, which explains person-to-person transmission. We investigated the prevalence of SARS-CoV2 receptors among reproductive tissues by exploring the single-cell sequencing datasets from uterus, myometrium, ovary, fallopian tube, and breast epithelium. We did not detect significant expression of either ACE2 or TMPRSS2 in the normal human myometrium, uterus, ovaries, fallopian tube, or breast. Furthermore, none of the cell types in the female reproductive organs we investigated, showed the co-expression of ACE2 with proteases, TMPRSS2, Cathepsin B (CTSB), and Cathepsin L (CTSL) known to facilitate the entry of SARS2-CoV2 into the host cell. These results suggest that myometrium, uterus, ovaries, fallopian tube, and breast are unlikely to be susceptible to infection by SARS-CoV2.	[Goad, Jyoti; Rajkovic, Aleksandar] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Goad, Jyoti; Rajkovic, Aleksandar] Univ Calif San Francisco, Dept OB GYN, San Francisco, CA 94143 USA; [Rudolph, Joshua] Univ Calif San Francisco, Dept Med, Lung Biol Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Rajkovic, A (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA.; Rajkovic, A (corresponding author), Univ Calif San Francisco, Dept OB GYN, San Francisco, CA 94143 USA.	aleks.rajkovic@ucsf.edu		Goad, Jyoti/0000-0002-1661-1936	AR-National Institute of Child Health and Human Development [5P50HD098580]	AR-National Institute of Child Health and Human Development	AR-National Institute of Child Health and Human Development (5P50HD098580). https://www.nichd.nih.gov The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432; Ahlberg M, 2020, JAMA-J AM MED ASSOC, V324, P1782, DOI 10.1001/jama.2020.19124; [Anonymous], 2020, Circulation, V141, pe33, DOI 10.1161/CIR.0000000000000746; Baud D, 2020, JAMA-J AM MED ASSOC, V323, P2198, DOI 10.1001/jama.2020.7233; Chambers Christina D, 2020, medRxiv, DOI 10.1101/2020.06.12.20127944; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Connors JM, 2020, BLOOD, V135, P2033, DOI 10.1182/blood.2020006000; Deb S, 2020, LANCET GLOB HEALTH, V8, pE545, DOI 10.1016/S2214-109X(20)30034-6; Fung TS, 2019, ANNU REV MICROBIOL, V73, P529, DOI 10.1146/annurev-micro-020518-115759; Han XP, 2020, NATURE, V581, P303, DOI 10.1038/s41586-020-2157-4; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hu ZY, 2020, CANCER CELL, V37, P226, DOI 10.1016/j.ccell.2020.01.003; Iwata-Yoshikawa N, 2019, J VIROL, V93, DOI 10.1128/JVI.01815-18; Li MM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230295; Mullins E, 2020, ULTRASOUND OBST GYN, V55, P586, DOI 10.1002/uog.22014; Nguyen QH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04334-1; Wagner M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14936-3; Younes M, 2019, EFSA J, V17, DOI 10.2903/j.efsa.2019.5674	18	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243959	10.1371/journal.pone.0243959	http://dx.doi.org/10.1371/journal.pone.0243959			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	32607512	gold, Green Submitted, Green Published			2022-12-27	WOS:000600186100075
J	Marcello, RK; Dolle, J; Grami, S; Adule, R; Li, ZY; Tatem, K; Anyaogu, C; Apfelroth, S; Ayinla, R; Boma, N; Brady, T; Cosme-Thormann, BF; Costarella, R; Ford, K; Gaither, K; Jacobson, J; Kanter, M; Kessler, S; Kristal, RB; Lieber, JJ; Mukherjee, V; Rizzo, V; Rowell, M; Stevens, D; Sydney, E; Wallach, A; Chokshi, DA; Davis, N				Kalyanaraman Marcello, Roopa; Dolle, Johanna; Grami, Sheila; Adule, Richard; Li, Zeyu; Tatem, Kathleen; Anyaogu, Chinyere; Apfelroth, Stephen; Ayinla, Raji; Boma, Noella; Brady, Terence; Cosme-Thormann, Braulio F.; Costarella, Roseann; Ford, Kenra; Gaither, Kecia; Jacobson, Jessica; Kanter, Marc; Kessler, Stuart; Kristal, Ross B.; Lieber, Joseph J.; Mukherjee, Vikramjit; Rizzo, Vincent; Rowell, Madden; Stevens, David; Sydney, Elana; Wallach, Andrew; Chokshi, Dave A.; Davis, Nichola		New York City Hlth Hosp COVID	Characteristics and outcomes of COVID-19 patients in New York City's public hospital system	PLOS ONE			English	Article								Background New York City (NYC) bore the greatest burden of COVID-19 in the United States early in the pandemic. In this case series, we describe characteristics and outcomes of racially and ethnically diverse patients tested for and hospitalized with COVID-19 in New York City's public hospital system. Methods We reviewed the electronic health records of all patients who received a SARS-CoV-2 test between March 5 and April 9, 2020, with follow up through April 16, 2020. The primary outcomes were a positive test, hospitalization, and death. Demographics and comorbidities were also assessed. Results 22254 patients were tested for SARS-CoV-2. 13442 (61%) were positive; among those, the median age was 52.7 years (interquartile range [IQR] 39.5-64.5), 7481 (56%) were male, 3518 (26%) were Black, and 4593 (34%) were Hispanic. Nearly half (4669, 46%) had at least one chronic disease (27% diabetes, 30% hypertension, and 21% cardiovascular disease). Of those testing positive, 6248 (46%) were hospitalized. The median age was 61.6 years (IQR 49.7-72.9); 3851 (62%) were male, 1950 (31%) were Black, and 2102 (34%) were Hispanic. More than half (3269, 53%) had at least one chronic disease (33% diabetes, 37% hypertension, 24% cardiovascular disease, 11% chronic kidney disease). 1724 (28%) hospitalized patients died. The median age was 71.0 years (IQR 60.0, 80.9); 1087 (63%) were male, 506 (29%) were Black, and 528 (31%) were Hispanic. Chronic diseases were common (35% diabetes, 37% hypertension, 28% cardiovascular disease, 15% chronic kidney disease). Male sex, older age, diabetes, cardiac history, and chronic kidney disease were significantly associated with testing positive, hospitalization, and death. Racial/ethnic disparities were observed across all outcomes. Conclusions and relevance This is the largest and most racially/ethnically diverse case series of patients tested and hospitalized for COVID-19 in New York City to date. Our findings highlight disparities in outcomes that can inform prevention and testing recommendations.	[Kalyanaraman Marcello, Roopa; Dolle, Johanna; Grami, Sheila; Adule, Richard; Li, Zeyu; Tatem, Kathleen; Chokshi, Dave A.; Davis, Nichola] New York City Hlth Hosp, Off Populat Hlth, New York, NY USA; [Anyaogu, Chinyere] New York City Hlth Hosp, North Cent Bronx, New York, NY USA; [Apfelroth, Stephen; Sydney, Elana] New York City Hlth Hosp Jacobi, New York, NY USA; [Ayinla, Raji] New York City Hlth Hosp Harlem, New York, NY USA; [Boma, Noella] New York City Hlth Hosp Metropolitan, New York, NY USA; [Brady, Terence] New York City Hlth Hosp Coney Isl, New York, NY USA; [Cosme-Thormann, Braulio F.] New York City Hlth Hosp Woodhull, New York, NY USA; [Costarella, Roseann; Ford, Kenra] New York City Hlth Hosp, Off Med & Profess Affairs, New York, NY USA; [Gaither, Kecia; Kanter, Marc] New York City Hlth Hosp Lincoln, New York, NY USA; [Jacobson, Jessica; Mukherjee, Vikramjit] New York City Hlth Hosp Bellevue, New York, NY USA; [Kessler, Stuart; Lieber, Joseph J.] New York City Hlth Hosp Elmhurst, New York, NY USA; [Kristal, Ross B.; Rowell, Madden; Wallach, Andrew] New York City Hlth Hosp, Off Ambulatory Care, New York, NY USA; [Rizzo, Vincent] New York City Hlth Hosp Queens, New York, NY USA; [Stevens, David] New York City Hlth Hosp Kings Cty, New York, NY USA		Marcello, RK (corresponding author), New York City Hlth Hosp, Off Populat Hlth, New York, NY USA.	marcellr@nychhc.org	Li, Zeyu/GXM-4336-2022	Stevens, David/0000-0002-8214-4221; Chokshi, Dave/0000-0001-7467-4591; Wallach, Andrew/0000-0003-4791-2376; Jacobson, Jessica/0000-0001-8847-2763; Li, Zeyu/0000-0002-3306-4348; Kalyanaraman Marcello, Roopa/0000-0002-5348-1990; Apfelroth, Stephen/0000-0002-0581-3006	Clinical & Translational Science Award from the National Institutes of Health [UL1TR001445]	Clinical & Translational Science Award from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded in part by the Clinical & Translational Science Award grant #UL1TR001445 from the National Institutes of Health. (RKM, JD). The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. There was no additional external funding received for this study.	Chow N, 2020, MMWR-MORBID MORTAL W, V69, P382, DOI 10.15585/mmwr.mm6913e2; Cumming MJ, 2020, EPIDEMIOLOGY CLIN CO, DOI [10.1101/2020.04.15.20067157, DOI 10.1101/2020.04.15.20067157]; Dhama K, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00028-20; Goyal P, 2020, NEW ENGL J MED, V382, P2372, DOI 10.1056/NEJMc2010419; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Halpin DMG, 2020, LANCET RESP MED, V8, P436, DOI 10.1016/S2213-2600(20)30167-3; Lighter J, 2020, CLIN INFECT DIS, V71, P896, DOI 10.1093/cid/ciaa415; New York City Department of Health and Mental Hygiene, COVID 19 DAT; New York City Department of Health and Mental Hygiene (NYC DOHMH), 2020, 2020 ADV 8 COVID 19; Nobel YR, 2020, GASTROENTEROLOGY, V159, P373, DOI 10.1053/j.gastro.2020.04.017; NYC DOHMH, 2020, AG ADJ RAT LAB CONF; NYC DOHMH, NYC HLTH DAT EPIQUER; NYC DOHMH, 2020, AG ADJ RAT LAB CONF; NYC H+H, NEW COR TEST GUID; Paranjpe Ishan, 2020, medRxiv, DOI 10.1101/2020.04.19.20062117; Petrilli CM, 2020, FACTORS ASS HOSPITAL, V2020, P4, DOI [DOI 10.1101/2020.04.08.20057794, 10.1101/2020.04.08.20057794, DOI 10.1136/BMJ.M1966]; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; U.S. Census Bureau, 2019, QUICK FACTS NEW YORK; U.S. Census Bureau, 2019, QUICK FACTS NEW YORK; van Dorn A, 2020, LANCET, V395, P1243, DOI 10.1016/S0140-6736(20)30893-X; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; Wang Z, 2020, ANAL HOSPITALIZED CO, DOI [10.1101/2020.04.28.20075788, DOI 10.1101/2020.04.28.20075788]; Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994	23	54	55	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2020	15	12							e0243027	10.1371/journal.pone.0243027	http://dx.doi.org/10.1371/journal.pone.0243027			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8BZ	32577680	Green Published, gold			2022-12-27	WOS:000601310900004
